Mammalian Phenotype Ontology Annotations

Mammalian Phenotype Ontology Annotations
Query Results - Summary

13777 genotypes with 43937 annotations displayed of selected term and subterms
Searched Term: hematopoietic system phenotype
Allelic Composition (Genetic Background)	Annotated Term	Reference
0610040J01Rik^{em1(IMPC)Ccpcz}/0610040J01Rik^{em1(IMPC)Ccpcz} (C57BL/6NCrl-0610040J01Rik^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	small spleen	J:211773
1700008O03Rik^{tm1a(KOMP)Wtsi}/1700008O03Rik^{tm1a(KOMP)Wtsi} (C57BL/6N-1700008O03Rik^{tm1a(KOMP)Wtsi}/Wtsi)	increased hematocrit	J:211773
1700016L21Rik^{Tg(Itgax-HBEGF/EGFP)57Lan}/0 (C.FVB-1700016L21Rik^{Tg(Itgax-HBEGF/EGFP)57Lan})	abnormal CD8-positive, alpha-beta T cell differentiation	J:93488
	abnormal T cell activation	J:93488
	decreased CD8-positive, alpha-beta T cell number	J:93488
	decreased cytotoxic T cell cytolysis	J:93488
	decreased dendritic cell number	J:93488
	increased neutrophil cell number	J:194800
1700016L21Rik^{Tg(Itgax-HBEGF/EGFP)57Lan}/0 (B6.FVB-1700016L21Rik^{Tg(Itgax-HBEGF/EGFP)57Lan}/J)	abnormal NK cell physiology	J:96123
	abnormal NK T cell physiology	J:96123
	decreased dendritic cell number	J:100867, J:113232, J:96123
	impaired natural killer cell mediated cytotoxicity	J:125611
1700016L21Rik^{Tg(Itgax-HBEGF/EGFP)57Lan}/0 (C.FVB-1700016L21Rik^{Tg(Itgax-HBEGF/EGFP)57Lan}/J)	abnormal NK cell physiology	J:96123
	decreased dendritic cell number	J:96123
1700016L21Rik^{Tg(Itgax-HBEGF/EGFP)57Lan}/0 (involves: C57BL/6 * FVB/N)	abnormal alveolar macrophage morphology	J:137452
	decreased dendritic cell number	J:137452
1700016L21Rik^{Tg(Itgax-HBEGF/EGFP)57Lan}/0 (NOD.FVB-1700016L21Rik^{Tg(Itgax-HBEGF/EGFP)57Lan}/Jdk)	decreased dendritic cell number	J:137009
	decreased macrophage cell number	J:137009
	decreased NK T cell number	J:137009
1700016L21Rik^{Tg(Itgax-HBEGF/EGFP)57Lan}/0 (involves: FVB/N)	decreased gamma-delta T cell number	J:193548
	decreased leukocyte cell number	J:193548
	decreased neutrophil cell number	J:193548
	decreased T cell number	J:193548
1700016L21Rik^{Tg(Itgax-HBEGF/EGFP)57Lan}/0 (B6.FVB-1700016L21Rik^{Tg(Itgax-HBEGF/EGFP)57Lan})	decreased dendritic cell number	J:194800
	decreased neutrophil cell number	J:194800
	impaired neutrophil recruitment	J:194800
	increased monocyte cell number	J:194800
	increased neutrophil cell number	J:194800
1700019D03Rik^{tm1.1(NCOM)Mfgc}/1700019D03Rik^{tm1.1(NCOM)Mfgc} (C57BL/6N-1700019D03Rik^{tm1.1(NCOM)Mfgc}/Tcp)	decreased mean corpuscular hemoglobin	J:211773
	thrombocytosis	J:211773
1700025G04Rik^em1(IMPC)Mbp/1700025G04Rik^em1(IMPC)Mbp (C57BL/6NCrl-1700025G04Rik^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased mean corpuscular volume	J:211773
	increased red blood cell distribution width	J:211773
1700034E13Rik^em1(IMPC)Mbp/1700034E13Rik^em1(IMPC)Mbp (C57BL/6NCrl-1700034E13Rik^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
1700069L16Rik^em1(IMPC)Mbp/1700069L16Rik^em1(IMPC)Mbp (C57BL/6NCrl-1700069L16Rik^em1(IMPC)Mbp/Mmucd)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
2310022B05Rik^{tm1a(EUCOMM)Hmgu}/2310022B05Rik^{tm1a(EUCOMM)Hmgu} (C57BL/6N-2310022B05Rik^{tm1a(EUCOMM)Hmgu}/H)	increased B cell number	J:165965
	increased leukocyte cell number	J:165965
2810408A11Rik^{tm1a(EUCOMM)Wtsi}/2810408A11Rik^{tm1a(EUCOMM)Wtsi} (C57BL/6N-2810408A11Rik^{tm1a(EUCOMM)Wtsi}/H)	decreased NK cell number	J:165965
	increased CD4-positive, alpha-beta T cell number	J:165965
	increased NK cell number	J:165965
3425401B19Rik^{em2(IMPC)Ccpcz}/3425401B19Rik^{em2(IMPC)Ccpcz} (C57BL/6NCrl-3425401B19Rik^{em2(IMPC)Ccpcz}/Ph)	increased effector memory T-helper cell number	J:211773
	increased eosinophil cell number	J:211773
4921509C19Rik^{tm1.1(KOMP)Vlcg}/4921509C19Rik^{tm1.1(KOMP)Vlcg} (B6N(Cg)-4921509C19Rik^{tm1.1(KOMP)Vlcg}/J)	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular hemoglobin concentration	J:211773
4930404H24Rik^{tm1a(KOMP)Wtsi}/4930404H24Rik^{tm1a(KOMP)Wtsi} (C57BL/6N-4930404H24Rik^{tm1a(KOMP)Wtsi}/Wtsi)	increased mean platelet volume	J:211773
4930591A17Rik^{tm1a(KOMP)Wtsi}/4930591A17Rik^{tm1a(KOMP)Wtsi} (C57BL/6N-4930591A17Rik^{tm1a(KOMP)Wtsi}/Wtsi)	increased red blood cell distribution width	J:211773
4933402N03Rik^{tm2a(KOMP)Wtsi}/4933402N03Rik^{tm2a(KOMP)Wtsi} (C57BL/6N-4933402N03Rik^{tm2a(KOMP)Wtsi}/Wtsi)	increased red blood cell distribution width	J:211773
4933430I17Rik^{tm1a(EUCOMM)Wtsi}/4933430I17Rik^{tm1a(EUCOMM)Wtsi} (C57BL/6N-4933430I17Rik^{tm1a(EUCOMM)Wtsi}/Ics)	increased mean corpuscular volume	J:211773
9430015G10Rik^tm1Lex/9430015G10Rik^tm1Lex (B6;129S5-9430015G10Rik^tm1Lex/Mmucd)	decreased CD4-positive, alpha-beta T cell number	J:171883
	increased B cell number	J:171883
a/a Hps6^ru/Hps6^ru (B6.Cg-Hps6^ru)	decreased platelet ADP level	J:7327
	decreased platelet ATP level	J:7327
	decreased platelet dense granule number	J:7327
	decreased platelet serotonin level	J:7327, J:29748
a/a Rab27a^ash/Rab27a^ash (involves: C3H/HeSnJ * C57BL/6J)	decreased platelet serotonin level	J:77395
a/a Rab27a^ash/Rab27a^ash (involves: C3H/HeSnJ * C57BL/6J)	hematopoietic system phenotype	J:77395
A1cf^{tm1b(EUCOMM)Hmgu}/A1cf^{tm1b(EUCOMM)Hmgu} (B6N(Cg)-A1cf^{tm1b(EUCOMM)Hmgu}/J)	increased mean corpuscular hemoglobin	J:211773
A2ml1^em1(IMPC)Tcp/A2ml1⁺ (C57BL/6N-A2ml1^em1(IMPC)Tcp/Tcp)	abnormal spleen morphology	J:211773
A2ml1^em1(IMPC)Tcp/A2ml1^em1(IMPC)Tcp (C57BL/6N-A2ml1^em1(IMPC)Tcp/Tcp)	abnormal spleen morphology	J:211773
A930024E05Rik^em2Zfa/A930024E05Rik^em2Zfa Bptf^em1Zfa/Bptf^em1Zfa Satb1^em1Zfa/Satb1^em1Zfa Tg(Rorc-cre)1Litt/0 (involves: C57BL/6 * FVB)	decreased common lymphocyte progenitor cell number	J:259392
A930024E05Rik^em2Zfa/A930024E05Rik^em2Zfa Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: C57BL/6 * C57BL/10 * CBA/Ca)	decreased common lymphocyte progenitor cell number	J:259392
A930024E05Rik^em2Zfa/A930024E05Rik^em2Zfa Satb1^em1Zfa/Satb1^em1Zfa Tg(Rorc-cre)1Litt/0 (involves: C57BL/6 * FVB)	decreased common lymphocyte progenitor cell number	J:259392
A930024E05Rik^em2Zfa/A930024E05Rik^em2Zfa Tg(Rorc-cre)1Litt/0 (involves: C57BL/6 * FVB)	decreased common lymphocyte progenitor cell number	J:259392
A^tm1Brd/A^tm1Brd Ypel4^{tm1a(EUCOMM)Wtsi}/Ypel4^{tm1a(EUCOMM)Wtsi} (C57BL/6N-A^tm1Brd Ypel4^{tm1a(EUCOMM)Wtsi}/WtsiIeg)	abnormal red blood cell deformability	J:313842
	anisocytosis	J:313842
	elliptocytosis	J:313842
	hematopoietic system phenotype	J:313842
	increased hematocrit	J:313842
	increased mean corpuscular volume	J:313842
	macrocytosis	J:313842
	polycythemia	J:313842
	reticulocytosis	J:313842
A^y/a Apoe^tm1Unc/Apoe^tm1Unc (involves: 129P2/OlaHsd * C57BL/6J * KK/TaJcl)	increased monocyte cell number	J:177084
Aabpr^NZB/Slc/? (involves: NZB/Slc * NZW/Slc)	increased B cell proliferation	J:87690
Aadac^em1(IMPC)Mbp/Aadac^em1(IMPC)Mbp (C57BL/6NCrl-Aadac^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	small thymus	J:211773
Aars2^{tm1(KOMP)Wtsi}/Aars2⁺ (C57BL/6N-Aars2^{tm1(KOMP)Wtsi}/Nju)	decreased red blood cell distribution width	J:211773
	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
	increased neutrophil cell number	J:211773
Abca1^tm1Blt/Abca1^tm1Blt (C57BL/6-Abca1^tm1Blt)	abnormal platelet physiology	J:95088
Abca1^tm1Jdm/Abca1^tm1Jdm (DBA/1LacJ-Abca1^tm1Jdm)	enlarged spleen	J:60210
	impaired macrophage phagocytosis	J:63265
	thrombocytopenia	J:60210
Abca1^tm1Jdm/Abca1^tm1Jdm (involves: C57BL/6 * DBA/1LacJ)	abnormal thymus morphology	J:132254
Abca1^tm1Jdm/Abca1^tm1Jdm (involves: C57BL/6 * DBA/1LacJ)	impaired macrophage phagocytosis	J:132254
Abca1^tm1Jdm/Abca1^tm1Jdm Abcg1^tm1Dgen/Abcg1^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6 * DBA * DBA/1LacJ)	abnormal bone marrow cell morphology/development	J:190966
	abnormal common myeloid progenitor cell morphology	J:190966
	abnormal hematopoietic system physiology	J:190966
	decreased monocyte cell number	J:190966
	extramedullary hematopoiesis	J:190966
	increased hematopoietic stem cell number	J:190966
	increased monocyte cell number	J:190966
	increased neutrophil cell number	J:190966
Abca1^tm1Jdm/Abca1^tm1Jdm Abcg1^tm1Dgen/Abcg1^tm1Dgen Apoe^tm1Unc/Apoe^tm1Unc (involves: 129P2/OlaHsd * C57BL/6 * DBA * DBA/1LacJ)	abnormal hematopoietic system physiology	J:190966
Abca1^tm1Jdm/Abca1^tm1Jdm Abcg1^tm1Dgen/Abcg1^tm1Dgen Tg(APOA1)1Rub/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA * DBA/1LacJ)	abnormal hematopoietic system physiology	J:190966
Abca1^tm1Jdm/Abca1^tm1Jdm Tgm2^tm1Gml/Tgm2^tm1Gml (involves: C57BL/6 * DBA/1LacJ)	abnormal thymus morphology	J:132254
	impaired macrophage phagocytosis	J:132254
Abca1^tm1Jp/Abca1^tm1Jp Abcg1^tm1Tall/Abcg1^tm1Tall Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6)	abnormal bone marrow cell morphology/development	J:190966
Abca1^tm1Jp/Abca1^tm1Jp Abcg1^tm1Tall/Abcg1^tm1Tall Tg(Itgax-cre,-EGFP)4097Ach/0 (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J)	abnormal bone marrow cell morphology/development	J:190966
Abca1^tm1Wpfl/Abca1^tm1Wpfl (involves: 129P2/OlaHsd * C57BL/6J)	abnormal thymus morphology	J:64390
Abca4^{tm1a(EUCOMM)Wtsi}/Abca4⁺ (C57BL/6N-Abca4^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased mean corpuscular hemoglobin	J:175295
Abca5^{em1(IMPC)Ccpcz}/Abca5^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Abca5^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Abca6^{tm2b(KOMP)Wtsi}/Abca6^{tm2b(KOMP)Wtsi} (C57BL/6N-Abca6^{tm2b(KOMP)Wtsi}/Tcp)	decreased mean corpuscular hemoglobin concentration	J:211773
	increased hematocrit	J:211773
Abca8a^em1(IMPC)J/Abca8a^em1(IMPC)J (C57BL/6NJ-Abca8a^em1(IMPC)J/Mmjax)	increased hematocrit	J:211773
Abcb1a^mds/Abcb1a^mds (involves: CF-1)	increased eosinophil cell number	J:64725
Abcb1a^tm1Bor/Abcb1a^tm1Bor (FVBTac.129P2-Abcb1a^tm1Bor)	abnormal CD8 positive, alpha-beta intraepithelial T cell morphology	J:102640
Abcb1a^tm1Bor/Abcb1a^tm1Bor (FVBTac.129P2-Abcb1a^tm1Bor)	decreased gamma-delta intraepithelial T cell number	J:102640
Abcb1a^tm1Bor/Abcb1a^tm1Bor (FVB.129P2-Abcb1a^tm1Bor/TacImx)	abnormal lymphocyte physiology	J:51190
	increased IgA level	J:51190
	increased IgE level	J:51190
	increased IgG1 level	J:51190
	increased IgG2 level	J:51190
	increased IgG2a level	J:51190
	increased IgG2b level	J:51190
	increased IgG3 level	J:51190
	increased IgM level	J:51190
	increased immunoglobulin level	J:51190
Abcb1a^tm1Bor/Abcb1a^tm1Bor Abcb1b^tm1Bor/Abcb1b^tm1Bor (FVBTac.129P2-Abcb1b^tm1Bor Abcb1a^tm1Bor)	abnormal CD8 positive, alpha-beta intraepithelial T cell morphology	J:102640
	abnormal T cell physiology	J:102640
	decreased gamma-delta intraepithelial T cell number	J:102640
	increased double-positive T cell number	J:102640
Abcb4^em1(IMPC)H/Abcb4^em1(IMPC)H (C57BL/6NTac-Abcb4^em1(IMPC)H/H)	decreased hemoglobin content	J:211773
	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular hemoglobin concentration	J:211773
	decreased mean corpuscular volume	J:211773
	increased basophil cell number	J:211773
	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
	increased red blood cell distribution width	J:211773
	increased spleen weight	J:211773
	thrombocytosis	J:211773
Abcb4^tm1Bor/Abcb4^tm1Bor (FVB.129P2-Abcb4^tm1Bor/J)	enlarged spleen	J:217802
Abcb4^tm1Bor/Abcb4^tm1Bor (CAnNCrl.12P2(FVB)-Abcb4^tm1Bor)	enlarged spleen	J:217802
Abcb6^tm1Jsch/Abcb6^tm1Jsch (involves: 129)	abnormal erythrocyte physiology	J:184574
Abcb6^tm1Jsch/Abcb6^tm1Jsch (involves: 129)	abnormal stress erythropoiesis	J:184574
Abcb10^tm1.1Tafu/Abcb10^tm1.2Tafu Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6J * C57BL/6NCrlj * CBA/J * CBA/JNCrlJ)	abnormal erythropoiesis	J:223428
	abnormal hemoglobin	J:223428
	decreased erythrocyte cell number	J:223428
	decreased hemoglobin content	J:223428
	decreased mean corpuscular hemoglobin concentration	J:223428
	decreased mean corpuscular volume	J:223428
	hypochromic microcytic anemia	J:223428
	reticulocytosis	J:223428
Abcb10^tm1.2Tafu/Abcb10^tm1.2Tafu (involves: C57BL/6NCrlj * CBA/JNCrlj)	abnormal blood cell morphology	J:223428
	abnormal embryonic hematopoiesis	J:223428
	abnormal hemoglobin	J:223428
Abcc1^tm1Acs/Abcc1^tm1Acs (involves: 129S1/Sv * C57BL/6)	hematopoietic system phenotype	J:44305
Abcc1^tm1Bor/Abcc1^tm1Bor (involves: 129P2/OlaHsd * FVB)	abnormal mast cell physiology	J:44110
Abcc1^tm1Bor/Abcc1^tm1Bor Tg(Thy1-APPSw,Thy1-PSEN1L166P)21Jckr/0 (FVB.Cg-Abcc1^tm1Bor Tg(Thy1-APPSw,Thy1-PSEN1L166P)21Jckr)	microgliosis	J:178230
Abcc2^tm1Ahs/Abcc2^tm1Ahs (involves: 129P2/OlaHsd * FVB)	decreased hemoglobin content	J:107822
Abcc2^{tm2b(KOMP)Wtsi}/Abcc2^{tm2b(KOMP)Wtsi} (C57BL/6N-Abcc2^{tm2b(KOMP)Wtsi}/H)	decreased lymphocyte cell number	J:211773
	decreased mean corpuscular volume	J:211773
	decreased mean platelet volume	J:211773
	increased neutrophil cell number	J:211773
Abcc4^tm1Kruh/Abcc4^tm1Kruh (B6.129-Abcc4^tm1Kruh)	abnormal spleen B cell follicle morphology	J:117326
	abnormal spleen red pulp morphology	J:117326
	decreased spleen B cell follicle number	J:117326
	decreased spleen B cell follicle size	J:117326
	small spleen	J:117326
	thymus cortex hypoplasia	J:117326
Abcc5^em1(IMPC)H/Abcc5^em1(IMPC)H (C57BL/6N-Abcc5^em1(IMPC)H/H)	decreased eosinophil cell number	J:211773
	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
Abcc9^em1(IMPC)H/Abcc9⁺ (C57BL/6N-Abcc9^em1(IMPC)H/H)	decreased lymphocyte cell number	J:211773
Abcc9^em1(IMPC)H/Abcc9⁺ (C57BL/6N-Abcc9^em1(IMPC)H/H)	increased neutrophil cell number	J:211773
Abcc10^tm1Eah/Abcc10^tm1Eah (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal spleen red pulp morphology	J:172648
	decreased bone marrow cell number	J:172648
	decreased leukocyte cell number	J:172648
	decreased spleen germinal center number	J:172648
	decreased spleen germinal center size	J:172648
	decreased spleen white pulp amount	J:172648
	small spleen	J:172648
	thymus cortex hypoplasia	J:172648
Abcd1^tm1Kds/Y (involves: 129S4/SvJae * C57BL/6J)	abnormal microglial cell morphology	J:94583
Abcd1^tm1Kds/Y Abcd2^tm1Apuj/Abcd2^tm1Apuj (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6J)	abnormal microglial cell morphology	J:94583
Abcd2^tm1Apuj/Abcd2^tm1Apuj (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal microglial cell morphology	J:94583
Abce1^{tm1.1(KOMP)Vlcg}/Abce1⁺ (C57BL/6N-Abce1^{tm1.1(KOMP)Vlcg}/Tcp)	increased neutrophil cell number	J:211773
Abce1^{tm1b(EUCOMM)Hmgu}/Abce1⁺ (C57BL/6N-Abce1^{tm1b(EUCOMM)Hmgu}/H)	increased large unstained cell number	J:211773
Abcg1^tm1Dgen/Abcg1^tm1Dgen (B6.129P2-Abcg1^tm1Dgen)	abnormal macrophage physiology	J:117028
Abcg1^tm1Dgen/Abcg1^tm1Dgen (B6.129P2-Abcg1^tm1Dgen)	increased macrophage derived foam cell number	J:117028
Abcg1^tm1Dgen/Abcg1^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6)	abnormal leukocyte morphology	J:132952
	abnormal macrophage morphology	J:132952
	abnormal monocyte differentiation	J:132952
	increased B cell number	J:132952
	increased CD4-positive, alpha-beta T cell number	J:132952
	increased CD8-positive, alpha-beta T cell number	J:132952
	increased dendritic cell number	J:132952
	increased eosinophil cell number	J:132952
	increased monocyte cell number	J:132952
	increased neutrophil cell number	J:132952
Abcg2^tm1.1Ssf/Abcg2^tm1.1Ssf (involves: 129 * C57BL/6 * FVB)	abnormal bone marrow cell morphology/development	J:201884
Abcg2^tm1Ahs/Abcg2^tm1Ahs (either: (involves: 129P2/OlaHsd * FVB) or (involves: FVB))	hematopoietic system phenotype	J:80519
Abcg2^tm1Bsor/Abcg2^tm1Bsor (involves: 129P2/OlaHsd * C57BL/6)	abnormal hematopoietic system morphology/development	J:98134
Abcg5^trac/Abcg5^trac (A/J-Abcg5^trac)	abnormal megakaryocyte differentiation	J:157223
	abnormal megakaryocyte morphology	J:157223
	abnormal megakaryocyte progenitor cell morphology	J:157223
	abnormal neutrophil morphology	J:157223
	abnormal platelet activation	J:157223
	abnormal platelet alpha-granule morphology	J:157223
	abnormal platelet morphology	J:157223
	anisocytosis	J:157223
	decreased hematocrit	J:157223
	decreased leukocyte cell number	J:157223
	decreased platelet aggregation	J:157223
	giant platelets	J:157223
	hemolytic anemia	J:157223
	increased erythrocyte osmotic fragility	J:157223
	increased mean platelet volume	J:157223
	increased megakaryocyte cell number	J:157223
	reticulocytosis	J:157223
	stomatocytosis	J:157223
	thrombocytopenia	J:157223
Abcg8^{tm1b(KOMP)Wtsi}/Abcg8^{tm1b(KOMP)Wtsi} (C57BL/6N-Abcg8^{tm1b(KOMP)Wtsi}/Ccpcz)	abnormal spleen morphology	J:211773
	decreased B-2 B cell number	J:211773
	decreased CD4-negative NK T cell number	J:211773
	decreased CD4-positive, alpha-beta T cell number	J:211773
	decreased CD8-positive, alpha-beta T cell number	J:211773
	decreased hemoglobin content	J:211773
	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular hemoglobin concentration	J:211773
	decreased mean corpuscular volume	J:211773
	decreased memory-marker CD4-negative NK T cell number	J:211773
	decreased NK T cell number	J:211773
	decreased T cell number	J:211773
	enlarged spleen	J:211773
	increased mean platelet volume	J:211773
	increased red blood cell distribution width	J:211773
Abhd5^tm1.1Rze/Abhd5^tm1.1Rze (involves: 129P2/OlaHsd * C57BL/6)	abnormal granulocyte morphology	J:160725
Abhd10^em1(IMPC)Mbp/Abhd10^em1(IMPC)Mbp (C57BL/6NCrl-Abhd10^em1(IMPC)Mbp/Mmucd)	increased eosinophil cell number	J:211773
Abhd12^tm1Crv/Abhd12^tm1Crv (involves: C57BL/6)	microgliosis	J:193716
Abhd13^em1(IMPC)Mbp/Abhd13^em1(IMPC)Mbp (C57BL/6NCrl-Abhd13^em1(IMPC)Mbp/Mmucd)	decreased spleen weight	J:211773
Abhd16a^{tm1a(EUCOMM)Wtsi}/Abhd16a^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6N * C57BL/6NTac)	abnormal macrophage physiology	J:232688
	decreased macrophage cytokine production	J:232688
Abhd17c^em1(IMPC)Mbp/Abhd17c^em1(IMPC)Mbp (C57BL/6N-Abhd17c^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Abi1^tm1Pen/Abi1⁺ Abi2^tm1Pen/Abi2^tm1Pen (Not Specified)	decreased T cell proliferation	J:104623
Abi3bp^{tm1e.1(KOMP)Mbp}/Abi3bp^{tm1e.1(KOMP)Mbp} (C57BL/6N-Abi3bp^{tm1e.1(KOMP)Mbp}/Tcp)	increased mean platelet volume	J:211773
	increased red blood cell distribution width	J:211773
Abl1^m1/Abl1^m1 (either: 129S/SvEv-Abl1^m1 or (involves: 129S/SvEv * CD-1) or (involves: 129S/SvEv * C57BL/6 * DBA/2))	abnormal B cell differentiation	J:14644
	abnormal spleen germinal center morphology	J:14644
	abnormal spleen morphology	J:14644
	abnormal spleen white pulp morphology	J:14644
	abnormal T cell number	J:14644
	abnormal thymus morphology	J:14644
	decreased immature B cell number	J:14644
	decreased pre-B cell number	J:14644
	decreased pro-B cell number	J:14644
	decreased single-positive T cell number	J:14644
	decreased thymocyte number	J:14644
	increased single-positive T cell number	J:14644
	spleen hypoplasia	J:14644
	thymus cortex hypoplasia	J:14644
	thymus hypoplasia	J:14644
Abl1^m1/Abl1^m1 (involves: 129S/SvEv)	abnormal B cell differentiation	J:28795
	abnormal bone marrow cell physiology	J:28795
	abnormal splenocyte physiology	J:34903
	decreased mature B cell number	J:28795
	decreased pre-B cell number	J:28795
	decreased pro-B cell number	J:28795
Abl1^m1/Abl1^m1 (involves: 129S/SvEv * C57BL/6)	abnormal B cell physiology	J:148105
	abnormal bone marrow cell physiology	J:148105
	abnormal lymphopoiesis	J:148105
	decreased pro-B cell number	J:148105
Abl1^tm1Mlg/Abl1^tm1Mlg (involves: 129S/SvEv * C57BL/6J)	decreased B cell number	J:72875
	decreased lymphocyte cell number	J:72875
	decreased T cell number	J:72875
	decreased thymocyte number	J:72875
	spleen atrophy	J:72875
	thymus atrophy	J:72875
Abl1^tm1Mlg/Abl1^tm1Mlg (involves: 129S/SvEv * C57BL/6J * CBA)	abnormal spleen morphology	J:34643
	decreased bone marrow cell number	J:34643
Abl1^tm1Mlg/Abl1^tm1Mlg Tg(ACTB-Abl1I)1Spg/0 (involves: 129S/SvEv C57BL/6J * CBA)	decreased bone marrow cell number	J:34643
Abl1^tm1Mlg/Abl1^tm1Mlg Tg(ACTB-Abl1IV)1Spg/0 (involves: 129S/SvEv C57BL/6J * CBA)	decreased bone marrow cell number	J:34643
Abl1^tm1Mlg/Abl1^tm1Mlg Tg(ACTB-Abl1K290R)1Spg/0 (involves: 129S/SvEv C57BL/6J * CBA)	abnormal spleen morphology	J:34643
Abl1^tm2.2Goff/Abl1^tm2.2Goff (involves: 129P2/OlaHsd * C57BL/6J * FVB/N)	spleen atrophy	J:166211
	thymus atrophy	J:166211
Ablim3^em1(IMPC)Tcp/Ablim3^em1(IMPC)Tcp (C57BL/6N-Ablim3^em1(IMPC)Tcp/Tcp)	decreased basophil cell number	J:211773
	increased hematocrit	J:211773
Abtb1^{em1(IMPC)Ccpcz}/Abtb1^{em1(IMPC)Ccpcz} (C57BL/6N-Abtb1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Abtb2^{tm1a(KOMP)Wtsi}/Abtb2^{tm1a(KOMP)Wtsi} (C57BL/6N-A^tm1Brd Abtb2^{tm1a(KOMP)Wtsi}/WtsiH)	decreased leukocyte cell number	J:211773
Acaca^tm1Dejs/Acaca^tm1Dejs Tg(Cd4-cre)1Cwi/? (involves: C57BL/6 * DBA/2)	abnormal T cell physiology	J:209886
	decreased memory T cell number	J:209886
	decreased T cell number	J:209886
Acaca^tm1Dejs/Acaca^tm1Dejs Tg(Cd4-cre)1Cwi/? Tg(TcraTcrb)1100Mjb/? (involves: C57BL/6 * DBA/2)	increased T cell proliferation	J:209886
Acad10^em1(IMPC)Tcp/Acad10^em1(IMPC)Tcp (C57BL/6N-Acad10^em1(IMPC)Tcp/Tcp)	abnormal spleen morphology	J:211773
Acbd3^{tm1b(EUCOMM)Hmgu}/Acbd3⁺ (C57BL/6N-Acbd3^{tm1b(EUCOMM)Hmgu}/Ieg)	increased mean corpuscular volume	J:211773
Acbd5^{tm1a(EUCOMM)Wtsi}/Acbd5^{tm1a(EUCOMM)Wtsi} (C57BL/6N-A^tm1Brd Acbd5^{tm1a(EUCOMM)Wtsi}/WtsiCnbc)	abnormal microglial cell morphology	J:299448
Acbd5^{tm1b(EUCOMM)Wtsi}/Acbd5^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Acbd5^{tm1b(EUCOMM)Wtsi}/Wtsi)	increased mean platelet volume	J:211773
	thrombocytopenia	J:211773
Ace2^{em1(IMPC)Ccpcz}/Y (C57BL/6NCrl-Ace2^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Ace2^{em1(IMPC)Ccpcz}/Ace2^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Ace2^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Ace2^{tm1a(KOMP)Wtsi}/Y Tg(FOXJ1-cre)F26Htzm/0 (involves: C57BL/6N * C57BL/6NTac)	increased neutrophil cell number	J:282139
Ace2^{tm1a(KOMP)Wtsi}/Ace2^{tm1a(KOMP)Wtsi} Tg(FOXJ1-cre)F26Htzm/0 (involves: C57BL/6N * C57BL/6NTac)	increased neutrophil cell number	J:282139
Ace2^tm1Pngr/Y (involves: 129P2/OlaHsd)	increased neutrophil cell number	J:282139
Ace2^tm1Pngr/Ace2^tm1Pngr (involves: 129P2/OlaHsd)	increased neutrophil cell number	J:282139
Ace^{tm1.1(KOMP)Vlcg}/Ace⁺ (C57BL/6N-Ace^{tm1.1(KOMP)Vlcg}/MbpMmucd)	increased basophil cell number	J:211773
Ace^tm4Keb/Ace^tm4Keb (involves: 129S1/Sv * 129X1/SvJ)	decreased hematocrit	J:83894
Ace^tm4Keb/Ace^tm4Keb Bdkrb2^tm1Jfh/Bdkrb2^tm1Jfh (involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/SvJ)	decreased hematocrit	J:83894
Ace^tm6Keb/Ace^tm6Keb (involves: 129 * C57BL/6)	increased T cell number	J:122178
Acer1^{tm1a(EUCOMM)Wtsi}/Acer1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Acer1^{tm1a(EUCOMM)Wtsi})	increased eosinophil cell number	J:235775
Acer2^em1Mvw/Acer2^em1Mvw (C57BL/6J-Acer2^em1Mvw/MvwJ)	hematopoietic system phenotype	J:256650
Ache^em1(IMPC)Mbp/Ache⁺ (C57BL/6N-Ache^em1(IMPC)Mbp/MbpMmucd)	increased neutrophil cell number	J:211773
Ache^tm1.1Pata/Ache^tm1.1Pata (involves: 129X1/SvJ * C57BL/6)	abnormal platelet physiology	J:132775
Ackr3^tm1.1Fma/Ackr3^tm1.1Fma (involves: BALB/cJ * C57BL/6)	decreased marginal zone B cell number	J:124878
Ackr3^tm1.1Rodb/Ackr3^tm1.1Rodb (involves: 129S6/SvEvTac * BALB/cJ * C57BL/6)	hematopoietic system phenotype	J:165184
Ackr3^{tm2b(EUCOMM)Wtsi}/Ackr3⁺ (C57BL/6N-Ackr3^{tm2b(EUCOMM)Wtsi}/Ics)	increased mean corpuscular hemoglobin concentration	J:211773
Ackr4^tm1.1Rjbn/Ackr4^tm1.1Rjbn (B6.129S6-Ackr4^tm1.1Rjbn)	abnormal CD4-positive, alpha-beta T cell number	J:166490
	abnormal CD4-positive, alpha-beta T cell physiology	J:166490
	abnormal T-helper 17 cell differentiation	J:166490
	decreased T cell proliferation	J:166490
	increased T-helper 17 cell number	J:166490
	spleen hyperplasia	J:166490
Acmsd^{tm1b(EUCOMM)Hmgu}/Acmsd^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Acmsd^{tm1b(EUCOMM)Hmgu}/Ieg)	increased mean platelet volume	J:211773
Aco1^em1(IMPC)J/Aco1^em1(IMPC)J (C57BL/6NJ-Aco1^em1(IMPC)J/Mmjax)	decreased mean corpuscular volume	J:211773
Acod1^{tm1a(KOMP)Wtsi}/Acod1^{tm1a(KOMP)Wtsi} (involves: C57BL/6N)	abnormal macrophage physiology	J:235002
Acot2^em1(IMPC)J/Acot2^em1(IMPC)J (C57BL/6NJ-Acot2^em1(IMPC)J/J)	decreased mean corpuscular volume	J:211773
Acot5^{tm1a(KOMP)Wtsi}/Acot5^{tm1a(KOMP)Wtsi} (C57BL/6N-Acot5^{tm1a(KOMP)Wtsi}/Wtsi)	increased red blood cell distribution width	J:211773
Acoxl^em1(IMPC)Mbp/Acoxl^em1(IMPC)Mbp (C57BL/6NCrl-Acoxl^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	decreased lymphocyte cell number	J:211773
	enlarged spleen	J:211773
	increased neutrophil cell number	J:211773
Acp2^{tm1a(EUCOMM)Wtsi}/Acp2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Acp2^{tm1a(EUCOMM)Wtsi}/H)	decreased CD4-positive, alpha-beta T cell number	J:165965
	decreased CD8-positive, alpha-beta T cell number	J:165965
	decreased erythrocyte cell number	J:165965
	decreased T cell number	J:165965
	increased B cell number	J:165965
Acp2^tm1Psa/Acp2^tm1Psa (involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6J)	abnormal microglial cell morphology	J:41986
Acp5^tm1Ahdm/Acp5^tm1Ahdm (involves: 129S/SvEv)	abnormal osteoclast physiology	J:36232
Acsf2^{tm1.1(KOMP)Vlcg}/Acsf2^{tm1.1(KOMP)Vlcg} (B6N(Cg)-Acsf2^{tm1.1(KOMP)Vlcg}/J)	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
Acsl3^{Gt(OST148301)Lex}/Acsl3^{Gt(OST148301)Lex} (B6;129S5-Acsl3^{Gt(OST148301)Lex}/Orl)	decreased B cell number	J:82809
	increased CD4-positive, alpha-beta T cell number	J:82809
Acsl4^{tm1a(EUCOMM)Wtsi}/Y (B6Brd;B6Dnk;B6N-Tyr^c-Brd Acsl4^{tm1a(EUCOMM)Wtsi}/Wtsi)	thrombocytopenia	J:175295
Acsl4^{tm1a(EUCOMM)Wtsi}/Acsl4⁺ (B6Brd;B6Dnk;B6N-Tyr^c-Brd Acsl4^{tm1a(EUCOMM)Wtsi}/Wtsi)	thrombocytopenia	J:175295
Acsl5^{tm1.1(KOMP)Vlcg}/Acsl5^{tm1.1(KOMP)Vlcg} (C57BL/6N-Acsl5^{tm1.1(KOMP)Vlcg}/Ucd)	increased spleen weight	J:211773
Acsl5^tm1Lex/Acsl5^tm1Lex (B6;129S5-Acsl5^tm1Lex/Mmucd)	thrombocytopenia	J:171883
Acsl6^tm1.1Jeme/Acsl6^tm1.1Jeme (involves: BALB/cJ * C57BL/6)	abnormal microglial cell activation	J:267563
Acsm1^{em1(IMPC)Mhzh}/Acsm1^{em1(IMPC)Mhzh} (C57BL/6N-Acsm1^{em1(IMPC)Mhzh}/Mhzh)	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
Actb^{tm4(cre/ERT2)Npa}/Actb⁺ Sgpl1^tm1.1Npa/Sgpl1^tm1.1Npa (involves: BALB/cJ * C57BL/6)	abnormal regulatory T cell number	J:199525
	decreased follicular B cell number	J:199525
	decreased marginal zone B cell number	J:199525
	decreased single-positive T cell number	J:199525
	increased thymocyte number	J:199525
	spleen hypoplasia	J:199525
Actl6a^tm1.1Grc/Actl6a⁺ Tg(Mx1-cre)1Cgn/0 (involves: 129S6/SvEvTac * C57BL/6J * CBA)	decreased common myeloid progenitor cell number	J:192124
	decreased granulocyte number	J:192124
	decreased macrophage cell number	J:192124
Actl6a^tm1.1Grc/Actl6a^tm1.1Grc Tg(Mx1-cre)1Cgn/0 (involves: 129S6/SvEvTac * C57BL/6J * CBA)	abnormal bone marrow cell physiology	J:192124
	abnormal definitive hematopoiesis	J:192124
	abnormal hematopoietic stem cell physiology	J:192124
	anemia	J:192124
	decreased B cell number	J:192124
	decreased bone marrow cell number	J:192124
	decreased common myeloid progenitor cell number	J:192124
	decreased erythrocyte cell number	J:192124
	decreased erythroid progenitor cell number	J:192124
	decreased granulocyte number	J:192124
	decreased hematopoietic stem cell number	J:192124
	decreased hematopoietic stem cell proliferation	J:192124
	decreased hemoglobin content	J:192124
	decreased leukocyte cell number	J:192124
	decreased lymphocyte cell number	J:192124
	decreased macrophage cell number	J:192124
	decreased megakaryocyte cell number	J:192124
	decreased monocyte cell number	J:192124
	increased erythroblast number	J:192124
	polycythemia	J:192124
	thrombocytopenia	J:192124
Actn4^tm1Mrpk/Actn4^tm1Mrpk (involves: 129 * C57BL/6)	abnormal lymphocyte chemotaxis	J:83911
Actr8^{tm1.1(KOMP)Vlcg}/Actr8⁺ (B6N(Cg)-Actr8^{tm1.1(KOMP)Vlcg}/J)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
Acvr2a^{tm1.1(KOMP)Vlcg}/Acvr2a⁺ (C57BL/6N-Acvr2a^{tm1.1(KOMP)Vlcg}/Ucd)	decreased eosinophil cell number	J:211773
	decreased neutrophil cell number	J:211773
Acvr2b^tm1Enl/Acvr2b^tm1Enl (either: (involves: 129S4/SvJae) or (involves: 129S4/SvJae * C57BL/6J))	abnormal spleen morphology	J:42018
	small spleen	J:42018
Acvrl1^tm1Dyl/Acvrl1^tm1Dyl (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal definitive hematopoiesis	J:85366, J:65521
Acvrl1^tm2.1Spo/Acvrl1^tm2.1Spo Gt(ROSA)26Sor^{tm1(cre/ERT)Nat}/Gt(ROSA)26Sor⁺ (involves: 129 * 129S1/Sv * 129X1/SvJ)	anemia	J:154620
	decreased hematocrit	J:154620
Acy3^em1(IMPC)J/Acy3^em1(IMPC)J (C57BL/6NJ-Acy3^em1(IMPC)J/Mmjax)	decreased mean corpuscular hemoglobin concentration	J:211773
Ada^tm1Mw/Ada^tm1Mw (involves: 129S7/SvEvBrd * C57BL/6)	decreased T cell number	J:25085
Ada^tm1Mw/Ada^tm1Mw (involves: 129S7/SvEvBrd)	increased dendritic cell number	J:138722
Ada^tm1Mw/Ada^tm1Mw Tg(PLADA)4118Rkmb/0 (involves: 129S7/SvEvBrd * C57BL/6)	abnormal spleen red pulp morphology	J:73418
	abnormal thymus corticomedullary boundary morphology	J:73418
	anemia	J:73418
	decreased double-positive T cell number	J:73418
	decreased immunoglobulin level	J:73418
	decreased leukocyte cell number	J:73418
	increased double-negative T cell number	J:73418
	increased eosinophil cell number	J:73418
	increased granulocyte number	J:73418
	increased macrophage cell number	J:73418
	small spleen	J:73418
	small thymus	J:73418
	spleen hypoplasia	J:73418
Ada^tm1Vlr/Ada^tm1Vlr (either: 129P2/OlaHsd-Ada^tm1Vlr or (involves: (129P2/OlaHsd * FVB/N))	extramedullary hematopoiesis	J:26731
Adal^{tm1a(EUCOMM)Wtsi}/Adal^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Adal^{tm1a(EUCOMM)Wtsi}/Wtsi)	thrombocytopenia	J:211773
Adam5^em1(IMPC)J/Adam5^em1(IMPC)J (C57BL/6NJ-Adam5^em1(IMPC)J/Mmjax)	decreased mean corpuscular volume	J:211773
Adam8^tm1.1Rood/Adam8^tm1.1Rood (involves: 129/Sv * C57BL/6 * FVB/N)	abnormal osteoclast differentiation	J:172936
Adam10^tm1.1Dhc/Adam10^tm1.1Dhc Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * SJL)	abnormal B cell differentiation	J:158127
	absent marginal zone B cells	J:158127
	decreased transitional stage T2 B cell number	J:158127
	increased follicular B cell number	J:158127
	increased transitional stage T1 B cell number	J:158127
Adam10^tm1.1Khr/Adam10^tm1.1Khr Csf3r^tm1Link/Csf3r^tm1Link Tg(Mx1-cre)1Cgn/0 (involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6 * C57BL/6N)	abnormal granulocyte differentiation	J:179060
	enlarged spleen	J:179060
	myeloid hyperplasia	J:179060
	spleen hyperplasia	J:179060
Adam10^tm1.1Khr/Adam10^tm1.1Khr Tg(Mx1-cre)1Cgn/0 (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6N)	abnormal definitive hematopoiesis	J:179060
	abnormal granulocyte differentiation	J:179060
	abnormal spleen morphology	J:179060
	abnormal T cell differentiation	J:179060
	decreased CD4-positive, alpha-beta T cell number	J:179060
	decreased CD8-positive, alpha-beta T cell number	J:179060
	decreased double-positive T cell number	J:179060
	decreased erythrocyte cell number	J:179060
	decreased hematocrit	J:179060
	decreased hemoglobin content	J:179060
	decreased T cell number	J:179060
	enlarged spleen	J:179060
	increased hematopoietic stem cell number	J:179060
	increased leukocyte cell number	J:179060
	increased neutrophil cell number	J:179060
	increased spleen red pulp amount	J:179060
	increased spleen weight	J:179060
	myeloid hyperplasia	J:179060
	small thymus	J:179060
	spleen hyperplasia	J:179060
	thymus hypoplasia	J:179060
Adam10^tm1Beni/Adam10^tm1Beni Adam17^tm1.1Srj/Adam17^tm1.1Srj Tg(Pf4-icre)Q3Rsko/0 (involves: 129/Sv * 129S/SvEv * C57BL/6)	abnormal platelet physiology	J:165863
Adam10^tm1Beni/Adam10^tm1Beni Tg(Pf4-icre)Q3Rsko/0 (involves: 129/Sv * C57BL/6)	abnormal platelet physiology	J:165863
Adam10^tm1Zhu/Adam10^tm1.1Zhu Tg(Lck-cre)#Zhu/0 (involves: 129S6/SvEvTac * C57BL/6 * SJL * SJL/J)	abnormal T cell differentiation	J:139042
	decreased CD4-positive, alpha-beta T cell number	J:139042
	decreased double-positive T cell number	J:139042
	thymus hypoplasia	J:139042
Adam10^tm1Zhu/Adam10^tm1Zhu Tg(Lck-cre)#Zhu/0 (involves: 129S6/SvEvTac * C57BL/6 * SJL/J)	abnormal T cell differentiation	J:139042
	decreased CD4-positive, alpha-beta T cell number	J:139042
	decreased double-positive T cell number	J:139042
	thymus hypoplasia	J:139042
Adam17^tm1.1Srj/Adam17^tm1.1Srj (involves: 129S/SvEv)	abnormal platelet physiology	J:165863
Adam17^tm1.2Bbl/Adam17^tm1.2Bbl Sox9^tm3(cre)Crm/Sox9⁺ (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)	abnormal spleen morphology	J:144795
	decreased B cell number	J:144795
	decreased hematocrit	J:144795
	decreased lymphocyte cell number	J:144795
	decreased T cell number	J:144795
	enlarged spleen	J:144795
	extramedullary hematopoiesis	J:144795
	increased bone marrow cell number	J:144795
	increased hemoglobin content	J:144795
	increased leukocyte cell number	J:144795
	increased macrophage cell number	J:144795
	increased neutrophil cell number	J:144795
	increased spleen red pulp amount	J:144795
	thrombocytosis	J:144795
Adam17^tm1.2Bbl/Adam17^tm1.2Bbl Sox9^tm3(cre)Crm/Sox9⁺ (B6.129(SJL)-Sox9^tm3(cre)Crm Adam17^tm1.2Bbl)	increased IgE level	J:229771
	increased T-helper 1 cell number	J:229771
	increased T-helper 2 cell number	J:229771
	increased T-helper 17 cell number	J:229771
Adam17^{tm1a(EUCOMM)Wtsi}/Adam17⁺ (involves: C57BL/6 * C57BL/6N)	increased erythrocyte cell number	J:213427
	myeloid hyperplasia	J:213427
Adam17^tm1Bbl/Adam17^tm1Bbl Lyz2^tm1(cre)Ifo/0 (involves: 129P2/OlaHsd)	abnormal macrophage physiology	J:139846
Adam17^tm1Imx/Adam17^tm1Imx (B6.129-Adam17^tm1Imx)	enhanced leukocyte tethering or rolling	J:174865
Adam17^tm1Rain/Adam17^tm1Rain (involves: C57BL/6)	enhanced leukocyte tethering or rolling	J:174865
Adam28^tm1.2Dica/Adam28^tm1.2Dica (B6JRj.129-Adam28^tm1.2Dica)	abnormal alpha-beta T cell morphology	J:298188
	abnormal lymphocyte morphology	J:298188
	decreased CD8-positive, alpha-beta T cell number	J:298188
Adam28^tm1.2Dica/Adam28^tm1.2Dica (CJRj.129-Adam28^tm1.2Dica)	decreased CD8-positive, alpha-beta T cell number	J:298188
Adamdec1^tm1Dgen/Adamdec1^tm1Dgen (B6.129P2-Adamdec1^tm1Dgen)	increased neutrophil cell number	J:301741
Adamts1^em1(IMPC)Mbp/Adamts1⁺ (C57BL/6N-Adamts1^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Adamts3^tm1.2Itl/Adamts3^tm1.2Itl (involves: BALB/cJ * C57BL/6NTac * SJL)	abnormal erythrocyte morphology	J:245044
Adamts6^b2b1879.1Clo/Adamts6^b2b1879.1Clo (C57BL/6J-Adamts6^b2b1879.1Clo)	thymus hypoplasia	J:175213
Adamts6^b2b2029Clo/Adamts6^b2b2029Clo (C57BL/6J-Adamts6^b2b2029Clo)	thymus hypoplasia	J:175213
Adamts6^b2b2182Clo/Adamts6^b2b2182Clo (C57BL/6J-Adamts6^b2b2182Clo)	thymus hypoplasia	J:175213
Adamts6^b2b2187.1Clo/Adamts6^b2b2187.1Clo (C57BL/6J-Adamts6^b2b2187.1Clo)	thymus hypoplasia	J:175213
Adamts6^b2b2228Clo/Adamts6^b2b2228Clo (C57BL/6J-Adamts6^b2b2228Clo)	thymus hypoplasia	J:175213
Adamts6^b2b2405Clo/Adamts6^b2b2405Clo (C57BL/6J-Adamts6^b2b2405Clo)	thymus hypoplasia	J:175213
Adamts6^b2b2407Clo/Adamts6^b2b2407Clo (C57BL/6J-Adamts6^b2b2407Clo)	thymus hypoplasia	J:175213
Adamts6^b2b2744Clo/Adamts6^b2b2744Clo (C57BL/6J-Adamts6^b2b2744Clo)	thymus hypoplasia	J:175213
Adamts6^b2b2966.2Clo/Adamts6^b2b2966.2Clo (C57BL/6J-Adamts6^b2b2966.2Clo)	thymus hypoplasia	J:175213
Adamts7^{tm1a(KOMP)Wtsi}/Adamts7^{tm1a(KOMP)Wtsi} (involves: C57BL/6N)	abnormal erythrocyte cell number	J:230573
Adamts13^tm1Dgi/Adamts13^tm1Dgi (involves: 129X1/SvJ * C57BL/6J * CASA/Rk)	abnormal erythrocyte morphology	J:101752
	abnormal platelet physiology	J:101752
	hematopoietic system phenotype	J:101752
	thrombocytopenia	J:101752
Adamts13^tm1Dgi/Adamts13^tm1Dgi Vwf^tm1Wgr/Vwf^tm1Wgr (involves: 129S2/SvPas * 129X1/SvJ * C57BL/6 * CASA/Rk)	abnormal platelet morphology	J:133469
Adamts13^tm1Dgi/Adamts13^tm1Dgi Vwf^tm1Wgr/Vwf^tm1Wgr (B6.129-Adamts13^tm1Dgi Vwf^tm1Wgr)	hematopoietic system phenotype	J:133469
Adamts13^tm1Myta/Adamts13^tm1Myta (involves: 129S6/SvEvTac)	abnormal platelet activation	J:125786
Adamts14^{Gt(511E11)Cmhd}/Adamts14^{Gt(511E11)Cmhd} Adamts2^tm1Prc/Adamts2^tm1Prc (involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal T cell activation	J:271185
	cutaneous mastocytosis	J:271185
	decreased B cell number	J:271185
	decreased CD8-positive, alpha-beta T cell number	J:271185
	increased CD4-positive, alpha-beta T cell number	J:271185
	increased T cell proliferation	J:271185
Adamts18^{tm1.1(KOMP)Vlcg}/Adamts18^{tm1.1(KOMP)Vlcg} (C57BL/6N-Adamts18^{tm1.1(KOMP)Vlcg}/Ucd)	decreased mean corpuscular hemoglobin concentration	J:211773
	increased hematocrit	J:211773
	increased mean corpuscular volume	J:211773
Adamtsl3^em1(IMPC)Tcp/Adamtsl3^em1(IMPC)Tcp (C57BL/6NCrl-Adamtsl3^em1(IMPC)Tcp/Tcp)	small spleen	J:211773
Adamtsl4^em1(IMPC)J/Adamtsl4^em1(IMPC)J (C57BL/6NJ-Adamtsl4^em1(IMPC)J/J)	increased erythrocyte cell number	J:211773
Adap1^{tm1a(EUCOMM)Wtsi}/Adap1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Adap1^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased memory-marker NK cell number	J:211773
	increased NK cell number	J:211773
Adar^em1Stsn/Adar^tm1Olds (involves: 129S/SvEv * C57BL/6J)	abnormal spleen morphology	J:308678
Adar^tm1.1Knk/Adar^tm1.1Knk (involves: 129S1/Sv * 129X1/SvJ)	hematopoietic system phenotype	J:87714
Adar^tm1.1Phs/Adar^tm2Phs Tg(Mx1-cre)1Cgn/? (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	abnormal definitive hematopoiesis	J:142338
Adar^tm1.1Phs/Adar^tm2Phs Tg(Tal1-cre/ERT)42-056Jrg/? (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal hematopoietic stem cell morphology	J:142338
	decreased bone marrow cell number	J:142338
Adar^tm1Knk/Adar^tm1Knk Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)	hematopoietic system phenotype	J:87714
Adar^tm1Phs/Adar^tm1Phs (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	absent common myeloid progenitor cells	J:87715
	impaired hematopoiesis	J:87715
Adar^tm1Phs/Adar^tm1Phs (involves: 129S1/Sv * 129X1/SvJ * NMRI)	absent common myeloid progenitor cells	J:87715
	impaired hematopoiesis	J:87715
Adar^tm2Knk/Adar⁺ (chimera involves: 129S1/Sv * 129X1/SvJ * FVB/N)	abnormal embryonic erythropoiesis	J:65981
Adar^tm2Phs/Adar^tm2Phs (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	absent common myeloid progenitor cells	J:87715
	impaired hematopoiesis	J:87715
Adar^tm2Phs/Adar^tm2Phs (involves: 129S1/Sv * 129X1/SvJ * NMRI)	absent common myeloid progenitor cells	J:87715
	impaired hematopoiesis	J:87715
Adar^tm2Phs/Adar^tm2Phs (B6.Cg-Adar^tm2Phs)	abnormal hematopoietic stem cell morphology	J:142338
Adarb2^em1(IMPC)Tcp/Adarb2^em1(IMPC)Tcp (C57BL/6NCrl-Adarb2^em1(IMPC)Tcp/Tcp)	abnormal spleen morphology	J:211773
Adcy1^{tm1b(EUCOMM)Wtsi}/Adcy1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Adcy1^{tm1b(EUCOMM)Wtsi}/H)	increased leukocyte cell number	J:211773
	increased mean corpuscular volume	J:211773
Adcy3^{tm1a(EUCOMM)Wtsi}/Adcy3⁺ (C57BL/6N-Adcy3^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased hematocrit	J:211773
	increased hemoglobin content	J:211773
Adcy9^{Gt(OST193739)Lex}/Adcy9^{Gt(OST193739)Lex} (involves: 129S5/SvEvBrd * C57BL/6J)	increased IgG1 level	J:103485
Adcyap1^tm1Clw/Adcyap1^tm1Clw (B6.129S4-Adcyap1^tm1Clw)	abnormal regulatory T cell physiology	J:194151
	abnormal T cell activation	J:194151
	increased microglial cell activation	J:194151
	increased T-helper 17 cell number	J:194151
Add1^tm1Llp/Add1^tm1Llp (involves: 129P2/OlaHsd * 129S1/SvImJ * C57BL/6J)	abnormal erythrocyte morphology	J:138919
	decreased hematocrit	J:138919
	decreased mean corpuscular hemoglobin	J:138919
	decreased mean corpuscular volume	J:138919
	decreased mean platelet volume	J:138919
	hematopoietic system phenotype	J:138919
	hemolytic anemia	J:138919
	increased hemoglobin concentration distribution width	J:138919
	increased mean corpuscular hemoglobin concentration	J:138919
	reticulocytosis	J:138919
	spherocytosis	J:138919
	thrombocytosis	J:138919
Add2^tm1Feb/Add2^tm1Feb (B6.129-Add2^tm1Feb)	anemia	J:63047
	decreased hematocrit	J:63047
	decreased hemoglobin content	J:63047
	decreased mean corpuscular hemoglobin	J:63047
	increased erythrocyte osmotic fragility	J:63047
	increased mean corpuscular hemoglobin concentration	J:63047
	increased spleen weight	J:63047
	microcytosis	J:63047
	poikilocytosis	J:63047
	reticulocytosis	J:63047
Add2^tm1Llp/Add2^tm1Llp (involves: 129S4/SvJae * C57BL/6J)	abnormal erythrocyte morphology	J:161920
	abnormal erythrocyte physiology	J:71029
	anemia	J:161920, J:71029
	anisopoikilocytosis	J:161920, J:71029
	decreased hematocrit	J:161920, J:71029
	decreased mean corpuscular volume	J:71029
	enlarged spleen	J:71029
	increased erythrocyte osmotic fragility	J:161920
	increased mean corpuscular hemoglobin concentration	J:71029
	increased spleen iron level	J:71029
	microcytosis	J:71029
	reticulocytosis	J:161920, J:71029
	spherocytosis	J:161920, J:71029
Add2^tm1Llp/Add2^tm1Llp Add3^tm1.2Llp/Add3^tm1.2Llp (involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6J * FVB/N)	abnormal erythrocyte morphology	J:161920
	anemia	J:161920
	anisopoikilocytosis	J:161920
	decreased hematocrit	J:161920
	decreased mean corpuscular volume	J:161920
	increased erythrocyte osmotic fragility	J:161920
	reticulocytosis	J:161920
	spherocytosis	J:161920
Adgb^em1(IMPC)Mbp/Adgb⁺ (C57BL/6NCrl-Adgb^em1(IMPC)Mbp/Mmucd)	increased eosinophil cell number	J:211773
Adgrb1^{tm2a(EUCOMM)Wtsi}/Adgrb1⁺ (C57BL/6N-Adgrb1^{tm2a(EUCOMM)Wtsi}/Wtsi)	decreased leukocyte cell number	J:211773
Adgre1^m2Btlr/Adgre1^m2Btlr (C57BL/6J-Adgre1^m2Btlr)	abnormal macrophage physiology	J:195410
Adgre1^m2Btlr/Adgre1^m2Btlr (C57BL/6J-Adgre1^m2Btlr)	decreased macrophage cell number	J:195410
Adgre1^m3Btlr/Adgre1^m3Btlr (C57BL/6J-Adgre1^m3Btlr)	abnormal macrophage physiology	J:234244
Adgre1^m3Btlr/Adgre1^m3Btlr (C57BL/6J-Adgre1^m3Btlr)	decreased macrophage cell number	J:234244
Adgre1^M4Btlr/Adgre1⁺ (C57BL/6J-Adgre1^M4Btlr)	decreased macrophage cell number	J:255001
Adgre1^M4Btlr/Adgre1^M4Btlr (C57BL/6J-Adgre1^M4Btlr)	decreased macrophage cell number	J:255001
Adgre1^tm1Stst/Adgre1^tm1Stst (B6.129S1-Emr1^tm1Stst)	abnormal regulatory T cell physiology	J:99213
Adgre5^tm1.1Joha/Adgre5^tm1.1Joha (involves: 129P2/OlaHsd * C57BL/6J * FVB/N)	increased granulocyte number	J:140713
Adgre5^tm1Kake/Adgre5^tm1Kake (B6.129S6-Adgre5^tm1Kake)	increased granulocyte number	J:118705
Adgrf5^tm1.2Bstc/Adgrf5^tm1.2Bstc (involves: 129S4/SvJae * C57BL/6J)	increased macrophage derived foam cell number	J:196943
Adgrf5^tm1.2Jpbs/Adgrf5^tm1.2Jpbs (BALB/c-Adgrf5^tm1.2Jpbs)	abnormal alveolar macrophage morphology	J:221769
Adgrf5^{tm1b(KOMP)Wtsi}/Adgrf5^{tm1b(KOMP)Wtsi} (C57BL/6N-Adgrf5^{tm1b(KOMP)Wtsi}/Tcp)	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
	decreased monocyte cell number	J:211773
	increased red blood cell distribution width	J:211773
Adgrf5^tm1Shiro/Adgrf5^tm1Shiro (B6.Cg-Adgrf5^tm1Shiro)	abnormal alveolar macrophage morphology	J:204701
Adgrf5^tm1Shiro/Adgrf5^tm1Shiro (B6.Cg-Adgrf5^tm1Shiro)	increased macrophage cell number	J:204701
Adgrg3^tm1Zgwg/Adgrg3^tm1Zgwg (involves: 129 * C57BL/6)	abnormal B cell morphology	J:222670
	abnormal IgG1 level	J:222670
	abnormal IgG2 level	J:222670
	abnormal IgG level	J:222670
	abnormal immunoglobulin level	J:222670
	abnormal spleen B cell follicle morphology	J:222670
	abnormal spleen B cell follicle shape	J:222670
	abnormal spleen marginal zone morphology	J:222670
	abnormal spleen morphology	J:222670
	decreased follicular B cell number	J:222670
	decreased IgA level	J:222670
	decreased IgG1 level	J:222670
	decreased IgG2b level	J:222670
	decreased IgG3 level	J:222670
	decreased IgM level	J:222670
	decreased mature B cell number	J:222670
	decreased transitional stage T1 B cell number	J:222670
	increased B cell apoptosis	J:222670
	increased IgG1 level	J:222670
	increased IgG2a level	J:222670
	increased marginal zone B cell number	J:222670
	increased transitional stage T2 B cell number	J:222670
Adgrl4^em1(IMPC)Mbp/Adgrl4^em1(IMPC)Mbp (C57BL/6N-Adgrl4^em1(IMPC)Mbp/MbpMmucd)	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
	increased neutrophil cell number	J:211773
Adh5^{tm1b(EUCOMM)Wtsi}/Adh5^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Adh5^{tm1b(EUCOMM)Wtsi}/H)	decreased spleen weight	J:211773
Adig^{tm1.1(KOMP)Vlcg}/Adig^{tm1.1(KOMP)Vlcg} (C57BL/6N-Adig^{tm1.1(KOMP)Vlcg}/Ucd)	decreased hemoglobin content	J:211773
Adip1^LG/J/? Capn10^tm1Chev/Capn10⁺ ((B6.129-Capn10^tm1Chev x LG/J)F1)	increased spleen weight	J:153477
Adipoq^tm1Chan/Adipoq⁺ (B6.129-Adipoq^tm1Chan)	abnormal leukocyte physiology	J:122020
Adipoq^tm1Chan/Adipoq⁺ (B6.129-Adipoq^tm1Chan)	increased leukocyte cell number	J:122020
Adipoq^tm1Chan/Adipoq^tm1Chan (B6.129-Adipoq^tm1Chan)	abnormal leukocyte physiology	J:122020
Adipoq^tm1Chan/Adipoq^tm1Chan (B6.129-Adipoq^tm1Chan)	increased leukocyte cell number	J:122020
Adipoq^tm1Ish/Adipoq^tm1Ish (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal osteoclast morphology	J:199264
Adipor1^{tm1b(EUCOMM)Hmgu}/Adipor1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Adipor1^{tm1b(EUCOMM)Hmgu}/H)	decreased hemoglobin content	J:211773
	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
	increased red blood cell distribution width	J:211773
Adipor2^{tm1b(EUCOMM)Hmgu}/Adipor2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Adipor2^{tm1b(EUCOMM)Hmgu}/H)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Adk^{em1(IMPC)Ccpcz}/Adk⁺ (C57BL/6N-Adk^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Adm2^em1Zhan/Adm2^em1Zhan (Not Specified)	increased Ly6C high monocyte number	J:266495
Adm^tm1Kmca/Adm^tm1Kmca (B6.129P2-Adm^tm1Kmca)	increased uterine NK cell number	J:201446
Adm^tm1Unc/Adm^tm1Unc (involves: 129S6/SvEvTac)	decreased uterine NK cell number	J:201446
Adnp2^em3(IMPC)Tcp/Adnp2⁺ (C57BL/6NCrl-Adnp2^em3(IMPC)Tcp/Tcp)	abnormal thymus morphology	J:211773
	small spleen	J:211773
Adora1^{tm1b(KOMP)Wtsi}/Adora1^{tm1b(KOMP)Wtsi} (B6N(Cg)-Adora1^{tm1b(KOMP)Wtsi}/J)	increased mean corpuscular hemoglobin	J:211773
Adora2a^em1(IMPC)H/Adora2a^em1(IMPC)H (C57BL/6N-Adora2a^em1(IMPC)H/H)	decreased hemoglobin content	J:211773
	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Adora2a^tm1Map/Adora2a^tm1Map (involves: 129S1/Sv * 129X1/SvJ * CD-1)	increased platelet aggregation	J:42276
Adora2b^tm1.1Msit/Adora2b^tm1.1Msit (either: (involves: C57BL/6) or (involves: C57BL/6 * CD-1 * ICR))	abnormal macrophage physiology	J:169155
Adora2b^tm1Kra/Adora2b^tm1Kra (involves: 129 * C57BL/6J)	abnormal leukocyte adhesion	J:111715
	abnormal leukocyte migration	J:111715
	enhanced leukocyte tethering or rolling	J:111715
Adora2b^tm1Till/Adora2b^tm1Till (B6.129P2-Adora2b^tm1Till)	abnormal cellular extravasation	J:125297
Adora3^{tm1(ADORA3)Msth}/Adora3^{tm1(ADORA3)Msth} (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal mast cell physiology	J:104494
	decreased mast cell degranulation	J:104494
Adora3^tm1Jbsn/Adora3^tm1Jbsn (either: (involves: 129P2/OlaHsd * C57BL/6 * DBA/2) or (involves: 129P2/OlaHsd * C57BL/6))	abnormal mast cell physiology	J:60293
Adora3^tm1Jbsn/Adora3^tm1Jbsn (B6.129P2-Adora3^tm1Jbsn)	abnormal mast cell degranulation	J:123463
Adora3^tm1Jbsn/Adora3^tm1Jbsn (B6.129P2-Adora3^tm1Jbsn)	impaired neutrophil recruitment	J:123463
Adra2b^tm1Gsb/Adra2b^tm1Gsb (B6.129-Adra2b^tm1Gsb)	hematopoietic system phenotype	J:166788
Adrb2^em1(IMPC)Mbp/Adrb2^em1(IMPC)Mbp (C57BL/6N-Adrb2^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Adrb2^tm1Bkk/Adrb2⁺ (involves: 129S1/Sv * 129X1/SvJ)	abnormal osteoclast differentiation	J:97566
Adrb2^tm1Bkk/Adrb2^tm1Bkk (involves: 129S1/Sv * 129X1/SvJ)	abnormal osteoclast differentiation	J:97566
	abnormal osteoclast morphology	J:97566
	abnormal osteoclast physiology	J:97566
Adrm1^{Gt(OST128063)Lex}/Adrm1^{Gt(OST128063)Lex} (involves: 129S5/SvEvBrd * C57BL/6J)	abnormal single-positive T cell number	J:166694
	enlarged thymus	J:166694
	increased CD4-positive, alpha-beta T cell number	J:166694
	increased CD8-positive, alpha-beta T cell number	J:166694
	thymus hyperplasia	J:166694
Ads3^NZB/Ads3^NZW (involves: NZB * NZW)	abnormal immunoglobulin level	J:7111
Ads3^NZW/Ads3^NZW (involves: NZB * NZW)	abnormal immunoglobulin level	J:7111
Ads4^NZB/Ads4^NZW (involves: NZB * NZW)	abnormal immunoglobulin level	J:7111
Ads4^NZW/Ads4^NZW (involves: NZB * NZW)	abnormal immunoglobulin level	J:7111
Adss2^{tm1b(EUCOMM)Wtsi}/Adss2⁺ (C57BL/6N-Adss2^{tm1b(EUCOMM)Wtsi}/Bay)	decreased eosinophil cell number	J:211773
Adtrp^tm1.1Clu/Adtrp^tm1.1Clu (involves: 129S4/SvJaeSor * C57BL/6)	increased mast cell number	J:295059
Afap1l2^{tm1b(KOMP)Wtsi}/Afap1l2^{tm1b(KOMP)Wtsi} (C57BL/6N-Afap1l2^{tm1b(KOMP)Wtsi}/Ucd)	abnormal spleen morphology	J:211773
	increased neutrophil cell number	J:211773
Afdn^em1(IMPC)Mbp/Afdn⁺ (C57BL/6N-Afdn^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	decreased lymphocyte cell number	J:211773
	decreased spleen weight	J:211773
	enlarged spleen	J:211773
	increased hematocrit	J:211773
	small spleen	J:211773
Aff1^Rob/Aff1⁺ (involves: BALB/cAnNCrl * C3H/HeN)	abnormal double-negative T cell morphology	J:82265
	decreased thymus weight	J:82265
	thymus hypoplasia	J:82265
Aff1^tm1Cim/Aff1^tm1Cim (involves: 129P2/OlaHsd * BALB/c)	abnormal T cell differentiation	J:63253
	decreased B cell number	J:63253
	decreased double-positive T cell number	J:63253
	decreased mature B cell number	J:63253
	decreased pre-B cell number	J:63253
	decreased single-positive T cell number	J:63253
	thymus hypoplasia	J:63253
Aff4^tm1Nosa/Aff4^tm1Nosa (involves: 129P2/OlaHsd * C57BL/6)	hematopoietic system phenotype	J:100030
Afg3l1^tm1.1Arte/Afg3l1^tm1.1Arte Afg3l2^tm1Arte/Afg3l2^tm1Arte Tg(Plp1-cre/ERT)3Pop/0 (involves: C57BL/6J * C57BL/6N)	microgliosis	J:237410
Afg3l2^tm1Arte/Afg3l2^tm1Arte Tg(Pcp2-cre)2Mpin/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	microgliosis	J:193564
Afm^{tm1a(KOMP)Wtsi}/Afm^{tm1a(KOMP)Wtsi} (C57BL/6N-Afm^{tm1a(KOMP)Wtsi}/Ics)	increased hemoglobin content	J:165965
Afmid^{tm1b(EUCOMM)Wtsi}/Afmid^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Afmid^{tm1b(EUCOMM)Wtsi}/H)	increased mean corpuscular volume	J:211773
Aftph^em1(IMPC)J/Aftph⁺ (C57BL/6NJ-Aftph^em1(IMPC)J/Mmjax)	increased erythrocyte cell number	J:211773
Aftph^em1(IMPC)J/Aftph⁺ (C57BL/6NJ-Aftph^em1(IMPC)J/Mmjax)	increased hematocrit	J:211773
Agbl4^em1(IMPC)Mbp/Agbl4^em1(IMPC)Mbp (C57BL/6NCrl-Agbl4^em1(IMPC)Mbp/Mmucd)	increased monocyte cell number	J:211773
Agbl4^{Tn(pb-Act-RFP)1.080115015-HRAZhu}/Agbl4^{Tn(pb-Act-RFP)1.080115015-HRAZhu} (involves: FVB/N)	abnormal megakaryocyte differentiation	J:233744
	abnormal megakaryocyte morphology	J:233744
	abnormal platelet alpha-granule morphology	J:233744
	abnormal platelet morphology	J:233744
	abnormal platelet physiology	J:233744
	abnormal platelet shape	J:233744
	abnormal spleen morphology	J:233744
	decreased platelet aggregation	J:233744
	decreased platelet alpha-granule number	J:233744
	hematopoietic system phenotype	J:233744
	increased megakaryocyte cell number	J:233744
	increased spleen weight	J:233744
	thrombocytosis	J:233744
Ager^tm1.1Arnd/Ager^tm1.1Arnd (B6.129P2-Ager^tm1.1Arnd)	decreased osteoclast cell number	J:104998
Ager^tm1Arnd/Ager⁺ Tg(Itgax-EGFP,-cre,-HBEGF,-luc)2Gjh/0 (involves: 129P2/OlaHsd * C57BL/6)	decreased dendritic cell number	J:194800
	decreased plasmacytoid dendritic cell number	J:194800
Agfg2^em1(IMPC)J/Agfg2^em1(IMPC)J (C57BL/6NJ-Agfg2^em1(IMPC)J/Mmjax)	decreased mean corpuscular hemoglobin	J:211773
Agk^em1Qiz/Agk^em1Qiz (involves: C57BL/6 * DBA/2)	abnormal CD8-positive, alpha beta T cell morphology	J:282052
	abnormal CD8-positive, alpha-beta T cell physiology	J:282052
	decreased effector memory CD8-positive, alpha-beta T cell number	J:282052
	hematopoietic system phenotype	J:282052
Agk^tm1.1Smoc/Agk^tm1.1Smoc (Not Specified)	decreased effector memory CD8-positive, alpha-beta T cell number	J:282052
Agk^tm1.1Smoc/Agk^tm1.1Smoc (Not Specified)	hematopoietic system phenotype	J:282052
Aglna/? (C57BL/6-Aglna/Anu)	abnormal spleen marginal zone morphology	J:169366
Aglna/? (C57BL/6-Aglna/Anu)	increased activated T cell number	J:169366
Ago2^tm1.1Tara/Ago2^tm1.1Tara Tg(Mx1-cre)1Cgn/0 (involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 * CBA)	abnormal erythrocyte morphology	J:165967
	abnormal erythrocyte physiology	J:165967
	abnormal erythropoiesis	J:165967
	anemia	J:165967
	decreased erythrocyte cell number	J:165967
	decreased hematocrit	J:165967
	decreased hemoglobin content	J:165967
	decreased mean corpuscular hemoglobin	J:165967
	decreased mean corpuscular volume	J:165967
	enlarged spleen	J:165967
	increased number of Heinz bodies	J:165967
	increased red blood cell distribution width	J:165967
	reticulocytosis	J:165967
Ago2^tm3.1Ghan/Ago2^tm3.1Ghan (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCr * CBA * Swiss Webster)	abnormal proerythroblast morphology	J:161968
	decreased erythrocyte cell number	J:161968
Agpat1^{tm1.1(KOMP)Vlcg}/Agpat1⁺ (B6N(Cg)-Agpat1^{tm1.1(KOMP)Vlcg}/J)	increased mean corpuscular hemoglobin	J:211773
Agpat2^tm1Garg/Agpat2^tm1Garg (involves: 129S6/SvEvTac)	increased spleen weight	J:146649
Agpat5^{em1(IMPC)Ccpcz}/Agpat5^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Agpat5^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	decreased NK cell number	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Agr2^tm1.1Lex/Agr2^tm1.1Lex (involves: 129S5/SvEvBrd * BALB/cJ * C57BL/6)	anemia	J:195573
Agr2^tm1.2Erle/Agr2^tm1.2Erle (involves: 129S4/SvJae * FVB/N)	increased mast cell number	J:148339
Agtpbp1^atms/Agtpbp1^atms (MRL/Mp-Agtpbp1^atms Fas^lpr)	decreased spleen weight	J:103944
Agtpbp1^atms/Agtpbp1^atms (MRL/Mp-Agtpbp1^atms)	abnormal lymphocyte cell number	J:103944
	abnormal spleen morphology	J:103944
	abnormal T cell differentiation	J:103944
	abnormal T cell physiology	J:103944
	abnormal T cell subpopulation ratio	J:103944
	decreased B cell number	J:103944
	decreased spleen weight	J:103944
	increased CD4-positive, alpha-beta T cell number	J:103944
	increased CD8-positive, alpha-beta T cell number	J:103944
	spleen hypoplasia	J:103944
Agtpbp1^atms/Agtpbp1^atms Fas^lpr/Fas^lpr (MRL/Mp-Agtpbp1^atms Fas^lpr)	enlarged spleen	J:103944
Agtpbp1^pcd-3J/Agtpbp1^pcd-3J (BALB/cByJ-Agtpbp1^pcd-3J/J)	hematopoietic system phenotype	J:233744
Agtr1a^{em1(IMPC)Rbrc}/Agtr1a^{em1(IMPC)Rbrc} (C57BL/6NJcl-Agtr1a^{em1(IMPC)Rbrc}/Rbrc)	abnormal erythrocyte cell number	J:211773
	abnormal hematocrit	J:211773
	abnormal hemoglobin content	J:211773
	abnormal mean corpuscular hemoglobin	J:211773
	abnormal platelet cell number	J:211773
	abnormal red blood cell distribution width	J:211773
	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased spleen weight	J:211773
Agtr1a^tm1Ecl/Agtr1a^tm1Ecl (involves: 129S2/SvPas * C57BL/6)	high mean erythrocyte cell number	J:124206
	increased hemoglobin content	J:124206
Agtrap^tm1Tamk/Agtrap^tm1Tamk (involves: C57BL/6N)	abnormal macrophage morphology	J:263253
aha/aha (Stock ICR/Ha)	hemolytic anemia	J:13761
Ahcy^{tm1b(EUCOMM)Hmgu}/Ahcy⁺ (C57BL/6N-Ahcy^{tm1b(EUCOMM)Hmgu}/Tcp)	increased basophil cell number	J:211773
Ahcyl1^{tm1a(EUCOMM)Wtsi}/Ahcyl1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Ahcyl1^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased mean platelet volume	J:211773
Ahnak^{tm1b(KOMP)Mbp}/Ahnak⁺ (C57BL/6N-Ahnak^{tm1b(KOMP)Mbp}/H)	increased large unstained cell number	J:211773
	increased monocyte cell number	J:211773
Ahnak^tm1Vtm/Ahnak^tm1Vtm (involves: 129S1/Sv * C57BL/6)	abnormal T cell activation	J:131148
	abnormal T-helper 1 physiology	J:131148
	decreased T cell proliferation	J:131148
Ahr^tm1Bra/Ahr^tm1Bra (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal Langerhans cell morphology	J:148870
	decreased spleen germinal center size	J:33827
	enlarged spleen	J:33827
	extramedullary hematopoiesis	J:33827
Ahr^tm1Bra/Ahr^tm1Bra (B6.129-Ahr^tm1Bra/J)	abnormal macrophage physiology	J:118646
Ahr^tm1Gonz/Ahr^tm1Gonz (involves: 129S4/SvJae * C57BL/6N)	abnormal spleen morphology	J:44690
	abnormal spleen red pulp morphology	J:44690
	decreased spleen white pulp amount	J:44690
	enlarged spleen	J:44690
	small spleen	J:25048
	spleen hypoplasia	J:25048
Ahr^tm2Bra/Ahr^tm2Bra (involves: 129/Sv * C57BL/6)	increased spleen weight	J:83597
Ahr^tm4.1Bra/Ahr^tm4.1Bra (involves: 129/Sv * C57BL/6)	enlarged spleen	J:141978
Ahrr^{tm1b(KOMP)Wtsi}/Ahrr^{tm1b(KOMP)Wtsi} (B6N(Cg)-Ahrr^{tm1b(KOMP)Wtsi}/J)	increased hemoglobin content	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
Ahsp^tm1.1Mjwe/Ahsp⁺ (involves: 129S6/SvEvTac * C57BL/6)	increased number of Heinz bodies	J:94421
Ahsp^tm1.1Mjwe/Ahsp⁺ Hbb-b1^tm1Unc/Hbb-b1⁺ Hbb-b2^tm1Unc/Hbb-b2⁺ (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6)	anemia	J:94421
	decreased hematocrit	J:94421
Ahsp^tm1.1Mjwe/Ahsp^tm1.1Mjwe (involves: 129S6/SvEvTac * C57BL/6)	abnormal definitive hematopoiesis	J:94421
	abnormal erythrocyte morphology	J:94421
	abnormal hemoglobin	J:94421
	abnormal hemoglobin content	J:94421
	acanthocytosis	J:94421
	anemia	J:94421
	anisopoikilocytosis	J:94421
	decreased hematocrit	J:94421
	decreased mean corpuscular hemoglobin	J:94421
	decreased mean corpuscular volume	J:94421
	enlarged spleen	J:94421
	increased erythroid progenitor cell number	J:94421
	increased hemoglobin concentration distribution width	J:94421
	increased number of Heinz bodies	J:94421
	increased red blood cell distribution width	J:94421
	leptocytosis	J:94421
	polychromatophilia	J:94421
	reticulocytosis	J:94421
Ahsp^tm1.1Mjwe/Ahsp^tm1.1Mjwe Hbb-b1^tm1Unc/Hbb-b1⁺ Hbb-b2^tm1Unc/Hbb-b2⁺ (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6)	abnormal erythrocyte morphology	J:94421
	anemia	J:94421
	anisocytosis	J:94421
	decreased hematocrit	J:94421
	decreased mean corpuscular volume	J:94421
	increased hemoglobin concentration distribution width	J:94421
	increased nucleated erythrocyte cell number	J:94421
	increased number of Heinz bodies	J:94421
Ahsp^tm1Mjwe/Ahsp⁺ (involves: 129 * C57BL/6)	reticulocytosis	J:77038
Ahsp^tm1Mjwe/Ahsp⁺ (involves: 129S6/SvEvTac * C57BL/6)	increased number of Heinz bodies	J:94421
Ahsp^tm1Mjwe/Ahsp⁺ Hbb-b1^tm1Unc/Hbb-b1⁺ Hbb-b2^tm1Unc/Hbb-b2⁺ (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6)	anemia	J:94421
	decreased hematocrit	J:94421
Ahsp^tm1Mjwe/Ahsp^tm1Mjwe (involves: 129 * C57BL/6)	abnormal erythropoiesis	J:77038
	abnormal hemoglobin	J:77038
	acanthocytosis	J:77038
	increased number of Heinz bodies	J:77038
	reticulocytosis	J:77038
Ahsp^tm1Mjwe/Ahsp^tm1Mjwe (involves: 129S6/SvEvTac * C57BL/6)	abnormal definitive hematopoiesis	J:94421
	abnormal erythrocyte morphology	J:94421
	abnormal hemoglobin	J:94421
	abnormal hemoglobin content	J:94421
	acanthocytosis	J:94421
	anemia	J:94421
	anisocytosis	J:94421
	anisopoikilocytosis	J:94421
	decreased hematocrit	J:94421
	decreased mean corpuscular hemoglobin	J:94421
	decreased mean corpuscular volume	J:94421
	enlarged spleen	J:94421
	increased erythroid progenitor cell number	J:94421
	increased hemoglobin concentration distribution width	J:94421
	increased number of Heinz bodies	J:94421
	leptocytosis	J:94421
	polychromatophilia	J:94421
	reticulocytosis	J:94421
Ahsp^tm1Mjwe/Ahsp^tm1Mjwe Hbb-b1^tm1Unc/Hbb-b1⁺ Hbb-b2^tm1Unc/Hbb-b2⁺ (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6)	abnormal erythrocyte morphology	J:94421
	anemia	J:94421
	anisocytosis	J:94421
	decreased hematocrit	J:94421
	decreased mean corpuscular volume	J:94421
	increased hemoglobin concentration distribution width	J:94421
	increased nucleated erythrocyte cell number	J:94421
	increased number of Heinz bodies	J:94421
Aia1^NZB/Omr/Aia1^NZB/Omr (involves: NZB/Omr * NZC/Omr)	increased susceptibility to autoimmune hemolytic anemia	J:6517
Aia1^NZB/Omr/Aia1^NZC/Omr (involves: NZB/Omr * NZC/Omr)	increased susceptibility to autoimmune hemolytic anemia	J:6517
Aicda^em1Jaych/Aicda^em1Jaych (involves: C57BL/6J)	abnormal class switch recombination	J:305843
	abnormal splenic cell ratio	J:305843
	hematopoietic system phenotype	J:305843
	increased IgM level	J:305843
Aicda^m1Btlr/Aicda^m1Btlr (C57BL/6J-Aicda^m1Btlr)	decreased IgE level	J:265155
Aicda^m1Btlr/Aicda^m1Btlr (C57BL/6J-Aicda^m1Btlr)	increased IgM level	J:265155
Aicda^m2Btlr/Aicda^m2Btlr (C57BL/6J-Aicda^m2Btlr)	decreased IgE level	J:265156
Aicda^m2Btlr/Aicda^m2Btlr (C57BL/6J-Aicda^m2Btlr)	increased IgM level	J:265156
Aicda^tm1(cre)Mnz/Aicda⁺ Igh^tm3Mnz/Igh⁺ Myc^tm37Mnz/Myc⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:145691
Aicda^tm1(cre)Mnz/Aicda⁺ Igh^tm3Mnz/Igh⁺ Myc^tm39Mnz/Myc⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:145691
Aicda^tm1.1Fwa/Aicda^tm1.1Fwa (involves: 129S6/SvEvTac)	abnormal class switch recombination	J:209271
Aicda^tm1.1Fwa/Aicda^tm1.1Fwa (involves: 129S6/SvEvTac)	abnormal somatic hypermutation frequency	J:209271
Aicda^{tm1b(EUCOMM)Hmgu}/Aicda^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Aicda^{tm1b(EUCOMM)Hmgu}/Wtsi)	decreased follicular B cell number	J:211773
	decreased late germinal center B cell number	J:211773
	increased early germinal center B cell number	J:211773
	increased germinal center B cell number	J:211773
	increased leukocyte cell number	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
Aicda^tm1Hon/Aicda⁺ (involves: C57BL/6 * CBA)	abnormal class switch recombination	J:136224, J:141427
Aicda^tm1Hon/Aicda⁺ (involves: C57BL/6 * CBA)	abnormal somatic hypermutation frequency	J:141427
Aicda^tm1Hon/Aicda^tm1.1Fwa (involves: 129S/SvEv * C57BL/6NCrlj * CBA/JNCrlj)	abnormal class switch recombination	J:209271
Aicda^tm1Hon/Aicda^tm1Hon (involves: C57BL/6 * CBA)	abnormal class switch recombination	J:141427, J:73659, J:120658
	abnormal somatic hypermutation frequency	J:136224, J:141427
	decreased IgA level	J:169227
	decreased IgG1 level	J:169227, J:73659
	decreased IgG2a level	J:73659
	decreased IgG2b level	J:169227
	decreased IgG3 level	J:169227
	decreased IgG level	J:169227
	increased germinal center B cell number	J:169227
	increased IgM level	J:169227, J:73659
Aicda^tm1Hon/Aicda^tm1Hon Bcl6^tm1.1Jwan/Bcl6^tm1.1Jwan (involves: 129S6/SvEvTac * C57BL/6NCrlj * CBA/JNCrlj)	abnormal somatic hypermutation frequency	J:190534
Aicda^tm1Hon/Aicda^tm1Hon Exo1^tm1Wed/Exo1^tm1Wed Igh^tm4.1Mnz/Igh⁺ (involves: C57BL/6 * CBA/JNCrlj * SJL)	abnormal immunoglobulin heavy chain V(D)J recombination	J:194603
Aicda^tm1Hon/Aicda^tm1Hon Exo1^tm1Wed/Exo1^tm1Wed Igh^tm4.1Mnz/Igh⁺ Trp53bp1^tm1Jc/Trp53bp1^tm1Jc (involves: 129 * C57BL/6 * CBA/JNCrlj * SJL)	abnormal immunoglobulin heavy chain V(D)J recombination	J:194603
Aicda^tm1Hon/Aicda^tm1Hon Igh^tm3Mnz/Igh^tm4.1Mnz Trp53bp1^tm1Jc/Trp53bp1^tm1Jc (involves: 129 * C57BL/6 * CBA)	abnormal class switch recombination	J:159173
Aicda^tm1Hon/Aicda^tm1Hon Igh^tm4.1Mnz/Igh⁺ (involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)	abnormal immunoglobulin heavy chain V(D)J recombination	J:194603
Aicda^tm1Hon/Aicda^tm1Hon Igh^tm4.1Mnz/Igh⁺ Trp53bp1^tm1Jc/Trp53bp1^tm1Jc (involves: 129 * C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)	abnormal immunoglobulin heavy chain V(D)J recombination	J:194603
Aicda^tm1Hon/Aicda^tm1Hon Ighm^{tm1.1(IGH-2)Cog}/Ighm⁺ (involves: 129P2/OlaHsd * C57BL/6 * CBA * FVB/N)	abnormal B cell physiology	J:157575
Aicda^tm1Hon/Aicda^tm3Mnz (involves: C57BL/6 * CBA)	abnormal class switch recombination	J:141427
Aicda^tm1Hon/Aicda^tm3Mnz (involves: C57BL/6 * CBA)	abnormal somatic hypermutation frequency	J:141427
Aicda^tm1Hon/Aicda^tm4Mnz (involves: C57BL/6 * CBA)	abnormal class switch recombination	J:141427
Aicda^tm1Hon/Aicda^tm4Mnz (involves: C57BL/6 * CBA)	abnormal somatic hypermutation frequency	J:141427
Aicda^tm2.1Hon/Aicda^tm2.1Hon (C57BL/6-Aicda^tm2.1Hon)	abnormal somatic hypermutation frequency	J:169227
	decreased IgG1 level	J:169227
	increased germinal center B cell number	J:169227
Aicda^tm2.1Hon/Aicda^tm2.1Hon (involves: BALB/c * C57BL/6)	increased germinal center B cell number	J:169227
Aicda^tm3.1Mnz/Aicda^tm3.1Mnz (involves: C57BL/6)	abnormal class switch recombination	J:147109
Aicda^tm3.1Mnz/Aicda^tm3.1Mnz (involves: C57BL/6)	abnormal somatic hypermutation frequency	J:147109
Aicda^tm3Mnz/Aicda⁺ (involves: C57BL/6 * CBA)	abnormal class switch recombination	J:141427
Aicda^tm3Mnz/Aicda⁺ (involves: C57BL/6 * CBA)	abnormal somatic hypermutation frequency	J:141427
Aicda^tm4.1Mnz/Aicda^tm4.1Mnz (involves: C57BL/6)	abnormal class switch recombination	J:147109
Aicda^tm4.1Mnz/Aicda^tm4.1Mnz (involves: C57BL/6)	abnormal somatic hypermutation frequency	J:147109
Aicda^tm4Mnz/Aicda⁺ (involves: C57BL/6 * CBA)	abnormal class switch recombination	J:141427
Aicda^tm4Mnz/Aicda⁺ (involves: C57BL/6 * CBA)	abnormal somatic hypermutation frequency	J:141427
Aif1^tm1Nsib/Aif1^tm1Nsib (involves: 129S/SvEv * C57BL/6)	decreased spleen weight	J:204462
Aif1^tm1Nsib/Aif1^tm1Nsib (involves: 129S/SvEv * C57BL/6)	thrombocytopenia	J:204462
Aif1l^{tm1b(EUCOMM)Wtsi}/Aif1l^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Aif1l^{tm1b(EUCOMM)Wtsi}/Bay)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased spleen weight	J:211773
	small thymus	J:211773
Aim2^{em1(IMPC)Ccpcz}/Aim2^{em1(IMPC)Ccpcz} (C57BL/6N-Aim2^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Aim2^{Gt(CSG445)Byg}/Aim2^{Gt(CSG445)Byg} (involves: 129P2/OlaHsd * C57BL/6)	abnormal macrophage physiology	J:158969
	decreased NK cell number	J:158969
Aim2^{Gt(CSG445)Byg}/Aim2^{Gt(CSG445)Byg} (B6.129P2-Aim2^{Gt(CSG445)Byg}/J)	decreased macrophage apoptosis	J:234263
Aim2^tm1.1Vmd/Aim2^tm1.1Vmd (C57BL/6-Aim2^tm1.1Vmd)	abnormal macrophage physiology	J:160545
Aim2^tm1.2Arte/Aim2^tm1.2Arte Dnase2a^tm1Osa/Dnase2a^tm1Osa Ifnar1^tm1Agt/Ifnar1^tm1Agt (involves: 129 * BALB/c * C57BL/6 * C57BL/6J)	abnormal spleen morphology	J:238323
	enlarged spleen	J:238323
	increased spleen weight	J:238323
Aimp1^em1(IMPC)Tcp/Aimp1^em1(IMPC)Tcp (C57BL/6NCrl-Aimp1^em1(IMPC)Tcp/Tcp)	enlarged spleen	J:211773
Aire^{tm1.1(cre)Ghr}/Aire^{tm1.1(cre)Ghr} (Not Specified)	decreased dendritic cell number	J:176844
	decreased regulatory T cell number	J:176844
	increased dendritic cell number	J:176844
Aire^{tm1.1(NCOM)Mfgc}/Aire^{tm1.1(NCOM)Mfgc} (C57BL/6N-Aire^{tm1.1(NCOM)Mfgc}/Tcp)	increased monocyte cell number	J:211773
Aire^tm1.1Doi/Aire^tm1.1Doi (involves: 129S2/SvPas * C57BL/6)	abnormal thymus medulla morphology	J:83422
	increased T cell number	J:83422
Aire^tm1.1Doi/Aire^tm1.1Doi (NOD.129S2-Aire^tm1.1Doi)	abnormal CD4-positive, alpha-beta T cell physiology	J:135154
Aire^tm1.1Doi/Aire^tm1.1Doi Tg(Ins2-TFRC/OVA)296Wehi/0 Tg(TcraTcrb)425Cbn/0 (involves: 129P2/OlaHsd * C57BL/6)	abnormal T cell differentiation	J:135154
	decreased CD4-positive, alpha-beta T cell number	J:135154
Aire^tm1Mand/Aire⁺ (NOD.129P2-Aire^tm1Mand)	abnormal CD4-positive, alpha-beta T cell physiology	J:135154, J:188686
Aire^tm1Mand/Aire⁺ Tg(Ins2-TFRC/OVA)296Wehi/0 Tg(TcraTcrb)425Cbn/0 (involves: 129P2/OlaHsd * C57BL/6)	abnormal T cell differentiation	J:135154
Aire^tm1Mand/Aire^tm1.1Doi (NOD.129-Aire^tm1Mand/Aire^tm1.1Doi)	abnormal CD4-positive, alpha-beta T cell physiology	J:135154
Aire^tm1Mmat/Aire^tm2Mmat (involves: C57BL/6 * CBA)	abnormal thymus morphology	J:141379
Aire^tm1Mmat/Aire^tm2Mmat Tg(TcraTcrb)425Cbn/? (involves: BALB/c * C57BL/6 * CBA)	abnormal thymus morphology	J:141379
Aire^tm1Pltn/Aire^tm1Pltn (involves: 129S4/SvJae * C57BL/6)	abnormal T cell morphology	J:77873
	increased T cell proliferation	J:77873
	thymus atrophy	J:77873
Aire^tm1Pltn/Aire^tm1Pltn (B6.129S4-Aire^tm1Pltn)	abnormal definitive hematopoiesis	J:115076
	abnormal metallophilic macrophage morphology	J:115076
	abnormal myelopoiesis	J:115076
	abnormal spleen marginal zone morphology	J:115076
	decreased follicular B cell number	J:115076
	enlarged spleen	J:115076
	increased B cell number	J:115076
	increased marginal zone B cell number	J:115076
	increased monocyte cell number	J:115076
	increased spleen weight	J:115076
Aire^tm1Ptsn/Aire^tm1Ptsn (C57BL/6-Aire^tm1Ptsn)	abnormal T cell activation	J:145910
Aire^tm1Ptsn/Aire^tm1Ptsn (C57BL/6-Aire^tm1Ptsn)	abnormal thymus medulla morphology	J:145910
Aire^tm1Ptsn/Aire^tm1Ptsn (C.B6-Aire^tm1Ptsn)	abnormal regulatory T cell physiology	J:174653
	abnormal T-helper 1 physiology	J:174653
	abnormal T-helper 17 cell physiology	J:174653
Aire^tm2Mmat/Aire^tm2Mmat (involves: C57BL/6 * CBA)	abnormal thymus morphology	J:141379
	abnormal thymus physiology	J:141379
	absent Hassall's corpuscle	J:141379
Ajuba^em1(IMPC)H/Ajuba^em1(IMPC)H (C57BL/6N-Ajuba^em1(IMPC)H/H)	decreased lymphocyte cell number	J:211773
	increased large unstained cell number	J:211773
	increased neutrophil cell number	J:211773
Ak4^{em1(IMPC)Kmpc}/Ak4^{em1(IMPC)Kmpc} (C57BL/6NTac-Ak4^{em1(IMPC)Kmpc}/Kmpc)	decreased erythrocyte cell number	J:211773
Ak7^{em1(IMPC)Ccpcz}/Ak7⁺ (C57BL/6NCrl-Ak7^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Akap8l^em1(IMPC)J/Akap8l^em1(IMPC)J (C57BL/6NJ-Akap8l^em1(IMPC)J/Mmjax)	thrombocytopenia	J:211773
Akap9^{tm1a(KOMP)Wtsi}/Akap9⁺ (involves: C57BL/6 * C57BL/6N)	decreased B cell number	J:213427
	decreased mature B cell number	J:213427
	increased CD4-positive, alpha-beta T cell number	J:213427
	increased CD8-positive, alpha-beta T cell number	J:213427
	increased T cell number	J:213427
Akap10^{tm1.1(KOMP)Vlcg}/Akap10⁺ (C57BL/6N-Akap10^{tm1.1(KOMP)Vlcg}/Ucd)	increased hematocrit	J:211773
Akap11^{tm1b(EUCOMM)Hmgu}/Akap11^{tm1b(EUCOMM)Hmgu} (B6N(Cg)-Akap11^{tm1b(EUCOMM)Hmgu}/J)	decreased leukocyte cell number	J:211773
Akap12^tm1Ihg/Akap12^tm1Ihg (involves: 129S4/SvJae * C57BL/6)	increased spleen red pulp amount	J:138882
Akap13^em1(IMPC)Mbp/Akap13^em1(IMPC)Mbp (C57BL/6N-Akap13^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Akap13^tm1Segj/Akap13⁺ (involves: 129)	abnormal lymphocyte physiology	J:111574
	abnormal splenocyte physiology	J:181088
	decreased B cell number	J:181088
	decreased IgG1 level	J:181088
	decreased spleen B cell follicle size	J:181088
	decreased spleen weight	J:181088
	decreased splenocyte number	J:181088
	decreased transitional stage T2 B cell number	J:181088
	increased transitional stage T1 B cell number	J:181088
	small spleen	J:181088
	spleen hypoplasia	J:181088
Akna^tm1Mak/Akna^tm1Mak (B6.129P2-Akna^tm1Mak)	increased neutrophil cell number	J:233952
Akr1a1^{Gt(OST222400)Lex}/Akr1a1^{Gt(OST222400)Lex} (B6.129S5-Akr1a1^{Gt(OST222400)Lex})	abnormal osteoclast physiology	J:164548
	increased osteoclast cell number	J:164548
Akr1c18^tm1Jni/Akr1c18^tm1Jni (involves: 129P2/OlaHsd * C57BL/6)	hematopoietic system phenotype	J:95560
Akr1c19^em1(IMPC)J/Akr1c19^em1(IMPC)J (C57BL/6NJ-Akr1c19^em1(IMPC)J/Mmjax)	increased erythrocyte cell number	J:211773
Akt1^tm1Nhy/Akt1^tm1Nhy (involves: 129/Sv * C57BL/6)	abnormal thymus morphology	J:71404
Akt1^tm1Pnt/Akt1^tm1Pnt Akt2^tm1.1Mbb/Akt2^tm1.1Mbb Akt3^tm1Mbb/Akt3^tm1Mbb Tg(Lck-cre)1Cwi/0 (involves: 129P2/OlaHsd)	arrested T cell differentiation	J:135903
	decreased double-positive T cell number	J:135903
	increased double-negative T cell number	J:135903
	increased T cell apoptosis	J:135903
	thymus hypoplasia	J:135903
Akt1^tm1Pnt/Akt1^tm1Pnt Akt2^tm1.1Mbb/Akt2^tm1.1Mbb Tg(Lck-cre)1Cwi/0 (involves: 129P2/OlaHsd)	arrested T cell differentiation	J:135903
	decreased double-positive T cell number	J:135903
	increased double-negative T cell number	J:135903
	increased T cell apoptosis	J:135903
	thymus hypoplasia	J:135903
Akt1^tm1Pnt/Akt1^tm1Pnt Akt3^tm1Mbb/Akt3^tm1Mbb Tg(Lck-cre)1Cwi/0 (Not Specified)	decreased double-positive T cell number	J:135903
	thymus hypoplasia	J:135903
Alad^em1(IMPC)Tcp/Alad⁺ (C57BL/6NCrl-Alad^em1(IMPC)Tcp/Tcp)	decreased red blood cell distribution width	J:211773
Alad^em1(IMPC)Tcp/Alad⁺ (C57BL/6NCrl-Alad^em1(IMPC)Tcp/Tcp)	enlarged thymus	J:211773
Alas2^tm1Mym/Y (involves: 129P2/OlaHsd * C57BL/6)	abnormal embryonic erythropoiesis	J:58508
	abnormal embryonic hematopoiesis	J:58508
	anemia	J:58508
	pancytopenia	J:58508
Aldh1a2^tm1Dll/Aldh1a2^tm1Ipc (involves: CD-1)	athymia	J:81969
Aldh1a2^tm1Dll/Aldh1a2^tm1Ipc (involves: CD-1)	thymus hypoplasia	J:81969
Aldh2^tm1.1Mak/Aldh2⁺ (involves: 129S6/SvEvTac * C57BL/6J)	decreased leukocyte cell number	J:223796
Aldh2^tm1.1Mak/Aldh2^tm1.1Mak (involves: 129S6/SvEvTac * C57BL/6J)	decreased leukocyte cell number	J:223796
Aldh2^{tm1a(EUCOMM)Wtsi}/Aldh2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Aldh2^{tm1a(EUCOMM)Wtsi}/Ieg)	decreased CD4-positive, alpha-beta T cell number	J:165965
	decreased CD8-positive, alpha-beta T cell number	J:165965
	decreased T cell number	J:165965
Aldh2^{tm1a(EUCOMM)Wtsi}/Aldh2^{tm1a(EUCOMM)Wtsi} Fancd2^tm1Hou/Fancd2^tm1Hou (involves: 129S4/SvJae * C57BL/6J * C57BL/6N)	abnormal bone marrow cell morphology/development	J:193232
	abnormal hematopoietic stem cell physiology	J:188123
	abnormal lymphopoiesis	J:193232
	abnormal spleen morphology	J:188123
	abnormal thymus morphology	J:188123
	anemia	J:188123, J:193232
	decreased bone marrow cell number	J:188123, J:193232
	decreased erythrocyte cell number	J:188123, J:193232
	decreased hematocrit	J:188123
	decreased hematopoietic stem cell number	J:188123
	decreased hemoglobin content	J:188123, J:193232
	decreased leukocyte cell number	J:188123
	enlarged spleen	J:193232
	extramedullary hematopoiesis	J:188123
	impaired hematopoiesis	J:193232
	increased CD8-positive, alpha-beta T cell number	J:193232
	increased double-positive T cell number	J:193232
	increased mean corpuscular volume	J:188123
	pancytopenia	J:188123
	thrombocytopenia	J:188123
Aldh3a2^{tm1a(EUCOMM)Wtsi}/Aldh3a2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Aldh3a2^{tm1a(EUCOMM)Wtsi}/Ics)	decreased erythrocyte cell number	J:165965
	decreased hemoglobin content	J:165965
	decreased mean corpuscular volume	J:165965
	increased mean corpuscular volume	J:165965
Aldh9a1^{tm1b(KOMP)Wtsi}/Aldh9a1^{tm1b(KOMP)Wtsi} (C57BL/6N-Aldh9a1^{tm1b(KOMP)Wtsi}/Bay)	decreased hemoglobin content	J:211773
Aldoa^{tm1.1(KOMP)Wtsi}/Aldoa⁺ (C57BL/6N-Aldoa^{tm1.1(KOMP)Wtsi}/Bay)	decreased leukocyte cell number	J:211773
Alg1^{tm1b(KOMP)Wtsi}/Alg1⁺ (C57BL/6N-Alg1^{tm1b(KOMP)Wtsi}/Nju)	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
Alg13^{tm1a(KOMP)Wtsi}/Alg13^{tm1a(KOMP)Wtsi} (C57BL/6N-Alg13^{tm1a(KOMP)Wtsi}/Wtsi)	increased leukocyte cell number	J:211773
Alkbh1^{tm1b(EUCOMM)Hmgu}/Alkbh1⁺ (C57BL/6N-Alkbh1^{tm1b(EUCOMM)Hmgu}/Ieg)	abnormal spleen morphology	J:211773
	increased plasmacytoid dendritic cell number	J:211773
Alkbh7^tm1.1Klng/Alkbh7^tm1.1Klng (involves: 129S2/SvPas * C57BL/6J)	hematopoietic system phenotype	J:299035
Alkbh8^{tm1b(EUCOMM)Hmgu}/Alkbh8^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Alkbh8^{tm1b(EUCOMM)Hmgu}/Ieg)	increased mean corpuscular volume	J:211773
	increased mean platelet volume	J:211773
Alo1/Alo1 (involves: C3H/HeJ * C57BL/6J)	enlarged spleen	J:109802
	extramedullary hematopoiesis	J:109802
	increased bone marrow cell number	J:109802
Alo1/Alo1⁺ (involves: C3H/HeJ * C57BL/6J)	enlarged spleen	J:109802
	extramedullary hematopoiesis	J:109802
	increased bone marrow cell number	J:109802
Alo2/Alo2 (involves: C3H/HeJ * C57BL/6J)	enlarged spleen	J:109802
	extramedullary hematopoiesis	J:109802
	increased bone marrow cell number	J:109802
Alo2/Alo2⁺ (involves: C3H/HeJ * C57BL/6J)	enlarged spleen	J:109802
	extramedullary hematopoiesis	J:109802
	increased bone marrow cell number	J:109802
Alox5^tm1Bhk/Alox5^tm1Bhk (either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * C57BL/6 * DBA/2))	abnormal neutrophil physiology	J:68714
	hematopoietic system phenotype	J:68714
	impaired neutrophil chemotaxis	J:68714
	impaired neutrophil recruitment	J:68714
Alox5^tm1Fun/Alox5^tm1Fun (involves: 129S2/SvPas * C57BL/6)	hematopoietic system phenotype	J:21372
Alox5^tm1Fun/Alox5^tm1Fun (involves: 129S2/SvPas * C57BL/6)	small spleen	J:21372
Alox5ap^tm1Bhk/Alox5ap^tm1Bhk (involves: 129P2/OlaHsd * 129S/SvEv)	impaired neutrophil recruitment	J:39229
Alox12^tm1Fun/Alox12^tm1Fun (involves: 129S2/SvPas * C57BL/6)	increased platelet aggregation	J:46896
Alox15^tm1Fun/Alox15^tm1Fun (involves: 129/Sv * C57BL/6)	hematopoietic system phenotype	J:44778
Alox15^tm1Fun/Alox15^tm1Fun (B6.129S2-Alox15^tm1Fun/J)	abnormal bone marrow cell number	J:119405
	abnormal myeloblast morphology/development	J:119405
	abnormal myelopoiesis	J:119405
	abnormal spleen red pulp morphology	J:119405
	abnormal spleen white pulp morphology	J:119405
	anemia	J:119405
	decreased spleen B cell follicle number	J:119405
	increased basophil cell number	J:119405
	increased leukocyte cell number	J:119405
	increased spleen weight	J:119405
	intermingled spleen red and white pulp	J:119405
Aloxe3^em1(IMPC)Mbp/Aloxe3⁺ (C57BL/6N-Aloxe3^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	small spleen	J:211773
Alpl^tm1Jlm/Alpl^tm1Jlm (either: (involves: 129S2/SvPas) or (involves: 129S2/SvPas * C57BL/6J))	abnormal spleen morphology	J:39015
	abnormal thymus cortex morphology	J:39015
	decreased leukocyte cell number	J:39015
	pale spleen	J:39015
	small spleen	J:39015
Altre^tm1.1Hbgl/Altre^tm1.1Hbgl Foxp3^{tm4(YFP/icre)Ayr}/Y (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal regulatory T cell physiology	J:342907
	decreased regulatory T cell number	J:342907
	decreased T cell number	J:342907
	increased CD8-positive, alpha-beta T cell number	J:342907
	increased memory T cell number	J:342907
	increased regulatory T cell apoptosis	J:342907
Amdhd1^{tm2b(EUCOMM)Hmgu}/Amdhd1^{tm2b(EUCOMM)Hmgu} (C57BL/6N-Amdhd1^{tm2b(EUCOMM)Hmgu}/BayMmucd)	increased lymphocyte cell number	J:211773
Amelx^{em1(IMPC)Ccpcz}/Y (C57BL/6N-Amelx^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	decreased CD4-positive NK T cell number	J:211773
	decreased memory-marker CD4-positive NK T cell number	J:211773
	decreased NK T cell number	J:211773
	enlarged thymus	J:211773
	small spleen	J:211773
Amelx^{em1(IMPC)Ccpcz}/Amelx⁺ (C57BL/6N-Amelx^{em1(IMPC)Ccpcz}/Ccpcz)	decreased lymphocyte cell number	J:211773
	increased eosinophil cell number	J:211773
Amelx^{em1(IMPC)Ccpcz}/Amelx^{em1(IMPC)Ccpcz} (C57BL/6N-Amelx^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Amer1^tm1.2Nbar/Y (involves: 129S4/SvJae * C57BL/6 * CD-1 * SJL)	spleen hypoplasia	J:173242
Amhr2^tm3(cre)Bhr/Amhr2⁺ Ctnnb1^tm1Mmt/Ctnnb1⁺ Pten^tm1Hwu/Pten^tm1Hwu (involves: 129S4/SvJae * 129S7/SvEvBrd * 129X1/SvJ)	anemia	J:142150
	decreased hematocrit	J:142150
	extramedullary hematopoiesis	J:142150
Amhr2^tm3(cre)Bhr/Amhr2⁺ Pten^tm1Hwu/Pten^tm1Hwu (involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6)	decreased uterine NK cell number	J:170203
Ampd1^{tm1b(KOMP)Wtsi}/Ampd1⁺ (C57BL/6N-Ampd1^{tm1b(KOMP)Wtsi}/Ucd)	decreased neutrophil cell number	J:211773
	increased mean platelet volume	J:211773
Ampd3^tm1Tm/Ampd3^tm1Tm (Not Specified)	abnormal erythrocyte physiology	J:203909
	increased erythrocyte osmotic fragility	J:203909
	increased mean corpuscular volume	J:203909
Ampd3^tm1Tm/Ampd3^tm1Tm Pklr^slc/Pklr^slc (involves: CBA/NSlc)	abnormal erythrocyte morphology	J:203909
	abnormal erythrocyte physiology	J:203909
	anemia	J:203909
	enlarged spleen	J:203909
	increased erythrocyte osmotic fragility	J:203909
	reticulocytosis	J:203909
Ampd3^{tm2a(KOMP)Wtsi}/Ampd3^{tm2a(KOMP)Wtsi} (B6JTyr;B6N-Ampd3^{tm2a(KOMP)Wtsi}/Wtsi)	increased leukocyte cell number	J:165965
Amt^em1(IMPC)Tcp/Amt⁺ (C57BL/6NCrl-Amt^em1(IMPC)Tcp/Tcp)	increased erythrocyte cell number	J:211773
Amtn^em1(IMPC)Mbp/Amtn^em1(IMPC)Mbp (C57BL/6N-Amtn^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	small spleen	J:211773
Anapc2^tm1Kna/Anapc2^tm2Kna Tg(Mx1-cre)1Cgn/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	anemia	J:87782
	decreased hemoglobin content	J:87782
Anapc7^em1(IMPC)J/Anapc7^em1(IMPC)J (C57BL/6NJ-Anapc7^em1(IMPC)J/Mmjax)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
	increased leukocyte cell number	J:211773
Anapc13^{tm2b(EUCOMM)Wtsi}/Anapc13⁺ (C57BL/6N-Anapc13^{tm2b(EUCOMM)Wtsi}/Bay)	increased mean corpuscular volume	J:211773
anem/anem (BALB/c-anem)	anemia	J:227974
	decreased erythrocyte cell number	J:227974
	increased leukocyte cell number	J:227974
	reticulocytosis	J:227974
Ang^{tm1.1(KOMP)Vlcg}/Ang^{tm1.1(KOMP)Vlcg} (C57BL/6N-Ang^{tm1.1(KOMP)Vlcg}/Ucd)	increased eosinophil cell number	J:211773
Ang^tm1Dats/Ang^tm1Dats (Not Specified)	abnormal common myeloid progenitor cell morphology	J:236081
	abnormal granulocyte monocyte progenitor cell morphology	J:236081
	abnormal hematopoietic stem cell physiology	J:236081
	abnormal hematopoietic system physiology	J:236081
	abnormal megakaryocyte-erythroid progenitor cell morphology	J:236081
	decreased hematopoietic cell number	J:236081
	decreased leukocyte cell number	J:236081
	increased hematopoietic stem cell number	J:236081
	increased hematopoietic stem cell proliferation	J:236081
	increased lymphocyte cell number	J:236081
Angel1^{tm1(NCOM)Cmhd}/Angel1^{tm1(NCOM)Cmhd} (C57BL/6N-Angel1^{tm1(NCOM)Cmhd}/2Tcp)	increased hematocrit	J:165965
	increased hemoglobin content	J:165965
Angpt2^em1(IMPC)Mbp/Angpt2^em1(IMPC)Mbp (C57BL/6NCrl-Angpt2^em1(IMPC)Mbp/Mmucd)	abnormal thymus morphology	J:211773
	small thymus	J:211773
Angptl2^tm1Yo/Angptl2^tm1Yo (B6.Cg-Angptl2^tm1Yo)	impaired macrophage chemotaxis	J:152387
Angptl7^em1Pli/Angptl7^em1Pli (Not Specified)	abnormal fetal liver hematopoietic progenitor cell morphology	J:301766
	decreased granulocyte monocyte progenitor cell number	J:301766
	decreased hematopoietic stem cell number	J:301766
Ank1^ity16/Ank1⁺ (involves: 129S1/Sv * 129X1/SvJ * DBA/2J)	extramedullary hematopoiesis	J:199427
Ank1^ity16/Ank1⁺ (involves: 129S1/Sv * 129X1/SvJ * DBA/2J)	increased erythrocyte cell number	J:199427
Ank1^ity16/Ank1^ity16 (involves: 129S1/Sv * 129X1/SvJ * DBA/2J)	abnormal erythrocyte morphology	J:199427
	abnormal erythropoiesis	J:199427
	anisocytosis	J:199427
	decreased erythrocyte cell number	J:199427
	decreased hematocrit	J:199427
	decreased hemoglobin content	J:199427
	decreased spleen iron level	J:199427
	enlarged spleen	J:199427
	hemolytic anemia	J:199427
	increased leukocyte cell number	J:199427
	increased lymphocyte cell number	J:199427
	increased neutrophil cell number	J:199427
	reticulocytosis	J:199427
Ank1^M1Btlr/Ank1⁺ (C57BL/6J-Ank1^m1Btlr)	decreased mean corpuscular hemoglobin	J:203831
	decreased mean corpuscular volume	J:203831
	hemolysis	J:203831
	increased erythrocyte cell number	J:203831
	increased erythrocyte osmotic fragility	J:203831
Ank1^M1Btlr/Ank1^M1Btlr (C57BL/6J-Ank1^m1Btlr)	abnormal erythrocyte morphology	J:203831
	abnormal spleen morphology	J:203831
	decreased mean corpuscular hemoglobin	J:203831
	decreased mean corpuscular volume	J:203831
	enlarged spleen	J:203831
	extramedullary hematopoiesis	J:203831
	hemolysis	J:203831
	increased erythrocyte cell number	J:203831
	increased erythrocyte osmotic fragility	J:203831
	increased spleen iron level	J:203831
	microcytosis	J:203831
	reticulocytosis	J:203831
	spherocytosis	J:203831
	stomatocytosis	J:203831
Ank1^M1Wlst/Ank1⁺ (involves: C3H/HeJ * C57BL/6)	decreased cellular hemoglobin content	J:170562
	decreased mean corpuscular volume	J:170562
	increased erythrocyte cell number	J:170562
Ank1^M1Wlst/Ank1⁺ (involves: 129S1/SvImJ * C3H/HeJ * C57BL/6)	abnormal erythrocyte morphology	J:170562
	enlarged spleen	J:170562
Ank1^M1Wlst/Ank1⁺ (C3.B6-Ank1^M1Wlst)	decreased cellular hemoglobin content	J:170562
	decreased mean corpuscular hemoglobin concentration	J:170562
	decreased mean corpuscular volume	J:170562
	increased erythrocyte cell number	J:170562
	increased erythrocyte osmotic fragility	J:170562
	polychromatophilia	J:170562
	reticulocytosis	J:170562
Ank1^M1Wlst/Ank1^M1Wlst (involves: C3H/HeJ * C57BL/6)	abnormal leukocyte cell number	J:170562
	decreased hematocrit	J:170562
	decreased hemoglobin content	J:170562
	decreased mean corpuscular hemoglobin concentration	J:170562
	decreased mean corpuscular volume	J:170562
	increased erythrocyte cell number	J:170562
Ank1^M1Wlst/Ank1^M1Wlst (involves: 129S1/SvImJ * C3H/HeJ * C57BL/6)	abnormal common myeloid progenitor cell morphology	J:170562
	abnormal erythrocyte morphology	J:170562
	abnormal myelopoiesis	J:170562
	decreased common myeloid progenitor cell number	J:170562
	decreased hematocrit	J:170562
	enlarged spleen	J:170562
	erythroblastosis	J:170562
	extramedullary hematopoiesis	J:170562
	hemolytic anemia	J:170562
	increased erythroid progenitor cell number	J:170562
	increased nucleated erythrocyte cell number	J:170562
	polychromatophilia	J:170562
	reticulocytosis	J:170562
	spherocytosis	J:170562
Ank1^MRI23420/Ank1⁺ (SJL/J-Ank1^MRI23420)	abnormal erythrocyte morphology	J:187820
	abnormal spleen morphology	J:187820
	anemia	J:187820
	decreased mean corpuscular hemoglobin	J:187820
	decreased mean corpuscular volume	J:187820
	enlarged spleen	J:187820
	hyperchromasia	J:187820
	increased erythrocyte cell number	J:187820
	increased erythrocyte osmotic fragility	J:187820
	increased spleen iron level	J:187820
	increased spleen weight	J:187820
	microcytosis	J:187820
	polycythemia	J:187820
	thrombocytosis	J:187820
Ank1^MRI23420/Ank1^MRI23420 (SJL/J-Ank1^MRI23420)	abnormal erythrocyte morphology	J:187820
	enlarged spleen	J:187820
	increased spleen weight	J:187820
	poikilocytosis	J:187820
	spherocytosis	J:187820
Ank1^nb/Ank1⁺ (involves: C57BL/6J * WB/Re)	abnormal erythrocyte morphology	J:111131
Ank1^nb/Ank1⁺ (involves: C57BL/6J * WB/Re)	increased erythrocyte protoporphyrin level	J:5985
Ank1^nb/Ank1^nb (either: (involves: non-inbred stock) or (involves: C57BL/6) or (involves: WB/Re))	abnormal thymus development	J:30699
	decreased erythrocyte cell number	J:30699
	decreased hematocrit	J:30699
	decreased hemoglobin content	J:30699
	enlarged spleen	J:30699
	hypochromic anemia	J:30699
	increased leukocyte cell number	J:30699
Ank1^nb/Ank1^nb (involves: C57BL/6J * WB/Re)	abnormal erythrocyte morphology	J:42526, J:111131, J:7501
	abnormal erythrocyte physiology	J:30033
	acanthocytosis	J:111131
	anisocytosis	J:111131
	anisopoikilocytosis	J:111131
	increased erythrocyte protoporphyrin level	J:5985
	low mean erythrocyte cell number	J:3122
	microcytic anemia	J:3122
	microcytosis	J:111131
	poikilocytosis	J:111131
	reticulocytosis	J:3122, J:42526
	spherocytosis	J:3122
	stomatocytosis	J:111131
Ank1^nb/Ank1^nb ((WB.Cg-Ank1^nb/BrkJ x B6.Cg-Ank1^nb/BrkJ)F1)	abnormal erythrocyte morphology	J:62355
	abnormal erythrocyte physiology	J:162532
	anisopoikilocytosis	J:162532
	decreased hematocrit	J:162532
	decreased hemoglobin content	J:162532
	enlarged spleen	J:162532
	extramedullary hematopoiesis	J:162532
	hemolysis	J:162532
	hemolytic anemia	J:162532
	increased erythrocyte clearance	J:162532
	increased erythrocyte osmotic fragility	J:162532
	increased nucleated erythrocyte cell number	J:162532
	low mean erythrocyte cell number	J:162532
	microcytosis	J:62355
	poikilocytosis	J:162532
	reticulocytosis	J:162532
	schistocytosis	J:162532
Ank1^Rbc2/Ank1⁺ (involves: 129S1/Sv * BALB/c)	decreased mean corpuscular volume	J:148127
Ank1^Rbc2/Ank1⁺ (involves: 129S1/Sv * BALB/c)	increased erythrocyte osmotic fragility	J:148127
Ank1^Rbc2/Ank1^Rbc2 (involves: 129S1/Sv * BALB/c)	abnormal erythrocyte morphology	J:148127
	abnormal erythrocyte physiology	J:148127
	anemia	J:148127
	anisocytosis	J:148127
	decreased erythrocyte cell number	J:148127
	decreased hematocrit	J:148127
	decreased hemoglobin content	J:148127
	decreased mean corpuscular hemoglobin concentration	J:148127
	enlarged spleen	J:148127
	extramedullary hematopoiesis	J:148127
	increased erythrocyte osmotic fragility	J:148127
	increased hemoglobin concentration distribution width	J:148127
	increased nucleated erythrocyte cell number	J:148127
	poikilocytosis	J:148127
	reticulocytosis	J:148127
	spherocytosis	J:148127
Ank^tm1.1Ejr/Ank⁺ (B6.129-Ank^tm1.1Ejr)	abnormal osteoclast differentiation	J:168526
Ank^tm1.1Ejr/Ank^tm1.1Ejr (B6.129-Ank^tm1.1Ejr)	abnormal osteoclast differentiation	J:168526
Ankfy1^{tm1b(KOMP)Mbp}/Ankfy1⁺ (C57BL/6N-Ankfy1^{tm1b(KOMP)Mbp}/Tcp)	increased monocyte cell number	J:211773
Ankle1^{tm1.2(KOMP)Wtsi}/Ankle1^{tm1.2(KOMP)Wtsi} (involves: C57BL/6J * C57BL/6N)	hematopoietic system phenotype	J:235782
Ankrd9^{tm1(KOMP)Wtsi}/Ankrd9^{tm1(KOMP)Wtsi} (C57BL/6N-Ankrd9^{tm1(KOMP)Wtsi}/Wtsi)	decreased erythrocyte cell number	J:211773
Ankrd11^{tm1c(EUCOMM)Wtsi}/Ankrd11^{tm1c(EUCOMM)Wtsi} E2f1^{Tg(Wnt1-cre)2Sor}/E2f1⁺ (involves: C3H * C57BL/6 * C57BL/6N)	decreased osteoclast cell number	J:306391
Ankrd11^Yod/Ankrd11⁺ (involves: BALB/cAnNCrl * C3H/HeH)	decreased osteoclast cell number	J:136455
Ankrd13c^em1(IMPC)Tcp/Ankrd13c^em1(IMPC)Tcp (C57BL/6N-Ankrd13c^em1(IMPC)Tcp/Tcp)	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
Ankrd44^em1(IMPC)J/Ankrd44^em1(IMPC)J (C57BL/6NJ-Ankrd44^em1(IMPC)J/Mmjax)	thrombocytopenia	J:211773
Ankrd52^em1(IMPC)J/Ankrd52⁺ (C57BL/6NJ-Ankrd52^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Ano2^{em1(IMPC)Ccpcz}/Ano2^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Ano2^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Ano5^em2Huyi/Ano5^em2Huyi (C57BL/6-Ano5^em2Huyi)	abnormal osteoclast physiology	J:336715
Ano5^em2Huyi/Ano5^em2Huyi (C57BL/6-Ano5^em2Huyi)	decreased osteoclast cell number	J:336715
Ano6^tm1.2Lyj/Ano6^tm1.2Lyj (involves: 129X1/SvJ * C57BL/6)	abnormal megakaryocyte morphology	J:188263
Ano6^tm1.2Lyj/Ano6^tm1.2Lyj (involves: 129X1/SvJ * C57BL/6)	abnormal platelet physiology	J:188263
Anpep^tm1.1Lsha/Anpep^tm1.1Lsha (B6.Cg-Anpep^tm1.1Lsha)	abnormal macrophage physiology	J:163945
Anpep^tm1.1Lsha/Anpep^tm1.1Lsha (B6.Cg-Anpep^tm1.1Lsha)	increased CD4-positive, alpha-beta T cell number	J:163945
Antxr2^{em1(IMPC)Wtsi}/Antxr2^{em1(IMPC)Wtsi} (C57BL/6N-Antxr2^{em1(IMPC)Wtsi}/Wtsi)	increased mean corpuscular hemoglobin concentration	J:211773
	increased red blood cell distribution width	J:211773
anx/anx (B6C3Fe a/a-anx/J)	decreased spleen weight	J:7689
	increased thymus weight	J:7689
	pale spleen	J:7689
	small spleen	J:7689
anx/anx (involves: DW/J * M. m. domesticus poschiavinus * Swiss)	abnormal spleen morphology	J:13936
	small spleen	J:13936
anx/anx Tyro3^m1/Tyro3^m1 (involves: C3HeB/FeJLe * C57BL/6J)	abnormal platelet activation	J:241666
	abnormal platelet morphology	J:241666
Anxa1^{em1(IMPC)Ccpcz}/Anxa1^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Anxa1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
	small spleen	J:211773
Anxa1^tm1Rjf/Anxa1^tm1Rjf (Not Specified)	abnormal leukocyte physiology	J:81498
Anxa1^tm1Rjf/Anxa1^tm1Rjf (Not Specified)	impaired macrophage phagocytosis	J:81498
Anxa2^tm1Kah/Anxa2^tm1Kah (involves: 129X1/SvJ * C57BL/6)	abnormal hematopoietic system physiology	J:87621
Anxa5^tm1Epo/Anxa5^tm1Epo Anxa6^tm1Moss/Anxa6^tm1Moss (involves: 129P2/OlaHsd * C57BL/6)	decreased dendritic cell number	J:193886
	increased B cell number	J:193886
Anxa5^tm1Epo/Anxa5^tm1Epo Anxa6^tm1Moss/Anxa6^tm1Moss Col10a1^tm1Ksec/Col10a1^tm1Ksec (involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6)	decreased dendritic cell number	J:193886
	increased B cell number	J:193886
	increased T-helper cell number	J:193886
Anxa7^tm1Ngl/Anxa7^tm1Ngl (involves: 129S2/SvPas)	abnormal erythrocyte morphology	J:91188
	abnormal platelet aggregation	J:91188
	hematopoietic system phenotype	J:91188
	thrombocytosis	J:91188
Anxa8^tm1Resc/Anxa8^tm1Resc Tg(Pgk1-cre)1Lni/0 (involves: 129 * C57BL/6J * BALB/c)	impaired leukocyte tethering or rolling	J:225224
Aoc3^tm1Salm/Aoc3^tm1Salm (involves: 129S6/SvEvTac * 129S7/SvEvBrd)	abnormal cellular extravasation	J:95656
	abnormal leukocyte adhesion	J:95656
	abnormal leukocyte migration	J:95656
	impaired leukocyte tethering or rolling	J:95656
Aopep^{tm1b(KOMP)Wtsi}/Aopep^{tm1b(KOMP)Wtsi} (C57BL/6N-Aopep^{tm1b(KOMP)Wtsi}/Ccpcz)	decreased mean platelet volume	J:211773
Ap1b1^b2b1660Clo/Ap1b1^b2b1660Clo (C57BL/6J-Ap1b1^b2b1660Clo)	absent spleen	J:175213
	spleen hypoplasia	J:175213
Ap1g1^tm1Schu/Ap1g1⁺ (either: (involves: 129P2/OlaHsd * 129X1/SvJ) or (involves: 129P2/OlaHsd * C57BL/6J))	decreased CD4-positive, alpha-beta T cell number	J:53252
Ap2a1^em1(IMPC)J/Ap2a1^em1(IMPC)J (C57BL/6NJ-Ap2a1^em1(IMPC)J/Mmjax)	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
Ap2a2^{tm1b(EUCOMM)Wtsi}/Ap2a2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Ap2a2^{tm1b(EUCOMM)Wtsi}/Wtsi)	decreased mean corpuscular hemoglobin	J:211773
Ap2b1^b2b2321Clo/Ap2b1^b2b2321Clo (C57BL/6J-Ap2b1^b2b2321Clo)	thymus hypoplasia	J:175213
Ap3b1^pe-rim2/Ap3b1^pe-rim2 (involves: B10.A(R201) * C57BL/10Slc)	abnormal platelet dense granule physiology	J:42685
	decreased platelet ADP level	J:42685
	decreased platelet aggregation	J:42685
	decreased platelet ATP level	J:42685
Ap3b1^pe/Ap3b1^pe (involves: C3H/He)	abnormal platelet dense granule physiology	J:7327
	decreased platelet dense granule number	J:7327
	decreased platelet serotonin level	J:7327
Ap3b1^pe/Ap3b1^pe (B6.C3-Ap3b1^pe/J)	abnormal platelet activation	J:221384
	abnormal platelet dense granule morphology	J:152219
	decreased platelet ADP level	J:7327
	decreased platelet aggregation	J:221384
	decreased platelet ATP level	J:7327
	decreased platelet dense granule number	J:7327
	decreased platelet serotonin level	J:7327
Ap3b1^pe/Ap3b1^pe Hps1^ep/Hps1^ep (involves: C3H/He * C3HeB/FeJ * C57BL/6J)	abnormal monocyte morphology	J:85431
Ap3b2^em1(IMPC)H/Ap3b2^em1(IMPC)H (C57BL/6N-Ap3b2^em1(IMPC)H/H)	increased mean corpuscular hemoglobin	J:211773
Ap3d1^mh/Ap3d1^mh (STOCK Mfsd12^gr +/+ Ap3d1^mh/J)	abnormal platelet dense granule morphology	J:29151
	decreased platelet aggregation	J:29151
	decreased platelet dense granule number	J:29151
	decreased platelet serotonin level	J:29151
	hematopoietic system phenotype	J:71349
Ap4e1^{tm1a(KOMP)Wtsi}/Ap4e1^{tm1a(KOMP)Wtsi} (involves: C57BL/6N)	anemia	J:200082
Ap4e1^{tm1a(KOMP)Wtsi}/Ap4e1^{tm1a(KOMP)Wtsi} (C57BL/6N-Ap4e1^{tm1a(KOMP)Wtsi}/Wtsi)	decreased hemoglobin content	J:175295
	decreased mean corpuscular hemoglobin	J:175295
Ap4e1^{tm1b(KOMP)Wtsi}/Ap4e1^{tm1b(KOMP)Wtsi} (C57BL/6N-Ap4e1^{tm1b(KOMP)Wtsi}/Wtsi)	increased hematocrit	J:211773
Ap4e1^{tm1b(KOMP)Wtsi}/Ap4e1^{tm1b(KOMP)Wtsi} (C57BL/6N-Ap4e1^{tm1b(KOMP)Wtsi}/Bay)	abnormal spleen morphology	J:211773
Ap4e1^{tm1b(KOMP)Wtsi}/Ap4e1^{tm1b(KOMP)Wtsi} (C57BL/6N-Ap4e1^{tm1b(KOMP)Wtsi}/MbpMmucd)	abnormal spleen morphology	J:211773
	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular hemoglobin concentration	J:211773
	enlarged spleen	J:211773
	increased red blood cell distribution width	J:211773
Ap4e1^{tm1b(KOMP)Wtsi}/Ap4e1^{tm1b(KOMP)Wtsi} (C57BL/6N-Ap4e1^{tm1b(KOMP)Wtsi}/Ccpcz)	increased erythrocyte cell number	J:211773
	increased hemoglobin content	J:211773
Ap4m1^{tm1b(EUCOMM)Wtsi}/Ap4m1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Ap4m1^{tm1b(EUCOMM)Wtsi}/Wtsi)	increased hematocrit	J:211773
	increased leukocyte cell number	J:211773
Apba3^tm1.2Ski/Apba3^tm1.2Ski (B6.129-Apba3^tm1.2Ski)	abnormal macrophage physiology	J:176742
Apbb1ip^{em1(IMPC)Ccpcz}/Apbb1ip^{em1(IMPC)Ccpcz} (C57BL/6N-Apbb1ip^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	decreased CD8-positive, alpha-beta T cell number	J:211773
	decreased CD8-positive, naive alpha-beta T cell number	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
	increased effector memory CD8-positive, alpha-beta T cell number	J:211773
	increased eosinophil cell number	J:211773
	increased leukocyte cell number	J:211773
	increased mean platelet volume	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
	increased red blood cell distribution width	J:211773
	increased spleen weight	J:211773
Apc^Min/Apc⁺ (involves: AKR/J * C57BL/6J)	anemia	J:10209
Apc^Min/Apc⁺ (involves: AKR/J * C57BL/6J)	decreased hematocrit	J:10209
Apc^Min/Apc⁺ (C57BL/6J-Apc^Min)	decreased macrophage cell number	J:85142
Apc^Min/Apc⁺ (involves: C57BL/6J)	anemia	J:75393
Apc^Min/Apc⁺ (involves: 129 * C57BL/6)	decreased NK cell number	J:156864
	decreased splenocyte number	J:156864
	decreased T cell number	J:156864
Apc^Min/Apc⁺ (B6(AKR)-Apc^Min)	anemia	J:10209
Apc^Min/Apc⁺ Col1a1^{tm1(CAG-Sirt1)Dsin}/Col1a1⁺ (involves: 129S4/SvJae * C57BL/6 * C57BL/6J)	anemia	J:134301
Apc^Min/Apc⁺ Elp3^tm1.1Tac/Elp3^tm1.1Tac Tg(Vil1-cre)997Gum/0 (involves: C57BL/6 * C57BL/6J * C57BL/6NTac * SJL)	hematopoietic system phenotype	J:227334
Apc^Min/Apc⁺ Mapkapk2^tm1.2Gkl/Mapkapk2^tm1.2Gkl (involves: BALB/cJ * C57BL/6J)	hematopoietic system phenotype	J:262876
Apc^Min/Apc⁺ Msh2^tm1Mak/Msh2^tm1Mak (involves: 129P2/OlaHsd * C57BL/6J)	anemia	J:75393
Apc^Min/Apc⁺ Myc^tm1Jlc/Myc⁺ (involves: 129S7/SvEvBrd * C57BL/6 * C57BL/6J)	abnormal hematopoietic system morphology/development	J:134087
	hematopoietic system phenotype	J:134087
Apc^Min/Apc⁺ Spata18^tm1.2Hifa/Spata18⁺ (involves: C57BL/6J)	anemia	J:254117
Apc^Min/Apc⁺ Spata18^tm1.2Hifa/Spata18^tm1.2Hifa (involves: C57BL/6J)	anemia	J:254117
Apc^Min/Apc⁺ Tg(Rorc-EGFP)1Ebe/? (involves: C57BL/6)	abnormal effector T cell morphology	J:137020
Apc^Min/Apc⁺ Tgfbr1^tm1Bopa/Tgfbr1⁺ (involves: 129S1/SvImJ * C57BL/6J)	hematopoietic system phenotype	J:143706
Apc^Min/Apc⁺ Thbs1^tm1Hyn/Thbs1^tm1Hyn (involves: C57BL/6J)	anemia	J:79641
Apc^tm1.1Alew/Apc⁺ (B6.129-Apc^tm1.1Alew)	anemia	J:180275
Apc^tm1.1Rsmi/Apc⁺ (involves: 129P2/OlaHsd * C57BL/6 * FVB/N)	anemia	J:159883
Apc^tm1.1Tno/Apc⁺ (involves: 129S4/SvJae * C57BL/6)	anemia	J:127452
Apc^tm1.1Tyj/Apc⁺ (involves: 129S4/SvJaeSor * C57BL/6)	anemia	J:160399
Apc^tm1Cip/Apc⁺ (involves: 129P2/OlaHsd * C57BL/6)	anemia	J:94108
Apc^tm1Hsa/Apc⁺ (involves: 129P2/OlaHsd * C57BL/6)	anemia	J:61978
Apc^tm1Kk/Apc^tm1Kk Tg(Lck-cre)1Cwi/? (involves: 129S6/SvEvTac * C57BL/6 * DBA/2)	abnormal T cell differentiation	J:100461
	arrested T cell differentiation	J:100461
	increased double-negative T cell number	J:100461
	increased mast cell number	J:128606
	small thymus	J:100461
	thymus hypoplasia	J:100461
Apc^tm1Rak/Apc⁺ Smad4^E6sad/Smad4⁺ (B6.129P2-Apc^tm1Rak Smad4^E6sad/+ +)	anemia	J:107273
	enlarged spleen	J:107273
Apc^tm1Tno/Apc⁺ Tg(CDX2-cre)101Erf/0 (involves: 129S4/SvJae * C57BL/6 * SJL)	anemia	J:126018
	decreased hematocrit	J:126018
Apc^tm1Tno/Apc⁺ Tg(Vil1-cre)997Gum/0 (involves: 129S4/SvJae * C57BL/6 * SJL)	anemia	J:126018
Apc^tm2.1Alew/Apc⁺ (B6.129-Apc^tm2.1Alew)	anemia	J:180057
Apc^tm2.1Cip/Apc⁺ Atg7^tm1Tchi/Atg7^tm1Tchi Tg(Vil1-cre/ERT2)23Syr/0 (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj * DBA/2)	increased CD8-positive, alpha-beta T cell number	J:227287
	increased CD103-positive CD11b-low dendritic cell number	J:227287
	increased regulatory T cell number	J:227287
Apc^tm2.1Cip/Apc^tm2.1Cip Lect2^tm1Ymg/Lect2^tm1Ymg Tg(Ttr-cre/Esr1)1Vco/0 (B6.Cg-Lect2^tm1Ymg Apc^tm2.1Cip Tg(Ttr-cre/Esr1)1Vco)	abnormal neutrophil physiology	J:184496
	abnormal NK T cell physiology	J:184496
	increased NK T cell number	J:184496
Apc^tm2.1Cip/Apc^tm2.1Cip Tg(Ttr-cre/Esr1)1Vco/0 (B6.Cg-Apc^tm2.1Cip Tg(Ttr-cre/Esr1)1Vco)	abnormal NK T cell physiology	J:184496
	decreased NK T cell number	J:184496
Apc^tm2.1Rak/Apc⁺ (involves: 129/Sv * C57BL/6J * SJL)	anemia	J:114152
Apc^tm2Rak/Apc⁺ Tg(Car1-cre)5Flt/0 (involves: 129/Sv * C57BL/6J * SJL)	anemia	J:164247
	decreased hematocrit	J:164247
Apc^tm2Rak/Apc^tm2Rak Tg(Car1-cre)5Flt/0 (involves: 129/Sv * C57BL/6J * SJL)	decreased hematocrit	J:164247
Apc^tm2Rak/Apc^tm2Rak Tg(KRT14-cre)8Brn/0 (involves: 129/Sv * C57BL/6J * FVB/N * SJL)	abnormal Hassall's corpuscle morphology	J:114152
	abnormal thymus morphology	J:114152
	decreased thymocyte number	J:114152
	small thymus	J:114152
Apcdd1^em1(IMPC)Mbp/Apcdd1^em1(IMPC)Mbp (C57BL/6NCrl-Apcdd1^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Apcs^tm1Mpe/Apcs⁺ (B6.Cg-Apcs^tm1Mpe)	abnormal spleen red pulp morphology	J:90502
	abnormal spleen white pulp morphology	J:90502
	increased spleen white pulp amount	J:90502
Apcs^tm1Mpe/Apcs^tm1Mpe (B6.Cg-Apcs^tm1Mpe)	abnormal spleen morphology	J:90502
	abnormal spleen red pulp morphology	J:90502
	abnormal spleen white pulp morphology	J:90502
	increased spleen white pulp amount	J:90502
Apex2^em1(IMPC)H/Apex2^em1(IMPC)H (C57BL/6NTac-Apex2^em1(IMPC)H/H)	decreased erythrocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	increased mean corpuscular volume	J:211773
	increased neutrophil cell number	J:211773
Apex2^tm1Yun/Y (B6.129S-Apex2^tm1Yun)	decreased B cell number	J:95267
	decreased erythrocyte cell number	J:95267
	decreased leukocyte cell number	J:95267
	decreased splenocyte proliferation	J:95267
	decreased T cell number	J:95267
	decreased thymocyte number	J:95267
	thymus atrophy	J:95267
Aplf^{Gt(RRF189)Byg}/Aplf^{Gt(RRF189)Byg} (involves: 129P2/OlaHsd * C57BL/6J)	abnormal class switch recombination	J:168260
Aplp2^{tm2b(EUCOMM)Hmgu}/Aplp2^{tm2b(EUCOMM)Hmgu} (C57BL/6N-Aplp2^{tm2b(EUCOMM)Hmgu}/Bay)	decreased mean corpuscular volume	J:211773
Apobec1^{em1(IMPC)Ccpcz}/Apobec1^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Apobec1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
	small spleen	J:211773
Apobec3^Gt(XN450)Byg/Apobec3^Gt(XN450)Byg (B6.129P2-Apobec3^Gt(XN450)Byg)	abnormal immunoglobulin level	J:138778
Apobec3^Gt(XN450)Byg/Apobec3^Gt(XN450)Byg (129P2/OlaHsd-Apobec3^Gt(XN450)Byg)	abnormal immunoglobulin level	J:138778
Apobec3^Gt(XN450)Byg/Apobec3^Rfv3-s H2^b/H2^b (involves: A.BY * C57BL/6)	abnormal immunoglobulin level	J:138778
Apobec3^Gt(XN450)Byg/Apobec3^Rfv3-s H2^b/H2^d (involves: BALB/c * C57BL/6)	abnormal immunoglobulin level	J:138778
Apoc4^{tm1.1(KOMP)Mbp}/Apoc4^{tm1.1(KOMP)Mbp} (C57BL/6N-Apoc4^{tm1.1(KOMP)Mbp}/Ieg)	increased leukocyte cell number	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
Apoe^tm1.1Mae/Apoe^tm1.1Mae Tg(Fabp4-cre)1Rev/0 (B6.Cg-Apoe^tm1.1Mae Tg(Fabp4-cre)1Rev)	decreased macrophage cell number	J:219838
	increased macrophage cell number	J:219838
Apoe^tm1Bres/Apoe^tm1Bres Bcl2^tm1Irt/Bcl2^tm1Irt Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6)	increased macrophage apoptosis	J:144243
Apoe^tm1Bres/Apoe^tm1Bres Cx3cr1^tm1Ifc/Cx3cr1^tm1Ifc (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	impaired macrophage chemotaxis	J:81822
Apoe^tm1Bres/Apoe^tm1Bres Mapk9^tm1Flv/Mapk9^tm1Flv (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	abnormal macrophage morphology	J:94044
	abnormal macrophage physiology	J:94044
	increased macrophage derived foam cell number	J:94044
Apoe^tm1Unc/Apoe^tm1Unc (B6.129P2-Apoe^tm1Unc/J)	abnormal B cell activation	J:133606
	abnormal CD4-positive, alpha-beta T cell number	J:108154, J:47027
	abnormal T cell number	J:47027
	decreased follicular B cell number	J:133606
	decreased hematocrit	J:108154
	decreased marginal zone B cell number	J:133606
	increased B cell number	J:133606
	increased IgM level	J:61564
	increased immunoglobulin level	J:133606
	increased marginal zone B cell number	J:133606
	increased spleen weight	J:61564
	increased T-helper 2 cell number	J:47027
Apoe^tm1Unc/Apoe^tm1Unc (B6.129P2-Apoe^tm1Unc)	increased CD4-positive, alpha-beta T cell number	J:125366
Apoe^tm1Unc/Apoe^tm1Unc (B6.Cg-Apoe^tm1Unc Fas^lpr)	increased immunoglobulin level	J:133606
Apoe^tm1Unc/Apoe^tm1Unc Cbs^tm1Unc/Cbs^tm1Unc Tg(Mt1-CBS)25Waku/0 (involves: 129P2/OlaHsd * C3H * C57BL/6)	increased Ly6C high monocyte number	J:168131
	increased monocyte cell number	J:168131
Apoe^tm1Unc/Apoe^tm1Unc Ccr2^tm1Ifc/Ccr2^tm1Ifc (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	impaired macrophage chemotaxis	J:111471
Apoe^tm1Unc/Apoe^tm1Unc Ccr2^tm1Ifc/Ccr2^tm1Ifc (B6.Cg-Apoe^tm1Unc Ccr2^tm1Ifc)	decreased monocyte cell number	J:153310
Apoe^tm1Unc/Apoe^tm1Unc Ccr2^tm1Ifc/Ccr2^tm1Ifc Cx3cl1^tm1Lira/Cx3cl1^tm1Lira (B6.Cg-Apoe^tm1Unc Cx3cl1^tm1Lira Ccr2^tm1Ifc)	decreased monocyte cell number	J:153310
Apoe^tm1Unc/Apoe^tm1Unc Ccr5^tm1Blck/Ccr5^tm1Blck (involves: 129P2/OlaHsd * C57BL/6)	abnormal lymphocyte physiology	J:128063
	abnormal mononuclear phagocyte morphology	J:128063
	decreased T cell number	J:128063
Apoe^tm1Unc/Apoe^tm1Unc Ccr5^tm1Kuz/Ccr5^tm1Kuz (involves: 129P2/OlaHsd * C57BL/6)	abnormal lymphocyte physiology	J:128063
	abnormal mononuclear phagocyte morphology	J:128063
	decreased T cell number	J:128063
Apoe^tm1Unc/Apoe^tm1Unc Cd36^tm1Mfe/Cd36^tm1Mfe (involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)	abnormal macrophage derived foam cell morphology	J:61672
	abnormal macrophage physiology	J:61672
Apoe^tm1Unc/Apoe^tm1Unc Cx3cl1^tm1Sgs/Cx3cl1^tm1Sgs (B6.129-Apoe^tm1Unc Cx3cl1^tm1Sgs)	impaired macrophage chemotaxis	J:95279
	increased macrophage derived foam cell number	J:95279
Apoe^tm1Unc/Apoe^tm1Unc Cxcl10^tm1Adl/Cxcl10^tm1Adl (B6.129-Cxcl10^tm1Adl Apoe^tm1Unc)	decreased CD4-positive, alpha-beta T cell number	J:166204
	impaired macrophage chemotaxis	J:166204
Apoe^tm1Unc/Apoe^tm1Unc Cyp4f13^{Gt(OST14770)Lex}/Cyp4f13^{Gt(OST14770)Lex} (involves: 129P2/OlaHsd * 129S5/SvEvBrd * C57BL/6)	abnormal macrophage chemotaxis	J:289999
Apoe^tm1Unc/Apoe^tm1Unc Fas^lpr/Fas^lpr (MRL.Cg-Apoe^tm1Unc Fas^lpr)	increased immunoglobulin level	J:133606
Apoe^tm1Unc/Apoe^tm1Unc Fas^lpr/Fas^lpr (B6.Cg-Apoe^tm1Unc Fas^lpr)	decreased CD4-positive, alpha-beta T cell number	J:121671
	decreased CD8-positive, alpha-beta T cell number	J:121671
	enlarged spleen	J:121671
	enlarged thymus	J:121671
	hematopoietic system phenotype	J:121671
	increased IgG level	J:121671
Apoe^tm1Unc/Apoe^tm1Unc Fasl^gld/Fasl^gld (B6.Cg-Fasl^gld Apoe^tm1Unc)	enlarged spleen	J:91058
	impaired macrophage phagocytosis	J:91058
	increased IgG level	J:91058
	increased spleen weight	J:200141, J:91058
	increased T cell number	J:91058
Apoe^tm1Unc/Apoe^tm1Unc Gja5^tm1Mchn/Gja5^tm1Mchn Tg(TIE2-lacZ)182Sato/0 (involves: 129P2/OlaHsd * BALB/c * C57BL/6)	abnormal neutrophil physiology	J:162224
Apoe^tm1Unc/Apoe^tm1Unc Glg1^{Gt(RST092)Byg}/Glg1⁺ (B6J.129P2-Apoe^tm1Unc Glg1^{Gt(RST092)Byg})	decreased macrophage cell number	J:226586
	impaired macrophage chemotaxis	J:226586
Apoe^tm1Unc/Apoe^tm1Unc Hp^tm1Alev/Hp^tm1Alev (involves: 129)	abnormal macrophage chemotaxis	J:134942
Apoe^tm1Unc/Apoe^tm1Unc Hsd11b1^tm1Lex/Hsd11b1^tm1Lex (B6.129-Hsd11b1^tm1Lex Apoe^tm1Unc)	abnormal bone marrow cell physiology	J:199430
	abnormal macrophage derived foam cell morphology	J:199430
	decreased macrophage cell number	J:199430
Apoe^tm1Unc/Apoe^tm1Unc Il1rn^tm1Dih/Il1rn^tm1Dih (involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6)	abnormal macrophage chemotaxis	J:132570
Apoe^tm1Unc/Apoe^tm1Unc Itgb3^tm1Hyn/Itgb3^tm1Hyn (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	anemia	J:83615
Apoe^tm1Unc/Apoe^tm1Unc Klf15^tm2Jain/Klf15^tm2Jain Tg(Tagln-cre)1Jjl/0 (involves: 129P2/OlaHsd * FVB/N)	increased macrophage cell number	J:203920
Apoe^tm1Unc/Apoe^tm1Unc Mmp9^tm1Tvu/Mmp9^tm1Tvu (involves: 129P2/OlaHsd * 129S6/SvEvTac)	decreased macrophage cell number	J:110044
Apoe^tm1Unc/Apoe^tm1Unc Nfe2l2^tm1Mym/Nfe2l2^tm1Mym (involves: 129P2/OlaHsd * C57BL/6J)	abnormal macrophage physiology	J:143903
Apoe^tm1Unc/Apoe^tm1Unc Pla2g15^tm1Ytan/Pla2g15^tm1Ytan (involves: 129S/SvEv * B6.129P2-Apoe^tm1Unc/J)	abnormal macrophage morphology	J:97471
Apoe^tm1Unc/Apoe^tm1Unc Scarb1^tm1Kri/Scarb1^tm1Kri (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	abnormal erythrocyte morphology	J:75090
	decreased hematocrit	J:75090
	decreased hemoglobin content	J:75090
	echinocytosis	J:75090
	hypochromic macrocytic anemia	J:75090
	macrocytosis	J:75090
	poikilocytosis	J:75090
	reticulocytosis	J:75090
Apoe^tm1Unc/Apoe^tm1Unc Spp1^tm1Blh/Spp1^tm1Blh (involves: 129P2/OlaHsd * 129S6/SvEvTac * Black Swiss * C57BL/6J)	abnormal macrophage physiology	J:86531
Apoe^{tm2(APOE3)Mae}/Apoe^{tm2(APOE3)Mae} Tg(Thy1-APPSwDutIowa)BWevn/? (involves: 129P2/OlaHsd * C57BL/6)	abnormal microglial cell morphology	J:136318
Apoe^{tm3(APOE4)Mae}/Apoe^{tm3(APOE4)Mae} Tg(Thy1-APPSwDutIowa)BWevn/? (involves: 129P2/OlaHsd * C57BL/6)	abnormal microglial cell morphology	J:136318
Apof^{tm1.1(KOMP)Vlcg}/Apof^{tm1.1(KOMP)Vlcg} (C57BL/6N-Apof^{tm1.1(KOMP)Vlcg}/Ucd)	increased basophil cell number	J:211773
App^tm1Ck/App^tm1Ck Tg(PDGFB-PSEN1M146L)2Jhd/0 (involves: 129 * Black Swiss * C57BL/6 * DBA/2 * SW)	abnormal microglial cell morphology	J:102542
App^tm2.1Tcs/App^tm2.1Tcs (involves: C57BL/6)	microgliosis	J:212758
App^tm2.1Tcs/App^tm2.1Tcs Cast^tm1Tcs/Cast^tm1Tcs (involves: 129P2/OlaHsd * C57BL/6)	microgliosis	J:212758
App^tm3.1Tcs/App^tm3.1Tcs (involves: C57BL/6)	microgliosis	J:212758
Appl1^Gt(XM073)Byg/Appl1^Gt(XM073)Byg (B6.129P2-Appl1^Gt(XM073)Byg)	increased T cell proliferation	J:164696
Appl1^tm1.2Test/Appl1^tm1.2Test (involves: 129X1/SvJ * C57BL/6)	hematopoietic system phenotype	J:159889
Appl1^tm1.2Test/Appl1^tm1.2Test (involves: 129X1/SvJ)	hematopoietic system phenotype	J:227340
	increased hematocrit	J:227340
	increased T cell proliferation	J:164696
Appl1^tm1.2Test/Appl1^tm1.2Test Appl2^tm1.1Test/Appl2^tm1.1Test (involves: 129X1/SvJ)	decreased mean corpuscular hemoglobin concentration	J:227340
	hematopoietic system phenotype	J:227340
	increased hematocrit	J:227340
	increased mean corpuscular volume	J:227340
Appl2^tm1.1Test/Appl2^tm1.1Test (Not Specified)	decreased mean corpuscular hemoglobin concentration	J:227340
	hematopoietic system phenotype	J:227340
	increased hematocrit	J:227340
	increased mean corpuscular volume	J:227340
Aprt^tm1Jat/Aprt^tm1Jat (involves: 129S2/SvPas * Black Swiss)	decreased hematocrit	J:111451
Aptx^tm1Pmc/Aptx^tm1Pmc Atm^tm2.1Mfgc/Atm^tm2.1Mfgc (involves: 129 * C57BL/6)	abnormal CD4-positive helper T cell morphology	J:316365
	abnormal T cell differentiation	J:316365
	decreased T cell number	J:316365
	increased CD8-positive, alpha-beta T cell number	J:316365
Aqp1^tm1Ask/Aqp1^tm1Ask Slc14a1^tm1Ask/Slc14a1^tm1Ask (involves: C57BL/6J)	abnormal mean corpuscular volume	J:79279
	high mean erythrocyte cell number	J:79279
	increased hematocrit	J:79279
Aqp1^{tm1b(EUCOMM)Wtsi}/Aqp1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Aqp1^{tm1b(EUCOMM)Wtsi}/H)	increased neutrophil cell number	J:211773
Aqp2^tm1(cre)Blyg/Aqp2^tm1(cre)Blyg (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	increased hematocrit	J:121445
Aqp4^tm1.1Mysi/Aqp4^tm1.1Mysi (involves: C57BL/6JJcl * C57BL/6NCrlj * CBA/JNCrlj)	abnormal microglial cell physiology	J:214906
Aqp9^tm1Nlsn/Aqp9^tm1Nlsn (involves: 129S1/Sv)	abnormal erythrocyte physiology	J:123305
Aqp9^tm1Nlsn/Aqp9^tm1Nlsn (involves: 129S1/Sv)	decreased erythrocyte osmotic fragility	J:123305
Aqp11^{tm1.1(KOMP)Vlcg}/Aqp11⁺ (B6N(Cg)-Aqp11^{tm1.1(KOMP)Vlcg}/J)	decreased leukocyte cell number	J:211773
Aqp12^{tm1.1(KOMP)Vlcg}/Aqp12^{tm1.1(KOMP)Vlcg} (C57BL/6N-Aqp12^{tm1.1(KOMP)Vlcg}/Ucd)	thrombocytopenia	J:211773
Ar^Tfm/Y (involves: STOCK Eda^Ta Atp7a^Mo-blo)	abnormal bone marrow cell number	J:110923
	abnormal erythropoiesis	J:110923
	abnormal myeloid leukocyte morphology	J:110923
	increased immature B cell number	J:110923
Ar^tm1Chc/Y Tmem163^{Tg(ACTB-cre)2Mrt}/0 (involves: 129S/SvEv * C57BL/6J * FVB/N)	increased osteoclast cell number	J:81789
Ar^tm1Chc/Ar^tm1.1Chc Tmem163^{Tg(ACTB-cre)2Mrt}/0 (involves: 129S/SvEv * C57BL/6J * FVB/N)	enlarged thymus	J:87193
Araf^tm1Mmc/Y (involves: 129P2/OlaHsd * C57BL/6)	small thymus	J:33951
Araf^tm1Mmc/Araf^tm1Mmc (involves: 129P2/OlaHsd * C57BL/6)	small thymus	J:33951
Arap1^{tm1b(EUCOMM)Wtsi}/Arap1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Arap1^{tm1b(EUCOMM)Wtsi}/Ucd)	decreased mean corpuscular hemoglobin	J:211773
Arb2a^{em2(IMPC)Ccpcz}/Arb2a^{em2(IMPC)Ccpcz} (C57BL/6NCrl-Arb2a^{em2(IMPC)Ccpcz}/Ph)	abnormal thymus morphology	J:211773
	decreased Ly6C-positive NK T cell number	J:211773
	enlarged thymus	J:211773
Arb2a^{Tg(Tyr)TpNpin}/Arb2a^{Tg(Tyr)TpNpin} (involves: FVB/N)	thymus hypoplasia	J:260599
Areg^{tm2b(EUCOMM)Hmgu}/Areg^{tm2b(EUCOMM)Hmgu} (C57BL/6N-Areg^{tm2b(EUCOMM)Hmgu}/H)	increased mean corpuscular volume	J:211773
Arf4^{tm1b(KOMP)Wtsi}/Arf4⁺ (C57BL/6N-Arf4^{tm1b(KOMP)Wtsi}/Ucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased spleen weight	J:211773
Arf6^tm1Yaka/Arf6^tm1Yaka (involves: 129P2/OlaHsd * C57BL/6)	anemia	J:111404
Arfgef1^{em1(IMPC)Hmgu}/Arfgef1⁺ (C57BL/6NCrl-Arfgef1^{em1(IMPC)Hmgu}/Ieg)	increased mean corpuscular hemoglobin concentration	J:211773
Arg1^tm1.1Lky/Arg1⁺ Tg(Sftpc-Chia)#Lky/0 (involves: 129S4/SvJae * BALB/c * C57BL/6 * DBA/2)	decreased macrophage cell number	J:122735
Arg1^tm1.1Pmu/Arg1^tm1.1Pmu (involves: C57BL/6 * NZB)	increased macrophage nitric oxide production	J:143229
Arg1^tm1Ekoe/Arg1^tm1Ekoe (involves: 129P2/OlaHsd)	abnormal macrophage physiology	J:183882
Arg1^tm1Pmu/Arg1^tm1Pmu Tg(Tek-cre)1Ywa/? (B6.Cg-Tg(Tek-cre)1Ywa Arg1^tm1Pmu)	abnormal macrophage physiology	J:143229
	increased macrophage nitric oxide production	J:143229
Arg2^{em1(IMPC)Ccpcz}/Arg2^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Arg2^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
	small spleen	J:211773
Arhgap1^tm1Yizh/Arhgap1^tm1Yizh (involves: 129S6/SvEvTac)	spleen hypoplasia	J:101418
Arhgap1^tm1Yizh/Arhgap1^tm1Yizh (involves: 129S6/SvEvTac)	thymus hypoplasia	J:101418
Arhgap1^tm1Yizh/Arhgap1^tm1Yizh (involves: 129S6/SvEvTac * C57BL/6)	abnormal hematopoietic stem cell morphology	J:119516
	abnormal hematopoietic system morphology/development	J:119516
	anemia	J:119516
	decreased bone marrow cell number	J:119516
	decreased spleen white pulp amount	J:119516
	spleen hypoplasia	J:119516
Arhgap5^tm1Jset/Arhgap5^tm1Jset (involves: 129S2/SvPas * C57BL/6J)	small thymus	J:76484
Arhgap10^em1(IMPC)Tcp/Arhgap10^em1(IMPC)Tcp (C57BL/6N-Arhgap10^em1(IMPC)Tcp/Tcp)	increased mean platelet volume	J:211773
Arhgap15^tm1Ehi/Arhgap15^tm1Ehi (B6.129-Arhgap15^tm1Ehi)	abnormal leukocyte cell number	J:174896
	abnormal leukocyte morphology	J:174896
	abnormal macrophage morphology	J:174896
	abnormal neutrophil physiology	J:174896
	decreased lymphocyte cell number	J:174896
	decreased macrophage cell number	J:174896
	decreased monocyte cell number	J:174896
	decreased neutrophil cell number	J:174896
	hematopoietic system phenotype	J:174896
Arhgap17^{tm1b(EUCOMM)Wtsi}/Arhgap17^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Arhgap17^{tm1b(EUCOMM)Wtsi}/Wtsi)	decreased B-1a cell number	J:211773
	decreased follicular B cell number	J:211773
	decreased mature B cell number	J:211773
	increased transitional stage T1 B cell number	J:211773
Arhgap21^{Gt(RRR629)Byg}/Arhgap21⁺ (B6.129P2-Arhgap21^{Gt(RRR629)Byg})	abnormal hematopoietic stem cell physiology	J:262703
	decreased erythrocyte cell number	J:262703
	decreased erythroid progenitor cell number	J:262703
	decreased hematopoietic stem cell number	J:262703
	decreased hemoglobin content	J:262703
	increased leukocyte cell number	J:262703
	increased megakaryocyte cell number	J:262703
	increased megakaryocyte progenitor cell number	J:262703
	increased neutrophil cell number	J:262703
	thrombocytopenia	J:262703
Arhgap22^{tm1a(KOMP)Wtsi}/Arhgap22^{tm1a(KOMP)Wtsi} (C57BL/6N-Arhgap22^{tm1a(KOMP)Wtsi}/Wtsi)	increased mean corpuscular hemoglobin	J:211773
Arhgap25^{tm1a(KOMP)Wtsi}/Arhgap25^{tm1a(KOMP)Wtsi} (C57BL/6N-Arhgap25^{tm1a(KOMP)Wtsi}/Wtsi)	increased mean corpuscular hemoglobin	J:175295
Arhgap25^{tm1a(KOMP)Wtsi}/Arhgap25^{tm1a(KOMP)Wtsi} (involves: C57BL/6N)	abnormal cellular extravasation	J:240521
	abnormal neutrophil physiology	J:240521
	enhanced leukocyte migration	J:240521
	enhanced leukocyte tethering or rolling	J:240521
	hematopoietic system phenotype	J:240521
	increased neutrophil cell number	J:240521
Arhgap26^{tm1b(EUCOMM)Hmgu}/Arhgap26^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Arhgap26^{tm1b(EUCOMM)Hmgu}/Ieg)	decreased mean corpuscular volume	J:211773
	increased leukocyte cell number	J:211773
Arhgap28^em1(IMPC)Mbp/Arhgap28^em1(IMPC)Mbp (C57BL/6NCrl-Arhgap28^em1(IMPC)Mbp/Mmucd)	small spleen	J:211773
Arhgap30^{tm1a(EUCOMM)Wtsi}/Arhgap30^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Arhgap30^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased leukocyte cell number	J:211773
	decreased mean corpuscular hemoglobin	J:211773
	increased mean platelet volume	J:211773
	increased red blood cell distribution width	J:211773
Arhgap45^em1Ciphe/Arhgap45^em1Ciphe (C57BL/6-Arhgap45^em1Ciphe)	decreased B cell number	J:309971
	decreased CD4-positive, alpha-beta T cell number	J:309971
	decreased CD8-positive, alpha-beta T cell number	J:309971
	decreased CD8-positive, naive alpha-beta T cell number	J:309971
	decreased DN1 thymic pro-T cell number	J:309971
	decreased lymphocyte chemotaxis	J:309971
	decreased naive B cell number	J:309971
	decreased T cell number	J:309971
Arhgdia^tm1Ytk/Arhgdia^tm1Ytk (involves: 129S/SvEv * C57BL/6 * DBA)	decreased T cell number	J:140671
Arhgdia^tm1Ytk/Arhgdia^tm1Ytk Arhgdib^tm1Miyo/Arhgdib^tm1Miyo (involves: 129S/SvEv)	abnormal B cell physiology	J:140671
	abnormal leukocyte cell number	J:140671
	abnormal T cell physiology	J:140671
	abnormal thymus medulla morphology	J:140671
	decreased double-positive T cell number	J:140671
	decreased follicular B cell number	J:140671
	decreased immature B cell number	J:140671
	decreased marginal zone B cell number	J:140671
	decreased mature B cell number	J:140671
	decreased pre-B cell number	J:140671
	decreased T cell number	J:140671
	decreased T cell proliferation	J:140671
	decreased transitional stage B cell number	J:140671
	disorganized spleen B cell follicle	J:140671
	increased B cell proliferation	J:140671
	increased eosinophil cell number	J:140671
	increased single-positive T cell number	J:140671
	spleen hypoplasia	J:140671
Arhgdib^tm1Len/Arhgdib^tm1Len (involves: 129S4/SvJae * C57BL/6)	increased B cell proliferation	J:42604
Arhgdib^tm1Miyo/Arhgdib^tm1Miyo (involves: 129S/SvEv)	decreased B cell number	J:140671
Arhgdib^tm1Miyo/Arhgdib^tm1Miyo (involves: 129S/SvEv)	decreased T cell number	J:140671
Arhgef1^tm1.1Rmt/Arhgef1^tm1.1Rmt (C57BL/6-Arhgef1^tm1.1Rmt)	abnormal marginal zone B cell physiology	J:113295
	decreased B cell number	J:113295
	decreased B-1 B cell number	J:113295
	decreased follicular B cell number	J:113295
	decreased IgM level	J:113295
	decreased marginal zone B cell number	J:113295
Arhgef1^{tm1a(EUCOMM)Wtsi}/Arhgef1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Arhgef1^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased CD8-positive, alpha-beta T cell number	J:211773
	decreased dendritic cell number	J:211773
	decreased immature NK cell number	J:211773
	decreased Ly6C-positive immature NK cell number	J:211773
	decreased marginal zone B cell number	J:211773
	decreased memory-marker CD4-positive NK T cell number	J:211773
	decreased memory-marker gamma-delta T cell number	J:211773
	increased CD4-positive, alpha-beta memory T cell number	J:211773
	increased CD4-positive, alpha-beta T cell number	J:211773
	increased CD8-positive, alpha-beta memory T cell number	J:211773
	increased effector memory CD8-positive, alpha-beta T cell number	J:211773
	increased erythrocyte cell number	J:211773
	increased gamma-delta T cell number	J:211773
	increased hematocrit	J:211773
	increased hemoglobin content	J:211773
	increased KLRG1-positive CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	increased KLRG1-positive NK cell number	J:211773
	increased Ly6C low monocyte number	J:211773
	increased Ly6C-positive NK T cell number	J:211773
	increased mature NK cell number	J:211773
	increased monocyte cell number	J:211773
	increased plasmacytoid dendritic cell number	J:211773
Arhgef1^tm1Djle/Arhgef1^tm1Djle (involves: 129S4/SvJae * C57BL/6)	abnormal neutrophil physiology	J:129331
	enlarged spleen	J:129331
	extramedullary hematopoiesis	J:129331
	increased leukocyte cell number	J:129331
Arhgef1^tm1Djle/Arhgef1^tm1Djle (involves: 129S4/SvJae)	increased germinal center B cell number	J:174313
Arhgef1^tm1Kdf/Arhgef1^tm1Kdf (involves: 129S1/Sv * 129X1/SvJ)	abnormal lymphocyte cell number	J:99463
	abnormal lymphocyte physiology	J:99463
	decreased B cell number	J:99463
	decreased B cell proliferation	J:99463
	decreased IgG level	J:99463
	decreased IgM level	J:99463
	decreased marginal zone B cell number	J:99463
	increased T cell proliferation	J:99463
Arhgef2^em1(IMPC)Mbp/Arhgef2^em1(IMPC)Mbp (C57BL/6N-Arhgef2^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	small spleen	J:211773
	thrombocytopenia	J:211773
Arhgef2^{Gt(IST13976A8)Tigm}/Arhgef2^{Gt(IST13976A8)Tigm} (involves: C57BL/6N)	abnormal macrophage physiology	J:209086
Arhgef3^{tm1(KOMP)Wtsi}/Arhgef3^{tm1(KOMP)Wtsi} (C57BL/6N-Arhgef3^{tm1(KOMP)Wtsi}/DkrsJ)	abnormal platelet physiology	J:241286
	hematopoietic system phenotype	J:241286
	increased mean platelet volume	J:241286
Arhgef4^{tm1a(KOMP)Wtsi}/Arhgef4^{tm1a(KOMP)Wtsi} (C57BL/6N-Arhgef4^{tm1a(KOMP)Wtsi}/Wtsi)	decreased hemoglobin content	J:165965
	decreased IgE level	J:165965
	decreased IgG1 level	J:165965
	decreased T cell number	J:165965
	increased mature B cell number	J:165965
Arhgef5^tm1.1Dwu/Arhgef5^tm1.1Dwu (involves: 129S1/Sv * 129S6/SvEvTac)	abnormal CD4-positive, alpha-beta T cell physiology	J:157812
	decreased eosinophil cell number	J:157812
Arhgef6^tm1Kdf/Arhgef6^tm1Kdf (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell number	J:137269
	abnormal B cell physiology	J:137269
	abnormal T cell physiology	J:137269
	decreased B cell proliferation	J:137269
	decreased CD4-positive, alpha-beta T cell number	J:137269
	decreased CD8-positive, alpha-beta T cell number	J:137269
	decreased lymphocyte cell number	J:137269
	decreased mature B cell number	J:137269
	decreased T cell proliferation	J:137269
Arhgef6^{tm2e.1(EUCOMM)Wtsi}/Arhgef6^{tm2e.1(EUCOMM)Wtsi} (C57BL/6N-Arhgef6^{tm2e.1(EUCOMM)Wtsi}/Tcp)	decreased lymphocyte cell number	J:211773
Arhgef11^tm1Sgkd/Arhgef11^tm1Sgkd Arhgef12^tm1Sgkd/Arhgef12^tm1Sgkd (involves: 129 * C57BL/6J)	abnormal embryonic erythrocyte morphology	J:198274
Arhgef12^tm1.1Wet/Arhgef12^tm1.1Wet Tg(Lck-cre)548Jxm/0 (involves: 129 * C57BL/6 * CBA)	abnormal T cell proliferation	J:149560
Arhgef15^{tm1.1(KOMP)Vlcg}/Arhgef15^{tm1.1(KOMP)Vlcg} (C57BL/6N-Arhgef15^{tm1.1(KOMP)Vlcg}/Ucd)	increased red blood cell distribution width	J:211773
Arhgef18^{tm1b(KOMP)Mbp}/Arhgef18⁺ (C57BL/6N-Arhgef18^{tm1b(KOMP)Mbp}/H)	increased basophil cell number	J:211773
Arid1a^m1Mag/Arid1a^m1Mag (involves: 129 * CD-1)	hematopoietic system phenotype	J:192829
Arid1a^tm1.1Gusa/Arid1a^tm1.1Gusa (B6.129-Arid1a^tm1.1Gusa)	abnormal hematopoietic system physiology	J:164526
Arid1a^tm1.1Gusa/Arid1a^tm1.1Gusa (B6.129-Arid1a^tm1.1Gusa)	increased hematopoietic stem cell number	J:164526
Arid1b^em1(IMPC)Tcp/Arid1b⁺ (C57BL/6NCrl-Arid1b^em1(IMPC)Tcp/Tcp)	abnormal spleen morphology	J:211773
Arid3a^{tm1b(KOMP)Wtsi}/Arid3a⁺ (B6N(Cg)-Arid3a^{tm1b(KOMP)Wtsi}/J)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	increased mean corpuscular hemoglobin	J:211773
Arid3a^tm1Pwt/Arid3a^tm1Pwt (involves: 129S6/SvEvTac * C57BL/6)	abnormal B cell differentiation	J:169178
	abnormal class switch recombination	J:169178
	abnormal common lymphocyte progenitor cell morphology	J:169178
	abnormal embryonic erythropoiesis	J:169178
	abnormal erythropoiesis	J:197237
	abnormal hematopoietic stem cell morphology	J:169178
	decreased B cell number	J:169178
	decreased B-1 B cell number	J:169178
	decreased B-1a cell number	J:169178
	decreased B-2 B cell number	J:169178
	decreased common myeloid progenitor cell number	J:169178
	decreased erythroid progenitor cell number	J:169178
	decreased hematopoietic stem cell number	J:169178
	decreased IgG1 level	J:169178
	decreased IgM level	J:169178
	decreased marginal zone B cell number	J:169178
	decreased pre-B cell number	J:169178
	decreased pro-B cell number	J:169178
	decreased transitional stage B cell number	J:169178
	decreased transitional stage T1 B cell number	J:169178
	decreased transitional stage T2 B cell number	J:169178
Arid3b^{tm1c(KOMP)Wtsi}/Arid3b^{tm1c(KOMP)Wtsi} Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6J * C57BL/6N * SJL)	abnormal B cell differentiation	J:236980
	decreased B cell number	J:236980
	decreased B-1b cell number	J:236980
	decreased CD4-positive, alpha-beta T cell number	J:236980
	decreased common lymphocyte progenitor cell number	J:236980
	decreased immature B cell number	J:236980
	decreased pre-B cell number	J:236980
	decreased pre-pro B cell number	J:236980
	decreased pro-B cell number	J:236980
	decreased transitional stage B cell number	J:236980
	hematopoietic system phenotype	J:236980
	increased B-1a cell number	J:236980
	increased follicular B cell number	J:236980
Arid4a^tm1Alb/Arid4a^tm1Alb (involves: 129S7/SvEvBrd)	abnormal common myeloid progenitor cell morphology	J:141004
	abnormal definitive hematopoiesis	J:141004
	abnormal mononuclear cell differentiation	J:141004
	anemia	J:141004
	decreased B cell number	J:141004
	decreased erythrocyte cell number	J:141004
	decreased leukocyte cell number	J:141004
	decreased lymphocyte cell number	J:141004
	decreased monocyte cell number	J:141004
	decreased neutrophil cell number	J:141004
	decreased T cell number	J:141004
	enlarged spleen	J:141004
	extramedullary hematopoiesis	J:141004
	increased erythrocyte cell number	J:141004
	increased erythroid progenitor cell number	J:141004
	increased hematopoietic stem cell number	J:141004
	increased leukocyte cell number	J:141004
	increased T cell number	J:141004
	poikilocytosis	J:141004
	thrombocytopenia	J:141004
Arid4a^tm1Alb/Arid4a^tm1Alb Arid4b^tm1Alb/Arid4b⁺ (involves: 129S7/SvEvBrd)	abnormal common myeloid progenitor cell morphology	J:141004
	abnormal definitive hematopoiesis	J:141004
	abnormal leukopoiesis	J:141004
	abnormal myeloblast morphology/development	J:141004
	decreased B cell number	J:141004
	decreased erythrocyte cell number	J:141004
	decreased lymphocyte cell number	J:141004
	decreased T cell number	J:141004
	enlarged spleen	J:141004
	extramedullary hematopoiesis	J:141004
	hemophagocytosis	J:141004
	increased erythrocyte cell number	J:141004
	increased hematopoietic stem cell number	J:141004
	increased leukocyte cell number	J:141004
	increased monocyte cell number	J:141004
	increased neutrophil cell number	J:141004
	increased T cell number	J:141004
	thrombocytopenia	J:141004
Arid5a^tm1Rnis/Arid5a^tm1Rnis (B6.Cg-Arid5a^tm1Rnis)	decreased T-helper 17 cell number	J:197418
Arid5a^tm1Rnis/Arid5a^tm1Rnis (B6.Cg-Arid5a^tm1Rnis)	increased T cell number	J:197418
Arid5b^tm1Pjh/Arid5b^tm1Pjh (involves: 129S4/SvJae * BALB/c)	abnormal lymphopoiesis	J:70658
	decreased bone marrow cell number	J:70658
	decreased double-positive T cell number	J:70658
	decreased pro-B cell number	J:70658
	increased single-positive T cell number	J:70658
	spleen hypoplasia	J:70658
	thymus cortex hypoplasia	J:70658
	thymus hypoplasia	J:70658
Arigm1^BALB/cByJ/? (involves: BALB/cByJ * NZB/BlNJ)	increased IgM level	J:93737
Arigm2^NZB/BlNJ/? (involves: BALB/cByJ * NZB/BlNJ)	increased IgM level	J:93737
Arigm3^NZB/BlNJ/? (involves: BALB/cByJ * NZB/BlNJ)	increased IgM level	J:93737
Arigm4^NZB/BlNJ/? (involves: BALB/cByJ * NZB/BlNJ)	increased IgM level	J:93737
Arigm5^NZB/BlNJ/? (involves: BALB/cByJ * NZB/BlNJ)	increased IgM level	J:93737
Arigm6^NZB/BlNJ/? (involves: BALB/cByJ * NZB/BlNJ)	increased IgM level	J:93737
Arigm7^NZB/BlNJ/? (involves: BALB/cByJ * NZB/BlNJ)	increased IgM level	J:93737
Arl6ip1^{tm1b(EUCOMM)Hmgu}/Arl6ip1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Arl6ip1^{tm1b(EUCOMM)Hmgu}/H)	decreased mean corpuscular volume	J:211773
Arl16^{em1(IMPC)Ccpcz}/Arl16^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Arl16^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
	small spleen	J:211773
Armc2^{tm1b(EUCOMM)Hmgu}/Armc2⁺ (C57BL/6N-Armc2^{tm1b(EUCOMM)Hmgu}/H)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Armh4^em1(IMPC)H/Armh4^em1(IMPC)H (C57BL/6N-Armh4^em1(IMPC)H/H)	enlarged spleen	J:211773
Arnt^em1(IMPC)H/Arnt⁺ (C57BL/6N-Arnt^em1(IMPC)H/H)	increased mean corpuscular volume	J:211773
Arnt^em1(IMPC)H/Arnt⁺ (C57BL/6N-Arnt^em1(IMPC)H/H)	increased mean platelet volume	J:211773
Arnt^tm1.1Gonz/Arnt^tm1.1Gonz Tg(Vil1-cre)20Syr/0 (involves: 129X1/SvJ * C57BL/6 * DBA/2)	decreased erythrocyte cell number	J:189504
	decreased hematocrit	J:189504
	decreased hemoglobin content	J:189504
Arnt^tm1Bra/Arnt^tm1Bra Hprt1^{tm1(Pck1-cre)Vhh}/Y Vhl^tm1Jae/Vhl^tm1Jae (involves: 129 * BALB/c * C57BL/6)	hematopoietic system phenotype	J:97652
Arnt^tm1Mcs/Arnt^tm1Mcs (involves: 129S1/Sv * 129X1/SvJ)	impaired hematopoiesis	J:70037
Arp^BALB/c/Arp^BALB/c (involves: B10.D2 * BALB/c)	spleen hyperplasia	J:6549
Arp^BALB/c/Arp^BALB/c (involves: B10.D2 * BALB/c)	thymus hyperplasia	J:6549
Arpc1b^{tm1a(EUCOMM)Wtsi}/Arpc1b^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Arpc1b^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased CD4-positive, alpha-beta T cell number	J:211773
	decreased KLRG1-positive NK cell number	J:211773
	decreased Ly6C-positive mature NK cell number	J:211773
	decreased macrophage cell number	J:211773
	decreased marginal zone precursor B cell number	J:211773
	decreased mature NK cell number	J:211773
	decreased mean corpuscular hemoglobin	J:211773
	decreased NK cell number	J:211773
	decreased transitional stage T2 B cell number	J:211773
	increased CD4-positive, alpha-beta memory T cell number	J:211773
	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	increased CD103-positive CD11b-low dendritic cell number	J:211773
	increased effector memory T-helper cell number	J:211773
	increased immature NK cell number	J:211773
	increased KLRG1+ CD4 alpha-beta T cell number	J:211773
	increased KLRG1-positive CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	increased KLRG1-positive T-helper cell number	J:211773
	increased leukocyte cell number	J:211773
	increased mean platelet volume	J:211773
	increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	increased memory-marker CD4-negative NK T cell number	J:211773
	increased memory-marker NK cell number	J:211773
	increased plasma cell number	J:211773
	increased red blood cell distribution width	J:211773
	thrombocytosis	J:211773
Arpc2^{tm1a(EUCOMM)Wtsi}/Arpc2⁺ (B6JTyr;B6N-Arpc2^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased mean corpuscular hemoglobin	J:175295
Arpc4^{tm1a(EUCOMM)Wtsi}/Arpc4⁺ (B6JTyr;B6N-Arpc4^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased leukocyte cell number	J:165965
	increased mean corpuscular volume	J:165965
Arrb1^{tm1b(KOMP)Wtsi}/Arrb1^{tm1b(KOMP)Wtsi} (B6N(Cg)-Arrb1^{tm1b(KOMP)Wtsi}/J)	increased mean corpuscular hemoglobin	J:211773
	thrombocytopenia	J:211773
Arrb2^tm1Rjl/Arrb2^tm1Rjl (involves: 129X1/SvJ * C57BL/6)	abnormal lymphocyte physiology	J:76872
Arrdc4^em1(IMPC)Tcp/Arrdc4^em1(IMPC)Tcp (C57BL/6N-Arrdc4^em1(IMPC)Tcp/Tcp)	increased monocyte cell number	J:211773
	increased red blood cell distribution width	J:211773
Arrdc5^{tm1b(EUCOMM)Wtsi}/Arrdc5^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Arrdc5^{tm1b(EUCOMM)Wtsi}/Wtsi)	increased mean corpuscular hemoglobin	J:211773
Arsa^tm1Gie/Arsa^tm1Gie (involves: 129P2/OlaHsd * C57BL/6J)	abnormal microglial cell morphology	J:37978
Arsb^tm1Cptr/Arsb^tm1Cptr (involves: 129P2/OlaHsd * C57BL/6J)	abnormal blood cell morphology/development	J:34831
Arsg^tm1Tdi/Arsg^tm1Tdi (involves: 129S2/SvPas * C57BL/6)	abnormal macrophage morphology	J:185592
	abnormal microglial cell morphology	J:185592
	abnormal perivascular macrophage morphology	J:185592
	microgliosis	J:185592, J:254592
Arsi^tm1Anjm/Arsi⁺ Csf1r^tm1Anjm/Csf1r⁺ Lmo2^tm2(cre)Thr/Lmo2⁺ (involves: 129P2/OlaHsd * C57BL/6)	hematopoietic system phenotype	J:155870
Art1^{tm1b(EUCOMM)Wtsi}/Art1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Art1^{tm1b(EUCOMM)Wtsi}/Tcp)	increased basophil cell number	J:211773
Art2a^tm1Fkn/Art2a^tm1Fkn Art2b^tm1Fkn/Art2b^tm1Fkn (NOD.129S4(B6)-Art2a^tm1Fkn Art2b^tm1Fkn/Lt)	decreased T cell apoptosis	J:108097
Art4^{tm1a(KOMP)Wtsi}/Art4^{tm1a(KOMP)Wtsi} (C57BL/6N-Art4^{tm1a(KOMP)Wtsi}/Wtsi)	increased red blood cell distribution width	J:211773
Arti1^C57BL/6J/Arti1^C57BL/6J Arti2^C57BL/6J/Arti2^C57BL/6J (involves: C57BL/6J * DBA/2J)	abnormal thymus involution	J:85261
Arti1^DBA/2J/Arti1^DBA/2J Arti2^DBA/2J/Arti2^DBA/2J (involves: C57BL/6J * DBA/2J)	abnormal thymus involution	J:85261
Asah1^tm1.2Geno/Asah1^tm1.2Geno (involves: C57BL/6)	abnormal thymus morphology	J:285931
	decreased B cell number	J:285931
	decreased CD4-positive, alpha-beta T cell number	J:285931
	decreased CD8-positive, alpha-beta T cell number	J:285931
	decreased double-positive T cell number	J:285931
	decreased leukocyte cell number	J:285931
	decreased lymphocyte cell number	J:285931
	decreased mean corpuscular hemoglobin	J:285931
	decreased mean corpuscular volume	J:285931
	decreased splenocyte number	J:285931
	decreased T cell number	J:285931
	enlarged spleen	J:285931
	increased erythrocyte cell number	J:285931
	increased granulocyte number	J:285931
	increased hematopoietic stem cell number	J:285931
	increased macrophage cell number	J:285931
	increased macrophage derived foam cell number	J:285931
	increased monocyte cell number	J:285931
Asah1^tm1Medin/Asah1^tm1Medin (involves: 129S6/SvEvTac * CD-1)	enlarged spleen	J:232306
	enlarged thymus	J:232306
	increased eosinophil cell number	J:232306
	increased erythrocyte cell number	J:232306
	increased hemoglobin content	J:232306
	increased leukocyte cell number	J:232306
	increased macrophage derived foam cell number	J:232306
	increased monocyte cell number	J:232306
	increased neutrophil cell number	J:232306
	increased spleen weight	J:232306
	pale spleen	J:232306
Asap1^{em1(IMPC)Wtsi}/Asap1^{em1(IMPC)Wtsi} (C57BL/6NCrl-Asap1^{em1(IMPC)Wtsi}/Wtsi)	increased mean platelet volume	J:211773
Asb1^{em1(IMPC)Ccpcz}/Asb1^{em1(IMPC)Ccpcz} (C57BL/6N-Asb1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Asb1^tm1Wehi/Asb1^tm1Wehi (involves: C57BL/6)	hematopoietic system phenotype	J:71266
	small spleen	J:71266
	spleen hypoplasia	J:71266
Asb2^{tm2b(KOMP)Wtsi}/Asb2⁺ (C57BL/6N-Asb2^{tm2b(KOMP)Wtsi}/Kmpc)	decreased effector memory T-helper cell number	J:211773
	decreased Ly6C-positive immature NK cell number	J:211773
	increased CD4-positive, alpha-beta T cell number	J:211773
	increased dendritic cell number	J:211773
	increased eosinophil cell number	J:211773
	increased Ly6C-positive immature NK cell number	J:211773
	increased Ly6C-positive mature NK cell number	J:211773
	increased Ly6C-positive NK T cell number	J:211773
	increased NK cell number	J:211773
	increased T cell number	J:211773
Asb4^{em1(IMPC)Ccpcz}/Asb4^{em1(IMPC)Ccpcz} (C57BL/6N-Asb4^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
Asb5^{em1(IMPC)Ccpcz}/Asb5^{em1(IMPC)Ccpcz} (C57BL/6N-Asb5^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Asb7^{em1(IMPC)Ccpcz}/Asb7^{em1(IMPC)Ccpcz} (C57BL/6N-Asb7^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	decreased CD8-positive, alpha-beta T cell number	J:211773
	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	enlarged spleen	J:211773
Asb10^{tm2b(KOMP)Wtsi}/Asb10^{tm2b(KOMP)Wtsi} (B6N(Cg)-Asb10^{tm2b(KOMP)Wtsi}/J)	increased hematocrit	J:211773
	increased hemoglobin content	J:211773
Asb16^{em1(IMPC)Ccpcz}/Asb16^{em1(IMPC)Ccpcz} (C57BL/6N-Asb16^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Ascc2^{tm1a(EUCOMM)Wtsi}/Ascc2⁺ (C57BL/6N-Ascc2^{tm1a(EUCOMM)Wtsi}/Bay)	enlarged spleen	J:211773
Ascl4^em1(IMPC)J/Ascl4^em1(IMPC)J (C57BL/6NJ-Ascl4^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Ascl5^{em1(IMPC)Ccpcz}/Ascl5^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Ascl5^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Asf1b^m1Btlr/Asf1b^m1Btlr (C57BL/6J-Asf1b^m1Btlr)	increased IgE level	J:267479
Asgr1^tm1Sau/Asgr1^tm1Sau St3gal4^tm1.1Jxm/St3gal4^tm1.1Jxm (B6.129-St3gal4^tm1.1Jxm Asgr2^tm1Her)	hematopoietic system phenotype	J:136946
Asgr2^tm1Her/Asgr2^tm1Her St3gal4^tm1.1Jxm/St3gal4^tm1.1Jxm (B6.129-St3gal4^tm1.1Jxm Asgr2^tm1Her)	hematopoietic system phenotype	J:136946
Ash1l^{tm2b(EUCOMM)Hmgu}/Ash1l⁺ (C57BL/6N-Ash1l^{tm2b(EUCOMM)Hmgu}/Nju)	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
Ash1l^{Tn(pb-Act-RFP)1.AF0-180T25Zhu}/Ash1l^{Tn(pb-Act-RFP)1.AF0-180T25Zhu} (B6.FVB-Ash1l^{Tn(pb-Act-RFP)1.AF0-180T25Zhu})	increased IgA level	J:208213
	increased IgG1 level	J:208213
	increased IgG2a level	J:208213
	increased IgG2b level	J:208213
	increased IgM level	J:208213
Asic2^em1(IMPC)Mbp/Asic2^em1(IMPC)Mbp (C57BL/6N-Asic2^em1(IMPC)Mbp/MbpMmucd)	small spleen	J:211773
Asic3^em1(IMPC)Mbp/Asic3^em1(IMPC)Mbp (C57BL/6NCrl-Asic3^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Asl^tm1Brle/Asl^tm1Brle (involves: 129S7/SvEvBrd)	abnormal erythrocyte morphology	J:180208
	acanthocytosis	J:180208
	decreased lymphocyte cell number	J:180208
	decreased spleen germinal center number	J:180208
	increased macrophage cell number	J:180208
	increased spleen red pulp amount	J:180208
	thymus cortex hypoplasia	J:180208
Asns^{tm1a(EUCOMM)Wtsi}/Asns^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Asns^{tm1a(EUCOMM)Wtsi}/H)	decreased hemoglobin content	J:165965
Aspa^{tm1b(EUCOMM)Wtsi}/Aspa^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Aspa^{tm1b(EUCOMM)Wtsi}/Ieg)	increased mean corpuscular volume	J:211773
Aspg^em1(IMPC)Tcp/Aspg^em1(IMPC)Tcp (C57BL/6NCrl-Aspg^em1(IMPC)Tcp/Tcp)	decreased mean corpuscular volume	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
Asphd1^{em1(IMPC)Ccpcz}/Asphd1^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Asphd1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Aspm^{tm1a(KOMP)Wtsi}/Aspm^{tm1a(KOMP)Wtsi} (C57BL/6N-Aspm^{tm1a(KOMP)Wtsi}/Wtsi)	thrombocytopenia	J:211773
Aspn^{tm1b(EUCOMM)Hmgu}/Aspn^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Aspn^{tm1b(EUCOMM)Hmgu}/Ieg)	decreased mean corpuscular volume	J:211773
Aspscr1^em1(IMPC)Tcp/Aspscr1^em1(IMPC)Tcp (C57BL/6NCrl-Aspscr1^em1(IMPC)Tcp/Tcp)	decreased neutrophil cell number	J:211773
	increased lymphocyte cell number	J:211773
Aste1^{tm1a(KOMP)Wtsi}/Aste1^{tm1a(KOMP)Wtsi} (B6JTyr;B6N-Aste1^{tm1a(KOMP)Wtsi}/Wtsi)	decreased leukocyte cell number	J:175295
Asxl1^tm1.1Iaai/Asxl1^tm1.1Iaai Tet2^tm1.1Iaai/Tet2^tm1.1Iaai Tg(Mx1-cre)1Cgn/0 (involves: 129S/SvEv * C57BL/6 * CBA)	abnormal myelopoiesis	J:208092
Asxl1^tm1.1Iaai/Asxl1^tm1.1Iaai Tet2^tm1.1Iaai/Tet2^tm1.1Iaai Tg(VAV1-cre)1Graf/0 (involves: 129S/SvEv * C57BL/6)	hematopoietic system phenotype	J:208092
Asxl1^tm1.1Iaai/Asxl1^tm1.1Iaai Tg(Mx1-cre)1Cgn/0 (involves: 129S/SvEv * C57BL/6 * CBA)	abnormal myelopoiesis	J:208092
	decreased hemoglobin content	J:208092
	decreased leukocyte cell number	J:208092
	decreased mature B cell number	J:208092
	decreased monocyte cell number	J:208092
	decreased neutrophil cell number	J:208092
	extramedullary hematopoiesis	J:208092
	increased erythroid progenitor cell number	J:208092
	increased nucleated erythrocyte cell number	J:208092
Asxl1^tm1.1Iaai/Asxl1^tm1.1Iaai Tg(VAV1-cre)1Graf/0 (involves: 129S/SvEv * C57BL/6)	abnormal definitive hematopoiesis	J:208092
	abnormal hematopoietic stem cell morphology	J:208092
	abnormal myelopoiesis	J:208092
	anemia	J:208092
	decreased bone marrow cell number	J:208092
	decreased hemoglobin content	J:208092
	decreased leukocyte cell number	J:208092
	decreased mature B cell number	J:208092
	decreased monocyte cell number	J:208092
	decreased neutrophil cell number	J:208092
	decreased splenocyte number	J:208092
	increased erythroid progenitor cell number	J:208092
	increased hematopoietic stem cell number	J:208092
	increased nucleated erythrocyte cell number	J:208092
Asxl1^tm1.1Mjxu/Asxl1⁺ (involves: 129 * C57BL/6)	abnormal blood cell morphology/development	J:208085
	abnormal bone marrow cell morphology/development	J:208085
	abnormal common myeloid progenitor cell morphology	J:208085
	abnormal leukocyte morphology	J:208085
	abnormal myelopoiesis	J:208085
	abnormal neutrophil morphology	J:208085
	abnormal neutrophil physiology	J:208085
	abnormal spleen morphology	J:208085
	anemia	J:208085
	decreased B cell number	J:208085
	decreased hematopoietic stem cell number	J:208085
	decreased leukocyte cell number	J:208085
	decreased neutrophil cell number	J:208085
	enlarged spleen	J:208085
	increased hematopoietic stem cell number	J:208085
	increased leukocyte cell number	J:208085
	increased monocyte cell number	J:208085
	polychromatophilia	J:208085
	thrombocytopenia	J:208085
Asxl1^tm1.1Mjxu/Asxl1^tm1.1Mjxu (involves: 129 * C57BL/6)	abnormal common myeloid progenitor cell morphology	J:208085
	abnormal hematopoietic stem cell physiology	J:208085
	abnormal leukocyte morphology	J:208085
	abnormal megakaryocyte morphology	J:208085
	abnormal neutrophil morphology	J:208085
	abnormal spleen white pulp morphology	J:208085
	anemia	J:208085
	decreased B cell number	J:208085
	decreased erythroid progenitor cell number	J:208085
	decreased hematopoietic stem cell number	J:208085
	decreased leukocyte cell number	J:208085
	decreased lymphocyte cell number	J:208085
	decreased spleen red pulp amount	J:208085
	decreased spleen weight	J:208085
	impaired hematopoiesis	J:208085
	increased bone marrow cell number	J:208085
	increased monocyte cell number	J:208085
	increased number of Howell-Jolly bodies	J:208085
	increased single-positive T cell number	J:208085
	myeloid hyperplasia	J:208085
	polychromatophilia	J:208085
	small spleen	J:208085
	spleen atrophy	J:208085
	thrombocytopenia	J:208085
Asxl1^{tm1a(EUCOMM)Wtsi}/Asxl1⁺ (B6Dnk;B6Brd;B6N-Asxl1^{tm1a(EUCOMM)Wtsi} Tyr^c-Brd/WtsiH)	decreased hemoglobin content	J:175295
	decreased leukocyte cell number	J:175295
	decreased mean corpuscular hemoglobin	J:175295
Asxl1^{tm1a(EUCOMM)Wtsi}/Asxl1⁺ (C57BL/6N-Asxl1^{tm1a(EUCOMM)Wtsi}/Cnrm)	decreased B cell number	J:165965
	increased mean corpuscular hemoglobin concentration	J:165965
Asxl1^tm1Bc/Asxl1^tm1Bc (involves: 129P2/OlaHsd * C57BL/6J)	abnormal blood cell morphology/development	J:155898
	abnormal common myeloid progenitor cell morphology	J:155898
	abnormal lymphopoiesis	J:155898
	abnormal thymus morphology	J:155898
	decreased B cell number	J:155898
	decreased bone marrow cell number	J:155898
	decreased CD4-positive, alpha-beta T cell number	J:155898
	decreased pre-B cell number	J:155898
	decreased T cell number	J:155898
	extramedullary hematopoiesis	J:155898
	increased double-negative T cell number	J:155898
	spleen hyperplasia	J:155898
Asxl2^{tm1b(EUCOMM)Hmgu}/Asxl2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Asxl2^{tm1b(EUCOMM)Hmgu}/Tcp)	decreased mean corpuscular volume	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
Atad2b^{tm1b(EUCOMM)Hmgu}/Atad2b^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Atad2b^{tm1b(EUCOMM)Hmgu}/Ics)	decreased NK T cell number	J:211773
Atad5^{Gt(RRF055)Byg}/Atad5⁺ (involves: 129P2/OlaHsd)	reticulocytosis	J:176672
Atat1^tm1.2Phep/Atat1^tm1.2Phep (involves: 129P2/OlaHsd * BALB/cJ * C57BL/6J)	hematopoietic system phenotype	J:205737
Atcay^ji/Atcay^ji (Not Specified)	abnormal thymus cortex morphology	J:14903
	abnormal thymus medulla morphology	J:14903
	abnormal thymus morphology	J:14903
Atf2^{Tg(Gzma-Klra1)7Wum}/Atf2⁺ (involves: C57BL/6)	abnormal NK cell physiology	J:61178
	decreased NK cell number	J:61178
	decreased NK T cell number	J:61178
Atf2^{tm1b(EUCOMM)Hmgu}/Atf2⁺ (C57BL/6N-Atf2^{tm1b(EUCOMM)Hmgu}/Ccpcz)	abnormal spleen morphology	J:211773
	decreased mean platelet volume	J:211773
Atf2^tm1Nicj/Atf2^tm1Nicj Atf7^tm1Nicj/Atf7^tm1Nicj (involves: 129P2/OlaHsd * C57BL/6)	abnormal common myeloid progenitor cell morphology	J:123909
	anemia	J:123909
Atf2^tm2Nicj/Atf2^tm2Nicj Atf7^tm1Nicj/Atf7^tm1Nicj (involves: 129P2/OlaHsd * C57BL/6)	abnormal common myeloid progenitor cell morphology	J:123909
	anemia	J:123909
Atf3^tm1Dron/Atf3^tm1Dron (involves: 129X1/SvJ * C57BL/6)	abnormal T-helper 2 physiology	J:140112
Atf3^tm1Dron/Atf3^tm1Dron (involves: 129X1/SvJ * C57BL/6)	decreased IgG2a level	J:140112
Atf4^tm1(KOMP)Mbp/Atf4⁺ (C57BL/6NCrl-Atf4^tm1(KOMP)Mbp/MbpMmucd)	decreased monocyte cell number	J:211773
	increased mean corpuscular hemoglobin	J:211773
Atf4^tm1Tow/Atf4^tm1Tow (involves: 129S1/Sv * 129X1/SvJ * NIH Black Swiss)	absent common myeloid progenitor cells	J:74479
	anemia	J:74479
	decreased hematocrit	J:74479
	impaired hematopoiesis	J:74479
Atg3^tm1.1Ywh/Atg3^tm1.1Ywh Fnip1^m1Btlr/Fnip1^m1Btlr Gt(ROSA)26Sor^{tm1(cre/ERT)Nat}/Gt(ROSA)26Sor⁺ (involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ * C57BL/6J)	absent B cells	J:234285
Atg3^tm1.1Ywh/Atg3^tm1.1Ywh Gt(ROSA)26Sor^{tm1(cre/ERT)Brn}/Gt(ROSA)26Sor⁺ (involves: 129P2/OlaHsd * 129S/SvEv * 129S4/SvJaeSor * C57BL/6)	abnormal T cell morphology	J:172749
	increased T cell apoptosis	J:172749
Atg3^tm1.1Ywh/Atg3^tm1.1Ywh Tg(Lck-cre)548Jxm/0 (involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6 * CBA)	abnormal T cell morphology	J:172749
	decreased CD4-positive, alpha-beta T cell number	J:172749
	decreased CD8-positive, alpha-beta T cell number	J:172749
	decreased T cell proliferation	J:172749
	increased T cell apoptosis	J:172749
	spleen hypoplasia	J:172749
	thymus hypoplasia	J:172749
Atg5^tm1Myok/Atg5^tm1Myok Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S/SvEv)	abnormal macrophage physiology	J:235399
	increased IgG level	J:235399
	increased lymphocyte cell number	J:235399
	increased monocyte cell number	J:235399
	increased neutrophil cell number	J:235399
Atg5^tm1Nmz/Atg5^tm1Nmz (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	hematopoietic system phenotype	J:103983
Atg5^tm1Nmz/Atg5^tm1Nmz (involves: 129 * BALB/c * C57BL/6)	abnormal thymus cortex morphology	J:140583
Atg5^tm1Nmz/Atg5^tm1Nmz Tg(CAG-EGFP/Map1lc3b)53Nmz/? (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal thymus morphology	J:140583
	abnormal thymus physiology	J:140583
Atg5^tm1Nmz/Atg5^tm1Nmz Tg(Cd4-cre)1Cwi/? (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)	abnormal T cell morphology	J:211733
	abnormal T cell physiology	J:211733
	abnormal T cell subpopulation ratio	J:211733
	decreased CD4-positive, alpha-beta T cell number	J:211733
	decreased CD8-positive, alpha-beta T cell number	J:211733
	decreased T cell number	J:211733
	decreased T cell proliferation	J:211733
Atg7^tm1Tchi/Atg7^tm1Tchi Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: C57BL/6NCrlj * C57BL/10 * CBA/Ca * CBA/JNCrlj)	abnormal common lymphocyte progenitor cell morphology	J:176843
	abnormal hematopoietic stem cell morphology	J:176843
	abnormal hematopoietic stem cell physiology	J:176843
	abnormal leukocyte morphology	J:176843
	decreased B cell number	J:176843
	decreased bone marrow cell number	J:176843
	decreased common myeloid progenitor cell number	J:176843
	decreased hematopoietic stem cell number	J:176843
	decreased leukocyte cell number	J:176843
	decreased NK cell number	J:176843
	decreased T cell number	J:176843
Atg7^tm1Tchi/Atg7^tm1Tchi Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6NCrlj * CBA/JNCrlj)	abnormal macrophage physiology	J:235399
	increased IgG level	J:235399
	increased lymphocyte cell number	J:235399
	increased monocyte cell number	J:235399
	increased neutrophil cell number	J:235399
Atg7^tm1Tchi/Atg7^tm1Tchi Lyz2^tm1(cre)Ifo/Lyz2⁺ Tg(CAG-EGFP/Map1lc3b)53Nmz/0 (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj * DBA/2)	abnormal macrophage physiology	J:235399
Atg16l1^tm1.1Mvlc/Atg16l1^tm1.1Mvlc (C57BL/6-Atg16l1^tm1.1Mvlc)	abnormal macrophage physiology	J:206931
	increased macrophage cytokine production	J:206931
Atg16l1^{tm1a(EUCOMM)Wtsi}/Atg16l1⁺ (C57BL/6N-Atg16l1^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased mean corpuscular hemoglobin	J:175295
Atg16l1^{tm1a(EUCOMM)Wtsi}/Atg16l1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Atg16l1^{tm1a(EUCOMM)Wtsi}/Wtsi)	abnormal thymus topology	J:239583
Atg16l1^tm1Aki/Atg16l1^tm1Aki (involves: 129/Sv * C57BL/6)	abnormal macrophage physiology	J:141420
Atg16l1^{tm1c(EUCOMM)Wtsi}/Atg16l1^{tm1c(EUCOMM)Wtsi} Tg(Vil1-cre)997Gum/? (involves: C57BL/6J * C57BL/6N * SJL)	increased macrophage cell number	J:221019
Atg16l2^m1Anu/Atg16l2^m1Anu (C57BL/6NCrlAnu-Atg16l2^m1Anu)	decreased lymphocyte cell number	J:104190
Atl2^{tm2b(EUCOMM)Hmgu}/Atl2⁺ (C57BL/6N-Atl2^{tm2b(EUCOMM)Hmgu}/H)	decreased mean corpuscular volume	J:211773
	decreased neutrophil cell number	J:211773
	decreased red blood cell distribution width	J:211773
	increased hemoglobin content	J:211773
	increased lymphocyte cell number	J:211773
Atm^m1Btlr/Atm^m1Btlr (C57BL/6J-Atm^m1Btlr)	decreased CD4-positive, alpha-beta T cell number	J:265252
	decreased CD8-positive, alpha-beta T cell number	J:265252
	decreased single-positive T cell number	J:265252
	decreased T cell number	J:265252
	increased IgM level	J:265252
Atm^m2Btlr/Atm^m2Btlr (C57BL/6J-Atm^m2Btlr)	decreased CD4-positive, alpha-beta T cell number	J:265253
	decreased CD8-positive, naive alpha-beta T cell number	J:265253
	decreased single-positive T cell number	J:265253
	increased central memory CD8 positive, alpha-beta T cell number	J:265253
	increased effector memory CD4-positive, alpha-beta T cell number	J:265253
Atm^m3Btlr/Atm^m3Btlr (C57BL/6J-Atm^m3Btlr)	increased B-1a cell number	J:272820
Atm^m3Btlr/Atm^m3Btlr (C57BL/6J-Atm^m3Btlr)	increased macrophage cell number	J:272820
Atm^M4Btlr/Atm^M4Btlr (C57BL/6J-Atm^M4Btlr)	abnormal CD8-positive, alpha-beta T cell differentiation	J:272821
Atm^m5Btlr/Atm^m5Btlr (C57BL/6J-Atm^m5Btlr)	abnormal lymphocyte morphology	J:272824
	impaired macrophage phagocytosis	J:272824
	increased B-1 B cell number	J:272824
Atm^m6Btlr/Atm^m6Btlr (C57BL/6J-Atm^m6Btlr)	abnormal CD4-positive T cell differentiation	J:274964
	abnormal CD8-positive, alpha-beta T cell differentiation	J:274964
	abnormal T cell differentiation	J:274964
	decreased CD4-positive, alpha-beta T cell number	J:274964
	decreased CD8-positive, naive alpha-beta T cell number	J:274964
	decreased T cell number	J:274964
	increased CD8-positive, alpha-beta memory T cell number	J:274964
	increased central memory CD4-positive, alpha-beta T cell number	J:274964
	increased central memory CD8 positive, alpha-beta T cell number	J:274964
	increased effector memory CD4-positive, alpha-beta T cell number	J:274964
Atm^tm1.1Mmpl/Atm^tm1.1Mmpl (involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6J)	decreased T cell number	J:226414
	increased B cell number	J:226414
Atm^tm1Awb/Atm⁺ (involves: 129/Sv * 129S6/SvEvTac * C57BL/6)	hematopoietic system phenotype	J:209141
Atm^tm1Awb/Atm⁺ Rad50^tm2Jpt/Rad50^tm2Jpt (involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6)	anemia	J:103922
	decreased macrophage cell number	J:103922
Atm^tm1Awb/Atm^tm1Awb (either: 129S6/SvEvTac-Atm^tm1Awb or (involves: 129S6/SvEvTac * NIH Black Swiss))	decreased activated T cell number	J:34193
	decreased double-positive T cell number	J:34193
	decreased T cell number	J:34193
	increased double-positive T cell number	J:34193
Atm^tm1Awb/Atm^tm1Awb (involves: 129S6/SvEvTac)	abnormal class switch recombination	J:150435
	decreased CD4-positive, alpha-beta T cell number	J:90941
	decreased CD8-positive, alpha-beta T cell number	J:90941
Atm^tm1Awb/Atm^tm1Awb (129S6/SvEvTac-Atm^tm1Awb/J)	decreased single-positive T cell number	J:226414
	decreased T cell number	J:226414
	increased B cell number	J:226414
	increased double-positive T cell number	J:226414
Atm^tm1Awb/Atm^tm1Awb Paxx^em1Spj/Paxx^em1Spj (involves: A/J * C57BL/6NTac)	abnormal class switch recombination	J:236776
	decreased B cell number	J:236776
	decreased splenocyte number	J:236776
	decreased T cell number	J:236776
Atm^tm1Awb/Atm^tm1Awb Rad50^tm2Jpt/Rad50^tm2Jpt (involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6)	anemia	J:103922
Atm^tm1Awb/Atm^tm1Awb Rad52^tm1Aps/Rad52^tm1Aps (involves: 129P2/OlaHsd * 129S6/SvEvTac)	decreased CD4-positive, alpha-beta T cell number	J:90941
	decreased CD8-positive, alpha-beta T cell number	J:90941
Atm^tm1Bal/Atm^tm1Bal (involves: 129S4/SvJae)	abnormal microglial cell physiology	J:44190
	abnormal T cell physiology	J:35914
	decreased IgG2a level	J:35914
	decreased IgG2b level	J:35914
	decreased IgG3 level	J:35914
	decreased IgG level	J:35914
	decreased pre-B cell number	J:35914
	decreased thymocyte number	J:35914
	small thymus	J:35914
Atm^tm1Fwa/Atm^tm1Fwa (involves: 129S4/SvJae * C57BL/6)	decreased immature B cell number	J:61201
	decreased lymphocyte cell number	J:61201
	decreased pre-B cell number	J:61201
	decreased splenocyte number	J:61201
	decreased T cell number	J:61201
	decreased thymocyte number	J:61201
Atm^tm1Fwa/Atm^tm1Fwa (involves: 129S4/SvJae)	abnormal class switch recombination	J:191288
Atm^tm1Led/Atm^tm1Led (involves: 129S6/SvEvTac * Black Swiss)	abnormal T cell differentiation	J:36561
	decreased CD4-positive, alpha-beta T cell number	J:36561
	increased double-positive T cell number	J:36561
	small thymus	J:36561
	thymus cortex hypoplasia	J:36561
Atm^tm1Mfl/Atm^tm1Mfl (involves: 129T2/SvEms * C57BL/6J)	abnormal T cell differentiation	J:69726
	decreased thymocyte number	J:69726
	enlarged spleen	J:69726
	increased double-negative T cell number	J:69726
	increased single-positive T cell number	J:69726
	small spleen	J:69726
	small thymus	J:69726
Atm^tm1Pmc/Atm^tm1Pmc Trp73^tm2Mak/Trp73^tm2Mak (involves: 129P2/OlaHsd * C57BL/6J)	decreased thymocyte apoptosis	J:157905
Atm^tm1Shzh/Atm^tm2.1Fwa Gt(ROSA)26Sor^{tm1(cre/ERT2)Thl}/Gt(ROSA)26Sor⁺ (involves: 129 * 129S6/SvEvTac)	abnormal class switch recombination	J:191288
Atm^tm2.1Fwa/Atm^tm2.1Fwa Tg(VAV1-cre)1Graf/0 (involves: 129S6/SvEvTac)	decreased B cell number	J:277750
	decreased T cell number	J:277750
	decreased thymocyte number	J:277750
Atm^tm2.1Mfgc/Atm^tm2.1Mfgc (C57BL/6-Atm^tm2.1Mfgc)	abnormal T cell differentiation	J:316365
Atm^tm2.1Mfgc/Atm^tm2.1Mfgc (C57BL/6-Atm^tm2.1Mfgc)	decreased T cell number	J:316365
Atmin^tm1.1Jhh/Atmin^tm1.1Jhh (C57BL/6-Atmin^tm1.1Jhh)	thymus hypoplasia	J:167544
Atmin^tm1.1Jhh/Atmin^tm1.1Jhh Cd79a^tm1(cre)Reth/Cd79a⁺ (B6.Cg-Cd79a^tm1(Cre)Reth Atmin^tm1.1Jhh)	decreased B cell number	J:230105
	decreased IgG1 level	J:230105
	decreased immature B cell number	J:230105
	increased B cell apoptosis	J:230105
Atmin^tm1.1Jhh/Atmin^tm1.1Jhh Cd79a^tm1(cre)Reth/Cd79a⁺ Tg(IghMyc)22Bri/0 (B6.Cg-Cd79a^tm1(Cre)Reth Atmin^tm1.1Jhh Tg(IghMyc)22Bri)	decreased B cell number	J:230105
	decreased immature B cell number	J:230105
	increased B cell apoptosis	J:230105
Atmin^tm1.1Jhh/Atmin^tm1.1Jhh Tg(Fcer2a-cre)5Mbu/0 (B6.Cg-Atmin^tm1.1Jhh Tg(Fcer2a-cre)5Mbu)	hematopoietic system phenotype	J:230105
Atmin^tm1.2Jhh/Atmin^tm1.2Jhh Bcl2l11^tm1.1Ast/Bcl2l11^tm1.1Ast Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: 129S1/Sv * BALB/c * C57BL/6)	enlarged spleen	J:191832
	increased B cell number	J:191832
	increased immature B cell number	J:191832
	increased pre-B cell number	J:191832
	increased spleen weight	J:191832
Atmin^tm1.2Jhh/Atmin^tm1.2Jhh Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: BALB/c * C57BL/6)	abnormal B cell differentiation	J:191832
	abnormal B cell physiology	J:191832
	decreased immature B cell number	J:191832
	decreased mature B cell number	J:191832
	decreased pre-B cell number	J:191832
	decreased spleen weight	J:191832
	small spleen	J:191832
Atmin^tm1.2Jhh/Atmin^tm1.2Jhh Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	decreased B cell number	J:191832
	decreased erythrocyte cell number	J:191832
	decreased lymphocyte cell number	J:191832
	decreased mature B cell number	J:191832
	decreased pre-B cell number	J:191832
Atmin^tm1.2Jhh/Atmin^tm1.2Jhh Trp53^tm1Brn/Trp53^tm1Brn Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: 129P2/OlaHsd * BALB/c * C57BL/6)	decreased B cell number	J:191832
	decreased immature B cell number	J:191832
Atn1^{tm1b(EUCOMM)Wtsi}/Atn1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Atn1^{tm1b(EUCOMM)Wtsi}/Cnrm)	decreased erythrocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	decreased monocyte cell number	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased neutrophil cell number	J:211773
Atp1a1^{em1(IMPC)Ccpcz}/Atp1a1⁺ (C57BL/6NCrl-Atp1a1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Atp1a3^Myk/Atp1a3⁺ (involves: 129S1/SvImJ * C57BL/6J * C57BL/6NCr * FVB/NCr)	microgliosis	J:151948
Atp2a2^{tm1b(EUCOMM)Hmgu}/Atp2a2⁺ (C57BL/6N-Atp2a2^{tm1b(EUCOMM)Hmgu}/H)	decreased mean platelet volume	J:211773
Atp2a2^tm1Ges/Atp2a2⁺ (involves: 129X1/SvJ)	abnormal osteoclast differentiation	J:198051
Atp2b4^tm1Ksch/Atp2b4^tm1Ksch (involves: 129P2/OlaHsd * C57BL/6)	increased mean corpuscular hemoglobin concentration	J:245643
Atp2c2^em1(IMPC)Tcp/Atp2c2^em1(IMPC)Tcp (C57BL/6NCrl-Atp2c2^em1(IMPC)Tcp/Tcp)	decreased hematocrit	J:211773
Atp4a^m1Btlr/Atp4a^m1Btlr (involves: C57BL/6J)	abnormal erythrocyte morphology	J:179090
	abnormal erythropoiesis	J:179090
	abnormal spleen morphology	J:179090
	anisocytosis	J:179090
	decreased erythrocyte osmotic fragility	J:179090
	decreased hematocrit	J:179090
	decreased hemoglobin content	J:179090
	decreased mean corpuscular hemoglobin	J:179090
	decreased mean corpuscular volume	J:179090
	enlarged spleen	J:179090
	extramedullary hematopoiesis	J:179090
	hematopoietic system phenotype	J:179090
	hypochromic anemia	J:179090
	increased erythroid progenitor cell number	J:179090
	increased red blood cell distribution width	J:179090
	poikilocytosis	J:179090
	reticulocytosis	J:179090
	thrombocytosis	J:179090
Atp4a^m1Btlr/Atp4a^tm1Ges (involves: 129X1/SvJ * Black Swiss * C57BL/6J)	hypochromic microcytic anemia	J:179090
Atp4a^tm1.1Ocalv/Atp4a^tm1.1Ocalv (involves: 129S6/SvEv * C57BL/6J * C57BL/6NCrl)	anemia	J:235360
Atp5f1e^{tm1b(EUCOMM)Wtsi}/Atp5f1e⁺ (C57BL/6N-Atp5f1e^{tm1b(EUCOMM)Wtsi}/Wtsi)	increased red blood cell distribution width	J:211773
Atp5if1^em1Jpy/Atp5if1^em1Jpy (C57BL/6J-Atp5if1^em1Jpy)	decreased neutrophil cell number	J:312819
Atp5if1^em1Jpy/Atp5if1^em1Jpy (C57BL/6J-Atp5if1^em1Jpy)	hematopoietic system phenotype	J:312819
Atp5if1^tm1Ksuj/Atp5if1^tm1Ksuj (C57BL/6J-Atp5if1^tm1Ksuj)	hematopoietic system phenotype	J:268424
Atp5mc1^em1(IMPC)H/Atp5mc1^em1(IMPC)H (C57BL/6NTac-Atp5mc1^em1(IMPC)H/H)	increased neutrophil cell number	J:211773
Atp5mg^{tm1b(EUCOMM)Hmgu}/Atp5mg⁺ (C57BL/6N-Atp5mg^{tm1b(EUCOMM)Hmgu}/H)	decreased eosinophil cell number	J:211773
	enlarged spleen	J:211773
	increased mean corpuscular hemoglobin	J:211773
Atp5mk^{tm1b(EUCOMM)Wtsi}/Atp5mk^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Atp5mk^{tm1b(EUCOMM)Wtsi}/H)	decreased hemoglobin content	J:211773
	increased leukocyte cell number	J:211773
	increased mean corpuscular volume	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Atp6v0a2^tm1Kdb/Atp6v0a2^tm1Kdb Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: C57BL/6 * C57BL/10 * CBA/Ca)	abnormal CD8-positive, alpha-beta cytotoxic T cell morphology	J:274048
	decreased alpha-beta T cell number	J:274048
	decreased CD4-positive, alpha-beta T cell number	J:274048
	decreased T cell number	J:274048
Atp6v0b^em1(IMPC)J/Atp6v0b⁺ (C57BL/6NJ-Atp6v0b^em1(IMPC)J/Mmjax)	increased hematocrit	J:211773
Atp6v0d1^{tm1b(EUCOMM)Hmgu}/Atp6v0d1⁺ (C57BL/6N-Atp6v0d1^{tm1b(EUCOMM)Hmgu}/Tcp)	decreased lymphocyte cell number	J:211773
	decreased mean corpuscular hemoglobin concentration	J:211773
	increased neutrophil cell number	J:211773
Atp6v0d2^tm1Ywc/Atp6v0d2^tm1Ywc (involves: 129P2/OlaHsd * C57BL/6)	abnormal osteoclast differentiation	J:117744
	abnormal osteoclast morphology	J:117744
Atp6v1b2^{tm1b(KOMP)Wtsi}/Atp6v1b2⁺ (C57BL/6N-Atp6v1b2^{tm1b(KOMP)Wtsi}/Tcp)	decreased hemoglobin content	J:211773
	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular hemoglobin concentration	J:211773
	decreased mean corpuscular volume	J:211773
Atp6v1c1^{tm1b(NCOM)Mfgc}/Atp6v1c1⁺ (C57BL/6N-Atp6v1c1^{tm1b(NCOM)Mfgc}/Tcp)	increased leukocyte cell number	J:211773
	increased mean corpuscular volume	J:211773
Atp6v1d^{tm1b(EUCOMM)Hmgu}/Atp6v1d⁺ (C57BL/6N-Atp6v1d^{tm1b(EUCOMM)Hmgu}/Tcp)	decreased mean platelet volume	J:211773
	thrombocytosis	J:211773
Atp6v1h^em1Xhd/Atp6v1h⁺ (involves: C57BL/6)	abnormal osteoclast differentiation	J:239439
	abnormal osteoclast physiology	J:239439
	hematopoietic system phenotype	J:239439
Atp7a^Mo-ml/Y (involves: C3Hf/He)	decreased spleen weight	J:12745
Atp7b^tx-J/Atp7b^tx-J (C3H/HeJ-Atp7b^tx-J/J)	increased eosinophil cell number	J:24233
Atp8a1^{tm1a(EUCOMM)Wtsi}/Atp8a1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Atp8a1^{tm1a(EUCOMM)Wtsi}/H)	decreased erythrocyte cell number	J:165965
	increased mean corpuscular hemoglobin concentration	J:165965
Atp8b1^em1(IMPC)Tcp/Atp8b1^em1(IMPC)Tcp (C57BL/6NCrl-Atp8b1^em1(IMPC)Tcp/Tcp)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
	increased leukocyte cell number	J:211773
Atp11a^{tm1a(KOMP)Wtsi}/Atp11a^{tm1a(KOMP)Wtsi} (C57BL/6N-Atp11a^{tm1a(KOMP)Wtsi}/Wtsi)	abnormal thymus morphology	J:239583
Atp11b^em1(IMPC)Tcp/Atp11b^em1(IMPC)Tcp (C57BL/6N-Atp11b^em1(IMPC)Tcp/Tcp)	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular hemoglobin concentration	J:211773
Atp11c^ambr/Y (C57BL/6-Atp11c^ambr)	abnormal B cell differentiation	J:171924
	anemia	J:171924
	decreased B cell number	J:171924
	decreased B-1 B cell number	J:171924
	decreased B-1a cell number	J:171924
	decreased B-1b cell number	J:171924
	decreased B-2 B cell number	J:171924
	decreased erythrocyte cell number	J:171924
	decreased follicular B cell number	J:171924
	decreased immature B cell number	J:171924
	decreased leukocyte cell number	J:171924
	decreased lymphocyte cell number	J:171924
	decreased mature B cell number	J:171924
	decreased pre-B cell number	J:171924
	decreased pro-B cell number	J:171924
	decreased T cell number	J:171924
	hematopoietic system phenotype	J:171924
Atp11c^ambr/Y Tg(H2-Ea-Il7)10Rhdr/0 (involves: C57BL/6 * C57BL/6JApb * DBA/2)	decreased B cell number	J:171924
Atp11c^ambr/Y Tg(IghelMD4)4Ccg/0 (involves: C57BL/6 * C57BL/6JApb)	decreased immature B cell number	J:171924
	decreased pro-B cell number	J:171924
Atp11c^ambr/Y Tg(Vav-BCL2)69Jad/0 (involves: C57BL/6 * C57BL/6J * C57BL/6JApb)	decreased B cell number	J:171924
	decreased immature B cell number	J:171924
	decreased pre-B cell number	J:171924
Atp11c^em1(IMPC)J/Y (C57BL/6NJ-Atp11c^em1(IMPC)J/Mmjax)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	decreased leukocyte cell number	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
Atp11c^em1(IMPC)J/Atp11c^em1(IMPC)J (C57BL/6NJ-Atp11c^em1(IMPC)J/Mmjax)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	decreased leukocyte cell number	J:211773
Atp11c^m1Btlr/Y (involves: C57BL/6J)	absent follicular B cells	J:171925
	arrested B cell differentiation	J:171925
	decreased B cell number	J:185495, J:171925
	decreased B-1 B cell number	J:171925
	decreased B-2 B cell number	J:171925
	decreased IgA level	J:171925
	decreased IgG1 level	J:171925
	decreased IgM level	J:171925
	decreased immature B cell number	J:171925
	decreased transitional stage B cell number	J:171925
	decreased transitional stage T1 B cell number	J:171925
	decreased transitional stage T2 B cell number	J:171925
	decreased transitional stage T3 B cell number	J:171925
Atp11c^m1Btlr/Y Tg(BCL2)22Wehi/0 (involves: C57BL/6J * C57BL/6JWehi * SJL/Wehi)	decreased B cell number	J:171925
	decreased follicular B cell number	J:171925
	decreased mature B cell number	J:171925
	increased marginal zone B cell number	J:171925
Atp11c^m1Btlr/Y Tg(IghmHyHEL10,IgkHyHEL10)4Ccg/0 (involves: C57BL/6 * C57BL/6J * C57BL/6JSfdAnu)	decreased B cell number	J:171925
Atp11c^m1Btlr/Atp11c^m1Btlr (involves: C57BL/6J)	decreased B cell number	J:185495
Atp11c^m1Btlr/Atp11c^m2Btlr (involves: C57BL/6J)	decreased B cell number	J:171925
Atp11c^m2Anu/Y (C57BL/6JAnu-Atp11c^m2Anu/AnuApb)	decreased B cell number	J:171924
Atp11c^m2Btlr/Y (involves: C57BL/6J)	decreased B cell number	J:185495, J:171925
Atp11c^m2Btlr/Atp11c^m2Btlr (involves: C57BL/6J)	decreased B cell number	J:185495
Atp13a3^em1(IMPC)J/Atp13a3^em1(IMPC)J (C57BL/6NJ-Atp13a3^em1(IMPC)J/Mmjax)	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
	increased erythrocyte cell number	J:211773
	increased hematocrit	J:211773
	increased leukocyte cell number	J:211773
	thrombocytopenia	J:211773
Atp13a5^tm1Lex/Atp13a5^tm1Lex (B6;129S5-Atp13a5^tm1Lex/Mmucd)	decreased NK cell number	J:171883
Atr^tm1Bal/Atr^tm2Bal Ndor1^{Tg(UBC-cre/ERT2)1Ejb}/0 (involves: 129S/SvEv * 129S2/SvPas * C57BL/6)	abnormal thymus involution	J:123200
	decreased thymocyte number	J:123200
Atr^tm1Ofc/Atr^tm1Ofc (Not Specified)	abnormal hematopoietic stem cell morphology	J:151542
	decreased bone marrow cell number	J:151542
	decreased spleen weight	J:151542
	decreased thymus weight	J:151542
	pancytopenia	J:151542
Atr^tm1Ofc/Atr^tm1Ofc Trp53^tm1Tyj/Trp53^tm1Tyj (involves: 129S2/SvPas)	pancytopenia	J:151542
Atrn^{tm1.1(KOMP)Vlcg}/Atrn^{tm1.1(KOMP)Vlcg} (C57BL/6N-Atrn^{tm1.1(KOMP)Vlcg}/Ucd)	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
Auh^em1(IMPC)Tcp/Auh^em1(IMPC)Tcp (C57BL/6NCrl-Auh^em1(IMPC)Tcp/Tcp)	increased eosinophil cell number	J:211773
Aurka^{tm1b(EUCOMM)Hmgu}/Aurka⁺ (B6N(Cg)-Aurka^{tm1b(EUCOMM)Hmgu}/J)	decreased leukocyte cell number	J:211773
Avp^{tm1b(EUCOMM)Wtsi}/Avp⁺ (C57BL/6N-Avp^{tm1b(EUCOMM)Wtsi}/H)	decreased large unstained cell number	J:211773
	decreased neutrophil cell number	J:211773
	increased lymphocyte cell number	J:211773
Avpr1a^tm1Sbhu/Avpr1a^tm1Sbhu (involves: C57BL/6)	abnormal B cell differentiation	J:105892
	abnormal immunoglobulin level	J:105892
	decreased IgG2b level	J:105892
	increased B-1a cell number	J:105892
	increased IgG2a level	J:105892
Avpr2^tm1Jwe/Y (involves: 129S1/Sv * 129X1/SvJ * CF-1)	increased hematocrit	J:66094
awg^{Tg(GBts1env)832Pkw}/awg^{Tg(GBts1env)832Pkw} (involves: C57BL/6J * SJL)	thymus atrophy	J:43273
Axl^tm1Grl/Axl^tm1Grl Mertk^tm1Grl/Mertk^tm1Grl Tyro3^tm1Grl/Tyro3^tm1Grl (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal B cell activation	J:70420
	abnormal macrophage physiology	J:70420
	abnormal T cell activation	J:70420
	enlarged spleen	J:54681, J:70420
	increased B cell proliferation	J:70420
	increased lymphocyte cell number	J:70420
	increased splenocyte apoptosis	J:54681
	increased T cell proliferation	J:70420
Azgp1^tm1.1Sbah/Azgp1^tm1.1Sbah (involves: 129P2/OlaHsd * C57BL/6)	enlarged spleen	J:118213
Azi2^tm1Aki/Azi2^tm1Aki (Not Specified)	abnormal bone marrow cell physiology	J:204786
Azi2^tm1Aki/Azi2^tm1Aki (Not Specified)	abnormal dendritic cell differentiation	J:204786
b2b227Clo/b2b227Clo (C57BL/6J-b2b227Clo)	spleen hypoplasia	J:175213
b2b386.1Clo/b2b386.1Clo (C57BL/6J-b2b386.1Clo)	absent spleen	J:175213
b2b386Clo/b2b386Clo (C57BL/6J-b2b386Clo)	absent spleen	J:175213
b2b954Clo/b2b954Clo (C57BL/6J-b2b954Clo)	thymus hypoplasia	J:175213
b2b1249Clo/b2b1249Clo (C57BL/6J-b2b1249Clo)	thymus hypoplasia	J:175213
b2b1702Clo/b2b1702Clo (C57BL/6J-b2b1702Clo)	spleen hypoplasia	J:175213
b2b1702Clo/b2b1702Clo (C57BL/6J-b2b1702Clo)	thymus hypoplasia	J:175213
b2b1941Clo/b2b1941Clo (C57BL/6J-b2b1941Clo)	athymia	J:175213
b2b2025Clo/b2b2025Clo (C57BL/6J-b2b2025Clo)	absent spleen	J:175213
b2b2025Clo/b2b2025Clo (C57BL/6J-b2b2025Clo)	spleen hypoplasia	J:175213
b2b2059Clo/b2b2059Clo (C57BL/6J-b2b2059Clo)	spleen hypoplasia	J:175213
b2b2140Clo/b2b2140Clo (C57BL/6J-b2b2140Clo)	spleen hypoplasia	J:175213
b2b2187Clo/b2b2187Clo (C57BL/6J-b2b2187Clo)	thymus hypoplasia	J:175213
b2b2463Clo/b2b2463Clo (C57BL/6J-b2b2463Clo)	thymus hypoplasia	J:175213
b2b2588Clo/b2b2588Clo (C57BL/6J-b2b2588Clo)	thymus hypoplasia	J:175213
b2b2696.1Clo/b2b2696.1Clo (C57BL/6J-b2b2696.1Clo)	absent spleen	J:175213
b2b2696.2Clo/b2b2696.2Clo (C57BL/6J-b2b2696.2Clo)	thymus hypoplasia	J:175213
b2b2696Clo/b2b2696Clo (C57BL/6J-b2b2696Clo)	absent spleen	J:175213
b2b2736.2Clo/b2b2736.2Clo (C57BL/6J-b2b2736.2Clo)	thymus hypoplasia	J:175213
b2b2736Clo/b2b2736Clo (C57BL/6J-b2b2736Clo)	accessory spleen	J:175213
	spleen hypoplasia	J:175213
	thymus hypoplasia	J:175213
b2b2821Clo/b2b2821Clo (C57BL/6J-b2b2821Clo)	thymus hypoplasia	J:175213
b2b2966Clo/b2b2966Clo (C57BL/6J-b2b2966Clo)	thymus hypoplasia	J:175213
b2b3077.2Clo/b2b3077.2Clo (C57BL/6J-b2b3077.2Clo)	thymus hypoplasia	J:175213
b2b3077Clo/b2b3077Clo (C57BL/6J-b2b3077Clo)	thymus hypoplasia	J:175213
b2b3121Clo/b2b3121Clo (C57BL/6J-b2b3121Clo)	thymus hypoplasia	J:175213
b2b3260.2Clo/b2b3260.2Clo (C57BL/6J-b2b3260.2Clo)	abnormal thymus morphology	J:175213
b2b3260.2Clo/b2b3260.2Clo (C57BL/6J-b2b3260.2Clo)	thymus hypoplasia	J:175213
b2b3260Clo/b2b3260Clo (C57BL/6J-b2b3260Clo)	abnormal thymus morphology	J:175213
b2b3260Clo/b2b3260Clo (C57BL/6J-b2b3260Clo)	thymus hypoplasia	J:175213
B2m^tm1Jae/B2m^tm1Jae (involves: 129S2/SvPas * C57BL/6J)	abnormal CD8-positive, alpha-beta cytotoxic T cell morphology	J:80910
	abnormal cytotoxic T cell physiology	J:80910
	decreased CD8-positive, alpha-beta T cell number	J:80910, J:744
	increased gamma-delta intraepithelial T cell number	J:744
	increased gamma-delta T cell number	J:744
B2m^tm1Jae/B2m^tm1Jae (involves: 129S2/SvPas)	decreased CD8-positive, alpha-beta T cell number	J:166104
B2m^tm1Jae/B2m^tm1Jae Cd4^tm1Jrp/Cd4^tm1Jrp (involves: 129S2/SvPas * C57BL/6)	increased CD8-positive, alpha-beta T cell number	J:45168
B2m^tm1Jae/B2m^tm1Jae Foxp3^sf Otc^spf/Y (involves: 129/Rl * 129S2/SvPas)	anemia	J:20865
	decreased hematocrit	J:20865
	enlarged spleen	J:20865
	increased CD4-positive, alpha-beta T cell number	J:20865
	increased IgG level	J:20865
	increased IgM level	J:20865
	increased immunoglobulin level	J:20865
	increased plasma cell number	J:20865
B2m^tm1Jae/B2m^tm1Jae Rr94^tm3.2Litt/Rr94^tm3.2Litt (involves: 129P2/OlaHsd * 129S2/SvPas * FVB/N)	abnormal T cell differentiation	J:158962
	abnormal T cell subpopulation ratio	J:158962
	decreased CD4-positive, alpha-beta T cell number	J:158962
	increased CD8-positive, alpha-beta T cell number	J:158962
	increased T cell proliferation	J:158962
B2m^tm1Jae/B2m^tm1Jae Rr96^tm1.1Yzo/Rr96^tm1.1Yzo (involves: 129P2/OlaHsd * 129S2/SvPas)	abnormal T cell differentiation	J:130559
B2m^tm1Jae/B2m^tm1Jae Tg(H2-K-Cd86)27All/0 (involves: 129S2/SvPas * C57BL/6 * CBA)	absent B cells	J:112475
B2m^tm1Jae/B2m^tm1Jae Tg(LckNotch1)9Erob/? (involves: 129S2/SvPas * C57BL/6 * CBA)	increased CD8-positive, alpha-beta T cell number	J:93005
B2m^tm1Jae/B2m^tm1Jae Themis^tm1Lov/Themis^tm1Lov (involves: 129)	abnormal CD8-positive, alpha-beta T cell differentiation	J:151075
B2m^tm1Jae/B2m^tm1Jae Tox^tm1.1Kay/Tox^tm1.1Kay (involves: 129S6/SvEvTac * 129S2/SvPas)	abnormal CD8-positive, alpha-beta T cell number	J:131287
B2m^tm1Jae/B2m^tm1Jae Zbtb7b^tm1Litt/Zbtb7b^tm1.2Litt (involves: 129S2/SvPas * C57BL/6)	abnormal CD8-positive, alpha-beta T cell differentiation	J:141144
	abnormal double-positive T cell morphology	J:141144
B2m^tm1Unc/B2m⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased CD8-positive, alpha-beta T cell number	J:64451
B2m^tm1Unc/B2m^tm1Unc (involves: 129P2/OlaHsd * C57BL/6)	abnormal T cell number	J:113083
B2m^tm1Unc/B2m^tm1Unc (involves: 129P2/OlaHsd * C57BL/6)	absent CD8-positive, alpha-beta T cells	J:64451
B2m^tm1Unc/B2m^tm1Unc (NOD.129P2-B2m^tm1Unc)	absent CD8-positive, alpha-beta T cells	J:121685
B2m^tm1Unc/B2m^tm1Unc (B6.129P2-B2m^tm1Unc/DcrJ)	decreased CD8-positive, alpha-beta T cell number	J:123934
	decreased IgG level	J:110885
	increased IgM level	J:110885
	increased T-helper 1 cell number	J:123934
B2m^tm1Unc/B2m^tm1Unc Cd4^tm1Mak/Cd4^tm1Mak Cd8a^{tm2.1(Cd4)Asin}/Cd8a^{tm2.1(Cd4)Asin} (involves: 129 * C57BL/6)	abnormal T cell physiology	J:180236
B2m^tm1Unc/B2m^tm1Unc Ciita^tm1Ccum/Ciita^tm1Ccum (NOD.Cg-B2m^tm1Unc Ciita^tm1Ccum)	decreased single-positive T cell number	J:107051
B2m^tm1Unc/B2m^tm1Unc H2-Ab1^b-tm1Doi/H2-Ab1^b-tm1Doi Lat^tm1.1Mal/Lat^tm1.1Mal (involves: 129P2/OlaHsd * 129S2/SvPas)	absent CD4-positive, alpha-beta T cells	J:77098
	absent CD8-positive, alpha-beta T cells	J:77098
B2m^tm1Unc/B2m^tm1Unc H2-D1^b-tm1Bpe/H2-D1^b-tm1Bpe (involves: 129P2/OlaHsd * C57BL/6)	decreased CD8-positive, alpha-beta T cell number	J:41077
B2m^tm1Unc/B2m^tm1Unc Il2^tm1Hor/Il2^tm1Hor (involves: 129 * C57BL/6)	abnormal CD4-positive T cell differentiation	J:39981
	abnormal CD4-positive, alpha-beta T cell physiology	J:51450
	abnormal CD8 positive, alpha-beta intraepithelial T cell morphology	J:39981
	abnormal CD8-positive, alpha beta T cell morphology	J:51450
	abnormal CD8-positive, alpha-beta cytotoxic T cell morphology	J:39981
B2m^tm1Unc/B2m^tm1Unc Il2rg^tm1.1Asin/Il2rg^tm1Wjl Tg(Cd8a-cre)B8Asin/0 (involves: 129P2/OlaHsd 129S4/SvJae * C57BL/6)	decreased CD8-positive, alpha-beta T cell number	J:190889
B2m^tm1Unc/B2m^tm1Unc Il7r^tm1.1Asin/Il7r^tm1Imx Tg(Cd8a-cre)B8Asin/0 (involves: 129P2/OlaHsd 129S7/SvEvBrd * C57BL/6)	decreased CD8-positive, alpha-beta T cell number	J:190889
B2m^tm1Unc/B2m^tm1Unc Prkdc^scid/Prkdc^scid (NOD.Cg-B2m^tm1Unc Prkdc^scid)	abnormal NK cell physiology	J:102141
	absent lymphocyte	J:102141
	arrested B cell differentiation	J:102141
	arrested T cell differentiation	J:102141
	increased macrophage cell number	J:102141
B2m^tm1Unc/B2m^tm1Unc Rr381^em2Kap/Rr381^em2Kap (involves: 129P2/OlaHsd * C57BL/6)	absent CD8-positive, alpha-beta T cells	J:333471
B2m^tm1Unc/B2m^tm1Unc Tespa1^tm1Smoc/Tespa1^tm1Smoc (involves: 129 * 129P2/OlaHsd * C57BL/6)	abnormal CD8-positive, alpha beta T cell morphology	J:186446
B2m^tm1Unc/B2m^tm1Unc Tg(GFAP-B2m)9Mdos/? (involves: 129P2/OlaHsd * C57BL/6 * NOD/ShiLtJ)	absent CD8-positive, alpha-beta T cells	J:135214
B2m^tm1Unc/B2m^tm1Unc Tg(GFAP-B2m)#Mdos/? (involves: 129P2/OlaHsd * C57BL/6 * NOD/ShiLtJ)	absent CD8-positive, alpha-beta T cells	J:135214
B2m^tm1Unc/B2m^tm1Unc Tg(HLA-A/H2-D/B2M)1Dvs/0 (NOD.Cg-B2m^tm1Unc Tg(HLA-A/H2-D/B2M)1Dvs)	abnormal CD8-positive, alpha-beta T cell physiology	J:121685
	abnormal cytotoxic T cell physiology	J:121685
	decreased CD8-positive, alpha-beta T cell number	J:121685
B2m^tm1Unc/B2m^tm1Unc Tg(TcraAI4)1Dvs/0 Tg(TcrbAI4)1Dvs/0 (NOD.Cg-B2m^tm1Unc Tg(TcraAI4)1Dvs Tg(TcrbAI4)1Dvs)	abnormal CD8-positive, alpha beta T cell morphology	J:93553
B2m^tm1Unc/B2m^tm1Unc Zbtb7b^tm4.1Itan/Zbtb7b^tm4.1Itan (involves: 129P2/OlaHsd)	increased CD8-positive, alpha-beta T cell number	J:193321
B3galt2^{tm1.1(KOMP)Vlcg}/B3galt2⁺ (C57BL/6N-B3galt2^{tm1.1(KOMP)Vlcg}/Tcp)	decreased lymphocyte cell number	J:211773
B3gnt2^{Gt(OST237555)Lex}/B3gnt2^{Gt(OST237555)Lex} (involves: 129S5/SvEvBrd * C57BL/6N)	abnormal macrophage physiology	J:125556
	increased T cell proliferation	J:125556
B3gnt5^tm1Big/B3gnt5^tm1Big (C57BL/6-B3gnt5^tm1Big)	abnormal spleen germinal center morphology	J:166763
	abnormal spleen morphology	J:166763
	absent spleen marginal zone	J:166763
	decreased B cell number	J:166763
	enlarged spleen	J:166763
	increased spleen white pulp amount	J:166763
	intermingled spleen red and white pulp	J:166763
B3gnt5^tm1Nari/B3gnt5^tm1Nari (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell morphology	J:161366
	increased IgG2a level	J:161366
	increased IgG2b level	J:161366
	increased IgG level	J:161366
B3gnt5^tm2.1Big/B3gnt5^tm2.1Big (involves: 129/Sv * C57BL/6 * FVB/N)	abnormal spleen germinal center morphology	J:166763
	abnormal spleen morphology	J:166763
	absent spleen marginal zone	J:166763
	decreased B cell number	J:166763
	enlarged spleen	J:166763
	increased spleen white pulp amount	J:166763
	intermingled spleen red and white pulp	J:166763
B3gnt6^tm1Lx/B3gnt6^tm1Lx (involves: 129S1/Sv * C57BL/6J)	increased macrophage cell number	J:123826
	increased monocyte cell number	J:123826
	increased T cell number	J:123826
B3gnt7^{tm1e.1(KOMP)Wtsi}/B3gnt7^{tm1e.1(KOMP)Wtsi} (C57BL/6N-B3gnt7^{tm1e.1(KOMP)Wtsi}/Ucd)	enlarged spleen	J:211773
B4galnt1^tm1Rlp/B4galnt1^tm1Rlp Hexb^tm1Rlp/Hexb^tm1Rlp (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6)	abnormal macrophage morphology	J:53080
B4galnt2^tm1Jbl/B4galnt2^tm1Jbl (involves: 129S1/Sv)	abnormal B cell number	J:217719
B4galnt2^tm1Jbl/B4galnt2^tm1Jbl (involves: 129S1/Sv)	increased neutrophil cell number	J:217719
B4galnt3^{tm1a(EUCOMM)Wtsi}/B4galnt3^{tm1a(EUCOMM)Wtsi} (C57BL/6N-B4galnt3^{tm1a(EUCOMM)Wtsi}/Ics)	increased CD8-positive, alpha-beta T cell number	J:165965
B4galt1^tm1Yiw/B4galt1^tm1Yiw (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal leukocyte physiology	J:106669
	abnormal neutrophil physiology	J:106669
	abnormal proerythroblast morphology	J:106669
	decreased erythrocyte cell number	J:106669
	decreased hematocrit	J:106669
	decreased hemoglobin content	J:106669
	enlarged spleen	J:106669
	extramedullary hematopoiesis	J:106669
	impaired macrophage chemotaxis	J:89125
	impaired neutrophil recruitment	J:89125
	increased leukocyte cell number	J:106669
	increased lymphocyte cell number	J:106669
	increased neutrophil cell number	J:106669
B4galt1^tm1Yiw/B4galt1^tm1Yiw (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal IgM level	J:117891
	increased IgA level	J:117891
B4gat1^tm1Mifu/B4gat1^tm1Mifu (B6.Cg-B4gat1^tm1Mifu)	impaired leukocyte tethering or rolling	J:120722
B4gat1^tm1Mifu/B4gat1^tm1Mifu Gcnt1^tm1Jxm/Gcnt1^tm1Jxm (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal leukocyte migration	J:120722
	impaired leukocyte tethering or rolling	J:120722
B9d2/Tgfb1^tm1Flv/B9d2/Tgfb1^tm1Flv Tg(Cd4-cre)1Cwi/0 (involves: 129S6/SvEvTac * C57BL/6 * SJL)	abnormal regulatory T cell physiology	J:204761
B9d2/Tgfb1^tm1Flv/B9d2/Tgfb1^tm1Flv Tg(CD207-cre)1Dhka/? (involves: 129S6/SvEvTac * C57BL/6J * SJL/J)	decreased Langerhans cell number	J:126147
B9d2/Tgfb1^tm1Flv/Tgfb1^tm2Flv Foxp3^{tm4(YFP/icre)Ayr}/Foxp3⁺ (involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ)	increased regulatory T cell number	J:169839
B9d2/Tgfb1^tm1Flv/Tgfb1^tm2Flv Tg(Cd4-cre)1Cwi/0 (involves: 129S6/SvEvTac * C57BL/6 * DBA/2)	abnormal T cell activation	J:123547
	abnormal T cell differentiation	J:123547
	abnormal T-helper 17 cell differentiation	J:169839
	increased T cell proliferation	J:123547
B9d2/Tgfb1^tm1Flv/Tgfb1^tm2Flv Tnfrsf4^tm2(cre)Nik/Tnfrsf4⁺ (involves: 129S6/SvEvTac * 129X1/SvJ)	abnormal T cell differentiation	J:169839
	decreased T-helper 17 cell number	J:169839
	increased regulatory T cell number	J:169839
	increased T-helper 1 cell number	J:169839
B9d2/Tgfb1^tm1Flv/B9d2/Tgfb1^tm1Flv Tg(Cd4-cre)1Cwi/0 (involves: 129S6/SvEvTac * C57BL/6 * SJL)	abnormal regulatory T cell physiology	J:204761
B9d2/Tgfb1^tm1Flv/B9d2/Tgfb1^tm1Flv Tg(CD207-cre)1Dhka/? (involves: 129S6/SvEvTac * C57BL/6J * SJL/J)	decreased Langerhans cell number	J:126147
B9d2/Tgfb1^tm1Flv/B9d2⁺ Foxp3^{tm4(YFP/icre)Ayr}/Foxp3⁺ (involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ)	increased regulatory T cell number	J:169839
B9d2/Tgfb1^tm1Flv/B9d2⁺ Tg(Cd4-cre)1Cwi/0 (involves: 129S6/SvEvTac * C57BL/6 * DBA/2)	abnormal T-helper 17 cell differentiation	J:169839
B9d2/Tgfb1^tm1Flv/B9d2⁺ Tg(CD207-cre)1Dhka/? (involves: 129S6/SvEvTac * C57BL/6J * SJL/J)	decreased Langerhans cell number	J:126147
B9d2/Tgfb1^tm1Flv/B9d2⁺ Tnfrsf4^tm2(cre)Nik/Tnfrsf4⁺ (involves: 129S6/SvEvTac * 129X1/SvJ)	abnormal T cell differentiation	J:169839
	decreased T-helper 17 cell number	J:169839
	increased regulatory T cell number	J:169839
	increased T-helper 1 cell number	J:169839
B9d2^{tm1a(EUCOMM)Wtsi}/B9d2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-B9d2^{tm1a(EUCOMM)Wtsi}/Wtsi)	abnormal thymus topology	J:239583
	accessory spleen	J:239583
	small spleen	J:239583
Baa1^BALB/cJ/Baa1^NZW/LacJ (involves: BALB/cJ * NZW/LacJ)	increased IgM level	J:35434
Baa2^BALB/cJ/Baa2^NZW/LacJ (involves: BALB/cJ * NZW/LacJ)	increased IgM level	J:35434
Baat^em1(IMPC)Mbp/Baat^em1(IMPC)Mbp (C57BL/6NCrl-Baat^em1(IMPC)Mbp/Mmucd)	increased mean corpuscular volume	J:211773
Babam1^{em1(IMPC)Ccpcz}/Babam1^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Babam1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	decreased CD4-positive NK T cell number	J:211773
	decreased NK T cell number	J:211773
	enlarged thymus	J:211773
	increased eosinophil cell number	J:211773
Babam1^{Gt(IST11207B9)Tigm}/Babam1^{Gt(IST11207B9)Tigm} (involves: C57BL/6N)	abnormal hematopoietic stem cell physiology	J:223526
	abnormal platelet physiology	J:223526
	hematopoietic system phenotype	J:223526
	increased bone marrow cell number	J:223526
	increased hematopoietic stem cell number	J:223526
	increased hematopoietic stem cell proliferation	J:223526
	thrombocytosis	J:223526
Babam1^{Gt(IST11207B9)Tigm}/Babam1^{Gt(IST11207B9)Tigm} Mpl^tm1Mwm/Mpl^tm1Mwm (involves: 129S2/SvPas * C57BL/6N)	decreased hematopoietic stem cell number	J:223526
	thrombocytopenia	J:223526
Bach2^M1Btlr/Bach2^M1Btlr (C57BL/6J-Bach2^M1Btlr)	decreased CD4-positive, alpha-beta T cell number	J:272023
Bach2^M1Btlr/Bach2^M1Btlr (C57BL/6J-Bach2^M1Btlr)	increased B-1 B cell number	J:272023
Bach2^m1Ccg/Bach2^m1Ccg (C57BL/6-Bach2^m1Ccg)	decreased B cell number	J:94077
	decreased marginal zone B cell number	J:94077
	myeloid hyperplasia	J:94077
Bach2^m2Anu/Bach2^m2Anu (C57BL/6NCrlAnu-Bach2^m2Anu)	decreased mature B cell number	J:104190
	increased IgM level	J:104190
	increased immature B cell number	J:104190
Bach2^{tm1a(EUCOMM)Wtsi}/Bach2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Bach2^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased B cell number	J:211773
	decreased CD8-positive, naive alpha-beta T cell number	J:211773
	decreased CD11b-high dendritic cell number	J:211773
	decreased effector memory CD8-positive, alpha-beta T cell number	J:211773
	decreased follicular B cell number	J:211773
	decreased mature B cell number	J:211773
	decreased memory-marker NK cell number	J:211773
	decreased regulatory T cell number	J:211773
	increased CD4-positive, alpha-beta memory T cell number	J:211773
	increased CD8-positive, alpha-beta memory T cell number	J:211773
	increased CD11b-low dendritic cell number	J:211773
	increased CD103-positive CD11b-low dendritic cell number	J:211773
	increased effector memory CD8-positive, alpha-beta T cell number	J:211773
	increased effector memory T-helper cell number	J:211773
	increased eosinophil cell number	J:211773
	increased immature B cell number	J:211773
	increased KLRG1+ CD4 alpha-beta T cell number	J:211773
	increased KLRG1+ CD8 alpha-beta T cell number	J:211773
	increased KLRG1-positive CD4-negative NK T cell number	J:211773
	increased KLRG1-positive CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	increased KLRG1-positive gamma-delta T cell number	J:211773
	increased KLRG1-positive NK cell number	J:211773
	increased Ly6C high monocyte number	J:211773
	increased Ly6C low monocyte number	J:211773
	increased macrophage cell number	J:211773
	increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	increased memory-marker CD4-negative NK T cell number	J:211773
	increased memory-marker NK cell number	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
	increased NK cell number	J:211773
	thrombocytosis	J:211773
Bach2^{tm1b(EUCOMM)Wtsi}/Bach2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Bach2^{tm1b(EUCOMM)Wtsi}/Ieg)	decreased B cell number	J:211773
	decreased B-1a cell number	J:211773
	decreased B-2 B cell number	J:211773
	decreased CD4-negative NK T cell number	J:211773
	decreased CD8-positive, naive alpha-beta T cell number	J:211773
	decreased CD11b-high dendritic cell number	J:211773
	decreased follicular B cell number	J:211773
	decreased Ly6C-positive immature NK cell number	J:211773
	decreased Ly6C-positive mature NK cell number	J:211773
	decreased marginal zone B cell number	J:211773
	decreased memory-marker CD4-negative NK T cell number	J:211773
	decreased NK cell number	J:211773
	decreased NK T cell number	J:211773
	decreased transitional stage B cell number	J:211773
	increased effector memory CD8-positive, alpha-beta T cell number	J:211773
	increased eosinophil cell number	J:211773
	increased granulocyte number	J:211773
	increased memory-marker CD4-negative NK T cell number	J:211773
	increased monocyte cell number	J:211773
	increased NK T cell number	J:211773
Bach2^tm1Igar/Bach2^tm1Igar (involves: 129P2/OlaHsd * C57BL/6J)	abnormal B cell differentiation	J:91110
	abnormal B cell physiology	J:91110
	abnormal class switch recombination	J:91110
	abnormal somatic hypermutation frequency	J:91110
	absent germinal center B cells	J:91110
	decreased B cell number	J:91110
	decreased IgA level	J:91110
	decreased IgG1 level	J:91110
	decreased IgG2a level	J:91110
	decreased IgG2b level	J:91110
	decreased IgG3 level	J:91110
	decreased IgG level	J:91110
	decreased mature B cell number	J:91110
	increased IgM level	J:91110
	spleen hypoplasia	J:91110
Bad^tm1Meg/Bad^tm1Meg (involves: 129S4/SvJae)	abnormal B cell differentiation	J:88139
	abnormal T cell differentiation	J:88139
	decreased mature B cell number	J:88139
	decreased pro-B cell number	J:88139
	decreased thymus weight	J:88139
	small thymus	J:88139
	thymus hypoplasia	J:88139
Bad^tm1Sjk/Bad^tm1Sjk (either: 129X1/SvJ or (involves: 129X1/SvJ * C57BL/6))	abnormal B cell physiology	J:84987
	abnormal T cell physiology	J:84987
Bag1^{tm1a(EUCOMM)Hmgu}/Bag1^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Bag1^{tm1a(EUCOMM)Hmgu}/Ics)	decreased mean corpuscular volume	J:165965
	increased hemoglobin content	J:165965
Bag3^tm1.1Jhl/Bag3^tm1.1Jhl (B6.129S2-Bag3^tm1.1Jhl)	decreased leukocyte cell number	J:144416
	decreased lymphocyte cell number	J:144416
	decreased neutrophil cell number	J:144416
	decreased spleen weight	J:144416
	decreased thymus weight	J:144416
	spleen hypoplasia	J:144416
	thymus hypoplasia	J:144416
Bag4^tm1Yeh/Bag4^tm1Yeh (involves: 129P2/OlaHsd * C57BL/6)	abnormal macrophage physiology	J:83559
	spleen hypoplasia	J:83559
	thymus hypoplasia	J:83559
Bahd1^{tm2b(KOMP)Wtsi}/Bahd1⁺ (C57BL/6N-Bahd1^{tm2b(KOMP)Wtsi}/Ics)	decreased effector memory CD8-positive, alpha-beta T cell number	J:211773
	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	increased CD4-negative NK T cell number	J:211773
	increased memory-marker CD4-negative NK T cell number	J:211773
	increased neutrophil cell number	J:211773
	increased NK cell number	J:211773
	increased NK T cell number	J:211773
	increased T cell number	J:211773
Baiap2^{tm1b(KOMP)Wtsi}/Baiap2⁺ (C57BL/6N-Baiap2^{tm1b(KOMP)Wtsi}/Tcp)	thrombocytopenia	J:211773
Baiap2l2^{tm1b(EUCOMM)Hmgu}/Baiap2l2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Baiap2l2^{tm1b(EUCOMM)Hmgu}/Ics)	decreased hematocrit	J:211773
Bak1^tm1Thsn/Bak1⁺ Bcl2l1^Plt20/Bcl2l1⁺ (involves: 129 * BALB/c * C57BL/6)	abnormal platelet morphology	J:149205
Bak1^tm1Thsn/Bak1⁺ Bcl2l1^tm1Dlo/Bcl2l1⁺ (B6.Cg-Bcl2l1^tm1Dlo Bak1^tm1Thsn)	abnormal platelet morphology	J:149205
Bak1^tm1Thsn/Bak1^tm1Thsn (B6.129-Bak1^tm1Thsn)	abnormal platelet physiology	J:149205
Bak1^tm1Thsn/Bak1^tm1Thsn (B6.129-Bak1^tm1Thsn)	thrombocytosis	J:149205
Bak1^tm1Thsn/Bak1^tm1Thsn Bax^tm1Sjk/Bax^tm1Sjk (involves: 129S1/Sv * 129S1/SvImJ * 129X1/SvJ * C57BL/6)	abnormal B cell morphology	J:66872
	abnormal definitive hematopoiesis	J:66872
	abnormal splenocyte physiology	J:66872
	abnormal T cell morphology	J:66872
	anemia	J:66872
	enlarged spleen	J:66872
	increased leukocyte cell number	J:66872
	increased lymphocyte cell number	J:66872
	increased spleen red pulp amount	J:66872
	increased spleen white pulp amount	J:66872
	thrombocytopenia	J:66872
Bak1^tm1Thsn/Bak1^tm1Thsn Bax^tm1Sjk/Bax^tm1Sjk (involves: 129S1/Sv * 129X1/SvJ)	hematopoietic system phenotype	J:141545
Bak1^tm1Thsn/Bak1^tm1Thsn Bax^tm1Sjk/Bax^tm2Sjk Bcl2l1^tm1.1Mam/Bcl2l1^tm1.1Mam Tg(MMTV-cre)#Mam/0 (involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * FVB)	hematopoietic system phenotype	J:141545
Bak1^tm1Thsn/Bak1^tm1Thsn Bax^tm1Sjk/Bax^tm2Sjk Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)	abnormal B cell number	J:100463
	abnormal B cell physiology	J:100463
	decreased marginal zone B cell number	J:100463
	increased B cell number	J:100463
	increased B-2 B cell number	J:100463
	increased bone marrow cell number	J:100463
	increased follicular B cell number	J:100463
	increased IgA level	J:100463
	increased IgG level	J:100463
	increased IgM level	J:100463
	increased immunoglobulin level	J:100463
	increased pre-B cell number	J:100463
	increased pro-B cell number	J:100463
	increased transitional stage B cell number	J:100463
Bak1^tm1Thsn/Bak1^tm1Thsn Bax^tm1Sjk/Bax^tm2Sjk Tg(Mx1-cre)1Cgn/0 (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	abnormal T cell differentiation	J:100463
	increased B cell number	J:100463
	increased leukocyte cell number	J:100463
	increased lymphocyte cell number	J:100463
Bak1^tm1Thsn/Bak1^tm1Thsn Bax^tm2Sjk/Bax^tm2Sjk Tg(Lck-cre)1Cwi/? (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)	decreased thymocyte apoptosis	J:220951
Bak1^tm1Thsn/Bak1^tm1Thsn Bax^tm2Sjk/Bax^tm2Sjk Tg(Lck-cre)548Jxm/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	increased regulatory T cell number	J:208318
Bak1^tm1Thsn/Bak1^tm1Thsn Bcl2l1^tm1Dlo/Bcl2l1⁺ (B6.Cg-Bcl2l1^tm1Dlo Bak1^tm1Thsn)	abnormal platelet physiology	J:149205
	thrombocytosis	J:149205
Bank1^tm1Kuro/Bank1^tm1Kuro (Not Specified)	abnormal B cell physiology	J:113321
	abnormal lymphocyte physiology	J:113321
	abnormal spleen germinal center morphology	J:113321
	abnormal splenic cell ratio	J:113321
	increased B cell proliferation	J:113321
	increased B-1a cell number	J:113321
	increased IgG2a level	J:113321
	increased IgM level	J:113321
	increased mature B cell number	J:113321
	increased spleen germinal center number	J:113321
	increased spleen germinal center size	J:113321
Bap1^em1Test/Bap1⁺ (involves: FVB)	hematopoietic system phenotype	J:213725
Bap1^tm1.1Geno/Bap1⁺ Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ (involves: C57BL/6 * C57BL/6NTac)	abnormal hematopoietic system morphology/development	J:187380
Bap1^tm1.1Geno/Bap1^tm1.1Geno Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ (involves: C57BL/6 * C57BL/6NTac)	abnormal bone marrow cell physiology	J:187380
	abnormal erythrocyte morphology	J:187380
	abnormal erythropoiesis	J:187380
	abnormal granulocyte morphology	J:187380
	abnormal hematopoietic stem cell physiology	J:187380
	abnormal myelopoiesis	J:187380
	abnormal neutrophil morphology	J:187380
	anemia	J:187380
	anisopoikilocytosis	J:187380
	enlarged spleen	J:187380
	extramedullary hematopoiesis	J:187380
	giant platelets	J:187380
	increased hematopoietic stem cell number	J:187380
	increased leukocyte cell number	J:187380
	increased monocyte cell number	J:187380
	increased neutrophil cell number	J:187380
	increased nucleated erythrocyte cell number	J:187380
	myeloid hyperplasia	J:187380
	thrombocytopenia	J:187380
Batf3^tm1Kmm/Batf3^tm1Kmm (involves: 129S6/SvEvTac * BALB/cJ)	abnormal cytotoxic T cell physiology	J:141064
	abnormal dendritic cell differentiation	J:141064
	decreased cytotoxic T cell cytolysis	J:141064
	decreased memory T cell number	J:141064
	decreased myeloid dendritic cell number	J:141064
Batf3^tm1Kmm/Batf3^tm1Kmm (involves: 129S6/SvEvTac)	abnormal cytotoxic T cell physiology	J:181366
Batf^tm1.1Ejt/Batf^tm1.1Ejt (involves: 129S/Sv * C57BL/6 * FVB/N)	abnormal class switch recombination	J:160935
	abnormal T-helper 2 cell differentiation	J:160935
	absent germinal center B cells	J:160935
	decreased CD4-positive, alpha-beta T cell number	J:160935
	decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:160935
	decreased IgA level	J:160935
	decreased IgE level	J:160935
	decreased IgG1 level	J:160935
	decreased IgG2c level	J:160935
	decreased IgM level	J:160935
	decreased T follicular helper cell number	J:160935
	decreased T-helper 17 cell number	J:160935
Batf^tm1.1Kmm/Batf^tm1.1Kmm (129S6/SvEvTac-Batf^tm1.1Kmm)	abnormal CD4-positive T cell differentiation	J:150643
Bax^tm1Sjk/Bax^tm1Sjk (involves: 129X1/SvJ)	enlarged spleen	J:29253
	increased B cell number	J:29253
	increased thymocyte number	J:29253
Baz1a^{tm1b(EUCOMM)Hmgu}/Baz1a^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Baz1a^{tm1b(EUCOMM)Hmgu}/Tcp)	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular hemoglobin concentration	J:211773
	increased mean platelet volume	J:211773
Baz2a^em1(IMPC)Tcp/Baz2a^em1(IMPC)Tcp (C57BL/6NCrl-Baz2a^em1(IMPC)Tcp/Tcp)	abnormal spleen morphology	J:211773
Baz2b^{em1(IMPC)Wtsi}/Baz2b^{em1(IMPC)Wtsi} (C57BL/6N-Baz2b^{em1(IMPC)Wtsi}/Wtsi)	increased leukocyte cell number	J:211773
Bbaa5^C57BL/6NCr/Bbaa5^C57BL/6NCr (involves: C3H/HeNCr * C57BL/6NCr)	increased IgM level	J:52017
Bbaa9^C57BL/6NCr/Bbaa9^C3H/HeNCr (involves: C3H/HeNCr * C57BL/6NCr)	abnormal immunoglobulin level	J:52017
Bbaa9^C57BL/6NCr/Bbaa9^C57BL/6NCr (involves: C3H/HeNCr * C57BL/6NCr)	abnormal immunoglobulin level	J:52017
Bbaa14^C3H/HeJ/? (involves: C3H/HeN * C57BL/6N)	increased IgG level	J:73060
Bbaa15^C3H/HeN/? (involves: C3H/HeN * C57BL/6N)	increased IgG level	J:73060
Bbaa19^C3H/HeN/? (involves: C3H/HeN * C57BL/6N)	increased IgG level	J:73060
Bbc3^tm1Ast/Bbc3^tm1Ast (involves: C57BL/6 * NZB)	abnormal CD8-positive, alpha-beta T cell physiology	J:132819
	abnormal splenic cell ratio	J:132819
	increased CD8-positive, alpha-beta T cell number	J:132819
	increased leukocyte cell number	J:132819
Bbc3^tm1Gpz/Bbc3^tm1Gpz (involves: 129P2/OlaHsd)	hematopoietic system phenotype	J:141545
Bbc3^tm1Gpz/Bbc3^tm1Gpz Bnip3l^tm1Ney/Bnip3l^tm1Ney (involves: 129P2/OlaHsd)	abnormal erythrocyte morphology	J:141545
Bbc3^tm1Gpz/Bbc3^tm1Gpz Trp53^tm1Brd/Trp53^tm8Xu (involves: 129P2/OlaHsd * 129S7/SvEvBrd)	decreased thymocyte number	J:170216
	hematopoietic system phenotype	J:170216
Bbln^{tm1(KOMP)Wtsi}/Bbln⁺ (involves: C57BL/6N)	abnormal osteoclast differentiation	J:296689
Bbln^{tm1(KOMP)Wtsi}/Bbln^{tm1(KOMP)Wtsi} (involves: C57BL/6N)	abnormal osteoclast differentiation	J:296689
	increased osteoclast cell number	J:296689
Bbs4^Gt1Nk/Bbs4^Gt1Nk (involves: 129S7/SvEvBrd)	increased immunoglobulin level	J:134093
Bbs5^{tm1b(EUCOMM)Wtsi}/Bbs5^{tm1b(EUCOMM)Wtsi} (C57BL/6NTac-Bbs5^{tm1b(EUCOMM)Wtsi}/H)	increased hematocrit	J:211773
	increased hemoglobin content	J:211773
	increased lymphocyte cell number	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
	increased monocyte cell number	J:211773
	thrombocytopenia	J:211773
Bbs12^{em1(IMPC)Ccpcz}/Bbs12⁺ (C57BL/6NCrl-Bbs12^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Bbx^{tm1a(EUCOMM)Wtsi}/Bbx^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6 * C57BL/6N)	increased IgA level	J:213427
BC049715^{tm1b(KOMP)Mbp}/BC049715^{tm1b(KOMP)Mbp} (C57BL/6N-BC049715^{tm1b(KOMP)Mbp}/Mhzh)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
Bcap31^tm1.1Bwang/Bcap31^tm1.1Bwang Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6)	increased microglial cell activation	J:292505
Bcap31^tm1.1Bwang/Bcap31^tm1.1Bwang Tg(Lck-cre)548Jxm/0 (involves: C57BL/6 * CBA)	abnormal T cell activation	J:274469
	decreased CD8-positive, naive alpha-beta T cell number	J:274469
	decreased single-positive T cell number	J:274469
	decreased T cell proliferation	J:274469
	decreased thymocyte number	J:274469
	decreased thymus weight	J:274469
	increased effector memory T-helper cell number	J:274469
	increased thymocyte apoptosis	J:274469
	small thymus	J:274469
	thymus hypoplasia	J:274469
Bcar3^em1(IMPC)Mbp/Bcar3^em1(IMPC)Mbp (C57BL/6N-Bcar3^em1(IMPC)Mbp/MbpMmucd)	increased basophil cell number	J:211773
Bcat1^tm1.2Eaa/Bcat1^tm1.2Eaa (involves: C57BL/6)	abnormal T cell physiology	J:216027
Bckdha^em1(IMPC)Tcp/Bckdha⁺ (C57BL/6NCrl-Bckdha^em1(IMPC)Tcp/Tcp)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Bcl2^tm1Dlo/Bcl2^tm1Dlo (involves: 129P2/OlaHsd * C57BL/6)	abnormal T cell differentiation	J:73660
	decreased CD8-positive, alpha-beta T cell number	J:73660
	decreased lymphocyte cell number	J:73660
	decreased mature B cell number	J:73660
	decreased pre-B cell number	J:73660
	decreased thymocyte number	J:73660
Bcl2^tm1Dlo/Bcl2^tm1Dlo (B6.129P2-Bcl2^tm1Dlo)	abnormal leukopoiesis	J:73316
	abnormal lymphocyte physiology	J:104487, J:73316
	decreased spleen weight	J:153846
	decreased spleen white pulp amount	J:153846
	increased B cell apoptosis	J:73316
	increased splenocyte apoptosis	J:153846
	increased T cell apoptosis	J:73316
	spleen atrophy	J:153846
Bcl2^tm1Dlo/Bcl2^tm1Dlo Bcl2l11^tm1.1Ast/Bcl2l11⁺ (B6.129-Bcl2^tm1Dlo Bcl2l11^tm1.1Ast)	abnormal lymphocyte physiology	J:73316
	increased T cell apoptosis	J:73316
Bcl2^tm1Dlo/Bcl2^tm1Dlo Bcl2l11^tm1.1Ast/Bcl2l11⁺ (B6.Cg-Bcl2^tm1Dlo Bcl2l11^tm1.1Ast)	increased leukocyte cell number	J:153846
	increased spleen weight	J:153846
Bcl2^tm1Dlo/Bcl2^tm1Dlo Bcl2l11^tm1.1Ast/Bcl2l11^tm1.1Ast (B6.129-Bcl2^tm1Dlo Bcl2l11^tm1.1Ast)	abnormal leukopoiesis	J:73316
	abnormal lymphocyte physiology	J:73316
	decreased B cell apoptosis	J:73316
	increased T cell apoptosis	J:73316
Bcl2^tm1Dlo/Bcl2^tm1Dlo Bcl2l11^tm1.1Ast/Bcl2l11^tm1.1Ast (B6.Cg-Bcl2^tm1Dlo Bcl2l11^tm1.1Ast)	increased leukocyte cell number	J:153846
	increased spleen weight	J:153846
Bcl2^tm1Dlo/Bcl2^tm1Dlo Bcl2l11^tm1.1Boui/Bcl2l11^tm1.1Boui (B6.Cg-Bcl2^tm1Dlo Bcl2l11^tm1.1Boui)	hematopoietic system phenotype	J:153846
Bcl2^tm1Dlo/Bcl2^tm1Dlo Bcl2l11^tm1.1Boui/Bcl2l11^tm2.1Boui (B6.Cg-Bcl2^tm1Dlo Bcl2l11^tm1.1Boui/Bcl2l11^tm2.1Boui)	hematopoietic system phenotype	J:153846
	increased leukocyte cell number	J:153846
	increased spleen weight	J:153846
Bcl2^tm1Dlo/Bcl2^tm1Dlo Bcl2l11^tm2.1Boui/Bcl2l11^tm2.1Boui (B6.Cg-Bcl2^tm1Dlo Bcl2l11^tm2.1Boui)	hematopoietic system phenotype	J:153846
Bcl2^tm1Dlo/Bcl2^tm1Dlo Bcl2l11^tm3.1Boui/Bcl2l11^tm3.1Boui (B6.Cg-Bcl2^tm1Dlo Bcl2l11^tm3.1Boui)	decreased splenocyte apoptosis	J:153846
	hematopoietic system phenotype	J:153846
	increased leukocyte cell number	J:153846
	increased spleen weight	J:153846
Bcl2^tm1Dlo/Bcl2^tm1Dlo Bik^tm1Ast/Bik^tm1Ast (B6.Cg-Bcl2^tm1Dlo Bik^tm1Ast)	abnormal lymphocyte physiology	J:104487
Bcl2^tm1Irt/Bcl2^tm1Irt Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6)	increased macrophage apoptosis	J:144243
Bcl2^tm1Lbox/Bcl2^tm1Lbox (involves: 129S1/Sv * 129X1/SvJ * FVB/N)	abnormal B cell activation	J:114637
	abnormal B cell differentiation	J:114637
	decreased B cell number	J:114637
	decreased B cell proliferation	J:114637
	decreased immature B cell number	J:114637
	decreased mature B cell number	J:114637
	decreased pre-B cell number	J:114637
	increased B cell apoptosis	J:114637
Bcl2^tm1Sjk/Bcl2^tm1Sjk (involves: 129S2/SvPas * C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:15224
	abnormal CD8-positive, alpha beta T cell morphology	J:15224
	abnormal spleen morphology	J:15224
	abnormal spleen red pulp morphology	J:15224
	abnormal spleen white pulp morphology	J:15224
	abnormal thymus involution	J:15224
	abnormal thymus morphology	J:15224
	decreased B cell number	J:15224
	decreased double-positive T cell number	J:15224
	decreased lymphocyte cell number	J:15224
	decreased T cell number	J:15224
	increased double-negative T cell number	J:15224
	increased T cell apoptosis	J:15224
	small spleen	J:15224
	small thymus	J:15224
Bcl2^tm1Tsu/Bcl2^tm1Tsu (involves: 129P2/OlaHsd * ICR)	abnormal lymphocyte morphology	J:22391
	abnormal T cell physiology	J:22391
	small spleen	J:22391
	small thymus	J:22391
	spleen atrophy	J:22391
	thymus atrophy	J:22391
Bcl2^tm2.1Lbox/Bcl2⁺ (involves: 129S1/Sv * 129X1/SvJ * FVB/N)	abnormal B cell physiology	J:175730
	enlarged spleen	J:175730
	increased B cell number	J:175730
	increased immature B cell number	J:175730
	increased mature B cell number	J:175730
	increased pre-B cell number	J:175730
Bcl2^tm2.1Lbox/Bcl2^tm2.1Lbox (involves: 129S1/Sv * 129X1/SvJ * FVB/N)	abnormal B cell physiology	J:175730
	enlarged spleen	J:175730
	increased B cell number	J:175730
	increased immature B cell number	J:175730
	increased mature B cell number	J:175730
	increased pre-B cell number	J:175730
Bcl2a1a^tm1.1Tac/Bcl2a1a^tm1.1Tac Bcl2a1b^tm1.1Tac/Bcl2a1b^tm1.1Tac Bcl2a1d^tm1.1Tac/Bcl2a1d^tm1.1Tac (involves: BALB/cJ * C57BL/6NTac)	decreased CD4-positive, alpha-beta memory T cell number	J:258915
	decreased central memory CD4-positive, alpha-beta T cell number	J:258915
	decreased dendritic cell number	J:258915
	decreased effector memory CD4-positive, alpha-beta T cell number	J:258915
	decreased gamma-delta T cell number	J:258915
	decreased regulatory T cell number	J:258915
Bcl2a1a^tm1Prys/Bcl2a1a^tm1Prys (involves: 129/Sv * C57BL/6J * SJL)	abnormal neutrophil physiology	J:74478
Bcl2a1a^tm1Sen/Bcl2a1a^tm1Sen (involves: 129P2/OlaHsd * C57BL/6)	abnormal neutrophil physiology	J:52127
Bcl2l1^Plt16/Bcl2l1⁺ (involves: BALB/c * C57BL/6)	abnormal platelet physiology	J:149205
	increased megakaryocyte cell number	J:149205
	thrombocytopenia	J:149205
Bcl2l1^Plt20/Bcl2l1⁺ (involves: BALB/c * C57BL/6)	abnormal platelet physiology	J:149205
	increased megakaryocyte cell number	J:149205
	thrombocytopenia	J:149205
Bcl2l1^Plt20/Bcl2l1^Plt16 (involves: BALB/c * C57BL/6)	thrombocytopenia	J:149205
Bcl2l1^Plt20/Bcl2l1^Plt20 (involves: BALB/c * C57BL/6)	abnormal platelet physiology	J:149205
	extramedullary hematopoiesis	J:149205
	increased megakaryocyte cell number	J:149205
	thrombocytopenia	J:149205
Bcl2l1^tm1Cant/Bcl2l1^tm1Cant (involves: 129S6/SvEvTac)	abnormal memory T cell physiology	J:77507
	abnormal T cell physiology	J:77507
	decreased memory T cell number	J:77507
	decreased T cell proliferation	J:77507
Bcl2l1^tm1Dlo/Bcl2l1⁺ (B6.Cg-Bcl2l1^tm1Dlo)	abnormal platelet physiology	J:149205
Bcl2l1^tm1Dlo/Bcl2l1⁺ (B6.Cg-Bcl2l1^tm1Dlo)	thrombocytopenia	J:149205
Bcl2l1^tm1Dlo/Bcl2l1^Plt20 (involves: BALB/c * C57BL/6)	thrombocytopenia	J:149205
Bcl2l1^tm1Dlo/Bcl2l1^tm1.1Mam Tg(Aicda-cre)9Mbu/0 (B6.Cg-Bcl2l1^tm1Dlo/Bcl2l1^tm1.1Mam Tg(Aicda-cre)9Mbu)	decreased IgG1 level	J:166069
Bcl2l1^tm1Ywh/Bcl2l1^tm1Ywh Mcl1^tm1Ywh/Mcl1^tm1Ywh Tg(Cd4-cre)1Cwi/0 (involves: 129S6/SvEvTac * C57BL/6 * DBA/2)	absent CD4-positive, alpha-beta T cells	J:137400
	absent CD8-positive, alpha-beta T cells	J:137400
	decreased double-positive T cell number	J:137400
Bcl2l1^tm1Ywh/Bcl2l1^tm1Ywh Tg(Lck-cre)548Jxm/? (involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * CBA)	decreased double-positive T cell number	J:99012
	decreased thymocyte number	J:99012
Bcl2l11^em1(IMPC)H/Bcl2l11^em1(IMPC)H (C57BL/6NTac-Bcl2l11^em1(IMPC)H/H)	decreased mean corpuscular hemoglobin	J:211773
	increased erythrocyte cell number	J:211773
	increased large unstained cell number	J:211773
	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
	increased spleen weight	J:211773
Bcl2l11^em1Flv/Bcl2l11⁺ Morrbid⁺/Morrbid^em1Flv (C57BL/6N-Bcl2l11^em1Flv +/+ Morrbid^em1Flv)	decreased eosinophil cell number	J:236609
	decreased Ly6C high monocyte number	J:236609
	decreased neutrophil cell number	J:236609
Bcl2l11^tm1.1Ast/Bcl2l11⁺ (involves: 129S1/Sv * C57BL/6)	abnormal lymphocyte physiology	J:58641
	increased IgA level	J:58641
	increased IgG level	J:58641
	increased IgM level	J:58641
Bcl2l11^tm1.1Ast/Bcl2l11⁺ (B6.129S1-Bcl2l11^tm1.1Ast)	increased leukocyte cell number	J:153846
Bcl2l11^tm1.1Ast/Bcl2l11⁺ (B6.129S1-Bcl2l11^tm1.1Ast)	increased spleen weight	J:153846
Bcl2l11^tm1.1Ast/Bcl2l11⁺ Pten^tm1Hwu/Pten⁺ Tg(CD2-icre)4Kio/0 (involves: 129S1/Sv * 129S4/SvJae * C57BL/10 * CBA/Ca)	abnormal T cell number	J:133215
	increased germinal center B cell number	J:133215
Bcl2l11^tm1.1Ast/Bcl2l11^tm1.1Ast (involves: 129S1/Sv * C57BL/6)	abnormal B cell proliferation	J:90963
	abnormal lymphocyte physiology	J:58641
	abnormal plasma cell morphology	J:58641
	abnormal spleen morphology	J:58641
	abnormal splenic cell ratio	J:132217
	decreased B cell apoptosis	J:90963
	decreased double-positive T cell number	J:58641
	enlarged spleen	J:58641
	increased B cell number	J:58641
	increased CD4-positive, alpha-beta T cell number	J:58641
	increased CD8-positive, alpha-beta T cell number	J:58641
	increased double-negative T cell number	J:58641
	increased follicular B cell number	J:132217
	increased granulocyte number	J:58641
	increased IgA level	J:58641
	increased IgG level	J:58641
	increased IgM level	J:58641
	increased immature B cell number	J:132217
	increased leukocyte cell number	J:58641
	increased marginal zone B cell number	J:132217
	increased monocyte cell number	J:58641
	increased splenocyte number	J:132217
	increased T cell number	J:58641
	increased transitional stage B cell number	J:132217
	spleen hyperplasia	J:58641
	thrombocytopenia	J:58641
Bcl2l11^tm1.1Ast/Bcl2l11^tm1.1Ast (B6.129S1-Bcl2l11^tm1.1Ast)	abnormal B cell morphology	J:133084
	abnormal leukopoiesis	J:73316
	abnormal lymphocyte physiology	J:73316
	abnormal NK cell morphology	J:123409
	decreased B cell apoptosis	J:73316
	decreased T cell apoptosis	J:73316, J:133084
	increased immature B cell number	J:133084
	increased leukocyte cell number	J:153846
	increased mature B cell number	J:133084
	increased NK cell number	J:123409
	increased regulatory T cell number	J:208318
	increased spleen weight	J:153846
	increased transitional stage B cell number	J:133084
Bcl2l11^tm1.1Ast/Bcl2l11^tm1.1Ast (B6.129-Bcl2l11^tm1.1Ast/J)	decreased lymphocyte cell number	J:137609
Bcl2l11^tm1.1Ast/Bcl2l11^tm1.1Ast (involves: 129S1/Sv)	abnormal CD4-positive, alpha-beta T cell number	J:132819
	abnormal CD8-positive, alpha-beta T cell physiology	J:132819
	abnormal splenic cell ratio	J:132819
	decreased splenocyte apoptosis	J:266833
	decreased thymocyte apoptosis	J:266833
	hematopoietic system phenotype	J:141545
	increased B cell number	J:132819
Bcl2l11^tm1.1Ast/Bcl2l11^tm1.1Ast (B6.129S1-Bcl2l11^tm1.1Ast/J)	decreased T cell apoptosis	J:153652
	increased B cell number	J:153652
	increased CD4-positive, alpha-beta T cell number	J:153652
	increased CD8-positive, alpha-beta T cell number	J:153652
	increased splenocyte number	J:153652
Bcl2l11^tm1.1Ast/Bcl2l11^tm1.1Ast Bik^tm1Ast/Bik^tm1Ast (B6.Cg-Bcl2l11^tm1.1Ast Bik^tm1Ast)	abnormal B cell differentiation	J:103605
	abnormal lymphocyte physiology	J:103605
	abnormal T cell differentiation	J:103605
	decreased immature B cell number	J:103605
	decreased pre-B cell number	J:103605
	decreased pro-B cell number	J:103605
	enlarged spleen	J:103605
	increased B cell number	J:103605
	increased granulocyte number	J:103605
	increased mature B cell number	J:103605
	increased monocyte cell number	J:103605
	increased T cell number	J:103605
Bcl2l11^tm1.1Ast/Bcl2l11^tm1.1Ast Bmf^tm1Rjd/Bmf^tm1Rjd (B6.129S-Bcl2l11^tm1.1Ast Bmf^tm1Rjd)	decreased T cell apoptosis	J:153652
	increased B cell number	J:153652
	increased CD4-positive, alpha-beta T cell number	J:153652
	increased CD8-positive, alpha-beta T cell number	J:153652
	increased splenocyte number	J:153652
	increased thymocyte number	J:153652
Bcl2l11^tm1.1Ast/Bcl2l11^tm1.1Ast Bmf^tm2.1Rjd/Bmf^tm2.1Rjd (B6.129S-Bcl2l11^tm1.1Ast Bmf^tm2.1Rjd)	increased B cell number	J:153652
	increased CD4-positive, alpha-beta T cell number	J:153652
	increased CD8-positive, alpha-beta T cell number	J:153652
	increased splenocyte number	J:153652
Bcl2l11^tm1.1Ast/Bcl2l11^tm1.1Ast Bnip3l^{Gt(XT0573)Wtsi}/Bnip3l^{Gt(XT0573)Wtsi} (involves: 129S1/Sv * C57BL/6)	decreased erythrocyte cell number	J:137609
	decreased lymphocyte cell number	J:137609
Bcl2l11^tm1.1Ast/Bcl2l11^tm1.1Ast Dicer1^tm1Mmk/Dicer1^tm1Mmk Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: 129S1/Sv * BALB/c)	decreased B cell number	J:135783
	decreased mature B cell number	J:135783
Bcl2l11^tm1.1Ast/Bcl2l11^tm1.1Ast Fas^lpr/Fas^lpr (B6.Cg-Bcl2l11^tm1.1Ast Fas^lpr)	abnormal effector T cell morphology	J:132217
	abnormal splenic cell ratio	J:132217
	abnormal T cell number	J:132217
	abnormal T cell subpopulation ratio	J:132217
	decreased B cell number	J:132217
	decreased spleen red pulp amount	J:132217
	enlarged spleen	J:132217
	increased dendritic cell number	J:132217
	increased follicular B cell number	J:132217
	increased immature B cell number	J:132217
	increased leukocyte cell number	J:132217
	increased macrophage cell number	J:132217
	increased marginal zone B cell number	J:132217
	increased memory T cell number	J:132217
	increased spleen white pulp amount	J:132217
	increased transitional stage B cell number	J:132217
	spleen hyperplasia	J:132217
Bcl2l11^tm1.1Ast/Bcl2l11^tm1.1Ast Gata1^tm1.1Yen/Gata1^tm1.1Yen (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)	decreased erythroid progenitor cell number	J:200716
Bcl2l11^tm1.1Ast/Bcl2l11^tm1.1Ast Mirc14^tm1.2Flv/Mirc14^tm1.2Flv (involves: 129S1/Sv * C57BL/6 * C57BL/6N * FVB/N * SJL)	decreased NK T cell number	J:203157
Bcl2l11^tm1.1Ast/Bcl2l11^tm1.1Ast Mlf1^tm1Swm/Mlf1^tm1Swm (involves: 129S1/Sv * C57BL/6)	decreased splenocyte apoptosis	J:266833
	decreased thymocyte apoptosis	J:266833
Bcl2l11^tm1.1Ast/Bcl2l11^tm1.1Ast Pmaip1^tm1Ast/Pmaip1^tm1Ast (involves: 129S1/Sv * C57BL/6)	abnormal NK cell morphology	J:123409
Bcl2l11^tm1.1Ast/Bcl2l11^tm1.1Ast Zbtb1^m1Btlr/Zbtb1^m1Btlr (involves: 129S1/Sv * C3H/HeN * C57BL/6 * C57BL/6J)	absent T cells	J:178820
Bcl2l11^tm1.1Boui/Bcl2l11⁺ Tg(IghMyc)22Bri/0 (involves: C57BL/6 * SJL)	increased leukocyte cell number	J:186117
Bcl2l11^tm1.1Boui/Bcl2l11^tm1.1Boui (C57BL/6-Bcl2l11^tm1.1Boui)	increased leukocyte cell number	J:153846
	increased spleen weight	J:153846
Bcl2l11^tm1.1Boui/Bcl2l11^tm1.1Boui Tg(IghMyc)22Bri/0 (involves: C57BL/6 * SJL)	increased leukocyte cell number	J:186117
Bcl2l11^tm1.1Boui/Bcl2l11^tm2.1Boui (C57BL/6-Bcl2l11^tm1.1Boui/Bcl2l11^tm2.1Boui)	increased leukocyte cell number	J:153846
	increased spleen weight	J:153846
Bcl2l11^tm1Ast/Bcl2l11^tm1Ast Dicer1^tm1Bdh/Dicer1^tm1Bdh Aicda^tm1(cre)Njen/Aicda⁺ (involves: 129S1/Sv * C57BL/6)	abnormal B cell differentiation	J:181782
	decreased germinal center B cell number	J:181782
	decreased plasma cell number	J:181782
Bcl2l11^tm1Sjk/Bcl2l11^tm1Sjk (involves: 129X1/SvJ)	abnormal B cell physiology	J:100463
	abnormal spleen marginal zone morphology	J:100463
	increased B cell number	J:100463
	increased B-2 B cell number	J:100463
	increased follicular B cell number	J:100463
	increased immunoglobulin level	J:100463
	increased transitional stage B cell number	J:100463
Bcl2l11^tm2.1Boui/Bcl2l11⁺ Tg(IghMyc)22Bri/0 (involves: C57BL/6 * SJL)	increased leukocyte cell number	J:186117
Bcl2l11^tm2.1Boui/Bcl2l11^tm2.1Boui (C57BL/6-Bcl2l11^tm2.1Boui)	increased leukocyte cell number	J:153846
	increased spleen weight	J:153846
Bcl2l11^tm2.1Boui/Bcl2l11^tm2.1Boui Tg(IghMyc)22Bri/0 (involves: C57BL/6 * SJL)	increased leukocyte cell number	J:186117
Bcl2l11^tm3.1Boui/Bcl2l11^tm3.1Boui (C57BL/6-Bcl2l11^tm3.1Boui)	increased leukocyte cell number	J:153846
	increased spleen weight	J:153846
Bcl2l11^tm3Rjd/Bcl2l11^tm3Rjd (B6.129S6-Bcl2l11^tm3Rjd)	decreased thymocyte apoptosis	J:137061
	increased B cell number	J:153652
	increased CD4-positive, alpha-beta T cell number	J:153652
	increased CD8-positive, alpha-beta T cell number	J:153652
	increased splenocyte number	J:153652
Bcl2l11^tm3Rjd/Bcl2l11^tm3Rjd Bmf^tm3.1Rjd/Bmf^tm3.1Rjd (B6.129S6-Bcl2l11^tm3Rjd Bmf^tm3.1Rjd)	increased B cell number	J:153652
	increased CD4-positive, alpha-beta T cell number	J:153652
	increased CD8-positive, alpha-beta T cell number	J:153652
	increased splenocyte number	J:153652
Bcl2l11^tm4Boul/Bcl2l11^tm4Boul (involves: C57BL/6)	hematopoietic system phenotype	J:203181
Bcl2l11^tm4Rjd/Bcl2l11^tm4Rjd (involves: 129S6/SvEvTac * C57BL/6)	hematopoietic system phenotype	J:203181
Bcl2l11^tm5Boul/Bcl2l11^tm5Boul (involves: C57BL/6)	hematopoietic system phenotype	J:203181
Bcl2l11^tm6.1Boui/Bcl2l11^tm6.1Boui Foxp3^{tm4(YFP/icre)Ayr}/Foxp3⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)	increased regulatory T cell number	J:208318
Bcl2l12^{tm1.1(KOMP)Vlcg}/Bcl2l12^{tm1.1(KOMP)Vlcg} (C57BL/6N-Bcl2l12^{tm1.1(KOMP)Vlcg}/Ucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased hematocrit	J:211773
	increased spleen weight	J:211773
Bcl2l15^{tm1b(EUCOMM)Hmgu}/Bcl2l15^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Bcl2l15^{tm1b(EUCOMM)Hmgu}/Ieg)	decreased hemoglobin content	J:211773
	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular hemoglobin concentration	J:211773
Bcl3^m1Btlr/Bcl3⁺ (C57BL/6J-Bcl3^m1Btlr)	decreased B cell number	J:255184
	decreased B-1b cell number	J:255184
	increased CD8-positive, alpha-beta T cell number	J:255184
	increased macrophage cell number	J:255184
Bcl3^m1Btlr/Bcl3^m1Btlr (C57BL/6J-Bcl3^m1Btlr)	decreased B cell number	J:255184
	decreased B-1b cell number	J:255184
	decreased IgE level	J:255184
	decreased IgG level	J:255184
	increased B-1 B cell number	J:255184
	increased CD8-positive, alpha-beta T cell number	J:255184
	increased central memory CD4-positive, alpha-beta T cell number	J:255184
	increased macrophage cell number	J:255184
Bcl3^m2Btlr/Bcl3^m2Btlr (C57BL/6J-Bcl3^m2Btlr)	decreased CD4-positive, alpha-beta T cell number	J:264818
	decreased IgD level	J:264818
	increased B-1 B cell number	J:264818
	increased CD8-positive, alpha-beta memory T cell number	J:264818
	increased IgM level	J:264818
Bcl3^m3Btlr/Bcl3^m3Btlr (C57BL/6J-Bcl3^m3Btlr)	decreased central memory CD8 positive, alpha-beta T cell number	J:274858
Bcl3^{tm1b(EUCOMM)Wtsi}/Bcl3^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Bcl3^{tm1b(EUCOMM)Wtsi}/H)	increased spleen weight	J:211773
	thrombocytopenia	J:211773
Bcl3^tm1Rie/Bcl3^tm1Rie (involves: 129)	abnormal dendritic cell number	J:77049
	abnormal myeloid dendritic cell morphology	J:77049
	decreased B cell number	J:77049
	increased plasmacytoid dendritic cell number	J:77049
Bcl3^tm1Rsch/Bcl3^tm1Rsch (B6.Cg-Bcl3^tm1Rsch)	abnormal macrophage physiology	J:116724
Bcl3^tm1Sbn/Bcl3^tm1Sbn (involves: 129S4/SvJae * C57BL/6)	abnormal B cell differentiation	J:39747
	abnormal class switch recombination	J:39747
	abnormal cytotoxic T cell physiology	J:39747
	abnormal lymphocyte morphology	J:39747
	abnormal metallophilic macrophage morphology	J:39747
	abnormal spleen marginal zone macrophage morphology	J:39747
	absent spleen germinal center	J:39747
	decreased B cell number	J:39747
	decreased IgG2a level	J:39747
	decreased macrophage cell number	J:39747
	decreased spleen germinal center size	J:39747
	disorganized spleen B cell follicle	J:39747
	intermingled spleen red and white pulp	J:39747
Bcl3^tm1Sbn/Bcl3^tm1Sbn (involves: 129S4/SvJae)	abnormal B cell physiology	J:207111
	decreased B cell proliferation	J:207111
	decreased follicular B cell number	J:207111
	decreased transitional stage T1 B cell number	J:207111
	decreased transitional stage T2 B cell number	J:207111
	increased B cell proliferation	J:207111
	increased marginal zone B cell number	J:207111
Bcl3^tm1Ver/Bcl3^tm1Ver (involves: 129P2/OlaHsd * FVB/NJ)	absent spleen germinal center	J:38092
Bcl6^tm1.1Dent/Bcl6^tm1.1Dent Tg(Cd4-cre)1Cwi/0 (involves: 129S/SvEv * C57BL/6 * DBA/2 * FVB/N)	abnormal T follicular helper cell differentiation	J:202372
	decreased germinal center B cell number	J:202372
	decreased IgG level	J:202372
	decreased T follicular helper cell number	J:202372
Bcl6^tm1.1Jwan/Bcl6^tm1.1Jwan (involves: 129S6/SvEvTac)	abnormal somatic hypermutation frequency	J:190534
Bcl6^tm1.1Meln/Bcl6^tm1.1Meln (involves: 129 * C57BL/6 * FVB/N)	abnormal germinal center B cell physiology	J:194821
	abnormal spleen germinal center morphology	J:194821
	decreased IgG1 level	J:194821
	decreased IgG2a level	J:194821
	decreased IgG level	J:194821
	decreased spleen germinal center number	J:194821
	decreased T follicular helper cell number	J:194821
Bcl6^tm1.1Mtto/Bcl6^tm1.1Mtto Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: BALB/c * C57BL/6 * C57BL/6JJcl)	abnormal memory B cell morphology	J:190943
	abnormal memory B cell physiology	J:190943
	abnormal somatic hypermutation frequency	J:190943
	decreased germinal center B cell number	J:190943
Bcl6^tm1.1Mtto/Bcl6^tm1.1Mtto Cd79a^tm1(cre)Reth/Cd79a⁺ Tg(Cd4-cre)1Cwi/0 (involves: BALB/c * C57BL/6 * C57BL/6JJcl * DBA/2)	decreased germinal center B cell number	J:190943
Bcl6^tm1.1Mtto/Bcl6^tm1.1Mtto Ighg1^tm1(cre)Cgn/Ighg1⁺ (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6JJcl)	decreased germinal center B cell number	J:190943
Bcl6^tm1.1Mtto/Bcl6^tm1.1Mtto Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * C57BL/6JJcl * DBA/2)	abnormal somatic hypermutation frequency	J:190943
	absent germinal center B cells	J:190943
	decreased germinal center B cell number	J:190943
	decreased T follicular helper cell number	J:190943
Bcl6^tm1.1Toka/Bcl6⁺ Tg(TcraTcrb)425Cbn/0 (involves: BALB/c * C57BL/6 * NZB)	decreased T cell proliferation	J:174014
Bcl6^tm1.1Toka/Bcl6^tm1.1Toka (involves: C57BL/6 * NZB)	decreased germinal center B cell number	J:174014
Bcl6^tm1.1Toka/Bcl6^tm1.1Toka (involves: C57BL/6 * NZB)	decreased T follicular helper cell number	J:174014
Bcl6^tm1.1Toka/Bcl6^tm1.1Toka Tg(IghelMD4)4Ccg/0 (involves: C57BL/6 * NZB)	abnormal germinal center B cell physiology	J:174014
	increased activation-induced B cell apoptosis	J:174014
Bcl6^tm1Htno/Bcl6^tm1Htno (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal spleen morphology	J:55952
Bcl6^tm1Rdf/Bcl6^tm1Rdf (involves: 129S1/Sv)	abnormal B cell physiology	J:40769
	abnormal T-helper 2 physiology	J:40769
	absent spleen germinal center	J:40769
	decreased IgG level	J:40769
	decreased IgM level	J:40769
	increased eosinophil cell number	J:40769
	small thymus	J:40769
	spleen hyperplasia	J:40769
Bcl6^tm1Sdt/Bcl6^tm1Sdt (involves: 129/Sv * C57BL/6)	abnormal blood cell morphology/development	J:123621
	decreased bone marrow cell number	J:123621
	spleen hypoplasia	J:123621
Bcl6^tm2Rdf/Bcl6^tm2Rdf (involves: 129S1/Sv)	abnormal B cell physiology	J:40769
	abnormal T-helper 2 physiology	J:40769
	absent spleen germinal center	J:40769
	decreased B cell proliferation	J:40769
	decreased IgG level	J:40769
	decreased IgM level	J:40769
	increased eosinophil cell number	J:40769
	small thymus	J:40769
	spleen hyperplasia	J:40769
Bcl6^tm2Rdf/Bcl6^tm2Rdf Ighm^tm1(Bcl6)Rdf/? (involves: 129/Sv * 129S1/Sv * C57BL/6)	abnormal spleen germinal center morphology	J:98937
Bcl6b^tm1Dtf/Bcl6b^tm1Dtf (involves: 129P2/OlaHsd)	decreased memory T cell number	J:99818
Bcl6b^tm1Dtf/Bcl6b^tm1Dtf (involves: 129P2/OlaHsd)	decreased T cell proliferation	J:99818
Bcl6b^tm1Tto/Bcl6b^tm1Tto (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:93656
	abnormal CD8-positive, alpha beta T cell morphology	J:93656
Bcl6b^tm2Dent/Bcl6b⁺ (involves: 129/Sv * C57BL/6)	abnormal blood cell morphology/development	J:123621
Bcl6b^tm2Dent/Bcl6b^tm2Dent (involves: 129/Sv * C57BL/6)	abnormal blood cell morphology/development	J:123621
	decreased neutrophil cell number	J:123621
	increased erythrocyte cell number	J:123621
	increased monocyte cell number	J:123621
Bcl6b^tm2Dent/Bcl6b^tm2Dent Rag1^tm1Mom/Rag1^tm1Mom (involves: 129/Sv * 129S7/SvEvBrd * C57BL/6)	abnormal blood cell morphology/development	J:123621
	decreased lymphocyte cell number	J:123621
Bcl10^m1Btlr/Bcl10^m1Btlr (C57BL/6J-Bcl10^m1Btlr)	decreased B-1 B cell number	J:265122
	decreased IgG level	J:265122
	increased CD4-positive, alpha-beta T cell number	J:265122
	increased IgE level	J:265122
	increased IgM level	J:265122
	increased single-positive T cell number	J:265122
	increased T cell number	J:265122
Bcl10^tm1Mak/Bcl10^tm1Mak (involves: 129P2/OlaHsd)	abnormal cytotoxic T cell physiology	J:67297
	abnormal T cell activation	J:67297
	abnormal T cell differentiation	J:67297
	decreased activated T cell number	J:67297
	decreased B cell proliferation	J:109545, J:67297
	decreased double-positive T cell number	J:67297
	decreased IgG level	J:67297
	decreased IgM level	J:67297
	decreased immunoglobulin level	J:67297
	decreased T cell proliferation	J:109545, J:67297
	decreased thymocyte number	J:67297
	increased double-negative T cell number	J:67297
Bcl10^tm1Swm/Bcl10^tm1Swm (involves: 129P2/OlaHsd)	abnormal B cell differentiation	J:85147
	abnormal marginal zone B cell physiology	J:85147
	decreased B cell number	J:85147
	decreased B cell proliferation	J:85147
	decreased B-1 B cell number	J:85147
	decreased follicular B cell number	J:85147
	decreased marginal zone B cell number	J:85147
	decreased mature B cell number	J:85147
Bcl11a^tm1.1Pwt/Bcl11a^tm1.1Pwt (Not Specified)	abnormal erythropoiesis	J:151995
Bcl11a^tm1.1Pwt/Bcl11a^tm1.1Pwt (Not Specified)	abnormal hemoglobin content	J:151995
Bcl11a^tm1Mbu/Bcl11a^tm1Mbu Epor^{tm1.1(EGFP/icre)Uk}/Epor⁺ Tg(HBB)8.1Gvs/0 (involves: 129 * BALB/cJ * FVB/N)	abnormal erythropoiesis	J:196405
	anemia	J:196405
	decreased erythrocyte cell number	J:196405
	decreased hematocrit	J:196405
	decreased hemoglobin content	J:196405
	reticulocytosis	J:196405
Bcl11a^tm1Mbu/Bcl11a^tm1Mbu Klf1^tm1Nimr/Klf1⁺ Epor^{tm1.1(EGFP/icre)Uk}/Epor⁺ Tg(HBB)8.1Gvs/0 (involves: 129P2/OlaHsd * BALB/cJ * FVB/N)	abnormal erythropoiesis	J:196405
	polychromatophilia	J:196405
Bcl11a^tm1Mbu/Bcl11a^tm1Mbu Klf1^tm1Nimr/Klf1⁺ Tg(HBB)8.1Gvs/0 (involves: 129P2/OlaHsd * FVB)	abnormal erythropoiesis	J:196405
	anemia	J:196405
	decreased erythrocyte cell number	J:196405
	decreased hematocrit	J:196405
	decreased hemoglobin content	J:196405
	decreased mean corpuscular hemoglobin	J:196405
	decreased mean corpuscular volume	J:196405
	polychromatophilia	J:196405
	reticulocytosis	J:196405
Bcl11a^tm1Ngc/Bcl11a⁺ (involves: 129S1/Sv)	abnormal common lymphocyte progenitor cell morphology	J:194616
	abnormal T cell differentiation	J:194616
	decreased DN2 thymocyte number	J:194616
	decreased hematopoietic stem cell number	J:194616
	decreased lymphocyte cell number	J:207383
Bcl11a^tm1Ngc/Bcl11a^tm1Ngc (involves: 129S1/Sv * C57BL/6J)	abnormal dendritic cell differentiation	J:207383
	abnormal immunoglobulin heavy chain V(D)J recombination	J:83646
	absent B cells	J:207383, J:83646
	absent CD4-positive, alpha-beta T cells	J:83646
	absent lymphocyte	J:207383
	decreased plasmacytoid dendritic cell number	J:207383
	decreased T cell number	J:83646
	increased CD8-positive, alpha-beta T cell number	J:83646
	increased double-negative T cell number	J:83646
	increased gamma-delta T cell number	J:83646
	small thymus	J:83646
	thymus hypoplasia	J:83646
Bcl11a^tm1Peli/Bcl11a^tm1Peli (Not Specified)	hematopoietic system phenotype	J:194616
Bcl11a^tm1Pwt/Bcl11a^tm1Pwt Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: C57BL/6 * C57BL/10 * CBA/Ca)	decreased B cell number	J:207383
	decreased hematopoietic stem cell number	J:207383
	decreased plasmacytoid dendritic cell number	J:207383
	hematopoietic system phenotype	J:207383
Bcl11a^tm1Pwt/Bcl11a^tm1Pwt Dnmt1^tm2Jae/Dnmt1⁺ Tg(Mx1-cre)1Cgn/0 (involves: 129S4/SvJae * C57BL/6 * CBA)	anemia	J:196140
	decreased erythrocyte cell number	J:196140
Bcl11a^tm1Pwt/Bcl11a^tm1Pwt Epor^{tm1.1(EGFP/icre)Uk}/Epor⁺ (involves: BALB/cJ)	hematopoietic system phenotype	J:196140
Bcl11a^tm1Pwt/Bcl11a^tm1Pwt Gt(ROSA)26Sor^tm1(EYFP)Cos/Gt(ROSA)26Sor⁺ Tg(Mx1-cre)1Cgn/0 (involves: 129X1/SvJ * C57BL/6 * CBA)	abnormal dendritic cell differentiation	J:207383
	decreased B cell number	J:207383
	decreased dendritic cell number	J:207383
	decreased plasmacytoid dendritic cell number	J:207383
Bcl11a^tm1Pwt/Bcl11a^tm1Pwt Kdm1a^tm1.1Sho/Kdm1a⁺ Epor^{tm1.1(EGFP/icre)Uk}/Epor⁺ (involves: 129 * BALB/cJ)	anemia	J:196140
	decreased erythrocyte cell number	J:196140
	decreased hemoglobin content	J:196140
Bcl11a^tm1Pwt/Bcl11a^tm1Pwt Kdm1a^tm1.1Sho/Kdm1a^tm1.1Sho Tg(Mx1-cre)1Cgn/0 (involves: 129 * C57BL/6 * CBA)	decreased erythrocyte cell number	J:196140
	decreased hemoglobin content	J:196140
	decreased leukocyte cell number	J:196140
Bcl11a^tm1Pwt/Bcl11a^tm1Pwt Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	decreased leukocyte cell number	J:196140
	hematopoietic system phenotype	J:196140
Bcl11a^tm2.1Peli/Bcl11a^tm2.1Peli Gt(ROSA)26Sor^{tm2(cre/ERT2)Brn}/Gt(ROSA)26Sor⁺ (involves: 129P2/OlaHsd * 129S1/Sv)	abnormal common lymphocyte progenitor cell morphology	J:194616
	abnormal hematopoietic stem cell physiology	J:194616
	abnormal T cell differentiation	J:194616
	decreased B cell number	J:194616
	decreased DN2 thymocyte number	J:194616
	decreased hematopoietic stem cell number	J:194616
	decreased immature B cell number	J:194616
	decreased pre-B cell number	J:194616
	decreased pro-B cell number	J:194616
	increased B cell apoptosis	J:194616
Bcl11a^tm2.1Peli/Bcl11a^tm2.1Peli Trp53^tm1Brn/Trp53^tm1Brn Gt(ROSA)26Sor^{tm2(cre/ERT2)Brn}/Gt(ROSA)26Sor⁺ (involves: 129P2/OlaHsd * 129S1/Sv)	abnormal hematopoietic stem cell physiology	J:194616
	decreased hematopoietic stem cell number	J:194616
	hematopoietic system phenotype	J:194616
Bcl11b^tm1.2Leid/Bcl11b^tm1.2Leid (involves: C57BL/6 * SJL)	absent T cells	J:147182
Bcl11b^tm1.2Leid/Bcl11b^tm1.2Leid (involves: C57BL/6 * SJL)	thymus hypoplasia	J:147182
Bcl11b^tm1Avram/Bcl11b^tm1Avram Tcra^tm1Mom/Tcra^tm1Mom Tg(Cd4-cre)1Cwi/? (involves: 129 * C57BL/6 * DBA/2)	abnormal positive T cell selection	J:128515
	decreased double-positive T cell number	J:128515
	thymus hypoplasia	J:128515
Bcl11b^tm1Avram/Bcl11b^tm1Avram Tg(Cd4-cre)1Cwi/? (involves: 129 * C57BL/6 * DBA/2)	abnormal leukocyte morphology	J:128515
	abnormal positive T cell selection	J:128515
	abnormal thymocyte activation	J:128515
	decreased CD4-positive, alpha-beta T cell number	J:128515
	decreased CD8-positive, alpha-beta T cell number	J:128515
	decreased double-negative T cell number	J:128515
	decreased double-positive T cell number	J:128515
	increased B cell number	J:128515
	increased dendritic cell number	J:128515
	increased gamma-delta T cell number	J:128515
	increased NK cell number	J:128515
	increased spleen weight	J:128515
	spleen hyperplasia	J:128515
	thymus hypoplasia	J:128515
Bcl11b^tm1Avram/Bcl11b^tm1Avram Tg(Cd4-cre)1Cwi/? Tg(LCKprBCL2)36Sjk/? (involves: 129 * C57BL/6 * DBA/2)	abnormal positive T cell selection	J:128515
	decreased CD4-positive, alpha-beta T cell number	J:128515
	decreased CD8-positive, alpha-beta T cell number	J:128515
	decreased double-positive T cell number	J:128515
	thymus hypoplasia	J:128515
Bcl11b^tm1Jpk/Bcl11b^tm1Jpk (involves: BALB/c * C57BL/6 * CBA)	abnormal T cell differentiation	J:83651
	abnormal T cell morphology	J:83651
	abnormal T cell receptor beta chain V(D)J recombination	J:83651
	abnormal thymus cortex morphology	J:83651
	abnormal thymus medulla morphology	J:83651
	absent thymus corticomedullary boundary	J:83651
	decreased double-positive T cell number	J:83651
	increased CD8-positive, alpha-beta T cell number	J:83651
	increased double-negative T cell number	J:83651
	increased thymocyte apoptosis	J:83651
	thymus hypoplasia	J:83651
Bcl11b^tm1Peli/Bcl11b^tm1Peli Gt(ROSA)26Sor^{tm2(cre/ERT2)Brn}/Gt(ROSA)26Sor⁺ (involves: 129P2/OlaHsd * 129S5/SvEvBrd * C57BL/6J)	abnormal NK cell differentiation	J:161373
Bcl11b^tm2.1Jpk/Bcl11b⁺ Tg(Lck-cre)1Jtak/0 (involves: C57BL/6)	abnormal T cell number	J:210122
	decreased CD4-positive, alpha-beta T cell number	J:210122
	decreased CD8-positive, alpha-beta T cell number	J:210122
	decreased double-positive T cell number	J:210122
	decreased thymocyte number	J:210122
	increased double-negative T cell number	J:210122
Bclaf1^tm1Raz/Bclaf1⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased T cell proliferation	J:158087
Bclaf1^tm1Raz/Bclaf1^tm1Raz (involves: 129P2/OlaHsd * C57BL/6)	decreased CD8-positive, alpha-beta T cell number	J:158087
	decreased T cell proliferation	J:158087
	increased B cell number	J:158087
Bcmd2^CAST/EiJ/Bcmd2^CAST/EiJ (AW.CAST-Bcmd2)	increased mast cell number	J:75340
Bco2^tm1Dnp/Bco2^tm1Dnp (involves: 129S6/SvEvTac * C57BL/6)	enlarged spleen	J:166153
Bco2^tm1Dnp/Bco2^tm1Dnp (involves: 129S6/SvEvTac * C57BL/6)	increased spleen weight	J:166153
Bcor^tm1.1Vjba/Y (involves: 129S1/Sv)	abnormal bone marrow cell physiology	J:231455
Bcor^tm1.1Vjba/Y Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: 129S1/Sv * C57BL/6 * CBA/Ca)	increased neutrophil cell number	J:231455
Bcorl1^em1(IMPC)Tcp/Y (C57BL/6N-Bcorl1^em1(IMPC)Tcp/Tcp)	decreased hematocrit	J:211773
Bcorl1^em1(IMPC)Tcp/Y (C57BL/6N-Bcorl1^em1(IMPC)Tcp/Tcp)	increased mean platelet volume	J:211773
Bcorl1^em1(IMPC)Tcp/Bcorl1^em1(IMPC)Tcp (C57BL/6N-Bcorl1^em1(IMPC)Tcp/Tcp)	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
	increased mean platelet volume	J:211773
Bcr^{tm1(BCR/ABL)Tsr}/Bcr⁺ (C57BL/6-Bcr^{tm1(BCR/ABL)Tsr})	abnormal bone marrow cell physiology	J:203111
Bcr^{tm1(BCR/ABL)Tsr}/Bcr⁺ (C57BL/6-Bcr^{tm1(BCR/ABL)Tsr})	decreased hematopoietic stem cell number	J:203111
Bcr^{tm1(BCR/ABL)Tsr}/Bcr⁺ Runx1^tm3Dow/Runx1⁺ Tg(Vav1-cre)#Cgp/0 (involves: C57BL/6)	decreased lymphocyte cell number	J:203111
	increased monocyte cell number	J:203111
	increased neutrophil cell number	J:203111
	thrombocytopenia	J:203111
Bcr^{tm1(BCR/ABL)Tsr}/Bcr⁺ Tg(Vav1-cre)#Cgp/0 (involves: C57BL/6)	abnormal bone marrow cell physiology	J:203111
Bcr^tm1Hkp/Bcr^tm1Hkp (involves: 129S2/SvPas)	abnormal definitive hematopoiesis	J:23804
	abnormal neutrophil physiology	J:23804
	increased leukocyte cell number	J:23804
	increased neutrophil cell number	J:23804
Bcs1l^tm1.1Levp/Bcs1l^tm1.1Levp (B6.129-Bcs1l^tm1.1Levp)	abnormal macrophage morphology	J:273501
	increased macrophage cell number	J:273501
	increased neutrophil cell number	J:273501
Bdh2^{tm1a(EUCOMM)Wtsi}/Bdh2^{tm1a(EUCOMM)Wtsi} (C57BL/6NTac-Bdh2^{tm1a(EUCOMM)Wtsi}/WtsiH)	increased mean corpuscular hemoglobin	J:175295
Bdkrb1^em1(IMPC)H/Bdkrb1^em1(IMPC)H (B6N;B6NTac-Bdkrb1^em1(IMPC)H/H)	decreased neutrophil cell number	J:211773
	increased large unstained cell number	J:211773
	increased monocyte cell number	J:211773
Bdp1^em1(IMPC)Tcp/Bdp1⁺ (C57BL/6NCrl-Bdp1^em1(IMPC)Tcp/Tcp)	abnormal spleen morphology	J:211773
	decreased neutrophil cell number	J:211773
	increased lymphocyte cell number	J:211773
Bean1^em1(IMPC)H/Bean1^em1(IMPC)H (C57BL/6N-Bean1^em1(IMPC)H/H)	decreased lymphocyte cell number	J:211773
	increased eosinophil cell number	J:211773
Becn1^tm1.1Bflu/Becn1^tm1.1Bflu Tg(Cd4-cre)1Cwi/0 (involves: 129S1/Sv * C57BL/6 * DBA/2)	abnormal CD4-positive, alpha-beta T cell physiology	J:203090
	decreased CD4-positive, alpha-beta T cell number	J:203090
	decreased CD8-positive, alpha-beta T cell number	J:203090
	decreased T cell proliferation	J:203090
	increased T cell apoptosis	J:203090
Becn1^{tm1b(KOMP)Wtsi}/Becn1⁺ (C57BL/6N-Becn1^{tm1b(KOMP)Wtsi}/Ieg)	increased leukocyte cell number	J:211773
Becn1^tm1Blev/Becn1⁺ (involves: 129X1/SvJ * C57BL/6J)	increased spleen germinal center number	J:86953
Becn1^tm1Blev/Becn1⁺ (involves: 129X1/SvJ * C57BL/6J)	increased spleen germinal center size	J:86953
Becn1^tm1Ebr/Becn1^tm1Ebr Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd)	abnormal macrophage physiology	J:235399
	abnormal spleen morphology	J:235399
	increased IgG level	J:235399
	increased lymphocyte cell number	J:235399
	increased monocyte cell number	J:235399
	increased neutrophil cell number	J:235399
Bex2^{tm1b(EUCOMM)Hmgu}/Bex2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Bex2^{tm1b(EUCOMM)Hmgu}/Ieg)	decreased red blood cell distribution width	J:211773
	increased leukocyte cell number	J:211773
Bex6^{tm1.1(KOMP)Vlcg}/Bex6^{tm1.1(KOMP)Vlcg} (B6N(Cg)-Bex6^{tm1.1(KOMP)Vlcg}/J)	decreased mean corpuscular volume	J:211773
	increased leukocyte cell number	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
Bglap/Bglap2^tm1Kry/Bglap/Bglap2^tm1Kry (involves: 129S7/SvEvBrd * C57BL/6)	increased osteoclast cell number	J:34440
Bglap/Bglap2^tm1Kry/Bglap/Bglap2^tm1Kry (involves: 129S7/SvEvBrd * C57BL/6)	increased osteoclast cell number	J:34440
Bhlhe40^{tm1b(KOMP)Wtsi}/Bhlhe40^{tm1b(KOMP)Wtsi} (C57BL/6N-Bhlhe40^{tm1b(KOMP)Wtsi}/Wtsi)	increased mean corpuscular hemoglobin	J:211773
Bhlhe40^tm1Tan/Bhlhe40^tm1Tan (either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))	abnormal CD4-positive T cell differentiation	J:72651
	abnormal CD4-positive, alpha-beta T cell physiology	J:72651
	abnormal T cell activation	J:72651
	decreased double-positive T cell number	J:72651
	decreased T cell proliferation	J:72651
	increased CD4-positive, alpha-beta T cell number	J:72651
	increased CD8-positive, alpha-beta T cell number	J:72651
	increased double-negative T cell number	J:72651
	increased IgE level	J:72651
	increased IgG1 level	J:72651
	increased spleen germinal center number	J:72651
	increased spleen white pulp amount	J:72651
	spleen hyperplasia	J:72651
	thymus hyperplasia	J:72651
Bhlhe41^tm1.1Cdon/Bhlhe41^tm1.1Cdon (B6.129S6-Bhlhe41^tm1.1Cdon)	abnormal lymphocyte cell number	J:157740
	abnormal T-helper 2 cell differentiation	J:157740
	decreased eosinophil cell number	J:157740
	decreased macrophage cell number	J:157740
	decreased neutrophil cell number	J:157740
	decreased T cell proliferation	J:157740
Bhmt^{tm1b(EUCOMM)Hmgu}/Bhmt^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Bhmt^{tm1b(EUCOMM)Hmgu}/Bay)	decreased hemoglobin content	J:211773
	increased spleen weight	J:211773
Bicdl1^{tm2b(EUCOMM)Wtsi}/Bicdl1^{tm2b(EUCOMM)Wtsi} (C57BL/6N-Bicdl1^{tm2b(EUCOMM)Wtsi}/Bay)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Bicdl2^em1(IMPC)Mbp/Bicdl2^em1(IMPC)Mbp (C57BL/6N-Bicdl2^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Bicra^em1(IMPC)J/Bicra⁺ (C57BL/6NJ-Bicra^em1(IMPC)J/Mmjax)	increased mean corpuscular hemoglobin	J:211773
Bicra^em1(IMPC)J/Bicra⁺ (C57BL/6NJ-Bicra^em1(IMPC)J/Mmjax)	increased mean corpuscular volume	J:211773
Bicral^em1(IMPC)J/Bicral^em1(IMPC)J (C57BL/6NJ-Bicral^em1(IMPC)J/Mmjax)	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
Bid^tm1.1Atgr/Bid^tm1.1Atgr (B6.129-Bid^tm1.1Atgr)	abnormal bone marrow cell physiology	J:185449
Bid^tm1.1Atgr/Bid^tm1.1Atgr (B6.129-Bid^tm1.1Atgr)	abnormal hematopoietic stem cell physiology	J:185449
Bin2^{em1(IMPC)Wtsi}/Bin2^{em1(IMPC)Wtsi} (C57BL/6N-Bin2^{em1(IMPC)Wtsi}/Wtsi)	decreased mean corpuscular hemoglobin	J:211773
	increased mean platelet volume	J:211773
	thrombocytopenia	J:211773
Bin2^tm1.1Beni/Bin2^tm1.1Beni Tg(Pf4-icre)Q3Rsko/0 (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac)	abnormal platelet activation	J:302510
	abnormal platelet calcium level	J:302510
	abnormal platelet physiology	J:302510
	decreased platelet aggregation	J:302510
	hematopoietic system phenotype	J:302510
Bin3^tm1Gcp/Bin3^tm1Gcp (involves: 129 * C57BL/6)	anemia	J:133313
	enlarged spleen	J:133313
	extramedullary hematopoiesis	J:133313
Birc2^tm1Jda/Birc2^tm1Jda (B6.129P2-Birc2^tm1Jda)	decreased lymphocyte cell number	J:97656
Birc2^tm1Rbr/Birc2^tm1Rbr Birc3^tm1.1Rbr/Birc3^tm1.1Rbr Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * C57BL/6 * NZB)	decreased B cell apoptosis	J:172843
	decreased germinal center B cell number	J:172843
	decreased spleen germinal center size	J:172843
	enlarged spleen	J:172843
	increased B cell number	J:172843
	increased follicular B cell number	J:172843
	increased marginal zone B cell number	J:172843
Birc2^tm2.1Jda/Birc2^tm2.1Jda (B6.Cg-Birc2^tm2.1Jda)	increased T cell proliferation	J:199221
Birc3^tm1Jda/Birc3^tm1Jda (B6.Cg-Birc3^tm1Jda)	abnormal lymphocyte cell number	J:166899
	decreased B cell apoptosis	J:166899
	decreased follicular B cell number	J:166899
	decreased IgG1 level	J:166899
	decreased immature B cell number	J:166899
	increased B cell number	J:166899
	increased B cell proliferation	J:166899
	increased IgA level	J:166899
	increased IgG3 level	J:166899
	increased IgM level	J:166899
	increased marginal zone B cell number	J:166899
	increased T cell number	J:166899
Birc3^tm1Jda/Birc3^tm1Jda (involves: 129 * C57BL/6)	increased T cell proliferation	J:199221
Birc3^tm1Rgk/Birc3^tm1Rgk (B6.129X1-Birc3^tm1Rgk)	abnormal leukocyte cell number	J:144012
	abnormal macrophage physiology	J:144012
	abnormal T cell physiology	J:144012
	decreased macrophage cell number	J:144012
Birc5^tm1Mak/Birc5^tm1Mak Tg(Lck-cre)I57Jxm/0 (involves: 129P2/OlaHsd)	abnormal T cell morphology	J:90892
	abnormal thymus corticomedullary boundary morphology	J:90892
	decreased double-negative T cell number	J:90892
	decreased thymocyte number	J:90892
	increased T cell apoptosis	J:90892
	small thymus	J:90892
Birc5^tm1Wnt/Birc5^tm1Emc Tg(Cd4-cre)1Cwi/0 (involves: 129S/SvEv * C57BL/6 * DBA/2)	abnormal T cell differentiation	J:87435
Birc5^tm1Wnt/Birc5^tm1Emc Tg(Lck-cre)1Cwi/0 (involves: 129S/SvEv * C57BL/6 * DBA/2)	decreased double-positive T cell number	J:87435
	decreased T cell number	J:87435
	increased double-negative T cell number	J:87435
	thymus hypoplasia	J:87435
Birc6^tm1Nai/Birc6^tm1Nai (involves: 129S4/SvJae * C57BL/6J)	increased thymocyte apoptosis	J:96768
Birc6^tm1Sjen/Birc6^tm1Sjen (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal definitive hematopoiesis	J:94169
	abnormal embryonic hematopoiesis	J:94169
Birc7^em1(IMPC)H/Birc7^em1(IMPC)H (C57BL/6N-Birc7^em1(IMPC)H/H)	increased mean platelet volume	J:211773
Blk^m1Btlr/Blk^m1Btlr (C57BL/6J-Blk^m1Btlr)	increased IgE level	J:255004
Blk^tm1Tara/Blk^tm1Tara Fyn^tm1Sor/Fyn^tm1Sor Lyn^tm1Ard/Lyn^tm1Ard (either: B6.129-Lyn^tm1Ard Fyn^tm1Sor Blk^tm1Tara or (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6))	abnormal B cell differentiation	J:115080
	abnormal pro-B cell differentiation	J:115080
	arrested B cell differentiation	J:115080
	decreased B cell number	J:115080
	decreased immature B cell number	J:115080
	decreased pre-B cell number	J:115080
Blm^tm1Ches/Blm^tm1Ches (involves: 129S6/SvEvTac * NIH Black Swiss)	abnormal erythrocyte morphology	J:50843
	abnormal erythropoiesis	J:50843
	abnormal proerythroblast morphology	J:50843
	abnormal reticulocyte morphology	J:50843
	anemia	J:50843
	macrocytosis	J:50843
Blm^tm3Brd/Blm^tm3Brd (involves: 129S7/SvEvBrd * C57BL/6)	decreased IgM level	J:66261
Blm^tm3Ches/Blm^tm3Ches (involves: 129S6/SvEvTac * NIH Black Swiss)	abnormal erythrocyte morphology	J:86827
	anisopoikilocytosis	J:86827
Blm^tm4Ches/Blm^tm4Ches Cd19^tm1(cre)Cgn/Cd19⁺ Nsmce2^tm2.1Ofc/Nsmce2^tm2.1Ofc (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * SJL)	abnormal B cell morphology	J:227197
	abnormal B cell physiology	J:227197
	decreased B cell number	J:227197
	small spleen	J:227197
Blm^tm4Ches/Blm^tm4Ches Trp53bp1^tm1Jc/Trp53bp1^tm1Jc Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * 129S6/SvEvTac)	abnormal class switch recombination	J:194603
Blnk^em1(IMPC)H/Blnk^em1(IMPC)H (C57BL/6N-Blnk^em1(IMPC)H/H)	decreased basophil cell number	J:211773
	decreased large unstained cell number	J:211773
	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	decreased spleen weight	J:211773
	increased eosinophil cell number	J:211773
	increased neutrophil cell number	J:211773
	small spleen	J:211773
Blnk^m1Btlr/Blnk^m1Btlr (C57BL/6J-Blnk^m1Btlr)	arrested B cell differentiation	J:159439
	decreased IgG level	J:159439
	decreased IgM level	J:159439
	decreased mature B cell number	J:159439
	increased CD4-positive, alpha-beta T cell number	J:159439
	increased CD8-positive, alpha-beta T cell number	J:159439
Blnk^m1Btlr/Blnk^m1Btlr (involves: C57BL/6J)	arrested B cell differentiation	J:185495
Blnk^m1Btlr/Blnk^m1Btlr (involves: C57BL/6J)	decreased IgM level	J:185495
Blnk^tm1Achn/Blnk⁺ (involves: 129S4/SvJae * 129X1/SvJ * BALB/c * C3H * C57BL/6)	decreased B cell proliferation	J:82430
Blnk^tm1Achn/Blnk⁺ Btk^tm1Wk/Btk^tm1Wk Tg(IGH-Btk)1Witt/0 (involves: 129S4/SvJae * 129X1/SvJ * BALB/c * C3H * C57BL/6)	abnormal B cell physiology	J:82430
	decreased B cell proliferation	J:82430
Blnk^tm1Achn/Blnk^tm1Achn (involves: 129X1/SvJ)	abnormal B cell differentiation	J:58805
	abnormal mature B cell morphology	J:58805
	absent B-1b cells	J:58805
	arrested B cell differentiation	J:58805
	decreased B-1a cell number	J:58805
	decreased immunoglobulin level	J:58805
	decreased mature B cell number	J:58805
	decreased splenocyte number	J:58805
	increased pro-B cell number	J:58805
Blnk^tm1Dkit/Blnk^tm1Dkit (involves: C57BL/6)	abnormal B cell apoptosis	J:143854
	abnormal B cell differentiation	J:84040
	abnormal immature B cell morphology	J:94297
	abnormal plasma cell differentiation	J:143854
	abnormal pre-B cell morphology	J:84040
	arrested B cell differentiation	J:143854
	decreased follicular B cell number	J:143854
	decreased IgG3 level	J:143854
	decreased IgM level	J:143854
	decreased immature B cell number	J:84040
	decreased marginal zone B cell number	J:143854
	decreased mature B cell number	J:84040
	decreased transitional stage B cell number	J:143854
	increased B cell apoptosis	J:143854
Blnk^tm1Dkit/Blnk^tm1Dkit Cd19^tm1(cre)Cgn/Cd19^tm1(cre)Cgn (involves: 129P2/OlaHsd * C57BL/6 * NZB)	abnormal pre-B cell morphology	J:84040
	absent immature B cells	J:84040
	absent mature B cells	J:84040
	arrested B cell differentiation	J:84040
	decreased pre-B cell number	J:84040
	enlarged spleen	J:84040
Blnk^tm1Dkit/Blnk^tm1Dkit Igh-J^{tm1(3H9-VDJ)Mwg}/Igh-J⁺ (involves: C57BL/6 * NZB)	abnormal immature B cell morphology	J:94297
Blnk^tm1Dkit/Blnk^tm1Dkit Igh-J^{tm1(3H9-VDJ)Mwg}/Igh-J⁺ Igk-J^tm1Mwg/Igk-J⁺ (involves: C57BL/6 * NZB)	abnormal immature B cell morphology	J:94297
Blnk^tm1Dkit/Blnk^tm1Dkit Prkcd^tm1Kin/Prkcd^tm1Kin (involves: 129P2/OlaHsd * C57BL/6 * NZB)	abnormal B cell proliferation	J:143854
	abnormal immunoglobulin level	J:143854
	abnormal plasma cell differentiation	J:143854
	arrested B cell differentiation	J:143854
	decreased B-1 B cell number	J:143854
	decreased B-2 B cell number	J:143854
	decreased follicular B cell number	J:143854
	decreased marginal zone B cell number	J:143854
	increased B cell apoptosis	J:143854
	increased IgA level	J:143854
	increased IgG1 level	J:143854
	increased IgG2b level	J:143854
	increased IgG3 level	J:143854
	increased IgM level	J:143854
Blnk^tm1Kplm/Blnk^tm1Kplm (involves: 129P2/OlaHsd)	abnormal B cell activation	J:61130, J:131161
	abnormal B cell differentiation	J:61130, J:131161
	absent B-1a cells	J:61130
	decreased B cell number	J:61130, J:131161
	decreased B cell proliferation	J:61130
	decreased immature B cell number	J:61130
	decreased mature B cell number	J:61130
	decreased pre-B cell number	J:61130, J:120460
	increased B cell apoptosis	J:131161
	increased pro-B cell number	J:61130, J:131161
	spleen hypoplasia	J:131161
Blnk^tm1Kplm/Blnk^tm1Kplm Igh^tm4Cgn/Igh⁺ Igk^tm1Rsky/Igk⁺ (involves: 129P2/OlaHsd)	abnormal B cell differentiation	J:120460
	decreased B cell number	J:120460
	increased pre-B cell number	J:120460
	increased transitional stage B cell number	J:120460
Blnk^tm1Kplm/Blnk^tm1Kplm Plcg2^tm1.1Kuro/Plcg2⁺ (involves: 129P2/OlaHsd)	abnormal B cell activation	J:131161
	decreased B cell number	J:131161
	increased B cell apoptosis	J:131161
Blnk^tm1Kplm/Blnk^tm1Kplm Plcg2^tm1.1Kuro/Plcg2^tm1.1Kuro (involves: 129P2/OlaHsd)	decreased B cell number	J:131161
	increased B cell apoptosis	J:131161
	spleen hypoplasia	J:131161
Blnk^tm1Pjln/Blnk^tm1Pjln (involves: BALB/c)	abnormal pre-B cell morphology	J:58740
	arrested B cell differentiation	J:58740
	decreased IgG3 level	J:58740
	decreased IgM level	J:58740
	decreased mature B cell number	J:58740
	enlarged spleen	J:80332
	increased mature B cell number	J:157575
	increased pre-B cell number	J:58740, J:80332
Blnk^tm1Pjln/Blnk^tm1Pjln Btk^tm1Gsv/Y (involves: 129P2/OlaHsd * BALB/c * C57BL/6)	abnormal B cell differentiation	J:94768
	decreased IgG3 level	J:94768
	decreased IgM level	J:94768
	decreased immature B cell number	J:94768
	decreased immunoglobulin level	J:94768
	decreased mature B cell number	J:94768
Blnk^tm1Pjln/Blnk^tm1Pjln Btk^tm1Gsv/Y Tg(CD19-BTKK430R)XK24Rwhe/? (involves: 129P2/OlaHsd BALB/c * C57BL/6 * FVB)	abnormal B cell differentiation	J:94768
	decreased IgG3 level	J:94768
	decreased IgM level	J:94768
	decreased immunoglobulin level	J:94768
Blnk^tm1Pjln/Blnk^tm1Pjln Btk^tm1Wk/Btk^tm1Wk (involves: 129S4/SvJae * BALB/c * C57BL/6)	arrested B cell differentiation	J:70406
Blnk^tm1Pjln/Blnk^tm1Pjln Cd79a^tm1(cre)Reth/Cd79a^tm1(cre)Reth Mzb1^tm1.1Rug/Mzb1^tm1.1Rug (involves: 129S2/SvPas * BALB/c * C57BL/6 * SJL)	abnormal bone marrow cell physiology	J:211639
Bloc1s2^{tm1.1(KOMP)Mbp}/Bloc1s2⁺ (B6N(Cg)-Bloc1s2^{tm1.1(KOMP)Mbp}/J)	thrombocytopenia	J:211773
Bloc1s2^tm1Wli/Bloc1s2^tm1Wli (involves: 129 * C57BL/6J)	abnormal hematopoietic stem cell morphology	J:238623
	decreased granulocyte monocyte progenitor cell number	J:238623
	impaired hematopoiesis	J:238623
	increased hematopoietic stem cell number	J:238623
	increased hematopoietic stem cell proliferation	J:238623
Bloc1s3^rp/Bloc1s3^rp (involves: C57BL/10ScSn * C57BL/Tb)	abnormal NK cell physiology	J:6801
Bloc1s4^cno/Bloc1s4^cno (C3H/HeJ-Bloc1s4^cno)	abnormal platelet dense granule physiology	J:61187
	decreased platelet aggregation	J:61187
	decreased platelet ATP level	J:61187
	decreased platelet calcium level	J:61187
	decreased platelet dense granule number	J:61187
	decreased platelet serotonin level	J:61187
Bloc1s5^em1(IMPC)Tcp/Bloc1s5⁺ (C57BL/6NCrl-Bloc1s5^em1(IMPC)Tcp/Tcp)	increased monocyte cell number	J:211773
Bloc1s5^mu/Bloc1s5^mu (involves: STOCK t)	abnormal platelet dense granule morphology	J:29151
	abnormal platelet physiology	J:29151
	decreased platelet aggregation	J:29151
	decreased platelet ATP level	J:29151
	decreased platelet serotonin level	J:29151
Bloc1s5^mu/Bloc1s5^mu (CHMU/Le)	abnormal platelet dense granule morphology	J:29151
	abnormal platelet dense granule physiology	J:29151
	decreased platelet aggregation	J:29151
	decreased platelet dense granule number	J:29151
	decreased platelet serotonin level	J:29151
	hematopoietic system phenotype	J:29151
Bloc1s6^em1(IMPC)Mbp/Bloc1s6^em1(IMPC)Mbp (C57BL/6N-Bloc1s6^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Bloc1s6^pa/Bloc1s6^pa (B6.Cg-Bloc1s6^pa/J)	abnormal NK cell physiology	J:6801
	abnormal platelet activation	J:7327, J:221384
	abnormal platelet physiology	J:221384
	decreased platelet ADP level	J:7327
	decreased platelet aggregation	J:221384
	decreased platelet ATP level	J:7327
	decreased platelet dense granule number	J:7327
	decreased platelet serotonin level	J:7327
Blvra^tm1.1Rsto/Blvra^tm1.1Rsto (involves: C57BL/6)	decreased mean corpuscular hemoglobin	J:331733
	decreased mean corpuscular volume	J:331733
	high mean erythrocyte cell number	J:331733
	increased mean corpuscular hemoglobin concentration	J:331733
Bmal1^em1Bwu/Bmal1^em1Bwu (C57BL/6-Bmal1^em1Bwu)	abnormal macrophage physiology	J:340220
Bmal1^tm1Bra/Bmal1^tm1Bra (B6.129-Bmal1^tm1Bra)	decreased basophil cell number	J:191844
	decreased leukocyte cell number	J:110697
	decreased lymphocyte cell number	J:110697
	decreased spleen weight	J:110697
	hematopoietic system phenotype	J:110697
	impaired leukocyte tethering or rolling	J:191844
	increased eosinophil cell number	J:191844
	increased leukocyte cell number	J:191844
	increased lymphocyte cell number	J:191844
	increased megakaryocyte cell number	J:191844
	increased monocyte cell number	J:110697
	increased neutrophil cell number	J:110697, J:191844
	thrombocytosis	J:191844
Bmal1^tm1Bra/Bmal1^tm1Bra (involves: 129/Sv * C57BL/6)	abnormal B cell differentiation	J:118522
	abnormal T cell subpopulation ratio	J:118522
	decreased B cell number	J:135933, J:118522
	decreased follicular B cell number	J:118522
	decreased IgG1 level	J:118522
	decreased lymphocyte cell number	J:135933, J:118522
	decreased transitional stage B cell number	J:118522
	increased neutrophil cell number	J:135933
	thrombocytosis	J:135933
Bmf^tm1.1Ast/Bmf^tm1.1Ast (B6.Cg-Bmf^tm1.1Anst)	abnormal B cell morphology	J:133084
	abnormal spleen morphology	J:133084
	decreased B cell apoptosis	J:133084
	decreased T cell apoptosis	J:133084
	enlarged spleen	J:133084
	increased follicular B cell number	J:133084
	increased immature B cell number	J:133084
	increased immunoglobulin level	J:133084
	increased mature B cell number	J:133084
	increased pre-B cell number	J:133084
	increased transitional stage B cell number	J:133084
	spleen hyperplasia	J:133084
Bmf^tm1Rjd/Bmf^tm1Rjd (B6.129S6-Bmf^tm1Rjd)	decreased T cell apoptosis	J:153652
	enlarged spleen	J:153652
	increased B cell number	J:153652
	increased CD8-positive, alpha-beta T cell number	J:153652
	increased splenocyte number	J:153652
Bmf^tm3.1Rjd/Bmf^tm3.1Rjd (B6.129S6-Bmf^tm3.1Rjd)	decreased CD4-positive, alpha-beta T cell number	J:153652
Bmi1^tm1Brn/Bmi1^tm1Brn (either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * FVB))	abnormal bone marrow cell morphology/development	J:17712
	abnormal definitive hematopoiesis	J:17712
	abnormal double-negative T cell morphology	J:17712
	abnormal spleen red pulp morphology	J:17712
	abnormal spleen white pulp morphology	J:17712
	abnormal thymus involution	J:17712
	anemia	J:17712
	decreased IgM level	J:17712
	decreased immature B cell number	J:17712
	decreased mature B cell number	J:17712
	decreased splenocyte proliferation	J:17712
	decreased thymocyte number	J:17712
	small spleen	J:17712
	thymus cortex hypoplasia	J:17712
Bmi1^tm1Brn/Bmi1^tm1Brn (involves: 129P2/OlaHsd)	abnormal bone marrow cell morphology/development	J:134271
	anemia	J:134271
	decreased bone marrow cell number	J:134271
	decreased double-positive T cell number	J:134271
	decreased hematopoietic cell number	J:134271
Bmi1^tm1Brn/Bmi1^tm1Brn E2f6^tm1Lees/E2f6^tm1Lees (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	abnormal bone marrow cell morphology/development	J:134271
	anemia	J:134271
	decreased bone marrow cell number	J:134271
	decreased double-positive T cell number	J:134271
	decreased hematopoietic cell number	J:134271
Bmi1^tm1Sgon/Bmi1^tm1Sgon Commd10^{Tg(Vav1-icre)A2Kio}/? (involves: 129S1/Sv * 129X1/SvJ * C57BL/10 * CBA/Ca)	abnormal erythropoiesis	J:221849
	abnormal hemopoiesis	J:221849
	abnormal spleen morphology	J:221849
	abnormal spleen periarteriolar lymphoid sheath morphology	J:221849
	abnormal spleen white pulp morphology	J:221849
	abnormal thymus morphology	J:221849
	absent spleen germinal center	J:221849
	decreased B cell number	J:221849
	decreased bone marrow cell number	J:221849
	decreased common myeloid progenitor cell number	J:221849
	decreased hematopoietic stem cell number	J:221849
	decreased myeloid cell number	J:221849
	decreased spleen red pulp amount	J:221849
	decreased spleen white pulp amount	J:221849
	decreased T cell number	J:221849
	increased common lymphocyte progenitor cell number	J:221849
	small spleen	J:221849
	small thymus	J:221849
	thymus atrophy	J:221849
Bmi1^tm1Sgon/Bmi1^tm1Sgon Gt(ROSA)26Sor^{tm1(cre/ERT2)Tyj}/? (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)	decreased hematopoietic stem cell number	J:221849
	decreased lymphocyte cell number	J:221849
	decreased spleen weight	J:221849
	hematopoietic system phenotype	J:221849
Bmp1^tm1.1Dgr/Bmp1^tm1.1Dgr Tll1^tm2.1Dgr/Tll1^tm2.1Dgr Ndor1^{Tg(UBC-cre/ERT2)1Ejb}/0 (involves: 129S/SvEv * 129S6/SvEvTac * C57BL/6 * SJL)	increased osteoclast cell number	J:210366
Bmp2^tm1.1Mis/Bmp2^tm1.2Mis Tg(Col1a1-cre)1Bek/0 (involves: 129S4/SvJaeSor * 129S7/SvEvBrd * CD-1)	decreased osteoclast cell number	J:210409
Bmp4^tm1Blh/Bmp4^tm1Blh (B6.129S2-Bmp4^tm1Blh)	decreased erythrocyte cell number	J:28717
Bmp6^{em1(IMPC)Ccpcz}/Bmp6^{em1(IMPC)Ccpcz} (C57BL/6N-Bmp6^{em1(IMPC)Ccpcz}/Ccpcz)	increased hemoglobin content	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
	increased mean corpuscular volume	J:211773
Bmp7^{tm1a(EUCOMM)Hmgu}/Bmp7⁺ (C57BL/6N-Bmp7^{tm1a(EUCOMM)Hmgu}/H)	decreased erythrocyte cell number	J:165965
	increased mean corpuscular volume	J:165965
	increased monocyte cell number	J:165965
Bmp10^b2b2711Clo/Bmp10^b2b2711Clo (C57BL/6J-Bmp10^b2b2711Clo)	thymus hypoplasia	J:175213
Bmpr1a^tm2.1Bhr/Bmpr1a^tm2.1Bhr Kdr^tm1(cre)Sato/Kdr⁺ (involves: 129S1/Sv * 129S7/SvEvBrd)	hematopoietic system phenotype	J:112269
Bmpr1a^tm2.1Bhr/Bmpr1a^tm2.1Bhr Tg(Col1a1-cre/Esr1*)1Mis/0 (involves: 129S7/SvEvBrd)	abnormal osteoclast differentiation	J:143588
	abnormal osteoclast physiology	J:143588
	decreased osteoclast cell number	J:143588
Bmpr2^tm1Kmi/Bmpr2⁺ (involves: 129S4/SvJae * C57BL/6J)	abnormal leukocyte physiology	J:117167
Bmrbc1^C57BL/6Ola/? (involves: C57BL/6Ola * CBA/HOla)	increased erythrocyte cell number	J:118313
Bmrbc2^C57BL/6Ola/Bmrbc2^CBA/HOla (involves: C57BL/6Ola * CBA/HOla)	increased erythrocyte cell number	J:118313
Bmrbc2^CBA/HOla/Bmrbc2^CBA/HOla (involves: C57BL/6Ola * CBA/HOla)	increased erythrocyte cell number	J:118313
Bmrbc3^C57BL/6Ola/Bmrbc3^C57BL/6Ola (involves: C57BL/6Ola * CBA/HOla)	increased erythrocyte cell number	J:118313
Bmrbc3^C57BL/6Ola/Bmrbc3^CBA/HOla (involves: C57BL/6Ola * CBA/HOla)	increased erythrocyte cell number	J:118313
Bmrbc4^C57BL/6Ola/Bmrbc4^C57BL/6Ola (involves: C57BL/6Ola * CBA/HOla)	increased erythrocyte cell number	J:118313
Bmrbc4^C57BL/6Ola/Bmrbc4^CBA/HOla (involves: C57BL/6Ola * CBA/HOla)	increased erythrocyte cell number	J:118313
Bmrbc4^CBA/HOla/Bmrbc4^CBA/HOla (involves: C57BL/6Ola * CBA/HOla)	increased erythrocyte cell number	J:118313
Bnc1^em1(IMPC)H/Bnc1^em1(IMPC)H (C57BL/6NTac-Bnc1^em1(IMPC)H/H)	abnormal spleen morphology	J:211773
	increased leukocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Bnip1^{tm2b(KOMP)Wtsi}/Bnip1⁺ (C57BL/6N-Bnip1^{tm2b(KOMP)Wtsi}/Nju)	increased eosinophil cell number	J:211773
Bnip2^{tm1b(EUCOMM)Wtsi}/Bnip2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Bnip2^{tm1b(EUCOMM)Wtsi}/Wtsi)	decreased erythrocyte cell number	J:211773
	increased mean corpuscular hemoglobin	J:211773
Bnip3^tm1Gwd/Bnip3^tm1Gwd (Not Specified)	hematopoietic system phenotype	J:127533
Bnip3l^{Gt(XT0573)Wtsi}/Bnip3l^{Gt(XT0573)Wtsi} (B6.Cg-Bnip3l^{Gt(XT0573)Wtsi})	abnormal erythrocyte morphology	J:137609
	abnormal erythrocyte physiology	J:137609
	abnormal reticulocyte morphology	J:137609
	decreased erythrocyte cell number	J:137609
	decreased mean corpuscular volume	J:137609
	increased erythrocyte osmotic fragility	J:137609
	polychromatophilia	J:137609
	reticulocytosis	J:137609
Bnip3l^tm1.1Gwd/Bnip3l^tm1.1Gwd (involves: 129 * C57BL/6)	abnormal bone marrow cell number	J:141583
	abnormal definitive hematopoiesis	J:141583
	abnormal erythroblast number	J:141583
	abnormal erythrocyte morphology	J:141583
	abnormal spleen morphology	J:141583
	abnormal thrombopoiesis	J:141583
	anisocytosis	J:141583
	enlarged spleen	J:141583
	increased mean corpuscular volume	J:141583
	increased spleen red pulp amount	J:141583
	poikilocytosis	J:141583
	polychromatophilia	J:141583
	reticulocytosis	J:141583
Bnip3l^tm1Ney/Bnip3l^tm1Ney (Not Specified)	abnormal definitive hematopoiesis	J:141545
	abnormal erythrocyte morphology	J:141545
	anemia	J:141545
	decreased erythrocyte cell number	J:141545
	decreased hematocrit	J:141545
	enlarged spleen	J:141545
	poikilocytosis	J:141545
	polychromatophilia	J:141545
	reticulocytosis	J:141545
	spherocytosis	J:141545
	spleen hyperplasia	J:141545
Bnip5^{tm1.1(KOMP)Vlcg}/Bnip5^{tm1.1(KOMP)Vlcg} (C57BL/6N-Bnip5^{tm1.1(KOMP)Vlcg}/MbpMmucd)	abnormal spleen morphology	J:211773
	small spleen	J:211773
Boc^{tm1b(KOMP)Wtsi}/Boc^{tm1b(KOMP)Wtsi} (C57BL/6N-Boc^{tm1b(KOMP)Wtsi}/H)	increased basophil cell number	J:211773
Bod1^{tm1b(KOMP)Wtsi}/Bod1⁺ (C57BL/6N-Bod1^{tm1b(KOMP)Wtsi}/Nju)	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
Bod1l^em1Bltn/Bod1l^em1Bltn Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * C57BL/6J)	decreased IgG1 level	J:337726
	decreased IgG level	J:337726
Bod1l^em1Bltn/Bod1l^em1Bltn Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ (involves: C57BL/6J * C57BL/6NTac)	abnormal class switch recombination	J:337726
	decreased IgG1 level	J:337726
Bok^tm1.1Ast/Bok^tm1.1Ast (involves: BALB/cJ * C57BL/6)	hematopoietic system phenotype	J:203179
	increased spleen weight	J:203179
	increased thymus weight	J:203179
Bok^{tm1b(EUCOMM)Hmgu}/Bok^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Bok^{tm1b(EUCOMM)Hmgu}/Tcp)	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
Bola1^{tm1.1(KOMP)Vlcg}/Bola1^{tm1.1(KOMP)Vlcg} (B6N(Cg)-Bola1^{tm1.1(KOMP)Vlcg}/J)	decreased mean corpuscular hemoglobin	J:211773
Bola2^{tm1(KOMP)Wtsi}/Bola2^{tm1(KOMP)Wtsi} (C57BL/6N-Bola2^{tm1(KOMP)Wtsi}/Nju)	decreased hemoglobin content	J:211773
	decreased mean corpuscular volume	J:211773
Bomb1^NSF/N/Bomb1^NSF/N (involves: NFS/N * SL/Kh)	increased pre-B cell number	J:55364
Bomb1^SL/Kh/Bomb1^SL/Kh (involves: NFS/N * SL/Kh)	increased pre-B cell number	J:55364
bpck/bpck (B6C3Fe a/a-bpck/J)	anemia	J:144929
Bpgm^m1Pgrs/Bpgm^m1Pgrs (involves: C57BL/6 * C57BL/10J)	abnormal erythrocyte physiology	J:301620
	abnormal erythropoiesis	J:301620
	abnormal reticulocyte cell number	J:301620
	abnormal stress erythropoiesis	J:301620
	enlarged spleen	J:301620
	increased erythroblast number	J:301620
	increased hematocrit	J:301620
	increased hemoglobin content	J:301620
	increased mean corpuscular hemoglobin	J:301620
	macrocytosis	J:301620
	polycythemia	J:301620
	reticulocytosis	J:301620
Bptf^em1Zfa/Bptf^em1Zfa Tg(Rorc-cre)1Litt/0 (involves: C57BL/6 * FVB)	decreased common lymphocyte progenitor cell number	J:259392
Bptf^tm1.1Cwu/Bptf^tm1.1Cwu Emx1^tm1(cre)Krj/Emx1⁺ (involves: 129S1/Sv * 129S2/SvPas * C57BL/6)	microgliosis	J:334252
Braf^tm1(ARAF)Urr/Braf^tm1(ARAF)Urr (involves: 129S1/Sv * C57BL/6 * CD-1)	decreased spleen weight	J:112971
	decreased thymus weight	J:112971
Braf^tm1Bbd/Braf⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal thymus morphology	J:170095
	decreased thymocyte number	J:170095
	increased splenocyte apoptosis	J:170095
	increased thymocyte apoptosis	J:170095
	thymus atrophy	J:170095
Braf^tm1Bbd/Braf⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CD-1)	abnormal thymus morphology	J:170095
	decreased thymocyte number	J:170095
	increased splenocyte apoptosis	J:170095
	increased thymocyte apoptosis	J:170095
	thymus atrophy	J:170095
Braf^tm1Bbd/Braf⁺ (B6.129-Braf^tm1Bbd)	abnormal thymus morphology	J:170095
	decreased thymocyte number	J:170095
	increased splenocyte apoptosis	J:170095
	increased thymocyte apoptosis	J:170095
	thymus atrophy	J:170095
Braf^tm1Cpri/Braf⁺ Tg(Mx1-cre)1Cgn/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	decreased bone marrow cell number	J:104375
	decreased erythrocyte cell number	J:104375
	decreased leukocyte cell number	J:104375
	enlarged spleen	J:104375
	extramedullary hematopoiesis	J:104375
Braf^tm1Mmcm/Braf^tm1Mmcm Cd207^{tm2.1(cre)Bjec}/Cd207⁺ (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	increased dendritic cell number	J:211690
Braf^tm1Mmcm/Braf^tm1Mmcm Tg(Itgax-cre)1-1Reiz/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	anemia	J:211690
	hepatosplenomegaly	J:211690
	increased dendritic cell number	J:211690
Braf^tm1Wds/Braf^tm1Wds Raf1^tm2Bacc/Raf1^tm2Bacc H2az2^{Tg(Wnt1-cre)11Rth}/H2az2⁺ (involves: 129P2/OlaHsd * C57BL/6J * CBA/J)	small thymus	J:144862
Braf^tm2Cpri/Braf⁺ Tg(CMV-cre)1Cgn/0 (B6.Cg-Braf^tm2Cpri Tg(CMV-cre)1Cgn)	enlarged spleen	J:187371
	increased spleen weight	J:187371
Brca1^tm2.1Cxd/Brca1^tm2.1Cxd Shld1^em1Nus/Shld1^em1Nus (involves: 129S6/SvEvTac * C57BL/6NCrl)	abnormal class switch recombination	J:307190
Brca1^tm2.1Cxd/Brca1^tm2.1Cxd Trp53^tm1Brd/Trp53⁺ (involves: 129S6/SvEvTac * 129S7/SvEvBrd)	enlarged thymus	J:81541
Brca1^tm2.1Cxd/Brca1^tm2.1Cxd Trp53bp1^tm1Jc/Trp53bp1^tm1Jc (involves: 129 * 129S6/SvEvTac)	abnormal class switch recombination	J:307190
Brca1^tm2Mak/Brca1^tm2Mak Cdkn1a^tm1Tyj/Cdkn1a^tm1Tyj Tg(Lck-cre)548Jxm/? (involves: 129P2/OlaHsd * C57BL/6 * CBA)	decreased thymocyte number	J:63282
Brca1^tm2Mak/Brca1^tm2Mak Tg(Lck-cre)548Jxm/? (involves: 129P2/OlaHsd * C57BL/6 * CBA)	abnormal T cell number	J:63282
	decreased double-positive T cell number	J:63282
	decreased single-positive T cell number	J:63282
	decreased T cell proliferation	J:63282
	decreased thymocyte number	J:63282
	increased double-negative T cell number	J:63282
Brca1^tm2Mak/Brca1^tm2Mak Tg(Lck-cre)548Jxm/? Tg(TcrLCMV)327Sdz/? (involves: 129P2/OlaHsd * C57BL/6 * CBA)	abnormal T cell number	J:63282
	decreased double-positive T cell number	J:63282
	decreased T cell proliferation	J:63282
	decreased thymocyte number	J:63282
	increased double-negative T cell number	J:63282
Brca2^tm1Cam/Brca2^tm1Cam (involves: 129S/SvEv * MF1)	increased thymus weight	J:46812
Brca2^tm1Kamc/Brca2^tm1Kamc (involves: 129P2/OlaHsd * BALB/c)	abnormal hematopoietic system morphology/development	J:144998
	decreased bone marrow cell number	J:144998
	decreased common myeloid progenitor cell number	J:144998
	impaired hematopoiesis	J:144998
	spleen hypoplasia	J:144998
Brca2^tm1Mak/Brca2^tm2Mak Tg(Lck-cre)548Jxm/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	increased T cell apoptosis	J:79697
Brca2^tm1Mak/Brca2^tm2Mak Trp53^tm1Brd/Trp53^tm1Brd Tg(Lck-cre)548Jxm/0 (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * CBA)	increased activated T cell number	J:79697
Brcc3^{em1(IMPC)Wtsi}/Brcc3^{em1(IMPC)Wtsi} (C57BL/6N-Brcc3^{em1(IMPC)Wtsi}/WtsiCnrm)	thrombocytosis	J:211773
Brd1^tm1Hko/Brd1^tm1Hko (B6.129-Brd1^tm1Hko)	abnormal embryonic erythropoiesis	J:177092
	abnormal embryonic hematopoiesis	J:177092
	abnormal erythropoiesis	J:177092
	abnormal fetal liver hematopoietic progenitor cell morphology	J:177092
	anemia	J:177092
	decreased erythroblast number	J:177092
	decreased erythroid progenitor cell number	J:177092
	impaired hematopoiesis	J:177092
Brd2^{em1(IMPC)Wtsi}/Brd2⁺ (C57BL/6N-Brd2^{em1(IMPC)Wtsi}/WtsiIeg)	decreased CD8-positive, alpha-beta T cell number	J:211773
	increased CD4-positive, alpha-beta T cell number	J:211773
	increased mean corpuscular hemoglobin	J:211773
Brd2^{em1(IMPC)Wtsi}/Brd2^{em1(IMPC)Wtsi} (C57BL/6N-Brd2^{em1(IMPC)Wtsi}/WtsiIeg)	abnormal thymus topology	J:239583
	small thymus	J:239583
Brd9^em1(IMPC)Tcp/Brd9⁺ (C57BL/6NCrl-Brd9^em1(IMPC)Tcp/Tcp)	increased neutrophil cell number	J:211773
Brip1^em1(IMPC)J/Brip1^em1(IMPC)J (C57BL/6NJ-Brip1^em1(IMPC)J/Mmjax)	increased mean corpuscular volume	J:211773
	thrombocytopenia	J:211773
Brix1^{tm1b(KOMP)Mbp}/Brix1⁺ (C57BL/6N-Brix1^{tm1b(KOMP)Mbp}/Mhzh)	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
Brpf1^{tm1a(EUCOMM)Wtsi}/Brpf1⁺ (Not Specified)	decreased T cell number	J:165965
Brpf1^{tm1a(EUCOMM)Wtsi}/Brpf1⁺ (Not Specified)	increased monocyte cell number	J:165965
Brpf3^{tm1d(EUCOMM)Wtsi}/Brpf3^{tm1d(EUCOMM)Wtsi} (involves: C3H * C57BL/6J * C57BL/6N * FVB/N)	hematopoietic system phenotype	J:231042
Brwd1^em1(IMPC)Tcp/Brwd1^em1(IMPC)Tcp (C57BL/6NCrl-Brwd1^em1(IMPC)Tcp/Tcp)	abnormal spleen morphology	J:211773
Bscl2^tm1.1Lchan/Bscl2^tm1.1Lchan (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	enlarged spleen	J:183701
Bscl2^tm1.2Gliu/Bscl2^tm1.2Gliu (involves: 129 * 129S4/SvJaeSor * C57BL/6 * FVB/N)	enlarged spleen	J:173404
Bscl2^{tm1b(EUCOMM)Hmgu}/Bscl2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Bscl2^{tm1b(EUCOMM)Hmgu}/Ics)	decreased erythrocyte cell number	J:211773
	increased large unstained cell number	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Bsg^tm1.1Znc/Bsg^tm1.1Znc Tg(Lck-cre)19Hhan/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)	abnormal T cell activation	J:207886
	decreased double-positive T cell number	J:207886
	decreased single-positive T cell number	J:207886
	decreased thymocyte number	J:207886
	decreased thymus weight	J:207886
	increased T cell proliferation	J:207886
Bsg^tm1Tmu/Bsg^tm1Tmu (involves: 129S2/SvPas)	increased spleen weight	J:287636
	increased splenocyte number	J:287636
	increased T-helper 17 cell number	J:287636
Bsnd^tm1Suc/Bsnd^tm1Suc (involves: 129S4/SvJae * C57BL/6)	increased hematocrit	J:175265
Bsp/Bsp (C57BL/6By)	abnormal spleen morphology	J:6856
Bsp/Bsp⁺ (C57BL/6By)	abnormal spleen morphology	J:6856
Bst1^tm1Thir/Bst1^tm1Thir (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:111424
	decreased B-1 B cell number	J:111424
	decreased IgA level	J:111424
	decreased IgG3 level	J:111424
	decreased immature B cell number	J:111424
	increased B cell number	J:111424
Bst2^tm1.1Bsz/Bst2^tm1.1Bsz (involves: C57BL/6)	enlarged spleen	J:180252
Btbd2^em1(IMPC)Mbp/Btbd2^em1(IMPC)Mbp (C57BL/6N-Btbd2^em1(IMPC)Mbp/MbpMmucd)	increased mean corpuscular volume	J:211773
Btbd3^{tm1b(EUCOMM)Hmgu}/Btbd3^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Btbd3^{tm1b(EUCOMM)Hmgu}/Ccpcz)	increased CD8-positive, CD25-positive alpha-beta T cell number	J:211773
Btbd7^{em1(IMPC)Ccpcz}/Btbd7^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Btbd7^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Btbd16^{tm2b(EUCOMM)Hmgu}/Btbd16^{tm2b(EUCOMM)Hmgu} (C57BL/6N-Btbd16^{tm2b(EUCOMM)Hmgu}/Bay)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased spleen weight	J:211773
Btbd17^em1(IMPC)Mbp/Btbd17^em1(IMPC)Mbp (C57BL/6NCrl-Btbd17^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
Btbd18^{em1(IMPC)Ccpcz}/Btbd18^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Btbd18^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Btc^em1(IMPC)Mbp/Btc^em1(IMPC)Mbp (C57BL/6N-Btc^em1(IMPC)Mbp/MbpMmucd)	increased neutrophil cell number	J:211773
Btf3^em1(IMPC)Tcp/Btf3⁺ (C57BL/6NCrl-Btf3^em1(IMPC)Tcp/Tcp)	decreased hematocrit	J:211773
	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
	increased red blood cell distribution width	J:211773
Btg1^em1(IMPC)Mbp/Btg1^em1(IMPC)Mbp (C57BL/6NCrl-Btg1^em1(IMPC)Mbp/Mmucd)	decreased lymphocyte cell number	J:211773
	enlarged spleen	J:211773
	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
Btg2^{tm1b(KOMP)Mbp}/Btg2^{tm1b(KOMP)Mbp} (B6N(Cg)-Btg2^{tm1b(KOMP)Mbp}/2J)	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
Btk^m1Anu/Btk^m1Anu (involves: BXSB/MpJ * C57BL/6JAnu * SB/Le)	decreased B cell number	J:104190
Btk^m1Anu/Btk^m1Anu X/Yaa (involves: BXSB/MpJ * C57BL/6JAnu * SB/Le)	decreased B cell number	J:104190
Btk^m2Anu/Btk^m2Anu (C57BL/6NCrlAnu-Btk^m2Anu)	increased IgM level	J:104190
Btk^m2Anu/Btk^m2Anu (C57BL/6NCrlAnu-Btk^m2Anu)	increased immature B cell number	J:104190
Btk^{tm1a(EUCOMM)Hmgu}/Y (C57BL/6N-Btk^{tm1a(EUCOMM)Hmgu}/Ics)	increased CD4-positive, alpha-beta T cell number	J:165965
Btk^tm1Gsv/Y (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell differentiation	J:35769
	abnormal B cell physiology	J:94768
	absent B-1a cells	J:35769
	absent mature B cells	J:35769
	decreased B cell number	J:35769
	decreased IgG3 level	J:35769
	decreased IgM level	J:35769
	decreased immature B cell number	J:35769
	decreased immunoglobulin level	J:120989
Btk^tm1Gsv/Y Tg(CD19-BTKK430R)XK24Rwhe/? (involves: 129P2/OlaHsd C57BL/6 * FVB)	abnormal lymphocyte cell number	J:120989
	abnormal pre-B cell morphology	J:120989
	absent B-1a cells	J:120989
	decreased B cell apoptosis	J:120989
	decreased B cell number	J:120989
	decreased immunoglobulin level	J:120989
Btk^tm1Gsv/Btk⁺ (involves: 129P2/OlaHsd * C57BL/6)	absent B-1a cells	J:35769
	decreased B cell number	J:35769
	decreased mature B cell number	J:35769
Btk^tm1Wk/Btk^tm1Wk (involves: 129S4/SvJae * C57BL/6)	abnormal B cell activation	J:28968
	abnormal B cell differentiation	J:28968
	decreased B cell proliferation	J:82298
	decreased IgG3 level	J:28968, J:82298
	decreased IgM level	J:28968, J:82298
	decreased mature B cell number	J:28968, J:82298
	decreased spleen germinal center number	J:82298
	decreased spleen germinal center size	J:82298
	increased pro-B cell number	J:28968
Btk^tm1Wk/Btk^tm1Wk Cd40^tm1Geha/Cd40^tm1Geha (involves: 129S4/SvJae * C57BL/6)	absent spleen germinal center	J:82298
	decreased B cell number	J:82298
	decreased B cell proliferation	J:82298
	decreased IgA level	J:82298
	decreased IgG2a level	J:82298
	decreased IgG2b level	J:82298
	decreased IgG3 level	J:82298
	decreased IgM level	J:82298
	decreased mature B cell number	J:82298
Btk^tm1Wk/Btk^tm1Wk Tec^tm1Welm/Tec^tm1Welm (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell differentiation	J:66080
	abnormal platelet physiology	J:86448
	abnormal spleen marginal zone morphology	J:66080
	abnormal spleen morphology	J:66080
	abnormal spleen white pulp morphology	J:66080
	decreased B cell number	J:66080
	decreased B cell proliferation	J:66080
	decreased IgG2a level	J:66080
	decreased IgG3 level	J:66080
	decreased IgM level	J:66080
	decreased immunoglobulin level	J:66080
	decreased platelet aggregation	J:86448
	increased pre-B cell number	J:66080
Btk^tm1Wk/Btk^tm1Wk Tg(IGH-Btk)1Witt/0 (involves: 129S4/SvJae * 129X1/SvJ * BALB/c * C3H * C57BL/6)	decreased B cell proliferation	J:82430
Btk^vila/Btk^vila (C57BL/6JAnu-Btk^vila/AnuApb)	abnormal leukocyte morphology	J:104190
	decreased B cell number	J:104190
	decreased IgD level	J:104190
	increased IgE level	J:104190
	increased IgG level	J:104190
Btk^xid/Y (CBA/HN-Btk^xid)	decreased B cell number	J:81429
	decreased B cell proliferation	J:81429
	decreased splenocyte number	J:81429
Btk^xid/Y (involves: CBA/HN * DBA/2N)	decreased B cell number	J:81429
	decreased B cell proliferation	J:81429
	spleen hypoplasia	J:81429
Btk^xid/? (involves: BALB/c * CBA/N)	decreased B cell proliferation	J:108696
	decreased B-1 B cell number	J:108696
	decreased IgG3 level	J:108696
	decreased IgM level	J:108696
	decreased mature B cell number	J:108696
Btk^xid/Y Ikzf3^tm1Kge/Ikzf3^tm1Kge (involves: 129S4/SvJae * CBA/CaHN)	decreased follicular B cell number	J:69477
Btk^xid/? Ptpn6^me/Ptpn6^me (involves: C57BL/6J * CBA/N * NFS)	increased IgM level	J:30994
	increased splenocyte proliferation	J:30994
Btk^xid/? Tg(IGH-Btk)1Witt/0 (involves: BALB/c * C3H * C57BL/6 * CBA/N)	decreased B cell proliferation	J:108696
	decreased B-1 B cell number	J:108696
	decreased IgG3 level	J:108696
	decreased IgM level	J:108696
Btk^xid/? Tg(IGH-Btk)1Witt/Tg(IGH-Btk)1Witt (involves: BALB/c * C3H * C57BL/6 * CBA/N)	decreased B cell proliferation	J:108696
	decreased B-1 B cell number	J:108696
	decreased IgG3 level	J:108696
	decreased IgM level	J:108696
Btk^xid/Btk^xid (CBA/CaHN-Btk^xid/J)	abnormal macrophage physiology	J:92639
	abnormal neutrophil physiology	J:92639
	decreased follicular B cell number	J:69477
	decreased neutrophil cell number	J:92639
	impaired myelopoiesis	J:92639
	impaired neutrophil phagocytosis	J:92639
Btk^xid/Btk^xid (involves: CBA/HN * DBA/2N)	abnormal B cell physiology	J:81429
	abnormal B cell proliferation	J:81429
	decreased B cell number	J:81429
	spleen hypoplasia	J:81429
Btk^xid/Btk^xid (CBA/HN-Btk^xid)	abnormal bone marrow cell number	J:7981
	abnormal lymphopoiesis	J:7981
	abnormal pre-B cell morphology	J:7981
	decreased B cell number	J:81429
	decreased B cell proliferation	J:81429
	decreased splenocyte number	J:81429
Btk^xid/Btk^xid (B6.CBA-Btk^xid)	decreased transitional stage B cell number	J:145687
Btk^xid/Btk^xid Ikzf3^tm1Kge/Ikzf3^tm1Kge (involves: 129S4/SvJae * CBA/CaHN)	decreased follicular B cell number	J:69477
Btla^tm1Dgra/Btla^tm1Dgra (involves: C57BL/6)	abnormal T cell activation	J:147751
Btla^tm1Kay/Btla^tm1Kay (involves: 129S6/SvEvTac * C57BL/6J)	abnormal T cell activation	J:89864
Btla^tm1Kmm/Btla^tm1Kmm (involves: 129S/SvEv)	increased B cell proliferation	J:84084
	increased IgG1 level	J:84084
	increased IgG2a level	J:84084
	increased IgG2b level	J:84084
	increased T cell proliferation	J:84084
Btla^tm1Kmm/Btla^tm1Kmm (B6.129S-Btla^tm1Kmm)	abnormal T cell activation	J:119356
	decreased T cell proliferation	J:119356
	increased T cell proliferation	J:119356
Btla^tm1Kmm/Btla^tm1Kmm Pdcd1^tm1Hon/Pdcd1^tm1Hon (B6.129S-Pdcd1^tm1Hon Btla^tm1Kmm)	increased T cell proliferation	J:119356
Btla^tm1Kmm/Btla^tm1Kmm Tg(DO11.10)10Dlo/? (involves: 129S/SvEv * BALB/c * C3H * C57BL/6)	increased T cell proliferation	J:84084
Btn2a2^tm1.2Wrth/Btn2a2^tm1.2Wrth (C57BL/6-Btn2a2^tm1.2Wrth)	abnormal T-helper 1 physiology	J:232636
	abnormal T-helper 2 physiology	J:232636
	increased IgG1 level	J:232636
	increased IgG2c level	J:232636
	increased IgG level	J:232636
Btnl1^em1Ahay/Btnl1^em1Ahay (Not Specified)	abnormal CD8 positive, alpha-beta intraepithelial T cell morphology	J:236526
Btnl1^em1Ahay/Btnl1^em1Ahay (Not Specified)	decreased gamma-delta intraepithelial T cell number	J:236526
Btnl1^tm1(KOMP)Mbp/Btnl1^tm1(KOMP)Mbp (C57BL/6N-Btnl1^tm1(KOMP)Mbp)	abnormal CD8 positive, alpha-beta intraepithelial T cell morphology	J:236526
	decreased gamma-delta intraepithelial T cell number	J:236526
Btnl1^tm1(KOMP)Mbp/Btnl1^tm1(KOMP)Mbp Foxn1^nu/Foxn1^nu (involves: albino stock * C57BL/6N)	decreased gamma-delta intraepithelial T cell number	J:236526
Btnl1^tm1(KOMP)Mbp/Btnl1^tm1(KOMP)Mbp Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}/0 Tg(tetO-Btnl1)#Ahay/0 (involves: 129S4/SvJae C57BL/6 * C57BL/6N)	decreased gamma-delta intraepithelial T cell number	J:236526
Btnl1^tm1(KOMP)Mbp/Btnl1^tm1(KOMP)Mbp Tg(tetO-Btnl1)#Ahay/0 Tg(Vil-rtTA2M2)1Rsmi/0 (involves: C57BL/6N FVB/N)	decreased gamma-delta intraepithelial T cell number	J:236526
Btnl2^em1Wche/Btnl2^em1Wche (C57BL/6-Btnl2^em1Wche)	abnormal gamma-delta T cell morphology	J:321348
Btnl4^em1(IMPC)Tcp/Btnl4^em1(IMPC)Tcp (C57BL/6NCrl-Btnl4^em1(IMPC)Tcp/Tcp)	enlarged spleen	J:211773
Btnl6^em1.1Ahay/Btnl6^em1.1Ahay (Not Specified)	decreased CD4-positive, gamma-delta intraepithelial T cell number	J:291989
Btnl6^em1Ahay/Btnl6^em1Ahay Tg(Vil1-cre)20Syr/0 (involves: C57BL/6 * DBA/2)	decreased CD4-positive, gamma-delta intraepithelial T cell number	J:291989
Btrc^{tm1b(KOMP)Wtsi}/Btrc^{tm1b(KOMP)Wtsi} (C57BL/6N-Btrc^{tm1b(KOMP)Wtsi}/H)	increased mean corpuscular volume	J:211773
	increased monocyte cell number	J:211773
Btrc^tm1Kin/Btrc^tm1Kin (involves: C57BL/6)	abnormal lymphocyte morphology	J:84639
Bub1^tm1.1Tvd/Bub1^tm1.1Tvd (B6.129P2-Bub1^tm1.1Tvd)	anemia	J:143035
Bub1^tm1.1Tvd/Bub1^tm1.1Tvd (B6.129P2-Bub1^tm1.1Tvd)	increased leukocyte cell number	J:143035
Bub1b^{Gt(neo-btk)1Dai}/Bub1b⁺ (involves: 129S4/SvJae * C57BL/6)	abnormal definitive hematopoiesis	J:88223
	abnormal megakaryocyte differentiation	J:88223
	absent common myeloid progenitor cells	J:88223
	decreased erythrocyte cell number	J:88223
	enlarged spleen	J:88223
Bub1b^tm1.1Hsl/Bub1b⁺ (involves: 129 * C57BL/6)	enlarged spleen	J:201641
	increased B cell proliferation	J:201641
	increased spleen white pulp amount	J:201641
Bxs6^BXSB/MpJ/Bxs6^BXSB/MpJ X/Yaa (B10.BXSB-(D13Mit3-D13Mit78) Yaa)	enlarged spleen	J:145049
C1galt1^ptl1/C1galt1^ptl1 (C57BL/6-C1galt1^ptl1)	abnormal thrombopoiesis	J:115272
	increased mean platelet volume	J:115272
	thrombocytopenia	J:115272
C1galt1^ptl1/C1galt1^ptl1 Rag1^tm1Bal/Rag1^tm1Bal (involves: 129S4/SvJae * C57BL/6)	increased mean platelet volume	J:115272
	thrombocytopenia	J:115272
C1galt1^tm1.1Staka/C1galt1^tm1.2Staka Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * C57BL/6J * CBA * DBA/2)	abnormal megakaryocyte differentiation	J:202276
	abnormal platelet morphology	J:202276
	giant platelets	J:202276
	hematopoietic system phenotype	J:202276
	thrombocytopenia	J:202276
C1galt1^tm1Rpmc/C1galt1^tm1Rpmc (involves: 129S1/Sv * C57BL/6J)	anemia	J:96775
C1qbp^tm1.1Tuch/C1qbp^tm1.1Tuch (involves: C57BL/6)	anemia	J:196232
C1ql2^em1(IMPC)Mbp/C1ql2^em1(IMPC)Mbp (C57BL/6N-C1ql2^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
C1ql3^em1(IMPC)H/C1ql3^em1(IMPC)H (C57BL/6NTac-C1ql3^em1(IMPC)H/H)	decreased eosinophil cell number	J:211773
	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	decreased monocyte cell number	J:211773
	decreased neutrophil cell number	J:211773
C1ql4^tm1Lex/C1ql4^tm1Lex (B6.129S5-C1ql4^tm1Lex)	decreased leukocyte cell number	J:344722
	decreased lymphocyte cell number	J:344722
	increased hematocrit	J:344722
	increased hemoglobin content	J:344722
	reticulocytosis	J:344722
C1qtnf1^em1(IMPC)Mbp/C1qtnf1^em1(IMPC)Mbp (C57BL/6N-C1qtnf1^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
C1qtnf3^tm1Yiw/C1qtnf3^tm1Yiw (involves: C57BL/6NSlc)	increased IgG level	J:211893
C1qtnf4^em1Smoc/C1qtnf4^em1Smoc (C57BL/6J-C1qtnf4^em1Smoc/Smoc)	abnormal macrophage differentiation	J:302282
C1qtnf6^tm1Yiw/C1qtnf6^tm1Yiw (B6.129P2-C1qtnf6^tm1Yiw)	increased B cell number	J:227217
C1qtnf6^tm1Yiw/C1qtnf6^tm1Yiw (B6.129P2-C1qtnf6^tm1Yiw)	increased IgG level	J:227217
C1qtnf7^{tm1(KOMP)Vlcg}/C1qtnf7^{tm1(KOMP)Vlcg} (C57BL/6N-C1qtnf7^{tm1(KOMP)Vlcg})	increased macrophage cell number	J:244352
C2cd3^em1(IMPC)Tcp/C2cd3⁺ (C57BL/6N-C2cd3^em1(IMPC)Tcp/Tcp)	decreased lymphocyte cell number	J:211773
C2cd3^em1(IMPC)Tcp/C2cd3⁺ (C57BL/6N-C2cd3^em1(IMPC)Tcp/Tcp)	increased neutrophil cell number	J:211773
C2cd4a^em1(IMPC)H/C2cd4a^em1(IMPC)H (C57BL/6NTac-C2cd4a^em1(IMPC)H/H)	increased mean platelet volume	J:211773
C2cd4b^{em1(IMPC)Wtsi}/C2cd4b^{em1(IMPC)Wtsi} (C57BL/6N-C2cd4b^{em1(IMPC)Wtsi}/Wtsi)	decreased hemoglobin content	J:211773
	increased mean platelet volume	J:211773
	increased red blood cell distribution width	J:211773
C3^tm1Crr/C3^tm1Crr (involves: 129S4/SvJae * C57BL/6)	abnormal mast cell physiology	J:44240
	abnormal spleen germinal center morphology	J:64282
	decreased mast cell number	J:44240
	decreased neutrophil cell number	J:44240
	decreased osteoclast cell number	J:166640
	decreased spleen germinal center number	J:64282
	decreased spleen germinal center size	J:64282
C3^tm1Crr/C3^tm1Crr (B6.129S4-C3^tm1Crr)	abnormal neutrophil morphology	J:113463
C3^tm1Crr/C3^tm1Crr (B6.129S4-C3^tm1Crr)	decreased susceptibility to autoimmune hemolytic anemia	J:145432
C3^tm1Crr/C3^tm1Crr C4b^tm1Crr/C4b^tm1Crr Fas^lpr/Fas^lpr (involves: 129S4/SvJae * C57BL/6 * MRL)	enlarged spleen	J:127292
C3^tm1Crr/C3^tm1Crr Cd59a^tm1Bpm/Cd59a^tm1Bpm (B6.129-Cd59a^tm1Bpm C3^tm1Crr)	increased T cell proliferation	J:122201
C3^tm1Crr/C3^tm1Crr Del(2Cd59b-Cd59a)1Jha/Del(2Cd59b-Cd59a)1Jha (involves: 129/Sv * 129S4/SvJae * C57BL/6)	hematopoietic system phenotype	J:170754
C3^tm1Crr/C3^tm1Crr Tg(Ins2-TFRC/OVA)296Wehi/0 (involves: 129S4/SvJae * C57BL/6)	increased T cell proliferation	J:122114
C3^tm1Crr/C3^tm1Crr Zbtb20^{Tg(PDGFB-APPSwInd)20Lms}/? (involves: 129S4/SvJae * C57BL/6)	increased microglial cell activation	J:135902
C3^tm1Hrc/C3^tm1Hrc Cd55^tm1Song/Cd55^tm1Song Cr1l^tm1Hmo/Cr1l^tm1Hmo (involves: 129/Sv * 129S6/SvEvTac * 129X1/SvJ)	abnormal platelet physiology	J:138410
C3^tm1Hrc/C3^tm1Hrc Cd55^tm1Song/Cd55^tm1Song Cr1l^tm1Hmo/Cr1l^tm1Hmo Vsig4^tm1Gne/Vsig4^tm1Gne (involves: 129/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6N)	abnormal platelet physiology	J:138410
C3^tm1Hrc/C3^tm1Hrc Lama2^dy/Lama2^dy (either: (involves: 129S2/SvPas * 129P1/ReJ) or (involves: 129X1/SvJ * 129P1/ReJ))	decreased IgM level	J:102959
	increased IgG level	J:102959
	increased IgM level	J:102959
C3ar1^tm1Cge/C3ar1^tm1Cge (involves: 129S4/SvJae * C57BL/6)	decreased osteoclast cell number	J:166640
C3ar1^tm1Raw/C3ar1^tm1Raw (involves: 129X1/SvJ * C57BL/6)	hematopoietic system phenotype	J:68807
C3ar1^tm1Raw/C3ar1^tm1Raw (B6.129X1(B6)-C3ar1^tm1Raw)	abnormal eosinophil physiology	J:80071
	abnormal T-helper 2 cell differentiation	J:80071
	abnormal T-helper 2 physiology	J:80071
	decreased eosinophil cell number	J:80071
	decreased IgE level	J:80071
	decreased IgG1 level	J:80071
	decreased lymphocyte cell number	J:80071
	decreased neutrophil cell number	J:80071
	impaired neutrophil recruitment	J:80071
C4b^tm1Crr/C4b^tm1Crr (involves: 129S4/SvJae * C57BL/6)	abnormal spleen germinal center morphology	J:64282
	decreased spleen germinal center number	J:64282
	decreased spleen germinal center size	J:64282
C4b^tm1Crr/C4b^tm1Crr (involves: 129S4/SvJae * C57BL/6J)	increased macrophage cell number	J:111811
	increased neutrophil cell number	J:111811
	increased spleen germinal center number	J:111811
	increased spleen weight	J:111811
C4b^tm1Crr/C4b^tm1Crr Fas^lpr/Fas^lpr (involves: 129S4/SvJae * C57BL/6 * MRL)	enlarged spleen	J:127292
C5ar1^tm1Cge/C5ar1^tm1Cge (involves: 129S4/SvJae)	impaired neutrophil recruitment	J:69177
C5ar1^tm1Cge/C5ar1^tm1Cge (involves: 129S4/SvJae * C57BL/6)	decreased osteoclast cell number	J:166640
C5ar1^tm1Raw/C5ar1^tm1Raw (B6.Cg-C5ar1^tm1Raw)	increased spleen germinal center number	J:139786
C5ar1^tm1Song/C5ar1^tm1Song (involves: 129S6/SvEvTac * C57BL/6)	abnormal neutrophil physiology	J:184056
C5ar2^em1(IMPC)H/C5ar2^em1(IMPC)H (C57BL/6NTac-C5ar2^em1(IMPC)H/H)	decreased eosinophil cell number	J:211773
	increased neutrophil cell number	J:211773
C8a^{tm1b(EUCOMM)Hmgu}/C8a^{tm1b(EUCOMM)Hmgu} (C57BL/6N-C8a^{tm1b(EUCOMM)Hmgu}/Tcp)	increased lymphocyte cell number	J:211773
C8b⁰/C8b⁰ (Mae or MSM/Ms)	abnormal hematopoietic system physiology	J:11000
C8b^{tm1b(EUCOMM)Hmgu}/C8b^{tm1b(EUCOMM)Hmgu} (C57BL/6N-C8b^{tm1b(EUCOMM)Hmgu}/H)	decreased red blood cell distribution width	J:211773
C9orf72^em1Eggn/C9orf72^em1Eggn (involves: C57BL/6)	decreased hematocrit	J:240357
C9orf72^em1Eggn/C9orf72^em1Eggn (involves: C57BL/6)	enlarged spleen	J:240357
C9orf72^em5Lutzy/C9orf72^em5Lutzy (C57BL/6-C9orf72^em5Lutzy)	abnormal macrophage physiology	J:101977
	abnormal microglial cell physiology	J:101977
	enlarged spleen	J:101977
C9orf72^{tm1.1(KOMP)Mbp}/C9orf72^{tm1.1(KOMP)Mbp} (C57BL/6N-C9orf72^{tm1.1(KOMP)Mbp}/Ucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased spleen weight	J:211773
C9orf72^tm1.1Eggn/C9orf72⁺ (involves: C57BL/6 * C57BL/6N)	increased IgG level	J:240357
C9orf72^tm1.1Eggn/C9orf72⁺ (involves: C57BL/6 * C57BL/6N)	increased IgM level	J:240357
C9orf72^tm1.1Eggn/C9orf72^tm1.1Eggn (involves: C57BL/6 * C57BL/6N)	abnormal lymphocyte morphology	J:240357
	abnormal spleen morphology	J:240357
	decreased erythrocyte cell number	J:240357
	decreased hematocrit	J:240357
	decreased mean corpuscular volume	J:240357
	enlarged spleen	J:240357
	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:240357
	increased IgG level	J:240357
	increased IgM level	J:240357
	increased leukocyte cell number	J:240357
	increased neutrophil cell number	J:240357
	increased splenocyte number	J:240357
	microcytic anemia	J:240357
	thrombocytopenia	J:240357
C9orf72^tm1Eggn/C9orf72^tm1Eggn (involves: C57BL/6 * C57BL/6N)	abnormal lymphocyte morphology	J:240357
	decreased erythrocyte cell number	J:240357
	decreased hematocrit	J:240357
	decreased mean corpuscular volume	J:240357
	enlarged spleen	J:240357
	increased leukocyte cell number	J:240357
	increased neutrophil cell number	J:240357
	microcytic anemia	J:240357
	thrombocytopenia	J:240357
C9orf72^tm1Lagi/C9orf72^tm1Lagi (involves: C57BL/6 * C57BL/6N)	decreased hematocrit	J:232242
	decreased hemoglobin content	J:232242
	decreased lymphocyte cell number	J:232242
	enlarged spleen	J:232242
	increased neutrophil cell number	J:232242
Cab39l^{tm1b(EUCOMM)Wtsi}/Cab39l^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Cab39l^{tm1b(EUCOMM)Wtsi}/H)	decreased mean corpuscular volume	J:211773
Cabin1^{em1(IMPC)Ccpcz}/Cabin1⁺ (C57BL/6NCrl-Cabin1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Cabin1^tm1.1Che/Cabin1^tm1.1Che (involves: 129S4/SvJae * BALB/c)	increased IgE level	J:72760
	increased IgG1 level	J:72760
	increased IgG2b level	J:72760
Cabp1^{tm1b(EUCOMM)Wtsi}/Cabp1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Cabp1^{tm1b(EUCOMM)Wtsi}/H)	decreased lymphocyte cell number	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Cacna1a^tg-6J/Cacna1a^tg-6J (involves: BALB/cByJ * C57BL/6J)	abnormal spleen red pulp morphology	J:82238
	decreased bone marrow cell number	J:82238
	thymus atrophy	J:82238
Cacna1c^em1(IMPC)Mbp/Cacna1c⁺ (C57BL/6N-Cacna1c^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Cacna1i^{tm1b(KOMP)Wtsi}/Cacna1i^{tm1b(KOMP)Wtsi} (C57BL/6N-Cacna1i^{tm1b(KOMP)Wtsi}/Bay)	abnormal spleen morphology	J:211773
Cacna2d1^em1(IMPC)Mbp/Cacna2d1^em1(IMPC)Mbp (C57BL/6N-Cacna2d1^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	increased monocyte cell number	J:211773
	small spleen	J:211773
Cacna2d2^du-td/Cacna2d2^du-td (involves: DBA/2J)	abnormal thymus involution	J:12166
Cacna2d2^em1(IMPC)Mbp/Cacna2d2⁺ (C57BL/6N-Cacna2d2^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased spleen weight	J:211773
Cacna2d2^em1(IMPC)Mbp/Cacna2d2^em1(IMPC)Mbp (C57BL/6N-Cacna2d2^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	small spleen	J:211773
Cacna2d2^tm1Svi/Cacna2d2^tm1Svi (involves: 129S1/Sv * C57BL/6J)	thymus hypoplasia	J:92396
Cacnb2^tm1.1Mfre/Cacnb2^tm1.1Mfre Tg(CAG-Bgeo/GFP)21Lbe/? (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6N * FVB/N)	decreased hemangioblast number	J:126506
Cacnb3^tm1Acv/Cacnb3^tm1Acv (involves: 129S1/Sv * 129X1/SvJ)	abnormal CD4-positive, alpha-beta T cell physiology	J:115345
Cacnb4^lh/Cacnb4^lh (B6EiC3Sn a/A-Cacnb4^lh/J)	abnormal CD4-positive, alpha-beta T cell physiology	J:115345
	abnormal thymus involution	J:5281
	absent thymus corticomedullary boundary	J:5281
	decreased double-positive T cell number	J:115345
	decreased lymphocyte cell number	J:5281
	small spleen	J:5281
	small thymus	J:5281
Cacnb4^lh/Cacnb4^lh (BALB/cGn-Cacnb4^lh)	abnormal thymus involution	J:12166
Cacnb4^lh/Cacnb4^lh (involves: BALB/cGn)	increased IgG1 level	J:5883
Cactin^{em1(IMPC)Ccpcz}/Cactin⁺ (C57BL/6NCrl-Cactin^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Cacybp^{GT(OST39970)Lex}/Cacybp^{GT(OST39970)Lex} (involves: 129S5/SvEvBrd)	abnormal spleen white pulp morphology	J:110899
	abnormal T cell morphology	J:110899
	decreased thymocyte number	J:110899
	small thymus medulla	J:110899
	spleen hypoplasia	J:110899
	thymus hypoplasia	J:110899
Cacybp^{tm1b(EUCOMM)Wtsi}/Cacybp⁺ (C57BL/6N-Cacybp^{tm1b(EUCOMM)Wtsi}/Tcp)	increased neutrophil cell number	J:211773
Cadm1^{Gt(Ayu21-W34)Imeg}/Cadm1^{Gt(Ayu21-W34)Imeg} (involves: C57BL/6 * CBA/JNCrlj)	abnormal T cell differentiation	J:178612
	abnormal T cell receptor V(D)J recombination	J:178612
	decreased CD4-positive, alpha-beta T cell number	J:178612
	decreased CD8-positive, alpha-beta T cell number	J:178612
	decreased T cell proliferation	J:178612
	increased double-positive T cell number	J:178612
Cadps2^{em1(IMPC)Rbrc}/Cadps2^{em1(IMPC)Rbrc} (C57BL/6NJcl-Cadps2^{em1(IMPC)Rbrc}/Rbrc)	abnormal mean corpuscular hemoglobin	J:211773
Calb1^{em1(IMPC)Ccpcz}/Calb1^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Calb1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
	small spleen	J:211773
Calcr^tm1Dgal/Calcr⁺ Iapp^tm1Sgm/Iapp⁺ (involves: 129P2/OlaHsd)	increased osteoclast cell number	J:88964
Calcr^tm1Rda/Calcr^tm1Rda Tg(CMV-cre)1Cgn/0 (B6.Cg-Calcr^tm1Rda Tg(CMV-cre)1Cgn)	abnormal osteoclast physiology	J:150982
Calcrl^tm1Kmca/Calcrl^tm1Kmca (involves: 129S6/SvEvTac)	decreased uterine NK cell number	J:201446
Camk1d^em1(IMPC)Mbp/Camk1d^em1(IMPC)Mbp (C57BL/6NCrl-Camk1d^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Camk2g^tm1.1Irt/Camk2g^tm1.1Irt (involves: C57BL/6 * C57BL/6J)	decreased macrophage apoptosis	J:154647
Camk4^{em1(IMPC)Ccpcz}/Camk4^{em1(IMPC)Ccpcz} (C57BL/6N-Camk4^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
	small spleen	J:211773
Camk4^tm1Tch/Camk4^tm1Tch (B6.129X1-Camk4^tm1Tch)	abnormal osteoclast differentiation	J:129599
Camk4^tm1Tch/Camk4^tm1Tch (B6.129X1-Camk4^tm1Tch)	decreased osteoclast cell number	J:129599
Camkmt^{tm1b(EUCOMM)Wtsi}/Camkmt^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Camkmt^{tm1b(EUCOMM)Wtsi}/Wtsi)	increased mean platelet volume	J:211773
Caml^tm1Rjb/Caml^tm2Rjb Tg(Lck-cre)1Cwi/0 (involves: 129 * C57BL/6 * DBA/2)	decreased single-positive T cell number	J:100536
	decreased thymocyte number	J:100536
	increased T cell apoptosis	J:100536
Caml^tm1Rjb/Caml^tm2Rjb Tg(Lck-cre)1Cwi/0 Tg(TcraTcrb)1100Mjb/0 (involves: 129 * C57BL/6 * DBA/2)	abnormal negative T cell selection	J:100536
	abnormal positive T cell selection	J:100536
	decreased thymocyte number	J:100536
Camp^tm1.1Jimw/Camp^tm1.1Jimw (involves: C57BL/6)	decreased dendritic cell number	J:199611
Camp^tm1Rlg/Camp^tm1Rlg (involves: 129X1/SvJ * C57BL/6)	increased neutrophil cell number	J:199719
Camsap3^{tm1a(EUCOMM)Wtsi}/Camsap3⁺ (C57BL/6N-Camsap3^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased hemoglobin content	J:211773
Camsap3^{tm1a(EUCOMM)Wtsi}/Camsap3^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Camsap3^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased gamma-delta T cell number	J:211773
	increased leukocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Cand1^em1(IMPC)Mbp/Cand1⁺ (C57BL/6NCrl-Cand1^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Cand2^{tm1a(EUCOMM)Wtsi}/Cand2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Cand2^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased red blood cell distribution width	J:211773
Canx^{em1(IMPC)Ccpcz}/Canx⁺ (C57BL/6NCrl-Canx^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Canx^{em1(IMPC)Ccpcz}/Canx^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Canx^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Cap2^{tm1b(EUCOMM)Wtsi}/Cap2⁺ (C57BL/6N-Cap2^{tm1b(EUCOMM)Wtsi}/Ieg)	decreased mean corpuscular hemoglobin	J:211773
	increased red blood cell distribution width	J:211773
Capg^tm1Djk/Capg^tm1Djk (involves: 129S4/SvJae)	abnormal macrophage physiology	J:86517
Capg^tm1Djk/Capg^tm1Djk (involves: 129S4/SvJae)	impaired macrophage phagocytosis	J:86517
Capg^tm1Djk/Capg^tm1Djk (involves: 129S4/SvJae * BALB/c * C57BL/6)	impaired macrophage phagocytosis	J:86277
	impaired neutrophil chemotaxis	J:86277
Capg^tm1Djk/Capg^tm1Djk Gsn^tm1Djk/Gsn^tm1Djk (involves: 129S4/SvJae)	abnormal macrophage physiology	J:86517
	impaired macrophage phagocytosis	J:86517
Capn1^tm1.1Arte/Capn1^tm1.1Arte Tg(Pf4-icre)Q3Rsko/0 (involves: C57BL/6)	abnormal platelet physiology	J:189100
Capn1^tm1Ahc/Capn1^tm1Ahc (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal platelet dense granule physiology	J:67798
	abnormal platelet physiology	J:67798
	decreased platelet aggregation	J:67798
	hematopoietic system phenotype	J:67798
Capn1^tm1Dgen/Capn1^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6)	abnormal leukocyte adhesion	J:183585
Capns1^tm1Pag/Capns1^tm1Pag (involves: 129S1/Sv * 129X1/SvJ * CD-1)	increased nucleated erythrocyte cell number	J:74966
Capop^NOD/Capop^NOD (involves: C57BL/6 * NOD)	decreased T cell apoptosis	J:68151
Capza1^em1(IMPC)Tcp/Capza1^em1(IMPC)Tcp (C57BL/6NCrl-Capza1^em1(IMPC)Tcp/Tcp)	decreased hematocrit	J:211773
	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	decreased mean corpuscular volume	J:211773
	increased mean platelet volume	J:211773
	increased monocyte cell number	J:211773
	thrombocytopenia	J:211773
Capza2^{tm1b(KOMP)Wtsi}/Capza2⁺ (C57BL/6N-Capza2^{tm1b(KOMP)Wtsi}/Wtsi)	increased mean platelet volume	J:211773
Car6^{em1(IMPC)Ccpcz}/Car6^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Car6^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	decreased NK cell number	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
	increased eosinophil cell number	J:211773
Car9^tm1Lex/Car9^tm1Lex (B6;129S5-Car9^tm1Lex/Mmucd)	increased mature B cell number	J:171883
Card9^tm1Tks/Card9^tm1Tks (B6.129-Card9^tm1Tks)	abnormal macrophage physiology	J:141143, J:122394
Card9^tm1Xlin/Card9^tm1Xlin (involves: 129/Sv * C57BL/6)	abnormal macrophage physiology	J:117799
Card11^{em1(IMPC)Ccpcz}/Card11^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Card11^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	decreased effector memory CD8-positive, alpha-beta T cell number	J:211773
	decreased effector memory T-helper cell number	J:211773
	decreased spleen weight	J:211773
	enlarged thymus	J:211773
	increased CD4-positive, alpha-beta T cell number	J:211773
	increased CD8-positive, alpha-beta T cell number	J:211773
	increased CD8-positive, naive alpha-beta T cell number	J:211773
	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
	increased T cell number	J:211773
	increased T-helper cell number	J:211773
	small spleen	J:211773
Card11^em1Welu/Card11⁺ (involves: C57BL/6)	decreased marginal zone B cell number	J:292926
	decreased transitional stage T1 B cell number	J:292926
	decreased transitional stage T3 B cell number	J:292926
	increased transitional stage T2 B cell number	J:292926
Card11^em1Welu/Card11^em1Welu (involves: C57BL/6)	abnormal B cell differentiation	J:292926
	abnormal germinal center B cell morphology	J:292926
	abnormal plasma cell differentiation	J:292926
	decreased B cell proliferation	J:292926
	decreased B-1 B cell number	J:292926
	decreased B-1a cell number	J:292926
	decreased germinal center B cell number	J:292926
	decreased IgG level	J:292926
	decreased IgM level	J:292926
	decreased marginal zone B cell number	J:292926
	decreased pre-B cell number	J:292926
	decreased transitional stage T1 B cell number	J:292926
	decreased transitional stage T3 B cell number	J:292926
	increased follicular B cell number	J:292926
	increased transitional stage T2 B cell number	J:292926
Card11^em2Welu/Card11⁺ (involves: C57BL/6)	increased B-1 B cell number	J:292926
Card11^em2Welu/Card11⁺ (involves: C57BL/6)	increased marginal zone B cell number	J:292926
Card11^em2Welu/Card11^em2Welu (involves: C57BL/6)	abnormal plasma cell differentiation	J:292926
	decreased mature B cell number	J:292926
	enlarged spleen	J:292926
	increased B cell proliferation	J:292926
	increased B-1a cell number	J:292926
	increased B-1b cell number	J:292926
	increased germinal center B cell number	J:292926
	increased marginal zone B cell number	J:292926
	increased pre-B cell number	J:292926
	increased transitional stage T2 B cell number	J:292926
Card11^em3Welu/Card11^em3Welu (Not Specified)	decreased B-1 B cell number	J:292926
Card11^em3Welu/Card11^em3Welu (Not Specified)	decreased marginal zone B cell number	J:292926
Card11^m1Btlr/Card11^m1Btlr (C57BL/6J-Card11^m1Btlr)	abnormal CD4-positive, CD25-positive, alpha-beta regulatory T cell morphology	J:149767
	abnormal cytotoxic T cell physiology	J:139069
	abnormal double-negative T cell morphology	J:149767, J:139069
	abnormal NK cell physiology	J:139069
	abnormal T cell activation	J:139069
	decreased B cell proliferation	J:149767, J:139069
	decreased B-1 B cell number	J:149767, J:139069
	decreased gamma-delta T cell number	J:149767, J:139069
	decreased IgG1 level	J:149767, J:139069
	decreased IgG2a level	J:149767, J:139069
	decreased IgG2b level	J:149767, J:139069
	decreased IgG2c level	J:149767
	decreased IgG3 level	J:149767, J:139069
	decreased IgM level	J:149767, J:139069
	decreased immunoglobulin level	J:139069
	decreased mature B cell number	J:149767, J:139069
	decreased memory T cell number	J:149767, J:139069
	decreased NK cell number	J:149767, J:139069
	decreased NK T cell number	J:149767, J:139069
	decreased regulatory T cell number	J:149767
	decreased T cell proliferation	J:149767, J:139069
Card11^M2Btlr/Card11^M2Btlr (involves: C57BL/6J)	decreased IgM level	J:198555
Card11^m3Btlr/Card11^m3Btlr (C57BL/6J-Card11^m3Btlr)	increased B-1a cell number	J:221487
Card11^M4Btlr/Card11⁺ (C57BL/6J-Card11^M4Btlr)	decreased B-1a cell number	J:254856
Card11^M4Btlr/Card11⁺ (C57BL/6J-Card11^M4Btlr)	increased B-1b cell number	J:254856
Card11^M4Btlr/Card11^M4Btlr (C57BL/6J-Card11^M4Btlr)	decreased B-1a cell number	J:254856
	decreased IgM level	J:254856
	increased B-1b cell number	J:254856
Card11^M5Btlr/Card11⁺ (C57BL/6J-Card11^M5Btlr)	decreased IgM level	J:254879
	increased B-1 B cell number	J:254879
	increased B-1a cell number	J:254879
Card11^M5Btlr/Card11^M5Btlr (C57BL/6J-Card11^M5Btlr)	decreased IgM level	J:254879
	increased B-1 B cell number	J:254879
	increased B-1a cell number	J:254879
Card11^M6Btlr/Card11^M6Btlr (C57BL/6J-Card11^M6Btlr)	increased alpha-beta T cell number	J:272116
Card11^M7Btlr/Card11^M7Btlr (C57BL/6J-Card11^M7Btlr)	abnormal T cell differentiation	J:274762
	decreased B cell number	J:274762
	decreased B-1 B cell number	J:274762
	decreased central memory CD4-positive, alpha-beta T cell number	J:274762
	decreased effector memory CD4-positive, alpha-beta T cell number	J:274762
	decreased effector memory CD8-positive, alpha-beta T cell number	J:274762
	increased CD4-positive, alpha-beta T cell number	J:274762
	increased CD8-positive, alpha-beta T cell number	J:274762
	increased T cell number	J:274762
Card11^m8Btlr/Card11^m8Btlr (C57BL/6J-Card11^m8Btlr)	abnormal B cell differentiation	J:274940
	decreased B cell number	J:274940
	decreased B-1a cell number	J:274940
	decreased effector memory CD8-positive, alpha-beta T cell number	J:274940
	decreased IgG level	J:274940
	decreased IgM level	J:274940
	increased B-1b cell number	J:274940
	increased CD4-positive, alpha-beta T cell number	J:274940
	increased CD8-positive, alpha-beta T cell number	J:274940
	increased NK T cell number	J:274940
	increased T cell number	J:274940
Card11^tm1.1Litt/Card11^tm1.1Litt Gt(ROSA)26Sor^{tm1(cre/ERT2)Thl}/Gt(ROSA)26Sor⁺ Tg(TcraTcrb)425Cbn/? (involves: 129/Sv * 129P2/OlaHsd * BALB/c * C57BL/6)	abnormal T cell activation	J:180410
Card11^tm1.1Litt/Card11^tm1.1Litt Tnfrsf4^tm2(cre)Nik/Tnfrsf4⁺ (involves: 129P2/OlaHsd * 129X1/SvJ)	abnormal T cell activation	J:180410
Card11^tm1Litt/Card11^tm1Litt (involves: 129P2/OlaHsd)	abnormal B cell proliferation	J:89322
	abnormal double-negative T cell morphology	J:89322
	abnormal T cell activation	J:89322
	abnormal T cell differentiation	J:89322
	abnormal T cell proliferation	J:89322
	absent B-1a cells	J:89322
	decreased IgA level	J:89322
	decreased IgG1 level	J:89322
	decreased IgG2b level	J:89322
	decreased IgG3 level	J:89322
	decreased IgM level	J:89322
	decreased immunoglobulin level	J:89322
Card11^tm1Pngr/Card11^tm1Pngr (involves: 129P2/OlaHsd)	abnormal B cell differentiation	J:84036
	abnormal B cell physiology	J:84036
	abnormal lymphocyte morphology	J:84036
	abnormal T cell activation	J:84036
	absent B-1a cells	J:84036
	decreased B cell proliferation	J:84036
	decreased IgA level	J:84036
	decreased IgE level	J:84036
	decreased IgG1 level	J:84036
	decreased IgG2a level	J:84036
	decreased IgG2b level	J:84036
	decreased IgG3 level	J:84036
	decreased IgG level	J:84036
	decreased IgM level	J:84036
	decreased immunoglobulin level	J:84036
	decreased NK cell number	J:84036
Card11^tm1Vmd/Card11⁺ (involves: 129S6/SvEvTac * C57BL/6N)	decreased B cell proliferation	J:95800
Card11^tm1Vmd/Card11^tm1Vmd (involves: 129S6/SvEvTac * C57BL/6N)	abnormal B cell physiology	J:95800
	absent immature B cells	J:95800
	decreased B cell proliferation	J:95800
	decreased IgA level	J:95800
	decreased IgG1 level	J:95800
	decreased IgG2a level	J:95800
	decreased IgG2b level	J:95800
	decreased IgG3 level	J:95800
	decreased IgG level	J:95800
	decreased IgM level	J:95800
	decreased T cell proliferation	J:95800
Card11^tm1Xav/Card11^tm1Xav (involves: 129 * C57BL/6)	abnormal T cell activation	J:132226
	abnormal T-helper 2 cell differentiation	J:132226
	decreased IgE level	J:132226
	increased CD4-positive, alpha-beta T cell number	J:132226
	increased CD8-positive, alpha-beta T cell number	J:132226
Card11^unm/Card11^unm (C57BL/6JSfdAnu-Card11^unm/Anu)	abnormal B cell differentiation	J:84042
	abnormal T cell activation	J:84042
	decreased B-1 B cell number	J:84042
	decreased IgG3 level	J:84042
	decreased IgM level	J:84042
	decreased immunoglobulin level	J:84042
	increased IgE level	J:84042
	increased immunoglobulin level	J:84042
	spleen hyperplasia	J:84042
Card14^em2Tshu/Card14⁺ (involves: C57BL/6)	abnormal gamma-delta T cell number	J:289239
Card14^em2Tshu/Card14⁺ (involves: C57BL/6)	increased alpha-beta T cell number	J:289239
Card19^tm1Rwen/Card19^tm1Rwen Tg(IghelMD4)4Ccg/0 (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell activation	J:336763
Card19^tm1Rwen/Card19^tm1Rwen Tg(IghelMD4)4Ccg/0 Tg(ML5sHEL)5Ccg/0 (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6JSfd)	decreased B cell number	J:336763
	decreased B cell proliferation	J:336763
	increased B cell apoptosis	J:336763
	increased B cell number	J:336763
Carm1^{tm1b(EUCOMM)Hmgu}/Carm1⁺ (C57BL/6N-Carm1^{tm1b(EUCOMM)Hmgu}/Nju)	decreased lymphocyte cell number	J:211773
Carm1^tm1Mtb/Carm1^tm1Mtb (involves: 129S6/SvEvTac)	arrested T cell differentiation	J:159958
Carm1^tm2.1Mtb/Carm1^tm2.1Mtb (involves: 129S4/SvJaeSor * 129S6/SvEvTac * Black Swiss)	arrested T cell differentiation	J:159958
	thymus hypoplasia	J:159958
Carmil2^bas/Carmil2^bas (involves: C3HeB/FeJ * C57BL/6)	decreased regulatory T cell number	J:205441
	decreased T cell proliferation	J:205441
	enlarged thymus	J:205441
Carmil2^bas/Carmil2^{tm1a(KOMP)Mbp} (involves: C3HeB/FeJ * C57BL/6 * C57BL/6N)	decreased regulatory T cell number	J:205441
	decreased T cell proliferation	J:205441
Cartpt^tm1Hmh/Cartpt^tm1Hmh (Not Specified)	abnormal osteoclast morphology	J:97566
Cartpt^tm1Hmh/Cartpt^tm1Hmh (Not Specified)	increased osteoclast cell number	J:97566
Casp1^tm1Flv/Casp1^tm1Flv Casp4^del/Casp4^del (involves: 129S2/SvPas * C57BL/6)	decreased thymocyte apoptosis	J:24258
	impaired neutrophil chemotaxis	J:124226
Casp1^tm1Sesh/Casp1⁺ Casp4^del/Casp4⁺ (involves: 129S1/SvImJ * 129S2/SvPas * NOD)	abnormal macrophage physiology	J:99748
Casp1^tm1Sesh/Casp1^tm1Sesh Casp4^del/Casp4^del (involves: 129S2/SvPas * C57BL/6)	abnormal macrophage physiology	J:22964
	abnormal neutrophil physiology	J:80568
	decreased T cell apoptosis	J:40691
	hematopoietic system phenotype	J:22964
Casp1^tm1Sesh/Casp1^tm1Sesh Casp4^del/Casp4^del (C3.129S2-Casp1^tm1Sesh Casp4^del)	abnormal macrophage physiology	J:136368
Casp1^tm1Sesh/Casp1^tm1Sesh Casp4^del/Casp4^del (B6.129S2(NOD)-Casp1^tm1Sesh Casp4^del)	decreased macrophage apoptosis	J:193522
Casp1^tm1Sesh/Casp1^tm1Sesh Casp4^del/Casp4^del Slc11a1^s/Slc11a1^s (B6.129S2-Casp1^tm1Sesh Casp4^del)	abnormal macrophage physiology	J:112400
Casp1^tm1Sesh/Casp1^tm1Sesh Casp4^del/Casp4^del Tg(Casp4)#Gne/0 (involves: 129S2/SvPas * C57BL/6 * NOD/ShiLtJ)	decreased macrophage apoptosis	J:193522
Casp2^tm1Vaux/Casp2^tm1Vaux Casp9^tm1Flv/Casp9^tm1Flv (involves: 129S1/Sv * C57BL/6)	abnormal T cell physiology	J:91156
	hematopoietic system phenotype	J:91156
Casp2^tm1Yuan/Casp2^tm1Yuan (involves: 129S4/SvJae * C57BL/6J * DBA/2)	abnormal B cell apoptosis	J:47601
Casp3^tm1Flv/Casp3^tm1Flv (involves: 129S1/Sv * C57BL/6)	abnormal osteoclast physiology	J:94703
Casp3^tm1Flv/Casp3^tm1Flv (involves: 129S1/Sv * C57BL/6)	decreased thymocyte number	J:36821
Casp3^tm1Flv/Casp3^tm1Flv Casp7^tm1Flv/Casp7⁺ (B6.129S-Casp3^tm1Flv Casp7^tm1Flv)	decreased thymocyte apoptosis	J:105496
Casp3^tm1Flv/Casp3^tm1Flv Casp7^tm1Flv/Casp7^tm1Flv (B6.129S-Casp3^tm1Flv Casp7^tm1Flv)	decreased thymocyte apoptosis	J:105496
Casp3^tm1Flv/Casp3^tm1Flv Tg(Scgb1a1-rtTA,tetO-Ifng)14Eli/0 (involves: 129S1/Sv * C57BL/6 * CBA)	increased lymphocyte cell number	J:100854
	increased macrophage cell number	J:100854
	increased neutrophil cell number	J:100854
Casp3^tm1Mak/Casp3^tm1Mak Tg(TcrLCMV)327Sdz/0 (B6.Cg-Casp3^tm1Mak Tg(TcrLCMV)327Sdz)	abnormal CD8-positive, alpha beta T cell morphology	J:97650
Casp4^tm1.1Vmd/Casp4^tm1.1Vmd (involves: C57BL/6)	decreased macrophage apoptosis	J:193522
Casp8^em1Hbz/Casp8^em1Hbz (involves: C57BL/6)	decreased CD8-positive, alpha-beta T cell number	J:342732
	enlarged spleen	J:342732
	hematopoietic system phenotype	J:342732
Casp8^em1Hbz/Casp8^em1Hbz Mlkl^em1Hbz/Mlkl^em1Hbz (involves: C57BL/6)	decreased B cell number	J:342732
	decreased leukocyte cell number	J:342732
	decreased lymphocyte cell number	J:342732
	decreased mature B cell number	J:342732
	decreased T cell number	J:342732
	enlarged spleen	J:342732
	increased CD11b-high dendritic cell number	J:342732
	increased granulocyte number	J:342732
	increased macrophage cell number	J:342732
Casp8^em1Hbz/Casp8^em1Hbz Ripk1^em1Hbz/Ripk1^em1Hbz Ripk3^tm1Xidw/Ripk3^tm1Xidw (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased leukocyte cell number	J:342732
	decreased lymphocyte cell number	J:342732
	decreased mature B cell number	J:342732
	decreased T cell number	J:342732
Casp8^em1Hbz/Casp8^em1Hbz Ripk3^tm1Xidw/Ripk3^tm1Xidw (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased B cell number	J:342732
	decreased leukocyte cell number	J:342732
	decreased lymphocyte cell number	J:342732
	decreased mature B cell number	J:342732
	decreased T cell number	J:342732
	enlarged spleen	J:342732
	increased CD11b-high dendritic cell number	J:342732
	increased granulocyte number	J:342732
	increased macrophage cell number	J:342732
Casp8^kuche/Casp8^kuche (involves: C57BL/6JAnu * C57BL/10SnJ)	impaired hematopoiesis	J:104190
Casp8^m1Btlr/Casp8^m1Btlr (C57BL/6J-Casp8^m1Btlr)	decreased CD4-positive, alpha-beta T cell number	J:255007
	decreased CD8-positive, naive alpha-beta T cell number	J:255007
	decreased T cell number	J:255007
	increased CD8-positive, alpha-beta T cell number	J:255007
	increased effector memory CD4-positive, alpha-beta T cell number	J:255007
Casp8^M2Btlr/Casp8^M2Btlr (C57BL/6J-Casp8^M2Btlr)	increased effector memory CD8-positive, alpha-beta T cell number	J:272851
Casp8^tm1.1Raz/Casp8^tm1.1Raz Ripk3^tm1Vmd/Ripk3^tm1Vmd (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)	abnormal macrophage physiology	J:170815
	decreased macrophage apoptosis	J:170815
	decreased thymocyte apoptosis	J:170814
	enlarged spleen	J:170815, J:170814
	enlarged thymus	J:170814
	hematopoietic system phenotype	J:170815, J:170814
	increased B cell number	J:170815
	increased leukocyte cell number	J:170815
	increased spleen white pulp amount	J:170815
	increased T cell number	J:170815, J:170814
Casp8^tm1.1Vmd/Casp8^tm1.1Vmd Ripk3^tm2Vmd/Ripk3^tm2Vmd (involves: C57BL/6N)	enlarged spleen	J:209137
	increased T cell number	J:209137
Casp8^tm1.1Yuan/Casp8^tm1.1Yuan (involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6 * MF1)	abnormal hematopoietic system morphology/development	J:49459
Casp8^tm1Hed/Casp8^tm1Hed Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd)	abnormal immunoglobulin level	J:116713
	decreased B cell number	J:116713
	decreased B cell proliferation	J:116713
	decreased B-1 B cell number	J:116713
	decreased marginal zone B cell number	J:116713
	spleen hypoplasia	J:116713
Casp8^tm1Hed/Casp8^tm1Hed Tg(KRT14-cre)1Efu/0 (Not Specified)	abnormal T cell physiology	J:167299
	increased IgE level	J:167299
	increased IgG1 level	J:167299
	increased mast cell number	J:167299
Casp8^tm1Raz/Casp8^tm1Raz Tg(Lck-cre)548Jxm/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	abnormal CD8-positive, alpha-beta T cell physiology	J:82759
	abnormal lymphocyte morphology	J:107455
	abnormal T cell activation	J:107455
	abnormal T cell morphology	J:82759
	abnormal T cell physiology	J:107455
	abnormal T cell proliferation	J:107455
	abnormal T cell subpopulation ratio	J:107455, J:82759
	decreased CD4-positive, alpha-beta T cell number	J:82759
	decreased CD8-positive, alpha-beta T cell number	J:82759
	decreased leukocyte cell number	J:107455
	decreased T cell apoptosis	J:82759
	decreased T cell number	J:82759
	decreased T cell proliferation	J:82759
	enlarged spleen	J:107455
	increased B cell number	J:107455
	increased lymphocyte cell number	J:107455
	increased T cell number	J:107455
Casp8^tm1Syon/Casp8^tm1Syon (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal embryonic hematopoiesis	J:103506
Casp8^tm1Wll/Casp8^tm1.1Yuan Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129S1/Sv * 129X1/SvJ * MF1)	abnormal macrophage differentiation	J:92722
Casp8^tm1Wll/Casp8^tm1.1Yuan Tg(Mx1-cre)1Cgn/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * MF1)	abnormal myeloblast morphology/development	J:92722
Casp8^tm1Wll/Casp8^tm1.1Yuan Tg(Tie1-cre)9Ref/0 (involves: 129S1/Sv * 129X1/SvJ * MF1)	hematopoietic system phenotype	J:92722
Casp8^tm1Yuan/Casp8^tm1Yuan (involves: 129S1/Sv * 129X1/SvJ * MF1)	abnormal blood cell morphology/development	J:49459
	increased erythrocyte cell number	J:49459
Casp9^tm1Flv/Casp9^tm1Flv (involves: 129S1/Sv * C57BL/6)	abnormal thymocyte apoptosis	J:49088
	decreased T cell apoptosis	J:91156
	hematopoietic system phenotype	J:91156
Casp9^tm1Mak/Casp9^tm1Mak (either: (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * CD-1))	abnormal splenocyte apoptosis	J:49087
	abnormal thymocyte apoptosis	J:49087
Casp14^{em1(IMPC)Ccpcz}/Casp14^{em1(IMPC)Ccpcz} (C57BL/6N-Casp14^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Casr^tm1Ces/Casr⁺ (involves: 129X1/SvJ * Black Swiss)	hematopoietic system phenotype	J:29900
Casr^tm1Ces/Casr^tm1Ces (involves: 129X1/SvJ * Black Swiss)	increased hematocrit	J:29900
Catip^{tm1b(KOMP)Wtsi}/Catip^{tm1b(KOMP)Wtsi} (C57BL/6N-Catip^{tm1b(KOMP)Wtsi}/Wtsi)	increased mean platelet volume	J:211773
Cav1^em2(IMPC)Ics/Cav1^em2(IMPC)Ics (C57BL/6N-Cav1^em2(IMPC)Ics/Ics)	increased hemoglobin content	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
Cav1^tm1Mls/Cav1^tm1Mls (involves: 129/Sv * C57BL/6 * SJL)	abnormal macrophage physiology	J:115914
	abnormal neutrophil physiology	J:139304
	abnormal osteoclast morphology	J:141361
	impaired neutrophil recruitment	J:115914
Cavin3^{tm1.1(KOMP)Vlcg}/Cavin3^{tm1.1(KOMP)Vlcg} (C57BL/6N-Cavin3^{tm1.1(KOMP)Vlcg}/Ucd)	increased mean corpuscular hemoglobin	J:211773
	increased mean platelet volume	J:211773
	increased red blood cell distribution width	J:211773
Cbfa2t3^tm1.1Swh/Cbfa2t3^tm1.1Swh (involves: 129S6/SvEvTac * C57BL/6 * FVB/N)	abnormal common myeloid progenitor cell morphology	J:140967
	abnormal megakaryocyte progenitor cell morphology	J:140967
	abnormal myelopoiesis	J:140967
	abnormal stress erythropoiesis	J:140967
	anemia	J:140967
	decreased erythroid progenitor cell number	J:140967
	decreased immature B cell number	J:140967
	enlarged spleen	J:140967
	extramedullary hematopoiesis	J:140967
	increased number of Howell-Jolly bodies	J:140967
	reticulocytosis	J:140967
Cbfb^tm1Itan/Cbfb^tm1Itan Rr94^tm3.1Litt/Rr94^tm3.1Litt Tg(Cd4-cre)1Cwi/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * FVB/N)	abnormal double-positive T cell morphology	J:158962
	abnormal T cell subpopulation ratio	J:158962
	decreased CD4-positive, alpha-beta T cell number	J:158962
	decreased double-positive T cell number	J:158962
	increased CD8-positive, alpha-beta T cell number	J:158962
	increased double-positive T cell number	J:158962
Cbfb^tm1Itan/Cbfb^tm1Itan Tg(Cd4-cre)1Cwi/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	abnormal CD8-positive, alpha beta T cell morphology	J:158962, J:125953
	abnormal CD8-positive, alpha-beta T cell number	J:125953
	abnormal T cell differentiation	J:125953
	abnormal T-helper 1 cell differentiation	J:125953
	decreased CD8-positive, alpha-beta T cell number	J:158962
	increased double-positive T cell number	J:158962
	increased IgA level	J:125953
	increased IgE level	J:125953
	increased IgG1 level	J:125953
	increased immunoglobulin level	J:125953
Cbfb^tm1Itan/Cbfb^tm1Itan Tg(Lck-cre)1Cwi/0 (involves: 129P2/OlaHsd)	abnormal CD4-positive T cell differentiation	J:125953
	abnormal CD8-positive, alpha-beta T cell differentiation	J:125953
	abnormal double-positive T cell morphology	J:125953
	abnormal T-helper 1 cell differentiation	J:125953
	decreased thymocyte number	J:125953
Cbfb^tm1Itan/Cbfb^tm1Itan Zbtb7b^tm2Litt/Zbtb7b⁺ Tg(Lck-cre)1Cwi/0 (involves: 129P2/OlaHsd * C57BL/6)	abnormal T cell differentiation	J:141144
	decreased CD4-positive, alpha-beta T cell number	J:141144
Cbfb^tm1Itan/Cbfb^tm1Itan Zbtb7b^tm2Litt/Zbtb7b^tm1.2Litt Tg(Lck-cre)1Cwi/0 (involves: 129P2/OlaHsd * C57BL/6)	abnormal T cell differentiation	J:141144
	decreased CD4-positive, alpha-beta T cell number	J:141144
Cbfb^tm1Lhc/Cbfb⁺ Tg(EIIa-cre)C5379Lmgd/0 (involves: 129S6/SvEvTac * C57BL/6 * FVB/N)	impaired hematopoiesis	J:105040
Cbfb^tm1Lhc/Cbfb^tm1Lhc Tg(Mx1-cre)1Cgn/0 (involves: 129S6/SvEvTac * C57BL/6 * CBA)	abnormal megakaryocyte differentiation	J:105040
	abnormal myelopoiesis	J:105040
	abnormal spleen morphology	J:105040
	anemia	J:105040
	enlarged spleen	J:105040
	increased hematopoietic stem cell number	J:105040
	increased leukocyte cell number	J:105040
	thrombocytopenia	J:105040
Cbfb^tm1Ppl/Cbfb⁺ (either: (involves: 129/Sv * 129S6/SvEvTac) or (involves: 129S6/SvEvTac * Black Swiss) or (involves: 129S6/SvEvTac * C57BL/6))	extramedullary hematopoiesis	J:36594
	impaired hematopoiesis	J:36594
Cbfb^tm1Spe/Cbfb^tm1Spe (either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6))	abnormal myeloblast morphology/development	J:36593
	decreased erythroblast number	J:36593
	impaired hematopoiesis	J:36593
Cbfb^tm1Spe/Cbfb^tm1Spe Tg(Tek-GFP/Cbfb)1Spe/0 (either: (involves: 129S4/SvJae * BALB/c * CD-1) or (involves: 129S4/SvJae * C57BL/6 * CD-1))	abnormal common myeloid progenitor cell morphology	J:80670
	abnormal definitive hematopoiesis	J:80670
	abnormal erythropoiesis	J:80670
	abnormal myelopoiesis	J:80670
	abnormal splenic cell ratio	J:80670
	increased CD4-positive, alpha-beta T cell number	J:80670
	increased erythroid progenitor cell number	J:80670
	increased hematopoietic stem cell number	J:80670
	small thymus	J:80670
	spleen hypoplasia	J:80670
Cbfb^tm1Spe/Cbfb^tm1Spe Tg(Tek-GFP/Cbfb)2Spe/0 (either: (involves: 129S4/SvJae * BALB/c * CD-1 * Swiss Webster) or (involves: 129S4/SvJae * C57BL/6 * CD-1 * Swiss Webster))	abnormal common myeloid progenitor cell morphology	J:80670
	abnormal definitive hematopoiesis	J:80670
	abnormal erythropoiesis	J:80670
	abnormal myelopoiesis	J:80670
	abnormal splenic cell ratio	J:80670
	increased CD4-positive, alpha-beta T cell number	J:80670
	increased erythroid progenitor cell number	J:80670
	increased hematopoietic stem cell number	J:80670
	small thymus	J:80670
	spleen hypoplasia	J:80670
Cbfb^tm1Spe/Cbfb^tm2.1Spe (involves: 129S4/SvJae)	abnormal megakaryocyte morphology	J:124224
	abnormal splenic cell ratio	J:124224
	abnormal T cell differentiation	J:124224
	abnormal thymus cell ratio	J:124224
	abnormal thymus morphology	J:124224
	decreased double-positive T cell number	J:124224
	extramedullary hematopoiesis	J:124224
	increased CD4-positive, alpha-beta T cell number	J:124224
	thrombocytopenia	J:124224
	thymus hypoplasia	J:124224
Cbfb^tm1Tno/Cbfb^tm1Tno (involves: 129S4/SvJae * C57BL/6J)	abnormal definitive hematopoiesis	J:40963
Cbfb^tm1Tno/Cbfb^tm1Tno (involves: 129S4/SvJae * C57BL/6J)	abnormal embryonic hematopoiesis	J:40963
Cbfb^tm1Tok/Cbfb^tm1Tok (involves: 129P2/OlaHsd * C57BL/6J)	abnormal definitive hematopoiesis	J:36250
Cbfb^tm1Tok/Cbfb^tm1Tok Tg(Gata1-Cbfb)1Tok/0 (involves: 129P2/OlaHsd * C57BL/6J)	abnormal definitive hematopoiesis	J:80668
	absent T cells	J:80668
	decreased lymphocyte cell number	J:80668
	small spleen	J:80668
	small thymus	J:80668
Cbfb^tm2.1Spe/Cbfb^tm2.1Spe (involves: 129S4/SvJae)	abnormal splenic cell ratio	J:124224
	abnormal T cell differentiation	J:124224
	abnormal thymus cell ratio	J:124224
	abnormal thymus morphology	J:124224
	decreased double-positive T cell number	J:124224
	increased CD4-positive, alpha-beta T cell number	J:124224
	thymus hypoplasia	J:124224
Cbfb^tm3Ppl/Cbfb⁺ (involves: 129S6/SvEvTac * C57BL/6)	decreased hematopoietic stem cell number	J:160522
Cbfb^tm3Ppl/Cbfb⁺ (involves: 129S6/SvEvTac * C57BL/6)	hematopoietic system phenotype	J:160522
Cbfb^tm4Ppl/Cbfb⁺ (involves: 129S6/SvEvTac * C57BL/6)	abnormal bone marrow cell morphology/development	J:160522
Cbfb^tm4Ppl/Cbfb⁺ (involves: 129S6/SvEvTac * C57BL/6)	absent megakaryocytes	J:160522
Cbfb^tm5Ppl/Cbfb⁺ (Not Specified)	abnormal mononuclear cell differentiation	J:193140
Cbfb^tm5Ppl/Cbfb⁺ (Not Specified)	myeloid hyperplasia	J:193140
Cbfb^tm5Ppl/Cbfb^tm5Ppl (Not Specified)	impaired hematopoiesis	J:193140
Cbfb^tm6Ppl/Cbfb⁺ (involves: 129S/SvEv * C57BL/6)	decreased B cell number	J:252447
	hematopoietic system phenotype	J:252447
	increased myeloid cell number	J:252447
Cbfb^tm6Ppl/Cbfb^tm6Ppl (involves: 129S/SvEv * C57BL/6)	impaired hematopoiesis	J:252447
Cbl^tm1.1Hua/Cbl^tm1.1Hua Lat^tm1Les/Lat^tm1Les (involves: 129P2/OlaHsd)	abnormal thymus development	J:91369
	increased CD4-positive, alpha-beta T cell number	J:91369
	thymus hypoplasia	J:91369
Cbl^tm1.1Hua/Cbl^tm1.1Hua Lcp2^tm1Gak/Lcp2^tm1Gak (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)	abnormal T cell differentiation	J:91369
	enlarged spleen	J:91369
	increased CD4-positive, alpha-beta T cell number	J:91369
Cbl^tm1.1Hua/Cbl^tm1.1Hua Lcp2^tm1Gak/Lcp2^tm1Gak Rag2^tm1Fwa/Rag2^tm1Fwa (involves: 129P2/OlaHsd * 129S/SvEv * 129S1/Sv * 129X1/SvJ)	abnormal T cell differentiation	J:91369
Cbl^tm1Ddlb/Cbl^tm1Ddlb (involves: 129S1/Sv * C57BL/6J)	abnormal bone marrow cell morphology/development	J:76895
	abnormal spleen morphology	J:76895
	abnormal splenic cell ratio	J:76895
	abnormal thymus cell ratio	J:76895
	enlarged spleen	J:76895
	extramedullary hematopoiesis	J:76895
	thrombocytosis	J:76895
Cbl^tm1Ddlb/Cbl^tm1Ddlb (involves: 129S1/Sv)	abnormal myeloblast morphology/development	J:81965
	abnormal T cell physiology	J:81965
	enlarged spleen	J:81965
	increased spleen red pulp amount	J:81965
	spleen hyperplasia	J:81965
Cbl^tm1Ddlb/Cbl^tm1Ddlb (involves: 129S1/Sv * C57BL/6)	enlarged spleen	J:103366
	increased spleen red pulp amount	J:103366
	spleen hyperplasia	J:103366
Cbl^tm1Ddlb/Cbl^tm2Wlan (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal double-negative T cell morphology	J:103366
	abnormal spleen morphology	J:103366
	abnormal splenic cell ratio	J:103366
	abnormal T cell activation	J:103366
	abnormal T cell differentiation	J:103366
	abnormal T cell physiology	J:103366
	abnormal thymus morphology	J:103366
	abnormal thymus size	J:103366
	decreased single-positive T cell number	J:103366
	enlarged spleen	J:103366
	increased spleen red pulp amount	J:103366
	spleen hyperplasia	J:103366
	thymus hypoplasia	J:103366
Cbl^tm1Soga/Cbl^tm1Soga (Not Specified)	enlarged spleen	J:151543
Cbl^tm1Soga/Cbl^tm1Soga (Not Specified)	increased hematopoietic stem cell number	J:151543
Cbl^tm1Wlan/Cbl^tm1Wlan (involves: 129S1/Sv * C57BL/6)	abnormal myeloblast morphology/development	J:81965
	abnormal T cell physiology	J:81965
	enlarged spleen	J:81965
	increased spleen red pulp amount	J:81965
	myeloid hyperplasia	J:81965
	spleen hyperplasia	J:81965
Cbl^tm2Hua/Cbl^tm2Hua Cblb^tm1Hua/Cblb^tm1Hua Tg(Lck-cre)I57Jxm/0 (involves: 129P2/OlaHsd * C57BL/6 * ICR)	abnormal T cell morphology	J:80427
	enlarged spleen	J:80427
	extramedullary hematopoiesis	J:80427
	increased T cell proliferation	J:80427
Cbl^tm2Wlan/Cbl^tm2Wlan (involves: 129X1/SvJ * C57BL/6)	abnormal spleen morphology	J:103366
	abnormal thymus morphology	J:103366
	abnormal thymus size	J:103366
	enlarged spleen	J:103366
	increased spleen red pulp amount	J:103366
	spleen hyperplasia	J:103366
	thymus hypoplasia	J:103366
Cblb^tm1Hua/Cblb^tm1Hua (Not Specified)	increased T cell proliferation	J:89761
Cblb^tm1Hua/Cblb^tm1Hua (B6.129P2-Cblb^tm1Hua)	increased T cell proliferation	J:94685
Cblb^tm1Hua/Cblb^tm1Hua Ubash3b^tm1Jni/Ubash3b^tm1Jni Ubash3a^tm1Jni/Ubash3a^tm1Jni (Not Specified)	increased T cell proliferation	J:89761
Cblb^tm1Pngr/Cblb^tm1Pngr (involves: 129 * C57BL/6)	abnormal mast cell physiology	J:126361
Cblb^tm1Pngr/Cblb^tm1Pngr (B6.129P2-Cblb^tm1Pngr)	increased T cell proliferation	J:141390
Cblb^tm1Pngr/Cblb^tm1Pngr Itk^tm1Litt/Itk^tm1Litt (B6.129-Itk^tm1Litt Cblb^tm1Pngr)	abnormal T cell morphology	J:141390
	abnormal T-helper 2 cell differentiation	J:141390
	decreased T cell number	J:141390
Cblb^tm1Pngr/Cblb^tm1Pngr Vav1^tm1Tyb/Vav1^tm1Tyb Was^tm1Sbs/Was^tm1Sbs (involves: 129P2/OlaHsd * 129S2/SvPas * 129S6/SvEvTac)	abnormal T cell physiology	J:79550
Cblb^tm1Pngr/Cblb^tm1Pngr Was^tm1Sbs/Was^tm1Sbs (Not Specified)	abnormal T cell physiology	J:79550
Cblb^tm1Wlan/Cblb^tm1Wlan (involves: 129X1/SvJ * C57BL/6)	abnormal mast cell physiology	J:126361
Cblif^{tm1a(KOMP)Wtsi}/Cblif^{tm1a(KOMP)Wtsi} (C57BL/6N-Cblif^{tm1a(KOMP)Wtsi})	abnormal megakaryocyte morphology	J:236022
	decreased erythrocyte cell number	J:236022
	extramedullary hematopoiesis	J:236022
	increased CD4-positive, alpha-beta T cell number	J:236022
	increased mean corpuscular volume	J:236022
	increased T cell number	J:236022
Cbs^tm1Unc/Cbs^tm1Unc (involves: 129P2/OlaHsd * C57BL/6J)	extramedullary hematopoiesis	J:23321
Cbs^tm1Unc/Cbs^tm1Unc Tg(Mt1-CBSS466L)EB86Waku/0 (involves: 129P2/OlaHsd C3H * C57BL/6)	increased Ly6C high monocyte number	J:168131
	increased monocyte cell number	J:168131
Cbx2^tm1Cim/Cbx2^tm1Cim (involves: 129P2/OlaHsd * BALB/c)	arrested T cell differentiation	J:38487
Cbx2^tm1Cim/Cbx2^tm1Cim (involves: 129P2/OlaHsd * BALB/c)	decreased splenocyte proliferation	J:38487
Cbx4^tm1.1Gxu/Cbx4^tm1.1Gxu Tg(Lck-cre)#Zhu/0 (involves: 129S2/SvPas * C57BL/6 * SJL/J)	hematopoietic system phenotype	J:194053
Cbx4^tm1.1Gxu/Cbx4^tm1.2Gxu Tg(Foxn1-cre)1Tbo/0 (involves: 129S2/SvPas * C57BL/6J)	abnormal lymphopoiesis	J:194053
	abnormal thymus development	J:194053
	abnormal thymus physiology	J:194053
	decreased double-positive T cell number	J:194053
	decreased T cell number	J:194053
	thymus atrophy	J:194053
	thymus hypoplasia	J:194053
Cbx4^tm1.2Gxu/Cbx4^tm1.2Gxu (involves: 129S2/SvPas * C57BL/6J)	abnormal thymus development	J:194053
	abnormal thymus physiology	J:194053
	hematopoietic system phenotype	J:194053
	thymus hypoplasia	J:194053
Cbx5^tm1.1Ics/Cbx5^tm1.1Ics (involves: 129S2/SvPas * C57BL/6)	abnormal T-helper 2 physiology	J:186702
Cbx6^{tm1a(EUCOMM)Wtsi}/Cbx6^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Cbx6^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased mean platelet volume	J:211773
Cbx8^tm1.1Hko/Cbx8^tm1.1Hko (involves: 129 * C57BL/6)	hematopoietic system phenotype	J:178955
Cbx8^tm1Hko/Cbx8^tm1Hko Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ (involves: 129 * C57BL/6 * C57BL/6NTac)	hematopoietic system phenotype	J:178955
Cby1^tm1Ktkm/Cby1^tm1Ktkm (B6.129-Cby1^tm1Ktkm)	anemia	J:147413
Cby1^tm1Ktkm/Cby1^tm1Ktkm (B6.129-Cby1^tm1Ktkm)	decreased hematocrit	J:147413
Ccbe1^tm1Mlkn/Ccbe1^tm1Mlkn (either: B6.129-Ccbe1^tm1Mlkn or (involves: 129 * C57BL/6))	abnormal erythropoiesis	J:196696
	abnormal macrophage physiology	J:196696
	anemia	J:196696
	decreased fetal derived definitive erythrocyte cell number	J:196696
	decreased hematocrit	J:196696
	decreased macrophage cell number	J:196696
	increased nucleated erythrocyte cell number	J:196696
Ccbe1^tm2.1Mlkn/Ccbe1^tm2.1Mlkn Ndor1^{Tg(UBC-cre/ERT2)1Ejb}/0 (involves: 129 * C57BL/6)	hematopoietic system phenotype	J:196696
Ccdc25^em1(IMPC)Mbp/Ccdc25⁺ (C57BL/6N-Ccdc25^em1(IMPC)Mbp/MbpMmucd)	small spleen	J:211773
Ccdc39^b2b2025.1Clo/Ccdc39^b2b2025.1Clo (C57BL/6J-Ccdc39^b2b2025.1Clo)	absent spleen	J:175213
	spleen hypoplasia	J:175213
Ccdc40^em1(IMPC)J/Ccdc40^em1(IMPC)J (C57BL/6NJ-Ccdc40^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Ccdc50^{tm1b(EUCOMM)Hmgu}/Ccdc50^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Ccdc50^{tm1b(EUCOMM)Hmgu}/H)	increased mean corpuscular hemoglobin concentration	J:211773
Ccdc51^em1(IMPC)J/Ccdc51^em1(IMPC)J (C57BL/6NJ-Ccdc51^em1(IMPC)J/Mmjax)	increased mean corpuscular hemoglobin	J:211773
Ccdc57^{tm1a(EUCOMM)Wtsi}/Ccdc57⁺ (B6JTyr;B6N-Ccdc57^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased mean corpuscular hemoglobin	J:175295
Ccdc59^em1(IMPC)J/Ccdc59⁺ (C57BL/6NJ-Ccdc59^em1(IMPC)J/J)	decreased mean corpuscular volume	J:211773
Ccdc86^tm1Hfuj/Ccdc86⁺ (involves: C57BL/6NTac)	abnormal T cell morphology	J:151722
Ccdc86^tm1Hfuj/Ccdc86⁺ (involves: C57BL/6NTac)	decreased T cell apoptosis	J:151722
Ccdc88b^em1(IMPC)Tcp/Ccdc88b^em1(IMPC)Tcp (C57BL/6NCrl-Ccdc88b^em1(IMPC)Tcp/Tcp)	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
Ccdc88b^m1Pgrs/Ccdc88b^m1Pgrs (involves: C57BL/6J * C57BL/10J)	decreased CD8-positive, alpha-beta T cell number	J:230618
	decreased T cell proliferation	J:230618
	increased myeloid cell number	J:230618
Ccdc92^{tm1a(KOMP)Mbp}/Ccdc92^{tm1a(KOMP)Mbp} (C57BL/6N-Ccdc92^{tm1a(KOMP)Mbp})	decreased macrophage cell number	J:332421
Ccdc110^{em1(IMPC)Ccpcz}/Ccdc110^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Ccdc110^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Ccdc122^{tm1a(KOMP)Wtsi}/Ccdc122^{tm1a(KOMP)Wtsi} (C57BL/6N-Ccdc122^{tm1a(KOMP)Wtsi}/Wtsi)	increased red blood cell distribution width	J:211773
Ccdc124^{tm1b(KOMP)Wtsi}/Ccdc124^{tm1b(KOMP)Wtsi} (C57BL/6N-Ccdc124^{tm1b(KOMP)Wtsi}/Nju)	small spleen	J:211773
Ccdc127^{tm1b(EUCOMM)Wtsi}/Ccdc127^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Ccdc127^{tm1b(EUCOMM)Wtsi}/Wtsi)	increased leukocyte cell number	J:211773
Ccdc134^tm1.2Jhua/Ccdc134^tm1.2Jhua (involves: C57BL/6NTac)	anemia	J:256995
Ccdc154^ntl/Ccdc154^ntl (involves: 129S7/SvEvBrd * C57BL/6J)	enlarged spleen	J:226596
Ccdc166^em1(IMPC)J/Ccdc166^em1(IMPC)J (C57BL/6NJ-Ccdc166^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Ccdc171^m1Anu/Ccdc171⁺ (C57BL/NCrlAnu-Ccdc171^m1Anu/Anu)	decreased IgD level	J:104190
	decreased mature B cell number	J:104190
	increased IgM level	J:104190
Ccdc171^m1Anu/Ccdc171^m1Anu (C57BL/NCrlAnu-Ccdc171^m1Anu/Anu)	decreased IgD level	J:104190
	decreased mature B cell number	J:104190
	increased IgM level	J:104190
Ccdc183^{em1(IMPC)Hmgu}/Ccdc183^{em1(IMPC)Hmgu} (C57BL/6NCrl-Ccdc183^{em1(IMPC)Hmgu}/Ieg)	increased hemoglobin content	J:211773
Ccdc198^{em1(IMPC)Ccpcz}/Ccdc198^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Ccdc198^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Ccl1^tm1Sman/Ccl1^tm1Sman (B6.129-Ccl1^tm1Sman)	abnormal regulatory T cell physiology	J:138942
Ccl2^tm1.1Pame/Ccl2^tm1.1Pame Tg(Nes-cre)1Kln/0 (involves: C57BL/6 * SJL)	abnormal leukocyte migration	J:171379
Ccl2^tm1.1Pame/Ccl2^tm1.1Pame Tg(Tek-cre)12Flv/0 (involves: C3H * C57BL/6)	abnormal leukocyte migration	J:171379
Ccl2^tm1.1Tyos/Ccl2^tm1.1Tyos (involves: 129S1/Sv * C57BL/6)	abnormal neutrophil physiology	J:151874
	impaired macrophage chemotaxis	J:151874
Ccl2^tm1.1Tyos/Ccl2^tm1.1Tyos (involves: 129S1/Sv)	abnormal dendritic cell chemotaxis	J:199611
Ccl2^tm1.1Tyos/Ccl2^tm1.1Tyos (involves: 129S1/Sv)	decreased dendritic cell number	J:199611
Ccl2^tm1Lex/Ccl2^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	impaired macrophage chemotaxis	J:191510
Ccl2^tm1Rol/Ccl2⁺ Mpz^tm1Msch/Mpz⁺ (involves: 129S4/SvJae * 129S7/SvEvBrd)	abnormal macrophage derived foam cell morphology	J:133028
	decreased macrophage cell number	J:133028
Ccl2^tm1Rol/Ccl2⁺ Tg(PMP22)C61Clh/0 (involves: 129S4/SvJae * C57BL/6J * CBA/Ca)	increased macrophage cell number	J:158350
Ccl2^tm1Rol/Ccl2^tm1Rol (involves: 129S4/SvJae * 129X1/SvJ * C57BL/6)	abnormal monocyte morphology	J:45920
	impaired macrophage chemotaxis	J:45920
Ccl2^tm1Rol/Ccl2^tm1Rol (involves: 129S4/SvJae * C57BL/6)	abnormal macrophage chemotaxis	J:116878
	abnormal T cell physiology	J:116878
	impaired macrophage chemotaxis	J:108533
Ccl2^tm1Rol/Ccl2^tm1Rol (involves: 129S4/SvJae)	abnormal macrophage physiology	J:155025
	abnormal monocyte morphology	J:121281
	decreased lymphocyte cell number	J:147697
	decreased macrophage cell number	J:147697
	impaired macrophage chemotaxis	J:147697
Ccl2^tm1Rol/Ccl2^tm1Rol (B6.129S4-Ccl2^tm1Rol)	abnormal macrophage chemotaxis	J:109290
	abnormal neutrophil physiology	J:151874
	decreased leukocyte cell number	J:68145
	decreased macrophage cell number	J:147328
	impaired macrophage chemotaxis	J:151874, J:68145, J:118606
	increased CD4-positive, alpha-beta T cell number	J:68145
	increased IgG1 level	J:68145
	increased IgG level	J:147328
	increased neutrophil cell number	J:118606
	increased osteoclast cell number	J:109290
Ccl2^tm1Rol/Ccl2^tm1Rol ((129S4/SvJae x C57BL/6)F1)	decreased macrophage cell number	J:119615
Ccl2^tm1Rol/Ccl2^tm1Rol (B6.129S4-Ccl2^tm1Rol/J)	abnormal microglial cell physiology	J:141739
Ccl2^tm1Rol/Ccl2^tm1Rol Cx3cr1^tm1Litt/Cx3cr1^tm1Litt (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6J)	abnormal macrophage physiology	J:200877
	abnormal microglial cell morphology	J:200877
	increased microglial cell activation	J:200877
Ccl2^tm1Rol/Ccl2^tm1Rol Mpz^tm1Msch/Mpz⁺ (involves: 129S4/SvJae * 129S7/SvEvBrd)	decreased macrophage cell number	J:133028
	increased macrophage cell number	J:133028
Ccl2^tm1Rol/Ccl2^tm1Rol Tg(Ccr2-GFP)8Pam/0 (involves: 129S4/SvJae * C57BL/6J)	abnormal leukocyte migration	J:171379
Ccl2^tm1Rol/Ccl2^tm1Rol Tg(PMP22)C61Clh/0 (involves: 129S4/SvJae * C57BL/6J * CBA/Ca)	increased macrophage cell number	J:158350
Ccl3^tm1Unc/Ccl3^tm1Unc (B6.129P2-Ccl3^tm1Unc/J)	decreased neutrophil cell number	J:94599
Ccl3^tm1Unc/Ccl3^tm1Unc (involves: 129P2/OlaHsd * C57BL/6)	decreased microglial cell activation	J:153059
Ccl5^tm1Hso/Ccl5^tm1Hso (involves: 129P2/OlaHsd * C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:75842
Ccl5^tm1Hso/Ccl5^tm1Hso (involves: 129P2/OlaHsd * C57BL/6)	decreased T cell proliferation	J:75842
Ccl7^tm1Ifc/Ccl7^tm1Ifc (involves: 129S4/SvJae)	abnormal monocyte morphology	J:121281
Ccl11^tm1Mer/Ccl11^tm1Mer (involves: 129S6/SvEvTac * NIH Black Swiss)	decreased eosinophil cell number	J:38945
	impaired eosinophil recruitment	J:38945
Ccl11^tm1Mer/Ccl11^tm1Mer (129S.129S6-Ccl11^tm1Mer)	decreased eosinophil cell number	J:102034
Ccl11^tm1Mer/Ccl11^tm1Mer Ccl24^tm1Mer/Ccl24^tm1Mer (involves: 129S6/SvEvTac)	decreased eosinophil cell number	J:115273
	hematopoietic system phenotype	J:115273
Ccl17^em1(IMPC)H/Ccl17^em1(IMPC)H (C57BL/6N-Ccl17^em1(IMPC)H/H)	increased spleen weight	J:211773
Ccl17^{tm2.1(cre)Ifo}/Ccl17⁺ Hif1a^tm3Rsjo/Hif1a^tm3Rsjo (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal dendritic cell number	J:187773
	abnormal leukocyte migration	J:187773
Ccl19^tm1Cys/Ccl19^tm1Cys (B6.129X1-Ccl19^tm1Cys)	decreased T cell number	J:126345
Ccl21a^tm1Yout/Ccl21a^tm1Yout (involves: C57BL/6NCrlj * CBA/JNCrlj)	abnormal negative T cell selection	J:244640
	abnormal spleen morphology	J:244640
	decreased alpha-beta T cell number	J:244640
	decreased B cell number	J:244640
	decreased thymocyte number	J:244640
	small thymus medulla	J:244640
Ccl25^em1(IMPC)H/Ccl25^em1(IMPC)H (C57BL/6N-Ccl25^em1(IMPC)H/H)	enlarged spleen	J:211773
	increased spleen weight	J:211773
Ccl25^tm1.1Mal/Ccl25^tm1.1Mal (B6.129S2-Ccl25^tm1.1Mal)	abnormal gamma-delta T cell number	J:136944
	abnormal T cell subpopulation ratio	J:136944
	decreased gamma-delta intraepithelial T cell number	J:136944
Ccl25^tm1.1Mal/Ccl25^tm1.1Mal Tnf^tm2Gkl/Tnf⁺ (involves: 129S/SvEv * 129S2/SvPas * C57BL/6)	abnormal alpha-beta intraepithelial T cell morphology	J:136667
	abnormal T cell subpopulation ratio	J:136667
	decreased gamma-delta intraepithelial T cell number	J:136667
Ccl26^{tm1.1(KOMP)Vlcg}/Ccl26^{tm1.1(KOMP)Vlcg} (B6N(Cg)-Ccl26^{tm1.1(KOMP)Vlcg}/J)	increased mean corpuscular hemoglobin	J:211773
Ccl28^{em1(IMPC)Ccpcz}/Ccl28^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Ccl28^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Ccl28^tm1Takna/Ccl28^tm1Takna (C57BL/6J-Ccl28^tm1Takna)	decreased IgA level	J:256896
Ccl28^tm1Takna/Ccl28^tm1Takna (C57BL/6J-Ccl28^tm1Takna)	increased IgG level	J:256896
Ccm2^tm2.1Sbn/Ccm2^tm2.1Sbn Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	microgliosis	J:174085
Ccn3^em1(IMPC)Mbp/Ccn3^em1(IMPC)Mbp (C57BL/6N-Ccn3^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	small spleen	J:211773
Ccn3^tm1.1Ecan/Ccn3^tm1.1Ecan (B6.Cg-Ccn3^tm1.1Ecan)	abnormal osteoclast differentiation	J:158478
Ccn3^tm1.1Ecan/Ccn3^tm1.1Ecan (B6.Cg-Ccn3^tm1.1Ecan)	abnormal osteoclast physiology	J:158478
Ccna1^tm1Djw/Ccna1^tm1Djw Ccna2^tm1.1Pisc/Ccna2^tm1.1Pisc (involves: 129S7/SvEvBrd)	abnormal definitive hematopoiesis	J:155178
	abnormal hematopoietic system physiology	J:155178
Ccna1^tm1Djw/Ccna1^tm1Djw Ccna2^tm1.1Pisc/Ccna2^tm1.1Pisc Tg(Mx1-cre)1Cgn/0 (involves: 129S7/SvEvBrd * C57BL/6 * CBA)	anemia	J:155178
	decreased bone marrow cell number	J:155178
	decreased common myeloid progenitor cell number	J:155178
	decreased erythrocyte cell number	J:155178
	decreased erythroid progenitor cell number	J:155178
	decreased hematopoietic stem cell number	J:155178
	decreased leukocyte cell number	J:155178
	thrombocytopenia	J:155178
Ccnb2^tm1Thnt/Ccnb2^tm1Thnt (involves: 129P2/OlaHsd * C57BL/6)	increased double-negative T cell number	J:47430
	small thymus	J:47430
Ccnd1^tm1Dsn/Ccnd1^tm1Dsn Ccnd2^tm1Wbg/Ccnd2^tm1Wbg Ccnd3^tm1Pisc/Ccnd3^tm1Pisc (involves: 129P2/OlaHsd * 129S2/SvPas)	abnormal common myeloid progenitor cell morphology	J:92563
	abnormal definitive hematopoiesis	J:92563
	abnormal hematopoietic stem cell morphology	J:92563
	abnormal lymphopoiesis	J:92563
	anemia	J:92563
	decreased erythrocyte cell number	J:92563
	decreased hematopoietic stem cell number	J:92563
Ccnd1^tm1Dsn/Ccnd1^tm1Dsn Cdkn1b^tm1Mlf/Cdkn1b^tm1Mlf (involves: 129 * C57BL/6)	enlarged spleen	J:66707
	enlarged thymus	J:66707
	thymus hyperplasia	J:66707
Ccnd2^{tm1b(KOMP)Mbp}/Ccnd2^{tm1b(KOMP)Mbp} (C57BL/6N-Ccnd2^{tm1b(KOMP)Mbp}/H)	increased mean corpuscular volume	J:211773
Ccnd2^tm1Wbg/Ccnd2^tm1Wbg Ccnd3^tm1Pisc/Ccnd3^tm1Pisc (Not Specified)	abnormal erythropoiesis	J:80994
	low mean erythrocyte cell number	J:80994
	macrocytic anemia	J:80994
	macrocytosis	J:80994
Ccnd3^{tm1.1(Ccnd2)Iaai}/Ccnd3^{tm1.1(Ccnd2)Iaai} (involves: 129S6/SvEvTac)	abnormal bone marrow cell physiology	J:192031
	decreased B cell proliferation	J:192031
	decreased bone marrow cell number	J:192031
	decreased double-positive T cell number	J:192031
	decreased pre-B cell number	J:192031
	decreased T cell proliferation	J:192031
	small thymus	J:192031
	thymus hypoplasia	J:192031
Ccnd3^tm1Pisc/Ccnd3^tm1Pisc (Not Specified)	decreased B cell proliferation	J:192031
	decreased bone marrow cell number	J:192031
	decreased double-positive T cell number	J:88120, J:192031
	decreased lymphocyte cell number	J:88120
	decreased pre-B cell number	J:192031
	decreased T cell proliferation	J:88120, J:192031
	increased double-negative T cell number	J:88120
	small thymus	J:192031
	thymus hypoplasia	J:88120, J:192031
Ccnd3^tm1Pisc/Ccnd3^tm1Pisc Cdkn1b^tm1Mlf/Cdkn1b^tm1Mlf (involves: 129S4/SvJaeSor)	abnormal bone marrow cell physiology	J:192031
	decreased double-positive T cell number	J:192031
	decreased T cell proliferation	J:192031
	thymus hypoplasia	J:192031
Ccnd3^tm1Pisc/Ccnd3^tm1Pisc Rag2^tm1Fwa/Rag2^tm1Fwa (involves: 129S/SvEv)	increased T cell proliferation	J:88120
Ccnd3^tm1Pisc/Ccnd3^tm1Pisc Rb1^tm2Brn/Rb1^tm2Brn Tg(Mx1-cre)1Cgn/0 (involves: 129 * C57BL/6 * CBA)	decreased double-positive T cell number	J:192031
	decreased T cell proliferation	J:192031
	thymus hypoplasia	J:192031
Ccnd3^tm2.1Pisc/Ccnd3^tm2.1Pisc Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	abnormal hematopoietic stem cell physiology	J:192032
	abnormal hematopoietic system morphology/development	J:192032
	decreased double-positive T cell number	J:192032
	decreased erythrocyte cell number	J:192032
	decreased leukocyte cell number	J:192032
	small thymus	J:192032
Ccne1^tm1Clur/Ccne1^tm1Clur (involves: 129S4/SvJae)	abnormal erythrocyte morphology	J:136692
	abnormal erythropoiesis	J:136692
	abnormal myeloid leukocyte morphology	J:136692
	abnormal spleen red pulp morphology	J:136692
	anemia	J:136692
	anisopoikilocytosis	J:136692
	enlarged spleen	J:136692
	increased bone marrow cell number	J:136692
	increased erythroid progenitor cell number	J:136692
	spleen hyperplasia	J:136692
Ccne1^tm1Jro/Ccne1^tm1Jro (either: 129-Ccne1^tm1Jro or B6.129-Ccne1^tm1Jro)	extramedullary hematopoiesis	J:99695
	increased spleen weight	J:99695
	increased splenocyte proliferation	J:99695
Ccne1^tm1Pisc/Ccne1^tm1Pisc Ccne2^tm1Pisc/Ccne2^tm1Pisc (involves: 129S2/SvPas)	abnormal definitive hematopoiesis	J:85224
	abnormal thrombopoiesis	J:85224
Ccno^em1(IMPC)Mbp/Ccno⁺ (C57BL/6N-Ccno^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Ccnt1^em1(IMPC)J/Ccnt1⁺ (C57BL/6NJ-Ccnt1^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Ccnt1^em1(IMPC)J/Ccnt1^em1(IMPC)J (C57BL/6NJ-Ccnt1^em1(IMPC)J/Mmjax)	decreased erythrocyte cell number	J:211773
	increased leukocyte cell number	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
Ccnt1^{Gt(RRR115)Byg}/Ccnt1^{Gt(RRR115)Byg} (involves: 129P2/OlaHsd)	abnormal thymus physiology	J:130071
Ccr1^tm1Cge/Ccr1^tm1Cge (involves: 129S4/SvJae)	impaired neutrophil recruitment	J:43569
Ccr1^tm1Cge/Ccr1^tm1Cge (involves: 129S4/SvJae)	increased IgG2a level	J:115119
Ccr1^tm1Cge/Ccr1^tm1Cge (involves: 129S4/SvJae * BALB/c)	abnormal macrophage physiology	J:169909
Ccr1^tm1Cge/Ccr1^tm1Cge (involves: 129S4/SvJae * BALB/c)	increased macrophage nitric oxide production	J:169909
Ccr1^tm1Cge/Ccr1^tm1Cge (C.129S4-Ccr1^tm1Cge)	decreased CD4-positive, alpha-beta T cell number	J:95242
Ccr1^tm1Cge/Ccr1^tm1Cge (C.129S4-Ccr1^tm1Cge)	decreased CD8-positive, alpha-beta T cell number	J:95242
Ccr1^tm1Gao/Ccr1^tm1Gao (involves: 129S4/SvJae * C57BL/6)	abnormal neutrophil physiology	J:41324
Ccr1^tm1Gao/Ccr1^tm1Gao (involves: 129S4/SvJae * C57BL/6)	impaired hematopoiesis	J:41324
Ccr1^tm1Gao/Ccr1^tm1Gao (involves: C57BL/6)	decreased mast cell number	J:94599
Ccr1^tm1Gao/Ccr1^tm1Gao (B6.129S4-Ccr1^tm1Gao)	abnormal cellular extravasation	J:104744
Ccr1^tm1Gao/Ccr1^tm1Gao (B6.129S4-Ccr1^tm1Gao)	abnormal leukocyte adhesion	J:104744
Ccr1^tm1Gao/Ccr1^tm1Gao (involves: 129S4/SvJae)	abnormal Kupffer cell morphology	J:152548
Ccr2^em1(IMPC)H/Ccr2^em1(IMPC)H (C57BL/6N-Ccr2^em1(IMPC)H/H)	decreased lymphocyte cell number	J:211773
	decreased monocyte cell number	J:211773
	decreased neutrophil cell number	J:211773
	increased eosinophil cell number	J:211773
Ccr2^{tm1.1(CCR2)Rodb}/Ccr2^{tm1.1(CCR2)Rodb} (involves: C57BL/6)	abnormal macrophage morphology	J:203000
Ccr2^tm1.1Dnc/Ccr2^tm1.1Dnc (Not Specified)	abnormal dendritic cell chemotaxis	J:223508
	decreased CD11b-high dendritic cell number	J:223508
	increased CD11b-high dendritic cell number	J:223508
	increased dendritic cell number	J:223508
Ccr2^tm1.1Mpa/Ccr2^tm1.1Mpa (involves: BALB/cJ * C57BL/6)	decreased macrophage cell number	J:189044
Ccr2^tm1.1Mpa/Ccr2^tm1.1Mpa (involves: BALB/cJ * C57BL/6)	decreased monocyte cell number	J:189044
Ccr2^tm1Blck/Ccr2^tm1Blck (B6.129P2-Ccr2^tm1Blck)	abnormal cellular extravasation	J:104744
Ccr2^tm1Blck/Ccr2^tm1Blck (B6.129P2-Ccr2^tm1Blck)	abnormal leukocyte adhesion	J:104744
Ccr2^tm1Blck/Ccr2^tm1Blck Fas^lpr/Fas^lpr (MRL.Cg-Ccr2^tm1Blck Fas^lpr)	abnormal lymphocyte cell number	J:113343
	enlarged spleen	J:113343
Ccr2^tm1Brv/Ccr2^tm1Brv (involves: 129S1/Sv * ICR)	abnormal spleen morphology	J:111517
	enlarged spleen	J:111517
	impaired macrophage chemotaxis	J:111517
	increased eosinophil cell number	J:111517
Ccr2^tm1Ifc/Ccr2⁺ (involves: 129S4/SvJae * C57BL/6)	impaired macrophage chemotaxis	J:121703
Ccr2^tm1Ifc/Ccr2^tm1Ifc (B6.129S4-Ccr2^tm1Ifc/J)	abnormal leukocyte migration	J:106738
	abnormal leukocyte physiology	J:122119
	abnormal microglial cell physiology	J:106738
	abnormal osteoclast cell number	J:149360
	abnormal osteoclast differentiation	J:149360
	abnormal osteoclast physiology	J:149360
	decreased osteoclast cell number	J:149360
Ccr2^tm1Ifc/Ccr2^tm1Ifc (involves: 129S4/SvJae)	abnormal monocyte morphology	J:121281
Ccr2^tm1Ifc/Ccr2^tm1Ifc (involves: 129S4/SvJae * C57BL/6)	abnormal macrophage chemotaxis	J:44345
	abnormal microglial cell physiology	J:121703
	decreased common myeloid progenitor cell number	J:44345
	decreased splenocyte proliferation	J:75838
	decreased T cell proliferation	J:75838
	impaired macrophage chemotaxis	J:81363, J:44345, J:121703
Ccr2^tm1Ifc/Ccr2^tm1Ifc (B6.129S4-Ccr2^tm1Ifc)	impaired leukocyte tethering or rolling	J:154558
Ccr2^tm1Ifc/Ccr2^tm1Ifc Tg(APPSWE)2576Kha/0 (involves: 129S4/SvJae * C57BL/6 * SJL)	abnormal microglial cell physiology	J:121703
Ccr2^tm1Mae/Ccr2^tm1Mae (involves: 129P2/OlaHsd * C57BL/6J)	decreased CD4-positive, alpha-beta T cell number	J:110814
	increased B cell number	J:110814
	increased CD8-positive, alpha-beta T cell number	J:110814
Ccr2^tm1Mae/Ccr2^tm1Mae (B6.129P2-Ccr2^tm1Mae)	decreased macrophage cell number	J:147328
Ccr2^tm1Mae/Ccr2^tm1Mae (B6.129P2-Ccr2^tm1Mae)	increased IgG level	J:147328
Ccr2^tm1Mae/Ccr2^tm1Mae (involves: 129P2/OlaHsd)	abnormal leukocyte migration	J:171379
Ccr2^tm1Mae/Ccr2^tm1Mae (involves: 129P2/OlaHsd)	impaired macrophage chemotaxis	J:191510, J:151874
Ccr2^tm1Mae/Ccr2^tm1Mae (involves: 129P2/OlaHsd * BALB/c)	abnormal leukocyte physiology	J:162714
	decreased neutrophil cell number	J:162714
	impaired macrophage chemotaxis	J:162714
Ccr2^tm1Mpa/Ccr2^tm1Mpa Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6 * CBA)	decreased macrophage cell number	J:189044
Ccr2^tm2.1Ifc/Ccr2^tm2.1Ifc Cx3cr1^tm1Litt/Cx3cr1⁺ (involves: 129P2/OlaHsd * C57BL/6 * FVB/N)	abnormal leukocyte physiology	J:166664
Ccr2^tm2.1Ifc/Ccr2^tm2.1Ifc Cx3cr1^tm1Litt/Cx3cr1^tm1Litt (involves: 129P2/OlaHsd * C57BL/6 * FVB/N)	abnormal leukocyte physiology	J:166664
Ccr3^{em1(IMPC)Ccpcz}/Ccr3^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Ccr3^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Ccr3^tm1Cge/Ccr3^tm1Cge (involves: 129S4/SvJae * BALB/c)	abnormal eosinophil cell number	J:74509
	abnormal eosinophil physiology	J:74509, J:75347
	abnormal mast cell physiology	J:74509
	decreased eosinophil cell number	J:115273, J:74509, J:75347
	decreased monocyte cell number	J:115273
	hematopoietic system phenotype	J:75347
	impaired eosinophil chemotaxis	J:74509
	impaired eosinophil recruitment	J:74509, J:75347
	increased eosinophil cell number	J:74509
	increased mast cell degranulation	J:74509
Ccr4^tm1Pwr/Ccr4^tm1Pwr (involves: 129P2/OlaHsd * C57BL/6)	abnormal splenocyte physiology	J:70088
	decreased eosinophil cell number	J:120221
	decreased IgE level	J:120221
	decreased lymphocyte cell number	J:70088
	decreased macrophage cell number	J:70088
	increased IgE level	J:120221
	increased IgG1 level	J:120221
	increased macrophage cell number	J:120221
	increased neutrophil cell number	J:120221
Ccr4^tm1Pwr/Ccr4^tm1Pwr (B6.129P2-Ccr4^tm1Pwr)	increased CD8-positive, alpha-beta T cell number	J:95239
Ccr4^tm1Pwr/Ccr4^tm1Pwr (B6.129P2-Ccr4^tm1Pwr)	increased NK T cell number	J:95239
Ccr5^tm1Blck/Ccr5^tm1Blck (B6.129P2-Ccr5^tm1Blck)	abnormal cellular extravasation	J:104744
Ccr5^tm1Blck/Ccr5^tm1Blck (B6.129P2-Ccr5^tm1Blck)	abnormal leukocyte adhesion	J:104744
Ccr5^tm1Brv/Ccr5^tm1Brv (either: (involves: 129S1/Sv * ICR) or (involves: 129S1/Sv * 129X1/SvJ * ICR))	increased IgG1 level	J:46941
Ccr5^tm1Kuz/Ccr5^tm1Kuz (involves: 129P2/OlaHsd * C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:110814
	abnormal CD8-positive, alpha beta T cell morphology	J:110814
	abnormal Kupffer cell morphology	J:152548
	abnormal NK T cell physiology	J:100869
	decreased microglial cell activation	J:153059
	decreased NK cell number	J:135308
	impaired macrophage chemotaxis	J:153059, J:84243, J:64293
	increased NK T cell number	J:110814
Ccr5^tm1Sush/Ccr5^tm1Sush (B6.129P2-Ccr5^tm1Sush)	abnormal leukocyte physiology	J:94937
Ccr5^tm1Sush/Ccr5^tm1Sush (B6.129P2-Ccr5^tm1Sush)	decreased T cell proliferation	J:94937
Ccr6^tm1(EGFP)Irw/Ccr6^tm1(EGFP)Irw (involves: 129S6/SvEvTac * C57BL/6)	abnormal alpha-beta intraepithelial T cell morphology	J:85086
	abnormal B cell physiology	J:120122
	abnormal CD4-positive, alpha-beta intraepithelial T cell morphology	J:85086
	abnormal CD8 positive, alpha-beta intraepithelial T cell morphology	J:85086
	abnormal T cell physiology	J:85086
	decreased B cell number	J:120122
	increased T cell proliferation	J:85086
Ccr6^{tm1.1(KOMP)Vlcg}/Ccr6^{tm1.1(KOMP)Vlcg} (C57BL/6N-Ccr6^{tm1.1(KOMP)Vlcg}/Ucd)	abnormal spleen morphology	J:211773
Ccr6^tm1.1Jmf/Ccr6^tm1.1Jmf (B6.129-Ccr6^tm1.1Jmf)	abnormal CD4-positive, alpha-beta T cell physiology	J:152716
Ccr6^tm1Gma/Ccr6^tm1Gma (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:68191
	abnormal myeloid dendritic cell morphology	J:68191
	decreased leukocyte cell number	J:68191
	increased leukocyte cell number	J:68191
Ccr6^tm1Gma/Ccr6^tm1Gma Tg(Rorc-EGFP)1Ebe/? (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal effector T cell morphology	J:137020
Ccr6^tm1Lira/Ccr6^tm1Lira (involves: 129)	abnormal T cell physiology	J:123150
Ccr6^tm1Lira/Ccr6^tm1Lira (involves: 129 * C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:148286
	abnormal CD4-positive, alpha-beta T cell physiology	J:148286
	abnormal intraepithelial T cell number	J:76461
	abnormal lymphocyte morphology	J:148286
	abnormal macrophage physiology	J:124358
	abnormal myeloid dendritic cell morphology	J:124358
	abnormal peritoneal macrophage morphology	J:124358
	decreased B cell number	J:148286
	decreased CD4-positive, alpha-beta T cell number	J:148286
	decreased CD8-positive, alpha-beta T cell number	J:148286
	decreased IgA level	J:76461
	decreased IgG3 level	J:76461
	decreased macrophage cytokine production	J:124358
	decreased macrophage nitric oxide production	J:124358
	increased activated T cell number	J:76461
	increased B-1 B cell number	J:124358
	increased double-positive T cell number	J:76461
	increased IgM level	J:76461
	increased T cell number	J:76461
Ccr6^tm1Lira/Ccr6^tm1Lira (B6.129-Ccr6^tm1Lira)	decreased IgE level	J:71096
Ccr6^tm1Lira/Ccr6^tm1Lira (B6.129-Ccr6^tm1Lira)	impaired eosinophil recruitment	J:71096
Ccr7^m1Btlr/Ccr7⁺ (C57BL/6J-Ccr7^m1Btlr)	decreased macrophage cell number	J:221477
Ccr7^m1Btlr/Ccr7^m1Btlr (C57BL/6J-Ccr7^m1Btlr)	decreased macrophage cell number	J:221477
Ccr7^m1Btlr/Ccr7^m1Btlr (C57BL/6J-Ccr7^m1Btlr)	increased single-positive T cell number	J:221477
Ccr7^tm1Rfor/Ccr7^tm1Rfor (involves: 129P2/OlaHsd * BALB/c)	abnormal B cell activation	J:57976
	abnormal B cell physiology	J:57976
	abnormal class switch recombination	J:57976
	abnormal leukocyte migration	J:57976
	abnormal spleen marginal sinus morphology	J:57976
	abnormal spleen periarteriolar lymphoid sheath morphology	J:57976
	abnormal spleen red pulp morphology	J:57976
	abnormal T cell physiology	J:57976
	decreased CD4-positive, alpha-beta T cell number	J:57976
	decreased dendritic cell number	J:57976
	decreased IgG3 level	J:57976
	decreased T cell number	J:57976
	enlarged spleen	J:57976
	increased CD4-positive, alpha-beta T cell number	J:57976
	increased IgE level	J:57976
	increased IgG1 level	J:57976
	increased IgG2a level	J:57976
	increased T cell number	J:57976
Ccr7^tm1Rfor/Ccr7^tm1Rfor (B6.129P2-Ccr7^tm1Rfor)	abnormal leukocyte migration	J:93960, J:110910
	abnormal thymus cortex morphology	J:93960
	small thymus medulla	J:93960
Ccr7^tm1Rfor/Ccr7^tm1Rfor (involves: 129P2/OlaHsd)	abnormal dendritic cell chemotaxis	J:223508
	decreased CD11b-high dendritic cell number	J:223508
	decreased CD103-positive CD11b-low dendritic cell number	J:223508
Ccr7^tm1Rfor/Ccr7^tm1Rfor Tg(DO11.10)10Dlo/? (involves: 129P2/OlaHsd * BALB/c * C3H * C57BL/6)	abnormal leukocyte migration	J:123482
	abnormal regulatory T cell physiology	J:123482
Ccr9^tm1.1Mal/Ccr9^tm1.1Mal (involves: 129S2/SvPas * C57BL/6)	abnormal leukocyte cell number	J:72386
	abnormal T cell differentiation	J:72386
	decreased double-positive T cell number	J:72386
	decreased pro-B cell number	J:72386
	decreased T cell number	J:72386
	increased T cell number	J:72386
Ccr9^tm1.1Mal/Ccr9^tm1.1Mal (involves: 129S2/SvPas)	abnormal gamma-delta T cell number	J:136944
	abnormal T cell subpopulation ratio	J:136944
	decreased gamma-delta intraepithelial T cell number	J:136944
Ccr9^tm1.1Mal/Ccr9^tm1.1Mal Tnf^tm2Gkl/Tnf⁺ (involves: 129S/SvEv * 129S2/SvPas * C57BL/6)	abnormal alpha-beta intraepithelial T cell morphology	J:136667
	abnormal T cell subpopulation ratio	J:136667
	decreased gamma-delta intraepithelial T cell number	J:136667
Ccr9^tm1Ccb/Ccr9^tm1Ccb (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal T cell differentiation	J:94596
	decreased thymocyte number	J:94596
Ccr9^tm1Lov/Ccr9^tm1Lov (involves: 129)	abnormal gamma-delta intraepithelial T cell morphology	J:110846
	decreased CD8-positive, gamma-delta intraepithelial T cell number	J:110846
	decreased lymphocyte cell number	J:110846
	increased gamma-delta T cell number	J:110846
Ccr10^tm1.1Nax/Ccr10^tm1.1Nax (B6.129S4(Cg)-Ccr10^tm1.1Nax)	decreased gamma-delta intraepithelial T cell number	J:165323
Ccr10^tm1Cge/Ccr10^tm1Cge (C.129S4-Ccr10^tm1Cge)	abnormal leukocyte migration	J:140728
	abnormal plasma cell morphology	J:140728
	decreased IgA level	J:140728
Ccrl2^tm1Ssoz/Ccrl2^tm1Ssoz (B6.129-Ccrl2^tm1Ssoz)	abnormal dendritic cell chemotaxis	J:165873
Ccrl2^tm1Ssoz/Ccrl2^tm1Ssoz (B6.129-Ccrl2^tm1Ssoz)	abnormal T-helper 2 physiology	J:165873
Cct3^em1(IMPC)Tcp/Cct3⁺ (C57BL/6N-Cct3^em1(IMPC)Tcp/Tcp)	decreased mean corpuscular hemoglobin	J:211773
Cct3^em1(IMPC)Tcp/Cct3⁺ (C57BL/6N-Cct3^em1(IMPC)Tcp/Tcp)	increased mean platelet volume	J:211773
Cd1^tm1Gru/Cd1^tm1Gru (involves: 129S2/SvPas * BALB/c)	abnormal eosinophil cell number	J:84720
	absent NK T cells	J:47769
	decreased CD4-positive, alpha-beta T cell number	J:126220
Cd1d1^em1(IMPC)H/Cd1d1^em1(IMPC)H (C57BL/6NTac-Cd1d1^em1(IMPC)H/H)	decreased red blood cell distribution width	J:211773
	increased basophil cell number	J:211773
Cd1d1^tm1.1Aben/Cd1d1^tm1.1Aben Tg(Cd4-cre)1Cwi/0 (B6.Cg-Cd1d1^tm1.1Aben Tg(Cd4-cre)1Cwi)	decreased NK T cell number	J:183087
Cd1d1^tm1.1Boes/Cd1d1^tm1.1Boes (involves: C57BL/6)	abnormal NK T cell morphology	J:151699
	abnormal NK T cell physiology	J:151699
	decreased NK T cell number	J:151699
Cd1d1^tm1.2Aben/Cd1d1^tm1.2Aben (B6(C)-Cd1d1^tm1.2Aben/J)	abnormal CD4-positive T cell differentiation	J:177038
Cd1d1^tm1.2Aben/Cd1d1^tm1.2Aben (B6(C)-Cd1d1^tm1.2Aben/J)	abnormal T cell activation	J:177038
Cd1d1^tm1Crw/Cd1d1^tm1Crw (involves: 129S4/SvJae * C57BL/6)	decreased NK T cell number	J:76976
Cd1d1^tm1Crw/Cd1d1^tm1Crw (B6.129S4-Cd1d1^tm1Crw)	decreased IgG level	J:99107
Cd1d1^tm1Luc/Cd1d1^tm1Luc (B6.129S6-Cd1d1^tm1Luc)	decreased regulatory T cell number	J:122245
Cd1d1^tm1Luc/Cd1d1^tm1Luc (involves: 129S6/SvEvTac * C57BL/6)	arrested T cell differentiation	J:125679
	decreased NK T cell number	J:39748
Cd1d1^tm1Luc/Cd1d1^tm1Luc (C.129S6-Cd1d1^tm1Luc)	increased IgG3 level	J:121187
Cd1d1^tm1Luc/Cd1d1^tm1Luc Cx3cr1^tm1Litt/Cx3cr1^tm1Litt (B6.129-Cd1d1^tm1Luc Cx3cr1^tm1Litt)	decreased NK cell number	J:129712
Cd1d1^tm2Aben/Cd1d1^tm2Aben (B6.129P2-Cd1d1^tm2Aben)	decreased NK T cell number	J:174337
Cd1d1^tm2Aben/Cd1d1^tm2Aben (involves: 129P2/OlaHsd * C57BL/6)	decreased NK T cell number	J:174337
Cd2ap^tm1Shaw/Cd2ap^tm1Shaw (involves: 129X1/SvJ)	decreased T cell proliferation	J:57971
	spleen atrophy	J:57971
	thymus atrophy	J:57971
Cd2bp2^tm1.1Tbh/Cd2bp2^tm1.1Tbh Tg(Mx1-cre)1Cgn/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * C57BL/6N * CBA/J)	impaired macrophage phagocytosis	J:283435
Cd3d^tm1Kap/Cd3d^tm1Kap (C57BL/6-Cd3d^tm1Kap)	arrested T cell differentiation	J:39925
	decreased CD4-positive, alpha-beta T cell number	J:39925
	decreased CD8-positive, alpha-beta T cell number	J:39925
Cd3e^m1Btlr/Cd3e^m1Btlr (C57BL/6J-Cd3e^m1Btlr)	abnormal thymus morphology	J:132486
	absent T cells	J:132486
	arrested T cell differentiation	J:132486
	increased T cell apoptosis	J:132486
	small thymus	J:132486
Cd3e^m1Btlr/Cd3e^m1Btlr (involves: C57BL/6J)	abnormal class switch recombination	J:185495
Cd3e^m2Btlr/Cd3e^m2Btlr (C57BL/6J-Cd3e^m2Btlr)	abnormal CD8-positive, alpha-beta T cell differentiation	J:274934
	abnormal T cell differentiation	J:274934
	decreased CD4-positive, alpha-beta T cell number	J:274934
	decreased CD8-positive, naive alpha-beta T cell number	J:274934
	increased CD8-positive, alpha-beta T cell number	J:274934
	increased central memory CD8 positive, alpha-beta T cell number	J:274934
Cd3e^tm1.1Geno/Cd3e^tm1.1Geno (involves: C57BL/6)	abnormal double-positive T cell morphology	J:192604
	abnormal T cell differentiation	J:192604
	abnormal T cell number	J:192604
	increased DN3 thymocyte number	J:192604
Cd3e^tm1.1Geno/Cd3e^tm1.1Geno Tg(TcraH-Y,TcrbH-Y)71Vbo/0 (involves: C57BL/6 * C57BL/6J * DBA/2J)	abnormal negative T cell selection	J:192604
	abnormal positive T cell selection	J:192604
	increased DN3 thymocyte number	J:192604
Cd3e^tm1.1Geno/Cd3e^tm1.1Geno Tg(TcrAND)53Hed/0 (involves: C57BL/6 * SJL)	abnormal CD4-positive T cell differentiation	J:192604
	abnormal positive T cell selection	J:192604
	increased DN3 thymocyte number	J:192604
Cd3e^tm1.1Geno/Cd3e^tm1.1Geno Tg(TcraTcrb)1100Mjb/0 (involves: C57BL/6)	abnormal positive T cell selection	J:192604
	abnormal T cell differentiation	J:192604
	abnormal thymus cell ratio	J:192604
	decreased double-positive T cell number	J:192604
	decreased T cell number	J:192604
	increased DN3 thymocyte number	J:192604
Cd3e^tm1.1Lov/Cd3e^tm1.1Lov (Not Specified)	abnormal T cell morphology	J:72144
	arrested T cell differentiation	J:72144
	decreased double-positive T cell number	J:72144
	increased double-negative T cell number	J:72144
Cd3e^tm1.1Lov/Cd3e^tm1.1Lov Trdc^tm1Mal/Trdc^tm1Mal (involves: C57BL/6)	abnormal double-negative T cell morphology	J:112658
Cd3e^tm1Cpt/Cd3e^tm1Cpt (involves: 129S4/SvJae * C57BL/6)	absent T cells	J:54756
	decreased double-positive T cell number	J:54756
	thymus hypoplasia	J:54756
Cd3e^tm1Cpt/Cd3e^tm1Cpt Tg(CD3E)26Cpt/0 (involves: 129S4/SvJae * C57BL/6 * CBA)	decreased double-positive T cell number	J:54756
	decreased T cell number	J:54756
	thymus hypoplasia	J:54756
Cd3e^tm1Lov/Cd3e^tm1Lov (involves: 129S1/Sv * 129X1/SvJ)	abnormal T cell morphology	J:72144
	arrested T cell differentiation	J:72144
	decreased double-positive T cell number	J:72144
	increased double-negative T cell number	J:72144
Cd3e^tm1Mal/Cd3e^tm1Mal (involves: C57BL/6)	absent CD4-positive, alpha-beta T cells	J:77098
	absent CD8-positive, alpha-beta T cells	J:77098
	arrested T cell differentiation	J:77098
Cd3e^tm1Mal/Cd3e^tm1Mal (C57BL/6-Cd3e^tm1Mal)	abnormal B cell morphology	J:81133
	abnormal double-negative T cell morphology	J:81133
	abnormal regulatory T cell physiology	J:125748
	absent T cells	J:131351
	arrested T cell differentiation	J:81133
Cd3e^tm1Mal/Cd3e^tm1Mal Lat^tm1.1Mal/Lat^tm1.1Mal (involves: 129S2/SvPas * C57BL/6)	absent CD4-positive, alpha-beta T cells	J:77098
	absent CD8-positive, alpha-beta T cells	J:77098
	arrested T cell differentiation	J:77098
Cd3e^tm1Mal/Cd3e^tm1Mal Nlrp1a^Neut1/Nlrp1a^Neut1 (involves: C57BL/6)	increased neutrophil cell number	J:191055
Cd3g^tm1.1Cage/Cd3g^tm1.1Cage (B6.129P2-Cd3g^tm1.1Cage)	decreased CD8-positive, alpha-beta T cell number	J:153813
	decreased thymocyte number	J:153813
	increased T cell apoptosis	J:153813
	spleen hypoplasia	J:153813
Cd3g^tm1.1Cage/Cd3g^tm1.1Cage Tg(TcrLCMV)318Sdz/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * FVB/N)	abnormal T cell physiology	J:142387
Cd3g^tm1Amk/Cd3g^tm1Amk (involves: 129P2/OlaHsd)	abnormal CD8-positive, alpha-beta T cell physiology	J:77504
	abnormal T cell activation	J:77504
	abnormal T cell differentiation	J:77504
	abnormal T cell physiology	J:77504
	abnormal T cell proliferation	J:77504
	decreased cytotoxic T cell cytolysis	J:77504
	decreased thymocyte number	J:114561
	thymus hypoplasia	J:77504
Cd3g^tm1Amk/Cd3g^tm1Amk Tg(Igh-Pim1)1Brn/0 (involves: 129P2/OlaHsd * C57BL/6LiA * CBA)	decreased thymocyte number	J:114561
Cd4^del/Cd4^del (C57BR/cdJ-Cd4^del)	abnormal spleen morphology	J:46692
	absent CD4-positive, alpha-beta T cells	J:46692
	decreased IgG level	J:46692
	decreased IgM level	J:46692
	decreased immunoglobulin level	J:46692
	increased CD8-positive, alpha-beta T cell number	J:46692
Cd4^em1Litt/Cd4^em1Litt Rr386^em1Pdi/Rr386^em1Pdi (involves: C57BL/6J)	abnormal lymphocyte activation involved in immune response	J:333574
	decreased T helper 1 cell number	J:333574
Cd4^m1Btlr/Cd4^m1Btlr (C57BL/6J-Cd4^m1Btlr)	absent CD4-positive, alpha-beta T cells	J:212900
Cd4^maat/Cd4^maat (C57BL/6JAnu-Cd4^maat/Apb)	abnormal CD4-positive, alpha beta T cell morphology	J:104190
	abnormal double-positive T cell morphology	J:104190
	decreased CD4-positive, alpha-beta T cell number	J:104190
	increased CD8-positive, alpha-beta T cell number	J:104190
Cd4^sesh/Cd4^sesh (C57BL/6JAnu-Cd4^sesh/AnuApb)	abnormal CD4-positive, alpha beta T cell morphology	J:104190
	abnormal double-positive T cell morphology	J:104190
	decreased T cell number	J:104190
Cd4^thth/Cd4^thth (C57BL/6JSfdAnu-Cd4^thth)	absent CD4-positive, alpha-beta T cells	J:104190
Cd4^{tm1(cre/ERT2)Thbu}/Cd4⁺ Gfm1^{tm1c(EUCOMM)Wtsi}/Gfm1^{tm1c(EUCOMM)Wtsi} (involves: C57BL/6 * C57BL/6N * SJL)	abnormal T-helper 17 cell differentiation	J:302272
	increased CD8-positive, alpha-beta T cell number	J:302272
	increased single-positive T cell number	J:302272
Cd4^{tm1(cre/ERT2)Thbu}/Cd4⁺ Tgfbr2^tm1Karl/Tgfbr2^tm1Karl (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	increased memory T cell number	J:204579
	increased regulatory T cell number	J:204579
Cd4^tm1Doi/Cd4^tm1Doi Lag3^tm1Doi/Lag3^tm1Doi (involves: 129 * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:33272
	increased double-negative T cell number	J:33272
Cd4^tm1Doi/Cd4^tm1Litt Lag3^tm1Doi/Lag3⁺ (involves: 129 * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:33272
	increased double-negative T cell number	J:33272
Cd4^tm1Jrp/Cd4^tm1Jrp (either: B6.129S2-Cd4^tm1Jrp or B10.Cg-Cd4^tm1Jrp)	abnormal T cell differentiation	J:45168
	decreased CD4-positive, alpha-beta T cell number	J:45168
	decreased double-positive T cell number	J:45168
	increased CD8-positive, alpha-beta T cell number	J:45168
Cd4^tm1Jrp/Cd4^tm1Jrp Tg(TcrAND)53Hed/0 (either: (involves: 129S2/SvPas * C57BL/6 * SJL) or (involves: 129S2/SvPas * C57BL/6 * C57BL/10 * SJL))	abnormal T cell number	J:45168
	thymus hyperplasia	J:45168
Cd4^tm1Knw/Cd4^tm1Knw (B6.129S-Cd4^tm1Knw/J)	decreased CD4-positive, alpha-beta T cell number	J:87828
Cd4^tm1Knw/Cd4^tm1Knw (B6.129S-Cd4^tm1Knw/J)	increased CD8-positive, alpha-beta T cell number	J:87828
Cd4^tm1Litt/Cd4^tm1Litt (involves: 129S2/SvPas)	abnormal CD4-positive, alpha-beta T cell physiology	J:50435
	absent CD4-positive, alpha-beta T cells	J:50435
	decreased CD4-positive, alpha-beta T cell number	J:158962
	decreased T cell proliferation	J:50435
	increased CD8-positive, alpha-beta T cell number	J:158962, J:50435
Cd4^tm1Litt/Cd4^tm1Litt Foxp3^sf Otc^spf/Y (involves: 129/Rl * 129S2/SvPas)	abnormal CD8-positive, alpha beta T cell morphology	J:20865
	increased IgG level	J:20865
	increased IgM level	J:20865
Cd4^tm1Litt/Cd4^tm1Nik Tg(Lck-cre)3778Nik/0 (involves: 129S2/SvPas * 129X1/SvJ * C57BL/6 * DBA/2)	abnormal CD4-positive, alpha-beta T cell physiology	J:73479
	abnormal T-helper 2 physiology	J:73479
	decreased T cell proliferation	J:73479
Cd4^tm1Litt/Cd4^tm1Nik Tg(Lck-cre)3785Nik/0 (involves: 129S2/SvPas * 129X1/SvJ * C57BL/6 * DBA/2)	abnormal CD4-positive, alpha-beta T cell physiology	J:73479
	decreased CD4-positive, alpha-beta T cell number	J:73479
	increased CD8-positive, alpha-beta T cell number	J:73479
	increased T cell apoptosis	J:73479
	increased T cell proliferation	J:73479
Cd4^tm1Litt/Cd4^tm1Nik Tg(Lck-icre)3779Nik/0 (involves: 129S2/SvPas * 129X1/SvJ * C57BL/6 * DBA/2)	abnormal CD4-positive, alpha-beta T cell physiology	J:73479
	decreased T cell proliferation	J:73479
Cd4^tm1Mak/Cd4^tm1Mak (involves: 129S2/SvPas * C57BL/6 * DBA/2)	abnormal CD4-positive, alpha-beta T cell physiology	J:68957
	increased CD8-positive, alpha-beta T cell number	J:68957
Cd4^tm1Mak/Cd4^tm1Mak (B6.129S2-Cd4^tm1Mak/J)	absent plasma cells	J:133047
Cd4^tm1Mak/Cd4^tm1Mak Cd8a^tm1Mak/Cd8a^tm1Mak (involves: 129S2/SvPas * C57BL/6 * DBA/2)	abnormal double-negative T cell morphology	J:12572
	abnormal gamma-delta T cell number	J:12572
	abnormal T cell differentiation	J:12572
	abnormal T cell number	J:12572
	decreased cytotoxic T cell cytolysis	J:12572
	decreased double-positive T cell number	J:12572
	small thymus medulla	J:12572
Cd4^tm1Nik/Cd4^tm1Nik Tnfrsf4^tm2(cre)Nik/Tnfrsf4⁺ (involves: 129X1/SvJ)	abnormal regulatory T cell physiology	J:152472
Cd4ts1^BALB/c/? (involves: BALB/c * C3H * C57BL/6 * DBA/2)	abnormal CD4-positive, alpha beta T cell morphology	J:83220
Cd4ts2^DBA/2/? (involves: BALB/c * C3H * C57BL/6 * DBA/2)	abnormal CD4-positive, alpha beta T cell morphology	J:83220
Cd4ts3^BALB/c/? (involves: BALB/c * C3H * C57BL/6 * DBA/2)	abnormal CD4-positive, alpha beta T cell morphology	J:83220
Cd4ts4^C3H/? (involves: BALB/c * C3H * C57BL/6 * DBA/2)	abnormal CD4-positive, alpha beta T cell morphology	J:83220
Cd4ts5^BALB/c/? (involves: BALB/c * C3H * C57BL/6 * DBA/2)	abnormal CD4-positive, alpha beta T cell morphology	J:83220
Cd4ts5^C57BL/6/? (involves: BALB/c * C3H * C57BL/6 * DBA/2)	increased memory T cell number	J:83220
Cd4ts6^DBA/2/? (involves: BALB/c * C3H * C57BL/6 * DBA/2)	abnormal CD4-positive, alpha beta T cell morphology	J:83220
Cd4vts1^DBA/2/? (involves: BALB/c * C3H * C57BL/6 * DBA/2)	abnormal CD4-positive, alpha beta T cell morphology	J:83220
Cd5^{tm1.1(KOMP)Mbp}/Cd5^{tm1.1(KOMP)Mbp} (C57BL/6N-Cd5^{tm1.1(KOMP)Mbp}/Ucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased spleen weight	J:211773
Cd5^tm1.1Chra/Cd5^tm1.1Chra (involves: C57BL/6 * FVB/N)	abnormal T cell physiology	J:189919
	decreased B cell number	J:189919
	decreased CD4-positive, alpha-beta T cell number	J:189919
	decreased double-positive T cell number	J:189919
	decreased follicular B cell number	J:189919
	decreased T cell proliferation	J:189919
	decreased T-helper 17 cell number	J:189919
	increased double-negative T cell number	J:189919
	increased T cell proliferation	J:189919
Cd5^tm1.1Chra/Cd5^tm1.1Chra Tg(Tcra2D2,Tcrb2D2)1Kuch/0 (involves: C57BL/6 * FVB/N)	decreased T cell proliferation	J:189919
	decreased T helper 1 cell number	J:189919
Cd5^tm1Cgn/Cd5^tm1Cgn (B6.129P2-Cd5^tm1Cgn)	increased regulatory T cell number	J:189919
Cd5^tm1Cgn/Cd5^tm1Cgn (B6.129P2-Cd5^tm1Cgn)	increased T cell proliferation	J:189919
Cd5l^tm1Nto/Cd5l^tm1Nto (involves: 129P2/OlaHsd * C57BL/6)	abnormal double-positive T cell morphology	J:52195
Cd5l^tm1Nto/Cd5l^tm1Nto (involves: 129P2/OlaHsd * C57BL/6)	decreased thymocyte number	J:52195
Cd6^tm1Linf/Cd6^tm1Linf (D1.Cg-Cd6^tm1Linf)	abnormal B cell physiology	J:238478
	decreased B cell proliferation	J:238478
	decreased B-1 B cell number	J:238478
	decreased B-1a cell number	J:238478
	decreased IgM level	J:238478
	increased B-1a cell number	J:238478
	increased B-1b cell number	J:238478
Cd7^tm1Bfh/Cd7^tm1Bfh (involves: 129 * C57BL/6)	increased double-positive T cell number	J:48758
Cd7^tm1Bfh/Cd7^tm1Bfh (involves: 129 * C57BL/6)	increased thymocyte number	J:48758
Cd7^tm1Bfh/Cd7^tm1Bfh (B6.129-Cd7^tm1Bfh)	decreased cytotoxic T cell cytolysis	J:48758
	increased double-positive T cell number	J:48758
	increased thymocyte number	J:48758
Cd8a^m1Btlr/Cd8a^m1Btlr (C57BL/6J-Cd8a^m1Btlr)	abnormal CD4-positive T cell differentiation	J:221492
Cd8a^m1Btlr/Cd8a^m1Btlr (C57BL/6J-Cd8a^m1Btlr)	abnormal CD8-positive, alpha-beta T cell differentiation	J:221492
Cd8a^m2Btlr/Cd8a^m2Btlr (C57BL/6J-Cd8a^m2Btlr)	abnormal CD8-positive, alpha-beta T cell physiology	J:236677
Cd8a^m2Btlr/Cd8a^m2Btlr (C57BL/6J-Cd8a^m2Btlr)	increased CD8-positive, alpha-beta memory T cell proliferation	J:236677
Cd8a^{tm1.1(cre)Koni}/Cd8a⁺ (involves: C57BL/6J * C57BL/6NHsd * SJL)	hematopoietic system phenotype	J:177182
Cd8a^{tm1.1(cre)Koni}/Cd8a^{tm1.1(cre)Koni} (involves: C57BL/6J * C57BL/6NHsd * SJL)	decreased CD8-positive, alpha-beta T cell number	J:177182
Cd8a^tm1.1Kio/Cd8a^tm1.1Kio (involves: 129S4/SvJae * C57BL/10 * CBA/Ca)	abnormal CD4-positive T cell differentiation	J:76799
Cd8a^tm1.1Litt/Cd8a^tm1.1Litt (either: (involves: 129P2/OlaHsd * AKR) or (involves: 129P2/OlaHsd * C57BL/6))	abnormal CD8-positive, alpha beta T cell morphology	J:50624
Cd8a^tm1Asin/Cd8a^tm1Asin (involves: 129S1/Sv * 129X1/SvJ * FVB/N)	abnormal double-positive T cell morphology	J:126026
Cd8a^tm1Asin/Cd8a^tm1Asin Cd8b1^tm1Litt/Cd8b1^tm1Litt H2-Ab1^b-tm1Gru/H2-Ab1^b-tm1Gru (involves: 129 * FVB/N)	decreased CD4-positive, alpha-beta T cell number	J:126026
	increased CD8-positive, alpha-beta T cell number	J:126026
Cd8a^tm1Asin/Cd8a^tm1Asin Rag2^tm1Fwa/Rag2^tm1Fwa Tg(TcraH-Y,TcrbH-Y)71Vbo/? (involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ * C57BL/6J * DBA/2J)	abnormal CD8-positive, alpha beta T cell morphology	J:125259
Cd8a^tm1Asin/Cd8a^tm1Asin Tg(CD2-TcraF5,CD2-TcrbF5)1Kio/? (involves: 129S1/Sv * 129X1/SvJ * C57BL/10 * FVB/N)	abnormal positive T cell selection	J:126026
	decreased CD4-positive, alpha-beta T cell number	J:126026
	increased CD8-positive, alpha-beta T cell number	J:126026
Cd8a^tm1Asin/Cd8a^tm1Mak (involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * FVB/N)	abnormal positive T cell selection	J:126026
	abnormal T cell subpopulation ratio	J:126026
	increased CD8-positive, alpha-beta T cell number	J:126026
Cd8a^tm1Mak/Cd8a^tm1Mak (involves: 129S2/SvPas * C57BL/6 * DBA/2)	abnormal cytotoxic T cell physiology	J:68956
	absent CD8-positive, alpha-beta T cells	J:68956
Cd8a^tm1Mak/Cd8a^tm1Mak Il15^tm1Imx/Il15^tm1Imx X/Yaa (BXSB.Cg-Cd8a^tm1Mak Il15^tm1Imx/Dcr)	abnormal spleen B cell follicle morphology	J:179430
	increased IgG1 level	J:179430
	increased IgG2a level	J:179430
	increased IgG2b level	J:179430
	increased monocyte cell number	J:179430
	increased splenocyte number	J:179430
Cd8a^tm1Mak/Cd8a^tm1Mak Zbtb7b^hd/Zbtb7b^hd (involves: B6.129S2-Cd8a^tm1Mak * B6.Cg-Thpok^hd)	absent CD4-positive, alpha-beta T cells	J:95867
Cd8b1^M1Btlr/Cd8b1⁺ (C57BL/6J-Cd8b1^M1Btlr)	decreased CD8-positive, naive alpha-beta T cell number	J:255009
Cd8b1^M1Btlr/Cd8b1⁺ (C57BL/6J-Cd8b1^M1Btlr)	increased CD4-positive, alpha-beta T cell number	J:255009
Cd8b1^M1Btlr/Cd8b1^M1Btlr (C57BL/6J-Cd8b1^M1Btlr)	decreased CD8-positive, naive alpha-beta T cell number	J:255009
	increased CD4-positive, alpha-beta T cell number	J:255009
	increased IgG level	J:255009
Cd8b1^m2Btlr/Cd8b1^m2Btlr (C57BL/6J-Cd8b1^m2Btlr)	abnormal B cell differentiation	J:274761
	abnormal CD8-positive, alpha-beta T cell differentiation	J:274761
	decreased CD8-positive, alpha-beta T cell number	J:274761
	decreased CD8-positive, naive alpha-beta T cell number	J:274761
	decreased T cell number	J:274761
	increased CD4-positive, alpha-beta T cell number	J:274761
	increased central memory CD8 positive, alpha-beta T cell number	J:274761
	increased effector memory CD8-positive, alpha-beta T cell number	J:274761
Cd8b1^tm1Litt/Cd8b1⁺ Tg(Cd8b1)46Erob/0 (involves: 129S4/SvJae * C57BL/6 * CBA)	abnormal T cell subpopulation ratio	J:110916
	decreased T cell number	J:110916
	decreased thymocyte number	J:110916
Cd8b1^tm1Litt/Cd8b1⁺ Tg(TcraH-Y,TcrbH-Y)71Vbo/0 (involves: 129S4/SvJae * C57BL/6J * DBA/2)	decreased double-positive T cell number	J:112551
Cd8b1^tm1Litt/Cd8b1^tm1Litt (involves: 129S4/SvJae * C57BL/6J)	abnormal cytotoxic T cell physiology	J:112551
	abnormal T cell subpopulation ratio	J:110916
	decreased CD8-positive, alpha-beta T cell number	J:112551, J:110916
	decreased thymocyte number	J:110916
Cd8b1^tm1Litt/Cd8b1^tm1Litt Tg(TcraH-Y,TcrbH-Y)71Vbo/0 (involves: 129S4/SvJae * C57BL/6J * DBA/2)	abnormal negative T cell selection	J:112551
	abnormal positive T cell selection	J:112551
	decreased CD8-positive, alpha-beta T cell number	J:112551
	increased CD4-positive, alpha-beta T cell number	J:112551
Cd8b1^tm1Wpfl/Cd8b1^tm1Wpfl (involves: 129S2/SvPas)	abnormal CD8-positive, alpha beta T cell morphology	J:19928
	abnormal CD8-positive, alpha-beta T cell differentiation	J:19928
	abnormal T cell subpopulation ratio	J:19928
	decreased CD8-positive, alpha-beta T cell number	J:19928
	decreased thymocyte number	J:19928
Cd8mts1^DBA/2/? (involves: BALB/c * C3H * C57BL/6 * DBA/2)	increased memory T cell number	J:83220
Cd8mts2^BALB/c/? (involves: BALB/c * C3H * C57BL/6 * DBA/2)	increased memory T cell number	J:83220
Cd8mts3^C57BL/6/? (involves: BALB/c * C3H * C57BL/6 * DBA/2)	increased memory T cell number	J:83220
Cd8mts4^DBA/2/? (involves: BALB/c * C3H * C57BL/6 * DBA/2)	increased memory T cell number	J:83220
Cd8mts5^BALB/c/? (involves: BALB/c * C3H * C57BL/6 * DBA/2)	abnormal CD4-positive, alpha beta T cell morphology	J:83220
Cd8mts5^C57BL/6/? (involves: BALB/c * C3H * C57BL/6 * DBA/2)	increased memory T cell number	J:83220
Cd8mts6^C3H/? (involves: BALB/c * C3H * C57BL/6 * DBA/2)	increased CD8-positive, alpha-beta T cell number	J:83220
Cd8ts1^DBA/2/? (involves: BALB/c * C3H * C57BL/6 * DBA/2)	increased CD8-positive, alpha-beta T cell number	J:83220
Cd8ts2^C57BL/6/? (involves: BALB/c * C3H * C57BL/6 * DBA/2)	increased CD8-positive, alpha-beta T cell number	J:83220
Cd8ts3^C3H/? (involves: BALB/c * C3H * C57BL/6 * DBA/2)	increased CD8-positive, alpha-beta T cell number	J:83220
Cd8ts3^DBA/2/? (involves: BALB/c * C3H * C57BL/6 * DBA/2)	abnormal CD4-positive, alpha beta T cell morphology	J:83220
Cd9^tm1Mek/Cd9^tm1Mek (involves: 129/Sv * C57BL/6)	abnormal definitive hematopoiesis	J:83795
Cd14^tm1Smg/Cd14^tm1Smg (C.129S1-CD14^tm1Smg)	abnormal macrophage physiology	J:116691
Cd14^tm1Smg/Cd14^tm1Smg (C.129S1-CD14^tm1Smg)	abnormal neutrophil physiology	J:127072
Cd14^tm1Smg/Cd14^tm1Smg Tlr4^Lps-d/Tlr4^Lps-d (C3.129S1-CD14^tm1Smg)	abnormal macrophage physiology	J:116691
Cd19^em2(IMPC)Ics/Cd19^em2(IMPC)Ics (C57BL/6N-Cd19^em2(IMPC)Ics/Ics)	decreased lymphocyte cell number	J:211773
	increased monocyte cell number	J:211773
Cd19^tm1(cre)Cgn/? Gt(ROSA)26Sor^{tm1(HBEGF)Awai}/Gt(ROSA)26Sor^{tm1(HBEGF)Awai} (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell morphology	J:131076
	abnormal bone marrow cell number	J:131076
	abnormal lymphocyte cell number	J:131076
	abnormal lymphocyte morphology	J:131076
	abnormal splenic cell ratio	J:131076
	absent immature B cells	J:131076
	absent mature B cells	J:131076
Cd19^tm1(cre)Cgn/Cd19⁺ Ctnnbl1^tm1.1Crad/Ctnnbl1^tm1.1Crad (involves: 129P2/OlaHsd * C57BL/6 * SJL)	decreased B cell proliferation	J:232010
Cd19^tm1(cre)Cgn/Cd19⁺ Cxcr4^tm1Tng/Cxcr4^tm2Tng (involves: 129P2/OlaHsd * C57BL/6)	decreased plasma cell number	J:109147
Cd19^tm1(cre)Cgn/Cd19⁺ Ell2^tm1.1Cmil/Ell2^tm1.1Cmil (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	decreased IgA level	J:234692
	decreased IgG1 level	J:234692
	decreased IgM level	J:234692
	decreased immunoglobulin level	J:234692
	decreased mature B cell number	J:234692
	decreased plasma cell number	J:234692
	decreased transitional stage T1 B cell number	J:234692
	decreased transitional stage T2 B cell number	J:234692
	decreased transitional stage T3 B cell number	J:234692
	increased follicular B cell number	J:234692
	increased immature B cell number	J:234692
	increased pre-B cell number	J:234692
	increased pro-B cell number	J:234692
Cd19^tm1(cre)Cgn/Cd19⁺ Ell2^tm2.1Cmil/Ell2^tm2.1Cmil (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	decreased IgA level	J:234692
	decreased IgG1 level	J:234692
	decreased IgM level	J:234692
	decreased immunoglobulin level	J:234692
	decreased mature B cell number	J:234692
Cd19^tm1(cre)Cgn/Cd19⁺ Ep300^tm2Reck/Ep300⁺ (involves: 129/Sv * 129P2/OlaHsd * C57BL/6)	abnormal B cell differentiation	J:147840
	abnormal spleen marginal zone macrophage morphology	J:147840
	abnormal transitional stage B cell morphology	J:147840
	decreased B cell proliferation	J:147840
	decreased marginal zone B cell number	J:147840
	enlarged spleen	J:147840
	extramedullary hematopoiesis	J:147840
	increased activated T cell number	J:147840
	increased B cell apoptosis	J:147840
	increased B cell number	J:147840
	increased IgG2b level	J:147840
	increased immunoglobulin level	J:147840
	increased megakaryocyte cell number	J:147840
	increased spleen weight	J:147840
	intermingled spleen red and white pulp	J:147840
Cd19^tm1(cre)Cgn/Cd19⁺ Fas^lpr/Fas^tm1Cgn (involves: 129P2/OlaHsd * C57BL/6 * MRL)	enlarged spleen	J:114948
Cd19^tm1(cre)Cgn/Cd19⁺ Fas^lpr/Fas^tm1Cgn Tg(Cd4-cre)1Cwi/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * MRL)	enlarged spleen	J:114948
	increased double-negative T cell number	J:114948
Cd19^tm1(cre)Cgn/Cd19⁺ Fas^tm1Ach/Fas^tm1Ach (involves: 129P2/OlaHsd * BALB/c)	enlarged spleen	J:123556
	increased immunoglobulin level	J:123556
	increased lymphocyte cell number	J:123556
Cd19^tm1(cre)Cgn/Cd19⁺ Gna11^tm1Soff/Gna11^tm1Soff Gnaq^tm2Soff/Gnaq^tm2Soff (B6N.129-Cd19^tm1(cre)Cgn Gna11^tm1Soff Gnaq^tm2Soff)	hematopoietic system phenotype	J:117663
Cd19^tm1(cre)Cgn/Cd19⁺ Gna12^tm1Citb/Gna12^tm1Citb Gna13^tm2.1Soff/Gna13^tm2.1Soff (involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6N)	abnormal B cell physiology	J:117663
	decreased marginal zone B cell number	J:117663
Cd19^tm1(cre)Cgn/Cd19⁺ Gt(ROSA)26Sor^tm1(DTA)Riet/Gt(ROSA)26Sor⁺ (involves: 129P2/OlaHsd)	decreased B cell number	J:92789
Cd19^tm1(cre)Cgn/Cd19⁺ Gt(ROSA)26Sor^{tm1(ITK/SYK)Jrld}/Gt(ROSA)26Sor⁺ (involves: 129P2/OlaHsd)	abnormal T cell activation	J:160931
	enlarged spleen	J:160931
	increased T cell proliferation	J:160931
Cd19^tm1(cre)Cgn/Cd19⁺ Gt(ROSA)26Sor^{tm2(CARD11*L225LI)Jrld}/Gt(ROSA)26Sor⁺ (involves: 129P2/OlaHsd)	abnormal B cell activation	J:228288
	abnormal bone marrow cell number	J:228288
	abnormal plasmablast number	J:228288
	abnormal spleen morphology	J:228288
	enlarged spleen	J:228288
	increased B cell number	J:228288
	increased B cell proliferation	J:228288
	increased plasma cell number	J:228288
	spleen hyperplasia	J:228288
Cd19^tm1(cre)Cgn/Cd19⁺ Gt(ROSA)26Sor^{tm2(Cd74/MOG)Awai}/Gt(ROSA)26Sor⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:140751
Cd19^tm1(cre)Cgn/Cd19⁺ Gt(ROSA)26Sor^{tm2(Cd74/MOG)Awai}/Gt(ROSA)26Sor⁺ Il10^tm1Roer/Il10^tm1Roer (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:140751
Cd19^tm1(cre)Cgn/Cd19⁺ Gt(ROSA)26Sor^{tm4(Ikbkb)Rsky}/Gt(ROSA)26Sor⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:113365
	abnormal splenic cell ratio	J:113365
	decreased B cell apoptosis	J:113365
	increased B cell number	J:113365
Cd19^tm1(cre)Cgn/Cd19⁺ Gt(ROSA)26Sor^{tm5(Map3k14)Rsky}/Gt(ROSA)26Sor^{tm5(Map3k14)Rsky} (involves: 129P2/OlaHsd * C57BL/6)	enlarged spleen	J:139293
	increased marginal zone B cell number	J:139293
	increased mature B cell number	J:139293
Cd19^tm1(cre)Cgn/Cd19⁺ Gt(ROSA)26Sor^{tm5(Map3k14)Rsky}/Gt(ROSA)26Sor^{tm5(Map3k14)Rsky} Tnfrsf13c^tm1Mass/Tnfrsf13c^tm1Mass (involves: 129P2/OlaHsd * C57BL/6)	decreased lymphocyte cell number	J:139293
	decreased mature B cell number	J:139293
Cd19^tm1(cre)Cgn/Cd19⁺ Gt(ROSA)26Sor^{tm6(Map3k14)Rsky}/Gt(ROSA)26Sor^{tm6(Map3k14)Rsky} (involves: 129P2/OlaHsd * C57BL/6)	abnormal spleen B cell follicle morphology	J:139293
	decreased B-1 B cell number	J:139293
	enlarged spleen	J:139293
	increased mature B cell number	J:139293
Cd19^tm1(cre)Cgn/Cd19⁺ Gt(ROSA)26Sor^{tm6(Map3k14)Rsky}/Gt(ROSA)26Sor^{tm6(Map3k14)Rsky} Tnfrsf13c^tm1Mass/Tnfrsf13c^tm1Mass (involves: 129P2/OlaHsd * C57BL/6)	increased lymphocyte cell number	J:139293
	increased mature B cell number	J:139293
Cd19^tm1(cre)Cgn/Cd19⁺ Ifnar1^tm1Uka/Ifnar1^tm1Uka (B6.129P2-Cd19^tm1(cre)Cgn Ifnar1^tm1Uka)	decreased IgG1 level	J:129128
	decreased IgG2a level	J:129128
	decreased IgG3 level	J:129128
	decreased IgM level	J:129128
Cd19^tm1(cre)Cgn/Cd19⁺ Igbp1^tm1Imku/Y (involves: 129P2/OlaHsd)	abnormal B cell physiology	J:74619
	abnormal somatic hypermutation frequency	J:74619
	abnormal spleen germinal center morphology	J:74619
	decreased B cell number	J:74619
	decreased B cell proliferation	J:74619
	decreased follicular B cell number	J:74619
	decreased immunoglobulin level	J:74619
	decreased pre-B cell number	J:74619
Cd19^tm1(cre)Cgn/Cd19⁺ Ikbkb^tm1Cgn/Ikbkb^tm1.1Cgn (involves: 129P2/OlaHsd * C57BL/6)	decreased B-1 B cell number	J:79132
	decreased follicular B cell number	J:79132
	decreased immature B cell number	J:79132
	decreased marginal zone B cell number	J:79132
	decreased mature B cell number	J:79132
	increased B cell proliferation	J:79132
Cd19^tm1(cre)Cgn/Cd19⁺ Ikbkb^tm2Cgn/Ikbkb^tm2.1Cgn (involves: 129P2/OlaHsd * C57BL/6)	decreased B-1 B cell number	J:79132
	decreased follicular B cell number	J:79132
	decreased marginal zone B cell number	J:79132
	decreased mature B cell number	J:79132
Cd19^tm1(cre)Cgn/Cd19⁺ Ikbkb^tm2Mka/Ikbkb^tm2Mka (involves: 129/Sv * 129P2/OlaHsd * C57BL/6)	abnormal B cell activation	J:82995
	decreased B cell number	J:82995
	decreased B cell proliferation	J:82995
	decreased B-1 B cell number	J:82995
	decreased IgG level	J:82995
	decreased IgM level	J:82995
	decreased marginal zone B cell number	J:82995
	increased B cell apoptosis	J:82995
Cd19^tm1(cre)Cgn/Cd19⁺ Ikbkg^tm1.1Mpa/Y (involves: 129P2/OlaHsd * C57BL/6)	decreased B-1 B cell number	J:79132
	decreased follicular B cell number	J:79132
	decreased immature B cell number	J:79132
	decreased marginal zone B cell number	J:79132
	decreased mature B cell number	J:79132
	increased B cell proliferation	J:79132
Cd19^tm1(cre)Cgn/Cd19⁺ Il10^tm1Roer/Il10^tm1Roer (involves: 129P2/OlaHsd)	abnormal CD8-positive, alpha-beta T cell physiology	J:151551
	abnormal myeloid leukocyte morphology	J:151551
	increased B cell number	J:151551
	increased CD4-positive, alpha-beta T cell number	J:151551
	increased plasma cell number	J:151551
Cd19^tm1(cre)Cgn/Cd19⁺ Inpp5d^tm1Rav/Inpp5d^tm1Rav Pten^tm1Hwu/Pten^tm1Hwu (involves: 129P2/OlaHsd * 129S4/SvJae)	abnormal B cell morphology	J:166155
	abnormal B cell physiology	J:166155
	abnormal myeloid leukocyte morphology	J:166155
	decreased B cell number	J:166155
	enlarged spleen	J:166155
	increased B cell number	J:166155
	increased B cell proliferation	J:166155
	increased spleen white pulp amount	J:166155
Cd19^tm1(cre)Cgn/Cd19⁺ Irf8^tm1.1Hm/Irf8^tm1.1Hm (involves: 129P2/OlaHsd * C57BL/6)	abnormal spleen marginal zone morphology	J:168923
	decreased follicular B cell number	J:168923
	increased B cell number	J:168923
	increased B-2 B cell number	J:168923
	increased follicular B cell number	J:168923
	increased marginal zone B cell number	J:168923
	increased transitional stage B cell number	J:168923
Cd19^tm1(cre)Cgn/Cd19⁺ Klhl6^tm2Sato/Klhl6^tm2Sato (either: (involves: 129P2/OlaHsd * 129T2/SvEms) or (involves: 129P2/OlaHsd * BALB/c) or (involves: 129P2/OlaHsd * CD-1))	abnormal B cell differentiation	J:101363
	decreased B cell number	J:101363
Cd19^tm1(cre)Cgn/Cd19⁺ Ltb^tm1Avt/Ltb^tm1Avt (involves: 129P2/OlaHsd * C57BL/6)	abnormal spleen B cell follicle morphology	J:79129
	abnormal spleen follicular dendritic cell network	J:79129
	decreased marginal zone B cell number	J:79129
	decreased spleen germinal center number	J:79129
	decreased spleen germinal center size	J:79129
Cd19^tm1(cre)Cgn/Cd19⁺ Map3k7^tm1Aki/Map3k7^tm1.1Aki (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:112597
	decreased B cell proliferation	J:112597
	decreased B-1 B cell number	J:112597
	decreased IgG1 level	J:112597
	decreased IgG3 level	J:112597
	decreased IgG level	J:112597
	decreased immunoglobulin level	J:112597
Cd19^tm1(cre)Cgn/Cd19⁺ Mcl1^tm2Sjk/Mcl1^tm3Sjk (involves: 129P2/OlaHsd * 129X1/SvJ)	abnormal B cell differentiation	J:86906
	absent early pro-B cells	J:86906
	absent late pro-B cells	J:86906
	absent pre-B cells	J:86906
	arrested B cell differentiation	J:86906
	decreased B cell number	J:86906
	increased B cell apoptosis	J:86906
Cd19^tm1(cre)Cgn/Cd19⁺ Mirc30^tm1.1Rdf/Mirc30^tm1.1Rdf (involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6)	increased B cell number	J:156946
	increased B-1a cell number	J:156946
	increased spleen white pulp amount	J:156946
Cd19^tm1(cre)Cgn/Cd19⁺ Myd88^em1.1Rsky/Myd88⁺ (involves: C57BL/6NTac)	abnormal splenic cell ratio	J:308792
	enlarged spleen	J:308792
	hematopoietic system phenotype	J:308792
	increased germinal center B cell number	J:308792
	increased IgM level	J:308792
	increased plasma cell number	J:308792
Cd19^tm1(cre)Cgn/Cd19⁺ Myd88^em1.1Rsky/Myd88^em1.1Rsky (involves: C57BL/6NTac)	increased B cell proliferation	J:308792
Cd19^tm1(cre)Cgn/Cd19⁺ Notch2^tm1.1Hhi/Notch2⁺ (involves: 129P2/OlaHsd * C57BL/6 * CBA)	decreased marginal zone B cell number	J:83476
Cd19^tm1(cre)Cgn/Cd19⁺ Notch2^tm2Hhi/Notch2^tm1.1Hhi (involves: 129P2/OlaHsd * C57BL/6 * CBA)	abnormal spleen marginal zone morphology	J:83476
	absent marginal zone B cells	J:83476
	decreased transitional stage B cell number	J:83476
Cd19^tm1(cre)Cgn/Cd19⁺ Pax5^tm1Mbu/Pax5^tm3Mbu (involves: 129P2/OlaHsd * 129S2/SvPas)	abnormal B cell differentiation	J:75504
	abnormal class switch recombination	J:75504
	decreased IgG1 level	J:75504
	decreased IgG3 level	J:75504
	decreased IgG level	J:75504
	decreased immature B cell number	J:75504
	decreased immunoglobulin level	J:75504
	decreased mature B cell number	J:75504
	decreased pre-B cell number	J:75504
Cd19^tm1(cre)Cgn/Cd19⁺ Pdia3^tm1Gjh/Pdia3^tm1Gjh (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:112606
Cd19^tm1(cre)Cgn/Cd19⁺ Prdm1^tm1Clme/Prdm1^tm1Clme (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)	abnormal B cell differentiation	J:101890
	abnormal memory B cell number	J:101890
	abnormal plasma cell differentiation	J:101890
	abnormal plasma cell morphology	J:101890, J:114881
	decreased IgG level	J:101890
	decreased IgM level	J:101890
	decreased immunoglobulin level	J:101890
	decreased plasma cell number	J:101890
	increased spleen germinal center number	J:101890
	increased spleen germinal center size	J:101890
Cd19^tm1(cre)Cgn/Cd19⁺ Pten^tm1Hwu/Pten^tm1Hwu (involves: 129P2/OlaHsd * 129S4/SvJae)	abnormal B cell negative selection	J:155314
	abnormal B cell physiology	J:83213
	abnormal class switch recombination	J:114881
	abnormal plasma cell morphology	J:114881
	decreased IgG level	J:114881
	decreased spleen germinal center number	J:83213
	increased B cell apoptosis	J:83213
	increased B cell number	J:83213
	increased B cell proliferation	J:155314, J:83213
	increased B-1 B cell number	J:83213
	increased IgM level	J:114881
	increased marginal zone B cell number	J:83213
Cd19^tm1(cre)Cgn/Cd19⁺ Ptpn6^tm1Rsky/Ptpn6^tm1Rsky (involves: 129P2/OlaHsd * C57BL/6)	abnormal leukocyte cell number	J:123568
	decreased B cell proliferation	J:123568
	decreased follicular B cell number	J:123568
	decreased marginal zone B cell number	J:123568
	enlarged spleen	J:123568
	increased B cell number	J:123568
	increased B-1a cell number	J:123568
	increased granulocyte number	J:123568
	increased macrophage cell number	J:123568
	increased plasma cell number	J:123568
	increased T cell number	J:123568
Cd19^tm1(cre)Cgn/Cd19⁺ Rac1^tm1Tyb/Rac1^tm1Tyb Rac2^tm1Mddw/Rac2^tm1Mddw (involves: 129P2/OlaHsd * 129S/SvEv * 129S4/SvJae * C57BL/6)	arrested B cell differentiation	J:86765
	decreased B cell number	J:86765
	decreased B-1 B cell number	J:86765
	decreased follicular B cell number	J:86765
	decreased marginal zone B cell number	J:86765
	decreased transitional stage B cell number	J:86765
Cd19^tm1(cre)Cgn/Cd19⁺ Rapgef2^tm1.1Hous/Rapgef2^tm1.1Hous (involves: 129P2/OlaHsd * 129S1/Sv)	hematopoietic system phenotype	J:165879
Cd19^tm1(cre)Cgn/Cd19⁺ Rbpj^tm1Hon/Rbpj^tm1Hon (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell differentiation	J:76240
	decreased marginal zone B cell number	J:121523, J:76240
	increased follicular B cell number	J:121523, J:76240
	increased IgG3 level	J:76240
Cd19^tm1(cre)Cgn/Cd19⁺ Rbpj^tm1Hon/Rbpj^tm1Hon Spen^tm2.1Hon/Spen^tm2.1Hon (involves: 129P2/OlaHsd * C57BL/6 * CBA)	decreased marginal zone B cell number	J:121523
	increased follicular B cell number	J:121523
Cd19^tm1(cre)Cgn/Cd19⁺ Slc3a2^tm1.1Mgin/Slc3a2^tm1.1Mgin (involves: 129 * C57BL/6 * SJL)	abnormal B cell activation	J:148000
	abnormal B cell physiology	J:148000
	abnormal class switch recombination	J:148000
	abnormal plasma cell differentiation	J:148000
	decreased B cell proliferation	J:148000
	decreased germinal center B cell number	J:148000
	decreased IgG level	J:148000
	decreased IgM level	J:148000
Cd19^tm1(cre)Cgn/Cd19⁺ Slc3a2^tm1.1Mgin/Slc3a2^tm1Yai (involves: 129 * C57BL/6 * SJL)	decreased IgG3 level	J:148000
	decreased IgM level	J:148000
Cd19^tm1(cre)Cgn/Cd19⁺ Spen^tm2.1Hon/Spen^tm2.1Hon (involves: 129P2/OlaHsd * C57BL/6 * CBA)	decreased follicular B cell number	J:121523
	increased marginal zone B cell number	J:121523
Cd19^tm1(cre)Cgn/Cd19⁺ Spi1^tm2Dgt/Spi1^tm2Dgt (involves: 129P2/OlaHsd * C57BL/6)	hematopoietic system phenotype	J:114150
Cd19^tm1(cre)Cgn/Cd19⁺ Srsf3^tm1Pjln/Srsf3^tm1Pjln (involves: 129P2/OlaHsd * BALB/c)	decreased B cell number	J:113645
Cd19^tm1(cre)Cgn/Cd19⁺ Tbl1xr1^{tm1c(EUCOMM)Hmgu}/Tbl1xr1^{tm1c(EUCOMM)Hmgu} Tg(Vav-BCL2)69Jad/0 (involves: 129P2/OlaHsd * C57BL/6J * C57BL/6N)	abnormal B cell differentiation	J:292118
	abnormal lymphocyte morphology	J:292118
	abnormal spleen morphology	J:292118
Cd19^tm1(cre)Cgn/Cd19⁺ Tcf3^tm1Mbu/Tcf3^tm1.2Mbu (involves: 129P2/OlaHsd * C57BL/6 * SJL)	decreased B cell number	J:137719
	decreased immature B cell number	J:137719
	decreased mature B cell number	J:137719
	decreased pre-B cell number	J:137719
	decreased pro-B cell number	J:137719
	decreased transitional stage B cell number	J:137719
Cd19^tm1(cre)Cgn/Cd19⁺ Tcf3^tm1Mbu/Tcf3^tm1.2Mbu Tg(Vav-BCL2)69Jad/0 (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * SJL)	decreased pre-B cell number	J:137719
Cd19^tm1(cre)Cgn/Cd19⁺ Tgfbr2^tm1Roes/Tgfbr2^tm1Roes (involves: 129P2/OlaHsd * BALB/c)	abnormal B cell physiology	J:90558
	abnormal B-1 B cell morphology	J:90558
	abnormal B-1 B cell number	J:90558
	absent plasma cells	J:90558
	decreased IgA level	J:90558
	increased IgG level	J:90558
	increased IgM level	J:90558
	increased leukocyte cell number	J:90558
Cd19^tm1(cre)Cgn/Cd19⁺ Tnfaip3^tm1.1Awai/Tnfaip3^tm1.1Awai (involves: 129P2/OlaHsd)	decreased B-1a cell number	J:175422
	decreased B-1b cell number	J:175422
	decreased marginal zone B cell number	J:175422
	decreased mature B cell number	J:175422
	enlarged spleen	J:175422
	increased B cell number	J:175422
	increased B cell proliferation	J:175422
	increased follicular B cell number	J:175422
	increased germinal center B cell number	J:175422
	increased IgA level	J:175422
	increased IgG2a level	J:175422
	increased IgM level	J:175422
	increased splenocyte number	J:175422
	increased T cell number	J:175422
Cd19^tm1(cre)Cgn/Cd19⁺ Tnfaip3^tm2Ama/Tnfaip3⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased B cell apoptosis	J:163917
	increased germinal center B cell number	J:163917
	increased immunoglobulin level	J:163917
	increased plasma cell number	J:163917
Cd19^tm1(cre)Cgn/Cd19⁺ Tnfrsf13c^tm1Mass/Tnfrsf13c^tm1Mass (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell differentiation	J:172843
Cd19^tm1(cre)Cgn/Cd19⁺ Tnfsf13b^tm1Msc/Tnfsf13b^tm1Msc Traf2^tm1Rbr/Traf2^tm1Rbr (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	increased follicular B cell number	J:132877
	increased marginal zone B cell number	J:132877
Cd19^tm1(cre)Cgn/Cd19⁺ Traf2^tm1Rbr/Traf2^tm1Rbr (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:132877
	increased follicular B cell number	J:132877
	increased marginal zone B cell number	J:132877
Cd19^tm1(cre)Cgn/Cd19⁺ Traf2^tm1Rbr/Traf2^tm1Rbr Traf3^tm1Rbr/Traf3^tm1Rbr (involves: 129P2/OlaHsd * C57BL/6 * SJL)	abnormal B cell physiology	J:132877
	increased marginal zone B cell number	J:132877
Cd19^tm1(cre)Cgn/Cd19⁺ Traf3^tm1Rbr/Traf3^tm1Rbr (involves: 129P2/OlaHsd * C57BL/6 * SJL)	abnormal B cell physiology	J:132877
	increased follicular B cell number	J:132877
	increased marginal zone B cell number	J:132877
Cd19^tm1(cre)Cgn/Cd19⁺ Ube2n^tm1Aki/Ube2n^tm1Aki (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:112287
	abnormal spleen marginal zone morphology	J:112287
	decreased B cell number	J:112287
	decreased B cell proliferation	J:112287
	decreased immunoglobulin level	J:112287
	decreased marginal zone B cell number	J:112287
	increased B cell apoptosis	J:112287
Cd19^tm1(cre)Cgn/Cd19^tm1(cre)Cgn (involves: 129P2/OlaHsd)	abnormal B cell differentiation	J:27463
	abnormal B cell physiology	J:27463
	abnormal immunoglobulin level	J:27463
	absent spleen germinal center	J:83213, J:27463
	decreased B-1 B cell number	J:83213, J:27463
	decreased IgE level	J:27463
	decreased IgG1 level	J:27463
	decreased IgM level	J:27463
Cd19^tm1(cre)Cgn/Cd19^tm1(cre)Cgn Igh^tm1Mnz/Igh^tm1Mnz (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:75653
Cd19^tm1(cre)Cgn/Cd19^tm1(cre)Cgn Igh^tm2Mnz/Igh^tm2Mnz (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:75653
Cd19^tm1(cre)Cgn/Cd19^tm1(cre)Cgn Tg(IghelMD4)4Ccg/0 (involves: 129P2/OlaHsd * C57BL/6)	decreased B cell number	J:155314
Cd19^tm1(cre)Cgn/Cd19^tm1(cre)Cgn Tg(IghelMD4)4Ccg/0 Tg(ML5sHEL)5Ccg/0 (involves: 129P2/OlaHsd * C57BL/6)	decreased B cell number	J:155314
Cd19^{tm1(cre/ERT2)Rsky}/Cd19⁺ Myd88^em1.1Rsky/Myd88⁺ (involves: 129P2/OlaHsd * C57BL/6NTac)	increased IgM level	J:308792
	increased plasma cell number	J:308792
Cd19^tm1Tft/Cd19^tm1Tft (Not Specified)	abnormal B cell physiology	J:27236
	decreased B cell number	J:27236
	decreased B cell proliferation	J:27236
	decreased B-1 B cell number	J:27236
	decreased IgA level	J:27236
	decreased IgG1 level	J:27236
	decreased IgG2a level	J:27236
	decreased IgG2b level	J:27236
	decreased IgG3 level	J:27236
	decreased IgM level	J:27236
Cd19^tm1Tft/Cd19^tm1Tft (involves: 129/Sv * C57BL/6)	decreased neutrophil cell number	J:66111
Cd19^tm1Tft/Cd19^tm1Tft (involves: 129 * C57BL/6)	decreased B cell number	J:71174
	decreased B cell proliferation	J:71174
	decreased B-1 B cell number	J:71174
	decreased IgA level	J:71174
	decreased IgG1 level	J:71174
	decreased IgG2b level	J:71174
	decreased IgM level	J:71174
Cd19^tm1Tft/Cd19^tm1Tft (B6.Cg-Cd19^tm1Tft)	abnormal B cell physiology	J:136210
	decreased IgA level	J:136210
	decreased IgG1 level	J:136210
	decreased IgG2a level	J:136210
	decreased IgG2b level	J:136210
	decreased IgG3 level	J:136210
	decreased IgM level	J:136210
	increased CD8-positive, alpha-beta T cell number	J:106487
Cd19^tm1Tft/Cd19^tm1Tft Lyn^tm1Sor/Lyn^tm1Sor (involves: 129S4/SvJaeSor * C57BL/6)	decreased B cell number	J:71174
	decreased B cell proliferation	J:71174
	decreased B-1 B cell number	J:71174
	decreased mature B cell number	J:71174
	enlarged spleen	J:71174
Cd22^m1Anu/Cd22^m1Anu (C57BL/6JAnu-Cd22^m1Anu/AnuApb)	arrested B cell differentiation	J:104190
Cd22^m1Anu/Cd22^m1Anu (C57BL/6JAnu-Cd22^m1Anu/AnuApb)	decreased B cell number	J:104190
Cd22^m1Btlr/Cd22^m1Btlr (C57BL/6J-Cd22^m1Btlr)	abnormal B cell differentiation	J:173079
Cd22^m1Btlr/Cd22^m1Btlr (involves: C57BL/6J)	abnormal B cell differentiation	J:185495
Cd22^m1Btlr/Cd22^m1Btlr (involves: C57BL/6J)	decreased IgM level	J:185495
Cd22^m2Btlr/Cd22^m2Btlr (C57BL/6J-Cd22^m2Btlr)	abnormal B cell differentiation	J:215821
Cd22^m2Btlr/Cd22^m2Btlr (C57BL/6J-Cd22^m2Btlr)	abnormal CD4-positive, alpha-beta T cell physiology	J:215821
Cd22^m3Btlr/Cd22^m3Btlr (C57BL/6J-Cd22^m3Btlr)	decreased B cell number	J:220066
Cd22^m3Btlr/Cd22^m3Btlr (C57BL/6J-Cd22^m3Btlr)	increased B-1a cell number	J:220066
Cd22^m4Btlr/Cd22^m4Btlr (C57BL/6J-Cd22^m4Btlr)	decreased B cell number	J:224660
	decreased B-2 B cell number	J:224660
	decreased memory B cell number	J:224660
	increased B-1a cell number	J:224660
Cd22^m5Btlr/Cd22^m5Btlr (C57BL/6J-Cd22^m5Btlr)	decreased B cell number	J:254827
	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:254827
	increased CD8-positive, alpha-beta memory T cell number	J:254827
Cd22^{tm1.1(CD22)Lnit}/Cd22^{tm1.1(CD22)Lnit} (involves: 129S4/SvJae)	abnormal B cell physiology	J:189017
	decreased B cell number	J:189017
	decreased marginal zone B cell number	J:189017
	decreased transitional stage T1 B cell number	J:189017
	decreased transitional stage T2 B cell number	J:189017
Cd22^{tm1b(EUCOMM)Wtsi}/Cd22^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Cd22^{tm1b(EUCOMM)Wtsi}/Tcp)	increased monocyte cell number	J:211773
Cd22^tm1Eac/Cd22⁺ Lyn^tm1Ard/Lyn⁺ Ptpn6^me-v/Ptpn6⁺ Tg(IghelMD4)4Ccg/0 (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell negative selection	J:110531
	abnormal mature B cell morphology	J:110531
	increased IgM level	J:110531
Cd22^tm1Eac/Cd22⁺ Lyn^tm1Ard/Lyn⁺ Tg(IghelMD4)4Ccg/0 (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell negative selection	J:110531
	abnormal mature B cell morphology	J:110531
Cd22^tm1Eac/Cd22⁺ Ptpn6^me-v/Ptpn6⁺ Tg(IghelMD4)4Ccg/0 (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell negative selection	J:110531
	abnormal mature B cell morphology	J:110531
Cd22^tm1Eac/Cd22⁺ Tg(IghelMD4)4Ccg/0 (involves: 129P2/OlaHsd * C57BL/6)	abnormal mature B cell morphology	J:110531
Cd22^tm1Eac/Cd22^tm1Eac (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell activation	J:37451
	abnormal B cell proliferation	J:37451, J:132991
	abnormal mature B cell morphology	J:37451
	abnormal transitional stage B cell morphology	J:132991
	decreased IgG1 level	J:37451
	decreased IgG3 level	J:37451
	decreased IgM level	J:37451
	decreased marginal zone B cell number	J:132991
	decreased mature B cell number	J:37451, J:132991
	decreased memory B cell number	J:37451
	increased B cell apoptosis	J:132991
Cd22^tm1Lam/Cd22^tm1Lam (involves: 129 * C57BL/6)	abnormal B cell activation	J:125719
	decreased marginal zone B cell number	J:125719
	decreased mature B cell number	J:125719
Cd22^tm1Lam/Cd22^tm1Lam Igh^tm1.2Rsky/Igh⁺ (involves: 129 * BALB/c * C57BL/6)	abnormal class switch recombination	J:125719
Cd22^tm1Lam/Cd22^tm1Lam Igh^tm1.2Rsky/Igh^tm1.2Rsky (involves: 129 * BALB/c * C57BL/6)	abnormal B cell activation	J:125719
	decreased B-1a cell number	J:125719
Cd22^tm1Lnit/Cd22^tm1Lnit (involves: 129P2/OlaHsd * C57BL/6)	decreased marginal zone B cell number	J:198790
Cd22^tm1Msn/Cd22^tm1Msn (either: (involves: 129S/SvEv * BALB/c) or (involves: 129S/SvEv * C57BL/6J))	abnormal B cell activation	J:76974
	abnormal B cell physiology	J:76974
	abnormal immunoglobulin level	J:76974
	abnormal mature B cell morphology	J:76974
	increased B-1 B cell number	J:76974
	increased IgG2a level	J:76975
	increased IgG level	J:76975
	increased IgM level	J:76974
Cd22^tm1Tft/Cd22^tm1Tft (involves: 129P2/OlaHsd * C57BL/6)	decreased B cell number	J:92736
	decreased marginal zone B cell number	J:92736
	decreased mature B cell number	J:92736
	increased B cell proliferation	J:92736
Cd22^tm2Lnit/Cd22^tm2Lnit (involves: 129P2/OlaHsd * C57BL/6)	absent mature B cells	J:198790
	decreased marginal zone B cell number	J:198790
Cd22^tm2Tft/Cd22^tm2Tft (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	decreased B cell number	J:92736
	decreased B cell proliferation	J:92736
	increased B cell proliferation	J:92736
Cd22^tm2Tft/Cd22^tm2Tft (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased B cell number	J:208364
	decreased B cell proliferation	J:208364
	increased activation-induced B cell apoptosis	J:208364
Cd22^tm3Lnit/Cd22^tm3Lnit (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	abnormal B cell physiology	J:198790
	absent mature B cells	J:198790
	decreased B cell number	J:198790
	decreased marginal zone B cell number	J:198790
	decreased transitional stage B cell number	J:198790
	increased B cell apoptosis	J:198790
	increased IgG1 level	J:198790
Cd22^tm3Tft/Cd22^tm3Tft (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	decreased B cell number	J:92736
	decreased B cell proliferation	J:92736
	increased B cell proliferation	J:92736
Cd24a^tm1Pjln/Cd24a^tm1Pjln (C57BL/6-Cd24a^tm1Pjln)	abnormal B cell differentiation	J:76695
	abnormal spleen morphology	J:76695
	decreased immature B cell number	J:76695
	decreased pre-B cell number	J:76695
	hematopoietic system phenotype	J:76695
	increased erythrocyte aggregation	J:76695
	increased erythrocyte clearance	J:76695
	increased erythrocyte osmotic fragility	J:76695
Cd27^{em1(IMPC)Ccpcz}/Cd27^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Cd27^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
Cd27^tm1Jbo/Cd27^tm1Jbo (either: B6.129P2-CD27^tm1Jbo or 129P2/OlaHsd-Tnfrsf7^tm1Jbo)	abnormal CD4-positive, alpha-beta T cell physiology	J:65516
	abnormal cytotoxic T cell physiology	J:65516
	abnormal T cell physiology	J:65516
Cd27^tm1Jbo/Cd27^tm1Jbo (B6.129P2-Cd27^tm1Jbo)	abnormal leukopoiesis	J:97606
	decreased regulatory T cell number	J:198200
	increased leukocyte cell number	J:97606
	increased T cell apoptosis	J:198200
Cd28^tm1.1Huen/Cd28^tm1.1Huen Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ (involves: C57BL/6 * C57BL/6NTac)	abnormal regulatory T cell physiology	J:191101
	decreased regulatory T cell number	J:191101
Cd28^{tm1a(EUCOMM)Hmgu}/Cd28^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Cd28^{tm1a(EUCOMM)Hmgu}/H)	decreased T cell number	J:165965
	increased CD4-positive, alpha-beta T cell number	J:165965
	increased leukocyte cell number	J:165965
Cd28^tm1Jmg/Cd28^tm1Jmg (involves: 129S2/SvPas * 129X1/SvJ * C57BL/6)	abnormal germinal center B cell physiology	J:124570
	abnormal lymphopoiesis	J:124570
	decreased immunoglobulin level	J:124570
Cd28^tm1Jmg/Cd28^tm1Mak (involves: 129S2/SvPas * 129X1/SvJ * C57BL/6)	abnormal germinal center B cell physiology	J:124570
	abnormal lymphopoiesis	J:124570
	decreased immunoglobulin level	J:124570
	decreased T cell proliferation	J:149888, J:124570
Cd28^tm1Ltu/Cd28^tm1Ltu Foxp3^{tm4(YFP/icre)Ayr}/Foxp3⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased regulatory T cell number	J:194503
	decreased T cell proliferation	J:194503
	enlarged spleen	J:194503
	increased activated T cell number	J:194503
	increased B cell number	J:194503
Cd28^tm1Mak/Cd28⁺ Cd5^tm1Cgn/Cd5^tm1Cgn (either: (involves: 129P2/OlaHsd * 129S2/SvPas * BALB/c * C57BL/6) or (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * DBA/1 * LP))	abnormal T cell clonal deletion	J:110925
Cd28^tm1Mak/Cd28^tm1Mak (involves: 129S2/SvPas * C57BL/6 * DBA/2)	abnormal CD4-positive, alpha-beta T cell physiology	J:14194
	abnormal class switch recombination	J:14194
	decreased IgG1 level	J:14194
	decreased IgG2b level	J:14194
	decreased immunoglobulin level	J:14194
	decreased T cell proliferation	J:14194
	increased IgG2a level	J:14194
Cd28^tm1Mak/Cd28^tm1Mak (NOD.129S2-Cd28^tm1Mak)	abnormal CD4-positive, alpha-beta T cell physiology	J:61905
Cd28^tm1Mak/Cd28^tm1Mak (NOD.129S2-Cd28^tm1Mak)	increased T cell proliferation	J:93421
Cd28^tm1Mak/Cd28^tm1Mak (involves: 129S2/SvPas)	abnormal class switch recombination	J:123989
	abnormal regulatory T cell physiology	J:191101
	decreased regulatory T cell number	J:191101, J:205441
	decreased spleen germinal center number	J:123989
	decreased T cell proliferation	J:205441, J:130882, J:123989
	enlarged thymus	J:205441
Cd28^tm1Mak/Cd28^tm1Mak (involves: 129S2/SvPas * NOD)	abnormal T-helper 1 physiology	J:35353
	abnormal T-helper 2 physiology	J:35353
	decreased IgG2a level	J:35353
	decreased T cell proliferation	J:35353
Cd28^tm1Mak/Cd28^tm1Mak (involves: 129S2/SvPas * C57BL/6)	abnormal NK cell physiology	J:95353
	decreased T cell proliferation	J:149888
	increased T cell apoptosis	J:149888
Cd28^tm1Mak/Cd28^tm1Mak (B6.129S2-Cd28^tm1Mak)	abnormal cytotoxic T cell physiology	J:76373
Cd28^tm1Mak/Cd28^tm1Mak Cd5^tm1Cgn/Cd5⁺ (either: (involves: 129P2/OlaHsd * 129S2/SvPas * BALB/c * C57BL/6) or (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * DBA/1 * LP))	abnormal T cell clonal deletion	J:110925
Cd28^tm1Mak/Cd28^tm1Mak Cd5^tm1Cgn/Cd5^tm1Cgn (either: (involves: 129P2/OlaHsd * 129S2/SvPas * BALB/c * C57BL/6) or (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * DBA/1 * LP))	abnormal T cell clonal deletion	J:110925
	increased CD4-positive, alpha-beta T cell number	J:110925
	increased CD8-positive, alpha-beta T cell number	J:110925
Cd28^tm1Mak/Cd28^tm1Mak Cd40lg^tm1Flv/Cd40lg^tm1Flv (NOD.Cg-Cd40lg^tm1Flv Cd28^tm1Mak)	decreased regulatory T cell number	J:93421
Cd28^tm1Mak/Cd28^tm1Mak Ndfip1^{Gt(RRD002)Byg}/Ndfip1^{Gt(RRD002)Byg} (involves: 129P2/OlaHsd * 129S2/SvPas)	increased eosinophil cell number	J:205692
Cd28^tm1Mak/Cd28^tm1Mak Tg(Cd4-cre)1Cwi/? Traf6^tm2Ywc/Traf6^tm2Ywc (involves: 129S2/SvPas * C57BL/6 * DBA/2)	decreased T cell proliferation	J:130882
	increased activated T cell number	J:130882
	increased memory T cell number	J:130882
Cd28^tm1Mak/Cd28^tm1Mak Tg(H2-K-Cd86)7All/0 (involves: BALB/c * C57BL/6 * CBA)	abnormal T cell differentiation	J:112266
Cd28^tm1Mak/Cd28^tm1Mak Tg(TcrLCMV)327Sdz/0 (involves: 129S2/SvPas * C57BL/6 * DBA/2)	decreased cytotoxic T cell cytolysis	J:123989
	decreased splenocyte proliferation	J:123989
	decreased T cell proliferation	J:123989
Cd28^tm1Mak/Cd28^tm1Mak Tnfsf9^tm1Thw/Tnfsf9^tm1Thw (involves: 129 * 129S2/SvPas * C57BL/6)	abnormal cytotoxic T cell physiology	J:76373
Cd28^tm1Pjl/Cd28^tm1Pjl (involves: 129P2/OlaHsd * C57BL/6)	abnormal class switch recombination	J:83722
	abnormal cytotoxic T cell physiology	J:83722
	abnormal immunoglobulin level	J:83722
	decreased IgG1 level	J:83722
	decreased IgG2a level	J:83722
	decreased IgM level	J:83722
	increased splenocyte proliferation	J:83722
Cd28^tm1Pjl/Cd28^tm1Pjl Tg(DO11.10)10Dlo/0 (involves: 129P2/OlaHsd * BALB/c * C3H * C57BL/6)	abnormal T cell activation	J:25536
	abnormal T cell proliferation	J:25536
	abnormal thymocyte activation	J:25536
Cd28^tm1Pjl/Cd28^tm1Pjl Tg(H2-K-Cd86)27All/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	decreased B cell number	J:112475
Cd28^tm1Pjl/Cd28^tm1Pjl Tnfrsf9^tm1Byk/Tnfrsf9^tm1Byk (either: B6.Cg-Cd28^tm1Pjl Tnfrsf9^tm1Byk or C.Cg-Cd28^tm1Pjl Tnfrsf9^tm1Byk)	abnormal class switch recombination	J:83722
	abnormal cytotoxic T cell physiology	J:83722
	decreased IgG1 level	J:83722
	decreased IgG2a level	J:83722
	decreased IgM level	J:83722
	decreased splenocyte proliferation	J:83722
Cd28^tm1Shr/Cd28^tm1Shr (involves: 129S4/SvJae * BALB/c * C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:68642
	decreased T cell proliferation	J:68642
Cd28^tm1Shr/Cd28^tm1Shr Ctla4^tm1Shr/Ctla4⁺ (C.129S4-Cd28^tm1Shr Ctla4^tm1Shr)	abnormal CD8-positive, alpha beta T cell morphology	J:125259
Cd28^tm1Shr/Cd28^tm1Shr Ctla4^tm1Shr/Ctla4^tm1Shr (C.129S4-Cd28^tm1Shr Ctla4^tm1Shr)	decreased CD4-positive, alpha-beta T cell number	J:68642
	decreased T cell proliferation	J:68642
Cd33^tm1Avrk/Cd33^tm1Avrk (involves: 129X1/SvJ * C57BL/6)	abnormal erythrocyte cell number	J:83728
Cd34^tm1Lal/Cd34^tm1Lal (involves: 129S2/SvPas)	abnormal common myeloid progenitor cell morphology	J:30621
	abnormal definitive hematopoiesis	J:30621
	decreased erythroid progenitor cell number	J:30621
	decreased splenocyte number	J:30621
Cd34^tm1Szk/Cd34^tm1Szk (involves: 129P2/OlaHsd * C57BL/6J)	decreased eosinophil cell number	J:32799
Cd34^tm1Szk/Cd34^tm1Szk (involves: 129P2/OlaHsd * C57BL/6J)	hematopoietic system phenotype	J:32799
Cd36^em1(IMPC)Mbp/Cd36^em1(IMPC)Mbp (C57BL/6N-Cd36^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Cd36^obl/Cd36^obl (C57BL/6-Cd36^obl)	abnormal macrophage physiology	J:96018
Cd36^tm1Frm/Cd36^tm1Frm (involves: 129S4/SvJae)	abnormal microglial cell physiology	J:140907
Cd36^tm1Frm/Cd36^tm1Frm (involves: 129S4/SvJae * C57BL/6J)	abnormal macrophage physiology	J:80658
Cd36^tm1Frm/Cd36^tm1Frm (B6.129S4-Cd36^tm1Frm)	impaired macrophage phagocytosis	J:100140
Cd36^tm1Mfe/Cd36^tm1Mfe (B6.129S1-Cd36^tm1Mfe)	abnormal B cell morphology	J:130897
	abnormal plasma cell differentiation	J:130897
	decreased IgG1 level	J:130897
	decreased IgG2a level	J:130897
	decreased IgG2c level	J:130897
	decreased IgG level	J:130897
	decreased IgM level	J:130897
	decreased immunoglobulin level	J:130897
	increased transitional stage B cell number	J:130897
Cd36^tm1Mfe/Cd36^tm1Mfe (involves: 129S1/Sv)	abnormal macrophage chemotaxis	J:89664
Cd37^tm1Hor/Cd37^tm1Hor (involves: 129P2/OlaHsd * C57BL/6)	abnormal class switch recombination	J:63315
	decreased IgG1 level	J:63315
	decreased spleen germinal center number	J:63315
	decreased spleen germinal center size	J:63315
Cd38^{em1(IMPC)Ccpcz}/Cd38^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Cd38^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	decreased CD4-positive NK T cell number	J:211773
	decreased CD4-positive, alpha-beta T cell number	J:211773
	decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	decreased effector memory T-helper cell number	J:211773
	decreased memory-marker CD4-positive NK T cell number	J:211773
	decreased NK T cell number	J:211773
	decreased T-helper cell number	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
	increased effector memory CD8-positive, alpha-beta T cell number	J:211773
	increased NK cell number	J:211773
Cd38^tm1Lnd/Cd38^tm1Lnd (NOD.129P2(B6)-Cd38^tm1Lnd/LtJ)	increased T cell apoptosis	J:108097
Cd40^m2Btlr/Cd40^m2Btlr (C57BL/6J-Cd40^m2Btlr)	decreased IgG level	J:254828
Cd40^tm1Arah/Cd40^tm1Arah (B6.129S1-Cd40^tm1Arah)	abnormal immunoglobulin level	J:120512
	absent spleen germinal center	J:120512
	decreased IgE level	J:120512
	decreased IgG1 level	J:120512
	decreased IgG2b level	J:120512
	decreased IgG level	J:120512
	decreased IgM level	J:120512
	increased IgG3 level	J:120512
	increased IgM level	J:120512
Cd40^tm1Geha/Cd40^tm1Geha (involves: 129S4/SvJae * C57BL/6)	decreased IgA level	J:82298
	decreased IgG1 level	J:82298
	decreased IgG2a level	J:82298
	decreased IgG2b level	J:82298
	decreased spleen germinal center number	J:82298
	decreased spleen germinal center size	J:82298
Cd40^tm1Kik/Cd40⁺ Mir146^tm1.1Lfl/Mir146^tm1.1Lfl Tg(Cr2-cre)3Cgn/0 (involves: 129P2/OlaHsd * C57BL/6)	increased T follicular helper cell number	J:266124
Cd40^tm1Kik/Cd40^tm1Kik (B6.129P2-Cd40^tm1Kik/J)	decreased platelet aggregation	J:108988
Cd40^tm1Kik/Cd40^tm1Kik (B6.129P2-Cd40^tm1Kik/J)	hematopoietic system phenotype	J:75152
Cd40^tm1Kik/Cd40^tm1Kik (involves: 129P2/OlaHsd * C57BL/6)	absent spleen germinal center	J:25007
	decreased IgA level	J:25007
	decreased IgE level	J:25007
	decreased IgG1 level	J:25007
	decreased IgG2a level	J:25007
	decreased IgG2b level	J:25007
	decreased IgG3 level	J:25007
	decreased immunoglobulin level	J:25007
	decreased neutrophil cell number	J:25007
Cd40^tm1Kik/Cd40^tm1Kik (involves: 129P2/OlaHsd)	absent germinal center B cells	J:190943
Cd40^tm1Kik/Cd40^tm1Kik (involves: 129P2/OlaHsd)	decreased B cell number	J:190943
Cd40^tm1Kik/Cd40^tm1Kik Ltbr^tm1Mmat/Ltbr^tm1Mmat (involves: 129P2/OlaHsd * C57BL/6 * CBA)	abnormal thymus epithelium morphology	J:173115
	abnormal thymus medulla morphology	J:173115
Cd40^tm1Kik/Cd40^tm1Kik Tg(Tnfsf13b)1Fma/? (B6.Cg-Cd40^tm1Kik Tg(Tnfsf13b)1Fma)	abnormal B cell activation	J:113556
	abnormal class switch recombination	J:113556
	absent spleen germinal center	J:113556
	increased marginal zone B cell number	J:113556
Cd40^tm1Kik/Cd40^tm1Kik Tnfsf11^tm1Pngr/Tnfsf11^tm1Pngr (involves: 129P2/OlaHsd)	abnormal thymus epithelium morphology	J:173115
Cd40^tm1Kik/Cd40^tm1Kik Traf3ip2^tm1.1Lix/Traf3ip2^tm1.1Lix (involves: 129 * 129P2/OlaHsd * BALB/c)	abnormal B cell physiology	J:138560
	enlarged spleen	J:93923
	increased follicular B cell number	J:138560
	increased marginal zone B cell number	J:138560
	increased transitional stage B cell number	J:138560
Cd40lg^m1Btlr/Y (involves: C57BL/6J)	abnormal class switch recombination	J:185495
Cd40lg^m1Btlr/Y (involves: C57BL/6J)	decreased IgG level	J:185495
Cd40lg^m1Btlr/Cd40lg^m1Btlr (C57BL/6J-Cd40lg^m1Btlr)	decreased IgG level	J:162147
Cd40lg^m1Btlr/Cd40lg^m1Btlr (involves: C57BL/6J)	abnormal class switch recombination	J:185495
Cd40lg^m1Btlr/Cd40lg^m1Btlr (involves: C57BL/6J)	decreased IgG level	J:185495
Cd40lg^tm1Flv/Y Fas^lpr/Fas^lpr (involves: 129P2/OlaHsd * 129S2/SvPas * MRL)	decreased IgG level	J:38492
	decreased immunoglobulin level	J:38492
Cd40lg^tm1Flv/Cd40lg^tm1Flv (involves: 129S2/SvPas * C57BL/6)	abnormal class switch recombination	J:25010
	abnormal osteoclast differentiation	J:120087
	abnormal T cell differentiation	J:25010
	abnormal T-helper 2 physiology	J:25010
	absent spleen germinal center	J:25010
	decreased double-positive T cell number	J:25010
	decreased IgA level	J:25010
	decreased IgD level	J:25010
	decreased IgE level	J:25010
	decreased IgG1 level	J:25010
	decreased IgG3 level	J:25010
	decreased immunoglobulin level	J:25010
	increased CD4-positive, alpha-beta T cell number	J:25010
Cd40lg^tm1Flv/Cd40lg^tm1Flv (NOD.129S2-Cd40lg^tm1Flv)	decreased regulatory T cell number	J:93421
Cd40lg^tm1Flv/Cd40lg^tm1Flv Fas^lpr/Fas^lpr (involves: 129P2/OlaHsd * 129S2/SvPas * MRL)	decreased IgG level	J:38492
	decreased immunoglobulin level	J:38492
Cd40lg^tm1Imx/Y (involves: 129S2/SvPas * C57BL/6)	abnormal class switch recombination	J:21137
	absent spleen germinal center	J:21137
	decreased IgA level	J:21137
	decreased IgE level	J:21137
	decreased IgG1 level	J:21137
	decreased IgG2b level	J:21137
	decreased immunoglobulin level	J:21137
Cd40lg^tm1Imx/Y (B6.129S2-Cd40lg^tm1Imx/J)	abnormal leukocyte adhesion	J:108988
Cd40lg^tm1Imx/Y (B6.129S2-Cd40lg^tm1Imx/J)	decreased platelet aggregation	J:108988
Cd40lg^tm1Imx/? (involves: 129S2/SvPas * C57BL/6)	decreased platelet aggregation	J:103954
Cd40lg^tm1Imx/? (involves: 129S2/SvPas * C57BL/6)	hematopoietic system phenotype	J:103954
Cd40lg^tm1Imx/Cd40lg^tm1Imx (involves: 129S2/SvPas * C57BL/6J * BALB/c)	abnormal T cell clonal deletion	J:110925
Cd40lg^tm1Imx/Cd40lg^tm1Imx (involves: 129S2/SvPas * C57BL/6)	microgliosis	J:115487
Cd40lg^tm1Parl/Y Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: 129 * C57BL/6 * C57BL/10 * CBA/Ca)	decreased IgM level	J:213459
	hematopoietic system phenotype	J:213459
	increased IgG1 level	J:213459
	thrombocytopenia	J:213459
Cd40lg^tm1Parl/Y Tg(Cd4-cre)1Cwi/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)	hematopoietic system phenotype	J:213459
Cd40lg^tm1Parl/Y Tg(Tek-cre)1Ywa/0 (involves: 129 * C57BL/6 * CD-1 * SJL)	decreased IgA level	J:213459
	decreased IgG1 level	J:213459
	decreased IgG2a level	J:213459
	decreased IgG3 level	J:213459
	decreased IgM level	J:213459
	hematopoietic system phenotype	J:213459
Cd40lg^tm1Parl/Cd40lg^tm1Parl Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: 129 * C57BL/6 * C57BL/10 * CBA/Ca)	decreased IgM level	J:213459
	hematopoietic system phenotype	J:213459
	increased IgG1 level	J:213459
	thrombocytopenia	J:213459
Cd40lg^tm1Parl/Cd40lg^tm1Parl Tg(Cd4-cre)1Cwi/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)	hematopoietic system phenotype	J:213459
Cd40lg^tm1Parl/Cd40lg^tm1Parl Tg(Tek-cre)1Ywa/0 (involves: 129 * C57BL/6 * CD-1 * SJL)	decreased IgA level	J:213459
	decreased IgG1 level	J:213459
	decreased IgG2a level	J:213459
	decreased IgG3 level	J:213459
	decreased IgM level	J:213459
	hematopoietic system phenotype	J:213459
Cd44^M1Btlr/Cd44^M1Btlr (C57BL/6J-Cd44^M1Btlr)	decreased alpha-beta T cell number	J:267483
	decreased CD4-positive, alpha-beta T cell number	J:267483
	decreased CD8-positive, alpha-beta T cell number	J:267483
	decreased central memory CD4-positive, alpha-beta T cell number	J:267483
	decreased central memory CD8 positive, alpha-beta T cell number	J:267483
	decreased effector memory CD4-positive, alpha-beta T cell number	J:267483
Cd44^tm1.1Ugu/Cd44^tm1.1Ugu (involves: 129/Sv * C57BL/6)	abnormal T-helper 1 physiology	J:62867
Cd44^tm1.1Ugu/Cd44^tm1.1Ugu (involves: 129/Sv * C57BL/6)	abnormal T-helper 2 physiology	J:62867
Cd44^tm1.1Ugu/Cd44^tm1.1Ugu (SJL.129(Cg)-Cd44^tm1.1Ugu)	decreased T cell proliferation	J:199279
Cd44^tm1Hbg/Cd44^tm1Hbg (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:68069
	abnormal CD8-positive, alpha beta T cell morphology	J:68069
	abnormal leukocyte migration	J:68069
	abnormal neutrophil physiology	J:94850
	hematopoietic system phenotype	J:110964
Cd44^tm1Hbg/Cd44^tm1Hbg (involves: 129S1/Sv * 129X1/SvJ)	abnormal osteoclast differentiation	J:101563
Cd44^tm1Hbg/Cd44^tm1Hbg (B6.129-Cd44^tm1Hbg)	decreased mast cell histamine storage	J:146846
Cd44^tm1Hbg/Cd44^tm1Hbg (B6.129-Cd44^tm1Hbg)	decreased mast cell number	J:146846
Cd44^tm1Hbg/Cd44^tm1Hbg Tg(TNF)197Gkl/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	abnormal osteoclast differentiation	J:97992
	abnormal osteoclast morphology	J:97992
	increased osteoclast cell number	J:97992
Cd44^tm1Mak/Cd44⁺ (involves: 129P2/OlaHsd * C57BL/6J)	abnormal leukocyte migration	J:99032
Cd44^tm1Mak/Cd44^tm1Mak (involves: 129P2/OlaHsd * C57BL/6J)	abnormal definitive hematopoiesis	J:72658
Cd44^tm1Mak/Cd44^tm1Mak (involves: 129P2/OlaHsd * C57BL/6J)	abnormal leukocyte migration	J:99032
Cd44^tm1Mak/Cd44^tm1Mak (B6.129P2-Cd44^tm1Mak)	abnormal leukocyte migration	J:108245
	decreased activation-induced cell death of T cells	J:69351
	impaired macrophage phagocytosis	J:111216
	impaired natural killer cell mediated cytotoxicity	J:110889
Cd44^tm1Mak/Cd44^tm1Mak Itgal^tm1Mak/Itgal^tm1Mak (B6.129P2-Cd44^tm1Mak Itgal^tm1Mak)	impaired natural killer cell mediated cytotoxicity	J:110889
Cd44^tm1Ugu/Cd44^tm1Ugu (involves: 129/Sv * C57BL/6)	abnormal T-helper 1 physiology	J:62867
Cd44^tm1Ugu/Cd44^tm1Ugu (involves: 129/Sv * C57BL/6)	abnormal T-helper 2 physiology	J:62867
Cd44^tm2.1Ugu/Cd44^tm2.1Ugu (B6.129-Cd44^tm2.1Ugu)	decreased T cell proliferation	J:199279
Cd44^tm2Kmz/Cd44^tm2Kmz (involves: BALB/c * DBA/1)	abnormal CD4-positive, alpha-beta T cell physiology	J:114317
	abnormal leukocyte adhesion	J:114317
	impaired leukocyte tethering or rolling	J:114317
	impaired neutrophil recruitment	J:114317
Cd44^tm2Kmz/Cd44^tm2Kmz Sell^tm2Hyn/Sell^tm2Hyn (involves: 129S2/SvPas * BALB/c * DBA/1)	abnormal CD4-positive, alpha-beta T cell physiology	J:114317
	abnormal leukocyte adhesion	J:114317
	impaired leukocyte tethering or rolling	J:114317
	impaired neutrophil recruitment	J:114317
Cd47^tm1Fpl/Cd47^tm1Fpl (involves: 129S7/SvEvBrd)	decreased T cell number	J:36489
Cd47^tm1Fpl/Cd47^tm1Fpl (involves: 129S7/SvEvBrd)	impaired neutrophil recruitment	J:148196
Cd47^tm1Fpl/Cd47^tm1Fpl (B6.129S7-Cd47^tm1Fpl)	abnormal neutrophil physiology	J:36489
	abnormal platelet physiology	J:98979
	decreased osteoclast cell number	J:116609
	impaired granulocyte bactericidal activity	J:36489
	impaired neutrophil chemotaxis	J:36489
	impaired neutrophil phagocytosis	J:36489
	thrombocytopenia	J:98979
Cd47^tm1Fpl/Cd47^tm1Fpl (C.129S7-Cd47^tm1Fpl)	abnormal platelet physiology	J:98979
	decreased osteoclast cell number	J:116609
	thrombocytopenia	J:98979
Cd47^tm1Fpl/Cd47^tm1Fpl (NOD.129S7-Cd47^tm1Fpl)	abnormal erythropoiesis	J:76580
	abnormal spleen morphology	J:76580
	abnormal splenic cell ratio	J:76580
	decreased hematocrit	J:76580
	enlarged spleen	J:76580
	hemolytic anemia	J:76580
	increased bone marrow cell number	J:76580
	reticulocytosis	J:76580
Cd47^tm1Fpl/Cd47^tm1Fpl (involves: 129S7/SvEvBrd * C57BL/6)	abnormal osteoclast differentiation	J:147367
	decreased hematocrit	J:134866
	decreased hemoglobin content	J:134866
	decreased leukocyte cell number	J:134866
	decreased neutrophil cell number	J:134866
Cd48^tm1Rsr/Cd48^tm1Rsr (B6.129S4-Cd48^tm1Rsr)	abnormal T cell activation	J:53718
	decreased T cell proliferation	J:53718
	increased CD4-positive, alpha-beta T cell number	J:53718
Cd53^tm1.1Nmg/Cd53^tm1.1Nmg (involves: C57BL/6J)	abnormal B cell physiology	J:260065
Cd55^tm1Song/Cd55^tm1Song (involves: 129S6/SvEvTac * C57BL/6)	hematopoietic system phenotype	J:52968
Cd55b^{tm1a(KOMP)Wtsi}/Cd55b^{tm1a(KOMP)Wtsi} (C57BL/6N-Cd55b^{tm1a(KOMP)Wtsi}/Wtsi)	thrombocytosis	J:211773
Cd59a^tm1Bpm/Cd59a^tm1Bpm (involves: 129/Sv * C57BL/6)	increased erythrocyte osmotic fragility	J:70419
Cd59a^tm1Bpm/Cd59a^tm1Bpm (involves: 129/Sv * C57BL/6)	reticulocytosis	J:70419
Cd59a^tm1Bpm/Cd59a^tm1Bpm (involves: 129)	increased macrophage cell number	J:148367
Cd59a^tm1Bpm/Cd59a^tm1Bpm (B6.129-Cd59a^tm1Bpm)	abnormal CD4-positive, alpha-beta T cell physiology	J:119703, J:123582
	decreased B cell proliferation	J:119703
	decreased IgG level	J:119703
	decreased plasma cell number	J:119703
	increased CD4-positive, alpha-beta T cell number	J:123582
	increased double-positive T cell number	J:123582
	increased neutrophil cell number	J:123582
	increased T cell proliferation	J:122201
Cd59a^tm1Song/Cd59a^tm1Song Cd55^tm1Song/Cd55^tm1Song (involves: 129S6/SvEvTac * C57BL/6)	hematopoietic system phenotype	J:76578
Cd59b^tm1Jha/Cd59b^tm1Jha (involves: 129/Sv * C57BL/6)	abnormal platelet physiology	J:82330
	anisopoikilocytosis	J:82330
	decreased erythrocyte cell number	J:82330
	decreased hematocrit	J:82330
	decreased hemoglobin content	J:82330
	echinocytosis	J:82330
	erythroblastosis	J:82330
	hemolytic anemia	J:82330
	reticulocytosis	J:82330
	schistocytosis	J:82330
Cd68^tm1Xfen/Cd68^tm1Xfen (C57BL/6J-Cd68^tm1Xfen)	abnormal osteoclast morphology	J:178120
Cd68^tm1Xfen/Cd68^tm1Xfen (C57BL/6J-Cd68^tm1Xfen)	abnormal osteoclast physiology	J:178120
Cd69^tm1Fsm/Cd69^tm1Fsm (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal B cell differentiation	J:61329
	hematopoietic system phenotype	J:61329
	increased IgG2a level	J:61329
	increased IgM level	J:61329
	increased immature B cell number	J:61329
	increased pre-B cell number	J:61329
Cd69^tm1Naka/Cd69^tm1Naka (C.129P2-Cd69^tm1Naka)	impaired neutrophil chemotaxis	J:84940
Cd69^tm1Naka/Cd69^tm1Naka (C.129P2-Cd69^tm1Naka)	impaired neutrophil recruitment	J:84940
Cd69^tm1Naka/Cd69^tm1Naka (B6.129P2-Cd69^tm1Naka)	abnormal CD4-positive, alpha-beta T cell physiology	J:184704
	abnormal memory T cell physiology	J:184704
	abnormal T cell physiology	J:184704
	decreased CD4-positive, alpha-beta T cell number	J:184704
Cd70^tm1(cre)Jbo/Cd70^tm1(cre)Jbo (B6.129P2-Cd70^tm1(cre)Jbo)	decreased regulatory T cell number	J:198200
Cd70^tm1.1Jda/Cd70^tm1.1Jda (B6.Cg-Cd70^tm1.1Jda)	abnormal CD8-positive, alpha-beta T cell physiology	J:193042
	abnormal T cell physiology	J:193042
	decreased CD8-positive, alpha-beta T cell number	J:193042
Cd72^b/Cd72^b Fas^lpr/Fas^lpr (involves: C57BL/6 * C57BL/6JJmsSlc * MRL/Mp)	abnormal B cell number	J:204782
	abnormal T cell number	J:204782
	decreased IgG level	J:204782
	decreased spleen weight	J:204782
Cd72^c/Cd72^c (involves: C57BL/6 * MRL)	increased B cell proliferation	J:204782
Cd72^c/Cd72^c Fas^lpr/Fas^lpr (involves: C57BL/6 * C57BL/6JJmsSlc * MRL/Mp)	abnormal B cell number	J:204782
	abnormal T cell number	J:204782
	increased IgG level	J:204782
	increased spleen weight	J:204782
Cd72^tm1Jrp/Cd72^tm1Jrp (either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6))	abnormal B cell activation	J:76990
	abnormal B cell differentiation	J:76990
	abnormal B cell physiology	J:76990
	decreased B cell number	J:76990
	decreased B-2 B cell number	J:76990
	decreased follicular B cell number	J:76990
	decreased mature B cell number	J:76990
	increased B cell proliferation	J:76990
	increased B-1 B cell number	J:76990
	increased B-1a cell number	J:76990
	increased IgM level	J:76990
	increased immature B cell number	J:76990
	increased marginal zone B cell number	J:76990
	increased pre-B cell number	J:76990
	increased pro-B cell number	J:76990
Cd72^tm1Jrp/Cd72^tm1Jrp Tg(BCL2)22Wehi/0 (either: (involves: 129P2/OlaHsd * C57BL/6JWehi * SJL/JWehi) or (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6JWehi * SJL/JWehi))	abnormal B cell physiology	J:76990
	decreased mature B cell number	J:76990
	increased immature B cell number	J:76990
Cd72^tm1Tsub/Cd72^tm1Tsub (involves: C57BL/6J)	increased B cell proliferation	J:204782
Cd72^tm1Tsub/Cd72^tm1Tsub (involves: C57BL/6J)	increased spleen weight	J:204782
Cd72^tm1Tsub/Cd72^tm1Tsub Fas^lpr/Fas^lpr (involves: C57BL/6J * C57BL/6JJmsSlc * MRL/Mp)	abnormal B cell number	J:204782
	abnormal T cell number	J:204782
	increased spleen weight	J:204782
Cd74^em1(IMPC)H/Cd74^em1(IMPC)H (C57BL/6N-Cd74^em1(IMPC)H/H)	decreased lymphocyte cell number	J:211773
	increased eosinophil cell number	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Cd74^tm1Anjm/Cd74⁺ Lmo2^tm2(cre)Thr/Lmo2⁺ Smim3^tm1Anjm/Smim3⁺ (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)	decreased erythrocyte cell number	J:155870
	decreased erythroid progenitor cell number	J:155870
	decreased granulocyte monocyte progenitor cell number	J:155870
	decreased hematopoietic stem cell number	J:155870
	decreased megakaryocyte-erythroid progenitor cell number	J:155870
	increased mean corpuscular volume	J:155870
	thrombocytopenia	J:155870
Cd74^tm1Doi/Cd74^tm1Doi (either: (involves: 129/Sv * B10.BR) or (involves: 129/Sv * C57BL/6))	decreased CD4-positive, alpha-beta T cell number	J:4119, J:45185
	increased CD8-positive, alpha-beta T cell number	J:4119
Cd74^tm1Doi/Cd74^tm1Doi H2-DMa^tm1Doi/H2-DMa^tm1Doi (involves: 129S2/SvPas * C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:42482
	increased CD8-positive, alpha-beta T cell number	J:42482
Cd74^tm1Doi/Cd74^tm1Doi Tap1^tm1Arp/Tap1^tm1Arp (involves: 129S2/SvPas * C57BL/6)	abnormal T cell number	J:113083
Cd74^tm1Eae/Cd74^tm1Eae (involves: 129S2/SvPas)	decreased B cell proliferation	J:113050, J:132865
	decreased CD4-positive, alpha-beta T cell number	J:113050
	decreased IgM level	J:113050
Cd74^tm1Eae/Cd74^tm1Eae (B6.129S2-Cd74^tm1Eae)	arrested B cell differentiation	J:112084
Cd74^tm1Liz/Cd74⁺ (involves: 129S/SvEv)	hematopoietic system phenotype	J:155870
Cd74^tm1Liz/Cd74^tm1Liz (involves: 129S/SvEv * C57BL/6J)	decreased CD4-positive, alpha-beta T cell number	J:65918
Cd74^tm1Liz/Cd74^tm1Liz (involves: 129S/SvEv * C57BL/6J)	decreased T cell proliferation	J:72243
Cd74^tm1Liz/Cd74^tm1Liz (B6.129S-Cd74^tm1Liz)	abnormal T-helper 1 physiology	J:125654
	decreased CD4-positive, alpha-beta T cell number	J:28966
	decreased T cell proliferation	J:28966
Cd74^tm1Liz/Cd74^tm1Liz (involves: 129S/SvEv * BALB/cAn)	abnormal B cell differentiation	J:110927
	decreased CD4-positive, alpha-beta T cell number	J:110927, J:113714
	increased immature B cell number	J:110927
Cd74^tm1Liz/Cd74^tm1Liz (involves: 129S/SvEv * BALB/c * C57BL)	abnormal B cell differentiation	J:110927
	abnormal T cell proliferation	J:110927
	increased immature B cell number	J:110927
Cd74^tm1Liz/Cd74^tm1Liz (involves: 129S/SvEv * C57BL * C57BL/10 * C57BR)	abnormal B cell differentiation	J:110927
	abnormal T cell proliferation	J:110927
	increased immature B cell number	J:110927
Cd74^tm1Liz/Cd74^tm1Liz (involves: 129S/SvEv)	abnormal positive T cell selection	J:125548
Cd74^tm1Liz/Cd74^tm1Liz (involves: 129S/SvEv)	hematopoietic system phenotype	J:155870
Cd74^tm1Liz/Cd74^tm1Liz (B6.129S-Cd74^tm1Liz/J)	decreased B cell number	J:194664
Cd74^tm1Liz/Cd74^tm1Liz H2-DMa^tm1Liz/H2-DMa^tm1Liz (involves: 129S/SvEv * BALB/c)	decreased CD4-positive, alpha-beta T cell number	J:113714
Cd74^tm1Liz/Cd74^tm1Liz H2-DMa^tm1Luc/H2-DMa^tm1Luc Tg(CD74)AR194Ayr/? (involves: 129S/SvEv * 129S4/SvJae * C57BL/6J * DBA/2J)	decreased CD4-positive, alpha-beta T cell number	J:88717
Cd74^tm1Liz/Cd74^tm1Liz H2-DMa^tm1Luc/H2-DMa^tm1Luc Tg(CD74)1Ayr/0 (involves: 129S/SvEv 129S4/SvJae * C57BL/6J * DBA/2J)	decreased CD4-positive, alpha-beta T cell number	J:88717
Cd74^tm1Liz/Cd74^tm1Liz Sppl2a^tm1Basc/Sppl2a^tm1Basc (B6.129-Sppl2a^tm1Basc Cd74^tm1Liz)	decreased B cell number	J:194664
Cd74^tm1Liz/Cd74^tm1Liz Sppl2a^tm1Dgen/Sppl2a^tm1Dgen (involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6)	decreased follicular B cell number	J:194595
Cd74^tm2Liz/Cd74^tm1Liz (involves: 129S/SvEv * C57BL/6)	increased T cell proliferation	J:28966
Cd79a^m1Anu/Cd79a^m1Anu (involves: C57BL/6JSfdAnu * C57BL/10Sg * C57BR/cd)	absent pre-B cells	J:104190
	decreased IgG level	J:104190
Cd79a^m1Anu/Cd79a^m1Anu (C57BL/6-Cd79a^m1Anu)	absent pre-B cells	J:171924
Cd79a^m1Btlr/Cd79a^m1Btlr (involves: C57BL/6J * C57BL/10J)	decreased B cell number	J:174338
	decreased IgG level	J:174338
	decreased IgM level	J:174338
Cd79a^m1Btlr/Cd79a^m1Btlr (involves: C57BL/6J)	abnormal class switch recombination	J:185495
	decreased B cell number	J:185495
	decreased IgG level	J:185495
	decreased IgM level	J:185495
Cd79a^m2Btlr/Cd79a^m2Btlr (C57BL/6J-Cd79a^m2Btlr)	decreased B-1 B cell number	J:254836
Cd79a^m2Btlr/Cd79a^m2Btlr (C57BL/6J-Cd79a^m2Btlr)	decreased IgM level	J:254836
Cd79a^tm1(cre)Reth/Cd79a⁺ Commd3^tm1.1Ksuz/Commd3^tm1.1Ksuz (involves: BALB/c * C57BL/6NSlc * SJL)	abnormal follicular B cell physiology	J:278399
	abnormal plasmablast number	J:278399
	abnormal spleen B cell follicle morphology	J:278399
	decreased follicular B cell number	J:278399
	decreased IgG1 level	J:278399
	decreased IgG2b level	J:278399
	decreased IgG2c level	J:278399
	decreased IgM level	J:278399
	decreased mature B cell number	J:278399
	decreased spleen germinal center number	J:278399
Cd79a^tm1(cre)Reth/Cd79a⁺ Commd8^tm1.1Ksuz/Commd8^tm1.1Ksuz (involves: BALB/c * C57BL/6NSlc * SJL)	abnormal follicular B cell physiology	J:278399
	abnormal plasmablast number	J:278399
	abnormal spleen B cell follicle morphology	J:278399
	decreased follicular B cell number	J:278399
	decreased IgG1 level	J:278399
	decreased IgG2b level	J:278399
	decreased IgG2c level	J:278399
	decreased IgG3 level	J:278399
	decreased IgM level	J:278399
	decreased mature B cell number	J:278399
	decreased spleen germinal center number	J:278399
Cd79a^tm1(cre)Reth/Cd79a⁺ Ctnnbl1^tm1.1Crad/Ctnnbl1^tm1.1Crad (involves: 129P2/OlaHsd * BALB/c * C57BL/6 * SJL)	abnormal B cell proliferation	J:232010
	abnormal class switch recombination	J:232010
	decreased B cell proliferation	J:232010
Cd79a^tm1(cre)Reth/Cd79a⁺ Dicer1^tm1Mmk/Dicer1^tm1Mmk Tg(BCL2)22Wehi/0 (involves: BALB/c * C57BL/6JWehi * SJL/JWehi)	decreased B cell number	J:135783
	decreased mature B cell number	J:135783
Cd79a^tm1(cre)Reth/Cd79a⁺ Dynll1^tm1.1Jhh/Dynll1^tm1.1Jhh (B6.Cg-Dynll1^tm1.1Jhh Cd79a^tm1(Cre)Reth)	abnormal B cell morphology	J:230105
	decreased immature B cell number	J:230105
	decreased mature B cell number	J:230105
	decreased pre-B cell number	J:230105
Cd79a^tm1(cre)Reth/Cd79a⁺ Dynll1^tm1.1Jhh/Dynll1^tm1.1Jhh Tg(IghMyc)22Bri/0 (B6.Cg-Dynll1^tm1.1Jhh Cd79a^tm1(Cre)Reth Tg(IghMyc)22Bri)	decreased immature B cell number	J:230105
Cd79a^tm1(cre)Reth/Cd79a⁺ Huwe1^tm1.1Mak/Y (B6.Cg-Cd79a^tm1(cre)Reth Huwe1^tm1.1Mak)	abnormal B cell differentiation	J:181705
	abnormal class switch recombination	J:181705
	absent B-1a cells	J:181705
	decreased B cell proliferation	J:181705
	decreased follicular B cell number	J:181705
	decreased IgA level	J:181705
	decreased IgG1 level	J:181705
	decreased IgG2a level	J:181705
	decreased IgG3 level	J:181705
	decreased IgM level	J:181705
	decreased marginal zone B cell number	J:181705
	decreased mature B cell number	J:181705
	decreased pre-B cell number	J:181705
	decreased transitional stage B cell number	J:181705
	increased B cell apoptosis	J:181705
Cd79a^tm1(cre)Reth/Cd79a⁺ Huwe1^tm1.1Mak/Y Trp53^tm1Brn/Trp53^tm1Brn (involves: 129P2/OlaHsd * C57BL/6 * SJL)	abnormal class switch recombination	J:181705
	absent B-1a cells	J:181705
	decreased IgG1 level	J:181705
	decreased IgM level	J:181705
Cd79a^tm1(cre)Reth/Cd79a⁺ Ikzf1^tm3.1Mbu/Ikzf1^tm3.1Mbu (involves: 129P2/OlaHsd * BALB/c * C57BL/6 * SJL)	abnormal B cell differentiation	J:209928
	abnormal B cell number	J:209928
	decreased pre-B cell number	J:209928
	increased pro-B cell number	J:209928
Cd79a^tm1(cre)Reth/Cd79a⁺ Inpp5d^tm1Rav/Inpp5d^tm1Rav (involves: 129 * BALB/c * C57BL/6)	increased IgG level	J:178833
Cd79a^tm1(cre)Reth/Cd79a⁺ Nr4a1^tm1Pcn/Nr4a1^tm1Pcn (involves: 129 * BALB/c)	increased B cell proliferation	J:306652
Cd79a^tm1(cre)Reth/Cd79a⁺ Nr4a1^tm1Pcn/Nr4a1^tm1Pcn Nr4a3^em1Juz/Nr4a3^em1Juz (involves: 129 * BALB/c * C57BL/6)	decreased B cell apoptosis	J:306652
	increased B cell proliferation	J:306652
Cd79a^tm1(cre)Reth/Cd79a⁺ Phf5a^tm1.1Oux/Phf5a^tm1.1Oux (involves: BALB/c * C57BL/6J)	abnormal B cell physiology	J:345807
	abnormal B cell receptor editing	J:345807
	abnormal immunoglobulin heavy chain V(D)J recombination	J:345807
	decreased B cell number	J:345807
	decreased early pro-B cell number	J:345807
	decreased immature B cell number	J:345807
	decreased late pro-B cell number	J:345807
	decreased mature B cell number	J:345807
	decreased pre-B cell number	J:345807
	increased pre-pro B cell number	J:345807
	small spleen	J:345807
Cd79a^tm1(cre)Reth/Cd79a⁺ Phf5a^tm1.1Oux/Phf5a^tm1.1Oux Tg(IghelMD4)4Ccg/0 (involves: BALB/c * C57BL/6 * C57BL/6J)	abnormal B cell number	J:345807
Cd79a^tm1(cre)Reth/Cd79a⁺ Slc39a10^tm1.1Tfk/Slc39a10^tm1.1Tfk (involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6J)	decreased B cell number	J:213935
	decreased IgA level	J:213935
	decreased IgE level	J:213935
	decreased IgG1 level	J:213935
	decreased IgG2b level	J:213935
	decreased IgG2c level	J:213935
	decreased IgG3 level	J:213935
	decreased IgM level	J:213935
	decreased immunoglobulin level	J:213935
	decreased pro-B cell number	J:213935
	spleen atrophy	J:213935
Cd79a^tm1(cre)Reth/Cd79a⁺ Was^tm1.1Ldn/Y (involves: BALB/c * C57BL/6)	abnormal B cell physiology	J:182528
	decreased B cell number	J:182528
	decreased follicular B cell number	J:182528
	decreased marginal zone B cell number	J:182528
	decreased mature B cell number	J:182528
	increased germinal center B cell number	J:182528
	increased IgM level	J:182528
	increased plasma cell number	J:182528
Cd79a^tm1(cre)Reth/Cd79a⁺ Was^tm1.1Ldn/Was⁺ (involves: BALB/c * C57BL/6)	abnormal B cell number	J:182528
	abnormal B cell proliferation	J:182528
Cd79a^tm1(cre)Reth/Cd79a⁺ Was^tm1.1Ldn/Was^tm1.1Ldn (involves: BALB/c * C57BL/6)	abnormal B cell physiology	J:182528
	decreased B cell number	J:182528
	decreased follicular B cell number	J:182528
	decreased marginal zone B cell number	J:182528
	decreased mature B cell number	J:182528
	increased germinal center B cell number	J:182528
	increased IgM level	J:182528
	increased plasma cell number	J:182528
Cd79a^tm1(cre)Reth/Cd79a^tm1(cre)Reth Mzb1^tm1.1Rug/Mzb1^tm1.1Rug (involves: 129S2/SvPas * BALB/c * C57BL/6 * SJL)	abnormal B cell number	J:211639
	decreased pre-B cell number	J:211639
	increased late pro-B cell number	J:211639
	increased pro-B cell number	J:211639
	small spleen	J:211639
Cd79a^tm1.1Cgn/Cd79a⁺ Cd79b^tm1Gzmn/Cd79b^tm1Gzmn (involves: 129P2/OlaHsd)	decreased B cell number	J:179254
	decreased pre-B cell number	J:179254
	increased pro-B cell number	J:179254
Cd79a^tm1.1Cgn/Cd79a^tm1.1Cgn (involves: 129P2/OlaHsd)	decreased B-1a cell number	J:124400
Cd79a^tm1.1Cgn/Cd79a^tm1.1Cgn (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell activation	J:71100
	decreased B-1 B cell number	J:71100
	decreased IgG1 level	J:71100
	decreased marginal zone B cell number	J:71100
	decreased mature B cell number	J:71100
Cd79a^tm1.1Cgn/Cd79a^tm1.1Cgn Cd79b^tm1Gzmn/Cd79b⁺ (involves: 129P2/OlaHsd)	decreased B cell number	J:179254
	decreased pre-B cell number	J:179254
	increased pro-B cell number	J:179254
Cd79a^tm1.1Cgn/Cd79a^tm1.1Cgn Cd79b^tm1Gzmn/Cd79b^tm1Gzmn (involves: 129/Sv * 129P2/OlaHsd * C57BL/6)	abnormal B cell differentiation	J:124400
Cd79a^tm1.1Cgn/Cd79a^tm1.1Cgn Cd79b^tm1Gzmn/Cd79b^tm1Gzmn (involves: 129P2/OlaHsd)	abnormal B cell differentiation	J:179254
	absent pre-B cells	J:179254
	decreased B cell number	J:179254
	increased pro-B cell number	J:179254
Cd79a^tm1.1Cgn/Cd79a^tm1.1Cgn Cd79b^tm2.1Mnz/Cd79b^tm2.1Mnz (involves: 129/Sv * 129P2/OlaHsd * C57BL/6)	absent mature B cells	J:71100
	arrested B cell differentiation	J:71100
Cd79a^tm1.1Rsky/Cd79a^tm1.1Rsky (involves: C57BL/6)	decreased IgG2b level	J:179254
	decreased IgG2c level	J:179254
	decreased IgG3 level	J:179254
	decreased marginal zone B cell number	J:179254
	decreased mature B cell number	J:179254
	hematopoietic system phenotype	J:179254
	increased IgG2b level	J:179254
	increased IgG2c level	J:179254
	increased immature B cell number	J:179254
	increased pre-B cell number	J:179254
	increased transitional stage B cell number	J:179254
	increased transitional stage T1 B cell number	J:179254
	increased transitional stage T2 B cell number	J:179254
	increased transitional stage T3 B cell number	J:179254
Cd79a^{tm2(cre/Esr1*)Reth}/Cd79a⁺ Rag1^tm1.1Sadu/Rag1^tm1.1Sadu (involves: BALB/c)	arrested B cell differentiation	J:155473
Cd79a^tm2Cgn/Cd79a^tm2Cgn (involves: C57BL/6 * C.B-20)	decreased B cell number	J:80885
	decreased immunoglobulin level	J:80885
	decreased mature B cell number	J:80885
Cd79a^tm2Cgn/Cd79a^tm2Cgn (involves: C57BL/6)	decreased mature B cell number	J:71100, J:66840
	decreased pre-B cell number	J:71100, J:66840
	increased pro-B cell number	J:66840
Cd79a^tm2Cgn/Cd79a^tm2Cgn Cd79b^tm2.1Mnz/Cd79b^tm2.1Mnz (involves: 129/Sv * C57BL/6)	arrested B cell differentiation	J:66840
	decreased transitional stage B cell number	J:66840
Cd79a^tm2Pld/Cd79a^tm2Pld (BALB/c-Cd79a^tm2Pld)	abnormal B cell differentiation	J:87492
	abnormal T cell differentiation	J:87492
	absent mature B cells	J:87492
	decreased double-positive T cell number	J:87492
Cd79a^tm2Pld/Cd79a^tm2Pld Cd79b^tm1Mnz/Cd79b^tm1Mnz (involves: 129S1/Sv * BALB/c)	absent pre-B cells	J:87492
Cd79a^tm3Cgn/Cd79a^tm3Cgn Tg(Mx1-cre)1Cgn/? (involves: C57BL/6 * CBA)	abnormal metallophilic macrophage morphology	J:88620
	abnormal spleen marginal zone macrophage morphology	J:88620
	abnormal spleen red pulp morphology	J:88620
	decreased B cell number	J:88620
Cd79a^tm4.1Cgn/Cd79a^tm4.1Cgn (involves: C57BL/6)	abnormal B cell differentiation	J:91091
Cd79a^tm4.1Cgn/Cd79a^tm4.1Cgn Igh^tm1.2Rsky/Igh⁺ (involves: BALB/c * C57BL/6)	abnormal pro-B cell differentiation	J:125719
Cd79a^tm4Cgn/Cd79a^tm4.1Cgn Tg(Cr2-cre)3Cgn/0 (involves: 129P2/OlaHsd * C57BL/6)	decreased B cell number	J:91091
	decreased IgD level	J:91091
	decreased IgM level	J:91091
Cd79a^tm4Cgn/Cd79a^tm4.1Cgn Tg(Mx1-cre)1Cgn/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	absent immature B cells	J:91091
	arrested B cell differentiation	J:91091
	decreased B cell number	J:91091
	decreased follicular B cell number	J:91091
	decreased marginal zone B cell number	J:91091
Cd79a^tm5.1Cgn/Cd79a⁺ Igh^tm1.2Rsky/Igh⁺ (involves: 129 * BALB/c * C57BL/6)	abnormal class switch recombination	J:125719
Cd79a^tm5.1Cgn/Cd79a^tm5.1Cgn (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell differentiation	J:91091
Cd79a^tm5.1Cgn/Cd79a^tm5.1Cgn (involves: 129 * C57BL/6)	abnormal B cell morphology	J:125719
	decreased B-1a cell number	J:125719
	decreased immature B cell number	J:125719
	decreased mature B cell number	J:125719
	decreased pre-B cell number	J:125719
	decreased T cell number	J:125719
	increased pro-B cell number	J:125719
Cd79a^tm5.1Cgn/Cd79a^tm5.1Cgn Igh^tm1.2Rsky/Igh⁺ (involves: 129 * BALB/c * C57BL/6)	abnormal class switch recombination	J:125719
Cd79a^tm5.1Cgn/Cd79a^tm5.1Cgn Igh^tm1.2Rsky/Igh^tm1.2Rsky (involves: 129 * BALB/c * C57BL/6)	abnormal B cell morphology	J:125719
	abnormal class switch recombination	J:125719
	decreased immature B cell number	J:125719
	decreased mature B cell number	J:125719
	decreased pre-B cell number	J:125719
	decreased T cell number	J:125719
	increased B-1b cell number	J:125719
	increased pro-B cell number	J:125719
Cd79a^tm5Cgn/Cd79a^tm5.1Cgn Tg(Cr2-cre)3Cgn/0 (involves: 129P2/OlaHsd * C57BL/6)	decreased B cell number	J:91091
Cd79a^tm5Cgn/Cd79a^tm5.1Cgn Tg(Mx1-cre)1Cgn/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	absent immature B cells	J:91091
	arrested B cell differentiation	J:91091
	decreased B cell number	J:91091
Cd79a^tm6Cgn/Cd79a^tm6Cgn (involves: C57BL/6)	abnormal B cell number	J:113407
	abnormal B cell physiology	J:113407
	abnormal immunoglobulin level	J:113407
	decreased B cell proliferation	J:113407
	decreased B-1a cell number	J:113407
	decreased IgG2a level	J:113407
	decreased IgG3 level	J:113407
	decreased IgM level	J:113407
	increased transitional stage B cell number	J:113407
Cd79b^m1Btlr/Cd79b^m1Btlr (C57BL/6J-Cd79b^m1Btlr)	decreased B cell number	J:267537
	decreased B-1 B cell number	J:267537
	decreased NK cell number	J:267537
	increased alpha-beta T cell number	J:267537
	increased CD4-positive, alpha-beta T cell number	J:267537
	increased CD8-positive, alpha-beta T cell number	J:267537
Cd79b^m1Ghost/Cd79b^m1Ghost (B10.Cg-Ptprc^a Cd79b^m1Ghost H2^a)	abnormal B cell differentiation	J:157450
	absent B cells	J:157450
	arrested B cell differentiation	J:157450
	decreased IgA level	J:157450
	decreased IgG level	J:157450
Cd79b^M2Btlr/Cd79b^M2Btlr (C57BL/6J-Cd79b^M2Btlr)	abnormal lymphocyte morphology	J:272863
	decreased B cell number	J:272863
	decreased B-1 B cell number	J:272863
Cd79b^tm1Gzmn/Cd79b^tm1Gzmn (involves: 129/Sv * C57BL/6)	decreased B-1a cell number	J:124400
	decreased IgG1 level	J:124400
	increased IgD level	J:124400
	increased IgM level	J:124400
Cd79b^tm1Mnz/Cd79b^tm1Mnz (involves: 129S1/Sv)	abnormal pro-B cell differentiation	J:78601
	abnormal pro-B cell morphology	J:78601
	arrested B cell differentiation	J:78601
Cd79b^tm1Mnz/Cd79b^tm1Mnz Tg(BCL2)22Wehi/0 Tg(IghelMD4)4Ccg/0 Tg(Rag2-Igb)1Mnz/0 (involves: 129S1/Sv * C57BL/6 * C57BL/6JWehi * SJL/JWehi)	arrested B cell differentiation	J:78601
Cd79b^tm1Mnz/Cd79b^tm1Mnz Tg(BCL2)22Wehi/0 Tg(Rag2-Igb)1Mnz/0 (involves: 129S1/Sv * C57BL/6JWehi * SJL/JWehi)	arrested B cell differentiation	J:78601
Cd79b^tm1Mnz/Cd79b^tm1Mnz Tg(IghelMD4)4Ccg/0 Tg(Rag2-Igb)1Mnz/0 (involves: 129S1/Sv * C57BL/6)	abnormal immature B cell morphology	J:78601
	arrested B cell differentiation	J:78601
Cd79b^tm1Mnz/Cd79b^tm1Mnz Tg(Rag2-Igb)1Mnz/0 (involves: 129S1/Sv)	abnormal pre-B cell morphology	J:78601
	arrested B cell differentiation	J:78601
Cd79b^tm2.1Mnz/Cd79b^tm2.1Mnz (involves: 129 * C57BL/6)	decreased mature B cell number	J:71100
Cd79b^tm2.1Mnz/Cd79b^tm2.1Mnz (involves: 129/Sv * C57BL/6)	abnormal B cell activation	J:66840
	arrested B cell differentiation	J:66840
	decreased mature B cell number	J:66840
	decreased pre-B cell number	J:66840
	decreased transitional stage B cell number	J:66840
	increased pro-B cell number	J:66840
Cd79b^tm3Mnz/Cd79b^tm3Mnz (involves: 129/Sv * C57BL/6)	abnormal B cell physiology	J:128768
	abnormal immature B cell morphology	J:128768
	decreased B cell number	J:128768
	decreased B cell proliferation	J:128768
	decreased B-1a cell number	J:128768
	decreased immature B cell number	J:128768
	decreased mature B cell number	J:128768
	increased marginal zone B cell number	J:128768
	increased pro-B cell number	J:128768
Cd80^tm1Lbgn/Cd80^tm1Lbgn (C3.Cg-Cd80^tm1Lbgn)	abnormal T cell physiology	J:110947
Cd80^tm1Shr/Cd80^tm1Shr (involves: 129S4/SvJae)	abnormal immunoglobulin level	J:39089
Cd80^tm1Shr/Cd80^tm1Shr (involves: 129S4/SvJae)	decreased B cell proliferation	J:74662
Cd80^tm1Shr/Cd80^tm1Shr Cd86^tm1Shr/Cd86^tm1Shr (B6.129S4-Cd80^tm1Shr Cd86^tm1Shr)	decreased T cell proliferation	J:57613
Cd80^tm1Shr/Cd80^tm1Shr Cd86^tm2Shr/Cd86^tm2Shr (involves: 129S4/SvJae)	abnormal spleen morphology	J:39089
	abnormal T cell physiology	J:57090
	abnormal T cell proliferation	J:57090
	decreased IgG1 level	J:39089
	decreased IgG2a level	J:39089
	decreased IgG level	J:39089
	decreased regulatory T cell number	J:205441, J:113109
	increased IgG3 level	J:39089
	increased IgM level	J:39089
Cd80^tm1Shr/Cd80^tm1Shr Cd86^tm2Shr/Cd86^tm2Shr (involves: 129S4/SvJae * NOD)	abnormal CD4-positive, alpha-beta T cell physiology	J:61905
Cd80^tm1Shr/Cd80^tm1Shr Cd86^tm2Shr/Cd86^tm2Shr (involves: 129S4/SvJae * BALB/c)	abnormal T cell number	J:112266
	decreased double-positive T cell number	J:112266
Cd80^tm1Shr/Cd80^tm1Shr Cd86^tm2Shr/Cd86^tm2Shr Ctla4^tm1Shr/Ctla4^tm1Shr (involves: 129S4/SvJae * BALB/c)	abnormal T cell physiology	J:57090
	increased T cell proliferation	J:57090
Cd80^tm1Shr/Cd80^tm1Shr Cd86^tm2Shr/Cd86^tm2Shr Tg(Ighm-Ctla4Ig/Cd80)1Jbs/0 (involves: 129S4/SvJae * FVB/N * NOD)	decreased regulatory T cell number	J:113109
Cd81^tm1Geha/Cd81^tm1Geha (involves: 129S4/SvJae * C57BL/6)	abnormal B cell morphology	J:43975
	decreased B-1 B cell number	J:43975
	decreased B-1a cell number	J:43975
	increased B cell proliferation	J:43975
	increased IgA level	J:43975
	increased IgG3 level	J:43975
	increased IgM level	J:43975
Cd81^tm1Lvy/Cd81^tm1Lvy (involves: 129S1/Sv * 129X1/SvJ)	abnormal B cell morphology	J:40394
	abnormal T-helper 2 physiology	J:40394
	decreased IgG1 level	J:40394
	decreased IgG level	J:40394
Cd81^tm1Lvy/Cd81^tm1Lvy (CByJ.129-Cd81^tm1Lvy)	abnormal T-helper 2 physiology	J:46171
Cd81^tm1Lvy/Cd81^tm1Lvy (either: (B6ByJ.129-Cd81^tm1Lvy x CByJ.129-Cd81^tm1Lvy)F1 or (CByJ.129-Cd81^tm1Lvy x B6ByJ.129-Cd81^tm1Lvy)F1)	abnormal microglial cell morphology	J:79426
Cd81^tm1Tmiy/Cd81^tm1Tmiy (involves: 129/Sv * C57BL/6)	abnormal B cell differentiation	J:41830
	abnormal macrophage physiology	J:83795
	abnormal T cell proliferation	J:41830
	decreased B cell proliferation	J:41830
	decreased B-1 B cell number	J:41830
	increased B cell proliferation	J:41830
Cd81^tm1Tmiy/Cd81^tm1Tmiy Cd9^tm1Mek/Cd9^tm1Mek (involves: 129/Sv * C57BL/6)	abnormal definitive hematopoiesis	J:83795
	abnormal macrophage physiology	J:83795
	increased osteoclast cell number	J:83795
Cd82^tm1Kjbr/Cd82^tm1Kjbr (Not Specified)	abnormal cellular extravasation	J:326451
	abnormal macrophage differentiation	J:326451
	abnormal neutrophil physiology	J:326451
	impaired leukocyte tethering or rolling	J:326451
	increased macrophage cell number	J:326451
	increased neutrophil cell number	J:326451
Cd83^anu/Cd83^anu (involves: C57BL/6JAnu * CBA/CaJAnu)	abnormal B cell morphology	J:104190
	abnormal dendritic cell morphology	J:104190
	decreased CD4-positive, alpha-beta T cell number	J:104190
Cd83^lcd4/Cd83^lcd4 (involves: C57BL/6J)	abnormal CD4-positive T cell differentiation	J:92721
	abnormal CD4-positive, alpha-beta T cell physiology	J:92721
	decreased T cell proliferation	J:92721
Cd83^tm1.1Lnjt/Cd83^tm1.1Lnjt (involves: C57BL/6 * C57BL/6N)	decreased CD4-positive, alpha-beta T cell number	J:236611
Cd83^tm1.1Lnjt/Cd83^tm1.1Lnjt Marchf1^tm1.1Sish/Marchf1^tm1.1Sish (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/6N)	decreased CD4-positive, alpha-beta T cell number	J:236611
Cd83^tm1Tft/Cd83^tm1Tft (involves: 129S4/SvJae * C57BL/6)	abnormal CD4-positive T cell differentiation	J:75700
	arrested T cell differentiation	J:75700
	decreased CD4-positive, alpha-beta T cell number	J:75700
	decreased IgA level	J:75700
	decreased IgG1 level	J:75700
	decreased IgG2a level	J:75700
	decreased IgG2b level	J:75700
	decreased IgG3 level	J:75700
	decreased IgM level	J:75700
Cd84^tm1Pls/Cd84^tm1Pls (C57BL/6J-Cd84^tm1Pls)	abnormal CD4-positive, alpha-beta T cell physiology	J:157915
	abnormal long lived plasma cell morphology	J:157915
	decreased CD4-positive, alpha-beta T cell number	J:157915
	decreased germinal center B cell number	J:157915
	decreased IgG level	J:157915
	decreased spleen germinal center size	J:157915
Cd84^tm1Pls/Cd84^tm1Pls Tg(TcraTcrb)425Cbn/? (B6.Cg-Cd84^tm1Pls Tg(TcraTcrb)425Cbn)	abnormal CD4-positive, alpha-beta T cell physiology	J:157915
Cd86^tm1Shr/Cd86^tm1Shr (NOD.129S4-Cd86^tm1Shr)	abnormal T cell proliferation	J:142046
	decreased regulatory T cell number	J:93421
	decreased T cell proliferation	J:93421
Cd86^tm1Shr/Cd86^tm1Shr (involves: 129S4/SvJae)	absent spleen germinal center	J:39089
Cd86^tm1Shr/Cd86^tm1Shr (involves: 129S4/SvJae)	decreased IgG level	J:39089
Cd86^tm1Shr/Cd86^tm1Shr (B6.129S4-Cd86^tm1Shr)	decreased T cell proliferation	J:57613
Cd93^tm1Mbo/Cd93^tm1Mbo (either: 129/Sv or B6.129-Cd93^tm1Mbo or (involves: 129/Sv * C57BL/6))	impaired macrophage phagocytosis	J:88610
Cd96^{em1(IMPC)Wtsi}/Cd96^{em1(IMPC)Wtsi} (C57BL/6N-Cd96^{em1(IMPC)Wtsi}/WtsiOulu)	increased leukocyte cell number	J:211773
Cd96^tm1.1Mjs/Cd96^tm1.1Mjs (B6.129P2(Cg)-Cd96^tm1.1Mjs)	abnormal NK cell physiology	J:209990
Cd96^tm1.1Mjs/Cd96^tm1.1Mjs (B6.129P2(Cg)-Cd96^tm1.1Mjs)	hematopoietic system phenotype	J:209990
Cd99^{Gt(Ayu21-B6T44)Imeg}/Cd99^{Gt(Ayu21-B6T44)Imeg} (involves: C57BL/6 * C57BL/6NSlc)	abnormal splenocyte physiology	J:212222
Cd99l2^tm1.1Dvst/Cd99l2^tm1.1Dvst Tg(Tek-cre)1Ywa/0 (involves: 129S6/SvEvTac * BALB/c * C57BL/6)	abnormal cellular extravasation	J:193021
Cd99l2^tm1.2Dvst/Cd99l2^tm1.2Dvst (involves: 129S6/SvEvTac * BALB/c * C57BL/6)	abnormal cellular extravasation	J:193021
	hematopoietic system phenotype	J:193021
Cd101^tm1.1Dil/Cd101^tm1.1Dil (involves: BALB/cJ * C57BL/6 * C57BL/6NTac)	decreased granulocyte number	J:175943
Cd151^tm1Lka/Cd151^tm1Lka (C57BL/6-Cd151^tm1Lka)	abnormal bone marrow cell number	J:91605
Cd151^tm1Lka/Cd151^tm1Lka (C57BL/6-Cd151^tm1Lka)	abnormal T cell proliferation	J:91605
Cd163^{tm1(KOMP)Vlcg}/Cd163^{tm1(KOMP)Vlcg} (involves: C57BL/6NTac)	abnormal macrophage chemotaxis	J:224919
Cd177^{tm1(KOMP)Vlcg}/Cd177^{tm1(KOMP)Vlcg} (involves: C57BL/6NTac)	abnormal neutrophil physiology	J:225335
	decreased monocyte cell number	J:225335
	decreased neutrophil cell number	J:225335
Cd180^tm1Kmiy/Cd180^tm1Kmiy (involves: 129P2/OlaHsd * C57BL/6)	decreased IgG2b level	J:137066
	decreased IgG3 level	J:137066
Cd180^tm1Kmiy/Cd180^tm1Kmiy (involves: 129P2/OlaHsd * C57BL/6 * NZB * NZW)	decreased IgG2a level	J:137066
	decreased IgG3 level	J:137066
Cd180^tm1Kmiy/Cd180^tm1Kmiy Fas^lpr/Fas^lpr (MRL.Cg-Cd180^tm1Kmiy Fas^lpr)	decreased B cell number	J:137066
	decreased CD8-positive, alpha-beta T cell number	J:137066
	decreased IgG2a level	J:137066
	decreased IgG3 level	J:137066
	enlarged spleen	J:137066
	hematopoietic system phenotype	J:137066
	increased double-negative T cell number	J:137066
Cd200^tm1Jods/Cd200^tm1Jods (C57BL/6-Cd200^tm1Jods)	abnormal macrophage physiology	J:65982
	abnormal microglial cell morphology	J:65982
	abnormal microglial cell physiology	J:65982
	increased macrophage cell number	J:79906, J:65982
	increased spleen red pulp amount	J:65982
Cd200r1^tm1Eakj/Cd200r1^tm1Eakj (Not Specified)	abnormal macrophage physiology	J:326965
Cd207^{tm1(Hbegf/EGFP)Bjec}/Cd207⁺ (involves: C57BL/6 * SJL)	absent Langerhans cell	J:137517
	decreased dendritic cell number	J:137452
Cd207^tm1.1Cfg/Cd207^tm1.1Cfg (involves: C57BL/6)	decreased IgA level	J:217719
	decreased IgG1 level	J:217719
	decreased IgG2a level	J:217719
	decreased IgG3 level	J:217719
	decreased IgM level	J:217719
Cd207^tm1Mal/Cd207^tm1Mal (B6.129S2-Cd207^tm1Mal)	abnormal Langerhans cell morphology	J:95147
Cd207^{tm2.1(cre)Bjec}/Cd207⁺ Tgfbr1^tm1.1Karl/Tgfbr1^tm1.1Karl (involves: 129S4/SvJaeSor * C57BL/6)	decreased dendritic cell number	J:179630
Cd207^tm2.1Mal/Cd207^{tm3.1(HBEGF/EGFP)Mal} (involves: 129S2/SvPas)	abnormal Langerhans cell morphology	J:99114
	absent Langerhans cell	J:99114
	decreased Langerhans cell number	J:99114
Cd209a^tm1.1Cfg/Cd209a^tm1.1Cfg (involves: C57BL/6)	decreased IgG2b level	J:217719
	increased lymphocyte cell number	J:217719
	increased mature B cell number	J:217719
	increased monocyte cell number	J:217719
	increased plasma cell number	J:217719
	increased spleen germinal center size	J:217719
	increased T cell proliferation	J:217719
Cd209b^tm1.1Cfg/Cd209b^tm1.1Cfg (involves: C57BL/6)	decreased mature B cell number	J:217719
	impaired macrophage phagocytosis	J:288225
	increased eosinophil cell number	J:288225
	increased IgG2b level	J:217719
	increased IgG3 level	J:217719
	increased IgM level	J:217719
	increased macrophage cell number	J:217719
Cd209b^tm1Anjm/Cd209b^tm1Anjm (involves: 129P2/OlaHsd * C57BL/6)	abnormal macrophage physiology	J:94698
	impaired macrophage phagocytosis	J:94698
Cd209d^tm1.1Cfg/Cd209d^tm1.1Cfg (involves: C57BL/6)	increased B cell number	J:217719
Cd209d^tm1.1Cfg/Cd209d^tm1.1Cfg (involves: C57BL/6)	increased B cell proliferation	J:217719
Cd226^tm1.1Cln/Cd226^tm1.1Cln (B6.129P2-Cd226^tm1.1Cln)	decreased T cell proliferation	J:159749
Cd226^tm1.1Cln/Cd226^tm1.1Cln (B6.129P2-Cd226^tm1.1Cln)	impaired natural killer cell mediated cytotoxicity	J:159749
Cd226^tm1.1Cln/Cd226^tm1.1Cln Tg(TcraTcrb)1100Mjb/0 (B6.Cg-Cd226^tm1.1Cln Tg(TcraTcrb)1100Mjb)	abnormal T cell activation	J:159749
	decreased cytotoxic T cell cytolysis	J:159749
	decreased T cell proliferation	J:159749
Cd226^tm1Shib/Cd226^tm1Shib (involves: BALB/c)	decreased cytotoxic T cell cytolysis	J:165704
Cd226^tm1Shib/Cd226^tm1Shib (involves: BALB/c)	impaired natural killer cell mediated cytotoxicity	J:165704
Cd244a^Chip/Cd244a⁺ (C57BL/6J-Cd244a^Chip)	abnormal NK cell physiology	J:196519
Cd244a^Chip/Cd244a⁺ (C57BL/6J-Cd244a^Chip)	impaired natural killer cell mediated cytotoxicity	J:196519
Cd244a^Chip/Cd244a^Chip (C57BL/6J-Cd244a^Chip)	abnormal NK cell physiology	J:196519
Cd244a^Chip/Cd244a^Chip (C57BL/6J-Cd244a^Chip)	impaired natural killer cell mediated cytotoxicity	J:196519
Cd244a^tm1Kmle/Cd244a^tm1Kmle (involves: C57BL/6)	impaired natural killer cell mediated cytotoxicity	J:166054
Cd244a^tm1Kmle/Cd244a^tm1Kmle (involves: C57BL/6)	increased natural killer cell mediated cytotoxicity	J:92740
Cd247^m1Btlr/Cd247^m1Btlr (C57BL/6J-Cd247^m1Btlr)	abnormal CD4-positive, alpha-beta T cell physiology	J:158794
Cd247^tm1Lov/Cd247^tm1Lov (involves: 129S4/SvJae)	abnormal single-positive T cell number	J:14170
	abnormal T-helper 1 cell morphology	J:14170
	abnormal T-helper 1 physiology	J:46914
	absent gamma-delta intraepithelial T cell	J:46914
	decreased CD4-positive, alpha-beta T cell number	J:14170
	decreased double-positive T cell number	J:14170
	decreased thymocyte number	J:14170
Cd247^tm1Lov/Cd247^tm1Lov Fcer1g^tm1Rav/Fcer1g^tm1Rav (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	abnormal effector T cell morphology	J:46914
	abnormal T cell activation	J:46914
	abnormal T-helper 1 physiology	J:46914
	absent gamma-delta intraepithelial T cell	J:46914
	decreased thymocyte number	J:46914
	impaired natural killer cell mediated cytotoxicity	J:64764
Cd247^tm1Mal/Cd247^tm1Mal (either: C57BL/6-Cd247^tm1Mal or (involves: BALB/c * C57BL/6))	abnormal intraepithelial T cell morphology	J:15272
	abnormal T cell differentiation	J:15272
	decreased CD4-positive, alpha-beta T cell number	J:15272
	decreased CD8-positive, alpha-beta T cell number	J:15272
	decreased double-positive T cell number	J:15272
	decreased single-positive T cell number	J:15272
	decreased thymocyte number	J:15272
	increased double-negative T cell number	J:15272
Cd247^tm1Mal/Cd247^tm1Mal (involves: C57BL/6)	abnormal double-negative T cell morphology	J:112990, J:110847
	abnormal T cell differentiation	J:112990
	abnormal T cell morphology	J:110847
	abnormal thymocyte activation	J:110847
	decreased double-positive T cell number	J:110847
Cd247^tm1Mal/Cd247^tm1Mal Lck^tm1Mak/Lck^tm1Mak (involves: 129S2/SvPas * C57BL/6)	abnormal double-negative T cell morphology	J:110847
	abnormal T cell differentiation	J:110847
	abnormal T cell morphology	J:110847
	abnormal thymocyte activation	J:110847
	decreased double-positive T cell number	J:110847
Cd247^tm1Mhu/Cd247^tm1Mhu (involves: 129S7/SvEvBrd * C57BL/6)	abnormal T cell differentiation	J:15579
	decreased CD4-positive, alpha-beta T cell number	J:15579
	decreased CD8-positive, alpha-beta T cell number	J:15579
	decreased double-positive T cell number	J:15579
	decreased splenocyte proliferation	J:15579
	decreased T cell proliferation	J:15579
	decreased thymocyte number	J:15579
	enlarged spleen	J:15579
	enlarged thymus cortex	J:15579
	increased double-negative T cell number	J:15579
	small thymus	J:15579
	small thymus medulla	J:15579
	thymus hypoplasia	J:15579
Cd247^tm1Mhu/Cd247^tm1Mhu Fcer1g^tm1Rav/Fcer1g^tm1Rav (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)	decreased uterine NK cell number	J:100668
Cd247^tm1Tks/Cd247^tm1Tks (involves: 129P2/OlaHsd * C57BL/6)	abnormal alpha-beta intraepithelial T cell morphology	J:15271
	abnormal T cell proliferation	J:15271
	decreased CD4-positive, alpha-beta T cell number	J:15271
	decreased CD8-positive, alpha-beta T cell number	J:15271
	decreased double-positive T cell number	J:15271
	decreased single-positive T cell number	J:15271
	decreased thymocyte number	J:15271
	small thymus medulla	J:15271
Cd247^tm1Tks/Cd247^tm1Tks (B6.129P2-Cd247^tm1Tks)	abnormal NK cell morphology	J:66403
	abnormal NK cell physiology	J:66403
	decreased NK T cell number	J:28282
	increased natural killer cell mediated cytotoxicity	J:66403
Cd247^tm2.1Lov/Cd247^tm2.1Lov (Not Specified)	abnormal bone marrow cell physiology	J:192915
	abnormal gamma-delta T cell differentiation	J:192915
	abnormal NK T cell morphology	J:192915
	abnormal regulatory T cell physiology	J:192915
	abnormal T cell differentiation	J:192915
	abnormal T cell physiology	J:192915
	abnormal T-helper 1 cell differentiation	J:192915
	decreased CD4-positive, alpha-beta T cell number	J:192915
	decreased CD8-positive, alpha-beta T cell number	J:192915
	decreased thymocyte apoptosis	J:192915
	decreased thymocyte number	J:192915
	increased regulatory T cell number	J:192915
Cd247^tm2.1Lov/Cd247^tm2.1Lov Tg(TcraH-Y,TcrbH-Y)71Vbo/0 (involves: C57BL/6J * DBA/2J)	abnormal T cell differentiation	J:192915
Cd274^tm1.1Lex/Cd274^tm1.1Lex (involves: 129S5/SvEvBrd)	decreased CD8-positive, alpha-beta T cell number	J:126829
Cd274^tm1Igu/Cd274^tm1Igu Vsir^tm1Lex/Vsir^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	abnormal T cell activation	J:222944
Cd274^tm1Lpc/Cd274^tm1Lpc (B6.129S-Cd274^tm1Lpc)	abnormal CD8-positive, alpha-beta T cell physiology	J:89781
	decreased T cell apoptosis	J:89781
	hematopoietic system phenotype	J:89781
	increased activated T cell number	J:89781
	increased CD8-positive, alpha-beta T cell number	J:89781
Cd274^tm1Lpc/Cd274^tm1Lpc (involves: 129S/SvEv * C57BL/6)	abnormal T cell morphology	J:136330
	abnormal T-helper 1 cell differentiation	J:162539
	decreased T cell apoptosis	J:136330
	decreased T helper 1 cell number	J:162539
	increased CD8-positive, alpha-beta T cell number	J:152305
	increased IgG1 level	J:162539
	increased IgG2c level	J:162539
	increased T cell number	J:142815
Cd274^tm1Lpc/Cd274^tm1Lpc (C.129S-Cd274^tm1Lpc)	abnormal regulatory T cell physiology	J:165841
	abnormal T follicular helper cell physiology	J:165841
	decreased germinal center B cell number	J:165841
	decreased IgG1 level	J:165841
	decreased IgG2a level	J:165841
	decreased plasma cell number	J:165841
	decreased T-helper 17 cell number	J:165841
	increased T cell proliferation	J:165841
Cd274^tm1Shr/Cd274^tm1Shr (involves: C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:91480
Cd274^tm1Shr/Cd274^tm1Shr (involves: C57BL/6)	abnormal CD8-positive, alpha beta T cell morphology	J:91480
Cd276^tm1Lpc/Cd276^tm1Lpc (B6.129-Cd276^tm1Lpc)	abnormal T-helper 1 physiology	J:237700
Cd276^tm1Lpc/Cd276^tm1Lpc (B6.129-Cd276^tm1Lpc)	abnormal T-helper 2 physiology	J:237700
Cd276^tm1Lpc/Cd276^tm1Lpc (D1J.129-Cd276^tm1Lpc)	abnormal T-helper 1 physiology	J:237700
Cd276^tm1Lpc/Cd276^tm1Lpc (D1J.129-Cd276^tm1Lpc)	abnormal T-helper 17 cell physiology	J:237700
Cd276^tm1Mak/Cd276^tm1Mak (involves: 129P2/OlaHsd * C57BL/6)	abnormal T-helper 1 physiology	J:84973
	increased T cell proliferation	J:84973
Cd276^tm1Mak/Cd276^tm1Mak (C.129P2-Cd276^tm1Mak)	abnormal T-helper 1 physiology	J:84973
Cd276^{tm2b(EUCOMM)Hmgu}/Cd276^{tm2b(EUCOMM)Hmgu} (C57BL/6N-Cd276^{tm2b(EUCOMM)Hmgu}/Orl)	decreased mean corpuscular volume	J:211773
Cd300a^{tm1b(EUCOMM)Hmgu}/Cd300a^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Cd300a^{tm1b(EUCOMM)Hmgu}/Bay)	decreased eosinophil cell number	J:211773
	increased mean platelet volume	J:211773
Cd300a^tm1Shib/Cd300a^tm1Shib (B6JJcl.C-Cd300a^tm1Shib)	abnormal mast cell physiology	J:189144
Cd300a^tm1Shib/Cd300a^tm1Shib (B6JJcl.C-Cd300a^tm1Shib)	increased neutrophil cell number	J:189144
Cd300c2^tm1Shib/Cd300c2^tm1Shib (B6.Cg-Cd300c2^tm1Shib)	increased B cell proliferation	J:177613
Cd300c^{em1(IMPC)Wtsi}/Cd300c^{em1(IMPC)Wtsi} (C57BL/6N-Cd300c^{em1(IMPC)Wtsi}/WtsiOulu)	increased leukocyte cell number	J:211773
Cd300lf^tm1Toki/Cd300lf^tm1Toki (Not Specified)	abnormal mast cell physiology	J:190979
Cd302^tm1.1Dnjh/Cd302^tm1.1Dnjh (involves: C57BL/6)	abnormal CD8-positive, alpha-beta T cell physiology	J:301848
Cd302^tm1.1Dnjh/Cd302^tm1.1Dnjh (involves: C57BL/6)	decreased dendritic cell number	J:301848
Cd320^{Gt(CC0426)Wtsi}/Cd320^{Gt(CC0426)Wtsi} (involves: 129P2/OlaHsd * C57BL/6)	decreased leukocyte cell number	J:199961
	hematopoietic system phenotype	J:199961
Cdan1^{tm1b(KOMP)Wtsi}/Cdan1⁺ (C57BL/6N-Cdan1^{tm1b(KOMP)Wtsi}/Ucd)	thrombocytopenia	J:211773
Cdc7^{tm1.1(KOMP)Vlcg}/Cdc7⁺ (C57BL/6N-Cdc7^{tm1.1(KOMP)Vlcg}/Tcp)	decreased neutrophil cell number	J:211773
	increased lymphocyte cell number	J:211773
Cdc20b^{em1(IMPC)Wtsi}/Cdc20b^{em1(IMPC)Wtsi} (C57BL/6N-Cdc20b^{em1(IMPC)Wtsi}/Wtsi)	increased erythrocyte cell number	J:211773
	increased hematocrit	J:211773
Cdc25a^m1Rfp/Cdc25a^m1Rfp (multiple strains)	abnormal erythropoiesis	J:80142
Cdc42^tm1Brak/Cdc42^tm1Brak Tg(Pf4-icre)Q3Rsko/0 (involves: 129 * C57BL/6)	abnormal platelet activation	J:160792
	abnormal platelet dense granule physiology	J:160792
	abnormal platelet morphology	J:160792
	abnormal platelet physiology	J:160792
	increased platelet aggregation	J:160792
	thrombocytopenia	J:160792
Cdc42ep1^tm1Yxz/Cdc42ep1^tm1Yxz (B6.Cg-Cdc42ep1^tm1Yzh)	hematopoietic system phenotype	J:310382
Cdc42ep5^{tm1(KOMP)Wtsi}/Cdc42ep5^{tm1(KOMP)Wtsi} (C57BL/6N-Cdc42ep5^{tm1(KOMP)Wtsi}/Nju)	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
Cdc73^tm1Btt/Cdc73^tm1Btt Tg(CAG-cre/Esr1)5Amc/0 (involves: 129S4/SvJae C57BL/6 * CBA)	small spleen	J:135255
Cdca7l^em1(IMPC)Mbp/Cdca7l^em1(IMPC)Mbp (C57BL/6NCrl-Cdca7l^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Cdcp2^em1(IMPC)Mbp/Cdcp2^em1(IMPC)Mbp (C57BL/6N-Cdcp2^em1(IMPC)Mbp/MbpMmucd)	small spleen	J:211773
Cdh5^tm1.1Pec/Cdh5^tm1.1Pec (Not Specified)	hematopoietic system phenotype	J:56509
Cdh5^tm1Pec/Cdh5^tm1Pec (Not Specified)	hematopoietic system phenotype	J:56509
Cdh5^tm2Pec/Cdh5^tm2Pec (Not Specified)	hematopoietic system phenotype	J:56509
Cdh5^{tm3(Cdh5/Ctnna1)Dvst}/Cdh5^{tm3(Cdh5/Ctnna1)Dvst} (involves: 129 * C57BL/6)	abnormal cellular extravasation	J:177191
	abnormal leukocyte migration	J:177191
	increased leukocyte cell number	J:177191
	increased neutrophil cell number	J:177191
Cdh5^{tm3(Cdh5/Ctnna1)Dvst}/Cdh5^{tm3(Cdh5/Ctnna1)Dvst} (B6.Cg-Cdh5^{tm3(Cdh5/Ctnna1)Dvst})	abnormal common myeloid progenitor cell morphology	J:213676
	abnormal definitive hematopoiesis	J:213676
	abnormal hematopoietic stem cell physiology	J:213676
	increased hematopoietic precursor cell number	J:213676
Cdh5^{tm4(Cdh5/Fkbp,Ptprb/Mtor)Dvst}/Cdh5^{tm4(Cdh5/Fkbp,Ptprb/Mtor)Dvst} (involves: C57BL/6)	abnormal cellular extravasation	J:178759
	impaired neutrophil recruitment	J:178759
Cdh5^tm5Dvst/Cdh5^tm5Dvst (B6.Cg-Cdh5^tm5Dvst)	abnormal cellular extravasation	J:209801
Cdh5^tm6Dvst/Cdh5^tm6Dvst (B6.Cg-Cdh5^tm6Dvst)	abnormal cellular extravasation	J:209801
Cdh10^{tm2b(KOMP)Wtsi}/Cdh10^{tm2b(KOMP)Wtsi} (C57BL/6N-Cdh10^{tm2b(KOMP)Wtsi}/Ucd)	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Cdh11^em1(IMPC)Mbp/Cdh11^em1(IMPC)Mbp (C57BL/6N-Cdh11^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Cdh17^tm1Ohn/Cdh17^tm1Ohn (involves: 129P2/OlaHsd * C57BL/6)	abnormal spleen marginal zone morphology	J:96738
	decreased B cell number	J:96738
	decreased B-1a cell number	J:96738
	decreased germinal center B cell number	J:96738
	decreased IgG level	J:96738
	decreased marginal zone B cell number	J:96738
	decreased mature B cell number	J:96738
	decreased spleen germinal center size	J:96738
	increased pre-B cell number	J:96738
	increased pro-B cell number	J:96738
Cdh23^{tm2b(EUCOMM)Wtsi}/Cdh23^{tm2b(EUCOMM)Wtsi} (C57BL/6N-Cdh23^{tm2b(EUCOMM)Wtsi}/Wtsi)	decreased leukocyte cell number	J:211773
	increased mean corpuscular hemoglobin	J:211773
Cdk2^tm1Kald/Cdk2^tm1Kald Cdk4^tm1Kiyo/Cdk4^tm1Kiyo (involves: 129S1/Sv * C57BL/6)	abnormal erythrocyte morphology	J:108720
	abnormal hematopoietic stem cell morphology	J:108720
Cdk2^tm1Sgo/Cdk2^tm1Sgo Cdk4^tm1Bbd/Cdk4^tm1Bbd Cdk6^tm1Bbd/Cdk6^tm1Bbd (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal common myeloid progenitor cell morphology	J:124678
Cdk2^tm1Sgo/Cdk2^tm1Sgo Cdk4^tm2.1Bbd/Cdk4^tm2.1Bbd (involves: 129S1/Sv * 129X1/SvJ * BALB/cJ * C57BL/6 * SJL)	abnormal definitive hematopoiesis	J:125217
	decreased erythrocyte cell number	J:125217
Cdk2^tm2Sgo/Cdk2^tm2Sgo Cdk4^tm2.1Bbd/Cdk4^tm2.1Bbd Polr2a^{tm1(cre/ERT2)Bbd}/? (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)	hematopoietic system phenotype	J:125217
Cdk2ap2^em1(IMPC)J/Cdk2ap2^em1(IMPC)J (C57BL/6NJ-Cdk2ap2^em1(IMPC)J/Mmjax)	decreased mean corpuscular hemoglobin	J:211773
Cdk4^{tm1b(NCOM)Mfgc}/Cdk4⁺ (C57BL/6N-Cdk4^{tm1b(NCOM)Mfgc}/Tcp)	increased mean corpuscular volume	J:211773
Cdk4^tm1Bbd/Cdk4^tm1Bbd Cdk6^tm1Bbd/Cdk6^tm1Bbd (involves: 129S1/Sv * 129X1/SvJ * CD-1 * ICR)	abnormal erythrocyte morphology	J:92529
	decreased erythrocyte cell number	J:92529
	decreased hematopoietic stem cell number	J:92529
	extramedullary hematopoiesis	J:92529
Cdk5rap2^an/Cdk5rap2^an (Not Specified)	abnormal erythrocyte morphology	J:5439
	abnormal erythropoiesis	J:5439
	anemia	J:208
	anisocytosis	J:5439
	decreased leukocyte cell number	J:5439
	macrocytic anemia	J:5439
	macrocytosis	J:5439
	reticulocytopenia	J:5439
Cdk5rap2^an/Cdk5rap2^an Tyrp1^B-lt/Tyrp1^B-lt (WBB6F1)	impaired hematopoiesis	J:7003
Cdk5rap2^{Gt(RRO242)Byg}/Cdk5rap2⁺ (involves: 129P2/OlaHsd * C57BL/6J)	decreased leukocyte cell number	J:160533
Cdk5rap2^{Gt(RRO242)Byg}/Cdk5rap2^an (involves: 129P2/OlaHsd * C57BL/6J)	decreased erythrocyte cell number	J:160533
	decreased leukocyte cell number	J:160533
	macrocytic anemia	J:160533
Cdk5rap2^{tm1a(EUCOMM)Wtsi}/Cdk5rap2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Cdk5rap2^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased leukocyte cell number	J:175295
	increased mean corpuscular hemoglobin	J:175295
	increased mean corpuscular volume	J:175295
Cdk5rap3^{tm1b(EUCOMM)Hmgu}/Cdk5rap3^{tm1b(EUCOMM)Hmgu} (involves: C57BL/6N * FVB/N)	abnormal erythropoiesis	J:272566
	anemia	J:272566
	decreased hematopoietic stem cell number	J:272566
	increased nucleated erythrocyte cell number	J:272566
Cdk5rap3^{tm1c(EUCOMM)Hmgu}/Cdk5rap3^{tm1c(EUCOMM)Hmgu} Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: 129S4/SvJaeSor * C57BL/6N * C57BL/10 * CBA/Ca)	abnormal hemopoiesis	J:272566
Cdk6^{tm1b(EUCOMM)Wtsi}/Cdk6^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Cdk6^{tm1b(EUCOMM)Wtsi}/Tcp)	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
Cdk6^tm1Bbd/Cdk6^tm1Bbd (involves: 129S1/Sv * 129X1/SvJ * CD-1)	abnormal definitive hematopoiesis	J:92529
	abnormal erythrocyte morphology	J:92529
	abnormal hematopoietic system morphology/development	J:92529
	abnormal spleen morphology	J:92529
	abnormal spleen red pulp morphology	J:92529
	abnormal thymus morphology	J:92529
	decreased erythrocyte cell number	J:92529
	decreased leukocyte cell number	J:92529
	decreased megakaryocyte cell number	J:92529
	decreased T cell proliferation	J:92529
	increased mean corpuscular hemoglobin concentration	J:92529
	increased mean corpuscular volume	J:92529
	increased single-positive T cell number	J:92529
	small spleen	J:92529
	spleen hypoplasia	J:92529
	thymus cortex atrophy	J:92529
	thymus hypoplasia	J:92529
Cdk6^tm1Phin/Cdk6^tm1Phin (involves: 129S4/SvJae)	abnormal lymphopoiesis	J:144975
	abnormal T cell differentiation	J:144975
	abnormal thymocyte activation	J:144975
	decreased CD8-positive, alpha-beta T cell number	J:144975
	decreased double-negative T cell number	J:144975
	decreased double-positive T cell number	J:144975
	decreased thymocyte apoptosis	J:144975
	decreased thymocyte number	J:144975
	thymus atrophy	J:144975
	thymus hypoplasia	J:144975
Cdk6^tm1Phin/Cdk6^tm1Phin (involves: 129S4/SvJae * C57BL/6)	abnormal hematopoietic stem cell physiology	J:174697
	decreased DN1 thymic pro-T cell number	J:174697
	decreased DN2 thymocyte number	J:174697
	decreased double-positive T cell number	J:174697
	decreased hematopoietic stem cell number	J:174697
	increased CD4-positive, alpha-beta T cell number	J:174697
	increased CD8-positive, alpha-beta T cell number	J:174697
	increased DN3 thymocyte number	J:174697
Cdk6^tm1Phin/Cdk6^tm1Phin Tg(Lck-Akt1*E40K)E-3Pnt/0 (involves: 129S4/SvJae)	abnormal T cell differentiation	J:144975
Cdk6^tm2.1Phin/Cdk6^tm2.1Phin (involves: 129 * C57BL/6 * FVB/N)	abnormal hematopoietic stem cell physiology	J:174697
	abnormal T cell differentiation	J:174697
	decreased DN1 thymic pro-T cell number	J:174697
	decreased DN2 thymocyte number	J:174697
	decreased DN4 thymocyte number	J:174697
	decreased double-positive T cell number	J:174697
	decreased hematopoietic stem cell number	J:174697
	decreased thymocyte number	J:174697
	increased CD4-positive, alpha-beta T cell number	J:174697
	increased CD8-positive, alpha-beta T cell number	J:174697
	increased DN3 thymocyte number	J:174697
	increased double-negative T cell number	J:174697
	small thymus	J:174697
Cdk6^tm2.1Phin/Cdk6^tm2.1Phin Il2ra^tm1Dw/Il2ra^tm1Dw (involves: 129S4/SvJae * C57BL/6 * FVB/N)	hematopoietic system phenotype	J:174697
	increased CD4-positive, alpha-beta T cell number	J:174697
	increased CD8-positive, alpha-beta T cell number	J:174697
	increased hematopoietic stem cell number	J:174697
Cdk6^tm3.1Phin/Cdk6^tm3.1Phin (involves: 129 * C57BL/6 * FVB/N)	abnormal hematopoietic stem cell physiology	J:174697
	abnormal T cell differentiation	J:174697
	enlarged thymus	J:174697
	increased CD4-positive, alpha-beta T cell number	J:174697
	increased DN1 thymic pro-T cell number	J:174697
	increased hematopoietic stem cell number	J:174697
	increased T cell apoptosis	J:174697
	increased thymocyte number	J:174697
Cdk6^tm4.1Phin/Cdk6^tm4.1Phin (involves: 129 * C57BL/6 * FVB/N)	abnormal hematopoietic stem cell physiology	J:174697
	abnormal T cell differentiation	J:174697
	decreased DN1 thymic pro-T cell number	J:174697
	decreased DN2 thymocyte number	J:174697
	decreased DN4 thymocyte number	J:174697
	decreased double-positive T cell number	J:174697
	decreased thymocyte number	J:174697
	increased CD4-positive, alpha-beta T cell number	J:174697
	increased CD8-positive, alpha-beta T cell number	J:174697
	increased DN3 thymocyte number	J:174697
	increased hematopoietic stem cell number	J:174697
	small thymus	J:174697
Cdk7^{Gt(D032B11)1.1Wrst}/Cdk7^{Gt(D032B11)1.1Wrst} Ndor1^{Tg(UBC-cre/ERT2)1Ejb}/0 (involves: 129S/SvPas * 129S2/SvPas * C57BL/6 * SJL)	decreased hematopoietic stem cell number	J:183925
Cdk10^tm1.2Kald/Cdk10^tm1.2Kald (involves: 129 * C57BL/6 * FVB/N)	abnormal spleen morphology	J:262333
Cdk12^em1(IMPC)Tcp/Cdk12⁺ (C57BL/6NCrl-Cdk12^em1(IMPC)Tcp/Tcp)	abnormal spleen morphology	J:211773
	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	enlarged spleen	J:211773
	increased red blood cell distribution width	J:211773
	increased spleen weight	J:211773
Cdk19^em1Smoc/Cdk19^em1Smoc (C57BL/6J-Cdk19^em1Smoc/Smoc)	abnormal hematopoietic stem cell physiology	J:322947
	decreased hematopoietic stem cell proliferation	J:322947
	decreased megakaryocyte-erythroid progenitor cell number	J:322947
	hematopoietic system phenotype	J:322947
	increased hematopoietic stem cell number	J:322947
Cdkl2^{tm1b(EUCOMM)Hmgu}/Cdkl2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Cdkl2^{tm1b(EUCOMM)Hmgu}/Bay)	abnormal spleen morphology	J:211773
Cdkn1a^{tm1.1(KOMP)Vlcg}/Cdkn1a^{tm1.1(KOMP)Vlcg} (C57BL/6N-Cdkn1a^{tm1.1(KOMP)Vlcg}/Ucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Cdkn1a^tm1Led/Cdkn1a^tm1Led (involves: 129S6/SvEvTac)	increased T cell proliferation	J:76041
Cdkn1a^tm1Led/Cdkn1a^tm1Led Cdkn1c^tm2.1Kei/Cdkn1c⁺ Tg(Mx1-cre)1Cgn/0 (B6.Cg-Cdkn1c^tm2.1Kei Cdkn1a^tm1Led Tg(Mx1-cre)1Cgn)	abnormal hematopoietic stem cell physiology	J:176209
Cdkn1a^tm1Led/Cdkn1a^tm1Led Gadd45a^tm1Ajf/Gadd45a^tm1Ajf (either: (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6))	abnormal lymphopoiesis	J:76041
	abnormal T cell activation	J:76041
	decreased basophil cell number	J:76041
	decreased eosinophil cell number	J:76041
	decreased leukocyte cell number	J:76041
	decreased lymphocyte cell number	J:76041
	increased IgG1 level	J:76041
	increased IgM level	J:76041
	increased T cell proliferation	J:76041
Cdkn1a^tm1Led/Cdkn1a^tm1Led Zbtb17^tm1Cksn/Zbtb17^tm1Cksn Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (B6.Cg-Zbtb17^tm1Cksn Cdkn1a^tm1Led Commd10^{Tg(Vav1-icre)A2Kio})	arrested T cell differentiation	J:170508
Cdkn1a^tm1Tyj/Cdkn1a^tm1Tyj (involves: 129S2/SvPas)	abnormal hematopoietic stem cell physiology	J:60945
Cdkn1a^tm1Tyj/Cdkn1a^tm1Tyj (involves: 129S2/SvPas)	increased hematopoietic stem cell number	J:60945
Cdkn1a^tm1Tyj/Cdkn1a^tm1Tyj (B6;129S2-Cdkn1a^tm1Tyj/J)	abnormal bone marrow cell morphology/development	J:108569
	decreased monocyte cell number	J:108569
	impaired macrophage chemotaxis	J:108569
Cdkn1a^tm1Tyj/Cdkn1a^tm1Tyj (involves: 129S2/SvPas * C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:60292
	abnormal thymus physiology	J:70894
	enlarged spleen	J:60292
	increased B cell number	J:60292
	increased IgG1 level	J:60292
	increased memory T cell number	J:60292
	increased spleen weight	J:60292
	increased T cell proliferation	J:60292
	spleen hyperplasia	J:60292
Cdkn1a^tm1Tyj/Cdkn1a^tm1Tyj Gata1^tm1.1Yen/Gata1^tm1.1Yen (involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6 * FVB/N)	hematopoietic system phenotype	J:200716
Cdkn1a^tm1Tyj/Cdkn1a^tm1Tyj Tg(MMTV-vHaras)SH1Led/0 (involves: 129S2/SvPas * C57BL/6J * CD-1 * FVB/N)	enlarged spleen	J:66183
	extramedullary hematopoiesis	J:66183
Cdkn1b^tm1Ako/Cdkn1b^tm1Ako (involves: 129S1/Sv * C57BL/6)	increased spleen weight	J:33401
	increased thymocyte number	J:33401
	increased thymus weight	J:33401
Cdkn1b^tm1Ako/Cdkn1b^tm1Ako Cdkn2c^tm1Yxi/Cdkn2c^tm1Yxi (involves: 129/Sv * 129S1/Sv * C57BL/6 * DBA/2)	enlarged spleen	J:50053
	enlarged thymus	J:50053
Cdkn1b^tm1Jro/Cdkn1b^tm1Jro (involves: 129S4/SvJaeSor * C57BL/6)	decreased T cell proliferation	J:71780
Cdkn1b^tm1Kin/Cdkn1b^tm1Kin (involves: 129P2/OlaHsd * C57BL/6)	enlarged spleen	J:33402
	enlarged thymus	J:33402
	increased T cell number	J:33402
	thymus hyperplasia	J:33402
Cdkn1b^tm1Mlf/Cdkn1b^tm1Mlf (involves: 129S4/SvJaeSor * C57BL/6J)	abnormal definitive hematopoiesis	J:33400
	abnormal spleen morphology	J:33400
	abnormal thymus morphology	J:33400
	enlarged spleen	J:33400
	enlarged thymus	J:33400
	increased T cell proliferation	J:33400
	spleen hyperplasia	J:33400
	thymus hyperplasia	J:33400
Cdkn1b^tm1Mlf/Cdkn1b^tm1Mlf (involves: 129S4/SvJaeSor)	enlarged spleen	J:107588
	enlarged thymus	J:107588
	spleen hypoplasia	J:107588
Cdkn1b^tm1Mlf/Cdkn1b^tm1Mlf Myc^tm1Atp/Myc⁺ (involves: 129P2/OlaHsd * 129S4/SvJaeSor * FVB/N)	decreased T cell proliferation	J:73369
Cdkn1b^tm1Mlf/Cdkn1b^tm1Mlf Tg(KRT5-CDK4)2303Mlrp/0 (involves: 129S4/SvJae * C57BL/6 * FVB * SENCAR * SSIN)	enlarged thymus	J:107588
	thymus hyperplasia	J:107588
Cdkn1b^tm3Jro/Cdkn1b^tm3Jro (involves: 129S4/SvJaeSor)	enlarged spleen	J:103819
Cdkn1b^tm3Jro/Cdkn1b^tm3Jro (involves: 129S4/SvJaeSor)	enlarged thymus	J:103819
Cdkn1c^{tm1.1(Cdkn1b)Kei}/Cdkn1c⁺ (B6.129P2-Cdkn1c^{tm1.1(Cdkn1b)Kei})	hematopoietic system phenotype	J:176209
Cdkn1c^tm1Kat/Cdkn1c⁺ (involves: 129P2/OlaHsd * C57BL/6)	thrombocytopenia	J:102331
Cdkn1c^tm1Kat/Cdkn1c⁺ (involves: 129P2/OlaHsd)	thrombocytopenia	J:102331
Cdkn1c^tm1Kat/Cdkn1c^tm1Kat (involves: 129P2/OlaHsd * C57BL/6)	abnormal spleen white pulp morphology	J:61190
Cdkn1c^tm1Kat/Cdkn1c^tm1Kat (involves: 129P2/OlaHsd)	thrombocytopenia	J:102331
Cdkn1c^tm2.1Kei/Cdkn1c⁺ Tg(Mx1-cre)1Cgn/0 (B6.Cg-Cdkn1c^tm2.1Kei Tg(Mx1-cre)1Cgn)	abnormal hematopoietic stem cell physiology	J:176209
	decreased hematopoietic stem cell number	J:176209
Cdkn2a^tm1Cjs/Cdkn2a^tm1Cjs Nop53^tm2.1Asuz/Nop53^tm2.1Asuz Tg(Lck-cre)#Jxm/0 (involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * CBA)	decreased thymocyte number	J:241062
Cdkn2a^tm1Rdp/Cdkn2a^tm1Rdp (involves: 129/Sv * C57BL/6 * SJL)	abnormal spleen morphology	J:53805
	abnormal spleen red pulp morphology	J:53805
	extramedullary hematopoiesis	J:53805
	increased spleen white pulp amount	J:53805
Cdkn2a^tm1Rdp/Cdkn2a^tm1Rdp Rnf2^tm1Mvi/Rnf2^tm1Mvi Tg(Mx1-cre)1Cgn/0 (involves: 129 * C57BL/6 * C57BL/10 * CBA * SJL)	abnormal common myeloid progenitor cell morphology	J:130397
	enlarged spleen	J:130397
	hematopoietic system phenotype	J:130397
Cdkn2a^tm2.1Rdp/Cdkn2a^tm2.1Rdp (involves: 129S6/SvEvTac * FVB/N)	increased CD4-positive, alpha-beta T cell number	J:71394
	increased CD8-positive, alpha-beta T cell number	J:71394
	increased double-positive T cell number	J:71394
	increased splenocyte proliferation	J:71394
	increased thymus weight	J:71394
	thymus hyperplasia	J:71394
Cdkn2a^tm2Brn/Cdkn2a^tm2Brn Ezh1^tm1Sgon/Ezh1^tm1Sgon Tg(VAV1-cre)1Graf/0 (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)	hematopoietic system phenotype	J:193722
Cdkn2b^tm1Bbd/Cdkn2b^tm1Bbd (involves: 129S1/Sv * C57BL/6)	abnormal lymphocyte morphology	J:63299
	abnormal spleen marginal zone morphology	J:63299
	abnormal spleen morphology	J:63299
	extramedullary hematopoiesis	J:63299
	increased mature B cell number	J:63299
	spleen hyperplasia	J:63299
Cdkn2b^tm1Bbd/Cdkn2b^tm1Bbd Cdkn2c^tm1Bbd/Cdkn2c^tm1Bbd (involves: 129S1/Sv * C57BL/6)	abnormal Langerhans cell morphology	J:63299
	abnormal lymphocyte morphology	J:63299
	enlarged spleen	J:63299
	extramedullary hematopoiesis	J:63299
Cdkn2b^tm1Bbd/Cdkn2b^tm1Bbd Pbx1^tm1Koss/Pbx1^tm1Koss Nkx2-5^tm2(cre)Rph/Nkx2-5⁺ (involves: 129P2/OlaHsd * 129S1/Sv)	abnormal spleen mesenchyme morphology	J:184521
	abnormal spleen morphology	J:184521
Cdkn2b^tm1Wff/Cdkn2b^tm1Wff Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)	abnormal common myeloid progenitor cell morphology	J:163498
	abnormal megakaryocyte progenitor cell morphology	J:163498
	decreased erythroid progenitor cell number	J:163498
	increased monocyte cell number	J:163498
	myeloid hyperplasia	J:163498
Cdkn2c^tm1Bbd/Cdkn2c^tm1Bbd (involves: 129S1/Sv * C57BL/6)	enlarged spleen	J:63299
Cdkn2c^tm1Bbd/Cdkn2c^tm1Bbd (involves: 129S1/Sv * C57BL/6)	increased spleen white pulp amount	J:63299
Cdkn2c^tm1Yxi/Cdkn2c^tm1Yxi (involves: 129/Sv * C57BL/6 * DBA/2)	abnormal T cell physiology	J:50053
	abnormal thymus size	J:50053
	enlarged spleen	J:50053
	increased B cell number	J:50053
	increased bone marrow cell number	J:50053
	increased T cell number	J:50053
	spleen hyperplasia	J:50053
	thymus hyperplasia	J:50053
Cds2^{Gt(OST184358)Lex}/Cds2⁺ (involves: 129S5/SvEvBrd * C57BL/6J)	decreased B cell number	J:103485
	increased T cell number	J:103485
Cdsn^{tm1b(EUCOMM)Hmgu}/Cdsn⁺ (C57BL/6N-Cdsn^{tm1b(EUCOMM)Hmgu}/Ieg)	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
Cdx1^tm1Pgr/Cdx1^tm1Pgr (involves: 129S1/Sv * 129X1/SvJ)	abnormal embryonic erythropoiesis	J:136405
Cdx4^tm1.1Gqda/Y (involves: 129S4/SvJae * C57BL/6)	abnormal embryonic erythropoiesis	J:136405
Cdx4^tm1.1Gqda/Cdx4^tm1.1Gqda (involves: 129S4/SvJae * C57BL/6)	abnormal embryonic erythropoiesis	J:136405
Cdyl2^em1(IMPC)Tcp/Cdyl2^em1(IMPC)Tcp (C57BL/6N-Cdyl2^em1(IMPC)Tcp/Tcp)	decreased erythrocyte cell number	J:211773
Ceacam1^tm1Rsb/Ceacam1^tm1Rsb Tg(Lck-cre)1Cwi/0 (involves: 129)	increased T cell proliferation	J:116136
Ceacam5^{em1(IMPC)Wtsi}/Ceacam5^{em1(IMPC)Wtsi} (C57BL/6N-Ceacam5^{em1(IMPC)Wtsi}/Wtsi)	decreased mean corpuscular hemoglobin concentration	J:211773
	increased leukocyte cell number	J:211773
	increased mean platelet volume	J:211773
Cebpa^{tm1.1(Cebpb)Ylee}/Cebpa^{tm1.1(Cebpb)Ylee} (involves: 129X1/SvJ * C57BL/6 * FVB/N)	abnormal hematopoietic system physiology	J:77646
Cebpa^{tm1.1(cre)Touw}/Cebpa⁺ (involves: 129/Sv * 129X1/SvJ * C57BL/6)	hematopoietic system phenotype	J:166620
Cebpa^tm1Dgt/Cebpa^tm1Dgt Tg(Mx1-cre)1Cgn/0 (involves: 129S6/SvEvTac * C57BL/6 * CBA)	abnormal myelopoiesis	J:94682
	decreased granulocyte number	J:94682
	failure of myelopoiesis	J:94682
Cebpa^tm1Dgt/Cebpa^tm1Dgt Tg(SFTPC-rtTA)5Jaw/0 Tg(tetO-cre)1Jaw/0 (involves: 129 * 129S6/SvEvTac * C57BL/6)	hematopoietic system phenotype	J:105593
Cebpa^tm1Gjd/Cebpa^tm1Gjd (B6.129S7-Cebpa^tm1Gjd)	absent common myeloid progenitor cells	J:94682
Cebpa^tm1Gjd/Cebpa^tm1Gjd (B6.129S7-Cebpa^tm1Gjd)	failure of myelopoiesis	J:94682
Cebpa^tm2Btp/Cebpa^tm2Btp (B6.129P2-Cebpa^tm2Btp)	abnormal bone marrow cell morphology/development	J:187834
	abnormal definitive hematopoiesis	J:187834
	abnormal myelopoiesis	J:187834
	decreased neutrophil cell number	J:187834
	enlarged spleen	J:187834
	hematopoietic system phenotype	J:187834
	increased erythroid progenitor cell number	J:187834
	increased hematopoietic stem cell number	J:187834
Cebpa^tm2Nerl/Cebpa^tm2Nerl (involves: 129P2/OlaHsd * C57BL/6)	abnormal granulocyte morphology	J:72330
	decreased granulocyte number	J:72330
Cebpa^tm4Nerl/Cebpa^tm4Nerl (involves: 129P2/OlaHsd * C57BL/6)	abnormal granulocyte morphology	J:72330
	decreased granulocyte number	J:72330
Cebpa^tm6Nerl/Cebpa^tm6Nerl (involves: 129P2/OlaHsd * C57BL/6)	hematopoietic system phenotype	J:120098
Cebpa^tm8.1Nerl/Cebpa⁺ (involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)	abnormal common myeloid progenitor cell morphology	J:136134
Cebpa^tm8.1Nerl/Cebpa^tm8.1Nerl (involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)	abnormal common myeloid progenitor cell morphology	J:136134
	abnormal definitive hematopoiesis	J:136134
	abnormal granulocyte morphology	J:136134
	abnormal leukocyte morphology	J:136134
	abnormal myeloid leukocyte morphology	J:136134
	decreased granulocyte number	J:136134
	decreased hematocrit	J:136134
	decreased monocyte cell number	J:136134
	decreased neutrophil cell number	J:136134
	enlarged spleen	J:136134
	extramedullary hematopoiesis	J:136134
Cebpb^tm1.1Acle/Cebpb^tm1.1Acle (involves: 129P2/OlaHsd * BALB/c * C57BL/6)	abnormal osteoclast differentiation	J:150006
	abnormal osteoclast morphology	J:150006
	abnormal osteoclast physiology	J:150006
Cebpb^tm1.1Elgaz/Cebpb^tm1.1Elgaz Lyz2^{em1.1(cre)Elgaz}/Lyz2⁺ (BALB/cJ-Cebpb^tm1.1Elgaz Lyz2^em1.1Elgaz/Elgaz)	abnormal myeloid cell number	J:247885
Cebpb^tm1Aki/Cebpb^tm1Aki (involves: 129P2/OlaHsd * C57BL/6)	abnormal macrophage physiology	J:153025
	abnormal T-helper 1 physiology	J:153025
Cebpb^tm1Kish/Cebpb^tm1Kish (involves: 129P2/OlaHsd)	abnormal macrophage physiology	J:77003
Cebpb^tm1Kish/Cebpb^tm1Kish (involves: 129P2/OlaHsd)	impaired macrophage phagocytosis	J:77003
Cebpb^tm1Pfj/Cebpb^tm1Pfj (involves: 129S1/Sv * C57BL/6)	abnormal osteoclast differentiation	J:150006
	abnormal osteoclast morphology	J:150006
	abnormal osteoclast physiology	J:150006
Cebpb^tm1Vpo/Cebpb^tm1Vpo (involves: 129S/SvEv * MF1)	abnormal definitive hematopoiesis	J:25215
	abnormal macrophage physiology	J:25215
	abnormal plasma cell morphology	J:25215
	abnormal spleen red pulp morphology	J:25215
	abnormal spleen secondary B follicle morphology	J:25215
	abnormal spleen white pulp morphology	J:25215
	abnormal T-helper 1 physiology	J:25215
	abnormal T-helper 2 physiology	J:25215
	enlarged spleen	J:25215
	extramedullary hematopoiesis	J:25215
	increased bone marrow cell number	J:25215
	increased IgG level	J:25215
Cebpb^tm1Vpo/Cebpb^tm1Vpo Il6^tm1Poli/Il6^tm1Poli (involves: 129S/SvEv * MF1)	hematopoietic system phenotype	J:35883
Cebpb^tm2.1Acle/Cebpb^tm2.1Acle (involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)	abnormal osteoclast morphology	J:155795
	decreased osteoclast cell number	J:155795
Cebpe^tm1Kgx/Cebpe^tm1Kgx (involves: 129S6/SvEvTac * NIH Black Swiss)	abnormal bone marrow cell morphology/development	J:76024
	abnormal common myeloid progenitor cell morphology	J:76024
	abnormal eosinophil differentiation	J:76024
	abnormal granulocyte differentiation	J:76024
	abnormal myelopoiesis	J:76024
	abnormal neutrophil differentiation	J:76024
	abnormal neutrophil morphology	J:76024
	abnormal neutrophil physiology	J:76024
	decreased eosinophil cell number	J:76024
	decreased granulocyte number	J:76024
	extramedullary hematopoiesis	J:76024
	impaired myelopoiesis	J:76024
	increased bone marrow cell number	J:76024
	increased plasma cell number	J:76024
Cebpe^tm1Kgx/Cebpe^tm1Kgx (involves: 129S6/SvEvTac)	abnormal bone marrow cell morphology/development	J:76024
	abnormal common myeloid progenitor cell morphology	J:76024
	abnormal eosinophil differentiation	J:76024
	abnormal granulocyte differentiation	J:76024
	abnormal myelopoiesis	J:76024
	abnormal neutrophil differentiation	J:76024
	abnormal neutrophil morphology	J:76024
	abnormal neutrophil physiology	J:76024
	decreased eosinophil cell number	J:76024
	decreased granulocyte number	J:76024
	extramedullary hematopoiesis	J:76024
	impaired myelopoiesis	J:76024
	increased bone marrow cell number	J:76024
	increased plasma cell number	J:76024
Cebpg^tm1Aki/Cebpg^tm1Aki (involves: 129P2/OlaHsd)	abnormal NK cell physiology	J:58801
Cebpg^tm1Aki/Cebpg^tm1Aki (involves: 129P2/OlaHsd)	impaired natural killer cell mediated cytotoxicity	J:58801
Celsr1^em1(IMPC)Mbp/Celsr1⁺ (C57BL/6N-Celsr1^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Cemip^tm1.1Okda/Cemip^tm1.1Okda (involves: C57BL/6NCrlj * CBA/JNCrlj)	decreased osteoclast cell number	J:241936
Cenpj^{tm1a(EUCOMM)Wtsi}/Cenpj^{tm1a(EUCOMM)Wtsi} (B6Brd;B6N-Tyr^c-Brd Cenpj^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased CD8-positive, alpha-beta T cell number	J:194085
	increased T cell number	J:194085
Cep15^{tm1b(KOMP)Wtsi}/Cep15^{tm1b(KOMP)Wtsi} (C57BL/6N-Cep15^{tm1b(KOMP)Wtsi}/Wtsi)	increased red blood cell distribution width	J:211773
Cep43^{tm1b(EUCOMM)Hmgu}/Cep43⁺ (C57BL/6N-Cep43^{tm1b(EUCOMM)Hmgu}/Ieg)	decreased mean corpuscular volume	J:211773
Cep68^em1(IMPC)J/Cep68^em1(IMPC)J (C57BL/6NJ-Cep68^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Cep76^{tm1b(EUCOMM)Hmgu}/Cep76^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Cep76^{tm1b(EUCOMM)Hmgu}/Bay)	abnormal spleen morphology	J:211773
Cep290^b2b1454Clo/Cep290^b2b1454Clo (C57BL/6J-Cep290^b2b1454Clo)	accessory spleen	J:175213
	spleen hypoplasia	J:175213
Cep290^b2b1752Clo/Cep290^b2b1752Clo (C57BL/6J-Cep290^b2b1752Clo)	spleen hypoplasia	J:175213
Cep290^em1(IMPC)Mbp/Cep290⁺ (C57BL/6N-Cep290^em1(IMPC)Mbp/MbpMmucd)	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular hemoglobin concentration	J:211773
Cer1^{em1(IMPC)Ccpcz}/Cer1^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Cer1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Cerk^tm1Fbor/Cerk^tm1Fbor (involves: BALB/c)	decreased granulocyte number	J:131522
	decreased neutrophil cell number	J:131522
	increased leukocyte cell number	J:131522
Cers1^{tm1b(EUCOMM)Hmgu}/Cers1⁺ (C57BL/6N-Cers1^{tm1b(EUCOMM)Hmgu}/H)	increased neutrophil cell number	J:211773
Cers6^tm1.1Kwi/Cers6^tm1.1Kwi (involves: 129P2/OlaHsd * C57BL/6)	microgliosis	J:201327
Cert1^{tm1a(KOMP)Wtsi}/Cert1⁺ (C57BL/6N-Cert1^{tm1a(KOMP)Wtsi}/Wtsi)	decreased mean corpuscular hemoglobin	J:211773
Ces1f^{tm1b(KOMP)Wtsi}/Ces1f^{tm1b(KOMP)Wtsi} (C57BL/6N-Ces1f^{tm1b(KOMP)Wtsi}/Nju)	increased mean corpuscular volume	J:211773
Ces2f^{tm1b(KOMP)Wtsi}/Ces2f^{tm1b(KOMP)Wtsi} (C57BL/6N-Ces2f^{tm1b(KOMP)Wtsi}/Nju)	increased red blood cell distribution width	J:211773
	thrombocytosis	J:211773
Cfap53^{em1(IMPC)Wtsi}/Cfap53^{em1(IMPC)Wtsi} (C57BL/6N-Cfap53^{em1(IMPC)Wtsi}/Wtsi)	abnormal thymus topology	J:239583
	small spleen	J:239583
Cfap161^{em1(IMPC)Ccpcz}/Cfap161^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Cfap161^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Cfb^{tm1.1(KOMP)Wtsi}/Cfb^{tm1.1(KOMP)Wtsi} (C57BL/6N-Cfb^{tm1.1(KOMP)Wtsi}/J)	increased erythrocyte cell number	J:211773
	increased hematocrit	J:211773
	increased hemoglobin content	J:211773
Cfc1^b2b2736.1Clo/Cfc1^b2b2736.1Clo (C57BL/6J-Cfc1^b2b2736.1Clo)	accessory spleen	J:175213
	spleen hypoplasia	J:175213
Cfc1^tm1Cbm/Cfc1^tm1Cbm (Not Specified)	small spleen	J:58530
Cfc1^tm1Cbm/Cfc1^tm1Cbm (Not Specified)	spleen hypoplasia	J:58530
Cfc1^tm1Mms/Cfc1^tm1Mms (either: (involves: 129S6/SvEvTac * Black Swiss) or (involves: 129S6/SvEvTac * C57BL/6J))	absent spleen	J:58104
Cfd^em1(IMPC)Mbp/Cfd^em1(IMPC)Mbp (C57BL/6NCrl-Cfd^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Cfh^tm1.1Song/Cfh^tm1.1Song (involves: C57BL/6)	anemia	J:240426
	decreased hemoglobin content	J:240426
	reticulocytosis	J:240426
	thrombocytopenia	J:240426
Cfh^{tm1a(EUCOMM)Wtsi}/Cfh^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Cfh^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased mean corpuscular hemoglobin	J:175295
Cfh^tm1Mbo/Cfh^tm1Mbo Tg(CAG-Cfh)#Mcp/0 (involves: 129/Sv C57BL/6 * CBA)	schistocytosis	J:125860
	thrombocytopenia	J:125860
Cfi^{tm1b(EUCOMM)Hmgu}/Cfi^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Cfi^{tm1b(EUCOMM)Hmgu}/H)	thrombocytopenia	J:211773
Cflar^tm1.1Pope/Cflar^tm1.2Pope Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd)	abnormal B cell number	J:167430
	abnormal bone marrow cell number	J:167430
	abnormal CD4-positive, alpha-beta T cell number	J:167430
	abnormal CD8-positive, alpha-beta T cell number	J:167430
	abnormal definitive hematopoiesis	J:167430
	abnormal erythropoiesis	J:167430
	abnormal lymphocyte cell number	J:167430
	abnormal myelopoiesis	J:167430
	abnormal spleen B cell follicle morphology	J:167430
	abnormal spleen marginal zone morphology	J:167430
	abnormal spleen morphology	J:167430
	abnormal spleen red pulp morphology	J:167430
	abnormal thymus corticomedullary boundary morphology	J:167430
	abnormal thymus morphology	J:167430
	anemia	J:167430
	decreased macrophage cell number	J:167430
	enlarged spleen	J:167430
	increased CD8-positive, alpha-beta T cell number	J:167430
	increased eosinophil cell number	J:167430
	increased granulocyte number	J:167430
	increased leukocyte cell number	J:167430
	increased monocyte cell number	J:167430
	increased neutrophil cell number	J:167430
	thrombocytosis	J:167430
Cflar^tm1Ywh/Cflar^tm1Ywh Tg(Lck-cre)548Jxm/0 (involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * CBA)	decreased single-positive T cell number	J:100558
	increased thymocyte apoptosis	J:100558
Cftr^tm1Unc/Cftr^tm1Unc (involves: 129P2/OlaHsd)	abnormal thymus involution	J:2079
Cftr^tm1Unc/Cftr^tm1Unc (involves: 129P2/OlaHsd)	spleen hyperplasia	J:2079
Cftr^tm2Mrc/Cftr^tm2Mrc (B6.129S6-Cftr^tm2Mrc)	abnormal alveolar macrophage morphology	J:112450
Cftr^tm2Mrc/Cftr^tm2Mrc (B6.129S6-Cftr^tm2Mrc)	decreased neutrophil cell number	J:112450
Cgas^{tm1a(EUCOMM)Hmgu}/Cgas^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Cgas^{tm1a(EUCOMM)Hmgu})	abnormal macrophage physiology	J:201167
Cgas^{tm1d(EUCOMM)Hmgu}/Cgas^{tm1d(EUCOMM)Hmgu} (involves: C57BL/6N)	hematopoietic system phenotype	J:265023
Cgref1^em1(IMPC)J/Cgref1^em1(IMPC)J (C57BL/6NJ-Cgref1^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Cgrrf1^{tm1b(KOMP)Wtsi}/Cgrrf1^{tm1b(KOMP)Wtsi} (C57BL/6N-Cgrrf1^{tm1b(KOMP)Wtsi}/Wtsi)	increased CD5-positive gamma-delta T cell number	J:211773
	increased gamma-delta T cell number	J:211773
Ch25h^tm1Rus/Ch25h^tm1Rus (B6.129S6-Ch25h^tm1Rus)	increased IgA level	J:170807
	increased IgG2a level	J:170807
	increased IgG2b level	J:170807
	increased IgG3 level	J:170807
Chaf1b^{tm2c(EUCOMM)Hmgu}/Chaf1b⁺ Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: C57BL/6J * C57BL/6N * C57BL/10 * CBA/Ca)	abnormal bone marrow cell morphology/development	J:266848
	decreased bone marrow cell number	J:266848
	decreased hematopoietic stem cell number	J:266848
Chaf1b^{tm2c(EUCOMM)Hmgu}/Chaf1b⁺ Kras^tm4Tyj/Kras⁺ Tg(Mx1-cre)1Cgn/0 (involves: 129S4/SvJae * C57BL/6J * C57BL/6N * CBA/J)	hematopoietic system phenotype	J:266848
	increased leukocyte cell number	J:266848
Chaf1b^{tm2c(EUCOMM)Hmgu}/Chaf1b⁺ Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6J * C57BL/6N * CBA/J)	abnormal bone marrow cell morphology/development	J:266848
	abnormal bone marrow cell physiology	J:266848
	decreased bone marrow cell number	J:266848
	decreased hematopoietic stem cell number	J:266848
Chaf1b^{tm2c(EUCOMM)Hmgu}/Chaf1b^{tm2c(EUCOMM)Hmgu} Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6J * C57BL/6N * CBA/J)	abnormal bone marrow cell morphology/development	J:266848
	abnormal bone marrow cell physiology	J:266848
	decreased bone marrow cell number	J:266848
	decreased hematopoietic cell number	J:266848
	decreased hematopoietic stem cell number	J:266848
	pancytopenia	J:266848
Champ1^em1(IMPC)Mbp/Champ1⁺ (C57BL/6NCrl-Champ1^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	small spleen	J:211773
Char4^C57BL/6J/Char4^C57BL/6J (involves: A/J * C57BL/6J)	reticulocytosis	J:86735
Chcmq1^C57BLKS/J/Chcmq1^C57BLKS/J (involves: C57BLKS/J * SM/J)	increased hemoglobin content	J:107220
Chcmq2^C57BLKS/J/Chcmq2^SM/J (involves: C57BLKS/J * SM/J)	increased hemoglobin content	J:107220
Chcmq2^SM/J/Chcmq2^SM/J (involves: C57BLKS/J * SM/J)	increased hemoglobin content	J:107220
Chd1^{tm1b(KOMP)Wtsi}/Chd1⁺ (C57BL/6N-Chd1^{tm1b(KOMP)Wtsi}/Tcp)	decreased mean corpuscular hemoglobin concentration	J:211773
	decreased red blood cell distribution width	J:211773
Chd2^{Gt(RRBO46)Byg}/Chd2⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal spleen morphology	J:146743
	decreased lymphocyte cell number	J:146176
	enlarged spleen	J:146743
	extramedullary hematopoiesis	J:146743, J:146176
	increased CD4-positive, alpha-beta T cell number	J:146176
	increased spleen red pulp amount	J:146743
Chd2^{Gt(RRBO46)Byg}/Chd2^{Gt(RRBO46)Byg} (involves: 129P2/OlaHsd * C57BL/6)	abnormal blood cell morphology/development	J:146176
	abnormal erythropoiesis	J:146176
	decreased erythroid progenitor cell number	J:146176
	increased megakaryocyte cell number	J:146176
Chd2^{tm1b(EUCOMM)Hmgu}/Chd2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Chd2^{tm1b(EUCOMM)Hmgu}/Tcp)	decreased erythrocyte cell number	J:211773
	decreased hemoglobin content	J:211773
	decreased mean platelet volume	J:211773
Chd4^tm1.1Kge/Chd4^tm1.1Kge Tg(Lck-cre)1Cwi/0 (involves: C57BL/6 * SJL)	abnormal CD4-positive, alpha beta T cell morphology	J:109547
	abnormal T cell physiology	J:109547
	arrested T cell differentiation	J:109547
	decreased double-positive T cell number	J:109547
	increased CD8-positive, alpha-beta T cell number	J:109547
	spleen hypoplasia	J:109547
Chd4^tm1.1Kge/Chd4^tm1.2Kge Tg(CAG-Bgeo/GFP)21Lbe/0 Tg(Lck-cre)1Cwi/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)	decreased T cell proliferation	J:109547
Chd4^tm1.1Kge/Chd4^tm1.2Kge Tg(Lck-cre)1Cwi/0 (involves: C57BL/6 * SJL)	thymus hypoplasia	J:109547
Chd4^tm1.2Kge/Chd4^tm1.2Kge Tg(Lck-cre)1Cwi/0 (involves: C57BL/6 * DBA/2 * SJL)	abnormal T cell differentiation	J:109547
	decreased double-positive T cell number	J:109547
	decreased T cell proliferation	J:109547
	increased CD8-positive, alpha-beta T cell number	J:109547
	increased double-negative T cell number	J:109547
	thymus hypoplasia	J:109547
Chd5^em1(IMPC)Mbp/Chd5^em1(IMPC)Mbp (C57BL/6NCrl-Chd5^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Chd6^em1(IMPC)Mbp/Chd6^em1(IMPC)Mbp (C57BL/6N-Chd6^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Chd7^em1Kangn/Chd7^em1Kangn Tg(Prrx1-cre)1Cjt/0 (involves: C57BL/6J * SJL/J)	abnormal bone marrow cell physiology	J:336448
Chd7^{Gt(RRR136)Byg}/Chd7⁺ (involves: 129P2/OlaHsd * C57BL/6)	ectopic thymus	J:154590
	small thymus	J:154590
	thymus hypoplasia	J:154590
Chd7^Gt(XK403)Byg/Chd7⁺ Tbx1^tm1Bld/Tbx1⁺ (either: (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6) or (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * CD-1))	ectopic thymus	J:154590
Chd7^{tm2a(EUCOMM)Wtsi}/Chd7⁺ (involves: 129S5/SvEvBrd * C57BL/6N)	decreased hematocrit	J:330596
	decreased hemoglobin content	J:330596
	decreased leukocyte cell number	J:330596
	decreased monocyte cell number	J:330596
	decreased red blood cell distribution width	J:330596
	increased NK T cell number	J:330596
Chd7^Whi/Chd7⁺ (C3HeB/FeJ-Chd7^Whi)	decreased hematocrit	J:330596
	decreased monocyte cell number	J:330596
	increased NK T cell number	J:330596
Chd9^{tm1a(EUCOMM)Wtsi}/Chd9^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Chd9^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased Langerhans cell number	J:211773
Chek2^tm1Mak/Chek2⁺ Rad50^tm2Jpt/Rad50^tm2Jpt (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)	abnormal pro-B cell morphology	J:103922
	anemia	J:103922
	decreased double-negative T cell number	J:103922
	decreased macrophage cell number	J:103922
Chek2^tm1Mak/Chek2^tm1Mak Rad50^tm2Jpt/Rad50^tm2Jpt (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)	hematopoietic system phenotype	J:103922
Chi3l1^tm1Eli/Chi3l1^tm1Eli (B6.Cg-Chi3l1^tm1Eli)	abnormal macrophage morphology	J:148490
	abnormal T-helper 2 physiology	J:148490
	decreased IgE level	J:148490
	decreased splenocyte proliferation	J:148490
	decreased T-helper 2 cell number	J:148490
	impaired eosinophil recruitment	J:148490
	impaired neutrophil recruitment	J:148490
	increased T cell apoptosis	J:148490
Chi3l1^tm1Eli/Chi3l1^tm1Eli Tg(Scgb1a1-rtTA,tetO-Il13)1Eli/0 (involves: C57BL/6 * CBA)	abnormal T-helper 2 cell number	J:148490
	abnormal T-helper 2 physiology	J:148490
Chia1^tm1.1Lof/Chia1^tm1.1Lof (C57BL/6-Chia1^tm1.1Lof)	increased lymphocyte cell number	J:257728
Chia1^tm1.1Lof/Chia1^tm1.1Lof (C57BL/6-Chia1^tm1.1Lof)	increased neutrophil cell number	J:257728
Chic2^{tm1b(EUCOMM)Wtsi}/Chic2⁺ (C57BL/6N-Chic2^{tm1b(EUCOMM)Wtsi}/H)	enlarged spleen	J:211773
Chmp2b^em1(IMPC)Mbp/Chmp2b⁺ (C57BL/6NCrl-Chmp2b^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Chmp4c^{tm1b(EUCOMM)Wtsi}/Chmp4c^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Chmp4c^{tm1b(EUCOMM)Wtsi}/H)	decreased basophil cell number	J:211773
Chn1^{tm1.1(KOMP)Vlcg}/Chn1^{tm1.1(KOMP)Vlcg} (B6N(Cg)-Chn1^{tm1.1(KOMP)Vlcg}/J)	increased hematocrit	J:211773
	increased hemoglobin content	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
chohr3/chohr3 (C3HeB/FeJ-chohr3/Ieg)	microcytic anemia	J:94145
Chordc1^em1(IMPC)Mbp/Chordc1⁺ (C57BL/6N-Chordc1^em1(IMPC)Mbp/MbpMmucd)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Chordc1^tm1Mbra/Chordc1⁺ (involves: 129 * C57BL/6)	abnormal bone marrow cell morphology/development	J:222040
	abnormal myelopoiesis	J:222040
	abnormal spleen morphology	J:222040
	anemia	J:222040
	anisocytosis	J:222040
	decreased hemoglobin content	J:222040
	enlarged spleen	J:222040
	increased leukocyte cell number	J:222040
	increased myeloid cell number	J:222040
	increased myeloid cell number in bone marrow	J:222040
	increased nucleated erythrocyte cell number	J:222040
	reticulocytosis	J:222040
Chp1^em1(IMPC)Tcp/Chp1⁺ (C57BL/6NCrl-Chp1^em1(IMPC)Tcp/Tcp)	decreased mean corpuscular hemoglobin	J:211773
Chp1^em1(IMPC)Tcp/Chp1⁺ (C57BL/6NCrl-Chp1^em1(IMPC)Tcp/Tcp)	decreased mean corpuscular volume	J:211773
Chrac1^{tm1.1(KOMP)Vlcg}/Chrac1^{tm1.1(KOMP)Vlcg} (C57BL/6N-Chrac1^{tm1.1(KOMP)Vlcg}/MbpMmucd)	increased mean platelet volume	J:211773
	thrombocytopenia	J:211773
Chrd^tm1Emdr/Chrd^tm1Emdr (either: B6SJL.129-Chrd^tm1Emdr or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL/J))	athymia	J:83662
Chrd^tm1Emdr/Chrd^tm1Emdr (129S6.129-Chrd^tm1Emdr)	athymia	J:146769
Chrd^tm1Emdr/Chrd^tm1Emdr Tbx1^m1Jlk/Tbx1^m1Jlk (129/Sv-Tbx1^m1Jlk Chrd^tm1Emdr)	athymia	J:146769
Chrm1^tm1Jwe/Chrm1^tm1Jwe (involves: 129S6/SvEvTac * CF-1)	decreased cytotoxic T cell cytolysis	J:106393
Chrna4^tm1Jpc/Chrna4^tm1Jpc (involves: C57BL/6)	decreased IgG level	J:103908
	decreased immunoglobulin level	J:103908
	increased IgG level	J:103908
Chrna5^em1(IMPC)H/Chrna5^em1(IMPC)H (C57BL/6N-Chrna5^em1(IMPC)H/H)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Chrna7^tm1Bay/Chrna7^tm1Bay (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal myeloblast morphology/development	J:140280
	decreased erythroblast number	J:140280
	decreased neutrophil cell number	J:140280
	increased lymphocyte cell number	J:140280
Chrna7^tm1Bay/Chrna7^tm1Bay (involves: 129S7/SvEvBrd * C57BL/6)	decreased IgG level	J:103908
	decreased immunoglobulin level	J:103908
Chrna10^em1(IMPC)Mbp/Chrna10^em1(IMPC)Mbp (C57BL/6NCrl-Chrna10^em1(IMPC)Mbp/MbpMmucd)	increased basophil cell number	J:211773
	increased monocyte cell number	J:211773
Chrnb2^tm1Jpc/Chrnb2^tm1Jpc (B6.129P2-Chrnb2^tm1Jpc)	decreased B cell number	J:112766
Chrnb2^tm1Jpc/Chrnb2^tm1Jpc (involves: 129P2/OlaHsd * C57BL/6J)	decreased erythroblast number	J:140280
	myeloid hyperplasia	J:140280
Chrnb2^tm1Jpc/Chrnb2^tm1Jpc (involves: 129P2/OlaHsd * C57BL/6)	abnormal immunoglobulin level	J:103908
	decreased B cell number	J:103908
	decreased immunoglobulin level	J:103908
	increased B cell proliferation	J:103908
	increased IgG level	J:103908
Chst1^{tm1(KOMP)Vlcg}/Chst1^{tm1(KOMP)Vlcg} (involves: C57BL/6NTac)	decreased B cell number	J:204813
	increased T cell number	J:204813
Chst1^{tm1(KOMP)Vlcg}/Chst1^{tm1(KOMP)Vlcg} Chst2^tm1Tmu/Chst2^tm1Tmu Chst4^tm1Sdr/Chst4^tm1Sdr (involves: 129S2/SvPas * C57BL/6NTac)	abnormal leukocyte migration	J:204813
Chst2^em1(IMPC)Mbp/Chst2^em1(IMPC)Mbp (C57BL/6N-Chst2^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Chst2^tm1Tmu/Chst2^tm1Tmu (involves: 129S2/SvPas * C57BL/6J)	abnormal leukocyte migration	J:92231
	abnormal leukocyte physiology	J:92231
Chst2^tm1Tmu/Chst2^tm1Tmu Chst4^tm1Sdr/Chst4^tm1Sdr (involves: 129S2/SvPas)	abnormal leukocyte migration	J:204813
Chst3^tm1Tmu/Chst3^tm1Tmu (involves: 129S2/SvPas * 129X1/SvJ)	decreased T cell number	J:73698
Chst3^tm1Tmu/Chst3^tm1Tmu (involves: 129S2/SvPas)	decreased neutrophil cell number	J:217719
Chst3^tm1Tmu/Chst3^tm1Tmu (involves: 129S2/SvPas)	increased T cell proliferation	J:217719
Chst4^tm1Mifu/Chst4^tm1Mifu (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal leukocyte migration	J:113195
	impaired leukocyte tethering or rolling	J:113195
Chst4^tm1Mifu/Chst4^tm1Mifu Gcnt1^tm1Jxm/Gcnt1^tm1Jxm (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal leukocyte migration	J:113195
	impaired leukocyte tethering or rolling	J:113195
Chst4^tm1Sdr/Chst4^tm1Sdr (involves: C57BL/6)	abnormal leukocyte adhesion	J:86759
Chst4^tm1Sdr/Chst4^tm1Sdr (involves: C57BL/6)	abnormal leukocyte migration	J:86759
Chst10^{em1(IMPC)Hmgu}/Chst10^{em1(IMPC)Hmgu} (C57BL/6NCrl-Chst10^{em1(IMPC)Hmgu}/Ieg)	increased red blood cell distribution width	J:211773
	increased spleen weight	J:211773
Chst11^{tm1a(KOMP)Wtsi}/Chst11^{tm1a(KOMP)Wtsi} (C57BL/6N-Chst11^{tm1a(KOMP)Wtsi}/Wtsi)	abnormal thymus morphology	J:239583
Chst15^tm1Oh/Chst15^tm1Oh (involves: 129P2/OlaHsd * C57BL/6)	abnormal mast cell morphology	J:165927
Chsy1^em1(IMPC)Mbp/Chsy1^em1(IMPC)Mbp (C57BL/6NCrl-Chsy1^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased mean corpuscular volume	J:211773
Chsy1^skt/Chsy1^skt Pde6b⁺/Pde6b⁺ (mixed)	decreased macrophage cell number	J:286529
	decreased neutrophil cell number	J:286529
	microgliosis	J:286529
Chsy1^skt/Chsy1^tm1Lex (mixed)	microgliosis	J:286529
Chsy1^tm1Lex/Chsy1^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	decreased red blood cell distribution width	J:171883
	increased mean corpuscular hemoglobin	J:171883
	microgliosis	J:286529
Chsy3^em2(IMPC)Mbp/Chsy3^em2(IMPC)Mbp (C57BL/6NCrl-Chsy3^em2(IMPC)Mbp/Mmucd)	increased mean platelet volume	J:211773
Chtop^{tm1a(EUCOMM)Wtsi}/Chtop^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Chtop^{tm1a(EUCOMM)Wtsi}/Wtsi)	absent spleen	J:239583
	spleen hypoplasia	J:239583
Chuk^{em1(IMPC)Ccpcz}/Chuk⁺ (C57BL/6NCrl-Chuk^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Chuk^tm1Lex/Chuk^tm1Lex Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S/SvEvBrd)	impaired macrophage chemotaxis	J:159873
	impaired neutrophil chemotaxis	J:159873
	impaired neutrophil recruitment	J:159873
Chuk^tm1Mka/Chuk^tm1Mka (B6.129-Chuk^tm1Mka)	abnormal B cell physiology	J:113556
Chuk^tm2Mka/Chuk^tm2Mka (B6.Cg-Chuk^tm2Mka)	abnormal B cell physiology	J:113556
Chuk^tm2Mka/Chuk^tm2Mka Tg(Tnfsf13b)1Fma/? (B6.Cg-Chuk^tm2Mka Tg(Tnfsf13b)1Fma)	abnormal B cell activation	J:113556
	absent spleen marginal zone	J:113556
	decreased marginal zone B cell number	J:113556
	increased transitional stage B cell number	J:113556
Chuk^tm2Yhu/Chuk^tm2Yhu Tg(Lor-CHUK)8Yhu/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)	increased CD4-positive, alpha-beta T cell number	J:197037
	increased CD8-positive, alpha-beta T cell number	J:197037
	increased macrophage cell number	J:197037
	increased neutrophil cell number	J:197037
Churc1^{tm1b(EUCOMM)Wtsi}/Churc1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Churc1^{tm1b(EUCOMM)Wtsi}/Wtsi)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
	increased effector memory T-helper cell number	J:211773
Cia27^DBA/1J/? (involves: DBA/1J * FVB/N)	increased IgG level	J:116665, J:94347
Ciao2a^{tm2a(EUCOMM)Wtsi}/Ciao2a^{tm2a(EUCOMM)Wtsi} (C57BL/6N-Ciao2a^{tm2a(EUCOMM)Wtsi}/Wtsi)	decreased erythrocyte cell number	J:211773
Ciao2b^{em1(IMPC)Ccpcz}/Ciao2b⁺ (C57BL/6N-Ciao2b^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased neutrophil cell number	J:211773
Ciapin1^tm1Yzka/Ciapin1^tm1Yzka (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal erythrocyte morphology	J:90889
	decreased erythrocyte cell number	J:90889
	decreased hematocrit	J:90889
	decreased hemoglobin content	J:90889
Cib1^{tm1b(EUCOMM)Hmgu}/Cib1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Cib1^{tm1b(EUCOMM)Hmgu}/Bay)	decreased eosinophil cell number	J:211773
	decreased neutrophil cell number	J:211773
	increased hematocrit	J:211773
	increased large unstained cell number	J:211773
	increased monocyte cell number	J:211773
Cib2^{tm1b(EUCOMM)Wtsi}/Cib2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Cib2^{tm1b(EUCOMM)Wtsi}/H)	increased basophil cell number	J:211773
Cibar1^{tm1b(KOMP)Wtsi}/Cibar1^{tm1b(KOMP)Wtsi} (C57BL/6N-Cibar1^{tm1b(KOMP)Wtsi}/Wtsi)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	decreased leukocyte cell number	J:274784, J:211773
Cideb^tm1Pli/Cideb^tm1Pli (Not Specified)	decreased spleen weight	J:126556
Cidec^{tm1b(EUCOMM)Wtsi}/Cidec^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Cidec^{tm1b(EUCOMM)Wtsi}/Ieg)	increased mean corpuscular volume	J:211773
Cigs2^tm1.1Anse/Cigs2⁺ Il4^tm1(CD2)Mmrs/Il4⁺ (involves: 129 * BALB/cJ * C57BL/6)	decreased basophil cell number	J:181313
	decreased IgE level	J:181313
	decreased IgG1 level	J:181313
Cigs2^tm1.1Anse/Cigs2^tm1.1Anse (involves: BALB/cJ * C57BL/6)	abnormal class switch recombination	J:181313
	decreased IgE level	J:181313
	decreased IgG1 level	J:181313
	increased IgG2b level	J:181313
Cigs2^tm1.1Kubo/Cigs2^tm1.1Kubo (B6.Cg-Cigs2^tm1.1Kubo)	abnormal mast cell physiology	J:129048
Cigs2^tm1.1Kubo/Cigs2^tm1.1Kubo (B6.Cg-Cigs2^tm1.1Kubo)	abnormal neutrophil physiology	J:129048
Ciita^m1Btlr/Ciita^m1Btlr (C57BL/6J-Ciita^m1Btlr)	abnormal CD4-positive T cell differentiation	J:221483
Ciita^m1Btlr/Ciita^m1Btlr (C57BL/6J-Ciita^m1Btlr)	abnormal CD8-positive, alpha-beta T cell differentiation	J:221483
Ciita^tm1.1Dim/Ciita^tm1.1Dim (involves: 129S2/SvPas * C57BL/6 * SJL)	decreased CD4-positive, alpha-beta T cell number	J:51885
	decreased dendritic cell number	J:51885
Ciita^tm1Ccum/Ciita^tm1Ccum (involves: 129S2/SvPas * C57BL/6J)	abnormal B cell physiology	J:96421
	abnormal CD4-positive, alpha-beta T cell physiology	J:31601
	abnormal lymphocyte physiology	J:96421
	abnormal MHC II cell surface expression on macrophages	J:31601
	abnormal T cell differentiation	J:64283
	abnormal T cell physiology	J:31601
	decreased CD4-positive, alpha-beta T cell number	J:31601
	decreased T cell proliferation	J:31601
	increased CD4-positive, alpha-beta T cell number	J:64283
	increased CD8-positive, alpha-beta T cell number	J:64283
Ciita^tm1Ccum/Ciita^tm1Ccum (NOD.129S2(B6)-Ciita^tm1Ccum)	abnormal T cell differentiation	J:106081
	decreased CD4-positive, alpha-beta T cell number	J:106081
	increased CD8-positive, alpha-beta T cell number	J:106081
Ciita^tm1Jpyt/Ciita^tm1Jpyt (involves: 129P2/OlaHsd * C57BL/6J)	abnormal T cell subpopulation ratio	J:57100
	decreased CD4-positive, alpha-beta T cell number	J:57100
	decreased IgG level	J:57100
	increased CD8-positive, alpha-beta T cell number	J:57100
	increased double-positive T cell number	J:57100
	increased IgM level	J:57100
Ciita^tm1Jpyt/Ciita^tm1Jpyt (B6.129P2-Ciita^tm1Jpyt)	abnormal T-helper 1 physiology	J:125654
Ciita^tm1Wrth/Ciita^tm1Wrth (involves: 129P2/OlaHsd * C57BL/6)	absent CD4-positive, alpha-beta T cells	J:233241
	increased osteoclast cell number	J:233241
Ciita^tm2Wrth/Ciita^tm2Wrth (involves: 129P2/OlaHsd * C57BL/6)	abnormal immunoglobulin level	J:92170
	decreased CD4-positive, alpha-beta T cell number	J:92170
Cilk1^{tm1b(KOMP)Mbp}/Cilk1^{tm1b(KOMP)Mbp} (C57BL/6N-Cilk1^{tm1b(KOMP)Mbp}/Ucd)	increased basophil cell number	J:211773
	increased neutrophil cell number	J:211773
Cimap1b^{em1(IMPC)Ccpcz}/Cimap1b^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Cimap1b^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	decreased NK T cell number	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Cimap2^Retro/Cimap2⁺ (involves: C57BL/6J)	increased CD8-positive, alpha-beta T cell number	J:223336
Cimap2^Retro/Cimap2⁺ (involves: C57BL/6J)	increased cytotoxic T cell cytolysis	J:223336
Cimap2^Retro/Cimap2^Retro (involves: C57BL/6J)	abnormal CD8-positive, alpha-beta cytotoxic T cell morphology	J:223336
	increased activated T cell number	J:223336
	increased CD8-positive, alpha-beta T cell number	J:223336
	increased central memory CD8 positive, alpha-beta T cell number	J:223336
	increased cytotoxic T cell cytolysis	J:223336
	increased T cell proliferation	J:223336
Cimap2^{tm1a(KOMP)Wtsi}/Cimap2⁺ (involves: C57BL/6)	decreased CD8-positive, alpha-beta T cell number	J:223336
Cimap2^{tm1a(KOMP)Wtsi}/Cimap2⁺ (involves: C57BL/6)	decreased cytotoxic T cell cytolysis	J:223336
Cimip2b^{tm1(KOMP)Wtsi}/Cimip2b^{tm1(KOMP)Wtsi} (C57BL/6N-Cimip2b^{tm1(KOMP)Wtsi}/Nju)	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
Cinda1^BALB/c/? (involves: BALB/c * CcS-4/Dem)	increased T cell proliferation	J:40728
Cinda2^STS/A/? (involves: BALB/c * CcS-4/Dem)	increased T cell proliferation	J:40728
Cinda3^O20/A/Cinda3^O20/A (involves: O20/A * OcB-9/Dem)	decreased T cell proliferation	J:95917
Cinda3^OcB9/Dem/Cinda3^O20/A (involves: O20/A * OcB-9/Dem)	increased T cell proliferation	J:95917
Cinda4^OcB9/Dem/Cinda4^O20/A (involves: O20/A * OcB-9/Dem)	increased T cell proliferation	J:95917
Cinda4^OcB9/Dem/Cinda4^OcB9/Dem (involves: O20/A * OcB-9/Dem)	increased T cell proliferation	J:95917
Cinda5^OcB9/Dem/Cinda5^O20/A (involves: O20/A * OcB-9/Dem)	increased T cell proliferation	J:95917
Cinda5^OcB9/Dem/Cinda5^OcB9/Dem (involves: O20/A * OcB-9/Dem)	increased T cell proliferation	J:95917
Cisd1^{em1(IMPC)Hmgu}/Cisd1^{em1(IMPC)Hmgu} (C57BL/6N-Cisd1^{em1(IMPC)Hmgu}/Ieg)	increased mean platelet volume	J:211773
Cish^tm1.1Cdon/Cish^tm1.1Cdon Tg(Cd4-cre)1Cwi/0 (involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * DBA/2)	abnormal T-helper 2 cell differentiation	J:204829
	increased eosinophil cell number	J:204829
Cish^tm1.2Cdon/Cish^tm1.2Cdon (B6.129S6(Cg)-Cish^tm1.2Cdon)	abnormal CD4-positive T cell differentiation	J:204829
	abnormal T-helper 2 cell differentiation	J:204829
	increased eosinophil cell number	J:204829
	increased lymphocyte cell number	J:204829
	increased T cell proliferation	J:204829
	spleen hyperplasia	J:204829
	thymus hyperplasia	J:204829
Cited2^tm1Bha/Cited2^tm1Bha (involves: 129P2/OlaHsd * C57BL/6J)	small spleen	J:92872
Cited2^tm1Bha/Cited2^tm1Bha (B6.129P2-Cited2^tm1Bha)	small spleen	J:92872
Ciz1^{Gt(IST13830B6)Tigm}/Ciz1^{Gt(IST13830B6)Tigm} (B6J.B6N-Ciz1^{Gt(IST13830B6)Tigm})	increased monocyte cell number	J:231433
	increased neutrophil cell number	J:231433
Ciz1^tm1.1Homy/Ciz1^tm1.1Homy (involves: 129P2/OlaHsd * C57BL/6 * DBA)	enlarged spleen	J:198470
	thymus hyperplasia	J:198470
Ckb^{tm1.1(KOMP)Wtsi}/Ckb^{tm1.1(KOMP)Wtsi} (C57BL/6N-Ckb^{tm1.1(KOMP)Wtsi}/Ucd)	decreased mean platelet volume	J:211773
	increased lymphocyte cell number	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
	increased red blood cell distribution width	J:211773
Cks1b^tm1Sir/Cks1b^tm1Sir Tg(IghMyc)22Bri/? (involves: C57BL * C57BL/6 * SJL)	decreased B cell proliferation	J:121564
	decreased leukocyte cell number	J:121564
	decreased lymphocyte cell number	J:121564
	decreased spleen weight	J:121564
Clasp1^em1(IMPC)Mbp/Clasp1⁺ (C57BL/6NCrl-Clasp1^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Clca1^tm1.1Lex/Clca1^tm1.1Lex (involves: 129S/SvEvBrd)	increased neutrophil cell number	J:125158
Clcc1^{tm1b(KOMP)Mbp}/Clcc1⁺ (B6N(Cg)-Clcc1^{tm1b(KOMP)Mbp}/2J)	increased mean corpuscular hemoglobin concentration	J:211773
Clcf1^{tm1.1(KOMP)Vlcg}/Clcf1⁺ (C57BL/6N-Clcf1^{tm1.1(KOMP)Vlcg}/Ucd)	decreased leukocyte cell number	J:211773
Clcn1^em1(IMPC)Mbp/Clcn1^em1(IMPC)Mbp (C57BL/6NCrl-Clcn1^em1(IMPC)Mbp/MbpMmucd)	decreased leukocyte cell number	J:211773
	decreased mean platelet volume	J:211773
	decreased monocyte cell number	J:211773
Clcn2^tm1Tjj/Clcn2^tm1Tjj (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal microglial cell physiology	J:122365
Clcn3^tm1Lamb/Clcn3^tm1Lamb (involves: 129S1/Sv * 129X1/SvJ)	abnormal neutrophil physiology	J:112692
	impaired neutrophil phagocytosis	J:112692
Clcn3^tm1Tjj/Clcn3^tm1Tjj (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal microglial cell physiology	J:77635
Clcn7^tm1.1Lex/Clcn7^tm1.1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	microgliosis	J:186049
Clcn7^tm1.1Mawa/Clcn7⁺ (involves: C57BL/6J * C57BL/6N * CD-1)	increased osteoclast cell number	J:254787
Clcn7^tm1.1Teti/Clcn7⁺ (involves: 129S2/SvPas * C57BL/6)	abnormal osteoclast physiology	J:203761
Clcn7^tm1.1Teti/Clcn7⁺ (involves: 129S2/SvPas * C57BL/6)	increased osteoclast cell number	J:203761
Clcn7^tm1Tjj/Clcn7^tm1Tjj (involves: 129P2/OlaHsd * C57BL/6)	abnormal osteoclast morphology	J:67273
	abnormal osteoclast physiology	J:67273
Clcn7^tm2Tjj/Clcn7^tm2Tjj (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal osteoclast morphology	J:67273, J:217031
	abnormal osteoclast physiology	J:67273
Clcn7^tm2Tjj/Clcn7^tm2Tjj (involves: 129S1/Sv * 129X1/SvJ)	microgliosis	J:155176
Clcn7^tm3.1Tjj/Clcn7^tm3.1Tjj Emx1^{tm1.1(cre)Ito}/Emx1⁺ (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * BALB/cJ * C57BL/6)	microgliosis	J:155176
Clcn7^tm4.1Tjj/Clcn7^tm4.1Tjj (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal osteoclast morphology	J:160702, J:217031
	abnormal osteoclast physiology	J:160702
Clcn7^tm5.1Tjj/Clcn7^tm5.1Tjj (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal osteoclast morphology	J:217031
Clcnkb^em1(IMPC)Mbp/Clcnkb^em1(IMPC)Mbp (C57BL/6NCrl-Clcnkb^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	decreased lymphocyte cell number	J:211773
	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
	enlarged spleen	J:211773
	increased basophil cell number	J:211773
	increased neutrophil cell number	J:211773
	increased red blood cell distribution width	J:211773
Cldn4^tm1.1Jhou/Cldn4^tm1.1Jhou Tg(Aqp2-cre)1Dek/0 (B6.Cg-Cldn4^tm1.1Jhou Tg(Aqp2-cre)1Dek)	increased hematocrit	J:216399
Cldn7^tm1Yche/Cldn7^tm1Yche (involves: C57BL/6)	increased hematocrit	J:155363
Cldn9^em1(IMPC)H/Cldn9^em1(IMPC)H (C57BL/6NTac-Cldn9^em1(IMPC)H/H)	increased basophil cell number	J:211773
Cldn12^{tm1.1(KOMP)Vlcg}/Cldn12^{tm1.1(KOMP)Vlcg} (B6J.B6N-Cldn12^{tm1.1(KOMP)Vlcg})	decreased erythrocyte cell number	J:279934
	increased leukocyte cell number	J:279934
	increased mean corpuscular hemoglobin	J:279934
	increased spleen weight	J:279934
	macrocytosis	J:279934
Cldn13^{tm1.1(KOMP)Vlcg}/Cldn13^{tm1.1(KOMP)Vlcg} (B6N(Cg)-Cldn13^{tm1.1(KOMP)Vlcg}/J)	decreased mean corpuscular volume	J:211773
	increased erythrocyte cell number	J:211773
	increased hemoglobin content	J:211773
Cldn18^{tm1.1(KOMP)Vlcg}/Cldn18^{tm1.1(KOMP)Vlcg} (C57BL/6N-Cldn18^{tm1.1(KOMP)Vlcg}/Ucd)	increased red blood cell distribution width	J:211773
Cldn18^tm1Lex/Cldn18^tm1Lex (involves: 129S5/SvEvBrd)	abnormal osteoclast differentiation	J:195931
Cldn18^tm1Lex/Cldn18^tm1Lex (involves: 129S5/SvEvBrd)	increased osteoclast cell number	J:195931
Clec1a^tm1Yiw/Clec1a^tm1Yiw (involves: C57BL/6J * C57BL/6NSlc)	decreased CD8-positive, alpha-beta memory T cell proliferation	J:329240
Clec1b^tm1.1Arte/Clec1b^tm1.1Arte Tg(Pf4-icre)Q3Rsko/0 (involves: C57BL/6)	abnormal platelet physiology	J:181715
Clec1b^tm1.1Ksi/Clec1b^tm1.1Ksi (involves: C57BL/6)	abnormal platelet activation	J:165898
Clec1b^tm1.1Ksi/Clec1b^tm1.1Ksi (involves: C57BL/6)	decreased platelet aggregation	J:165898
Clec1b^tm1.2Arte/Clec1b^tm1.2Arte (involves: 129 * C57BL/6)	abnormal platelet physiology	J:181754
Clec1b^tm1.2Arte/Clec1b^tm1.2Arte (Not Specified)	decreased platelet aggregation	J:181715
Clec1b^tm1Lex/Clec1b^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	abnormal mononuclear cell morphology	J:161922
	anemia	J:161922
	decreased hematocrit	J:161922
	decreased hemoglobin content	J:161922
	thrombocytopenia	J:161922
Clec1b^tm1Mlkn/Clec1b^tm1Mlkn (involves: 129S4/SvJae * C57BL/6)	abnormal platelet activation	J:162815
Clec2d^tm1.1Mgil/Clec2d^tm1.1Mgil (C57BL/6-Clec2d^tm1.1Mgil)	abnormal osteoclast differentiation	J:143122
	increased osteoclast cell number	J:143122
Clec4a2^tm1.1Cfg/Clec4a2^tm1.1Cfg (involves: C57BL/6)	increased B cell proliferation	J:217719
	increased IgG2a level	J:217719
	increased IgG2b level	J:217719
	increased IgG3 level	J:217719
Clec4a2^tm1Yiw/Clec4a2^tm1Yiw (involves: 129P2/OlaHsd * C57BL/6J)	increased dendritic cell number	J:217720
	increased IgG1 level	J:217720
	increased IgG3 level	J:217720
	increased IgG level	J:217720
	increased single-positive T cell number	J:217720
Clec4d^tm1.1Cfg/Clec4d^tm1.1Cfg (involves: C57BL/6)	decreased B cell proliferation	J:217719
	decreased T cell proliferation	J:217719
	extramedullary hematopoiesis	J:217719
	increased B cell number	J:217719
	increased mature B cell number	J:217719
Clec4d^tm1.1Shoy/Clec4d^tm1.1Shoy (involves: 129P2/OlaHsd * C57BL/6)	abnormal thymus morphology	J:203159
	decreased dendritic cell number	J:203159
	decreased IgG level	J:203159
Clec4e^tm1.1Cfg/Clec4e^tm1.1Cfg (B6.Cg-Clec4e^tm1.1Cfg)	abnormal macrophage physiology	J:136334
	decreased lymphocyte cell number	J:136334
	decreased monocyte cell number	J:136334
	decreased neutrophil cell number	J:136334
Clec4e^tm1Tks/Clec4e^tm1Tks (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased neutrophil cell number	J:172959
Clec4e^tm1Tks/Clec4e^tm1Tks (involves: 129S1/Sv * 129X1/SvJ)	decreased dendritic cell number	J:203159
	decreased IgG level	J:203159
Clec4f^tm1Ymed/Clec4f^tm1Ymed (B6.129S7-Clec4f^tm1Ymed)	abnormal macrophage cytokine production	J:203199
Clec4g^tm1.1Cfg/Clec4g^tm1.1Cfg (involves: C57BL/6)	increased erythrocyte cell number	J:217719
	increased lymphocyte cell number	J:217719
	increased monocyte cell number	J:217719
	thrombocytopenia	J:217719
Clec4g^tm1.1Fhe/Clec4g^tm1.1Fhe (B6.129-Clec4g^tm1.1Fhe)	increased activated T cell number	J:200968
	increased CD4-positive, alpha-beta T cell number	J:200968
	increased CD8-positive, alpha-beta T cell number	J:200968, J:194891
Clec4n^tm1.2Mgne/Clec4n^tm1.2Mgne (involves: C57BL/6 * C57BL/6J)	abnormal macrophage physiology	J:209284
	abnormal neutrophil physiology	J:209284
	impaired macrophage phagocytosis	J:209284
	impaired neutrophil phagocytosis	J:209284
Clec4n^tm1Yiw/Clec4n^tm1Yiw (B6.129P2-Clec4n^tm1Yiw)	abnormal CD4-positive T cell differentiation	J:160680
Clec5a^em1(IMPC)Mbp/Clec5a^em1(IMPC)Mbp (C57BL/6NCrl-Clec5a^em1(IMPC)Mbp/MbpMmucd)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Clec7a^tm1.1Bpip/Clec7a^tm1.1Bpip Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6J)	abnormal macrophage physiology	J:203908
	impaired macrophage phagocytosis	J:203908
Clec7a^tm1Gdb/Clec7a^tm1Gdb (involves: 129S6/SvEvTac * C57BL/6)	abnormal macrophage physiology	J:116669
	abnormal neutrophil physiology	J:116669
Clec7a^tm1Yiw/Clec7a^tm1Yiw (C.129P2-Clec7a^tm1Yiw)	abnormal macrophage physiology	J:116670
Clec10a^tm1Hed/Clec10a⁺ St3gal1^tm1Jxm/St3gal1^tm1Jxm (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	decreased CD8-positive, alpha-beta T cell number	J:78035
Clec10a^tm1Hed/Clec10a^tm1Hed (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	decreased mean corpuscular hemoglobin	J:78035
	increased erythrocyte cell number	J:78035
	increased hematocrit	J:78035
	increased hemoglobin content	J:78035
	increased mean corpuscular volume	J:78035
	thrombocytosis	J:78035
Clec10a^tm1Hed/Clec10a^tm1Hed St3gal1^tm1Jxm/St3gal1^tm1Jxm (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	decreased CD8-positive, alpha-beta T cell number	J:78035
Clec11a^em1Sjm/Clec11a^em1Sjm (involves: C57BL/6 * C57BL/Ka)	abnormal bone marrow cell morphology/development	J:239391
	hematopoietic system phenotype	J:239391
Clec12a^tm1Jrld/Clec12a^tm1Jrld (B6J.129-Clec12a^tm1Jrld)	abnormal bone marrow cell physiology	J:210326
Clec12a^tm1Jrld/Clec12a^tm1Jrld (B6J.129-Clec12a^tm1Jrld)	abnormal neutrophil physiology	J:210326
Clic1^tm1.1Breit/Clic1^tm1.1Breit (involves: 129 * C57BL/6J)	abnormal platelet activation	J:158394
	decreased platelet aggregation	J:158394
	thrombocytosis	J:158394
Clic4^tm1.1Yus/Clic4^tm1.1Yus (involves: 129S4/SvJae * C57BL/6J)	impaired macrophage phagocytosis	J:183611
Clic5^jbg/Clic5^jbg (involves: C3H/HeJ * C57BL/6)	decreased eosinophil cell number	J:160186
	decreased monocyte cell number	J:160186
	decreased neutrophil cell number	J:160186
Clk1^{tm1a(EUCOMM)Wtsi}/Clk1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Clk1^{tm1a(EUCOMM)Wtsi}/Ics)	decreased granulocyte number	J:165965
Cln3^em1Dprc/Cln3^em1Dprc (C57BL/6-Cln3^em1Dprc)	increased microglial cell activation	J:294634
Cln3^tm1Nbm/Cln3^tm1Nbm (involves: 129S6/SvEvTac * C57BL/6J)	abnormal macrophage physiology	J:233445
	decreased macrophage cytokine production	J:233445
Cln8^em1(IMPC)Mbp/Cln8^em1(IMPC)Mbp (C57BL/6N-Cln8^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Clnk^{em1(IMPC)Ccpcz}/Clnk^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Clnk^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Clnk^tm1Rygo/Clnk^tm1Rygo (B6.129P2-Clnk^tm1Rygo)	abnormal NK T cell physiology	J:131738
Clnk^tm1Rygo/Clnk^tm1Rygo (B6.129P2-Clnk^tm1Rygo)	increased natural killer cell mediated cytotoxicity	J:131738
Clnk^tm1Rygo/Clnk^tm1Rygo (involves: 129P2/OlaHsd * BALB/c)	increased natural killer cell mediated cytotoxicity	J:131621
Clnk^tm1Rygo/Clnk^tm1Rygo Lcp2^tm1Geha/Lcp2^tm1Geha (involves: 129P2/OlaHsd * 129S4/SvJae * BALB/c)	impaired natural killer cell mediated cytotoxicity	J:131621
	increased NK cell number	J:131621
Clnk^tm1Vei/Clnk^tm1Vei (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal mast cell physiology	J:91590
	increased natural killer cell mediated cytotoxicity	J:91590
Clock^{em1(IMPC)Ccpcz}/Clock^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Clock^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	decreased CD8-positive, naive alpha-beta T cell number	J:211773
	decreased effector memory T-helper cell number	J:211773
	decreased red blood cell distribution width	J:211773
	decreased spleen weight	J:211773
	enlarged thymus	J:211773
	increased CD4-positive, alpha-beta T cell number	J:211773
	increased eosinophil cell number	J:211773
	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
	increased T-helper cell number	J:211773
Clp1^tm1.1Pngr/Clp1^tm1.1Pngr (CBA.Cg-Clp1^tm1.1Pngr)	abnormal microglial cell morphology	J:209564
Clpp^{Gt(IST11134F10)Tigm}/Clpp^{Gt(IST11134F10)Tigm} (involves: C57BL/6N)	abnormal T cell activation	J:203140
Clpp^{Gt(IST13563G11)Tigm}/Clpp^{Gt(IST13563G11)Tigm} (involves: C57BL/6N)	abnormal T cell activation	J:203140
Clpp^{tm1a(EUCOMM)Wtsi}/Clpp^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Clpp^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased CD4-positive NK T cell number	J:211773
	decreased effector memory CD8-positive, alpha-beta T cell number	J:211773
	decreased gamma-delta T cell number	J:211773
	decreased memory-marker CD4-negative NK T cell number	J:211773
	decreased memory-marker CD4-positive NK T cell number	J:211773
	decreased NK T cell number	J:211773
	decreased red blood cell distribution width	J:211773
	increased B cell number	J:211773
	increased hematocrit	J:211773
	increased hemoglobin content	J:211773
	increased KLRG1-positive NK cell number	J:211773
	increased leukocyte cell number	J:211773
	increased Ly6C high monocyte number	J:211773
	increased Ly6C low monocyte number	J:211773
	increased mature B cell number	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased monocyte cell number	J:211773
	thrombocytopenia	J:211773
Clptm1^em1(IMPC)Tcp/Clptm1⁺ (C57BL/6NCrl-Clptm1^em1(IMPC)Tcp/Tcp)	decreased hematocrit	J:211773
	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
	increased monocyte cell number	J:211773
Clptm1l^{tm1d(EUCOMM)Wtsi}/Clptm1l⁺ (involves: 129S4/SvJaeSor * BALB/cJ * C57BL/6N)	abnormal class switch recombination	J:265892
Clptq1^NZB/BlNJ/Clptq1^NZB/BlNJ (B6.NZB-(D4Mit193-D4Mit33))	enlarged spleen	J:143646
	enlarged thymus	J:143646
	increased B-1a cell number	J:143646
	increased NK T cell number	J:143646
Clrn1^{tm1.1(KOMP)Vlcg}/Clrn1^{tm1.1(KOMP)Vlcg} (C57BL/6N-Clrn1^{tm1.1(KOMP)Vlcg}/Ucd)	abnormal spleen morphology	J:211773
Clspn^{tm1(KOMP)Vlcg}/Clspn⁺ (C57BL/6N-Clspn^{tm1(KOMP)Vlcg})	increased B cell number	J:332163
	increased bone marrow cell number	J:332163
Clstn1^{tm1b(EUCOMM)Hmgu}/Clstn1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Clstn1^{tm1b(EUCOMM)Hmgu}/H)	increased basophil cell number	J:211773
	increased hematocrit	J:211773
	increased mean corpuscular volume	J:211773
Clstn3^{tm1b(EUCOMM)Hmgu}/Clstn3^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Clstn3^{tm1b(EUCOMM)Hmgu}/Cnrm)	decreased spleen weight	J:211773
Clta^tm1.2Fmb/Clta^tm1.2Fmb (involves: C57BL/6)	abnormal class switch recombination	J:235591
Clta^tm1.2Fmb/Clta^tm1.2Fmb (involves: C57BL/6)	decreased germinal center B cell number	J:235591
Cluh^{em1(IMPC)Ccpcz}/Cluh⁺ (C57BL/6N-Cluh^{em1(IMPC)Ccpcz}/Ccpcz)	increased Ly6C-positive mature NK cell number	J:211773
Cma1^tm1Mfg/Cma1^tm1Mfg (either: (involves: 129 * C57BL/6) or (involves: 129 * BALB/c))	abnormal mast cell physiology	J:98963
Cmah^tm1Avrk/Cmah^tm1Avrk Dmd^mdx/Dmd^mdx (involves: 129X1/SvJ * C57BL/10ScSn)	increased macrophage cell number	J:164594
	increased monocyte cell number	J:164594
Cmah^tm1Avrk/Cmah^tm1Avrk Dock2^m1Hsd/Dock2^m1Hsd (B6NHsd.Cg-Dock2^m1Hsd Cmah^tm1Avrk)	abnormal B cell activation	J:144035
	decreased follicular B cell number	J:144035
	decreased marginal zone B cell number	J:144035
Cmah^tm1Avrk/Cmah^tm1Avrk Dock2^m1Hsd/Dock2^m1Hsd Siae^tm1.2Avrk/Siae^tm1.2Avrk (B6NHsd.Cg-Siae^tm1.2Avrk Dock2^m1Hsd Cmah^tm1Avrk)	abnormal B cell activation	J:144035
	decreased follicular B cell number	J:144035
	decreased marginal zone B cell number	J:144035
Cmah^tm1Ykoz/Cmah^tm1Ykoz (B6.129P2-Cmah^tm1Ykoz)	abnormal B cell physiology	J:121365
	abnormal T cell physiology	J:121365
	hematopoietic system phenotype	J:121365
	increased B cell proliferation	J:121365
	increased IgG1 level	J:121365
Cmklr1^tm1Dgen/Cmklr1^tm1Dgen (B6.Cg-Cmklr1^tm1Dgen)	abnormal alveolar macrophage morphology	J:157190
	abnormal definitive hematopoiesis	J:157190
	abnormal macrophage chemotaxis	J:157190
	increased neutrophil cell number	J:157190
Cmklr1^tm1Drg/Cmklr1^tm1Drg (Not Specified)	impaired macrophage chemotaxis	J:133968
Cmklr1^tm1Drg/Cmklr1^tm1Drg (Not Specified)	impaired neutrophil recruitment	J:133968
Cmtm4^{tm1d(EUCOMM)Wtsi}/Cmtm4^{tm1d(EUCOMM)Wtsi} (involves: C57BL/6J * C57BL/6N)	decreased CD8-positive, alpha-beta T cell number	J:333836
	increased B cell number	J:333836
Cmtm5^{tm1c(KOMP)Wtsi}/Cmtm5^{tm1c(KOMP)Wtsi} Cnp^tm1(cre)Kan/Cnp⁺ (B6.Cg-Cnp^tm1(cre)Kan Cmtm5^{tm1c(KOMP)Wtsi})	microgliosis	J:327261
Cmtm7^{tm2a(EUCOMM)Hmgu}/Cmtm7⁺ Rag1^tm1Fwa/Rag1^tm1Fwa (chimera involves: C57BL/6 * C57BL/6N)	abnormal B cell physiology	J:207033
	abnormal B-1a B cell morphology	J:207033
	decreased B cell proliferation	J:207033
	decreased B-1a cell number	J:207033
	decreased IgG2b level	J:207033
	decreased IgM level	J:207033
	decreased plasma cell number	J:207033
Cnga2^em1(IMPC)H/Cnga2^em1(IMPC)H (C57BL/6N-Cnga2^em1(IMPC)H/H)	increased mean platelet volume	J:211773
Cnga3^{tm1.1(KOMP)Vlcg}/Cnga3⁺ (C57BL/6N-Cnga3^{tm1.1(KOMP)Vlcg}/Ucd)	enlarged spleen	J:211773
Cngb3^{em1(IMPC)Ccpcz}/Cngb3^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Cngb3^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Cnmd^tm1Ska/Cnmd^tm1Ska (involves: C57BL/6 * CBA)	abnormal osteoclast physiology	J:81137
Cnn2^tm1.2Jin/Cnn2^tm1.2Jin (B6.129X1-Cnn2^tm1.2Jin)	abnormal macrophage chemotaxis	J:141867
	abnormal macrophage physiology	J:141867
	decreased granulocyte number	J:141867
	decreased monocyte cell number	J:141867
	decreased neutrophil cell number	J:141867
	increased bone marrow cell number	J:141867
	increased macrophage cell number	J:141867
Cnn2^tm1Jin/Cnn2^tm1Jin (B6.129X1-Cnn2^tm1Jin)	decreased monocyte cell number	J:141867
Cnn2^tm1Jin/Cnn2^tm1Jin (B6.129X1-Cnn2^tm1Jin)	decreased neutrophil cell number	J:141867
Cnot3^tm1.1Tya/Cnot3⁺ (B6.129P2(Cg)-Cnot3^tm1.1Tya)	abnormal osteoclast differentiation	J:206802
Cnot3^tm1.1Tya/Cnot3⁺ (B6.129P2(Cg)-Cnot3^tm1.1Tya)	increased osteoclast cell number	J:206802
Cnot4^{tm1b(EUCOMM)Wtsi}/Cnot4⁺ (C57BL/6N-Cnot4^{tm1b(EUCOMM)Wtsi}/Wtsi)	decreased KLRG1-positive NK cell number	J:211773
Cnot7^{em1(IMPC)Rbrc}/Cnot7^{em1(IMPC)Rbrc} (C57BL/6NJcl-Cnot7^{em1(IMPC)Rbrc}/Rbrc)	increased red blood cell distribution width	J:211773
Cnppd1^{tm1.1(KOMP)Vlcg}/Cnppd1^{tm1.1(KOMP)Vlcg} (B6N(Cg)-Cnppd1^{tm1.1(KOMP)Vlcg}/J)	decreased mean corpuscular hemoglobin	J:211773
	increased leukocyte cell number	J:211773
Cnpy2^{em1(IMPC)Wtsi}/Cnpy2⁺ (C57BL/6N-Cnpy2^{em1(IMPC)Wtsi}/Wtsi)	increased effector memory T-helper cell number	J:211773
Cnpy3^tm1Kmiy/Cnpy3^tm1Kmiy (involves: C57BL/6)	abnormal lymphocyte physiology	J:128513
Cnpy3^tm1Kmiy/Cnpy3^tm1Kmiy (involves: C57BL/6)	abnormal macrophage physiology	J:128513
Cnr2^em1(IMPC)Mbp/Cnr2^em1(IMPC)Mbp (C57BL/6N-Cnr2^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Cnr2^tm1Zim/Cnr2^tm1Zim (involves: 129 * C57BL/6)	abnormal macrophage physiology	J:62417
Cntd1^em1(IMPC)Mbp/Cntd1^em1(IMPC)Mbp (C57BL/6NCrl-Cntd1^em1(IMPC)Mbp/Mmucd)	increased mean corpuscular volume	J:211773
Cntf^tm1Mpin/Cntf^tm1Mpin (involves: 129S2/SvPas)	abnormal microglial cell morphology	J:15313
Cntnap5a^em1(IMPC)J/Cntnap5a^em1(IMPC)J (C57BL/6NJ-Cntnap5a^em1(IMPC)J/Mmjax)	decreased hematocrit	J:211773
Coasy^em1(IMPC)H/Coasy⁺ (C57BL/6NTac-Coasy^em1(IMPC)H/H)	increased mean platelet volume	J:211773
Coasy^em1(IMPC)H/Coasy⁺ (C57BL/6NTac-Coasy^em1(IMPC)H/H)	increased neutrophil cell number	J:211773
Cobll1^{em1(IMPC)Ccpcz}/Cobll1^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Cobll1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Cog2^{tm1a(KOMP)Wtsi}/Cog2⁺ (B6JTyr;B6N-Cog2^{tm1a(KOMP)Wtsi}/Wtsi)	increased hematocrit	J:175295
Cog5^{em1(IMPC)Ccpcz}/Cog5⁺ (C57BL/6NCrl-Cog5^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Cog6^{tm1a(EUCOMM)Wtsi}/Cog6^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Cog6^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased alpha-beta T cell number	J:211773
	decreased CD4-positive NK T cell number	J:211773
	decreased CD8-positive, alpha-beta T cell number	J:211773
	decreased CD8-positive, naive alpha-beta T cell number	J:211773
	decreased effector memory CD8-positive, alpha-beta T cell number	J:211773
	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	decreased Ly6C-positive immature NK cell number	J:211773
	decreased Ly6C-positive mature NK cell number	J:211773
	decreased marginal zone B cell number	J:211773
	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular hemoglobin concentration	J:211773
	decreased memory-marker CD4-negative NK T cell number	J:211773
	decreased memory-marker CD4-positive NK T cell number	J:211773
	decreased memory-marker gamma-delta T cell number	J:211773
	decreased memory-marker NK cell number	J:211773
	decreased NK cell number	J:211773
	decreased NK T cell number	J:211773
	decreased T cell number	J:211773
	decreased T-helper cell number	J:211773
	decreased transitional stage T2 B cell number	J:211773
	increased B-2 B cell number	J:211773
	increased CD4-negative NK T cell number	J:211773
	increased CD4-positive, alpha-beta memory T cell number	J:211773
	increased CD4-positive, alpha-beta T cell number	J:211773
	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	increased CD5-positive gamma-delta T cell number	J:211773
	increased effector memory T-helper cell number	J:211773
	increased eosinophil cell number	J:211773
	increased follicular B cell number	J:211773
	increased gamma-delta T cell number	J:211773
	increased granulocyte number	J:211773
	increased KLRG1+ CD4 alpha-beta T cell number	J:211773
	increased KLRG1+ CD8 alpha-beta T cell number	J:211773
	increased KLRG1-positive CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	increased KLRG1-positive NK cell number	J:211773
	increased KLRG1-positive T-helper cell number	J:211773
	increased leukocyte cell number	J:211773
	increased Ly6C high monocyte number	J:211773
	increased mean platelet volume	J:211773
	increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	increased memory-marker gamma-delta T cell number	J:211773
	increased memory-marker NK cell number	J:211773
	increased monocyte cell number	J:211773
	increased plasma cell number	J:211773
	increased red blood cell distribution width	J:211773
Col1a1^{tm1(CAG-Ezh2)Meln}/Col1a1⁺ Ighg1^tm1(cre)Cgn/Ighg1⁺ (involves: 129P2/OlaHsd 129S4/SvJae * C57BL/6)	increased germinal center B cell number	J:199122
	increased spleen germinal center number	J:199122
	increased spleen germinal center size	J:199122
Col1a1^{tm1(CAG-Mir22)Ppp}/Col1a1^{tm1(CAG-Mir22)Ppp} Tg(Mx1-cre)1Cgn/0 (Not Specified)	abnormal erythropoiesis	J:199366
	abnormal hematopoietic system morphology/development	J:199366
	anemia	J:199366
	decreased leukocyte cell number	J:199366
	enlarged spleen	J:199366
	increased hematopoietic stem cell number	J:199366
	increased myeloid dendritic cell number	J:199366
Col1a1^{tm1(tetO-cre)Haho}/? Gfi1b^tm1.1Haho/Gfi1b^tm1.1Haho (involves: 129S4/SvJaeSor * C57BL/6)	abnormal megakaryocyte differentiation	J:207446
	abnormal megakaryocyte progenitor cell morphology	J:207446
	absent erythroid progenitor cell	J:207446
	absent platelets	J:207446
	anemia	J:207446
	decreased hemoglobin content	J:207446
	thrombocytopenia	J:207446
Col1a1^{tm1(tetO-Fos)Wag}/Col1a1⁺ Tg(KRT5-rtTA)T2D6Sgkd/0 (involves: 129S4/SvJae * C57BL/6 * FVB/N)	increased CD4-positive, alpha-beta T cell number	J:201145
	increased granulocyte number	J:201145
Col1a1^{tm1(tetO-GFP/RNAi:Rad21)Iaai}/Col1a1⁺ Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}/Gt(ROSA)26Sor⁺ (involves: 129S4/SvJae C57BL/6)	abnormal bone marrow cell number	J:229031
	abnormal definitive hematopoiesis	J:229031
	abnormal hematopoietic stem cell morphology	J:229031
	decreased B cell number	J:229031
	extramedullary hematopoiesis	J:229031
	increased hematopoietic stem cell number	J:229031
	increased myeloid cell number	J:229031
Col1a1^{tm1(tetO-Irf4)Sing}/Col1a1^{tm1(tetO-Irf4)Sing} Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}/Gt(ROSA)26Sor⁺ Irf4^tm1Mak/Irf4⁺ (involves: 129P2/OlaHsd 129S4/SvJae * C57BL/6)	abnormal class switch recombination	J:203903
	abnormal plasma cell differentiation	J:203903
Col1a1^{tm1(tetO-Irf4)Sing}/Col1a1^{tm1(tetO-Irf4)Sing} Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}/Gt(ROSA)26Sor⁺ Irf4^tm1Mak/Irf4^tm1Mak (involves: 129P2/OlaHsd 129S4/SvJae * C57BL/6)	abnormal class switch recombination	J:203903
	abnormal plasma cell differentiation	J:203903
Col1a1^{tm1(tetO-RNAi:Rps19)Karl}/Col1a1⁺ Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}/Gt(ROSA)26Sor^{tm1(rtTAM2)Jae} (involves: 129S4/SvJae * C57BL/6)	abnormal bone marrow cell morphology/development	J:179085
	abnormal bone marrow cell physiology	J:179085
	abnormal proerythroblast morphology	J:179085
	decreased bone marrow cell number	J:179085
	decreased erythrocyte cell number	J:179085
	decreased hematopoietic cell number	J:179085
	decreased lymphocyte cell number	J:179085
	decreased megakaryocyte cell number	J:179085
	macrocytosis	J:179085
	reticulocytopenia	J:179085
	thrombocytosis	J:179085
Col1a1^{tm1(tetO-RNAi:Rps19)Karl}/Col1a1^{tm1(tetO-RNAi:Rps19)Karl} Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}/Gt(ROSA)26Sor^{tm1(rtTAM2)Jae} (involves: 129S4/SvJae * C57BL/6)	abnormal bone marrow cell morphology/development	J:179085
	abnormal bone marrow cell physiology	J:179085
	abnormal proerythroblast morphology	J:179085
	decreased bone marrow cell number	J:179085
	decreased erythrocyte cell number	J:179085
	decreased hematopoietic cell number	J:179085
	decreased lymphocyte cell number	J:179085
	decreased megakaryocyte cell number	J:179085
	decreased neutrophil cell number	J:179085
	macrocytosis	J:179085
	reticulocytopenia	J:179085
	thrombocytopenia	J:179085
	thrombocytosis	J:179085
Col1a1^{tm1(tetO-U2AF1S34F)Mjwa}/Col1a1⁺ Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}/? (involves: 129S4/SvJae * C57BL/6)	abnormal definitive hematopoiesis	J:221403
Col1a1^{tm1(tetO-Yod1)Hpl}/Col1a1^{tm1(tetO-Yod1)Hpl} Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}/Gt(ROSA)26Sor^{tm1(rtTAM2)Jae} (involves: 129S4/SvJae * C57BL/6)	abnormal CD8-positive, alpha-beta T cell physiology	J:194608
Col1a1^tm1Jae/Col1a1^tm1Jae (involves: 129S4/SvJae * C57BL/6)	abnormal osteoclast physiology	J:53079
Col1a1^{tm2(tetO-Fosl2,-DsRed)Wag}/Col1a1⁺ Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0 (involves: 129S4/SvJae * C57BL/6 * CD-1)	abnormal osteoclast morphology	J:211215
Col1a1^{tm2(tetO-GFP/RNAi:Smc1a)Iaai}/Col1a1⁺ Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}/Gt(ROSA)26Sor⁺ (involves: 129S4/SvJae C57BL/6)	abnormal bone marrow cell number	J:229031
	abnormal definitive hematopoiesis	J:229031
	abnormal hematopoietic stem cell morphology	J:229031
	decreased B cell number	J:229031
	decreased hematopoietic stem cell number	J:229031
	enlarged spleen	J:229031
	extramedullary hematopoiesis	J:229031
	increased bone marrow cell number	J:229031
	increased granulocyte monocyte progenitor cell number	J:229031
	increased hematopoietic stem cell number	J:229031
	increased myeloid cell number	J:229031
	increased neutrophil cell number	J:229031
	increased spleen red pulp amount	J:229031
	myeloid hyperplasia	J:229031
	myeloid metaplasia	J:229031
Col1a1^{tm2(tetO-GFP/RNAi:Smc1a)Iaai}/Col1a1^{tm3(tetO-GFP/RNAi:Stag2)Iaai} Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}/Gt(ROSA)26Sor⁺ (involves: 129S4/SvJae C57BL/6)	abnormal definitive hematopoiesis	J:229031
	abnormal spleen morphology	J:229031
	anemia	J:229031
	decreased B cell number	J:229031
	enlarged spleen	J:229031
	myeloid hyperplasia	J:229031
Col1a1^{tm2(tetO-IDH2R140Q)Ppp}/Col1a1^{tm2(tetO-IDH2R140Q)Ppp} Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}/? (involves: 129S4/SvJae C57BL/6)	abnormal hematopoietic stem cell proliferation	J:210097
	enlarged spleen	J:210097
	extramedullary hematopoiesis	J:210097
	hematopoietic system phenotype	J:210097
	increased hematopoietic stem cell proliferation	J:210097
Col1a1^{tm2(tetO-Pou5f1)Jae}/Col1a1⁺ Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}/Gt(ROSA)26Sor⁺ (involves: 129S4/SvJae C57BL/6)	spleen atrophy	J:98920
	thymus atrophy	J:98920
Col1a1^{tm2(tetO-RNAi:Rps19)Karl}/Col1a1⁺ Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}/Gt(ROSA)26Sor^{tm1(rtTAM2)Jae} (involves: 129S4/SvJae * C57BL/6)	decreased erythrocyte cell number	J:179085
	decreased hematopoietic cell number	J:179085
	decreased lymphocyte cell number	J:179085
	macrocytosis	J:179085
	reticulocytopenia	J:179085
	thrombocytopenia	J:179085
	thrombocytosis	J:179085
Col1a1^{tm2(tetO-RNAi:Rps19)Karl}/Col1a1^{tm2(tetO-RNAi:Rps19)Karl} Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}/Gt(ROSA)26Sor^{tm1(rtTAM2)Jae} (involves: 129S4/SvJae * C57BL/6)	decreased erythrocyte cell number	J:179085
	decreased hematopoietic cell number	J:179085
	decreased lymphocyte cell number	J:179085
	decreased neutrophil cell number	J:179085
	macrocytosis	J:179085
	reticulocytopenia	J:179085
	thrombocytopenia	J:179085
	thrombocytosis	J:179085
Col1a1^{tm2(tetO-U2AF1)Mjwa}/Col1a1⁺ Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}/0 (involves: 129S4/SvJae C57BL/6)	hematopoietic system phenotype	J:221403
Col1a1^{tm3(tetO-Fosl1,-DsRed)Wag}/Col1a1⁺ Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}/Gt(ROSA)26Sor⁺ (involves: 129S4/SvJae C57BL/6)	enlarged spleen	J:213764
Col1a1^{tm3(tetO-GFP/RNAi:Stag2)Iaai}/Col1a1⁺ Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}/Gt(ROSA)26Sor⁺ (involves: 129S4/SvJae C57BL/6)	abnormal definitive hematopoiesis	J:229031
	abnormal hematopoietic stem cell morphology	J:229031
	decreased B cell number	J:229031
	decreased hematopoietic stem cell number	J:229031
	increased myeloid cell number	J:229031
Col1a1^{tm6(tetO-MSI2)Jae}/Col1a1⁺ Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}/Gt(ROSA)26Sor⁺ (involves: 129S4/SvJae C57BL/6)	abnormal bone marrow cell morphology/development	J:163322
	abnormal erythrocyte morphology	J:163322
	abnormal leukocyte morphology	J:163322
	abnormal myelopoiesis	J:163322
	decreased common myeloid progenitor cell number	J:163322
	decreased lymphocyte cell number	J:163322
	decreased neutrophil cell number	J:163322
	enlarged spleen	J:163322
	increased bone marrow cell number	J:163322
	increased erythrocyte cell number	J:163322
	increased hematocrit	J:163322
	increased hematopoietic stem cell number	J:163322
	increased leukocyte cell number	J:163322
	increased mean corpuscular volume	J:163322
	increased spleen weight	J:163322
	spleen hyperplasia	J:163322
	thrombocytopenia	J:163322
Col1a1^{tm10(tetO-RFP/RNAi:Rpa3)Slowe}/Col1a1⁺ Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}/Gt(ROSA)26Sor^{tm1(rtTAM2)Jae} (involves: 129S4/SvJae C57BL/6)	decreased erythroid progenitor cell number	J:171348
Col1a1^{tm11(tetO-RFP/RNAi:Rpa3)Slowe}/Col1a1⁺ Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}/Gt(ROSA)26Sor^{tm1(rtTAM2)Jae} (involves: 129S4/SvJae C57BL/6)	decreased erythroid progenitor cell number	J:171348
Col1a2^{tm1b(EUCOMM)Wtsi}/Col1a2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Col1a2^{tm1b(EUCOMM)Wtsi}/BayMmucd)	decreased lymphocyte cell number	J:211773
	enlarged spleen	J:211773
	increased large unstained cell number	J:211773
	increased leukocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Col3a1^m1Btlr/Col3a1^m1Btlr (C57BL/6J-Col3a1^m1Btlr)	increased alpha-beta T cell number	J:271973
	increased CD4-positive, alpha-beta T cell number	J:271973
	increased CD8-positive, alpha-beta T cell number	J:271973
Col4a1^Acso/Col4a1⁺ (C3.Cg-Col4a1^Acso)	decreased erythrocyte cell number	J:163225
	decreased hematocrit	J:163225
	decreased hemoglobin content	J:163225
Col4a1^Bru/Col4a1⁺ (Not Specified)	anemia	J:13980
Col4a1^D456/Col4a1⁺ (C3.D2-Col4a1^D456)	decreased erythrocyte cell number	J:163225
	decreased hematocrit	J:163225
	decreased hemoglobin content	J:163225
Col4a1^ENU911/Col4a1⁺ (C3.Cg-Col4a1^ENU911)	decreased erythrocyte cell number	J:163225
	decreased hematocrit	J:163225
	decreased hemoglobin content	J:163225
Col4a1^ENU4004/Col4a1⁺ (C3.D2-Col4a1^ENU4004)	decreased erythrocyte cell number	J:163225
	decreased hematocrit	J:163225
	decreased hemoglobin content	J:163225
Col4a1^ENU6005/Col4a1⁺ (C3H/HeJ-Col4a1^ENU6005)	decreased erythrocyte cell number	J:163225
	decreased hematocrit	J:163225
	decreased hemoglobin content	J:163225
Col4a1^ENU6009/Col4a1⁺ (C3H/HeJ-Col4a1^ENU6009)	decreased erythrocyte cell number	J:163225
	decreased hematocrit	J:163225
	decreased hemoglobin content	J:163225
Col4a1^ENU6019/Col4a1⁺ (C3H/HeJ-Col4a1^ENU6019)	decreased erythrocyte cell number	J:163225
	decreased hematocrit	J:163225
	decreased hemoglobin content	J:163225
Col4a1^ENU6024/Col4a1⁺ (C3H/HeJ-Col4a1^ENU6024)	decreased erythrocyte cell number	J:163225
	decreased hematocrit	J:163225
	decreased hemoglobin content	J:163225
Col4a1^F247/Col4a1⁺ (C3.Cg-Col4a1^F247)	decreased erythrocyte cell number	J:163225
	decreased hematocrit	J:163225
	decreased hemoglobin content	J:163225
Col4a2^{em1(IMPC)Wtsi}/Col4a2^{em1(IMPC)Wtsi} (C57BL/6N-Col4a2^{em1(IMPC)Wtsi}/WtsiOulu)	abnormal thymus topology	J:239583
	small thymus	J:239583
Col4a2^ENU415/Col4a2⁺ (C3.Cg-Col4a2^ENU415)	decreased erythrocyte cell number	J:163225
	decreased hematocrit	J:163225
	decreased hemoglobin content	J:163225
Col4a2^ENU4003/Col4a2⁺ (C3.D2-Col4a2^ENU4003)	decreased erythrocyte cell number	J:163225
	decreased hematocrit	J:163225
	decreased hemoglobin content	J:163225
Col4a2^ENU4020/Col4a2⁺ (C3.D2-Col4a2^ENU4020)	decreased erythrocyte cell number	J:163225
	decreased hematocrit	J:163225
	decreased hemoglobin content	J:163225
Col4a3^{tm1b(EUCOMM)Wtsi}/Col4a3^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Col4a3^{tm1b(EUCOMM)Wtsi}/H)	decreased basophil cell number	J:211773
	decreased hemoglobin content	J:211773
	decreased lymphocyte cell number	J:211773
	increased large unstained cell number	J:211773
	increased neutrophil cell number	J:211773
Col4a4^em1(IMPC)H/Col4a4^em1(IMPC)H (C57BL/6N-Col4a4^em1(IMPC)H/H)	small thymus	J:211773
Col4a4^m1H/Col4a4^m1H (involves: C3H/HeH * C57BL/6J)	increased leukocyte cell number	J:285510
Col4a5^{tm1b(EUCOMM)Wtsi}/Y (C57BL/6N-Col4a5^{tm1b(EUCOMM)Wtsi}/Cnrm)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
	increased leukocyte cell number	J:211773
	thrombocytosis	J:211773
Col4a5^{tm1b(EUCOMM)Wtsi}/Col4a5^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Col4a5^{tm1b(EUCOMM)Wtsi}/Cnrm)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	increased large unstained cell number	J:211773
	increased neutrophil cell number	J:211773
	increased red blood cell distribution width	J:211773
	increased spleen weight	J:211773
	thrombocytosis	J:211773
Col7a1^em#Jtol/Col7a1^em#Jtol (involves: 129S4/SvJae * BALB/c * C57BL/Ka * NOD)	absent B cells	J:280214
	absent NK T cells	J:280214
	absent T cells	J:280214
Col9a3^em1(IMPC)Tcp/Col9a3^em1(IMPC)Tcp (C57BL/6N-Col9a3^em1(IMPC)Tcp/Tcp)	enlarged spleen	J:211773
Col10a1^tm1.1Rpbh/Col10a1^tm1.1Rpbh (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased osteoclast cell number	J:154052
Col10a1^tm1Bhr/Col10a1^tm1Bhr (involves: 129S7/SvEvBrd * C57BL/6)	abnormal proerythroblast morphology	J:62230
	abnormal spleen morphology	J:62230
	decreased B cell number	J:62230
	decreased double-positive T cell number	J:62230
	decreased spleen red pulp amount	J:62230
	decreased spleen weight	J:62230
	decreased thymocyte number	J:62230
	decreased thymus weight	J:62230
	increased CD4-positive, alpha-beta T cell number	J:62230
	increased double-negative T cell number	J:62230
	increased single-positive T cell number	J:62230
	small spleen	J:62230
	small thymus	J:62230
	spleen hypoplasia	J:62230
	thymus hypoplasia	J:62230
Col10a1^tm1Ksec/Col10a1^tm1Ksec (involves: 129S/SvEv * C57BL/6)	abnormal T-helper 2 cell differentiation	J:193886
	decreased dendritic cell number	J:193886
	increased B cell number	J:193886
	increased T-helper cell number	J:193886
Col11a2^{tm1b(KOMP)Wtsi}/Col11a2⁺ (C57BL/6N-Col11a2^{tm1b(KOMP)Wtsi}/Ieg)	decreased mean corpuscular volume	J:211773
Col17a1^{tm1.1(COL17A1)Zliu}/Col17a1^{tm1.1(COL17A1)Zliu} (involves: 129P2/OlaHsd * C57BL/6J)	increased mast cell degranulation	J:261781
	increased neutrophil cell number	J:261781
Col17a1^tm1Tiin/Col17a1^tm1Tiin (involves: C57BL/6)	increased basophil cell number	J:220622
	increased eosinophil cell number	J:220622
	increased IgE level	J:220622
	increased monocyte cell number	J:220622
	increased neutrophil cell number	J:220622
Col26a1^em3(IMPC)Tcp/Col26a1^em3(IMPC)Tcp (C57BL/6NCrl-Col26a1^em3(IMPC)Tcp/Tcp)	increased red blood cell distribution width	J:211773
Col27a1^em1(IMPC)Mbp/Col27a1⁺ (C57BL/6N-Col27a1^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	small spleen	J:211773
Colec12^em1(IMPC)Mbp/Colec12^em1(IMPC)Mbp (C57BL/6N-Colec12^em1(IMPC)Mbp/MbpMmucd)	small spleen	J:211773
Colgalt2^tm1.1Hwei/Colgalt2^tm1.1Hwei (involves: C57BL/6J)	abnormal CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:310468
	abnormal regulatory T cell morphology	J:310468
	increased T cell apoptosis	J:310468
Commd8^tm1.1Ksuz/Commd8^tm1.1Ksuz Igh^tm1Mnz/Igh⁺ Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: 129P2/OlaHsd * BALB/c * C57BL/6NSlc * SJL)	abnormal spleen B cell follicle morphology	J:278399
Commd9^{tm1b(KOMP)Wtsi}/Commd9⁺ (C57BL/6N-Commd9^{tm1b(KOMP)Wtsi}/H)	decreased erythrocyte cell number	J:211773
	decreased hemoglobin content	J:211773
	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
	increased red blood cell distribution width	J:211773
Commd10^{Tg(Vav1-icre)A2Kio}/0 Map3k7^tm1.1Arte/Map3k7^tm1.1Arte (involves: C57BL/10 * C57BL/6J * C57BL/6NTac * CBA/Ca)	decreased macrophage cell number	J:332172
	enlarged spleen	J:332172
	increased B cell number	J:332172
	increased lymphocyte cell number	J:332172
	increased neutrophil cell number	J:332172
	increased splenocyte number	J:332172
Commd10^{Tg(Vav1-icre)A2Kio}/0 Nfil3^tm1.2Kubo/Nfil3^tm1.2Kubo (involves: 129 * C57BL/6 * C57BL/10 * CBA/Ca)	decreased dendritic cell number	J:334296
Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ Ociad1^tm1Msin/Ociad1^tm1Msin (involves: C57BL/6NCrlj * C57BL/10 * CBA/Ca * CBA/JNCrlj)	increased hematopoietic cell number	J:279239
	increased hematopoietic stem cell number	J:279239
Comt^tm1Kara/Comt^tm1Kara (involves: 129S4/SvJaeSor)	increased uterine NK cell number	J:137276
Cop1^{Gt(XR0653)Wtsi}/Cop1^{Gt(XR0653)1.1Wtsi} (involves: 129P2/OlaHsd * C57BL/6 * CBA)	anemia	J:178271
Copa^tm1.1Shum/Copa⁺ (B6(CBA)-Copa^tm1.1Shum)	abnormal B cell morphology	J:288425
	abnormal T cell activation	J:288425
	decreased double-positive T cell number	J:288425
	increased effector memory T-helper cell number	J:288425
	increased single-positive T cell number	J:288425
Copg1^em1Geha/Copg1^em1Geha (involves: C57BL/6)	abnormal B cell physiology	J:345528
	abnormal IgG level	J:345528
	increased T cell apoptosis	J:345528
Copg1^{tm1a(EUCOMM)Wtsi}/Copg1⁺ (C57BL/6N-Copg1^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased mean corpuscular hemoglobin	J:175295
	thrombocytosis	J:175295
Cops4^{tm1a(EUCOMM)Hmgu}/Cops4⁺ (C57BL/6N-Cops4^{tm1a(EUCOMM)Hmgu}/Ics)	increased hemoglobin content	J:165965
	increased mean corpuscular hemoglobin concentration	J:165965
Cops5^tm1Rpar/Cops5^tm1Rpar Tg(Lck-cre)548Jxm/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * SJL)	decreased double-positive T cell number	J:132114
	decreased single-positive T cell number	J:132114
	decreased thymocyte number	J:132114
	increased T cell apoptosis	J:132114
	thymus medulla hypoplasia	J:132114
Cops5^tm1Rpar/Cops5^tm1Rpar Tg(Lck-cre)548Jxm/0 Tg(TcraTcrb)425Cbn/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * SJL)	decreased thymocyte number	J:132114
Cops5^tm1Rpar/Cops5^tm1Rpar Tg(Lck-cre)548Jxm/0 Trp53^tm1Tyj/Trp53^tm1Tyj (involves: 129 * C57BL/6 * CBA * SJL)	decreased thymocyte number	J:132114
Cops6^{Gt(RRI087)Byg}/Cops6⁺ (involves: 129P2/OlaHsd * C57BL/6J)	increased thymocyte apoptosis	J:172038
Cops7a^{tm1b(KOMP)Mbp}/Cops7a^{tm1b(KOMP)Mbp} (C57BL/6N-Cops7a^{tm1b(KOMP)Mbp}/Ucd)	increased monocyte cell number	J:211773
Cops8^tm1Nwe/Cops8^tm1.1Nwe Tg(Cd4-cre)1Cwi/? (involves: 129S1/Sv * C57BL/6 * DBA/2)	abnormal CD4-positive, alpha-beta T cell physiology	J:126339
	abnormal T cell activation	J:126339
	decreased T cell number	J:126339
	decreased T cell proliferation	J:126339
Coq8b^{tm1b(EUCOMM)Hmgu}/Coq8b⁺ (B6N(Cg)-Coq8b^{tm1b(EUCOMM)Hmgu}/J)	decreased mean corpuscular hemoglobin concentration	J:211773
Coro1a^koy/Coro1a^koy (C57BL/6-Coro1a^koy)	abnormal T cell physiology	J:141431
	decreased CD4-positive, alpha-beta T cell number	J:141431
	decreased CD8-positive, alpha-beta T cell number	J:141431
	decreased thymocyte number	J:141431
Coro1a^{Lmb3-C57BL/6Scr}/Coro1a^{Lmb3-C57BL/6Scr} (MRL.Cg-Coro1a^C57BL/6Scr Fas^lpr)	decreased spleen weight	J:125557
Coro1a^{Lmb3-MRL/MpScr}/Coro1a^{Lmb3-MRL/MpScr} (involves: C57BL/6-Fas^lpr * MRL-Fas^lpr)	enlarged spleen	J:45708
Coro1a^{Lmb3-MRL/MpScr}/Coro1a^{Lmb3-MRL/MpScr} (B6.MRL-Coro1a^MRL/MpScr Fas^lpr)	increased spleen weight	J:125557
Coro1a^ptcd/Coro1a^ptcd (B6.CTS-Coro1a^ptcd)	abnormal effector T cell morphology	J:141431
	abnormal T cell activation	J:141431
	abnormal T cell physiology	J:141431
	decreased CD4-positive, alpha-beta T cell number	J:141431
	decreased CD8-positive, alpha-beta T cell number	J:141431
	increased T cell apoptosis	J:141431
	increased thymocyte number	J:141431
Coro1a^ptcd/Coro1a^tm1Achn (B6.Cg-Coro1a^ptcd Coro1a^tm1Achn)	abnormal effector T cell morphology	J:141431
	abnormal T cell activation	J:141431
	abnormal T cell physiology	J:141431
	decreased CD4-positive, alpha-beta T cell number	J:141431
	decreased CD8-positive, alpha-beta T cell number	J:141431
	increased thymocyte number	J:141431
Coro1a^tm1Achn/Coro1a^tm1Achn (involves: 129X1/SvJ * C57BL/6)	abnormal leukocyte migration	J:111593
	decreased CD4-positive, alpha-beta T cell number	J:111593
	decreased CD8-positive, alpha-beta T cell number	J:111593
	decreased memory T cell number	J:111593
	decreased T cell number	J:111593
Coro1a^tm1Achn/Coro1a^tm1Achn (B6.129X1-Coro1a^tm1Achn)	decreased thymocyte number	J:141431
Coro1a^tm1Achn/Coro1a^tm1Achn (B6.129X1-Coro1a^tm1Achn)	increased T cell apoptosis	J:141431
Coro1a^tm1Achn/Coro1a^tm1Achn (involves: 129X1/SvJ)	increased mast cell degranulation	J:177785
Coro1a^tm1Achn/Coro1a^tm1Achn Coro1b^tm1.1Nfoe/Coro1b^tm1.1Nfoe (involves: 129X1/SvJ * C57BL/6N)	increased mast cell degranulation	J:177785
Coro1a^tm1Jpie/Coro1a^tm1Jpie (involves: 129 * C57BL/6)	abnormal T cell activation	J:133258
	abnormal thymocyte activation	J:133258
	decreased B cell number	J:133258
	decreased CD4-positive, alpha-beta T cell number	J:133258
	decreased CD8-positive, alpha-beta T cell number	J:133258
	decreased monocyte cell number	J:133258
	decreased T cell proliferation	J:133258
	impaired macrophage phagocytosis	J:133404
Coro1c^{tm1a(KOMP)Wtsi}/Coro1c⁺ (C57BL/6N-Coro1c^{tm1a(KOMP)Wtsi}/Wtsi)	decreased mean corpuscular hemoglobin	J:211773
	increased erythrocyte cell number	J:211773
Coro1c^{tm1d(KOMP)Wtsi}/Coro1c^{tm1d(KOMP)Wtsi} (involves: C57BL/6N)	abnormal platelet morphology	J:290447
	thrombocytosis	J:290447
Cotl1^{tm1b(EUCOMM)Hmgu}/Cotl1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Cotl1^{tm1b(EUCOMM)Hmgu}/Ieg)	decreased red blood cell distribution width	J:211773
	increased leukocyte cell number	J:211773
Cox6b1^em1(IMPC)Tcp/Cox6b1⁺ (C57BL/6NCrl-Cox6b1^em1(IMPC)Tcp/Tcp)	increased spleen weight	J:211773
Cox10^tm1Ctm/Cox10^tm1Ctm Slc6a3^{tm1.1(cre)Bkmn}/? (B6.Cg-Cox10^tm1Ctm Slc6a3^{tm1.1(cre)Bkmn})	increased microglial cell activation	J:231810
	microgliosis	J:231810
Cp^{tm1b(KOMP)Wtsi}/Cp^{tm1b(KOMP)Wtsi} (B6N(Cg)-Cp^{tm1b(KOMP)Wtsi}/J)	decreased hemoglobin content	J:211773
	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular hemoglobin concentration	J:211773
	decreased mean corpuscular volume	J:211773
Cp^tm1Hrs/Cp^tm1Hrs (involves: 129X1/SvJ * Black Swiss)	hematopoietic system phenotype	J:57730
Cp^tm1Hrs/Cp^tm1Hrs (involves: 129X1/SvJ * Black Swiss)	increased spleen iron level	J:57730
Cp^tm1Hrs/Cp^tm1Hrs Heph^tm1.2Jdun/Heph^tm1.2Jdun (involves: 129X1/SvJ * C57BL/6 * C57BL/6NTac)	anemia	J:196540
Cp^tm1Yos/Cp^tm1Yos (involves: 129P2/OlaHsd * BALB/c)	abnormal Kupffer cell morphology	J:79916
Cp^tm1Yos/Cp^tm1Yos (involves: 129P2/OlaHsd * BALB/c)	microcytic anemia	J:79916
Cpa3^tm1Hrr/Cpa3^tm1Hrr (involves: 129P2/OlaHsd * C57BL/6)	abnormal mast cell morphology	J:99367
Cpa3^tm3(icre)Hrr/Cpa3⁺ (B6.129P2-Cpa3^tm3(icre)Hrr)	absent mast cells	J:178942
	decreased basophil cell number	J:178942
	hematopoietic system phenotype	J:178942
Cpa3^tm3(icre)Hrr/Cpa3⁺ Fgfr1^tm1Upir/Fgfr1^tm1Upir Fgfr2^tm1Dor/Fgfr2^tm1Dor Tg(KRT5-cre)5132Jlj/0 (involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * C57BL/6J * DBA/2J)	absent mast cells	J:221184
Cpa3^tm3(icre)Hrr/Cpa3⁺ Gt(ROSA)26Sor^tm1Hjf/? Notch1^tm1Agt/Notch1^tm1Agt (involves: 129 * C57BL/6)	abnormal dendritic cell differentiation	J:143731
	abnormal T cell receptor beta chain V(D)J recombination	J:143731
Cpa3^tm3(icre)Hrr/Cpa3⁺ Notch1^tm1Agt/Notch1^tm1Agt (involves: 129 * C57BL/6)	abnormal B cell differentiation	J:143731
	abnormal B cell morphology	J:143731
	abnormal T cell receptor beta chain V(D)J recombination	J:143731
	decreased double-negative T cell number	J:143731
	decreased double-positive T cell number	J:143731
	increased single-positive T cell number	J:143731
	thymus hypoplasia	J:143731
Cpe^{tm1b(EUCOMM)Hmgu}/Cpe^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Cpe^{tm1b(EUCOMM)Hmgu}/Ieg)	increased hematocrit	J:211773
	increased leukocyte cell number	J:211773
	increased mean corpuscular volume	J:211773
Cpeb4^{tm1a(EUCOMM)Wtsi}/Cpeb4^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6 * C57BL/6NTac)	abnormal erythropoiesis	J:232458
	abnormal fetal derived definitive erythrocyte morphology	J:232458
	decreased fetal derived definitive erythrocyte cell number	J:232458
Cpgi5563^{tm1.1(NCC)Wcs}/Cpgi5563^{tm1.1(NCC)Wcs} (C57BL/6N-Cpgi5563^{tm1.1(NCC)Wcs}/Wtsi)	decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:277622
	decreased CD8-positive, alpha-beta T cell number	J:277622
	decreased effector memory CD4-positive, alpha-beta T cell number	J:277622
	decreased gamma-delta T cell number	J:277622
Cplane2^b2b2827Clo/Cplane2^b2b2827Clo (C57BL/6J-Cplane2^b2b2827Clo)	thymus hypoplasia	J:175213
Cplx4^em1(IMPC)H/Cplx4^em1(IMPC)H (C57BL/6NTac-Cplx4^em1(IMPC)H/H)	decreased mean corpuscular hemoglobin	J:211773
Cpm^{em1(IMPC)Ccpcz}/Cpm^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Cpm^{em1(IMPC)Ccpcz}/Ccpcz)	decreased CD8-positive, alpha-beta T cell number	J:211773
	increased effector memory CD8-positive, alpha-beta T cell number	J:211773
	increased effector memory T-helper cell number	J:211773
Cpne5^{tm2b(EUCOMM)Hmgu}/Cpne5^{tm2b(EUCOMM)Hmgu} (C57BL/6N-Cpne5^{tm2b(EUCOMM)Hmgu}/Bay)	abnormal spleen morphology	J:211773
Cpox^Rbc16/Cpox⁺ (involves: C57BL/6)	abnormal erythrocyte morphology	J:244493
	decreased mean corpuscular volume	J:244493
	enlarged spleen	J:244493
	hypochromic microcytic anemia	J:244493
	increased erythroblast number	J:244493
	increased red blood cell distribution width	J:244493
	increased spleen red pulp amount	J:244493
	microcytic anemia	J:244493
Cpox^Rgsc0129/Cpox⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	anisocytosis	J:133634
	decreased mean corpuscular hemoglobin	J:133634
	decreased mean corpuscular volume	J:133634
Cpq^em1(IMPC)Tcp/Cpq^em1(IMPC)Tcp (C57BL/6N-Cpq^em1(IMPC)Tcp/Tcp)	decreased mean corpuscular hemoglobin	J:211773
Cps1^em1(IMPC)H/Cps1⁺ (C57BL/6NTac-Cps1^em1(IMPC)H/H)	decreased neutrophil cell number	J:211773
	increased lymphocyte cell number	J:211773
	thrombocytosis	J:211773
Cpt1c^Gt(XL823)Byg/Cpt1c⁺ Nf1^tm1Tyj/Nf1⁺ Trp53^tm1Tyj/Trp53⁺ (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	spleen hyperplasia	J:228258
Cpxm1^em1(IMPC)Tcp/Cpxm1^em1(IMPC)Tcp (C57BL/6N-Cpxm1^em1(IMPC)Tcp/Tcp)	increased monocyte cell number	J:211773
Cr1l^tm1.1Song/Cr1l^tm1.1Song Tg(Cd4-cre)1Cwi/0 (involves: 129S6/SvEvTac * C57BL/6 * DBA/2 * SJL)	decreased CD4-positive, alpha-beta T cell number	J:146538
	decreased CD8-positive, alpha-beta T cell number	J:146538
	decreased lymphocyte cell number	J:146538
	increased B cell number	J:146538
Cr1l^tm1.1Song/Cr1l^tm1.1Song Tg(Lck-cre)548Jxm/0 (involves: 129S6/SvEvTac * C57BL/6 * DBA/2 * SJL)	decreased CD4-positive, alpha-beta T cell number	J:146538
	decreased CD8-positive, alpha-beta T cell number	J:146538
	decreased lymphocyte cell number	J:146538
	increased B cell number	J:146538
Cr1l^tm1.1Song/Cr1l^tm1.1Song Vsig4^tm1Gne/Vsig4^tm1Gne Tg(Cd4-cre)1Cwi/0 (involves: 129S6/SvEvTac * C57BL/6N * DBA/2 * SJL)	decreased lymphocyte cell number	J:146538
Cr2^M1Btlr/Cr2^M1Btlr (C57BL/6J-Cr2^M1Btlr)	decreased IgG level	J:267527
Cr2^tm1.1Jhws/Cr2^tm1.1Jhws (Not Specified)	abnormal germinal center B cell physiology	J:205353
	decreased B-1a cell number	J:205353
	decreased IgG2b level	J:205353
	decreased IgG2c level	J:205353
	decreased IgG3 level	J:205353
	decreased IgM level	J:205353
Cr2^tm1Crr/Cr2^tm1Crr (involves: 129S7/SvEvBrd * C57BL/6)	abnormal B-1 B cell morphology	J:31942
	abnormal spleen germinal center morphology	J:31942
	decreased B cell number	J:31942
	decreased B-1a cell number	J:69452
	decreased IgG2a level	J:31942
	decreased IgG2b level	J:31942
	decreased IgG3 level	J:31942
	decreased IgG level	J:31942, J:69452
	decreased IgM level	J:69452
	decreased immunoglobulin level	J:69452
	decreased neutrophil cell number	J:66111
	decreased spleen germinal center number	J:31942, J:69452
	decreased spleen germinal center size	J:31942
Cr2^tm1Crr/Cr2^tm1Crr (involves: 129S7/SvEvBrd)	decreased follicular B cell number	J:69477
Cr2^tm1Crr/Cr2^tm1Crr (involves: 129S7/SvEvBrd)	increased marginal zone B cell number	J:69477
Cr2^tm1Hmo/Cr2^tm1Hmo (involves: 129S7/SvEvBrd)	decreased IgG level	J:35112
Cr2^tm1Hmo/Cr2^tm1Hmo (involves: 129S7/SvEvBrd)	decreased IgM level	J:35112
Cr2^tm1Hmo/Cr2^tm1Hmo (involves: 129S7/SvEvBrd * C57BL/6)	abnormal B cell activation	J:151991
	abnormal B cell physiology	J:151991
	abnormal class switch recombination	J:151991
	abnormal memory B cell differentiation	J:151991
Cr2^tm1Tft/Cr2^tm1Tft (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	decreased IgG1 level	J:95979
	decreased IgG2b level	J:95979
	decreased IgG3 level	J:95979
	decreased IgG level	J:95979
	decreased IgM level	J:95979
	decreased spleen germinal center number	J:95979
Cr2^{tm2.1(HLA-A)Crr}/Cr2^{tm2.1(HLA-A)Crr} (involves: C57BL/6)	abnormal B cell physiology	J:151991
	abnormal class switch recombination	J:151991
	abnormal memory B cell differentiation	J:151991
Cr2^{tm2.1(HLA-A)Crr}/Cr2^{tm2.1(HLA-A)Crr} Tg(IghelMD4)4Ccg/? (involves: C57BL/6)	abnormal B cell activation	J:151991
Cr2^tm2.1Jhws/Cr2^tm2.1Jhws (B6.129-Cr2^tm2.1Jhws)	abnormal germinal center B cell physiology	J:205353
	decreased IgG3 level	J:205353
	decreased IgM level	J:205353
	increased IgM level	J:205353
Crabp1^{tm1b(EUCOMM)Wtsi}/Crabp1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Crabp1^{tm1b(EUCOMM)Wtsi}/Tcp)	increased monocyte cell number	J:211773
Crabp2^em1(IMPC)Mbp/Crabp2^em1(IMPC)Mbp (C57BL/6N-Crabp2^em1(IMPC)Mbp/MbpMmucd)	decreased erythrocyte cell number	J:211773
Cracr2a^tm1.1Ygwa/Cracr2a^tm1.1Ygwa Tg(Cd4-cre)1Cwi/0 (B6.Cg-Cracr2a^tm1.1Ygwa Tg(Cd4-cre)1Cwi)	abnormal CD4-positive, alpha-beta T cell physiology	J:259523
Crb1^rd8+em1Boc/Crb1^rd8+em1Boc Jak3^m1J/Jak3^m1J (B6.Cg-Crb1^rd8+em1Boc Jak3^m1J/Boc)	small spleen	J:265859
	small thymus	J:265859
Crb1^rd8/Crb1^rd8 Jak3^m1J/Jak3^m1J (B6.Cg-Crb1^rd8 Jak3^m1J/BocJ)	decreased spleen weight	J:265859
	small spleen	J:265859
	small thymus	J:265859
Crbn^tm1.1Ble/Crbn^tm1.1Ble (involves: C57BL/6)	abnormal bone marrow hematopoietic cell morphology	J:267091
	decreased B cell number	J:267091
	decreased common myeloid progenitor cell number	J:267091
	decreased granulocyte monocyte progenitor cell number	J:267091
	decreased granulocyte number	J:267091
	decreased leukocyte cell number	J:267091
	decreased T cell number	J:267091
	thrombocytopenia	J:267091
Creb3l1^tm1Kaim/Creb3l1^tm1Kaim (involves: 129S2/SvPas * C57BL/6)	abnormal bone marrow cell morphology/development	J:158242
Crebbp^{Gt(U-San)112Imeg}/Crebbp^{Gt(U-San)112Imeg} (involves: C57BL/6 * CBA)	anemia	J:54568
	impaired hematopoiesis	J:54568
Crebbp^tm1Dli/Crebbp⁺ (involves: 129S6/SvEvTac * C57BL/6)	abnormal common myeloid progenitor cell morphology	J:191503
	abnormal definitive hematopoiesis	J:191503, J:60630
	abnormal granulocyte morphology	J:191503
	abnormal leukocyte morphology	J:191503
	abnormal megakaryocyte morphology	J:191503
	absent pre-B cells	J:60630
	decreased B cell number	J:60630
	decreased common myeloid progenitor cell number	J:191503, J:60630
	decreased hematopoietic stem cell number	J:191503
	decreased lymphocyte cell number	J:191503
	enlarged spleen	J:191503, J:60630
	extramedullary hematopoiesis	J:60630
	increased bone marrow cell number	J:191503
	increased granulocyte number	J:191503
	increased megakaryocyte cell number	J:191503
Crebbp^tm1Jvd/Crebbp^tm1Jvd Ep300^tm2Pkb/Ep300^tm2Pkb Tg(Lck-cre)548Jxm/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	abnormal T cell number	J:105505
	decreased double-positive T cell number	J:105505
	increased double-negative T cell number	J:105505
Crebbp^tm1Jvd/Crebbp^tm1Jvd Tg(Lck-cre)548Jxm/0 (involves: 129 * C57BL/6 * CBA)	decreased CD4-positive, alpha-beta T cell number	J:105505
	decreased T cell number	J:105505
	decreased thymocyte number	J:105505
	increased double-positive T cell number	J:105505
	small thymus	J:105505
Crebbp^tm1Jvd/Crebbp^tm1Jvd Tg(MMTV-cre)4Mam/0 (involves: 129 * C57BL/6 * FVB)	decreased double-positive T cell number	J:88323
	increased CD8-positive, alpha-beta T cell number	J:88323
Crebbp^tm1Pkb/Crebbp^tm1Pkb (involves: 129P2/OlaHsd * C57BL/6)	decreased thymocyte number	J:98329
Crebbp^tm1Sis/Crebbp^tm1Sis (involves: BALB/cCrSlc * C57BL/6NCrlj * CBA/JNCrlj)	impaired hematopoiesis	J:63763
Crh^tm1Maj/Crh^tm1Maj (involves: 129S2/SvPas * C57BL/6)	decreased T cell proliferation	J:98419
Crh^tm1Maj/Crh^tm1Maj (involves: 129S2/SvPas * C57BL/6)	increased splenocyte number	J:98419
cri/cri (involves: DBA/2J)	abnormal erythrocyte cell number	J:5277
	anemia	J:5277
	decreased erythrocyte cell number	J:5277
	decreased leukocyte cell number	J:6327
	decreased neutrophil cell number	J:6327
Crim1^{Gt(KST264)Byg}/Crim1^{Gt(KST264)Byg} (involves: 129P2/OlaHsd * C57BL/6 * CD-1)	hematopoietic system phenotype	J:147543
Crip3^tm1Mjb/Crip3^tm1Mjb (either: (involves: 129S/Sv) or (involves: 129S/Sv * C57BL/6))	decreased thymocyte number	J:72942
	small thymus	J:72942
	thymus hypoplasia	J:72942
Cript^{tm1.1(KOMP)Vlcg}/Cript⁺ (B6N(Cg)-Cript^{tm1.1(KOMP)Vlcg}/J)	decreased mean corpuscular hemoglobin	J:211773
Crkl^tm1Imo/Crkl^tm1Imo (involves: 129S4/SvJaeSor * C57BL/6J)	abnormal thymus development	J:67826
Crl1^A/WySnJ/Crl1^A/WySnJ (B10.A-H2^a/SgSnJ)	abnormal B cell physiology	J:5442
Crl1^AKR/J/Crl1^AKR/J (involves: AKR/J * DBA/2J)	abnormal B cell physiology	J:5442
Crl1^DBA/2J/Crl1^DBA/2J (involves: AKR/J * DBA/2J)	abnormal B cell physiology	J:5442
Crlf1^tm1Wsa/Crlf1^tm1Wsa (involves: 129S1/Sv * C57BL/6)	impaired hematopoiesis	J:55482
Crlf2^em1(IMPC)Mbp/Crlf2^em1(IMPC)Mbp (C57BL/6N-Crlf2^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased mean corpuscular volume	J:211773
Crlf2^tm1Jni/Crlf2^tm1Jni (involves: 129P2/OlaHsd * C57BL/6)	hematopoietic system phenotype	J:89031
Crlf2^tm1Wjl/Crlf2^tm1Wjl (involves: 129 * C57BL/6)	abnormal lymphopoiesis	J:108209
	decreased B cell number	J:108209
	decreased single-positive T cell number	J:108209
Crlf2^tm1Wjl/Crlf2^tm1Wjl (involves: BALB/c)	abnormal T cell proliferation	J:107431
	decreased immunoglobulin level	J:107431
	decreased splenocyte proliferation	J:107431
Crlf3^{em1(IMPC)Wtsi}/Crlf3^{em1(IMPC)Wtsi} (C57BL/6N-Crlf3^{em1(IMPC)Wtsi}/WtsiH)	increased red blood cell distribution width	J:211773
	thrombocytopenia	J:211773
Crlf3^{tm1a(KOMP)Wtsi}/Crlf3^{tm1a(KOMP)Wtsi} (B6JTyr;B6N-Crlf3^{tm1a(KOMP)Wtsi}/Wtsi)	decreased mean corpuscular hemoglobin concentration	J:175295
	increased hemoglobin content	J:175295
	increased mean corpuscular hemoglobin concentration	J:175295
	thrombocytopenia	J:165965
Crlf3^{tm1b(KOMP)Wtsi}/Crlf3^{tm1b(KOMP)Wtsi} (B6Brd;B6Dnk;B6N-Tyr^c-Brd Crlf3^{tm1b(KOMP)Wtsi}/Wtsi)	decreased mean corpuscular volume	J:211773
	thrombocytopenia	J:211773
Crmp1^em1(IMPC)Mbp/Crmp1^em1(IMPC)Mbp (C57BL/6NCrl-Crmp1^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Crppa^em1(IMPC)H/Crppa⁺ (C57BL/6NTac-Crppa^em1(IMPC)H/H)	decreased lymphocyte cell number	J:211773
	increased mean platelet volume	J:211773
	increased neutrophil cell number	J:211773
Crtam^tm1Achn/Crtam^tm1Achn (involves: 129 * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:145314
	abnormal T cell activation	J:145314
	abnormal T-helper 1 physiology	J:145314
	increased CD4-positive, alpha-beta T cell number	J:145314
	increased CD8-positive, alpha-beta T cell number	J:145314
	increased T cell proliferation	J:145314
Crtc1^{tm1a(EUCOMM)Wtsi}/Crtc1⁺ (C57BL/6N-Crtc1^{tm1a(EUCOMM)Wtsi}/Ics)	increased IgG2b level	J:165965
Crx^{em1(IMPC)Ccpcz}/Crx^{em1(IMPC)Ccpcz} (C57BL/6N-Crx^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
	increased NK cell number	J:211773
	small thymus	J:211773
Cry1^tm1Jhjh/Cry1^tm1Jhjh Cry2^tm1Jhjh/Cry2^tm1Jhjh (involves: 129P2/OlaHsd * C57BL/6)	abnormal T cell activation	J:159504
Cry2^tm1Jhjh/Cry2^tm1Jhjh (involves: 129P2/OlaHsd * C57BL/6)	abnormal osteoclast physiology	J:163112
Csf1^op/Csf1^op (C57BL/6J-Csf1^op)	abnormal osteoclast morphology	J:5634
	abnormal spleen red pulp morphology	J:5634
	decreased macrophage cell number	J:110981
	decreased osteoclast cell number	J:5634
Csf1^op/Csf1^op (B6C3Fe a/a-Csf1^op/J)	abnormal bone marrow cell morphology/development	J:19549
	abnormal hematopoietic stem cell morphology	J:19549
	abnormal Kupffer cell morphology	J:26978
	abnormal Langerhans cell morphology	J:112594
	abnormal microglial cell morphology	J:49613
	abnormal osteoclast differentiation	J:19549, J:4732
	abnormal osteoclast morphology	J:26978
	abnormal perivascular macrophage morphology	J:49613
	abnormal spleen red pulp morphology	J:26978
	abnormal splenic cell ratio	J:104139
	abnormal splenocyte physiology	J:19549
	absent Langerhans cell	J:112594
	decreased bone marrow cell number	J:104139
	decreased leukocyte cell number	J:104139
	decreased macrophage cell number	J:26978, J:104139
	decreased monocyte cell number	J:104139
	decreased osteoclast cell number	J:73663
	extramedullary hematopoiesis	J:26978
	thymus cortex hypoplasia	J:26978
	thymus medulla atrophy	J:26978
Csf1^op/Csf1^op (involves: C3HeB/FeJ * C57BL/6J)	abnormal osteoclast cell number	J:33189
	abnormal osteoclast differentiation	J:38039
	decreased osteoclast cell number	J:33189
Csf1^op/Csf1^op (B6;C3Fe a/a-Csf1^op/J)	abnormal microglial cell morphology	J:170081
	decreased macrophage cell number	J:30863, J:147697
	impaired macrophage chemotaxis	J:147697
Csf1^op/Csf1^op Csf2^tm1Ard/Csf2^tm1Ard (involves: 129P2/OlaHsd * C57BL/6)	decreased leukocyte cell number	J:19089
	extramedullary hematopoiesis	J:19089
	increased hemoglobin content	J:19089
	increased neutrophil cell number	J:19089
	polycythemia	J:19089
Csf1^op/Csf1^op Galc^twi/Galc^twi (involves: C3HeB/Fe * C57BL/6J * CE/J)	impaired macrophage chemotaxis	J:170081
Csf1^{tm1.1(CSF1)Flv}/Csf1^{tm1.1(CSF1)Flv} Il2rg^tm1.1Flv/Il2rg^tm1.1Flv Rag2^tm1.1Flv/Rag2^tm1.1Flv (involves: 129P2/OlaHsd * 129S/SvEv * 129S4/SvJae * BALB/cAnNTac)	hematopoietic system phenotype	J:177073
Csf1^tm1.2Sabw/Csf1^tm1.2Sabw (involves: 129S4/SvJaeSor * C57BL/6)	abnormal Kupffer cell morphology	J:180199
	abnormal myeloid leukocyte morphology	J:180199
	decreased B cell number	J:180199
	decreased bone marrow cell number	J:180199
	decreased lymphocyte cell number	J:180199
	decreased macrophage cell number	J:180199
	decreased monocyte cell number	J:180199
	decreased osteoclast cell number	J:180199
	decreased spleen weight	J:180199
	increased granulocyte number	J:180199
	increased T cell number	J:180199
	small spleen	J:180199
Csf1r^tm1Ers/Csf1r⁺ (B6.129X1-Csf1r^tm1Ers)	microgliosis	J:219294
Csf1r^tm1Ers/Csf1r^tm1Ers (involves: 129X1/SvJ * C3Heb/FeJ * C57BL/6J)	abnormal blood cell morphology/development	J:73663
	abnormal leukocyte cell number	J:73663
	abnormal osteoclast differentiation	J:73663
	abnormal spleen morphology	J:73663
	decreased Langerhans cell number	J:73663
	decreased lymphocyte cell number	J:73663
	decreased macrophage cell number	J:73663
	decreased monocyte cell number	J:73663
	increased granulocyte number	J:73663
	increased spleen weight	J:73663
Csf1r^tm1Ers/Csf1r^tm1Ers (FVB.129X1-Csf1r^tm1Ers)	abnormal macrophage differentiation	J:112594
	abnormal osteoclast morphology	J:111489
	absent Langerhans cell	J:112594
Csf2^tm1Ard/Csf2^tm1Ard (involves: 129P2/OlaHsd * C57BL/6)	abnormal alveolar macrophage morphology	J:18747
	abnormal leukocyte physiology	J:86386
	abnormal MHC II cell surface expression on macrophages	J:86386
	abnormal spleen size	J:67766
	hematopoietic system phenotype	J:18747
	impaired macrophage chemotaxis	J:86386
Csf2^tm1Dran/Csf2^tm1Dran Ifng^tm1Ts/Ifng^tm1Ts Il3^tm1Glli/Il3^tm1Glli (involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6)	increased eosinophil cell number	J:83086
	increased IgE level	J:83086
	increased IgG1 level	J:83086
	increased immunoglobulin level	J:83086
Csf2^tm1Dran/Csf2^tm1Dran Il3^tm1Glli/Il3^tm1Glli (B6.129S2-Csf2^tm1Dran Il3^tm1Glli)	abnormal leukocyte physiology	J:83086
	increased eosinophil cell number	J:67404
Csf2^tm1Dran/Csf2^tm1Dran Il3^tm1Glli/Il3^tm1Glli (C.129S2-Csf2^tm1Dran Il3^tm1Glli)	increased eosinophil cell number	J:67404
Csf2^tm1Mlg/Csf2^tm1Mlg (involves: 129S2/SvPas)	abnormal alveolar macrophage morphology	J:17978
Csf2^tm1Mlg/Csf2^tm1Mlg (involves: 129S2/SvPas)	hematopoietic system phenotype	J:17978
Csf2ra^em1Szut/Csf2ra^em1Szut (C57BL/6-Csf2ra^em1Szut)	abnormal alveolar macrophage morphology	J:322934
	impaired macrophage phagocytosis	J:322934
	increased lymphocyte cell number	J:322934
Csf2rb2^tm1Cgb/Csf2rb2⁺ (involves: 129S1/Sv * C57BL/6)	abnormal bone marrow cell morphology/development	J:32978
Csf2rb2^tm1Cgb/Csf2rb2^tm1Cgb (involves: 129S1/Sv * C57BL/6)	abnormal bone marrow cell morphology/development	J:32978
Csf2rb^tm1Cgb/Csf2rb^tm1Cgb (involves: 129S1/Sv * C57BL/6)	abnormal myeloblast morphology/development	J:29737
Csf2rb^tm1Cgb/Csf2rb^tm1Cgb (involves: 129S1/Sv * C57BL/6)	decreased eosinophil cell number	J:29737
Csf2rb^tm1Clsc/Csf2rb^tm1Clsc Csf2rb2^tm1Cgb/Csf2rb2^tm1Cgb (C.129S1-Csf2rb2^tm1Cgb Csf2rb^tm1Clsc)	abnormal T cell activation	J:130939
	abnormal T cell physiology	J:130939
	decreased T cell proliferation	J:130939
	impaired eosinophil recruitment	J:130939
	increased IgG1 level	J:130939
Csf2rb^tm1Clsc/Csf2rb^tm1Clsc Csf2rb2^tm1Cgb/Csf2rb2^tm1Cgb (involves: 129S1/Sv)	abnormal bone marrow cell number	J:109889
Csf2rb^tm1Mur/Csf2rb^tm1Mur (involves: 129P2/OlaHsd * C57BL/6)	abnormal eosinophil physiology	J:35829
	abnormal myeloblast morphology/development	J:35829
	decreased eosinophil cell number	J:35829
Csf2rb^tm1Mur/Csf2rb^tm1Mur (involves: 129P2/OlaHsd)	abnormal eosinophil physiology	J:24122
	abnormal myeloblast morphology/development	J:24122
	decreased eosinophil cell number	J:24122
Csf2rb^tm1Mur/Csf2rb^tm1Mur Il3^tm1Tyb/Il3^tm1Tyb (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	abnormal eosinophil physiology	J:35829
	abnormal myeloblast morphology/development	J:35829
	decreased eosinophil cell number	J:35829
Csf2rb^{tm2b(EUCOMM)Hmgu}/Csf2rb⁺ (C57BL/6N-Csf2rb^{tm2b(EUCOMM)Hmgu}/Orl)	increased eosinophil cell number	J:211773
Csf3^em1(IMPC)H/Csf3^em1(IMPC)H (C57BL/6NTac-Csf3^em1(IMPC)H/H)	decreased eosinophil cell number	J:211773
	decreased neutrophil cell number	J:211773
	increased hematocrit	J:211773
	increased lymphocyte cell number	J:211773
Csf3^tm1Ard/Csf3⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased neutrophil cell number	J:20400
Csf3^tm1Ard/Csf3^tm1Ard (involves: 129P2/OlaHsd * C57BL/6)	abnormal neutrophil physiology	J:20400
	decreased leukocyte cell number	J:20400
	decreased monocyte cell number	J:20400
	decreased neutrophil cell number	J:20400
	impaired myelopoiesis	J:20400
Csf3r^tm1Eur/Csf3r^tm1Eur (involves: 129P2/OlaHsd * C57BL/6 * FVB)	abnormal hematopoietic system morphology/development	J:51444
	abnormal myeloblast morphology/development	J:48503
	abnormal neutrophil differentiation	J:48503
	decreased neutrophil cell number	J:48503
	increased bone marrow cell number	J:48503
Csf3r^tm1Link/Csf3r^tm1Link (involves: 129X1/SvJ * NIH Black Swiss)	abnormal bone marrow cell morphology/development	J:37618
	abnormal monocyte morphology	J:37618
	decreased bone marrow cell number	J:37618
	decreased hematopoietic stem cell number	J:37618
	decreased monocyte cell number	J:37618
	decreased neutrophil cell number	J:37618
Csf3r^tm1Link/Csf3r^tm1Link (involves: 129X1/SvJ)	impaired neutrophil chemotaxis	J:79825
Csf3r^tm1Link/Csf3r^tm1Link (B6.129X1-Csf3r^tm1Link)	impaired neutrophil chemotaxis	J:79567
Csf3r^tm2Eur/Csf3r^tm2Eur (involves: 129P2/OlaHsd * FVB)	decreased neutrophil cell number	J:185115
Csf3r^tm2Link/Csf3r⁺ Elane^tm1Link/Elane⁺ (involves: 129X1/SvJ * C57BL/6)	hematopoietic system phenotype	J:131496
Csf3r^tm2Link/Csf3r^tm2Link (B6.129X1-Csf3r^tm2Link)	abnormal neutrophil physiology	J:79567
Csf3r^tm3Link/Csf3r^tm3Link (involves: 129X1/SvJ * C57BL/6)	abnormal common myeloid progenitor cell morphology	J:67612
Csf3r^tm3Link/Csf3r^tm3Link (involves: 129X1/SvJ * C57BL/6)	decreased neutrophil cell number	J:67612
Csf3r^{tm4(Epor)Link}/Csf3r^{tm4(Epor)Link} (involves: 129X1/SvJ * C57BL/6)	abnormal common myeloid progenitor cell morphology	J:79825
	decreased granulocyte number	J:79825
	decreased neutrophil cell number	J:79825
	impaired neutrophil chemotaxis	J:79825
Csf3r^{tm4(Epor)Link}/Csf3r^{tm4(Epor)Link} (B6.129X1-Csf3r^{tm4(Epor)Link})	decreased neutrophil cell number	J:79567
	impaired neutrophil chemotaxis	J:79567
	increased bone marrow cell number	J:79567
Csk^tm1Sor/Csk⁺ Ptprc^ltng/Ptprc^ltng (involves: 129S7/SvEvBrd * C57BL/6)	thymus hypoplasia	J:158876
Csk^tm1Sor/Csk⁺ Ptprc^ltng/Ptprc^tm1Mak (involves: 129S7/SvEvBrd * C57BL/6)	abnormal T cell differentiation	J:158876
	thymus hypoplasia	J:158876
Csk^tm1Tara/Csk^tm1Tara Tg(Mx1-cre)1Cgn/0 (involves: 129P2/OlaHsd * C57BL/6 * CB20 * CBA)	abnormal CD4-positive T cell differentiation	J:49654
	absent CD8-positive, alpha-beta T cells	J:49654
	enlarged thymus	J:49654
Csk^tm1Tara/Csk^tm2Tara Elane^tm1(cre)Roes/Elane⁺ (involves: 129P2/OlaHsd * CB20 * C57BL/6)	abnormal granulocyte physiology	J:89716
	abnormal myelopoiesis	J:89716
Csmd3^em1(IMPC)Mbp/Csmd3^em1(IMPC)Mbp (C57BL/6NCrl-Csmd3^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
Csnk1a1^{tm1c(KOMP)Wtsi}/Csnk1a1⁺ Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * C57BL/6N * CBA)	abnormal erythroid lineage cell morphology	J:216977
	abnormal hematopoietic system morphology/development	J:216977
	abnormal megakaryocyte morphology	J:216977
	decreased bone marrow cell number	J:216977
	decreased common myeloid progenitor cell number	J:216977
	decreased hematopoietic stem cell number	J:216977
	decreased myeloid cell number	J:216977
	pancytopenia	J:216977
Csnk1a1^{tm1c(KOMP)Wtsi}/Csnk1a1^{tm1c(KOMP)Wtsi} Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * C57BL/6N * CBA)	abnormal blood cell morphology	J:216977
	abnormal hematopoietic stem cell physiology	J:216977
	abnormal spleen red pulp morphology	J:216977
	bone marrow failure	J:216977
	decreased hematopoietic stem cell number	J:216977
	extramedullary hematopoiesis	J:216977
Csnk1g1^em1(IMPC)J/Csnk1g1^em1(IMPC)J (C57BL/6NJ-Csnk1g1^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
Csnk1g2^{tm1b(EUCOMM)Wtsi}/Csnk1g2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Csnk1g2^{tm1b(EUCOMM)Wtsi}/Ieg)	increased mean corpuscular volume	J:211773
Csnk1g3^{tm1a(EUCOMM)Wtsi}/Csnk1g3^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Csnk1g3^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	increased mean corpuscular hemoglobin	J:211773
Csnk2a2^em1(IMPC)Mbp/Csnk2a2^em1(IMPC)Mbp (C57BL/6N-Csnk2a2^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased mean corpuscular volume	J:211773
Cspg4^tm1Wbst/Cspg4^tm1Wbst (involves: 129S1/Sv * 129X1/SvJ)	abnormal macrophage physiology	J:184220
cspr/cspr (involves: C57BL/6 * FVB/NCrl)	anemia	J:184743
Cspt^C57BL/6/Cspt^C57BL/6 (involves: C57BL/6 * NOD/ShLtDoi * SJL)	increased CD8-positive, alpha-beta T cell number	J:97046
Cspt^C57BL/6/Cspt^NOD/ShiLtDoi (involves: C57BL/6 * NOD/ShLtDoi * SJL)	increased CD8-positive, alpha-beta T cell number	J:97046
Csrnp1^tm1Jni/Csrnp1^tm1Jni (involves: 129P2/OlaHsd * C57BL/6)	hematopoietic system phenotype	J:129366
Csrnp1^tm1Jni/Csrnp1^tm1Jni Csrnp2^tm1Jni/Csrnp2^tm1Jni (involves: 129P2/OlaHsd * C57BL/6)	hematopoietic system phenotype	J:129366
Csrnp2^tm1Jni/Csrnp2^tm1Jni (involves: 129P2/OlaHsd * C57BL/6)	hematopoietic system phenotype	J:129366
Csrnp3^tm1Jni/Csrnp3^tm1Jni (involves: 129P2/OlaHsd * C57BL/6)	hematopoietic system phenotype	J:129366
Cst6^{em1(IMPC)Ccpcz}/Cst6⁺ (C57BL/6NCrl-Cst6^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	small spleen	J:211773
Cstb^{tm1b(EUCOMM)Wtsi}/Cstb^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Cstb^{tm1b(EUCOMM)Wtsi}/Orl)	decreased lymphocyte cell number	J:211773
	increased monocyte cell number	J:211773
Ctbs^tm1Tbec/Ctbs^tm1Tbec (involves: 129S2/SvPas * C57BL/6N)	abnormal Kupffer cell morphology	J:185162
Ctc1^tm1.1Schg/Ctc1^tm1.1Schg (involves: 129S7/SvEvBrd * C57BL/6)	abnormal bone marrow cell morphology/development	J:184809
	abnormal hematopoietic stem cell morphology	J:184809
	decreased hematopoietic stem cell number	J:184809
	decreased splenocyte proliferation	J:184809
	impaired hematopoiesis	J:184809
	small spleen	J:184809
	small thymus	J:184809
Ctcf^tm2Gal/Ctcf⁺ Tg(Lck-cre)1Cwi/0 (involves: 129P2/OlaHsd * C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:143271
	decreased CD8-positive, alpha-beta T cell number	J:143271
	thymus hypoplasia	J:143271
Ctcf^tm2Gal/Ctcf^tm2Gal Rag2^tm1Fwa/Rag2^tm1Fwa Tg(Lck-cre)1Cwi/0 (involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6 * C57BL/10)	decreased double-positive T cell number	J:143271
Ctcf^tm2Gal/Ctcf^tm2Gal Tg(Lck-cre)1Cwi/0 (involves: 129P2/OlaHsd * C57BL/6)	abnormal T cell differentiation	J:143271
	abnormal T cell morphology	J:143271
	decreased CD4-positive, alpha-beta T cell number	J:143271
	decreased CD8-positive, alpha-beta T cell number	J:143271
	decreased double-positive T cell number	J:143271
	decreased single-positive T cell number	J:143271
	increased double-negative T cell number	J:143271
	increased single-positive T cell number	J:143271
	thymus hypoplasia	J:143271
Ctcf^tm2Gal/Ctcf^tm2Gal Tg(Lck-cre)1Cwi/0 Tg(TcraH-Y,TcrbH-Y)71Vbo/0 (involves: 129P2/OlaHsd * C57BL/6 * C57BL/10 * DBA/2J)	abnormal T cell differentiation	J:143271
	decreased CD4-positive, alpha-beta T cell number	J:143271
	decreased CD8-positive, alpha-beta T cell number	J:143271
	decreased double-positive T cell number	J:143271
Ctcf^tm2Gal/Ctcf^tm2Gal Tg(Lck-cre)1Cwi/0 Tg(TcraTcrb)425Cbn/0 (involves: 129P2/OlaHsd * C57BL/6)	abnormal T cell differentiation	J:143271
	decreased CD4-positive, alpha-beta T cell number	J:143271
	decreased double-positive T cell number	J:143271
	decreased T cell number	J:143271
	increased double-negative T cell number	J:143271
	increased single-positive T cell number	J:143271
Ctdspl2^{tm2b(KOMP)Wtsi}/Ctdspl2⁺ (C57BL/6N-Ctdspl2^{tm2b(KOMP)Wtsi}/Bay)	increased spleen weight	J:211773
Ctl1^NZB/BlN/Ctl1^C57BL/10 (involves: C57BL/10 * NZB/BlN)	abnormal T cell physiology	J:6736
Ctla4^m1Btlr/Ctla4^m1Btlr (C57BL/6J-Ctla4^m1Btlr)	decreased CD8-positive, naive alpha-beta T cell number	J:265263
	increased effector memory CD4-positive, alpha-beta T cell number	J:265263
	increased effector memory CD8-positive, alpha-beta T cell number	J:265263
Ctla4^tm1All/Ctla4^tm1All (involves: 129S1/Sv * 129X1/SvJ)	abnormal thymus morphology	J:42481
	decreased double-positive T cell number	J:42481
	decreased T cell number	J:42481
	increased double-negative T cell number	J:42481
Ctla4^tm1All/Ctla4^tm1All Rag1^tm1Mom/Rag1^tm1Mom Tg(TcrAND)53Hed/0 (involves: 129S/Sv * 129X1/SvJ * C57BL/6 * SJL)	abnormal T cell activation	J:119845
	increased T cell proliferation	J:119845
Ctla4^tm1All/Ctla4^tm1All Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * NOD * SJL)	abnormal splenocyte physiology	J:109887
	enlarged spleen	J:109887
Ctla4^tm1All/Ctla4^tm1All Tg(TcrAND)53Hed/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)	abnormal lymphopoiesis	J:119845
	abnormal T cell activation	J:119845
	abnormal T cell subpopulation ratio	J:119845
	increased CD4-positive, alpha-beta T cell number	J:119845
	increased CD8-positive, alpha-beta T cell number	J:119845
Ctla4^tm1All/Ctla4^tm1All Tg(TcraTcrb)8Rest/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased CD8-positive, alpha-beta T cell number	J:140448
	increased CD4-positive, alpha-beta T cell number	J:140448
Ctla4^tm1Saka/Ctla4^tm1Saka Foxp3^tm1(cre)Saka/Y (involves: BALB/c)	abnormal immunoglobulin level	J:140085
	abnormal regulatory T cell physiology	J:140085
	abnormal splenic cell ratio	J:140085
	increased IgE level	J:140085
	increased IgG level	J:140085
	increased regulatory T cell number	J:140085
	spleen hyperplasia	J:140085
Ctla4^tm1Shr/Ctla4^tm1Shr (either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6))	abnormal splenic cell ratio	J:30393
	abnormal T cell differentiation	J:30393
	abnormal T cell morphology	J:30393
	decreased double-positive T cell number	J:30393
	enlarged spleen	J:30393
	increased double-negative T cell number	J:30393
	increased T cell number	J:30393
	increased T cell proliferation	J:30393
Ctla4^tm1Shr/Ctla4^tm1Shr (B6.129S4-Ctla4^tm1Shr)	abnormal regulatory T cell physiology	J:146644
Ctla4^tm1Shr/Ctla4^tm1Shr (B6.129S4-Ctla4^tm1Shr)	abnormal T cell physiology	J:146644
Ctla4^tm1Shr/Ctla4^tm1Shr Rag2^tm1Fwa/Rag2^tm1Fwa Tg(DO11.10)10Dlo/0 (involves: 129S/Sv * BALB/c * C3H * C57BL/6)	abnormal T cell physiology	J:110446
Ctla4^tm1Shr/Ctla4^tm1Shr Tg(DO11.10)10Dlo/0 (involves: 129S4/SvJae * BALB/c * C3H * C57BL/6)	abnormal T cell physiology	J:57090
	enlarged spleen	J:57090
	increased T cell proliferation	J:57090
Ctnna2^cdf/Ctnna2^cdf (C3Sn.C3-Ctnna2^cdf/J)	increased erythrocyte cell number	J:38887
Ctnnb1^{tm1(Nfkbia)Rsu}/Ctnnb1⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal macrophage physiology	J:71744
	increased granulocyte number	J:71744
	increased leukocyte cell number	J:71744
Ctnnb1^tm1Mmt/Ctnnb1⁺ Ctsk^tm1(cre)Ska/Ctsk⁺ (involves: 129X1/SvJ * C57BL/6NCrlj * CBA/JNCrlj)	abnormal osteoclast differentiation	J:178340
	decreased bone marrow cell number	J:178340
Ctnnb1^tm1Mmt/Ctnnb1⁺ Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129X1/SvJ)	abnormal osteoclast differentiation	J:178340
	decreased bone marrow cell number	J:178340
Ctnnb1^tm1Mmt/Ctnnb1⁺ Pparg^{tm1.1(tTA)Jmgr}/Pparg⁺ Tg(tetO-cre)1Jaw/0 (involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6)	abnormal osteoclast differentiation	J:178340
	absent bone marrow cell	J:178340
	decreased bone marrow cell number	J:178340
	decreased osteoclast cell number	J:178340
	extramedullary hematopoiesis	J:178340
	increased splenocyte number	J:178340
Ctnnb1^tm1Mmt/Ctnnb1⁺ Tg(Col1a1-cre)1Kry/0 (involves: 129X1/SvJ * FVB)	decreased osteoclast cell number	J:98430
Ctnnb1^tm1Mmt/Ctnnb1⁺ Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0 (involves: 129X1/SvJ * CD-1)	abnormal osteoclast differentiation	J:114494
Ctnnb1^{tm2(Nfkbia)Rsu}/Ctnnb1⁺ Tg(CMV-cre)1Cgn/0 (involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)	abnormal macrophage physiology	J:71744
	increased granulocyte number	J:71744
	increased leukocyte cell number	J:71744
Ctnnb1^tm2Kem/Ctnnb1⁺ Ctsk^tm1(cre)Ska/Ctsk⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6NCrlj * CBA/JNCrlj)	increased osteoclast cell number	J:178340
Ctnnb1^tm2Kem/Ctnnb1⁺ Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)	increased osteoclast cell number	J:178340
Ctnnb1^tm2Kem/Ctnnb1⁺ Pparg^{tm1.1(tTA)Jmgr}/Pparg⁺ Tg(tetO-cre)1Jaw/0 (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal osteoclast physiology	J:178340
	increased osteoclast cell number	J:178340
Ctnnb1^tm2Kem/Ctnnb1⁺ Pten^tm1Hwu/Pten^tm1Hwu Tg(Cdh5-cre)7Mlia/0 (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * BALB/c * C57BL/6 * FVB/N)	abnormal definitive hematopoiesis	J:135172
Ctnnb1^tm2Kem/Ctnnb1⁺ Tg(Tek-cre)1Ywa/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)	increased osteoclast cell number	J:178340
Ctnnb1^tm2Kem/Ctnnb1^tm2Kem Ctsk^tm1(cre)Ska/Ctsk⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6NCrlj * CBA/JNCrlj)	increased osteoclast cell number	J:178340
Ctnnb1^tm2Kem/Ctnnb1^tm2Kem Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)	increased osteoclast cell number	J:178340
Ctnnb1^tm2Kem/Ctnnb1^tm2Kem Pparg^{tm1.1(tTA)Jmgr}/Pparg⁺ Tg(tetO-cre)1Jaw/0 (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal osteoclast physiology	J:178340
	decreased osteoclast cell number	J:178340
	extramedullary hematopoiesis	J:178340
Ctnnb1^tm2Kem/Ctnnb1^tm2Kem Pparg^{tm1.1(tTA)Jmgr}/Pparg⁺ Tg(tetO-cre)1Jaw/0 Tg(tetO-HIST1H2BJ/GFP)47Efu/0 (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1)	abnormal osteoclast differentiation	J:178340
Ctnnb1^tm2Kem/Ctnnb1^tm2Kem Tg(Col1a1-cre)1Kry/0 (involves: 129S1/Sv * 129X1/SvJ * FVB)	increased osteoclast cell number	J:98430
Ctnnb1^tm2Kem/Ctnnb1^tm2Kem Tg(KRT14-cre/ERT)20Efu/0 (involves: 129S1/Sv * 129X1/SvJ * CD-1)	cutaneous mastocytosis	J:204142
Ctnnb1^tm2Kem/Ctnnb1^tm2Kem Tg(Tek-cre)1Ywa/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)	decreased osteoclast cell number	J:178340
Ctnnb1^tm4Wbm/Ctnnb1^tm4Wbm Krt14^tm1(cre)Wbm/Krt14⁺ (involves: 129P2/OlaHsd)	decreased gamma-delta T cell number	J:202499
	increased neutrophil cell number	J:202499
Ctnnbip1^{tm1b(EUCOMM)Wtsi}/Ctnnbip1⁺ (C57BL/6N-Ctnnbip1^{tm1b(EUCOMM)Wtsi}/H)	thrombocytosis	J:211773
Ctsa^tm1Adz/Ctsa^tm1Adz (either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * FVB/NJ))	enlarged spleen	J:29674
Ctsa^{tm2b(EUCOMM)Hmgu}/Ctsa^{tm2b(EUCOMM)Hmgu} (C57BL/6N-Ctsa^{tm2b(EUCOMM)Hmgu}/H)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	enlarged spleen	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
	increased monocyte cell number	J:211773
	increased spleen weight	J:211773
	thrombocytopenia	J:211773
Ctsc^tm1Ley/Ctsc^tm1Ley (either: 129X1/SvJ-Ctsc^tm1Ley or (involves: 129X1/SvJ * C57BL/6))	abnormal cytotoxic T cell physiology	J:77312
	abnormal T cell physiology	J:77312
Ctsc^tm1Ley/Ctsc^tm1Ley (B6.129X1-Ctsc^tm1Ley)	abnormal leukocyte migration	J:131520
Ctsc^tm1Ley/Ctsc^tm1Ley (B6.129X1-Ctsc^tm1Ley)	impaired neutrophil recruitment	J:131520
Ctsd^m1J/Ctsd^m1J (C3HeB/FeJ-Ctsd^m1J/GrsrJ)	thymus atrophy	J:229377
Ctsd^tm1.1Thre/Ctsd^tm1.1Thre Edil3^{Tg(Sox2-cre)1Amc}/Edil3⁺ (involves: C57BL/6 * C57BL/6N * CBA * SJL)	decreased double-positive T cell number	J:227618
	microgliosis	J:227618
	thymus atrophy	J:227618
Ctsd^tm1.1Thre/Ctsd^tm1.1Thre Tg(Nes-cre)1Kln/0 (involves: C57BL/6 * C57BL/6N * SJL)	abnormal thymus morphology	J:227618
	decreased double-positive T cell number	J:227618
	microgliosis	J:227618
Ctsd^{tm1b(EUCOMM)Wtsi}/Ctsd⁺ (C57BL/6N-Ctsd^{tm1b(EUCOMM)Wtsi}/Ics)	decreased hematocrit	J:211773
Ctsd^tm1Cptr/Ctsd^tm1Cptr (either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd))	abnormal microglial cell morphology	J:71688
	abnormal spleen B cell follicle morphology	J:28201
	abnormal spleen white pulp morphology	J:28201
	decreased double-positive T cell number	J:28201
	decreased lymphocyte cell number	J:28201
	thymus hypoplasia	J:28201
Ctse^tm1Kjy/Ctse⁺ (involves: C57BL/6)	increased IgE level	J:108745
Ctse^tm1Kjy/Ctse^tm1Kjy (involves: C57BL/6)	increased double-positive T cell number	J:108745
	increased eosinophil cell number	J:108745
	increased IgE level	J:108745
Ctsg^tm1Ley/Ctsg^tm1Ley (either: (involves: 129X1/SvJ * C57BL/6) or (involves: 129X1/SvJ))	hematopoietic system phenotype	J:59006
Ctsg^tm1Ley/Ctsg^tm1Ley Elane^tm1Sds/Elane^tm1Sds (involves: 129X1/SvJ)	hematopoietic system phenotype	J:131496
Ctsg^{tm2.1(PML/RARA)Ley}/Ctsg⁺ (involves: 129X1/SvJ * C57BL/6)	abnormal myelopoiesis	J:84230, J:86458
	anemia	J:84230
	enlarged spleen	J:84230
	extramedullary hematopoiesis	J:84230
	increased leukocyte cell number	J:84230
	thrombocytopenia	J:84230
Ctsg^{tm2.1(PML/RARA)Ley}/Ctsg⁺ (involves: 129 * 129X1/SvJ * C57BL/6)	abnormal bone marrow cell morphology/development	J:166479
	abnormal common myeloid progenitor cell morphology	J:166479
	abnormal spleen morphology	J:166479
	enlarged spleen	J:166479
	increased spleen weight	J:166479
Ctsg^{tm2.1(PML/RARA)Ley}/Ctsg⁺ Elane^tm1Sds/Elane^tm1Sds (involves: 129S/SvEv * 129X1/SvJ * C57BL/6)	abnormal myelopoiesis	J:86458
Ctsg^{tm3.1(PML/RARA)Ley}/Ctsg⁺ (involves: 129 * C57BL/6)	abnormal bone marrow cell morphology/development	J:166479
	abnormal common myeloid progenitor cell morphology	J:166479
	abnormal spleen morphology	J:166479
	enlarged spleen	J:166479
	increased spleen weight	J:166479
Ctsk^tm1(cre)Ska/Ctsk⁺ Esr1^tm1Mma/Esr1^tm1Mma (involves: 129S2/SvPas * C57BL/6 * SJL)	abnormal osteoclast physiology	J:127179
	increased osteoclast cell number	J:127179
Ctsk^tm1(cre)Ska/Ctsk⁺ Plekhm1^tm1.1Hzhao/Plekhm1^tm1.1Hzhao (involves: C57BL/6J * C57BL/6NCrlj * CBA/JNCrlj)	abnormal osteoclast morphology	J:236517
	abnormal osteoclast physiology	J:236517
Ctsk^tm1(cre)Ska/Ctsk⁺ Snx10^{tm1c(EUCOMM)Raba}/Snx10^{tm1c(EUCOMM)Raba} (involves: 129S4/SvJae * C57BL/6 * C57BL/6J * C57BL/6NCrlj * CBA/JNCrlj)	abnormal osteoclast physiology	J:224711
Ctsk^tm1.1Rbar/Ctsk^tm1.1Rbar Tg(Itgam-cre)AJva/0 (involves: C57BL/6)	increased osteoclast cell number	J:194492
Ctsk^tm1.1Rbar/Ctsk^tm1.1Rbar Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	abnormal osteoclast differentiation	J:194492
	abnormal osteoclast physiology	J:194492
	increased osteoclast cell number	J:194492
Ctsk^tm1Mbs/Ctsk^tm1Mbs (B6.129-Ctsk^tm1Mbs)	abnormal osteoclast physiology	J:128098
Ctsk^tm1Mbs/Ctsk^tm1Mbs (B6.129-Ctsk^tm1Mbs)	increased osteoclast cell number	J:128098
Ctsk^tm1Psa/Ctsk^tm1Psa (involves: 129X1/SvJ * C57BL/6J)	abnormal osteoclast physiology	J:50934
Ctsk^tm1Vuo/Ctsk^tm1Vuo (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal osteoclast morphology	J:95525
	increased osteoclast cell number	J:95525
Ctsk^tm1Ypl/Ctsk^tm1Ypl (B6.129S4-Ctsk^tm1Ypl)	increased osteoclast cell number	J:117870
Ctsk^tm1Ypl/Ctsk^tm1Ypl (129S4/SvJae-Ctsk^tm1Ypl)	increased osteoclast cell number	J:117870
Ctsl^m1Btlr/Ctsl^m1Btlr (C57BL/6J-Ctsl^m1Btlr)	abnormal CD4-positive T cell differentiation	J:272869
	abnormal CD8-positive, alpha beta T cell morphology	J:272869
	abnormal CD8-positive, alpha-beta T cell differentiation	J:272869
	abnormal T cell differentiation	J:272869
	decreased alpha-beta T cell number	J:272869
	decreased CD4-positive, alpha-beta T cell number	J:272869
	increased alpha-beta T cell number	J:272869
	increased CD8-positive, alpha-beta T cell number	J:272869
	increased central memory CD4-positive, alpha-beta T cell number	J:272869
	increased central memory CD8 positive, alpha-beta T cell number	J:272869
	increased effector memory CD4-positive, alpha-beta T cell number	J:272869
Ctsl^nkt/Ctsl^nkt (either: (involves: 129S2/SvPas * BALB/c) or (involves: 129S2/SvPas * C57BL/6) or (involves: 129S2/SvPas * DBA/2))	decreased CD4-positive, alpha-beta T cell number	J:54856
	thymus atrophy	J:54856
Ctsl^nkt/Ctsl^nkt (C.Cg-Ctsl^nkt)	abnormal leukocyte cell number	J:99009
	abnormal thymus corticomedullary boundary morphology	J:99009
	abnormal thymus lobule morphology	J:99009
	abnormal thymus morphology	J:99009
	decreased CD4-positive, alpha-beta T cell number	J:99009
	enlarged thymus cortex	J:99009
	increased CD8-positive, alpha-beta T cell number	J:99009
Ctsl^tm1.2Thre/Ctsl^tm1.2Thre (involves: C57BL/6 * C57BL/6N)	decreased CD4-positive, alpha-beta T cell number	J:216506
Ctsl^tm1Alpk/Ctsl^tm1Alpk (involves: 129P2/OlaHsd * C57BL/6)	abnormal osteoclast physiology	J:99755
	decreased osteoclast cell number	J:99755
Ctsl^tm1Cptr/Ctsl^tm1Cptr (involves: 129P2/OlaHsd * C57BL/6J)	increased regulatory T cell number	J:153355
Ctsl^tm1Cptr/Ctsl^tm1Cptr (NOD.129P2-Ctsl^tm1Cptr)	decreased CD4-positive, alpha-beta T cell number	J:153355
Ctsl^tm1Cptr/Ctsl^tm1Cptr (NOD.129P2-Ctsl^tm1Cptr)	increased regulatory T cell number	J:153355
Ctsl^tm1Cptr/Ctsl^tm1Cptr (involves: 129P2/OlaHsd)	decreased CD4-positive, alpha-beta T cell number	J:216506
Ctsm^{tm1(KOMP)Wtsi}/Ctsm^{tm1(KOMP)Wtsi} (C57BL/6N-Ctsm^{tm1(KOMP)Wtsi}/Nju)	decreased mean corpuscular volume	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
	increased monocyte cell number	J:211773
Ctso^{tm2b(KOMP)Wtsi}/Ctso^{tm2b(KOMP)Wtsi} (C57BL/6N-Ctso^{tm2b(KOMP)Wtsi}/Cnrm)	increased mean platelet volume	J:211773
Ctss^em1(IMPC)H/Ctss^em1(IMPC)H (C57BL/6NTac-Ctss^em1(IMPC)H/H)	decreased spleen weight	J:211773
Ctss^m1Btlr/Ctss^m1Btlr (C57BL/6J-Ctss^m1Btlr)	decreased IgG level	J:267491
Ctss^tm1Eae/Ctss^tm1Eae (involves: C57BL/6 * DBA/1LacJ)	abnormal B lymphocyte antigen presentation	J:53399
Ctss^tm1Hap/Ctss^tm1Hap (B6.129S2-Ctss^tm1Hap)	abnormal B cell physiology	J:96401
	abnormal T cell physiology	J:96401
	decreased IgG level	J:96401
	decreased IgM level	J:96401
Ctss^tm1Hap/Ctss^tm1Hap Ldlr^tm1Her/Ldlr^tm1Her (B6.129S-Ctss^tm1Hap Ldlr^tm1Her)	abnormal leukocyte migration	J:82520
Ctss^tm1Hap/Ctss^tm1Hap Tg(Scgb1a1-rtTA,tetO-Ifng)14Eli/0 (involves: 129S2/SvPas * C57BL/6 * CBA)	increased lymphocyte cell number	J:100854
	increased macrophage cell number	J:100854
	increased neutrophil cell number	J:100854
Ctsz^em1(IMPC)H/Ctsz^em1(IMPC)H (C57BL/6NTac-Ctsz^em1(IMPC)H/H)	increased mean platelet volume	J:211773
Cttn^tm1.2Dvst/Cttn^tm1.2Dvst (either: B6.Cg-Cttn^tm1.2Dvst or (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * DBA/2 * SJL))	abnormal cellular extravasation	J:177602
	abnormal leukocyte adhesion	J:177602
	abnormal leukocyte migration	J:177602
	abnormal neutrophil physiology	J:177602
Cttnbp2^{tm1b(KOMP)Wtsi}/Cttnbp2^{tm1b(KOMP)Wtsi} (C57BL/6N-Cttnbp2^{tm1b(KOMP)Wtsi}/Wtsi)	decreased transitional stage T1 B cell number	J:211773
	increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	increased plasma cell number	J:211773
Cttnbp2nl^em1(IMPC)J/Cttnbp2nl^em1(IMPC)J (C57BL/6NJ-Cttnbp2nl^em1(IMPC)J/Mmjax)	decreased mean corpuscular hemoglobin	J:211773
Ctu2^{tm1(KOMP)Wtsi}/Ctu2⁺ (C57BL/6N-Ctu2^{tm1(KOMP)Wtsi}/Nju)	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
Cuedc1^em1(IMPC)J/Cuedc1^em1(IMPC)J (C57BL/6NJ-Cuedc1^em1(IMPC)J/J)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased mean corpuscular volume	J:211773
Cuedc2^tm1Qxia/Cuedc2^tm1Qxia (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac)	abnormal macrophage physiology	J:211782
	increased macrophage cytokine production	J:211782
Cul4a/Pcid2^tm2Ktc/Cul4a/Pcid2^tm2Ktc Tg(Mx1-cre)1Cgn/0 (involves: 129S/SvEv * C57BL/6 * CBA * FVB/N)	abnormal definitive hematopoiesis	J:138468
	abnormal leukocyte morphology	J:138468
	abnormal spleen capsule morphology	J:138468
	abnormal spleen morphology	J:138468
	decreased bone marrow cell number	J:138468
	decreased hematocrit	J:138468
	decreased hematopoietic stem cell number	J:138468
	decreased lymphocyte cell number	J:138468
	decreased monocyte cell number	J:138468
	decreased neutrophil cell number	J:138468
	decreased spleen red pulp amount	J:138468
	decreased spleen weight	J:138468
	decreased spleen white pulp amount	J:138468
	impaired hematopoiesis	J:138468
	small thymus	J:138468
	spleen hypoplasia	J:138468
	thrombocytopenia	J:138468
Cul4a/Pcid2^tm2Ktc/Cul4a/Pcid2^tm2Ktc Tg(Mx1-cre)1Cgn/0 (involves: 129S/SvEv * C57BL/6 * CBA * FVB/N)	abnormal definitive hematopoiesis	J:138468
	abnormal leukocyte morphology	J:138468
	abnormal spleen capsule morphology	J:138468
	abnormal spleen morphology	J:138468
	decreased bone marrow cell number	J:138468
	decreased hematocrit	J:138468
	decreased hematopoietic stem cell number	J:138468
	decreased lymphocyte cell number	J:138468
	decreased monocyte cell number	J:138468
	decreased neutrophil cell number	J:138468
	decreased spleen red pulp amount	J:138468
	decreased spleen weight	J:138468
	decreased spleen white pulp amount	J:138468
	impaired hematopoiesis	J:138468
	small thymus	J:138468
	spleen hypoplasia	J:138468
	thrombocytopenia	J:138468
Cul4a^{tm1b(EUCOMM)Hmgu}/Cul4a^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Cul4a^{tm1b(EUCOMM)Hmgu}/Ccpcz)	decreased mean platelet volume	J:211773
	decreased spleen weight	J:211773
Cul5^{tm1.1(KOMP)Vlcg}/Cul5⁺ (C57BL/6N-Cul5^{tm1.1(KOMP)Vlcg}/Ucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased spleen weight	J:211773
Cul9^{em1(IMPC)Ccpcz}/Cul9^{em1(IMPC)Ccpcz} (C57BL/6N-Cul9^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Cux1^tm1Rhsc/Cux1^tm1Rhsc (involves: 129S1/Sv * C57BL/6J)	abnormal myelopoiesis	J:100055
	abnormal T cell differentiation	J:100055
	decreased B cell number	J:100055
	decreased double-positive T cell number	J:100055
	decreased thymocyte number	J:100055
	small thymus	J:100055
	thymus cortex hypoplasia	J:100055
	thymus hypoplasia	J:100055
Cwc22^em1(IMPC)Mbp/Cwc22⁺ (C57BL/6NCrl-Cwc22^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
Cx3cl1^tm1Lira/Cx3cl1^tm1Lira (involves: 129S/SvEv * C57BL/6)	hematopoietic system phenotype	J:68831
Cx3cl1^tm1Lira/Cx3cl1^tm1Lira (involves: C57BL/6)	decreased monocyte cell number	J:145036
Cx3cl1^tm1Sgs/Cx3cl1^tm1Sgs Ldlr^tm1Her/Ldlr^tm1Her (involves: B6.129S4-Cx3cl1^tm1Sgs * B6.129S7-Ldlr^tm1Her/J)	impaired macrophage chemotaxis	J:95279
Cx3cr1^tm1Ifc/Cx3cr1^tm1Ifc (involves: 129S4/SvJae * C57BL/6)	abnormal NK cell physiology	J:82033
	impaired macrophage chemotaxis	J:82033
Cx3cr1^tm1Litt/Cx3cr1⁺ (B6.129P2-Cx3cr1^tm1Litt)	microgliosis	J:110266
Cx3cr1^tm1Litt/Cx3cr1⁺ Psen1^tm1Mpm/Psen1^tm1Mpm Tg(APPSwe,tauP301L)1Lfa/0 Tg(Thy1-YFP)HJrs/0 (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	abnormal microglial cell morphology	J:159680
	abnormal microglial cell physiology	J:159680
Cx3cr1^tm1Litt/Cx3cr1^tm1Litt (involves: 129P2/OlaHsd * C57BL/6)	abnormal leukocyte physiology	J:162714
	decreased monocyte cell number	J:145036
	impaired macrophage chemotaxis	J:162714
Cx3cr1^tm1Litt/Cx3cr1^tm1Litt (involves: 129P2/OlaHsd)	increased dendritic cell number	J:210086
Cx3cr1^tm1Litt/Cx3cr1^tm1Litt (B6.129P2-Cx3cr1^tm1Litt)	abnormal leukocyte physiology	J:124722
	abnormal microglial cell morphology	J:265696
	abnormal microglial cell physiology	J:110266, J:265696
	abnormal NK cell physiology	J:129712
	decreased NK cell number	J:129712
	microgliosis	J:110266
Cx3cr1^tm1Zm/Cx3cr1^tm1Zm (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal splenocyte physiology	J:103047
Cx3cr1^{tm2.1(cre/ERT2)Litt}/Cx3cr1⁺ Vps35^{Gt(RRK261)Byg}/Vps35^{Gt(RRK261)Byg} (involves: 129P2/OlaHsd * C57BL/6)	increased macrophage cell number	J:292365
	microgliosis	J:292365
Cxadr^em1(IMPC)Mbp/Cxadr⁺ (C57BL/6N-Cxadr^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	small spleen	J:211773
Cxadr^tm1.1Ics/Cxadr^tm1.1Ics Tg(CAG-cre/Esr1)5Amc/0 (involves: 129S2/SvPas C57BL/6 * C57BL/6J * CBA)	enlarged thymus	J:174138
	increased thymocyte number	J:174138
Cxcl1^em1(IMPC)Mbp/Cxcl1^em1(IMPC)Mbp (C57BL/6N-Cxcl1^em1(IMPC)Mbp/MbpMmucd)	increased monocyte cell number	J:211773
Cxcl5^tm1.1Mkch/Cxcl5^tm1.1Mkch (B6.129P2-Cxcl5^tm1.1Mkch)	decreased neutrophil cell number	J:208901
Cxcl5^tm1Gscw/Cxcl5^tm1Gscw (involves: 129)	abnormal neutrophil physiology	J:162629
Cxcl5^tm1Gscw/Cxcl5^tm1Gscw (involves: 129)	increased granulocyte number	J:162629
Cxcl9^{tm1b(EUCOMM)Wtsi}/Cxcl9^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Cxcl9^{tm1b(EUCOMM)Wtsi}/H)	decreased neutrophil cell number	J:211773
	increased lymphocyte cell number	J:211773
Cxcl9^tm1Jmf/Cxcl9^tm1Jmf (either: B6.129S4-Cxcl9^tm1Jmf or (involves: 129S4/SvJae * C57BL/6))	decreased IgG level	J:121818
	decreased immunoglobulin level	J:121818
Cxcl10^tm1Adl/Cxcl10^tm1Adl (involves: 129S4/SvJae * 129X1/SvJ)	decreased IgG2a level	J:75584
	decreased splenocyte proliferation	J:75584
Cxcl10^tm1Adl/Cxcl10^tm1Adl (involves: 129S4/SvJae * C57BL/6)	abnormal T cell physiology	J:75584
	decreased CD8-positive, alpha-beta T cell number	J:75584
Cxcl11^em1Groj/Cxcl11^em1Groj (C57BL/6J-Cxcl11^em1Groj)	abnormal B cell morphology	J:345391
Cxcl11^em1Groj/Cxcl11^em1Groj (C57BL/6J-Cxcl11^em1Groj)	increased CD8-positive, alpha-beta T cell number	J:345391
Cxcl12^{tm1.1(KOMP)Vlcg}/Cxcl12⁺ (C57BL/6N-Cxcl12^{tm1.1(KOMP)Vlcg}/Ucd)	thrombocytopenia	J:211773
Cxcl12^tm1.1Sjm/Cxcl12^tm1.1Sjm Commd10^{Tg(Vav1-icre)A2Kio}/? (involves: C57BL/6 * C57BL/10 * CBA/Ca)	hematopoietic system phenotype	J:194748
Cxcl12^tm1.1Sjm/Cxcl12^tm1.1Sjm Lepr^tm2(cre)Rck/Lepr⁺ (involves: C57BL/6)	abnormal hematopoietic system morphology/development	J:194748
Cxcl12^tm1.1Sjm/Cxcl12^tm1.1Sjm Ndor1^{Tg(UBC-cre/ERT2)1Ejb}/? (involves: 129S/SvEv * C57BL/6)	decreased bone marrow cell number	J:194748
	decreased hematopoietic stem cell number	J:194748
	decreased leukocyte cell number	J:194748
	decreased lymphocyte cell number	J:194748
Cxcl12^tm1.1Sjm/Cxcl12^tm1.1Sjm Tg(Col1a1-cre)2Bek/? (involves: C57BL/6 * CD-1)	abnormal bone marrow cell physiology	J:194748
	decreased bone marrow cell number	J:194748
Cxcl12^tm1.1Sjm/Cxcl12^tm1.1Sjm Tg(Nes-cre)1Kln/? (involves: C57BL/6 * SJL)	hematopoietic system phenotype	J:194748
Cxcl12^tm1.1Sjm/Cxcl12^tm1.1Sjm Tg(Prrx1-cre)1Cjt/? (involves: C57BL/6 * SJL/J)	abnormal B cell differentiation	J:194748
	decreased bone marrow cell number	J:194748
Cxcl12^tm1.1Sjm/Cxcl12^tm1.1Sjm Tg(Tek-cre)12Flv/? (involves: C3H * C57BL/6)	abnormal bone marrow cell physiology	J:194748
	decreased hematopoietic stem cell number	J:194748
Cxcl12^tm1.1Ystz/Cxcl12^tm1.2Ystz Tg(CAG-cre/Esr1)5Amc/0 (involves: 129X1/SvJ C57BL/6 * CBA * FVB/N)	abnormal hematopoietic stem cell physiology	J:168434
	abnormal hematopoietic system physiology	J:168434
	decreased hematopoietic stem cell number	J:168434
	decreased pro-B cell number	J:168434
	increased hematopoietic stem cell number	J:168434
	increased neutrophil cell number	J:168434
Cxcl12^tm1Tng/Cxcl12^tm1.1Link Tg(BGLAP-cre)1Clem/0 (involves: 129P2/OlaHsd * C57BL/6J * C57BL/6NTac * FVB/N)	decreased B cell number	J:193594
	hematopoietic system phenotype	J:193594
Cxcl12^tm1Tng/Cxcl12^tm1.1Link Tg(Prrx1-cre)1Cjt/0 (involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL/J)	abnormal bone marrow cell physiology	J:193594
	abnormal common lymphocyte progenitor cell morphology	J:193594
	abnormal hematopoietic stem cell physiology	J:193594
	decreased B cell number	J:193594
	decreased bone marrow cell number	J:193594
	decreased common myeloid progenitor cell number	J:193594
	decreased hematopoietic stem cell number	J:193594
	decreased pre-pro B cell number	J:193594
Cxcl12^tm1Tng/Cxcl12^tm1.1Link Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0 (involves: 129P2/OlaHsd * C57BL/6 * CD-1 * FVB/N)	abnormal blood cell morphology/development	J:193594
	abnormal hematopoietic stem cell physiology	J:193594
	decreased B cell number	J:193594
	decreased bone marrow cell number	J:193594
	decreased hematopoietic stem cell number	J:193594
	decreased pre-pro B cell number	J:193594
Cxcl12^tm1Tng/Cxcl12^tm1.1Link Tg(Tek-cre)1Ywa/0 (involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL)	abnormal bone marrow cell physiology	J:193594
	hematopoietic system phenotype	J:193594
Cxcl12^tm1Tng/Cxcl12^tm1Tng (involves: 129P2/OlaHsd)	decreased bone marrow cell number	J:49070, J:34750
	decreased pre-B cell number	J:34750
	decreased pro-B cell number	J:34750
	impaired myelopoiesis	J:49070
Cxcl12^{tm3.1(HBEGF/EGFP)Tng}/Cxcl12⁺ (B6.Cg-Cxcl12^{tm3.1(HBEGF/EGFP)Tng})	abnormal bone marrow cell physiology	J:164657
	abnormal common lymphocyte progenitor cell morphology	J:164657
	abnormal hematopoietic stem cell morphology	J:164657
	abnormal hematopoietic system morphology/development	J:164657
	abnormal hematopoietic system physiology	J:164657
	abnormal proerythroblast morphology	J:164657
	decreased bone marrow cell number	J:164657
	decreased common myeloid progenitor cell number	J:164657
	decreased hematopoietic stem cell number	J:164657
	decreased pro-B cell number	J:164657
	increased B cell apoptosis	J:164657
Cxcl13^em2(IMPC)H/Cxcl13^em2(IMPC)H (C57BL/6NTac-Cxcl13^em2(IMPC)H/H)	increased basophil cell number	J:211773
	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
Cxcl13^m1Btlr/Cxcl13^m1Btlr (C57BL/6J-Cxcl13^m1Btlr)	increased B-1 B cell number	J:221480
Cxcl13^tm1Cys/Cxcl13^tm1Cys (involves: 129X1/SvJ * C57BL/6)	abnormal B cell physiology	J:78282
	abnormal spleen B cell follicle morphology	J:78282
	abnormal spleen marginal zone morphology	J:78282
	decreased spleen germinal center size	J:78282
Cxcl13^tm1Cys/Cxcl13^tm1Cys (B6.129X1-Cxcl13^tm1Cys)	abnormal B cell physiology	J:118931
Cxcl13^tm1Mmi/Cxcl13^tm1Mmi (involves: C57BL/6)	abnormal B cell physiology	J:84804
	abnormal leukocyte adhesion	J:84804
	abnormal leukocyte migration	J:84804
Cxcl14^tm1Tha/Cxcl14^tm1Tha (involves: C57BL/6 * CBA)	decreased macrophage cell number	J:126841
Cxcl15^tm1Lira/Cxcl15^tm1Lira (involves: 129 * C57BL/6J)	decreased neutrophil cell number	J:67605
Cxcl15^tm1Lira/Cxcl15^tm1Lira (involves: 129 * C57BL/6J)	hematopoietic system phenotype	J:67605
Cxcl16^tm1Syon/Cxcl16^tm1Syon (B6.129P2-Cxcl16^tm1Syon)	decreased NK T cell number	J:155199
Cxcl17^{tm1b(EUCOMM)Wtsi}/Cxcl17^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Cxcl17^{tm1b(EUCOMM)Wtsi}/Ucd)	increased mean platelet volume	J:211773
Cxcr1^{tm1a(EUCOMM)Wtsi}/Cxcr1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Cxcr1^{tm1a(EUCOMM)Wtsi}/Wtsi)	thrombocytopenia	J:211773
Cxcr2^{tm1(IL8RB)Dktr}/Cxcr2^{tm1(IL8RB)Dktr} (involves: 129S2/SvPas * C57BL/6)	decreased spleen weight	J:113489
	increased granulocyte number	J:113489
	increased leukocyte cell number	J:113489
Cxcr2^{tm1a(EUCOMM)Wtsi}/Cxcr2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Cxcr2^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased B cell number	J:211773
	decreased CD8-positive, alpha-beta T cell number	J:211773
	decreased immature B cell number	J:211773
	decreased mature B cell number	J:211773
	decreased mean corpuscular hemoglobin	J:211773
	decreased pre-B cell number	J:211773
	decreased pre-pro B cell number	J:211773
	decreased T cell number	J:211773
	increased CD4-positive, alpha-beta memory T cell number	J:211773
	increased CD8-positive, alpha-beta memory T cell number	J:211773
	increased CD103-positive CD11b-low dendritic cell number	J:211773
	increased effector memory CD8-positive, alpha-beta T cell number	J:211773
	increased effector memory T-helper cell number	J:211773
	increased eosinophil cell number	J:211773
	increased gamma-delta T cell number	J:211773
	increased granulocyte number	J:211773
	increased KLRG1+ CD4 alpha-beta T cell number	J:211773
	increased KLRG1+ CD8 alpha-beta T cell number	J:211773
	increased leukocyte cell number	J:211773
	increased Ly6C high monocyte number	J:211773
	increased Ly6C low monocyte number	J:211773
	increased memory-marker CD4-positive NK T cell number	J:211773
	increased memory-marker gamma-delta T cell number	J:211773
	increased memory-marker NK cell number	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
	increased red blood cell distribution width	J:211773
	thrombocytosis	J:211773
Cxcr2^tm1Mwm/Cxcr2⁺ (C.129S2(B6)-Cxcr2^tm1Mwm/J)	impaired neutrophil recruitment	J:63935
Cxcr2^tm1Mwm/Cxcr2^tm1Mwm (involves: 129S2/SvPas * C57BL/6J)	abnormal granulocyte differentiation	J:19570
	abnormal myelopoiesis	J:19570
	abnormal spleen white pulp morphology	J:19570
	enlarged spleen	J:19570
	hematopoietic system phenotype	J:19570
	impaired neutrophil chemotaxis	J:19570
	increased B cell number	J:19570
	increased neutrophil cell number	J:19570
	myeloid hyperplasia	J:19570
Cxcr2^tm1Mwm/Cxcr2^tm1Mwm (C.129S2(B6)-Cxcr2^tm1Mwm/J)	abnormal eosinophil physiology	J:73947
	abnormal leukocyte physiology	J:94170
	abnormal neutrophil physiology	J:93946, J:73947
	abnormal NK T cell physiology	J:66399
	abnormal T cell physiology	J:73947
	abnormal T-helper 1 physiology	J:73947
	abnormal T-helper 2 physiology	J:73947
	impaired neutrophil chemotaxis	J:65905, J:72824
	impaired neutrophil recruitment	J:65425, J:63935, J:93116
	increased IgE level	J:73947
Cxcr2^tm1Mwm/Cxcr2^tm1Mwm (involves: 129S2/SvPas * BALB/c)	abnormal myelopoiesis	J:113489
	abnormal neutrophil physiology	J:113489
	decreased thymus weight	J:113489
	extramedullary hematopoiesis	J:113489
	increased granulocyte number	J:113489
	increased spleen weight	J:113489
Cxcr2^tm1Rmra/Cxcr2^tm1Rmra Tg(Mx1-cre)1Cgn/0 (involves: 129S/SvEv * C57BL/6 * C57BL/6NTac * CBA)	abnormal neutrophil physiology	J:204482
Cxcr3^tm1Wwh/Y (B6.Cg-Cxcr3^tm1Wwh)	abnormal cellular extravasation	J:107646
Cxcr3^tm1Wwh/Y (B6.Cg-Cxcr3^tm1Wwh)	impaired macrophage chemotaxis	J:107646
Cxcr3^tm1Wwh/Cxcr3^tm1Wwh (B6.Cg-Cxcr3^tm1Wwh)	abnormal cellular extravasation	J:96905, J:107646
Cxcr3^tm1Wwh/Cxcr3^tm1Wwh (B6.Cg-Cxcr3^tm1Wwh)	impaired macrophage chemotaxis	J:107646
Cxcr4^em1(IMPC)Mbp/Cxcr4⁺ (C57BL/6NCrl-Cxcr4^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
	increased monocyte cell number	J:211773
Cxcr4^tm1.1Bala/Cxcr4⁺ (B6.129S2-Cxcr4^tm1.1Bala)	abnormal CD4-positive, alpha-beta T cell number	J:186735
	abnormal neutrophil morphology	J:186735
	abnormal NK cell physiology	J:178789
	abnormal spleen morphology	J:186735
	abnormal spleen white pulp morphology	J:186735
	abnormal thymus morphology	J:186735
	decreased B cell apoptosis	J:186735
	decreased B cell number	J:186735
	decreased immature B cell number	J:186735
	decreased leukocyte cell number	J:186735
	decreased NK cell number	J:178789
	decreased spleen weight	J:186735
	decreased T cell number	J:186735
	increased IgG level	J:186735
	increased IgM level	J:186735
	increased immunoglobulin level	J:186735
	increased mature B cell number	J:186735
	increased NK cell number	J:178789
Cxcr4^tm1Qma/Cxcr4^tm1Qma (involves: 129X1/SvJ)	decreased bone marrow cell number	J:49070
	decreased pro-B cell number	J:49070
	impaired myelopoiesis	J:49070
Cxcr4^tm1Tng/Cxcr4^tm1Tng (involves: 129P2/OlaHsd)	abnormal B cell differentiation	J:69256
Cxcr4^tm1Tng/Cxcr4^tm1Tng (involves: 129P2/OlaHsd)	failure of myelopoiesis	J:69256
Cxcr4^tm1Tng/Cxcr4^tm1Tng (B6.Cg-Cxcr4^tm1Tng)	abnormal T cell differentiation	J:82996
Cxcr4^tm1Tng/Cxcr4^tm1Tng (B6.Cg-Cxcr4^tm1Tng)	decreased double-positive T cell number	J:82996
Cxcr4^tm1Yiw/Cxcr4^tm1Yiw Tg(Lck-cre)1Jtak/0 (involves: 129P2/OlaHsd)	abnormal leukocyte migration	J:164872
	decreased thymocyte number	J:164872
Cxcr4^tm1Yzo/Cxcr4^tm1Yzo (Not Specified)	abnormal B cell differentiation	J:167314
	abnormal B cell physiology	J:167314
	abnormal leukopoiesis	J:69255
	abnormal lymphopoiesis	J:69255
	impaired myelopoiesis	J:69255
Cxcr4^tm2Yzo/Cxcr4^tm2Yzo Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd)	abnormal B cell differentiation	J:94911
	decreased B-1 B cell number	J:94911
	decreased B-2 B cell number	J:94911
	decreased immunoglobulin level	J:94911
	decreased mature B cell number	J:94911
	decreased plasma cell number	J:94911
Cxcr4^tm2Yzo/Cxcr4^tm2Yzo Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6)	increased lymphocyte cell number	J:217569
	increased monocyte cell number	J:217569
	increased neutrophil cell number	J:217569
Cxcr4^tm2Yzo/Cxcr4^tm2Yzo Tg(Fabp4-cre)1Rev/0 (involves: 129P2/OlaHsd * C57BL/6)	abnormal macrophage cell number	J:217569
	decreased B cell number	J:217569
	decreased CD4-positive, alpha-beta T cell number	J:217569
	increased CD8-positive, alpha-beta T cell number	J:217569
Cxcr4^tm2Yzo/Cxcr4^tm3.1Yzo Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd)	abnormal B cell differentiation	J:167314
Cxcr4^tm3.1Yzo/Cxcr4^tm3.1Yzo (Not Specified)	abnormal B cell physiology	J:167314
	decreased pro-B cell number	J:167314
	impaired myelopoiesis	J:167314
Cxcr5^tm1.1Namt/Cxcr5^tm1.1Namt Tg(Itgax-cre)1-1Reiz/0 (involves: C57BL/6 * C57BL/6J * CBA)	abnormal dendritic cell chemotaxis	J:241561
Cxcr5^tm1Lipp/Cxcr5^tm1Lipp (involves: 129S2/SvPas * CD-1)	abnormal leukocyte migration	J:37126
	abnormal spleen primary B follicle morphology	J:37126
	abnormal spleen secondary B follicle morphology	J:37126
	absent spleen germinal center	J:37126
	increased B cell number	J:37126
Cyb5d1^{tm1.1(KOMP)Vlcg}/Cyb5d1^{tm1.1(KOMP)Vlcg} (B6N(Cg)-Cyb5d1^{tm1.1(KOMP)Vlcg}/J)	increased leukocyte cell number	J:211773
Cyb5r3^{tm1c(KOMP)Wtsi}/Cyb5r3^{tm1c(KOMP)Wtsi} Tg(Myh11-icre/ERT2)1Soff/0 (B6.Cg-Cyb5r3^{tm1c(KOMP)Wtsi} Tg(Myh11-icre/ERT2)1Soff)	decreased monocyte cell number	J:280543
Cyb561^{tm1a(EUCOMM)Wtsi}/Cyb561^{tm1a(EUCOMM)Wtsi} (B6JTyr;B6N-Cyb561^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased erythrocyte cell number	J:175295
	increased hematocrit	J:175295
	increased hemoglobin content	J:175295
Cyb561a3^{tm2b(EUCOMM)Hmgu}/Cyb561a3^{tm2b(EUCOMM)Hmgu} (C57BL/6N-Cyb561a3^{tm2b(EUCOMM)Hmgu}/Ieg)	decreased mean platelet volume	J:211773
Cyb561d2^{tm1b(EUCOMM)Wtsi}/Cyb561d2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Cyb561d2^{tm1b(EUCOMM)Wtsi}/Bay)	abnormal spleen morphology	J:211773
Cyba^nmf333/Cyba^nmf333 (A.B6 Tyr⁺-Cyba^nmf333/J)	abnormal neutrophil physiology	J:132359
Cyba^{tm1a(EUCOMM)Wtsi}/Cyba^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Cyba^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased leukocyte cell number	J:211773
	increased mean platelet volume	J:211773
Cyba^tm1Dgh/Cyba^tm1Dgh (B6.Cg-Cyba^tm1Dgh)	abnormal T cell activation	J:231269
Cybb^tm1.1Abk/Cybb^tm1.1Abk Lyz2^tm1(cre)Ifo/? (B6.Cg-Lyz2^tm1(cre)Ifo Cybb^tm1.1Abk)	abnormal macrophage chemotaxis	J:245699
	enlarged spleen	J:245699
Cybb^tm1Din/Y (involves: 129S/SvEv * C57BL/6)	abnormal macrophage physiology	J:22868
Cybb^tm1Din/Y (involves: 129S/SvEv * C57BL/6)	abnormal neutrophil physiology	J:22868
Cybb^tm1Din/Cybb^tm1Din (B6.129S-Cybb^tm1Din/J)	abnormal macrophage physiology	J:235399
	increased IgG level	J:235399
	increased lymphocyte cell number	J:235399
	increased monocyte cell number	J:235399
	increased neutrophil cell number	J:235399
Cybb^{tm2b(KOMP)Wtsi}/Cybb^{tm2b(KOMP)Wtsi} (C57BL/6N-Cybb^{tm2b(KOMP)Wtsi}/H)	decreased mean corpuscular volume	J:211773
	increased spleen weight	J:211773
Cycs^tm1Mak/Cycs^tm1Mak (involves: C57BL/6)	absent pre-B cells	J:98949
	decreased B cell number	J:98949
	decreased leukocyte cell number	J:98949
	decreased T cell number	J:98949
	increased spleen weight	J:98949
	spleen hyperplasia	J:98949
	thymus atrophy	J:98949
	thymus hypoplasia	J:98949
Cyld^tm1.1Awai/Cyld^tm1.1Awai (Not Specified)	abnormal B cell differentiation	J:126113
	abnormal B cell morphology	J:126113
	abnormal B cell physiology	J:126113
	abnormal class switch recombination	J:126113
	abnormal spleen marginal zone morphology	J:126113
	abnormal spleen morphology	J:126113
	decreased B-1 B cell number	J:126113
	decreased IgG3 level	J:126113
	decreased IgM level	J:126113
	decreased immature B cell number	J:126113
	enlarged spleen	J:126113
	increased B cell number	J:126113
	increased follicular B cell number	J:126113
	increased IgA level	J:126113
	increased IgG1 level	J:126113
	increased IgG2a level	J:126113
	increased IgG2b level	J:126113
	increased marginal zone B cell number	J:126113
	increased pro-B cell number	J:126113
Cyld^tm1Awai/Cyld^tm1Awai Tg(CD19-cre/ERT2)1Cgn/? (Not Specified)	abnormal mature B cell morphology	J:126113
	decreased B-1 B cell number	J:126113
	decreased immature B cell number	J:126113
	enlarged spleen	J:126113
	increased B cell number	J:126113
Cyld^tm1Lex/Cyld^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	thymus hyperplasia	J:114972
Cyld^tm1Scs/Cyld^tm1Scs (involves: 129S1/Sv * 129X1/SvJ)	abnormal B cell differentiation	J:112392
	abnormal T cell number	J:112392
	decreased CD4-positive, alpha-beta T cell number	J:112392
	decreased CD8-positive, alpha-beta T cell number	J:112392
	increased double-positive T cell number	J:112392
Cyp1a1^tm1.1Dwn/Cyp1a1^tm1.1Dwn (B6.129P2-Cyp1a1^tm1.1Dwn)	abnormal hemoglobin content	J:163973
	decreased hematocrit	J:163973
	decreased lymphocyte cell number	J:163973
	decreased spleen weight	J:163973
	decreased thymus weight	J:163973
	increased hemoglobin content	J:163973
	increased neutrophil cell number	J:163973
Cyp1a1^tm1.1Dwn/Cyp1a1^tm1.1Dwn (involves: 129P2/OlaHsd * C57BL/6)	decreased leukocyte cell number	J:122409
	small spleen	J:122409
	small thymus	J:122409
Cyp1a1^tm4.1Dwn/Cyp1a1^tm4.1Dwn (B6.129X1-Cyp1a1^tm4.1Dwn)	abnormal hemoglobin content	J:163973
	decreased hematocrit	J:163973
	decreased lymphocyte cell number	J:163973
	decreased spleen weight	J:163973
	decreased thymus weight	J:163973
	increased hemoglobin content	J:163973
	increased neutrophil cell number	J:163973
Cyp1a^tm1Dwn/Cyp1a^tm1Dwn (B6.129-Cyp1a^tm1Dwn)	decreased leukocyte cell number	J:122409
	small spleen	J:122409
	small thymus	J:122409
Cyp2ab1^{tm1b(KOMP)Wtsi}/Cyp2ab1^{tm1b(KOMP)Wtsi} (C57BL/6N-Cyp2ab1^{tm1b(KOMP)Wtsi}/Bay)	abnormal spleen morphology	J:211773
Cyp2c23^{tm1b(EUCOMM)Hmgu}/Cyp2c23^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Cyp2c23^{tm1b(EUCOMM)Hmgu}/J)	increased mean corpuscular hemoglobin	J:211773
Cyp2f2^em1(IMPC)H/Cyp2f2^em1(IMPC)H (C57BL/6N-Cyp2f2^em1(IMPC)H/H)	enlarged spleen	J:211773
Cyp2g1^{tm1(rtTA)Lane}/Cyp2g1⁺ Tg(SFTPC-rtTA,tetO-Tnf)320-1Gwho/0 (involves: 129 * C57BL/6 * SJL)	increased macrophage cell number	J:157842
Cyp4v3^em1Xsu/Cyp4v3^em1Xsu (C57BL/6J-Cyp4v3^em1Xsu)	increased microglial cell activation	J:321817
Cyp7a1^{tm1b(EUCOMM)Wtsi}/Cyp7a1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Cyp7a1^{tm1b(EUCOMM)Wtsi}/Ieg)	increased leukocyte cell number	J:211773
Cyp7b1^tm1Rus/Cyp7b1^tm1Rus (involves: 129S/SvEv * C57BL/6J)	decreased IgA level	J:170807
Cyp11a1^tm2Bcc/Cyp11a1^tm2Bcc (Not Specified)	decreased T cell apoptosis	J:133007
Cyp11b1^tm1Chjk/Cyp11b1^tm1Chjk (involves: 129P2/OlaHsd * C57BL/6J)	decreased thymus weight	J:147610
Cyp19a1^{tm1b(EUCOMM)Hmgu}/Cyp19a1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Cyp19a1^{tm1b(EUCOMM)Hmgu}/H)	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	decreased mean corpuscular hemoglobin concentration	J:211773
	increased neutrophil cell number	J:211773
	thrombocytosis	J:211773
Cyp19a1^tm1Esi/Cyp19a1^tm1Esi (involves: 129S6/SvEvTac * C57BL/6)	abnormal spleen germinal center morphology	J:92438
	enlarged spleen	J:92438
	increased B cell number	J:92438
	increased bone marrow cell number	J:92438
	increased granulocyte number	J:92438
	increased IgG level	J:92438
	increased leukocyte cell number	J:92438
	increased lymphocyte cell number	J:92438
	increased mature B cell number	J:92438
	spleen hyperplasia	J:92438
Cyp19a1^tm1Sih/Cyp19a1^tm1Sih (involves: 129S/SvEv)	increased dendritic cell number	J:216958
Cyp19a1^tm1Sih/Cyp19a1^tm1Sih (involves: 129S/SvEv)	increased macrophage cell number	J:216958
Cyp19a1^tm1Toda/Cyp19a1^tm1Toda (involves: 129P2/OlaHsd * C57BL/6J)	increased osteoclast cell number	J:114305
Cyp21a1^em1(IMPC)Tcp/Cyp21a1⁺ (C57BL/6NCrl-Cyp21a1^em1(IMPC)Tcp/Tcp)	enlarged spleen	J:211773
Cyp27a1^{tm1.1(KOMP)Vlcg}/Cyp27a1^{tm1.1(KOMP)Vlcg} (C57BL/6N-Cyp27a1^{tm1.1(KOMP)Vlcg}/Ucd)	decreased mean platelet volume	J:211773
Cyp27b1^{tm1b(EUCOMM)Hmgu}/Cyp27b1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Cyp27b1^{tm1b(EUCOMM)Hmgu}/Tcp)	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
Cyp27b1^tm1Dgo/Cyp27b1^tm1Dgo (involves: 129S1/Sv * 129X1/SvJ * BALB/c)	decreased osteoclast cell number	J:70030
	decreased T cell number	J:70030
Cyren^em1Vokh/Cyren^em1Vokh (C57BL/6-Cyren^em1Vokh)	abnormal class switch recombination	J:306598
Cyren^{tm1.1(KOMP)Vlcg}/Cyren^{tm1.1(KOMP)Vlcg} (involves: C57BL/6NTac)	abnormal class switch recombination	J:265834
Cyrib^m1Ivdi/Cyrib^m1Ivdi (involves: 129S1/Sv * 129X1/SvJ * DBA/2J)	abnormal spleen morphology	J:282597
	abnormal spleen white pulp morphology	J:282597
	increased neutrophil cell number	J:282597
Cyrib^{tm1c(KOMP)Wtsi}/Cyrib^{tm1d(KOMP)Wtsi} Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S4/SvJaeSor * BcA17/Skmn * C57BL/6N)	abnormal neutrophil physiology	J:282597
Cys1^cpk/Cys1^cpk (B6(Cg)-Cys1^cpk/J)	decreased hematocrit	J:9290
Cys1^cpk/Cys1^cpk (involves: C57BL/6J * CD-1)	spleen hypoplasia	J:33739
Cys1^cpk/Cys1^cpk (involves: C57BL/6J * CD-1)	thymus hypoplasia	J:33739
Cystm1^{tm1b(EUCOMM)Hmgu}/Cystm1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Cystm1^{tm1b(EUCOMM)Hmgu}/Ieg)	increased leukocyte cell number	J:211773
	increased mean corpuscular volume	J:211773
Cyth2^{tm1d(EUCOMM)Wtsi}/Cyth2^{tm1d(EUCOMM)Wtsi} (involves: C57BL/6N)	decreased eosinophil cell number	J:307633
Cytip^tm1Tes/Cytip^tm1Tes (involves: 129S1/Sv * FVB/N)	abnormal CD8-positive, alpha-beta cytotoxic T cell morphology	J:110320
	abnormal cellular extravasation	J:110320
	abnormal leukocyte migration	J:110320
	decreased leukocyte cell number	J:110320
	decreased lymphocyte cell number	J:110320
D5Ertd579e^em1(IMPC)J/D5Ertd579e^em1(IMPC)J (C57BL/6NJ-D5Ertd579e^em1(IMPC)J/Mmjax)	thrombocytopenia	J:211773
D6Wsu163e^{tm1b(EUCOMM)Wtsi}/D6Wsu163e^{tm1b(EUCOMM)Wtsi} (C57BL/6N-D6Wsu163e^{tm1b(EUCOMM)Wtsi}/Wtsi)	decreased CD4-positive, alpha-beta T cell number	J:211773
	decreased mean corpuscular hemoglobin	J:211773
	decreased memory-marker NK cell number	J:211773
	increased CD8-positive, alpha-beta T cell number	J:211773
	increased CD8-positive, naive alpha-beta T cell number	J:211773
	increased erythrocyte cell number	J:211773
	thrombocytopenia	J:211773
D16Ertd472e^{tm1b(EUCOMM)Wtsi}/D16Ertd472e^{tm1b(EUCOMM)Wtsi} (C57BL/6N-D16Ertd472e^{tm1b(EUCOMM)Wtsi}/Orl)	decreased mean corpuscular volume	J:211773
D130043K22Rik^{tm1b(KOMP)Wtsi}/D130043K22Rik^{tm1b(KOMP)Wtsi} (C57BL/6N-D130043K22Rik^{tm1b(KOMP)Wtsi}/Ucd)	increased mean corpuscular volume	J:211773
Daam2^{tm1b(KOMP)Wtsi}/Daam2^{tm1b(KOMP)Wtsi} (C57BL/6N-Daam2^{tm1b(KOMP)Wtsi}/Wtsi)	increased hemoglobin content	J:211773
	increased large unstained cell number	J:211773
Dab1^scm-4J/Dab1^scm-4J (CBA/J-Dab1^scm-4J/GrsrJ)	thymus atrophy	J:153275
Dach2^{em1(IMPC)Ccpcz}/Dach2^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Dach2^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased eosinophil cell number	J:211773
	small spleen	J:211773
Dact2^{tm1b(EUCOMM)Wtsi}/Dact2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Dact2^{tm1b(EUCOMM)Wtsi}/Bay)	abnormal spleen morphology	J:211773
	increased mean corpuscular volume	J:211773
Dad1^tm1Kni/Dad1⁺ (involves: 129S/SvEv)	decreased thymus weight	J:99897
Dagla^{tm1a(EUCOMM)Wtsi}/Dagla^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Dagla^{tm1a(EUCOMM)Wtsi}/Nju)	small spleen	J:211773
	small thymus	J:211773
Dap3^{Gt(OST147863)Lex}/Dap3^{Gt(OST147863)Lex} (involves: 129S5/SvEvBrd * C57BL/6)	anemia	J:129756
Dapp1^{Gt(OST111213)Lex}/Dapp1^{Gt(OST111213)Lex} (B6.Cg-Dapp1^{Gt(OST111213)Lex})	decreased B cell proliferation	J:110009
	decreased IgG3 level	J:110009
Dapp1^tm1Mnz/Dapp1^tm1Mnz (B6.129P2-Dapp1^tm1Mnz)	abnormal B cell activation	J:86182
	decreased B cell proliferation	J:86182
	decreased B-1a cell number	J:86182
	decreased IgG3 level	J:86182
	decreased IgM level	J:86182
Daw1^b2b1116Clo/Daw1^b2b1116Clo (C57BL/6J-Daw1^b2b1116Clo)	spleen hypoplasia	J:175213
Daw1^b2b1584Clo/Daw1^b2b1584Clo (C57BL/6J-Daw1^b2b1584Clo)	absent spleen	J:175213
Dazap1^{em1(IMPC)Ccpcz}/Dazap1⁺ (C57BL/6NCrl-Dazap1^{em1(IMPC)Ccpcz}/Ccpcz)	increased eosinophil cell number	J:211773
Dbn1^{tm1a(KOMP)Wtsi}/Dbn1⁺ (C57BL/6N-Dbn1^{tm1a(KOMP)Wtsi}/Wtsi)	increased leukocyte cell number	J:211773
Dbn1^{tm1a(KOMP)Wtsi}/Dbn1^{tm1a(KOMP)Wtsi} (C57BL/6N-Dbn1^{tm1a(KOMP)Wtsi}/Wtsi)	decreased mean corpuscular volume	J:175295
Dbn1^{tm1b(KOMP)Wtsi}/Dbn1⁺ (C57BL/6N-Dbn1^{tm1b(KOMP)Wtsi}/Wtsi)	increased CD8-positive, alpha-beta T cell number	J:211773
Dbn1^{tm1b(KOMP)Wtsi}/Dbn1⁺ (C57BL/6N-Dbn1^{tm1b(KOMP)Wtsi}/Ieg)	decreased mean platelet volume	J:211773
	increased red blood cell distribution width	J:211773
Dbndd2^{tm1b(EUCOMM)Wtsi}/Dbndd2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Dbndd2^{tm1b(EUCOMM)Wtsi}/Tcp)	thrombocytosis	J:211773
Dbnl^{Gt(betageo)11Byg}/Dbnl^{Gt(betageo)11Byg} (involves: 129P2/OlaHsd * C57BL/6)	abnormal T cell activation	J:119847
	abnormal T cell physiology	J:119847
	decreased IgG1 level	J:119847
	decreased IgM level	J:119847
	decreased immunoglobulin level	J:119847
	decreased T cell proliferation	J:119847
Dbnl^{tm1b(KOMP)Wtsi}/Dbnl^{tm1b(KOMP)Wtsi} (C57BL/6N-Dbnl^{tm1b(KOMP)Wtsi}/Orl)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
Dbnl^tm1Jwnd/Dbnl⁺ (involves: BALB/c)	increased spleen weight	J:109363
Dbnl^tm1Jwnd/Dbnl^tm1Jwnd (involves: BALB/c)	increased spleen weight	J:109363
Dbr1^{Gt(YTA280)Byg}/Dbr1⁺ (involves: 129P2/OlaHsd)	abnormal class switch recombination	J:223318
Dcaf8^{em1(IMPC)Ccpcz}/Dcaf8^{em1(IMPC)Ccpcz} (C57BL/6N-Dcaf8^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Dcaf10^{tm1.1(KOMP)Vlcg}/Dcaf10^{tm1.1(KOMP)Vlcg} (C57BL/6N-Dcaf10^{tm1.1(KOMP)Vlcg}/J)	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
Dcaf11^{tm1a(KOMP)Wtsi}/Dcaf11^{tm1a(KOMP)Wtsi} (C57BL/6N-Dcaf11^{tm1a(KOMP)Wtsi}/Wtsi)	decreased erythrocyte cell number	J:211773
Dcaf12^{em1(IMPC)Ccpcz}/Dcaf12^{em1(IMPC)Ccpcz} (C57BL/6N-Dcaf12^{em1(IMPC)Ccpcz}/Ccpcz)	decreased CD8-positive, naive alpha-beta T cell number	J:211773
	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Dcc^{Tg(H2-Kb-Jak2V617F)1Shmd}/Dcc⁺ (involves: C57BL/6 DBA/2)	abnormal definitive hematopoiesis	J:130189
	abnormal megakaryocyte morphology	J:130189
	abnormal neutrophil morphology	J:130189
	abnormal spleen morphology	J:130189
	decreased erythroid progenitor cell number	J:130189
	decreased hematocrit	J:130189
	decreased spleen white pulp amount	J:130189
	enhanced megakaryocyte emperipolesis	J:130189
	enlarged spleen	J:130189
	increased bone marrow cell number	J:130189
	increased erythroblast number	J:130189
	increased granulocyte number	J:130189
	increased leukocyte cell number	J:130189
	increased megakaryocyte cell number	J:130189
	increased spleen red pulp amount	J:130189
	increased spleen weight	J:130189
	myeloid hyperplasia	J:130189
	polycythemia	J:130189
	thrombocytosis	J:130189
Dcc^{tm1b(NCOM)Mfgc}/Dcc⁺ (C57BL/6N-Dcc^{tm1b(NCOM)Mfgc}/Tcp)	increased neutrophil cell number	J:211773
Dcdc2b^{tm1b(KOMP)Wtsi}/Dcdc2b^{tm1b(KOMP)Wtsi} (C57BL/6N-Dcdc2b^{tm1b(KOMP)Wtsi}/Wtsi)	increased erythrocyte cell number	J:211773
	increased hematocrit	J:211773
Dck^m1Btlr/Dck⁺ (C57BL/6J-Dck^m1Btlr)	decreased B cell number	J:236696
Dck^m1Btlr/Dck⁺ (C57BL/6J-Dck^m1Btlr)	impaired hematopoiesis	J:236696
Dck^m1Btlr/Dck^m1Btlr (C57BL/6J-Dck^m1Btlr)	decreased B cell number	J:236696
	decreased CD4-positive, alpha-beta T cell number	J:236696
	decreased IgG level	J:236696
	impaired hematopoiesis	J:236696
	increased CD8-positive, alpha-beta T cell number	J:236696
	increased IgE level	J:236696
	increased macrophage cell number	J:236696
Dck^memi/Dck^memi (C57BL/6J-Dck^memi)	abnormal myeloid leukocyte morphology	J:184080
	abnormal T cell differentiation	J:184080
	decreased B cell number	J:184080
	decreased CD4-positive, alpha-beta T cell number	J:184080
	enlarged spleen	J:184080
	increased effector memory CD4-positive, alpha-beta T cell number	J:184080
	increased effector memory CD8-positive, alpha-beta T cell number	J:184080
	increased erythroid progenitor cell number	J:184080
	increased T cell apoptosis	J:184080
	increased T cell proliferation	J:184080
	small thymus	J:184080
	thymus hypoplasia	J:184080
Dck^tm1.1Radu/Dck^tm1.1Radu (involves: 129S4/SvJae * BALB/cJ * C57BL/6 * C57BL/6J)	abnormal double-negative T cell morphology	J:158373
	abnormal spleen morphology	J:158373
	abnormal T cell differentiation	J:158373
	abnormal thymus morphology	J:158373
	absent spleen white pulp	J:158373
	decreased B cell number	J:158373
	decreased double-positive T cell number	J:158373
	decreased pre-B cell number	J:158373
	decreased T cell number	J:158373
	extramedullary hematopoiesis	J:158373
	increased double-negative T cell number	J:158373
	increased pro-B cell number	J:158373
	increased spleen weight	J:158373
	reticulocytosis	J:158373
	thymus hypoplasia	J:158373
Dclre1c^m1Brck/Dclre1c^m1Brck (involves: C3H * C57BL/6)	absent B cells	J:207533
Dclre1c^m1Brck/Dclre1c^m1Brck (involves: C3H * C57BL/6)	absent T cells	J:207533
Dclre1c^m1Brck/Dclre1c^m1Brck (involves: C57BL/6)	absent B cells	J:207533
	absent CD4-positive, alpha-beta T cells	J:207533
	absent CD8-positive, alpha-beta T cells	J:207533
	decreased DN1 thymic pro-T cell number	J:207533
	decreased DN4 thymocyte number	J:207533
	decreased double-positive T cell number	J:207533
	decreased pre-B cell number	J:207533
Dclre1c^m1Btlr/Dclre1c^m1Btlr (C57BL/6J-Dclre1c^m1Btlr)	decreased B cell number	J:217790
	decreased IgM level	J:217790
	decreased single-positive T cell number	J:217790
	decreased T cell number	J:217790
	increased macrophage cell number	J:217790
	increased neutrophil cell number	J:217790
	increased NK cell number	J:217790
Dclre1c^M2Btlr/Dclre1c^M2Btlr (C57BL/6J-Dclre1c^M2Btlr)	decreased CD4-positive, alpha-beta T cell number	J:265131
	decreased CD8-positive, naive alpha-beta T cell number	J:265131
	decreased single-positive T cell number	J:265131
	decreased T cell number	J:265131
	increased central memory CD8 positive, alpha-beta T cell number	J:265131
	increased effector memory CD4-positive, alpha-beta T cell number	J:265131
	increased effector memory CD8-positive, alpha-beta T cell number	J:265131
Dclre1c^m3Btlr/Dclre1c^m3Btlr (C57BL/6J-Dclre1c^m3Btlr)	decreased B cell number	J:265132
	decreased B-1 B cell number	J:265132
	decreased CD4-positive, alpha-beta T cell number	J:265132
	decreased CD8-positive, alpha-beta T cell number	J:265132
	decreased CD8-positive, naive alpha-beta T cell number	J:265132
	decreased NK T cell number	J:265132
	decreased single-positive T cell number	J:265132
	decreased T cell number	J:265132
	increased central memory CD4-positive, alpha-beta T cell number	J:265132
	increased effector memory CD4-positive, alpha-beta T cell number	J:265132
	increased effector memory CD8-positive, alpha-beta T cell number	J:265132
Dclre1c^tm1.1Fwa/Dclre1c^tm1.1Fwa (involves: 129S6/SvEvTac * C57BL/6)	arrested B cell differentiation	J:80995
	arrested T cell differentiation	J:80995
Dclre1c^tm1.1Jpdv/Dclre1c^tm1.1Jpdv (involves: 129P1/ReJ)	abnormal B cell differentiation	J:137743
	abnormal T cell receptor V(D)J recombination	J:194422
	arrested T cell differentiation	J:137712
Dclre1c^tm1Fwa/Dclre1c^tm1Fwa (involves: 129S6/SvEvTac * C57BL/6)	absent immature B cells	J:80995
	arrested B cell differentiation	J:80995
	arrested T cell differentiation	J:80995
	decreased thymocyte number	J:80995
Dclre1c^tm1Fwa/Dclre1c^tm1Fwa (involves: 129S6/SvEvTac)	abnormal T cell receptor beta chain V(D)J recombination	J:147864
	absent B cells	J:147864
	arrested B cell differentiation	J:147864
	decreased CD4-positive, alpha-beta T cell number	J:147864
	decreased CD8-positive, alpha-beta T cell number	J:147864
	decreased double-positive T cell number	J:147864
	decreased thymocyte number	J:147864
	spleen hypoplasia	J:147864
Dclre1c^tm1Jsek/Dclre1c^tm1Jsek (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal immunoglobulin heavy chain V(D)J recombination	J:147864
	abnormal T cell receptor beta chain V(D)J recombination	J:147864
	decreased B cell number	J:147864
	decreased CD4-positive, alpha-beta T cell number	J:147864
	decreased CD8-positive, alpha-beta T cell number	J:147864
	decreased double-positive T cell number	J:147864
	decreased pre-B cell number	J:147864
	decreased thymocyte number	J:147864
	increased pro-B cell number	J:147864
	spleen hypoplasia	J:147864
Dclre1c^tm2.1Jpdv/Dclre1c^tm2.2Jpdv Tg(Cr2-cre)3Cgn/0 (involves: 129S2/SvPas * C57BL/6)	abnormal class switch recombination	J:153841
Dclre1c^tm2.2Jpdv/Dclre1c^tm2.2Jpdv (B6.129S2-Dclre1c^tm2.2Jpdv)	abnormal mononuclear cell morphology	J:153841
	absent immature B cells	J:153841
	arrested B cell differentiation	J:153841
	arrested T cell differentiation	J:153841
	decreased CD4-positive, alpha-beta T cell number	J:153841
	decreased CD8-positive, alpha-beta T cell number	J:153841
	decreased double-positive T cell number	J:153841
	decreased mature B cell number	J:153841
	decreased splenocyte number	J:153841
	decreased thymocyte number	J:153841
Dclre1c^tm2Mcow/Dclre1c^tm2Mcow (involves: 129/Sv * C57BL/6)	abnormal leukocyte physiology	J:96535
	abnormal spleen B cell follicle morphology	J:96535
	absent thymus cortex	J:96535
	arrested B cell differentiation	J:96535
	arrested T cell differentiation	J:96535
	decreased B cell proliferation	J:96535
	decreased lymphocyte cell number	J:96535
	decreased T cell proliferation	J:96535
	decreased thymocyte number	J:96535
	decreased thymus weight	J:96535
	small spleen	J:96535
Dcn^tm1Ioz/Dcn^tm1Ioz (involves: 129S1/Sv * 129X1/SvJ * Black Swiss)	hematopoietic system phenotype	J:39212
Dcn^tm1Ioz/Dcn^tm1Ioz Trp53^tm1Brd/Trp53^tm1Brd (involves: 129/Sv * Black Swiss * C57BL/6)	enlarged thymus	J:53511
	thymus hyperplasia	J:53511
Dcstamp^tm1Suda/Dcstamp^tm1Suda (Not Specified)	abnormal macrophage physiology	J:100555
	abnormal osteoclast differentiation	J:100555
	abnormal osteoclast physiology	J:100555
Dctn1^tm2.1Cai/Dctn1^tm2.1Cai Tg(Thy1-cre)1Vln/? (involves: 129S4/SvJaeSor * 129X1/SvJ * C57BL/6 * FVB/N)	microgliosis	J:264431
Dctn5^{tm2a(KOMP)Wtsi}/Dctn5⁺ (B6JTyr;B6N-Dctn5^{tm2a(KOMP)Wtsi}/Wtsi)	decreased hematocrit	J:175295
	increased hematocrit	J:175295
Dcun1d1^{Gt(RRR261)Byg}/Dcun1d1^{Gt(RRR261)Byg} (involves: 129P2/OlaHsd)	spleen hypoplasia	J:262901
Dcun1d3^{em1(IMPC)Wtsi}/Dcun1d3^{em1(IMPC)Wtsi} (C57BL/6N-Dcun1d3^{em1(IMPC)Wtsi}/WtsiIeg)	increased red blood cell distribution width	J:211773
	thrombocytopenia	J:211773
Ddah1^{tm2a(EUCOMM)Wtsi}/Ddah1^{tm2a(EUCOMM)Wtsi} (C57BL/6N-Ddah1^{tm2a(EUCOMM)Wtsi}/Wtsi)	decreased erythrocyte cell number	J:211773
Ddb1^{em1(IMPC)Ccpcz}/Ddb1⁺ (C57BL/6N-Ddb1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Ddias^tm1Enik/Ddias^tm1Enik (Not Specified)	abnormal hematopoietic system morphology/development	J:123623
Ddit3^tm1Dron/Ddit3^tm1Dron (B6.129-Ddit3^tm1Dron)	abnormal macrophage activation involved in immune response	J:153833
Ddit3^tm1Dron/Ddit3^tm1Dron (B6.129-Ddit3^tm1Dron)	decreased macrophage apoptosis	J:153833
Ddit3^tm2.1Dron/Ddit3^tm2.1Dron (B6.129S(Cg)-Ddit3^tm2.1Dron/J)	abnormal T cell morphology	J:214136
Ddost^{tm1.1(KOMP)Vlcg}/Ddost⁺ (C57BL/6N-Ddost^{tm1.1(KOMP)Vlcg}/Ucd)	decreased hemoglobin content	J:211773
	small spleen	J:211773
Ddr1^tm1Wfv/Ddr1^tm1Wfv Ldlr^tm1Her/Ldlr^tm1Her (involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/SvJ)	decreased macrophage cell number	J:149015
Ddrgk1^em1Brle/Ddrgk1^em1Brle (C57BL/6J-Ddrgk1^em1Brle)	decreased erythrocyte cell number	J:243374
Ddrgk1^{tm1b(EUCOMM)Hmgu}/Ddrgk1^{tm1b(EUCOMM)Hmgu} (involves: C57BL/6N)	abnormal embryonic erythrocyte morphology	J:231701
	abnormal embryonic erythropoiesis	J:231701
	decreased common myeloid progenitor cell number	J:231701
	decreased erythrocyte cell number	J:231701
	decreased erythroid progenitor cell number	J:231701
Ddrgk1^{tm1c(EUCOMM)Hmgu}/Ddrgk1^{tm1c(EUCOMM)Hmgu} Gt(ROSA)26Sor^{tm1(cre/ERT2)Tyj}/Gt(ROSA)26Sor⁺ (involves: 129S4/SvJae * C3H * C57BL/6 * C57BL/6N)	abnormal embryonic erythropoiesis	J:231701
	abnormal hematopoietic stem cell physiology	J:231701
	decreased erythrocyte cell number	J:231701
	decreased granulocyte number	J:231701
	decreased hemoglobin content	J:231701
	decreased lymphocyte cell number	J:231701
	decreased monocyte cell number	J:231701
	pancytopenia	J:231701
Ddx6^em1(IMPC)Mbp/Ddx6⁺ (C57BL/6N-Ddx6^em1(IMPC)Mbp/Ucd)	increased mean corpuscular hemoglobin	J:211773
Ddx6^em1(IMPC)Mbp/Ddx6⁺ (C57BL/6N-Ddx6^em1(IMPC)Mbp/Ucd)	increased mean corpuscular volume	J:211773
Ddx23^{em1(IMPC)Wtsi}/Ddx23⁺ (C57BL/6N-Ddx23^{em1(IMPC)Wtsi}/Wtsi)	increased leukocyte cell number	J:211773
Ddx41^tm1.1Arte/Ddx41^tm1.1Arte Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6N)	hematopoietic system phenotype	J:265023
Ddx41^tm1.1Arte/Ddx41^tm1.1Arte Tg(Itgax-cre)1-1Reiz/0 (involves: C57BL/6 * C57BL/6N * CBA)	hematopoietic system phenotype	J:265023
Ddx46^em1(IMPC)Tcp/Ddx46⁺ (C57BL/6N-Ddx46^em1(IMPC)Tcp/Tcp)	decreased mean corpuscular hemoglobin	J:211773
Ddx46^em1Caox/Ddx46⁺ (involves: C57BL/6J)	abnormal macrophage physiology	J:271836
Ddx46^em1Caox/Ddx46⁺ (involves: C57BL/6J)	increased macrophage cytokine production	J:271836
Ddx52^{tm1a(EUCOMM)Wtsi}/Ddx52⁺ (C57BL/6N-Ddx52^{tm1a(EUCOMM)Wtsi}/Ics)	decreased NK cell number	J:165965
Ddx55^{tm1a(EUCOMM)Wtsi}/Ddx55⁺ (C57BL/6N-Ddx55^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased red blood cell distribution width	J:211773
Dedd^tm1Tmiy/Dedd^tm1Tmiy (B6.Cg-Dedd^tm1Tmiy)	decreased spleen weight	J:119734
Def6^{Gt(OST307148)Lex}/Def6^{Gt(OST307148)Lex} (involves: 129S5/SvEvBrd * C57BL/6)	abnormal spleen germinal center morphology	J:106469
	decreased T cell apoptosis	J:106469
	enlarged spleen	J:106469
	increased IgG level	J:106469
	increased immature B cell number	J:106469
	increased immunoglobulin level	J:106469
	increased memory T cell number	J:106469
	increased T cell number	J:106469
Defb3^tm1Xen/Defb3^tm1Xen (involves: C57BL/6)	increased neutrophil cell number	J:199719
Defb14^{tm1b(KOMP)Wtsi}/Defb14^{tm1b(KOMP)Wtsi} (C57BL/6N-Defb14^{tm1b(KOMP)Wtsi}/Wtsi)	increased mean platelet volume	J:211773
Degs1^{Gt(OST368559)Lex}/Degs1^{Gt(OST368559)Lex} (involves: 129S5/SvEvBrd)	abnormal hematopoietic system morphology/development	J:203554
Del(1)1Brk/Steap3^tm1.1Mdf (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6J * CBA/J)	abnormal erythrocyte morphology	J:103440
	abnormal reticulocyte morphology	J:103440
	anisopoikilocytosis	J:103440
	decreased hematocrit	J:103440
	decreased hemoglobin content	J:103440
	decreased mean corpuscular hemoglobin	J:103440
	decreased mean corpuscular hemoglobin concentration	J:103440
	decreased mean corpuscular volume	J:103440
	increased erythrocyte cell number	J:103440
	reticulocytosis	J:103440
	thrombocytosis	J:103440
Del(1)1Brk/Del(1)1Brk (CBA/J-Del(1)1Brk)	anemia	J:100202
Del(1)1Brk/Del(1)1Brk (B6.CBA-Del(1)1Brk)	anemia	J:100202
Del(1)1Brk/Del(1)1Brk (involves: 129S6/SvEvTac * C57BL/6J * CBA/J)	abnormal erythrocyte morphology	J:100202
	abnormal spleen morphology	J:100202
	abnormal spleen white pulp morphology	J:100202
	anisocytosis	J:100202
	anisopoikilocytosis	J:100202
	decreased hematocrit	J:100202
	decreased hemoglobin content	J:100202
	decreased mean corpuscular hemoglobin	J:100202
	decreased mean corpuscular hemoglobin concentration	J:100202
	decreased mean corpuscular volume	J:100202
	enlarged spleen	J:100202
	increased bone marrow cell number	J:100202
	increased leukocyte cell number	J:100202
	increased spleen red pulp amount	J:100202
	microcytic anemia	J:100202
	microcytosis	J:100202
	polychromatophilia	J:100202
	reticulocytosis	J:100202
	thrombocytosis	J:100202
Del(1)1Brk/Del(1)1Brk (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6J * CBA/J)	abnormal erythrocyte morphology	J:103440
	abnormal hemoglobin	J:103440
	abnormal reticulocyte morphology	J:103440
	anisopoikilocytosis	J:103440
	decreased hematocrit	J:103440
	decreased hemoglobin content	J:103440
	decreased mean corpuscular hemoglobin	J:103440
	decreased mean corpuscular hemoglobin concentration	J:103440
	decreased mean corpuscular volume	J:103440
	increased erythrocyte cell number	J:103440
	reticulocytosis	J:103440
	thrombocytosis	J:103440
Del(1Aim2-Ifi205)1Stsn/Del(1Aim2-Ifi205)1Stsn (B6(129S4)-Del(1Aim2-Ifi205)1Stsn)	decreased macrophage apoptosis	J:234263
Del(2Cd59b-Cd59a)1Jha/Del(2Cd59b-Cd59a)1Jha (B6.129-Del(2Cd59b-Cd59a)1Jha)	decreased hemoglobin content	J:170754
	hemolysis	J:170754
	hemolytic anemia	J:170754
	reticulocytosis	J:170754
Del(2Duoxa2-Duoxa1)1Sref/Del(2Duoxa2-Duoxa1)1Sref (involves: 129S6/SvEvTac * C57BL/6J)	decreased spleen weight	J:205165
Del(3Cd1d2-Cd1d1)1Crw/Del(3Cd1d2-Cd1d1)1Crw (involves: 129S4/SvJae * C57BL/6)	abnormal NK T cell physiology	J:112657
	decreased CD4-positive, alpha-beta T cell number	J:174337
	decreased NK T cell number	J:112657, J:174337, J:39749, J:76976
Del(3Cd1d2-Cd1d1)1Crw/Del(3Cd1d2-Cd1d1)1Crw Tcra^Ln1Ogu/Tcra⁺ (involves: 129/Sv * C57BL/6)	abnormal NK T cell morphology	J:152041
Del(3Cd1d2-Cd1d1)1Crw/Del(3Cd1d2-Cd1d1)1Crw Tg(TcraAV19AJ33)1Shima/0 (involves: 129S4/SvJae * C57BL/6)	abnormal NK T cell morphology	J:112657
Del(3Cd1d2-Cd1d1)1Sbp/Del(3Cd1d2-Cd1d1)1Sbp (involves: 129S6/SvEvTac)	decreased NK T cell number	J:151699
Del(4C4-C5)1Lap/+ (involves: 129S6/SvEvTac)	enlarged spleen	J:158126
Del(4C4-C5)1Lap/Del(4C4-C5)1Lap (involves: 129S6/SvEvTac)	enlarged spleen	J:158126
Del(4C4-C5)1Lap/Del(4C4-C5)1Lap (involves: 129S6/SvEvTac)	extramedullary hematopoiesis	J:158126
Del(4D4Mit190-D4Mit51)2Aam/+ (involves: 129S7/SvEvBrd)	spleen hyperplasia	J:121726
Del(6Gimap5-Gimap3)1Yout/Del(6Gimap5-Gimap3)1Yout (involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)	abnormal T cell physiology	J:209926
	decreased B cell number	J:209926
	decreased NK cell number	J:209926
	decreased T cell number	J:209926
Del(6Snca)1Slab/Del(6Snca)1Slab Tg(Th-SNCA)1Mgsp/0 (involves: C57BL/6J C57BL/6JOlaHsd * CBA/Ca)	abnormal microglial cell morphology	J:108310
Del(7)Tyr^c-3H/Del(7)Tyr^c-3H (involves: 101/H * C3H/HeH)	abnormal thymus morphology	J:5063
Del(7Mrgpra2a-Mrgpra2b)1Xzd/Del(7Mrgpra2a-Mrgpra2b)1Xzd (C57BL/6J-Del(7Mrgpra2a-Mrgpra2b)1Xzd)	abnormal neutrophil physiology	J:332494
Del(9Apoa1-Apoa4)1Hmez/Del(9Apoa1-Apoa4)1Hmez (involves: 129P2/OlaHsd * C57BL/6)	increased macrophage derived foam cell number	J:109005
Del(9Casp1-Casp4)1Bhk/Del(9Casp1-Casp4)1Bhk (129-Del(9Casp1-Casp4)1Bhk)	abnormal macrophage physiology	J:189777
Del(9Cd3g-Cd3d)1Cpt/Del(9Cd3g-Cd3d)1Cpt (involves: 129S4/SvJae * C57BL/6)	absent gamma-delta T cells	J:76991
	arrested T cell differentiation	J:76991
	decreased alpha-beta T cell number	J:76991
	thymus hypoplasia	J:76991
Del(10Prmt2-Col6a1)1Yah/+ (involves: 129P2/OlaHsd * C57BL/6 * SJL)	abnormal macrophage physiology	J:167506
	decreased hematocrit	J:167506
	increased red blood cell distribution width	J:167506
Del(10Prtn3-Elane)1Deje/Del(10Prtn3-Elane)1Deje (involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ)	abnormal neutrophil physiology	J:137674
	impaired neutrophil recruitment	J:137674
Del(11Cxcl16-Zmynd15)1Ifc/Del(11Cxcl16-Zmynd15)1Ifc (B6.129S-Ldlr^tm1Her Del(11Cxcl16-Zmynd15)1Ifc)	abnormal macrophage physiology	J:123851
Del(11Hoxb3-Hoxb4)1Karl/Del(11Hoxb3-Hoxb4)1Karl (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal common myeloid progenitor cell morphology	J:83563
	abnormal definitive hematopoiesis	J:83563
	abnormal hematopoietic stem cell morphology	J:83563
	abnormal spleen morphology	J:83563
	decreased bone marrow cell number	J:83563
	decreased erythrocyte cell number	J:83563
	decreased hemoglobin content	J:83563
	decreased spleen weight	J:83563
	spleen hypoplasia	J:83563
Del(11Hoxb3-Hoxb4)1Karl/Del(11Hoxb3-Hoxb4)1Karl Hoxa9^tm1Mrc/Hoxa9^tm1Mrc (involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/SvJ * C57BL/6)	abnormal common myeloid progenitor cell morphology	J:126371
	decreased bone marrow cell number	J:126371
	decreased spleen weight	J:126371
	increased hematopoietic stem cell number	J:126371
	spleen hypoplasia	J:126371
Del(11Jmjd6-Mettl23)1Ysfk/Del(11Jmjd6-Mettl23)1Ysfk (involves: C57BL/6)	abnormal erythropoiesis	J:90288
	abnormal thymus development	J:90288
	decreased hematocrit	J:90288
	decreased hemoglobin content	J:90288
	impaired macrophage chemotaxis	J:90288
	impaired macrophage phagocytosis	J:90288
	increased nucleated erythrocyte cell number	J:90288
	thymus hypoplasia	J:90288
Del(11Nlrp1a-Nlrp1c-ps)1Smas/Del(11Nlrp1a-Nlrp1c-ps)1Smas (Not Specified)	decreased erythrocyte cell number	J:191055
	decreased neutrophil cell number	J:191055
	increased hematocrit	J:191055
Del(11Nme2-Nme1)1Zou/Del(11Nme2-Nme1)1Zou (involves: 129 * C57BL/6)	anemia	J:146219
	anisocytosis	J:146219
	decreased erythrocyte cell number	J:146219
	decreased hematocrit	J:146219
	decreased hematopoietic stem cell number	J:146219
	decreased hemoglobin content	J:146219
	extramedullary hematopoiesis	J:146219
	hematopoietic system phenotype	J:146219
	increased nucleated erythrocyte cell number	J:146219
Del(11Nmur2-Sparc)2Anjm/+ Del(11Sparc-Gpx3)91Anjm/+ (involves: 129P2/OlaHsd * C57BL/6)	hematopoietic system phenotype	J:155870
Del(11Stat5a-Stat5b)1Mam/Del(11Stat5a-Stat5b)1Mam (involves: 129S6/SvEvTac * Black Swiss)	anemia	J:92770
Del(11Stat5a-Stat5b)1Mam/Del(11Stat5a-Stat5b)1Mam (involves: 129 * 129S6/SvEvTac * C57BL/6)	absent gamma-delta T cells	J:122463
	anemia	J:122463
	arrested B cell differentiation	J:122463
	decreased B cell number	J:122463
	decreased CD8-positive, alpha-beta T cell number	J:122463
	small spleen	J:122463
	small thymus	J:122463
Del(11Stat5a-Stat5b)1Mam/Del(11Stat5a-Stat5b)1Mam (involves: 129S6/SvEvTac * FVB/N)	decreased hematocrit	J:138904
	decreased mean corpuscular hemoglobin	J:138904
	hypochromic microcytic anemia	J:138904
Del(14Ltb4r2-Ltb4r1)1Bodd/Del(14Ltb4r2-Ltb4r1)1Bodd (involves: 129S4/SvJaeSor * C57BL/6)	impaired neutrophil chemotaxis	J:163271
Del(14Trim13-Dleu2)4Rdf/Del(14Trim13-Dleu2)4Rdf (involves: 129S1/Sv * 129S4/SvJaeSor * C57BL/6)	abnormal B cell proliferation	J:156946
	increased B cell number	J:156946
	increased B-1a cell number	J:156946
	increased spleen white pulp amount	J:156946
Del(14Trim13-Rnaseh2b)6Rdf/+ Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6)	abnormal lymphopoiesis	J:179879
	increased B cell number	J:179879
Del(15Rr316124-Rr313939)2Fsp/+ Myc^tm1Atp/Myc⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased B cell number	J:257739
	decreased bone marrow cell number	J:257739
	decreased granulocyte number	J:257739
	hematopoietic system phenotype	J:257739
	increased megakaryocyte cell number	J:257739
	increased myeloid cell number in bone marrow	J:257739
Del(15Rr316124-Rr313939)2Fsp/+ Rr331^em1Fsp/Rr331⁺ (involves: C57BL/6)	decreased B cell number	J:257739
	increased pre-B cell number	J:257739
Del(15Rr316124-Rr313939)2Fsp/+ Rr307328^em1Fsp/Rr307328⁺ (involves: C57BL/6)	decreased B cell number	J:257739
	increased pre-B cell number	J:257739
Del(15Rr316124-Rr313939)2Fsp/Del(15Rr316124-Rr313939)2Fsp (Not Specified)	decreased B cell number	J:257739
	decreased bone marrow cell number	J:257739
	decreased granulocyte number	J:257739
	hematopoietic system phenotype	J:257739
	increased megakaryocyte cell number	J:257739
	increased myeloid cell number in bone marrow	J:257739
Del(16Pi4ka-Hira)1Atai/+ (C57BL/6N-Del(16Pi4ka-Hira)1Atai)	thymus hypoplasia	J:285407
Del(17Abcg5-Abcg8)1Hobb/Del(17Abcg5-Abcg8)1Hobb (involves: 129S6/SvEvTac * C57BL/6)	increased mean platelet volume	J:157223
	thrombocytopenia	J:157223
Del(17Btnl1-Btnl6)1Ahay/Del(17Btnl1-Btnl6)1Ahay (involves: BALB/c * C57BL/6J)	decreased CD4-positive, gamma-delta intraepithelial T cell number	J:291989
Del(17Trem1-Trem3)1Jkt/Del(17Trem1-Trem3)1Jkt (involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)	impaired neutrophil chemotaxis	J:194295
Del(18Pcdhg)1Xzw/Del(18Pcdhg)1Xzw (Not Specified)	microgliosis	J:188341
Del(MTmt-Tk-mt-Nd5)1Jiha (involves: C57BL/6J * CBA * DBA/2)	anemia	J:65025
Dennd1a^em1Jgfu/Dennd1a^em1Jgfu (Not Specified)	abnormal embryonic hematopoiesis	J:276703
Dennd1b^tm1.2Achn/Dennd1b^tm1.2Achn (involves: C57BL/6)	abnormal T cell number	J:229307
Dennd1b^tm1.2Achn/Dennd1b^tm1.2Achn (involves: C57BL/6)	abnormal T-helper 2 physiology	J:229307
Dennd5b^em1(IMPC)Tcp/Dennd5b^em1(IMPC)Tcp (C57BL/6N-Dennd5b^em1(IMPC)Tcp/Tcp)	abnormal spleen morphology	J:211773
	decreased red blood cell distribution width	J:211773
	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
Dennd10^{em1(IMPC)Ccpcz}/Dennd10^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Dennd10^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Deup1^{tm1.1(KOMP)Vlcg}/Deup1^{tm1.1(KOMP)Vlcg} (C57BL/6N-Deup1^{tm1.1(KOMP)Vlcg}/MbpMmucd)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
Dffb^tm1Osa/Dffb^tm1Osa Dnase2a^tm1Osa/Dnase2a^tm1Osa (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal T cell differentiation	J:81474
	abnormal thymus morphology	J:81474
	anemia	J:81474
	decreased double-positive T cell number	J:81474
	increased double-negative T cell number	J:81474
	small thymus	J:81474
	thymus hypoplasia	J:81474
Dgcr2^{tm1b(EUCOMM)Wtsi}/Dgcr2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Dgcr2^{tm1b(EUCOMM)Wtsi}/Bay)	abnormal spleen morphology	J:211773
Dgka^tm1Xpz/Dgka^tm1Xpz (involves: 129 * C57BL/6)	increased T cell number	J:113564
Dgka^tm1Xpz/Dgka^tm1Xpz Dgkz^tm1Gak/Dgkz^tm1Gak (involves: 129 * 129X1/SvJ * C57BL/6)	abnormal T cell differentiation	J:113564
	abnormal thymocyte activation	J:113564
Dgkz^tm1Gak/Dgkz^tm1Gak (involves: 129X1/SvJ * C57BL/6)	abnormal macrophage physiology	J:293120
	abnormal T cell activation	J:85149
	abnormal T cell physiology	J:85149
	decreased CD4-positive, alpha-beta T cell number	J:85149
	decreased CD8-positive, alpha-beta T cell number	J:85149
	increased B cell number	J:85149
	increased T cell proliferation	J:85149
Dgkz^tm1Gak/Dgkz^tm1Gak (B6.129X1-Dgkz^tm1Gak)	increased T cell number	J:113564
Dh/Dh (Not Specified)	absent spleen	J:152370, J:112
Dh/Dh⁺ (Not Specified)	absent spleen	J:152370, J:112
	increased granulocyte number	J:30753
	increased lymphocyte cell number	J:30753
	thrombocytosis	J:30753
Dh/Dh⁺ (B6.CBA-Dh)	abnormal T cell differentiation	J:5834
	absent spleen	J:5834
	decreased immunoglobulin level	J:5834
Dh/Dh⁺ Foxn1^nu/Foxn1^nu (involves: N:NIH(S))	absent spleen	J:6062
	athymia	J:6062
	decreased leukocyte cell number	J:6062
	increased erythroid progenitor cell number	J:6062
	increased IgA level	J:6062
	thrombocytosis	J:6062
Dh/Dh⁺ H2^d/H2^d (NZB.Cg-Dh)	absent spleen	J:12036
	decreased B cell proliferation	J:12036
	decreased IgG1 level	J:12036
	decreased IgG level	J:12036
	decreased IgM level	J:12036
	increased T cell proliferation	J:12036
Dhcr7^em1(IMPC)Mbp/Dhcr7⁺ (C57BL/6N-Dhcr7^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Dhfr^orana/Dhfr⁺ (involves: C57BL/6JAnu)	abnormal hemopoiesis	J:236197
	decreased granulocyte monocyte progenitor cell number	J:236197
	enlarged spleen	J:236197
	extramedullary hematopoiesis	J:236197
Dhfr^orana/Dhfr^orana (involves: C57BL/6JAnu)	decreased common myeloid progenitor cell number	J:236197
	decreased erythrocyte cell number	J:236197
	decreased erythroid progenitor cell number	J:236197
	decreased granulocyte monocyte progenitor cell number	J:236197
	increased nucleated erythrocyte cell number	J:236197
Dhfr^{tm1b(EUCOMM)Wtsi}/Dhfr⁺ (C57BL/6N-Dhfr^{tm1b(EUCOMM)Wtsi}/Tcp)	decreased mean corpuscular hemoglobin	J:211773
Dhps^{tm2a(EUCOMM)Wtsi}/Dhps⁺ (C57BL/6N-Dhps^{tm2a(EUCOMM)Wtsi}/Wtsi)	increased hemoglobin content	J:211773
Dhps^{tm2c(EUCOMM)Wtsi}/Dhps^{tm2c(EUCOMM)Wtsi} Tg(CAG-cre/Esr1)5Amc/0 (involves: C57BL/6J C57BL/6N * CBA * SJL)	decreased bone marrow cell number	J:236582
	decreased spleen red pulp amount	J:236582
	spleen hypoplasia	J:236582
Dhrs4^tm1Lex/Dhrs4^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	decreased IgG2a level	J:171883
Dhrs7b^{Gt(OST255410)Lex}/Dhrs7b^{Gt(OST255410)Lex} (B6;129S5-Dhrs7b^{Gt(OST255410)Lex}/Mmucd)	thymus atrophy	J:171883
Dhx8^em1(IMPC)Mbp/Dhx8⁺ (C57BL/6N-Dhx8^em1(IMPC)Mbp/MbpMmucd)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Dhx9^{Tn(pb-Act-RFP)1.071225026-HRAZhu}/Dhx9⁺ Igs12^tm1Zhu/Igs12^tm1Zhu Ptprc^a/Ptprc^b Tg(Lck-cre)#Zhu/0 (involves: 129S6/SvEvTac * C57BL/6 * FVB/NJ * SJL/J)	abnormal T cell differentiation	J:207361
Dhx15^em1(IMPC)Tcp/Dhx15⁺ (C57BL/6NCrl-Dhx15^em1(IMPC)Tcp/Tcp)	decreased hematocrit	J:211773
	decreased mean corpuscular volume	J:211773
	increased erythrocyte cell number	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
Dhx15^{tm1c(EUCOMM)Wtsi}/Dhx15^{tm1c(EUCOMM)Wtsi} Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * C3H * C57BL/6N)	abnormal B cell differentiation	J:284624
	decreased B cell number	J:284624
	decreased B cell proliferation	J:284624
	decreased pre-B cell number	J:284624
	decreased spleen weight	J:284624
	spleen hypoplasia	J:284624
Dhx15^{tm1c(EUCOMM)Wtsi}/Dhx15^{tm1c(EUCOMM)Wtsi} Tg(Cd4-cre)1Cwi/0 (involves: C3H * C57BL/6N * DBA/2)	decreased CD4-positive, alpha-beta T cell number	J:284624
	decreased CD8-positive, alpha-beta T cell number	J:284624
Dhx36^tm1.2Pmt/Dhx36^tm1.2Pmt Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: 129P2/Ola * 129S4/SvJaeSor * C57BL/6 * C57BL/10 * CBA/Ca)	abnormal erythrocyte physiology	J:185179
	abnormal erythropoiesis	J:185179
	abnormal proerythroblast morphology	J:185179
	anemia	J:185179
	decreased erythroblast number	J:185179
	decreased erythrocyte cell number	J:185179
	decreased granulocyte monocyte progenitor cell number	J:185179
	decreased hemoglobin content	J:185179
	enlarged spleen	J:185179
	hemolytic anemia	J:185179
	increased erythroblast number	J:185179
	increased hematopoietic stem cell number	J:185179
	increased mean corpuscular volume	J:185179
	increased megakaryocyte-erythroid progenitor cell number	J:185179
	intermingled spleen red and white pulp	J:185179
	reticulocytosis	J:185179
	spherocytosis	J:185179
	thymus hypoplasia	J:185179
Dhx36^tm1.2Pmt/Dhx36^tm1.2Pmt Tg(Mx1-cre)1Cgn/0 (involves: 129P2/Ola * 129S4/SvJaeSor * C57BL/6 * CBA)	abnormal erythropoiesis	J:185179
	abnormal leukopoiesis	J:185179
Dhx38^em1(IMPC)J/Dhx38⁺ (C57BL/6NJ-Dhx38^em1(IMPC)J/Mmjax)	decreased erythrocyte cell number	J:211773
Dhx38^em1(IMPC)J/Dhx38⁺ (C57BL/6NJ-Dhx38^em1(IMPC)J/Mmjax)	decreased hematocrit	J:211773
Dhx40^{tm1b(KOMP)Wtsi}/Dhx40^{tm1b(KOMP)Wtsi} (C57BL/6N-Dhx40^{tm1b(KOMP)Wtsi}/Wtsi)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	increased spleen weight	J:211773
Dhx58^tm1Itl/Dhx58^tm1Itl (C57BL/6-Dhx58^tm1Itl)	increased T cell apoptosis	J:187386
Diaph1^M1Btlr/Diaph1⁺ (C57BL/6J-Diaph1^M1Btlr)	abnormal CD4-positive, alpha-beta T cell number	J:254820
	abnormal CD8-positive, alpha-beta T cell number	J:254820
	decreased IgE level	J:254820
	increased central memory CD4-positive, alpha-beta T cell number	J:254820
	increased central memory CD8 positive, alpha-beta T cell number	J:254820
Diaph1^M1Btlr/Diaph1^M1Btlr (C57BL/6J-Diaph1^M1Btlr)	abnormal CD4-positive, alpha-beta T cell number	J:254820
	abnormal CD8-positive, alpha-beta T cell number	J:254820
	decreased effector memory CD8-positive, alpha-beta T cell number	J:254820
	decreased IgE level	J:254820
	increased central memory CD4-positive, alpha-beta T cell number	J:254820
	increased central memory CD8 positive, alpha-beta T cell number	J:254820
Diaph1^M2Btlr/Diaph1⁺ (C57BL/6J-Diaph1^M2Btlr)	decreased B-1 B cell number	J:254819
Diaph1^M2Btlr/Diaph1^M2Btlr (C57BL/6J-Diaph1^M2Btlr)	decreased B-1 B cell number	J:254819
Diaph1^M2Btlr/Diaph1^M2Btlr (C57BL/6J-Diaph1^M2Btlr)	decreased CD8-positive, alpha-beta memory T cell number	J:254819
Diaph1^m3Btlr/Diaph1^m3Btlr (C57BL/6J-Diaph1^m3Btlr)	decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:254818
	decreased CD8-positive, naive alpha-beta T cell number	J:254818
	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:254818
	increased CD8-positive, alpha-beta memory T cell number	J:254818
	increased central memory CD4-positive, alpha-beta T cell number	J:254818
	increased central memory CD8 positive, alpha-beta T cell number	J:254818
	increased effector memory CD4-positive, alpha-beta T cell number	J:254818
	increased effector memory CD8-positive, alpha-beta T cell number	J:254818
Diaph1^tm1.1Sna/Diaph1^tm1.1Sna (B6.Cg-Diaph1^tm1.1Sna)	abnormal leukocyte migration	J:126090
	decreased CD4-positive, alpha-beta T cell number	J:126090
	decreased CD8-positive, alpha-beta T cell number	J:126090
	decreased T cell number	J:126090
	decreased T cell proliferation	J:126090
	increased single-positive T cell number	J:126090
Diaph1^tm1Asal/Diaph1⁺ (involves: 129S1/Sv * C57BL/6)	abnormal bone marrow cell morphology/development	J:124319
	abnormal definitive hematopoiesis	J:124319
	increased bone marrow cell number	J:124319
Diaph1^tm1Asal/Diaph1^tm1Asal (involves: 129S1/Sv * C57BL/6)	abnormal bone marrow cell morphology/development	J:124319
	abnormal definitive hematopoiesis	J:124319
	abnormal spleen germinal center morphology	J:124319
	abnormal spleen morphology	J:124319
	absent spleen white pulp	J:124319
	anemia	J:124319
	decreased lymphocyte cell number	J:124319
	echinocytosis	J:124319
	extramedullary hematopoiesis	J:124319
	increased bone marrow cell number	J:124319
	increased granulocyte number	J:124319
	increased leukocyte cell number	J:124319
	increased monocyte cell number	J:124319
	increased neutrophil cell number	J:124319
	increased spleen weight	J:124319
Diaph3^tm1.1Pji/Diaph3^tm1.1Pji Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6J * CBA/J)	abnormal erythropoiesis	J:293763
	anemia	J:293763
	anisopoikilocytosis	J:293763
	decreased erythrocyte cell number	J:293763
	decreased hematocrit	J:293763
	decreased hemoglobin content	J:293763
	enlarged spleen	J:293763
	extramedullary hematopoiesis	J:293763
	increased red blood cell distribution width	J:293763
	polychromatophilia	J:293763
Diaph3^tm1.1Sna/Diaph3^tm1.1Sna (B6NSlc.Cg-Diaph3^tm1.1Sna)	abnormal nucleated erythrocyte cell number	J:205519
	decreased erythroblast number	J:205519
	extramedullary hematopoiesis	J:205519
Diaph3^{tm1b(KOMP)Mbp}/Diaph3⁺ (C57BL/6N-Diaph3^{tm1b(KOMP)Mbp}/J)	decreased mean corpuscular volume	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
Dicer1^m1Btlr/Dicer1^m1Btlr (C57BL/6J-Dicer1^m1Btlr)	decreased CD4-positive, alpha-beta T cell number	J:265172
	decreased CD8-positive, alpha-beta T cell number	J:265172
	decreased CD8-positive, naive alpha-beta T cell number	J:265172
	decreased single-positive T cell number	J:265172
	decreased T cell number	J:265172
	increased B-1 B cell number	J:265172
	increased central memory CD8 positive, alpha-beta T cell number	J:265172
	increased effector memory CD4-positive, alpha-beta T cell number	J:265172
	increased effector memory CD8-positive, alpha-beta T cell number	J:265172
Dicer1^{tm1b(EUCOMM)Wtsi}/Dicer1⁺ (C57BL/6N-Dicer1^{tm1b(EUCOMM)Wtsi}/H)	absent spleen	J:211773
	decreased neutrophil cell number	J:211773
	decreased red blood cell distribution width	J:211773
Dicer1^tm1Bdh/Dicer1⁺ H2az2^{Tg(Wnt1-cre)11Rth}/H2az2⁺ (involves: 129 * C57BL/6 * CBA/J)	abnormal thymus development	J:166758
Dicer1^tm1Bdh/Dicer1^tm1Bdh Aicda^tm1(cre)Njen/Aicda⁺ (involves: 129 * C57BL/6)	abnormal germinal center B cell physiology	J:181782
	absent memory B cells	J:181782
	absent plasma cells	J:181782
	decreased germinal center B cell number	J:181782
	decreased immunoglobulin level	J:181782
Dicer1^tm1Bdh/Dicer1^tm1Bdh Foxp3^{tm4(YFP/icre)Ayr}/Y (involves: 129S1/Sv * 129X1/SvJ)	enlarged spleen	J:138683
Dicer1^tm1Bdh/Dicer1^tm1Bdh Foxp3^{tm4(YFP/icre)Ayr}/Foxp3^{tm4(YFP/icre)Ayr} (involves: 129S1/Sv * 129X1/SvJ)	enlarged spleen	J:138683
Dicer1^tm1Bdh/Dicer1^tm1Bdh H2az2^{Tg(Wnt1-cre)11Rth}/H2az2⁺ (involves: 129 * C57BL/6 * CBA/J)	athymia	J:166758
Dicer1^tm1Bdh/Dicer1^tm1Bdh Tg(Cd4-cre)1Cwi/0 (involves: 129 * C57BL/6 * DBA/2)	decreased regulatory T cell number	J:138683
Dicer1^tm1Bdh/Dicer1^tm1Bdh Tg(Foxp3-EGFP/icre)1aJbs/0 (involves: 129 * NOD/ShiLt)	abnormal CD4-positive, alpha-beta T cell physiology	J:138808
	abnormal effector T cell morphology	J:138808
	abnormal regulatory T cell morphology	J:138808
	abnormal regulatory T cell physiology	J:138808
	abnormal splenic cell ratio	J:138808
	decreased regulatory T cell number	J:138808
	enlarged spleen	J:138808
Dicer1^tm1Dli/Dicer1^tm1Dli Tg(Cd4-cre)1Cwi/? (involves: 129 * C57BL/6 * DBA/2)	abnormal cytotoxic T cell physiology	J:100546
	abnormal T-helper 1 physiology	J:100546
	abnormal T-helper 2 physiology	J:100546
	decreased T cell number	J:100546
	decreased T cell proliferation	J:100546
	increased T cell apoptosis	J:100546
Dicer1^tm1Mmk/Dicer1^tm1.1Mmk Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: BALB/c)	abnormal immunoglobulin V(D)J recombination	J:135783
	decreased B cell number	J:135783
Dicer1^tm1Mmk/Dicer1^tm1Mmk Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: BALB/c)	arrested B cell differentiation	J:135783
	decreased immature B cell number	J:135783
	decreased mature B cell number	J:135783
	decreased pre-B cell number	J:135783
	increased pro-B cell number	J:135783
Dicer1^tm1Mmk/Dicer1^tm1Mmk Tg(BGLAP-cre)1Clem/0 (involves: 129 * C57BL/6 * FVB/N)	hematopoietic system phenotype	J:158901
Dicer1^tm1Mmk/Dicer1^tm1Mmk Tg(IghelMD4)4Ccg/0 Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: BALB/c)	decreased B cell number	J:135783
	decreased mature B cell number	J:135783
Dicer1^tm1Mmk/Dicer1^tm1Mmk Tg(Lck-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	decreased T cell number	J:98192
	decreased thymocyte number	J:98192
	increased gamma-delta T cell number	J:98192
Dicer1^tm1Mmk/Dicer1^tm1Mmk Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0 (involves: 129 * C57BL/6 * CD-1)	abnormal granulocyte differentiation	J:158901
	abnormal megakaryocyte differentiation	J:158901
	abnormal megakaryocyte morphology	J:158901
	abnormal myeloid leukocyte morphology	J:158901
	abnormal neutrophil morphology	J:158901
	anemia	J:158901
	decreased B cell number	J:158901
	decreased leukocyte cell number	J:158901
	enlarged spleen	J:158901
	extramedullary hematopoiesis	J:158901
	giant platelets	J:158901
	hematopoietic system phenotype	J:158901
	impaired hematopoiesis	J:158901
	increased bone marrow cell number	J:158901
	thrombocytopenia	J:158901
Dicer1^tm1Tara/Dicer1^tm1Tara Foxn1^tm3(cre)Nrm/Foxn1⁺ (involves: 129P2/OlaHsd * C57BL/6NHsd)	abnormal positive T cell selection	J:180783
	abnormal thymus cortex morphology	J:180783
	abnormal thymus epithelium morphology	J:180783
	abnormal thymus involution	J:180783
	abnormal thymus medulla morphology	J:180783
	abnormal thymus morphology	J:180783
	abnormal thymus physiology	J:180783
	decreased CD4-positive, alpha-beta T cell number	J:180783
	decreased CD8-positive, alpha-beta T cell number	J:180783
Dido1^tm1Cmar/Dido1⁺ (involves: 129S1/Sv * 129X1/SvJ)	abnormal bone marrow cell morphology/development	J:101201
	abnormal splenic cell ratio	J:101201
	abnormal splenocyte morphology	J:101201
	increased granulocyte number	J:101201
	increased monocyte cell number	J:101201
	increased spleen weight	J:101201
	spleen hyperplasia	J:101201
Dido1^tm1Cmar/Dido1^tm1Cmar (involves: 129S1/Sv * 129X1/SvJ)	abnormal bone marrow cell morphology/development	J:101201
	abnormal erythropoiesis	J:101201
	abnormal proerythroblast morphology	J:101201
	abnormal splenic cell ratio	J:101201
	abnormal splenocyte morphology	J:101201
	anemia	J:101201
	hematopoietic system phenotype	J:101201
	increased erythrocyte cell number	J:101201
	increased granulocyte number	J:101201
	increased megakaryocyte cell number	J:101201
	increased monocyte cell number	J:101201
	increased spleen weight	J:101201
	increased spleen white pulp amount	J:101201
	spleen hyperplasia	J:101201
Dip2b^{tm1a(EUCOMM)Wtsi}/Dip2b⁺ (B6JTyr;B6N-Dip2b^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased leukocyte cell number	J:175295
Dip2c^em1(IMPC)Tcp/Dip2c⁺ (C57BL/6N-Dip2c^em1(IMPC)Tcp/Tcp)	increased monocyte cell number	J:211773
Dip2c^em1(IMPC)Tcp/Dip2c⁺ (C57BL/6N-Dip2c^em1(IMPC)Tcp/Tcp)	small thymus	J:211773
Dis3^tm1.1Uba/Dis3^tm1.1Uba Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac)	abnormal B cell morphology	J:302856
	abnormal class switch recombination	J:302856
Disc1^em1(IMPC)Mbp/Disc1^em1(IMPC)Mbp (C57BL/6N-Disc1^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
Disc1^{tm1(DISC1/DISC1FP1,DISC1FP1/DISC1,DISC1)Xzho}/Disc1^del (129S2/SvPasCrl-Disc1^del Disc1^{tm1(DISC1/DISC1FP1,DISC1FP1/DISC1,DISC1)Xzho})	anemia	J:214737
	decreased hemoglobin content	J:214737
	increased red blood cell distribution width	J:214737
Disp3^em1(IMPC)Mbp/Disp3^em1(IMPC)Mbp (C57BL/6N-Disp3^em1(IMPC)Mbp/Ucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Dkc1^tm1.1Pjma/Y (involves: 129X1/SvJ * C57BL/6 * FVB/N)	hematopoietic system phenotype	J:138335
Dkc1^tm1.1Pjma/Y (B6.129X1(FVB)-Dkc1^tm1.1Pjma)	decreased B cell number	J:217050
	decreased hematopoietic stem cell proliferation	J:217050
	decreased T cell number	J:217050
Dkc1^tm1.1Pjma/Dkc1⁺ (involves: 129X1/SvJ * C57BL/6 * FVB/N)	abnormal hematopoietic system morphology/development	J:138335
Dkc1^tm1Ppp/Y (involves: 129S1/Sv)	abnormal bone marrow cell physiology	J:81054
	abnormal definitive hematopoiesis	J:81054
	abnormal spleen morphology	J:81054
	anemia	J:81054
	decreased B cell number	J:81054
	decreased bone marrow cell number	J:81054
	decreased common myeloid progenitor cell number	J:81054
	decreased erythroid progenitor cell number	J:81054
	decreased hemoglobin content	J:81054
	decreased leukocyte cell number	J:81054
	decreased lymphocyte cell number	J:81054
	decreased pre-B cell number	J:81054
	decreased spleen red pulp amount	J:81054
	decreased spleen white pulp amount	J:81054
	enlarged spleen	J:81054
	extramedullary hematopoiesis	J:81054
	thrombocytopenia	J:81054
Dkc1^tm1Ppp/Dkc1⁺ (involves: 129S1/Sv)	abnormal bone marrow cell morphology/development	J:81054
	abnormal definitive hematopoiesis	J:81054
	abnormal erythrocyte morphology	J:81054
	abnormal hematopoietic system physiology	J:81054
Dkk2^tm1Dwu/Dkk2^tm1Dwu (involves: 129)	abnormal osteoclast differentiation	J:100858
Dkk2^tm1Dwu/Dkk2^tm1Dwu (involves: 129)	increased osteoclast cell number	J:100858
Dkk3^tm1Cni/Dkk3^tm1Cni (involves: 129X1/SvJ * C57BL/6)	decreased NK cell number	J:106922
	increased hematocrit	J:106922
	increased hemoglobin content	J:106922
	increased IgM level	J:106922
	increased mean corpuscular hemoglobin	J:106922
	increased mean corpuscular volume	J:106922
Dlc1^Gt(XE082)Byg/Dlc1^Gt(XE082)Byg (involves: 129P2/OlaHsd * C57BL/6)	abnormal blood cell morphology/development	J:189950
Dlec1^{tm1b(EUCOMM)Wtsi}/Dlec1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Dlec1^{tm1b(EUCOMM)Wtsi}/Ieg)	decreased mean corpuscular volume	J:211773
Dlg1^tm1Rlh/Dlg1^tm1Rlh Tg(Cd4-cre)1Cwi/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)	abnormal CD4-positive, alpha-beta T cell physiology	J:191788
	abnormal T-helper 1 physiology	J:191788
	abnormal T-helper 2 physiology	J:191788
Dlgap2^{em1(IMPC)Mhzh}/Dlgap2^{em1(IMPC)Mhzh} (C57BL/6N-Dlgap2^{em1(IMPC)Mhzh}/Mhzh)	decreased lymphocyte cell number	J:211773
	increased eosinophil cell number	J:211773
	increased neutrophil cell number	J:211773
Dlgap4^{tm1b(KOMP)Wtsi}/Dlgap4⁺ (C57BL/6N-Dlgap4^{tm1b(KOMP)Wtsi}/Wtsi)	decreased erythrocyte cell number	J:211773
Dlk1^{em1(IMPC)Wtsi}/Dlk1^{em1(IMPC)Wtsi} (C57BL/6N-Dlk1^{em1(IMPC)Wtsi}/WtsiIeg)	increased mean corpuscular hemoglobin	J:211773
Dlk1^tm1Srba/Dlk1^tm1Srba (involves: 129X1/SvJ * C57BL/6)	abnormal B cell number	J:145076
	abnormal spleen B cell follicle morphology	J:145076
	abnormal spleen marginal zone morphology	J:145076
	decreased immature B cell number	J:145076
	decreased mature B cell number	J:145076
	increased IgG1 level	J:145076
	increased IgG2a level	J:145076
	increased IgG2b level	J:145076
	increased IgG2c level	J:145076
	increased IgG3 level	J:145076
	increased IgM level	J:145076
	increased immature B cell number	J:145076
	increased immunoglobulin level	J:145076
	increased marginal zone B cell number	J:145076
	increased transitional stage B cell number	J:145076
Dll1^tm1Gos/Dll1⁺ (C3Fe.129-Dll1^tm1Gos)	decreased B-1 B cell number	J:150183
	decreased CD4-positive, alpha-beta T cell number	J:150183
	decreased CD8-positive, alpha-beta T cell number	J:150183
	decreased IgA level	J:150183
	decreased IgG1 level	J:150183
	decreased IgG2b level	J:150183
	decreased IgG3 level	J:150183
	increased B cell number	J:150183
	increased CD8-positive, alpha-beta T cell number	J:150183
Dll1^tm1Gos/Dll1⁺ (involves: 129S1/Sv * 129X1/SvJ)	decreased CD4-positive, alpha-beta T cell number	J:150183
Dll1^tm1Gos/Dll1⁺ (involves: 129S1/Sv * 129X1/SvJ)	increased B cell number	J:150183
Dll1^tm1Mjo/Dll1^tm1Mjo Tg(Mx1-cre)1Cgn/? (involves: 129 * C57BL/6 * CBA)	absent marginal zone B cells	J:90630
Dll4^tm1Frad/Dll4^tm1Frad Foxn1^tm3(cre)Nrm/Foxn1⁺ (B6.Cg-Dll4^tm1Frad Foxn1^tm3(cre)Nrm)	abnormal T cell differentiation	J:143472
	abnormal thymus cell ratio	J:143472
	decreased CD4-positive, alpha-beta T cell number	J:143472
	decreased CD8-positive, alpha-beta T cell number	J:143472
	decreased double-positive T cell number	J:143472
	decreased thymocyte number	J:143472
	increased immature B cell number	J:143472
Dll4^tm1Kaho/Dll4^tm1Kaho Tg(Foxn1-cre)8Ghr/0 (involves: C57BL/6 * DBA/2)	abnormal lymphopoiesis	J:143473
	absent CD4-positive, alpha-beta T cells	J:143473
	absent CD8-positive, alpha-beta T cells	J:143473
	decreased double-positive T cell number	J:143473
	thymus hypoplasia	J:143473
dm/dm (involves: 129 * BALB/cJ * C57L/J)	decreased common myeloid progenitor cell number	J:5439
dm/dm (involves: 129 * BALB/cJ * C57L/J)	macrocytic anemia	J:2479
Dmd^{em1(IMPC)Hmgu}/Y (C57BL/6N-Dmd^{em1(IMPC)Hmgu}/Ieg)	decreased mean corpuscular volume	J:211773
Dmd^{em1(IMPC)Hmgu}/Dmd^{em1(IMPC)Hmgu} (C57BL/6N-Dmd^{em1(IMPC)Hmgu}/Ieg)	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
	increased red blood cell distribution width	J:211773
	thrombocytosis	J:211773
Dmd^mdx/Y Spp1^tm1Blh/Spp1^tm1Blh (involves: 129S6/SvEvTac * C57BL/6 * C57BL/10 * C57BL/10ScSn)	decreased granulocyte number	J:150572
	decreased neutrophil cell number	J:150572
	decreased T cell number	J:150572
	increased regulatory T cell number	J:150572
	increased T cell number	J:150572
Dmd^mdx/Dmd^mdx Mmp9^tm1Tvu/Mmp9⁺ (B10.Cg-Mmp9^tm1Tvu Dmd^mdx)	decreased macrophage cell number	J:150030
Dmd^mdx/Dmd^mdx Mmp9^tm1Tvu/Mmp9^tm1Tvu (B10.Cg-Mmp9^tm1Tvu Dmd^mdx)	decreased macrophage cell number	J:150030
Dmd^mdx/Dmd^mdx Prkdc^scid/Prkdc^scid (involves: BALB/c * C57BL/10ScSn * C57BL/Ka)	absent CD4-positive, alpha-beta T cells	J:125527
	absent CD8-positive, alpha-beta T cells	J:125527
	decreased B cell number	J:125527
Dmd^mdx/Dmd^mdx Spp1^tm1Blh/Spp1^tm1Blh (involves: 129S6/SvEvTac * C57BL/6 * C57BL/10 * C57BL/10ScSn)	decreased granulocyte number	J:150572
	decreased neutrophil cell number	J:150572
	decreased T cell number	J:150572
	increased regulatory T cell number	J:150572
	increased T cell number	J:150572
Dmgdh^{tm1a(KOMP)Wtsi}/Dmgdh^{tm1a(KOMP)Wtsi} (C57BL/6N-Dmgdh^{tm1a(KOMP)Wtsi}/Wtsi)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
Dmp1^tm1Mis/Dmp1^tm1Mis (involves: 129S7/SvEvBrd * CD-1)	decreased osteoclast cell number	J:184352
Dmtf1^tm1Cjs/Dmtf1^tm1Cjs (involves: 129/Sv * C57BL/6)	abnormal T cell physiology	J:63444
Dmtf1^tm1Cjs/Dmtf1^tm1Cjs (involves: 129/Sv * C57BL/6)	decreased thymocyte number	J:63444
Dmtn^tm1Ahc/Dmtn^tm1Ahc (involves: 129S4/SvJaeSor * C57BL/6J)	anemia	J:76575
	decreased hematocrit	J:76575
	decreased mean corpuscular volume	J:76575
	increased erythrocyte osmotic fragility	J:76575
	microcytosis	J:76575
	reticulocytosis	J:76575
	spherocytosis	J:76575
Dnaaf4^b2b811.1Clo/Dnaaf4^b2b811.1Clo (C57BL/6J-Dnaaf4^b2b811.1Clo)	abnormal spleen morphology	J:205312
Dnaaf4^tm1.2Jjlo/Dnaaf4^tm1.2Jjlo (involves: 129S1/Sv * 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6J)	abnormal spleen morphology	J:205312
Dnaaf9^{tm1b(EUCOMM)Hmgu}/Dnaaf9^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Dnaaf9^{tm1b(EUCOMM)Hmgu}/Tcp)	increased neutrophil cell number	J:211773
Dnah5^b2b2451Clo/Dnah5^b2b2451Clo (C57BL/6J-Dnah5^b2b2451Clo)	abnormal spleen morphology	J:175213
Dnah5^b2b2925Clo/Dnah5^b2b2925Clo (C57BL/6J-Dnah5^b2b2925Clo)	absent spleen	J:175213
Dnah5^hlb612/Dnah5^hlb612 (involves: C57BL/6J)	abnormal spleen morphology	J:130755
Dnah5^hlb612/Dnah5^hlb612 (involves: C57BL/6J)	absent spleen	J:130755
Dnah11^b2b1289Clo/Dnah11^b2b1289Clo (C57BL/6J-Dnah11^b2b1289Clo)	accessory spleen	J:175213
Dnah11^b2b1727Clo/Dnah11^b2b1727Clo (C57BL/6J-Dnah11^b2b1727Clo)	spleen hypoplasia	J:175213
Dnah11^b2b1775Clo/Dnah11^b2b1775Clo (C57BL/6J-Dnah11^b2b1775Clo)	spleen hypoplasia	J:175213
Dnah11^iv/Dnah11^iv (SI/Col Tyrp1^b Dnah11^iv/J)	abnormal spleen morphology	J:4058
Dnai1^b2b1526Clo/Dnai1^b2b1526Clo (C57BL/6J-Dnai1^b2b1526Clo)	spleen hypoplasia	J:175213
Dnai4^em1(IMPC)J/Dnai4^em1(IMPC)J (C57BL/6NJ-Dnai4^em1(IMPC)J/Mmjax)	increased mean corpuscular volume	J:211773
Dnaja4^{tm1b(KOMP)Wtsi}/Dnaja4^{tm1b(KOMP)Wtsi} (C57BL/6N-Dnaja4^{tm1b(KOMP)Wtsi}/J)	decreased mean corpuscular volume	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
Dnajb4^tm1Suky/Dnajb4^tm1Suky (Not Specified)	hematopoietic system phenotype	J:321624
Dnajc2^em1(IMPC)J/Dnajc2⁺ (C57BL/6NJ-Dnajc2^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Dnajc3^m1Btlr/Dnajc3^m1Btlr (C57BL/6J-Dnajc3^m1Btlr)	increased CD4-positive, alpha-beta T cell number	J:265248
	increased CD8-positive, alpha-beta memory T cell number	J:265248
	increased single-positive T cell number	J:265248
	increased T cell number	J:265248
Dnajc7^{tm1b(KOMP)Wtsi}/Dnajc7^{tm1b(KOMP)Wtsi} (C57BL/6N-Dnajc7^{tm1b(KOMP)Wtsi}/J)	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
Dnajc8^{tm1b(KOMP)Wtsi}/Dnajc8⁺ (C57BL/6N-Dnajc8^{tm1b(KOMP)Wtsi}/Wtsi)	increased mean corpuscular hemoglobin	J:211773
Dnajc10^{tm1a(EUCOMM)Hmgu}/Dnajc10^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Dnajc10^{tm1a(EUCOMM)Hmgu}/H)	increased mean corpuscular hemoglobin concentration	J:165965
Dnajc11^spc/Dnajc11^spc (B6.Cg-Dnajc11^spc)	decreased B cell number	J:221543
	decreased double-positive T cell number	J:221543
	decreased erythrocyte cell number	J:221543
	decreased leukocyte cell number	J:221543
	decreased thymus weight	J:221543
	enlarged thymus medulla	J:221543
	hematopoietic system phenotype	J:221543
	increased CD4-positive, alpha-beta T cell number	J:221543
	increased CD8-positive, alpha-beta T cell number	J:221543
	increased DN1 thymic pro-T cell number	J:221543
	increased double-negative T cell number	J:221543
	spleen hypoplasia	J:221543
	thymus cortex atrophy	J:221543
	thymus hypoplasia	J:221543
Dnajc13^em1(IMPC)J/Dnajc13⁺ (C57BL/6NJ-Dnajc13^em1(IMPC)J/Mmjax)	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
Dnajc15^{Gt(RRN226)Byg}/Dnajc15^{Gt(RRN226)Byg} (B6.129P2-Dnajc15^{Gt(RRN226)Byg})	abnormal CD8-positive, alpha beta T cell morphology	J:204025
Dnajc15^{tm1b(KOMP)Wtsi}/Dnajc15^{tm1b(KOMP)Wtsi} (C57BL/6N-Dnajc15^{tm1b(KOMP)Wtsi}/Bay)	abnormal spleen morphology	J:211773
Dnal1^{tm1.1(KOMP)Vlcg}/Dnal1⁺ (C57BL/6N-Dnal1^{tm1.1(KOMP)Vlcg}/Ucd)	decreased eosinophil cell number	J:211773
Dnase1^tm1Tmo/Dnase1⁺ (involves: 129P2/OlaHsd * C57BL/6)	enlarged spleen	J:62549
Dnase1^tm1Tmo/Dnase1^tm1Tmo (involves: 129P2/OlaHsd * C57BL/6)	enlarged spleen	J:62549
Dnase1l2^em1(IMPC)Bay/Dnase1l2^em1(IMPC)Bay (C57BL/6N-Dnase1l2^em1(IMPC)Bay/Bay)	abnormal spleen morphology	J:211773
Dnase1l2^em1(IMPC)J/Dnase1l2^em1(IMPC)J (C57BL/6NJ-Dnase1l2^em1(IMPC)J/J)	increased mean corpuscular hemoglobin concentration	J:211773
Dnase1l2^{tm1.1(KOMP)Wtsi}/Dnase1l2^{tm1.1(KOMP)Wtsi} (C57BL/6N-Dnase1l2^{tm1.1(KOMP)Wtsi}/Bay)	abnormal spleen morphology	J:211773
Dnase1l3^em1(IMPC)Mbp/Dnase1l3^em1(IMPC)Mbp (C57BL/6NCrl-Dnase1l3^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased red blood cell distribution width	J:211773
	increased spleen weight	J:211773
Dnase2a^tm1Aea/Dnase2a^tm1Aea (involves: 129 * C57BL/6)	abnormal definitive hematopoiesis	J:89469
Dnase2a^tm1Aea/Dnase2a^tm1Aea (involves: 129 * C57BL/6)	anemia	J:89469
Dnase2a^tm1Osa/Dnase2a^tm1Osa (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal erythropoiesis	J:69831
	abnormal thymus morphology	J:81474
	anemia	J:69831
	decreased erythrocyte cell number	J:69831
	increased nucleated erythrocyte cell number	J:69831, J:81474
	small thymus	J:81474
	thymus hypoplasia	J:81474
Dnase2a^tm1Osa/Dnase2a^tm1Osa Ifnar1^tm1Agt/Ifnar1^tm1Agt (involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6)	abnormal macrophage morphology	J:114982
	abnormal spleen morphology	J:238323
	anemia	J:114982
	enlarged spleen	J:238323, J:114982
	increased spleen red pulp amount	J:114982
	increased spleen weight	J:238323
Dnase2a^tm1Osa/Dnase2a^tm2Osa Tg(Mx1-cre)1Cgn/0 (involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6 * CBA)	abnormal macrophage morphology	J:114982
	anemia	J:114982
Dnm2^Rbc12/Dnm2⁺ (involves: C57BL/6)	abnormal bone marrow cell physiology	J:330452
	abnormal erythrocyte morphology	J:330452
	abnormal proerythroblast morphology	J:330452
	decreased hematocrit	J:330452
	decreased hemoglobin content	J:330452
	decreased mean corpuscular hemoglobin	J:330452
	microcytic anemia	J:330452
Dnm2^{tm1.1(KOMP)Vlcg}/Dnm2⁺ (C57BL/6N-Dnm2^{tm1.1(KOMP)Vlcg}/Ucd)	decreased mean corpuscular hemoglobin	J:211773
Dnm2^tm1.1Ics/Dnm2⁺ (involves: 129S2/SvPas)	anemia	J:330452
Dnm2^tm1.2Pdc/Dnm2⁺ (involves: 129S1/SvImJ * C57BL/6)	hematopoietic system phenotype	J:330452
Dnm2^tm2.1Ics/Dnm2⁺ (involves: C57BL/6J)	increased macrophage cell number	J:288372
Dnmbp^em1(IMPC)Mbp/Dnmbp^em1(IMPC)Mbp (C57BL/6N-Dnmbp^em1(IMPC)Mbp/Ucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Dnmt1^{tm1(tetO-BCL2)Sjk}/Dnmt1⁺ Tg(IghMyc)22Bri/0 Tg(MMTVtTA)1Mam/0 (involves: 129S4/SvJae * C57BL/6)	enlarged spleen	J:93549
Dnmt1^tm2Jae/Dnmt1^tm2Jae Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: 129S4/SvJae * BALB/c * C57BL/6)	abnormal B cell differentiation	J:113645
	decreased pro-B cell number	J:113645
Dnmt3a^tm1Trow/Dnmt3a⁺ Gt(ROSA)26Sor^{tm3(CAG-flpo/ERT2)Alj}/Gt(ROSA)26Sor⁺ Npm1^tm1Trow/Npm1⁺ Tg(Mx1-cre)1Cgn/0 (B6.Cg-Gt(ROSA)26Sor^{tm3(CAG-flpo/ERT2)Alj} Npm1^tm1Trow Dnmt3a^tm1Trow Tg(Mx1-cre)1Cgn)	abnormal bone marrow cell physiology	J:272803
Dnmt3a^tm1Trow/Dnmt3a⁺ Tg(Mx1-cre)1Cgn/0 (B6.Cg-Dnmt3a^tm1Trow Tg(Mx1-cre)1Cgn)	abnormal bone marrow hematopoietic cell morphology	J:272803
	increased common myeloid progenitor cell number	J:272803
	increased hematopoietic stem cell number	J:272803
Dnmt3b^tm1Enl/Dnmt3b^tm6Enl (involves: 129S4/SvJae * C57BL/6)	decreased thymocyte number	J:106540
	increased thymocyte apoptosis	J:106540
	small thymus	J:106540
Dnmt3b^tm1Enl/Dnmt3b^tm7Enl (involves: 129S4/SvJae * C57BL/6)	decreased double-positive T cell number	J:106540
	decreased thymocyte number	J:106540
	increased double-negative T cell number	J:106540
	increased thymocyte apoptosis	J:106540
	small thymus	J:106540
Dnmt3b^tm6Enl/Dnmt3b^tm6Enl (involves: 129S4/SvJae * C57BL/6)	decreased thymocyte number	J:106540
	increased thymocyte apoptosis	J:106540
	small thymus	J:106540
Dnmt3b^tm6Enl/Dnmt3b^tm7Enl (involves: 129S4/SvJae * C57BL/6)	decreased thymocyte number	J:106540
	increased thymocyte apoptosis	J:106540
Dnmt3b^tm7Enl/Dnmt3b^tm7Enl (involves: 129S4/SvJae * C57BL/6)	decreased thymocyte number	J:106540
	increased thymocyte apoptosis	J:106540
	small thymus	J:106540
Dnmt3l^{tm1b(EUCOMM)Hmgu}/Dnmt3l^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Dnmt3l^{tm1b(EUCOMM)Hmgu}/Ieg)	increased mean corpuscular hemoglobin	J:211773
Dnpep^{tm1e(EUCOMM)Wtsi}/Dnpep^{tm1e(EUCOMM)Wtsi} (C57BL/6N-Dnpep^{tm1e(EUCOMM)Wtsi}/Wtsi)	increased mean platelet volume	J:211773
Dntt^tm1Gfn/Dntt^tm1Gfn Polm^tm1Crey/Polm^tm1Crey (involves: 129P2/OlaHsd * 129S2/SvPas)	abnormal immunoglobulin light chain V-J recombination	J:113406
Dntt^tm1Tok/Dntt^tm1Tok (involves: 129P2/OlaHsd * C57BL/6)	abnormal lymphocyte cell number	J:61801
	abnormal T cell morphology	J:61801
	decreased gamma-delta T cell number	J:61801
Dnttip1^em1Shmc/Dnttip1^em1Shmc (C57BL/6J-Dnttip1^em1Shmc)	absent erythrocytes	J:291786
Dnttip1^{tm1b(KOMP)Wtsi}/Dnttip1⁺ (C57BL/6N-Dnttip1^{tm1b(KOMP)Wtsi}/J)	thrombocytosis	J:211773
Dock1^b2b3190Clo/Dock1^b2b3190Clo (C57BL/6J-Dock1^b2b3190Clo)	thymus hypoplasia	J:175213
Dock2^m1Anu/Dock2^m1Anu (C57BL/6JAnu-Dock2^m1Anu)	decreased B cell number	J:104190
Dock2^m1Anu/Dock2^m1Anu (C57BL/6JAnu-Dock2^m1Anu)	decreased T cell number	J:104190
Dock2^m1Btlr/Dock2^m1Btlr (involves: C57BL/6J)	abnormal B cell differentiation	J:173592
	abnormal class switch recombination	J:185495
	decreased B cell number	J:185495
	decreased IgG level	J:185495
	decreased T cell number	J:185495
Dock2^m1Hsd/Dock2^m1Hsd Irf5^tm1Ttg/Irf5^tm1Ttg (B6NHsd.Cg-Irf5^tm1Ttg Dock2^m1Hsd)	abnormal B cell differentiation	J:182658
	absent marginal zone B cells	J:182658
	decreased follicular B cell number	J:182658
	decreased plasmacytoid dendritic cell number	J:182658
	decreased splenocyte number	J:182658
	increased B cell number	J:182658
	increased immature B cell number	J:182658
	increased plasmacytoid dendritic cell number	J:182658
Dock2^m1Hsd/Dock2^m1Hsd Siae^tm1.2Avrk/Siae^tm1.2Avrk (B6NHsd.Cg-Siae^tm1.2Avrk Dock2^m1Hsd)	abnormal B cell activation	J:144035
	abnormal immunoglobulin level	J:144035
	decreased B-1a cell number	J:144035
	decreased follicular B cell number	J:144035
	decreased marginal zone B cell number	J:231437, J:144035
	decreased T cell number	J:144035
	increased B cell proliferation	J:144035
	increased B-1b cell number	J:144035
	increased CD4-positive, alpha-beta memory T cell number	J:231437
	increased IgE level	J:144035
	increased IgG1 level	J:144035
	increased IgG2a level	J:144035
	increased IgG2b level	J:144035
	increased IgG3 level	J:144035
	increased IgM level	J:144035
	spleen hypoplasia	J:144035
Dock2^m2Anu/Dock2^m2Anu (C57BL/6JAnu-Dock2^m2Anu)	abnormal T cell morphology	J:104190
	decreased mature B cell number	J:104190
	decreased T cell number	J:104190
Dock2^m2Btlr/Dock2^m2Btlr (C57BL/6J-Dock2^m2Btlr)	decreased B cell number	J:173670
	decreased CD4-positive, alpha-beta T cell number	J:173670
	decreased CD8-positive, alpha-beta T cell number	J:173670
Dock2^m2Btlr/Dock2^m2Btlr (involves: C57BL/6J)	abnormal B cell differentiation	J:185495
	abnormal class switch recombination	J:185495
	decreased B cell number	J:185495
	decreased IgG level	J:185495
	decreased T cell number	J:185495
Dock2^m3Anu/Dock2^m3Anu (C57BL/6NCrlAnu-Dock2^m3Anu)	abnormal CD4-positive, alpha beta T cell morphology	J:104190
	abnormal CD8-positive, alpha beta T cell morphology	J:104190
	decreased CD4-positive, alpha-beta T cell number	J:104190
Dock2^m3Btlr/Dock2^m3Btlr (C57BL/6J-Dock2^m3Btlr)	abnormal CD4-positive T cell differentiation	J:191187
	abnormal CD8-positive, alpha-beta T cell differentiation	J:191187
	decreased CD4-positive, alpha-beta T cell number	J:191187
	decreased CD8-positive, alpha-beta T cell number	J:191187
Dock2^m4Btlr/Dock2^m4Btlr (C57BL/6J-Dock2^m4Btlr)	abnormal B cell differentiation	J:221486
	abnormal CD4-positive T cell differentiation	J:221486
	abnormal CD8-positive, alpha-beta T cell differentiation	J:221486
Dock2^m5Btlr/Dock2⁺ (C57BL/6J-Dock2^m5Btlr)	abnormal CD4-positive T cell differentiation	J:225938
	abnormal CD8-positive, alpha-beta T cell differentiation	J:225938
	decreased CD4-positive, alpha-beta T cell number	J:225938
	decreased single-positive T cell number	J:225938
	impaired hematopoiesis	J:225938
	increased CD8-positive, alpha-beta T cell number	J:225938
	increased single-positive T cell number	J:225938
Dock2^m5Btlr/Dock2^m5Btlr (C57BL/6J-Dock2^m5Btlr)	abnormal B cell differentiation	J:225938
	abnormal CD4-positive T cell differentiation	J:225938
	abnormal CD8-positive, alpha-beta T cell differentiation	J:225938
	decreased CD4-positive, alpha-beta T cell number	J:225938
	decreased single-positive T cell number	J:225938
	impaired hematopoiesis	J:225938
	increased B cell number	J:225938
	increased CD8-positive, alpha-beta T cell number	J:225938
	increased single-positive T cell number	J:225938
Dock2^m6Btlr/Dock2^m6Btlr (C57BL/6J-Dock2^m6Btlr)	decreased IgE level	J:236689
Dock2^m7Btlr/Dock2⁺ (C57BL/6J-Dock2^m7Btlr)	decreased B cell number	J:255181
	increased macrophage cell number	J:255181
	increased neutrophil cell number	J:255181
Dock2^m7Btlr/Dock2^m7Btlr (C57BL/6J-Dock2^m7Btlr)	decreased B cell number	J:255181
	increased IgE level	J:255181
	increased macrophage cell number	J:255181
	increased neutrophil cell number	J:255181
	increased NK cell number	J:255181
Dock2^m8Btlr/Dock2^m8Btlr (C57BL/6J-Dock2^m8Btlr)	decreased CD4-positive, alpha-beta T cell number	J:272402
Dock2^m8Btlr/Dock2^m8Btlr (C57BL/6J-Dock2^m8Btlr)	increased CD8-positive, alpha-beta T cell number	J:272402
Dock2^M9Btlr/Dock2^M9Btlr (C57BL/6J-Dock2^M9Btlr)	increased CD8-positive, alpha-beta T cell number	J:272403
Dock2^m10Btlr/Dock2^m10Btlr (C57BL/6J-Dock2^m10Btlr)	decreased B-1b cell number	J:272404
Dock2^m10Btlr/Dock2^m10Btlr (C57BL/6J-Dock2^m10Btlr)	increased NK cell number	J:272404
Dock2^m11Btlr/Dock2^m11Btlr (C57BL/6J-Dock2^m11Btlr)	abnormal B cell differentiation	J:272405
	abnormal CD4-positive T cell differentiation	J:272405
	abnormal CD8-positive, alpha-beta cytotoxic T cell morphology	J:272405
	decreased B cell number	J:272405
	decreased CD4-positive, alpha-beta T cell number	J:272405
	decreased CD8-positive, naive alpha-beta T cell number	J:272405
	decreased NK cell number	J:272405
	increased B-1 B cell number	J:272405
	increased CD8-positive, alpha-beta T cell number	J:272405
	increased central memory CD4-positive, alpha-beta T cell number	J:272405
	increased central memory CD8 positive, alpha-beta T cell number	J:272405
	increased effector memory CD4-positive, alpha-beta T cell number	J:272405
Dock2^M12Btlr/Dock2^M12Btlr (C57BL/6J-Dock2^M12Btlr)	decreased B-1a cell number	J:272406
Dock2^m13Btlr/Dock2^m13Btlr (C57BL/6J-Dock2^m13Btlr)	increased alpha-beta T cell number	J:272437
Dock2^m13Btlr/Dock2^m13Btlr (C57BL/6J-Dock2^m13Btlr)	increased CD8-positive, alpha-beta T cell number	J:272437
Dock2^M14Btlr/Dock2^M14Btlr (C57BL/6J-Dock2^M14Btlr)	abnormal lymphocyte morphology	J:272438
Dock2^M14Btlr/Dock2^M14Btlr (C57BL/6J-Dock2^M14Btlr)	increased CD8-positive, alpha-beta T cell number	J:272438
Dock2^m15Btlr/Dock2^m15Btlr (C57BL/6J-Dock2^m15Btlr)	decreased B cell number	J:274942
	decreased CD4-positive, alpha-beta T cell number	J:274942
	decreased CD8-positive, naive alpha-beta T cell number	J:274942
	decreased T cell number	J:274942
	increased B-1 B cell number	J:274942
	increased CD8-positive, alpha-beta T cell number	J:274942
	increased central memory CD8 positive, alpha-beta T cell number	J:274942
	increased NK cell number	J:274942
Dock2^M16Btlr/Dock2^M16Btlr (C57BL/6J-Dock2^M16Btlr)	abnormal CD8-positive, alpha-beta T cell number	J:274971
Dock2^{tm1b(EUCOMM)Wtsi}/Dock2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Dock2^{tm1b(EUCOMM)Wtsi}/BayMmucd)	increased spleen weight	J:211773
Dock2^tm1Tsas/Dock2^tm1Tsas (involves: C57BL/6)	abnormal leukocyte migration	J:71005
	abnormal spleen morphology	J:71005
	abnormal spleen white pulp morphology	J:71005
	decreased marginal zone B cell number	J:71005
	spleen hypoplasia	J:71005
Dock2^tm1Tsas/Dock2^tm1Tsas (B6.Cg-Dock2^tm1Tsas)	abnormal hematopoietic system morphology/development	J:130919
	decreased lymphocyte cell number	J:130919
	decreased mature B cell number	J:130919
	decreased T cell number	J:130919
	impaired neutrophil chemotaxis	J:113266
Dock2^tm1Tsas/Dock2^tm1Tsas Tg(Tcra2B4)1Mmd/? Tg(Tcrb2B4)1Mmd/? (involves: C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:84581
	abnormal T cell physiology	J:84581
	decreased double-positive T cell number	J:84581
Dock3^tm1Dasc/Dock3^tm1Dasc (B6.Cg-Dock3^tm1Dasc)	abnormal microglial cell physiology	J:144341
Dock6^em1(IMPC)J/Dock6⁺ (C57BL/6NJ-Dock6^em1(IMPC)J/J)	increased erythrocyte cell number	J:211773
Dock6^em1(IMPC)J/Dock6⁺ (C57BL/6NJ-Dock6^em1(IMPC)J/J)	increased hemoglobin content	J:211773
Dock7^m/Dock7^m (B6.D(Cg)-Dock7^m)	decreased platelet ADP level	J:45425
Dock8^cpm/Dock8^cpm (C57BL/6JSfdAnu-Dock8^cpm)	decreased marginal zone B cell number	J:155516
	decreased spleen germinal center size	J:155516
	decreased T cell number	J:155516
Dock8^cpm/Dock8^pri (C57BL/6J-Dock8^cpm/Dock8^pri)	decreased marginal zone B cell number	J:155516
Dock8^cpm/Dock8^pri (C57BL/6J-Dock8^cpm/Dock8^pri)	decreased T cell number	J:155516
Dock8^m1Anu/Dock8^m1Anu (C57BL/6NCrlAnu-Dock8^m1Anu)	decreased activated T cell number	J:104190
	decreased IgM level	J:104190
	decreased T cell number	J:104190
Dock8^m1Btlr/Dock8^m1Btlr (C57BL/6J-Dock8^m1Btlr)	decreased IgG level	J:234247
Dock8^m2Anu/Dock8^m2Anu (C57BL/6NCrlAnu-Dock8^m2Anu)	absent marginal zone B cells	J:104190
	decreased activated T cell number	J:104190
	decreased IgM level	J:104190
	decreased T cell number	J:104190
Dock8^M2Btlr/Dock8^M2Btlr (C57BL/6J-Dock8^M2Btlr)	decreased CD8-positive, alpha-beta T cell number	J:272530
Dock8^M3Btlr/Dock8^M3Btlr (C57BL/6J-Dock8^M3Btlr)	decreased IgG level	J:272531
Dock8^m4Btlr/Dock8^m4Btlr (C57BL/6J-Dock8^m4Btlr)	abnormal B cell differentiation	J:274856
	abnormal CD4-positive T cell differentiation	J:274856
	abnormal CD8-positive, alpha-beta T cell differentiation	J:274856
	abnormal T cell differentiation	J:274856
	decreased B-1 B cell number	J:274856
	decreased CD4-positive, alpha-beta T cell number	J:274856
	decreased CD8-positive, alpha-beta T cell number	J:274856
	decreased CD8-positive, naive alpha-beta T cell number	J:274856
	decreased T cell number	J:274856
	increased CD4-positive, alpha-beta T cell number	J:274856
	increased central memory CD4-positive, alpha-beta T cell number	J:274856
	increased central memory CD8 positive, alpha-beta T cell number	J:274856
	increased effector memory CD4-positive, alpha-beta T cell number	J:274856
	increased effector memory CD8-positive, alpha-beta T cell number	J:274856
Dock8^pri/Dock8^pri (C57BL/6JAnu-Dock8^pri)	decreased B-1 B cell number	J:155516
	decreased germinal center B cell number	J:155516
	decreased marginal zone B cell number	J:155516
	decreased spleen germinal center size	J:155516
	decreased T cell number	J:155516
Dock8^pri/Dock8^pri (involves: C57BL/6JAnu)	abnormal cellular extravasation	J:238772
Dock8^tm1Ysfk/Dock8^tm1Ysfk (B6.Cg-Dock8^tm1Ysfk)	decreased CD4-positive, alpha-beta T cell number	J:185165
	decreased CD8-positive, alpha-beta T cell number	J:185165
	decreased IgG level	J:185165
	decreased marginal zone B cell number	J:185165
	decreased T cell proliferation	J:185165
Dock9^em1(IMPC)J/Dock9^em1(IMPC)J (C57BL/6NJ-Dock9^em1(IMPC)J/J)	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
Dock10^{tm1a(EUCOMM)Hmgu}/Dock10^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Dock10^{tm1a(EUCOMM)Hmgu}/Ieg)	abnormal B cell physiology	J:236911
	abnormal follicular B cell physiology	J:236911
	abnormal spleen marginal zone morphology	J:238172
	abnormal thymus cell ratio	J:238172
	arrested B cell differentiation	J:236911
	decreased B cell number	J:236911
	decreased follicular B cell number	J:236911
	decreased hemoglobin content	J:165965
	decreased marginal zone B cell number	J:236911
	increased hematocrit	J:165965
	increased hemoglobin content	J:165965
	increased single-positive T cell number	J:236911
	increased T cell number	J:236911
Dock10^tm1Thar/Dock10^tm1Thar (involves: C57BL/6)	abnormal microglial cell chemotaxis	J:300632
	decreased B cell number	J:300632
	impaired macrophage chemotaxis	J:300632
Dock11^tm1.1Mmar/Dock11^tm1.1Mmar (Not Specified)	abnormal metallophilic macrophage morphology	J:238172
	abnormal spleen marginal zone morphology	J:238172
	abnormal thymus cell ratio	J:238172
	decreased marginal zone B cell number	J:238172
Dock11^tm1Thar/Dock11^tm1Thar (involves: C57BL/6)	impaired macrophage chemotaxis	J:300632
Dohh^tm1.1Sbal/Dohh^tm1.1Sbal Tg(CAG-cre/Esr1)5Amc/0 (involves: 129S1/Sv 129X1/SvJ * BALB/cJ)	hematopoietic system phenotype	J:236582
Dohh^tm1.2Sbal/Dohh⁺ (B6.129(Cg)-Dohh^tm1.2Sbal)	abnormal spleen morphology	J:214321
Dok1^tm1Ppp/Dok1^tm1Ppp (129S1/Sv-Dok1^tm1Ppp)	abnormal bone marrow cell morphology/development	J:95640
Dok1^tm1Ppp/Dok1^tm1Ppp (129S1/Sv-Dok1^tm1Ppp)	abnormal T cell proliferation	J:95640
Dok1^tm1Ppp/Dok1^tm1Ppp Dok2^tm1Ppp/Dok2^tm1Ppp (129S1/Sv-Dok1^tm1Ppp Dok2^tm1Ppp)	abnormal leukocyte physiology	J:95334
	enlarged spleen	J:95334
	increased bone marrow cell number	J:95334
	increased leukocyte cell number	J:95334
	increased monocyte cell number	J:95334
	increased neutrophil cell number	J:95334
Dok1^tm1Ppp/Dok1^tm1Ppp Dok2^tm1Ppp/Dok2^tm1Ppp Dok3^tm1Ppp/Dok3^tm1Ppp (129S1/Sv-Dok1^tm1Ppp Dok2^tm1Ppp Dok3^tm1Ppp)	increased leukocyte cell number	J:158011
Dok1^tm1Yyam/Dok1^tm1Yyam (involves: 129S4/SvJae * C57BL/6)	decreased IgM level	J:95641
Dok1^tm1Yyam/Dok1^tm1Yyam (involves: 129S4/SvJae * C57BL/6)	increased B cell proliferation	J:95641
Dok1^tm1Yyam/Dok1^tm1Yyam Dok2^tm1Yyam/Dok2^tm1Yyam (B6.129-Dok1^tm1Yyam Dok2^tm1Yyam)	abnormal leukocyte physiology	J:95335
	abnormal myelopoiesis	J:95335
	enlarged spleen	J:95335
	extramedullary hematopoiesis	J:95335
	increased erythroblast number	J:95335
	increased leukocyte cell number	J:95335
	increased megakaryocyte cell number	J:95335
	increased monocyte cell number	J:95335
	increased neutrophil cell number	J:95335
Dok1^tm1Yyam/Dok1^tm1Yyam Dok2^tm1Yyam/Dok2^tm1Yyam (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	abnormal macrophage physiology	J:163407
Dok1^tm1Yyam/Dok1^tm1Yyam Dok2^tm1Yyam/Dok2^tm1Yyam Dok3^tm1Brs/Dok3^tm1Brs (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	abnormal macrophage physiology	J:163407
	increased macrophage cell number	J:163407
Dok1^tm1Yyam/Dok1^tm1Yyam Dok2^tm1Yyam/Dok2^tm1Yyam Tg(Tec-BCR/ABL1)5Hhi/0 (involves: C57BL/6)	enlarged thymus	J:95335
Dok1^tm1Yyam/Dok1^tm1Yyam Tg(Tec-BCR/ABL1)5Hhi/0 (involves: C57BL/6)	enlarged thymus	J:95335
Dok2^tm1Ppp/Dok2^tm1Ppp (129S1/Sv-Dok2^tm1Ppp)	abnormal granulocyte physiology	J:95334
Dok2^tm1Yyam/Dok2^tm1Yyam Tg(Tec-BCR/ABL1)5Hhi/0 (involves: C57BL/6)	enlarged thymus	J:95335
Dok3^tm1Brs/Dok3^tm1Brs (involves: C57BL/6)	increased macrophage cell number	J:163407
Dok3^tm1Kplm/Dok3^tm1Kplm (involves: 129P2/OlaHsd)	abnormal B cell physiology	J:280795
	increased B cell proliferation	J:280795
	increased IgG3 level	J:280795
	increased IgM level	J:280795
Dok7^{tm1.1(KOMP)Vlcg}/Dok7⁺ (C57BL/6N-Dok7^{tm1.1(KOMP)Vlcg}/Ucd)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Dop1a^em1(IMPC)Tcp/Dop1a^em1(IMPC)Tcp (C57BL/6N-Dop1a^em1(IMPC)Tcp/Tcp)	decreased mean corpuscular hemoglobin	J:211773
Dop1b^{tm1a(EUCOMM)Wtsi}/Dop1b^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Dop1b^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased leukocyte cell number	J:211773
Dot1l^tm1.1Saam/Dot1l^tm1.1Saam (involves: 129S1/Sv * C57BL/6)	abnormal bone marrow cell morphology/development	J:193161
	abnormal bone marrow cell physiology	J:193161
Dot1l^tm1.1Saam/Dot1l^tm1.1Saam Tg(VAV1-cre)1Graf/0 (involves: 129S1/Sv * C57BL/6)	abnormal definitive hematopoiesis	J:193161
	abnormal leukopoiesis	J:193161
	anemia	J:193161
	decreased bone marrow cell number	J:193161
	decreased common myeloid progenitor cell number	J:193161
	decreased hematopoietic stem cell number	J:193161
	decreased lymphocyte cell number	J:193161
	decreased neutrophil cell number	J:193161
	impaired hematopoiesis	J:193161
Dp(11Cops3-Rnf112)1Jrl/0 (involves: 129S7/SvEvBrd * C57BL/6)	decreased spleen weight	J:83302
Dp(16Cbr1-Fam3b)1Rhr/0 (involves: 129S6/SvEvTac)	abnormal common myeloid progenitor cell morphology	J:184564
	abnormal megakaryocyte progenitor cell morphology	J:184564
	decreased erythrocyte cell number	J:184564
	increased hematopoietic stem cell number	J:184564
	increased megakaryocyte cell number	J:184564
	thrombocytosis	J:184564
Dp(16Cbr1-Fam3b)1Rhr/0 Gata1^tm8.2Sho/Y (involves: 129S1/Sv * 129S6/SvEvTac)	abnormal bone marrow cell morphology/development	J:184564
	abnormal bone marrow cell number	J:184564
	abnormal megakaryocyte progenitor cell morphology	J:184564
	anemia	J:184564
	enlarged spleen	J:184564
	extramedullary hematopoiesis	J:184564
	increased megakaryocyte cell number	J:184564
	increased monocyte cell number	J:184564
	thrombocytosis	J:184564
Dp(17Nfkbil1-Or2h1)1Cogr/0 (involves: 129S6/SvEvTac * C57BL/6J)	hematopoietic system phenotype	J:190754
Dph1^tm1Bhr/Dph1^tm1Bhr (either: 129/Sv or (involves: 129/Sv * C57BL/6))	increased nucleated erythrocyte cell number	J:88090
Dph1^tm2Bhr/Dph1^tm2Bhr (either: 129/Sv or (involves: 129/Sv * C57BL/6))	increased nucleated erythrocyte cell number	J:88090
Dph6^{tm1a(KOMP)Wtsi}/Dph6^{tm1a(KOMP)Wtsi} (C57BL/6N-Dph6^{tm1a(KOMP)Wtsi}/Wtsi)	decreased CD8-positive, alpha-beta T cell number	J:211773
	decreased CD8-positive, naive alpha-beta T cell number	J:211773
	decreased effector memory CD8-positive, alpha-beta T cell number	J:211773
	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	decreased Ly6C-positive mature NK cell number	J:211773
	decreased mature B cell number	J:211773
	decreased NK T cell number	J:211773
	decreased T-helper cell number	J:211773
	increased CD4-positive, alpha-beta memory T cell number	J:211773
	increased CD4-positive, alpha-beta T cell number	J:211773
	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	increased CD5-positive gamma-delta T cell number	J:211773
	increased CD11b-low dendritic cell number	J:211773
	increased dendritic cell number	J:211773
	increased effector memory T-helper cell number	J:211773
	increased gamma-delta T cell number	J:211773
	increased granulocyte number	J:211773
	increased KLRG1-positive CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	increased KLRG1-positive T-helper cell number	J:211773
	increased marginal zone B cell number	J:211773
	increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	increased memory-marker CD4-negative NK T cell number	J:211773
	increased memory-marker gamma-delta T cell number	J:211773
	increased monocyte cell number	J:211773
	increased plasma cell number	J:211773
	increased plasmacytoid dendritic cell number	J:211773
	increased red blood cell distribution width	J:211773
Dpp3^{tm1d(EUCOMM)Hmgu}/Dpp3^{tm1d(EUCOMM)Hmgu} (involves: BALB/c * C57BL/6 * C57BL/6J * C57BL/6N * SJL)	increased bone marrow cell number	J:294242
	increased osteoclast cell number	J:294242
Dpp4^em1Rba/Dpp4^em1Rba (C57BL/6J-Dpp4^em1Rba)	decreased lymphocyte cell number	J:279723
	increased monocyte cell number	J:279723
	increased neutrophil cell number	J:279723
Dpp4^{tm1(DPP4)Vlcg}/? (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac)	increased CD4-positive, alpha-beta T cell number	J:238079
	increased CD8-positive, alpha-beta T cell number	J:238079
	increased macrophage cell number	J:238079
	increased neutrophil cell number	J:238079
Dpp4^{tm1b(EUCOMM)Wtsi}/Dpp4^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Dpp4^{tm1b(EUCOMM)Wtsi}/Ics)	decreased lymphocyte cell number	J:211773
Dpp8^em1(IMPC)J/Dpp8^em1(IMPC)J (C57BL/6NJ-Dpp8^em1(IMPC)J/Mmjax)	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
Dppa1^{tm1b(KOMP)Wtsi}/Dppa1⁺ (C57BL/6N-Dppa1^{tm1b(KOMP)Wtsi}/Bay)	abnormal spleen morphology	J:211773
Dpy19l3^{tm1a(EUCOMM)Wtsi}/Dpy19l3^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Dpy19l3^{tm1a(EUCOMM)Wtsi}/Ics)	decreased erythrocyte cell number	J:165965
	decreased hematocrit	J:165965
	decreased hemoglobin content	J:165965
Drc1^b2b1654Clo/Drc1^b2b1654Clo (C57BL/6J-Drc1^b2b1654Clo)	absent spleen	J:175213
Drd1^tm2Jcd/Drd1⁺ Tg(Camk2a-cre)2Gsc/0 (involves: 129S4/SvJae * FVB/N)	abnormal microglial cell physiology	J:120070
Drd2^tm1Low/Drd2^tm1Low (B6.129S2-Drd2^tm1Low/J)	decreased spleen weight	J:106832
Drd2^tm1Low/Drd2^tm1Low (B6.129S2-Drd2^tm1Low/J)	microgliosis	J:194407
Drd3^em1(IMPC)Mbp/Drd3^em1(IMPC)Mbp (C57BL/6N-Drd3^em1(IMPC)Mbp/MbpMmucd)	small spleen	J:211773
Drg1^em1(IMPC)Tcp/Drg1⁺ (C57BL/6NCrl-Drg1^em1(IMPC)Tcp/Tcp)	increased red blood cell distribution width	J:211773
Drgx^em1(IMPC)Mbp/Drgx⁺ (C57BL/6N-Drgx^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Drosha^tm1Litt/Drosha^tm1.1Litt Foxp3^{tm4(YFP/icre)Ayr}/Y (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)	abnormal T cell activation	J:138683
	enlarged spleen	J:138683
	increased CD8-positive, alpha-beta T cell number	J:138683
	increased leukocyte cell number	J:138683
Drosha^tm1Litt/Drosha^tm1.1Litt Foxp3^{tm4(YFP/icre)Ayr}/Foxp3^{tm4(YFP/icre)Ayr} (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)	abnormal regulatory T cell morphology	J:138683
	abnormal T cell activation	J:138683
	enlarged spleen	J:138683
	increased CD8-positive, alpha-beta T cell number	J:138683
	increased leukocyte cell number	J:138683
Drosha^tm1Litt/Drosha^tm1.1Litt Tg(Cd4-cre)1Cwi/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * FVB/N)	decreased CD8-positive, alpha-beta T cell number	J:138683
	decreased double-positive T cell number	J:138683
	decreased lymphocyte cell number	J:138683
	decreased regulatory T cell number	J:138683
	decreased thymocyte number	J:138683
	increased activated T cell number	J:138683
	increased gamma-delta T cell number	J:138683
	increased granulocyte number	J:138683
Dsg1b^{tm1a(KOMP)Wtsi}/Dsg1b^{tm1a(KOMP)Wtsi} (C57BL/6N-Dsg1b^{tm1a(KOMP)Wtsi}/Wtsi)	thrombocytopenia	J:211773
Dsg3^bal/Dsg3^bal (C57BL/6J-Dsg3^bal/J)	cutaneous mastocytosis	J:18223
Dsg3^bal/Dsg3^bal (C57BL/6J-Dsg3^bal/J)	increased IgE level	J:18223
Dsg3^sqk/Dsg3^sqk (C57BL/6-Dsg3^sqk)	decreased B cell number	J:219200
	decreased double-positive T cell number	J:219200
	decreased immature B cell number	J:219200
	decreased lymphocyte cell number	J:219200
	decreased pre-B cell number	J:219200
	decreased single-positive T cell number	J:219200
	decreased transitional stage B cell number	J:219200
	increased neutrophil cell number	J:219200
Dsg4^hage/Dsg4^hage Fas^lpr/Fas^lpr X/Yaa (EOD-Dsg4^hage)	abnormal effector T cell morphology	J:140028
Dsg4^hage/Dsg4^hage Fas^lpr/Fas^lpr X/Yaa (EOD-Dsg4^hage)	abnormal mast cell morphology	J:140028
Dsg4^lah-J/Dsg4^lah-J (involves: DBA/1LacJ)	increased IgE level	J:83117
Dst^dt-37J/Dst^dt-37J (C57BL/6J-Dst^dt-37J/J)	decreased bone marrow cell number	J:82238
Dtnbp1^sdy-Btlr/Dtnbp1^sdy-Btlr (C57BL/6J-Dtnbp1^sdy-Btlr)	impaired natural killer cell mediated cytotoxicity	J:133620
Dtnbp1^sdy/Dtnbp1^sdy (involves: DBA/2J)	abnormal platelet physiology	J:85123, J:323340
	decreased platelet aggregation	J:85123
	decreased platelet dense granule number	J:85123, J:1958
	decreased platelet serotonin level	J:85123
	thrombocytopenia	J:1958
Dtnbp1^{tm1b(EUCOMM)Hmgu}/Dtnbp1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Dtnbp1^{tm1b(EUCOMM)Hmgu}/Tcp)	decreased lymphocyte cell number	J:211773
	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Dtx1^tm1.1Mzl/Dtx1^tm1.1Mzl Tg(Cd4-cre)1Cwi/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)	abnormal thymocyte activation	J:151605
	increased T cell proliferation	J:151605
Dtx1^tm1.2Mzl/Dtx1^tm1.2Mzl (B6.129-Dtx1^tm1.2Mzl)	abnormal lymphocyte morphology	J:151605
	abnormal lymphocyte physiology	J:151605
	abnormal regulatory T cell physiology	J:151605
	abnormal thymocyte activation	J:151605
	decreased marginal zone B cell number	J:151605
	decreased thymocyte apoptosis	J:151605
	increased B cell proliferation	J:151605
	increased T cell proliferation	J:151605
	spleen hyperplasia	J:151605
Dtx3^em1(IMPC)J/Dtx3^em1(IMPC)J (C57BL/6NJ-Dtx3^em1(IMPC)J/Mmjax)	decreased mean corpuscular hemoglobin	J:211773
Dtx3l^em1(IMPC)H/Dtx3l^em1(IMPC)H (C57BL/6N-Dtx3l^em1(IMPC)H/H)	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
Dtx4^{em1(IMPC)Ccpcz}/Dtx4⁺ (C57BL/6N-Dtx4^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Duox2^em1(IMPC)Mbp/Duox2^em1(IMPC)Mbp (C57BL/6N-Duox2^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	decreased lymphocyte cell number	J:211773
	decreased red blood cell distribution width	J:211773
	enlarged spleen	J:211773
	increased mean corpuscular volume	J:211773
	increased neutrophil cell number	J:211773
	small spleen	J:211773
Duoxa2^{tm1b(KOMP)Wtsi}/Duoxa2^{tm1b(KOMP)Wtsi} (C57BL/6N-Duoxa2^{tm1b(KOMP)Wtsi}/Wtsi)	decreased B cell number	J:211773
	decreased B-2 B cell number	J:211773
	decreased CD8-positive, alpha-beta T cell number	J:211773
	decreased CD11b-high dendritic cell number	J:211773
	decreased effector memory T-helper cell number	J:211773
	decreased erythrocyte cell number	J:211773
	decreased follicular B cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	decreased immature B cell number	J:211773
	decreased KLRG1-positive NK cell number	J:211773
	decreased leukocyte cell number	J:211773
	decreased Ly6C low monocyte number	J:211773
	decreased mature B cell number	J:211773
	decreased mean platelet volume	J:211773
	decreased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	decreased memory-marker gamma-delta T cell number	J:211773
	decreased NK cell number	J:211773
	decreased red blood cell distribution width	J:211773
	decreased transitional stage T1 B cell number	J:211773
	increased alpha-beta T cell number	J:211773
	increased CD4-positive, alpha-beta T cell number	J:211773
	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	increased CD8-positive, alpha-beta T cell number	J:211773
	increased CD8-positive, naive alpha-beta T cell number	J:211773
	increased effector memory CD8-positive, alpha-beta T cell number	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
	increased neutrophil cell number	J:211773
	increased plasmacytoid dendritic cell number	J:211773
	increased T cell number	J:211773
	increased T-helper cell number	J:211773
Dus2^{tm1b(EUCOMM)Wtsi}/Dus2⁺ (C57BL/6N-Dus2^{tm1b(EUCOMM)Wtsi}/Wtsi)	increased red blood cell distribution width	J:211773
Dusp1^tm1Brv/Dusp1^tm1Brv (involves: 129S2/SvPas * various)	increased mast cell degranulation	J:125919
Dusp1^tm1Brv/Dusp1^tm1Brv (C3.129S2-Dusp1^tm1Brv)	increased granulocyte number	J:164929
Dusp2^tm1Cmac/Dusp2^tm1Cmac (B6.Cg-Dusp2^tm1Cmac)	abnormal macrophage activation involved in immune response	J:112609
Dusp2^tm1Cmac/Dusp2^tm1Cmac (B6.Cg-Dusp2^tm1Cmac)	abnormal mast cell physiology	J:112609
Dusp3^{tm1b(KOMP)Wtsi}/Dusp3^{tm1b(KOMP)Wtsi} (B6Brd;B6Dnk;B6N-Tyr^c-Brd Dusp3^{tm1b(KOMP)Wtsi}/Wtsi)	decreased red blood cell distribution width	J:211773
Dusp3^tm1Srah/Dusp3^tm1Srah (involves: 129 * C57BL/6)	decreased hemoglobin content	J:235051
Dusp4^Gt(XG164)Byg/Dusp4^Gt(XG164)Byg (B6.129P2-Dusp4^Gt(XG164)Byg)	increased CD4-positive, alpha-beta T cell number	J:180366
	increased T cell proliferation	J:180366
Dusp4^tm1Jmol/Dusp4^tm1Jmol (involves: 129)	decreased B cell apoptosis	J:140567
Dusp4^tm1Plev/Dusp4^tm1Plev (involves: 129/Sv * C57BL/6)	abnormal macrophage physiology	J:170774
	decreased IgG2a level	J:170774
	increased IgG1 level	J:170774
Dusp5^tm1.1Achn/Dusp5^tm1.1Achn (involves: C57BL/6NCrl)	increased T cell proliferation	J:218203
Dusp5^tm1.1Achn/Dusp5^tm1.1Achn (involves: C57BL/6NCrl)	increased thymocyte number	J:218203
Dusp5^tm1.1Achn/Dusp5^tm1.1Achn Rag2^tm1.1Cgn/Rag2^tm1.1Cgn (involves: C57BL/6NCrl)	abnormal eosinophil physiology	J:218203
	increased eosinophil cell number	J:218203
Dusp5^{tm1a(KOMP)Wtsi}/Dusp5^{tm1a(KOMP)Wtsi} (C57BL/6-Dusp5^{tm1a(KOMP)Wtsi})	abnormal bone marrow cell morphology/development	J:240637
	abnormal CD8-positive, alpha beta T cell morphology	J:240637
	abnormal T cell physiology	J:240637
	increased effector memory CD8-positive, alpha-beta T cell number	J:240637
	increased T cell apoptosis	J:240637
	increased T cell proliferation	J:240637
Dusp5^{tm1d(KOMP)Wtsi}/Dusp5^{tm1d(KOMP)Wtsi} (B6(Cg)-Dusp5^{tm1d(KOMP)Wtsi})	increased T cell apoptosis	J:240637
Dusp6^tm1Jmol/Dusp6^tm1Jmol (involves: 129 * C57BL/6)	increased spleen weight	J:142966
Dusp8^em1(IMPC)Mbp/Dusp8^em1(IMPC)Mbp (C57BL/6N-Dusp8^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Dusp10^tm1Flv/Dusp10^tm1Flv (involves: 129S6/SvEvTac)	decreased T cell proliferation	J:92104
Dusp10^tm1Flv/Dusp10^tm1Flv (involves: 129S6/SvEvTac)	increased activated T cell number	J:92104
Dusp11^{Gt(BB0198)Wtsi}/Dusp11^{Gt(BB0198)Wtsi} (B6.129P2-Dusp11^{Gt(BB0198)Wtsi})	abnormal macrophage activation involved in immune response	J:301503
	increased macrophage cytokine production	J:301503
Dusp14^{Gt(OST210117)Lex}/Dusp14^{Gt(OST210117)Lex} (B6.129S5-Dusp14^{Gt(OST210117)Lex})	abnormal T cell activation	J:209403
	hematopoietic system phenotype	J:209403
	increased T cell proliferation	J:209403
	increased T-helper 1 cell number	J:209403
	increased T-helper 17 cell number	J:209403
Dusp16^em1(IMPC)Tcp/Dusp16^em1(IMPC)Tcp (C57BL/6NCrl-Dusp16^em1(IMPC)Tcp/Tcp)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	enlarged spleen	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased spleen weight	J:211773
Dusp16^{Gt(AE0704)Wtsi}/Dusp16^{Gt(AE0704)Wtsi} (B6.129P2-Dusp16^{Gt(AE0704)Wtsi})	abnormal hematopoietic system physiology	J:209529
Dusp22^tm1Tht/Dusp22^tm1Tht (B6.129S7-Dusp22^tm1Tht)	abnormal B cell activation	J:213253
	abnormal T cell activation	J:213253
	decreased B cell proliferation	J:213253
	decreased IgG3 level	J:213253
	decreased IgM level	J:213253
	decreased immunoglobulin level	J:213253
	enlarged spleen	J:213253
	increased spleen white pulp amount	J:213253
	increased T cell proliferation	J:213253
Dvl3^b2b2866Clo/Dvl3^b2b2866Clo (C57BL/6J-Dvl3^b2b2866Clo)	thymus hypoplasia	J:175213
Dym^em1(IMPC)Tcp/Dym^em1(IMPC)Tcp (C57BL/6N-Dym^em1(IMPC)Tcp/Tcp)	increased mean corpuscular volume	J:211773
Dync1li1^em1(IMPC)Tcp/Dync1li1⁺ (C57BL/6NCrl-Dync1li1^em1(IMPC)Tcp/Tcp)	increased red blood cell distribution width	J:211773
Dynlrb2^{tm1a(KOMP)Wtsi}/Dynlrb2⁺ (C57BL/6N-Dynlrb2^{tm1a(KOMP)Wtsi}/Wtsi)	increased mean platelet volume	J:211773
Dynlt4^{tm1e(EUCOMM)Wtsi}/Dynlt4^{tm1e(EUCOMM)Wtsi} (C57BL/6N-Dynlt4^{tm1e(EUCOMM)Wtsi}/Wtsi)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
Dyrk1a^tm1Jdc/Dyrk1a^tm1Jdc Tg(Mx1-cre)1Cgn/0 (involves: 129/Sv * C57BL/6J * C57BL/6NTac * CBA/J)	decreased B cell number	J:223138
	decreased double-positive T cell number	J:223138
	decreased immature B cell number	J:223138
	decreased mature B cell number	J:223138
	decreased pre-B cell number	J:223138
	decreased thymocyte number	J:223138
	increased T cell apoptosis	J:223138
Dyrk1b^{tm1b(EUCOMM)Wtsi}/Dyrk1b⁺ (C57BL/6N-Dyrk1b^{tm1b(EUCOMM)Wtsi}/Ics)	decreased large unstained cell number	J:211773
	decreased lymphocyte cell number	J:211773
Dyrk2^em1(IMPC)Ics/Dyrk2⁺ (C57BL/6N-Dyrk2^em1(IMPC)Ics/Ics)	decreased large unstained cell number	J:211773
Dyrk3^tm1Dowo/Dyrk3^tm1Dowo (involves: 129P2/OlaHsd * C57BL/6 * FVB/N)	abnormal stress erythropoiesis	J:144586
	decreased erythroid progenitor cell number	J:144586
	hematopoietic system phenotype	J:144586
Dyrk3^tm1Dowo/Dyrk3^tm1Dowo Epor^tm2Jni/Epor^tm2Jni (involves: 129P2/OlaHsd * C57BL/6 * FVB/N)	abnormal stress erythropoiesis	J:144586
Dytn^em1(IMPC)J/Dytn^em1(IMPC)J (C57BL/6NJ-Dytn^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
E2f1^{Tg(Wnt1-cre)2Sor}/E2f1⁺ Snrpb^em1Lajm/Snrpb⁺ (involves: C3H * C57BL/6 * C57BL/6J * CD1)	athymia	J:326544
E2f1^tm1Meg/E2f1^tm1Meg (either: (involves: 129/Sv * 129S4/SvJae) or (involves: 129/Sv * 129S4/SvJae * C57BL/6))	abnormal double-positive T cell morphology	J:33100
	enlarged thymus	J:33100
	increased CD4-positive, alpha-beta T cell number	J:33100
	increased CD8-positive, alpha-beta T cell number	J:33100
	increased thymocyte number	J:33100
	increased thymus weight	J:33100
E2f1^tm1Meg/E2f1^tm1Meg (NOD.Cg-E2f1^tm1Meg)	abnormal CD4-positive, alpha beta T cell morphology	J:93708
	abnormal CD8-positive, alpha beta T cell morphology	J:93708
	abnormal double-positive T cell morphology	J:93708
	decreased double-positive T cell number	J:93708
	decreased regulatory T cell number	J:93708
	enlarged thymus	J:93708
	increased T cell number	J:93708
	increased thymocyte number	J:93708
E2f1^tm1Meg/E2f1^tm1Meg (involves: 129S4/SvJae * C57BL/6)	decreased T cell proliferation	J:76318
E2f2^tm1Zubi/E2f2^tm1Zubi (involves: 129S1/Sv * C57BL/6)	abnormal spleen white pulp morphology	J:76318
	abnormal T cell differentiation	J:76318
	abnormal T cell subpopulation ratio	J:76318
	enlarged spleen	J:76318
	increased memory T cell number	J:76318
	increased spleen weight	J:76318
	increased T cell proliferation	J:76318
E2f2^tm1Zubi/E2f2^tm1Zubi Tg(TcraH-Y,TcrbH-Y)71Vbo/? (involves: 129S1/Sv * C57BL/6 * C57BL/6J * DBA/2J)	enlarged spleen	J:76318
	increased CD8-positive, alpha-beta T cell number	J:76318
	increased T cell proliferation	J:76318
	thymus hypoplasia	J:76318
E2f4^tm1Jrn/E2f4^tm1Jrn (involves: 129P2/OlaHsd * C57BL/6)	abnormal definitive hematopoiesis	J:64192
	abnormal granulocyte morphology	J:64192
	abnormal reticulocyte morphology	J:64192
	anemia	J:64192
	decreased double-positive T cell number	J:64192
	decreased granulocyte number	J:64192
	decreased hematocrit	J:64192
	decreased thymocyte number	J:64192
	increased double-negative T cell number	J:64192
	increased NK cell number	J:64192
	increased number of Howell-Jolly bodies	J:64192
	macrocytosis	J:64192
	thymus hypoplasia	J:64192
E2f4^tm1Lees/E2f4^tm1Lees (involves: 129S2/SvPas * C57BL/6)	abnormal proerythroblast morphology	J:64193
	abnormal stress erythropoiesis	J:64193
	anemia	J:64193
	anisocytosis	J:64193
	decreased erythrocyte cell number	J:64193
	decreased hematocrit	J:64193
	increased nucleated erythrocyte cell number	J:64193
	increased number of Howell-Jolly bodies	J:64193
	macrocytosis	J:64193
	reticulocytosis	J:64193
E2f6^tm1Lees/E2f6^tm1Lees (involves: 129S4/SvJae * C57BL/6)	hematopoietic system phenotype	J:134271
Ebag9^tm1Rehm/Ebag9^tm1Rehm (either: (involves: 129P2/OlaHsd * BALB/c) or (involves: 129P2/OlaHsd * C57BL/6))	abnormal CD8-positive, alpha beta T cell morphology	J:152534
	abnormal cytotoxic T cell physiology	J:152534
	abnormal memory T cell physiology	J:152534
Ebf1^em1(IMPC)Mbp/Ebf1⁺ (C57BL/6N-Ebf1^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	small spleen	J:211773
Ebf1^m1Btlr/Ebf1^m1Btlr (C57BL/6J-Ebf1^m1Btlr)	decreased B cell number	J:265157
	decreased IgD level	J:265157
	increased CD4-positive, alpha-beta T cell number	J:265157
	increased single-positive T cell number	J:265157
	increased T cell number	J:265157
Ebf1^m2Btlr/Ebf1^m2Btlr (C57BL/6J-Ebf1^m2Btlr)	decreased B cell number	J:265158
	decreased B-1 B cell number	J:265158
	decreased B-2 B cell number	J:265158
	decreased IgD level	J:265158
	decreased IgM level	J:265158
	increased B-1a cell number	J:265158
	increased B-1b cell number	J:265158
	increased CD4-positive, alpha-beta T cell number	J:265158
	increased IgM level	J:265158
	increased single-positive T cell number	J:265158
	increased T cell number	J:265158
Ebf1^M3Btlr/Ebf1^M3Btlr (C57BL/6J-Ebf1^M3Btlr)	decreased B-1 B cell number	J:265160
	increased CD4-positive, alpha-beta T cell number	J:265160
	increased single-positive T cell number	J:265160
	increased T cell number	J:265160
Ebf1^M4Btlr/Ebf1^M4Btlr (C57BL/6J-Ebf1^M4Btlr)	decreased B cell number	J:267560
	decreased NK cell number	J:267560
	increased alpha-beta T cell number	J:267560
	increased CD4-positive, alpha-beta T cell number	J:267560
	increased CD8-positive, alpha-beta T cell number	J:267560
Ebf1^M5Btlr/Ebf1^M5Btlr (C57BL/6J-Ebf1^M5Btlr)	abnormal lymphocyte morphology	J:272841
	decreased B cell number	J:272841
	decreased B-1 B cell number	J:272841
Ebf1^m6Btlr/Ebf1^m6Btlr (C57BL/6J-Ebf1^m6Btlr)	abnormal lymphocyte morphology	J:272842
	decreased B cell number	J:272842
	decreased B-1 B cell number	J:272842
	decreased effector memory CD4-positive, alpha-beta T cell number	J:272842
	decreased IgD level	J:272842
	increased alpha-beta T cell number	J:272842
	increased CD4-positive, alpha-beta T cell number	J:272842
	increased CD8-positive, alpha-beta T cell number	J:272842
Ebf1^Serv/Ebf1⁺ (C57BL/6JAnu-Ebf1^Serv)	decreased B cell number	J:104190
Ebf1^tm1.1Rug/Ebf1^tm1.1Rug Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * C57BL/6 * SJL)	decreased B-1 B cell number	J:182210
	decreased marginal zone B cell number	J:182210
Ebf1^tm1.1Rug/Ebf1^tm1.1Rug Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: BALB/c * C57BL/6 * SJL)	arrested B cell differentiation	J:182210
Ebf1^tm1.1Rug/Ebf1^tm1.1Rug Ighg1^tm1(cre)Cgn/Ighg1⁺ (involves: 129P2/OlaHsd * C57BL/6 * SJL)	decreased germinal center B cell number	J:182210
Ebf1^tm1.1Rug/Ebf1^tm1.1Rug Polr2a^{tm1(cre/ERT2)Bbd}/Polr2a⁺ (involves: C57BL/6 * SJL)	abnormal germinal center B cell physiology	J:182210
	arrested B cell differentiation	J:182210
	decreased B cell proliferation	J:182210
	decreased germinal center B cell number	J:182210
	decreased IgG1 level	J:182210
	decreased IgG3 level	J:182210
	decreased immature B cell number	J:182210
	decreased marginal zone B cell number	J:182210
	decreased pre-B cell number	J:182210
	decreased spleen germinal center number	J:182210
	decreased transitional stage B cell number	J:182210
	increased B cell apoptosis	J:182210
	increased B cell number	J:182210
Ebf1^tm1.1Rug/Ebf1^tm1.1Rug Polr2a^{tm1(cre/ERT2)Bbd}/Polr2a⁺ Tg(BCL2)#Wehi/0 (involves: C57BL/6 * C57BL/6JWehi * SJL * SJL/JWehi)	decreased immature B cell number	J:182210
	decreased pre-B cell number	J:182210
Ebf1^tm1.1Rug/Ebf1^tm1.1Rug Tg(Cr2-cre)3Cgn/0 (involves: C57BL/6 * SJL)	decreased B-1 B cell number	J:182210
	decreased marginal zone B cell number	J:182210
Ebf1^tm1Rug/Ebf1^tm1Rug (involves: 129S2/SvPas)	abnormal B cell morphology	J:52607
	absent B-1 B cells	J:52607
	absent mature B cells	J:52607
	arrested B cell differentiation	J:52607
	decreased IgM level	J:52607
	decreased pro-B cell number	J:52607
	hematopoietic system phenotype	J:52607
Ebf1^tm1Rug/Ebf1^tm1Rug (involves: 129S2/SvPas * 129X1/SvJ * C57BL/6)	decreased bone marrow cell number	J:147179
	increased osteoclast cell number	J:147179
Ebf2^em1(IMPC)Mbp/Ebf2⁺ (C57BL/6N-Ebf2^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	small spleen	J:211773
Ebi3^Gt716Lex/Ebi3^Gt716Lex (involves: 129S5/SvEvBrd * C57BL/6)	abnormal CD4-positive, alpha-beta T cell number	J:286951
	abnormal T cell activation	J:286951
	increased CD8-positive, alpha-beta T cell number	J:286951
	increased macrophage cell number	J:286951
Ebi3^Gt716Lex/Ebi3^Gt716Lex Tg(DO11.10)10Dlo/0 (involves: 129S5/SvEvBrd * BALB/c * C3H * C57BL/6)	abnormal T cell differentiation	J:134148
Ebi3^tm1Nkma/Ebi3^tm1Nkma Fas^lpr/Fas^lpr (MRL.Cg-Ebi3^tm1Nkma Fas^lpr)	increased IgE level	J:181669
	increased IgG1 level	J:181669
	increased IgG level	J:181669
	increased immunoglobulin level	J:181669
Ebi3^tm1Rsb/Ebi3^tm1Rsb (involves: 129X1/SvJ * C57BL/6)	abnormal T-helper 1 cell morphology	J:97822
	abnormal T-helper 2 cell morphology	J:97822
	decreased NK cell number	J:81014
	decreased T-helper 2 cell number	J:81014
Ebna1bp2^em1(IMPC)Tcp/Ebna1bp2⁺ (C57BL/6NCrl-Ebna1bp2^em1(IMPC)Tcp/Tcp)	decreased mean corpuscular hemoglobin	J:211773
	enlarged spleen	J:211773
Ebp^Td-ho/Y ((CKH.Cg-Ebp^Td-ho x NJL)F1)	abnormal embryonic erythrocyte morphology	J:60400
	abnormal embryonic erythropoiesis	J:60400
	abnormal embryonic hematopoiesis	J:60400
Ece1^tm1Reh/Ece1^tm1Reh (involves: 129S6/SvEvTac * C57BL/6)	persistent cervical thymus	J:46640
Ecm1^{tm1b(EUCOMM)Hmgu}/Ecm1⁺ (C57BL/6N-Ecm1^{tm1b(EUCOMM)Hmgu}/H)	decreased neutrophil cell number	J:211773
Ecm1^tm1Bsun/Ecm1^tm1Bsun (involves: 129 * C57BL/6)	abnormal T-helper 2 physiology	J:168252
Ecm1^tm1Bsun/Ecm1^tm1Bsun (involves: 129 * C57BL/6)	decreased IgE level	J:168252
Ecrg4^{tm1b(EUCOMM)Hmgu}/Ecrg4^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Ecrg4^{tm1b(EUCOMM)Hmgu}/Orl)	decreased large unstained cell number	J:211773
	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular hemoglobin concentration	J:211773
Ecscr^{tm1.1(KOMP)Vlcg}/Ecscr^{tm1.1(KOMP)Vlcg} (C57BL/6N-Ecscr^{tm1.1(KOMP)Vlcg}/Ucd)	abnormal thymus morphology	J:211773
	small thymus	J:211773
Edaradd^cr/Edaradd^cr (involves: C57BL/6 * C3H)	anemia	J:5680
Edc3^em1(IMPC)Tcp/Edc3^em1(IMPC)Tcp (C57BL/6NCrl-Edc3^em1(IMPC)Tcp/Tcp)	increased mean platelet volume	J:211773
Edc4^{tm1a(EUCOMM)Wtsi}/Edc4⁺ (C57BL/6N-Edc4^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased erythrocyte cell number	J:211773
Eddm3b^{tm1b(KOMP)Wtsi}/Eddm3b^{tm1b(KOMP)Wtsi} (C57BL/6N-Eddm3b^{tm1b(KOMP)Wtsi}/Nju)	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
Edem1^{em1(IMPC)Kmpc}/Edem1^{em1(IMPC)Kmpc} (C57BL/6NTac-Edem1^{em1(IMPC)Kmpc}/Kmpc)	increased mean platelet volume	J:211773
Edil3^tm1Tq/Edil3^tm1Tq (B6.129S6-Edil3^tm1Tq)	abnormal cellular extravasation	J:141063
	abnormal leukocyte adhesion	J:141063
	abnormal neutrophil physiology	J:141063
	enhanced leukocyte tethering or rolling	J:141063
Edil3^tm1Tq/Edil3^tm1Tq Itgal^tm1Bll/Itgal^tm1Bll (involves: 129 * C57BL/6)	abnormal cellular extravasation	J:141063
	abnormal neutrophil physiology	J:141063
Edn2^tm1Ywa/Edn2^tm1Ywa (involves: 129S6/SvEvTac)	increased hematocrit	J:201436
Ednra^tm1Ywa/Ednra^tm1Ywa (129S/SvEv-Ednra^tm1Ywa)	ectopic thymus	J:46639
Ednra^tm1Ywa/Ednra^tm1Ywa (129S/SvEv-Ednra^tm1Ywa)	thymus hypoplasia	J:46639
Ednrb^tm1Nrd/Ednrb^tm1Nrd Gt(ROSA)26Sor^{tm14(CAG-tdTomato)Hze}/Gt(ROSA)26Sor⁺ H2az2^{Tg(Wnt1-cre)11Rth}/H2az2⁺ (involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6 * CBA/J)	abnormal mature B cell number	J:233811
	abnormal spleen morphology	J:233811
	abnormal splenic cell ratio	J:233811
	decreased B cell number	J:233811
	decreased germinal center B cell number	J:233811
	decreased IgA level	J:233811
	decreased marginal zone B cell number	J:233811
	decreased spleen red pulp amount	J:233811
	decreased spleen weight	J:233811
	decreased spleen white pulp amount	J:233811
	small spleen	J:233811
Eed^tm1Sho/Eed^tm1Sho Epor^{tm1.1(EGFP/icre)Uk}/Epor⁺ Gt(ROSA)26Sor^tm1(EYFP)Cos/Gt(ROSA)26Sor^tm1(EYFP)Cos (involves: 129S1/Sv * 129X1/SvJ * BALB/cJ)	abnormal erythropoiesis	J:154730
Eef1a1^tm2Arge/Eef1a1⁺ Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ (involves: C57BL/6 * C57BL/6NTac)	abnormal bone marrow cell physiology	J:196407
Eef1a1^tm2Arge/Eef1a1⁺ Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	abnormal double-positive T cell morphology	J:197167
Eef1a2^wst/Eef1a2^wst (B6C3Fe a/a-Eef1a2^wst/J)	decreased plasma cell number	J:7903
	decreased spleen weight	J:6766
	decreased thymus weight	J:6766
Eef1a2^wst/Eef1a2^wst (Not Specified)	thymus atrophy	J:50410
Eef1d^em1(IMPC)Mbp/Eef1d⁺ (C57BL/6NCrl-Eef1d^em1(IMPC)Mbp/MbpMmucd)	increased neutrophil cell number	J:211773
Eef1e1^{Gt(OST377244)Lex}/Eef1e1⁺ (involves: 129S5/SvEvBrd * C57BL/6)	decreased splenocyte apoptosis	J:96923
	increased splenocyte proliferation	J:96923
Efcc1^em1(IMPC)Tcp/Efcc1^em1(IMPC)Tcp (C57BL/6N-Efcc1^em1(IMPC)Tcp/Tcp)	decreased mean corpuscular hemoglobin	J:211773
Efemp1^tm2Lmar/Efemp1^tm2Lmar (involves: 129X1/SvJ * C57BL/6)	abnormal spleen morphology	J:132043
	decreased spleen weight	J:132043
Efhd2^{tm1(KOMP)Vlcg}/Efhd2^{tm1(KOMP)Vlcg} (C57BL/6-Efhd2^{tm1(KOMP)Vlcg})	increased germinal center B cell number	J:228565
	increased IgE level	J:228565
	increased IgG1 level	J:228565
	increased IgG2a level	J:228565
	increased IgM level	J:228565
	increased plasma cell number	J:228565
	increased spleen germinal center size	J:228565
Efnb1^tm1.1Jwu/Efnb1^tm1.1Jwu Efnb2^tm1.1Jwu/Efnb2^tm1.1Jwu Tg(Lck-cre)I540Jxm/0 (B6.Cg-Efnb2^tm1.1Jwu Efnb1^tm1.1Jwu Tg(Lck-cre)I540Jxm)	abnormal bone marrow cell morphology/development	J:178148
	abnormal T cell differentiation	J:178148
	abnormal T-helper 1 cell differentiation	J:178148
	abnormal T-helper 17 cell differentiation	J:178148
	decreased CD4-positive, alpha-beta T cell number	J:178148
	decreased CD8-positive, alpha-beta T cell number	J:178148
	decreased DN4 thymocyte number	J:178148
	decreased double-positive T cell number	J:178148
	decreased spleen weight	J:178148
	decreased T cell number	J:178148
	decreased thymus weight	J:178148
	increased DN3 thymocyte number	J:178148
	increased double-negative T cell number	J:178148
	increased thymocyte apoptosis	J:178148
	small spleen	J:178148
	small thymus	J:178148
	spleen hypoplasia	J:178148
	thymus hypoplasia	J:178148
Efs^tm1Kale/Efs⁺ (either: (involves: 129X1/SvJ) or (involves: 129X1/SvJ * C57BL/6J))	increased IgA level	J:103757
	increased IgG level	J:103757
Efs^tm1Kale/Efs^tm1Kale (either: (involves: 129X1/SvJ) or (involves: 129X1/SvJ * C57BL/6J))	abnormal T cell physiology	J:103757
	increased IgA level	J:103757
	increased IgG level	J:103757
	increased immunoglobulin level	J:103757
Eftud2^{tm1b(KOMP)Wtsi}/Eftud2⁺ (C57BL/6N-Eftud2^{tm1b(KOMP)Wtsi}/Ics)	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	thrombocytosis	J:211773
Egfem1^em1(IMPC)J/Egfem1^em1(IMPC)J (C57BL/6NJ-Egfem1^em1(IMPC)J/J)	decreased mean corpuscular volume	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
Egfr^{tm1a(EUCOMM)Wtsi}/Egfr⁺ (C57BL/6N-Egfr^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased leukocyte cell number	J:175295
Egfr^tm1Dwt/Egfr^tm1Dwt Sox9^tm3(cre)Crm/Sox9⁺ (involves: 129S6/SvEvTac * 129S7/SvEvBrd)	increased IgE level	J:229771
	increased T-helper 1 cell number	J:229771
	increased T-helper 2 cell number	J:229771
	increased T-helper 17 cell number	J:229771
Egln1^{Gt(RRG405)Byg}/Egln1^{Gt(RRG405)Byg} (involves: 129P2/OlaHsd)	hematopoietic system phenotype	J:162597
Egln1^{Gt(RRG405)Byg}/Egln1^{Gt(RRG405)Byg} P4htm^tm1Jomy/P4htm^tm1Jomy (Not Specified)	increased hematocrit	J:213191
	increased mean corpuscular hemoglobin concentration	J:213191
Egln1^tm1.1Brei/Egln1^tm1.1Brei Egln3^tm2Fong/Egln3^tm2Fong Tg(CD68-icre)1Bwlx/0 (involves: 129S6/SvEvTac * C57BL/6)	polycythemia	J:194598
Egln1^tm1.1Brei/Egln1^tm1.1Brei Epas1^tm1Mcs/Epas1^tm1Mcs Tg(CD68-icre)1Bwlx/0 (involves: 129X1/SvJ * C57BL/6)	decreased hematocrit	J:194598
	decreased hemoglobin content	J:194598
	hematopoietic system phenotype	J:194598
Egln1^tm1.1Brei/Egln1^tm1.1Brei Hif1a^tm3Rsjo/Hif1a^tm3Rsjo Tg(CD68-icre)1Bwlx/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	hematopoietic system phenotype	J:194598
	increased hematocrit	J:194598
Egln1^tm1.1Brei/Egln1^tm1.1Brei Tg(CD68-icre)1Bwlx/0 (involves: C57BL/6)	abnormal lymphocyte cell number	J:194598
	abnormal megakaryocyte progenitor cell morphology	J:194598
	abnormal nucleated erythrocyte cell number	J:194598
	abnormal spleen morphology	J:194598
	enlarged spleen	J:194598
	hematopoietic system phenotype	J:194598
	increased erythroblast number	J:194598
	increased hematocrit	J:194598
	increased spleen weight	J:194598
	polycythemia	J:194598
	thrombocytopenia	J:194598
Egln1^tm1.1Fsl/Egln1⁺ (C57BL/6-Egln1^tm1.1Fsl)	increased hematocrit	J:202737
	increased hemoglobin content	J:202737
	increased spleen weight	J:202737
	polycythemia	J:202737
Egln1^tm1.1Fsl/Egln1⁺ Hif1a^tm3.1Rsjo/Hif1a⁺ (B6.Cg-Egln1^tm1.1Fsl Hif1a^tm3.1Rsjo)	increased hematocrit	J:202737
Egln1^tm1Kael/Egln1^tm1Kael Tg(CAG-cre/Esr1)5Amc/0 (involves: 129S6/SvEvTac C57BL/6 * CBA)	polycythemia	J:132718
Egln1^tm2.1Fsl/Egln1⁺ Pax3^tm1(cre)Joe/Pax3⁺ (involves: 129 * C57BL/6)	increased hematocrit	J:202737
	polycythemia	J:202737
Egln1^tm2.1Fsl/Egln1^tm2.1Fsl Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (B6.Cg-Egln1^tm2.1Fsl Commd10^{Tg(Vav1-icre)A2Kio})	increased erythroid progenitor cell number	J:202737
	increased hematocrit	J:202737
	increased hemoglobin content	J:202737
	polycythemia	J:202737
Egln1^tm2.1Fsl/Egln1^tm2.1Fsl Epas1^tm1Mcs/Epas1^tm1Mcs Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ (B6.Cg-Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte} Egln1^tm2.1Fsl Epas1^tm1Mcs)	hematopoietic system phenotype	J:202737
Egln1^tm2.1Fsl/Egln1^tm2.1Fsl Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ (B6.Cg-Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte} Egln1^tm2.1Fsl)	extramedullary hematopoiesis	J:202737
	increased hematocrit	J:202737
	increased spleen weight	J:202737
	polycythemia	J:202737
Egln1^tm2.1Fsl/Egln1^tm2.1Fsl Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ Hif1a^tm3Rsjo/Hif1a^tm3Rsjo (B6.Cg-Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte} Egln1^tm2.1Fsl Hif1a^tm3Rsjo)	extramedullary hematopoiesis	J:202737
	increased hematocrit	J:202737
	increased spleen weight	J:202737
Egln1^tm2.1Fsl/Egln1^tm2.1Fsl Pax3^tm1(cre)Joe/Pax3⁺ (involves: 129 * C57BL/6)	increased hematocrit	J:202737
	increased spleen weight	J:202737
	polycythemia	J:202737
Egln1^tm2.2Fsl/Egln1⁺ (B6.Cg-Egln1^tm2.2Fsl)	increased hematocrit	J:202737
	increased hemoglobin content	J:202737
	increased spleen weight	J:202737
	polycythemia	J:202737
Egln1^tm2Fong/Egln1^tm2Fong Egln2^tm2Fong/Egln2^tm2Fong Egln3^tm2Fong/Egln3^tm2Fong Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0 (involves: 129S6/SvEvTac * C57BL/6NCr * CD-1)	increased hematocrit	J:186085
Egln1^tm2Fong/Egln1^tm2Fong Gt(ROSA)26Sor^{tm1(cre/ERT2)Alj}/Gt(ROSA)26Sor⁺ (involves: 129S6/SvEvTac * C57BL/6)	abnormal definitive hematopoiesis	J:132720
	abnormal splenic cell ratio	J:132720
	enlarged spleen	J:132720
	extramedullary hematopoiesis	J:132720
	increased hematocrit	J:132720
	increased hemoglobin content	J:132720
	increased leukocyte cell number	J:132720
	polycythemia	J:132720
Egln2^tm1Fong/Egln2^tm1Fong (involves: 129S6/SvEvTac * C57BL/6)	hematopoietic system phenotype	J:132720
Egln2^tm1Fong/Egln2^tm1Fong Egln3^tm1Fong/Egln3^tm1Fong (involves: 129S6/SvEvTac * C57BL/6)	abnormal definitive hematopoiesis	J:132720
	abnormal splenic cell ratio	J:132720
	enlarged spleen	J:132720
	extramedullary hematopoiesis	J:132720
	increased hematocrit	J:132720
	increased hemoglobin content	J:132720
	polycythemia	J:132720
Egln3^tm1Fong/Egln3^tm1Fong (involves: 129S6/SvEvTac * C57BL/6)	hematopoietic system phenotype	J:132720
Egr1^{tm1b(NCOM)Mfgc}/Egr1⁺ (C57BL/6N-Egr1^{tm1b(NCOM)Mfgc}/Tcp)	increased lymphocyte cell number	J:211773
Egr1^tm1Jmi/Egr1^tm1Jmi (B6.129-Egr1^tm1Jmi)	increased osteoclast cell number	J:51107
Egr1^tm1Jmi/Egr1^tm1Jmi (involves: 129 * C57BL/6)	abnormal erythropoiesis	J:123870
	abnormal hematopoietic stem cell morphology	J:149801
	abnormal leukocyte cell number	J:123870
	abnormal leukocyte morphology	J:123870
	abnormal microglial cell physiology	J:135238
	abnormal neutrophil morphology	J:123870
	anemia	J:123870
	increased bone marrow cell number	J:123870
	increased lymphocyte cell number	J:123870
	increased spleen weight	J:123870
	thrombocytopenia	J:123870
Ehbp1l1^em1Aha/Ehbp1l1^em1Aha (Not Specified)	anemia	J:236573
Ehd1^{tm1a(EUCOMM)Wtsi}/Ehd1⁺ (C57BL/6N-Ehd1^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased mean corpuscular hemoglobin	J:175295
Ehf^{em1(IMPC)Kmpc}/Ehf^{em1(IMPC)Kmpc} (C57BL/6NTac-Ehf^{em1(IMPC)Kmpc}/Kmpc)	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	increased red blood cell distribution width	J:211773
	thrombocytosis	J:211773
Ehmt1^{tm1b(EUCOMM)Hmgu}/Ehmt1⁺ (C57BL/6N-Ehmt1^{tm1b(EUCOMM)Hmgu}/Nju)	increased mean platelet volume	J:211773
	increased neutrophil cell number	J:211773
Ehmt2^tm1.1Cza/Ehmt2^tm1.1Cza Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2 * SJL)	decreased IgG1 level	J:160938
	increased IgG2a level	J:160938
Eid2b^em1(IMPC)J/Eid2b⁺ (C57BL/6NJ-Eid2b^em1(IMPC)J/Mmjax)	decreased mean corpuscular volume	J:211773
Eid2b^em1(IMPC)J/Eid2b⁺ (C57BL/6NJ-Eid2b^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Eif1ad^{tm1b(EUCOMM)Hmgu}/Eif1ad⁺ (C57BL/6N-Eif1ad^{tm1b(EUCOMM)Hmgu}/Bay)	increased large unstained cell number	J:211773
Eif2a^em1(IMPC)Mbp/Eif2a^em1(IMPC)Mbp (C57BL/6N-Eif2a^em1(IMPC)Mbp/Ucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased mean platelet volume	J:211773
Eif2ak1^em1(IMPC)Bay/Eif2ak1^em1(IMPC)Bay (C57BL/6N-Eif2ak1^em1(IMPC)Bay/BayMmucd)	increased spleen weight	J:211773
Eif2ak1^tm1Jjch/Eif2ak1^tm1Jjch (Not Specified)	abnormal erythrocyte morphology	J:85896
	abnormal erythrocyte physiology	J:85896
	abnormal erythropoiesis	J:85896
	abnormal mean corpuscular hemoglobin	J:85896
	extramedullary hematopoiesis	J:85896
	increased erythrocyte osmotic fragility	J:85896
	increased mean corpuscular volume	J:85896
	increased number of Heinz bodies	J:85896
	macrocytic anemia	J:85896
Eif2ak2^em1(IMPC)Mbp/Eif2ak2^em1(IMPC)Mbp (C57BL/6N-Eif2ak2^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	small spleen	J:211773
Eif2ak2^tm1Cwe/Eif2ak2^tm1Cwe (involves: 129S/SvEv * C57BL/6)	increased T cell proliferation	J:66112
Eif2ak2^tm1Jcbe/Eif2ak2^tm1Jcbe (involves: 129S4/SvJae * BALB/c)	decreased erythroid progenitor cell number	J:53258
Eif2ak4^m1Btlr/Eif2ak4^m1Btlr (C57BL/6J-Eif2ak4^m1Btlr)	abnormal macrophage physiology	J:173669
Eif2b2^{tm2a(KOMP)Wtsi}/Eif2b2⁺ (C57BL/6N-Eif2b2^{tm2a(KOMP)Wtsi}/Wtsi)	increased mean corpuscular hemoglobin	J:175295
Eif2b3^{tm1b(EUCOMM)Hmgu}/Eif2b3⁺ (C57BL/6N-Eif2b3^{tm1b(EUCOMM)Hmgu}/H)	decreased hemoglobin content	J:211773
	decreased mean corpuscular hemoglobin	J:211773
Eif2b5^{tm1a(EUCOMM)Wtsi}/Eif2b5⁺ (C57BL/6N-Eif2b5^{tm1a(EUCOMM)Wtsi}/Ics)	decreased mean corpuscular hemoglobin concentration	J:165965
	decreased mean corpuscular volume	J:165965
Eif2b5^tm1Itl/Eif2b5^tm1Itl (involves: 129S/SvEv)	abnormal microglial cell physiology	J:192103
Eif2d^em1(IMPC)Mbp/Eif2d^em1(IMPC)Mbp (C57BL/6N-Eif2d^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Eif2s1^em1(IMPC)Mbp/Eif2s1⁺ (C57BL/6N-Eif2s1^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Eif2s1^tm1Rjk/Eif2s1⁺ Ppp1r15b^tm1Dron/Ppp1r15b^tm1Dron (involves: 129P2/OlaHsd)	decreased erythrocyte cell number	J:144954
Eif2s1^tm1Rjk/Eif2s1^tm1Rjk Ppp1r15b^tm1Dron/Ppp1r15b^tm1Dron (involves: 129P2/OlaHsd)	decreased erythrocyte cell number	J:144954
Eif2s2^em3(IMPC)Bay/Eif2s2⁺ (C57BL/6N-Eif2s2^em3(IMPC)Bay/Bay)	abnormal spleen morphology	J:211773
Eif4b^tm1.1Smoc/Eif4b^tm1.1Smoc Ndor1^{Tg(UBC-cre/ERT2)1Ejb}/Ndor1⁺ (involves: 129 * C57BL/6)	decreased leukocyte cell number	J:311140
	decreased lymphocyte cell number	J:311140
	decreased NK cell number	J:311140
	increased macrophage cell number	J:311140
	increased neutrophil cell number	J:311140
	small spleen	J:311140
	small thymus	J:311140
Eif4g1^{em1(IMPC)Hmgu}/Eif4g1⁺ (C57BL/6NCrl-Eif4g1^{em1(IMPC)Hmgu}/Ieg)	decreased spleen weight	J:211773
Eipr1^em1(IMPC)J/Eipr1⁺ (C57BL/6NJ-Eipr1^em1(IMPC)J/J)	decreased erythrocyte cell number	J:211773
Eipr1^em1(IMPC)J/Eipr1⁺ (C57BL/6NJ-Eipr1^em1(IMPC)J/J)	decreased hematocrit	J:211773
Elane^tm1(cre)Roes/Elane^tm1(cre)Roes (involves: 129S6/SvEvTac)	impaired neutrophil recruitment	J:137674
Elane^tm1Link/Elane^tm1Link (involves: 129X1/SvJ * C57BL/6)	hematopoietic system phenotype	J:131496
Elane^tm1Sds/Elane^tm1Sds (129X1/SvJ-Elane^tm1Sds)	abnormal neutrophil physiology	J:47420
Elapor1^{tm1b(EUCOMM)Hmgu}/Elapor1⁺ (C57BL/6N-Elapor1^{tm1b(EUCOMM)Hmgu}/Ics)	decreased lymphocyte cell number	J:211773
Elavl1^tm1.1Atas/Elavl1^tm1.1Atas Tnfrsf4^tm2(cre)Nik/Tnfrsf4⁺ (involves: 129X1/SvJ * C57BL/6)	decreased T cell proliferation	J:207013
	decreased T-helper 17 cell number	J:207013
Elavl1^tm1.1Dkon/Elavl1^tm1.1Dkon Lyz2^tm1(cre)Ifo/Lyz2⁺ (B6.129P2-Elavl1^tm1.1Dkon Lyz2^tm1(cre)Ifo)	abnormal macrophage chemotaxis	J:184388
	increased macrophage cell number	J:184388
	increased monocyte cell number	J:184388
Elavl1^tm1.1Thla/Elavl1⁺ (involves: 129S1/Sv)	decreased bone marrow cell number	J:155109
	spleen hypoplasia	J:155109
	thymus hypoplasia	J:155109
Elavl1^{tm1b(EUCOMM)Hmgu}/Elavl1⁺ (C57BL/6N-Elavl1^{tm1b(EUCOMM)Hmgu}/J)	decreased mean corpuscular hemoglobin	J:211773
Elavl1^tm1Dkon/Elavl1^tm1Dkon Edil3^{Tg(Sox2-cre)1Amc}/Edil3⁺ (involves: 129P2/OlaHsd * C57BL/6 * CBA)	abnormal spleen development	J:149149
	absent spleen	J:149149
Elavl1^tm1Dkon/Elavl1^tm1Dkon Tg(Lck-cre)I57Jxm/0 (B6.Cg-Elavl1^tm1Dkon Tg(Lck-cre)I57Jxm)	abnormal positive T cell selection	J:148866
	abnormal T cell physiology	J:148866
	abnormal thymocyte activation	J:148866
	decreased CD4-positive, alpha-beta T cell number	J:148866
	decreased CD8-positive, alpha-beta T cell number	J:148866
	increased double-negative T cell number	J:148866
	increased double-positive T cell number	J:148866
	increased single-positive T cell number	J:148866
Elavl1^tm1Dkon/Elavl1^tm1Dkon Tg(Lck-cre)I57Jxm/0 Tg(TcraH-Y,TcrbH-Y)71Vbo/? (B6.Cg-Elavl1^tm1Dkon Tg(Lck-cre)I57Jxm Tg(TcraH-Y,TcrbH-Y)71Vbo)	abnormal negative T cell selection	J:148866
	increased thymocyte number	J:148866
Elavl1^tm1Thla/Elavl1^tm1Thla Gt(ROSA)26Sor^{tm1(cre/ERT2)Alj}/Gt(ROSA)26Sor⁺ (involves: 129)	abnormal B cell physiology	J:155109
	abnormal definitive hematopoiesis	J:155109
	abnormal myeloid leukocyte morphology	J:155109
	decreased B cell apoptosis	J:155109
	decreased bone marrow cell number	J:155109
	decreased common myeloid progenitor cell number	J:155109
	decreased double-positive T cell number	J:155109
	decreased erythroid progenitor cell number	J:155109
	decreased granulocyte number	J:155109
	decreased leukocyte cell number	J:155109
	increased granulocyte number	J:155109
	increased T cell apoptosis	J:155109
	spleen hypoplasia	J:155109
	thymus hypoplasia	J:155109
Elf1^tm1Jml/Elf1^tm1Jml (Not Specified)	abnormal B cell differentiation	J:100734
Elf1^tm1Jml/Elf1^tm1Jml (Not Specified)	abnormal B cell physiology	J:100734
Elf4^em1Hdu/Elf4^em1Hdu (C57BL/6-Elf4^em1Hdu)	abnormal CD4-positive T cell differentiation	J:328935
Elf4^em1Hdu/Elf4^em1Hdu (C57BL/6-Elf4^em1Hdu)	abnormal macrophage physiology	J:328935
Elf4^tm1Nim/Elf4^tm1Nim (B6.129S1-Elf4^tm1Nim)	abnormal definitive hematopoiesis	J:107070
	abnormal hematopoietic stem cell morphology	J:107070
	abnormal lymphocyte morphology	J:79568
	abnormal lymphocyte physiology	J:79568
	abnormal NK cell physiology	J:79568
	abnormal T cell differentiation	J:79568
	decreased cytotoxic T cell cytolysis	J:79568
	decreased NK cell number	J:79568
	decreased NK T cell number	J:79568
	impaired natural killer cell mediated cytotoxicity	J:79568
	increased B cell number	J:79568
	increased B cell proliferation	J:79568
	increased hematopoietic stem cell number	J:107070
	increased T cell proliferation	J:79568
Elfn2^{tm1.1(KOMP)Vlcg}/Elfn2^{tm1.1(KOMP)Vlcg} (C57BL/6N-Elfn2^{tm1.1(KOMP)Vlcg}/Ucd)	increased eosinophil cell number	J:211773
Elk4^{tm1a(EUCOMM)Wtsi}/Elk4^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Elk4^{tm1a(EUCOMM)Wtsi}/H)	decreased CD4-positive, alpha-beta T cell number	J:165965
	decreased CD8-positive, alpha-beta T cell number	J:165965
	decreased mature B cell number	J:165965
	decreased T cell number	J:165965
	increased B cell number	J:165965
	increased T cell number	J:165965
Elk4^{tm1a(EUCOMM)Wtsi}/Elk4^{tm1a(EUCOMM)Wtsi} (Not Specified)	decreased erythrocyte cell number	J:165965
	decreased hematocrit	J:165965
Elk4^tm1Rtr/Elk4^tm1Rtr (either: (involves: 129/Sv) or (involves: 129/Sv * C57BL/6))	abnormal positive T cell selection	J:88515
	abnormal T cell selection	J:88515
	decreased CD4-positive, alpha-beta T cell number	J:88515
	decreased CD8-positive, alpha-beta T cell number	J:88515
	decreased single-positive T cell number	J:88515
	decreased T cell number	J:88515
	decreased thymocyte number	J:88515
Elk4^tm1Rtr/Elk4^tm1Rtr Tg(TcraH-Y,TcrbH-Y)71Vbo/? (involves: 129/Sv * C57BL/6 * DBA/2J)	abnormal positive T cell selection	J:88515
	decreased CD8-positive, alpha-beta T cell number	J:88515
Elk4^tm1Rtr/Elk4^tm1Rtr Tg(TcraTcrb)425Cbn/? (involves: 129/Sv * C57BL/6)	abnormal positive T cell selection	J:88515
	abnormal splenic cell ratio	J:88515
	decreased CD4-positive, alpha-beta T cell number	J:88515
Elk4^tm1Rtr/Elk4^tm1Rtr Tg(TcrLCMV)327Sdz/? (involves: 129/Sv * C57BL/6 * DBA/2)	abnormal positive T cell selection	J:88515
	decreased CD8-positive, alpha-beta T cell number	J:88515
Elmo1^M1Btlr/Elmo1^M1Btlr (C57BL/6J-Elmo1^M1Btlr)	decreased B cell number	J:265231
	decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:265231
	decreased IgM level	J:265231
	increased B-1 B cell number	J:265231
	increased CD8-positive, alpha-beta memory T cell number	J:265231
Elmo1^m2Btlr/Elmo1^m2Btlr (C57BL/6J-Elmo1^m2Btlr)	decreased B cell number	J:265232
Elmo1^m3Btlr/Elmo1^m3Btlr (C57BL/6J-Elmo1^m3Btlr)	decreased central memory CD8 positive, alpha-beta T cell number	J:271894
	decreased NK cell number	J:271894
	increased CD8-positive, alpha-beta T cell number	J:271894
Elmo1^M4Btlr/Elmo1^M4Btlr (C57BL/6J-Elmo1^M4Btlr)	abnormal B cell morphology	J:271969
	abnormal T cell morphology	J:271969
	decreased CD4-positive, alpha-beta T cell number	J:271969
	increased B-1 B cell number	J:271969
	increased CD8-positive, alpha-beta T cell number	J:271969
Elmo1^{tm1a(EUCOMM)Wtsi}/Elmo1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Elmo1^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased leukocyte cell number	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased red blood cell distribution width	J:211773
Elmod1^{tm1a(EUCOMM)Hmgu}/Elmod1^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Elmod1^{tm1a(EUCOMM)Hmgu}/H)	decreased B cell number	J:165965
	decreased hemoglobin content	J:165965
	decreased leukocyte cell number	J:165965
	increased hemoglobin content	J:165965
	thrombocytopenia	J:165965
Elmod1^{tm1b(EUCOMM)Hmgu}/Elmod1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Elmod1^{tm1b(EUCOMM)Hmgu}/H)	decreased large unstained cell number	J:211773
	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	decreased monocyte cell number	J:211773
	decreased spleen weight	J:211773
	increased eosinophil cell number	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
	increased red blood cell distribution width	J:211773
Elmod2^{tm1b(EUCOMM)Hmgu}/Elmod2⁺ (C57BL/6N-Elmod2^{tm1b(EUCOMM)Hmgu}/H)	increased hemoglobin content	J:211773
Elovl4^tm1Kzh/Elovl4^tm1Kzh (involves: C57BL/6)	abnormal erythrocyte morphology	J:124499
Elovl6^{tm1b(EUCOMM)Hmgu}/Elovl6⁺ (C57BL/6N-Elovl6^{tm1b(EUCOMM)Hmgu}/H)	increased red blood cell distribution width	J:211773
Elp1^{Gt(BGB184)Byg}/Elp1^{Gt(BGB184)Byg} (B6.129P2-^{Gt(BGB184)Byg})	abnormal embryonic erythropoiesis	J:145561
Emc4^{tm1(KOMP)Wtsi}/Emc4⁺ (C57BL/6N-Emc4^{tm1(KOMP)Wtsi}/Nju)	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
Emc6^{tm1.1(KOMP)Vlcg}/Emc6⁺ (C57BL/6N-Emc6^{tm1.1(KOMP)Vlcg}/Ucd)	increased hematocrit	J:211773
Emc8^{tm1b(EUCOMM)Hmgu}/Emc8⁺ (C57BL/6N-Emc8^{tm1b(EUCOMM)Hmgu}/H)	increased neutrophil cell number	J:211773
	increased red blood cell distribution width	J:211773
Emcn^{em1(IMPC)Wtsi}/Emcn^{em1(IMPC)Wtsi} (C57BL/6N-Emcn^{em1(IMPC)Wtsi}/Wtsi)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	increased mean platelet volume	J:211773
Eme1^{tm1.1(KOMP)Wtsi}/Eme1^{tm1.1(KOMP)Wtsi} (C57BL/6N-Eme1^{tm1.1(KOMP)Wtsi}/Bay)	abnormal spleen morphology	J:211773
	increased erythrocyte cell number	J:211773
	increased hematocrit	J:211773
Emg1^tm1.1Btr/Emg1^tm1.1Btr (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1)	decreased erythrocyte cell number	J:230556
Emilin1^tm1Gmb/Emilin1^tm1Gmb (involves: 129S1/Sv * 129X1/SvJ)	decreased platelet aggregation	J:226863
Emilin1^tm1Gmb/Emilin1^tm1Gmb Emilin2^tm1.2Jhp/Emilin2^tm1.2Jhp (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased platelet aggregation	J:226863
Emilin2^tm1.2Jhp/Emilin2^tm1.2Jhp (involves: C57BL/6)	decreased platelet aggregation	J:226863
Eml1^{em1(IMPC)Wtsi}/Eml1^{em1(IMPC)Wtsi} (C57BL/6N-Eml1^{em1(IMPC)Wtsi}/Wtsi)	decreased erythrocyte cell number	J:211773
	increased mean corpuscular hemoglobin	J:211773
Eml2^{tm1b(EUCOMM)Wtsi}/Eml2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Eml2^{tm1b(EUCOMM)Wtsi}/Bay)	decreased hemoglobin content	J:211773
Emp2^tm1.1Tac/Emp2^tm1.1Tac Tg(Zp3-cre)93Knw/0 (involves: C57BL/6 * C57BL/6J * C57BL/6N)	increased leukocyte cell number	J:243365
	increased uterine NK cell number	J:243365
Emsy^{em1(IMPC)Ccpcz}/Emsy⁺ (C57BL/6NCrl-Emsy^{em1(IMPC)Ccpcz}/Ccpcz)	increased NK cell number	J:211773
	increased red blood cell distribution width	J:211773
Emv72^a/Emv72^a (involves: BALB/cAnNCr * C57BL/6NCr)	abnormal cytotoxic T cell physiology	J:194735
Emv72^b/Emv72^b (CAnNCr.B6NCr-Emv72^b)	abnormal cytotoxic T cell physiology	J:194735
Emv72^b/Emv72^b (CAnNCr.B6NCr-Emv72^b)	abnormal T cell morphology	J:194735
Emv72^b/Emv72^b (involves: BALB/cAnNCr * C57BL/6NCr)	abnormal cytotoxic T cell physiology	J:194735
En1^tm1(Tnf)Fpit/En1^tm1(Tnf)Fpit (involves: C57BL/6)	increased monocyte cell number	J:170743
En1^tm1(Tnf)Fpit/En1^tm1(Tnf)Fpit (involves: C57BL/6)	microgliosis	J:170743
Enam^Abte2/Enam⁺ (C3HeB/FeJ-Enam^Abte2)	hematopoietic system phenotype	J:220423
Enam^abte/Enam⁺ (C3HeB/FeJ-Enam^abte)	decreased erythrocyte cell number	J:220423
	decreased hematocrit	J:220423
	decreased hemoglobin concentration distribution width	J:220423
	increased mean corpuscular volume	J:220423
Endou^tm1Tft/Endou^tm1Tft Tg(IghelMD4)4Ccg/0 Tg(ML5sHEL)5Ccg/0 (involves: 129S/SvEv * C57BL/6 * C57BL/6JSfd)	decreased activation-induced B cell apoptosis	J:208364
Eng^em1(IMPC)Mbp/Eng⁺ (C57BL/6N-Eng^em1(IMPC)Mbp/MbpMmucd)	increased neutrophil cell number	J:211773
Eng^tm1Hma/Eng^tm1Hma (involves: 129P2/OlaHsd * C57BL/6J)	abnormal embryonic hematopoiesis	J:73415
Eng^tm1Hma/Eng^tm1Hma (involves: 129P2/OlaHsd * C57BL/6J)	anemia	J:73415
Enkur^tm1Hmf/Enkur^tm1Hmf (involves: 129 * C57BL/6J)	abnormal spleen morphology	J:253966
Enkur^tm1Hmf/Enkur^tm1Hmf (involves: 129 * C57BL/6J)	absent spleen	J:253966
Enox1^{tm1.1(KOMP)Vlcg}/Enox1⁺ (C57BL/6N-Enox1^{tm1.1(KOMP)Vlcg}/J)	decreased hematocrit	J:211773
Enpp3^tm1Ktak/Enpp3^tm1Ktak (either: (involves: 129S4/SvJae * C57BL/6) or (involves: 129S4/SvJae * BALB/c * C57BL/6))	abnormal basophil physiology	J:223825
	abnormal mast cell physiology	J:223825
	increased basophil cell number	J:223825
	increased IgE level	J:223825
	increased mast cell number	J:223825
Enpp3^tm1Ktak/Enpp3^tm1Ktak P2rx7^tm1Gab/P2rx7^tm1Gab (either: (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) or (involves: 129P2/OlaHsd * 129S4/SvJae * BALB/c * C57BL/6))	increased basophil cell number	J:223825
	increased mast cell number	J:223825
Entpd1^{tm1a(EUCOMM)Wtsi}/Entpd1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Entpd1^{tm1a(EUCOMM)Wtsi}/Ieg)	increased T cell number	J:165965
Entpd1^tm1Djp/Entpd1^tm1Djp (involves: 129 * C57BL/6)	abnormal platelet physiology	J:76092
Entpd1^tm1Djp/Entpd1^tm1Djp (involves: 129 * C57BL/6)	hematopoietic system phenotype	J:76092
Entpd1^tm1Djp/Entpd1^tm1Djp (B6.129-Entpd1^tm1Djp)	decreased platelet aggregation	J:143010
Entpd1^tm1Rdr/Entpd1^tm1Rdr (involves: 129S2/SvPas)	abnormal neutrophil physiology	J:129091
	decreased platelet aggregation	J:57505
	spleen fibrosis	J:57505
	thrombocytopenia	J:57505
Entpd5^tm1Rre/Entpd5^tm1Rre (involves: 129S5/SvEvBrd * C57BL/6J)	abnormal Kupffer cell morphology	J:163795
Entpd6^{tm1a(KOMP)Wtsi}/Entpd6^{tm1a(KOMP)Wtsi} (C57BL/6N-Entpd6^{tm1a(KOMP)Wtsi}/Wtsi)	increased red blood cell distribution width	J:211773
Entpd7^tm1Ktak/Entpd7^tm1Ktak (B6.Cg-Entpd7^tm1Ktak)	abnormal CD4-positive, alpha-beta T cell number	J:191188
Entpd7^tm1Ktak/Entpd7^tm1Ktak (B6.Cg-Entpd7^tm1Ktak)	increased T-helper 17 cell number	J:191188
Entr1^em1(IMPC)Mbp/Entr1^em1(IMPC)Mbp (C57BL/6N-Entr1^em1(IMPC)Mbp/MbpMmucd)	thrombocytopenia	J:211773
Eomes^tm1.1Bflu/Eomes^tm1.1Bflu Tbx21^tm1Glm/Tbx21^tm1Glm Tg(Cd4-cre)1Cwi/0 (involves: 129S6/SvEvTac * C57BL/6 * DBA/2 * SJL)	abnormal leukocyte migration	J:163822
	decreased CD4-positive, alpha-beta T cell number	J:163822
	decreased CD8-positive, alpha-beta T cell number	J:163822
	decreased memory T cell number	J:163822
Eomes^tm1.1Bflu/Eomes^tm1.1Bflu Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2 * SJL)	abnormal leukocyte migration	J:163822
	decreased memory T cell number	J:163822
Eomes^tm1.1Twa/? Il15^tm1Imx/Il15^tm1Imx (involves: C57BL/6 * C57BL/6N)	abnormal NK cell differentiation	J:210160
Eomes^tm1.1Twa/? Tbx21^tm1Glm/Tbx21^tm1Glm (involves: 129S6/SvEvTac * C57BL/6N)	abnormal NK cell differentiation	J:210160
Eomes^tm1.1Twa/? Tg(CD2-Tbx21)#Staka/? (involves: C57BL/6N)	abnormal NK cell differentiation	J:210160
Eomes^tm1.1Twa/? Tg(Itgax-TGFBR2)1Flv/? (involves: C3H * C57BL/6 * C57BL/6N)	abnormal NK cell differentiation	J:210160
Eomes^tm1Apr/Eomes⁺ (involves: C57BL/6)	decreased memory T cell number	J:112679
Eomes^tm1Apr/Eomes⁺ (involves: C57BL/6)	decreased NK cell number	J:112679
Eomes^tm1Apr/Eomes⁺ Tbx21^tm1Srnr/Tbx21^tm1Srnr (involves: C57BL/6)	decreased memory T cell number	J:112679
	decreased NK cell number	J:112679
	decreased NK T cell number	J:112679
Eomes^tm1Srnr/Eomes^tm1Srnr Tbx21^tm1Srnr/Tbx21^tm1Srnr Tg(Cd4-cre)1Cwi/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)	abnormal CD8-positive, alpha-beta T cell differentiation	J:137655
	abnormal leukocyte physiology	J:137655
	abnormal T cell morphology	J:137655
	decreased CD8-positive, alpha-beta T cell number	J:137655
	decreased memory T cell number	J:137655
	increased neutrophil cell number	J:137655
Eomes^tm1Srnr/Eomes^tm1Srnr Tg(Cd4-cre)1Cwi/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)	decreased memory T cell number	J:137655
Ep300^Plt6/Ep300⁺ Mpl^tm1Wsa/Mpl^tm1Wsa (involves: 129S1/Sv * C57BL/6)	abnormal megakaryocyte progenitor cell morphology	J:140200
	abnormal platelet morphology	J:140200
	increased eosinophil cell number	J:140200
	increased megakaryocyte cell number	J:140200
Ep300^Plt6/Ep300^Plt6 (involves: 129S1/Sv * C57BL/6)	decreased B cell number	J:140200
	decreased eosinophil cell number	J:140200
	decreased leukocyte cell number	J:140200
	decreased lymphocyte cell number	J:140200
	thrombocytosis	J:140200
Ep300^Plt6/Ep300^Plt6 Mpl^tm1Wsa/Mpl^tm1Wsa (involves: 129S1/Sv * C57BL/6)	abnormal megakaryocyte progenitor cell morphology	J:140200
	increased megakaryocyte cell number	J:140200
	thrombocytosis	J:140200
Ep300^tm1Dli/Ep300⁺ (involves: 129S4/SvJae * C57BL/6)	hematopoietic system phenotype	J:60630
Ep300^tm1Pkb/Ep300⁺ (involves: 129P2/OlaHsd * C57BL/6)	thrombocytosis	J:98329
Ep300^tm1Pkb/Ep300⁺ Myb^tm1Ssp/Myb⁺ (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	abnormal megakaryocyte morphology	J:98329
	decreased thymocyte number	J:98329
	thrombocytosis	J:98329
Ep300^tm1Pkb/Ep300^tm1Pkb (involves: 129P2/OlaHsd * C57BL/6)	abnormal erythrocyte morphology	J:98329
	anemia	J:98329
	anisocytosis	J:98329
	decreased thymocyte number	J:98329
	increased megakaryocyte cell number	J:98329
	thrombocytosis	J:98329
Ep300^tm2Pkb/Ep300^tm2Pkb Tg(Lck-cre)548Jxm/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	decreased single-positive T cell number	J:105505
	decreased thymocyte number	J:105505
	increased double-positive T cell number	J:105505
	small thymus	J:105505
Ep400^tm1Fuku/Ep400^tm1Fuku (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal common myeloid progenitor cell morphology	J:127131
	absent erythrocytes	J:127131
	anemia	J:127131
Ep400^tm3Fuku/Ep400^tm3.1Fuku Tg(Mx1-cre)1Cgn/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	abnormal bone marrow cell morphology/development	J:166397
	abnormal bone marrow cell physiology	J:166397
	abnormal definitive hematopoiesis	J:166397
	abnormal megakaryocyte progenitor cell morphology	J:166397
	decreased bone marrow cell number	J:166397
	decreased erythroid progenitor cell number	J:166397
	decreased hematopoietic stem cell number	J:166397
Epas1^tm1.1Fsl/Epas1⁺ (involves: C57BL/6 * C57BL/6NTac)	increased erythrocyte cell number	J:199595
	increased hematocrit	J:199595
	increased hemoglobin content	J:199595
	increased leukocyte cell number	J:199595
	increased lymphocyte cell number	J:199595
	increased monocyte cell number	J:199595
Epas1^tm1.1Fsl/Epas1^tm1.1Fsl (involves: C57BL/6 * C57BL/6NTac)	increased erythrocyte cell number	J:199595
	increased hematocrit	J:199595
	increased hemoglobin content	J:199595
	increased leukocyte cell number	J:199595
	increased monocyte cell number	J:199595
	increased spleen weight	J:199595
Epas1^{tm1b(EUCOMM)Hmgu}/Epas1⁺ (C57BL/6N-Epas1^{tm1b(EUCOMM)Hmgu}/H)	decreased hemoglobin content	J:211773
Epas1^tm1Mcs/Epas1^tm1.1Mcs Ndor1^{Tg(UBC-cre/ERT2)1Ejb}/0 (involves: 129X1/SvJ * FVB/N)	abnormal hematopoietic system physiology	J:119731
	abnormal proerythroblast morphology	J:119731
	anemia	J:119731
	decreased erythrocyte cell number	J:119731
	decreased hematocrit	J:119731
	decreased hemoglobin content	J:119731
	enlarged spleen	J:119731
	reticulocytopenia	J:119731
Epas1^tm1Mcs/Epas1^tm1.1Mcs Tg(CAG-cre/Esr1)5Amc/0 (involves: 129X1/SvJ C57BL/6 * CBA)	anemia	J:302384
	decreased hematocrit	J:302384
Epas1^tm1Mcs/Epas1^tm1Mcs Hif1a^tm3Rsjo/Hif1a^tm3Rsjo Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0 (involves: 129S1/Sv * 129X1/SvJ * CD-1)	decreased erythroid progenitor cell number	J:186085
	hematopoietic system phenotype	J:186085
Epas1^tm1Mcs/Epas1^tm1Mcs Hif1a^tm3Rsjo/Hif1a^tm3Rsjo Vhl^tm1Jae/Vhl^tm1Jae Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0 (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * CD-1)	hematopoietic system phenotype	J:186085
Epas1^tm1Mcs/Epas1^tm1Mcs Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0 (involves: 129S1/Sv * 129X1/SvJ * CD-1)	decreased erythroid progenitor cell number	J:186085
Epas1^tm1Mcs/Epas1^tm1Mcs Vhl^tm1Jae/Vhl^tm1Jae Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0 (involves: 129S4/SvJae * 129X1/SvJ * CD-1)	hematopoietic system phenotype	J:186085
Epas1^tm1Yms/Epas1^tm1Yms Tg(Vil1-cre)20Syr/0 (B6.Cg-Epas1^tm1Yms Tg(Vil1-cre)20Syr)	decreased erythrocyte cell number	J:189504
	decreased hematocrit	J:189504
	decreased hemoglobin content	J:189504
Epb41^{tm1b(KOMP)Mbp}/Epb41⁺ (C57BL/6N-Epb41^{tm1b(KOMP)Mbp}/J)	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
Epb41^tm1Cnby/Epb41^tm1Cnby (involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ)	abnormal erythrocyte morphology	J:77852
	abnormal erythropoiesis	J:77852
	anisopoikilocytosis	J:77852
	decreased cellular hemoglobin content	J:77852
	decreased hematocrit	J:77852
	decreased mean corpuscular volume	J:77852
	decreased spleen iron level	J:77852
	enlarged spleen	J:77852
	extramedullary hematopoiesis	J:77852
	hemolytic anemia	J:77852
	increased mean corpuscular hemoglobin	J:77852
	increased spleen red pulp amount	J:77852
	reticulocytosis	J:77852
	spherocytosis	J:77852
Epb41l4a^{tm1b(KOMP)Mbp}/Epb41l4a^{tm1b(KOMP)Mbp} (C57BL/6N-Epb41l4a^{tm1b(KOMP)Mbp}/J)	increased mean corpuscular hemoglobin	J:211773
Epb41l5^{tm1a(EUCOMM)Hmgu}/Epb41l5⁺ (C57BL/6N-Epb41l5^{tm1a(EUCOMM)Hmgu}/H)	increased mean corpuscular volume	J:165965
Epb42^tm1Llp/Epb42^tm1Llp (involves: 129P2/OlaHsd * C57BL/6J)	abnormal erythrocyte morphology	J:67412
	anemia	J:67412
	decreased erythrocyte cell number	J:67412
	decreased hematocrit	J:67412
	decreased hemoglobin content	J:67412
	decreased mean corpuscular volume	J:67412
	increased mean corpuscular hemoglobin concentration	J:67412
	increased spleen iron level	J:67412
	increased spleen weight	J:67412
	reticulocytosis	J:67412
	spherocytosis	J:67412
Epc1^{tm1a(EUCOMM)Wtsi}/Epc1⁺ (Not Specified)	decreased leukocyte cell number	J:175295
Epc1^{tm1a(EUCOMM)Wtsi}/Epc1⁺ (Not Specified)	increased mean corpuscular volume	J:175295
Epcam^tm1.1Mcu/Epcam^tm1.1Mcu Tg(CD207-cre)1Dhka/0 (involves: 129 * C57BL/6 * C57BL/6J * SJL/J)	abnormal Langerhans cell morphology	J:182665
Epdr1^{tm1b(NCOM)Mfgc}/Epdr1^{tm1b(NCOM)Mfgc} (C57BL/6N-Epdr1^{tm1b(NCOM)Mfgc}/Tcp)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Epg5^em1(IMPC)H/Epg5^em1(IMPC)H (C57BL/6NTac-Epg5^em1(IMPC)H/H)	decreased lymphocyte cell number	J:211773
	increased basophil cell number	J:211773
	increased large unstained cell number	J:211773
	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
	increased red blood cell distribution width	J:211773
	increased spleen weight	J:211773
Epg5^tm1Ygz/Epg5^tm1Ygz (involves: 129S1/Sv * 129X1/SvJ * C57BL/6N)	microgliosis	J:196603
Epgn^tm1.1Msdr/Epgn^tm1.1Msdr (involves: 129P2/OlaHsd * C57BL/6N)	increased spleen weight	J:194427
Epha3^em1(IMPC)Mbp/Epha3^em1(IMPC)Mbp (C57BL/6N-Epha3^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	small spleen	J:211773
Epha6^{tm1b(KOMP)Wtsi}/Epha6^{tm1b(KOMP)Wtsi} (C57BL/6N-Epha6^{tm1b(KOMP)Wtsi}/Tcp)	abnormal spleen morphology	J:211773
Ephb1^em1(IMPC)Mbp/Ephb1^em1(IMPC)Mbp (C57BL/6N-Ephb1^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	small spleen	J:211773
Ephb2^em1(IMPC)Mbp/Ephb2^em1(IMPC)Mbp (C57BL/6N-Ephb2^em1(IMPC)Mbp/MbpMmucd)	small spleen	J:211773
Ephb6^tm1Jwu/Ephb6^tm1Jwu (involves: 129)	decreased T cell proliferation	J:94701
Ephb6^tm1Tom/Ephb6^tm1Tom (involves: 129S4/SvJae * C57BL/6J)	hematopoietic system phenotype	J:79747
Ephb6^tm2Tom/Ephb6^tm2Tom (involves: 129S4/SvJae * C57BL/6J)	hematopoietic system phenotype	J:79747
epi/? (involves: CBA/J)	decreased hematocrit	J:27487
	decreased leukocyte cell number	J:27487
	decreased lymphocyte cell number	J:27487
	increased neutrophil cell number	J:27487
Epm2a^{Tg(TcraK,TcrbK)TG-BFlv}/Epm2a⁺ (involves: C57BL/6J * CBA/J)	increased CD8-positive, alpha-beta T cell number	J:107545
Epn3^{tm1b(KOMP)Wtsi}/Epn3^{tm1b(KOMP)Wtsi} (C57BL/6N-Epn3^{tm1b(KOMP)Wtsi}/Ucd)	increased mean corpuscular hemoglobin	J:211773
Epo^{Tg(TAg/Epo)134.3LCPjr}/Epo⁺ ((C57BL/10 x CBA)F1 X CFLP)	anemia	J:128415
Epo^{Tg(TAg/Epo)134.3LCPjr}/Epo⁺ (involves: C57BL/6 * CBA)	anemia	J:79374
Epo^{Tg(TAg/Epo)134.3LCPjr}/Epo^{Tg(TAg/Epo)134.3LCPjr} ((C57BL/10 x CBA)F1 X CFLP)	anemia	J:128415
Epo^{Tg(TAg/Epo)134.3LCPjr}/Epo^{Tg(TAg/Epo)134.3LCPjr} (involves: C57BL/6 * CBA)	anemia	J:128248, J:79374
	increased spleen weight	J:79374
Epo^tm1Jae/Epo^tm1Jae (either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6))	abnormal erythropoiesis	J:29254
	anemia	J:29254
	increased erythroid progenitor cell number	J:29254
Epo^tm1Jae/Epo^tm1Jae (involves: 129S4/SvJae)	anemia	J:53885
Epo^tm1Knni/Epo^tm1Knni Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ (involves: 129S/Sv * C57BL/6)	abnormal erythropoiesis	J:165479
	decreased erythrocyte cell number	J:165479
	decreased hematocrit	J:165479
	decreased hemoglobin content	J:165479
Epo^tm1Knni/Epo^tm1Knni Tg(EIIa-cre)C5379Lmgd/0 (involves: C57BL/6 * FVB/N)	decreased erythrocyte cell number	J:165479
Epor^{tm1.1(EGFP/icre)Uk}/Epor⁺ Rasa3^tm1.1Llp/Rasa3^tm1.1Llp (involves: 129S1/SvImJ * BALB/cJ * C57BL/6J)	hematopoietic system phenotype	J:301035
Epor^{tm1.1(EGFP/icre)Uk}/Epor⁺ Rasa3^tm1.1Llp/Rasa3^tm1.3Llp (involves: 129S1/SvImJ * BALB/cJ * C57BL/6J)	hematopoietic system phenotype	J:301035
Epor^tm1.2Jtp/Epor^tm1.2Jtp (involves: 129P2/OlaHsd * C57BL/6)	decreased hematocrit	J:67205
	decreased spleen weight	J:67205
Epor^tm1.4Jtp/Epor⁺ (involves: 129P2/OlaHsd * C57BL/6)	increased hematocrit	J:67205
	increased hemoglobin content	J:67205
	polycythemia	J:67205
Epor^tm1.4Jtp/Epor^tm1.4Jtp (involves: 129P2/OlaHsd * C57BL/6)	abnormal proerythroblast morphology	J:67205
	anisocytosis	J:67205
	increased hematocrit	J:67205
	microcytosis	J:67205
	polycythemia	J:67205
Epor^tm1Cos/Epor^tm1Cos (involves: 129S/SvEv * C57BL/6J)	abnormal embryonic erythrocyte morphology	J:31156
	abnormal erythrocyte morphology	J:31156
	abnormal erythropoiesis	J:31156
	anemia	J:31156
	decreased erythrocyte cell number	J:31156
Epor^tm1Jae/Epor^tm1Jae (either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6))	abnormal erythropoiesis	J:29254
	anemia	J:29254
	increased erythroid progenitor cell number	J:29254
Epor^tm1Jae/Epor^tm1Jae (involves: 129S4/SvJae)	anemia	J:53885
Epor^tm1Jni/Epor^tm1Jni (involves: 129S1/Sv * C57BL/6)	abnormal erythropoiesis	J:70036
Epor^tm1Jni/Epor^tm1Jni (involves: 129S1/Sv * C57BL/6)	increased hematocrit	J:70036
Epor^tm1Lizon/Epor^tm1Lizon (involves: 129S4/SvJae * C57BL/6)	absent erythroid progenitor cell	J:35594
	anemia	J:35594
	decreased erythrocyte cell number	J:35594
	hematopoietic system phenotype	J:35594
	impaired hematopoiesis	J:35594
Epor^tm2Jni/Epor^tm2Jni (involves: 129P2/OlaHsd * C57BL/6)	abnormal erythropoiesis	J:70036
Epor^tm2Jni/Epor^tm2Jni (involves: 129P2/OlaHsd * C57BL/6)	decreased hematocrit	J:70036
Eppin^em1(IMPC)Mbp/Eppin^em1(IMPC)Mbp (C57BL/6N-Eppin^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Eps8l1^{tm2b(KOMP)Wtsi}/Eps8l1^{tm2b(KOMP)Wtsi} (C57BL/6N-Eps8l1^{tm2b(KOMP)Wtsi}/Ucd)	increased red blood cell distribution width	J:211773
Eps15^{tm1a(KOMP)Wtsi}/Eps15^{tm1a(KOMP)Wtsi} (B6JTyr;B6N-Eps15^{tm1a(KOMP)Wtsi}/Wtsi)	decreased leukocyte cell number	J:165965
	decreased mean corpuscular hemoglobin	J:165965
Eps15^{tm1a(KOMP)Wtsi}/Eps15^{tm1a(KOMP)Wtsi} (involves: C57BL/6 * C57BL/6N)	decreased mean corpuscular hemoglobin	J:213427
	decreased mean corpuscular hemoglobin concentration	J:213427
Eps15^{tm1c(KOMP)Wtsi}/Eps15^{tm1c(KOMP)Wtsi} Eps15l1^tm1.1Noff/Eps15l1^tm1.1Noff Tg(Tek-cre)1Ywa/0 (involves: C57BL/6 * C57BL/6N * SJL)	anisocytosis	J:272122
	decreased mean corpuscular volume	J:272122
	increased red blood cell distribution width	J:272122
	reticulocytosis	J:272122
Eps15^{tm1c(KOMP)Wtsi}/Eps15^{tm1c(KOMP)Wtsi} Eps15l1^tm2.1Noff/Eps15l1^tm2.1Noff Tg(Tek-cre)1Ywa/0 (involves: C57BL/6 * C57BL/6N * SJL)	abnormal erythropoiesis	J:272122
	anemia	J:272122
	anisopoikilocytosis	J:272122
	decreased erythrocyte cell number	J:272122
	decreased hematocrit	J:272122
	decreased hemoglobin content	J:272122
	decreased mean corpuscular volume	J:272122
	extramedullary hematopoiesis	J:272122
	hypochromic microcytic anemia	J:272122
	reticulocytosis	J:272122
Eps15^tm1Noff/Eps15^tm1Noff (B6.129-Eps15^tm1Noff)	abnormal spleen B cell follicle morphology	J:195689
	abnormal spleen marginal zone morphology	J:195689
	abnormal spleen white pulp morphology	J:195689
	decreased B cell number	J:195689
	decreased leukocyte cell number	J:195689
	decreased lymphocyte cell number	J:195689
	increased marginal zone B cell number	J:195689
Eps15^tm1Noff/Eps15^tm1Noff (involves: 129 * C57BL/6)	abnormal marginal zone B cell morphology	J:195689
	increased marginal zone B cell number	J:195689
	increased transitional stage T1 B cell number	J:195689
Eps15l1^em1(IMPC)J/Eps15l1^em1(IMPC)J (C57BL/6NJ-Eps15l1^em1(IMPC)J/Mmjax)	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
Epsti1^em1Mjnh/Epsti1^em1Mjnh (Not Specified)	abnormal macrophage differentiation	J:272013
Epsti1^em1Mjnh/Epsti1^em1Mjnh (Not Specified)	decreased macrophage cell number	J:272013
Epx^{tm1.1(cre)Jlee}/Epx⁺ Gt(ROSA)26Sor^tm1(DTA)Lky/Gt(ROSA)26Sor⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased eosinophil cell number	J:198489
Epx^{tm1b(EUCOMM)Wtsi}/Epx^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Epx^{tm1b(EUCOMM)Wtsi}/Orl)	increased monocyte cell number	J:211773
Epx^tm1Nal/Epx^tm1Nal (involves: 129P2/OlaHsd * 129X1/SvJ)	abnormal eosinophil morphology	J:70567
Erap1^tm1.1Gnie/Erap1^tm1.1Gnie (involves: 129S6/SvEvTac * C57BL/6)	abnormal cytotoxic T cell physiology	J:143988
	decreased T cell proliferation	J:143988
Erap1^tm1Dgen/Erap1^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6)	enlarged spleen	J:101679
	extramedullary hematopoiesis	J:101679
	thymus hyperplasia	J:101679
Erap1^tm1Iay/Erap1^tm1Iay (involves: C57BL/6)	abnormal cytotoxic T cell physiology	J:111047
Erap1^tm1Luc/Erap1^tm1Luc (involves: 129S6/SvEvTac)	abnormal CD8-positive, alpha-beta T cell physiology	J:122479
Erap1^tm1Luc/Erap1^tm1Luc (involves: 129S6/SvEvTac)	abnormal lymphocyte physiology	J:122479
Erap1^tm1Nsha/Erap1^tm1Nsha (B6.129S6-Erap1^tm1Nsha)	abnormal CD8-positive, alpha-beta T cell physiology	J:112389, J:116606
Erap1^{tm2b(EUCOMM)Wtsi}/Erap1^{tm2b(EUCOMM)Wtsi} (C57BL/6N-Erap1^{tm2b(EUCOMM)Wtsi}/Kmpc)	thrombocytosis	J:211773
Erars1^DBA/2J/? (involves: BXD2/TyJ * C57BL/6J * DBA/2J)	increased immunoglobulin level	J:96064
Erars2^C57BL/6J/? (involves: BXD2/TyJ * C57BL/6J * DBA/2J)	increased immunoglobulin level	J:96064
Erbb4^tm1Grl/Erbb4^tm1Grl Tg(Myh6-ERBB4)HT2Gass/0 (involves: 129S1/Sv * 129X1/SvJ)	increased granulocyte number	J:132190
Ercc1^tm1Jhjh/Ercc1^tm1Jhjh (involves: C57BL/6 * FVB/N)	abnormal class switch recombination	J:92471
	decreased B cell proliferation	J:92471
	spleen hypoplasia	J:92471
Ercc1^tm1Jhjh/Ercc1^tm1Jhjh (involves: 129P2/OlaHsd * C57BL/6 * FVB/N)	decreased common myeloid progenitor cell number	J:206925
	decreased erythroid progenitor cell number	J:206925
	decreased granulocyte monocyte progenitor cell number	J:206925
	decreased hematopoietic stem cell number	J:206925
	decreased megakaryocyte-erythroid progenitor cell number	J:206925
Ercc1^tm1Jhjh/Ercc1^tm2Jhjh (involves: 129P2/OlaHsd * C57BL/6 * FVB/N)	decreased common myeloid progenitor cell number	J:206925
	decreased erythroid progenitor cell number	J:206925
	decreased granulocyte monocyte progenitor cell number	J:206925
	decreased hematopoietic stem cell number	J:206925
	decreased megakaryocyte-erythroid progenitor cell number	J:206925
Ercc1^tm1Jhjh/Ercc1^tm3Jhjh Tg(Tek-cre)12Flv/0 (involves: 129P2/OlaHsd * C3H * C57BL/6 * FVB/N)	hematopoietic system phenotype	J:206925
Ercc1^tm2Jhjh/Ercc1^tm2Jhjh (involves: 129P2/OlaHsd * C57BL/6)	abnormal spleen morphology	J:41161
Ercc1^tm2Jhjh/Ercc1^tm2Jhjh (involves: 129P2/OlaHsd * C57BL/6 * FVB/N)	decreased common myeloid progenitor cell number	J:206925
	decreased erythroid progenitor cell number	J:206925
	decreased granulocyte monocyte progenitor cell number	J:206925
	decreased hematopoietic stem cell number	J:206925
	decreased megakaryocyte-erythroid progenitor cell number	J:206925
Ercc2^tm1Jhjh/Ercc2^{tm2(ERCC2)Jhjh} (involves: 129P2/OlaHsd * C57BL/6)	abnormal hemoglobin	J:48256
	anemia	J:48256
	decreased erythrocyte cell number	J:48256
	decreased hematocrit	J:48256
Ercc2^{tm2(ERCC2)Jhjh}/Ercc2^{tm2(ERCC2)Jhjh} (involves: 129P2/OlaHsd * C57BL/6)	anemia	J:116054, J:76608
	decreased erythrocyte cell number	J:76608
	decreased hematocrit	J:76608
	decreased hemoglobin content	J:76608
	enlarged spleen	J:76608
Ercc2^{tm2(ERCC2)Jhjh}/Ercc2^tm2Jmch (involves: 129P2/OlaHsd * C57BL/6)	anemia	J:116054
Ercc2^tm3Jhjh/Ercc2^tm3Jhjh (involves: 129P2/OlaHsd * C57BL/6 * FVB)	hematopoietic system phenotype	J:112689
Ercc2^tm3Jhjh/Ercc2^tm3Jhjh (involves: 129 * C57BL/6J)	microgliosis	J:179808
Ercc3^{tm1b(NCOM)Mfgc}/Ercc3⁺ (C57BL/6N-Ercc3^{tm1b(NCOM)Mfgc}/Tcp)	decreased mean corpuscular hemoglobin	J:211773
Ercc5^tm1Shm/Ercc5^tm1Shm (involves: 129S2/SvPas * C57BL/6J)	decreased spleen weight	J:53756
Ercc5^{tm2b(EUCOMM)Hmgu}/Ercc5⁺ (C57BL/6N-Ercc5^{tm2b(EUCOMM)Hmgu}/Bay)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
	thrombocytosis	J:211773
Ercc6^tm1Gvh/Ercc6^tm1Gvh (involves: 129P2/OlaHsd * C57BL/6J)	microgliosis	J:179808
Ercc6^tm1Gvh/Ercc6^tm1Gvh Xpa^tm1Gvh/Xpa^tm1Hvs Tg(Camk2a-cre)1Szi/0 (involves: 129P2/OlaHsd * C57BL/6J * CBA)	microgliosis	J:179808
Ercc6^tm1Gvh/Ercc6^tm1Gvh Xpa^tm1Gvh/Xpa^tm1Hvs Tg(Pcp2-cre)2Mpin/0 (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6J)	microgliosis	J:179808
Ercc6l2^em1Mengf/Ercc6l2^em1Mengf (Not Specified)	abnormal class switch recombination	J:311900
	decreased IgA level	J:311900
	decreased IgG1 level	J:311900
	decreased IgG2b level	J:311900
	decreased IgG3 level	J:311900
	decreased IgG level	J:311900
	decreased T cell number	J:311900
Ercc6l2^em1Mengf/Ercc6l2^em1Mengf Nhej1^em1Mengf/Nhej1^em1Mengf (Not Specified)	abnormal T cell receptor V(D)J recombination	J:311900
Ercc6l2^em2Mengf/Ercc6l2^em2Mengf (Not Specified)	abnormal class switch recombination	J:311900
Ercc8^tm1Jhjh/Ercc8^tm1Jhjh (involves: 129P2/OlaHsd * C57BL/6J)	microgliosis	J:179808
Erf^tm1Gmav/Erf^tm1Gmav (involves: 129S4/SvJae * C57BL/6 * CBA)	anemia	J:123628
Erfe^tm1Lex/Erfe⁺ (B6;129S5-Erfe^tm1Lex/Mmucd)	decreased hemoglobin content	J:211331
Erfe^tm1Lex/Erfe^tm1Lex (B6;129S5-Erfe^tm1Lex/Mmucd)	decreased hematocrit	J:211331
	decreased hemoglobin content	J:211331
	decreased mean corpuscular hemoglobin	J:211331
	decreased mean corpuscular hemoglobin concentration	J:211331
	decreased mean corpuscular volume	J:211331
Erfe^tm1Lex/Erfe^tm1Lex Hbb-b1^tm1Unc/Hbb-b1⁺ Hbb-b2^tm1Unc/Hbb-b2⁺ (involves: 129P2/OlaHsd * 129S5/SvEvBrd * C57BL/6)	decreased mean corpuscular hemoglobin	J:211331
	decreased mean corpuscular volume	J:211331
Erg^em1(IMPC)Bay/Erg⁺ (C57BL/6N-Erg^em1(IMPC)Bay/Bay)	abnormal spleen morphology	J:211773
Erg^em1(IMPC)Bay/Erg⁺ (C57BL/6N-Erg^em1(IMPC)Bay/Bay)	decreased leukocyte cell number	J:211773
Erg^mld2/Erg⁺ (involves: 129S1/Sv * C57BL/6)	decreased hematopoietic stem cell number	J:137835
	decreased transitional stage B cell number	J:137835
	hematopoietic system phenotype	J:137835
	thrombocytopenia	J:137835
Erg^mld2/Erg⁺ Mpl^tm1Wsa/Mpl^tm1Wsa (B6.Cg-Mpl^tm1Wsa Erg^mld2)	anemia	J:137835
	decreased leukocyte cell number	J:137835
	thrombocytopenia	J:137835
Erg^mld2/Erg^mld2 (involves: 129S1/Sv * C57BL/6)	abnormal embryonic erythropoiesis	J:137835
Erg^tm1.1Path/Erg^tm1.1Path (Not Specified)	pancytopenia	J:227456
Erlin1^em1(IMPC)Tcp/Erlin1^em1(IMPC)Tcp (C57BL/6N-Erlin1^em1(IMPC)Tcp/Tcp)	abnormal spleen morphology	J:211773
Ern1^tm1Rjk/Ern1^tm1Rjk (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal definitive hematopoiesis	J:106975
	abnormal pro-B cell morphology	J:106975
Ero1a^{Gt(XST171)Byg}/Ero1a^{Gt(XST171)Byg} (involves: 129P2/OlaHsd * C57BL/6J)	abnormal macrophage physiology	J:153833
	decreased macrophage apoptosis	J:153833
Errfi1^tm1Gvw/Errfi1^tm1Gvw (Not Specified)	enlarged thymus	J:100927
Esam^tm1Dvst/Esam^tm1Dvst (B6.129-Esam1^tm1Dvst)	abnormal cellular extravasation	J:124397
Esam^tm1Dvst/Esam^tm1Dvst (B6.129-Esam1^tm1Dvst)	abnormal leukocyte migration	J:124397
Esd^em1(IMPC)J/Esd^em1(IMPC)J (C57BL/6NJ-Esd^em1(IMPC)J/Mmjax)	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
Esm1^tm1.1Rha/Esm1^tm1.1Rha (involves: 129S6/SvEvTac * BALB/c * C57BL/6 * C57BL/6NTac)	abnormal cellular extravasation	J:246778
Espl1^Gt(XL058)Byg/Espl1⁺ Trp53^tm1Tyj/Trp53^tm1Tyj (B6.129-Trp53^tm1Tyj Espl1^Gt(XL058)Byg)	abnormal bone marrow cell physiology	J:174926
	abnormal splenocyte morphology	J:174926
	increased splenocyte proliferation	J:174926
Espl1^tm1.1Kna/Espl1^tm1.1Kna Tg(Mx1-cre)1Cgn/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	decreased bone marrow cell number	J:107916
Espn^je/? f/f Hps6^ru/Hps6^ru (JE/LeJ)	abnormal mast cell degranulation	J:37255
Espn^{tm1a(EUCOMM)Wtsi}/Espn^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Espn^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased hemoglobin content	J:175295
	increased mean corpuscular hemoglobin	J:175295
Esr1^tm1.1Lja/Esr1^tm1.1Mma (involves: 129P2/OlaHsd * 129S2/SvPas * 129X1/SvJ * C57BL/6)	abnormal osteoclast physiology	J:128135
Esr1^tm1.1Mma/Esr1^tm1.1Mma (involves: 129S2/SvPas * C57BL/6)	abnormal bone marrow cell physiology	J:171276
	abnormal immunoglobulin level	J:171276
	abnormal thymus physiology	J:171276
Esr1^tm1.1Ohl/Esr1^tm1.1Ohl (involves: 129S2/SvPas * C57BL/6)	abnormal bone marrow cell physiology	J:171276
	abnormal immunoglobulin level	J:171276
	abnormal thymus physiology	J:171276
Esr1^tm1.1Scma/Esr1^tm1.1Scma Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6)	abnormal osteoclast physiology	J:156947
	increased osteoclast cell number	J:156947
Esr1^tm1Arnal/Esr1^tm1Arnal (involves: C57BL/6)	abnormal immunoglobulin level	J:171276
Esr1^tm1Arnal/Esr1^tm1Arnal (involves: C57BL/6)	increased osteoclast cell number	J:171276
Esr1^tm1Ksk/Esr1^tm1Ksk (involves: 129P2/OlaHsd * C57BL/6J)	abnormal B cell number	J:82423
	abnormal bone marrow cell number	J:82423
	abnormal class switch recombination	J:82423
	abnormal immunoglobulin level	J:82423
	decreased CD4-positive, alpha-beta T cell number	J:110416
	decreased CD8-positive, alpha-beta T cell number	J:110416
	increased double-positive T cell number	J:110416
	increased IgG3 level	J:88156
	increased plasma cell number	J:88156
	increased spleen germinal center number	J:88156
	thymus hypoplasia	J:110416
Esr1^tm1Ksk/Esr1^tm1Ksk (involves: 129P2/OlaHsd)	abnormal bone marrow cell number	J:110923
	decreased immature B cell number	J:110923
	decreased mature B cell number	J:110923
	hematopoietic system phenotype	J:110923
Esr1^tm1Ksk/Esr1^tm1Ksk (involves: 129P2/OlaHsd * C57BL/6N)	abnormal B cell differentiation	J:63462
	abnormal definitive hematopoiesis	J:63462
	abnormal thymus physiology	J:111590
	decreased B cell number	J:63462
	decreased immature B cell number	J:63462
	decreased mature B cell number	J:63462
	decreased thymocyte number	J:111590
	decreased thymus weight	J:111590
Esr1^tm1Ksk/Esr1^tm1Ksk Esr2^tm1Unc/Esr2^tm1Unc (involves: 129P2/OlaHsd * C57BL/6J)	abnormal B cell number	J:82423
	abnormal bone marrow cell number	J:82423
	abnormal class switch recombination	J:82423
	abnormal immunoglobulin level	J:82423
	decreased CD4-positive, alpha-beta T cell number	J:110416
	decreased CD8-positive, alpha-beta T cell number	J:110416
	decreased spleen weight	J:110416
	increased double-positive T cell number	J:110416
	thymus hypoplasia	J:110416
Esr2^tm1Mma/Esr2^tm1Mma (involves: 129S2/SvPas)	increased neutrophil cell number	J:165719
Esr2^tm1Unc/Esr2^tm1Unc (involves: 129P2/OlaHsd * C57BL/6J)	abnormal B cell number	J:82423
	abnormal bone marrow cell number	J:82423
	abnormal leukopoiesis	J:83617
	abnormal lymphopoiesis	J:83617
	anemia	J:83617
	enlarged spleen	J:83617
	increased bone marrow cell number	J:83617
	increased erythrocyte cell number	J:83617
	increased granulocyte number	J:83617
	increased leukocyte cell number	J:83617
	increased megakaryocyte cell number	J:83617
	increased monocyte cell number	J:83617
	increased neutrophil cell number	J:83617
	increased pre-B cell number	J:83617
	increased pro-B cell number	J:83617
	spleen hyperplasia	J:83617
	spleen hypoplasia	J:110416
Esrra^{tm1.1(KOMP)Vlcg}/Esrra^{tm1.1(KOMP)Vlcg} (C57BL/6N-Esrra^{tm1.1(KOMP)Vlcg}/J)	increased mean corpuscular hemoglobin concentration	J:211773
Esrra^tm1Vgi/Esrra^tm1Vgi (involves: 129S1/Sv * 129X1/SvJ)	abnormal osteoclast differentiation	J:160910
	decreased bone marrow cell number	J:160910
	decreased osteoclast cell number	J:160910
	extramedullary hematopoiesis	J:160910
	increased splenocyte number	J:160910
Ess2^tm1.1Nbioc/Ess2^tm1.1Nbioc Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6N * DBA/2)	abnormal CD4-positive, alpha-beta T cell physiology	J:339504
	decreased CD4-positive, alpha-beta T cell number	J:339504
	decreased CD8-positive, alpha-beta T cell number	J:339504
	decreased CD8-positive, naive alpha-beta T cell number	J:339504
	decreased memory T cell number	J:339504
	increased gamma-delta T cell number	J:339504
	increased NK T cell number	J:339504
Esyt2^{tm2b(KOMP)Wtsi}/Esyt2⁺ (C57BL/6N-Esyt2^{tm2b(KOMP)Wtsi}/Bay)	enlarged spleen	J:211773
Esyt3^{tm1b(EUCOMM)Wtsi}/Esyt3^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Esyt3^{tm1b(EUCOMM)Wtsi}/H)	decreased erythrocyte cell number	J:211773
	increased mean corpuscular volume	J:211773
Etfb^{em1(IMPC)Hmgu}/Etfb⁺ (C57BL/6NCrl-Etfb^{em1(IMPC)Hmgu}/Ieg)	increased spleen weight	J:211773
Ethe1^{tm1b(EUCOMM)Wtsi}/Ethe1⁺ (C57BL/6N-Ethe1^{tm1b(EUCOMM)Wtsi}/H)	decreased mean platelet volume	J:211773
Etnk1^{tm1b(EUCOMM)Wtsi}/Etnk1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Etnk1^{tm1b(EUCOMM)Wtsi}/Bay)	abnormal spleen morphology	J:211773
Ets1^tm1.1Dds/Ets1⁺ (129S6/SvEvTac-Ets1^tm1.1Dds)	abnormal thymus morphology	J:121460
	decreased memory T cell number	J:121460
	decreased thymocyte apoptosis	J:121460
	enlarged thymus	J:121460
	increased splenocyte apoptosis	J:121460
	increased thymus weight	J:121460
Ets1^tm1.1Dds/Ets1^tm1.1Dds (129S6/SvEvTac-Ets1^tm1.1Dds)	abnormal CD8-positive, alpha beta T cell morphology	J:121460
	abnormal lymphopoiesis	J:121460
	abnormal spleen morphology	J:121460
	abnormal spleen red pulp morphology	J:121460
	abnormal thymus cortex morphology	J:121460
	abnormal thymus morphology	J:121460
	abnormal thymus subcapsular epithelium morphology	J:121460
	decreased B cell number	J:121460
	decreased CD4-positive, alpha-beta T cell number	J:121460
	decreased leukocyte cell number	J:121460
	decreased memory T cell number	J:121460
	decreased spleen weight	J:121460
	decreased thymocyte apoptosis	J:121460
	enlarged thymus	J:121460
	increased double-positive T cell number	J:121460
	increased splenocyte apoptosis	J:121460
	increased thymus weight	J:121460
	small spleen	J:121460
Ets1^tm1Fwa/Ets1^tm1Fwa (B6.129S4-Ets1^tm1Fwa)	abnormal B cell differentiation	J:93845
	absent B-1a cells	J:93845
	decreased B cell number	J:93845
	decreased B cell proliferation	J:93845
	decreased mature B cell number	J:93845
	decreased pro-B cell number	J:93845
	increased B cell apoptosis	J:93845
	increased pro-B cell number	J:93845
Ets1^tm1Jml/Ets1^tm1Jml (involves: 129S/SvEv * C57BL/6)	abnormal CD8-positive, alpha-beta T cell differentiation	J:125056
	decreased CD4-positive, alpha-beta T cell number	J:125056
	decreased CD8-positive, alpha-beta T cell number	J:125056
	increased double-negative T cell number	J:125056
	thymus hypoplasia	J:125056
Ets1^tm1Jml/Ets1^tm1Jml Tg(TcraH-Y,TcrbH-Y)71Vbo/0 (involves: 129S/SvEv * C57BL/6 * C57BL/6J * DBA/2J)	decreased CD8-positive, alpha-beta T cell number	J:125056
	increased double-negative T cell number	J:125056
Ets1^tm2Jml/Ets1^tm2Jml (involves: 129X1/SvJ * C57BL/6)	abnormal CD8-positive, alpha beta T cell morphology	J:50627
	abnormal leukocyte physiology	J:50627
	abnormal NK cell physiology	J:50627
	abnormal T cell activation	J:50627
	decreased NK cell number	J:50627
	decreased T cell number	J:50627
	decreased T cell proliferation	J:50627
	decreased thymocyte number	J:50627
	hematopoietic system phenotype	J:50627
	impaired natural killer cell mediated cytotoxicity	J:50627
	increased plasma cell number	J:50627
Etv2^tm1Dlim/Etv2⁺ (Not Specified)	decreased hematopoietic stem cell number	J:172687
Etv2^tm1Dlim/Etv2^tm1Dlim (involves: C57BL/6)	abnormal embryonic erythropoiesis	J:155850
Etv2^tm1Dlim/Etv2^tm2.1Dlim Tg(Mx1-cre)1Cgn/0 (involves: 129S4/SvJaeSor * C57BL/6 * CBA)	abnormal hematopoietic stem cell physiology	J:172687
	abnormal myeloblast morphology/development	J:172687
	decreased bone marrow cell number	J:172687
	decreased hematopoietic stem cell number	J:172687
	decreased leukocyte cell number	J:172687
	impaired myelopoiesis	J:172687
	spleen hypoplasia	J:172687
Etv2^tm1Vkou/Etv2^tm1Vkou Tg(Pgk1-cre)1Lni/0 (involves: BALB/c * C57BL/6)	absent erythrocytes	J:194572
	absent erythroid progenitor cell	J:194572
Etv2^tm2.1Nshk/Etv2^tm2.1Nshk Tg(Pdgfra-cre/ERT2)1Wdr/0 (involves: C57BL/6NCrlj * CBA/JNCrlj)	decreased hematopoietic cell number	J:193389
Etv6^{em1(IMPC)Rbrc}/Etv6⁺ (C57BL/6NJcl-Etv6^{em1(IMPC)Rbrc}/Rbrc)	decreased erythrocyte cell number	J:211773
	increased large unstained cell number	J:211773
	increased spleen weight	J:211773
	thrombocytopenia	J:211773
Etv6^em3Knic/Etv6⁺ (involves: C57BL/6J)	abnormal B cell number	J:342774
	abnormal common myeloid progenitor cell morphology	J:342774
	abnormal hematopoietic precursor cell morphology	J:342774
	abnormal hemopoiesis	J:342774
	abnormal platelet shape	J:342774
	hematopoietic system phenotype	J:342774
Etv6^{tm1(RUNX1)Haho}/Etv6⁺ Runx1^tm3Spe/Runx1⁺ Tg(Mx1-cre)1Cgn/0 (involves: 129S1/Sv * 129S4/SvJae * C57BL/6 * CBA)	increased hematopoietic stem cell number	J:151639
Etv6^{tm1(RUNX1)Haho}/Etv6⁺ Runx1^tm3Spe/Runx1^tm3Spe Tg(Mx1-cre)1Cgn/0 (involves: 129S1/Sv * 129S4/SvJae * C57BL/6 * CBA)	anemia	J:151639
	decreased hematopoietic stem cell number	J:151639
Etv6^{tm1(RUNX1)Haho}/Etv6⁺ Tg(Gata1-cre)1Sho/0 (involves: 129S1/Sv * C57BL/6 * CD-1 * Swiss Webster)	abnormal B cell differentiation	J:151639
Etv6^{tm1(RUNX1)Haho}/Etv6⁺ Tg(Mx1-cre)1Cgn/0 (involves: 129S1/Sv * C57BL/6 * CBA)	abnormal bone marrow cell physiology	J:151639
	abnormal common lymphocyte progenitor cell morphology	J:151639
	abnormal common myeloid progenitor cell morphology	J:151639
	abnormal definitive hematopoiesis	J:151639
	abnormal lymphopoiesis	J:151639
	decreased B cell number	J:151639
	decreased erythroid progenitor cell number	J:151639
	decreased lymphocyte cell number	J:151639
	decreased neutrophil cell number	J:151639
	increased hematopoietic stem cell number	J:151639
	myeloid hyperplasia	J:151639
	thrombocytopenia	J:151639
Etv6^{tm1(RUNX1)Haho}/Etv6⁺ Tg(VAV1-cre)1Graf/0 (involves: 129S1/Sv * C57BL/6)	abnormal myeloblast morphology/development	J:151639
	arrested B cell differentiation	J:151639
	decreased B cell number	J:151639
	decreased pre-B cell number	J:151639
	decreased pro-B cell number	J:151639
	increased hematopoietic stem cell number	J:151639
Etv6^tm2.1Sho/Etv6^tm2.1Sho (involves: 129S1/Sv)	abnormal erythropoiesis	J:93052
Etv6^tm2Sho/Etv6^tm2Sho Tg(Gata1-cre)1Sho/? (involves: 129S1/Sv)	abnormal megakaryocyte differentiation	J:93052
	thrombocytopenia	J:93052
Etv6^tm2Sho/Etv6^tm2Sho Tg(Mx1-cre)1Cgn/? (involves: 129S1/Sv * C57BL/6 * CBA)	decreased neutrophil cell number	J:93052
	thrombocytopenia	J:93052
Evc2^em1(IMPC)Mbp/Evc2^em1(IMPC)Mbp (C57BL/6N-Evc2^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	small spleen	J:211773
Evl^{tm1b(KOMP)Wtsi}/Evl^{tm1b(KOMP)Wtsi} (C57BL/6N-Evl^{tm1b(KOMP)Wtsi}/H)	thrombocytosis	J:211773
Evl^tm1Lfr/Evl^tm1Lfr (involves: 129X1/SvJ * C57BL/6)	abnormal leukocyte migration	J:94077
Ewsr1^tm1(ERG)Thr/Ewsr1⁺ Rag1^tm1(cre)Thr/Rag1⁺ (involves: 129S/SvEv)	increased lymphocyte cell number	J:98679
Ewsr1^{tm1b(EUCOMM)Wtsi}/Ewsr1⁺ (C57BL/6N-Ewsr1^{tm1b(EUCOMM)Wtsi}/Tcp)	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
Ewsr1^tm1Sblee/Ewsr1^tm1Sblee (involves: 129S6/SvEvTac * Black Swiss)	decreased double-positive T cell number	J:122058
	decreased immature B cell number	J:122058
	decreased leukocyte cell number	J:122058
	decreased mature B cell number	J:122058
	decreased pre-B cell number	J:122058
	spleen hypoplasia	J:122058
	thymus hypoplasia	J:122058
Exd1^{tm1b(EUCOMM)Hmgu}/Exd1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Exd1^{tm1b(EUCOMM)Hmgu}/Orl)	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular hemoglobin concentration	J:211773
Exo1^tm2Wed/Exo1^tm2Wed (involves: 129 * C57BL/6)	abnormal class switch recombination	J:198719
Exo1^tm2Wed/Exo1^tm2Wed (involves: 129 * C57BL/6)	abnormal somatic hypermutation frequency	J:198719
Exoc3^{tm2c(EUCOMM)Hmgu}/Exoc3^{tm2c(EUCOMM)Hmgu} Tg(Pf4-icre)Q3Rsko/0 (involves: C57BL/6 * C57BL/6N)	abnormal platelet physiology	J:302300
	decreased platelet aggregation	J:302300
	decreased platelet dense granule secretion	J:302300
	increased mean platelet volume	J:302300
	increased platelet dense granule secretion	J:302300
Exoc6^hbd/Exoc6^hbd (AB.Cg-Exoc6^hbd)	anisocytosis	J:8251
	decreased erythrocyte osmotic fragility	J:8251
	decreased hemoglobin content	J:8251
	decreased mean corpuscular hemoglobin	J:8251
	decreased spleen iron level	J:8251
	enlarged spleen	J:8251
	increased erythrocyte protoporphyrin level	J:8251
	microcytic anemia	J:8251
	microcytosis	J:8251
	poikilocytosis	J:8251
	polychromatophilia	J:8251
	reticulocytosis	J:8251
Exoc6^hbd/Exoc6^hbd (B6.Cg-Exoc6^hbd/J)	abnormal erythrocyte morphology	J:105712
	abnormal erythropoiesis	J:42436
	decreased hematocrit	J:42436, J:105712
	decreased hemoglobin content	J:42436, J:105712
	decreased mean corpuscular hemoglobin concentration	J:42436
	decreased mean corpuscular volume	J:42436, J:105712
	increased erythrocyte protoporphyrin level	J:42436
	microcytic anemia	J:42436, J:105712
	microcytosis	J:42436
Exoc6^hbd/Exoc6^hbd (involves: STOCK A^y)	abnormal proerythroblast morphology	J:5439
	decreased erythrocyte cell number	J:5439
	decreased erythrocyte osmotic fragility	J:5439
	decreased mean corpuscular hemoglobin	J:5439
	hyperchromasia	J:5439
	hypochromic anemia	J:5439
	increased mean corpuscular volume	J:5439
	macrocytosis	J:5439
	polychromatophilia	J:5439
Exosc8^{tm1.1(KOMP)Vlcg}/Exosc8⁺ (C57BL/6N-Exosc8^{tm1.1(KOMP)Vlcg}/J)	increased mean corpuscular hemoglobin	J:211773
Exph5^tm1Tiz/Exph5^tm1Tiz (B6NJcl.Cg-Exph5^tm1Tiz/Tiz)	abnormal T-helper 2 physiology	J:313415
Extl3^em1(IMPC)Mbp/Extl3⁺ (C57BL/6N-Extl3^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Eya1^tm1Rilm/Eya1^tm1Rilm (either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * BALB/c) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))	athymia	J:79848, J:57313
Eya2^em1(IMPC)Mbp/Eya2^em1(IMPC)Mbp (C57BL/6N-Eya2^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	small spleen	J:211773
Eya2^tm2Px/Eya2^tm2Px (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	small thymus	J:311538
Ezh1^{tm1b(EUCOMM)Wtsi}/Ezh1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Ezh1^{tm1b(EUCOMM)Wtsi}/Nju)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased red blood cell distribution width	J:211773
Ezh1^tm1Sgon/Ezh1^tm1Sgon Tg(VAV1-cre)1Graf/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal bone marrow cell physiology	J:193722
	abnormal common lymphocyte progenitor cell morphology	J:193722
	abnormal hematopoietic stem cell physiology	J:193722
	abnormal myeloid leukocyte morphology	J:193722
	absent spleen germinal center	J:193722
	decreased B cell number	J:193722
	decreased bone marrow cell number	J:193722
	decreased hematopoietic stem cell number	J:193722
	decreased immature B cell number	J:193722
	decreased pro-B cell number	J:193722
	decreased spleen red pulp amount	J:193722
	decreased spleen white pulp amount	J:193722
	hematopoietic system phenotype	J:193722
	small spleen	J:193722
Ezh2^em1Jbn/Ezh2⁺ (C57BL/6J-Ezh2^em1Jbn)	increased spleen weight	J:267184
Ezh2^tm1.1Nesh/Ezh2⁺ Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129 * 129P2/OlaHsd * C57BL/6)	abnormal spleen morphology	J:239472
	abnormal spleen white pulp morphology	J:239472
	enlarged spleen	J:239472
Ezh2^tm1.1Nesh/Ezh2^tm1.1Nesh Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129 * 129P2/OlaHsd * C57BL/6)	enlarged spleen	J:239472
Ezh2^{tm1a(EUCOMM)Wtsi}/Ezh2⁺ (C57BL/6N-Ezh2^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased mean corpuscular hemoglobin	J:175295
Ezh2^tm1Tara/Ezh2^tm1Tara Ighg1^tm1(cre)Cgn/Ighg1⁺ (involves: 129P2/OlaHsd)	decreased B cell proliferation	J:199122
	decreased germinal center B cell number	J:199122
	decreased IgG1 level	J:199122
	decreased IgG2b level	J:199122
	decreased IgG3 level	J:199122
	decreased spleen germinal center number	J:199122
	decreased spleen germinal center size	J:199122
Ezh2^tm1Tara/Ezh2^tm1Tara Tg(Mx1-cre)1Cgn/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	abnormal B cell differentiation	J:83216
	abnormal immunoglobulin V(D)J recombination	J:83216
	abnormal pro-B cell morphology	J:83216
	decreased immature B cell number	J:83216
	decreased pre-B cell number	J:83216
Ezh2^tm2Sho/Ezh2^tm2.1Sho Tg(Mx1-cre)1Cgn/0 (involves: 129S1/Sv * C57BL/6 * CBA)	decreased double-positive T cell number	J:182211
	decreased thymocyte number	J:182211
	enlarged spleen	J:182211
	increased double-negative T cell number	J:182211
Ezh2^tm2Sho/Ezh2^tm2Sho Pgr^tm2(cre)Lyd/Pgr⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased uterine NK cell number	J:290765
Ezh2^tm2Sho/Ezh2^tm2Sho Tg(Mx1-cre)1Cgn/0 (involves: 129S1/Sv * C57BL/6 * CBA)	decreased double-positive T cell number	J:182211
	decreased thymocyte number	J:182211
	enlarged spleen	J:182211
	increased double-negative T cell number	J:182211
f/f (Not Specified)	abnormal definitive hematopoiesis	J:13598
	anemia	J:12951, J:13090
	decreased erythrocyte cell number	J:13090
	hypochromic microcytic anemia	J:13598
f/f (FL/1ReJ)	decreased erythrocyte cell number	J:24610
	decreased hematocrit	J:24610
	decreased mean corpuscular volume	J:24610
	impaired hematopoiesis	J:5654
f/f (involves: CBA/St)	anemia	J:164714, J:14979
	decreased mean corpuscular hemoglobin	J:164714
	hypochromic anemia	J:164714
	increased siderocyte number	J:14979
	reticulocytosis	J:164714
f/f Kit^W/Kit⁺ (FL/1Re-Kit^W/J)	abnormal erythrocyte cell number	J:24610
	decreased hematocrit	J:24610
	decreased mean corpuscular volume	J:24610
F2^{tm1b(EUCOMM)Hmgu}/F2⁺ (C57BL/6N-F2^{tm1b(EUCOMM)Hmgu}/H)	decreased mean corpuscular volume	J:211773
F2r^tm1Ajc/F2r^tm1Ajc (involves: 129S4/SvJae * C57BL/6J)	hematopoietic system phenotype	J:33380
F2rl1^tm1Cgh/F2rl1^tm1Cgh (involves: 129S4/SvJae * C57BL/6)	impaired leukocyte tethering or rolling	J:76626
F2rl1^tm1Cgh/F2rl1^tm1Cgh (B6.129S4-F2rl1^tm1Cgh)	decreased dendritic cell number	J:113591
F2rl1^tm1Mslb/F2rl1^tm1Mslb (involves: 129X1/SvJ * C57BL/6)	decreased IgE level	J:79757
F2rl2^tm1Cgh/F2rl2^tm1Cgh (involves: 129S4/SvJae * C57BL/6)	abnormal platelet physiology	J:49283
F3^tm1.1Dwr/F3^tm1.1Dwr (involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6)	hematopoietic system phenotype	J:71271
F3^tm1.1Dwr/F3^tm1.1Dwr (involves: 129S1/Sv * 129X1/SvJ * MF1 * Swiss)	abnormal cellular extravasation	J:91165
	abnormal leukocyte adhesion	J:91165
	decreased B cell number	J:91165
	decreased leukocyte cell number	J:91165
	decreased neutrophil cell number	J:91165
	impaired leukocyte tethering or rolling	J:91165
F3^tm1Fct/F3^tm1Fct (involves: 129P2/OlaHsd * C57BL/6J)	abnormal embryonic erythrocyte morphology	J:216519
F3^tm1Gjb/F3⁺ (involves: 129X1/SvJ * C57BL/6)	abnormal macrophage physiology	J:128891
F3^tm1Jld/F3^tm1Jld (involves: 129P2/OlaHsd * NIH Black Swiss)	abnormal embryonic erythrocyte morphology	J:33831
F8^tm1Kaz/Y (involves: 129S4/SvJae * C57BL/6)	hematopoietic system phenotype	J:24941, J:36698
F8^tm1Kaz/F8^tm1Kaz (involves: 129S4/SvJae * C57BL/6)	hematopoietic system phenotype	J:36698
F9^tm1Dws/Y (involves: 129P2/OlaHsd * C57BL/6)	enlarged spleen	J:44497
F9^tm1Dws/Y (involves: 129P2/OlaHsd)	decreased hematocrit	J:166332
F9^tm1Dws/F9^tm1Dws (involves: 129P2/OlaHsd)	decreased hematocrit	J:166332
F9^tm3Dws/Y (B6.129P2-F9^tm3Dws)	decreased hematocrit	J:166332
F9^tm3Dws/F9^tm3Dws (B6.129P2-F9^tm3Dws)	decreased hematocrit	J:166332
F11^tm1Gjb/F11^tm1Gjb (involves: 129X1/SvJ * C57BL/6)	decreased platelet aggregation	J:100529
F11^tm1Gjb/F11^tm1Gjb Proc^tm1Fjc/Proc^tm1Fjc (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal neutrophil morphology	J:67398
	anisocytosis	J:67398
	decreased leukocyte cell number	J:67398
	decreased neutrophil cell number	J:67398
	increased number of Howell-Jolly bodies	J:67398
	reticulocytosis	J:67398
F13a1^tm1Gdi/F13a1^tm1Gdi (involves: 129P2/OlaHsd * CBA/Ca)	hematopoietic system phenotype	J:87293
Fa2h^em1(IMPC)Mbp/Fa2h^em1(IMPC)Mbp (C57BL/6NCrl-Fa2h^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Faah^em1(IMPC)H/Faah^em1(IMPC)H (C57BL/6NTac-Faah^em1(IMPC)H/H)	increased mean platelet volume	J:211773
Faap20^tm1(KOMP)Mbp/Faap20^tm1(KOMP)Mbp (involves: C57BL/6 * C57BL/6N)	abnormal hematopoietic system physiology	J:224688
	pancytopenia	J:224688
Faap20^tm1(KOMP)Mbp/Faap20^tm1(KOMP)Mbp Fanca^tm1.1Wong/Fanca^tm1.1Wong (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6N)	abnormal hematopoietic system physiology	J:224688
Fabp1^{tm1b(EUCOMM)Hmgu}/Fabp1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Fabp1^{tm1b(EUCOMM)Hmgu}/Cnrm)	decreased large unstained cell number	J:211773
	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	decreased monocyte cell number	J:211773
Fabp7^em1(IMPC)H/Fabp7^em1(IMPC)H (C57BL/6N-Fabp7^em1(IMPC)H/H)	decreased erythrocyte cell number	J:211773
	increased mean corpuscular hemoglobin	J:211773
Fadd^tm1Wnt/Fadd^tm1Wnt Tg(Fadd)33Wnt/0 Tg(Lck-cre)I57Jxm/0 (involves: 129S4/SvJae * C57BL/6 * CBA * ICR)	abnormal T cell differentiation	J:69617
	decreased CD4-positive, alpha-beta T cell number	J:69617
	decreased CD8-positive, alpha-beta T cell number	J:69617
	decreased double-positive T cell number	J:69617
	increased B cell number	J:69617
	increased double-negative T cell number	J:69617
	thymus hypoplasia	J:69617
Fadd^tm1Wnt/Fadd^tm1Wnt Tg(Fadd)33Wnt/0 Tg(Lck-cre)I57Jxm/0 Tg(Tcra2C,Tcrb2C)1Dlo/0 (involves: 129S4/SvJae * C57BL/6 * C57L * CBA * ICR * SJL)	increased double-negative T cell number	J:69617
	thymus hypoplasia	J:69617
Fadd^tm1Wnt/Fadd^tm1Wnt Tg(Fadd/EGFP)#Jizh/? Tg(Cd4-cre)1Cwi/? (involves: 129S4/SvJae * C57BL/6 * DBA/2)	decreased activated T cell number	J:113207
	decreased single-positive T cell number	J:113207
	increased B cell number	J:113207
Fadd^tm1Wnt/Fadd^tm1Wnt Tg(Fadd/EGFP)#Jizh/? Tg(Lck-cre)1Cwi/? (involves: 129S4/SvJae)	decreased activated T cell number	J:113207
	decreased single-positive T cell number	J:113207
	increased B cell number	J:113207
Fadd^tm1Wnt/Fadd^tm1Wnt Tg(Fadd/EGFP)#Jizh/? Tg(Mx1-cre)1Cgn/? (involves: 129S4/SvJae * C57BL/6 * CBA)	abnormal bone marrow cell morphology/development	J:168722
	abnormal erythrocyte morphology	J:168722
	decreased bone marrow cell number	J:168722
	spleen hypoplasia	J:168722
	thymus hypoplasia	J:168722
Fadd^tm2.1Wnt/Fadd^tm2.1Wnt Tg(Cd4-cre)1Cwi/? (B6.Cg-Tg(Cd4-cre)1Cwi Fadd^tm2.1Wnt)	abnormal erythrocyte cell number	J:162312
	abnormal T cell proliferation	J:162312
	abnormal T cell subpopulation ratio	J:162312
	abnormal thymocyte apoptosis	J:162312
	enlarged spleen	J:162312
	increased B cell number	J:162312
Fads1^{Gt(IST11525H2)Tigm}/Fads1^{Gt(IST11525H2)Tigm} (C57BL/6-Fads1^{Gt(IST11525H2)Tigm})	abnormal mononuclear cell morphology	J:186265
	decreased regulatory T cell number	J:186265
Fads2^tm1Mtna/Fads2^tm1Mtna (involves: 129S6/SvEvTac * C57BL/6J)	abnormal spleen white pulp morphology	J:153293
	abnormal thymus cortex morphology	J:153293
	enlarged spleen	J:153293
	increased spleen red pulp amount	J:153293
	small thymus	J:153293
Fads2^tm1Wst/Fads2^tm1Wst (involves: 129P2/OlaHsd)	abnormal macrophage physiology	J:140341
	abnormal platelet physiology	J:140341
	decreased platelet aggregation	J:140341
Fah^em1(IMPC)Mbp/Fah⁺ (C57BL/6N-Fah^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
Fah^em1(IMPC)Mbp/Fah⁺ (C57BL/6N-Fah^em1(IMPC)Mbp/MbpMmucd)	enlarged spleen	J:211773
Faim^tm1Kplm/Faim^tm1Kplm (involves: 129P2/OlaHsd * C57BL/6)	increased B cell apoptosis	J:164184
	increased thymocyte apoptosis	J:164184
Fam3a^em1Cya/Fam3a^em1Cya (involves: C57BL/6)	increased macrophage cell number	J:295206
	increased NK T cell number	J:295206
	increased T cell number	J:295206
Fam3d^em1Wko/Fam3d^em1Wko (C57BL/6-Fam3d^em1Wko)	abnormal neutrophil physiology	J:304594
	decreased Ly6C high monocyte number	J:304594
	decreased macrophage cell number	J:304594
	decreased neutrophil cell number	J:304594
	enlarged spleen	J:300819
	increased leukocyte cell number	J:300819
	increased neutrophil cell number	J:304594, J:300819
Fam20c^tm1Lex/Fam20c^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	extramedullary hematopoiesis	J:186384
Fam24b^em1(IMPC)J/Fam24b^em1(IMPC)J (C57BL/6NJ-Fam24b^em1(IMPC)J/Mmjax)	decreased mean corpuscular volume	J:211773
Fam53a^{em1(IMPC)Ccpcz}/Fam53a^{em1(IMPC)Ccpcz} (C57BL/6N-Fam53a^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Fam53b^{tm1b(EUCOMM)Hmgu}/Fam53b^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Fam53b^{tm1b(EUCOMM)Hmgu}/Cnrm)	decreased erythrocyte cell number	J:211773
	decreased red blood cell distribution width	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
Fam72a^{tm1.1(KOMP)Vlcg}/Fam72a^{tm1.1(KOMP)Vlcg} (C57BL/6NTac-Fam72a^{tm1.1(KOMP)Vlcg})	abnormal class switch recombination	J:326431
	abnormal somatic hypermutation frequency	J:326431
	increased B cell apoptosis	J:326431
	increased germinal center B cell number	J:326431
Fam72a^{tm1.1(KOMP)Vlcg}/Fam72a^{tm1.1(KOMP)Vlcg} Msh2^tm1Mak/Msh2^tm1Mak (C57BL/6NTac-Fam72a^{tm1.1(KOMP)Vlcg} Msh2^tm1Mak)	abnormal class switch recombination	J:326431
	abnormal somatic hypermutation frequency	J:326431
Fam81a^{em1(IMPC)Ccpcz}/Fam81a^{em1(IMPC)Ccpcz} (C57BL/6N-Fam81a^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Fam83b^em1(IMPC)Mbp/Fam83b^em1(IMPC)Mbp (C57BL/6NCrl-Fam83b^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Fam83d^{em1(IMPC)Ccpcz}/Fam83d^{em1(IMPC)Ccpcz} (C57BL/6N-Fam83d^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Fam83g^{tm1a(EUCOMM)Wtsi}/Fam83g^{tm1a(EUCOMM)Wtsi} (Not Specified)	increased erythrocyte cell number	J:165965
	increased hematocrit	J:165965
Fam83h^{em1(IMPC)Ccpcz}/Fam83h^{em1(IMPC)Ccpcz} (C57BL/6N-Fam83h^{em1(IMPC)Ccpcz}/Ccpcz)	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
Fam107b^{tm1a(KOMP)Wtsi}/Fam107b^{tm1a(KOMP)Wtsi} (B6JTyr;B6N-Fam107b^{tm1a(KOMP)Wtsi}/Wtsi)	increased erythrocyte cell number	J:175295
Fam110b^{tm1a(EUCOMM)Wtsi}/Fam110b⁺ (C57BL/6N-Fam110b^{tm1a(EUCOMM)Wtsi}/Cnrm)	decreased mature B cell number	J:165965
	increased erythrocyte cell number	J:165965
	increased leukocyte cell number	J:165965
Fam120c^{em1(IMPC)Ccpcz}/Fam120c^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Fam120c^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Fam124a^{em1(IMPC)Ccpcz}/Fam124a^{em1(IMPC)Ccpcz} (C57BL/6N-Fam124a^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Fam135a^em1(IMPC)Tcp/Fam135a^em1(IMPC)Tcp (C57BL/6NCrl-Fam135a^em1(IMPC)Tcp/Tcp)	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
Fam151b^{tm1b(EUCOMM)Hmgu}/Fam151b^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Fam151b^{tm1b(EUCOMM)Hmgu}/H)	increased neutrophil cell number	J:211773
Fam161a^{Gt(462E7)Cmhd}/Fam161a^{Gt(462E7)Cmhd} (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	microgliosis	J:214319
Fam161b^{em1(IMPC)Ccpcz}/Fam161b^{em1(IMPC)Ccpcz} (C57BL/6N-Fam161b^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Fam163a^{tm2b(KOMP)Wtsi}/Fam163a^{tm2b(KOMP)Wtsi} (C57BL/6N-Fam163a^{tm2b(KOMP)Wtsi}/Wtsi)	increased erythrocyte cell number	J:211773
	increased hematocrit	J:211773
	increased hemoglobin content	J:211773
	increased leukocyte cell number	J:211773
Fam167a^{em1(IMPC)Ccpcz}/Fam167a^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Fam167a^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Fam185a^{em1(IMPC)Ccpcz}/Fam185a^{em1(IMPC)Ccpcz} (C57BL/6N-Fam185a^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Fam193a^em1(IMPC)J/Fam193a⁺ (C57BL/6NJ-Fam193a^em1(IMPC)J/Mmjax)	increased mean corpuscular volume	J:211773
Fam209^{tm1b(KOMP)Wtsi}/Fam209^{tm1b(KOMP)Wtsi} (C57BL/6N-Fam209^{tm1b(KOMP)Wtsi}/Bay)	abnormal spleen morphology	J:211773
Fam210a^{tm1b(EUCOMM)Wtsi}/Fam210a⁺ (C57BL/6N-Fam210a^{tm1b(EUCOMM)Wtsi}/Tcp)	increased mean corpuscular volume	J:211773
Fam210a^{tm1b(EUCOMM)Wtsi}/Fam210a⁺ (involves: BALB/cJ * C57BL/6N)	increased osteoclast cell number	J:261817
Fam210a^{tm1c(EUCOMM)Wtsi}/Fam210a^{tm1c(EUCOMM)Wtsi} Tg(ACTA1-cre/Esr1)2Kesr/0 (involves: C3H C57BL/6N * SJL)	increased osteoclast cell number	J:261817
Fam210a^{tm1c(EUCOMM)Wtsi}/Fam210a^{tm1c(EUCOMM)Wtsi} Tg(CAG-cre/Esr1)5Amc/0 (involves: C57BL/6N CBA * SJL)	increased osteoclast cell number	J:261817
Fam210b^{tm1b(KOMP)Mbp}/Fam210b^{tm1b(KOMP)Mbp} (C57BL/6N-Fam210b^{tm1b(KOMP)Mbp}/Ucd)	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Fam219a^{em1(IMPC)Ccpcz}/Fam219a^{em1(IMPC)Ccpcz} (C57BL/6N-Fam219a^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Fam221a^{em1(IMPC)Ccpcz}/Fam221a^{em1(IMPC)Ccpcz} (C57BL/6N-Fam221a^{em1(IMPC)Ccpcz}/Ccpcz)	increased CD8-positive, naive alpha-beta T cell number	J:211773
	increased erythrocyte cell number	J:211773
	increased hematocrit	J:211773
	increased neutrophil cell number	J:211773
Fam227b^{em1(IMPC)Ccpcz}/Fam227b^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Fam227b^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Fam234b^{tm1a(EUCOMM)Wtsi}/Fam234b^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Fam234b^{tm1a(EUCOMM)Wtsi}/Cnrm)	decreased CD8-positive, alpha-beta T cell number	J:165965
Fan1^{tm1d(KOMP)Wtsi}/Fan1^{tm1d(KOMP)Wtsi} (involves: C57BL/6N * FVB/N)	abnormal hematopoietic stem cell physiology	J:232402
	hematopoietic system phenotype	J:232402
Fan1^{tm1d(KOMP)Wtsi}/Fan1^{tm1d(KOMP)Wtsi} Fancd2^tm1Hou/Fancd2^tm1Hou (involves: 129S4/SvJae * C57BL/6N * FVB/N)	abnormal hematopoietic stem cell morphology	J:232402
Fanca^tm1Faw/Fanca^tm1Faw (involves: 129P2/OlaHsd * FVB)	increased mean corpuscular volume	J:63742
Fanca^tm1Faw/Fanca^tm1Faw (involves: 129P2/OlaHsd * FVB)	thrombocytopenia	J:63742
Fancc^tm1Mab/Fancc^tm1Mab (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal common lymphocyte progenitor cell morphology	J:71134
	abnormal hematopoietic stem cell physiology	J:47897
	abnormal hematopoietic system physiology	J:47897
	decreased common myeloid progenitor cell number	J:71134
	hematopoietic system phenotype	J:32080
	thrombocytopenia	J:71134
Fancc^tm1Mab/Fancc^tm1Mab Sod1^tm1Cep/Sod1^tm1Cep (involves: 129S1/Sv * 129X1/SvJ)	abnormal bone marrow cell morphology/development	J:71134
	abnormal common lymphocyte progenitor cell morphology	J:71134
	abnormal lymphocyte morphology	J:71134
	decreased bone marrow cell number	J:71134
	decreased common myeloid progenitor cell number	J:71134
	decreased erythrocyte cell number	J:71134
	decreased hemoglobin content	J:71134
	decreased leukocyte cell number	J:71134
	decreased lymphocyte cell number	J:71134
	decreased neutrophil cell number	J:71134
	increased mean corpuscular volume	J:71134
	polychromatophilia	J:71134
Fancc^tm1Mgo/Fancc^tm1Mgo (involves: 129S4/SvJaeSor * C57BL/6)	absent common myeloid progenitor cells	J:61512
Fancd2^em1Tzh/Fancd2^em1Tzh (C57BL/6-Fancd2^em1Tzh)	abnormal bone marrow cell morphology/development	J:284566
	abnormal erythropoiesis	J:284566
	abnormal hematopoietic stem cell physiology	J:284566
	anemia	J:284566
	decreased erythroblast number	J:284566
	decreased erythrocyte cell number	J:284566
	decreased hematopoietic stem cell number	J:284566
	decreased hemoglobin content	J:284566
	enlarged spleen	J:284566
	increased erythroblast number	J:284566
Fancd2^{Gt(OST57859)Lex}/Fancd2^{Gt(OST57859)Lex} (involves: 129S5/SvEvBrd)	abnormal bone marrow cell morphology/development	J:285384
	decreased hematopoietic stem cell number	J:285384
	thrombocytopenia	J:285384
Fancd2^{Gt(OST57859)Lex}/Fancd2^{Gt(OST57859)Lex} Fanci^tm1.1Itl/Fanci^tm1.1Itl (involves: 129S5/SvEvBrd * C57BL/6J * CBA)	abnormal bone marrow cell morphology/development	J:285384
	decreased hematopoietic stem cell number	J:285384
	thrombocytopenia	J:285384
Fancd2^tm1Hou/Fancd2^tm1Hou (involves: 129S4/SvJae)	decreased hematopoietic stem cell number	J:188123
Fancf^em1(IMPC)J/Fancf^em1(IMPC)J (C57BL/6NJ-Fancf^em1(IMPC)J/Mmjax)	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
Fanci^tm1.1Itl/Fanci^tm1.1Itl (involves: C57BL/6J * CBA)	abnormal hematopoietic precursor cell morphology	J:285384
	abnormal hematopoietic stem cell physiology	J:285384
	decreased granulocyte monocyte progenitor cell number	J:285384
	decreased hematopoietic stem cell number	J:285384
	thrombocytopenia	J:285384
Fancl^{tm1b(EUCOMM)Hmgu}/Fancl^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Fancl^{tm1b(EUCOMM)Hmgu}/Nju)	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
Fancm^em1Qsh/Fancm^em1Qsh (C57BL/6-Fancm^em1Qsh)	hematopoietic system phenotype	J:301639
Fancm^tm1.1Htr/Fancm^tm1.1Htr (involves: C57BL/6 * FVB)	hematopoietic system phenotype	J:151714
Farp2^tm1Akum/Farp2^tm1Akum (B6.Cg-Farp2^tm1Akum)	abnormal osteoclast physiology	J:166376
	decreased osteoclast cell number	J:166376
	increased osteoclast cell number	J:166376
Farsa^{tm2a(EUCOMM)Wtsi}/Farsa⁺ (C57BL/6N-Farsa^{tm2a(EUCOMM)Wtsi}/Wtsi)	decreased leukocyte cell number	J:211773
Fas^lpr-cg/Fas^lpr-cg (CBA/KlJms-Fas^lpr-cg/J)	abnormal T cell differentiation	J:24805
	enlarged spleen	J:24805
	increased IgG level	J:24805, J:81770
	increased IgM level	J:24805, J:81770
	increased immunoglobulin level	J:24805
	increased spleen weight	J:81770
Fas^lpr/Fas⁺ Raf1^tm1Bacc/Raf1⁺ (involves: 129/SvHsd * 129P2/OlaHsd * C57BL/6 * MRL)	hematopoietic system phenotype	J:135681
Fas^lpr/Fas⁺ Raf1^tm1Bacc/Raf1^tm1Bacc (involves: 129/SvHsd * 129P2/OlaHsd * C57BL/6 * MRL)	abnormal erythropoiesis	J:135681
	hematopoietic system phenotype	J:135681
Fas^lpr/Fas^lpr (MRL/Mp-Fas^lpr)	abnormal B cell morphology	J:108760
	abnormal B cell receptor editing	J:131138
	abnormal cytotoxic T cell physiology	J:7488
	abnormal marginal zone B cell morphology	J:131138
	abnormal T cell morphology	J:108760, J:8267
	abnormal T cell physiology	J:8267
	abnormal T cell proliferation	J:8267
	abnormal T-helper 2 physiology	J:6257
	abnormal thymus medulla morphology	J:28885
	enlarged spleen	J:28885
	enlarged thymus	J:13757
	increased IgA level	J:28885
	increased IgG1 level	J:13757, J:28885
	increased IgG2a level	J:13757, J:28885
	increased IgG2b level	J:28885
	increased IgG level	J:27634
	increased IgM level	J:28885
	increased immunoglobulin level	J:13757, J:28885, J:6257
	increased thymus weight	J:28885
	thymus atrophy	J:27634
	thymus cortex atrophy	J:13757, J:28885
Fas^lpr/Fas^lpr (MRL/Mp-Agtpbp1^atms Fas^lpr)	enlarged spleen	J:103944
Fas^lpr/Fas^lpr (MRL/Mp-Agtpbp1^atms Fas^lpr)	enlarged thymus	J:103944
Fas^lpr/Fas^lpr (MRL/MpJ-Fas^lpr/J)	abnormal immunoglobulin level	J:122315
	decreased IgG level	J:122315
	decreased immature B cell number	J:122315
	decreased marginal zone B cell number	J:122315
	decreased mature B cell number	J:122315
	decreased spleen germinal center number	J:122315
	decreased transitional stage B cell number	J:122315
	increased IgG level	J:92084
	increased immunoglobulin level	J:122315, J:7454
	increased neutrophil cell number	J:127199
	increased plasma cell number	J:122315
Fas^lpr/Fas^lpr (involves: C3H * MRL/Mp)	increased spleen weight	J:34296
Fas^lpr/Fas^lpr (B6.MRL-Fas^lpr/J)	abnormal NK cell physiology	J:115033
	abnormal splenic cell ratio	J:132217
	decreased B cell apoptosis	J:135830
	increased follicular B cell number	J:132217
	increased immature B cell number	J:132217
	increased marginal zone B cell number	J:132217
	increased splenocyte number	J:132217
	increased transitional stage B cell number	J:132217
Fas^lpr/Fas^lpr (MRL-Fas^lpr)	abnormal T-helper 2 physiology	J:6257
	increased IgG level	J:126261
	increased IgM level	J:126261
	increased immunoglobulin level	J:6257
	increased spleen weight	J:126261
Fas^lpr/Fas^lpr (C3.MRL-Fas^lpr/J)	abnormal B cell activation	J:7454
	abnormal T cell morphology	J:7454
	decreased eosinophil cell number	J:106288
	increased immunoglobulin level	J:7454
Fas^lpr/Fas^lpr (B6.MRL-Fas^lpr)	enlarged spleen	J:135036
	increased double-negative T cell number	J:135036
	increased immunoglobulin level	J:7454
Fas^lpr/Fas^lpr (AK.MRL-Fas^lpr)	increased immunoglobulin level	J:7454
Fas^lpr/Fas^lpr (C3.MRL-Fas^lpr)	abnormal T cell morphology	J:8267
	abnormal T cell physiology	J:8267
	abnormal T cell proliferation	J:8267
Fas^lpr/Fas^lpr (MRL/MpJ-Fas^lpr)	abnormal leukocyte adhesion	J:126009
	abnormal leukocyte morphology	J:126009
	decreased activated T cell number	J:137066
	decreased B cell number	J:137066
	decreased CD4-positive, alpha-beta T cell number	J:137066
	decreased CD8-positive, alpha-beta T cell number	J:137066
	enlarged spleen	J:137066
	impaired leukocyte tethering or rolling	J:126009
	increased double-negative T cell number	J:137066
	increased immunoglobulin level	J:125114
Fas^lpr/Fas^lpr (involves: MRL/Mp)	decreased macrophage apoptosis	J:154647
Fas^lpr/Fas^lpr (involves: C57BL/6 * MRL/Mp)	enlarged spleen	J:73396
	increased IgA level	J:73396
	increased IgG1 level	J:73396
	increased IgG2a level	J:73396
	increased IgG2b level	J:73396
	increased IgG3 level	J:73396
	increased IgM level	J:73396
Fas^lpr/Fas^lpr (involves: 129P2/OlaHsd * MRL)	increased double-negative T cell number	J:26250
Fas^lpr/Fas^lpr (involves: 129P2/OlaHsd * MRL)	increased gamma-delta T cell number	J:26250
Fas^lpr/Fas^lpr Fcer1g^tm1Tks/Fcer1g^tm1Tks (MRL.Cg-Fcer1g^tm1Tks Fas^lpr)	increased double-negative T cell number	J:106188
	increased IgG level	J:106188
	increased spleen weight	J:106188
Fas^lpr/Fas^lpr Havcr1^tm1Kuch/Havcr1^tm1Kuch (B6.Cg-Havcr1^tm1Kuch Fas^lpr)	abnormal immunoglobulin level	J:186484
	enlarged spleen	J:186484
	increased activated T cell number	J:186484
	increased B cell number	J:186484
	increased CD4-positive, alpha-beta T cell number	J:186484
	increased CD8-positive, alpha-beta T cell number	J:186484
	increased double-negative T cell number	J:186484
	increased IgG1 level	J:186484
	increased IgG2a level	J:186484
	increased IgG2b level	J:186484
	increased IgG3 level	J:186484
	increased T cell number	J:186484
Fas^lpr/Fas^lpr Ifnar1^tm1Agt/Ifnar1^tm1Agt (MRL.Cg-Ifnar1^tm1Agt Fas^lpr)	increased IgA level	J:92084
	increased IgG2b level	J:92084
	increased IgG3 level	J:92084
	increased IgG level	J:92084
	increased IgM level	J:92084
Fas^lpr/Fas^lpr Ifnar1^tm1Agt/Ifnar1^tm1Agt Ifngr1^tm1Agt/Ifngr1^tm1Agt (MRL.Cg-Ifngr1^tm1Agt Ifnar1^tm1Agt Fas^lpr)	decreased IgG level	J:92084
	increased IgG level	J:92084
Fas^lpr/Fas^lpr Ifng^tm1Ts/Ifng⁺ (MRL.Cg-Ifng^tm1Ts Fas^lpr)	abnormal macrophage chemotaxis	J:123834
Fas^lpr/Fas^lpr Ifng^tm1Ts/Ifng^tm1Ts (MRL.Cg-Ifng^tm1Ts Fas^lpr)	abnormal macrophage chemotaxis	J:123834
Fas^lpr/Fas^lpr Ifng^tm1Ts/Ifng^tm1Ts (involves: 129S7/SvEvBrd * DBA/1 * MRL/Mp)	abnormal spleen size	J:39600
	decreased double-negative T cell number	J:39600
	decreased IgA level	J:39600
	decreased IgG2a level	J:39600
	decreased IgG2b level	J:39600
	decreased IgM level	J:39600
	decreased immunoglobulin level	J:39600
	enlarged spleen	J:39600
Fas^lpr/Fas^lpr Ifngr1^tm1Agt/Ifngr1^tm1Agt (MRL.Cg-Ifngr1^tm1Agt Fas^lpr)	decreased IgA level	J:92084
	decreased IgG2a level	J:92084
	decreased IgG2b level	J:92084
	decreased IgG3 level	J:92084
	decreased IgM level	J:92084
	increased IgG1 level	J:92084
	increased IgG level	J:92084
Fas^lpr/Fas^lpr Igh-J^{tm2(3H9-VDJ)Mwg}/Igh-J⁺ (MRL.Cg-Fas^lpr Igh-J^{tm2(3H9-VDJ)Mwg})	abnormal B cell receptor editing	J:131138
	abnormal marginal zone B cell morphology	J:131138
Fas^lpr/Fas^lpr Ighm^tm1Cgn/Ighm^tm1Cgn (involves: 129S2/SvPas * C57BL/6 * MRL/Mp)	abnormal immunoglobulin level	J:119584
	arrested B cell differentiation	J:119584
	decreased IgM level	J:119584
	decreased mature B cell number	J:119584
	increased T cell number	J:119584
Fas^lpr/Fas^lpr Il2ra^tm1Dw/Il2ra^tm1Dw Tg(CD2-Ccdc86)1Hfuj/? (B6.Cg-Il2ra^tm1Dw Fas^lpr Tg(CD2-Ccdc86)1Hfuj)	enlarged spleen	J:151722
Fas^lpr/Fas^lpr Il4^tm1Cgn/Il4^tm1Cgn (involves: 129P2/OlaHsd * C57BL/6J * MRL/Mp)	abnormal spleen size	J:39600
	decreased IgA level	J:39600
	decreased IgE level	J:39600
	decreased IgG1 level	J:39600
	decreased IgG3 level	J:39600
	decreased immunoglobulin level	J:39600
	enlarged spleen	J:39600
	increased spleen weight	J:39600
	spleen hyperplasia	J:39600
Fas^lpr/Fas^lpr Il27ra^tm1Mak/Il27ra^tm1Mak (MRL.Cg-Il27ra^tm1Mak Fas^lpr)	abnormal T-helper 2 physiology	J:122148
	decreased IgG2a level	J:122148
	increased IgE level	J:122148
	increased IgG1 level	J:122148
Fas^lpr/Fas^lpr Irf1^tm1Mak/Irf1⁺ (MRL.Cg-Irf1^tm1Mak Fas^lpr)	increased CD4-positive, alpha-beta T cell number	J:114771
Fas^lpr/Fas^lpr Irf1^tm1Mak/Irf1^tm1Mak (MRL.Cg-Irf1^tm1Mak Fas^lpr)	increased CD4-positive, alpha-beta T cell number	J:114771
Fas^lpr/Fas^lpr Itfg2^{Gt(OST215121)Lex}/Itfg2^{Gt(OST215121)Lex} (involves: 129S5/SvEvBrd * C57BL/6J * MRL/Mp)	decreased B cell number	J:205951
	enlarged spleen	J:205951
	increased double-negative T cell number	J:205951
	increased IgG2a level	J:205951
	increased IgM level	J:205951
Fas^lpr/Fas^lpr Nos2^tm1Mrl/Nos2^tm1Mrl (involves: 129S7/SvEvBrd * MRL)	abnormal immunoglobulin level	J:42666
	decreased IgG level	J:42666
	decreased IgM level	J:42666
Fas^lpr/Fas^lpr Pou2af1^tm1Pmt/Pou2af1^tm1Pmt (involves: 129P2/OlaHsd * C57BL/6 * MRL)	abnormal T cell number	J:125114
	decreased immunoglobulin level	J:125114
	decreased plasma cell number	J:125114
	hematopoietic system phenotype	J:125114
	increased B cell number	J:125114
Fas^lpr/Fas^lpr Raf1^tm1Bacc/Raf1^tm1Bacc (involves: 129/SvHsd * 129P2/OlaHsd * C57BL/6 * MRL)	abnormal erythropoiesis	J:135681
Fas^lpr/Fas^lpr Selp^tm1Bay/Selp^tm1Bay (MRL.Cg-Selp^tm1Bay Fas^lpr)	abnormal leukocyte adhesion	J:126009
	impaired leukocyte tethering or rolling	J:126009
	increased neutrophil cell number	J:127199
Fas^lpr/Fas^lpr Spp1^tm1Rit/Spp1^tm1Rit (involves: 129S7/SvEvBrd * C57BL/6 * MRL/Mp)	enlarged spleen	J:73396
	increased IgA level	J:73396
	increased IgG1 level	J:73396
	increased IgG2a level	J:73396
	increased IgG2b level	J:73396
	increased IgG3 level	J:73396
	increased IgM level	J:73396
Fas^lpr/Fas^lpr Tcra^tm1Mjo/Tcra^tm1Mjo (involves: 129P2/OlaHsd * MRL)	increased gamma-delta intraepithelial T cell number	J:26250
	increased gamma-delta T cell number	J:26250
	increased T cell number	J:26250
Fas^lpr/Fas^lpr Tcra^tm1Mjo/Tcra^tm1Mjo (involves: 129P2/OlaHsd * 129S2/SvPas * MRL)	decreased immunoglobulin level	J:38492
Fas^lpr/Fas^lpr Tg(CD2-Foxj1)#Stlp/0 (MRL.Cg-Fas^lpr Tg(CD2-Foxj1)#Stlp)	abnormal T cell physiology	J:122222
	decreased CD4-positive, alpha-beta T cell number	J:122222
	enlarged spleen	J:122222
	increased double-negative T cell number	J:122222
Fas^lpr/Fas^lpr Tg(H2-K-Cd86)27All/0 (involves: C57BL/6 * CBA * MRL/MpJ)	decreased B cell number	J:112475
Fas^lpr/Fas^lpr Tlr7^tm1Flv/Y (involves: 129S1/Sv * C57BL/6 * MRL/Mp)	abnormal B cell activation	J:113557
	abnormal CD4-positive, alpha beta T cell morphology	J:113557
	decreased double-negative T cell number	J:113557
	decreased IgG2a level	J:113557
	decreased IgG3 level	J:113557
	decreased spleen weight	J:113557
Fas^lpr/Fas^lpr Tlr9^tm1Aki/Tlr9^tm1Aki (B6.Cg-Tlr9^tm1Aki Fas^lpr)	decreased IgM level	J:135036
	enlarged spleen	J:135036
	increased double-negative T cell number	J:135036
	increased IgG level	J:135036
Fas^lpr/Fas^lpr Tlr9^tm1Aki/Tlr9^tm1Aki (MRL.Cg-Tlr9^tm1Aki Fas^lpr)	abnormal B cell activation	J:113557
	enlarged spleen	J:113557
	increased CD4-positive, alpha-beta T cell number	J:113557
	increased double-negative T cell number	J:113557
	increased IgG2a level	J:113557
	increased IgG3 level	J:113557
	increased IgG level	J:113557
Fas^lpr/Fas^lpr Tnfrsf9^tm1Byk/Tnfrsf9^tm1Byk (MRL.Cg-Tnfrsf9^tm1Byk Fas^lpr)	enlarged spleen	J:127197
	hematopoietic system phenotype	J:127197
	increased B-1 B cell number	J:127197
	increased B-2 B cell number	J:127197
	increased CD4-positive, alpha-beta T cell number	J:127197, J:126929
	increased double-negative T cell number	J:127197, J:126929
	increased immunoglobulin level	J:127197
	increased spleen germinal center number	J:127197
Fas^lpr/Fas^lpr Tnfrsf13c^Bcmd1/Tnfrsf13c⁺ (MRL.Cg-Tnfrsf13c^Bcmd1 Fas^lpr)	decreased B cell number	J:122315
	decreased marginal zone B cell number	J:122315
Fas^lpr/Fas^tm1.1Cgn (involves: C57BL/6 * MRL)	enlarged spleen	J:114948
Fas^lpr/Fas^tm1Cgn Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2 * MRL)	enlarged spleen	J:114948
	increased double-negative T cell number	J:114948
Fas^m1Btlr/Fas^m1Btlr (C57BL/6J-Fas^m1Btlr)	decreased CD4-positive, alpha-beta T cell number	J:216052
	decreased CD8-positive, alpha-beta T cell number	J:216052
	increased neutrophil cell number	J:216052
	increased NK cell number	J:216052
Fas^m2Btlr/Fas^m2Btlr (C57BL/6J-Fas^m2Btlr)	increased central memory CD4-positive, alpha-beta T cell number	J:271891
Fas^m2Btlr/Fas^m2Btlr (C57BL/6J-Fas^m2Btlr)	increased effector memory CD4-positive, alpha-beta T cell number	J:271891
Fas^tm1.1Cgn/Fas^tm1.1Cgn (involves: C57BL/6)	enlarged spleen	J:114948
Fas^tm1Ach/Fas^tm1Ach Tg(GZMB-cre)1Jcb/? (involves: C57BL/6 * FVB/N)	increased double-positive T cell number	J:123556
Fas^tm1Ach/Fas^tm1Ach Tg(Itgax-cre,-EGFP)4097Ach/? (Not Specified)	abnormal spleen morphology	J:123556
	abnormal spleen periarteriolar lymphoid sheath morphology	J:123556
	enlarged spleen	J:123556
	increased dendritic cell number	J:123556
	increased IgG level	J:123556
	increased IgM level	J:123556
	increased immunoglobulin level	J:123556
Fas^tm1Ach/Fas^tm1Ach Tg(Lck-cre)548Jxm/? (involves: C57BL/6 * CBA)	increased double-positive T cell number	J:123556
Fas^tm1Cgn/Fas^tm1Cgn Tg(Cd4-cre)1Cwi/0 (B6.Cg-Tg(Cd4-cre)1Cwi Fas^tm1Cgn)	abnormal thymus involution	J:114948
	decreased B cell number	J:114948
	decreased T cell number	J:114948
	enlarged spleen	J:114948
	increased activated T cell number	J:114948
	increased double-negative T cell number	J:114948
	increased memory T cell number	J:114948
	increased T cell apoptosis	J:114948
	spleen hypoplasia	J:114948
Fas^tm1Cgn/Fas^tm1Cgn Tg(Mx1-cre)1Cgn/0 (B6.Cg-Fas^tm1Cgn Tg(Mx1-cre)1Cgn)	enlarged spleen	J:114948
Fas^tm1Dlo/Fas^tm1Dlo (involves: 129P2/OlaHsd * C57BL/6)	abnormal thymus involution	J:90750
	enlarged spleen	J:31847
	increased immunoglobulin level	J:31847
Fas^tm1Osa/Fas^tm1Osa (involves: 129P2/OlaHsd * C57BL/6)	abnormal T cell clonal deletion	J:32125
	enlarged spleen	J:64296, J:32125
	increased B cell number	J:32125
	increased IgG1 level	J:32125
	increased IgG2a level	J:32125
	increased IgG2b level	J:32125
	increased IgG3 level	J:32125
	increased IgG level	J:32125
	increased leukocyte cell number	J:32125
	increased lymphocyte cell number	J:64296, J:32125
Fasl^del1Hong/Fasl^del1Hong (either: (involves: 129 * BALB/c * C57BL/6) or (involves: 129X1/SvJ * C3H/HeJ * C57BL/6))	abnormal definitive hematopoiesis	J:112563
	abnormal thymus cell ratio	J:112563
	enlarged spleen	J:112563
	enlarged thymus	J:112563
	increased IgG level	J:112563
	increased IgM level	J:112563
Fasl^gld/Fasl^gld (C3H/HeJ-Fasl^gld/J)	abnormal T cell differentiation	J:12002, J:8267
	anemia	J:7306
	decreased B cell number	J:29572
	decreased cytotoxic T cell cytolysis	J:17698
	enlarged spleen	J:7306, J:29572
	increased IgA level	J:7306, J:29572
	increased IgG1 level	J:7306
	increased IgG2a level	J:7306
	increased IgG2b level	J:7306
	increased IgG level	J:29572
	increased IgM level	J:7306, J:29572
	increased immunoglobulin level	J:7306, J:29572
	increased leukocyte cell number	J:7306
	increased lymphocyte cell number	J:7306, J:29572
	increased neutrophil cell number	J:7306
	increased T cell number	J:29572
Fasl^gld/Fasl^gld (B6Smn.C3-Fasl^gld/J)	abnormal NK cell physiology	J:115033
	abnormal osteoclast physiology	J:127179
	decreased granulocyte number	J:136745
Fasl^gld/Fasl^gld (C3H/HeJ-Fasl^gld)	abnormal T cell morphology	J:8267
	abnormal T cell physiology	J:8267
	abnormal T cell proliferation	J:8267
Fasl^gld/Fasl^gld (involves: C3H/HeJ * C57BL/6)	enlarged spleen	J:153501
	increased IgE level	J:153501
	increased IgG1 level	J:153501
	increased IgG2a level	J:153501
	increased IgG2b level	J:153501
	increased IgG level	J:153501
	increased T cell number	J:153501
Fasl^gld/Fasl^gld (involves: C3H/HeJ)	abnormal osteoclast physiology	J:156947
	enlarged spleen	J:171440
	increased spleen weight	J:171440
Fasl^gld/Fasl^gld (B6.C3-Fasl^gld)	enlarged spleen	J:91058
	impaired macrophage phagocytosis	J:91058
	increased spleen weight	J:91058
Fasl^m2Btlr/Fasl^m2Btlr (C57BL/6J-Fasl^m2Btlr)	decreased IgG level	J:224659
Fasl^tm1.1Ast/Fasl^tm1.1Ast (involves: BALB/cJ * C57BL/6)	decreased cytotoxic T cell cytolysis	J:153501
	enlarged spleen	J:153501
	increased IgA level	J:153501
	increased IgE level	J:153501
	increased IgG1 level	J:153501
	increased IgG2a level	J:153501
	increased IgG2b level	J:153501
	increased IgG level	J:153501
	increased IgM level	J:153501
	increased immunoglobulin level	J:153501
Fasl^tm1.1Bksa/Fasl^tm1.1Bksa (involves: 129)	enlarged spleen	J:171440
Fasl^tm1.1Bksa/Fasl^tm1.1Bksa (involves: 129)	increased spleen weight	J:171440
Fasl^tm1.1Cgm/Fasl^tm1.1Cgm (involves: 129S2/SvPas * C57BL/6 * C57BL/6N)	increased B cell proliferation	J:168406
	increased germinal center B cell number	J:168406
	increased IgM level	J:168406
	increased plasma cell number	J:168406
	increased T cell proliferation	J:168406
Fasl^tm1.1Lest/Fasl^tm1.1Lest (involves: 129 * C57BL/6)	abnormal double-negative T cell morphology	J:87990
	enlarged spleen	J:87990
	increased IgG level	J:87990
Fasl^tm2.1Ast/Fasl^tm2.1Ast (involves: BALB/cJ * C57BL/6)	abnormal cytotoxic T cell physiology	J:153501
Fastk^tm1.1Andp/Fastk^tm1.1Andp (B6.129S6-Fastk^tm1.1Andp)	abnormal neutrophil physiology	J:160443
Fastk^tm1.1Andp/Fastk^tm1.1Andp (B6.129S6-Fastk^tm1.1Andp)	decreased neutrophil cell number	J:160443
Fastkd2^{tm1b(EUCOMM)Wtsi}/Fastkd2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Fastkd2^{tm1b(EUCOMM)Wtsi}/Bay)	decreased spleen weight	J:211773
Fbf1^{tm1a(EUCOMM)Wtsi}/Fbf1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Fbf1^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased leukocyte cell number	J:211773
Fblim1^tm1.1Chen/Fblim1^tm1.1Chen (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)	abnormal osteoclast differentiation	J:186501
	abnormal osteoclast physiology	J:186501
	increased osteoclast cell number	J:186501
Fbln1^{Gt(XST011)Byg}/Fbln1^{Gt(XST011)Byg} (involves: 129P2/OlaHsd * C57BL/6)	thymus hypoplasia	J:137690
Fbln1^tm1Tmpl/Fbln1^tm1Tmpl (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased hematocrit	J:71581
	thymus hypoplasia	J:137690
Fbn1^em1(IMPC)H/Fbn1⁺ (C57BL/6NTac-Fbn1^em1(IMPC)H/H)	decreased lymphocyte cell number	J:211773
	increased mean platelet volume	J:211773
	increased neutrophil cell number	J:211773
	increased spleen weight	J:211773
Fbn1^tm1.1Itl/Fbn1^tm3Rmz Tg(Prrx1-cre)1Cjt/0 (involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6J * SJL/J)	abnormal bone marrow cell morphology/development	J:187484
Fbn1^tm2.1Hcd/Fbn1⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)	abnormal T-helper 1 cell morphology	J:206074
	increased B cell number	J:206074
	increased plasma cell number	J:206074
Fbn1^tm3.1Hcd/Fbn1⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)	abnormal T-helper 1 cell morphology	J:206074
	increased B cell number	J:206074
	increased plasma cell number	J:206074
Fbn1^Tsk Bloc1s6⁺/Fbn1⁺ Bloc1s6^pa (B6.Cg-Fbn1^Tsk +/+ Bloc1s6^pa/J)	hematopoietic system phenotype	J:29151
Fbn1^Tsk/Fbn1⁺ (B6.Cg-Fbn1^Tsk)	abnormal uterine NK cell morphology	J:1377
Fbn1^Tsk/Fbn1⁺ (B6.Cg-Fbn1^Tsk)	increased mast cell number	J:8047
Fbn1^Tsk/Fbn1⁺ Kit^W/Kit^W-v (involves: C57BL/6 * C57BL/10 * DBA/2 * WB/ReJ)	absent mast cells	J:24076
	anemia	J:24076
Fbn2^{em1(IMPC)Rbrc}/Fbn2^{em1(IMPC)Rbrc} (C57BL/6NJcl-Fbn2^{em1(IMPC)Rbrc}/Rbrc)	thrombocytopenia	J:211773
Fbp2^{tm2b(EUCOMM)Hmgu}/Fbp2⁺ (C57BL/6N-Fbp2^{tm2b(EUCOMM)Hmgu}/Ieg)	increased leukocyte cell number	J:211773
Fbrsl1^em1(IMPC)Tcp/Fbrsl1^em1(IMPC)Tcp (C57BL/6N-Fbrsl1^em1(IMPC)Tcp/Tcp)	enlarged spleen	J:211773
	increased red blood cell distribution width	J:211773
	small thymus	J:211773
Fbxl3^{em1(IMPC)Ccpcz}/Fbxl3^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Fbxl3^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	decreased spleen weight	J:211773
Fbxl5^{Gt(OST386421)Lex}/Fbxl5⁺ (129S(B6)-Fbxl5^{Gt(OST386421)Lex})	abnormal erythrocyte morphology	J:193752
Fbxl5^{Gt(OST386421)Lex}/Fbxl5⁺ (involves: 129S5/SvEvBrd * C57BL/6)	abnormal erythrocyte morphology	J:193752
	increased spleen iron level	J:193752
Fbxl5^{Gt(OST386421)Lex}/Fbxl5^{Gt(OST386421)Lex} Ireb2^tm1.2Mwh/Ireb2^tm1.2Mwh (involves: 129P2/OlaHsd * 129S5/SvEvBrd * C57BL/6)	anemia	J:193752
Fbxl5^tm1Kei/Fbxl5^tm1Kei Ireb2^tm1Roua/Ireb2^tm1Roua (B6.129-Fbxl5^tm1Kei Ireb2^tm1Roua)	decreased hematocrit	J:176655
	decreased hemoglobin content	J:176655
	decreased mean corpuscular hemoglobin	J:176655
	decreased mean corpuscular hemoglobin concentration	J:176655
	decreased mean corpuscular volume	J:176655
	microcytosis	J:176655
Fbxl18^{tm1b(EUCOMM)Hmgu}/Fbxl18^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Fbxl18^{tm1b(EUCOMM)Hmgu}/Mhzh)	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
Fbxl19^{tm1b(EUCOMM)Wtsi}/Fbxl19⁺ (C57BL/6N-Fbxl19^{tm1b(EUCOMM)Wtsi}/Nju)	decreased lymphocyte cell number	J:211773
	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
	increased leukocyte cell number	J:211773
	increased mean platelet volume	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Fbxl20^{tm1b(KOMP)Wtsi}/Fbxl20⁺ (C57BL/6N-Fbxl20^{tm1b(KOMP)Wtsi}/H)	increased mean corpuscular volume	J:211773
	increased mean platelet volume	J:211773
Fbxo4^tm1.1Jadi/Fbxo4⁺ (Not Specified)	extramedullary hematopoiesis	J:178645
Fbxo4^tm1.1Jadi/Fbxo4⁺ (Not Specified)	myeloid hyperplasia	J:178645
Fbxo4^tm1.1Jadi/Fbxo4^tm1.1Jadi (Not Specified)	extramedullary hematopoiesis	J:178645
Fbxo4^tm1.1Jadi/Fbxo4^tm1.1Jadi (Not Specified)	myeloid hyperplasia	J:178645
Fbxo5^em1(IMPC)Mbp/Fbxo5⁺ (C57BL/6NCrl-Fbxo5^em1(IMPC)Mbp/MbpMmucd)	decreased mean corpuscular volume	J:211773
Fbxo7^{tm1a(EUCOMM)Hmgu}/Fbxo7^{tm1a(EUCOMM)Hmgu} (involves: C57BL/6N)	abnormal proerythroblast morphology	J:183053
	decreased erythroblast number	J:183053
	increased erythroid progenitor cell number	J:183053
	increased pro-B cell number	J:183053
Fbxo7^{tm1a(EUCOMM)Wtsi}/Fbxo7^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Fbxo7^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	decreased leukocyte cell number	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased red blood cell distribution width	J:211773
	thrombocytosis	J:211773
Fbxo7^{tm1a(EUCOMM)Wtsi}/Fbxo7^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6N)	abnormal effector T cell number	J:272313
	abnormal reticulocyte cell number	J:272313
	abnormal T cell differentiation	J:272313
	anemia	J:272313
	anisocytosis	J:272313
	decreased CD4-positive, alpha-beta T cell number	J:272313
	decreased CD8-positive, alpha-beta T cell number	J:272313
	decreased erythrocyte cell number	J:272313
	decreased hematocrit	J:272313
	decreased hemoglobin content	J:272313
	decreased T cell number	J:272313
	enlarged spleen	J:272313
	extramedullary hematopoiesis	J:272313
	hyperchromic macrocytic anemia	J:272313
	increased activated T cell number	J:272313
	increased double-negative T cell number	J:272313
	increased effector memory CD4-positive, alpha-beta T cell number	J:272313
	increased effector memory CD8-positive, alpha-beta T cell number	J:272313
	increased erythroblast number	J:272313
	increased erythrocyte clearance	J:272313
	increased mean corpuscular hemoglobin concentration	J:272313
	increased mean corpuscular volume	J:272313
	increased memory T cell number	J:272313
	increased red blood cell distribution width	J:272313
	increased spleen weight	J:272313
	reticulocytosis	J:272313
	thymus atrophy	J:272313
	thymus hypoplasia	J:272313
Fbxo7^{tm1c(EUCOMM)Wtsi}/Fbxo7^{tm1c(EUCOMM)Wtsi} Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6J * C57BL/6N)	decreased CD8-positive, alpha-beta T cell number	J:272313
	decreased T cell number	J:272313
	hematopoietic system phenotype	J:272313
Fbxo9^{tm1b(EUCOMM)Hmgu}/Fbxo9^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Fbxo9^{tm1b(EUCOMM)Hmgu}/Tcp)	increased basophil cell number	J:211773
Fbxo10^{tm1b(KOMP)Wtsi}/Fbxo10^{tm1b(KOMP)Wtsi} (C57BL/6N-Fbxo10^{tm1b(KOMP)Wtsi}/Nju)	decreased hematocrit	J:211773
	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
	decreased neutrophil cell number	J:211773
Fbxo11^{tm2b(EUCOMM)Wtsi}/Fbxo11⁺ (C57BL/6N-Fbxo11^{tm2b(EUCOMM)Wtsi}/H)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	increased red blood cell distribution width	J:211773
Fbxo21^em1Smbk/Fbxo21^em1Smbk Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (B6.Cg-Fbxo21^em1Smbk Commd10^{Tg(Vav1-icre)A2Kio})	abnormal bone marrow cell physiology	J:333469
	abnormal stress erythropoiesis	J:333469
	decreased spleen weight	J:333469
	increased granulocyte monocyte progenitor cell number	J:333469
	increased T cell number	J:333469
Fbxo25^{em1(IMPC)Ccpcz}/Fbxo25^{em1(IMPC)Ccpcz} (C57BL/6N-Fbxo25^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	decreased mean platelet volume	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Fbxo28^{em1(IMPC)Mhzh}/Fbxo28⁺ (C57BL/6N-Fbxo28^{em1(IMPC)Mhzh}/Mhzh)	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
Fbxo36^{tm1b(KOMP)Wtsi}/Fbxo36^{tm1b(KOMP)Wtsi} (C57BL/6N-Fbxo36^{tm1b(KOMP)Wtsi}/Nju)	decreased hematocrit	J:211773
	decreased mean corpuscular volume	J:211773
	decreased mean platelet volume	J:211773
	decreased monocyte cell number	J:211773
	increased basophil cell number	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
	increased neutrophil cell number	J:211773
	increased red blood cell distribution width	J:211773
	thrombocytopenia	J:211773
Fbxo42^em1(IMPC)J/Fbxo42⁺ (C57BL/6NJ-Fbxo42^em1(IMPC)J/Mmjax)	thrombocytosis	J:211773
Fbxw2^{tm1b(EUCOMM)Hmgu}/Fbxw2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Fbxw2^{tm1b(EUCOMM)Hmgu}/Nju)	increased basophil cell number	J:211773
Fbxw7^tm1Iaai/Fbxw7^tm1Iaai Tg(Mx1-cre)1Cgn/0 (involves: 129/Sv * C57BL/6 * CBA)	abnormal T cell differentiation	J:137138
	decreased bone marrow cell number	J:137138
	decreased double-negative T cell number	J:137138
	decreased hematopoietic stem cell number	J:137138
	thymus hypoplasia	J:137138
Fbxw7^tm1Iaai/Fbxw7^tm1Iaai Tg(Mx1-cre)1Cgn/0 (involves: 129 * C57BL/6 * CBA)	abnormal hematopoietic stem cell physiology	J:200006
	abnormal T cell differentiation	J:200006
	decreased hematopoietic stem cell number	J:200006
Fbxw7^tm1Kei/Fbxw7^tm1Kei Rbpj^tm1Hon/Rbpj^tm1Hon Tg(Cd4-cre)1Cwi/? (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	increased double-positive T cell number	J:128523
Fbxw7^tm1Kei/Fbxw7^tm1Kei Tg(Cd4-cre)1Cwi/? (involves: 129P2/OlaHsd * C57BL/6)	increased double-positive T cell number	J:128523
Fbxw7^tm1Kei/Fbxw7^tm1Kei Tg(Lck-cre)1Cwi/? (involves: 129P2/OlaHsd * C57BL/6)	abnormal T cell activation	J:128523
	arrested T cell differentiation	J:128523
	decreased single-positive T cell number	J:128523
	enlarged thymus	J:128523
	increased double-positive T cell number	J:128523
	increased T cell apoptosis	J:128523
Fbxw7^tm1Sje/Fbxw7^tm1Sje (involves: 129S7/SvEvBrd * C57BL/6)	abnormal erythrocyte cell number	J:88903
Fbxw7^tm2Iaai/Fbxw7⁺ Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	hematopoietic system phenotype	J:200006
Fbxw8^{tm1b(EUCOMM)Hmgu}/Fbxw8⁺ (C57BL/6N-Fbxw8^{tm1b(EUCOMM)Hmgu}/Nju)	decreased lymphocyte cell number	J:211773
	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
	increased neutrophil cell number	J:211773
Fbxw9^{tm1a(EUCOMM)Wtsi}/Fbxw9⁺ (C57BL/6N-Fbxw9^{tm1a(EUCOMM)Wtsi}/Bay)	absent spleen	J:211773
Fbxw9^{tm1b(EUCOMM)Wtsi}/Fbxw9^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Fbxw9^{tm1b(EUCOMM)Wtsi}/Bay)	abnormal spleen morphology	J:211773
Fbxw16^{em1(IMPC)Ccpcz}/Fbxw16⁺ (C57BL/6N-Fbxw16^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
	increased CD8-positive, naive alpha-beta T cell number	J:211773
	small thymus	J:211773
Fbxw18^{em1(IMPC)Ccpcz}/Fbxw18⁺ (C57BL/6N-Fbxw18^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
	small spleen	J:211773
Fbxw20^{em1(IMPC)Ccpcz}/Fbxw20^{em1(IMPC)Ccpcz} (C57BL/6N-Fbxw20^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Fbxw25^{em1(IMPC)Ccpcz}/Fbxw25^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Fbxw25^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Fbxw26^{tm1b(KOMP)Wtsi}/Fbxw26^{tm1b(KOMP)Wtsi} (C57BL/6N-Fbxw26^{tm1b(KOMP)Wtsi}/Wtsi)	decreased memory-marker NK cell number	J:211773
	increased KLRG1-positive NK cell number	J:211773
	increased NK cell number	J:211773
Fcamr^tm1Shib/Fcamr^tm1Shib (involves: 129P2/OlaHsd * C57BL/6)	abnormal marginal zone B cell physiology	J:150824
	abnormal memory B cell differentiation	J:150824
	abnormal somatic hypermutation frequency	J:150824
	abnormal spleen germinal center morphology	J:150824
	increased spleen germinal center number	J:150824
	increased spleen germinal center size	J:150824
Fcamr^tm2Shib/Fcamr^tm2Shib (BALB/c-Fcamr^tm2Shib)	abnormal marginal zone B cell physiology	J:150824
	increased spleen germinal center number	J:150824
	increased spleen germinal center size	J:150824
Fcer1a^tm1Ftl/Fcer1a^tm1Ftl (CBy.129S2-Fcer1a^tm1Ftl)	abnormal mast cell physiology	J:120702
Fcer1a^tm1Ftl/Fcer1a^tm1Ftl (CBy.129S2-Fcer1a^tm1Ftl)	decreased eosinophil cell number	J:120702
Fcer1a^tm1Knt/Fcer1a^tm1Knt (either: (involves: 129 * C57BL/6) or (involves: 129 * C57BL/6 * DBA/2))	abnormal mast cell physiology	J:39250
Fcer1a^tm1Knt/Fcer1a^tm1Knt (involves: 129 * BALB/c)	abnormal mast cell physiology	J:78659
Fcer1a^tm1Knt/Fcer1a^tm1Knt Fcer2a^tm1Max/Fcer2a^tm1Max (B6.Cg-Fcer1a^tm1Knt Fcer2a^tm1Max)	abnormal mast cell physiology	J:144620
Fcer1a^tm1Knt/Fcer1a^tm1Knt Fcer2a^tm1Max/Fcer2a^tm1Max Fcgr1^tm1Jsv/Fcgr1^tm1Jsv Fcgr2b^tm1Ttk/Fcgr2b^tm1Ttk Fcgr3^tm1Jsv/Fcgr3^tm1Jsv (B6.Cg-Fcgr2b^tm1Ttk Fcgr3^tm1Jsv Fcer1a^tm1Knt Fcgr1^tm1Jsv Fcer2a^tm1Max)	abnormal macrophage physiology	J:144620
	abnormal mast cell physiology	J:144620
Fcer1a^tm1Knt/Fcer1a^tm1Knt Tg(FCER1A)1Bhk/? (B6.129-Fcer1a^tm1Knt Tg(FCER1A)1Bhk)	abnormal macrophage physiology	J:144620
Fcer1g^{tm1b(KOMP)Wtsi}/Fcer1g^{tm1b(KOMP)Wtsi} (C57BL/6N-Fcer1g^{tm1b(KOMP)Wtsi}/Ucd)	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
Fcer1g^tm1Rav/Fcer1g^tm1Rav (involves: 129P2/OlaHsd * C57BL/6)	abnormal immunoglobulin level	J:78659
	abnormal mast cell physiology	J:39248
	abnormal NK cell physiology	J:39248
	abnormal platelet activation	J:118488
	decreased platelet aggregation	J:112819
	decreased platelet calcium level	J:118488
	impaired macrophage phagocytosis	J:39248
	increased IgE level	J:78659
Fcer1g^tm1Rav/Fcer1g^tm1Rav (involves: 129P2/OlaHsd)	abnormal hemoglobin	J:168556
Fcer1g^tm1Rav/Fcer1g^tm1Rav (involves: 129P2/OlaHsd)	decreased platelet aggregation	J:165893
Fcer1g^tm1Rav/Fcer1g^tm1Rav Del(7Tyrobp-Hcst)1Ttk/Del(7Tyrobp-Hcst)1Ttk (involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6)	abnormal osteoclast physiology	J:147155
Fcer1g^tm1Rav/Fcer1g^tm1Rav Hexb^tm1Rlp/Hexb^tm1Rlp (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	increased immunoglobulin level	J:87617
Fcer1g^tm1Rav/Fcer1g^tm1Rav Tg(Ins2-TFRC/OVA)296Wehi/0 (involves: 129P2/OlaHsd * C57BL/6)	decreased T cell proliferation	J:122114
Fcer1g^tm1Rav/Fcer1g^tm1Rav Tyrobp^tm1.1Viv/Tyrobp^tm1.1Viv (involves: 129P2/OlaHsd * C57BL/6)	decreased uterine NK cell number	J:100668
Fcer1g^tm1Rav/Fcer1g^tm1Rav Tyrobp^tm1Lll/Tyrobp^tm1Lll (involves: 129P2/OlaHsd * C57BL/6)	abnormal osteoclast differentiation	J:89583
Fcer1g^tm1Rav/Fcer1g^tm1Rav Tyrobp^tm1Lll/Tyrobp^tm1Lll (involves: 129P2/OlaHsd)	abnormal osteoclast physiology	J:147155
Fcer1g^tm1Tks/Fcer1g^tm1Tks (involves: C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:112160
	abnormal macrophage physiology	J:141143
	abnormal NK cell physiology	J:111365
	abnormal NK T cell physiology	J:111365
	decreased IgG1 level	J:112160
	decreased IgG2a level	J:112160
	decreased IgG2b level	J:112160
	decreased IgG3 level	J:112160
	decreased IgG level	J:112160
	decreased T cell proliferation	J:112160
	impaired macrophage phagocytosis	J:50023
	impaired natural killer cell mediated cytotoxicity	J:111365
Fcer1g^tm1Tks/Fcer1g^tm1Tks (C57BL/6-Fcer1g^tm1Tks)	decreased susceptibility to autoimmune hemolytic anemia	J:145432
Fcer1g^tm1Tks/Fcer1g^tm1Tks (involves: C57BL/6J)	decreased dendritic cell number	J:203159
Fcer2a^Hie/Fcer2a^Hie (NZB)	increased IgE level	J:93999
Fcer2a^tm1Kik/Fcer2a^tm1Kik (involves: 129P2/OlaHsd * C57BL/6)	increased immunoglobulin level	J:129296
Fcer2a^tm1Max/Fcer2a^tm1Max (involves: C57BL/6)	abnormal macrophage chemotaxis	J:57738
	decreased IgG1 level	J:18952
	decreased IgG2b level	J:18952
	impaired eosinophil recruitment	J:57738
	increased IgE level	J:57738, J:18952, J:107857
	increased IgM level	J:18952
Fcer2a^tm1Max/Fcer2a^tm1Max Ighg1^tm1.1Pyu/Ighg1⁺ (involves: 129 * BALB/cJ * C57BL/6 * C57BL/6J)	decreased IgG1 level	J:198154
	decreased IgG2c level	J:198154
	decreased IgG level	J:198154
	increased IgE level	J:198154
	increased IgG2a level	J:198154
Fcer2a^tm1Max/Fcer2a^tm1Max Ighg1^tm1.1Pyu/Ighg1^tm1.1Pyu (involves: 129 * BALB/cJ * C57BL/6 * C57BL/6J)	abnormal immunoglobulin level	J:198154
	decreased IgG2c level	J:198154
	decreased IgG level	J:198154
	increased IgE level	J:198154
	increased IgG2a level	J:198154
Fcer2a^tm1Putt/Fcer2a⁺ (involves: 129S/SvEv * C57BL/6)	increased IgE level	J:69547
Fcer2a^tm1Putt/Fcer2a^tm1Putt (involves: 129S/SvEv * C57BL/6)	abnormal B cell proliferation	J:69547
Fcgr1^tm1Hoga/Fcgr1^tm1Hoga (involves: 129S1/Sv * 129X1/SvJ)	abnormal macrophage antigen presentation	J:86281
	impaired macrophage phagocytosis	J:86281
	increased IgG level	J:86281
Fcgr1^tm1Jgjw/Fcgr1^tm1Jgjw (involves: 129 * C57BL/6)	abnormal dendritic cell differentiation	J:112436
Fcgr1^tm1Jsv/Fcgr1^tm1Jsv (involves: 129P2/OlaHsd * BALB/c)	abnormal macrophage physiology	J:83995
Fcgr1^tm1Jsv/Fcgr1^tm1Jsv (involves: 129P2/OlaHsd * BALB/c)	decreased susceptibility to autoimmune hemolytic anemia	J:83995
Fcgr1^tm1Jsv/Fcgr1^tm1Jsv Fcgr2b^tm1Ttk/Fcgr2b^tm1Ttk Fcgr3^tm1Jsv/Fcgr3^tm1Jsv (involves: 129P2/OlaHsd * 129S4/SvJae * BALB/c * C57BL/6)	impaired macrophage phagocytosis	J:83995
Fcgr2b^tm1.2Jsv/Fcgr2b⁺ X/Yaa (involves: C57BL/6 * FVB/N * SB/Le)	enlarged spleen	J:179175
	increased monocyte cell number	J:179175
Fcgr2b^tm1.2Jsv/Fcgr2b^tm1.2Jsv Sle16^C57BL/6/Sle16^C57BL/6 (involves: C57BL/6 * FVB/N)	increased immunoglobulin level	J:179175
Fcgr2b^tm1Kgcs/Fcgr2b⁺ (involves: C57BL/6)	decreased B cell apoptosis	J:190890
	increased germinal center B cell number	J:190890
	increased IgG1 level	J:190890
	increased IgG3 level	J:190890
	increased IgM level	J:190890
Fcgr2b^tm1Ttk/Fcgr2b⁺ X/Yaa (involves: 129S4/SvJae * C57BL/6 * SB/Le)	increased monocyte cell number	J:129409
Fcgr2b^tm1Ttk/Fcgr2b^tm1.2Jsv Sle21^129P2/Ola/Sle21^C57BL/6 (involves: 129P2/Ola * 129S4/SvJae * C57BL/6 * FVB/N)	enlarged spleen	J:179175
	increased spleen weight	J:179175
Fcgr2b^tm1Ttk/Fcgr2b^tm1Ttk (involves: 129S4/SvJae)	abnormal mast cell physiology	J:31133
	increased IgA level	J:31133
	increased IgG1 level	J:31133
	increased IgG2a level	J:31133
	increased IgG2b level	J:31133
	increased IgG3 level	J:31133
	increased IgG level	J:31133
	increased IgM level	J:31133
Fcgr2b^tm1Ttk/Fcgr2b^tm1Ttk (B6.129S4-Fcgr2b^tm1Ttk)	anemia	J:64152
	enlarged spleen	J:64152
	increased immunoglobulin level	J:64152
Fcgr2b^tm1Ttk/Fcgr2b^tm1Ttk Il17a^tm1Yiw/Il17a⁺ (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	increased plasma cell number	J:191090
	increased spleen germinal center number	J:191090
Fcgr2b^tm1Ttk/Fcgr2b^tm1Ttk Il17a^tm1Yiw/Il17a^tm1Yiw (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	increased double-negative T cell number	J:191090
	increased plasma cell number	J:191090
	increased spleen germinal center number	J:191090
Fcgr2b^tm1Ttk/Fcgr2b^tm1Ttk Sle21^129P2/Ola/Sle21^129P2/Ola (B6.129S4-Fcgr2b^tm1Ttk)	enlarged spleen	J:179175
	increased IgG2a level	J:179175
	increased immunoglobulin level	J:179175
	increased spleen weight	J:179175
Fcgr2b^tm1Ttk/Fcgr2b^tm1Ttk Tlr7^tm1Flv/Y X/Yaa (B6.Cg-Fcgr2b^tm1Ttk Tlr7^tm1Flv Yaa)	abnormal splenocyte physiology	J:127600
	enlarged spleen	J:127600
Fcgr2b^tm1Ttk/Fcgr2b^tm1Ttk Traf3ip2^tm1Sbn/Traf3ip2⁺ (involves: 129 * 129S4/SvJae * C57BL/6)	abnormal neutrophil morphology	J:191090
	abnormal T cell morphology	J:191090
	increased double-negative T cell number	J:191090
	increased IgG level	J:191090
	increased memory T cell number	J:191090
	increased monocyte cell number	J:191090
	increased myeloid dendritic cell number	J:191090
	increased neutrophil cell number	J:191090
	increased plasma cell number	J:191090
	increased plasmacytoid dendritic cell number	J:191090
	increased single-positive T cell number	J:191090
	increased spleen germinal center number	J:191090
Fcgr2b^tm1Ttk/Fcgr2b^tm1Ttk Traf3ip2^tm1Sbn/Traf3ip2^tm1Sbn (involves: 129 * 129S4/SvJae * C57BL/6)	abnormal T cell morphology	J:191090
	increased double-negative T cell number	J:191090
	increased IgG level	J:191090
Fcgr2b^tm1Ttk/Fcgr2b^tm1Ttk Traf3ip2^tm2Sbn/Traf3ip2⁺ (involves: 129S4/SvJae * BALB/c * C57BL/6)	enlarged spleen	J:191090
	increased germinal center B cell number	J:191090
	increased plasma cell number	J:191090
	increased spleen weight	J:191090
	spleen hyperplasia	J:191090
Fcgr2b^tm1Ttk/Fcgr2b^tm1Ttk Traf3ip2^tm2Sbn/Traf3ip2^tm2Sbn Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: 129S4/SvJae * BALB/c * C57BL/6)	increased germinal center B cell number	J:191090
	increased plasma cell number	J:191090
Fcgr2b^tm1Ttk/Fcgr2b^tm1Ttk X/Yaa (B6.Cg-Fcgr2b^tm1Ttk Yaa)	enlarged spleen	J:127600
Fcgr3^tm1Jsv/Fcgr3^tm1Jsv (involves: 129P2/OlaHsd * C57BL/6)	decreased mast cell degranulation	J:35057
	decreased susceptibility to autoimmune hemolytic anemia	J:83995
	impaired macrophage phagocytosis	J:35057
	impaired natural killer cell mediated cytotoxicity	J:35057
Fcgr3^tm1Jsv/Fcgr3^tm1Jsv (B6.129P2-Fcgr3^tm1Jsv/J)	abnormal leukocyte cell number	J:78297
	abnormal neutrophil physiology	J:78297
	impaired neutrophil recruitment	J:78297
	increased neutrophil cell number	J:78297
Fcgr3^tm1Jsv/Fcgr3^tm1Jsv Sle21^129P2/Ola/Sle21^129P2/Ola (B6.129P2-Fcgr3^tm1Jsv)	enlarged spleen	J:179175
	increased activated T cell number	J:179175
	increased B cell number	J:179175
	increased spleen weight	J:179175
Fcgr4^tm1Rav/Fcgr4^tm1Rav Tg(Ctsk-cre)1Rda/0 (involves: C57BL/6)	decreased osteoclast cell number	J:197378
Fcgrt^tm1Dcr/Fcgrt^tm1Dcr (either: 129 or (involves: 129 * C57BL/6))	decreased IgG level	J:94189
Fcgrt^tm1Dcr/Fcgrt^tm1Dcr (B6.129X1-Fcgrt^tm1Dcr/DcrJ)	decreased IgG level	J:110885
Fcgrt^tm1Esw/Fcgrt^tm1Esw Tg(Tek-cre)1Ywa/0 (B6.Cg-Tg(Tek-cre)1Ywa Fcgrt^tm1Esw)	decreased IgG1 level	J:146640
Fcho2^{tm1b(EUCOMM)Hmgu}/Fcho2⁺ (C57BL/6N-Fcho2^{tm1b(EUCOMM)Hmgu}/Wtsi)	decreased mean corpuscular hemoglobin	J:211773
	increased red blood cell distribution width	J:211773
Fcmr^tm1.2Khl/Fcmr^tm1.2Khl (involves: C57BL/6)	abnormal granulocyte physiology	J:194323
	decreased B cell number	J:174871
	increased T cell apoptosis	J:174871
Fcmr^tm1Mak/Fcmr^tm1Mak (B6.129S2-Fcmr^tm1Mak)	abnormal granulocyte physiology	J:194323
	hematopoietic system phenotype	J:194323
	impaired granulocyte bactericidal activity	J:194323
Fcmr^tm1Ohno/Fcmr^tm1Ohno (B6.129-Fcmr^tm1Ohno)	abnormal B cell morphology	J:190117
	abnormal immunoglobulin level	J:190117
	decreased IgG1 level	J:190117
	decreased IgM level	J:190117
	decreased marginal zone B cell number	J:190117
	increased B-1 B cell number	J:190117
	increased IgG3 level	J:190117
	increased IgM level	J:190117
	increased T cell number	J:190117
Fcrl2^tm1Lex/Fcrl2^tm1Lex (B6;129S5-Fcrl2^tm1Lex/Mmucd)	decreased CD8-positive, alpha-beta T cell number	J:171883
Fcrla^tm1.1Cln/Fcrla^tm1.1Cln (involves: 129P2/OlaHsd * C57BL/6)	increased IgG1 level	J:163261
Fcrla^{tm1b(KOMP)Wtsi}/Fcrla^{tm1b(KOMP)Wtsi} (C57BL/6N-Fcrla^{tm1b(KOMP)Wtsi}/Ucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased red blood cell distribution width	J:211773
Fcrlb^tm1Pdb/Fcrlb^tm1Pdb (B6.129-Fcrlb^tm1Pdb)	increased IgG1 level	J:165408
Fdx2^{em1(IMPC)Rbrc}/Fdx2^{em1(IMPC)Rbrc} (C57BL/6NJcl-Fdx2^{em1(IMPC)Rbrc}/Rbrc)	abnormal erythrocyte cell number	J:211773
	abnormal hemoglobin content	J:211773
	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased spleen weight	J:211773
Fech^m1Pas/Fech^m1Pas (involves: 129/Sv * BALB/c)	abnormal erythrocyte morphology	J:2021
	abnormal erythropoiesis	J:2021
	anisocytosis	J:2021
	decreased erythrocyte cell number	J:2021
	decreased erythrocyte osmotic fragility	J:2021
	decreased hematocrit	J:2021
	decreased hemoglobin content	J:2021
	hypochromic anemia	J:2021
	increased erythrocyte protoporphyrin level	J:2021
	increased red blood cell distribution width	J:2021
	increased spleen weight	J:2021
	leptocytosis	J:2021
	polychromatophilia	J:2021
	reticulocytosis	J:2021
Fech^m1Pas/Fech^m1Pas hem6/hem6 (involves: 129 * BALB/c * C57BL/6)	decreased hemoglobin content	J:142791
	increased erythrocyte protoporphyrin level	J:142791
Fech^m1Pas/Fech^m1Pas hem6/hem6⁺ (involves: 129 * BALB/c * C57BL/6)	decreased hemoglobin content	J:142791
	increased erythrocyte protoporphyrin level	J:142791
Fech^m1Pas/Fech^{tm1.1(FECH)Emi} (involves: 129 BALB/cJ * C57BL/6J)	decreased eosinophil cell number	J:239515
	decreased erythrocyte cell number	J:239515
	decreased hematocrit	J:239515
	decreased mean corpuscular hemoglobin	J:239515
	decreased mean corpuscular hemoglobin concentration	J:239515
	decreased mean corpuscular volume	J:239515
	enlarged spleen	J:239515
	hypochromic microcytic anemia	J:239515
	reticulocytosis	J:239515
	thrombocytosis	J:239515
Fen1^tm1Bhsh/Fen1^tm1Bhsh (involves: 129S1/Sv)	abnormal embryonic erythropoiesis	J:121378
	abnormal embryonic hematopoiesis	J:121378
	pale spleen	J:121378
Fen1^tm1Rak/Fen1⁺ (involves: 129/Sv * C57BL/6 * SJL/J)	thymus atrophy	J:77962
Fen1^tm2Klng/Fen1^tm2Klng (involves: 129X1/SvJ * C57BL/6)	abnormal spleen B cell follicle morphology	J:138901
	abnormal spleen marginal zone morphology	J:138901
	enlarged spleen	J:138901
	increased spleen B cell follicle number	J:138901
	increased spleen B cell follicle size	J:138901
Fen1^tm3.1Bhsh/Fen1⁺ (Not Specified)	enlarged spleen	J:231218
	extramedullary hematopoiesis	J:231218
	increased plasma cell number	J:231218
Fen1^tm3.1Bhsh/Fen1^tm3.1Bhsh (Not Specified)	enlarged spleen	J:231218
	extramedullary hematopoiesis	J:231218
	increased plasma cell number	J:231218
Fer^em1(IMPC)Tcp/Fer⁺ (C57BL/6N-Fer^em1(IMPC)Tcp/Tcp)	abnormal spleen morphology	J:211773
	increased mean platelet volume	J:211773
	increased red blood cell distribution width	J:211773
	increased spleen weight	J:211773
Fer^em1(IMPC)Tcp/Fer^em1(IMPC)Tcp (C57BL/6N-Fer^em1(IMPC)Tcp/Tcp)	enlarged spleen	J:211773
Fermt3^tm1.1Efp/Fermt3^tm1.1Efp (involves: C57BL/6)	abnormal platelet activation	J:227094
	abnormal platelet physiology	J:227094
	acanthocytosis	J:227094
	decreased erythrocyte cell number	J:227094
	decreased platelet aggregation	J:227094
	hematopoietic system phenotype	J:227094
	increased leukocyte cell number	J:227094
Fermt3^tm1Ref/Fermt3^tm1Ref (involves: 129S1/Sv * 129X1/SvJ)	abnormal erythrocyte morphology	J:145476
	abnormal platelet activation	J:133659
	anemia	J:145476
	anisopoikilocytosis	J:145476
	decreased erythrocyte cell number	J:145476
	decreased platelet aggregation	J:133659
	increased nucleated erythrocyte cell number	J:145476
Fermt3^tm2.1Ref/Fermt3^tm2.1Ref Tg(Cd4-cre)1Cwi/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)	abnormal effector T cell morphology	J:203436
	abnormal T cell physiology	J:203436
Fermt3^tm2.2Ref/Fermt3^tm2.2Ref (involves: 129S1/Sv * 129X1/SvJ)	abnormal hematopoietic system morphology/development	J:203436
Fes^tm1Mcs/Fes^tm1Mcs (involves: 129X1/SvJ)	abnormal bone marrow cell morphology/development	J:64748
	abnormal leukocyte cell number	J:64748
	abnormal macrophage physiology	J:64748
	abnormal megakaryocyte progenitor cell morphology	J:64748
	decreased B cell number	J:64748
	decreased bone marrow cell number	J:64748
	increased granulocyte number	J:64748
	increased monocyte cell number	J:64748
	increased neutrophil cell number	J:64748
	thymus hypoplasia	J:64748
Fes^tm1Pag/Fes^tm1Pag (involves: 129S1/Sv * 129X1/SvJ * CD-1)	hematopoietic system phenotype	J:84535
Fes^tm2Pag/Fes^tm2Pag (involves: 129S1/Sv * 129X1/SvJ * CD-1)	abnormal myelopoiesis	J:98590
	decreased B cell number	J:98590
	increased erythrocyte cell number	J:98590
	increased hematocrit	J:98590
	increased hemoglobin content	J:98590
	increased pre-B cell number	J:98590
	increased pro-B cell number	J:98590
Ffar2^tm1Dgen/Ffar2^tm1Dgen (involves: C57BL/6)	abnormal granulocyte physiology	J:153951
	abnormal neutrophil physiology	J:153951
	impaired neutrophil chemotaxis	J:153951
	impaired neutrophil phagocytosis	J:153951
	increased T cell number	J:153951
Ffar2^tm2Lex/Ffar2^tm2Lex (involves: 129S7/SvEvBrd * C57BL/6)	abnormal neutrophil morphology	J:157383
	impaired neutrophil chemotaxis	J:157383
Fga^tm1Jld/Fga^tm1Jld (involves: 129P2/OlaHsd * CF-1)	decreased platelet aggregation	J:28436
Fga^tm1Jld/Fga^tm1Jld (B6.129P2-Fga^tm1Jld)	decreased platelet aggregation	J:28436
Fgb^{tm1.1(KOMP)Vlcg}/Fgb^{tm1.1(KOMP)Vlcg} (C57BL/6N-Fgb^{tm1.1(KOMP)Vlcg}/Ucd)	increased red blood cell distribution width	J:211773
Fgd1^em1(IMPC)Tcp/Fgd1⁺ (C57BL/6NCrl-Fgd1^em1(IMPC)Tcp/Tcp)	enlarged thymus	J:211773
Fgd3^{em1(IMPC)Ccpcz}/Fgd3^{em1(IMPC)Ccpcz} (C57BL/6N-Fgd3^{em1(IMPC)Ccpcz}/Ccpcz)	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
Fgd5^em1(IMPC)Mbp/Fgd5⁺ (C57BL/6NCrl-Fgd5^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased red blood cell distribution width	J:211773
Fgf1^tm1Bas/Fgf1^tm1Bas Fgf2^tm1Bas/Fgf2^tm1Bas (involves: 129P2/OlaHsd * C57BL/6)	abnormal bone marrow cell morphology/development	J:60597
Fgf2^tm1Bas/Fgf2^tm1Bas (involves: 129P2/OlaHsd * C57BL/6)	abnormal myeloblast morphology/development	J:60597
Fgf2^tm1Doe/Fgf2^tm1Doe (involves: 129P2/OlaHsd * Black Swiss)	abnormal common myeloid progenitor cell morphology	J:45775
	thrombocytosis	J:45775
Fgf7^tm1Efu/Fgf7^tm1Efu (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	hematopoietic system phenotype	J:129368
	spleen hypoplasia	J:129368
Fgf8^tm1.3Mrt/Fgf8^tm1.4Mrt Tg(Tbx1-cre)1Joe/0 (involves: 129P2/OlaHsd)	abnormal thymus morphology	J:88814
	small thymus	J:88814
Fgf8^tm1.4Mrt/Fgf8⁺ Tbx1^tm1Bld/Tbx1⁺ (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * ICR)	thymus hypoplasia	J:78686
Fgf8^tm1Mrc/Fgf8^tm1Moon Hoxa3^tm1(cre)Moon/Hoxa3⁺ (involves: 129/Sv * C57BL/6)	ectopic thymus	J:87304
	thymus hypoplasia	J:87304
Fgf8^tm1Mrc/Fgf8^tm2Mrc Hoxa3^tm1(cre)Moon/Hoxa3⁺ (involves: 129/Sv * C57BL/6)	ectopic thymus	J:87304
	thymus hypoplasia	J:87304
Fgf10^{tm1b(EUCOMM)Wtsi}/Fgf10⁺ (C57BL/6N-Fgf10^{tm1b(EUCOMM)Wtsi}/H)	decreased leukocyte cell number	J:211773
Fgf10^tm1Ska/Fgf10^tm1Ska (involves: C57BL/6 * CBA)	small thymus	J:114183
Fgf11^{tm1a(EUCOMM)Wtsi}/Fgf11^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Fgf11^{tm1a(EUCOMM)Wtsi}/Cnrm)	increased mean corpuscular volume	J:165965
Fgf14^{em1(IMPC)Ccpcz}/Fgf14^{em1(IMPC)Ccpcz} (C57BL/6N-Fgf14^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
Fgf23^tm1Blan/Fgf23^tm1Blan (involves: 129/Sv * C57BL/6)	small spleen	J:121006
Fgf23^tm1Tyam/Fgf23^tm1Tyam (involves: C57BL/6 * CBA)	decreased lymphocyte cell number	J:88172
	spleen hypoplasia	J:88172
	thymus atrophy	J:88172
Fgfbp3^{tm1.1(KOMP)Wtsi}/Fgfbp3^{tm1.1(KOMP)Wtsi} (C57BL/6N-Fgfbp3^{tm1.1(KOMP)Wtsi}/Ucd)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Fgfr1^tm1Upir/Fgfr1^tm1Upir Fgfr2^tm1Dor/Fgfr2^tm1Dor Tg(KRT5-cre)5132Jlj/0 (involves: 129X1/SvJ * C57BL/6 * C57BL/6J * DBA/2J)	abnormal mast cell morphology	J:221184
	increased IgE level	J:158802
	increased IgG1 level	J:158802
	increased IgG2a level	J:158802
	increased mast cell number	J:221184
Fgfr2^tm1Dor/Fgfr2^tm1.1Dor Twist2^tm1(cre)Dor/Twist2⁺ (involves: 129X1/SvJ)	abnormal osteoclast differentiation	J:90391
Fgfr2^tm1Dsn/Fgfr2^tm1Dsn Tg(KRT5-cre)5132Jlj/0 (involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)	increased gamma-delta T cell number	J:119723
Fgfr2^tm1Ewj/Fgfr2⁺ Tg(EIIa-cre)C5379Lmgd/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)	abnormal thymus morphology	J:101174
	decreased osteoclast cell number	J:101174
Fgfr2^tm3Dsn/Fgfr2^tm3Dsn (involves: 129P2/OlaHsd * C57BL/6)	abnormal thymus development	J:67731
Fgfr3^{tm1.1(FGFR3*)Ytc}/Fgfr3⁺ (involves: 129)	decreased osteoclast cell number	J:287271
Fgfr3^{tm1.1(FGFR3)Ytc}/Fgfr3^{tm1.1(FGFR3)Ytc} (involves: 129)	decreased osteoclast cell number	J:287271
Fgfr3^tm1Led/Fgfr3^tm1Led (involves: 129S6/SvEvTac)	increased osteoclast cell number	J:32105
Fgfr3^tm2Llm/Fgfr3⁺ Tg(CMV-cre)1Ipc/? (involves: 129S2/SvPas * C57BL/6 * SJL)	increased osteoclast cell number	J:183772
Fgfr3^tm2Llm/Fgfr3⁺ Tg(Col2a1-cre)1Bhr/? (involves: 129S2/SvPas * C57BL/6 * SJL)	increased osteoclast cell number	J:183772
Fgfr3^tm3.1Cxd/Fgfr3^tm3.1Cxd (involves: 129S6/SvEvTac)	abnormal osteoclast physiology	J:69849
Fgfr4^M1Btlr/Fgfr4^M1Btlr (C57BL/6J-Fgfr4^M1Btlr)	decreased B-1a cell number	J:265097
Fgfrl1^tm1.1Ptew/Fgfrl1^tm1.1Ptew (B6.129-Fgfrl1^tm1.1Ptew)	abnormal erythroblast number	J:149673
	anemia	J:149673
	decreased erythrocyte cell number	J:149673
	decreased hematocrit	J:149673
	decreased hemoglobin content	J:149673
Fgg^tm1Jld/Fgg^tm1Jld (involves: 129P2/OlaHsd * NIH Black Swiss)	decreased platelet aggregation	J:36873
Fgg^tm1Lord/Fgg^tm1Lord (involves: 129P2/OlaHsd * C57BL/6)	decreased hematocrit	J:129828
	decreased mean corpuscular volume	J:129828
	increased leukocyte cell number	J:129828
Fgg^tm2Jld/Fgg^tm2Jld (involves: 129P2/OlaHsd * Black Swiss * C57BL/6)	abnormal neutrophil physiology	J:90908
	hematopoietic system phenotype	J:90908
Fgl1^{tm1b(EUCOMM)Hmgu}/Fgl1^{tm1b(EUCOMM)Hmgu} (involves: BALB/cJ * C57BL/6N)	decreased B cell number	J:269578
	increased central memory CD8 positive, alpha-beta T cell number	J:269578
Fgl2^tm1Pam/Fgl2^tm1Pam (B6.129X1-Fgl2^tm1Pam)	abnormal B cell physiology	J:130895
	abnormal regulatory T cell physiology	J:130895
	abnormal T cell physiology	J:130895
	enlarged spleen	J:130895
	increased dendritic cell number	J:130895
	increased IgA level	J:130895
	increased IgG level	J:130895
	increased IgM level	J:130895
	increased regulatory T cell number	J:130895
	increased T cell proliferation	J:130895
Fgr^tm1Hev/Fgr^tm1Hev Hck^tm1Hev/Hck^tm1Hev (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal macrophage morphology	J:59037
	abnormal macrophage physiology	J:59037
	impaired macrophage phagocytosis	J:16994
Fgr^tm1Hev/Fgr^tm1Hev Hck^tm1Hev/Hck^tm1Hev Lyn^tm1Sor/Lyn^tm1Sor (B6.Cg-Hck^tm1Hev Fgr^tm1Hev Lyn^tm1Sor)	abnormal neutrophil physiology	J:113463
Fhip1a^{tm1b(EUCOMM)Wtsi}/Fhip1a⁺ (C57BL/6N-Fhip1a1^{tm1b(EUCOMM)Wtsi}/Wtsi)	decreased erythrocyte cell number	J:211773
	increased mean corpuscular hemoglobin	J:211773
Fhip1b^em1(IMPC)Tcp/Fhip1b^em1(IMPC)Tcp (C57BL/6NCrl-Fhip1b^em1(IMPC)Tcp/Tcp)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Fhip2b^{em1(IMPC)Ccpcz}/Fhip2b^{em1(IMPC)Ccpcz} (C57BL/6N-Fhip2b^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Fhip2b^em1Wwan/Fhip2b^em1Wwan (involves: C57BL/6)	enlarged spleen	J:285283
Fhip2b^em1Wwan/Fhip2b^em1Wwan (involves: C57BL/6)	increased leukocyte cell number	J:285283
Fhit^tm1Hbn/Fhit⁺ (involves: 129X1/SvJ * C57BL/6)	decreased granulocyte number	J:71303
Fhit^tm1Hbn/Fhit^tm1Hbn (involves: 129X1/SvJ * C57BL/6)	decreased granulocyte number	J:71303
Fibp^{tm1e(EUCOMM)Wtsi}/Fibp⁺ (C57BL/6N-Fibp^{tm1e(EUCOMM)Wtsi}/Wtsi)	decreased erythrocyte cell number	J:211773
	increased mean corpuscular hemoglobin	J:211773
Fig4^plt1/Fig4^plt1 (involves: 129P2/OlaHsd * C3H * C57BL/6 * CAST/Ei * SJL)	spleen hypoplasia	J:122737
Fig4^plt1/Fig4^plt1 (involves: 129P2/OlaHsd * C3H * SJL)	abnormal bone marrow cell morphology/development	J:203638
Firrm^{tm1a(EUCOMM)Hmgu}/Firrm⁺ (C57BL/6N-Firrm^{tm1a(EUCOMM)Hmgu}/H)	increased mean corpuscular volume	J:165965
Fkbp4^em1(IMPC)Mbp/Fkbp4^em1(IMPC)Mbp (C57BL/6N-Fkbp4^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	decreased mean corpuscular volume	J:211773
	enlarged spleen	J:211773
	small spleen	J:211773
Fkbp5^{tm1b(KOMP)Wtsi}/Fkbp5^{tm1b(KOMP)Wtsi} (C57BL/6N-Fkbp5^{tm1b(KOMP)Wtsi}/MbpMmucd)	increased basophil cell number	J:211773
	increased neutrophil cell number	J:211773
Fkbp6^{tm1b(KOMP)Wtsi}/Fkbp6^{tm1b(KOMP)Wtsi} (C57BL/6N-Fkbp6^{tm1b(KOMP)Wtsi}/J)	increased mean corpuscular hemoglobin concentration	J:211773
Fkbp10^{tm2a(EUCOMM)Wtsi}/Fkbp10⁺ (C57BL/6N-Fkbp10^{tm2a(EUCOMM)Wtsi}/Ics)	decreased hemoglobin content	J:165965
	decreased mean corpuscular volume	J:165965
	increased hemoglobin content	J:165965
Fkbp11^em1(IMPC)Mbp/Fkbp11^em1(IMPC)Mbp (C57BL/6N-Fkbp11^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	small spleen	J:211773
Fkbp11^{Gt(OST298786)Lex}/Fkbp11^{Gt(OST298786)Lex} (involves: 129S5/SvEvBrd * C57BL/6J)	increased immunoglobulin level	J:103485
Flcn^tm1Baba/Flcn^tm1.1Lss Tg(CAG-cre/Esr1)1Lbe/0 (involves: 129S1/Sv 129X1/SvJ)	arrested B cell differentiation	J:189078
	decreased B cell number	J:189078
Flg^ft/Flg^ft (B6.Cg-Flg^ft)	increased IgE level	J:202453, J:151110
	increased IgG1 level	J:151110
	increased IgG2a level	J:151110
	increased IgG level	J:151110
	increased splenocyte proliferation	J:151110
Flg^ft/Flg^ft Tmem79^ma/Tmem79^ma (involves: CBA/CaGr)	increased IgE level	J:202453
Flg^tm1Amag/Flg^tm1Amag (involves: 129S6/SvEvTac * BALB/c * C57BL/6NTac)	increased IgE level	J:198332
	increased IgG1 level	J:198332
Fli1^tm1.1Dkw/Fli1⁺ (B6.129S6-Fli1^tm1.1Dkw)	decreased B cell number	J:137876
Fli1^tm1.1Dkw/Fli1^tm1.1Dkw (B6.129S6-Fli1^tm1.1Dkw)	abnormal B cell differentiation	J:137876
	abnormal class switch recombination	J:137876
	abnormal splenic cell ratio	J:137876
	decreased B cell number	J:137876
	decreased B cell proliferation	J:137876
	decreased follicular B cell number	J:137876
	decreased IgG1 level	J:137876
	decreased IgG3 level	J:137876
	increased marginal zone B cell number	J:137876
	increased transitional stage B cell number	J:137876
	spleen hyperplasia	J:137876
Fli1^tm1Adh/Fli1^tm1Adh (either: (involves: 129S1/Sv * 129X1/SvJ * C57BL/6) or (involves: 129S1/Sv * 129X1/SvJ * CD-1))	abnormal megakaryocyte morphology	J:64178
	abnormal megakaryocyte progenitor cell morphology	J:64178
Fli1^tm1Ber/Fli1^tm1Ber (either: (involves: 129S1/Sv * 129X1/SvJ * C57BL/6) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1))	decreased thymocyte number	J:33052
Fli1^tm1Ber/Fli1^tm1Ber (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1)	anemia	J:33052
	decreased hematocrit	J:33052
	enlarged spleen	J:33052
Fli1^tm1Dkw/Fli1⁺ Mpl^tm1Wsa/Mpl^tm1Wsa (involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6)	hematopoietic system phenotype	J:137835
	thrombocytopenia	J:137835
Fli1^tm1Dkw/Fli1^tm1Dkw (either: B6.Cg-Fli1^tm1Dkw or (involves: CD-1) or (involves: 129S6/SvEvTac * C57BL/6))	abnormal proerythroblast morphology	J:74166
	decreased megakaryocyte cell number	J:74166
	impaired hematopoiesis	J:63242
Fli1^tm1Morl/Fli1^tm1.1Morl Tg(Mx1-cre)1Cgn/0 (involves: 129/Sv * C57BL/6 * CBA * DBA)	abnormal megakaryocyte differentiation	J:167426
	hematopoietic system phenotype	J:167426
	thrombocytopenia	J:167426
Fli1^tm1Morl/Fli1^tm1Morl Tg(Mx1-cre)1Cgn/0 (involves: 129/Sv * C57BL/6 * CBA)	abnormal erythropoiesis	J:167426
	abnormal leukocyte morphology	J:167426
	abnormal megakaryocyte differentiation	J:167426
	abnormal thrombopoiesis	J:167426
	decreased granulocyte number	J:167426
	hematopoietic system phenotype	J:167426
	increased erythrocyte cell number	J:167426
	increased erythroid progenitor cell number	J:167426
	increased monocyte cell number	J:167426
	increased NK cell number	J:167426
	thrombocytopenia	J:167426
Flna^tm1.2Caw/Flna⁺ (involves: 129S4/SvJae * C57BL/6)	increased leukocyte cell number	J:118252
Flnb^{tm1b(KOMP)Wtsi}/Flnb⁺ (C57BL/6N-Flnb^{tm1b(KOMP)Wtsi}/H)	decreased neutrophil cell number	J:211773
	decreased red blood cell distribution width	J:211773
Flot1^tm1.1Arte/Flot1^tm1.1Arte (involves: C57BL/6J)	abnormal leukocyte physiology	J:166672
	impaired neutrophil chemotaxis	J:166672
	impaired neutrophil recruitment	J:166672
Flt1^tm1.1Fong/Flt1^tm1.1Fong Gt(ROSA)26Sor^{tm1(cre/ERT2)Thl}/Gt(ROSA)26Sor⁺ (involves: 129S6/SvEvTac * C57BL/6NCr * CD-1)	increased macrophage cell number	J:202202
Flt1^tm1Jrt/Flt1^tm1Jrt (either: (involves: 129/Sv) or (involves: CD-1) or (involves: ICR))	abnormal embryonic erythrocyte morphology	J:54830
	increased hemangioblast number	J:54830
Flt1^tm1Msh/Flt1^tm1Msh (involves: 129S4/SvJae * C57BL/6J)	impaired macrophage chemotaxis	J:49507
Flt3^{em1(IMPC)Ccpcz}/Flt3^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Flt3^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	decreased effector memory T-helper cell number	J:211773
	decreased NK cell number	J:211773
Flt3^m1Btlr/Flt3^m1Btlr (C57BL/6J-Flt3^m1Btlr)	abnormal macrophage physiology	J:105543
	abnormal NK cell physiology	J:159599
	decreased dendritic cell number	J:159599
	decreased NK cell number	J:159599
	decreased plasmacytoid dendritic cell number	J:159599
	decreased splenocyte number	J:159599
Flt3^tm1.1Dosm/Flt3⁺ (B6.129(C)-Flt3^tm1.1Dosm)	abnormal bone marrow cell number	J:205200
	abnormal bone marrow cell physiology	J:205200
	abnormal definitive hematopoiesis	J:205200
	abnormal spleen morphology	J:205200
	arrested B cell differentiation	J:205200
	decreased bone marrow cell number	J:205200
	enlarged spleen	J:205200
	increased bone marrow cell number	J:205200
	increased spleen white pulp amount	J:205200
Flt3^tm1Dgg/Flt3⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal B cell differentiation	J:126003
	abnormal definitive hematopoiesis	J:126003
	decreased B cell number	J:126003
	decreased mature B cell number	J:126003
	decreased T cell number	J:126003
	enlarged spleen	J:126003
	increased granulocyte number	J:126003
	increased leukocyte cell number	J:126003
	increased monocyte cell number	J:126003
	increased spleen red pulp amount	J:126003
	increased spleen white pulp amount	J:126003
Flt3^tm1Dgg/Flt3⁺ (involves: 129S1/Sv * 129X1/SvJ * BALB/c)	abnormal hematopoietic system morphology/development	J:126003
Flt3^tm1Dgg/Flt3⁺ Kmt2a^tm1Clgr/Kmt2a⁺ (involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6J)	anemia	J:189096
	enlarged spleen	J:189096
	increased erythroblast number	J:189096
	increased leukocyte cell number	J:189096
	thrombocytopenia	J:189096
Flt3^tm1Dgg/Flt3^tm1Dgg (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal B cell differentiation	J:126003
	abnormal common myeloid progenitor cell morphology	J:126003
	abnormal definitive hematopoiesis	J:126003
	decreased B cell number	J:126003
	decreased mature B cell number	J:126003
	decreased T cell number	J:126003
	enlarged spleen	J:126003
	increased granulocyte number	J:126003
	increased leukocyte cell number	J:126003
	increased monocyte cell number	J:126003
	increased spleen red pulp amount	J:126003
	increased spleen white pulp amount	J:126003
Flt3^tm1Dgg/Flt3^tm1Dgg (involves: 129S1/Sv * 129X1/SvJ * BALB/c)	abnormal hematopoietic system morphology/development	J:126003
Flt3^tm1Dgg/Flt3^tm1Dgg Kmt2a^tm1Clgr/Kmt2a⁺ (involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6J)	enlarged spleen	J:189096
	increased leukocyte cell number	J:189096
Flt3^tm1Dosm/Flt3⁺ Tg(Mx1-cre)1Cgn/0 (B6.Cg-Flt3^tm1Dosm Tg(Mx1-cre)1Cgn)	abnormal bone marrow cell morphology/development	J:133528
	abnormal definitive hematopoiesis	J:133528
	abnormal spleen white pulp morphology	J:133528
	arrested B cell differentiation	J:133528
	decreased B cell number	J:133528
	decreased erythrocyte cell number	J:133528
	decreased hemoglobin content	J:133528
	decreased leukocyte cell number	J:133528
	decreased lymphocyte cell number	J:133528
	decreased megakaryocyte cell number	J:133528
	decreased neutrophil cell number	J:133528
	decreased pre-B cell number	J:133528
	enlarged spleen	J:133528
	extramedullary hematopoiesis	J:133528
	increased bone marrow cell number	J:133528
	increased dendritic cell number	J:133528
	increased granulocyte number	J:133528
	increased hematopoietic stem cell number	J:133528
	increased leukocyte cell number	J:133528
	increased monocyte cell number	J:133528
	increased neutrophil cell number	J:133528
	increased pro-B cell number	J:133528
	intermingled spleen red and white pulp	J:133528
Flt3^tm1Irl/Flt3^tm1Irl (either: 129S/SvEv-Flt3^tm1Irl or (involves: 129S/SvEv * C57BL/6J))	abnormal B cell differentiation	J:27238, J:99149
	decreased pre-B cell number	J:27238
	decreased pro-B cell number	J:27238
Flt3^tm1Irl/Flt3^tm1Irl Kit^W/Kit^W-v (involves: 129S/SvEv * C57BL/6)	abnormal blood cell morphology/development	J:27238
	abnormal common myeloid progenitor cell morphology	J:27238
	abnormal leukocyte morphology	J:27238
	abnormal myelopoiesis	J:27238
	abnormal T cell number	J:27238
	decreased B cell number	J:27238
	decreased bone marrow cell number	J:27238
	decreased double-negative T cell number	J:27238
	decreased double-positive T cell number	J:27238
	decreased lymphocyte cell number	J:27238
	decreased pre-B cell number	J:27238
	decreased pro-B cell number	J:27238
	thymus hypoplasia	J:27238
Flt3^tm2.1Dosm/Flt3⁺ (B6.129(C)-Flt3^tm2.1Dosm)	abnormal B cell morphology	J:205200
	abnormal bone marrow cell physiology	J:205200
	abnormal definitive hematopoiesis	J:205200
	abnormal myelopoiesis	J:205200
	abnormal spleen morphology	J:205200
	enlarged spleen	J:205200
	extramedullary hematopoiesis	J:205200
	increased bone marrow cell number	J:205200
	increased leukocyte cell number	J:205200
	increased megakaryocyte cell number	J:205200
	increased pre-pro B cell number	J:205200
	increased pro-B cell number	J:205200
	increased spleen white pulp amount	J:205200
	intermingled spleen red and white pulp	J:205200
	myeloid hyperplasia	J:205200
	thrombocytosis	J:205200
Flt3l^tm1Imx/Flt3l^tm1Imx (C57BL/6-Flt3l^tm1Imx)	abnormal common lymphocyte progenitor cell morphology	J:79569
	abnormal common myeloid progenitor cell morphology	J:62536
	abnormal dendritic cell morphology	J:62536, J:89868
	abnormal immature B cell morphology	J:62536
	abnormal leukocyte morphology	J:62536
	decreased B cell number	J:79569
	decreased bone marrow cell number	J:62536
	decreased double-negative T cell number	J:79569
	decreased hematopoietic stem cell number	J:62536
	decreased leukocyte cell number	J:62536
	decreased lymphocyte cell number	J:62536
	decreased myeloid dendritic cell number	J:62536, J:89868
	decreased NK cell number	J:62536
	decreased plasmacytoid dendritic cell number	J:62536, J:89868
	decreased pre-B cell number	J:79569
	decreased pro-B cell number	J:79569, J:62536
	impaired myelopoiesis	J:62536
	increased IgM level	J:62536
	increased neutrophil cell number	J:62536
	spleen hypoplasia	J:62536
Flt3l^tm1Imx/Flt3l^tm1Imx (involves: C57BL/6)	abnormal dendritic cell chemotaxis	J:223508
	abnormal memory T cell physiology	J:189122
	abnormal T-helper 1 physiology	J:189122
	decreased CD11b-high dendritic cell number	J:223508
	decreased CD103-positive CD11b-low dendritic cell number	J:223508
	decreased dendritic cell number	J:189122
	decreased macrophage cell number	J:189122
	decreased monocyte cell number	J:189122
	decreased NK cell number	J:189122
	decreased plasmacytoid dendritic cell number	J:189122
	increased neutrophil cell number	J:189122
Flvcr1^tm1.1Jlab/Flvcr1^tm1.1Jlab (involves: 129S4/SvJae * C57BL/6 * DBA/2)	abnormal erythropoiesis	J:132057
	abnormal spleen morphology	J:132057
	anemia	J:132057
	enlarged spleen	J:132057
	hyperchromic macrocytic anemia	J:132057
	reticulocytopenia	J:132057
Flvcr1^tm1Etol/Flvcr1^tm1Etol (either: (involves: 129) or (involves: 129 * C57BL/6))	hematopoietic system phenotype	J:194202
fm/fm (involves: CBA/H)	abnormal spleen morphology	J:5417, J:275
fm/fm (involves: CBA/H)	abnormal thymus morphology	J:275
Fmnl1^tm1.2Sdb/Fmnl1^tm1.2Sdb Lyz2^tm1(cre)Ifo/Lyz2^tm1(cre)Ifo (involves: C3H * C57BL/6 * FVB/N)	abnormal Kupffer cell morphology	J:250144
	abnormal macrophage morphology	J:250144
	abnormal macrophage physiology	J:250144
	decreased macrophage cell number	J:250144
	hematopoietic system phenotype	J:250144
	impaired macrophage chemotaxis	J:250144
Fmo3^em1(IMPC)Mbp/Fmo3^em1(IMPC)Mbp (C57BL/6N-Fmo3^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Fmo5^em1(IMPC)Mbp/Fmo5^em1(IMPC)Mbp (C57BL/6N-Fmo5^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Fn1^tm4Hyn/Fn1^tm4Hyn (involves: 129P2/OlaHsd * C57BL/6J)	anemia	J:126737
Fnbp1^em1(IMPC)J/Fnbp1^em1(IMPC)J (C57BL/6NJ-Fnbp1^em1(IMPC)J/Mmjax)	decreased mean corpuscular hemoglobin	J:211773
Fndc3a^em1(IMPC)Tcp/Fndc3a^em1(IMPC)Tcp (C57BL/6N-Fndc3a^em1(IMPC)Tcp/Tcp)	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
Fndc9^{tm1.1(KOMP)Vlcg}/Fndc9^{tm1.1(KOMP)Vlcg} (C57BL/6N-Fndc9^{tm1.1(KOMP)Vlcg}/Ucd)	decreased lymphocyte cell number	J:211773
	increased mean platelet volume	J:211773
	increased neutrophil cell number	J:211773
Fnip1^{Gt(RRM154)Byg}/Fnip1^{Gt(RRM154)Byg} (involves: 129P2/OlaHsd * C57BL/6J)	absent B cells	J:189078
	absent B-2 B cells	J:189078
	arrested B cell differentiation	J:189078
	decreased B cell number	J:189078
	decreased B-1 B cell number	J:189078
	decreased mature B cell number	J:189078
	decreased pre-B cell number	J:189078
	decreased transitional stage B cell number	J:189078
	increased B cell apoptosis	J:189078
	increased pro-B cell number	J:189078
	small spleen	J:189078
Fnip1^{Gt(RRM154)Byg}/Fnip1^{Gt(RRM154)Byg} Igh^tm2Cgn/Igh^tm2Cgn (involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL)	absent B cells	J:189078
	absent B-2 B cells	J:189078
	decreased B-1 B cell number	J:189078
Fnip1^{Gt(RRM154)Byg}/Fnip1^{Gt(RRM154)Byg} Tg(BCL2)22Wehi/0 (involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL)	increased B cell number	J:189078
Fnip1^{Gt(RRM154)Byg}/Fnip1^{Gt(RRM154)Byg} Tg(IghelMD4)4Ccg/0 (involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL)	absent B cells	J:189078
	absent B-2 B cells	J:189078
	decreased B-1 B cell number	J:189078
	increased immature B cell number	J:189078
Fnip1^LPAB.1/Fnip1^LPAB.1 (C57BL/6J-Fnip1^LPAB.1)	abnormal B cell physiology	J:187318
	absent B cells	J:187318
	arrested B cell differentiation	J:187318
	decreased B-1 B cell number	J:187318
	decreased IgE level	J:187318
	decreased IgG1 level	J:187318
	decreased IgG2a level	J:187318
	decreased IgG level	J:187318
	decreased IgM level	J:187318
	increased B cell apoptosis	J:187318
Fnip1^LPAB.1/Fnip1^LPAB.1 Tg(IghMyc)22Bri/0 (involves: C57BL * C57BL/6J * SJL)	increased B cell apoptosis	J:187318
Fnip1^m1Btlr/Fnip1^m1Btlr (C57BL/6J-Fnip1^m1Btlr)	abnormal bone marrow cell number	J:234285
	abnormal splenocyte morphology	J:234285
	absent B cells	J:234285
	decreased IgM level	J:234285
	decreased marginal zone B cell number	J:234285
	impaired hematopoiesis	J:234285
Fnip1^m2Btlr/Fnip1^m2Btlr (C57BL/6J-Fnip1^m2Btlr)	decreased B cell number	J:265134
	increased B-1 B cell number	J:265134
	increased CD4-positive, alpha-beta T cell number	J:265134
	increased single-positive T cell number	J:265134
	increased T cell number	J:265134
Fnip1^M3Btlr/Fnip1^M3Btlr (C57BL/6J-Fnip1^M3Btlr)	abnormal B cell differentiation	J:272802
Fnip1^tm1.2Baba/Fnip1^tm1.2Baba (involves: C57BL/6 * C57BL/6J * FVB/N * SJL)	absent B cells	J:189078
	absent B-2 B cells	J:189078
	arrested B cell differentiation	J:189078
	decreased B cell number	J:189078
	decreased B-1 B cell number	J:189078
	decreased mature B cell number	J:189078
	decreased pre-B cell number	J:189078
	decreased transitional stage B cell number	J:189078
	increased B cell apoptosis	J:189078
	increased pro-B cell number	J:189078
	small spleen	J:189078
Fnip1^tm1.2Baba/Fnip1^tm1.2Baba Igh^tm2Cgn/Igh^tm2Cgn (involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL)	absent B cells	J:189078
	absent B-2 B cells	J:189078
	decreased B-1 B cell number	J:189078
Fnip1^tm1.2Baba/Fnip1^tm1.2Baba Tg(BCL2)22Wehi/0 (involves: C57BL/6 * FVB/N * SJL)	increased B cell number	J:189078
Fnip1^tm1.2Baba/Fnip1^tm1.2Baba Tg(IghelMD4)4Ccg/0 (involves: C57BL/6 * C57BL/6J * FVB/N * SJL)	absent B cells	J:189078
	absent B-2 B cells	J:189078
	decreased B-1 B cell number	J:189078
	increased immature B cell number	J:189078
Fntb^{tm1b(EUCOMM)Hmgu}/Fntb⁺ (C57BL/6N-Fntb^{tm1b(EUCOMM)Hmgu}/Nju)	thrombocytopenia	J:211773
Fntb^tm1Bbd/Fntb^tm1.1Bbd Polr2a^{tm1(cre/ERT2)Bbd}/Polr2a^{tm1(cre/ERT2)Bbd} (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1 * SJL)	abnormal hematopoietic system physiology	J:98944
	small spleen	J:98944
Fntb^tm1Bbd/Fntb^tm1Bbd Polr2a^{tm1(cre/ERT2)Bbd}/Polr2a^{tm1(cre/ERT2)Bbd} (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1 * SJL)	abnormal hematopoietic system physiology	J:98944
	small spleen	J:98944
Fos^tm1Pa/Fos^tm1Pa (involves: 129X1/SvJ * C57BL/6J)	abnormal lymphopoiesis	J:3233
Fos^tm1Wag/Fos^tm1Wag (involves: 129S2/SvPas)	decreased osteoclast cell number	J:65766
Fos^tm1Wag/Fos^tm1Wag (involves: 129S2/SvPas * C57BL/6)	abnormal macrophage physiology	J:118693
	abnormal spleen morphology	J:3493
	abnormal spleen white pulp morphology	J:3493
	abnormal thymus size	J:3493
	decreased B cell number	J:3493
	decreased double-positive T cell number	J:3493
	decreased splenocyte number	J:3493
	decreased thymocyte number	J:3493
	increased macrophage apoptosis	J:118693
	increased macrophage cytokine production	J:118693
	increased T cell number	J:3493
Fos^tm1Wag/Fos^{tm2(Fosl1)Wag} (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	decreased osteoclast cell number	J:65766
Fos^tm5.1Wag/Fos^tm5.1Wag (involves: 129P2/OlaHsd * C57BL/6 * SJL)	abnormal osteoclast differentiation	J:175064
	decreased osteoclast cell number	J:175064
Fos^tm6.1Wag/Fos^tm6.1Wag (involves: 129P2/OlaHsd * C57BL/6 * SJL)	abnormal osteoclast differentiation	J:175064
Fos^tm7Wag/Fos^tm7Wag Tg(Cd4-cre)1Cwi/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	decreased CD4-positive, alpha-beta T cell number	J:190150
Fosb^{tm1b(KOMP)Wtsi}/Fosb^{tm1b(KOMP)Wtsi} (C57BL/6N-Fosb^{tm1b(KOMP)Wtsi}/Ucd)	decreased mean corpuscular volume	J:211773
Fosl1^tm1Wag/Fosl1^tm1Wag (either: 129/Sv or (involves: 129/Sv * C57BL/6))	abnormal embryonic erythrocyte morphology	J:65292
Fosl2^tm2.1Wag/Fosl2^tm2.1Wag (involves: 129P2/OlaHsd * C57BL/6)	abnormal osteoclast differentiation	J:137646
	abnormal osteoclast morphology	J:137646
	abnormal osteoclast physiology	J:137646
	increased osteoclast cell number	J:137646
Fosl2^tm2Wag/Fosl2^tm2Wag Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal osteoclast differentiation	J:137646
Fosl2^tm2Wag/Fosl2^tm2Wag Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0 (involves: 129P2/OlaHsd * C57BL/6 * CD-1)	abnormal osteoclast morphology	J:211215
Foxa2^tm1Khk/Foxa2^tm1Khk Tg(SFTPC-rtTA)5Jaw/0 Tg(tetO-cre)1Jaw/0 (involves: 129 * 129P2/OlaHsd * C57BL/6)	increased macrophage cell number	J:88601
	increased neutrophil cell number	J:88601
Foxh1^b2b2662Clo/Foxh1^b2b2662Clo (C57BL/6J-Foxh1^b2b2662Clo)	absent spleen	J:175213
	thymus hypoplasia	J:175213
Foxh1^tm1Hmd/Foxh1^tm1.1Hmd Tg(Leftb-cre)1Hmd/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6Cr)	spleen hypoplasia	J:82311
Foxi3^em3Akg/Foxi3^tm1.2Akg (involves: 129X1/SvJ * C57BL/6)	athymia	J:336768
Foxj3^{tm1b(EUCOMM)Wtsi}/Foxj3⁺ (C57BL/6N-Foxj3^{tm1b(EUCOMM)Wtsi}/Bay)	increased leukocyte cell number	J:211773
Foxn1^nu-2J/Foxn1^nu-2J (B6(SJL)-Foxn1^nu-2J/GrsrJ)	athymia	J:192383
Foxn1^nu-StL/Foxn1^nu-StL (involves: C57BL/6)	absent T cells	J:63313
Foxn1^nu-StL/Foxn1^nu-StL (involves: C57BL/6)	athymia	J:63313
Foxn1^nu-StL/Foxn1^tm1Tbo (involves: 129S1/Sv * C57BL/6)	abnormal thymus development	J:63313
Foxn1^nu-StL/Foxn1^tm1Tbo (involves: 129S1/Sv * C57BL/6)	athymia	J:63313
Foxn1^nu-str/Foxn1^nu-str (AKR/J-Foxn1^nu-str/J)	athymia	J:24755
	decreased immunoglobulin level	J:30715
	decreased lymphocyte cell number	J:30715
	decreased T cell number	J:30715
	increased eosinophil cell number	J:30715
	increased granulocyte number	J:30715
	increased neutrophil cell number	J:30715
	spleen hypoplasia	J:30715
Foxn1^nu-Y/Foxn1^nu-Y (101/HY-Foxn1^nu-Y)	abnormal thymus development	J:4060
	absent T cells	J:4060
	athymia	J:4060, J:29022
Foxn1^nu/Foxn1⁺ (C.Cg-Foxn1^nu)	small thymus	J:7330
Foxn1^nu/Foxn1⁺ (NFS.Cg-Foxn1^nu)	abnormal thymus morphology	J:7330
Foxn1^nu/Foxn1⁺ (NFS.Cg-Foxn1^nu)	small thymus	J:7330
Foxn1^nu/Foxn1⁺ (B6N.Cg-Foxn1^nu)	small thymus	J:7330
Foxn1^nu/Foxn1⁺ (C3N.Cg-Foxn1^nu)	small thymus	J:7330
Foxn1^nu/Foxn1^nu (involves: NMRI)	abnormal thymus development	J:6363
Foxn1^nu/Foxn1^nu (Not Specified)	abnormal spleen morphology	J:202296
	abnormal splenic cell ratio	J:202296
	abnormal thymus morphology	J:202297
	athymia	J:202296, J:5059
	decreased leukocyte cell number	J:5059
	small spleen	J:202296
Foxn1^nu/Foxn1^nu (involves: C57BL/10Sn * C57BR/cd)	abnormal thymus development	J:7898
Foxn1^nu/Foxn1^nu (involves: CD-1)	athymia	J:106251
Foxn1^nu/Foxn1^nu (involves: CBA)	abnormal T cell activation	J:202299
	decreased leukocyte cell number	J:202299
	decreased lymphocyte cell number	J:202299
	decreased T cell number	J:202808
Foxn1^nu/Foxn1^nu Map3k14^aly/Map3k14^aly (involves: BALB/cAJcl * C57BL/6J)	absent B cells	J:96579
	athymia	J:96579
	decreased gamma-delta intraepithelial T cell number	J:96579
	decreased T cell number	J:96579
Foxn1^nu/Foxn1^nu Tg(Foxn1)E1Hon/0 (involves: CD-1)	athymia	J:33866
Foxn1^nu/Foxn1^nu Tgfb1^tm1Doe/Tgfb1^tm1Doe (involves: 129S2/SvPas * BALB/c * CF-1)	abnormal T cell physiology	J:99033
Foxn1^nu/Foxn1^tm1.1Dmsu Tg(CAG-cre/Esr1)5Amc/0 (involves: 129/Sv C57BL/6 * CBA * SJL)	abnormal thymus epithelium morphology	J:159773
	decreased thymocyte number	J:159773
	increased thymocyte apoptosis	J:159773
Foxn1^sepe/Foxn1^sepe (BALB/c-Foxn1^sepe)	athymia	J:227974
Foxn1^{tm1.1(KOMP)Vlcg}/Foxn1^{tm1.1(KOMP)Vlcg} (C57BL/6N-Foxn1^{tm1.1(KOMP)Vlcg}/Tcp)	abnormal thymus morphology	J:211773
	athymia	J:211773
Foxn1^tm1.1Cbln/Foxn1⁺ (involves: 129P2/OlaHsd * C57BL/6)	thymus hyperplasia	J:177992
Foxn1^tm1.1Cbln/Foxn1^tm1.1Cbln (involves: 129P2/OlaHsd * C57BL/6)	abnormal lymphocyte cell number	J:177992
	decreased single-positive T cell number	J:177992
	increased DN1 thymic pro-T cell number	J:177992
	increased double-positive T cell number	J:177992
	thymus hypoplasia	J:177992
Foxn1^tm1.1Cbln/Foxn1^tm1Tbo (involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)	absent T cells	J:177992
	small thymus	J:177992
Foxn1^tm1.1Dmsu/Foxn1^tm1.1Dmsu Tg(CAG-cre/Esr1)5Amc/0 (involves: 129/Sv C57BL/6 * CBA * SJL)	abnormal thymus morphology	J:159773
	decreased double-positive T cell number	J:159773
	decreased thymocyte number	J:159773
	small thymus	J:159773
	thymus atrophy	J:159773
Foxn1^tm1.1Dmsu/Foxn1^tm1.1Dmsu Tg(KRT5-cre/ERT2)2Ipc/0 (involves: 129/Sv * C57BL/6 * SJL)	abnormal thymus corticomedullary boundary morphology	J:159773
	abnormal thymus medulla morphology	J:159773
	decreased thymocyte number	J:159773
	small thymus	J:159773
	thymus atrophy	J:159773
Foxn1^tm1Dmsu/Foxn1^tm1Dmsu (involves: 129/Sv * C57BL/6)	athymia	J:159773
Foxn1^tm1Nrm/Foxn1^tm1Nrm (involves: 129X1/SvJ * C57BL/6J)	abnormal CD4-positive, alpha beta T cell morphology	J:86255
	abnormal CD8-positive, alpha beta T cell morphology	J:86255
	abnormal T cell differentiation	J:86255
	abnormal thymus development	J:86255
	abnormal thymus epithelium morphology	J:86255
	absent thymus cortex	J:86255
	absent thymus medulla	J:86255
	decreased CD4-positive, alpha-beta T cell number	J:86255
	decreased double-negative T cell number	J:86255
	decreased double-positive T cell number	J:86255
	decreased T cell number	J:86255
	decreased thymocyte number	J:86255
	small thymus	J:86255
	thymus cyst	J:86255
Foxn1^tm1Tbo/Foxn1^tm1Tbo (involves: 129S1/Sv)	abnormal leukocyte cell number	J:33796
	abnormal thymus development	J:33796
	abnormal thymus epithelium morphology	J:177992
	abnormal thymus morphology	J:33796
	absent T cells	J:33796
	athymia	J:33796
	increased B cell number	J:33796
Foxn1^tm2Tbo/Foxn1^tm2Tbo Tg(KRT14-cre/ERT2)1Ipc/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	increased T cell number	J:110046
Foxn1^tm3(cre)Nrm/Foxn1⁺ Gt(ROSA)26Sor^{tm1(Tbx1)Rche}/Gt(ROSA)26Sor⁺ (involves: C57BL/6 * C57BL/6NHsd)	abnormal thymus development	J:214094
	abnormal thymus epithelium morphology	J:214094
	decreased thymocyte number	J:214094
	thymus hypoplasia	J:214094
Foxn1^tm3(cre)Nrm/Foxn1⁺ Mir205hg^tm1Oers/Mir205hg^tm1Oers (B6(Cg)-Mir205hg^tm1Oers Foxn1^tm3(cre)Nrm)	decreased thymocyte number	J:278363
	decreased thymus weight	J:278363
	thymus hypoplasia	J:278363
Foxo1^tm1.1Rdp/Foxo1⁺ Igh-J^tm1Cgn/Igh^tm4Cgn Tg(Cr2-cre)3Cgn/0 (involves: 129P2/OlaHsd * 129S1/Sv)	increased B cell number	J:157297
Foxo1^tm1.1Stlp/Foxo1^tm1.1Stlp Tg(Lck-cre)1Cwi/0 (involves: 129S4/SvJae)	abnormal single-positive T cell number	J:154205
	decreased CD8-positive, alpha-beta T cell number	J:154205
	decreased double-positive T cell number	J:154205
	decreased T cell number	J:154205
	decreased T cell proliferation	J:154205
	decreased thymocyte apoptosis	J:154205
	increased CD4-positive, alpha-beta T cell number	J:154205
	increased CD8-positive, alpha-beta T cell number	J:154205
	small spleen	J:154205
Foxo1^{tm1b(EUCOMM)Wtsi}/Foxo1⁺ (C57BL/6N-Foxo1^{tm1b(EUCOMM)Wtsi}/J)	decreased erythrocyte cell number	J:211773
	increased mean corpuscular volume	J:211773
Foxo1^tm1Flv/Foxo1^tm1Flv Foxp3^{tm4(YFP/icre)Ayr}/Foxp3⁺ (involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ)	abnormal regulatory T cell physiology	J:189962
	enlarged spleen	J:189962
	increased CD4-positive, alpha-beta T cell number	J:189962
	increased CD8-positive, alpha-beta T cell number	J:189962
	increased regulatory T cell number	J:189962
	increased T cell number	J:189962
	increased T cell proliferation	J:189962
Foxo1^tm1Flv/Foxo1^tm1Flv Ifng^tm1Ts/Ifng^tm1Ts Foxp3^{tm4(YFP/icre)Ayr}/Foxp3⁺ (involves: 129S1/Sv * 129S6/SvEvTac * 129S7/SvEvBrd * 129X1/SvJ)	increased CD4-positive, alpha-beta T cell number	J:189962
	increased CD8-positive, alpha-beta T cell number	J:189962
Foxo1^tm1Flv/Foxo1^tm1Flv Rag1^tm1Mom/Rag1^tm1Mom Tg(CD2-Il7r)1Asin/? Tg(Cd4-cre)1Cwi/? Tg(TcraTcrb)425Cbn/? (involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6 * DBA/2)	decreased T cell number	J:147057
Foxo1^tm1Flv/Foxo1^tm1Flv Rag1^tm1Mom/Rag1^tm1Mom Tg(Cd4-cre)1Cwi/? Tg(TcraTcrb)425Cbn/? (involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6 * DBA/2)	decreased T cell number	J:147057
Foxo1^tm1Flv/Foxo1^tm1Flv Tg(Cd4-cre)1Cwi/? (involves: 129S6/SvEvTac * C57BL/6 * DBA/2)	abnormal CD4-positive, alpha-beta T cell physiology	J:147057
	abnormal CD8-positive, alpha-beta T cell physiology	J:147057
	abnormal T cell activation	J:147057
	abnormal T cell physiology	J:147057
	increased single-positive T cell number	J:147057
	increased T cell proliferation	J:147057
Foxo1^tm1Rdp/Foxo1^tm1.1Rdp Igh-J^tm1Cgn/Igh^tm4Cgn Tg(Cr2-cre)3Cgn/0 (involves: 129P2/OlaHsd * 129S1/Sv)	absent marginal zone B cells	J:157297
	increased B cell number	J:157297
Foxo3^Gt(XAO26)Byg/Foxo3^Gt(XAO26)Byg (involves: 129P2/OlaHsd)	abnormal T cell activation	J:93593
	abnormal T cell physiology	J:93593
	enlarged spleen	J:93593
	increased T cell proliferation	J:93593
	spleen hyperplasia	J:93593
Foxo3^{tm1.1(KOMP)Vlcg}/Foxo3^{tm1.1(KOMP)Vlcg} (C57BL/6N-Foxo3^{tm1.1(KOMP)Vlcg}/J)	decreased erythrocyte cell number	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
	thrombocytopenia	J:211773
Foxo3^tm1.1Rdp/Foxo3^tm1.1Rdp (involves: 129S6/SvEvTac * FVB/N)	anemia	J:84269
	hemolytic anemia	J:118179
	reticulocytosis	J:84269
Foxo3^tm1Nmt/Foxo3^tm1Nmt (B6.Cg-Foxo3^tm1Nmt)	abnormal NK cell morphology	J:123409
Foxo3^tm1Nmt/Foxo3^tm1Nmt (B6.Cg-Foxo3^tm1Nmt)	increased NK cell number	J:123409
Foxo3^tm1Nmt/Foxo3^tm1Nmt (involves: C57BL/6)	abnormal hematopoietic stem cell morphology	J:142870
	decreased erythrocyte cell number	J:142870
	decreased hematopoietic stem cell number	J:142870
	hematopoietic system phenotype	J:142870
	increased mean corpuscular hemoglobin	J:142870
	increased mean corpuscular volume	J:142870
	reticulocytosis	J:142870
Foxo6^{tm1(KOMP)Vlcg}/Foxo6^{tm1(KOMP)Vlcg} (B6J.B6NTac-Foxo6^{tm1(KOMP)Vlcg})	abnormal Kupffer cell morphology	J:236585
	impaired macrophage chemotaxis	J:236585
Foxp1^tm1.1Pwt/Foxp1^tm1.1Pwt Tg(Cd4-cre)1Cwi/0 (involves: 129 * C57BL/6 * DBA/2)	abnormal T cell activation	J:156832
	decreased CD4-positive, alpha-beta T cell number	J:156832
	decreased CD8-positive, alpha-beta T cell number	J:156832
	increased T cell apoptosis	J:156832
Foxp1^tm1Rao/Foxp1^tm1Rao (B6.129-Foxp1^tm1Rao)	abnormal B cell differentiation	J:112644
	abnormal B cell physiology	J:112644
	arrested B cell differentiation	J:112644
	decreased mature B cell number	J:112644
Foxp2^tm2.2Woen/Foxp2⁺ (involves: C57BL/6 * C57BL/6J)	increased CD4-positive, alpha-beta T cell number	J:150425
Foxp2^tm2.2Woen/Foxp2⁺ (involves: C57BL/6 * C57BL/6J)	increased CD8-positive, alpha-beta T cell number	J:150425
Foxp3^sf/Y (either: 129Rl.Cg-Foxp3^sf or (involves: 101/Rl * C3Hf/Rl * STOCK MR))	abnormal B cell physiology	J:11262
	abnormal erythrocyte morphology	J:11262
	abnormal lymphocyte morphology	J:11262
	abnormal macrophage morphology	J:11262
	abnormal spleen morphology	J:11262
	abnormal spleen white pulp morphology	J:11262
	abnormal thymus cortex morphology	J:11262
	abnormal thymus morphology	J:11262
	absent spleen marginal zone	J:11262
	anemia	J:11262
	anisocytosis	J:11262
	decreased hematocrit	J:11262
	decreased hemoglobin content	J:11262
	decreased spleen B cell follicle number	J:11262
	extramedullary hematopoiesis	J:11262
	increased IgG level	J:11262
	increased IgM level	J:11262
	increased leukocyte cell number	J:11262
	increased mean corpuscular volume	J:11262
	increased spleen red pulp amount	J:11262
	increased spleen weight	J:11262
	poikilocytosis	J:11262
	polychromatophilia	J:11262
	small thymus	J:11262
Foxp3^sf/Y (involves: 101/H * C3H/HeH * STOCK MR)	abnormal erythrocyte morphology	J:10398
	abnormal reticulocyte morphology	J:10398
	abnormal spleen morphology	J:10398
	anemia	J:10398
	decreased erythrocyte cell number	J:10398
	decreased hematocrit	J:10398
	decreased hemoglobin content	J:10398
	decreased megakaryocyte cell number	J:10398
	extramedullary hematopoiesis	J:10398
	increased leukocyte cell number	J:10398
	increased spleen red pulp amount	J:10398
	increased spleen weight	J:10398
	increased spleen white pulp amount	J:10398
	intermingled spleen red and white pulp	J:10398
	thrombocytopenia	J:10398
Foxp3^sf/Y (B6.Cg-Foxp3^sf)	abnormal CD4-positive, alpha beta T cell morphology	J:82560
	abnormal CD4-positive, alpha-beta T cell physiology	J:82560
	abnormal megakaryocyte progenitor cell morphology	J:167802
	decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:82560
	decreased megakaryocyte cell number	J:167802
	increased mean platelet volume	J:167802
	thrombocytopenia	J:167802
Foxp3^sf Otc^spf/Y (involves: 129/Rl)	anemia	J:20865
	decreased hematocrit	J:20865
	enlarged spleen	J:20865
	increased CD4-positive, alpha-beta T cell number	J:20865
Foxp3^sf/Foxp3^sf Tg(Rorc-EGFP)1Ebe/? (involves: C57BL/6)	abnormal effector T cell morphology	J:137020
Foxp3^{tm1(CD2/CD52)Shori}/Foxp3^{tm1(CD2/CD52)Shori} (involves: C57BL/6)	decreased regulatory T cell number	J:171378
Foxp3^tm1.1Ayr/Y (involves: 129S1/Sv * 129X1/SvJ)	abnormal CD4-positive, alpha beta T cell morphology	J:82560
	abnormal CD4-positive, CD25-positive, alpha-beta regulatory T cell morphology	J:82560
	enlarged spleen	J:82560
Foxp3^tm1.1Ayr/Y (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	enlarged spleen	J:117743
Foxp3^tm1.1Ayr/Foxp3^tm1.1Ayr (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal T cell differentiation	J:125405
	decreased double-positive T cell number	J:125405
	enlarged spleen	J:117743
	thymus hypoplasia	J:125405
Foxp3^tm1.1Ayr/Foxp3^tm1.1Ayr Mir146^tm1.1Bal/Mir146^tm1.1Bal (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal lymphocyte physiology	J:167922
	increased regulatory T cell number	J:167922
Foxp3^tm1.1Mal/Foxp3^tm1.1Mal Lat^tm1.1Mal/Lat^tm1.1Mal (involves: 129S2/SvPas * C57BL/6)	abnormal regulatory T cell physiology	J:131351
	decreased regulatory T cell number	J:131351
	thymus hypoplasia	J:131351
Foxp3^tm1Ayr/Y Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	enlarged spleen	J:97029
Foxp3^tm1Ayr/Foxp3^tm1Ayr Tg(Cd4-cre)1Cwi/? (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)	abnormal T cell differentiation	J:125405
	decreased double-positive T cell number	J:125405
	thymus hypoplasia	J:125405
Foxp3^tm1Flv/Foxp3⁺ B9d2/Tgfb1^tm1Flv/Tgfb1^tm2Flv Tg(Cd4-cre)1Cwi/? (involves: 129S6/SvEvTac * C57BL/6 * DBA/2)	increased regulatory T cell number	J:123547
Foxp3^tm1Kuch/? Il6^tm1Kopf/Il6^tm1Kopf (involves: 129S2/SvPas * C57BL/6)	abnormal CD4-positive T cell differentiation	J:123352
	increased regulatory T cell number	J:123352
Foxp3^tm1Tch/Y (C.129X1-Foxp3^tm1Tch)	abnormal lymphocyte physiology	J:117165
	absent regulatory T cells	J:117165
	anemia	J:117165
	enlarged spleen	J:117165
	increased activated T cell number	J:117165
	increased CD4-positive, alpha-beta T cell number	J:117165
	increased CD8-positive, alpha-beta T cell number	J:117165
	increased eosinophil cell number	J:117165
	increased IgE level	J:117165
	increased IgG1 level	J:117165
	increased leukocyte cell number	J:117165
	increased lymphocyte cell number	J:117165
	increased monocyte cell number	J:117165
	thrombocytopenia	J:117165
Foxp3^tm1Tch/Y (B6.129X1-Foxp3^tm1Tch)	anemia	J:117165
	increased eosinophil cell number	J:117165
	increased IgE level	J:117165
	increased leukocyte cell number	J:117165
	increased lymphocyte cell number	J:117165
	increased monocyte cell number	J:117165
	thrombocytopenia	J:117165
Foxp3^tm1Tch/Y Stat6^tm1Gru/Stat6^tm1Gru (C.129-Stat6^tm1Gru Foxp3^tm1Tch)	increased eosinophil cell number	J:117165
Foxp3^{tm2.1(EGFP/cre)Shori}/Y (involves: 129 * C57BL/6)	decreased regulatory T cell number	J:234397
Foxp3^{tm2.1(EGFP/cre)Shori}/Y Pdcd1^tm1Hon/Pdcd1^tm1Hon (involves: 129 * 129S2/SvPas * C57BL/6)	enlarged spleen	J:234397
	increased effector memory T-helper cell number	J:234397
	spleen hyperplasia	J:234397
Foxp3^tm2Ayr/? Zap70^rps/Zap70^rps (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:211510
	abnormal double-positive T cell morphology	J:211510
	abnormal regulatory T cell number	J:211510
	abnormal T cell differentiation	J:211510
	decreased CD4-positive, alpha-beta T cell number	J:211510
	decreased CD8-positive, alpha-beta T cell number	J:211510
Foxp3^tm2Ayr/Foxp3⁺ Rnf128^tm1Cdon/Rnf128^tm1Cdon (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal regulatory T cell physiology	J:160681
Foxp3^tm2Flv/Y (involves: C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:118631
	abnormal CD8-positive, alpha-beta T cell physiology	J:118631
	enlarged spleen	J:118631
Foxp3^{tm3(HBEGF/GFP)Ayr}/Foxp3^{tm3(HBEGF/GFP)Ayr} (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:117743
	decreased T cell number	J:117743
	enlarged spleen	J:117743
	increased dendritic cell number	J:117743
Foxp3^tm3Tch/Y (C.129X1-Foxp3^tm3Tch)	abnormal CD4-positive, alpha beta T cell morphology	J:120636
	abnormal CD4-positive, alpha-beta T cell physiology	J:120636
	abnormal lymphocyte physiology	J:120636
	abnormal regulatory T cell physiology	J:120636
	abnormal T cell subpopulation ratio	J:120636
	enlarged spleen	J:120636
	increased T cell proliferation	J:120636
	thymus hypoplasia	J:120636
Foxp3^tm3Tch/Foxp3⁺ (C.129X1-Foxp3^tm3Tch)	abnormal CD4-positive, alpha-beta T cell physiology	J:120636
	decreased T cell number	J:120636
	decreased thymocyte number	J:120636
	increased T cell apoptosis	J:120636
Foxp3^{tm4(YFP/icre)Ayr}/Foxp3⁺ Nr4a2^tm1.1Pcn/Nr4a2^tm1.1Pcn (involves: 129S1/Sv * 129X1/SvJ)	abnormal regulatory T cell morphology	J:205658
	abnormal regulatory T cell physiology	J:205658
Foxp3^{tm4(YFP/icre)Ayr}/Foxp3^{tm4(YFP/icre)Ayr} Ikzf4^tm1Djr/Ikzf4^tm1Djr (involves: 129S1/Sv * 129X1/SvJ)	decreased regulatory T cell number	J:294549
	enlarged spleen	J:294549
	increased germinal center B cell number	J:294549
	increased immunoglobulin level	J:294549
	increased spleen B cell follicle number	J:294549
	increased spleen germinal center number	J:294549
	increased T cell number	J:294549
	increased T follicular helper cell number	J:294549
Foxp3^tm5.2Ayr/Foxp3^tm5.2Ayr (involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ)	abnormal intraepithelial T cell morphology	J:156942
	abnormal T cell differentiation	J:156942
	decreased regulatory T cell number	J:156942
	increased T cell number	J:156942
Foxp3^tm6.2Ayr/Foxp3^tm6.2Ayr (involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ)	decreased regulatory T cell number	J:156942
Foxp3^tm7.2Ayr/Foxp3⁺ (involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ)	decreased regulatory T cell number	J:156942
Foxp3^tm7.2Ayr/Foxp3^tm7.2Ayr (involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ)	abnormal regulatory T cell morphology	J:156942
	decreased regulatory T cell number	J:156942
Foxq1^sa-e1/Foxq1^sa-e1 (involves: 101/Rl * C3H/Rl)	abnormal lymphocyte cell number	J:75422
Foxq1^sa/Foxq1^sa (involves: 101/Rl * C3H/Rl)	impaired natural killer cell mediated cytotoxicity	J:7649
Foxq1^sa/Foxq1^sa Lyst^bg/Lyst^bg (involves: 101/Rl * C3H/Rl * C57BL10/Rl)	enlarged spleen	J:5311
Foxr1^em1(IMPC)Tcp/Foxr1⁺ (C57BL/6NCrl-Foxr1^em1(IMPC)Tcp/Tcp)	small spleen	J:211773
Foxr1^em1(IMPC)Tcp/Foxr1^em1(IMPC)Tcp (C57BL/6NCrl-Foxr1^em1(IMPC)Tcp/Tcp)	abnormal spleen morphology	J:211773
Foxred1^em1(IMPC)Bay/Foxred1⁺ (C57BL/6N-Foxred1^em1(IMPC)Bay/Bay)	increased spleen weight	J:211773
Fpr1^tm1Gao/Fpr1^tm1Gao (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	impaired neutrophil chemotaxis	J:53354
Fpr2^tm1.2Jimw/Fpr2^tm1.2Jimw (B6.129X1-Fpr2^tm1.2Jimw)	abnormal bone marrow cell physiology	J:160074
	decreased dendritic cell number	J:160074
	decreased IgE level	J:160074
	decreased IgG1 level	J:160074
	decreased IgG2b level	J:160074
	decreased immunoglobulin level	J:160074
	impaired macrophage chemotaxis	J:160074
	impaired neutrophil chemotaxis	J:160074
Fpr2^tm1.2Jimw/Fpr2^tm1.2Jimw (involves: 129X1/SvJ)	abnormal dendritic cell chemotaxis	J:199611
Fpr2^tm1.2Jimw/Fpr2^tm1.2Jimw (involves: 129X1/SvJ)	decreased dendritic cell number	J:199611
Fpr2^tm1Rjf/Fpr2^tm1Rjf (involves: 129S/SvEv * C57BL/6)	abnormal neutrophil physiology	J:159658
Fpr2^tm1Rjf/Fpr2^tm1Rjf (involves: 129S/SvEv * C57BL/6)	impaired macrophage chemotaxis	J:159658
Fpr3^{tm1b(EUCOMM)Hmgu}/Fpr3^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Fpr3^{tm1b(EUCOMM)Hmgu}/Ics)	increased hematocrit	J:211773
	increased hemoglobin content	J:211773
Frmd3^em1(IMPC)J/Frmd3^em1(IMPC)J (C57BL/6NJ-Frmd3^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Frmd8^em2Smoc/Frmd8^em2Smoc Tg(Vil1-cre)997Gum/0 (involves: C57BL/6J * SJL)	increased spleen weight	J:338904
Fryl^{tm1b(KOMP)Wtsi}/Fryl⁺ (C57BL/6N-Fryl^{tm1b(KOMP)Wtsi}/Wtsi)	increased mean corpuscular hemoglobin	J:211773
Frzb^tm1.1Fplu/Frzb^tm1.1Fplu (involves: CD-1 * Swiss)	decreased hematocrit	J:184281
Fsbp^em1(IMPC)J/Fsbp^em1(IMPC)J (C57BL/6NJ-Fsbp^em1(IMPC)J/Mmjax)	thrombocytopenia	J:211773
Fscn1^{Gt(OST124903)Lex}/Fscn1^{Gt(OST124903)Lex} (B6.129S5-Fscn1^{Gt(OST124903)Lex})	abnormal dendritic cell chemotaxis	J:169408
Fsd2^em1(IMPC)Mbp/Fsd2^em1(IMPC)Mbp (C57BL/6N-Fsd2^em1(IMPC)Mbp/Ucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Fshr^tm1Saco/Fshr^tm1Saco (involves: 129)	anemia	J:70933
	enlarged spleen	J:70933
	increased pre-B cell number	J:65577
Fstl1^{tm1b(EUCOMM)Hmgu}/Fstl1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Fstl1^{tm1b(EUCOMM)Hmgu}/H)	decreased neutrophil cell number	J:211773
	increased lymphocyte cell number	J:211773
Fth1^tm1.1Lck/Fth1^tm1.1Lck Tg(Mx1-cre)1Cgn/0 (B6.Cg-Fth1^tm1.1Lck Tg(Mx1-cre)1Cgn)	decreased spleen iron level	J:166515
Ftl1^{em1(IMPC)Rbrc}/Ftl1^{em1(IMPC)Rbrc} (C57BL/6NJcl-Ftl1^{em1(IMPC)Rbrc}/Rbrc)	abnormal platelet cell number	J:211773
	increased red blood cell distribution width	J:211773
Ftl1^tm1.1Ruvi/Ftl1^tm1.1Ruvi (involves: 129 * C57BL/6)	abnormal mononuclear phagocyte morphology	J:244236
Fts/Fts⁺ (involves: C57BL/6 * SJL)	thymus hyperplasia	J:20159
Fts/Fts⁺ (B6.Cg-Fts)	abnormal CD4-positive T cell differentiation	J:108193
	abnormal T cell morphology	J:108193
	abnormal T cell physiology	J:108193
	increased thymocyte number	J:108193
	thymus hyperplasia	J:108193
Fubp1^tm1.1Dlev/Fubp1^tm1.1Dlev (involves: 129 * C57BL/6)	abnormal definitive hematopoiesis	J:229985
	abnormal hematopoietic stem cell physiology	J:229985
	anemia	J:229985
	decreased B cell number	J:229985
	decreased bone marrow cell number	J:229985
	decreased hematopoietic precursor cell number	J:229985
	decreased megakaryocyte cell number	J:229985
	spleen hypoplasia	J:229985
	thymus hypoplasia	J:229985
Fundc2^tm1Qim/Fundc2^tm1Qim (involves: C57BL/6)	hematopoietic system phenotype	J:301633
Fundc2^tm1Qim/Fundc2^tm1Qim (involves: C57BL/6)	thrombocytopenia	J:301633
Furin^tm1Jwmc/Furin^tm1Jwmc Tg(Cd4-cre)1Cwi/0 (involves: 129P2/OlaHsd * C57BL/6 * SJL)	abnormal regulatory T cell physiology	J:204761
Fus^{Gt(U3NeoSV1)HO14Ggh}/Fus^{Gt(U3NeoSV1)HO14Ggh} (B6.129S2-Fus^{Gt(U3NeoSV1)HO14Ggh})	abnormal immunoglobulin level	J:60213
	decreased B cell number	J:60213
	decreased lymphocyte cell number	J:60213
	small thymus	J:60213
Fut4^tm1Jbl/Fut4^tm1Jbl (B6.129S2-Fut4^tm1Jbl)	impaired leukocyte tethering or rolling	J:79397
	increased eosinophil cell number	J:79397
	increased granulocyte number	J:79397
	increased monocyte cell number	J:79397
	increased neutrophil cell number	J:79397
Fut4^tm1Jbl/Fut4^tm1Jbl Fut7^tm1Jbl/Fut7^tm1Jbl (B6.129S2-Fut7^tm1Jbl Fut4^tm1Jbl)	abnormal leukocyte migration	J:79397
	abnormal leukocyte physiology	J:79397
	abnormal neutrophil physiology	J:79397
	impaired leukocyte tethering or rolling	J:79397
	increased leukocyte cell number	J:79397
	increased neutrophil cell number	J:79397
Fut7^tm1Jbl/Fut7^tm1Jbl (involves: 129S2/SvPas * C57BL/6J * DBA/2J)	abnormal granulocyte physiology	J:35023
	abnormal leukocyte adhesion	J:35023
	abnormal leukocyte migration	J:35023
	abnormal leukocyte physiology	J:35023
	abnormal leukocyte tethering or rolling	J:35023
	decreased megakaryocyte cell number	J:35023
	impaired neutrophil recruitment	J:35023
Fut7^tm1Jbl/Fut7^tm1Jbl (B6.129S2-Fut7^tm1Jbl)	impaired neutrophil recruitment	J:79397
Fxr1^tm1Dln/Fxr1^tm1Dln (involves: 129P2/OlaHsd * C57BL/6)	small spleen	J:91191
Fyb1^{tm1b(EUCOMM)Hmgu}/Fyb1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Fyb1^{tm1b(EUCOMM)Hmgu}/Cnrm)	thrombocytopenia	J:211773
Fyb1^tm1Gak/Fyb1^tm1Gak (involves: 129S1/Sv * 129X1/SvJ)	abnormal leukocyte adhesion	J:111368
	abnormal T cell physiology	J:126545
	decreased T cell proliferation	J:111368, J:126545
	decreased thymocyte number	J:111368
	thrombocytopenia	J:111368
Fyn^tm1Rmp/Fyn^tm1Rmp (involves: 129S2/SvPas * C57BL/6)	abnormal T cell activation	J:70886
	abnormal thymocyte activation	J:70886
	decreased T cell proliferation	J:70886
Fyn^tm1Rmp/Fyn^tm1Rmp (involves: 129S2/SvPas)	decreased gamma-delta T cell number	J:37062
Fyn^tm1Rmp/Fyn^tm1Rmp (involves: 129S2/SvPas)	decreased T cell number	J:37062
Fyn^tm1Rmp/Fyn^tm1Rmp (B6.129S2-Fyn^tm1Rmp)	abnormal eosinophil physiology	J:114287
Fyn^tm1Rmp/Fyn^tm1Rmp (B6.129S2-Fyn^tm1Rmp)	decreased IgE level	J:114287
Fyn^tm1Rmp/Fyn^tm1Rmp Lck^tm1Mak/Lck^tm1Mak (involves: 129S2/SvPas)	abnormal alpha-beta intraepithelial T cell morphology	J:112977
	abnormal NK T cell number	J:37940
	absent CD4-positive, alpha-beta T cells	J:37940
	absent CD8-positive, alpha-beta T cells	J:37940
	absent T cells	J:37062
	arrested T cell differentiation	J:37062, J:37940
	decreased double-positive T cell number	J:37940
	decreased gamma-delta intraepithelial T cell number	J:112977, J:37940
	thymus hypoplasia	J:37062, J:37940
Fyn^tm1Sor/Fyn^tm1Sor (either: 129S7/SvEvBrd-Fyn^tm1Sor or (involves: 129S7/SvEvBrd * C57BL/6J))	abnormal T cell clonal deletion	J:2242
	abnormal T cell physiology	J:2242
	abnormal thymocyte activation	J:2242
	decreased T cell proliferation	J:2242
	increased IgG2a level	J:2242
	increased IgM level	J:2242
Fyn^tm1Sor/Fyn^tm1Sor (B6.129S7-Fyn^tm1Sor)	abnormal CD4-positive, alpha-beta T cell physiology	J:93886
	abnormal NK cell physiology	J:187430
	abnormal T cell proliferation	J:93886
	decreased IgE level	J:93886
Fyn^tm1Sor/Fyn^tm1Sor (involves: 129S7/SvEvBrd)	abnormal macrophage physiology	J:80658
Fyn^tm1Sor/Fyn^tm1Sor Lck^tm1Litt/Lck^tm1.1Litt Tnfrsf4^tm2(cre)Nik/Tnfrsf4⁺ (involves: 129S7/SvEvBrd * 129X1/SvJ)	abnormal regulatory T cell physiology	J:152472
	decreased regulatory T cell number	J:152472
	decreased T cell proliferation	J:152472
	increased regulatory T cell number	J:152472
	increased T cell number	J:152472
Fyn^tm1Sor/Fyn^tm1Sor Yes1^tm1Sor/Yes1^tm1Sor (involves: 129S7/SvEvBrd)	enlarged spleen	J:20346
	extramedullary hematopoiesis	J:20346
	increased spleen white pulp amount	J:20346
	myeloid hyperplasia	J:20346
Fyn^tm1Yik/Fyn^tm1Yik Ptk2^tm1Lfr/Ptk2⁺ (involves: 129X1/SvJ * C57BL/6 * CBA)	abnormal T cell differentiation	J:110771
	decreased double-positive T cell number	J:110771
	decreased thymocyte number	J:110771
	thymus cortex atrophy	J:110771
Fyttd1^em1(IMPC)J/Fyttd1^em1(IMPC)J (C57BL/6NJ-Fyttd1^em1(IMPC)J/Mmjax)	decreased mean corpuscular hemoglobin	J:211773
Fzd1^em1(IMPC)Mbp/Fzd1^em1(IMPC)Mbp (C57BL/6N-Fzd1^em1(IMPC)Mbp/MbpMmucd)	increased eosinophil cell number	J:211773
	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
	increased monocyte cell number	J:211773
Fzd9^tm1Uta/Fzd9^tm1Uta (involves: 129S6/SvEvTac * 129X1/SvJ)	abnormal spleen marginal zone morphology	J:98133
	abnormal spleen red pulp morphology	J:98133
	decreased B cell number	J:98133
	decreased pre-B cell number	J:98133
	decreased pro-B cell number	J:98133
	enlarged spleen	J:98133
	increased eosinophil cell number	J:98133
	increased leukocyte cell number	J:98133
	increased monocyte cell number	J:98133
	increased neutrophil cell number	J:98133
	thymus atrophy	J:98133
Fzr1^tm1.1Mama/Fzr1^tm1.1Mama (involves: BALB/cJ * C57BL/6 * SJL)	decreased erythroid progenitor cell number	J:137456
G2e3^em1(IMPC)Tcp/G2e3^em1(IMPC)Tcp (C57BL/6NCrl-G2e3^em1(IMPC)Tcp/Tcp)	abnormal spleen morphology	J:211773
G6pc2^tm1.1Pesa/G6pc2^tm1.1Pesa (NOD.129S2-G6pc2^tm1.1Pesa)	abnormal CD8-positive, alpha beta T cell morphology	J:160286
	abnormal CD8-positive, alpha-beta T cell physiology	J:160286
	decreased T cell proliferation	J:160286
G6pc3^tm1Jyc/G6pc3^tm1Jyc (involves: 129S4/SvJae * C57BL/6)	abnormal neutrophil physiology	J:120741
	decreased neutrophil cell number	J:120741
	impaired granulocyte bactericidal activity	J:120741
	increased granulocyte number	J:120741
G6pdx^a-m1Neu/Y (involves: 102/El * C3H/El * T-stock)	abnormal erythrocyte morphology	J:95754
	abnormal erythrocyte physiology	J:95754
	abnormal hemoglobin content	J:95754
	anemia	J:95754
	decreased erythrocyte cell number	J:95754
	decreased mean corpuscular hemoglobin	J:95754
	hematopoietic system phenotype	J:58685, J:13991
G6pdx^a-m1Neu/G6pdx⁺ (involves: 102/El * C3H/El * T-stock)	hematopoietic system phenotype	J:58685
G6pdx^a-m1Neu/G6pdx^a-m1Neu (involves: 102/El * C3H/El * T-stock)	hematopoietic system phenotype	J:58685
Gab2^tm1Hhg/Gab2^tm1Hhg (involves: 129S4/SvJae)	decreased mast cell degranulation	J:70424
Gab2^tm1Hhg/Gab2^tm1Hhg (involves: 129S4/SvJae)	decreased mast cell number	J:70424
Gab2^tm1Pngr/Gab2^tm1Pngr (B6.Cg-Gab2^tm1Pngr)	abnormal osteoclast differentiation	J:97515
	abnormal osteoclast morphology	J:97515
	decreased bone marrow cell number	J:97515
	decreased osteoclast cell number	J:97515
Gab2^tm1Thir/Gab2^tm1Thir (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal mast cell differentiation	J:75092
	abnormal mast cell physiology	J:75092
	decreased mast cell number	J:75092
	hematopoietic system phenotype	J:75092
Gab2^tm3.1Thir/Gab2^tm3.1Thir (involves: 129T/SvJcl * C57BL/6Jcl)	decreased mast cell degranulation	J:178045
	decreased mast cell number	J:178045
Gab2^tm4.1Thir/Gab2^tm4.1Thir (involves: 129T/SvJcl * C57BL/6Jcl)	decreased mast cell degranulation	J:178045
	decreased mast cell number	J:178045
Gab3^em1Khoe/Gab3^em1Khoe (C57BL/6-Gab3^em1Khoe)	abnormal mature NK cell morphology	J:291290
	abnormal NK cell physiology	J:291290
	abnormal uterine NK cell morphology	J:291290
	decreased NK cell number	J:291290
Gab3^m1Khoe/Gab3^m1Khoe (C57BL/6-Gab3^m1Khoe)	abnormal mature NK cell morphology	J:291290
	abnormal NK cell physiology	J:291290
	abnormal uterine NK cell morphology	J:291290
	decreased NK cell number	J:291290
Gabarapl2^{tm1b(EUCOMM)Hmgu}/Gabarapl2⁺ (C57BL/6N-Gabarapl2^{tm1b(EUCOMM)Hmgu}/H)	decreased hemoglobin content	J:211773
	decreased lymphocyte cell number	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Gabpa^Gt(XH074)Byg/Gabpa^Gt(XH074)Byg (involves: 129P2/OlaHsd * C57BL/6)	decreased thymocyte number	J:92671
	small thymus	J:92671
Gabpb2^{Gt(RRJ488)Byg}/Gabpb2^{Gt(RRJ488)Byg} (involves: 129P2/OlaHsd)	increased B cell proliferation	J:141846
	increased IgG1 level	J:141846
	increased IgM level	J:141846
	increased spleen germinal center number	J:141846
Gabra5^{em1(IMPC)Ccpcz}/Gabra5^{em1(IMPC)Ccpcz} (C57BL/6N-Gabra5^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
	small spleen	J:211773
Gadd45a^tm1Ajf/Gadd45a^tm1Ajf (either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129X1/SvJ * C57BL/6))	abnormal bone marrow cell morphology/development	J:102680
	abnormal lymphopoiesis	J:76041
	decreased basophil cell number	J:76041
	decreased eosinophil cell number	J:76041
	decreased leukocyte cell number	J:76041
	decreased lymphocyte cell number	J:76041
	increased IgG1 level	J:76041
	increased IgM level	J:76041
	increased T cell number	J:76041
	increased T cell proliferation	J:76041
	increased thymocyte number	J:57882
	increased thymus weight	J:57882
Gadd45b^tm1Daa/Gadd45b^tm1Daa (involves: 129X1/SvJ * C57BL/6)	abnormal bone marrow cell morphology/development	J:102680
Gadd45b^tm1Flv/Gadd45b^tm1Flv (involves: 129S6/SvEvTac)	abnormal CD4-positive, alpha-beta T cell physiology	J:87396
	abnormal T-helper 1 cell differentiation	J:87396
	abnormal T-helper 1 physiology	J:87396
	abnormal T-helper 2 physiology	J:87396
Gadd45b^tm1Flv/Gadd45b^tm1Flv (B6.129S6-Gadd45b^tm1Flv)	abnormal T-helper 1 physiology	J:118837
	increased T cell proliferation	J:118837
	spleen hyperplasia	J:118837
Gadd45b^tm1Flv/Gadd45b^tm1Flv Gadd45g^tm1Flv/Gadd45g^tm1Flv (involves: 129S1/Sv * 129S6/SvEvTac)	abnormal T-helper 1 cell differentiation	J:87396
Gadd45b^tm1Flv/Gadd45b^tm1Flv Gadd45g^tm1Flv/Gadd45g^tm1Flv (involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6)	increased IgG1 level	J:118837
	increased IgM level	J:118837
	increased mature B cell number	J:118837
	increased memory T cell number	J:118837
	spleen hyperplasia	J:118837
Gadd45g^tm1Flv/Gadd45g^tm1Flv (involves: 129S1/Sv)	abnormal NK cell physiology	J:87396
	abnormal T-helper 1 cell differentiation	J:87396
	abnormal T-helper 1 physiology	J:69475
Gadd45g^tm1Jni/Gadd45g^tm1Jni (involves: 129P2/OlaHsd)	hematopoietic system phenotype	J:68832
Galc^twi-5J/Galc^twi-5J (BXD32/TyJ-Galc^twi-5J/J)	abnormal leukocyte morphology	J:199132
Galc^twi/Galc^twi (B6.CE-Galc^twi/J)	abnormal microglial cell morphology	J:108359
Galc^twi/Galc^twi (B6.CE-Galc^twi/J)	abnormal osteoclast physiology	J:165361
Galc^twi/Galc^twi (involves: C57BL/6J * CE/J)	abnormal macrophage morphology	J:6390
Galc^twi/Galc^twi Glb1^tm1Adz/Glb1^tm1Adz (involves: 129P2/OlaHsd * C57BL/6J * CE/J)	abnormal macrophage physiology	J:63197
	enlarged spleen	J:63197
Galnt1^tm1.1Jxm/Galnt1^tm1.1Jxm (B6NHsd.Cg-Galnt1^tm1.1Jxm)	decreased B cell number	J:128982
	decreased basophil cell number	J:128982
	decreased eosinophil cell number	J:128982
	decreased germinal center B cell number	J:128982
	decreased IgG level	J:128982
	decreased leukocyte cell number	J:128982
	decreased plasma cell number	J:128982
	decreased spleen germinal center number	J:128982
	decreased T cell number	J:128982
	impaired leukocyte tethering or rolling	J:128982
	increased lymphocyte cell number	J:128982
Galnt3^tm1.1Cfg/Galnt3^tm1.1Cfg (involves: C57BL/6)	decreased monocyte cell number	J:217719
Galnt3^tm1.1Cfg/Galnt3^tm1.1Cfg (involves: C57BL/6)	thrombocytopenia	J:217719
Galnt13^em1(IMPC)Mbp/Galnt13^em1(IMPC)Mbp (C57BL/6N-Galnt13^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	small spleen	J:211773
Galnt18^{tm1b(KOMP)Wtsi}/Galnt18^{tm1b(KOMP)Wtsi} (C57BL/6N-Galnt18^{tm1b(KOMP)Wtsi}/Wtsi)	increased NK cell number	J:211773
	increased red blood cell distribution width	J:211773
Galr1^em1(IMPC)H/Galr1^em1(IMPC)H (C57BL/6N-Galr1^em1(IMPC)H/H)	decreased lymphocyte cell number	J:211773
	enlarged spleen	J:211773
	increased eosinophil cell number	J:211773
Galr2^{Gt(OST105469)Lex}/Galr2^{Gt(OST105469)Lex} (involves: 129S5/SvEvBrd * C57BL/6J)	decreased B cell number	J:103485
	increased T cell number	J:103485
Galr3^tm1Lex/Galr3^tm1Lex (B6.129S5-Galr3^tm1Lex)	hematopoietic system phenotype	J:211066
Gapdh^M6Neu/Gapdh^M6Neu (C3.Cg-Gapdh^M6Neu)	abnormal hematocrit	J:126359
	decreased hemoglobin content	J:126359
	hematopoietic system phenotype	J:126359
Gapt^tm1.1Wz/Gapt^tm1.1Wz (Not Specified)	increased B cell proliferation	J:138146
	increased IgG2b level	J:138146
	increased IgG3 level	J:138146
	increased IgM level	J:138146
	increased marginal zone B cell number	J:138146
Gapvd1^em1(IMPC)Mbp/Gapvd1⁺ (C57BL/6N-Gapvd1^em1(IMPC)Mbp/Ucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Garem1^em1(IMPC)Mbp/Garem1^em1(IMPC)Mbp (C57BL/6N-Garem1^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	small spleen	J:211773
Garin1a^{em1(IMPC)Ccpcz}/Garin1a^{em1(IMPC)Ccpcz} (C57BL/6N-Garin1a^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Garin1b^{em1(IMPC)Ccpcz}/Garin1b^{em1(IMPC)Ccpcz} (C57BL/6N-Garin1b^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Garin2^{em1(IMPC)Ccpcz}/Garin2^{em1(IMPC)Ccpcz} (C57BL/6N-Garin2^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Gars1^em1(IMPC)Tcp/Gars1⁺ (C57BL/6NCrl-Gars1^em1(IMPC)Tcp/Tcp)	small spleen	J:211773
Gas2l2^{tm1a(KOMP)Wtsi}/Gas2l2^{tm1a(KOMP)Wtsi} (C57BL/6N-Gas2l2^{tm1a(KOMP)Wtsi}/Wtsi)	abnormal thymus topology	J:239583
Gas6^tm1Pec/Gas6^tm1Pec (involves: 129S1/Sv * 129X1/SvJ)	abnormal platelet dense granule physiology	J:77462
Gas6^tm1Pec/Gas6^tm1Pec (involves: 129S1/Sv * 129X1/SvJ)	decreased platelet aggregation	J:77462
Gas7^em1(IMPC)J/Gas7^em1(IMPC)J (C57BL/6NJ-Gas7^em1(IMPC)J/J)	decreased mean corpuscular hemoglobin concentration	J:211773
	increased mean corpuscular volume	J:211773
Gata1^Plt13/Y (BALB/c-Gata1^Plt13)	anemia	J:113720
Gata1^Plt13/Gata1⁺ (BALB/c-Gata1^Plt13)	abnormal megakaryocyte morphology	J:113720
	abnormal megakaryocyte progenitor cell morphology	J:113720
	abnormal myelopoiesis	J:113720
	abnormal thrombopoiesis	J:113720
	enlarged spleen	J:113720
	extramedullary hematopoiesis	J:113720
	increased megakaryocyte cell number	J:113720
	increased spleen weight	J:113720
	thrombocytopenia	J:113720
Gata1^tm1.1Yen/Gata1^tm1.1Yen (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)	abnormal erythropoiesis	J:200716
	decreased erythroid progenitor cell number	J:200716
	hematopoietic system phenotype	J:200716
Gata1^tm1Mym/Y (involves: 129P2/OlaHsd * BALB/c)	abnormal embryonic erythropoiesis	J:40321
	anemia	J:40321
	decreased erythroid progenitor cell number	J:40321
Gata1^tm1Mym/Y Tg(Gata1)#Mym/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2J)	hematopoietic system phenotype	J:158252
Gata1^tm1Mym/Y Tg(Gata1)#Mym/0 (involves: 129P2/OlaHsd C57BL/6 * DBA/2J)	abnormal definitive hematopoiesis	J:158252
	abnormal erythrocyte morphology	J:158252
	abnormal erythropoiesis	J:158252
	abnormal megakaryocyte morphology	J:158252
	abnormal megakaryocyte progenitor cell morphology	J:158252
	abnormal platelet morphology	J:158252
	anemia	J:158252
	decreased erythrocyte cell number	J:158252
	decreased erythroid progenitor cell number	J:158252
	decreased hematocrit	J:158252
	decreased hemoglobin content	J:158252
	increased leukocyte cell number	J:158252
	increased megakaryocyte cell number	J:158252
	thrombocytosis	J:158252
Gata1^tm1Mym/Y Tg(Gata1V205G)1Mym/0 (involves: C57BL/6 DBA/2)	abnormal bone marrow cell morphology/development	J:89054
	abnormal erythrocyte morphology	J:89054
	abnormal megakaryocyte differentiation	J:89054
	abnormal megakaryocyte morphology	J:89054
	abnormal mononuclear cell morphology	J:89054
	abnormal platelet morphology	J:89054
	abnormal stress erythropoiesis	J:89054
	abnormal thrombopoiesis	J:89054
	anisocytosis	J:89054
	increased megakaryocyte cell number	J:89054
	thrombocytopenia	J:89054
Gata1^tm1Mym/Gata1⁺ (involves: 129P2/OlaHsd * BALB/c)	abnormal erythropoiesis	J:40321
Gata1^tm1Mym/Gata1⁺ (involves: 129P2/OlaHsd * BALB/c)	anemia	J:40321
Gata1^tm1Mym/Gata1⁺ (involves: 129P2/OlaHsd)	abnormal erythropoiesis	J:88685
	abnormal megakaryocyte morphology	J:88685
	abnormal proerythroblast morphology	J:88685
	anemia	J:88685
	decreased hematocrit	J:88685
	decreased spleen red pulp amount	J:88685
	decreased spleen white pulp amount	J:88685
	enlarged spleen	J:88685
	extramedullary hematopoiesis	J:88685
	pale spleen	J:88685
	thrombocytopenia	J:88685
Gata1^tm1Mym/Gata1^tm1Mym Tg(Gata1)#Mym/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2J)	hematopoietic system phenotype	J:158252
Gata1^tm1Mym/Gata1^tm1Mym Tg(Gata1)#Mym/0 (involves: 129P2/OlaHsd C57BL/6 * DBA/2J)	abnormal definitive hematopoiesis	J:158252
	abnormal erythrocyte morphology	J:158252
	abnormal erythropoiesis	J:158252
	abnormal megakaryocyte morphology	J:158252
	abnormal megakaryocyte progenitor cell morphology	J:158252
	abnormal platelet morphology	J:158252
	anemia	J:158252
	decreased erythrocyte cell number	J:158252
	decreased erythroid progenitor cell number	J:158252
	decreased hematocrit	J:158252
	decreased hemoglobin content	J:158252
	increased leukocyte cell number	J:158252
	increased megakaryocyte cell number	J:158252
	thrombocytosis	J:158252
Gata1^tm1Phi/Gata1⁺ Tg(HBB-cre)1Phi/0 (involves: FVB)	abnormal erythropoiesis	J:98277
Gata1^tm1Phi/Gata1⁺ Tg(HBB-cre)1Phi/0 (involves: FVB)	anemia	J:98277
Gata1^tm1Phi/Gata1⁺ Tg(HBB-cre)1Phi/0 Tg(HBB-Gata1)G4Phi/0 (involves: FVB)	abnormal erythropoiesis	J:98277
	anemia	J:98277
Gata1^tm1Phi/Gata1⁺ Tg(HBB-Gata1)G4Phi/0 (involves: FVB)	abnormal erythropoiesis	J:98277
Gata1^tm1Sho/Y (involves: 129S4/SvJae * C57BL/6)	abnormal erythropoiesis	J:36249
Gata1^tm1Sho/Y (involves: 129S4/SvJae * C57BL/6)	anemia	J:36249
Gata1^tm1Sho/Y Tg(Gata1)#Mym/0 (involves: 129S4/SvJae * C57BL/6 * DBA/2J)	hematopoietic system phenotype	J:158252
Gata1^tm1Sho/Y Tg(Gata1)#Mym/0 (involves: 129S4/SvJae C57BL/6 * DBA/2J)	abnormal megakaryocyte progenitor cell morphology	J:158252
	decreased erythrocyte cell number	J:158252
	decreased hematocrit	J:158252
	decreased hemoglobin content	J:158252
	increased leukocyte cell number	J:158252
	increased megakaryocyte cell number	J:158252
	thrombocytosis	J:158252
Gata1^tm1Sho/Gata1⁺ (involves: 129S4/SvJae * C57BL/6)	anemia	J:36249
Gata1^tm1Sho/Gata1⁺ (involves: 129S4/SvJae * C57BL/6)	decreased eosinophil cell number	J:88711
Gata1^tm1Sho/Gata1^tm1Sho Tg(Gata1)#Mym/0 (involves: 129S4/SvJae * C57BL/6 * DBA/2J)	hematopoietic system phenotype	J:158252
Gata1^tm1Sho/Gata1^tm1Sho Tg(Gata1)#Mym/0 (involves: 129S4/SvJae C57BL/6 * DBA/2J)	abnormal megakaryocyte progenitor cell morphology	J:158252
	decreased erythrocyte cell number	J:158252
	decreased hematocrit	J:158252
	decreased hemoglobin content	J:158252
	increased leukocyte cell number	J:158252
	increased megakaryocyte cell number	J:158252
	thrombocytosis	J:158252
Gata1^tm2.1Sho/Y (involves: 129S4/SvJae * C57BL/6)	abnormal megakaryocyte differentiation	J:41605
	abnormal megakaryocyte morphology	J:41605
	abnormal megakaryocyte progenitor cell morphology	J:41605
	hematopoietic system phenotype	J:41605
	increased mean platelet volume	J:41605
	increased megakaryocyte cell number	J:41605
	thrombocytopenia	J:41605
Gata1^tm2.1Sho/Gata1⁺ (involves: 129S4/SvJae * C57BL/6)	abnormal megakaryocyte differentiation	J:41605
	abnormal megakaryocyte progenitor cell morphology	J:41605
	increased megakaryocyte cell number	J:41605
Gata1^tm2.1Sho/Gata1^tm2.1Sho (involves: 129/Sv * 129S4/SvJae)	abnormal hematopoietic system physiology	J:106670
Gata1^tm2.1Yen/Gata1^tm2.1Yen (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)	hematopoietic system phenotype	J:200716
Gata1^tm2Sho/Y (involves: 129S4/SvJae * C57BL/6)	abnormal megakaryocyte differentiation	J:41605
	abnormal megakaryocyte morphology	J:41605
	abnormal megakaryocyte progenitor cell morphology	J:41605
	anemia	J:41605
	increased mean platelet volume	J:41605
	increased megakaryocyte cell number	J:41605
	thrombocytopenia	J:41605
Gata1^tm2Sho/Y (involves: 129S4/SvJae * C57BL/6 * CD-1)	abnormal common myeloid progenitor cell morphology	J:78348, J:78540
	abnormal definitive hematopoiesis	J:78348
	abnormal erythroid progenitor cell morphology	J:78348, J:78540
	abnormal hematocrit	J:78540
	abnormal megakaryocyte progenitor cell morphology	J:78348
	abnormal platelet shape	J:78348, J:78540
	abnormal spleen morphology	J:78348
	abnormal spleen red pulp morphology	J:78540
	anemia	J:78348
	decreased bone marrow cell number	J:78348, J:78540
	decreased erythrocyte cell number	J:78348
	decreased erythroid progenitor cell number	J:78540
	decreased hematocrit	J:78348
	decreased lymphocyte cell number	J:78348
	enlarged spleen	J:78348, J:78540
	extramedullary hematopoiesis	J:78540
	increased erythroid progenitor cell number	J:78348, J:78540
	increased neutrophil cell number	J:78348
	increased number of Howell-Jolly bodies	J:78348
	increased splenocyte number	J:78540
	poikilocytosis	J:78348
	polychromatophilia	J:78348
	thrombocytopenia	J:78348, J:78540
Gata1^tm2Sho/Gata1⁺ (involves: 129S4/SvJae * C57BL/6)	abnormal megakaryocyte differentiation	J:41605
	abnormal megakaryocyte progenitor cell morphology	J:41605
	increased megakaryocyte cell number	J:41605
Gata1^tm2Sho/Gata1^tm2Sho (involves: 129S4/SvJae * C57BL/6 * CD-1)	abnormal common myeloid progenitor cell morphology	J:78348, J:78540
	abnormal definitive hematopoiesis	J:78348
	abnormal erythroid progenitor cell morphology	J:78348, J:78540
	abnormal hematocrit	J:78540
	abnormal megakaryocyte progenitor cell morphology	J:78348
	abnormal platelet shape	J:78348, J:78540
	abnormal spleen morphology	J:78348
	abnormal spleen red pulp morphology	J:78540
	anemia	J:78348
	decreased bone marrow cell number	J:78348, J:78540
	decreased erythrocyte cell number	J:78348
	decreased erythroid progenitor cell number	J:78540
	decreased hematocrit	J:78348
	decreased lymphocyte cell number	J:78348
	enlarged spleen	J:78348, J:78540
	extramedullary hematopoiesis	J:78540
	increased erythroid progenitor cell number	J:78348, J:78540
	increased neutrophil cell number	J:78348
	increased number of Howell-Jolly bodies	J:78348
	increased splenocyte number	J:78540
	poikilocytosis	J:78348
	polychromatophilia	J:78348
	thrombocytopenia	J:78348, J:78540
Gata1^tm2Sho/Gata1^tm2Sho (involves: 129S4/SvJae)	increased osteoclast cell number	J:111270
Gata1^tm4Sho/Y (involves: 129S6/SvEvTac * C57BL/6)	abnormal erythropoiesis	J:77724
	abnormal megakaryocyte differentiation	J:77724
	abnormal megakaryocyte progenitor cell morphology	J:77724
	anemia	J:77724
Gata1^tm4Sho/Y Gata2^tm2Sho/Gata2^tm2Sho (involves: 129S6/SvEvTac * C57BL/6)	abnormal erythropoiesis	J:77724
	abnormal megakaryocyte progenitor cell morphology	J:77724
	hematopoietic system phenotype	J:77724
Gata1^{tm5(GATA3)Sho}/Y (involves: 129S4/SvJae * C57BL/6)	abnormal erythropoiesis	J:47295
Gata1^{tm5(GATA3)Sho}/Y (involves: 129S4/SvJae * C57BL/6)	anemia	J:47295
Gata1^{tm5(GATA3)Sho}/Gata1⁺ (involves: 129S4/SvJae * C57BL/6)	abnormal definitive hematopoiesis	J:47295
	anemia	J:47295
	decreased erythrocyte cell number	J:47295
Gata1^tm6Sho/Y (involves: 129S1/Sv)	decreased eosinophil cell number	J:88711
	decreased erythrocyte cell number	J:88711
	decreased hematocrit	J:88711
	enlarged spleen	J:88711
	hematopoietic system phenotype	J:88711
Gata1^tm6Sho/Gata1^tm6Sho (involves: 129S1/Sv)	decreased eosinophil cell number	J:88711
Gata1^tm6Sho/Gata1^tm6Sho (involves: 129S1/Sv)	hematopoietic system phenotype	J:88711
Gata1^tm6Sho/Gata1^tm6Sho (involves: 129S1/Sv * BALB/c)	abnormal leukocyte cell number	J:115273
	decreased eosinophil cell number	J:115273
	decreased lymphocyte cell number	J:115273
	increased neutrophil cell number	J:115273
Gata1^tm7Sho/Y (involves: 129S1/Sv * C57BL/6)	abnormal erythropoiesis	J:99310
Gata1^tm7Sho/Y (involves: 129S1/Sv * C57BL/6)	abnormal megakaryocyte progenitor cell morphology	J:99310
Gata1^tm7Sho/Gata1^tm7Sho (involves: 129S1/Sv * C57BL/6)	abnormal erythropoiesis	J:99310
Gata1^tm7Sho/Gata1^tm7Sho (involves: 129S1/Sv * C57BL/6)	abnormal megakaryocyte progenitor cell morphology	J:99310
Gata1^tm8.1Sho/Y (involves: 129S1/Sv * C57BL/6)	abnormal megakaryocyte morphology	J:99310
Gata1^tm8.1Sho/Gata1^tm8.1Sho (involves: 129S1/Sv * C57BL/6)	abnormal megakaryocyte morphology	J:99310
Gata1^tm8.2Sho/Y (involves: 129S1/Sv)	abnormal erythropoiesis	J:99310
Gata1^tm8.2Sho/Y (involves: 129S1/Sv)	abnormal megakaryocyte morphology	J:99310
Gata1^tm8.2Sho/Gata1^tm8.2Sho (involves: 129S1/Sv)	abnormal erythropoiesis	J:99310
Gata1^tm8.2Sho/Gata1^tm8.2Sho (involves: 129S1/Sv)	abnormal megakaryocyte morphology	J:99310
Gata1^tm9Sho/Y (Not Specified)	impaired hematopoiesis	J:100411
Gata1^tm9Sho/Y (involves: C57BL/6)	hematopoietic system phenotype	J:132560
Gata1^tm10Sho/Y (involves: C57BL/6)	decreased erythroid progenitor cell number	J:132560
Gata1^tm10Sho/Y (involves: C57BL/6)	hematopoietic system phenotype	J:132560
Gata2^tm1.1Sac/Gata2^tm1.1Sac (involves: 129S1/Sv * 129X1/SvJ)	anemia	J:108963
Gata2^tm1Mym/Gata2⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal definitive hematopoiesis	J:84836
Gata2^tm1Mym/Gata2^tm1Mym (involves: 129P2/OlaHsd * C57BL/6)	abnormal blood cell morphology/development	J:84836
	abnormal definitive hematopoiesis	J:106045
Gata2^tm1Sho/Gata2^tm1Sho (involves: 129S4/SvJae * C57BL/6)	abnormal embryonic hematopoiesis	J:20316
	anemia	J:20316
	impaired hematopoiesis	J:20316
Gata2^tm2Sho/Gata2^tm2Sho (involves: 129S6/SvEvTac * C57BL/6)	hematopoietic system phenotype	J:77724
Gata2^tm3.1Sho/Gata2^tm3.1Sho (B6.129S1-Gata2^tm3.1Sho)	abnormal stress erythropoiesis	J:165427
	anemia	J:165427
	decreased erythroid progenitor cell number	J:165427
	increased erythroid progenitor cell number	J:165427
Gata2^tm3.1Sho/Gata2^tm3.1Sho (involves: 129S1/Sv)	hematopoietic system phenotype	J:173274
Gata2^tm4.1Sho/Gata2^tm4.1Sho (Not Specified)	abnormal megakaryocyte progenitor cell morphology	J:173274
	decreased common myeloid progenitor cell number	J:173274
	hematopoietic system phenotype	J:173274
Gata3^tm1Iho/Gata3^tm1Iho Il13^{tm1(YFP/cre)Lky}/Il13⁺ (involves: 129S4/SvJae)	decreased eosinophil cell number	J:178986
Gata3^tm1Iho/Gata3^tm1Iho Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	abnormal T cell differentiation	J:86996
	decreased CD4-positive, alpha-beta T cell number	J:86996
Gata3^tm1Iho/Gata3^tm1Iho Tg(Cd4-cre)1Cwi/0 Tg(DO11.10)10Dlo/0 (involves: BALB/c * C3H * C57BL/6 * DBA/2)	decreased CD4-positive, alpha-beta T cell number	J:86996
Gata3^tm1Iho/Gata3^tm1Iho Tg(DO11.10)10Dlo/0 Tg(Lck-cre)1Cwi/0 (involves: BALB/c * C3H * C57BL/6)	arrested T cell differentiation	J:86996
	decreased CD4-positive, alpha-beta T cell number	J:86996
	decreased CD8-positive, alpha-beta T cell number	J:86996
	decreased double-positive T cell number	J:86996
	small thymus	J:86996
Gata3^tm1Iho/Gata3^tm1Iho Tg(Lck-cre)1Cwi/0 (involves: BALB/c)	abnormal CD8-positive, alpha-beta T cell number	J:86996
	abnormal T cell subpopulation ratio	J:86996
	arrested T cell differentiation	J:86996
	decreased CD4-positive, alpha-beta T cell number	J:86996
	decreased double-positive T cell number	J:86996
	decreased thymocyte number	J:86996
	increased T cell apoptosis	J:86996
	small thymus	J:86996
Gata3^tm1Jeng/Gata3^tm1Jeng (involves: 129S7/SvEvBrd)	abnormal definitive hematopoiesis	J:28393
Gata3^tm1Jeng/Gata3^tm1Jeng (involves: 129S7/SvEvBrd)	abnormal erythrocyte morphology	J:28393
Gata3^tm1Jfz/Gata3^tm1Jfz Rag2^tm1Fwa/Rag2^tm1Fwa Tg(Cd4-cre)1Cwi/0 Tg(Tcra5CC7,Tcrb5CC7)IWep/0 (involves: 129S/SvEv * C57BL/6 * DBA/2)	abnormal T cell differentiation	J:141145
Gata3^tm1Jfz/Gata3^tm1Jfz Tg(Cd4-cre)1Cwi/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)	abnormal CD4-positive, alpha beta T cell morphology	J:93538
	abnormal T cell differentiation	J:141145
	decreased CD4-positive, alpha-beta T cell number	J:141145
Gata3^tm1Jfz/Gata3^tm1Jfz Tg(Tnfrsf4-cre)1Nik/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:93538
	decreased IgE level	J:93538
	decreased T-helper 2 cell number	J:93538
	increased T-helper 1 cell number	J:93538
Gata3^tm2Jeng/Gata3^tm2Jeng (Not Specified)	abnormal double-positive T cell morphology	J:155686
	abnormal T cell differentiation	J:155686
	abnormal T cell number	J:155686
	decreased double-negative T cell number	J:155686
	decreased gamma-delta T cell number	J:155686
	decreased thymocyte number	J:155686
Gata3^tm3Gsv/Gata3^tm3Gsv Tg(KRT14-cre)8Brn/0 (involves: 129P2/OlaHsd * FVB/N)	decreased T cell number	J:117058
Gata4^tm1Eno/Gata4⁺ Gata6^tm1Eno/Gata6⁺ (involves: 129/Sv * 129S7/SvEvBrd * C57BL/6)	decreased erythrocyte cell number	J:111824
Gatad2b^{tm1b(EUCOMM)Hmgu}/Gatad2b⁺ (C57BL/6N-Gatad2b^{tm1b(EUCOMM)Hmgu}/Ics)	increased mean corpuscular volume	J:211773
	increased monocyte cell number	J:211773
Gatm^{tm1b(KOMP)Wtsi}/Gatm^{tm1b(KOMP)Wtsi} (C57BL/6N-Gatm^{tm1b(KOMP)Wtsi}/Ieg)	decreased red blood cell distribution width	J:211773
	increased mean corpuscular hemoglobin	J:211773
	thrombocytopenia	J:211773
Gba1^em1(IMPC)H/Gba1⁺ (C57BL/6N-Gba1^em1(IMPC)H/H)	increased mean platelet volume	J:211773
Gba1^tm1.1Pmis/Gba1^tm1.1Pmis Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	abnormal T cell differentiation	J:167081
	abnormal thymus morphology	J:167081
	decreased double-positive T cell number	J:167081
	decreased hemoglobin content	J:167081
	enlarged spleen	J:167081
	extramedullary hematopoiesis	J:167081
	spleen hyperplasia	J:167081
Gba1^tm1.1Pmis/Gba1^tm1.2Pmis Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	abnormal T cell differentiation	J:167081
	abnormal thymus morphology	J:167081
	decreased double-positive T cell number	J:167081
	decreased hemoglobin content	J:167081
	enlarged spleen	J:167081
	extramedullary hematopoiesis	J:167081
	spleen hyperplasia	J:167081
Gba1^tm1Clk/Gba1^tm1.1Clk Tg(Tek-cre)12Flv/0 (involves: 129S1/Sv * 129X1/SvJ * C3H * C57BL/6J)	abnormal macrophage morphology	J:117763
	abnormal spleen morphology	J:117763
	increased spleen weight	J:117763
Gba1^tm1Karl/Gba1^tm1.1Karl Tg(Mx1-cre)1Cgn/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	abnormal spleen morphology	J:113751
	decreased hematocrit	J:113751
	decreased hemoglobin content	J:113751
	decreased mean corpuscular volume	J:113751
	enlarged spleen	J:113751
	intermingled spleen red and white pulp	J:113751
Gba1^tm1Karl/Gba1^tm1Karl Tg(Nes-cre)1Kln/? (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)	abnormal microglial cell morphology	J:127108
Gba1^tm1Nsb/Gba1^tm1Nsb (involves: 129S/SvEv * C57BL/6)	abnormal macrophage morphology	J:1100
Gba1^tm1Rlp/Gba1^tm1Rlp (involves: 129S4/SvJae * C57BL/6)	abnormal Kupffer cell morphology	J:76409
	abnormal macrophage morphology	J:76409
	anemia	J:76409
	decreased erythrocyte cell number	J:76409
	decreased hematocrit	J:76409
	decreased hemoglobin content	J:76409
	decreased leukocyte cell number	J:76409
	increased IgG level	J:76409
	increased spleen weight	J:76409
Gba1^tm2Ggb/Gba1^tm1Nsb (involves: 129S/SvEv * 129S5/SvEvBrd * C57BL/6)	abnormal spleen morphology	J:86334
Gba1^tm2Ggb/Gba1^tm2Ggb (involves: 129S5/SvEvBrd * C57BL/6)	abnormal spleen morphology	J:86334
Gba1^tm2Karl/Gba1^tm2Karl Tg(KRT14-cre)8Brn/? (involves: 129S1/Sv * 129X1/SvJ * FVB/N)	abnormal macrophage morphology	J:127108
Gba1^tm3Ggb/Gba1^tm1Nsb (involves: 129S/SvEv * 129S5/SvEvBrd * C57BL/6)	abnormal spleen morphology	J:86334
Gba1^tm3Ggb/Gba1^tm3Ggb (involves: 129S5/SvEvBrd)	abnormal spleen morphology	J:86334
Gba1^tm4Ggb/Gba1^tm1Nsb (involves: 129S/SvEv * 129S5/SvEvBrd * C57BL/6)	abnormal spleen morphology	J:86334
Gba1^tm4Ggb/Gba1^tm4Ggb (involves: 129S5/SvEvBrd * C57BL/6)	abnormal spleen morphology	J:86334
Gbp2b^tm1Tigm/Gbp2b^tm1Tigm (B6.129S5-Gbp2b^tm1Tigm/Jdmm)	abnormal macrophage physiology	J:172364
Gbp5^tm1Tigm/Gbp5^tm1Tigm (B6.Cg-Gbp5^tm1Tigm)	impaired neutrophil recruitment	J:183942
Gbx2^tm1.1Mrt/Gbx2^tm1.1Mrt Fgf8^tm1.4Mrt/Fgf8⁺ (B6.129-Gbx2^tm1.1Mrt Fgf8^tm1.4Mrt)	abnormal thymus development	J:100584
Gcgr^{tm1.1(KOMP)Vlcg}/Gcgr^{tm1.1(KOMP)Vlcg} (C57BL/6N-Gcgr^{tm1.1(KOMP)Vlcg}/Ucd)	decreased mean corpuscular hemoglobin concentration	J:211773
	increased mean corpuscular volume	J:211773
Gck^Rgsc149/Gck⁺ (involves: C57BL/6J * DBA/2J)	increased glycosylated hemoglobin level	J:88919
Gck^Rgsc210/Gck⁺ (involves: C57BL/6J * DBA/2J)	increased glycosylated hemoglobin level	J:88919
Gck^Rgsc236/Gck⁺ (involves: C57BL/6J * DBA/2J)	increased glycosylated hemoglobin level	J:88919
Gck^Rgsc272/Gck⁺ (involves: C57BL/6J * DBA/2J)	increased glycosylated hemoglobin level	J:88919
Gck^Rgsc341/Gck⁺ (involves: C57BL/6J * DBA/2J)	increased glycosylated hemoglobin level	J:88919
Gck^Rgsc392/Gck⁺ (involves: C57BL/6J * DBA/2J)	increased glycosylated hemoglobin level	J:88919
Gck^Rgsc475/Gck⁺ (involves: C57BL/6J * DBA/2J)	increased glycosylated hemoglobin level	J:88919
Gck^Rgsc552/Gck⁺ (involves: C57BL/6J * DBA/2J)	increased glycosylated hemoglobin level	J:88919
Gck^Rgsc553/Gck⁺ (involves: C57BL/6J * DBA/2J)	increased glycosylated hemoglobin level	J:88919
Gck^Rgsc702/Gck⁺ (involves: C57BL/6J * DBA/2J)	increased glycosylated hemoglobin level	J:88919
Gck^Rgsc735/Gck⁺ (involves: C57BL/6J * DBA/2J)	increased glycosylated hemoglobin level	J:88919
Gcn1^em1(IMPC)J/Gcn1⁺ (C57BL/6NJ-Gcn1^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Gcnt1^tm1Jxm/Gcnt1^tm1Jxm (involves: 129/Sv * C57BL/6)	abnormal B cell differentiation	J:86387
	increased leukocyte cell number	J:86387
	increased neutrophil cell number	J:86387
Gcnt1^tm1Jxm/Gcnt1^tm1Jxm (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal leukocyte migration	J:113195
	impaired leukocyte tethering or rolling	J:113195
Gcnt2^tm1Tmu/Gcnt2^tm1Tmu (involves: 129S2/SvPas * C57BL/6)	decreased B cell number	J:100533
Gcnt3^tm1.1Jxm/Gcnt3^tm1.1Jxm (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased IgA level	J:149909
	decreased IgG1 level	J:149909
	decreased IgG2a level	J:149909
	decreased IgG2b level	J:149909
Gcnt4^tm1.1Jxm/Gcnt4^tm1.1Jxm (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	increased neutrophil cell number	J:149909
Gcsfis^C57BL/6J/? (involves: C57BL/6J * DBA/2J)	enlarged spleen	J:61462
Gcsfis^C57BL/6J/Gcsfis^C57BL/6J (B6.SJL-Ptprc^a Pepc^b/BoyJ)	enlarged spleen	J:61462
Gda^{tm1a(KOMP)Wtsi}/Gda^{tm1a(KOMP)Wtsi} (C57BL/6N-Gda^{tm1a(KOMP)Wtsi}/Wtsi)	decreased hematocrit	J:211773
	decreased T-helper cell number	J:211773
	increased effector memory T-helper cell number	J:211773
	increased red blood cell distribution width	J:211773
Gdap1^{tm2b(KOMP)Wtsi}/Gdap1^{tm2b(KOMP)Wtsi} (C57BL/6N-Gdap1^{tm2b(KOMP)Wtsi}/Ucd)	abnormal thymus morphology	J:211773
	small thymus	J:211773
Gdap2^{em1(IMPC)Wtsi}/Gdap2^{em1(IMPC)Wtsi} (C57BL/6N-Gdap2^{em1(IMPC)Wtsi}/WtsiIeg)	thrombocytosis	J:211773
Gde1^{tm1b(EUCOMM)Hmgu}/Gde1⁺ (C57BL/6N-Gde1^{tm1b(EUCOMM)Hmgu}/Ieg)	decreased mean corpuscular volume	J:211773
Gdf1^tm1Sjl/Gdf1^tm1Sjl (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal spleen morphology	J:60755
Gdf2^{tm1.1(KOMP)Vlcg}/Gdf2^{tm1.1(KOMP)Vlcg} (C57BL/6N-Gdf2^{tm1.1(KOMP)Vlcg}/Ucd)	increased mean corpuscular volume	J:211773
Gdf5^em1(IMPC)H/Gdf5^em1(IMPC)H (C57BL/6NTac-Gdf5^em1(IMPC)H/H)	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
Gdf6^{em1(IMPC)Ccpcz}/Gdf6⁺ (C57BL/6NCrl-Gdf6^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Gdf11^tm1Sjl/Gdf11^tm1Sjl (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal spleen morphology	J:94455
Gdf15^tm1Sjl/Gdf15^tm1Sjl (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	increased platelet aggregation	J:195443
Gdnf^tm1Rosl/Gdnf^tm1Rosl (involves: 129S2/SvPas)	abnormal spleen red pulp morphology	J:33808
Gdpd5^{tm1b(EUCOMM)Hmgu}/Gdpd5⁺ (C57BL/6N-Gdpd5^{tm1b(EUCOMM)Hmgu}/Bay)	abnormal spleen morphology	J:211773
Gemin5^em1(IMPC)H/Gemin5⁺ (C57BL/6N-Gemin5^em1(IMPC)H/H)	increased large unstained cell number	J:211773
Gfi1^Gen/Gfi1⁺ (C57BL/6J-Gfi1^Gen)	abnormal myelopoiesis	J:182679
	abnormal NK cell differentiation	J:182679
	abnormal NK cell physiology	J:182679
	absent neutrophils	J:182679
	decreased NK cell degranulation	J:182679
Gfi1^tm1.1Wep/Gfi1^tm1.1Wep (B6.129-Gfi1^tm1.1Wep)	arrested T cell differentiation	J:117105
	decreased B cell number	J:117105
	small thymus	J:117105
	thymus hypoplasia	J:117105
Gfi1^tm1Tmo/Gfi1^tm1Tmo (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal granulocyte differentiation	J:75143
	abnormal monocyte differentiation	J:75143
	abnormal myelopoiesis	J:75143
	abnormal T cell differentiation	J:75143
	decreased B cell number	J:75143
	decreased granulocyte number	J:75143
	decreased lymphocyte cell number	J:75143
	decreased neutrophil cell number	J:75143
	decreased T cell number	J:75143
	decreased thymocyte number	J:75143
Gfi1^tm1Tmo/Gfi1^tm1Tmo (involves: 129S1/Sv * 129X1/SvJ)	decreased B cell number	J:192927
	decreased granulocyte number	J:192927
	decreased neutrophil cell number	J:192927
	decreased thymocyte number	J:192927
	increased hematopoietic stem cell number	J:192927
	increased monocyte cell number	J:192927
Gfi1^tm1Wep/Gfi1^tm1Wep (B6.129-Gfi1^tm1Wep)	abnormal definitive hematopoiesis	J:117105
Gfi1^tm1Wep/Gfi1^tm1Wep (B6.129-Gfi1^tm1Wep)	abnormal T cell proliferation	J:117105
Gfi1^tm1Wep/Gfi1^tm1Wep Gfi1b^tm2Tmo/Gfi1b^tm2Tmo Tg(Mx1-cre)1Cgn/? (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	decreased hematopoietic stem cell number	J:167416
Gfi1^tm1Wep/Gfi1^tm1Wep Tg(Cd4-cre)1Cwi/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)	abnormal T cell proliferation	J:117105
	abnormal T cell subpopulation ratio	J:117105
	abnormal T-helper 2 physiology	J:117105
Gfi1^tm2Tmo/Gfi1^tm2Tmo (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal T cell differentiation	J:93337
	decreased neutrophil cell number	J:93337
	decreased thymocyte number	J:93337
Gfi1^{tm3(Gfib1)Tmo}/Gfi1^{tm3(Gfib1)Tmo} (involves: 129S1/Sv * 129X1/SvJ)	abnormal monocyte morphology	J:116870
	decreased granulocyte number	J:116870
	hematopoietic system phenotype	J:116870
Gfi1^tm4Tmo/Gfi1^tm4Tmo (involves: 129S1/Sv * 129X1/SvJ)	abnormal lymphopoiesis	J:116870
	abnormal monocyte morphology	J:116870
	abnormal neutrophil morphology	J:116870
	abnormal T cell differentiation	J:116870
	decreased double-negative T cell number	J:116870
	decreased lymphocyte cell number	J:116870
	decreased neutrophil cell number	J:116870
	decreased thymocyte number	J:116870
Gfi1^{tm5.1(GFI1)Tmo}/Gfi1⁺ (involves: 129S1/Sv 129X1/SvJ * C57BL/6)	abnormal definitive hematopoiesis	J:192927
Gfi1^{tm5.1(GFI1)Tmo}/Gfi1⁺ Kras^tm4Tyj/Kras⁺ Tg(Mx1-cre)1Cgn/0 (involves: 129S1/Sv 129S4/SvJae * 129X1/SvJ * C57BL/6 * CBA)	myeloid hyperplasia	J:192927
Gfi1^{tm5.1(GFI1)Tmo}/Gfi1^{tm5.1(GFI1)Tmo} (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal definitive hematopoiesis	J:192927
	hematopoietic system phenotype	J:192927
	increased monocyte cell number	J:192927
Gfi1^{tm5.1(GFI1)Tmo}/Gfi1^{tm5.1(GFI1)Tmo} Kras^tm4Tyj/Kras⁺ Tg(Mx1-cre)1Cgn/0 (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * CBA)	myeloid hyperplasia	J:192927
Gfi1^{tm6.1(GFI1)Tmo}/Gfi1^{tm6.1(GFI1)Tmo} (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	hematopoietic system phenotype	J:192927
Gfi1^{tm6.1(GFI1)Tmo}/Gfi1^{tm6.1(GFI1)Tmo} Kras^tm4Tyj/Kras⁺ Tg(Mx1-cre)1Cgn/0 (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * CBA)	myeloid hyperplasia	J:192927
Gfi1b^tm1.1Haho/Gfi1b^tm1.1Haho Tg(Mx1-cre)1Cgn/0 (involves: 129S4/SvJaeSor * C57BL/6)	abnormal bone marrow cell morphology/development	J:207446
	abnormal megakaryocyte differentiation	J:207446
	abnormal megakaryocyte progenitor cell morphology	J:207446
	absent erythroid progenitor cell	J:207446
	absent platelets	J:207446
	anemia	J:207446
	decreased hemoglobin content	J:207446
	thrombocytopenia	J:207446
Gfi1b^{tm1b(EUCOMM)Hmgu}/Gfi1b⁺ (C57BL/6N-Gfi1b^{tm1b(EUCOMM)Hmgu}/H)	decreased neutrophil cell number	J:211773
	increased lymphocyte cell number	J:211773
Gfi1b^tm1Sho/Gfi1b^tm1Sho (involves: 129S1/Sv)	abnormal embryonic erythrocyte morphology	J:74523
	abnormal embryonic erythropoiesis	J:74523
	abnormal erythropoiesis	J:74523
	abnormal megakaryocyte differentiation	J:74523
	absent erythrocytes	J:74523
Gfi1b^tm1Tmo/Gfi1b^tm1Tmo (B6.129-Gfi1b^tm1Tmo)	abnormal erythropoiesis	J:141749
Gfi1b^tm2Tmo/Gfi1b^tm2Tmo Tg(Mx1-cre)1Cgn/? (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	abnormal blood cell morphology/development	J:167416
	abnormal hematopoietic stem cell physiology	J:167416
	decreased erythrocyte cell number	J:167416
	hematopoietic system phenotype	J:167416
	increased hematopoietic stem cell number	J:167416
	increased splenocyte number	J:167416
	thrombocytopenia	J:167416
Gfpt2^{tm1b(EUCOMM)Wtsi}/Gfpt2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Gfpt2^{tm1b(EUCOMM)Wtsi}/Ieg)	increased red blood cell distribution width	J:211773
Gfus^tm1Jbl/Gfus^tm1Jbl (involves: 129S2/SvPas * C57BL/6J)	abnormal common myeloid progenitor cell morphology	J:82239
	abnormal definitive hematopoiesis	J:82239
	increased leukocyte cell number	J:82239
	increased neutrophil cell number	J:82239
Ggct^tm1.2Smoc/Ggct^tm1.2Smoc (involves: C57BL/6J)	abnormal erythrocyte morphology	J:322242
	anemia	J:322242
	decreased erythrocyte cell number	J:322242
	decreased hematocrit	J:322242
	decreased hemoglobin content	J:322242
	enlarged spleen	J:322242
	increased erythroid progenitor cell number	J:322242
	increased spleen red pulp amount	J:322242
	reticulocytosis	J:322242
Ggcx^tm1Sinos/Ggcx^tm1Sinos Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (B6.Cg-Ggcx^tm1Sinos Speer6-ps1^{Tg(Alb-cre)21Mgn})	anemia	J:212951
ggld/ggld (MRL/MpJ-Fas^lpr/J-ggld)	decreased IgG1 level	J:14258
Ggps1^{tm1b(EUCOMM)Wtsi}/Ggps1⁺ (C57BL/6N-Ggps1^{tm1b(EUCOMM)Wtsi}/Ieg)	increased leukocyte cell number	J:211773
Ggt1^dwg/Ggt1^dwg ((STOCK Pou1f1^dw x T(8;16)17H)F1)	decreased spleen red pulp amount	J:14281
Ggt1^dwg/Ggt1^dwg ((STOCK Pou1f1^dw x T(8;16)17H)F1)	increased osteoclast cell number	J:14281
Ggta1^tm1Jbl/Ggta1⁺ Igh^tm1Jiac/Igh⁺ Igk^tm1Jiac/Igk^tm1Jiac (involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)	decreased mature B cell number	J:133032
Ggta1^tm1Jbl/Ggta1⁺ Igh^tm1Jiac/Igh^tm1Jiac Igk^tm1Jiac/Igk⁺ (involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)	decreased mature B cell number	J:133032
Ggta1^tm1Jbl/Ggta1⁺ Igh^tm1Jiac/Igh^tm1Jiac Igk^tm1Jiac/Igk^tm1Jiac (involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)	abnormal B cell physiology	J:133032
	abnormal B cell selection	J:133032
	decreased mature B cell number	J:133032
Ggta1^tm1Jbl/Ggta1^tm1Jbl (involves: 129S2/SvPas)	abnormal immunoglobulin level	J:113488
	decreased IgG level	J:90851
	increased IgM level	J:90851
Gh^{tm1.1(KOMP)Vlcg}/Gh^{tm1.1(KOMP)Vlcg} (C57BL/6N-Gh^{tm1.1(KOMP)Vlcg}/Ucd)	abnormal spleen morphology	J:211773
	decreased spleen weight	J:211773
	decreased thymus weight	J:211773
	small spleen	J:211773
	thrombocytopenia	J:211773
Ghr^tm1Arge/Ghr^tm1Arge (involves: 129S/SvEv * C57BL/6J)	small spleen	J:66913
Ghr^{tm1c(KOMP)Wtsi}/Ghr^{tm1c(KOMP)Wtsi} Tg(Fabp4-cre)1Rev/0 (involves: C57BL/6N)	decreased spleen weight	J:206358
Ghr^tm1Jjk/Ghr^tm1Jjk (involves: 129P2/OlaHsd * BALB/c)	decreased spleen weight	J:60207
Ghr^tm2Mwat/Ghr^tm2Mwat (involves: 129X1/SvJ * C57BL)	small spleen	J:95149
Ghrhr^{tm1.1(KOMP)Vlcg}/Ghrhr^{tm1.1(KOMP)Vlcg} (C57BL/6N-Ghrhr^{tm1.1(KOMP)Vlcg}/J)	decreased mean corpuscular hemoglobin	J:211773
	thrombocytopenia	J:211773
Gigyf2^{tm1b(EUCOMM)Wtsi}/Gigyf2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Gigyf2^{tm1b(EUCOMM)Wtsi}/Bay)	decreased eosinophil cell number	J:211773
	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	increased red blood cell distribution width	J:211773
	increased spleen weight	J:211773
Gimap1^m1Btlr/Gimap1^m1Btlr (C57BL/6J-Gimap1^m1Btlr)	decreased B cell number	J:267546
	decreased B-1 B cell number	J:267546
	decreased CD8-positive, alpha-beta T cell number	J:267546
	decreased IgD level	J:267546
	increased CD4-positive, alpha-beta T cell number	J:267546
	increased IgM level	J:267546
Gimap1^tm1.1Gwb/Gimap1^tm1.1Gwb Tg(CD2-icre)4Kio/0 (involves: 129 * C57BL/6 * C57BL/10 * CBA/Ca)	abnormal CD4-positive, alpha-beta T cell physiology	J:160782
	abnormal CD8-positive, alpha-beta T cell physiology	J:160782
	decreased B cell number	J:160782
	decreased B-1a cell number	J:160782
	decreased B-1b cell number	J:160782
	decreased B-2 B cell number	J:160782
	decreased CD4-positive, alpha-beta T cell number	J:160782
	decreased CD8-positive, alpha-beta T cell number	J:160782
	decreased follicular B cell number	J:160782
	decreased lymphocyte cell number	J:160782
	decreased marginal zone B cell number	J:160782
	decreased T cell number	J:160782
	decreased thymocyte number	J:160782
	decreased transitional stage T2 B cell number	J:160782
Gimap3^tm1.1Yout/Gimap3^tm1.1Yout (involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)	decreased T cell number	J:209926
	decreased thymocyte number	J:209926
	hematopoietic system phenotype	J:209926
Gimap4^tm1Jcbs/Gimap4^tm1Jcbs (B6.129P2-Gimap4^tm1Jcbs)	abnormal T cell physiology	J:135744
Gimap5^m1Btlr/Gimap5^m1Btlr (involves: C57BL/6J)	abnormal B cell physiology	J:160090
	abnormal B cell proliferation	J:160090
	abnormal bone marrow cell morphology/development	J:160090
	abnormal common lymphocyte progenitor cell morphology	J:160090
	abnormal common myeloid progenitor cell morphology	J:160090
	abnormal NK T cell physiology	J:160090
	abnormal spleen B cell follicle morphology	J:160090
	anemia	J:160090
	decreased B cell number	J:160090
	decreased B cell proliferation	J:160090
	decreased B-1 B cell number	J:160090
	decreased CD8-positive, alpha-beta T cell number	J:160090
	decreased hemoglobin content	J:160090
	decreased IgG1 level	J:160090
	decreased IgG2a level	J:160090
	decreased IgG2b level	J:160090
	decreased IgG3 level	J:160090
	decreased IgG level	J:160090
	decreased IgM level	J:160090
	decreased lymphocyte cell number	J:160090
	decreased mature B cell number	J:160090
	decreased NK cell number	J:160090
	decreased NK T cell number	J:160090
	decreased spleen B cell follicle number	J:160090
	decreased spleen B cell follicle size	J:160090
	extramedullary hematopoiesis	J:160090
	increased granulocyte number	J:160090
	increased hematopoietic stem cell number	J:160090
	increased neutrophil cell number	J:160090
	increased red blood cell distribution width	J:160090
	thrombocytopenia	J:160090
	thymus atrophy	J:160090
Gimap5^m1Btlr/Gimap5^m1Btlr (either: (involves: BALB/cJ * C57BL/6J) or (involves: C3H/HeN * C57BL/6J) or (C57BL/6J * DBA/2J) or (involves: C57BL/6J * FVB/NJ) or (involves: C57BL/6J * NOD/ShiLtJ))	extramedullary hematopoiesis	J:160090
Gimap5^m1Btlr/Gimap5^m1Btlr Tg(TcraH-Y,TcrbH-Y)71Vbo/0 (involves: C57BL/6J * DBA/2J)	decreased CD8-positive, alpha-beta T cell number	J:160090
	decreased thymocyte number	J:160090
Gimap5^tm1Wlr/Gimap5^tm1Wlr (either: B6.129-Gimap5^tm1Wlr or C.129-Gimap5^tm1Wlr)	abnormal CD8-positive, alpha-beta T cell differentiation	J:143620
	abnormal erythrocyte cell number	J:143620
	abnormal erythrocyte morphology	J:143620
	abnormal erythropoiesis	J:143620
	abnormal hemoglobin content	J:143620
	abnormal leukocyte morphology	J:143620
	abnormal lymphocyte cell number	J:143620
	abnormal spleen morphology	J:143620
	anisocytosis	J:143620
	decreased B cell number	J:143620
	decreased CD4-positive, alpha-beta T cell number	J:143620
	decreased CD8-positive, alpha-beta T cell number	J:143620
	decreased hematocrit	J:143620
	decreased NK cell number	J:143620
	decreased NK T cell number	J:143620
	decreased T cell number	J:143620
	increased granulocyte number	J:143620
	spleen hypoplasia	J:143620
	thrombocytopenia	J:143620
Gimap5^tm1Yout/Gimap5^tm1Yout (involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)	decreased T cell number	J:209926
	hematopoietic system phenotype	J:209926
Gimap6^tm1.1Gwb/Gimap6^tm1.1Gwb Tg(CD2-icre)4Kio/0 (involves: C57BL/6 * C57BL/10 * CBA/Ca)	abnormal leukocyte morphology	J:262059
	abnormal T cell physiology	J:262059
	decreased B cell number	J:262059
	decreased T cell number	J:262059
	increased B cell number	J:262059
	increased T cell apoptosis	J:262059
Gimap6^{tm1a(KOMP)Wtsi}/Gimap6^{tm1a(KOMP)Wtsi} (C57BL/6N-Gimap6^{tm1a(KOMP)Wtsi}/Wtsi)	decreased CD4-negative NK T cell number	J:211773
	decreased memory-marker CD4-negative NK T cell number	J:211773
	increased memory-marker CD4-negative NK T cell number	J:211773
	increased monocyte cell number	J:211773
Gimap6^{tm1b(KOMP)Wtsi}/Gimap6^{tm1b(KOMP)Wtsi} (C57BL/6N-Gimap6^{tm1b(KOMP)Wtsi}/J)	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
Gimap8^{tm1.1(KOMP)Vlcg}/Gimap8^{tm1.1(KOMP)Vlcg} (C57BL/6N-Gimap8^{tm1.1(KOMP)Vlcg}/J)	decreased erythrocyte cell number	J:211773
Gin1^em1(IMPC)Mbp/Gin1^em1(IMPC)Mbp (C57BL/6N-Gin1^em1(IMPC)Mbp/MbpMmucd)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Gipc3^{tm1b(KOMP)Wtsi}/Gipc3^{tm1b(KOMP)Wtsi} (C57BL/6N-Gipc3^{tm1b(KOMP)Wtsi}/J)	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
	thrombocytopenia	J:211773
Git2^Gt(XG510)Byg/Git2^Gt(XG510)Byg (B6.129P2-Git2^Gt(XG510)Byg)	decreased marginal zone B cell number	J:160613
Git2^Gt(XG510)Byg/Git2^Gt(XG510)Byg (C.129P2-Git2^Gt(XG510)Byg)	decreased marginal zone B cell number	J:160613
Git2^Gt(XG510)Byg/Git2^Gt(XG510)Byg Tg(DO11.10)10Dlo/0 (involves: 129P2/OlaHsd * BALB/c * C3H * C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:160613
Git2^Gt(XG510)Byg/Git2^Gt(XG510)Byg Tg(TcraH-Y,TcrbH-Y)71Vbo/0 (involves: 129 * C57BL/6J * DBA/2J)	abnormal CD4-positive, alpha-beta T cell physiology	J:160613
	abnormal CD8-positive, alpha-beta T cell physiology	J:160613
	abnormal positive T cell selection	J:160613
	decreased CD8-positive, alpha-beta T cell number	J:160613
Git2^Gt(XG510)Byg/Git2^Gt(XG510)Byg Tg(TcraTcrb)425Cbn/0 (involves: 129P2/OlaHsd * C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:160613
Git2^tm1Hsb/Git2^tm1Hsb (involves: C57BL/6 * CBA)	abnormal neutrophil differentiation	J:112663
	abnormal neutrophil physiology	J:112663
	enlarged spleen	J:112663
	extramedullary hematopoiesis	J:112663
	impaired neutrophil chemotaxis	J:112663
Gja1^M1Jrt/Gja1⁺ (involves: C3H/HeJ * C57BL/6J)	abnormal bone marrow cell morphology/development	J:101733
	abnormal proerythroblast morphology	J:101733
	decreased bone marrow cell number	J:101733
Gja1^tm1.1Kwi/Gja1⁺ (involves: 129P2/OlaHsd)	abnormal neutrophil physiology	J:129091
Gja1^tm1Kwi/Gja1^{tm5(cre/ERT)Kwi} (involves: 129P2/OlaHsd)	abnormal neutrophil physiology	J:129091
Gjb1^tm1Kwi/Y Gjc2^tm1(EGFP)Kwi/Gjc2^tm1(EGFP)Kwi (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	microgliosis	J:219594
Gjb3^{tm1.1(KOMP)Vlcg}/Gjb3⁺ (C57BL/6N-Gjb3^{tm1.1(KOMP)Vlcg}/Ucd)	increased mean corpuscular volume	J:211773
Gjb4^{tm1.1(KOMP)Vlcg}/Gjb4^{tm1.1(KOMP)Vlcg} (C57BL/6N-Gjb4^{tm1.1(KOMP)Vlcg}/Ucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Gjc1^tm2.1Kni/Gjc1^tm2.1Kni (Not Specified)	impaired hematopoiesis	J:103078
Gjc1^tm2Kni/Gjc1^tm2Kni Tg(ACTC1-cre)1Miwa/0 (involves: C57BL/6 * DBA)	impaired hematopoiesis	J:103078
Gjc2^tm1(EGFP)Kwi/Gjc2^tm1(EGFP)Kwi (involves: 129P2/OlaHsd * C57BL/6)	microgliosis	J:174197
Gjc2^tm1(EGFP)Kwi/Gjc2^tm1(EGFP)Kwi Gjb1^tm1Kwi/Gjb1^tm1Kwi (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	microgliosis	J:219594
Gjc2^tm2.1Kwi/Gjc2⁺ (involves: C57BL/6 * SJL)	microgliosis	J:174197
Gjc2^tm2.1Kwi/Gjc2^tm2.1Kwi (involves: C57BL/6 * SJL)	microgliosis	J:174197
Gjd4^tm1.1Malt/Gjd4^tm1.1Malt (involves: 129S2/SvPas * C57BL/6 * SJL)	decreased macrophage cell number	J:172698
Gk5^m5Btlr/Gk5^m5Btlr (C57BL/6J-Gk5^m5Btlr)	increased alpha-beta T cell number	J:265118
	increased CD8-positive, alpha-beta memory T cell number	J:265118
	increased central memory CD8 positive, alpha-beta T cell number	J:265118
Gkn2^{tm1.1(KOMP)Vlcg}/Gkn2^{tm1.1(KOMP)Vlcg} (C57BL/6N-Gkn2^{tm1.1(KOMP)Vlcg}/Ucd)	decreased mean corpuscular volume	J:211773
Gkn2^{tm1.1(KOMP)Vlcg}/Gkn2^{tm1.1(KOMP)Vlcg} (involves: C57BL/6NTac)	abnormal T-helper 1 physiology	J:234656
	decreased myeloid cell number	J:234656
Glb1^tm1Jmat/Glb1^tm1Jmat (involves: C57BL/6 * CBA * ICR)	abnormal lymphopoiesis	J:43534
	abnormal macrophage chemotaxis	J:102576
	small spleen	J:43534
Glb1l2^tm1Lex/Glb1l2^tm1Lex (B6;129S5-Glb1l2^tm1Lex/Mmucd)	decreased leukocyte cell number	J:171883
	decreased lymphocyte cell number	J:171883
	decreased NK cell number	J:171883
Glg1^{Gt(RST092)Byg}/Glg1⁺ (B6J.129P2-Glg1^{Gt(RST092)Byg})	abnormal cellular extravasation	J:226586
	abnormal leukocyte adhesion	J:226586
	enhanced leukocyte tethering or rolling	J:226586
Glmp^{Gt(P084H04)Wrst}/Glmp^{Gt(P084H04)Wrst} (involves: 129S2/SvPas * C57BL/6)	abnormal Kupffer cell morphology	J:208774
	increased spleen weight	J:208774
Glmp^tm1Lex/Glmp^tm1Lex (B6;129S5-Glmp^tm1Lex/Mmucd)	anemia	J:171883
Glra1^nmf11/Glra1^nmf11 (C57BL/6J-Glra1^nmf11/J)	small spleen	J:78134
Glra1^nmf11/Glra1^nmf11 (C57BL/6J-Glra1^nmf11/J)	thymus atrophy	J:78134
Glra2^{tm1b(KOMP)Wtsi}/Y (C57BL/6N-Glra2^{tm1b(KOMP)Wtsi}/H)	decreased mean corpuscular volume	J:211773
	decreased monocyte cell number	J:211773
	decreased neutrophil cell number	J:211773
	decreased red blood cell distribution width	J:211773
	increased lymphocyte cell number	J:211773
Glrb^em1(IMPC)Tcp/Glrb⁺ (C57BL/6NCrl-Glrb^em1(IMPC)Tcp/Tcp)	increased neutrophil cell number	J:211773
Glrb^em1(IMPC)Tcp/Glrb⁺ (C57BL/6NCrl-Glrb^em1(IMPC)Tcp/Tcp)	increased spleen weight	J:211773
Gls2^em1(IMPC)Tcp/Gls2^em1(IMPC)Tcp (C57BL/6N-Gls2^em1(IMPC)Tcp/Tcp)	enlarged spleen	J:211773
	thrombocytosis	J:211773
Glt8d2^tm1Lex/Glt8d2^tm1Lex (B6;129S5-Glt8d2^tm1Lex/Mmucd)	decreased IgG1 level	J:171883
Glt8d2^tm1Lex/Glt8d2^tm1Lex (B6;129S5-Glt8d2^tm1Lex/Mmucd)	decreased IgG2a level	J:171883
Glyr1^em1(IMPC)Tcp/Glyr1⁺ (C57BL/6N-Glyr1^em1(IMPC)Tcp/Tcp)	decreased mean corpuscular hemoglobin concentration	J:211773
Gm572^b2b1167Clo/Gm572^b2b1167Clo (C57BL/6J-Gm572^b2b1167Clo)	spleen hypoplasia	J:175213
Gm614^tm1.1Cya/Gm614^tm1.1Cya Ighg1^tm1(cre)Cgn/Ighg1⁺ (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N)	increased B cell apoptosis	J:307345
Gm4922^em1(IMPC)Tcp/Gm4922^em1(IMPC)Tcp (C57BL/6NCrl-Gm4922^em1(IMPC)Tcp/Tcp)	increased mean corpuscular volume	J:211773
Gm5127^em1(IMPC)J/Y (C57BL/6NJ-Gm5127^em1(IMPC)J/Mmjax)	increased erythrocyte cell number	J:211773
Gm5127^em1(IMPC)J/Y (C57BL/6NJ-Gm5127^em1(IMPC)J/Mmjax)	increased hematocrit	J:211773
Gm5544^{tm1a(KOMP)Wtsi}/Gm5544⁺ (C57BL/6N-Gm5544^{tm1a(KOMP)Wtsi}/Wtsi)	decreased marginal zone B cell number	J:211773
Gm7694^em1(IMPC)J/Gm7694^em1(IMPC)J (C57BL/6NJ-Gm7694^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Gm10800^em1(IMPC)Mbp/Gm10800^em1(IMPC)Mbp (C57BL/6N-Gm10800^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Gm16685^em1Osb/Gm16685^em1Osb (C57BL/6N-Gm16685^em1Osb)	hematopoietic system phenotype	J:303079
Gm26330^em1Liuq/Gm26330^em1Liuq (C57BL/6-Gm26330^em1Liuq)	decreased NK cell number	J:341056
Gm28729^em1(IMPC)J/Gm28729^em1(IMPC)J (C57BL/6NJ-Gm28729^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Gm36723^em1Flv/Gm36723^em1Flv (C57BL/6-Gm36723^em1Flv)	abnormal lymphopoiesis	J:258967
	abnormal NK cell physiology	J:258967
	decreased lymphocyte cell number	J:258967
	decreased mature NK cell number	J:258967
	decreased NK cell number	J:258967
	impaired natural killer cell mediated cytotoxicity	J:258967
	increased immature NK cell number	J:258967
Gm36723^em3Flv/Gm36723^em3Flv (C57BL/6-Gm36723^em3Flv)	decreased mature NK cell number	J:258967
Gm40600^em1Cya/Gm40600^em1Cya (C57BL/6-Gm40600^em1Cya)	abnormal plasmablast number	J:311878
	decreased B cell number	J:311878
	decreased IgA level	J:311878
	decreased IgE level	J:311878
	decreased IgG1 level	J:311878
	decreased IgG2b level	J:311878
	decreased IgG2c level	J:311878
	decreased IgG3 level	J:311878
	decreased IgG level	J:311878
	decreased IgM level	J:311878
	decreased plasma cell number	J:311878
	increased B cell number	J:311878
	increased IgA level	J:311878
	increased IgE level	J:311878
	increased IgG1 level	J:311878
	increased IgG2b level	J:311878
	increased IgG2c level	J:311878
	increased IgG3 level	J:311878
	increased IgG level	J:311878
	increased IgM level	J:311878
	increased plasma cell number	J:311878
Gmds^{tm1a(KOMP)Wtsi}/Gmds^{tm1a(KOMP)Wtsi} (C57BL/6N-Gmds^{tm1a(KOMP)Wtsi}/Wtsi)	decreased alpha-beta T cell number	J:211773
	decreased CD4-positive NK T cell number	J:211773
	decreased CD4-positive, alpha-beta T cell number	J:211773
	decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	decreased CD8-positive, alpha-beta T cell number	J:211773
	decreased CD8-positive, naive alpha-beta T cell number	J:211773
	decreased dendritic cell number	J:211773
	decreased effector memory CD8-positive, alpha-beta T cell number	J:211773
	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	decreased KLRG1+ CD8 alpha-beta T cell number	J:211773
	decreased KLRG1-positive NK cell number	J:211773
	decreased Ly6C-positive mature NK cell number	J:211773
	decreased macrophage cell number	J:211773
	decreased mature NK cell number	J:211773
	decreased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	decreased memory-marker CD4-negative NK T cell number	J:211773
	decreased memory-marker CD4-positive NK T cell number	J:211773
	decreased NK cell number	J:211773
	decreased plasmacytoid dendritic cell number	J:211773
	decreased regulatory T cell number	J:211773
	decreased T-helper cell number	J:211773
	decreased transitional stage T2 B cell number	J:211773
	increased CD4-negative NK T cell number	J:211773
	increased CD4-positive, alpha-beta T cell number	J:211773
	increased CD8-positive, alpha-beta T cell number	J:211773
	increased gamma-delta T cell number	J:211773
	increased granulocyte number	J:211773
	increased immature NK cell number	J:211773
	increased leukocyte cell number	J:211773
	increased Ly6C-positive NK T cell number	J:211773
	increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	increased memory-marker NK cell number	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
	increased NK T cell number	J:211773
Gmnn^tm1.1Kio/Gmnn^tm1.2Kio Tg(CD2-icre)4Kio/0 (involves: 129S4/SvJae * C57BL/10 * CBA/Ca)	decreased CD4-positive, alpha-beta T cell number	J:159657
	decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:159657
	decreased CD8-positive, alpha-beta T cell number	J:159657
	decreased DN1 thymic pro-T cell number	J:159657
	decreased DN4 thymocyte number	J:159657
	decreased double-positive T cell number	J:159657
	decreased memory T cell number	J:159657
	decreased T cell proliferation	J:159657
	decreased thymocyte number	J:159657
Gmnn^tm1Tjm/Gmnn^tm1Tjm Tg(Mx1-cre)1Cgn/0 (involves: 129/Sv * C57BL/6 * C57BL/6J * CBA)	abnormal bone marrow cell morphology/development	J:171741
	abnormal bone marrow cell physiology	J:171741
	abnormal common lymphocyte progenitor cell morphology	J:171741
	abnormal common myeloid progenitor cell morphology	J:171741
	abnormal megakaryocyte progenitor cell morphology	J:171741
	abnormal proerythroblast morphology	J:171741
	abnormal spleen red pulp morphology	J:171741
	absent erythroid progenitor cell	J:171741
	anemia	J:171741
	decreased bone marrow cell number	J:171741
	decreased erythrocyte cell number	J:171741
	decreased erythroid progenitor cell number	J:171741
	decreased granulocyte number	J:171741
	decreased hematopoietic stem cell proliferation	J:171741
	decreased leukocyte cell number	J:171741
	decreased neutrophil cell number	J:171741
	increased hematopoietic stem cell number	J:171741
	increased megakaryocyte cell number	J:171741
	reticulocytopenia	J:171741
	thrombocytosis	J:171741
Gmps^em1(IMPC)Tcp/Gmps⁺ (C57BL/6NCrl-Gmps^em1(IMPC)Tcp/Tcp)	increased leukocyte cell number	J:211773
Gmps^em1(IMPC)Tcp/Gmps⁺ (C57BL/6NCrl-Gmps^em1(IMPC)Tcp/Tcp)	increased lymphocyte cell number	J:211773
Gna11^{tm1a(EUCOMM)Wtsi}/Gna11^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Gna11^{tm1a(EUCOMM)Wtsi}/Cnrm)	decreased hemoglobin content	J:165965
Gna11^{tm1b(EUCOMM)Wtsi}/Gna11^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Gna11^{tm1b(EUCOMM)Wtsi}/H)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	decreased mean corpuscular volume	J:211773
	increased red blood cell distribution width	J:211773
	thrombocytopenia	J:211773
Gna12^tm1.1Cgh/Gna12^tm1.1Cgh Gna13^tm2Cgh/Gna13^tm2Cgh Tg(Mx1-cre)1Cgn/0 (involves: 129S4/SvJae * C57BL/6 * CBA)	abnormal germinal center B cell morphology	J:174313
	decreased B cell apoptosis	J:174313
	increased germinal center B cell number	J:174313
Gna12^tm1Citb/Gna12^tm1Citb Gna13^tm2.1Soff/Gna13^tm2.1Soff Tg(Lck-cre)548Jxm/0 (involves: 129S1/Sv * C57BL/6 * CBA)	abnormal CD4-positive, alpha-beta T cell physiology	J:149560
	increased CD4-positive, alpha-beta T cell number	J:149560
	increased CD8-positive, alpha-beta T cell number	J:149560
	increased T cell proliferation	J:149560
	thymus hyperplasia	J:149560
Gna12^tm1Citb/Gna12^tm1Citb Gna13^tm2.1Soff/Gna13^tm2.1Soff Tg(Mx1-cre)1Cgn/0 (involves: 129S1/Sv * C57BL/6 * CBA * FVB/N)	abnormal platelet physiology	J:99597
	decreased platelet aggregation	J:99597
Gna13^tm2.1Soff/Gna13^tm2.1Soff Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA * FVB/N)	abnormal platelet physiology	J:99597
Gna13^tm2.2Soff/Gna13^tm2.2Soff Tg(EIIa-cre)C5379Lmgd/? (involves: FVB)	abnormal platelet physiology	J:99597
Gna15^em1(IMPC)Mbp/Gna15^em1(IMPC)Mbp (C57BL/6N-Gna15^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Gnai1^{tm1b(EUCOMM)Wtsi}/Gnai1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Gnai1^{tm1b(EUCOMM)Wtsi}/Bay)	abnormal spleen morphology	J:211773
Gnai2^tm1Lbi/Gnai2^tm1Lbi (involves: 129S7/SvEvBrd)	abnormal neutrophil physiology	J:121471
	increased granulocyte number	J:30507
	increased IgA level	J:30507
	increased IgG level	J:30507
	increased immunoglobulin level	J:30507
	increased single-positive T cell number	J:30507
	increased T cell number	J:30507
	increased T cell proliferation	J:30507
Gnai2^tm1Lbi/Gnai2^tm1Lbi (either: 129 or (involves: 129S7/SvEvBrd * C57BL/6J))	increased granulocyte number	J:24434
	increased IgG level	J:24434
	increased IgM level	J:24434
	increased thymocyte number	J:24434
Gnai2^tm1Lbi/Gnai2^tm1Lbi (B6.129S7-Gnai2^tm1Lbi)	abnormal cellular extravasation	J:120069
	abnormal eosinophil physiology	J:120069
	abnormal leukocyte adhesion	J:120069
	abnormal leukocyte cell number	J:121161
	abnormal T cell physiology	J:121161
	decreased eosinophil cell number	J:120069
	increased eosinophil cell number	J:120069
	increased lymphocyte cell number	J:120069
	increased monocyte cell number	J:120069
	increased neutrophil cell number	J:120069
Gnai2^tm2.1Lbi/Gnai2^tm2.1Lbi Tg(Cd4-cre)1Cwi/0 (involves: 129S/SvEv * C57BL/6 * C57BL/6NTac * DBA)	decreased T-helper 17 cell number	J:194587
Gnai3^tm1Lbi/Gnai3^tm1Lbi (B6.129S-Gnai3^tm1Lbi)	abnormal T cell physiology	J:121161
Gnao1^{tm1b(EUCOMM)Hmgu}/Gnao1⁺ (C57BL/6N-Gnao1^{tm1b(EUCOMM)Hmgu}/H)	decreased eosinophil cell number	J:211773
	decreased erythrocyte cell number	J:211773
	decreased red blood cell distribution width	J:211773
	increased mean corpuscular hemoglobin	J:211773
Gnaq^tm1Soff/Gnaq^tm1Soff (involves: 129S1/Sv * C57BL/6)	abnormal platelet physiology	J:118488, J:42882
Gnaq^tm1Soff/Gnaq^tm1Soff (involves: 129S1/Sv)	decreased platelet aggregation	J:114266
Gnas^tm1Lsw/Gnas⁺ (involves: 129S4/SvJae * CD-1)	thymus cortex atrophy	J:49340
Gnaz^tm1Lfb/Gnaz^tm1Lfb (involves: 129/Sv * C57BL/6 * C57BL/6J * SJL)	decreased platelet aggregation	J:77282
Gnb1l^em1(IMPC)Tcp/Gnb1l⁺ (C57BL/6NCrl-Gnb1l^em1(IMPC)Tcp/Tcp)	increased erythrocyte cell number	J:211773
	increased hemoglobin content	J:211773
Gnb1l^{Gt(OST35527)Lex}/Gnb1l⁺ (B6;129S5-Gnb1l^{Gt(OST35527)Lex}/Orl)	abnormal spleen B cell follicle morphology	J:82809
Gnb2^em1(IMPC)J/Gnb2^em1(IMPC)J (C57BL/6NJ-Gnb2^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
	increased mean corpuscular hemoglobin	J:211773
Gnb4^em1(IMPC)H/Gnb4^em1(IMPC)H (C57BL/6NTac-Gnb4^em1(IMPC)H/H)	enlarged spleen	J:211773
Gngt2^em1(IMPC)Bay/Gngt2^em1(IMPC)Bay (C57BL/6N-Gngt2^em1(IMPC)Bay/BayMmucd)	increased spleen weight	J:211773
Gnl1^em1(IMPC)Tcp/Gnl1^em1(IMPC)Tcp (C57BL/6N-Gnl1^em1(IMPC)Tcp/Tcp)	decreased erythrocyte cell number	J:211773
	decreased hemoglobin content	J:211773
	decreased mean corpuscular hemoglobin concentration	J:211773
	increased mean platelet volume	J:211773
	thrombocytopenia	J:211773
Gnmt^tm1Ymac/Gnmt^tm1Ymac (involves: 129 * C57BL/6)	decreased leukocyte cell number	J:147857
	decreased monocyte cell number	J:147857
	decreased neutrophil cell number	J:147857
Gnpda1^{tm1b(KOMP)Mbp}/Gnpda1⁺ (C57BL/6N-Gnpda1^{tm1b(KOMP)Mbp}/Tcp)	increased neutrophil cell number	J:211773
Gnpda2^{tm1.1(KOMP)Vlcg}/Gnpda2^{tm1.1(KOMP)Vlcg} (C57BL/6N-Gnpda2^{tm1.1(KOMP)Vlcg}/Ucd)	increased mean corpuscular volume	J:211773
Gnptab^em1(IMPC)Mbp/Gnptab⁺ (C57BL/6N-Gnptab^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Gnptab^tm1Kkol/Gnptab^tm1Kkol (involves: 129 * C57BL/6)	abnormal osteoclast physiology	J:202751
Gnptab^tm1Kkol/Gnptab^tm1Kkol (involves: 129 * C57BL/6)	increased osteoclast cell number	J:202751
Gnptg^em1(IMPC)Mbp/Gnptg^em1(IMPC)Mbp (C57BL/6N-Gnptg^em1(IMPC)Mbp/MbpMmucd)	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular hemoglobin concentration	J:211773
	increased red blood cell distribution width	J:211773
Gnrh1^hpg/Gnrh1^hpg (HPG/BmJ)	abnormal splenic cell ratio	J:19436
	increased B cell number	J:19436
	increased bone marrow cell number	J:19436
	increased immature B cell number	J:19436
	increased mature B cell number	J:19436
Gns^{tm1e(EUCOMM)Hmgu}/Gns^{tm1e(EUCOMM)Hmgu} (C57BL/6N-A^tm1Brd Gns^{tm1e(EUCOMM)Hmgu})	microgliosis	J:242250
Golga2^{tm1(KOMP)Vlcg}/Golga2^{tm1(KOMP)Vlcg} (involves: C57BL/6NTac)	increased alveolar macrophage number	J:270564
Golga3^{tm1b(EUCOMM)Hmgu}/Golga3^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Golga3^{tm1b(EUCOMM)Hmgu}/H)	decreased hemoglobin content	J:211773
Golga5^{tm1b(KOMP)Wtsi}/Golga5^{tm1b(KOMP)Wtsi} (C57BL/6N-Golga5^{tm1b(KOMP)Wtsi}/J)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
Golph3^em1(IMPC)Tcp/Golph3^em1(IMPC)Tcp (C57BL/6NCrl-Golph3^em1(IMPC)Tcp/Tcp)	abnormal spleen morphology	J:211773
	enlarged thymus	J:211773
	increased mean platelet volume	J:211773
Golt1a^{tm1b(KOMP)Wtsi}/Golt1a^{tm1b(KOMP)Wtsi} (C57BL/6N-Golt1a^{tm1b(KOMP)Wtsi}/Wtsi)	increased mean corpuscular hemoglobin	J:211773
	thrombocytopenia	J:211773
Golt1b^{tm1b(EUCOMM)Wtsi}/Golt1b^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Golt1b^{tm1b(EUCOMM)Wtsi}/Ieg)	enlarged spleen	J:211773
	enlarged thymus	J:211773
	increased mean corpuscular hemoglobin	J:211773
Gon4l^justy/Gon4l^justy (C3HeB/FeJ-Gon4l^justy)	abnormal bone marrow cell morphology/development	J:163412
	absent B cells	J:163412
	arrested B cell differentiation	J:163412
	decreased B cell number	J:163412
	decreased immature B cell number	J:163412
	decreased immunoglobulin level	J:163412
	decreased pro-B cell number	J:163412
	decreased spleen white pulp amount	J:163412
	decreased T cell number	J:163412
	small spleen	J:163412
	spleen hypoplasia	J:163412
Got1^{tm1b(EUCOMM)Hmgu}/Got1⁺ (C57BL/6N-Got1^{tm1b(EUCOMM)Hmgu}/H)	decreased basophil cell number	J:211773
	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
Got2^em1(IMPC)Mbp/Got2⁺ (C57BL/6N-Got2^em1(IMPC)Mbp/MbpMmucd)	small spleen	J:211773
Gp1ba^Plt17/Gp1ba⁺ (involves: BALB/c)	thrombocytopenia	J:149205
Gp1ba^tm1Ware/Gp1ba^tm1Ware (involves: 129S1/Sv * 129X1/SvJ)	abnormal megakaryocyte differentiation	J:63389
	giant platelets	J:63389
	thrombocytopenia	J:63389
Gp1bb^{tm1.1(KOMP)Vlcg}/Gp1bb^{tm1.1(KOMP)Vlcg} (C57BL/6N-Gp1bb^{tm1.1(KOMP)Vlcg}/Ucd)	increased mean corpuscular volume	J:211773
	increased mean platelet volume	J:211773
	thrombocytopenia	J:211773
Gp1bb^tm1Frla/Gp1bb^tm1Frla (involves: 129S2/SvPas * C57BL/6)	abnormal platelet morphology	J:135065
	thrombocytopenia	J:135065
Gp1bb^tm1Ware/Gp1bb⁺ (Not Specified)	increased mean platelet volume	J:93756
Gp1bb^tm1Ware/Gp1bb⁺ (Not Specified)	thrombocytopenia	J:93756
Gp1bb^tm1Ware/Gp1bb^tm1Ware (Not Specified)	increased mean platelet volume	J:93756
Gp1bb^tm1Ware/Gp1bb^tm1Ware (Not Specified)	thrombocytopenia	J:93756
Gp1bb^tm2Frla/Gp1bb^tm2Frla (involves: 129S2/SvPas * C57BL/6)	abnormal platelet morphology	J:135065
	thrombocytopenia	J:135065
Gp2^em1(IMPC)Mbp/Gp2^em1(IMPC)Mbp (C57BL/6N-Gp2^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	thrombocytopenia	J:211773
Gp6^{tm1.1(GP6)Ics}/Gp6^{tm1.1(GP6)Ics} (involves: 129S2/SvPas)	hematopoietic system phenotype	J:199351
Gp6^tm1Beni/Gp6^tm1Beni Clec1b^tm1.1Arte/Clec1b^tm1.1Arte Tg(Pf4-icre)Q3Rsko/0 (involves: 129 * C57BL/6)	abnormal platelet cell number	J:217963
Gp6^tm1Ware/Gp6^tm1Ware (involves: Black Swiss)	abnormal definitive hematopoiesis	J:85315
	abnormal platelet activation	J:85315
	decreased platelet aggregation	J:85315
Gp6^{tm2b(EUCOMM)Hmgu}/Gp6^{tm2b(EUCOMM)Hmgu} (C57BL/6N-Gp6^{tm2b(EUCOMM)Hmgu}/Orl)	increased lymphocyte cell number	J:211773
Gp9^{tm1.1(KOMP)Vlcg}/Gp9^{tm1.1(KOMP)Vlcg} (C57BL/6N-Gp9^{tm1.1(KOMP)Vlcg}/Ucd)	increased basophil cell number	J:211773
	increased mean platelet volume	J:211773
Gpa33^tm1Jkhh/Gpa33^tm1Jkhh (B6.129-Gpa33^tm1Jkhh)	increased dendritic cell number	J:224768
Gpalpp1^{em1(IMPC)Hmgu}/Gpalpp1^{em1(IMPC)Hmgu} (C57BL/6NCrl-Gpalpp1^{em1(IMPC)Hmgu}/Ieg)	increased erythrocyte cell number	J:211773
	increased hematocrit	J:211773
	increased hemoglobin content	J:211773
Gpatch2^em1Boui/Gpatch2^em1Boui (C57BL/6-Gpatch2^em1Boui)	decreased B cell number	J:336774
Gpatch3^em1(IMPC)Mbp/Gpatch3^em1(IMPC)Mbp (C57BL/6N-Gpatch3^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	small spleen	J:211773
Gpc1^em1(IMPC)Mbp/Gpc1^em1(IMPC)Mbp (C57BL/6N-Gpc1^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased red blood cell distribution width	J:211773
Gpc1^{Gt(GST062)Byg}/Gpc1^{Gt(GST062)Byg} (involves: 129P2/OlaHsd)	hematopoietic system phenotype	J:195867
Gpc3^tm1Arge/Y (either: (involves: 129S/SvEv * 129S1/Sv) or (involves: 129S1/Sv * C57BL/6J))	decreased spleen weight	J:75054
	increased spleen B cell follicle size	J:75054
	small spleen	J:75054
Gpc3^tm1Fil/? (involves: 129 * C57BL/6)	abnormal bone marrow cell morphology/development	J:195867
	abnormal hematopoietic stem cell physiology	J:195867
	decreased hematopoietic stem cell number	J:195867
Gpc3^tm1Snd/Y (involves: 129X1/SvJ * C57BL/6)	abnormal osteoclast differentiation	J:104555
Gpc4^tm1Lex/Y (involves: 129S5/SvEvBrd * C57BL/6J)	anemia	J:94077
Gpc4^{tm2b(EUCOMM)Wtsi}/Y (C57BL/6N-Gpc4^{tm2b(EUCOMM)Wtsi}/J)	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
Gper1^tm1Dgen/Gper1^tm1Dgen (B6.129-Gper1^tm1Dgen)	decreased CD4-positive, alpha-beta T cell number	J:151816
	decreased CD8-positive, alpha-beta T cell number	J:151816
	decreased T cell number	J:151816
Gpi1^b-m1Neu/Gpi1^b-m1Neu (C3.Cg-Gpi1^b-m1Neu)	abnormal erythrocyte morphology	J:35956
	abnormal erythrocyte physiology	J:35956
	decreased erythrocyte cell number	J:35956
	decreased erythrocyte osmotic fragility	J:35956
	decreased hematocrit	J:35956
	decreased mean corpuscular hemoglobin	J:35956
	decreased mean corpuscular hemoglobin concentration	J:35956
	increased mean corpuscular volume	J:35956
	increased spleen weight	J:35956
	reticulocytosis	J:35956
Gpi1^b-m2Neu/Gpi1^b-m2Neu (C3.Cg-Gpi1^b-m2Neu)	abnormal erythrocyte morphology	J:35956
	abnormal erythrocyte physiology	J:35956
	decreased erythrocyte cell number	J:35956
	decreased erythrocyte osmotic fragility	J:35956
	decreased hematocrit	J:35956
	decreased mean corpuscular hemoglobin	J:35956
	decreased mean corpuscular hemoglobin concentration	J:35956
	increased mean corpuscular volume	J:35956
	increased spleen weight	J:35956
	reticulocytosis	J:35956
Gpld1^{tm1.1(KOMP)Vlcg}/Gpld1^{tm1.1(KOMP)Vlcg} (C57BL/6N-Gpld1^{tm1.1(KOMP)Vlcg}/Ucd)	increased spleen weight	J:211773
Gpm6b^tm1Kan Plp1^tm1Kan/Y (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	microgliosis	J:193310
Gpnmb^{tm1.1(KOMP)Vlcg}/Gpnmb^{tm1.1(KOMP)Vlcg} (C57BL/6N-Gpnmb^{tm1.1(KOMP)Vlcg}/Ucd)	increased hemoglobin content	J:211773
Gpr15^em1(IMPC)J/Gpr15^em1(IMPC)J (C57BL/6NJ-Gpr15^em1(IMPC)J/J)	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular hemoglobin concentration	J:211773
Gpr15^tm1.1Litt/Gpr15^tm1.1Litt (B6.129P2-Gpr15^tm1.1Litt)	abnormal bone marrow cell physiology	J:199126
	abnormal regulatory T cell physiology	J:199126
	decreased CD4-positive, alpha-beta T cell number	J:199126
	decreased double-negative T cell number	J:199126
	decreased regulatory T cell number	J:199126
	increased CD8-positive, alpha-beta T cell number	J:199126
Gpr15^tm1.1Litt/Gpr15^tm1.1Litt (involves: 129P2/OlaHsd * C57BL/6)	decreased regulatory T cell number	J:199126
Gpr15lg^tm1Lex/Gpr15lg^tm1Lex (B6;129S5-Gpr15lg^tm1Lex/Mmucd)	increased IgG2a level	J:171883
Gpr17^{tm1b(KOMP)Mbp}/Gpr17^{tm1b(KOMP)Mbp} (C57BL/6N-Gpr17^{tm1b(KOMP)Mbp}/Tcp)	increased mean platelet volume	J:211773
	increased neutrophil cell number	J:211773
Gpr18^tm1.1Cys/Gpr18^tm1.1Cys (involves: C57BL/6)	decreased CD8-positive, alpha-beta T cell number	J:219661
Gpr18^tm1.1Cys/Gpr18^tm1.1Cys (involves: C57BL/6)	decreased CD8-positive, gamma-delta intraepithelial T cell number	J:219661
Gpr22^{tm1b(KOMP)Wtsi}/Gpr22^{tm1b(KOMP)Wtsi} (C57BL/6N-Gpr22^{tm1b(KOMP)Wtsi}/H)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
Gpr34^tm1.1Shbg/Gpr34^tm1.1Shbg (B6.Cg-Gpr34^tm1.1Shbg)	abnormal leukocyte migration	J:168120
Gpr55^tm1.1Mijr/Gpr55^tm1.1Mijr (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal osteoclast differentiation	J:153225
	abnormal osteoclast morphology	J:153225
	abnormal osteoclast physiology	J:153225
	decreased osteoclast cell number	J:153225
	increased osteoclast cell number	J:153225
Gpr65^tm1Witt/Gpr65^tm1Witt (B6.Cg-Gpr65^tm1Witt)	abnormal leukocyte physiology	J:96112
Gpr65^tm1Witt/Gpr65^tm1Witt (C.Cg-Gpr65^tm1Witt)	abnormal leukocyte physiology	J:96112
Gpr65^{Tn(sb-lacZ,GFP)T1.88Jtak}/Gpr65^{Tn(sb-lacZ,GFP)T1.88Jtak} (B6.Cg-Gpr65^{Tn(sb-lacZ,GFP)T1.88Jtak})	abnormal macrophage physiology	J:146233
Gpr68^tm1.1Yaxu/Gpr68^tm1.1Yaxu (B6.Cg-Gpr68^tm1.1Yaxu)	abnormal osteoclast differentiation	J:149315
Gpr68^tm1.1Yaxu/Gpr68^tm1.1Yaxu (B6.Cg-Gpr68^tm1.1Yaxu)	abnormal osteoclast physiology	J:149315
Gpr68^tm1.1Yaxu/Gpr68^tm1.1Yaxu (involves: 129S4/SvJae * C57BL/6 * FVB/N)	abnormal macrophage physiology	J:149315
	abnormal osteoclast differentiation	J:149315
	abnormal osteoclast physiology	J:149315
	decreased macrophage cell number	J:149315
	increased monocyte cell number	J:149315
Gpr68^tm1Yaxu/Gpr68^tm1Yaxu (involves: C57BL/6)	abnormal macrophage physiology	J:149315
	abnormal osteoclast differentiation	J:149315
	abnormal osteoclast physiology	J:149315
	decreased monocyte cell number	J:149315
Gpr83^{em1(IMPC)Ccpcz}/Gpr83^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Gpr83^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	decreased CD4-positive NK T cell number	J:211773
	decreased memory-marker CD4-positive NK T cell number	J:211773
	decreased NK T cell number	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Gpr83^tm1.1Fpow/Gpr83^tm1.1Fpow (C.129-Gpr83^tm1.1Fpow)	decreased CD4-positive, alpha-beta T cell number	J:144445
Gpr83^tm1.1Fpow/Gpr83^tm1.1Fpow (C.129-Gpr83^tm1.1Fpow)	spleen hyperplasia	J:144445
Gpr84^tm1Lex/Gpr84^tm1Lex (involves: 129S/SvEvBrd * C57BL/6)	abnormal T-helper 2 physiology	J:186985
Gpr89^ex/Gpr89^ex (C57BL/6J-Gpr89^ex)	abnormal T cell morphology	J:287198
Gpr89^ex/Gpr89^ex (C57BL/6J-Gpr89^ex)	abnormal T cell number	J:287198
Gpr132^tm1Witt/Gpr132^tm1Witt (B6.129X1-Gpr132^tm1Witt)	impaired macrophage chemotaxis	J:96613
Gpr132^tm1Witt/Gpr132^tm1Witt (involves: 129X1/SvJ * BALB/c)	abnormal lymphocyte physiology	J:69473
	enlarged spleen	J:69473
	increased B cell proliferation	J:69473
	increased IgA level	J:69473
	increased IgG1 level	J:69473
	increased immunoglobulin level	J:69473
	increased T cell proliferation	J:69473
Gpr132^tm1Witt/Gpr132^tm1Witt Ldlr^tm1Her/Ldlr^tm1Her (B6.129-Ldlr^tm1Her Gpr132^tm1Witt)	decreased macrophage apoptosis	J:100498
Gpr142^{tm1.1(KOMP)Vlcg}/Gpr142^{tm1.1(KOMP)Vlcg} (C57BL/6N-Gpr142^{tm1.1(KOMP)Vlcg}/J)	decreased hemoglobin content	J:211773
Gpr146^em1(IMPC)H/Gpr146^em1(IMPC)H (C57BL/6NTac-Gpr146^em1(IMPC)H/H)	decreased hemoglobin content	J:211773
	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular hemoglobin concentration	J:211773
	decreased mean corpuscular volume	J:211773
	increased red blood cell distribution width	J:211773
	increased spleen weight	J:211773
	thrombocytosis	J:211773
Gpr161^vl/Gpr161^vl (C3Fe;C3Sn-Gpr161^vl/J)	hematopoietic system phenotype	J:29151
Gpr174^tm1Cys/Y (B6.129-Gpr174^tm1Cys)	abnormal regulatory T cell physiology	J:222307
	abnormal T-helper 1 cell differentiation	J:222307
	increased single-positive T cell number	J:222307
	increased T cell proliferation	J:222307
Gpr182^{tm2b(KOMP)Wtsi}/Gpr182^{tm2b(KOMP)Wtsi} (C57BL/6N-Gpr182^{tm2b(KOMP)Wtsi}/Ucd)	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
	increased spleen weight	J:211773
Gpr182^{tm2c(KOMP)Wtsi}/Gpr182^{tm2c(KOMP)Wtsi} Tg(Cdh5-cre/ERT2)1Rha/0 (B6.Cg-Gpr182^{tm2c(KOMP)Wtsi} Tg(Cdh5-cre/ERT2)1Rha)	abnormal hematopoietic system morphology/development	J:305796
	decreased hematopoietic stem cell number	J:305796
	increased monocyte cell number	J:305796
	increased neutrophil cell number	J:305796
Gpr183^{tm1.1(KOMP)Vlcg}/Gpr183^{tm1.1(KOMP)Vlcg} (C57BL/6N-Gpr183^{tm1.1(KOMP)Vlcg}/J)	increased erythrocyte cell number	J:211773
	increased hematocrit	J:211773
Gpr183^tm1.1Cys/Gpr183^tm1.1Cys (B6.129P2-Gpr183^tm1.1Cys)	abnormal follicular B cell physiology	J:151077
Gpr183^tm1.2Rbr/Gpr183^tm1.2Rbr (involves: C57BL/6 * FVB/N * SJL)	abnormal B cell physiology	J:151883
	decreased plasma cell number	J:151883
Gpr183^tm1.2Rbr/Gpr183^tm1.2Rbr Igh^tm1Rbr/Igh^tm1Rbr Tg(IgkHyHEL10)1Rbr/0 (involves: C57BL/6 * FVB/N * SJL)	abnormal B cell physiology	J:151883
	abnormal B cell proliferation	J:151883
	decreased B cell number	J:151883
	decreased IgG1 level	J:151883
	decreased IgM level	J:151883
	decreased plasma cell number	J:151883
Gpr183^tm1Lex/Gpr183^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	decreased myeloid dendritic cell number	J:211122
	decreased plasmacytoid dendritic cell number	J:211122
Gprc5c^tm1Yhir/Gprc5c^tm1Yhir (B6.Cg-Gprc5c^tm1Yhir)	decreased mean corpuscular hemoglobin concentration	J:176063
	increased basophil cell number	J:176063
	increased mean corpuscular volume	J:176063
	reticulocytosis	J:176063
Gprc6a^{tm1.1(KOMP)Vlcg}/Gprc6a^{tm1.1(KOMP)Vlcg} (C57BL/6N-Gprc6a^{tm1.1(KOMP)Vlcg}/Ucd)	increased hemoglobin content	J:211773
	increased thymus weight	J:211773
Gprin1^em1(IMPC)H/Gprin1^em1(IMPC)H (C57BL/6N-Gprin1^em1(IMPC)H/H)	decreased neutrophil cell number	J:211773
Gpsm2^{tm1b(EUCOMM)Wtsi}/Gpsm2⁺ (C57BL/6N-Gpsm2^{tm1b(EUCOMM)Wtsi}/Ieg)	increased mean platelet volume	J:211773
Gpsm3^{Gt(IST12408A1)Tigm}/Gpsm3^{Gt(IST12408A1)Tigm} (involves: C57BL/6N)	abnormal leukocyte migration	J:193270
	abnormal leukocyte physiology	J:193270
	decreased monocyte cell number	J:193270
Gpx1^tm1Ysh/Gpx1^tm1Ysh (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal platelet physiology	J:41169
Gpx3^tm1Jlos/Gpx3⁺ (B6N.Cg-Gpx3^tm1Jlos)	increased platelet aggregation	J:183744
Gpx3^tm1Jlos/Gpx3^tm1Jlos (B6N.Cg-Gpx3^tm1Jlos)	increased platelet aggregation	J:183744
Gpx7^{tm1.1(KOMP)Vlcg}/Gpx7^{tm1.1(KOMP)Vlcg} (C57BL/6N-Gpx7^{tm1.1(KOMP)Vlcg}/Ucd)	increased erythrocyte cell number	J:211773
	increased hematocrit	J:211773
Gpx7^tm1Whle/Gpx7^tm1Whle (involves: 129P2/OlaHsd * C57BL/6)	enlarged spleen	J:193993
Gramd1c^{tm1b(KOMP)Wtsi}/Gramd1c^{tm1b(KOMP)Wtsi} (C57BL/6N-Gramd1c^{tm1b(KOMP)Wtsi}/J)	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
Gramd2b^em1(IMPC)J/Gramd2b^em1(IMPC)J (C57BL/6NJ-Gramd2b^em1(IMPC)J/Mmjax)	decreased mean corpuscular hemoglobin concentration	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
Grap2^tm1Amch/Grap2^tm1Amch (involves: 129S1/Sv * 129X1/SvJ)	arrested T cell differentiation	J:76696
	decreased CD4-positive, alpha-beta T cell number	J:76696
	decreased CD8-positive, alpha-beta T cell number	J:76696
	decreased thymocyte number	J:76696
	increased double-negative T cell number	J:76696
Grap2^tm1Amch/Grap2^tm1Amch Lcp2^tm1.1Wz/Lcp2^tm1.1Wz (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal T cell differentiation	J:150304
	decreased CD4-positive, alpha-beta T cell number	J:150304
	decreased CD8-positive, alpha-beta T cell number	J:150304
	decreased double-positive T cell number	J:150304
	decreased single-positive T cell number	J:150304
Grap2^tm1Eac/Grap2^tm1Eac (involves: C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:92023
	abnormal double-negative T cell morphology	J:92023
	decreased T cell number	J:92023
	decreased thymocyte number	J:92023
	increased activated T cell number	J:92023
	increased memory T cell number	J:92023
Grap^tm1Gsf/Grap^tm1Gsf (B6.129-Grap^tm1Gsf)	increased CD4-positive, alpha-beta T cell number	J:76243
Grap^tm1Gsf/Grap^tm1Gsf (B6.129-Grap^tm1Gsf)	increased T cell proliferation	J:76243
Grb2^tm1.1Hua/Grb2^tm1.1Hua Tg(DO11.10)10Dlo/0 Tg(Lck-cre)1Jtak/0 (involves: 129 * BALB/c * C3H * C57BL/6)	abnormal T cell differentiation	J:161294
	decreased CD4-positive, alpha-beta T cell number	J:161294
Grb2^tm1.1Hua/Grb2^tm1.1Hua Tg(Lck-cre)1Jtak/0 (involves: 129 * C57BL/6)	abnormal T cell differentiation	J:161294
	decreased CD4-positive, alpha-beta T cell number	J:161294
	decreased CD8-positive, alpha-beta T cell number	J:161294
	decreased double-positive T cell number	J:161294
	decreased thymocyte number	J:161294
Grb2^tm1.1Hua/Grb2^tm1.1Hua Tg(Lck-cre)1Jtak/0 Tg(TcraH-Y,TcrbH-Y)71Vbo/0 (involves: 129 * C57BL/6 * C57BL/6J * DBA/2J)	abnormal T cell differentiation	J:161294
	decreased CD4-positive, alpha-beta T cell number	J:161294
	decreased CD8-positive, alpha-beta T cell number	J:161294
	increased CD8-positive, alpha-beta T cell number	J:161294
	increased double-positive T cell number	J:161294
Grb2^tm1Lnit/Grb2^tm1Lnit Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: BALB/c * BALB/cJ)	abnormal B cell differentiation	J:171222
	abnormal B cell physiology	J:171222
	abnormal memory B cell physiology	J:171222
	decreased B cell number	J:171222
	decreased follicular B cell number	J:171222
	decreased IgG3 level	J:171222
	decreased IgG level	J:171222
	decreased mature B cell number	J:171222
	decreased spleen germinal center number	J:171222
	decreased spleen germinal center size	J:171222
	decreased transitional stage T1 B cell number	J:171222
	decreased transitional stage T2 B cell number	J:171222
	increased B cell apoptosis	J:171222
	increased B cell proliferation	J:171222
	increased IgM level	J:171222
	increased plasma cell number	J:171222
Grb14^tm1Daly/Grb14^tm1Daly (involves: 129X1/SvJ * C57BL/6)	decreased spleen weight	J:87892
Grem2^tm1Akh/Grem2^tm1Akh (involves: 129/Sv * C57BL/6)	increased leukocyte cell number	J:250034
Grhl3^{tm1a(EUCOMM)Wtsi}/Grhl3⁺ (C57BL/6N-Grhl3^{tm1a(EUCOMM)Wtsi}/Ics)	decreased IgE level	J:165965
Gria1^tm1Lex/Gria1^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	decreased glycosylated hemoglobin level	J:82809
Grik3^em1(IMPC)Mbp/Grik3^em1(IMPC)Mbp (C57BL/6N-Grik3^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
Grik5^em1(IMPC)Mbp/Grik5^em1(IMPC)Mbp (C57BL/6N-Grik5^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Grin1^{tm1a(EUCOMM)Wtsi}/Grin1⁺ (C57BL/6N-Grin1^{tm1a(EUCOMM)Wtsi}/Wtsi)	thrombocytopenia	J:175295
Grin2b^{tm1e.1(KOMP)Wtsi}/Grin2b⁺ (C57BL/6N-Grin2b^{tm1e.1(KOMP)Wtsi}/Tcp)	increased mean platelet volume	J:211773
Grin3b^{tm1b(KOMP)Wtsi}/Grin3b^{tm1b(KOMP)Wtsi} (C57BL/6N-Grin3b^{tm1b(KOMP)Wtsi}/H)	increased red blood cell distribution width	J:211773
Grk2^tm1Gwd/Grk2^tm1Gwd Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: 129 * BALB/c * C57BL/6)	abnormal B cell physiology	J:176118
	decreased B cell number	J:176118
	increased B cell number	J:176118
	increased CD4-positive, alpha-beta T cell number	J:176118
	increased CD8-positive, alpha-beta T cell number	J:176118
	increased follicular B cell number	J:176118
	increased marginal zone B cell number	J:176118
Grk2^tm1Gwd/Grk2^tm1Mca Tg(Cd4-cre)1Cwi/0 (involves: 129 * C57BL/6 * DBA/2)	abnormal T cell physiology	J:176118
	decreased CD4-positive, alpha-beta T cell number	J:176118
	decreased CD8-positive, alpha-beta T cell number	J:176118
	decreased T cell number	J:176118
	impaired leukocyte tethering or rolling	J:176118
	increased B cell number	J:176118
Grk6^tm1.1Mca/Grk6^tm1.1Mca (involves: 129S4/SvJae * C57BL/6J)	abnormal B cell physiology	J:76872
	abnormal T cell physiology	J:76872
Grk6^tm1.1Mca/Grk6^tm1.1Mca (B6.129S4-Grk6^tm1.1Mca)	abnormal T cell subpopulation ratio	J:225063
	decreased CD8-positive, alpha-beta T cell number	J:225063
	decreased CD8-positive, naive alpha-beta T cell number	J:225063
	enlarged spleen	J:225063
	impaired macrophage phagocytosis	J:225063
	increased IgG level	J:225063
	increased memory T cell number	J:225063
	increased spleen iron level	J:225063
	increased spleen weight	J:225063
	increased spleen white pulp amount	J:225063
	increased splenocyte number	J:225063
Grm7^em1(IMPC)H/Grm7^em1(IMPC)H (C57BL/6NTac-Grm7^em1(IMPC)H/H)	increased mean platelet volume	J:211773
Grn^em1(IMPC)H/Grn^em1(IMPC)H (C57BL/6NTac-Grn^em1(IMPC)H/H)	increased mean platelet volume	J:211773
Grn^tm1.1Aidi/Grn^tm1.1Aidi (involves: C57BL/6 * C57BL/6J)	abnormal macrophage physiology	J:156824
	abnormal microglial cell physiology	J:156824
	microgliosis	J:156824
Grn^tm1.1Far/Grn^tm1.1Far (involves: 129S4/SvJae * FVB/N)	abnormal macrophage physiology	J:170823
Grn^tm1.1Far/Grn^tm1.1Far (involves: 129S4/SvJae * C57BL/6J * FVB/N)	microgliosis	J:188324
Grn^tm1.1Geno/Grn^tm1.1Geno (involves: 129 * C57BL/6J)	microgliosis	J:188420
Grn^tm1Blrl/Grn^tm1Blrl (involves: C57BL/6J)	microgliosis	J:182051
Grn^tm1Far/Grn^tm1Far Tg(ITGAM-cre)2781Gkl/0 (involves: 129S4/SvJae * C57BL/6 * CBA * FVB/N)	microgliosis	J:188324
Grn^tm2.1Far/Grn^tm2.1Far (involves: 129S4/SvJae * C57BL/6)	abnormal macrophage physiology	J:259651
Grn^tm2.1Far/Grn^tm2.1Far (involves: 129S4/SvJae * C57BL/6)	microgliosis	J:259651
gro20/gro20 (Not Specified)	polycythemia	J:85113
Grsf1^{tm1b(EUCOMM)Wtsi}/Grsf1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Grsf1^{tm1b(EUCOMM)Wtsi}/Wtsi)	decreased leukocyte cell number	J:211773
Gsdma3^Ae/Gsdma3⁺ (involves: C57BL/6J * CAST/Ei)	enlarged spleen	J:180149
Gsdma3^Ae/Gsdma3⁺ (involves: C57BL/6J * CAST/Ei)	enlarged thymus	J:180149
Gsdma3^{tm1(KOMP)Vlcg}/Gsdma3^{tm1(KOMP)Vlcg} (C57BL/6N-Gsdma3^{tm1(KOMP)Vlcg}/Nju)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	increased lymphocyte cell number	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
Gsdmc^em1(IMPC)Tcp/Gsdmc^em1(IMPC)Tcp (C57BL/6NCrl-Gsdmc^em1(IMPC)Tcp/TcpMmucd)	increased monocyte cell number	J:211773
Gsdmd^em1Fcw/Gsdmd^em2Fcw (involves: C57BL/6)	abnormal macrophage apoptosis	J:226781
Gsdmd^em3Fcw/Gsdmd^em3Fcw (involves: C57BL/6)	abnormal macrophage apoptosis	J:226781
Gsdmd^em4Fcw/Gsdmd^em4Fcw (C57BL/6N-Gsdmd^em4Fcw/J)	abnormal macrophage apoptosis	J:101977
Gsdme^{tm1b(KOMP)Wtsi}/Gsdme^{tm1b(KOMP)Wtsi} (C57BL/6N-Gsdme^{tm1b(KOMP)Wtsi}/Wtsi)	increased mean corpuscular hemoglobin concentration	J:211773
Gse1^{tm1a(EUCOMM)Wtsi}/Gse1⁺ (C57BL/6N-Gse1^{tm1a(EUCOMM)Wtsi}/H)	decreased erythrocyte cell number	J:165965
Gsg1l^em1(IMPC)Mbp/Gsg1l^em1(IMPC)Mbp (C57BL/6N-Gsg1l^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Gsk3a^{tm1b(EUCOMM)Hmgu}/Gsk3a^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Gsk3a^{tm1b(EUCOMM)Hmgu}/Ieg)	decreased mean platelet volume	J:211773
Gsn^tm1Djk/Gsn^tm1Djk (either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6))	abnormal osteoclast differentiation	J:60625
	abnormal osteoclast physiology	J:60625
	abnormal platelet activation	J:24346
	impaired neutrophil chemotaxis	J:24346
	impaired neutrophil recruitment	J:24346
	increased leukocyte cell number	J:24346
	increased neutrophil cell number	J:24346
Gsr^em1(IMPC)Mbp/Gsr^em1(IMPC)Mbp (C57BL/6N-Gsr^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Gsta4^{tm1b(EUCOMM)Hmgu}/Gsta4^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Gsta4^{tm1b(EUCOMM)Hmgu}/Ieg)	increased red blood cell distribution width	J:211773
Gstcd^{tm1b(EUCOMM)Wtsi}/Gstcd^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Gstcd^{tm1b(EUCOMM)Wtsi}/Bay)	enlarged spleen	J:211773
Gstk1^tm1Pgb/Gstk1^tm1Pgb (BALB/c-Gstk1^tm1Pgb)	decreased spleen red pulp amount	J:177201
Gstk1^tm1Pgb/Gstk1^tm1Pgb (BALB/c-Gstk1^tm1Pgb)	decreased spleen weight	J:177201
Gstm4^{tm2b(EUCOMM)Hmgu}/Gstm4^{tm2b(EUCOMM)Hmgu} (C57BL/6N-Gstm4^{tm2b(EUCOMM)Hmgu}/Bay)	abnormal spleen morphology	J:211773
Gsto1^em1(IMPC)J/Gsto1^em1(IMPC)J (C57BL/6NJ-Gsto1^em1(IMPC)J/Mmjax)	decreased mean corpuscular hemoglobin	J:211773
Gstz1^tm1Pgb/Gstz1^tm1Pgb (BALB/c-Gstz1^tm1Pgb/AnuApb)	decreased leukocyte cell number	J:91519
Gstz1^tm1Pgb/Gstz1^tm1Pgb (BALB/c-Gstz1^tm1Pgb/AnuApb)	decreased spleen weight	J:91519
Gsx1^tm1Ssp/Gsx1^tm1Ssp (involves: 129P2/OlaHsd)	decreased leukocyte cell number	J:31764
	decreased lymphocyte cell number	J:31764
	decreased neutrophil cell number	J:31764
Gt(ROSA)26Sor^{tm1(B4galt1)Clib}/Gt(ROSA)26Sor^{tm1(B4galt1)Clib} Tg(Nes-cre)Wme/? (involves: 129S6/SvEvTac * C57BL/6 * CBA)	hematopoietic system phenotype	J:209737
Gt(ROSA)26Sor^{tm1(BcorA)Vjba}/Gt(ROSA)26Sor^{tm1(BcorA)Vjba} (involves: 129S1/Sv)	abnormal bone marrow cell physiology	J:231455
Gt(ROSA)26Sor^{tm1(Bmi1)Aiwa}/Gt(ROSA)26Sor⁺ Tg(Tek-cre)1Ywa/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)	abnormal hematopoietic stem cell physiology	J:198331
	hematopoietic system phenotype	J:198331
	increased hematopoietic stem cell number	J:198331
	increased hematopoietic stem cell proliferation	J:198331
Gt(ROSA)26Sor^{tm1(CAG-Bcl3,-EGFP)Hoev}/Gt(ROSA)26Sor⁺ Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd)	abnormal B cell differentiation	J:208980
	abnormal B-2 B cell morphology	J:208980
	abnormal class switch recombination	J:208980
	abnormal follicular B cell morphology	J:208980
	abnormal transitional stage T3 B cell morphology	J:208980
	absent marginal zone B cells	J:208980
	decreased B cell apoptosis	J:208980
	decreased B cell proliferation	J:208980
	decreased B-1 B cell number	J:208980
	decreased B-1a cell number	J:208980
	decreased IgG1 level	J:208980
	decreased IgG2b level	J:208980
	decreased IgG3 level	J:208980
	decreased IgM level	J:208980
	decreased immature B cell number	J:208980
	decreased marginal zone B cell number	J:208980
	decreased transitional stage T1 B cell number	J:208980
	enlarged spleen	J:208980
	increased lymphocyte cell number	J:208980
Gt(ROSA)26Sor^{tm1(CAG-Etv2,-GFP)Hkata}/Gt(ROSA)26Sor⁺ Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: C57BL/6NCrlj * C57BL/10 * CBA/Ca * CBA/JNCrlj)	abnormal bone marrow cell morphology/development	J:203163
	abnormal hematopoietic system morphology/development	J:203163
	anemia	J:203163
	decreased common myeloid progenitor cell number	J:203163
	decreased erythroid progenitor cell number	J:203163
Gt(ROSA)26Sor^{tm1(CAG-Etv2,-GFP)Hkata}/Gt(ROSA)26Sor⁺ Sox1^tm1(cre)Take/Sox1⁺ (involves: C57BL/6NCrlj * CBA/JNCrlj)	hematopoietic system phenotype	J:203163
Gt(ROSA)26Sor^{tm1(CAG-Etv2,-GFP)Hkata}/Gt(ROSA)26Sor⁺ Tg(Tek-cre)1Ywa/0 (involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj * SJL)	abnormal definitive hematopoiesis	J:203163
Gt(ROSA)26Sor^{tm1(CAG-Foxn1/ERT2,-GFP)Cbln}/Gt(ROSA)26Sor⁺ Foxn1^tm3(cre)Nrm/Foxn1⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal thymus involution	J:208852
	increased T cell number	J:208852
Gt(ROSA)26Sor^{tm1(CAG-NPM1)Geno}/Gt(ROSA)26Sor⁺ Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 CBA)	abnormal megakaryocyte differentiation	J:196690
	abnormal platelet morphology	J:196690
	enlarged spleen	J:196690
	increased megakaryocyte cell number	J:196690
	myeloid hyperplasia	J:196690
	thrombocytopenia	J:196690
Gt(ROSA)26Sor^{tm1(CAG-NPM1)Geno}/Gt(ROSA)26Sor^{tm1(CAG-NPM1)Geno} Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	abnormal megakaryocyte differentiation	J:196690
	abnormal platelet morphology	J:196690
	enlarged spleen	J:196690
	increased megakaryocyte cell number	J:196690
	thrombocytopenia	J:196690
Gt(ROSA)26Sor^{tm1(CAG-Slc39a14*L438R)Wvh}/Gt(ROSA)26Sor⁺ Tg(Runx2-icre)1Jtuc/0 (involves: FVB/N)	increased osteoclast cell number	J:261326
Gt(ROSA)26Sor^{tm1(CAG-Trp53,-EGFP)Medz}/Gt(ROSA)26Sor⁺ Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 CBA)	abnormal hematopoietic system physiology	J:158953
Gt(ROSA)26Sor^{tm1(CAG-Trp53,-EGFP)Medz}/Gt(ROSA)26Sor⁺ Tg(Nes-cre)1Wme/0 (involves: C57BL/6 CBA)	abnormal hematopoietic system physiology	J:158953
	hematopoietic system phenotype	J:158953
Gt(ROSA)26Sor^{tm1(CAG-Trp53,-EGFP)Medz}/Gt(ROSA)26Sor^{tm1(cre/ERT)Nat} (involves: 129 C57BL/6)	abnormal hematopoietic system physiology	J:158953
	hematopoietic system phenotype	J:158953
Gt(ROSA)26Sor^{tm1(CAG-Trp53,-EGFP)Medz}/Gt(ROSA)26Sor^{tm1(cre/ERT)Nat} Tg(H2-K-BCL2)1Josd/0 (involves: 129 C3H * C57BL/6)	abnormal hematopoietic system physiology	J:158953
Gt(ROSA)26Sor^{tm1(CAG-Trp53,-EGFP)Medz}/Gt(ROSA)26Sor^{tm1(cre/ERT)Nat} Trp53^tm1Tyj/Trp53⁺ (involves: 129 129S2/SvPas * C57BL/6)	hematopoietic system phenotype	J:158953
Gt(ROSA)26Sor^{tm1(CAG-Trp53,-EGFP)Medz}/Gt(ROSA)26Sor^{tm1(cre/ERT)Nat} Trp53^tm1Tyj/Trp53^tm1Tyj (involves: 129 129S2/SvPas * C57BL/6)	hematopoietic system phenotype	J:158953
Gt(ROSA)26Sor^{tm1(CARD14)Ribt}/Gt(ROSA)26Sor⁺ Malt1^{tm1c(EUCOMM)Hmgu}/Malt1^{tm1c(EUCOMM)Hmgu} Tg(KRT14-cre/ERT)20Efu/0 (involves: 129S6/SvEvTac C57BL/6NCrl * CD-1)	increased dendritic cell number	J:292094
	increased neutrophil cell number	J:292094
Gt(ROSA)26Sor^{tm1(CARD14)Ribt}/Gt(ROSA)26Sor⁺ Tg(KRT14-cre/ERT)20Efu/0 (involves: 129S6/SvEvTac C57BL/6NCrl * CD-1)	increased dendritic cell number	J:292094
	increased neutrophil cell number	J:292094
Gt(ROSA)26Sor^{tm1(cre/ERT2)Thl}/0 Picalm^tm1.1Tmae/Picalm^tm1.1Tmae (involves: 129 * C57BL/6 * SJL)	abnormal erythropoiesis	J:220728
	hypochromic microcytic anemia	J:220728
Gt(ROSA)26Sor^{tm1(cre/ERT2)Thl}/Gt(ROSA)26Sor⁺ Mcl1^tm1Ywh/Mcl1^tm1Ywh (involves: 129/Sv * 129S6/SvEvTac * C57BL/6)	increased T cell apoptosis	J:137400
Gt(ROSA)26Sor^{tm1(cre/ERT2)Thl}/Gt(ROSA)26Sor^{tm1(Tcfe2a/Tal1)Xhsu} (involves: 129/Sv * C57BL/6)	abnormal lymphopoiesis	J:144569
	abnormal myelopoiesis	J:144569
Gt(ROSA)26Sor^{tm1(cre/ERT2)Tyj}/Gt(ROSA)26Sor^tm1(Pyy)Paba (involves: 129S4/SvJae)	abnormal osteoclast morphology	J:189512
	increased osteoclast cell number	J:189512
Gt(ROSA)26Sor^{tm1(CTNNB1)Nerl}/Gt(ROSA)26Sor^{tm1(CTNNB1)Nerl} Tg(Mx1-cre)1Cgn/0 (involves: 129P2/OlaHsd * BALB/c * C57BL/6 * CBA)	abnormal bone marrow cell number	J:112660
	abnormal proerythroblast morphology	J:112660
	anemia	J:112660
	arrested T cell differentiation	J:112660
	decreased double-negative T cell number	J:112660
	decreased erythrocyte cell number	J:112660
	decreased granulocyte number	J:112660
	decreased hemoglobin content	J:112660
	decreased leukocyte cell number	J:112660
	impaired myelopoiesis	J:112660
	thrombocytopenia	J:112660
	thymus hypoplasia	J:112660
Gt(ROSA)26Sor^tm1(DTA)Jpmb/Gt(ROSA)26Sor⁺ Tg(Plp1-cre/ERT)3Pop/0 (involves: 129S/SvEv * C57BL/6 * DBA/2)	increased activated T cell number	J:234435
Gt(ROSA)26Sor^tm1(DTA)Lky/Gt(ROSA)26Sor⁺ Il13^{tm1(YFP/cre)Lky}/Il13^{tm1(YFP/cre)Lky} (involves: 129P2/OlaHsd * 129S4/SvJae)	decreased eosinophil cell number	J:178986
	decreased IgG1 level	J:178986
Gt(ROSA)26Sor^tm1(DTA)Lky/Gt(ROSA)26Sor^tm1(DTA)Lky Tg(Cd4-cre)1Cwi/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	abnormal CD4-positive, alpha-beta T cell physiology	J:133382
	abnormal CD8-positive, alpha-beta T cell differentiation	J:133382
	abnormal spleen morphology	J:133382
	abnormal T cell receptor V(D)J recombination	J:133382
	decreased CD4-positive, alpha-beta T cell number	J:133382
	decreased CD8-positive, alpha-beta T cell number	J:133382
	decreased double-positive T cell number	J:133382
	decreased lymphocyte cell number	J:133382
	decreased NK T cell number	J:133382
	decreased regulatory T cell number	J:133382
Gt(ROSA)26Sor^tm1(DTA)Mrc/Gt(ROSA)26Sor⁺ Chrna7^{tm2.1(cre)Swr}/Chrna7⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	anemia	J:223063
Gt(ROSA)26Sor^tm1(DTA)Riet/Gt(ROSA)26Sor^tm1(DTA)Riet Tg(Rorc-cre)1Litt/? (involves: 129P2/OlaHsd)	abnormal effector T cell morphology	J:137020
Gt(ROSA)26Sor^{tm1(ETV6/SYK)Hjum}/Gt(ROSA)26Sor⁺ Cd79a^{tm3(cre/ERT2)Reth}/Cd79a⁺ (involves: 129S6/SvEvTac * BALB/c)	abnormal plasma cell differentiation	J:208904
	enlarged spleen	J:208904
	increased B cell apoptosis	J:208904
	increased B cell number	J:208904
	increased B cell proliferation	J:208904
	increased IgM level	J:208904
Gt(ROSA)26Sor^{tm1(ETV6/SYK)Hjum}/Gt(ROSA)26Sor⁺ Cd79a^{tm3(cre/ERT2)Reth}/Cd79a⁺ Tg(BCL2)22Wehi/0 (involves: 129S6/SvEvTac * BALB/c * C57BL/6JWehi * SJL/JWehi)	abnormal B cell physiology	J:208904
	abnormal plasma cell differentiation	J:208904
	enlarged spleen	J:208904
Gt(ROSA)26Sor^{tm1(EWSR1/FLI1)Sbk}/Gt(ROSA)26Sor⁺ Tg(Mx1-cre)1Cgn/? (involves: 129S1/Sv * C57BL/6 * CBA)	abnormal blood cell morphology/development	J:129039
	abnormal myelopoiesis	J:129039
	anemia	J:129039
	decreased erythrocyte cell number	J:129039
	decreased hematocrit	J:129039
	enlarged spleen	J:129039
	increased leukocyte cell number	J:129039
	increased spleen red pulp amount	J:129039
	thrombocytosis	J:129039
Gt(ROSA)26Sor^tm1(EYFP)Cos/Gt(ROSA)26Sor⁺ Ighg1^tm1(cre)Cgn/Ighg1⁺ Prdm1^tm2Masu/Prdm1^tm2Masu (involves: 129P2/OlaHsd * 129X1/SvJ)	abnormal germinal center B cell physiology	J:167612
	abnormal plasma cell differentiation	J:167612
	decreased IgG1 level	J:167612
	enlarged spleen	J:167612
	increased germinal center B cell number	J:167612
Gt(ROSA)26Sor^tm1(EYFP)Cos/Gt(ROSA)26Sor⁺ Plcg1^tm1Gcrp/Plcg1^tm1Rwen Tg(Cd4-cre)1Cwi/0 (involves: 129X1/SvJ * C57BL/6 * DBA/2)	abnormal CD4-positive T cell differentiation	J:157757
	abnormal CD8-positive, alpha-beta T cell differentiation	J:157757
	abnormal regulatory T cell physiology	J:157757
	abnormal T cell activation	J:157757
	decreased CD4-positive, alpha-beta T cell number	J:157757
	decreased CD8-positive, alpha-beta T cell number	J:157757
	decreased single-positive T cell number	J:157757
	decreased T cell number	J:157757
	decreased T cell proliferation	J:157757
	increased double-positive T cell number	J:157757
	increased T cell apoptosis	J:157757
Gt(ROSA)26Sor^tm1(EYFP)Cos/Gt(ROSA)26Sor⁺ Rev3l^tm1.1Diaz/Rev3l^tm1.1Diaz Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * 129X1/SvJ * BALB/c * C57BL/6 * C57BL/6NTac)	abnormal class switch recombination	J:188723
	abnormal somatic hypermutation frequency	J:188723
	decreased B cell proliferation	J:188723
Gt(ROSA)26Sor^tm1(EYFP)Cos/Gt(ROSA)26Sor⁺ Runx1^{tm2.1(cre/Esr1)Ims}/Runx1^tm1Medv (B6.Cg-Gt(ROSA)26Sor^tm1(EYFP)Cos Runx1^{tm2.1(cre/Esr1)Ims})	abnormal hematopoietic system morphology/development	J:182232
	hematopoietic system phenotype	J:182232
Gt(ROSA)26Sor^{tm1(gp80,EGFP)Eces}/Gt(ROSA)26Sor⁺ Cd19^tm1(cre)Cgn/Cd19⁺ (either: (involves: 129/Sv * 129P2/OlaHsd * C57BL/6) or (involves: 129/Sv * 129P2/OlaHsd * BALB/c * C57BL/6))	abnormal class switch recombination	J:172031
	absent spleen germinal center	J:172031
	decreased B cell apoptosis	J:172031
	decreased B cell number	J:172031
	decreased germinal center B cell number	J:172031
	decreased IgA level	J:172031
	decreased IgG1 level	J:172031
	decreased IgG2a level	J:172031
	decreased IgG3 level	J:172031
	decreased plasma cell number	J:172031
	enlarged spleen	J:172031
	increased B cell number	J:172031
	increased IgE level	J:172031
	increased macrophage cell number	J:172031
	increased marginal zone B cell number	J:172031
	increased spleen weight	J:172031
	increased T cell number	J:172031
Gt(ROSA)26Sor^{tm1(gp80,EGFP)Eces}/Gt(ROSA)26Sor⁺ Ighg1^tm1(cre)Cgn/Ighg1⁺ (either: (involves: 129/Sv * 129P2/OlaHsd * C57BL/6) or (involves: 129/Sv * 129P2/OlaHsd * BALB/c * C57BL/6))	abnormal class switch recombination	J:172031
	absent spleen germinal center	J:172031
	decreased B cell number	J:172031
	decreased follicular B cell number	J:172031
	decreased germinal center B cell number	J:172031
	decreased IgA level	J:172031
	decreased IgG1 level	J:172031
	decreased IgG2a level	J:172031
	decreased IgG2b level	J:172031
	decreased IgG3 level	J:172031
	decreased plasma cell number	J:172031
	enlarged spleen	J:172031
	increased B cell number	J:172031
	increased IgE level	J:172031
	increased macrophage cell number	J:172031
	increased marginal zone B cell number	J:172031
	increased spleen weight	J:172031
Gt(ROSA)26Sor^{tm1(H1/tetO-RNAi:Pdpk1)Mrl}/Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte} Pten^tm1Hwu/Pten^tm1Hwu (involves: 129S4/SvJae * C57BL/6)	decreased B cell number	J:170965
	enlarged spleen	J:170965
	increased memory B cell number	J:170965
	increased spleen weight	J:170965
Gt(ROSA)26Sor^{tm1(HBEGF)Awai}/Gt(ROSA)26Sor^{tm1(HBEGF)Awai} Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	abnormal lymphocyte cell number	J:131076
	decreased single-positive T cell number	J:131076
Gt(ROSA)26Sor^{tm1(ITK/SYK)Jrld}/Gt(ROSA)26Sor⁺ Tg(Cd4-cre)1Cwi/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	abnormal spleen morphology	J:160931
	abnormal T cell activation	J:160931
	abnormal T cell differentiation	J:160931
	decreased double-positive T cell number	J:160931
	decreased single-positive T cell number	J:160931
	decreased T cell number	J:160931
	enlarged spleen	J:160931
	increased T cell proliferation	J:160931
Gt(ROSA)26Sor^{tm1(MAML1)Wsp}/Gt(ROSA)26Sor⁺ Tg(Cd4-cre)1Cwi/0 (B6.Cg-Tg(Cd4-cre)1Cwi Gt(ROSA)26Sor^{tm1(MAML1)Wsp})	abnormal immunoglobulin level	J:113262
	abnormal T-helper 1 physiology	J:113262
	abnormal T-helper 2 physiology	J:113262
Gt(ROSA)26Sor^{tm1(Mirn155)Rsky}/Gt(ROSA)26Sor^{tm1(Mirn155)Rsky} (involves: BALB/c * C57BL/6)	increased germinal center B cell number	J:121084
Gt(ROSA)26Sor^{tm1(Nfatc2)Rao}/Gt(ROSA)26Sor⁺ Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 DBA/2)	abnormal T cell activation	J:148341
Gt(ROSA)26Sor^{tm1(Nfatc2*)Rao}/Gt(ROSA)26Sor⁺ Tg(CMV-cre)1Cgn/0 (involves: BALB/cJ)	abnormal hematopoietic system morphology/development	J:148341
Gt(ROSA)26Sor^{tm1(Notch1)Dam}/Gt(ROSA)26Sor⁺ Hes1^tm1.1Frad/Hes1^tm1.1Frad Tg(Mx1-cre)1Cgn/0 (involves: 129S4/SvJaeSor * C57BL/6 * CBA)	decreased B cell number	J:167000
Gt(ROSA)26Sor^{tm1(Notch1)Dam}/Gt(ROSA)26Sor⁺ Tg(Mx1-cre)1Cgn/0 (involves: 129S4/SvJaeSor * C57BL/6 * CBA)	decreased B cell number	J:167000
	enlarged spleen	J:167000
	increased leukocyte cell number	J:167000
Gt(ROSA)26Sor^{tm1(OVAL/fla,GFP)Vnce}/Gt(ROSA)26Sor⁺ Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6J)	anemia	J:260047
	decreased B cell number	J:260047
	decreased hematocrit	J:260047
	decreased lymphocyte cell number	J:260047
	enlarged spleen	J:260047
	increased monocyte cell number	J:260047
	increased neutrophil cell number	J:260047
	increased T cell number	J:260047
Gt(ROSA)26Sor^{tm1(OVAL/fla,GFP)Vnce}/Gt(ROSA)26Sor⁺ Tg(Itgax-cre)1-1Reiz/0 (involves: C3H * C57BL/6 * C57BL/6J)	increased monocyte cell number	J:260047
	increased neutrophil cell number	J:260047
Gt(ROSA)26Sor^{tm1(OVAL/fla,GFP)Vnce}/Gt(ROSA)26Sor⁺ Tg(S100A8-cre,-EGFP)1Ilw/0 (involves: C3H * C57BL/6 * C57BL/6J)	increased monocyte cell number	J:260047
	increased neutrophil cell number	J:260047
Gt(ROSA)26Sor^{tm1(Ptpn22)Draw}/Gt(ROSA)26Sor⁺ Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd C57BL/6)	enlarged spleen	J:201448
	increased B cell number	J:201448
	increased germinal center B cell number	J:201448
	spleen hyperplasia	J:201448
Gt(ROSA)26Sor^{tm1(RNAi:Bmpr2)Dliu}/Gt(ROSA)26Sor⁺ (involves: 129 * C57BL/6J)	abnormal spleen morphology	J:145514
	abnormal spleen white pulp morphology	J:145514
	anemia	J:145514
	decreased erythrocyte cell number	J:145514
	enlarged spleen	J:145514
	extramedullary hematopoiesis	J:145514
	reticulocytosis	J:145514
Gt(ROSA)26Sor^tm1(rtTA)Awu/Gt(ROSA)26Sor^tm1(rtTA)Awu Xist^tm1Awu/Y (involves: 129S4/SvJae)	abnormal B cell differentiation	J:112954
	abnormal definitive hematopoiesis	J:112954
	abnormal erythropoiesis	J:112954
	abnormal myelopoiesis	J:112954
	abnormal T cell differentiation	J:112954
	abnormal thymus morphology	J:112954
	absent pre-B cells	J:112954
	anemia	J:112954
	decreased bone marrow cell number	J:112954
	decreased double-positive T cell number	J:112954
	decreased granulocyte number	J:112954
	decreased hematocrit	J:112954
	decreased immature B cell number	J:112954
	decreased macrophage cell number	J:112954
	decreased pro-B cell number	J:112954
	decreased thymocyte number	J:112954
	increased hematopoietic stem cell number	J:112954
	small thymus	J:112954
	thymus hypoplasia	J:112954
Gt(ROSA)26Sor^tm1(rtTA)Awu/Gt(ROSA)26Sor^tm1(rtTA)Awu Xist^tm1Awu/Xist^tm1Awu (involves: 129S4/SvJae)	decreased bone marrow cell number	J:112954
	decreased hematocrit	J:112954
	small thymus	J:112954
Gt(ROSA)26Sor^{tm1(rtTA,EGFP)Nagy}/Gt(ROSA)26Sor⁺ Tg(CAG-cre)1Nagy/0 Tg(tetO-Vegfa)90Ala/0 (involves: 129S1/Sv * 129X1/SvJ * FVB/N * ICR)	thymus atrophy	J:99607
Gt(ROSA)26Sor^{tm1(rtTA,EGFP)Nagy}/Gt(ROSA)26Sor⁺ Tg(Col2a1-cre)1Bhr/0 Tg(tetO-Vegfa)90Ala/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N * SJL)	abnormal hematopoietic system morphology/development	J:156474
	abnormal megakaryocyte progenitor cell morphology	J:156474
	decreased osteoclast cell number	J:156474
	enlarged spleen	J:156474
	extramedullary hematopoiesis	J:156474
	increased hematopoietic stem cell number	J:156474
	increased megakaryocyte cell number	J:156474
	thrombocytopenia	J:156474
Gt(ROSA)26Sor^{tm1(Stat3A661CN663C)Sbkv}/Gt(ROSA)26Sor^{tm1(Stat3A661CN663C)Sbkv} (involves: C57BL/6)	abnormal T-helper 17 cell differentiation	J:205858
Gt(ROSA)26Sor^{tm1(Stat3A661CN663C)Sbkv}/Gt(ROSA)26Sor^{tm1(Stat3A661CN663C)Sbkv} Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	increased regulatory T cell number	J:205858
	increased T-helper 1 cell number	J:205858
	increased T-helper 17 cell number	J:205858
Gt(ROSA)26Sor^{tm1(Tbx1/GFP)Bem}/Gt(ROSA)26Sor⁺ Foxg1^tm1(cre)Skm/Foxg1⁺ (involves: 129P2/OlaHsd * C57BL/6 * SJL)	athymia	J:204435
Gt(ROSA)26Sor^{tm1(tTA,tetO-Mir21)Fjsl}/Gt(ROSA)26Sor⁺ Tg(Nes-cre)1Wmz/0 (involves: C57BL/6 * C57BL/6J * SJL/J)	abnormal spleen morphology	J:163919
	abnormal thymus corticomedullary boundary morphology	J:163919
	abnormal thymus morphology	J:163919
	anemia	J:163919
	decreased erythrocyte cell number	J:163919
	decreased hemoglobin content	J:163919
	decreased leukocyte cell number	J:163919
	enlarged spleen	J:163919
	enlarged thymus	J:163919
	intermingled spleen red and white pulp	J:163919
Gt(ROSA)26Sor^{tm1(tTA,tetO-Mir155)Fjsl}/Gt(ROSA)26Sor⁺ Tg(Nes-cre)1Wmz/0 (involves: 129 * C57BL/6 * FVB/N * SJL/J)	enlarged spleen	J:185598
	increased spleen weight	J:185598
	increased spleen white pulp amount	J:185598
	thymus hyperplasia	J:185598
Gt(ROSA)26Sor^{tm1.1(Aco1)Mwh}/Gt(ROSA)26Sor^{tm1.1(Aco1)Mwh} (B6.129P2(129S1)-Gt(ROSA)26Sor^{tm1.1(Aco1*)Mwh})	abnormal erythropoiesis	J:196374
	decreased erythrocyte cell number	J:196374
	decreased hematocrit	J:196374
	decreased hemoglobin content	J:196374
	increased mean corpuscular hemoglobin	J:196374
	increased mean corpuscular volume	J:196374
	increased spleen iron level	J:196374
Gt(ROSA)26Sor^{tm1.1(CAG-Trp53,-EGFP)Medz}/Gt(ROSA)26Sor^{tm1.1(CAG-Trp53,-EGFP)Medz} (involves: C57BL/6)	decreased thymocyte apoptosis	J:158953
Gt(ROSA)26Sor^{tm1.1(PDGFB)Cbet}/Gt(ROSA)26Sor^{tm1.1(PDGFB)Cbet} (involves: 129X1/SvJ * C57BL/6 * SJL)	abnormal embryonic hematopoiesis	J:138069
Gt(ROSA)26Sor^{tm1.1(Ubc-BCL3)Sbn}/Gt(ROSA)26Sor⁺ Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: BALB/c * C57BL/6)	decreased B cell proliferation	J:207111
	decreased follicular B cell number	J:207111
	decreased marginal zone B cell number	J:207111
	increased follicular B cell number	J:207111
Gt(ROSA)26Sor^{tm1.1(Wls/YFP)Mbtr}/Gt(ROSA)26Sor⁺ (involves: C57BL/6)	decreased neutrophil cell number	J:202499
Gt(ROSA)26Sor^{tm1.2(CAG-PLS3,-GFP)Bwir}/Gt(ROSA)26Sor⁺ (B6N.Cg-Gt(ROSA)26Sor^{tm1.1(CAG-PLS3,-GFP)Bwir})	decreased osteoclast cell number	J:267292
Gt(ROSA)26Sor^tm1Fia/Gt(ROSA)26Sor⁺ Nf1^tm1Fcr/Nf1^tm1Par Tg(Tek-cre)1Ywa/0 (involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)	abnormal spleen morphology	J:114455
Gt(ROSA)26Sor^tm1Iaai/Gt(ROSA)26Sor⁺ Ndor1^{Tg(UBC-cre/ERT2)1Ejb}/0 (involves: 129S/SvEv * C57BL/6)	abnormal bone marrow cell physiology	J:196407
Gt(ROSA)26Sor^tm1Iaai/Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte} (involves: C57BL/6 * C57BL/6NTac)	abnormal bone marrow cell physiology	J:196407
Gt(ROSA)26Sor^tm1Jus/Gt(ROSA)26Sor⁺ Tg(MMTV-cre)4Mam/0 (involves: C57BL/6J * C57BL/6N * FVB/N)	abnormal leukocyte morphology	J:202090
	abnormal thymus physiology	J:202090
	anemia	J:202090
	arrested B cell differentiation	J:202090
	decreased B cell number	J:202090
	decreased double-positive T cell number	J:202090
	decreased mature B cell number	J:202090
	decreased pre-B cell number	J:202090
	decreased pro-B cell number	J:202090
	enlarged spleen	J:202090
	enlarged thymus	J:202090
	increased CD8-positive, alpha-beta T cell number	J:202090
	increased large unstained cell number	J:202090
	increased leukocyte cell number	J:202090
	increased single-positive T cell number	J:202090
	intermingled spleen red and white pulp	J:202090
	thrombocytopenia	J:202090
Gt(ROSA)26Sor^tm1Jus/Gt(ROSA)26Sor⁺ Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * C57BL/6J * C57BL/6N * CBA)	abnormal leukocyte morphology	J:202090
	abnormal thymus physiology	J:202090
	anemia	J:202090
	arrested B cell differentiation	J:202090
	decreased B cell number	J:202090
	decreased double-positive T cell number	J:202090
	decreased mature B cell number	J:202090
	decreased pre-B cell number	J:202090
	decreased pro-B cell number	J:202090
	enlarged spleen	J:202090
	enlarged thymus	J:202090
	increased CD8-positive, alpha-beta T cell number	J:202090
	increased large unstained cell number	J:202090
	increased leukocyte cell number	J:202090
	increased single-positive T cell number	J:202090
	intermingled spleen red and white pulp	J:202090
	thrombocytopenia	J:202090
Gt(ROSA)26Sor^tm1Jus/Gt(ROSA)26Sor^{tm4(ACTB-tdTomato,-EGFP)Luo} Tg(MMTV-cre)4Mam/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB)	abnormal common lymphocyte progenitor cell morphology	J:202090
	increased hematopoietic stem cell number	J:202090
Gt(ROSA)26Sor^tm1Jus/Gt(ROSA)26Sor^{tm4(ACTB-tdTomato,-EGFP)Luo} Tg(Mx1-cre)1Cgn/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	abnormal common lymphocyte progenitor cell morphology	J:202090
	increased hematopoietic stem cell number	J:202090
Gt(ROSA)26Sor^tm1Sor/Gt(ROSA)26Sor⁺ Id3^tm2.1Zhu/Id3^tm2.1Zhu Tg(Lck-cre)#Zhu/0 (involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * SJL)	decreased T cell number	J:172701
Gt(ROSA)26Sor^{tm2(CAG-Notch2)Uzs}/Gt(ROSA)26Sor⁺ Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd 129S6/SvEvTac * C57BL/6J)	abnormal B cell differentiation	J:179036
	abnormal marginal zone B cell physiology	J:179036
	abnormal spleen marginal zone morphology	J:179036
	decreased B cell number	J:179036
	decreased B-1a cell number	J:179036
	decreased B-2 B cell number	J:179036
	decreased follicular B cell number	J:179036
	decreased IgG1 level	J:179036
	decreased IgG3 level	J:179036
	decreased IgM level	J:179036
	decreased spleen B cell follicle size	J:179036
	decreased spleen germinal center number	J:179036
	decreased transitional stage T2 B cell number	J:179036
	increased B cell proliferation	J:179036
	increased marginal zone B cell number	J:179036
	increased spleen weight	J:179036
	increased T cell number	J:179036
	increased transitional stage T1 B cell number	J:179036
Gt(ROSA)26Sor^{tm2(CAG-Notch2)Uzs}/Gt(ROSA)26Sor⁺ Cd19^tm1(cre)Cgn/Cd19^tm1(cre)Cgn (involves: 129P2/OlaHsd 129S6/SvEvTac * C57BL/6J)	abnormal B cell differentiation	J:179036
	abnormal spleen marginal zone morphology	J:179036
	decreased follicular B cell number	J:179036
	decreased mature B cell number	J:179036
	decreased pre-B cell number	J:179036
	decreased transitional stage T2 B cell number	J:179036
	increased marginal zone B cell number	J:179036
	increased transitional stage T1 B cell number	J:179036
Gt(ROSA)26Sor^{tm2(CAG-Notch2)Uzs}/Gt(ROSA)26Sor⁺ Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: 129S6/SvEvTac BALB/c * C57BL/6J)	arrested B cell differentiation	J:179036
	decreased B cell number	J:179036
	decreased splenocyte number	J:179036
	increased bone marrow cell number	J:179036
	increased T cell number	J:179036
Gt(ROSA)26Sor^{tm2(H1/tetO-RNAi:Kdm1a)Arte}/Gt(ROSA)26Sor⁺ (involves: C57BL/6)	abnormal bone marrow cell morphology/development	J:192055
	abnormal erythropoiesis	J:192055
	abnormal granulocyte differentiation	J:192055
	abnormal megakaryocyte morphology	J:192055
	abnormal megakaryocyte progenitor cell morphology	J:192055
	abnormal monocyte differentiation	J:192055
	abnormal platelet morphology	J:192055
	abnormal proerythroblast morphology	J:192055
	anemia	J:192055
	decreased erythroid progenitor cell number	J:192055
	enlarged spleen	J:192055
	hematopoietic system phenotype	J:192055
	increased erythroid progenitor cell number	J:192055
	increased hematopoietic stem cell number	J:192055
	increased hematopoietic stem cell proliferation	J:192055
	increased leukocyte cell number	J:192055
	increased mean platelet volume	J:192055
	increased megakaryocyte cell number	J:192055
Gt(ROSA)26Sor^{tm2(ITK/Syk)Hjum}/Gt(ROSA)26Sor⁺ Tg(Cd4-cre)1Cwi/0 (involves: 129S6/SvEvTac * C57BL/6 * DBA/2)	abnormal immunoglobulin level	J:207306
	abnormal spleen morphology	J:207306
	enlarged spleen	J:207306
	increased activated T cell number	J:207306
	increased CD4-positive, alpha-beta T cell number	J:207306
	increased IgA level	J:207306
	increased IgG level	J:207306
	increased IgM level	J:207306
	increased mature B cell number	J:207306
	increased plasma cell number	J:207306
Gt(ROSA)26Sor^{tm2(ITK/Syk)Hjum}/Gt(ROSA)26Sor⁺ Tg(Lck-cre)I57Jxm/0 (involves: 129S6/SvEvTac * ICR)	abnormal immunoglobulin level	J:207306
	abnormal spleen morphology	J:207306
	enlarged spleen	J:207306
	increased activated T cell number	J:207306
	increased CD4-positive, alpha-beta T cell number	J:207306
	increased IgA level	J:207306
	increased IgG level	J:207306
	increased IgM level	J:207306
	increased mature B cell number	J:207306
	increased plasma cell number	J:207306
Gt(ROSA)26Sor^{tm2(Lmp1/CD40)Uzs}/Gt(ROSA)26Sor⁺ Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * BALB/c * C57BL/6)	abnormal B cell activation	J:137122
	abnormal B cell physiology	J:137122
	abnormal class switch recombination	J:137122
	abnormal T cell activation	J:137122
	enlarged spleen	J:137122
	increased B cell number	J:137122
	increased B cell proliferation	J:137122
	increased follicular B cell number	J:137122
	increased marginal zone B cell number	J:137122
	increased spleen B cell follicle size	J:137122
	increased spleen weight	J:137122
	increased T cell number	J:137122
Gt(ROSA)26Sor^{tm2(Mirn150)Rsky}/Gt(ROSA)26Sor⁺ (involves: C57BL/6 * SJL/J)	decreased mature B cell number	J:127234
Gt(ROSA)26Sor^{tm2(Mirn150)Rsky}/Gt(ROSA)26Sor^{tm2(Mirn150)Rsky} (involves: C57BL/6 * SJL/J)	decreased B-1 B cell number	J:127234
	decreased B-2 B cell number	J:127234
	decreased CD4-positive, alpha-beta T cell number	J:127234
	decreased CD8-positive, alpha-beta T cell number	J:127234
	increased B cell apoptosis	J:127234
Gt(ROSA)26Sor^{tm2(Nfatc2)Rao}/Gt(ROSA)26Sor⁺ Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 DBA/2)	abnormal T cell activation	J:148341
Gt(ROSA)26Sor^{tm2(Nfatc2*)Rao}/Gt(ROSA)26Sor⁺ Tg(CMV-cre)1Cgn/0 (involves: BALB/cJ)	abnormal hematopoietic system morphology/development	J:148341
Gt(ROSA)26Sor^{tm2.1(Mirn150)Rsky}/Gt(ROSA)26Sor⁺ (involves: C57BL/6 * SJL/J)	decreased mature B cell number	J:127234
Gt(ROSA)26Sor^{tm2.1(Mirn150)Rsky}/Gt(ROSA)26Sor^{tm2.1(Mirn150)Rsky} (involves: C57BL/6 * SJL/J)	arrested B cell differentiation	J:127234
	arrested T cell differentiation	J:127234
	decreased B-1 B cell number	J:127234
	decreased B-2 B cell number	J:127234
	decreased lymphocyte cell number	J:127234
	increased B cell apoptosis	J:127234
Gt(ROSA)26Sor^tm2Iaai/Gt(ROSA)26Sor⁺ Ndor1^{Tg(UBC-cre/ERT2)1Ejb}/0 (involves: 129S/SvEv * C57BL/6)	abnormal bone marrow cell physiology	J:196407
Gt(ROSA)26Sor^tm2Sho/Gt(ROSA)26Sor⁺ Lef1^tm1Hhx/Lef1^tm1Hhx Tg(GZMB-cre)1Jcb/0 (involves: 129S4/SvJaeSor * C57BL/6 * FVB/N)	abnormal memory T cell physiology	J:189838
	decreased CD8-positive, alpha-beta T cell number	J:189838
Gt(ROSA)26Sor^{tm3(CAG-EYFP)Hze}/Gt(ROSA)26Sor⁺ Stat5a^tm2Mam Stat5b^tm1Mam/Del(11Stat5a-Stat5b)1Mam Tg(Mx1-cre)1Cgn/0 (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCr * CBA)	abnormal CD4-positive T cell differentiation	J:204829
Gt(ROSA)26Sor^{tm3(CAG-flpo/ERT2)Alj}/Gt(ROSA)26Sor⁺ Npm1^tm1Trow/Npm1⁺ (B6.Cg-Gt(ROSA)26Sor^{tm3(CAG-flpo/ERT2)Alj} Npm1^tm1Trow)	abnormal bone marrow cell physiology	J:272803
	abnormal bone marrow hematopoietic cell morphology	J:272803
	decreased hematopoietic stem cell number	J:272803
	increased granulocyte monocyte progenitor cell number	J:272803
Gt(ROSA)26Sor^{tm3(CAG-Il17a)Awai}/Gt(ROSA)26Sor⁺ Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	abnormal neutrophil physiology	J:144710
	increased granulocyte number	J:144710
Gt(ROSA)26Sor^{tm3(CAG-MIR17-92,-EGFP)Rsky}/Gt(ROSA)26Sor⁺ Tg(CD2-icre)4Kio/0 (involves: C57BL/6 * C57BL/10 * CBA/Ca)	decreased marginal zone B cell number	J:133215
	increased B-1a cell number	J:133215
Gt(ROSA)26Sor^{tm3(CAG-MIR17-92,-EGFP)Rsky}/Gt(ROSA)26Sor^{tm3(CAG-MIR17-92,-EGFP)Rsky} Tg(CD2-icre)4Kio/0 (involves: C57BL/6 * C57BL/10 * CBA/Ca)	abnormal B cell activation	J:133215
	abnormal B cell morphology	J:133215
	abnormal CD4-positive, alpha beta T cell morphology	J:133215
	abnormal CD4-positive, alpha-beta T cell physiology	J:133215
	abnormal immunoglobulin level	J:133215
	abnormal spleen marginal zone morphology	J:133215
	abnormal T cell activation	J:133215
	abnormal T cell differentiation	J:133215
	decreased marginal zone B cell number	J:133215
	decreased spleen red pulp amount	J:133215
	extramedullary hematopoiesis	J:133215
	increased B cell number	J:133215
	increased B cell proliferation	J:133215
	increased B-1a cell number	J:133215
	increased CD4-positive, alpha-beta T cell number	J:133215
	increased CD8-positive, alpha-beta T cell number	J:133215
	increased germinal center B cell number	J:133215
	increased IgG2a level	J:133215
	increased IgG2b level	J:133215
	increased IgG3 level	J:133215
	increased IgM level	J:133215
	increased lymphocyte cell number	J:133215
	increased spleen weight	J:133215
	increased spleen white pulp amount	J:133215
	intermingled spleen red and white pulp	J:133215
	spleen hyperplasia	J:133215
Gt(ROSA)26Sor^{tm3(HIF1A)Kael}/Gt(ROSA)26Sor^{tm4(HIF2A)Kael} Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S6/SvEvTac * BALB/c * C57BL/6 * DBA)	increased hematocrit	J:144666
	reticulocytosis	J:144666
Gt(ROSA)26Sor^{tm3.1(CAG-Il17a)Awai}/Gt(ROSA)26Sor⁺ (involves: BALB/c * C57BL/6)	anemia	J:144710
	decreased hematocrit	J:144710
	decreased hemoglobin content	J:144710
	decreased mean corpuscular hemoglobin	J:144710
	decreased mean corpuscular volume	J:144710
	increased granulocyte number	J:144710
Gt(ROSA)26Sor^{tm4(ACTB-tdTomato,-EGFP)Luo}/Gt(ROSA)26Sor⁺ Hnrnpl^tm1.1Tmo/Hnrnpl^tm1.1Tmo Tg(Lck-cre)548Jxm/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	abnormal T cell differentiation	J:188749
Gt(ROSA)26Sor^{tm4(CAG-hsb5)Nki}/Gt(ROSA)26Sor⁺ Tg(Mx1-cre)1Cgn/0 Tg(Tal1-tTA)19Dgt/0 Tg(tetO-BCR/ABL1)2Dgt/0 TgTn(pb-sb-GrOnc)#aGsva/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA/J * DBA/2 * FVB/N)	abnormal hematopoietic stem cell physiology	J:227558
	decreased hemoglobin content	J:227558
	increased basophil cell number	J:227558
	increased granulocyte number	J:227558
	increased hematopoietic stem cell number	J:227558
	increased leukocyte cell number	J:227558
	increased myeloid cell number	J:227558
	increased spleen weight	J:227558
Gt(ROSA)26Sor^{tm4(HIF2A)Kael}/Gt(ROSA)26Sor⁺ Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S6/SvEvTac BALB/c * C57BL/6 * DBA)	increased hematocrit	J:144666
	reticulocytosis	J:144666
Gt(ROSA)26Sor^{tm4(Ikbkb)Rsky}/Gt(ROSA)26Sor⁺ Ighg1^tm1(cre)Cgn/Ighg1⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal spleen morphology	J:167612
	decreased germinal center B cell number	J:167612
	enlarged spleen	J:167612
	increased B cell number	J:167612
	increased IgG1 level	J:167612
	increased IgM level	J:167612
	increased plasma cell number	J:167612
Gt(ROSA)26Sor^{tm4(Ikbkb)Rsky}/Gt(ROSA)26Sor⁺ Ighg1^tm1(cre)Cgn/Ighg1⁺ Prdm1^tm2Masu/Prdm1^tm2Masu (involves: 129P2/OlaHsd * C57BL/6)	abnormal germinal center B cell physiology	J:167612
	abnormal plasma cell differentiation	J:167612
	decreased IgG1 level	J:167612
	increased germinal center B cell number	J:167612
Gt(ROSA)26Sor^{tm4(Ikbkb)Rsky}/Gt(ROSA)26Sor^{tm4(Ikbkb)Rsky} Igh-J^tm1Cgn/Igh^tm4Cgn Tg(Cr2-cre)3Cgn/0 (involves: 129P2/OlaHsd * C57BL/6)	increased B cell number	J:157297
Gt(ROSA)26Sor^{tm4(Wnt7b)Flng}/Gt(ROSA)26Sor⁺ Tg(Col1a1-cre)1Ack/0 (involves: FVB/N)	decreased osteoclast cell number	J:208766
	enlarged spleen	J:208766
	increased spleen weight	J:208766
Gt(ROSA)26Sor^{tm4(Wnt7b)Flng}/Gt(ROSA)26Sor⁺ Tg(Runx2-rtTAM2)#Flng/0 Tg(tetO-cre)1Jaw/0 (involves: 129 C57BL/6)	decreased osteoclast cell number	J:208766
Gt(ROSA)26Sor^{tm7(Pik3ca,EGFP)Rsky}/Gt(ROSA)26Sor⁺ Tg(CAG-cre/Esr1)5Amc/0 (B6.Cg-Gt(ROSA)26Sor^{tm7(Pik3ca,EGFP)Rsky} Tg(CAG-cre/Esr1)5Amc)	abnormal spleen morphology	J:264410
Gt(ROSA)26Sor^{tm7(Pik3ca,EGFP)Rsky}/Gt(ROSA)26Sor^{tm13(CAG-MYC,-CD2)Rsky} Ighg1^tm1(cre)Cgn/Ighg1⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal class switch recombination	J:191824
	increased germinal center B cell number	J:191824
Gt(ROSA)26Sor^{tm8(Map2k1,EGFP)Rsky}/Gt(ROSA)26Sor^{tm8(Map2k1,EGFP)Rsky} Igh-J^tm1Cgn/Igh^tm4Cgn Tg(Cr2-cre)3Cgn/0 (involves: 129P2/OlaHsd * C57BL/6)	decreased mature B cell number	J:157297
Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/? Tnfaip3^tm1Homy/Tnfaip3^tm1Homy (involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NTac)	abnormal blood cell morphology/development	J:212681
	hematopoietic system phenotype	J:212681
	pale spleen	J:212681
	thymus atrophy	J:212681
Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ Map3k14^tm1.1Gne/Map3k14^tm1.1Gne (B6(Cg)-Map3k14^tm1.1Gne Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte})	abnormal immunoglobulin level	J:240453
	decreased B cell number	J:240453
	decreased B cell proliferation	J:240453
	decreased germinal center B cell number	J:240453
	decreased IgA level	J:240453
	decreased IgG1 level	J:240453
	decreased IgM level	J:240453
Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ Pcgf5^tm1.1Aiwa/Pcgf5^tm1.1Aiwa (B6.Cg-Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte} Pcgf5^tm1.1Aiwa)	hematopoietic system phenotype	J:248956
Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ Pten^tm1Hwu/Pten^tm1Hwu (involves: 129S4/SvJae * C57BL/6)	enlarged spleen	J:170965
	increased spleen weight	J:170965
Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ Ripk3^tm1Arte/Ripk3^tm1Arte (involves: C57BL/6NTac)	abnormal lymphocyte morphology	J:209137
	thymus atrophy	J:209137
Gt(ROSA)26Sor^{tm9(Rac1,EGFP)Rsky}/Gt(ROSA)26Sor^{tm9(Rac1,EGFP)Rsky} Igh-J^tm1Cgn/Igh^tm4Cgn Tg(Cr2-cre)3Cgn/0 (involves: 129P2/OlaHsd * C57BL/6)	decreased mature B cell number	J:157297
Gt(ROSA)26Sor^{tm10(Lmp1)Rsky}/Gt(ROSA)26Sor⁺ (involves: BALB/cJ)	abnormal B cell morphology	J:181546
	increased B cell proliferation	J:181546
Gt(ROSA)26Sor^{tm10(Lmp1)Rsky}/Gt(ROSA)26Sor⁺ Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * BALB/cJ)	abnormal B cell differentiation	J:181546
	abnormal CD8-positive, alpha-beta T cell physiology	J:181546
	decreased B cell number	J:181546
	decreased mature B cell number	J:181546
	decreased pre-B cell number	J:181546
	enlarged spleen	J:181546
	increased B cell number	J:181546
	increased B cell proliferation	J:181546
	increased CD4-positive, alpha-beta T cell number	J:181546
	increased CD8-positive, alpha-beta T cell number	J:181546
	increased pro-B cell number	J:181546
Gt(ROSA)26Sor^{tm10(Lmp1)Rsky}/Gt(ROSA)26Sor⁺ Tcrb^tm1Mom/Tcrb⁺ Tcrd^tm1Mom/Tcrd^tm1Mom Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * 129S2/SvPas * BALB/cJ)	enlarged spleen	J:181546
	increased B cell number	J:181546
Gt(ROSA)26Sor^{tm10(Lmp1)Rsky}/Gt(ROSA)26Sor⁺ Tcrb^tm1Mom/Tcrb^tm1Mom Tcrd^tm1Mom/Tcrd^tm1Mom Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * 129S2/SvPas * BALB/cJ)	enlarged spleen	J:181546
	increased B cell number	J:181546
Gt(ROSA)26Sor^{tm11(Lmp1)Rsky}/Gt(ROSA)26Sor⁺ (involves: C57BL/6)	abnormal B cell morphology	J:181546
	increased B cell proliferation	J:181546
Gt(ROSA)26Sor^{tm11(Lmp1)Rsky}/Gt(ROSA)26Sor⁺ Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell differentiation	J:181546
	abnormal CD4-positive, alpha-beta T cell physiology	J:181546
	abnormal CD8-positive, alpha-beta T cell physiology	J:181546
	decreased B cell number	J:181546
	decreased mature B cell number	J:181546
	decreased pre-B cell number	J:181546
	enlarged spleen	J:181546
	increased B cell number	J:181546
	increased B cell proliferation	J:181546
	increased CD4-positive, alpha-beta T cell number	J:181546
	increased CD8-positive, alpha-beta T cell number	J:181546
	increased pro-B cell number	J:181546
Gt(ROSA)26Sor^{tm11(Lmp1)Rsky}/Gt(ROSA)26Sor⁺ Cd19^{tm1(cre/ERT2)Rsky}/Cd19⁺ (involves: 129P2/OlaHsd * C57BL/6J)	abnormal T cell physiology	J:217520
	enlarged spleen	J:217520
	increased activated T cell number	J:217520
	increased B cell number	J:217520
	increased CD4-positive, alpha-beta T cell number	J:217520
	increased CD8-positive, alpha-beta T cell number	J:217520
Gt(ROSA)26Sor^{tm11(Lmp1)Rsky}/Gt(ROSA)26Sor⁺ Tcrb^tm1Mom/Tcrb⁺ Tcrd^tm1Mom/Tcrd^tm1Mom Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	enlarged spleen	J:181546
	increased B cell number	J:181546
Gt(ROSA)26Sor^{tm11(Lmp1)Rsky}/Gt(ROSA)26Sor⁺ Tcrb^tm1Mom/Tcrb^tm1Mom Tcrd^tm1Mom/Tcrd^tm1Mom Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	enlarged spleen	J:181546
	increased B cell number	J:181546
Gt(ROSA)26Sor^{tm12(CD2)Rsky}/Gt(ROSA)26Sor⁺ Myc^tm2Fwa/Myc^tm2Fwa Ighg1^tm1(cre)Cgn/Ighg1⁺ (involves: 129P2/OlaHsd 129S6/SvEvTac * C57BL/6)	decreased spleen germinal center size	J:188564
Gtf2e2^{tm1b(EUCOMM)Wtsi}/Gtf2e2⁺ (C57BL/6N-Gtf2e2^{tm1b(EUCOMM)Wtsi}/H)	increased mean platelet volume	J:211773
Gtpbp4^em1(IMPC)Tcp/Gtpbp4⁺ (C57BL/6N-Gtpbp4^em1(IMPC)Tcp/Tcp)	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
Gtpbp10^{tm1b(KOMP)Mbp}/Gtpbp10^{tm1b(KOMP)Mbp} (C57BL/6N-Gtpbp10^{tm1b(KOMP)Mbp}/J)	decreased mean corpuscular volume	J:211773
	increased hemoglobin content	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
Gtsf1l^em1(IMPC)J/Gtsf1l^em1(IMPC)J (C57BL/6NJ-Gtsf1l^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Gucy1a1^tm1.1Dko/Gucy1a1^tm1.1Dko (involves: C57BL/6)	abnormal platelet aggregation	J:110362
Gucy1a2^tm1.1Dko/Gucy1a2^tm1.1Dko (involves: C57BL/6)	hematopoietic system phenotype	J:110362
Gucy1b1^tm1.1Frb/Gucy1b1^tm1.1Frb (involves: 129 * C57BL/6 * FVB/N)	abnormal platelet activation	J:121321
Gucy1b1^tm1Zhen/Gucy1b1^tm1Zhen Tg(Pf4-icre)Q3Rsko/0 (involves: 129P2/OlaHsd * C57BL/6J)	abnormal platelet physiology	J:177066
	decreased platelet aggregation	J:177066
	hematopoietic system phenotype	J:177066
Gulo^{em1(IMPC)Ccpcz}/Gulo^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Gulo^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Gulo^sfx/Gulo^sfx (BALB/cBy-Gulo^sfx/J)	abnormal osteoclast differentiation	J:66648
	decreased hematocrit	J:66648
	small spleen	J:66648
	small thymus	J:66648
Gulo^tm1Mae/Gulo^tm1Mae (involves: 129 * C57BL/6)	anemia	J:59931
	decreased erythrocyte cell number	J:59931
	decreased hematocrit	J:59931
	decreased mean corpuscular hemoglobin	J:59931
Gusb^mps/Gusb^mps Kit^W-41J/Kit^W-41J (B6(C)-Kit^W-41J Gusb^mps/BrkJ)	decreased hematopoietic stem cell number	J:58272
Gypa^tm1Skmz/Gypa^tm1Skmz (involves: 129P2/OlaHsd * C57BL/6)	abnormal erythrocyte morphology	J:89319
Gypc^{em1(IMPC)Rbrc}/Gypc^{em1(IMPC)Rbrc} (C57BL/6NJcl-Gypc^{em1(IMPC)Rbrc}/Rbrc)	decreased glycosylated hemoglobin level	J:211773
Gzf1^em1(IMPC)Tcp/Gzf1⁺ (C57BL/6NCrl-Gzf1^em1(IMPC)Tcp/Tcp)	decreased mean corpuscular volume	J:211773
Gzma^tm1Ley/Gzma^tm1Ley (involves: 129X1/SvJ * C57BL/6)	decreased cytotoxic T cell cytolysis	J:49361
Gzma^tm1Simn/Gzma^tm1Simn (B6.Cg-Gzma^tm1Simn)	hematopoietic system phenotype	J:28773
Gzma^tm1Simn/Gzma^tm1Simn Gzmb^tm1Ley/Gzmb^tm1Ley (involves: 129S2/SvPas * C57BL/6)	abnormal leukocyte physiology	J:44204
Gzmb^tm1Ley/Gzmb^tm1Ley (involves: 129S2/SvPas * C57BL/6J)	decreased cytotoxic T cell cytolysis	J:23560
Gzmb^tm1Ley/Gzmb^tm1Ley (B6.129S2-Gzmb^tm1Ley)	impaired natural killer cell mediated cytotoxicity	J:113213
Gzmb^tm1Ley/Gzmb^tm1Ley (involves: 129X1/SvJ)	abnormal NK cell physiology	J:126114
Gzmb^tm1Ley/Gzmb^tm1Ley (involves: 129X1/SvJ)	decreased T cell apoptosis	J:126114
Gzmb^tm1Ley/Gzmb^tm1Ley Serpinb9^tm1.1Pib/Serpinb9^tm1.1Pib (involves: 129S2/SvPas * BALB/cJ * C57BL/6J)	decreased cytotoxic T cell apoptosis	J:252016
Gzmb^tm1Ley/Gzmb^tm1Ley Serpinb9^tm1Arp/Serpinb9^tm1Arp (involves: 129S2/SvPas * C57BL/6)	abnormal CD8-positive, alpha-beta cytotoxic T cell morphology	J:113349
	abnormal cytotoxic T cell physiology	J:113349
Gzmb^tm2.1Ley/Gzmb^tm2.1Ley (129X1/SvJ-Gzmb^tm2.1Ley)	decreased cytotoxic T cell cytolysis	J:96538
Gzmb^tm2Ley/Gzmb^tm2Ley (129X1/SvJ-Gzmb^tm2Ley)	decreased cytotoxic T cell cytolysis	J:96538
Gzmk^tm1.1Pib/Gzmk^tm1.1Pib (B6(Cg)-Gzmk^tm1.1Pib)	hematopoietic system phenotype	J:302067
H1f0^tm1Ais/H1f0^tm1Ais H1f2^tm2Ais/H1f2^tm2Ais H1f4^tm2Ais/H1f4^tm2Ais (involves: 129/Sv * C57BL/6 * SJL)	small thymus	J:83954
H1f2^tm2Ais/H1f2^tm2Ais H1f3^tm2Ais/H1f3⁺ H1f4^tm2Ais/H1f4^tm2Ais (involves: 129/Sv * C57BL/6 * SJL)	small thymus	J:83954
H1f10^{tm1.1(KOMP)Vlcg}/H1f10^{tm1.1(KOMP)Vlcg} (C57BL/6N-H1f10^{tm1.1(KOMP)Vlcg}/J)	increased mean corpuscular hemoglobin	J:211773
H2-Aa^b-tm1Blt/H2-Aa^b-tm1Blt (C57BL/6-H2-Aa^b-tm1Blt)	abnormal MHC II cell surface expression on macrophages	J:67924
	abnormal splenocyte physiology	J:16372
	abnormal T cell morphology	J:16372
	decreased CD4-positive, alpha-beta T cell number	J:16372
	enlarged thymus	J:16372
	increased CD8-positive, alpha-beta T cell number	J:16372
	thymus hyperplasia	J:16372
H2-Ab1^b-tm1.1Jssh/H2-Ab1^b-tm1.1Jssh (C57BL/6-H2-Ab1^b-tm1.1Jssh)	abnormal T cell differentiation	J:201198
	decreased regulatory T cell number	J:201198
H2-Ab1^b-tm1Doi/H2-Ab1^b-tm1Doi (involves: 129S2/SvPas * C57BL/6)	abnormal B cell physiology	J:65736
	abnormal CD4-positive, alpha beta T cell morphology	J:65736
	abnormal CD4-positive, alpha-beta T cell physiology	J:65736
	abnormal spleen B cell follicle morphology	J:65736
	abnormal spleen marginal zone morphology	J:65736
	abnormal spleen morphology	J:65736
	abnormal spleen periarteriolar lymphoid sheath morphology	J:65736
	abnormal T cell physiology	J:65736
	absent spleen germinal center	J:65736
	decreased CD4-positive, alpha-beta T cell number	J:51885, J:65736
	decreased IgG1 level	J:65736
	increased CD4-positive, alpha-beta T cell number	J:64283
	increased CD8-positive, alpha-beta T cell number	J:65736, J:64283
H2-Ab1^b-tm1Gru/H2-Ab1^b-tm1Gru (involves: 129S2/SvPas * C57BL/6J)	decreased CD4-positive, alpha-beta T cell number	J:74418
	decreased IgG level	J:74418
	increased CD8-positive, alpha-beta T cell number	J:74418
	increased IgM level	J:74418
H2-Ab1^b-tm1Gru/H2-Ab1^b-tm1Gru (B6.129S2-H2-Ab1^b-tm1Gru)	abnormal B cell physiology	J:91341
	abnormal lymphocyte physiology	J:91341
	decreased CD4-positive, alpha-beta T cell number	J:91341
H2-Ab1^b-tm1Gru/H2-Ab1^b-tm1Gru (involves: 129S2/SvPas * C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:67941
	decreased IgG1 level	J:67941
	decreased IgM level	J:67941
	decreased single-positive T cell number	J:67941
H2-Ab1^b-tm1Gru/H2-Ab1^b-tm1Gru Runx1^tm1Toku/Runx1^tm1Toku Runx3^tm1Itan/Runx3^tm1Itan Tg(Cd4-cre)1Cwi/0 (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * DBA/2)	increased CD4-positive, alpha-beta T cell number	J:131081
H2-Ab1^b-tm1Gru/H2-Ab1^b-tm1Gru Tespa1^tm1Smoc/Tespa1^tm1Smoc (involves: 129 * 129S2/SvPas * C57BL/6)	absent CD4-positive, alpha-beta T cells	J:186446
	decreased CD8-positive, alpha-beta T cell number	J:186446
H2-Ab1^b-tm1Gru/H2-Ab1^b-tm1Gru Tg(Ab1TL)1Gru/0 (B6.Cg-H2-Ab1^b-tm1Gru Tg(Ab1TL)1Gru)	abnormal CD4-positive T cell differentiation	J:91341
	abnormal macrophage antigen presentation	J:91341
H2-Ab1^b-tm1Gru/H2-Ab1^b-tm1Gru Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell/Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell (NOD.Cg-H2-Ab1^b-tm1Gru Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell)	hematopoietic system phenotype	J:87013
H2-Ab1^b-tm1Gru/H2-Ab1^b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)1Dv/0 Tg(HLA-DRB1)31Dmz/0 Tg(Ins2-CD80)3B7Flv/0 (involves: 129S2/SvPas * C57BL/6 * C57BL/10SnJ * CBA * SJL)	abnormal CD4-positive, alpha beta T cell morphology	J:68641
	abnormal CD8-positive, alpha beta T cell morphology	J:68641
H2-Ab1^b-tm1Gru/H2-Ab1^b-tm1Gru Tg(HLA-DRB1)31Dmz/0 Tg(Ins2-CD80)3B7Flv/0 (involves: 129S2/SvPas * C57BL/6 * CBA * SJL)	abnormal CD4-positive, alpha beta T cell morphology	J:68641
	abnormal CD8-positive, alpha beta T cell morphology	J:68641
H2-Ab1^b-tm1Gru/H2-Ab1^b-tm1Gru Themis^tm1Lov/Themis^tm1Lov (involves: 129)	abnormal negative T cell selection	J:151075
H2-Ab1^b-tm1Koni/H2-Ab1^b-tm1.1Koni Tg(Tek-cre)12Flv/0 (involves: 129X1/SvJ * C3H * C57BL/6 * C57BL/6J)	abnormal CD4-positive, CD25-positive, alpha-beta regulatory T cell morphology	J:131774
	abnormal T cell activation	J:131774
	decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:131774
	increased CD4-positive, alpha-beta T cell number	J:131774
H2-Ab1^b-tm1Wug/H2-Ab1^b-tm1Wug (involves: C57BL/6)	abnormal B cell physiology	J:204951
H2-Ab1^b-tm1Wug/H2-Ab1^b-tm1Wug (involves: C57BL/6)	absent CD4-positive, alpha-beta T cells	J:204951
H2-Ab1^b-tm1Wug/H2-Ab1^b-tm1Wug Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129S2/SvPas * C57BL/6)	abnormal B cell physiology	J:204951
H2-Ab1^bm12/H2-Ab1^bm12 (B6(C)-H2-Ab1^bm12/KhEgJ)	abnormal T cell physiology	J:100123
H2-Ab1^bm12/H2-Ab1^bm12 (NZB.B6(C)-H2-Ab1^bm12)	abnormal immunoglobulin level	J:104189
	decreased CD8-positive, alpha-beta T cell number	J:4554
	hemolytic anemia	J:4554
	increased B cell number	J:104189
	increased CD4-positive, alpha-beta T cell number	J:4554
	increased double-negative T cell number	J:4554
H2-Ab1^g7-em1Dvs/H2-Ab1^g7-em1Dvs H2-D1^b-em5Dvs/H2-D1^b-em5Dvs H2-K1^d-em1Dvs/H2-K1^d-em1Dvs (NOD/ShiLtDvs-H2-K1^d-em1Dvs H2-Ab1^g7-em1Dvs H2-D1^em5Dvs/Dvs)	abnormal T cell subpopulation ratio	J:257229
	decreased alpha-beta T cell number	J:257229
	decreased CD4-positive, alpha-beta T cell number	J:257229
H2-Ab1^g7-em1Ygch/H2-Ab1^g7-em1Ygch (NOD/ShiLtJ-H2-Ab1^g7-em1Ygch)	decreased CD4-positive, alpha-beta T cell number	J:101977
H2-D1^b-em5Dvs/H2-D1^b-em5Dvs H2-K1^d-em1Dvs/H2-K1^d-em1Dvs (NOD/ShiLtDvs-H2-K1^d-em1Dvs H2-D1^b-em5Dvs/Dvs)	abnormal T cell subpopulation ratio	J:257229
H2-D1^b-tm1Bpe/H2-D1^b-tm1Bpe H2-K1^b-tm1Bpe/H2-K1^b-tm1Bpe (involves: 129P2/OlaHsd * C57BL/6)	absent CD8-positive, alpha-beta T cells	J:57703
	decreased CD8-positive, alpha-beta T cell number	J:54709
	increased CD4-positive, alpha-beta T cell number	J:54709
H2-D1^b-tm1Bpe/H2-D1^b-tm1Bpe H2-K1^b-tm1Bpe/H2-K1^b-tm1Bpe (B6.129P-H2-D1^b-tm1Bpe H2-K1^b-tm1Bpe)	abnormal cytotoxic T cell physiology	J:118960
H2-D1^b-tm1Bpe/H2-D1^b-tm1Bpe H2-K1^b-tm1Bpe/H2-K1^b-tm1Bpe Klra1^tm1.1Wyok/Klra1^tm1.1Wyok (involves: 129P2/OlaHsd * BALB/cJ * C57BL/6NTac)	hematopoietic system phenotype	J:252851
H2-D1^b-tm1Bpe/H2-D1^b-tm1Bpe H2-K1^b-tm1Bpe/H2-K1^b-tm1Bpe Klra1^tm1.1Wyok/Klra1^tm1.1Wyok Tg(H2-D^d)28Bee/0 (involves: 129P2/OlaHsd * BALB/cJ * C57BL/6NTac * DBA/2)	abnormal NK cell physiology	J:252851
	hematopoietic system phenotype	J:252851
H2-D1^bm14/H2-D1^bm14 (C57BL/6)	abnormal T cell activation	J:97717
H2-DMa^tm1Liz/H2-DMa^tm1Liz (involves: BALB/cJ)	abnormal CD4-positive, alpha beta T cell morphology	J:113714
H2-DMa^tm1Lkrl/H2-DMa^tm1Lkrl (involves: 129P2/OlaHsd)	abnormal CD4-positive, alpha-beta T cell physiology	J:31786
	abnormal positive T cell selection	J:31786
	decreased CD4-positive, alpha-beta T cell number	J:31786
H2-DMa^tm1Luc/H2-DMa^tm1Luc (involves: 129S4/SvJae)	abnormal CD4-positive, alpha-beta T cell physiology	J:31625
	abnormal positive T cell selection	J:125548
	decreased CD4-positive, alpha-beta T cell number	J:31625, J:45185
H2-DMa^tm1Luc/H2-DMa^tm1Luc (B6.129S4-H2-Dma^tm1Luc)	abnormal T-helper 1 physiology	J:125654
H2-DMa^tm2Liz/H2-DMa^tm2Liz (involves: C57BL/6 * C57BL/10 * C57BR * CBA)	decreased T cell proliferation	J:111565
H2-K1^b-tm1Bpe/H2-K1^b-tm1Bpe (involves: 129P2/OlaHsd * C57BL/6)	decreased CD8-positive, alpha-beta T cell number	J:54709
	increased CD4-positive, alpha-beta T cell number	J:54709
H2-K^bm1/H2-K^bm1 Tg(TcraTcrb)1100Mjb/? (involves: C57BL/6)	abnormal positive T cell selection	J:92867
H2-K^bm5/H2-K^bm5 Tg(TcraTcrb)1100Mjb/? (involves: C57BL/6)	abnormal positive T cell selection	J:133645
H2-M3^tm1Crw/H2-M3^tm1Crw (B6.129-H2-M3^tm1Crw)	abnormal CD8-positive, alpha beta T cell morphology	J:118960
	abnormal cytotoxic T cell physiology	J:118960
	decreased activated T cell number	J:118960
	decreased macrophage nitric oxide production	J:118960
	impaired natural killer cell mediated cytotoxicity	J:118960
H2-M5^{tm1(KOMP)Wtsi}/H2-M5^{tm1(KOMP)Wtsi} (C57BL/6N-H2-M5^{tm1(KOMP)Wtsi}/Wtsi)	increased mean corpuscular hemoglobin	J:175295
H2-Oa^tm1Dma/H2-Oa^tm1Dma (involves: 129/Sv * C57BL/6)	increased CD4-positive, alpha-beta T cell number	J:65235
H2-Oa^tm1Lkar/H2-Oa^tm1Lkar (involves: 129P2/OlaHsd)	increased IgG1 level	J:85084
H2-Q10^{tm1.1(KOMP)Mbp}/H2-Q10^{tm1.1(KOMP)Mbp} (involves: C57BL/6 * C57BL/6N)	decreased gamma-delta T cell number	J:294888
	decreased immature NK cell number	J:294888
	decreased mature NK cell number	J:294888
	decreased NK cell number	J:294888
	increased NK cell number	J:294888
H2-T18^b/H2-T18^b H2-T3^tm1Luc/H2-T3^tm1Luc (C57BL/6-H2-T3^tm1Luc)	abnormal CD8 positive, alpha-beta intraepithelial T cell morphology	J:142515
	abnormal CD8-positive, gamma-delta intraepithelial T cell morphology	J:142515
	abnormal intraepithelial T cell morphology	J:142515
H2-T18^b/H2-T18^b H2-T3^tm1Luc/H2-T3^tm1Luc Tcra^tm1Mom/Tcra^tm1Mom (B6.Cg-Tcra^tm1Mom H2-T3^tm1Luc)	abnormal intraepithelial T cell number	J:142515
H2-T23^tm1Cant/H2-T23^tm1Cant (involves: 129S6/SvEvTac * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:142087, J:123555
	abnormal memory T cell physiology	J:123555
H2-T23^tm2Cant/H2-T23^tm2Cant (involves: 129S6/SvEvTac)	abnormal CD4-positive, alpha-beta T cell physiology	J:123555
H2-T23^tm2Cant/H2-T23^tm2Cant (B6.129S6-H2-T23^tm2Cant)	abnormal CD4-positive, alpha-beta T cell physiology	J:142087
H2-T23^tm2Cant/H2-T23^tm2Cant Tg(Tcra2D2,Tcrb2D2)1Kuch/? (involves: 129S6/SvEvTac)	abnormal CD4-positive, alpha-beta T cell physiology	J:142087
H2-T23^tm3Cant/H2-T23^tm3Cant Tg(Tcra2D2,Tcrb2D2)1Kuch/? (involves: 129S6/SvEvTac * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:142087
H2-T23^tm3Cant/H2-T23^tm3Cant Tg(TcraTcrb)425Cbn/? (involves: 129S6/SvEvTac * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:142087
H2-T24^{em1(IMPC)Wtsi}/H2-T24^{em1(IMPC)Wtsi} (C57BL/6N-H2-T24^{em1(IMPC)Wtsi}/Wtsi)	increased leukocyte cell number	J:211773
H2^b/H2^b Itk^tm1Ljb/Itk^tm1Ljb Tg(TcrAND)53Hed/? (involves: C3H/HeJ * C57BL/6 * C57BL/10)	abnormal positive T cell selection	J:123795
	decreased CD4-positive, alpha-beta T cell number	J:123795
H2^b/H2^b Nfkbid^tm1Clay/Nfkbid^tm1Clay Rag2^tm1Fwa/Rag2^tm1Fwa Tg(TcraN15,TcrbN15)L2Elre/? (involves: 129S/SvEv * 129S6/SvEvTac * C57BL/6)	abnormal thymocyte activation	J:132071
	decreased T cell proliferation	J:132071
H2^b/H2^b Ptcra^tm1Vbo/Ptcra^tm1Vbo (involves: 129P2/OlaHsd)	decreased double-positive T cell number	J:131357
	decreased thymocyte number	J:131357
	spleen hypoplasia	J:131357
H2^b/H2^b Ptcra^tm1Vbo/Ptcra^tm1Vbo Tcra^tm1Mom/Tcra/Tcrd^{tm1.1(Tcra)Rsky} Tg(Tcrb)93Vbo/? (involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)	abnormal T cell differentiation	J:131357
	decreased thymocyte number	J:131357
H2^b/H2^b Ptcra^tm1Vbo/Ptcra^tm1Vbo Tg(TcraH-Y,TcrbH-Y)71Vbo/? (involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)	abnormal T cell differentiation	J:131357
H2^b/H2^b Rag2^tm1Fwa/Rag2^tm1Fwa Tg(TcraN15,TcrbN15)L2Elre/? (involves: 129S/SvEv * C57BL/6)	abnormal cytotoxic T cell physiology	J:133112
	arrested T cell differentiation	J:133112
	decreased CD4-positive, alpha-beta T cell number	J:133112
	increased CD8-positive, alpha-beta T cell number	J:133112
	increased T cell proliferation	J:133112
H2^b/H2^b Tcra/Tcrd^{tm1.1(Tcra)Rsky}/Tcra/Tcrd^{tm1.1(Tcra)Rsky} Tg(Tcrb)93Vbo/? (involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)	abnormal negative T cell selection	J:81564
	abnormal T cell differentiation	J:81564
H2^b/H2^b Tcra/Tcrd^{tm1.1(Tcra)Rsky}/Tcra/Tcrd^{tm1.1(Tcra)Rsky} Tg(Tcrb)93Vbo/? (involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)	abnormal negative T cell selection	J:81564
	abnormal T cell differentiation	J:81564
H2^b/H2^b Tcra^tm1Mom/Tcra/Tcrd^{tm1.1(Tcra)Rsky} Tg(Tcrb)93Vbo/? (involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)	abnormal double-negative T cell morphology	J:131357
	abnormal double-positive T cell morphology	J:81564
	abnormal negative T cell selection	J:81564
	abnormal T cell differentiation	J:81564
	decreased double-positive T cell number	J:131357
	decreased thymocyte number	J:131357
H2^b/H2^d ((C57BL/6 x DBA/2)F1)	abnormal T cell differentiation	J:106141
H2^b/H2^d ((C57BL/6 x DBA/2)F1)	decreased hematocrit	J:106141
H2^b/H2^d Tg(TcraTcrb)1100Mjb/? (involves: BALB/c * C57BL/6)	abnormal negative T cell selection	J:133645
	decreased CD8-positive, alpha-beta T cell number	J:133645
	small thymus	J:133645
H2^b/H2^d Themis^tm1Gasc/Themis^tm1Gasc (involves: 129S6/SvEvTac * C57BL/6 * C57BL/10 * DBA/2)	abnormal negative T cell selection	J:151074
H2^b/H2^k Itk^tm1Ljb/Itk^tm1Ljb Tg(TcrAND)53Hed/? (involves: C3H/HeJ * C57BL/6 * C57BL/10)	abnormal positive T cell selection	J:123795
	decreased CD4-positive, alpha-beta T cell number	J:123795
H2^b/H2^k Tg(TcraTcrb)1100Mjb/? (involves: C57BL/6 * C57BL/10Sg * C57BR/c)	abnormal negative T cell selection	J:133645
	decreased CD8-positive, alpha-beta T cell number	J:133645
	small thymus	J:133645
H2^b/H2^s Tg(TcraTcrb)1100Mjb/? (involves: A/WySn * C57BL/6 * C57BL/10Sg * Swiss)	abnormal negative T cell selection	J:133645
	decreased CD8-positive, alpha-beta T cell number	J:133645
	small thymus	J:133645
H2^d/H2^d (DBA/2)	abnormal T cell differentiation	J:106141
H2^d/H2^d (DBA/2)	decreased hematocrit	J:106141
H2^d/H2^d Rag2^tm1Fwa/Rag2^tm1Fwa Tg(TcraN15,TcrbN15)L2Elre/? (involves: 129S/SvEv * C57BL/6)	arrested T cell differentiation	J:133112
	decreased CD4-positive, alpha-beta T cell number	J:133112
	decreased CD8-positive, alpha-beta T cell number	J:133112
H2^d/H2^d Tcra/Tcrd^{tm1.1(Tcra)Rsky}/Tcra/Tcrd^{tm1.1(Tcra)Rsky} Tg(Tcrb)93Vbo/0 (involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)	abnormal T cell differentiation	J:131357
	decreased thymocyte number	J:131357
H2^d/H2^d Tg(TcraP1.5,TcrbP1.5)29Amsv/0 Trap1a^tm1.1Jvde/Y (involves: 129 * BALB/cJ * C57BL/10 * DBA/2)	abnormal T cell clonal deletion	J:180807
H2^d/H2^d Trap1a^tm1.1Jvde/Y (involves: 129 * BALB/cJ * C57BL/10 * DBA/2)	abnormal CD8-positive, alpha-beta T cell physiology	J:180807
H2^dlAb1-Ea/H2^dlAb1-Ea (involves: 129S2/SvPas * C57BL/6)	abnormal immunoglobulin level	J:57484
	abnormal T cell number	J:57484
	decreased CD4-positive, alpha-beta T cell number	J:57484
	decreased IgG1 level	J:57484
	decreased IgG2a level	J:57484
	increased CD8-positive, alpha-beta T cell number	J:57484
	increased IgM level	J:57484
H2^dlAb1-Ea/H2^dlAb1-Ea Psmb11^{tm1(Psmb8)Khog}/Psmb11^{tm1(Psmb8)Khog} (involves: 129S2/SvPas * C57BL/6)	abnormal T cell differentiation	J:196156
	decreased CD8-positive, alpha-beta T cell number	J:196156
H2^dlAb1-Ea/H2^dlAb1-Ea Rr381^em2Kap/Rr381^em2Kap (involves: 129S2/SvPas * C57BL/6)	absent CD4-positive, alpha-beta T cells	J:333471
H2^dlAb1-Ea/H2^dlAb1-Ea Rr381^em4Kap/Rr381^em4Kap (involves: 129S2/SvPas * C57BL/6)	absent CD8-positive, alpha-beta T cells	J:333471
H2^dlAb1-Ea/H2^dlAb1-Ea Rr381^em5Kap/Rr381^em5Kap (involves: 129S2/SvPas * C57BL/6)	absent CD8-positive, alpha-beta T cells	J:333471
H2^dlAb1-Ea/H2^dlAb1-Ea Tg(HLA-DRA,HLA-DRB50101)hiKito/0 Tg(TRATL3A6,TRBTL3A6)#Kito/0 (involves: 129S2/SvPas C57BL/6)	increased CD4-positive, alpha-beta T cell number	J:189816
	increased T-helper 1 cell number	J:189816
	increased T-helper 17 cell number	J:189816
H2^g7/H2^g7 Tg(Ins2-Vtcn1)#Xxz/0 Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0 (involves: C57BL/6 * NOD * SJL)	decreased regulatory T cell number	J:177612
H2^k/H2^k Tg(TcraTcrbAD10)1Hed/? (involves: C57BL/6 * SJL)	increased CD4-positive, alpha-beta T cell number	J:124701
H2^u/H2^u Tg(TCRA)B1Jg/0 (B10.PL-H2^u H2-T18^a/(73NS)Sn-Tg(TCRA)B1Jg/J)	abnormal thymus cell ratio	J:92992
	decreased CD4-positive, alpha-beta T cell number	J:92992
	decreased double-positive T cell number	J:92992
	decreased thymocyte number	J:92992
	increased double-negative T cell number	J:92992
H2^u/H2^u Tg(TCRA)B1Jg/? Tg(TCRB)C14Jg/? (involves: C57BL/6 * C57BL/10SnSg * DBA/2 * PL/J)	abnormal CD4-positive, alpha-beta T cell physiology	J:92991
	abnormal effector T cell morphology	J:92991
	decreased CD8-positive, alpha-beta T cell number	J:92991
	decreased double-positive T cell number	J:92991
	increased CD4-positive, alpha-beta T cell number	J:92991
H2^u/H2^u Tg(TCRA)B1Jg/0 Tg(TCRB)C14Jg/0 (B10.PL-H2^u H2-T18^a/(73NS)Sn-Tg(TCRA)B1Jg Tg(TCRB)C14Jg)	abnormal double-negative T cell morphology	J:92992
	abnormal double-positive T cell morphology	J:92992
	abnormal thymus cell ratio	J:92992
	absent gamma-delta T cells	J:92992
	decreased double-positive T cell number	J:92992
	increased CD4-positive, alpha-beta T cell number	J:92992
	increased double-negative T cell number	J:92992
H2^u/H2^u Tg(TCRB)C14Jg/0 (B10.PL-H2^u H2-T18^a/(73NS)Sn-Tg(TCRB)C14Jg/J)	abnormal double-negative T cell morphology	J:92992
	abnormal double-positive T cell morphology	J:92992
	absent gamma-delta T cells	J:92992
H2ax^tm1Fwa/H2ax^tm1Fwa (involves: 129S6/SvEvTac)	abnormal class switch recombination	J:84879
H2ax^tm1Fwa/H2ax^tm1Fwa (involves: 129S6/SvEvTac)	decreased lymphocyte cell number	J:84879
H2ax^tm1Nus/H2ax^tm1Nus (Not Specified)	abnormal class switch recombination	J:194603, J:120658
	decreased B cell number	J:76360
	decreased IgG level	J:73342
	decreased T cell number	J:76360
H2bc4^em1(IMPC)Tcp/H2bc4^em1(IMPC)Tcp (C57BL/6N-H2bc4^em1(IMPC)Tcp/Tcp)	enlarged spleen	J:211773
H4c16^em1(IMPC)Mbp/H4c16^em1(IMPC)Mbp (C57BL/6N-H4c16^em1(IMPC)Mbp/MbpMmucd)	decreased mean corpuscular hemoglobin	J:211773
H13^{tm1b(KOMP)Wtsi}/H13^{tm1b(KOMP)Wtsi} (C57BL/6N-H13^{tm1b(KOMP)Wtsi}/Wtsi)	abnormal thymus topology	J:239583
Hacd3^em1(IMPC)Mbp/Hacd3^em1(IMPC)Mbp (C57BL/6N-Hacd3^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Hagh^em1(IMPC)Tcp/Hagh^em1(IMPC)Tcp (C57BL/6NCrl-Hagh^em1(IMPC)Tcp/Tcp)	decreased hematocrit	J:211773
	decreased mean corpuscular volume	J:211773
	increased red blood cell distribution width	J:211773
Hamp/Hamp2^{tm1.1(HAMP)Bjs}/Hamp/Hamp2^{tm1.1(HAMP)Bjs} (involves: 129 * NTac:NIHBS)	hematopoietic system phenotype	J:203898
Hamp/Hamp2^{tm1.1(HAMP)Bjs}/Hamp/Hamp2^{tm1.1(HAMP)Bjs} (involves: 129 * NTac:NIHBS)	hematopoietic system phenotype	J:203898
Hamp^{tm1.1(HAMP)Bjs}/Hamp^{tm1.1(HAMP)Bjs} (involves: 129 * NTac:NIHBS)	hematopoietic system phenotype	J:203898
Hamp^tm1Svl/Hamp^tm1Svl (involves: 129S2/SvPas * C57BL/6)	abnormal erythrocyte morphology	J:119004
Hamp^tm1Svl/Hamp^tm1Svl (involves: 129S2/SvPas * C57BL/6)	decreased spleen iron level	J:119004
Hand2^tm1Cse/Hand2⁺ H2az2^{Tg(Wnt1-cre)11Rth}/H2az2⁺ (involves: 129S1/Sv * C57BL/6J * CBA/J)	abnormal thymus development	J:155265
Has1^{tm1b(KOMP)Wtsi}/Has1^{tm1b(KOMP)Wtsi} (C57BL/6N-Has1^{tm1b(KOMP)Wtsi}/H)	decreased eosinophil cell number	J:211773
	increased basophil cell number	J:211773
Havcr1^tm1Kuch/Havcr1^tm1Kuch (B6.Cg-Havcr1^tm1Kuch)	abnormal B cell physiology	J:186484
	abnormal CD4-positive, alpha-beta T cell physiology	J:186484
	abnormal T cell differentiation	J:186484
	enlarged spleen	J:186484
	increased activated T cell number	J:186484
	increased CD4-positive, alpha-beta T cell number	J:186484
	increased CD8-positive, alpha-beta T cell number	J:186484
	increased double-negative T cell number	J:186484
	increased T cell number	J:186484
Havcr2^{tm1b(KOMP)Wtsi}/Havcr2^{tm1b(KOMP)Wtsi} (C57BL/6N-Havcr2^{tm1b(KOMP)Wtsi}/Ucd)	increased spleen weight	J:211773
Havcr2^tm1Bmed/Havcr2^tm1Bmed (B6.Cg-Havcr2^tm1Bmed)	abnormal CD8-positive, alpha-beta T cell physiology	J:189839
	decreased activation-induced cell death of T cells	J:189839
	decreased T cell proliferation	J:189839
Havcr2^tm1Vlcg/Havcr2^tm1Vlcg (B6.129-Havcr2^tm1Vlcg)	decreased T cell number	J:209885
Havcr2^tm1Vlcg/Havcr2^tm1Vlcg Tg(TcraTcrb)1100Mjb/? (B6.Cg-Havcr2^tm1Vlcg Tg(TcraTcrb)1100Mjb)	decreased T cell number	J:209885
Hax1^tm1.1Gach/Hax1^tm1.1Gach (involves: BALB/c)	abnormal B cell number	J:174159
	abnormal lymphocyte morphology	J:174159
	abnormal T cell number	J:174159
	decreased B cell number	J:174159
	decreased B-1a cell number	J:174159
	decreased bone marrow cell number	J:174159
	decreased CD4-positive, alpha-beta T cell number	J:174159
	decreased CD8-positive, alpha-beta T cell number	J:174159
	decreased double-positive T cell number	J:174159
	decreased hematopoietic stem cell number	J:174159
	decreased IgG2a level	J:174159
	decreased immature B cell number	J:174159
	decreased marginal zone B cell number	J:174159
	decreased mature B cell number	J:174159
	decreased pre-B cell number	J:174159
	decreased pro-B cell number	J:174159
	decreased thymocyte number	J:174159
	decreased transitional stage T1 B cell number	J:174159
	decreased transitional stage T2 B cell number	J:174159
	increased follicular B cell number	J:174159
	spleen hypoplasia	J:174159
	thymus hypoplasia	J:174159
Hax1^tm1Jni/Hax1^tm1Jni (involves: 129P2/OlaHsd * C57BL/6)	decreased bone marrow cell number	J:132627
	decreased double-positive T cell number	J:132627
	decreased immature B cell number	J:132627
	decreased leukocyte cell number	J:132627
	decreased lymphocyte cell number	J:132627
	decreased neutrophil cell number	J:132627
	decreased single-positive T cell number	J:132627
	decreased T cell number	J:132627
Hba-a1^tm1Led/Hba-a1⁺ (involves: 129S6/SvEvTac)	abnormal erythrocyte morphology	J:41934
	abnormal hemoglobin	J:41934
	abnormal mean corpuscular hemoglobin	J:41934
	abnormal mean corpuscular volume	J:41934
Hba-a1^tm1Led/Hba-a1⁺ (involves: 129S6/SvEvTac * NIH Black Swiss)	abnormal hemoglobin	J:41934
	abnormal mean corpuscular hemoglobin	J:41934
	abnormal mean corpuscular volume	J:41934
Hba-a1^tm1Led/Hba-a1⁺ Hba-x^tm1Led/Hba-x⁺ (involves: 129S6/SvEvTac * NIH Black Swiss)	abnormal hemoglobin	J:41934
	abnormal mean corpuscular hemoglobin	J:41934
	abnormal mean corpuscular volume	J:41934
	thrombocytosis	J:41934
Hba-a1^tm1Led/Hba-a1^tm1Led (involves: 129S6/SvEvTac)	abnormal erythrocyte morphology	J:41934
	abnormal hemoglobin	J:41934
	abnormal mean corpuscular hemoglobin	J:41934
	abnormal mean corpuscular volume	J:41934
	anisocytosis	J:41934
	poikilocytosis	J:41934
	polychromatophilia	J:41934
Hba-a1^tm1Led/Hba-a1^tm1Led (involves: 129S6/SvEvTac * NIH Black Swiss)	abnormal erythrocyte morphology	J:41934
	abnormal hemoglobin	J:41934
	abnormal mean corpuscular hemoglobin	J:41934
	abnormal mean corpuscular volume	J:41934
	thrombocytosis	J:41934
Hba-a1^tm1Shs/Hba-a1⁺ (involves: C57BL/6CrSlc)	abnormal hemoglobin	J:81902
Hba-a1^tm1Shs/Hba-a1⁺ (involves: C57BL/6CrSlc)	anemia	J:81902
Hba-a1^tm1Ywk/Hba-a1⁺ (involves: 129X1/SvJ * C57BL/6J)	anemia	J:35018
Hba-a1^tm1Ywk/Hba-a1⁺ (involves: 129X1/SvJ * C57BL/6J)	decreased mean corpuscular volume	J:35018
Hba-a1^tm1Ywk/Hba^th-J (involves: 129X1/SvJ * C57BL/6J)	abnormal erythrocyte morphology	J:35018
	abnormal hemoglobin	J:35018
	anisocytosis	J:35018
	hemolytic anemia	J:35018
	leptocytosis	J:35018
	poikilocytosis	J:35018
	polychromatophilia	J:35018
	reticulocytosis	J:35018
Hba-a1^tm1Ywk/Hba-a1^tm1Ywk (involves: 129X1/SvJ * C57BL/6J)	abnormal hemoglobin	J:35018
	decreased hemoglobin content	J:35018
	decreased mean corpuscular hemoglobin	J:35018
	decreased mean corpuscular volume	J:35018
	hemolytic anemia	J:35018
	reticulocytosis	J:35018
Hba-x^tm1Led/Hba-x⁺ (involves: 129S6/SvEvTac * NIH Black Swiss)	abnormal hemoglobin	J:41934
	abnormal mean corpuscular hemoglobin	J:41934
	abnormal mean corpuscular volume	J:41934
Hba-x^tm1Led/Hba-x^tm1Led (involves: 129S6/SvEvTac * NIH Black Swiss)	abnormal erythrocyte morphology	J:41934
	abnormal hemoglobin	J:41934
	abnormal mean corpuscular hemoglobin	J:41934
	abnormal mean corpuscular volume	J:41934
	anemia	J:41934
	anisocytosis	J:41934
	poikilocytosis	J:41934
	polychromatophilia	J:41934
	thrombocytosis	J:41934
Hba^b2(th)/Hba⁺ (involves: 101/Rl * SEC/Rl)	abnormal hemoglobin	J:5686
Hba^b2(th)/Hba⁺ (involves: 101/Rl * SEC/Rl)	increased erythrocyte clearance	J:150481
Hba^b2(th)/Hba⁺ (either: (involves: 101 * SEC) or (involves: 101 * C57BL * SEC))	acanthocytosis	J:86011
	anisocytosis	J:123943
	anisopoikilocytosis	J:86011
	dacryocytosis	J:86011
	decreased hematocrit	J:123943
	decreased hemoglobin content	J:123943
	decreased mean corpuscular hemoglobin	J:123943
	decreased mean corpuscular volume	J:123943
	hypochromic microcytic anemia	J:123943
	increased erythrocyte cell number	J:123943
	increased leukocyte cell number	J:123943
	leptocytosis	J:86011
	microcytosis	J:123943
	poikilocytosis	J:86011
	reticulocytosis	J:123943
Hba^b2(th)/Hba⁺ (SEC-Hba^b2(th))	abnormal fetal derived definitive erythrocyte morphology	J:6452
Hba^b3(th)/Hba⁺ (involves: 101 * SEC)	abnormal hemoglobin	J:5686
Hba^b3(th)/Hba⁺ (either: (involves: 101 * SEC) or (involves: 101 * C57BL * SEC))	acanthocytosis	J:86011
	anisocytosis	J:123943
	anisopoikilocytosis	J:86011
	dacryocytosis	J:86011
	decreased hematocrit	J:123943
	decreased hemoglobin content	J:123943
	decreased mean corpuscular hemoglobin	J:123943
	decreased mean corpuscular volume	J:123943
	hypochromic microcytic anemia	J:123943
	increased erythrocyte cell number	J:123943
	leptocytosis	J:86011
	microcytosis	J:123943
	poikilocytosis	J:86011
	reticulocytosis	J:123943
Hba^b3(th)/Hba⁺ (SEC-Hba^b3(th))	abnormal fetal derived definitive erythrocyte morphology	J:6452
Hba^th-J/Hba⁺ (involves: C57BL/6J)	decreased hemoglobin content	J:45721
	increased erythrocyte cell number	J:45721
	microcytosis	J:45721
Hba^tm1(HBA)Tow/Hba^tm1(HBA)Tow Hbb^{tm2(HBG1,HBB)Tow}/Hbb^{tm2(HBG1,HBB)Tow} (Not Specified)	abnormal erythrocyte morphology	J:134980
	abnormal Kupffer cell morphology	J:134980
	abnormal spleen white pulp morphology	J:134980
	anemia	J:137709
	anisocytosis	J:134980
	decreased erythrocyte cell number	J:134980
	decreased hematocrit	J:134980
	decreased hemoglobin content	J:134980
	enlarged spleen	J:134980
	extramedullary hematopoiesis	J:134980
	increased spleen red pulp amount	J:134980
	poikilocytosis	J:134980
	polychromatophilia	J:134980
	reticulocytosis	J:134980
	spleen vascular congestion	J:134980
Hba^tm1(HBA)Tow/Hba^tm1(HBA)Tow Hbb^{tm2(HBG1,HBB)Tow}/Hbb^{tm2(HBG1,HBB)Tow} Slc12a4^Rbc10/Slc12a4⁺ (involves: 129 * BALB/c * C57BL/6J)	abnormal erythrocyte physiology	J:227339
	enlarged spleen	J:227339
	microcytic anemia	J:227339
	reticulocytosis	J:227339
Hba^tm1(HBA)Tow/Hba^tm1(HBA)Tow Hbb^{tm2(HBG1,HBB*)Tow}/Hbb^{tm3(HBG1,HBB)Tow} (Not Specified)	anemia	J:137709
	hematopoietic system phenotype	J:134980
Hba^tm1(HBA)Tow/Hba^tm1(HBA)Tow Hbb^{tm2(HBG1,HBB)Tow}/Hbb^{tm3(HBG1,HBB)Tow} Slc12a4^Rbc10/Slc12a4^Rbc10 (involves: 129 BALB/c * C57BL/6J)	microcytic anemia	J:227339
Hba^tm1(HBA)Tow/Hba^tm1(HBA)Tow Hbb^{tm2(HBG1,HBD,HBB)Ryan}/Hbb^{tm2(HBG1,HBD,HBB)Ryan} (Not Specified)	abnormal proerythroblast morphology	J:148521
	anemia	J:148521
	anisopoikilocytosis	J:148521
	decreased hemoglobin content	J:148521
	decreased mean corpuscular volume	J:148521
	extramedullary hematopoiesis	J:148521
	hemolytic anemia	J:148521
	intermingled spleen red and white pulp	J:148521
	low mean erythrocyte cell number	J:148521
	polychromatophilia	J:148521
	reticulocytosis	J:148521
	spherocytosis	J:148521
	spleen hyperplasia	J:148521
Hba^tm1(HBA)Tow/Hba^tm1(HBA)Tow Hbb^{tm2(HBG1,HBD,HBB*)Ryan}/Hbb^{tm3(HBG1,HBB)Tow} (Not Specified)	abnormal definitive hematopoiesis	J:148521
	decreased hemoglobin content	J:148521
	decreased mean corpuscular volume	J:148521
	high mean erythrocyte cell number	J:148521
	reticulocytosis	J:148521
	spleen hyperplasia	J:148521
Hba^tm1(HBA)Tow/Hba^tm1(HBA)Tow Hbb^{tm3(HBG1,HBB)Tow}/Hbb^{tm3(HBG1,HBB)Tow} (Not Specified)	anemia	J:137709
Hba^tm1(HBA)Tow/Hba^tm1(HBA)Tow Hbb^tm4(HBB)Tow/Hbb^tm4(HBB)Tow (Not Specified)	abnormal erythrocyte physiology	J:137709
	anemia	J:137709
Hba^tm1(HBA)Tow/Hba^tm1(HBA)Tow Hbb^{tm5(HBG1,HBB)Tow}/Hbb^{tm5(HBG1,HBB)Tow} (Not Specified)	abnormal erythrocyte physiology	J:137709
	anemia	J:137709
Hba^tm1Ney/Hba^tm1Ney (either: (involves: 129P2/OlaHsd) or (involves: 129X1/SvJ))	abnormal erythrocyte morphology	J:86682
	anemia	J:86682
	anisopoikilocytosis	J:86682
	decreased hemoglobin content	J:86682
	decreased mean corpuscular hemoglobin	J:86682
	decreased mean corpuscular volume	J:86682
	increased erythrocyte cell number	J:86682
	leptocytosis	J:86682
	reticulocytosis	J:86682
	schistocytosis	J:86682
Hba^tm1Paz/Hba⁺ (involves: 129S7/SvEvBrd)	decreased hemoglobin content	J:117887
	decreased mean corpuscular hemoglobin	J:117887
	decreased mean corpuscular volume	J:117887
	reticulocytosis	J:117887
Hba^tm1Paz/Hba⁺ Hbb^tm1Tow/Hbb^tm1Tow (involves: 129S2/SvPas * 129S7/SvEvBrd)	abnormal erythroid progenitor cell morphology	J:204029
	decreased erythroid progenitor cell number	J:204029
Hba^tm1Paz/Hba^tm1Paz (involves: 129S7/SvEvBrd)	abnormal erythrocyte morphology	J:28392
	decreased mean corpuscular hemoglobin	J:28392
	decreased mean corpuscular volume	J:28392
Hba^tm1Paz/Hba^tm1Paz Hbb^tm1Tow/Hbb⁺ (involves: 129S2/SvPas * 129S7/SvEvBrd)	hematopoietic system phenotype	J:204029
Hba^tm1Paz/Hba^tm1Paz Hbb^tm1Tow/Hbb^tm1Tow (involves: 129S2/SvPas * 129S7/SvEvBrd)	abnormal embryonic erythrocyte morphology	J:204029
	abnormal embryonic erythropoiesis	J:204029
	abnormal erythroid progenitor cell morphology	J:204029
	decreased erythroid progenitor cell number	J:204029
	microcytic anemia	J:204029
	microcytosis	J:204029
Hba^tm1Paz/Hba^tm1Paz Hbb^tm1Tow/Hbb^tm1Tow Tg(HBA-HBBs)41Paz/? (involves: 129S2/SvPas * 129S7/SvEvBrd * Black Swiss * C57BL/6 * DBA/2* FVB/N)	abnormal erythrocyte morphology	J:44161
	abnormal hemoglobin	J:44161
	anemia	J:44161
	anisopoikilocytosis	J:44161
	decreased erythrocyte osmotic fragility	J:44161
	decreased hematocrit	J:44161
	decreased mean corpuscular hemoglobin	J:44161
	decreased mean corpuscular hemoglobin concentration	J:44161
	decreased mean corpuscular volume	J:44161
	increased spleen weight	J:44161
	reticulocytosis	J:44161
	spleen vascular congestion	J:44161
Hbb-b1^MommeD7/Hbb-b1⁺ (involves: FVB/N)	abnormal definitive hematopoiesis	J:190446
	anisocytosis	J:190446
	anisopoikilocytosis	J:190446
	decreased mean corpuscular hemoglobin	J:190446
	decreased mean corpuscular volume	J:190446
	enlarged spleen	J:142335, J:190446
	extramedullary hematopoiesis	J:190446
	hypochromic microcytic anemia	J:190446
	increased erythrocyte clearance	J:190446
	increased nucleated erythrocyte cell number	J:190446
	increased red blood cell distribution width	J:190446
	increased spleen red pulp amount	J:190446
	leptocytosis	J:190446
	microcytic anemia	J:190446
	poikilocytosis	J:190446
	polychromatophilia	J:190446
	reticulocytosis	J:142335
	schistocytosis	J:190446
	spherocytosis	J:190446
Hbb-b1^MommeD7/Hbb-b1^MommeD7 (involves: FVB/N)	decreased erythrocyte cell number	J:142335
Hbb-b1^MommeD7/Hbb-b1^tm1Unc Hbb-b2^tm1Unc/Hbb-b2⁺ (involves: 129P2/OlaHsd * FVB/N)	anemia	J:190446
Hbb-b1^Rbc13/Hbb-b1⁺ (involves: BALB/c * C57BL/6)	abnormal definitive hematopoiesis	J:190446
	anisocytosis	J:190446
	anisopoikilocytosis	J:190446
	decreased mean corpuscular hemoglobin	J:190446
	decreased mean corpuscular volume	J:190446
	enlarged spleen	J:190446
	extramedullary hematopoiesis	J:190446
	hypochromic microcytic anemia	J:190446
	increased erythrocyte clearance	J:190446
	increased nucleated erythrocyte cell number	J:190446
	increased red blood cell distribution width	J:190446
	increased spleen red pulp amount	J:190446
	leptocytosis	J:190446
	microcytic anemia	J:190446
	poikilocytosis	J:190446
	polychromatophilia	J:190446
	schistocytosis	J:190446
	spherocytosis	J:190446
Hbb-b1^Rbc13/Hbb-b1^tm1Unc Hbb-b2^tm1Unc/Hbb-b2⁺ (involves: 129P2/OlaHsd * BALB/c * C57BL/6)	anemia	J:190446
Hbb-b1^tm1Ley/Hbb-b1^tm1Ley (129X1/SvJ-Hbb-b1^tm1Ley)	hematopoietic system phenotype	J:70187
Hbb-b1^tm1Shs/Hbb-b1⁺ (involves: C57BL/6CrSlc)	abnormal hemoglobin	J:81902
	anemia	J:81902
	decreased hemoglobin content	J:81902
Hbb-b1^tm1Shs/Hbb-b1^tm1Shs (involves: C57BL/6)	abnormal erythrocyte physiology	J:78271
	abnormal erythropoiesis	J:78271
	anisopoikilocytosis	J:78271
	decreased erythrocyte cell number	J:78271
	decreased hematocrit	J:78271
	decreased mean corpuscular hemoglobin	J:78271
	decreased mean corpuscular volume	J:78271
	enlarged spleen	J:78271
	extramedullary hematopoiesis	J:78271
	hemolytic anemia	J:78271
	hypochromic anemia	J:78271
	increased erythroid progenitor cell number	J:78271
	increased number of Heinz bodies	J:78271
	increased spleen iron level	J:78271
	reticulocytosis	J:78271
Hbb-b1^tm1Unc/Hbb-b1⁺ Hbb-b2^tm1Unc/Hbb-b2⁺ (involves: 129P2/OlaHsd * C57BL/6J)	abnormal spleen morphology	J:88672, J:30155
	anemia	J:88672, J:30155
	decreased hematocrit	J:30155
	decreased hemoglobin content	J:30155
	decreased spleen white pulp amount	J:30155
	increased bone marrow cell number	J:30155
	increased nucleated erythrocyte cell number	J:30155
	increased spleen weight	J:30155
	intermingled spleen red and white pulp	J:30155
	reticulocytosis	J:30155
Hbb-b1^tm1Unc/Hbb-b1⁺ Hbb-b2^tm1Unc/Hbb-b2⁺ (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6)	decreased hematocrit	J:94421
Hbb-b1^tm1Unc/Hbb-b1⁺ Hbb-b2^tm1Unc/Hbb-b2⁺ (involves: 129P2/OlaHsd * C57BL/6N)	abnormal erythrocyte morphology	J:185154
	abnormal erythropoiesis	J:185154
	decreased erythrocyte cell number	J:185154
	decreased hemoglobin content	J:185154
	decreased mean corpuscular volume	J:185154
	enlarged spleen	J:185154
	increased erythroid progenitor cell number	J:185154
	increased spleen iron level	J:185154
	reticulocytosis	J:185154
Hbb-b1^tm1Unc/Hbb-b1⁺ Hbb-b2^tm1Unc/Hbb-b2⁺ (B6;129-Hbb-b1^tm1Unc Hbb-b2^tm1Unc/J)	abnormal spleen morphology	J:211331
	anemia	J:211331
Hbb-b1^tm1Unc/Hbb-b1⁺ Hbb-b2^tm1Unc/Hbb-b2⁺ (involves: 129P2/OlaHsd)	abnormal erythropoiesis	J:97548
	abnormal reticulocyte cell number	J:154187
	anemia	J:154187
	decreased erythrocyte cell number	J:97548
	decreased hematocrit	J:97548
	decreased hemoglobin content	J:97548
	decreased mean corpuscular volume	J:97548
	enlarged spleen	J:97548
	increased erythroblast number	J:154187
	increased red blood cell distribution width	J:97548
	reticulocytosis	J:97548
Hbb-b1^tm1Unc/Hbb-b1⁺ Hbb-b2^tm1Unc/Hbb-b2⁺ Tg(HBB)L2Pai/0 (involves: 129P2/OlaHsd C57BL/6)	abnormal erythropoiesis	J:97548
	anisocytosis	J:97548
	decreased erythrocyte cell number	J:97548
	decreased hematocrit	J:97548
	decreased hemoglobin content	J:97548
	decreased mean corpuscular volume	J:97548
	enlarged spleen	J:97548
	increased red blood cell distribution width	J:97548
	poikilocytosis	J:97548
	reticulocytosis	J:97548
Hbb-b1^tm1Unc/Hbb-b1⁺ Hbb-b2^tm1Unc/Hbb-b2⁺ Tmprss6^tm1Otin/Tmprss6⁺ (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N)	abnormal erythrocyte cell number	J:185154
	abnormal erythrocyte morphology	J:185154
	abnormal hemoglobin content	J:185154
	abnormal spleen iron level	J:185154
	abnormal spleen size	J:185154
	decreased mean corpuscular volume	J:185154
Hbb-b1^tm1Unc/Hbb-b1⁺ Hbb-b2^tm1Unc/Hbb-b2⁺ Tmprss6^tm1Otin/Tmprss6^tm1Otin (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N)	abnormal erythrocyte cell number	J:185154
	abnormal erythrocyte morphology	J:185154
	abnormal erythroid progenitor cell morphology	J:185154
	abnormal erythropoiesis	J:185154
	abnormal hemoglobin content	J:185154
	abnormal spleen size	J:185154
	reticulocytopenia	J:185154
Hbb-b1^tm1Unc/Hbb-b1^tm1Unc Hbb-b2^tm1Unc/Hbb-b2^tm1Unc Tg(HBB)L2Pai/0 (involves: 129P2/OlaHsd C57BL/6)	anemia	J:97548
Hbb-bh2^{tm1b(EUCOMM)Hmgu}/Hbb-bh2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Hbb-bh2^{tm1b(EUCOMM)Hmgu}/Rbrc)	decreased mean corpuscular hemoglobin	J:211773
	increased red blood cell distribution width	J:211773
Hbb^d3th/Hbb⁺ Tg(HBB-AR-HBA2,-HBB)58Rub/0 Tg(LCR-HBA2,LCR-HBB)11Cos/0 (involves: FVB/N Swiss Webster)	abnormal erythrocyte morphology	J:94190
	anemia	J:94190
	reticulocytosis	J:94190
Hbb^d3th/Hbb⁺ Tg(LCR-HBA1,LCR-HBB)1Tow/0 (involves: C57BL/6 DBA/2J * SJL)	anemia	J:127701
	anisopoikilocytosis	J:127701
	decreased erythrocyte cell number	J:127701
	decreased hematocrit	J:127701
	decreased hemoglobin content	J:127701
	echinocytosis	J:127701
	enlarged spleen	J:127701
	reticulocytosis	J:127701
Hbb^d3th/Hbb⁺ Tg(LCR-HBA2,LCR-HBB)1Cos/0 (involves: C57BL/6J CBA/J * DBA/2J)	abnormal erythrocyte morphology	J:94193
	abnormal hemoglobin	J:94193
	anemia	J:94193
	decreased hematocrit	J:94193
	decreased mean corpuscular volume	J:94193
	enlarged spleen	J:94193
	increased mean corpuscular hemoglobin concentration	J:94193
	reticulocytosis	J:94193
Hbb^d3th/Hbb^d3th (involves: C57BL/6 * DBA/2J)	abnormal erythrocyte morphology	J:7209
	abnormal hemoglobin	J:7209
	abnormal hemoglobin content	J:7209
	anisocytosis	J:7209
	anisopoikilocytosis	J:7209
	decreased hematocrit	J:7209
	decreased mean corpuscular hemoglobin	J:7209
	decreased mean corpuscular volume	J:7209
	hyperchromasia	J:7209
	low mean erythrocyte cell number	J:7209
	microcytosis	J:7209
	poikilocytosis	J:7209
	reticulocytosis	J:7209
Hbb^d3th/Hbb^d3th (Not Specified)	decreased hematocrit	J:136653
	decreased mean corpuscular volume	J:136653
	reticulocytosis	J:136653
Hbb^d3th/Hbb^d3th Tg(HBB-AR-HBA2,-HBB*)58Rub/0 (involves: Swiss Webster)	abnormal erythrocyte morphology	J:136653
	abnormal mean corpuscular volume	J:136653
	hematopoietic system phenotype	J:136653
	reticulocytosis	J:94190
Hbb^d3th/Hbb^d3th Tg(HBB-AR-HBA2,-HBB)58Rub/0 Tg(LCR-HBA2,LCR-HBB)11Cos/0 (involves: FVB/N Swiss Webster)	abnormal erythrocyte morphology	J:94190
	abnormal hemoglobin	J:94190
	abnormal spleen morphology	J:94190
	anemia	J:94190
	enlarged spleen	J:94190
	increased mean corpuscular hemoglobin	J:94190
	increased spleen red pulp amount	J:94190
	reticulocytosis	J:94190
	spleen fibrosis	J:94190
	spleen vascular congestion	J:94190
Hbb^d3th/Hbb^d3th Tg(LCR-HBA2,LCR-HBB)11Cos/0 (involves: FVB/N)	abnormal erythrocyte morphology	J:94190
	increased mean corpuscular hemoglobin	J:94190
	reticulocytosis	J:94190
Hbb^d4/Hbb⁺ (involves: 101/H)	increased erythrocyte cell number	J:7972
	increased hematocrit	J:7972
	increased mean corpuscular hemoglobin concentration	J:7972
	polycythemia	J:7972
Hbb^d4/Hbb^d4 (involves: 101/H)	abnormal bone marrow cell physiology	J:7972
	abnormal hemoglobin	J:7972
	abnormal macrophage morphology	J:7972
	enlarged spleen	J:7972
	increased erythrocyte cell number	J:7972
	increased hematocrit	J:7972
	increased mean corpuscular hemoglobin concentration	J:7972
	increased spleen red pulp amount	J:7972
	polycythemia	J:7972
Hbb^{tm1.1(HBG1,HBB*)Ryan}/Hbb⁺ (involves: C57BL/6J)	abnormal spleen morphology	J:147906
	anisopoikilocytosis	J:147906
	decreased erythrocyte cell number	J:147906
	decreased mean corpuscular hemoglobin	J:147906
	decreased mean corpuscular hemoglobin concentration	J:147906
	decreased mean corpuscular volume	J:147906
	enlarged spleen	J:147906
	extramedullary hematopoiesis	J:147906
	increased erythroid progenitor cell number	J:147906
	increased hemoglobin concentration distribution width	J:147906
	increased spleen iron level	J:147906
	increased spleen red pulp amount	J:147906
	intermingled spleen red and white pulp	J:147906
	microcytic anemia	J:147906
	reticulocytosis	J:147906
Hbb^tm1Tow/Hbb⁺ (involves: 129S2/SvPas * C57BL/6)	anemia	J:29087
	anisopoikilocytosis	J:29087
	decreased hemoglobin content	J:29087
	enlarged spleen	J:29087
	increased bone marrow cell number	J:29087
	increased spleen weight	J:29087
	reticulocytosis	J:29087
Hbb^tm1Unc/Hbb^tm1Unc (involves: 129P2/OlaHsd * C57BL/6J)	abnormal erythrocyte morphology	J:4932
	anemia	J:4932
	decreased hematocrit	J:4932
	decreased mean corpuscular hemoglobin	J:4932
	poikilocytosis	J:4932
	reticulocytosis	J:4932
Hbb^tm2Unc/Hbb⁺ (involves: 129P2/OlaHsd * C57BL/6J)	abnormal erythrocyte morphology	J:64295
	anisocytosis	J:64295
	decreased erythrocyte cell number	J:64295
	decreased hematocrit	J:64295
	decreased hemoglobin content	J:64295
	decreased mean corpuscular volume	J:64295
	enlarged spleen	J:64295
	extramedullary hematopoiesis	J:64295
	increased hemoglobin concentration distribution width	J:64295
	increased mean corpuscular hemoglobin concentration	J:64295
	increased spleen iron level	J:64295
	poikilocytosis	J:64295
Hbnr2^SWR/Hbnr2^SWR (involves: CBA * SWR)	decreased IgE level	J:85787
Hbnr6^SWR/Hbnr6^SWR (involves: CBA * SWR)	increased IgE level	J:85787
Hbnr7^CBA/Hbnr7^SWR (involves: CBA * SWR)	decreased IgG1 level	J:85787
Hbnr7^SWR/Hbnr7^SWR (involves: CBA * SWR)	decreased IgG2b level	J:85787
Hbq1a^{tm1.1(KOMP)Vlcg}/Hbq1a^{tm1.1(KOMP)Vlcg} (C57BL/6N-Hbq1a^{tm1.1(KOMP)Vlcg}/Rbrc)	decreased mean corpuscular hemoglobin	J:211773
	increased erythrocyte cell number	J:211773
Hbs1l^{tm1a(KOMP)Wtsi}/Hbs1l^{tm1a(KOMP)Wtsi} (C57BL/6N-Hbs1l^{tm1a(KOMP)Wtsi}/Wtsi)	decreased effector memory CD8-positive, alpha-beta T cell number	J:211773
	decreased Langerhans cell number	J:211773
	decreased mature B cell number	J:211773
	decreased memory-marker CD4-negative NK T cell number	J:211773
	decreased monocyte cell number	J:211773
	decreased T-helper cell number	J:211773
	increased CD4-positive, alpha-beta memory T cell number	J:211773
	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	increased CD5-positive gamma-delta T cell number	J:211773
	increased effector memory CD8-positive, alpha-beta T cell number	J:211773
	increased leukocyte cell number	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased mean platelet volume	J:211773
	increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	increased regulatory T cell number	J:211773
	thrombocytosis	J:211773
Hcar1^{em1(IMPC)Ccpcz}/Hcar1^{em1(IMPC)Ccpcz} (C57BL/6N-Hcar1^{em1(IMPC)Ccpcz}/Ccpcz)	decreased effector memory T-helper cell number	J:211773
Hcfc1^em1Poche/Y (C57BL/6J-Hcfc1^em1Poche)	decreased erythrocyte cell number	J:317822
	decreased hematocrit	J:317822
	decreased hemoglobin content	J:317822
Hck^tm1Ern/Hck^tm1Ern (involves: 129S1/Sv * C57BL/6)	abnormal alveolar macrophage morphology	J:111432
	abnormal macrophage physiology	J:111432
	increased eosinophil cell number	J:111432
Hck^tm1Hev/Hck^tm1Hev (involves: 129S7/SvEvBrd * C57BL/6J)	impaired macrophage phagocytosis	J:16994
Hck^tm1Hev/Hck^tm1Hev (B6.129S7-Hck^tm1Hev)	abnormal neutrophil physiology	J:113463
Hck^tm1Hev/Hck^tm1Hev Src^tm1Sor/Src^tm1Sor (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal spleen germinal center morphology	J:31647
	abnormal spleen morphology	J:31647
	abnormal splenic cell ratio	J:31647
	anemia	J:31647
	decreased bone marrow cell number	J:31647
	decreased leukocyte cell number	J:31647
	increased macrophage cell number	J:31647
	thymus hypoplasia	J:31647
Hcls1^tm1Wtn/Hcls1^tm1Wtn (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:28146
	decreased B cell number	J:28146
	decreased T cell proliferation	J:28146
Hcls1^tm1Wtn/Hcls1^tm1Wtn Tg(TcraH-Y,TcrbH-Y)71Vbo/0 (involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)	abnormal negative T cell selection	J:28146
	decreased double-positive T cell number	J:28146
Hcls1^tm2Wtn/Hcls1^tm2Wtn (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:28146
	decreased B cell number	J:28146
	decreased T cell proliferation	J:28146
Hcn2^m1Btlr/Hcn2^m1Btlr (C57BL/6J-Hcn2^m1Btlr)	decreased CD8-positive, alpha-beta T cell number	J:255187
Hcn2^m1Btlr/Hcn2^m1Btlr (C57BL/6J-Hcn2^m1Btlr)	increased CD4-positive, alpha-beta T cell number	J:255187
Hcrt^{tm1.1(KOMP)Vlcg}/Hcrt^{tm1.1(KOMP)Vlcg} (C57BL/6N-Hcrt^{tm1.1(KOMP)Vlcg}/Ucd)	increased lymphocyte cell number	J:211773
Hcst^tm1.1Cln/Hcst^tm1.1Cln (involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)	decreased CD8-positive, alpha-beta T cell number	J:80426
	impaired natural killer cell mediated cytotoxicity	J:80426
Hcst^tm1.1Cln/Hcst^tm1.1Cln (involves: 129P2/OlaHsd * C57BL/6)	decreased uterine NK cell number	J:100668
Hcst^tm1.1Cln/Hcst^tm1.1Cln (B6.129P2-Hcst^tm1.1Cln)	abnormal osteoclast differentiation	J:147155
	abnormal osteoclast physiology	J:147155
	decreased osteoclast cell number	J:147155
Hcst^tm1.1Cln/Hcst^tm1.1Cln Tyrobp^tm1Lll/Tyrobp^tm1Lll (B6.Cg-Hcst^tm1.1Cln Tyrobp^tm1Lll)	abnormal NK T cell physiology	J:147867
Hcst^tm1.1Dnax/Hcst^tm1.1Dnax (involves: C57BL/6)	abnormal NK T cell physiology	J:147867, J:148086
	impaired natural killer cell mediated cytotoxicity	J:148086
	increased spleen weight	J:148086
Hctq1^NZW/LacJ/Hctq1^NZW/LacJ (involves: NZW/LacJ * SM/J)	increased hematocrit	J:107220
Hdac1^tm1.1Mrl/Hdac1^tm1.1Mrl Hdac2^tm1.1Rdp/Hdac2⁺ Tg(Mx1-cre)1Cgn/0 (involves: 129S4/SvJae * C57BL/6 * CBA)	abnormal megakaryocyte morphology	J:197818
	anemia	J:197818
	decreased bone marrow cell number	J:197818
	decreased erythrocyte cell number	J:197818
	decreased megakaryocyte cell number	J:197818
	thrombocytopenia	J:197818
Hdac1^tm1.1Mrl/Hdac1^tm1.1Mrl Hdac2^tm1.1Rdp/Hdac2^tm1.1Rdp Tg(Mx1-cre)1Cgn/0 (involves: 129S4/SvJae * C57BL/6 * CBA)	anemia	J:197818
	decreased bone marrow cell number	J:197818
	decreased erythrocyte cell number	J:197818
	decreased megakaryocyte cell number	J:197818
	thrombocytopenia	J:197818
Hdac1^tm1.1Mrl/Hdac1^tm1.1Mrl Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	hematopoietic system phenotype	J:197818
Hdac1^tm1.1Pmt/Hdac1^tm1.1Pmt Hdac2^tm1.1Pmt/Hdac2^tm1.1Pmt Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: 129P2/OlaHsd * BALB/c * C57BL/6 * FVB/N)	abnormal spleen morphology	J:157903
	arrested B cell differentiation	J:157903
	decreased B cell number	J:157903
	decreased bone marrow cell number	J:157903
	decreased pre-B cell number	J:157903
	decreased pro-B cell number	J:157903
	increased B cell apoptosis	J:157903
Hdac1^tm1.1Pmt/Hdac1^tm1.1Pmt Hdac2^tm1.1Pmt/Hdac2^tm1.1Pmt Tg(Fcer2a-cre)5Mbu/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA * FVB/N)	decreased B cell proliferation	J:157903
	increased B cell apoptosis	J:157903
Hdac1^tm1.1Shmc/Hdac1^tm1.1Shmc Hdac2^tm1.1Shmc/Hdac2⁺ Tg(Lck-cre)1Cwi/0 (involves: 129S7/SvEvBrd)	arrested T cell differentiation	J:194769
	decreased CD4-positive, alpha-beta T cell number	J:194769
	decreased CD8-positive, alpha-beta T cell number	J:194769
	decreased double-positive T cell number	J:194769
	enlarged spleen	J:194769
	enlarged thymus	J:194769
	increased double-negative T cell number	J:194769
	increased double-positive T cell number	J:194769
	increased single-positive T cell number	J:194769
	thymus hypoplasia	J:194769
Hdac1^tm1.1Shmc/Hdac1^tm1.1Shmc Hdac2^tm1.1Shmc/Hdac2^tm1.1Shmc Tg(Lck-cre)1Cwi/0 (involves: 129S7/SvEvBrd)	abnormal thymus corticomedullary boundary morphology	J:194769
	arrested T cell differentiation	J:194769
	decreased double-positive T cell number	J:194769
	decreased thymocyte number	J:194769
	enlarged spleen	J:194769
	enlarged thymus	J:194769
	increased double-positive T cell number	J:194769
	increased single-positive T cell number	J:194769
	increased T cell proliferation	J:194769
	increased thymocyte apoptosis	J:194769
	increased thymocyte number	J:194769
Hdac1^{tm1b(EUCOMM)Wtsi}/Hdac1⁺ (C57BL/6N-Hdac1^{tm1b(EUCOMM)Wtsi}/Ieg)	decreased mean corpuscular hemoglobin	J:211773
Hdac4^{em1(IMPC)Ccpcz}/Hdac4⁺ (C57BL/6N-Hdac4^{em1(IMPC)Ccpcz}/Ccpcz)	increased NK cell number	J:211773
Hdac6^tm1.1Pmt/Y (involves: 129P2/OlaHsd * C57BL/6)	decreased IgG level	J:132629
Hdac6^tm1.1Pmt/Y (involves: 129P2/OlaHsd * C57BL/6)	decreased IgM level	J:132629
Hdac6^tm1.1Pmt/Hdac6^tm1.1Pmt (involves: 129P2/OlaHsd * C57BL/6)	decreased IgG level	J:132629
	decreased IgM level	J:132629
Hdc^tm1Nagy/Hdc^tm1Nagy (involves: 129S1/Sv * 129X1/SvJ)	abnormal mast cell morphology	J:70702
	decreased mast cell histamine storage	J:70702
	decreased mast cell number	J:70702
	decreased mast cell protease storage	J:70702
Hddc2^em1(IMPC)H/Hddc2^em1(IMPC)H (C57BL/6NTac-Hddc2^em1(IMPC)H/H)	decreased erythrocyte cell number	J:211773
	decreased hemoglobin content	J:211773
	decreased lymphocyte cell number	J:211773
	increased basophil cell number	J:211773
	increased neutrophil cell number	J:211773
Hddc3^{tm1.1(KOMP)Vlcg}/Hddc3^{tm1.1(KOMP)Vlcg} (C57BL/6N-Hddc3^{tm1.1(KOMP)Vlcg}/Ucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Hectd1^{tm1b(EUCOMM)Hmgu}/Hectd1⁺ (C57BL/6N-Hectd1^{tm1b(EUCOMM)Hmgu}/Nju)	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
Hectd3^{tm1(NCOM)Cmhd}/Hectd3^{tm1(NCOM)Cmhd} (C57BL/6N-Hectd3^{tm1(NCOM)Cmhd}/Nju)	small spleen	J:211773
	small thymus	J:211773
Heg1^{tm1.1(KOMP)Vlcg}/Heg1⁺ (C57BL/6N-Heg1^{tm1.1(KOMP)Vlcg}/J)	increased mean corpuscular hemoglobin	J:211773
Hells^{tm1a(EUCOMM)Wtsi}/Hells^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Hells^{tm1a(EUCOMM)Wtsi}/Ieg)	decreased granulocyte number	J:165965
	decreased IgG1 level	J:165965
Hells^tm1Kmu/Hells^tm1Kmu (involves: 129S1/Sv)	decreased B cell number	J:61948
	increased CD8-positive, alpha-beta T cell number	J:61948
	increased double-negative T cell number	J:61948
	small spleen	J:61948
	small thymus	J:61948
Hells^tm1Rarc/Hells^tm1Rarc (involves: 129X1/SvJ * C57BL/6J)	small thymus	J:107145
	thymus hypoplasia	J:107145
Helq^em1(IMPC)Mbp/Helq^em1(IMPC)Mbp (C57BL/6N-Helq^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
hem1/hem1 (Not Specified)	decreased leukocyte cell number	J:85113
hem2/hem2 (Not Specified)	decreased leukocyte cell number	J:85113
hem3/hem3 (Not Specified)	decreased erythrocyte cell number	J:85113
	decreased hematocrit	J:85113
	decreased hemoglobin content	J:85113
hem4/hem4 (Not Specified)	decreased erythrocyte cell number	J:85113
	decreased hematocrit	J:85113
	decreased hemoglobin content	J:85113
hem5/hem5 (Not Specified)	decreased erythrocyte cell number	J:85113
	decreased hematocrit	J:85113
	decreased hemoglobin content	J:85113
hem6/hem6 (Not Specified)	abnormal erythrocyte cell number	J:89098
	decreased mean corpuscular hemoglobin	J:89098
	microcytic anemia	J:89098
hem6/hem6 (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6)	abnormal hematopoietic system physiology	J:142791
	abnormal reticulocyte morphology	J:142791
	decreased hemoglobin content	J:142791
	decreased mean corpuscular hemoglobin concentration	J:142791
	decreased mean corpuscular volume	J:142791
	high mean erythrocyte cell number	J:142791
	hypochromic microcytic anemia	J:142791
Hemgn^em1Xguo/Hemgn^em1Xguo (Not Specified)	decreased erythroblast number	J:326018
Hemgn^{tm1.1(KOMP)Vlcg}/Hemgn^{tm1.1(KOMP)Vlcg} (C57BL/6N-Hemgn^{tm1.1(KOMP)Vlcg}/J)	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
Hemq1^DBA/2J/? (involves: C57BL/6J * DBA/2J)	increased hematocrit	J:110791
Hemq2^C57BL/6J/? (involves: C57BL/6J * DBA/2J)	increased hematocrit	J:110791
Hemq3^C57BL/6J/? (involves: C57BL/6J * DBA/2J)	increased hematocrit	J:110791
Hemq3^DBA/2J/? (involves: C57BL/6J * DBA/2J)	increased hematocrit	J:110791
Hemq4^DBA/2J/? (involves: C57BL/6J * DBA/2J)	increased hematocrit	J:110791
Hemq5^C57BL/6J/? (involves: C57BL/6J * DBA/2J)	increased hematocrit	J:110791
Hemq5^DBA/2J/? (involves: C57BL/6J * DBA/2J)	increased hematocrit	J:110791
Hemq6^C57BL/6J/? (involves: C57BL/6J * DBA/2J)	increased hematocrit	J:110791
Heph^sla/Y (involves: C57BL/6J * WB/Re)	increased erythrocyte protoporphyrin level	J:5985
Heph^sla/Y (B6.Cg-Heph^sla)	anemia	J:6052
Heph^sla/Y (B6.Cg-Heph^sla)	decreased hemoglobin content	J:6052
Heph^sla/Y (Not Specified)	anisopoikilocytosis	J:128474
	decreased erythrocyte cell number	J:128474
	decreased hematocrit	J:128474
	decreased hemoglobin content	J:128474
	decreased mean corpuscular hemoglobin	J:128474
	decreased mean corpuscular volume	J:128474
	hypochromic anemia	J:128474
	macrocytosis	J:128474
	microcytosis	J:128474
	polychromatophilia	J:128474
Heph^sla/Heph⁺ (Not Specified)	hematopoietic system phenotype	J:155791
Heph^sla/Heph^sla (Not Specified)	abnormal definitive hematopoiesis	J:64261
	abnormal erythrocyte morphology	J:64261
	anisopoikilocytosis	J:128474
	decreased erythrocyte cell number	J:128474, J:64261
	decreased hematocrit	J:128474
	decreased hemoglobin content	J:128474
	decreased mean corpuscular hemoglobin	J:128474
	decreased mean corpuscular hemoglobin concentration	J:64261
	decreased mean corpuscular volume	J:128474
	hypochromic anemia	J:128474
	macrocytosis	J:128474
	microcytosis	J:128474
	polychromatophilia	J:128474
Heph^sla/Heph^sla (B6.Cg-Heph^sla)	anemia	J:6052
Heph^sla/Heph^sla (B6.Cg-Heph^sla)	decreased hemoglobin content	J:6052
Heph^Sla/Heph^Sla (involves: BALB/c * C3H)	anemia	J:63816
Hephl1^cw/Hephl1^cw (CWD/LeJ)	abnormal spleen morphology	J:24875
	enlarged spleen	J:24875
	enlarged thymus	J:24875
Herc1^{em3(IMPC)Wtsi}/Herc1^{em3(IMPC)Wtsi} (C57BL/6N-Herc1^{em3(IMPC)Wtsi}/Wtsi)	increased eosinophil cell number	J:211773
	increased leukocyte cell number	J:211773
	increased Ly6C high monocyte number	J:211773
	increased Ly6C low monocyte number	J:211773
	increased mean platelet volume	J:211773
	increased monocyte cell number	J:211773
	increased red blood cell distribution width	J:211773
Herc4^{tm1b(KOMP)Wtsi}/Herc4^{tm1b(KOMP)Wtsi} (C57BL/6N-Herc4^{tm1b(KOMP)Wtsi}/Nju)	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
Herc6^{tm1b(EUCOMM)Hmgu}/Herc6^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Herc6^{tm1b(EUCOMM)Hmgu}/Nju)	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
	thrombocytopenia	J:211773
Herc6^tm1Kshim/Herc6^tm1Kshim (either: B6.Cg-Herc6^tm1Kshim or (involves: C57BL/6NCrlj * CBA/JNCrlj))	hematopoietic system phenotype	J:330459
Hes1^tm1.1Frad/Hes1^tm1.1Frad Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	abnormal T cell differentiation	J:167000
	decreased DN1 thymic pro-T cell number	J:167000
	decreased DN2 thymocyte number	J:167000
	decreased DN3 thymocyte number	J:167000
	decreased DN4 thymocyte number	J:167000
	decreased double-positive T cell number	J:167000
	decreased gamma-delta T cell number	J:167000
	hematopoietic system phenotype	J:167000
	increased DN1 thymic pro-T cell number	J:167000
	increased immature B cell number	J:167000
	thymus hypoplasia	J:167000
Hexb^{tm1b(EUCOMM)Hmgu}/Hexb^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Hexb^{tm1b(EUCOMM)Hmgu}/H)	increased monocyte cell number	J:211773
	thrombocytosis	J:211773
Hexb^tm1Rlp/Hexb^tm1Rlp (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	increased immunoglobulin level	J:87617
Hexb^tm1Rlp/Hexb^tm1Rlp Tg(Hexb-tTA2S,tetO-Hexb)#Tjsa/0 (involves: 129S4/SvJae * C57BL/6 * CBA)	microgliosis	J:190450
Hexb^tm1Rlp/Hexb^tm1Rlp Tg(SYN1-tTA2S,tetO-Hexb)#Tjsa/0 (involves: 129S4/SvJae * C57BL/6 * CBA)	microgliosis	J:190450
Hfe^tm1.1Wsr/Hfe^tm1.1Wsr (involves: 129P2/OlaHsd * C57BL/6)	decreased spleen iron level	J:132134
Hfe^tm1Gfn/Hfe^tm1Gfn (involves: 129P2/OlaHsd * C57BL/6)	increased osteoclast cell number	J:262906
Hfe^tm1Gfn/Hfe^tm1Gfn (involves: 129P2/OlaHsd * C57BL/6)	increased spleen iron level	J:68025
Hfe^tm1Wsr/Hfe^tm1Wsr Tg(Alb1-cre)7Gsc/? (involves: 129P2/OlaHsd * C57BL/6 * FVB/N)	decreased spleen iron level	J:132134
Hfe^tm2Nca/Hfe^tm2Nca (involves: 129S6/SvEvTac)	decreased spleen iron level	J:78536
Hfe^tm2Nca/Hfe^tm2Nca (involves: 129S6/SvEvTac * C57BL/6J)	decreased spleen iron level	J:78536
Hfe^tm2Nca/Hfe^tm2Nca Slc11a2^tm1Nca/Slc11a2^tm1Nca (involves: 129S6/SvEvTac * 129S6.129S4-Slc11a2^tm1Nca)	decreased hematocrit	J:98088
Hfe^tm2Nca/Hfe^tm2Nca Tg(Ttr-Hfe)1Nca/0 (involves: 129S6/SvEvTac * C57BL/6)	hypochromic microcytic anemia	J:133221
Hfgi1^C57BL/6Ola/? (involves: C57BL/6Ola * BALB/cOla)	abnormal lymphopoiesis	J:123483
Hfgi2^C57BL/6Ola/? (involves: C57BL/6Ola * BALB/cOla)	abnormal lymphopoiesis	J:123483
Hgbq1^C57BLKS/J/Hgbq1^SM/J (involves: C57BLKS/J * SM/J)	increased hemoglobin content	J:107220
Hgbq1^SM/J/Hgbq1^SM/J (involves: C57BLKS/J * SM/J)	increased hemoglobin content	J:107220
Hgf^tm1Cbm/Hgf^tm1Cbm (involves: 129P2/OlaHsd * C57BL/6)	decreased erythrocyte cell number	J:23170
Hgsnat^{tm1a(EUCOMM)Wtsi}/Hgsnat^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6N * C57BL/6NTac)	abnormal Kupffer cell morphology	J:235361
	enlarged spleen	J:235361
	increased spleen weight	J:235361
	microgliosis	J:235361
Hhex^tm1Ngu/Hhex^tm1Ngu (involves: 129/Sv * C57BL/6)	abnormal monocyte differentiation	J:65105
Hhex^tm1Ngu/Hhex^tm1Ngu (involves: 129/Sv * C57BL/6)	impaired hematopoiesis	J:65105
Hhip^tm1Amc/Hhip^tm1Amc (involves: 129S1/Sv * 129X1/SvJ)	abnormal spleen morphology	J:85472
Hhip^tm1Amc/Hhip^tm1Amc (involves: 129S1/Sv * 129X1/SvJ)	small spleen	J:85472
Hif1a^tm3Rsjo/Hif1a^tm3Rsjo Hprt1^{tm1(Pck1-cre)Vhh}/Y Vhl^tm1Jae/Vhl^tm1Jae (involves: 129 * BALB/c * C57BL/6)	increased hemoglobin content	J:97652
	polycythemia	J:97652
Hif1a^tm3Rsjo/Hif1a^tm3Rsjo Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)	abnormal leukocyte physiology	J:117348
	abnormal macrophage physiology	J:107682
	impaired macrophage chemotaxis	J:107682
Hif1a^tm3Rsjo/Hif1a^tm3Rsjo Tg(Itgax-cre)1-1Reiz/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	abnormal dendritic cell number	J:187773
	abnormal leukocyte migration	J:187773
Hif1a^tm3Rsjo/Hif1a^tm3Rsjo Tg(Tal1-cre/ERT)42-056Jrg/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal B cell differentiation	J:192126
	abnormal hematopoietic stem cell physiology	J:192126
	abnormal T cell differentiation	J:192126
	decreased common myeloid progenitor cell number	J:192126
	increased hematopoietic stem cell number	J:192126
Hif1a^tm3Rsjo/Hif1a^tm3Rsjo Vhl^tm1Jae/Vhl^tm1Jae Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0 (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * CD-1)	increased hematocrit	J:186085
Hif1an^em1(IMPC)Mbp/Hif1an^em1(IMPC)Mbp (C57BL/6N-Hif1an^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased neutrophil cell number	J:211773
Hint1^{tm1a(EUCOMM)Wtsi}/Hint1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Hint1^{tm1a(EUCOMM)Wtsi}/H)	decreased erythrocyte cell number	J:165965
	increased mean corpuscular hemoglobin concentration	J:165965
Hip1^tm1Tsr/Hip1^tm1Tsr (involves: 129X1/SvJ * C57BL/6)	absent common myeloid progenitor cells	J:90400
Hip1^tm1Tsr/Hip1^tm1Tsr (involves: 129X1/SvJ * C57BL/6)	hematopoietic system phenotype	J:90400
Hip1^tm2.1Tsr/Hip1^tm2.1Tsr (involves: 129X1/SvJ)	hematopoietic system phenotype	J:90400
Hip1^tm3Tsr/Hip1^tm3Tsr (involves: 129X1/SvJ * C57BL/6)	absent common myeloid progenitor cells	J:90400
Hip1^tm3Tsr/Hip1^tm3Tsr (involves: 129X1/SvJ * C57BL/6)	hematopoietic system phenotype	J:90400
Hip1^tm4Tsr/Hip1⁺ Runx1^tm3Dow/Runx1⁺ Tg(Mx1-cre)1Cgn/0 (involves: 129X1/SvJ * C57BL/6 * CBA)	abnormal bone marrow cell morphology/development	J:151974
	abnormal bone marrow cell physiology	J:151974
	abnormal definitive hematopoiesis	J:151974
	abnormal myelopoiesis	J:151974
	abnormal spleen B cell follicle morphology	J:151974
	abnormal spleen morphology	J:151974
	decreased bone marrow cell number	J:151974
	decreased common myeloid progenitor cell number	J:151974
	decreased hematopoietic stem cell number	J:151974
	enlarged spleen	J:151974
	extramedullary hematopoiesis	J:151974
	increased granulocyte number	J:151974
	increased hematopoietic stem cell number	J:151974
	increased leukocyte cell number	J:151974
	increased neutrophil cell number	J:151974
	increased spleen red pulp amount	J:151974
	increased spleen weight	J:151974
	spleen hyperplasia	J:151974
Hip1^tm4Tsr/Hip1⁺ Tg(Mx1-cre)1Cgn/0 (involves: 129X1/SvJ * C57BL/6 * CBA)	abnormal myelopoiesis	J:151974
	abnormal spleen morphology	J:151974
	decreased hematopoietic stem cell number	J:151974
	enlarged spleen	J:151974
	hematopoietic system phenotype	J:151974
	increased spleen red pulp amount	J:151974
Hipk3^{tm1b(EUCOMM)Hmgu}/Hipk3^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Hipk3^{tm1b(EUCOMM)Hmgu}/Ieg)	increased mean platelet volume	J:211773
	thrombocytosis	J:211773
Hira^{tm1a(EUCOMM)Wtsi}/Hira⁺ (C57BL/6N-Hira^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased leukocyte cell number	J:175295
Hirip3^{tm1.1(KOMP)Mbp}/Hirip3^{tm1.1(KOMP)Mbp} (C57BL/6N-Hirip3^{tm1.1(KOMP)Mbp}/Ucd)	increased basophil cell number	J:211773
	increased neutrophil cell number	J:211773
Hivep2^tm1Sis/Hivep2⁺ (involves: BALB/cA * C57BL/6NCrlj * CBA/JNCrlj)	decreased CD8-positive, alpha-beta T cell number	J:72249
	decreased single-positive T cell number	J:72249
Hivep2^tm1Sis/Hivep2^tm1Sis (involves: BALB/cA * C57BL/6NCrlj * CBA/JNCrlj)	abnormal thymus cortex morphology	J:72249
	abnormal thymus lobule morphology	J:72249
	abnormal thymus medulla morphology	J:72249
	decreased single-positive T cell number	J:72249
	enlarged thymus cortex	J:72249
Hivep2^tm1Sis/Hivep2^tm1Sis (C.Cg-Hivep2^tm1Sis)	abnormal T-helper 2 cell morphology	J:96024
Hivep2^tm1Sis/Hivep2^tm1Sis Tg(DO11.10)10Dlo/? (involves: BALB/cA * C3H * C57BL/6NCrlj * CBA/JNCrlj)	abnormal positive T cell selection	J:96024
	abnormal T-helper 2 cell morphology	J:96024
	decreased single-positive T cell number	J:72249
Hivep3^tm1Glm/Hivep3^tm1Glm (Not Specified)	abnormal osteoclast differentiation	J:184764
	abnormal osteoclast physiology	J:184764
	decreased osteoclast cell number	J:184764
Hivep3^tm1Lcw/Hivep3^tm1Lcw (chimera involves: 129S/SvEv * 129X1/SvJ)	decreased double-positive T cell number	J:79652
Hjv^tm1Arbr/Hjv^tm1Arbr (involves: 129S4/SvJae * 129X1/SvJ)	decreased spleen iron level	J:100173
Hjv^{tm1b(KOMP)Wtsi}/Hjv^{tm1b(KOMP)Wtsi} (C57BL/6N-Hjv^{tm1b(KOMP)Wtsi}/J)	increased hemoglobin content	J:211773
	increased mean corpuscular hemoglobin	J:211773
Hjv^tm1Kpan/Hjv^tm1Kpan Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S6/SvEvTac * C57BL/6)	abnormal macrophage morphology	J:231428
	decreased spleen iron level	J:231428
Hjv^tm1Nca/Hjv⁺ Tmprss6^tm1Dgen/Tmprss6^tm1Dgen (involves: 129P2/OlaHsd * 129S4/SvJae * 129S6/SvEvTac * C57BL/6)	decreased erythrocyte cell number	J:160248
	decreased hematocrit	J:160248
	decreased hemoglobin content	J:160248
	decreased mean corpuscular hemoglobin concentration	J:160248
	decreased mean corpuscular volume	J:160248
	increased red blood cell distribution width	J:160248
	microcytic anemia	J:160248
Hjv^tm1Nca/Hjv^tm1Nca (involves: 129S4/SvJae * 129S6/SvEvTac)	decreased spleen iron level	J:100178
	hematopoietic system phenotype	J:100178
Hjv^tm1Nca/Hjv^tm1Nca (involves: 129P2/OlaHsd * 129S4/SvJae * 129S6/SvEvTac * C57BL/6)	abnormal macrophage morphology	J:160248
	decreased spleen iron level	J:160248
Hjv^tm1Nca/Hjv^tm1Nca Tmprss6^tm1Dgen/Tmprss6⁺ (involves: 129P2/OlaHsd * 129S4/SvJae * 129S6/SvEvTac * C57BL/6)	abnormal macrophage morphology	J:160248
	decreased spleen iron level	J:160248
Hjv^tm1Nca/Hjv^tm1Nca Tmprss6^tm1Dgen/Tmprss6^tm1Dgen (involves: 129P2/OlaHsd * 129S4/SvJae * 129S6/SvEvTac * C57BL/6)	abnormal macrophage morphology	J:160248
	decreased spleen iron level	J:160248
Hk1^dea/Hk1^dea (A/J-Hk1^dea/J)	abnormal erythrocyte morphology	J:72146
	abnormal erythropoiesis	J:72146
	abnormal spleen morphology	J:72146
	anemia	J:72146
	anisocytosis	J:72146
	decreased erythrocyte cell number	J:72146
	decreased hematocrit	J:72146
	decreased hemoglobin content	J:72146
	decreased mean corpuscular hemoglobin	J:72146
	hemolytic anemia	J:72146
	hyperchromasia	J:72146
	increased mean corpuscular volume	J:72146
	increased spleen red pulp amount	J:72146
	increased spleen weight	J:72146
	polychromatophilia	J:72146
	reticulocytosis	J:72146
Hlb18/? (C57BL/6J-Hlb18)	increased leukocyte cell number	J:82961
Hlb95/? (C57BL/6J-Hlb95)	increased leukocyte cell number	J:82961
Hlb141/? (C57BL/6J-Hlb141)	decreased leukocyte cell number	J:82961
Hlb141/? (C57BL/6J-Hlb141)	decreased neutrophil cell number	J:82961
hlb145/? (C57BL/6J-hlb145/J)	decreased leukocyte cell number	J:82961
hlb156/? (C57BL/6J-hlb156/J)	decreased neutrophil cell number	J:82961
Hlb304/? (C57BL/6J-Hlb304)	decreased hematocrit	J:82961
	decreased hemoglobin content	J:82961
	macrocytic anemia	J:82961
hlb385/? (C57BL/6J-hlb385/J)	decreased leukocyte cell number	J:82961
Hlx^tm1Rph/Hlx^tm1Rph (involves: 129P2/OlaHsd)	abnormal erythropoiesis	J:31553
	anemia	J:31553
	impaired hematopoiesis	J:31553
Hmbox1^em1(IMPC)Tcp/Hmbox1^em1(IMPC)Tcp (C57BL/6N-Hmbox1^em1(IMPC)Tcp/Tcp)	decreased lymphocyte cell number	J:211773
	decreased mean corpuscular hemoglobin	J:211773
Hmbs^tm1.1Rjde/Hmbs^tm1.1Rjde (involves: 129/Sv * C57BL/6)	increased erythrocyte protoporphyrin level	J:275245
Hmcn2^{tm1b(EUCOMM)Wtsi}/Hmcn2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Hmcn2^{tm1b(EUCOMM)Wtsi}/Bay)	increased hematocrit	J:211773
	increased hemoglobin content	J:211773
Hmga1^tm1Afus/Hmga1⁺ (involves: 129S7/SvEvBrd * C57BL/6)	enlarged spleen	J:106702
Hmga1^tm1Afus/Hmga1^tm1Afus (involves: 129S7/SvEvBrd * C57BL/6)	enlarged spleen	J:106702
	myeloid hyperplasia	J:106702
Hmgb1^tm1.1Ttg/Hmgb1^tm1.1Ttg Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd)	abnormal macrophage physiology	J:205499
	decreased macrophage cell number	J:205499
	hematopoietic system phenotype	J:205499
	impaired macrophage phagocytosis	J:205499
	increased macrophage apoptosis	J:205499
Hmgb3^tm1Dmb/Y (involves: 129S6/SvEvTac * 129X1/SvJ)	abnormal common lymphocyte progenitor cell morphology	J:96514
	abnormal common myeloid progenitor cell morphology	J:96514
	abnormal definitive hematopoiesis	J:96514
	abnormal erythropoiesis	J:96514
	abnormal leukopoiesis	J:96514
	decreased mean corpuscular volume	J:96514
	increased erythrocyte cell number	J:96514
	increased hematocrit	J:96514
	increased hemoglobin content	J:96514
Hmgn5^tm1.2Mbus/Y (involves: 129S4/SvJae * C57BL/6J)	abnormal erythrocyte cell number	J:199604
	decreased granulocyte number	J:199604
	decreased IgE level	J:199604
	increased CD8-positive, alpha-beta T cell number	J:199604
	increased IgA level	J:199604
Hmgn5^tm1.2Mbus/Hmgn5^tm1.2Mbus (involves: 129S4/SvJae * C57BL/6J)	abnormal erythrocyte cell number	J:199604
	decreased granulocyte number	J:199604
	decreased IgE level	J:199604
	increased CD8-positive, alpha-beta T cell number	J:199604
	increased IgA level	J:199604
Hmox1^tm1.1Gkl/Hmox1^tm1.1Gkl Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129 * 129P2/OlaHsd * BALB/cJ * C57BL/6)	increased B cell number	J:148498
	increased CD4-positive, alpha-beta T cell number	J:148498
	increased CD8-positive, alpha-beta T cell number	J:148498
	increased granulocyte number	J:148498
	increased macrophage cell number	J:148498
	increased splenocyte proliferation	J:148498
Hmox1^tm1.2Gkl/Hmox1^tm1.2Gkl (involves: 129 * BALB/cJ * C57BL/6)	enlarged spleen	J:148498
Hmox1^tm1Poss/Hmox1⁺ Slc48a1^em1Ih/Slc48a1^em1Ih (involves: 129 * 129S2/SvPas * C57BL/6J)	decreased macrophage cell number	J:282829
	impaired hematopoiesis	J:282829
	increased erythroid progenitor cell number	J:282829
Hmox1^tm1Poss/Hmox1^tm1Poss (involves: 129S2/SvPas * C57BL/6)	abnormal leukocyte cell number	J:79254
	abnormal splenic cell ratio	J:79254
	anisocytosis	J:79254
	decreased erythrocyte cell number	J:79254
	decreased hematocrit	J:79254
	decreased hemoglobin content	J:79254
	decreased mean corpuscular volume	J:79254
	enlarged spleen	J:79254
	extramedullary hematopoiesis	J:79254
	microcytic anemia	J:79254
	spleen hyperplasia	J:79254
Hmox1^tm1Poss/Hmox1^tm1Poss (involves: 129 * 129S2/SvPas * C57BL/6J)	anemia	J:282829
	decreased macrophage cell number	J:282829
Hmox1^tm1Poss/Hmox1^tm1Poss Slc48a1^em1Ih/Slc48a1^em1Ih (involves: 129 * 129S2/SvPas * C57BL/6J)	anemia	J:282829
	decreased macrophage cell number	J:282829
Hmox1^tm1Poss/Hmox1^tm1Poss Spic^tm2Kmm/Spic^tm2Kmm (involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6 * FVB/N)	decreased macrophage cell number	J:210804
Hmox2^{tm1b(EUCOMM)Hmgu}/Hmox2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Hmox2^{tm1b(EUCOMM)Hmgu}/H)	decreased monocyte cell number	J:211773
	increased red blood cell distribution width	J:211773
	increased spleen weight	J:211773
Hnrnpd^{tm1b(KOMP)Wtsi}/Hnrnpd⁺ (C57BL/6N-Hnrnpd^{tm1b(KOMP)Wtsi}/Nju)	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
Hnrnpd^tm1Rjsc/Hnrnpd^tm1Rjsc (involves: 129S6/SvEvTac * C57BL/6J)	abnormal macrophage physiology	J:116112
Hnrnph1^{tm1b(KOMP)Wtsi}/Hnrnph1⁺ (C57BL/6N-Hnrnph1^{tm1b(KOMP)Wtsi}/Nju)	decreased mean corpuscular hemoglobin concentration	J:211773
	decreased neutrophil cell number	J:211773
	increased lymphocyte cell number	J:211773
	increased mean corpuscular volume	J:211773
	increased mean platelet volume	J:211773
Hnrnpl^tm1.1Tmo/Hnrnpl^tm1.1Tmo Tg(Lck-cre)548Jxm/0 (B6.Cg-Hnrnpl^tm1.1Tmo Tg(Lck-cre)548Jxm)	abnormal T cell differentiation	J:188749
	decreased CD4-positive, alpha-beta T cell number	J:188749
	decreased CD8-positive, alpha-beta T cell number	J:188749
	decreased double-positive T cell number	J:188749
	decreased T cell number	J:188749
	increased double-negative T cell number	J:188749
	increased T cell proliferation	J:188749
	thymus hypoplasia	J:188749
Hnrnpll^thdr/Hnrnpll^thdr (C57BL/6JSfdAnu-Hnrnpll^thdr/Anu)	abnormal memory T cell morphology	J:142641
	abnormal memory T cell physiology	J:142641
	abnormal T cell differentiation	J:142641
	decreased CD4-positive, alpha-beta T cell number	J:142641
Hook1^em1(IMPC)Tcp/Hook1^em1(IMPC)Tcp (C57BL/6NCrl-Hook1^em1(IMPC)Tcp/Tcp)	small spleen	J:211773
Hook2^em1(IMPC)Tcp/Hook2^em1(IMPC)Tcp (C57BL/6N-Hook2^em1(IMPC)Tcp/Tcp)	decreased mean corpuscular hemoglobin	J:211773
	increased red blood cell distribution width	J:211773
Hook3^{tm1b(NCOM)Mfgc}/Hook3^{tm1b(NCOM)Mfgc} (C57BL/6N-Hook3^{tm1b(NCOM)Mfgc}/Tcp)	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
Hoxa1^tm3.1Mrc/Hoxa1^tm3.1Mrc (involves: 129S1/Sv * 129X1/SvJ)	thymus hypoplasia	J:178887
Hoxa1^tm3.1Mrc/Hoxa1^tm3.1Mrc Hoxb1^tm3Mrc/Hoxb1⁺ (involves: 129S1/Sv * 129X1/SvJ)	small thymus	J:41540
Hoxa1^tm3.1Mrc/Hoxa1^tm3.1Mrc Hoxb1^tm3Mrc/Hoxb1^tm3Mrc (involves: 129S1/Sv * 129X1/SvJ)	athymia	J:41540
Hoxa3^tm1Kth/Hoxa3^tm1Kth (involves: 129S1/Sv * 129X1/SvJ)	athymia	J:60296
Hoxa3^tm1Kth/Hoxa3^tm1Kth Hoxd3^{tm3(Hoxa3)Mrc}/Hoxd3⁺ (involves: 129S1/Sv * 129X1/SvJ)	athymia	J:60296
Hoxa3^tm1Mrc/Hoxa3⁺ Hoxb3^tm1Mrc/Hoxb3^tm1Mrc (involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6J)	ectopic thymus	J:46523
Hoxa3^tm1Mrc/Hoxa3⁺ Hoxd3^tm1Mrc/Hoxd3^tm1Mrc (involves: 129S7/SvEvBrd * C57BL/6J)	ectopic thymus	J:46523
Hoxa3^tm1Mrc/Hoxa3^tm1Mrc (involves: 129S7/SvEvBrd)	athymia	J:17753, J:161296
Hoxa3^tm1Mrc/Hoxa3^tm1Mrc Hoxd3^tm1Mrc/Hoxd3^tm1Mrc (involves: 129S7/SvEvBrd * C57BL/6J)	athymia	J:19447
Hoxa3^tm1Mrc/Hoxa3^tm2Nrm (involves: 129S7/SvEvBrd * C3H * C57BL/6 * C57BL/6NHsd)	athymia	J:161296
Hoxa3^tm1Mrc/Hoxa3^tm3.1Nrm H2az2^{Tg(Wnt1-cre)11Rth}/H2az2⁺ (involves: 129S7/SvEvBrd * C57BL/6J * CBA/J)	ectopic thymus	J:161296
Hoxa3^tm1Nrm/Hoxa3^tm1Mrc (involves: 129S7/SvEvBrd * C3H * C57BL/6 * C57BL/6NHsd)	athymia	J:161296
Hoxa3^tm1Nrm/Hoxa3^tm1Nrm (involves: C3H * C57BL/6 * C57BL/6NHsd)	athymia	J:161296
Hoxa3^tm2Nrm/Hoxa3^tm2Nrm (involves: C3H * C57BL/6 * C57BL/6NHsd)	athymia	J:161296
Hoxa3^tm2Nrm/Hoxa3^tm3.1Nrm H2az2^{Tg(Wnt1-cre)11Rth}/H2az2⁺ (involves: C3H * C57BL/6 * CBA/J)	ectopic thymus	J:161296
Hoxa5^tm1Rob/Hoxa5^tm1Rob (involves: 129S/SvEv * C57BL/6 * MF1)	abnormal alveolar macrophage morphology	J:113378
Hoxa7^tm1Mrc/Hoxa7^tm1Mrc Hoxb7^tm1Mrc/Hoxb7^tm1Mrc (involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/SvJ)	small thymus	J:50942
Hoxa9^tm1Mrc/Hoxa9^tm1Mrc (B6.129S7-Hoxa9^tm1Mrc)	abnormal common myeloid progenitor cell morphology	J:126371
	decreased bone marrow cell number	J:126371
	decreased spleen weight	J:126371
	increased hematopoietic stem cell number	J:126371
	spleen hypoplasia	J:126371
Hoxb4^tm1.1Karl/Hoxb4^tm1.1Karl (involves: 129 * C57BL/6J)	abnormal definitive hematopoiesis	J:90976
	decreased bone marrow cell number	J:90976
	decreased erythrocyte cell number	J:90976
	decreased hemoglobin content	J:90976
	spleen hypoplasia	J:90976
Hoxb6^tm1Cka/Hoxb6^tm1Cka (involves: 129P2/OlaHsd * C57BL/6)	abnormal definitive hematopoiesis	J:133561
	abnormal erythropoiesis	J:133561
Hoxb8^tm1.1Mrc/Hoxb8^tm1.1Mrc (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)	abnormal microglial cell morphology	J:162102
Hoxb9^tm1Mrc/Hoxb9^tm1Mrc (involves: 129S7/SvEvBrd)	small thymus	J:37847
Hoxc4^tm2.1Mrc/Hoxc4^tm2.1Mrc (involves: 129S/SvEv * C57BL/6)	abnormal class switch recombination	J:148278
	abnormal somatic hypermutation frequency	J:148278
	decreased IgA level	J:148278
	decreased IgE level	J:148278
	decreased IgG1 level	J:148278
	decreased IgG2a level	J:148278
	decreased IgG2b level	J:148278
	decreased IgG3 level	J:148278
	decreased IgM level	J:148278
Hp^tm1Skl/Hp^tm1Skl Hpx^tm1Altr/Hpx^tm1Altr (involves: 129/Sv * 129P2/OlaHsd * C57BL/6J)	enlarged spleen	J:80539
	increased spleen red pulp amount	J:80539
Hpf1^{em1(IMPC)Wtsi}/Hpf1^{em1(IMPC)Wtsi} (C57BL/6N-Hpf1^{em1(IMPC)Wtsi}/Wtsi)	increased red blood cell distribution width	J:211773
Hprt1^b-m3/Y Impdh1^tm1Bmi/Impdh1^tm1Bmi (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal lymphopoiesis	J:85443
	decreased cytotoxic T cell cytolysis	J:85443
	decreased splenocyte proliferation	J:85443
	decreased T cell proliferation	J:85443
Hprt1^b-m3/Y Impdh2^tm1Bmi/Impdh2⁺ (involves: 129P2/OlaHsd)	abnormal cytotoxic T cell physiology	J:86045
Hprt1^b-m3/Y Impdh2^tm1Bmi/Impdh2⁺ (involves: 129P2/OlaHsd)	abnormal lymphocyte cell number	J:86045
Hprt1^{tm1(ACTB-Epor)Unc}/Y (involves: 129P2/OlaHsd)	abnormal definitive hematopoiesis	J:81859
Hprt1^{tm1(ACTB-Epor)Unc}/Y (involves: 129P2/OlaHsd)	hematopoietic system phenotype	J:81859
Hprt1^{tm1(ACTB-Epor)Unc}/Hprt1^{tm1(ACTB-Epor)Unc} (involves: 129P2/OlaHsd)	abnormal definitive hematopoiesis	J:81859
	hematopoietic system phenotype	J:81859
Hprt1^{tm1(CAG-Tgfbr1)Lba}/Y Tg(Cd4-cre)1Cwi/0 (involves: 129 C57BL/6 * DBA/2)	abnormal T cell activation	J:148747
Hprt1^{tm1(CAG-Tgfbr1)Lba}/Hprt1^{tm1(CAG-Tgfbr1)Lba} Tg(Cd4-cre)1Cwi/0 (involves: 129 * C57BL/6 * DBA/2)	abnormal T cell activation	J:148747
Hprt1^{tm1(CUX1)Anep}/Hprt1⁺ (either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * C57BL/6 * FVB))	abnormal hematopoietic system morphology/development	J:113393
	abnormal hematopoietic system physiology	J:113393
	abnormal spleen white pulp morphology	J:113393
	abnormal splenic cell ratio	J:113393
	anemia	J:113393
	decreased B cell number	J:113393
	decreased erythrocyte cell number	J:113393
	decreased hematocrit	J:113393
	decreased mean corpuscular hemoglobin concentration	J:113393
	enlarged spleen	J:113393
	increased leukocyte cell number	J:113393
	increased neutrophil cell number	J:113393
	myeloid hyperplasia	J:113393
	spleen hyperplasia	J:113393
Hprt1^{tm1(Pck1-cre)Vhh}/Y Vhl^tm1Jae/Vhl^tm1Jae (involves: 129P2/OlaHsd * 129S4/SvJae * BALB/c * C57BL/6)	increased hemoglobin content	J:97652
	polycythemia	J:97652
Hprt1^{tm1(Rcan1)Zyga}/Hprt1⁺ (B6.129P2-Hprt1^{tm1(Rcan1)Zyga})	abnormal megakaryocyte progenitor cell morphology	J:197570
	increased megakaryocyte cell number	J:197570
	thrombocytosis	J:197570
Hprt1^{tm1a(EUCOMM)Hmgu}/Hprt1^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Hprt1^{tm1a(EUCOMM)Hmgu}/Ieg)	decreased erythrocyte cell number	J:165965
	decreased hemoglobin content	J:165965
Hps1^ep/Hps1^ep (involves: C3HeB/FeJ * C57BL/6J)	abnormal macrophage physiology	J:7869
	abnormal platelet physiology	J:7327, J:42484
	decreased platelet ADP level	J:7327
	decreased platelet ATP level	J:7327
	decreased platelet dense granule number	J:42484
	decreased platelet serotonin level	J:7327
Hps1^ep/Hps1^ep (B6.C3Fe-Hps1^ep/J)	abnormal NK cell physiology	J:6801
	decreased platelet ADP level	J:7327
	decreased platelet ATP level	J:7327
	decreased platelet serotonin level	J:7327, J:29748
Hps3^coa/Hps3^coa (involves: C57BL/10J)	abnormal platelet dense granule physiology	J:9300
	decreased platelet aggregation	J:9300
	decreased platelet ATP level	J:9300
	decreased platelet dense granule number	J:9300
	decreased platelet serotonin level	J:9300
Hps4^le/Hps4^le (B6.C3-Pde6b^rd1 Hps4^le)	abnormal platelet dense granule morphology	J:7327
	abnormal platelet physiology	J:11990
	decreased platelet serotonin level	J:7327, J:29748
Hps4^le/Hps4^le Pde6b^rd1/Pde6b^rd1 (B6.C3-Pde6b^rd1 Hps4^le/J)	abnormal platelet activation	J:221384
	decreased platelet aggregation	J:221384
Hps5^ru2-mr/Hps5^ru2-mr (B6.Cg-Hps5^ru2-mr/Re)	decreased platelet ADP level	J:7327
	decreased platelet ATP level	J:7327
	decreased platelet dense granule number	J:7327
	decreased platelet serotonin level	J:7327, J:29748
Hps6^em1(IMPC)Tcp/Hps6^em1(IMPC)Tcp (C57BL/6N-Hps6^em1(IMPC)Tcp/Tcp)	small spleen	J:211773
	small thymus	J:211773
Hpse^tm1.2Mdh/Hpse^tm1.2Mdh (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal dendritic cell chemotaxis	J:209913
	abnormal Langerhans cell morphology	J:209913
	decreased leukocyte cell number	J:209913
	impaired eosinophil recruitment	J:209913
	increased eosinophil cell number	J:209913
Hpse^tm1Jpli/Hpse^tm1Jpli (B6.129-Hpse^tm1Jpli)	increased hemoglobin content	J:148281
Hpx^tm1Altr/Hpx^tm1Altr (either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))	hematopoietic system phenotype	J:58821
Hr^em1(IMPC)H/Hr^em1(IMPC)H (C57BL/6NTac-Hr^em1(IMPC)H/H)	decreased lymphocyte cell number	J:211773
Hr^em1(IMPC)H/Hr^em1(IMPC)H (C57BL/6NTac-Hr^em1(IMPC)H/H)	increased neutrophil cell number	J:211773
Hr^hr/Hr^hr (HRS/J)	decreased T cell number	J:6087
	decreased T cell proliferation	J:6375
	increased macrophage cell number	J:150402
Hr^m1Btlr/Hr^m1Btlr (C57BL/6J-Hr^m1Btlr)	hematopoietic system phenotype	J:138686
Hr^rh-R/Hr^rh-R (involves: 101 * C3H/Rl * C57BL/RlEl * C57BL/10Rl * SEC/El)	decreased thymus weight	J:156542
Hr^rh/Hr^rh (RHJ/LeJ)	thymus atrophy	J:57947
Hr^rhsl/Hr^rhsl (involves: BALB/c)	thymus atrophy	J:98859
Hr^USP/Hr^USP (either: (involves: A/J * BALB/c) or (involves: BALB/c * C57BL/6) or (involves: BALB/c * DBA/2))	abnormal immunoglobulin level	J:21316
	abnormal thymus involution	J:21316
	decreased IgM level	J:21316
	increased IgG level	J:21316
	thymus cortex atrophy	J:21316
Hrec^C57BL/6J/? (involves: C57BL/6J * DBA/2J)	abnormal definitive hematopoiesis	J:76791
Hrec^DBA/2J/? (involves: C57BL/6J * DBA/2J)	abnormal definitive hematopoiesis	J:76791
Hrg^tm1Wja/Hrg^tm1Wja (involves: 129P2/OlaHsd * C57BL/6)	increased monocyte cell number	J:134621
Hrh1^tm1Wtn/Hrh1^tm1Wtn (involves: 129P2/OlaHsd * C57BL/6)	decreased B cell proliferation	J:111704
	decreased IgG3 level	J:111704
	decreased IgM level	J:111704
	decreased T cell number	J:111704
	decreased T cell proliferation	J:111704
Hrh1^tm1Wtn/Hrh1^tm1Wtn (B6.129P2-Hrh1^tm1Wtn)	increased IgG level	J:110367
Hrh1^tm1Wtn/Hrh1^tm1Wtn (B6.129P2-Hrh1^tm1Wtn)	increased IgM level	J:110367
Hrh4^tm1Lex/Hrh4⁺ (involves: 129S/SvEv * C57BL/6)	abnormal mast cell physiology	J:132140
Hrh4^tm1Lex/Hrh4^tm1Lex (involves: 129S/SvEv * C57BL/6)	abnormal mast cell physiology	J:131785
Hrh4^tm1Lex/Hrh4^tm1Lex (involves: 129S/SvEv * BALB/c)	decreased IgE level	J:131785
Hrh4^tm1Lex/Hrh4^tm1Lex (involves: 129S/SvEv * BALB/c)	decreased IgG1 level	J:131785
Hs3st3a1^{tm1(KOMP)Vlcg}/Hs3st3a1^{tm1(KOMP)Vlcg} (C57BL/6N-Hs3st3a1^{tm1(KOMP)Vlcg}/MbpMmucd)	increased mean platelet volume	J:211773
	thrombocytopenia	J:211773
Hs3st3b1^em2(IMPC)Mbp/Hs3st3b1^em2(IMPC)Mbp (C57BL/6N-Hs3st3b1^em2(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
Hscfr^AKR/J/? (involves: AKR/J * C57BL/6Ka)	abnormal definitive hematopoiesis	J:73737
Hsd17b1^{tm1.1(KOMP)Vlcg}/Hsd17b1^{tm1.1(KOMP)Vlcg} (C57BL/6N-Hsd17b1^{tm1.1(KOMP)Vlcg}/J)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	decreased mean corpuscular volume	J:211773
Hsd17b3^tm1.2Mpo/Hsd17b3^tm1.2Mpo (involves: 129S6/SvEvTac * C57BL/6N * C57BL/6NCrl)	increased spleen weight	J:301756
Hsd17b4^em1(IMPC)Tcp/Hsd17b4^em1(IMPC)Tcp (C57BL/6NCrl-Hsd17b4^em1(IMPC)Tcp/Tcp)	abnormal spleen morphology	J:211773
Hsd17b4^tm1Baes/Hsd17b4^tm1Baes (involves: 129S1/Sv * 129X1/SvJ)	microgliosis	J:201698
Hsd17b4^tm2Baes/Hsd17b4^tm2Baes Tg(Nes-cre)1Kln/0 (involves: 129 * C57BL/6 * SJL)	microgliosis	J:201698
Hsd17b11^{Gt(OST237628)Lex}/Hsd17b11^{Gt(OST237628)Lex} (B6;129S5-Hsd17b11^{Gt(OST237628)Lex}/Mmucd)	increased IgG2a level	J:171883
	increased immature B cell number	J:171883
Hsd17b14^tm1Lex/Hsd17b14^tm1Lex (B6;129S5-Hsd17b14^tm1Lex/Mmucd)	increased IgG2a level	J:171883
Hsf2bp^{tm1a(EUCOMM)Hmgu}/Hsf2bp⁺ (C57BL/6N-Hsf2bp^{tm1a(EUCOMM)Hmgu}/Cnrm)	thrombocytopenia	J:165965
Hsf2bp^{tm1a(EUCOMM)Hmgu}/Hsf2bp^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Hsf2bp^{tm1a(EUCOMM)Hmgu}/Cnrm)	increased mean corpuscular hemoglobin concentration	J:165965
Hsh2d^tm1Viss/Hsh2d^tm1Viss (B6.129-Hsh2d^tm1Viss)	increased T cell proliferation	J:111408
Hsh2d^tm1Viss/Hsh2d^tm1Viss (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:111408
	abnormal CD8-positive, alpha-beta T cell physiology	J:111408
	increased spleen weight	J:111408
Hsm1^C3H/HeJ/Hsm1^CAST/EiJ (involves: C3H/HeJ-Slc4a1^wan/J * CAST/EiJ)	decreased mean corpuscular volume	J:89043
Hsm1^CAST/EiJ/Hsm1^CAST/EiJ (involves: C3H/HeJ-Slc4a1^wan/J * CAST/EiJ)	decreased mean corpuscular volume	J:89043
Hsp90b1^tm1Zhli/Hsp90b1^tm1.1Zhli Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S/SvEv)	abnormal macrophage physiology	J:118427
Hspa9^{Gt(IST14901H6)Tigm}/Hspa9⁺ (involves: C57BL/6N)	decreased pre-B cell number	J:227164
Hspa9^{Gt(IST14901H6)Tigm}/Hspa9⁺ (involves: C57BL/6N)	hematopoietic system phenotype	J:227164
Hspa12a^tm1.1Zdi/Hspa12a^tm1.1Zdi (involves: 129 * C57BL/6)	abnormal macrophage morphology	J:302786
Hspa13^tm1.1Smoc/Hspa13^tm1.1Smoc Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * 129S * C57BL/6)	abnormal class switch recombination	J:303927
	abnormal plasmablast number	J:303927
	abnormal somatic hypermutation frequency	J:303927
	decreased IgA level	J:303927
	decreased IgE level	J:303927
	decreased IgG1 level	J:303927
	decreased IgG2b level	J:303927
	decreased IgG2c level	J:303927
	decreased IgG3 level	J:303927
	decreased IgG level	J:303927
	decreased IgM level	J:303927
	decreased plasma cell number	J:303927
Hspb1^{tm1.1(KOMP)Vlcg}/Hspb1^{tm1.1(KOMP)Vlcg} (C57BL/6N-Hspb1^{tm1.1(KOMP)Vlcg}/J)	increased mean corpuscular hemoglobin	J:211773
Hspb1^tm1.1Jdn/Hspb1^tm1.1Jdn (B6.129S2(Cg)-Hspb1^tm1.1Jdn)	abnormal macrophage physiology	J:209117
Hspb1^tm1.1Jdn/Hspb1^tm1.1Jdn (B6.129S2(Cg)-Hspb1^tm1.1Jdn)	abnormal neutrophil physiology	J:209117
Hspb8^em1(IMPC)J/Hspb8^em1(IMPC)J (C57BL/6NJ-Hspb8^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Hspbap1^{tm1b(EUCOMM)Hmgu}/Hspbap1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Hspbap1^{tm1b(EUCOMM)Hmgu}/Bay)	increased spleen weight	J:211773
Hspd1^{tm1c(EUCOMM)Hmgu}/Hspd1^{tm1c(EUCOMM)Hmgu} Tg(Tek-cre)12Flv/0 (involves: Black Swiss * C3H * C57BL/6 * C57BL/6N)	abnormal blood cell morphology	J:282096
	abnormal erythrocyte physiology	J:282096
	anemia	J:282096
	decreased erythrocyte cell number	J:282096
Hspg2^tm1Rdgr/Hspg2^tm1Rdgr (involves: 129S1/Sv * 129X1/SvJ)	abnormal osteoclast morphology	J:121855
	increased osteoclast cell number	J:121855
Htr1f^{tm1.1(KOMP)Vlcg}/Htr1f^{tm1.1(KOMP)Vlcg} (C57BL/6N-Htr1f^{tm1.1(KOMP)Vlcg}/J)	increased mean corpuscular volume	J:211773
Htr3a^tm1Ckn/Htr3a^tm1Ckn (involves: 129S1/Sv * C57BL/6J * DBA/2)	decreased lymphocyte cell number	J:90942
	increased bone marrow cell number	J:90942
Htra2^mnd2/Htra2^mnd2 (involves: C3H/HeJ * C57BL/6J * CAST/Ei)	abnormal thymus morphology	J:12780
	spleen atrophy	J:12780
Htra2^mnd2/Htra2^mnd2 (involves: C57BL/6J)	abnormal bone marrow cell morphology/development	J:132627
	decreased double-positive T cell number	J:132627
	decreased pre-B cell number	J:132627
	decreased pro-B cell number	J:132627
	decreased single-positive T cell number	J:132627
Htra2^tm1.1Hohj/Htra2^tm1.1Hohj Tg(Nes-cre)1Kln/0 (involves: C57BL/6J)	spleen atrophy	J:225666
	thymus atrophy	J:225666
Htra2^tm1.2Hohj/Htra2^tm1.2Hohj (involves: C57BL/6 * C57BL/6J)	decreased lymphocyte cell number	J:225666
	spleen atrophy	J:225666
	thymus atrophy	J:225666
Htra2^tm1Jdo/Htra2^tm1Jdo (involves: 129P/Ola * C57BL/6)	small spleen	J:94227
Htra2^tm1Jdo/Htra2^tm1Jdo (involves: 129P/Ola * C57BL/6)	small thymus	J:94227
Htt^tm2Detl/Htt⁺ (B6J.129P2-Htt^tm2Detl)	microgliosis	J:220868
hubb/hubb (involves: ICR)	increased hematocrit	J:8170
hubb/hubb (involves: ICR)	increased spleen weight	J:8170
Hus1^tm1Led/Hus1^tm1Led (either: (involves: 129S6/SvEvTac) or (involves: 129S6/SvEvTac * Black Swiss))	abnormal embryonic hematopoiesis	J:63869
Hvcn1^{Gt(RRN293)Byg}/Hvcn1^{Gt(RRN293)Byg} (B6.129P2-Hvcn1^{Gt(RRN293)Byg})	abnormal macrophage physiology	J:148032
	abnormal neutrophil physiology	J:148032
Hyal2^tm1.1Bfla/Hyal2^tm1.1Bfla (involves: 129P2/OlaHsd * BALB/c * C57BL/6)	anemia	J:146040
	decreased erythrocyte cell number	J:146040
	decreased hemoglobin content	J:146040
	increased spleen iron level	J:146040
	polychromatophilia	J:146040
	reticulocytosis	J:146040
	thrombocytopenia	J:146040
Hycc1^{em1(IMPC)Ccpcz}/Hycc1^{em1(IMPC)Ccpcz} (C57BL/6N-Hycc1^{em1(IMPC)Ccpcz}/Ccpcz)	enlarged thymus	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
	increased red blood cell distribution width	J:211773
Hydin^hyrh/Hydin^hyrh (involves: C57BL/6J * C57BL/10J * RIII)	thymus atrophy	J:137815
Iapp^tm1Sgm/Iapp⁺ (involves: 129P2/OlaHsd)	increased osteoclast cell number	J:88964
Iapp^tm1Sgm/Iapp^tm1Sgm (involves: 129P2/OlaHsd)	increased osteoclast cell number	J:88964
Iars2^em1(IMPC)Tcp/Iars2⁺ (C57BL/6NCrl-Iars2^em1(IMPC)Tcp/Tcp)	increased hematocrit	J:211773
Ibsp^tm1Jeau/Ibsp^tm1Jeau (involves: 129S1/Sv * 129X1/SvJ * CD-1)	abnormal osteoclast morphology	J:228156, J:136223
	decreased osteoclast cell number	J:136223
	increased osteoclast cell number	J:228156
Ibtk^Gt(XF224)Byg/Ibtk^Gt(XF224)Byg (involves: 129P2/OlaHsd * C57BL/6)	abnormal splenocyte physiology	J:174707
Ica1^{tm1b(EUCOMM)Wtsi}/Ica1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Ica1^{tm1b(EUCOMM)Wtsi}/Tcp)	abnormal spleen morphology	J:211773
	small spleen	J:211773
Ica1^tm1Mdos/Ica1^tm1Mdos (NOD.129-Ica1^tm1Mdos)	abnormal T cell physiology	J:83526
Icam1^tm1Alb/Icam1^tm1Alb (B6.Cg-Icam1^tm1Alb)	abnormal leukocyte adhesion	J:100242
	abnormal leukocyte tethering or rolling	J:100242
	increased leukocyte cell number	J:100242
	increased neutrophil cell number	J:100242
Icam1^tm1Bay/Icam1^tm1Bay (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal cellular extravasation	J:14565
	increased neutrophil cell number	J:14565
Icam1^tm1Bay/Icam1^tm1Bay (B6.129S7-Icam1^tm1Bay)	abnormal cellular extravasation	J:48271
	abnormal leukocyte migration	J:24239
	abnormal leukocyte tethering or rolling	J:48271
	increased eosinophil cell number	J:48271
	increased lymphocyte cell number	J:48271
	increased monocyte cell number	J:48271
	increased neutrophil cell number	J:48271, J:24239
Icam1^tm1Bay/Icam1^tm1Bay (either: B6.129S7-Icam1^tm1Bay or (involves: 129S7/SvEvBrd * C57BL/6))	abnormal leukocyte tethering or rolling	J:31374
	increased leukocyte cell number	J:31374
Icam1^tm1Bay/Icam1^tm1Bay (involves: 129S7/SvEvBrd * C57BL/6)	impaired neutrophil recruitment	J:112286
	increased neutrophil cell number	J:112286
Icam1^tm1Bay/Icam1^tm1Bay Sele^tm2Alb/Sele^tm2Alb Selp^tm1Bay/Selp^tm1Bay (involves: 129S7/SvEvBrd * C57BL/6)	impaired neutrophil chemotaxis	J:112286
	increased neutrophil cell number	J:112286
Icam1^tm1Bay/Icam1^tm1Bay Sell^tm1Tft/Sell^tm1Tft (B6.129-Sell^tm1Tft Icam1^tm1Bay)	abnormal cellular extravasation	J:48271
	abnormal leukocyte tethering or rolling	J:48271
	abnormal macrophage physiology	J:124291
	abnormal mast cell physiology	J:124291
	impaired macrophage chemotaxis	J:124291
	increased eosinophil cell number	J:48271
	increased lymphocyte cell number	J:48271
	increased monocyte cell number	J:48271
	increased neutrophil cell number	J:48271
Icam1^tm1Bay/Icam1^tm1Bay Selp^tm1Bay/Selp^tm1Bay (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal leukocyte migration	J:24239
	increased neutrophil cell number	J:24239
Icam1^tm1Bay/Icam1^tm1Bay Selp^tm1Bay/Selp^tm1Bay (either: B6.129S7-Selp^tm1Bay Icam1^tm1Bay or (involves: 129S7/SvEvBrd * C57BL/6))	impaired leukocyte tethering or rolling	J:31374
Icam1^tm1Cws/Icam1^tm1Cws (involves: C57BL/6)	abnormal macrophage morphology	J:100353
Icam1^tm1Jcgr/Icam1^tm1Jcgr (involves: 129S4/SvJae * C57BL/6 * DBA/2)	abnormal T cell physiology	J:18743
	increased lymphocyte cell number	J:18743
	increased neutrophil cell number	J:18743
Icam1^tm1Jcgr/Icam1^tm1Jcgr Ldlr^tm1Her/Ldlr^tm1Her (involves: 129S4/SvJae * 129S7/SvEvBrd)	increased neutrophil cell number	J:69597
Icam1^tm1Jcgr/Icam1^tm1Jcgr Ldlr^tm1Her/Ldlr^tm1Her Vcam1^tm1Dmil/Vcam1^tm1Dmil (involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6)	increased leukocyte cell number	J:69597
	increased lymphocyte cell number	J:69597
	increased monocyte cell number	J:69597
	increased neutrophil cell number	J:69597
Icam1^tm1Jcgr/Icam1^tm1Jcgr Vcam1^tm1Dmil/Vcam1^tm1Dmil (involves: 129S4/SvJae * C57BL/6)	impaired macrophage chemotaxis	J:227109
Icam2^tm1Jcgr/Icam2^tm1Jcgr (involves: 129S4/SvJae * C57BL/6)	abnormal eosinophil physiology	J:54748
	abnormal megakaryocyte progenitor cell morphology	J:54748
Icam4^tm1Jach/Icam4^tm1Jach (involves: 129 * C57BL/6)	abnormal erythropoiesis	J:138068
Icam4^tm1Jach/Icam4^tm1Jach (involves: 129 * C57BL/6)	hematopoietic system phenotype	J:138068
Icmt^tm1Hzo/Icmt^tm1Hzo (involves: 129S/SvEv)	abnormal definitive hematopoiesis	J:77742
Icos^tm1.1Wks/Icos^tm1.1Wks (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal B cell number	J:155586
	abnormal B cell physiology	J:155586
	abnormal B cell selection	J:155586
	abnormal class switch recombination	J:155586
	abnormal spleen morphology	J:155586
	decreased CD4-positive, alpha-beta T cell number	J:155586
	decreased IgA level	J:155586
	decreased IgG1 level	J:155586
	decreased IgG2b level	J:155586
	decreased IgG2c level	J:155586
	decreased spleen germinal center number	J:155586
Icos^tm1Dgry/Icos^tm1Dgry (B6.129P2-Icos^tm1Dgry)	abnormal CD4-positive, alpha-beta T cell physiology	J:123477
	abnormal leukocyte cell number	J:123477
	abnormal memory B cell number	J:123477
	abnormal T cell physiology	J:123477
	decreased germinal center B cell number	J:123477
	decreased IgG level	J:123477
	decreased plasma cell number	J:123477
	increased plasma cell number	J:123477
Icos^tm1Flv/Icos^tm1Flv (involves: 129/Sv * C57BL/6)	abnormal immunoglobulin level	J:87123
	abnormal T-helper 2 physiology	J:87123
	decreased IgE level	J:87123
	decreased IgG1 level	J:87123
Icos^tm1Flv/Icos^tm1Flv (NOD.129S1-Icos^tm1Flv)	decreased IgG level	J:131529
Icos^tm1Flv/Icos^tm1Flv (NOD.129S1-Icos^tm1Flv)	decreased T cell number	J:131529
Icos^tm1Mak/Icos^tm1Mak (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell number	J:155586
	abnormal B cell physiology	J:66702
	abnormal class switch recombination	J:66702
	abnormal spleen morphology	J:66702
	abnormal T cell physiology	J:66702
	decreased CD4-positive, alpha-beta T cell number	J:155586
	decreased IgA level	J:155586
	decreased IgE level	J:66702
	decreased IgG1 level	J:66702, J:155586
	decreased IgG2b level	J:155586
	decreased IgG2c level	J:155586
	decreased spleen germinal center number	J:66702, J:155586
	decreased spleen germinal center size	J:66702
	decreased T cell proliferation	J:66702
Icos^tm1Shr/Icos^tm1Shr (Not Specified)	abnormal CD4-positive, alpha-beta T cell physiology	J:87124
	abnormal immunoglobulin level	J:87124
	abnormal spleen germinal center morphology	J:87124
	abnormal T cell differentiation	J:87124
	decreased IgE level	J:87124
	decreased IgG1 level	J:87124
	decreased IgG2a level	J:87124
	decreased IgG level	J:87124
	increased IgG3 level	J:87124
Icos^tm1Tkan/Icos^tm1Tkan (involves: 129S7/SvEvBrd * C57BL/6)	abnormal NK cell physiology	J:95353
Icosl^tm1Cdon/Icosl^tm1Cdon (involves: 129S6/SvEvTac)	abnormal immunoglobulin level	J:86697
	abnormal T cell differentiation	J:86697
	abnormal T-helper 2 physiology	J:86697
	decreased IgE level	J:86697
	decreased IgG1 level	J:86697
	decreased IgG2a level	J:86697
	decreased IgG level	J:86697
	decreased IgM level	J:86697
	small spleen	J:86697
Icosl^tm1Kplm/Icosl^tm1Kplm (involves: 129P2/OlaHsd)	abnormal spleen germinal center morphology	J:84893
	decreased IgA level	J:84893
	decreased IgG2a level	J:84893
	decreased IgG2b level	J:84893
Icosl^tm1Mak/Icosl^tm1Mak (involves: 129P2/OlaHsd * C57BL/6)	abnormal class switch recombination	J:84668
	abnormal spleen morphology	J:84668
	abnormal T-helper 2 cell differentiation	J:84668
	decreased IgG1 level	J:84668
	decreased spleen germinal center number	J:84668
	decreased spleen germinal center size	J:84668
Id1^tm1Xhsu/Id1^tm1Xhsu (B6.129X1-Id1^tm1Xhsu)	decreased hematopoietic stem cell number	J:144696
Id1^tm1Zhu/Id1^tm1Zhu (either: 129/Sv-Id1^tm1Zhu or (involves: 129S1/Sv * C57BL/6))	hematopoietic system phenotype	J:44278
Id1^tm1Zhu/Id1^tm1Zhu (involves: 129S1/Sv * C57BL/6)	abnormal bone marrow cell morphology/development	J:119519
	abnormal hematopoietic stem cell physiology	J:119519, J:155384
	abnormal myelopoiesis	J:155384
	abnormal osteoclast differentiation	J:155384
	decreased bone marrow cell number	J:119519
	decreased erythrocyte cell number	J:119519, J:155384
	decreased hematopoietic stem cell number	J:119519
	decreased lymphocyte cell number	J:119519
	increased monocyte cell number	J:155384
	increased neutrophil cell number	J:155384
	increased osteoclast cell number	J:155384
	myeloid hyperplasia	J:155384
	thrombocytopenia	J:155384
Id1^tm1Zhu/Id1^tm1Zhu Tcf3^tm1Wein/Tcf3^tm1Wein (involves: 129S1/Sv * 129S4/SvJaeSor * C57BL/6)	abnormal thymus corticomedullary boundary morphology	J:44278
	absent B cells	J:44278
	arrested B cell differentiation	J:44278
	decreased lymphocyte cell number	J:44278
	intermingled spleen red and white pulp	J:44278
Id2^tm1Ago/Id2^tm1Ago (B6.129-Id2^tm1Ago)	absent NK cells	J:116119
Id2^tm1Ago/Id2^tm1Ago (B6.129-Id2^tm1Ago)	decreased CD8-positive, alpha-beta T cell number	J:116119
Id2^tm1Ago/Id2^tm1Ago Tg(TcraTcrb)1100Mjb/0 (B6.Cg-Id2^tm1Ago Tg(TcraTcrb)1100Mjb)	abnormal T cell activation	J:116119
Id2^tm1Gtbz/Id2^tm1Gtbz Irf8^tm1Hor/Irf8^tm1Hor (involves: 129P2/OlaHsd * C57BL/6)	abnormal bone marrow cell morphology/development	J:194760
Id2^tm1Gtbz/Id2^tm1Gtbz Nfil3^tm1.1Brad/Nfil3^tm1.1Brad (involves: C57BL/6)	hematopoietic system phenotype	J:194760
Id2^tm1Yyk/Id2^tm1Yyk (involves: 129S1/Sv * 129X1/SvJ)	decreased NK cell number	J:53267
Id2^tm1Yyk/Id2^tm1Yyk (involves: 129S1/Sv * 129X1/SvJ * NMRI)	decreased NK cell number	J:53267
Id2^tm1Yyk/Id2^tm1Yyk (either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * FVB/NJ))	abnormal common lymphocyte progenitor cell morphology	J:125739
	decreased NK T cell number	J:125739
Id2^tm1Yyk/Id2^tm1Yyk Tcf3^tm1Cmu/Tcf3⁺ (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)	decreased NK T cell number	J:125739
Id2^tm1Yyk/Id2^tm1Yyk Tcf3^tm1Cmu/Tcf3^tm1Cmu (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)	decreased B cell number	J:125739
	decreased NK T cell number	J:125739
Id2^tm2.1Gtbz/Id2^tm2.1Gtbz Tg(Itgax-cre)1-1Reiz/0 (involves: C57BL/6 * CBA)	hematopoietic system phenotype	J:194760
Id3^em1(IMPC)Mbp/Id3^em1(IMPC)Mbp (C57BL/6N-Id3^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased mean corpuscular volume	J:211773
	increased mean platelet volume	J:211773
	increased red blood cell distribution width	J:211773
	increased spleen weight	J:211773
Id3^tm1Cmu/Id3^tm1Cmu (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal double-positive T cell morphology	J:59969
	abnormal T cell differentiation	J:59969
Id3^tm1Zhu/Id3^tm1Zhu (involves: 129/Sv * C57BL/6)	abnormal T cell physiology	J:56950
	decreased B cell proliferation	J:56950
	decreased immunoglobulin level	J:56950
Id3^tm1Zhu/Id3^tm1Zhu (involves: 129S4/SvJaeSor * C57BL/6)	abnormal T cell differentiation	J:144696
Id3^tm2.1Cmu/Id3^tm2.1Cmu (Not Specified)	decreased thymocyte number	J:176462
	increased B cell number	J:176462
	increased gamma-delta T cell number	J:176462
	increased T follicular helper cell number	J:176462
Id3^tm2.1Cmu/Id3^tm2.1Cmu Tcf3^tm4Zhu/Tcf3^tm4Zhu Tg(Cd4-cre)1Cwi/0 (involves: 129S4/SvJaeSor * C57BL/6 * DBA/2)	decreased thymocyte number	J:176462
Id3^tm2.1Zhu/Id3^tm2.1Zhu Tg(Lck-cre)#Zhu/0 (involves: 129S6/SvEvTac * C57BL/6 * SJL * SJL/J)	abnormal T cell differentiation	J:172701
	decreased CD4-positive, alpha-beta T cell number	J:172701
	decreased CD8-positive, alpha-beta T cell number	J:172701
	decreased T cell number	J:172701
	increased CD4-positive, alpha-beta memory T cell number	J:172701
	increased CD8-positive, alpha-beta memory T cell number	J:172701
	increased gamma-delta T cell number	J:172701
Idd1^NOD/Uf/Idd1^NOD/Uf (B6.NOD-(D17Mit164-D17Mit152))	increased CD4-positive, alpha-beta T cell number	J:92304
Idd2^NOD/Smrf/Idd2^NOD/Smrf (involves: NON/Lt * NOD/Smrf)	increased CD4-positive, alpha-beta T cell number	J:30526
Idd4.3^C57L/Idd4.3^C57L (involves: C57L/J * NOD)	abnormal macrophage physiology	J:118951
Idd4^C57BL/6/Idd4^C57BL/6 (involves: C57BL/6 * DBA/2)	increased T cell proliferation	J:25969
Idd4^C57BL/6/Idd4^C57BL/6 (involves: C57BL/6 * NOD)	increased T cell proliferation	J:25969
Idd4^NOD/Idd4^NOD (B6.NOD-Idd4)	decreased NK T cell number	J:85823
Idd6.2^C3H/HeJ/Idd6.2^C3H/HeJ (NOD.C3-Idd6.2^C3H/HeJ)	decreased NK cell number	J:137837
Idd6.2^NOD/Idd6.2^NOD (B6.NOD-(D6Mit259-D6Mit304))	abnormal T cell differentiation	J:120148
Idd6^C3H/HeJ/Idd6^C3H/HeJ (NOD.C3-Idd6^C3H/HeJ)	decreased NK cell number	J:137837
Idd6^C57BL/6/Idd6^NOD (involves: C57BL/6 * NOD)	decreased T cell proliferation	J:72360
Idd6^NOD/Idd6^NOD (involves: C57BL/6 * NOD)	decreased T cell proliferation	J:72360
Idd6^NOD/Idd6^NOD (B6.NOD-Idd6)	abnormal NK cell physiology	J:85823
Idd7^NOD/ShiLt/Idd7^NOD/ShiLt (involves: C57BL/6 * NOD/ShiLt)	abnormal T cell clonal deletion	J:131557
Idd9.1^C57BL/10SnJ/Idd9.1^C57BL/10SnJ (NOD.B10-Idd9.1^C57BL/10SnJ)	increased NK T cell number	J:85823
Idd10^NOD/ShiLt/Idd10^NOD/ShiLt Idd3^NOD/Idd3^NOD (B6.NOD-Idd3^NOD Idd10^NOD/Lt)	abnormal NK T cell physiology	J:85823
Idd13^NOD/ShiLt/Idd13^NOD/ShiLt (B6.NOD-Idd13)	abnormal NK T cell physiology	J:85823
Idh1^tm1Mak/Idh1^tm1Mak Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: 129P2/OlaHsd * C57BL/6 * C57BL/10 * CBA/Ca)	abnormal common lymphocyte progenitor cell morphology	J:186700
	abnormal common myeloid progenitor cell morphology	J:186700
	hematopoietic system phenotype	J:186700
	increased hematopoietic stem cell number	J:186700
Idh1^tm1Mak/Idh1^tm1Mak Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal bone marrow cell morphology/development	J:186700
	abnormal bone marrow cell physiology	J:186700
	abnormal myeloblast morphology/development	J:186700
	abnormal spleen morphology	J:186700
	anemia	J:186700
	decreased B cell number	J:186700
	decreased bone marrow cell number	J:186700
	decreased CD4-positive, alpha-beta T cell number	J:186700
	decreased CD8-positive, alpha-beta T cell number	J:186700
	decreased common myeloid progenitor cell number	J:186700
	decreased hematocrit	J:186700
	decreased hemoglobin content	J:186700
	enlarged spleen	J:186700
	extramedullary hematopoiesis	J:186700
	hematopoietic system phenotype	J:186700
	increased CD4-positive, alpha-beta T cell number	J:186700
	increased hematopoietic stem cell number	J:186700
Idh1^tm2Mak/Idh1^tm2Mak Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: C57BL/6 * C57BL/10 * CBA/Ca)	abnormal common lymphocyte progenitor cell morphology	J:186700
	abnormal common myeloid progenitor cell morphology	J:186700
	hematopoietic system phenotype	J:186700
	increased hematopoietic stem cell number	J:186700
Idh1^tm2Mak/Idh1^tm2Mak Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal bone marrow cell morphology/development	J:186700
	abnormal bone marrow cell physiology	J:186700
	abnormal myeloblast morphology/development	J:186700
	abnormal spleen morphology	J:186700
	anemia	J:186700
	decreased B cell number	J:186700
	decreased bone marrow cell number	J:186700
	decreased CD4-positive, alpha-beta T cell number	J:186700
	decreased CD8-positive, alpha-beta T cell number	J:186700
	decreased common myeloid progenitor cell number	J:186700
	decreased hematocrit	J:186700
	decreased hemoglobin content	J:186700
	enlarged spleen	J:186700
	extramedullary hematopoiesis	J:186700
	hematopoietic system phenotype	J:186700
	increased CD4-positive, alpha-beta T cell number	J:186700
	increased hematopoietic stem cell number	J:186700
Idh2^{tm1b(EUCOMM)Hmgu}/Idh2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Idh2^{tm1b(EUCOMM)Hmgu}/H)	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
	increased hemoglobin content	J:211773
Idh2^tm1Jwpk/Idh2^tm1Jwpk (involves: 129S4/SvJae * C57BL/6)	increased osteoclast cell number	J:272241
Idh3g^em1(IMPC)Bay/Idh3g^em1(IMPC)Bay (C57BL/6N-Idh3g^em1(IMPC)Bay/Bay)	abnormal spleen morphology	J:211773
Ido1^tm1Alm/Ido1^tm1Alm (involves: 129X1/SvJ * BALB/c)	decreased leukocyte cell number	J:170565
Ido1^tm1Alm/Ido1^tm1Alm (involves: 129X1/SvJ * C57BL/6J)	abnormal macrophage morphology	J:282516
Ido1^tm1Alm/Ido1^tm1Alm (involves: 129X1/SvJ * C57BL/6J)	abnormal macrophage physiology	J:282516
Ido2^tm1.2Gcp/Ido2^tm1.2Gcp (involves: C57BL/6J * FVB/N)	abnormal regulatory T cell physiology	J:211949
Ido2^tm1.2Gcp/Ido2^tm1.2Gcp (involves: C57BL/6J * FVB/N)	hematopoietic system phenotype	J:211949
Ids^tm1Muen/Y (involves: C57BL/6)	increased spleen weight	J:259752
Idua^tm1Efn/Idua^tm1Efn (involves: C57BL/6)	abnormal microglial cell morphology	J:81974
Idua^tm1Efn/Idua^tm1Efn (involves: C57BL/6)	abnormal microglial cell physiology	J:81974
Ier3^tm1Mxw/Ier3^tm1Mxw (involves: 129 * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:157504
	abnormal macrophage physiology	J:157504
	decreased regulatory T cell number	J:157504
	impaired macrophage phagocytosis	J:157504
	increased granulocyte number	J:157504
	increased neutrophil cell number	J:157504
Ier3^tm1Mxw/Ier3^tm1Mxw (involves: C57BL/6)	increased T-helper 17 cell number	J:194587
Ier5l^em1(IMPC)J/Ier5l^em1(IMPC)J (C57BL/6NJ-Ier5l^em1(IMPC)J/Mmjax)	thrombocytopenia	J:211773
Ifi44^{tm1b(KOMP)Wtsi}/Ifi44^{tm1b(KOMP)Wtsi} (C57BL/6N-Ifi44^{tm1b(KOMP)Wtsi}/Tcp)	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
Ifi44^{tm1b(KOMP)Wtsi}/Ifi44^{tm1b(KOMP)Wtsi} (involves: C57BL/6N)	increased CD8-positive, alpha-beta T cell number	J:297991
Ifi208^em1(IMPC)Mbp/Ifi208^em1(IMPC)Mbp (C57BL/6N-Ifi208^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	small spleen	J:211773
Ifih1^Rgsc422/Ifih1⁺ (D2JJcl.B6JJcl-Ifih1^Rgsc422)	abnormal leukocyte cell number	J:209917
	abnormal macrophage activation involved in immune response	J:209917
	abnormal T cell activation	J:209917
	increased dendritic cell number	J:209917
	increased granulocyte number	J:209917
	increased IgA level	J:209917
	increased IgG level	J:209917
	increased IgM level	J:209917
	increased immunoglobulin level	J:209917
	increased macrophage cell number	J:209917
	increased plasma cell number	J:209917
Ifit1^{tm1(KOMP)Vlcg}/Ifit1^{tm1(KOMP)Vlcg} (involves: C57BL/6 * C57BL/6NTac)	abnormal T cell physiology	J:205203
Ifit2^tm1.1Ebsb/Ifit2^tm1.1Ebsb (B6.129P2(C)-Ifit2^tm1.1Ebsb)	increased IgE level	J:233986
	increased IgG1 level	J:233986
	increased IgG3 level	J:233986
	increased IgM level	J:233986
Ifitm1^tm1.1Ieg/Ifitm1^tm1.1Ieg (B6.129P2-Ifitm1^tm1.1Ieg)	decreased granulocyte number	J:192287
	decreased T cell number	J:192287
	increased IgE level	J:192287
Ifitm5^em1Pmof/Ifitm5⁺ (involves: CD-1)	abnormal osteoclast morphology	J:255349
Ifna6^tm1Aki/Ifna6⁺ Myd88^tm1Aki/Myd88^tm1Aki (involves: 129P2/OlaHsd)	abnormal plasmacytoid dendritic cell morphology	J:124340
Ifnar1^m1Btlr/Ifnar1^m1Btlr (C57BL/6J-Ifnar1^m1Btlr)	abnormal macrophage physiology	J:142790
Ifnar1^tm1Agt/Ifnar1^tm1Agt (involves: 129S2/SvPas)	abnormal immunoglobulin level	J:101427
	abnormal NK cell physiology	J:79552, J:139001
	impaired natural killer cell mediated cytotoxicity	J:79552
Ifnar1^tm1Agt/Ifnar1^tm1Agt (B6.129S2-Ifnar1^tm1Agt)	abnormal osteoclast morphology	J:76097
Ifnar1^tm1Agt/Ifnar1^tm1Agt (B6.129S2-Ifnar1^tm1Agt)	impaired natural killer cell mediated cytotoxicity	J:118750
Ifnar1^tm1Agt/Ifnar1^tm1Agt (involves: 129S2/SvPas * 129S6/SvEvTac)	abnormal CD8-positive, alpha-beta T cell physiology	J:54482
Ifnar1^tm1Agt/Ifnar1^tm1Agt (involves: 129S2/SvPas * BALB/c)	abnormal mononuclear phagocyte morphology	J:291874
	decreased Ly6C high monocyte number	J:291874
	decreased T cell apoptosis	J:291874
	increased CD4-positive, alpha-beta T cell number	J:291874
	increased CD8-positive, alpha-beta T cell number	J:291874
Ifnar1^tm1Agt/Ifnar1^tm1Agt Ifngr1^tm1Agt/Ifngr1^tm1Agt (involves: 129S2/SvPas * 129S7/SvEvBrd)	abnormal immunoglobulin level	J:101427
Ifnar1^tm1Agt/Ifnar1^tm1Agt Myd88^tm1Aki/Myd88^tm1Aki (involves: 129P2/OlaHsd * 129S2/SvPas)	abnormal leukocyte migration	J:171379
Ifnar1^tm1Agt/Ifnar1^tm1Agt Slamf1^tm1Oono/Slamf1^tm1Oono (B6.129-Slamf1^tm1Oono Ifnar1^tm1Agt)	abnormal lymphopoiesis	J:117810
Ifnar1^tm1Agt/Ifnar1^tm1Agt Ythdf3^em1Caox/Ythdf3^em1Caox (involves: C57BL/6J)	abnormal macrophage physiology	J:276397
Ifnar1^tm1Pjh/Ifnar1^tm1Pjh (involves: 129S2/SvPas * BALB/c)	abnormal macrophage physiology	J:36004
	increased leukocyte cell number	J:36004
Ifnar1^tm1Pjh/Ifnar1^tm1Pjh (B6.129S2-Ifnar1^tm1Pjh)	decreased NK cell number	J:125812
Ifnar1^tm1Pjh/Ifnar1^tm1Pjh (B6.129S2-Ifnar1^tm1Pjh)	impaired natural killer cell mediated cytotoxicity	J:125812
Ifnar2^m1Btlr/Ifnar2^m1Btlr (C57BL/6J-Ifnar2^m1Btlr)	abnormal macrophage physiology	J:147329
Ifnar2^tm1Pjh/Ifnar2^tm1Pjh (B6.Cg-Ifnar2^tm1Pjh)	decreased NK cell number	J:125812
Ifnar2^tm1Pjh/Ifnar2^tm1Pjh (B6.Cg-Ifnar2^tm1Pjh)	impaired natural killer cell mediated cytotoxicity	J:125812
Ifnar2^tm1Pjh/Ifnar2^tm1Pjh (involves: C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:132662
	abnormal cytotoxic T cell physiology	J:132662
	decreased IgG1 level	J:132662
	decreased IgG2a level	J:132662
	decreased IgG level	J:132662
Ifnb1^tm1Acgp/Ifnb1^tm1Acgp (involves: 129P2/OlaHsd)	abnormal spleen primary B follicle morphology	J:86527
	decreased common myeloid progenitor cell number	J:86527
	decreased erythroid progenitor cell number	J:86527
	decreased macrophage cell number	J:86527
	decreased mature B cell number	J:86527
	decreased monocyte cell number	J:86527
	decreased neutrophil cell number	J:86527
	decreased pro-B cell number	J:86527
	increased T cell proliferation	J:86527
Ifnb1^tm1Acgp/Ifnb1^tm1Acgp (B6.129P2-Ifnb1^tm1Acgp)	abnormal macrophage physiology	J:136368
Ifnb1^tm1Tl/Ifnb1^tm1Tl (B10.129P2-Ifnb1^tm1Tl)	abnormal macrophage physiology	J:83021
Ifnb1^tm1Tl/Ifnb1^tm1Tl (B10.129P2-Ifnb1^tm1Tl)	abnormal microglial cell physiology	J:83021
Ifnb1^tm1Ttg/Ifnb1^tm1Ttg (B6.Cg-Ifnb1^tm1Ttg)	abnormal osteoclast morphology	J:76097
Ifne^tm1.2Pjh/Ifne^tm1.2Pjh (involves: C57BL/6)	decreased NK cell number	J:197569
Ifng^{tm1.1(KOMP)Vlcg}/Ifng⁺ (C57BL/6N-Ifng^{tm1.1(KOMP)Vlcg}/Ucd)	increased hematocrit	J:211773
Ifng^tm1.1Hayg/Ifng^tm1.1Hayg (Not Specified)	abnormal B cell differentiation	J:220784
	abnormal bone marrow cell morphology/development	J:220784
	abnormal erythropoiesis	J:220784
	abnormal hematopoietic stem cell morphology	J:220784
	abnormal proerythroblast morphology	J:220784
	abnormal T cell activation	J:220784
	anemia	J:220784
	decreased bone marrow cell number	J:220784
	decreased common myeloid progenitor cell number	J:220784
	decreased erythrocyte cell number	J:220784
	decreased erythroid progenitor cell number	J:220784
	decreased granulocyte monocyte progenitor cell number	J:220784
	decreased leukocyte cell number	J:220784
	decreased mature B cell number	J:220784
	decreased megakaryocyte cell number	J:220784
	decreased megakaryocyte-erythroid progenitor cell number	J:220784
	decreased myeloid cell number in bone marrow	J:220784
	decreased pre-B cell number	J:220784
	impaired hematopoiesis	J:220784
	increased erythroblast number	J:220784
	increased hematopoietic stem cell number	J:220784
	increased nucleated erythrocyte cell number	J:220784
	increased T cell number	J:220784
	pancytopenia	J:220784
	spleen atrophy	J:220784
	thrombocytopenia	J:220784
	thymus atrophy	J:220784
Ifng^tm1Ts/Ifng^tm1Ts (involves: 129S7/SvEvBrd * C57BL/6)	abnormal macrophage physiology	J:66802
	abnormal MHC II cell surface expression on macrophages	J:66802
	abnormal NK cell physiology	J:66802, J:115033
	increased splenocyte proliferation	J:66802
Ifng^tm1Ts/Ifng^tm1Ts (NOD.129S7(B6)-Ifng^tm1Ts/DvsJ)	abnormal cytotoxic T cell physiology	J:72818
Ifng^tm1Ts/Ifng^tm1Ts (NOD.129S7(B6)-Ifng^tm1Ts/DvsJ)	abnormal diapedesis	J:72818
Ifng^tm1Ts/Ifng^tm1Ts (involves: 129S7/SvEvBrd)	abnormal immunoglobulin level	J:29170
	impaired natural killer cell mediated cytotoxicity	J:73948
	increased IgG1 level	J:110721
Ifng^tm1Ts/Ifng^tm1Ts (B6.129S7-Ifng^tm1Ts/J)	abnormal dendritic cell chemotaxis	J:134949
	abnormal immunoglobulin level	J:45665
	abnormal macrophage chemotaxis	J:136628
	abnormal spleen morphology	J:47459
	abnormal spleen red pulp morphology	J:47459
	abnormal spleen white pulp morphology	J:47459
	enlarged spleen	J:47459
	extramedullary hematopoiesis	J:47459
	increased granulocyte number	J:47459
	increased leukocyte cell number	J:47459
	increased monocyte cell number	J:47459
	increased NK T cell number	J:122801
	pale spleen	J:47459
Ifng^tm1Ts/Ifng^tm1Ts (B6.129S7-Ifng^tm1Ts)	abnormal B cell physiology	J:112084
	abnormal immunoglobulin level	J:18801
	decreased IgG2a level	J:18801
	decreased IgG3 level	J:18801
	increased CD8-positive, alpha-beta T cell number	J:112048
	increased IgE level	J:18801
	increased IgG1 level	J:18801, J:112048
Ifng^tm1Ts/Ifng^tm1Ts (C.129S7-Ifng^tm1Ts)	abnormal immunoglobulin level	J:45665
Ifng^tm1Ts/Ifng^tm1Ts (involves: 129S7/SvEvBrd * BALB/c)	decreased IgE level	J:114213
Ifng^tm1Ts/Ifng^tm1Ts (involves: 129S7/SvEvBrd * DBA/1 * MRL/Mp)	decreased IgA level	J:39600
	decreased IgG2a level	J:39600
	decreased IgG2b level	J:39600
	decreased IgG3 level	J:39600
	decreased IgM level	J:39600
	decreased immunoglobulin level	J:39600
Ifng^tm1Ts/Ifng^tm1Ts (C.129S7(B6)-Ifng^tm1Ts/J)	abnormal cytotoxic T cell physiology	J:115144
	abnormal macrophage physiology	J:115144
	abnormal NK cell physiology	J:115144
	abnormal spleen morphology	J:115144
	abnormal spleen red pulp morphology	J:47459
	abnormal spleen white pulp morphology	J:47459
	abnormal uterine NK cell morphology	J:56503
	abnormal uterine NK cell physiology	J:56503
	enlarged spleen	J:47459
	extramedullary hematopoiesis	J:47459
	increased granulocyte number	J:47459
	increased leukocyte cell number	J:47459
	increased monocyte cell number	J:47459
	increased uterine NK cell number	J:56503
	pale spleen	J:47459
Ifng^tm1Ts/Ifng^tm1Ts (involves: 129S7/SvEvBrd * A/WySn * C57BL/10SnSg * Swiss)	decreased IgG2a level	J:119207
	decreased IgG level	J:119207
	increased IgG1 level	J:119207
Ifng^tm1Ts/Ifng^tm1Ts Ldlr^tm1Her/Ldlr^tm1Her (B6.129S7-Ldlr^tm1Her Ifng^tm1Ts)	increased T cell number	J:103072
Ifng^tm1Ts/Ifng^tm1Ts Pld4^tm1.2Nemz/Pld4^tm1.2Nemz (involves: 129 * 129S7/SvEvBrd * C57BL/6J * FVB/N)	decreased NK T cell number	J:281205
	hematopoietic system phenotype	J:281205
Ifng^tm1Ts/Ifng^tm1Ts Socs1^tm1Wehi/Socs1^tm1Wehi (involves: 129S1/Sv * 129S7/SvEvBrd * C57BL/6)	enlarged thymus medulla	J:57474
	hematopoietic system phenotype	J:57474
Ifng^tm1Ts/Ifng^tm1Ts Tnfrsf1a^tm1Blt/Tnfrsf1a^tm1Blt Tnfrsf1b^tm1Mwm/Tnfrsf1b^tm1Mwm (involves: 129P2/OlaHsd * 129S2/SvPas * 129S7/SvEvBrd * C57BL/6)	absent spleen germinal center	J:119206
	increased eosinophil cell number	J:119206
	increased leukocyte cell number	J:119206
	increased lymphocyte cell number	J:119206
Ifngr1^m1Btlr/Ifngr1^m1Btlr (C57BL/6J-Ifngr1^m1Btlr)	decreased macrophage cell number	J:236694
	impaired hematopoiesis	J:236694
	increased B cell number	J:236694
Ifngr1^tm1Agt/Ifngr1^tm1Agt (involves: 129S7/SvEvBrd)	abnormal immunoglobulin level	J:38363, J:101427
	abnormal uterine NK cell morphology	J:56503
	abnormal uterine NK cell physiology	J:56503
	decreased IgG2a level	J:38363
	increased uterine NK cell number	J:56503
Ifngr1^tm1Agt/Ifngr1^tm1Agt (involves: 129S7/SvEvBrd * C57BL/6)	abnormal cytotoxic T cell physiology	J:63815
	decreased IgG2a level	J:63815
	decreased IgG3 level	J:63815
	increased splenocyte proliferation	J:99347
Ifngr1^tm1Agt/Ifngr1^tm1Agt (B6.129S7-Ifngr1^tm1Agt/J)	abnormal hematopoietic system physiology	J:138728
	abnormal lymphopoiesis	J:138728
	abnormal osteoclast differentiation	J:233116
	decreased bone marrow cell number	J:138728
	decreased CD4-positive, alpha-beta T cell number	J:138728
	decreased CD8-positive, alpha-beta T cell number	J:138728
	decreased lymphocyte cell number	J:138728
	spleen hypoplasia	J:138728
Ifngr1^tm1Agt/Ifngr1^tm1Agt (involves: 129S7/SvEvBrd * DBA/1OlaHsd)	decreased IgG2a level	J:40634
Ifngr1^tm1Agt/Ifngr1^tm1Agt Tg(GZMB-Tax)#Lera/0 (involves: 129S7/SvEvBrd * C57BL/6)	abnormal osteoclast differentiation	J:147601
	abnormal osteoclast physiology	J:147601
	increased osteoclast cell number	J:147601
Ifngr2^tm1Pbro/Ifngr2^tm1Pbro (involves: 129S1/Sv)	abnormal class switch recombination	J:48016
Ifngr2^tm1Pbro/Ifngr2^tm1Pbro (involves: 129S1/Sv)	abnormal T-helper 1 cell differentiation	J:48016
Ifngr2^tm1Pbro/Ifngr2^tm1Pbro (NOD.129S1-Ifngr2^tm1Pbro)	abnormal cytotoxic T cell physiology	J:72818
	abnormal diapedesis	J:72818
	abnormal T-helper 2 physiology	J:65986
Ifnk^{tm1.1(KOMP)Vlcg}/Ifnk^{tm1.1(KOMP)Vlcg} (C57BL/6NTac-Ifnk^{tm1.1(KOMP)Vlcg})	enlarged spleen	J:322130
Ift70b^em1(IMPC)Bay/Ift70b^em1(IMPC)Bay (C57BL/6N-Ift70b^em1(IMPC)Bay/Bay)	abnormal spleen morphology	J:211773
Ift80^{tm1a(KOMP)Wtsi}/Ift80⁺ (C57BL/6N-Ift80^{tm1a(KOMP)Wtsi}/Wtsi)	increased red blood cell distribution width	J:211773
Ift140^b2b1283Clo/Ift140^b2b1283Clo (C57BL/6J-Ift140^b2b1283Clo)	absent spleen	J:175213
Igbp1^tm1Cbt/Y Tg(Lck-cre)1Cwi/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)	decreased thymocyte number	J:93221
Igbp1^tm1Cbt/Igbp1⁺ Tg(Lck-cre)1Cwi/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)	decreased thymocyte number	J:93221
Igbp1^tm1Imku/Y Tg(Lck-cre)I57Jxm/? (involves: 129P2/OlaHsd * ICR)	abnormal thymus cortex morphology	J:84395
	abnormal thymus corticomedullary boundary morphology	J:84395
	decreased double-negative T cell number	J:84395
	decreased T cell number	J:84395
	decreased thymocyte number	J:84395
Igf1^tm1.1Dlr/Igf1^tm1.1Dlr Tg(Ttr-IGF1)1Sykr/0 (FVB.Cg-Igf1^tm1.1Dlr Tg(Ttr-IGF1)1Sykr)	increased spleen weight	J:157350
Igf1r^tm1.2Mhz/Igf1r⁺ Zfand2b^tm1Otin/Zfand2b^tm1Otin (involves: 129/Sv * 129S7/SvEvBrd * C57BL/6)	hematopoietic system phenotype	J:233169
Igf1r^tm2Arge/Igf1r^tm2Arge Tg(BGLAP-cre)1Clem/0 (involves: 129 * FVB/N)	abnormal osteoclast physiology	J:80190
	decreased osteoclast cell number	J:80190
Igf1sl2^C3H/HeJ/Igf1sl2^C3H/HeJ (B6.C3H-Igf1sl2^C3H/HeJ)	increased osteoclast cell number	J:111677
Igf2^tm1Snha/Igf2⁺ (involves: 129S1/Sv * 129X1/SvJ * ICR)	abnormal osteoclast differentiation	J:167738
Igf2bp1^{Gt(OST33739)Lex}/Igf2bp1^{Gt(OST33739)Lex} (involves: 129S5/SvEvBrd * C57BL/6)	anemia	J:89882
	spleen hypoplasia	J:89882
Igf2bp3^em1(IMPC)J/Igf2bp3^em1(IMPC)J (C57BL/6NJ-Igf2bp3^em1(IMPC)J/Mmjax)	thrombocytosis	J:211773
Igf2r^tm1Arge/Igf2r⁺ (involves: 129)	increased nucleated erythrocyte cell number	J:34584
Igf2r^tm1Arge/Igf2r^tm1Arge (involves: 129)	increased nucleated erythrocyte cell number	J:34584
Igf2r^tm2Arge/Igf2r⁺ (involves: 129)	increased nucleated erythrocyte cell number	J:34584
Igf2r^tm2Arge/Igf2r^tm2Arge (involves: 129)	increased nucleated erythrocyte cell number	J:34584
Igfbp2^tm1Jep/Igfbp2^tm1Jep (either: (involves: 129P1/ReJ * 129S/SvEv) or (involves: 129S/SvEv * C57BL/6))	small spleen	J:64338
Igh-7^tm1.1Lam/Igh-7^tm1.1Lam (involves: BALB/c)	decreased IgE level	J:146733
Igh-7^tm1.1Lam/Igh-7^tm1.1Lam (involves: BALB/c)	decreased mature B cell number	J:146733
Igh-7^tm1Gach/Igh-7^tm1Gach (BALB/c-Igh-7^tm1Gach)	abnormal B cell number	J:143266
	abnormal B cell physiology	J:143266
	increased IgE level	J:143266
	increased memory B cell number	J:143266
	increased plasma cell number	J:143266
Igh-7^tm1Lam/Igh-7^tm1Lam (involves: BALB/c)	decreased IgE level	J:146733
Igh-7^tm1Lam/Igh-7^tm1Lam (involves: BALB/c)	decreased mature B cell number	J:146733
Igh-7^tm1Lcwu/Igh-7^tm1Lcwu (involves: C57BL/6)	decreased IgE level	J:161452
Igh-7^tm1Lcwu/Igh-7^tm1Lcwu (involves: C57BL/6)	decreased mature B cell number	J:161452
Igh-7^tm1Led/Igh-7^tm1Led (C.129S4-Igh-7^tm1Led)	impaired eosinophil recruitment	J:133373
Igh-7^tm1Led/Igh-7^tm1Led Lyn^tm1Ard/Lyn^tm1Ard (involves: 129P2/OlaHsd * 129S4/SvJae)	decreased B cell number	J:161523
	increased basophil cell number	J:161523
	increased IgA level	J:161523
	increased IgM level	J:161523
Igh-8^tm1.1Aak/Igh-8^tm1.1Aak (involves: 129S2/SvPas * C57BL/6)	abnormal class switch recombination	J:171251
Igh-8^tm1Aak/Igh-8^tm1Aak (involves: 129S2/SvPas * C57BL/6)	abnormal class switch recombination	J:107063
Igh-8^tm1Schr/Igh-8^tm1Schr (involves: 129P2/OlaHsd * Black Swiss)	increased IgM level	J:49847
Igh-8^tm1Schr/Igh-8^tm1Schr (C.129P2(BKSW)-Igh-8^tm1Schr)	increased IgG level	J:75577
Igh-8^tm1Schr/Igh-8^tm1Schr (C.129P2(BKSW)-Igh-8^tm1Schr)	increased IgM level	J:75577
Igh-8^{tm2(Ighg1)Aak}/Igh-8^{tm2(Ighg1)Aak} (involves: 129S2/SvPas)	abnormal class switch recombination	J:130574
	decreased IgG3 level	J:130574
Igh-J^{tm1(3H9-VDJ)Mwg}/Igh-J^{tm1(3H9-VDJ)Mwg} (involves: 129P2/OlaHsd * BALB/c * C57BL/6)	abnormal B cell receptor editing	J:126940
Igh-J^{tm1(CB20)Riho}/Igh-J⁺ (involves: C57BL/10 * DBA/1)	abnormal B cell differentiation	J:179456
	decreased pre-B cell number	J:179456
	increased immature B cell number	J:179456
	increased marginal zone B cell number	J:179456
	increased mature B cell number	J:179456
Igh-J^{tm1(CB20)Riho}/Igh-J^{tm1(CB20)Riho} (involves: C57BL/10 * DBA/1)	abnormal B cell differentiation	J:179456
	decreased pre-B cell number	J:179456
	increased immature B cell number	J:179456
	increased marginal zone B cell number	J:179456
	increased mature B cell number	J:179456
Igh-J^{tm1(Ighel)Cys}/Igh-J^{tm1(Ighel)Cys} Myd88^tm1Aki/Myd88^tm1Aki Igkj1^{tm1(IgkHyHEL10)Mnz}/0 (involves: 129P2/OlaHsd)	increased IgM level	J:115059
Igh-J^{tm1(VDJ-KL25)Zbz}/Igh-J⁺ (involves: C57BL/6 * C57BL/6J * BALB/cJ)	increased IgG level	J:86411
	increased IgM level	J:86411
Igh-J^tm1.1Lave/Igh-J⁺ (Not Specified)	abnormal B cell differentiation	J:155798
	decreased B cell number	J:155798
	decreased immature B cell number	J:155798
	decreased mature B cell number	J:155798
	decreased spleen weight	J:155798
	decreased T cell number	J:155798
	decreased transitional stage B cell number	J:155798
	decreased transitional stage T1 B cell number	J:155798
	decreased transitional stage T2 B cell number	J:155798
	increased pre-B cell number	J:155798
	increased pro-B cell number	J:155798
Igh-J^tm1.1Lave/Igh-J^tm1.1Lave (Not Specified)	abnormal B cell differentiation	J:155798
	abnormal immunoglobulin level	J:179317
	arrested B cell differentiation	J:179317
	decreased B cell number	J:155798, J:179317
	decreased IgM level	J:155798
	decreased immature B cell number	J:155798
	decreased mature B cell number	J:155798
	decreased spleen weight	J:155798
	decreased T cell number	J:155798
	decreased transitional stage B cell number	J:155798
	decreased transitional stage T1 B cell number	J:155798
	decreased transitional stage T2 B cell number	J:155798
	increased IgG level	J:155798
	increased pre-B cell number	J:155798
	increased pro-B cell number	J:155798
Igh-J^tm1.1Lave/Igh-J^tm1.1Lave Igk-J^tm1.1Lave/Igk-J^tm1.1Lave (Not Specified)	abnormal B cell clonal deletion	J:179317
	abnormal B cell differentiation	J:205708
	abnormal B cell physiology	J:205708
	abnormal immunoglobulin level	J:179317
	arrested B cell differentiation	J:205708, J:179317
	decreased B cell number	J:205708, J:179317
	decreased immature B cell number	J:205708
	decreased mature B cell number	J:205708
Igh-J^tm1.1Lave/Igh-J^tm1.1Lave Igk-J^tm1.1Lave/Igk-J^tm1.1Lave Tg(BCL2)22Wehi/0 (involves: C57BL/6JWehi * SJL/JWehi)	abnormal B cell differentiation	J:179317
Igh-J^tm1Aigl/Igh-J⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal B cell morphology	J:111543
	decreased B cell number	J:111543
	decreased B-1 B cell number	J:111543
Igh-J^tm1Cgn/Igh^tm4Cgn Tg(Cr2-cre)3Cgn/0 (Not Specified)	decreased B cell number	J:79299
	decreased follicular B cell number	J:79299
	decreased marginal zone B cell number	J:79299
Igh-J^tm1Cgn/Igh^tm4Cgn Tg(Cr2-cre)3Cgn/0 (involves: 129P2/OlaHsd)	decreased mature B cell number	J:157297
Igh-J^tm1Cgn/Igh^tm11.1Cgn (involves: 129P2/OlaHsd)	abnormal B cell differentiation	J:113434
Igh-J^tm1Cgn/Igh-J⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell differentiation	J:64285
Igh-J^tm1Cgn/Igh^tm1Leck (involves: 129P2/OlaHsd * C57BL/6)	abnormal immunoglobulin light chain V-J recombination	J:144033
Igh-J^tm1Cgn/Igh-J^tm1Cgn (involves: 129P2/OlaHsd * C57BL/6)	absent mature B cells	J:64285
	arrested B cell differentiation	J:64285
Igh-J^tm1Dhu/Igh^tm3Tim (involves: 129 * C57BL/6)	abnormal B cell differentiation	J:102308
Igh-J^tm1Dhu/Igh^tm3Tim (involves: 129 * C57BL/6)	decreased B cell number	J:102308
Igh-J^tm1Dhu/Igh^tm1Tim (involves: 129X1/SvJ * C57BL/6)	abnormal B cell differentiation	J:88410
	abnormal B cell morphology	J:87624
	abnormal spleen marginal zone morphology	J:87624
	abnormal spleen morphology	J:87624
Igh-J^tm1Dhu/Igh^tm2Tim (involves: 129X1/SvJ * C57BL/6)	abnormal spleen morphology	J:87624
Igh-J^tm1Dhu/Igh^tm2Tim (involves: 129X1/SvJ * C57BL/6)	decreased marginal zone B cell number	J:87624
Igh-J^tm1Dhu/Igh-J⁺ Il2^tm1Hor/Il2^tm1Hor (involves: 129/Sv * C57BL/6)	anemia	J:29999
Igh-J^tm1Dhu/Igh-J^{tm1(VDJ-17.2.25)Wabl} Igk^tm1Dhu/Igk^tm1Dhu (Not Specified)	abnormal B cell differentiation	J:33628
	abnormal immature B cell morphology	J:89757
Igh-J^tm1Dhu/Igh-J^tm1Dhu Il2^tm1Hor/Il2^tm1Hor (involves: 129/Sv * C57BL/6)	abnormal blood cell morphology/development	J:29999
Igh-J^tm1Dhu/Igh-J^tm1Dhu Wdr1^rede/Wdr1^rede (involves: 129S7/SvEvBrd * BALB/c * C57BL/6)	thrombocytopenia	J:134092
Igh-J^tm1Dim/Igh-J⁺ Igk-J^tm1Dim/Igk-J⁺ (involves: 129S4/SvJae * C57BL/6)	abnormal B cell differentiation	J:107241
	increased IgG level	J:107241
	increased IgM level	J:107241
Igh-J^tm1Jkbv/Igh-J^tm1Jkbv (involves: 129P2/OlaHsd * C57BL/6)	abnormal T cell number	J:113083
	absent B cells	J:70038
	decreased IgM level	J:70038
Igh-J^tm1Jkbv/Igh-J^tm1Jkbv (involves: 129P2/OlaHsd)	absent mature B cells	J:137738
	arrested B cell differentiation	J:137738
	increased late pro-B cell number	J:137738
Igh-J^tm1Jkbv/Igh-J^tm1Jkbv Igkc^tm1Jkbv/Igkc^tm1Jkbv (involves: 129P2/OlaHsd)	absent B cells	J:23827
	absent mature B cells	J:137738, J:70620
	arrested B cell differentiation	J:137738, J:23827
	increased late pro-B cell number	J:137738
Igh-J^tm1Jkbv/Igh-J^tm1Jkbv Igkc^tm1Jkbv/Igkc^tm1Jkbv Tg(IGH@yH1)2BJkbv/0 Tg(IGK@yK1)9.2CJkbv/0 (involves: 129P2/OlaHsd)	abnormal B cell morphology	J:23827
	abnormal immunoglobulin level	J:23827
	increased mature B cell number	J:23827
Igh-J^tm1Jkbv/Igh-J^tm1Jkbv Igkc^tm1Jkbv/Igkc^tm1Jkbv Tg(IGH@yH1)2BJkbv/0 Tg(IGK@yK1)9.2CJkbv/Tg(IGK@yK1)9.2CJkbv (involves: 129P2/OlaHsd)	abnormal B cell differentiation	J:137738
	decreased immature B cell number	J:137738
	decreased mature B cell number	J:137738
	decreased pre-B cell number	J:137738
	increased late pro-B cell number	J:137738
Igh-J^tm1Jkbv/Igh-J^tm1Jkbv Igkc^tm1Jkbv/Igkc^tm1Jkbv Tg(IGH@yH1)2BJkbv/Tg(IGH@yH1)2BJkbv Tg(IGK@yK1)9.2CJkbv/Tg(IGK@yK1)9.2CJkbv (involves: 129P2/OlaHsd)	abnormal B cell differentiation	J:137738
	abnormal immunoglobulin level	J:137738
	decreased immature B cell number	J:137738
	decreased mature B cell number	J:137738
	decreased pre-B cell number	J:137738
	increased late pro-B cell number	J:137738
Igh-J^tm1Jkbv/Igh-J^tm1Jkbv Igkc^tm1Jkbv/Igkc^tm1Jkbv Tg(IGH@yH1)2BJkbv/Tg(IGH@yH1)2BJkbv Tg(IGK@yK2)J23.1Jkbv/Tg(IGK@yK2)J23.1Jkbv (involves: 129P2/OlaHsd)	abnormal B cell differentiation	J:137738
	decreased immature B cell number	J:137738
	decreased mature B cell number	J:137738
	decreased pre-B cell number	J:137738
	increased late pro-B cell number	J:137738
Igh-J^tm1Jkbv/Igh-J^tm1Jkbv Igkc^tm1Jkbv/Igkc^tm1Jkbv Tg(IGH@yH2)J9.2Jkbv/0 Tg(IGK@yK2)J23.1Jkbv/0 (involves: 129P2/OlaHsd * C57BL/6J)	abnormal B cell morphology	J:70620
	abnormal immunoglobulin heavy chain V(D)J recombination	J:70620
	abnormal immunoglobulin level	J:70620
	abnormal immunoglobulin light chain V-J recombination	J:70620
	increased mature B cell number	J:70620
Igh-J^tm1Jkbv/Igh-J^tm1Jkbv Igkc^tm1Jkbv/Igkc^tm1Jkbv Tg(IGH@yH2)J9.2Jkbv/0 Tg(IGK@yK2)J23.1Jkbv/Tg(IGK@yK2)J23.1Jkbv (involves: 129P2/OlaHsd)	abnormal immunoglobulin level	J:137738
	decreased immature B cell number	J:137738
	decreased mature B cell number	J:137738
Igh-J^tm1Jkbv/Igh-J^tm1Jkbv Igkc^tm1Jkbv/Igkc^tm1Jkbv Tg(IGH@yH2BM)7Amgn/0 Tg(IGK@yK2)J23.1Jkbv/0 (involves: 129P2/OlaHsd)	abnormal immunoglobulin level	J:139792
	decreased B cell number	J:139792
Igh-J^tm1Jkbv/Igh-J^tm1Jkbv Igkc^tm1Jkbv/Igkc^tm1Jkbv Tg(IGH@yH2CM)2Amgn/0 Tg(IGK@yK2)J23.1Jkbv/0 (involves: 129P2/OlaHsd)	abnormal immunoglobulin level	J:139792
	decreased B cell number	J:139792
Igh-J^tm1Jkbv/Igh-J^tm1Jkbv Igkc^tm1Jkbv/Igkc^tm1Jkbv Tg(IGH@yHG1/2)1Amgn/0 Tg(IGK@yK2)J23.1Jkbv/0 (involves: 129P2/OlaHsd)	abnormal immunoglobulin level	J:139792
Igh-J^tm1Jkbv/Igh-J^tm1Jkbv Igkc^tm1Jkbv/Igkc^tm1Jkbv Tg(IGH@yHG4)1Amgn/0 Tg(IGK@yK2)J23.1Jkbv/0 (involves: 129P2/OlaHsd)	abnormal immunoglobulin level	J:139792
Igh-J^tm1Jkbv/Igh-J^tm1Jkbv Tg(IGH@*)SALed/0 (involves: 129P2/OlaHsd)	decreased mature B cell number	J:137738
Igh-J^tm1Jkbv/Igh-J^tm1Jkbv Tg(IGH@yH1)2BJkbv/0 (involves: 129P2/OlaHsd)	abnormal B cell differentiation	J:137738
	decreased mature B cell number	J:137738
	decreased pre-B cell number	J:137738
	increased late pro-B cell number	J:137738
Igh-J^tm1Jkbv/Igh-J^tm1Jkbv Tg(IGH@yH1)2BJkbv/0 Tg(IGK@yK1)9.2CJkbv/0 (involves: 129P2/OlaHsd)	abnormal B cell morphology	J:23827
	abnormal immunoglobulin level	J:23827
	increased late pro-B cell number	J:23827
	increased mature B cell number	J:23827
Igh-J^tm1Jkbv/Igh-J^tm1Jkbv Tg(IGH@yH1)2BJkbv/Tg(IGH@yH1)2BJkbv (involves: 129P2/OlaHsd)	abnormal B cell differentiation	J:137738
	abnormal immunoglobulin level	J:137738
	decreased immature B cell number	J:137738
	decreased mature B cell number	J:137738
	decreased pre-B cell number	J:137738
	increased late pro-B cell number	J:137738
Igh-J^tm1Jkbv/Igh-J^tm1Jkbv Tg(IGH@yH2)J9.2Jkbv/0 (involves: 129P2/OlaHsd)	abnormal immunoglobulin level	J:137738
	decreased mature B cell number	J:137738
Igh-J^tm1Khyk/Igh-J⁺ (CB17.129X1-Igh-J^tm1Khyk)	hematopoietic system phenotype	J:109979
Igh-J^tm1Khyk/Igh-J⁺ (CB17.129X1-Igh-J^tm1Khyk)	increased B-1 B cell number	J:109979
Igh-J^tm1Mcdl/Igh-J^tm1Mcdl Igk-J^tm1Mcdl/Igk-J^tm1Mcdl Rag1^tm1Mom/Rag1^tm1Mom Tg(DO11.10)10Dlo/? (involves: 129S/Sv * BALB/c * C3H * C57BL/6)	abnormal spleen germinal center morphology	J:100072
	abnormal T cell differentiation	J:100072
	increased IgE level	J:100072
	increased IgG level	J:100072
Igh-J^{tm2(3H9-VDJ)Mwg}/Igh-J⁺ (involves: 129P2/OlaHsd BALB/c * C57BL/6)	abnormal B cell receptor editing	J:126940
Igh-J^{tm2(3H9-VDJ)Mwg}/Igh-J⁺ (involves: 129P2/OlaHsd BALB/c)	abnormal B cell receptor editing	J:131138
	abnormal marginal zone B cell morphology	J:131138
Igh-J^{tm2(3H9-VDJ)Mwg}/Igh-J⁺ (B6.129P2-Igh-J^{tm2(3H9-VDJ)Mwg})	decreased B cell number	J:142389
	increased marginal zone B cell number	J:142389
	spleen hypoplasia	J:142389
Igh-J^{tm2.1(4E10)Lave}/Igh-J^{tm2.1(4E10)Lave} (involves: C57BL/6)	arrested B cell differentiation	J:205708
	decreased B-1a cell number	J:205708
	decreased IgG1 level	J:205708
	decreased IgG2b level	J:205708
	decreased IgG3 level	J:205708
	decreased IgG level	J:205708
	decreased IgM level	J:205708
Igh-J^{tm2.1(4E10)Lave}/Igh-J^{tm2.1(4E10)Lave} Igk-J^{tm2.1(4E10)Lave}/Igk-J^{tm2.1(4E10)Lave} (involves: C57BL/6)	abnormal B cell differentiation	J:205708
	abnormal B cell physiology	J:205708
	arrested B cell differentiation	J:205708
	decreased immature B cell number	J:205708
	decreased mature B cell number	J:205708
Igh-J^{tm3(3H9-VDJ)Mwg}/Igh-J^{tm3(3H9-VDJ)Mwg} (involves: 129P2/OlaHsd * BALB/c * C57BL/6)	abnormal B cell receptor editing	J:126940
Igh-J^{tm3.1(48d)Lave}/Igh-J^{tm3.1(48d)Lave} (involves: C57BL/6)	decreased B-1a cell number	J:205708
	decreased IgG1 level	J:205708
	decreased IgG2b level	J:205708
	decreased IgM level	J:205708
Igh^deltaD/Igh⁺ (involves: C57BL/6 * DBA/2)	abnormal B cell differentiation	J:95981
	decreased B cell number	J:95981
	decreased immunoglobulin level	J:95981
Igh^deltaD/Igh^deltaD (involves: C57BL/6 * DBA/2)	abnormal B cell differentiation	J:95981
	abnormal immunoglobulin level	J:95981
	abnormal spleen morphology	J:95981
	arrested B cell differentiation	J:95981
	decreased B cell number	J:95981
	decreased follicular B cell number	J:95981
	decreased IgG1 level	J:95981
	increased IgA level	J:95981
	increased marginal zone B cell number	J:95981
Igh^deltaD/Igh^tm11.1Cgn (involves: C57BL/6 * DBA/2)	abnormal B cell differentiation	J:113434
Igh^tm1(Myc)Janz/Igh⁺ (involves: 129X1/SvJ * C57BL/6)	enlarged spleen	J:96785
	increased B cell apoptosis	J:96785
	increased B cell proliferation	J:96785
Igh^tm1(Myc)Janz/Igh⁺ Mdm4^tm1.1Wahl/Mdm4^tm1.1Wahl (involves: 129S/Sv * C57BL/6)	enlarged spleen	J:150341
	increased splenocyte proliferation	J:150341
Igh^tm1(PAX5)Mbu/Igh⁺ (B6.Cg-Igh^tm1(PAX5)Mbu)	abnormal spleen morphology	J:118111
	abnormal T cell differentiation	J:118111
	abnormal thymus morphology	J:118111
	decreased double-negative T cell number	J:118111
	decreased double-positive T cell number	J:118111
	enlarged spleen	J:118111
	enlarged thymus	J:118111
	increased pro-B cell number	J:118111
	thymus hypoplasia	J:118111
Igh^tm1(PAX5)Mbu/Igh⁺ Pax5^tm1Mbu/Pax5^tm1Mbu (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * CBA)	abnormal B cell differentiation	J:118111
	decreased B cell number	J:118111
Igh^tm1(PAX5)Mbu/Igh^tm1(PAX5)Mbu (B6.Cg-Igh^tm1(PAX5)Mbu)	abnormal spleen morphology	J:118111
	abnormal T cell differentiation	J:118111
	abnormal thymus morphology	J:118111
	decreased double-negative T cell number	J:118111
	decreased double-positive T cell number	J:118111
	enlarged spleen	J:118111
	enlarged thymus	J:118111
	increased pro-B cell number	J:118111
	thymus hypoplasia	J:118111
Igh^{tm1(VH558)Mss}/Igh⁺ (involves: FVB/N)	abnormal B cell differentiation	J:130421
Igh^{tm1(VH558)Mss}/Igh^{tm1(VH558)Mss} (involves: FVB/N)	abnormal B cell differentiation	J:130421
Igh^{tm1.1(b12)Nemz}/Igh^{tm1.1(b12)Nemz} (involves: C57BL/6N * FVB/N)	decreased IgM level	J:205766
	decreased immature B cell number	J:205766
	increased B cell number	J:205766
Igh^{tm1.1(b12)Nemz}/Igh^{tm1.1(b12)Nemz} Igk^{tm1.1(b12)Nemz}/Igk^{tm1.1(b12)Nemz} (involves: C57BL/6N * C57BL/6NTac * FVB/N)	decreased IgM level	J:205766
	decreased immature B cell number	J:205766
	increased B cell number	J:205766
Igh^{tm1.1(Rr361-HBB)Aak}/Igh^{tm1.1(Rr361-HBB)Aak} (129.129S2(Cg)-Igh^{tm1.1(Rr361-HBB)Aak})	abnormal class switch recombination	J:333279
	decreased IgA level	J:333279
	decreased IgE level	J:333279
	decreased IgG1 level	J:333279
	decreased IgG2a level	J:333279
	decreased IgG2b level	J:333279
Igh^{tm1.1(Tag)Rwhe}/Igh⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell morphology	J:150315
	enlarged spleen	J:150315
	increased B cell number	J:150315
Igh^tm1.1Hmj/Igh^tm1.1Hmj (involves: 129S6/SvEvTac * C57BL/6J * FVB/N)	abnormal B cell differentiation	J:140486
	abnormal immunoglobulin heavy chain V(D)J recombination	J:140486
	decreased mature B cell number	J:140486
	spleen hypoplasia	J:140486
Igh^tm1.1Hws/Igh^tm1.1Hws (BALB/cJ-Igh^tm1.1Hws)	decreased IgM level	J:119391
	decreased immature B cell number	J:119391
	decreased immunoglobulin level	J:119391
	decreased pre-B cell number	J:119391
	increased late pro-B cell number	J:119391
Igh^tm1.1Hws/Igh^tm1.1Hws (involves: BALB/c)	decreased immature B cell number	J:142069
	decreased late pro-B cell number	J:142069
	increased early pro-B cell number	J:142069
	increased IgG3 level	J:142069
	increased IgM level	J:142069
Igh^tm1.1Lnit/Igh⁺ (involves: BALB/c * C57BL/6)	abnormal B cell differentiation	J:119484
Igh^tm1.1Rsky/Igh^tm1.1Rsky (BALB/c-Igh^tm1.1Rsky)	abnormal class switch recombination	J:125719
Igh^tm1.1Rsky/Igh^tm1.1Rsky (BALB/c-Igh^tm1.1Rsky)	decreased IgM level	J:125719
Igh^tm1.1Twin/Igh⁺ (involves: 129 * 129S4/SvJae * C57BL/6)	decreased pre-B cell number	J:174233
Igh^tm1.1Twin/Igh⁺ (involves: 129 * 129S4/SvJae * C57BL/6)	increased pro-B cell number	J:174233
Igh^tm1.1Twin/Igh^tm1.1Twin (involves: 129 * 129S4/SvJae * C57BL/6)	abnormal B cell differentiation	J:174233
	abnormal B cell morphology	J:174233
	abnormal B cell number	J:174233
	abnormal marginal zone B cell morphology	J:174233
	abnormal marginal zone B cell physiology	J:174233
	absent plasma cells	J:174233
	decreased B cell number	J:174233
	decreased B-1a cell number	J:174233
	decreased follicular B cell number	J:174233
	decreased IgG3 level	J:174233
	decreased IgG level	J:174233
	decreased IgM level	J:174233
	decreased immature B cell number	J:174233
	decreased mature B cell number	J:174233
	decreased transitional stage T2 B cell number	J:174233
Igh^tm1.1Twin/Igh^tm1.1Twin Plcg2^Ali5/Plcg2⁺ (involves: 129 * 129S4/SvJae * C3HeB/FeJ * C57BL/6)	increased B-1a cell number	J:174233
Igh^tm1.1Vmd/Igh⁺ (involves: C57BL/6)	abnormal class switch recombination	J:201147
Igh^tm1.1Vmd/Igh^tm1.1Vmd (involves: C57BL/6)	abnormal class switch recombination	J:201147
	decreased IgG1 level	J:201147
	decreased IgG3 level	J:201147
	increased IgE level	J:201147
Igh^tm1.2Rsky/Igh⁺ (BALB/c-Igh^tm1.2Rsky)	increased IgG1 level	J:125719
Igh^tm1.2Rsky/Igh⁺ Tnfrsf13c^tm1Mass/Tnfrsf13c^tm1Mass (involves: BALB/c * C57BL/6)	decreased mature B cell number	J:125719
Igh^tm1.2Rsky/Igh^tm1.2Rsky (BALB/c-Igh^tm1.2Rsky)	abnormal B cell activation	J:125719
	abnormal B cell morphology	J:125719
	abnormal B cell proliferation	J:125719
	abnormal mature B cell morphology	J:125719
	decreased B-1a cell number	J:125719
	decreased IgA level	J:125719
	decreased IgD level	J:125719
	decreased IgE level	J:125719
	decreased IgM level	J:125719
	decreased immunoglobulin level	J:125719
	decreased pre-B cell number	J:125719
	decreased transitional stage B cell number	J:125719
	increased marginal zone B cell number	J:125719
	increased pro-B cell number	J:125719
Igh^tm1.2Rsky/Igh^tm1.2Rsky Tg(CD19-cre/ERT2)1Cgn/? (involves: BALB/c)	abnormal B cell activation	J:125719
	abnormal class switch recombination	J:125719
Igh^tm1Aak/Igh^tm1Aak (Not Specified)	abnormal B cell differentiation	J:158402
	decreased B cell number	J:158402
	decreased pre-B cell number	J:158402
	increased pro-B cell number	J:158402
Igh^tm1Cgn/Igh⁺ (involves: 129P2/OlaHsd)	abnormal B cell differentiation	J:79556
Igh^tm1Cgn/Igh^tm2Cgn (involves: 129P2/OlaHsd * BALB/c * C57BL/Ka)	abnormal B cell differentiation	J:79556
Igh^tm1Cog/Igh^tm1Cog (involves: 129S2/SvPas * C57BL/6)	abnormal immunoglobulin heavy chain V(D)J recombination	J:80654
	absent B cells	J:80654
	arrested B cell differentiation	J:80654
	decreased IgA level	J:80654
	decreased IgE level	J:80654
	decreased IgG1 level	J:80654
	decreased IgG2a level	J:80654
	decreased IgG2b level	J:80654
	decreased IgG3 level	J:80654
	decreased IgM level	J:80654
	decreased immunoglobulin level	J:80654
Igh^tm1Cys/Igh⁺ Tg(Igk)5Cys/0 (B6.Cg-Igh^tm1Cys Tg(Igk)5Cys)	abnormal B cell physiology	J:118931
Igh^tm1Kplm/Igh⁺ (involves: A/WySnJ * BALB/c)	abnormal B-1 B cell morphology	J:115788
Igh^tm1Kplm/Igh⁺ (Not Specified)	abnormal B cell differentiation	J:115292
Igh^tm1Kplm/Igh⁺ (Not Specified)	increased B cell number	J:115292
Igh^tm1Kplm/Igh⁺ Tg(Igk-V4CH27)1-2Shc/0 (involves: C57BL/6 * SJL)	increased B cell number	J:115292
Igh^tm1Kplm/Igh^tm3Cgn (involves: C57BL/6)	abnormal B cell differentiation	J:115292
Igh^tm1Kplm/Igh^tm3Cgn (involves: C57BL/6)	abnormal B cell number	J:115292
Igh^tm1Kplm/Igh^tm4Cgn (involves: 129P2/OlaHsd)	abnormal B cell differentiation	J:115292
	abnormal B cell number	J:115292
	abnormal B-1 B cell morphology	J:115292
Igh^tm1Kplm/Igh^tm4Cgn Tg(Igk-V4CH27)1-2Shc/0 (involves: 129P2/OlaHsd * C57BL/6 * SJL)	increased B cell number	J:115292
Igh^tm1Ktom/Igh^tm1Ktom (involves: ICR)	abnormal B cell physiology	J:59894
	abnormal immunoglobulin level	J:178635
	absent mature B cells	J:178635
Igh^tm1Ktom/Igh^tm1Ktom Igk^tm1Ktom/Igk^tm1Ktom Tc(HSA14)SC20Ktom/0 Tc(HSA2)W23Ktom/0 (involves: C57BL/6NCrlj * CBA/JNCrlj * ICR)	abnormal B cell physiology	J:59894
Igh^tm1Ktom/Igh^tm1Ktom Tc(HSA2)W23Ktom/0 (involves: C57BL/6NCrlj * CBA/JNCrlj * ICR)	abnormal B cell physiology	J:59894
Igh^tm1Leck/Igh⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell morphology	J:144033
	abnormal B-1a B cell morphology	J:144033
	abnormal immature B cell morphology	J:144033
	abnormal immunoglobulin light chain V-J recombination	J:144033
	abnormal mature B cell morphology	J:144033
Igh^tm1Leck/Igh^tm1Leck (involves: 129P2/OlaHsd * C57BL/6)	decreased B cell number	J:144033
Igh^tm1Mnz/Igh^tm1Mnz (B6.129P2-Igh^tm1Mnz)	abnormal B cell physiology	J:75653
	increased B cell apoptosis	J:75653
	increased B cell proliferation	J:75653
	increased IgG level	J:75653
	increased IgM level	J:75653
Igh^tm1Mnz/Igh^tm1Mnz Dis3^tm1.1Uba/Dis3^tm1.1Uba Aicda^tm1(cre)Uba/Aicda⁺ (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6)	abnormal somatic hypermutation frequency	J:302856
Igh^tm1Mnz/Igh^tm1Mnz Lyn^tm1Sor/Lyn^tm1Sor (involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6)	abnormal B cell physiology	J:75653
	increased B cell proliferation	J:75653
Igh^tm1Rbr/Igh⁺ (C57BL/6-Igh^tm1Rbr)	abnormal B cell morphology	J:132538
Igh^tm1Rbr/Igh⁺ Tg(IgkHyHEL10)1Rbr/0 (involves: C57BL/6)	abnormal B cell morphology	J:132538
	abnormal B-2 B cell morphology	J:132538
	increased IgA level	J:132538
	increased IgG1 level	J:132538
	increased IgG2a level	J:132538
	increased IgG2b level	J:132538
	increased IgG3 level	J:132538
	increased IgM level	J:132538
	increased immature B cell number	J:132538
	increased immunoglobulin level	J:132538
Igh^tm1Rbr/Igh⁺ Tg(IgkHyHEL10)1Rbr/0 Tg(ML5sHEL)5Ccg/0 (involves: C57BL/6 * C57BL/6JSfd)	abnormal B cell morphology	J:132538
	decreased follicular B cell number	J:132538
	decreased marginal zone B cell number	J:132538
	increased immature B cell number	J:132538
Igh^{tm2.1(4E10)Nemz}/Igh^{tm2.1(4E10)Nemz} Igk^{tm2.1(4E10)Nemz}/Igk^{tm2.1(4E10)Nemz} (involves: C57BL/6 * C57BL/6N * C57BL/6NTac * FVB/N)	decreased B cell number	J:101977
	decreased IgG level	J:101977
	decreased IgM level	J:101977
Igh^{tm2.1(Tag)Rwhe}/Igh⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell morphology	J:150315
	enlarged spleen	J:150315
	increased B cell number	J:150315
Igh^tm2.1Fwa/Igh^tm2.1Fwa (involves: 129S/SvEv * C57BL/6)	abnormal class switch recombination	J:161437
	abnormal somatic hypermutation frequency	J:161437
	decreased IgG1 level	J:161437
	decreased mature B cell number	J:161437
	increased IgE level	J:161437
Igh^tm2.1Hws/Igh^tm2.1Hws (involves: BALB/c * C57BL/6NCrl * DBA/2NCrl)	decreased B cell number	J:124421
	decreased B-1a cell number	J:124421
	decreased B-1b cell number	J:124421
	decreased follicular B cell number	J:124421
	decreased IgG level	J:124421
	decreased IgM level	J:124421
	decreased pre-B cell number	J:124421
	decreased transitional stage B cell number	J:124421
	increased early pro-B cell number	J:124421
	increased marginal zone B cell number	J:124421
Igh^tm2.1Hws/Igh^tm2.1Hws (involves: BALB/c)	abnormal B cell differentiation	J:142069
	decreased B-1a cell number	J:142069
	decreased follicular B cell number	J:142069
	decreased IgM level	J:142069
	decreased immature B cell number	J:142069
	decreased late pro-B cell number	J:142069
	decreased mature B cell number	J:142069
	decreased transitional stage B cell number	J:142069
	increased early pro-B cell number	J:142069
	increased marginal zone B cell number	J:142069
Igh^tm2Cgn/Igh⁺ (involves: 129P2/OlaHsd * BALB/c * C57BL/Ka)	abnormal B cell differentiation	J:79556
Igh^tm2Cgn/Igh⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal immunoglobulin light chain V-J recombination	J:144033
Igh^tm2Cgn/Igh⁺ Igk^tm1Rsky/Igk⁺ (either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * BALB/c))	abnormal B cell differentiation	J:111431
	absent pre-B cells	J:111431
Igh^tm2Cgn/Igh⁺ Igk^tm2Rsky/Igk⁺ (involves: 129P2/OlaHsd)	abnormal class switch recombination	J:150435
Igh^tm2Cgn/Igh⁺ Igk^tm2Rsky/Igk⁺ Prkdc^scid/Prkdc^scid (involves: 129P2/OlaHsd * BALB/c * C57BL/Ka)	abnormal class switch recombination	J:150435
Igh^tm2Cgn/Igh⁺ Rr158^tm1Cgn/Rr158^tm1Cgn Arhgef1^tm1.1Rmt/Arhgef1^tm1.1Rmt (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:113295
Igh^tm2Cgn/Igh⁺ Xrcc6^tm1Fwa/Xrcc6^tm1Fwa (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6)	abnormal B cell differentiation	J:44361
Igh^tm2Cgn/Igh^tm2Cgn Igk^tm1Rsky/Igk^tm1Rsky Lig4^tm1Fwa/Lig4^tm1Fwa Trp53^tm1Tyj/Trp53^tm1Tyj (involves: 129P2/OlaHsd * 129S2/SvPas * 129S6/SvEvTac)	abnormal class switch recombination	J:126758
Igh^tm2Cgn/Igh^tm2Cgn Igk^tm1Rsky/Igk^tm1Rsky Trp53^tm1Tyj/Trp53^tm1Tyj Xrcc4^tm1Fwa/Xrcc4^tm1Fwa (involves: 129P2/OlaHsd * 129S2/SvPas * 129S6/SvEvTac)	abnormal class switch recombination	J:126758
Igh^tm2Cgn/Igh^tm3Cgn (involves: 129P2/OlaHsd * BALB/c * C57BL/6 * C57BL/Ka)	abnormal B cell differentiation	J:79556
Igh^tm2Cgn/Igh^tm4.1Fwa (involves: 129P2/OlaHsd * 129S6/SvEvTac)	abnormal immunoglobulin V(D)J recombination	J:176649
Igh^tm2Cog/Igh⁺ (involves: 129S2/SvPas * C57BL/6)	decreased IgG1 level	J:90548
	decreased IgG2b level	J:90548
	decreased IgG3 level	J:90548
	decreased IgG level	J:90548
Igh^tm2Cog/Igh^tm2Cog (involves: 129S2/SvPas * C57BL/6)	decreased IgG1 level	J:90548
	decreased IgG2a level	J:90548
	decreased IgG2b level	J:90548
	decreased IgG3 level	J:90548
	decreased IgG level	J:90548
	increased pre-B cell number	J:90548
Igh^tm2Emo/Igh^tm2Emo (involves: 129S1/Sv * C57BL/6 * FVB/N)	abnormal B cell differentiation	J:108098
	absent pre-B cells	J:108098
Igh^tm2Mnz/Igh^tm2Mnz (B6.129P2-Igh^tm2Mnz)	increased B cell proliferation	J:75653
	increased IgG level	J:75653
	increased IgM level	J:75653
Igh^tm2Mnz/Igh^tm2Mnz Lyn^tm1Sor/Lyn^tm1Sor (involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6)	abnormal B cell physiology	J:75653
	increased B cell proliferation	J:75653
Igh^tm2Rsky/Igh⁺ Igk^tm1Rsky/Igk⁺ (either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * BALB/c))	abnormal B cell differentiation	J:111431
Igh^tm2Rsky/Igh⁺ Igk^tm2Rsky/Igk⁺ (either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * BALB/c))	abnormal B cell differentiation	J:111431
Igh^tm3.1Cog/Igh^tm3.1Cog (involves: 129P2/OlaHsd * C57BL/6 * FVB/N)	abnormal class switch recombination	J:71300
	decreased IgA level	J:71300
	decreased IgE level	J:71300
	decreased IgG2a level	J:71300
	decreased IgG2b level	J:71300
	decreased IgG3 level	J:71300
	decreased IgG level	J:71300
	decreased immunoglobulin level	J:71300
Igh^tm3.1Tim/Igh⁺ (involves: 129 * C57BL/6)	abnormal B cell differentiation	J:102308
	abnormal bone marrow cell number	J:102308
	abnormal spleen B cell follicle morphology	J:102308
Igh^tm3Cgn/Igh⁺ (involves: C57BL/6)	abnormal B cell differentiation	J:79556, J:115292
Igh^tm3Cgn/Igh^tm3Cgn (involves: C57BL/6)	decreased immature B cell number	J:76117
Igh^tm3Hws/Igh^tm3Hws (BALB/c-Igh^tm3Hws)	abnormal immunoglobulin heavy chain V(D)J recombination	J:142068
Igh^tm3Hws/Igh^tm3Hws (involves: BALB/c)	abnormal immunoglobulin level	J:142069
	decreased B cell number	J:142069
	decreased bone marrow cell number	J:142069
	decreased follicular B cell number	J:142069
	decreased IgG1 level	J:142069
	decreased IgG2a level	J:142069
	decreased IgG2b level	J:142069
	decreased IgM level	J:142069
	decreased immature B cell number	J:142069
	decreased late pro-B cell number	J:142069
	decreased mature B cell number	J:142069
	decreased transitional stage B cell number	J:142069
	increased IgM level	J:142069
	spleen hypoplasia	J:142069
Igh^tm3Tim/Igh⁺ (involves: 129 * C57BL/6)	abnormal B cell differentiation	J:102308
	abnormal bone marrow cell number	J:102308
	abnormal spleen B cell follicle morphology	J:102308
Igh^tm4.1Cog/Igh^tm4.1Cog (involves: 129P2/OlaHsd * C57BL/6 * FVB/N)	abnormal class switch recombination	J:184094
	decreased IgA level	J:184094
	increased IgM level	J:184094
Igh^tm4.1Fwa/Igh⁺ (involves: 129S6/SvEvTac)	abnormal B cell differentiation	J:176649
Igh^tm4.1Fwa/Igh⁺ (involves: 129S6/SvEvTac)	abnormal immunoglobulin V(D)J recombination	J:176649
Igh^tm4.1Fwa/Igh^tm4.1Fwa (involves: 129S6/SvEvTac)	abnormal B cell differentiation	J:176649
Igh^tm4.1Fwa/Igh^tm4.1Fwa (involves: 129S6/SvEvTac)	abnormal immunoglobulin V(D)J recombination	J:176649
Igh^tm4Cgn/Igh⁺ (involves: 129P2/OlaHsd)	abnormal B cell differentiation	J:115292
Igh^tm4Cog/Igh⁺ (involves: 129S2/SvPas * C57BL/6)	decreased IgM level	J:109988
Igh^tm4Cog/Igh⁺ (involves: 129S2/SvPas * C57BL/6)	increased IgA level	J:109988
Igh^tm4Cog/Igh^tm4Cog (involves: 129S2/SvPas * C57BL/6)	absent spleen germinal center	J:109988
Igh^tm4Cog/Igh^tm4Cog (involves: 129S2/SvPas * C57BL/6)	small spleen	J:109988
Igh^tm5.1Cgn/Igh^tm5.1Cgn (BALB/c-Igh^tm5.1Cgn)	abnormal B cell activation	J:88472
	abnormal B cell differentiation	J:88472
	abnormal mature B cell morphology	J:88472
	absent B-1 B cells	J:88472
	absent B-1a cells	J:88472
	absent B-1b cells	J:88472
	absent spleen germinal center	J:88472
	decreased B cell number	J:88472
	decreased immature B cell number	J:88472
	decreased marginal zone B cell number	J:88472
	increased pro-B cell number	J:88472
Igh^tm5.1Cog/Igh^tm5.1Cog (involves: 129P2/OlaHsd * C57BL/6)	abnormal class switch recombination	J:164513
	abnormal somatic hypermutation frequency	J:164513, J:333348
	decreased IgA level	J:164513
	decreased IgE level	J:164513
	decreased IgG2b level	J:164513
	decreased IgG3 level	J:164513
	decreased IgM level	J:164513
Igh^tm5.1Fwa/Igh⁺ (involves: 129S6/SvEvTac)	abnormal B cell differentiation	J:176649
Igh^tm5.1Fwa/Igh⁺ (involves: 129S6/SvEvTac)	decreased pre-B cell number	J:176649
Igh^tm5.1Fwa/Igh^tm5.1Fwa (involves: 129S6/SvEvTac)	abnormal B cell differentiation	J:176649
Igh^tm5.1Fwa/Igh^tm5.1Fwa (involves: 129S6/SvEvTac)	decreased pre-B cell number	J:176649
Igh^tm5Cgn/Igh^tm5Cgn (involves: BALB/c)	absent B cells	J:88472
Igh^tm5Cgn/Igh^tm5Cgn (involves: BALB/c)	arrested B cell differentiation	J:88472
Igh^tm5Cgn/Igh^tm5Cgn Tg(CD19-cre/ERT2)1Cgn/0 (C.Cg-Igh^tm5Cgn Tg(CD19-cre/ERT2)1Cgn)	abnormal B cell differentiation	J:88472
	abnormal mature B cell morphology	J:88472
	absent follicular B cells	J:88472
	absent marginal zone B cells	J:88472
	increased B cell number	J:88472
	increased pro-B cell number	J:88472
Igh^{tm7(VHB1-8)Cgn}/Igh⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal somatic hypermutation frequency	J:48835
Igh^{tm8(VHB1-8)Cgn}/Igh⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal somatic hypermutation frequency	J:48835
Igh^{tm9(VHB1-8)Cgn}/Igh⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal somatic hypermutation frequency	J:48835
Igh^tm11.1Cgn/Igh^tm11.1Cgn (Not Specified)	abnormal B cell differentiation	J:113434
	decreased B cell number	J:113434
	decreased immature B cell number	J:113434
	decreased mature B cell number	J:113434
	increased pro-B cell number	J:113434
Igh^tm12Cgn/Igh^tm12Cgn (involves: 129P2/OlaHsd)	abnormal somatic hypermutation frequency	J:66031
Igha^tm1(Myc)Janz/Igha⁺ (involves: 129S1/Sv * C57BL/6)	increased B cell apoptosis	J:90901
	increased B cell proliferation	J:90901
	increased plasma cell number	J:90901
Igha^tm1(Myc)Janz/Igha⁺ Tg(Igk-V21-Bax)1967Bvn/0 (involves: 129S1/Sv * C57BL/6 * FVB/N)	abnormal B cell apoptosis	J:90901
	abnormal plasma cell morphology	J:90901
	enlarged spleen	J:90901
	increased IgG level	J:90901
	increased IgM level	J:90901
	increased plasma cell number	J:90901
Igha^tm1(Myc)Janz/Igha⁺ Tg(Tnfsf13b)1Fma/0 (involves: 129S1/Sv * C57BL/6 * DBA/2J)	enlarged spleen	J:166158
	increased B cell number	J:166158
	increased lymphocyte cell number	J:166158
	increased mature B cell number	J:166158
	increased spleen white pulp amount	J:166158
Igha^tm1Grh/Igha^tm1Grh (involves: 129S7/SvEvBrd * C57BL/6)	abnormal immunoglobulin level	J:125472
	abnormal memory T cell physiology	J:125472
	abnormal T cell activation	J:53217
	decreased IgA level	J:53217, J:125472
	decreased IgE level	J:53217
	decreased IgG3 level	J:53217
	decreased T cell proliferation	J:125472
	increased IgG1 level	J:53217, J:125472
	increased IgG2a level	J:53217
	increased IgG2b level	J:53217
	increased IgG level	J:53217
	increased IgM level	J:53217, J:125472
Igha^tm2Grh/Igha^tm2Grh (involves: 129S7/SvEvBrd * C57BL/6)	abnormal class switch recombination	J:72521
Ighd^dmit/Ighd^dmit (C57BL/6JAnu-Ighd^dmit/AnuApb)	abnormal immunoglobulin level	J:104190
Ighd^M1Btlr/Ighd⁺ (C57BL/6J-Ighd^M1Btlr)	decreased B cell number	J:255202
Ighd^M1Btlr/Ighd^M1Btlr (C57BL/6J-Ighd^M1Btlr)	decreased B cell number	J:255202
Ighd^M1Btlr/Ighd^M1Btlr (C57BL/6J-Ighd^M1Btlr)	decreased IgD level	J:255202
Ighd^m2Btlr/Ighd⁺ (C57BL/6J-Ighd^m2Btlr)	decreased B cell number	J:255203
Ighd^m2Btlr/Ighd^m2Btlr (C57BL/6J-Ighd^m2Btlr)	decreased B cell number	J:255203
Ighd^m2Btlr/Ighd^m2Btlr (C57BL/6J-Ighd^m2Btlr)	decreased IgD level	J:255203
Ighd^tm1Cgn/Ighd^tm1Cgn (involves: 129P2/OlaHsd * C57BL/6)	decreased IgE level	J:64281
Ighd^tm1Lam/Ighd⁺ (involves: 129S2/SvPas * C57BL/6)	decreased B cell number	J:111020
Ighd^tm1Lam/Ighd^tm1Lam (involves: 129S2/SvPas * C57BL/6)	abnormal B cell physiology	J:111020
	abnormal leukopoiesis	J:111020
	decreased IgG2b level	J:111020
	increased IgA level	J:111020
Ighe^M1Btlr/Ighe^M1Btlr (C57BL/6J-Ighe^M1Btlr)	decreased IgE level	J:267480
Ighg1^em1Wliu/Ighg1^em1Wliu (C57BL/6-Ighg1^em1Wliu)	abnormal plasma cell differentiation	J:266937
	increased germinal center B cell number	J:266937
	increased IgG1 level	J:266937
	increased plasma cell number	J:266937
Ighg1^tm1(cre)Cgn/0 Mef2b^tm1.1Rdf/Mef2b⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased germinal center B cell number	J:265465
Ighg1^tm1(cre)Cgn/0 Mef2b^tm1.1Rdf/Mef2b^tm1.1Rdf (involves: 129P2/OlaHsd * C57BL/6)	abnormal mature B cell morphology	J:265465
	decreased germinal center B cell number	J:265465
Ighg1^tm1(cre)Cgn/0 Mef2b^tm1.1Rdf/Mef2b^tm1.1Rdf Mef2c^tm2Eno/Mef2c^tm2Eno (involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6)	decreased germinal center B cell number	J:265465
Ighg1^tm1(cre)Cgn/0 Mef2b^tm2Rdf/Mef2b⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal mature B cell morphology	J:265465
	increased germinal center B cell number	J:265465
Ighg1^tm1(cre)Cgn/0 Mef2b^tm2Rdf/Mef2b^tm1.1Rdf (involves: 129P2/OlaHsd * C57BL/6)	abnormal mature B cell morphology	J:265465
	increased germinal center B cell number	J:265465
Ighg1^tm1(cre)Cgn/0 Mef2c^tm2Eno/Mef2c^tm2Eno (involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6)	decreased germinal center B cell number	J:265465
Ighg1^tm1(cre)Cgn/0 Mef2d^tm3Eno/Mef2d^tm3Eno (involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6)	hematopoietic system phenotype	J:265465
Ighg1^tm1(cre)Cgn/Ighg1⁺ Irf4^tm1Rdf/Irf4^tm1.1Rdf (involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6)	abnormal class switch recombination	J:112643
	abnormal memory B cell morphology	J:112643
	absent plasma cells	J:112643
	decreased IgG1 level	J:112643
Ighg1^tm1(cre)Cgn/Ighg1⁺ Myd88^em1.1Rsky/Myd88⁺ (involves: 129P2/OlaHsd * C57BL/6NTac)	abnormal somatic hypermutation frequency	J:308792
	abnormal splenic cell ratio	J:308792
	hematopoietic system phenotype	J:308792
	increased germinal center B cell number	J:308792
	increased IgM level	J:308792
	increased plasma cell number	J:308792
Ighg1^tm1(cre)Cgn/Ighg1⁺ Tbl1xr1^tm1.1Meln/Tbl1xr1⁺ (involves: 129P2/OlaHsd * C57BL/6J)	abnormal B cell differentiation	J:292118
	abnormal spleen morphology	J:292118
Ighg1^tm1(cre)Cgn/Ighg1⁺ Tbl1xr1^{tm1c(EUCOMM)Hmgu}/Tbl1xr1^{tm1c(EUCOMM)Hmgu} (involves: 129P2/OlaHsd * C57BL/6J)	abnormal B cell differentiation	J:292118
	abnormal spleen morphology	J:292118
Ighg1^tm1.1Ksho/Ighg1⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:39568
Ighg1^tm1.1Ksho/Ighg1⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased IgG1 level	J:39568
Ighg1^tm1.1Ksho/Ighg1^tm1.1Ksho (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:39568
	decreased IgG1 level	J:39568
Ighg1^tm1.1Pyu/Ighg1⁺ (B6.C(Cg)-Ighg1^tm1.1Pyu)	decreased IgG1 level	J:198154
	decreased IgG2c level	J:198154
	increased IgE level	J:198154
	increased IgG2a level	J:198154
Ighg1^tm1.1Pyu/Ighg1^tm1.1Pyu (B6.C(Cg)-Ighg1^tm1.1Pyu)	decreased IgG1 level	J:198154
	decreased IgG2c level	J:198154
	increased IgE level	J:198154
	increased IgG2a level	J:198154
	increased IgG2b level	J:198154
Ighg1^tm1Ksho/Ighg1⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:39568
Ighg1^tm1Ksho/Ighg1⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased IgG1 level	J:39568
Ighg1^tm1Ksho/Ighg1^tm1Ksho (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:39568
	absent memory B cells	J:39568
	decreased IgG1 level	J:39568
Ighg1^tm2Cgn/Ighg1⁺ ((C57BL/6 x 129P2/OlaHsd)F1)	abnormal class switch recombination	J:146428
Ighg1^tm2Cgn/Ighg1⁺ ((C57BL/6 x 129P2/OlaHsd)F1)	decreased IgG1 level	J:146428
Ighg1^tm3Cgn/Ighg1⁺ (involves: 129P2/OlaHsd * BALB/c * C57BL/6)	abnormal class switch recombination	J:166887
	decreased IgG1 level	J:166887
Ighm^tm1(Bcl6)Rdf/? (involves: 129/Sv * C57BL/6)	abnormal B cell proliferation	J:98937
	abnormal spleen B cell follicle morphology	J:98937
	abnormal spleen morphology	J:98937
	decreased immunoglobulin level	J:98937
	decreased plasma cell number	J:98937
	enlarged spleen	J:98937
	increased spleen germinal center number	J:98937
	increased spleen white pulp amount	J:98937
Ighm^{tm1.1(IGH-2)Cog}/Ighm^{tm1.1(IGH-2)Cog} (involves: 129P2/OlaHsd * C57BL/6 * FVB/N)	abnormal B cell differentiation	J:157575
	abnormal plasma cell differentiation	J:157575
	decreased B cell number	J:157575
	decreased B cell proliferation	J:157575
	decreased B-1 B cell number	J:157575
	decreased follicular B cell number	J:157575
	decreased IgA level	J:157575
	decreased IgG1 level	J:157575
	decreased IgG2a level	J:157575
	decreased IgG3 level	J:157575
	decreased IgG level	J:157575
	decreased IgM level	J:157575
	decreased marginal zone B cell number	J:157575
	decreased mature B cell number	J:157575
	decreased pre-B cell number	J:157575
	decreased transitional stage B cell number	J:157575
	increased B cell number	J:157575
	increased B cell proliferation	J:157575
	increased plasma cell number	J:157575
	increased pro-B cell number	J:157575
Ighm^tm1.1Aak/Ighm^tm1.1Aak (involves: 129S2/SvPas * C57BL/6)	abnormal class switch recombination	J:171251
	decreased B cell number	J:171251
	decreased pre-B cell number	J:171251
	increased pro-B cell number	J:171251
Ighm^tm1Cgn/Igh^tm3Tim (involves: 129 * C57BL/6)	abnormal B cell differentiation	J:102308
Ighm^tm1Cgn/Igh^tm3Tim (involves: 129 * C57BL/6)	decreased B cell number	J:102308
Ighm^tm1Cgn/Ighm⁺ (involves: 129S2/SvPas * C57BL/6)	arrested B cell differentiation	J:70398
Ighm^tm1Cgn/Ighm⁺ Tgfb1^tm1Doe/Tgfb1^tm1Doe (involves: 129S2/SvPas * C57BL/6 * CF-1)	thymus hypoplasia	J:99033
Ighm^tm1Cgn/Ighm^tm1Cgn (involves: 129S2/SvPas * C57BL/6)	abnormal B cell differentiation	J:64298, J:70398
	absent immature B cells	J:64298
	absent mature B cells	J:64298
	arrested B cell differentiation	J:64298
	decreased IgM level	J:64298
Ighm^tm1Cgn/Ighm^tm1Cgn (B6.129S2-Ighm^tm1Cgn/J)	abnormal spleen morphology	J:73100
	arrested B cell differentiation	J:119584
	decreased CD4-positive, alpha-beta T cell number	J:73100, J:118565
	decreased CD8-positive, alpha-beta T cell number	J:73100
	decreased dendritic cell number	J:73100
	decreased IgE level	J:125656
	decreased IgG1 level	J:125656
	decreased IgG level	J:119584, J:125656
	decreased immunoglobulin level	J:119584
	decreased spleen weight	J:73100
Ighm^tm1Cgn/Ighm^tm1Cgn (involves: 129S2/SvPas)	abnormal CD4-positive, alpha-beta T cell physiology	J:112160
	abnormal metallophilic macrophage morphology	J:88620
	abnormal spleen marginal sinus morphology	J:88620
	abnormal spleen marginal zone macrophage morphology	J:88620
	absent mature B cells	J:118453
	arrested B cell differentiation	J:118453
	decreased IgA level	J:157450
	decreased IgG level	J:157450
	decreased T cell proliferation	J:112160
	increased osteoclast cell number	J:157619
Ighm^tm1Cgn/Ighm^tm1Cgn (B6.129S2-Ighm^tm1Cgn)	abnormal CD8 positive, alpha-beta intraepithelial T cell morphology	J:126867
Ighm^tm1Cgn/Ighm^tm1Cgn (NOD.129S2-Ighm^tm1Cgn/DvsJ)	abnormal T cell number	J:80859
	abnormal T cell proliferation	J:80859
	absent B cells	J:80859
	decreased spleen B cell follicle number	J:80859
Ighm^tm1Cgn/Ighm^tm1Cgn Igkc^tm1Bgmn/Igkc^tm1Bgmn Igl^tm2.1Bgmn/Igl^tm2.1Bgmn (involves: 129)	decreased IgG level	J:130864
	decreased IgM level	J:130864
Ighm^tm1Cgn/Ighm^tm1Cgn Tg(IghelMD4)4Ccg/Tg(IghelMD4)4Ccg (NOD.Cg-Ighm^tm1Cgn Tg(IghelMD4)4Ccg/DvsJ)	abnormal B lymphocyte antigen presentation	J:80859
	abnormal mature B cell morphology	J:80859
	abnormal T cell proliferation	J:80859
	decreased CD8-positive, alpha-beta T cell number	J:80859
Ighm^tm1Cgn/Ighm^tm1Cgn Tgfb1^tm1Doe/Tgfb1^tm1Doe (involves: 129S2/SvPas * C57BL/6 * CF-1)	thymus hypoplasia	J:99033
Ighm^tm1Cgn/Ighm^tm1Cgn Unc93b1^tm1.1Kmiy/Unc93b1^tm1.1Kmiy (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	hematopoietic system phenotype	J:174308
	thrombocytopenia	J:174308
Ighm^tm1Che/Ighm^tm1Che (involves: 129S4/SvJae * C57BL/6)	abnormal B cell physiology	J:47425
	abnormal metallophilic macrophage morphology	J:125338
	abnormal spleen B cell follicle morphology	J:125338
	abnormal spleen germinal center morphology	J:47425
	abnormal spleen marginal zone morphology	J:125338
	abnormal spleen morphology	J:125338
	abnormal spleen periarteriolar lymphoid sheath morphology	J:125338
	abnormal spleen white pulp morphology	J:125338
	decreased IgG1 level	J:47425
	decreased IgG2b level	J:47425
	decreased IgM level	J:47425
	increased B-1 B cell number	J:47425
	increased IgA level	J:47425
	increased IgG2a level	J:47425
	increased IgG3 level	J:47425
Ighm^tm1Msn/Ighm⁺ (involves: 129S/SvEv)	decreased IgM level	J:49405
Ighm^tm1Msn/Ighm^tm1Msn (involves: 129S/SvEv)	abnormal B-1a B cell morphology	J:49405
	abnormal immature B cell morphology	J:49405
	abnormal mature B cell morphology	J:49405
	decreased IgG1 level	J:49405
	decreased IgM level	J:49405
	increased IgG3 level	J:49405
Ighm^tm1Msn/Ighm^tm1Msn (B6.129S-Ighm^tm1Msn)	abnormal B-1a B cell morphology	J:80656
	abnormal splenic cell ratio	J:80656
	decreased follicular B cell number	J:80656
	decreased IgM level	J:80656
	increased marginal zone B cell number	J:80656
Ighm^tm1Msn/Ighm^tm1Msn Tg(Igh-6)1Msn/? (B6.129S-Ighm^tm1Msn)	abnormal B-1a B cell morphology	J:80656
	abnormal splenic cell ratio	J:80656
	decreased follicular B cell number	J:80656
	decreased IgM level	J:80656
	increased marginal zone B cell number	J:80656
Ighm^tm1Sls/Ighm^tm1Sls (Not Specified)	abnormal class switch recombination	J:99465
	decreased IgG1 level	J:99465
	decreased IgG2b level	J:99465
	decreased IgG3 level	J:99465
	decreased IgG level	J:99465
	increased IgM level	J:99465
Ighm^tm2.1Bgmn/Ighm^tm2.1Bgmn (involves: 129/Sv * C57BL/6 * CBA)	absent mature B cells	J:118453
	arrested B cell differentiation	J:118453
	decreased immunoglobulin level	J:118453
Ighm^tm3Bgmn/Ighm^tm3Bgmn (involves: 129)	abnormal B cell activation	J:131633
	decreased B cell proliferation	J:131633
	decreased IgM level	J:131633
	decreased immature B cell number	J:131633
	decreased mature B cell number	J:131633
	increased B-1 B cell number	J:131633
Ighm^tm3Bgmn/Ighm^tm3Bgmn Igkc^tm1Bgmn/Igkc^tm1Bgmn Igl^tm2.1Bgmn/Igl^tm2.1Bgmn (involves: 129P2/OlaHsd * 129/Sv)	abnormal B cell differentiation	J:130864
	decreased IgG level	J:130864
	decreased IgM level	J:130864
Ighm^tm4Bgmn/Ighm^tm4Bgmn (involves: 129)	abnormal B cell activation	J:131633
	decreased B cell proliferation	J:131633
	decreased IgM level	J:131633
	decreased immature B cell number	J:131633
	decreased mature B cell number	J:131633
	increased B-1 B cell number	J:131633
Igk-J^tm1Cog/Igk-J^tm1.1Cog (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell number	J:110100
	abnormal plasma cell morphology	J:110100
	decreased B cell number	J:110100
	decreased naive B cell number	J:110100
	increased plasma cell number	J:110100
	increased pre-B cell number	J:110100
Igk-J^tm1Cog/Igk-J^tm1Cog (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:110100
	decreased B cell number	J:110100
Igk^tm1Dhu/Igk^tm1Dhu Iglc1^tm1.1Ust/Iglc1⁺ (involves: 129S7/SvEvBrd * C57BL/6 * FVB/N)	decreased B cell number	J:68144
Igk^tm1Dhu/Igk^tm1Dhu Iglc1^tm1.1Ust/Iglc1^tm1.1Ust (involves: 129S7/SvEvBrd * C57BL/6 * FVB/N)	decreased B cell number	J:68144
Igk^tm1Dhu/Igk^tm1Dhu Iglc1^tm1Ust/Iglc1⁺ (involves: 129S7/SvEvBrd * C57BL/6)	abnormal B cell differentiation	J:68144
	increased B cell number	J:68144
Igk^tm1Dhu/Igk^tm1Dhu Iglc1^tm1Ust/Iglc1^tm1Ust (involves: 129S7/SvEvBrd * C57BL/6)	increased B cell number	J:68144
Igk^tm1Dhu/Igk^tm1Dhu Iglc1^tm2Ust/Iglc1^tm2Ust (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal B cell differentiation	J:74717
	decreased B cell number	J:74717
	decreased immature B cell number	J:74717
	decreased marginal zone B cell number	J:74717
	decreased mature B cell number	J:74717
	decreased transitional stage T1 B cell number	J:74717
	decreased transitional stage T2 B cell number	J:74717
Igk^tm1Dhu/Igk^tm1Dhu Iglc1^tm2Ust/Iglc1^tm2Ust (involves: 129S7/SvEvBrd)	increased B-1a cell number	J:113218
Igk^tm1Dhu/Igk^tm1Dhu Tg(H2-Ea-HA)HACIIAjca/0 Tg(TcraS106-1,TcrbS106-1)TS1SWAjca/0 (C.Cg-Igk^tm1Dhu Tg(H2-Ea-HA)HACIIAjca Tg(TcraS106-1,TcrbS106-1)TS1SWAjca)	abnormal CD4-positive, alpha beta T cell morphology	J:209872
	abnormal spleen morphology	J:209872
	absent B cells	J:209872
	increased CD4-positive, alpha-beta T cell number	J:209872
Igk^tm1Rsky/Igk⁺ Igll1^tm1Cgn/Igll1^tm1Cgn (involves: 129P2/OlaHsd * 129S2/SvPas * BALB/c * C57BL/6)	abnormal B cell differentiation	J:35357
	decreased B cell number	J:35357
	decreased immature B cell number	J:35357
	decreased mature B cell number	J:35357
	decreased pre-B cell number	J:35357
Igk^tm2Ybgn/Igk^tm2Ybgn (Not Specified)	decreased pre-B cell number	J:123344
Igk^tm2Ybgn/Igk^tm2Ybgn (Not Specified)	increased immature B cell number	J:123344
Igkc^tm1(IGKC)Mnz/Igkc⁺ Igk-J^tm1(CD4*)Mss/Igk-J⁺ (involves: 129S4/SvJae)	abnormal immunoglobulin light chain V-J recombination	J:143876
Igkc^tm1(IGKC)Mnz/Igkc⁺ Rr158^tm1(Igh)Xu/Rr158⁺ (Not Specified)	decreased B cell number	J:124407
Igkc^tm1(IGKC)Mnz/Rr166^tm4.1Wtg (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6)	abnormal B cell physiology	J:193015
	abnormal immunoglobulin level	J:193015
Igkc^tm1Bgmn/Igkc^tm1Bgmn (involves: 129P2/OlaHsd)	abnormal B cell number	J:28868, J:118712
Igkc^tm1Bgmn/Igkc^tm1Bgmn Igl^tm1.1Bgmn/Igl^tm1.1Bgmn (involves: 129P2/OlaHsd * BALB/c * C57BL/6 * CBA)	abnormal immature B cell morphology	J:118712
	absent B cells	J:118712
	absent B-1 B cells	J:118712
	absent B-2 B cells	J:118712
	decreased B cell number	J:118712
	spleen hypoplasia	J:118712
Igkc^tm1Bgmn/Igkc^tm1Bgmn Igl^tm1Bgmn/Igl^tm1Bgmn (involves: 129P2/OlaHsd * BALB/c * C57BL/6 * CBA)	abnormal immature B cell morphology	J:118712
	absent B-1 B cells	J:118712
	absent B-2 B cells	J:118712
	absent mature B cells	J:118712
	decreased B cell number	J:118712
	spleen hypoplasia	J:118712
Igkc^tm1Bgmn/Igkc^tm1Bgmn Igl^tm2.1Bgmn/Igl^tm2.1Bgmn (involves: 129P2/OlaHsd * BALB/c * C57BL/6 * CBA)	absent B cells	J:118712
	arrested B cell differentiation	J:118712
Igkc^tm1Bgmn/Igkc^tm1Bgmn Igl^tm2.1Bgmn/Igl^tm2.1Bgmn (involves: 129P2/OlaHsd)	abnormal B cell differentiation	J:130864
	abnormal immunoglobulin heavy chain V(D)J recombination	J:130864
	abnormal plasma cell morphology	J:130864
	decreased IgG level	J:130864
	decreased IgM level	J:130864
Igkc^tm1Bgmn/Igkc^tm1Bgmn Igl^tm2Bgmn/Igl^tm2Bgmn (involves: 129P2/OlaHsd * BALB/c * C57BL/6 * CBA)	absent B cells	J:118712
	arrested B cell differentiation	J:118712
Igkc^tm1Cgn/Igkc⁺ (involves: C57BL/6)	increased mature B cell number	J:64287
Igkc^tm1Cgn/Igkc^tm1Cgn (involves: C57BL/6)	abnormal B cell differentiation	J:64287
	decreased mature B cell number	J:64287
	increased immature B cell number	J:64287
	increased mature B cell number	J:64287
	spleen hypoplasia	J:64287
Igkc^tm1Jkbv/Igkc^tm1Jkbv (Not Specified)	abnormal B cell differentiation	J:137738
	abnormal immunoglobulin level	J:137738
	abnormal immunoglobulin light chain V-J recombination	J:137738
	decreased immature B cell number	J:137738
	decreased mature B cell number	J:137738
	increased pre-B cell number	J:137738
Igkc^tm1Jkbv/Igkc^tm1Jkbv Tg(IGK@yK1)9.2CJkbv/0 (involves: 129P2/OlaHsd)	abnormal immunoglobulin level	J:137738
	decreased immature B cell number	J:137738
	decreased mature B cell number	J:137738
	increased pre-B cell number	J:137738
Igkc^tm1Jkbv/Igkc^tm1Jkbv Tg(IGK@yK1)9.2CJkbv/Tg(IGK@yK1)9.2CJkbv (involves: 129P2/OlaHsd)	abnormal B cell differentiation	J:137738
	abnormal immunoglobulin level	J:137738
	decreased immature B cell number	J:137738
	decreased mature B cell number	J:137738
	increased pre-B cell number	J:137738
Igkc^tm1Jkbv/Igkc^tm1Jkbv Tg(IGK@yK2)J23.1Jkbv/0 (involves: 129P2/OlaHsd)	abnormal B cell morphology	J:137738
	abnormal immunoglobulin level	J:137738
Igkc^tm1Jkbv/Igkc^tm1Jkbv Tg(IGK@yK2)J23.1Jkbv/Tg(IGK@yK2)J23.1Jkbv (involves: 129P2/OlaHsd)	abnormal B cell morphology	J:137738
Igkc^tm2(IGKC)Cgn/Igkc^tm2(IGKC)Cgn (involves: 129P2/OlaHsd)	abnormal B cell differentiation	J:113008
Igkrs^tm1Nemz/Igkrs^tm1Nemz (B6.129-Igkrs^tm1Nemz)	abnormal immunoglobulin light chain V-J recombination	J:132125
	decreased immature B cell number	J:132125
	decreased mature B cell number	J:132125
Igkrs^tm1Nemz/Igkrs^tm1Nemz Tg(UBC-scFv)2Nemz/? (involves: 129 * C57BL/6 * DBA/2)	abnormal B cell clonal deletion	J:132125
	decreased immature B cell number	J:132125
	decreased mature B cell number	J:132125
Iglc1^tm1Ust/Iglc1^tm1Ust (involves: 129S7/SvEvBrd * C57BL/6)	abnormal B cell number	J:68144
	increased lymphocyte cell number	J:68144
Iglc1^tm2Ust/Iglc1⁺ (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal immunoglobulin light chain V-J recombination	J:74717
Iglc1^tm2Ust/Iglc1^tm2Ust (involves: 129S7/SvEvBrd)	decreased B cell number	J:113218
Iglc1^tm2Ust/Iglc1^tm2Ust Ptpn6^me-v/Ptpn6^me-v (involves: 129S7/SvEvBrd * C57BL/6J)	decreased B cell number	J:113218
Igll1^tm1Cgn/Igll1^tm1Cgn (involves: 129S2/SvPas * C57BL/6)	abnormal B cell morphology	J:64284
	abnormal B-1 B cell number	J:64284
	abnormal lymphopoiesis	J:64284
	abnormal pre-B cell morphology	J:64284
	decreased B cell number	J:64284, J:35357
	decreased IgG1 level	J:64284
	decreased IgG2b level	J:64284
	decreased IgG3 level	J:64284
	decreased IgG level	J:64284
	increased pro-B cell number	J:64284
	spleen hypoplasia	J:64284
Igll1^tm1Cgn/Igll1^tm1Cgn Tg(Igk-V4CH27)1-2Shc/0 (involves: 129S2/SvPas * BALB/c * C57BL/6 * SJL)	abnormal B cell differentiation	J:35357
	decreased pre-B cell number	J:35357
Igll1^tm1Shim/Igll1^tm1Shim Vpreb1a^tm1Shim/Vpreb1a^tm1Shim Vpreb1b^tm1Shim/Vpreb1b^tm1Shim (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell differentiation	J:76947
	decreased B cell number	J:76947
	decreased B-1a cell number	J:76947
	decreased immature B cell number	J:76947
	decreased mature B cell number	J:76947
	decreased pre-B cell number	J:76947
	increased late pro-B cell number	J:76947
Iglon5^em1(IMPC)Mbp/Iglon5^em1(IMPC)Mbp (C57BL/6NCrl-Iglon5^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Ignpq1^BALB/cAJcl/Ignpq1^HIGA/Nsc (involves: BALB/cAJcl * HIGA/Nsc)	increased IgA level	J:116904
Ignpq1^HIGA/Nsc/Ignpq1^HIGA/Nsc (involves: BALB/cAJcl * HIGA/Nsc)	increased IgA level	J:116904
Ignpq2^BALB/cAJcl/Ignpq2^HIGA/Nsc (involves: BALB/cAJcl * HIGA/Nsc)	increased IgA level	J:116904
Ignpq2^HIGA/Nsc/Ignpq2^HIGA/Nsc (involves: BALB/cAJcl * HIGA/Nsc)	increased IgA level	J:116904
Igs2^{em1(Alb-Golm1)Jdon}/Igs2⁺ (involves: C57BL/6N)	decreased CD8-positive, alpha-beta T cell number	J:306528
Iigp1c^{em1(IMPC)Hmgu}/Iigp1c^{em1(IMPC)Hmgu} (C57BL/6N-Iigp1c^{em1(IMPC)Hmgu}/Ieg)	increased mean corpuscular volume	J:211773
Ikbip^em1Bcgen/Ikbip^em1Bcgen Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd)	decreased macrophage cytokine production	J:282971
Ikbkb^em1Macc/Ikbkb⁺ (involves: C57BL/6NCrl)	abnormal effector T cell number	J:290616
	abnormal T cell activation	J:290616
	decreased B cell number	J:290616
	decreased CD4-positive, alpha-beta T cell number	J:290616
	decreased CD8-positive, alpha-beta T cell number	J:290616
	decreased memory B cell number	J:290616
	decreased T cell number	J:290616
	increased regulatory T cell number	J:290616
Ikbkb^em1Macc/Ikbkb^em1Macc (involves: C57BL/6NCrl)	abnormal effector T cell number	J:290616
	abnormal T cell activation	J:290616
	decreased B cell number	J:290616
	decreased CD4-positive, alpha-beta T cell number	J:290616
	decreased CD8-positive, alpha-beta T cell number	J:290616
	decreased memory B cell number	J:290616
	decreased T cell number	J:290616
	increased regulatory T cell number	J:290616
Ikbkb^em1Smoc/Ikbkb^em1Smoc (C57BL/6J-Ikbkb^em1Smoc)	decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:309163
Ikbkb^M1Btlr/Ikbkb⁺ (C57BL/6J-Ikbkb^M1Btlr)	abnormal B cell physiology	J:225271
Ikbkb^M1Btlr/Ikbkb⁺ (C57BL/6J-Ikbkb^M1Btlr)	abnormal CD8-positive, alpha-beta T cell differentiation	J:225271
Ikbkb^M1Btlr/Ikbkb^M1Btlr (C57BL/6J-Ikbkb^M1Btlr)	abnormal B cell physiology	J:225271
Ikbkb^M1Btlr/Ikbkb^M1Btlr (C57BL/6J-Ikbkb^M1Btlr)	abnormal CD8-positive, alpha-beta T cell differentiation	J:225271
Ikbkb^M2Btlr/Ikbkb^M2Btlr (C57BL/6J-Ikbkb^M2Btlr)	decreased central memory CD4-positive, alpha-beta T cell number	J:274802
Ikbkb^tm1Cgn/Ikbkb^tm1.1Cgn Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	decreased CD4-positive, alpha-beta T cell number	J:85810
	decreased CD8-positive, alpha-beta T cell number	J:85810
	decreased single-positive T cell number	J:85810
	decreased T cell number	J:85810
Ikbkb^tm1Cgn/Ikbkb^tm1Cgn Tg(Lck-cre)I57Jxm/0 (involves: C57BL/6 * ICR)	decreased CD4-positive, alpha-beta T cell number	J:85810
	decreased CD8-positive, alpha-beta T cell number	J:85810
Ikbkb^tm1Lex/Ikbkb^tm1Lex Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S/SvEvBrd)	impaired macrophage chemotaxis	J:159873
	impaired neutrophil chemotaxis	J:159873
	impaired neutrophil recruitment	J:159873
Ikbkb^tm2Cgn/Ikbkb^tm2.1Cgn Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	decreased CD4-positive, alpha-beta T cell number	J:85810
	decreased CD8-positive, alpha-beta T cell number	J:85810
	decreased IgE level	J:85810
Ikbkb^tm2Cgn/Ikbkb^tm2Cgn Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	decreased CD4-positive, alpha-beta T cell number	J:85810
	decreased memory T cell number	J:85810
	decreased regulatory T cell number	J:85810
Ikbkb^tm2Mka/Ikbkb^tm2.1Mka Tg(Vil-cre)1Mka/0 (involves: 129/Sv * C57BL/6)	impaired neutrophil recruitment	J:83313
Ikbkb^tm2Mka/Ikbkb^tm2Mka Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129/Sv * 129P2/OlaHsd)	increased macrophage apoptosis	J:80159
Ikbkg^m1Btlr/Y (C57BL/6J-Ikbkg^m1Btlr)	decreased regulatory T cell number	J:139558
Ikbkg^tm1.1Chtr/Y Tg(Alb1-cre)7Gsc/0 (involves: C57BL/6 * FVB/N * SJL)	abnormal NK cell physiology	J:151485
	abnormal NK T cell physiology	J:151485
	decreased NK cell number	J:151485
	decreased NK T cell number	J:151485
Ikbkg^tm1.1Chtr/Ikbkg^tm1.1Chtr Tg(Alb1-cre)7Gsc/0 (involves: C57BL/6 * FVB/N * SJL)	abnormal NK cell physiology	J:151485
	abnormal NK T cell physiology	J:151485
	decreased NK cell number	J:151485
	decreased NK T cell number	J:151485
Ikbkg^tm1.1Dwat/Ikbkg⁺ (B6.Cg-Ikbkg^tm1.1Dwat)	decreased B cell number	J:202106
Ikbkg^tm1.1Dwat/Ikbkg⁺ (B6.Cg-Ikbkg^tm1.1Dwat)	enlarged spleen	J:202106
Ikbkg^tm1.1Mpa/Y Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	decreased CD4-positive, alpha-beta T cell number	J:85810
	decreased CD8-positive, alpha-beta T cell number	J:85810
	decreased single-positive T cell number	J:85810
	decreased T cell number	J:85810
	increased T cell apoptosis	J:85810
Ikbkg^tm1.1Mpa/Ikbkg^tm1.1Mpa Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: BALB/c * C57BL/6)	abnormal B cell differentiation	J:113365
	decreased B cell number	J:113365
	decreased mature B cell number	J:113365
Ikbkg^tm1Mka/Ikbkg⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal bone marrow cell morphology/development	J:63054
	absent megakaryocytes	J:63054
	small spleen	J:63054
	small thymus	J:63054
Ikzf1^m1Btlr/Ikzf1^m1Btlr (C57BL/6J-Ikzf1^m1Btlr)	abnormal natural killer cell mediated cytotoxicity	J:265249
	decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:265249
	decreased CD8-positive, naive alpha-beta T cell number	J:265249
	increased B-1 B cell number	J:265249
	increased CD4-positive, alpha-beta T cell number	J:265249
	increased CD8-positive, alpha-beta T cell number	J:265249
	increased central memory CD4-positive, alpha-beta T cell number	J:265249
	increased central memory CD8 positive, alpha-beta T cell number	J:265249
	increased effector memory CD4-positive, alpha-beta T cell number	J:265249
	increased IgG level	J:265249
	increased single-positive T cell number	J:265249
	increased T cell number	J:265249
Ikzf1^m2Btlr/Ikzf1^m2Btlr (C57BL/6J-Ikzf1^m2Btlr)	decreased B cell number	J:265250
	decreased CD4-positive, alpha-beta T cell number	J:265250
	decreased CD8-positive, naive alpha-beta T cell number	J:265250
	decreased single-positive T cell number	J:265250
	decreased T cell number	J:265250
	increased CD8-positive, alpha-beta T cell number	J:265250
	increased central memory CD4-positive, alpha-beta T cell number	J:265250
	increased central memory CD8 positive, alpha-beta T cell number	J:265250
	increased effector memory CD4-positive, alpha-beta T cell number	J:265250
	increased effector memory CD8-positive, alpha-beta T cell number	J:265250
	increased single-positive T cell number	J:265250
Ikzf1^m3Btlr/Ikzf1^m3Btlr (C57BL/6J-Ikzf1^m3Btlr)	decreased CD4-positive, alpha-beta T cell number	J:265251
	increased B-1 B cell number	J:265251
	increased CD8-positive, alpha-beta T cell number	J:265251
	increased single-positive T cell number	J:265251
	increased T cell number	J:265251
Ikzf1^plstc/Ikzf1⁺ (C57BL/6JSfdAnu-Ikzf1^plstc)	abnormal B cell differentiation	J:84569
	abnormal lymphopoiesis	J:84569
	abnormal T cell differentiation	J:84569
	decreased double-negative T cell number	J:84569
	decreased double-positive T cell number	J:84569
	decreased mature B cell number	J:84569
	decreased pre-B cell number	J:84569
	decreased thymocyte number	J:84569
	increased pro-B cell number	J:84569
	myeloid hyperplasia	J:84569
Ikzf1^plstc/Ikzf1^plstc (C57BL/6JSfdAnu-Ikzf1^plstc)	abnormal erythroblast morphology	J:84569
	abnormal granulocyte differentiation	J:84569
	abnormal lymphopoiesis	J:84569
	abnormal macrophage differentiation	J:84569
	abnormal myelopoiesis	J:84569
	absent pro-B cells	J:84569
	absent T cells	J:84569
	anemia	J:84569
	arrested B cell differentiation	J:84569
	decreased erythrocyte cell number	J:84569
	decreased erythroid progenitor cell number	J:84569
	decreased fetal derived definitive erythrocyte cell number	J:84569
	decreased granulocyte number	J:84569
	decreased hematocrit	J:84569
	decreased hemoglobin content	J:84569
	increased macrophage cell number	J:84569
	reticulocytopenia	J:84569
	thymus hypoplasia	J:84569
Ikzf1^plstc/Ikzf1^tm2Kge (involves: 129S4/SvJae * C57BL/6 * C57BL/6JSfdAnu)	abnormal erythropoiesis	J:84569
	anemia	J:84569
Ikzf1^tm1(Pax5)Mbu/Ikzf1^tm1(Pax5)Mbu (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell number	J:80815
	abnormal dendritic cell morphology	J:80815
	abnormal T cell differentiation	J:80815
Ikzf1^tm1(Pax5)Mbu/Ikzf1^tm1(Pax5)Mbu Tg(Mx1-cre)1Cgn/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	abnormal T cell differentiation	J:80815
	arrested T cell differentiation	J:80815
	increased B cell number	J:80815
	increased early pro-B cell number	J:80815
	thymus hypoplasia	J:80815
Ikzf1^{tm1.1(Pax5)Mbu}/Ikzf1⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell differentiation	J:80815
	abnormal erythropoiesis	J:80815
	decreased double-positive T cell number	J:118111
	enlarged spleen	J:118111
	enlarged thymus	J:118111
	increased B cell number	J:80815
	increased pro-B cell number	J:80815
	thymus hypoplasia	J:118111
Ikzf1^{tm1.1(Pax5)Mbu}/Ikzf1⁺ Tcf3^tm1Mbu/Tcf3^tm1Mbu Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: 129P2/OlaHsd * C57BL/10 * CBA/Ca)	abnormal immunoglobulin heavy chain V(D)J recombination	J:137719
Ikzf1^tm1.1Smale/Ikzf1^tm1.1Smale (B6.Cg-Ikzf1^tm1.1Smale)	decreased B cell number	J:208211
	decreased B-1a cell number	J:208211
	decreased B-1b cell number	J:208211
	decreased DN1 thymic pro-T cell number	J:208211
	decreased immature B cell number	J:208211
	decreased mature B cell number	J:208211
	decreased pre-B cell number	J:208211
	thymus hypoplasia	J:208211
Ikzf1^tm1Kast/Ikzf1^tm1Kast (involves: 129S2/SvPas)	abnormal B cell activation	J:82813
	abnormal B cell differentiation	J:82813
	decreased B cell number	J:82813
	decreased B cell proliferation	J:82813
	decreased B-1a cell number	J:82813
	decreased B-1b cell number	J:82813
	decreased IgG3 level	J:82813
	decreased spleen germinal center number	J:82813
Ikzf1^tm1Kge/Ikzf1⁺ (involves: 129S4/SvJae * C57BL/6)	abnormal T cell differentiation	J:29355
	abnormal thymocyte activation	J:29355
	abnormal thymus lobule morphology	J:29355
	abnormal thymus medulla morphology	J:29355
	decreased spleen red pulp amount	J:29355
	enlarged thymus	J:29355
	increased spleen white pulp amount	J:29355
	increased T cell proliferation	J:29355
	spleen hyperplasia	J:29355
	thymus cortex hypoplasia	J:29355
Ikzf1^tm1Kge/Ikzf1⁺ (involves: 129S4/SvJae * BALB/c)	abnormal T cell differentiation	J:29355
	abnormal thymocyte activation	J:29355
	abnormal thymus lobule morphology	J:29355
	abnormal thymus medulla morphology	J:29355
	decreased spleen red pulp amount	J:29355
	enlarged thymus	J:29355
	increased spleen white pulp amount	J:29355
	increased T cell proliferation	J:29355
	spleen hyperplasia	J:29355
	thymus cortex hypoplasia	J:29355
Ikzf1^tm1Kge/Ikzf1^tm1Kge (involves: 129S4/SvJae * C57BL/6)	abnormal common myeloid progenitor cell morphology	J:20671
	abnormal definitive hematopoiesis	J:20671
	abnormal eosinophil morphology	J:20671
	abnormal erythroid progenitor cell morphology	J:20671
	abnormal NK cell morphology	J:20671
	abnormal spleen morphology	J:20671
	abnormal thymus cortex morphology	J:20671
	abnormal thymus morphology	J:20671
	absent B cells	J:20671
	absent pre-B cells	J:20671
	arrested T cell differentiation	J:20671
	decreased bone marrow cell number	J:20671
	decreased gamma-delta intraepithelial T cell number	J:20671
	enlarged spleen	J:20671
	extramedullary hematopoiesis	J:20671
	increased basophil cell number	J:20671
	increased nucleated erythrocyte cell number	J:20671
	intermingled spleen red and white pulp	J:20671
	thymus hypoplasia	J:20671
Ikzf1^tm1Kge/Ikzf1^tm1Kge (involves: 129S4/SvJae * BALB/c)	abnormal common myeloid progenitor cell morphology	J:20671
	abnormal definitive hematopoiesis	J:20671
	abnormal eosinophil morphology	J:20671
	abnormal erythroid progenitor cell morphology	J:20671
	abnormal NK cell morphology	J:20671
	abnormal spleen morphology	J:20671
	abnormal thymus cortex morphology	J:20671
	abnormal thymus morphology	J:20671
	absent B cells	J:20671
	absent pre-B cells	J:20671
	arrested T cell differentiation	J:20671
	decreased bone marrow cell number	J:20671
	decreased gamma-delta intraepithelial T cell number	J:20671
	enlarged spleen	J:20671
	extramedullary hematopoiesis	J:20671
	increased basophil cell number	J:20671
	increased nucleated erythrocyte cell number	J:20671
	intermingled spleen red and white pulp	J:20671
	thymus hypoplasia	J:20671
Ikzf1^tm2.1Smale/Ikzf1^tm2.1Smale (B6.Cg-Ikzf1^tm2.1Smale)	abnormal definitive hematopoiesis	J:208211
	abnormal lymphopoiesis	J:208211
	abnormal T cell differentiation	J:208211
	absent NK cells	J:208211
	decreased B cell number	J:208211
	decreased DN2 thymocyte number	J:208211
	decreased DN3 thymocyte number	J:208211
	decreased double-negative T cell number	J:208211
	decreased double-positive T cell number	J:208211
	decreased immature B cell number	J:208211
	decreased mature B cell number	J:208211
	decreased plasmacytoid dendritic cell number	J:208211
	decreased pre-pro B cell number	J:208211
	increased gamma-delta T cell number	J:208211
	increased pre-B cell number	J:208211
	thymus cortex hypoplasia	J:208211
	thymus hypoplasia	J:208211
Ikzf1^tm2Kge/Ikzf1^tm2Kge (involves: 129S4/SvJae)	abnormal dendritic cell number	J:37317
	abnormal erythropoiesis	J:37317
	abnormal splenic cell ratio	J:37317
	abnormal T cell differentiation	J:208211, J:37317
	abnormal thymus development	J:37317
	absent B cells	J:208211, J:37317
	absent B-1a cells	J:37317
	absent NK cells	J:208211, J:37317
	absent pre-B cells	J:37317
	absent pro-B cells	J:37317
	decreased double-positive T cell number	J:37317
	decreased gamma-delta intraepithelial T cell number	J:37317
	decreased granulocyte number	J:37317
	decreased mature gamma-delta T cell number	J:37317
	decreased plasmacytoid dendritic cell number	J:208211
	decreased splenocyte number	J:37317
	increased T cell proliferation	J:37317
	thymus hypoplasia	J:37317
Ikzf1^tm3.1Mbu/Ikzf1^tm3.1Mbu Cd79a^tm1(cre)Reth/Cd79a⁺ Rag2^tm1Fwa/Rag2^tm1Fwa (involves: 129P2/OlaHsd * 129S/SvEv * BALB/c * C57BL/6 * SJL)	decreased pro-B cell number	J:209928
Ikzf1^tm3Kge/Ikzf1^tm3Kge Tg(CD2-icre)4Kio/? (involves: C57BL/10 * CBA/Ca)	abnormal B cell physiology	J:209927
Ikzf1^tm3Kge/Ikzf1^tm3Kge Tg(CD19-cre/ERT2)1Cgn/? (Not Specified)	abnormal B cell apoptosis	J:209927
	absent pre-B cells	J:209927
	decreased pre-B cell number	J:209927
Ikzf2^tm1.1Etms/Ikzf2^tm1.1Etms Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	abnormal regulatory T cell physiology	J:160098
Ikzf3^{tm1(KOMP)Vlcg}/Ikzf3^{tm1(KOMP)Vlcg} (C57BL/6N-Ikzf3^{tm1(KOMP)Vlcg}/Rbrc)	decreased large unstained cell number	J:211773
	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
	thrombocytopenia	J:211773
Ikzf3^tm1Kge/Ikzf3^tm1Kge (involves: 129S4/SvJae * C57BL/6)	abnormal B cell differentiation	J:50626
	abnormal spleen marginal zone morphology	J:50626
	decreased B cell number	J:81805
	decreased IgG2b level	J:50626
	decreased IgG3 level	J:50626
	decreased IgM level	J:50626
	decreased naive B cell number	J:81805
	enlarged spleen	J:50626
	increased B cell proliferation	J:50626
	increased IgE level	J:50626
	increased IgG1 level	J:50626
	increased IgG2a level	J:50626
	increased pre-B cell number	J:50626
	increased spleen germinal center number	J:50626
	increased T cell proliferation	J:50626
Ikzf3^tm1Kge/Ikzf3^tm1Kge (involves: 129S4/SvJae)	decreased marginal zone B cell number	J:69477
Ikzf3^tm1Kge/Ikzf3^tm1Kge (involves: 129S4/SvJae)	increased follicular B cell number	J:69477
Ikzf4^tm1.1Etms/Ikzf4^tm1.1Etms (Not Specified)	decreased T cell proliferation	J:295208
Ikzf4^tm1.1Etms/Ikzf4^tm1.1Etms (Not Specified)	hematopoietic system phenotype	J:295208
Ikzf5^{tm1(KOMP)Wtsi}/Ikzf5^{tm1(KOMP)Wtsi} (C57BL/6N-Ikzf5^{tm1(KOMP)Wtsi}/Rbrc)	increased large unstained cell number	J:211773
Il1a^{tm1b(EUCOMM)Wtsi}/Il1a^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Il1a^{tm1b(EUCOMM)Wtsi}/J)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
Il1a^tm1Yiw/Il1a^tm1Yiw Il1b^tm1Yiw/Il1b^tm1Yiw (involves: 129S1/Sv * 129X1/SvJ * BALB/c)	impaired neutrophil recruitment	J:50775
Il1a^tm1Yiw/Il1a^tm1Yiw Nlrp1a^Neut1/Nlrp1a^Neut1 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	increased neutrophil cell number	J:191055
Il1b^tm1Lvp/Il1b^tm1Lvp (involves: 129S7/SvEvBrd * C57BL/6)	abnormal lymphocyte physiology	J:67001
Il1b^tm1Lvp/Il1b^tm1Lvp (involves: 129S7/SvEvBrd)	abnormal macrophage physiology	J:136368
Il1r1^{em1(IMPC)Ccpcz}/Il1r1^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Il1r1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Il1r1^tm1Imx/Il1r1^tm1Imx (involves: 129S7/SvEvBrd)	abnormal neutrophil physiology	J:113110
Il1r1^tm1Imx/Il1r1^tm1Imx (involves: 129S7/SvEvBrd * C57BL/6)	abnormal neutrophil physiology	J:112999
Il1r1^tm1Imx/Il1r1^tm1Imx Tnfrsf1a^tm1Imx/Tnfrsf1a^tm1Imx (involves: 129S7/SvEvBrd * C57BL/6)	impaired neutrophil recruitment	J:126652
Il1r1^tm1Imx/Il1r1^tm1Imx Vsig4^tm1Gne/Vsig4^tm1Gne (B6.Cg-Il1r1^tm1Imx Vsig4^tm1Gne)	decreased T helper 1 cell number	J:281762
	decreased T-helper 17 cell number	J:281762
Il1r1^tm1Quan/Il1r1^tm1Quan (involves: C57BL/6)	abnormal microglial cell activation	J:219864
Il1r1^tm1Quan/Il1r1^tm1Quan Lyz2^tm1(cre)Ifo/Lyz2^tm1(cre)Ifo (involves: 129P2/OlaHsd * C57BL/6)	abnormal microglial cell activation	J:219864
Il1r1^tm1Quan/Il1r1^tm1Quan Tg(Tek-cre)12Flv/0 (involves: C3H * C57BL/6)	abnormal microglial cell activation	J:219864
Il1r1^tm1Roml/Il1r1^tm1Roml (C.Cg-Il1r1^tm1Roml)	decreased eosinophil cell number	J:82863
	decreased immunoglobulin level	J:82863
	decreased T cell number	J:82863
	decreased T cell proliferation	J:82863
Il1r1^tm1Roml/Il1r1^tm1Roml (involves: 129S1/Sv * BALB/c)	impaired neutrophil chemotaxis	J:124226
Il1r1^tm1Roml/Il1r1^tm1Roml (involves: 129S1/Sv)	decreased neutrophil cell number	J:193548
Il1r1^tm1Roml/Il1r1^tm1Roml Nlrp1a^Neut1/Nlrp1a^Neut1 (involves: 129S1/Sv * C57BL/6)	abnormal leukocyte cell number	J:191055
	abnormal leukopoiesis	J:191055
	decreased eosinophil cell number	J:191055
	decreased lymphocyte cell number	J:191055
	decreased monocyte cell number	J:191055
	thrombocytopenia	J:191055
Il1rl1^tm1Anjm/Il1rl1^tm1Anjm (involves: 129P2/OlaHsd * C57BL/6)	abnormal eosinophil physiology	J:61108
	abnormal T-helper 2 physiology	J:61108
Il1rl1^tm1Anjm/Il1rl1^tm1Anjm (involves: 129P2/OlaHsd)	decreased eosinophil cell number	J:159464
Il1rl1^tm1Anjm/Il1rl1^tm1Anjm (involves: 129P2/OlaHsd)	decreased IgE level	J:159464
Il1rl1^tm1Brl/Il1rl1^tm1Brl (involves: 129S/SvEv * C57BL/6)	increased eosinophil cell number	J:63507
Il1rl2^tm1Hblu/Il1rl2^tm1Hblu (involves: 129 * C57BL/6)	abnormal macrophage activation involved in immune response	J:296074
Il1rl2^tm1Hblu/Il1rl2^tm1Hblu (involves: 129)	decreased gamma-delta T cell number	J:193548
	decreased leukocyte cell number	J:193548
	decreased macrophage cell number	J:193548
	decreased neutrophil cell number	J:193548
	increased regulatory T cell number	J:256437
Il1rn^tm1.1Cga/Il1rn^tm1.1Cga Lyz2^tm1(cre)Ifo/Lyz2⁺ (D1.Cg-Il1rn^tm1.1Cga Lyz2^tm1(cre)Ifo)	increased T cell proliferation	J:162760
Il1rn^tm1Sush/Il1rn^tm1Sush (involves: 129P2/OlaHsd * C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:97684
	abnormal dendritic cell differentiation	J:97684
	abnormal dendritic cell number	J:97684
	abnormal T-helper 1 cell morphology	J:97684
	abnormal T-helper 2 cell morphology	J:97684
Il2^m1/Il2^m1 (MRL/MpJ)	abnormal T cell activation	J:75331
Il2^tm1Hor/Il2^tm1Hor (involves: 129P2/OlaHsd * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:39981, J:39989, J:15573
	abnormal CD8 positive, alpha-beta intraepithelial T cell morphology	J:39981, J:15223
	abnormal class switch recombination	J:15573
	abnormal cytotoxic T cell physiology	J:39981
	abnormal gamma-delta intraepithelial T cell morphology	J:15223
	abnormal lymphocyte cell number	J:15223
	abnormal lymphocyte morphology	J:37220
	abnormal lymphocyte physiology	J:15223
	abnormal T-helper 1 cell differentiation	J:37220
	abnormal thymocyte activation	J:37220, J:39989
	anemia	J:29999, J:15223
	decreased cytotoxic T cell cytolysis	J:15573, J:26198, J:26861
	decreased double-negative T cell number	J:15223
	decreased double-positive T cell number	J:37220
	decreased splenocyte proliferation	J:79241
	decreased T cell proliferation	J:39989, J:26198
	enlarged spleen	J:15223
	impaired natural killer cell mediated cytotoxicity	J:15573
	increased B cell proliferation	J:16662
	increased double-negative T cell number	J:37220
	increased IgA level	J:15223
	increased IgE level	J:16662
	increased IgG1 level	J:39989, J:15223, J:16662
	increased IgG2a level	J:16662
	increased IgG2b level	J:16662
	increased pre-B cell number	J:16662
	increased pro-B cell number	J:16662
	increased single-positive T cell number	J:37220
	increased T cell proliferation	J:15223, J:16662
Il2^tm1Hor/Il2^tm1Hor (C.129P2-Il2^tm1Hor)	abnormal bone marrow cell number	J:29799
	abnormal lymphocyte morphology	J:29799
	abnormal regulatory T cell physiology	J:112603
	abnormal reticulocyte morphology	J:29799
	abnormal spleen morphology	J:29799
	decreased hematocrit	J:29799
	increased B cell proliferation	J:29799
	increased germinal center B cell number	J:29799
	increased IgG level	J:29799
	increased mean corpuscular hemoglobin	J:29799
	increased plasma cell number	J:29799
	increased spleen red pulp amount	J:29799
	increased susceptibility to autoimmune hemolytic anemia	J:29799
	increased T cell proliferation	J:29799
	low mean erythrocyte cell number	J:29799
	spleen hyperplasia	J:29799
Il2^tm1Hor/Il2^tm1Hor (B6.129P2-Il2^tm1Hor)	increased activated T cell number	J:28924
	increased CD4-positive, alpha-beta T cell number	J:28924
	increased CD8-positive, alpha-beta T cell number	J:28924
	increased T cell number	J:125748
	increased T cell proliferation	J:28924
Il2^tm1Hor/Il2^tm1Hor (C3.129P2-Il2^tm1Hor)	increased CD4-positive, alpha-beta T cell number	J:28924
Il2^tm1Hor/Il2^tm1Hor (C3.129P2-Il2^tm1Hor)	increased CD8-positive, alpha-beta T cell number	J:28924
Il2^tm1Hor/Il2^tm1Hor (B6.129P2-Il2^tm1Hor/J)	abnormal T cell activation	J:190168
	abnormal T cell proliferation	J:190168
	decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:131774
	decreased regulatory T cell number	J:113547
	increased CD4-positive, alpha-beta T cell number	J:131774
	increased splenocyte number	J:131774
Il2^tm1Hor/Il2^tm1Hor (involves: 129P2/OlaHsd)	increased regulatory T cell number	J:208318
Il2^tm1Hor/Il2^tm1Hor (involves: 129P2/OlaHsd * C57BL/6J)	increased T-helper 17 cell number	J:120176
Il2^tm1Hor/Il2^tm1Hor Il4^tm1Cgn/Il4^tm1Cgn (involves: 129P2/OlaHsd * C57BL/6)	decreased cytotoxic T cell cytolysis	J:26861
	decreased IgG level	J:16662, J:26861
	increased B cell proliferation	J:16662
	increased pre-B cell number	J:16662
	increased pro-B cell number	J:16662
	increased T cell proliferation	J:16662
Il2^tm1Hor/Il2^tm1Hor Rag2^tm1Fwa/Rag2⁺ (involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6)	anemia	J:29999
Il2^tm1Hor/Il2^tm1Hor Rag2^tm1Fwa/Rag2^tm1Fwa (involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6)	abnormal blood cell morphology/development	J:29999
Il2^tm1Hor/Il2^tm1Hor Rag2^tm1Fwa/Rag2^tm1Fwa Tg(Tcra5CC7,Tcrb5CC7)IWep/0 (involves: 129P2/OlaHsd * C57BL/10)	abnormal T cell number	J:120176
	increased T-helper 17 cell number	J:120176
Il2^tm1Hor/Il2^tm1Hor Tg(DO11.10)10Dlo/? (C.Cg-Il2^tm1Hor Tg(DO11.10)10Dlo)	abnormal regulatory T cell physiology	J:88349
	increased activated T cell number	J:88349
	increased T cell proliferation	J:88349
Il2^tm1Hor/Il2^tm1Hor Tg(Pgk1-HA)1.1Vbo/? Tg(Tcra/Tcrb)1Vbo/? (C.Cg-Il2^tm1Hor Tg(Pgk1-HA)1.1Vbo Tg(Tcra/Tcrb)1Vbo)	abnormal regulatory T cell physiology	J:112603
	decreased regulatory T cell number	J:112603
	increased regulatory T cell number	J:112603
Il2ra^M1J/Il2ra^M1J (involves: 129S4/SvJae * C57BL/6)	abnormal regulatory T cell physiology	J:268677
Il2ra^{tm1b(EUCOMM)Wtsi}/Il2ra^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Il2ra^{tm1b(EUCOMM)Wtsi}/Orl)	abnormal spleen morphology	J:211773
	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	decreased lymphocyte cell number	J:211773
	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular hemoglobin concentration	J:211773
	decreased mean corpuscular volume	J:211773
	increased large unstained cell number	J:211773
	increased neutrophil cell number	J:211773
Il2ra^tm1Dw/Il2ra^tm1Dw (involves: 129S4/SvJae * C57BL/6)	abnormal B cell physiology	J:64279
	abnormal T cell morphology	J:64279
	abnormal T cell physiology	J:64279
	decreased hematocrit	J:64279
	enlarged spleen	J:64279
	hemolytic anemia	J:64279
	increased IgA level	J:64279
	increased IgG1 level	J:64279
	increased IgG2a level	J:64279
	increased IgG2b level	J:64279
	increased IgG level	J:64279
	increased lymphocyte cell number	J:64279
	increased memory T cell number	J:64279
Il2ra^tm1Dw/Il2ra^tm1Dw (B6.129S4-Il2ra^tm1Dw)	abnormal regulatory T cell physiology	J:125748
	abnormal T cell activation	J:125748
	anemia	J:125748
Il2ra^tm1Dw/Il2ra^tm1Dw Tg(CD2-Ccdc86)1Hfuj/? (B6.Cg-Il2ra^tm1Dw Tg(CD2-Ccdc86)1Hfuj)	increased activated T cell number	J:151722
Il2ra^tm1Dw/Il2ra^tm1Dw Tg(Pgk1-HA)1.1Vbo/? Tg(Tcra/Tcrb)1Vbo/? (C.Cg-Il2ra^tm1Dw Tg(Pgk1-HA)1.1Vbo Tg(Tcra/Tcrb)1Vbo)	abnormal regulatory T cell physiology	J:112603
	decreased regulatory T cell number	J:112603
	increased regulatory T cell number	J:112603
Il2rb^m1Btlr/Il2rb^m1Btlr (C57BL/6J-Il2rb^m1Btlr)	decreased B cell number	J:267694
	decreased CD4-positive, alpha-beta T cell number	J:267694
	decreased CD8-positive, naive alpha-beta T cell number	J:267694
	increased effector memory CD4-positive, alpha-beta T cell number	J:267694
	increased effector memory CD8-positive, alpha-beta T cell number	J:267694
Il2rb^m2Btlr/Il2rb^m2Btlr (C57BL/6J-Il2rb^m2Btlr)	increased IgE level	J:272832
Il2rb^M3Btlr/Il2rb^M3Btlr (C57BL/6J-Il2rb^M3Btlr)	abnormal CD8-positive, alpha-beta T cell differentiation	J:272833
	abnormal T cell morphology	J:272833
	decreased CD8-positive, alpha-beta T cell number	J:272833
	decreased central memory CD8 positive, alpha-beta T cell number	J:272833
	decreased NK cell number	J:272833
	decreased NK T cell number	J:272833
	increased CD4-positive, alpha-beta T cell number	J:272833
	increased IgM level	J:272833
Il2rb^tm1Mak/Il2rb^tm1Mak (either: (involves: 129P2/OlaHsd) or (involves: 129S2/SvPas))	abnormal B cell activation	J:25940
	abnormal common myeloid progenitor cell morphology	J:25940
	abnormal mononuclear cell morphology	J:25940
	abnormal T cell activation	J:25940
	decreased B cell number	J:25940
	decreased double-positive T cell number	J:25940
	decreased memory T cell number	J:25940
	enlarged spleen	J:25940
	increased activated T cell number	J:25940
	increased CD4-positive, alpha-beta T cell number	J:25940
	increased CD8-positive, alpha-beta T cell number	J:25940
	increased erythroid progenitor cell number	J:25940
	increased granulocyte number	J:25940
	increased IgE level	J:25940
	increased IgG1 level	J:25940
	increased neutrophil cell number	J:25940
	increased plasma cell number	J:25940
	increased susceptibility to autoimmune hemolytic anemia	J:25940
	thymus hypoplasia	J:25940
Il2rb^tm1Mak/Il2rb^tm1Mak (B6.129-Il2rb^tm1Mak)	abnormal lymphocyte morphology	J:113547
	abnormal spleen periarteriolar lymphoid sheath morphology	J:113547
	abnormal T cell activation	J:113547
	decreased regulatory T cell number	J:113547
	decreased T cell proliferation	J:113547
	enlarged spleen	J:113547
	increased susceptibility to autoimmune hemolytic anemia	J:113547
Il2rb^tm1Mak/Il2rb^tm1Mak (C.129-Il2rb^tm1Mak)	abnormal lymphocyte morphology	J:113547
	abnormal marginal zone B cell morphology	J:113547
	abnormal spleen periarteriolar lymphoid sheath morphology	J:113547
	abnormal T cell activation	J:113547
	abnormal T cell clonal deletion	J:113547
	decreased CD8-positive, alpha-beta T cell number	J:113547
	decreased T cell proliferation	J:113547
	enlarged spleen	J:113547
	increased susceptibility to autoimmune hemolytic anemia	J:113547
Il2rb^tm1Mak/Il2rb^tm1Mak (D2.129-Il2rb^tm1Mak)	abnormal T cell clonal deletion	J:113547
Il2rb^tm1Mak/Il2rb^tm1Mak Lck^tm1Mak/Lck^tm1Mak (involves: 129)	absent uterine NK cells	J:134589
Il2rb^tm1Mak/Il2rb^tm1Mak Rag2^tm1Fwa/Rag2^tm1Fwa (involves: 129 * 129S/SvEv)	decreased NK cell number	J:142654
Il2rg^tm1.1Asin/Il2rg^tm1Wjl Tg(Cd4-cre)1Cwi/0 (involves: 129S4/SvJae * C57BL/6 * DBA/2)	decreased CD4-positive, alpha-beta T cell number	J:190889
	decreased CD8-positive, alpha-beta T cell number	J:190889
Il2rg^tm1.1Asin/Il2rg^tm1Wjl Tg(Cd8a-cre)B8Asin/0 (involves: 129S4/SvJae C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:190889
	decreased CD8-positive, alpha-beta T cell number	J:190889
	decreased NK T cell number	J:190889
	decreased regulatory T cell number	J:190889
Il2rg^tm1.1Asin/Il2rg^tm1Wjl Tg(Cd8a-cre)B8Asin/0 Tg(LCKprBCL2)36Sjk/0 (involves: 129S4/SvJae C57BL/6)	decreased NK T cell number	J:190889
Il2rg^tm1.1Flv/Il2rg^tm1.1Flv Rag2^tm1.1Flv/Rag2^tm1.1Flv Thpo^{tm1.1(TPO)Flv}/Thpo^{tm1.1(TPO)Flv} (involves: 129S4/SvJae * BALB/cAnNTac)	thrombocytopenia	J:168301
Il2rg^tm1Cgn/Y (involves: 129 * CB20)	abnormal alpha-beta intraepithelial T cell morphology	J:22521
	abnormal class switch recombination	J:22521
	abnormal gamma-delta T cell differentiation	J:111821
	abnormal leukocyte morphology	J:22521
	abnormal thymocyte activation	J:22521
	absent gamma-delta intraepithelial T cell	J:111821
	absent gamma-delta T cells	J:111821
	absent NK cells	J:22521
	absent spleen germinal center	J:22521
	decreased IgE level	J:22521
	decreased IgM level	J:22521
	decreased mature B cell number	J:22521
	decreased plasma cell number	J:22521
	decreased pre-B cell number	J:22521
	decreased spleen white pulp amount	J:22521
	decreased T cell number	J:22521
	decreased T cell proliferation	J:22521
	impaired natural killer cell mediated cytotoxicity	J:22521
	spleen hypoplasia	J:22521
	thymus hypoplasia	J:111821, J:22521
Il2rg^tm1Cgn/Y Rag2^tm1Fwa/Rag2^tm1Fwa (B6.129-Rag2^tm1Fwa Il2rg^tm1Cgn)	absent B cells	J:132257
	absent NK cells	J:132257
	absent T cells	J:132257
Il2rg^tm1Cgn/Il2rg^tm1Cgn (involves: 129 * CB20)	abnormal alpha-beta intraepithelial T cell morphology	J:22521
	abnormal class switch recombination	J:22521
	abnormal hematopoietic system morphology/development	J:22521
	abnormal leukocyte morphology	J:22521
	abnormal thymocyte activation	J:22521
	absent NK cells	J:22521
	absent spleen germinal center	J:22521
	decreased IgE level	J:22521
	decreased IgM level	J:22521
	decreased mature B cell number	J:22521
	decreased plasma cell number	J:22521
	decreased pre-B cell number	J:22521
	decreased spleen white pulp amount	J:22521
	decreased T cell number	J:22521
	decreased T cell proliferation	J:22521
	impaired natural killer cell mediated cytotoxicity	J:22521
	spleen hypoplasia	J:22521
	thymus hypoplasia	J:22521
Il2rg^tm1Cgn/Il2rg^tm1Cgn Kit^tm1.1Bsm/Kit^tm1.1Bsm (involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)	arrested T cell differentiation	J:90485
Il2rg^tm1Cgn/Il2rg^tm1Cgn Rag2^tm1Fwa/Rag2^tm1Fwa (involves: 129P2/OlaHsd * 129S/SvEv)	decreased NK cell number	J:142654
Il2rg^tm1Krf/Il2rg^tm1Krf (either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * FVB/N))	decreased thymocyte number	J:114561
Il2rg^tm1Krf/Il2rg^tm1Krf Tg(BCL2/IGH)1Tjd/0 (either: (involves: 129P2/OlaHsd * C3H/He * C57BL/6) or (involves: 129P2/OlaHsd * C3H/He * C57BL/6 * FVB/N))	decreased thymocyte number	J:114561
Il2rg^tm1Krf/Il2rg^tm1Krf Tg(Igh-Pim1)1Brn/0 (either: (involves: 129P2/OlaHsd * C57BL/6 * CBA) or (involves: 129P2/OlaHsd * C57BL/6 * CBA * FVB/N))	decreased thymocyte number	J:114561
Il2rg^tm1Sug/Y (either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129S6/SvEvTac * C57BL/6))	abnormal immunoglobulin level	J:31167
	abnormal myelopoiesis	J:31167
	abnormal proerythroblast morphology	J:31167
	abnormal splenic cell ratio	J:31167
	absent NK cells	J:31167
	absent spleen white pulp	J:31167
	arrested B cell differentiation	J:31167
	decreased IgG3 level	J:31167
	decreased IgG level	J:31167
	decreased lymphocyte cell number	J:31167
	decreased T cell number	J:31167
	decreased thymocyte number	J:31167
	enlarged spleen	J:31167
	increased macrophage cell number	J:31167
	increased megakaryocyte cell number	J:31167
	increased monocyte cell number	J:31167
	increased neutrophil cell number	J:31167
	small thymus	J:31167
	thymus cortex hypoplasia	J:31167
	thymus hypoplasia	J:31167
Il2rg^tm1Sug/Il2rg^tm1Sug (B6.129-Il2rg^tm1Sug)	absent uterine NK cells	J:116952
Il2rg^tm1Wjl/Y (involves: 129S4/SvJae * C57BL/6)	abnormal B cell number	J:108209
	abnormal basophil physiology	J:24117
	abnormal CD4-positive, alpha beta T cell morphology	J:108209
	abnormal lymphocyte morphology	J:108209
	abnormal mast cell physiology	J:24117
	abnormal thymocyte activation	J:24117
	absent gamma-delta intraepithelial T cell	J:24117
	absent gamma-delta T cells	J:24117
	absent NK cells	J:24117
	decreased CD8-positive, alpha-beta T cell number	J:24117
	decreased double-negative T cell number	J:24117
	decreased double-positive T cell number	J:24117
	decreased immature B cell number	J:24117
	decreased immunoglobulin level	J:24117
	decreased single-positive T cell number	J:24117
	decreased T cell proliferation	J:24117
	impaired natural killer cell mediated cytotoxicity	J:24117
	small thymus	J:24117
	small thymus cortex	J:24117
	spleen hyperplasia	J:24117
	spleen hypoplasia	J:24117
	thymus hyperplasia	J:108209
Il2rg^tm1Wjl/Y Crlf2^tm1Wjl/Crlf2^tm1Wjl (involves: 129S4/SvJae * C57BL/6)	thymus hypoplasia	J:108209
Il2rg^tm1Wjl/Y Prkdc^scid/Prkdc^scid (NOD.Cg-Prkdc^scid Il2rg^tm1Wjl/Sz)	abnormal splenic cell ratio	J:109833
	abnormal thymus morphology	J:109833
	decreased CD4-positive, alpha-beta T cell number	J:109833
	decreased CD8-positive, alpha-beta T cell number	J:109833
	decreased immature B cell number	J:109833
	decreased immunoglobulin level	J:109833
	decreased leukocyte cell number	J:109833
	decreased mature B cell number	J:109833
	decreased mean corpuscular volume	J:109833
	decreased NK cell number	J:109833
	decreased spleen B cell follicle number	J:109833
Il2rg^tm1Wjl/Y Rag1^tm1Mom/Rag1^tm1Mom (NOD.Cg-Rag1^tm1Mom Il2rg^tm1Wjl/SzJ)	abnormal spleen morphology	J:140388
	abnormal thymus morphology	J:140388
	absent NK T cells	J:140388
	absent thymus cortex	J:140388
	absent thymus medulla	J:140388
	decreased macrophage cell number	J:140388
	decreased spleen B cell follicle number	J:140388
	thymus cyst	J:140388
Il2rg^tm1Wjl/Il2rg^tm1Wjl (B6.129S4-Il2rg^tm1Wjl/J)	abnormal splenic cell ratio	J:123902
Il2rg^tm1Wjl/Il2rg^tm1Wjl (B6.129S4-Il2rg^tm1Wjl/J)	decreased myeloid dendritic cell number	J:123902
Il2rg^tm1Wjl/Il2rg^tm1Wjl Prkdc^scid/Prkdc^scid (NOD.Cg-Prkdc^scid Il2rg^tm1Wjl/Sz)	abnormal splenic cell ratio	J:109833
	abnormal thymus morphology	J:109833
	decreased CD4-positive, alpha-beta T cell number	J:109833
	decreased CD8-positive, alpha-beta T cell number	J:109833
	decreased immature B cell number	J:109833
	decreased immunoglobulin level	J:109833
	decreased leukocyte cell number	J:109833
	decreased mature B cell number	J:109833
	decreased mean corpuscular volume	J:109833
	decreased NK cell number	J:109833
	decreased spleen B cell follicle number	J:109833
	thymus cyst	J:109833
Il2rg^tm1Wjl/Il2rg^tm1Wjl Rag2^tm1Fwa/Rag2^tm1Fwa (involves: 129S/SvEv * 129S4/SvJae)	absent NK cells	J:140483
	absent T cells	J:140483
Il2rg^tm1Wjl/Il2rg^tm1Wjl Tg(CD2-Ccdc86)1Hfuj/? (B6.Cg-Il2rg^tm1Wjl Tg(CD2-Ccdc86)1Hfuj)	decreased CD4-positive, alpha-beta T cell number	J:151722
	decreased CD8-positive, alpha-beta T cell number	J:151722
	decreased regulatory T cell number	J:151722
	decreased splenocyte number	J:151722
Il2rg^tm2Cgn/Y Tg(Mx1-cre)1Cgn/? (involves: 129P2/OlaHsd * C57BL/6 * CBA)	decreased NK cell number	J:132257
Il3^tm1Glli/Il3^tm1Glli (either: (involves: 129S2/SvPas * BALB/c) or (involves: 129S2/SvPas * C57BL/6))	abnormal mast cell differentiation	J:80500
Il3ra^m1/Il3ra^m1 (A/J)	abnormal common myeloid progenitor cell morphology	J:24918
Il3ra^m1/Il3ra^m1 (A/J)	abnormal leukopoiesis	J:23971
Il3ra^m1/Il3ra^m1 (C58/J)	abnormal common myeloid progenitor cell morphology	J:24918
Il3ra^m1/Il3ra^m1 (AKR/J)	abnormal common myeloid progenitor cell morphology	J:24918
Il3ra^m1/Il3ra^m1 (RF/J)	abnormal common myeloid progenitor cell morphology	J:24918
Il3ra^m1/Il3ra^m1 (NZB/BlNJ)	abnormal common myeloid progenitor cell morphology	J:24918
Il3ra^m1/Il3ra^m1 (A/WySnJ)	abnormal common myeloid progenitor cell morphology	J:24918
Il3ra^m1/Il3ra^m1 (A/HeJ)	abnormal common myeloid progenitor cell morphology	J:24918
Il3ra^m1/Il3ra^m1 (BUB/BnJ)	abnormal common myeloid progenitor cell morphology	J:24918
Il3ra^m1/Il3ra^m1 (SM/J)	abnormal common myeloid progenitor cell morphology	J:24918
Il3ra^m1/Il3ra^m1 (CE/J)	abnormal common myeloid progenitor cell morphology	J:24918
Il4/Il13^tm3Anjm/Il4/Il13^tm3Anjm (involves: 129P2/OlaHsd * C57BL/6)	abnormal splenocyte physiology	J:72587
	abnormal T-helper 2 physiology	J:89095
	decreased IgE level	J:113543, J:72587
	decreased IgG1 level	J:72587
	decreased IgG level	J:89095
	increased eosinophil cell number	J:113543
Il4/Il13^tm3Anjm/Il4/Il13^tm3Anjm (C.129P2/OlaHsd-Il4/Il13^tm3Anjm)	decreased IgE level	J:91403
	increased IgG2a level	J:91403
Il4/Il13^tm3Anjm/Il4/Il13^tm3Anjm (involves: 129P2/OlaHsd * BALB/c)	abnormal splenocyte physiology	J:60609
	decreased IgG1 level	J:178986
Il4/Il13^tm3Anjm/Il4/Il13^tm3Anjm (involves: 129P2/OlaHsd * C57BL/6)	abnormal splenocyte physiology	J:72587
	abnormal T-helper 2 physiology	J:89095
	decreased IgE level	J:113543, J:72587
	decreased IgG1 level	J:72587
	decreased IgG level	J:89095
	increased eosinophil cell number	J:113543
Il4/Il13^tm3Anjm/Il4/Il13^tm3Anjm (C.129P2/OlaHsd-Il4/Il13^tm3Anjm)	decreased IgE level	J:91403
	increased IgG2a level	J:91403
Il4/Il13^tm3Anjm/Il4/Il13^tm3Anjm (involves: 129P2/OlaHsd * BALB/c)	abnormal splenocyte physiology	J:60609
	decreased IgG1 level	J:178986
Il4^tm1(CD2)Mmrs/Il4^tm1(CD2)Mmrs (involves: 129)	decreased basophil cell number	J:181313
	decreased IgE level	J:178986
	decreased IgG1 level	J:178986
Il4^tm1.1Wep/Il4⁺ (C.129P2-Il4^tm1.1Wep)	decreased IgE level	J:138827
Il4^tm1.1Wep/Il4⁺ Stat6^tm1Gru/Stat6^tm1Gru (C.129-Stat6^tm1Gru Il4^tm1.1Wep)	abnormal T-helper 2 cell differentiation	J:138827
	decreased IgE level	J:138827
	impaired eosinophil recruitment	J:138827
Il4^tm1.1Wep/Il4^tm1.1Wep (C.129P2-Il4^tm1.1Wep)	abnormal T-helper 2 cell differentiation	J:138827
	decreased IgE level	J:138827
	impaired eosinophil recruitment	J:138827
Il4^tm1.1Wep/Il4^tm1.1Wep Stat6^tm1Gru/Stat6^tm1Gru (C.129-Stat6^tm1Gru Il4^tm1.1Wep)	abnormal T-helper 2 cell differentiation	J:138827
	decreased IgE level	J:138827
	impaired eosinophil recruitment	J:138827
Il4^tm1Cgn/Il4^tm1Cgn (B6.Cg-Il4^tm1Cgn)	abnormal T-helper 2 physiology	J:89095
Il4^tm1Cgn/Il4^tm1Cgn (involves: 129P2/OlaHsd * NOD)	decreased IgG1 level	J:85924
Il4^tm1Cgn/Il4^tm1Cgn (involves: 129P2/OlaHsd * C57BL/6)	decreased IgE level	J:704
Il4^tm1Cgn/Il4^tm1Cgn (involves: 129P2/OlaHsd * C57BL/6)	decreased IgG1 level	J:704
Il4^tm1Cgn/Il4^tm1Cgn (involves: 129P2/OlaHsd * C57BL/6J * MRL/Mp)	decreased IgE level	J:39600
	decreased IgG1 level	J:39600
Il4^tm1Cgn/Il4^tm1Cgn (involves: 129P2/OlaHsd * A/WySn * C57BL/10SnSg * Swiss)	decreased IgG1 level	J:119207
	increased IgG2a level	J:119207
Il4^tm1Cgn/Il4^tm1Cgn Ndfip1^{Gt(RRD002)Byg}/Ndfip1^{Gt(RRD002)Byg} (involves: 129P2/OlaHsd)	increased CD4-positive, alpha-beta T cell number	J:205692
	increased eosinophil cell number	J:205692
	increased neutrophil cell number	J:205692
	increased T cell number	J:205692
Il4^tm1Kopf/Il4^tm1Kopf (involves: 129S2/SvPas * C57BL/6)	decreased IgE level	J:14593
	decreased IgG1 level	J:14593
	increased IgG level	J:14593
Il4^tm1Kopf/Il4^tm1Kopf (involves: 129S2/SvPas)	decreased eosinophil cell number	J:113065
Il4^tm1Kopf/Il4^tm1Kopf (involves: 129S2/SvPas)	decreased IgE level	J:113065
Il4^tm1Kopf/Il4^tm1Kopf Lyn^tm1Ard/Lyn^tm1Ard (involves: 129P2/OlaHsd * 129S2/SvPas)	decreased B cell number	J:161523
	decreased IgE level	J:161523
	decreased IgG1 level	J:161523
	increased basophil cell number	J:161523
	increased IgA level	J:161523
	increased IgG2a level	J:161523
	increased IgG2b level	J:161523
	increased IgM level	J:161523
	increased mast cell number	J:161523
Il4^tm1Lky/Il4⁺ Lat^tm1.1Mal/Lat^tm1.1Mal (involves: 129S2/SvPas * C57BL/6)	abnormal T-helper 2 physiology	J:151840
Il4^tm1Lky/Il4^tm1Lky Itk^tm1Litt/Itk^tm1Litt (involves: 129S4/SvJae * BALB/c * C57BL/6J)	abnormal T-helper 2 physiology	J:129883
Il4^tm1Nnt/Il4^tm1Nnt (C57BL/6-Il4^tm1Nnt/J)	abnormal microglial cell morphology	J:125605
	abnormal T-helper 2 physiology	J:37196
	decreased IgE level	J:37196
	decreased IgG1 level	J:37196
	decreased IgM level	J:37196
	increased IgA level	J:37196
Il4^tm1Rao/Il4^tm1Rao (involves: 129S6/SvEvTac * C57BL/6)	abnormal mast cell physiology	J:78089
Il4^tm1Rao/Il4^tm1Rao (involves: 129S6/SvEvTac * C57BL/6)	abnormal T-helper 2 physiology	J:78089
Il4^tm2.1Kubo/Il4^tm2.1Kubo (B6.Cg-Il4^tm2.1Kubo)	decreased IgE level	J:167446
	decreased IgG1 level	J:167446
	impaired eosinophil recruitment	J:167446
	increased IgG2c level	J:167446
Il4^tm2Nnt/Il4^tm2Nnt (BALB/c-Il4^tm2Nnt/J)	abnormal dendritic cell differentiation	J:141937
	decreased IgE level	J:31486
	decreased IgG1 level	J:31486
Il4^tm2Nnt/Il4^tm2Nnt (BALB/c-Il4^tm2Nnt)	abnormal splenocyte physiology	J:60609
Il4ra^M1Btlr/Il4ra^M1Btlr (C57BL/6J-Il4ra^M1Btlr)	decreased IgE level	J:267558
Il4ra^M2Btlr/Il4ra^M2Btlr (C57BL/6J-Il4ra^M2Btlr)	decreased IgE level	J:272804
Il4ra^tm1Fbb/Il4ra^tm1Fbb (involves: BALB/cJ)	abnormal macrophage physiology	J:114751
	decreased T-helper 2 cell number	J:172134
	impaired macrophage chemotaxis	J:114751
Il4ra^tm1Fbb/Il4ra^tm2Fbb Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * BALB/c)	abnormal macrophage physiology	J:114751
Il4ra^tm1Sz/Il4ra^tm1Sz (BALB/c-Il4ra^tm1Sz/J)	abnormal microglial cell morphology	J:125605
	abnormal T-helper 2 physiology	J:43656
	decreased IgE level	J:43656
	decreased IgG1 level	J:43656
	increased IgG2a level	J:43656
Il4ra^tm1Sz/Il4ra^tm1Sz (BALB/c-Il4ra^tm1Sz)	increased IgG2a level	J:110429
Il4ra^tm1Sz/Il4ra^tm1Sz Il7r^tm1.1Asin/Il7r^tm1Imx Tg(Cd8a-cre)B8Asin/0 (involves: 129S7/SvEvBrd BALB/cJ * C57BL/6)	decreased CD8-positive, alpha-beta T cell number	J:190889
Il4ra^tm1Tch/Il4ra^tm1Tch (involves: 129X1/SvJ * BALB/c)	abnormal T-helper 2 cell morphology	J:86215
	decreased T cell proliferation	J:86215
	increased IgE level	J:86215
	increased IgG level	J:86215
Il4ra^tm2Tch/Il4ra^tm2Tch (C.129X1-Il4ra^tm2Tch)	abnormal T-helper 2 physiology	J:152376
	increased eosinophil cell number	J:152376
	increased IgE level	J:152376
	increased monocyte cell number	J:152376
Il4ra^tm2Tch/Il4ra^tm2Tch Tg(Scgb1a1-rtTA,tetO-Il13)1Eli/? (B6.Cg-Il4ra^tm2Tch Tg(Scgb1a1-rtTA,tetO-IL13)1Eli)	increased eosinophil cell number	J:152376
Il4ra^tm3.1Tch/Il4ra^tm3.1Tch (C.129X1-Il4ra^tm3.1Tch)	abnormal macrophage activation involved in immune response	J:160806
Il4ra^tm3.1Tch/Il4ra^tm3.1Tch (C.129X1-Il4ra^tm3.1Tch)	increased IgE level	J:160806
Il5^tm1Anjm/Il5^tm1Anjm (involves: 129P2/OlaHsd * C57BL/6)	abnormal mast cell morphology	J:113543
	abnormal mast cell physiology	J:113543
	decreased eosinophil cell number	J:113543
	decreased IgE level	J:113543
Il5^tm1Anjm/Il5^tm1Anjm Il9^tm1Anjm/Il9^tm1Anjm (involves: 129P2/OlaHsd * C57BL/6)	abnormal mast cell morphology	J:113543
	abnormal mast cell physiology	J:113543
	decreased eosinophil cell number	J:113543
	decreased IgE level	J:113543
Il5^tm1Kopf/Il5^tm1Kopf (C57BL/6-Il5^tm1Kopf/J)	increased eosinophil cell number	J:30867
Il5^tm1Kopf/Il5^tm1Kopf (C57BL/6-Il5^tm1Kopf)	increased lymphocyte cell number	J:30641
Il5^tm1Kopf/Il5^tm1Kopf (C57BL/6-Il5^tm1Kopf)	increased neutrophil cell number	J:30641
Il5^tm1Ktk/Il5^tm1Ktk (B6.129S4-Il5^tm1Ktk)	abnormal B-1 B cell morphology	J:180790
Il5^tm2Anjm/Il5^tm2Anjm Il9^tm1Anjm/Il9^tm1Anjm (involves: 129P2/OlaHsd * C57BL/6)	abnormal immunoglobulin level	J:113543
	increased eosinophil cell number	J:113543
Il5ra^tm1Ktk/Il5ra^tm1Ktk (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell differentiation	J:33140
	abnormal eosinophil cell number	J:33140
	abnormal lymphopoiesis	J:33140
	abnormal T cell differentiation	J:33140
	decreased CD4-positive, alpha-beta T cell number	J:33140
	decreased IgA level	J:33140
	decreased IgG3 level	J:33140
	decreased IgM level	J:33140
	decreased immunoglobulin level	J:33140
Il5ra^tm1Ktk/Il5ra^tm1Ktk (B6.129P2-Il5ra^tm1Ktk)	abnormal B-1 B cell morphology	J:89849
	decreased B cell proliferation	J:89849
	decreased B-1 B cell number	J:89849
	decreased IgA level	J:89849
	decreased IgG1 level	J:89849
	decreased IgG3 level	J:89849
	decreased IgM level	J:89849
Il5ra^tm1Ktk/Il5ra^tm1Ktk Lyn^tm1Tya/Lyn^tm1Tya (involves: 129P2/OlaHsd * C57BL/6)	abnormal spleen B cell corona morphology	J:91089
	abnormal spleen white pulp morphology	J:91089
	decreased B-1 B cell number	J:91089
	enlarged spleen	J:91089
	increased IgA level	J:91089
	increased IgM level	J:91089
	increased immunoglobulin level	J:91089
Il6^tm1.1Jho/Il6^tm1.1Jho Tg(GFAP-cre)8Gtm/0 (involves: 129S4/SvJaeSor * 129X1/SvJ * C57BL/6 * CBA)	microgliosis	J:211914
Il6^tm1Kopf/Il6^tm1Kopf (involves: 129S2/SvPas * C57BL/6)	abnormal microglial cell morphology	J:79142
	abnormal T cell differentiation	J:17360
	decreased cytotoxic T cell cytolysis	J:17360
	decreased T cell number	J:17360
Il6^tm1Kopf/Il6^tm1Kopf (B6.129S2-Il6^tm1Kopf/J)	decreased pro-B cell number	J:117320
Il6^tm1Kopf/Il6^tm1Kopf (involves: 129S2/SvPas)	abnormal T cell physiology	J:159479
Il6^tm1Kopf/Il6^tm1Kopf Inpp5d^tm1Rkh/Inpp5d^tm1Rkh (involves: 129 * C57BL/6)	abnormal hematopoietic stem cell morphology	J:117320
	abnormal lymphopoiesis	J:117320
	abnormal myelopoiesis	J:117320
	decreased pro-B cell number	J:117320
Il6^tm1Kopf/Il6^tm1Kopf Tg(H2-K-IL6)2Srj/0 (involves: 129S2/SvPas * C57BL/6 * DBA/2)	hematopoietic system phenotype	J:185153
Il6^tm1Kopf/Il6^tm1Kopf Tg(Rorc-EGFP)1Ebe/? (involves: 129S2/SvPas * C57BL/6)	abnormal effector T cell morphology	J:137020
Il6^tm1Mur/Il6^tm1Mur (involves: 129P2/OlaHsd * C57BL/6)	abnormal neutrophil physiology	J:25684
Il6^tm1Mur/Il6^tm1Mur (involves: 129/Sv * C57BL/6)	abnormal lymphocyte cell number	J:40579
Il6^tm1Mur/Il6^tm1Mur (involves: 129/Sv * C57BL/6)	absent NK cells	J:40579
Il6^tm1Mur/Il6^tm1Mur (B6.129P2(B6)-Il6^tm1Mur)	abnormal microglial cell morphology	J:85581
	abnormal microglial cell physiology	J:85581
	abnormal osteoclast differentiation	J:65093
	abnormal osteoclast physiology	J:65093
Il6^tm1Poli/Il6^tm1Poli (involves: 129S/SvEv * MF1)	abnormal macrophage physiology	J:79314
	abnormal neutrophil physiology	J:79314
	abnormal osteoclast physiology	J:17249
	abnormal T-helper 1 cell morphology	J:79314
	abnormal T-helper 1 physiology	J:79314
	abnormal T-helper 2 physiology	J:79314
	decreased IgA level	J:79314
	decreased IgE level	J:79314
	increased IgG2a level	J:79314
Il6^tm1Poli/Il6^tm1Poli (involves: 129S/SvEv * C57BL/6)	impaired neutrophil recruitment	J:68063
Il6^tm1Poli/Il6^tm1Poli (CAnNCrl.129S(Cg)-Il6^tm1Poli)	abnormal B cell proliferation	J:42869
Il6ra^{em1(IMPC)Wtsi}/Il6ra^{em1(IMPC)Wtsi} (C57BL/6N-Il6ra^{em1(IMPC)Wtsi}/Wtsi)	increased red blood cell distribution width	J:211773
Il6ra^{tm1.1(IL6R)Csk}/Il6ra^{tm1.1(IL6R)Csk} Tg(H2-L-IL6)40Csk/0 (involves: 129S6/SvEvTac * C57BL/6)	enlarged spleen	J:207264
	increased plasma cell number	J:207264
	increased spleen weight	J:207264
	increased spleen white pulp amount	J:207264
Il6ra^tm1Saj/Il6ra^tm1Saj (involves: 129P2/OlaHsd * C57BL/6J)	abnormal CD4-positive, alpha-beta T cell physiology	J:159479
Il6st^tm1Ard/Il6st^tm1Ard (involves: 129S1/Sv * C57BL/6)	abnormal common myeloid progenitor cell morphology	J:110742
	abnormal leukocyte cell number	J:110742
	abnormal megakaryocyte morphology	J:110742
	abnormal thrombopoiesis	J:110742
	decreased IgA level	J:79555
	decreased IgG level	J:79555
	decreased immunoglobulin level	J:79555
	decreased megakaryocyte cell number	J:110742
	increased megakaryocyte cell number	J:110742
	thrombocytopenia	J:110742
Il6st^{tm1b(KOMP)Mbp}/Il6st⁺ (C57BL/6N-Il6st^{tm1b(KOMP)Mbp}/J)	increased mean corpuscular hemoglobin concentration	J:211773
Il6st^tm1Ern/Il6st^tm1Ern (involves: 129S1/Sv * C57BL/6)	enlarged spleen	J:79073
Il6st^tm1Ern/Il6st^tm1Ern (involves: 129S1/Sv * C57BL/6)	increased osteoclast cell number	J:87612
Il6st^tm1Ern/Il6st^tm1Ern (involves: 129S1/Sv)	increased neutrophil cell number	J:168781
Il6st^tm1Ern/Il6st^tm1Ern Tg(RP11-H2112)5Trme/0 (involves: 129S1/Sv * C57BL/6J * DBA/2J)	abnormal spleen size	J:234656
Il6st^tm1Ern/Il6st^tm1Ern Tg(RP11-H2112)9Trme/0 (involves: 129S1/Sv * C57BL/6J * DBA/2J)	abnormal spleen size	J:234656
Il6st^tm1Kish/Il6st^tm1Kish (involves: 129P2/OlaHsd * C57BL/6)	anemia	J:75419
	decreased common myeloid progenitor cell number	J:75419
	decreased erythroid progenitor cell number	J:75419
	decreased hematopoietic stem cell number	J:75419
	increased nucleated erythrocyte cell number	J:75419
	thymus hypoplasia	J:75419
Il6st^tm1Kish/Il6st^tm1Kish (involves: 129P2/OlaHsd * CD-1)	abnormal osteoclast differentiation	J:88710
	abnormal osteoclast morphology	J:88710
	abnormal osteoclast physiology	J:88710
	increased osteoclast cell number	J:88710
Il6st^tm1Thir/Il6st^tm1Thir (Not Specified)	abnormal B cell physiology	J:59922
	increased B cell number	J:59922
	increased CD4-positive, alpha-beta T cell number	J:59922
	increased CD8-positive, alpha-beta T cell number	J:59922
	increased IgG2a level	J:59922
	increased IgG2b level	J:59922
	spleen hyperplasia	J:59922
Il6st^tm1Thir/Il6st^tm1Thir (involves: 129 * C57BL/6)	abnormal T cell activation	J:133059
	abnormal T cell clonal deletion	J:133059
	abnormal thymocyte activation	J:133059
	decreased double-positive T cell number	J:133059
	increased activated T cell number	J:133059
	increased double-negative T cell number	J:133059
	increased IgA level	J:133059
	increased IgG1 level	J:133059
	increased IgG2a level	J:133059
	increased IgG2b level	J:133059
	increased neutrophil cell number	J:133059
	increased single-positive T cell number	J:133059
Il6st^tm1Thir/Il6st^tm1Thir Tg(TcraH-Y,TcrbH-Y)71Vbo/? (involves: 129 * C57BL/6 * DBA)	abnormal negative T cell selection	J:133059
Il6st^tm1Wme/Il6st^tm1Wme (involves: 129P2/OlaHsd * C57BL/6)	abnormal erythropoiesis	J:67677
	abnormal immunoglobulin level	J:67677
	abnormal T cell differentiation	J:67677
	abnormal thrombopoiesis	J:67677
	decreased thymocyte number	J:67677
	increased IgE level	J:67677
	increased IgG level	J:67677
	increased leukocyte cell number	J:67677
Il6st^tm2Thir/Il6st^tm2Thir (Not Specified)	abnormal bone marrow cell morphology/development	J:59922
	decreased B-1a cell number	J:59922
	decreased IgG1 level	J:59922
	decreased IgG2a level	J:59922
	decreased IgG2b level	J:59922
	increased IgM level	J:59922
Il6st^tm3Thir/Il6st^tm3Thir (Not Specified)	abnormal bone marrow cell morphology/development	J:59922
	decreased IgA level	J:59922
	decreased IgG2a level	J:59922
	decreased IgG2b level	J:59922
Il7^hlb368/Il7^hlb368 (C57BL/6J-Il7^hlb368/J)	abnormal T cell subpopulation ratio	J:118450
	decreased leukocyte cell number	J:82961, J:118450
	decreased T cell number	J:118450
	small spleen	J:118450
	small thymus	J:118450
	spleen hypoplasia	J:118450
	thymus hypoplasia	J:118450
Il7^m1Jyen/Il7^m1Jyen (involves: C3H * C57BL/6)	abnormal myeloid leukocyte morphology	J:136470
	decreased B cell number	J:136470
	decreased single-positive T cell number	J:136470
	spleen hypoplasia	J:136470
	thymus hypoplasia	J:136470
Il7^tm1.1Mysl/Il7⁺ (B6.129P2(Cg)-Il7^tm1.1Mysl)	decreased T cell number	J:200544
Il7^tm1.1Mysl/Il7^tm1.1Mysl (B6.129P2(Cg)-Il7^tm1.1Mysl)	arrested B cell differentiation	J:200544
	decreased T cell number	J:200544
	decreased thymocyte number	J:200544
	thymus hypoplasia	J:200544
Il7^tm1Dnax/Il7^tm1Dnax (involves: 129P2/OlaHsd * C57BL/6)	abnormal CD8-positive, alpha beta T cell morphology	J:125259
	arrested B cell differentiation	J:24165
	decreased lymphocyte cell number	J:24165
	decreased spleen weight	J:24165
	decreased thymus weight	J:24165
	small spleen	J:24165
	small thymus	J:24165
	spleen hypoplasia	J:24165
	thymus hypoplasia	J:24165
Il7^tm1Dnax/Il7^tm1Dnax (involves: 129P2/OlaHsd)	decreased thymocyte number	J:64861
Il7^tm1Dnax/Il7^tm1Dnax Rag2^tm1Fwa/Rag2^tm1Fwa (involves: 129P2/OlaHsd * 129S/SvEv)	decreased NK cell number	J:132257
Il7^tm1Hms/Il7^tm1Hms (involves: 129S6/SvEvTac)	decreased bone marrow cell number	J:43971
	spleen hypoplasia	J:43971
	thymus hypoplasia	J:43971
Il7^tm2.1Iku/Il7^tm2.1Iku Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * DBA)	abnormal B cell differentiation	J:190615
	abnormal NK T cell physiology	J:190615
	decreased B cell number	J:190615
	decreased double-negative T cell number	J:190615
	decreased lymphocyte cell number	J:190615
	decreased NK T cell number	J:190615
	decreased T cell number	J:190615
	hematopoietic system phenotype	J:190615
Il7r^tm1.1Asin/Il7r^tm1Imx Tg(Cd4-cre)1Cwi/0 (involves: 129S7/SvEvBrd * C57BL/6 * DBA/2)	decreased CD8-positive, alpha-beta T cell number	J:190889
Il7r^tm1.1Asin/Il7r^tm1Imx Tg(Cd8a-cre)B8Asin/0 (involves: 129S7/SvEvBrd C57BL/6)	decreased CD8-positive, alpha-beta T cell number	J:190889
Il7r^tm1Abra/Il7r^tm1Abra (B6.129S4-Il7r^tm1Abra)	abnormal CD4-positive, alpha-beta T cell physiology	J:125360
	abnormal T cell differentiation	J:125360
	abnormal T cell proliferation	J:125360
	decreased B cell number	J:125360
	decreased CD4-positive, alpha-beta T cell number	J:125360
	decreased CD8-positive, alpha-beta T cell number	J:125360
	decreased memory T cell number	J:125360
	decreased thymocyte number	J:125360
	increased double-positive T cell number	J:125360
Il7r^tm1Iku/Il7r^tm1Iku (involves: 129P2/OlaHsd * C57BL/6J)	abnormal B cell differentiation	J:34658
	abnormal gamma-delta T cell differentiation	J:34658
	abnormal T cell subpopulation ratio	J:34658
	absent mature gamma-delta T cells	J:34658
	decreased B-1 B cell number	J:34658
	decreased bone marrow cell number	J:34658
	decreased double-positive T cell number	J:34658
	decreased immature B cell number	J:34658
	decreased leukocyte cell number	J:34658
	decreased lymphocyte cell number	J:34658
	decreased mature B cell number	J:34658
	decreased T cell number	J:34658
	increased double-negative T cell number	J:34658
	small thymus	J:34658
	spleen hypoplasia	J:34658
	thymus hypoplasia	J:34658
Il7r^tm1Imx/Il7r^tm1Imx (involves: 129P3/J * 129S7/SvEvBrd)	arrested B cell differentiation	J:21135
	arrested T cell differentiation	J:21135
	decreased B cell number	J:21135
	decreased T cell number	J:21135
	spleen hypoplasia	J:21135
	thymus hypoplasia	J:21135
Il7r^tm1Imx/Il7r^tm1Imx (B6.129S7-Il7r^tm1Imx)	abnormal T cell differentiation	J:125360
	decreased double-positive T cell number	J:125360
	decreased thymocyte number	J:125360
Il7r^tm1Imx/Il7r^tm1Imx (involves: 129S7/SvEvBrd)	decreased thymocyte number	J:64861
Il7r^tm1Imx/Il7r^tm1Imx Tg(Lck-Il7r)1676Trma/? (involves: 129S7/SvEvBrd * C57BL/6 * SJL)	decreased T cell proliferation	J:66400
	decreased thymocyte number	J:66400
	increased thymocyte apoptosis	J:66400
Il7r^tm2Iku/Il7r^tm2Iku Tg(Cd4-cre)1Cwi/? (involves: 129S6/SvEvTac * C57BL/6 * DBA/2)	abnormal CD4-positive T cell differentiation	J:193283
	abnormal CD8-positive, alpha-beta T cell differentiation	J:193283
	abnormal T cell morphology	J:193283
	decreased NK T cell number	J:193283
	increased B cell number	J:193283
	increased gamma-delta T cell number	J:193283
	increased thymocyte number	J:193283
Il9^em1(IMPC)Mbp/Il9^em1(IMPC)Mbp (C57BL/6NCrl-Il9^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Il9^tm1Anjm/Il9^tm1Anjm (involves: 129P2/OlaHsd * C57BL/6)	abnormal mast cell morphology	J:82881
Il9r^tm1Jcrd/Il9r^tm1Jcrd (involves: C57BL/6)	abnormal regulatory T cell physiology	J:151907
Il9r^tm1Jcrd/Il9r^tm1Jcrd (involves: C57BL/6)	increased T-helper 1 cell number	J:151907
Il10^tm1.1Roer/Il10^tm1.1Roer (involves: 129P2/OlaHsd)	abnormal myeloid leukocyte morphology	J:151551
	increased B cell number	J:151551
	increased myeloid dendritic cell number	J:151551
	increased plasma cell number	J:151551
	increased T cell number	J:151551
	spleen hyperplasia	J:151551
Il10^tm1Cgn/Il10^tm1Cgn (involves: 129P2/OlaHsd * C57BL/6)	abnormal leukocyte morphology	J:35020
	abnormal lymphocyte cell number	J:35020
	abnormal myelopoiesis	J:15222
	absent erythroid progenitor cell	J:15222
	anemia	J:15222
	decreased erythrocyte cell number	J:15222
	decreased hemoglobin content	J:15222
	decreased spleen iron level	J:15222
	decreased spleen red pulp amount	J:15222
	decreased T cell proliferation	J:125760
	hypochromic anemia	J:15222
	increased CD4-positive, alpha-beta T cell number	J:35020
	increased granulocyte number	J:35020, J:15222
	increased IgE level	J:62283
	increased IgG1 level	J:62283
	increased IgG2a level	J:62283
	increased thymus weight	J:107077
	microcytic anemia	J:15222
	thymus hyperplasia	J:107077
Il10^tm1Cgn/Il10^tm1Cgn (B6.129P2-Il10^tm1Cgn/J)	abnormal regulatory T cell physiology	J:125748
Il10^tm1Cgn/Il10^tm1Cgn Il4^tm1Cgn/Il4^tm1Cgn (involves: 129P2/OlaHsd * C57BL/6)	abnormal T-helper 1 cell differentiation	J:111712
Il10^tm1Cgn/Il10^tm1Cgn Il12b^tm1Jm/Il12b^tm1Jm (involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)	abnormal T-helper 2 cell differentiation	J:111712
Il10^tm1Cgn/Il10^tm1Cgn Il27ra^tm1Mak/Il27ra^tm1Mak (involves: 129P2/OlaHsd * C57BL/6)	abnormal T-helper 1 physiology	J:136179
	abnormal T-helper 2 physiology	J:136179
Il10^tm1Cgn/Il10^tm1Cgn Vdr^tm1Mbd/Vdr^tm1Mbd (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:107077
	abnormal splenic cell ratio	J:107077
	abnormal thymus corticomedullary boundary morphology	J:107077
	abnormal thymus involution	J:107077
	absent spleen white pulp	J:107077
	anemia	J:107077
	decreased lymphocyte cell number	J:107077
	decreased T cell proliferation	J:107077
	enlarged spleen	J:107077
	increased macrophage cell number	J:107077
	increased neutrophil cell number	J:107077
	increased spleen red pulp amount	J:107077
	increased T cell apoptosis	J:107077
	thymus hypoplasia	J:107077
Il10^tm1Roer/Il10^tm1Roer Foxp3^{tm4(YFP/icre)Ayr}/Y (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal regulatory T cell physiology	J:134513
Il10ra^NZW/Il10ra⁺ ((NZB x NZW)F1)	increased IgG level	J:102087
Il10ra^tm1.1Tlg/Il10ra^tm1.1Tlg Tg(Cd4-cre)1Cwi/? (B6.Cg-Tg(Cd4-cre)1Cwi Il10ra^tm1.1Tlg)	abnormal lymphocyte cell number	J:189797
	abnormal regulatory T cell number	J:189797
	decreased splenocyte proliferation	J:189797
	decreased T cell number	J:189797
Il10ra^{tm1b(KOMP)Wtsi}/Il10ra^{tm1b(KOMP)Wtsi} (C57BL/6N-Il10ra^{tm1b(KOMP)Wtsi}/Orl)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Il10rb^tm1Agt/Il10rb^tm1Agt (involves: 129S2/SvPas * C57BL/6)	abnormal granulocyte differentiation	J:45917
	abnormal spleen morphology	J:45917
	decreased hemoglobin content	J:45917
	extramedullary hematopoiesis	J:45917
	increased leukocyte cell number	J:45917
	increased spleen weight	J:45917
	spleen hyperplasia	J:45917
Il11ra1^tm1Gos/Il11ra1^tm1Gos (involves: 129S2/SvPas * C57BL/6J * CD-1)	abnormal NK cell differentiation	J:93811
	abnormal uterine NK cell morphology	J:93811
Il11ra1^tm1Wehi/Il11ra1^tm1Wehi (involves: 129S1/Sv * C57BL/6)	hematopoietic system phenotype	J:42921
Il12a^tm1Cab/Il12a^tm1Cab (B6.129S4-Il12a^tm1Cab)	abnormal NK cell physiology	J:79552
Il12a^tm1Jm/Il12a^tm1Jm (129S1/Sv-Il12a^tm1Jm)	abnormal CD4-positive, alpha-beta T cell physiology	J:34164
Il12a^tm1Jm/Il12a^tm1Jm (C.129S1-Il12a^tm1Jm)	impaired natural killer cell mediated cytotoxicity	J:125611
Il12a^tm1Jm/Il12a^tm1Jm (involves: 129S1/Sv)	abnormal NK cell physiology	J:139001
Il12a^tm1Jm/Il12a^tm1Jm Il12b^tm1Jm/Il12b^tm1Jm (B6.129S1-Il12a^tm1Jm Il12b^tm1Jm)	impaired natural killer cell mediated cytotoxicity	J:125611
Il12b^tm1Jm/Il12b^tm1Jm (B6.129S1-Il12b^tm1Jm/J)	abnormal CD8-positive, alpha-beta T cell physiology	J:111568
	abnormal granulocyte physiology	J:111568
	abnormal lymphocyte physiology	J:120806
	abnormal macrophage physiology	J:111568
	abnormal NK cell physiology	J:120806
Il12b^tm1Jm/Il12b^tm1Jm (129S1/Sv-Il12b^tm1Jm)	abnormal CD4-positive, alpha-beta T cell physiology	J:34164
Il12b^tm1Jm/Il12b^tm1Jm (involves: 129S1/SvImJ)	abnormal T-helper 1 physiology	J:46514
Il12b^tm1Jm/Il12b^tm1Jm (involves: 129S1/SvImJ)	impaired natural killer cell mediated cytotoxicity	J:46514
Il12b^tm1Jm/Il12b^tm1Jm Il18^tm1Aki/Il18^tm1Aki (involves: 129P2/OlaHsd * 129S1/SvImJ)	abnormal T-helper 1 physiology	J:46514
	impaired natural killer cell mediated cytotoxicity	J:46514
Il12rb1^{tm1b(KOMP)Wtsi}/Il12rb1^{tm1b(KOMP)Wtsi} (C57BL/6N-Il12rb1^{tm1b(KOMP)Wtsi}/Bay)	decreased hemoglobin content	J:211773
Il12rb1^tm1Jm/Il12rb1^tm1Jm (involves: 129S1/Sv * C57BL/6J)	abnormal lymphocyte physiology	J:42105
Il12rb1^tm1Jm/Il12rb1^tm1Jm Tg(Rorc-EGFP)1Ebe/? (involves: 129S1/Sv * C57BL/6)	abnormal effector T cell morphology	J:137020
Il12rb2^Ifnm-d/Il12rb2^Ifnm-d Tlr4^lps-del/Tlr4^lps-del (C57BL/10ScCr)	abnormal granulocyte physiology	J:91014
	abnormal macrophage physiology	J:91014
	abnormal NK cell physiology	J:91014
Il12rb2^tm1Jm/Il12rb2^tm1Jm (either: (involves: 129S1/Sv * BALB/cByJ) or (involves: 129S1/Sv * C57BL/6J))	abnormal lymphocyte physiology	J:65891
	abnormal NK cell physiology	J:65891
Il12rb2^tm1Jm/Il12rb2^tm1Jm (B6;129S1-Il12rb2^tm1Jm/J)	abnormal B cell activation	J:106805
Il12rb2^tm1Jm/Il12rb2^tm1Jm (B6;129S1-Il12rb2^tm1Jm/J)	abnormal T cell activation	J:106805
Il13^{tm1(YFP/cre)Lky}/Il13⁺ Il4^tm1(CD2)Mmrs/Il4⁺ Gt(ROSA)26Sor^tm1(DTA)Lky/Gt(ROSA)26Sor⁺ (involves: 129P2/OlaHsd * 129S4/SvJae)	decreased eosinophil cell number	J:178986
Il13^tm1.1Anjm/Il13^tm1.1Anjm (involves: 129P2/OlaHsd * C57BL/6)	abnormal T-helper 2 cell differentiation	J:67965
	decreased IgE level	J:67965
	decreased T-helper 2 cell number	J:67965
	increased IgG2b level	J:67965
	increased IgM level	J:67965
Il13^tm1.1Anjm/Il13^tm1.1Anjm (C.129P2-Il13^tm1.1Anjm)	abnormal dendritic cell differentiation	J:141937
	decreased IgE level	J:91403
	increased IgG2a level	J:91403
Il13^tm1.1Anjm/Il13^tm1.1Anjm Tg(DO11.10)10Dlo/0 (involves: 129P2/OlaHsd * BALB/c * C3H * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:91403
Il13^tm1Anjm/Il13^tm1Anjm (involves: 129P2/OlaHsd * C57BL/6)	decreased eosinophil cell number	J:82881
Il13^tm2Anjm/Il13^tm2Anjm (involves: 129P2/OlaHsd * C57BL/6)	abnormal splenocyte physiology	J:72587
	abnormal T-helper 2 physiology	J:89095
Il13^tm2Anjm/Il13^tm2Anjm (involves: 129)	abnormal T-helper 2 cell differentiation	J:67965
	decreased IgE level	J:67965
	decreased T-helper 2 cell number	J:67965
	increased IgG2b level	J:67965
	increased IgM level	J:67965
Il13^tm2Anjm/Il13^tm2Anjm (involves: 129P2/OlaHsd * BALB/c * C57BL/6)	abnormal macrophage physiology	J:176092
	impaired eosinophil recruitment	J:126675
	impaired neutrophil recruitment	J:105813
Il13^tm2Anjm/Il13^tm2Anjm (B6.129P2-Il13^tm2Anjm)	abnormal leukocyte physiology	J:131969
Il13^tm2Anjm/Il13^tm2Anjm (B6.129P2-Il13^tm2Anjm)	decreased macrophage cell number	J:131969
Il13^tm3.1Anjm/Il13⁺ Il1rl1^tm1Anjm/Il1rl1^tm1Anjm (involves: 129P2/OlaHsd * BALB/c)	decreased eosinophil cell number	J:159464
Il13^tm3.1Anjm/Il13⁺ Il17rb^tm1Anjm/Il17rb^tm1Anjm (involves: BALB/c * C57BL/6)	decreased eosinophil cell number	J:159464
Il13^tm3.1Anjm/Il13⁺ Il17rb^tm1Anjm/Il17rb^tm1Anjm Il1rl1^tm1Anjm/Il1rl1^tm1Anjm (involves: 129P2/OlaHsd * BALB/c)	decreased eosinophil cell number	J:159464
Il13ra1^tm1Twy/Y (C.Cg-Il13ra1^tm1Twy)	abnormal T-helper 2 physiology	J:130488
	decreased IgE level	J:130488
	increased CD4-positive, alpha-beta T cell number	J:130488
	increased eosinophil cell number	J:130488
	increased IgA level	J:130488
	increased IgG1 level	J:130488
	increased IgG3 level	J:130488
	increased T-helper 2 cell number	J:130488
Il13ra1^tm1Zagh/Il13ra1^tm1Zagh (involves: BALB/c * C57BL/6)	abnormal thymus development	J:183111
	impaired myelopoiesis	J:183111
Il13ra2^tm1Gru/Il13ra2^tm1Gru (C.Cg-Il13ra2^tm1Gru)	abnormal bone marrow cell morphology/development	J:82376
	abnormal macrophage physiology	J:82376
	decreased erythroid progenitor cell number	J:82376
	increased IgA level	J:82376
	increased IgE level	J:82376
	increased IgG2a level	J:82376
	increased IgG2b level	J:82376
Il15^m1Hwata/Il15^m1Hwata (Not Specified)	abnormal NK T cell number	J:184570
	decreased NK cell number	J:184570
	decreased NK T cell number	J:184570
Il15^tm1Imx/Il15⁺ Myc^tm1Atp/Myc⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased memory T cell number	J:132730
Il15^tm1Imx/Il15^tm1Imx (involves: C57BL/6)	abnormal CD8-positive, alpha-beta T cell physiology	J:95221
	abnormal lymphocyte morphology	J:60915
	absent uterine NK cells	J:84009
	decreased CD8-positive, alpha-beta T cell number	J:113408, J:60915
	decreased CD8-positive, gamma-delta intraepithelial T cell number	J:155298
	decreased dendritic cell number	J:97620
	decreased IgG level	J:97620
	decreased IgM level	J:97620
	decreased immunoglobulin level	J:97620
	decreased memory T cell number	J:132730
	decreased NK cell number	J:132730, J:142654, J:60915
	decreased regulatory T cell number	J:208318
	impaired natural killer cell mediated cytotoxicity	J:97620
Il15^tm1Imx/Il15^tm1Imx (C57BL/6-Il15^tm1Imx/Tac)	abnormal CD8-positive, alpha-beta T cell differentiation	J:111786
	abnormal thymus cell ratio	J:111786
	decreased CD8-positive, alpha-beta T cell number	J:111786
Il15^tm1Imx/Il15^tm1Imx Il7r^tm1.1Asin/Il7r^tm1Imx Tg(Cd8a-cre)B8Asin/0 (involves: 129S7/SvEvBrd C57BL/6)	decreased CD8-positive, alpha-beta T cell number	J:190889
Il15^tm1Imx/Il15^tm1Imx Itk^tm1Litt/Itk^tm1Litt (involves: 129S4/SvJae * C57BL/6)	abnormal thymus cell ratio	J:111786
Il15^tm1Imx/Il15^tm1Imx Itk^tm1Ljb/Itk^tm1Ljb (involves: 129 * C57BL/6 * C57BL/10)	decreased CD8-positive, alpha-beta T cell number	J:113408
Il15^tm1Imx/Il15^tm1Imx Myc^tm1Atp/Myc⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased memory T cell number	J:132730
	decreased NK cell number	J:132730
Il15^tm1Imx/Il15^tm1Imx Rag2^tm1Fwa/Rag2^tm1Fwa (involves: 129S/SvEv * C57BL/6)	decreased NK cell number	J:132257
Il15ra^tm1.1Nsl/Il15ra^tm1.1Nsl (involves: 129X1/SvJ * C57BL/6)	abnormal T cell apoptosis	J:73738
	decreased CD8-positive, alpha-beta T cell number	J:73738
	decreased memory T cell number	J:73738
	decreased NK cell number	J:73738
	decreased NK T cell number	J:73738
	decreased single-positive T cell number	J:73738
	increased CD4-positive, alpha-beta T cell number	J:73738
	increased thymocyte apoptosis	J:73738
Il15ra^tm1.1Nsl/Il15ra^tm1.1Nsl (B6.129X1-Il15ra^tm1.1Nsl)	abnormal T cell activation	J:92705
	abnormal T cell proliferation	J:92705
	increased T cell proliferation	J:92705
Il15ra^tm1.1Nsl/Il15ra^tm1.1Nsl Tg(TcrAND)53Hed/? (involves: 129X1/SvJ * C57BL/6 * SJL)	increased T cell proliferation	J:92705
Il15ra^tm1Ama/Il15ra^tm1Ama (involves: 129X1/SvJ)	abnormal NK cell physiology	J:119213
	decreased CD8-positive, alpha-beta T cell number	J:142570
	decreased CD8-positive, gamma-delta intraepithelial T cell number	J:155298
	decreased memory T cell number	J:142570
	decreased NK cell number	J:119213, J:142570
	decreased NK T cell number	J:142570
	decreased T cell proliferation	J:142570
	impaired natural killer cell mediated cytotoxicity	J:142570
Il15ra^tm1Ama/Il15ra^tm2.1Ama Lyz2^tm1(cre)Ifo/0 Tg(Itgax-cre)1-1Reiz/0 (involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * CBA)	decreased CD8-positive, alpha-beta T cell number	J:155298
	decreased memory T cell number	J:155298
	decreased NK cell number	J:155298
Il15ra^tm1Ama/Il15ra^tm2.1Ama Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6J)	abnormal NK cell differentiation	J:155298
	abnormal NK cell physiology	J:155298
	decreased CD8-positive, alpha-beta T cell number	J:155298
	decreased memory T cell number	J:155298
	decreased NK cell number	J:155298
Il15ra^tm1Ama/Il15ra^tm2.1Ama Tg(Itgax-cre)1-1Reiz/0 (involves: 129X1/SvJ * C57BL/6J * CBA)	abnormal NK cell differentiation	J:155298
	abnormal NK cell physiology	J:155298
	abnormal T cell subpopulation ratio	J:155298
	decreased CD8-positive, alpha-beta T cell number	J:155298
	decreased memory T cell number	J:155298
	decreased NK cell number	J:155298
Il15ra^tm1Ama/Il15ra^tm2.1Ama Tg(Vil1-cre)997Gum/0 (involves: C57BL/6J * SJL)	decreased CD8-positive, gamma-delta intraepithelial T cell number	J:155298
Il15ra^tm1Wjl/Il15ra^tm1Wjl (involves: 129 * C57BL/6)	abnormal T cell physiology	J:142570
	decreased CD8-positive, alpha-beta T cell number	J:142570
	decreased memory T cell number	J:142570
	decreased NK cell number	J:142570
	decreased NK T cell number	J:142570
	decreased T cell proliferation	J:142570
Il16^tm1Korn/Il16^tm1Korn (either: B6.129X1-Il16^tm1Korn or C.129X1-Il16^tm1Korn)	abnormal T cell physiology	J:97739
Il17a/Il17f^tm1.1Impr/Il17a/Il17f^tm1.1Impr (involves: C57BL/6)	abnormal effector T cell morphology	J:187400
	absent gamma-delta T cells	J:187400
	increased gamma-delta T cell number	J:187400
	increased T cell proliferation	J:187400
Il17a/Il17f^tm1.1Impr/Il17a/Il17f^tm1.1Impr (involves: C57BL/6)	abnormal effector T cell morphology	J:187400
	absent gamma-delta T cells	J:187400
	increased gamma-delta T cell number	J:187400
	increased T cell proliferation	J:187400
Il17a^em1(IMPC)Mbp/Il17a^em1(IMPC)Mbp (C57BL/6N-Il17a^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Il17a^tm1Cdon/Il17a^tm1Cdon (involves: C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:136279
	decreased IgG1 level	J:136279
	decreased IgG2a level	J:136279
	decreased IgG2b level	J:136279
	decreased IgM level	J:136279
Il17a^tm1Yiw/Il17a^tm1Yiw (involves: 129P2/OlaHsd * C57BL/6J)	decreased IgG level	J:79127
	decreased immunoglobulin level	J:79127
Il17a^tm1Yiw/Il17a^tm1Yiw (involves: 129P2/OlaHsd * BALB/cA * C57BL/6J)	decreased IgE level	J:79127
	decreased IgG1 level	J:79127
	decreased immunoglobulin level	J:79127
Il17a^tm1Yiw/Il17a^tm1Yiw (involves: 129P2/OlaHsd)	decreased neutrophil cell number	J:193548
Il17a^tm1Yiw/Il17a^tm1Yiw (involves: 129P2/OlaHsd)	increased gamma-delta T cell number	J:193548
Il17a^tm1Yiw/Il17a^tm1Yiw Il17f^tm2Yiw/Il17f^tm2Yiw (involves: 129P2/OlaHsd * BALB/c)	decreased IgG3 level	J:143719
	increased IgG1 level	J:143719
	increased IgG2a level	J:143719
	increased IgG2b level	J:143719
Il17a^tm1Yiw/Il17a^tm1Yiw Il17f^tm2Yiw/Il17f^tm2Yiw (B6.129P2-Il17a^tm1Yiw Il17f^tm2Yiw)	decreased IgG3 level	J:143719
	increased IgG1 level	J:143719
	increased IgG2a level	J:143719
	increased IgG2b level	J:143719
Il17b^em1Cya/Il17b^em1Cya (C57BL/6-Il17b^em1Cya)	increased macrophage cytokine production	J:339366
Il17b^em1Cya/Il17b^em1Cya (C57BL/6-Il17b^em1Cya)	increased neutrophil cell number	J:339366
Il17b^{Gt(371C12)Cmhd}/Il17b^{Gt(371C12)Cmhd} (B6.129-Il17b^{Gt(371C12)Cmhd})	increased eosinophil cell number	J:229778
	increased T-helper 2 cell number	J:229778
Il17c^tm1.1Cdon/Il17c^tm1.1Cdon (involves: 129S6/SvEvTac)	decreased CD4-positive, alpha-beta T cell number	J:177650
Il17f^tm1Cdon/Il17f^tm1Cdon (involves: C57BL/6)	increased IgG2a level	J:136279
Il17ra^tm1.2Kurs/Il17ra^tm1.2Kurs (involves: 129S4/SvJae * BALB/cJ * C57BL/6 * SJL)	increased CD4-positive, alpha-beta T cell number	J:196483
	increased gamma-delta T cell number	J:196483
	increased T-helper 17 cell number	J:196483
Il17ra^tm1Koll/Il17ra^tm1Koll (involves: 129 * C57BL/6)	abnormal granulocyte differentiation	J:71097
	decreased neutrophil cell number	J:71097
	impaired neutrophil recruitment	J:71097
Il17ra^tm1Koll/Il17ra^tm1Koll (involves: 129)	abnormal T-helper 2 cell differentiation	J:158594
Il17ra^tm1Koll/Il17ra^tm1Koll (involves: 129)	impaired neutrophil recruitment	J:136279
Il17rb^tm1Anjm/Il17rb^tm1Anjm (BALB/c-Il17rb^tm1Anjm)	decreased eosinophil cell number	J:159464
Il17rb^tm1Anjm/Il17rb^tm1Anjm (BALB/c-Il17rb^tm1Anjm)	decreased IgE level	J:159464
Il17rb^tm1Anjm/Il17rb^tm1Anjm Il1rl1^tm1Anjm/Il1rl1^tm1Anjm (involves: 129P2/OlaHsd * BALB/c)	decreased eosinophil cell number	J:159464
	decreased IgE level	J:159464
Il17rb^tm1Lex/Il17rb^tm1Lex (C.129-Il17rb^tm1Lex)	abnormal osteoclast differentiation	J:159874
Il17rb^tm1Tgi/Il17rb^tm1Tgi (B6.Cg-Il17rb^tm1Tgi)	decreased NK T cell number	J:184570
Il17rc^em1(IMPC)Mbp/Il17rc^em1(IMPC)Mbp (C57BL/6NCrl-Il17rc^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Il18^tm1Aki/Il18^tm1Aki (involves: 129P2/OlaHsd)	abnormal macrophage physiology	J:112400
	abnormal T-helper 1 physiology	J:46514
	impaired natural killer cell mediated cytotoxicity	J:46514
Il18^tm1Aki/Il18^tm1Aki (involves: 129P2/OlaHsd * C57BL/6)	abnormal microglial cell morphology	J:122031
Il18^tm1Aki/Il18^tm1Aki (B6.129P2-Il18^tm1Aki)	impaired neutrophil chemotaxis	J:125285
Il18^tm1Aki/Il18^tm1Aki Nlrp1a^Neut1/Nlrp1a^Neut1 (involves: 129P2/OlaHsd * C57BL/6)	increased neutrophil cell number	J:191055
Il18^tm1Aki/Il18^tm1Aki Tg(KRT14-CASP1)1Miz/0 (involves: 129P2/OlaHsd * C57BL/6)	decreased IgE level	J:78602
	decreased IgG1 level	J:78602
Il18^tm1Khe/Il18^tm1Khe (involves: 129P2/OlaHsd)	abnormal T cell morphology	J:62263
Il18^tm1Khe/Il18^tm1Khe (B6.129P2-Il18^tm1Khe)	increased dendritic cell number	J:138759
	increased macrophage cell number	J:138759
	increased NK cell number	J:138759
Il18bp^{tm1(KOMP)Vlcg}/Il18bp^{tm1(KOMP)Vlcg} (C57BL/6-Il18bp^{tm1(KOMP)Vlcg})	abnormal NK cell differentiation	J:255309
	decreased KLRG1-positive NK cell number	J:255309
	decreased mature NK cell number	J:255309
	decreased NK cell number	J:255309
	increased immature NK cell number	J:255309
Il18bp^{tm1.1(KOMP)Vlcg}/Il18bp^{tm1.1(KOMP)Vlcg} (involves: C57BL/6N)	abnormal macrophage activation involved in immune response	J:261967
	abnormal phagocyte morphology	J:261967
	abnormal spleen morphology	J:261967
	enlarged spleen	J:261967
	increased B cell number	J:261967
	increased macrophage cell number	J:261967
	increased monocyte cell number	J:261967
	pancytopenia	J:261967
Il18r1^tm1Aki/Il18r1^tm1Aki (either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6))	abnormal T-helper 1 physiology	J:70298
	impaired natural killer cell mediated cytotoxicity	J:70298
Il18rap^{em1(IMPC)Wtsi}/Il18rap^{em1(IMPC)Wtsi} (C57BL/6N-Il18rap^{em1(IMPC)Wtsi}/WtsiCnrm)	decreased mean platelet volume	J:211773
Il18rap^tm1Yeh/Il18rap^tm1Yeh (Not Specified)	abnormal leukocyte physiology	J:98417
Il20ra^{tm1.1(KOMP)Vlcg}/Il20ra^{tm1.1(KOMP)Vlcg} (C57BL/6N-Il20ra^{tm1.1(KOMP)Vlcg}/Ucd)	increased red blood cell distribution width	J:211773
Il20ra^tm1.1Misc/Il20ra^tm1.1Misc (involves: C57BL/6)	abnormal osteoclast differentiation	J:177783
Il20rb^tm1Uwe/Il20rb^tm1Uwe (B6.129P2-Il20rb^tm1Uwe)	abnormal cytotoxic T cell physiology	J:143497
	abnormal T-helper 1 physiology	J:143497
	increased memory T cell number	J:143497
	increased T cell proliferation	J:143497
Il21^tm1Lex/Il21^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	abnormal gamma-delta T cell morphology	J:123351
	abnormal T cell differentiation	J:123351
	decreased CD4-positive, alpha-beta T cell number	J:123351
Il21^tm1Lex/Il21^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:137867
	abnormal CD4-positive, alpha-beta T cell physiology	J:137867
	abnormal germinal center B cell physiology	J:137867
	abnormal spleen germinal center morphology	J:137867
	decreased germinal center B cell number	J:137867
	decreased IgG1 level	J:137867
	decreased spleen germinal center number	J:137867
Il21^tm1Llit/Il21^tm1Llit (involves: 129 * C57BL/6J)	abnormal class switch recombination	J:114783
Il21^tm1Llit/Il21^tm1Llit (involves: 129 * C57BL/6J)	increased IgE level	J:114783
Il21r^tm1Day/Il21r^tm1Day (involves: BALB/c * C57BL/6)	abnormal CD4-positive T cell differentiation	J:136955, J:123352
	abnormal memory T cell physiology	J:76043
	abnormal NK cell physiology	J:76043
	abnormal T cell activation	J:76043
	abnormal T cell physiology	J:76043
	abnormal thymocyte activation	J:76043
	decreased CD4-positive, alpha-beta T cell number	J:123352
	decreased cytotoxic T cell cytolysis	J:76043
	decreased IgE level	J:144708
	decreased IgG1 level	J:76043, J:144708
	decreased IgG2a level	J:144708
	decreased IgG2b level	J:76043
	impaired natural killer cell mediated cytotoxicity	J:76043
	increased IgE level	J:76043
Il21r^tm1Day/Il21r^tm1Day (C57BL/6-Il21r^tm1Day)	abnormal T-helper 2 physiology	J:111712
	decreased IgG1 level	J:111712
	decreased IgG2b level	J:111712
Il21r^tm1Kopf/Il21r^tm1Kopf (involves: 129/Sv * BALB/c)	abnormal immunoglobulin level	J:137508
	abnormal lymphocyte physiology	J:137508
	decreased IgA level	J:137508
	decreased IgG1 level	J:137508
	impaired eosinophil recruitment	J:137508
	increased IgE level	J:137508
Il21r^tm1Kopf/Il21r^tm1Kopf (B6.129-Il21r^tm1Kopf)	abnormal immunoglobulin level	J:137508
	abnormal leukocyte physiology	J:137508
	abnormal lymphocyte physiology	J:137508
	abnormal T-helper 1 physiology	J:137508
	abnormal T-helper 2 physiology	J:137508
	decreased basophil cell number	J:137508
	decreased eosinophil cell number	J:137508
	decreased granulocyte number	J:137508
	decreased IgA level	J:137508
	decreased IgG1 level	J:137508
	impaired eosinophil recruitment	J:137508
	increased IgE level	J:137508
Il21r^tm1Wjl/Il21r^tm1Wjl (involves: 129 * C57BL/6)	abnormal CD8-positive, alpha-beta T cell physiology	J:95221
	abnormal immunoglobulin level	J:80474
	decreased cytotoxic T cell cytolysis	J:95221
	decreased IgG1 level	J:80474
	decreased IgG2a level	J:80474
	decreased IgG2b level	J:80474
	decreased IgG3 level	J:80474
	increased IgE level	J:80474
Il21r^tm1Wjl/Il21r^tm1Wjl (NOD.Cg-Il21r^tm1Wjl)	abnormal CD4-positive T cell differentiation	J:139075
Il21r^tm1Wjl/Il21r^tm1Wjl (NOD.Cg-Il21r^tm1Wjl)	decreased T cell proliferation	J:139075
Il21r^tm1Wjl/Il21r^tm1Wjl Il4^tm1Cgn/Il4^tm1Cgn (involves: 129 * C57BL/6)	abnormal immunoglobulin level	J:80474
	decreased IgA level	J:80474
	decreased IgG1 level	J:80474
	decreased IgG2a level	J:80474
	decreased IgG2b level	J:80474
	decreased IgG3 level	J:80474
	decreased IgM level	J:80474
Il22^tm1.1Lex/Il22^tm1.1Lex Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: 129S5/SvEvBrd * C57BL/6N * C57BL/10 * CBA/Ca)	increased erythrocyte cell number	J:305794
Il22^tm1.1Lex/Il22^tm1.1Lex Riok2^{tm1c(KOMP)Wtsi}/Riok2⁺ Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: 129S5/SvEvBrd * C57BL/6N * C57BL/10 * CBA/Ca)	increased erythrocyte cell number	J:305794
	increased erythroid progenitor cell number	J:305794
Il22^tm1Jcrd/Il22^tm1Jcrd (Not Specified)	decreased neutrophil cell number	J:193548
Il22ra1^tm1.1Koll/Il22ra1^tm1.1Koll Epor^{tm1.1(EGFP/icre)Uk}/Epor⁺ (involves: BALB/cJ * C57BL/6)	increased erythrocyte cell number	J:305794
	increased erythroid progenitor cell number	J:305794
	increased hematocrit	J:305794
Il22ra1^tm1.1Koll/Il22ra1^tm1.1Koll Riok2^{tm1c(KOMP)Wtsi}/Riok2⁺ Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: C57BL/6N * C57BL/10 * CBA/Ca)	hematopoietic system phenotype	J:305794
Il23a^tm1.1Thak/Il23a^tm1.1Thak (C57BL/6-Il23a^tm1.1Thak)	decreased T cell proliferation	J:143970
Il23a^tm1Dnax/Il23a^tm1Dnax (involves: 129 * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:95542
Il23a^tm1Dnax/Il23a^tm1Dnax (B6.Cg-Il23a^tm1Dnax)	abnormal CD8-positive, alpha-beta T cell physiology	J:111568
	abnormal granulocyte physiology	J:111568
	abnormal macrophage physiology	J:111568
Il23a^tm1Dnax/Il23a^tm1Dnax (Not Specified)	decreased gamma-delta T cell number	J:193548
	decreased leukocyte cell number	J:193548
	decreased neutrophil cell number	J:193548
	decreased T cell number	J:193548
Il23a^tm1Ngh/Il23a^tm1Ngh (involves: 129S/SvEv * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:88235
	abnormal CD8-positive, alpha beta T cell morphology	J:88235
	abnormal memory T cell physiology	J:88235
	decreased IgA level	J:88235
	decreased IgG2a level	J:88235
	decreased immunoglobulin level	J:88235
Il23a^tm1Ngh/Il23a^tm1Ngh (involves: 129 * C57BL/6)	abnormal memory T cell physiology	J:120806
Il23a^tm1Ngh/Il23a^tm1Ngh (involves: 129 * C57BL/6)	decreased activated T cell number	J:120806
Il23r^tm1.1Kuch/Il23r^tm1.1Kuch (involves: C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:151907
Il23r^tm1Kuch/Il23r^tm1Kuch (C57BL/6-Il23r^tm1Kuch)	abnormal CD4-positive T cell differentiation	J:148248
Il23r^tm1Kuch/Il23r^tm1Kuch (C57BL/6-Il23r^tm1Kuch)	abnormal CD4-positive, alpha-beta T cell physiology	J:148248
Il24^{tm1.1(KOMP)Vlcg}/Il24^{tm1.1(KOMP)Vlcg} (C57BL/6N-Il24^{tm1.1(KOMP)Vlcg}/J)	increased hematocrit	J:211773
	increased hemoglobin content	J:211773
Il25^tm1.1Cdon/Il25^tm1.1Cdon (involves: 129S6/SvEvTac)	decreased eosinophil cell number	J:229778
Il25^tm1.1Cdon/Il25^tm1.1Cdon (involves: 129S6/SvEvTac)	decreased T-helper 2 cell number	J:229778
Il25^tm1Anjm/Il25^tm1Anjm (involves: 129P2/OlaHsd * C57BL/6)	decreased eosinophil cell number	J:123748
	increased IgE level	J:123748
Il25^tm1Dart/Il25^tm1Dart (C57BL/6-Il25^tm1Dart)	decreased IgG2a level	J:123808
Il25^tm1Dart/Il25^tm1Dart (involves: C57BL/6)	increased T cell number	J:125296
Il27^{tm1b(EUCOMM)Wtsi}/Il27^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Il27^{tm1b(EUCOMM)Wtsi}/Wtsi)	decreased CD4-positive, alpha-beta memory T cell number	J:211773
	increased KLRG1-positive CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
Il27^tm1Cua/Il27^tm1Cua (C57BL/6-Il27^tm1Cua)	abnormal CD4-positive T cell differentiation	J:147706
Il27ra^tm1Fjs/Il27ra^tm1Fjs (B6.Cg-Il27ra^tm1Fjs)	abnormal T-helper 1 physiology	J:94856
Il27ra^tm1Fjs/Il27ra^tm1Fjs (B6.Cg-Il27ra^tm1Fjs)	increased lymphocyte cell number	J:94856
Il27ra^tm1Mak/Il27ra^tm1Mak (B6.129P2-Il27ra^tm1Mak)	abnormal T-helper 1 physiology	J:116610, J:89509
	hematopoietic system phenotype	J:89509
	increased T cell proliferation	J:89509
Il31ra^tm1Ngh/Il31ra^tm1Ngh (C57BL/6-Il31ra^tm1Ngh)	abnormal bone marrow cell morphology/development	J:123111
	abnormal common myeloid progenitor cell morphology	J:123111
	decreased bone marrow cell number	J:123111
	spleen hypoplasia	J:123111
Il31ra^tm1Ngh/Il31ra^tm1Ngh (involves: C57BL/6)	abnormal macrophage physiology	J:123198
	increased IgE level	J:123198
	increased T cell proliferation	J:123198
Il33^{tm1(KOMP)Vlcg}/Il33^{tm1(KOMP)Vlcg} (C57BL/6-Il33^{tm1(KOMP)Vlcg})	impaired macrophage chemotaxis	J:232676
Il33^tm1Aki/Il33^tm1Aki (involves: 129X1/SvJ * C57BL/6)	abnormal T-helper 2 physiology	J:182160
	decreased eosinophil cell number	J:182160
	decreased IgE level	J:182160
Il33^tm1Amgn/Il33^tm1Amgn (B6.129-Il33^tm1Amgn)	decreased lymphocyte cell number	J:192531
Il34^{tm1b(EUCOMM)Wtsi}/Il34^{tm1b(EUCOMM)Wtsi} (involves: BALB/cJ * C57BL/6N)	abnormal microglial cell morphology	J:187643
	absent Langerhans cell	J:187643
	decreased dendritic cell number	J:187643
	decreased Langerhans cell number	J:187643
Il36g^tm1Lex/Il36g^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	abnormal macrophage morphology	J:264077
	decreased alveolar macrophage number	J:264077
	increased CD11b-high dendritic cell number	J:264077
	increased macrophage apoptosis	J:264077
Il36g^tm1Lex/Il36g^tm1Lex (involves: 129S5/SvEvBrd)	decreased CD4-positive, alpha-beta T cell number	J:256437
	impaired neutrophil recruitment	J:280917
	increased CD4-positive, alpha-beta T cell number	J:256437
	increased regulatory T cell number	J:256437
Il36g^tm1Lex/Il36g^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	abnormal macrophage activation involved in immune response	J:296074
	impaired macrophage phagocytosis	J:296074
Il36rn^tm1Kopf/Il36rn^tm1Kopf (B6.129S5-Il36rn^tm1Kopf)	increased leukocyte cell number	J:193548
Il36rn^tm1Kopf/Il36rn^tm1Kopf (B6.129S5-Il36rn^tm1Kopf)	increased neutrophil cell number	J:193548
Ilk^tm1Star/Ilk^tm2Star Tg(Acp5-cre)1Star/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal osteoclast physiology	J:197593
	increased osteoclast cell number	J:197593
Imebt1^DU6/? (involves: DU6 * DUKs)	increased spleen weight	J:99475
Imh1^NZB/Imh1^NZB (involves: NZB * NZW)	increased IgM level	J:26266
Imh1^NZB/Imh1^NZW (involves: NZB * NZW)	increased IgM level	J:26266
Immp2l^{Tg(HLA-A/H2-D)2Enge}/? ((C57BL/6 x CBA)F1)	abnormal cytotoxic T cell physiology	J:31937
	abnormal negative T cell selection	J:31937
	abnormal positive T cell selection	J:31937
Impdh1^tm1Bmi/Impdh1^tm1Bmi (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased T cell proliferation	J:85443
Impdh1^tm1Bmi/Impdh1^tm1Bmi Impdh2^tm1Bmi/Impdh2⁺ (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal cytotoxic T cell physiology	J:85443
	abnormal lymphopoiesis	J:85443
	decreased splenocyte proliferation	J:85443
	decreased T cell proliferation	J:85443
Impdh2^tm1Bmi/Impdh2⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal lymphocyte cell number	J:86045
Impg1^em1Visu/Impg1^em1Visu Impg2^em1Visu/Impg2^em1Visu (involves: C57BL/6J * DBA/2)	microgliosis	J:288311
Impg2^em1Visu/Impg2^em1Visu (involves: C57BL/6J * DBA/2)	microgliosis	J:288311
Imraq1^DBA/2J/? (involves: C57BL/6J * DBA/2J)	increased IgG level	J:100370
Imraq2^DBA/2J/? Imraq3^C57BL/6J/? (involves: C57BL/6J * DBA/2J)	increased IgG level	J:100370
Imrfq1^C57BL/6J/? Imrfq2^C57BL/6J/? (involves: C57BL/6J * DBA/2J)	increased IgG level	J:100370
In(2a;Itch)18H/In(2a;Itch)18H (involves: 101/H * C3H/HeH)	abnormal alveolar macrophage morphology	J:24934
In(2a;Itch)18H/In(2a;Itch)18H (involves: 101/H * C3H/HeH)	increased spleen red pulp amount	J:24934
In(7Oca2;7Sox6)100H/In(7Oca2;7Sox6)100H (Not Specified)	abnormal definitive hematopoiesis	J:115753
In(7Oca2;7Sox6)100H/In(7Oca2;7Sox6)100H (Not Specified)	increased nucleated erythrocyte cell number	J:115753
Inca1^tm1Cmt/Inca1^tm1Cmt (involves: 129 * C57BL/6N)	abnormal spleen B cell follicle morphology	J:175667
	abnormal spleen morphology	J:175667
	abnormal spleen white pulp morphology	J:175667
	extramedullary hematopoiesis	J:175667
	increased IgA level	J:175667
	increased megakaryocyte cell number	J:175667
Inf2^{tm1.1(KOMP)Vlcg}/Inf2^{tm1.1(KOMP)Vlcg} (C57BL/6N-Inf2^{tm1.1(KOMP)Vlcg}/Ucd)	decreased hematocrit	J:211773
Ing1^{Gt(OST206270)Lex}/Ing1^{Gt(OST206270)Lex} (involves: 129S5/SvEvBrd * C57BL/6)	decreased thymocyte number	J:118602
	increased thymocyte apoptosis	J:118602
Ing1^tm1Avg/Ing1^tm1Avg (involves: 129S1/Sv * C57BL/6)	enlarged spleen	J:105658
Ing2^{tm1.1(KOMP)Vlcg}/Ing2⁺ (C57BL/6N-Ing2^{tm1.1(KOMP)Vlcg}/J)	increased mean corpuscular volume	J:211773
Ing2^tm1.1Ccha/Ing2^tm1.1Ccha (involves: 129 * C57BL/6J * FVB/N)	spleen hyperplasia	J:167311
Ing4^em1(IMPC)Tcp/Ing4^em1(IMPC)Tcp (C57BL/6NCrl-Ing4^em2(IMPC)Tcp/Tcp)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Ing5^tm1.1Ttho/Ing5⁺ (B6.Cg-Ing5^tm1.1Ttho)	abnormal proerythroblast morphology	J:345308
Ing5^tm1.1Ttho/Ing5^tm1.1Ttho (B6.Cg-Ing5^tm1.1Ttho)	abnormal fetal liver hematopoietic progenitor cell morphology	J:345308
	abnormal proerythroblast morphology	J:345308
	decreased fetal derived definitive erythrocyte cell number	J:345308
	spleen hypoplasia	J:345308
Inha^tm1Bay/Inha^tm1Bay (involves: 129S7/SvEvBrd * C57BL/6)	anemia	J:20450
Inha^tm1Bay/Inha^tm1Bay (involves: 129S7/SvEvBrd * C57BL/6)	pancytopenia	J:20450
Inhba^tm1Zuk/Inhba^tm2Zuk (involves: 129S7/SvEvBrd)	anemia	J:63882
Inhba^tm1Zuk/Inhba^tm2Zuk (involves: 129S7/SvEvBrd)	decreased hematocrit	J:63882
Inhba^tm2Zuk/Inhba^tm2Zuk (involves: 129S7/SvEvBrd)	anemia	J:63882
Inhba^tm2Zuk/Inhba^tm2Zuk (involves: 129S7/SvEvBrd)	decreased hematocrit	J:63882
Inhbb^{tm1b(EUCOMM)Hmgu}/Inhbb^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Inhbb^{tm1b(EUCOMM)Hmgu}/Bay)	decreased erythrocyte cell number	J:211773
Inpp4b^tm1.1Jva/Inpp4b^tm1.1Jva (B6.129-Inpp4b^tm1.1Jva)	abnormal osteoclast differentiation	J:177648
	abnormal osteoclast morphology	J:177648
	increased osteoclast cell number	J:177648
Inpp5d^el20/Inpp5d^el20 (B6.129-Inpp5d^el20)	abnormal erythropoiesis	J:173266
	abnormal lymphocyte cell number	J:173266
	anemia	J:173266
	decreased lymphocyte cell number	J:173266
	decreased pre-B cell number	J:173266
	decreased thymocyte number	J:173266
	enlarged spleen	J:173266
	increased IgG2a level	J:173266
	increased IgM level	J:173266
	increased immunoglobulin level	J:173266
	increased macrophage cell number	J:173266
	small thymus	J:173266
	thrombocytopenia	J:173266
Inpp5d^m1Btlr/Inpp5d^m1Btlr (C57BL/6J-Inpp5d^m1Btlr)	abnormal B cell differentiation	J:140987
	abnormal eosinophil physiology	J:140987
	abnormal neutrophil physiology	J:140987
	decreased cytotoxic T cell cytolysis	J:140987
	enlarged spleen	J:140987
	enlarged thymus	J:140987
	impaired natural killer cell mediated cytotoxicity	J:140987
Inpp5d^m2Btlr/Inpp5d^m2Btlr (C57BL/6J-Inpp5d^m2Btlr)	decreased B cell number	J:216053
Inpp5d^M3Btlr/Inpp5d⁺ (C57BL/6J-Inpp5d^M3Btlr)	decreased NK cell number	J:254907
Inpp5d^m5Btlr/Inpp5d^m5Btlr (C57BL/6J-Inpp5d^m5Btlr)	abnormal CD8-positive, alpha-beta T cell differentiation	J:272856
	abnormal lymphocyte morphology	J:272856
	abnormal T cell differentiation	J:272856
	decreased alpha-beta T cell number	J:272856
	decreased B cell number	J:272856
	decreased CD4-positive, alpha-beta T cell number	J:272856
	decreased CD8-positive, alpha-beta T cell number	J:272856
	decreased CD8-positive, naive alpha-beta T cell number	J:272856
	decreased NK cell number	J:272856
	increased B-1 B cell number	J:272856
	increased CD8-positive, alpha-beta T cell number	J:272856
	increased central memory CD8 positive, alpha-beta T cell number	J:272856
	increased effector memory CD4-positive, alpha-beta T cell number	J:272856
	increased effector memory CD8-positive, alpha-beta T cell number	J:272856
Inpp5d^tm1.1Wgk/Inpp5d^tm1.1Wgk (involves: 129S6/SvEvTac * C57BL/6J)	abnormal leukocyte physiology	J:94861
	abnormal mononuclear cell differentiation	J:94861
	abnormal NK cell morphology	J:95215
	increased dendritic cell number	J:94861
	increased monocyte cell number	J:94861
	increased NK cell number	J:95215
Inpp5d^tm1Dmt/Inpp5d^tm1Dmt (involves: 129P2/OlaHsd)	abnormal leukocyte physiology	J:77739
	decreased B cell number	J:77739
	enlarged spleen	J:77739
	increased leukocyte cell number	J:77739
Inpp5d^tm1Dmt/Inpp5d^tm1Dmt (involves: 129P2/OlaHsd * C57BL/6)	abnormal platelet activation	J:121283
	decreased platelet aggregation	J:121283
Inpp5d^tm1Dmt/Inpp5d^tm1Dmt (B6.129P2/OlaHsd-Inpp5d^tm1Dmt)	anemia	J:173266
	decreased lymphocyte cell number	J:173266
	decreased pre-B cell number	J:173266
	thrombocytopenia	J:173266
Inpp5d^tm1Rav/Inpp5d^tm1.1Rav Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal spleen marginal zone macrophage morphology	J:119256
	absent marginal zone B cells	J:119256
	enlarged spleen	J:119256
Inpp5d^tm1Rav/Inpp5d^tm1Rav Cd79a^tm1(cre)Reth/Cd79a⁺ Tg(IghAb36-65)1Wys/0 (involves: 129 * BALB/c * C57BL/6 * FVB/N)	abnormal B cell negative selection	J:178833
	decreased B cell number	J:178833
	increased plasma cell number	J:178833
Inpp5d^tm1Rav/Inpp5d^tm1Rav Tg(Cd4-cre)1Cwi/? (involves: C57BL/6 * DBA/2)	abnormal cytotoxic T cell physiology	J:122796
Inpp5d^tm1Rkh/Inpp5d^tm1Rkh (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal definitive hematopoiesis	J:48193
	abnormal granulocyte differentiation	J:48193
	abnormal lymphopoiesis	J:48193
	abnormal macrophage chemotaxis	J:48193
	abnormal monocyte differentiation	J:48193
	decreased bone marrow cell number	J:48193
	decreased lymphocyte cell number	J:48193
	increased monocyte cell number	J:48193
	increased neutrophil cell number	J:48193
	increased spleen weight	J:48193
	spleen hyperplasia	J:48193
Inpp5d^tm1Rkh/Inpp5d^tm1Rkh (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal myelopoiesis	J:117320
	decreased pro-B cell number	J:117320
Inpp5d^tm1Rkh/Inpp5d^tm1Rkh (involves: 129S1/Sv * 129X1/SvJ)	abnormal B cell physiology	J:110864
	abnormal bone marrow cell physiology	J:110864
	abnormal CD4-positive, alpha-beta T cell physiology	J:110864
	abnormal CD8-positive, alpha-beta T cell physiology	J:110864
	abnormal macrophage chemotaxis	J:110864
	abnormal osteoclast differentiation	J:78771
	abnormal osteoclast morphology	J:78771
	abnormal osteoclast physiology	J:78771
	abnormal T cell physiology	J:110864
	increased mast cell degranulation	J:120426
	increased osteoclast cell number	J:78771
Inpp5d^tm1Rkh/Inpp5d^tm1Rkh Rag1^tm1(GFP)Imku/Rag1⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	abnormal lymphopoiesis	J:117320
Inpp5d^tm1Wgk/Inpp5d^tm1.1Wgk Tg(Mx1-cre)1Cgn/0 (B6.Cg-Inpp5d^tm1Wgk/Inpp5d^tm1.1Wgk Tg(Mx1-cre)1Cgn)	abnormal leukocyte physiology	J:144110
	abnormal myeloid leukocyte morphology	J:144110
Inpp5j^em1(IMPC)Mbp/Inpp5j^em1(IMPC)Mbp (C57BL/6NCrl-Inpp5j^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Inpp5k^em1(IMPC)H/Inpp5k⁺ (C57BL/6NTac-Inpp5k^em1(IMPC)H/H)	increased neutrophil cell number	J:211773
Ins1^tm1Jja/Ins1^tm1Jja Ins2^tm1Mnt/Ins2^tm1Mnt Tg(Aire-cre)1Mnt/0 (involves: 129S2/SvPas * 129S4/SvJaeSor * C57BL/6 * FVB/N)	abnormal T cell physiology	J:152798
Ins2^Akita/Ins2⁺ (C57BL/6-Ins2^Akita/J)	abnormal microglial cell morphology	J:99412
Ins2^Akita/Ins2⁺ (C57BL/6-Ins2^Akita/J)	increased leukocyte cell number	J:99412
Ins2^Akita/Ins2⁺ Prf1^tm1Sdz/Prf1^tm1Sdz Rag1^tm1Mom/Rag1^tm1Mom (NOD.Cg-Rag1^tm1Mom Ins2^Akita Prf1^tm1Sdz)	absent mature B cells	J:138005
	absent T cells	J:138005
	increased erythrocyte cell number	J:138005
	increased granulocyte number	J:138005
	increased macrophage cell number	J:138005
	increased monocyte cell number	J:138005
Insig1^{em1(IMPC)Ccpcz}/Insig1^{em1(IMPC)Ccpcz} (C57BL/6N-Insig1^{em1(IMPC)Ccpcz}/Ccpcz)	increased mean corpuscular hemoglobin	J:211773
Insr^Rgsc824/Insr⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	increased glycosylated hemoglobin level	J:133634
Insyn2b^em1(IMPC)J/Insyn2b^em1(IMPC)J (C57BL/6NJ-Insyn2b^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Ints3^em1(IMPC)J/Ints3⁺ (C57BL/6NJ-Ints3^em1(IMPC)J/Mmjax)	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
	increased erythrocyte cell number	J:211773
Ints8^em1(IMPC)Tcp/Ints8⁺ (C57BL/6NCrl-Ints8^em1(IMPC)Tcp/Tcp)	decreased mean corpuscular volume	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
Ints9^{tm1b(KOMP)Wtsi}/Ints9⁺ (C57BL/6N-Ints9^{tm1b(KOMP)Wtsi}/Wtsi)	decreased mean corpuscular hemoglobin	J:211773
Ints12^{tm1b(EUCOMM)Wtsi}/Ints12⁺ (C57BL/6N-Ints12^{tm1b(EUCOMM)Wtsi}/H)	decreased red blood cell distribution width	J:211773
Invs^inv/Invs^inv (FVB/N-Invs^inv)	abnormal spleen morphology	J:48533
Invs^inv/Invs^inv (FVB/N-Invs^inv)	spleen hypoplasia	J:48533
Ip6k2^tm1.1Snyd/Ip6k2^tm1.1Snyd (B6.129-Ip6k2^tm1.1Snyd)	abnormal B cell physiology	J:212482
Ipo7^em1(IMPC)Mbp/Ipo7⁺ (C57BL/6N-Ipo7^em1(IMPC)Mbp/Ucd)	abnormal spleen morphology	J:211773
Ipo7^em1(IMPC)Mbp/Ipo7⁺ (C57BL/6N-Ipo7^em1(IMPC)Mbp/Ucd)	enlarged spleen	J:211773
Ipo8^{tm1.1(KOMP)Vlcg}/Ipo8⁺ (C57BL/6N-Ipo8^{tm1.1(KOMP)Vlcg}/J)	increased mean corpuscular hemoglobin	J:211773
Ipp^{tm1.1(KOMP)Vlcg}/Ipp^{tm1.1(KOMP)Vlcg} (C57BL/6N-Ipp^{tm1.1(KOMP)Vlcg}/J)	decreased leukocyte cell number	J:211773
Iqce^{tm1b(EUCOMM)Hmgu}/Iqce^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Iqce^{tm1b(EUCOMM)Hmgu}/Ics)	decreased lymphocyte cell number	J:211773
	increased mean corpuscular volume	J:211773
	increased neutrophil cell number	J:211773
Iqcj^em1(IMPC)J/Iqcj^em1(IMPC)J (C57BL/6NJ-Iqcj^em1(IMPC)J/J)	decreased mean corpuscular hemoglobin concentration	J:211773
	increased mean corpuscular volume	J:211773
Iqgap1^{tm1b(EUCOMM)Wtsi}/Iqgap1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Iqgap1^{tm1b(EUCOMM)Wtsi}/Tcp)	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
Irag1^{em1(IMPC)Ccpcz}/Irag1^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Irag1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	decreased erythrocyte cell number	J:211773
	decreased hemoglobin content	J:211773
	decreased lymphocyte cell number	J:211773
	enlarged spleen	J:211773
	increased effector memory T-helper cell number	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
	increased neutrophil cell number	J:211773
	increased red blood cell distribution width	J:211773
	increased spleen weight	J:211773
	thrombocytosis	J:211773
Irak1^tm1Jth/Y Irak2^tm1Aki/Irak2^tm1Aki (involves: 129/Sv * C57BL/6)	abnormal macrophage physiology	J:136290
Irak2^tm1Aki/Irak2^tm1Aki (involves: 129/Sv * C57BL/6)	abnormal macrophage physiology	J:136290
Irak3^tm1Flv/Irak3^tm1Flv (involves: 129S1/Sv * C57BL/6)	abnormal osteoclast physiology	J:98035
	increased neutrophil cell number	J:78189
	increased osteoclast cell number	J:98035
Irak3^tm1Flv/Irak3^tm1Flv (NOD.129S1(B6)-Irak3^tm1Flv)	abnormal T cell activation	J:229884
	abnormal T cell differentiation	J:229884
	increased effector memory T-helper cell number	J:229884
Irak4^tm1Aki/Irak4^tm1Aki (involves: 129X1/SvJ * C57BL/6)	decreased B cell proliferation	J:125729
Irak4^tm1Yeh/Irak4^tm1Yeh (involves: 129P2/OlaHsd * C57BL/6J)	abnormal macrophage physiology	J:76098
	abnormal NK cell physiology	J:76098
	decreased B cell proliferation	J:76098
Irak4^tm2Aki/Irak4^tm2Aki (involves: 129X1/SvJ * C57BL/6)	decreased B cell proliferation	J:125729
Ireb2^tm1.1Eal/Ireb2^tm1.1Eal (B6J.129-Ireb2^tm1.1Eal)	decreased hematocrit	J:217335
	decreased hemoglobin content	J:217335
	decreased mean corpuscular hemoglobin	J:217335
	decreased mean corpuscular hemoglobin concentration	J:217335
	decreased mean corpuscular volume	J:217335
	decreased mean platelet volume	J:217335
	increased red blood cell distribution width	J:217335
	microcytic anemia	J:217335
	thrombocytopenia	J:217335
Ireb2^tm1.2Mwh/Ireb2^tm1.2Mwh (involves: 129P2/OlaHsd * BALB/c * C57BL/6 * SJL)	abnormal erythrocyte morphology	J:103414
	decreased erythrocyte cell number	J:103414
	decreased hematocrit	J:103414
	decreased hemoglobin content	J:103414
	decreased spleen iron level	J:103414
	microcytosis	J:103414
Ireb2^tm1Mwh/Ireb2^tm1Mwh (involves: 129P2/OlaHsd * C57BL/6J)	abnormal erythrocyte morphology	J:105124
	decreased hematocrit	J:105124
	decreased hemoglobin content	J:105124
	decreased mean corpuscular volume	J:105124
	decreased spleen iron level	J:105124
	microcytosis	J:105124
Ireb2^tm1Roua/Ireb2^tm1Roua (B6.Cg-Ireb2^tm1Roua)	decreased hematocrit	J:176655
	decreased hemoglobin content	J:176655
	decreased mean corpuscular hemoglobin	J:176655
	decreased mean corpuscular hemoglobin concentration	J:176655
	decreased mean corpuscular volume	J:176655
	decreased spleen iron level	J:176655
	microcytosis	J:176655
Irf1^M1Btlr/Irf1⁺ (C57BL/6J-Irf1^M1Btlr)	decreased CD8-positive, alpha-beta T cell number	J:162995
	decreased NK cell number	J:162995
	hematopoietic system phenotype	J:162995
	impaired natural killer cell mediated cytotoxicity	J:162995
Irf1^M1Btlr/Irf1^M1Btlr (C57BL/6J-Irf1^M1Btlr)	decreased CD8-positive, alpha-beta T cell number	J:162995
	decreased NK cell number	J:162995
	hematopoietic system phenotype	J:162995
	impaired natural killer cell mediated cytotoxicity	J:162995
Irf1^m2Btlr/Irf1^m2Btlr (C57BL/6J-Irf1^m2Btlr)	decreased CD8-positive, alpha-beta T cell number	J:267675
	decreased NK cell number	J:267675
	increased B-1 B cell number	J:267675
	increased CD4-positive, alpha-beta T cell number	J:267675
Irf1^M3Btlr/Irf1^M3Btlr (C57BL/6J-Irf1^M3Btlr)	decreased CD8-positive, alpha-beta T cell number	J:267677
Irf1^M3Btlr/Irf1^M3Btlr (C57BL/6J-Irf1^M3Btlr)	increased CD4-positive, alpha-beta T cell number	J:267677
Irf1^tm1Cwe/Irf1^tm1Cwe (involves: 129/Sv * C57BL/6)	abnormal immunoglobulin level	J:101427
	abnormal macrophage physiology	J:43086
	abnormal splenocyte morphology	J:21235
	abnormal T cell morphology	J:21235, J:36025
	abnormal thymus cell ratio	J:36025
	decreased CD8-positive, alpha-beta T cell number	J:21235
	increased T-helper 2 cell number	J:110672
Irf1^tm1Cwe/Irf1^tm1Cwe (involves: 129)	abnormal T cell proliferation	J:84367
Irf1^tm1Mak/Irf1^tm1Mak (either: (involves: 129S2/SvPas * C57BL/6J) or (involves: 129S2/SvPas * C57BL/6J * DBA/2))	abnormal T cell number	J:64286
	decreased CD8-positive, alpha-beta T cell number	J:64286
	increased CD4-positive, alpha-beta T cell number	J:64286
	increased double-positive T cell number	J:64286
Irf1^tm1Mak/Irf1^tm1Mak (B6.129S2-Irf1^tm1Mak/J)	abnormal lymphocyte physiology	J:91927
Irf2^tm1Mak/Irf2^tm1Mak (either: (involves: 129S2/SvPas * C57BL/6J) or (involves: 129S2/SvPas * C57BL/6J * DBA/2))	decreased B cell proliferation	J:64286
	decreased IgG2a level	J:64286
	decreased mature B cell number	J:64286
	decreased T cell number	J:64286
Irf2^tm1Mak/Irf2^tm1Mak (involves: 129S2/SvPas * C57BL/6)	increased memory T cell number	J:66034
Irf2bp2^{Gt(IST11591C1)Tigm}/Irf2bp2^{Gt(IST11591C1)Tigm} (involves: C57BL/6 * C57BL/6N * FVB/N)	abnormal embryonic erythropoiesis	J:228010
	abnormal proerythroblast morphology	J:228010
	decreased erythrocyte cell number	J:228010
	decreased erythroid progenitor cell number	J:228010
	increased erythroblast number	J:228010
Irf3^tm1Ttg/Irf3^tm1Ttg Sting1^em1Jmin/Sting1^em1Jmin (involves: 129S/SvEv * C57BL/6N)	decreased single-positive T cell number	J:251372
	increased myeloid cell number	J:251372
Irf4^em1(IMPC)Mbp/Irf4^em1(IMPC)Mbp (C57BL/6N-Irf4^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	decreased lymphocyte cell number	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
	increased neutrophil cell number	J:211773
	increased spleen weight	J:211773
Irf4^m1Btlr/Irf4^m1Btlr (C57BL/6J-Irf4^m1Btlr)	abnormal B cell activation	J:160882
	decreased IgG level	J:160882
	decreased IgM level	J:160882
Irf4^m1Btlr/Irf4^m1Btlr (involves: C57BL/6J)	abnormal class switch recombination	J:185495
	decreased IgG level	J:185495
	decreased IgM level	J:185495
Irf4^M2Btlr/Irf4⁺ (C57BL/6J-Irf4^M2Btlr)	abnormal B cell activation	J:234245
	decreased IgG level	J:234245
	decreased IgM level	J:234245
Irf4^M2Btlr/Irf4^M2Btlr (C57BL/6J-Irf4^M2Btlr)	abnormal B cell activation	J:234245
	decreased IgG level	J:234245
	decreased IgM level	J:234245
Irf4^tm1.1Rdf/Irf4^tm1.1Rdf (involves: 129S1/Sv * 129S4/SvJae * C57BL/6)	abnormal B cell differentiation	J:112643
	abnormal B cell physiology	J:112643
	absent spleen germinal center	J:112643
	decreased B cell proliferation	J:112643
	decreased IgG1 level	J:112643
Irf4^tm1Mak/Irf4^tm1Mak (involves: 129P2/OlaHsd)	abnormal B cell differentiation	J:42683
	abnormal spleen morphology	J:42683
	absent plasma cells	J:42683
	absent spleen germinal center	J:42683
	arrested B cell differentiation	J:42683
	decreased B cell proliferation	J:42683
	decreased dendritic cell number	J:91043
	decreased immunoglobulin level	J:42683
	decreased T cell proliferation	J:42683
	enlarged spleen	J:42683
	increased lymphocyte cell number	J:42683
Irf4^tm1Mak/Irf4^tm1Mak (B6.129P2-Irf4^tm1Mak)	abnormal CD4-positive, alpha beta T cell morphology	J:78909
Irf4^tm1Mak/Irf4^tm1Mak (B6.129P2-Irf4^tm1Mak)	abnormal T-helper 1 cell differentiation	J:78909
Irf4^tm1Mak/Irf4^tm1Mak (involves: 129P2/OlaHsd * C57BL/6)	decreased plasmacytoid dendritic cell number	J:97716
Irf4^tm1Rdf/Irf4^tm1.1Rdf (involves: 129S1/Sv * 129S4/SvJae * C57BL/6)	abnormal B cell physiology	J:112643
Irf5^{tm1e(EUCOMM)Wtsi}/Irf5^{tm1e(EUCOMM)Wtsi} (C57BL/6N-Irf5^{tm1e(EUCOMM)Wtsi}/Wtsi)	decreased CD4-positive, alpha-beta memory T cell number	J:211773
	decreased leukocyte cell number	J:211773
Irf5^tm1Ttg/Irf5^tm1Ttg (involves: 129P2/OlaHsd * C57BL/6)	abnormal T-helper 1 physiology	J:97567
Irf7^tm1Ttg/Irf7^tm1Ttg (involves: 129P2/OlaHsd)	abnormal T cell physiology	J:97662
Irf8^em1Kmm/Irf8^em1Kmm Rr253^em6Kmm/Rr253^em6Kmm (C57BL/6J-Irf8^em1Kmm Rr253^em6Kmm)	decreased dendritic cell number	J:334296
	decreased granulocyte monocyte progenitor cell number	J:334296
	decreased monocyte cell number	J:334296
	hematopoietic system phenotype	J:334296
	increased dendritic cell number	J:334296
Irf8^M1Btlr/Irf8^M1Btlr (C57BL/6J-Irf8^M1Btlr)	decreased macrophage cell number	J:166600
	decreased monocyte cell number	J:166600
	increased neutrophil cell number	J:166600
Irf8^m2Btlr/Irf8^m2Btlr (C57BL/6J-Irf8^m2Btlr)	decreased CD8-positive, alpha-beta T cell number	J:274937
Irf8^m2Btlr/Irf8^m2Btlr (C57BL/6J-Irf8^m2Btlr)	increased CD4-positive, alpha-beta T cell number	J:274937
Irf8^myls/Irf8⁺ (involves: BXH2/TyJ * C57BL/6)	increased B cell number	J:168923
	increased B-1b cell number	J:168923
	increased follicular B cell number	J:168923
	increased transitional stage B cell number	J:168923
Irf8^myls/Irf8^myls (involves: BALB/cJ * BXH2/TyJ-Irf8^myls)	abnormal myelopoiesis	J:97931
	enlarged spleen	J:97931
Irf8^myls/Irf8^myls Slc11a1^r/Slc11a1^r (BXH2/TyJ)	abnormal myelopoiesis	J:97931
Irf8^myls/Irf8^myls Slc11a1^r/Slc11a1^r (BXH2/TyJ)	enlarged spleen	J:97931
Irf8^myls/Irf8^myls Slc11a1^r/Slc11a1^r (involves: BXH2/TyJ * C3H/HeJ)	enlarged spleen	J:97931
Irf8^{tm1b(KOMP)Wtsi}/Irf8^{tm1b(KOMP)Wtsi} (C57BL/6N-Irf8^{tm1b(KOMP)Wtsi}/J)	decreased erythrocyte cell number	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
	thrombocytopenia	J:211773
Irf8^tm1Hor/Irf8⁺ (either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6))	abnormal definitive hematopoiesis	J:36038
Irf8^tm1Hor/Irf8^tm1Hor (either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6))	abnormal cytotoxic T cell physiology	J:36038
	abnormal erythropoiesis	J:36038
	abnormal megakaryocyte morphology	J:36038
	abnormal plasma cell number	J:36038
	decreased B cell number	J:36038
	decreased lymphocyte cell number	J:36038
	decreased T cell number	J:36038
	hepatosplenomegaly	J:36038
	increased B cell number	J:36038
	increased bone marrow cell number	J:36038
	increased granulocyte number	J:36038
	increased immunoglobulin level	J:36038
	increased leukocyte cell number	J:36038
	increased lymphocyte cell number	J:36038
	increased macrophage cell number	J:36038
	increased mature B cell number	J:36038
	increased spleen red pulp amount	J:36038
	increased spleen weight	J:36038
	spleen hyperplasia	J:36038
Irf8^tm1Hor/Irf8^tm1Hor (B6.129P2-Irf8^tm1Hor)	decreased follicular B cell number	J:168923
	increased B-1b cell number	J:168923
	increased marginal zone B cell number	J:168923
Irf8^tm1Hor/Irf8^tm1Hor Irf4^tm1Mak/Irf4^tm1Mak (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell differentiation	J:84577
	abnormal pre-B cell morphology	J:84577
	absent B cells	J:84577
	arrested B cell differentiation	J:84577
	decreased dendritic cell number	J:97716
	decreased IgM level	J:84577
	decreased lymphocyte cell number	J:84577
	decreased plasmacytoid dendritic cell number	J:97716
	decreased T cell number	J:84577
	increased pre-B cell number	J:84577
Irgc^em1(IMPC)Tcp/Irgc^em1(IMPC)Tcp (C57BL/6N-Irgc^em1(IMPC)Tcp/Tcp)	increased monocyte cell number	J:211773
Irgm1^{em1(IMPC)Wtsi}/Irgm1^{em1(IMPC)Wtsi} (C57BL/6N-Irgm1^{em1(IMPC)Wtsi}/Wtsi)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	increased mean platelet volume	J:211773
	increased red blood cell distribution width	J:211773
	thrombocytopenia	J:211773
Irs1^em1(IMPC)H/Irs1⁺ (C57BL/6NTac-Irs1^em1(IMPC)H/H)	increased mean platelet volume	J:211773
Irs1^Sml/Irs1^Sml (C3.Cg-Irs1^Sml H2^b/GrsrJ)	increased osteoclast cell number	J:163661
Irs1^tm1Tka/Irs1^tm1Tka (involves: C57BL/6 * CBA)	abnormal osteoclast differentiation	J:61479
Irs1^tm1Tka/Irs1^tm1Tka (involves: C57BL/6 * CBA)	abnormal osteoclast physiology	J:61479
Is(14)1Rdf Is(14)2Rdf/Del(14Trim13-Dleu2)4Rdf Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6)	increased B cell number	J:156946
	increased B-1a cell number	J:156946
	increased spleen white pulp amount	J:156946
Is(14)1Rdf Is(14)5Rdf/Del(14Trim13-Rnaseh2b)6Rdf Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6)	abnormal lymphopoiesis	J:179879
	increased B cell number	J:179879
Is(14)1Rdf/Is(14)1Rdf Is(14)5Rdf/Is(14)5Rdf Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6)	abnormal lymphopoiesis	J:179879
	increased B cell number	J:179879
Isl1^tm1(cre)Sev/Isl1⁺ Pax9^tm1Rbal/Pax9^tm1.1Hpt (involves: 129 * C57BL/6J)	ectopic thymus	J:311535
	thymus hypoplasia	J:311535
Islr^{tm1b(EUCOMM)Wtsi}/Islr^{tm1b(EUCOMM)Wtsi} (involves: C57BL/6J * C57BL/6N)	abnormal bone marrow cell morphology/development	J:244530
	hematopoietic system phenotype	J:244530
Isy1^em1(IMPC)J/Isy1⁺ (C57BL/6NJ-Isy1^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Itch^{tm1(NCOM)Cmhd}/Itch⁺ (C57BL/6N-Itch^{tm1(NCOM)Cmhd}/Tcp)	increased mean corpuscular volume	J:165965
Itch^tm1.1Alta/Itch^tm1.1Alta Foxp3^{tm4(YFP/icre)Ayr}/Foxp3⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal immunoglobulin level	J:204685
	abnormal lymphopoiesis	J:204685
	abnormal regulatory T cell physiology	J:204685
	abnormal T-helper 2 cell differentiation	J:204685
	abnormal T-helper 2 physiology	J:204685
	decreased CD4-positive, alpha-beta T cell number	J:204685
	enlarged spleen	J:204685
	increased CD4-positive, alpha-beta T cell number	J:204685
	increased CD8-positive, alpha-beta T cell number	J:204685
	increased eosinophil cell number	J:204685
	increased IgA level	J:204685
	increased IgE level	J:204685
	increased IgG1 level	J:204685
	increased leukocyte cell number	J:204685
	increased regulatory T cell apoptosis	J:204685
	increased regulatory T cell number	J:204685
Itch^{tm1b(EUCOMM)Hmgu}/Itch^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Itch^{tm1b(EUCOMM)Hmgu}/H)	enlarged spleen	J:211773
	increased spleen weight	J:211773
Itfg2^em1(IMPC)J/Itfg2⁺ (C57BL/6NJ-Itfg2^em1(IMPC)J/Mmjax)	increased mean corpuscular hemoglobin concentration	J:211773
Itfg2^{Gt(OST215121)Lex}/Itfg2^{Gt(OST215121)Lex} (involves: 129S5/SvEvBrd * C57BL/6J)	abnormal B cell activation	J:205951
	abnormal splenocyte physiology	J:205951
	decreased B cell number	J:205951
	decreased IgE level	J:205951
	decreased IgG1 level	J:205951
	decreased IgG2a level	J:205951
	decreased IgG2b level	J:205951
	decreased IgG3 level	J:205951
	decreased lymphocyte cell number	J:205951
	decreased spleen germinal center number	J:205951
	decreased T follicular helper cell number	J:205951
	increased B cell number	J:205951
	spleen hyperplasia	J:205951
Itga2^tm1.1Eck/Itga2⁺ (involves: 129P2/OlaHsd)	abnormal platelet physiology	J:75683
Itga2^tm1.1Eck/Itga2⁺ (involves: 129P2/OlaHsd)	decreased platelet aggregation	J:75683
Itga2^tm1.1Eck/Itga2^tm1.1Eck (involves: 129P2/OlaHsd)	abnormal platelet aggregation	J:75683
	abnormal platelet physiology	J:75683
	decreased platelet aggregation	J:75683
	hematopoietic system phenotype	J:75683
Itga2^tm1.1Tkun/Itga2^tm1.1Tkun Tg(Pf4-icre)Q3Rsko/0 (involves: C57BL/6 * SJL)	abnormal platelet physiology	J:195799
	decreased mean platelet volume	J:195799
	decreased platelet aggregation	J:195799
Itga2^tm1Ztr/Itga2^tm1Ztr (involves: 129S1/Sv * 129X1/SvJ)	abnormal platelet physiology	J:108331
Itga2b^{tm1(GFP/cre)Emam}/Itga2b^{tm1(GFP/cre)Emam} (involves: 129S6/SvEvTac * C57BL/6)	abnormal definitive hematopoiesis	J:84564
	abnormal embryonic hematopoiesis	J:84564
	abnormal platelet physiology	J:84564
	anemia	J:84564
	increased hematopoietic stem cell number	J:84564
	thrombocytopenia	J:84564
Itga2b^{tm1(GFP/cre)Emam}/Itga2b^{tm1(GFP/cre)Emam} Rhoa^tm1Csab/Rhoa^tm1Csab Tg(ITGA2B)3Mako/0 Tg(Pf4-icre)Q3Rsko/0 (involves: 129S6/SvEvTac * C57BL/6)	abnormal megakaryocyte differentiation	J:204459
	abnormal megakaryocyte morphology	J:204459
	decreased megakaryocyte cell number	J:204459
Itga2b^tm1Graf/Itga2b⁺ (B6.Cg-Itga2b^tm1Graf)	abnormal platelet activation	J:123159
Itga2b^tm1Graf/Itga2b⁺ (B6.Cg-Itga2b^tm1Graf)	thrombocytopenia	J:123159
Itga2b^tm1Tlr/Itga2b⁺ (either: (involves: 129S1/Sv * 129X1/SvJ * BALB/c) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))	abnormal platelet activation	J:63961
	abnormal platelet aggregation	J:63961
	abnormal platelet physiology	J:63961
Itga2b^tm1Tlr/Itga2b^tm1Tlr (either: (involves: 129S1/Sv * 129X1/SvJ * BALB/c) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))	abnormal platelet activation	J:63961
	abnormal platelet alpha-granule morphology	J:63961
	abnormal platelet physiology	J:63961
	decreased erythrocyte cell number	J:63961
	decreased platelet aggregation	J:63961
	enlarged spleen	J:63961
Itga4^tm1Mgin/Itga4^tm1Mgin (B6.129-Itga4^tm1Mgin)	abnormal B cell physiology	J:106471
	abnormal lymphocyte physiology	J:106471
	abnormal T cell physiology	J:106471
	decreased monocyte cell number	J:106471
	impaired macrophage chemotaxis	J:106471
Itga4^tm1Mshi/Itga4^tm1Mshi (C57BL/6-Itga4^tm1Mshi)	abnormal cellular extravasation	J:144092
	abnormal leukocyte adhesion	J:144092
	abnormal leukocyte migration	J:144092
	abnormal mononuclear cell morphology	J:144092
	decreased B cell number	J:144092
	decreased lymphocyte cell number	J:144092
	decreased T cell number	J:144092
Itga4^tm1Tpa/Itga4^tm1Tpa Tg(Mx1-cre)1Cgn/? (involves: 129S4/SvJaeSor * C57BL/6 * CBA)	abnormal B cell differentiation	J:86861
	abnormal definitive hematopoiesis	J:86861
	abnormal myeloblast morphology/development	J:86861
	abnormal reticulocyte morphology	J:86861
	decreased CD4-positive, alpha-beta T cell number	J:86861
	increased leukocyte cell number	J:86861
Itga6^tm1Son/Itga6^tm1Son (involves: 129P2/OlaHsd * FVB)	abnormal T cell physiology	J:50235
Itga6^tm1Son/Itga6^tm1Son (involves: 129P2/OlaHsd * FVB)	decreased T cell number	J:50235
Itga8^{tm1b(KOMP)Wtsi}/Itga8⁺ (C57BL/6N-Itga8^{tm1b(KOMP)Wtsi}/J)	decreased mean corpuscular hemoglobin concentration	J:211773
	increased mean corpuscular volume	J:211773
Itga11^em1(IMPC)H/Itga11^em1(IMPC)H (C57BL/6N-Itga11^em1(IMPC)H/H)	decreased spleen weight	J:211773
Itgad^tm1.1Zimm/Itgad^tm1.1Zimm (involves: 129S6/SvEvTac * C57BL/6)	abnormal macrophage physiology	J:130908
	increased spleen weight	J:130908
Itgad^tm1Bll/Itgad^tm1Bll (B6.129S7-Itgad^tm1Bll)	abnormal lymphocyte cell number	J:90954
	abnormal T cell activation	J:90954
	abnormal T cell subpopulation ratio	J:90954
	decreased CD4-positive, alpha-beta T cell number	J:90954
	decreased T cell proliferation	J:90954
	increased CD8-positive, alpha-beta T cell number	J:90954
Itgae^{tm1b(EUCOMM)Wtsi}/Itgae^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Itgae^{tm1b(EUCOMM)Wtsi}/H)	decreased large unstained cell number	J:211773
	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	decreased monocyte cell number	J:211773
	decreased neutrophil cell number	J:211773
Itgae^tm1Cmp/Itgae^tm1Cmp (involves: 129S2/SvPas * BALB/c)	decreased lymphocyte cell number	J:55333
Itgae^tm1Cmp/Itgae^tm1Cmp (involves: 129S2/SvPas * BALB/c)	decreased T cell number	J:55333
Itgal^tm1.1Mshi/Itgal^tm1.1Mshi (involves: C57BL/6)	abnormal diapedesis	J:168533
	abnormal leukocyte adhesion	J:168533
	abnormal leukocyte migration	J:168533
	decreased lymphocyte cell number	J:168533
	enhanced leukocyte tethering or rolling	J:168533
Itgal^tm1Bll/Itgal⁺ (involves: 129S7/SvEvBrd)	abnormal CD4-positive, alpha-beta T cell physiology	J:267548
Itgal^tm1Bll/Itgal^tm1Bll (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal cellular extravasation	J:83226
	abnormal leukocyte adhesion	J:83226
	abnormal leukocyte migration	J:83226
	increased eosinophil cell number	J:83226
	increased leukocyte cell number	J:83226
	increased monocyte cell number	J:83226
	increased neutrophil cell number	J:83226
Itgal^tm1Bll/Itgal^tm1Bll (B6.129S7-Itgal^tm1Bll)	abnormal leukocyte adhesion	J:100242
	abnormal leukocyte tethering or rolling	J:100242
	decreased T cell proliferation	J:90954
	impaired natural killer cell mediated cytotoxicity	J:90954
	increased leukocyte cell number	J:100242
	increased neutrophil cell number	J:100242
Itgal^tm1Bll/Itgal^tm1Bll (involves: 129S7/SvEvBrd)	abnormal CD4-positive, alpha-beta T cell physiology	J:267548
	abnormal cellular extravasation	J:141063
	abnormal leukocyte adhesion	J:141063
	abnormal neutrophil physiology	J:141063
Itgal^tm1Hlz/Itgal^tm1Hlz (involves: 129P2/OlaHsd)	abnormal cellular extravasation	J:99286
	abnormal leukocyte adhesion	J:99286
	abnormal T cell activation	J:99286
	decreased cytotoxic T cell cytolysis	J:99286
	decreased lymphocyte cell number	J:99286
	decreased neutrophil cell number	J:99286
	spleen hyperplasia	J:99286
Itgal^tm1Hogg/Itgal^tm1Hogg (involves: 129P2/OlaHsd)	abnormal leukocyte adhesion	J:82587
	abnormal leukocyte migration	J:82587
	decreased B cell number	J:82587
	decreased CD4-positive, alpha-beta T cell number	J:82587
	decreased CD8-positive, alpha-beta T cell number	J:82587
	decreased lymphocyte cell number	J:82587
	enlarged spleen	J:82587
	increased CD4-positive, alpha-beta T cell number	J:82587
	increased CD8-positive, alpha-beta T cell number	J:82587
Itgal^tm1Mak/Itgal^tm1Mak (B6.129P2-Itgal^tm1Mak)	impaired natural killer cell mediated cytotoxicity	J:110889
Itgal^tm1Mak/Itgal^tm1Mak (B6.129P2-Itgal^tm1Mak)	thrombocytopenia	J:123460
Itgal^tm1Wpfl/Itgal^tm1Wpfl (involves: 129)	abnormal cytotoxic T cell physiology	J:37160
	abnormal leukocyte physiology	J:37160
	abnormal lymphocyte physiology	J:37160
Itgam^{em1(IMPC)Wtsi}/Itgam^{em1(IMPC)Wtsi} (C57BL/6N-Itgam^{em1(IMPC)Wtsi}/Wtsi)	increased mean corpuscular hemoglobin	J:211773
Itgam^m1Btlr/Itgam⁺ (C57BL/6J-Itgam^m1Btlr)	abnormal dendritic cell number	J:236681
	decreased macrophage cell number	J:236681
	decreased neutrophil cell number	J:236681
	impaired hematopoiesis	J:236681
	increased plasmacytoid dendritic cell number	J:236681
Itgam^m1Btlr/Itgam^m1Btlr (C57BL/6J-Itgam^m1Btlr)	abnormal dendritic cell number	J:236681
	decreased macrophage cell number	J:236681
	decreased neutrophil cell number	J:236681
	impaired hematopoiesis	J:236681
	increased plasmacytoid dendritic cell number	J:236681
Itgam^m2Btlr/Itgam^m2Btlr (C57BL/6J-Itgam^m2Btlr)	decreased CD11b-high dendritic cell number	J:272532
Itgam^m3Btlr/Itgam^m3Btlr (C57BL/6J-Itgam^m3Btlr)	decreased CD11b-high dendritic cell number	J:272533
Itgam^tm1Bll/Itgam^tm1Bll (B6.129S7-Itgam^tm1Bll)	abnormal leukocyte adhesion	J:100242
	abnormal lymphocyte cell number	J:90954
	abnormal T cell activation	J:90954
	abnormal T cell subpopulation ratio	J:90954
	decreased CD4-positive, alpha-beta T cell number	J:90954
	decreased T cell proliferation	J:90954
	increased CD8-positive, alpha-beta T cell number	J:90954
	increased leukocyte cell number	J:100242
	increased neutrophil cell number	J:100242
Itgam^tm1Bll/Itgam^tm1Bll (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal cellular extravasation	J:83226
	abnormal leukocyte adhesion	J:83226
	abnormal leukocyte migration	J:83226
	abnormal neutrophil physiology	J:39092
	decreased eosinophil cell number	J:83226
	impaired neutrophil phagocytosis	J:39092
Itgam^tm1Myd/Itgam^tm1Myd (involves: 129S4/SvJae * BALB/c * C57BL/6)	abnormal leukocyte adhesion	J:38052
	impaired neutrophil phagocytosis	J:38052
	increased eosinophil cell number	J:38052
	increased neutrophil cell number	J:38052
Itgam^tm1Myd/Itgam^tm1Myd (involves: 129S4/SvJae * C57BL/6)	decreased neutrophil cell number	J:103873
Itgam^tm1Myd/Itgam^tm1Myd (B6.129S4-Itgam^tm1Myd)	abnormal neutrophil morphology	J:113463
Itgam^tm1Myd/Itgam^tm1Myd (B6.129S4-Itgam^tm1Myd)	abnormal neutrophil physiology	J:113463
Itgam^tm1Myd/Itgam^tm1Myd (involves: 129S4/SvJae)	impaired leukocyte tethering or rolling	J:198197
Itgam^tm1Myd/Itgam^tm1Myd (involves: 129S4/SvJae)	impaired neutrophil phagocytosis	J:155479
Itgam^tm1Myd/Itgam^tm1Myd Syk^tm1Tyb/Syk^tm1.2Tara Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S2/SvPas * 129S4/SvJae * C57BL/6)	impaired granulocyte bactericidal activity	J:155479
Itgam^tm1Rws/Itgam^tm1Rws (involves: 129P2/OlaHsd * C57BL/6J)	abnormal macrophage physiology	J:65847
Itgav^tm1Blb/Itgav^tm1Blb Itgb1^tm1Ref/Itgb1^tm1Ref Itgb2^tm2Bay/Itgb2^tm2Bay Itgb7^tm1Cgn/Itgb7^tm1Cgn Tg(Mx1-cre)1Cgn/0 (involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/SvJ * C57BL/6 * CBA)	abnormal cellular extravasation	J:134784
Itgav^tm2Hyn/Itgav^tm2.1Hyn Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * FVB)	impaired macrophage phagocytosis	J:125508
Itgav^tm2Hyn/Itgav^tm2.1Hyn Tg(Tek-cre)1Ywa/? (involves: 129S2/SvPas * C57BL/6 * FVB * SJL)	abnormal dendritic cell differentiation	J:125508
	abnormal leukocyte morphology	J:125508
	decreased regulatory T cell number	J:125508
	impaired macrophage phagocytosis	J:125508
	increased regulatory T cell number	J:125508
Itgax^M1Btlr/Itgax⁺ (C57BL/6J-Itgax^M1Btlr)	decreased dendritic cell number	J:236684
	impaired hematopoiesis	J:236684
	increased plasmacytoid dendritic cell number	J:236684
Itgax^M1Btlr/Itgax^M1Btlr (C57BL/6J-Itgax^M1Btlr)	decreased dendritic cell number	J:236684
	impaired hematopoiesis	J:236684
	increased plasmacytoid dendritic cell number	J:236684
Itgax^tm1Bll/Itgax^tm1Bll (B6.129S7-Itgax^tm1Bll)	increased T cell proliferation	J:122187
Itgb1^tm1Ref/Itgb1^tm1Ref Tg(Mx1-cre)1Cgn/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	abnormal platelet physiology	J:118488
	decreased platelet calcium level	J:118488
Itgb1^tm1Ross/Itgb1^tm1Ross Tg(Hoxb7-cre)13Amc/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased hematocrit	J:149831
Itgb1^tm2Mlkn/Itgb1^tm2Mlkn (involves: 129/Sv * C57BL/6 * SJL)	abnormal platelet physiology	J:108331
Itgb1^tm2Son/Itgb1^tm2Son (either: 129P2/OlaHsd-Itgb1^tm2Son or (involves: 129P2/OlaHsd * FVB))	anemia	J:47279
Itgb2^M1Btlr/Itgb2^M1Btlr (C57BL/6J-Itgb2^M1Btlr)	abnormal NK cell differentiation	J:139559
Itgb2^m3Btlr/Itgb2^m3Btlr (C57BL/6J-Itgb2^m3Btlr)	abnormal cytotoxic T cell cytolysis	J:265126
	decreased B cell number	J:265126
	decreased CD4-positive, alpha-beta T cell number	J:265126
	decreased CD8-positive, alpha-beta T cell number	J:265126
	decreased dendritic cell number	J:265126
	decreased IgG level	J:265126
	decreased macrophage cell number	J:265126
	decreased neutrophil cell number	J:265126
	decreased single-positive T cell number	J:265126
	impaired natural killer cell mediated cytotoxicity	J:265126
	increased dendritic cell number	J:265126
	increased effector memory CD4-positive, alpha-beta T cell number	J:265126
	increased IgE level	J:265126
	increased NK T cell number	J:265126
Itgb2^M4Btlr/Itgb2^M4Btlr (C57BL/6J-Itgb2^M4Btlr)	abnormal T cell differentiation	J:272843
Itgb2^M4Btlr/Itgb2^M4Btlr (C57BL/6J-Itgb2^M4Btlr)	increased effector memory CD4-positive, alpha-beta T cell number	J:272843
Itgb2^m5Btlr/Itgb2^m5Btlr (C57BL/6J-Itgb2^m5Btlr)	increased B-1b cell number	J:272844
Itgb2^tm1.1Arte/Itgb2^tm1.1Arte (involves: C57BL/6NTac)	abnormal T cell physiology	J:202261
	decreased T cell proliferation	J:202261
	enlarged spleen	J:202261
	increased B cell number	J:202261
	increased dendritic cell number	J:202261
	increased neutrophil cell number	J:202261
	increased T cell number	J:202261
Itgb2^tm1Bay/Itgb2^tm1Bay (involves: 129S7/SvEvBrd)	increased granulocyte number	J:13599
	increased leukocyte cell number	J:13599, J:32126
	increased lymphocyte cell number	J:13599
Itgb2^tm1Bay/Itgb2^tm1Bay (involves: 129S7/SvEvBrd * PL/J)	abnormal spleen morphology	J:32126
	abnormal T cell activation	J:109598
	increased basophil cell number	J:32126
	increased eosinophil cell number	J:32126
	increased leukocyte cell number	J:32126
	increased lymphocyte cell number	J:32126
	increased monocyte cell number	J:32126
	increased neutrophil cell number	J:32126
	increased T cell number	J:109598
	increased T-helper 1 cell number	J:109598
	myeloid hyperplasia	J:32126
	thrombocytosis	J:32126
Itgb2^tm1Bay/Itgb2^tm1Bay (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal spleen red pulp morphology	J:13599
	myeloid hyperplasia	J:13599
Itgb2^tm2Bay/Itgb2^tm2Bay (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal leukocyte physiology	J:48542
	abnormal neutrophil morphology	J:48542
	abnormal neutrophil physiology	J:48542
	abnormal T cell proliferation	J:48542
	enlarged spleen	J:48542
	increased bone marrow cell number	J:48542
	increased IgA level	J:48542
	increased IgG level	J:48542
	increased IgM level	J:48542
	increased immunoglobulin level	J:48542
	increased leukocyte cell number	J:48542
	increased lymphocyte cell number	J:48542
	increased monocyte cell number	J:48542
	increased neutrophil cell number	J:48542
	myeloid hyperplasia	J:48542
Itgb2^tm2Bay/Itgb2^tm2Bay (involves: 129S7/SvEvBrd)	decreased T cell proliferation	J:90954
Itgb2^tm2Bay/Itgb2^tm2Bay (B6.129S7-Itgb2^tm2Bay)	abnormal leukocyte adhesion	J:83226
	abnormal leukocyte migration	J:83226
	increased eosinophil cell number	J:83226
	increased leukocyte cell number	J:83226
	increased lymphocyte cell number	J:83226
	increased monocyte cell number	J:83226
	increased neutrophil cell number	J:83226
Itgb2^tm2Bay/Itgb2^tm2Bay (involves: 129S7/SvEvBrd * C57BL/6)	impaired neutrophil recruitment	J:112286
	increased neutrophil cell number	J:112286
Itgb3^tm1Aja/Itgb3^tm1Aja (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal platelet activation	J:148306
	abnormal platelet dense granule physiology	J:148306
	abnormal platelet physiology	J:148306
Itgb3^tm1Hyn/Itgb3^tm1.1Wlbcr Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	abnormal osteoclast differentiation	J:224675
	abnormal osteoclast morphology	J:224675
	decreased osteoclast cell number	J:224675
Itgb3^tm1Hyn/Itgb3^tm1.1Wlbcr Tg(Pf4-icre)Q3Rsko/0 (involves: 129S2/SvPas * C57BL/6)	decreased hemoglobin content	J:224675
	decreased platelet aggregation	J:224675
	enlarged spleen	J:224675
Itgb3^tm1Hyn/Itgb3^tm1Hyn (involves: 129S2/SvPas * C57BL/6)	abnormal macrophage physiology	J:119666
	abnormal platelet activation	J:52262
	anemia	J:52262
	decreased erythrocyte cell number	J:52262
	decreased hematocrit	J:52262
	decreased hemoglobin content	J:52262
	enlarged spleen	J:52262
	extramedullary hematopoiesis	J:52262
	impaired macrophage chemotaxis	J:119666
	increased monocyte cell number	J:119666
	reticulocytosis	J:52262
Itgb3^tm1Hyn/Itgb3^tm1Hyn (involves: 129S2/SvPas)	abnormal osteoclast morphology	J:60672
	abnormal osteoclast physiology	J:60672
	abnormal platelet physiology	J:96049
	decreased macrophage cell number	J:96049
	increased osteoclast cell number	J:60672
Itgb3^tm1Hyn/Itgb3^tm1Hyn (involves: 129S2/SvPas * BALB/c)	increased IgG level	J:131241
Itgb3^tm1Mgin/Itgb3^tm1Mgin (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)	abnormal platelet activation	J:123968
	decreased erythrocyte cell number	J:123968
	decreased hematocrit	J:123968
	decreased hemoglobin content	J:123968
	increased mean corpuscular hemoglobin	J:123968
	increased mean corpuscular volume	J:123968
Itgb3^tm2Mgin/Itgb3^tm2Mgin (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)	abnormal platelet activation	J:123968
	decreased erythrocyte cell number	J:123968
	increased mean corpuscular hemoglobin	J:123968
Itgb3bp^em1(IMPC)J/Itgb3bp^em1(IMPC)J (C57BL/6NJ-Itgb3bp^em1(IMPC)J/Mmjax)	increased mean corpuscular hemoglobin concentration	J:211773
Itgb5^{tm1a(EUCOMM)Wtsi}/Itgb5^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Itgb5^{tm1a(EUCOMM)Wtsi}/Ics)	increased hematocrit	J:165965
	increased leukocyte cell number	J:165965
Itgb6^{em1(IMPC)Ccpcz}/Itgb6^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Itgb6^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Itgb6^tm1Des/Itgb6^tm1Des (involves: 129S4/SvJae)	absent Langerhans cell	J:120085
Itgb6^tm1Des/Itgb6^tm1Des (involves: 129S4/SvJae)	decreased Langerhans cell number	J:120085
Itgb7^tm1Cgn/Itgb7^tm1Cgn (involves: C57BL/6)	abnormal lymphocyte physiology	J:34306
	abnormal uterine NK cell morphology	J:44813
	decreased B cell number	J:34306
	decreased CD4-positive, alpha-beta T cell number	J:34306
	decreased eosinophil cell number	J:62733
	decreased mast cell number	J:62733
	impaired leukocyte tethering or rolling	J:34306
	increased uterine NK cell number	J:44813
Itgb7^tm1Cgn/Itgb7^tm1Cgn (C57BL/6-Itgb7^tm1Cgn/J)	abnormal leukocyte migration	J:127413
Itgb7^tm1Mshi/Itgb7^tm1Mshi (involves: C57BL/6)	abnormal leukocyte adhesion	J:127413
Itgb7^tm1Mshi/Itgb7^tm1Mshi (involves: C57BL/6)	abnormal leukocyte migration	J:127413
Itk^em1(IMPC)Mbp/Itk^em1(IMPC)Mbp (C57BL/6N-Itk^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Itk^m1Btlr/Itk^m1Btlr (C57BL/6J-Itk^m1Btlr)	abnormal CD4-positive, alpha-beta T cell physiology	J:236673
	abnormal CD8-positive, alpha-beta T cell physiology	J:236673
	increased CD8-positive, alpha-beta memory T cell proliferation	J:236673
	increased IgE level	J:236673
Itk^m2Btlr/Itk^m2Btlr (C57BL/6J-Itk^m2Btlr)	decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:254826
	decreased CD8-positive, alpha-beta memory T cell number	J:254826
	decreased CD8-positive, naive alpha-beta T cell number	J:254826
	increased B cell number	J:254826
	increased central memory CD4-positive, alpha-beta T cell number	J:254826
	increased central memory CD8 positive, alpha-beta T cell number	J:254826
	increased effector memory CD4-positive, alpha-beta T cell number	J:254826
Itk^tm1Lex/Itk^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	decreased CD4-positive, alpha-beta T cell number	J:103485
	decreased CD8-positive, alpha-beta T cell number	J:103485
	increased B cell number	J:103485
Itk^tm1Litt/Itk^tm1Litt (involves: 129S4/SvJae * C57BL/6J)	decreased B cell number	J:31230
	decreased CD4-positive, alpha-beta T cell number	J:31230
	decreased T cell number	J:31230
	decreased T cell proliferation	J:31230
Itk^tm1Litt/Itk^tm1Litt (involves: 129S4/SvJae)	decreased T cell proliferation	J:54449
Itk^tm1Litt/Itk^tm1Litt (involves: 129S4/SvJae * C57BL/6)	abnormal CD8-positive, alpha-beta T cell differentiation	J:111786
	abnormal thymus cell ratio	J:111786
	decreased CD8-positive, alpha-beta T cell number	J:111786
Itk^tm1Litt/Itk^tm1Litt (B6.129S4-Itk^tm1Litt)	abnormal positive T cell selection	J:141390
	abnormal T cell morphology	J:141390
	decreased T cell number	J:141390
	decreased T cell proliferation	J:141390
	increased double-negative T cell number	J:141390
Itk^tm1Litt/Itk^tm1Litt Tg(DO11.10)10Dlo/0 (involves: 129S4/SvJae * BALB/c * C3H * C57BL/6J)	abnormal T-helper 2 physiology	J:129883
Itk^tm1Litt/Itk^tm1Litt Tg(TcraH-Y,TcrbH-Y)71Vbo/0 (involves: 129S4/SvJae * C57BL/6 * DBA/2J)	abnormal positive T cell selection	J:31230
	decreased CD4-positive, alpha-beta T cell number	J:31230
	increased double-positive T cell number	J:31230
Itk^tm1Litt/Itk^tm1Litt Tg(TcrAND)53Hed/0 (involves: 129S4/SvJae * C57BL/6 * SJL)	abnormal lymphocyte morphology	J:31230
	decreased CD4-positive, alpha-beta T cell number	J:31230
	increased double-negative T cell number	J:31230
Itk^tm1Litt/Itk^tm1Litt Txk^tm1Pls/Txk^tm1Pls (involves: 129S4/SvJae * 129S6/SvEvTac)	decreased CD4-positive, alpha-beta T cell number	J:54449
	decreased single-positive T cell number	J:54449
	decreased T cell proliferation	J:54449
Itk^tm1Litt/Itk^tm1Litt Vav1^tm2Bbd/Vav1^tm2Bbd (B6.129-Itk^tm1Litt Vav1^tm2Bbd)	abnormal CD4-positive T cell differentiation	J:141390
	abnormal CD8-positive, alpha-beta T cell differentiation	J:141390
	abnormal positive T cell selection	J:141390
	abnormal T cell morphology	J:141390
	abnormal T cell physiology	J:141390
	decreased CD4-positive, alpha-beta T cell number	J:141390
	decreased CD8-positive, alpha-beta T cell number	J:141390
	decreased double-positive T cell number	J:141390
	decreased T cell number	J:141390
	decreased thymocyte number	J:141390
	increased B cell number	J:141390
	increased T cell apoptosis	J:141390
Itk^tm1Ljb/Itk^tm1Ljb (B6.129-Itk^tm1Ljb)	abnormal NK T cell morphology	J:120689
Itk^tm1Ljb/Itk^tm1Ljb (B6.129-Itk^tm1Ljb)	decreased NK T cell number	J:120689
Itk^tm1Ljb/Itk^tm1Ljb (involves: 129 * C57BL/6)	abnormal T cell activation	J:48231
Itk^tm1Ljb/Itk^tm1Ljb (involves: 129 * C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:48231
Itk^tm1Ljb/Itk^tm1Ljb (B10.129-Itk^tm1Ljb)	abnormal CD8-positive, alpha-beta T cell differentiation	J:113408
	abnormal CD8-positive, alpha-beta T cell physiology	J:113408
	abnormal gamma-delta T cell morphology	J:148531
	decreased CD4-positive, alpha-beta T cell number	J:123795
	increased CD8-positive, alpha-beta T cell number	J:113408, J:123795
	increased germinal center B cell number	J:148531
	increased IgE level	J:148531
	increased mature gamma-delta T cell number	J:148531
	increased memory T cell number	J:113408
Itk^tm1Ljb/Itk^tm1Ljb Rag1^tm1Mom/Rag1^tm1Mom Tg(Tcra5CC7,Tcrb5CC7)IWep/? (involves: 129 * C57BL/10)	abnormal CD4-positive T cell differentiation	J:93606
Itk^tm1Ljb/Itk^tm1Ljb Tg(Tcra2B4)1Mmd/? Tg(Tcrb2B4)1Mmd/? (involves: C3H/HeJ * C57BL/6 * C57BL/10)	decreased CD4-positive, alpha-beta T cell number	J:123795
Itk^tm1Ljb/Itk^tm1Ljb Tg(Tcra5CC7,Tcrb5CC7)IWep/? (involves: 129 * C57BL/10)	decreased CD4-positive, alpha-beta T cell number	J:123795
Itk^tm1Ljb/Itk^tm1Ljb Txk^tm1Pls/Txk^tm1Pls (B6.129-Txk^tm1Pls Itk^tm1Ljb)	abnormal CD8-positive, alpha-beta T cell physiology	J:113408
	increased CD8-positive, alpha-beta T cell number	J:113408
	increased memory T cell number	J:113408
Itln1^em1Cya/Itln1^em1Cya (involves: C57BL/6)	abnormal osteoclast physiology	J:282124
Itln1^em1Cya/Itln1^em1Cya (involves: C57BL/6)	increased osteoclast cell number	J:282124
Itpa^tm1Skmi/Itpa^tm1Skmi (involves: 129S/SvEv * C57BL/6J)	extramedullary hematopoiesis	J:169285
Itpkb^T-less/Itpkb^T-less (C57BL/6-Itpkb^T-less)	abnormal T cell physiology	J:89286
Itpkb^T-less/Itpkb^T-less (C57BL/6-Itpkb^T-less)	arrested T cell differentiation	J:89286
Itpkb^tm1Ssch/Itpkb^tm1Ssch (involves: 129S1/Sv * 129X1/SvJ * CD-1)	abnormal thymocyte activation	J:86257
	abnormal thymus involution	J:86257
	absent CD4-positive, alpha-beta T cells	J:86257
	absent CD8-positive, alpha-beta T cells	J:86257
	absent T cells	J:86257
	absent thymus medulla	J:86257
	arrested T cell differentiation	J:86257
	decreased IgG1 level	J:86257
	decreased IgG2a level	J:86257
	decreased IgG2b level	J:86257
	decreased IgG level	J:86257
	increased double-positive T cell number	J:86257
Itpkb^tm1Ssch/Itpkb^tm1Ssch Itpkc^tm1Ssch/Itpkc^tm1Ssch (involves: 129S1/Sv * 129X1/SvJ * CD-1)	abnormal thymocyte activation	J:86257
	absent CD4-positive, alpha-beta T cells	J:86257
	absent CD8-positive, alpha-beta T cells	J:86257
	arrested T cell differentiation	J:86257
Itpr3^em1(IMPC)Mbp/Itpr3^em1(IMPC)Mbp (C57BL/6N-Itpr3^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Izumo1r^{tm2a(KOMP)Wtsi}/Izumo1r^{tm2a(KOMP)Wtsi} (C57BL/6N-Izumo1r^{tm2a(KOMP)Wtsi}/Wtsi)	increased red blood cell distribution width	J:211773
Jade2^em1(IMPC)Tcp/Jade2^em1(IMPC)Tcp (C57BL/6N-Jade2^em1(IMPC)Tcp/Tcp)	small spleen	J:211773
Jag1^tm1Frad/Jag1^tm1Frad Notch1^tm1Agt/Notch1^tm1Agt Tg(Mx1-cre)1Cgn/0 (involves: 129 * C57BL/6 * CBA)	hematopoietic system phenotype	J:98129
Jag1^tm1Frad/Jag1^tm1Frad Tg(Mx1-cre)1Cgn/0 (involves: 129 * C57BL/6 * CBA)	hematopoietic system phenotype	J:98129
Jag2^tm1Grid/Jag2^tm1Grid (involves: 129S1/Sv * C57BL/6J)	abnormal gamma-delta T cell differentiation	J:46930
	abnormal thymus medulla morphology	J:46930
	abnormal thymus morphology	J:46930
	decreased gamma-delta T cell number	J:46930
Jagn1^{tm1c(EUCOMM)Hmgu}/Jagn1^{tm1c(EUCOMM)Hmgu} Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: C57BL/6N * C57BL/10 * CBA/Ca)	abnormal neutrophil morphology	J:214828
	abnormal neutrophil physiology	J:214828
	impaired neutrophil chemotaxis	J:214828
	impaired neutrophil recruitment	J:214828
Jak1^M1Mhda/Jak1⁺ (C3HeB/FeJ-Jak1^M1Mhda)	abnormal plasma cell morphology	J:199153
	anisocytosis	J:199153
	decreased cellular hemoglobin content	J:199153
	decreased mean corpuscular volume	J:199153
	decreased mean platelet volume	J:199153
	decreased megakaryocyte cell number	J:199153
	enlarged spleen	J:199153
	increased erythrocyte cell number	J:199153
	increased IgA level	J:199153
	increased IgG1 level	J:199153
	increased IgG2a level	J:199153
	increased IgM level	J:199153
	increased immunoglobulin level	J:199153
	increased plasma cell number	J:199153
	microcytic anemia	J:199153
	thrombocytopenia	J:199153
Jak1^tm1Rds/Jak1^tm1Rds (involves: 129)	abnormal B cell differentiation	J:47300
	abnormal lymphopoiesis	J:47300
	abnormal T cell differentiation	J:47300
	arrested B cell differentiation	J:47300
	decreased B cell number	J:47300
	decreased thymocyte number	J:47300
	increased double-negative T cell number	J:47300
	small thymus	J:47300
Jak2^m1Dlbr/Jak2⁺ (involves: 129S1/SvImJ * C57BL/6J)	decreased erythrocyte cell number	J:207740
	hematopoietic system phenotype	J:207740
	increased megakaryocyte cell number	J:207740
	thrombocytosis	J:207740
Jak2^m1Dlbr/Jak2^m1Dlbr (involves: 129S1/SvImJ * C57BL/6J)	anemia	J:207740
Jak2^m1Dlbr/Jak2^tm1Jni (involves: 129P2/OlaHsd * 129S1/SvImJ * C57BL/6J)	anemia	J:207740
Jak2^{tm1(JAK2)Argr}/Jak2⁺ Dppa3^tm1(cre)Peli/Dppa3⁺ (involves: 129S5/SvEvBrd * 129S7/SvEvBrd * C57BL/6)	increased hematopoietic stem cell number	J:233169
	increased leukocyte cell number	J:233169
	increased spleen weight	J:233169
	thrombocytosis	J:233169
Jak2^{tm1(JAK2)Argr}/Jak2⁺ Tg(Mx1-cre)1Cgn/0 (involves: 129S7/SvEvBrd * C57BL/6 * CBA)	abnormal bone marrow cell morphology/development	J:164539
	abnormal common myeloid progenitor cell morphology	J:164539
	abnormal erythropoiesis	J:164539
	abnormal hematopoietic system physiology	J:164539
	abnormal megakaryocyte differentiation	J:164539
	anemia	J:164539
	decreased hematopoietic stem cell number	J:164539
	decreased leukocyte cell number	J:164539
	enlarged spleen	J:164539
	increased erythrocyte cell number	J:164539
	increased erythroid progenitor cell number	J:164539
	increased hematocrit	J:164539
	increased hemoglobin content	J:164539
	increased leukocyte cell number	J:164539
	increased megakaryocyte cell number	J:164539
	thrombocytosis	J:164539
Jak2^tm1.1Ble/Jak2⁺ Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: 129 * C57BL/6 * C57BL/10 * CBA/Ca)	abnormal erythrocyte morphology	J:257910
	enlarged spleen	J:257910
	extramedullary hematopoiesis	J:257910
	increased erythrocyte cell number	J:257910
	increased erythroid progenitor cell number	J:257910
	increased granulocyte number	J:257910
	increased leukocyte cell number	J:257910
	increased megakaryocyte cell number	J:257910
	increased megakaryocyte progenitor cell number	J:257910
	increased neutrophil cell number	J:257910
	reticulocytosis	J:257910
	thrombocytosis	J:257910
Jak2^tm1.1Jlvl/Jak2^tm1.1Jlvl (involves: 129S2/SvPas * C57BL/6)	abnormal bone marrow cell morphology/development	J:163497
	abnormal common myeloid progenitor cell morphology	J:163497
	abnormal erythrocyte morphology	J:163497
	abnormal spleen morphology	J:163497
	anisocytosis	J:163497
	decreased mean corpuscular volume	J:163497
	decreased spleen white pulp amount	J:163497
	enlarged spleen	J:163497
	extramedullary hematopoiesis	J:163497
	giant platelets	J:163497
	increased erythrocyte cell number	J:163497
	increased erythroid progenitor cell number	J:163497
	increased granulocyte number	J:163497
	increased hematocrit	J:163497
	increased leukocyte cell number	J:163497
	increased lymphocyte cell number	J:163497
	increased mean platelet volume	J:163497
	increased megakaryocyte cell number	J:163497
	increased monocyte cell number	J:163497
	increased spleen red pulp amount	J:163497
	microcytosis	J:163497
	poikilocytosis	J:163497
	polychromatophilia	J:163497
	thrombocytosis	J:163497
Jak2^tm1.1Kuw/Jak2^tm1.1Kuw (involves: 129X1/SvJ)	abnormal erythropoiesis	J:90883
Jak2^tm1.2Ble/Jak2⁺ (involves: 129S6/SvEvTac * C57BL/6 * FVB/N)	abnormal definitive hematopoiesis	J:160883
	abnormal erythropoiesis	J:160883
	abnormal hematopoietic system physiology	J:160883
	abnormal megakaryocyte morphology	J:160883
	abnormal spleen morphology	J:160883
	abnormal spleen red pulp morphology	J:160883
	enhanced megakaryocyte emperipolesis	J:160883
	enlarged spleen	J:160883
	extramedullary hematopoiesis	J:160883
	hematopoietic system phenotype	J:160883
	increased erythroid progenitor cell number	J:160883
	increased hematocrit	J:160883
	increased leukocyte cell number	J:160883
	increased megakaryocyte cell number	J:160883
Jak2^tm1.2Ble/Jak2⁺ Picalm^tm1.1Tmae/Picalm⁺ Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: 129S6/SvEvTac * C57BL/6 * C57BL/10 * CBA * SJL)	decreased mean corpuscular hemoglobin	J:220728
	decreased mean corpuscular volume	J:220728
	increased erythrocyte cell number	J:220728
	increased hematocrit	J:220728
	increased hemoglobin content	J:220728
	reticulocytosis	J:220728
	thrombocytosis	J:220728
Jak2^tm1.2Ble/Jak2⁺ Picalm^tm1.1Tmae/Picalm^tm1.1Tmae Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: 129S6/SvEvTac * C57BL/6 * C57BL/10 * CBA * SJL)	decreased CD4-positive, alpha-beta T cell number	J:220728
	decreased CD8-positive, alpha-beta T cell number	J:220728
	decreased erythrocyte cell number	J:220728
	decreased hematocrit	J:220728
	decreased hemoglobin content	J:220728
	decreased mean corpuscular hemoglobin	J:220728
	decreased mean corpuscular volume	J:220728
	hypochromic microcytic anemia	J:220728
	reticulocytosis	J:220728
Jak2^tm1Jni/Jak2⁺ (involves: 129P2/OlaHsd)	decreased erythrocyte cell number	J:207740
	hematopoietic system phenotype	J:207740
	thrombocytosis	J:207740
Jak2^tm1Jni/Jak2^tm1Jni (involves: 129P2/OlaHsd)	abnormal erythropoiesis	J:47299
	abnormal megakaryocyte differentiation	J:47299
	anemia	J:207740
	extramedullary hematopoiesis	J:47299
Jak2^tm1Kf/Jak2⁺ (involves: 129S1/Sv * 129X1/SvJ)	hematopoietic system phenotype	J:112700
Jak2^tm1Kf/Jak2^tm1Kf (involves: 129S1/Sv * 129X1/SvJ)	abnormal erythropoiesis	J:112700
Jak2^tm1Kpf/Jak2^tm1Kpf (either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * CD-1))	absent common myeloid progenitor cells	J:47298
	anemia	J:47298
	impaired hematopoiesis	J:47298
Jak2^tm1Mohi/Jak2⁺ Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	abnormal bone marrow cell morphology/development	J:183821
	abnormal common myeloid progenitor cell morphology	J:183821
	abnormal spleen red pulp morphology	J:183821
	abnormal spleen white pulp morphology	J:183821
	decreased B cell number	J:183821
	enlarged spleen	J:183821
	increased erythrocyte cell number	J:183821
	increased erythroid progenitor cell number	J:183821
	increased hematocrit	J:183821
	increased hematopoietic stem cell number	J:183821
	increased hemoglobin content	J:183821
	increased leukocyte cell number	J:183821
	increased megakaryocyte cell number	J:183821
	increased neutrophil cell number	J:183821
	increased spleen red pulp amount	J:183821
	increased spleen weight	J:183821
	microcytosis	J:183821
	myeloid hyperplasia	J:183821
	polycythemia	J:183821
	reticulocytosis	J:183821
	spleen fibrosis	J:183821
	thrombocytosis	J:183821
Jak2^tm1Mohi/Jak2^tm1Mohi Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	abnormal bone marrow cell morphology/development	J:183821
	abnormal common myeloid progenitor cell morphology	J:183821
	abnormal spleen red pulp morphology	J:183821
	abnormal spleen white pulp morphology	J:183821
	decreased B cell number	J:183821
	decreased bone marrow cell number	J:183821
	decreased spleen white pulp amount	J:183821
	enlarged spleen	J:183821
	increased erythrocyte cell number	J:183821
	increased erythroid progenitor cell number	J:183821
	increased hematocrit	J:183821
	increased hematopoietic stem cell number	J:183821
	increased hemoglobin content	J:183821
	increased leukocyte cell number	J:183821
	increased megakaryocyte cell number	J:183821
	increased neutrophil cell number	J:183821
	increased spleen red pulp amount	J:183821
	increased spleen weight	J:183821
	microcytosis	J:183821
	myeloid hyperplasia	J:183821
	polycythemia	J:183821
	reticulocytosis	J:183821
	spleen fibrosis	J:183821
	thrombocytosis	J:183821
Jak2^tm2.1Jlvl/Jak2⁺ Tg(Vav1-cre)#Cgp/0 (involves: 129S2/SvPas * C57BL/6NTac)	abnormal bone marrow cell physiology	J:202234
	abnormal definitive hematopoiesis	J:202234
	abnormal myelopoiesis	J:202234
	decreased B cell number	J:202234
	decreased bone marrow cell number	J:202234
	decreased erythroblast number	J:202234
	enlarged spleen	J:202234
	extramedullary hematopoiesis	J:202234
	increased erythrocyte cell number	J:202234
	increased erythroid progenitor cell number	J:202234
	increased granulocyte number	J:202234
	increased hematocrit	J:202234
	increased hematopoietic stem cell number	J:202234
	increased hemoglobin content	J:202234
	increased leukocyte cell number	J:202234
	increased spleen weight	J:202234
	microcytosis	J:202234
	myeloid hyperplasia	J:202234
	reticulocytosis	J:202234
	spleen fibrosis	J:202234
	thrombocytosis	J:202234
Jak2^tm2.1Kpf/Jak2^tm2.1Kpf (involves: 129P2/OlaHsd)	abnormal embryonic erythropoiesis	J:207710
Jak2^tm2.2Jlvl/Jak2⁺ (involves: 129S2/SvPas * C57BL/6 * C57BL/6NTac * SJL)	enlarged spleen	J:202234
	increased leukocyte cell number	J:202234
	polycythemia	J:202234
	thrombocytosis	J:202234
Jak3^bfy/Jak3^bfy (C57BL/6JSfdAnu-Jak3^bfy/AnuApb)	abnormal lymphopoiesis	J:104190
	abnormal T cell subpopulation ratio	J:104190
	decreased B cell number	J:104190
	decreased lymphocyte cell number	J:104190
	decreased T cell number	J:104190
	decreased thymocyte number	J:104190
	small thymus	J:104190
Jak3^em1(IMPC)Mbp/Jak3⁺ (C57BL/6N-Jak3^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Jak3^m1Btlr/Jak3^m1Btlr (C57BL/6J-Jak3^m1Btlr)	abnormal T cell subpopulation ratio	J:217795
	decreased IgG level	J:217795
	decreased NK cell number	J:217795
	decreased single-positive T cell number	J:217795
	decreased T cell number	J:217795
	increased effector memory CD4-positive, alpha-beta T cell number	J:217795
	increased effector memory CD8-positive, alpha-beta T cell number	J:217795
	increased IgE level	J:217795
	increased neutrophil cell number	J:217795
	increased single-positive T cell number	J:217795
Jak3^m1J/Jak3^m1J (B6.Cg-Crb1⁺ Jak3^m1J/Boc)	decreased spleen weight	J:265859
	decreased thymus weight	J:265859
	small spleen	J:265859
	small thymus	J:265859
Jak3^M1Pgrs/Jak3^M1Pgrs (involves: C57BL/6J * C57BL/10J)	absent B cells	J:185217
	decreased B cell number	J:185217
	decreased hematopoietic stem cell number	J:185217
	decreased NK cell number	J:185217
	enlarged spleen	J:185217
	increased CD4-positive, alpha-beta T cell number	J:185217
	increased CD8-positive, alpha-beta T cell number	J:185217
	small thymus	J:185217
Jak3^m2Btlr/Jak3^m2Btlr (C57BL/6J-Jak3^m2Btlr)	increased B cell number	J:217796
Jak3^m2Btlr/Jak3^m2Btlr (C57BL/6J-Jak3^m2Btlr)	increased memory B cell number	J:217796
Jak3^m3Btlr/Jak3^m3Btlr (C57BL/6J-Jak3^m3Btlr)	abnormal T cell subpopulation ratio	J:225935
	decreased B cell number	J:225935
	decreased B-1 B cell number	J:225935
	decreased IgG level	J:225935
	decreased immature B cell number	J:225935
	decreased mature B cell number	J:225935
	decreased memory B cell number	J:225935
	decreased NK cell number	J:225935
	decreased single-positive T cell number	J:225935
	decreased T cell number	J:225935
	impaired hematopoiesis	J:225935
	increased effector memory CD8-positive, alpha-beta T cell number	J:225935
	increased macrophage cell number	J:225935
	increased myeloid dendritic cell number	J:225935
Jak3^m4Btlr/Jak3^m4Btlr (C57BL/6J-Jak3^m4Btlr)	increased CD4-positive, alpha-beta T cell number	J:272398
Jak3^M5Btlr/Jak3^M5Btlr (C57BL/6J-Jak3^M5Btlr)	decreased NK T cell number	J:272399
Jak3^m6Btlr/Jak3^m6Btlr (C57BL/6J-Jak3^m6Btlr)	decreased CD8-positive, alpha-beta T cell number	J:272400
	decreased IgG level	J:272400
	increased CD4-positive, alpha-beta T cell number	J:272400
Jak3^M7Btlr/Jak3^M7Btlr (C57BL/6J-Jak3^M7Btlr)	abnormal CD4-positive T cell differentiation	J:272401
Jak3^m8Btlr/Jak3^m8Btlr (C57BL/6J-Jak3^m8Btlr)	decreased B cell number	J:274939
	decreased B-1 B cell number	J:274939
	decreased B-2 B cell number	J:274939
	decreased CD4-positive, alpha-beta T cell number	J:274939
	decreased CD8-positive, alpha-beta T cell number	J:274939
	decreased CD8-positive, naive alpha-beta T cell number	J:274939
	decreased dendritic cell number	J:274939
	decreased IgG level	J:274939
	decreased IgM level	J:274939
	decreased T cell number	J:274939
	increased B-1b cell number	J:274939
	increased effector memory CD4-positive, alpha-beta T cell number	J:274939
Jak3^tm1Flv/Jak3^tm1Flv (involves: 129S1/Sv)	abnormal T cell proliferation	J:95794
	arrested B cell differentiation	J:95794
	decreased CD8-positive, alpha-beta T cell number	J:95794
	enlarged spleen	J:95794
	increased CD4-positive, alpha-beta T cell number	J:95794
	thymus hypoplasia	J:95794
Jak3^tm1Jni/Jak3^tm1Jni Crlf2^tm1Jni/Crlf2^tm1Jni (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell differentiation	J:89031
	decreased B cell number	J:89031
Jak3^tm1Ljb/Jak3⁺ (involves: 129S4/SvJae)	abnormal leukocyte morphology	J:56629
	decreased lymphocyte cell number	J:56629
	increased leukocyte cell number	J:56629
	increased monocyte cell number	J:56629
	increased neutrophil cell number	J:56629
Jak3^tm1Ljb/Jak3^tm1Ljb (involves: 129S4/SvJae * C57BL/6)	abnormal B cell morphology	J:29722
	abnormal leukocyte physiology	J:90510
	abnormal lymphocyte physiology	J:90510
	abnormal splenic cell ratio	J:29722
	abnormal T cell activation	J:29722
	arrested B cell differentiation	J:29722
	decreased IgG level	J:29722
	decreased immature B cell number	J:29722
	decreased mature B cell number	J:29722
	decreased T cell proliferation	J:29722
	small thymus	J:29722
	spleen hypoplasia	J:29722
	thymus hypoplasia	J:29722
Jak3^tm1Ljb/Jak3^tm1Ljb (involves: 129S4/SvJae)	abnormal erythropoiesis	J:56629
	abnormal leukocyte morphology	J:56629
	abnormal myelopoiesis	J:56629
	abnormal spleen morphology	J:56629
	abnormal spleen white pulp morphology	J:56629
	abnormal T cell activation	J:128694, J:56629
	abnormal T cell differentiation	J:64861
	abnormal T cell physiology	J:128694
	abnormal thymus cell ratio	J:128694
	absent B cells	J:128694
	decreased lymphocyte cell number	J:56629
	decreased T cell proliferation	J:128694
	decreased thymocyte number	J:64861
	enlarged spleen	J:56629
	increased leukocyte cell number	J:56629
	increased monocyte cell number	J:56629
	increased neutrophil cell number	J:56629
	thymus hypoplasia	J:128694
Jak3^tm1Ljb/Jak3^tm1Ljb (B6;129S4-Jak3^tm1Ljb/J)	abnormal dendritic cell differentiation	J:123902
	abnormal dendritic cell morphology	J:123902
	abnormal splenic cell ratio	J:123902
	decreased CD4-positive, alpha-beta T cell number	J:123902
	decreased CD8-positive, alpha-beta T cell number	J:123902
	decreased myeloid dendritic cell number	J:123902
Jak3^tm1Ljb/Jak3^tm1Ljb Rag1^tm1Mom/Rag1^tm1Mom (involves: 129S4/SvJae * 129S7/SvEvBrd)	abnormal splenic cell ratio	J:56629
Jak3^tm1Ljb/Jak3^tm1Ljb Tg(Lck-Jak3)1Ljb/0 (involves: 129S4/SvJae * C3H * C57BL/6 * C57BL/10)	absent B cells	J:128694
	decreased T cell proliferation	J:128694
Jak3^tm1Ljb/Jak3^tm1Ljb Tg(Lck-Jak3)2Ljb/0 (involves: 129S4/SvJae * C3H * C57BL/6)	abnormal T cell activation	J:56629
	enlarged spleen	J:56629
	increased leukocyte cell number	J:56629
Jak3^tm1Ljb/Jak3^tm1Ljb Tg(Lck-Jak3)2Ljb/0 (involves: 129S4/SvJae * C3H * C57BL/6 * C57BL/10)	abnormal T cell activation	J:128694
	abnormal T cell physiology	J:128694
	absent B cells	J:128694
	decreased T cell proliferation	J:128694
Jak3^tm1Tks/Jak3⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal leukocyte physiology	J:31231
Jak3^tm1Tks/Jak3^tm1Tks (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell differentiation	J:31231
	abnormal CD4-positive, alpha beta T cell morphology	J:31231
	abnormal lymphopoiesis	J:31231
	abnormal spleen periarteriolar lymphoid sheath morphology	J:31231
	abnormal spleen white pulp morphology	J:31231
	abnormal T cell morphology	J:31231
	abnormal T cell number	J:31231
	abnormal T cell physiology	J:31231
	abnormal thymus cortex morphology	J:31231
	abnormal thymus corticomedullary boundary morphology	J:31231
	abnormal thymus medulla morphology	J:31231
	absent Hassall's corpuscle	J:31231
	absent NK cells	J:31231
	decreased B cell number	J:31231
	decreased pre-B cell number	J:31231
	decreased thymocyte number	J:31231
	small spleen	J:31231
	small thymus medulla	J:31231
	spleen hypoplasia	J:31231
	thymus cortex hypoplasia	J:31231
	thymus hypoplasia	J:31231
Jak3^wil/Jak3^wil (C57BL/6JSfdAnu-Jak3^wil/Anu)	arrested B cell differentiation	J:104190
	decreased CD8-positive, alpha-beta T cell number	J:104190
	decreased leukocyte cell number	J:104190
Jak3^X887Y/Jak3^X887Y (Not Specified)	abnormal hematopoietic system morphology/development	J:112658
	abnormal lymphocyte morphology	J:112658
	abnormal spleen morphology	J:112658
	abnormal thymus morphology	J:112658
Jakmip2^em1(IMPC)J/Jakmip2^em1(IMPC)J (C57BL/6NJ-Jakmip2^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Jam2^tm1.2Rha/Jam2^tm1.2Rha (B6.Cg-Jam2^tm1.2Rha)	abnormal bone marrow cell morphology/development	J:178387
	abnormal hematopoietic stem cell morphology	J:178387
	abnormal hematopoietic stem cell physiology	J:178387
	increased bone marrow cell number	J:178387
Jam3^tm1Lex/Jam3^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	decreased neutrophil cell number	J:145994
	increased bone marrow cell number	J:145994
	increased common myeloid progenitor cell number	J:145994
	increased erythroid progenitor cell number	J:145994
	increased granulocyte number	J:145994
Jam3^tm1Rha/Jam3^tm1Rha (involves: 129P2/OlaHsd * C57BL/6)	increased granulocyte number	J:121841
Jarid2^jumonji/Jarid2^jumonji (C.129P2-Jarid2^jumonji)	abnormal definitive hematopoiesis	J:51843
	abnormal erythropoiesis	J:51843
	abnormal megakaryocyte progenitor cell morphology	J:68443
	abnormal splenic cell ratio	J:42772
	abnormal thymus cell ratio	J:42772
	anemia	J:51843
	decreased fetal derived definitive erythrocyte cell number	J:51843
	spleen hypoplasia	J:42772
	thymus hypoplasia	J:42772
Jarid2^jumonji/Jarid2^jumonji (either: B6.129P2-Jarid2^jumonji or D2.129P2-Jarid2^jumonji)	spleen hypoplasia	J:42772
	thymus hypoplasia	J:42772
Jchain^Mat1/? Miju^C3HeB/FeJ/Miju^C57BL/6J (involves: C3HeB/FeJ * C57BL/6J)	increased IgA level	J:91062
Jchain^tm1Jse/Jchain^tm1Jse (involves: 129X1/SvJ)	abnormal B cell physiology	J:75843
Jchain^tm1Jse/Jchain^tm1Jse (involves: 129X1/SvJ)	increased IgA level	J:34042, J:75843
Jchain^tm1Tl/Jchain^tm1Tl (involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)	decreased IgG level	J:71355
	decreased IgM level	J:71355
	increased IgA level	J:71355
Jchain^tm3Tl/Jchain⁺ (involves: 129P2/OlaHsd)	abnormal B cell physiology	J:56158
	decreased IgM level	J:49168, J:56158
	decreased plasma cell number	J:49168
	increased IgA level	J:56158
Jchain^tm3Tl/Jchain^tm3Tl (involves: 129P2/OlaHsd)	abnormal B cell physiology	J:56158
	decreased IgG level	J:49168
	decreased IgM level	J:49168, J:56158
	decreased plasma cell number	J:49168, J:56158
	increased IgA level	J:49168, J:56158
Jdp2^tm1Aki/Jdp2^tm1Aki (Not Specified)	abnormal neutrophil physiology	J:191061
	abnormal osteoclast differentiation	J:191061
	abnormal osteoclast morphology	J:191061
Jmjd4^{em1(IMPC)Wtsi}/Jmjd4^{em1(IMPC)Wtsi} (C57BL/6N-Jmjd4^{em1(IMPC)Wtsi}/Wtsi)	increased leukocyte cell number	J:211773
	increased mean corpuscular hemoglobin	J:211773
Jmjd6^{tm1b(EUCOMM)Wtsi}/Jmjd6⁺ (C57BL/6N-Jmjd6^{tm1b(EUCOMM)Wtsi}/Ieg)	decreased mean platelet volume	J:211773
Jmjd6^tm1Gbf/Jmjd6^tm1Gbf (C57BL/6-Ptdsr^tm1Gbf)	abnormal erythropoiesis	J:98905
	abnormal macrophage activation involved in immune response	J:98905
	small thymus	J:102098
	thymus hypoplasia	J:102098
Jph4^tm1Hta/Jph4^tm1Hta (involves: 129S4/SvJae * C57BL/6J)	abnormal T cell activation	J:230995
Jun^tm1Wag/Jun^tm1Wag (either: (involves: 129S2/SvPas) or (involves: 129S2/SvPas * C57BL/6))	increased nucleated erythrocyte cell number	J:14538
Junb^{tm1b(EUCOMM)Hmgu}/Junb⁺ (C57BL/6N-Junb^{tm1b(EUCOMM)Hmgu}/Bay)	increased spleen weight	J:211773
Junb^tm3Wag/Junb^tm3Wag Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal osteoclast morphology	J:88126
Junb^tm3Wag/Junb^tm3Wag Meox2^tm1(cre)Sor/Meox2⁺ (involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6)	abnormal osteoclast differentiation	J:88126
	decreased osteoclast cell number	J:88126
Junb^tm3Wag/Junb^tm3Wag Tg(KRT5-cre)1Tak/0 (involves: 129/Sv * 129P2/OlaHsd * C3H * C57BL/6)	increased IgE level	J:155575
	increased plasma cell number	J:155575
Jund^tm1Mya/Jund^tm1Mya (either: 129S2/SvPas or (involves: 129S2/SvPas * C57BL/6))	abnormal T-helper 2 physiology	J:89085
	increased T cell proliferation	J:89085
Jup^{tm1.1(KOMP)Vlcg}/Jup⁺ (C57BL/6N-Jup^{tm1.1(KOMP)Vlcg}/J)	increased hemoglobin content	J:211773
Kash5^em1(IMPC)J/Kash5^em1(IMPC)J (C57BL/6NJ-Kash5^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Kat2b^{em1(IMPC)Wtsi}/Kat2b^{em1(IMPC)Wtsi} (C57BL/6N-Kat2b^{em1(IMPC)Wtsi}/WtsiIeg)	decreased mean corpuscular hemoglobin	J:211773
	increased red blood cell distribution width	J:211773
Kat5^tm1Jwl/Kat5⁺ Tg(IghMyc)22Bri/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL * C57BL/6 * SJL)	abnormal B cell physiology	J:125164
Kat6a^tm1.1Glac/Kat6a⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal hematopoietic stem cell morphology	J:148955
	decreased erythroid progenitor cell number	J:148955
	decreased hematopoietic stem cell number	J:148955
Kat6a^tm1.1Glac/Kat6a^tm1.1Glac (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell differentiation	J:148955
	abnormal hematopoietic stem cell morphology	J:148955
	decreased common myeloid progenitor cell number	J:148955
	decreased hematopoietic stem cell number	J:148955
	decreased immature B cell number	J:148955
	decreased pre-B cell number	J:148955
	decreased pro-B cell number	J:148955
	decreased spleen weight	J:148955
	decreased thymus weight	J:148955
	spleen hypoplasia	J:148955
	thymus hypoplasia	J:148955
Kat6a^tm1Avo/Kat6a⁺ (involves: 129 * BALB/c * FVB/N)	abnormal definitive hematopoiesis	J:108453
Kat6a^tm1Avo/Kat6a⁺ (involves: 129 * BALB/c * FVB/N)	small thymus	J:188772
Kat6a^tm1Avo/Kat6a^tm1Avo (involves: 129/Sv * BALB/c * FVB/N)	abnormal erythropoiesis	J:108453
	abnormal hematopoietic stem cell morphology	J:188772
	abnormal thymus development	J:108453
	absent spleen	J:108453
	athymia	J:188772
	decreased bone marrow cell number	J:108453
	decreased double-negative T cell number	J:108453
	decreased hematopoietic stem cell number	J:108453
	increased nucleated erythrocyte cell number	J:108453
	small thymus	J:108453, J:188772
	thymus hypoplasia	J:108453
Kat6a^tm1Iki/Kat6a^tm1Iki (Not Specified)	abnormal erythropoiesis	J:108699
	abnormal myelopoiesis	J:108699
	absent common myeloid progenitor cells	J:108699
	decreased B cell number	J:108699
	decreased hematopoietic stem cell number	J:108699
Kat6a^tm2.2Avo/Kat6a⁺ Tbx1^tm1Bld/Tbx1⁺ (involves: 129S7/SvEvBrd * C57BL/6)	small thymus	J:188772
Kat6a^tm2.2Avo/Kat6a^tm2.2Avo (involves: BALB/c * FVB)	abnormal hematopoietic stem cell morphology	J:188772
Kat14^{tm1a(KOMP)Wtsi}/Kat14^{tm1a(KOMP)Wtsi} (B6JTyr;B6N-Kat14^{tm1a(KOMP)Wtsi}/Wtsi)	decreased hemoglobin content	J:165965
Katnal1^em1(IMPC)Tcp/Katnal1⁺ (C57BL/6NCrl-Katnal1^em1(IMPC)Tcp/Tcp)	decreased mean corpuscular volume	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
Katnal1^em1(IMPC)Tcp/Katnal1^em1(IMPC)Tcp (C57BL/6NCrl-Katnal1^em1(IMPC)Tcp/Tcp)	abnormal spleen morphology	J:211773
Katnal2^em1(IMPC)Tcp/Katnal2^em1(IMPC)Tcp (C57BL/6N-Katnal2^em1(IMPC)Tcp/Tcp)	enlarged spleen	J:211773
	increased monocyte cell number	J:211773
	small spleen	J:211773
Katnb1^{tm1a(EUCOMM)Hmgu}/Katnb1^{tm1a(EUCOMM)Hmgu} (C57BL/6-Katnb1^{tm1a(EUCOMM)Hmgu})	abnormal erythropoiesis	J:220901
Kbtbd3^{em1(IMPC)Ccpcz}/Kbtbd3^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Kbtbd3^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
	increased neutrophil cell number	J:211773
Kbtbd8^em1(IMPC)Tcp/Kbtbd8^em1(IMPC)Tcp (C57BL/6N-Kbtbd8^em1(IMPC)Tcp/Tcp)	decreased mean corpuscular hemoglobin	J:211773
Kbtbd11^{em1(IMPC)Wtsi}/Kbtbd11^{em1(IMPC)Wtsi} (C57BL/6N-Kbtbd11^{em1(IMPC)Wtsi}/Wtsi)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Kcna2^em1(IMPC)H/Kcna2⁺ (C57BL/6NTac-Kcna2^em1(IMPC)H/H)	increased neutrophil cell number	J:211773
Kcna5^tm1Hket/Kcna5^tm1Hket (involves: 129S6/SvEvTac * 129S7/SvEvBrd)	abnormal microglial cell morphology	J:116545
Kcna10^em3(IMPC)Mbp/Kcna10⁺ (C57BL/6N-Kcna10^em3(IMPC)Mbp/Ucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Kcnb1^{tm1b(EUCOMM)Hmgu}/Kcnb1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Kcnb1^{tm1b(EUCOMM)Hmgu}/H)	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
Kcnb2^em1(IMPC)J/Kcnb2^em1(IMPC)J (C57BL/6NJ-Kcnb2^em1(IMPC)J/J)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
Kcnc1^em4(IMPC)H/Kcnc1^em4(IMPC)H (C57BL/6NTac-Kcnc1^em4(IMPC)H/H)	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
	increased neutrophil cell number	J:211773
Kcne1^{tm1b(EUCOMM)Hmgu}/Kcne1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Kcne1^{tm1b(EUCOMM)Hmgu}/Ics)	decreased lymphocyte cell number	J:211773
	increased mean corpuscular volume	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Kcne1^tm1Sfh/Kcne1^tm1Sfh (involves: 129S1/Sv)	increased hematocrit	J:77288
Kcne2^{tm1a(EUCOMM)Wtsi}/Kcne2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Kcne2^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased erythrocyte cell number	J:175295
Kcne2^{tm1a(EUCOMM)Wtsi}/Kcne2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Kcne2^{tm1a(EUCOMM)Wtsi})	anemia	J:230226
	decreased erythrocyte cell number	J:230226
	decreased hematocrit	J:230226
	decreased hemoglobin content	J:230226
	decreased mean corpuscular hemoglobin	J:230226
	decreased mean corpuscular volume	J:230226
	decreased spleen iron level	J:230226
	hematopoietic system phenotype	J:230226
	hypochromic microcytic anemia	J:230226
	increased red blood cell distribution width	J:230226
	thrombocytosis	J:230226
Kcng3^em1(IMPC)Mbp/Kcng3^em1(IMPC)Mbp (C57BL/6NCrl-Kcng3^em1(IMPC)Mbp/MbpMmucd)	increased monocyte cell number	J:211773
Kcnh3^{tm1.1(KOMP)Vlcg}/Kcnh3^{tm1.1(KOMP)Vlcg} (C57BL/6N-Kcnh3^{tm1.1(KOMP)Vlcg}/J)	increased hemoglobin content	J:211773
Kcnh8^em1(IMPC)Mbp/Kcnh8^em1(IMPC)Mbp (C57BL/6N-Kcnh8^em1(IMPC)Mbp/Ucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Kcnip1^em1(IMPC)H/Kcnip1^em1(IMPC)H (C57BL/6N-Kcnip1^em1(IMPC)H/H)	increased eosinophil cell number	J:211773
Kcnip4^{tm1a(KOMP)Wtsi}/Kcnip4^{tm1a(KOMP)Wtsi} (C57BL/6N-Kcnip4^{tm1a(KOMP)Wtsi}/Wtsi)	thrombocytopenia	J:211773
Kcnj1^tm1Ges/Kcnj1^tm1Ges (involves: 129X1/SvJ * Black Swiss)	increased hematocrit	J:79354
Kcnj9^{tm1b(EUCOMM)Hmgu}/Kcnj9^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Kcnj9^{tm1b(EUCOMM)Hmgu}/H)	increased basophil cell number	J:211773
	increased neutrophil cell number	J:211773
Kcnj10^{tm1b(KOMP)Wtsi}/Kcnj10⁺ (C57BL/6N-Kcnj10^{tm1b(KOMP)Wtsi}/H)	decreased basophil cell number	J:211773
	decreased mean platelet volume	J:211773
Kcnj11^{tm1b(EUCOMM)Wtsi}/Kcnj11^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Kcnj11^{tm1b(EUCOMM)Wtsi}/H)	decreased hemoglobin content	J:211773
Kcnk13^em1(IMPC)H/Kcnk13^em1(IMPC)H (involves: C57BL/6NTac)	abnormal microglial cell morphology	J:256020
Kcnk13^em1(IMPC)H/Kcnk13^em1(IMPC)H (involves: C57BL/6NTac)	abnormal microglial cell physiology	J:256020
Kcnk13^em1(IMPC)H/Kcnk13^em1(IMPC)H (C57BL/6N-Kcnk13^em1(IMPC)H/H)	increased basophil cell number	J:211773
	increased mean corpuscular volume	J:211773
	increased monocyte cell number	J:211773
	increased red blood cell distribution width	J:211773
Kcnma1^em1(IMPC)H/Kcnma1^em1(IMPC)H (C57BL/6N-Kcnma1^em1(IMPC)H/H)	decreased spleen weight	J:211773
Kcnn1^{tm1b(KOMP)Wtsi}/Kcnn1^{tm1b(KOMP)Wtsi} (C57BL/6N-Kcnn1^{tm1b(KOMP)Wtsi}/H)	increased red blood cell distribution width	J:211773
Kcnn4^{em1(IMPC)Ccpcz}/Kcnn4^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Kcnn4^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	decreased erythrocyte cell number	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
	increased red blood cell distribution width	J:211773
	increased spleen weight	J:211773
	small thymus	J:211773
Kcnn4^tm1Jemn/Kcnn4^tm1Jemn (involves: 129S1/Sv * C57BL/6J)	abnormal hematopoietic system physiology	J:94478
Kcnn4^tm1Jemn/Kcnn4^tm1Jemn (involves: 129S1/Sv * C57BL/6J)	abnormal T cell physiology	J:94478
Kcnn4^tm1Rklr/Kcnn4^tm1Rklr (involves: 129S/SvEv * C57BL/6)	abnormal red blood cell deformability	J:148910
	enlarged spleen	J:148910
	increased erythrocyte osmotic fragility	J:148910
	increased hematocrit	J:148910
	increased hemoglobin concentration distribution width	J:148910
	increased mean corpuscular volume	J:148910
	increased spleen iron level	J:148910
	increased spleen weight	J:148910
	macrocytosis	J:148910
Kcnt1^em1(IMPC)Mbp/Kcnt1^em1(IMPC)Mbp (C57BL/6N-Kcnt1^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	small spleen	J:211773
Kcnt2^em1(IMPC)Mbp/Kcnt2^em1(IMPC)Mbp (C57BL/6N-Kcnt2^em1(IMPC)Mbp/MbpMmucd)	small spleen	J:211773
Kctd1^em1(IMPC)J/Kctd1^em1(IMPC)J (C57BL/6NJ-Kctd1^em1(IMPC)J/Mmjax)	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
	increased leukocyte cell number	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
	thrombocytopenia	J:211773
Kctd1^Mhdahst014/Kctd1⁺ (C3HeB/FeJ-Kctd1^Mhdahst014)	anemia	J:250423
	decreased erythrocyte cell number	J:250423
	decreased hematocrit	J:250423
	decreased hemoglobin content	J:250423
	decreased mean corpuscular hemoglobin	J:250423
	decreased mean corpuscular volume	J:250423
Kctd2^{em1(IMPC)Hmgu}/Kctd2^{em1(IMPC)Hmgu} (C57BL/6NCrl-Kctd2^{em1(IMPC)Hmgu}/Ieg)	thrombocytopenia	J:211773
Kctd3^em1(IMPC)Tcp/Kctd3⁺ (C57BL/6N-Kctd3^em1(IMPC)Tcp/Tcp)	decreased mean corpuscular hemoglobin	J:211773
Kctd9^em1(IMPC)J/Kctd9^em1(IMPC)J (C57BL/6NJ-Kctd9^em1(IMPC)J/J)	decreased erythrocyte cell number	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
Kctd9^em1Beij/Kctd9^em1Beij (BALB/c-Kctd9^em1Beij)	abnormal immature NK cell morphology	J:281803
	abnormal NK cell differentiation	J:281803
	abnormal NK cell physiology	J:281803
	decreased mature NK cell number	J:281803
	impaired natural killer cell mediated cytotoxicity	J:281803
	increased immature NK cell number	J:281803
	increased NK cell number	J:281803
Kctd11^em1(IMPC)J/Kctd11^em1(IMPC)J (C57BL/6NJ-Kctd11^em1(IMPC)J/Mmjax)	increased erythrocyte cell number	J:211773
	increased hemoglobin content	J:211773
Kdelr1^em1Btlr/Kdelr1^em1Btlr (involves: C57BL/6J * C57BL/6JJcl)	decreased lymphocyte cell number	J:224970
Kdelr1^em1Btlr/Kdelr1^em1Btlr Tg(Gt(ROSA)26Sor-Kdelr1)#Btlr/0 (C57BL/6J-Kdelr1^em1Btlr Tg(Gt(ROSA)26Sor-Kdelr1)#Btlr)	abnormal lymphocyte morphology	J:224970
Kdelr1^m1Btlr/Kdelr1^m1Btlr (C57BL/6J-Kdelr1^m1Btlr)	abnormal lymphocyte morphology	J:224970
	abnormal T cell differentiation	J:224970
	absent NK T cells	J:224970
	decreased B cell number	J:224970
	decreased CD4-positive, alpha-beta T cell number	J:224970, J:158794
	decreased CD8-positive, alpha-beta T cell number	J:224970, J:158794
	decreased follicular B cell number	J:224970
	decreased lymphocyte cell number	J:224970
	decreased transitional stage T1 B cell number	J:224970
	decreased transitional stage T2 B cell number	J:224970
	increased marginal zone B cell number	J:224970
	thymus hypoplasia	J:158794
Kdm1a^{tm1(NCOM)Mfgc}/Kdm1a⁺ (C57BL/6N-Kdm1a^{tm1(NCOM)Mfgc}/Nju)	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
	increased mean platelet volume	J:211773
	small spleen	J:211773
Kdm1a^tm1.1Sho/Kdm1a^tm1.1Sho Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: 129 * C57BL/6 * C57BL/10 * CBA/Ca)	abnormal definitive hematopoiesis	J:201572
	decreased bone marrow cell number	J:201572
	decreased common myeloid progenitor cell number	J:201572
	decreased erythrocyte cell number	J:201572
	decreased hematopoietic stem cell number	J:201572
	decreased leukocyte cell number	J:201572
	thrombocytopenia	J:201572
Kdm1a^tm1.1Sho/Kdm1a^tm1.1Sho Epor^{tm1.1(EGFP/icre)Uk}/Epor⁺ (involves: 129 * BALB/cJ)	abnormal erythropoiesis	J:201572
	abnormal proerythroblast morphology	J:201572
	decreased fetal derived definitive erythrocyte cell number	J:201572
	reticulocytopenia	J:201572
Kdm1a^tm1.1Sho/Kdm1a^tm1.1Sho Tg(Mx1-cre)1Cgn/? (involves: 129 * C57BL/6 * CBA/Ca)	abnormal common myeloid progenitor cell morphology	J:201572
	abnormal definitive hematopoiesis	J:201572
	decreased common myeloid progenitor cell number	J:201572
	decreased granulocyte number	J:201572
	decreased hematopoietic stem cell number	J:201572
	decreased neutrophil cell number	J:201572
	increased hematopoietic stem cell number	J:201572
	pancytopenia	J:201572
Kdm3a^em1(IMPC)Mbp/Kdm3a^em1(IMPC)Mbp (C57BL/6N-Kdm3a^em1(IMPC)Mbp/MbpMmucd)	small spleen	J:211773
Kdm3b^em1(IMPC)Tcp/Kdm3b⁺ (C57BL/6NCrl-Kdm3b^em1(IMPC)Tcp/Tcp)	increased mean corpuscular volume	J:211773
Kdm4c^{tm1a(KOMP)Wtsi}/Kdm4c⁺ (C57BL/6N-Kdm4c^{tm1a(KOMP)Wtsi}/Wtsi)	increased B cell number	J:165965
Kdm5a^tm1.1Kael/Kdm5a^tm1.1Kael (involves: 129S6/SvEvTac * C57BL/6 * FVB/N * SJL)	abnormal definitive hematopoiesis	J:137185
	abnormal hematopoietic stem cell morphology	J:137185
	increased neutrophil cell number	J:137185
Kdm6a^tm1.1Afst/Y Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/6NTac)	hematopoietic system phenotype	J:196401
Kdm6a^tm1.1Afst/Kdm6a^tm1.1Afst Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/6NTac)	abnormal bone marrow cell morphology/development	J:196401
	abnormal erythropoiesis	J:196401
	abnormal granulocyte morphology	J:196401
	abnormal hematopoietic stem cell physiology	J:196401
	abnormal megakaryocyte morphology	J:196401
	anemia	J:196401
	decreased common myeloid progenitor cell number	J:196401
	decreased erythrocyte cell number	J:196401
	decreased erythroid progenitor cell number	J:196401
	decreased hemoglobin content	J:196401
	decreased leukocyte cell number	J:196401
	decreased mean corpuscular volume	J:196401
	enlarged spleen	J:196401
	extramedullary hematopoiesis	J:196401
	increased B cell number	J:196401
	increased spleen weight	J:196401
	thrombocytopenia	J:196401
Kdm6a^tm1.2Kaig/Kdm6a^tm1.2Kaig (involves: 129S4/SvJaeSor * C57BL/6 * FVB/N)	anemia	J:190157
Kdm6a^tm1Cdcn/Y Tg(CAG-cre/Esr1)5Amc/0 (involves: C57BL/6J CBA)	abnormal hematopoietic stem cell physiology	J:263565
	decreased erythrocyte cell number	J:263565
	decreased erythroid progenitor cell number	J:263565
	decreased megakaryocyte-erythroid progenitor cell number	J:263565
	enlarged spleen	J:263565
	extramedullary hematopoiesis	J:263565
	increased granulocyte monocyte progenitor cell number	J:263565
	increased granulocyte number	J:263565
	increased hematopoietic stem cell number	J:263565
	increased monocyte cell number	J:263565
	increased myeloid cell number	J:263565
	increased neutrophil cell number	J:263565
	increased nucleated erythrocyte cell number	J:263565
	thrombocytopenia	J:263565
Kdm6a^tm1Cdcn/Y Tg(CAG-cre/Esr1)5Amc/0 Trp53^tm1Tyj/Trp53^tm1Tyj (involves: 129S2/SvPas C57BL/6J * CBA * FVB/N)	anemia	J:263565
	decreased erythrocyte cell number	J:263565
	enlarged spleen	J:263565
	increased granulocyte monocyte progenitor cell number	J:263565
	increased hematopoietic stem cell number	J:263565
	increased monocyte cell number	J:263565
	increased myeloid cell number	J:263565
	increased neutrophil cell number	J:263565
	thrombocytopenia	J:263565
Kdm6a^tm1Cdcn/Kdm6a^tm1Cdcn Tg(CAG-cre/Esr1)5Amc/0 (involves: C57BL/6J CBA)	abnormal hematopoietic stem cell physiology	J:263565
	decreased erythrocyte cell number	J:263565
	decreased erythroid progenitor cell number	J:263565
	decreased megakaryocyte-erythroid progenitor cell number	J:263565
	enlarged spleen	J:263565
	extramedullary hematopoiesis	J:263565
	increased granulocyte monocyte progenitor cell number	J:263565
	increased granulocyte number	J:263565
	increased hematopoietic stem cell number	J:263565
	increased monocyte cell number	J:263565
	increased myeloid cell number	J:263565
	increased neutrophil cell number	J:263565
	increased nucleated erythrocyte cell number	J:263565
	thrombocytopenia	J:263565
Kdm6b^tm1Aki/Kdm6b^tm1Aki (involves: 129X1/SvJ * C57BL/6)	impaired eosinophil recruitment	J:164690
Kdm8^{tm1a(EUCOMM)Wtsi}/Kdm8⁺ (C57BL/6N-Kdm8^{tm1a(EUCOMM)Wtsi}/Ics)	increased B cell number	J:165965
Kdr^tm1.1Msh/Kdr^tm1.1Msh (involves: 129P2/OlaHsd * C57BL/6J)	impaired hematopoiesis	J:96124
Kdr^tm1Jrt/Kdr^tm1Jrt (involves: 129S1/Sv * 129X1/SvJ)	abnormal definitive hematopoiesis	J:26846
Kdr^tm1Jrt/Kdr^tm1Jrt (B6.129-Kdr^tm1Jrt/J)	impaired hematopoiesis	J:96124
Keg1^{tm1b(KOMP)Mbp}/Keg1^{tm1b(KOMP)Mbp} (C57BL/6N-Keg1^{tm1b(KOMP)Mbp}/J)	increased erythrocyte cell number	J:211773
	increased hemoglobin content	J:211773
Kel^tm1Slee/Kel^tm1Slee (B6.129X1-Kel^tm1Slee)	abnormal cellular hemoglobin content	J:212529
	decreased erythrocyte magnesium level	J:212528
	decreased erythrocyte potassium level	J:212528
	decreased mean corpuscular hemoglobin concentration	J:212528
	increased hemoglobin concentration distribution width	J:212528, J:212529
	increased mean corpuscular hemoglobin	J:212529
	increased mean corpuscular hemoglobin concentration	J:212529
	increased mean corpuscular volume	J:212528, J:212529
	reticulocytosis	J:212528
Kel^tm1Slee/Kel^tm1Slee Xk^tm1Ariv/Y (B6.Cg-Kel^tm1Slee Xk^tm1Ariv)	abnormal erythrocyte ion content	J:212528
	abnormal reticulocyte cell number	J:212528
	decreased mean corpuscular hemoglobin concentration	J:212528
	increased erythrocyte sodium level	J:212528
	increased mean corpuscular volume	J:212528
Kera^tm1Cyl/Kera^tm1Cyl (involves: 129S6/SvEvTac)	decreased neutrophil cell number	J:128992
Khsrp^em1(IMPC)Mbp/Khsrp^em1(IMPC)Mbp (C57BL/6NCrl-Khsrp^em1(IMPC)Mbp/MbpMmucd)	increased red blood cell distribution width	J:211773
Kif1b^{tm1b(KOMP)Wtsi}/Kif1b⁺ (C57BL/6N-Kif1b^{tm1b(KOMP)Wtsi}/J)	increased mean corpuscular hemoglobin concentration	J:211773
Kif5c^tm1dIcs/Kif5c⁺ (C57BL/6N-Kif5c^tm1dIcs/Ics)	decreased lymphocyte cell number	J:211773
Kif5c^tm1dIcs/Kif5c⁺ (C57BL/6N-Kif5c^tm1dIcs/Ics)	increased eosinophil cell number	J:211773
Kif9^em1(IMPC)Mbp/Kif9^em1(IMPC)Mbp (C57BL/6N-Kif9^em1(IMPC)Mbp/MbpMmucd)	small spleen	J:211773
Kif13a^em1(IMPC)Mbp/Kif13a^em1(IMPC)Mbp (C57BL/6N-Kif13a^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Kif13b^{tm1b(EUCOMM)Wtsi}/Kif13b^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Kif13b^{tm1b(EUCOMM)Wtsi}/Wtsi)	decreased leukocyte cell number	J:211773
Kif15^em1Lium/Kif15^em1Lium (C57BL/6-Kif15^em1Lium)	decreased spleen white pulp amount	J:336767
	increased CD8-positive, alpha-beta T cell number	J:336767
	increased spleen red pulp amount	J:336767
	increased spleen weight	J:336767
	intermingled spleen red and white pulp	J:336767
Kif16b^{em1(IMPC)Ccpcz}/Kif16b^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Kif16b^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Kif20a^{tm1b(EUCOMM)Hmgu}/Kif20a⁺ (C57BL/6N-Kif20a^{tm1b(EUCOMM)Hmgu}/Ieg)	increased mean corpuscular volume	J:211773
Kifc3^tm1Gsn/Kifc3^tm1Gsn (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	hematopoietic system phenotype	J:67352
Kiss1r^{tm1.1(KOMP)Vlcg}/Kiss1r^{tm1.1(KOMP)Vlcg} (C57BL/6N-Kiss1r^{tm1.1(KOMP)Vlcg}/Ucd)	increased spleen weight	J:211773
Kiss1r^tm1.1Lex/Kiss1r⁺ (involves: 129S4/SvJae)	decreased eosinophil cell number	J:181650
Kiss1r^tm1.1Lex/Kiss1r⁺ (involves: 129S4/SvJae)	decreased lymphocyte cell number	J:181650
Kiss1r^tm1.1Lex/Kiss1r^tm1.1Lex (involves: 129S4/SvJae)	decreased basophil cell number	J:181650
	decreased lymphocyte cell number	J:181650
	decreased monocyte cell number	J:181650
	decreased neutrophil cell number	J:181650
	increased spleen weight	J:181650
	increased thymus weight	J:181650
	thrombocytopenia	J:181650
Kiss1r^tm1Gstn/Kiss1r^tm1Gstn (involves: 129P2/OlaHsd)	increased thymus weight	J:102113
Kit^M1Hmgu/Kit⁺ (C3HeB/FeJ-Kit^M1Hmgu)	decreased mean corpuscular hemoglobin	J:186868
	decreased mean corpuscular volume	J:186868
	increased erythrocyte cell number	J:186868
	increased hematocrit	J:186868
Kit^Mhdasco1/Kit^Mhdasco1 (C3HeB/FeJ-Kit^Mhdasco1)	abnormal erythrocyte morphology	J:125831
	decreased erythrocyte cell number	J:125831
	decreased hematocrit	J:125831
	increased hemoglobin content	J:125831
	increased mean corpuscular volume	J:125831
	macrocytic anemia	J:125831
Kit^Mhdasco5/Kit^Mhdasco5 (C3HeB/FeJ-Kit^Mhdasco5)	abnormal erythrocyte morphology	J:125831
	decreased erythrocyte cell number	J:125831
	decreased hematocrit	J:125831
	increased hemoglobin content	J:125831
	increased mean corpuscular volume	J:125831
	macrocytic anemia	J:125831
Kit^Ssm/Kit^Ssm (involves: C57BL/10 * Non-inbred)	anemia	J:14020
Kit^tm1.1Bsm/Kit^tm1.1Bsm (involves: 129S1/Sv * BALB/c * C57BL/6J * FVB/N)	abnormal mast cell physiology	J:61141
	decreased mast cell number	J:61141
	hematopoietic system phenotype	J:61141
Kit^tm1.1Bsm/Kit^tm1.1Bsm (B6.129S1-Kit^tm1.1Bsm)	hematopoietic system phenotype	J:90485
Kit^tm1Alf/Kit^tm1Alf (involves: 129S2/SvPas)	anemia	J:103157
Kit^tm1Alf/Kit^tm1Alf (involves: 129S2/SvPas)	macrocytic anemia	J:36230
Kit^tm1Ber/Kit^tm1Ber (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased mast cell number	J:89602
Kit^tm1Bpr/Kit^tm1Bpr (either: (involves: 129/Sv) or (involves: 129/Sv * C57BL/6))	decreased mast cell number	J:100778
Kit^tm1Bsm/Kit^tm1Bsm (involves: 129S1/Sv * C57BL/6J)	decreased mast cell number	J:61141
Kit^tm1Hntr/Kit^tm1Hntr (either: (involves: 129/Sv * C57BL/6 * DBA/2) or (involves: 129S1))	hematopoietic system phenotype	J:60192
Kit^tm2Ber/Kit^tm2Ber (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased mast cell number	J:89602
Kit^tm2Ber/Kit^tm3.1Bsm (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal erythroid progenitor cell morphology	J:146561
	abnormal proerythroblast morphology	J:146561
Kit^tm2Bsm/Kit⁺ (involves: 129X1/SvJ * C57BL/6J)	increased mast cell degranulation	J:83616
Kit^tm2Bsm/Kit⁺ (involves: 129X1/SvJ * C57BL/6J)	increased mast cell number	J:83616
Kit^tm3.1Bsm/Kit^tm3.1Bsm (involves: 129S1/Sv * C57BL/6)	abnormal B cell differentiation	J:90485
	abnormal mast cell physiology	J:90485
	abnormal T cell differentiation	J:90485
	decreased B cell number	J:90485
	decreased mast cell number	J:90485
	hematopoietic system phenotype	J:90485
Kit^tm3.1Bsm/Kit^tm3.1Bsm (B6.129S1-Kit^tm3.1Bsm)	abnormal proerythroblast morphology	J:146561
	abnormal stress erythropoiesis	J:146561
	decreased erythrocyte cell number	J:146561
	decreased hematocrit	J:146561
	increased erythroblast number	J:146561
	increased mean corpuscular volume	J:146561
	spleen hypoplasia	J:146561
Kit^tm3Ber/Kit^tm3Ber (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	arrested B cell differentiation	J:89602
	decreased mast cell number	J:89602
	enlarged spleen	J:89602
	increased B cell number	J:89602
	increased megakaryocyte cell number	J:89602
	spleen hyperplasia	J:89602
Kit^tm4.1Bsm/Kit⁺ (involves: 129S1/Sv * C57BL/6J * FVB/N)	abnormal erythrocyte morphology	J:188434
	decreased mean corpuscular volume	J:188434
	enlarged spleen	J:188434
	increased erythrocyte cell number	J:188434
	increased erythroid progenitor cell number	J:188434
	increased hematocrit	J:188434
	increased mast cell number	J:188434
	increased mean platelet volume	J:188434
	polycythemia	J:188434
	spleen hyperplasia	J:188434
Kit^tm5.1Bsm/Kit⁺ (involves: 129S1/Sv * C57BL/6J * FVB/N)	decreased mean corpuscular volume	J:188434
Kit^W-3Bao/Kit⁺ (involves: C57BL/6J)	hematopoietic system phenotype	J:163026
Kit^W-3Bao/Kit^W-3Bao (involves: C57BL/6J)	decreased erythrocyte cell number	J:163026
	decreased hematocrit	J:163026
	decreased hemoglobin content	J:163026
	increased mean corpuscular hemoglobin	J:163026
	increased mean corpuscular hemoglobin concentration	J:163026
	macrocytic anemia	J:163026
	macrocytosis	J:163026
Kit^W-25J/Kit^W-25J (involves: A/J * C57BL/6J)	microcytic anemia	J:64109
Kit^W-27H/Kit^W-27H (CBA/H-Kit^W-27H)	anemia	J:13934
Kit^W-28H/Kit^W-28H (involves: 101/H * C3H/HeH)	anemia	J:18375
Kit^W-34J/Kit⁺ (C57BL/6J-Kit^W-34J/J)	polycythemia	J:6571
Kit^W-35J/Kit⁺ (C57BL/6J-Kit^W-35J/J)	polycythemia	J:6571
Kit^W-36H/Kit^W-36H (involves: 101/H * C3H/HeH)	anemia	J:20782
Kit^W-37J/Kit⁺ (C57BL/6J-Kit^W-37J/J)	polycythemia	J:6571
Kit^W-37J/Kit⁺ (involves: C57BL/6 * C57BL/6J)	decreased mast cell number	J:27513
Kit^W-37J/Kit^W (involves: C57BL/6 * C57BL/6J * WB)	abnormal mast cell physiology	J:27513
Kit^W-37J/Kit^W (involves: C57BL/6 * C57BL/6J * WB)	decreased mast cell number	J:27513
Kit^W-38J/Kit⁺ (involves: C57BL/6J)	polycythemia	J:6571
Kit^W-39J/Kit⁺ (C57BL/6J-Kit^W-39J/J)	macrocytic anemia	J:6571
Kit^W-40J/Kit⁺ (C57BL/6J-Kit^W-40J/J)	polycythemia	J:6571
Kit^W-41J/Kit⁺ (C57BL/6J-Kit^W-41J/J)	macrocytic anemia	J:6571
Kit^W-41J/Kit^W-41J (C57BL/6J-Kit^W-41J/J)	macrocytic anemia	J:6571
Kit^W-42J/Kit⁺ (C57BL/6J-Kit^W-42J/J)	macrocytic anemia	J:6571
Kit^W-42J/Kit⁺ (involves: C57BL/6 * C57BL/6J * WB)	decreased erythrocyte cell number	J:27513
Kit^W-42J/Kit⁺ (involves: C57BL/6 * C57BL/6J * WB)	decreased mast cell number	J:27513
Kit^W-42J/Kit^W-42J (C57BL/6J-Kit^W-42J/J)	macrocytic anemia	J:6571
Kit^W-42J/Kit^W (involves: C57BL/6 * C57BL/6J * WB)	abnormal mast cell physiology	J:27513
Kit^W-42J/Kit^W (involves: C57BL/6 * C57BL/6J * WB)	decreased mast cell number	J:27513
Kit^W-43J/Kit⁺ (C57BL/6J-Kit^W-43J/J)	polycythemia	J:6571
Kit^W-44J/Kit⁺ (B6.C3-Kit^W-44J/J)	hematopoietic system phenotype	J:6571
Kit^W-44J/Kit^W-44J (B6.C3-Kit^W-44J/J)	hematopoietic system phenotype	J:6571
Kit^W-55J/Kit⁺ (C57BL/6J-Kit^W-55J/J)	anemia	J:28221
Kit^W-55J/Kit^W-55J (C57BL/6J-Kit^W-55J/J)	anemia	J:28221
Kit^W-57J/Kit^W-57J (involves: C58/J)	anemia	J:38382
Kit^W-73J/Kit^W-73J (involves: DBA/2J)	anemia	J:16572
Kit^W-a/Kit^W-a (involves: Z)	anemia	J:28886
Kit^W-b/Kit^W-b (involves: C57BL/St)	anemia	J:13078
Kit^W-b/Kit^W-s (involves: BRS * C57BL/St)	anemia	J:13078
Kit^W-Bs/Kit^W-v (involves: C57BL/6J)	anemia	J:157
Kit^W-Btlr/Kit^W-Btlr (C57BL/6J-Kit^W-Btlr)	decreased mast cell number	J:133270
Kit^W-ct/Kit⁺ (involves: 101/H * C3H/HeH)	macrocytic anemia	J:7216
Kit^W-ct/Kit^W-ct (involves: 101/H * C3H/HeH)	anemia	J:7216
Kit^W-e/Kit^W-e (involves: 101/H * C3H/HeH)	anemia	J:13765
Kit^W-f/Kit⁺ (involves: C3H/HePas)	macrocytic anemia	J:6187
Kit^W-f/Kit^W-f (involves: C3H/HePas)	decreased erythrocyte cell number	J:27513
	decreased mast cell number	J:27513
	macrocytic anemia	J:6187
Kit^W-j/Kit^W-j (involves: C3H)	anemia	J:3398
Kit^W-Jic/Kit⁺ (involves: C57BL/6)	decreased erythrocyte cell number	J:27513
Kit^W-Jic/Kit⁺ (involves: C57BL/6)	decreased mast cell number	J:27513
Kit^W-Jic/Kit^W (involves: C57BL/6 * WB)	abnormal mast cell physiology	J:27513
Kit^W-Jic/Kit^W (involves: C57BL/6 * WB)	decreased mast cell number	J:27513
Kit^W-n/Kit^W-n (Not Specified)	decreased mast cell number	J:12107
Kit^W-n/Kit^W-n (Not Specified)	macrocytic anemia	J:12107
Kit^W-n/Kit^W (involves: WB)	abnormal mast cell physiology	J:27513
Kit^W-n/Kit^W (involves: WB)	decreased mast cell number	J:27513
Kit^W-pw/Kit^W-pw (involves: STOCK Prop1^df Myo5a^d Bmp5^se)	anemia	J:13655
Kit^W-rio/Kit^W-rio (DBA/2-Kit^W-rio)	macrocytic anemia	J:29400
Kit^W-s/Kit^W-s (involves: BRS)	anemia	J:15330
Kit^W-sh/Kit^W-sh (involves: 101/H * C3H/HeH)	abnormal definitive hematopoiesis	J:6857
	abnormal erythrocyte cell number	J:6857
	decreased erythrocyte cell number	J:6857
	decreased mast cell degranulation	J:157470
	decreased mast cell number	J:145444
Kit^W-sh/Kit^W-sh Lyn^tm1Ard/Lyn^tm1Ard (involves: 101 * 129P2/OlaHsd * C3H/HeH)	decreased B cell number	J:161523
	increased basophil cell number	J:161523
	increased IgA level	J:161523
	increased IgE level	J:161523
	increased IgG2b level	J:161523
	increased IgM level	J:161523
Kit^W-sh/Kit^W-v (involves: 101/H * C3H/HeH)	abnormal definitive hematopoiesis	J:6857
	abnormal erythrocyte cell number	J:6857
	decreased erythrocyte cell number	J:6857
	macrocytic anemia	J:6857
Kit^W-v/Kit⁺ (involves: C57BL/6)	macrocytic anemia	J:3400
Kit^W-v/Kit⁺ (involves: C57BL * C57BL/6)	decreased erythrocyte cell number	J:27513
Kit^W-v/Kit⁺ (involves: C57BL * C57BL/6)	decreased mast cell number	J:27513
Kit^W-v/Kit⁺ (involves: C57BL * DBA)	macrocytic anemia	J:125080
Kit^W-v/Kit^W-v (involves: C57BL/6)	macrocytic anemia	J:3400
Kit^W-v/Kit^W-v (C57BL/6J-Kit^W-v/J)	macrocytic anemia	J:243758
Kit^W-v/Kit^W-v Ly6a^tm1Pmf/Ly6a^tm1Pmf (involves: 129P2/OlaHsd * C57BL/6)	abnormal common myeloid progenitor cell morphology	J:81387
	anemia	J:81387
Kit^W-vkd/Kit^W-vkd (involves: 129P2/OlaHsd * BALB/c * C57BL/6 * WB)	abnormal B cell differentiation	J:79128
	abnormal T cell differentiation	J:79128
	decreased B cell number	J:79128
	decreased bone marrow cell number	J:79128
	decreased thymocyte number	J:79128
	low mean erythrocyte cell number	J:79128
Kit^W/Kit⁺ (Not Specified)	hematopoietic system phenotype	J:14978
Kit^W/Kit⁺ (FL/1Re-Kit^W/J)	high mean erythrocyte cell number	J:24610
Kit^W/Kit⁺ (FL/1Re-Kit^W/J)	increased hematocrit	J:24610
Kit^W/Kit⁺ Tg(PGK1-KITLG*220)441Daw/0 (involves: C3H/HeJ)	decreased mast cell number	J:32600
Kit^W/Kit^W-v ((WB/ReJ x C57BL/6J-Kit^W-v/J)F1-Kit^W/Kit^W-v/J)	impaired neutrophil recruitment	J:123463
	increased erythrocyte protoporphyrin level	J:5985
Kit^W/Kit^W-v (involves: C57BL/6J)	macrocytic anemia	J:243758
Kit^W/Kit^W-v (involves: C57BL/6)	decreased basophil cell number	J:178942
Kit^W/Kit^W-v (involves: C57BL/6)	decreased mast cell number	J:178942
Kit^W/Kit^W (Not Specified)	macrocytic anemia	J:14978
Kit^W/Kit^W (B6.Cg-Kit^W/J)	macrocytic anemia	J:243758
Kit^W/Kit^W Tg(PDGFB-EPO)321Zbz/? (involves: C3H * C57BL/6)	abnormal B cell differentiation	J:79128
	abnormal T cell differentiation	J:79128
	decreased B cell number	J:79128
	decreased thymocyte number	J:79128
Kit^Wads/Kit⁺ (C57BL/6J-Kit^Wads)	increased mean platelet volume	J:96391
Kit^Wads/Kit^Wads (C57BL/6J-Kit^Wads)	decreased erythrocyte cell number	J:96391
	decreased mast cell number	J:96391
	increased mean corpuscular volume	J:96391
	increased mean platelet volume	J:96391
	macrocytic anemia	J:96391
	thrombocytosis	J:96391
Kit^Whc1/Kit^Whc1 (involves: C3HeB/Fe * C57BL/6)	abnormal erythrocyte morphology	J:125831
	decreased erythrocyte cell number	J:125831
	decreased hematocrit	J:125831
	increased hemoglobin content	J:125831
	increased mean corpuscular volume	J:125831
	macrocytic anemia	J:125831
Kitl^Sl-1Neu/Kitl⁺ (involves: 102/El * C3H/El)	decreased erythrocyte cell number	J:37172
	decreased hematocrit	J:37172
	decreased hemoglobin content	J:37172
	decreased mean corpuscular hemoglobin concentration	J:37172
	increased mean corpuscular hemoglobin	J:37172
	increased mean corpuscular volume	J:37172
	macrocytic anemia	J:37172
Kitl^Sl-1Neu/Kitl^Sl-1Neu (involves: 102/El * C3H/El)	decreased erythrocyte cell number	J:37172
	decreased hematocrit	J:37172
	decreased hemoglobin content	J:37172
	decreased mean corpuscular hemoglobin concentration	J:37172
	increased mean corpuscular hemoglobin	J:37172
	increased mean corpuscular volume	J:37172
	macrocytic anemia	J:37172
Kitl^Sl-2Neu/Kitl⁺ (involves: 102/El * C3H/El)	decreased hematocrit	J:37172
Kitl^Sl-2Neu/Kitl⁺ (involves: 102/El * C3H/El)	decreased hemoglobin content	J:37172
Kitl^Sl-2Neu/Kitl^Sl-2Neu (involves: 102/El * C3H/El)	decreased hematocrit	J:37172
Kitl^Sl-2Neu/Kitl^Sl-2Neu (involves: 102/El * C3H/El)	decreased hemoglobin content	J:37172
Kitl^Sl-3Neu/Kitl^Sl-3Neu (involves: 102/El * C3H/El)	hematopoietic system phenotype	J:43966
Kitl^Sl-5R/Kitl⁺ (C3.Cg-Kitl^Sl-5R)	decreased erythrocyte cell number	J:82263
Kitl^Sl-5R/Kitl^Sl-5R (C3.Cg-Kitl^Sl-5R)	low mean erythrocyte cell number	J:82263
Kitl^Sl-10H/Kitl^Sl-10H (involves: 101/H * C3H/HeH)	anemia	J:14014, J:31566
Kitl^Sl-18H/Kitl⁺ (involves: 101/H * C3H/HeH)	anemia	J:18280
Kitl^Sl-18R/Kitl⁺ (C3.Cg-Kitl^Sl-18R)	decreased erythrocyte cell number	J:82263
Kitl^Sl-18R/Kitl^Sl-18R (C3.Cg-Kitl^Sl-18R)	low mean erythrocyte cell number	J:82263
Kitl^Sl-20J/Kitl^Sl-20J (C57BL/6J-Kitl^Sl-20J/J)	abnormal erythropoiesis	J:86436
Kitl^Sl-21H/Kitl^Sl-21H (involves: C3H/HeH)	anemia	J:179353
Kitl^Sl-22R/Kitl⁺ (C3H-Kitl^Sl-22R)	hematopoietic system phenotype	J:79293
	increased mean corpuscular hemoglobin	J:79293
	increased mean corpuscular volume	J:79293
	macrocytic anemia	J:79293
Kitl^Sl-22R/Kitl^Sl-22R (C3H-Kitl^Sl-22R)	low mean erythrocyte cell number	J:79293
Kitl^Sl-22R/Kitl^Sl-22R (C3H-Kitl^Sl-22R)	macrocytic anemia	J:79293
Kitl^Sl-28R/Kitl⁺ (C3.101Rl-Kitl^Sl-28R)	increased mean corpuscular hemoglobin	J:79293
	increased mean corpuscular volume	J:79293
	macrocytic anemia	J:79293
Kitl^Sl-28R/Kitl^Sl-28R (C3.101Rl-Kitl^Sl-28R)	low mean erythrocyte cell number	J:79293
Kitl^Sl-28R/Kitl^Sl-28R (C3.101Rl-Kitl^Sl-28R)	macrocytic anemia	J:79293
Kitl^Sl-30R/Kitl⁺ (C3.101Rl-Kitl^Sl-30R)	decreased hematocrit	J:79293
	increased mean corpuscular hemoglobin	J:79293
	increased mean corpuscular volume	J:79293
	macrocytic anemia	J:79293
Kitl^Sl-30R/Kitl^Sl-30R (C3.101Rl-Kitl^Sl-30R)	low mean erythrocyte cell number	J:79293
Kitl^Sl-30R/Kitl^Sl-30R (C3.101Rl-Kitl^Sl-30R)	macrocytic anemia	J:79293
Kitl^Sl-31R/Kitl⁺ (C3H-Kitl^Sl-31R)	increased mean corpuscular hemoglobin	J:79293
	increased mean corpuscular volume	J:79293
	macrocytic anemia	J:79293
Kitl^Sl-31R/Kitl^Sl-31R (C3H-Kitl^Sl-31R)	low mean erythrocyte cell number	J:79293
Kitl^Sl-31R/Kitl^Sl-31R (C3H-Kitl^Sl-31R)	macrocytic anemia	J:79293
Kitl^Sl-34H/Kitl^Sl-34H (involves: 101/H * C3H/HeH)	anemia	J:44592
Kitl^Sl-36R/Kitl⁺ (C3H-Kitl^Sl-36R)	increased mean corpuscular hemoglobin	J:79293
	increased mean corpuscular volume	J:79293
	low mean erythrocyte cell number	J:79293
	macrocytic anemia	J:79293
Kitl^Sl-36R/Kitl^Sl-36R (C3H-Kitl^Sl-36R)	decreased hematocrit	J:79293
	increased mean corpuscular hemoglobin	J:79293
	increased mean corpuscular hemoglobin concentration	J:79293
	low mean erythrocyte cell number	J:79293
	macrocytic anemia	J:79293
Kitl^Sl-39R/Kitl⁺ (C3.B10Rl-Kitl^Sl-39R)	increased mean corpuscular hemoglobin	J:79293
	increased mean corpuscular volume	J:79293
	low mean erythrocyte cell number	J:79293
	macrocytic anemia	J:79293
Kitl^Sl-39R/Kitl^Sl-39R (C3.B10Rl-Kitl^Sl-39R)	decreased hematocrit	J:79293
	increased mean corpuscular hemoglobin	J:79293
	increased mean corpuscular hemoglobin concentration	J:79293
	increased mean corpuscular volume	J:79293
	low mean erythrocyte cell number	J:79293
	macrocytic anemia	J:79293
Kitl^Sl-42R/Kitl⁺ (C3.101Rl-Kitl^Sl-42R)	decreased hematocrit	J:79293
	increased mean corpuscular hemoglobin	J:79293
	increased mean corpuscular volume	J:79293
	macrocytic anemia	J:79293
Kitl^Sl-42R/Kitl^Sl-42R (C3.101Rl-Kitl^Sl-42R)	low mean erythrocyte cell number	J:79293
Kitl^Sl-42R/Kitl^Sl-42R (C3.101Rl-Kitl^Sl-42R)	macrocytic anemia	J:79293
Kitl^Sl-con/Kitl^Sl-con (either: (involves: C3H/HeJ) or (involves: C3H/HeN))	increased mast cell number	J:23593
Kitl^Sl-d/Kitl⁺ (either: (involves: C57BL/6 * DBA/2J) or (involves: C3H * C57BL/6 * DBA/2J * WC))	anemia	J:6084
	decreased mast cell number	J:6084
Kitl^Sl-d/Kitl⁺ (C3.D2-Kitl^Sl-d)	increased mean corpuscular hemoglobin	J:79293
	increased mean corpuscular volume	J:79293
	low mean erythrocyte cell number	J:79293
	macrocytic anemia	J:79293
Kitl^Sl-d/Kitl⁺ (involves: DBA/2J)	macrocytic anemia	J:125080
Kitl^Sl-d/Kitl^Sl-d (either: DBA/2J or (C57BL/6 x DBA/2)F1)	anemia	J:13392, J:20286
Kitl^Sl-d/Kitl^Sl-d (C3.D2-Kitl^Sl-d)	decreased hematocrit	J:79293
	increased mean corpuscular hemoglobin concentration	J:79293
	increased mean corpuscular volume	J:79293
	low mean erythrocyte cell number	J:79293
	macrocytic anemia	J:79293
Kitl^sl-du/Kitl^sl-du (C3H/HeJ-Kitl^sl-du)	anemia	J:13630
Kitl^Sl-gb/Kitl⁺ (C3.Cg-Kitl^Sl-gb)	increased mean corpuscular hemoglobin	J:79293
	increased mean corpuscular volume	J:79293
	macrocytic anemia	J:79293
Kitl^Sl-gb/Kitl^Sl-gb (C3.Cg-Kitl^Sl-gb)	low mean erythrocyte cell number	J:79293
Kitl^Sl-gb/Kitl^Sl-gb (C3.Cg-Kitl^Sl-gb)	macrocytic anemia	J:79293
Kitl^Sl-J/Kitl^Sl-J (C3HeB/FeHu-Kitl^Sl-J)	anemia	J:145144
Kitl^Sl-m/Kitl^Sl-m (involves: C57BL/6)	anemia	J:5009, J:13416
Kitl^Sl-pan/Kitl^Sl-pan (involves: C3H)	macrocytic anemia	J:4746
Kitl^Sl-so/Kitl^Sl-so (involves: C57BL/6)	anemia	J:13416
Kitl^Sl/Kitl⁺ (involves: C3H)	anemia	J:3399
Kitl^Sl/Kitl⁺ (involves: C3H)	decreased erythrocyte cell number	J:3399
Kitl^Sl/Kitl⁺ (either: (involves: C3H * WC) or (involves: C3H * C57BL/6 * DBA/2J * WC))	anemia	J:6084
	decreased mast cell number	J:6084
Kitl^Sl/Kitl⁺ Tg(PGK1-KITLG*220)441Daw/0 (involves: C3H)	decreased mast cell number	J:32600
Kitl^Sl/Kitl^Sl-d (involves: C57BL/6 * WC)	anemia	J:27511, J:2777
	decreased hematocrit	J:27511
	reticulocytosis	J:27511
	thymus atrophy	J:5758
Kitl^Sl/Kitl^Sl-d (involves: C3H * C57BL/6 * DBA/2J * WC)	decreased mast cell number	J:6084
Kitl^Sl/Kitl^Sl-d ((WC/ReJ Kitl^Sl x B6.D2-Kitl^Sl-d/J)F1-Kitl^Sl/Kitl^Sl-d/J)	abnormal osteoclast morphology	J:111273
	increased erythrocyte protoporphyrin level	J:5985
Kitl^Sl/Kitl^Sl (involves: C3H)	anemia	J:3399
Kitl^tm1.1Sjm/Kitl^tm1.1Sjm (BKa.129S6-Kitl^tm1.1Sjm)	abnormal bone marrow cell physiology	J:180431
	anemia	J:180431
	decreased erythrocyte cell number	J:180431
	decreased hematopoietic cell number	J:180431
Kitl^tm1.1Sjm/Kitl^tm2.1Sjm Lepr^tm2(cre)Rck/Lepr⁺ (involves: 129S6/SvEvTac * C57BL/6 * C57BL/Ka * SJL)	decreased hematopoietic cell number	J:180431
	enlarged spleen	J:180431
	extramedullary hematopoiesis	J:180431
	spleen hyperplasia	J:180431
Kitl^tm1.1Sjm/Kitl^tm2.1Sjm Lepr^tm2(cre)Rck/Lepr⁺ Tg(Tek-cre)12Flv/0 (involves: 129S6/SvEvTac * C3H * C57BL/6 * C57BL/Ka * SJL)	decreased bone marrow cell number	J:180431
	decreased hematopoietic cell number	J:180431
	spleen hyperplasia	J:180431
Kitl^tm1Pbes/Kitl^tm1Pbes (involves: 129S1/Sv * C57BL/6J)	decreased mast cell number	J:50150
Kitl^tm1Pbes/Kitl^tm1Pbes (involves: 129S1/Sv * C57BL/6J)	hematopoietic system phenotype	J:50150
Kitl^tm2.1Pbes/Kitl^tm2.1Pbes (involves: 129S1/Sv * C57BL/6J * FVB/N)	abnormal common myeloid progenitor cell morphology	J:157170
	increased mast cell number	J:157170
Kitl^tm2.1Sjm/Kitl^tm2.1Sjm Ndor1^{Tg(UBC-cre/ERT2)1Ejb}/0 (involves: 129S/SvEv * C57BL/6 * C57BL/Ka * SJL)	abnormal bone marrow cell physiology	J:180431
	anemia	J:180431
	decreased bone marrow cell number	J:180431
	decreased erythrocyte cell number	J:180431
	decreased hematopoietic cell number	J:180431
Kitl^tm2.1Sjm/Kitl^tm2.2Sjm Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: BALB/cJ * C57BL * CBA/Ca * SJL)	decreased hematopoietic cell number	J:180431
	hematopoietic system phenotype	J:180431
Kitl^tm2.1Sjm/Kitl^tm2.2Sjm Tg(Col1a1-cre)2Bek/0 (involves: BALB/cJ * C57BL/6 * C57BL/Ka * CD-1 * SJL)	decreased hematopoietic cell number	J:180431
	hematopoietic system phenotype	J:180431
Kitl^tm2.1Sjm/Kitl^tm2.2Sjm Tg(Nes-cre)1Kln/0 (involves: BALB/cJ * C57BL/6 * C57BL/Ka * SJL)	hematopoietic system phenotype	J:180431
Kitl^tm2.1Sjm/Kitl^tm2.2Sjm Tg(Nes-cre/ERT2)1Fsh/0 (involves: BALB/cJ * C57BL/6 * C57BL/Ka * FVB/N * SJL)	hematopoietic system phenotype	J:180431
Kitl^tm2.1Sjm/Kitl^tm2.2Sjm Tg(Tek-cre)12Flv/0 (involves: BALB/cJ * C3H * C57BL/6 * C57BL/Ka * SJL)	abnormal bone marrow cell physiology	J:180431
	decreased hematopoietic cell number	J:180431
	hematopoietic system phenotype	J:180431
Kitl^tm2.2Sjm/Kitl⁺ (involves: BALB/cJ * C57BL/6 * C57BL/Ka * SJL)	decreased hematopoietic cell number	J:180431
Kitl^tm2.2Sjm/Kitl^tm2.2Sjm (involves: BALB/cJ * C57BL/6 * C57BL/Ka * SJL)	anemia	J:180431
Kitl^tm3.1Pbes/Kitl^tm3.1Pbes (involves: 129S1/Sv * C57BL/6J * FVB/N)	abnormal bone marrow cell physiology	J:157170
	decreased double-negative T cell number	J:157170
	decreased double-positive T cell number	J:157170
	decreased erythrocyte cell number	J:157170
	decreased mast cell number	J:157170
	decreased T cell number	J:157170
	decreased thymocyte number	J:157170
	increased mean corpuscular volume	J:157170
Kl^kl/Kl^kl (either: C.Cg-Kl^kl or (involves: C3H/HeJ * C57BL/6J))	abnormal leukocyte cell number	J:44109
	decreased osteoclast cell number	J:44109
	thymus atrophy	J:44109
Kl^kl/Kl^kl (involves: C3H/HeJ * C57BL/6J)	decreased B cell number	J:80503
Kl^kl/Kl^kl (involves: C3H/HeJ * C57BL/6J)	decreased osteoclast cell number	J:80503
Kl^kl/Kl^kl (involves: C3H/J * C57BL/6J)	abnormal osteoclast morphology	J:56666
Kl^kl/Kl^kl Tnfrsf11b^tm1Khs/Tnfrsf11b⁺ (involves: 129P2/OlaHsd * C3H * C57BL/6)	decreased B cell number	J:80503
Kl^m1Anu/Kl^m1Anu (C57BL/6NCrlAnu-Kl^m1Anu)	abnormal definitive hematopoiesis	J:104190
	abnormal spleen morphology	J:104190
	small spleen	J:104190
Klf1^Nan/Klf1⁺ (either: B6.Cg-Klf1^Nan or WB.Cg-Klf1^Nan)	abnormal erythrocyte morphology	J:162530
	anisocytosis	J:162530
	decreased erythrocyte cell number	J:162530
	decreased hematocrit	J:162530
	decreased hemoglobin content	J:162530
	decreased mean corpuscular hemoglobin	J:162530
	increased erythrocyte osmotic fragility	J:162530
	increased spleen weight	J:162530
	poikilocytosis	J:162530
	polychromatophilia	J:162530
Klf1^Nan/Klf1⁺ (involves: 101/H * C3H/HeH * PT)	anemia	J:13933
	anisocytosis	J:13933
	decreased erythrocyte cell number	J:13933
	enlarged spleen	J:13933
	increased nucleated erythrocyte cell number	J:13933
	increased spleen iron level	J:13933
Klf1^Nan/Klf1^Nan (involves: 101/H * C3H/HeH * PT)	impaired hematopoiesis	J:13933
Klf1^tm1.1Ryan/Klf1^tm1.1Ryan (involves: 129S4/SvJae * C57BL/6 * C57BL/6J)	hematopoietic system phenotype	J:204029
Klf1^tm1Nimr/Klf1^tm1Nimr (either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * CBA) or (involves: 129P2/OlaHsd * FVB))	abnormal erythropoiesis	J:25650
	anemia	J:25650
	decreased hemoglobin content	J:25650
	erythroblastosis	J:25650
	impaired hematopoiesis	J:25650
Klf1^tm1Sho/Klf1^tm1Sho (involves: 129S4/SvJae * C57BL/6)	abnormal embryonic erythrocyte morphology	J:25651
	abnormal erythrocyte morphology	J:25651
	abnormal erythropoiesis	J:25651
	anemia	J:25651
Klf2^tm1Jml/Klf2^tm1Jml (either: (involves: 129X1/SvJ * C57BL/6) or (involves: 129X1/SvJ * C57BL/6 * CD-1))	anemia	J:44352
Klf2^tm1Ling/Klf2^tm1Ling (involves: 129P2/OlaHsd * C57BL/6J)	anemia	J:51402
	impaired hematopoiesis	J:51402
	increased nucleated erythrocyte cell number	J:51402
Klf2^tm1Mlkn/Klf2^tm1Mlkn Tg(Tek-cre)12Flv/? (involves: C3H * C57BL/6)	anemia	J:127228
Klf2^tm1Mlkn/Klf2^tm1Mlkn Tg(VAV1-cre)1Graf/0 (Not Specified)	absent T cells	J:127228
Klf2^tm2Ling/Klf2^tm2Ling Lyz2^tm1(cre)Ifo/0 (involves: 129P2/OlaHsd * 129S6/SvEvTac)	decreased Ly6C low monocyte number	J:239509
Klf2^tm2Ling/Klf2^tm2Ling Tg(Cd4-cre)1Cwi/? (involves: 129S6/SvEvTac * C57BL/6 * DBA/2)	abnormal T cell differentiation	J:151604
	decreased T cell number	J:151604
	increased IgE level	J:151604
	increased IgG1 level	J:151604
	increased single-positive T cell number	J:151604
Klf3^{Gt(CH0516)Wtsi}/Klf3^{Gt(CH0516)Wtsi} (involves: 129P2/OlaHsd * C57BL/6)	hematopoietic system phenotype	J:206507
	increased leukocyte cell number	J:206507
	increased red blood cell distribution width	J:206507
	increased spleen weight	J:206507
	reticulocytosis	J:206507
Klf3^{Gt(XS0187)Wtsi}/Klf3^{Gt(XS0187)Wtsi} (involves: 129P2/OlaHsd * C57BL/6)	hematopoietic system phenotype	J:206507
	increased leukocyte cell number	J:206507
	increased red blood cell distribution width	J:206507
	increased spleen weight	J:206507
	reticulocytosis	J:206507
Klf3^m1Cmhd/Klf3⁺ (involves: C3H/HeJ * C57BL/6J)	anemia	J:206507
	decreased erythrocyte cell number	J:206507
	decreased hemoglobin content	J:206507
	increased spleen weight	J:206507
	reticulocytosis	J:206507
Klf4^tm1Khk/Klf4^tm1Khk Lyz2^tm1(cre)Ifo/0 (involves: 129P2/OlaHsd * 129S6/SvEvTac)	decreased Ly6C low monocyte number	J:239509
Klf6^tm1Fdmn/Klf6⁺ (involves: C57BL/6)	abnormal embryonic hematopoiesis	J:122926
Klf7^{tm1b(EUCOMM)Hmgu}/Klf7⁺ (C57BL/6N-Klf7^{tm1b(EUCOMM)Hmgu}/H)	increased mean platelet volume	J:211773
Klf8^{Gt(AD0101)Wtsi}/Y (FVB.129P2-Klf8^{Gt(AD0101)Wtsi}/Apb)	hematopoietic system phenotype	J:204573
Klf8^{Gt(AD0101)Wtsi}/Klf8^{Gt(AD0101)Wtsi} (FVB.129P2-Klf8^{Gt(AD0101)Wtsi}/Apb)	hematopoietic system phenotype	J:204573
Klf11^tm1Czs/Klf11^tm1Czs (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	hematopoietic system phenotype	J:94499
Klf13^tm1Coll/Klf13^tm1Coll (involves: 129S/SvEv)	abnormal erythropoiesis	J:136545
	decreased erythrocyte cell number	J:136545
	decreased leukocyte cell number	J:136545
	decreased lymphocyte cell number	J:136545
	enlarged spleen	J:136545
	increased erythroid progenitor cell number	J:136545
	increased mean corpuscular hemoglobin	J:136545
	increased mean corpuscular volume	J:136545
	increased red blood cell distribution width	J:136545
	spleen hyperplasia	J:136545
Klf13^tm1Kren/Klf13^tm1Kren (B6.129-Klf13^tm1Kren)	abnormal spleen morphology	J:145839
	abnormal T cell number	J:145839
	decreased splenocyte apoptosis	J:145839
	decreased thymocyte apoptosis	J:145839
	decreased thymocyte number	J:145839
	increased double-positive T cell number	J:145839
	increased splenocyte number	J:145839
	increased thymocyte number	J:145839
	spleen hyperplasia	J:145839
	thymus hyperplasia	J:145839
Klf14^{tm1.1(KOMP)Vlcg}/Klf14^{tm1.1(KOMP)Vlcg} (C57BL/6N-Klf14^{tm1.1(KOMP)Vlcg}/Ucd)	decreased mean corpuscular hemoglobin	J:211773
	increased red blood cell distribution width	J:211773
Klf15^tm1Jain/Klf15^tm1Jain (involves: 129X1/SvJ)	increased macrophage cell number	J:203920
Klf16^em1(IMPC)J/Klf16⁺ (C57BL/6NJ-Klf16^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
Klhdc2^{tm1b(EUCOMM)Hmgu}/Klhdc2⁺ (C57BL/6N-Klhdc2^{tm1b(EUCOMM)Hmgu}/H)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
	small thymus	J:211773
Klhdc7b^em1(IMPC)H/Klhdc7b^em1(IMPC)H (C57BL/6N-Klhdc7b^em1(IMPC)H/H)	decreased lymphocyte cell number	J:211773
	increased eosinophil cell number	J:211773
Klhl1^{em1(IMPC)Ccpcz}/Klhl1^{em1(IMPC)Ccpcz} (C57BL/6N-Klhl1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
	small spleen	J:211773
Klhl2^em1(IMPC)J/Klhl2^em1(IMPC)J (C57BL/6NJ-Klhl2^em1(IMPC)J/J)	increased mean corpuscular volume	J:211773
Klhl3^{tm1b(KOMP)Wtsi}/Klhl3^{tm1b(KOMP)Wtsi} (C57BL/6N-Klhl3^{tm1b(KOMP)Wtsi}/H)	decreased hemoglobin content	J:211773
Klhl6^m1Anu/Klhl6^m1Anu (C57BL/6JAnu-Klhl6^m1Anu)	decreased B cell number	J:104190
	decreased mature B cell number	J:104190
	increased immature B cell number	J:104190
Klhl6^m1Btlr/Klhl6^m1Btlr (C57BL/6J-Klhl6^m1Btlr)	decreased B cell number	J:265167
	decreased central memory CD4-positive, alpha-beta T cell number	J:265167
	increased B-1b cell number	J:265167
	increased CD4-positive, alpha-beta T cell number	J:265167
	increased single-positive T cell number	J:265167
	increased T cell number	J:265167
Klhl6^m2Btlr/Klhl6^m2Btlr (C57BL/6J-Klhl6^m2Btlr)	decreased CD8-positive, alpha-beta T cell number	J:265168
	increased CD4-positive, alpha-beta T cell number	J:265168
	increased single-positive T cell number	J:265168
	increased T cell number	J:265168
Klhl6^M3Btlr/Klhl6^M3Btlr (C57BL/6J-Klhl6^M3Btlr)	increased alpha-beta T cell number	J:267699
	increased B-1a cell number	J:267699
	increased CD4-positive, alpha-beta T cell number	J:267699
	increased CD8-positive, alpha-beta T cell number	J:267699
Klhl6^m4Btlr/Klhl6^m4Btlr (C57BL/6J-Klhl6^m4Btlr)	increased B-1 B cell number	J:272394
Klhl6^M5Btlr/Klhl6^M5Btlr (C57BL/6J-Klhl6^M5Btlr)	increased B-1 B cell number	J:272395
Klhl6^m6Btlr/Klhl6^m6Btlr (C57BL/6J-Klhl6^m6Btlr)	increased alpha-beta T cell number	J:272396
Klhl6^m6Btlr/Klhl6^m6Btlr (C57BL/6J-Klhl6^m6Btlr)	increased CD4-positive, alpha-beta T cell number	J:272396
Klhl6^M7Btlr/Klhl6^M7Btlr (C57BL/6J-Klhl6^M7Btlr)	abnormal B cell differentiation	J:272397
Klhl6^M8Btlr/Klhl6^M8Btlr (C57BL/6J-Klhl6^M8Btlr)	decreased B cell number	J:274963
	increased CD4-positive, alpha-beta T cell number	J:274963
	increased T cell number	J:274963
Klhl6^tm1Sato/Klhl6^tm1Sato (either: (involves: 129T2/SvEms) or (involves: BALB/c) or (involves: CD-1))	abnormal B cell differentiation	J:101363
	abnormal spleen morphology	J:101363
	decreased B cell number	J:101363
	decreased follicular B cell number	J:101363
	decreased spleen weight	J:101363
	spleen hypoplasia	J:101363
Klhl14^tm1.1Jyw/Klhl14⁺ (involves: C57BL/6)	decreased B-1a cell number	J:263511
Klhl14^tm1.1Jyw/Klhl14⁺ (involves: C57BL/6)	increased B-1b cell number	J:263511
Klhl18^{tm1a(KOMP)Wtsi}/Klhl18^{tm1a(KOMP)Wtsi} (C57BL/6N-Klhl18^{tm1a(KOMP)Wtsi}/Wtsi)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
Klhl29^{tm1b(EUCOMM)Hmgu}/Klhl29⁺ (C57BL/6N-Klhl29^{tm1b(EUCOMM)Hmgu}/Ics)	increased large unstained cell number	J:211773
Klhl42^{tm1b(EUCOMM)Hmgu}/Klhl42^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Klhl42^{tm1b(EUCOMM)Hmgu}/Wtsi)	thrombocytosis	J:211773
Klk4^{tm1.1(KOMP)Vlcg}/Klk4^{tm1.1(KOMP)Vlcg} (C57BL/6N-Klk4^{tm1.1(KOMP)Vlcg}/Ucd)	increased basophil cell number	J:211773
	increased neutrophil cell number	J:211773
Klk5^{tm2b(KOMP)Wtsi}/Klk5^{tm2b(KOMP)Wtsi} (C57BL/6N-Klk5^{tm2b(KOMP)Wtsi}/Ccpcz)	decreased mean corpuscular hemoglobin concentration	J:211773
	increased mean corpuscular volume	J:211773
	increased red blood cell distribution width	J:211773
Klk8^{em1(IMPC)Ccpcz}/Klk8^{em1(IMPC)Ccpcz} (C57BL/6N-Klk8^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	decreased lymphocyte cell number	J:211773
	enlarged spleen	J:211773
Klk11^{em1(IMPC)Ccpcz}/Klk11^{em1(IMPC)Ccpcz} (C57BL/6N-Klk11^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Klra1^tm1.1Wyok/Klra1^tm1.1Wyok (involves: BALB/cJ * C57BL/6NTac)	abnormal natural killer cell mediated cytotoxicity	J:252851
	hematopoietic system phenotype	J:252851
Klra8^Cmv1-r/Klra8^Cmv1-r (C.B6-Klra8^Cmv1-r)	decreased IgG1 level	J:97203
	decreased IgG2a level	J:97203
	decreased IgG2b level	J:97203
	decreased IgG3 level	J:97203
	decreased IgG level	J:97203
	increased IgM level	J:97203
Klra15^tm1.1Apma/Klra15^tm1.1Apma (B6.129-Klra15^tm1.1Apma)	impaired natural killer cell mediated cytotoxicity	J:189106
Klra17^tm1.1Apma/Klra17^tm1.1Apma (involves: 129S1/Sv * 129X1/SvJ)	increased plasmacytoid dendritic cell number	J:152288
Klrb1^{tm1b(EUCOMM)Wtsi}/Klrb1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Klrb1^{tm1b(EUCOMM)Wtsi}/Ieg)	decreased leukocyte cell number	J:211773
	increased follicular B cell number	J:211773
Klrb1b^tm1.1Apma/Klrb1b^tm1.1Apma (B6.Cg-Klrb1b^tm1.1Apma)	abnormal NK cell physiology	J:222057
Klrc1^tm1Mmka/Klrc1^tm1Mmka (B6.129-Klrc1^tm1Mmka)	decreased CD8-positive, alpha-beta T cell number	J:222503
Klre1^tm1Tgi/Klre1^tm1Tgi (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	impaired natural killer cell mediated cytotoxicity	J:92262
Klrg2^em1(IMPC)H/Klrg2^em1(IMPC)H (C57BL/6NTac-Klrg2^em1(IMPC)H/H)	enlarged spleen	J:211773
Klrk1^em1(IMPC)Mbp/Klrk1^em1(IMPC)Mbp (C57BL/6NCrl-Klrk1^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Klrk1^tm1.1Bpol/Klrk1^tm1.1Bpol (C57BL/6-Klrk1^tm1.1Bpol)	abnormal NK cell differentiation	J:151878
	abnormal NK cell physiology	J:151878
	decreased B cell number	J:151878
	decreased T cell number	J:151878
	impaired natural killer cell mediated cytotoxicity	J:151878
	spleen hypoplasia	J:151878
Klrk1^tm1Dhr/Klrk1^tm1Dhr (involves: C57BL/6 * CD-1)	impaired natural killer cell mediated cytotoxicity	J:134509
Klrk1^tm1Dhr/Klrk1^tm1Dhr (B6.Cg-Klrk1^tm1Dhr/J)	increased natural killer cell mediated cytotoxicity	J:221188
Klrk1^tm2.1Bpol/Klrk1^tm2.1Bpol (Not Specified)	abnormal NK cell differentiation	J:215590
Kmt2a^tm1(AFF1)Ksy/Kmt2a⁺ (involves: 129S1/Sv * C57BL/6 * FVB)	abnormal blood cell morphology/development	J:110241
	abnormal lymphocyte morphology	J:110241
	enlarged spleen	J:110241
	increased leukocyte cell number	J:110241
	increased monocyte cell number	J:110241
	increased neutrophil cell number	J:110241
	increased pro-B cell number	J:110241
	myeloid hyperplasia	J:110241
Kmt2a^{tm1(MLL1/ERT)Divo}/? (involves: 129S4/SvJae * C57BL/6)	enlarged spleen	J:189329
	myeloid hyperplasia	J:189329
Kmt2a^{tm1.1(Sh3gl1)Lcc}/Kmt2a⁺ Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6)	enlarged spleen	J:205605
	myeloid hyperplasia	J:205605
Kmt2a^tm1.1Brad/Kmt2a^tm1.1Brad (involves: 129S4/SvJae * C57BL/6)	abnormal hematopoietic stem cell morphology	J:149811
	decreased common myeloid progenitor cell number	J:149811
	decreased hematopoietic stem cell number	J:149811
Kmt2a^tm1.1Erns/Kmt2a^tm1.1Erns (involves: 129S2/SvPas * C57BL/6 * SJL)	abnormal definitive hematopoiesis	J:147265
	decreased common myeloid progenitor cell number	J:147265
	decreased erythroid progenitor cell number	J:147265
Kmt2a^tm1.1Erns/Kmt2a^tm1.1Erns Tg(Mx1-cre)1Cgn/0 (involves: 129S2/SvPas * C57BL/6 * CBA * SJL)	abnormal common lymphocyte progenitor cell morphology	J:147265
	abnormal definitive hematopoiesis	J:147265
	abnormal hematopoietic stem cell morphology	J:147265
	decreased bone marrow cell number	J:147265
	decreased common myeloid progenitor cell number	J:147265
	decreased erythroid progenitor cell number	J:147265
	decreased hematopoietic stem cell number	J:147265
Kmt2a^tm1.1Mlc/Kmt2a^tm1.1Mlc (involves: 129P2/OlaHsd * C57BL/6)	abnormal blood cell morphology/development	J:183048
	abnormal hematopoietic stem cell physiology	J:183048
	decreased common myeloid progenitor cell number	J:183048
	decreased hematopoietic stem cell number	J:183048
Kmt2a^tm1Brad/Kmt2a^tm1Brad Commd10^{Tg(Vav1-icre)A2Kio}/? (involves: 129S4/SvJae * C57BL/6 * C57BL/10 * CBA/Ca)	abnormal bone marrow cell physiology	J:149811
	decreased common myeloid progenitor cell number	J:149811
	decreased pre-B cell number	J:149811
Kmt2a^tm1Clgr/Kmt2a⁺ (B6.129-Kmt2a^tm1Clgr)	abnormal common myeloid progenitor cell morphology	J:115001
	abnormal myelopoiesis	J:115001
	abnormal proerythroblast morphology	J:115001
	increased erythroid progenitor cell number	J:115001
Kmt2a^tm1Sjk/Kmt2a⁺ (involves: 129S2/SvPas * C3H * C57BL/6)	anemia	J:29958
	decreased B cell number	J:29958
	decreased erythrocyte cell number	J:29958
	decreased hemoglobin content	J:29958
	thrombocytopenia	J:29958
Kmt2a^tm1Thr/Kmt2a⁺ Mllt3^tm2Thr/Mllt3⁺ Tg(Lck-cre)1Thr/? (involves: 129S/SvEv)	abnormal spleen red pulp morphology	J:100794
	abnormal spleen white pulp morphology	J:100794
	enlarged spleen	J:100794
Kmt2a^{tm2(MLLT3)Thr}/Kmt2a⁺ (involves: 129P2/OlaHsd)	abnormal definitive hematopoiesis	J:56340
Kmt2a^{tm2(MLLT3)Thr}/Kmt2a⁺ (involves: 129P2/OlaHsd)	enlarged spleen	J:56340
Kmt2a^{tm2(MLLT3)Thr}/Kmt2a^{tm2(MLLT3)Thr} (involves: 129P2/OlaHsd * C57BL/6 * FVB)	abnormal blood cell morphology/development	J:110241
	abnormal definitive hematopoiesis	J:110241
	increased leukocyte cell number	J:110241
	increased neutrophil cell number	J:110241
	increased pro-B cell number	J:110241
Kmt2a^tm2.1Mlc/Kmt2a^tm2.1Mlc (involves: 129P2/OlaHsd * C57BL/6)	abnormal hematopoietic system morphology/development	J:207555
	decreased hematopoietic stem cell number	J:207555
Kmt2a^tm2Sjk/Kmt2a⁺ Tg(Mx1-cre)1Cgn/0 (involves: 129X1/SvJ * C57BL/6 * CBA)	abnormal bone marrow cell morphology/development	J:95914
	abnormal spleen morphology	J:95914
	anemia	J:95914
	enlarged spleen	J:95914
	increased leukocyte cell number	J:95914
	increased spleen red pulp amount	J:95914
	myeloid hyperplasia	J:95914
	thrombocytopenia	J:95914
Kmt2d^tm1.1Kaig/Kmt2d⁺ Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * C57BL/6)	increased germinal center B cell number	J:228913
	increased spleen germinal center size	J:228913
Kmt2d^tm1.1Kaig/Kmt2d^tm1.1Kaig Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell differentiation	J:228913
	decreased B cell number	J:228913
	decreased follicular B cell number	J:228913
	decreased IgG1 level	J:228913
	decreased IgM level	J:228913
	decreased mature B cell number	J:228913
	increased B cell proliferation	J:228913
	increased germinal center B cell number	J:228913
	increased spleen germinal center number	J:228913
	increased spleen germinal center size	J:228913
Kmt2e^tm1.1Hjf/Kmt2e⁺ (B6.129P2-Kmte^tm1.1Hjf)	decreased thymocyte number	J:145579
	spleen hypoplasia	J:145579
	thymus hypoplasia	J:145579
Kmt2e^tm1.1Hjf/Kmt2e^tm1.1Hjf (B6.129P2-Kmte^tm1.1Hjf)	abnormal bone marrow cell morphology/development	J:145579
	abnormal lymphopoiesis	J:145579
	abnormal myeloblast morphology/development	J:145579
	decreased B cell number	J:145579
	decreased common myeloid progenitor cell number	J:145579
	decreased double-negative T cell number	J:145579
	decreased double-positive T cell number	J:145579
	decreased erythrocyte cell number	J:145579
	decreased hematocrit	J:145579
	decreased hematopoietic stem cell number	J:145579
	decreased leukocyte cell number	J:145579
	decreased macrophage cell number	J:145579
	decreased pre-B cell number	J:145579
	decreased pro-B cell number	J:145579
	decreased T cell number	J:145579
	decreased thymocyte number	J:145579
	small spleen	J:145579
	small thymus	J:145579
	spleen hypoplasia	J:145579
	thrombocytopenia	J:145579
	thymus hypoplasia	J:145579
Kmt2e^tm1Apa/Kmt2e^tm1Apa (129S6/SvEvTac-Kmt2e^tm1Apa)	abnormal definitive hematopoiesis	J:145445
	abnormal granulocyte differentiation	J:145445
	abnormal neutrophil differentiation	J:145445
	abnormal neutrophil physiology	J:145445
	decreased hematocrit	J:145445
	decreased hemoglobin content	J:145445
	increased hemoglobin concentration distribution width	J:145445
	low mean erythrocyte cell number	J:145445
Kmt2e^tm1Nik/Kmt2e^tm1Nik (B6.Cg-Kmte^tm1Nik)	abnormal definitive hematopoiesis	J:145449
	abnormal hematopoietic stem cell morphology	J:145449
	decreased hematopoietic stem cell number	J:145449
	decreased NK cell number	J:145449
	decreased NK T cell number	J:145449
	hematopoietic system phenotype	J:145449
	increased hematopoietic stem cell number	J:145449
	increased neutrophil cell number	J:145449
Kmt5b^tm1Jnw/Kmt5b^tm1Jnw Kmt5c^tm1.1Jnw/Kmt5c^tm1.1Jnw Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: 129/Sv * C57BL/6J * C57BL/10 * CBA/Ca)	abnormal class switch recombination	J:139510
	abnormal lymphopoiesis	J:139510
	decreased B cell number	J:139510
	decreased double-positive T cell number	J:139510
Knl1^{tm1c(EUCOMM)Hmgu}/Knl1^{tm1c(EUCOMM)Hmgu} Tg(GFAP-cre)25Mes/0 (involves: 129S4/SvJaeSor * C57BL/6N * FVB/N)	microgliosis	J:278483
Knop1^{tm1b(EUCOMM)Wtsi}/Knop1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Knop1^{tm1b(EUCOMM)Wtsi}/Bay)	increased spleen weight	J:211773
Knstrn^{tm1b(KOMP)Wtsi}/Knstrn^{tm1b(KOMP)Wtsi} (C57BL/6N-Knstrn^{tm1b(KOMP)Wtsi}/Ics)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
	thrombocytopenia	J:211773
Kpna1^tm1.2Yyo/Kpna1^tm1.2Yyo (involves: 129S2/SvPas * C57BL/6 * SJL)	thrombocytopenia	J:188099
Kprp^tm1Msug/Kprp⁺ (involves: C57BL/6)	increased IgE level	J:286659
Kras^tm1.1Khai/Kras⁺ Tg(Mx1-cre)1Cgn/0 (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * C57BL/6J * CBA/J)	abnormal hematopoietic system morphology/development	J:276349
	anemia	J:276349
	decreased hemoglobin content	J:276349
	enlarged spleen	J:276349
	increased leukocyte cell number	J:276349
	increased myeloid cell number	J:276349
	increased myeloid cell number in bone marrow	J:276349
Kras^tm1Mok/Kras^tm1Mok (involves: 129S/SvEv * C57BL/6J)	hematopoietic system phenotype	J:42943
Kras^tm1Tyj/Kras⁺ Nras^tm1Rak/Nras^tm1Rak (involves: 129/Sv * C57BL/6)	abnormal embryonic hematopoiesis	J:43433
	abnormal erythropoiesis	J:43433
	anemia	J:43433
Kras^tm1Tyj/Kras^tm1Tyj (involves: 129S2/SvPas)	abnormal definitive hematopoiesis	J:43433
Kras^tm1Tyj/Kras^tm1Tyj (involves: 129S2/SvPas)	anemia	J:43433
Kras^tm4.1Bbd/Kras⁺ (involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6J * FVB/N)	enlarged spleen	J:223433
Kras^tm4.1Bbd/Kras^tm4.1Bbd (involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6J * FVB/N)	abnormal bone marrow cell physiology	J:223433
	abnormal common lymphocyte progenitor cell morphology	J:223433
	abnormal common myeloid progenitor cell morphology	J:223433
	abnormal hematopoietic system morphology/development	J:223433
	anemia	J:223433
	decreased CD8-positive, alpha-beta T cell number	J:223433
	enlarged spleen	J:223433
	extramedullary hematopoiesis	J:223433
	increased basophil cell number	J:223433
	increased eosinophil cell number	J:223433
	increased granulocyte monocyte progenitor cell number	J:223433
	increased hematopoietic stem cell number	J:223433
	increased leukocyte cell number	J:223433
	increased myeloid cell number	J:223433
	increased neutrophil cell number	J:223433
	spleen vascular congestion	J:223433
	thrombocytopenia	J:223433
Kras^tm4Tyj/Kras⁺ (involves: 129S4/SvJae)	increased regulatory T cell number	J:154046
Kras^tm4Tyj/Kras⁺ Gt(ROSA)26Sor^{tm4(ACTB-tdTomato,-EGFP)Luo}/Gt(ROSA)26Sor⁺ Tg(Flt3-cre)#Ccb/0 (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6)	anemia	J:247853
	decreased B cell number	J:247853
	decreased double-negative T cell number	J:247853
	decreased double-positive T cell number	J:247853
	decreased hematopoietic stem cell number	J:247853
	decreased T cell number	J:247853
	hepatosplenomegaly	J:247853
	increased dendritic cell number	J:247853
	increased leukocyte cell number	J:247853
	increased monocyte cell number	J:247853
	thrombocytopenia	J:247853
	thymus atrophy	J:247853
Kras^tm4Tyj/Kras⁺ Lrrc17^tm1Nik/Lrrc17⁺ Srpk2^tm1Nik/Srpk2⁺ Tg(Mx1-cre)1Cgn/0 (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * CBA)	abnormal blood cell morphology/development	J:161558
	anemia	J:161558
	increased leukocyte cell number	J:161558
Kras^tm4Tyj/Kras⁺ Meox2^tm1(cre)Sor/Meox2⁺ (involves: 129S4/SvJae * 129S4/SvJaeSor)	abnormal embryonic erythrocyte morphology	J:119477
	abnormal embryonic erythropoiesis	J:119477
Kras^tm4Tyj/Kras⁺ Pggt1b^tm1Mbrg/Pggt1b⁺ Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129/Sv * 129P2/OlaHsd * C57BL/6)	abnormal definitive hematopoiesis	J:122107
	abnormal spleen morphology	J:122107
	decreased lymphocyte cell number	J:122107
	increased neutrophil cell number	J:122107
Kras^tm4Tyj/Kras⁺ Stk11^tm1.2Rdp/Stk11^tm1.2Rdp (involves: 129S4/SvJae * 129S6/SvEvTac)	increased macrophage cell number	J:197037
Kras^tm4Tyj/Kras⁺ Tg(MUC1)79.24Gend/0 (involves: 129S4/SvJae * C57BL/6)	increased IgG level	J:154046
	increased IgM level	J:154046
	increased regulatory T cell number	J:154046
Kras^tm4Tyj/Kras⁺ Tg(Mx1-cre)1Cgn/0 (involves: 129S4/SvJae * BALB/c * C57BL/6 * CBA)	abnormal definitive hematopoiesis	J:88163
	abnormal erythrocyte morphology	J:88163
	abnormal myelopoiesis	J:88163
	anemia	J:88163
	decreased hematocrit	J:88163
	enlarged spleen	J:88163
	extramedullary hematopoiesis	J:88163
	increased granulocyte number	J:88163
	increased leukocyte cell number	J:88163
	increased spleen red pulp amount	J:88163
	myeloid hyperplasia	J:88163
Kras^tm4Tyj/Kras⁺ Tg(Mx1-cre)1Cgn/0 (involves: 129S4/SvJae * C57BL/6 * CBA)	abnormal erythropoiesis	J:87429, J:115071
	abnormal myelopoiesis	J:87429
	anemia	J:87429, J:115071
	anisopoikilocytosis	J:115071
	decreased mean corpuscular hemoglobin	J:115071
	enlarged spleen	J:87429, J:115071
	increased leukocyte cell number	J:87429
	increased monocyte cell number	J:87429
	increased splenocyte proliferation	J:87429
	myeloid hyperplasia	J:87429
	polychromatophilia	J:115071
	reticulocytosis	J:115071
Kras^tm4Tyj/Kras⁺ Tg(Mx1-cre)1Cgn/0 (involves: 129S4/SvJae * C57BL/6 * C57BL/6J * CBA/J)	abnormal hematopoietic system morphology/development	J:276349
	anemia	J:276349
	enlarged spleen	J:276349
	increased myeloid cell number	J:276349
	increased myeloid cell number in bone marrow	J:276349
Kras^tm4Tyj/Kras⁺ Tgfbr2^tm1.2Hlm/Tgfbr2^tm1.2Hlm (B6.129-Kras^tm4Tyj Tgfbr2^tm1.2Hlm)	abnormal myeloid leukocyte morphology	J:177379
	increased B cell number	J:177379
	increased T cell number	J:177379
Kras^tm4Tyj/Kras⁺ Tgfbr2^tm1.2Hlm/Tgfbr2^tm1.2Hlm Ptf1a^{tm1.1(cre)Cvw}/Ptf1a⁺ (involves: 129S/Sv * 129X1/SvJ * C57BL/6 * DBA/2)	enlarged spleen	J:116129
Krt1^tm1Tmm/Krt1^tm1Tmm (involves: 129 * C57BL/6)	abnormal blood cell morphology/development	J:200244
Krt8^{tm1b(EUCOMM)Hmgu}/Krt8⁺ (C57BL/6N-Krt8^{tm1b(EUCOMM)Hmgu}/Ics)	increased neutrophil cell number	J:211773
Krt8^tm1Rgo/Krt8^tm1Rgo (involves: 129S2/SvPas * C57BL/6)	extramedullary hematopoiesis	J:12899
Krt8^tm1Rgo/Krt8^tm1Rgo (involves: 129S2/SvPas * C57BL/6 * FVB/N)	enlarged spleen	J:22116
Krt17^{tm1.1(KOMP)Vlcg}/Krt17⁺ (C57BL/6N-Krt17^{tm1.1(KOMP)Vlcg}/J)	decreased hematocrit	J:211773
	increased hemoglobin content	J:211773
Krt27^{em1(IMPC)Ccpcz}/Krt27^{em1(IMPC)Ccpcz} (C57BL/6N-Krt27^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
	increased CD8-positive, alpha-beta T cell number	J:211773
Krt32^{em1(IMPC)Kmpc}/Krt32^{em1(IMPC)Kmpc} (C57BL/6NTac-Krt32^{em1(IMPC)Kmpc}/Kmpc)	increased hemoglobin content	J:211773
Krt33a^{em1(IMPC)Ccpcz}/Krt33a^{em1(IMPC)Ccpcz} (C57BL/6N-Krt33a^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Krt33b^{em1(IMPC)Ccpcz}/Krt33b^{em1(IMPC)Ccpcz} (C57BL/6N-Krt33b^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
	increased eosinophil cell number	J:211773
Krt34^{em1(IMPC)Ccpcz}/Krt34^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Krt34^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Krt72^{em1(IMPC)Ccpcz}/Krt72^{em1(IMPC)Ccpcz} (C57BL/6N-Krt72^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Krtap7-1^{em1(IMPC)Ccpcz}/Krtap7-1^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Krtap7-1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
	small spleen	J:211773
Krtap8-1^{em1(IMPC)Ccpcz}/Krtap8-1^{em1(IMPC)Ccpcz} (C57BL/6N-Krtap8-1^{em1(IMPC)Ccpcz}/Ccpcz)	decreased CD4-positive, alpha-beta T cell number	J:211773
	decreased T-helper cell number	J:211773
Krtap9-5^{em1(IMPC)Ccpcz}/Krtap9-5^{em1(IMPC)Ccpcz} (C57BL/6N-Krtap9-5^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Ksr1^tm1Shaw/Ksr1^tm1Shaw (Not Specified)	decreased T cell proliferation	J:75739
Ksr1^tm1Shaw/Ksr1^tm1Shaw Tg(DO11.10)10Dlo/0 (involves: BALB/c * C3H * C57BL/6)	abnormal CD4-positive T cell differentiation	J:75739
	decreased T cell proliferation	J:75739
Kxd1^tm1Wli/Kxd1^tm1Wli (involves: 129 * C57BL/6J)	decreased platelet dense granule number	J:192646
Ky^em1(IMPC)J/Ky⁺ (C57BL/6NJ-Ky^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
L3mbtl1^tm1.1Haho/L3mbtl1^tm1.1Haho (involves: 129S4/SvJae * C57BL/6)	hematopoietic system phenotype	J:166180
L3mbtl3^tm1Tmiy/L3mbtl3^tm1Tmiy (Not Specified)	abnormal definitive hematopoiesis	J:98498
L3mbtl3^tm1Tmiy/L3mbtl3^tm1Tmiy (Not Specified)	anemia	J:98498
Lacc1^em1Arkr/Lacc1^em1Arkr (C57BL/6NTac-Lacc1^em1Arkr)	abnormal macrophage physiology	J:244365
Lacc1^em2Arkr/Lacc1^em2Arkr (C57BL/6NTac-Lacc1^em2Arkr)	abnormal macrophage physiology	J:244365
Lacc1^em3Arkr/Lacc1^em3Arkr (C57BL/6NTac-Lacc1^em3Arkr)	abnormal macrophage physiology	J:244365
Lacc1^em4Arkr/Lacc1^em4Arkr (C57BL/6NTac-Lacc1^em4Arkr)	abnormal macrophage physiology	J:244365
Lacc1^{tm1a(KOMP)Wtsi}/Lacc1^{tm1a(KOMP)Wtsi} (involves: C57BL/6N * C57BL/6NTac)	abnormal macrophage morphology	J:244365
	abnormal macrophage physiology	J:244365
Lag3^tm1Daav/Lag3^tm1Daav Tg(Foxp3-EGFP/cre)1cJbs/0 (NOD.Cg-Lag3^tm1Daav Tg(Foxp3-EGFP/cre)1cJbs)	abnormal CD8-positive, alpha-beta T cell physiology	J:260063
	abnormal effector T cell number	J:260063
Lag3^tm1Doi/Lag3^tm1Doi (involves: 129S2/SvPas * C57BL/6)	abnormal NK cell physiology	J:32509
	abnormal T cell physiology	J:89653
	enlarged spleen	J:89653
	increased CD4-positive, alpha-beta T cell number	J:89653
	increased CD8-positive, alpha-beta T cell number	J:89653
	increased single-positive T cell number	J:89653
Lage3^em1(IMPC)Tcp/Lage3^em1(IMPC)Tcp (C57BL/6N-Lage3^em1(IMPC)Tcp/Tcp)	increased neutrophil cell number	J:211773
Lair1^tm1.1Jco/Lair1^tm1.1Jco (involves: C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:180203
	decreased CD8-positive, alpha-beta T cell number	J:180203
	decreased IgG1 level	J:180203
	decreased thymocyte number	J:180203
	increased activated T cell number	J:180203
	increased B cell number	J:180203
	increased CD4-positive, alpha-beta memory T cell number	J:180203
	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:180203
	increased CD8-positive, alpha-beta memory T cell number	J:180203
	increased dendritic cell number	J:180203
	increased eosinophil cell number	J:180203
	increased marginal zone B cell number	J:180203
	thrombocytosis	J:180203
Lair1^tm1Jco/Lair1^tm1Jco Tg(Cd4-cre)1Cwi/? (involves: C57BL/6 * DBA/2)	decreased IgG2a level	J:180203
	decreased IgG2b level	J:180203
Lama2^dy/Lama2^dy (involves: 129P1/ReJ)	increased IgG level	J:102959
Lama2^dy/Lama2^dy (involves: 129P1/ReJ)	increased IgM level	J:102959
Lama2^tm1Stk/Lama2^tm1Stk (involves: 129P2/OlaHsd * BALB/c)	abnormal thymus corticomedullary boundary morphology	J:61802
	abnormal thymus physiology	J:61802
	decreased double-positive T cell number	J:61802
	decreased T cell number	J:61802
	thymus cortex hypoplasia	J:61802
Lama3^tm1.1Grsb/Lama3^tm1.1Grsb (involves: C57BL/6)	increased alveolar macrophage number	J:235712
Lama4^{tm1.1(KOMP)Vlcg}/Lama4^{tm1.1(KOMP)Vlcg} (C57BL/6N-Lama4^{tm1.1(KOMP)Vlcg}/Ucd)	increased basophil cell number	J:211773
Lama4^tm1Ktry/Lama4^tm1Ktry (either: B6.129X1-Lama4^tm1Ktry or (involves: 129X1/SvJ * C57BL/6))	anemia	J:74287
	decreased erythrocyte cell number	J:74287
	decreased hematocrit	J:74287
	decreased hemoglobin content	J:74287
	reticulocytosis	J:74287
Lama5^b2b2966.1Clo/Lama5^b2b2966.1Clo (C57BL/6J-Lama5^b2b2966.1Clo)	thymus hypoplasia	J:175213
Lama5^tm1Lsor/Lama5^tm1Lsor Tg(Tek-cre)1Ywa/0 (involves: C57BL/6 * SJL)	abnormal marginal zone B cell physiology	J:198783
	decreased marginal zone B cell number	J:198783
	decreased transitional stage T2 B cell number	J:198783
	increased B cell number	J:198783
	increased IgM level	J:198783
	increased transitional stage T1 B cell number	J:198783
Lamc3^{tm1a(KOMP)Wtsi}/Lamc3^{tm1a(KOMP)Wtsi} (C57BL/6N-Lamc3^{tm1a(KOMP)Wtsi}/Wtsi)	thrombocytopenia	J:211773
Lamp1^em1(IMPC)Mbp/Lamp1^em1(IMPC)Mbp (C57BL/6N-Lamp1^em1(IMPC)Mbp/MbpMmucd)	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
	small spleen	J:211773
Lamp2^tm1Psa/Lamp2^tm1Psa (either: (involves: 129P2/OlaHsd * 129/Sv * C57BL/6J) or (involves: 129P2/OlaHsd * 129/Sv))	abnormal thymus morphology	J:64151
	intermingled spleen red and white pulp	J:64151
Lamp3^em1Damme/Lamp3^em1Damme (involves: C57BL/6N)	increased macrophage cell number	J:324174
Lancl2^{tm2a(KOMP)Wtsi}/Lancl2^{tm2a(KOMP)Wtsi} (involves: C57BL/6N)	decreased macrophage cell number	J:250673
	decreased regulatory T cell number	J:250673
Lancl2^{tm2c(KOMP)Wtsi}/Lancl2^{tm2c(KOMP)Wtsi} Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: C57BL/6N)	decreased macrophage cell number	J:250673
	decreased regulatory T cell number	J:250673
Laptm5^{tm1a(EUCOMM)Wtsi}/Laptm5^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Laptm5^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased mean corpuscular hemoglobin	J:175295
Laptm5^tm1Jow/Laptm5^tm1Jow (C57BL/6-Laptm5^tm1Jow)	abnormal T cell activation	J:137841
Laptm5^tm1Jow/Laptm5^tm1Jow (C57BL/6-Laptm5^tm1Jow)	increased T cell proliferation	J:137841
Larp1^em1(IMPC)Mbp/Larp1⁺ (C57BL/6N-Larp1^em1(IMPC)Mbp/Ucd)	abnormal spleen morphology	J:211773
Larp1^em1(IMPC)Mbp/Larp1⁺ (C57BL/6N-Larp1^em1(IMPC)Mbp/Ucd)	enlarged spleen	J:211773
Larp4b^{em1(IMPC)Wtsi}/Larp4b^{em1(IMPC)Wtsi} (C57BL/6N-Larp4b^{em1(IMPC)Wtsi}/Wtsi)	decreased hemoglobin content	J:211773
	increased mean platelet volume	J:211773
Lat2^tm1Mal/Lat2^tm1Mal (involves: 129S2/SvPas)	abnormal mast cell physiology	J:93950
Lat2^tm1Wz/Lat2^tm1Wz (involves: C57BL/6)	abnormal mast cell physiology	J:93951
Lat2^tm1Wz/Lat2^tm1Wz (B6.Cg-Lat2^tm1Wz)	abnormal CD8-positive, alpha-beta T cell physiology	J:116157
	abnormal T cell physiology	J:116157
	increased T cell proliferation	J:116157
	spleen hyperplasia	J:116157
Lat2^tm1Wz/Lat2^tm1Wz (Not Specified)	abnormal T cell physiology	J:181866
Lat2^tm1Wz/Lat2^tm1Wz (Not Specified)	increased mast cell degranulation	J:181866
Lat2^tm2Wz/Lat2^tm2Wz Tg(Lck-cre)548Jxm/0 (involves: C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:116157
	enlarged spleen	J:116157
	increased activated T cell number	J:116157
Lat2^tm3.1Wz/Lat2^tm3.1Wz (B6.Cg-Lat2^tm3.1Wz)	abnormal T cell physiology	J:181866
	enlarged spleen	J:181866
	increased mast cell degranulation	J:181866
	increased memory T cell number	J:181866
Lat^tm1.1Lov/Lat^tm1.1Lov (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:116157, J:77099
	abnormal CD8-positive, alpha beta T cell morphology	J:77099
	abnormal double-negative T cell morphology	J:77099
	abnormal immunoglobulin level	J:77099
	abnormal T cell differentiation	J:77099
	abnormal T cell physiology	J:77099
	decreased double-positive T cell number	J:77099
	decreased T cell proliferation	J:77099
	decreased thymocyte number	J:77099
	enlarged spleen	J:116157, J:77099
	increased activated T cell number	J:77099
	increased IgE level	J:77099
	increased IgG1 level	J:77099
	increased IgM level	J:77099
	increased T cell proliferation	J:77099
	small thymus	J:77099
	spleen hyperplasia	J:116157
Lat^tm1.1Lov/Lat^tm1.1Lov Lat2^tm1Wz/Lat2^tm1Wz (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:116157
	enlarged spleen	J:116157
	spleen hyperplasia	J:116157
Lat^tm1.1Mal/Lat^tm1.1Mal (involves: 129S2/SvPas)	abnormal B cell activation	J:77098
	abnormal gamma-delta T cell differentiation	J:77098
	abnormal lymphocyte morphology	J:77098
	abnormal spleen periarteriolar lymphoid sheath morphology	J:125722
	abnormal T cell selection	J:77098
	abnormal T cell subpopulation ratio	J:77098
	abnormal T-helper 2 physiology	J:125722
	decreased double-positive T cell number	J:77098
	enlarged spleen	J:77098
	increased B cell number	J:77098
	increased CD4-positive, alpha-beta T cell number	J:125722, J:77098
	increased eosinophil cell number	J:77098
	increased IgE level	J:125722, J:77098
	increased IgG1 level	J:262891, J:125722, J:77098
	increased IgM level	J:125722
	increased memory T cell number	J:77098
	increased plasma cell number	J:125722
	increased spleen germinal center number	J:125722
	increased spleen weight	J:262891
	increased susceptibility to autoimmune hemolytic anemia	J:125722
	increased T cell proliferation	J:77098
	increased T-helper 2 cell number	J:77098
	spleen hyperplasia	J:77098
	thymus hypoplasia	J:77098
Lat^tm1.1Mal/Lat^tm1.1Mal (involves: 129S2/SvPas * C57BL/6)	abnormal T cell proliferation	J:131351
Lat^tm1.1Mal/Lat^tm1.1Mal (involves: 129S2/SvPas * C57BL/6)	abnormal T-helper 2 physiology	J:131351
Lat^tm1.1Mal/Lat^tm1.1Mal Rag1^tm1Bal/Rag1^tm1Bal (involves: 129S2/SvPas * 129S4/SvJae)	abnormal platelet dense granule physiology	J:125744
	decreased platelet aggregation	J:125744
Lat^tm1.1Mal/Lat^{tm6.1(HBEGF/EGFP)Mal} (involves: 129S2/SvPas * C57BL/6)	abnormal T-helper 2 physiology	J:151840
Lat^tm1Bpay/Lat^tm1Bpay (involves: 129S2/SvPas)	abnormal platelet aggregation	J:103904
	abnormal T cell differentiation	J:103904
	arrested T cell differentiation	J:103904
	decreased double-negative T cell number	J:103904
	decreased T cell number	J:103904
	decreased thymocyte number	J:103904
	small thymus	J:103904
Lat^tm1Les/Lat^tm1.1Wz (involves: C57BL/6)	abnormal effector T cell morphology	J:147946
Lat^tm1Les/Lat^tm1.1Wz Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	abnormal effector T cell morphology	J:147946
	abnormal T cell differentiation	J:147946
	abnormal T cell physiology	J:147946
	decreased CD4-positive, alpha-beta T cell number	J:147946
	decreased CD8-positive, alpha-beta T cell number	J:147946
	decreased regulatory T cell number	J:147946
	decreased thymocyte number	J:147946
	increased double-positive T cell number	J:147946
	increased gamma-delta T cell number	J:147946
	small thymus	J:147946
Lat^tm1Les/Lat^tm1.2Wz (involves: C57BL/6 * FVB/N)	absent T cells	J:147946
Lat^tm1Les/Lat^tm1.2Wz (involves: C57BL/6 * FVB/N)	arrested T cell differentiation	J:147946
Lat^tm1Les/Lat^tm1Les (Not Specified)	abnormal T cell morphology	J:54059
	arrested T cell differentiation	J:116964, J:54059
	decreased double-negative T cell number	J:54059
	decreased T cell number	J:54059
	decreased thymocyte number	J:54059
	small thymus	J:54059
Lat^tm1Les/Lat^tm1Les Lat2^tm1Wz/Lat2^tm1Wz (involves: C57BL/6)	abnormal mast cell physiology	J:93951
Lat^tm1Les/Lat^tm1Les Lcp2^{tm5(Lat/Lcp2)Gak}/Lcp2^{tm5(Lat/Lcp2)Gak} (involves: 129S1/Sv * 129X1/SvJ)	arrested T cell differentiation	J:147721
	decreased double-positive T cell number	J:147721
Lat^tm1Les/Lat^tm1Les Tg(CD2-LAT2)1Wz/0 (Not Specified)	abnormal B cell physiology	J:116964
	abnormal leukocyte physiology	J:116964
	abnormal single-positive T cell number	J:116964
	abnormal spleen periarteriolar lymphoid sheath morphology	J:116964
	abnormal T cell differentiation	J:116964
	decreased double-positive T cell number	J:116964
	enlarged spleen	J:116964
	increased IgG1 level	J:116964
	increased IgM level	J:116964
	small thymus	J:116964
	spleen hyperplasia	J:116964
Lat^tm2.1Lov/Lat^tm2.1Lov (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)	abnormal T cell differentiation	J:77695
	decreased T cell number	J:77695
	small thymus	J:77695
Lat^tm2.1Mal/Lat^tm2.1Mal (involves: 129S2/SvPas)	abnormal B cell activation	J:94074
	abnormal B cell differentiation	J:94074
	abnormal gamma-delta T cell differentiation	J:94074
	abnormal lymphocyte morphology	J:94074
	abnormal lymphopoiesis	J:94074
	abnormal mature gamma-delta T cell morphology	J:94074
	abnormal plasma cell morphology	J:94074
	abnormal spleen morphology	J:94074
	abnormal spleen periarteriolar lymphoid sheath morphology	J:94074
	abnormal spleen white pulp morphology	J:94074
	abnormal T cell activation	J:94074
	abnormal T-helper 2 cell morphology	J:94074
	abnormal thymocyte activation	J:94074
	absent CD4-positive, alpha-beta T cells	J:94074
	absent CD8-positive, alpha-beta T cells	J:94074
	arrested T cell differentiation	J:94074
	decreased double-positive T cell number	J:94074
	enlarged spleen	J:94074
	increased B cell number	J:94074
	increased IgE level	J:94074
	increased IgG1 level	J:94074
	increased immunoglobulin level	J:94074
	increased mature gamma-delta T cell number	J:94074
	thymus hypoplasia	J:94074
Lat^tm2.1Mal/Lat^tm2.1Mal Lat2^tm1Mal/Lat2^tm1Mal (involves: 129S2/SvPas)	abnormal mast cell physiology	J:93950
Lat^tm2.1Mal/Lat^tm2.1Mal Rag1^tm1Bal/Rag1^tm1Bal (involves: 129S2/SvPas * 129S4/SvJae)	abnormal platelet dense granule physiology	J:125744
	decreased platelet aggregation	J:125744
Lat^tm3.1Mal/Lat^tm3.1Mal (involves: 129S2/SvPas)	abnormal gamma-delta T cell differentiation	J:94074
	abnormal splenic cell ratio	J:94074
	abnormal thymocyte activation	J:94074
	abnormal thymus cell ratio	J:94074
	absent CD4-positive, alpha-beta T cells	J:94074
	absent CD8-positive, alpha-beta T cells	J:94074
	absent mature gamma-delta T cells	J:94074
	arrested T cell differentiation	J:94074
	decreased double-positive T cell number	J:94074
	decreased T cell number	J:94074
	increased T cell number	J:94074
Lat^tm4.1Mal/Lat^tm4.1Mal (involves: 129P2/OlaHsd)	abnormal gamma-delta T cell differentiation	J:94074
	abnormal lymphocyte morphology	J:94074
	abnormal splenic cell ratio	J:94074
	abnormal thymocyte activation	J:94074
	abnormal thymus cell ratio	J:94074
	absent CD4-positive, alpha-beta T cells	J:94074
	absent CD8-positive, alpha-beta T cells	J:94074
	absent mature gamma-delta T cells	J:94074
	arrested T cell differentiation	J:94074
	decreased double-positive T cell number	J:94074
	decreased platelet aggregation	J:125744
	decreased T cell number	J:94074
Lat^tm4.1Mal/Lat^tm4.1Mal Tg(LckF505)3073Rmp/? (involves: 129P2/OlaHsd C57BL/6 * DBA/2)	abnormal T-helper 2 physiology	J:151840
	increased CD4-positive, alpha-beta T cell number	J:151840
	increased IgE level	J:151840
	increased IgG1 level	J:151840
	spleen hyperplasia	J:151840
Lat^tm4.1Mal/Lat^tm4.1Mal Trdc^tm1Mal/Trdc^tm1Mal (involves: 129P2/OlaHsd * C57BL/6)	abnormal double-negative T cell morphology	J:112658
Lat^tm4.1Mal/Lat^{tm6.1(HBEGF/EGFP)Mal} (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	abnormal T-helper 2 physiology	J:151840
Lat^tm5.1Mal/Lat^tm5.1Mal (involves: C57BL/6)	arrested T cell differentiation	J:152363
Lat^{tm6.1(HBEGF/EGFP)Mal}/? Rag2^tm1Fwa/Rag2^tm1Fwa Tg(TcraH-Y,TcrbH-Y)1Pas/? (involves: 129S/SvEv * 129S2/SvPas * C57BL/6)	abnormal T cell physiology	J:138401
Lat^{tm6.1(HBEGF/EGFP)Mal}/Lat^{tm6.1(HBEGF/EGFP)Mal} (involves: 129S2/SvPas * C57BL/6)	abnormal T cell activation	J:151840
	abnormal T-helper 2 physiology	J:151840
Lat^{tm8.1(CD2,-ECFP)Mal}/Lat^{tm8.1(CD2,-ECFP)Mal} (involves: 129S2/SvPas * C57BL/6)	abnormal lymphocyte morphology	J:152149
	abnormal T cell receptor delta chain V(D)J recombination	J:152149
	abnormal T cell receptor gamma chain V-J recombination	J:152149
	arrested T cell differentiation	J:152149
	increased double-negative T cell number	J:152149
Lat^tm9Mal/Lat^tm9Mal (involves: C57BL/6)	abnormal B cell number	J:205441
	abnormal lymphopoiesis	J:205441
	increased T-helper 2 cell number	J:205441
Lats1^em1(IMPC)H/Lats1^em1(IMPC)H (C57BL/6NTac-Lats1^em1(IMPC)H/H)	decreased hemoglobin content	J:211773
	increased neutrophil cell number	J:211773
Lax1^tm1Wz/Lax1^tm1Wz (involves: C57BL/6)	abnormal B cell physiology	J:98403
	abnormal spleen germinal center morphology	J:98403
	abnormal splenic cell ratio	J:98403
	abnormal T cell activation	J:98403
	abnormal T cell physiology	J:98403
	increased IgE level	J:98403
	increased IgG1 level	J:98403
	increased IgG2a level	J:98403
Layn^em1Romd/Layn^em1Romd Tg(Cd8a-cre,-GFP)1Yzo/0 (involves: C57BL/6)	abnormal CD8-positive, alpha-beta T cell physiology	J:302853
Lbca1^C57BL/6Igc/Lbca1^C57BL/6Igc (involves: BALB/cIgc * C57BL/6Igc)	abnormal B cell activation	J:139348
	increased B cell proliferation	J:139348
Lbca2^BALB/cIgc/Lbca2^C57BL/6Igc (involves: BALB/cIgc * C57BL/6Igc)	abnormal B cell activation	J:139348
	increased B cell proliferation	J:139348
Lbca2^C57BL/6Igc/Lbca2^C57BL/6Igc (involves: BALB/cIgc * C57BL/6Igc)	abnormal B cell activation	J:139348
	increased B cell proliferation	J:139348
Lbp^{tm1b(EUCOMM)Hmgu}/Lbp^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Lbp^{tm1b(EUCOMM)Hmgu}/H)	increased spleen weight	J:211773
Lbp^tm1Buru/Lbp^tm1Buru (B6.129-Lbp^tm1Buru)	abnormal neutrophil physiology	J:129411
Lbr^em1(IMPC)Tcp/Lbr^em1(IMPC)Tcp (C57BL/6N-Lbr^em1(IMPC)Tcp/Tcp)	decreased lymphocyte cell number	J:211773
	decreased mean corpuscular hemoglobin	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Lbr^Gt(XE569)Byg/Lbr^Gt(XE569)Byg (involves: 129P2/OlaHsd * C57BL/6Cr)	abnormal granulocyte differentiation	J:138854
	abnormal granulocyte morphology	J:138854
	abnormal lymphocyte morphology	J:138854
	abnormal neutrophil morphology	J:138854
Lbr^ic-2J/Lbr^ic-2J (involves: A/J)	abnormal blood cell morphology/development	J:80915
Lbr^ic-3J/Lbr^ic-3J (involves: A/J)	abnormal blood cell morphology/development	J:80915
Lbr^ic-J/Lbr⁺ (C57BL/6J-Lbr^ic-J)	abnormal granulocyte morphology	J:80915
Lbr^ic-J/Lbr⁺ ((NZW/LacJ x C57BL/6J-Lbr^ic-J/J)F1)	abnormal neutrophil morphology	J:234168
Lbr^ic-J/Lbr⁺ ((NZW/LacJ x C57BL/6J-Lbr^ic-J/J)F1)	enlarged spleen	J:234168
Lbr^ic-J/Lbr⁺ Tm7sf2^tm1Fdp/Tm7sf2^tm1Fdp (involves: 129S4/SvJae * C57BL/6)	abnormal spleen morphology	J:143838
Lbr^ic-J/Lbr^ic-J (C57BL/6J-Lbr^ic-J)	abnormal eosinophil morphology	J:80915
	abnormal lymphocyte morphology	J:80915
	abnormal neutrophil morphology	J:80915
Lbr^ic-J/Lbr^ic-J (involves: 129S4/SvJae * C57BL/6)	abnormal neutrophil differentiation	J:143838
Lbr^ic-J/Lbr^ic-J (involves: 129S4/SvJae * C57BL/6)	abnormal spleen morphology	J:143838
Lbr^ic-J/Lbr^ic-J Tm7sf2^tm1Fdp/Tm7sf2⁺ (involves: 129S4/SvJae * C57BL/6)	extramedullary hematopoiesis	J:143838
Lbr^ic-J/Lbr^lym3 (C57BL/6-Lbr^ic-J/Lbr^lym3)	decreased leukocyte cell number	J:180355
Lbr^ic-J/Lbr^lym3 (C57BL/6-Lbr^ic-J/Lbr^lym3)	decreased lymphocyte cell number	J:180355
Lbr^lym3/Lbr⁺ (C57BL/6-Lbr^lym3)	abnormal neutrophil morphology	J:180355
Lbr^lym3/Lbr^lym3 (C57BL/6-Lbr^lym3)	abnormal B cell physiology	J:180355
	abnormal blood cell morphology/development	J:180355
	abnormal lymphocyte cell number	J:180355
	abnormal lymphocyte morphology	J:180355
	abnormal neutrophil morphology	J:180355
	abnormal T cell physiology	J:180355
	decreased B cell number	J:180355
	decreased CD4-positive, alpha-beta T cell number	J:180355
	decreased CD8-positive, alpha-beta T cell number	J:180355
	decreased leukocyte cell number	J:180355
	decreased lymphocyte cell number	J:180355
	decreased T cell number	J:180355
	decreased T cell proliferation	J:180355
	spleen hypoplasia	J:180355
	thymus hypoplasia	J:180355
Lbw2^NZB/BlScr/Lbw2^NZB/BlScr (involves: NZB * NZW)	increased spleen weight	J:98150
Lbw2^NZW/LacScr/Lbw2^NZW/LacScr (involves: NZB * NZW)	decreased IgG level	J:98150
Lbw2^NZW/LacScr/Lbw2^NZW/LacScr (involves: NZB * NZW)	decreased IgM level	J:98150
Lbw4^NZW/LacScr/? (involves: C57BL/6J * NZM2410/Aeg)	decreased immunoglobulin level	J:52863
Lca5l^em1(IMPC)Ics/Lca5l^em1(IMPC)Ics (C57BL/6N-Lca5l^em1(IMPC)Ics/Ics)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	thrombocytopenia	J:211773
Lcat^tm1Nsa/Lcat^tm1Nsa (B6.Cg-Lcat^tm1Nsa)	decreased erythrocyte osmotic fragility	J:69299
	hematopoietic system phenotype	J:69299
	hemolytic anemia	J:69299
	reticulocytosis	J:69299
Lck^m1Btlr/Lck^m1Btlr (C57BL/6J-Lck^m1Btlr)	abnormal CD4-positive T cell differentiation	J:144695
	abnormal CD8-positive, alpha-beta T cell differentiation	J:144695
	decreased CD4-positive, alpha-beta T cell number	J:144695
	decreased CD8-positive, alpha-beta T cell number	J:144695
	decreased cytotoxic T cell cytolysis	J:144695
	thymus atrophy	J:144695
	thymus hypoplasia	J:144695
Lck^m2Btlr/Lck^m2Btlr (C57BL/6J-Lck^m2Btlr)	decreased CD4-positive, alpha-beta T cell number	J:203759
	decreased CD8-positive, alpha-beta T cell number	J:203759
	decreased IgG level	J:203759
Lck^m3Btlr/Lck^m3Btlr (C57BL/6J-Lck^m3Btlr)	abnormal T cell subpopulation ratio	J:217863
	decreased single-positive T cell number	J:217863
	increased activated T cell number	J:217863
	increased single-positive T cell number	J:217863
Lck^tm1.1Litt/Lck^tm1.1Litt (Not Specified)	abnormal immunoglobulin level	J:152472
	abnormal lymphocyte morphology	J:152472
	abnormal thymus morphology	J:152472
Lck^tm1Dbs/Lck^tm1Dbs (involves: C3H * C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:114660
	abnormal CD8-positive, alpha beta T cell morphology	J:114660
	abnormal double-negative T cell morphology	J:114660
	abnormal T cell differentiation	J:114660
	decreased T cell number	J:114660
	decreased T cell proliferation	J:114660
	decreased thymocyte number	J:114660
Lck^tm1Dbs/Lck^tm1Dbs Tg(TcraH-Y,TcrbH-Y)71Vbo/0 (involves: C3H * C57BL/6 * DBA/2J)	abnormal positive T cell selection	J:114660
	abnormal T cell differentiation	J:114660
	arrested T cell differentiation	J:114660
Lck^tm1Dbs/Lck^tm1Dbs Tg(TcraTcrb)425Cbn/0 (involves: C3H * C57BL/6)	abnormal positive T cell selection	J:114660
	arrested T cell differentiation	J:114660
Lck^tm1Dbs/Lck^tm1Dbs Tg(TcraTcrb)1100Mjb/0 (involves: C3H * C57BL/6)	abnormal positive T cell selection	J:114660
	decreased T cell proliferation	J:114660
Lck^tm1Litt/Lck^tm1.1Litt Tnfrsf4^tm2(cre)Nik/Tnfrsf4⁺ (involves: 129X1/SvJ)	abnormal regulatory T cell physiology	J:152472
	decreased regulatory T cell number	J:152472
	decreased T cell proliferation	J:152472
	increased regulatory T cell number	J:152472
	increased T cell number	J:152472
Lck^tm1Mak/Lck^tm1Mak (involves: 129S2/SvPas)	abnormal alpha-beta intraepithelial T cell morphology	J:112977
	abnormal double-negative T cell morphology	J:110847
	abnormal lymphocyte morphology	J:1119
	abnormal single-positive T cell number	J:37062
	abnormal T cell morphology	J:110847
	abnormal thymocyte activation	J:110847
	decreased CD4-positive, alpha-beta T cell number	J:37940
	decreased CD8-positive, alpha-beta T cell number	J:37940
	decreased double-positive T cell number	J:1119, J:110847
	decreased gamma-delta intraepithelial T cell number	J:112977, J:37940
	decreased gamma-delta T cell number	J:37062
	decreased IgG1 level	J:1119
	decreased T cell number	J:1119, J:37062
	decreased thymocyte number	J:1119
	increased IgG2a level	J:1119
	increased IgG3 level	J:1119
	increased IgM level	J:1119
	thymus atrophy	J:1119
	thymus hypoplasia	J:37062, J:37940
Lck^tm1Mak/Lck^tm1Mak (B6.129S2-Lck^tm1Mak)	abnormal intraepithelial T cell morphology	J:111646
	abnormal intraepithelial T cell number	J:111646
	abnormal T cell differentiation	J:111646
	decreased cytotoxic T cell cytolysis	J:111646
	decreased gamma-delta intraepithelial T cell number	J:111646
Lck^tm1Mak/Lck^tm1Mak Rag1^tm1Mom/Rag1⁺ Tg(Lck-FynY528F)5525Cjg/0 (involves: 129S2/SvPas 129S7/SvEvBrd * C57BL/6)	abnormal T cell differentiation	J:37062
	decreased T cell number	J:37062
Lclat1^em1(IMPC)Mbp/Lclat1^em1(IMPC)Mbp (C57BL/6N-Lclat1^em1(IMPC)Mbp/MbpMmucd)	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
Lcmt1^{em1(IMPC)Rbrc}/Lcmt1⁺ (C57BL/6NJcl-Lcmt1^{em1(IMPC)Rbrc}/Rbrc)	increased spleen weight	J:211773
Lcn2^tm1Aade/Lcn2^tm1Aade (B6.129P2-Lcn2^tm1Aade)	increased spleen weight	J:169355
Lcn2^{tm1b(KOMP)Wtsi}/Lcn2^{tm1b(KOMP)Wtsi} (C57BL/6N-Lcn2^{tm1b(KOMP)Wtsi}/J)	increased mean corpuscular volume	J:211773
Lcn2^tm1Mrgr/Lcn2^tm1Mrgr (129(B6)-Lcn2^tm1Mrgr)	abnormal erythropoiesis	J:173490
	abnormal mast cell physiology	J:173490
	abnormal myelopoiesis	J:173490
	decreased thymocyte apoptosis	J:173490
	hematopoietic system phenotype	J:173490
	increased B cell number	J:173490
	increased bone marrow cell number	J:173490
	increased erythroblast number	J:173490
	increased erythrocyte cell number	J:173490
	increased erythroid progenitor cell number	J:173490
	increased hematocrit	J:173490
	increased leukocyte cell number	J:173490
	increased lymphocyte cell number	J:173490
	increased macrophage cell number	J:173490
	increased mean corpuscular hemoglobin	J:173490
	increased monocyte cell number	J:173490
	increased neutrophil cell number	J:173490
	increased splenocyte number	J:173490
	myeloid hyperplasia	J:173490
	spleen hyperplasia	J:173490
	thrombocytopenia	J:173490
	thymus hyperplasia	J:173490
Lcn2^tm1Mrgr/Lcn2^tm1Mrgr (B6.129-Lcn2^tm1Mrgr)	abnormal mast cell physiology	J:173490
Lcn2^tm1Mrgr/Lcn2^tm1Mrgr (involves: 129 * C57BL/6)	abnormal mast cell physiology	J:173490
Lcp1^{tm1e.1(KOMP)Wtsi}/Lcp1⁺ (C57BL/6N-Lcp1^{tm1e.1(KOMP)Wtsi}/J)	decreased hematocrit	J:211773
	thrombocytopenia	J:211773
Lcp1^tm1Erjb/Lcp1^tm1Erjb (involves: 129X1/SvJ)	abnormal macrophage physiology	J:161042
Lcp1^tm1Erjb/Lcp1^tm1Erjb (involves: 129X1/SvJ)	abnormal neutrophil physiology	J:161042
Lcp2^m1Khoe/Lcp2^m1Khoe (C57BL/6J-Lcp2^m1Khoe)	abnormal NK cell physiology	J:196519
Lcp2^m1Khoe/Lcp2^m1Khoe (C57BL/6J-Lcp2^m1Khoe)	impaired natural killer cell mediated cytotoxicity	J:196519
Lcp2^tm1.1Wz/Lcp2^tm1.1Wz (B6.Cg-Lcp2^tm1.1Wz)	abnormal effector T cell morphology	J:150304
	abnormal T cell differentiation	J:150304
	abnormal T cell subpopulation ratio	J:150304
	decreased CD4-positive, alpha-beta T cell number	J:150304
	decreased CD8-positive, alpha-beta T cell number	J:150304
	decreased double-negative T cell number	J:150304
	decreased T cell number	J:150304
	decreased T cell proliferation	J:150304
	decreased thymocyte number	J:150304
	increased double-negative T cell number	J:150304
	small thymus	J:150304
Lcp2^tm1.1Wz/Lcp2^tm1.1Wz Tg(TcraH-Y,TcrbH-Y)71Vbo/0 (involves: C57BL/6 * C57BL/6J * DBA/2J)	abnormal T cell differentiation	J:150304
Lcp2^tm1Gak/Lcp2^tm1Gak (involves: 129S1/Sv * 129X1/SvJ)	abnormal platelet activation	J:162815
Lcp2^tm1Gak/Lcp2^tm1Gak (involves: 129S1/Sv * 129X1/SvJ)	decreased platelet aggregation	J:162815
Lcp2^tm1Gak/Lcp2^tm2Gak Tg(Pf4-icre)Q3Rsko/0 Gt(ROSA)26Sor^tm1(EYFP)Cos/Gt(ROSA)26Sor⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal platelet activation	J:162815
Lcp2^tm1Geha/Lcp2^tm1Geha (involves: 129S4/SvJae)	impaired natural killer cell mediated cytotoxicity	J:131621
Lcp2^tm1Geha/Lcp2^tm1Geha (involves: 129S4/SvJae)	increased NK cell number	J:131621
Lcp2^tm2Gak/Lcp2^tm2Gak Tg(Cd4-cre)1Cwi/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)	decreased CD4-positive, alpha-beta T cell number	J:107467
	decreased T cell apoptosis	J:107467
	increased CD8-positive, alpha-beta T cell number	J:107467
	increased gamma-delta T cell number	J:107467
	thymus hypoplasia	J:107467
Lcp2^tm3Gak/Lcp2^tm3Gak (involves: 129S6/SvEvTac * C57BL/6)	abnormal double-negative T cell morphology	J:132995
	abnormal negative T cell selection	J:132995
	abnormal T cell activation	J:132995
	abnormal T cell subpopulation ratio	J:132995
	decreased NK T cell number	J:132995
Lcp2^tm3Gak/Lcp2^tm3Gak (involves: 129S6/SvEvTac * BALB/c * C57BL/6)	abnormal negative T cell selection	J:132995
Lcp2^tm3Gak/Lcp2^tm3Gak Tg(TcraH-Y,TcrbH-Y)71Vbo/? (involves: 129S6/SvEvTac * C57BL/6 * DBA/2J)	abnormal negative T cell selection	J:132995
	increased CD8-positive, alpha-beta T cell number	J:132995
	increased double-positive T cell number	J:132995
Lcp2^tm3Gak/Lcp2^tm3Gak Tg(TcrAND)53Hed/? (involves: 129S6/SvEvTac * C57BL/6 * SJL)	abnormal positive T cell selection	J:132995
	abnormal thymocyte activation	J:132995
Lcp2^tm4Gak/Lcp2^tm4Gak (involves: 129S6/SvEvTac * C57BL/6 * FVB/N)	abnormal double-negative T cell morphology	J:132995
	abnormal negative T cell selection	J:132995
	abnormal T cell activation	J:132995
	abnormal T cell subpopulation ratio	J:132995
	decreased NK T cell number	J:132995
Lcp2^tm4Gak/Lcp2^tm4Gak (involves: 129S6/SvEvTac * BALB/c * C57BL/6)	abnormal negative T cell selection	J:132995
Lcp2^tm4Gak/Lcp2^tm4Gak Tg(TcraH-Y,TcrbH-Y)71Vbo/? (involves: 129S6/SvEvTac * C57BL/6 * DBA * FVB/N)	abnormal negative T cell selection	J:132995
	increased double-positive T cell number	J:132995
Lcp2^tm4Gak/Lcp2^tm4Gak Tg(TcrAND)53Hed/? (involves: 129S6/SvEvTac * C57BL/6 * SJL)	abnormal positive T cell selection	J:132995
	abnormal thymocyte activation	J:132995
Lcp2^{tm5(Lat/Lcp2)Gak}/Lcp2^{tm5(Lat/Lcp2)Gak} (involves: 129S1/Sv * 129X1/SvJ)	abnormal thymocyte activation	J:147721
	arrested T cell differentiation	J:147721
	decreased double-positive T cell number	J:147721
	decreased single-positive T cell number	J:147721
	thymus hypoplasia	J:147721
Lcp2^twm/Lcp2^twm (C57BL/6JSfdAnu-Lcp2^twm/Anu)	abnormal double-positive T cell morphology	J:104190
	abnormal negative T cell selection	J:104190
	abnormal positive T cell selection	J:104190
	abnormal T cell physiology	J:104190
	arrested T cell differentiation	J:104190
	decreased T cell number	J:104190
	decreased thymocyte number	J:104190
	increased IgE level	J:104190
	increased IgG level	J:104190
Lctlp1^DBA/1J/Lctlp1^DBA/1J (involves: DBA/1J * FVB/NJ)	increased CD8-positive, alpha-beta T cell number	J:122919
Lctlp1^DBA/1J/Lctlp1^FVB/NJ (involves: DBA/1J * FVB/NJ)	increased CD8-positive, alpha-beta T cell number	J:122919
Lctlp2^DBA/1J/Lctlp2^DBA/1J (involves: DBA/1J * FVB/NJ)	increased CD8-positive, alpha-beta T cell number	J:122919
Lctlp2^DBA/1J/Lctlp2^FVB/NJ (involves: DBA/1J * FVB/NJ)	increased CD8-positive, alpha-beta T cell number	J:122919
Ldb1^tm1.1Gsv/Ldb1^tm1.1Gsv (involves: 129P2/OlaHsd * C57BL/6 * FVB)	abnormal embryonic erythropoiesis	J:196469
Ldb1^tm1Lmgd/Ldb1^tm1Lmgd (involves: CD-1)	abnormal hematopoietic system morphology/development	J:81152
Ldb3^{tm2b(EUCOMM)Hmgu}/Ldb3⁺ (C57BL/6N-Ldb3^{tm2b(EUCOMM)Hmgu}/Bay)	increased basophil cell number	J:211773
	increased large unstained cell number	J:211773
Ldha^a-m1Neu/Ldha^a-m1Neu (C3.Cg-Ldha^a-m1Neu)	decreased erythrocyte cell number	J:14326
	decreased hematocrit	J:14326
	decreased hemoglobin content	J:14326
	hemolytic anemia	J:14326
	reticulocytosis	J:14326
Ldha^a-m1Neu/Ldha^a-m1Neu (involves: 101/El * C3H/El)	abnormal common myeloid progenitor cell morphology	J:132674
	abnormal erythrocyte morphology	J:132674
	abnormal leukocyte morphology	J:132674
	decreased erythrocyte cell number	J:132674
	decreased hematocrit	J:132674
	decreased hemoglobin content	J:132674
	hemolytic anemia	J:132674
	increased mean corpuscular volume	J:132674
	increased neutrophil cell number	J:132674
	increased spleen weight	J:132674
	reticulocytosis	J:132674
	spleen hyperplasia	J:132674
Ldha^a-m2Neu/Ldha⁺ (C3.Cg-Ldha^a-m2Neu)	hematopoietic system phenotype	J:1072
Ldha^a-m3Neu/Ldha⁺ (C3.Cg-Ldha^a-m3Neu)	hematopoietic system phenotype	J:1072
Ldha^a-m3Neu/Ldha^a-m3Neu (C3.Cg-Ldha^a-m3Neu)	decreased hemoglobin content	J:1072
Ldha^a-m4Neu/Ldha⁺ (C3.Cg-Ldha^a-m4Neu)	hematopoietic system phenotype	J:1072
Ldha^a-m6Neu/Ldha^a-m6Neu (C3.Cg-Ldha^a-m6Neu)	hematopoietic system phenotype	J:7771
Ldlr^Hlb301/Ldlr⁺ (C57BL/6J-Ldlr^Hlb301/J)	increased macrophage derived foam cell number	J:82961
Ldlr^Hlb301/Ldlr^Hlb301 (C57BL/6J-Ldlr^Hlb301/J)	increased macrophage derived foam cell number	J:82961
Ldlr^{tm1b(EUCOMM)Wtsi}/Ldlr^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Ldlr^{tm1b(EUCOMM)Wtsi}/Ieg)	increased mean corpuscular volume	J:211773
Ldlr^tm1Her/Ldlr^tm1Her (involves: 129S7/SvEvBrd * C57BL/6)	abnormal microglial cell morphology	J:116493
Ldlr^tm1Her/Ldlr^tm1Her (B6.129S7-Ldlr^tm1Her)	abnormal microglial cell morphology	J:137264
Ldlr^tm1Her/Ldlr^tm1Her Lrp1^tm2Her/Lrp1^tm2Her Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S7/SvEvBrd)	impaired macrophage phagocytosis	J:137404
Ldlr^tm1Her/Ldlr^tm1Her Lrp1^tm2Her/Lrp1^tm2Her Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J)	abnormal microglial cell physiology	J:144185
Ldlr^tm1Her/Ldlr^tm1Her Mapkapk2^tm1Mgl/Mapkapk2^tm1Mgl (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)	abnormal macrophage derived foam cell morphology	J:142788
	decreased macrophage cell number	J:142788
Ldlr^tm1Her/Ldlr^tm1Her Pfn1^tm1Wit/Pfn1⁺ (B6.129S-Ldlr^tm1Her Pfn1^tm1Wit)	impaired macrophage chemotaxis	J:140294
Ldlr^tm1Her/Ldlr^tm1Her Tbx21^tm1Glm/Tbx21^tm1Glm (involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6)	decreased IgG level	J:96110
	increased IgM level	J:96110
Ldlr^tm1Her/Ldlr^tm1Her Tg(H2-K-AKR1B1)1Tj/0 (involves: 129S7/SvEvBrd * C57BL/6 * DBA/2)	abnormal macrophage physiology	J:100916
Ldlr^tm1Her/Ldlr^tm1Her Tlr2^tm1Kir/Tlr2^tm1Kir (B6.129-Tlr2^tm1Kir Ldlr^tm1Her)	abnormal cellular extravasation	J:131783
Ldlr^tm1Her/Ldlr^tm1Her Vwf^tm1Wgr/Vwf^tm1Wgr (B6.129S-Vwf^tm1Wgr Ldlr^tm1Her)	impaired leukocyte tethering or rolling	J:106677
Ldlrad4^{tm1b(EUCOMM)Wtsi}/Ldlrad4^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Ldlrad4^{tm1b(EUCOMM)Wtsi}/Wtsi)	decreased monocyte cell number	J:211773
Lect2^tm1Ymg/Lect2^tm1Ymg (involves: 129P2/OlaHsd * C57BL/6J)	abnormal leukocyte physiology	J:90961
	increased T cell apoptosis	J:90961
	increased T cell number	J:90961
Lef1^{tm1.1(KOMP)Vlcg}/Lef1⁺ (C57BL/6N-Lef1^{tm1.1(KOMP)Vlcg}/Ucd)	increased monocyte cell number	J:211773
Lef1^tm1Hhx/Lef1^tm1Hhx Tcf7^tm1Cle/Tcf7^tm1Cle Gt(ROSA)26Sor^tm2Sho/Gt(ROSA)26Sor⁺ Tg(GZMB-cre)1Jcb/0 (involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 * FVB/N)	abnormal memory T cell physiology	J:189838
	decreased CD8-positive, alpha-beta T cell number	J:189838
Lefty2^tm2Hmd/Lefty2^tm2Hmd (involves: 129P2/OlaHsd * C57BL/6)	accessory spleen	J:70483
Lemd2^em1(IMPC)Bay/Lemd2⁺ (C57BL/6N-Lemd2^em1(IMPC)Bay/Bay)	abnormal spleen morphology	J:211773
Lemd2^{Gt(DD0639)Wtsi}/Lemd2^{Gt(DD0639)Wtsi} (B6.129P2-Lemd2^{Gt(DD0639)Wtsi})	anemia	J:221495
Lep^m1Yst/Lep^m1Yst (C57BL/6J-Lep^m1Yst)	increased macrophage cell number	J:167736
Lep^ob/Lep^ob (involves: C57BL/6J)	abnormal osteoclast differentiation	J:60001
Lep^ob/Lep^ob (B6.Cg-Lep^ob/J)	decreased NK cell number	J:117826
Lep^ob/Lep^ob (involves: STOCK Mlph^ln a Tgfa^wa1 Cdh23^v Ednrb^s)	abnormal microglial cell physiology	J:115569
Lep^ob/Lep^ob (involves: C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:164339
	decreased splenocyte number	J:164339
	decreased T cell proliferation	J:164339
Lep^{tm1b(EUCOMM)Hmgu}/Lep^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Lep^{tm1b(EUCOMM)Hmgu}/Bay)	decreased spleen weight	J:211773
Lepr^db-5J/Lepr^db-5J (NOD/ShiLt-Lepr^db-5J)	abnormal CD4-positive, alpha beta T cell morphology	J:118304
Lepr^db-5J/Lepr^db-5J (NOD/ShiLt-Lepr^db-5J)	abnormal CD8-positive, alpha beta T cell morphology	J:118304
Lepr^db-Nokl/Lepr^db-Nokl (C57BL/6N-Lepr^db-Nokl)	increased glycosylated hemoglobin level	J:313303
Lepr^db-Pas/Lepr^db-Pas (involves: DW/Pas)	enlarged spleen	J:174584
Lepr^db/Lepr^db-Nokl (B6NTac.Cg-Lepr^db Lepr^db-Nokl)	increased glycosylated hemoglobin level	J:313303
Lepr^db/Lepr^db (involves: C57BLKS/J)	increased glycosylated hemoglobin level	J:104790
Lepr^db/Lepr^db (B6.Cg-Dock7^m +/+ Lepr^db/J)	abnormal leukocyte morphology	J:115772
	decreased leukocyte cell number	J:115772
	increased neutrophil cell number	J:115772
Lepr^db/Lepr^db (involves: C57BL/6)	abnormal osteoclast differentiation	J:60001
Lepr^db/Lepr^db (B6NTac.BKS(D)-Lepr^db)	increased glycosylated hemoglobin level	J:313303
Lepr^m7Btlr/Lepr^m7Btlr (C57BL/6J-Lepr^m7Btlr)	increased IgE level	J:236685
Lepr^m8Btlr/Lepr^m8Btlr (C57BL/6J-Lepr^m8Btlr)	decreased CD8-positive, naive alpha-beta T cell number	J:267679
	increased effector memory CD4-positive, alpha-beta T cell number	J:267679
	increased effector memory CD8-positive, alpha-beta T cell number	J:267679
Lepr^{tm1b(EUCOMM)Wtsi}/Lepr^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Lepr^{tm1b(EUCOMM)Wtsi}/H)	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	decreased spleen weight	J:211773
	increased eosinophil cell number	J:211773
	increased hematocrit	J:211773
	increased hemoglobin content	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
	increased mean platelet volume	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
	increased red blood cell distribution width	J:211773
	thrombocytopenia	J:211773
Lepr^tm4Mgmj/Lepr^tm4Mgmj (B6.Cg-Lepr^tm4Mgmj)	decreased CD4-positive, alpha-beta T cell number	J:164339
	decreased splenocyte number	J:164339
	decreased T cell proliferation	J:164339
Leprot^{tm2a(KOMP)Wtsi}/Leprot^{tm2a(KOMP)Wtsi} (C57BL/6N-Leprot^{tm2a(KOMP)Wtsi}/Wtsi)	increased red blood cell distribution width	J:211773
Lfng^tm1Rjo/Lfng^tm1Rjo (involves: 129S7/SvEvBrd * C57BL/6)	abnormal embryonic hematopoiesis	J:146621
Lfng^tm1Rjo/Lfng^tm1Rjo Mfng^tm1Cjg/Mfng^tm1Cjg (B6.Cg-Lfng^tm1Rjo Mfng^tm1Cjg)	abnormal embryonic hematopoiesis	J:146621
Lgals2^tm1.1Cfg/Lgals2^tm1.1Cfg (involves: C57BL/6)	decreased neutrophil cell number	J:217719
	increased CD4-positive, alpha-beta T cell number	J:217719
	increased CD8-positive, alpha-beta T cell number	J:217719
	increased IgG2b level	J:217719
	increased IgG3 level	J:217719
	increased leukocyte cell number	J:217719
	increased lymphocyte cell number	J:217719
	increased spleen red pulp amount	J:217719
	increased T cell number	J:217719
Lgals3^tm1Ftl/Lgals3^tm1Ftl (B6.129S2-Lgals3^tm1Ftl)	abnormal CD8-positive, alpha-beta cytotoxic T cell morphology	J:109126
	decreased macrophage cell number	J:109126
	increased IgG level	J:109126
Lgals3^tm1Ftl/Lgals3^tm1Ftl (involves: 129S2/SvPas * C57BL/6)	abnormal leukocyte physiology	J:60741
	abnormal macrophage physiology	J:60741
	abnormal monocyte morphology	J:60741
	decreased lymphocyte cell number	J:60741
	decreased macrophage cell number	J:313172, J:60741
	decreased monocyte cell number	J:60741
	increased eosinophil cell number	J:60741
	increased macrophage apoptosis	J:60741
Lgals3^tm1Poi/Lgals3^tm1Poi (involves: 129/Sv * C57BL/6 * SJL)	abnormal macrophage physiology	J:131971
	impaired macrophage chemotaxis	J:131971
	impaired macrophage phagocytosis	J:131407
	impaired neutrophil recruitment	J:131407
Lgals3^tm1Poi/Lgals3^tm1Poi (involves: 129/Sv * C57BL/6 * MF1 * SJL)	decreased granulocyte number	J:110422
Lgals9^tm1.1Cfg/Lgals9^tm1.1Cfg (involves: C57BL/6)	increased B cell proliferation	J:217719
	increased lymphocyte cell number	J:217719
	increased neutrophil cell number	J:217719
	increased spleen germinal center size	J:217719
	spleen hyperplasia	J:217719
	thymus hyperplasia	J:217719
Lgals9^tm1Glp/Lgals9^tm1Glp (B6.129S6-Lgals9^tm1Glp)	decreased regulatory T cell number	J:132889
Lgals9^tm1Glp/Lgals9^tm1Glp (B6.129S6-Lgals9^tm1Glp)	increased T-helper 1 cell number	J:132889
Lgi3^em1(IMPC)Mbp/Lgi3^em1(IMPC)Mbp (C57BL/6N-Lgi3^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Lgmn^tm1Cptr/Lgmn^tm1Cptr (B6.129S6-Lgmn^tm1Cptr)	enlarged spleen	J:172774
Lgmn^tm1Ihn/Lgmn^tm1Ihn (involves: 129P2/OlaHsd * C57BL/6)	abnormal bone marrow cell morphology/development	J:143886
	abnormal erythrocyte morphology	J:143886
	abnormal macrophage physiology	J:143886
	abnormal NK cell physiology	J:143886
	abnormal spleen morphology	J:143886
	anemia	J:143886
	decreased erythrocyte cell number	J:143886
	decreased hematocrit	J:143886
	decreased hemoglobin content	J:143886
	decreased mean corpuscular hemoglobin	J:143886
	decreased mean corpuscular hemoglobin concentration	J:143886
	extramedullary hematopoiesis	J:143886
	increased lymphocyte cell number	J:143886
	increased spleen weight	J:143886
	reticulocytosis	J:143886
Lgr5^{em1(IMPC)Kmpc}/Lgr5⁺ (C57BL/6NTac-Lgr5^{em1(IMPC)Kmpc}/Kmpc)	increased CD4-negative, CD25-positive NK T cell number	J:211773
	increased CD8-positive, CD25-positive alpha-beta T cell number	J:211773
	increased CD11b-high dendritic cell number	J:211773
Lgr6^{em1(IMPC)Ccpcz}/Lgr6^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Lgr6^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
	increased lymphocyte cell number	J:211773
Lhcgr^{tm1(KOMP)Vlcg}/Lhcgr^{tm1(KOMP)Vlcg} (C57BL/6N-Lhcgr^{tm1(KOMP)Vlcg}/Nju)	decreased mean corpuscular volume	J:211773
	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
	small spleen	J:211773
	small thymus	J:211773
	thrombocytopenia	J:211773
Lhcgr^tm1Hht/Lhcgr^tm1Hht (involves: 129S7/SvEvBrd * C57BL/6J)	enlarged spleen	J:105533
Lhx2^tm1Dra/Lhx2^tm1Dra (involves: 129S4/SvJae)	abnormal erythropoiesis	J:64676
	anemia	J:64676
	decreased erythroid progenitor cell number	J:64676
	decreased hematocrit	J:64676
Lhx2^tm1Lcar/Lhx2^tm1Lcar (involves: 129/Sv * C57BL/6)	anemia	J:159209
Lhx5^{em1(IMPC)Ccpcz}/Lhx5⁺ (C57BL/6N-Lhx5^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
	increased leukocyte cell number	J:211773
Lif^tm1Cgre/Lif^tm1Cgre (involves: MF1)	abnormal macrophage morphology	J:96965
	increased eosinophil cell number	J:96965
	increased uterine NK cell number	J:96965
Lif^tm1Phb/Lif⁺ (involves: 129S2/SvPas * C57BL/6 * DBA/2)	decreased erythroid progenitor cell number	J:77410
	decreased hematopoietic stem cell number	J:77410
	decreased T cell proliferation	J:77410
Lif^tm1Phb/Lif^tm1Phb (involves: 129S2/SvPas * C57BL/6 * DBA/2)	decreased common myeloid progenitor cell number	J:77410
	decreased erythroid progenitor cell number	J:77410
	decreased hematopoietic stem cell number	J:77410
	decreased T cell proliferation	J:77410
	hematopoietic system phenotype	J:77410
Lif^tm1Stw/Lif^tm1Stw (involves: 129S1/Sv * BALB/c)	decreased leukocyte cell number	J:136940
Lif^tm1Stw/Lif^tm1Stw (involves: 129S1/Sv * BALB/c)	thrombocytopenia	J:136940
Lif^tm1Stw/Lif^tm1Stw (involves: 129S1/Sv * MF1)	abnormal osteoclast differentiation	J:137646
	abnormal osteoclast morphology	J:137646
	abnormal osteoclast physiology	J:137646
	increased osteoclast cell number	J:137646
Lifr^tm1Imx/Lifr^tm1Imx (involves: 129P3/J * 129S7/SvEvBrd * C57BL/6)	increased osteoclast cell number	J:25253
Lig1^m1Anu/Lig1^m1Anu (involves: C3H/HeH * C57BL/6JAnu)	anemia	J:199856
Lig1^m1Anu/Lig1^m1Anu (involves: C3H/HeH * C57BL/6JAnu)	increased nucleated erythrocyte cell number	J:199856
Lig1^tm1Dwm/Lig1^tm1Dwm (involves: 129P2/OlaHsd * BALB/c)	abnormal blood cell morphology/development	J:76371
	abnormal erythropoiesis	J:76371
	absent erythrocytes	J:76371
	anemia	J:76371
	anisocytosis	J:76371
	decreased erythroid progenitor cell number	J:76371
	poikilocytosis	J:76371
Lig1^tm1Dwm/Lig1^tm1Dwm (involves: 129P2/OlaHsd)	abnormal definitive hematopoiesis	J:75962
	anemia	J:75962
	decreased hematocrit	J:75962
	enlarged spleen	J:75962
	increased bone marrow cell number	J:75962
	macrocytosis	J:75962
	reticulocytosis	J:75962
Lig1^tm2Dwm/Lig1^tm2Dwm (involves: 129P2/OlaHsd)	abnormal erythropoiesis	J:75962
Lig1^tm2Dwm/Lig1^tm2Dwm (involves: 129P2/OlaHsd)	anemia	J:75962
Lig1^tm3Dwm/Lig1^tm3Dwm (involves: 129P2/OlaHsd * C57BL/6)	abnormal bone marrow cell physiology	J:77902
	abnormal thymus physiology	J:77902
	enlarged spleen	J:77902
	hematopoietic system phenotype	J:77902
	reticulocytosis	J:77902
Lig4^m1Btlr/Lig4^m1Btlr (C57BL/6J-Lig4^m1Btlr)	decreased B cell number	J:267684
	decreased CD4-positive, alpha-beta T cell number	J:267684
	decreased CD8-positive, naive alpha-beta T cell number	J:267684
	decreased IgD level	J:267684
	decreased IgG level	J:267684
	increased CD8-positive, alpha-beta T cell number	J:267684
	increased central memory CD8 positive, alpha-beta T cell number	J:267684
	increased effector memory CD4-positive, alpha-beta T cell number	J:267684
	increased NK cell number	J:267684
Lig4^m2Btlr/Lig4^m2Btlr (C57BL/6J-Lig4^m2Btlr)	decreased CD4-positive, alpha-beta T cell number	J:267692
Lig4^m2Btlr/Lig4^m2Btlr (C57BL/6J-Lig4^m2Btlr)	increased effector memory CD4-positive, alpha-beta T cell number	J:267692
Lig4^tiny/Lig4^tiny (C57BL/6-Lig4^tiny)	abnormal proerythroblast morphology	J:122725
	absent CD8-positive, alpha-beta T cells	J:104190
	decreased B cell number	J:122725
	decreased bone marrow cell number	J:122725
	decreased hematopoietic stem cell number	J:122725
	decreased lymphocyte cell number	J:122725
Lig4^tm1Fwa/Lig4^tm1Fwa (involves: 129S6/SvEvTac * C57BL/6)	abnormal B cell differentiation	J:50865
	abnormal lymphopoiesis	J:50865
	abnormal T cell differentiation	J:63078
	arrested B cell differentiation	J:63078
	arrested T cell differentiation	J:50865
	decreased thymocyte number	J:63078
	hematopoietic system phenotype	J:50865
	small thymus	J:50865
Lig4^tm1Fwa/Lig4^tm1Fwa Tg(Cr2-cre)3Cgn/0 Xrcc4^tm2Fwa/Xrcc4^tm2Fwa (involves: 129S6/SvEvTac)	abnormal class switch recombination	J:126758
Lig4^tm1Fwa/Lig4^tm1Fwa Trp53^tm1Brd/Trp53^tm1Brd (involves: 129S6/SvEvTac * 129S7/SvEvBrd)	decreased thymocyte number	J:63078
	increased B cell number	J:63078
Lig4^tm2.1Fwa/Lig4^tm2.1Fwa (involves: 129S6/SvEvTac)	abnormal B cell activation	J:157574
	abnormal B cell differentiation	J:157574
	abnormal lymphocyte cell number	J:157574
	abnormal regulatory T cell morphology	J:157574
	abnormal T cell activation	J:157574
	abnormal T cell differentiation	J:157574
	abnormal T cell receptor beta chain V(D)J recombination	J:157574
	abnormal T cell receptor V(D)J recombination	J:157574
	abnormal thymus morphology	J:157574
	decreased B cell number	J:157574
	decreased CD4-positive, alpha-beta T cell number	J:157574
	decreased CD8-positive, alpha-beta T cell number	J:157574
	decreased double-negative T cell number	J:157574
	decreased double-positive T cell number	J:157574
	decreased IgA level	J:157574
	decreased IgG2b level	J:157574
	decreased IgG3 level	J:157574
	decreased IgG level	J:157574
	decreased IgM level	J:157574
	decreased immunoglobulin level	J:157574
	decreased spleen weight	J:157574
	decreased splenocyte number	J:157574
	decreased T cell proliferation	J:157574
	decreased thymocyte number	J:157574
	decreased thymus weight	J:157574
	increased T cell apoptosis	J:157574
	small spleen	J:157574
	small thymus	J:157574
Lig4^tm3.1Fwa/Lig4^tm3.1Fwa Tg(Cr2-cre)3Cgn/0 (Not Specified)	abnormal class switch recombination	J:157537
Lilrb4a^tm1Eol/Lilrb4a^tm1Eol (B6.129P2-Lilrb4a^tm1Eol)	abnormal cellular extravasation	J:129969
	abnormal leukocyte physiology	J:129969
	decreased IgE level	J:129969
	increased macrophage cell number	J:129969
	increased mast cell degranulation	J:129969
	increased plasma cell number	J:129969
Lilrb4a^tm1Hrk/Lilrb4a^tm1Hrk (involves: 129/Sv * BALB/c)	abnormal mast cell physiology	J:70491
Lilrb4a^tm1Hrk/Lilrb4a^tm1Hrk (involves: 129/Sv * BALB/c)	increased mast cell degranulation	J:70491
Limd1^em1(IMPC)H/Limd1^em1(IMPC)H (C57BL/6NTac-Limd1^em1(IMPC)H/H)	increased basophil cell number	J:211773
	increased mean platelet volume	J:211773
Limd1^tm1Gdl/Limd1^tm1Gdl (involves: 129X1/SvJ)	abnormal macrophage physiology	J:118130
	abnormal osteoclast cell number	J:118130
	abnormal osteoclast physiology	J:118130
Lime1^tm1.1Mal/Lime1^tm1.1Mal Rag2^tm1Fwa/Rag2^tm1Fwa Tg(TcraH-Y,TcrbH-Y)1Pas/? (B6.Cg-Rag2^tm1Fwa Lime1^tm1.1Mal Tg(TcraH-Y,TcrbH-Y)1Pas)	abnormal CD4-positive T cell differentiation	J:126321
	increased CD4-positive, alpha-beta T cell number	J:126321
Lin52^em1(IMPC)J/Lin52⁺ (C57BL/6NJ-Lin52^em1(IMPC)J/Mmjax)	increased mean corpuscular volume	J:211773
Lipa^tm1Ggb/Lipa^tm1Ggb (involves: 129P2/OlaHsd * CF-1)	abnormal alveolar macrophage morphology	J:101217
	abnormal Kupffer cell morphology	J:68812
	abnormal spleen morphology	J:49674, J:68812
	enlarged spleen	J:68812
	hepatosplenomegaly	J:68812
	increased spleen weight	J:49674, J:68812
Lipt1^em1(IMPC)Bay/Lipt1⁺ (C57BL/6N-Lipt1^em1(IMPC)Bay/Bay)	abnormal spleen morphology	J:211773
Litaf^tm1.1Ics/Litaf^tm1.1Ics (Not Specified)	impaired macrophage chemotaxis	J:186411
Litaf^tm1.1Ics/Litaf^tm1.1Ics (Not Specified)	increased macrophage cell number	J:186411
ll/ll X/Yaa (BXSB/MpJScr-ll)	abnormal monocyte morphology	J:10973
	decreased CD4-positive, alpha-beta T cell number	J:10973
	decreased IgG level	J:10973
Lman1^{tm1c(KOMP)Wtsi}/Lman1^{tm1c(KOMP)Wtsi} Tg(Tek-cre)12Flv/0 (involves: C57BL/6 * C57BL/6J * C57BL/6N)	abnormal platelet morphology	J:213133
Lmb1^C57BL/6Scr/Lmb1^C57BL/6Scr (involves: C57BL/6-Fas^lpr * MRL-Fas^lpr)	enlarged spleen	J:45708
Lmb1^C57BL/6Scr/Lmb1^C57BL/6Scr (MRL.Cg-Lmb1^C57BL/6Scr Fas^lpr)	increased CD8-positive, alpha-beta T cell number	J:125557
	increased double-negative T cell number	J:125557
	increased spleen weight	J:125557
Lmb1^C57BL/6Scr/Lmb1^MRL/MpScr (involves: C57BL/6-Fas^lpr * MRL-Fas^lpr)	enlarged spleen	J:45708
Lmb2^C57BL/6Scr/Lmb2^MRL/MpScr (involves: C57BL/6-Fas^lpr * MRL-Fas^lpr)	enlarged spleen	J:45708
Lmb2^MRL/MpScr/Lmb2^MRL/MpScr (involves: C57BL/6-Fas^lpr * MRL-Fas^lpr)	enlarged spleen	J:45708
Lmb2^MRL/MpScr/Lmb2^MRL/MpScr (B6.MRL-Lmb2^MRL/MpScr Fas^lpr)	decreased double-negative T cell number	J:125557
Lmb4^MRL/MpScr/Lmb4^MRL/MpScr (involves: C57BL/6-Fas^lpr * MRL-Fas^lpr)	enlarged spleen	J:45708
Lmbr1l^em1Btlr/Lmbr1l^em1Btlr (C57BL/6J-Lmbr1l^em1Btlr)	abnormal alpha-beta T cell morphology	J:274568
	abnormal B cell differentiation	J:274568
	abnormal bone marrow cell morphology/development	J:274568
	abnormal cytotoxic T cell physiology	J:274568
	abnormal lymphocyte morphology	J:274568
	decreased CD4-positive, alpha-beta T cell number	J:274568
	decreased common lymphocyte progenitor cell number	J:274568
	decreased IgD level	J:274568
	decreased IgG level	J:274568
	decreased IgM level	J:274568
	decreased leukocyte cell number	J:274568
	decreased lymphocyte cell number	J:274568
	decreased monocyte cell number	J:274568
	decreased T cell number	J:274568
	impaired natural killer cell mediated cytotoxicity	J:274568
	increased hematopoietic cell number	J:274568
	increased IgM level	J:274568
Lmbr1l^m1Btlr/Lmbr1l^m1Btlr (C57BL/6J-Lmbr1l^m1Btlr)	abnormal CD4-positive T cell differentiation	J:274568
	abnormal CD8-positive, alpha-beta T cell differentiation	J:274568
	abnormal cytotoxic T cell physiology	J:274568
	abnormal T cell differentiation	J:274568
	decreased CD4-positive, alpha-beta T cell number	J:274568
	decreased CD8-positive, alpha-beta T cell number	J:274568
	decreased CD8-positive, naive alpha-beta T cell number	J:274568
	decreased dendritic cell number	J:274568
	decreased IgE level	J:274568
	decreased IgG level	J:274568
	decreased IgM level	J:274568
	decreased NK cell number	J:274568
	decreased NK T cell number	J:274568
	decreased T cell number	J:274568
	impaired natural killer cell mediated cytotoxicity	J:274568
	increased B-1 B cell number	J:274568
	increased central memory CD8 positive, alpha-beta T cell number	J:274568
	increased effector memory CD4-positive, alpha-beta T cell number	J:274568
	increased macrophage cell number	J:274568
	increased neutrophil cell number	J:274568
Lmbr1l^m2Btlr/Lmbr1l^m2Btlr (C57BL/6J-Lmbr1l^m2Btlr)	increased central memory CD4-positive, alpha-beta T cell number	J:274857
Lmbrd1^{tm1b(EUCOMM)Hmgu}/Lmbrd1⁺ (C57BL/6N-Lmbrd1^{tm1b(EUCOMM)Hmgu}/Tcp)	decreased mean corpuscular hemoglobin	J:211773
Lmna^Dhe/Lmna⁺ (B6(D2)-Lmna^Dhe/TyGrsrJ)	abnormal peritoneal macrophage morphology	J:188496
Lmna^tm1.1Otin/Lmna^tm1.1Otin (involves: 129P2/OlaHsd * C57BL/6)	small spleen	J:177632
	small thymus	J:177632
Lmna^tm1Stw/Lmna^tm1Stw (involves: 129S1/Sv)	small spleen	J:58702
Lmna^tm1Stw/Lmna^tm1Stw (involves: 129S1/Sv)	thymus atrophy	J:58702
Lmnb1^{tm1a(EUCOMM)Wtsi}/Lmnb1⁺ (B6Dnk;B6Brd;B6N-Tyr^c-Brd Lmnb1^{tm1a(EUCOMM)Wtsi}/WtsiH)	increased mean corpuscular hemoglobin	J:175295
Lmo2^tm1Thr/Lmo2^tm1Thr (either: (involves: 129P2/OlaHsd * MF1) or (involves: 129/Sv * 129P2/OlaHsd))	abnormal embryonic hematopoiesis	J:19175
Lmo2^tm2(cre)Thr/Lmo2⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal common myeloid progenitor cell morphology	J:155870
	abnormal megakaryocyte progenitor cell morphology	J:155870
	decreased erythrocyte cell number	J:155870
	decreased granulocyte number	J:155870
	decreased hemoglobin content	J:155870
	decreased monocyte cell number	J:155870
	increased mean corpuscular volume	J:155870
	thrombocytopenia	J:155870
Lmo2^tm2(cre)Thr/Lmo2⁺ Kmt2a^tm1Thr/Kmt2a⁺ Mllt1^tm1Thr/Mllt1⁺ (involves: 129S/SvEv)	abnormal spleen red pulp morphology	J:100794
	abnormal spleen white pulp morphology	J:100794
	enlarged spleen	J:84518, J:100794
Lmo2^tm3Thr/Lmo2^tm4Thr Cd19^tm1(cre)Thr/Cd19⁺ (involves: 129S/SvEv)	hematopoietic system phenotype	J:86869
Lmo2^tm3Thr/Lmo2^tm4Thr Rag1^tm1(cre)Thr/Rag1⁺ (involves: 129S/SvEv)	hematopoietic system phenotype	J:86869
Lmo2^tm3Thr/Lmo2^tm4Thr Tg(Lck-cre)1Thr/0 (involves: 129S/SvEv)	hematopoietic system phenotype	J:86869
Lmo4^tm1Slp/Lmo4^tm1Slp Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: 129S1/Sv * C57BL/6 * C57BL/10 * CBA/Ca)	abnormal lymphocyte physiology	J:282740
	abnormal lymphopoiesis	J:282740
Lmo4^tm1Slp/Lmo4^tm1Slp Yeats4^em1Zfa/Yeats4^em1Zfa Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: 129S1/Sv * C57BL/6 * C57BL/10 * CBA/Ca)	abnormal lymphocyte physiology	J:282740
	abnormal lymphopoiesis	J:282740
Lmo4^tm1Thr/Lmo4^tm2Thr (involves: 129S/SvEv * C57BL/6)	hematopoietic system phenotype	J:88167
Lmod3^em1(IMPC)Mbp/Lmod3⁺ (C57BL/6N-Lmod3^em1(IMPC)Mbp/Ucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased erythrocyte cell number	J:211773
	increased hematocrit	J:211773
	increased hemoglobin content	J:211773
Lmod3^em1(IMPC)Mbp/Lmod3^em1(IMPC)Mbp (C57BL/6N-Lmod3^em1(IMPC)Mbp/Ucd)	decreased lymphocyte cell number	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
	increased neutrophil cell number	J:211773
Lmr3^BALB/cHeA/? (involves: BALB/cHeA * STS/A)	enlarged spleen	J:82715
Lmr3^BALB/cHeA/? (involves: BALB/cHeA * STS/A)	increased IgE level	J:82715
Lmr3^BALB/cHeA/Lmr3^BALB/cHeA (involves: BALB/cHeA * STS/A)	spleen hyperplasia	J:108764
Lmr3^BALB/cHeA/Lmr3^CcS5/Dem (involves: BALB/cHeA * STS/A)	spleen hyperplasia	J:108764
Lmr5^BALB/cHeA/? (involves: BALB/cHeA * STS/A)	increased IgE level	J:82715
Lmr7^BALB/cHeA/? (involves: BALB/cHeA * STS/A)	decreased splenocyte proliferation	J:108764
Lmr7^CcS5/Dem/? (involves: BALB/cHeA * STS/A)	spleen hyperplasia	J:82715
Lmr8^BALB/cHeA/? (involves: BALB/cHeA * STS/A)	increased IgE level	J:82717
Lmr8^BALB/cHeA/Lmr8^BALB/cHeA (involves: BALB/cHeA * STS/A)	spleen hyperplasia	J:108764
Lmr8^BALB/cHeA/Lmr8^CcS20/Dem (involves: BALB/cHeA * STS/A)	spleen hyperplasia	J:108764
Lmr9^BALB/cHeA/? (involves: BALB/cHeA * STS/A)	increased IgE level	J:82717
Lmr9^CcS20/Dem/? (involves: BALB/cHeA * STS/A)	decreased IgE level	J:82717
Lmr10^BALB/cHeA/? (involves: BALB/cHeA * STS/A)	increased IgE level	J:82717
Lmr10^CcS20/Dem/? (involves: BALB/cHeA * STS/A)	decreased IgE level	J:82717
Lmr11^BALB/cHeA/Lmr11^BALB/cHeA Lmr8^CcS20/Dem/Lmr8^CcS20/Dem (involves: BALB/cHeA * STS/A)	decreased IgE level	J:82717
Lmr12^BALB/cHeA/? (involves: BALB/cHeA * STS/A)	decreased IgE level	J:82717
Lmr12^CcS16/Dem/? (involves: BALB/cHeA * STS/A)	increased IgE level	J:82717
Lmr12^CcS16/Dem/Lmr12^CcS16/Dem Lmr19^BALB/cHeA/Lmr19^BALB/cHeA (involves: BALB/cHeA * STS/A)	spleen hyperplasia	J:108764
Lmr13^BALB/cHeA/? (involves: BALB/cHeA * STS/A)	decreased IgE level	J:82717
Lmr14^BALB/cHeA/? (involves: BALB/cHeA * STS/A)	spleen hyperplasia	J:108764
Lmr14^BALB/cHeA/Lmr14^BALB/cHeA Lmr5^BALB/cHeA/? (involves: BALB/cHeA * STS/A)	increased IgE level	J:82715
Lmr14^BALB/cHeA/Lmr14^BALB/cHeA Lmr5^BALB/cHeA/Lmr5^BALB/cHeA (involves: BALB/cHeA * STS/A)	increased IgE level	J:82717
Lmr14^CcS16/Dem/? (involves: BALB/cHeA * STS/A)	enlarged spleen	J:82716
Lmr14^CcS16/Dem/Lmr14^CcS16/Dem Lmr5^BALB/cHeA/? (involves: BALB/cHeA * STS/A)	increased IgE level	J:82715
Lmr14^CcS16/Dem/Lmr14^CcS16/Dem Lmr5^BALB/cHeA/Lmr5^BALB/cHeA (involves: BALB/cHeA * STS/A)	increased IgE level	J:82717
Lmr16^STS/A/Lmr16^STS/A Lmr18^BALB/cHeA/Lmr18^BALB/cHeA (involves: BALB/cHeA * STS/A)	spleen hyperplasia	J:108764
Lmr18^BALB/cHeA/Lmr18^BALB/cHeA (involves: BALB/cHeA * STS/A)	decreased splenocyte proliferation	J:108764
Lmr18^BALB/cHeA/Lmr18^CcS20/Dem (involves: BALB/cHeA * STS/A)	decreased splenocyte proliferation	J:108764
Lnx1^tm1Lex/Lnx1^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	increased B-1b cell number	J:171883
Loricrin^{tm1.1(KOMP)Vlcg}/Loricrin⁺ (C57BL/6N-Loricrin^{tm1.1(KOMP)Vlcg}/Ucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Loricrin^{tm1.1(KOMP)Vlcg}/Loricrin^{tm1.1(KOMP)Vlcg} (C57BL/6N-Loricrin^{tm1.1(KOMP)Vlcg}/Ucd)	increased spleen weight	J:211773
Lox^em1(IMPC)Mbp/Lox⁺ (C57BL/6N-Lox^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
Lox^em1(IMPC)Mbp/Lox⁺ (C57BL/6N-Lox^em1(IMPC)Mbp/MbpMmucd)	enlarged spleen	J:211773
Lox^tm1.1Khki/Lox^tm1.1Khki (involves: C57BL/6)	increased lymphocyte cell number	J:264295
Lpar2^tm1Dgen/Lpar2^tm1Dgen (B6.Cg-Lpar2^tm1Dgen)	increased IgE level	J:184061
Lpcat2^em1(IMPC)J/Lpcat2^em1(IMPC)J (C57BL/6NJ-Lpcat2^em1(IMPC)J/Mmjax)	increased erythrocyte cell number	J:211773
	increased hematocrit	J:211773
Lpin2^{tm1b(KOMP)Wtsi}/Lpin2^{tm1b(KOMP)Wtsi} (C57BL/6N-Lpin2^{tm1b(KOMP)Wtsi}/Tcp)	decreased hemoglobin content	J:211773
	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular hemoglobin concentration	J:211773
	increased mean platelet volume	J:211773
	increased red blood cell distribution width	J:211773
Lpin2^tm1Reue/Lpin2^tm1Reue (involves: C57BL/6J)	abnormal erythrocyte morphology	J:189894
	anemia	J:189894
	decreased hemoglobin content	J:189894
	increased red blood cell distribution width	J:189894
Lpin3^{tm1b(KOMP)Wtsi}/Lpin3^{tm1b(KOMP)Wtsi} (C57BL/6N-Lpin3^{tm1b(KOMP)Wtsi}/Ucd)	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Lppl1^C57BL/6J/? (involves: C57BL/6J * DBA/2J)	abnormal leukocyte physiology	J:90647
Lprm4^MRL/MpJ/Lprm4^MRL/MpJ (involves: C3H/HeJ-Fas^lpr * MRL/MpJ-Fas^lpr)	enlarged spleen	J:44625
Lpxn^{tm1b(EUCOMM)Hmgu}/Lpxn^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Lpxn^{tm1b(EUCOMM)Hmgu}/Wtsi)	abnormal plasma cell differentiation	J:305662
	decreased IgM level	J:305662
Lratd2^{em1(IMPC)Ccpcz}/Lratd2^{em1(IMPC)Ccpcz} (C57BL/6N-Lratd2^{em1(IMPC)Ccpcz}/Ccpcz)	decreased eosinophil cell number	J:211773
	increased B-2 B cell number	J:211773
Lrba^{Gt(OST69142)Lex}/Lrba^{Gt(OST69142)Lex} (involves: 129 * 129S5/SvEvBrd)	abnormal NK cell physiology	J:237187
	impaired natural killer cell mediated cytotoxicity	J:237187
	increased myeloid cell number	J:237187
	increased regulatory T cell number	J:237187
Lrch1^em1Hwa/Lrch1^em1Hwa (Not Specified)	abnormal cellular extravasation	J:238772
Lrfn2^{Tg(CD2-Myb/en)5Kmw}/Lrfn2⁺ (involves: C57BL/10 * CBA)	abnormal bone marrow cell morphology/development	J:125805
	abnormal common myeloid progenitor cell morphology	J:125805
	decreased T cell number	J:126456
	decreased T cell proliferation	J:126456
Lrfn2^{Tg(CD2-Myb/en)5Kmw}/Lrfn2⁺ Tg(H2-K-Myc)1Brn/? (involves: C57BL/10 * CBA * FVB/N)	abnormal bone marrow cell morphology/development	J:125805
	abnormal common myeloid progenitor cell morphology	J:125805
	abnormal erythropoiesis	J:125805
	enlarged spleen	J:125805
	extramedullary hematopoiesis	J:125805
	spleen hyperplasia	J:125805
Lrfn2^{Tg(CD2-Myb/en)5Kmw}/Lrfn2^{Tg(CD2-Myb/en)5Kmw} (involves: C57BL/10 * CBA)	abnormal thymus cortex morphology	J:126456
	abnormal thymus medulla morphology	J:126456
	decreased CD8-positive, alpha-beta T cell number	J:126456
	decreased double-negative T cell number	J:126456
	decreased T cell number	J:126456
	decreased T cell proliferation	J:126456
	small spleen	J:126456
	small thymus	J:126456
Lrfn2^tm1.1Jaru/Lrfn2^tm1.1Jaru (B6.129P2(Cg)-Lrfn2^tm1.1Jaru)	abnormal bone marrow hematopoietic cell morphology	J:301285
	abnormal erythropoiesis	J:301285
	decreased erythroid progenitor cell number	J:301285
	decreased granulocyte number	J:301285
	decreased hematocrit	J:301285
	decreased leukocyte cell number	J:301285
	decreased lymphocyte cell number	J:301285
	decreased mean corpuscular hemoglobin	J:301285
	increased erythrocyte cell number	J:301285
	increased hemoglobin content	J:301285
Lrif1^em1(IMPC)J/Lrif1^em1(IMPC)J (C57BL/6NJ-Lrif1^em1(IMPC)J/Mmjax)	increased mean corpuscular hemoglobin	J:211773
Lrig3^{em1(IMPC)Ccpcz}/Lrig3^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Lrig3^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Lrp2^b2b2671Clo/Lrp2^b2b2671Clo (C57BL/6J-Lrp2^b2b2671Clo)	thymus hypoplasia	J:175213
Lrp5^tm1Grw/Lrp5^tm1Grw (involves: 129S1/Sv * 129X1/SvJ)	decreased osteoclast cell number	J:104382
Lrp12^em1Gpt/Lrp12^em1Gpt Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * C57BL/6JGpt * DBA/2)	abnormal CD4-positive, alpha-beta T cell physiology	J:338432
	enhanced leukocyte migration	J:338432
	increased T cell number	J:338432
Lrpprc^{tm1a(KOMP)Wtsi}/Lrpprc⁺ (C57BL/6N-Lrpprc^{tm1a(KOMP)Wtsi}/Wtsi)	increased mean corpuscular hemoglobin	J:175295
Lrrc3^{tm1b(EUCOMM)Hmgu}/Lrrc3^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Lrrc3^{tm1b(EUCOMM)Hmgu}/Ics)	decreased lymphocyte cell number	J:211773
Lrrc4b^em1(IMPC)J/Lrrc4b^em1(IMPC)J (C57BL/6NJ-Lrrc4b^em1(IMPC)J/Mmjax)	increased hematocrit	J:211773
Lrrc8a^tm1.1Geha/Lrrc8a^tm1.1Geha (B6.129S1(Cg)-Lrrc8a^tm1.1Geha)	abnormal B cell differentiation	J:211308
	abnormal T cell differentiation	J:211308
	abnormal T cell physiology	J:211308
	abnormal T cell selection	J:211308
	abnormal thymus apoptosis	J:211308
	abnormal thymus medulla morphology	J:211308
	abnormal thymus morphology	J:211308
	abnormal thymus physiology	J:211308
	absent thymus corticomedullary boundary	J:211308
	decreased B cell number	J:211308
	decreased CD4-positive, alpha-beta T cell number	J:211308
	decreased CD8-positive, alpha-beta T cell number	J:211308
	decreased DN2 thymocyte number	J:211308
	decreased DN3 thymocyte number	J:211308
	decreased DN4 thymocyte number	J:211308
	decreased double-negative T cell number	J:211308
	decreased double-positive T cell number	J:211308
	decreased immature B cell number	J:211308
	decreased marginal zone B cell number	J:211308
	decreased pre-B cell number	J:211308
	decreased T cell number	J:211308
	decreased T cell proliferation	J:211308
	decreased thymocyte number	J:211308
	decreased transitional stage B cell number	J:211308
	increased IgG2a level	J:211308
	increased pro-B cell number	J:211308
	increased regulatory T cell number	J:211308
	increased thymocyte apoptosis	J:211308
	small spleen	J:211308
	small thymus	J:211308
	small thymus cortex	J:211308
	thymus hypoplasia	J:211308
Lrrc8c^em1(IMPC)Mbp/Lrrc8c^em1(IMPC)Mbp (C57BL/6N-Lrrc8c^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
Lrrc17^{em1(IMPC)Ccpcz}/Lrrc17^{em1(IMPC)Ccpcz} (C57BL/6N-Lrrc17^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Lrrc17^tm1Nik/Lrrc17⁺ Nf1^tm1Par/Nf1^tm1Par Srpk2^tm1Nik/Srpk2⁺ Tg(Mx1-cre)1Cgn/0 (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	increased leukocyte cell number	J:161558
Lrrc17^tm1Nik/Lrrc17⁺ Srpk2^tm1Nik/Srpk2⁺ Tg(Mx1-cre)1Cgn/0 (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * CBA)	hematopoietic system phenotype	J:161558
Lrrc30^{em1(IMPC)Rbrc}/Lrrc30^{em1(IMPC)Rbrc} (C57BL/6NJcl-Lrrc30^{em1(IMPC)Rbrc}/Rbrc)	abnormal mean corpuscular hemoglobin	J:211773
Lrrc32^tm1.1Hfuj/Lrrc32^tm1.1Hfuj Tg(Cd4-cre)1Cwi/0 (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac * DBA/2)	abnormal regulatory T cell physiology	J:204761
Lrrc38^em1(IMPC)Tcp/Lrrc38^em1(IMPC)Tcp (C57BL/6NCrl-Lrrc38^em1(IMPC)Tcp/Tcp)	decreased mean corpuscular hemoglobin	J:211773
	increased erythrocyte cell number	J:211773
Lrrcc1^{tm1b(EUCOMM)Wtsi}/Lrrcc1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Lrrcc1^{tm1b(EUCOMM)Wtsi}/Tcp)	decreased erythrocyte cell number	J:211773
Lrrk1^tm1.1Smo/Lrrk1^tm1.1Smo (involves: 129S/Sv)	abnormal osteoclast physiology	J:208677
Lrrk1^tm1.1Smo/Lrrk1^tm1.1Smo (involves: 129S/Sv)	increased osteoclast cell number	J:208677
Lrrk1^{tm1b(KOMP)Wtsi}/Lrrk1^{tm1b(KOMP)Wtsi} (C57BL/6N-Lrrk1^{tm1b(KOMP)Wtsi}/H)	decreased eosinophil cell number	J:211773
	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
	increased red blood cell distribution width	J:211773
	small thymus	J:211773
	thrombocytopenia	J:211773
Lrrk2^tm1.1Cai/Lrrk2⁺ Tg(Camk2a-tTA)1Mmay/0 Tg(tetO-SNCAA53T)E2Cai/0 (involves: 129X1/SvJ C57BL/6)	microgliosis	J:156512
Lrrk2^tm1.1Cai/Lrrk2^tm1.1Cai (involves: 129X1/SvJ * C57BL/6)	microgliosis	J:156512
Lrrtm2^em1(IMPC)Mbp/Lrrtm2^em1(IMPC)Mbp (C57BL/6N-Lrrtm2^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Lskcn2^DBA/2J/? (involves: C57BL/6J * DBA/2J)	abnormal definitive hematopoiesis	J:92256
Lskpf1^CBA/H/Lskpf1^CBA/H (involves: C57BL/6JOlaHsd * CBA/H)	abnormal bone marrow cell morphology/development	J:132780
Lskpf2^C57BL/6Ola/Lskpf2^CBA/H (involves: C57BL/6JOlaHsd * CBA/H)	abnormal bone marrow cell morphology/development	J:132780
Lskpf2^CBA/H/Lskpf2^CBA/H (involves: C57BL/6JOlaHsd * CBA/H)	abnormal bone marrow cell morphology/development	J:132780
Lskpf3^C57BL/6Ola/Lskpf3^C57BL/6Ola (involves: C57BL/6JOlaHsd * CBA/H)	abnormal bone marrow cell morphology/development	J:132780
Lskpf3^C57BL/6Ola/Lskpf3^CBA/H (involves: C57BL/6JOlaHsd * CBA/H)	abnormal bone marrow cell morphology/development	J:132780
Lsm1^{tm1b(EUCOMM)Hmgu}/Lsm1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Lsm1^{tm1b(EUCOMM)Hmgu}/Ieg)	increased mean corpuscular volume	J:211773
Lsm11^{tm1a(KOMP)Wtsi}/Lsm11⁺ (C57BL/6N-Lsm11^{tm1a(KOMP)Wtsi}/Wtsi)	increased mean corpuscular hemoglobin	J:175295
Lsm14a^{tm1b(KOMP)Wtsi}/Lsm14a⁺ (C57BL/6N-Lsm14a^{tm1b(KOMP)Wtsi}/Nju)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	increased basophil cell number	J:211773
Lsm14b^{tm1b(KOMP)Mbp}/Lsm14b^{tm1b(KOMP)Mbp} (C57BL/6N-Lsm14b^{tm1b(KOMP)Mbp}/Wtsi)	decreased mean corpuscular hemoglobin	J:211773
Lsp1^tm1Jejb/Lsp1^tm1Jejb (involves: 129S1/Sv * 129X1/SvJ)	abnormal cellular extravasation	J:96022
	abnormal leukocyte physiology	J:68128
	abnormal lymphopoiesis	J:64219
	impaired neutrophil chemotaxis	J:68128
	increased macrophage cell number	J:64219
Lss^{tm1b(KOMP)Wtsi}/Lss⁺ (C57BL/6N-Lss^{tm1b(KOMP)Wtsi}/Ieg)	increased leukocyte cell number	J:211773
Lta/Tnf^tm1Eug/Lta/Tnf^tm1Eug (involves: 129)	abnormal spleen marginal zone morphology	J:31129
	abnormal spleen morphology	J:31129
	decreased IgA level	J:31129
	decreased T cell number	J:31129
	increased B cell number	J:31129
	increased leukocyte cell number	J:31129
Lta/Tnf^tm1Eug/Lta/Tnf^tm1Eug (B6.129-Lta/Tnf^tm1Eug)	decreased IgG1 level	J:115034
	decreased IgG2a level	J:115034
	decreased IgG3 level	J:115034
	impaired macrophage phagocytosis	J:115034
	increased IgM level	J:115034
Lta/Tnf^tm1Eug/Lta/Tnf^tm1Eug (involves: 129 * C57BL/6J)	increased spleen weight	J:112797
Lta/Tnf^tm1Eug/Lta/Tnf^tm1Eug (involves: 129)	abnormal spleen marginal zone morphology	J:31129
	abnormal spleen morphology	J:31129
	decreased IgA level	J:31129
	decreased T cell number	J:31129
	increased B cell number	J:31129
	increased leukocyte cell number	J:31129
Lta/Tnf^tm1Eug/Lta/Tnf^tm1Eug (B6.129-Lta/Tnf^tm1Eug)	decreased IgG1 level	J:115034
	decreased IgG2a level	J:115034
	decreased IgG3 level	J:115034
	impaired macrophage phagocytosis	J:115034
	increased IgM level	J:115034
Lta/Tnf^tm1Eug/Lta/Tnf^tm1Eug (involves: 129 * C57BL/6J)	increased spleen weight	J:112797
Lta/Tnf^tm1Jods/Lta/Tnf^tm1Jods (C57BL/6J-Lta/Tnf^tm1Jods)	abnormal spleen morphology	J:43602
	abnormal spleen white pulp morphology	J:43602
	decreased immunoglobulin level	J:43602
	enlarged spleen	J:43602
	increased leukocyte cell number	J:43602
Lta/Tnf^tm1Jods/Lta/Tnf^tm1Jods (C57BL/6-Lta/Tnf^tm1Jods)	abnormal spleen white pulp morphology	J:78229
Lta/Tnf^tm1Jods/Lta/Tnf^tm1Jods (involves: C57BL/6)	abnormal gamma-delta T cell morphology	J:169863
Lta/Tnf^tm1Jods/Lta/Tnf^tm1Jods (C57BL/6J-Lta/Tnf^tm1Jods)	abnormal spleen morphology	J:43602
	decreased immunoglobulin level	J:43602
	enlarged spleen	J:43602
	increased leukocyte cell number	J:43602
Lta/Tnf^tm1Jods/Lta/Tnf^tm1Jods (C57BL/6-Lta/Tnf^tm1Jods)	abnormal spleen white pulp morphology	J:78229
Lta/Tnf^tm1Jods/Lta/Tnf^tm1Jods (involves: C57BL/6)	abnormal gamma-delta T cell morphology	J:169863
Lta^hlb382/Lta^hlb382 (C57BL/6J-Lta^hlb382/J)	absent marginal zone B cells	J:134498
	absent spleen germinal center	J:134498
	absent spleen marginal zone	J:134498
	decreased NK cell number	J:134498
	decreased transitional stage B cell number	J:134498
	increased B-1b cell number	J:134498
	increased leukocyte cell number	J:82961
Lta^{tm1.1(KOMP)Vlcg}/Lta^{tm1.1(KOMP)Vlcg} (C57BL/6N-Lta^{tm1.1(KOMP)Vlcg}/Ucd)	decreased monocyte cell number	J:211773
	increased eosinophil cell number	J:211773
	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Lta^tm1.1Sned/Lta^tm1.1Sned (B6.129-Lta^tm1.1Sned)	abnormal class switch recombination	J:109621
	abnormal lymphopoiesis	J:109621
	decreased spleen white pulp amount	J:109621
	enlarged spleen	J:109621
Lta^tm1Dch/Lta^tm1Dch (B6.129S2-Lta^tm1Dch)	abnormal class switch recombination	J:80616
	abnormal spleen morphology	J:80616
	absent spleen germinal center	J:80616
	absent spleen marginal zone	J:80616
	decreased IgG level	J:80616
	decreased spleen B cell follicle number	J:80616
	decreased spleen white pulp amount	J:80616
	increased IgM level	J:80616
	increased leukocyte cell number	J:80616
Lta^tm1Dch/Lta^tm1Dch (involves: 129S2/SvPas * C57BL/6)	abnormal class switch recombination	J:109621
	abnormal leukocyte cell number	J:17976
	abnormal spleen morphology	J:17976, J:39746
	abnormal spleen periarteriolar lymphoid sheath morphology	J:17976
	absent spleen marginal zone	J:17976
	decreased spleen white pulp amount	J:109621
	decreased T cell number	J:17976
	increased B cell number	J:17976
	increased leukocyte cell number	J:17976
Lta^tm1Dch/Lta^tm1Dch (involves: 129S2/SvPas)	abnormal lymphocyte morphology	J:173115
	abnormal thymus epithelium morphology	J:173115
	abnormal thymus medulla morphology	J:173115
	small thymus medulla	J:173115
Lta^tm1Dch/Lta^tm1Dch Tg(Igk-Lta/Ltb)4Cys/0 (involves: 129S2/SvPas * C57BL/6J * DBA/2J)	abnormal spleen morphology	J:73100
Lta^tm1Dch/Lta^tm1Dch Tnfsf14^tm1Lpc/Tnfsf14^tm1Lpc (involves: 129S2/SvPas * 129X1/SvJ)	abnormal lymphocyte morphology	J:173115
	abnormal thymus epithelium morphology	J:173115
	small thymus medulla	J:173115
Lta^tm1Jods/Lta^tm1Jods (C57BL/6-Lta^tm1Jods)	abnormal spleen morphology	J:47428
	abnormal spleen white pulp morphology	J:78229
	increased lymphocyte cell number	J:47428
Lta^tm1Jods/Lta^tm1Jods (involves: C57BL/6)	abnormal thymus epithelium morphology	J:125864
Lta^tm1Tab/Lta^tm1Tab (either: (involves: 129S2/SvPas * C57BL/6J) or (involves: 129S2/SvPas * CF-1))	absent spleen marginal zone	J:28061
	decreased IgA level	J:28061
	decreased spleen white pulp amount	J:28061
	increased IgM level	J:28061
	increased leukocyte cell number	J:28061
	increased spleen weight	J:28061
Ltb4r1^tm1Adl/Ltb4r1^tm1Adl (involves: 129S4/SvJae * C57BL/6)	abnormal leukocyte adhesion	J:63873
	abnormal leukocyte migration	J:63873
	abnormal macrophage physiology	J:63873
	abnormal neutrophil physiology	J:63873
	impaired eosinophil recruitment	J:63873
	impaired neutrophil chemotaxis	J:63873
Ltb4r1^tm1Bodd/Ltb4r1^tm1Bodd (either: (involves: 129S4/SvJaeSor * BALB/c ) or (involves: 129S4/SvJaeSor * C57BL/6))	impaired neutrophil chemotaxis	J:163271
Ltb4r1^tm1Tksh/Ltb4r1^tm1Tksh (B6.Cg-Ltb4r1^tm1Tksh)	decreased eosinophil cell number	J:118995
Ltb4r1^tm1Tksh/Ltb4r1^tm1Tksh (B6.Cg-Ltb4r1^tm1Tksh)	decreased IgE level	J:118995
Ltb4r1^tm1Tksh/Ltb4r1^tm1Tksh (C.Cg-Ltb4r1^tm1Tksh)	abnormal mast cell physiology	J:133998
Ltb4r1^tm1Tksh/Ltb4r1^tm1Tksh (involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)	abnormal granulocyte physiology	J:118995
Ltb4r2^tm1Tksh/Ltb4r2^tm1Tksh (C.Cg-Ltb4r2^tm1Tksh)	abnormal mast cell physiology	J:133998
Ltb/Tnf/Lta^tm1Dvk/Ltb/Tnf/Lta^tm1Dvk (involves: C57BL/6)	decreased spleen white pulp amount	J:109621
Ltb/Tnf/Lta^tm1Dvk/Ltb/Tnf/Lta^tm1Dvk (B6.Cg-Ltb/Tnf/Lta^tm1Dvk)	abnormal class switch recombination	J:80616
	abnormal spleen morphology	J:80616
	absent spleen germinal center	J:80616
	absent spleen marginal zone	J:80616
	decreased IgG level	J:80616
	decreased spleen B cell follicle number	J:80616
	decreased spleen white pulp amount	J:80616
	increased leukocyte cell number	J:80616
Ltb/Tnf/Lta^tm1Dvk/Ltb/Tnf/Lta^tm1Dvk (involves: C57BL/6)	decreased spleen white pulp amount	J:109621
Ltb/Tnf/Lta^tm1Dvk/Ltb/Tnf/Lta^tm1Dvk (B6.Cg-Ltb/Tnf/Lta^tm1Dvk)	abnormal class switch recombination	J:80616
	abnormal spleen morphology	J:80616
	absent spleen germinal center	J:80616
	absent spleen marginal zone	J:80616
	decreased IgG level	J:80616
	decreased spleen B cell follicle number	J:80616
	decreased spleen white pulp amount	J:80616
	increased leukocyte cell number	J:80616
Ltb/Tnf/Lta^tm1Dvk/Ltb/Tnf/Lta^tm1Dvk (involves: C57BL/6)	decreased spleen white pulp amount	J:109621
Ltb/Tnf/Lta^tm1Dvk/Ltb/Tnf/Lta^tm1Dvk (B6.Cg-Ltb/Tnf/Lta^tm1Dvk)	abnormal class switch recombination	J:80616
	abnormal spleen morphology	J:80616
	absent spleen germinal center	J:80616
	absent spleen marginal zone	J:80616
	decreased IgG level	J:80616
	decreased spleen B cell follicle number	J:80616
	decreased spleen white pulp amount	J:80616
	increased leukocyte cell number	J:80616
Ltb/Tnf^tm1.1Dvk/Ltb/Tnf^tm1.1Dvk (involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)	abnormal spleen morphology	J:58981
	absent germinal center B cells	J:58981
	absent spleen marginal zone	J:58981
	intermingled spleen red and white pulp	J:58981
Ltb/Tnf^tm1.1Dvk/Ltb/Tnf^tm1.1Dvk (involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)	abnormal spleen morphology	J:58981
	absent germinal center B cells	J:58981
	absent spleen marginal zone	J:58981
	intermingled spleen red and white pulp	J:58981
Ltb^tm1Flv/Ltb^tm1Flv (involves: 129S1/Sv * C57BL/6J)	abnormal spleen morphology	J:39746
	abnormal spleen red pulp morphology	J:39746
	abnormal spleen white pulp morphology	J:39746
	decreased IgA level	J:39746
Ltb^tm1Kpf/Ltb^tm1Kpf (B6.129P2-Ltb^tm1Kpf)	abnormal class switch recombination	J:80616
	abnormal spleen morphology	J:80616
	absent spleen marginal zone	J:80616
	decreased IgG level	J:80616
	decreased spleen B cell follicle number	J:80616
	decreased spleen white pulp amount	J:80616
	increased IgM level	J:80616
	increased leukocyte cell number	J:80616
Ltb^tm1Kpf/Ltb^tm1Kpf (involves: 129P2/OlaHsd * C57BL/6)	abnormal spleen follicular dendritic cell network	J:42508
	abnormal spleen germinal center morphology	J:42508
	abnormal spleen marginal zone morphology	J:42508
	abnormal spleen morphology	J:58981, J:42508
	abnormal spleen red pulp morphology	J:42508
	absent spleen marginal zone	J:58981
	decreased spleen white pulp amount	J:109621
	increased lymphocyte cell number	J:42508
Ltb^tm1Kpf/Ltb^tm1Kpf Tnfsf14^tm1Kpf/Tnfsf14^tm1Kpf (involves: 129P2/OlaHsd * C57BL/6)	abnormal spleen morphology	J:77250
Ltb^tm1Krn/Ltb^tm1Krn (C57BL/6-Ltb^tm1Krn)	abnormal spleen morphology	J:78229
	decreased IgG1 level	J:78229
	decreased IgG2a level	J:78229
	increased IgM level	J:78229
	spleen hyperplasia	J:78229
Ltbp1^{tm1a(EUCOMM)Wtsi}/Ltbp1⁺ (B6JTyr;B6N-Ltbp1^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased leukocyte cell number	J:175295
Ltbp1^{tm1a(EUCOMM)Wtsi}/Ltbp1^{tm1a(EUCOMM)Wtsi} (B6JTyr;B6N-Ltbp1^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased hemoglobin content	J:175295
	increased mean corpuscular hemoglobin	J:175295
Ltbp4^em1(IMPC)Tcp/Ltbp4^em1(IMPC)Tcp (C57BL/6NCrl-Ltbp4^em1(IMPC)Tcp/Tcp)	enlarged spleen	J:211773
Ltbp4^{Gt(U3Cre)1Vmel}/Ltbp4^{Gt(U3Cre)1Vmel} (B6.129S2-Ltbp4^{Gt(U3Cre)1Vmel})	enlarged spleen	J:78819
Ltbr^m1Btlr/Ltbr^m1Btlr (C57BL/6J-Ltbr^m1Btlr)	abnormal B cell physiology	J:212068
Ltbr^m2Btlr/Ltbr^m2Btlr (C57BL/6J-Ltbr^m2Btlr)	abnormal IgG level	J:254823
Ltbr^m3Btlr/Ltbr^m3Btlr (C57BL/6J-Ltbr^m3Btlr)	impaired natural killer cell mediated cytotoxicity	J:264642
Ltbr^m3Btlr/Ltbr^m3Btlr (C57BL/6J-Ltbr^m3Btlr)	increased NK T cell number	J:264642
Ltbr^m4Btlr/Ltbr^m4Btlr (C57BL/6J-Ltbr^m4Btlr)	decreased alpha-beta T cell number	J:264820
	decreased CD4-positive, alpha-beta T cell number	J:264820
	decreased CD8-positive, alpha-beta T cell number	J:264820
	decreased NK cell number	J:264820
	decreased single-positive T cell number	J:264820
	increased B cell number	J:264820
	increased B-1 B cell number	J:264820
Ltbr^tm1.1Thhe/Ltbr^tm1.1Thhe Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6 * SJL)	abnormal macrophage physiology	J:183109
Ltbr^tm1Avt/Ltbr^tm1Avt Tg(Rorc-cre)1Litt/0 (Not Specified)	decreased neutrophil cell number	J:158663
Ltbr^tm1Avt/Ltbr^tm1Avt Tg(Vil1-cre)997Gum/0 (involves: C57BL/6J * SJL)	decreased neutrophil cell number	J:158663
Ltbr^tm1Kpf/Ltbr^tm1Kpf (involves: 129P2/OlaHsd)	abnormal gamma-delta T cell morphology	J:169863
	abnormal spleen B cell follicle morphology	J:48837
	abnormal spleen morphology	J:48837
	abnormal spleen periarteriolar lymphoid sheath morphology	J:48837
	absent marginal zone B cells	J:48837
	decreased IgE level	J:86810
	enlarged spleen	J:48837
	increased B cell number	J:48837
	increased lymphocyte cell number	J:48837
	increased T cell number	J:48837
Ltbr^tm1Kpf/Ltbr^tm1Kpf (involves: 129P2/OlaHsd * C57BL/6)	decreased spleen white pulp amount	J:109621
Ltbr^tm1Kpf/Ltbr^tm1Kpf (B6.129P2-Ltbr^tm1Kpf)	decreased neutrophil cell number	J:158663
Ltbr^tm1Mmat/Ltbr^tm1Mmat (involves: C57BL/6 * CBA)	abnormal lymphocyte morphology	J:173115
	abnormal spleen morphology	J:173115
	abnormal thymus epithelium morphology	J:173115
	abnormal thymus medulla morphology	J:173115
	absent spleen germinal center	J:173115
	small thymus medulla	J:173115
Ltbr^tm1Mmat/Ltbr^tm1Mmat Tnfsf11^tm1Pngr/Tnfsf11^tm1Pngr (involves: 129P2/OlaHsd * C57BL/6 * CBA)	abnormal thymus epithelium morphology	J:173115
Ltf^tm1Omc/Ltf^tm1Omc (either: 129S/SvEv or (involves: 129S/SvEv * C57BL/6))	decreased spleen iron level	J:81005
	hematopoietic system phenotype	J:81005
Ltn1^{tm1b(EUCOMM)Hmgu}/Ltn1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Ltn1^{tm1b(EUCOMM)Hmgu}/Ccpcz)	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	increased red blood cell distribution width	J:211773
	thrombocytopenia	J:211773
Ltv1^em1(IMPC)J/Ltv1⁺ (C57BL/6NJ-Ltv1^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Luc7l3^em1(IMPC)J/Luc7l3⁺ (C57BL/6NJ-Luc7l3^em1(IMPC)J/Mmjax)	increased erythrocyte cell number	J:211773
Luc7l^em1(IMPC)Mbp/Luc7l^em1(IMPC)Mbp (C57BL/6N-Luc7l^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased erythrocyte cell number	J:211773
Lum^tm1Wwk/Lum^tm1Wwk (involves: 129P2/OlaHsd)	decreased neutrophil cell number	J:128992
Lxw5^BXSB/Scr/Lxw5^BXSB/Scr (involves: BXSB/Scr * NZW/LacScr)	enlarged spleen	J:86924
Lxw5^NZW/LacScr/Lxw5^BXSB/Scr (involves: BXSB/Scr * NZW/LacScr)	enlarged spleen	J:86924
Lxw6^NZW/LacScr/Lxw6^NZW/LacScr (involves: BXSB/Scr * NZW/LacScr)	enlarged spleen	J:86924
Ly6a^tm1Pmf/Ly6a^tm1Pmf (B6.129P2-Ly6a^tm1Pmf)	abnormal common myeloid progenitor cell morphology	J:81387
	abnormal definitive hematopoiesis	J:81387
	abnormal immunoglobulin level	J:42594
	abnormal myeloid leukocyte morphology	J:81387
	abnormal T cell proliferation	J:42594
	decreased granulocyte number	J:81387
	decreased megakaryocyte cell number	J:81387
	decreased monocyte cell number	J:81387
	increased lymphocyte cell number	J:81387
	thrombocytopenia	J:81387
Ly6a^tm1Pmf/Ly6a^tm1Pmf (C.129P2-Ly6a^tm1Pmf)	abnormal common myeloid progenitor cell morphology	J:83409
	abnormal osteoclast differentiation	J:83409
	decreased osteoclast cell number	J:83409
Ly6a^{tm2(RUNX1)Grau}/Ly6a⁺ (involves: 129X1/SvJ * C57BL/6J)	abnormal spleen B cell follicle morphology	J:93408
	absent common myeloid progenitor cells	J:93408
	enlarged spleen	J:93408
	extramedullary hematopoiesis	J:93408
	increased erythroid progenitor cell number	J:93408
	increased leukocyte cell number	J:93408
	increased neutrophil cell number	J:93408
	myeloid hyperplasia	J:93408
	polychromatophilia	J:93408
Ly6e^{tm1c(EUCOMM)Hmgu}/Ly6e^{tm1c(EUCOMM)Hmgu} Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (B6.Cg-Ly6e^{tm1c(EUCOMM)Hmgu} Commd10^{Tg(Vav1-icre)A2Kio})	abnormal mononuclear cell morphology	J:291868
	decreased B cell number	J:291868
	decreased CD4-positive, alpha-beta T cell number	J:291868
	decreased dendritic cell number	J:291868
	decreased macrophage cell number	J:291868
	decreased neutrophil cell number	J:291868
	decreased NK cell number	J:291868
Ly6g6d^{tm1b(EUCOMM)Hmgu}/Ly6g6d^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Ly6g6d^{tm1b(EUCOMM)Hmgu}/Ieg)	increased mean platelet volume	J:211773
	thrombocytopenia	J:211773
Ly9^tm1Mckn/Ly9^tm1Mckn (involves: 129/Sv * C57BL/6)	abnormal T-helper 2 cell morphology	J:105482
Ly9^tm1Mckn/Ly9^tm1Mckn (involves: 129/Sv * C57BL/6)	decreased T cell proliferation	J:105482
Ly75^tm1Mnz/Ly75^tm1Mnz (Not Specified)	abnormal CD8-positive, alpha beta T cell morphology	J:97290
Ly75^tm1Mnz/Ly75^tm1Mnz (Not Specified)	abnormal cytotoxic T cell physiology	J:97289
Ly86^{tm1a(KOMP)Wtsi}/Ly86⁺ (C57BL/6N-Ly86^{tm1a(KOMP)Wtsi}/MbpMmucd)	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
Ly86^{tm1a(KOMP)Wtsi}/Ly86^{tm1a(KOMP)Wtsi} (C57BL/6N-Ly86^{tm1a(KOMP)Wtsi}/MbpMmucd)	increased lymphocyte cell number	J:211773
Ly86^tm1Kmiy/Ly86^tm1Kmiy (involves: 129P2/OlaHsd * C57BL/6)	decreased B cell proliferation	J:109720
	decreased IgG2b level	J:137066
	decreased IgG3 level	J:137066
	increased IgG level	J:109720
	increased IgM level	J:109720
Ly96^m1Btlr/Ly96^m1Btlr (C57BL/6J-Ly96^m1Btlr)	decreased macrophage apoptosis	J:265259
Ly96^tm1Kmiy/Ly96^tm1Kmiy (involves: 129P2/OlaHsd * C57BL/6)	abnormal macrophage physiology	J:92494
	decreased B cell proliferation	J:92494
	impaired neutrophil recruitment	J:92479
Lyg1^{tm1(KOMP)Vlcg}/Lyg1^{tm1(KOMP)Vlcg} (involves: C57BL/6NTac)	decreased CD4-positive, alpha-beta T cell number	J:256594
	decreased CD8-positive, alpha-beta T cell number	J:256594
Lyl1^tm1Fsky/Lyl1^tm1Fsky (involves: 129P2/OlaHsd * C57BL/6)	abnormal hematopoietic stem cell physiology	J:173665
	abnormal T cell differentiation	J:116300
	arrested B cell differentiation	J:116300
	decreased B cell number	J:116300
	decreased pro-B cell number	J:116300
	hematopoietic system phenotype	J:173665
	thrombocytopenia	J:173665
Lyl1^tm1Mago/Lyl1^tm1Mago (B6.129S7-Lyl1^tm1Mago)	abnormal hematopoietic stem cell physiology	J:173665
	hematopoietic system phenotype	J:173665
	thrombocytopenia	J:173665
Lyn^m1Anu/Lyn^m1Anu (C57BL/6JAnu-Lyn^m1Anu)	decreased B cell number	J:195155
Lyn^M1Btlr/Lyn⁺ (C57BL/6J-Lyn^M1Btlr)	decreased B cell number	J:214511
Lyn^M1Btlr/Lyn⁺ (C57BL/6J-Lyn^M1Btlr)	increased neutrophil cell number	J:214511
Lyn^M1Btlr/Lyn^M1Btlr (C57BL/6J-Lyn^M1Btlr)	decreased B cell number	J:214511
Lyn^M1Btlr/Lyn^M1Btlr (C57BL/6J-Lyn^M1Btlr)	increased neutrophil cell number	J:214511
Lyn^m2Anu/Lyn^m2Anu (C57B/6JAnu-Lyn^m2Anu/AnuApb)	decreased mature B cell number	J:104190
Lyn^m2Anu/Lyn^m2Anu (C57B/6JAnu-Lyn^m2Anu/AnuApb)	increased immature B cell number	J:104190
Lyn^M2Btlr/Lyn⁺ (C57BL/6J-Lyn^M2Btlr)	decreased IgG level	J:217146
Lyn^M2Btlr/Lyn⁺ (C57BL/6J-Lyn^M2Btlr)	decreased IgM level	J:217146
Lyn^M2Btlr/Lyn^M2Btlr (C57BL/6J-Lyn^M2Btlr)	decreased IgG level	J:217146
Lyn^M2Btlr/Lyn^M2Btlr (C57BL/6J-Lyn^M2Btlr)	decreased IgM level	J:217146
Lyn^M3Btlr/Lyn⁺ (C57BL/6J-Lyn^M3Btlr)	decreased T cell number	J:236679
	impaired hematopoiesis	J:236679
	increased B-1 B cell number	J:236679
	increased dendritic cell number	J:236679
	increased macrophage cell number	J:236679
Lyn^M3Btlr/Lyn^M3Btlr (C57BL/6J-Lyn^M3Btlr)	decreased T cell number	J:236679
	impaired hematopoiesis	J:236679
	increased B-1 B cell number	J:236679
	increased dendritic cell number	J:236679
	increased macrophage cell number	J:236679
Lyn^m4Btlr/Lyn^m4Btlr (C57BL/6J-Lyn^m4Btlr)	decreased IgG level	J:272816
Lyn^mld4/Lyn^mld4 (involves: C57BL/6)	abnormal B cell activation	J:144799
	abnormal B cell morphology	J:144799
	abnormal myelopoiesis	J:144799
	decreased follicular B cell number	J:144799
	decreased marginal zone B cell number	J:144799
	decreased transitional stage B cell number	J:144799
	increased erythroid progenitor cell number	J:144799
	increased IgE level	J:144799
	increased IgM level	J:144799
	increased macrophage cell number	J:144799
	increased neutrophil cell number	J:144799
	increased T cell number	J:144799
	spleen hypoplasia	J:144799
Lyn^mld4/Lyn^mld4 Mpl^tm1Wsa/Mpl^tm1Wsa (B6.129S1-Mpl^tm1Wsa)	decreased erythrocyte cell number	J:144799
	decreased leukocyte cell number	J:144799
	thrombocytopenia	J:144799
Lyn^tm1.1Calo/Lyn^tm1.1Calo Tg(Itgax-cre)1-1Reiz/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	abnormal leukocyte physiology	J:200745
	abnormal T cell activation	J:200745
	enlarged spleen	J:200745
	increased activated T cell number	J:200745
	increased dendritic cell number	J:200745
	increased granulocyte number	J:200745
	increased leukocyte cell number	J:200745
	increased monocyte cell number	J:200745
	increased plasma cell number	J:200745
	increased T cell number	J:200745
	myeloid hyperplasia	J:200745
Lyn^tm1Ard/Lyn⁺ Ptpn6^me-v/Ptpn6⁺ Tg(IghelMD4)4Ccg/0 (involves: 129P2/OlaHsd * C57BL/6)	abnormal mature B cell morphology	J:110531
Lyn^tm1Ard/Lyn⁺ Tg(IghelMD4)4Ccg/0 (involves: 129P2/OlaHsd * C57BL/6)	abnormal mature B cell morphology	J:110531
Lyn^tm1Ard/Lyn^tm1Ard (involves: 129P2/OlaHsd)	decreased spleen red pulp amount	J:72269
	decreased spleen white pulp amount	J:72269
	enlarged spleen	J:72269
	extramedullary hematopoiesis	J:72269
	increased basophil cell number	J:161523
	increased IgA level	J:161523
	increased IgE level	J:161523
	increased IgG2b level	J:161523
	increased IgM level	J:161523
	increased mast cell number	J:161523
	increased neutrophil cell number	J:72269
	thrombocytopenia	J:72269
Lyn^tm1Ard/Lyn^tm1Ard (B6.129P2-Lyn^tm1Ard)	abnormal B cell activation	J:144799
	abnormal B cell morphology	J:144799
	abnormal myelopoiesis	J:144799
	decreased follicular B cell number	J:144799
	decreased marginal zone B cell number	J:144799
	decreased transitional stage B cell number	J:144799
	increased T cell number	J:144799
	spleen hypoplasia	J:144799
Lyn^tm1Ard/Lyn^tm1Ard Tg(IghelMD4)4Ccg/0 (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell activation	J:110531
	abnormal B cell negative selection	J:110531
	abnormal mature B cell morphology	J:110531
	absent B-1 B cells	J:110531
	increased IgM level	J:110531
Lyn^{tm1b(EUCOMM)Hmgu}/Lyn^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Lyn^{tm1b(EUCOMM)Hmgu}/H)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	enlarged spleen	J:211773
	increased eosinophil cell number	J:211773
	increased mean platelet volume	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
	increased red blood cell distribution width	J:211773
	increased spleen weight	J:211773
	small thymus	J:211773
	thrombocytopenia	J:211773
Lyn^tm1Mhi/Lyn^tm1Mhi (involves: 129S1/Sv)	decreased spleen weight	J:72269
Lyn^tm1Mhi/Lyn^tm1Mhi (involves: 129S1/Sv)	increased neutrophil cell number	J:72269
Lyn^tm1Sor/Lyn^tm1Sor (involves: 129S4/SvJae)	decreased B cell number	J:42037
	decreased mature B cell number	J:42037
	enlarged spleen	J:42037
	increased B cell proliferation	J:42037
Lyn^tm1Sor/Lyn^tm1Sor (involves: 129S4/SvJaeSor)	abnormal macrophage physiology	J:80658
	abnormal microglial cell physiology	J:80658
	abnormal proerythroblast morphology	J:146561
	decreased B cell number	J:200745
	decreased follicular B cell number	J:146161
	decreased marginal zone B cell number	J:146161
	decreased mature B cell number	J:146161
	decreased transitional stage B cell number	J:146161
	increased B cell proliferation	J:146161
	increased erythroid progenitor cell number	J:146561
	increased IgA level	J:146161
	increased IgM level	J:146161
	increased plasma cell number	J:200745
	myeloid hyperplasia	J:146161
	spleen hyperplasia	J:146161
Lyn^tm1Sor/Lyn^tm1Sor (involves: 129S4/SvJaeSor * C57BL/6)	decreased B cell number	J:71174
	decreased B-1 B cell number	J:71174
	decreased mature B cell number	J:71174
	enlarged spleen	J:71174
	increased B cell proliferation	J:71174
	increased IgA level	J:71174
	increased IgG1 level	J:71174
	increased IgG2b level	J:71174
	increased IgG level	J:71174
	increased IgM level	J:71174
Lyn^tm1Tya/Lyn^tm1Tya (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:29751
	abnormal class switch recombination	J:29751
	abnormal spleen morphology	J:29751
	anemia	J:29751
	decreased B cell number	J:29751
	decreased B cell proliferation	J:29751
	decreased lymphocyte cell number	J:29751
	enlarged spleen	J:29751
	increased IgA level	J:29751
	increased IgM level	J:29751
	increased immunoglobulin level	J:29751
	increased spleen white pulp amount	J:29751
Lyn^weeb/Lyn^weeb (C57BL/6-Lyn^weeb)	decreased follicular B cell number	J:146161
	decreased marginal zone B cell number	J:146161
	decreased mature B cell number	J:146161
	decreased transitional stage B cell number	J:146161
	disorganized spleen B cell follicle	J:146161
	increased B cell proliferation	J:146161
	increased IgM level	J:146161
	spleen hyperplasia	J:146161
Lyplal1^{tm1b(KOMP)Wtsi}/Lyplal1^{tm1b(KOMP)Wtsi} (C57BL/6N-Lyplal1^{tm1b(KOMP)Wtsi}/Ucd)	decreased mean corpuscular volume	J:211773
	increased hematocrit	J:211773
Lyst^bg-2Btlr/Lyst^bg-2Btlr (C57BL/6J-Lyst^bg-2Btlr)	abnormal NK cell physiology	J:133617
Lyst^bg-5Btlr/Lyst⁺ (C57BL/6J-Lyst^bg-5Btlr)	impaired macrophage phagocytosis	J:217864
Lyst^bg-5Btlr/Lyst^bg-5Btlr (C57BL/6J-Lyst^bg-5Btlr)	impaired macrophage phagocytosis	J:217864
Lyst^bg-Btlr/Lyst^bg-Btlr (C57BL/6J-Lyst^bg-Btlr)	abnormal NK cell physiology	J:133616
Lyst^bg-grey/Lyst^bg-grey (C57BL/6-Lyst^bg-grey)	abnormal dermal mast cell morphology	J:106442
Lyst^bg-J/Lyst^bg-J (C57BL/6J-Lyst^bg-J/J)	abnormal granulocyte morphology	J:34814
	abnormal neutrophil morphology	J:34814
	decreased macrophage cell number	J:34814
	decreased platelet ADP level	J:7327
	decreased platelet ATP level	J:7327
	decreased platelet serotonin level	J:7327
	impaired natural killer cell mediated cytotoxicity	J:34814
Lyst^bg-J/Lyst^bg-J Prkdc^scid/Prkdc^scid (B6.Cg-Lyst^bg-J Prkdc^scid/Sz)	abnormal granulocyte morphology	J:34814
	abnormal neutrophil morphology	J:34814
	abnormal spleen white pulp morphology	J:34814
	abnormal thymus morphology	J:34814
	decreased B cell number	J:34814
	decreased CD4-positive, alpha-beta T cell number	J:34814
	decreased CD8-positive, alpha-beta T cell number	J:34814
	decreased immunoglobulin level	J:34814
	decreased lymphocyte cell number	J:34814
	decreased pre-B cell number	J:34814
	decreased T cell number	J:34814
	impaired natural killer cell mediated cytotoxicity	J:34814
	increased eosinophil cell number	J:34814
	increased granulocyte number	J:34814
	increased macrophage cell number	J:34814
	increased monocyte cell number	J:34814
	increased neutrophil cell number	J:34814
	increased NK cell number	J:34814
	small thymus	J:34814
	spleen hypoplasia	J:34814
	thymus cyst	J:34814
Lyst^bg-Lac/Lyst^bg-Lac (CBA/CaLac-Lyst^bg-Lac)	absent NK T cells	J:29745
Lyst^bg/Lyst^bg (B6.C3Rl-Lyst^bg)	abnormal eosinophil morphology	J:5078
	abnormal lymphocyte morphology	J:5078
	abnormal neutrophil morphology	J:5078
	decreased cytotoxic T cell cytolysis	J:6692
	impaired natural killer cell mediated cytotoxicity	J:6302, J:6213
Lyst^bg/Lyst^bg (B6.C3Rl-Lyst^bg/J)	abnormal NK cell physiology	J:6801
Lyst^{tm1b(EUCOMM)Wtsi}/Lyst^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Lyst^{tm1b(EUCOMM)Wtsi}/Tcp)	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
Lyve1^{tm1.1(EGFP/cre)Cys}/Lyve1⁺ Sphk1^tm2Cgh/Sphk1^tm2Cgh Sphk2^tm1.1Cgh/Sphk2^tm1.1Cgh (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	abnormal leukocyte migration	J:156826
	abnormal lymphocyte cell number	J:156826
	decreased B cell number	J:156826
	decreased splenocyte number	J:156826
	decreased T cell number	J:156826
Lyz2^tm1(cre)Ifo/0 Nup85^tm1.1Yter/Nup85^tm1.1Yter (involves: 129P2/OlaHsd * C57BL/6)	decreased macrophage cell number	J:292726
Lyz2^tm1(cre)Ifo/0 Pld4^tm1.1Nemz/Pld4^tm1.1Nemz (involves: 129 * 129P2/OlaHsd * C57BL/6J)	hematopoietic system phenotype	J:281205
Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6)	enlarged spleen	J:172024
Lyz2^tm1(cre)Ifo/Lyz2⁺ Pdcd10^tm1Wami/Pdcd10^tm1Wami (involves: 129 * 129P2/OlaHsd * C57BL/6)	abnormal neutrophil morphology	J:256076
	abnormal neutrophil physiology	J:256076
Lyz2^tm1(cre)Ifo/Lyz2⁺ Pikfyve^{tm1b(EUCOMM)Hmgu}/Pikfyve^{tm1b(EUCOMM)Hmgu} (involves: 129P2/OlaHsd * C57BL/6N)	abnormal alveolar macrophage morphology	J:244776
	decreased alveolar macrophage number	J:244776
	decreased regulatory T cell number	J:244776
	increased eosinophil cell number	J:244776
Lyz2^tm1(cre)Ifo/Lyz2⁺ Selenow^{tm1c(EUCOMM)Wtsi}/Selenow^{tm1c(EUCOMM)Wtsi} (B6.Cg-Selenow^{tm1c(EUCOMM)Wtsi} Lyz2^tm1(cre)Ifo)	abnormal osteoclast differentiation	J:317012
Lyz2^tm1(cre)Ifo/Lyz2^tm1(cre)Ifo Nrros^tm1Wouy/Nrros^tm1Wouy (involves: 129P2/OlaHsd)	abnormal cellular extravasation	J:209569
Lyz2^{tm1(HBEGF)Mtka}/Lyz2⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal alveolar macrophage morphology	J:145285
Lztr1^{tm1a(EUCOMM)Wtsi}/Lztr1⁺ (C57BL/6N-Lztr1^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased red blood cell distribution width	J:211773
m1Hefl/m1Hefl (C3HeB/FeJ-m1Hefl)	decreased B cell number	J:137446
X/m1Nish (involves: BALB/c * C57BL/6N)	absent B cells	J:204833
X/m1Nish (involves: BALB/c * C57BL/6N)	decreased NK cell number	J:204833
X/m1Nish (involves: C57BL/6N)	abnormal B cell differentiation	J:204833
	abnormal NK cell differentiation	J:204833
	absent B cells	J:204833
	absent B-1 B cells	J:204833
	absent B-2 B cells	J:204833
	decreased B cell number	J:204833
	decreased B-1 B cell number	J:204833
	decreased IgG level	J:204833
	decreased IgM level	J:204833
	decreased immature B cell number	J:204833
	decreased NK cell number	J:204833
	decreased T cell proliferation	J:204833
m2Hefl/m2Hefl (C3HeB/FeJ-m2Hefl)	absent B cells	J:137446
m2Hefl/m2Hefl (C3HeB/FeJ-m2Hefl)	absent T cells	J:137446
m3Hefl/m3Hefl (C3HeB/FeJ-m3Hefl)	decreased CD8-positive, alpha-beta T cell number	J:137446
m3Hefl/m3Hefl (C3HeB/FeJ-m3Hefl)	decreased NK cell number	J:137446
m4Hefl/m4Hefl (C3HeB/FeJ-m4Hefl)	decreased T cell number	J:137446
m5Hefl/m5Hefl (C3HeB/FeJ-m5Hefl)	decreased T cell number	J:137446
M6pr^em1(IMPC)Mbp/M6pr^em1(IMPC)Mbp (C57BL/6N-M6pr^em1(IMPC)Mbp/MbpMmucd)	small spleen	J:211773
M7321Wlst/M7321Wlst⁺ (involves: 129S1/SvImJ * C57BL/6J)	abnormal thrombopoiesis	J:189491
M7321Wlst/M7321Wlst⁺ (involves: 129S1/SvImJ * C57BL/6J)	thrombocytosis	J:189491
M7323Wlst/M7323Wlst⁺ (involves: 129S1/SvImJ * C57BL/6J)	hematopoietic system phenotype	J:189491
M7323Wlst/M7323Wlst⁺ (involves: 129S1/SvImJ * C57BL/6J)	thrombocytosis	J:189491
M7324Wlst/M7324Wlst⁺ (involves: 129S1/SvImJ * C57BL/6J)	abnormal thrombopoiesis	J:189491
M7324Wlst/M7324Wlst⁺ (involves: 129S1/SvImJ * C57BL/6J)	thrombocytopenia	J:189491
M7325Wlst/M7325Wlst⁺ (involves: 129S1/SvImJ * C57BL/6J)	abnormal thrombopoiesis	J:189491
M7325Wlst/M7325Wlst⁺ (involves: 129S1/SvImJ * C57BL/6J)	thrombocytosis	J:189491
m12137Asr/m12137Asr⁺ (C57BL/6J-m12137Asr)	decreased osteoclast cell number	J:132290
Macrod2^{tm1.1(KOMP)Vlcg}/Macrod2^{tm1.1(KOMP)Vlcg} (C57BL/6N-Macrod2^{tm1.1(KOMP)Vlcg}/J)	increased hemoglobin content	J:211773
Macroh2a1^tm1.1Oxbo/Macroh2a1^tm1.1Oxbo (B6.Cg-Macroh2a1^tm1.1Oxbo)	decreased B cell number	J:293382
	decreased hematocrit	J:293382
	decreased neutrophil cell number	J:293382
	increased eosinophil cell number	J:293382
	increased lymphocyte cell number	J:293382
	increased myeloid cell number	J:293382
Mad2l1^tm1Sorg/Mad2l1⁺ (involves: 129S2/SvPas * C57BL/6)	increased spleen germinal center number	J:62829
Madcam1^tm1.2Nwag/Madcam1^tm1.2Nwag (B6.129P2-Madcam1^tm1.2Nwag)	abnormal B cell physiology	J:169739
	decreased B cell number	J:169739
	decreased IgA level	J:169739
	decreased plasma cell number	J:169739
	increased plasma cell number	J:169739
Maea^Gt(XG702)Byg/Maea^Gt(XG702)Byg (involves: 129P2/OlaHsd * C57BL/6J)	abnormal erythropoiesis	J:114865
	decreased macrophage cell number	J:114865
	increased nucleated erythrocyte cell number	J:114865
Maf^em1(IMPC)Mbp/Maf⁺ (C57BL/6N-Maf^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	small spleen	J:211773
Mafg^tm1Jeng/Mafg^tm1Jeng (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal megakaryocyte differentiation	J:78982
	thrombocytopenia	J:78982
Mafg^tm1Jeng/Mafg^tm1Jeng (involves: 129S1/Sv * 129X1/SvJ * CD-1)	abnormal megakaryocyte differentiation	J:78982
	thrombocytopenia	J:78982
Mafg^tm1Jeng/Mafg^tm1Jeng Mafk^tm1Jeng/Mafk⁺ (involves: 129S1/Sv * 129X1/SvJ)	abnormal megakaryocyte differentiation	J:61142
	thrombocytopenia	J:61142
Mafg^tm1Jeng/Mafg^tm1Jeng Mafk^tm1Jeng/Mafk^tm1Jeng (involves: 129S1/Sv * 129X1/SvJ)	abnormal erythrocyte morphology	J:61142
	anemia	J:61142
	enlarged spleen	J:61142
	extramedullary hematopoiesis	J:61142
	increased erythrocyte osmotic fragility	J:61142
	reticulocytosis	J:61142
	thrombocytopenia	J:61142
Mafk^tm1Sho/Mafk^tm1Sho (either: (involves: 129 * 129S4/SvJae) or (involves: 129S4/SvJae * C57BL/6))	hematopoietic system phenotype	J:35116
Mag^{tm1.1(KOMP)Vlcg}/Mag^{tm1.1(KOMP)Vlcg} (C57BL/6N-Mag^{tm1.1(KOMP)Vlcg}/J)	decreased leukocyte cell number	J:211773
Mag^tm1Rod/Mag^tm1Rod (involves: 129S1/Sv * 129X1/SvJ)	increased B cell proliferation	J:217719
Magix^{em1(IMPC)Hmgu}/Y (C57BL/6NCrl-Magix^{em1(IMPC)Hmgu}/Ieg)	decreased erythrocyte cell number	J:211773
	decreased hemoglobin content	J:211773
	decreased leukocyte cell number	J:211773
	increased mean platelet volume	J:211773
Magix^{em1(IMPC)Hmgu}/Magix^{em1(IMPC)Hmgu} (C57BL/6NCrl-Magix^{em1(IMPC)Hmgu}/Ieg)	decreased erythrocyte cell number	J:211773
	increased mean platelet volume	J:211773
Magt1^{Gt(IST13422E1)Tigm}/Y (involves: C57BL/6N)	abnormal B cell morphology	J:260923
	decreased plasma cell number	J:260923
	decreased T cell number	J:260923
	increased B cell number	J:260923
	increased B cell proliferation	J:260923
	increased marginal zone B cell number	J:260923
Malrd1^em1(IMPC)Mbp/Malrd1^em1(IMPC)Mbp (C57BL/6N-Malrd1^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Malt1^m2Btlr/Malt1⁺ (C57BL/6J-Malt1^m2Btlr)	decreased IgM level	J:224671
Malt1^m2Btlr/Malt1^m2Btlr (C57BL/6J-Malt1^m2Btlr)	decreased IgG level	J:224671
Malt1^m2Btlr/Malt1^m2Btlr (C57BL/6J-Malt1^m2Btlr)	decreased IgM level	J:224671
Malt1^m3Btlr/Malt1⁺ (C57BL/6J-Malt1^m3Btlr)	decreased IgM level	J:224672
Malt1^m3Btlr/Malt1^m3Btlr (C57BL/6J-Malt1^m3Btlr)	decreased IgG level	J:224672
Malt1^m3Btlr/Malt1^m3Btlr (C57BL/6J-Malt1^m3Btlr)	decreased IgM level	J:224672
Malt1^tm1Mak/Malt1^tm1Mak (involves: 129P2/OlaHsd)	decreased IgG level	J:109545
	decreased IgM level	J:109545
	decreased T cell proliferation	J:109545
Malt1^tm1Vmd/Malt1^tm1Vmd (involves: C57BL/6N)	abnormal B cell differentiation	J:86770
	abnormal double-negative T cell morphology	J:86770
	abnormal spleen marginal zone morphology	J:86770
	abnormal T cell differentiation	J:86770
	abnormal T cell proliferation	J:86770
	absent B-1a cells	J:86770
	decreased immunoglobulin level	J:86770
Maml1^tm1Mkit/Maml1^tm1Mkit (involves: 129P2/OlaHsd * C57BL/6)	decreased marginal zone B cell number	J:122286
	decreased thymocyte number	J:122286
	increased double-negative T cell number	J:122286
Mamld1^{tm1.1(NCOM)Mfgc}/Y (C57BL/6N-Mamld1^{tm1.1(NCOM)Mfgc}/Tcp)	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
Man2a1^{em1(IMPC)Hmgu}/Man2a1^{em1(IMPC)Hmgu} (C57BL/6N-Man2a1^{em1(IMPC)Hmgu}/Ieg)	decreased hemoglobin content	J:211773
	decreased mean corpuscular volume	J:211773
	increased mean platelet volume	J:211773
	increased red blood cell distribution width	J:211773
	thrombocytopenia	J:211773
Man2a1^tm1Jxm/Man2a1^tm1Jxm (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal erythrocyte morphology	J:41621
	abnormal hematopoietic system morphology/development	J:41621
	abnormal spleen morphology	J:74579
	anemia	J:41621
	anisocytosis	J:41621
	decreased erythrocyte osmotic fragility	J:41621
	enlarged spleen	J:41621
	increased hematopoietic stem cell number	J:41621
	increased IgA level	J:74579
	increased IgG level	J:74579
	increased IgM level	J:74579
	increased memory T cell number	J:74579
	reticulocytosis	J:41621
Man2b1^tm1Psa/Man2b1^tm1Psa (involves: 129 * C57BL/6J)	abnormal Kupffer cell morphology	J:56659
Man2b1^tm1Psa/Man2b1^tm1Psa (involves: 129 * C57BL/6J)	abnormal spleen red pulp morphology	J:56659
Man2b2^{tm1b(KOMP)Wtsi}/Man2b2^{tm1b(KOMP)Wtsi} (C57BL/6N-Man2b2^{tm1b(KOMP)Wtsi}/Tcp)	decreased lymphocyte cell number	J:211773
	increased eosinophil cell number	J:211773
	increased neutrophil cell number	J:211773
Man2c1^tm1.1Tbec/Man2c1^tm1.1Tbec (B6N.129P2-Man2c1^tm1.1Tbec)	abnormal microglial cell activation	J:205550
Manba^tm1Khf/Manba^tm1Khf (B6.129-Manba^tm1Khf)	abnormal Kupffer cell morphology	J:105427
Maneal^{tm1a(KOMP)Wtsi}/Maneal^{tm1a(KOMP)Wtsi} (C57BL/6N-Maneal^{tm1a(KOMP)Wtsi}/Wtsi)	increased mean corpuscular hemoglobin	J:175295
Map2k3^tm1Flv/Map2k3^tm1Flv (involves: 129S1/Sv)	abnormal CD4-positive, alpha-beta T cell physiology	J:85266
Map2k3^tm1Flv/Map2k3^tm1Flv (involves: 129S1/Sv)	decreased T cell apoptosis	J:85266
Map2k4^tm1Pngr/Map2k4^tm1Pngr (involves: 129P2/OlaHsd * C57BL/6)	anemia	J:51597
Map2k6^tm1Flv/Map2k6^tm1Flv (involves: 129S1/Sv)	abnormal thymocyte apoptosis	J:85266
Map2k6^tm1Ina/Map2k6^tm1Ina Tg(TcraH-Y,TcrbH-Y)71Vbo/0 (involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)	abnormal thymus cell ratio	J:100093
Map3k1^{tm1a(KOMP)Wtsi}/Map3k1⁺ (C57BL/6N-Map3k1^{tm1a(KOMP)Wtsi}/Wtsi)	increased red blood cell distribution width	J:211773
Map3k2^tm1Bisu/Map3k2^tm1Bisu (Not Specified)	abnormal T cell activation	J:78072
Map3k2^tm1Bisu/Map3k2^tm1Bisu (Not Specified)	increased T cell proliferation	J:78072
Map3k3^tm1Bisu/Map3k3^tm2Bisu Tg(Lck-cre)548Jxm/0 (involves: C57BL/6 * CBA)	abnormal T cell physiology	J:145923
	abnormal T cell proliferation	J:145923
	decreased CD4-positive, alpha-beta T cell number	J:145923
	decreased CD8-positive, alpha-beta T cell number	J:145923
	spleen hypoplasia	J:145923
Map3k3^tm1Kuro/Map3k3^tm1Kuro Tg(Lck-cre)1Jtak/0 (involves: C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:147103
	decreased CD8-positive, alpha-beta T cell number	J:147103
	decreased double-positive T cell number	J:147103
	decreased single-positive T cell number	J:147103
	decreased T cell proliferation	J:147103
	decreased thymocyte number	J:147103
	increased double-negative T cell number	J:147103
Map3k4^tm1Flv/Map3k4^tm1Flv (involves: 129S6/SvEvTac * C57BL/6)	abnormal T-helper 1 physiology	J:90112
Map3k7^tm1Aki/Map3k7^tm1Aki Tg(Lck-cre)1Jtak/0 (involves: 129P2/OlaHsd)	abnormal spleen morphology	J:112837
	abnormal T cell activation	J:112837
	absent regulatory T cells	J:112837
	decreased CD4-positive, alpha-beta T cell number	J:112837
	decreased CD8-positive, alpha-beta T cell number	J:112837
	decreased single-positive T cell number	J:112837
	decreased T cell number	J:112837
	decreased T cell proliferation	J:112837
	enlarged spleen	J:112837
	increased memory T cell number	J:112837
	spleen hyperplasia	J:112837
Map3k7^tm1Aki/Map3k7^tm1Aki Tg(Lck-cre)1Jtak/0 (involves: 129P2/OlaHsd * C57BL/6)	abnormal alpha-beta intraepithelial T cell morphology	J:238318
	abnormal CD4-positive, alpha-beta T cell physiology	J:238318
	abnormal intraepithelial T cell number	J:238318
	abnormal regulatory T cell number	J:238318
	abnormal regulatory T cell physiology	J:238318
	abnormal T cell morphology	J:238318
	decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:238318
	decreased NK T cell number	J:238318
	increased CD4-positive, alpha-beta T cell number	J:238318
	increased gamma-delta intraepithelial T cell number	J:238318
Map3k7^tm1Zjc/Map3k7^tm1Zjc Tg(Lck-cre)548Jxm/0 (involves: 129S7/SvEvBrd * C57BL/6 * CBA)	decreased CD4-positive, alpha-beta T cell number	J:111794
	decreased CD8-positive, alpha-beta T cell number	J:111794
	decreased T cell number	J:111794
	increased thymocyte apoptosis	J:111794
Map3k8^M1Btlr/Map3k8^M1Btlr (C57BL/6J-Map3k8^M1Btlr)	impaired natural killer cell mediated cytotoxicity	J:140986
Map3k8^m3Btlr/Map3k8⁺ (C57BL/6J-Map3k8^m3Btlr)	decreased macrophage cytokine production	J:224668
Map3k8^m3Btlr/Map3k8^m3Btlr (C57BL/6J-Map3k8^m3Btlr)	decreased macrophage cytokine production	J:224668
Map3k8^tm1Pnt/Map3k8^tm1Pnt Tnf^tm2Gkl/Tnf⁺ (involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6J)	increased CD8-positive, alpha-beta T cell number	J:108572
	increased single-positive T cell number	J:108572
Map3k8^tm1Tmat/Map3k8^tm1Tmat (involves: 129S/SvEv * C57BL/6)	decreased IgE level	J:92844
	decreased IgG1 level	J:92844
	increased IgG2a level	J:92844
	increased T cell proliferation	J:92844
Map3k9^em1(IMPC)Mbp/Map3k9^em1(IMPC)Mbp (C57BL/6N-Map3k9^em1(IMPC)Mbp/MbpMmucd)	increased neutrophil cell number	J:211773
Map3k14^aly/Map3k14⁺ Relb^{Tg(H2-K1/GH1)106Bri}/Relb⁺ (involves: C57BL/6 * C57BL/6J)	decreased NK T cell number	J:120659
Map3k14^aly/Map3k14^aly (involves: C57BL/6J)	abnormal CD4-positive, CD25-positive, alpha-beta regulatory T cell morphology	J:87993, J:128211
	abnormal NK T cell morphology	J:120659
	abnormal T cell activation	J:38580
	abnormal thymus corticomedullary boundary morphology	J:87993
	abnormal thymus medulla morphology	J:87993
	decreased dendritic cell number	J:128211
	decreased IgE level	J:135748
	decreased mast cell number	J:135748
	decreased NK T cell number	J:120659
	decreased regulatory T cell number	J:128211
	increased eosinophil cell number	J:135748
	small thymus	J:147681
	thymus cyst	J:147681
Map3k14^aly/Map3k14^aly (involves: AEJ/GnRk * C57BL/6J)	abnormal lymphocyte morphology	J:16865
	abnormal lymphopoiesis	J:16865
	abnormal spleen primary B follicle morphology	J:54529
	absent spleen marginal zone	J:54529
	absent thymus corticomedullary boundary	J:16865, J:54529
	decreased B cell number	J:54529
	decreased IgA level	J:16865, J:54529
	decreased IgG level	J:16865, J:54529
	decreased IgM level	J:16865, J:54529
	decreased spleen B cell follicle number	J:16865
Map3k14^m1Btlr/Map3k14^m1Btlr (C57BL/6J-Map3k14^m1Btlr)	abnormal B cell activation	J:152065
	arrested B cell differentiation	J:152065
	decreased B cell number	J:152065
	decreased IgG level	J:152065
Map3k14^m1Btlr/Map3k14^m1Btlr (involves: C57BL/6J)	abnormal class switch recombination	J:185495
	arrested B cell differentiation	J:185495
	decreased IgG level	J:185495
Map3k14^tm1.1Gne/Map3k14^tm1.1Gne Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6NTac)	decreased B cell number	J:280549
Map3k14^tm1.2Gne/Map3k14^tm1.2Gne (B6(Cg)-Map3k14^tm1.2Gne)	abnormal B cell physiology	J:240453
	abnormal spleen marginal zone morphology	J:240453
	abnormal thymus cell ratio	J:240453
	decreased B cell number	J:240453
	decreased B-2 B cell number	J:240453
	decreased follicular B cell number	J:240453
	decreased germinal center B cell number	J:240453
	decreased IgA level	J:240453
	decreased marginal zone B cell number	J:240453
	decreased transitional stage T1 B cell number	J:240453
	decreased transitional stage T2 B cell number	J:240453
Map3k14^tm1Rds/Map3k14^tm1Rds (involves: 129/Sv * C57BL/6)	abnormal spleen morphology	J:68125
	abnormal thymus morphology	J:68125
	decreased IgA level	J:68125
	decreased IgG2b level	J:68125
	decreased immunoglobulin level	J:68125
Map3k14^tm1Rds/Map3k14^tm1Rds (involves: 129)	abnormal class switch recombination	J:188560
Map4k1^tm1Tht/Map4k1^tm1Tht (involves: 129S7/SvEvBrd)	increased T cell proliferation	J:116613
Map4k3^{Gt(RRO270)Byg}/Map4k3^{Gt(RRO270)Byg} (involves: 129P2/OlaHsd)	abnormal T-helper 1 cell differentiation	J:177642
	abnormal T-helper 2 cell differentiation	J:177642
	abnormal T-helper 17 cell differentiation	J:177642
	decreased IgG1 level	J:177642
	decreased IgG2a level	J:177642
	decreased IgG2b level	J:177642
	decreased IgG3 level	J:177642
	decreased IgM level	J:177642
	decreased immunoglobulin level	J:177642
	decreased T cell proliferation	J:177642
Map4k5^{Gt(OST218153)Lex}/Map4k5^{Gt(OST218153)Lex} (B6;129S5-Map4k5^{Gt(OST218153)Lex}/Ieg)	increased CD4-positive, alpha-beta T cell number	J:82809
	increased IgG1 level	J:82809
Mapk1^tm1.1Hed/Mapk1^tm1.1Hed Tg(Lck-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	abnormal T cell subpopulation ratio	J:113280
	decreased CD4-positive, alpha-beta T cell number	J:113280
	decreased CD8-positive, alpha-beta T cell number	J:113280
Mapk1^tm1Gela/Mapk1^tm1Gela H2az2^{Tg(Wnt1-cre)11Rth}/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CBA/J)	abnormal thymus morphology	J:144862
Mapk1^tm1Gela/Mapk1^tm1Gela Mapk3^tm1Gela/Mapk3⁺ H2az2^{Tg(Wnt1-cre)11Rth}/H2az2⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CBA/J)	abnormal thymus morphology	J:144862
Mapk1^tm1Gela/Mapk1^tm1Gela Mapk3^tm1Gela/Mapk3^tm1Gela H2az2^{Tg(Wnt1-cre)11Rth}/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CBA/J)	athymia	J:144862
Mapk1^tm1Hed/Mapk1^tm1Hed Mapk3^tm1Gpg/Mapk3^tm1Gpg Tg(Cd4-cre)1Cwi/0 (involves: 129/Sv * C57BL/6 * DBA/2)	abnormal positive T cell selection	J:113280
Mapk1^tm1Hed/Mapk1^tm1Hed Mapk3^tm1Gpg/Mapk3^tm1Gpg Tg(Cd4-cre)1Cwi/0 Tg(TcrAND)53Hed/0 (involves: 129/Sv * C57BL/6 * DBA/2 * SJL)	abnormal positive T cell selection	J:113280
	abnormal T cell subpopulation ratio	J:113280
Mapk1^tm1Hed/Mapk1^tm1Hed Mapk3^tm1Gpg/Mapk3^tm1Gpg Tg(Lck-cre)1Cwi/0 (involves: 129/Sv * C57BL/6 * DBA/2)	abnormal T cell proliferation	J:113280
	decreased thymocyte number	J:113280
	increased double-positive T cell number	J:113280
	small thymus	J:113280
Mapk1^tm1Hed/Mapk1^tm1Hed Mapk3^tm1Gpg/Mapk3^tm1Gpg Tg(TcraTcrb)1100Mjb/0 (involves: 129/Sv * C57BL/6)	decreased thymocyte number	J:113280
Mapk1^tm1Hed/Mapk1^tm1Hed Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	abnormal positive T cell selection	J:113280
	decreased CD4-positive, alpha-beta T cell number	J:113280
	decreased CD8-positive, alpha-beta T cell number	J:113280
	increased double-positive T cell number	J:113280
Mapk1^tm1Hed/Mapk1^tm1Hed Tg(Lck-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	abnormal T cell subpopulation ratio	J:113280
	decreased double-positive T cell number	J:113280
	decreased T cell proliferation	J:113280
Mapk1^tm1Hed/Mapk1^tm1Hed Tg(Lck-cre)1Cwi/0 Tg(TcrAND)53Hed/0 (involves: C57BL/6 * DBA/2 * SJL)	abnormal positive T cell selection	J:113280
	abnormal T cell subpopulation ratio	J:113280
Mapk1^tm1Hed/Mapk1^tm1Hed Tg(TcrAND)53Hed/0 (involves: C57BL/6 * DBA/2 * SJL)	abnormal double-positive T cell morphology	J:113280
	abnormal positive T cell selection	J:113280
Mapk1^tm1Hed/Mapk1^tm1Hed Tg(TcraTcrb)1100Mjb/0 (involves: C57BL/6)	decreased thymocyte number	J:113280
Mapk1^tm2Moga/Mapk1^tm2Moga Mapk3^tm1Gpg/Mapk3^tm1Gpg Tg(Mx1-cre)1Cgn/? (involves: 129/Sv * 129P2/OlaHsd * C57BL/6 * CBA)	abnormal pro-B cell differentiation	J:134528
	abnormal pro-B cell morphology	J:134528
	decreased pre-B cell number	J:134528
Mapk3^tm1Gpg/Mapk3^tm1Gpg (involves: 129)	decreased T cell number	J:58468
Mapk3^tm1Gpg/Mapk3^tm1Gpg (involves: 129)	decreased T cell proliferation	J:58468
Mapk8^tm1Flv/Mapk8^tm1Flv (involves: 129S1/Sv)	abnormal T-helper 1 cell differentiation	J:51510
Mapk8^tm1Flv/Mapk8^tm1Flv (involves: 129S1/Sv)	increased T cell proliferation	J:51510
Mapk8^tm1Rjd/Mapk8^tm1Rjd Mapk9^tm2.1Rjd/Mapk9^tm2.1Rjd Lyz2^tm1(cre)Ifo/Lyz2⁺ (B6J.Cg-Lyz2^tm1(cre)Ifo Mapk9^tm2.1Rjd Mapk8^tm1Rjd)	abnormal macrophage differentiation	J:192551
	abnormal macrophage physiology	J:192551
	decreased macrophage cell number	J:192551
	decreased macrophage cytokine production	J:192551
	impaired macrophage chemotaxis	J:192551
Mapk8^tm1Wag/Mapk8⁺ Mapk9^tm1Mka/Mapk9⁺ (involves: 129)	abnormal T cell activation	J:78190
	decreased T cell apoptosis	J:78190
	decreased T cell proliferation	J:78190
Mapk8^tm1Wag/Mapk8⁺ Mapk9^tm1Mka/Mapk9^tm1Mka (involves: 129)	abnormal T cell activation	J:78190
	decreased T cell apoptosis	J:78190
	decreased T cell proliferation	J:78190
Mapk8^tm1Wag/Mapk8^tm1Wag (involves: 129P2/OlaHsd)	abnormal T cell activation	J:78190
	decreased T cell apoptosis	J:78190
	decreased T cell proliferation	J:78190
Mapk8^tm1Wag/Mapk8^tm1Wag Mapk9^tm1Mka/Mapk9⁺ (involves: 129)	abnormal T cell activation	J:78190
	decreased T cell apoptosis	J:78190
	decreased T cell proliferation	J:78190
Mapk9^tm1Flv/Mapk9^tm1Flv (involves: 129S2/SvPas)	abnormal T-helper 1 cell differentiation	J:50628
Mapk9^tm1Mka/Mapk9^tm1Mka (either: (involves: 129S2/SvPas) or (involves: 129S1/Sv * 129X1/SvJ))	abnormal T cell activation	J:78129
	decreased T cell apoptosis	J:78129
	decreased T cell proliferation	J:78129
Mapk11^tm1Jda/Mapk11^tm1Jda Mapk14^tm1Jda/Mapk14^tm1Jda (involves: 129 * C57BL/6)	abnormal T-helper 1 cell differentiation	J:165966
	abnormal T-helper 2 cell differentiation	J:165966
	abnormal T-helper 17 cell differentiation	J:165966
	decreased T cell proliferation	J:165966
Mapk14^tm1Jda/Mapk14^tm1Jda (B6.Cg-Mapk14^tm1Jda)	abnormal T-helper 1 physiology	J:146088
	decreased T cell proliferation	J:146088
	increased double-negative T cell number	J:146088
Mapk14^tm1Mka/Mapk14^tm1Mka (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal erythropoiesis	J:63425
	anemia	J:63425
Mapk14^tm1Mms/Mapk14^tm1Mms (involves: 129S7/SvEvBrd * C57BL/6)	hematopoietic system phenotype	J:73417
Mapk15^{tm1b(EUCOMM)Hmgu}/Mapk15^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Mapk15^{tm1b(EUCOMM)Hmgu}/J)	increased mean corpuscular hemoglobin concentration	J:211773
Mapkapk2^{tm1b(EUCOMM)Hmgu}/Mapkapk2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Mapkapk2^{tm1b(EUCOMM)Hmgu}/H)	increased eosinophil cell number	J:211773
	increased large unstained cell number	J:211773
	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
Mapkapk2^tm1Mgl/Mapkapk2^tm1Mgl (involves: 129P2/OlaHsd * C57BL/6J)	abnormal macrophage derived foam cell morphology	J:142788
	increased spleen germinal center size	J:59678
Mapkapk2^tm1Mgl/Mapkapk2^tm1Mgl (involves: 129S * C57BL/6)	impaired macrophage phagocytosis	J:76161
Mapkapk3^{em1(IMPC)Ccpcz}/Mapkapk3^{em1(IMPC)Ccpcz} (C57BL/6N-Mapkapk3^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Mapkbp1^{tm1b(EUCOMM)Hmgu}/Mapkbp1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Mapkbp1^{tm1b(EUCOMM)Hmgu}/H)	increased spleen weight	J:211773
Mapre3^{tm1a(EUCOMM)Wtsi}/Mapre3⁺ (C57BL/6N-Mapre3^{tm1a(EUCOMM)Wtsi}/Ics)	increased hematocrit	J:165965
Mapt^tm1(EGFP)Klt/Mapt^tm1(EGFP)Klt Tg(MAPT)8cPdav/? (involves: 129S4/SvJae * C57BL/6 * Swiss Webster)	abnormal spleen B cell follicle morphology	J:174270
	abnormal spleen B cell follicle shape	J:174270
	abnormal spleen red pulp morphology	J:174270
	increased spleen B cell follicle size	J:174270
Mapt^{tm2.1(FUS)Neas}/Mapt⁺ (B6J.129P2(129S)-Mapt^{tm2.1(FUS)Neas})	microgliosis	J:232167
Mapt^{tm3.1(FUS)Neas}/Mapt⁺ (B6J.129P2(129S)-Mapt^{tm3.1(FUS)Neas})	microgliosis	J:232167
Mar1^tm1Wtg/Mar1⁺ (involves: 129S6/SvEvTac * C57BL/6)	abnormal somatic hypermutation frequency	J:68024
Mar1^tm1Wtg/Mar1^tm1Wtg (involves: 129S6/SvEvTac * C57BL/6)	abnormal somatic hypermutation frequency	J:68024
Marchf1^tm1.1Sish/Marchf1^tm1.1Sish (involves: 129S1/Sv * 129X1/SvJ)	abnormal B cell physiology	J:119918
	abnormal dendritic cell morphology	J:119918
	abnormal T cell differentiation	J:201198
	decreased regulatory T cell number	J:201198
Marchf3^{tm1b(EUCOMM)Hmgu}/Marchf3^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Marchf3^{tm1b(EUCOMM)Hmgu}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Marchf5^tm1.1Ygi/Marchf5^tm1.1Ygi Tg(Emx1-cre)#Ito/0 (involves: C57BL/6)	increased microglial cell activation	J:284572
Marchf6^{tm1b(EUCOMM)Hmgu}/Marchf6^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Marchf6^{tm1b(EUCOMM)Hmgu}/Ccpcz)	decreased mean platelet volume	J:211773
Marchf7^{Gt(ROSABetageo)1Summ}/Marchf7⁺ (involves: BALB/c)	increased T cell proliferation	J:96167
Marchf7^{Gt(ROSABetageo)1Summ}/Marchf7^{Gt(ROSABetageo)1Summ} (involves: BALB/c)	increased T cell proliferation	J:96167
Marchf8^{em2(IMPC)Ccpcz}/Marchf8^{em2(IMPC)Ccpcz} (C57BL/6N-Marchf8^{em2(IMPC)Ccpcz}/Ccpcz)	decreased eosinophil cell number	J:211773
	increased mean corpuscular volume	J:211773
Marchf9^{tm1a(EUCOMM)Wtsi}/Marchf9^{tm1a(EUCOMM)Wtsi} (Not Specified)	decreased B cell number	J:165965
Marcksl1^tm1Fsh/Marcksl1^tm1Fsh (involves: 129S4/SvJae)	abnormal macrophage physiology	J:115146
Marco^tm1Ktry/Marco^tm1Ktry (B6.129S6-Marco^tm1Ktry)	abnormal macrophage physiology	J:115081
	abnormal spleen marginal zone morphology	J:122271
	impaired macrophage phagocytosis	J:115081
Marco^tm1Ktry/Marco^tm1Ktry Msr1^tm1Csk/Msr1^tm1Csk (B6.129-Marco^tm1Ktry Msr1^tm1Csk)	abnormal macrophage physiology	J:122271
	abnormal spleen marginal zone morphology	J:122271
	increased IgM level	J:122271
Marco^tm1Spt/Marco^tm1Spt (C57BL/6-Marco^tm1Spt)	abnormal dendritic cell chemotaxis	J:204315
Mark2^tm1Hpw/Mark2^tm1Hpw (involves: 129X1/SvJ * C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:68830
	abnormal spleen B cell follicle morphology	J:68830
	decreased B cell proliferation	J:68830
	decreased IgG3 level	J:68830
	decreased IgM level	J:68830
	enlarged spleen	J:68830
	increased B cell number	J:68830
	increased B cell proliferation	J:68830
	increased spleen weight	J:68830
	spleen hyperplasia	J:68830
Mark4^em1(IMPC)Mbp/Mark4^em1(IMPC)Mbp (C57BL/6N-Mark4^em1(IMPC)Mbp/Ucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Marveld2^tm1.1Sria/Marveld2^tm1.1Sria (involves: 129X1/SvJ * C57BL/6J)	increased spleen weight	J:201580
Marveld3^{em1(IMPC)Ccpcz}/Marveld3^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Marveld3^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Matk^tm1Sor/Matk^tm1Sor (B6.129S4-Matk^tm1Sor)	abnormal bone marrow cell morphology/development	J:109203
	abnormal hematopoietic system physiology	J:109203
	hematopoietic system phenotype	J:109203
	increased hematopoietic stem cell number	J:109203
Matn1^tm1Ref/Matn1^tm1Ref Matn2^tm1Asz/Matn2^tm1Asz Matn3^tm1Asz/Matn3^tm1Asz Matn4^tm1.1Asz/Matn4^tm1.1Asz (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased double-positive T cell number	J:237230
	decreased erythrocyte cell number	J:237230
	decreased hematopoietic stem cell number	J:237230
	increased granulocyte number	J:237230
	increased hematopoietic stem cell proliferation	J:237230
	increased megakaryocyte cell number	J:237230
Matn4^tm1.1Asz/Matn4^tm1.1Asz (B6.129-Matn4^tm1.1Asz)	decreased hematopoietic stem cell number	J:237230
Matn4^tm1.1Asz/Matn4^tm1.1Asz (B6.129-Matn4^tm1.1Asz)	increased hematopoietic stem cell proliferation	J:237230
Matr3^em1Tcp/Matr3^em1Tcp (C57BL/6J-Matr3^em1Tcp)	increased microglial cell activation	J:298091
Mavs^tm1Aki/Mavs^tm1Aki (involves: 129P2/OlaHsd * C57BL/6)	decreased CD8-positive, alpha-beta T cell number	J:130954
	decreased IgG1 level	J:130954
	decreased IgG2a level	J:130954
	decreased IgG level	J:130954
Mavs^tm1Aki/Mavs^tm1Aki (involves: 129S/SvEv * C57BL/6)	abnormal macrophage physiology	J:162888
	decreased CD4-positive, alpha-beta T cell number	J:162888
	decreased CD8-positive, alpha-beta T cell number	J:162888
	enlarged spleen	J:162888
	increased dendritic cell number	J:162888
	increased IgG2a level	J:162888
	increased IgG level	J:162888
	increased IgM level	J:162888
Mavs^tm1Aki/Mavs^tm1Aki Ifna6^tm1Aki/Ifna6⁺ (involves: 129P2/OlaHsd)	abnormal alveolar macrophage morphology	J:124340
	abnormal macrophage morphology	J:124340
	abnormal myeloid dendritic cell morphology	J:124340
Mavs^tm1Aki/Mavs^tm1Aki Ticam1^tm1Aki/Ticam1^tm1Aki (involves: 129P2/OlaHsd * C57BL/6)	decreased CD8-positive, alpha-beta T cell number	J:130954
	decreased cytotoxic T cell cytolysis	J:130954
	decreased IgG1 level	J:130954
	decreased IgG2a level	J:130954
	decreased IgG level	J:130954
Mavs^tm1Camb/Mavs^tm1Camb (involves: 129S6/SvEvTac * C57BL/6)	abnormal B cell physiology	J:180356
	decreased B cell proliferation	J:180356
Mavs^tm1Zjc/Mavs^tm1Zjc (involves: 129/Sv * C57BL/6)	abnormal macrophage physiology	J:110905
Mb21d2^em1(IMPC)Mbp/Mb21d2^em1(IMPC)Mbp (C57BL/6N-Mb21d2^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
Mb^tm1Jsc/Mb^tm1Jsc (involves: 129S1/Sv * 129X1/SvJ * NMRI)	increased hematocrit	J:57481
Mb^tm1Jsc/Mb^tm1Jsc (involves: 129S1/Sv * 129X1/SvJ * NMRI)	increased hemoglobin content	J:57481
Mb^tm1Wlm/Mb^tm1Wlm (either: (involves: 129/Sv) or (involves: C57BL/6))	hematopoietic system phenotype	J:74121
Mbd1^{em1(IMPC)Wtsi}/Mbd1^{em1(IMPC)Wtsi} (C57BL/6N-Mbd1^{em1(IMPC)Wtsi}/Wtsi)	increased mean corpuscular hemoglobin	J:211773
Mbd2^tm1Bh/Mbd2^tm1Bh (NOD.129P2(B6)-Mbd2^tm1Bh)	abnormal CD4-positive, alpha-beta T cell physiology	J:323838
	abnormal CD8-positive, alpha-beta cytotoxic T cell morphology	J:323838
	abnormal effector T cell morphology	J:323838
	enlarged spleen	J:323838
	increased T cell proliferation	J:323838
	increased T-helper 1 cell number	J:323838
	increased T-helper 2 cell number	J:323838
Mbd5^{tm1b(EUCOMM)Wtsi}/Mbd5⁺ (C57BL/6N-Mbd5^{tm1b(EUCOMM)Wtsi}/Ics)	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
Mbip^em1(IMPC)J/Mbip⁺ (C57BL/6NJ-Mbip^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Mbl1^tm1Kata/Mbl1^tm1Kata Mbl2^tm1Kata/Mbl2^tm1Kata (involves: 129 * C57BL/6)	abnormal B cell number	J:97686
	decreased germinal center B cell number	J:97686
	decreased macrophage cell number	J:98124
	decreased monocyte cell number	J:98124
	impaired macrophage phagocytosis	J:97686, J:98124
	increased B-1 B cell number	J:97686
Mbl1^tm1Rala/Mbl1^tm1Rala (involves: 129X1/SvJ * C57BL/6J)	abnormal immunoglobulin level	J:145279
	decreased IgG2b level	J:145279
	decreased IgM level	J:145279
	increased IgG1 level	J:145279
	increased IgG2a level	J:145279
	increased IgG3 level	J:145279
Mboat2^em1(IMPC)Mbp/Mboat2^em1(IMPC)Mbp (C57BL/6N-Mboat2^em1(IMPC)Mbp/Ucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Mboat7^{tm1b(KOMP)Wtsi}/Mboat7⁺ (C57BL/6N-Mboat7^{tm1b(KOMP)Wtsi}/H)	increased lymphocyte cell number	J:211773
Mbp^shi/Mbp^shi (involves: BALB/c * C3HeB/Fe * SWV)	increased T cell proliferation	J:48412
Mbtd1^tm1Homy/Mbtd1^tm1Homy (B6.Cg-Ptprc^a Mbtd1^tm1Homy)	decreased hematopoietic stem cell number	J:169112
Mbtps1^tm1Jdh/Mbtps1^tm1Jdh Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0 (involves: 129S6/SvEvTac * C57BL/6 * CD-1)	abnormal bone marrow cell morphology/development	J:258274
Mbtps1^wrt/Mbtps1^wrt (C57BL/6J-Mbtps1^wrt)	decreased cytotoxic T cell cytolysis	J:94077
Mc2r^tm1Dchi/Mc2r^tm1Dchi (B6.129P2-Mc2r^tm1Dchi)	increased spleen weight	J:127445
Mc2r^tm1Dchi/Mc2r^tm1Dchi (B6.129P2-Mc2r^tm1Dchi)	increased thymus weight	J:127445
Mc4r^tm1Dhu/Mc4r^tm1Dhu (involves: 129S4/SvJae * C57BL/6J)	decreased osteoclast cell number	J:97566
Mc5r^em1(IMPC)Mbp/Mc5r^em1(IMPC)Mbp (C57BL/6NCrl-Mc5r^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Mcam^tm1Lex/Mcam^tm1Lex (involves: 129S/SvEvBrd)	decreased macrophage cytokine production	J:193167
Mcat^tm1.1Ssmi/Mcat^tm1.1Ssmi Tg(CAG-cre/Esr1)5Amc/0 (involves: 129P2/OlaHsd C57BL/6 * C57BL/6J * CBA)	abnormal erythrocyte physiology	J:192213
	abnormal myelopoiesis	J:192213
	abnormal reticulocyte morphology	J:192213
	anemia	J:192213
	decreased erythrocyte cell number	J:192213
	decreased hematocrit	J:192213
	decreased hemoglobin content	J:192213
	decreased leukocyte cell number	J:192213
	decreased lymphocyte cell number	J:192213
	enlarged spleen	J:192213
	extramedullary hematopoiesis	J:192213
	increased mean corpuscular volume	J:192213
	increased red blood cell distribution width	J:192213
	reticulocytosis	J:192213
Mccc2^em1(IMPC)J/Mccc2⁺ (C57BL/6NJ-Mccc2^em1(IMPC)J/Mmjax)	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
	increased erythrocyte cell number	J:211773
Mcemp1^em1Jngj/Mcemp1^em1Jngj (C57BL/6-Mcemp1^em1Jngj)	abnormal mast cell differentiation	J:335318
Mchq1^SM/J/Mchq1^SM/J (involves: C57BLKS/J * SM/J)	increased mean corpuscular hemoglobin	J:107220
Mcidas^em2(IMPC)Tcp/Mcidas^em2(IMPC)Tcp (C57BL/6NCrl-Mcidas^em2(IMPC)Tcp/Tcp)	abnormal spleen morphology	J:211773
	increased leukocyte cell number	J:211773
Mcl1^em1(IMPC)Mbp/Mcl1⁺ (C57BL/6N-Mcl1^em1(IMPC)Mbp/MbpMmucd)	increased mean corpuscular volume	J:211773
	small spleen	J:211773
Mcl1^tm1Dmta/Mcl1⁺ Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ (B6.Cg-Mcl1^tm1Dmta Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte})	decreased germinal center B cell number	J:166069
	decreased memory B cell number	J:166069
Mcl1^tm1Dmta/Mcl1⁺ Tg(Aicda-cre)9Mbu/0 (B6.Cg-Mcl1^tm1Dmta Tg(Aicda-cre)9Mbu)	decreased germinal center B cell number	J:166069
	decreased memory B cell number	J:166069
Mcl1^tm1Dmta/Mcl1^tm1Dmta Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ (B6.Cg-Mcl1^tm1Dmta Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte})	abnormal B cell differentiation	J:166069
	absent germinal center B cells	J:166069
	absent memory B cells	J:166069
	decreased naive B cell number	J:166069
Mcl1^tm1Dmta/Mcl1^tm1Dmta Tg(Aicda-cre)9Mbu/0 (B6.Cg-Mcl1^tm1Dmta Tg(Aicda-cre)9Mbu)	absent germinal center B cells	J:166069
	absent memory B cells	J:166069
	decreased IgG1 level	J:166069
Mcl1^tm1Yen/Mcl1^tm1Yen (B6.129-Mcl1^tm1Yen)	abnormal CD8-positive, alpha-beta T cell physiology	J:146246
	abnormal double-positive T cell morphology	J:146246
	decreased CD8-positive, alpha-beta T cell number	J:146246
	decreased double-negative T cell number	J:146246
	decreased single-positive T cell number	J:146246
Mcl1^tm1Yen/Mcl1^tm1Yen Tg(TcraH-Y,TcrbH-Y)71Vbo/? (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)	abnormal double-positive T cell morphology	J:146246
	decreased CD8-positive, alpha-beta T cell number	J:146246
Mcl1^tm1Yen/Mcl1^tm1Yen Tg(TcraTcrb)425Cbn/? (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal double-positive T cell morphology	J:146246
	decreased CD4-positive, alpha-beta T cell number	J:146246
Mcl1^tm1Ywh/Mcl1^tm1Ywh Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S4/SvJae * 129S6/SvEvTac * C57BL/6)	abnormal neutrophil physiology	J:137502
	decreased granulocyte number	J:137502
	decreased neutrophil cell number	J:137502
	impaired neutrophil recruitment	J:137502
	increased eosinophil cell number	J:137502
Mcl1^tm1Ywh/Mcl1^tm1Ywh Tg(Cd4-cre)1Cwi/0 (involves: 129S6/SvEvTac * C57BL/6 * DBA/2)	decreased CD4-positive, alpha-beta T cell number	J:137400
	decreased CD8-positive, alpha-beta T cell number	J:137400
	decreased T cell number	J:137400
	increased double-positive T cell number	J:137400
	increased T cell apoptosis	J:137400
Mcl1^tm1Ywh/Mcl1^tm1Ywh Tg(Lck-cre)548Jxm/0 (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * CBA)	abnormal T cell differentiation	J:137400
	decreased CD4-positive, alpha-beta T cell number	J:137400
	decreased CD8-positive, alpha-beta T cell number	J:137400
	decreased double-negative T cell number	J:137400
	decreased double-positive T cell number	J:137400
	decreased T cell number	J:137400
	increased T cell apoptosis	J:137400
	thymus hypoplasia	J:137400
Mcl1^tm2Sjk/Mcl1^tm3Sjk Tg(Lck-cre)1Cwi/0 (involves: 129X1/SvJ * C57BL/6 * DBA/2)	arrested T cell differentiation	J:86906
	decreased double-negative T cell number	J:86906
	decreased double-positive T cell number	J:86906
	decreased T cell number	J:86906
	decreased thymocyte number	J:86906
	increased T cell apoptosis	J:86906
Mcl1^tm2Sjk/Mcl1^tm3Sjk Tg(Mx1-cre)1Cgn/0 (involves: 129X1/SvJ * C57BL/6 * CBA)	decreased B cell number	J:86906
	decreased T cell number	J:86906
Mcl1^tm3Sjk/Mcl1^tm3Sjk Tg(Cpa3-cre)3Glli/0 (involves: 129X1/Sv * C57BL/6)	decreased basophil cell number	J:179080
	decreased erythrocyte cell number	J:179080
	decreased hematocrit	J:179080
	decreased mast cell number	J:179080
	hematopoietic system phenotype	J:179080
	macrocytic anemia	J:179080
Mcm2^{Gt(AB0178)Wtsi}/Mcm2⁺ (involves: 129P2/OlaHsd * C3HeB/FeJ)	abnormal erythrocyte morphology	J:165667
Mcm2^{Gt(AB0178)Wtsi}/Mcm2⁺ Mcm3^{Gt(RRR002)Byg}/Mcm3⁺ (involves: 129P2/OlaHsd * C3HeB/FeJ)	abnormal erythrocyte morphology	J:165667
Mcm2^{Gt(AB0178)Wtsi}/Mcm2⁺ Mcm3^{Gt(RRR002)Byg}/Mcm3⁺ Mcm4^chaos3/Mcm4^chaos3 (involves: 129P2/OlaHsd * C3HeB/FeJ * C57BL/6J)	abnormal erythrocyte morphology	J:165667
	hematopoietic system phenotype	J:165667
Mcm2^{Gt(AB0178)Wtsi}/Mcm2⁺ Mcm3^{Gt(RRR002)Byg}/Mcm3⁺ Mcm4^{Gt(RRE056)Byg}/Mcm4⁺ (involves: 129P2/OlaHsd * C3HeB/FeJ)	abnormal erythrocyte morphology	J:165667
Mcm2^{Gt(AB0178)Wtsi}/Mcm2⁺ Mcm3^{Gt(RRR002)Byg}/Mcm3⁺ Mcm4^{Gt(RRE056)Byg}/Mcm4⁺ Mcm6^{Gt(YHD248)Byg}/Mcm6⁺ (involves: 129P2/OlaHsd * C3HeB/FeJ)	abnormal erythrocyte morphology	J:165667
Mcm2^{Gt(AB0178)Wtsi}/Mcm2⁺ Mcm3^{Gt(RRR002)Byg}/Mcm3⁺ Mcm4^{Gt(RRE056)Byg}/Mcm4⁺ Mcm6^{Gt(YHD248)Byg}/Mcm6⁺ Mcm7^{Gt(YTA285)Byg}/Mcm7⁺ (involves: 129P2/OlaHsd * C3HeB/FeJ)	abnormal erythrocyte morphology	J:165667
Mcm2^{Gt(AB0178)Wtsi}/Mcm2⁺ Mcm3^{Gt(RRR002)Byg}/Mcm3⁺ Mcm6^{Gt(YHD248)Byg}/Mcm6⁺ (involves: 129P2/OlaHsd * C3HeB/FeJ)	abnormal erythrocyte morphology	J:165667
Mcm2^{Gt(AB0178)Wtsi}/Mcm2⁺ Mcm3^{Gt(RRR002)Byg}/Mcm3⁺ Mcm6^{Gt(YHD248)Byg}/Mcm6⁺ Mcm7^{Gt(YTA285)Byg}/Mcm7⁺ (involves: 129P2/OlaHsd * C3HeB/FeJ)	abnormal erythrocyte morphology	J:165667
Mcm2^{Gt(AB0178)Wtsi}/Mcm2⁺ Mcm4^chaos3/Mcm4^chaos3 (involves: 129P2/OlaHsd * C3HeB/FeJ * C57BL/6J)	abnormal erythrocyte morphology	J:165667
	reticulocytosis	J:165667
Mcm2^{Gt(AB0178)Wtsi}/Mcm2⁺ Mcm4^{Gt(RRE056)Byg}/Mcm4⁺ (involves: 129P2/OlaHsd * C3HeB/FeJ)	abnormal erythrocyte morphology	J:165667
Mcm2^{Gt(AB0178)Wtsi}/Mcm2⁺ Mcm4^{Gt(RRE056)Byg}/Mcm4⁺ Mcm6^{Gt(YHD248)Byg}/Mcm6⁺ (involves: 129P2/OlaHsd * C3HeB/FeJ)	abnormal erythrocyte morphology	J:165667
Mcm2^{tm1(cre/ERT2)Scpr}/Mcm2^{tm1(cre/ERT2)Scpr} (involves: 129S6/SvEvTac)	abnormal erythrocyte morphology	J:141493
	enlarged spleen	J:141493
Mcm3^{Gt(RRR002)Byg}/Mcm3⁺ (involves: 129P2/OlaHsd * C3HeB/FeJ)	abnormal erythrocyte morphology	J:165667
Mcm3^{Gt(RRR002)Byg}/Mcm3⁺ Mcm4^{Gt(RRE056)Byg}/Mcm4⁺ (involves: 129P2/OlaHsd * C3HeB/FeJ)	abnormal erythrocyte morphology	J:165667
Mcm3^{Gt(RRR002)Byg}/Mcm3⁺ Mcm4^{Gt(RRE056)Byg}/Mcm4⁺ Mcm6^{Gt(YHD248)Byg}/Mcm6⁺ (involves: 129P2/OlaHsd * C3HeB/FeJ)	abnormal erythrocyte morphology	J:165667
Mcm3^tm1.1Geno/Mcm3^tm1.1Geno (involves: 129S2/SvPas * C57BL/6)	abnormal erythrocyte morphology	J:227638
	abnormal erythropoiesis	J:227638
	abnormal proerythroblast morphology	J:227638
	abnormal reticulocyte cell number	J:227638
	decreased fetal derived definitive erythrocyte cell number	J:227638
	decreased hematocrit	J:227638
	decreased hematopoietic stem cell proliferation	J:227638
	decreased hemoglobin content	J:227638
	increased erythroblast number	J:227638
	increased hematopoietic stem cell number	J:227638
Mcm3ap^tm1Imku/Mcm3ap^tm1Imku Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * C57BL/6 * CBA)	abnormal germinal center B cell physiology	J:88276
	abnormal memory B cell number	J:88276
	abnormal spleen germinal center morphology	J:88276
	decreased B cell number	J:88276
	decreased B cell proliferation	J:88276
	decreased germinal center B cell number	J:88276
	decreased IgG level	J:88276
Mcm4^chaos3/Mcm4^chaos3 (involves: C57BL/6J)	abnormal erythrocyte morphology	J:117494, J:165667
Mcm4^chaos3/Mcm4^chaos3 Mcm7^{Gt(YTA285)Byg}/Mcm7⁺ (involves: 129P2/OlaHsd * C3HeB/FeJ * C57BL/6J)	abnormal erythrocyte morphology	J:165667
	reticulocytosis	J:165667
Mcm4^{Gt(RRE056)Byg}/Mcm4⁺ (involves: 129P2/OlaHsd * C3HeB/FeJ)	abnormal erythrocyte morphology	J:165667
Mcm4^Sdla/Mcm4⁺ (involves: C57BL/6)	decreased DN1 thymic pro-T cell number	J:194117
	enlarged spleen	J:194117
	reticulocytosis	J:194117
Mcm6^{Gt(YHD248)Byg}/Mcm6⁺ (involves: 129P2/OlaHsd * C3HeB/FeJ)	abnormal erythrocyte morphology	J:165667
Mcm7^{Gt(YTA285)Byg}/Mcm7⁺ (involves: 129P2/OlaHsd * C3HeB/FeJ)	abnormal erythrocyte morphology	J:165667
Mcm9^Gt(XG743)Byg/Mcm9^Gt(XG743)Byg (involves: 129P2/OlaHsd * C3HeB/FeJ)	abnormal definitive hematopoiesis	J:177420
Mcmbp^em1(IMPC)J/Mcmbp⁺ (C57BL/6NJ-Mcmbp^em1(IMPC)J/J)	decreased mean corpuscular hemoglobin	J:211773
Mcmbp^em1(IMPC)J/Mcmbp⁺ (C57BL/6NJ-Mcmbp^em1(IMPC)J/J)	decreased mean corpuscular volume	J:211773
Mcoln1^tm1Sasl/Mcoln1^tm1Sasl (involves: 129S6/SvEvTac * C57BL/6)	abnormal macrophage physiology	J:189070
Mcoln2^{tm1e.1(KOMP)Wtsi}/Mcoln2^{tm1e.1(KOMP)Wtsi} (involves: C57BL/6J * C57BL/6N)	impaired macrophage chemotaxis	J:239875
	impaired neutrophil chemotaxis	J:239875
Mcph1^tm1.2Kali/Mcph1^tm1.2Kali (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal T cell physiology	J:156371
Mcph1^{tm1a(EUCOMM)Wtsi}/Mcph1^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6 * C57BL/6N)	increased B cell number	J:213427
Mcpt1^tm1Hrpm/Mcpt1^tm1Hrpm (involves: 129P2/OlaHsd * MF1)	abnormal mast cell morphology	J:93795
Mcpt4^tm1Mabr/Mcpt4^tm1Mabr (involves: 129X1/SvJ * C57BL/6J)	abnormal mast cell physiology	J:84839
Mcpt8^{tm1.1(HBEGF)Hkar}/Mcpt8^{tm1.1(HBEGF)Hkar} (B6.Cg-Mcpt8^{tm1.1(HBEGF)Hkar})	decreased basophil cell number	J:163761
Mcr^C57BL/10J/Mcr^NC (involves: C57BL/10J * NC)	cutaneous mastocytosis	J:8804
Mcr^NC/Mcr^NC (involves: C57BL/10J * NC)	cutaneous mastocytosis	J:8804
Mcts1^em1(IMPC)Mbp/Y (C57BL/6N-Mcts1^em1(IMPC)Mbp/Ucd)	enlarged spleen	J:211773
Mcvq1^SM/J/Mcvq1^SM/J (involves: C57BLKS/J * NZW/LacJ * SM/J)	increased mean corpuscular volume	J:107220
Mcvq2^NZW/LacJ/Mcvq2^SM/J (involves: NZW/LacJ * SM/J)	decreased mean corpuscular volume	J:107220
Mcvq3^SM/J/Mcvq3^SM/J (involves: C57BLKS/J * SM/J)	increased mean corpuscular volume	J:107220
Mdc1^{Gt(OST441263)Lex}/Mdc1^{Gt(OST441263)Lex} (involves: 129S5/SvEvBrd * C57BL/6)	abnormal class switch recombination	J:137341
	small spleen	J:137341
	small thymus	J:137341
Mdga2^{Tg(Prnp-PFN1*G118V)838Kiaei}/Mdga2⁺ (involves: C57BL/6N)	microgliosis	J:241428
Mdk^{tm1.1(KOMP)Mbp}/Mdk^{tm1.1(KOMP)Mbp} (C57BL/6N-Mdk^{tm1.1(KOMP)Mbp}/J)	decreased mean corpuscular volume	J:211773
Mdk^tm1Tmu/Mdk^tm1Tmu (B6.129S2-Mdk^tm1Tmu)	abnormal macrophage chemotaxis	J:102069
	decreased macrophage cell number	J:102069
	impaired neutrophil chemotaxis	J:102069
Mdm2^tm1.1Ypz/Mdm2^tm1.1Ypz Tg(IghMyc)22Bri/0 (B6.Cg-Mdm2^tm1.1Ypz Tg(IghMyc)22Bri)	enlarged thymus	J:164200
	spleen hyperplasia	J:164200
Mdm2^tm1Bay/Mdm2^tm1Mep (involves: 129S7/SvEvBrd * C57BL/6)	abnormal B cell differentiation	J:81065
	anemia	J:81065
	decreased bone marrow cell number	J:81065
	decreased double-negative T cell number	J:81065
	decreased double-positive T cell number	J:81065
	decreased erythrocyte cell number	J:81065
	decreased granulocyte number	J:81065
	decreased immature B cell number	J:81065
	decreased leukocyte cell number	J:81065
	decreased lymphocyte cell number	J:81065
	decreased neutrophil cell number	J:81065
	decreased spleen weight	J:81065
	decreased T cell number	J:81065
	decreased thymocyte number	J:81065
	decreased thymus weight	J:81065
	spleen hypoplasia	J:81065
	thymus hypoplasia	J:81065
Mdm2^tm1Bay/Mdm2^tm1Mep Trp53^tm1Tyj/Trp53^tm1Tyj (involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6)	abnormal bone marrow cell morphology/development	J:81065
	hematopoietic system phenotype	J:81065
Mdm2^tm1Glo/Mdm2⁺ Mdm4^tm1Glo/Mdm4⁺ (involves: 129S7/SvEvBrd)	anemia	J:174216
	decreased bone marrow cell number	J:174216
Mdm2^tm1Glo/Mdm2⁺ Mdm4^tm1Glo/Mdm4⁺ (involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6)	abnormal definitive hematopoiesis	J:123661
	anemia	J:123661
	decreased bone marrow cell number	J:123661
	decreased erythrocyte cell number	J:123661
	decreased hemoglobin content	J:123661
	decreased leukocyte cell number	J:123661
	pancytopenia	J:123661
	spleen atrophy	J:123661
	spleen hypoplasia	J:123661
	thrombocytopenia	J:123661
	thymus atrophy	J:123661
	thymus hypoplasia	J:123661
Mdm2^tm1Glo/Mdm2⁺ Trp53^tm1.1Tldo/Trp53⁺ (involves: 129S2/SvPas * 129S7/SvEvBrd * BALB/c * C57BL/6)	decreased bone marrow cell number	J:199308
Mdm2^tm1Glo/Mdm2⁺ Trp53^tm2Wahl/Trp53^tm2Wahl (involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6)	decreased erythrocyte cell number	J:174375
	decreased leukocyte cell number	J:174375
	small thymus	J:174375
	spleen atrophy	J:174375
	thrombocytopenia	J:174375
Mdm2^tm1Glo/Mdm2^tm1Glo (involves: 129S7/SvEvBrd)	abnormal hematopoietic system physiology	J:158953
Mdm2^tm1Glo/Mdm2^tm1Glo Trp53^tm2Glo/Trp53^tm2Glo (involves: 129S7/SvEvBrd)	anemia	J:174216
	decreased bone marrow cell number	J:174216
Mdm2^tm1Mep/Mdm2^tm1.1Mep (involves: 129S7/SvEvBrd * C57BL/6 * FVB)	decreased spleen weight	J:81065
	decreased thymus weight	J:81065
Mdm2^tm2.1Snj/Mdm2^tm2.1Snj (involves: 129S4/SvJae * C57BL/6)	decreased thymocyte apoptosis	J:189297
	enlarged spleen	J:189297
Mdm4^m1Btlr/Mdm4^m1Btlr (C57BL/6J-Mdm4^m1Btlr)	decreased CD8-positive, alpha-beta T cell number	J:265262
	decreased single-positive T cell number	J:265262
	increased CD4-positive, alpha-beta T cell number	J:265262
	increased single-positive T cell number	J:265262
Mdm4^m2Btlr/Mdm4^m2Btlr (C57BL/6J-Mdm4^m2Btlr)	decreased CD8-positive, alpha-beta T cell number	J:272830
Mdm4^m2Btlr/Mdm4^m2Btlr (C57BL/6J-Mdm4^m2Btlr)	increased CD4-positive, alpha-beta T cell number	J:272830
Mdm4^tm1.1Wahl/Mdm4^tm1.1Wahl (involves: 129S/Sv * C57BL/6)	decreased thymocyte apoptosis	J:150341
	increased erythrocyte cell number	J:150341
	increased leukocyte cell number	J:150341
	thrombocytosis	J:150341
Mdm4^tm1Glo/Mdm4⁺ Trp53^tm1.1Tldo/Trp53⁺ (involves: 129S2/SvPas * BALB/c * C57BL/6)	decreased bone marrow cell number	J:199308
Mecom^em1(IMPC)J/Mecom⁺ (C57BL/6NJ-Mecom^em1(IMPC)J/Mmjax)	thrombocytopenia	J:211773
Mecom^Jbo/Mecom⁺ (C3N.C-Mecom^Jbo)	abnormal neutrophil differentiation	J:113445
Mecom^tm1.1Miku/Mecom⁺ (B6.Cg-Mecom^tm1.1Miku)	abnormal hematopoietic stem cell morphology	J:149794
	abnormal platelet morphology	J:149794
	decreased hematopoietic stem cell number	J:149794
Mecom^tm1.1Miku/Mecom⁺ (involves: C57BL/6NCrlj * CBA/JNCrlj)	abnormal hematopoietic stem cell physiology	J:178616
	decreased hematopoietic stem cell number	J:178616
Mecom^tm1.1Miku/Mecom^tm1.1Miku (B6.Cg-Mecom^tm1.1Miku)	abnormal fetal liver hematopoietic progenitor cell morphology	J:149794
	abnormal hematopoietic stem cell morphology	J:149794
	decreased hematopoietic stem cell number	J:149794
Mecom^tm1Aspe/Mecom^tm1Aspe (involves: 129S6/SvEvTac * C57BL/6)	abnormal bone marrow cell morphology/development	J:178429
	abnormal common myeloid progenitor cell morphology	J:178429
	abnormal hematopoietic stem cell physiology	J:178429
	decreased hematopoietic stem cell number	J:178429
	hematopoietic system phenotype	J:178429
	increased leukocyte cell number	J:178429
	thrombocytopenia	J:178429
Mecom^tm1Aspe/Mecom^tm2.1Aspe Tg(CAG-cre/Esr1)5Amc/0 (involves: 129S1/SvImJ C57BL/6 * C57BL/6J * CBA)	abnormal bone marrow cell morphology/development	J:178429
	abnormal common myeloid progenitor cell morphology	J:178429
	decreased common myeloid progenitor cell number	J:178429
Mecom^tm1Miku/Mecom⁺ Tg(Tek-cre)12Flv/0 (involves: C3H * C57BL/6 * CBA)	decreased hematopoietic stem cell number	J:149794
Mecom^tm1Miku/Mecom^tm1Miku Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	abnormal hematopoietic stem cell morphology	J:149794
	abnormal platelet morphology	J:149794
	decreased hematopoietic stem cell number	J:149794
	thrombocytopenia	J:149794
Mecom^tm1Miku/Mecom^tm1Miku Tg(Tek-cre)12Flv/0 (involves: C3H * C57BL/6 * CBA)	decreased hematopoietic stem cell number	J:149794
Mecom^tm2.1Aspe/Mecom^tm2.1Aspe Tg(CAG-cre/Esr1)5Amc/0 (involves: 129S1/SvImJ C57BL/6 * CBA)	abnormal bone marrow cell morphology/development	J:178429
	abnormal common myeloid progenitor cell morphology	J:178429
	decreased common myeloid progenitor cell number	J:178429
Mecom^tm2.2Aspe/Mecom^tm2.2Aspe (involves: 129 * C57BL/6J * FVB/N)	decreased B cell number	J:213829
	decreased hematopoietic precursor cell number	J:213829
	decreased hematopoietic stem cell number	J:213829
	decreased leukocyte cell number	J:213829
	thrombocytopenia	J:213829
Med1^tm1.1Mpk/Med1^tm1.1Mpk (involves: 129P2/OlaHsd * C57BL/6J)	absent megakaryocytes	J:86857
	increased nucleated erythrocyte cell number	J:86857
Med1^tm1Jkr/Med1^tm1Jkr (involves: 129P2/OlaHsd * C57BL/6)	abnormal definitive hematopoiesis	J:74328
Med1^tm1Jkr/Med1^tm1Jkr (involves: 129P2/OlaHsd * C57BL/6)	absent megakaryocytes	J:74328
Med1^tm1Mpk/Med1^tm1Mpk (involves: 129P2/OlaHsd * C57BL/6J)	increased nucleated erythrocyte cell number	J:86857
Med10^em1(IMPC)J/Med10⁺ (C57BL/6NJ-Med10^em1(IMPC)J/J)	decreased erythrocyte cell number	J:211773
	decreased hemoglobin content	J:211773
	decreased mean corpuscular hemoglobin concentration	J:211773
	increased mean corpuscular volume	J:211773
Med18^{tm1a(EUCOMM)Wtsi}/Med18⁺ (C57BL/6N-Med18^{tm1a(EUCOMM)Wtsi}/H)	decreased leukocyte cell number	J:165965
Med20^em1(IMPC)J/Med20⁺ (C57BL/6NJ-Med20^em1(IMPC)J/J)	decreased leukocyte cell number	J:211773
Med23^{em1(IMPC)Wtsi}/Med23⁺ (C57BL/6N-Med23^{em1(IMPC)Wtsi}/Wtsi)	increased red blood cell distribution width	J:211773
Med24^tm1Rgr/Med24^tm1Rgr (involves: 129X1/SvJ * C57BL/6 * CD-1)	abnormal embryonic erythropoiesis	J:77765
	anemia	J:77765
Med25^{tm1b(KOMP)Wtsi}/Med25⁺ (C57BL/6N-Med25^{tm1b(KOMP)Wtsi}/Ics)	decreased mean corpuscular volume	J:211773
Med28^{tm1.1(KOMP)Vlcg}/Med28⁺ (C57BL/6N-Med28^{tm1.1(KOMP)Vlcg}/Ucd)	abnormal spleen morphology	J:211773
	small spleen	J:211773
Med30^m1Btlr/Med30^m1Btlr (involves: C57BL/6J)	anemia	J:180728
Med30^m1Btlr/Med30^m1Btlr (involves: C57BL/6J)	increased erythroid progenitor cell number	J:180728
Mef2b^tm2Rdf/Mef2b⁺ Tg(Cr2-cre)3Cgn/0 (involves: C57BL/6)	abnormal mature B cell morphology	J:265465
	enlarged spleen	J:265465
	increased germinal center B cell number	J:265465
Mef2c^tm1Eno/Mef2c^tm1Eno (involves: 129S7/SvEvBrd)	abnormal definitive hematopoiesis	J:56426
Mef2c^tm1Jjs/Mef2c^tm1Jjs Mir223^tm1Fcam/Mir223^tm1Fcam Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129 * C57BL/6)	abnormal neutrophil differentiation	J:140009
	abnormal neutrophil physiology	J:140009
	increased neutrophil cell number	J:140009
Mefv^tm1Chae/Mefv^tm1Chae (either: (involves: 129S6/SvEvTac) or (involves: 129S6/SvEvTac * C57BL/6))	decreased macrophage apoptosis	J:82763
Mefv^{tm3.1(MEFV)Chae}/Mefv^{tm3.1(MEFV)Chae} (B6.129S6-Mefv^{tm3.1(MEFV)Chae})	increased leukocyte cell number	J:172117
Mefv^{tm4.1(MEFV)Chae}/Mefv^{tm4.1(MEFV)Chae} (B6.129S6-Mefv^{tm4.1(MEFV)Chae})	increased leukocyte cell number	J:172117
Mefv^{tm5.1(MEFV)Chae}/Mefv^{tm5.1(MEFV)Chae} (B6.129S6-Mefv^{tm5.1(MEFV)Chae})	abnormal spleen germinal center morphology	J:172117
	anemia	J:172117
	decreased B cell number	J:172117
	decreased lymphocyte cell number	J:172117
	decreased T cell number	J:172117
	enlarged spleen	J:172117
	increased granulocyte number	J:172117
	increased leukocyte cell number	J:172117
	increased macrophage cell number	J:172117
	increased monocyte cell number	J:172117
	increased neutrophil cell number	J:172117
Megf8^b2b1702.2Clo/Megf8^b2b1702.2Clo (C57BL/6J-Megf8^b2b1702.2Clo)	spleen hypoplasia	J:175213
	thymus hypoplasia	J:175213
Megf8^hlb611/Megf8^hlb611 (involves: C57BL/6J)	absent spleen	J:146805
	accessory spleen	J:146805
	hematopoietic system phenotype	J:146805
Megf8^hlb611/Megf8^hlb611 (involves: C57BL/6J * C3H/HeJ)	absent spleen	J:146957
Megf8^hlb611/Megf8^hlb611 (involves: C57BL/6J * C3H/HeJ)	accessory spleen	J:146957
Mei4^em1(IMPC)Mbp/Mei4^em1(IMPC)Mbp (C57BL/6NCrl-Mei4^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Meis1^tm1Mtor/Meis1^tm1Mtor (involves: CD-1)	abnormal megakaryocyte progenitor cell morphology	J:98307
	absent common myeloid progenitor cells	J:98307
	absent platelets	J:98307
	impaired hematopoiesis	J:98307
Meis1^tm1Ngc/Meis1^tm1Ngc (involves: 129 * C57BL/6NCr)	absent megakaryocytes	J:87890
Meis1^tm1Ngc/Meis1^tm1Ngc (involves: 129 * C57BL/6NCr)	decreased common myeloid progenitor cell number	J:87890
Meis1^tm2.1Mtor/Meis1^tm2.1Mtor (involves: 129S1/Sv * 129X1/SvJ)	absent megakaryocytes	J:217599
Meis1^tm2Ngc/Meis1^tm2Ngc Tg(Tal1-cre/ERT)42-056Jrg/0 (involves: 129S4/SvJae * C57BL/6 * C57BL/6J)	abnormal bone marrow cell morphology/development	J:192126
	abnormal hematopoietic stem cell physiology	J:192126
	decreased common myeloid progenitor cell number	J:192126
	increased hematopoietic stem cell number	J:192126
Meis2^tm1.2Zkoz/Meis2^tm1.2Zkoz (involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6J)	anemia	J:229604
Meis3^{tm1b(EUCOMM)Hmgu}/Meis3^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Meis3^{tm1b(EUCOMM)Hmgu}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Meltf^tm1Drrn/Meltf^tm1Drrn (involves: 129X1/SvJ * C57BL/6)	hematopoietic system phenotype	J:115256
Men1^tm1.2Zqw/Men1^tm1.2Zqw Pgr^tm2(cre)Lyd/Pgr⁺ (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased uterine NK cell number	J:322043
Meox2^tm1(cre)Sor/Meox2⁺ Procr^tm2Cte/Procr^tm2Cte (involves: 129S4/SvJaeSor * 129S7/SvEvBrd * Black Swiss * C57BL/6)	abnormal hematopoietic system morphology/development	J:119529
	thrombocytopenia	J:119529
Meox2^tm1(cre)Sor/Meox2⁺ Slc40a1^tm2Nca/Slc40a1^tm2Nca (involves: 129S4/SvJae * 129S6/SvEvTac)	abnormal erythrocyte morphology	J:129846
	anemia	J:129846
	anisocytosis	J:129846
	decreased hemoglobin content	J:129846
	decreased mean corpuscular hemoglobin	J:129846
	decreased mean corpuscular volume	J:129846
	increased spleen iron level	J:129846
	poikilocytosis	J:129846
	reticulocytosis	J:129846
Meox2^tm1(cre)Sor/Meox2⁺ Tg(CAG-lacZ,-FUSR521G,-EGFP)682Gyu/0 (involves: 129S4/SvJaeSor C57BL/6)	microgliosis	J:216672
Meox2^tm1(cre)Sor/Meox2⁺ Tg(CAG-lacZ,-FUS,-EGFP)629Gyu/0 (involves: 129S4/SvJaeSor * C57BL/6)	microgliosis	J:216672
Mep1a^tm1Bond/Mep1a^tm1Bond (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal leukocyte physiology	J:145037
Mepe^tm1Tbrw/Mepe^tm1Tbrw (involves: 129P2/OlaHsd * C57BL/6)	abnormal osteoclast morphology	J:81218
Mertk^tm1Gkm/Mertk^tm1Gkm (NOD.129P2-Mertk^tm1Gkm)	abnormal mononuclear cell morphology	J:147153
	decreased T cell number	J:147153
	increased T cell apoptosis	J:147153
Mertk^tm1Gkm/Mertk^tm1Gkm Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0 (NOD.Cg-Mertk^tm1Gkm Tg(TcraBDC2.5,TcrbBDC2.5)1Doi)	decreased double-positive T cell number	J:147153
	increased CD8-positive, alpha-beta T cell number	J:147153
	increased T cell apoptosis	J:147153
Mertk^tm1Grl/Mertk^tm1Grl (involves: 129P2/OlaHsd)	enlarged spleen	J:54681
Mertk^tm1Lex/Mertk^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	decreased platelet aggregation	J:102333
Mesp1^tm2(cre)Ysa/Mesp1⁺ Tbx1^tm1Bld/Tbx1^tm3Bld (involves: 129S7/SvEvBrd * C57BL/6 * CBA)	athymia	J:112457
	thymus hypoplasia	J:112457
Mesp1^tm2(cre)Ysa/Mesp1⁺ Tbx1^tm1Bld/Tbx1^tm5Bld (involves: 129S7/SvEvBrd * C57BL/6 * CBA)	athymia	J:112457
Metrn^em1(IMPC)Mbp/Metrn^em1(IMPC)Mbp (C57BL/6NCrl-Metrn^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased neutrophil cell number	J:211773
Metrnl^{tm1d(KOMP)Wtsi}/Metrnl^{tm1d(KOMP)Wtsi} (involves: C57BL/6J * C57BL/6N)	decreased IgG level	J:268270
	increased IgM level	J:268270
Mettl4^em1Dfel/Mettl4^em1Dfel (involves: 129/Sv * C57BL/6N)	anemia	J:278437
	decreased leukocyte cell number	J:278437
	enlarged spleen	J:278437
Mettl5^{em1(IMPC)Hmgu}/Mettl5⁺ (C57BL/6N-Mettl5^{em1(IMPC)Hmgu}/Ieg)	increased hematocrit	J:211773
Mettl5^{em1(IMPC)Hmgu}/Mettl5^{em1(IMPC)Hmgu} (C57BL/6N-Mettl5^{em1(IMPC)Hmgu}/Ieg)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	increased spleen weight	J:211773
Mettl14^em1(IMPC)Tcp/Mettl14⁺ (C57BL/6NCrl-Mettl14^em1(IMPC)Tcp/Tcp)	abnormal spleen morphology	J:211773
	small spleen	J:211773
Mettl16^{tm1b(KOMP)Mbp}/Mettl16⁺ (C57BL/6N-Mettl16^{tm1b(KOMP)Mbp}/J)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
Mettl23^{em1(IMPC)Hmgu}/Mettl23^{em1(IMPC)Hmgu} (C57BL/6NCrl-Mettl23^{em1(IMPC)Hmgu}/Ieg)	enlarged spleen	J:211773
	increased mean platelet volume	J:211773
	increased spleen weight	J:211773
Mettl24^{tm1a(KOMP)Wtsi}/Mettl24^{tm1a(KOMP)Wtsi} (C57BL/6N-Mettl24^{tm1a(KOMP)Wtsi}/Wtsi)	increased red blood cell distribution width	J:211773
Mettl25^em1(IMPC)Bay/Mettl25^em1(IMPC)Bay (C57BL/6N-Mettl25^em1(IMPC)Bay/BayMmucd)	increased spleen weight	J:211773
Mex3b^tm1.2Mbld/Mex3b^tm1.2Mbld (involves: C57BL/6 * CBA)	impaired macrophage phagocytosis	J:213588
Mexis^tm1.1Pton/Mexis^tm1.1Pton (involves: C57BL/6)	increased macrophage derived foam cell number	J:264834
Mfap2^{tm1a(KOMP)Wtsi}/Mfap2^{tm1a(KOMP)Wtsi} (involves: C57BL/6J * C57BL/6N)	abnormal hemopoiesis	J:236092
	decreased B cell number	J:236092
	decreased leukocyte cell number	J:236092
	decreased neutrophil cell number	J:236092
	increased B cell number	J:236092
	increased macrophage cell number	J:236092
	increased monocyte cell number	J:236092
	increased myeloid dendritic cell number	J:236092
	increased splenocyte number	J:236092
Mfap2^tm1Mech/Mfap2^tm1Mech (B6.129X1-Mfap2^tm1Mech)	thrombocytopenia	J:134343
Mfap2^tm1Mech/Mfap2^tm1Mech (involves: 129X1/SvJ)	decreased macrophage cell number	J:203960
Mfap2^tm1Mech/Mfap2^tm1Mech (involves: 129X1/SvJ)	decreased monocyte cell number	J:203960
Mfap2^tm1Mech/Mfap2^tm1Mech Mfap5^tm1Mech/Mfap5^tm1Mech (involves: 129X1/SvJ)	decreased monocyte cell number	J:203960
	decreased neutrophil cell number	J:203960
Mfap5^tm1Mech/Mfap5^tm1Mech (Not Specified)	decreased neutrophil cell number	J:203960
Mfge8^{Gt(KST227)Byg}/Mfge8^{Gt(KST227)Byg} (B6.129P2-Mfge8^{Gt(KST227)Byg})	enlarged spleen	J:98314
	impaired macrophage phagocytosis	J:98314
Mfge8^{Gt(KST227)Byg}/Mfge8^{Gt(KST227)Byg} (involves: 129P2/OlaHsd * C57BL/6)	enlarged spleen	J:107106
	impaired macrophage phagocytosis	J:107106
Mfge8^tm1Mcu/Mfge8^tm1Mcu (involves: 129X1/SvJ * C57BL/6NCr)	enlarged spleen	J:123138
Mfge8^tm1Mcu/Mfge8^tm1Mcu Tg(RIP1-Tag)2Dh/? (involves: 129X1/SvJ * C57BL/6J * C57BL/6NCr * DBA/2J)	decreased Langerhans cell number	J:123138
Mfge8^tm1Osa/Mfge8^tm1Osa (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal spleen morphology	J:90633
	enlarged spleen	J:90633
	impaired macrophage phagocytosis	J:90633
	increased spleen B cell follicle size	J:90633
	increased spleen weight	J:90633
	increased spleen white pulp amount	J:90633
	spleen hyperplasia	J:90633
Mfge8^tm1Osa/Mfge8^tm1Osa Timd4^tm1Osa/Timd4^tm1Osa (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	impaired macrophage phagocytosis	J:187181
Mfng^{em1(IMPC)Ccpcz}/Mfng^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Mfng^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	decreased NK T cell number	J:211773
	enlarged thymus	J:211773
Mfng^tm1.1Cfg/Mfng^tm1.1Cfg (involves: C57BL/6)	decreased macrophage cell number	J:217719
	decreased mature B cell number	J:217719
	decreased neutrophil cell number	J:217719
	increased B cell number	J:217719
	increased B cell proliferation	J:217719
	increased lymphocyte cell number	J:217719
Mfng^tm1Cjg/Mfng^tm1Cjg (B6.Cg-Mfng^tm1Cjg)	abnormal marginal zone B cell morphology	J:146621
Mfsd1^em1(IMPC)Tcp/Mfsd1^em1(IMPC)Tcp (C57BL/6N-Mfsd1^em1(IMPC)Tcp/Tcp)	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	enlarged spleen	J:211773
	increased mean platelet volume	J:211773
	increased neutrophil cell number	J:211773
	increased red blood cell distribution width	J:211773
	thrombocytopenia	J:211773
Mfsd1^{tm1a(KOMP)Wtsi}/Mfsd1^{tm1a(KOMP)Wtsi} (involves: C57BL/6N)	enlarged spleen	J:280713
Mfsd2a^tm1Dls/Mfsd2a^tm1Dls (B6.Cg-Mfsd2a^tm1Dls)	abnormal microglial cell activation	J:234197
Mfsd2b^{tm1a(KOMP)Wtsi}/Mfsd2b^{tm1a(KOMP)Wtsi} (B6JTyr;B6N-Mfsd2b^{tm1a(KOMP)Wtsi}/Wtsi)	decreased erythrocyte cell number	J:175295
	increased mean corpuscular hemoglobin	J:175295
Mfsd2b^{tm1a(KOMP)Wtsi}/Mfsd2b^{tm1a(KOMP)Wtsi} (C57BL/6-Mfsd2b^{tm1a(KOMP)Wtsi})	abnormal mean corpuscular volume	J:250123
	abnormal stress erythropoiesis	J:250123
	decreased B cell number	J:250123
	decreased erythrocyte cell number	J:250123
	decreased leukocyte cell number	J:250123
	decreased T cell number	J:250123
	enlarged spleen	J:250123
	hematopoietic system phenotype	J:250123
	hemolysis	J:250123
	reticulocytopenia	J:250123
	stomatocytosis	J:250123
Mfsd8^{tm1a(EUCOMM)Hmgu}/Mfsd8^{tm1a(EUCOMM)Hmgu} (involves: C57BL/6N)	abnormal spleen morphology	J:211608
	microgliosis	J:211608
Mfsd10^{tm1.1(KOMP)Vlcg}/Mfsd10^{tm1.1(KOMP)Vlcg} (C57BL/6N-Mfsd10^{tm1.1(KOMP)Vlcg}/J)	decreased leukocyte cell number	J:211773
Mgat1^{tm1b(EUCOMM)Hmgu}/Mgat1⁺ (C57BL/6N-Mgat1^{tm1b(EUCOMM)Hmgu}/Ieg)	decreased red blood cell distribution width	J:211773
Mgat1^tm1Jxm/Mgat1^tm1Jxm (involves: 129S2/SvPas * C57BL/6J)	anemia	J:68330
Mgat2^tm1.1Jxm/Mgat2^tm1.1Jxm (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	anemia	J:80661
	increased mean corpuscular volume	J:80661
	reticulocytosis	J:80661
Mgat2^tm1.1Jxm/Mgat2^tm1.1Jxm (involves: 129S1/Sv * 129X1/SvJ * ICR)	abnormal B cell differentiation	J:80661
	decreased T cell number	J:80661
	enlarged spleen	J:80661
Mgat4b^tm1.1Jxm/Mgat4b^tm1.1Jxm (B6.129-Mgat4b^tm1.1Jxm)	decreased neutrophil cell number	J:212313
	decreased red blood cell distribution width	J:212313
	increased leukocyte cell number	J:212313
	increased mean corpuscular hemoglobin	J:212313
	increased mean corpuscular volume	J:212313
Mgat4d^{tm1b(KOMP)Wtsi}/Mgat4d^{tm1b(KOMP)Wtsi} (C57BL/6N-Mgat4d^{tm1b(KOMP)Wtsi}/Bay)	abnormal spleen morphology	J:211773
Mgat5^tm1Jwd/Mgat5^tm1Jwd (involves: 129S1/Sv * 129X1/SvJ)	abnormal leukocyte physiology	J:94864
Mgat5^tm1Jwd/Mgat5^tm1Jwd (involves: 129S1/Sv * 129X1/SvJ)	abnormal T cell physiology	J:60960
Mgat5b^tm1.1Cfg/Mgat5b^tm1.1Cfg (involves: 129S6/SvEvTac)	decreased pre-B cell number	J:217719
Mgat5b^tm1.1Cfg/Mgat5b^tm1.1Cfg (involves: 129S6/SvEvTac)	increased IgG2b level	J:217719
Mgl2^{tm1.1(HBEGF/EGFP)Aiwsk}/Mgl2⁺ (involves: C57BL/6 * FVB/N)	abnormal T-helper 2 cell morphology	J:201044
	decreased B cell number	J:201044
	decreased CD4-positive, alpha-beta T cell number	J:201044
	decreased CD8-positive, alpha-beta T cell number	J:201044
	decreased dendritic cell number	J:201044
	decreased Langerhans cell number	J:201044
Mgll^{em1(IMPC)Hmgu}/Mgll^{em1(IMPC)Hmgu} (C57BL/6N-Mgll^{em1(IMPC)Hmgu}/Ieg)	increased mean platelet volume	J:211773
Mgme1^em1(IMPC)J/Mgme1^em1(IMPC)J (C57BL/6NJ-Mgme1^em1(IMPC)J/Mmjax)	increased mean corpuscular hemoglobin	J:211773
Mgme1^tm1.2Lrsn/Mgme1^tm1.2Lrsn (involves: C57BL/6NTac)	anemia	J:259702
Mgme1^tm1.2Lrsn/Mgme1^tm1.2Lrsn (involves: C57BL/6NTac)	decreased hemoglobin content	J:259702
Mgrn1^em1(IMPC)Tcp/Mgrn1⁺ (C57BL/6NCrl-Mgrn1^em1(IMPC)Tcp/Tcp)	decreased lymphocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
	increased spleen weight	J:211773
Mgrn1^em1(IMPC)Tcp/Mgrn1^em1(IMPC)Tcp (C57BL/6NCrl-Mgrn1^em1(IMPC)Tcp/Tcp)	increased mean corpuscular hemoglobin	J:211773
Mgst2^em1(IMPC)Mbp/Mgst2^em1(IMPC)Mbp (C57BL/6N-Mgst2^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	small spleen	J:211773
Mgst3^{tm1a(KOMP)Wtsi}/Mgst3^{tm1a(KOMP)Wtsi} (B6JTyr;B6N-Mgst3^{tm1a(KOMP)Wtsi}/Wtsi)	decreased mean corpuscular volume	J:175295
	increased mean corpuscular volume	J:175295
Mhstq2^{M. macedonius}/Mhstq2^{M. macedonius} (involves: C57BL/6J * M. macedonius)	thrombocytopenia	J:94029
Mib1^tm1Kong/Mib1^tm1Kong (involves: 129P2/OlaHsd)	abnormal definitive hematopoiesis	J:137915
Mib1^tm2Kong/Mib1^tm2Kong Tg(Tek-cre)12Flv/0 (involves: 129P2/OlaHsd * C3H * C57BL/6)	abnormal definitive hematopoiesis	J:137915
Mical3^em1(IMPC)J/Mical3^em1(IMPC)J (C57BL/6NJ-Mical3^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
	increased mean corpuscular hemoglobin	J:211773
Micu1^em#Fink/Micu1^em#Fink (C57BL/6N-Micu1^em#Fink)	decreased B cell number	J:238984
	decreased follicular B cell number	J:238984
	increased B cell apoptosis	J:238984
Micu1^em#Fink/Micu1^em#Fink Smdt1^em1Fink/Smdt1⁺ (involves: C57BL/6J * C57BL/6N * CBA)	decreased B cell number	J:238984
Micu1^tm1bNarl/Micu1^tm1bNarl (C57BL/6N-Micu1^tm1bNarl/Narl)	enlarged spleen	J:211773
Micu2^{tm1a(EUCOMM)Wtsi}/Micu2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Micu2^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased red blood cell distribution width	J:211773
Mid1^em1(IMPC)Mbp/Mid1^em1(IMPC)Mbp (C57BL/6NCrl-Mid1^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Mid2^{tm1b(KOMP)Wtsi}/Y (C57BL/6N-Mid2^{tm1b(KOMP)Wtsi}/Ucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Mideas^em1Shmc/Mideas^em1Shmc (C57BL/6J-Mideas^em1Shmc)	absent erythrocytes	J:291786
Mif^tm1Mky/Mif^tm1Mky (C.129-Mif^tm1Mky)	decreased eosinophil cell number	J:106380
Miga2^{tm1a(KOMP)Wtsi}/Miga2^{tm1a(KOMP)Wtsi} (B6JTyr;B6N-Miga2^{tm1a(KOMP)Wtsi}/Wtsi)	decreased hematocrit	J:175295
	decreased hemoglobin content	J:175295
Miju^C3HeB/FeJ/Miju^C57BL/6J (involves: C3HeB/FeJ * C57BL/6J)	increased IgA level	J:91062
Milr1^tm1Shib/Milr1^tm1Shib (involves: C57BL/6N)	decreased mast cell degranulation	J:161854
Minar1^em1(IMPC)Tcp/Minar1^em1(IMPC)Tcp (C57BL/6NCrl-Minar1^em1(IMPC)Tcp/Tcp)	abnormal thymus morphology	J:211773
Mindy1^{tm1a(EUCOMM)Wtsi}/Mindy1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Mindy1^{tm1a(EUCOMM)Wtsi}/Ics)	increased hemoglobin content	J:165965
Mindy3^em1(IMPC)H/Mindy3^em1(IMPC)H (C57BL/6NTac-Mindy3^em1(IMPC)H/H)	decreased mean corpuscular volume	J:211773
Mink1^tm1.2Lgrl/Mink1^tm1.2Lgrl (involves: 129S6/SvEvTac * C57BL/6)	abnormal platelet dense granule physiology	J:231551
	abnormal platelet physiology	J:231551
	decreased platelet aggregation	J:231551
	hematopoietic system phenotype	J:231551
Mir33^tm1.1Koho/Mir33^tm1.1Koho (involves: C57BL/6)	abnormal macrophage physiology	J:165420
Mir34a^tm1.2Arte/Mir34a^tm1.2Arte (involves: C57BL/6N)	increased B cell number	J:221990
Mir92-1^tm1.1Sdim/Mir92-1^tm1.1Sdim (involves: 129S2/SvPas)	hematopoietic system phenotype	J:218943
Mir122^tm1.1Apts/Mir122^tm1.1Apts (involves: 129 * C57BL/6)	increased macrophage cell number	J:190066
Mir122^tm1.1Apts/Mir122^tm1.1Apts (involves: 129 * C57BL/6)	increased monocyte cell number	J:190066
Mir122^tm1.2Kgh/Mir122^tm1.2Kgh Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)	increased monocyte cell number	J:190067
	increased neutrophil cell number	J:190067
Mir125a^tm1Smoc/Mir125a^tm1Smoc (involves: C57BL/6)	abnormal regulatory T cell physiology	J:224880
Mir125a^tm1Smoc/Mir125a^tm1Smoc (involves: C57BL/6)	decreased regulatory T cell number	J:224880
Mir142^tm1.1Sbel/Mir142^tm1.1Sbel (involves: C57BL/6N)	decreased eosinophil cell number	J:227228
	decreased leukocyte cell number	J:227228
	decreased lymphocyte cell number	J:227228
	decreased monocyte cell number	J:227228
	increased mean platelet volume	J:227228
	thrombocytopenia	J:227228
Mir142^tm1Teyo/Mir142^tm1Teyo (involves: C57BL/6)	decreased mast cell degranulation	J:211850
Mir142hg^{Gt(IST11580H2)Tigm}/Mir142hg^{Gt(IST11580H2)Tigm} (involves: C57BL/6N)	abnormal bone marrow cell physiology	J:207516
	abnormal definitive hematopoiesis	J:207516
	abnormal dendritic cell differentiation	J:207516
	abnormal dendritic cell morphology	J:207516
	decreased dendritic cell number	J:207516
	enlarged spleen	J:207516
	hematopoietic system phenotype	J:207516
	increased dendritic cell number	J:207516
	increased neutrophil cell number	J:207516
Mir144/Mir451a^tm1.1Mjwe/Mir144/Mir451a^tm1.1Mjwe (Not Specified)	anemia	J:163250
	decreased hemoglobin content	J:163250
	decreased mean corpuscular hemoglobin	J:163250
	decreased mean corpuscular volume	J:163250
	increased number of Heinz bodies	J:163250
	increased red blood cell distribution width	J:163250
	increased spleen weight	J:163250
	polychromatophilia	J:163250
	reticulocytosis	J:163250
	spleen hyperplasia	J:163250
Mir144/Mir451a^tm1.1Mjwe/Mir144/Mir451a^tm1.1Mjwe (Not Specified)	anemia	J:163250
	decreased hemoglobin content	J:163250
	decreased mean corpuscular hemoglobin	J:163250
	decreased mean corpuscular volume	J:163250
	increased number of Heinz bodies	J:163250
	increased red blood cell distribution width	J:163250
	increased spleen weight	J:163250
	polychromatophilia	J:163250
	reticulocytosis	J:163250
	spleen hyperplasia	J:163250
Mir144/Mir451a^tm1.2Doca/Mir144/Mir451a^tm1.2Doca (involves: 129P2/OlaHsd * 129S4/SvJaeSor * BALB/cJ)	abnormal erythropoiesis	J:163418
	anemia	J:163418
	anisocytosis	J:163418
	decreased erythrocyte cell number	J:163418
	decreased hematocrit	J:163418
	decreased hemoglobin content	J:163418
	enlarged spleen	J:163418
	increased erythroid progenitor cell number	J:163418
	increased red blood cell distribution width	J:163418
Mir144/Mir451a^tm1.2Doca/Mir144/Mir451a^tm1.2Doca (involves: 129P2/OlaHsd * 129S4/SvJaeSor * BALB/cJ)	abnormal erythropoiesis	J:163418
	anemia	J:163418
	anisocytosis	J:163418
	decreased erythrocyte cell number	J:163418
	decreased hematocrit	J:163418
	decreased hemoglobin content	J:163418
	enlarged spleen	J:163418
	increased erythroid progenitor cell number	J:163418
	increased red blood cell distribution width	J:163418
Mir146^tm1.1Bal/Mir146^tm1.1Bal (involves: C57BL/6)	abnormal bone marrow cell morphology/development	J:173230
	abnormal lymphopoiesis	J:167922
	abnormal regulatory T cell physiology	J:167922
	anemia	J:173230
	decreased erythrocyte cell number	J:173230
	decreased hematocrit	J:173230
	decreased hemoglobin content	J:173230
	decreased leukocyte cell number	J:173230
	decreased lymphocyte cell number	J:173230
	decreased monocyte cell number	J:173230
	enlarged spleen	J:173230
	extramedullary hematopoiesis	J:173230
	increased bone marrow cell number	J:173230
	increased regulatory T cell number	J:167922
	increased spleen weight	J:173230
	myeloid hyperplasia	J:167922, J:173230
	thrombocytopenia	J:173230
Mir146^tm1.1Bal/Mir146^tm1.1Bal (involves: C57BL/6 * FVB/N)	abnormal macrophage physiology	J:173671
	abnormal T cell activation	J:173671
	increased macrophage nitric oxide production	J:173671
	myeloid hyperplasia	J:173671
Mir146^tm1.1Bal/Mir146^tm1.1Bal Nfkb1^tm1Bal/Nfkb1^tm1Bal (involves: 129P2/OlaHsd * C57BL/6)	hematopoietic system phenotype	J:173230
Mir146^tm1.1Bal/Mir146^tm1.1Bal Tifab^tm1.1Dsta/Tifab^tm1.1Dsta (involves: 129 * C57BL/6 * C57BL/6J)	abnormal hematopoietic stem cell morphology	J:229024
	decreased lymphocyte cell number	J:229024
	decreased neutrophil cell number	J:229024
Mir146^tm1.1Lfl/Mir146^tm1.1Lfl Ighg1^tm1(cre)Cgn/Ighg1⁺ (involves: 129P2/OlaHsd * C57BL/6)	increased germinal center B cell number	J:266124
	increased T follicular helper cell number	J:266124
Mir146^tm1.1Lfl/Mir146^tm1.1Lfl Mir146b^tm1.1Lfl/Mir146b^tm1.1Lfl Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	increased germinal center B cell number	J:266124
	increased IgG level	J:266124
	increased T follicular helper cell number	J:266124
Mir146^tm1.1Lfl/Mir146^tm1.1Lfl Tg(CD2-icre)4Kio/0 (involves: C57BL/6 * C57BL/10 * CBA/Ca)	increased germinal center B cell number	J:266124
	increased T follicular helper cell number	J:266124
Mir146^tm1.1Lfl/Mir146^tm1.1Lfl Tg(Cr2-cre)3Cgn/0 (involves: C57BL/6)	increased germinal center B cell number	J:266124
	increased IgG1 level	J:266124
	increased IgG level	J:266124
	increased plasma cell number	J:266124
	increased T follicular helper cell number	J:266124
Mir146^tm2.1Bal/Mir146^tm2.1Bal (involves: 129S1/Sv * C57BL/6 * FVB/N)	abnormal bone marrow cell physiology	J:173671
	abnormal macrophage physiology	J:173671
	abnormal spleen B cell follicle morphology	J:173671
	abnormal T cell activation	J:173671
	anemia	J:173671
	decreased hematocrit	J:173671
	decreased hemoglobin content	J:173671
	decreased lymphocyte cell number	J:173671
	decreased monocyte cell number	J:173671
	enlarged spleen	J:173671
	extramedullary hematopoiesis	J:173671
	increased macrophage nitric oxide production	J:173671
	increased spleen germinal center number	J:173671
	increased spleen germinal center size	J:173671
	increased spleen weight	J:173671
	myeloid hyperplasia	J:173671
	thrombocytopenia	J:173671
Mir148a^tm2942.1Arte/Mir148a^tm2942.1Arte Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal plasmablast number	J:307366
	decreased IgA level	J:307366
	decreased IgG level	J:307366
	decreased IgM level	J:307366
	decreased plasma cell number	J:307366
	increased memory B cell number	J:307366
Mir148a^tm2942.1Arte/Mir148a^tm2942.1Arte Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ (involves: C57BL/6 * C57BL/6NTac)	abnormal B cell physiology	J:307366
	abnormal plasmablast number	J:307366
	decreased plasma cell number	J:307366
	increased plasma cell number	J:307366
Mir148a^tm2942.2Arte/Mir148a^tm2942.2Arte (involves: C57BL/6 * FVB/N)	abnormal B cell physiology	J:307366
	decreased plasma cell number	J:307366
Mir150^tm1Rsky/Mir150^tm1Rsky (involves: C57BL/6)	decreased B-2 B cell number	J:127234
	increased B-1 B cell number	J:127234
	increased IgA level	J:127234
	increased IgG1 level	J:127234
	increased IgG2b level	J:127234
	increased IgM level	J:127234
Mir155^tm1.1Brd/Mir155^tm1.1Brd (B6.Cg-Mir155^tm1.1Brd Tyr^c-Brd)	abnormal CD4-positive, alpha beta T cell morphology	J:121095
	abnormal CD4-positive, alpha-beta T cell physiology	J:121095
	abnormal T-helper 1 cell morphology	J:121095
	decreased IgG1 level	J:121095
	increased T-helper 2 cell number	J:121095
Mir155^tm1.1Brd/Mir155^tm1.1Brd (B6.129S7-Mir155^tm1.1Brd)	decreased regulatory T cell number	J:146268
Mir155^tm1.1Rsky/Mir155^tm1.1Rsky (involves: 129 * C57BL/6)	abnormal B cell physiology	J:121084
	abnormal germinal center B cell physiology	J:121084
	abnormal T cell physiology	J:121084
	decreased germinal center B cell number	J:121084
Mir155^tm1.1Rsky/Mir155^tm1.1Rsky (B6.Cg-Mir155^tm1Rsky/J)	abnormal T cell physiology	J:226678
	abnormal T-helper 17 cell differentiation	J:226678
	decreased effector memory T-helper cell number	J:226678
	decreased regulatory T cell number	J:226678
	decreased T-helper 17 cell number	J:226678
Mir155^tm1Brd/Mir155^tm1Brd (involves: 129S7/SvEvBrd * C57BL/6)	abnormal B cell physiology	J:121095
	abnormal class switch recombination	J:121095
	decreased IgM level	J:121095
Mir155^tm1Rsky/Mir155^tm1Rsky (involves: 129/Sv * C57BL/6)	decreased spleen germinal center number	J:121084
Mir155^tm1Rsky/Mir155^tm1Rsky (involves: 129/Sv * C57BL/6)	decreased spleen germinal center size	J:121084
Mir155^tm1Rsky/Mir155^tm1Rsky (involves: 129 * C57BL/6)	abnormal class switch recombination	J:136224
Mir181d^tm1.1Oers/Mir181d^tm1.1Oers (involves: C57BL/6)	increased T cell number	J:212571
Mir205hg^tm1.1Oers/Mir205hg^tm1.1Oers (B6(Cg)-Mir205hg^tm1.1Oers)	small thymus	J:278363
Mir210^tm1.1Wtsi/Mir210^tm1.1Wtsi (involves: C57BL/6J * C57BL/6N)	decreased germinal center B cell number	J:205868
Mir223^tm1Fcam/Mir223^tm1Fcam (involves: 129S4/SvJae * C57BL/6)	abnormal granulocyte physiology	J:140009
	abnormal neutrophil differentiation	J:140009
	abnormal neutrophil physiology	J:140009
	increased granulocyte number	J:140009
	increased neutrophil cell number	J:140009
Mir338^em1Zchn/Mir338^em1Zchn (C57BL/6-Mir338^em1Zchn)	abnormal bone marrow cell physiology	J:285968
Mir338^em1Zchn/Mir338^em1Zchn (C57BL/6-Mir338^em1Zchn)	decreased osteoclast cell number	J:285968
Mir451a^tm1.2Doca/Mir451a^tm1.2Doca (involves: 129P2/OlaHsd * 129S4/SvJaeSor * BALB/cJ)	abnormal hematopoietic system morphology/development	J:163418
	decreased erythrocyte cell number	J:163418
	decreased hematocrit	J:163418
	enlarged spleen	J:163418
	increased erythroid progenitor cell number	J:163418
	increased red blood cell distribution width	J:163418
Mir451a^tm1Eno/Mir451a⁺ (involves: C57BL/6)	abnormal erythrocyte cell number	J:163251
Mir451a^tm1Eno/Mir451a^tm1Eno (involves: C57BL/6)	abnormal fetal derived definitive erythrocyte cell number	J:163251
	enlarged spleen	J:163251
	increased erythroid progenitor cell number	J:163251
Mir511^em1Clib/Mir511^em1Clib (C57BL/6J-Mir511^em1Clib)	abnormal macrophage physiology	J:345580
Mirc1^tm1.1Aven/Mirc1^tm1.1Aven (involves: 129S4/SvJae * C57BL/6 * SJL/J)	decreased alpha-beta T cell number	J:223213
	decreased B cell number	J:223213
	decreased myeloid cell number	J:223213
	decreased pre-B cell number	J:223213
	decreased pro-B cell number	J:223213
	increased B cell apoptosis	J:223213
	small spleen	J:223213
Mirc1^tm1.2Tyj/Mirc1^tm1.2Tyj (involves: 129S4/SvJae * C57BL/6 * FVB/N * SJL)	abnormal B cell differentiation	J:134861
	decreased pre-B cell number	J:134861
	increased B cell apoptosis	J:134861
Mirc1^tm1.3Tyj/Mirc1^tm1.3Tyj (involves: 129S4/SvJae * C57BL/6 * FVB/N)	abnormal B cell differentiation	J:134861
	decreased pre-B cell number	J:134861
	increased B cell apoptosis	J:134861
Mirc1^tm1Tyj/Mirc1^tm1Tyj Tg(Mx1-cre)1Cgn/0 (involves: 129S4/SvJae * C57BL/6 * CBA * SJL)	abnormal immunoglobulin heavy chain V(D)J recombination	J:134861
	decreased pre-B cell number	J:134861
	increased B cell apoptosis	J:134861
Mirc1^tm2.1Aven/Mirc1^tm2.1Aven (involves: 129S4/SvJae * C57BL/6 * SJL/J)	decreased B cell number	J:223213
	decreased myeloid cell number	J:223213
Mirc1^tm2.1Aven/Mirc1^tm2.1Aven Tg(IghMyc)22Bri/? (involves: 129S4/SvJae * C57BL/6 * SJL/J)	abnormal pre-B cell morphology	J:223213
	increased B cell apoptosis	J:223213
Mirc1^tm3.1Aven/Mirc1^tm3.1Aven (involves: 129S4/SvJae * C57BL/6 * SJL/J)	decreased alpha-beta T cell number	J:223213
	decreased B cell number	J:223213
	decreased myeloid cell number	J:223213
	decreased pre-B cell number	J:223213
	decreased pro-B cell number	J:223213
	increased B cell apoptosis	J:223213
	small spleen	J:223213
Mirc11^tm1Rdhl/Mirc11^tm1Rdhl (B6.129-Mirc11^tm1Rdhl)	abnormal B cell differentiation	J:243248
	decreased common myeloid progenitor cell number	J:243248
	decreased myeloid cell number	J:243248
	impaired myelopoiesis	J:243248
	increased B cell number	J:243248
	increased common lymphocyte progenitor cell number	J:243248
	increased follicular B cell number	J:243248
	increased immature B cell number	J:243248
	increased mature B cell number	J:243248
	increased plasma cell number	J:243248
	increased pre-pro B cell number	J:243248
	increased pro-B cell number	J:243248
	increased transitional stage T1 B cell number	J:243248
Mirc12^tm1.1Doca/Mirc12^tm1.1Doca (involves: 129P2/OlaHsd * C57BL/6)	abnormal proerythroblast morphology	J:177074
	hematopoietic system phenotype	J:177074
	increased erythroblast number	J:177074
Mirc13^tm1.1Mtm/Mirc13^tm1.1Mtm (Not Specified)	abnormal macrophage activation involved in immune response	J:256444
Mirc14^tm1.1Ankr/Mirc14^tm1.1Ankr (involves: C57BL/6)	abnormal alpha-beta intraepithelial T cell morphology	J:196134
	abnormal NK T cell morphology	J:196134
	abnormal T cell differentiation	J:196134
	decreased double-positive T cell number	J:196134
	decreased NK T cell number	J:196134
	increased CD4-positive, alpha-beta T cell number	J:196134
Mirc14^tm1.1Czc/Mirc14^tm1.1Czc Gt(ROSA)26Sor^{tm1(cre/ERT2)Tyj}/Gt(ROSA)26Sor⁺ (either: (involves: 129P2/OlaHsd * 129S4/SvJae * 129S4/SvJaeSor) or (involves: 129P2/OlaHsd * 129S4/SvJae * 129S4/SvJaeSor * C57BL/6))	decreased double-positive T cell number	J:188125
	thymus hypoplasia	J:188125
Mirc14^tm1.1Flv/Mirc14^tm1.1Flv Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * C57BL/6N * DBA/2 * SJL)	decreased NK T cell number	J:203157
Mirc14^tm1.2Czc/Mirc14^tm1.2Czc (either: (involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor) or (involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6))	decreased B cell number	J:188125
	decreased DN3 thymocyte number	J:188125
	decreased double-positive T cell number	J:188125
	decreased germinal center B cell number	J:188125
	decreased thymocyte number	J:188125
	increased CD4-positive, alpha-beta T cell number	J:188125
	increased marginal zone B cell number	J:188125
Mirc14^tm1.2Flv/Mirc14^tm1.2Flv (involves: C57BL/6 * C57BL/6N * FVB/N * SJL)	abnormal T cell differentiation	J:203157
	abnormal T cell physiology	J:203157
	abnormal T cell receptor V(D)J recombination	J:203157
	decreased B cell number	J:203157
	decreased CD4-positive, alpha-beta T cell number	J:203157
	decreased CD8-positive, alpha-beta T cell number	J:203157
	decreased DN1 thymic pro-T cell number	J:203157
	decreased double-positive T cell number	J:203157
	decreased NK T cell number	J:203157
	decreased T cell proliferation	J:203157
	decreased thymocyte apoptosis	J:203157
	decreased thymocyte number	J:203157
Mirc14^tm1.2Flv/Mirc14^tm1.2Flv Mirc15^tm1.2Flv/Mirc15^tm1.2Flv (involves: C57BL/6 * C57BL/6N * FVB/N * SJL)	decreased B cell number	J:203157
	decreased immature B cell number	J:203157
	decreased pre-B cell number	J:203157
	increased pro-B cell number	J:203157
Mirc14^tm1.2Flv/Mirc14^tm1.2Flv Tg(Cd4-TcraDN32D3)1Aben/0 (involves: C57BL/6 * C57BL/6N * FVB/N * SJL)	abnormal NK T cell physiology	J:203157
	decreased NK T cell number	J:203157
Mirc14^tm1.2Flv/Mirc14^tm1.2Flv Tg(LCKprBCL2L1)12Sjk/0 (involves: C57BL/6 * C57BL/6N * FVB/N * SJL)	decreased NK T cell number	J:203157
Mirc16^tm1.2Czc/Mirc16^tm1.2Czc (either: (involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor) or (involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6))	increased CD8-positive, alpha-beta T cell number	J:188125
Mirc30^em1Hhzg/Mirc30^em1Hhzg Tg(Vav1-cre)#Cgp/0 (involves: 129S4/SvJae * C57BL/6 * C57BL/6NRj)	abnormal NK cell morphology	J:320883
	increased B cell number	J:320883
	increased pre-B cell number	J:320883
	increased pro-B cell number	J:320883
	increased spleen weight	J:320883
Mirc30^tm1.2Rdf/Mirc30^tm1.2Rdf (involves: 129S1/Sv * 129S4/SvJaeSor * C57BL/6)	abnormal B cell proliferation	J:156946
	increased B cell number	J:156946
	increased B-1a cell number	J:156946
	increased spleen white pulp amount	J:156946
Mirc33^tm1.1Cwh/Mirc33^tm1.1Cwh (involves: 129X1/SvJ)	abnormal T cell morphology	J:189763
	increased T-helper 1 cell number	J:189763
	spleen hypoplasia	J:189763
	thymus hypoplasia	J:189763
Mirc33^tm1Bdes/Mirc33^tm1Bdes (Not Specified)	abnormal thymus involution	J:180783
Mirc40^tm1Jzb/Mirc40^tm1Jzb (Not Specified)	increased microglial cell activation	J:244554
Mirc55^tm1.1Eno/Mirc55^tm1.1Eno (Not Specified)	increased erythrocyte cell number	J:139708
Mitf^mi-di/Mitf^mi-di ((PT x C3H/HeH)F1)	abnormal spleen germinal center morphology	J:8196
	abnormal spleen morphology	J:8196
	abnormal spleen red pulp morphology	J:8196
	abnormal spleen white pulp morphology	J:8196
Mitf^mi-ew/Mitf^mi-ew Tfe3^tm1Est/Tfe3^tm1Est (either: (involves: 129/Sv * 129S1/Sv * C57BL/6Bn * NAW) or (involves: 129S1/Sv * C57BL/6Bn * C57BL/6J * NAW))	abnormal osteoclast morphology	J:89821
Mitf^Mi-Or/Mitf^Mi-Or (involves: 101/Rl * C3H/Rl)	abnormal osteoclast morphology	J:30149
	abnormal osteoclast physiology	J:30149
	decreased osteoclast cell number	J:30149
	increased osteoclast cell number	J:30149
Mitf^mi-tg/Mitf^mi-tg (B6.Cg-Mitf^mi-tg)	abnormal mast cell physiology	J:53161
Mitf^mi-vga9/Mitf^mi-vga9 Tfe3^tm1Est/Tfe3^tm1Est (either: (involves: 129/Sv * 129S1/Sv * C57BL/6 * CBA) or (involves: 129S1/Sv * C57BL/6 * C57BL/6J * CBA))	abnormal osteoclast morphology	J:89821
Mitf^Mi/Mitf^Mi (Not Specified)	abnormal osteoclast morphology	J:5046
	decreased mast cell number	J:6889
	increased osteoclast cell number	J:5046
Mitf^Mi/Mitf^Mi (B6.Cg-Mitf^Mi)	abnormal mast cell physiology	J:53161
Mitf^Mi/Mitf^Mi (involves: C57BL/6J)	abnormal osteoclast morphology	J:89821
Mitf^Mi/Mitf^Mi Tfe3^tm1Est/Tfe3^tm1Est (either: (involves: 129/Sv * 129S1/Sv * C57BL/6J) or (involves: 129S1/Sv * C57BL/6J))	abnormal osteoclast morphology	J:89821
Mkrn2^{em1(IMPC)Wtsi}/Mkrn2^{em1(IMPC)Wtsi} (C57BL/6N-Mkrn2^{em1(IMPC)Wtsi}/WtsiOulu)	decreased mean corpuscular hemoglobin concentration	J:211773
Mkrn2^{tm1b(KOMP)Wtsi}/Mkrn2^{tm1b(KOMP)Wtsi} (C57BL/6N-Mkrn2^{tm1b(KOMP)Wtsi}/Wtsi)	decreased dendritic epidermal T cell number	J:211773
Mks1^hlb614/Mks1^hlb614 (involves: C3H * C57BL/6)	absent spleen	J:167534
Mks1^hlb614/Mks1^hlb614 (involves: C3H * C57BL/6)	accessory spleen	J:167534
Mlf1^tm1Swm/Mlf1^tm1Swm (involves: 129 * C57BL/6)	decreased splenocyte apoptosis	J:266833
Mlf1^tm1Swm/Mlf1^tm1Swm (involves: 129 * C57BL/6)	increased B cell number	J:266833
Mlh1^m1Btlr/Mlh1^m1Btlr (C57BL/6J-Mlh1^m1Btlr)	increased IgM level	J:265206
Mlh1^m2Btlr/Mlh1^m2Btlr (C57BL/6J-Mlh1^m2Btlr)	decreased IgE level	J:265207
Mlh1^m2Btlr/Mlh1^m2Btlr (C57BL/6J-Mlh1^m2Btlr)	increased IgM level	J:265207
Mlh1^m3Btlr/Mlh1^m3Btlr (C57BL/6J-Mlh1^m3Btlr)	decreased IgE level	J:265208
Mlh1^m3Btlr/Mlh1^m3Btlr (C57BL/6J-Mlh1^m3Btlr)	increased IgM level	J:265208
Mlh1^{tm1b(EUCOMM)Hmgu}/Mlh1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Mlh1^{tm1b(EUCOMM)Hmgu}/H)	increased spleen weight	J:211773
Mlkl^em1Jhan/Mlkl^em1Jhan (involves: C57BL/6)	abnormal macrophage physiology	J:204622
Mllt3^tm1.1Thr/Mllt3^tm1.1Thr (involves: 129S/SvEv * C57BL/6)	hematopoietic system phenotype	J:79367
Mllt3^{tm1b(EUCOMM)Hmgu}/Mllt3⁺ (C57BL/6N-Mllt3^{tm1b(EUCOMM)Hmgu}/Cnrm)	thrombocytopenia	J:211773
Mllt3^tm1Thr/Mllt3^tm1Thr (involves: 129S/SvEv * C57BL/6)	hematopoietic system phenotype	J:79367
Mllt6^em1(IMPC)Tcp/Mllt6^em1(IMPC)Tcp (C57BL/6NCrl-Mllt6^em1(IMPC)Tcp/Tcp)	decreased lymphocyte cell number	J:211773
	enlarged spleen	J:211773
	increased mean platelet volume	J:211773
	increased neutrophil cell number	J:211773
	increased spleen weight	J:211773
Mllt10^em1(IMPC)Mbp/Mllt10⁺ (C57BL/6N-Mllt10^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	decreased lymphocyte cell number	J:211773
	enlarged spleen	J:211773
	increased neutrophil cell number	J:211773
Mlx^{tm1.1(KOMP)Vlcg}/Mlx^{tm1.1(KOMP)Vlcg} (C57BL/6N-Mlx^{tm1.1(KOMP)Vlcg}/J)	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
Mmaa^em1(IMPC)J/Mmaa^em1(IMPC)J (C57BL/6NJ-Mmaa^em1(IMPC)J/Mmjax)	decreased erythrocyte cell number	J:211773
	decreased mean corpuscular hemoglobin concentration	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
	thrombocytopenia	J:211773
Mmab^{em1(IMPC)Hmgu}/Mmab⁺ (C57BL/6NCrl-Mmab^{em1(IMPC)Hmgu}/Ieg)	abnormal spleen morphology	J:211773
Mmd^tm1Beij/Mmd^tm1Beij (Not Specified)	abnormal macrophage differentiation	J:304637
Mmd^tm1Beij/Mmd^tm1Beij (Not Specified)	increased macrophage apoptosis	J:304637
Mmgt2^{tm1b(EUCOMM)Wtsi}/Mmgt2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Mmgt2^{tm1b(EUCOMM)Wtsi}/Bay)	decreased lymphocyte cell number	J:211773
	increased basophil cell number	J:211773
Mmp2^em1(IMPC)Mbp/Mmp2^em1(IMPC)Mbp (C57BL/6N-Mmp2^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Mmp2^tm1Ito/Mmp2^tm1Ito (involves: 129P2/OlaHsd)	abnormal bone marrow cell physiology	J:121780
Mmp2^tm1Ito/Mmp2^tm1Ito (involves: 129P2/OlaHsd)	decreased osteoclast cell number	J:121780
Mmp3^tm1Mrl/Mmp3^tm1Mrl (either: 129S7/SvEvBrd or (involves: 129S7/SvEvBrd * C57BL/6))	abnormal CD4-positive, alpha-beta T cell physiology	J:93706
Mmp3^tm1Mrl/Mmp3^tm1Mrl (involves: 129S7/SvEvBrd * C57BL/10ScSn * RIII)	abnormal lymphocyte physiology	J:55723
Mmp7^tm1Lmm/Mmp7^tm1Lmm (involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ)	abnormal macrophage physiology	J:124841
	impaired macrophage chemotaxis	J:124841
Mmp9^tm1Tvu/Mmp9^tm1Tvu (involves: 129S6/SvEvTac)	decreased dendritic cell number	J:84293
Mmp9^tm1Tvu/Mmp9^tm1Tvu (involves: 129S6/SvEvTac)	decreased IgE level	J:84293
Mmp9^tm1Tvu/Mmp9^tm1Tvu (FVB.129S6-Mmp9^tm1Tvu)	abnormal neutrophil physiology	J:104644
Mmp9^tm1Tvu/Mmp9^tm1Tvu (involves: 129S6/SvEvTac * CD-1)	abnormal bone marrow cell physiology	J:149957
	abnormal hematopoietic stem cell morphology	J:149957
	abnormal megakaryocyte differentiation	J:149957
	impaired hematopoiesis	J:149957
	impaired myelopoiesis	J:149957
Mmp9^tm1Tvu/Mmp9^tm1Tvu (involves: 129S6/SvEvTac * C57BL/6)	abnormal leukocyte morphology	J:88065
	increased eosinophil cell number	J:88065
	increased IgE level	J:88065
	increased lymphocyte cell number	J:88065
	increased macrophage cell number	J:88065
	increased monocyte cell number	J:88065
	increased T cell proliferation	J:88065
	increased T-helper 2 cell number	J:88065
Mmp11^{tm1b(EUCOMM)Hmgu}/Mmp11^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Mmp11^{tm1b(EUCOMM)Hmgu}/Ics)	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular hemoglobin concentration	J:211773
	increased monocyte cell number	J:211773
Mmp12^tm1Sds/Mmp12^tm1Sds (involves: 129X1/SvJ)	abnormal macrophage physiology	J:32902
Mmp14^tm1Hbh/Mmp14^tm1Hbh (involves: 129P2/OlaHsd * Black Swiss)	abnormal osteoclast physiology	J:57969, J:86538
Mmp15^{tm1b(KOMP)Wtsi}/Mmp15^{tm1b(KOMP)Wtsi} (C57BL/6N-Mmp15^{tm1b(KOMP)Wtsi}/Bay)	athymia	J:211773
	enlarged spleen	J:211773
Mmp19^tm1Rase/Mmp19^tm1Rase (B6.129P2-Mmp19^tm1Rase)	abnormal T cell activation	J:137128
	abnormal T cell differentiation	J:137128
	decreased CD4-positive, alpha-beta T cell number	J:137128
	decreased CD8-positive, alpha-beta T cell number	J:137128
	decreased T cell proliferation	J:137128
	increased double-positive T cell number	J:137128
Mmp20^{em1(IMPC)Ccpcz}/Mmp20^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Mmp20^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
Mmp24^tm1Otin/Mmp24^tm1Otin (involves: 129P2/OlaHsd * C57BL/6J)	abnormal mast cell degranulation	J:153230
	increased mast cell degranulation	J:153230
Mmp28^tm1Mani/Mmp28^tm1Mani (B6.129X1-Mmp28^tm1Mani)	abnormal macrophage chemotaxis	J:145912
Mmp28^tm1Mani/Mmp28^tm1Mani (B6.129X1-Mmp28^tm1Mani)	impaired neutrophil recruitment	J:145912
Mmrn1^{tm1b(EUCOMM)Hmgu}/Mmrn1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Mmrn1^{tm1b(EUCOMM)Hmgu}/Cnrm)	increased large unstained cell number	J:211773
Mnek1a^CAST/Ei/Mnek1a^CAST/Ei (involves: C57BL/6J-Nek1^kat-2J/+ * CAST/Ei)	decreased hematocrit	J:55632
Mnek1b^C57BL/6J/Mnek1b^C57BL/6J (involves: C57BL/6J-Nek1^kat-2J/+ * CAST/Ei)	decreased hematocrit	J:55632
Mnek1b^C57BL/6J/Mnek1b^CAST/Ei (involves: C57BL/6J-Nek1^kat-2J/+ * CAST/Ei)	decreased hematocrit	J:55632
Mnx1^tm4(cre)Tmj/Mnx1⁺ Tardbp^tm1.1Ckjs/Tardbp^tm1.2Cjks (involves: 129S1/Sv * C57BL/6J)	increased microglial cell activation	J:190254
Mocos^em2(IMPC)Ics/Mocos^em2(IMPC)Ics (involves: C57BL/6N)	anemia	J:336718
	decreased erythrocyte cell number	J:336718
	decreased hematocrit	J:336718
	decreased hemoglobin content	J:336718
Mog^tm1Reid/Mog^tm1Reid (129/Sv-Mog^tm1Reid)	abnormal T-helper 1 physiology	J:86663
Mog^tm1Reid/Mog^tm1Reid (129/Sv-Mog^tm1Reid)	increased T cell proliferation	J:86663
Mogat2^em1(IMPC)Mbp/Mogat2^em1(IMPC)Mbp (C57BL/6N-Mogat2^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Mogs^{tm1(KOMP)Vlcg}/Mogs⁺ (C57BL/6N-Mogs^{tm1(KOMP)Vlcg}/Bay)	enlarged thymus	J:211773
Mol1^BALB/cByJ/Mol1^BALB/cByJ (involves: BALB/cByJ * C57BL/6ByJ)	decreased B cell proliferation	J:58921
Mon1b^em1(IMPC)J/Mon1b^em1(IMPC)J (C57BL/6NJ-Mon1b^em1(IMPC)J/Mmjax)	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
Morc2a^{em1(IMPC)Wtsi}/Morc2a^{em1(IMPC)Wtsi} (C57BL/6N-Morc2a^{em1(IMPC)Wtsi}/WtsiOulu)	abnormal thymus topology	J:239583
	athymia	J:239583
	small thymus	J:239583
Morc3^{tm1b(EUCOMM)Hmgu}/Morc3⁺ (C57BL/6N-Morc3^{tm1b(EUCOMM)Hmgu}/Ics)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	decreased lymphocyte cell number	J:211773
	increased large unstained cell number	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Morf4l1^tm1Kto/Morf4l1^tm1Kto (involves: 129S7/SvEvBrd)	spleen vascular congestion	J:97640
Morn3^em1(IMPC)J/Morn3^em1(IMPC)J (C57BL/6NJ-Morn3^em1(IMPC)J/Mmjax)	increased erythrocyte cell number	J:211773
Morrbid^em1Flv/Morrbid⁺ (C57BL/6N-Morrbid^em1Flv)	decreased eosinophil cell number	J:236609
	decreased Ly6C high monocyte number	J:236609
	decreased neutrophil cell number	J:236609
Morrbid^em1Flv/Morrbid^em1Flv (C57BL/6N-Morrbid^em1Flv)	abnormal eosinophil physiology	J:236609
	abnormal leukocyte physiology	J:236609
	abnormal myelopoiesis	J:236609
	abnormal neutrophil physiology	J:236609
	decreased eosinophil cell number	J:236609
	decreased Ly6C high monocyte number	J:236609
	decreased Ly6C low monocyte number	J:236609
	decreased neutrophil cell number	J:236609
Mospd1^{tm1a(KOMP)Wtsi}/Y (C57BL/6N-Mospd1^{tm1a(KOMP)Wtsi}/Wtsi)	decreased mean corpuscular hemoglobin concentration	J:211773
Mov10^em1(IMPC)Tcp/Mov10^em1(IMPC)Tcp (C57BL/6NCrl-Mov10^em1(IMPC)Tcp/Tcp)	increased erythrocyte cell number	J:211773
Mpg^tm1Rhe/Mpg^tm1Rhe (involves: 129P2/OlaHsd * C57BL/6J)	increased CD4-positive, alpha-beta T cell number	J:70603
Mpig6b^{tm1.1(KOMP)Vlcg}/Mpig6b^{tm1.1(KOMP)Vlcg} (C57BL/6N-Mpig6b^{tm1.1(KOMP)Vlcg}/Ucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased mean platelet volume	J:211773
	increased spleen weight	J:211773
	thrombocytopenia	J:211773
Mpig6b^tm1.1Arte/Mpig6b^tm1.1Arte (involves: C57BL/6NTac)	abnormal megakaryocyte differentiation	J:201266
	abnormal platelet physiology	J:201266
	abnormal spleen red pulp morphology	J:201266
	decreased platelet aggregation	J:201266
	decreased platelet ATP level	J:201266
	enlarged spleen	J:201266
	extramedullary hematopoiesis	J:201266
	increased mean platelet volume	J:201266
	increased megakaryocyte cell number	J:201266
	spleen fibrosis	J:201266
	thrombocytopenia	J:201266
Mpig6b^tm1.1Arte/Mpig6b^tm1.1Arte Gp6^tm1Ware/Gp6^tm1Ware (involves: C57BL/6 * C57BL/6NTac)	thrombocytopenia	J:201266
Mpl^hlb219/Mpl⁺ (C57BL/6J-Mpl^hlb219/J)	abnormal definitive hematopoiesis	J:146577
	decreased erythrocyte cell number	J:146577
	decreased hemoglobin content	J:146577
	thrombocytosis	J:146577
Mpl^hlb219/Mpl^hlb219 (C57BL/6J-Mpl^hlb219/J)	abnormal definitive hematopoiesis	J:146577
	abnormal megakaryocyte progenitor cell morphology	J:146577
	anemia	J:146577
	decreased common myeloid progenitor cell number	J:146577
	decreased erythrocyte cell number	J:146577
	decreased hematocrit	J:146577
	decreased hemoglobin content	J:146577
	decreased leukocyte cell number	J:146577
	decreased megakaryocyte cell number	J:146577
	enlarged spleen	J:146577
	thrombocytopenia	J:146577, J:82961
Mpl^tm1Fjs/Mpl^tm1Fjs (involves: 129 * C57BL/6J)	abnormal definitive hematopoiesis	J:87416
Mpl^tm1Fjs/Mpl^tm1Fjs (involves: 129 * C57BL/6J)	abnormal megakaryocyte progenitor cell morphology	J:87416
Mpl^tm1Mwm/Mpl^tm1Mwm (B6;129S2)	absent megakaryocytes	J:83264
	increased mean platelet volume	J:83264
	thrombocytopenia	J:83264
Mpl^tm1Wsa/Mpl^tm1Wsa (involves: 129S1/Sv * C57BL/6)	abnormal megakaryocyte progenitor cell morphology	J:32131
	absent megakaryocytes	J:32131
	decreased hematopoietic stem cell number	J:32131
	thrombocytopenia	J:32131
Mpl^tm1Wsa/Mpl^tm1Wsa (involves: 129S1/Sv)	thrombocytopenia	J:162629
Mpl^tm1Wsa/Mpl^tm1Wsa Myb^Plt3/Myb⁺ (involves: 129S1/Sv * C57BL/6)	abnormal definitive hematopoiesis	J:89601
	abnormal megakaryocyte differentiation	J:89601
	abnormal thrombopoiesis	J:89601
	thrombocytosis	J:89601
Mpl^tm1Wsa/Mpl^tm1Wsa Myb^Plt3/Myb^Plt3 (involves: 129S1/Sv * C57BL/6)	abnormal B cell differentiation	J:89601
	abnormal definitive hematopoiesis	J:89601
	abnormal erythropoiesis	J:89601
	abnormal megakaryocyte differentiation	J:89601
	abnormal spleen morphology	J:89601
	abnormal thrombopoiesis	J:89601
	anemia	J:89601
	decreased spleen B cell follicle size	J:89601
	increased spleen red pulp amount	J:89601
	thrombocytosis	J:89601
Mpl^tm1Wsa/Mpl^tm1Wsa Myb^Plt4/Myb⁺ (involves: 129S1/Sv * C57BL/6)	abnormal definitive hematopoiesis	J:89601
	abnormal megakaryocyte differentiation	J:89601
	abnormal thrombopoiesis	J:89601
	thrombocytosis	J:89601
Mpl^tm1Wsa/Mpl^tm1Wsa Myb^Plt4/Myb^Plt4 (involves: 129S1/Sv * C57BL/6)	abnormal definitive hematopoiesis	J:89601
	abnormal erythropoiesis	J:89601
	abnormal megakaryocyte differentiation	J:89601
	abnormal spleen morphology	J:89601
	abnormal thrombopoiesis	J:89601
	anemia	J:89601
	decreased leukocyte cell number	J:89601
	decreased spleen B cell follicle size	J:89601
	increased spleen red pulp amount	J:89601
	thrombocytosis	J:89601
Mpl^tm1Wsa/Mpl^tm1Wsa Suz12^{Gt(Betageo)1Khe}/Suz12⁺ (involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)	abnormal thrombopoiesis	J:136262
	increased leukocyte cell number	J:136262
	increased lymphocyte cell number	J:136262
	thrombocytopenia	J:136262
Mpl^tm1Wsa/Mpl^tm1Wsa Suz12^Plt8/Suz12⁺ (B6.Cg-Mpl^tm1Wsa Suz12^Plt8)	abnormal bone marrow cell morphology/development	J:136262
	abnormal megakaryocyte differentiation	J:136262
	abnormal thrombopoiesis	J:136262
	increased leukocyte cell number	J:136262
	increased lymphocyte cell number	J:136262
	thrombocytopenia	J:136262
Mpl^tm2.1Wsa/Mpl^tm2.1Wsa Tg(Pf4-icre)Q3Rsko/0 (involves: C57BL/6)	abnormal common myeloid progenitor cell morphology	J:208120
	abnormal megakaryocyte morphology	J:208120
	decreased erythroid progenitor cell number	J:208120
	enlarged spleen	J:208120
	increased hematopoietic stem cell proliferation	J:208120
	increased megakaryocyte cell number	J:208120
	thrombocytosis	J:208120
Mpl^tm2.2Wsa/Mpl^tm2.2Wsa (involves: BALB/cJ * C57BL/6)	thrombocytopenia	J:208120
Mpo^tm1Lus/Mpo^tm1Lus (involves: 129X1/SvJ * C57BL/6J)	abnormal neutrophil physiology	J:67586
Mpo^tm1Lus/Mpo^tm1Lus (involves: 129X1/SvJ * C57BL/6J)	increased monocyte cell number	J:67586
Mpo^tm1Lus/Mpo^tm1Lus (B6.129X1-Mpo^tm1Lus)	abnormal neutrophil physiology	J:112488
Mpo^tm1Mae/Mpo^tm1Mae (involves: 129P2/OlaHsd * C57BL/6)	abnormal neutrophil physiology	J:53993
Mpp1^tm1Ahc/Mpp1^tm1Ahc (B6.129-Mpp1^tm1Ahc)	abnormal neutrophil physiology	J:154749
Mpp1^tm1Ahc/Mpp1^tm1Ahc (B6.129-Mpp1^tm1Ahc)	impaired neutrophil chemotaxis	J:154749
Mpped2^em1(IMPC)J/Mpped2^em1(IMPC)J (C57BL/6NJ-Mpped2^em1(IMPC)J/J)	increased leukocyte cell number	J:211773
Mpv17/Mpv17 (CFW-Mpv17/J)	anemia	J:10661
	decreased erythrocyte cell number	J:10661
	decreased hemoglobin content	J:10661
Mpv17^em1(IMPC)J/Mpv17^em1(IMPC)J (C57BL/6NJ-Mpv17^em1(IMPC)J/J)	decreased mean corpuscular hemoglobin	J:211773
	thrombocytopenia	J:211773
Mpv17l2^{tm1.1(KOMP)Mbp}/Mpv17l2^{tm1.1(KOMP)Mbp} (C57BL/6N-Mpv17l2^{tm1.1(KOMP)Mbp}/Ucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Mpvq1^NZW/LacJ/Mpvq1^SM/J (involves: NZW/LacJ * SM/J)	increased mean platelet volume	J:102636
Mpvq1^SM/J/Mpvq1^SM/J (involves: C57BLKS/J * SM/J)	increased mean platelet volume	J:102636
Mpvq1^SM/J/Mpvq1^SM/J (involves: NZW/LacJ * SM/J)	increased mean platelet volume	J:102636
Mpvq2^SM/J/Mpvq2^SM/J (involves: C57BLKS/J * SM/J)	increased mean platelet volume	J:102636
Mpz^em1(IMPC)Tcp/Mpz^em1(IMPC)Tcp (C57BL/6NCrl-Mpz^em1(IMPC)Tcp/Tcp)	increased mean platelet volume	J:211773
	increased neutrophil cell number	J:211773
Mpz^tm1Msch/Mpz⁺ (involves: 129S7/SvEvBrd * C57BL/6)	abnormal macrophage chemotaxis	J:67581
	abnormal T-helper 1 physiology	J:82432
	increased monocyte cell number	J:82432
Mpz^tm1Msch/Mpz⁺ (involves: 129S7/SvEvBrd)	increased macrophage cell number	J:133028
Mpz^tm1Msch/Mpz⁺ Rag1^tm1Mom/Rag1^tm1Mom (B6.129S7-Mpz^tm1Msch Rag1^tm1Mom)	absent CD4-positive, alpha-beta T cells	J:59319
	absent CD8-positive, alpha-beta T cells	J:59319
Mpz^tm1Msch/Mpz⁺ Tcra^tm1Mjo/Tcra^tm1Mjo (involves: 129P2/OlaHsd * 129S7/SvEvBrd * BALB/c * C57BL/6)	decreased T cell number	J:59319
Mpzl2^{tm1b(EUCOMM)Hmgu}/Mpzl2⁺ (C57BL/6N-Mpzl2^{tm1b(EUCOMM)Hmgu}/Bay)	increased red blood cell distribution width	J:211773
Mpzl2^tm1Lex/Mpzl2^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	decreased B cell number	J:171883
	increased CD8-positive, alpha-beta T cell number	J:171883
Mpzl3^rc/Mpzl3^rc (C57BL/6J-Mpzl3^rc/J)	abnormal spleen morphology	J:93038
Mpzl3^rc/Mpzl3^rc (C57BL/6J-Mpzl3^rc/J)	increased bone marrow cell number	J:93038
Mr1^tm1Gfn/Mr1^tm1Gfn (involves: 129P2/OlaHsd * BALB/c * C57BL/6)	abnormal B cell physiology	J:113083
	abnormal T cell number	J:113083
Mrap2^{tm1a(EUCOMM)Wtsi}/Mrap2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Mrap2^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased red blood cell distribution width	J:211773
Mras^{Gt(OST108223)Lex}/Mras^{Gt(OST108223)Lex} (B6;129S5-Mras^{Gt(OST108223)Lex}/Ieg)	decreased B cell number	J:82809
Mrc1^tm1Mnz/Mrc1^tm1Mnz (involves: 129P2/OlaHsd)	abnormal macrophage physiology	J:124290
Mrc1^tm1Mnz/Mrc1^tm1Mnz (B6.129P2-Mrc1^tm1Mnz)	decreased T cell number	J:194065
Mrc1^tm1Mnz/Mrc1^tm1Mnz (B6.129P2-Mrc1^tm1Mnz)	increased granulocyte number	J:194065
Mrc1^tm1Mnz/Mrc1^tm1Mnz Mrc2^tm1Cmi/Mrc2^tm1Cmi (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)	abnormal macrophage physiology	J:124290
Mre11a^tm1.1Rchd/Mre11a^tm1.1Rchd (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal class switch recombination	J:184053
Mre11a^tm1Jpt/Mre11a⁺ Rad50^tm2Jpt/Rad50^tm2Jpt (involves: 129S7/SvEvBrd * C57BL/6)	abnormal hematopoietic system morphology/development	J:103922
	anemia	J:103922
Mre11a^tm1Jpt/Mre11a^tm1Jpt Rad50^tm2Jpt/Rad50^tm2Jpt (involves: 129S7/SvEvBrd * C57BL/6)	hematopoietic system phenotype	J:103922
Mrgprb2^em1(IMPC)Tcp/Mrgprb2^em1(IMPC)Tcp (C57BL/6NCrl-Mrgprb2^em1(IMPC)Tcp/Tcp)	small spleen	J:211773
Mrgprb2^em1Xzd/Mrgprb2^em1Xzd (C57BL/6-Mrgprb2^em1Xzd)	decreased mast cell degranulation	J:219209
Mrgprb2^em1Xzd/Mrgprb2^em1Xzd (C57BL/6-Mrgprb2^em1Xzd)	hematopoietic system phenotype	J:219209
Mri1^em1(IMPC)Bay/Mri1^em1(IMPC)Bay (C57BL/6N-Mri1^em1(IMPC)Bay/BayMmucd)	increased spleen weight	J:211773
Mrpl3^em1(IMPC)J/Mrpl3⁺ (C57BL/6NJ-Mrpl3^em1(IMPC)J/J)	increased hemoglobin content	J:211773
Mrpl3^em1(IMPC)J/Mrpl3⁺ (C57BL/6NJ-Mrpl3^em1(IMPC)J/J)	increased mean corpuscular hemoglobin concentration	J:211773
Mrpl58^{tm1b(EUCOMM)Hmgu}/Mrpl58⁺ (C57BL/6N-Mrpl58^{tm1b(EUCOMM)Hmgu}/J)	decreased hematocrit	J:211773
Mrps18c^{tm1.1(KOMP)Vlcg}/Mrps18c⁺ (C57BL/6N-Mrps18c^{tm1.1(KOMP)Vlcg}/J)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
Mrps22^{tm1.1(KOMP)Vlcg}/Mrps22⁺ (C57BL/6N-Mrps22^{tm1.1(KOMP)Vlcg}/J)	increased leukocyte cell number	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
Ms4a1^tm1Tft/Ms4a1^tm1Tft (involves: 129 * C57BL/6)	abnormal B cell number	J:88933
	abnormal B cell physiology	J:88933
	decreased B-1 B cell number	J:88933
	increased transitional stage B cell number	J:88933
Ms4a2^tm1Chr/Ms4a2^tm1Chr (involves: 129S1/Sv * 129X1/SvJ)	abnormal mast cell physiology	J:53106
Ms4a2^tm1Knt/Ms4a2^tm1Knt (involves: 129 * BALB/c)	abnormal mast cell physiology	J:47138
Ms4a2^tm1Knt/Ms4a2^tm1Knt Tg(SV40/HTLV-FCER1A)1Bhk/0 (involves: 129 * BALB/c)	abnormal mast cell physiology	J:47138
Ms4a4a^em1Wwz/Ms4a4a^em1Wwz (C57BL/6NCrl-Ms4a4a^em1Wwz)	abnormal macrophage physiology	J:296429
	decreased eosinophil cell number	J:296429
	impaired eosinophil recruitment	J:296429
Msantd3^em1(IMPC)J/Msantd3^em1(IMPC)J (C57BL/6NJ-Msantd3^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Msh2^tm1Htr/Msh2^tm1Htr (involves: 129P2/OlaHsd)	abnormal class switch recombination	J:80893
	abnormal somatic hypermutation frequency	J:155454
	decreased IgG1 level	J:80893
	decreased IgG3 level	J:80893
Msh2^tm1Htr/Msh2^tm1Htr Pcna^tm1Jcbs/Pcna^tm1Jcbs (involves: 129P2/OlaHsd)	abnormal somatic hypermutation frequency	J:155454
Msh2^tm1Mak/Msh2^tm1Mak (C57BL/6NTac-Msh2^tm1Mak)	abnormal class switch recombination	J:326431
Msh2^tm1Mak/Msh2^tm1Mak (C57BL/6NTac-Msh2^tm1Mak)	abnormal somatic hypermutation frequency	J:326431
Msh2^tm1Rak/Msh2^tm1Rak (involves: 129P2/OlaHsd)	abnormal class switch recombination	J:56764
Msh2^tm1Rak/Msh2^tm1Rak (involves: 129P2/OlaHsd)	decreased mature B cell number	J:56764
Msh2^tm1Wed/Msh2^tm1Wed (involves: C57BL/6)	abnormal class switch recombination	J:86278
Msh2^tm1Wed/Msh2^tm1Wed (involves: C57BL/6)	decreased IgG level	J:86278
Msh2^tm1Whl/Msh2^tm1Whl Rb1^tm1Brd/Rb1⁺ (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J)	abnormal definitive hematopoiesis	J:79016
Msh2^tm1Whl/Msh2^tm1Whl Rb1^tm1Brd/Rb1^tm1Brd (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J)	abnormal definitive hematopoiesis	J:79016
Msh5^{tm1b(EUCOMM)Wtsi}/Msh5^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Msh5^{tm1b(EUCOMM)Wtsi}/Ieg)	increased leukocyte cell number	J:211773
Msh6^m1Btlr/Msh6^m1Btlr (C57BL/6J-Msh6^m1Btlr)	decreased IgE level	J:255208
Msi2^em1(IMPC)Mbp/Msi2^em1(IMPC)Mbp (C57BL/6N-Msi2^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	decreased neutrophil cell number	J:211773
	decreased spleen weight	J:211773
	increased mean platelet volume	J:211773
	small spleen	J:211773
Msi2^{Gt(Ayu21-T2)Imeg}/Msi2^{Gt(Ayu21-T2)Imeg} (involves: C57BL/6 * CBA/JNCrlj)	decreased hematopoietic stem cell number	J:162770
Msi2^{Gt(E035H03)Wrst}/Msi2^{Gt(E035H03)Wrst} (B6.129P2-Msi2^{Gt(E035H03)Wrst})	abnormal bone marrow cell morphology/development	J:174870
	abnormal common lymphocyte progenitor cell morphology	J:174870
	abnormal hematopoietic stem cell physiology	J:174870
	abnormal myeloid leukocyte morphology	J:174870
	decreased B cell number	J:174870
	decreased CD4-positive, alpha-beta T cell number	J:174870
	decreased CD8-positive, alpha-beta T cell number	J:174870
	decreased common myeloid progenitor cell number	J:174870
	decreased DN2 thymocyte number	J:174870
	decreased DN3 thymocyte number	J:174870
	decreased double-negative T cell number	J:174870
	decreased double-positive T cell number	J:174870
	decreased erythrocyte cell number	J:174870
	decreased granulocyte number	J:174870
	decreased hematopoietic stem cell number	J:174870
	decreased immature B cell number	J:174870
	decreased leukocyte cell number	J:174870
	decreased macrophage cell number	J:174870
	decreased mature B cell number	J:174870
	decreased pre-B cell number	J:174870
	hematopoietic system phenotype	J:174870
	small spleen	J:174870
	small thymus	J:174870
	spleen hypoplasia	J:174870
	thymus hypoplasia	J:174870
Msi2^tm1.1Cjl/Msi2^tm1.1Cjl Tg(Mx1-cre)1Cgn/0 (involves: 129S4/SvJae * C57BL/6 * CBA)	abnormal hematopoietic stem cell physiology	J:208349
	decreased bone marrow cell number	J:208349
	decreased hematopoietic stem cell number	J:208349
	decreased spleen weight	J:208349
	spleen hypoplasia	J:208349
Msmp^em1Jzx/Msmp^em1Jzx (C57BL/6-Msmp^em1Jzx)	abnormal hematopoietic stem cell physiology	J:311042
Msmp^em1Jzx/Msmp^em1Jzx (C57BL/6-Msmp^em1Jzx)	abnormal macrophage differentiation	J:311042
Msn^{tm1b(EUCOMM)Hmgu}/Y (C57BL/6N-Msn^{tm1b(EUCOMM)Hmgu}/J)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	increased mean corpuscular hemoglobin	J:211773
Msn^{tm1b(EUCOMM)Hmgu}/Msn^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Msn^{tm1b(EUCOMM)Hmgu}/J)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	decreased leukocyte cell number	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
	thrombocytopenia	J:211773
Msn^tm1Sts/Y (involves: 129S4/SvJae * C57BL/6)	decreased B cell number	J:189837
	decreased CD4-positive, alpha-beta T cell number	J:189837
	decreased eosinophil cell number	J:189837
	decreased lymphocyte cell number	J:189837
	decreased neutrophil cell number	J:189837
	impaired leukocyte migration	J:189837
Msr1^tm1Csk/Msr1^tm1Csk (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal macrophage physiology	J:91911
Msr1^tm1Csk/Msr1^tm1Csk Scarf1^tm1Ishi/Scarf1^tm1Ishi (involves: 129S7/SvEvBrd * 129X1/SvJ * C57BL/6J)	abnormal macrophage physiology	J:91911
Mst1^{tm1(KOMP)Wtsi}/Mst1^{tm1(KOMP)Wtsi} (C57BL/6N-Mst1^{tm1(KOMP)Wtsi}/Wtsi)	increased mean corpuscular hemoglobin	J:175295
Mst1^tm1Jab/Mst1^tm1Jab (involves: 129P2/OlaHsd * Black Swiss)	abnormal macrophage physiology	J:46185
	hematopoietic system phenotype	J:46185
Mst1r^Fv2-s/Mst1r^Fv2-s (B6.DDD-Mst1r^Fv2-s)	enlarged spleen	J:5120
Mst1r^Fv2-s/Mst1r^Fv2-s (either: BALB/cCrgl or DBA/2Crgl or Swiss)	enlarged spleen	J:167666
Mst1r^tm1.1Sew/Mst1r^tm1.1Sew (involves: 129/Ola * CD-1 * NIH Black Swiss)	abnormal macrophage physiology	J:75503
Mst1r^tm1Ber/Mst1r^tm1Ber (involves: 129S1/Sv * 129X1/SvJ * CD-1)	abnormal macrophage physiology	J:76451
Mst1r^tm1Sjd/Mst1r⁺ (either: (involves: 129 * C57BL/6) or (involves: 129 * CD-1) or (involves: 129 * NIH Black Swiss))	abnormal macrophage physiology	J:54903
Mst1r^{tm2(Mst1r)Sew}/Mst1r^{tm2(Mst1r)Sew} (involves: 129P2/OlaHsd * Black Swiss * FVB/N)	decreased spleen weight	J:215969
Msto1^em1(IMPC)Tcp/Msto1⁺ (C57BL/6N-Msto1^em1(IMPC)Tcp/Tcp)	small spleen	J:211773
Msx1^tm1Rilm/Msx1⁺ Pax9^tm1Rbal/Pax9^tm1Rbal (involves: 129 * CD-1)	ectopic thymus	J:311535
	thymus hypoplasia	J:311535
Msx2^tm1Rilm/Msx2^tm1Rilm (either: (involves: 129S4/SvJae) or (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6J))	decreased osteoclast cell number	J:61509
Mt1^tm1Bri/Mt1^tm1Bri Mt2^tm1Bri/Mt2^tm1Bri (involves: 129S7/SvEvBrd)	abnormal microglial cell morphology	J:103102, J:53929
	abnormal microglial cell physiology	J:53929
	increased macrophage cell number	J:53929
Mt1^tm1Bri/Mt1^tm1Bri Mt2^tm1Bri/Mt2^tm1Bri (129S7/SvEvBrd-Mt1^tm1Bri Mt2^tm1Bri/J)	abnormal lymphocyte physiology	J:110643
	abnormal microglial cell morphology	J:89429
	decreased B cell number	J:110643
	decreased T cell number	J:110643
	enlarged spleen	J:110643
	increased CD4-positive, alpha-beta T cell number	J:110643
	increased CD8-positive, alpha-beta T cell number	J:110643
	increased IgG level	J:110643
	increased IgM level	J:110643
	increased lymphocyte cell number	J:110643
	increased neutrophil cell number	J:120196
	increased plasma cell number	J:110643
	increased spleen weight	J:110643
	increased thymocyte apoptosis	J:57169
	spleen hyperplasia	J:110643
Mta1^{tm1a(EUCOMM)Wtsi}/Mta1^{tm1a(EUCOMM)Wtsi} (129S/SvEvBrd-Mta1^{tm1a(EUCOMM)Wtsi}/WtsiH)	thrombocytopenia	J:175295
Mta2^tm1.1Yzha/Mta2^tm1.1Yzha (involves: 129S4/SvJae * C57BL/6 * FVB/N)	increased T cell proliferation	J:137101
Mta2^tm1Yzha/Mta2^tm1Yzha Tg(Lck-cre)#Zhu/0 (involves: 129S4/SvJae * C57BL/6 * SJL)	increased T cell proliferation	J:137101
Mta3^{tm3a(KOMP)Wtsi}/Mta3^{tm3a(KOMP)Wtsi} (Not Specified)	decreased erythrocyte cell number	J:165965
Mtap^em1(IMPC)Mbp/Mtap⁺ (C57BL/6N-Mtap^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Mtarc1^em1(IMPC)H/Mtarc1^em1(IMPC)H (C57BL/6NTac-Mtarc1^em1(IMPC)H/H)	increased spleen weight	J:211773
Mtbcq2^NMRI8/Fbn/? (involves: DBA/2OlaHsd * NMRI8/Fbn)	increased spleen weight	J:122125
Mtch2^{tm1b(EUCOMM)Hmgu}/Mtch2⁺ (C57BL/6N-Mtch2^{tm1b(EUCOMM)Hmgu}/Cnrm)	increased monocyte cell number	J:211773
Mtdh^tm1.2Dsar/Mtdh^tm1.2Dsar (either: B6.129(FVB)-Mtdh^tm1.2Dsar or (129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N))	decreased macrophage proliferation	J:216688
Mtf1^tm1Wsc/Mtf1^tm1Wsc Tg(Mx1-cre)1Cgn/0 Tg(UBC-Mtf1)1Wsc/0 (involves: 129/Sv * C57BL/6 * CBA)	decreased leukocyte cell number	J:91119
	decreased lymphocyte cell number	J:91119
Mtgq4^NMRI8/Fbn/? (involves: DBA/2OlaHsd * NMRI8/Fbn)	increased spleen weight	J:122125
Mthfd1^tm1.1Rzn/Mthfd1⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6N)	decreased leukocyte cell number	J:199578
	decreased neutrophil cell number	J:199578
Mtmr1^{tm2b(KOMP)Wtsi}/Y (C57BL/6N-Mtmr1^{tm2b(KOMP)Wtsi}/Wtsi)	increased mean platelet volume	J:211773
	increased red blood cell distribution width	J:211773
Mtmr2^{em1(IMPC)Hmgu}/Mtmr2^{em1(IMPC)Hmgu} (C57BL/6NCrl-Mtmr2^{em1(IMPC)Hmgu}/Ieg)	increased mean platelet volume	J:211773
Mtmr3^{tm1b(EUCOMM)Hmgu}/Mtmr3^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Mtmr3^{tm1b(EUCOMM)Hmgu}/J)	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
Mtmr4^{tm1a(EUCOMM)Wtsi}/Mtmr4⁺ (Not Specified)	decreased IgE level	J:165965
Mtmr7^em1(IMPC)Mbp/Mtmr7^em1(IMPC)Mbp (C57BL/6N-Mtmr7^em1(IMPC)Mbp/MbpMmucd)	increased mean corpuscular hemoglobin concentration	J:211773
Mtmr11^em1(IMPC)Tcp/Mtmr11^em1(IMPC)Tcp (C57BL/6NCrl-Mtmr11^em1(IMPC)Tcp/Tcp)	enlarged spleen	J:211773
Mtor^chino/Mtor^chino (involves: C57BL/6JAnu)	decreased CD4-positive, alpha-beta T cell number	J:207898
Mtor^chino/Mtor^chino (involves: C57BL/6JAnu)	decreased splenocyte number	J:207898
Mtor^chino/Mtor^chino Rasgrp1^m1Anu/Rasgrp1^m1Anu (involves: C57BL/6JAnu * C57BL/6JSfdAnu * CBA/J)	hematopoietic system phenotype	J:207898
Mtor^tm1.2Koz/Mtor^tm1.2Koz Tg(Cd4-cre)1Cwi/0 (involves: 129S4/SvJae * C57BL/6 * DBA/2)	abnormal T cell differentiation	J:150108
	abnormal T cell subpopulation ratio	J:150108
	abnormal thymus cell ratio	J:150108
	decreased T cell proliferation	J:150108
	increased regulatory T cell number	J:150108
Mtor^{tm1a(EUCOMM)Wtsi}/Mtor⁺ (C57BL/6N-Mtor^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased mean corpuscular hemoglobin	J:175295
Mtor^tm1Lgm/Mtor^tm1Lgm (involves: 129S1/Sv * C57BL/6)	abnormal B cell differentiation	J:168600
	abnormal B cell physiology	J:168600
	abnormal T cell morphology	J:168600
	abnormal T cell physiology	J:168600
	decreased B cell number	J:168600
	decreased B cell proliferation	J:168600
	decreased double-positive T cell number	J:168600
	decreased follicular B cell number	J:168600
	decreased IgG level	J:168600
	decreased IgM level	J:168600
	decreased marginal zone B cell number	J:168600
	decreased monocyte cell number	J:168600
	decreased neutrophil cell number	J:168600
	decreased plasma cell number	J:168600
	decreased splenocyte apoptosis	J:168600
	decreased splenocyte proliferation	J:168600
	decreased thymocyte number	J:168600
	decreased transitional stage T1 B cell number	J:168600
	increased CD4-positive, alpha-beta T cell number	J:168600
	increased CD8-positive, alpha-beta T cell number	J:168600
	small spleen	J:168600
Mtpap^{tm1.1(KOMP)Vlcg}/Mtpap⁺ (C57BL/6N-Mtpap^{tm1.1(KOMP)Vlcg}/Ucd)	increased erythrocyte cell number	J:211773
Mtss1^{Gt(CSC156)Byg}/Mtss1^{Gt(CSC156)Byg} (B6.129P2-Mtss1^{Gt(CSC156)Byg})	abnormal B cell differentiation	J:186118
	abnormal B cell number	J:186118
	abnormal B cell physiology	J:186118
	decreased immature B cell number	J:186118
	enlarged spleen	J:186118
	increased leukocyte cell number	J:186118
	increased pre-B cell number	J:186118
Mttp^tm1Sgy/Mttp^tm1Sgy (involves: 129S4/SvJae)	decreased erythrocyte cell number	J:48934
Mtus1^{Gt(RRA048)Byg}/Mtus1^{Gt(RRA048)Byg} (involves: 129P2/OlaHsd * C57BL/6)	anemia	J:212144
	decreased erythrocyte cell number	J:212144
	decreased hematocrit	J:212144
	decreased hemoglobin content	J:212144
	increased leukocyte cell number	J:212144
	increased lymphocyte cell number	J:212144
	thrombocytopenia	J:212144
Mtx2^em1(IMPC)J/Mtx2⁺ (C57BL/6NJ-Mtx2^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Muc2^eey/Muc2^eey (C57BL/6-Muc2^eey)	increased leukocyte cell number	J:194148
Muc2^wnn/Muc2⁺ (C57BL/6-Muc2^wnn)	decreased hematocrit	J:194148
Muc2^wnn/Muc2^wnn (C57BL/6-Muc2^wnn)	decreased hematocrit	J:194148
	increased leukocyte cell number	J:194148
	increased lymphocyte cell number	J:194148
Muc5b^tm1.2Evns/Muc5b^tm1.2Evns (B6.129S1-Muc5b^tm1.2Evns)	impaired macrophage phagocytosis	J:207159
Muc5b^tm1.2Evns/Muc5b^tm1.2Evns (B6.129S1-Muc5b^tm1.2Evns)	increased macrophage apoptosis	J:207159
Muc13^tm1.1Mamg/Muc13^tm1.1Mamg (involves: 129 * C57BL/6)	decreased hematocrit	J:313870
Mug1^tm2Vln/Mug1^tm2Vln Pzp^tm1Vln/Pzp^tm1Vln (B.129P2-Pzp^tm1Vln Mug1^tm2Vln)	abnormal uterine NK cell morphology	J:117841
Mul1^em1(IMPC)H/Mul1^em1(IMPC)H (C57BL/6N-Mul1^em1(IMPC)H/H)	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular hemoglobin concentration	J:211773
	decreased mean corpuscular volume	J:211773
	decreased spleen weight	J:211773
	increased erythrocyte cell number	J:211773
	increased red blood cell distribution width	J:211773
	small thymus	J:211773
	thrombocytosis	J:211773
Mvd003/Mvd003⁺ (C3HeB/FeJ-Mvd003)	decreased mean corpuscular volume	J:186868
Mvd005/Mvd005⁺ (C3HeB/FeJ-Mvd005)	decreased mean corpuscular hemoglobin	J:186868
Mvd005/Mvd005⁺ (C3HeB/FeJ-Mvd005)	decreased mean corpuscular volume	J:186868
Mvd007/Mvd007⁺ (C3HeB/FeJ-Mvd007)	decreased mean corpuscular volume	J:186868
Mvd009/Mvd009⁺ (C3HeB/FeJ-Mvd009)	decreased mean corpuscular volume	J:186868
Mvd016/Mvd016⁺ (C3HeB/FeJ-Mvd016)	decreased mean corpuscular hemoglobin	J:186868
	decreased mean corpuscular volume	J:186868
	increased erythrocyte cell number	J:186868
Mvd017/Mvd017⁺ (C3HeB/FeJ-Mvd017)	decreased mean corpuscular hemoglobin	J:186868
Mvd017/Mvd017⁺ (C3HeB/FeJ-Mvd017)	decreased mean corpuscular volume	J:186868
Mvd018/Mvd018⁺ (C3HeB/FeJ-Mvd018)	decreased mean corpuscular hemoglobin	J:186868
Mvd018/Mvd018⁺ (C3HeB/FeJ-Mvd018)	decreased mean corpuscular volume	J:186868
Mvd019/Mvd019⁺ (C3HeB/FeJ-Mvd019)	decreased mean corpuscular volume	J:186868
Mvd021/Mvd021⁺ (C3HeB/FeJ-Mvd021)	decreased mean corpuscular volume	J:186868
Mvd023/Mvd023⁺ (C3HeB/FeJ-Mvd023)	decreased hematocrit	J:186868
	decreased hemoglobin content	J:186868
	decreased mean corpuscular volume	J:186868
mvu008/mvu008 (C3HeB/FeJ-mvu008)	increased mean corpuscular hemoglobin	J:186868
mvu008/mvu008 (C3HeB/FeJ-mvu008)	increased mean corpuscular volume	J:186868
Mx1^s1/Mx1^s1 (C57BL/6)	abnormal peritoneal macrophage morphology	J:23752
Mxd1^tm1Rne/Mxd1^tm1Rne (involves: 129S4/SvJaeSor * C57BL/6)	abnormal B cell physiology	J:45945
	abnormal common myeloid progenitor cell morphology	J:45945
	abnormal myeloid leukocyte morphology	J:45945
	increased granulocyte number	J:45945
Mxi1^tm1Rdp/Mxi1^tm1Rdp (involves: 129/Sv * C57BL/6J * SJL)	abnormal lymphocyte morphology	J:48236
	enlarged spleen	J:48236
	increased spleen white pulp amount	J:48236
	increased T cell proliferation	J:48236
Myb^boo/Myb^boo (involves: C57BL/6)	abnormal B cell differentiation	J:167270
	abnormal common lymphocyte progenitor cell morphology	J:167270
	abnormal definitive hematopoiesis	J:167270
	abnormal embryonic erythropoiesis	J:167270
	abnormal erythrocyte morphology	J:167270
	abnormal erythropoiesis	J:167270
	abnormal leukocyte morphology	J:167270
	abnormal megakaryocyte morphology	J:167270
	abnormal spleen morphology	J:167270
	anemia	J:167270
	decreased neutrophil cell number	J:167270
	decreased spleen white pulp amount	J:167270
	enlarged spleen	J:167270
	increased hematopoietic stem cell number	J:167270
	increased megakaryocyte cell number	J:167270
	increased nucleated erythrocyte cell number	J:167270
	increased number of Howell-Jolly bodies	J:167270
	increased spleen red pulp amount	J:167270
	polychromatophilia	J:167270
	reticulocytosis	J:167270
	thrombocytosis	J:167270
Myb^M303V/Myb^M303V (involves: 129S1/SvlmJ * C57BL/6)	abnormal megakaryocyte differentiation	J:96507
	abnormal platelet shape	J:96507
	absent common myeloid progenitor cells	J:96507
	anemia	J:96507
	arrested B cell differentiation	J:96507
	arrested T cell differentiation	J:96507
	decreased B cell number	J:96507
	decreased eosinophil cell number	J:96507
	decreased erythrocyte cell number	J:96507
	decreased single-positive T cell number	J:96507
	decreased thymocyte number	J:96507
	increased bone marrow cell number	J:96507
	increased hematopoietic stem cell number	J:96507
	macrocytosis	J:96507
	thrombocytosis	J:96507
Myb^tm1.1Cgn/Myb⁺ (involves: 129P2/OlaHsd * C57BL/6)	arrested B cell differentiation	J:127234
	decreased B-1 B cell number	J:127234
	decreased mature B cell number	J:127234
	decreased pre-B cell number	J:127234
Myb^tm1.1Cgn/Myb^tm1.1Cgn (involves: 129P2/OlaHsd * C57BL/6)	anemia	J:91122
Myb^tm1Cgn/Myb^tm1.1Cgn Tg(Lck-cre)548Jxm/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	decreased CD4-positive, alpha-beta T cell number	J:91122
	decreased double-positive T cell number	J:91122
	thymus hypoplasia	J:91122
Myb^tm1Cgn/Myb^tm1Cgn Tg(Lck-cre)1Cwi/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	arrested T cell differentiation	J:91122
	decreased CD4-positive, alpha-beta T cell number	J:91122
	decreased CD8-positive, alpha-beta T cell number	J:91122
	decreased double-negative T cell number	J:91122
	decreased double-positive T cell number	J:91122
	decreased gamma-delta T cell number	J:91122
	thymus hypoplasia	J:91122
Myb^tm1Cgn/Myb^tm1Cgn Tg(Lck-cre)548Jxm/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	decreased CD4-positive, alpha-beta T cell number	J:91122
	decreased double-positive T cell number	J:91122
	thymus hypoplasia	J:91122
Myb^tm1Epr/Myb^tm1Epr Tg(Cd4-cre)1Cwi/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)	abnormal T cell differentiation	J:93481
	decreased CD4-positive, alpha-beta T cell number	J:93481
	decreased double-positive T cell number	J:93481
	increased CD8-positive, alpha-beta T cell number	J:93481
	thymus hypoplasia	J:93481
Myb^tm1Epr/Myb^tm1Epr Tg(Lck-cre)548Jxm/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	abnormal double-negative T cell morphology	J:93481
	abnormal T cell differentiation	J:93481
	decreased double-positive T cell number	J:93481
	thymus hypoplasia	J:93481
Myb^tm1Jof/Myb^tm1Jof (involves: 129/Sv * C57BL/6)	abnormal B cell differentiation	J:85344
	abnormal definitive hematopoiesis	J:85344
	abnormal double-negative T cell morphology	J:85344
	abnormal erythropoiesis	J:85344
	abnormal myeloblast morphology/development	J:85344
	abnormal T cell differentiation	J:85344
	decreased thymocyte number	J:85344
	increased megakaryocyte cell number	J:85344
Myb^tm1Jof/Myb^tm1Ssp (involves: 129/Sv * C57BL/6)	abnormal definitive hematopoiesis	J:85344
	abnormal erythropoiesis	J:85344
	abnormal myeloblast morphology/development	J:85344
	abnormal T cell differentiation	J:85344
	decreased thymocyte number	J:85344
	increased megakaryocyte cell number	J:85344
Myb^tm1Ssp/Myb^tm1Ssp (either: (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * CD-1))	abnormal erythropoiesis	J:43747
	anemia	J:43747
	decreased common myeloid progenitor cell number	J:43747
	decreased erythroid progenitor cell number	J:43747
	decreased hematocrit	J:43747
	decreased hematopoietic stem cell number	J:43747
	increased nucleated erythrocyte cell number	J:43747
Myb^tm1Ssp/Myb^tm1Ssp (involves: 129S2/SvPas)	abnormal definitive hematopoiesis	J:63424
	abnormal erythropoiesis	J:63424
	abnormal hematopoietic stem cell morphology	J:63424
Myb^tm2.2Epr/Myb^tm2.2Epr (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	hematopoietic system phenotype	J:160189
Mybbp1a^{tm1b(EUCOMM)Hmgu}/Mybbp1a⁺ (C57BL/6N-Mybbp1a^{tm1b(EUCOMM)Hmgu}/Ieg)	increased erythrocyte cell number	J:211773
	increased hematocrit	J:211773
	increased hemoglobin content	J:211773
	thrombocytosis	J:211773
Mybl1^tm1Epr/Mybl1^tm1Epr (involves: 129 * C57BL/6)	abnormal spleen B cell follicle morphology	J:67604
	abnormal spleen marginal zone morphology	J:67604
	decreased B cell number	J:67604
	decreased IgG1 level	J:67604
	decreased IgG2a level	J:67604
	decreased IgG3 level	J:67604
	decreased spleen germinal center number	J:67604
	increased spleen red pulp amount	J:67604
	small spleen	J:67604
	spleen hypoplasia	J:67604
Mybl2^tm1.1Epr/Mybl2^tm1.1Epr Tg(Mx1-cre)1Cgn/0 (involves: 129X1/SvJ * C57BL/6 * CBA * FVB/N)	abnormal common lymphocyte progenitor cell morphology	J:206816
	abnormal hematopoietic cell number	J:206816
	abnormal myelopoiesis	J:206816
	decreased B cell number	J:206816
	decreased bone marrow cell number	J:206816
	decreased common myeloid progenitor cell number	J:206816
	decreased erythroid progenitor cell number	J:206816
	decreased hematopoietic stem cell number	J:206816
	decreased hematopoietic stem cell proliferation	J:206816
	decreased leukocyte cell number	J:206816
	decreased lymphocyte cell number	J:206816
	decreased neutrophil cell number	J:206816
	decreased splenocyte number	J:206816
	decreased T cell number	J:206816
	thrombocytopenia	J:206816
Mybl2^tm1.1Jof/Mybl2⁺ Tg(Zp3-cre)3Mrt/0 (involves: 129S2/SvPas * C57BL/6 * FVB/N)	abnormal erythrocyte morphology	J:196804
	abnormal myelopoiesis	J:196804
	anemia	J:196804
	anisocytosis	J:196804
	decreased erythrocyte cell number	J:196804
	decreased leukocyte cell number	J:196804
	decreased neutrophil cell number	J:196804
	enlarged spleen	J:196804
	increased bone marrow cell number	J:196804
	increased granulocyte number	J:196804
	increased leukocyte cell number	J:196804
	increased megakaryocyte cell number	J:196804
	increased monocyte cell number	J:196804
	increased number of Howell-Jolly bodies	J:196804
	myeloid hyperplasia	J:196804
	poikilocytosis	J:196804
	thrombocytopenia	J:196804
	thrombocytosis	J:196804
Mybphl^{tm1b(KOMP)Wtsi}/Mybphl^{tm1b(KOMP)Wtsi} (C57BL/6N-Mybphl^{tm1b(KOMP)Wtsi}/Wtsi)	abnormal thymus morphology	J:239583
Myc^tm1Atp/Myc⁺ (involves: 129P2/OlaHsd * FVB/N)	decreased bone marrow cell number	J:73369
	decreased T cell proliferation	J:73369
	spleen hypoplasia	J:73369
Myc^tm1Atp/Myc⁺ (B6.129P2-Myc^tm1Atp)	abnormal NK cell physiology	J:132730
	decreased memory T cell number	J:132730
	decreased T cell proliferation	J:132730
Myc^tm1Atp/Myc^tm1Atp (involves: 129P2/OlaHsd * FVB/N)	absent common myeloid progenitor cells	J:73369
Myc^tm1Atp/Myc^tm1Atp (involves: 129P2/OlaHsd * FVB/N)	absent erythroid progenitor cell	J:73369
Myc^tm1Atp/Myc^tm2.1Atp (involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL)	decreased bone marrow cell number	J:73369
	decreased T cell proliferation	J:73369
	spleen hypoplasia	J:73369
Myc^tm1Jlc/Myc^tm1Jlc (involves: 129S7/SvEvBrd)	abnormal embryonic erythropoiesis	J:79427
	decreased common myeloid progenitor cell number	J:79427
	decreased erythroid progenitor cell number	J:79427
Myc^tm1Lbox/Myc⁺ (involves: 129S1/Sv * 129X1/SvJ * FVB/N)	enlarged spleen	J:97900
	increased B cell number	J:97900
	increased spleen weight	J:97900
Myc^tm1Lbox/Myc^tm1Lbox (involves: 129S1/Sv * 129X1/SvJ * FVB/N)	decreased T cell number	J:97900
	enlarged spleen	J:97900
	increased B cell apoptosis	J:97900
	increased B cell number	J:97900
	increased B cell proliferation	J:97900
	increased spleen weight	J:97900
Myc^tm2.1Atp/Myc⁺ (involves: 129P2/OlaHsd * C57BL/6 * SJL)	decreased T cell proliferation	J:73369
Myc^tm2.1Atp/Myc^tm2.1Atp Edil3^{Tg(Sox2-cre)1Amc}/Edil3⁺ (involves: 129P2/OlaHsd * C57BL/6 * CBA)	abnormal common myeloid progenitor cell morphology	J:137630
	abnormal proerythroblast morphology	J:137630
	decreased erythroid progenitor cell number	J:137630
	impaired hematopoiesis	J:137630
Myc^tm2.1Atp/Myc^tm2.1Atp Tg(Tek-cre)1Rwng/0 (involves: 129P2/OlaHsd * FVB/N)	abnormal hematopoietic system morphology/development	J:137630
Myc^tm2Fwa/Myc^tm2Fwa Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * 129S6/SvEvTac)	decreased B cell proliferation	J:67222
Myc^tm3(Tcrb)Fwa/Myc⁺ (involves: 129)	abnormal T cell receptor beta chain V(D)J recombination	J:131995
Mycl^tm1.1Kmm/Mycl^tm1.1Kmm (B6.129S6(C)-Mycl^tm1.1Kmm)	decreased dendritic cell number	J:206430
Mycn^tm1Fwa/Mycn^tm1Fwa (involves: 129S/SvEv)	decreased hematopoietic stem cell number	J:46520
Mycn^tm1Par/Mycn^tm1Par (involves: 129S2/SvPas * C57BL/6J)	anemia	J:3432
Myct1^em1(IMPC)Mbp/Myct1^em1(IMPC)Mbp (C57BL/6N-Myct1^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	decreased mean corpuscular hemoglobin concentration	J:211773
	enlarged spleen	J:211773
	increased red blood cell distribution width	J:211773
Myct1^em1Choi/Myct1^em1Choi (involves: C57BL/6)	abnormal macrophage cell number	J:303692
	decreased regulatory T cell number	J:303692
	increased CD8-positive, alpha-beta T cell number	J:303692
Myd88^lkd/Myd88^lkd (C57BL/6-Myd88^lkd)	abnormal macrophage physiology	J:110094
Myd88^poc/Myd88^poc (C57BL/6-Myd88^poc)	abnormal macrophage physiology	J:110094
Myd88^tm1.1Defr/Myd88^tm1.1Defr (B6.129P2(SJL)-Myd88^tm1.1Defr)	abnormal CD4-positive, alpha-beta T cell physiology	J:224849
	abnormal macrophage physiology	J:224849
	abnormal microglial cell physiology	J:224849
	decreased effector memory CD4-positive, alpha-beta T cell number	J:224849
	decreased leukocyte cell number	J:224849
	decreased macrophage cell number	J:224849
	decreased monocyte cell number	J:224849
	decreased neutrophil cell number	J:224849
Myd88^tm1.1Medz/Myd88^tm1.1Medz Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	abnormal CD4-positive, alpha-beta T cell physiology	J:209373
	abnormal memory T cell physiology	J:209373
	abnormal T-helper 1 physiology	J:209373
	abnormal T-helper 17 cell physiology	J:209373
Myd88^{tm1a(EUCOMM)Wtsi}/Myd88^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Myd88^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased mean corpuscular volume	J:175295
Myd88^tm1Aki/Myd88^tm1Aki (Not Specified)	abnormal macrophage physiology	J:96773
	abnormal NK cell physiology	J:88906
	abnormal NK T cell physiology	J:88906
	abnormal T cell physiology	J:96773
	decreased B cell proliferation	J:96773
Myd88^tm1Aki/Myd88^tm1Aki (B6.129P2-Myd88^tm1Aki)	abnormal dendritic cell differentiation	J:139001
	abnormal macrophage physiology	J:116670
	abnormal NK cell physiology	J:139001
	abnormal T cell physiology	J:97662
	increased dendritic cell number	J:116763
Myd88^tm1Aki/Myd88^tm1Aki (involves: 129P2/OlaHsd)	abnormal macrophage physiology	J:174941
	abnormal neutrophil physiology	J:145345
	hematopoietic system phenotype	J:135830
	increased IgA level	J:210086
	increased IgE level	J:115059
	increased IgG1 level	J:115059
Myd88^tm1Aki/Myd88^tm1Aki (involves: 129P2/OlaHsd * C57BL/6)	abnormal macrophage physiology	J:141143, J:117688
	decreased IgG2b level	J:137066
	decreased IgG3 level	J:137066
	decreased IgG level	J:137066
Myd88^tm1Aki/Myd88^tm1Aki Tg(IghelMD4)4Ccg/0 Tg(KLK4mHEL)6Ccg/0 (involves: 129P2/OlaHsd * C57BL/6)	decreased mature B cell number	J:115059
	increased B-1 B cell number	J:115059
Myd88^tm1Aki/Myd88^tm1Aki Ticam1^tm1Aki/Ticam1⁺ (B6.129P2-Myd88^tm1Aki Ticam1^tm1Aki)	decreased macrophage cytokine production	J:140485
	decreased macrophage nitric oxide production	J:140485
Myd88^tm1Aki/Myd88^tm1Aki Ticam1^tm1Aki/Ticam1^tm1Aki (involves: 129P2/OlaHsd)	abnormal macrophage physiology	J:174941
Myd88^tm1Aki/Myd88^tm1Aki Ticam1^tm1Aki/Ticam1^tm1Aki (B6.129P2-Myd88^tm1Aki Ticam1^tm1Aki)	decreased macrophage cytokine production	J:140485
	decreased macrophage nitric oxide production	J:140485
Myd88^tm1Aki/Myd88^tm1Aki Unc93b1^tm1.1Kmiy/Unc93b1^tm1.1Kmiy (involves: 129P2/OlaHsd * C57BL/6)	hematopoietic system phenotype	J:174308
Myd88^tm1Defr/Myd88^tm1Defr Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: 129P2/OlaHsd * C57BL/6 * SJL)	abnormal NK cell physiology	J:139001
Myd88^tm1Defr/Myd88^tm1Defr Tg(Itgax-cre)1-1Reiz/0 (B6.Cg-Myd88^tm1Defr Tg(Itgax-cre)1-1Reiz)	abnormal dendritic cell differentiation	J:139001
	abnormal NK cell physiology	J:139001
	abnormal T-helper 1 cell differentiation	J:139001
	decreased IgG1 level	J:139001
	decreased IgG2b level	J:139001
	decreased IgG2c level	J:139001
Myd88^tm1Defr/Myd88^tm1Defr Tnip1^tm1.2Ama/Tnip1^tm1.2Ama Tg(Itgax-cre)1-1Reiz/0 (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * CBA)	hematopoietic system phenotype	J:205446
Myd88^tm1Hlz/Myd88^tm1Hlz (B6.129P2-Myd88^tm1Hlz)	decreased neutrophil cell number	J:188968
Myh1^{tm1b(KOMP)Wtsi}/Myh1^{tm1b(KOMP)Wtsi} (C57BL/6N-Myh1^{tm1b(KOMP)Wtsi}/J)	decreased leukocyte cell number	J:211773
	increased erythrocyte cell number	J:211773
	increased hematocrit	J:211773
	increased hemoglobin content	J:211773
Myh7b^{tm1a(KOMP)Wtsi}/Myh7b^{tm1a(KOMP)Wtsi} (C57BL/6N-Myh7b^{tm1a(KOMP)Wtsi}/Wtsi)	increased red blood cell distribution width	J:211773
Myh8^em1(IMPC)Tcp/Myh8⁺ (C57BL/6N-Myh8^em1(IMPC)Tcp/Tcp)	decreased hematocrit	J:211773
Myh9^{Gt(Betageo-btk)1Dash}/Myh9⁺ (involves: 129X1/SvJ * C57BL/6)	hematopoietic system phenotype	J:94067
Myh9^{tm1.1(MYH9)Mjk}/Myh9⁺ (B6.Cg-Myh9^{tm1.1(MYH9)Mjk})	abnormal neutrophil morphology	J:175367
	abnormal platelet morphology	J:175367
	thrombocytopenia	J:175367
Myh9^{tm1.1(MYH9)Mjk}/Myh9^{tm1.1(MYH9)Mjk} (B6.129-Myh9^{tm1.1(MYH9*)Mjk})	abnormal megakaryocyte morphology	J:175367
	abnormal neutrophil morphology	J:175367
	abnormal platelet morphology	J:175367
	thrombocytopenia	J:175367
Myh9^tm1.1Dash/Myh9⁺ (involves: 129S2/SvPas * C57BL/6 * C57BL/6J * CBA)	abnormal megakaryocyte differentiation	J:204923
	abnormal platelet morphology	J:204923
	abnormal thrombopoiesis	J:204923
	thrombocytopenia	J:204923
Myh9^tm1.1Gac/Myh9⁺ Tg(Pf4-icre)Q3Rsko/0 (involves: 129 * C57BL/6)	abnormal platelet physiology	J:148233
Myh9^tm1.1Gac/Myh9^tm1.1Gac Tg(Pf4-icre)Q3Rsko/0 (involves: 129 * C57BL/6)	abnormal platelet morphology	J:148233
	abnormal platelet physiology	J:148233
	abnormal platelet shape	J:148233
	thrombocytopenia	J:148233
Myh9^tm1.2Gac/Myh9^tm1.2Gac (involves: 129)	hematopoietic system phenotype	J:195436
Myh9^tm5Rsad/Myh9^tm5Rsad (involves: 129S6/SvEvTac * C57BL/6J)	abnormal leukocyte migration	J:164684
	abnormal T cell physiology	J:164684
Myh9^tm5Rsad/Myh9^tm5Rsad Tg(Lck-cre)#Nik/0 (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * DBA/2)	abnormal CD8-positive, alpha-beta T cell physiology	J:164684
	abnormal leukocyte adhesion	J:164684
	abnormal leukocyte migration	J:164684
	abnormal T cell physiology	J:164684
	decreased CD8-positive, alpha-beta T cell number	J:164684
Myh9^{tm6.1(EGFP/MYH9)Rsad}/Myh9⁺ (involves: 129S4/SvJae BALB/cJ * C57BL/6)	abnormal neutrophil morphology	J:175367
	abnormal platelet morphology	J:175367
	increased megakaryocyte cell number	J:175367
	thrombocytopenia	J:175367
Myh9^tm7.1Rsad/Myh9⁺ (involves: BALB/cJ)	abnormal neutrophil morphology	J:175367
	abnormal platelet morphology	J:175367
	increased megakaryocyte cell number	J:175367
	thrombocytopenia	J:175367
Myh9^tm7.1Rsad/Myh9^tm7.1Rsad (involves: BALB/cJ)	abnormal megakaryocyte morphology	J:175367
	abnormal neutrophil morphology	J:175367
	abnormal platelet morphology	J:175367
	increased megakaryocyte cell number	J:175367
	thrombocytopenia	J:175367
Myl2^tm1(cre)Krc/Myl2⁺ Pip5k1c^tm2Csab/Pip5k1c^tm2Csab (Not Specified)	abnormal platelet aggregation	J:196476
	abnormal platelet physiology	J:196476
Myl2^{tm1b(EUCOMM)Hmgu}/Myl2⁺ (C57BL/6N-Myl2^{tm1b(EUCOMM)Hmgu}/Ieg)	decreased mean corpuscular volume	J:211773
Myl12b^{tm1a(EUCOMM)Wtsi}/Myl12b^{tm1a(EUCOMM)Wtsi} (B6JTyr;B6N-Myl12b^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased hematocrit	J:175295
	decreased hemoglobin content	J:175295
	decreased mean corpuscular hemoglobin	J:175295
Mylip^{tm1.1(KOMP)Vlcg}/Mylip^{tm1.1(KOMP)Vlcg} (C57BL/6N-Mylip^{tm1.1(KOMP)Vlcg}/J)	increased mean corpuscular hemoglobin	J:211773
Myo1c^tm1.1Biat/Myo1c^tm1.1Biat (B6N.129S2-Myo1c^tm1.1Biat)	decreased erythrocyte cell number	J:200573
	decreased mean corpuscular hemoglobin concentration	J:200573
	increased mean corpuscular hemoglobin	J:200573
	increased mean corpuscular volume	J:200573
	macrocytosis	J:200573
Myo1e^{Gt(ROSA)74Sor}/Myo1e^{Gt(ROSA)74Sor} (involves: 129S4/SvJaeSor)	anemia	J:117491
	decreased erythrocyte cell number	J:117491
	decreased hematocrit	J:117491
	decreased hemoglobin content	J:117491
	polychromatophilia	J:117491
	reticulocytosis	J:117491
Myo1e^{Gt(ROSA)74Sor}/Myo1e^{Gt(ROSA)74Sor} Pdgfra^tm2Sor/Pdgfra⁺ (involves: 129S4/SvJaeSor)	anemia	J:117491
Myo1e^{Gt(ROSA)74Sor}/Myo1e^{Gt(ROSA)74Sor} Pdgfrb^tm1Sor/Pdgfrb⁺ (involves: 129S4/SvJaeSor * 129S7/SvEvBrd)	hematopoietic system phenotype	J:117491
Myo1f^tm1.1Flv/Myo1f^tm1.1Flv (involves: 129S6/SvEvTac)	impaired neutrophil chemotaxis	J:113020
Myo1g^tm1.2Mfk/Myo1g^tm1.2Mfk (Not Specified)	abnormal B cell physiology	J:209304
	decreased B cell number	J:209304
	increased B cell number	J:209304
Myo1g^tm1.2Mfk/Myo1g^tm1.2Mfk (involves: C57BL/6 * FVB/N * SJL)	abnormal T cell physiology	J:212451
Myo1g^tm1.2Mfk/Myo1g^tm1.2Mfk Tg(TcraTcrb)1100Mjb/0 (involves: C57BL/6 * FVB/N * SJL)	abnormal T cell physiology	J:212451
Myo3b^{tm1b(EUCOMM)Hmgu}/Myo3b^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Myo3b^{tm1b(EUCOMM)Hmgu}/J)	decreased leukocyte cell number	J:211773
Myo5a^{tm1e(KOMP)Wtsi}/Myo5a^{tm1e(KOMP)Wtsi} (involves: C57BL/6J * C57BL/6N)	hematopoietic system phenotype	J:195694
Myo6^em1(IMPC)Tcp/Myo6^em1(IMPC)Tcp (C57BL/6N-Myo6^em1(IMPC)Tcp/Tcp)	decreased leukocyte cell number	J:211773
	increased mean corpuscular volume	J:211773
Myo9b^tm1.2Bah/Myo9b^tm1.2Bah (B6.Cg-Myo9b^tm1.2Bah)	abnormal macrophage physiology	J:162326
	decreased leukocyte cell number	J:162326
	impaired macrophage chemotaxis	J:162326
Myoz1^{tm1b(EUCOMM)Hmgu}/Myoz1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Myoz1^{tm1b(EUCOMM)Hmgu}/Ieg)	increased marginal zone B cell number	J:211773
Mypn^em1(IMPC)J/Mypn^em1(IMPC)J (C57BL/6NJ-Mypn^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
mypy/mypy (C57BL/6J-mypy)	abnormal macrophage physiology	J:105543
Mysm1^{tm1a(KOMP)Wtsi}/Mysm1⁺ (Not Specified)	increased mean corpuscular volume	J:165965
Mysm1^{tm1a(KOMP)Wtsi}/Mysm1^{tm1a(KOMP)Wtsi} (Not Specified)	decreased B cell number	J:165965
	decreased erythrocyte cell number	J:165965
	decreased hematocrit	J:165965
	decreased hemoglobin content	J:165965
	decreased leukocyte cell number	J:165965
	decreased mature B cell number	J:165965
	increased granulocyte number	J:165965
	increased IgG2b level	J:165965
	increased mean corpuscular hemoglobin concentration	J:165965
	increased mean corpuscular volume	J:165965
	increased T cell number	J:165965
	thrombocytosis	J:165965
Mysm1^{tm1b(KOMP)Wtsi}/Mysm1^{tm1b(KOMP)Wtsi} Tg(MMTV-cre)4Mam/0 (involves: 129 * C57BL/6N * FVB/N)	abnormal common lymphocyte progenitor cell morphology	J:179287
	abnormal T cell differentiation	J:179287
	arrested B cell differentiation	J:179287
	decreased B cell number	J:179287
	decreased hematopoietic cell number	J:179287
	decreased immature B cell number	J:179287
	decreased pre-B cell number	J:179287
	decreased pro-B cell number	J:179287
	pancytopenia	J:179287
Mzb1^tm1.2Rug/Mzb1^tm1.2Rug (involves: 129S2/SvPas * BALB/cJ * C57BL/6 * SJL)	decreased pre-B cell number	J:211639
	hematopoietic system phenotype	J:211639
	increased pro-B cell number	J:211639
Mzf1^tm1Ppp/Mzf1^tm1Ppp (involves: 129)	abnormal myelopoiesis	J:70407
	extramedullary hematopoiesis	J:70407
	hematopoietic system phenotype	J:70407
N4bp1^tm1.2Vmd/N4bp1^tm1.2Vmd (involves: C57BL/6)	abnormal macrophage physiology	J:297419
	anemia	J:297419
	increased activated T cell number	J:297419
	increased germinal center B cell number	J:297419
	increased Ly6C high monocyte number	J:297419
Naa10^em1(IMPC)Mbp/Y (C57BL/6NCrl-Naa10^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
Naa10^em1(IMPC)Mbp/Y (C57BL/6NCrl-Naa10^em1(IMPC)Mbp/Mmucd)	small spleen	J:211773
Naa10^em1(IMPC)Mbp/Naa10^em1(IMPC)Mbp (C57BL/6NCrl-Naa10^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Naa16^em1(IMPC)J/Naa16^em1(IMPC)J (C57BL/6NJ-Naa16^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Naa25^em1(IMPC)Tcp/Naa25⁺ (C57BL/6NCrl-Naa25^em1(IMPC)Tcp/Tcp)	enlarged thymus	J:211773
Naa35^em1(IMPC)J/Naa35⁺ (C57BL/6NJ-Naa35^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Naa38^{em1(IMPC)Ccpcz}/Naa38⁺ (C57BL/6N-Naa38^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Naa50^em1(IMPC)Mbp/Naa50⁺ (C57BL/6N-Naa50^em1(IMPC)Mbp/Ucd)	abnormal spleen morphology	J:211773
Naa50^em1(IMPC)Mbp/Naa50⁺ (C57BL/6N-Naa50^em1(IMPC)Mbp/Ucd)	enlarged spleen	J:211773
Naaa^{tm1a(KOMP)Wtsi}/Naaa^{tm1a(KOMP)Wtsi} (C57BL/6N-Naaa^{tm1a(KOMP)Wtsi}/Wtsi)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
Nabp1^tm1.1Kkha/Nabp1^tm1.1Kkha (B6.Cg-Nabp1^tm1.1Kkha)	hematopoietic system phenotype	J:220670
Nabp2^tm1.1Kkha/Nabp2^tm1.1Kkha Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ (involves: C57BL/6 * C57BL/6NTac)	hematopoietic system phenotype	J:195140
	increased thymocyte apoptosis	J:195140
Nabp2^tm1Schg/Nabp2^tm1Schg (involves: 129S7/SvEvBrd * C57BL/6)	increased spleen red pulp amount	J:228558
Nacc1^{em1(IMPC)Hmgu}/Nacc1^{em1(IMPC)Hmgu} (C57BL/6N-Nacc1^{em1(IMPC)Hmgu}/Ieg)	increased mean corpuscular volume	J:211773
Nadk2^em1(IMPC)J/Nadk2⁺ (C57BL/6NJ-Nadk2^em1(IMPC)J/J)	increased mean corpuscular hemoglobin concentration	J:211773
Nadsyn1^{tm1b(KOMP)Wtsi}/Nadsyn1^{tm1b(KOMP)Wtsi} (C57BL/6N-Nadsyn1^{tm1b(KOMP)Wtsi}/Ucd)	enlarged spleen	J:211773
Nae1^{tm1b(EUCOMM)Wtsi}/Nae1⁺ (C57BL/6N-Nae1^{tm1b(EUCOMM)Wtsi}/Ics)	decreased erythrocyte cell number	J:211773
	increased mean corpuscular volume	J:211773
Nagk^{tm1b(EUCOMM)Hmgu}/Nagk^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Nagk^{tm1b(EUCOMM)Hmgu}/H)	increased neutrophil cell number	J:211773
Naglu^tm1Efn/Naglu^tm1Efn (either: (involves: 129S/SvEv * C57BL/6) or (involves: C57BL/6))	abnormal Kupffer cell morphology	J:58950
	abnormal macrophage morphology	J:58950
Nalcn^em1(IMPC)Mbp/Nalcn⁺ (C57BL/6N-Nalcn^em1(IMPC)Mbp/Ucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased neutrophil cell number	J:211773
Nampt^{Gt(RRR084)Byg}/Nampt⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased neutrophil cell number	J:194883
Nampt^tm1Oleo/Nampt^tm1Oleo Tg(CD2-icre)4Kio/0 (involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/10 * CBA/Ca)	decreased B cell number	J:141448
	decreased double-negative T cell number	J:141448
	decreased T cell number	J:141448
	thymus hypoplasia	J:141448
Natd1^{tm1b(EUCOMM)Wtsi}/Natd1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Natd1^{tm1b(EUCOMM)Wtsi}/Wtsi)	increased red blood cell distribution width	J:211773
Nav1^em1(IMPC)Mbp/Nav1^em1(IMPC)Mbp (C57BL/6N-Nav1^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Nav2^em1(IMPC)Tcp/Nav2^em1(IMPC)Tcp (C57BL/6NCrl-Nav2^em1(IMPC)Tcp/Tcp)	increased neutrophil cell number	J:211773
Nba4^NZB/Nba4^NZB (involves: NZB * SWR)	increased IgG3 level	J:96263
Nba4^NZB/Nba4^SWR (involves: NZB * SWR)	increased IgG3 level	J:96263
Nba10^NZB/Nba10^NZB Tg(Tnfsf13b)1Fma/0 (involves: C57BL/6 * DBA/2J * NZB)	increased B cell number	J:134128
	increased IgG level	J:134128
	increased IgM level	J:134128
	increased marginal zone B cell number	J:134128
Nba10^NZB/Nba10^NZB Tlr7^tm1Aki/Y X/Yaa (B6.Cg-Nba10^NZB Tlr7^tm1Aki Yaa)	increased monocyte cell number	J:137656
Nba10^NZB/Nba10^NZB X/Yaa (C57BL/6-Nba2 Yaa)	increased monocyte cell number	J:137656, J:129409
Nbeal2^gps/Nbeal2^gps (129S1/SvImJ-Nbeal2^gps)	decreased neutrophil cell number	J:236370
	decreased platelet alpha-granule number	J:236370
	enhanced megakaryocyte emperipolesis	J:236370
	thrombocytopenia	J:236370
Nbeal2^{tm1a(EUCOMM)Wtsi}/Nbeal2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Nbeal2^{tm1a(EUCOMM)Wtsi}/Wtsi)	abnormal megakaryocyte differentiation	J:220801
	abnormal megakaryocyte morphology	J:220801
	abnormal platelet morphology	J:220801
	abnormal platelet shape	J:220801
	decreased platelet alpha-granule number	J:220801
	enlarged spleen	J:220801
	increased leukocyte cell number	J:211773
	increased mean platelet volume	J:220801, J:211773
	thrombocytopenia	J:220801, J:211773
Nbeal2^tm1Lex/Nbeal2^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	abnormal megakaryocyte morphology	J:201413
	abnormal platelet activation	J:201413
	abnormal platelet morphology	J:201413
	decreased platelet aggregation	J:201413
	decreased platelet alpha-granule number	J:201413
	enhanced megakaryocyte emperipolesis	J:201413
	enlarged spleen	J:201413
	increased megakaryocyte cell number	J:201413
	thrombocytopenia	J:201413
Nbn^em7Jpt/Nbn^tm2Zqw Tg(VAV1-cre)1Graf/0 (involves: 129P2/OlaHsd)	abnormal T cell morphology	J:277750
	absent mature B cells	J:277750
	decreased B cell number	J:277750
	decreased bone marrow cell number	J:277750
	decreased erythrocyte cell number	J:277750
	decreased leukocyte cell number	J:277750
	decreased myeloid cell number	J:277750
	decreased T cell number	J:277750
	decreased thymocyte number	J:277750
	impaired hematopoiesis	J:277750
	increased CD8-positive, alpha-beta T cell number	J:277750
	increased pro-B cell number	J:277750
	thrombocytosis	J:277750
Nbn^tm1Jpt/Nbn⁺ Rad50^tm2Jpt/Rad50^tm2Jpt (involves: 129S7/SvEvBrd * C57BL/6)	hematopoietic system phenotype	J:103922
Nbn^tm1Jpt/Nbn^tm1Jpt Rad50^tm2Jpt/Rad50^tm2Jpt (involves: 129S7/SvEvBrd * C57BL/6)	hematopoietic system phenotype	J:103922
Nbn^tm1Nus/Nbn^tm2Nus Tg(CD19-cre/ERT2)1Cgn/0 (Not Specified)	abnormal B cell physiology	J:96102
	decreased B cell proliferation	J:96102
	decreased IgG1 level	J:96102
	decreased IgG2a level	J:96102
	decreased IgG2b level	J:96102
	decreased IgG3 level	J:96102
	decreased IgG level	J:96102
Nbn^tm1Xu/Nbn^tm1Xu (Not Specified)	decreased CD4-positive, alpha-beta T cell number	J:75272
	decreased mature B cell number	J:75272
	decreased pre-B cell number	J:75272
	decreased T cell number	J:75272
	thymus hypoplasia	J:75272
Nbn^tm2.1Jpt/Nbn⁺ Rad50^tm2Jpt/Rad50^tm2Jpt (involves: 129S7/SvEvBrd * 129/Sv)	anemia	J:129762
Nbn^tm2.1Jpt/Nbn^tm2.1Jpt Rad50^tm2Jpt/Rad50^tm2Jpt (involves: 129S7/SvEvBrd * 129/Sv)	anemia	J:129762
Nbn^tm2Zqw/Nbn^tm2Zqw Tg(VAV1-cre)1Graf/0 (involves: 129P2/OlaHsd)	anemia	J:277750
	decreased erythrocyte cell number	J:251434
	decreased leukocyte cell number	J:251434
Nbr1^tm1.1Jmos/Nbr1^tm1.1Jmos Tnfrsf4^tm2(cre)Nik/Tnfrsf4⁺ (involves: 129X1/SvJ * C57BL/6J)	abnormal T-helper 1 cell differentiation	J:165438
	abnormal T-helper 2 cell differentiation	J:165438
Nbr1^tm1Whca/Nbr1^tm1Whca (B6.129P2-Nbr1^tm1Whca)	abnormal osteoclast physiology	J:162412
Nbwa2^NZB/? (involves: BALB/c * NZB * NZW)	increased IgG level	J:88464
Nbwa2^NZB/? (involves: BALB/c * NZB * NZW)	increased IgM level	J:88464
Ncam2^{tm1b(EUCOMM)Hmgu}/Ncam2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Ncam2^{tm1b(EUCOMM)Hmgu}/Orl)	increased eosinophil cell number	J:211773
Ncaph2^nes/Ncaph2^nes (C57BL/6JSfdAnu-Ncaph2^nes/Anu)	abnormal double-negative T cell morphology	J:123300
	abnormal splenic cell ratio	J:123300
	abnormal T cell morphology	J:123300
	abnormal thymus cell ratio	J:123300
	abnormal thymus cortex morphology	J:123300
	abnormal thymus corticomedullary boundary morphology	J:123300
	decreased CD8-positive, alpha-beta T cell number	J:123300
	decreased double-negative T cell number	J:123300
	decreased double-positive T cell number	J:123300
	decreased T cell number	J:123300
	decreased thymocyte number	J:123300
	thymus hypoplasia	J:123300
Ncaph2^nes/Ncaph2^nes Tg(TcrHEL3A9)1Mmd/0 (C57BL/6-Ncaph2^nes Tg(TcrHEL3A9)1Mmd)	abnormal double-negative T cell morphology	J:123300
	abnormal thymus cell ratio	J:123300
	decreased double-positive T cell number	J:123300
Nceh1^tm1Ishi/Nceh1^tm1Ishi (B6.129S7-Nceh1^tm1Ishi)	abnormal macrophage physiology	J:152385
Ncf1^em1(IMPC)Mbp/Ncf1^em1(IMPC)Mbp (C57BL/6N-Ncf1^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Ncf1^em1Nansh/Ncf1^em1Nansh (involves: C57BL/6J)	hematopoietic system phenotype	J:329553
Ncf1^m1J/Ncf1^m1J (B6.Cg-Dock7^m +/+ Lepr^db/J)	abnormal macrophage physiology	J:83428
Ncf1^m1J/Ncf1^m1J (B6.Cg-Dock7^m +/+ Lepr^db/J)	impaired granulocyte bactericidal activity	J:83428
Ncf1^tm1Hbd/Ncf1^tm1Hbd (involves: 129)	abnormal neutrophil physiology	J:77597, J:74593
Ncf2^{tm1a(EUCOMM)Wtsi}/Ncf2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Ncf2^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased alpha-beta T cell number	J:211773
	decreased leukocyte cell number	J:211773
	decreased NK cell number	J:211773
	decreased NK T cell number	J:211773
	decreased regulatory T cell number	J:211773
	decreased T cell number	J:211773
	increased KLRG1-positive NK cell number	J:211773
	increased mean platelet volume	J:211773
Ncf2^{tm1b(EUCOMM)Wtsi}/Ncf2⁺ (NZM2328.B6(Cg)-Ncf2^{tm1b(EUCOMM)Wtsi})	abnormal spleen germinal center morphology	J:260777
	increased activated T cell number	J:260777
	increased B cell number	J:260777
	increased CD4-positive, alpha-beta memory T cell number	J:260777
	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:260777
	increased CD8-positive, alpha-beta T cell number	J:260777
	increased follicular B cell number	J:260777
	increased germinal center B cell number	J:260777
	increased T cell number	J:260777
Ncf2^{tm1b(EUCOMM)Wtsi}/Ncf2^{tm1b(EUCOMM)Wtsi} (B6(Cg)-Ncf2^{tm1b(EUCOMM)Wtsi})	decreased CD8-positive, alpha-beta T cell number	J:260777
Ncf2^{tm1b(EUCOMM)Wtsi}/Ncf2^{tm1b(EUCOMM)Wtsi} (NZM2328.B6(Cg)-Ncf2^{tm1b(EUCOMM)Wtsi})	abnormal spleen germinal center morphology	J:260777
	increased activated T cell number	J:260777
	increased B cell number	J:260777
	increased follicular B cell number	J:260777
	increased germinal center B cell number	J:260777
	increased T cell number	J:260777
Ncf4^tm1Pth/Ncf4^tm2Pth (involves: 129P2/OlaHsd * C57BL/6)	abnormal neutrophil physiology	J:119217
Ncf4^tm2Pth/Ncf4^tm2Pth (involves: 129P2/OlaHsd * C57BL/6)	abnormal neutrophil physiology	J:121820
Nckap1l^m1Btlr/Nckap1l^m1Btlr (C57BL/6J-Nckap1l^m1Btlr)	decreased alpha-beta T cell number	J:272079
	decreased B cell number	J:272079
	decreased CD4-positive, alpha-beta T cell number	J:272079
	decreased CD8-positive, alpha-beta T cell number	J:272079
	decreased CD8-positive, naive alpha-beta T cell number	J:272079
	decreased central memory CD8 positive, alpha-beta T cell number	J:272079
	decreased NK cell number	J:272079
	increased alpha-beta T cell number	J:272079
	increased CD8-positive, alpha-beta T cell number	J:272079
	increased effector memory CD4-positive, alpha-beta T cell number	J:272079
	increased effector memory CD8-positive, alpha-beta T cell number	J:272079
Nckap1l^m1Iri/Nckap1l^m1Iri (involves: C57BL/6)	abnormal CD4-positive T cell differentiation	J:141377
	abnormal common myeloid progenitor cell morphology	J:141377
	abnormal erythroid progenitor cell morphology	J:141377
	abnormal lymphopoiesis	J:141377
	abnormal regulatory T cell number	J:141377
	abnormal thymus lobule morphology	J:141377
	acanthocytosis	J:141377
	dacryocytosis	J:141377
	decreased CD4-positive, alpha-beta T cell number	J:141377
	decreased CD8-positive, alpha-beta T cell number	J:141377
	decreased double-positive T cell number	J:141377
	decreased hematocrit	J:141377
	decreased lymphocyte cell number	J:141377
	decreased mature B cell number	J:141377
	decreased mature gamma-delta T cell number	J:141377
	decreased mean corpuscular volume	J:141377
	decreased T cell proliferation	J:141377
	extramedullary hematopoiesis	J:141377
	hypochromic microcytic anemia	J:141377
	impaired macrophage phagocytosis	J:141377
	impaired neutrophil chemotaxis	J:141377
	impaired neutrophil phagocytosis	J:141377
	increased double-negative T cell number	J:141377
	increased erythrocyte osmotic fragility	J:141377
	increased leukocyte cell number	J:141377
	increased neutrophil cell number	J:141377
	poikilocytosis	J:141377
	reticulocytosis	J:141377
	schistocytosis	J:141377
	spleen hyperplasia	J:141377
	thymus hypoplasia	J:141377
Ncoa2^em1(IMPC)Mbp/Ncoa2⁺ (C57BL/6N-Ncoa2^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased neutrophil cell number	J:211773
Ncoa3^tm1Jxu/Ncoa3^tm1Jxu (involves: 129S6/SvEvTac * C57BL/6J)	abnormal B cell morphology	J:109522
	abnormal lymphopoiesis	J:109522
	abnormal spleen red pulp morphology	J:109522
	decreased splenocyte apoptosis	J:109522
	enlarged spleen	J:109522
	increased B cell number	J:109522
	increased B cell proliferation	J:109522
	increased CD4-positive, alpha-beta T cell number	J:109522
	increased CD8-positive, alpha-beta T cell number	J:109522
	increased leukocyte cell number	J:109522
	increased lymphocyte cell number	J:109522
	increased spleen germinal center size	J:109522
	increased T cell proliferation	J:109522
	thrombocytopenia	J:109522
Ncoa5^{tm1.1(KOMP)Mbp}/Ncoa5⁺ (C57BL/6N-Ncoa5^{tm1.1(KOMP)Mbp}/Tcp)	increased eosinophil cell number	J:211773
Ncoa6^tm1.1Jkr/Ncoa6^tm1.1Jkr (involves: 129P2/OlaHsd * C57BL/6 * FVB/N)	abnormal embryonic hematopoiesis	J:81217
	decreased erythroid progenitor cell number	J:81217
Ncor1^tm1Rsd/Ncor1^tm1Rsd (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal erythropoiesis	J:65417
	abnormal hematocrit	J:65417
	anemia	J:65417
	arrested T cell differentiation	J:65417
	decreased erythrocyte cell number	J:65417
	decreased hematocrit	J:65417
	increased nucleated erythrocyte cell number	J:65417
	small thymus	J:65417
Ncor2^tm1Rev/Ncor2^tm1Rev (involves: 129/Sv * C57BL/6)	abnormal bone marrow cell number	J:202976
	abnormal hematopoietic stem cell morphology	J:202976
	abnormal spleen morphology	J:202976
	enlarged spleen	J:202976
	extramedullary hematopoiesis	J:202976
	increased erythroid progenitor cell number	J:202976
	increased megakaryocyte cell number	J:202976
	increased osteoclast cell number	J:202976
Ncr1^m1J/Ncr1^m1J Pepc^b/Pepc^b Ptprc^a/Ptprc^a (B6.SJL-Ptprc^a Pepc^b/BoyJ)	abnormal NK cell physiology	J:257226
Ncr1^noe/Ncr1^noe (involves: C57BL/6J)	abnormal NK cell physiology	J:179728
	decreased CD4-positive, alpha-beta T cell number	J:179728
	decreased CD8-positive, alpha-beta memory T cell number	J:179728
	decreased CD8-positive, alpha-beta T cell number	J:179728
	increased NK cell number	J:179728
Ncr1^{tm1.1(icre)Viv}/Ncr1⁺ (involves: C57BL/6)	hematopoietic system phenotype	J:180265
Ncr1^{tm1.1(icre)Viv}/Ncr1^{tm1.1(icre)Viv} (involves: C57BL/6)	abnormal NK cell physiology	J:179728
Ncr1^tm1Oman/Ncr1^tm1Oman (involves: 129S1/Sv * 129X1/SvJ)	decreased NK cell number	J:112394
Ncr1^tm1Oman/Ncr1^tm1Oman (involves: 129S1/Sv * 129X1/SvJ)	impaired natural killer cell mediated cytotoxicity	J:112394
Ncstn^tm1.1Akli/Ncstn^tm1.1Akli Tet2^tm1.1Iaai/Tet2^tm1.1Iaai Tg(VAV1-cre)1Graf/0 (involves: 129S/SvEv * C57BL/6)	abnormal common myeloid progenitor cell morphology	J:196407
	enlarged spleen	J:196407
	increased leukocyte cell number	J:196407
	myeloid hyperplasia	J:196407
Ncstn^tm1.1Akli/Ncstn^tm1.1Akli Tg(Mx1-cre)1Cgn/0 (involves: 129 * C57BL/6 * CBA * SJL)	abnormal definitive hematopoiesis	J:172442
	abnormal hematopoietic stem cell morphology	J:172442
	abnormal spleen morphology	J:172442
	enlarged spleen	J:172442
	increased hematopoietic stem cell number	J:172442
	increased leukocyte cell number	J:172442
	increased monocyte cell number	J:172442
	increased spleen red pulp amount	J:172442
Ncstn^tm1.1Akli/Ncstn^tm1.1Akli Tg(VAV1-cre)1Graf/0 (involves: 129 * C57BL/6 * SJL)	abnormal definitive hematopoiesis	J:172442
	abnormal hematopoietic stem cell morphology	J:172442
	abnormal spleen morphology	J:172442
	enlarged spleen	J:172442
	increased hematopoietic stem cell number	J:172442
	increased leukocyte cell number	J:172442
	increased monocyte cell number	J:172442
	increased spleen red pulp amount	J:172442
Ncstn^tm1.1Akli/Ncstn^tm1.1Akli Tg(VAV1-cre)1Graf/0 (involves: 129)	abnormal splenocyte physiology	J:196407
	enlarged spleen	J:196407
Ndfip1^{Gt(RRD002)Byg}/Ndfip1^{Gt(RRD002)Byg} (involves: 129P2/OlaHsd * C57BL/6)	abnormal bone marrow cell number	J:116617
	abnormal T cell physiology	J:116617
	abnormal T-helper 2 physiology	J:116617
	extramedullary hematopoiesis	J:116617
	increased activated T cell number	J:116617
	increased spleen weight	J:116617
	increased T cell proliferation	J:116617
Ndfip1^{Gt(RRD002)Byg}/Ndfip1^{Gt(RRD002)Byg} (involves: 129P2/OlaHsd)	abnormal T cell physiology	J:205692
	increased activated T cell number	J:205692
	increased T cell proliferation	J:205692
Ndfip1^kru/Ndfip1^kru (involves: C57BL/6JSfdAnu)	increased T-helper 2 cell number	J:188722
Ndfip1^tm1.1Pmo/Ndfip1^tm1.1Pmo Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	increased activated T cell number	J:205692
	increased eosinophil cell number	J:205692
Ndfip2^{tm1a(EUCOMM)Hmgu}/Ndfip2^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Ndfip2^{tm1a(EUCOMM)Hmgu})	hematopoietic system phenotype	J:235779
Ndor1^{Tg(UBC-cre/ERT2)1Ejb}/Ndor1⁺ Rnpc3^{tm1c(EUCOMM)Wtsi}/Rnpc3^{tm1c(EUCOMM)Wtsi} (involves: 129S/SvEv * C57BL/6 * C57BL/6N)	anemia	J:267519
	decreased erythrocyte cell number	J:267519
	decreased leukocyte cell number	J:267519
	decreased lymphocyte cell number	J:267519
	decreased monocyte cell number	J:267519
	decreased thymus weight	J:267519
	thrombocytopenia	J:267519
	thymus atrophy	J:267519
	thymus cortex atrophy	J:267519
	thymus medulla atrophy	J:267519
Ndor1^{Tg(UBC-cre/ERT2)1Ejb}/Ndor1⁺ Rpl11^tm1.1Srn/Rpl11⁺ (involves: 129S6/SvEvTac * C57BL/6NCrl * CD-1)	abnormal erythropoiesis	J:292575
	abnormal proerythroblast morphology	J:292575
	anemia	J:292575
	decreased erythroblast number	J:292575
	decreased erythrocyte cell number	J:292575
	decreased hemoglobin content	J:292575
	macrocytosis	J:292575
Ndor1^{Tg(UBC-cre/ERT2)1Ejb}/Ndor1⁺ Rpl11^tm1.1Srn/Rpl11^tm1.1Srn (involves: 129S6/SvEvTac * C57BL/6NCrl * CD-1)	abnormal bone marrow cell morphology/development	J:292575
	anemia	J:292575
	decreased erythroblast number	J:292575
Ndor1^{Tg(UBC-cre/ERT2)1Ejb}/Ndor1⁺ Rraga^tm2Dmsa/Rraga^tm2Dmsa (involves: 129S/SvEv * 129S4/SvJae * C57BL/6)	decreased B cell number	J:213516
	enlarged spleen	J:213516
	increased monocyte cell number	J:213516
	myeloid hyperplasia	J:213516
Ndor1^{Tg(UBC-cre/ERT2)1Ejb}/Ndor1⁺ Stag2^tm1.1Alos/Y (involves: 129S6/SvEvTac * C57BL/6NCrl)	abnormal hematopoietic stem cell physiology	J:298088
	hematopoietic system phenotype	J:298088
Ndor1^{Tg(UBC-cre/ERT2)1Ejb}/Ndor1⁺ Stag2^tm1.1Alos/Stag2^tm1.1Alos (involves: 129S6/SvEvTac * C57BL/6NCrl)	abnormal hematopoietic stem cell physiology	J:298088
	hematopoietic system phenotype	J:298088
Ndrg2^tm1.1Hori/Ndrg2^tm1.1Hori (B6.129-Ndrg2^tm1.1Hori)	abnormal microglial cell chemotaxis	J:214686
Ndrg3^em1(IMPC)Mbp/Ndrg3⁺ (C57BL/6NCrl-Ndrg3^em1(IMPC)Mbp/Mmucd)	enlarged spleen	J:211773
Ndst1^b2b2230Clo/Ndst1^b2b2230Clo (C57BL/6J-Ndst1^b2b2230Clo)	thymus hypoplasia	J:175213
Ndst1^tm1.1Grob/Ndst1⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	hematopoietic system phenotype	J:155870
Ndst1^tm1Je/Ndst1^tm1Je Tg(Tek-cre)1Ywa/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)	abnormal leukocyte adhesion	J:100456
	abnormal leukocyte migration	J:100456
	impaired leukocyte tethering or rolling	J:100456
Ndst2^tm1Lkj/Ndst2^tm1Lkj (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal mast cell morphology	J:57121
	decreased mast cell degranulation	J:57121
	decreased mast cell histamine storage	J:57121
	decreased mast cell number	J:57121
	decreased mast cell protease storage	J:57121
Ndst2^tm1Rls/Ndst2^tm1Rls (Not Specified)	decreased mast cell degranulation	J:57120
	decreased mast cell histamine storage	J:57120
	decreased mast cell protease storage	J:57120
Ndst2^tm1Rls/Ndst2^tm1Rls (B6.Cg-Ndst2^tm1Rls)	abnormal mast cell differentiation	J:142880
Ndst3^tm1.1Grob/Ndst3^tm1.1Grob (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)	decreased CD8-positive, alpha-beta T cell number	J:138557
	decreased lymphocyte cell number	J:138557
Ndufs3^{tm1a(EUCOMM)Wtsi}/Ndufs3⁺ (B6JTyr;B6N-Ndufs3^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased erythrocyte cell number	J:175295
Ndufs4^tm1.1Rpa/Ndufs4^tm1.1Rpa (involves: 129S4/SvJaeSor)	microgliosis	J:161393
Ndufs4^tm1.1Rpa/Ndufs4^tm1.1Rpa (B6.129S4-Ndufs4^tm1.1Rpa)	microgliosis	J:190475
Ndufs4^tm1Rpa/Ndufs4^tm1Rpa (B6.129S4-Ndufs4^tm1Rpa)	microgliosis	J:190475
Ndufs4^tm1Rpa/Ndufs4^tm1Rpa Tg(Nes-cre)1Kln/0 (involves: 129S4/SvJaeSor * C57BL/6 * SJL)	microgliosis	J:161393
Ndufs4^tm1Rpa/Ndufs4^tm1Rpa Tg(Nes-cre)1Kln/0 (B6.Cg-Tg(Nes-cre)1Kln Ndufs4^tm1Rpa)	microgliosis	J:190475
Ndufs7^{tm1b(EUCOMM)Hmgu}/Ndufs7⁺ (C57BL/6N-Ndufs7^{tm1b(EUCOMM)Hmgu}/Bay)	decreased hemoglobin content	J:211773
Ndufv1^{tm1.1(KOMP)Vlcg}/Ndufv1⁺ (C57BL/6N-Ndufv1^{tm1.1(KOMP)Vlcg}/J)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
Necap2^em1(IMPC)J/Necap2^em1(IMPC)J (C57BL/6NJ-Necap2^em1(IMPC)J/Mmjax)	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
Nedd4^Gt(XA209)Byg/Nedd4^Gt(XA209)Byg (involves: 129P2/OlaHsd)	abnormal T cell activation	J:143560
	decreased B cell number	J:143560
	decreased IgG1 level	J:143560
	decreased IgG2b level	J:143560
	decreased IgG3 level	J:143560
	decreased T cell proliferation	J:143560
	increased CD4-positive, alpha-beta T cell number	J:143560
	increased CD8-positive, alpha-beta T cell number	J:143560
	increased IgM level	J:143560
	increased T cell number	J:143560
Nedd4^Gt(XB398)Byg/Nedd4^Gt(XB398)Byg (involves: 129P2/OlaHsd)	decreased B cell number	J:143560
	decreased IgG1 level	J:143560
	decreased IgG2b level	J:143560
	decreased IgG3 level	J:143560
	decreased T cell proliferation	J:143560
	increased CD4-positive, alpha-beta T cell number	J:143560
	increased CD8-positive, alpha-beta T cell number	J:143560
	increased IgM level	J:143560
	increased T cell number	J:143560
Nedd4^{tm2b(EUCOMM)Hmgu}/Nedd4⁺ (C57BL/6N-Nedd4^{tm2b(EUCOMM)Hmgu}/H)	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
Nedd4l^tm1Shkr/Nedd4l^tm1Shkr (involves: C57BL/6 * C57BL/6J)	increased neutrophil cell number	J:205657
Nedd9^m1Btlr/Nedd9^m1Btlr (C57BL/6J-Nedd9^m1Btlr)	decreased B-1a cell number	J:267702
Nedd9^m1Btlr/Nedd9^m1Btlr (C57BL/6J-Nedd9^m1Btlr)	decreased B-1b cell number	J:267702
Nedd9^tm1Miku/Nedd9^tm1Miku (B6.CBA-Nedd9^tm1Miku)	abnormal B cell number	J:116716
	abnormal follicular B cell physiology	J:116716
	abnormal leukocyte migration	J:116716
	abnormal T cell physiology	J:116716
	decreased lymphocyte cell number	J:116716
	decreased marginal zone B cell number	J:116716
	increased follicular B cell number	J:116716
	spleen hypoplasia	J:116716
Nefh^{tm1.1(KOMP)Vlcg}/Nefh^{tm1.1(KOMP)Vlcg} (C57BL/6N-Nefh^{tm1.1(KOMP)Vlcg}/J)	decreased mean corpuscular hemoglobin concentration	J:211773
Neil2^tm1.1Tkhz/Neil2^tm1.1Tkhz (involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NCrl)	increased neutrophil cell number	J:225791
Neil3^tm1Bjor/Neil3^tm1Bjor (involves: 129 * C57BL/6)	decreased microglial cell activation	J:180177
Nek1^kat-2J/Nek1^kat-2J (C57BL/6J-Nek1^kat-2J/J)	anemia	J:59839, J:37799
Nek1^kat-2J/Nek1^kat-2J (C57BL/6J-Nek1^kat-2J/J)	poikilocytosis	J:59839
Nek1^kat/Nek1^kat (involves: C3HeB/FeJLe * C57BL/6J * RBF/Dn)	abnormal erythrocyte osmotic lysis	J:59839
	anemia	J:59839
Nek7^M1Btlr/Nek7⁺ (C57BL/6J-Nek7^M1Btlr)	abnormal macrophage physiology	J:226677
Nek7^M1Btlr/Nek7⁺ (C57BL/6J-Nek7^M1Btlr)	hematopoietic system phenotype	J:226677
Nek7^M1Btlr/Nek7^M1Btlr (C57BL/6J-Nek7^M1Btlr)	abnormal macrophage physiology	J:226677
Nek7^M1Btlr/Nek7^M1Btlr (C57BL/6J-Nek7^M1Btlr)	hematopoietic system phenotype	J:226677
Nek8^m1Btlr/Nek8^m1Btlr (C57BL/6J-Nek8^m1Btlr)	decreased CD8-positive, alpha-beta T cell number	J:267544
	decreased effector memory CD4-positive, alpha-beta T cell number	J:267544
	decreased effector memory CD8-positive, alpha-beta T cell number	J:267544
	increased CD4-positive, alpha-beta T cell number	J:267544
Nek9^{tm1a(EUCOMM)Wtsi}/Nek9⁺ (C57BL/6N-Nek9^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased leukocyte cell number	J:211773
Nelfa^em1(IMPC)Tcp/Nelfa⁺ (C57BL/6NCrl-Nelfa^em1(IMPC)Tcp/Tcp)	increased red blood cell distribution width	J:211773
	increased spleen weight	J:211773
Nell1^em1(IMPC)Mbp/Nell1^em1(IMPC)Mbp (C57BL/6N-Nell1^em1(IMPC)Mbp/MbpMmucd)	decreased mean corpuscular hemoglobin	J:211773
Nemp1^em1(IMPC)Mbp/Nemp1^em1(IMPC)Mbp (C57BL/6NCrl-Nemp1^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
	enlarged spleen	J:211773
	increased red blood cell distribution width	J:211773
	increased spleen weight	J:211773
Nemp1^em1Hmc/Nemp1^em1Hmc (C57BL/6N-Nemp1^em1Hmc)	anemia	J:303621
Nemp2^em1(IMPC)Tcp/Nemp2^em1(IMPC)Tcp (C57BL/6N-Nemp2^em1(IMPC)Tcp/Tcp)	abnormal spleen morphology	J:211773
Neu1^a/Neu1^a (SM/J)	abnormal Kupffer cell morphology	J:147881
Neu1^tm1Adz/Neu1^tm1Adz (either: (involves: 129S1/Sv * C57BL/6) or (involves: 129S1/Sv * NMRI))	abnormal Kupffer cell morphology	J:76937
	abnormal microglial cell morphology	J:76937
	enlarged spleen	J:76937
	extramedullary hematopoiesis	J:76937
	spleen hyperplasia	J:76937
Neurl2^{tm1.1(KOMP)Vlcg}/Neurl2^{tm1.1(KOMP)Vlcg} (C57BL/6N-Neurl2^{tm1.1(KOMP)Vlcg}/J)	decreased leukocyte cell number	J:211773
Neurl4^em1(IMPC)Mbp/Neurl4^em1(IMPC)Mbp (C57BL/6NCrl-Neurl4^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	decreased leukocyte cell number	J:211773
	decreased neutrophil cell number	J:211773
	enlarged spleen	J:211773
	small spleen	J:211773
Nexmif^em1(IMPC)Tcp/Y (C57BL/6N-Nexmif^em1(IMPC)Tcp/Tcp)	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
	increased monocyte cell number	J:211773
	increased red blood cell distribution width	J:211773
	small spleen	J:211773
Nexmif^em1(IMPC)Tcp/Nexmif⁺ (C57BL/6N-Nexmif^em1(IMPC)Tcp/Tcp)	increased neutrophil cell number	J:211773
Nf1^tm1Fcr/Nf1⁺ Pten^tm1Hwu/Pten^tm1Hwu Tg(Mx1-cre)1Cgn/0 (B6.Cg-Tg(Mx1-cre)1Cgn Nf1^tm1Fcr Pten^tm1Hwu)	abnormal hematopoietic stem cell morphology	J:232645
	abnormal hemopoiesis	J:232645
	abnormal spleen morphology	J:232645
	anemia	J:232645
	decreased B cell number	J:232645
	decreased bone marrow cell number	J:232645
	decreased hemoglobin content	J:232645
	decreased lymphocyte cell number	J:232645
	decreased T cell number	J:232645
	enlarged spleen	J:232645
	increased granulocyte number	J:232645
	increased leukocyte cell number	J:232645
	increased macrophage cell number	J:232645
	increased monocyte cell number	J:232645
	increased spleen weight	J:232645
	thrombocytosis	J:232645
Nf1^tm1Fcr/Nf1^tm1Par Tg(Tek-cre)1Ywa/0 (involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)	abnormal spleen morphology	J:114455
	absent spleen germinal center	J:114455
	enlarged spleen	J:114455
	spleen fibrosis	J:114455
Nf1^tm1Par/Nf1^tm1Fcr Tg(GFAP-cre)#Gtm/0 (involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	abnormal microglial cell morphology	J:165209
Nf1^tm1Par/Nf1^tm1Par Tg(Mx1-cre)1Cgn/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	abnormal bone marrow cell morphology/development	J:90973
	abnormal common myeloid progenitor cell morphology	J:90973
	abnormal definitive hematopoiesis	J:90973
	abnormal hematopoietic cell number	J:90973
	abnormal myeloid leukocyte morphology	J:90973
	abnormal myelopoiesis	J:90973
	abnormal spleen morphology	J:90973
	enlarged spleen	J:90973
	increased granulocyte number	J:90973
	increased leukocyte cell number	J:90973
	increased lymphocyte cell number	J:90973
	increased monocyte cell number	J:90973
	increased neutrophil cell number	J:90973
Nf1^tm1Par/Nf1^tm1Par Tg(Prrx1-cre)1Cjt/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * C57BL/6N * SJL/J)	increased osteoclast cell number	J:193350
Nf1^tm1Tyj/Nf1⁺ (involves: 129S2/SvPas)	abnormal mast cell physiology	J:142439
Nf1^tm1Tyj/Nf1⁺ (involves: 129S2/SvPas)	increased mast cell degranulation	J:142439
Nf1^tm1Tyj/Nf1⁺ Pak1^tm1Cher/Pak1^tm1Cher (involves: 129S2/SvPas * C57BL/6)	abnormal mast cell physiology	J:142439
Nf1^tm1Tyj/Nf1⁺ Trp53^tm1Tyj/Trp53⁺ (involves: 129S2/SvPas * C57BL/6)	spleen hyperplasia	J:228258
Nfam1^{em1(IMPC)Ccpcz}/Nfam1^{em1(IMPC)Ccpcz} (C57BL/6N-Nfam1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Nfat5^tm1.1Joar/Nfat5^tm1.1Joar Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2 * SJL)	abnormal T cell physiology	J:148271
Nfat5^{tm1b(KOMP)Wtsi}/Nfat5⁺ (C57BL/6N-Nfat5^{tm1b(KOMP)Wtsi}/J)	decreased hematocrit	J:211773
Nfat5^tm1Skc/Nfat5^tm1Skc (involves: 129S7/SvEvBrd * C57BL/6)	anemia	J:175527
Nfat5^tm1Snh/Nfat5⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal immunoglobulin level	J:91482
	decreased IgG level	J:91482
	decreased T cell proliferation	J:91482
	spleen hypoplasia	J:91482
	thymus hypoplasia	J:91482
Nfatc1^tm1Glm/Nfatc1^tm2Glm (chimera involves: 129S2/SvPas)	abnormal B cell physiology	J:78376
	abnormal immunoglobulin level	J:78376
	abnormal lymphocyte cell number	J:78376
	abnormal lymphocyte physiology	J:78376
	abnormal T cell physiology	J:78376
	abnormal T-helper 2 physiology	J:78376
	decreased double-positive T cell number	J:78376
	decreased IgE level	J:78376
	decreased IgG1 level	J:78376
	decreased IgG2b level	J:78376
	decreased IgG3 level	J:78376
	decreased immunoglobulin level	J:78376
	decreased lymphocyte cell number	J:78376
	increased double-negative T cell number	J:78376
	increased IgA level	J:78376
	increased IgG2a level	J:78376
	increased IgM level	J:78376
	increased immunoglobulin level	J:78376
Nfatc1^tm1Mak/Nfatc1^tm1Mak (involves: 129P2/OlaHsd * C57BL/6)	anemia	J:46399
Nfatc1^tm1Rao/Nfatc1^tm1Rao Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: BALB/c)	abnormal B cell physiology	J:177319
	abnormal class switch recombination	J:177319
	abnormal marginal zone B cell physiology	J:177319
	decreased B cell number	J:177319
	decreased B cell proliferation	J:177319
	decreased B-1a cell number	J:177319
	increased B cell apoptosis	J:177319
Nfatc1^tm1Rao/Nfatc1^tm1Rao Nfatc2^tm1Rao/Nfatc2^tm1Rao Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: BALB/c)	abnormal B cell physiology	J:177319
Nfatc1^tm1Rao/Nfatc1^tm1Rao Tg(Fcer2a-cre)5Mbu/0 (involves: C57BL/6 * CBA)	abnormal B cell physiology	J:177319
	abnormal class switch recombination	J:177319
	decreased B cell proliferation	J:177319
	decreased IgG2a level	J:177319
	decreased IgG3 level	J:177319
	decreased IgM level	J:177319
	increased IgM level	J:177319
Nfatc1^tm3Glm/Nfatc1^tm3Glm Sh3bp2^tm1Bjro/Sh3bp2^tm1Bjro Tg(Mx1-cre)1Cgn/0 (involves: 129S4/SvJae * C57BL/6 * CBA)	abnormal osteoclast differentiation	J:144598
	decreased osteoclast cell number	J:144598
Nfatc1^tm3Glm/Nfatc1^tm3Glm Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	abnormal osteoclast differentiation	J:144598
	decreased osteoclast cell number	J:144598
Nfatc2^tm1Glm/Nfatc2^tm1Glm Nfatc3^tm1Glm/Nfatc3^tm1Glm (involves: 129S2/SvPas)	abnormal lymphocyte cell number	J:51339
	decreased T cell number	J:51339
	enlarged spleen	J:51339
	increased B cell number	J:51339
	increased T cell number	J:51339
Nfatc2^tm1Rao/Nfatc2^tm1Rao (B6.Cg-Nfatc2^tm1Rao)	abnormal mast cell physiology	J:78089
Nfatc2^tm1Rao/Nfatc2^tm1Rao Nfatc3^tm1Grc/Nfatc3^tm1Grc Tg(Lck-cre)I57Jxm/0 (involves: ICR)	abnormal double-negative T cell morphology	J:141917
	abnormal T cell differentiation	J:141917
	increased T cell apoptosis	J:141917
Nfatc2^tm1Srf/Nfatc2^tm1Srf (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell number	J:110686
	abnormal B cell physiology	J:110686
	abnormal lymphocyte physiology	J:110686
	abnormal spleen germinal center morphology	J:110686
	abnormal T cell physiology	J:110686
	abnormal thymus involution	J:110686
	enlarged spleen	J:110686
	enlarged thymus	J:110686
	increased activated T cell number	J:110686
	thymus hyperplasia	J:110686
Nfatc2^tm1Srf/Nfatc2^tm1Srf (involves: 129P2/OlaHsd)	abnormal T cell physiology	J:45252
	enlarged spleen	J:45252
	increased B cell number	J:45252
	increased lymphocyte cell number	J:45252
	increased T cell number	J:45252
Nfatc2^tm1Srf/Nfatc2^tm1Srf (B6.Cg-Nfatc2^tm1Srf)	abnormal CD4-positive, alpha-beta T cell physiology	J:86279
	abnormal T-helper 1 physiology	J:86279
	abnormal T-helper 2 physiology	J:86279
	increased IgE level	J:86279
	increased IgG1 level	J:86279
	increased immunoglobulin level	J:86279
Nfatc2ip^em1(IMPC)Ics/Nfatc2ip^em1(IMPC)Ics (C57BL/6N-Nfatc2ip^em1(IMPC)Ics/Ics)	increased eosinophil cell number	J:211773
Nfatc2ip^tm1.1Glm/Nfatc2ip^tm1.1Glm (either: B6.129-Nfatc2ip^tm1.1Glm or C.129-Nfatc2ip^tm1.1Glm)	abnormal leukocyte morphology	J:157559
	abnormal T-helper 2 physiology	J:157559
	decreased mast cell number	J:157559
	decreased T-helper 2 cell number	J:157559
Nfatc3^tm1Glm/Nfatc3^tm1Glm Nfatc4^tm1Jmk/Nfatc4^tm1Jmk (involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6)	anemia	J:84138
Nfatc3^tm1Glm/Nfatc3^tm1Glm Tg(DO11.10)10Dlo/? (involves: 129S2/SvPas * BALB/c * C3H * C57BL/6)	decreased double-positive T cell number	J:50124
	increased double-negative T cell number	J:50124
	small thymus	J:50124
Nfatc3^tm1Grc/Nfatc3^tm1Grc Tg(Lck-cre)I57Jxm/0 (involves: ICR)	abnormal T cell differentiation	J:141917
	decreased CD4-positive, alpha-beta T cell number	J:141917
	decreased CD8-positive, alpha-beta T cell number	J:141917
	decreased thymocyte number	J:141917
	increased double-negative T cell number	J:141917
	increased T cell apoptosis	J:141917
	thymus hypoplasia	J:141917
Nfe2^tm1Sho/Nfe2⁺ (C.129S4-Nfe2^tm1Sho)	enlarged spleen	J:125982
Nfe2^tm1Sho/Nfe2^tm1Sho (involves: 129/Sv * 129S4/SvJae)	abnormal hematopoietic system physiology	J:106670, J:20132
	abnormal megakaryocyte morphology	J:106670, J:20132
	absent platelets	J:20132
	anemia	J:20132
	decreased hemoglobin content	J:20132
	increased megakaryocyte cell number	J:20132
	increased osteoclast cell number	J:111270
	microcytosis	J:20132
	thrombocytopenia	J:106670
Nfe2^tm1Sho/Nfe2^tm1Sho (involves: 129S4/SvJae * C57BL/6J)	abnormal hematopoietic system physiology	J:20132
	abnormal megakaryocyte morphology	J:20132
	absent platelets	J:20132
	anemia	J:20132
	decreased hemoglobin content	J:20132
	enhanced megakaryocyte emperipolesis	J:20132
	increased megakaryocyte cell number	J:20132
	microcytosis	J:20132
Nfe2^tm1Sho/Nfe2^tm1Sho Nfe2l2^tm1Ney/Nfe2l2^tm1Ney (involves: 129/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6)	anemia	J:47440
	thrombocytopenia	J:47440
Nfe2l1^tm1Tow/Nfe2l1^tm1Tow (involves: 129S1/Sv * 129X1/SvJ)	abnormal hematopoietic system morphology/development	J:39447
Nfe2l1^tm1Ywk/Nfe2l1^tm1Ywk (involves: 129X1/SvJ * C57BL/6J)	abnormal erythropoiesis	J:46990
	anemia	J:46990
	decreased hematocrit	J:46990
	increased nucleated erythrocyte cell number	J:46990
Nfe2l2^{em1(IMPC)Ccpcz}/Nfe2l2^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Nfe2l2^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased mean platelet volume	J:211773
Nfe2l2^tm1Mym/Nfe2l2^tm1Mym (involves: 129P2/OlaHsd * ICR)	abnormal macrophage physiology	J:118068
	decreased CD4-positive, alpha-beta T cell number	J:104016
	decreased T cell number	J:104016
	hematopoietic system phenotype	J:41943
	increased IgG level	J:104016
	increased IgM level	J:104016
	increased spleen weight	J:104016
Nfe2l2^tm1Mym/Nfe2l2^tm1Mym (involves: 129P2/OlaHsd * C57BL/6)	abnormal leukocyte adhesion	J:150597
Nfe2l2^tm1Ney/Nfe2l2^tm1Ney (involves: 129X1/SvJ * C57BL/6)	hematopoietic system phenotype	J:47440
Nfe2l2^tm1Ywk/Nfe2l2^tm1Ywk (involves: 129X1/SvJ)	abnormal erythrocyte physiology	J:91407
	abnormal splenocyte physiology	J:91407
	acanthocytosis	J:91407
	anisocytosis	J:91407
	decreased erythrocyte cell number	J:91407
	decreased hematocrit	J:91407
	decreased hemoglobin content	J:91407
	enlarged spleen	J:91407
	hematopoietic system phenotype	J:37053
	hemolytic anemia	J:91407
	increased macrophage cell number	J:100106
	increased number of Howell-Jolly bodies	J:91407
	increased spleen weight	J:91407
	increased splenocyte apoptosis	J:91407
	poikilocytosis	J:91407
	reticulocytosis	J:91407
	schistocytosis	J:91407
	thrombocytopenia	J:91407
Nfe2l2^tm1Ywk/Nfe2l2^tm1Ywk (B6.129X1-Nfe2l2^tm1Ywk/J)	abnormal neutrophil physiology	J:233699
Nfil3^{tm1.1(KOMP)Vlcg}/Nfil3^{tm1.1(KOMP)Vlcg} (C57BL/6N-Nfil3^{tm1.1(KOMP)Vlcg}/Ucd)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	increased spleen weight	J:211773
	small thymus	J:211773
Nfil3^tm1.1Brad/Nfil3⁺ (B6.Cg-Nfil3^tm1.1Brad)	decreased NK cell number	J:152774
Nfil3^tm1.1Brad/Nfil3^tm1.1Brad (B6.Cg-Nfil3^tm1.1Brad)	abnormal NK cell differentiation	J:152774
	decreased NK cell number	J:152774
	impaired natural killer cell mediated cytotoxicity	J:152774
	increased memory T cell number	J:152774
	increased NK T cell number	J:152774
Nfil3^tm1.2Kubo/Nfil3^tm1.2Kubo Tg(Itgax-cre)1-1Reiz/0 (involves: 129 * C57BL/6 * CBA)	hematopoietic system phenotype	J:334296
Nfil3^tm1Look/Nfil3^tm1Look (B6.129X1-Nfil3^tm1Look)	abnormal NK cell differentiation	J:155677
	decreased NK cell number	J:155677
	impaired natural killer cell mediated cytotoxicity	J:155677
Nfil3^tm1Pbro/Nfil3^tm1Pbro (involves: 129S6/SvEvTac * C57BL/6)	abnormal class switch recombination	J:156521
	decreased IgE level	J:156521
	decreased IgG1 level	J:156521
Nfil3^tm1Pbro/Nfil3^tm1Pbro (B6.129S6-Nfil3^tm1Pbro)	abnormal leukocyte morphology	J:209365
	abnormal plasma cell morphology	J:209365
	decreased NK cell number	J:209365
	increased macrophage cytokine production	J:209365
	increased T-helper 17 cell number	J:209365
Nfkb1^M1Btlr/Nfkb1⁺ (C57BL/6J-Nfkb1^M1Btlr)	decreased IgG level	J:216054
Nfkb1^M1Btlr/Nfkb1^M1Btlr (C57BL/6J-Nfkb1^M1Btlr)	decreased IgG level	J:216054
Nfkb1^m2Btlr/Nfkb1⁺ (C57BL/6J-Nfkb1^m2Btlr)	decreased central memory CD4-positive, alpha-beta T cell number	J:254822
	decreased effector memory CD4-positive, alpha-beta T cell number	J:254822
	decreased IgM level	J:254822
Nfkb1^m2Btlr/Nfkb1^m2Btlr (C57BL/6J-Nfkb1^m2Btlr)	decreased CD8-positive, naive alpha-beta T cell number	J:254822
	decreased central memory CD4-positive, alpha-beta T cell number	J:254822
	decreased effector memory CD4-positive, alpha-beta T cell number	J:254822
	decreased IgE level	J:254822
	decreased IgG level	J:254822
	decreased IgM level	J:254822
	increased central memory CD8 positive, alpha-beta T cell number	J:254822
Nfkb1^M3Btlr/Nfkb1⁺ (C57BL/6J-Nfkb1^M3Btlr)	decreased IgE level	J:254821
	decreased IgG level	J:254821
	increased central memory CD8 positive, alpha-beta T cell number	J:254821
Nfkb1^M3Btlr/Nfkb1^M3Btlr (C57BL/6J-Nfkb1^M3Btlr)	decreased IgE level	J:254821
	decreased IgG level	J:254821
	increased central memory CD8 positive, alpha-beta T cell number	J:254821
Nfkb1^M4Btlr/Nfkb1^M4Btlr (C57BL/6J-Nfkb1^M4Btlr)	decreased B-1 B cell number	J:265169
Nfkb1^M5Btlr/Nfkb1^M5Btlr (C57BL/6J-Nfkb1^M5Btlr)	decreased B-1a cell number	J:272117
Nfkb1^M5Btlr/Nfkb1^M5Btlr (C57BL/6J-Nfkb1^M5Btlr)	decreased IgE level	J:272117
Nfkb1^M6Btlr/Nfkb1^M6Btlr (C57BL/6J-Nfkb1^M6Btlr)	decreased IgE level	J:272148
Nfkb1^{tm1a(KOMP)Wtsi}/Nfkb1^{tm1a(KOMP)Wtsi} (B6JTyr;B6N-Nfkb1^{tm1a(KOMP)Wtsi}/Wtsi)	decreased mean corpuscular hemoglobin concentration	J:175295
	increased leukocyte cell number	J:175295, J:165965
Nfkb1^{tm1a(KOMP)Wtsi}/Nfkb1^{tm1a(KOMP)Wtsi} (involves: C57BL/6 * C57BL/6N)	decreased IgA level	J:213427
	decreased IgG1 level	J:213427
	decreased NK cell number	J:213427
	decreased regulatory T cell number	J:213427
	increased leukocyte cell number	J:213427
Nfkb1^tm1Bal/Nfkb1^tm1Bal (B6;129P-Nfkb1^tm1Bal/J)	abnormal CD4-positive, alpha-beta T cell physiology	J:118907
Nfkb1^tm1Bal/Nfkb1^tm1Bal (B6;129P-Nfkb1^tm1Bal/J)	abnormal macrophage physiology	J:118907
Nfkb1^tm1Bal/Nfkb1^tm1Bal (involves: 129P2/OlaHsd * C57BL/6)	abnormal class switch recombination	J:30268
	decreased B cell proliferation	J:37184, J:30268
	decreased IgA level	J:37184
	decreased IgE level	J:37184
	decreased IgG1 level	J:37184
	decreased IgM level	J:30268
	decreased immunoglobulin level	J:37184
	decreased myeloid dendritic cell number	J:77049
Nfkb1^tm1Bal/Nfkb1^tm1Bal (involves: 129P2/OlaHsd)	decreased marginal zone B cell number	J:65246
Nfkb1^tm1Bal/Nfkb1^tm1Bal (B6.Cg-Nfkb1^tm1Bal/J)	abnormal B cell physiology	J:113556
Nfkb1^tm1Bal/Nfkb1^tm1Bal Nfkb2^tm1Sbn/Nfkb2^tm1Sbn (involves: 129P2/OlaHsd * 129S4/SvJae)	abnormal macrophage physiology	J:45119
	abnormal osteoclast differentiation	J:45119
	abnormal spleen morphology	J:45119
	abnormal thymus cortex morphology	J:45119
	abnormal thymus medulla morphology	J:45119
	absent spleen white pulp	J:45119
	arrested B cell differentiation	J:45119
	decreased B cell number	J:45119
	decreased CD4-positive, alpha-beta T cell number	J:45119
	decreased CD8-positive, alpha-beta T cell number	J:45119
	decreased dendritic cell number	J:45119
	decreased double-positive T cell number	J:45119
	decreased mature B cell number	J:45119
	decreased osteoclast cell number	J:45119
	decreased single-positive T cell number	J:45119
	decreased T cell number	J:45119
	increased granulocyte number	J:45119
	increased macrophage cell number	J:45119
	thymus hypoplasia	J:45119
Nfkb1^tm1Bal/Nfkb1^tm1Bal Rela^tm1Bal/Rela^tm1Bal (involves: 129P2/OlaHsd * 129S4/SvJae)	abnormal dendritic cell differentiation	J:113514
	decreased dendritic cell number	J:113514
Nfkb1^tm1Bal/Nfkb1^tm1Bal Tg(Tnfsf13b)1Fma/? (B6.Cg-Nfkb1^tm1Bal Tg(Tnfsf13b)1Fma)	abnormal B cell activation	J:113556
	abnormal class switch recombination	J:113556
	decreased marginal zone B cell number	J:113556
	increased transitional stage B cell number	J:113556
Nfkb1^tm1Brv/Nfkb1^tm1Brv (involves: 129S1/Sv)	abnormal bone marrow cell morphology/development	J:46912
	abnormal lymphocyte physiology	J:46912
	decreased erythrocyte cell number	J:46912
	decreased IgG3 level	J:46912
	decreased single-positive T cell number	J:46912
	decreased T cell proliferation	J:46912
	enlarged spleen	J:46912
	extramedullary hematopoiesis	J:46912
	increased B cell proliferation	J:46912
	increased IgE level	J:46912
	increased IgG1 level	J:46912
	increased immunoglobulin level	J:46912
	myeloid hyperplasia	J:46912
Nfkb1^tm1Brv/Nfkb1^tm1Brv (involves: 129S1/Sv * C57BL/6)	decreased osteoclast cell number	J:44112
Nfkb1^tm1Brv/Nfkb1^tm1Brv Nfkb2^tm1Brv/Nfkb2⁺ (involves: 129S1/Sv * C57BL/6)	abnormal osteoclast differentiation	J:44112
	decreased osteoclast cell number	J:44112
Nfkb1^tm1Brv/Nfkb1^tm1Brv Nfkb2^tm1Brv/Nfkb2^tm1Brv (involves: 129S1/Sv * C57BL/6)	abnormal osteoclast differentiation	J:44112
	decreased osteoclast cell number	J:44112
	increased macrophage cell number	J:44112
Nfkb1^tm1Sley/Nfkb1^tm1Sley (involves: 129S4/SvJae * 129S8/SvEv)	decreased memory T cell number	J:142340
	decreased regulatory T cell number	J:142340
	decreased T cell proliferation	J:142340
Nfkb1^tm1Sley/Nfkb1^tm1Sley (involves: 129S4/SvJae * 129S8/SvEv * C57BL/6)	decreased memory T cell number	J:142340
	decreased NK T cell number	J:142340
	decreased regulatory T cell number	J:142340
Nfkb2^Lym1/Nfkb2⁺ (BALB/c-Nfkb2^Lym1)	abnormal spleen white pulp morphology	J:154812
Nfkb2^Lym1/Nfkb2⁺ (BALB/c-Nfkb2^Lym1)	increased lymphocyte cell number	J:154812
Nfkb2^Lym1/Nfkb2⁺ (involves: BALB/c)	abnormal B cell differentiation	J:188560
Nfkb2^Lym1/Nfkb2^Lym1 (involves: BALB/c)	abnormal class switch recombination	J:154812
	abnormal osteoclast differentiation	J:154812
	abnormal plasma cell differentiation	J:154812
	abnormal spleen follicular dendritic cell network	J:154812
	abnormal spleen periarteriolar lymphoid sheath morphology	J:154812
	abnormal spleen primary B follicle morphology	J:154812
	abnormal spleen white pulp morphology	J:154812
	abnormal T cell differentiation	J:154812
	abnormal thymus cell ratio	J:154812
	abnormal thymus physiology	J:154812
	abnormal thymus size	J:154812
	decreased B cell proliferation	J:154812
	decreased follicular B cell number	J:154812
	decreased IgA level	J:154812
	decreased IgG1 level	J:154812
	decreased IgG2b level	J:154812
	decreased IgM level	J:154812
	decreased immunoglobulin level	J:154812
	decreased marginal zone B cell number	J:154812
	decreased mature B cell number	J:154812
	decreased transitional stage B cell number	J:154812
	enlarged spleen	J:154812
	extramedullary hematopoiesis	J:154812
	hematopoietic system phenotype	J:154812
	increased CD4-positive, alpha-beta T cell number	J:154812
	increased CD8-positive, alpha-beta T cell number	J:154812
	increased double-negative T cell number	J:154812
	increased double-positive T cell number	J:154812
	increased spleen red pulp amount	J:154812
	increased spleen weight	J:154812
	increased transitional stage B cell number	J:154812
Nfkb2^m2Btlr/Nfkb2^m2Btlr (C57BL/6J-Nfkb2^m2Btlr)	increased B-1a cell number	J:221493
Nfkb2^m3Btlr/Nfkb2^m3Btlr (C57BL/6J-Nfkb2^m3Btlr)	abnormal B cell differentiation	J:274960
	abnormal CD4-positive T cell differentiation	J:274960
	abnormal CD8-positive, alpha-beta T cell differentiation	J:274960
	abnormal T cell differentiation	J:274960
	decreased B cell number	J:274960
	decreased CD4-positive, alpha-beta T cell number	J:274960
	decreased effector memory CD8-positive, alpha-beta T cell number	J:274960
	decreased NK cell number	J:274960
	increased B-1 B cell number	J:274960
	increased CD4-positive, alpha-beta T cell number	J:274960
	increased CD8-positive, alpha-beta T cell number	J:274960
	increased CD8-positive, naive alpha-beta T cell number	J:274960
	increased T cell number	J:274960
Nfkb2^M4Btlr/Nfkb2^M4Btlr (C57BL/6J-Nfkb2^M4Btlr)	increased CD4-positive, alpha-beta T cell number	J:274961
	increased CD8-positive, alpha-beta T cell number	J:274961
	increased T cell number	J:274961
Nfkb2^m5Btlr/Nfkb2^m5Btlr (C57BL/6J-Nfkb2^m5Btlr)	increased B-1 B cell number	J:274962
Nfkb2^tm1Brv/Nfkb2^tm1Brv (involves: 129S1/Sv * C57BL/6)	abnormal definitive hematopoiesis	J:43469
	abnormal lymphocyte cell number	J:43469
	abnormal T cell number	J:43469
	abnormal T cell subpopulation ratio	J:43469
	abnormal thymus corticomedullary boundary morphology	J:43469
	anemia	J:43469
	decreased double-positive T cell number	J:43469
	decreased spleen weight	J:43469
	increased B cell proliferation	J:43469
	increased granulocyte number	J:43469
	increased T cell proliferation	J:43469
	intermingled spleen red and white pulp	J:43469
	spleen atrophy	J:43469
	spleen hypoplasia	J:43469
	thymus atrophy	J:43469
Nfkb2^tm1Rsch/Nfkb2^tm1Rsch (involves: 129P2/OlaHsd)	abnormal myeloid dendritic cell morphology	J:77049
	decreased B cell number	J:77049
	decreased dendritic cell number	J:77049
	decreased myeloid dendritic cell number	J:77049
	increased plasmacytoid dendritic cell number	J:77049
Nfkb2^tm1Sbn/Nfkb2^tm1Sbn (involves: 129S4/SvJae * C57BL/6)	abnormal class switch recombination	J:45437
	abnormal immunoglobulin level	J:45437
	abnormal lymphocyte cell number	J:45437
	abnormal metallophilic macrophage morphology	J:45437
	abnormal spleen B cell follicle morphology	J:45437
	abnormal spleen marginal zone macrophage morphology	J:45437
	abnormal spleen marginal zone morphology	J:45437
	abnormal spleen white pulp morphology	J:45437
	absent spleen germinal center	J:45437
	decreased B cell number	J:45437
	decreased IgA level	J:45437
	decreased IgG1 level	J:45437
	decreased IgG2a level	J:45437
	decreased IgG2b level	J:45437
	increased IgM level	J:45437
	increased T cell number	J:45437
Nfkb2^tm2Brv/Nfkb2^tm2Brv (involves: 129S1/Sv * C57BL/6)	abnormal metallophilic macrophage morphology	J:76380
	abnormal spleen morphology	J:76380
	absent spleen germinal center	J:76380
	absent spleen marginal zone	J:76380
	decreased B cell number	J:76380
	decreased B cell proliferation	J:76380
	decreased IgA level	J:76380
	decreased IgG1 level	J:76380
	decreased IgG3 level	J:76380
	increased CD4-positive, alpha-beta T cell number	J:76380
	increased CD8-positive, alpha-beta T cell number	J:76380
	increased IgG2a level	J:76380
	increased IgM level	J:76380
	increased splenocyte apoptosis	J:76380
Nfkb2^tm2Brv/Nfkb2^tm2Brv (involves: 129S1/Sv)	abnormal gamma-delta T cell morphology	J:169863
Nfkb2^tm2Brv/Nfkb2^tm2Brv (involves: 129S1/Sv)	decreased gamma-delta T cell number	J:169863
Nfkb2^tm2Brv/Nfkb2^tm2Brv Tg(Tnfsf13b)1Fma/? (B6.Cg-Nfkb2^tm2Brv Tg(Tnfsf13b)1Fma)	abnormal B cell activation	J:113556
	absent spleen marginal zone	J:113556
	decreased marginal zone B cell number	J:113556
Nfkb2^xdr/Nfkb2^xdr (C57BL/6JSfdAnu-Nfkb2^xdr/Anu)	abnormal metallophilic macrophage morphology	J:79725
	abnormal spleen follicular dendritic cell network	J:79725
	abnormal spleen morphology	J:79725
	abnormal spleen secondary B follicle morphology	J:79725
	decreased B-2 B cell number	J:79725
	decreased follicular B cell number	J:79725
	decreased marginal zone B cell number	J:79725
	decreased mature B cell number	J:79725
	decreased transitional stage T2 B cell number	J:79725
	hematopoietic system phenotype	J:79725
	increased B-1 B cell number	J:79725
Nfkb2^xdr/Nfkb2^xdr (involves: C57BL/6JSfdAnu * C57BL/10Sg * C57BR/cd * NOD)	decreased B cell number	J:79725
Nfkbia^tm1.1Kbp/Nfkbia^tm1.1Kbp (involves: 129P2/OlaHsd * C57BL/6)	abnormal erythropoiesis	J:97945
	abnormal granulocyte morphology	J:97945
	increased bone marrow cell number	J:97945
	increased granulocyte number	J:97945
Nfkbia^tm1.1Pjc/Nfkbia^tm1.1Pjc (involves: C57BL/6)	abnormal T cell activation	J:163686
	abnormal T cell number	J:163686
	decreased CD4-positive, alpha-beta T cell number	J:163686
	decreased CD8-positive, alpha-beta T cell number	J:163686
	increased activated T cell number	J:163686
	increased double-positive T cell number	J:163686
	increased memory T cell number	J:163686
	increased T cell apoptosis	J:163686
	increased T cell proliferation	J:163686
	increased thymocyte number	J:163686
Nfkbia^tm1.1Smiy/Nfkbia⁺ (B6.129-Nfkbia^tm1.1Smiy)	decreased B cell number	J:168977
	decreased follicular B cell number	J:168977
	decreased marginal zone B cell number	J:168977
	decreased transitional stage T2 B cell number	J:168977
	increased pro-B cell number	J:168977
Nfkbia^tm1.1Smiy/Nfkbia^tm1.1Smiy (B6.129-Nfkbia^tm1.1Smiy)	abnormal B cell differentiation	J:168977
	abnormal marginal zone B cell morphology	J:168977
	decreased B cell number	J:168977
	decreased B cell proliferation	J:168977
	decreased B-2 B cell number	J:168977
	decreased CD4-positive, alpha-beta memory T cell number	J:168977
	decreased follicular B cell number	J:168977
	decreased IgA level	J:168977
	decreased IgG1 level	J:168977
	decreased IgG2b level	J:168977
	decreased marginal zone B cell number	J:168977
	decreased mature B cell number	J:168977
	decreased regulatory T cell number	J:168977
	decreased transitional stage T2 B cell number	J:168977
	increased activation-induced B cell apoptosis	J:168977
	increased immature B cell number	J:168977
	increased pre-B cell number	J:168977
	increased pro-B cell number	J:168977
Nfkbia^tm1Bal/Nfkbia^tm1Bal (involves: 129S4/SvJae * C57BL/6J)	abnormal granulocyte differentiation	J:30058
	decreased double-positive T cell number	J:30058
	increased leukocyte cell number	J:30058
	spleen atrophy	J:30058
	thymus atrophy	J:30058
Nfkbia^tm1Bal/Nfkbia^tm1Bal Nfkbie^tm1Syme/Nfkbie^tm1Syme (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA/2)	abnormal B cell differentiation	J:88142
	abnormal T cell differentiation	J:88142
	decreased immature B cell number	J:88142
	decreased pre-B cell number	J:88142
	increased B cell apoptosis	J:88142
	increased T cell apoptosis	J:88142
Nfkbia^tm1Fey/Nfkbia^tm1Fey (involves: 129S6/SvEvTac * C57BL/6)	abnormal B cell differentiation	J:110817
	absent spleen germinal center	J:110817
	anemia	J:110817
	decreased double-negative T cell number	J:110817
	decreased T cell proliferation	J:110817
	decreased thymocyte number	J:110817
	increased B cell proliferation	J:110817
	increased IgA level	J:110817
	increased IgE level	J:110817
	increased IgG level	J:110817
	increased single-positive T cell number	J:110817
	small spleen	J:110817
	thymus atrophy	J:110817
Nfkbia^tm1Kbp/Nfkbia^tm1Kbp Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6)	hematopoietic system phenotype	J:97945
Nfkbia^tm1Stw/Nfkbia^tm1Stw (involves: 129S1/Sv)	abnormal erythropoiesis	J:32527
	abnormal macrophage physiology	J:32527
	abnormal myelopoiesis	J:32527
	extramedullary hematopoiesis	J:32527
	increased macrophage cell number	J:32527
	increased monocyte cell number	J:32527
Nfkbib^tm1.2Rsch/Nfkbib^tm1.2Rsch (B6.129P2-Nfkbib^tm1.2Rsch)	decreased B cell number	J:176877
	increased macrophage cell number	J:176877
	increased marginal zone B cell number	J:176877
	increased memory T cell number	J:176877
Nfkbid^m1Btlr/Nfkbid^m1Btlr (involves: C57BL/6J)	abnormal class switch recombination	J:185495
	absent marginal zone B cells	J:185495
	decreased B cell proliferation	J:185495
	decreased B-1 B cell number	J:185495
	decreased B-1a cell number	J:185495
	decreased IgG1 level	J:185495
	decreased IgG3 level	J:185495
	decreased IgG level	J:185495
	decreased IgM level	J:185495
	increased B cell apoptosis	J:185495
Nfkbid^{tm1a(EUCOMM)Wtsi}/Nfkbid⁺ (C57BL/6N-Nfkbid^{tm1a(EUCOMM)Wtsi}/Cnrm)	decreased B cell number	J:165965
Nfkbid^{tm1a(EUCOMM)Wtsi}/Nfkbid^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6N)	abnormal class switch recombination	J:185495
	decreased IgG level	J:185495
	decreased IgM level	J:185495
Nfkbid^tm1Clay/Nfkbid^tm1Clay (involves: 129S6/SvEvTac * C57BL/6)	abnormal NK cell physiology	J:132071
	abnormal thymocyte activation	J:132071
	decreased T cell proliferation	J:132071
Nfkbie^tm1Syme/Nfkbie^tm1Syme (either: (involves: 129P2/OlaHsd * C57BL/6 * DBA/2) or (involves: 129P2/OlaHsd * C57BL/6))	abnormal double-negative T cell morphology	J:88538
	increased IgG1 level	J:88538
	increased IgM level	J:88538
Nfkbiz^tm1Aki/Nfkbiz^tm1Aki (involves: 129P2/OlaHsd)	abnormal leukocyte physiology	J:91297
	abnormal lymphocyte morphology	J:194832
	abnormal T-helper 1 cell morphology	J:194832
	enlarged spleen	J:194832
	increased immunoglobulin level	J:194832
Nfkbiz^tm1Aki/Nfkbiz^tm1Aki (C.129P2-Nfkbiz^tm1Aki)	increased IgE level	J:141704
Nfkbiz^tm1Mamo/Nfkbiz^tm1Mamo (involves: 129S7/SvEvBrd)	increased IgE level	J:95040
Ngfr^tm1Jae/Ngfr^tm1Jae (B6.129S4-Ngfr^tm1Jae)	abnormal Kupffer cell morphology	J:120368
Ngp^{tm1b(KOMP)Wtsi}/Ngp^{tm1b(KOMP)Wtsi} (C57BL/6N-Ngp^{tm1b(KOMP)Wtsi}/Bay)	increased spleen weight	J:211773
Nhej1^tm1.1Ics/Nhej1⁺ (involves: 129 * C57BL/6)	decreased thymocyte number	J:194422
Nhej1^tm1.1Ics/Nhej1^tm1.1Ics (involves: 129 * C57BL/6)	abnormal T cell receptor V(D)J recombination	J:194422
	decreased lymphocyte cell number	J:194422
	decreased NK T cell number	J:194422
	decreased thymocyte number	J:194422
	increased thymocyte apoptosis	J:194422
Nhej1^tm1.1Ics/Nhej1^tm1.1Ics Trp53^tm1Tyj/Trp53^tm1Tyj (involves: 129S2/SvPas * C57BL/6)	abnormal T cell receptor V(D)J recombination	J:194422
	decreased NK T cell number	J:194422
	decreased thymocyte apoptosis	J:194422
Nhej1^tm1Fwa/Nhej1^tm1Fwa (involves: 129)	abnormal class switch recombination	J:138774
	decreased IgG1 level	J:138774
	decreased IgG3 level	J:138774
	increased IgM level	J:138774
	spleen hypoplasia	J:138774
	thymus hypoplasia	J:138774
Nhej1^tm1Fwa/Nhej1^tm1Fwa Xrcc5^tm1Nus/Xrcc5^tm1Nus (involves: 129S6/SvEvTac * C57BL/6)	athymia	J:236776
	small spleen	J:236776
Nherf1^em1(IMPC)H/Nherf1^em1(IMPC)H (C57BL/6NTac-Nherf1^em1(IMPC)H/H)	increased basophil cell number	J:211773
	increased leukocyte cell number	J:211773
Nherf2^{tm2a(EUCOMM)Hmgu}/Nherf2^{tm2a(EUCOMM)Hmgu} (C57BL/6N-Nherf2^{tm2a(EUCOMM)Hmgu}/Wtsi)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	increased mean corpuscular hemoglobin	J:211773
Nhlh2^{tm1b(KOMP)Mbp}/Nhlh2^{tm1b(KOMP)Mbp} (C57BL/6N-Nhlh2^{tm1b(KOMP)Mbp}/Tcp)	decreased mean corpuscular hemoglobin concentration	J:211773
	increased mean corpuscular volume	J:211773
	increased spleen weight	J:211773
Nhlrc2^em1Rhtl/Nhlrc2^{tm1a(KOMP)Wtsi} (C57BL/6N-Nhlrc2^em1Rhtl Nhlrc2^{tm1a(KOMP)Wtsi})	hematopoietic system phenotype	J:299152
Nhp2^{tm1a(KOMP)Wtsi}/Nhp2⁺ (C57BL/6N-Nhp2^{tm1a(KOMP)Wtsi}/Wtsi)	increased mean platelet volume	J:211773
Nhsl2^em1(IMPC)Tcp/Y (C57BL/6N-Nhsl2^em1(IMPC)Tcp/Tcp)	enlarged spleen	J:211773
Nhsl2^em1(IMPC)Tcp/Nhsl2^em1(IMPC)Tcp (C57BL/6N-Nhsl2^em1(IMPC)Tcp/Tcp)	abnormal spleen morphology	J:211773
Niban1^{em1(IMPC)Ccpcz}/Niban1^{em1(IMPC)Ccpcz} (C57BL/6N-Niban1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
Niban3^em1(IMPC)Mbp/Niban3^em1(IMPC)Mbp (C57BL/6N-Niban3^em1(IMPC)Mbp/MbpMmucd)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Niban3^tm1Jyw/Niban3^tm1Jyw (B6.Cg-Niban3^tm1Jyw)	abnormal B cell differentiation	J:282961
	abnormal B cell physiology	J:282961
	abnormal class switch recombination	J:282961
	abnormal transitional stage B cell morphology	J:282961
	decreased B-1a cell number	J:282961
	decreased IgA level	J:282961
	decreased IgG2c level	J:282961
	increased B cell number	J:282961
	increased B cell proliferation	J:282961
	increased follicular B cell number	J:282961
	increased IgG1 level	J:282961
	increased IgG3 level	J:282961
	increased IgG level	J:282961
	increased IgM level	J:282961
	increased transitional stage T2 B cell number	J:282961
Nidd3k^KK/TaJcl/Nidd3k^KK/TaJcl (involves: KK * PWK)	increased glycosylated hemoglobin level	J:76775
Ninj1^tm1Gto/Ninj1^tm1Gto (B6.129P2-Ninj1^tm1Gto)	abnormal leukocyte adhesion	J:209516
	abnormal leukocyte physiology	J:209516
	hematopoietic system phenotype	J:209516
	impaired macrophage chemotaxis	J:209516
Ninj2^{tm1a(KOMP)Wtsi}/Ninj2^{tm1a(KOMP)Wtsi} (C57BL/6N-Ninj2^{tm1a(KOMP)Wtsi}/Wtsi)	increased red blood cell distribution width	J:211773
Ninl^{tm2a(EUCOMM)Wtsi}/Ninl^{tm2a(EUCOMM)Wtsi} (B6JTyr;B6N-Ninl^{tm2a(EUCOMM)Wtsi}/Wtsi)	increased myeloid cell number in bone marrow	J:213427
Nipal3^tm1Pbfd/Nipal3^tm1Pbfd (either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J))	decreased IgM level	J:152829
	decreased NK cell number	J:152829
	increased IgA level	J:152829
	increased IgE level	J:152829
	increased IgG2a level	J:152829
	increased IgM level	J:152829
Nipsnap1^{tm1a(EUCOMM)Wtsi}/Nipsnap1^{tm1a(EUCOMM)Wtsi} (Not Specified)	increased mean corpuscular volume	J:165965
Nipsnap3a^{tm1b(KOMP)Wtsi}/Nipsnap3a^{tm1b(KOMP)Wtsi} (C57BL/6N-Nipsnap3a^{tm1b(KOMP)Wtsi}/Wtsi)	increased effector memory T-helper cell number	J:211773
Nkap^tm1.1Viss/Y Tg(Lck-cre)1Cwi/0 (involves: 129S1/Sv * 129X1/SvJ)	arrested T cell differentiation	J:165961
	decreased CD4-positive, alpha-beta T cell number	J:165961
	decreased CD8-positive, alpha-beta T cell number	J:165961
	decreased DN4 thymocyte number	J:165961
	decreased double-positive T cell number	J:165961
	decreased thymocyte number	J:165961
	increased DN3 thymocyte number	J:165961
	thymus hypoplasia	J:165961
Nkg7^{tm1.1(KOMP)Vlcg}/Nkg7^{tm1.1(KOMP)Vlcg} (C57BL/6N-Nkg7^{tm1.1(KOMP)Vlcg}/Ucd)	decreased mean corpuscular hemoglobin	J:211773
	increased eosinophil cell number	J:211773
Nkg7^{tm1.1(KOMP)Vlcg}/Nkg7^{tm1.1(KOMP)Vlcg} (involves: C57BL/6NTac)	abnormal CD8-positive, alpha-beta cytotoxic T cell morphology	J:301637
	abnormal mononuclear cell morphology	J:301637
	decreased CD4-positive, alpha-beta T cell number	J:301637
	decreased T helper 1 cell number	J:301637
	hematopoietic system phenotype	J:301637
Nktcn1^C57BL/6J/Nktcn1^C57BL/6J (involves: C57BL/6J * NOD.B6-(D6Mit105-D6Mit135))	increased NK T cell number	J:85376
Nktcn1^C57BL/6J/Nktcn1^C57BL/6J (NOD.B6-(D1Mit369-D1Mit155)(D6Mit105-D6Mit135))	abnormal T cell differentiation	J:137521
	increased NK T cell number	J:137521
Nktcn1^C57BL/6J/Nktcn1^NOD/ShiLt (involves: C57BL/6J * NOD.B6-(D6Mit105-D6Mit135))	increased NK T cell number	J:85376
Nktcn2^C57BL/6J/Nktcn2^C57BL/6J (involves: C57BL/6J * NOD.B6-(D6Mit105-D6Mit135))	increased NK T cell number	J:85376
Nktcn2^C57BL/6J/Nktcn2^NOD/ShiLt (involves: C57BL/6J * NOD.B6-(D6Mit105-D6Mit135))	increased NK T cell number	J:85376
Nkx2-3^tm1Hha/Nkx2-3^tm1Hha (involves: 129S4/SvJae * C57BL/6)	abnormal spleen primary B follicle morphology	J:54198
	abnormal splenic cell ratio	J:54198
	absent spleen	J:54198
	absent spleen marginal zone	J:54198
	decreased spleen white pulp amount	J:54198
	small spleen	J:54198
Nkx2-3^tm1Hha/Nkx2-3^tm1Hha (involves: 129S4/SvJae)	abnormal leukocyte migration	J:62129
	abnormal marginal zone B cell morphology	J:62129
	abnormal metallophilic macrophage morphology	J:62129
	abnormal spleen marginal sinus morphology	J:62129
	abnormal spleen marginal zone macrophage morphology	J:62129
	abnormal spleen morphology	J:62129
	abnormal spleen periarteriolar lymphoid sheath morphology	J:62129
	absent marginal zone B cells	J:62129
	absent spleen marginal zone	J:62129
	decreased B cell number	J:62129
	decreased lymphocyte cell number	J:62129
	decreased spleen weight	J:62129
	decreased spleen white pulp amount	J:62129
	decreased T cell number	J:62129
	intermingled spleen red and white pulp	J:62129
	small spleen	J:62129
Nkx2-3^tm1Rph/Nkx2-3^tm1Rph (involves: 129S1/Sv * C57BL/6)	abnormal leukocyte migration	J:64018
	abnormal metallophilic macrophage morphology	J:64018
	abnormal spleen B cell follicle morphology	J:64018
	abnormal spleen periarteriolar lymphoid sheath morphology	J:64018
	abnormal spleen red pulp morphology	J:64018
	absent spleen	J:64018
	absent spleen marginal zone	J:64018
	decreased CD4-positive, alpha-beta T cell number	J:64018
	decreased plasma cell number	J:64018
	increased leukocyte cell number	J:64018
	small spleen	J:64018
	spleen atrophy	J:64018
Nkx2-5^tm1(cre)Rjs/Nkx2-5⁺ Tbx1^tm1Bld/Tbx1^tm3Bld (involves: 129S7/SvEvBrd * C57BL/6)	small thymus	J:91013
Nkx2-5^tm1Siz/Nkx2-5^tm1Siz (involves: 129S4/SvJaeSor * C57BL/6J)	abnormal embryonic hematopoiesis	J:52597
	anemia	J:52597
Nkx2-5^tm1Wehi/Nkx2-5⁺ (involves: 129P2/OlaHsd)	spleen hypoplasia	J:184521
Nkx2-5^tm2(cre)Rph/Nkx2-5⁺ Pbx1^tm1.1Koss/Pbx1^tm1.1Koss (involves: 129P2/OlaHsd * 129S1/Sv)	abnormal spleen morphology	J:184521
	spleen hypoplasia	J:184521
Nkx2-5^tm2(cre)Rph/Nkx2-5^tm4Rph (involves: 129S1/Sv)	spleen hypoplasia	J:184521
Nkx3-2^tm1.1Tlu/Nkx3-2^tm1.1Tlu (either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J))	absent spleen	J:55583
Nkx3-2^tm1Bobh/Nkx3-2^tm1Bobh (involves: 129P2/OlaHsd * C57BL/6)	absent spleen	J:57112
Nkx3-2^tm1Tlu/Nkx3-2^tm1Tlu (either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J))	absent spleen	J:55583
Nkx3-2^tm1Tno/Nkx3-2^tm1Tno (involves: 129S4/SvJae * C57BL/6J)	absent spleen	J:77612
Nle1^tm1Cba/Nle1^tm1.1Cota Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * 129S2/SvPas)	hematopoietic system phenotype	J:204063
Nle1^tm1Cba/Nle1^tm1.1Cota Gt(ROSA)26Sor^{tm2(cre/ERT2)Brn}/Gt(ROSA)26Sor⁺ (involves: 129P2/OlaHsd * 129S2/SvPas)	abnormal bone marrow cell morphology/development	J:204063
	abnormal common lymphocyte progenitor cell morphology	J:204063
	abnormal hematopoietic stem cell physiology	J:204063
	decreased bone marrow cell number	J:204063
	decreased common myeloid progenitor cell number	J:204063
	decreased granulocyte number	J:204063
	decreased macrophage cell number	J:204063
	decreased NK cell number	J:204063
	decreased T cell number	J:204063
	hematopoietic system phenotype	J:204063
	impaired hematopoiesis	J:204063
	spleen hypoplasia	J:204063
	thymus hypoplasia	J:204063
Nle1^tm1Cba/Nle1^tm1.1Cota Gt(ROSA)26Sor^{tm2(cre/ERT2)Brn}/Gt(ROSA)26Sor⁺ Trp53^tm1Tyj/Trp53^tm1Tyj (involves: 129P2/OlaHsd * 129S2/SvPas)	hematopoietic system phenotype	J:204063
Nlgn3^{em1(IMPC)Rbrc}/Y (C57BL/6NJcl-Nlgn3^{em1(IMPC)Rbrc}/Rbrc)	abnormal eosinophil cell number	J:211773
	abnormal hematocrit	J:211773
	abnormal hemoglobin content	J:211773
	abnormal red blood cell distribution width	J:211773
Nlgn3^{em1(IMPC)Rbrc}/Nlgn3^{em1(IMPC)Rbrc} (C57BL/6NJcl-Nlgn3^{em1(IMPC)Rbrc}/Rbrc)	abnormal neutrophil cell number	J:211773
Nlk^tm1Tbo/Nlk^tm1Tbo (129S1/Sv-Nlk^tm1Tbo)	abnormal definitive hematopoiesis	J:73353
	decreased bone marrow cell number	J:73353
	decreased double-positive T cell number	J:73353
	decreased gamma-delta T cell number	J:73353
	decreased lymphocyte cell number	J:73353
	decreased NK cell number	J:73353
	decreased pro-B cell number	J:73353
	decreased thymocyte number	J:73353
	impaired myelopoiesis	J:73353
	spleen hypoplasia	J:73353
	thymus hypoplasia	J:73353
Nlrc3^tm1Bhk/Nlrc3^tm1Bhk (B6.129S6-Nlrc3^tm1Bhk)	increased monocyte cell number	J:187586
Nlrc4^tm1Nnz/Nlrc4^tm1Nnz (involves: 129 * C57BL/6J)	abnormal macrophage physiology	J:112671, J:117251
Nlrc5^tm1.1Ggaur/Nlrc5^tm1.1Ggaur (involves: BALB/cJ)	abnormal T cell physiology	J:184076
	decreased CD8-positive, alpha-beta T cell number	J:184076
	enlarged spleen	J:184076
Nlrp1a^m1Btlr/Nlrp1a^m1Btlr (C57BL/6J-Nlrp1a^m1Btlr)	decreased B cell number	J:265173
	decreased B-1 B cell number	J:265173
	decreased B-1b cell number	J:265173
	decreased B-2 B cell number	J:265173
	decreased CD8-positive, alpha-beta T cell number	J:265173
	decreased central memory CD8 positive, alpha-beta T cell number	J:265173
	decreased NK cell number	J:265173
	decreased single-positive T cell number	J:265173
	decreased T cell number	J:265173
	increased effector memory CD8-positive, alpha-beta T cell number	J:265173
	increased IgE level	J:265173
	increased macrophage apoptosis	J:265173
Nlrp1a^m2Btlr/Nlrp1a^m2Btlr (C57BL/6J-Nlrp1a^m2Btlr)	decreased B cell number	J:265174
	decreased NK cell number	J:265174
	increased dendritic cell number	J:265174
	increased macrophage apoptosis	J:265174
	increased neutrophil cell number	J:265174
Nlrp1a^Neut1/Nlrp1a^Neut1 (C.B6-Nlrp1a^Neut1)	decreased lymphocyte cell number	J:191055
	decreased macrophage cell number	J:191055
	enlarged spleen	J:191055
	increased macrophage cytokine production	J:191055
	increased neutrophil cell number	J:191055
Nlrp1a^Neut1/Nlrp1a^Neut1 Pycard^tm1Vmd/Pycard^tm1Vmd (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	increased neutrophil cell number	J:191055
Nlrp1b^tm1Bhk/Nlrp1b^tm1Bhk (129S6/SvEvTac-Nlrp1b^tm1Bhk)	abnormal macrophage physiology	J:189777
Nlrp3^M7Btlr/Nlrp3⁺ (C57BL/6J-Nlrp3^M7Btlr)	abnormal macrophage cytokine production	J:216048
Nlrp3^M7Btlr/Nlrp3^M7Btlr (C57BL/6J-Nlrp3^M7Btlr)	abnormal macrophage cytokine production	J:216048
Nlrp3^tm1Flv/Nlrp3^tm1Flv (involves: 129S5/SvEvBrd * C57BL/6)	abnormal macrophage physiology	J:113333
Nlrp3^tm1Hhf/Nlrp3⁺ Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129/Sv * 129P2/OlaHsd * C57BL/6)	increased leukocyte cell number	J:150054
	increased neutrophil cell number	J:150054
	thrombocytosis	J:150054
Nlrp3^tm1Hhf/Nlrp3⁺ Rag1^tm1Mom/Rag1^tm1Mom Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129/Sv * 129P2/OlaHsd * C57BL/6)	absent B cells	J:150054
	absent T cells	J:150054
Nlrp3^tm1Hhf/Nlrp3⁺ Tg(CAG-cre/Esr1)5Amc/? (involves: 129/Sv C57BL/6 * CBA)	abnormal macrophage physiology	J:150054
Nlrp3^tm1Hhf/Nlrp3⁺ Tg(Zp3-cre)3Mrt/? (involves: 129/Sv * FVB/N)	increased leukocyte cell number	J:150054
	increased neutrophil cell number	J:150054
	thrombocytosis	J:150054
Nlrp3^tm1Wstr/Nlrp3⁺ (involves: C57BL/6)	abnormal bone marrow cell physiology	J:150053
	abnormal CD4-positive, alpha-beta T cell number	J:150053
	abnormal macrophage physiology	J:150053
	abnormal spleen red pulp morphology	J:150053
	enlarged spleen	J:150053
	increased activated T cell number	J:150053
	increased leukocyte cell number	J:150053
	increased T-helper 1 cell number	J:150053
Nlrp3^tm2Hhf/Nlrp3⁺ Tg(CAG-cre/Esr1)5Amc/? (involves: 129/Sv C57BL/6 * CBA)	abnormal macrophage physiology	J:150054
Nlrp3^tm3.1Hhf/Nlrp3⁺ (involves: 129)	abnormal bone marrow cell physiology	J:202147
	abnormal osteoclast differentiation	J:202147
	anemia	J:202147
	decreased erythrocyte cell number	J:202147
	decreased lymphocyte cell number	J:202147
	increased granulocyte number	J:202147
	increased lymphocyte cell number	J:202147
	increased monocyte cell number	J:202147
	increased neutrophil cell number	J:202147
	increased osteoclast cell number	J:202147
	thrombocytosis	J:202147
Nlrp6^tm1Flv/Nlrp6^tm1Flv (B6.Cg-Nlrp6^tm1Flv)	increased B cell number	J:173245
	increased IgA level	J:173245
	increased IgG2c level	J:173245
	increased leukocyte cell number	J:173245
Nlrp9b^{tm1b(KOMP)Wtsi}/Nlrp9b^{tm1b(KOMP)Wtsi} (C57BL/6N-Nlrp9b^{tm1b(KOMP)Wtsi}/H)	enlarged spleen	J:211773
Nlrp10^tm1Seis/Nlrp10^tm1Seis (B6.Cg-Nlrp10^tm1Seis)	abnormal T-helper 2 physiology	J:183989
	decreased dendritic cell number	J:183989
	decreased IgG1 level	J:183989
Nlrp12^tm1Jpyt/Nlrp12^tm1Jpyt (B6.Cg-Nlrp12^tm1Jpyt)	abnormal leukocyte migration	J:164725
	decreased neutrophil cell number	J:164725
	impaired neutrophil chemotaxis	J:164725
Nlrp12^tm1Tdk/Nlrp12^tm1Tdk (B6.Cg-Nlrp12^tm1Tdk)	enlarged spleen	J:178951
Nlrx1^em1(IMPC)Mbp/Nlrx1^em1(IMPC)Mbp (C57BL/6N-Nlrx1^em1(IMPC)Mbp/MbpMmucd)	small spleen	J:211773
Nlrx1^tm1Jpyt/Nlrx1^tm1Jpyt (involves: C57BL/6 * C57BL/6J)	abnormal macrophage physiology	J:173995
Nlrx1^tm1Jpyt/Nlrx1^tm1Jpyt (involves: C57BL/6 * C57BL/6J)	abnormal neutrophil physiology	J:173995
Nme2^{Gt(69C10)Cmhd}/Nme2^{Gt(69C10)Cmhd} (B6.129-Nme2^{Gt(69C10)Cmhd})	abnormal CD4-positive, alpha-beta T cell physiology	J:167387
	abnormal T-helper 1 physiology	J:167387
	abnormal T-helper 2 physiology	J:167387
nmf4/nmf4 (C57BL/6J-nmf4/J)	small spleen	J:78134
nmf4/nmf4 (C57BL/6J-nmf4/J)	thymus cortex atrophy	J:78134
nmf356/nmf356 (C57BL/6J-nmf356/J)	thymus atrophy	J:87349
Nmnat1^{tm1a(EUCOMM)Wtsi}/Nmnat1⁺ (C57BL/6N-Nmnat1^{tm1a(EUCOMM)Wtsi}/Cnrm)	increased mean corpuscular volume	J:165965
Nmnat3^Gt(3020)Tgen/Nmnat3^Gt(3020)Tgen (involves: C57BL/6NCrlj * CBA/JNCrlj)	abnormal erythrocyte morphology	J:214107
	abnormal erythrocyte physiology	J:214107
	abnormal erythropoiesis	J:214107
	acanthocytosis	J:214107
	decreased erythrocyte cell number	J:214107
	decreased erythroid progenitor cell number	J:214107
	decreased hematocrit	J:214107
	decreased hemoglobin content	J:214107
	echinocytosis	J:214107
	enlarged spleen	J:214107
	hemolytic anemia	J:214107
	increased erythrocyte clearance	J:214107
	increased erythroid progenitor cell number	J:214107
	increased spleen iron level	J:214107
	increased spleen red pulp amount	J:214107
	increased spleen weight	J:214107
	reticulocytosis	J:214107
Nmt1^tm1.1Poru/Nmt1^tm1.1Poru Nmt2^tm1.1Poru/Nmt2^tm1.1Poru Tg(Lck-cre)1Cwi/0 (involves: C57BL/6 * DBA/2 * SJL)	abnormal CD4-positive, alpha beta T cell morphology	J:226234
	abnormal CD8-positive, alpha beta T cell morphology	J:226234
	decreased DN4 thymocyte number	J:226234
	decreased double-positive T cell number	J:226234
	decreased single-positive T cell number	J:226234
	decreased splenocyte proliferation	J:226234
	decreased T cell number	J:226234
	decreased T cell proliferation	J:226234
	increased double-negative T cell number	J:226234
	increased gamma-delta T cell number	J:226234
	increased T cell apoptosis	J:226234
	small thymus medulla	J:226234
Nmt1^tm1.1Poru/Nmt1^tm1.1Poru Tg(Lck-cre)1Cwi/0 (involves: C57BL/6 * DBA/2 * SJL)	abnormal CD4-positive, alpha beta T cell morphology	J:226234
	abnormal CD8-positive, alpha beta T cell morphology	J:226234
	decreased double-positive T cell number	J:226234
	decreased single-positive T cell number	J:226234
	decreased T cell number	J:226234
Nmt2^tm1.1Poru/Nmt2^tm1.1Poru Tg(Lck-cre)1Cwi/0 (involves: C57BL/6 * DBA/2 * SJL)	decreased double-positive T cell number	J:226234
	decreased single-positive T cell number	J:226234
	decreased T cell number	J:226234
Nnmt^em1(IMPC)Mbp/Nnmt^em1(IMPC)Mbp (C57BL/6NCrl-Nnmt^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Noa/Noa⁺ (NOA)	cutaneous mastocytosis	J:43274
Noa/Noa⁺ (NOA)	increased IgE level	J:43274
Noc2l^tm1.1Arte/Noc2l^tm1.1Arte Tg(CD2-icre)4Kio/0 (involves: C57BL/6 * C57BL/10 * CBA/Ca)	abnormal B cell morphology	J:216490
	abnormal T cell morphology	J:216490
	abnormal T cell proliferation	J:216490
	abnormal thymus cell ratio	J:216490
	abnormal thymus involution	J:216490
	abnormal thymus morphology	J:216490
	absent T cells	J:216490
	arrested T cell differentiation	J:216490
	decreased alpha-beta T cell number	J:216490
	decreased DN3 thymocyte number	J:216490
	decreased DN4 thymocyte number	J:216490
	decreased double-positive T cell number	J:216490
	decreased immature B cell number	J:216490
	decreased mature B cell number	J:216490
	decreased pre-B cell number	J:216490
	decreased pro-B cell number	J:216490
	decreased single-positive T cell number	J:216490
	increased thymocyte apoptosis	J:216490
	small thymus	J:216490
	spleen hypoplasia	J:216490
	thymus hypoplasia	J:216490
Noc2l^tm1.1Arte/Noc2l^tm1.1Arte Trp53^tm1Brn/Trp53^tm1Brn Tg(CD2-icre)4Kio/0 (involves: 129P2/OlaHsd * C57BL/6 * C57BL/10 * CBA/Ca)	decreased pre-B cell number	J:216490
	hematopoietic system phenotype	J:216490
Nod1^tm1Inoh/Nod1^tm1Inoh (involves: 129P2/OlaHsd * C57BL/6)	abnormal macrophage physiology	J:132126, J:118808
Nod1^tm1Inoh/Nod1^tm1Inoh Nod2^tm1Flv/Nod2^tm1Flv (involves: 129 * 129P2/OlaHsd * C57BL/6)	abnormal macrophage physiology	J:132126
Nod2^tm1Daph/Nod2^tm1Daph (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal macrophage physiology	J:157879
Nod2^tm1Flv/Nod2^tm1Flv (involves: 129S1/Sv * C57BL/6)	abnormal macrophage physiology	J:132126, J:96035
Nod2^tm1Flv/Nod2^tm1Flv (involves: 129S1/Sv * C57BL/6)	decreased IgG level	J:96035
Nod2^tm1Flv/Nod2^tm1Flv (involves: 129S1/Sv)	abnormal T-helper 1 physiology	J:147177
	impaired macrophage phagocytosis	J:147177
	impaired neutrophil phagocytosis	J:147177
	increased leukocyte cell number	J:147177
	increased neutrophil cell number	J:147177
Nod2^tm1Jhgt/Nod2^tm1Jhgt (B6.Cg-Nod2^tm1Jhgt)	increased CD4-positive, alpha-beta T cell number	J:124575
Nod2^tm1Jhgt/Nod2^tm1Jhgt (B6.Cg-Nod2^tm1Jhgt)	increased double-negative T cell number	J:124575
Nod2^tm1Mka/Nod2^tm1Mka (involves: C57BL/6)	abnormal macrophage morphology	J:96128
Nod2^tm1Pmu/Nod2^tm1Pmu (involves: BALB/c * C57BL/6)	abnormal macrophage physiology	J:86264
Nodal^tm1.1Mku/Nodal^tm2Mku Tg(T-cre)1Lwd/0 (involves: 129S1/Sv * C3H * C57BL/6)	absent spleen	J:142430
	small spleen	J:142430
Nodal^tm1.2Rob/Nodal^tm3Rob (involves: 129S/SvEv * MF1)	small spleen	J:79098
Nodal^{tm1b(EUCOMM)Wtsi}/Nodal⁺ (C57BL/6N-Nodal^{tm1b(EUCOMM)Wtsi}/H)	increased large unstained cell number	J:211773
Nodal^tm1Hmd/Nodal⁺ Tg(Rr443-Lefty1,-lacZ)36Hmd/0 (either: (involves: 129S1/Sv * 129X1/SvJ * C57BL/6N) or (involves: 129S1/Sv * 129T2/SvEms * 129X1/SvJ))	small spleen	J:82703
Nodal^tm1Hmd/Nodal^tm1Hmd (either: (involves: 129S1/Sv * 129X1/SvJ * C57BL/6N) or (involves: 129S1/Sv * 129T2/SvEms * 129X1/SvJ))	abnormal spleen morphology	J:82703
	spleen hypoplasia	J:82703
Nol3^em1(IMPC)Mbp/Nol3^em1(IMPC)Mbp (C57BL/6N-Nol3^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	small spleen	J:211773
Nop53^tm2.1Asuz/Nop53^tm2.1Asuz Tg(Lck-cre)#Jxm/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	decreased thymocyte number	J:241062
Nop53^tm2.1Asuz/Nop53^tm2.1Asuz Trp53^tm1Tyj/Trp53^tm1Tyj Tg(Lck-cre)#Jxm/0 (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * CBA)	decreased thymocyte number	J:241062
Nos1^tm1Plh/Nos1^tm1Plh (involves: 129S4/SvJae)	abnormal leukocyte adhesion	J:55936
	abnormal neutrophil physiology	J:55936
	enhanced leukocyte tethering or rolling	J:55936
Nos1^tm1Plh/Nos1^tm1Plh (B6;129S4-Nos1^tm1Plh/J)	abnormal osteoclast differentiation	J:105612
Nos1^tm1Plh/Nos1^tm1Plh Nos2^tm1Mrl/Nos2^tm1Mrl Nos3^tm1Plh/Nos3^tm1Plh (involves: 129S4/SvJae * 129S7/SvEvBrd)	abnormal osteoclast physiology	J:150159
	increased osteoclast cell number	J:150159
Nos2^tm1Lau/Nos2^tm1Lau (involves: 129P2/OlaHsd * C57BL/6)	increased single-positive T cell number	J:90903
Nos2^tm1Lau/Nos2^tm1Lau (involves: 129P2/OlaHsd * C57BL/6)	increased T cell proliferation	J:90903
Nos2^tm1Lau/Nos2^tm1Lau (B6.129P2-Nos2^tm1Lau)	abnormal osteoclast morphology	J:112399
Nos2^tm1Lau/Nos2^tm1Lau (B6.129P2-Nos2^tm1Lau)	abnormal platelet physiology	J:117987
Nos2^tm1Liew/Nos2^tm1Liew (involves: 129P2/Ola * MF1)	abnormal T-helper 1 physiology	J:25755
Nos2^tm1Liew/Nos2^tm1Liew (involves: 129P2/Ola * MF1)	increased T cell proliferation	J:25755
Nos2^tm1Mrl/Nos2^tm1Mrl (involves: 129S7/SvEvBrd)	abnormal eosinophil cell number	J:51635
	abnormal macrophage physiology	J:120499
	abnormal platelet aggregation	J:120499
	decreased eosinophil cell number	J:51635
	increased IgG2a level	J:51635
Nos2^tm1Mrl/Nos2^tm1Mrl (B6.129S7-Nos2^tm1Mrl)	abnormal osteoclast differentiation	J:98070
	abnormal osteoclast morphology	J:98070
	decreased osteoclast cell number	J:98070
Nos3^em1(IMPC)Mbp/Nos3^em1(IMPC)Mbp (C57BL/6N-Nos3^em1(IMPC)Mbp/Ucd)	abnormal spleen morphology	J:211773
	decreased lymphocyte cell number	J:211773
	enlarged spleen	J:211773
	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
	increased neutrophil cell number	J:211773
Nos3^tm1Plh/Nos3^tm1Plh (involves: 129S4/SvJae)	abnormal leukocyte adhesion	J:55936
	abnormal neutrophil physiology	J:55936
	enhanced leukocyte tethering or rolling	J:55936
Nos3^tm1Unc/Nos3^tm1Unc (B6.129P2-Nos3^tm1Unc/J)	abnormal osteoclast physiology	J:129477
Notch1^tm1Agt/Notch1^tm1Agt Notch2^tm1Frad/Notch2^tm1Frad Tg(Mx1-cre)1Cgn/0 (involves: 129 * BALB/c * C57BL/6 * CBA)	abnormal T cell differentiation	J:125373
	arrested T cell differentiation	J:125373
Notch1^tm1Agt/Notch1^tm1Agt Tg(Mx1-cre)1Cgn/0 (involves: 129 * C57BL/6 * CBA)	abnormal B cell differentiation	J:125373
	abnormal T cell differentiation	J:125373, J:55400
	abnormal thymus cell ratio	J:55400, J:143472
	abnormal thymus morphology	J:55400
	decreased CD4-positive, alpha-beta T cell number	J:55400
	decreased CD8-positive, alpha-beta T cell number	J:55400
	decreased double-negative T cell number	J:55400
	decreased double-positive T cell number	J:55400
	decreased single-positive T cell number	J:55400
	decreased thymocyte number	J:55400
	hematopoietic system phenotype	J:98129
	increased immature B cell number	J:143472
	small thymus	J:55400
Notch1^tm2Pst/Notch1^tm2.1Pst (involves: 129/Sv * C57BL/6 * SJL)	anemia	J:131563
Notch1^tm2Pst/Notch1^tm2Pst (B6.Cg-Notch1^tm2Pst)	abnormal T cell differentiation	J:131563
	decreased double-negative T cell number	J:131563
	decreased T cell number	J:131563
	decreased thymocyte number	J:131563
	increased T cell apoptosis	J:131563
Notch1^tm2Rko/Notch1^tm2Rko Notch2^tm1Rko/Notch2^tm1Rko Notch3^{Gt(PST033)Byg}/Notch3⁺ Tg(Mx1-cre)1Cgn/0 (involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * CBA)	abnormal spleen morphology	J:172442
	enlarged spleen	J:172442
	extramedullary hematopoiesis	J:172442
	increased hematopoietic cell number	J:172442
	increased spleen red pulp amount	J:172442
Notch1^tm2Rko/Notch1^tm2Rko Notch2^tm1Rko/Notch2^tm1Rko Notch3^{Gt(PST033)Byg}/Notch3^{Gt(PST033)Byg} Tg(Mx1-cre)1Cgn/0 (involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * CBA)	abnormal definitive hematopoiesis	J:172442
	abnormal spleen morphology	J:172442
	enlarged spleen	J:172442
	extramedullary hematopoiesis	J:172442
	increased hematopoietic cell number	J:172442
	increased spleen red pulp amount	J:172442
Notch1^tm2Rko/Notch1^tm3(cre)Rko (involves: 129X1/SvJ * C57BL/6)	abnormal spleen morphology	J:171829
	enlarged spleen	J:171829
	extramedullary hematopoiesis	J:171829
Notch2^{Gt(betageo)1Byg}/Notch2⁺ (B6.129P2-Notch2^{Gt(betageo)1Byg})	decreased marginal zone B cell number	J:146621
Notch2^tm1.1Ecan/Notch2⁺ (involves: 129 * 129S1/Sv * C57BL/6J)	abnormal osteoclast differentiation	J:230045
	abnormal osteoclast morphology	J:230045
	increased osteoclast cell number	J:230045
Notch2^tm1.1Hhi/Notch2^tm1.1Hhi Tg(Cd8a-cre)1Itan/0 (involves: C57BL/6 * CBA)	abnormal CD8-positive, alpha-beta T cell physiology	J:141009
	abnormal cytotoxic T cell physiology	J:141009
Notch2^tm1.1Hhtg/Notch2⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal osteoclast differentiation	J:311038
	increased osteoclast cell number	J:311038
Notch2^tm1Frad/Notch2^tm1Frad Tg(Mx1-cre)1Cgn/0 (involves: BALB/c * C57BL/6 * CBA)	abnormal B cell differentiation	J:125373
	absent marginal zone B cells	J:125373
	hematopoietic system phenotype	J:125373
Notch2^tm1Yha/Notch2⁺ (B6.129-Notch2^tm1Yha)	abnormal spleen marginal zone morphology	J:85379
	decreased B-1 B cell number	J:85379
	decreased marginal zone B cell number	J:85379
Notch2^tm2.1Ecan/Notch2^tm2.1Ecan Tg(BGLAP-cre)1Clem/0 (involves: C57BL/6J * FVB/NJ)	increased osteoclast cell number	J:246017
Notch2^tm2Hhi/Notch2^tm1.1Hhi Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	decreased marginal zone B cell number	J:83476
Notch3^em1Ecan/Notch3⁺ (C57BL/6J-Notch3^em1Ecan)	abnormal osteoclast differentiation	J:270682
Notch3^em1Ecan/Notch3⁺ (C57BL/6J-Notch3^em1Ecan)	increased osteoclast cell number	J:270682
Notch3^{tm1.1(KOMP)Vlcg}/Notch3^{tm1.1(KOMP)Vlcg} (C57BL/6N-Notch3^{tm1.1(KOMP)Vlcg}/Ucd)	increased neutrophil cell number	J:211773
	increased red blood cell distribution width	J:211773
	increased spleen weight	J:211773
Notch3^tm1Khan/Notch3^tm1Khan (involves: C57BL/6 * CBA)	decreased thymocyte number	J:98284
Notch3^tm1Khan/Notch3^tm1Khan (involves: C57BL/6 * CBA)	small thymus	J:98284
Notum^em1(IMPC)Tcp/Notum⁺ (C57BL/6NCrl-Notum^em1(IMPC)Tcp/Tcp)	small spleen	J:211773
Notum^{Gt(OST172035)Lex}/Notum^{Gt(OST172035)Lex} (involves: 129S5/SvEvBrd * C57BL/6)	anemia	J:274615
	increased leukocyte cell number	J:274615
Npas2^em1(IMPC)Mbp/Npas2^em1(IMPC)Mbp (C57BL/6N-Npas2^em1(IMPC)Mbp/MbpMmucd)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Npas4^em1(IMPC)H/Npas4^em1(IMPC)H (C57BL/6NTac-Npas4^em1(IMPC)H/H)	abnormal thymus morphology	J:211773
Npc1^m1N/Npc1^m1N (involves: BALB/c)	abnormal alveolar macrophage morphology	J:204311
Npc1^m1N/Npc1^m1N (involves: BALB/c)	enlarged spleen	J:76733
Npc1^m1N/Npc1^m1N (BALB/cNctr-Npc1^m1N/J)	enlarged spleen	J:179744
Npc1^m1N/Npc1^m1N (BALB/cNctr-Npc1^m1N/J)	microgliosis	J:209834
Npc1^m1N/Npc1^m1N (involves: BALB/c * C57BL/6 * CBA)	abnormal microglial cell physiology	J:144240
Npc1^m1N/Npc1^m1N (B6.C-Npc1^m1N)	microgliosis	J:157113
Npc1^m1N/Npc1^m1N (BALB/c-Npc1^m1N)	abnormal macrophage morphology	J:221855
	abnormal microglial cell activation	J:221855
	increased macrophage derived foam cell number	J:221855
	increased microglial cell activation	J:221855
Npc1^m1N/Npc1^m1N (involves: BALB/c * C3H/HeJ * C57BL/6J)	microgliosis	J:188345
Npc1^m1N/Npc1^m1N Tg(PRNP-APPSweInd)8Dwst/0 (involves: BALB/c * C3H/HeJ * C57BL/6J)	microgliosis	J:188345
Npc1^m1N/Npc1^tm1.1Apl Tg(CAG-cre/Esr1)5Amc/0 (B6J.Cg-Npc1^m1N/Npc1^tm1.1Apl Tg(CAG-cre/Esr1)5Amc)	microgliosis	J:176888
Npc1^m1N/Npc1^tm1.1Apl Tg(Syn1-cre)671Jxm/0 (B6J.Cg-Npc1^m1N/Npc1^tm1.1Apl Tg(Syn1-cre)671Jxm)	microgliosis	J:176888
Npc1^m1N/Npc1^tm1.2Apl (B6.Cg-Npc1^m1N/Npc1^tm1.2Apl)	microgliosis	J:157113
Npc1^nmf164/Npc1^nmf164 (C57BL/6J-Npc1^nmf164/J)	enlarged spleen	J:179744
	increased macrophage derived foam cell number	J:179744
	increased microglial cell activation	J:179744
Npc1^spm/Npc1^spm (C57BLKS/J-Npc1^spm/J)	enlarged spleen	J:7245
Npc1^spm/Npc1^spm (C57BLKS/J-Npc1^spm/J)	increased macrophage derived foam cell number	J:7245
Npc1^tm1.1Apl/Npc1^tm1.2Apl Tg(Pcp2-cre)2Mpin/0 (B6.Cg-Npc1^tm1.1Apl/Npc1^tm1.2Apl Tg(Pcp2-cre)2Mpin)	microgliosis	J:157113
Npc1^tm1.1Dso/Npc1^tm1.1Dso (B6.129-Npc1^tm1.1Dso)	abnormal macrophage morphology	J:221855
	abnormal microglial cell activation	J:221855
	increased macrophage cell number	J:221855
	increased macrophage derived foam cell number	J:221855
	increased microglial cell activation	J:221855
	microgliosis	J:221855
Npc2^tm1Plob/Npc2^tm1Plob (involves: 129S1/Sv * C57BL/6)	decreased NK cell number	J:125609
Npc2^tm1Plob/Npc2^tm1Plob (C.129S1-Npc2^tm1Plob)	abnormal NK cell physiology	J:125609
	abnormal T cell physiology	J:125609
	decreased NK cell number	J:125609
Npc2^tm1Plob/Npc2^tm1Plob (involves: 129S1/Sv * BALB/c)	abnormal alveolar macrophage morphology	J:204311
Npepps^{em1(IMPC)Hmgu}/Npepps^{em1(IMPC)Hmgu} (C57BL/6N-Npepps^{em1(IMPC)Hmgu}/Ieg)	decreased erythrocyte cell number	J:211773
	decreased hemoglobin content	J:211773
	thrombocytopenia	J:211773
Npffr2^tm1.2Ics/Npffr2^tm1.2Ics (involves: C57BL/6N)	abnormal macrophage activation involved in immune response	J:245025
	decreased macrophage cell number	J:245025
	decreased macrophage proliferation	J:245025
Nphp3^pcy/Nphp3^pcy (KK-Nphp3^pcy)	anemia	J:8302
Npm1^{Gt(OST331547)Lex}/Npm1⁺ (B6;129S5-Npm1^{Gt(OST331547)Lex}/Mmucd)	abnormal hematopoietic stem cell physiology	J:188985
	hematopoietic system phenotype	J:188985
	increased hematopoietic stem cell number	J:188985
Npm1^tm1Gsva/Npm1⁺ Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	abnormal common myeloid progenitor cell morphology	J:172071
	decreased B cell number	J:172071
	enlarged spleen	J:172071
	increased granulocyte number	J:172071
	increased leukocyte cell number	J:172071
	increased mean corpuscular volume	J:172071
	increased mean platelet volume	J:172071
	increased spleen weight	J:172071
Npm1^tm1Hft/Npm1⁺ (involves: 129)	abnormal bone marrow cell morphology/development	J:194999
	abnormal common myeloid progenitor cell morphology	J:194999
	abnormal granulocyte differentiation	J:194999
	abnormal spleen B cell follicle morphology	J:194999
	enlarged spleen	J:194999
	extramedullary hematopoiesis	J:194999
	hematopoietic system phenotype	J:194999
	increased granulocyte number	J:194999
	increased hematopoietic stem cell number	J:194999
	increased leukocyte cell number	J:194999
	increased monocyte cell number	J:194999
	increased spleen weight	J:194999
	myeloid hyperplasia	J:194999
	thrombocytosis	J:194999
Npm1^tm1Ppp/Npm1⁺ (involves: 129S1/Sv * C57BL/6)	abnormal megakaryocyte morphology	J:101494
	abnormal proerythroblast morphology	J:101494
	abnormal thrombopoiesis	J:101494
	anisocytosis	J:101494
	increased bone marrow cell number	J:101494
	increased mean corpuscular volume	J:101494
	reticulocytopenia	J:101494
Npm1^tm1Ppp/Npm1^tm1Ppp (involves: 129S1/Sv * C57BL/6)	abnormal embryonic hematopoiesis	J:101494
Npm1^tm1Ppp/Npm1^tm1Ppp (involves: 129S1/Sv * C57BL/6)	anemia	J:101494
Npm1^tm2Ppp/Npm1^tm2Ppp (involves: 129S1/Sv * C57BL/6)	abnormal embryonic hematopoiesis	J:101494
Npm1^tm2Ppp/Npm1^tm2Ppp (involves: 129S1/Sv * C57BL/6)	anemia	J:101494
Nppa^tm1Unc/Nppa^tm1Unc (involves: 129P2/OlaHsd * C57BL/6)	decreased hematocrit	J:76312
Npr1^tm1Gar/Npr1^tm1Gar (B6.129S7-Npr1^tm1Gar)	impaired neutrophil chemotaxis	J:70496
Npr2^cn/Npr2^cn (AKR/J)	small spleen	J:5109
Npr3^tm1Unc/Npr3⁺ (involves: 129 * C57BL/6)	increased erythrocyte cell number	J:56058
	increased hematocrit	J:56058
	increased hemoglobin content	J:56058
Npr3^tm1Unc/Npr3^tm1Unc (involves: 129 * C57BL/6)	abnormal osteoclast morphology	J:56058
	increased erythrocyte cell number	J:56058
	increased hematocrit	J:56058
	increased hemoglobin content	J:56058
Nprl2^tm1.2Bpt/Nprl2^tm1.2Bpt (involves: C57BL/6)	abnormal erythropoiesis	J:224837
	decreased erythroid progenitor cell number	J:224837
	decreased hematopoietic precursor cell number	J:224837
	hematopoietic system phenotype	J:224837
	impaired hematopoiesis	J:224837
Npsr1^{tm1b(KOMP)Wtsi}/Npsr1^{tm1b(KOMP)Wtsi} (C57BL/6N-Npsr1^{tm1b(KOMP)Wtsi}/Rbrc)	increased eosinophil cell number	J:211773
Nptn^{tm1b(EUCOMM)Hmgu}/Nptn^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Nptn^{tm1b(EUCOMM)Hmgu}/H)	increased hemoglobin content	J:211773
	increased mean corpuscular volume	J:211773
Npy1r^tm1.1Wpg/Npy1r^tm1.1Wpg (involves: 129X1/SvJ * C57BL/6)	abnormal immunoglobulin level	J:118850
	abnormal macrophage physiology	J:118850
	abnormal spleen morphology	J:118850
	abnormal splenic cell ratio	J:118850
	abnormal T cell activation	J:118850
	abnormal T cell number	J:118850
	abnormal T-helper 1 physiology	J:118850
	decreased B cell number	J:118850
	decreased CD8-positive, alpha-beta T cell number	J:118850
	decreased IgG2a level	J:118850
	decreased marginal zone B cell number	J:118850
	decreased mature B cell number	J:118850
	decreased transitional stage B cell number	J:118850
	increased CD4-positive, alpha-beta T cell number	J:118850
	increased CD8-positive, alpha-beta T cell number	J:118850
	increased IgA level	J:118850
	increased IgG2b level	J:118850
	increased IgM level	J:118850
	increased immunoglobulin level	J:118850
	increased single-positive T cell number	J:118850
	small spleen	J:118850
Npy2r^em1(IMPC)H/Npy2r^em1(IMPC)H (C57BL/6N-Npy2r^em1(IMPC)H/H)	enlarged spleen	J:211773
	increased spleen weight	J:211773
Npy2r^tm1.1Hhz/Npy2r^tm1.1Hhz (involves: 129X1/SvJ * BALB/cJ * C57BL/6)	decreased osteoclast cell number	J:84570
Npy2r^tm1Hhz/Npy2r^tm1Hhz (involves: 129X1/SvJ * C57BL/6)	decreased osteoclast cell number	J:97455
Nqo2^tm1Akj/Nqo2^tm1Akj (Not Specified)	abnormal lymphopoiesis	J:80549
	increased granulocyte number	J:80549
	thrombocytosis	J:80549
Nr0b1^{em2(IMPC)Wtsi}/Y (C57BL/6N-Nr0b1^{em2(IMPC)Wtsi}/Wtsi)	increased hemoglobin content	J:211773
Nr1d1^{tm1(KOMP)Vlcg}/Nr1d1^{tm1(KOMP)Vlcg} (C57BL/6N-Nr1d1^{tm1(KOMP)Vlcg}/Bay)	decreased NK cell number	J:211773
Nr1h2^tm1.1Gstr/Nr1h2^tm1.1Gstr (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	increased microglial cell activation	J:278794
Nr1h2^tm1.1Gstr/Nr1h2^tm1.1Gstr Nr1h3^tm1.1Gstr/Nr1h3^tm1.1Gstr (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	increased macrophage derived foam cell number	J:81790, J:234268
Nr1h2^tm1Djm/Nr1h2^tm1Djm Nr1h3^tm1Djm/Nr1h3^tm1Djm (involves: 129S6/SvEvTac * C57BL/6)	abnormal bone marrow cell physiology	J:125452
	abnormal macrophage morphology	J:125452
Nr1h4^tm1.1Mbj/Nr1h4^tm1.1Mbj (B6N.B6-Nr1h4^tm1.1Mbj)	increased spleen weight	J:200842
Nr2c1^tm1Chc/Nr2c1^tm1Chc (involves: 129S5/SvEvBrd)	abnormal hemoglobin	J:121628
Nr2c2^tm1Chc/Nr2c2^tm1Chc (Not Specified)	abnormal hemoglobin	J:121628
Nr3c1^tm1.1Jda/Nr3c1⁺ Tg(Lck-cre)548Jxm/0 (B6.Cg-Nr3c1^tm1.1Jda Tg(Lck-cre)548Jxm)	decreased thymocyte apoptosis	J:189951
Nr3c1^tm1.1Jda/Nr3c1^tm1.1Jda Rag2^tm1.1Cgn/Rag2^tm1.1Cgn Tg(Lck-cre)548Jxm/0 Tg(TcrAND)53Hed/0 (B6.Cg-Rag2^tm1.1Cgn Nr3c1^tm1.1Jda Tg(Lck-cre)548Jxm Tg(TcrAND)53Hed)	decreased double-positive T cell number	J:189951
Nr3c1^tm1.1Jda/Nr3c1^tm1.1Jda Tcra^tm1Mom/Tcra^tm1Mom Tg(Lck-cre)548Jxm/0 (B6.Cg-Tcra^tm1Mom Nr3c1^tm1.1Jda Tg(Lck-cre)548Jxm)	decreased double-positive T cell number	J:189951
Nr3c1^tm1.1Jda/Nr3c1^tm1.1Jda Tg(Lck-cre)548Jxm/0 (B6.Cg-Nr3c1^tm1.1Jda Tg(Lck-cre)548Jxm)	decreased CD4-positive, alpha-beta T cell number	J:189951
	decreased CD8-positive, alpha-beta T cell number	J:189951
	decreased double-positive T cell number	J:189951
	decreased single-positive T cell number	J:189951
	decreased thymocyte apoptosis	J:189951
	thymus hypoplasia	J:189951
Nr3c1^tm1Dage/Nr3c1⁺ (involves: 129P1/ReJ * C57BL/6 * C57BL/6J * SJL)	decreased B cell number	J:147914
Nr3c1^tm1Dage/Nr3c1^tm1Dage (involves: 129P1/ReJ * C57BL/6 * C57BL/6J * SJL)	decreased B cell number	J:147914
	decreased CD4-positive, alpha-beta T cell number	J:147914
	decreased CD8-positive, alpha-beta T cell number	J:147914
	decreased macrophage cell number	J:147914
Nr3c1^tm1Ljm/Nr3c1^tm1Ljm (involves: 129S6/SvEvTac * C57BL/6)	abnormal thymocyte apoptosis	J:82174
Nr3c1^tm2.1Gsc/Nr3c1⁺ (B6.129P2-Nr3c1^tm2.1Gsc)	decreased T cell apoptosis	J:126427
Nr3c1^tm2.1Gsc/Nr3c1^tm2.1Gsc (involves: 129P2/OlaHsd)	decreased erythroid progenitor cell number	J:58790
Nr3c1^tm2.1Ljm/Nr3c1^tm2.1Ljm Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S6/SvEvTac)	abnormal monocyte cell number	J:197150
Nr3c1^tm2Gsc/Nr3c1^tm2Gsc Tg(Lck-cre)I57Jxm/0 (B6.Cg-Nr3c1^tm2Gsc Tg(Lck-cre)I57Jxm)	decreased T cell apoptosis	J:137157
Nr3c1^tm3Gsc/Nr3c1^tm3Gsc (involves: 129P2/OlaHsd)	decreased erythroid progenitor cell number	J:58790
Nr3c2^tm1Gsc/Nr3c2^tm1Gsc (involves: 129P2/OlaHsd * C57BL/6)	increased hematocrit	J:77285
Nr4a1^tm1Jmi/Nr4a1^tm1Jmi (involves: 129S2/SvPas)	decreased B cell apoptosis	J:306652
Nr4a1^tm1Jmi/Nr4a1^tm1Jmi (involves: 129S2/SvPas)	increased B cell proliferation	J:306652
Nr4a1^tm1Jmi/Nr4a1^tm1Jmi (involves: 129S2/SvPas * C57BL/6)	decreased Ly6C low monocyte number	J:239509
Nr4a1^tm1Jmi/Nr4a1^tm1Jmi Nr4a3^tm1Omc/Nr4a3^tm1Omc (involves: 129S/SvEv * 129S2/SvPas * C57BL/6)	abnormal bone marrow cell number	J:121903
	abnormal common myeloid progenitor cell morphology	J:121903
	abnormal leukopoiesis	J:121903
	abnormal myelopoiesis	J:121903
	abnormal spleen morphology	J:121903
	abnormal thymus morphology	J:121903
	anemia	J:121903
	decreased lymphocyte cell number	J:121903
	enlarged spleen	J:121903
	increased eosinophil cell number	J:121903
	increased granulocyte number	J:121903
	increased hematopoietic stem cell number	J:121903
	increased leukocyte cell number	J:121903
	increased neutrophil cell number	J:121903
Nr4a1^tm1Pcn/Nr4a1^tm1Pcn Tg(Cr2-cre)3Cgn/0 (involves: 129)	increased B cell proliferation	J:306652
Nr4a2^tm1.1Pcn/Nr4a2⁺ Foxp3^{tm4(YFP/icre)Ayr}/Foxp3⁺ (involves: 129S1/Sv * 129X1/SvJ)	abnormal regulatory T cell morphology	J:205658
Nr4a2^tm1.1Pcn/Nr4a2^tm1.1Pcn Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ (involves: C57BL/6 * C57BL/6NTac)	abnormal regulatory T cell morphology	J:205658
	abnormal T-helper 1 cell differentiation	J:205658
	abnormal T-helper 17 cell differentiation	J:205658
Nr4a2^tm1.1Pcn/Nr4a2^tm1.1Pcn Tg(Lck-cre)1Jtak/0 (Not Specified)	abnormal regulatory T cell morphology	J:205658
	abnormal T-helper 1 cell differentiation	J:205658
	abnormal T-helper 17 cell differentiation	J:205658
	decreased regulatory T cell number	J:205658
	increased CD4-positive, alpha-beta T cell number	J:205658
	increased T-helper 1 cell number	J:205658
Nrarp^tm1Grid/Nrarp^tm1Grid (involves: 129S1/Sv * 129S1/SvImj * 129X1/SvJ)	hematopoietic system phenotype	J:187871
Nras^tm1.1Emfu/Nras^tm1.1Emfu (involves: 129S1/Sv * FVB/N)	abnormal granulocyte differentiation	J:189834
	abnormal leukocyte cell number	J:189834
	abnormal thymus morphology	J:189834
	decreased monocyte cell number	J:189834
	decreased spleen weight	J:189834
	increased granulocyte number	J:189834
	increased T cell number	J:189834
Nras^tm1Tyj/Nras⁺ Meox2^tm1(cre)Sor/Meox2⁺ (B6.Cg-Nras^tm1Tyj Meox2^tm1(cre)Sor)	abnormal definitive hematopoiesis	J:305401
	abnormal fetal liver hematopoietic progenitor cell morphology	J:305401
	increased erythroid progenitor cell number	J:305401
	increased hematopoietic stem cell number	J:305401
Nras^tm1Tyj/Nras^tm1Tyj Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	abnormal definitive hematopoiesis	J:204263
	abnormal myelopoiesis	J:174880
	anemia	J:204263
	enlarged spleen	J:204263, J:174880
	increased leukocyte cell number	J:204263
	increased monocyte cell number	J:204263
	increased neutrophil cell number	J:204263
	myeloid hyperplasia	J:204263
Nras^tm1Tyj/Nras^tm2.1Tyj Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	hematopoietic system phenotype	J:204263
Nrbp1^{tm3b(EUCOMM)Wtsi}/Nrbp1⁺ (C57BL/6N-Nrbp1^{tm3b(EUCOMM)Wtsi}/Wtsi)	decreased CD4-positive, alpha-beta T cell number	J:211773
	increased CD8-positive, alpha-beta T cell number	J:211773
Nrp1^tm1Ddg/Nrp1^tm1Ddg (involves: 129P2/OlaHsd)	abnormal T cell physiology	J:161856
Nrsn2^{em1(IMPC)Kmpc}/Nrsn2^{em1(IMPC)Kmpc} (C57BL/6NTac-Nrsn2^{em1(IMPC)Kmpc}/Kmpc)	increased red blood cell distribution width	J:211773
Nrxn1^{tm1b(KOMP)Wtsi}/Nrxn1⁺ (C57BL/6N-Nrxn1^{tm1b(KOMP)Wtsi}/H)	small thymus	J:211773
Nsa2^em1(IMPC)Mbp/Nsa2⁺ (C57BL/6N-Nsa2^em1(IMPC)Mbp/Ucd)	abnormal spleen morphology	J:211773
Nsa2^em1(IMPC)Mbp/Nsa2⁺ (C57BL/6N-Nsa2^em1(IMPC)Mbp/Ucd)	enlarged spleen	J:211773
Nsd3^{tm1b(EUCOMM)Hmgu}/Nsd3^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Nsd3^{tm1b(EUCOMM)Hmgu}/H)	small spleen	J:211773
Nsf^{tm1b(KOMP)Mbp}/Nsf⁺ (C57BL/6N-Nsf^{tm1b(KOMP)Mbp}/J)	increased hemoglobin content	J:211773
Nsg1^{tm1.1(KOMP)Vlcg}/Nsg1^{tm1.1(KOMP)Vlcg} (C57BL/6N-Nsg1^{tm1.1(KOMP)Vlcg}/Ucd)	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
	increased mean platelet volume	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Nsl1^em1(IMPC)J/Nsl1⁺ (C57BL/6NJ-Nsl1^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Nsmaf^tm1Mkr/Nsmaf^tm1Mkr (involves: 129P2/OlaHsd)	abnormal T cell physiology	J:54972
Nsmaf^tm1Mkr/Nsmaf^tm1Mkr (involves: 129P2/OlaHsd)	hematopoietic system phenotype	J:54972
Nsmce1^{em1(IMPC)Wtsi}/Nsmce1⁺ (C57BL/6N-Nsmce1^{em1(IMPC)Wtsi}/Wtsi)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Nsmce2^tm2.1Ofc/Nsmce2^tm2.1Ofc Ndor1^{Tg(UBC-cre/ERT2)1Ejb}/0 (involves: 129S/SvEv * C57BL/6 * SJL)	abnormal thymus physiology	J:227197
	anemia	J:227197
Nsmf^{tm1a(KOMP)Wtsi}/Nsmf^{tm1a(KOMP)Wtsi} (C57BL/6N-Nsmf^{tm1a(KOMP)Wtsi}/Wtsi)	increased mean corpuscular hemoglobin	J:175295
Nsrp1^tm1.1Cdj/Nsrp1^tm1.1Cdj Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2 * SJL)	abnormal T cell number	J:306261
	decreased CD4-positive, alpha-beta T cell number	J:306261
	decreased CD8-positive, alpha-beta T cell number	J:306261
	increased memory T cell number	J:306261
	increased T cell apoptosis	J:306261
	increased T cell proliferation	J:306261
Nsun2^{tm1a(EUCOMM)Wtsi}/Nsun2⁺ (B6JTyr;B6N-Nsun2^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased mean corpuscular volume	J:165965
Nsun2^{tm1a(EUCOMM)Wtsi}/Nsun2^{tm1a(EUCOMM)Wtsi} (B6JTyr;B6N-Nsun2^{tm1a(EUCOMM)Wtsi}/Wtsi)	abnormal thymus capsule morphology	J:239583
Nsun2^{tm1a(EUCOMM)Wtsi}/Nsun2^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6 * C57BL/6N)	decreased mean corpuscular hemoglobin	J:213427
	decreased mean corpuscular volume	J:213427
	increased erythrocyte cell number	J:213427
Nsun5^{tm2b(EUCOMM)Wtsi}/Nsun5^{tm2b(EUCOMM)Wtsi} (C57BL/6N-Nsun5^{tm2b(EUCOMM)Wtsi}/J)	decreased lymphocyte cell number	J:211773
	decreased spleen weight	J:211773
	increased neutrophil cell number	J:211773
	thrombocytopenia	J:211773
Nsun5^{tm2b(EUCOMM)Wtsi}/Nsun5^{tm2b(EUCOMM)Wtsi} (C57BL/6NJ-Nsun5^{tm2b(EUCOMM)Wtsi}/J)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	thrombocytopenia	J:211773
Nt5c1b^{tm1b(KOMP)Wtsi}/Nt5c1b^{tm1b(KOMP)Wtsi} (C57BL/6N-Nt5c1b^{tm1b(KOMP)Wtsi}/J)	increased mean corpuscular hemoglobin concentration	J:211773
Nt5c2^tm1.1Aafo/Nt5c2⁺ Gt(ROSA)26Sor^{tm1(cre/ERT2)Thl}/Gt(ROSA)26Sor⁺ (involves: 129 * C57BL/6 * SJL)	abnormal bone marrow cell physiology	J:257751
Nt5c3^em1(IMPC)Tcp/Nt5c3^em1(IMPC)Tcp (C57BL/6NCrl-Nt5c3^em1(IMPC)Tcp/Tcp)	increased red blood cell distribution width	J:211773
Nt5e^em1(IMPC)Mbp/Nt5e^em1(IMPC)Mbp (C57BL/6NCrl-Nt5e^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Nt5e^tm1Jsc/Nt5e^tm1Jsc (involves: 129S1/Sv * 129X1/SvJ * NMRI)	abnormal platelet physiology	J:102299
Ntan1^tm1Avar/Ntan1^tm1Avar (involves: 129)	abnormal T cell physiology	J:62140
Ntan1^tm1Avar/Ntan1^tm1Avar (involves: 129)	decreased splenocyte proliferation	J:62140
Ntaq1^{tm1.1(KOMP)Vlcg}/Ntaq1^{tm1.1(KOMP)Vlcg} (C57BL/6N-Ntaq1^{tm1.1(KOMP)Vlcg}/J)	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
	increased leukocyte cell number	J:211773
Ntf5^{tm1b(EUCOMM)Hmgu}/Ntf5^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Ntf5^{tm1b(EUCOMM)Hmgu}/Ics)	decreased mean corpuscular volume	J:211773
Nthl1^em1(IMPC)Mbp/Nthl1^em1(IMPC)Mbp (C57BL/6NCrl-Nthl1^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Ntn4^{tm1b(KOMP)Wtsi}/Ntn4^{tm1b(KOMP)Wtsi} (C57BL/6N-Ntn4^{tm1b(KOMP)Wtsi}/Wtsi)	abnormal spleen morphology	J:211773
	decreased hematocrit	J:211773
	thrombocytopenia	J:211773
Ntrk1^{tm1b(EUCOMM)Wtsi}/Ntrk1⁺ (C57BL/6N-Ntrk1^{tm1b(EUCOMM)Wtsi}/H)	increased basophil cell number	J:211773
Ntrk1^tm1Tes/Ntrk1^tm1Tes Tg(Tuba1-cre)1Tes/0 (involves: 129S1/Sv)	abnormal mast cell physiology	J:93578
	increased B-1 B cell number	J:93578
	increased IgG1 level	J:93578
	increased IgG2a level	J:93578
	increased IgM level	J:93578
	increased immunoglobulin level	J:93578
Nub1^{tm1b(EUCOMM)Hmgu}/Nub1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Nub1^{tm1b(EUCOMM)Hmgu}/Ccpcz)	abnormal spleen morphology	J:211773
	decreased CD4-negative NK T cell number	J:211773
	decreased CD4-positive, alpha-beta T cell number	J:211773
	decreased CD5-positive Ly6C-positive T cell number	J:211773
	decreased CD8-positive, alpha-beta T cell number	J:211773
	decreased CD11b-high dendritic cell number	J:211773
	decreased Ly6C-positive NK T cell number	J:211773
	decreased memory-marker CD4-negative NK T cell number	J:211773
	decreased NK cell number	J:211773
	decreased NK T cell number	J:211773
	enlarged spleen	J:211773
	increased effector memory CD8-positive, alpha-beta T cell number	J:211773
	increased effector memory T-helper cell number	J:211773
	increased Ly6C-positive NK T cell number	J:211773
Nucb1^em1(IMPC)Mbp/Nucb1^em1(IMPC)Mbp (C57BL/6NCrl-Nucb1^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	small spleen	J:211773
	thrombocytopenia	J:211773
Nudc^{tm1c(KOMP)Mbp}/Nudc^{tm1c(KOMP)Mbp} Tg(Rho-icre)1Ck/0 (involves: C57BL/6 * C57BL/6N * SJL)	increased microglial cell activation	J:346299
Nudcd3^{em1(IMPC)Wtsi}/Nudcd3^{em1(IMPC)Wtsi} (C57BL/6N-Nudcd3^{em1(IMPC)Wtsi}/Wtsi)	increased red blood cell distribution width	J:211773
Nudt1^tm1Tts/Nudt1^tm1Tts Ogg1^tm1Yun/Ogg1^tm1Yun (involves: 129S/SvEv * C57BL/6JJcl)	microgliosis	J:193978
Nudt15^em1Maska/Nudt15⁺ (C57BL/6-Nudt15^em1Maska)	decreased neutrophil cell number	J:285800
Nudt15^em1Maska/Nudt15⁺ (C57BL/6-Nudt15^em1Maska)	pancytopenia	J:285800
Nudt15^em1Maska/Nudt15^em1Maska (C57BL/6-Nudt15^em1Maska)	decreased bone marrow cell number	J:285800
	decreased hematopoietic precursor cell number	J:285800
	decreased hematopoietic stem cell number	J:285800
	decreased neutrophil cell number	J:285800
	pancytopenia	J:285800
Nudt19^{tm1.1(KOMP)Vlcg}/Nudt19^{tm1.1(KOMP)Vlcg} (C57BL/6N-Nudt19^{tm1.1(KOMP)Vlcg}/Ucd)	increased mean platelet volume	J:211773
Nufip2^em1(IMPC)J/Nufip2⁺ (C57BL/6NJ-Nufip2^em1(IMPC)J/Mmjax)	decreased mean corpuscular hemoglobin	J:211773
Nuggc^{em1(IMPC)Ccpcz}/Nuggc^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Nuggc^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Nuggc^tm1Diaz/Nuggc^tm1Diaz Edil3^{Tg(Sox2-cre)1Amc}/Edil3⁺ (involves: C57BL/6 * C57BL/6J * CBA)	abnormal somatic hypermutation frequency	J:190402
Numb^tm1Zili/Numb^tm1Zili Numbl^tm1Zili/Numbl^tm1Zili Tg(Mx1-cre)1Cgn/? (involves: 129/Sv * C57BL/6 * CBA)	hematopoietic system phenotype	J:133550
Nup35^m1Apb/Nup35^m1Apb (involves: C57BL/6N)	abnormal macrophage morphology	J:235141
Nup35^m1Apb/Nup35^m1Apb (involves: C57BL/6N)	hematopoietic system phenotype	J:235141
Nup85^tm1.1Yter/Nup85^tm1.1Yter Tg(CAG-cre/Esr1)5Amc/0 (involves: C57BL/6 CBA)	decreased Ly6C high monocyte number	J:292726
	decreased Ly6C low monocyte number	J:292726
	decreased macrophage cell number	J:292726
Nup98^tm1Bmaf/Nup98⁺ (involves: 129S6/SvEvTac * C57BL/6)	abnormal MHC II cell surface expression on macrophages	J:110907
	decreased B cell number	J:110907
	decreased CD4-positive, alpha-beta T cell number	J:110907
	decreased IgG1 level	J:110907
	decreased IgG level	J:110907
	decreased T cell proliferation	J:110907
	increased T cell proliferation	J:110907
Nup155^em1(IMPC)Mbp/Nup155⁺ (C57BL/6N-Nup155^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Nup160^tm1Mdan/Nup160^tm1Mdan Gt(ROSA)26Sor^{tm1(cre/ERT2)Tyj}/Gt(ROSA)26Sor⁺ (involves: 129S4/SvJae * C57BL/6)	abnormal hematopoietic stem cell physiology	J:301567
	decreased hematopoietic stem cell proliferation	J:301567
Nup210^enuI476T/Nup210^enuI476T (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal alpha-beta T cell morphology	J:266693
	decreased CD4-positive, alpha-beta T cell number	J:266693
Nup210^enuI476T/Nup210^{tm1a(EUCOMM)Hmgu} (involves: 129S1/Sv * 129X1/SvJ * C57BL/6N)	decreased CD4-positive, alpha-beta T cell number	J:266693
Nup210^tm1.1Mdan/Nup210^tm1.1Mdan (B6.Cg-Nup210^tm1.1Mdan)	abnormal CD4-positive, alpha-beta T cell number	J:282451
	abnormal CD4-positive, alpha-beta T cell physiology	J:282451
	abnormal lymphocyte morphology	J:282451
	abnormal T cell activation	J:282451
	decreased CD4-positive, alpha-beta T cell number	J:282451
	decreased leukocyte cell number	J:282451
	hematopoietic system phenotype	J:282451
	increased effector memory T-helper cell number	J:282451
Nup210^{tm1b(EUCOMM)Hmgu}/Nup210^{tm1b(EUCOMM)Hmgu} (involves: C57BL/6N)	decreased alpha-beta T cell number	J:266693
	decreased CD4-positive, alpha-beta T cell number	J:266693
	decreased CD8-positive, alpha-beta T cell number	J:266693
	decreased T cell number	J:266693
	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:266693
	increased CD8-positive, alpha-beta T cell number	J:266693
	increased central memory CD8 positive, alpha-beta T cell number	J:266693
	increased T-helper 1 cell number	J:266693
Nup210^tm1Mdan/Nup210^tm1Mdan Tg(Cd4-cre/ERT2)11Gnri/0 (involves: 129X1/SvJ * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:282451
Nutm1^{tm1b(KOMP)Wtsi}/Nutm1^{tm1b(KOMP)Wtsi} (C57BL/6N-Nutm1^{tm1b(KOMP)Wtsi}/Wtsi)	increased mean corpuscular hemoglobin	J:211773
	increased red blood cell distribution width	J:211773
Nwd2^{em1(IMPC)Ccpcz}/Nwd2^{em1(IMPC)Ccpcz} (C57BL/6N-Nwd2^{em1(IMPC)Ccpcz}/Ccpcz)	decreased CD8-positive, naive alpha-beta T cell number	J:211773
Nxn^em1(IMPC)J/Nxn⁺ (C57BL/6NJ-Nxn^em1(IMPC)J/J)	increased mean corpuscular hemoglobin concentration	J:211773
Nxn^{tm1b(EUCOMM)Wtsi}/Nxn⁺ (C57BL/6N-Nxn^{tm1b(EUCOMM)Wtsi}/Ccpcz)	increased effector memory CD8-positive, alpha-beta T cell number	J:211773
Nxnl1^tm1.2Tlev/Nxnl1^tm1.2Tlev (involves: BALB/c * BALB/cJ * C57BL/6)	microgliosis	J:186370
Nxnl2^{em1(IMPC)Ccpcz}/Nxnl2⁺ (C57BL/6NCrl-Nxnl2^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Nxnl2^{em1(IMPC)Ccpcz}/Nxnl2^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Nxnl2^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Nxpe5^{tm1a(EUCOMM)Wtsi}/Nxpe5^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Nxpe5^{tm1a(EUCOMM)Wtsi}/H)	decreased erythrocyte cell number	J:165965
Oas1c^{em1(IMPC)Ccpcz}/Oas1c^{em1(IMPC)Ccpcz} (C57BL/6N-Oas1c^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
	small spleen	J:211773
Oaz2^em1(IMPC)J/Oaz2^em1(IMPC)J (C57BL/6NJ-Oaz2^em1(IMPC)J/J)	increased mean corpuscular volume	J:211773
Oca2^p-3Btlr/Oca2^p-3Btlr (C57BL/6J-Oca2^p-3Btlr)	abnormal NK cell physiology	J:133623
Oca2^p-23DFiOD/Oca2^p-x (Not Specified)	increased spleen weight	J:66645
Oca2^p-30PUb/Oca2^p-x (Not Specified)	increased spleen weight	J:89922
Ociad1^em1(IMPC)J/Ociad1^em1(IMPC)J (C57BL/6NJ-Ociad1^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Ociad1^tm1.1Msin/Ociad1⁺ (involves: BALB/cJ * C57BL/6NCrlj * CBA/JNCrlj)	abnormal platelet cell number	J:279239
	increased erythrocyte cell number	J:279239
Ociad1^tm1.1Msin/Ociad1^tm1.1Msin (involves: BALB/cJ * C57BL/6NCrlj * CBA/JNCrlj)	abnormal bone marrow cell number	J:279239
	abnormal hematopoietic stem cell physiology	J:279239
	decreased B cell number	J:279239
	decreased bone marrow cell number	J:279239
	decreased common lymphocyte progenitor cell number	J:279239
	decreased T cell number	J:279239
	enlarged spleen	J:279239
	increased bone marrow cell number	J:279239
	increased granulocyte monocyte progenitor cell number	J:279239
	increased granulocyte number	J:279239
	increased hematopoietic cell number	J:279239
	increased hematopoietic stem cell proliferation	J:279239
	increased macrophage cell number	J:279239
	increased monocyte cell number	J:279239
	increased myeloid cell number in bone marrow	J:279239
	increased neutrophil cell number	J:279239
	increased spleen germinal center size	J:279239
Ocstamp^{tm2a(KOMP)Wtsi}/Ocstamp^{tm2a(KOMP)Wtsi} (involves: C57BL/6J * C57BL/6N)	abnormal osteoclast morphology	J:233553
Odad2^b2b227.1Clo/Odad2^b2b227.1Clo (C57BL/6J-Odad2^b2b227.1Clo)	spleen hypoplasia	J:175213
Odad2^em1(IMPC)Mbp/Odad2^em1(IMPC)Mbp (C57BL/6N-Odad2^em1(IMPC)Mbp/MbpMmucd)	small spleen	J:211773
Odad3^b2b1885Clo/Odad3^b2b1885Clo (C57BL/6J-Odad3^b2b1885Clo)	spleen hypoplasia	J:175213
Odad3^{tm1b(EUCOMM)Hmgu}/Odad3^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Odad3^{tm1b(EUCOMM)Hmgu}/Cnrm)	abnormal spleen morphology	J:278798
	absent spleen	J:278798
	enlarged spleen	J:278798
Odaph^{em1(IMPC)Ccpcz}/Odaph^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Odaph^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
oed/oed (STOCK pc-oed)	increased granulocyte number	J:5609
oed/oed (STOCK pc-oed)	increased leukocyte cell number	J:5609
Ofcc1^em1(IMPC)J/Ofcc1^em1(IMPC)J (C57BL/6NJ-Ofcc1^em1(IMPC)J/J)	thrombocytopenia	J:211773
Ogdh^{tm1e(KOMP)Wtsi}/Ogdh⁺ (C57BL/6N-Ogdh^{tm1e(KOMP)Wtsi}/Wtsi)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
Ogg1^tm1Yun/Ogg1^tm1Yun (involves: 129S/SvEv * C57BL/6JJcl)	microgliosis	J:193978
Ogn^{tm1b(KOMP)Wtsi}/Ogn^{tm1b(KOMP)Wtsi} (C57BL/6N-Ogn^{tm1b(KOMP)Wtsi}/J)	decreased leukocyte cell number	J:211773
Ogt^tm1Gwh/Y Tg(Lck-cre)548Jxm/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	decreased CD4-positive, alpha-beta T cell number	J:93112
	decreased CD8-positive, alpha-beta T cell number	J:93112
	decreased double-positive T cell number	J:93112
	decreased T cell number	J:93112
	decreased thymocyte number	J:93112
	increased T cell apoptosis	J:93112
oh/oh (Not Specified)	increased erythrocyte cell number	J:5300
oh/oh (Not Specified)	increased macrophage cell number	J:5300
Ola1^{Gt(OST312288)Lex}/Ola1^{Gt(OST312288)Lex} (involves: 129S5/SvEvBrd * C57BL/6)	abnormal definitive hematopoiesis	J:236306
Olah^{tm1b(KOMP)Wtsi}/Olah^{tm1b(KOMP)Wtsi} (C57BL/6N-Olah^{tm1b(KOMP)Wtsi}/Ucd)	decreased mean corpuscular hemoglobin concentration	J:211773
	increased mean corpuscular volume	J:211773
Olfm4^tm1Gpro/Olfm4^tm1Gpro (involves: 129X1/SvJ * Black Swiss)	hematopoietic system phenotype	J:161279
Oplah^{tm1b(KOMP)Wtsi}/Oplah^{tm1b(KOMP)Wtsi} (C57BL/6N-Oplah^{tm1b(KOMP)Wtsi}/Ieg)	decreased red blood cell distribution width	J:211773
Opn3^em1(IMPC)Mbp/Opn3^em1(IMPC)Mbp (C57BL/6NCrl-Opn3^em1(IMPC)Mbp/Mmucd)	increased basophil cell number	J:211773
Oprl1^em1(IMPC)Mbp/Oprl1^em1(IMPC)Mbp (C57BL/6N-Oprl1^em1(IMPC)Mbp/MbpMmucd)	decreased mean corpuscular hemoglobin	J:211773
	enlarged spleen	J:211773
	increased mean platelet volume	J:211773
	increased red blood cell distribution width	J:211773
Oprm1^tm1Lyu/Oprm1⁺ (involves: Black Swiss)	abnormal bone marrow cell physiology	J:39864
Oprm1^tm1Lyu/Oprm1⁺ (involves: Black Swiss)	increased splenocyte proliferation	J:39864
Oprm1^tm1Lyu/Oprm1^tm1Lyu (involves: Black Swiss)	abnormal bone marrow cell physiology	J:39864
	abnormal common myeloid progenitor cell morphology	J:39864
	increased erythroid progenitor cell number	J:39864
	increased splenocyte proliferation	J:39864
Or2l13b^em1Scjc/Or2l13b^em1Scjc (FVB/NTac-Or2l13b^em1Scjc)	abnormal platelet activation	J:324598
Or2l13b^em1Scjc/Or2l13b^em1Scjc (FVB/NTac-Or2l13b^em1Scjc)	abnormal platelet morphology	J:324598
Or9g4^em1(IMPC)Mbp/Or9g4^em1(IMPC)Mbp (C57BL/6N-Or9g4^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Or51e1^tm1Jplu/Or51e1^tm1Jplu (involves: C57BL/6)	hematopoietic system phenotype	J:346436
Orai1^Gt(XL922)Byg/Orai1⁺ (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	abnormal mast cell physiology	J:130479
Orai1^Gt(XL922)Byg/Orai1^Gt(XL922)Byg (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	abnormal mast cell physiology	J:130479
Orai1^tm1.1Hjm/Orai1^tm1.1Hjm Orai2^{tm1.1(KOMP)Vlcg}/Orai2^{tm1.1(KOMP)Vlcg} Tg(Cd4-cre)1Cwi/0 (B6.Cg-Tg(Cd4-cre)1Cwi Orai1^tm1.1Hjm Orai2^{tm1.1(KOMP)Vlcg})	abnormal CD4-positive helper T cell morphology	J:241365
	abnormal T cell physiology	J:241365
	decreased germinal center B cell number	J:241365
	decreased IgG level	J:241365
	decreased regulatory T cell number	J:241365
	decreased single-positive T cell number	J:241365
	hematopoietic system phenotype	J:241365
	spleen hyperplasia	J:241365
Orai1^tm1.1Hjm/Orai1^tm1.1Hjm Tg(Cd4-cre)1Cwi/0 (B6.Cg-Orai1^tm1.1Hjm Tg(Cd4-cre)1Cwi)	abnormal T cell physiology	J:241365
Orai1^tm1Fesk/Orai1^tm1Fesk (C57BL/6-Orai1^tm1Fesk)	abnormal platelet activation	J:144861
Orai1^tm1Fesk/Orai1^tm1Fesk (C57BL/6-Orai1^tm1Fesk)	decreased platelet calcium level	J:144861
Orai1^tm1Rao/Orai1⁺ (C57BL/6-Orai1^tm1Rao)	abnormal B cell activation	J:139730
Orai1^tm1Rao/Orai1⁺ (C57BL/6-Orai1^tm1Rao)	abnormal T cell activation	J:139730
Orai1^tm1Rao/Orai1^tm1Rao (involves: C57BL/6NTac * ICR)	abnormal B cell activation	J:139730
	abnormal mast cell physiology	J:139730
	abnormal T cell activation	J:139730
	abnormal thymocyte activation	J:139730
Orai2^{tm1.1(KOMP)Vlcg}/Orai2^{tm1.1(KOMP)Vlcg} (B6.Cg-Orai2^{tm1.1(KOMP)Vlcg})	abnormal macrophage physiology	J:241365
	abnormal T cell physiology	J:241365
Orai2^tm1.2Itl/Orai2^tm1.2Itl (involves: 129S4/SvJaeSor * BALB/cJ * C57BL/6 * C57BL/6N)	abnormal mast cell physiology	J:278536
	increased mast cell degranulation	J:278536
Orgwq1^M16i/? (involves: CAST/Ei * M16i)	increased spleen weight	J:78471
Orgwq2^M16i/? (involves: CAST/Ei * M16i)	increased spleen weight	J:78471
Orgwq6^M16i/? (involves: CAST/Ei * M16i)	increased spleen weight	J:78471
Orgwq7^M16i/? (involves: CAST/Ei * M16i)	increased spleen weight	J:78471
Orgwq8^M16i/? (involves: CAST/Ei * M16i)	increased spleen weight	J:78471
Ormdl2^em1Pdra/Ormdl2^em1Pdra Ormdl3^em1Pdra/Ormdl3^em1Pdra (C57BL/6-Ormdl2^em1Pdra Ormdl3^em1Pdra)	abnormal mast cell physiology	J:328837
	increased mast cell degranulation	J:328837
Ormdl3^em1Pdra/Ormdl3^em1Pdra (C57BL/6-Ormdl3^em1Pdra)	abnormal mast cell physiology	J:328837
Ormdl3^em1Pdra/Ormdl3^em1Pdra (C57BL/6-Ormdl3^em1Pdra)	increased mast cell degranulation	J:328837
Ormdl3^em1Quli/Ormdl3^em1Quli (Not Specified)	abnormal spleen morphology	J:251260
	abnormal splenic cell ratio	J:251260
	small spleen	J:251260
Osbp^em1(IMPC)Tcp/Osbp⁺ (C57BL/6NCrl-Osbp^em1(IMPC)Tcp/Tcp)	decreased mean corpuscular hemoglobin	J:211773
Osbpl8^em1(IMPC)Tcp/Osbpl8^em1(IMPC)Tcp (C57BL/6NCrl-Osbpl8^em1(IMPC)Tcp/Tcp)	increased red blood cell distribution width	J:211773
Oscar^tm1Ywc/Oscar^tm1Ywc (involves: 129P2/OlaHsd)	abnormal osteoclast differentiation	J:178250
Oscar^tm1Ywc/Oscar^tm1Ywc Tyrobp^tm1Ttk/Tyrobp^tm1Ttk (involves: 129P2/OlaHsd * C57BL/6)	abnormal osteoclast differentiation	J:178250
	abnormal osteoclast morphology	J:178250
	abnormal osteoclast physiology	J:178250
	decreased osteoclast cell number	J:178250
Oscp1^{tm1b(EUCOMM)Hmgu}/Oscp1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Oscp1^{tm1b(EUCOMM)Hmgu}/Ieg)	increased hematocrit	J:211773
Osm^{tm1b(KOMP)Wtsi}/Osm^{tm1b(KOMP)Wtsi} (C57BL/6N-Osm^{tm1b(KOMP)Wtsi}/J)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
	thrombocytopenia	J:211773
Osmr^tm1Mtan/Osmr^tm1Mtan (B6.129S-Osmr^tm1Mtan)	abnormal common myeloid progenitor cell morphology	J:86261
	abnormal definitive hematopoiesis	J:86261
	abnormal erythroid progenitor cell morphology	J:86261
	abnormal megakaryocyte progenitor cell morphology	J:86261
	anemia	J:86261
	decreased erythrocyte cell number	J:86261
	decreased hematocrit	J:86261
	decreased megakaryocyte cell number	J:86261
	hematopoietic system phenotype	J:86261
	thrombocytopenia	J:86261
Ostm1^om/Ostm1^om (C3HeB/FeJ-Ostm1^om)	decreased hemoglobin content	J:195249
Otc^em1(IMPC)Tcp/Otc⁺ (C57BL/6NCrl-Otc^em1(IMPC)Tcp/Tcp)	enlarged thymus	J:211773
Otoa^{tm1.1(KOMP)Vlcg}/Otoa^{tm1.1(KOMP)Vlcg} (C57BL/6N-Otoa^{tm1.1(KOMP)Vlcg}/Ucd)	decreased mean corpuscular hemoglobin	J:211773
Otop1^{em1(IMPC)Ccpcz}/Otop1^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Otop1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Otp^{tm1b(EUCOMM)Wtsi}/Otp⁺ (C57BL/6N-Otp^{tm1b(EUCOMM)Wtsi}/H)	decreased mean platelet volume	J:211773
Otub1^{tm1c(EUCOMM)Hmgu}/Otub1^{tm1c(EUCOMM)Hmgu} Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N)	abnormal B cell activation	J:280549
	abnormal follicular B cell morphology	J:280549
	decreased B-1 B cell number	J:280549
	decreased immature B cell number	J:280549
	decreased T cell number	J:280549
	enlarged spleen	J:280549
	increased B cell number	J:280549
	increased B-2 B cell number	J:280549
	increased IgA level	J:280549
	increased IgG2a level	J:280549
	increased IgG2b level	J:280549
	increased IgM level	J:280549
	increased immunoglobulin level	J:280549
	increased marginal zone B cell number	J:280549
	increased mature B cell number	J:280549
Otud5^tm1Vmd/Otud5^tm1Vmd Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	abnormal T-helper 17 cell differentiation	J:219495
	decreased regulatory T cell number	J:219495
	decreased thymocyte number	J:219495
Otud5^tm1Vmd/Otud5^tm1Vmd Tg(Vav1-cre)#Cgp/0 (involves: C57BL/6)	abnormal T-helper 17 cell differentiation	J:219495
Otud6a^{tm1(KOMP)Vlcg}/Otud6a^{tm1(KOMP)Vlcg} (C57BL/6N-Otud6a^{tm1(KOMP)Vlcg}/Nju)	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
Otud6b^{tm1b(EUCOMM)Wtsi}/Otud6b⁺ (C57BL/6N-Otud6b^{tm1b(EUCOMM)Wtsi}/Wtsi)	increased basophil cell number	J:211773
Otud7b^{tm1(NCOM)Cmhd}/Otud7b^{tm1(NCOM)Cmhd} (involves: C57BL/6N)	abnormal granulocyte physiology	J:209709
Otud7b^tm1Dgen/Otud7b^tm1Dgen (involves: 129 * C57BL/6)	decreased activation-induced B cell apoptosis	J:194553
	increased B cell number	J:194553
	increased B cell proliferation	J:194553
	increased IgA level	J:194553
Otulin^em1(IMPC)Bay/Otulin⁺ (C57BL/6N-Otulin^em1(IMPC)Bay/Bay)	abnormal spleen morphology	J:211773
Otulin^m3Sapc/Otulin^m3Sapc (C57BL/6J-Otulin^m3Sapc)	abnormal hematopoietic system morphology/development	J:163657
Ovol1^{tm1b(KOMP)Wtsi}/Ovol1⁺ (C57BL/6N-Ovol1^{tm1b(KOMP)Wtsi}/J)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	thrombocytopenia	J:211773
Oxr1^{tm1a(EUCOMM)Wtsi}/Oxr1⁺ (C57BL/6N-Oxr1^{tm1a(EUCOMM)Wtsi}/Wtsi)	thrombocytopenia	J:211773
Oxsr1^tm1.1Arte/Oxsr1⁺ (involves: 129S/SvEvBrd)	abnormal dendritic cell morphology	J:191351
P2rx4^{tm1b(EUCOMM)Wtsi}/P2rx4^{tm1b(EUCOMM)Wtsi} (C57BL/6N-P2rx4^{tm1b(EUCOMM)Wtsi}/H)	decreased mean corpuscular volume	J:211773
P2rx4^tm1Dgen/P2rx4^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6)	abnormal macrophage physiology	J:145232
P2rx5^tm1Lex/P2rx5^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	decreased CD8-positive, alpha-beta T cell number	J:82809
	increased NK cell number	J:82809
P2rx7^tm1Gab/P2rx7^tm1Gab (either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * C57BL/6 * DBA/2))	increased osteoclast cell number	J:84145
P2rx7^tm1Gab/P2rx7^tm1Gab (B6.129P2-P2rx7^tm1Gab/J)	abnormal mast cell physiology	J:190651
P2rx7^tm1Ipch/P2rx7^tm1Ipch (involves: 129 * C57BL/6)	abnormal macrophage physiology	J:118561
P2rx7^tm1Lex/P2rx7^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	abnormal macrophage physiology	J:145020
P2ry1^tm1Bhk/P2ry1^tm1Bhk (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	decreased platelet aggregation	J:57960
P2ry1^tm1Gac/P2ry1⁺ (involves: 129S2/SvPas * C57BL/6)	decreased platelet aggregation	J:59055
P2ry1^tm1Gac/P2ry1^tm1Gac (involves: 129S2/SvPas * C57BL/6)	decreased platelet aggregation	J:59055
P2ry6^tm1.1Brob/P2ry6^tm1.1Brob (involves: 129S1/Sv * 129X1/SvJ * CD-1)	abnormal macrophage physiology	J:169742
P2ry6^tm1Jabo/P2ry6^tm1Jabo Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ (involves: 129 * C57BL/6 * C57BL/6NTac)	decreased IgE level	J:179177
	decreased T cell apoptosis	J:179177
	increased eosinophil cell number	J:179177
	increased neutrophil cell number	J:179177
	increased T cell proliferation	J:179177
P2ry6^tm1Jabo/P2ry6^tm1Jabo Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ (B6.Cg-Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte} P2ry6^tm1Jabo)	increased eosinophil cell number	J:179177
	increased neutrophil cell number	J:179177
P2ry12^tm1Cjf/P2ry12^tm1Cjf (involves: 129)	decreased platelet aggregation	J:70017
P2ry12^tm1Pcon/P2ry12^tm1Pcon (involves: 129P2/OlaHsd * C57BL/6)	abnormal platelet physiology	J:84917
	decreased platelet aggregation	J:84917
P2ry14^tm1.1Shbg/P2ry14^tm1.1Shbg (involves: 129S6/SvEvTac * C57BL/6)	increased spleen weight	J:223427
P3h3^{tm1.1(KOMP)Vlcg}/P3h3^{tm1.1(KOMP)Vlcg} (C57BL/6N-P3h3^{tm1.1(KOMP)Vlcg}/Ucd)	increased mean corpuscular volume	J:211773
P4hb^tm1.1Geno/P4hb^tm1.1Geno Tg(Mx1-cre)1Cgn/0 (involves: 129 * C57BL/6 * C57BL/6J * CBA/J)	decreased platelet aggregation	J:229395
	hematopoietic system phenotype	J:229395
P4hb^tm1.1Geno/P4hb^tm1.1Geno Tg(Pf4-icre)Q3Rsko/0 (involves: 129 * C57BL/6)	abnormal platelet dense granule physiology	J:229395
	decreased platelet aggregation	J:229395
	hematopoietic system phenotype	J:229395
P4hb^tm1.1Geno/P4hb^tm1.2Geno Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd)	decreased neutrophil cell number	J:197556
	impaired neutrophil recruitment	J:197556
p23-ST1/p23-ST1 (C57BL/6J-p23-ST1)	microgliosis	J:158278
Pa2g4^{tm1a(EUCOMM)Wtsi}/Pa2g4⁺ (Not Specified)	increased mean corpuscular volume	J:165965
Pabir2^{em1(IMPC)Ccpcz}/Y (C57BL/6NCrl-Pabir2^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
	small spleen	J:211773
Pabir2^{em1(IMPC)Ccpcz}/Pabir2^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Pabir2^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Pabpc1l^{tm1a(EUCOMM)Wtsi}/Pabpc1l^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Pabpc1l^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased mean corpuscular hemoglobin	J:175295
Pabpc5^em1(IMPC)Mbp/Y (C57BL/6N-Pabpc5^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Pacsin2^{tm1b(EUCOMM)Hmgu}/Pacsin2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Pacsin2^{tm1b(EUCOMM)Hmgu}/J)	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular hemoglobin concentration	J:211773
	decreased mean corpuscular volume	J:211773
	thrombocytosis	J:211773
Padi2^tm1Lex/Padi2^tm1Lex (B6.129S5-Padi2^tm1Lex)	abnormal mast cell physiology	J:190651
Padi4^em1(IMPC)Mbp/Padi4^em1(IMPC)Mbp (C57BL/6N-Padi4^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
Padi4^tm1.1Kmow/Padi4^tm1.1Kmow (involves: BALB/cJ * C57BL/6)	abnormal neutrophil physiology	J:174934
Padi4^tm1.1Ywan/Padi4^tm1.1Ywan (involves: 129S4/SvJae)	abnormal neutrophil physiology	J:165718
Padi4^tm1.1Ywan/Padi4^tm1.1Ywan (involves: 129S4/SvJae)	impaired neutrophil phagocytosis	J:165718
Pag1^tm1Kplm/Pag1^tm1Kplm (involves: 129P2/OlaHsd * C57BL/6)	increased thymocyte number	J:101365
Pah^em1(IMPC)Tcp/Pah⁺ (C57BL/6NCrl-Pah^em1(IMPC)Tcp/Tcp)	small spleen	J:211773
Paip1^em1(IMPC)Tcp/Paip1^em1(IMPC)Tcp (C57BL/6NCrl-Paip1^em1(IMPC)Tcp/Tcp)	decreased hematocrit	J:211773
	decreased mean corpuscular volume	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
	increased red blood cell distribution width	J:211773
	thrombocytosis	J:211773
Pak1^tm1Cher/Pak1^tm1Cher (B6.129S2-Pak1^tm1Cher)	abnormal mast cell physiology	J:142439
Pak1^tm1Cher/Pak1^tm1Cher (B6.129S2-Pak1^tm1Cher)	decreased mast cell degranulation	J:145444
Pak1^tm1Cher/Pak1^tm1Cher (involves: 129S2/SvPas)	hematopoietic system phenotype	J:195865
Pak2^em1(IMPC)H/Pak2⁺ (C57BL/6NTac-Pak2^em1(IMPC)H/H)	increased mean corpuscular hemoglobin	J:211773
Pak2^em1(IMPC)H/Pak2⁺ (C57BL/6NTac-Pak2^em1(IMPC)H/H)	increased mean corpuscular volume	J:211773
Pak2^tm1.1Cher/Pak2^tm1.1Cher (Not Specified)	abnormal hematopoietic stem cell physiology	J:195865
Pals1^tm1Caw/Pals1^tm1Caw Tg(rx3-icre)1Mjam/0 (Not Specified)	microgliosis	J:184469
Pals2^{em1(IMPC)Rbrc}/Pals2^{em1(IMPC)Rbrc} (C57BL/6NJcl-Pals2^{em1(IMPC)Rbrc}/Rbrc)	abnormal spleen morphology	J:211773
Pan2^{tm1b(KOMP)Wtsi}/Pan2^{tm1b(KOMP)Wtsi} (C57BL/6N-Pan2^{tm1b(KOMP)Wtsi}/Mhzh)	increased eosinophil cell number	J:211773
Pan3^em1(IMPC)Tcp/Pan3⁺ (C57BL/6N-Pan3^em1(IMPC)Tcp/Tcp)	decreased mean corpuscular hemoglobin	J:211773
Pank1^tm1.1Suja/Pank1^tm1.1Suja Pank2^tm1.1Suja/Pank2^tm1.1Suja (involves: 129S/SvEv * C57BL/6J * FVB/N)	decreased spleen weight	J:189609
	small spleen	J:189609
Pank2^{em1(IMPC)Ccpcz}/Pank2^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Pank2^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	decreased CD8-positive, alpha-beta T cell number	J:211773
	increased effector memory CD8-positive, alpha-beta T cell number	J:211773
Pank3^{tm1b(KOMP)Mbp}/Pank3^{tm1b(KOMP)Mbp} (C57BL/6N-Pank3^{tm1b(KOMP)Mbp}/Bay)	decreased erythrocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Panx1^tm1.2Vmd/Panx1^tm1.2Vmd (C57BL/6N-Panx1^tm1.2Vmd)	abnormal T cell physiology	J:173213
Panx1^{tm1b(KOMP)Wtsi}/Panx1^{tm1b(KOMP)Wtsi} (C57BL/6N-Panx1^{tm1b(KOMP)Wtsi}/Ucd)	decreased mean corpuscular hemoglobin	J:211773
Panx2^{tm1b(KOMP)Wtsi}/Panx2^{tm1b(KOMP)Wtsi} (C57BL/6N-Panx2^{tm1b(KOMP)Wtsi}/Ucd)	increased spleen weight	J:211773
Paox^{tm1.1(KOMP)Wtsi}/Paox^{tm1.1(KOMP)Wtsi} (C57BL/6N-Paox^{tm1.1(KOMP)Wtsi}/Ieg)	thrombocytopenia	J:211773
Pappa2^tm1Lex/Pappa2^tm1Lex (C57BL/6-Pappa2^tm1Lex)	increased spleen weight	J:174887
Pard3^{tm1b(KOMP)Wtsi}/Pard3⁺ (C57BL/6N-Pard3^{tm1b(KOMP)Wtsi}/H)	decreased basophil cell number	J:211773
	decreased spleen weight	J:211773
Parg^{tm2b(KOMP)Mbp}/Parg⁺ (C57BL/6N-Parg^{tm2b(KOMP)Mbp}/J)	decreased leukocyte cell number	J:211773
Parl^tm1.1Bdes/Parl^tm1.1Bdes (involves: 129P2/OlaHsd * C57BL/6J)	abnormal B cell morphology	J:116017
	decreased B cell number	J:116017
	decreased double-positive T cell number	J:116017
	decreased lymphocyte cell number	J:116017
	increased T cell apoptosis	J:116017
	spleen atrophy	J:116017
	thymus atrophy	J:116017
Parl^tm1.1Bdes/Parl^tm1.1Bdes (involves: 129P2/OlaHsd)	abnormal thymus apoptosis	J:269785
	microgliosis	J:269785
	spleen atrophy	J:269785
	thymus atrophy	J:269785
Parl^{tm1a(EUCOMM)Hmgu}/Parl⁺ (C57BL/6N-Parl^{tm1a(EUCOMM)Hmgu}/H)	increased mean corpuscular volume	J:165965
Parl^tm1Bdes/Parl^tm1Bdes Tg(Nes-cre)1Kln/0 (involves: 129P2/OlaHsd * C57BL/6 * SJL)	abnormal thymus apoptosis	J:269785
	spleen atrophy	J:269785
	thymus atrophy	J:269785
Parp1^{tm1b(EUCOMM)Hmgu}/Parp1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Parp1^{tm1b(EUCOMM)Hmgu}/Ics)	decreased NK cell number	J:211773
	increased effector memory CD8-positive, alpha-beta T cell number	J:211773
Parp1^tm1Jmdm/Parp1^tm1Jmdm (involves: 129S2/SvPas * C57BL/6)	abnormal leukocyte migration	J:117701
Parp1^tm1Zqw/Parp1^tm1Zqw (129S-Parp1^tm1Zqw/J)	abnormal microglial cell physiology	J:96548
Parp1^tm2Zqw/Parp1^tm2Zqw (either: (involves: 129P2/OlaHsd * 129/Sv) or (involves: 129P2/OlaHsd * C57BL/6))	abnormal macrophage physiology	J:93479
Parp12^{tm1.1(KOMP)Vlcg}/Parp12^{tm1.1(KOMP)Vlcg} (C57BL/6N-Parp12^{tm1.1(KOMP)Vlcg}/Ucd)	increased basophil cell number	J:211773
	increased mean platelet volume	J:211773
	increased neutrophil cell number	J:211773
Parp14^{Gt(OST415485)Lex}/Parp14^{Gt(OST415485)Lex} (involves: 129S5/SvEvBrd * C57BL/6)	decreased B cell proliferation	J:146533
	decreased IgA level	J:146533
	decreased marginal zone B cell number	J:146533
	increased B cell apoptosis	J:146533
	increased B cell proliferation	J:146533
	increased follicular B cell number	J:146533
Parva^{em1(IMPC)Ccpcz}/Parva⁺ (C57BL/6NCrl-Parva^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Parvb^{tm1a(EUCOMM)Wtsi}/Parvb^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Parvb^{tm1a(EUCOMM)Wtsi}/Cnrm)	decreased mature B cell number	J:165965
	decreased NK cell number	J:165965
	decreased T cell number	J:165965
Pate4^{tm1.1(KOMP)Mbp}/Pate4^{tm1.1(KOMP)Mbp} (C57BL/6N-Pate4^{tm1.1(KOMP)Mbp}/J)	decreased mean corpuscular hemoglobin concentration	J:211773
Patz1^tm1.1Welm/Patz1^tm1.1Welm (involves: 129P2/OlaHsd)	abnormal T cell subpopulation ratio	J:158947
	decreased splenocyte number	J:158947
	decreased thymocyte number	J:158947
Patz1^tm1.1Welm/Patz1^tm1.1Welm Tg(TcraTcrb)425Cbn/0 (involves: C57BL/6)	abnormal T cell subpopulation ratio	J:158947
	decreased CD8-positive, alpha-beta T cell number	J:158947
	increased CD4-positive, alpha-beta T cell number	J:158947
Patz1^tm1.1Welm/Patz1^tm1.1Welm Tg(TcraTcrb)1100Mjb/0 (involves: 129P2/OlaHsd * C57BL/6)	abnormal T cell subpopulation ratio	J:158947
	decreased CD8-positive, alpha-beta T cell number	J:158947
	increased CD4-positive, alpha-beta T cell number	J:158947
Patz1^tm1.2Welm/Patz1^tm1.2Welm Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (B6.Cg-Patz1^tm1.2Welm Commd10^{Tg(Vav1-icre)A2Kio})	abnormal mast cell differentiation	J:209168
Pawr^tm1Jmos/Pawr^tm1Jmos (involves: 129/Sv * CD-1)	abnormal T-helper 2 physiology	J:85495
	enlarged spleen	J:85495
	increased B cell proliferation	J:85495
	increased lymphocyte cell number	J:85495
	increased T cell proliferation	J:85495
	spleen hyperplasia	J:85495
Pax1^un-i/Pax1⁺ (either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J))	decreased CD4-positive, alpha-beta T cell number	J:100951
	decreased CD8-positive, alpha-beta T cell number	J:100951
	decreased thymocyte number	J:100951
Pax1^un-i/Pax1^un-i (either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J))	decreased CD4-positive, alpha-beta T cell number	J:100951
	decreased CD8-positive, alpha-beta T cell number	J:100951
	decreased double-negative T cell number	J:100951
	decreased double-positive T cell number	J:100951
	decreased thymocyte number	J:100951
	increased double-negative T cell number	J:100951
Pax1^un/Pax1⁺ Tcf3^tm1Cmu/Tcf3^tm1Cmu (involves: 129P2/OlaHsd * C3H * C57BL/6)	abnormal T cell differentiation	J:103567
	abnormal T cell subpopulation ratio	J:103567
Pax3^Sp-1H/Pax3^Sp-1H (involves: 101/H * C3H/HeH * C57BL/6)	abnormal thymus morphology	J:88412
Pax3^{tm1(FOXO1A)Gcg}/Pax3⁺ (either: (involves: 129X1/SvJ * C57BL/6) or (involves: 129X1/SvJ * NMRI))	abnormal thymus lobule morphology	J:79365
	ectopic thymus	J:79365
Pax5^m1Btlr/Pax5^m1Btlr (C57BL/6J-Pax5^m1Btlr)	decreased B cell number	J:220072
	decreased IgA level	J:220072
	decreased IgG1 level	J:220072
	decreased IgG2a level	J:220072
	decreased IgG2b level	J:220072
	decreased IgG level	J:220072
	decreased IgM level	J:220072
	increased macrophage cell number	J:220072
	increased monocyte cell number	J:220072
	increased single-positive T cell number	J:220072
	increased T cell number	J:220072
Pax5^m2Btlr/Pax5⁺ (C57BL/6J-Pax5^m2Btlr)	decreased B-1b cell number	J:254824
Pax5^m2Btlr/Pax5^m2Btlr (C57BL/6J-Pax5^m2Btlr)	decreased B-1b cell number	J:254824
Pax5^m2Btlr/Pax5^m2Btlr (C57BL/6J-Pax5^m2Btlr)	increased B-1 B cell number	J:254824
Pax5^m3Btlr/Pax5⁺ (C57BL/6J-Pax5^m3Btlr)	decreased B cell number	J:254825
Pax5^m3Btlr/Pax5^m3Btlr (C57BL/6J-Pax5^m3Btlr)	decreased B cell number	J:254825
	decreased B-1 B cell number	J:254825
	decreased IgG level	J:254825
	decreased IgM level	J:254825
	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:254825
	increased CD8-positive, alpha-beta memory T cell number	J:254825
Pax5^m4Btlr/Pax5^m4Btlr (C57BL/6J-Pax5^m4Btlr)	decreased IgD level	J:265140
Pax5^M5Btlr/Pax5^M5Btlr (C57BL/6J-Pax5^M5Btlr)	decreased IgD level	J:265141
Pax5^{tm1b(EUCOMM)Wtsi}/Pax5⁺ (C57BL/6N-Pax5^{tm1b(EUCOMM)Wtsi}/Ieg)	decreased leukocyte cell number	J:211773
	increased CD4-positive NK T cell number	J:211773
	increased memory-marker CD4-positive NK T cell number	J:211773
Pax5^tm1Mbu/Pax5^tm1Mbu (involves: 129S2/SvPas * C57BL/6)	abnormal B cell differentiation	J:38813
	abnormal lymphopoiesis	J:38813
	absent B-2 B cells	J:113076
	absent mature B cells	J:113076
	arrested B cell differentiation	J:113076
	decreased B cell number	J:113076
	decreased B-1 B cell number	J:113076
	decreased immature B cell number	J:113076
	decreased immunoglobulin level	J:113076
	increased T cell number	J:113076
Pax5^tm1Mbu/Pax5^tm1Mbu (involves: 129S2/SvPas)	abnormal B cell physiology	J:123629
	abnormal immunoglobulin heavy chain V(D)J recombination	J:139510
	arrested B cell differentiation	J:75504
Pax5^tm1Mbu/Pax5^tm1Mbu (either: 129 or (involves: 129S2/SvPas * C57BL/6J))	abnormal late pro-B cell	J:21935
	abnormal lymphopoiesis	J:21935
	absent late pro-B cells	J:21935
	arrested B cell differentiation	J:21935
Pax5^tm1Mbu/Pax5^tm3Mbu Tg(Mx1-cre)1Cgn/? (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * CBA)	decreased mature B cell number	J:75504
Pax5^tm3.1Mbu/Pax5^tm3.1Mbu (involves: 129P2/OlaHsd * C57BL/6)	arrested B cell differentiation	J:75504
Pax5^tm3Mbu/Pax5⁺ Tcf3^tm1(PBX1)Mlc/Tcf3⁺ Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal pro-B cell morphology	J:226241
	arrested B cell differentiation	J:226241
	decreased immature B cell number	J:226241
Pax9^tm1.1Hpt/Pax9^tm1.1Hpt Tg(Pgk1-cre)1Lni/? (involves: 129S2/SvPas * BALB/c * C57BL/6 * SJL)	abnormal thymus lobule morphology	J:125026
Pax9^tm1Rbal/Pax9^tm1Rbal (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	athymia	J:49857
Pax9^tm1Rbal/Pax9^tm1Rbal (involves: 129S1/Sv * 129X1/SvJ * CD-1)	ectopic thymus	J:311535
	thymus hypoplasia	J:311535
Paxx^em1Spj/Paxx^em1Spj (C57BL/6NTac-Paxx^em1Spj)	decreased B cell number	J:236776
	decreased CD4-positive, alpha-beta T cell number	J:236776
	decreased CD8-positive, alpha-beta T cell number	J:236776
	decreased follicular B cell number	J:236776
	decreased splenocyte number	J:236776
	decreased T cell number	J:236776
	decreased transitional stage B cell number	J:236776
	increased mature B cell number	J:236776
Paxx^em1Spj/Paxx^em1Spj Nhej1^tm1Fwa/Nhej1^tm1Fwa (involves: 129S6/SvEvTac * C57BL/6NTac)	abnormal thymus involution	J:236776
	absent lymphocyte	J:236776
	athymia	J:236776
	decreased spleen weight	J:236776
	decreased splenocyte number	J:236776
	small spleen	J:236776
Pbat1^BXSB/Slc/Pbat1^BXSB/Slc (involves: BXSB/Slc * NZW/Slc)	thrombocytopenia	J:49899
Pbat1^BXSB/Slc/Pbat1^NZW/Slc (involves: BXSB/Slc * NZW/Slc)	thrombocytopenia	J:49899
Pbat2^BXSB/Slc/Pbat2^BXSB/Slc (involves: BXSB/Slc * NZW/Slc)	thrombocytopenia	J:49899
Pbat2^BXSB/Slc/Pbat2^NZW/Slc (involves: BXSB/Slc * NZW/Slc)	thrombocytopenia	J:49899
Pbbcp1^C57BL/6J/? (involves: C57BL/6J * DBA/2J)	increased B cell number	J:74270
Pbrbc1^CBA/HOla/Pbrbc1^CBA/HOla (involves: C57BL/6Ola * CBA/HOla)	increased erythrocyte cell number	J:118313
Pbrbc2^A/J/? (involves: A/J * C57BL/6J)	increased erythrocyte cell number	J:118313
Pbrbc3^C57BL/6J/? (involves: A/J * C57BL/6J)	increased erythrocyte cell number	J:118313
Pbrbc4^C57BL/6J/? (involves: A/J * C57BL/6J)	increased erythrocyte cell number	J:118313
Pbrgcsf1^C57BL/6J/Pbrgcsf1^DBA/2J (involves: C57BL/6J * DBA/2J)	abnormal definitive hematopoiesis	J:87464
Pbrgcsf1^C57BL/6J/Pbrgcsf1^DBA/2J Pbrgcsf2^C57BL/6J/Pbrgcsf2^DBA/2J (involves: C57BL/6J * DBA/2J)	abnormal definitive hematopoiesis	J:87464
Pbrgcsf2^C57BL/6J/Pbrgcsf2^DBA/2J (involves: C57BL/6J * DBA/2J)	abnormal definitive hematopoiesis	J:87464
Pbrgcsf2^DBA/2J/Pbrgcsf2^DBA/2J (involves: C57BL/6J * DBA/2J)	abnormal definitive hematopoiesis	J:87464
Pbrm1^{tm1b(EUCOMM)Wtsi}/Pbrm1⁺ (C57BL/6N-Pbrm1^{tm1b(EUCOMM)Wtsi}/Ieg)	increased mean platelet volume	J:211773
Pbrm1^tm1Zhwa/Pbrm1^tm1Zhwa Tg(Cd4-cre)1Cwi/? (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	abnormal T-helper 2 cell differentiation	J:236906
	decreased T cell proliferation	J:236906
Pbwg1.9^{M. m. castaneus}/? (involves: C57BL/6J * M. m. castaneus)	increased spleen weight	J:121981
Pbx1^em1Dunw/Pbx1^em1Dunw (C57BL/6J-Pbx1^em1Dunw)	ectopic thymus	J:320934
	spleen hypoplasia	J:320934
	thymus hypoplasia	J:320934
Pbx1^tm1.1Koss/Pbx1^tm1.1Koss Tg(WT1-cre)AG11Dbdr/0 (involves: 129P2/OlaHsd * C57BL/6)	spleen hypoplasia	J:184521
Pbx1^tm1.1Koss/Pbx1^tm1.2Koss Tmem163^{Tg(ACTB-cre)2Mrt}/0 (involves: 129P2/OlaHsd * FVB/N)	absent spleen	J:184521
Pbx1^tm1Koss/Pbx1^tm1Koss Nkx2-5^tm2(cre)Rph/Nkx2-5⁺ (involves: 129P2/OlaHsd * 129S1/Sv)	abnormal spleen mesenchyme morphology	J:184521
	abnormal spleen morphology	J:184521
	spleen hypoplasia	J:184521
Pbx1^tm1Koss/Pbx1^tm1Koss Pbx2^tm1Mlc/Pbx2⁺ Nkx2-5^tm2(cre)Rph/Nkx2-5⁺ (involves: 129P2/OlaHsd * 129S/Sv * 129S1/Sv)	abnormal spleen morphology	J:184521
	spleen hypoplasia	J:184521
Pbx1^tm1Mlc/Pbx1^tm1Mlc (involves: 129S6/SvEvTac * C57BL/6)	absent common myeloid progenitor cells	J:70684
	absent spleen	J:71996, J:70684
	anemia	J:70684
	decreased hematocrit	J:70684
	ectopic thymus	J:71996
	impaired hematopoiesis	J:70684
	low mean erythrocyte cell number	J:70684
Pbx1^tm1Mlc/Pbx1^tm2.1Mlc (involves: 129S6/SvEvTac)	decreased CD4-positive, alpha-beta T cell number	J:132963
	decreased CD8-positive, alpha-beta T cell number	J:132963
	decreased mature B cell number	J:132963
Pbx1^tm1Mlc/Pbx1^tm3.1Mlc Tg(Mx1-cre)1Cgn/0 (involves: 129S6/SvEvTac * C57BL/6 * CBA)	abnormal common lymphocyte progenitor cell morphology	J:149799
	abnormal definitive hematopoiesis	J:149799
	abnormal hematopoietic stem cell morphology	J:149799
	decreased hematopoietic stem cell number	J:149799
Pbx1^tm1Mlc/Pbx1^tm3.1Mlc Tg(Tek-cre)1Ywa/0 (involves: 129S6/SvEvTac * C57BL/6 * SJL)	abnormal common lymphocyte progenitor cell morphology	J:149799
	abnormal definitive hematopoiesis	J:149799
	abnormal hematopoietic stem cell morphology	J:149799
	abnormal spleen morphology	J:149799
	abnormal thymus morphology	J:149799
	decreased B cell number	J:149799
	decreased bone marrow cell number	J:149799
	decreased common myeloid progenitor cell number	J:149799
	decreased double-negative T cell number	J:149799
	decreased hematopoietic stem cell number	J:149799
	decreased pre-B cell number	J:149799
	decreased pro-B cell number	J:149799
	decreased T cell number	J:149799
	small spleen	J:149799
	small thymus	J:149799
	spleen hypoplasia	J:149799
	thymus hypoplasia	J:149799
Pbx2^tm1Mlc/Pbx2^tm1Mlc (either: 129S/Sv or (involves: 129S/Sv * C57BL/6))	hematopoietic system phenotype	J:91079
Pcare^tm1Kpal/Pcare^tm1Kpal (involves: C57BL/6J * C57BL/6NTac)	increased microglial cell activation	J:220866
Pcbp1^em2Salr/Pcbp1⁺ (C57BL/6-Pcbp1^em2Salr)	hematopoietic system phenotype	J:235912
Pcbp2^tm1.2Salr/Pcbp2⁺ (involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6 * FVB/N)	abnormal erythroblast morphology	J:235912
	abnormal platelet cell number	J:235912
Pcd4ts1^DBA/2/? (involves: BALB/c * C3H * C57BL/6 * DBA/2)	abnormal CD4-positive, alpha beta T cell morphology	J:83220
Pcd4ts2^BALB/c/? (involves: BALB/c * C3H * C57BL/6 * DBA/2)	abnormal CD4-positive, alpha beta T cell morphology	J:83220
Pcd4ts3^BALB/c/? (involves: BALB/c * C3H * C57BL/6 * DBA/2)	abnormal CD4-positive, alpha beta T cell morphology	J:83220
Pcd8ts1^C57BL/6/? (involves: BALB/c * C3H * C57BL/6 * DBA/2)	increased CD8-positive, alpha-beta T cell number	J:83220
Pcdh7^em1Ywc/Pcdh7^em1Ywc (Not Specified)	decreased osteoclast cell number	J:298915
Pcdhb10^em1(IMPC)Tcp/Pcdhb10^em1(IMPC)Tcp (C57BL/6N-Pcdhb10^em1(IMPC)Tcp/Tcp)	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
Pcdhb13^em1(IMPC)Tcp/Pcdhb13^em1(IMPC)Tcp (C57BL/6N-Pcdhb13^em1(IMPC)Tcp/Tcp)	decreased basophil cell number	J:211773
Pcdhb22^{tm1.1(KOMP)Vlcg}/Pcdhb22^{tm1.1(KOMP)Vlcg} (C57BL/6N-Pcdhb22^{tm1.1(KOMP)Vlcg}/J)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
Pcdhg^em5Rwb/Pcdhg^em5Rwb (C57BL/6J-Pcdhg^em5Rwb/Rwb)	microgliosis	J:285314
Pcdhg^em41Rwb/Pcdhg^em41Rwb (C57BL/6J-Pcdhg^em41Rwb/Rwb)	microgliosis	J:285314
Pcdhg^tm1.1Tman/Pcdhg^tm1.1Tman (involves: 129S4/SvJae * C57BL/6)	microgliosis	J:188341
Pcgf2^{tm1b(KOMP)Mbp}/Pcgf2⁺ (C57BL/6N-Pcgf2^{tm1b(KOMP)Mbp}/Tcp)	abnormal spleen morphology	J:211773
	small spleen	J:211773
Pcgf2^tm1Hko/Pcgf2^tm1Hko (involves: BALB/c * C57BL/6)	abnormal T-helper 2 physiology	J:71268
	decreased lymphocyte cell number	J:71268
	decreased thymocyte number	J:71268
Pcgf3^{TgTn(sb-cHS4,Tyr)2349AOve}/Pcgf3^{TgTn(sb-cHS4,Tyr)2349AOve} (FVB/N-Pcgf3^{TgTn(sb-cHS4,Tyr)2349AOve})	absent spleen	J:175597
Pcgf6^tm1.2Hko/Pcgf6^tm1.2Hko (involves: 129 * C57BL/6)	decreased nucleated erythrocyte cell number	J:258919
Pcid2^tm1Imku/Pcid2^tm1Imku Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * C57BL/6 * CBA)	abnormal spleen B cell follicle morphology	J:166080
	decreased follicular B cell number	J:166080
	decreased marginal zone B cell number	J:166080
	decreased mature B cell number	J:166080
Pclaf^tm1.1Lkd/Pclaf^tm1.1Lkd (involves: C57BL/6)	abnormal common lymphocyte progenitor cell morphology	J:177782
	abnormal hematopoietic stem cell physiology	J:177782
	abnormal hematopoietic system physiology	J:177782
	decreased bone marrow cell number	J:177782
	decreased common myeloid progenitor cell number	J:177782
	decreased hematopoietic stem cell number	J:177782
	decreased leukocyte cell number	J:177782
	spleen hypoplasia	J:177782
	thymus hypoplasia	J:177782
Pclaf^tm1.1Lkd/Pclaf^tm1.1Lkd Trp53^tm1Tyj/Trp53⁺ (involves: 129S2/SvPas * C57BL/6)	increased hematopoietic stem cell number	J:177782
Pclaf^{tm1a(EUCOMM)Wtsi}/Pclaf^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Pclaf^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased CD11b-high dendritic cell number	J:211773
	decreased dendritic cell number	J:211773
	decreased immature NK cell number	J:211773
	decreased plasmacytoid dendritic cell number	J:211773
	decreased regulatory T cell number	J:211773
	decreased T cell number	J:211773
	increased CD11b-low dendritic cell number	J:211773
	increased dendritic cell number	J:211773
	increased mature NK cell number	J:211773
	increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	increased pro-B cell number	J:211773
Pcm1^em1(IMPC)Tcp/Pcm1^em1(IMPC)Tcp (C57BL/6NCrl-Pcm1^em1(IMPC)Tcp/Tcp)	decreased spleen weight	J:211773
	small spleen	J:211773
Pcmt1^tm1Shs/Pcmt1^tm1Shs (involves: 129P2/OlaHsd * C57BL/6)	small spleen	J:46228
Pcna^tm1.1Mdsc/Pcna^tm1.1Mdsc Tg(Pcna*K164R)1Mdsc/0 (involves: FVB/N)	abnormal class switch recombination	J:141098
	abnormal somatic hypermutation frequency	J:141098
Pcna^tm1Jcbs/Pcna^tm1Jcbs (involves: 129P2/OlaHsd * C57BL/6)	abnormal somatic hypermutation frequency	J:125916
Pcna^tm1Jcbs/Pcna^tm1Jcbs (involves: 129P2/OlaHsd)	abnormal somatic hypermutation frequency	J:155454, J:177630
Pcna^tm1Jcbs/Pcna^tm1Jcbs Ung^tm1Tld/Ung^tm1Tld (involves: 129P2/OlaHsd)	abnormal somatic hypermutation frequency	J:155454
Pcsk1^tm1Dfs/Pcsk1^tm1Dfs (involves: 129 * C57BL/6J)	abnormal peritoneal macrophage morphology	J:184882
	abnormal spleen marginal zone morphology	J:184882
	abnormal spleen white pulp morphology	J:184882
	abnormal T-helper 1 cell differentiation	J:184882
	decreased NK T cell number	J:184882
	decreased T cell number	J:184882
	enlarged spleen	J:184882
	increased lymphocyte cell number	J:184882
	intermingled spleen red and white pulp	J:184882
Pcsk2^em1(IMPC)H/Pcsk2^em1(IMPC)H (C57BL/6NTac-Pcsk2^em1(IMPC)H/H)	increased mean corpuscular volume	J:211773
Pcsk5^vcc/Pcsk5^vcc (involves: C57BL/6J)	abnormal thymus lobule morphology	J:136243
Pcsk5^vcc/Pcsk5^vcc (involves: C57BL/6J)	small thymus	J:136243
Pctp^tm1Bor/Pctp^tm1Bor (B6.129P2-Pctp^tm1Bor)	abnormal macrophage physiology	J:115284
Pctp^tm1Bor/Pctp^tm1Bor (B6.129P2-Pctp^tm1Bor)	increased macrophage apoptosis	J:115284
Pcyt1a^tm1Irt/Pcyt1a^tm1Irt Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129 * C57BL/6J)	abnormal macrophage physiology	J:65639
Pdap1^em1Rkuhn/Pdap1^em1Rkuhn Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N)	abnormal B cell physiology	J:298705
	abnormal class switch recombination	J:298705
	abnormal somatic hypermutation frequency	J:298705
	decreased germinal center B cell number	J:298705
	decreased mature B cell number	J:298705
	increased B cell apoptosis	J:298705
Pdcd1^tm1.1Liux/Pdcd1^tm1.1Liux (involves: C57BL/6)	decreased regulatory T cell number	J:190150
Pdcd1^tm1.1Liux/Pdcd1^tm1.1Liux (involves: C57BL/6)	increased T-helper 1 cell number	J:190150
Pdcd1^tm1.1Liux/Pdcd1^tm1.1Liux Tg(MMTV-PyVT)634Mul/0 (involves: C57BL/6 * FVB/N)	decreased regulatory T cell number	J:190150
	decreased T-helper 2 cell number	J:190150
	decreased T-helper 17 cell number	J:190150
	increased T-helper 1 cell number	J:190150
Pdcd1^tm1.1Shr/Pdcd1^tm1.1Shr (involves: C57BL/6)	decreased B-1 B cell number	J:153040
Pdcd1^tm1.1Shr/Pdcd1^tm1.1Shr (involves: C57BL/6)	increased regulatory T cell number	J:153040
Pdcd1^tm1.1Shr/Pdcd1^tm1.1Shr Tg(TcraTcrb)1100Mjb/0 (involves: C57BL/6)	decreased T cell proliferation	J:153040
	increased T cell proliferation	J:153040
Pdcd1^tm1Hon/Pdcd1^tm1Hon (involves: 129S2/SvPas * C57BL/6)	abnormal immunoglobulin level	J:50688
	abnormal leukopoiesis	J:50688
	abnormal myelopoiesis	J:50688
	enlarged spleen	J:50688
	increased B cell number	J:50688
	increased B cell proliferation	J:50688
	increased B-1 B cell number	J:50688
	increased IgA level	J:50688
	increased IgG2b level	J:50688
	increased IgG3 level	J:50688
	increased lymphocyte cell number	J:50688
Pdcd1^tm1Hon/Pdcd1^tm1Hon (involves: 129S2/SvPas)	abnormal T cell activation	J:222944
	increased IgA level	J:222944
	increased IgM level	J:222944
Pdcd1^tm1Hon/Pdcd1^tm1Hon Vsir^tm1Lex/Vsir^tm1Lex (involves: 129S2/SvPas * 129S5/SvEvBrd * C57BL/6)	abnormal T cell activation	J:222944
	increased IgA level	J:222944
	increased IgM level	J:222944
Pdcd1^tm1Llc/Pdcd1^tm1Llc (involves: 129S5/SvEvBrd)	decreased CD8-positive, alpha-beta T cell number	J:126829
Pdcd1lg2^tm1.1Lex/Pdcd1lg2^tm1.1Lex (involves: 129S5/SvEvBrd)	decreased CD8-positive, alpha-beta T cell number	J:126829
Pdcd1lg2^tm1Dmp/Pdcd1lg2^tm1Dmp (C.129-Pdcd1lg2^tm1Dmp)	abnormal cytotoxic T cell physiology	J:99212
	decreased IgG2a level	J:99212
	decreased T cell proliferation	J:99212
Pdcd1lg2^tm1Shr/Pdcd1lg2^tm1Shr (involves: 129/Sv * 129S4/SvJae)	increased IgG2a level	J:113851
	increased IgM level	J:113851
Pdcd1lg2^tm3Shr/Pdcd1lg2^tm3Shr (involves: C57BL/6 * NOD/MrkTac)	abnormal CD8-positive, alpha-beta T cell physiology	J:123785
	increased CD4-positive, alpha-beta T cell number	J:123785
	increased CD8-positive, alpha-beta T cell number	J:123785
Pdcd6ip^em1(IMPC)Mbp/Pdcd6ip^em1(IMPC)Mbp (C57BL/6NCrl-Pdcd6ip^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased mean platelet volume	J:211773
Pdcd7^em1(IMPC)Mbp/Pdcd7⁺ (C57BL/6N-Pdcd7^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased red blood cell distribution width	J:211773
Pdcd10^tm1.1Wami/Pdcd10^tm1.1Wami (involves: 129 * C57BL/6)	anemia	J:171969
Pdcd10^tm1.1Wami/Pdcd10^tm1.1Wami (involves: 129 * C57BL/6)	impaired hematopoiesis	J:171969
Pdcd10^tm1Wami/Pdcd10^tm1Wami Tg(Tek-cre)12Flv/0 (involves: 129 * C3H * C57BL/6)	anemia	J:171969
	impaired hematopoiesis	J:171969
Pde1b^{tm1b(EUCOMM)Wtsi}/Pde1b^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Pde1b^{tm1b(EUCOMM)Wtsi}/Bay)	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
Pde2a^em1(IMPC)H/Pde2a⁺ (C57BL/6NTac-Pde2a^em1(IMPC)H/H)	increased neutrophil cell number	J:211773
Pde4b^tm1Mct/Pde4b⁺ Pde4d^tm1Mct/Pde4d^tm1Mct (involves: 129P2/OlaHsd * C57BL/6)	impaired neutrophil recruitment	J:94853
Pde4b^tm1Mct/Pde4b^tm1Mct (involves: 129P2/OlaHsd * C57BL/6)	impaired neutrophil chemotaxis	J:94853
	impaired neutrophil recruitment	J:94853
Pde4b^tm1Mct/Pde4b^tm1Mct Pde4d^tm1Mct/Pde4d⁺ (involves: 129P2/OlaHsd * C57BL/6)	impaired neutrophil recruitment	J:94853
Pde4d^tm1Mct/Pde4d^tm1Mct (involves: 129P2/OlaHsd * C57BL/6)	impaired neutrophil chemotaxis	J:94853
	impaired neutrophil recruitment	J:94853
Pde4dip^{tm1b(KOMP)Wtsi}/Pde4dip⁺ (C57BL/6N-Pde4dip^{tm1b(KOMP)Wtsi}/Bay)	increased hemoglobin content	J:211773
Pde5a^em1(IMPC)Mbp/Pde5a⁺ (C57BL/6N-Pde5a^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Pde10a^em1(IMPC)H/Pde10a^em1(IMPC)H (C57BL/6NTac-Pde10a^em1(IMPC)H/H)	increased mean corpuscular volume	J:211773
	increased mean platelet volume	J:211773
Pdgfb^tm1Cbet/Pdgfb^tm1Cbet (involves: 129P2/OlaHsd * C57BL/6)	decreased hematocrit	J:20017
	decreased hemoglobin content	J:20017
	erythroblastosis	J:20017
	increased mean corpuscular volume	J:20017
	macrocytic anemia	J:20017
	thrombocytopenia	J:20017
Pdgfb^tm1Cbet/Pdgfb^tm2Cbet Tg(Tie1-cre)9Ref/0 (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	abnormal microglial cell morphology	J:89186
Pdgfc^{tm1b(EUCOMM)Hmgu}/Pdgfc⁺ (C57BL/6N-Pdgfc^{tm1b(EUCOMM)Hmgu}/Ieg)	decreased erythrocyte cell number	J:211773
	enlarged spleen	J:211773
	increased granulocyte number	J:211773
	increased monocyte cell number	J:211773
	increased red blood cell distribution width	J:211773
Pdgfra^{tm1.1(cre/Esr1)Nshk}/Pdgfra⁺ Runx1^tm1Medv/Runx1^tm1Medv (involves: 129P2/OlaHsd C57BL/6NCrlj * CBA/JNCrlj)	abnormal hematopoietic cell number	J:193389
	anemia	J:193389
Pdgfra^{tm1.1(cre/Esr1)Nshk}/Pdgfra^{tm1.1(cre/Esr1)Nshk} (involves: C57BL/6NCrlj * CBA/JNCrlj)	hematopoietic system phenotype	J:193389
Pdgfra^tm8Sor/Pdgfra^tm8Sor H2az2^{Tg(Wnt1-cre)11Rth}/H2az2⁺ (Not Specified)	small thymus	J:81153
Pdgfra^tm8Sor/Pdgfra^tm8Sor Pdgfrb^tm1Mdt/Pdgfrb^tm1Mdt H2az2^{Tg(Wnt1-cre)11Rth}/H2az2⁺ (involves: C57BL/6 * CBA)	abnormal thymus development	J:122584
	thymus hypoplasia	J:122584
Pdgfrb^b2b2903Clo/Pdgfrb^b2b2903Clo (C57BL/6J-Pdgfrb^b2b2903Clo)	thymus hypoplasia	J:175213
Pdgfrb^tm1Rheu/Pdgfrb^tm1Rheu (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal embryonic hematopoiesis	J:138069
Pdgfrb^tm1Sor/Pdgfrb^tm1Sor (either: 129S7/SvEvBrd-Pdgfrb^tm1Sor or (involves: 129S7/SvEvBrd * C57BL/6J))	abnormal erythrocyte morphology	J:20016
	anemia	J:20016
	anisocytosis	J:20016
	increased nucleated erythrocyte cell number	J:20016
	poikilocytosis	J:20016
	polychromatophilia	J:20016
	schistocytosis	J:20016
	thrombocytopenia	J:20016
Pdgfrb^tm2Sor/Pdgfrb^tm2Sor (either: 129S7/SvEvBrd-Pdgfrb^tm2Sor or (involves: 129S7/SvEvBrd * C57BL/6J))	abnormal erythrocyte morphology	J:20016
	anemia	J:20016
	anisocytosis	J:20016
	increased nucleated erythrocyte cell number	J:20016
	poikilocytosis	J:20016
	polychromatophilia	J:20016
	schistocytosis	J:20016
	thrombocytopenia	J:20016
Pdgfrl^em1(IMPC)J/Pdgfrl^em1(IMPC)J (C57BL/6NJ-Pdgfrl^em1(IMPC)J/J)	increased hemoglobin content	J:211773
Pdha2^em1(IMPC)Bay/Pdha2^em1(IMPC)Bay (C57BL/6N-Pdha2^em1(IMPC)Bay/Bay)	abnormal spleen morphology	J:211773
Pdia4^{tm1b(EUCOMM)Wtsi}/Pdia4^{tm1b(EUCOMM)Wtsi} Tg(Pf4-icre)Q3Rsko/0 (involves: C57BL/6N)	decreased platelet aggregation	J:244748
	decreased platelet ATP level	J:244748
	hematopoietic system phenotype	J:244748
Pdia4^{tm1b(EUCOMM)Wtsi}/Pdia4^{tm1b(EUCOMM)Wtsi} Tg(Tek-cre)12Flv/0 (involves: C3H * C57BL/6N)	decreased platelet aggregation	J:244748
	hematopoietic system phenotype	J:244748
Pdia6^em1Btlr/Pdia6^m1Btlr (involves: C57BL/6J)	abnormal T cell physiology	J:288824
	decreased B cell number	J:288824
	decreased common lymphocyte progenitor cell number	J:288824
	decreased common myeloid progenitor cell number	J:288824
	decreased double-negative T cell number	J:288824
	decreased double-positive T cell number	J:288824
	decreased follicular B cell number	J:288824
	decreased hematopoietic stem cell number	J:288824
	decreased leukocyte cell number	J:288824
	decreased lymphocyte cell number	J:288824
	decreased monocyte cell number	J:288824
	decreased NK T cell number	J:288824
	decreased pre-B cell number	J:288824
	decreased transitional stage B cell number	J:288824
	hematopoietic system phenotype	J:288824
	increased granulocyte monocyte progenitor cell number	J:288824
	increased marginal zone B cell number	J:288824
	increased marginal zone precursor B cell number	J:288824
	increased mature B cell number	J:288824
	spleen hypoplasia	J:288824
	thrombocytopenia	J:288824
	thymus hypoplasia	J:288824
Pdia6^{tm1b(EUCOMM)Hmgu}/Pdia6⁺ (C57BL/6N-Pdia6^{tm1b(EUCOMM)Hmgu}/Ieg)	decreased CD4-positive NK T cell number	J:211773
Pdik1l^em1(IMPC)Mbp/Pdik1l^em1(IMPC)Mbp (C57BL/6NCrl-Pdik1l^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	enlarged spleen	J:211773
	increased red blood cell distribution width	J:211773
	increased spleen weight	J:211773
Pdk2^em1(IMPC)Mbp/Pdk2^em1(IMPC)Mbp (C57BL/6N-Pdk2^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Pdk4^tm1Tok/Pdk4^tm1Tok (B6.129P2-Pdk4^tm1Tok)	abnormal osteoclast cell number	J:179789
	abnormal osteoclast differentiation	J:179789
	abnormal osteoclast morphology	J:179789
Pdlim1^{Gt(IST12013D3)Tigm}/Pdlim1^{Gt(IST12013D3)Tigm} (involves: C57BL/6N)	abnormal platelet physiology	J:212221
	hematopoietic system phenotype	J:212221
	increased platelet aggregation	J:212221
Pdlim1^Gt(XC262)Byg/Pdlim1^Gt(XC262)Byg (involves: 129P2/OlaHsd)	abnormal platelet dense granule physiology	J:212221
	abnormal platelet physiology	J:212221
	hematopoietic system phenotype	J:212221
	increased mean platelet volume	J:212221
	increased platelet aggregation	J:212221
Pdlim2^tm1Gru/Pdlim2^tm1Gru (Not Specified)	abnormal T-helper 1 physiology	J:99108
Pdlim7^em1(IMPC)Mbp/Pdlim7^em1(IMPC)Mbp (C57BL/6N-Pdlim7^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased mean platelet volume	J:211773
Pdlim7^{Gt(OST445990)Lex}/Pdlim7^{Gt(OST445990)Lex} (B6.129S5-Pdlim7^{Gt(OST445990)Lex})	hematopoietic system phenotype	J:209780
	increased lymphocyte cell number	J:209780
	increased monocyte cell number	J:209780
Pdpk1^tm1.1Mlw/Pdpk1^tm1.1Mlw Tnfrsf4^tm2(cre)Nik/Tnfrsf4⁺ Gt(ROSA)26Sor^tm1(EYFP)Cos/Gt(ROSA)26Sor⁺ (involves: 129X1/SvJ * C57BL/6)	abnormal regulatory T cell number	J:226194
	abnormal T cell physiology	J:226194
	enlarged spleen	J:226194
Pdpk1^tm1Dral/Pdpk1^tm1Dral (B6.129P2-Pdpk1^tm1Dral)	small spleen	J:136089
Pdpk1^tm1Mlw/Pdpk1^tm1.1Daca Tg(Cd4-cre)1Cwi/0 (involves: 129P2/OlaHsd * BALB/c * C57BL/6 * DBA/2)	abnormal CD8-positive, alpha beta T cell morphology	J:165626
	decreased NK T cell number	J:165626
	decreased T cell number	J:165626
Pdpk1^tm1Mlw/Pdpk1^tm1Mlw Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	abnormal CD8-positive, alpha beta T cell morphology	J:165626
	abnormal NK T cell morphology	J:165626
	abnormal T cell differentiation	J:165626
	absent NK T cells	J:165626
	decreased NK T cell number	J:165626
	decreased T cell number	J:165626
	decreased T cell proliferation	J:165626
Pdpn^tm2.1Mlkn/Pdpn^tm2.1Mlkn Rag1^tm1Mom/Rag1^tm1Mom Tg(Pdgfrb-cre)9Rha/0 (involves: 129S7/SvEvBrd * C57BL/6)	absent lymphocyte	J:205423
Pdpr^{tm1b(EUCOMM)Wtsi}/Pdpr^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Pdpr^{tm1b(EUCOMM)Wtsi}/Ics)	decreased large unstained cell number	J:211773
	increased hematocrit	J:211773
Pdss2^{tm1b(EUCOMM)Hmgu}/Pdss2⁺ (C57BL/6N-Pdss2^{tm1b(EUCOMM)Hmgu}/H)	thrombocytopenia	J:211773
Pdxp^em1(IMPC)J/Pdxp^em1(IMPC)J (C57BL/6NJ-Pdxp^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Pdyn^{em1(IMPC)Rbrc}/Pdyn^{em1(IMPC)Rbrc} (C57BL/6NJcl-Pdyn^{em1(IMPC)Rbrc}/Rbrc)	abnormal platelet cell number	J:211773
Pdzd8^{tm1b(EUCOMM)Wtsi}/Pdzd8⁺ (C57BL/6N-Pdzd8^{tm1b(EUCOMM)Wtsi}/Wtsi)	increased large unstained cell number	J:211773
	increased mean platelet volume	J:211773
Pdzd8^{tm1b(EUCOMM)Wtsi}/Pdzd8^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Pdzd8^{tm1b(EUCOMM)Wtsi}/Wtsi)	increased red blood cell distribution width	J:211773
Peak1^em1(IMPC)J/Peak1^em1(IMPC)J (C57BL/6NJ-Peak1^em1(IMPC)J/Mmjax)	thrombocytopenia	J:211773
Peak1^tm1.2Itl/Peak1^tm1.2Itl (involves: C57BL/6NTac * FVB/N)	hematopoietic system phenotype	J:278882
Pear1^{tm1a(KOMP)Wtsi}/Pear1^{tm1a(KOMP)Wtsi} (involves: C57BL/6N)	decreased platelet aggregation	J:237835
Pebp1^em1(IMPC)Tcp/Pebp1^em1(IMPC)Tcp (C57BL/6NCrl-Pebp1^em1(IMPC)Tcp/Tcp)	decreased eosinophil cell number	J:211773
	small spleen	J:211773
Pecam1^tm1Mak/Pecam1^tm1Mak (D1.129P2-Pecam1^tm1Mak)	abnormal leukocyte physiology	J:106275
Pecam1^tm1Mak/Pecam1^tm1Mak (B6.129P2-Pecam1^tm1Mak)	spleen vascular congestion	J:95226
Peds1^{tm1a(KOMP)Wtsi}/Peds1^{tm1a(KOMP)Wtsi} (B6Brd;B6Dnk;B6N-Peds1^{tm1a(KOMP)Wtsi} Tyr^c-Brd/Wtsi)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	increased mean corpuscular volume	J:211773
	increased mean platelet volume	J:211773
Peli1^{tm1b(EUCOMM)Wtsi}/Peli1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Peli1^{tm1b(EUCOMM)Wtsi}/Ucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased neutrophil cell number	J:211773
	increased spleen weight	J:211773
Peli1^tm1Tigm/Peli1^tm1Tigm (involves: 129/Sv * C57BL/6)	decreased B cell proliferation	J:152781
Peli1^tm1Tigm/Peli1^tm1Tigm (involves: 129/Sv * C57BL/6)	increased B cell apoptosis	J:152781
Peli2^tm1.1Arte/Peli2^tm1.1Arte (involves: C57BL/6)	increased macrophage apoptosis	J:265431
Peli3^tm1.1Arte/Peli3^tm1.1Arte (involves: C57BL/6NTac)	abnormal macrophage cytokine production	J:188556
Penk-rs^tm1Pig/Penk-rs^tm1Pig (B6.129-Penk-rs^tm1Pig)	abnormal T-helper 2 physiology	J:62435
Penk-rs^tm1Pig/Penk-rs^tm1Pig (B6.129-Penk-rs^tm1Pig)	decreased T-helper 2 cell number	J:62435
Pepd^{tm1a(KOMP)Wtsi}/Pepd^{tm1a(KOMP)Wtsi} (C57BL/6N-Pepd^{tm1a(KOMP)Wtsi}/Ucd)	decreased immature B cell number	J:211773
	decreased Ly6C-positive NK T cell number	J:211773
	decreased mean corpuscular hemoglobin	J:211773
	decreased transitional stage T1 B cell number	J:211773
	increased CD4-positive, alpha-beta T cell number	J:211773
	increased effector memory CD8-positive, alpha-beta T cell number	J:211773
	increased effector memory T-helper cell number	J:211773
	increased leukocyte cell number	J:211773
	increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	increased memory-marker CD4-negative NK T cell number	J:211773
	increased memory-marker NK cell number	J:211773
Pepd^{tm1b(KOMP)Wtsi}/Pepd^{tm1b(KOMP)Wtsi} (C57BL/6N-Pepd^{tm1b(KOMP)Wtsi}/Ieg)	decreased B cell number	J:211773
	decreased B-2 B cell number	J:211773
	decreased CD5-positive Ly6C-positive T cell number	J:211773
	decreased follicular B cell number	J:211773
	decreased mean corpuscular volume	J:211773
Per1^tm1Brd/Per1^tm1Brd Per2^tm1Brd/Per2^tm1Brd (involves: 129S7/SvEvBrd)	abnormal bone marrow cell morphology/development	J:115188
Per2^tm1Drw/Per2^tm1Drw (B6.129-Per2^tm1Drw/J)	abnormal bone marrow cell morphology/development	J:208598
	abnormal hematopoietic stem cell physiology	J:208598
	decreased hematopoietic stem cell proliferation	J:208598
	increased hematopoietic stem cell number	J:208598
Perp^tm1Att/Perp^tm1Att (involves: 129S4/SvJae)	decreased thymocyte apoptosis	J:86549
Pes1^{tm1b(EUCOMM)Wtsi}/Pes1⁺ (C57BL/6N-Pes1^{tm1b(EUCOMM)Wtsi}/Bay)	increased mean platelet volume	J:211773
Pex3^{tm1a(EUCOMM)Wtsi}/Pex3^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Pex3^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased mean corpuscular hemoglobin	J:175295
Pex5^tm1Pec/Pex5^tm1Pec Cnp^tm1(cre)Kan/Cnp⁺ (involves: 129S1/Sv * 129X1/SvJ)	microgliosis	J:123503
Pex6^em1(IMPC)Tcp/Pex6⁺ (C57BL/6N-Pex6^em1(IMPC)Tcp/Tcp)	decreased mean corpuscular hemoglobin concentration	J:211773
Pex7^tm1Rjaw/Pex7^tm1Rjaw (Swiss)	abnormal osteoclast morphology	J:92346
Pex26^{tm1.1(KOMP)Vlcg}/Pex26⁺ (C57BL/6N-Pex26^{tm1.1(KOMP)Vlcg}/Ucd)	enlarged spleen	J:211773
Pf4^tm1Mako/Pf4⁺ (B6.129X1-Pf4^tm1Mako)	thrombocytosis	J:94900
Pf4^tm1Mako/Pf4^tm1Mako (B6.129X1-Pf4^tm1Mako)	thrombocytosis	J:94900
Pfas^Sofa-2J/Pfas⁺ (B6(Cg)-Pfas^Sofa-2J/GrsrJ)	abnormal transitional stage B cell morphology	J:223062
Pfdn1^{Gt(GTR1.3)1Rul}/Pfdn1^{Gt(GTR1.3)1Rul} (involves: 129)	abnormal B cell activation	J:137415
	abnormal B cell differentiation	J:137415
	abnormal B cell morphology	J:137415
	abnormal erythrocyte morphology	J:137415
	abnormal neutrophil morphology	J:137415
	abnormal spleen morphology	J:137415
	abnormal spleen red pulp morphology	J:137415
	abnormal spleen white pulp morphology	J:137415
	abnormal splenic cell ratio	J:137415
	abnormal T cell activation	J:137415
	abnormal thymus cell ratio	J:137415
	abnormal thymus morphology	J:137415
	decreased B-1 B cell number	J:137415
	decreased B-2 B cell number	J:137415
	decreased bone marrow cell number	J:137415
	decreased erythrocyte cell number	J:137415
	decreased pre-B cell number	J:137415
	decreased thymus weight	J:137415
	small spleen	J:137415
	spleen hypoplasia	J:137415
	thymus hypoplasia	J:137415
Pfdn6^{tm1.1(KOMP)Vlcg}/Pfdn6⁺ (C57BL/6N-Pfdn6^{tm1.1(KOMP)Vlcg}/J)	decreased mean corpuscular hemoglobin concentration	J:211773
	increased mean corpuscular volume	J:211773
Pfkfb2^{tm1b(KOMP)Wtsi}/Pfkfb2^{tm1b(KOMP)Wtsi} (C57BL/6N-Pfkfb2^{tm1b(KOMP)Wtsi}/Nju)	decreased neutrophil cell number	J:211773
	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
	increased lymphocyte cell number	J:211773
Pfkfb3^tm1.1Pec/Pfkfb3^tm1.1Pec Tg(Pdgfb-icre/ERT2,-EGFP)1Frut/0 (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCrl * CBA)	abnormal macrophage morphology	J:296552
	abnormal macrophage physiology	J:296552
Pfkm^tm1Fbos/Pfkm^tm1Fbos (involves: 129S6/SvEvTac * C57BL/6J)	decreased hematocrit	J:152153
	enlarged spleen	J:152153
	increased erythrocyte osmotic fragility	J:152153
	increased hematopoietic stem cell number	J:152153
	increased spleen weight	J:152153
	reticulocytosis	J:152153
Pgam1^tm1.1Hiko/Pgam1^tm1.1Hiko Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	abnormal CD4-positive T cell differentiation	J:293746
	abnormal CD8-positive, alpha-beta T cell differentiation	J:293746
	abnormal effector T cell number	J:293746
	decreased CD4-positive, alpha-beta T cell number	J:293746
	decreased CD8-positive, alpha-beta T cell number	J:293746
	decreased NK T cell number	J:293746
	decreased T-helper 2 cell number	J:293746
	decreased T-helper 17 cell number	J:293746
	hematopoietic system phenotype	J:293746
Pgam5^{tm1b(EUCOMM)Wtsi}/Pgam5^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Pgam5^{tm1b(EUCOMM)Wtsi}/Ics)	decreased erythrocyte cell number	J:211773
	increased mean corpuscular volume	J:211773
Pgam5^{tm1d(EUCOMM)Wtsi}/Pgam5^{tm1d(EUCOMM)Wtsi} (involves: C57BL/6N)	abnormal macrophage activation involved in immune response	J:240016
Pgap3^tm1.1Ymra/Pgap3^tm1.1Ymra (involves: 129 * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:181221
	abnormal T cell morphology	J:181221
	decreased T cell proliferation	J:181221
	increased T cell proliferation	J:181221
Pgap3^tm1.1Ymra/Pgap3^tm1.1Ymra (B6.Cg-Pgap3^tm1.1Ymra)	abnormal T-helper 2 cell differentiation	J:203443
	decreased B cell proliferation	J:203443
	impaired macrophage phagocytosis	J:203443
	increased spleen germinal center number	J:203443
Pgap4^em1Osbir/Pgap4^em1Osbir (involves: C57BL/6NSlc)	increased Ly6C-positive immature NK cell number	J:333707
Pgc^em1Hcz/Pgc^em1Hcz (Not Specified)	decreased erythrocyte cell number	J:338079
Pgc^em1Hcz/Pgc^em1Hcz (Not Specified)	decreased hemoglobin content	J:338079
Pgd^tm1.1Pse/Pgd^tm1.1Pse Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	abnormal alpha-beta T cell morphology	J:306553
	abnormal CD8-positive, alpha beta T cell morphology	J:306553
	abnormal CD8-positive, alpha-beta T cell physiology	J:306553
	abnormal T cell differentiation	J:306553
	decreased CD4-positive, alpha-beta T cell number	J:306553
	decreased CD8-positive, alpha-beta T cell number	J:306553
Pgd^tm1.1Pse/Pgd^tm1.1Pse Tg(Cd4-cre)1Cwi/0 Tg(TcraTcrb)8Rest/0 (involves: C57BL/6 * DBA/2)	abnormal CD8-positive, alpha-beta T cell physiology	J:306553
Pgd^tm1.1Pse/Pgd^tm1.1Pse Tg(Cd4-cre)1Cwi/0 Tg(TcraTcrb)1100Mjb/0 (involves: C57BL/6 * DBA/2)	abnormal cytotoxic T cell physiology	J:306553
Pglyrp1^tm1.1Lky/Pglyrp1^tm1.1Lky (B6.129S4-Pglyrp1^tm1.1Lky)	abnormal neutrophil physiology	J:171412
Pglyrp1^tm1Rdz/Pglyrp1^tm1Rdz (involves: 129S5/SvEvBrd)	abnormal neutrophil physiology	J:84680
Pglyrp1^tm1Rdz/Pglyrp1^tm1Rdz (involves: 129S5/SvEvBrd)	impaired granulocyte bactericidal activity	J:84680
Pglyrp2^tm1Lky/Pglyrp2^tm1Lky (involves: 129S4/SvJae * C57BL/6)	abnormal macrophage physiology	J:159600
Pglyrp4^{em1(IMPC)Ccpcz}/Pglyrp4^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Pglyrp4^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
	small thymus	J:211773
Pgm3^{Gt(W037B08)Wrst}/Pgm3^mld1 (involves: 129S1/Sv * C57BL/6)	abnormal T cell differentiation	J:125094
	absent follicular B cells	J:125094
	anemia	J:125094
	decreased B cell number	J:125094
	decreased bone marrow cell number	J:125094
	decreased erythrocyte cell number	J:125094
	decreased hematocrit	J:125094
	decreased leukocyte cell number	J:125094
	decreased T cell number	J:125094
	increased pro-B cell number	J:125094
	increased spleen red pulp amount	J:125094
	thrombocytopenia	J:125094
Pgm3^mld1/Pgm3^mld1 (C57BL/6-Pgm3^mld1)	abnormal erythropoiesis	J:125094
	abnormal megakaryocyte progenitor cell morphology	J:125094
	abnormal thrombopoiesis	J:125094
	absent follicular B cells	J:125094
	anemia	J:125094
	decreased B cell number	J:125094
	decreased bone marrow cell number	J:125094
	decreased erythrocyte cell number	J:125094
	decreased hematocrit	J:125094
	decreased leukocyte cell number	J:125094
	extramedullary hematopoiesis	J:125094
	increased pro-B cell number	J:125094
	increased spleen red pulp amount	J:125094
	increased spleen weight	J:125094
	thrombocytopenia	J:125094
Pgp^tm1.1Ango/Pgp^tm1.1Ango Tg(Tek-cre)1Ywa/0 (involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6J * SJL)	hematopoietic system phenotype	J:259970
Pgr^tm1Bwo/Pgr^tm1Bwo (involves: 129S7/SvEvBrd)	abnormal osteoclast morphology	J:145383
Pgrmc2^tm1.1Jjp/Pgrmc2^tm1.1Jjp Pgr^tm2(cre)Lyd/Pgr⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	decreased uterine NK cell number	J:247103
Phactr1^em1(IMPC)Mbp/Phactr1^em1(IMPC)Mbp (C57BL/6NCrl-Phactr1^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	decreased leukocyte cell number	J:211773
Phb1^em1(IMPC)H/Phb1⁺ (C57BL/6NTac-Phb1^em1(IMPC)H/H)	decreased red blood cell distribution width	J:211773
Phb1^em1(IMPC)H/Phb1⁺ (C57BL/6NTac-Phb1^em1(IMPC)H/H)	increased large unstained cell number	J:211773
Phc1^tm1Os/Phc1^tm1Os (involves: 129S2/SvPas * C57BL/6)	abnormal B cell differentiation	J:75707
	abnormal hematopoietic stem cell morphology	J:75707
	decreased spleen weight	J:43764
	decreased thymus weight	J:43764
	extramedullary hematopoiesis	J:75707
	impaired hematopoiesis	J:75707
Phc3^{tm2b(KOMP)Wtsi}/Phc3^{tm2b(KOMP)Wtsi} (C57BL/6N-Phc3^{tm2b(KOMP)Wtsi}/Ucd)	decreased thymus weight	J:211773
Phex^Ska1/Phex^Ska1 (C57BL/6-Phex^Ska1)	abnormal osteoclast physiology	J:79953
Phf6^em1Wencc/Y Tg(Vav1-cre)#Cgp/0 (Not Specified)	abnormal effector T cell number	J:278804
	abnormal megakaryocyte morphology	J:278804
	abnormal splenic cell ratio	J:278804
	abnormal thymus cell ratio	J:278804
	decreased bone marrow cell number	J:278804
	decreased CD4-positive, alpha-beta T cell number	J:278804
	decreased CD8-positive, alpha-beta T cell number	J:278804
	decreased double-negative T cell number	J:278804
	decreased granulocyte monocyte progenitor cell number	J:278804
	decreased hematopoietic stem cell number	J:278804
	decreased lymphocyte cell number	J:278804
	enlarged spleen	J:278804
	extramedullary hematopoiesis	J:278804
	hematopoietic system phenotype	J:278804
	increased B cell number	J:278804
	increased bone marrow cell number	J:278804
	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:278804
	increased hematopoietic stem cell number	J:278804
	increased hematopoietic stem cell proliferation	J:278804
	increased megakaryocyte cell number	J:278804
	increased pro-B cell number	J:278804
	thrombocytopenia	J:278804
Phf6^em1Wencc/Phf6^em1Wencc Tg(Vav1-cre)#Cgp/0 (Not Specified)	abnormal effector T cell number	J:278804
	abnormal megakaryocyte morphology	J:278804
	abnormal splenic cell ratio	J:278804
	abnormal thymus cell ratio	J:278804
	decreased bone marrow cell number	J:278804
	decreased CD4-positive, alpha-beta T cell number	J:278804
	decreased CD8-positive, alpha-beta T cell number	J:278804
	decreased double-negative T cell number	J:278804
	decreased granulocyte monocyte progenitor cell number	J:278804
	decreased hematopoietic stem cell number	J:278804
	decreased lymphocyte cell number	J:278804
	enlarged spleen	J:278804
	extramedullary hematopoiesis	J:278804
	increased B cell number	J:278804
	increased bone marrow cell number	J:278804
	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:278804
	increased hematopoietic stem cell number	J:278804
	increased hematopoietic stem cell proliferation	J:278804
	increased leukocyte cell number	J:278804
	increased megakaryocyte cell number	J:278804
	increased pro-B cell number	J:278804
	thrombocytopenia	J:278804
Phf6^tm1.1Avo/Y Tg(Tek-cre)1Ywa/0 (involves: C57BL/6 * SJL)	abnormal hematopoietic precursor cell morphology	J:276228
	abnormal hematopoietic system physiology	J:276228
	abnormal T cell differentiation	J:276228
	decreased DN2 thymocyte number	J:276228
	decreased hematopoietic stem cell number	J:276228
	increased common lymphocyte progenitor cell number	J:276228
	increased hematopoietic precursor cell number	J:276228
	increased hematopoietic stem cell number	J:276228
	increased hematopoietic stem cell proliferation	J:276228
	increased plasmacytoid dendritic cell number	J:276228
Phf8^{em2(IMPC)Wtsi}/Y (C57BL/6N-Phf8^{em2(IMPC)Wtsi}/Wtsi)	decreased erythrocyte cell number	J:211773
Phf8^{em2(IMPC)Wtsi}/Y (C57BL/6N-Phf8^{em2(IMPC)Wtsi}/Wtsi)	increased mean corpuscular hemoglobin	J:211773
Phf8^{em2(IMPC)Wtsi}/Phf8^{em2(IMPC)Wtsi} (C57BL/6N-Phf8^{em2(IMPC)Wtsi}/Wtsi)	increased mean corpuscular hemoglobin	J:211773
Phf8^tm1dIcs/Phf8^tm1dIcs (C57BL/6N-Phf8^tm1dIcs/Ics)	decreased lymphocyte cell number	J:211773
Phf8^tm1dIcs/Phf8^tm1dIcs (C57BL/6N-Phf8^tm1dIcs/Ics)	increased neutrophil cell number	J:211773
Phf11d^m1H/Phf11d^m1H (C3H.CAnNCrl(C3)-Phf11d^m1H)	hematopoietic system phenotype	J:217094
Phf19^tm1.1Ldc/Phf19^tm1.1Ldc (Not Specified)	abnormal hematopoietic stem cell physiology	J:313068
	decreased bone marrow cell number	J:313068
	decreased hematopoietic cell number	J:313068
	enlarged spleen	J:313068
	impaired hematopoiesis	J:313068
	increased hematopoietic cell number	J:313068
	increased hematopoietic stem cell proliferation	J:313068
Phf20^Gt(XN131)Byg/Phf20^Gt(XN131)Byg (involves: 129P2/OlaHsd)	abnormal hematopoietic system morphology/development	J:228714
	abnormal T cell differentiation	J:228714
	decreased bone marrow cell number	J:228714
	decreased double-positive T cell number	J:228714
	decreased thymocyte number	J:228714
	increased double-negative T cell number	J:228714
	intermingled spleen red and white pulp	J:228714
	small spleen	J:228714
	small thymus	J:228714
	thymus hypoplasia	J:228714
Phf20l1^em1(IMPC)Tcp/Phf20l1^em1(IMPC)Tcp (C57BL/6N-Phf20l1^em1(IMPC)Tcp/Tcp)	decreased lymphocyte cell number	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
	increased mean platelet volume	J:211773
	increased spleen weight	J:211773
Phip^{em1(IMPC)Wtsi}/Phip⁺ (C57BL/6N-Phip^{em1(IMPC)Wtsi}/Wtsi)	increased leukocyte cell number	J:211773
Phka1^em1(IMPC)Tcp/Y (C57BL/6N-Phka1^em1(IMPC)Tcp/Tcp)	small spleen	J:211773
Phkg2^{tm1.1(KOMP)Vlcg}/Phkg2⁺ (C57BL/6N-Phkg2^{tm1.1(KOMP)Vlcg}/J)	increased erythrocyte cell number	J:211773
	increased hematocrit	J:211773
	increased hemoglobin content	J:211773
Phldb1^em1(IMPC)J/Phldb1^em1(IMPC)J (C57BL/6NJ-Phldb1^em1(IMPC)J/Mmjax)	thrombocytopenia	J:211773
Phldb2^em1(IMPC)H/Phldb2^em1(IMPC)H (C57BL/6NTac-Phldb2^em1(IMPC)H/H)	increased basophil cell number	J:211773
Phrf1^em1(IMPC)Tcp/Phrf1^em1(IMPC)Tcp (C57BL/6N-Phrf1^em1(IMPC)Tcp/Tcp)	small spleen	J:211773
Phyh^{tm1b(EUCOMM)Wtsi}/Phyh^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Phyh^{tm1b(EUCOMM)Wtsi}/Tcp)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Pi4ka^m1Btlr/Pi4ka^m1Btlr (C57BL/6J-Pi4ka^m1Btlr)	decreased macrophage apoptosis	J:265261
Pi4ka^m2Btlr/Pi4ka^m2Btlr (C57BL/6J-Pi4ka^m2Btlr)	increased alpha-beta T cell number	J:272852
	increased CD4-positive, alpha-beta T cell number	J:272852
	increased central memory CD4-positive, alpha-beta T cell number	J:272852
Pi4ka^{tm1b(EUCOMM)Wtsi}/Pi4ka⁺ (C57BL/6N-Pi4ka^{tm1b(EUCOMM)Wtsi}/Tcp)	increased erythrocyte cell number	J:211773
	increased hematocrit	J:211773
	increased monocyte cell number	J:211773
Pi4ka^tm2.1Arte/Pi4ka⁺ Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ (involves: C57BL/6NTac)	abnormal spleen morphology	J:188779
Pi16^em1(IMPC)Mbp/Pi16^em1(IMPC)Mbp (C57BL/6NCrl-Pi16^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Pi16^{Gt(OST292194)Lex}/Pi16^{Gt(OST292194)Lex} (involves: 129S5/SvEvBrd * C57BL/6J)	abnormal spleen germinal center morphology	J:94077
	increased regulatory T cell number	J:94077
Pias4^tm1Rug/Pias4^tm1Rug (involves: 129S2/SvPas * C57BL/6)	abnormal myelopoiesis	J:94291
Picalm^fit1-494SB/Picalm^fit1-494SB (involves: BALB/cRl)	anemia	J:100221
Picalm^fit1-764SB/Picalm^fit1-764SB (involves: BALB/cRl)	anemia	J:100221
Picalm^fit1-3452SB/Picalm^fit1-3452SB (involves: BALB/cRl)	anemia	J:100221
Picalm^fit1-4226SB/Picalm^fit1-4226SB (involves: BALB/cRl)	anemia	J:100221
Picalm^fit1-4397SB/Picalm^fit1-4397SB (involves: BALB/cRl)	anemia	J:100221
Picalm^tm1.1Tmae/Picalm^tm1.1Tmae Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: 129S6/SvEvTac * C57BL/6 * C57BL/10 * CBA * SJL)	decreased CD4-positive, alpha-beta T cell number	J:220728
	decreased CD8-positive, alpha-beta T cell number	J:220728
	decreased erythrocyte cell number	J:220728
	decreased mean corpuscular hemoglobin	J:220728
	decreased mean corpuscular volume	J:220728
	microcytic anemia	J:220728
	reticulocytosis	J:220728
Picalm^tm1.1Tmae/Picalm^tm1.1Tmae Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA * SJL)	abnormal erythrocyte morphology	J:220728
	abnormal erythropoiesis	J:220728
	decreased CD4-positive, alpha-beta T cell number	J:220728
	decreased CD8-positive, alpha-beta T cell number	J:220728
	decreased erythroblast number	J:220728
	decreased erythrocyte cell number	J:220728
	decreased hematocrit	J:220728
	decreased hemoglobin content	J:220728
	decreased mean corpuscular hemoglobin	J:220728
	decreased mean corpuscular volume	J:220728
	enlarged spleen	J:220728
	hypochromic microcytic anemia	J:220728
	impaired hematopoiesis	J:220728
	increased erythroblast number	J:220728
	increased red blood cell distribution width	J:220728
	reticulocytosis	J:220728
Picalm^tm1.2Tmae/Picalm⁺ (involves: C57BL/6 * FVB/N)	microcytic anemia	J:220728
Picalm^tm1.2Tmae/Picalm^tm1.2Tmae (involves: C57BL/6 * FVB/N)	abnormal erythropoiesis	J:220728
	abnormal fetal liver hematopoietic progenitor cell morphology	J:220728
	decreased erythroblast number	J:220728
	increased erythroblast number	J:220728
Picalm^tm1Towa/Picalm^tm1Towa (involves: C57BL/6J * C57BL/6NCrlj * CBA/JNCrlj)	abnormal B cell differentiation	J:185312
	abnormal bone marrow cell morphology/development	J:185312
	abnormal erythrocyte physiology	J:185312
	abnormal erythropoiesis	J:185312
	decreased bone marrow cell number	J:185312
	decreased erythrocyte cell number	J:185312
	decreased erythroid progenitor cell number	J:185312
	decreased hemoglobin content	J:185312
	decreased mean corpuscular hemoglobin	J:185312
	decreased spleen B cell follicle number	J:185312
	enlarged spleen	J:185312
	hypochromic microcytic anemia	J:185312
Pierce1^{Gt(OST3440)Lex}/Pierce1^{Gt(OST3440)Lex} (either: (involves: 129S5/SvEvBrd * C57BL/6J) or (involves: 129S5/SvEvBrd * C57BL/6J * FVB/N))	abnormal spleen morphology	J:252050
Piezo1^tm2.1Apat/Piezo1^tm2.1Apat Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: C57BL/6 * C57BL/10 * CBA)	abnormal erythrocyte ion transport	J:229436
	abnormal spleen morphology	J:229436
	abnormal splenic cell ratio	J:229436
	decreased erythrocyte cell number	J:229436
	decreased hematocrit	J:229436
	decreased mean corpuscular hemoglobin concentration	J:229436
	increased erythrocyte osmotic fragility	J:229436
	increased mean corpuscular hemoglobin	J:229436
	increased mean corpuscular volume	J:229436
	increased red blood cell distribution width	J:229436
	macrocytosis	J:229436
Piga^tm1Bsl/Piga⁺ Tg(EIIa-cre)C5379Lmgd/0 (involves: 129S1/Sv * FVB/NJ)	abnormal definitive hematopoiesis	J:75506
	abnormal erythrocyte morphology	J:75506
	abnormal erythrocyte physiology	J:75506
	increased erythrocyte osmotic fragility	J:75506
	reticulocytosis	J:75506
Piga^tm1Tak/Piga^tm1Tak Tg(FES-cre)31Bsl/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA/Ca)	abnormal T cell activation	J:162065
	abnormal T cell morphology	J:162065
	abnormal T cell physiology	J:162065
	decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:162065
Pigc^em1(IMPC)J/Pigc⁺ (C57BL/6NJ-Pigc^em1(IMPC)J/J)	decreased mean corpuscular hemoglobin concentration	J:211773
Pigc^em1(IMPC)J/Pigc⁺ (C57BL/6NJ-Pigc^em1(IMPC)J/J)	increased mean corpuscular volume	J:211773
Pign^em1(IMPC)Mbp/Pign⁺ (C57BL/6N-Pign^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Pigr^tm1Fejo/Pigr^tm1Fejo (involves: 129P2/OlaHsd * C57BL/6)	abnormal immunoglobulin level	J:57987
	decreased IgA level	J:57987
	increased IgA level	J:57987
	increased IgG level	J:57987
Pigr^tm1Fejo/Pigr^tm1Fejo (involves: 129 * C57BL/6)	increased IgA level	J:140515
Pigr^tm1Ohw/Pigr^tm1Ohw (involves: 129X1/SvJ * C57BL/6J)	decreased IgA level	J:58454
	increased IgA level	J:58454
	increased IgE level	J:58454
	increased IgG level	J:58454
Pigr^tm1Ohw/Pigr^tm1Ohw (B6.129X1-Pigr^tm1Ohw)	abnormal CD8 positive, alpha-beta intraepithelial T cell morphology	J:97824
	abnormal intraepithelial T cell number	J:97824
	abnormal lymphocyte physiology	J:97824
	decreased IgA level	J:108538
	increased IgA level	J:108538, J:97824
Pigr^tm1Ohw/Pigr^tm1Ohw Tcrb^tm1Mom/Tcrb^tm1Mom Tcrd^tm1Mom/Tcrd^tm1Mom (involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6J)	decreased lymphocyte cell number	J:97824
	increased IgA level	J:97824
Pigr^tm1Rast/Pigr^tm1Rast (C57BL/6-Pigr^tm1Rast)	abnormal immunoglobulin level	J:81984
	decreased IgA level	J:81984
	increased IgA level	J:81984
	increased IgG level	J:81984
Pigv^b2b2859Clo/Pigv^b2b2859Clo (C57BL/6J-Pigv^b2b2859Clo)	thymus hypoplasia	J:175213
Pik3ap1^m1Btlr/Pik3ap1^m1Btlr (involves: C57BL/6J)	arrested B cell differentiation	J:185495
Pik3ap1^m1Btlr/Pik3ap1^m1Btlr (involves: C57BL/6J)	decreased IgM level	J:185495
Pik3ap1^m2Btlr/Pik3ap1^m2Btlr (C57BL/6J-Pik3ap1^m2Btlr)	decreased B-1a cell number	J:255271
	increased B-1b cell number	J:255271
	increased IgM level	J:255271
Pik3ap1^M3Btlr/Pik3ap1^M3Btlr (C57BL/6J-Pik3ap1^M3Btlr)	decreased B-1 B cell number	J:272019
Pik3ap1^{tm1b(KOMP)Wtsi}/Pik3ap1^{tm1b(KOMP)Wtsi} (C57BL/6N-Pik3ap1^{tm1b(KOMP)Wtsi}/Orl)	decreased lymphocyte cell number	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Pik3ap1^tm1Kuro/Pik3ap1^tm1Kuro (involves: 129P2/OlaHsd)	abnormal B cell differentiation	J:75075
	absent B-1a cells	J:84669
	decreased B cell number	J:84669
	decreased B cell proliferation	J:84669
	decreased follicular B cell number	J:84669
	decreased IgG2b level	J:75075
	decreased IgG3 level	J:75075
	decreased IgM level	J:75075
	decreased immunoglobulin level	J:75075
	decreased pre-B cell number	J:75075
	spleen hypoplasia	J:75075
Pik3c2a^{Gt(OST288105)Lex}/Pik3c2a^{Gt(OST288105)Lex} (involves: 129S5/SvEvBrd * C57BL/6J)	decreased erythrocyte cell number	J:169710
	decreased hematocrit	J:169710
	decreased hemoglobin content	J:169710
	enlarged spleen	J:169710
	increased B cell number	J:169710
	increased CD4-positive, alpha-beta T cell number	J:169710
	increased CD8-positive, alpha-beta T cell number	J:169710
	increased granulocyte number	J:169710
	increased IgA level	J:169710
	increased IgG level	J:169710
	increased IgM level	J:169710
	increased leukocyte cell number	J:169710
	increased mean platelet volume	J:169710
	increased monocyte cell number	J:169710
	increased neutrophil cell number	J:169710
	thrombocytosis	J:169710
Pik3c2a^{tm1b(EUCOMM)Hmgu}/Pik3c2a⁺ (C57BL/6N-Pik3c2a^{tm1b(EUCOMM)Hmgu}/Tcp)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Pik3c2a^tm1Bvan/Pik3c2a⁺ (involves: C57BL/6)	abnormal megakaryocyte morphology	J:226344
	abnormal platelet alpha-granule morphology	J:226344
	abnormal platelet morphology	J:226344
	abnormal platelet physiology	J:226344
	abnormal platelet shape	J:226344
	abnormal thrombopoiesis	J:226344
	decreased platelet aggregation	J:226344
	decreased platelet alpha-granule number	J:226344
	increased hematocrit	J:226344
Pik3c3^tm1.1Flv/Pik3c3^tm1.1Flv Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * C57BL/6N * DBA/2)	abnormal T cell number	J:184753
	decreased CD4-positive, alpha-beta T cell number	J:184753
	decreased CD8-positive, alpha-beta T cell number	J:184753
Pik3c3^tm1.1Flv/Pik3c3^tm1.1Flv Tg(Cd8a-cre)1Itan/0 (involves: C57BL/6 * C57BL/6N)	abnormal CD4-positive, alpha beta T cell morphology	J:184753
	abnormal CD8-positive, alpha beta T cell morphology	J:184753
	decreased CD4-positive, alpha-beta T cell number	J:184753
	decreased CD8-positive, alpha-beta T cell number	J:184753
	decreased lymphocyte cell number	J:184753
	increased T cell apoptosis	J:184753
Pik3cb^tm1.1Ehi/Pik3cb^tm1.1Ehi (involves: 129P2/OlaHsd)	abnormal platelet physiology	J:152267
Pik3cb^tm1.1Ehi/Pik3cb^tm1.1Ehi (involves: 129P2/OlaHsd)	decreased platelet aggregation	J:152267
Pik3cb^{tm1a(EUCOMM)Wtsi}/Pik3cb⁺ (B6JTyr;B6N-Pik3cb^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased hemoglobin content	J:175295
	increased mean corpuscular hemoglobin	J:175295
Pik3cb^{tm1a(EUCOMM)Wtsi}/Pik3cb^{tm1a(EUCOMM)Wtsi} (B6JTyr;B6N-Pik3cb^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased hemoglobin content	J:175295
	increased mean corpuscular hemoglobin	J:175295
Pik3cb^tm1Bvan/Pik3cb^tm1Bvan Tg(Pf4-icre)Q3Rsko/0 (involves: 129P2/OlaHsd)	decreased platelet aggregation	J:158839
Pik3cd^{Gt(OST451938)Lex}/Pik3cd^{Gt(OST451938)Lex} (involves: 129S5/SvEvBrd * C57BL/6J)	decreased IgG1 level	J:103485
	increased leukocyte cell number	J:103485
	increased lymphocyte cell number	J:103485
Pik3cd^m2Btlr/Pik3cd⁺ (C57BL/6J-Pik3cd^m2Btlr)	decreased B-1 B cell number	J:236693
	decreased IgG level	J:236693
	decreased IgM level	J:236693
	impaired hematopoiesis	J:236693
Pik3cd^m2Btlr/Pik3cd^m2Btlr (C57BL/6J-Pik3cd^m2Btlr)	decreased B-1 B cell number	J:236693
	decreased B-1a cell number	J:236693
	decreased IgG level	J:236693
	decreased IgM level	J:236693
	impaired hematopoiesis	J:236693
	increased IgE level	J:236693
Pik3cd^tm1.1Bvan/Pik3cd^tm1.1Bvan (involves: 129P2/OlaHsd * BALB/c)	abnormal B cell differentiation	J:78412
	absent spleen germinal center	J:78412
	decreased B-1 B cell number	J:78412
	decreased IgA level	J:78412
	decreased IgM level	J:78412
	decreased immunoglobulin level	J:78412
	increased neutrophil cell number	J:78412
	spleen hypoplasia	J:78412
Pik3cd^tm1.1Bvan/Pik3cd^tm1.1Bvan (B6.129P2-Pik3cd^tm1.1Bvan)	abnormal platelet aggregation	J:114310
Pik3cd^tm1Jni/Pik3cd^tm1Jni (involves: 129P2/OlaHsd)	abnormal B cell physiology	J:80614
	absent B-1 B cells	J:80614
	absent spleen germinal center	J:80614
	decreased B cell number	J:80614
	decreased B cell proliferation	J:80614
	decreased immunoglobulin level	J:80614
	decreased mature B cell number	J:80614
	small spleen	J:80614
Pik3cd^tm1Jni/Pik3cd^tm1Jni Pik3cg^tm1Pngr/Pik3cg^tm1Pngr (involves: 129P2/OlaHsd * C57BL/6)	abnormal NK cell differentiation	J:124330
	decreased cytotoxic T cell cytolysis	J:124330
	decreased NK cell number	J:124330
	decreased T cell number	J:124330
	spleen hypoplasia	J:124330
Pik3cd^tm1Tnr/Pik3cd^tm1Tnr (involves: 129S4/SvJae)	abnormal B cell physiology	J:113491
	decreased B cell number	J:79133
	decreased B cell proliferation	J:113491, J:79133
	decreased B-1 B cell number	J:79133
	decreased B-2 B cell number	J:79133
	decreased IgG1 level	J:79133
	decreased IgG2a level	J:79133
	decreased IgG2b level	J:79133
	decreased IgG3 level	J:79133
	decreased IgM level	J:79133
	decreased marginal zone B cell number	J:79133
Pik3cd^tm1Tnr/Pik3cd^tm1Tnr (B6.129S4-Pik3cd^tm1Tnr)	abnormal platelet aggregation	J:114310
Pik3cd^tm1Tnr/Pik3cd^tm1Tnr Pik3cg^tm1Pngr/Pik3cg^tm1Pngr (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	abnormal T cell differentiation	J:125791
	abnormal T cell physiology	J:125791
	abnormal thymus lobule morphology	J:125791
	decreased CD4-positive, alpha-beta T cell number	J:125791
	decreased CD8-positive, alpha-beta T cell number	J:125791
	decreased double-positive T cell number	J:125791
	decreased lymphocyte cell number	J:125791
	decreased T cell number	J:125791
	small thymus	J:125791
	thymus hypoplasia	J:125791
Pik3cd^tm1Tnr/Pik3cd^tm1Tnr Pik3cg^tm1Pngr/Pik3cg^tm1Pngr (B6.129-Pik3cd^tm1Tnr Pik3cg^tm1Pngr)	impaired neutrophil chemotaxis	J:134324
	impaired neutrophil recruitment	J:134324
Pik3cd^tm1Tnr/Pik3cd^tm1Tnr Pten^tm2.1Ppp/Pten^tm2.1Ppp Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJae * C57BL/6)	abnormal class switch recombination	J:130950
	increased marginal zone B cell number	J:130950
Pik3cd^tm1Tnr/Pik3cd^tm1Tnr Tg(BCL2)36Wehi/0 (involves: 129S4/SvJae * C57BL/6JWehi * SJL/JWehi)	decreased follicular B cell number	J:130950
Pik3cd^tm2.1Tnr/Pik3cd^tm2.1Tnr Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * C57BL/6)	increased IgE level	J:164283
Pik3cd^tm2.1Tnr/Pik3cd^tm2.1Tnr Tg(Cd4-cre)1Cwi/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	decreased CD4-positive, alpha-beta T cell number	J:164283
	decreased CD8-positive, alpha-beta T cell number	J:164283
	decreased germinal center B cell number	J:164283
	decreased IgG1 level	J:164283
	decreased spleen germinal center number	J:164283
	decreased spleen germinal center size	J:164283
	decreased T cell number	J:164283
	decreased T follicular helper cell number	J:164283
Pik3cd^tm2.1Tnr/Pik3cd^tm2.1Tnr Tnfrsf4^tm2(cre)Nik/Tnfrsf4⁺ (involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6)	decreased germinal center B cell number	J:164283
	decreased IgG1 level	J:164283
	decreased spleen germinal center number	J:164283
	decreased T follicular helper cell number	J:164283
Pik3cg^tm1Dwu/Pik3cg^tm1Dwu (Not Specified)	decreased immunoglobulin level	J:60348
Pik3cg^tm1Dwu/Pik3cg^tm1Dwu (Not Specified)	impaired neutrophil chemotaxis	J:60348
Pik3cg^tm1Dwu/Pik3cg^tm1Dwu (B6.Cg-Pik3cg^tm1Dwu)	abnormal CD8-positive, alpha-beta T cell physiology	J:131923
	abnormal platelet physiology	J:107460
	decreased CD8-positive, alpha-beta T cell number	J:131923
	decreased platelet aggregation	J:107460
	decreased platelet calcium level	J:107460
Pik3cg^tm1Dwu/Pik3cg^tm1Dwu Tg(TcraTcrb)1100Mjb/0 (involves: C57BL/6)	abnormal CD8-positive, alpha-beta T cell physiology	J:131923
Pik3cg^tm1Ehi/Pik3cg^tm1Ehi (Not Specified)	decreased platelet aggregation	J:152267
	impaired macrophage chemotaxis	J:91945
	impaired neutrophil recruitment	J:91945
Pik3cg^tm1Lste/Pik3cg^tm1Lste (involves: 129P2/OlaHsd * C57BL/6)	abnormal neutrophil physiology	J:147259
	impaired neutrophil chemotaxis	J:147259
	impaired neutrophil recruitment	J:147259
Pik3cg^tm1Lste/Pik3cg^tm1Lste (involves: 129P2/OlaHsd)	impaired neutrophil chemotaxis	J:238900
Pik3cg^tm1Pngr/Pik3cg^tm1Pngr (involves: 129P2/OlaHsd * C57BL/6)	abnormal definitive hematopoiesis	J:60347
	abnormal neutrophil physiology	J:60347
	abnormal NK cell differentiation	J:124330
	abnormal T cell activation	J:60347
	abnormal T cell differentiation	J:60347
	abnormal T cell physiology	J:60347
	abnormal T-helper 2 physiology	J:60347
	decreased CD4-positive, alpha-beta T cell number	J:60347
	decreased cytotoxic T cell cytolysis	J:124330
	decreased T cell proliferation	J:60347
	decreased thymocyte number	J:60347
	impaired neutrophil chemotaxis	J:60347
	impaired neutrophil recruitment	J:60347
	increased eosinophil cell number	J:60347
	increased monocyte cell number	J:60347
	increased neutrophil cell number	J:60347
	thymus hypoplasia	J:60347
Pik3cg^tm1Pngr/Pik3cg^tm1Pngr (B6.129P2-Pik3cg^tm1Pngr)	impaired neutrophil chemotaxis	J:134324
Pik3cg^tm1Wym/Pik3cg^tm1Wym (either: 129/Sv-Pik3cg^tm1Wym or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))	abnormal leukocyte physiology	J:60349
	abnormal neutrophil physiology	J:60349
	impaired macrophage chemotaxis	J:60349
	impaired neutrophil chemotaxis	J:60349
	impaired neutrophil recruitment	J:60349
	increased neutrophil cell number	J:60349
Pik3cg^tm1Wym/Pik3cg^tm1Wym (involves: 129S1/Sv * 129X1/SvJ)	abnormal neutrophil physiology	J:147259
	impaired neutrophil chemotaxis	J:238900
	impaired neutrophil recruitment	J:147259
Pik3cg^tm2Ehi/Pik3cg^tm2Ehi (Not Specified)	abnormal macrophage physiology	J:124856
	decreased macrophage cell number	J:124856
	decreased neutrophil cell number	J:124856
	impaired macrophage chemotaxis	J:124856
	impaired neutrophil chemotaxis	J:124856
	increased leukocyte cell number	J:124856
Pik3r1^m1Btlr/Pik3r1^m1Btlr (C57BL/6J-Pik3r1^m1Btlr)	decreased B cell number	J:254890
	decreased B-1a cell number	J:254890
	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:254890
	increased CD8-positive, alpha-beta memory T cell number	J:254890
Pik3r1^M2Btlr/Pik3r1⁺ (C57BL/6J-Pik3r1^M2Btlr)	decreased B-1 B cell number	J:254892
	decreased B-1a cell number	J:254892
	decreased B-1b cell number	J:254892
	decreased B-2 B cell number	J:254892
	decreased NK T cell number	J:254892
	increased B-1b cell number	J:254892
Pik3r1^m3Btlr/Pik3r1^m3Btlr (C57BL/6J-Pik3r1^m3Btlr)	increased B-1b cell number	J:272853
Pik3r1^tm1Dfr/Pik3r1^tm1Dfr (involves: 129S6/SvEvTac * C57BL/6)	arrested B cell differentiation	J:52229
	decreased B cell proliferation	J:52229
	decreased mature B cell number	J:52229
Pik3r1^tm1Dfr/Pik3r1^tm1Dfr (involves: 129S6/SvEvTac)	abnormal B cell differentiation	J:104166
	decreased immature B cell number	J:104166
	decreased mature B cell number	J:104166
	decreased pre-B cell number	J:104166
	increased pro-B cell number	J:104166
Pik3r1^tm1Dfr/Pik3r1^tm1Dfr Plcg2^tm1Jni/Plcg2^tm1Jni (involves: 129P2/OlaHsd * 129S6/SvEvTac)	abnormal B cell differentiation	J:104166
	arrested B cell differentiation	J:104166
	decreased immature B cell number	J:104166
	decreased mature B cell number	J:104166
	decreased pre-B cell number	J:104166
	hematopoietic system phenotype	J:104166
	increased B cell apoptosis	J:104166
Pik3r1^tm1Tka/Pik3r1^tm1Tka (involves: C57BL/6 * CBA)	abnormal B cell physiology	J:113491
	decreased B cell number	J:52228
	decreased B cell proliferation	J:113491, J:52228
	decreased mature B cell number	J:52228
	decreased pre-B cell number	J:52228
	decreased pro-B cell number	J:52228
Pik3r1^tm2Dfr/Pik3r1^tm2Dfr (either: C.129S6-Pik3r1^tm2Dfr or (involves: 129S6/SvEvTac * BALB/c * C57BL/6))	abnormal B cell differentiation	J:94077
	abnormal erythropoiesis	J:94077
Pik3r5^tm1Lste/Pik3r5^tm1Lste (involves: 129P2/OlaHsd * C57BL/6)	impaired neutrophil chemotaxis	J:147259
	impaired neutrophil recruitment	J:147259
Pik3r5^tm1Lste/Pik3r5^tm1Lste (involves: 129P2/OlaHsd)	impaired neutrophil chemotaxis	J:238900
Pik3r5^tm1Lste/Pik3r5^tm1Lste (involves: 129P2/OlaHsd)	increased neutrophil cell number	J:238900
Pik3r6^tm1.1Lste/Pik3r6^tm1.1Lste (Not Specified)	abnormal neutrophil physiology	J:238900
	decreased granulocyte number	J:238900
	decreased lymphocyte cell number	J:238900
	increased neutrophil cell number	J:238900
Pikfyve^{Gt(AT0926)Wtsi}/Pikfyve^{Gt(AT0926)Wtsi} (involves: 129P2/OlaHsd * C57BL/6)	abnormal spleen morphology	J:190368
	abnormal thymus morphology	J:190368
	spleen hypoplasia	J:190368
	thymus hypoplasia	J:190368
Pilra^tm1Osb/Pilra^tm1Osb (B6.129-Pilra^tm1Osb)	abnormal leukocyte adhesion	J:191085
	abnormal neutrophil physiology	J:191085
	increased neutrophil cell number	J:191085
Pim1^tm1Pwl/Pim1^tm1Pwl (involves: 129P2/OlaHsd * BALB/c)	abnormal erythropoiesis	J:15268
	abnormal hemoglobin	J:15268
	abnormal mast cell physiology	J:15259, J:14715
	decreased mean corpuscular volume	J:15268
Pim1^tm1Pwl/Pim1^tm1Pwl Pim2^tm1Brn/Pim2^tm1Brn Pim3^tm1Brn/Pim3^tm1Brn (involves: 129P/Ola * FVB/N)	abnormal proerythroblast morphology	J:91592
	decreased B cell number	J:91592
	decreased B cell proliferation	J:91592
	decreased mean corpuscular volume	J:91592
	decreased megakaryocyte cell number	J:91592
	decreased pre-B cell number	J:91592
	decreased pro-B cell number	J:91592
	decreased T cell proliferation	J:91592
	increased early pro-B cell number	J:91592
	increased erythrocyte cell number	J:91592
Pim2^tm1Brn/Pim2^tm1Brn (involves: 129P/Ola * FVB/N)	decreased T cell proliferation	J:91592
Pink1^{tm1b(EUCOMM)Wtsi}/Pink1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Pink1^{tm1b(EUCOMM)Wtsi}/H)	decreased mean platelet volume	J:211773
Pinx1^tm1.1Kplu/Pinx1^tm1.1Kplu (involves: 129S7/SvEvBrd * C57BL/6 * FVB/N)	anemia	J:171997
Pip4k2c^{tm1b(KOMP)Wtsi}/Pip4k2c^{tm1b(KOMP)Wtsi} (involves: C57BL/6J * C57BL/6N)	abnormal T cell activation	J:234283
	decreased regulatory T cell number	J:234283
	increased CD4-positive, alpha-beta T cell number	J:234283
	increased CD8-positive, alpha-beta T cell number	J:234283
	increased IgG3 level	J:234283
	increased T cell proliferation	J:234283
	increased T-helper cell number	J:234283
Pip4p1^{em1(IMPC)Ccpcz}/Pip4p1^{em1(IMPC)Ccpcz} (C57BL/6N-Pip4p1^{em1(IMPC)Ccpcz}/Ccpcz)	increased CD4-negative, CD25-positive NK T cell number	J:211773
Pip5k1a^Gt(XE248)Byg/Pip5k1a^Gt(XE248)Byg (involves: 129P2/OlaHsd)	hematopoietic system phenotype	J:131289
Pip5k1b^tm1Tssk/Pip5k1b^tm1Tssk (involves: 129P2/OlaHsd * C57BL/6)	abnormal mast cell physiology	J:97991
Pip5k1b^tm1Tssk/Pip5k1b^tm1Tssk (involves: 129P2/OlaHsd)	hematopoietic system phenotype	J:131289
Pip5k1c^Gt(XD096)Byg/Pip5k1c^Gt(XD096)Byg (involves: 129P2/OlaHsd)	abnormal megakaryocyte morphology	J:131289
Pip5k1c^tm1.2Ref/Pip5k1c^tm1.2Ref Tg(TcraTcrb)425Cbn/0 (involves: BALB/c * C57BL/6)	abnormal T cell physiology	J:164732
	decreased B cell number	J:164732
	decreased dendritic cell number	J:164732
	increased T cell proliferation	J:164732
Pip5k1c^tm1Csab/Pip5k1c^tm1Csab Tg(Pf4-icre)Q3Rsko/0 (Not Specified)	abnormal platelet physiology	J:196476
Pip^tm1Myal/Pip^tm1Myal (involves: 129S/SvEv * C57BL/6)	abnormal thymus corticomedullary boundary morphology	J:202016
	enlarged thymus	J:202016
	enlarged thymus medulla	J:202016
Pirb^tm1Ttk/Pirb^tm1Ttk (involves: 129X1/SvJ)	abnormal B cell physiology	J:76770
	abnormal dendritic cell differentiation	J:76770
	abnormal leukocyte physiology	J:76770
	abnormal T cell physiology	J:76770
	abnormal T-helper 2 physiology	J:76770
	increased B cell proliferation	J:76770
	increased B-1 B cell number	J:76770
Pitpnm1^{tm1a(EUCOMM)Wtsi}/Pitpnm1^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6N)	decreased leukocyte cell number	J:207051
Pitpnm1^{tm1a(EUCOMM)Wtsi}/Pitpnm1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Pitpnm1^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased mean corpuscular hemoglobin	J:175295
Pitx2^tm1Hmd/Pitx2^tm1Hmd (involves: C3H * C57BL/6 * C57BL/6J)	small spleen	J:128475
Pitx2^tm1Jfm/Pitx2^tm1Jfm (involves: 129S4/SvJaeSor)	spleen hypoplasia	J:57674
Pitx2^tm1Rsd/Pitx2^tm1Rsd (involves: 129S1/Sv * 129X1/SvJ)	abnormal spleen morphology	J:57673
Pitx2^tm3.1Jfm/Pitx2^tm3.1Jfm (involves: 129S4/SvJaeSor)	small spleen	J:92872
Pitx3^eyl/Pitx3^eyl (involves: C3H/He * C57BL/6)	abnormal immunoglobulin level	J:156878
	decreased IgG3 level	J:156878
	decreased IgM level	J:156878
	decreased leukocyte cell number	J:156878
	increased CD4-positive, alpha-beta T cell number	J:156878
	increased CD8-positive, alpha-beta T cell number	J:156878
	increased granulocyte number	J:156878
	thrombocytopenia	J:156878
Pitx3^tm1.1Cai/Pitx3⁺ Tg(tetO-SNCAA53T)E2Cai/0 (involves: 129 C57BL/6J * FVB/N)	microgliosis	J:185958
Pja2^{tm1b(EUCOMM)Wtsi}/Pja2⁺ (C57BL/6N-Pja2^{tm1b(EUCOMM)Wtsi}/Bay)	abnormal spleen morphology	J:211773
Pja2^{tm1b(EUCOMM)Wtsi}/Pja2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Pja2^{tm1b(EUCOMM)Wtsi}/Bay)	abnormal spleen morphology	J:211773
Pkd1^{tm1b(EUCOMM)Hmgu}/Pkd1⁺ (C57BL/6N-Pkd1^{tm1b(EUCOMM)Hmgu}/Bay)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	increased neutrophil cell number	J:211773
Pkd1^tm1Jzh/Pkd1^tm1Jzh (either: (involves: 129S4/SvJae * C57BL/6) or (involves: 129S4/SvJae * BALB/c))	hematopoietic system phenotype	J:72627
Pkd1l2^{tm1b(KOMP)Mbp}/Pkd1l2^{tm1b(KOMP)Mbp} (C57BL/6N-Pkd1l2^{tm1b(KOMP)Mbp}/H)	increased large unstained cell number	J:211773
Pkd2^tm1Dwo/Pkd2^tm1Dwo (either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))	absent spleen	J:77401
Pkhd1^tm1Som/Pkhd1^tm1Som (involves: 129S/SvEv * C57BL/6)	enlarged spleen	J:131370
Pklr^char4/Pklr^char4 (involves: A/J * C57BL/6)	abnormal erythrocyte morphology	J:86735
	abnormal erythropoiesis	J:141722
	anemia	J:141722
	decreased hemoglobin content	J:141722
	enlarged spleen	J:86735
	hemolytic anemia	J:86735
	increased erythrocyte clearance	J:141722
	reticulocytosis	J:141722, J:86735
Pklr^slc/Pklr^slc (CBA/NSlc-Pklr^slc)	abnormal common myeloid progenitor cell morphology	J:30035
	abnormal erythropoiesis	J:141722, J:30035
	anemia	J:141722
	decreased erythrocyte cell number	J:30035
	decreased hematocrit	J:30035
	decreased hemoglobin content	J:141722, J:30035
	enlarged spleen	J:30035
	hemolytic anemia	J:29199, J:30035
	increased erythroblast number	J:30035
	increased erythrocyte clearance	J:141722
	increased erythroid progenitor cell number	J:29199
	increased mean corpuscular volume	J:30035
	increased nucleated erythrocyte cell number	J:30035
	reticulocytosis	J:141722, J:30035
Pklr^slc/Pklr^slc (involves: CBA/NSlc)	abnormal erythrocyte morphology	J:203909
	anemia	J:203909
	increased erythrocyte osmotic fragility	J:203909
Pkn1^{tm1b(KOMP)Wtsi}/Pkn1^{tm1b(KOMP)Wtsi} (C57BL/6N-Pkn1^{tm1b(KOMP)Wtsi}/H)	decreased large unstained cell number	J:211773
	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	decreased monocyte cell number	J:211773
	decreased neutrophil cell number	J:211773
	decreased red blood cell distribution width	J:211773
	increased hemoglobin content	J:211773
Pkn1^tm1Kik/Pkn1^tm1Kik (B6.129P2-Pkn1^tm1Kik)	abnormal germinal center B cell physiology	J:193187
	abnormal somatic hypermutation frequency	J:193187
	decreased activation-induced B cell apoptosis	J:193187
	increased B cell proliferation	J:193187
	increased germinal center B cell number	J:193187
	increased IgG1 level	J:193187
	increased IgG2a level	J:193187
	increased IgG2b level	J:193187
	increased IgM level	J:193187
	increased spleen germinal center size	J:193187
	increased splenocyte number	J:193187
Pkn3^tm1.1Mrl/Pkn3⁺ Pten^tm1Hwu/Pten^tm1Hwu Tg(Mx1-cre)1Cgn/0 (involves: 129S4/SvJae * C57BL/6 * CBA/J)	enlarged spleen	J:216983
	enlarged thymus	J:216983
	extramedullary hematopoiesis	J:216983
Pkn3^tm1.1Mrl/Pkn3^tm1.1Mrl Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (B6.Cg-Pkn3^tm1.1Mrl Commd10^{Tg(Vav1-icre)A2Kio})	hematopoietic system phenotype	J:216983
Pkn3^tm1.1Mrl/Pkn3^tm1.1Mrl Pten^tm1Hwu/Pten^tm1Hwu Tg(Mx1-cre)1Cgn/0 (involves: 129S4/SvJae * C57BL/6 * CBA/J)	enlarged spleen	J:216983
	enlarged thymus	J:216983
	extramedullary hematopoiesis	J:216983
Pkn3^tm1.1Mrl/Pkn3^tm1.1Mrl Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA/J)	hematopoietic system phenotype	J:216983
Pknox1^{Gt(OST71835)Lex}/Pknox1^{Gt(OST71835)Lex} (involves: 129S5/SvEvBrd * C57BL/6)	decreased single-positive T cell number	J:103769
	increased double-negative T cell number	J:103769
	increased T cell apoptosis	J:103769
	thymus hypoplasia	J:103769
Pknox1^{Gt(OST71835)Lex}/Pknox1^{Gt(OST71835)Lex} (B6.129S5-Pknox1^{Gt(OST71835)Lex})	abnormal erythropoiesis	J:111418
	anemia	J:111418
	decreased erythroid progenitor cell number	J:111418
	decreased hematocrit	J:111418
	increased nucleated erythrocyte cell number	J:111418
Pknox1^{Gt(OST71835)Lex}/Pknox1^{Gt(OST71835)Lex} (involves: 129S5/SvEvBrd)	abnormal blood cell morphology/development	J:192251
Pknox1^tm1Ngc/Pknox1⁺ Tg(IghMyc)22Bri/0 (involves: C57BL * SJL)	decreased B cell apoptosis	J:192251
	increased B cell proliferation	J:192251
Pknox1^tm2.1Fbla/Pknox1^tm2.1Fbla Gt(ROSA)26Sor^{tm2(cre/ERT2)Brn}/Gt(ROSA)26Sor⁺ (involves: 129P2/OlaHsd)	decreased pre-B cell number	J:192251
	increased pro-B cell number	J:192251
Pknox2^{em1(IMPC)Ccpcz}/Pknox2^{em1(IMPC)Ccpcz} (C57BL/6N-Pknox2^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	small spleen	J:211773
Pla1a^em1Appsc/Pla1a^em1Appsc (C57BL/6J-Pla1a^em1Appsc)	increased lymphocyte cell number	J:333902
Pla2g2d^{tm1.1(KOMP)Vlcg}/Pla2g2d^{tm1.1(KOMP)Vlcg} (C57BL/6N-Pla2g2d^{tm1.1(KOMP)Vlcg}/J)	decreased leukocyte cell number	J:211773
Pla2g2d^tm1.1Mhg/Pla2g2d^tm1.1Mhg (B6NCrSlc.Cg-Pla2g2d^tm1.1Mhg)	abnormal cytotoxic T cell physiology	J:229035
	abnormal dendritic cell migration	J:229035
	abnormal effector T cell morphology	J:201008
	increased CD4-positive, alpha-beta T cell number	J:229035, J:201008
	increased CD8-positive, alpha-beta T cell number	J:229035
	increased dendritic cell number	J:201008
Pla2g2e^{tm1b(EUCOMM)Wtsi}/Pla2g2e^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Pla2g2e^{tm1b(EUCOMM)Wtsi}/Ieg)	increased red blood cell distribution width	J:211773
Pla2g2f^{em1(IMPC)Ccpcz}/Pla2g2f^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Pla2g2f^{em1(IMPC)Ccpcz}/Ccpcz)	increased mean platelet volume	J:211773
Pla2g3^tm1Murm/Pla2g3^tm1Murm (involves: 129S/SvEv * C57BL/6)	abnormal mast cell differentiation	J:197334
	abnormal mast cell morphology	J:197334
	decreased mast cell degranulation	J:197334
Pla2g4a^tm1Jvb/Pla2g4a^tm1Jvb (involves: 129S4/SvJae)	abnormal mast cell differentiation	J:54619
	increased mast cell degranulation	J:54619
	polycythemia	J:76813
Pla2g4a^tm1Tksh/Pla2g4a^tm1Tksh (NOD.129P2(B6)-Pla2g4a^tm1Tksh)	abnormal macrophage physiology	J:99775
Pla2g5^tm1Jarm/Pla2g5^tm1Jarm (involves: 129 * C57BL/6J)	abnormal macrophage physiology	J:89490
Pla2g5^tm1Jarm/Pla2g5^tm1Jarm (involves: 129 * BALB/c)	impaired macrophage phagocytosis	J:110309
Pla2g5^tm1Jarm/Pla2g5^tm1Jarm (C.129-Pla2g5^tm1Jarm)	impaired macrophage phagocytosis	J:110309
Pla2g5^tm1Jarm/Pla2g5^tm1Jarm (involves: 129 * C57BL/6)	impaired macrophage phagocytosis	J:110309
Pla2g5^tm1Jarm/Pla2g5^tm1Jarm (B6.129-Pla2g5^tm1Jarm)	impaired macrophage phagocytosis	J:110309
Pla2g6^m1Sein/Pla2g6^m1Sein (C57BL/6JJcl-Pla2g6^m1Sein)	decreased double-positive T cell number	J:155328
Pla2g10^Gt712Lex/Pla2g10^Gt712Lex (involves: 129S5/SvEvBrd * C57BL/6J)	decreased CD4-positive, alpha-beta T cell number	J:125607
	decreased CD8-positive, alpha-beta T cell number	J:125607
	decreased eosinophil cell number	J:125607
	decreased IgE level	J:125607
	decreased T cell number	J:125607
Pla2g10^tm1Kiku/Pla2g10^tm1Kiku (B6.129P2-Pla2g10^tm1Kiku)	abnormal neutrophil physiology	J:155082
	decreased neutrophil cell number	J:155082
	impaired neutrophil chemotaxis	J:155082
Pla2g15^tm1.1Jash/Pla2g15^tm1.1Jash (involves: 129S1/Sv * C57BL/6)	abnormal macrophage morphology	J:111561
	abnormal macrophage physiology	J:111561
	abnormal spleen morphology	J:111561
	increased macrophage cell number	J:111561
	increased macrophage derived foam cell number	J:111561
	increased spleen weight	J:111561
Plaat3^em1(IMPC)Tcp/Plaat3^em1(IMPC)Tcp (C57BL/6NCrl-Plaat3^em1(IMPC)Tcp/Tcp)	abnormal spleen morphology	J:211773
	increased mean corpuscular hemoglobin	J:211773
Plaat5^em1(IMPC)Tcp/Plaat5^em1(IMPC)Tcp (C57BL/6N-Plaat5^em1(IMPC)Tcp/Tcp)	increased eosinophil cell number	J:211773
Plac8^tm1Bhk/Plac8^tm1Bhk (involves: 129S6/SvEvTac * C57BL/6)	abnormal neutrophil physiology	J:145277
Plac8^tm1Bhk/Plac8^tm1Bhk (129S/SvEv-Plac8^tm1Bhk)	abnormal neutrophil physiology	J:145277
	increased leukocyte cell number	J:145277
	increased neutrophil cell number	J:145277
Plac9^{tm1b(EUCOMM)Hmgu}/Plac9^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Plac9^{tm1b(EUCOMM)Hmgu}/H)	decreased mean corpuscular volume	J:211773
	decreased neutrophil cell number	J:211773
	decreased red blood cell distribution width	J:211773
Plag1^{em1(IMPC)Hmgu}/Plag1^{em1(IMPC)Hmgu} (C57BL/6N-Plag1^{em1(IMPC)Hmgu}/Ieg)	decreased CD8-positive, naive alpha-beta T cell number	J:211773
	increased red blood cell distribution width	J:211773
Plat^tm1Mlg/Plat^tm1Mlg (involves: 129S2/SvPas * C57BL/6)	increased macrophage cell number	J:63134
Plat^tm1Mlg/Plat^tm1Mlg (involves: 129S2/SvPas)	abnormal microglial cell physiology	J:144185
Plau^{tm1b(EUCOMM)Wtsi}/Plau^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Plau^{tm1b(EUCOMM)Wtsi}/H)	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Plau^tm1Mlg/Plau^tm1Mlg (involves: 129S2/SvPas * C57BL/6)	abnormal macrophage physiology	J:17427
	abnormal neutrophil physiology	J:75573, J:91980
	hematopoietic system phenotype	J:17427
	impaired granulocyte bactericidal activity	J:91980
	impaired macrophage chemotaxis	J:63134
	impaired neutrophil phagocytosis	J:91980
	increased lymphocyte cell number	J:63134
Plau^tm1Mlg/Plau^tm1Mlg (B6.Cg-Plau^tm1Mlg)	decreased T cell proliferation	J:75303
Plau^tm1Mlg/Plau^tm1Mlg (B6.Cg-Plau^tm1Mlg)	impaired macrophage chemotaxis	J:68083
Plaur^tm1Jld/Plaur^tm1Jld (involves: 129P2/OlaHsd * Black Swiss)	abnormal macrophage physiology	J:26874
Plaur^tm1Mlg/Plaur^tm1Mlg (involves: 129S2/SvPas * C57BL/6)	abnormal macrophage physiology	J:31253
	abnormal neutrophil physiology	J:75573, J:91980
	hematopoietic system phenotype	J:31253
	impaired neutrophil phagocytosis	J:91980
Plbd2^em1(IMPC)J/Plbd2^em1(IMPC)J (C57BL/6NJ-Plbd2^em1(IMPC)J/Mmjax)	decreased mean corpuscular hemoglobin	J:211773
Plcb1^em1(IMPC)Mbp/Plcb1⁺ (C57BL/6N-Plcb1^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Plcb2^{tm1b(KOMP)Wtsi}/Plcb2^{tm1b(KOMP)Wtsi} (C57BL/6N-Plcb2^{tm1b(KOMP)Wtsi}/Ucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Plcb2^tm1Dwu/Plcb2^tm1Dwu (involves: 129)	abnormal leukocyte physiology	J:41948
Plcb2^tm1Dwu/Plcb2^tm1Dwu Plcb3^tm1Dwu/Plcb3^tm1Dwu (involves: 129S1/Sv)	abnormal neutrophil physiology	J:60348
	increased immunoglobulin level	J:60348
Plcb2^tm1Dwu/Plcb2^tm1Dwu Plcb3^tm1Dwu/Plcb3^tm1Dwu (involves: 129S1/Sv * CD-1)	abnormal platelet physiology	J:60348
	decreased platelet aggregation	J:60348
	decreased platelet calcium level	J:60348
	increased platelet ATP level	J:60348
Plcd1^tm1.1Kfu/Plcd1^tm1.1Kfu Tg(KRT14-cre)1Amc/0 (involves: C57BL/6 * C57BL/6JJcl * CBA)	decreased B cell number	J:205633
	decreased erythrocyte cell number	J:205633
	increased granulocyte number	J:205633
	increased NK T cell number	J:205633
Plcd1^tm1Tta/Plcd1^tm1Tta (involves: 129P2/OlaHsd)	abnormal common myeloid progenitor cell morphology	J:205633
	abnormal granulocyte differentiation	J:205633
	decreased B cell number	J:205633
	decreased erythrocyte cell number	J:205633
	enlarged spleen	J:205633
	hematopoietic system phenotype	J:205633
	increased granulocyte number	J:205633
	increased leukocyte cell number	J:205633
Plce1^em1(IMPC)Mbp/Plce1^em1(IMPC)Mbp (C57BL/6N-Plce1^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	decreased lymphocyte cell number	J:211773
	enlarged spleen	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Plcg1^tm1Gcrp/Plcg1^tm1Rwen Tg(Cd4-cre)1Cwi/0 (either: B6.Cg-Plcg1^tm1Gcrp/Plcg1^tm1Rwen Tg(Cd4-cre)1Cwi or (involves: 129X1/SvJ * C57BL/6 * DBA/2))	abnormal T cell activation	J:157757
	decreased regulatory T cell number	J:157757
	decreased T cell number	J:157757
	increased CD4-positive, alpha-beta T cell number	J:157757
	increased T cell proliferation	J:157757
Plcg1^tm1Gcrp/Plcg1^tm1Rwen Tg(Cd4-cre)1Cwi/0 Tg(TcraH-Y,TcrbH-Y)71Vbo/0 (involves: 129X1/SvJ * C57BL/6 * DBA/2)	decreased CD8-positive, alpha-beta T cell number	J:157757
	decreased double-negative T cell number	J:157757
	increased CD8-positive, alpha-beta T cell number	J:157757
	increased double-positive T cell number	J:157757
	thymus hyperplasia	J:157757
Plcg1^tm1Ine/Plcg1^tm1Ine (involves: 129P2/OlaHsd)	abnormal embryonic hematopoiesis	J:73254
Plcg1^tm2Gcrp/Plcg1^tm2Gcrp (involves: 129/Sv * CD-1)	abnormal embryonic hematopoiesis	J:75316
Plcg1^tm2Gcrp/Plcg1^tm2Gcrp (involves: 129/Sv * CD-1)	abnormal proerythroblast morphology	J:75316
Plcg2^Ali5/Plcg2⁺ (C3HeB/FeJ-Plcg2^Ali5)	abnormal B cell physiology	J:97930
Plcg2^Ali5/Plcg2⁺ (C3HeB/FeJ-Plcg2^Ali5)	decreased B-2 B cell number	J:97930
Plcg2^Ali5/Plcg2⁺ (involves: C57BL/6J * C3HeB/FeJ-Plcg2^Ali5)	abnormal B cell physiology	J:97930
Plcg2^Ali5/Plcg2^Ali5 (involves: C57BL/6J * C3HeB/FeJ-Plcg2^Ali5)	abnormal B cell physiology	J:97930
	decreased mature B cell number	J:97930
	decreased transitional stage B cell number	J:97930
Plcg2^em1Msasn/Plcg2^em1Msasn (B6.Cg-Plcg2^em1Msasn/J)	impaired macrophage phagocytosis	J:308279
Plcg2^m1Btlr/Plcg2^m1Btlr (C57BL/6J-Plcg2^m1Btlr)	decreased IgM level	J:165702
Plcg2^m1Btlr/Plcg2^m1Btlr (involves: C57BL/6J)	abnormal B cell differentiation	J:185495
Plcg2^m1Btlr/Plcg2^m1Btlr (involves: C57BL/6J)	decreased IgM level	J:185495
Plcg2^M3Btlr/Plcg2^M3Btlr (C57BL/6J-Plcg2^M3Btlr)	decreased B-1a cell number	J:265101
Plcg2^M3Btlr/Plcg2^M3Btlr (C57BL/6J-Plcg2^M3Btlr)	decreased IgM level	J:265101
Plcg2^m4Btlr/Plcg2^m4Btlr (C57BL/6J-Plcg2^m4Btlr)	decreased CD8-positive, naive alpha-beta T cell number	J:272862
Plcg2^m4Btlr/Plcg2^m4Btlr (C57BL/6J-Plcg2^m4Btlr)	increased effector memory CD8-positive, alpha-beta T cell number	J:272862
Plcg2^tm1.1Kuro/Plcg2^tm1.1Kuro (B6.Cg-Plcg2^tm1.1Kuro)	impaired natural killer cell mediated cytotoxicity	J:131621
Plcg2^tm1.1Kuro/Plcg2^tm1.1Kuro (Not Specified)	abnormal B cell differentiation	J:131161
	abnormal NK cell physiology	J:187430
	increased pro-B cell number	J:131161
	spleen hyperplasia	J:131161
Plcg2^tm1Jni/Plcg2^tm1Jni (involves: 129P2/OlaHsd)	abnormal B cell physiology	J:80614
	abnormal dendritic cell chemotaxis	J:157619
	abnormal dendritic cell morphology	J:157619
	arrested B cell differentiation	J:86373
	decreased B cell proliferation	J:80614
	decreased follicular B cell number	J:86373
	decreased mature B cell number	J:104166
	decreased platelet aggregation	J:114266
	increased B cell apoptosis	J:86373
	increased pro-B cell number	J:104166
	increased transitional stage T2 B cell number	J:86373
Plcg2^tm1Jni/Plcg2^tm1Jni (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell differentiation	J:117023
	abnormal B cell physiology	J:117023
	abnormal osteoclast differentiation	J:114607
	decreased osteoclast cell number	J:114607
	impaired natural killer cell mediated cytotoxicity	J:100716
	increased B cell proliferation	J:117023
	increased pre-B cell number	J:117023
Plcg2^tm1Kuro/Plcg2^tm1Kuro Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	decreased B cell proliferation	J:63744
	decreased mature B cell number	J:63744
	decreased pre-B cell number	J:63744
	increased B-1a cell number	J:63744
	increased immature B cell number	J:63744
	increased pro-B cell number	J:63744
Plcl2^tm1Tta/Plcl2^tm1Tta (involves: 129P2/OlaHsd)	abnormal B cell physiology	J:85960
	decreased B-1a cell number	J:85960
	decreased mature B cell number	J:85960
	increased B cell proliferation	J:85960
	increased IgM level	J:85960
Plcz1^em1(IMPC)H/Plcz1^em1(IMPC)H (C57BL/6N-Plcz1^em1(IMPC)H/H)	decreased mean platelet volume	J:211773
Pld1^tm1.1Mafr/Pld1^tm1.1Mafr (B6.Cg-Pld1^tm1.1Mafr)	abnormal platelet physiology	J:193451
Pld1^tm3Mafr/Pld1^tm3Mafr (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased platelet aggregation	J:211547
	increased mean platelet volume	J:211547
Pld1^tm3Mafr/Pld1^tm3Mafr (B6.129-Pld1^tm3Mafr)	abnormal platelet activation	J:216114
Pld1^tm3Mafr/Pld1^tm3Mafr Pld2^{tm1(KOMP)Vlcg}/Pld2^{tm1(KOMP)Vlcg} (involves: C57BL/6 * C57BL/6NTac)	abnormal platelet activation	J:216114
Pld2^tm1.1Mjow/Pld2^tm1.1Mjow (Not Specified)	abnormal neutrophil physiology	J:183062
Pld3^em1Nemz/Pld3^em1Nemz (C57BL/6J-Pld3^em1Nemz)	hematopoietic system phenotype	J:281205
Pld3^em1Nemz/Pld3^em1Nemz Pld4^tm1.2Nemz/Pld4^tm1.2Nemz (B6.Cg-Pld3^em1Nemz Pld4^tm1.1Nemz)	hemophagocytosis	J:281205
Pld3^{tm1e(EUCOMM)Wtsi}/Pld3^{tm1e(EUCOMM)Wtsi} (C57BL/6N-Pld3^{tm1e(EUCOMM)Wtsi}/Wtsi)	decreased mean corpuscular hemoglobin	J:211773
	thrombocytopenia	J:211773
Pld4^em1(IMPC)Mbp/Pld4^em1(IMPC)Mbp (C57BL/6N-Pld4^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased leukocyte cell number	J:211773
	increased monocyte cell number	J:211773
	increased spleen weight	J:211773
Pld4^thss/Pld4^thss (BALB/cJ-Pld4^thss/GrsrJ)	abnormal alpha-beta T cell morphology	J:278304
	abnormal immunoglobulin level	J:278304
	enlarged spleen	J:278304
	increased IgA level	J:278304
	increased IgE level	J:278304
	increased IgG2b level	J:278304
	increased IgG3 level	J:278304
	increased IgG level	J:278304
	increased IgM level	J:278304
	increased macrophage cell number	J:278304
	increased marginal zone B cell number	J:278304
	increased plasma cell number	J:278304
	increased plasmacytoid dendritic cell number	J:278304
	increased spleen germinal center number	J:278304
	spleen hyperplasia	J:278304
Pld4^tm1.1Nemz/Pld4^tm1.1Nemz Tg(Itgax-cre)1-1Reiz/0 (involves: 129 * C57BL/6 * C57BL/6J * CBA)	abnormal peritoneal macrophage morphology	J:281205
Pld4^tm1.2Nemz/Pld4^tm1.2Nemz (B6.129(Cg)-Pld4^tm1.1Nemz)	abnormal leukocyte cell number	J:281205
	abnormal peritoneal macrophage morphology	J:281205
	decreased B-1 B cell number	J:281205
	decreased NK T cell number	J:281205
	enlarged spleen	J:281205
	increased marginal zone B cell number	J:281205
	increased monocyte cell number	J:281205
	thrombocytopenia	J:281205
Pld4^tm1.2Nemz/Pld4^tm1.2Nemz Rag1^tm1Mom/Rag1^tm1Mom (involves: 129 * 129S7/SvEvBrd * C57BL/6J * FVB/N)	abnormal peritoneal macrophage morphology	J:281205
	decreased NK T cell number	J:281205
Pld4^tm1.2Nemz/Pld4^tm1.2Nemz Tlr9^M7Btlr/Tlr9^M7Btlr (involves: 129 * C57BL/6J * FVB/N)	hematopoietic system phenotype	J:281205
Pld5^{tm1b(KOMP)Wtsi}/Pld5^{tm1b(KOMP)Wtsi} (B6Brd;B6Dnk;B6N-Pld5^{tm1b(KOMP)Wtsi} Tyr^c-Brd/Wtsi)	decreased mean platelet volume	J:211773
	decreased red blood cell distribution width	J:211773
Plec^tm3Gwi/Plec^tm3Gwi (involves: 129P2/OlaHsd)	abnormal T cell physiology	J:104701
Plec^tm3Gwi/Plec^tm3Gwi (involves: 129P2/OlaHsd)	impaired macrophage chemotaxis	J:104701
Plek2^tm1Pji/Plek2^tm1Pji (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal erythropoiesis	J:257910
	abnormal granulocyte differentiation	J:257910
	abnormal megakaryocyte differentiation	J:257910
	abnormal reticulocyte cell number	J:257910
	anemia	J:257910
	enlarged spleen	J:257910
	increased erythroblast number	J:257910
Plek2^tm1Pji/Plek2^tm1Pji Jak2^tm1.1Ble/Jak2⁺ Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: 129 * C57BL/6 * C57BL/10 * CBA/Ca)	abnormal granulocyte differentiation	J:257910
	abnormal megakaryocyte differentiation	J:257910
	extramedullary hematopoiesis	J:257910
	hematopoietic system phenotype	J:257910
Plek^tm1Csab/Plek^tm1Csab (involves: 129P2/OlaHsd * C57BL/6J)	abnormal platelet activation	J:148429
	decreased platelet aggregation	J:148429
	thrombocytopenia	J:148429
Plekha1^{tm1b(EUCOMM)Hmgu}/Plekha1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Plekha1^{tm1b(EUCOMM)Hmgu}/Ieg)	increased mean corpuscular volume	J:211773
Plekha5^em1(IMPC)Tcp/Plekha5^em1(IMPC)Tcp (C57BL/6NCrl-Plekha5^em1(IMPC)Tcp/Tcp)	decreased mean corpuscular hemoglobin	J:211773
	increased spleen weight	J:211773
Plekhf1^tm1.1Caox/Plekhf1^tm1.1Caox Lyz2^tm1(cre)Ifo/Lyz2⁺ (B6.Cg-Plekhf1^tm1.1Caox Lyz2^tm1(cre)Ifo)	abnormal macrophage physiology	J:277440
Plekhf2^{em1(IMPC)Wtsi}/Plekhf2^{em1(IMPC)Wtsi} (C57BL/6NCrl-Plekhf2^{em1(IMPC)Wtsi}/Wtsi)	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
Plekhg2^em1(IMPC)J/Plekhg2^em1(IMPC)J (C57BL/6NJ-Plekhg2^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Plekhm1^tm1.2Hzhao/Plekhm1^tm1.2Hzhao (involves: 129S1/Sv * C57BL/6J)	abnormal osteoclast morphology	J:236517
	abnormal osteoclast physiology	J:236517
Plekhm2^{tm1a(EUCOMM)Wtsi}/Plekhm2^{tm1a(EUCOMM)Wtsi} (B6JTyr;B6N-Plekhm2^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased hematocrit	J:165965
	decreased hemoglobin content	J:165965
	increased leukocyte cell number	J:165965
Plekhm2^{tm1a(EUCOMM)Wtsi}/Plekhm2^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6J * C57BL/6N)	increased leukocyte cell number	J:233985
Plekho2^em1Lzhn/Plekho2^em1Lzhn (C57BL/6-Plekho2^em1Lzhn)	decreased macrophage cell number	J:270531
Plekho2^em1Lzhn/Plekho2^em1Lzhn (C57BL/6-Plekho2^em1Lzhn)	increased macrophage apoptosis	J:270531
Plet1^tm1Cupe/Plet1^tm1Cupe (Not Specified)	abnormal dendritic cell migration	J:271548
	abnormal dendritic cell number	J:271548
	increased dendritic cell number	J:271548
Plg^tm1Jld/Plg^tm1Jld (B6.129P2-Plg^tm1Jld/J)	abnormal microglial cell physiology	J:141739
Plgrkt^tm1Rjpr/Plgrkt^tm1Rjpr (B6.Cg-Plgrkt^tm1Rjpr)	abnormal macrophage physiology	J:282437
	impaired leukocyte migration	J:282437
	impaired macrophage chemotaxis	J:282437
Plp1^jp-rsh/Plp1⁺ (either: STOCK Rb(1.3)1Bnr or (involves: BALB/c * DBA/2 * STOCK Rb(1.3)1Bnr))	abnormal microglial cell morphology	J:604
Plp1^{tm1c(EUCOMM)Wtsi}/Y Cnp^tm1(cre)Kan/Cnp⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6N)	increased T cell number	J:245100
	microgliosis	J:245100
Plp1^tm1Kan/Y (involves: 129S1/Sv * 129X1/SvJ)	abnormal microglial cell morphology	J:48031
Plp1^tm1Kan/Y (involves: 129S1/Sv * 129X1/SvJ)	microgliosis	J:245100
Plp1^tm1Kan/Y (B6.129-Plp1^tm1Kan)	microgliosis	J:201143
Plp1^tm1Kan/Y Cnp^tm1(cre)Kan/Cnp⁺ (involves: 129S1/Sv * 129X1/SvJ)	increased T cell number	J:245100
	microgliosis	J:245100
Plp1^tm1Kan/Y Tspan2^tm1Hbw/Tspan2^tm1Hbw (B6.Cg-Tspan2^tm1Hbw Plp1^tm1Kan)	microgliosis	J:201143
Plpp3^{tm1b(EUCOMM)Hmgu}/Plpp3⁺ (C57BL/6N-Plpp3^{tm1b(EUCOMM)Hmgu}/Cnrm)	decreased mean corpuscular hemoglobin	J:211773
Plpp6^{tm1.1(KOMP)Vlcg}/Plpp6^{tm1.1(KOMP)Vlcg} (C57BL/6N-Plpp6^{tm1.1(KOMP)Vlcg}/Ucd)	increased mean platelet volume	J:211773
Plppr5^{em1(IMPC)Ccpcz}/Plppr5^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Plppr5^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Plppr5^em1(IMPC)H/Plppr5^em1(IMPC)H (C57BL/6NTac-Plppr5^em1(IMPC)H/H)	increased neutrophil cell number	J:211773
Pls3^{tm1a(EUCOMM)Wtsi}/Pls3^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Pls3^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased mean corpuscular hemoglobin	J:211773
Plscr1^tm1Lex/Plscr1^tm1Lex (129S/SvEvBrd-Plscr1^tm1Lex)	abnormal granulocyte differentiation	J:76790
	abnormal myelopoiesis	J:76790
	abnormal neutrophil differentiation	J:76790
	decreased granulocyte number	J:76790
	decreased neutrophil cell number	J:76790
Plscr1^tm1Lex/Plscr1^tm1Lex Plscr3^tm1Sims/Plscr3^tm1Sims (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal myelopoiesis	J:92404
plt/plt (involves: DDD/1)	abnormal leukocyte cell number	J:47819
	abnormal leukocyte migration	J:47819, J:47460
	abnormal spleen red pulp morphology	J:47460
	abnormal spleen white pulp morphology	J:47460
	decreased single-positive T cell number	J:15290
	decreased T cell number	J:47819
	increased memory T cell number	J:47460
	increased T cell number	J:47819
plt/plt (C.DDD-plt)	abnormal T cell activation	J:119345
plt/plt (C.DDD-plt)	decreased single-positive T cell number	J:119345
plt/plt (B6.DDD-plt)	abnormal leukocyte migration	J:93960
	abnormal thymus cortex morphology	J:93960
	small thymus medulla	J:93960
plt/plt (either: B6.DDD-plt or C.DDD-plt)	abnormal leukocyte migration	J:110910
Plt001/Plt001⁺ (C3HeB/FeJ-Plt001)	thrombocytosis	J:186868
plt005/plt005 (C3HeB/FeJ-plt005)	thrombocytosis	J:186868
plt008/plt008 (C3HeB/FeJ-plt008)	thrombocytopenia	J:186868
plt009/plt009 (C3HeB/FeJ-plt009)	thrombocytosis	J:186868
Plt18/Plt18⁺ (involves: BALB/c)	thrombocytopenia	J:149205
Plt21/Plt21⁺ (involves: BALB/c)	thrombocytopenia	J:149205
Pltct1^QSi5/Ianm/? (involves: CBA/CaH * QSi5)	thrombocytopenia	J:93967
Pltct2^QSi5/Ianm/? (involves: CBA/CaH * QSi5)	thrombocytosis	J:93967
Pltq1^SM/J/Pltq1^SM/J (involves: NZW/LacJ * SM/J)	thrombocytosis	J:102636
Pltq2^NZW/LacJ/Pltq2^NZW/LacJ (involves: NZW/LacJ * SM/J)	thrombocytosis	J:102636
Pltq2^NZW/LacJ/Pltq2^SM/J (involves: NZW/LacJ * SM/J)	thrombocytosis	J:102636
Pltq3^NZW/LacJ/Pltq3^NZW/LacJ (involves: NZW/LacJ * SM/J)	thrombocytosis	J:102636
Pltq3^NZW/LacJ/Pltq3^SM/J (involves: NZW/LacJ * SM/J)	thrombocytosis	J:102636
Plvap^{tm1e(EUCOMM)Hmgu}/Plvap^{tm1e(EUCOMM)Hmgu} (C57BL/6N-Plvap^{tm1e(EUCOMM)Hmgu})	abnormal erythrocyte morphology	J:203907
	anemia	J:203907
	increased nucleated erythrocyte cell number	J:203907
Plvap^{tm1e(EUCOMM)Hmgu}/Plvap^{tm1e(EUCOMM)Hmgu} Tg(TIE2GFP)287Sato/0 (involves: C57BL/6N * FVB/N)	anemia	J:203907
	small spleen	J:203907
Plxna1^tm1Kik/Plxna1^tm1Kik (either: B6.Cg-Plxna1^tm1Kik or C.Cg-Plxna1^tm1Kik)	abnormal CD4-positive, alpha-beta T cell physiology	J:110786
Plxna1^tm1Kik/Plxna1^tm1Kik Tg(TcraTcrb)425Cbn/? (involves: BALB/c * C57BL/6)	decreased T cell proliferation	J:161856
Plxna2^{tm1a(EUCOMM)Wtsi}/Plxna2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Plxna2^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased mean corpuscular hemoglobin	J:211773
Plxna4^em1(IMPC)Mbp/Plxna4^em1(IMPC)Mbp (C57BL/6NCrl-Plxna4^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	small spleen	J:211773
Plxnc1^em1(IMPC)Mbp/Plxnc1^em1(IMPC)Mbp (C57BL/6N-Plxnc1^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	small spleen	J:211773
Plxnd1^b2b1863Clo/Plxnd1^b2b1863Clo (C57BL/6J-Plxnd1^b2b1863Clo)	thymus hypoplasia	J:175213
Plxnd1^b2b3150Clo/Plxnd1^b2b3150Clo (C57BL/6J-Plxnd1^b2b3150Clo)	thymus hypoplasia	J:175213
Plyid^HIGA/Nsc/Plyid^HIGA/Nsc (involves: BALB/cA * HIGA/Nsc)	increased IgA level	J:91769
Pm20d1^em1(IMPC)H/Pm20d1^em1(IMPC)H (C57BL/6NTac-Pm20d1^em1(IMPC)H/H)	increased hematocrit	J:211773
Pmaip1^tm1Ast/Pmaip1^tm1Ast (C57BL/6-Pmaip1^tm1Ast)	abnormal NK cell morphology	J:123409
Pmel^si/Pmel^si (Not Specified)	hematopoietic system phenotype	J:29151
Pmepa1^em1Akt/Pmepa1^em1Akt (C57BL/6N-Pmepa1^em1Akt)	abnormal osteoclast differentiation	J:329578
	abnormal osteoclast physiology	J:329578
	decreased osteoclast cell number	J:329578
Pml^{tm1(PML/RARA)Ley}/Pml⁺ Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)	hematopoietic system phenotype	J:172024
Pml^{tm1(PML/RARA)Ley}/Pml⁺ Tg(CAG-cre/Esr1)5Amc/0 (involves: BALB/cJ C57BL/6 * CBA)	abnormal hematopoietic stem cell physiology	J:172024
	decreased hematopoietic stem cell number	J:172024
	enlarged spleen	J:172024
Pml^tm1.1Ews/Pml^tm1.1Ews (FVB.129P2-Pml^tm1.1Ews)	increased hematopoietic stem cell number	J:262172
Pml^tm1.1Ews/Pml^tm1.1Ews Tg(PML-RARA)556Kog/0 (FVB.Cg-Pml^tm1.1Ews Tg(PML-RARA)556Kog)	anemia	J:262172
	enlarged spleen	J:262172
	increased leukocyte cell number	J:262172
	thrombocytosis	J:262172
Pml^tm1Ppp/Pml⁺ Trp53^tm3.1Glo/Trp53⁺ (B6.129S7(Cg)-Pml^tm1Ppp Trp53^tm3.1Glo)	extramedullary hematopoiesis	J:317504
	hepatosplenomegaly	J:317504
Pml^tm1Ppp/Pml^tm1Ppp (involves: 129S7/SvEvBrd)	abnormal myelopoiesis	J:46381
	decreased granulocyte number	J:46381
	decreased leukocyte cell number	J:46381
Pml^tm1Ppp/Pml^tm1Ppp (FVB.129S7-Pml^tm1Ppp)	increased hematopoietic stem cell number	J:262172
Pml^tm1Ppp/Pml^tm1Ppp Trp53^tm3.1Glo/Trp53⁺ (B6.129S7(Cg)-Pml^tm1Ppp Trp53^tm3.1Glo)	hematopoietic system phenotype	J:317504
	hepatosplenomegaly	J:317504
Pmm2^tm1.1Jins/Pmm2^tm2.1Jins (involves: 129S6/SvEvTac * C57BL/6J)	hematopoietic system phenotype	J:236704
Pms2^tm1.1Wed/Pms2^tm1.1Wed (involves: 129S6/SvEvTac * C57BL/6NCr)	abnormal class switch recombination	J:162378
Pms2^tm1Lisk/Pms2^tm1Lisk (involves: 129S2/SvPas)	abnormal class switch recombination	J:162378
Pnliprp2^tm1Gru/Pnliprp2^tm1Gru (involves: 129S2/SvPas * BALB/c)	decreased cytotoxic T cell cytolysis	J:51627
Pnp^bata/Pnp^bata (C57BL/6JSfdAnu-Pnp^bata)	decreased B cell proliferation	J:104190
	decreased marginal zone B cell number	J:104190
	increased T follicular helper cell number	J:104190
Pnp^e/Pnp^e (C57BL/6J-Pnp^e)	abnormal leukocyte physiology	J:39328
Pnp^e/Pnp^e (C57BL/6J-Pnp^e)	thymus hypoplasia	J:39328
Pnp^f/Pnp^f (involves: C3H/HeHa * C57BL/6J)	increased double-negative T cell number	J:522
Pnp^f/Pnp^f (C57BL/6J-Pnp^f)	abnormal leukocyte cell number	J:39328
	abnormal leukocyte physiology	J:39328
	decreased CD8-positive, alpha-beta T cell number	J:39328
	decreased double-positive T cell number	J:39328
	thymus hypoplasia	J:39328
Pnp^g/Pnp^g (involves: C57BL/6 * DBA/2J)	abnormal leukocyte cell number	J:39328
	abnormal leukocyte physiology	J:39328
	decreased CD8-positive, alpha-beta T cell number	J:39328
	decreased double-positive T cell number	J:39328
	increased double-negative T cell number	J:39328
	thymus hypoplasia	J:39328
Pnp^M1Btlr/Pnp^M1Btlr (C57BL/6J-Pnp^M1Btlr)	increased IgM level	J:265147
Pnp^m2Btlr/Pnp^m2Btlr (C57BL/6J-Pnp^m2Btlr)	decreased B-1a cell number	J:265150
	decreased B-2 B cell number	J:265150
	decreased CD4-positive, alpha-beta T cell number	J:265150
	decreased CD8-positive, naive alpha-beta T cell number	J:265150
	decreased T cell number	J:265150
	increased B-1b cell number	J:265150
	increased CD8-positive, alpha-beta memory T cell number	J:265150
	increased central memory CD4-positive, alpha-beta T cell number	J:265150
	increased central memory CD8 positive, alpha-beta T cell number	J:265150
	increased effector memory CD4-positive, alpha-beta T cell number	J:265150
	increased effector memory CD8-positive, alpha-beta T cell number	J:265150
Pnp^tm1Cmr/Pnp^tm1Cmr (involves: 129)	abnormal myelopoiesis	J:62870
	decreased CD4-positive, alpha-beta T cell number	J:62870
	decreased CD8-positive, alpha-beta T cell number	J:62870
	decreased cytotoxic T cell cytolysis	J:62870
	decreased double-positive T cell number	J:62870
	decreased single-positive T cell number	J:62870
	increased double-negative T cell number	J:62870
	increased pre-B cell number	J:62870
	increased thymocyte apoptosis	J:62870
Pnpla5^em1(IMPC)Mbp/Pnpla5^em1(IMPC)Mbp (C57BL/6N-Pnpla5^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Pnpt1^{tm1a(KOMP)Wtsi}/Pnpt1⁺ (B6JTyr;B6N-Pnpt1^{tm1a(KOMP)Wtsi}/Wtsi)	increased mean corpuscular hemoglobin	J:165965
	increased mean corpuscular volume	J:165965
Podxl2^{tm1.1(KOMP)Vlcg}/Podxl2^{tm1.1(KOMP)Vlcg} (C57BL/6N-Podxl2^{tm1.1(KOMP)Vlcg}/Ucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased neutrophil cell number	J:211773
Pofut2^{Gt(RST434)Byg}/Pofut2^{Gt(RST434)Byg} (involves: 129P2/OlaHsd)	abnormal embryonic erythropoiesis	J:165751
Pogz^tm1.2Jrk/Pogz^tm1.2Jrk (involves: 129S1/Sv * C57BL/6J)	anemia	J:271614
Polb^tm1.1Jbsw/Polb⁺ (involves: 129/Sv * C57BL/6)	increased IgG level	J:206872
Polb^tm1.1Jbsw/Polb^tm1.1Jbsw (involves: 129/Sv * C57BL/6)	abnormal immunoglobulin heavy chain V(D)J recombination	J:206872
	abnormal somatic hypermutation frequency	J:206872
	abnormal spleen germinal center morphology	J:206872
	increased germinal center B cell number	J:206872
	increased IgG level	J:206872
	increased spleen germinal center number	J:206872
	increased splenocyte apoptosis	J:183837, J:206872
	increased T-helper 2 cell number	J:206872
Polb^{tm1a(KOMP)Wtsi}/Polb⁺ (C57BL/6N-Polb^{tm1a(KOMP)Wtsi}/Wtsi)	increased mean platelet volume	J:211773
Pold1^tm1.1Uchi/Pold1^tm1.1Uchi (C57BL/6-Pold1^tm1.1Uchi)	enlarged thymus	J:144992
Pold1^tm1Uchi/Pold1^tm1.1Uchi (C57BL/6-Pold1^tm1Uchi/Pold1^tm1.1Uchi)	enlarged thymus	J:144992
Pold4^em1(IMPC)J/Pold4^em1(IMPC)J (C57BL/6NJ-Pold4^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Pole2^em1(IMPC)Mbp/Pole2⁺ (C57BL/6NCrl-Pole2^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Pole3^em1Tbo/Pole3^em1Tbo (FVB-Pole3^em1Tbo)	decreased B cell number	J:298827
	decreased lymphocyte cell number	J:298827
	decreased splenocyte number	J:298827
	decreased thymocyte number	J:298827
Pole3^em2Tbo/Pole3^em2Tbo (FVB-Pole3^em2Tbo)	decreased B cell number	J:298827
	decreased lymphocyte cell number	J:298827
	decreased splenocyte number	J:298827
	decreased thymocyte number	J:298827
Pole3^em3Tbo/Pole3^em3Tbo (FVB-Pole3^em3Tbo)	abnormal thymus apoptosis	J:298827
	decreased B cell number	J:298827
	decreased DN4 thymocyte number	J:298827
	decreased double-positive T cell number	J:298827
	decreased gamma-delta T cell number	J:298827
	decreased immature B cell number	J:298827
	decreased lymphocyte cell number	J:298827
	decreased pre-B cell number	J:298827
	decreased splenocyte number	J:298827
	decreased thymocyte number	J:298827
	increased DN3 thymocyte number	J:298827
	increased thymocyte apoptosis	J:298827
	small spleen	J:298827
	small thymus	J:298827
Pole3^em4Tbo/Pole3^em4Tbo (FVB-Pole3^em4Tbo)	abnormal thymus apoptosis	J:298827
	decreased B cell number	J:298827
	decreased DN4 thymocyte number	J:298827
	decreased immature B cell number	J:298827
	decreased lymphocyte cell number	J:298827
	decreased pre-B cell number	J:298827
	decreased splenocyte number	J:298827
	decreased thymocyte number	J:298827
	increased DN3 thymocyte number	J:298827
	increased thymocyte apoptosis	J:298827
Pole3^{tm1(KOMP)Vlcg}/Pole3^{tm1(KOMP)Vlcg} (involves: C57BL/6NTac * FVB)	decreased DN4 thymocyte number	J:298827
	increased DN3 thymocyte number	J:298827
Pole4^{tm1(KOMP)Vlcg}/Pole4^{tm1(KOMP)Vlcg} (involves: 129S1/Sv * 129X1/SvJ * C57BL/6NTac * FVB/N)	abnormal B cell differentiation	J:261973
	abnormal spleen B cell follicle morphology	J:261973
	abnormal T cell differentiation	J:261973
	abnormal thymus morphology	J:261973
	absent thymus cortex	J:261973
	anemia	J:261973
	arrested B cell differentiation	J:261973
	athymia	J:261973
	decreased B cell number	J:261973
	decreased hematopoietic stem cell number	J:261973
	decreased leukocyte cell number	J:261973
	decreased lymphocyte cell number	J:261973
	decreased single-positive T cell number	J:261973
	decreased spleen weight	J:261973
	increased double-negative T cell number	J:261973
	increased granulocyte number	J:261973
	increased hematopoietic stem cell number	J:261973
	increased monocyte cell number	J:261973
	small spleen	J:261973
	thrombocytosis	J:261973
Pole4^{tm1(KOMP)Vlcg}/Pole4^{tm1(KOMP)Vlcg} Trp53^tm1Brd/Trp53⁺ (involves: C57BL/6J * C57BL/6NTac)	decreased leukocyte cell number	J:261973
	decreased lymphocyte cell number	J:261973
	increased granulocyte number	J:261973
	increased monocyte cell number	J:261973
Pole^tm1.1Bdp/Pole^tm1.1Bdp (B6.129-Pole^tm1.1Bdp)	enlarged spleen	J:153684
Polg^tm1.1Lrsn/Polg^tm1.1Lrsn (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased hemoglobin content	J:91077
	hypochromic macrocytic anemia	J:91077
Polg^tm1Jiha/Polg⁺ (involves: C57BL/6JJcl)	abnormal bone marrow cell physiology	J:199416
Polg^tm1Prol/Polg^tm1Prol (involves: 129S7/SvEvBrd * C57BL/6J * ICR)	abnormal thymus involution	J:99764
	decreased erythrocyte cell number	J:99764
Polg^tm1Prol/Polg^tm1Prol (B6J.129S7-Polg^tm1Prol)	abnormal erythroid lineage cell morphology	J:154187
	abnormal lymphopoiesis	J:154187
	decreased double-positive T cell number	J:154187
	decreased hemoglobin content	J:154187
	decreased immature B cell number	J:154187
	decreased lymphocyte cell number	J:154187
	decreased mature B cell number	J:154187
	decreased pre-B cell number	J:154187
	decreased pro-B cell number	J:154187
	decreased thymocyte number	J:154187
	increased erythroblast number	J:154187
	increased mean corpuscular volume	J:154187
	macrocytic anemia	J:154187
	macrocytosis	J:154187
Polh^tm1Crey/Polh^tm1Crey (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:98037
Polh^tm1Crey/Polh^tm1Crey Poli^d/Poli^d (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:98037
Polh^tm1Fmh/Polh^tm1Fmh (involves: C57BL/6)	abnormal B cell physiology	J:99721
Poli^{tm1b(EUCOMM)Hmgu}/Poli^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Poli^{tm1b(EUCOMM)Hmgu}/BayMmucd)	decreased hematocrit	J:211773
Poll^tm1Crey/Poll^tm1Crey (involves: 129P2/OlaHsd)	abnormal immunoglobulin heavy chain V(D)J recombination	J:113406
Poll^tm1Crey/Poll^tm1Crey Polm^tm1Crey/Polm^tm1Crey (involves: 129P2/OlaHsd)	abnormal B cell differentiation	J:113406
	abnormal immunoglobulin heavy chain V(D)J recombination	J:113406
	abnormal immunoglobulin light chain V-J recombination	J:113406
	decreased B cell number	J:113406
Polm^m1Btlr/Polm^m1Btlr (C57BL/6J-Polm^m1Btlr)	decreased B cell number	J:272866
Polm^m2Btlr/Polm^m2Btlr (C57BL/6J-Polm^m2Btlr)	abnormal lymphocyte morphology	J:272867
Polm^m2Btlr/Polm^m2Btlr (C57BL/6J-Polm^m2Btlr)	decreased B cell number	J:272867
Polm^tm1Abnd/Polm^tm1Abnd (involves: 129/Sv * BALB/c)	abnormal B cell number	J:97782
Polm^tm1Crey/Polm^tm1Crey (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell proliferation	J:85190
	decreased B cell number	J:75927, J:85190
Polm^tm1Crey/Polm^tm1Crey (involves: 129P2/OlaHsd)	abnormal immunoglobulin light chain V-J recombination	J:113406
Polq^em1(IMPC)Mbp/Polq^em1(IMPC)Mbp (C57BL/6N-Polq^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	small spleen	J:211773
Polq^tm1Jcs/Polq^tm1Jcs (involves: 129S4/SvJae * C57BL/6J)	abnormal somatic hypermutation frequency	J:103365
Polq^tm1Jow/Polq^tm1Jow (involves: 129S1/Sv * 129X1/SvJ * C57BL/6N)	abnormal B cell physiology	J:101409
	abnormal somatic hypermutation frequency	J:101409
	decreased IgG1 level	J:101409
	decreased IgG level	J:101409
	decreased IgM level	J:101409
	decreased immunoglobulin level	J:101409
Polq^tm2Jow/Polq^tm2Jow (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal somatic hypermutation frequency	J:115989
Polr1b^em1(IMPC)Tcp/Polr1b⁺ (C57BL/6NCrl-Polr1b^em1(IMPC)Tcp/Tcp)	enlarged thymus	J:211773
Polr2a^{tm1(cre/ERT2)Bbd}/Polr2a⁺ Rnf2^tm1Mvi/Rnf2^tm1Mvi (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/10 * SJL)	abnormal bone marrow cell morphology/development	J:130397
	abnormal common myeloid progenitor cell morphology	J:130397
	decreased B cell number	J:130397
Polr3a^em2(IMPC)Tcp/Polr3a⁺ (C57BL/6NCrl-Polr3a^em2(IMPC)Tcp/Tcp)	increased mean platelet volume	J:211773
Polr3d^em1(IMPC)Tcp/Polr3d⁺ (C57BL/6N-Polr3d^em1(IMPC)Tcp/Tcp)	decreased mean platelet volume	J:211773
Pomc^{em1(IMPC)Rbrc}/Pomc⁺ (C57BL/6NJcl-Pomc^{em1(IMPC)Rbrc}/Rbrc)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Pomc^tm1Low/Pomc^tm1Low (involves: 129S2/SvPas * C57BL/6)	increased splenocyte proliferation	J:102955
Pomk^{em1(IMPC)Hmgu}/Pomk⁺ (C57BL/6NCrl-Pomk^{em1(IMPC)Hmgu}/Ieg)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	increased spleen weight	J:211773
Pomt1^{Gt(OST194127)Lex}/Pomt1⁺ (involves: 129S5/SvEvBrd * C57BL/6J)	decreased IgG level	J:103485
	increased neutrophil cell number	J:103485
Pon2^Gt(XE661)Byg/Pon2^Gt(XE661)Byg (B6.129P2-Pon2^Gt(XE661)Byg)	abnormal macrophage chemotaxis	J:116935
	abnormal macrophage physiology	J:116935
Pon2^{tm1b(EUCOMM)Hmgu}/Pon2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Pon2^{tm1b(EUCOMM)Hmgu}/H)	decreased neutrophil cell number	J:211773
Postn^{tm1.1(KOMP)Vlcg}/Postn^{tm1.1(KOMP)Vlcg} (C57BL/6N-Postn^{tm1.1(KOMP)Vlcg}/J)	thrombocytosis	J:211773
Postn^tm1Sjc/Postn^tm1Sjc (B6.Cg-Postn^tm1Sjc)	increased osteoclast cell number	J:200192
Pot1b^tm1.1Schg/Pot1b^tm1.1Schg Terc^tm1Rdp/Terc⁺ (involves: 129/Sv * 129S6/SvEvTac * C57BL/6 * SJL)	abnormal blood cell morphology/development	J:144553
	abnormal definitive hematopoiesis	J:144553
	abnormal granulocyte morphology	J:144553
	absent bone marrow cell	J:144553
	anemia	J:144553
	decreased erythrocyte cell number	J:144553
	decreased granulocyte number	J:144553
	decreased hematopoietic stem cell number	J:144553
	decreased leukocyte cell number	J:144553
	impaired hematopoiesis	J:144553
	thrombocytopenia	J:144553
Pot1b^tm1.1Schg/Pot1b^tm1.1Schg Terc^tm1Rdp/Terc^tm1Rdp (involves: 129/Sv * 129S6/SvEvTac * C57BL/6 * SJL)	abnormal erythrocyte morphology	J:144553
	abnormal granulocyte morphology	J:144553
	absent bone marrow cell	J:144553
	pancytopenia	J:144553
Pou1f1^dw/Pou1f1^dw (DW/J Pou1f1^dw)	decreased B cell number	J:110683
Pou2af1^{tm1b(KOMP)Wtsi}/Pou2af1^{tm1b(KOMP)Wtsi} (C57BL/6N-Pou2af1^{tm1b(KOMP)Wtsi}/Ucd)	decreased lymphocyte cell number	J:211773
	decreased spleen weight	J:211773
	increased neutrophil cell number	J:211773
Pou2af1^tm1Pjln/Pou2af1^tm1Pjln (C57BL/6-Pou2af1^tm1Pjln)	absent spleen germinal center	J:37085
	decreased B cell number	J:37085
	decreased IgA level	J:37085
	decreased IgG1 level	J:37085
	decreased IgG2a level	J:37085
	decreased IgG2b level	J:37085
	decreased IgG3 level	J:37085
	spleen hypoplasia	J:37085
Pou2af1^tm1Pjln/Pou2af1^tm1Pjln (involves: C57BL/6)	abnormal B cell differentiation	J:67362
	abnormal T-helper 1 physiology	J:123039
	abnormal T-helper 2 physiology	J:123039
	decreased B cell number	J:123039, J:67362
	decreased immature B cell number	J:67362
	decreased mature B cell number	J:67362
	decreased T cell number	J:123039
	increased B cell apoptosis	J:67362
Pou2af1^tm1Pjln/Pou2af1^tm1Pjln Tg(tetO-Pou2af1)1Pjln/0 Tg(tTA)1Pjln/0 (involves: C57BL/6)	decreased B cell number	J:67362
	decreased immunoglobulin level	J:67362
	decreased mature B cell number	J:67362
Pou2af1^tm1Pmt/Pou2af1^tm1Pmt (involves: 129P2/OlaHsd * C57BL/6)	decreased immunoglobulin level	J:125114
Pou2af1^tm1Pmt/Pou2af1^tm1Pmt Ikzf3^tm1Kge/Ikzf3^tm1Kge (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	absent spleen germinal center	J:81805
	arrested B cell differentiation	J:81805
	decreased IgA level	J:81805
	decreased IgD level	J:81805
	decreased IgE level	J:81805
	decreased IgG level	J:81805
	decreased IgM level	J:81805
	decreased immunoglobulin level	J:81805
Pou2af1^tm1Rgr/Pou2af1^tm1Rgr (either: (involves: 129P2/OlaHsd) or (involves: 129S1/Sv))	abnormal B cell differentiation	J:114816, J:35785
	abnormal pre-B cell morphology	J:114816
	absent spleen germinal center	J:35785
	arrested B cell differentiation	J:114816
	decreased B cell number	J:114816
	decreased B cell proliferation	J:35785
	decreased IgA level	J:35785
	decreased IgE level	J:35785
	decreased IgG1 level	J:35785
	decreased IgG2a level	J:35785
	decreased IgG2b level	J:35785
	decreased IgG3 level	J:35785
	decreased IgG level	J:35785
	decreased immunoglobulin level	J:35785
	increased B cell proliferation	J:114816
	increased IgM level	J:35785
Pou2af3^{tm1b(NCOM)Mfgc}/Pou2af3^{tm1b(NCOM)Mfgc} (C57BL/6N-Pou2af3^{tm1b(NCOM)Mfgc}/Tcp)	decreased lymphocyte cell number	J:211773
	increased leukocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Pou2f1^tm1Shrp/Pou2f1^tm1Shrp (involves: 129S4/SvJae * C57BL/6)	abnormal erythropoiesis	J:87664
	anemia	J:87664
Pou2f2^tm1Bal/Pou2f2⁺ (involves: 129S2/SvPas)	decreased IgG1 level	J:4555
	decreased IgM level	J:4555
	decreased mature B cell number	J:4555
Pou2f2^tm1Bal/Pou2f2^tm1Bal (involves: 129S2/SvPas * C57BL/6)	arrested B cell differentiation	J:88240
	decreased B cell number	J:88240
	decreased immunoglobulin level	J:88240
Pou2f2^tm1Bal/Pou2f2^tm1Bal (involves: 129S2/SvPas)	decreased IgG1 level	J:4555
	decreased IgM level	J:4555
	decreased mature B cell number	J:4555
Pou2f2^tm1Lmc/Pou2f2^tm1Lmc (involves: C57BL/6)	arrested B cell differentiation	J:88240
	decreased B cell number	J:88240
	decreased B-1 B cell number	J:88240
	decreased immunoglobulin level	J:88240
Pou5f1^tm1Scho/Pou5f1^tm1Scho Tg(Mx1-cre)1Cgn/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	hematopoietic system phenotype	J:130248
Ppard^tm1Dsvg/Ppard^tm1Dsvg (involves: 129S2/SvPas * C57BL/6)	increased osteoclast cell number	J:219677
Pparg^tm1.1Gonz/Pparg^tm1.1Gonz Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6)	abnormal macrophage activation involved in immune response	J:168799
	abnormal peritoneal macrophage morphology	J:168799
	impaired macrophage phagocytosis	J:168799
	increased IgG level	J:168799
	increased IgM level	J:168799
Pparg^tm1.1Gonz/Pparg^tm1.1Gonz Tg(Aqp2-cre)1Dek/0 (involves: 129X1/SvJ * C57BL/6 * SJL)	abnormal hematocrit	J:99873
Pparg^tm1.1Gonz/Pparg^tm1.1Gonz Tg(Mx1-cre)1Cgn/? (involves: 129X1/SvJ * C57BL/6 * CBA * FVB/N)	abnormal macrophage physiology	J:75777
Pparg^tm1Tka/Pparg⁺ (involves: C57BL/6 * CBA)	leukostasis	J:116269
Pparg^tm1Tka/Pparg⁺ (involves: C57BL/6 * CBA * ICR)	abnormal B cell physiology	J:58222
	increased B cell proliferation	J:58222
	increased IgG level	J:58222
	increased IgM level	J:58222
Pparg^tm2Rev/Pparg^tm2Rev Tg(Cd4-cre)1Cwi/? (involves: 129S4/SvJae * C57BL/6 * DBA/2)	abnormal T-helper 17 cell differentiation	J:153358
Pparg^tm2Rev/Pparg^tm2Rev Tg(Tek-cre)1Ywa/? (involves: 129S4/SvJae * C57BL/6 * SJL)	abnormal bone marrow cell morphology/development	J:130475
	abnormal osteoclast differentiation	J:160910
	abnormal osteoclast morphology	J:130475
	abnormal spleen morphology	J:130475
	abnormal splenocyte morphology	J:130475
	decreased bone marrow cell number	J:130475
	decreased osteoclast cell number	J:130475
	enlarged spleen	J:130475
	extramedullary hematopoiesis	J:130475
	hematopoietic system phenotype	J:130475
	increased splenocyte number	J:130475
Pparg^tm2Rev/Pparg^tm2Rev Tg(Tek-cre)12Flv/? (B6.Cg-Pparg^tm2Rev Tg(Tek-cre)12Flv)	decreased hematocrit	J:154216
	enlarged spleen	J:154216
Ppargc1a^tm1Aztc/Ppargc1a⁺ (C57BL/6-Ppargc1a^tm1Aztc)	increased thymus weight	J:82809
Ppargc1a^tm1Aztc/Ppargc1a⁺ (C57BL/6-Ppargc1a^tm1Aztc)	thrombocytopenia	J:82809
Ppargc1b^tm1.2Rev/Ppargc1b^tm1.2Rev Tg(Tek-cre)1Ywa/0 (involves: 129/Sv * C57BL/6 * C57BL/6J * SJL)	abnormal osteoclast differentiation	J:160910
Ppat^em1(IMPC)Tcp/Ppat⁺ (C57BL/6NCrl-Ppat^em1(IMPC)Tcp/Tcp)	decreased hematocrit	J:211773
Ppat^em1(IMPC)Tcp/Ppat⁺ (C57BL/6NCrl-Ppat^em1(IMPC)Tcp/Tcp)	increased mean corpuscular hemoglobin concentration	J:211773
Ppbp^{tm1(KOMP)Vlcg}/Ppbp^{tm1(KOMP)Vlcg} (involves: C57BL/6NTac)	abnormal leukocyte migration	J:198197
	abnormal leukocyte physiology	J:198197
Ppbp^{tm1.1(KOMP)Vlcg}/Ppbp^{tm1.1(KOMP)Vlcg} (C57BL/6N-Ppbp^{tm1.1(KOMP)Vlcg}/Ucd)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
	increased spleen weight	J:211773
Ppia^em1(IMPC)Mbp/Ppia^em1(IMPC)Mbp (C57BL/6NCrl-Ppia^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	decreased erythrocyte cell number	J:211773
	enlarged spleen	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
	increased mean platelet volume	J:211773
	increased red blood cell distribution width	J:211773
	increased spleen weight	J:211773
Ppia^tm1Lubn/Ppia^tm1Lubn (129S6.129P2-Ppia^tm1Lubn)	abnormal CD4-positive, alpha-beta T cell physiology	J:93591
	increased IgE level	J:93591
	increased IgG1 level	J:93591
	increased immunoglobulin level	J:93591
	increased T cell number	J:93591
	spleen hyperplasia	J:93591
Ppic^em1Igc/Ppic^em1Igc (C57BL/6-Ppic^em1Igc)	decreased NK cell number	J:321155
	hematopoietic system phenotype	J:321155
	increased transitional stage T1 B cell number	J:321155
	increased transitional stage T2 B cell number	J:321155
Ppie^em1(IMPC)Tcp/Ppie⁺ (C57BL/6N-Ppie^em1(IMPC)Tcp/Tcp)	decreased mean corpuscular hemoglobin	J:211773
Ppie^em1(IMPC)Tcp/Ppie⁺ (C57BL/6N-Ppie^em1(IMPC)Tcp/Tcp)	decreased mean corpuscular hemoglobin concentration	J:211773
Ppil1^em1(IMPC)Mbp/Ppil1⁺ (C57BL/6N-Ppil1^em1(IMPC)Mbp/MbpMmucd)	small spleen	J:211773
Ppm1d^tm1Lad/Ppm1d^tm1Lad (involves: 129S7/SvEvBrd * C57BL/6)	decreased B cell proliferation	J:74284
	decreased CD8-positive, alpha-beta T cell number	J:74284
	decreased T cell proliferation	J:74284
	enlarged spleen	J:74284
	increased CD4-positive, alpha-beta T cell number	J:74284
	myeloid hyperplasia	J:74284
	small thymus	J:74284
	spleen hyperplasia	J:74284
Ppm1m^{tm2b(EUCOMM)Hmgu}/Ppm1m^{tm2b(EUCOMM)Hmgu} (C57BL/6N-Ppm1m^{tm2b(EUCOMM)Hmgu}/Bay)	decreased large unstained cell number	J:211773
Ppm1n^em1(IMPC)Mbp/Ppm1n^em1(IMPC)Mbp (C57BL/6N-Ppm1n^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased neutrophil cell number	J:211773
Ppp1cc^{em1(IMPC)Wtsi}/Ppp1cc^{em1(IMPC)Wtsi} (C57BL/6N-Ppp1cc^{em1(IMPC)Wtsi}/WtsiOulu)	increased mean corpuscular hemoglobin	J:211773
Ppp1r14d^{tm1b(KOMP)Wtsi}/Ppp1r14d^{tm1b(KOMP)Wtsi} (C57BL/6N-Ppp1r14d^{tm1b(KOMP)Wtsi}/Nju)	decreased red blood cell distribution width	J:211773
Ppp1r15a^em2(IMPC)H/Ppp1r15a^em2(IMPC)H (C57BL/6NTac-Ppp1r15a^em2(IMPC)H/H)	decreased mean corpuscular hemoglobin	J:211773
	increased red blood cell distribution width	J:211773
Ppp1r15a^tm1.1Ajf/Ppp1r15a^tm1.1Ajf (involves: 129 * C57BL/6)	abnormal erythrocyte morphology	J:106905
	abnormal erythropoiesis	J:106905
	abnormal splenic cell ratio	J:106905
	acanthocytosis	J:106905
	anisopoikilocytosis	J:106905
	decreased erythrocyte osmotic fragility	J:106905
	decreased hemoglobin content	J:106905
	decreased mean corpuscular hemoglobin	J:106905
	decreased mean corpuscular volume	J:106905
	increased number of Howell-Jolly bodies	J:106905
	increased spleen weight	J:106905
	leptocytosis	J:106905
	microcytosis	J:106905
Ppp1r15b^tm1Dron/Ppp1r15b^tm1Dron (involves: 129P2/OlaHsd)	abnormal erythrocyte morphology	J:144954
	decreased erythrocyte cell number	J:144954
	decreased hematocrit	J:144954
	decreased hemoglobin content	J:144954
	decreased mean corpuscular hemoglobin concentration	J:144954
	decreased mean corpuscular volume	J:144954
	echinocytosis	J:144954
Ppp1r17^em1(IMPC)H/Ppp1r17^em1(IMPC)H (C57BL/6NTac-Ppp1r17^em1(IMPC)H/H)	decreased lymphocyte cell number	J:211773
	decreased mean corpuscular volume	J:211773
	increased neutrophil cell number	J:211773
	increased red blood cell distribution width	J:211773
Ppp1r18^em1Mgin/Ppp1r18^em1Mgin (B6J.B6N-Ppp1r18^em1Mgin)	abnormal T cell physiology	J:331428
	decreased B cell number	J:331428
	decreased T cell number	J:331428
	impaired leukocyte migration	J:331428
	increased leukocyte cell number	J:331428
	increased neutrophil cell number	J:331428
	small spleen	J:331428
	spleen hypoplasia	J:331428
Ppp1r18^em3Mgin/Ppp1r18^em3Mgin (B6J.B6N-Ppp1r18^em3Mgin)	abnormal T cell physiology	J:331428
	decreased B cell number	J:331428
	decreased T cell number	J:331428
	impaired leukocyte migration	J:331428
	increased leukocyte cell number	J:331428
	increased neutrophil cell number	J:331428
	small spleen	J:331428
	spleen hypoplasia	J:331428
Ppp2ca^tm1.1Nju/Ppp2ca^tm1.1Nju Tg(Tek-cre)12Flv/0 (involves: 129S6/SvEvTac * C57BL/6)	abnormal erythrocyte physiology	J:171578
	abnormal erythropoiesis	J:171578
	anemia	J:171578
	decreased fetal derived definitive erythrocyte cell number	J:171578
	increased hematopoietic stem cell number	J:171578
Ppp2r2b^{tm1a(KOMP)Wtsi}/Ppp2r2b^{tm1a(KOMP)Wtsi} (C57BL/6N-Ppp2r2b^{tm1a(KOMP)Wtsi}/Wtsi)	decreased mean corpuscular hemoglobin	J:175295
	decreased mean corpuscular volume	J:175295
	thrombocytopenia	J:175295
Ppp2r2b^{tm1b(KOMP)Wtsi}/Ppp2r2b^{tm1b(KOMP)Wtsi} (C57BL/6N-Ppp2r2b^{tm1b(KOMP)Wtsi}/Tcp)	increased leukocyte cell number	J:211773
	increased monocyte cell number	J:211773
Ppp2r2d^em1Gct/Ppp2r2d^em1Gct Tg(Lck-icre)3779Nik/0 (involves: C57BL/6 * DBA/2)	abnormal regulatory T cell physiology	J:308373
	hematopoietic system phenotype	J:308373
Ppp2r3c^em1(IMPC)H/Ppp2r3c⁺ (C57BL/6NTac-Ppp2r3c^em1(IMPC)H/H)	increased mean platelet volume	J:211773
Ppp2r3c^tm1Imku/Ppp2r3c^tm1Imku Tg(CD19-cre/ERT2)1Cgn/? (involves: C57BL/6)	abnormal B cell activation	J:100706
	decreased B cell number	J:100706
	decreased B cell proliferation	J:100706
	decreased B-1a cell number	J:100706
	decreased follicular B cell number	J:100706
	decreased immature B cell number	J:100706
	decreased mature B cell number	J:100706
	decreased pre-B cell number	J:100706
	decreased spleen germinal center size	J:100706
	decreased transitional stage B cell number	J:100706
	increased pro-B cell number	J:100706
	increased T cell number	J:100706
	increased transitional stage B cell number	J:100706
	small spleen	J:100706
Ppp2r5a^{Gt(IST13127C10)Tigm}/Ppp2r5a^{Gt(IST13127C10)Tigm} (C57BL/6N-Ppp2r5a^{Gt(IST13127C10)Tigm})	enlarged spleen	J:254808
	extramedullary hematopoiesis	J:254808
Ppp2r5c^em1(IMPC)Mbp/Ppp2r5c^em1(IMPC)Mbp (C57BL/6N-Ppp2r5c^em1(IMPC)Mbp/Ucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Ppp3ca^tm1Jse/Ppp3ca^tm1Jse (either: (involves: 129S4/SvJae * Black Swiss) or (involves: 129S4/SvJae * C57BL/6))	decreased T cell proliferation	J:71750
Ppp3cb^M1Btlr/Ppp3cb⁺ (C57BL/6J-Ppp3cb^M1Btlr)	abnormal CD4-positive, alpha-beta T cell physiology	J:236670
	abnormal CD8-positive, alpha-beta T cell physiology	J:236670
	abnormal NK cell physiology	J:236670
	increased CD8-positive, alpha-beta memory T cell proliferation	J:236670
Ppp3cb^M1Btlr/Ppp3cb^M1Btlr (C57BL/6J-Ppp3cb^M1Btlr)	abnormal CD4-positive, alpha-beta T cell physiology	J:236670
	abnormal CD8-positive, alpha-beta T cell physiology	J:236670
	abnormal NK cell physiology	J:236670
	increased CD8-positive, alpha-beta memory T cell proliferation	J:236670
Ppp3cb^m2Btlr/Ppp3cb⁺ (C57BL/6J-Ppp3cb^m2Btlr)	abnormal CD4-positive, alpha-beta T cell physiology	J:236671
	abnormal CD8-positive, alpha-beta T cell physiology	J:236671
	increased CD8-positive, alpha-beta memory T cell proliferation	J:236671
Ppp3cb^m2Btlr/Ppp3cb^m2Btlr (C57BL/6J-Ppp3cb^m2Btlr)	abnormal CD4-positive, alpha-beta T cell physiology	J:236671
	abnormal CD8-positive, alpha-beta T cell physiology	J:236671
	abnormal NK cell physiology	J:236671
	increased CD8-positive, alpha-beta memory T cell proliferation	J:236671
Ppp3cb^M3Btlr/Ppp3cb⁺ (C57BL/6J-Ppp3cb^M3Btlr)	decreased CD8-positive, alpha-beta memory T cell number	J:254889
Ppp3cb^M3Btlr/Ppp3cb⁺ (C57BL/6J-Ppp3cb^M3Btlr)	increased central memory CD4-positive, alpha-beta T cell number	J:254889
Ppp3cb^M3Btlr/Ppp3cb^M3Btlr (C57BL/6J-Ppp3cb^M3Btlr)	decreased CD8-positive, alpha-beta memory T cell number	J:254889
	decreased CD8-positive, naive alpha-beta T cell number	J:254889
	increased central memory CD4-positive, alpha-beta T cell number	J:254889
	increased central memory CD8 positive, alpha-beta T cell number	J:254889
Ppp3cb^M4Btlr/Ppp3cb⁺ (C57BL/6J-Ppp3cb^M4Btlr)	decreased CD8-positive, alpha-beta memory T cell number	J:254905
Ppp3cb^M4Btlr/Ppp3cb⁺ (C57BL/6J-Ppp3cb^M4Btlr)	increased central memory CD8 positive, alpha-beta T cell number	J:254905
Ppp3cb^M4Btlr/Ppp3cb^M4Btlr (C57BL/6J-Ppp3cb^M4Btlr)	decreased CD8-positive, alpha-beta memory T cell number	J:254905
Ppp3cb^M4Btlr/Ppp3cb^M4Btlr (C57BL/6J-Ppp3cb^M4Btlr)	increased central memory CD8 positive, alpha-beta T cell number	J:254905
Ppp3cb^m5Btlr/Ppp3cb^m5Btlr (C57BL/6J-Ppp3cb^m5Btlr)	abnormal T cell morphology	J:272839
Ppp3cb^m5Btlr/Ppp3cb^m5Btlr (C57BL/6J-Ppp3cb^m5Btlr)	decreased CD8-positive, alpha-beta T cell number	J:272839
Ppp3cb^M6Btlr/Ppp3cb^M6Btlr (C57BL/6J-Ppp3cb^M6Btlr)	abnormal lymphocyte morphology	J:272840
	decreased alpha-beta T cell number	J:272840
	decreased CD4-positive, alpha-beta T cell number	J:272840
	decreased CD8-positive, alpha-beta T cell number	J:272840
Ppp3cb^tm1Jmk/Ppp3cb^tm1Jmk (involves: 129S6/SvEvTac * C57BL/6)	abnormal T cell differentiation	J:77729
	decreased single-positive T cell number	J:77729
	decreased T cell number	J:77729
	decreased T cell proliferation	J:77729
	decreased thymus weight	J:75775
	thymus hypoplasia	J:77729
Ppp3cb^tm1Jmk/Ppp3cb^tm1Jmk (involves: 129S6/SvEvTac)	decreased T cell proliferation	J:109586
Ppp3cc^{tm1b(EUCOMM)Hmgu}/Ppp3cc^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Ppp3cc^{tm1b(EUCOMM)Hmgu}/H)	decreased mean platelet volume	J:211773
Ppp3r1^tm2Grc/Ppp3r1^tm2.1Grc Tg(Lck-cre)1Cwi/0 (involves: 129S6/SvEvTac * C57BL/6 * DBA/2)	abnormal positive T cell selection	J:89771
	abnormal splenic cell ratio	J:89771
Ppp3r1^tm2Grc/Ppp3r1^tm2Grc Tg(Lck-cre)1Cwi/0 (involves: 129S6/SvEvTac * C57BL/6 * DBA/2)	decreased thymocyte number	J:89771
	thymus hypoplasia	J:89771
Ppp3r2^{tm1.1(KOMP)Vlcg}/Ppp3r2^{tm1.1(KOMP)Vlcg} (C57BL/6N-Ppp3r2^{tm1.1(KOMP)Vlcg}/Ucd)	increased red blood cell distribution width	J:211773
Ppp4c^tm1Tht/Ppp4c^tm1Tht Tg(Lck-cre)548Jxm/0 (involves: C57BL/6 * CBA)	abnormal positive T cell selection	J:117684
	abnormal T cell activation	J:117684
	abnormal T cell differentiation	J:117684
	decreased CD4-positive, alpha-beta T cell number	J:117684
	decreased CD8-positive, alpha-beta T cell number	J:117684
	decreased double-positive T cell number	J:117684
	decreased single-positive T cell number	J:117684
	increased double-negative T cell number	J:117684
Ppp4c^tm1Tht/Ppp4c^tm1Tht Tg(Lck-cre)548Jxm/0 Tg(TcraTcrb)425Cbn/0 (involves: BALB/c * C57BL/6 * CBA)	abnormal positive T cell selection	J:117684
	decreased double-positive T cell number	J:117684
	decreased single-positive T cell number	J:117684
Ppp4r1^{em1(IMPC)Rbrc}/Ppp4r1^{em1(IMPC)Rbrc} (C57BL/6N-Ppp4r1^{em1(IMPC)Rbrc}/Rbrc)	thrombocytosis	J:211773
Ppp4r3b^{tm1b(EUCOMM)Hmgu}/Ppp4r3b^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Ppp4r3b^{tm1b(EUCOMM)Hmgu}/Ieg)	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
Ppp5c^tm1.2Rhon/Ppp5c^tm1.2Rhon (B6.129X1-Ppp5c^tm1.2Rhon)	enlarged spleen	J:178164
Ppp5c^{tm1a(EUCOMM)Wtsi}/Ppp5c^{tm1a(EUCOMM)Wtsi} (B6Dnk;B6Brd;B6N-Ppp5c^{tm1a(EUCOMM)Wtsi} Tyr^c-Brd/WtsiH)	decreased mean corpuscular hemoglobin concentration	J:175295
Ppp5c^{tm1a(EUCOMM)Wtsi}/Ppp5c^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6 * C57BL/6N)	increased CD4-positive, alpha-beta T cell number	J:213427
	increased CD8-positive, alpha-beta T cell number	J:213427
	increased T cell number	J:213427
Ppp6c^{tm1b(EUCOMM)Hmgu}/Ppp6c⁺ (C57BL/6N-Ppp6c^{tm1b(EUCOMM)Hmgu}/Ics)	increased mean corpuscular volume	J:211773
Ppt1^tm1.1Dprc/Ppt1^tm1.1Dprc (involves: 129S6/SvEvTac * BALB/cJ * C57BL/6)	abnormal microglial cell activation	J:213552
Ppt1^tm1Aj/Ppt1^tm1Aj (involves: 129S4/SvJae * C57BL/6)	abnormal spleen morphology	J:95522
Ppt1^tm1Hof/Ppt1^tm1Hof (involves: 129S6/SvEvTac * C57BL/6J)	microgliosis	J:280337
Ppt2^tm1Hof/Ppt2^tm1Hof (involves: 129S6/SvEvTac * C57BL/6J)	abnormal bone marrow cell morphology/development	J:86202
	abnormal spleen morphology	J:86202
	decreased spleen B cell follicle number	J:86202
	enlarged spleen	J:86202
	extramedullary hematopoiesis	J:86202
	hematopoietic system phenotype	J:86202
	increased macrophage cell number	J:86202
	increased spleen weight	J:86202
Pram1^tm1Gak/Pram1^tm1Gak (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal neutrophil physiology	J:95253
Pramel12^em1(IMPC)Mbp/Pramel12^em1(IMPC)Mbp (C57BL/6N-Pramel12^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Prap1^tm1Lex/Prap1^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	increased immunoglobulin level	J:171883
Prcd^tm1Vya/Prcd^tm1Vya (B6.Cg-Prcd^tm1Vya)	increased microglial cell activation	J:276708
Prdm1^tm1.1Liz/Prdm1^tm1.1Liz (involves: 129S/SvEv)	abnormal splenocyte physiology	J:163979
Prdm1^tm1.1Liz/Prdm1^tm1.1Liz (involves: 129S/SvEv)	absent plasma cells	J:196531
Prdm1^tm1Clme/Prdm1^tm1Clme Tg(Itgax-cre)1-1Reiz/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	abnormal CD4-positive, alpha-beta T cell physiology	J:178876
	abnormal germinal center B cell physiology	J:178876
	abnormal T follicular helper cell differentiation	J:178876
	increased germinal center B cell number	J:178876
	increased IgG level	J:178876
	increased immunoglobulin level	J:178876
	increased spleen germinal center number	J:178876
	increased splenocyte number	J:178876
	increased T follicular helper cell number	J:178876
Prdm1^tm3.1Liz/Prdm1^tm3.1Liz (involves: 129S/SvEv)	hematopoietic system phenotype	J:196531
Prdm4^{tm1b(EUCOMM)Hmgu}/Prdm4^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Prdm4^{tm1b(EUCOMM)Hmgu}/H)	absent spleen	J:211773
Prdm8^{em1(IMPC)Wtsi}/Prdm8⁺ (C57BL/6N-Prdm8^{em1(IMPC)Wtsi}/Wtsi)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
	small spleen	J:211773
Prdm8^{em1(IMPC)Wtsi}/Prdm8^{em1(IMPC)Wtsi} (C57BL/6N-Prdm8^{em1(IMPC)Wtsi}/Wtsi)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Prdm11^tm1.1Ahl/Prdm11^tm1.1Ahl (B6.129(C)-Prdm11^tm1.1Ahl)	abnormal hematopoietic precursor cell morphology	J:222765
	decreased CD4-positive, alpha-beta T cell number	J:233986
	decreased megakaryocyte progenitor cell number	J:222765
	decreased neutrophil cell number	J:233986
	increased B cell number	J:233986
	increased megakaryocyte progenitor cell proliferation	J:222765
Prdm13^em1(IMPC)Tcp/Prdm13^em1(IMPC)Tcp (C57BL/6NCrl-Prdm13^em1(IMPC)Tcp/Tcp)	abnormal spleen morphology	J:211773
	increased spleen weight	J:211773
Prdm14^{tm1a(EUCOMM)Wtsi}/Prdm14^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Prdm14^{tm1a(EUCOMM)Wtsi}/Bay)	increased effector memory T-helper cell number	J:211773
Prdm16^{Gt(OST67423)Lex}/Prdm16⁺ (involves: 129S5/SvEvBrd * C57BL/6J)	increased leukocyte cell number	J:103485
Prdm16^tm1.1Brsp/Prdm16^tm1.1Brsp Tg(Adipoq-cre)1Evdr/0 (involves: 129/Sv * C57BL/6 * FVB/N)	increased macrophage cell number	J:208683
Prdx1^flro/Prdx1^flro (C57BL/10JAnu-Prdx1^flro/AnuApb)	abnormal erythrocyte morphology	J:104190
Prdx1^flro/Prdx1^flro (C57BL/10JAnu-Prdx1^flro/AnuApb)	abnormal lymphocyte morphology	J:104190
Prdx1^tm1Rave/Prdx1⁺ (involves: 129S6/SvEvTac * C57BL/6)	hemolytic anemia	J:84677
Prdx1^tm1Rave/Prdx1^tm1Rave (involves: 129S6/SvEvTac * C57BL/6)	abnormal erythrocyte morphology	J:84677
	abnormal NK T cell number	J:84677
	abnormal spleen morphology	J:84677
	anisocytosis	J:84677
	decreased hematocrit	J:84677
	decreased hemoglobin content	J:84677
	enlarged spleen	J:84677
	extramedullary hematopoiesis	J:84677
	hemolytic anemia	J:84677
	impaired natural killer cell mediated cytotoxicity	J:84677
	increased hemoglobin concentration distribution width	J:84677
	increased spleen weight	J:84677
	microcytosis	J:84677
	poikilocytosis	J:84677
	polychromatophilia	J:84677
	reticulocytosis	J:84677
Prdx2^tm1Yu/Prdx2^tm1Yu (involves: 129S4/SvJae)	abnormal bone marrow cell morphology/development	J:84271
	abnormal erythrocyte morphology	J:84271
	abnormal erythropoiesis	J:84271
	abnormal proerythroblast morphology	J:84271
	decreased hematocrit	J:84271
	decreased hemoglobin content	J:84271
	echinocytosis	J:84271
	enlarged spleen	J:84271
	hemolytic anemia	J:84271
	increased number of Heinz bodies	J:84271
	increased spleen red pulp amount	J:84271
	increased spleen weight	J:84271
	reticulocytosis	J:84271
	schistocytosis	J:84271
	spherocytosis	J:84271
Prep^{Gt(RRM213)Byg}/Prep⁺ (B6.129P2-Prep^{Gt(RRM213)Byg})	increased spleen weight	J:151643
Prex1^tm1Dwu/Prex1^tm1Dwu (Not Specified)	impaired neutrophil chemotaxis	J:102213
Prex1^tm1Hcew/Prex1^tm1Hcew (involves: 129P2/OlaHsd * C57BL/6)	impaired neutrophil chemotaxis	J:102214
	impaired neutrophil recruitment	J:102214
	increased neutrophil cell number	J:102214
Prf1^{tm1.1(KOMP)Vlcg}/Prf1^{tm1.1(KOMP)Vlcg} (C57BL/6N-Prf1^{tm1.1(KOMP)Vlcg}/Ucd)	decreased mean corpuscular hemoglobin concentration	J:211773
Prf1^tm1Clrk/Prf1^tm1Clrk (involves: 129S7/SvEvBrd * C57BL/6)	decreased cytotoxic T cell cytolysis	J:21531
Prf1^tm1Clrk/Prf1^tm1Clrk (C.129S7(B6)-Prf1^tm1Clrk)	increased activated T cell number	J:71576
Prf1^tm1Sdz/Prf1⁺ (A.B6-Prf1^tm1Sdz)	impaired natural killer cell mediated cytotoxicity	J:211842
Prf1^tm1Sdz/Prf1^tm1Sdz (C57BL/6-Prf1^tm1Sdz)	abnormal leukocyte physiology	J:17986
	abnormal NK cell physiology	J:113213
	decreased cytotoxic T cell cytolysis	J:17986
	impaired natural killer cell mediated cytotoxicity	J:17986
Prf1^tm1Sdz/Prf1^tm1Sdz (C57BL/6-Prf1^tm1Sdz/J)	abnormal cytotoxic T cell physiology	J:193137
	abnormal lymphocyte physiology	J:120427
	abnormal macrophage activation involved in immune response	J:92260
	abnormal spleen white pulp morphology	J:92260
	abnormal T cell activation	J:92260
	decreased bone marrow cell number	J:92260
	decreased cytotoxic T cell cytolysis	J:193137
	decreased erythrocyte cell number	J:193137
	decreased leukocyte cell number	J:193137
	decreased neutrophil cell number	J:193137
	decreased NK cell degranulation	J:193137
	increased spleen red pulp amount	J:92260
	pancytopenia	J:92260, J:193137
	thrombocytopenia	J:193137
Prf1^tm1Sdz/Prf1^tm1Sdz (involves: BALB/c * C57BL/6)	impaired natural killer cell mediated cytotoxicity	J:73948
Prf1^tm1Sdz/Prf1^tm1Sdz (A.B6-Prf1^tm1Sdz)	impaired natural killer cell mediated cytotoxicity	J:211842
Prf1^tm1Tsc/Prf1⁺ (involves: 129S2/SvPas)	decreased cytotoxic T cell cytolysis	J:21731
Prf1^tm1Tsc/Prf1⁺ (involves: 129S2/SvPas)	impaired natural killer cell mediated cytotoxicity	J:21731
Prf1^tm1Tsc/Prf1^tm1Tsc (involves: 129S2/SvPas)	decreased cytotoxic T cell cytolysis	J:21731
Prf1^tm1Tsc/Prf1^tm1Tsc (involves: 129S2/SvPas)	impaired natural killer cell mediated cytotoxicity	J:21731
Prf1^tm1Tsc/Prf1^tm1Tsc (129X1.129S2-Prf1^tm1Tsc)	abnormal NK cell physiology	J:126114
Prf1^tm1Tsc/Prf1^tm1Tsc (129X1.129S2-Prf1^tm1Tsc)	decreased T cell apoptosis	J:126114
Prg2^tm1Nal/Prg2^tm1Nal (involves: 129P2/OlaHsd * 129X1/SvJ)	abnormal eosinophil morphology	J:65655
Primpol^em1Nki/Primpol^em1Nki (C57BL/6-Primpol^em1Nki)	abnormal somatic hypermutation frequency	J:242620
Prkaa1^tm1.1Sjm/Prkaa1^tm1.1Sjm Prkaa2^tm1.1Sjm/Prkaa2^tm1.1Sjm Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA * SJL)	decreased hematopoietic stem cell number	J:165090
	hematopoietic system phenotype	J:165090
Prkaa1^tm1Sbj/Prkaa1^tm1Sbj (involves: 129)	abnormal erythrocyte osmotic lysis	J:147215
	decreased hematocrit	J:147215
	decreased mean corpuscular hemoglobin	J:147215
	hemolytic anemia	J:147215
	increased red blood cell distribution width	J:147215
	increased spleen weight	J:147215
	low mean erythrocyte cell number	J:147215
	reticulocytosis	J:147215
Prkaa2^{tm1b(EUCOMM)Hmgu}/Prkaa2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Prkaa2^{tm1b(EUCOMM)Hmgu}/H)	enlarged spleen	J:211773
Prkab1^em1(IMPC)Bay/Prkab1^em1(IMPC)Bay (C57BL/6N-Prkab1^em1(IMPC)Bay/Bay)	increased spleen weight	J:211773
Prkab1^em1(IMPC)J/Prkab1^em1(IMPC)J (C57BL/6NJ-Prkab1^em1(IMPC)J/J)	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
Prkab1^em2(IMPC)Mbp/Prkab1^em2(IMPC)Mbp (C57BL/6N-Prkab1^em2(IMPC)Mbp/Ucd)	abnormal thymus morphology	J:211773
	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
	enlarged thymus	J:211773
	increased red blood cell distribution width	J:211773
Prkab1^{tm1a(KOMP)Wtsi}/Prkab1^{tm1a(KOMP)Wtsi} (C57BL/6N-Prkab1^{tm1a(KOMP)Wtsi}/Wtsi)	decreased erythrocyte cell number	J:175295
	decreased hematocrit	J:175295
	decreased hemoglobin content	J:175295
	decreased mean corpuscular hemoglobin	J:175295
Prkab1^{tm1b(KOMP)Wtsi}/Prkab1⁺ (C57BL/6N-Prkab1^{tm1b(KOMP)Wtsi}/Ccpcz)	decreased Ly6C-positive mature NK cell number	J:211773
	decreased lymphocyte cell number	J:211773
Prkab1^{tm1b(KOMP)Wtsi}/Prkab1^{tm1b(KOMP)Wtsi} (C57BL/6N-Prkab1^{tm1b(KOMP)Wtsi}/Wtsi)	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	decreased mean corpuscular hemoglobin	J:211773
	increased mean platelet volume	J:211773
	increased memory-marker CD4-negative NK T cell number	J:211773
	increased memory-marker gamma-delta T cell number	J:211773
	increased red blood cell distribution width	J:211773
Prkab1^{tm1b(KOMP)Wtsi}/Prkab1^{tm1b(KOMP)Wtsi} (C57BL/6N-Prkab1^{tm1b(KOMP)Wtsi}/Ucd)	abnormal spleen morphology	J:211773
	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
	enlarged spleen	J:211773
	increased red blood cell distribution width	J:211773
	increased spleen weight	J:211773
Prkab1^{tm1b(KOMP)Wtsi}/Prkab1^{tm1b(KOMP)Wtsi} (C57BL/6N-Prkab1^{tm1b(KOMP)Wtsi}/H)	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	decreased lymphocyte cell number	J:211773
	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular hemoglobin concentration	J:211773
	decreased mean corpuscular volume	J:211773
	increased neutrophil cell number	J:211773
	increased red blood cell distribution width	J:211773
	increased spleen weight	J:211773
Prkab1^{tm1b(KOMP)Wtsi}/Prkab1^{tm1b(KOMP)Wtsi} (C57BL/6N-Prkab1^{tm1b(KOMP)Wtsi}/Rbrc)	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular hemoglobin concentration	J:211773
	decreased mean corpuscular volume	J:211773
	increased glycosylated hemoglobin level	J:211773
	increased red blood cell distribution width	J:211773
Prkab1^{tm1b(KOMP)Wtsi}/Prkab1^{tm1b(KOMP)Wtsi} (B6N(Cg)-Prkab1^{tm1b(KOMP)Wtsi}/J)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular hemoglobin concentration	J:211773
	decreased mean corpuscular volume	J:211773
Prkab1^{tm1b(KOMP)Wtsi}/Prkab1^{tm1b(KOMP)Wtsi} (C57BL/6N-Prkab1^{tm1b(KOMP)Wtsi}/Bay)	increased spleen weight	J:211773
Prkab1^{tm1b(KOMP)Wtsi}/Prkab1^{tm1b(KOMP)Wtsi} (C57BL/6N-Prkab1^{tm1b(KOMP)Wtsi}/Orl)	decreased hemoglobin content	J:211773
	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular hemoglobin concentration	J:211773
	decreased mean corpuscular volume	J:211773
Prkab1^{tm1b(KOMP)Wtsi}/Prkab1^{tm1b(KOMP)Wtsi} (involves: C57BL/6N)	abnormal erythrocyte morphology	J:236972
	abnormal erythropoiesis	J:236972
	abnormal reticulocyte cell number	J:236972
	acanthocytosis	J:236972
	anisocytosis	J:236972
	decreased erythrocyte cell number	J:236972
	decreased erythrocyte osmotic fragility	J:236972
	decreased hematocrit	J:236972
	decreased hemoglobin content	J:236972
	decreased mean corpuscular hemoglobin concentration	J:236972
	echinocytosis	J:236972
	enlarged spleen	J:236972
	extramedullary hematopoiesis	J:236972
	hemolytic anemia	J:236972
	increased erythroblast number	J:236972
	increased erythroid progenitor cell number	J:236972
	increased mean platelet volume	J:236972
	increased red blood cell distribution width	J:236972
	increased spleen iron level	J:236972
	increased spleen red pulp amount	J:236972
	increased spleen weight	J:236972
	microcytic anemia	J:236972
	microcytosis	J:236972
	reticulocytosis	J:236972
	schistocytosis	J:236972
	stomatocytosis	J:236972
Prkab1^{tm1b(KOMP)Wtsi}/Prkab1^{tm1b(KOMP)Wtsi} (C57BL/6N-Prkab1^{tm1b(KOMP)Wtsi}/MbpMmucd)	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
	increased red blood cell distribution width	J:211773
Prkab1^{tm1b(KOMP)Wtsi}/Prkab1^{tm1b(KOMP)Wtsi} (C57BL/6N-Prkab1^{tm1b(KOMP)Wtsi}/Ccpcz)	abnormal spleen morphology	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
	enlarged spleen	J:211773
	increased red blood cell distribution width	J:211773
	increased spleen weight	J:211773
Prkab2^{tm1b(EUCOMM)Hmgu}/Prkab2⁺ (C57BL/6N-Prkab2^{tm1b(EUCOMM)Hmgu}/H)	decreased mean platelet volume	J:211773
	increased eosinophil cell number	J:211773
Prkag1^tm1.2Mfor/Prkag1^tm1.2Mfor (involves: 129S2/SvPas * C57BL/6 * C57BL/6NTac * FVB/N)	abnormal erythrocyte morphology	J:167779
	abnormal erythrocyte physiology	J:167779
	abnormal hematopoietic system morphology/development	J:167779
	abnormal Kupffer cell morphology	J:167779
	abnormal red blood cell deformability	J:167779
	anemia	J:167779
	anisocytosis	J:167779
	decreased erythrocyte cell number	J:167779
	decreased hematocrit	J:167779
	decreased hemoglobin content	J:167779
	decreased mean corpuscular hemoglobin	J:167779
	decreased mean corpuscular hemoglobin concentration	J:167779
	decreased mean corpuscular volume	J:167779
	enlarged spleen	J:167779
	extramedullary hematopoiesis	J:167779
	hemolytic anemia	J:167779
	increased erythrocyte clearance	J:167779
	increased red blood cell distribution width	J:167779
	increased spleen iron level	J:167779
	increased spleen red pulp amount	J:167779
	macrocytosis	J:167779
	microcytosis	J:167779
	reticulocytosis	J:167779
Prkar1a^tm2Gsm/Prkar1a^tm2Gsm Tg(Cr2-cre)3Cgn/0 (involves: 129X1/SvJ * C57BL/6)	abnormal class switch recombination	J:147785
Prkcb^M1Btlr/Prkcb⁺ (C57BL/6J-Prkcb^M1Btlr)	decreased IgM level	J:164864
Prkcb^M1Btlr/Prkcb^M1Btlr (C57BL/6J-Prkcb^M1Btlr)	decreased IgM level	J:164864
Prkcb^M1Btlr/Prkcb^M1Btlr (involves: C57BL/6J)	decreased IgM level	J:185495
Prkcb^M2Btlr/Prkcb⁺ (C57BL/6J-Prkcb^M2Btlr)	decreased IgM level	J:217791
Prkcb^M2Btlr/Prkcb^M2Btlr (C57BL/6J-Prkcb^M2Btlr)	decreased IgM level	J:217791
Prkcb^M3Btlr/Prkcb⁺ (C57BL/6J-Prkcb^M3Btlr)	decreased IgM level	J:217793
Prkcb^M3Btlr/Prkcb^M3Btlr (C57BL/6J-Prkcb^M3Btlr)	decreased IgM level	J:217793
Prkcb^M4Btlr/Prkcb^M4Btlr (C57BL/6J-Prkcb^M4Btlr)	decreased B-1 B cell number	J:274860
	increased CD4-positive, alpha-beta T cell number	J:274860
	increased CD8-positive, alpha-beta T cell number	J:274860
	increased T cell number	J:274860
Prkcb^M5Btlr/Prkcb^M5Btlr (C57BL/6J-Prkcb^M5Btlr)	decreased IgM level	J:274861
Prkcb^M6Btlr/Prkcb^M6Btlr (C57BL/6J-Prkcb^M6Btlr)	decreased B-1 B cell number	J:274862
Prkcb^tilc/Prkcb⁺ (involves: C57BL/6JSfdAnu)	decreased IgG3 level	J:221236
Prkcb^tilc/Prkcb⁺ (involves: C57BL/6JSfdAnu)	decreased IgM level	J:221236
Prkcb^tilc/Prkcb^tilc (C57BL/6JSfdAnu-Prkcb^tilc/AnuApb)	decreased IgM level	J:104190
Prkcb^tilc/Prkcb^tilc (involves: C57BL/6JSfdAnu)	decreased B cell proliferation	J:221236
	decreased B-1a cell number	J:221236
	decreased IgG3 level	J:221236
	decreased IgM level	J:221236
Prkcb^tm1Tara/Prkcb⁺ (involves: 129)	decreased IgG3 level	J:34818
Prkcb^tm1Tara/Prkcb⁺ (involves: 129)	decreased IgM level	J:34818
Prkcb^tm1Tara/Prkcb^tm1Tara (involves: 129)	decreased B cell number	J:34818
	decreased B cell proliferation	J:34818
	decreased B-1 B cell number	J:34818
	decreased B-1a cell number	J:34818
	decreased IgG3 level	J:34818
	decreased IgM level	J:34818
Prkcd^m2Btlr/Prkcd^m2Btlr (C57BL/6J-Prkcd^m2Btlr)	increased IgM level	J:265146
Prkcd^m2Btlr/Prkcd^m2Btlr (C57BL/6J-Prkcd^m2Btlr)	increased NK cell number	J:265146
Prkcd^tm1.1Chou/Prkcd^tm1.1Chou (involves: C57BL/6 * C57BL/6NTac)	abnormal neutrophil physiology	J:217880
Prkcd^tm1Kin/Prkcd^tm1Kin (involves: 129P2/OlaHsd * C57BL/6)	abnormal immunoglobulin level	J:143854
	abnormal plasma cell differentiation	J:143854
	enlarged spleen	J:76135
	increased B cell number	J:76135
	increased B cell proliferation	J:76135, J:143854
	increased follicular B cell number	J:143854
	increased IgA level	J:76135, J:143854
	increased IgG1 level	J:76135, J:143854
	increased IgM level	J:143854
	increased marginal zone B cell number	J:143854
	increased spleen germinal center number	J:76135
	increased transitional stage B cell number	J:143854
Prkcd^tm1Msg/Prkcd^tm1Msg (involves: 129X1/SvJ * C57BL/6J)	abnormal neutrophil physiology	J:91377
Prkcd^tm1Msg/Prkcd^tm1Msg (involves: 129X1/SvJ * C57BL/6J)	decreased neutrophil cell number	J:91377
Prkcd^tm1Qxu/Prkcd^tm1Qxu (involves: 129P2/OlaHsd * C57BL/6)	enlarged spleen	J:76134
	increased B cell apoptosis	J:76134
	increased B cell number	J:76134
	increased erythrocyte cell number	J:76134
	increased IgA level	J:76134
	increased IgG1 level	J:76134
	increased IgM level	J:76134
Prkcd^tm1Qxu/Prkcd^tm1Qxu Tg(IghelMD4)4Ccg/0 Tg(ML5sHEL)5Ccg/0 (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:76134
	abnormal B cell proliferation	J:76134
	abnormal spleen primary B follicle morphology	J:76134
	decreased B cell number	J:76134
	increased spleen germinal center number	J:76134
Prkce^m1Btlr/Prkce^m1Btlr (C57BL/6J-Prkce^m1Btlr)	decreased dendritic cell number	J:267703
Prkce^m1Btlr/Prkce^m1Btlr (C57BL/6J-Prkce^m1Btlr)	decreased NK cell number	J:267703
Prkce^tm1Bsca/Prkce^tm1Bsca (involves: 129P2/OlaHsd * C57BL/6)	decreased macrophage apoptosis	J:103337
	decreased macrophage nitric oxide production	J:103337
	decreased T cell proliferation	J:103337
Prkch^tm1.2Gasc/Prkch^tm1.2Gasc (involves: C57BL/6 * FVB/N * SJL)	abnormal effector T cell morphology	J:186080
	decreased B cell number	J:186080
	decreased CD4-positive, alpha-beta T cell number	J:186080
	decreased CD8-positive, alpha-beta T cell number	J:186080
	decreased DN1 thymic pro-T cell number	J:186080
	decreased DN4 thymocyte number	J:186080
	decreased double-positive T cell number	J:186080
	decreased lymphocyte cell number	J:186080
	decreased T cell number	J:186080
	decreased T cell proliferation	J:186080
	increased B cell number	J:186080
	increased CD4-positive, alpha-beta T cell number	J:186080
	increased CD8-positive, alpha-beta T cell number	J:186080
	increased memory T cell number	J:186080
	increased T cell number	J:186080
	thymus hypoplasia	J:186080
Prkch^tm1.2Gasc/Prkch^tm1.2Gasc Prkcq^tm1Litt/Prkcq^tm1Litt (involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL)	abnormal positive T cell selection	J:186080
	decreased CD4-positive, alpha-beta T cell number	J:186080
	decreased CD8-positive, alpha-beta T cell number	J:186080
	decreased DN1 thymic pro-T cell number	J:186080
	decreased DN4 thymocyte number	J:186080
	decreased double-negative T cell number	J:186080
	decreased double-positive T cell number	J:186080
	decreased T cell proliferation	J:186080
Prkcq^m1Btlr/Prkcq^m1Btlr (C57BL/6J-Prkcq^m1Btlr)	decreased IgG level	J:255214
Prkcq^m2Btlr/Prkcq^m2Btlr (C57BL/6J-Prkcq^m2Btlr)	decreased IgG level	J:255216
Prkcq^tm1.1Bai/Prkcq^tm1.1Bai (involves: 129P2/OlaHsd * C57BL/6J)	abnormal T cell physiology	J:83733
	decreased T cell proliferation	J:83733
Prkcq^tm1Litt/Prkcq^tm1Litt (involves: 129P2/OlaHsd)	abnormal T cell activation	J:83922
Prkcq^tm1Litt/Prkcq^tm1Litt (involves: 129P2/OlaHsd)	decreased T cell proliferation	J:83922, J:123989
Prkcq^tm1Litt/Prkcq^tm1Litt (B6.129P2-Prkcq^tm1Litt)	abnormal CD4-positive, alpha-beta T cell physiology	J:94285
	abnormal T-helper 1 cell differentiation	J:94285
	abnormal T-helper 2 physiology	J:94285
	decreased splenocyte proliferation	J:129421
	decreased T cell proliferation	J:94285
Prkcq^tm1Litt/Prkcq^tm1Litt (involves: 129P2/OlaHsd * C57BL/6)	abnormal effector T cell morphology	J:186080
	abnormal positive T cell selection	J:186080
	decreased CD4-positive, alpha-beta T cell number	J:186080
	decreased CD8-positive, alpha-beta T cell number	J:186080
	decreased DN1 thymic pro-T cell number	J:186080
	decreased NK T cell number	J:141128
	decreased T cell proliferation	J:186080
	increased T cell apoptosis	J:141128
Prkcq^tm1Litt/Prkcq^tm1Litt (either: (involves: 129/Sv * 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6))	decreased T cell apoptosis	J:141930
	decreased T cell proliferation	J:141930
Prkcq^tm1Litt/Prkcq^tm1Litt (involves: 129P2/OlaHsd * C57BL/6J)	abnormal platelet activation	J:144254
	abnormal platelet dense granule physiology	J:144254
	abnormal platelet physiology	J:144254
	increased platelet aggregation	J:144254
Prkcq^tm1Litt/Prkcq^tm1Litt Tcra^tm1Mom/Tcra^tm1Mom (involves: 129P2/OlaHsd * 129S2/SvPas)	decreased T cell proliferation	J:135589
Prkcq^tm1Litt/Prkcq^tm1Litt Tg(DO11.10)10Dlo/0 (involves: 129 * BALB/c * C3H * C57BL/6)	decreased T cell apoptosis	J:141930
Prkcq^tm1Litt/Prkcq^tm1Litt Tg(Lck-Notch3)#Issc/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	enlarged spleen	J:96010
	increased spleen weight	J:96010
Prkcq^tm1Litt/Prkcq^tm1Litt Tg(LCKprBCL2L1)12Sjk/0 (involves: 129P2/OlaHsd * C57BL/6)	decreased NK T cell number	J:141128
Prkcq^tm1Litt/Prkcq^tm1Litt Tg(TcrLCMV)327Sdz/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	decreased cytotoxic T cell cytolysis	J:123989
	decreased splenocyte proliferation	J:123989
	decreased T cell proliferation	J:123989
Prkcz^tm1Jmos/Prkcz^tm1Jmos (involves: 129P2/OlaHsd * 129/Sv)	abnormal spleen marginal zone morphology	J:72720
	decreased B cell number	J:72720
	decreased spleen B cell follicle size	J:72720
Prkd1^{em2(IMPC)Wtsi}/Prkd1⁺ (C57BL/6N-Prkd1^{em2(IMPC)Wtsi}/Wtsi)	increased leukocyte cell number	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
Prkd2^tm1.1Daca/Prkd2^tm1.1Daca (involves: C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:166867
	abnormal CD8-positive, alpha-beta T cell physiology	J:166867
	decreased IgG1 level	J:166867
	decreased IgM level	J:166867
Prkd2^tm1.1Shoy/Prkd2^tm1.1Shoy Prkd3^tm1.1Shoy/Prkd3^tm1.1Shoy Tg(BCL2)25Wehi/0 Tg(Lck-cre)1Jtak/0 (involves: 129 * C57BL/6 * C57BL/6JWehi * SJL/JWehi)	decreased thymocyte number	J:236298
Prkd2^tm1.1Shoy/Prkd2^tm1.1Shoy Prkd3^tm1.1Shoy/Prkd3^tm1.1Shoy Tg(Lck-cre)1Jtak/0 (involves: 129 * C57BL/6)	decreased thymocyte number	J:236298
	small thymus medulla	J:236298
Prkd2^tm1.1Shoy/Prkd2^tm1.1Shoy Prkd3^tm1.1Shoy/Prkd3^tm1.1Shoy Tg(Lck-cre)1Jtak/0 Tg(TcraH-Y,TcrbH-Y)71Vbo/0 (involves: 129 * C57BL/6 * C57BL/6J * DBA/2J)	decreased thymocyte number	J:236298
	increased double-positive T cell number	J:236298
Prkd2^tm1.1Shoy/Prkd2^tm1.1Shoy Prkd3^tm1.1Shoy/Prkd3^tm1.1Shoy Tg(Lck-cre)1Jtak/0 Tg(TcraTcrb)425Cbn/0 (involves: 129 * BALB/c * C57BL/6)	decreased thymocyte number	J:236298
Prkd2^tm1.1Shoy/Prkd2^tm1.1Shoy Prkd3^tm1.1Shoy/Prkd3^tm1.1Shoy Tg(Lck-cre)1Jtak/0 Tg(TcraTcrb)1100Mjb/0 (involves: 129 * C57BL/6)	decreased thymocyte number	J:236298
Prkdc^berty/Prkdc^berty (C57BL/6JAnu-Prkdc^berty)	absent B cells	J:104190
Prkdc^berty/Prkdc^berty (C57BL/6JAnu-Prkdc^berty)	absent T cells	J:104190
Prkdc^em2(IMPC)Ics/Prkdc^em2(IMPC)Ics (C57BL/6N-Prkdc^em2(IMPC)Ics/Ics)	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	decreased mean corpuscular hemoglobin concentration	J:211773
	increased eosinophil cell number	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Prkdc^hanky/Prkdc^hanky (either: C57BL/6JAnu or (involves: C57BL/6JAnu * CBA/CaJ))	decreased lymphocyte cell number	J:104190
	increased bone marrow cell number	J:104190
	increased plasma cell number	J:104190
	myeloid hyperplasia	J:104190
Prkdc^m1Anu/Prkdc^m1Anu (C57BL/6JAnu-Prkdc^m1Anu)	abnormal lymphocyte morphology	J:104190
Prkdc^m1Btlr/Prkdc^m1Btlr (involves: C57BL/6J)	abnormal class switch recombination	J:185495
	decreased B cell number	J:185495
	decreased IgG level	J:185495
	decreased IgM level	J:185495
Prkdc^m2Btlr/Prkdc^m2Btlr (C57BL/6J-Prkdc^m2Btlr)	abnormal B cell physiology	J:204502
	decreased B cell number	J:204502
	decreased CD4-positive, alpha-beta T cell number	J:204502
	decreased CD8-positive, alpha-beta T cell number	J:204502
	decreased IgG level	J:204502
	decreased IgM level	J:204502
Prkdc^m3Btlr/Prkdc^m3Btlr (C57BL/6J-Prkdc^m3Btlr)	decreased IgG level	J:224665
Prkdc^m4Btlr/Prkdc^m4Btlr (C57BL/6J-Prkdc^m4Btlr)	decreased B cell number	J:255217
	increased B-1b cell number	J:255217
	increased neutrophil cell number	J:255217
Prkdc^m5Btlr/Prkdc^m5Btlr (C57BL/6J-Prkdc^m5Btlr)	increased alpha-beta T cell number	J:255220
Prkdc^m5Btlr/Prkdc^m5Btlr (C57BL/6J-Prkdc^m5Btlr)	increased CD4-positive, alpha-beta T cell number	J:255220
Prkdc^m6Btlr/Prkdc^m6Btlr (C57BL/6J-Prkdc^m6Btlr)	decreased CD8-positive, naive alpha-beta T cell number	J:255221
	increased alpha-beta T cell number	J:255221
	increased CD4-positive, alpha-beta T cell number	J:255221
	increased CD8-positive, alpha-beta T cell number	J:255221
Prkdc^m7Btlr/Prkdc^m7Btlr (C57BL/6J-Prkdc^m7Btlr)	decreased IgG level	J:255223
Prkdc^m7Btlr/Prkdc^m7Btlr (C57BL/6J-Prkdc^m7Btlr)	increased effector memory CD4-positive, alpha-beta T cell number	J:255223
Prkdc^M8Btlr/Prkdc⁺ (C57BL/6J-Prkdc^M8Btlr)	decreased CD8-positive, alpha-beta T cell number	J:255224
Prkdc^M8Btlr/Prkdc^M8Btlr (C57BL/6J-Prkdc^M8Btlr)	decreased CD8-positive, alpha-beta T cell number	J:255224
	increased CD4-positive, alpha-beta T cell number	J:255224
	increased plasmacytoid dendritic cell number	J:255224
Prkdc^M9Btlr/Prkdc⁺ (C57BL/6J-Prkdc^M9Btlr)	decreased B-1a cell number	J:255268
	decreased effector memory CD4-positive, alpha-beta T cell number	J:255268
	increased B cell number	J:255268
	increased B-1b cell number	J:255268
Prkdc^M9Btlr/Prkdc^M9Btlr (C57BL/6J-Prkdc^M9Btlr)	decreased B-1a cell number	J:255268
	decreased effector memory CD4-positive, alpha-beta T cell number	J:255268
	increased B cell number	J:255268
	increased B-1b cell number	J:255268
Prkdc^M10Btlr/Prkdc⁺ (C57BL/6J-Prkdc^M10Btlr)	decreased CD8-positive, alpha-beta T cell number	J:255269
Prkdc^M10Btlr/Prkdc^M10Btlr (C57BL/6J-Prkdc^M10Btlr)	decreased CD8-positive, alpha-beta T cell number	J:255269
Prkdc^M11Btlr/Prkdc⁺ (C57BL/6J-Prkdc^M11Btlr)	increased IgM level	J:255270
Prkdc^M11Btlr/Prkdc^M11Btlr (C57BL/6J-Prkdc^M11Btlr)	increased IgM level	J:255270
Prkdc^m12Btlr/Prkdc^m12Btlr (C57BL/6J-Prkdc^m12Btlr)	decreased B cell number	J:264708
	decreased B-1 B cell number	J:264708
	decreased CD4-positive, alpha-beta T cell number	J:264708
	decreased CD8-positive, alpha-beta T cell number	J:264708
	decreased CD8-positive, naive alpha-beta T cell number	J:264708
	decreased NK T cell number	J:264708
	decreased single-positive T cell number	J:264708
	decreased T cell number	J:264708
	increased central memory CD4-positive, alpha-beta T cell number	J:264708
	increased central memory CD8 positive, alpha-beta T cell number	J:264708
	increased effector memory CD4-positive, alpha-beta T cell number	J:264708
	increased NK cell number	J:264708
Prkdc^m13Btlr/Prkdc^m13Btlr (C57BL/6J-Prkdc^m13Btlr)	increased effector memory CD4-positive, alpha-beta T cell number	J:272441
Prkdc^m14Btlr/Prkdc^m14Btlr (C57BL/6J-Prkdc^m14Btlr)	abnormal CD4-positive T cell differentiation	J:272442
Prkdc^M15Btlr/Prkdc^M15Btlr (C57BL/6J-Prkdc^M15Btlr)	decreased B-1 B cell number	J:272445
Prkdc^M16Btlr/Prkdc^M16Btlr (C57BL/6J-Prkdc^M16Btlr)	abnormal CD8-positive, alpha-beta T cell differentiation	J:272520
Prkdc^m17Btlr/Prkdc^m17Btlr (C57BL/6J-Prkdc^m17Btlr)	increased plasmacytoid dendritic cell number	J:272521
Prkdc^m18Btlr/Prkdc^m18Btlr (C57BL/6J-Prkdc^m18Btlr)	abnormal B cell differentiation	J:274730
	abnormal CD4-positive T cell differentiation	J:274730
	abnormal CD8-positive, alpha-beta T cell differentiation	J:274730
	abnormal T cell differentiation	J:274730
	decreased alpha-beta T cell number	J:274730
	decreased B cell number	J:274730
	decreased B-1 B cell number	J:274730
	decreased CD4-positive, alpha-beta T cell number	J:274730
	decreased CD8-positive, alpha-beta T cell number	J:274730
	decreased CD8-positive, naive alpha-beta T cell number	J:274730
	increased CD4-positive, alpha-beta T cell number	J:274730
	increased CD8-positive, alpha-beta T cell number	J:274730
	increased central memory CD4-positive, alpha-beta T cell number	J:274730
	increased central memory CD8 positive, alpha-beta T cell number	J:274730
	increased effector memory CD4-positive, alpha-beta T cell number	J:274730
	increased effector memory CD8-positive, alpha-beta T cell number	J:274730
	increased T cell number	J:274730
Prkdc^m19Btlr/Prkdc^m19Btlr (C57BL/6J-Prkdc^m19Btlr)	abnormal B cell differentiation	J:274763
	abnormal CD4-positive T cell differentiation	J:274763
	abnormal CD8-positive, alpha-beta T cell differentiation	J:274763
	abnormal T cell differentiation	J:274763
	decreased B cell number	J:274763
	decreased B-1 B cell number	J:274763
	decreased CD4-positive, alpha-beta T cell number	J:274763
	decreased CD8-positive, alpha-beta T cell number	J:274763
	decreased CD8-positive, naive alpha-beta T cell number	J:274763
	decreased T cell number	J:274763
	increased central memory CD4-positive, alpha-beta T cell number	J:274763
	increased central memory CD8 positive, alpha-beta T cell number	J:274763
	increased effector memory CD4-positive, alpha-beta T cell number	J:274763
	increased effector memory CD8-positive, alpha-beta T cell number	J:274763
	increased NK cell number	J:274763
Prkdc^scid/Prkdc^scid (C.BKa-Prkdc^scid)	abnormal spleen white pulp morphology	J:6958
	abnormal thymus morphology	J:6958
	absent B cells	J:6958
	absent pre-B cells	J:6958
	absent thymus cortex	J:6958
	decreased B cell proliferation	J:6958
	decreased IgG level	J:6958
	decreased immunoglobulin level	J:6958, J:22026
	decreased leukocyte cell number	J:6958
	decreased T cell proliferation	J:6958
	hematopoietic system phenotype	J:22026
	small thymus	J:6958
	thymus cyst	J:6958
Prkdc^scid/Prkdc^scid (NOD.Cg-Prkdc^scid)	abnormal spleen white pulp morphology	J:109833, J:22026
	abnormal thymus corticomedullary boundary morphology	J:22026
	abnormal thymus lobule morphology	J:22026
	decreased B cell number	J:22026
	decreased bone marrow cell number	J:22026
	decreased CD4-positive, alpha-beta T cell number	J:109833, J:22026
	decreased CD8-positive, alpha-beta T cell number	J:109833, J:22026
	decreased erythrocyte cell number	J:22026
	decreased immunoglobulin level	J:22026
	decreased lymphocyte cell number	J:22026
	decreased mature B cell number	J:109833
	decreased NK cell number	J:22026
	decreased pre-B cell number	J:22026
	decreased T cell number	J:22026
	impaired natural killer cell mediated cytotoxicity	J:22026
	increased granulocyte number	J:22026
	increased macrophage cell number	J:22026
	increased mean corpuscular volume	J:22026
	spleen hypoplasia	J:109833, J:22026
	thymus cyst	J:22026
Prkdc^scid/Prkdc^scid (B6.Cg-Prkdc^scid/Sz)	abnormal NK cell physiology	J:34814
	abnormal spleen white pulp morphology	J:34814
	abnormal thymus morphology	J:34814
	decreased B cell number	J:34814
	decreased CD4-positive, alpha-beta T cell number	J:34814
	decreased CD8-positive, alpha-beta T cell number	J:34814
	decreased immunoglobulin level	J:34814
	decreased lymphocyte cell number	J:34814
	decreased pre-B cell number	J:34814
	decreased T cell number	J:34814
	increased eosinophil cell number	J:34814
	increased granulocyte number	J:34814
	increased macrophage cell number	J:34814
	increased monocyte cell number	J:34814
	increased neutrophil cell number	J:34814
	increased NK cell number	J:34814
	small thymus	J:34814
	spleen hypoplasia	J:34814
	thymus cyst	J:34814
Prkdc^scid/Prkdc^scid (involves: BALB/c * C57BL/6 * C57BL/Ka)	abnormal NK cell physiology	J:115033
Prkdc^scid/Prkdc^scid Mcph1^{Tg(HLA-A2.1)1Enge}/Mcph1⁺ (NOD.Cg-Mcph1^{Tg(HLA-A2.1)1Enge} Prkdc^scid/Dvs)	abnormal splenocyte morphology	J:91764
Prkdc^scid/Prkdc^scid Rasa3^scat/Rasa3^scat (involves: BALB/c * BALB/cBy * C57BL)	abnormal hematopoietic system morphology/development	J:186485
Prkdc^scid/Prkdc^scid Tg(HLA-DRA0101,HLA-DRB10101)1Dmz/Tg(HLA-DRA0101,HLA-DRB10101)1Dmz (NOD.Cg-Tg(HLA-DRA0101,HLA-DRB10101)1Dmz Prkdc^scid/Gck)	absent T cells	J:126700
Prkdc^scid/Prkdc^scid Tg(TcraAI4)1Dvs/0 Tg(TcrbAI4)1Dvs/0 (NOD.Cg-Prkdc^scid Tg(TcraAI4)1Dvs Tg(TcrbAI4)1Dvs)	abnormal CD4-positive, alpha beta T cell morphology	J:93553
Prkdc^scid/Prkdc^scid Tg(Tcrb)93Vbo/0 (involves: Balb/c * C57BL/Ka * C57BL/Lia * CBA/BrA)	abnormal CD4-positive, alpha beta T cell morphology	J:111476
	abnormal CD8-positive, alpha beta T cell morphology	J:111476
	abnormal double-positive T cell morphology	J:111476
	abnormal single-positive T cell number	J:111476
	abnormal T cell differentiation	J:111476
Prkdc^scid/Prkdc^scid Tgfb1^tm1Doe/Tgfb1^tm1Doe (involves: 129 * C3H * CF-1)	decreased spleen weight	J:129629
Prkdc^{Tg(INS-PDE2)5-1Lmb}/? (involves: FVB/N)	abnormal thymus morphology	J:108405
Prkdc^tm1.1Bpcc/Prkdc^tm1.1Bpcc (involves: 129 * C57BL/6)	abnormal hematopoietic stem cell physiology	J:171351
	abnormal immunoglobulin V(D)J recombination	J:171351
	arrested B cell differentiation	J:171351
	decreased bone marrow cell number	J:171351
	decreased CD4-positive, alpha-beta T cell number	J:171351
	decreased CD8-positive, alpha-beta T cell number	J:171351
	decreased double-negative T cell number	J:171351
	decreased double-positive T cell number	J:171351
	decreased erythrocyte cell number	J:171351
	decreased gamma-delta T cell number	J:171351
	decreased granulocyte number	J:171351
	decreased hematopoietic stem cell number	J:171351
	decreased leukocyte cell number	J:171351
	decreased lymphocyte cell number	J:171351
	decreased macrophage cell number	J:171351
	decreased mature B cell number	J:171351
	decreased T cell number	J:171351
	pancytopenia	J:171351
	thrombocytopenia	J:171351
Prkdc^tm1Fwa/Prkdc^tm1Fwa (involves: 129S6/SvEvTac * C57BL/6)	abnormal T cell receptor beta chain V(D)J recombination	J:50221
	abnormal T cell receptor V(D)J recombination	J:50221
	absent pre-B cells	J:50221
	arrested B cell differentiation	J:50221
	arrested T cell differentiation	J:50221
	decreased double-positive T cell number	J:50221
	decreased thymocyte number	J:50221
Prkdc^tm1Fwa/Prkdc^tm1Fwa (involves: 129S6/SvEvTac)	decreased splenocyte number	J:306598
Prkdc^tm1Gcl/Prkdc^tm1Gcl (involves: 129S1/Sv * C57BL/6)	abnormal immunoglobulin heavy chain V(D)J recombination	J:53765
	abnormal spleen morphology	J:53765
	abnormal T cell receptor beta chain V(D)J recombination	J:53765
	abnormal T cell receptor delta chain V(D)J recombination	J:53765
	absent mature B cells	J:53765
	absent thymus corticomedullary boundary	J:53765
	arrested B cell differentiation	J:53765
	small spleen	J:53765
	small thymus	J:53765
	thymus hypoplasia	J:53765
Prkdc^tm1Gcl/Prkdc^tm1Gcl (involves: 129S1/Sv)	decreased thymocyte apoptosis	J:126920
Prkdc^tm1Get/Prkdc^tm1Get (involves: 129S4/SvJae * Black Swiss)	abnormal B cell differentiation	J:50222
	abnormal immunoglobulin heavy chain V(D)J recombination	J:50222
	abnormal immunoglobulin light chain V-J recombination	J:50222
	abnormal T cell differentiation	J:50222
	abnormal T cell number	J:50222
	abnormal T cell receptor alpha chain V-J recombination	J:50222
	abnormal T cell receptor beta chain V(D)J recombination	J:50222
	abnormal T cell receptor delta chain V(D)J recombination	J:50222
	abnormal thymus corticomedullary boundary morphology	J:50222
	arrested B cell differentiation	J:50222
	arrested T cell differentiation	J:50222
	decreased IgM level	J:50222
	decreased single-positive T cell number	J:50222
	decreased spleen white pulp amount	J:50222
	increased double-negative T cell number	J:50222
	increased double-positive T cell number	J:50222
	increased NK cell number	J:50222
	spleen hypoplasia	J:50222
	thymus hypoplasia	J:50222
Prkg1^{tm1b(KOMP)Wtsi}/Prkg1^{tm1b(KOMP)Wtsi} (C57BL/6N-Prkg1^{tm1b(KOMP)Wtsi}/H)	enlarged spleen	J:211773
Prkg1^tm2.1Naw/Prkg1^tm2.1Naw (involves: 129S1/Sv * 129X1/SvJ)	abnormal erythrocyte morphology	J:134639
	anemia	J:134639
	decreased erythrocyte cell number	J:134639
	decreased hematocrit	J:134639
	enlarged spleen	J:134639
	increased erythrocyte clearance	J:134639
	increased mean corpuscular hemoglobin	J:134639
	increased mean corpuscular volume	J:134639
	increased red blood cell distribution width	J:134639
	reticulocytosis	J:134639
Prl7d1^em1Liga/Prl7d1^em1Liga (involves: C57BL/6)	increased uterine NK cell number	J:288761
Prmt3^{tm1a(EUCOMM)Wtsi}/Prmt3^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6 * C57BL/6N)	increased CD4-positive, alpha-beta T cell number	J:213427
	increased CD8-positive, alpha-beta T cell number	J:213427
	increased T cell number	J:213427
Prmt7^{tm1a(EUCOMM)Wtsi}/Prmt7^{tm1a(EUCOMM)Wtsi} (B6JTyr;B6N-Prmt7^{tm1a(EUCOMM)Wtsi}/Wtsi)	abnormal thymus topology	J:239583
	decreased erythrocyte cell number	J:175295
Prmt9^em1(IMPC)J/Prmt9^em1(IMPC)J (C57BL/6NJ-Prmt9^em1(IMPC)J/Mmjax)	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
Prnp^tm1Cwe/Prnp^tm1Cwe Tg(Lck-Prnp)33Cwe/0 (involves: 129S7/SvEvBrd * C57BL/6)	increased CD8-positive, alpha-beta T cell number	J:129512
	increased gamma-delta T cell number	J:129512
	thymus hypoplasia	J:129512
Prnp^tm1Cwe/Prnp^tm1Cwe Tg(Prnp)a20Cwe/0 (involves: 129S7/SvEvBrd * C57BL/6)	abnormal B cell morphology	J:129512
	abnormal T cell differentiation	J:129512
	decreased CD4-positive, alpha-beta T cell number	J:129512
	decreased CD8-positive, alpha-beta T cell number	J:129512
	decreased DN2 thymocyte number	J:129512
	decreased DN4 thymocyte number	J:129512
	decreased double-positive T cell number	J:129512
	decreased thymocyte number	J:129512
	increased DN3 thymocyte number	J:129512
	increased double-negative T cell number	J:129512
	increased gamma-delta T cell number	J:129512
	thymus atrophy	J:129512
Prnp^tm1Cwe/Prnp^tm1Cwe Tg(PrnpS170NN174T)1020Aag/0 (involves: 129S7/SvEvBrd * C57BL/6)	microgliosis	J:143528
Prnp^{tm3(PRNP129V)Tkit}/Prnp^{tm3(PRNP129V)Tkit} (Not Specified)	abnormal spleen morphology	J:126777
Procr^tm1.1Pcl/Procr^tm1.1Pcl (involves: 129S2/SvPas * C57BL/6)	bone marrow failure	J:225914
	decreased bone marrow cell number	J:225914
	enlarged spleen	J:225914
	extramedullary hematopoiesis	J:225914
	hematopoietic system phenotype	J:225914
	increased spleen red pulp amount	J:225914
	increased spleen weight	J:225914
	increased splenocyte number	J:225914
	thrombocytopenia	J:225914
Procr^tm1Cte/Procr⁺ (B6.129S7-Procr^tm1Cte)	thrombocytopenia	J:144388
Prom2^{tm1.1(KOMP)Vlcg}/Prom2^{tm1.1(KOMP)Vlcg} (C57BL/6N-Prom2^{tm1.1(KOMP)Vlcg}/J)	increased hemoglobin content	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
Prom2^tm1Lex/Prom2^tm1Lex (B6;129S5-Prom2^tm1Lex/Mmucd)	anemia	J:171883
	decreased erythrocyte cell number	J:171883
	decreased hematocrit	J:171883
	decreased mean corpuscular hemoglobin	J:171883
Pros1^tm1.1Ansc/Pros1^tm1.1Ansc (involves: 129/Sv * C57BL/6J * FVB/N)	increased megakaryocyte cell number	J:152423
	thrombocytopenia	J:152423
Proser2^{em1(IMPC)Ccpcz}/Proser2^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Proser2^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Prox1^tm1Gco/Prox1⁺ (involves: 129S1/Sv * 129X1/SvJ * NMRI)	increased macrophage cell number	J:102652
Prpf3^{tm1b(KOMP)Wtsi}/Prpf3⁺ (C57BL/6N-Prpf3^{tm1b(KOMP)Wtsi}/Bay)	increased neutrophil cell number	J:211773
Prpf6^{tm1.1(KOMP)Vlcg}/Prpf6⁺ (C57BL/6N-Prpf6^{tm1.1(KOMP)Vlcg}/J)	increased mean corpuscular hemoglobin	J:211773
Prpf39^em1(IMPC)Tcp/Prpf39⁺ (C57BL/6NCrl-Prpf39^em1(IMPC)Tcp/Tcp)	decreased hematocrit	J:211773
	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
Prpf40a^em1(IMPC)J/Prpf40a⁺ (C57BL/6NJ-Prpf40a^em1(IMPC)J/Mmjax)	decreased erythrocyte cell number	J:211773
	decreased hemoglobin content	J:211773
	decreased mean corpuscular hemoglobin concentration	J:211773
	increased mean corpuscular volume	J:211773
Prph2^em1Sal/Prph2^em1Sal (C57BL/6J-Prph2^em1Sal)	increased microglial cell activation	J:342243
Prph2^Rd2/Prph2^Rd2 (O20/A-Prph2^Rd2)	abnormal macrophage morphology	J:6432
Prps2^{tm1a(KOMP)Wtsi}/Y (involves: C57BL/6N)	abnormal B cell physiology	J:214383
Prps2^{tm1a(KOMP)Wtsi}/Y (involves: C57BL/6N)	hematopoietic system phenotype	J:214383
Prps2^{tm1a(KOMP)Wtsi}/Y Tg(IghMyc)22Bri/0 (involves: C57BL/6N * SJL)	abnormal B cell physiology	J:214383
	hematopoietic system phenotype	J:214383
	increased B cell apoptosis	J:214383
Prr7^{tm1(KOMP)Vlcg}/Prr7^{tm1(KOMP)Vlcg} (involves: C57BL/6NTac)	decreased CD4-positive, alpha-beta T cell number	J:237776
Prrg4^em1(IMPC)Mbp/Prrg4^em1(IMPC)Mbp (C57BL/6NCrl-Prrg4^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Prss8^tm1.1Hum/Prss8^tm1.2Hum Tg(KRT14-cre)1Ipc/0 (involves: 129/Sv * C57BL/6 * FVB/N * SJL)	thymus medulla hypoplasia	J:100139
Prss8^{tm1b(EUCOMM)Hmgu}/Prss8⁺ (C57BL/6N-Prss8^{tm1b(EUCOMM)Hmgu}/J)	decreased mean corpuscular hemoglobin concentration	J:211773
Prss12^{em1(IMPC)Ccpcz}/Prss12^{em1(IMPC)Ccpcz} (C57BL/6N-Prss12^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Prss16^tm1.1Mal/Prss16⁺ Rag2^tm1Fwa/Rag2^tm1Fwa Tg(TcraH-Y,TcrbH-Y)1Pas/? (involves: 129S/SvEv * 129S2/SvPas * C57BL/6)	abnormal positive T cell selection	J:148034
	decreased CD4-positive, alpha-beta T cell number	J:148034
	decreased single-positive T cell number	J:148034
Prss16^tm1.1Mal/Prss16^tm1.1Mal (involves: 129S2/SvPas * C57BL/6)	abnormal thymus cortex morphology	J:148034
Prss16^tm1.1Mal/Prss16^tm1.1Mal Rag2^tm1Fwa/Rag2^tm1Fwa Tg(TcraH-Y,TcrbH-Y)1Pas/? (involves: 129S/SvEv * 129S2/SvPas * C57BL/6)	abnormal positive T cell selection	J:148034
	decreased CD4-positive, alpha-beta T cell number	J:148034
	decreased double-positive T cell number	J:148034
	decreased single-positive T cell number	J:148034
	spleen hypoplasia	J:148034
	thymus hypoplasia	J:148034
Prss21^{em1(IMPC)Ccpcz}/Prss21⁺ (C57BL/6N-Prss21^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Prss27^{tm1.1(NCOM)Mfgc}/Prss27^{tm1.1(NCOM)Mfgc} (C57BL/6N-Prss27^{tm1.1(NCOM)Mfgc}/Tcp)	decreased monocyte cell number	J:211773
Prss33^{em1(IMPC)Ccpcz}/Prss33^{em1(IMPC)Ccpcz} (C57BL/6N-Prss33^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
	small spleen	J:211773
Prss35^{em1(IMPC)Ccpcz}/Prss35^{em1(IMPC)Ccpcz} (C57BL/6N-Prss35^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Prss47^{em1(IMPC)Ccpcz}/Prss47^{em1(IMPC)Ccpcz} (C57BL/6N-Prss47^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Prss48^{em1(IMPC)Ccpcz}/Prss48^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Prss48^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Prss50^{tm1a(EUCOMM)Hmgu}/Prss50^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Prss50^{tm1a(EUCOMM)Hmgu}/H)	decreased CD8-positive, alpha-beta T cell number	J:165965
	decreased T cell number	J:165965
Prss53^{em3(IMPC)Wtsi}/Prss53^{em3(IMPC)Wtsi} (C57BL/6N-Prss53^{em3(IMPC)Wtsi}/Wtsi)	decreased leukocyte cell number	J:211773
Prss54^{em1(IMPC)Ccpcz}/Prss54^{em1(IMPC)Ccpcz} (C57BL/6N-Prss54^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Prss55^{em1(IMPC)Ccpcz}/Prss55^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Prss55^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Prss56^em1(IMPC)J/Prss56^em1(IMPC)J (C57BL/6NJ-Prss56^em1(IMPC)J/J)	decreased leukocyte cell number	J:211773
Prss57^{em1(IMPC)Ccpcz}/Prss57^{em1(IMPC)Ccpcz} (C57BL/6N-Prss57^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	decreased NK T cell number	J:211773
	enlarged thymus	J:211773
Prss57^tm1.1Gne/Prss57^tm1.1Gne (C57BL/6N-Prss57^tm1.1Gne)	abnormal mast cell morphology	J:301479
	abnormal mast cell physiology	J:301479
	decreased mast cell histamine storage	J:301479
Prss57^tm1Lex/Prss57^tm1Lex (involves: 129S5/SvEvBrd)	abnormal mast cell physiology	J:301479
Prtn3^tm1.1Hrlu/Prtn3^tm1.1Hrlu (involves: C57BL/6)	abnormal neutrophil physiology	J:217636
Prtn3^tm1.1Hrlu/Prtn3^tm1.1Hrlu (involves: C57BL/6)	increased neutrophil cell number	J:217636
Prxl2b^{tm1b(EUCOMM)Hmgu}/Prxl2b^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Prxl2b^{tm1b(EUCOMM)Hmgu}/Wtsi)	increased red blood cell distribution width	J:211773
Psap^tm1Ggb/Psap^tm1Ggb (involves: 129S/SvEv * C57BL/6J)	abnormal microglial cell physiology	J:121761
Psap^tm1Ggb/Psap^tm1Ggb (involves: 129S/SvEv * C57BL/6J)	abnormal spleen morphology	J:121761
Psap^tm1Juma/Psap^tm1Juma (FVB.129S-Psap^tm1Juma)	abnormal microglial cell physiology	J:121761
Psap^tm1Suz/Psap^tm1Suz (involves: 129P2/OlaHsd)	abnormal macrophage morphology	J:113052
Psap^tm1Suz/Psap^tm1Suz (involves: 129P2/OlaHsd)	decreased spleen weight	J:106511
Psap^tm1Suz/Psap^tm2.1Juma (involves: 129 * 129P2/OlaHsd * C57BL/6J * FVB/N)	hematopoietic system phenotype	J:283977
Psap^tm2.1Juma/Psap^tm2.1Juma (involves: 129 * C57BL/6J * FVB/N)	hematopoietic system phenotype	J:283977
Psap^tm2Ggb/Psap^tm2Ggb (involves: 129S/SvEv * C57BL/6J)	microgliosis	J:198242
Psap^tm2Suz/Psap^tm2Suz (involves: 129S/SvEv * C57BL/6J)	abnormal macrophage morphology	J:78223
Psap^tm2Suz/Psap^tm2Suz (involves: 129S/SvEv * C57BL/6J)	microgliosis	J:198242
Psap^tm4.1Ggb/Psap^tm4.1Ggb (involves: 129S/SvEv * C57BL/6J)	microgliosis	J:198242
Psca^{tm1b(EUCOMM)Hmgu}/Psca^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Psca^{tm1b(EUCOMM)Hmgu}/Bay)	abnormal spleen morphology	J:211773
Psd^em1(IMPC)Mbp/Psd^em1(IMPC)Mbp (C57BL/6NCrl-Psd^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	small spleen	J:211773
Psen1^tm1.1Ruvi/Psen1^tm1.1Ruvi Tg(APP)8.9Btla/0 (involves: 129S2/SvPas * C57BL/6J)	microgliosis	J:187475
Psen1^tm1Bdes/Psen1⁺ Psen2^tm1Bdes/Psen2^tm1Bdes (involves: 129P2/OlaHsd)	abnormal T cell subpopulation ratio	J:91235
	enlarged spleen	J:91235
	increased immunoglobulin level	J:91235
	increased leukocyte cell number	J:91235
Psen1^tm2Shn/Psen1^tm4.1Shn Psen2^tm1Haa/Psen2^tm1Haa Tg(Camk2a-cre)1Shn/0 (involves: 129 * 129S4/SvJae * C57BL/6 * C57BL/6J * CBA)	microgliosis	J:219929
Psen2^{em1(IMPC)Ccpcz}/Psen2^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Psen2^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
	increased mean corpuscular hemoglobin	J:211773
Psip1^{Gt(betageo)1Hgs}/Psip1^{Gt(betageo)1Hgs} (B6.129P2-Psip1^{Gt(betageo)1Hgs})	spleen atrophy	J:112975
Psip1^{Gt(betageo)1Hgs}/Psip1^{Gt(betageo)1Hgs} (either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * MF1))	spleen atrophy	J:112975
Psma8^em1(IMPC)Tcp/Psma8^em1(IMPC)Tcp (C57BL/6N-Psma8^em1(IMPC)Tcp/Tcp)	increased monocyte cell number	J:211773
	small thymus	J:211773
Psmb8^tm1Hjf/Psmb8^tm1Hjf Tg(TcraTcrb)1100Mjb/? (involves: 129P2/OlaHsd * C57BL/6)	decreased CD8-positive, alpha-beta T cell number	J:107657
Psmb9^tm1Stl/Psmb9^tm1Stl (involves: 129P2/OlaHsd * C57BL/6)	abnormal CD8-positive, alpha-beta cytotoxic T cell morphology	J:21549
	decreased CD8-positive, alpha-beta T cell number	J:21549
Psmb10^tm1Mgro/Psmb10^tm1Mgro (involves: 129S2/SvPas * C57BL/6)	abnormal CD8-positive, alpha-beta cytotoxic T cell morphology	J:125058
	abnormal cytotoxic T cell physiology	J:125058
	decreased CD8-positive, alpha-beta T cell number	J:125058
	decreased T cell proliferation	J:125058
Psmb10^tm1Mgro/Psmb10^tm1Mgro Psmb9/Psmb8^tm1Klr/Psmb9/Psmb8^tm1Klr (B6.129-Psmb10^tm1Mgro Psmb9/Psmb8^tm1Klr)	abnormal B lymphocyte antigen presentation	J:180765
	decreased CD8-positive, alpha-beta T cell number	J:180765
Psmb10^tm1Mgro/Psmb10^tm1Mgro Psmb9/Psmb8^tm1Klr/Psmb9/Psmb8^tm1Klr (B6.129-Psmb10^tm1Mgro Psmb9/Psmb8^tm1Klr)	abnormal B lymphocyte antigen presentation	J:180765
	decreased CD8-positive, alpha-beta T cell number	J:180765
Psmb10^tm1Mgro/Psmb10^Tub6 (involves: 129S2/SvPas * C3HeB/FeJ)	decreased NK cell number	J:261081
	decreased T cell number	J:261081
	increased granulocyte number	J:261081
Psmb10^Tub6/Psmb10⁺ (C3HeB/FeJ-Psmb10^Tub6)	abnormal T cell activation	J:261081
	decreased CD4-positive, alpha-beta T cell number	J:261081
	decreased CD8-positive, alpha-beta T cell number	J:261081
	decreased T cell number	J:261081
Psmb10^Tub6/Psmb10^Tub6 (C3HeB/FeJ-Psmb10^Tub6)	absent spleen white pulp	J:261081
	athymia	J:261081
	decreased B cell number	J:261081
	decreased immunoglobulin level	J:261081
	decreased leukocyte cell number	J:261081
	decreased NK cell number	J:261081
	decreased spleen red pulp amount	J:261081
	decreased T cell number	J:261081
	increased granulocyte number	J:261081
Psmb10^Tub6/Psmb10^Tub6 (B6.C3Fe-Psmb10^Tub6)	increased granulocyte number	J:261081
Psmb10^Tub6/Psmb10^Tub6 (C.C3Fe-Psmb10^Tub6)	increased granulocyte number	J:261081
Psmb11^{em1(IMPC)Ccpcz}/Psmb11^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Psmb11^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	decreased CD8-positive, alpha-beta T cell number	J:211773
	decreased effector memory T-helper cell number	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
	increased CD4-positive NK T cell number	J:211773
	increased CD4-positive, alpha-beta T cell number	J:211773
	increased effector memory CD8-positive, alpha-beta T cell number	J:211773
	increased effector memory T-helper cell number	J:211773
	increased memory-marker CD4-positive NK T cell number	J:211773
	increased NK T cell number	J:211773
	increased T-helper cell number	J:211773
Psmb11^{tm1(Psmb8)Khog}/Psmb11⁺ (involves: C57BL/6)	decreased CD8-positive, alpha-beta T cell number	J:196156
Psmb11^{tm1(Psmb8)Khog}/Psmb11^{tm1(Psmb8)Khog} (involves: C57BL/6)	abnormal CD8-positive, alpha beta T cell morphology	J:196156
	abnormal T cell differentiation	J:196156
	abnormal T cell receptor V(D)J recombination	J:196156
	decreased CD8-positive, alpha-beta T cell number	J:196156
	decreased memory T cell number	J:196156
	increased T cell proliferation	J:196156
Psmb11^{tm1(Psmb8)Khog}/Psmb11^{tm1(Psmb8)Khog} Psmb8^tm1Hjf/Psmb8^tm1Hjf (involves: 129P2/OlaHsd * C57BL/6)	decreased CD8-positive, alpha-beta T cell number	J:196156
Psmb11^{tm1.1(Psmb8)Khog}/Psmb11^{tm1.1(Psmb8)Khog} Psmb8^tm1Hjf/Psmb8^tm1Hjf (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6NTac)	abnormal T cell receptor V(D)J recombination	J:196156
	decreased CD8-positive, alpha-beta T cell number	J:196156
Psmb11^tm1Smta/Psmb11^tm1Smta (involves: C57BL/6 * CBA)	decreased CD8-positive, alpha-beta T cell number	J:121869
Psmc4^tm1.1Ryot/Psmc4^tm1.2Ryot Tg(SLC18A3-cre)KMisa/0 (involves: C57BL/6 * C57BL/6N)	microgliosis	J:193770
Psme2^tm1Yya/Psme2^tm1Yya (involves: 129P2/OlaHsd)	abnormal CD8-positive, alpha-beta T cell physiology	J:58875
Psme2^tm1Yya/Psme2^tm1Yya (involves: 129P2/OlaHsd)	decreased cytotoxic T cell cytolysis	J:58875
Psme3^tm1Jjm/Psme3^tm1Jjm (B6.129X1-Psme3^tm1Jjm)	decreased double-positive T cell number	J:88626
Psme4^b2b1508Clo/Psme4^b2b1508Clo (C57BL/6J-Psme4^b2b1508Clo)	thymus hypoplasia	J:175213
Psmf1^{tm1c(EUCOMM)Hmgu}/Psmf1^{tm1c(EUCOMM)Hmgu} Tg(Pcp2-cre)GN135Gsat/0 (involves: C57BL/6J * C57BL/6N * FVB/N)	microgliosis	J:282431
Pspc1^em1(IMPC)Mbp/Pspc1^em1(IMPC)Mbp (C57BL/6N-Pspc1^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	small spleen	J:211773
Psph^{tm1.1(KOMP)Vlcg}/Psph⁺ (C57BL/6N-Psph^{tm1.1(KOMP)Vlcg}/Ucd)	thrombocytopenia	J:211773
Psph^{tm1a(EUCOMM)Hmgu}/Psph^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Psph^{tm1a(EUCOMM)Hmgu}/Wtsi)	abnormal thymus morphology	J:239583
	abnormal thymus topology	J:239583
	athymia	J:239583
	spleen hypoplasia	J:239583
Pstpip1^{em1(IMPC)Ccpcz}/Pstpip1^{em1(IMPC)Ccpcz} (C57BL/6N-Pstpip1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
	increased CD4-positive, alpha-beta T cell number	J:211773
	increased T-helper cell number	J:211773
Pstpip1^tm1Spg/Pstpip1^tm1Spg (involves: 129S/SvEv * C57BL/6)	abnormal T cell physiology	J:101977
Pstpip2^cmo/Pstpip2^cmo (C.Cg-Pstpip2^cmo/J)	enlarged spleen	J:104476
Pstpip2^cmo/Pstpip2^cmo (C.Cg-Pstpip2^cmo/J)	extramedullary hematopoiesis	J:104476
Pstpip2^em1(IMPC)Tcp/Pstpip2^em1(IMPC)Tcp (C57BL/6NCrl-Pstpip2^em1(IMPC)Tcp/Tcp)	decreased erythrocyte cell number	J:211773
Pstpip2^Lupo/Pstpip2^Lupo (either: (involves: C3HeB/FeJ) or (involves: C3HeB/FeJ * C57BL/6J))	increased IgE level	J:125785
	increased IgG1 level	J:125785
	increased IgG2a level	J:125785
	increased IgG level	J:125785
Pstpip2^m1Bcs/Pstpip2^m1Bcs (involves: C57BL/6)	abnormal microglial cell morphology	J:196534
Pstpip2^m1Bcs/Pstpip2^m1Bcs (involves: C57BL/6)	increased megakaryocyte cell number	J:196534
pta/pta (C57BL/6J-pta)	thymus hypoplasia	J:94456
Ptcd3^{tm1.1(KOMP)Vlcg}/Ptcd3⁺ (C57BL/6N-Ptcd3^{tm1.1(KOMP)Vlcg}/J)	increased mean corpuscular hemoglobin	J:211773
Ptch1^tm1Bjw/Ptch1^tm1Bjw Tg(KRT14-cre)8Brn/0 (involves: 129T2/SvEms * FVB/N)	thymus hypoplasia	J:231264
Ptch1^tm1Hahn/Ptch1^tm1Hahn Gt(ROSA)26Sor^{tm2(cre/ERT2)Brn}/Gt(ROSA)26Sor⁺ (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal double-negative T cell morphology	J:127207
	abnormal hematopoietic system morphology/development	J:127207
	abnormal thymus lobule morphology	J:127207
	decreased B cell number	J:127207
	decreased double-positive T cell number	J:127207
	decreased immature B cell number	J:127207
	decreased lymphocyte cell number	J:127207
	decreased pre-B cell number	J:127207
	decreased transitional stage B cell number	J:127207
	increased B cell number	J:127207
	increased double-negative T cell number	J:127207
	increased mature B cell number	J:127207
	increased neutrophil cell number	J:127207
	increased single-positive T cell number	J:127207
	thymus hypoplasia	J:127207
Ptch2^tm1Dgen/Ptch2^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6)	abnormal bone marrow cell number	J:101679
	abnormal erythrocyte morphology	J:101679
	anemia	J:101679
	decreased hematocrit	J:101679
	decreased hemoglobin content	J:101679
	enlarged spleen	J:101679
	extramedullary hematopoiesis	J:101679
	increased neutrophil cell number	J:101679
Ptch2^{tm3b(EUCOMM)Hmgu}/Ptch2^{tm3b(EUCOMM)Hmgu} (C57BL/6N-Ptch2^{tm3b(EUCOMM)Hmgu}/Bay)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Ptchd1^{tm1b(KOMP)IcsOrl}/Y (C57BL/6N-Ptchd1^{tm1b(KOMP)IcsOrl}/Ics)	abnormal spleen morphology	J:211773
Ptchd1^{tm1b(KOMP)IcsOrl}/Ptchd1^{tm1b(KOMP)IcsOrl} (C57BL/6N-Ptchd1^{tm1b(KOMP)IcsOrl}/Ics)	decreased erythrocyte cell number	J:211773
Ptcra^tm1(icre)Hjf/Ptcra^tm1(icre)Hjf (B6.129P2-Ptcra^tm1(icre)Hjf)	decreased DN4 thymocyte number	J:197923
	decreased double-positive T cell number	J:197923
	decreased thymocyte number	J:197923
Ptcra^tm1.1Shoy/Ptcra^tm1.1Shoy (involves: C57BL/6)	decreased double-positive T cell number	J:166147
	decreased T cell number	J:166147
	decreased thymocyte number	J:166147
	increased DN3 thymocyte number	J:166147
	increased gamma-delta T cell number	J:166147
	increased T cell number	J:166147
Ptcra^tm1Bjf/Ptcra⁺ (involves: 129X1/SvJ)	abnormal T cell differentiation	J:94338
	decreased double-negative T cell number	J:94338
	decreased single-positive T cell number	J:94338
Ptcra^tm1Vbo/Ptcra^tm1Vbo (involves: 129P2/OlaHsd * C57BL/6)	arrested T cell differentiation	J:91542
	increased double-negative T cell number	J:91542
Ptcra^tm1Vbo/Ptcra^tm1Vbo (involves: 129P2/OlaHsd)	abnormal double-positive T cell morphology	J:123569
	decreased DN4 thymocyte number	J:123569
	increased DN3 thymocyte number	J:123569
	thymus hypoplasia	J:123569
Ptdss1^{tm1b(EUCOMM)Hmgu}/Ptdss1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Ptdss1^{tm1b(EUCOMM)Hmgu}/Ics)	decreased large unstained cell number	J:211773
Pten^tm1Engc/Pten^tm1Engc (involves: CD-1)	abnormal microglial cell physiology	J:210487
Pten^tm1Hwu/Pten^tm1Hwu Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S4/SvJae)	abnormal alveolar macrophage morphology	J:148947
	abnormal macrophage chemotaxis	J:148947
	abnormal neutrophil physiology	J:148947, J:114699, J:145331
	impaired neutrophil recruitment	J:148947
Pten^tm1Hwu/Pten^tm1Hwu Rps6kb1^tm1Gtho/Rps6kb1^tm1Gtho Tg(Mx1-cre)1Cgn/0 (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * CBA)	enlarged spleen	J:169097
	enlarged thymus	J:169097
Pten^tm1Hwu/Pten^tm1Hwu Tg(CAG-EGFP,-PAX8/PPARG)1Rkoe/0 Tg(TPO-cre)1Shk/0 (involves: 129S4/SvJae * FVB/NCr * FVB/NJ)	abnormal thymus physiology	J:177181
Pten^tm1Hwu/Pten^tm1Hwu Tg(CD2-icre)4Kio/0 (involves: 129S4/SvJae * C57BL/6 * C57BL/10 * CBA/Ca)	enlarged thymus	J:216983
Pten^tm1Hwu/Pten^tm1Hwu Tg(Cdh5-cre)7Mlia/0 (involves: 129S4/SvJae * BALB/c * C57BL/6 * FVB/N)	abnormal definitive hematopoiesis	J:135172
	enlarged spleen	J:135172
	enlarged thymus	J:135172
	increased leukocyte cell number	J:135172
	increased neutrophil cell number	J:135172
Pten^tm1Hwu/Pten^tm1Hwu Tg(GZMB-cre)1Jcb/0 (involves: 129S4/SvJae * FVB/N)	abnormal CD8-positive, alpha-beta T cell physiology	J:164425
Pten^tm1Hwu/Pten^tm1Hwu Tg(Mx1-cre)1Cgn/0 (involves: 129S4/SvJae * C57BL/6 * CBA)	enlarged spleen	J:169097
	enlarged thymus	J:169097
Pten^tm1Hwu/Pten^tm1Hwu Tg(Mx1-cre)1Cgn/0 (BKS.Cg-Ptprc^b Thy1^a Tg(Mx1-cre)1Cgn Pten^tm1Hwu)	abnormal blood cell morphology/development	J:109085
	abnormal hematopoietic stem cell physiology	J:109085
	decreased bone marrow cell number	J:109085
	enlarged thymus	J:109085
	extramedullary hematopoiesis	J:109085
	spleen hyperplasia	J:109085
Pten^tm1Hwu/Pten^tm1Hwu Tg(Mx1-cre)1Cgn/0 (involves: 129S4/SvJae * C57BL/6 * C57BL/6J * CBA)	abnormal platelet activation	J:165893
	increased platelet aggregation	J:165893
	thrombocytosis	J:165893
Pten^tm1Hwu/Pten^tm1Hwu Tg(Mx1-cre)1Cgn/0 (B6.Cg-Tg(Mx1-cre)1Cgn Pten^tm1Hwu)	anemia	J:232645
	decreased B cell number	J:232645
	decreased lymphocyte cell number	J:232645
	decreased T cell number	J:232645
	enlarged spleen	J:232645
	increased granulocyte number	J:232645
	increased macrophage cell number	J:232645
	increased monocyte cell number	J:232645
	increased spleen weight	J:232645
	thrombocytosis	J:232645
Pten^tm1Rps/Pten⁺ (involves: 129S1/Sv * C57BL/6J)	enlarged spleen	J:53065
Pten^tm1Rps/Pten⁺ (involves: 129S1/Sv * C57BL/6J)	enlarged thymus	J:53065
Pten^tm2.1Ppp/Pten^tm2.1Ppp Tnfrsf4^tm2(cre)Nik/Tnfrsf4⁺ (involves: 129S1/Sv * 129X1/SvJ)	increased germinal center B cell number	J:164283
	increased IgG1 level	J:164283
	increased T follicular helper cell number	J:164283
Ptf1a^tm1Pkwe/Ptf1a^tm1Pkwe (involves: 129P2/OlaHsd * C57BL/6)	abnormal spleen morphology	J:51571
Ptgdr2^tm1Byl/Ptgdr2^tm1Byl (involves: C57BL/6J)	increased eosinophil cell number	J:107519
Ptgdr2^tm1Tasa/Ptgdr2^tm1Tasa (involves: 129/Sv * BALB/c)	impaired eosinophil recruitment	J:130892
Ptgdr2^tm1Tasa/Ptgdr2^tm1Tasa (C.129-Ptgdr2^tm1Tasa)	decreased IgE level	J:131146
Ptgdr^tm1Sna/Ptgdr^tm1Sna (involves: 129P2/OlaHsd * C57BL/6)	abnormal macrophage activation involved in immune response	J:243958
	decreased microglial cell activation	J:243958
	increased CD4-positive, alpha-beta T cell number	J:243958
	increased regulatory T cell number	J:243958
Ptgdr^tm1Sna/Ptgdr^tm1Sna (B6.129P2-Ptgdr^tm1Sna/Sna)	abnormal dermal mast cell morphology	J:197334
	abnormal mast cell physiology	J:197334
	decreased mast cell degranulation	J:197334
	decreased mast cell histamine storage	J:197334
Ptgds^tm1Ohy/Ptgds^tm1Ohy (B6.129P2-Ptgds^tm1Ohy)	abnormal dermal mast cell morphology	J:197334
	decreased mast cell degranulation	J:197334
	decreased mast cell histamine storage	J:197334
Ptger1^tm1Sna/Ptger1^tm1Sna (B6CrSlc.129P2-Ptger1^tm1Sna/Sna)	abnormal CD8-positive, alpha-beta T cell differentiation	J:128435
	abnormal T-helper 1 cell differentiation	J:128435
Ptger2^tm1.1Kand/Ptger2^tm1.1Kand Tg(ITGAM-cre)2781Gkl/0 (involves: C57BL/6 * CBA)	abnormal microglial cell physiology	J:202677
Ptger2^tm1Brey/Ptger2^tm1Brey (C.129S6-Ptger2^tm1Brey)	abnormal microglial cell physiology	J:97062
Ptger2^tm1Rsz/Ptger2^tm1Rsz (involves: 129S6/SvEvTac * C57BL/6)	abnormal osteoclast differentiation	J:77408
Ptger4^tm1Bhk/Ptger4^tm1Bhk (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	abnormal macrophage physiology	J:78964
Ptger4^tm1Sna/Ptger4^tm1Sna (involves: 129P2/OlaHsd * C57BL/6)	abnormal osteoclast differentiation	J:63070
	abnormal osteoclast physiology	J:63070
	abnormal T cell activation	J:83725
	decreased T cell proliferation	J:83725
Ptges2^{tm1a(EUCOMM)Wtsi}/Ptges2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Ptges2^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased mean corpuscular hemoglobin	J:165965
Ptges^tm1.1Gaf/Ptges^tm1.1Gaf Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129 * C57BL/6)	abnormal leukocyte physiology	J:210141
	increased leukocyte cell number	J:210141
Ptges^tm1Aki/Ptges^tm1Aki (involves: 129X1/SvJ * C57BL/6)	impaired macrophage chemotaxis	J:91821
Ptgir^tm1Sna/Ptgir^tm1Sna (involves: 129P2/OlaHsd * C57BL/6)	abnormal platelet activation	J:79049
Ptgis^em1(IMPC)Mbp/Ptgis^em1(IMPC)Mbp (C57BL/6N-Ptgis^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	decreased mean corpuscular volume	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
	increased red blood cell distribution width	J:211773
Ptgs1^tm1Fun/Ptgs1^tm1Fun (involves: 129S6/SvEvTac * C57BL/6)	decreased platelet aggregation	J:97351
Ptgs1^tm1Unc/Ptgs1^tm1Unc (involves: 129P2/OlaHsd * C57BL/6)	decreased platelet aggregation	J:29511
	enlarged spleen	J:60668
Ptgs2^tm1Fun/Ptgs2^tm1Fun (involves: 129S6/SvEvTac * C57BL/6)	abnormal platelet physiology	J:108957
Ptgs2^tm1Jed/Ptgs2^tm1Jed (involves: 129S7/SvEvBrd)	hematopoietic system phenotype	J:29974
Ptgs2^tm1Unc/Ptgs2⁺ (involves: 129/Sv * 129P2/OlaHsd * C57BL/6)	abnormal osteoclast differentiation	J:124756
Ptgs2^tm1Unc/Ptgs2^tm1Unc (involves: 129P2/OlaHsd * C57BL/6J)	abnormal macrophage physiology	J:29510
	spleen hyperplasia	J:29510
Ptgs2^tm1Unc/Ptgs2^tm1Unc (D1.129P2(B6J)-Ptgs2^tm1Unc)	decreased hematocrit	J:102777
Ptgs2^tm1Unc/Ptgs2^tm1Unc (involves: 129/Sv * 129P2/OlaHsd * C57BL/6)	abnormal osteoclast differentiation	J:124756
	decreased platelet calcium level	J:124756
Ptgs2^tm1Unc/Ptgs2^tm1Unc (involves: 129P2/OlaHsd * C57BL/6)	anemia	J:60668
	decreased hematocrit	J:60668
	enlarged spleen	J:60668
	increased leukocyte cell number	J:60668
Ptgs2^tm1Unc/Ptgs2^tm1Unc (B6.129P2-Ptgs2^tm1Unc)	abnormal class switch recombination	J:140698
	abnormal memory B cell differentiation	J:140698
	decreased IgG1 level	J:140698
	decreased IgG2a level	J:140698
	decreased IgG3 level	J:140698
	increased IgM level	J:140698
Ptgs2^{tm2(Ptgs1)Fun}/Ptgs2^{tm2(Ptgs1)Fun} (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal macrophage physiology	J:118171
Ptgs2^{tm2.1(Ptgs1)Fun}/Ptgs2^{tm2.1(Ptgs1)Fun} (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB)	abnormal macrophage physiology	J:118171
Ptgs2^tm3Fun/Ptgs2^tm3Fun (involves: 129S6/SvEvTac * C57BL/6J)	increased platelet aggregation	J:148699
Ptgs2os^tm1Scrp/Ptgs2os^tm1Scrp (Not Specified)	decreased neutrophil cell number	J:325487
Pth1r^{tm1a(EUCOMM)Hmgu}/Pth1r^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Pth1r^{tm1a(EUCOMM)Hmgu}/Wtsi)	abnormal thymus morphology	J:239583
Pth^tm1Dgo/Pth^tm1Dgo (involves: 129S2/SvPas * C57BL/6J)	abnormal osteoclast morphology	J:76407
Pth^tm1Dgo/Pth^tm1Dgo (involves: 129S2/SvPas * C57BL/6J)	decreased osteoclast cell number	J:76407
Pth^tm1Dgo/Pth^tm1Dgo Pthlh^tm1Hmk/Pthlh^tm1Hmk (involves: 129S2/SvPas * C57BL/6J)	abnormal osteoclast morphology	J:76407
	decreased osteoclast cell number	J:76407
Pthlh^tm1Ack/Pthlh^tm1Ack Tg(Col1a1-cre)1Ack/0 (involves: 129S1/Sv * 129X1/SvJ * FVB/N)	abnormal osteoclast morphology	J:100918
	decreased osteoclast cell number	J:100918
Pthlh^tm1Ack/Pthlh^tm1Hmk Tg(LGB-cre)74Acl/0 (involves: 129 * C57BL/6 * CBA)	abnormal osteoclast morphology	J:86536
Pthlh^tm1Hmk/Pthlh⁺ (involves: 129S2/SvPas)	abnormal osteoclast morphology	J:100918
Pthlh^tm1Hmk/Pthlh^tm1Hmk (involves: 129S2/SvPas * C57BL/6J)	abnormal osteoclast morphology	J:76407
	decreased osteoclast cell number	J:76407
Pthlh^tm2Ack/Pthlh^tm2Ack (involves: 129S2/SvPas * C57BL/6)	decreased osteoclast cell number	J:142669
Ptk2b^tm1Schl/Ptk2b^tm1Schl (involves: 129S1/Sv * 129X1/SvJ)	abnormal macrophage physiology	J:99741
	impaired macrophage chemotaxis	J:99741
Ptn^tm1Tmu/Ptn^tm1Tmu (B6.Cg-Ptn^tm1Tmu)	decreased macrophage cell number	J:102069
	impaired macrophage chemotaxis	J:102069
	impaired neutrophil recruitment	J:102069
Ptp4a1^em2(IMPC)Tcp/Ptp4a1^em2(IMPC)Tcp (C57BL/6NCrl-Ptp4a1^em2(IMPC)Tcp/Tcp)	small spleen	J:211773
Ptp4a2^em1(IMPC)Tcp/Ptp4a2^em1(IMPC)Tcp (C57BL/6N-Ptp4a2^em1(IMPC)Tcp/Tcp)	decreased mean corpuscular volume	J:211773
	increased mean platelet volume	J:211773
Ptp4a2^{Gt(AQ0673)Wtsi}/Ptp4a2^{Gt(AQ0673)Wtsi} (involves: 129P2/OlaHsd * C57BL/6)	decreased spleen weight	J:190411
Ptp4a3^em1(IMPC)Mbp/Ptp4a3^em1(IMPC)Mbp (C57BL/6N-Ptp4a3^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	small spleen	J:211773
Ptpmt1^tm2.1Ckq/Ptpmt1^tm2.1Ckq Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * SJL)	hematopoietic system phenotype	J:194929
Ptpmt1^tm2.1Ckq/Ptpmt1^tm2.1Ckq Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * SJL)	hematopoietic system phenotype	J:194929
Ptpmt1^tm2.1Ckq/Ptpmt1^tm2.1Ckq Tg(Lck-cre)1Cwi/0 (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * SJL)	hematopoietic system phenotype	J:194929
Ptpmt1^tm2.1Ckq/Ptpmt1^tm2.1Ckq Tg(Mx1-cre)1Cgn/0 (involves: 129S6/SvEvTac * C57BL/6 * CBA * SJL)	abnormal common lymphocyte progenitor cell morphology	J:194929
	abnormal hematopoietic stem cell physiology	J:194929
	anemia	J:194929
	decreased common myeloid progenitor cell number	J:194929
	hematopoietic system phenotype	J:194929
	increased hematopoietic stem cell number	J:194929
	pancytopenia	J:194929
Ptpmt1^tm2.1Ckq/Ptpmt1^tm2.1Ckq Tg(VAV1-cre)1Graf/0 (involves: 129S6/SvEvTac * C57BL/6J * SJL)	anemia	J:194929
	decreased bone marrow cell number	J:194929
	impaired hematopoiesis	J:194929
	increased hematopoietic stem cell number	J:194929
	pancytopenia	J:194929
	small spleen	J:194929
	small thymus	J:194929
Ptpn2^tm1.1Kry/Ptpn2^tm1.1Kry Tg(Col1a1-cre)1Kry/0 (involves: 129 * C57BL/6J * FVB)	abnormal osteoclast differentiation	J:183709
	abnormal osteoclast physiology	J:183709
Ptpn2^tm1.1Ttig/Ptpn2^tm1.1Ttig Tg(Nes-cre)1Kln/0 (involves: C57BL/6 * C57BL/6J * SJL)	decreased bone marrow cell number	J:179621
Ptpn2^{tm1a(EUCOMM)Wtsi}/Ptpn2⁺ (C57BL/6N-Ptpn2^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased hemoglobin content	J:175295
	increased mean corpuscular hemoglobin	J:175295
Ptpn2^tm1Mtr/Ptpn2^tm1Mtr (involves: 129S4/SvJae * BALB/c)	abnormal B cell number	J:42595
	abnormal bone marrow cell morphology/development	J:42595
	abnormal erythropoiesis	J:42595
	abnormal spleen morphology	J:42595
	abnormal thymus involution	J:42595
	anemia	J:42595
	decreased B cell number	J:42595
	decreased double-positive T cell number	J:42595
	decreased hematocrit	J:42595
	enlarged spleen	J:42595
	increased B cell number	J:42595
	increased macrophage cell number	J:42595
	increased mature B cell number	J:42595
	increased pre-B cell number	J:42595
	increased spleen red pulp amount	J:42595
	spleen hyperplasia	J:42595
Ptpn2^tm1Mtr/Ptpn2^tm1Mtr (C.129S4-Ptpn2^tm1Mtr)	abnormal bone marrow cell number	J:186843
	abnormal negative T cell selection	J:186843
	abnormal positive T cell selection	J:186843
	abnormal T cell differentiation	J:186843
	abnormal T cell subpopulation ratio	J:186843
	decreased B cell number	J:186843
	decreased B-1 B cell number	J:186843
	decreased bone marrow cell number	J:186843
	decreased CD4-positive, alpha-beta T cell number	J:186843
	decreased double-positive T cell number	J:186843
	decreased erythrocyte cell number	J:186843
	decreased erythroid progenitor cell number	J:186843
	decreased follicular B cell number	J:186843
	decreased immature B cell number	J:186843
	decreased marginal zone B cell number	J:186843
	decreased mature B cell number	J:186843
	decreased single-positive T cell number	J:186843
	decreased T cell number	J:186843
	decreased thymocyte number	J:186843
	enlarged spleen	J:186843
	increased splenocyte number	J:186843
	thymus atrophy	J:186843
Ptpn2^tm1Mtr/Ptpn2^tm1Mtr (B6.129S4(C)-Ptpn2^tm1Mtr)	abnormal bone marrow cell number	J:186843
	decreased B cell number	J:186843
	decreased B-1 B cell number	J:186843
	decreased bone marrow cell number	J:186843
	decreased CD4-positive, alpha-beta T cell number	J:186843
	decreased double-positive T cell number	J:186843
	decreased erythrocyte cell number	J:186843
	decreased erythroid progenitor cell number	J:186843
	decreased follicular B cell number	J:186843
	decreased immature B cell number	J:186843
	decreased marginal zone B cell number	J:186843
	decreased mature B cell number	J:186843
	decreased single-positive T cell number	J:186843
	decreased T cell number	J:186843
	decreased thymocyte number	J:186843
	hematopoietic system phenotype	J:186843
	thymus atrophy	J:186843
Ptpn2^tm2.1Ttig/Ptpn2^tm2.1Ttig (B6.Cg-Ptpn2^tm2.1Ttig)	abnormal bone marrow cell number	J:186843
	abnormal negative T cell selection	J:186843
	abnormal positive T cell selection	J:186843
	abnormal T cell differentiation	J:186843
	abnormal T cell subpopulation ratio	J:186843
	decreased B cell number	J:186843
	decreased B-1 B cell number	J:186843
	decreased bone marrow cell number	J:186843
	decreased CD4-positive, alpha-beta T cell number	J:186843
	decreased double-positive T cell number	J:186843
	decreased erythrocyte cell number	J:186843
	decreased erythroid progenitor cell number	J:186843
	decreased follicular B cell number	J:186843
	decreased immature B cell number	J:186843
	decreased marginal zone B cell number	J:186843
	decreased mature B cell number	J:186843
	decreased single-positive T cell number	J:186843
	decreased thymocyte number	J:186843
	hematopoietic system phenotype	J:186843
	thymus atrophy	J:186843
Ptpn6^em1.1Shoy/Ptpn6^em1.1Shoy (involves: C57BL/6)	decreased thymocyte number	J:236298
Ptpn6^m1Anu/Ptpn6^m1Anu (C57BL/6JAnu-Ptpn6^m1Anu)	decreased IgM level	J:225105
Ptpn6^m1Btlr/Ptpn6^m1Btlr (C57BL/6J-Ptpn6^m1Btlr/Mmucd)	abnormal myeloid leukocyte morphology	J:142845
	decreased mature B cell number	J:142845
	enlarged spleen	J:94077, J:142845
	increased erythroid progenitor cell number	J:142845
	increased IgM level	J:142845
	increased neutrophil cell number	J:142845
Ptpn6^m3Btlr/Ptpn6⁺ (C57BL/6J-Ptpn6^m3Btlr)	abnormal CD8-positive, alpha beta T cell morphology	J:234259
	decreased B cell number	J:234259
	decreased B-2 B cell number	J:234259
	decreased immature B cell number	J:234259
	decreased mature B cell number	J:234259
	increased B-1 B cell number	J:234259
	increased B-1a cell number	J:234259
	increased dendritic cell number	J:234259
	increased macrophage cell number	J:234259
Ptpn6^m3Btlr/Ptpn6^m3Btlr (C57BL/6J-Ptpn6^m3Btlr)	abnormal CD8-positive, alpha beta T cell morphology	J:234259
	decreased B cell number	J:234259
	decreased B-2 B cell number	J:234259
	decreased immature B cell number	J:234259
	decreased mature B cell number	J:234259
	increased B-1 B cell number	J:234259
	increased B-1b cell number	J:234259
	increased dendritic cell number	J:234259
	increased macrophage cell number	J:234259
Ptpn6^m4Btlr/Ptpn6^m4Btlr (C57BL/6J-Ptpn6^m4Btlr)	decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:264807
	decreased CD8-positive, naive alpha-beta T cell number	J:264807
	increased B-1 B cell number	J:264807
	increased CD8-positive, alpha-beta memory T cell number	J:264807
	increased central memory CD8 positive, alpha-beta T cell number	J:264807
	increased effector memory CD4-positive, alpha-beta T cell number	J:264807
	increased effector memory CD8-positive, alpha-beta T cell number	J:264807
Ptpn6^M5Btlr/Ptpn6^M5Btlr (C57BL/6J-Ptpn6^M5Btlr)	decreased B cell number	J:265075
	decreased B-1 B cell number	J:265075
	decreased CD8-positive, naive alpha-beta T cell number	J:265075
	decreased IgD level	J:265075
	decreased IgM level	J:265075
	increased central memory CD8 positive, alpha-beta T cell number	J:265075
Ptpn6^m6Btlr/Ptpn6^m6Btlr (C57BL/6J-Ptpn6^m6Btlr)	abnormal CD8-positive, alpha-beta T cell differentiation	J:272439
Ptpn6^m6Btlr/Ptpn6^m6Btlr (C57BL/6J-Ptpn6^m6Btlr)	abnormal T cell differentiation	J:272439
Ptpn6^m7Btlr/Ptpn6^m7Btlr (C57BL/6J-Ptpn6^m7Btlr)	abnormal T cell differentiation	J:272440
Ptpn6^me-B2/Ptpn6^me-B2 (involves: BALB/c)	abnormal bone marrow cell physiology	J:169850
	increased IgG level	J:169850
	increased IgM level	J:169850
	increased neutrophil cell number	J:169850
	small thymus	J:169850
Ptpn6^me-v/Ptpn6⁺ Tg(IghelMD4)4Ccg/0 (involves: 129P2/OlaHsd * C57BL/6)	abnormal mature B cell morphology	J:110531
Ptpn6^me-v/Ptpn6^me-v (C57BL/6J-Ptpn6^me-v)	abnormal immunoglobulin level	J:7665
	abnormal plasma cell morphology	J:14936
	abnormal T cell physiology	J:1661
	abnormal thymus development	J:16613
	decreased B cell number	J:113218
	decreased mature B cell number	J:7905
	increased plasma cell number	J:7905
Ptpn6^me/Ptpn6^me (C57BL/6J-Ptpn6^me/J)	abnormal granulocyte morphology	J:5579
	abnormal leukocyte cell number	J:5579
	abnormal thymus morphology	J:5579
	enlarged spleen	J:5579
	increased granulocyte number	J:5579
	increased IgA level	J:5579
	increased IgG level	J:5579
	increased IgM level	J:5579
	increased immunoglobulin level	J:5579
	increased leukocyte cell number	J:5579
	increased monocyte cell number	J:5579
	small thymus	J:5579
Ptpn6^me/Ptpn6^me (involves: C3H/HeN * C57BL/6J * NFS)	increased IgM level	J:30994
Ptpn6^me/Ptpn6^me (involves: C3H/HeN * C57BL/6J * NFS)	increased splenocyte proliferation	J:30994
Ptpn6^me/Ptpn6^me (involves: C3HeB/FeJ * C57BL/6)	abnormal microglial cell morphology	J:72655
Ptpn6^me/Ptpn6^me (C3FeLe.B6 a/a-Ptpn6^me/J)	increased microglial cell activation	J:88807
Ptpn6^me/Ptpn6^me (either: (involves: C3H * C57BL/6J) or (involves: C57BL/6J * C57BL/6N))	thymus atrophy	J:5999
Ptpn7^tm1Bwz/Ptpn7^tm1Bwz (involves: 129P2/OlaHsd)	hematopoietic system phenotype	J:73798
Ptpn9^tm1Dny/Ptpn9^tm1Dny (B6.129-Ptpn9^tm1Dny)	abnormal platelet physiology	J:118880
	abnormal T cell differentiation	J:118880
	decreased platelet aggregation	J:118880
	decreased T cell proliferation	J:118880
Ptpn11^tm1.1Ics/Ptpn11⁺ (involves: 129S2/SvPas * C57BL/6 * FVB/N)	enlarged spleen	J:216593
Ptpn11^tm1Bgn/Ptpn11⁺ (involves: 129S4/SvJae * C57BL/6J)	enlarged spleen	J:91609
	increased leukocyte cell number	J:91609
	increased lymphocyte cell number	J:91609
	increased neutrophil cell number	J:91609
	myeloid hyperplasia	J:91609
Ptpn11^tm1Bgn/Ptpn11⁺ (involves: 129S4/SvJae * C57BL/6)	abnormal common myeloid progenitor cell morphology	J:147154
Ptpn11^tm1Ckq/Ptpn11⁺ Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J)	myeloid hyperplasia	J:177285
Ptpn11^tm1Ckq/Ptpn11⁺ Tg(Mx1-cre)1Cgn/0 (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * CBA)	abnormal bone marrow cell morphology/development	J:177285
	abnormal hematopoietic stem cell physiology	J:177285
	anemia	J:177285
	arrested B cell differentiation	J:177285
	decreased common myeloid progenitor cell number	J:177285
	decreased hematopoietic stem cell number	J:177285
	enlarged spleen	J:177285
	extramedullary hematopoiesis	J:177285
	increased hematopoietic stem cell number	J:177285
	increased leukocyte cell number	J:177285
	increased neutrophil cell number	J:177285
	increased spleen weight	J:177285
	myeloid hyperplasia	J:177285
Ptpn11^tm4.2Bgn/Ptpn11⁺ (involves: 129S6/SvEvTac * C57BL/6J * FVB/N)	hematopoietic system phenotype	J:172033
Ptpn11^tm6Bgn/Ptpn11⁺ Tg(CAG-cre/Esr1)5Amc/0 (involves: 129S6/SvEvTac C57BL/6 * CBA)	abnormal definitive hematopoiesis	J:148430
	abnormal leukopoiesis	J:148430
Ptpn11^tm6Bgn/Ptpn11⁺ Tg(Mx1-cre)1Cgn/0 (involves: 129S6/SvEvTac * C57BL/6 * CBA)	abnormal bone marrow cell number	J:148430
	abnormal definitive hematopoiesis	J:148430
	abnormal erythropoiesis	J:148430
	abnormal leukopoiesis	J:148430
	abnormal splenic cell ratio	J:148430
	anemia	J:148430
	decreased bone marrow cell number	J:148430
	decreased common myeloid progenitor cell number	J:148430
	decreased granulocyte monocyte progenitor cell number	J:148430
	decreased hematopoietic stem cell number	J:148430
	enlarged spleen	J:148430
	extramedullary hematopoiesis	J:148430
	increased granulocyte number	J:148430
	increased leukocyte cell number	J:148430
	increased monocyte cell number	J:148430
	intermingled spleen red and white pulp	J:148430
Ptpn11^tm7Bgn/Ptpn11⁺ (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6)	abnormal common myeloid progenitor cell morphology	J:147154
Ptpn11^tm7Bgn/Ptpn11^tm7Bgn (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6)	abnormal common myeloid progenitor cell morphology	J:147154
Ptpn12^tm1Vei/Ptpn12^tm1Vei Tg(Cd4-cre)1Cwi/0 (B6.Cg-Tg(Cd4-cre)1Cwi Ptpn12^tm1Vei)	abnormal T cell physiology	J:163910
	decreased T cell proliferation	J:163910
Ptpn13^tm1Gru/Ptpn13^tm1Gru (involves: C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:118426
Ptpn13^tm1Wjh/Ptpn13^tm1Wjh (involves: 129P2/OlaHsd * C57BL/6)	increased T-helper 2 cell number	J:144351
Ptpn18^em1(IMPC)J/Ptpn18⁺ (C57BL/6NJ-Ptpn18^em1(IMPC)J/Mmjax)	decreased erythrocyte cell number	J:211773
Ptpn22^tm1.1Draw/Ptpn22⁺ (involves: 129 * C57BL/6)	abnormal B cell differentiation	J:201448
	abnormal B cell morphology	J:201448
	abnormal B cell number	J:201448
	abnormal B cell physiology	J:201448
	abnormal T cell morphology	J:201448
	abnormal T cell number	J:201448
	abnormal T cell physiology	J:201448
	abnormal thymus morphology	J:201448
	decreased B cell apoptosis	J:201448
	decreased follicular B cell number	J:201448
	decreased mature B cell number	J:201448
	enlarged spleen	J:201448
	increased B cell number	J:201448
	increased B cell proliferation	J:201448
	increased CD4-positive, alpha-beta memory T cell number	J:201448
	increased double-positive T cell number	J:201448
	increased germinal center B cell number	J:201448
	increased IgG1 level	J:201448
	increased regulatory T cell number	J:201448
	increased spleen germinal center size	J:201448
	increased T cell proliferation	J:201448
	increased transitional stage T1 B cell number	J:201448
	spleen hyperplasia	J:201448
	thymus hyperplasia	J:201448
Ptpn22^tm1.1Draw/Ptpn22^tm1.1Draw (involves: 129 * C57BL/6)	abnormal B cell activation	J:201448
	abnormal B cell differentiation	J:201448
	abnormal B cell morphology	J:201448
	abnormal B cell physiology	J:201448
	abnormal T cell differentiation	J:201448
	abnormal T cell morphology	J:201448
	abnormal T cell physiology	J:201448
	abnormal thymus morphology	J:201448
	decreased B cell apoptosis	J:201448
	decreased follicular B cell number	J:201448
	decreased mature B cell number	J:201448
	enlarged spleen	J:201448
	increased B cell number	J:201448
	increased B cell proliferation	J:201448
	increased double-positive T cell number	J:201448
	increased effector memory CD4-positive, alpha-beta T cell number	J:201448
	increased effector memory CD8-positive, alpha-beta T cell number	J:201448
	increased germinal center B cell number	J:201448
	increased IgE level	J:201448
	increased IgG1 level	J:201448
	increased IgG3 level	J:201448
	increased IgM level	J:201448
	increased regulatory T cell number	J:201448
	increased spleen germinal center size	J:201448
	increased T cell proliferation	J:201448
	increased transitional stage T1 B cell number	J:201448
	spleen hyperplasia	J:201448
	thymus hyperplasia	J:201448
Ptpn22^tm1.1Kas/Ptpn22^tm1.1Kas (involves: C57BL/6)	enlarged spleen	J:176519
	enlarged thymus	J:176519
	increased B cell proliferation	J:176519
	increased CD4-positive, alpha-beta T cell number	J:176519
	increased CD8-positive, alpha-beta T cell number	J:176519
	increased dendritic cell number	J:176519
	increased IgG2a level	J:176519
	increased IgG3 level	J:176519
	increased IgM level	J:176519
	increased spleen germinal center number	J:176519
	increased spleen germinal center size	J:176519
	increased T cell number	J:176519
	increased T cell proliferation	J:176519
Ptpn22^tm1.1Kas/Ptpn22^tm1.1Kas Tg(TcraTcrb)425Cbn/0 (involves: BALB/c * C57BL/6)	increased CD4-positive, alpha-beta T cell number	J:176519
	increased T cell proliferation	J:176519
Ptpn22^tm1Achn/Ptpn22^tm1Achn (involves: C57BL/6)	abnormal T cell physiology	J:90029
	enlarged spleen	J:90029
	increased B cell number	J:90029
	increased follicular B cell number	J:90029
	increased IgE level	J:90029
	increased IgG1 level	J:90029
	increased IgG2a level	J:90029
	increased spleen germinal center number	J:90029
Ptpn22^tm2Achn/Ptpn22^tm2Achn (involves: C57BL/6)	abnormal T cell physiology	J:90029
	enlarged spleen	J:90029
	increased B cell number	J:90029
	increased follicular B cell number	J:90029
	increased IgE level	J:90029
	increased IgG1 level	J:90029
	increased IgG2a level	J:90029
	increased spleen germinal center number	J:90029
Ptpn22^tm2Achn/Ptpn22^tm2Achn (B6.Cg-Ptpn22^tm2Achn)	abnormal double-positive T cell morphology	J:147129
	abnormal T cell activation	J:147129
	abnormal T cell subpopulation ratio	J:147129
	abnormal thymocyte activation	J:147129
	increased memory T cell number	J:147129
Ptpn22^tm2Achn/Ptpn22^tm2Achn Ptprc^tm1Weis/Ptprc^tm1Weis (B6.Cg-Ptprc^tm1Weis Ptpn22^tm2Achn)	abnormal B cell activation	J:147129
	abnormal double-positive T cell morphology	J:147129
	abnormal follicular B cell physiology	J:147129
	abnormal lymphocyte cell number	J:147129
	abnormal T cell activation	J:147129
	abnormal T cell subpopulation ratio	J:147129
	abnormal thymocyte activation	J:147129
	decreased follicular B cell number	J:147129
	increased memory T cell number	J:147129
	increased plasma cell number	J:147129
	increased transitional stage B cell number	J:147129
Ptpra^{tm1b(EUCOMM)Hmgu}/Ptpra^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Ptpra^{tm1b(EUCOMM)Hmgu}/Orl)	increased mean corpuscular hemoglobin	J:211773
Ptprc^loc/Ptprc^loc (C57BL/6JSfdAnu-Ptprc^loc/AnuApb)	abnormal B cell number	J:104190
	abnormal double-positive T cell morphology	J:104190
	abnormal memory T cell number	J:104190
	abnormal T cell morphology	J:104190
	abnormal T cell selection	J:104190
	abnormal thymocyte activation	J:104190
	arrested T cell differentiation	J:104190
	decreased CD4-positive, alpha-beta T cell number	J:104190
	decreased CD8-positive, alpha-beta T cell number	J:104190
	decreased double-positive T cell number	J:104190
	decreased T cell number	J:104190
Ptprc^ltng/Ptprc^ltng (C57BL/6-Ptprc^ltng)	abnormal T cell differentiation	J:158876
	decreased CD4-positive, alpha-beta T cell number	J:158876
	decreased double-positive T cell number	J:158876
	thymus hypoplasia	J:158876
Ptprc^ltng/Ptprc^tm1Mak (involves: 129/Sv * C57BL/6)	abnormal T cell differentiation	J:158876
	decreased CD4-positive, alpha-beta T cell number	J:158876
	decreased double-positive T cell number	J:158876
	thymus hypoplasia	J:158876
Ptprc^ltng/Ptprc^tm1Mak Tg(TcraTcrb)425Cbn/0 (involves: 129/Sv * BALB/c * C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:158876
	thymus hypoplasia	J:158876
Ptprc^m1Btlr/Ptprc^m1Btlr (involves: C57BL/6J)	absent T cells	J:152064
Ptprc^m1Smv/Ptprc^m1Smv (involves: C57BL/6J * C57BL/10J)	abnormal CD4-positive T cell differentiation	J:214487
	abnormal CD8-positive, alpha-beta T cell differentiation	J:214487
	decreased DN4 thymocyte number	J:214487
	increased DN3 thymocyte number	J:214487
	increased double-negative T cell number	J:214487
Ptprc^m2Btlr/Ptprc^m2Btlr (C57BL/6J-Ptprc^m2Btlr)	decreased B-1a cell number	J:216796
	decreased B-2 B cell number	J:216796
	decreased CD4-positive, alpha-beta memory T cell number	J:216796
	decreased CD8-positive, alpha-beta memory T cell number	J:216796
	decreased mature B cell number	J:216796
	decreased memory B cell number	J:216796
	decreased memory T cell number	J:216796
	decreased single-positive T cell number	J:216796
	increased B-1 B cell number	J:216796
	increased B-1b cell number	J:216796
	increased dendritic cell number	J:216796
	increased neutrophil cell number	J:216796
	increased single-positive T cell number	J:216796
Ptprc^m3Btlr/Ptprc^m3Btlr (C57BL/6J-Ptprc^m3Btlr)	decreased B cell number	J:254899
	decreased B-1a cell number	J:254899
	decreased B-2 B cell number	J:254899
	decreased CD8-positive, alpha-beta T cell number	J:254899
	increased B-1b cell number	J:254899
Ptprc^m4Btlr/Ptprc^m4Btlr (C57BL/6J-Ptprc^m4Btlr)	decreased B cell number	J:264808
	decreased CD4-positive, alpha-beta T cell number	J:264808
	decreased CD8-positive, alpha-beta T cell number	J:264808
	decreased CD8-positive, naive alpha-beta T cell number	J:264808
	decreased single-positive T cell number	J:264808
	decreased T cell number	J:264808
	increased B-1 B cell number	J:264808
	increased central memory CD4-positive, alpha-beta T cell number	J:264808
	increased central memory CD8 positive, alpha-beta T cell number	J:264808
	increased effector memory CD4-positive, alpha-beta T cell number	J:264808
	increased effector memory CD8-positive, alpha-beta T cell number	J:264808
Ptprc^M5Btlr/Ptprc^M5Btlr (C57BL/6J-Ptprc^M5Btlr)	increased alpha-beta T cell number	J:265143
Ptprc^M6Btlr/Ptprc^M6Btlr (C57BL/6J-Ptprc^M6Btlr)	decreased B-1a cell number	J:265186
	decreased B-1b cell number	J:265186
	decreased CD8-positive, naive alpha-beta T cell number	J:265186
	increased B-1 B cell number	J:265186
Ptprc^m7Btlr/Ptprc^m7Btlr (C57BL/6J-Ptprc^m7Btlr)	decreased alpha-beta T cell number	J:267486
	decreased B cell number	J:267486
	decreased CD4-positive, alpha-beta T cell number	J:267486
	decreased CD8-positive, alpha-beta T cell number	J:267486
	decreased CD8-positive, naive alpha-beta T cell number	J:267486
	decreased NK T cell number	J:267486
	increased B-1 B cell number	J:267486
	increased central memory CD4-positive, alpha-beta T cell number	J:267486
	increased central memory CD8 positive, alpha-beta T cell number	J:267486
	increased effector memory CD4-positive, alpha-beta T cell number	J:267486
	increased effector memory CD8-positive, alpha-beta T cell number	J:267486
Ptprc^M8Btlr/Ptprc^M8Btlr (C57BL/6J-Ptprc^M8Btlr)	increased B-1 B cell number	J:267487
Ptprc^M8Btlr/Ptprc^M8Btlr (C57BL/6J-Ptprc^M8Btlr)	increased central memory CD8 positive, alpha-beta T cell number	J:267487
Ptprc^M9Btlr/Ptprc^M9Btlr (C57BL/6J-Ptprc^M9Btlr)	abnormal B cell differentiation	J:272745
	abnormal CD8-positive, alpha beta T cell morphology	J:272745
	abnormal lymphocyte morphology	J:272745
	decreased B cell number	J:272745
	decreased NK cell number	J:272745
	increased CD8-positive, alpha-beta T cell number	J:272745
	increased effector memory CD4-positive, alpha-beta T cell number	J:272745
Ptprc^M10Btlr/Ptprc^M10Btlr (C57BL/6J-Ptprc^M10Btlr)	decreased B-1b cell number	J:272777
Ptprc^M10Btlr/Ptprc^M10Btlr (C57BL/6J-Ptprc^M10Btlr)	decreased IgE level	J:272777
Ptprc^M11Btlr/Ptprc^M11Btlr (C57BL/6J-Ptprc^M11Btlr)	abnormal B cell differentiation	J:274863
	abnormal CD8-positive, alpha-beta T cell differentiation	J:274863
	increased B-1 B cell number	J:274863
Ptprc^m12Btlr/Ptprc^m12Btlr (C57BL/6J-Ptprc^m12Btlr)	decreased B cell number	J:274972
	decreased CD4-positive, alpha-beta T cell number	J:274972
	decreased CD8-positive, alpha-beta T cell number	J:274972
	decreased CD8-positive, naive alpha-beta T cell number	J:274972
	decreased central memory CD8 positive, alpha-beta T cell number	J:274972
	decreased effector memory CD4-positive, alpha-beta T cell number	J:274972
	decreased T cell number	J:274972
	increased B-1 B cell number	J:274972
Ptprc^nim/Ptprc^nim (C57BL/6JAnu-Ptprc^nim)	decreased B cell number	J:225105
	decreased leukocyte cell number	J:225105
	decreased T cell number	J:225105
Ptprc^rain/Ptprc^rain (C57BL/6JAnu-Ptprc^rain/AnuApb)	abnormal leukocyte morphology	J:104190
Ptprc^strm/Ptprc^strm (C57BL/6JAnu-Ptprc^strm/AnuApb)	decreased B cell number	J:104190
Ptprc^strm/Ptprc^strm (C57BL/6JAnu-Ptprc^strm/AnuApb)	decreased T cell number	J:104190
Ptprc^tm1Holm/Ptprc^tm1Holm (involves: 129/Sv * C57BL/6)	abnormal B cell number	J:33466
	abnormal lymphopoiesis	J:33466
	abnormal T cell differentiation	J:33466
	decreased CD4-positive, alpha-beta T cell number	J:33466
	decreased CD8-positive, alpha-beta T cell number	J:33466
	decreased double-positive T cell number	J:33466
	decreased T cell number	J:33466
	decreased thymocyte number	J:33466
	increased double-negative T cell number	J:33466
	spleen hyperplasia	J:33466
Ptprc^tm1Holm/Ptprc^tm1Holm Tg(LckF505)2964Rmp/? (involves: 129/Sv C57BL/6 * DBA/2)	thymus hyperplasia	J:64671
Ptprc^tm1Holm/Ptprc^tm1Holm Tg(LckF505)3073Rmp/? (involves: 129/Sv C57BL/6 * DBA/2)	thymus hyperplasia	J:64671
Ptprc^tm1Mak/Ptprc^tm1Mak (involves: 129/Sv * C57BL/6)	abnormal T cell subpopulation ratio	J:13163
	arrested T cell differentiation	J:158876
	decreased B cell proliferation	J:13163
	decreased CD4-positive, alpha-beta T cell number	J:13163
	decreased CD8-positive, alpha-beta T cell number	J:13163
	decreased cytotoxic T cell cytolysis	J:13163
	decreased T cell number	J:13163
	decreased T cell proliferation	J:13163
	decreased thymocyte number	J:13163
	increased double-negative T cell number	J:13163
Ptprc^tm1Mak/Ptprc^tm1Mak (involves: 129)	abnormal bone marrow cell morphology/development	J:141275
	abnormal osteoclast morphology	J:141275
	abnormal osteoclast physiology	J:141275
	decreased mast cell degranulation	J:110782
Ptprc^tm1Mak/Ptprc^tm1Mak (B6.Cg-Ptprc^tm1Mak)	abnormal CD4-positive, alpha-beta intraepithelial T cell morphology	J:111646
	abnormal intraepithelial T cell morphology	J:111646
	abnormal intraepithelial T cell number	J:111646
	abnormal NK cell physiology	J:109462
	abnormal T cell differentiation	J:111646
	decreased cytotoxic T cell cytolysis	J:111646
	decreased gamma-delta intraepithelial T cell number	J:111646
	increased T cell apoptosis	J:111646
Ptprc^tm1Mak/Ptprc^tm1Mak Ptprj^tm1.2Weis/Ptprj^tm1.2Weis (involves: 129/Sv * 129P2/OlaHsd * BALB/cJ * C57BL/6)	abnormal B cell physiology	J:131736
	abnormal follicular B cell morphology	J:131736
	abnormal myelopoiesis	J:131736
	decreased B cell number	J:131736
	impaired macrophage phagocytosis	J:131736
Ptprc^tm1Mak/Ptprc^tm1Mak Ptprj^tm1.2Weis/Ptprj^tm1.2Weis (B6.Cg-Ptprc^tm1Mak Ptprj^tm1.2Weis)	abnormal B cell differentiation	J:131736
	abnormal follicular B cell morphology	J:131736
	abnormal myelopoiesis	J:131736
	abnormal spleen morphology	J:131736
	abnormal transitional stage B cell morphology	J:131736
	anemia	J:131736
	decreased B cell number	J:131736
	decreased immature B cell number	J:131736
	decreased mature B cell number	J:131736
	extramedullary hematopoiesis	J:131736
Ptprc^tm1Mak/Ptprc^tm1Mak Tg(TcraTcrb)425Cbn/0 (involves: 129/Sv * BALB/c * C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:158876
Ptprc^tm1Tyb/Ptprc^tm1Tyb (C.129S2-Ptprc^tm1Tyb)	abnormal positive T cell selection	J:57681
	abnormal T cell differentiation	J:57681
	abnormal T cell physiology	J:57681
	decreased CD4-positive, alpha-beta T cell number	J:57681
	decreased CD8-positive, alpha-beta T cell number	J:57681
	decreased double-positive T cell number	J:57681
	enlarged spleen	J:57681
	hematopoietic system phenotype	J:57681
	increased double-negative T cell number	J:57681
	thymus hypoplasia	J:57681
Ptprc^tm1Tyb/Ptprc^tm1Tyb (B6.129S2-Ptprc^tm1Tyb)	abnormal NK cell physiology	J:98190
Ptprc^tm1Tyb/Ptprc^tm1Tyb (B6.129S2-Ptprc^tm1Tyb)	increased NK cell number	J:98190
Ptprc^tm1Weis/Ptprc⁺ (involves: 129X1/SvJ * C57BL/6)	increased IgG2a level	J:66501
Ptprc^tm1Weis/Ptprc^tm1Weis (involves: 129X1/SvJ * C57BL/6)	abnormal B cell activation	J:66501
	abnormal erythropoiesis	J:66501
	abnormal granulocyte differentiation	J:66501
	abnormal leukocyte cell number	J:66501
	abnormal T cell activation	J:66501
	enlarged spleen	J:66501
	extramedullary hematopoiesis	J:66501
	increased B cell number	J:66501
	increased IgA level	J:66501
	increased IgG2a level	J:66501
	increased plasmacytoid dendritic cell number	J:66501
	increased spleen red pulp amount	J:66501
	increased spleen white pulp amount	J:66501
	increased T cell number	J:66501
Ptprc^tm1Weis/Ptprc^tm1Weis (B6.129X1-Ptprc^tm1Weis)	abnormal B cell activation	J:147129
	abnormal double-positive T cell morphology	J:147129
	abnormal follicular B cell physiology	J:147129
	abnormal T cell activation	J:147129
	abnormal T cell subpopulation ratio	J:147129
	abnormal thymocyte activation	J:147129
	decreased follicular B cell number	J:147129
	increased memory T cell number	J:147129
	increased plasma cell number	J:147129
	increased transitional stage B cell number	J:147129
Ptprcap^tm1Tkda/Ptprcap^tm1Tkda (involves: 129X1/SvJ)	abnormal cytotoxic T cell physiology	J:48387
	decreased B cell proliferation	J:48387
	decreased T cell proliferation	J:48387
Ptprd^{tm2a(KOMP)Wtsi}/Ptprd^{tm2a(KOMP)Wtsi} (C57BL/6N-Ptprd^{tm2a(KOMP)Wtsi}/Wtsi)	increased leukocyte cell number	J:211773
Ptpre^tm1Ael/Ptpre^tm1Ael (involves: 129S6/SvEvTac * C57BL/6)	abnormal osteoclast differentiation	J:90031
	abnormal osteoclast physiology	J:90031
Ptprj^tm1.2Weis/Ptprj^tm1.2Weis (involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)	abnormal B cell differentiation	J:131736
	abnormal splenic cell ratio	J:131736
	increased B-2 B cell number	J:131736
	increased marginal zone B cell number	J:131736
Ptprs^{tm1b(KOMP)Mbp}/Ptprs⁺ (C57BL/6N-Ptprs^{tm1b(KOMP)Mbp}/Tcp)	increased mean platelet volume	J:211773
Ptrh2^tm1.1Eruo/Ptrh2^tm1.1Eruo (C57BL/6-Ptrh2^tm1.1Eruo)	decreased neutrophil cell number	J:131853
Pts^{tm1b(EUCOMM)Wtsi}/Pts⁺ (C57BL/6N-Pts^{tm1b(EUCOMM)Wtsi}/H)	increased large unstained cell number	J:211773
Pttg1^{tm1b(EUCOMM)Wtsi}/Pttg1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Pttg1^{tm1b(EUCOMM)Wtsi}/Tcp)	small spleen	J:211773
Pttg1^tm1Sme/Pttg1^tm1Sme (involves: 129S4/SvJae * C57BL/6)	decreased IgG level	J:72267
	decreased IgM level	J:72267
	decreased immunoglobulin level	J:72267
	decreased spleen weight	J:72267
	increased T cell number	J:72267
	thrombocytopenia	J:72267
	thymus hyperplasia	J:72267
Ptx3^tm1Mant/Ptx3^tm1Mant (either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))	abnormal macrophage physiology	J:85080
	abnormal T-helper 1 physiology	J:85080
	impaired macrophage phagocytosis	J:85080
Puf60^tm1.1Kmtsu/Puf60⁺ Trp53^tm1Sia/Trp53^tm1Sia (involves: C57BL/6NCrlj * C57BL/6NCrSlc * CBA/JNCrlj)	decreased erythrocyte cell number	J:233347
	increased leukocyte cell number	J:233347
	increased spleen weight	J:233347
	increased thymus weight	J:233347
	thrombocytopenia	J:233347
Pum1^em1(IMPC)Mbp/Pum1^em1(IMPC)Mbp (C57BL/6NCrl-Pum1^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Pum2^{tm1b(KOMP)Wtsi}/Pum2^{tm1b(KOMP)Wtsi} (C57BL/6N-Pum2^{tm1b(KOMP)Wtsi}/Tcp)	increased mean platelet volume	J:211773
Pura^tm1Kkh/Pura^tm1Kkh (involves: 129)	abnormal spleen morphology	J:85759
	abnormal thymus morphology	J:85759
	decreased spleen weight	J:85759
	reticulocytopenia	J:85759
	small spleen	J:85759
Pvr^tm1Gbn/Pvr^tm1Gbn (either: (involves: 129S2/SvPas) or (involves: 129S2/SvPas * BALB/c))	decreased IgA level	J:123540
	decreased IgG1 level	J:123540
	decreased IgG2a level	J:123540
	decreased IgG2b level	J:123540
	decreased IgG level	J:123540
Pvrig^tm1.2Sgng/Pvrig^tm1.2Sgng (B6(Cg)-Pvrig^tm1.1Sgng)	abnormal CD8-positive, alpha-beta T cell physiology	J:324171
Pvrig^tm1.2Sgng/Pvrig^tm1.2Sgng (B6(Cg)-Pvrig^tm1.1Sgng)	abnormal T cell physiology	J:324171
Pwwp3a^em1(IMPC)Tcp/Pwwp3a^em1(IMPC)Tcp (C57BL/6NCrl-Pwwp3a^em1(IMPC)Tcp/Tcp)	small thymus	J:211773
	thrombocytosis	J:211773
Pxdc1^{tm1e.1(KOMP)Wtsi}/Pxdc1^{tm1e.1(KOMP)Wtsi} (C57BL/6N-Pxdc1^{tm1e.1(KOMP)Wtsi}/Tcp)	increased red blood cell distribution width	J:211773
Pxk^em1(IMPC)Tcp/Pxk^em1(IMPC)Tcp (C57BL/6N-Pxk^em1(IMPC)Tcp/Tcp)	decreased mean corpuscular hemoglobin concentration	J:211773
Pxylp1^{tm1a(KOMP)Wtsi}/Pxylp1^{tm1a(KOMP)Wtsi} (B6JTyr;B6N-Pxylp1^{tm1a(KOMP)Wtsi}/Wtsi)	decreased mean corpuscular hemoglobin	J:175295
Pycard^tm1Flv/Pycard^tm1Flv (involves: 129S5/SvEvBrd * C57BL/6)	abnormal macrophage physiology	J:113333
	decreased NK cell number	J:158969
Pycard^tm1Flv/Pycard^tm1Flv (B6.129S5-Pycard^tm1Flv)	increased IgA level	J:173245
Pycard^tm1Flv/Pycard^tm1Flv (B6.129S5-Pycard^tm1Flv)	increased IgG2c level	J:173245
Pycard^tm1Vmd/Pycard^tm1Vmd (B6.129-Pycard^tm1Vmd)	abnormal macrophage physiology	J:160545
Pycr2^m1J/Pycr2^m1J (involves: C3H/HeJ * C57BL/6J)	decreased basophil cell number	J:308336
	decreased leukocyte cell number	J:308336
	decreased lymphocyte cell number	J:308336
Pycr2^{tm1a(EUCOMM)Wtsi}/Pycr2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Pycr2^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased Ly6C low monocyte number	J:211773
	decreased monocyte cell number	J:211773
	increased mean corpuscular hemoglobin	J:211773
Qki^tm1Imeg/Qki^tm1Imeg (involves: 129P2/OlaHsd)	abnormal hematopoietic system morphology/development	J:88215
Qpct^tm1.1Gne/Qpct^tm1.1Gne Qpctl^tm1.1Gne/Qpctl^tm1.1Gne (C57BL/6N-Qpctl^tm1.1Gne Qpct^tm1.1Gne)	decreased monocyte cell number	J:324112
Qpctl^tm1.1Gne/Qpctl^tm1.1Gne (C57BL/6N-Qpctl^tm1.1Gne)	decreased monocyte cell number	J:324112
Qpctl^tm1.1Gne/Qpctl^tm1.1Gne (C57BL/6N-Qpctl^tm1.1Gne)	increased monocyte cell number	J:324112
Qprt^{Gt(OST337946)Lex}/Qprt^{Gt(OST337946)Lex} (involves: 129S5/SvEvBrd * C57BL/6J)	abnormal macrophage morphology	J:282516
	abnormal macrophage physiology	J:282516
Qrich1^b2b2404Clo/Qrich1^b2b2404Clo (C57BL/6J-Qrich1^b2b2404Clo)	thymus hypoplasia	J:175213
Qsox1^b2b2673Clo/Qsox1^b2b2673Clo (C57BL/6J-Qsox1^b2b2673Clo)	spleen hypoplasia	J:175213
R3hcc1l^{tm1b(KOMP)Wtsi}/R3hcc1l^{tm1b(KOMP)Wtsi} (C57BL/6N-R3hcc1l^{tm1b(KOMP)Wtsi}/J)	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
Rab2a^em2(IMPC)Tcp/Rab2a⁺ (C57BL/6NCrl-Rab2a^em2(IMPC)Tcp/Tcp)	decreased erythrocyte cell number	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
	increased red blood cell distribution width	J:211773
	increased spleen weight	J:211773
Rab3c^{tm1b(EUCOMM)Wtsi}/Rab3c^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Rab3c^{tm1b(EUCOMM)Wtsi}/J)	increased erythrocyte cell number	J:211773
Rab3gap1^em1(IMPC)J/Rab3gap1^em1(IMPC)J (C57BL/6NJ-Rab3gap1^em1(IMPC)J/Mmjax)	decreased mean corpuscular hemoglobin	J:211773
Rab3gap2^{tm1b(KOMP)Wtsi}/Rab3gap2^{tm1b(KOMP)Wtsi} (C57BL/6N-Rab3gap2^{tm1b(KOMP)Wtsi}/J)	decreased hematocrit	J:211773
	thrombocytopenia	J:211773
Rab3ip^{tm1.1(KOMP)Vlcg}/Rab3ip^{tm1.1(KOMP)Vlcg} (C57BL/6N-Rab3ip^{tm1.1(KOMP)Vlcg}/J)	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
Rab5a^{tm1b(KOMP)Wtsi}/Rab5a^{tm1b(KOMP)Wtsi} (C57BL/6N-Rab5a^{tm1b(KOMP)Wtsi}/J)	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
	increased erythrocyte cell number	J:211773
Rab7^tm1.1Ale/Rab7^tm1.1Ale Tg(Cd4-cre)1Cwi/? (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)	abnormal T cell morphology	J:211733
	abnormal T cell physiology	J:211733
	abnormal T cell subpopulation ratio	J:211733
	decreased CD4-positive, alpha-beta T cell number	J:211733
	decreased CD8-positive, alpha-beta T cell number	J:211733
	decreased T cell number	J:211733
	decreased T cell proliferation	J:211733
Rab7b^tm1Ciphe/Rab7b^tm1Ciphe Tg(Itgax-cre)1-1Reiz/0 (involves: C57BL/6N * CBA)	abnormal dendritic cell migration	J:321707
Rab10^em1(IMPC)J/Rab10⁺ (C57BL/6NJ-Rab10^em1(IMPC)J/Mmjax)	decreased mean corpuscular hemoglobin	J:211773
Rab10^em1(IMPC)J/Rab10⁺ (C57BL/6NJ-Rab10^em1(IMPC)J/Mmjax)	decreased mean corpuscular volume	J:211773
Rab11b^em1(IMPC)J/Rab11b^em1(IMPC)J (C57BL/6NJ-Rab11b^em1(IMPC)J/J)	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular hemoglobin concentration	J:211773
	decreased mean corpuscular volume	J:211773
Rab13^tm1.1Ktg/Rab13^tm1.1Ktg (involves: C57BL/6)	abnormal leukocyte adhesion	J:259093
	abnormal T cell physiology	J:259093
	decreased lymphocyte cell number	J:259093
	decreased lymphocyte chemotaxis	J:259093
	impaired leukocyte migration	J:259093
	small spleen	J:259093
Rab19^{tm1b(EUCOMM)Hmgu}/Rab19^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Rab19^{tm1b(EUCOMM)Hmgu}/Ics)	decreased large unstained cell number	J:211773
	increased eosinophil cell number	J:211773
Rab20^{tm1a(EUCOMM)Hmgu}/Rab20^{tm1a(EUCOMM)Hmgu} (involves: C57BL/6N)	abnormal macrophage physiology	J:243883
Rab23^{tm1b(EUCOMM)Wtsi}/Rab23⁺ (C57BL/6N-Rab23^{tm1b(EUCOMM)Wtsi}/H)	increased mean platelet volume	J:211773
Rab27a^ash/Rab27a^ash (involves: C3H/HeDiSn)	abnormal NK cell degranulation	J:111253
	decreased cytotoxic T cell cytolysis	J:111253, J:67600
	decreased platelet dense granule number	J:63231
	decreased platelet serotonin level	J:63231
	impaired natural killer cell mediated cytotoxicity	J:111253
Rab27a^ash/Rab27a^ash (C3H/HeSn-Rab27a^ash/JRos)	decreased platelet serotonin level	J:137593
Rab27a^ash/Rab27a^ash (B6.C3Sn-Rab27a^ash)	abnormal cytotoxic T cell physiology	J:193137
	decreased cytotoxic T cell cytolysis	J:193137
	decreased erythrocyte cell number	J:193137
	decreased leukocyte cell number	J:193137
	decreased neutrophil cell number	J:193137
	decreased NK cell degranulation	J:193137
	pancytopenia	J:193137
	thrombocytopenia	J:193137
Rab27a^ash/Rab27a^ash (C3H/HeSn-Rab27a^ash/J)	abnormal platelet dense granule morphology	J:77395
	abnormal platelet dense granule physiology	J:77395
	decreased platelet ADP level	J:77395
	decreased platelet aggregation	J:77395
	decreased platelet ATP level	J:77395
	decreased platelet dense granule number	J:77395
	decreased platelet serotonin level	J:77395
Rab27a^ash/Rab27a^ash Rab27b^tm1.2Seab/Rab27b^tm1.2Seab (involves: 129X1/SvJ * C3H/HeSn * C57BL/6J)	abnormal platelet dense granule physiology	J:120307
	decreased platelet aggregation	J:120307
	decreased platelet dense granule number	J:120307
	decreased platelet serotonin level	J:120307
Rab27a^cct/Rab27a^cct (C57BL/6-Rab27a^cct)	abnormal neutrophil physiology	J:114299
Rab27b^tm1.2Seab/Rab27b^tm1.2Seab (involves: 129X1/SvJ * C57BL/6J)	abnormal platelet dense granule physiology	J:120307
	decreased platelet aggregation	J:120307
	decreased platelet dense granule number	J:120307
	decreased platelet serotonin level	J:120307
Rab32^{tm1b(KOMP)Wtsi}/Rab32⁺ Rab38^tm1.1Ics/Rab38^tm1.1Ics (involves: C57BL/6N * C57BL/6NTac)	decreased platelet ADP level	J:293385
	decreased platelet ATP level	J:293385
	decreased platelet serotonin level	J:293385
Rab32^{tm1b(KOMP)Wtsi}/Rab32^{tm1b(KOMP)Wtsi} Rab38^tm1.1Ics/Rab38⁺ (involves: C57BL/6N * C57BL/6NTac)	decreased platelet ADP level	J:293385
	decreased platelet ATP level	J:293385
	decreased platelet serotonin level	J:293385
Rab32^{tm1b(KOMP)Wtsi}/Rab32^{tm1b(KOMP)Wtsi} Rab38^tm1.1Ics/Rab38^tm1.1Ics (involves: C57BL/6N * C57BL/6NTac)	abnormal platelet dense granule morphology	J:293385
	decreased platelet ADP level	J:293385
	decreased platelet aggregation	J:293385
	decreased platelet ATP level	J:293385
	decreased platelet dense granule number	J:293385
	decreased platelet serotonin level	J:293385
Rab32^{tm1c(KOMP)Wtsi}/Rab32^{tm1c(KOMP)Wtsi} Tg(Itgax-cre)1-1Reiz/0 (involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6N * CBA)	hematopoietic system phenotype	J:267497
	increased neutrophil cell number	J:267497
Rab33b^em1Rmr/Rab33b⁺ (involves: C57BL/6)	abnormal osteoclast differentiation	J:338833
	abnormal osteoclast morphology	J:338833
	increased osteoclast cell number	J:338833
Rab33b^em1Rmr/Rab33b^em1Rmr (involves: C57BL/6)	abnormal osteoclast morphology	J:338833
Rab33b^em1Rmr/Rab33b^em1Rmr (involves: C57BL/6)	increased osteoclast cell number	J:338833
Rab36^{tm1b(KOMP)Wtsi}/Rab36^{tm1b(KOMP)Wtsi} (C57BL/6N-Rab36^{tm1b(KOMP)Wtsi}/J)	increased mean corpuscular hemoglobin	J:211773
Rab38^cht/Rab38^cht (C57BL/6J-Rab38^cht/J)	hematopoietic system phenotype	J:75774
Rab39b^em1(IMPC)Tcp/Y (C57BL/6NCrl-Rab39b^em1(IMPC)Tcp/Tcp)	decreased spleen weight	J:211773
Rab40b^em1(IMPC)J/Rab40b^em1(IMPC)J (C57BL/6NJ-Rab40b^em1(IMPC)J/J)	decreased mean corpuscular hemoglobin concentration	J:211773
Rab40c^{tm1b(KOMP)Wtsi}/Rab40c⁺ (C57BL/6N-Rab40c^{tm1b(KOMP)Wtsi}/J)	decreased mean corpuscular hemoglobin	J:211773
Rab43^{tm1.1(KOMP)Vlcg}/Rab43^{tm1.1(KOMP)Vlcg} (C57BL/6N-Rab43^{tm1.1(KOMP)Vlcg}/J)	increased mean corpuscular hemoglobin	J:211773
Rab44^em1Rbrc/Rab44^em1Rbrc (Not Specified)	abnormal mast cell physiology	J:304506
Rabgap1^{tm1b(EUCOMM)Hmgu}/Rabgap1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Rabgap1^{tm1b(EUCOMM)Hmgu}/Ieg)	enlarged spleen	J:211773
	small spleen	J:211773
Rabgef1^tm1Glli/Rabgef1^tm1Glli (either: (involves: 129P2/OlaHsd * 129S/SvEv) or (involves: 129P2/OlaHsd * C57BL/6))	abnormal mast cell morphology	J:91790
	cutaneous mastocytosis	J:91790
	increased IgE level	J:91790
Rabggta^gm/Rabggta⁺ (C57BL/6J-Rabggta^gm)	decreased cytotoxic T cell cytolysis	J:67600
Rabggta^gm/Rabggta^gm (C57BL/6J-Rabggta^gm)	abnormal megakaryocyte differentiation	J:12434
	abnormal platelet alpha-granule morphology	J:12434
	decreased cytotoxic T cell cytolysis	J:67600
	decreased platelet dense granule number	J:12434
	decreased platelet serotonin level	J:12434
	increased mean platelet volume	J:12434
	thrombocytopenia	J:12434
Rabggta^{tm1.1(KOMP)Vlcg}/Rabggta⁺ (C57BL/6N-Rabggta^{tm1.1(KOMP)Vlcg}/Nju)	decreased neutrophil cell number	J:211773
	increased hemoglobin content	J:211773
Rabl3^xm/Rabl3^em1Btlr (C57BL/6J-Rabl3^xm Rabl3^em1Btlr)	decreased leukocyte cell number	J:287198
	decreased lymphocyte cell number	J:287198
	hematopoietic system phenotype	J:287198
	spleen hypoplasia	J:287198
	thymus hypoplasia	J:287198
Rabl3^xm/Rabl3^xm (C57BL/6J-Rabl3^xm)	abnormal T cell morphology	J:287198
Rabl3^xm/Rabl3^xm (C57BL/6J-Rabl3^xm)	abnormal T cell number	J:287198
Rac1^em1(IMPC)Mbp/Rac1⁺ (C57BL/6N-Rac1^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	decreased mean corpuscular hemoglobin	J:211773
	enlarged spleen	J:211773
Rac1^tm1Djk/Rac1^tm1.1Djk Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	decreased leukocyte cell number	J:83457
	decreased neutrophil cell number	J:83457
	impaired neutrophil chemotaxis	J:83457
	impaired neutrophil recruitment	J:83457
Rac1^tm1Djk/Rac1^tm1Djk Tg(Pf4-icre)Q3Rsko/0 (involves: 129S4/SvJae * C57BL/6)	abnormal platelet activation	J:214607
	decreased platelet aggregation	J:214607
Rac2^em1Shl/Rac2⁺ (involves: C57BL/6)	abnormal neutrophil morphology	J:276213
	decreased alpha-beta T cell number	J:276213
	decreased CD4-positive, alpha-beta T cell number	J:276213
	decreased CD8-positive, alpha-beta T cell number	J:276213
	decreased leukocyte cell number	J:276213
	decreased lymphocyte cell number	J:276213
	decreased T cell number	J:276213
	increased neutrophil cell number	J:276213
Rac2^m1Btlr/Rac2⁺ (C57BL/6J-Rac2^m1Btlr)	decreased IgM level	J:221478
Rac2^m1Btlr/Rac2^m1Btlr (C57BL/6J-Rac2^m1Btlr)	decreased IgM level	J:221478
Rac2^M2Btlr/Rac2⁺ (C57BL/6J-Rac2^M2Btlr)	decreased B-1 B cell number	J:231801
	decreased B-1a cell number	J:231801
	increased B-1b cell number	J:231801
Rac2^M2Btlr/Rac2^M2Btlr (C57BL/6J-Rac2^M2Btlr)	decreased B-1 B cell number	J:231801
	decreased B-1a cell number	J:231801
	increased B-1b cell number	J:231801
Rac2^m3Btlr/Rac2⁺ (C57BL/6J-Rac2^m3Btlr)	decreased B-1a cell number	J:236680
	impaired hematopoiesis	J:236680
	increased B-1 B cell number	J:236680
Rac2^m3Btlr/Rac2^m3Btlr (C57BL/6J-Rac2^m3Btlr)	decreased B cell number	J:236680
	decreased B-1a cell number	J:236680
	decreased IgM level	J:236680
	impaired hematopoiesis	J:236680
	increased B-1b cell number	J:236680
	increased neutrophil cell number	J:236680
Rac2^M4Btlr/Rac2⁺ (C57BL/6J-Rac2^M4Btlr)	abnormal cytotoxic T cell physiology	J:255273
	decreased alpha-beta T cell number	J:255273
	decreased CD4-positive, alpha-beta T cell number	J:255273
	decreased CD8-positive, alpha-beta T cell number	J:255273
	decreased CD8-positive, naive alpha-beta T cell number	J:255273
	decreased IgG level	J:255273
	decreased IgM level	J:255273
	impaired natural killer cell mediated cytotoxicity	J:255273
	increased alpha-beta T cell number	J:255273
	increased CD8-positive, alpha-beta T cell number	J:255273
	increased central memory CD8 positive, alpha-beta T cell number	J:255273
	increased effector memory CD4-positive, alpha-beta T cell number	J:255273
	increased effector memory CD8-positive, alpha-beta T cell number	J:255273
	increased IgM level	J:255273
Rac2^M4Btlr/Rac2^M4Btlr (C57BL/6J-Rac2^M4Btlr)	abnormal cytotoxic T cell physiology	J:255273
	decreased alpha-beta T cell number	J:255273
	decreased CD4-positive, alpha-beta T cell number	J:255273
	decreased CD8-positive, alpha-beta T cell number	J:255273
	decreased CD8-positive, naive alpha-beta T cell number	J:255273
	decreased IgE level	J:255273
	decreased IgG level	J:255273
	decreased IgM level	J:255273
	impaired natural killer cell mediated cytotoxicity	J:255273
	increased alpha-beta T cell number	J:255273
	increased CD8-positive, alpha-beta T cell number	J:255273
	increased central memory CD4-positive, alpha-beta T cell number	J:255273
	increased central memory CD8 positive, alpha-beta T cell number	J:255273
	increased effector memory CD4-positive, alpha-beta T cell number	J:255273
	increased effector memory CD8-positive, alpha-beta T cell number	J:255273
Rac2^M5Btlr/Rac2⁺ (C57BL/6J-Rac2^M5Btlr)	increased CD8-positive, alpha-beta T cell number	J:255283
Rac2^M5Btlr/Rac2^M5Btlr (C57BL/6J-Rac2^M5Btlr)	decreased B-1a cell number	J:255283
	increased B-1b cell number	J:255283
	increased CD8-positive, alpha-beta T cell number	J:255283
Rac2^tm1Mddw/Rac2^tm1Mddw (involves: 129S/SvEv * C57BL/6)	abnormal granulocyte differentiation	J:53362
	abnormal neutrophil physiology	J:53362
	decreased leukocyte cell number	J:53362
	decreased neutrophil cell number	J:53362
	decreased T cell proliferation	J:119437
	impaired neutrophil chemotaxis	J:53362
	increased leukocyte cell number	J:53362
	increased neutrophil cell number	J:53362
Rac2^tm1Mddw/Rac2^tm1Mddw (involves: 129S/SvEv)	abnormal neutrophil physiology	J:131305
Rac2^tm1Mddw/Rac2^tm1Mddw (B6.129S-Rac2^tm1Mddw)	abnormal neutrophil physiology	J:83457
Rac2^tm1Mddw/Rac2^tm1Mddw Tg(TcrAND)53Hed/0 (involves: 129S/SvEv * C57BL/6 * SJL)	abnormal T cell activation	J:119437
	decreased T cell proliferation	J:119437
Rac3^tm1Hkp/Rac3^tm1Hkp (B6.129-Rac3^tm1Hkp)	hematopoietic system phenotype	J:99168
Racgap1^tm1Mahi/Racgap1^tm1Mahi Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	abnormal B cell differentiation	J:137760
	abnormal definitive hematopoiesis	J:137760
	abnormal erythrocyte morphology	J:137760
	abnormal myelopoiesis	J:137760
	decreased bone marrow cell number	J:137760
	decreased pro-B cell number	J:137760
	decreased transitional stage B cell number	J:137760
Rad1^{tm1b(KOMP)Wtsi}/Rad1⁺ (C57BL/6N-Rad1^{tm1b(KOMP)Wtsi}/J)	increased erythrocyte cell number	J:211773
	increased hematocrit	J:211773
Rad18^{tm1a(EUCOMM)Wtsi}/Rad18^{tm1a(EUCOMM)Wtsi} (B6JTyr;B6N-Rad18^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased hematocrit	J:165965
	increased mean corpuscular hemoglobin concentration	J:175295
	increased mean corpuscular volume	J:165965
Rad21^tm1.1Mmk/Rad21^tm1.1Mmk Tg(Cd4-cre)1Cwi/0 (involves: 129 * C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:175827
	abnormal CD4-positive, alpha-beta T cell physiology	J:175827
	abnormal T cell differentiation	J:175827
	decreased CD4-positive, alpha-beta T cell number	J:175827
	decreased CD8-positive, alpha-beta T cell number	J:175827
	decreased double-positive T cell number	J:175827
Rad50^tm1Flv/Rad50^tm1Flv (involves: 129S6/SvEvTac * C57BL/6)	abnormal T-helper 2 physiology	J:94870
Rad50^tm1Jpt/Rad50^tm2Jpt (involves: 129S7/SvEvBrd * C57BL/6)	abnormal hematopoietic system physiology	J:103922
	anemia	J:103922
Rad50^tm1Jpt/Rad50^tm3Jpt Tg(Mx1-cre)1Cgn/0 (involves: 129S7/SvEvBrd * C57BL/6 * CBA)	decreased bone marrow cell number	J:144766
Rad50^tm2.1Flv/Rad50^tm2.2Flv Tg(Cd4-cre)1Cwi/0 (involves: 129S6/SvEvTac * C57BL/6 * DBA/2)	abnormal CD4-positive, alpha beta T cell morphology	J:165055
	abnormal T-helper 1 physiology	J:165055
	abnormal T-helper 2 physiology	J:165055
	decreased IgE level	J:165055
Rad50^tm2Jpt/Rad50^tm2Jpt (either: (involves: 129S6/SvEvTac * 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6))	abnormal bone marrow cell morphology/development	J:78820
	abnormal spleen morphology	J:78820
	abnormal thymus morphology	J:78820
	absent bone marrow cell	J:78820
	anemia	J:78820
	decreased B cell number	J:78820
	decreased immature B cell number	J:78820
	decreased pre-B cell number	J:78820
	decreased T cell number	J:78820
	impaired hematopoiesis	J:78820
	increased late pro-B cell number	J:78820
	increased macrophage cell number	J:78820
	spleen hyperplasia	J:78820
Rad50^tm2Jpt/Rad50^tm2Jpt (involves: 129S7/SvEvBrd * C57BL/6)	abnormal bone marrow cell morphology/development	J:103922
	anemia	J:103922
	decreased double-negative T cell number	J:103922
	decreased macrophage cell number	J:103922
	decreased pro-B cell number	J:103922
	pancytopenia	J:103922
	thrombocytopenia	J:103922
Rad50^tm2Jpt/Rad50^tm2Jpt (involves: 129S7/SvEvBrd)	anemia	J:129762
Rad50^tm2Jpt/Rad50^tm2Jpt Smc1a^tm1Mbk/Smc1a^tm1Mbk (involves: 129S1/Sv * 129S7/SvEvBrd * C57BL/6)	abnormal hematopoietic system morphology/development	J:103922
	abnormal pro-B cell morphology	J:103922
	anemia	J:103922
	decreased double-negative T cell number	J:103922
	decreased macrophage cell number	J:103922
Rad50^tm2Jpt/Rad50^tm2Jpt Tg(BCL2)22Wehi/0 (involves: 129S7/SvEvBrd * C57BL/6 * C57BL/6JWehi * SJL/JWehi)	anemia	J:103922
Rad50^tm4.1Jpt/Rad50⁺ (involves: 129/Sv * C57BL/6)	abnormal hematopoietic stem cell morphology	J:209141
Rad50^tm4.1Jpt/Rad50⁺ (involves: 129/Sv * C57BL/6)	impaired hematopoiesis	J:209141
Rad52^tm1Aps/Rad52^tm1Aps Rad54l^tm1Jhjh/Rad54l^tm1Jhjh (involves: 129P2/OlaHsd * C57BL/6)	abnormal definitive hematopoiesis	J:101697
Rad54b^tm1Roka/Rad54b^tm1Roka Rad54l^tm1Jhjh/Rad54l^tm1Jhjh (involves: 129P2/OlaHsd * C57BL/6)	abnormal erythrocyte morphology	J:105544
Rad54l2^em1(IMPC)Tcp/Rad54l2⁺ (C57BL/6NCrl-Rad54l2^em1(IMPC)Tcp/Tcp)	thrombocytosis	J:211773
Rad54l^tm1Jhjh/Rad54l^tm1Jhjh (involves: 129P2/OlaHsd * C57BL/6)	abnormal definitive hematopoiesis	J:101697
Radil^em1(IMPC)Tcp/Radil^em1(IMPC)Tcp (C57BL/6NCrl-Radil^em1(IMPC)Tcp/Tcp)	abnormal spleen morphology	J:211773
Raet1d^em1Dhr/Raet1d^em1Dhr Raet1e^em1Dhr/Raet1e^em1Dhr (involves: C57BL/6)	increased natural killer cell mediated cytotoxicity	J:221188
Raf1^tm1.1Bgn/Raf1⁺ (involves: 129S6/SvEvTac * C57BL/6NCr)	abnormal common myeloid progenitor cell morphology	J:172034
	enlarged spleen	J:172034
	increased leukocyte cell number	J:172034
	increased monocyte cell number	J:172034
	increased neutrophil cell number	J:172034
Raf1^tm1Ulb/Raf1^tm1Ulb (involves: 129P2/OlaHsd * C57BL/6)	anemia	J:89619
Raf1^tm2.1Ara/Raf1^tm2.1Ara (involves: 129S6/SvEvTac * C57BL/6NCr)	hematopoietic system phenotype	J:189143
Rag1/Rag2^tm1Mnz/Rag1/Rag2^tm1Mnz (involves: 129P2/OlaHsd * C57BL/6)	abnormal double-negative T cell morphology	J:90487
	abnormal double-positive T cell morphology	J:90487
	abnormal T cell morphology	J:90487
	decreased T cell number	J:90487
Rag1/Rag2^tm1Mnz/Rag1/Rag2^tm1Mnz (involves: 129P2/OlaHsd * C57BL/6)	abnormal double-negative T cell morphology	J:90487
	abnormal double-positive T cell morphology	J:90487
	abnormal T cell morphology	J:90487
	decreased T cell number	J:90487
Rag1^coln/Rag1^coln (C57BL/6JAnu-Rag1^coln/AnuApb)	absent B cells	J:104190
Rag1^coln/Rag1^coln (C57BL/6JAnu-Rag1^coln/AnuApb)	absent T cells	J:104190
Rag1^em2Mvw/Rag1^em2Mvw (A/J-Rag1^em2Mvw/MvwJ)	absent B cells	J:332675
	absent T cells	J:332675
	arrested B cell differentiation	J:332675
	arrested T cell differentiation	J:332675
Rag1^em3Mvw/Rag1^em3Mvw (129S1/SvImJ-Rag1^em3Mvw/Mvw)	absent B cells	J:332675
	absent T cells	J:332675
	arrested B cell differentiation	J:332675
	arrested T cell differentiation	J:332675
Rag1^m1Anu/Rag1^m1Anu (C57BL/6NCrlAnu-Rag1^m1Anu)	decreased lymphocyte cell number	J:104190
Rag1^m1Btlr/Rag1^m1Btlr (C57BL/6J-Rag1^m1Btlr)	absent late pro-B cells	J:150635
	decreased CD4-positive, alpha-beta T cell number	J:150635
	decreased CD8-positive, alpha-beta T cell number	J:150635
Rag1^m2Btlr/Rag1^m2Btlr (involves: C57BL/6J)	abnormal class switch recombination	J:185495
	decreased B cell number	J:185495
	decreased IgG level	J:185495
	decreased IgM level	J:185495
	decreased T cell number	J:185495
Rag1^m3Btlr/Rag1^m3Btlr (C57BL/6J-Rag1^m3Btlr)	increased central memory CD8 positive, alpha-beta T cell number	J:272858
Rag1^m4Btlr/Rag1^m4Btlr (C57BL/6J-Rag1^m4Btlr)	abnormal CD8-positive, alpha-beta T cell differentiation	J:272094
	abnormal T cell differentiation	J:272094
	decreased B cell number	J:272094
	decreased CD8-positive, naive alpha-beta T cell number	J:272094
	increased alpha-beta T cell number	J:272094
	increased CD8-positive, alpha-beta T cell number	J:272094
	increased central memory CD8 positive, alpha-beta T cell number	J:272094
Rag1^tm1(cre)Thr/Rag1^tm1(cre)Thr (Not Specified)	abnormal lymphopoiesis	J:86869
Rag1^tm1(cre)Thr/Rag1^tm1(cre)Thr (Not Specified)	absent lymphocyte	J:86869
Rag1^tm1(GFP)Imku/? Zfp335^blt/Zfp335^blt (involves: C57BL/6 * CBA)	abnormal CD4-positive T cell differentiation	J:214793
Rag1^tm1(GFP)Imku/Rag1^tm1(GFP)Imku (involves: C57BL/6 * CBA)	abnormal immunoglobulin V(D)J recombination	J:79416
Rag1^tm1.1Sadu/Rag1^tm1.1Sadu (involves: BALB/c)	arrested B cell differentiation	J:155473
Rag1^tm1.1Sadu/Rag1^tm1.1Sadu Trdc^tm1Mal/Trdc^tm1Mal Gt(ROSA)26Sor^{tm2(cre/ERT2)Brn}/Gt(ROSA)26Sor⁺ (involves: 129P2/OlaHsd * BALB/c * C57BL/6)	absent gamma-delta T cells	J:187400
	decreased gamma-delta T cell number	J:187400
	increased gamma-delta T cell number	J:187400
	small thymus	J:187400
Rag1^tm1Bal/Rag1^tm1Bal Tg(TcraTcrb)1100Mjb/? (involves: 129S4/SvJae * C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:133645
	decreased CD4-positive, alpha-beta T cell number	J:133645
	increased CD8-positive, alpha-beta T cell number	J:133645
Rag1^tm1Bal/Rag1^tm1Bal Vav1^tm2Tyb/Vav1^tm2Tyb (involves: 129S4/SvJae * 129S8/SvEv)	arrested T cell differentiation	J:113270
Rag1^tm1Bal/Rag1^tm1Bal Vav1^tm2Tyb/Vav1^tm2Tyb Tg(TcrAND)53Hed/0 (involves: 129S4/SvJae * 129S8/SvEv * C57BL/6 * SJL)	decreased CD4-positive, alpha-beta T cell number	J:113270
Rag1^tm1Fwa/Rag1^tm1Fwa (involves: 129)	abnormal B cell differentiation	J:86464
	abnormal T cell differentiation	J:86464
	decreased B cell number	J:86464
	increased double-negative T cell number	J:86464
	thymus hypoplasia	J:86464
Rag1^tm1Jsek/Rag1⁺ (involves: 129S6/SvEvTac)	abnormal B cell differentiation	J:146912
	abnormal immunoglobulin heavy chain V(D)J recombination	J:146912
	abnormal T cell differentiation	J:146912
	abnormal T cell receptor beta chain V(D)J recombination	J:146912
	decreased double-positive T cell number	J:146912
Rag1^tm1Jsek/Rag1^tm1Jsek (involves: 129S6/SvEvTac)	abnormal immunoglobulin heavy chain V(D)J recombination	J:146912
	abnormal immunoglobulin level	J:146912
	abnormal lymphopoiesis	J:146912
	abnormal T cell receptor beta chain V(D)J recombination	J:146912
	abnormal T cell receptor V(D)J recombination	J:146912
	absent immature B cells	J:146912
	absent mature B cells	J:146912
	arrested B cell differentiation	J:146912
	arrested T cell differentiation	J:146912
	decreased CD4-positive, alpha-beta T cell number	J:146912
	decreased CD8-positive, alpha-beta T cell number	J:146912
	decreased double-positive T cell number	J:146912
	decreased gamma-delta T cell number	J:146912
	increased double-negative T cell number	J:146912
	increased pro-B cell number	J:146912
	thymus hypoplasia	J:146912
Rag1^tm1Mom/Rag1^tm1Mom (involves: 129S7/SvEvBrd * CD-1)	abnormal B cell differentiation	J:1934
	abnormal immunoglobulin V(D)J recombination	J:1934
	abnormal T cell differentiation	J:1934
	abnormal T cell morphology	J:1934
	abnormal T cell receptor V(D)J recombination	J:1934
	absent mature B cells	J:1934
	decreased IgM level	J:1934
	spleen hypoplasia	J:1934
	thymus hypoplasia	J:1934
Rag1^tm1Mom/Rag1^tm1Mom (B6.129S7-Rag1^tm1Mom)	decreased IgM level	J:78613
	decreased immunoglobulin level	J:111828
	increased eosinophil cell number	J:111828
Rag1^tm1Mom/Rag1^tm1Mom (involves: 129S7/SvEvBrd * C57BL/6 * FVB * NOD)	decreased lymphocyte cell number	J:111874
	small thymus	J:111874
Rag1^tm1Mom/Rag1^tm1Mom (NOD.129S7(B6)-Rag1^tm1Mom)	decreased CD4-positive, alpha-beta T cell number	J:109843
	decreased CD8-positive, alpha-beta T cell number	J:109843
	decreased immunoglobulin level	J:109843
	decreased mature B cell number	J:109843
	impaired natural killer cell mediated cytotoxicity	J:109843
	increased granulocyte number	J:109843
	increased immature B cell number	J:109843
	increased macrophage cell number	J:109843
	increased NK cell number	J:109843
	spleen hypoplasia	J:109843
Rag1^tm1Mom/Rag1^tm1Mom (involves: 129S7/SvEvBrd * C57BL/6)	decreased neutrophil cell number	J:119344
Rag1^tm1Mom/Rag1^tm1Mom (involves: 129S7/SvEvBrd)	abnormal double-negative T cell morphology	J:112990
Rag1^tm1Mom/Rag1^tm1Mom (involves: 129S7/SvEvBrd)	abnormal thymus epithelium morphology	J:125864
Rag1^tm1Mom/Rag1^tm1Mom Prf1^tm1Sdz/Prf1^tm1Sdz (NOD.Cg-Rag1^tm1Mom Prf1^tm1Sdz/Sz)	abnormal spleen white pulp morphology	J:109843
	abnormal thymus cortex morphology	J:109843
	decreased CD4-positive, alpha-beta T cell number	J:109843
	decreased CD8-positive, alpha-beta T cell number	J:109843
	decreased immunoglobulin level	J:109843
	decreased mature B cell number	J:109843
	impaired natural killer cell mediated cytotoxicity	J:109843
	increased granulocyte number	J:109843
	increased immature B cell number	J:109843
	increased macrophage cell number	J:109843
	increased NK cell number	J:109843
	spleen hypoplasia	J:109843
	thymus hypoplasia	J:109843
Rag1^tm1Mom/Rag1^tm1Mom Rasa3^scat/Rasa3^scat (involves: 129S7/SvEvBrd * BALB/cBy)	abnormal hematopoietic system morphology/development	J:186485
Rag1^tm1Mom/Rag1^tm1Mom Sh3bp2^tm1Bjro/Sh3bp2^tm1Bjro (involves: 129S4/SvJae * 129S7/SvEvBrd * BALB/cJ * C57BL/6J)	abnormal osteoclast differentiation	J:117880
Rag1^tm1Mom/Rag1^tm1Mom Slc46a2^tm1Moki/Slc46a2⁺ Tg(TcraB12,TcrbB12)1Rest/0 (involves: 129 * C57BL/6)	arrested T cell differentiation	J:140121
	decreased double-positive T cell number	J:140121
	increased T cell apoptosis	J:140121
	thymus hypoplasia	J:140121
Rag1^tm1Mom/Rag1^tm1Mom Tg(Lck-Akt1E40K)E-3Pnt/0 (involves: 129S7/SvEvBrd C3H/He * C57BL/6)	increased double-positive T cell number	J:135903
	increased thymocyte number	J:135903
Rag1^tm1Mom/Rag1^tm1Mom Tg(LPV-TAg1135)11Tvd/0 (involves: 129/Sv * C57BL/6 * DBA/2)	abnormal T cell receptor V(D)J recombination	J:47667
Rag1^tm1Mom/Rag1^tm1Mom Tg(Tcra,Tcrb)HRCAll/0 (B6.Cg-Rag1^tm1Mom Tg(Tcra,Tcrb)HRCAll)	abnormal T cell differentiation	J:131347
	abnormal T cell subpopulation ratio	J:131347
	absent CD4-positive, alpha-beta T cells	J:131347
	increased CD8-positive, alpha-beta T cell number	J:131347
Rag1^tm1Mom/Rag1^tm1Mom Tg(TcraBDC12-4.1)10Jos/0 Tg(TcrbBDC12-4.1)82Gse/0 (involves: 129S7/SvEvBrd * C57BL/6 * FVB * NOD)	decreased CD4-positive, alpha-beta T cell number	J:111874
	decreased lymphocyte cell number	J:111874
	decreased thymus weight	J:111874
	increased double-positive T cell number	J:111874
Rag1^tm1Mom/Rag1^tm1Mom Tnfrsf25^tm1Mjo/Tnfrsf25^tm1Mjo (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)	abnormal T cell differentiation	J:84536
Rag1^tm1Mom/Rag1^tm1Mom Tnfsf14^tm1Kpf/Tnfsf14^tm1Kpf (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)	decreased osteoclast cell number	J:294030
Rag1^tm1Mom/Rag1^tm1Mom Tyrobp^tm1.1Viv/Tyrobp^tm1.1Viv (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * C57BL/10)	abnormal osteoclast physiology	J:129304
Rag1^tm1Mom/Rag1^tm1Mom Vtcn1^tm1Lpc/Vtcn1^tm1Lpc (involves: 129S/SvEvBrd * 129S7/SvEvBrd * C57BL/6)	abnormal neutrophil differentiation	J:145712
	increased neutrophil cell number	J:145712
	increased spleen weight	J:145712
Rag2^m1Btlr/Rag2^m1Btlr (C57BL/6J-Rag2^m1Btlr)	decreased B cell number	J:203045
	decreased CD4-positive, alpha-beta T cell number	J:203045
	decreased IgG level	J:203045
	decreased IgM level	J:203045
Rag2^tm1.1Cgn/Rag2^tm1.1Cgn (C57BL/6-Rag2^tm1.1Cgn)	arrested B cell differentiation	J:72214
Rag2^tm1.1Cgn/Rag2^tm1.1Cgn (C57BL/6-Rag2^tm1.1Cgn)	arrested T cell differentiation	J:72214
Rag2^tm1.1Desi/Rag2^tm1.1Desi (involves: 129X1/SvJ * C57BL/6)	abnormal immunoglobulin V(D)J recombination	J:168974
Rag2^tm1.1Mss/Rag2^tm1.1Mss (involves: 129S6/SvEvTac)	abnormal lymphopoiesis	J:171970
	abnormal pre-B cell morphology	J:171970
	decreased pre-B cell number	J:171970
	increased DN3 thymocyte number	J:171970
Rag2^tm1Avla/Rag2^tm1Avla (involves: 129/Sv * C57BL/6)	abnormal B cell physiology	J:122108
	abnormal lymphocyte physiology	J:122108
	abnormal spleen morphology	J:122108
	abnormal thymus morphology	J:122108
	absent Hassall's corpuscle	J:122108
	arrested B cell differentiation	J:122108
	arrested T cell differentiation	J:122108
	decreased double-positive T cell number	J:122108
	decreased IgA level	J:122108
	decreased IgG level	J:122108
	decreased lymphocyte cell number	J:122108
	decreased NK T cell number	J:122108
	decreased spleen white pulp amount	J:122108
	decreased T cell proliferation	J:122108
	small spleen	J:122108
Rag2^tm1Cgn/Rag2^tm1.1Cgn Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	abnormal B cell activation	J:72214
	absent immature B cells	J:72214
	absent pre-B cells	J:72214
	arrested B cell differentiation	J:72214
	arrested T cell differentiation	J:72214
	decreased follicular B cell number	J:72214
	decreased marginal zone B cell number	J:72214
	decreased mature B cell number	J:72214
	increased plasma cell number	J:72214
Rag2^tm1Cgn/Rag2^tm1Cgn Xrcc4^tm1Fwa/Xrcc4^tm2Fwa Tg(Cr2-cre)3Cgn/? (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6)	abnormal class switch recombination	J:150339
Rag2^tm1Fwa/Rag2^tm1Fwa (involves: 129S/SvEv * MF1)	abnormal effector T cell morphology	J:1935
	abnormal immunoglobulin V(D)J recombination	J:1935
	abnormal spleen morphology	J:1935
	abnormal T cell receptor V(D)J recombination	J:1935
	absent mature B cells	J:1935
	arrested B cell differentiation	J:1935
	arrested T cell differentiation	J:1935
	decreased CD4-positive, alpha-beta T cell number	J:1935
	decreased CD8-positive, alpha-beta T cell number	J:1935
	decreased double-positive T cell number	J:1935
	decreased IgM level	J:1935
	increased granulocyte number	J:1935
	increased macrophage cell number	J:1935
	increased natural killer cell mediated cytotoxicity	J:1935
	spleen hypoplasia	J:1935
	thymus hypoplasia	J:1935
Rag2^tm1Fwa/Rag2^tm1Fwa (involves: 129S/SvEv)	abnormal macrophage physiology	J:140483
	abnormal T-helper 1 physiology	J:116136
	decreased thymocyte number	J:114561
Rag2^tm1Fwa/Rag2^tm1Fwa (involves: 129S/SvEv * C57BL/6)	abnormal B cell morphology	J:81133
	arrested T cell differentiation	J:91542
	decreased double-negative T cell number	J:81133, J:91542
	increased double-negative T cell number	J:91542
Rag2^tm1Fwa/Rag2^tm1Fwa Cd47^tm1Fpl/Cd47^tm1Fpl Il2rg^tm1Cgn/Y (involves: 129P2/OlaHsd * 129S/SvEv * 129S7/SvEvBrd * C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:203904
	decreased lymphocyte cell number	J:203904
	increased activated T cell number	J:203904
	increased CD8-positive, alpha-beta T cell number	J:203904
Rag2^tm1Fwa/Rag2^tm1Fwa Rr299391^tm1.1Fwa/Rr299391^tm1.1Fwa (involves: 129P2/OlaHsd * 129S/SvEv)	abnormal T cell receptor delta chain V(D)J recombination	J:149413
Rag2^tm1Fwa/Rag2^tm1Fwa Sos1^tm1.1Les/Sos1^tm1.1Les Tg(Lck-cre)1Cwi/0 (involves: 129S/SvEv * C57BL/6)	abnormal T cell differentiation	J:174536
	decreased T cell proliferation	J:174536
Rag2^tm1Fwa/Rag2^tm1Fwa Tbata^tm1Faf/Tbata^tm1Faf (involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6)	abnormal bone marrow cell physiology	J:166065
	abnormal T cell differentiation	J:166065
	increased thymocyte number	J:166065
Rag2^tm1Fwa/Rag2^tm1Fwa Tcra^Ln3Jae/Tcra⁺ Tcrb^Ln3Jae/Tcrb⁺ (involves: 129S/SvEv * 129S4/SvJae * C57BL/6)	abnormal double-negative T cell morphology	J:143006
	absent gamma-delta T cells	J:143006
	decreased CD4-positive, alpha-beta T cell number	J:143006
	increased CD8-positive, alpha-beta T cell number	J:143006
Rag2^tm1Fwa/Rag2^tm1Fwa Tcrb^Ln3Jae/Tcrb⁺ (involves: 129S/SvEv * 129S4/SvJae * C57BL/6)	abnormal double-negative T cell morphology	J:143006
	absent gamma-delta T cells	J:143006
	decreased CD4-positive, alpha-beta T cell number	J:143006
	increased double-positive T cell number	J:143006
Rag2^tm1Fwa/Rag2^tm1Fwa Tg(Cd4-NPM/ALK)N1Ingh/0 (involves: 129S/SvEv * C57BL/6 * Swiss Webster)	increased DN3 thymocyte number	J:235890
Rag2^tm1Fwa/Rag2^tm1Fwa Tg(EmuSR-tTa)83Bop/0 Tg(tetO-Nfatct1)1Grc/0 (involves: 129S/SvEv C57BL/6J * CBA/J * FVB/N)	abnormal double-positive T cell morphology	J:141917
Rag2^tm1Fwa/Rag2^tm1Fwa Tg(Igh-Pim1)1Brn/0 (involves: 129S/SvEv * C57BL/6LiA * CBA)	decreased thymocyte number	J:114561
Rag2^tm1Fwa/Rag2^tm1Fwa Tg(Lck-Akt1)M-1Pnt/0 (involves: 129S/SvEv C3H/He * C57BL/6)	absent CD4-positive, alpha-beta T cells	J:135903
	absent CD8-positive, alpha-beta T cells	J:135903
	increased double-positive T cell number	J:135903
Rag2^tm1Fwa/Rag2^tm1Fwa Tg(Tcra5CC7,Tcrb5CC7)IWep/? Themis^5AT161/Themis^5AT161 (involves: 129S/SvEv * C57BL/6)	arrested T cell differentiation	J:151076
	increased double-positive T cell number	J:151076
Rag2^tm1Fwa/Rag2^tm1Fwa Tg(Tcra51-11.5,Tcrb51-11.5)AR206Ayr/0 (involves: 129S/SvEv * C57BL/6 * C57BL/6NTac * DBA/2)	abnormal CD4-positive T cell differentiation	J:125548
	abnormal positive T cell selection	J:125548
	decreased CD4-positive, alpha-beta T cell number	J:125548
	increased double-positive T cell number	J:125548
	thymus hyperplasia	J:125548
Rag2^tm1Fwa/Rag2^tm1Fwa Tg(TcraH-Y,TcrbH-Y)71Vbo/? (involves: 129S/SvEv * C57BL/6J * DBA/2J)	abnormal CD8-positive, alpha beta T cell morphology	J:125259
	abnormal CD8-positive, alpha-beta T cell physiology	J:125259
	abnormal cytotoxic T cell physiology	J:66565
Rag2^tm1Fwa/Rag2^tm1Fwa Tg(TcraH-Y,TcrbH-Y)71Vbo/? Themis^5AT161/Themis^5AT161 (involves: 129S/SvEv * C57BL/6 * DBA/2)	decreased single-positive T cell number	J:151076
Rag2^tm1Fwa/Rag2^tm1Fwa Tg(TcrHEL3A9)1Mmd/0 (involves: 129S/SvEv * C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:78309
	abnormal double-positive T cell morphology	J:78309
	abnormal T cell activation	J:78309
	abnormal T cell proliferation	J:78309
	abnormal thymus cell ratio	J:78309
	decreased CD4-positive, alpha-beta T cell number	J:78309
Rag2^tm1Fwa/Rag2^tm1Fwa Tg(TcrHEL3A9)1Mmd/0 Tg(TLK2mHEL)2Ccg/0 (involves: 129S/SvEv * C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:78309
	abnormal CD4-positive, alpha-beta T cell physiology	J:78309
	abnormal T cell activation	J:78309
	abnormal T cell proliferation	J:78309
	decreased CD4-positive, alpha-beta T cell number	J:78309
	decreased double-positive T cell number	J:78309
Rag2^tm1Fwa/Rag2^tm1Fwa Unc93b1^tm1.1Kmiy/Unc93b1^tm1.1Kmiy (involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6)	hematopoietic system phenotype	J:174308
Rag2^tm1Fwa/Rag2^tm1Fwa Wdr1^rede/Wdr1^rede (involves: 129S/SvEv * C57BL/6)	thrombocytopenia	J:134092
Rag2^tm1Fwa/Rag2^tm1Mao (involves: 129S/SvEv * C57BL/6)	abnormal B cell number	J:81837
	abnormal gamma-delta T cell differentiation	J:81837
	arrested B cell differentiation	J:81837
	arrested T cell differentiation	J:81837
	decreased double-negative T cell number	J:81837
	decreased immature B cell number	J:81837
	decreased mature B cell number	J:81837
	decreased pre-B cell number	J:81837
	increased immature B cell number	J:81837
	thymus hypoplasia	J:81837
Rag2^tm1Libo/Rag2^tm1Libo (involves: 129S6/SvEvTac * C57BL/6 * FVB/N)	abnormal B cell differentiation	J:84563
	abnormal B cell physiology	J:84563
	decreased B cell number	J:84563
	decreased bone marrow cell number	J:84563
	decreased monocyte cell number	J:84563
	decreased pre-B cell number	J:84563
Rag2^tm1Mao/Rag2^tm1Mao (involves: 129 * C57BL/6)	abnormal B cell number	J:81837
	abnormal gamma-delta T cell differentiation	J:81837
	arrested B cell differentiation	J:81837
	arrested T cell differentiation	J:81837
	decreased double-negative T cell number	J:81837
	decreased immature B cell number	J:81837
	decreased mature B cell number	J:81837
	decreased pre-B cell number	J:81837
	increased immature B cell number	J:81837
	thymus hypoplasia	J:81837
Rag2^tm1Tgi/Rag2^tm1Tgi (involves: 129S1/Sv * 129X1/SvJ)	arrested B cell differentiation	J:113641
	arrested T cell differentiation	J:113641
	decreased B cell number	J:113641
	decreased double-positive T cell number	J:113641
	decreased thymocyte number	J:113641
Rai14^em1(IMPC)J/Rai14⁺ (C57BL/6NJ-Rai14^em1(IMPC)J/J)	decreased mean corpuscular hemoglobin concentration	J:211773
Rai14^em1(IMPC)J/Rai14⁺ (C57BL/6NJ-Rai14^em1(IMPC)J/J)	increased mean corpuscular volume	J:211773
Ralb^{tm1a(EUCOMM)Wtsi}/Ralb^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Ralb^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased leukocyte cell number	J:211773
Ralgps1^em1(IMPC)J/Ralgps1^em1(IMPC)J (C57BL/6NJ-Ralgps1^em1(IMPC)J/Mmjax)	thrombocytopenia	J:211773
Ramp1^{tm1b(EUCOMM)Wtsi}/Ramp1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Ramp1^{tm1b(EUCOMM)Wtsi}/H)	increased basophil cell number	J:211773
Ranbp10^{Gt(RRZ226)Byg}/Ranbp10^{Gt(RRZ226)Byg} (either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6))	abnormal megakaryocyte differentiation	J:193236
	abnormal platelet dense granule physiology	J:193236
	abnormal platelet shape	J:193236
	decreased erythrocyte cell number	J:193236
	decreased platelet aggregation	J:193236
	hematopoietic system phenotype	J:193236
	increased mean corpuscular volume	J:193236
Ranbp17^em1(IMPC)Tcp/Ranbp17^em1(IMPC)Tcp (C57BL/6N-Ranbp17^em1(IMPC)Tcp/Tcp)	enlarged spleen	J:211773
Rap1a^tm1Laaq/Rap1a^tm1Laaq (either: B6.Cg-Rap1a^tm1Laaq or (involves: C57BL/6))	abnormal leukocyte migration	J:140471
	abnormal macrophage physiology	J:140471
	abnormal neutrophil physiology	J:140471
Rap1a^tm1Tze/Rap1a^tm1Tze (involves: 129P2/OlaHsd * C57BL/6)	abnormal leukocyte adhesion	J:144145
	decreased T cell proliferation	J:144145
Rap1b^tm1Gwht/Rap1b^tm1Gwht (involves: 129S/SvEv * C57BL/6)	decreased platelet aggregation	J:96758
Rap1gap^em1(IMPC)H/Rap1gap^em1(IMPC)H (C57BL/6NTac-Rap1gap^em1(IMPC)H/H)	decreased lymphocyte cell number	J:211773
	increased eosinophil cell number	J:211773
	increased neutrophil cell number	J:211773
	increased red blood cell distribution width	J:211773
	increased spleen weight	J:211773
Rap1gds1^tm1Ytk/Rap1gds1^tm1Ytk (involves: 129X1/SvJ * C57BL/6 * DBA)	abnormal thymus morphology	J:62244
	decreased thymocyte number	J:62244
	increased thymocyte apoptosis	J:62244
	small thymus	J:62244
Rapgef2^tm1.1Hous/Rapgef2^tm1.1Hous Tg(CAG-cre/Esr1)5Amc/0 (involves: 129S1/Sv C57BL/6 * CBA)	abnormal definitive hematopoiesis	J:165879
	decreased erythroid progenitor cell number	J:165879
Rapgef2^tm1.1Hous/Rapgef2^tm1.1Hous Tg(Cd4-cre)1Cwi/0 (involves: 129S1/Sv * C57BL/6 * CBA)	hematopoietic system phenotype	J:165879
Rapgef2^tm1.1Hous/Rapgef2^tm1.1Hous Tg(Cdh5-cre)7Mlia/0 (involves: 129S1/Sv * FVB/N)	hematopoietic system phenotype	J:165879
Rapgef2^tm1.1Hous/Rapgef2^tm1.1Hous Tg(Mx1-cre)1Cgn/0 (involves: 129S1/Sv * C57BL/6 * CBA)	hematopoietic system phenotype	J:165879
Rapgef2^tm1.1Hous/Rapgef2^tm1.1Hous Tg(VAV1-cre)1Graf/0 (involves: 129S1/Sv)	hematopoietic system phenotype	J:165879
Rapgef2^tm1.1Tkat/Rapgef2^tm1.1Tkat (involves: 129P2/OlaHsd * C57BL/6)	decreased erythrocyte cell number	J:125199
Rapgef2^tm1.2Hous/Rapgef2^tm1.2Hous (involves: 129S1/Sv)	abnormal embryonic hematopoiesis	J:165879
	abnormal erythropoiesis	J:165879
	abnormal hematopoietic stem cell physiology	J:165879
	absent erythrocytes	J:165879
	decreased common myeloid progenitor cell number	J:165879
	decreased erythroid progenitor cell number	J:165879
	decreased hematopoietic stem cell number	J:165879
Rapgef3^tm1Fsel/Rapgef3^tm1Fsel (involves: C57BL/6JBomTac)	hematopoietic system phenotype	J:210778
Rapgef4^em1(IMPC)H/Rapgef4⁺ (C57BL/6NTac-Rapgef4^em1(IMPC)H/H)	increased red blood cell distribution width	J:211773
	thrombocytopenia	J:211773
Rapgef6^tm1.1Tkat/Rapgef6^tm1.1Tkat (involves: 129P2/OlaHsd * C57BL/6)	enlarged spleen	J:126164
Rapgef6^tm1.1Tkat/Rapgef6^tm1.1Tkat (involves: 129P2/OlaHsd)	enlarged spleen	J:218581
Raph1^tm1.2Fbg/Raph1^tm1.2Fbg (involves: 129S4/SvJae * C57BL/6)	increased myeloid cell number	J:238262
Rara^tm1.1Ybe/Rara^tm1.1Ybe (involves: C57BL/6N)	abnormal lymphopoiesis	J:207485
Rara^tm1Ipc/Rara^tm1Ipc Rarb^tm1Ipc/Rarb^tm1Ipc (involves: 129S2/SvPas)	persistent cervical thymus	J:21034
Rara^tm1Ipc/Rara^tm1Ipc Rarb^tm1Mma/Rarb^tm1Mma (involves: 129S2/SvPas * C57BL/6)	abnormal thymus morphology	J:43344
	persistent cervical thymus	J:43344
Rara^tm1Ipc/Rara^tm1Ipc Rarg^tm1Ipc/Rarg^tm1Ipc (involves: 129S2/SvPas)	persistent cervical thymus	J:21034
Rara^tm1Ipc/Rara^tm1Ipc Rarg^tm2Ipc/Rarg^tm2Ipc (involves: 129S2/SvPas)	ectopic thymus	J:42773
Rarres1^tm1.2Mhl/Rarres1^tm1.2Mhl (involves: 129S1/SvImJ * C57BL/6 * FVB/N * NIH Black Swiss)	abnormal B cell activation	J:324270
	abnormal B cell differentiation	J:324270
	abnormal B cell physiology	J:324270
	abnormal plasma cell differentiation	J:324270
	decreased B cell apoptosis	J:324270
	decreased spleen germinal center number	J:324270
	extramedullary hematopoiesis	J:324270
	increased B cell proliferation	J:324270
Rarres2^tm1Yktk/Rarres2^tm1Yktk (B6.Cg-Rarres2^tm1Yktk)	decreased macrophage cell number	J:206120
Rasa1^{tm1b(EUCOMM)Hmgu}/Rasa1⁺ (C57BL/6N-Rasa1^{tm1b(EUCOMM)Hmgu}/J)	increased mean corpuscular hemoglobin	J:211773
	thrombocytopenia	J:211773
Rasa3^hlb381/? (C57BL/6J-Rasa3^hlb381/J)	thrombocytopenia	J:82961
Rasa3^hlb381/Rasa3^hlb381 (C57BL/6J-Rasa3^hlb381/J)	abnormal platelet physiology	J:221899
	decreased leukocyte cell number	J:301035, J:221899
	enlarged spleen	J:221899
	increased mean platelet volume	J:221899
	increased megakaryocyte cell number	J:221899
	increased spleen weight	J:301035
	reticulocytosis	J:301035
	thrombocytopenia	J:301035, J:221899
Rasa3^hlb381/Rasa3^hlb381 Rasgrp2^tm1Amg/Rasgrp2^tm1Amg (involves: C57BL/6J)	abnormal platelet cell number	J:221899
Rasa3^scat/Rasa3^scat (involves: BALB/cBy)	abnormal erythropoiesis	J:186485
	abnormal megakaryocyte differentiation	J:186485
	abnormal megakaryocyte morphology	J:186485
	abnormal spleen morphology	J:186485
	anemia	J:186485
	anisocytosis	J:186485
	decreased B cell number	J:186485
	decreased bone marrow cell number	J:186485
	decreased CD4-positive, alpha-beta T cell number	J:186485
	decreased CD8-positive, alpha-beta T cell number	J:186485
	decreased leukocyte cell number	J:186485
	decreased mean corpuscular hemoglobin	J:186485
	decreased T cell number	J:186485
	enlarged spleen	J:186485
	hemolysis	J:186485
	increased megakaryocyte cell number	J:186485
	increased spleen red pulp amount	J:186485
	pale spleen	J:186485
	poikilocytosis	J:186485
	polychromatophilia	J:186485
	reticulocytosis	J:186485
	thrombocytopenia	J:186485
Rasa3^scat/Rasa3^scat (involves: BALB/cBy * BALB/cByJ)	abnormal erythroblast morphology	J:281271
	abnormal erythropoiesis	J:281271
	decreased erythrocyte cell number	J:301035
	decreased hematocrit	J:301035
	decreased hemoglobin content	J:301035
	decreased leukocyte cell number	J:301035
	decreased mean corpuscular hemoglobin concentration	J:301035
	increased hemoglobin concentration distribution width	J:301035
	increased mean corpuscular volume	J:301035
	increased mean platelet volume	J:301035
	increased red blood cell distribution width	J:301035
	increased spleen weight	J:301035
	reticulocytosis	J:301035
	thrombocytopenia	J:301035
Rasa3^tm1.1Llp/Rasa3^tm1.1Llp Tg(Mx1-cre)1Cgn/? (involves: 129S1/SvImJ * C57BL/6J * CBA/J)	abnormal erythropoiesis	J:301035
	anemia	J:301035
	anisocytosis	J:301035
	bone marrow failure	J:301035
	decreased erythrocyte cell number	J:301035
	decreased hematocrit	J:301035
	decreased hemoglobin content	J:301035
	decreased leukocyte cell number	J:301035
	hemolysis	J:301035
	increased mean corpuscular volume	J:301035
	increased mean platelet volume	J:301035
	increased megakaryocyte-erythroid progenitor cell number	J:301035
	increased red blood cell distribution width	J:301035
	increased spleen weight	J:301035
	pancytopenia	J:301035
	poikilocytosis	J:301035
	reticulocytosis	J:301035
	thrombocytopenia	J:301035
Rasa3^tm1.1Llp/Rasa3^tm1.1Llp Tg(Tek-cre)1Ywa/? (involves: 129S1/SvImJ * C57BL/6J * SJL/J)	abnormal embryonic hematopoiesis	J:301035
Rasa3^tm1.1Llp/Rasa3^tm1.1Llp Tg(Vav1-cre)1Cgp/? (involves: 129S1/SvImJ * C57BL/6J)	abnormal embryonic hematopoiesis	J:301035
Rasa4^tm1Ywh/Rasa4^tm1Ywh (B6.129S6-Rasa4^tm1Ywh)	impaired macrophage phagocytosis	J:100455
Rasal3^tm1.1Fuj/Rasal3^tm1.1Fuj (involves: C57BL/6N * C57BL/6NCrlj * CBA/JNCrlj)	decreased NK T cell number	J:229641
	increased granulocyte number	J:229641
Rasal3^{tm1b(EUCOMM)Hmgu}/Rasal3^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Rasal3^{tm1b(EUCOMM)Hmgu}/Orl)	decreased lymphocyte cell number	J:211773
	increased eosinophil cell number	J:211773
Rasgrf2^tm1Esn/Rasgrf2^tm1Esn Vav1^tm1Tyb/Vav1^tm1Tyb (involves: 129S1/Sv * 129S2/SvPas * C57BL/10 * C57BR/cd)	abnormal T cell physiology	J:128985
	decreased T cell proliferation	J:128985
Rasgrp1^lag/Rasgrp1^lag (involves: 129 * C57BL/6)	abnormal positive T cell selection	J:85189
	abnormal T cell physiology	J:85189
	decreased T cell proliferation	J:85189
	enlarged spleen	J:85189
	increased B cell number	J:85189
	increased IgG level	J:85189
	increased T cell number	J:85189
Rasgrp1^m1Anu/Rasgrp1^m1Anu (C57BL/6JSfdAnu-Rasgrp1^m1Anu)	abnormal T cell differentiation	J:104190
Rasgrp1^m1Anu/Rasgrp1^m1Anu (involves: C57BL/6JSfdAnu * CBA/J)	abnormal CD4-positive, alpha beta T cell morphology	J:207898
	increased effector memory CD4-positive, alpha-beta T cell number	J:207898
Rasgrp1^m1Btlr/Rasgrp1^m1Btlr (C57BL/6J-Rasgrp1^m1Btlr)	decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:265163
	decreased CD8-positive, naive alpha-beta T cell number	J:265163
	decreased IgM level	J:265163
	increased CD8-positive, alpha-beta memory T cell number	J:265163
	increased effector memory CD4-positive, alpha-beta T cell number	J:265163
	increased IgA level	J:265163
	increased IgE level	J:265163
	increased IgM level	J:265163
	increased NK cell number	J:265163
Rasgrp1^m2Btlr/Rasgrp1^m2Btlr (C57BL/6J-Rasgrp1^m2Btlr)	decreased CD4-positive, alpha-beta T cell number	J:265163
	decreased CD8-positive, alpha-beta T cell number	J:265163
	decreased CD8-positive, naive alpha-beta T cell number	J:265163
	decreased single-positive T cell number	J:265163
	decreased T cell number	J:265163
	increased central memory CD4-positive, alpha-beta T cell number	J:265163
	increased central memory CD8 positive, alpha-beta T cell number	J:265163
	increased effector memory CD4-positive, alpha-beta T cell number	J:265163
	increased effector memory CD8-positive, alpha-beta T cell number	J:265163
	increased NK cell number	J:265163
Rasgrp1^m3Btlr/Rasgrp1^m3Btlr (C57BL/6J-Rasgrp1^m3Btlr)	decreased CD4-positive, alpha-beta T cell number	J:265255
	decreased CD8-positive, alpha-beta T cell number	J:265255
	decreased CD8-positive, naive alpha-beta T cell number	J:265255
	decreased single-positive T cell number	J:265255
	decreased T cell number	J:265255
	increased B cell number	J:265255
	increased B-1b cell number	J:265255
	increased central memory CD8 positive, alpha-beta T cell number	J:265255
	increased effector memory CD4-positive, alpha-beta T cell number	J:265255
	increased effector memory CD8-positive, alpha-beta T cell number	J:265255
	increased IgM level	J:265255
	increased neutrophil cell number	J:265255
	increased NK cell number	J:265255
Rasgrp1^M4Btlr/Rasgrp1^M4Btlr (C57BL/6J-Rasgrp1^M4Btlr)	abnormal T cell morphology	J:267490
Rasgrp1^m5Btlr/Rasgrp1^m5Btlr (C57BL/6J-Rasgrp1^m5Btlr)	increased NK cell number	J:272846
Rasgrp1^tm1.1Wz/Rasgrp1^tm1.1Wz (B6.Cg-Rasgrp1^tm1.1Wz)	abnormal CD4-positive T cell differentiation	J:225109
	abnormal CD8-positive, alpha-beta T cell differentiation	J:225109
	abnormal immunoglobulin level	J:225109
	abnormal T cell differentiation	J:225109
	decreased single-positive T cell number	J:225109
	decreased T cell proliferation	J:225109
	enlarged spleen	J:225109
	increased CD4-positive, alpha-beta memory T cell number	J:225109
	increased IgE level	J:225109
	increased IgG1 level	J:225109
	increased single-positive T cell number	J:225109
	increased spleen weight	J:225109
Rasgrp1^tm1.1Wz/Rasgrp1^tm1.1Wz Tg(TcraH-Y,TcrbH-Y)71Vbo/? (involves: C57BL/6J * DBA/2J)	decreased single-positive T cell number	J:225109
	increased double-positive T cell number	J:225109
Rasgrp1^tm1.1Wz/Rasgrp1^tm1.1Wz Tg(TcraTcrb)425Cbn/? (involves: C57BL/6 * BALB/c)	abnormal CD4-positive T cell differentiation	J:225109
Rasgrp1^tm1Jstn/Rasgrp1^tm1Jstn (involves: 129P3/J * C57BL/6J)	decreased B cell number	J:108677
	decreased thymocyte number	J:108677
	enlarged spleen	J:108677
	increased immunoglobulin level	J:108677
	increased plasma cell number	J:108677
Rasgrp1^tm1Jstn/Rasgrp1^tm1Jstn (involves: 129P3/J)	abnormal CD4-positive, alpha beta T cell morphology	J:207898
	abnormal double-positive T cell morphology	J:207898
	decreased CD4-positive, alpha-beta T cell number	J:207898
	decreased CD8-positive, alpha-beta T cell number	J:207898
Rasgrp1^tm1Jstn/Rasgrp1^tm1Jstn Rasgrp3^tm1Jstn/Rasgrp3^tm1Jstn (involves: 129P3/J * C57BL/6J)	decreased B cell number	J:108677
	decreased plasma cell number	J:108677
Rasgrp2^tm1Amg/Rasgrp2^tm1Amg (Not Specified)	abnormal neutrophil physiology	J:122618
	abnormal platelet physiology	J:92864
	decreased platelet aggregation	J:122618, J:92864
	impaired neutrophil recruitment	J:122618
Rasgrp3^{em1(IMPC)Wtsi}/Rasgrp3^{em1(IMPC)Wtsi} (C57BL/6N-Rasgrp3^{em1(IMPC)Wtsi}/Wtsi)	decreased mean corpuscular hemoglobin	J:211773
	decreased mean platelet volume	J:211773
	increased CD8-positive, naive alpha-beta T cell number	J:211773
Rasgrp3^tm1Jstn/Rasgrp3^tm1Jstn (involves: 129P3/J * C57BL/6J)	decreased B cell number	J:108677
	decreased IgG1 level	J:108677
	decreased IgG2a level	J:108677
	decreased IgG level	J:108677
Rasgrp4^{tm1a(KOMP)Lste}/Rasgrp4^{tm1a(KOMP)Lste} (involves: C57BL/6)	abnormal neutrophil physiology	J:186412
	impaired neutrophil chemotaxis	J:186412
Rasgrp4^{tm1d(KOMP)Lste}/Rasgrp4^{tm1d(KOMP)Lste} (involves: 129S4/SvJaeSor * BALB/cJ * C57BL/6)	abnormal neutrophil physiology	J:186412
	impaired neutrophil chemotaxis	J:186412
Rasgrp4^{tm2a(KOMP)Wtsi}/Rasgrp4^{tm2a(KOMP)Wtsi} (C57BL/6N-Rasgrp4^{tm2a(KOMP)Wtsi}/Wtsi)	increased mean platelet volume	J:211773
Rassf2^tm1Dlim/Rassf2^tm1Dlim (B6.Cg-Rassf2^tm1Dlim)	abnormal myeloid leukocyte morphology	J:181952
	abnormal osteoclast differentiation	J:181952
	abnormal spleen red pulp morphology	J:181952
	abnormal thymus epithelium morphology	J:181952
	decreased B cell number	J:181952
	decreased bone marrow cell number	J:181952
	decreased CD4-positive, alpha-beta T cell number	J:181952
	decreased CD8-positive, alpha-beta T cell number	J:181952
	decreased common myeloid progenitor cell number	J:181952
	decreased erythrocyte cell number	J:181952
	decreased hematopoietic stem cell number	J:181952
	decreased leukocyte cell number	J:181952
	decreased osteoclast cell number	J:181952
	decreased spleen weight	J:181952
	decreased T cell number	J:181952
	decreased thymus weight	J:181952
	spleen hypoplasia	J:181952
	thymus hypoplasia	J:181952
Rassf5^tm1Kina/Rassf5^tm1Kina (involves: C57BL/6 * CBA * ICR)	abnormal B cell differentiation	J:92670
	abnormal leukocyte migration	J:92670
	abnormal spleen red pulp morphology	J:92670
	abnormal thymus cell ratio	J:92670
	abnormal thymus corticomedullary boundary morphology	J:92670
	abnormal thymus medulla morphology	J:92670
	decreased thymocyte number	J:92670
	spleen hypoplasia	J:92670
Rassf5^tm1Kina/Rassf5^tm1Kina (B6.Cg-Rassf5^tm1Kina)	abnormal lymphocyte physiology	J:168749
	enlarged spleen	J:168749
	increased B cell number	J:168749
	increased B cell proliferation	J:168749
	increased IgG level	J:168749
	increased memory T cell number	J:168749
	increased plasma cell number	J:168749
	increased T cell number	J:168749
	increased T cell proliferation	J:168749
Raver1^{em1(IMPC)Hmgu}/Raver1^{em1(IMPC)Hmgu} (C57BL/6NCrl-Raver1^{em1(IMPC)Hmgu}/Ieg)	increased spleen weight	J:211773
Rb1^tm1Brd/Rb1^tm1Brd (involves: 129S7/SvEvBrd * C57BL/6)	abnormal erythrocyte morphology	J:2516
Rb1^tm1Brd/Rb1^tm1Brd (involves: 129S7/SvEvBrd * C57BL/6)	increased nucleated erythrocyte cell number	J:2516
Rb1^tm1Dwg/Rb1^tm1Dwg (involves: 129/Sv * C57BL/6)	abnormal erythropoiesis	J:105548
Rb1^tm1Dwg/Rb1^tm1Dwg (involves: 129/Sv * C57BL/6)	abnormal macrophage morphology	J:105548
Rb1^tm1Dwg/Rb1^tm1Tyj (involves: 129/Sv * 129S2/SvPas * C57BL/6)	abnormal erythropoiesis	J:105548
Rb1^tm1Mlh/Rb1^tm1Mlh (either: 129P2/OlaHsd-Rb1^tm1Mlh or (involves: 129P2/OlaHsd * BALB/c) or (involves: 129P2/OlaHsd * FVB/N))	abnormal definitive hematopoiesis	J:2498
	abnormal erythrocyte morphology	J:2498
	abnormal erythropoiesis	J:20542, J:2498
	abnormal myelopoiesis	J:2498
	decreased erythrocyte cell number	J:2498
	increased megakaryocyte cell number	J:2498
Rb1^tm1Tyj/Rb1^tm1Tyj (involves: 129S2/SvPas)	abnormal erythropoiesis	J:105548
	abnormal macrophage differentiation	J:105548
	increased nucleated erythrocyte cell number	J:81643
Rb1^tm1Tyj/Rb1^tm1Tyj (involves: 129S2/SvPas * C57BL/6)	abnormal erythrocyte morphology	J:2511
	abnormal erythropoiesis	J:2511
	anemia	J:2511
	low mean erythrocyte cell number	J:2511
Rb1^tm1Tyj/Rb1^tm1Tyj Tg(Rb1)1Blg/0 (involves: 129S2/SvPas * C57BL/6)	abnormal erythropoiesis	J:37145
Rb1^tm2Mlh/Rb1^tm2Mlh (either: 129P2/OlaHsd-Rb1^tm2Mlh or (involves: 129P2/OlaHsd * BALB/c) or (involves: 129P2/OlaHsd * FVB/N))	abnormal definitive hematopoiesis	J:2498
	abnormal erythrocyte morphology	J:2498
	abnormal erythropoiesis	J:20542, J:2498
	abnormal myelopoiesis	J:2498
	decreased erythrocyte cell number	J:2498
	increased megakaryocyte cell number	J:2498
Rb1^tm3Tyj/Rb1^tm3.1Tyj Tg(Nes-cre)1Atp/0 (involves: 129S4/SvJae * FVB/N)	hematopoietic system phenotype	J:81643
Rb1cc1^tm1.1Guan/Rb1cc1^tm1.1Guan Tg(BEST1-cre)1Jdun/0 (involves: 129P2/OlaHsd * C57BL/6)	microgliosis	J:282249
Rb1cc1^tm1.1Guan/Rb1cc1^tm1.1Guan Tg(Mx1-cre)1Cgn/0 (B6.Cg-Rb1cc1^tm1.1Guan Tg(Mx1-cre)1Cgn)	abnormal hematopoietic stem cell morphology	J:167258
Rb1cc1^tm1.1Guan/Rb1cc1^tm1.1Guan Tg(Tek-cre)12Flv/0 (B6.Cg-Rb1cc1^tm1.1Guan Tg(Tek-cre)12Flv)	abnormal erythropoiesis	J:167258
	abnormal myelopoiesis	J:167258
	anemia	J:167258
	decreased erythrocyte cell number	J:167258
	decreased hematocrit	J:167258
	decreased hematopoietic stem cell number	J:167258
	decreased hemoglobin content	J:167258
	increased erythroblast number	J:167258
	increased hematopoietic stem cell proliferation	J:167258
	increased neutrophil cell number	J:167258
	increased red blood cell distribution width	J:167258
Rbbp4^em1(IMPC)Mbp/Rbbp4⁺ (C57BL/6NCrl-Rbbp4^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Rbcq1^SM/J/Rbcq1^SM/J (involves: NZW/LacJ * SM/J)	increased erythrocyte cell number	J:107220
Rbcq2^SM/J/Rbcq2^SM/J (involves: NZW/LacJ * SM/J)	increased erythrocyte cell number	J:107220
Rbcq3^NZW/LacJ/Rbcq3^SM/J (involves: NZW/LacJ * SM/J)	increased erythrocyte cell number	J:107220
Rbcq3^SM/J/Rbcq3^SM/J (involves: NZW/LacJ * SM/J)	increased erythrocyte cell number	J:107220
Rbcq4^C57BLKS/J/Rbcq4^C57BLKS/J (involves: C57BLKS/J * SM/J)	increased erythrocyte cell number	J:107220
Rbcq4^C57BLKS/J/Rbcq4^SM/J (involves: C57BLKS/J * SM/J)	increased erythrocyte cell number	J:107220
Rbl1^tm1Mru/Rbl1^tm1Mru (involves: 129S4/SvJae * BALB/cJ)	abnormal common myeloid progenitor cell morphology	J:51060
	abnormal definitive hematopoiesis	J:51060
	abnormal spleen red pulp morphology	J:51060
	extramedullary hematopoiesis	J:51060
	increased bone marrow cell number	J:51060
Rbm4^{tm1a(EUCOMM)Hmgu}/Rbm4⁺ (C57BL/6N-Rbm4^{tm1a(EUCOMM)Hmgu}/Cnrm)	decreased IgG2b level	J:165965
Rbm7^em1Aki/Rbm7^em1Aki (B6.Cg-Rbm7^em1Aki)	decreased monocyte cell number	J:288329
Rbm10^em1(IMPC)Mbp/Rbm10⁺ (C57BL/6NCrl-Rbm10^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Rbm15^{tm1.1(MAL)Dgg}/Rbm15^{tm1.1(MAL)Dgg} (B6.129-Rbm15^{tm1.1(MAL)Dgg})	abnormal common myeloid progenitor cell morphology	J:149622
	extramedullary hematopoiesis	J:149622
	increased hematopoietic stem cell number	J:149622
Rbm15^tm1Dgg/Rbm15^tm1.1Dgg Tg(Mx1-cre)1Cgn/0 (involves: 129/Sv * C57BL/6 * CBA * FVB/N)	abnormal B cell differentiation	J:120321
	decreased B cell number	J:120321
	decreased pre-B cell number	J:120321
	increased hematopoietic stem cell number	J:120321
	increased megakaryocyte cell number	J:120321
	increased spleen red pulp amount	J:120321
Rbm15^tm1Swm/Rbm15^tm1Swm Tg(Mx1-cre)1Cgn/0 (involves: 129X1/SvJ * C57BL/6 * CBA)	abnormal definitive hematopoiesis	J:152262
	abnormal megakaryocyte differentiation	J:152262
	decreased hemoglobin content	J:152262
	decreased leukocyte cell number	J:152262
	decreased lymphocyte cell number	J:152262
	decreased neutrophil cell number	J:152262
	increased hematopoietic stem cell number	J:152262
	increased megakaryocyte cell number	J:152262
	increased spleen red pulp amount	J:152262
Rbm20^em1(IMPC)Mbp/Rbm20^em1(IMPC)Mbp (C57BL/6N-Rbm20^em1(IMPC)Mbp/MbpMmucd)	small spleen	J:211773
Rbm22^em1(IMPC)Mbp/Rbm22⁺ (C57BL/6NCrl-Rbm22^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
Rbm38^tm1.1Xch/Rbm38^tm1.1Xch (involves: C57BL/6 * FVB/N)	abnormal erythrocyte morphology	J:216929
	anemia	J:216929
	decreased bone marrow cell number	J:216929
	decreased hematocrit	J:216929
	decreased hemoglobin content	J:216929
	enlarged spleen	J:216929
	extramedullary hematopoiesis	J:216929
	increased megakaryocyte cell number	J:216929
	increased spleen white pulp amount	J:216929
Rbm38^tm1.1Xch/Rbm38^tm1.1Xch Trp53^tm1Tyj/Trp53⁺ (involves: 129S2/SvPas * C57BL/6 * FVB/N)	abnormal spleen B cell follicle morphology	J:216929
Rbp1^tm1Ipc/Rbp1^tm1Ipc (involves: 129S2/SvPas)	increased granulocyte number	J:67762
Rbp1^tm1Ipc/Rbp1^tm1Ipc (involves: 129S2/SvPas)	increased neutrophil cell number	J:67762
Rbp4^{tm1.1(KOMP)Vlcg}/Rbp4^{tm1.1(KOMP)Vlcg} (C57BL/6N-Rbp4^{tm1.1(KOMP)Vlcg}/Ucd)	increased mean corpuscular hemoglobin	J:211773
Rbpj^tm1Hon/Rbpj^tm1Hon Tg(Cd4-cre)1Cwi/? (involves: 129P2/OlaHsd * C57BL/6 * DBA)	abnormal T-helper 2 cell differentiation	J:90018
Rbpj^tm1Hon/Rbpj^tm1Hon Tg(Itgax-cre)1-1Reiz/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	decreased dendritic cell number	J:125869
Rbpj^tm1Hon/Rbpj^tm1Hon Tg(Lck-cre)19Hhan/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA)	abnormal CD4-positive helper T cell morphology	J:168475
	abnormal regulatory T cell physiology	J:168475
	increased macrophage cell number	J:168475
	increased single-positive T cell number	J:168475
	increased splenocyte number	J:168475
	increased T cell number	J:168475
	increased T cell proliferation	J:168475
Rbpj^tm1Hon/Rbpj^tm1Hon Tg(Mx1-cre)1Cgn/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	abnormal B cell differentiation	J:99747
	abnormal lymphopoiesis	J:99747
	arrested T cell differentiation	J:125869, J:99747
	decreased dendritic cell number	J:125869
	decreased double-positive T cell number	J:99747
	decreased marginal zone B cell number	J:76240, J:99747
	decreased single-positive T cell number	J:99747
	decreased thymocyte number	J:99747
	increased B cell number	J:125869, J:99747
	increased double-negative T cell number	J:99747
	increased follicular B cell number	J:99747
	increased macrophage cell number	J:125869
	increased monocyte cell number	J:125869
	increased plasmacytoid dendritic cell number	J:125869
	small thymus	J:99747
Rc3h1^san/Rc3h1⁺ (involves: C57BL/6JSfdAnu)	abnormal T follicular helper cell physiology	J:189087
	increased IgG level	J:189087
	increased spleen weight	J:189087
	increased T follicular helper cell number	J:189087
Rc3h1^san/Rc3h1^san (either: C57BL/6JSfdAnu-Rc3h1^san/Anu or (involves: C57BL/6JSfdAnu * CBA/Ca))	abnormal T cell differentiation	J:98938
	anemia	J:98938
	thrombocytopenia	J:98938
Rc3h1^san/Rc3h1^san (involves: C57BL/6JSfdAnu)	abnormal effector T cell morphology	J:199407
	abnormal intraepithelial T cell number	J:199407
	enlarged spleen	J:199407
	increased activated T cell number	J:199407
	increased CD4-positive, alpha-beta T cell number	J:199407
	increased T cell proliferation	J:199407
Rc3h1^san/Rc3h1^san Rc3h2^tm1.2Cgv/Rc3h2^tm1.2Cgv (involves: C57BL/6 * C57BL/6JSfdAnu)	increased T follicular helper cell number	J:196137
Rc3h1^tm1.1Mass/Rc3h1^tm1.1Mass Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * C57BL/6 * NZB * SJL)	abnormal effector T cell morphology	J:177784
	enlarged spleen	J:177784
	increased B cell number	J:177784
	increased eosinophil cell number	J:177784
	increased regulatory T cell number	J:177784
	increased spleen weight	J:177784
Rc3h1^tm1.1Mass/Rc3h1^tm1.1Mass Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: C57BL/6 * C57BL/10 * CBA/Ca * NZB * SJL)	abnormal B cell differentiation	J:177784
	abnormal effector T cell morphology	J:177784
	abnormal germinal center B cell physiology	J:177784
	abnormal spleen B cell follicle morphology	J:177784
	decreased B cell number	J:177784
	decreased bone marrow cell number	J:177784
	decreased IgA level	J:177784
	decreased IgG1 level	J:177784
	decreased IgG3 level	J:177784
	decreased immature B cell number	J:177784
	enlarged spleen	J:177784
	increased eosinophil cell number	J:177784
	increased IgG2b level	J:177784
	increased macrophage cell number	J:177784
	increased regulatory T cell number	J:177784
	increased spleen weight	J:177784
	increased splenocyte number	J:177784
	spleen hyperplasia	J:177784
Rc3h1^tm1.1Mass/Rc3h1^tm1.1Mass Rc3h2^{tm1c(KOMP)Wtsi}/Rc3h2^{tm1c(KOMP)Wtsi} Tg(Cd4-cre)1Cwi/? (involves: C57BL/6N * DBA/2)	abnormal B cell number	J:196136
	abnormal spleen B cell follicle morphology	J:196136
	abnormal spleen morphology	J:196136
	abnormal spleen periarteriolar lymphoid sheath morphology	J:196136
	decreased CD4-positive, alpha-beta T cell number	J:196136
	decreased CD8-positive, alpha-beta T cell number	J:196136
	decreased T cell number	J:196136
	enlarged spleen	J:196136
	increased germinal center B cell number	J:196136
	increased T cell proliferation	J:196136
	increased T follicular helper cell number	J:196136
Rc3h1^tm1.1Mass/Rc3h1^tm1.1Mass Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2 * NZB * SJL)	increased CD8-positive, alpha-beta T cell number	J:177784
	increased eosinophil cell number	J:177784
	increased macrophage cell number	J:177784
Rc3h1^tm1.2Cgv/Rc3h1^san (involves: C57BL/6 * C57BL/6JSfdAnu)	increased CD4-positive, alpha-beta T cell number	J:196137
	increased T follicular helper cell number	J:196137
Rc3h1^tm1.2Mass/Rc3h1^tm1.2Mass (involves: C57BL/6 * CBA * NZB * SJL)	abnormal thymus development	J:177784
Rc3h1^tm1.2Mass/Rc3h1^tm1.2Mass (involves: C57BL/6 * CBA * CD-1 * NZB * SJL)	abnormal effector T cell morphology	J:177784
	enlarged spleen	J:177784
	increased spleen weight	J:177784
Rc3h2^tm1.2Cgv/Rc3h2^tm1.2Cgv (involves: C57BL/6)	increased macrophage cytokine production	J:196137
Rcan1^tm1Fmc/Rcan1^tm1Fmc (involves: 129S4/SvJae)	abnormal T cell apoptosis	J:85148
	abnormal T-helper 1 physiology	J:85148
	decreased IgG2a level	J:85148
	decreased T cell proliferation	J:85148
Rcan1^tm1Jmol/Rcan1^tm1Jmol Rcan2^tm1Jmol/Rcan2^tm1Jmol (involves: 129 * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:109586
	decreased T cell proliferation	J:109586
Rcan1^tm1Jmol/Rcan1^tm1Jmol Rcan2^tm1Jmol/Rcan2^tm1Jmol Ppp3cb^tm1Jmk/Ppp3cb^tm1Jmk (involves: 129S6/SvEvTac * C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:109586
	abnormal CD4-positive, alpha-beta T cell physiology	J:109586
	abnormal CD8-positive, alpha beta T cell morphology	J:109586
	decreased T cell proliferation	J:109586
Rcbtb2^tm1.1Xyw/Rcbtb2⁺ (involves: C57BL/6 * CBA)	enlarged spleen	J:282928
Rcbtb2^tm1.1Xyw/Rcbtb2^tm1.1Xyw (involves: C57BL/6 * CBA)	abnormal bone marrow cell physiology	J:282928
	abnormal splenocyte physiology	J:282928
	enlarged spleen	J:282928
Rcc1l^{tm1a(EUCOMM)Hmgu}/Rcc1l⁺ (Not Specified)	decreased IgG1 level	J:165965
Rcc2^{tm1b(EUCOMM)Wtsi}/Rcc2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Rcc2^{tm1b(EUCOMM)Wtsi}/H)	decreased mean corpuscular volume	J:211773
Rcor1^tm2.2Gman/Rcor1^tm2.2Gman (B6.129S1(SJL)-Rcor1^tm2.2Gman)	abnormal embryonic erythropoiesis	J:211681
	decreased erythroid progenitor cell number	J:211681
Rcor3^em1(IMPC)J/Rcor3^em1(IMPC)J (C57BL/6NJ-Rcor3^em1(IMPC)J/Mmjax)	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
Rd3^em1(IMPC)Bay/Rd3^em1(IMPC)Bay (C57BL/6N-Rd3^em1(IMPC)Bay/BayMmucd)	decreased mean corpuscular hemoglobin concentration	J:211773
	increased hematocrit	J:211773
Rdh7^{tm1c(KOMP)Wtsi}/Rdh7^{tm1c(KOMP)Wtsi} Tg(RARE-Hspa1b/lacZ)12Jrt/0 Tg(Vil1-cre)997Gum/0 (involves: C57BL/6J * C57BL/6N * CD-1 * SJL)	decreased lymphocyte cell number	J:279231
Rdx^{tm1.1(KOMP)Vlcg}/Rdx⁺ (C57BL/6N-Rdx^{tm1.1(KOMP)Vlcg}/J)	increased mean corpuscular hemoglobin	J:211773
Rec8^{tm1b(KOMP)Wtsi}/Rec8^{tm1b(KOMP)Wtsi} (C57BL/6N-Rec8^{tm1b(KOMP)Wtsi}/J)	increased mean corpuscular hemoglobin concentration	J:211773
Recql4^tm1Abe/Recql4^tm1Abe (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal thymus corticomedullary boundary morphology	J:85574
	decreased spleen white pulp amount	J:85574
	small thymus	J:85574
Reg3b^em1(IMPC)Mbp/Reg3b^em1(IMPC)Mbp (C57BL/6NCrl-Reg3b^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Reg3g^tm1.1Lvh/Reg3g^tm1.1Lvh (B6.129-Reg3g^tm1.1Lvh)	increased IgA level	J:177506
Reg3g^tm1.1Lvh/Reg3g^tm1.1Lvh (B6.129-Reg3g^tm1.1Lvh)	increased T-helper 1 cell number	J:177506
Reg4^{tm1b(EUCOMM)Hmgu}/Reg4^{tm1b(EUCOMM)Hmgu} (C57BL/6NTac-Reg4^{tm1b(EUCOMM)Hmgu}/H)	decreased hemoglobin content	J:211773
	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular hemoglobin concentration	J:211773
Rel^M1Btlr/Rel⁺ (C57BL/6J-Rel^M1Btlr)	decreased IgE level	J:236682
	decreased IgG level	J:236682
	decreased IgM level	J:236682
	impaired hematopoiesis	J:236682
	increased CD4-positive, alpha-beta T cell number	J:236682
	increased T cell number	J:236682
Rel^M1Btlr/Rel^M1Btlr (C57BL/6J-Rel^M1Btlr)	decreased B-1 B cell number	J:236682
	decreased CD4-positive, alpha-beta T cell number	J:236682
	decreased CD8-positive, alpha-beta T cell number	J:236682
	decreased IgE level	J:236682
	decreased IgG level	J:236682
	decreased IgM level	J:236682
	impaired hematopoiesis	J:236682
	increased CD4-positive, alpha-beta T cell number	J:236682
	increased CD8-positive, alpha-beta T cell number	J:236682
	increased effector memory CD4-positive, alpha-beta T cell number	J:236682
	increased T cell number	J:236682
Rel^M2Btlr/Rel^M2Btlr (C57BL/6J-Rel^M2Btlr)	abnormal CD4-positive T cell differentiation	J:272778
	abnormal T cell differentiation	J:272778
	decreased alpha-beta T cell number	J:272778
	decreased B-1 B cell number	J:272778
	decreased CD4-positive, alpha-beta T cell number	J:272778
	decreased central memory CD4-positive, alpha-beta T cell number	J:272778
	decreased effector memory CD4-positive, alpha-beta T cell number	J:272778
Rel^m3Btlr/Rel^m3Btlr (C57BL/6J-Rel^m3Btlr)	decreased IgM level	J:272801
Rel^{tm1b(EUCOMM)Wtsi}/Rel^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Rel^{tm1b(EUCOMM)Wtsi}/H)	decreased monocyte cell number	J:211773
Rel^tm1Brv/Rel^tm1Brv (involves: 129S1/Sv)	abnormal leukocyte physiology	J:46911
	abnormal macrophage morphology	J:46911
	abnormal macrophage physiology	J:46911
	abnormal spleen morphology	J:46911
	abnormal splenic cell ratio	J:46911
	abnormal T cell physiology	J:46911
	decreased bone marrow cell number	J:46911
	decreased IgG1 level	J:46911
	decreased IgG2b level	J:46911
	decreased IgG3 level	J:46911
	decreased IgG level	J:46911
	decreased spleen germinal center number	J:46911
	enlarged spleen	J:46911
	extramedullary hematopoiesis	J:46911
	impaired macrophage chemotaxis	J:46911
	increased IgA level	J:46911
	increased IgG2a level	J:46911
	increased IgM level	J:46911
	increased spleen B cell follicle size	J:46911
Rel^tm1Grd/Rel⁺ (involves: 129S1/Sv * C57BL/6)	decreased B cell proliferation	J:28435
Rel^tm1Grd/Rel^tm1Grd (involves: 129S1/Sv * C57BL/6)	abnormal macrophage physiology	J:37541
	decreased B cell proliferation	J:28435
	decreased IgG1 level	J:28435
	decreased IgG2a level	J:28435
	decreased IgG2b level	J:28435
	decreased IgG3 level	J:28435
	decreased IgM level	J:28435
	decreased T cell proliferation	J:28435
Rel^tm1Grd/Rel^tm1Grd Rela^tm1Bal/Rela^tm1Bal (B6.129S-Rel^tm1Grd Rela^tm1Bal)	abnormal erythropoiesis	J:111325
	abnormal monocyte differentiation	J:111325
	decreased common myeloid progenitor cell number	J:111325
	hematopoietic system phenotype	J:111325
	hyperchromasia	J:111325
	increased granulocyte number	J:111325
Rel^tm1Hcl/Rel⁺ (involves: 129S4/SvJae * C57BL/6)	decreased T cell proliferation	J:53513
Rel^tm1Hcl/Rel^tm1Hcl (involves: 129S4/SvJae * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:79107, J:118907
	abnormal macrophage physiology	J:118907
	abnormal memory B cell number	J:75621
	abnormal T-helper 1 cell differentiation	J:79107
	decreased B cell proliferation	J:75621
	decreased cytotoxic T cell cytolysis	J:53513
	decreased IgE level	J:58987
	decreased T cell proliferation	J:53513, J:79107
	increased eosinophil cell number	J:58987
Rela^tm1Bal/Rela^tm1Bal (involves: 129S4/SvJae)	decreased marginal zone B cell number	J:65246
Rela^tm1Bal/Rela^tm1Bal Tnfrsf1a^tm1Imx/Tnfrsf1a^tm1Imx (involves: 129S4/SvJae * C57BL/6)	abnormal spleen germinal center morphology	J:60742
	abnormal thymus morphology	J:60742
	decreased spleen white pulp amount	J:60742
	extramedullary hematopoiesis	J:60742
Rela^tm1Rsch/Rela^tm1Rsch Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	abnormal gamma-delta T cell morphology	J:169863
Rela^tm1Rsch/Rela^tm1Rsch Tg(Lck-cre)I57Jxm/0 (involves: ICR)	abnormal gamma-delta T cell morphology	J:169863
Rela^tm1Yuo/Rela^tm1Yuo (involves: 129S/SvEv)	abnormal lymphocyte physiology	J:63099
	decreased B cell proliferation	J:63099
	decreased double-positive T cell number	J:63099
	decreased IgA level	J:63099
	decreased IgG1 level	J:63099
	decreased T cell proliferation	J:63099
Rela^tm2.1Gho/Rela^tm2.1Gho (involves: 129S6/SvEvTac * C57BL/6)	abnormal spleen morphology	J:163663
	extramedullary hematopoiesis	J:163663
	increased neutrophil cell number	J:163663
Relb^shep/Relb^shep (A;C-Relb^shep/GrsrJ)	anemia	J:171971
Relb^{Tg(H2-K1/GH1)106Bri}/Relb⁺ (involves: C57BL/6)	decreased NK T cell number	J:120659
Relb^{Tg(H2-K1/GH1)106Bri}/Relb^{Tg(H2-K1/GH1)106Bri} (C57BL/6-Relb^{Tg(H2-K1/GH1)106Bri})	absent thymus medulla	J:23081, J:76450
	decreased B cell number	J:76450
	decreased pre-B cell number	J:76450
	decreased T cell number	J:76450
	decreased T cell proliferation	J:76450
	enlarged spleen	J:76450
	increased granulocyte number	J:23081, J:76450
	increased macrophage cell number	J:23081, J:76450
Relb^{Tg(H2-K1/GH1)106Bri}/Relb^{Tg(H2-K1/GH1)106Bri} (involves: C57BL/6)	decreased NK T cell number	J:120659
Relb^tm1.1Fwei/Relb^tm1.1Fwei Tg(Lck-cre)I57Jxm/0 (involves: ICR)	abnormal gamma-delta T cell morphology	J:169863
Relb^tm1Brv/Relb^tm1Brv (involves: 129S2/SvPas * C57BL/6)	abnormal cytotoxic T cell physiology	J:40630
	abnormal definitive hematopoiesis	J:22675
	abnormal erythropoiesis	J:22675
	abnormal immunoglobulin level	J:40630
	abnormal macrophage physiology	J:40630
	abnormal proerythroblast morphology	J:22675
	decreased B cell proliferation	J:40630
	decreased dendritic cell number	J:22675
	decreased spleen white pulp amount	J:22675
	decreased T cell number	J:22675
	extramedullary hematopoiesis	J:22675
	impaired neutrophil phagocytosis	J:40630
	increased bone marrow cell number	J:22675
	increased IgE level	J:40630
	increased IgM level	J:40630
	increased spleen red pulp amount	J:22675
	increased spleen weight	J:22675
	myeloid hyperplasia	J:22675
	thymus atrophy	J:22675
	thymus hypoplasia	J:22675
Relb^tm1Brv/Relb^tm1Brv (either: (involves: 129S2/SvPas) or (involves: C57BL/6) or (involves: 129S2/SvPas * C57BL/6))	increased eosinophil cell number	J:63950
Relb^tm1Brv/Relb^tm1Brv (involves: 129S2/SvPas)	abnormal gamma-delta T cell morphology	J:169863
	decreased dendritic cell number	J:85808
	spleen hyperplasia	J:85808
Relch^em1(IMPC)J/Relch^em1(IMPC)J (C57BL/6NJ-Relch^em1(IMPC)J/Mmjax)	decreased mean corpuscular hemoglobin concentration	J:211773
	increased mean corpuscular volume	J:211773
Reln^em1(IMPC)Mbp/Reln⁺ (C57BL/6N-Reln^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Relt^tm1Hlee/Relt^tm1Hlee (Not Specified)	abnormal T cell morphology	J:266480
	hematopoietic system phenotype	J:266480
	increased T cell proliferation	J:266480
Ren1^tm1.2Sig/Ren1^tm1.2Sig (involves: C57BL/6J)	decreased hematocrit	J:169129
Rest^{tm2b(EUCOMM)Wtsi}/Rest⁺ (C57BL/6N-Rest^{tm2b(EUCOMM)Wtsi}/Ieg)	decreased mean platelet volume	J:211773
Ret^tm6.1Vpa/Ret^tm6.2Vpa Tg(CD2-icre)4Kio/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/10 * CBA/Ca)	hematopoietic system phenotype	J:195828
Retnla^tm1Mer/Retnla^tm1Mer (C57BL/6-Retnla^tm1Mer)	impaired eosinophil recruitment	J:144784
Retnla^tm1Mer/Retnla^tm1Mer (involves: C57BL/6)	abnormal macrophage physiology	J:147863
	abnormal T-helper 2 physiology	J:147863
	increased IgE level	J:147863
	increased IgG1 level	J:147863
Retnlb^tm1Lex/Retnlb^tm1Lex (FVB.129S5-Retnlb^tm1Lex)	abnormal CD4-positive, alpha-beta T cell physiology	J:235058
Retnlb^tm1Lex/Retnlb^tm1Lex (FVB.129S5-Retnlb^tm1Lex)	increased neutrophil cell number	J:235058
Retnlb^tm1Mer/Retnlb^tm1Mer (involves: 129S1/Sv)	decreased IgG2a level	J:141446
Retnlb^tm1Mer/Retnlb^tm1Mer (involves: 129S1/Sv)	increased IgG1 level	J:141446
Retnlg^em1(IMPC)J/Retnlg^em1(IMPC)J (C57BL/6NJ-Retnlg^em1(IMPC)J/Mmjax)	decreased mean corpuscular hemoglobin concentration	J:211773
Retreg2^{em2(IMPC)Ccpcz}/Retreg2^{em2(IMPC)Ccpcz} (C57BL/6N-Retreg2^{em2(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased leukocyte cell number	J:211773
Retreg3^{tm2a(EUCOMM)Wtsi}/Retreg3^{tm2a(EUCOMM)Wtsi} (C57BL/6N-Retreg3^{tm2a(EUCOMM)Wtsi}/Wtsi)	decreased hemoglobin content	J:165965
Retreg3^{tm2b(EUCOMM)Wtsi}/Retreg3^{tm2b(EUCOMM)Wtsi} (C57BL/6N-Fam134c^{tm2b(EUCOMM)Wtsi}/Wtsi)	increased neutrophil cell number	J:211773
Rev1^tm1.1Jow/Rev1^tm1.1Jow (involves: C57BL/6)	abnormal somatic hypermutation frequency	J:151700
Rev1^tm1Ndew/Rev1^tm1Ndew (involves: 129P2/OlaHsd * C57BL/6)	abnormal somatic hypermutation frequency	J:119176
Rev3l^tm1.1Kunk/Rev3l^tm1.1Kunk (involves: C57BL/6)	abnormal somatic hypermutation frequency	J:188723
Rev3l^{tm1b(EUCOMM)Hmgu}/Rev3l⁺ (C57BL/6N-Rev3l^{tm1b(EUCOMM)Hmgu}/J)	decreased mean corpuscular volume	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
Rev3l^tm1Rsky/Rev3l^tm1.1Rsky Tg(Cr2-cre)3Cgn/? (involves: C57BL/6)	abnormal class switch recombination	J:146453
	abnormal somatic hypermutation frequency	J:146453
	decreased B cell proliferation	J:146453
	decreased germinal center B cell number	J:146453
	decreased IgG1 level	J:146453
Rexo2^{tm1b(EUCOMM)Wtsi}/Rexo2⁺ (C57BL/6N-Rexo2^{tm1b(EUCOMM)Wtsi}/H)	decreased neutrophil cell number	J:211773
	increased lymphocyte cell number	J:211773
Rfc1^{tm1b(KOMP)Mbp}/Rfc1⁺ (B6N(Cg)-Rfc1^{tm1b(KOMP)Mbp}/J)	increased mean corpuscular hemoglobin concentration	J:211773
Rffl^{em1(IMPC)Ccpcz}/Rffl^{em1(IMPC)Ccpcz} (C57BL/6N-Rffl^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Rfk^em1(IMPC)Mbp/Rfk⁺ (C57BL/6NCrl-Rfk^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	small spleen	J:211773
Rfk^tm1.1Jcbr/Rfk^tm1.1Jcbr Tg(Mx1-cre)1Cgn/? (involves: C57BL/6 * CBA)	decreased macrophage nitric oxide production	J:151999
Rft1^{tm1b(KOMP)Wtsi}/Rft1⁺ (C57BL/6N-Rft1^{tm1b(KOMP)Wtsi}/Bay)	decreased erythrocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	increased basophil cell number	J:211773
	increased hemoglobin content	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
	increased monocyte cell number	J:211773
Rftn1^tm1Ayos/Rftn1^tm1Ayos (B6.Cg-Rftn1^tm1Ayos)	abnormal CD4-positive T cell differentiation	J:150299
	decreased IgG2a level	J:150299
	decreased splenocyte number	J:150299
Rfx5^tm1.1Ifo/Rfx5^tm1.1Ifo (involves: 129 * C57BL/6)	abnormal B lymphocyte antigen presentation	J:67941
	abnormal dendritic cell morphology	J:67941
	abnormal Kupffer cell morphology	J:67941
	abnormal MHC II cell surface expression on macrophages	J:67941
	abnormal thymus cortex morphology	J:67941
	decreased CD4-positive, alpha-beta T cell number	J:67941
	decreased IgG1 level	J:67941
	decreased IgM level	J:67941
	decreased single-positive T cell number	J:67941
Rfx5^tm1Ifo/Rfx5^tm1.1Ifo Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129 * C57BL/6 * C.B-20)	abnormal MHC II cell surface expression on macrophages	J:67924
Rfx7^tm1.1Ggaur/Rfx7^tm1.1Ggaur Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: C57BL/6 * C57BL/10 * CBA/Ca)	abnormal NK cell morphology	J:282535
	decreased NK cell number	J:282535
	small spleen	J:282535
Rfx7^tm1.1Ggaur/Rfx7^tm1.1Ggaur Ncr1^{tm1.1(icre)Viv}/Ncr1⁺ (involves: C57BL/6)	abnormal NK cell physiology	J:282535
	decreased NK cell number	J:282535
Rfx7^tm1.1Ggaur/Rfx7^tm1.1Ggaur Rptor^tm1.1Dmsa/Rptor⁺ Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: 129S/SvEv * C57BL/10 * CBA/Ca)	abnormal NK cell morphology	J:282535
	decreased NK cell number	J:282535
	small spleen	J:282535
Rgcc^tm1Hrus/Rgcc^tm1Hrus (involves: 129S6/SvEvTac * C57BL/6)	increased T cell proliferation	J:279555
Rgl1^em1(IMPC)Mbp/Rgl1⁺ (C57BL/6N-Rgl1^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	decreased mean corpuscular volume	J:211773
	enlarged spleen	J:211773
	increased neutrophil cell number	J:211773
Rgs1^tm1Jhk/Rgs1^tm1Jhk (B6.129P2-Rgs1^tm1Jhk)	abnormal B cell physiology	J:90780
	abnormal spleen germinal center morphology	J:90780
	decreased plasma cell number	J:90780
	increased immunoglobulin level	J:90780
	increased marginal zone B cell number	J:90780
Rgs2^em1(IMPC)H/Rgs2⁺ (C57BL/6NTac-Rgs2^em1(IMPC)H/H)	increased large unstained cell number	J:211773
Rgs2^em1(IMPC)H/Rgs2^em1(IMPC)H (C57BL/6NTac-Rgs2^em1(IMPC)H/H)	enlarged spleen	J:211773
Rgs2^tm1Pngr/Rgs2^tm1Pngr (involves: C57BL/6J)	abnormal T cell proliferation	J:77273
Rgs2^tm1Pngr/Rgs2^tm1Pngr (involves: C57BL/6J)	hematopoietic system phenotype	J:77273
Rgs3^tm1Ndul/Rgs3^tm1Ndul (B6.129-Rgs3^tm1Ndul)	increased B cell number	J:210195
	increased CD4-positive, alpha-beta T cell number	J:210195
	increased CD8-positive, alpha-beta T cell number	J:210195
Rgs4^em1(IMPC)H/Rgs4^em1(IMPC)H (C57BL/6N-Rgs4^em1(IMPC)H/H)	decreased lymphocyte cell number	J:211773
	increased eosinophil cell number	J:211773
	increased mean corpuscular volume	J:211773
	increased spleen weight	J:211773
Rgs4^tm1Sdlk/Rgs4^tm1Sdlk Tg(Myh11-icre/ERT2)1Soff/? (involves: FVB/N)	abnormal macrophage chemotaxis	J:215588
Rgs5^tm1Jhk/Rgs5^tm1Jhk (involves: 129S/SvEv * C57BL/6)	decreased lymphocyte cell number	J:133897
Rgs10^tm1Ypl/Rgs10^tm1Ypl (involves: 129S4/SvJae * C57BL/6J)	abnormal osteoclast differentiation	J:123167
	decreased osteoclast cell number	J:123167
Rgs12^tm1.1Syy/Rgs12^tm1.1Syy Tg(Mx1-cre)1Cgn/0 (involves: 129 * C57BL/6 * CBA)	decreased osteoclast cell number	J:194057
Rgs13^tm1.1Jhk/Rgs13^tm1.1Jhk (involves: C57BL/6)	abnormal B cell differentiation	J:199530
	abnormal spleen morphology	J:199530
	decreased B cell number	J:199530
	increased B cell number	J:199530
	increased germinal center B cell number	J:199530
	increased IgA level	J:199530
	increased IgG1 level	J:199530
	increased IgG2b level	J:199530
	increased IgG2c level	J:199530
	increased IgG3 level	J:199530
	increased IgM level	J:199530
	increased spleen germinal center number	J:199530
	increased spleen germinal center size	J:199530
Rgs13^tm1Drue/Rgs13^tm1Drue (B6.129S-Rgs13^tm1Drue)	abnormal mast cell physiology	J:130209
Rgs14^tm1Lex/Rgs14^tm1Lex (involves: 129S5/SvEvBrd)	hematopoietic system phenotype	J:103485
Rgs16^tm1.1Drue/Rgs16^tm1.1Drue (involves: C57BL/6)	abnormal T-helper 1 physiology	J:188966
Rgs16^tm1.1Drue/Rgs16^tm1.1Drue (involves: C57BL/6)	abnormal T-helper 2 physiology	J:188966
Rgs18^m1H/Rgs18^m1H (BALB/cAnN-Rgs18^m1H/H)	increased platelet aggregation	J:228457
Rgs18^tm1.1Ics/Rgs18^tm1.1Ics (involves: 129S2/SvPas * C57BL/6J)	abnormal bone marrow cell morphology/development	J:225296
	abnormal megakaryocyte differentiation	J:225296
	decreased megakaryocyte cell number	J:225296
	increased platelet aggregation	J:225296
	thrombocytopenia	J:225296
Rgsc14/Rgsc14⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	increased leukocyte cell number	J:133634
Rgsc14/Rgsc14⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	increased lymphocyte cell number	J:133634
Rgsc15/Rgsc15⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	increased leukocyte cell number	J:133634
Rgsc15/Rgsc15⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	increased lymphocyte cell number	J:133634
Rgsc16/Rgsc16⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	decreased erythrocyte cell number	J:133634
Rgsc16/Rgsc16⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	increased red blood cell distribution width	J:133634
Rgsc17/Rgsc17⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	decreased leukocyte cell number	J:133634
Rgsc17/Rgsc17⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	decreased lymphocyte cell number	J:133634
Rgsc278/Rgsc278⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	anisocytosis	J:133634
Rgsc278/Rgsc278⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	increased hemoglobin concentration distribution width	J:133634
Rgsc279/Rgsc279⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	decreased erythrocyte cell number	J:133634
Rgsc279/Rgsc279⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	decreased hemoglobin content	J:133634
Rgsc344/Rgsc344⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	decreased erythrocyte cell number	J:133634
Rgsc344/Rgsc344⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	increased mean corpuscular hemoglobin	J:133634
Rgsc350/Rgsc350⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	anisocytosis	J:133634
Rgsc375/Rgsc375⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	anisocytosis	J:133634
Rgsc393/Rgsc393⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	anisocytosis	J:133634
Rgsc393/Rgsc393⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	increased hemoglobin concentration distribution width	J:133634
Rgsc411/Rgsc411⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	anisocytosis	J:133634
Rgsc460/Rgsc460⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	anisocytosis	J:133634
Rgsc461/Rgsc461⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	anisocytosis	J:133634
Rgsc471/Rgsc471⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	anisocytosis	J:133634
Rgsc485/Rgsc485⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	anisocytosis	J:133634
Rgsc485/Rgsc485⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	decreased mean corpuscular volume	J:133634
Rgsc486/Rgsc486⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	anisocytosis	J:133634
Rgsc486/Rgsc486⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	increased hemoglobin concentration distribution width	J:133634
Rgsc530/Rgsc530⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	decreased mean corpuscular hemoglobin	J:133634
Rgsc530/Rgsc530⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	decreased mean corpuscular volume	J:133634
Rgsc538/Rgsc538⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	anisocytosis	J:133634
	decreased mean corpuscular hemoglobin	J:133634
	decreased mean corpuscular volume	J:133634
Rgsc546/Rgsc546⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	anisocytosis	J:133634
Rgsc546/Rgsc546⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	decreased mean corpuscular hemoglobin	J:133634
Rgsc548/Rgsc548⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	anisocytosis	J:133634
Rgsc548/Rgsc548⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	decreased mean corpuscular volume	J:133634
Rgsc630/Rgsc630⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	anisocytosis	J:133634
Rgsc649/Rgsc649⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	thrombocytopenia	J:133634
Rgsc669/Rgsc669⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	decreased erythrocyte cell number	J:133634
	increased mean corpuscular hemoglobin	J:133634
	increased mean corpuscular volume	J:133634
Rgsc710/Rgsc710⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	decreased erythrocyte cell number	J:133634
Rgsc710/Rgsc710⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	increased mean corpuscular hemoglobin	J:133634
Rgsc719/Rgsc719⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	anisocytosis	J:133634
	decreased mean corpuscular volume	J:133634
	increased hemoglobin concentration distribution width	J:133634
Rgsc747/Rgsc747⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	anisocytosis	J:133634
Rgsc758/Rgsc758⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	anisocytosis	J:133634
Rgsc758/Rgsc758⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	decreased mean corpuscular volume	J:133634
Rgsc844/Rgsc844⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	abnormal neutrophil physiology	J:133634
Rgsc859/Rgsc859⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	anisocytosis	J:133634
	decreased mean corpuscular hemoglobin	J:133634
	decreased mean corpuscular volume	J:133634
	increased erythrocyte cell number	J:133634
	increased hemoglobin concentration distribution width	J:133634
Rgsc861/Rgsc861⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	decreased erythrocyte cell number	J:133634
Rgsc900/Rgsc900⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	decreased mean corpuscular hemoglobin	J:133634
Rgsc900/Rgsc900⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	decreased mean corpuscular volume	J:133634
Rgsc919/Rgsc919⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	abnormal erythrocyte morphology	J:133634
	anisocytosis	J:133634
	decreased mean corpuscular hemoglobin	J:133634
	decreased mean corpuscular volume	J:133634
	increased erythrocyte cell number	J:133634
	increased hemoglobin concentration distribution width	J:133634
Rgsc930/Rgsc930⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	abnormal erythrocyte morphology	J:133634
	anisocytosis	J:133634
	decreased mean corpuscular hemoglobin	J:133634
	decreased mean corpuscular volume	J:133634
Rgsc933/Rgsc933⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	decreased erythrocyte cell number	J:133634
Rgsc1045/Rgsc1045⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	abnormal neutrophil physiology	J:133634
Rgsc1088/Rgsc1088⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	decreased mean corpuscular hemoglobin	J:133634
Rgsc1088/Rgsc1088⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	decreased mean corpuscular volume	J:133634
Rgsc1142/Rgsc1142⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	decreased mean corpuscular hemoglobin	J:133634
Rgsc1142/Rgsc1142⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	decreased mean corpuscular volume	J:133634
Rgsc1175/Rgsc1175⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	decreased erythrocyte cell number	J:133634
Rgsc1175/Rgsc1175⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	increased mean corpuscular hemoglobin	J:133634
Rgsc1177/Rgsc1177⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	decreased mean corpuscular volume	J:133634
Rgsc1354/Rgsc1354⁺ (involves: C3H * C57BL/6JJcl)	abnormal neutrophil physiology	J:133634
Rgsc1471/Rgsc1471⁺ (involves: C3H * C57BL/6JJcl)	thrombocytopenia	J:133634
Rgsc1605/Rgsc1605⁺ (involves: C3H * C57BL/6JJcl)	decreased mean corpuscular volume	J:133634
Rgsc1605/Rgsc1605⁺ (involves: C3H * C57BL/6JJcl)	increased erythrocyte cell number	J:133634
Rgsc1686/Rgsc1686⁺ (involves: C3H * C57BL/6JJcl)	increased mean corpuscular hemoglobin	J:133634
Rgsc1700/Rgsc1700⁺ (involves: C3H * C57BL/6JJcl)	thrombocytopenia	J:133634
Rgsc1701/Rgsc1701⁺ (involves: C3H * C57BL/6JJcl)	thrombocytopenia	J:133634
Rgsc1716/Rgsc1716⁺ (involves: C3H * C57BL/6JJcl)	thrombocytosis	J:133634
Rhag^{em1(IMPC)Ccpcz}/Rhag^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Rhag^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	decreased mean corpuscular hemoglobin	J:211773
	enlarged thymus	J:211773
Rhag^tm1Goo/Rhag^tm1Goo (involves: 129P2/OlaHsd * C57BL/6)	abnormal erythrocyte physiology	J:182122
Rhag^tm1Goo/Rhag^tm1Goo Rhd^tm1Goo/Rhd^tm1Goo (involves: 129P2/OlaHsd * C57BL/6)	hematopoietic system phenotype	J:182122
Rhbdd3^tm1Caox/Rhbdd3^tm1Caox (B6.129S6-Rhbdd3^tm1Caox)	increased natural killer cell mediated cytotoxicity	J:197348
Rhbdd3^tm1Caox/Rhbdd3^tm1Caox (B6.129S6-Rhbdd3^tm1Caox)	increased NK cell number	J:197348
Rhbdf1/Hba^{tm1(RHBDF1/HBA)Ajhs}/Rhbdf1/Hba^{tm1(RHBDF1/HBA)Ajhs} (involves: 129P2/OlaHsd * C57BL/6 * CBA)	anisopoikilocytosis	J:117887
	decreased hemoglobin content	J:117887
	decreased mean corpuscular hemoglobin	J:117887
	decreased mean corpuscular volume	J:117887
	microcytosis	J:117887
	reticulocytosis	J:117887
Rhbdf1/Hba^{tm1(RHBDF1/HBA)Ajhs}/Rhbdf1⁺ (involves: 129P2/OlaHsd * C57BL/6 * CBA)	anisopoikilocytosis	J:117887
Rhbdf1/Hba^{tm1(RHBDF1/HBA)Ajhs}/Hba⁺ (involves: 129P2/OlaHsd * C57BL/6 * CBA)	anisopoikilocytosis	J:117887
Rhbdf1/Hba^{tm1(RHBDF1/HBA)Ajhs}/Rhbdf1/Hba^{tm1(RHBDF1/HBA)Ajhs} (involves: 129P2/OlaHsd * C57BL/6 * CBA)	anisopoikilocytosis	J:117887
	decreased hemoglobin content	J:117887
	decreased mean corpuscular hemoglobin	J:117887
	decreased mean corpuscular volume	J:117887
	microcytosis	J:117887
	reticulocytosis	J:117887
Rhbdf1/Hba^{tm1.1(RHBDF1/HBA)Ajhs}/Rhbdf1/Hba^{tm1.1(RHBDF1/HBA)Ajhs} (involves: 129P2/OlaHsd * C57BL/6 * CBA)	decreased hemoglobin content	J:117887
	decreased mean corpuscular hemoglobin	J:117887
	decreased mean corpuscular volume	J:117887
	reticulocytosis	J:117887
Rhbdf1/Hba^{tm1.1(RHBDF1/HBA)Ajhs}/Rhbdf1/Hba^{tm1.1(RHBDF1/HBA)Ajhs} (involves: 129P2/OlaHsd * C57BL/6 * CBA)	decreased hemoglobin content	J:117887
	decreased mean corpuscular hemoglobin	J:117887
	decreased mean corpuscular volume	J:117887
	reticulocytosis	J:117887
Rhbdf1/Hba^tm2.1Ajhs/Hba⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased hemoglobin content	J:117887
	decreased mean corpuscular hemoglobin	J:117887
	decreased mean corpuscular volume	J:117887
Rhbdf1/Hba^tm2.1Ajhs/Rhbdf1⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased hemoglobin content	J:117887
	decreased mean corpuscular hemoglobin	J:117887
	decreased mean corpuscular volume	J:117887
Rhbdf1/Hba^tm2Ajhs/Hba⁺ (involves: 129P2/OlaHsd * C57BL/6)	anisopoikilocytosis	J:117887
	decreased hemoglobin content	J:117887
	decreased mean corpuscular hemoglobin	J:117887
	decreased mean corpuscular volume	J:117887
	microcytosis	J:117887
Rhbdf1/Hba^tm2Ajhs/Rhbdf1/Hba^tm2Ajhs (involves: 129P2/OlaHsd * C57BL/6)	anemia	J:117887
Rhbdf1/Hba^tm2Ajhs/Rhbdf1/Hba^tm2Ajhs (involves: 129P2/OlaHsd * C57BL/6)	anemia	J:117887
Rhbdf1/Hba^tm2Ajhs/Rhbdf1⁺ (involves: 129P2/OlaHsd * C57BL/6)	anisopoikilocytosis	J:117887
	decreased hemoglobin content	J:117887
	decreased mean corpuscular hemoglobin	J:117887
	decreased mean corpuscular volume	J:117887
	microcytosis	J:117887
Rhbdf1^tm1.1Mfm/Rhbdf1^tm1.1Mfm (involves: 129S/SvEv * 129S6/SvEvTac * C57BL/6J)	decreased bone marrow cell number	J:203951
	hematopoietic system phenotype	J:203951
	small spleen	J:203951
	small thymus	J:203951
Rhbdf2^{em1(IMPC)Wtsi}/Rhbdf2^{em1(IMPC)Wtsi} (C57BL/6N-Rhbdf2^{em1(IMPC)Wtsi}/Wtsi)	increased mean corpuscular hemoglobin	J:211773
Rhbdf2^tm1Mak/Rhbdf2^tm1Mak (B6.129P2-Rhbdf2^tm1Mak)	abnormal B cell physiology	J:179653
Rhbdf2^tm1Mak/Rhbdf2^tm1Mak (involves: 129P2/OlaHsd * C57BL/6)	abnormal leukocyte physiology	J:221411
	abnormal microglial cell physiology	J:221411
Rhbdl2^{tm1b(KOMP)Wtsi}/Rhbdl2^{tm1b(KOMP)Wtsi} (C57BL/6N-Rhbdl2^{tm1b(KOMP)Wtsi}/J)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
Rhd^{tm1a(EUCOMM)Wtsi}/Rhd^{tm1a(EUCOMM)Wtsi} (B6JTyr;B6N-Rhd^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased hemoglobin content	J:175295
	decreased mean corpuscular hemoglobin concentration	J:175295
	decreased mean corpuscular volume	J:175295
Rhd^tm1Goo/Rhd^tm1Goo (involves: 129P2/OlaHsd * C57BL/6)	abnormal erythrocyte physiology	J:182122
Rho^tm2.1Kpal/Rho^tm2.1Kpal (involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NTac)	microgliosis	J:194158
Rhoa^tm1.1Tpal/Rhoa⁺ Tg(Cd4-cre/ERT2)11Gnri/0 (involves: C57BL/6)	increased regulatory T cell number	J:257764
	increased T cell proliferation	J:257764
	increased T follicular helper cell number	J:257764
Rhoa^tm1Csab/Rhoa^tm1Csab Tg(Pf4-icre)Q3Rsko/0 (involves: C57BL/6)	increased mean platelet volume	J:204459
	thrombocytopenia	J:204459
Rhobtb1^{em2(IMPC)Ccpcz}/Rhobtb1^{em2(IMPC)Ccpcz} (C57BL/6N-Rhobtb1^{em2(IMPC)Ccpcz}/Ccpcz)	increased Ly6C-positive NK T cell number	J:211773
Rhobtb3^{tm1a(KOMP)Wtsi}/Rhobtb3^{tm1a(KOMP)Wtsi} (involves: C57BL/6N)	decreased spleen weight	J:226884
Rhobtb3^{tm1a(KOMP)Wtsi}/Rhobtb3^{tm1a(KOMP)Wtsi} (B6JTyr;B6N-Rhobtb3^{tm1a(KOMP)Wtsi}/Wtsi)	increased mean corpuscular volume	J:175295
Rhof^tm1.2Dash/Rhof^tm1.2Dash (involves: 129)	abnormal spleen marginal zone morphology	J:303076
Rhof^tm1.2Dash/Rhof^tm1.2Dash (involves: 129)	decreased marginal zone B cell number	J:303076
Rhof^tm1.2Tac/Rhof^tm1.2Tac (involves: C57BL/6)	hematopoietic system phenotype	J:195926
Rhof^tm1.2Tac/Rhof^tm1.2Tac (involves: C57BL/6)	thrombocytopenia	J:195926
Rhog^tm1Tnr/Rhog^tm1Tnr (involves: 129)	abnormal CD4-positive, alpha-beta T cell physiology	J:87580
	abnormal leukocyte physiology	J:87580
	abnormal T-helper 2 physiology	J:87580
	increased B cell proliferation	J:87580
	increased immunoglobulin level	J:87580
Rhoh^tm1Brak/Rhoh^tm1Brak (involves: 129/Sv * C57BL/6)	abnormal double-negative T cell morphology	J:143161
	abnormal lymphocyte cell number	J:143161
	abnormal splenic cell ratio	J:143161
	abnormal T cell proliferation	J:143161
	decreased CD4-positive, alpha-beta T cell number	J:143161
	decreased CD8-positive, alpha-beta T cell number	J:143161
	decreased double-positive T cell number	J:143161
	decreased single-positive T cell number	J:143161
	decreased T cell apoptosis	J:143161
	decreased T cell number	J:143161
	decreased T cell proliferation	J:143161
	increased double-negative T cell number	J:143161
	increased gamma-delta T cell number	J:143161
	increased NK cell number	J:143161
	increased NK T cell number	J:143161
	increased T cell number	J:143161
	increased T cell proliferation	J:143161
	spleen hypoplasia	J:143161
	thymus hypoplasia	J:143161
Rhoh^tm1Brak/Rhoh^tm1Brak Itgb2^tm2Bay/Itgb2^tm2Bay (involves: 129/Sv * C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:143161
	decreased CD8-positive, alpha-beta T cell number	J:143161
	decreased double-positive T cell number	J:143161
	decreased single-positive T cell number	J:143161
	increased double-negative T cell number	J:143161
Rhoh^tm1Brak/Rhoh^tm1Brak Tg(TcraTcrb)425Cbn/? (involves: 129/Sv * C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:143161
Rhoh^tm1Daw/Rhoh^tm1Daw (involves: 129 * C57BL/6)	arrested T cell differentiation	J:113565
	decreased double-positive T cell number	J:113565
	decreased T cell number	J:113565
	thymus hypoplasia	J:113565
Rhoh^tm1Hasu/Rhoh^tm1Hasu (B6.Cg-Rhoh^tm1Hasu)	abnormal mast cell physiology	J:143491
Rhoh^tm1Hasu/Rhoh^tm1Hasu (B6.Cg-Rhoh^tm1Hasu)	decreased mast cell degranulation	J:143491
Rhou^{tm1a(KOMP)Wtsi}/Rhou^{tm1a(KOMP)Wtsi} (C57BL/6N-Rhou^{tm1a(KOMP)Wtsi}/Wtsi)	increased mean corpuscular volume	J:175295
Rhpn1^{tm1b(KOMP)Wtsi}/Rhpn1^{tm1b(KOMP)Wtsi} (C57BL/6N-Rhpn1^{tm1b(KOMP)Wtsi}/Ucd)	decreased erythrocyte cell number	J:211773
	decreased hemoglobin content	J:211773
	increased mean platelet volume	J:211773
Ric1^{tm1a(EUCOMM)Hmgu}/Ric1^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Ric1^{tm1a(EUCOMM)Hmgu}/H)	decreased B cell number	J:165965
	decreased erythrocyte cell number	J:165965
	decreased hematocrit	J:165965
	decreased hemoglobin content	J:165965
	decreased leukocyte cell number	J:165965
	decreased mature B cell number	J:165965
	increased mean corpuscular volume	J:165965
Ric8b^{tm1b(EUCOMM)Hmgu}/Ric8b⁺ (C57BL/6N-Ric8b^{tm1b(EUCOMM)Hmgu}/Cnrm)	increased basophil cell number	J:211773
	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
Rictor^tm1.1Klg/Rictor^tm1.1Klg Tg(Mx1-cre)1Cgn/0 (B6.Cg-Rictor^tm1.1Klg Tg(Mx1-cre)1Cgn)	abnormal double-negative T cell morphology	J:189736
	decreased DN1 thymic pro-T cell number	J:189736
	decreased DN2 thymocyte number	J:189736
	decreased DN3 thymocyte number	J:189736
	decreased DN4 thymocyte number	J:189736
	decreased double-positive T cell number	J:189736
	decreased single-positive T cell number	J:189736
	decreased T cell proliferation	J:189736
	decreased thymus weight	J:189736
	hematopoietic system phenotype	J:189736
	increased double-negative T cell number	J:189736
	thymus hypoplasia	J:189736
Rictor^tm1.1Mnh/Rictor^tm1.1Mnh Tg(Fabp4-cre)1Rev/0 (B6.Cg-Rictor^tm1.1Mnh Tg(Fabp4-cre)1Rev)	increased spleen weight	J:150064
Rida^{tm1a(KOMP)Wtsi}/Rida^{tm1a(KOMP)Wtsi} (C57BL/6N-Rida^{tm1a(KOMP)Wtsi}/Wtsi)	decreased hematocrit	J:211773
Rif1^{Gt(XT0278)Wtsi}/Rif1^{Gt(XT0278)Wtsi} (involves: 129P2/OlaHsd * CD-1 * MF1)	abnormal class switch recombination	J:195061
	decreased IgA level	J:195061
	decreased IgG1 level	J:195061
	decreased IgG2b level	J:195061
	decreased IgG3 level	J:195061
	decreased IgG level	J:195061
Rigi^tm1Zgwg/Rigi^tm1Zgwg (involves: 129S1/Sv)	abnormal B cell differentiation	J:139016
	abnormal granulocyte morphology	J:139016
	abnormal granulocyte physiology	J:139016
	decreased T cell number	J:139868
	enlarged spleen	J:139016
	extramedullary hematopoiesis	J:139016
	increased activated T cell number	J:139868
	increased granulocyte number	J:139016
	increased memory T cell number	J:139868
Rimklb^{tm1.1(KOMP)Vlcg}/Rimklb^{tm1.1(KOMP)Vlcg} (C57BL/6N-Rimklb^{tm1.1(KOMP)Vlcg}/J)	increased mean corpuscular hemoglobin	J:211773
Rinl^em1(IMPC)Mbp/Rinl^em1(IMPC)Mbp (C57BL/6NCrl-Rinl^em1(IMPC)Mbp/Mmucd)	increased red blood cell distribution width	J:211773
Riok2^{tm1c(KOMP)Wtsi}/Riok2⁺ Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: C57BL/6N * C57BL/10 * CBA/Ca)	abnormal bone marrow cell physiology	J:305794
	abnormal CD4-positive, alpha beta T cell morphology	J:305794
	abnormal CD4-positive, alpha-beta T cell physiology	J:305794
	abnormal erythropoiesis	J:305794
	abnormal hematopoietic system physiology	J:305794
	anemia	J:305794
	decreased erythrocyte cell number	J:305794
	decreased erythroid progenitor cell number	J:305794
	decreased hematocrit	J:305794
	decreased hemoglobin content	J:305794
	decreased neutrophil cell number	J:305794
	increased granulocyte monocyte progenitor cell number	J:305794
	increased hematopoietic stem cell number	J:305794
	increased monocyte cell number	J:305794
	increased myeloid cell number	J:305794
	increased NK T cell number	J:305794
Riok2^{tm1c(KOMP)Wtsi}/Riok2⁺ Gt(ROSA)26Sor^{tm1(cre/ERT2)Tyj}/Gt(ROSA)26Sor⁺ (involves: 129S4/SvJae * C57BL/6 * C57BL/6N)	anemia	J:305794
	decreased erythrocyte cell number	J:305794
	decreased hematocrit	J:305794
	decreased hemoglobin content	J:305794
Riok2^{tm1c(KOMP)Wtsi}/Riok2⁺ Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * C57BL/6N * DBA/2)	anemia	J:305794
	decreased erythrocyte cell number	J:305794
	decreased hematocrit	J:305794
	decreased hemoglobin content	J:305794
Riox1^tm1Qch/Riox1^tm1Qch Tg(Prrx1-cre)1Cjt/0 (involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NCrl * SJL/J)	decreased osteoclast cell number	J:224562
Riox2^tm1Mtsun/Riox2^tm1Mtsun (B6CrSlc.Cg-Riox2^tm1Mtsun)	abnormal immunoglobulin level	J:201871
	decreased eosinophil cell number	J:201871
	decreased macrophage cell number	J:201871
	decreased neutrophil cell number	J:201871
Ripk1^tm1.1Vmd/Ripk1⁺ Ripk3^tm2Vmd/Ripk3^tm2Vmd (involves: C57BL/6N)	decreased hematopoietic cell number	J:209137
Ripk1^tm1.1Vmd/Ripk1^tm1.1Vmd (involves: C57BL/6N)	increased thymocyte apoptosis	J:209137
Ripk1^tm1Led/Ripk1^tm1Led (involves: 129S6/SvEvTac)	abnormal leukocyte cell number	J:46522
	abnormal thymus morphology	J:46522
	decreased thymocyte number	J:46522
	increased spleen red pulp amount	J:46522
Ripk2^tm1Cfl/Ripk2^tm1Cfl (involves: 129S5/SvEvBrd)	abnormal macrophage physiology	J:107130
Ripk2^tm1Flv/Ripk2^tm1Flv (involves: 129S1/Sv)	abnormal T-helper 1 physiology	J:75400
Ripk2^tm1Flv/Ripk2^tm1Flv (involves: 129S1/Sv)	decreased T cell proliferation	J:75400
Ripk2^tm1Flv/Ripk2^tm1Flv (involves: 129S1/Sv * C57BL/6)	abnormal macrophage physiology	J:132126
Ripk2^tm1Flv/Ripk2^tm1Flv Tnip1^tm1.1Pcoh/Tnip1^tm1.1Pcoh (involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)	enlarged spleen	J:176826
Ripk2^tm1Ghc/Ripk2^tm1Ghc (involves: 129S4/SvJae * C57BL/6)	decreased IgG2a level	J:75401
Ripk2^tm1Ghc/Ripk2^tm1Ghc (involves: 129S4/SvJae * C57BL/6)	decreased T cell proliferation	J:75401
Ripk4^tm1Pmh/Ripk4^tm1Pmh (involves: 129 * C57BL/6)	hematopoietic system phenotype	J:78593
Ripply3^{tm1a(EUCOMM)Wtsi}/Ripply3^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Ripply3^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased mean corpuscular hemoglobin	J:165965
Ripply3^tm1Sjt/Ripply3^tm1Sjt (involves: 129S1/Sv * C57BL/6)	abnormal thymus development	J:167713
	ectopic thymus	J:167713
	small thymus	J:167713
Rit1^em1(IMPC)Mbp/Rit1^em1(IMPC)Mbp (C57BL/6N-Rit1^em1(IMPC)Mbp/MbpMmucd)	increased mean platelet volume	J:211773
	increased red blood cell distribution width	J:211773
Rit1^tm1.1Tumg/Rit1⁺ (B6.Cg-Rit1^tm1.1Tumg)	anemia	J:277548
Rit1^tm1.1Tumg/Rit1⁺ (B6.Cg-Rit1^tm1.1Tumg)	enlarged spleen	J:277548
Rlim^{em1(IMPC)Rbrc}/Y (C57BL/6NJcl-Rlim^{em1(IMPC)Rbrc}/Rbrc)	abnormal mean corpuscular hemoglobin	J:211773
	abnormal mean corpuscular volume	J:211773
Rlim^{em1(IMPC)Rbrc}/Rlim⁺ (C57BL/6NJcl-Rlim^{em1(IMPC)Rbrc}/Rbrc)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Rln3^tm1(KOMP)Mbp/Rln3^tm1(KOMP)Mbp (C57BL/6N-Rln3^tm1(KOMP)Mbp/Ucd)	decreased erythrocyte cell number	J:211773
	decreased hemoglobin content	J:211773
Rnase6^em1(IMPC)Tcp/Rnase6^em1(IMPC)Tcp (C57BL/6N-Rnase6^em1(IMPC)Tcp/Tcp)	increased monocyte cell number	J:211773
Rnase11^em1(IMPC)Mbp/Rnase11^em1(IMPC)Mbp (C57BL/6N-Rnase11^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased lymphocyte cell number	J:211773
	small spleen	J:211773
Rnase12^em1(IMPC)Mbp/Rnase12^em1(IMPC)Mbp (C57BL/6N-Rnase12^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Rnase13^em1(IMPC)Mbp/Rnase13^em1(IMPC)Mbp (C57BL/6N-Rnase13^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	small spleen	J:211773
Rnaseh2a^em1(IMPC)Tcp/Rnaseh2a⁺ (C57BL/6NCrl-Rnaseh2a^em1(IMPC)Tcp/Tcp)	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
	increased mean platelet volume	J:211773
	increased monocyte cell number	J:211773
	increased spleen weight	J:211773
	thrombocytosis	J:211773
Rnaseh2b^em1Anu/Rnaseh2b⁺ Tlr7^em2Anu/Tlr7⁺ (C57BL/6NCrl-Rnaseh2b^em1Anu Tlr7^em2Anu)	abnormal mature B cell morphology	J:324448
	increased CD4-positive, alpha-beta T cell number	J:324448
	increased germinal center B cell number	J:324448
	increased plasma cell number	J:324448
	increased T follicular helper cell number	J:324448
Rnaseh2b^{tm1a(EUCOMM)Wtsi}/Rnaseh2b^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6N)	thymus hypoplasia	J:186986
Rnaseh2b^{tm1c(EUCOMM)Wtsi}/Rnaseh2b^{tm1c(EUCOMM)Wtsi} Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N * SJL)	decreased B cell proliferation	J:186986
Rnasel^tm1Slvm/Rnasel^tm1Slvm (involves: 129P2/OlaHsd)	abnormal thymus morphology	J:44292
	decreased T cell apoptosis	J:44292
	enlarged thymus	J:44292
	thymus hyperplasia	J:44292
Rnaset2b^{tm1b(EUCOMM)Hmgu}/Rnaset2b^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Rnaset2b^{tm1b(EUCOMM)Hmgu}/H)	enlarged spleen	J:211773
Rnd2^em1(IMPC)Mbp/Rnd2^em1(IMPC)Mbp (C57BL/6NCrl-Rnd2^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Rnd3^{tm1b(EUCOMM)Hmgu}/Rnd3⁺ (C57BL/6N-Rnd3^{tm1b(EUCOMM)Hmgu}/H)	increased large unstained cell number	J:211773
Rnf2^tm1Mvi/Rnf2^tm1Mvi Tg(Mx1-cre)1Cgn/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/10 * CBA)	abnormal B cell differentiation	J:130397
	abnormal bone marrow cell morphology/development	J:130397
	abnormal common myeloid progenitor cell morphology	J:130397
	decreased B cell number	J:130397
	decreased bone marrow cell number	J:130397
	decreased erythrocyte cell number	J:130397
	decreased monocyte cell number	J:130397
	thrombocytosis	J:130397
Rnf5^{tm1.1(KOMP)Vlcg}/Rnf5⁺ (C57BL/6N-Rnf5^{tm1.1(KOMP)Vlcg}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Rnf5^{tm1.1(KOMP)Vlcg}/Rnf5^{tm1.1(KOMP)Vlcg} (C57BL/6N-Rnf5^{tm1.1(KOMP)Vlcg}/Ccpcz)	abnormal spleen morphology	J:211773
Rnf8^{Gt(AS0574)Wtsi}/Rnf8⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal class switch recombination	J:161240
Rnf8^{Gt(AS0574)Wtsi}/Rnf8^{Gt(AS0574)Wtsi} (involves: 129P2/OlaHsd * C57BL/6)	abnormal class switch recombination	J:161240
	decreased B cell number	J:161240
	decreased bone marrow cell number	J:161240
	decreased CD4-positive, alpha-beta T cell number	J:161240
	decreased CD8-positive, alpha-beta T cell number	J:161240
	decreased double-negative T cell number	J:161240
	decreased double-positive T cell number	J:161240
	decreased IgG1 level	J:161240
	decreased IgG2b level	J:161240
	decreased IgG3 level	J:161240
	decreased immature B cell number	J:161240
	decreased pre-B cell number	J:161240
	decreased pro-B cell number	J:161240
	decreased splenocyte number	J:161240
	decreased T cell number	J:161240
	decreased thymocyte number	J:161240
	increased thymocyte apoptosis	J:161240
Rnf8^{Gt(RRR260)Byg}/Rnf8^{Gt(RRR260)Byg} (involves: 129P2/OlaHsd * C57BL/6)	abnormal class switch recombination	J:161240
	decreased B cell number	J:161240
	decreased bone marrow cell number	J:161240
	decreased CD4-positive, alpha-beta T cell number	J:161240
	decreased CD8-positive, alpha-beta T cell number	J:161240
	decreased double-negative T cell number	J:161240
	decreased double-positive T cell number	J:161240
	decreased IgG1 level	J:161240
	decreased IgG2b level	J:161240
	decreased IgG3 level	J:161240
	decreased immature B cell number	J:161240
	decreased pre-B cell number	J:161240
	decreased pro-B cell number	J:161240
	decreased splenocyte number	J:161240
	decreased T cell number	J:161240
	decreased thymocyte number	J:161240
	increased thymocyte apoptosis	J:161240
Rnf10^em1(IMPC)J/Rnf10^em1(IMPC)J (C57BL/6NJ-Rnf10^em1(IMPC)J/J)	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
Rnf10^{tm1b(KOMP)Wtsi}/Rnf10^{tm1b(KOMP)Wtsi} (C57BL/6N-Rnf10^{tm1b(KOMP)Wtsi}/Ics)	decreased lymphocyte cell number	J:211773
	increased monocyte cell number	J:211773
Rnf10^{tm1b(KOMP)Wtsi}/Rnf10^{tm1b(KOMP)Wtsi} (C57BL/6N-Rnf10^{tm1b(KOMP)Wtsi}/H)	decreased hemoglobin content	J:211773
	decreased spleen weight	J:211773
	increased large unstained cell number	J:211773
	increased red blood cell distribution width	J:211773
Rnf10^{tm1b(KOMP)Wtsi}/Rnf10^{tm1b(KOMP)Wtsi} (C57BL/6N-Rnf10^{tm1b(KOMP)Wtsi}/J)	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular hemoglobin concentration	J:211773
Rnf10^{tm1b(KOMP)Wtsi}/Rnf10^{tm1b(KOMP)Wtsi} (C57BL/6N-Rnf10^{tm1b(KOMP)Wtsi}/Rbrc)	decreased hemoglobin content	J:211773
	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
Rnf10^{tm1b(KOMP)Wtsi}/Rnf10^{tm1b(KOMP)Wtsi} (C57BL/6N-Rnf10^{tm1b(KOMP)Wtsi}/Bay)	abnormal spleen morphology	J:211773
Rnf13^{tm1.1(KOMP)Vlcg}/Rnf13^{tm1.1(KOMP)Vlcg} (C57BL/6N-Rnf13^{tm1.1(KOMP)Vlcg}/J)	increased mean corpuscular hemoglobin	J:211773
Rnf19b^{em1(IMPC)Ccpcz}/Rnf19b⁺ (C57BL/6N-Rnf19b^{em1(IMPC)Ccpcz}/Ccpcz)	increased eosinophil cell number	J:211773
Rnf19b^tm1Jkorn/Rnf19b^tm1Jkorn (B6.129S-Rnf19b^tm1Jkorn)	impaired natural killer cell mediated cytotoxicity	J:157393
Rnf20^{Gt(RRJ249)Byg}/Rnf20⁺ (involves: 129P2/OlaHsd)	abnormal leukocyte physiology	J:268221
	abnormal T cell physiology	J:268221
	enlarged spleen	J:268221
	increased myeloid cell number	J:268221
	increased spleen weight	J:268221
Rnf24^em1(IMPC)J/Rnf24^em1(IMPC)J (C57BL/6NJ-Rnf24^em1(IMPC)J/Mmjax)	decreased erythrocyte cell number	J:211773
	decreased hemoglobin content	J:211773
Rnf25^{tm1.1(KOMP)Vlcg}/Rnf25^{tm1.1(KOMP)Vlcg} (C57BL/6N-Rnf25^{tm1.1(KOMP)Vlcg}/J)	increased mean corpuscular volume	J:211773
Rnf31^tm1.1Kiwa/Rnf31^tm1.1Kiwa Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: BALB/c * C57BL/6NCrlj * CBA/JNCrlj)	abnormal B-1 B cell morphology	J:201885
	decreased B-1a cell number	J:201885
	decreased B-1b cell number	J:201885
	decreased IgA level	J:201885
	decreased IgG1 level	J:201885
	decreased IgG2a level	J:201885
	decreased IgG2b level	J:201885
	decreased IgG3 level	J:201885
	decreased IgM level	J:201885
Rnf43^em1(IMPC)Tcp/Rnf43^em1(IMPC)Tcp (C57BL/6NCrl-Rnf43^em1(IMPC)Tcp/Tcp)	enlarged spleen	J:211773
	increased hematocrit	J:211773
	increased hemoglobin content	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
Rnf43^em2Mage/Rnf43^em2Mage (Not Specified)	hyperchromasia	J:285428
Rnf114^{em1(IMPC)Wtsi}/Rnf114^{em1(IMPC)Wtsi} (C57BL/6N-Rnf114^{em1(IMPC)Wtsi}/Wtsi)	increased mean platelet volume	J:211773
Rnf115^em1(IMPC)H/Rnf115^em1(IMPC)H (C57BL/6N-Rnf115^em1(IMPC)H/H)	increased spleen weight	J:211773
Rnf128^{tm1.1(KOMP)Vlcg}/Y (C57BL/6N-Rnf128^{tm1.1(KOMP)Vlcg}/Ccpcz)	increased effector memory T-helper cell number	J:211773
Rnf128^tm1.1Flv/Y (involves: 129S6/SvEvTac * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:153216
Rnf128^tm1.1Flv/Y (involves: 129S6/SvEvTac * C57BL/6)	increased T cell proliferation	J:153216
Rnf128^tm1.1Flv/Y Tg(TcraTcrb)425Cbn/0 (involves: 129S6/SvEvTac * BALB/c * C57BL/6)	decreased T cell proliferation	J:153216
Rnf128^tm1.1Flv/Rnf128^tm1.1Flv (involves: 129S6/SvEvTac * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:153216
	increased T cell proliferation	J:153216
Rnf128^tm1.1Flv/Rnf128^tm1.1Flv Tg(TcraTcrb)425Cbn/0 (involves: 129S6/SvEvTac * BALB/c * C57BL/6)	decreased T cell proliferation	J:153216
Rnf128^tm1.2Cmse/Rnf128^tm1.2Cmse (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal macrophage physiology	J:245025
Rnf128^tm1Cdon/Rnf128^tm1Cdon (involves: C57BL/6)	increased T cell proliferation	J:160681
Rnf128^tm1Cdon/Rnf128^tm1Cdon (involves: 129 * C57BL/6)	abnormal regulatory T cell physiology	J:160681
	enlarged spleen	J:160681
	increased IgG1 level	J:160681
	increased IgM level	J:160681
	increased splenocyte proliferation	J:160681
Rnf128^tm1Cdon/Rnf128^tm1Cdon Tg(TcraTcrb)425Cbn/0 (involves: 129 * BALB/c * C57BL/6)	increased splenocyte proliferation	J:160681
Rnf146^tm1.1Rtpl/Rnf146^tm1.1Rtpl Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6J)	abnormal osteoclast differentiation	J:243612
	increased osteoclast cell number	J:243612
Rnf148^{em1(IMPC)Ccpcz}/Rnf148^{em1(IMPC)Ccpcz} (C57BL/6N-Rnf148^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Rnf168^em1(IMPC)H/Rnf168^em1(IMPC)H (C57BL/6NTac-Rnf168^em1(IMPC)H/H)	decreased spleen weight	J:211773
Rnf168^{Gt(156B6)Cmhd}/Rnf168^{Gt(156B6)Cmhd} (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal class switch recombination	J:198260
	abnormal T cell receptor delta chain V(D)J recombination	J:198260
	decreased gamma-delta T cell number	J:198260
	decreased IgG1 level	J:198260
	decreased IgG2a level	J:198260
	decreased IgG3 level	J:198260
	decreased IgG level	J:198260
	increased DN3 thymocyte number	J:198260
	increased double-negative T cell number	J:198260
Rnf168^{Gt(405F11)Cmhd}/Rnf168^{Gt(405F11)Cmhd} (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal class switch recombination	J:198260
	abnormal T cell receptor delta chain V(D)J recombination	J:198260
	decreased gamma-delta T cell number	J:198260
	decreased IgG1 level	J:198260
	decreased IgG2a level	J:198260
	decreased IgG3 level	J:198260
	decreased IgG level	J:198260
	increased DN3 thymocyte number	J:198260
	increased double-negative T cell number	J:198260
Rnf168^{tm2b(EUCOMM)Hmgu}/Rnf168^{tm2b(EUCOMM)Hmgu} (C57BL/6N-Rnf168^{tm2b(EUCOMM)Hmgu}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	enlarged thymus	J:211773
	increased eosinophil cell number	J:211773
	increased mean platelet volume	J:211773
Rnf169^{tm1a(EUCOMM)Hmgu}/Rnf169^{tm1a(EUCOMM)Hmgu} (B6NTac;B6N-Rnf169^{tm1a(EUCOMM)Hmgu}/H)	increased monocyte cell number	J:165965
Rnf180^em1(IMPC)J/Rnf180^em1(IMPC)J (C57BL/6NJ-Rnf180^em1(IMPC)J/Mmjax)	increased mean corpuscular volume	J:211773
Rnf208^{em1(IMPC)Ccpcz}/Rnf208^{em1(IMPC)Ccpcz} (C57BL/6N-Rnf208^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
	increased eosinophil cell number	J:211773
Rnf214^em1(IMPC)J/Rnf214^em1(IMPC)J (C57BL/6NJ-Rnf214^em1(IMPC)J/Mmjax)	decreased mean corpuscular hemoglobin	J:211773
Rnf216^{tm1b(EUCOMM)Wtsi}/Rnf216^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Rnf216^{tm1b(EUCOMM)Wtsi}/Tcp)	decreased lymphocyte cell number	J:211773
	increased monocyte cell number	J:211773
Rnf223^{em1(IMPC)Ccpcz}/Rnf223^{em1(IMPC)Ccpcz} (C57BL/6N-Rnf223^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Rnft2^{tm1b(EUCOMM)Hmgu}/Rnft2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Rnft2^{tm1b(EUCOMM)Hmgu}/Bay)	abnormal spleen morphology	J:211773
Rnh1^tm1Rall/Rnh1⁺ (involves: 129S/SvEv * C57BL/6)	abnormal erythroblast morphology	J:261784
Rnh1^tm1Rall/Rnh1⁺ (involves: 129S/SvEv * C57BL/6)	abnormal erythropoiesis	J:261784
Rnh1^tm1Rall/Rnh1^tm1Rall (involves: 129S/SvEv * C57BL/6)	abnormal embryonic erythrocyte morphology	J:261784
	abnormal embryonic erythropoiesis	J:261784
	abnormal erythroblast morphology	J:261784
	abnormal erythroid progenitor cell morphology	J:261784
	anemia	J:261784
	decreased erythroid progenitor cell number	J:261784
Ro60^tm1Woln/Ro60⁺ (involves: 129S1/Sv * C57BL/6)	increased IgG2a level	J:84627
Ro60^tm1Woln/Ro60^tm1Woln (involves: 129S1/Sv * C57BL/6)	increased IgG2a level	J:84627
Ro60^tm1Woln/Ro60^tm1Woln (involves: 129S1/Sv * C57BL/6)	increased IgM level	J:84627
Rock1^tm1Liao/Rock1⁺ (C57BL/6-Rock1^tm1Liao)	abnormal leukocyte adhesion	J:135152
	abnormal leukocyte migration	J:135152
	impaired macrophage chemotaxis	J:135152
	impaired neutrophil recruitment	J:135152
rol/rol (BXD31/Ty)	decreased erythrocyte osmotic fragility	J:9830
Ror1^{em1(IMPC)Ccpcz}/Ror1⁺ (C57BL/6NCrl-Ror1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Rora^sg/Rora^sg (involves: C57BL/6)	abnormal macrophage physiology	J:28095
	increased IgE level	J:135863
	spleen atrophy	J:2228
	thymus atrophy	J:2228
Rorc^m1Btlr/Rorc^m1Btlr (C57BL/6J-Rorc^m1Btlr)	decreased CD4-positive, alpha-beta T cell number	J:203039
Rorc^m1Btlr/Rorc^m1Btlr (C57BL/6J-Rorc^m1Btlr)	decreased CD8-positive, alpha-beta T cell number	J:203039
Rorc^m2Btlr/Rorc^m2Btlr (C57BL/6J-Rorc^m2Btlr)	decreased IgM level	J:217792
Rorc^m3Btlr/Rorc^m3Btlr (C57BL/6J-Rorc^m3Btlr)	abnormal CD4-positive, alpha beta T cell morphology	J:234257
	decreased B-2 B cell number	J:234257
	decreased CD4-positive, alpha-beta T cell number	J:234257
	decreased CD8-positive, naive alpha-beta T cell number	J:234257
	decreased IgG level	J:234257
	decreased IgM level	J:234257
	increased B-1a cell number	J:234257
	increased B-1b cell number	J:234257
	increased CD8-positive, alpha-beta T cell number	J:234257
	increased effector memory CD4-positive, alpha-beta T cell number	J:234257
	increased effector memory CD8-positive, alpha-beta T cell number	J:234257
Rorc^tm1.1Zsun/Rorc^tm1.1Zsun (B6(129S4)-Rorc^tm1.1Zsun)	abnormal T-helper 17 cell differentiation	J:248565
Rorc^tm1Amj/Rorc^tm1Amj (either: (involves: 129/Sv * C57BL/6) or (involves: 129/Sv * C57BL/6 * DBA/2))	abnormal splenic cell ratio	J:64381
	abnormal T cell physiology	J:64381
	decreased CD4-positive, alpha-beta T cell number	J:64381
	decreased CD8-positive, alpha-beta T cell number	J:64381
	decreased double-positive T cell number	J:64381
	decreased T cell number	J:64381
	decreased thymus weight	J:64381
	enlarged spleen	J:64381
	increased double-negative T cell number	J:64381
	increased T cell apoptosis	J:64381
	thymus hypoplasia	J:64381
Rorc^tm1Litt/Rorc^tm1Litt (involves: 129P2/OlaHsd)	abnormal CD8-positive, alpha-beta T cell differentiation	J:248565
	abnormal T cell differentiation	J:128344, J:248565
	abnormal T cell morphology	J:248565
	abnormal T-helper 17 cell differentiation	J:248565
	decreased CD4-positive, alpha-beta T cell number	J:248565
	decreased double-positive T cell number	J:248565
	decreased thymocyte number	J:248565
	increased thymocyte apoptosis	J:248565
Rorc^tm1Litt/Rorc^tm1Litt Tcra-J^tm3.1Krg/Tcra-J^tm3.1Krg (involves: 129P2/OlaHsd * 129S6/SvEvTac)	abnormal T cell differentiation	J:128344
Rorc^tm2Litt/Rorc^tm2Litt (involves: 129P2/OlaHsd)	abnormal CD4-positive, alpha-beta intraepithelial T cell morphology	J:91566
	abnormal CD8 positive, alpha-beta intraepithelial T cell morphology	J:91566
	decreased double-negative T cell number	J:91566
	decreased double-positive T cell number	J:87395
	decreased NK cell number	J:142654
	increased thymocyte apoptosis	J:87395
Rosq1^DBA/1J/Rosq1^DBA/1J (involves: DBA/1J * FVB/NJ)	abnormal neutrophil physiology	J:122919
Rosq1^DBA/1J/Rosq1^FVB/NJ (involves: DBA/1J * FVB/NJ)	abnormal neutrophil physiology	J:122919
Rpa1^{tm1b(KOMP)Wtsi}/Rpa1⁺ (C57BL/6N-Rpa1^{tm1b(KOMP)Wtsi}/J)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	increased mean corpuscular volume	J:211773
Rpa1^tm1Wed/Rpa1⁺ (involves: 129/Sv * C57BL/6J * SJL)	abnormal definitive hematopoiesis	J:99303
Rpa1^tm1Wed/Rpa1⁺ (involves: 129/Sv * C57BL/6J * SJL)	increased lymphocyte cell number	J:99303
Rpap3^em1(IMPC)Mbp/Rpap3⁺ (C57BL/6N-Rpap3^em1(IMPC)Mbp/Ucd)	abnormal thymus morphology	J:211773
Rpap3^em1(IMPC)Mbp/Rpap3⁺ (C57BL/6N-Rpap3^em1(IMPC)Mbp/Ucd)	enlarged thymus	J:211773
Rpe65^{tm1a(EUCOMM)Hmgu}/Rpe65^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Rpe65^{tm1a(EUCOMM)Hmgu}/H)	decreased leukocyte cell number	J:165965
	increased leukocyte cell number	J:165965
Rpe^em1(IMPC)Mbp/Rpe⁺ (C57BL/6NCrl-Rpe^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
Rpe^em1(IMPC)Mbp/Rpe⁺ (C57BL/6NCrl-Rpe^em1(IMPC)Mbp/Mmucd)	enlarged spleen	J:211773
Rpgrip1l^{tm1a(EUCOMM)Wtsi}/Rpgrip1l^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Rpgrip1l^{tm1a(EUCOMM)Wtsi}/Wtsi)	absent spleen	J:239583
	spleen hypoplasia	J:239583
Rpl5^Skax23-Jus/Rpl5⁺ (129S6.B6-Rpl5^Skax23-Jus)	abnormal proerythroblast morphology	J:330162
	decreased hemoglobin content	J:330162
	macrocytic anemia	J:330162
	pancytopenia	J:330162
	thrombocytopenia	J:330162
Rpl12^em1(IMPC)Mbp/Rpl12⁺ (C57BL/6NCrl-Rpl12^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Rpl13a^tm1.1Mazu/Rpl13a^tm1.1Mazu Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: C57BL/6)	abnormal macrophage chemotaxis	J:194920
Rpl22^{Gt(GST000137)Lex}/Rpl22^{Gt(GST000137)Lex} (involves: 129S5/SvEvBrd)	abnormal T cell differentiation	J:123569
	abnormal T cell number	J:123569
	arrested T cell differentiation	J:123569
	decreased CD4-positive, alpha-beta T cell number	J:123569
	decreased CD8-positive, alpha-beta T cell number	J:123569
	decreased double-negative T cell number	J:123569
	decreased T cell number	J:123569
	increased T cell apoptosis	J:123569
	thymus hypoplasia	J:123569
Rpl22^{Gt(YHB332)Byg}/Rpl22^{Gt(YHB332)Byg} (involves: 129P2/OlaHsd * C57BL/6)	abnormal thymus development	J:201164
	decreased B cell number	J:201164
	decreased T cell number	J:201164
Rpl27a^Sfa/Rpl27a⁺ (C57BL/6J-Rpl27a^Sfa)	abnormal bone marrow cell physiology	J:174216
	abnormal hematopoietic system morphology/development	J:174216
	anemia	J:174216
	decreased bone marrow cell number	J:174216
	decreased erythrocyte cell number	J:174216
	decreased hematopoietic cell number	J:174216
	decreased hematopoietic stem cell number	J:174216
	decreased leukocyte cell number	J:174216
	increased hematopoietic stem cell proliferation	J:174216
	pancytopenia	J:174216
	small spleen	J:174216
	small thymus	J:174216
	thrombocytopenia	J:174216
Rpl27a^Sfa/Rpl27a⁺ Trp53^tm1Tyj/Trp53⁺ (B6.Cg-Rpl27a^Sfa Trp53^tm1Tyj)	hematopoietic system phenotype	J:174216
Rpl32^{tm1b(EUCOMM)Hmgu}/Rpl32^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Rpl32^{tm1b(EUCOMM)Hmgu}/Ieg)	increased red blood cell distribution width	J:211773
Rpl38^Ts/Rpl38⁺ (BALB/c-Rpl38^Ts)	anemia	J:15012
Rpl38^Ts/Rpl38⁺ ((BALB/c x C3H)F1)	anemia	J:13063
Rpl38^Ts/Rpl38⁺ (TSJ/Le)	abnormal embryonic erythropoiesis	J:6184
Rpl38^Ts/Rpl38⁺ (TSJ/Le)	hematopoietic system phenotype	J:6184
Rplag^FVB/NJ/? (involves: C57BL/6J * FVB/NJ)	abnormal platelet physiology	J:90287
Rplp1^tm1.1Melt/Rplp1^tm1.2Melt (Not Specified)	decreased erythroblast number	J:218949
	impaired hematopoiesis	J:218949
	small thymus	J:218949
Rprd1b^{tm1a(EUCOMM)Hmgu}/Rprd1b⁺ (C57BL/6N-Rprd1b^{tm1a(EUCOMM)Hmgu}/H)	increased mean corpuscular hemoglobin concentration	J:165965
Rps6ka3^tm1.1Kry/Rps6ka3⁺ (involves: 129X1/SvJ)	hematopoietic system phenotype	J:89403
Rps6ka3^tm1.1Kry/Rps6ka3^tm1.1Kry (involves: 129X1/SvJ)	hematopoietic system phenotype	J:89403
Rps6ka4^tm1Jsca/Rps6ka4^tm1Jsca Rps6ka5^tm1Jsca/Rps6ka5^tm1Jsca (Not Specified)	decreased T cell proliferation	J:124301
	spleen hypoplasia	J:124301
Rps7^Mtu/Rps7⁺ (involves: BALB/cOlaHsd * C3H/HeH)	increased mean corpuscular volume	J:195156
Rps7^Zma/Rps7⁺ (involves: BALB/c * C3H/HeH * C57BL/6J)	abnormal erythropoiesis	J:195156
Rps7^Zma/Rps7⁺ Trp53^tm1Tyj/Trp53⁺ (involves: 129S2/SvPas * BALB/c * C3H/HeH * C57BL/6J)	hematopoietic system phenotype	J:195156
Rps9^tm1.1Geno/Rps9^tm1.1Geno (involves: C57BL/6)	anemia	J:329922
	decreased leukocyte cell number	J:329922
	extramedullary hematopoiesis	J:329922
	increased monocyte cell number	J:329922
Rps12^em1.1Nbakr/Rps12⁺ (involves: C57BL/6J * FVB/N)	abnormal erythroblast morphology	J:338970
	abnormal erythropoiesis	J:338970
	abnormal hematopoietic stem cell proliferation	J:338970
	decreased bone marrow cell number	J:338970
	decreased erythroblast number	J:338970
	decreased erythrocyte cell number	J:338970
	decreased erythroid progenitor cell number	J:338970
	decreased hematopoietic stem cell number	J:338970
	decreased leukocyte cell number	J:338970
	decreased spleen weight	J:338970
	increased mean corpuscular volume	J:338970
	pancytopenia	J:338970
Rps12^em1Nbakr/Rps12^em1Nbakr Tg(Tal1-cre/ERT)42-056Jrg/0 (C57BL/6J-Rps12^em1Nbakr Tg(Tal1-cre/ERT)42-056Jrg)	decreased hematopoietic stem cell number	J:338970
	pancytopenia	J:338970
Rps14^tm1.1Ble/Rps14⁺ Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6J * C57BL/6NTac * CBA/J)	abnormal bone marrow cell physiology	J:233322
	abnormal erythroid progenitor cell morphology	J:233322
	abnormal megakaryocyte morphology	J:233322
	abnormal platelet shape	J:233322
	enlarged spleen	J:233322
	hematopoietic system phenotype	J:233322
	impaired hematopoiesis	J:233322
	thrombocytosis	J:233322
Rps14^tm1.1Ble/Rps14⁺ Tg(Mx1-cre)1Cgn/0 Trp53^tm2.1Tyj/Trp53⁺ (involves: 129S4/SvJae * C57BL/6J * C57BL/6NTac * CBA/J)	hematopoietic system phenotype	J:233322
Rps19^Mhdadsk3/Rps19⁺ (C3HeB/FeJ-Rps19^Mhdadsk3/Ieg)	decreased erythrocyte cell number	J:139244
Rps19^Mhdadsk3/Rps19⁺ (C3HeB/FeJ-Rps19^Mhdadsk3/Ieg)	reticulocytopenia	J:139244
Rps19^Mhdadsk3/Rps19⁺ Trp53^tm1Tyj/Trp53⁺ (involves: 129S2/SvPas * C3HeB/FeJ)	abnormal hematopoietic system morphology/development	J:139244
Rps19^tm1Dahl/Rps19⁺ (B6.129-Rps19^tm1Dahl)	hematopoietic system phenotype	J:89889
Rps19bp1^{tm1.1(KOMP)Wtsi}/Rps19bp1⁺ (C57BL/6N-Rps19bp1^{tm1.1(KOMP)Wtsi}/Bay)	abnormal spleen morphology	J:211773
Rps27l^{Gt(IST11658B7)Tigm}/Rps27l^{Gt(IST11658B7)Tigm} (C57BL/6-Rps27l^{Gt(IST11658B7)Tigm})	abnormal hematopoietic stem cell physiology	J:223276
	decreased bone marrow cell number	J:223276
	decreased common myeloid progenitor cell number	J:223276
	decreased hematopoietic stem cell number	J:223276
	decreased spleen weight	J:223276
	decreased thymus weight	J:223276
	increased thymocyte apoptosis	J:223276
	thymus cortex hypoplasia	J:223276
Rps27l^{Gt(IST11658B7)Tigm}/Rps27l^{Gt(IST11658B7)Tigm} (involves: 129 * C57BL/6N)	decreased bone marrow cell number	J:223276
	spleen hypoplasia	J:223276
	thymus hypoplasia	J:223276
Rps27l^{Gt(IST11658B7)Tigm}/Rps27l^{Gt(IST11658B7)Tigm} Trp53^tm1Tyj/Trp53⁺ (involves: 129S2/SvPas * C57BL/6N)	decreased bone marrow cell number	J:223276
	enlarged spleen	J:223276
Rps27l^{Gt(IST11658B7)Tigm}/Rps27l^{Gt(IST11658B7)Tigm} Trp53^tm1Tyj/Trp53^tm1Tyj (involves: 129S2/SvPas * C57BL/6N)	hematopoietic system phenotype	J:223276
Rpsa^tm1Ells/Rpsa⁺ (involves: 129S6/SvEvTac * C57BL/6)	decreased mean corpuscular hemoglobin concentration	J:138267
Rptor^tm1Ahir/Rptor^tm1Ahir Tg(Itgax-cre)1-1Reiz/0 (B6.Cg-Rptor^tm1Ahir Tg(Itgax-cre)1-1Reiz)	increased dendritic cell number	J:188676
Rpusd2^{tm1b(KOMP)Wtsi}/Rpusd2^{tm1b(KOMP)Wtsi} (C57BL/6N-Rpusd2^{tm1b(KOMP)Wtsi}/Bay)	increased spleen weight	J:211773
Rr7^tm1.1Kio/Rr7^tm1.1Kio (involves: 129S4/SvJae * C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:179326, J:164573
Rr7^tm2.1Kio/Rr7^tm2.1Kio (involves: 129S4/SvJae * C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:164573
Rr7^tm3.1Kio/Rr7⁺ (B6.129S4-Rr7^tm3.1Kio)	abnormal CD4-positive, alpha beta T cell morphology	J:179326
Rr7^tm3.1Kio/Rr7⁺ Tg(Lck-cre)#Nik/0 (involves: 129S4/SvJae * C57BL/6 * DBA/2)	abnormal CD4-positive, alpha beta T cell morphology	J:179326
Rr7^tm4.1Kio/Rr7^tm4.1Kio (involves: 129S4/SvJae * C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:179326
Rr38^tm1.2Aafo/Rr38⁺ (involves: 129S4/SvJaeSor * BALB/cJ * C57BL/6)	decreased thymocyte number	J:227747
Rr38^tm1.2Aafo/Rr38^tm1.2Aafo (involves: 129S4/SvJaeSor * BALB/cJ * C57BL/6)	abnormal thymus physiology	J:227747
	decreased CD4-positive, alpha-beta T cell number	J:227747
	decreased CD8-positive, alpha-beta T cell number	J:227747
	decreased double-positive T cell number	J:227747
	decreased single-positive T cell number	J:227747
	decreased thymocyte number	J:227747
	decreased thymus weight	J:227747
	increased DN3 thymocyte number	J:227747
	small thymus	J:227747
	thymus hypoplasia	J:227747
Rr39^em1Ched/Rr39^em1Ched (C57BL/6-Rr39^em1Ched)	decreased Ly6C low monocyte number	J:239509
Rr79^em2Rtew/Rr79^em2Rtew (C57BL/6J-Rr79^em2Rtew/J)	abnormal T cell activation	J:332957
	abnormal T cell physiology	J:332957
	abnormal T cell subpopulation ratio	J:332957
Rr79^em2Rtew/Rr79^em2Rtew Tg(TcraTcrb)1100Mjb/? (involves: C57BL/6J)	abnormal T cell activation	J:332957
Rr94^tm3.1Litt/Rr94⁺ Tg(Cd4-cre)1Cwi/0 Rr112^tm4.1Litt/Rr112⁺ (involves: 129P2/OlaHsd * 129S4/SvJaeSor * FVB/N)	abnormal T cell differentiation	J:158962
	abnormal T cell subpopulation ratio	J:158962
	decreased CD4-positive, alpha-beta T cell number	J:158962
	increased CD8-positive, alpha-beta T cell number	J:158962
Rr94^tm3.1Litt/Rr94^tm3.1Litt Tg(Cd4-cre)1Cwi/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * FVB/N)	abnormal T cell differentiation	J:158962
	abnormal T cell subpopulation ratio	J:158962
	decreased CD4-positive, alpha-beta T cell number	J:158962
	decreased double-positive T cell number	J:158962
	increased CD8-positive, alpha-beta T cell number	J:158962
Rr94^tm3.2Litt/Rr94⁺ Rr112^tm4.1Litt/Rr112⁺ (involves: 129P2/OlaHsd * 129S4/SvJaeSor * FVB/N)	abnormal T cell differentiation	J:158962
	abnormal T cell subpopulation ratio	J:158962
	decreased CD4-positive, alpha-beta T cell number	J:158962
	increased CD8-positive, alpha-beta T cell number	J:158962
Rr94^tm3.2Litt/Rr94^tm3.2Litt (involves: 129P2/OlaHsd * FVB/N)	abnormal CD4-positive, alpha beta T cell morphology	J:158962
	abnormal double-positive T cell morphology	J:158962
	abnormal T cell differentiation	J:158962
	abnormal T cell subpopulation ratio	J:158962
	decreased CD4-positive, alpha-beta T cell number	J:158962
	decreased double-positive T cell number	J:158962
	increased CD8-positive, alpha-beta T cell number	J:158962
Rr94^tm3.2Litt/Rr94^tm3.2Litt H2-Ab1^b-tm1Gru/H2-Ab1^b-tm1Gru (involves: 129P2/OlaHsd * 129S2/SvPas * FVB/N)	abnormal T cell subpopulation ratio	J:158962
	decreased CD4-positive, alpha-beta T cell number	J:158962
	increased CD8-positive, alpha-beta T cell number	J:158962
Rr96^tm1.1Tich/Rr96⁺ Gt(ROSA)26Sor^{tm1(cre/ERT2)Thl}/Gt(ROSA)26Sor^{tm1(rtTAM2)Jae} (involves: 129 129S4/SvJae * C57BL/6)	abnormal T cell differentiation	J:191711
Rr96^tm1.1Tich/Rr96⁺ Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}/Gt(ROSA)26Sor⁺ (involves: 129 129S4/SvJae * C57BL/6)	abnormal CD4-positive T cell differentiation	J:191711
Rr96^tm1.1Tich/Rr96^tm1.1Tich Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}/Gt(ROSA)26Sor^{tm1(rtTAM2)Jae} (involves: 129 * 129S4/SvJae * C57BL/6)	abnormal T cell differentiation	J:191711
Rr96^tm1.1Tich/Rr96^tm1.1Tich Tg(ACTB-tTS)1Mllo/? (involves: 129 * C57BL/6)	decreased double-positive T cell number	J:191711
Rr96^tm1.1Yzo/Rr96^tm1.1Yzo (involves: 129P2/OlaHsd)	abnormal T cell differentiation	J:130559
	increased CD4-positive, alpha-beta T cell number	J:130559
	increased double-positive T cell number	J:130559
Rr96^tm1.1Yzo/Rr96^tm1.1Yzo H2-Ab1^b-tm1Gru/H2-Ab1^b-tm1Gru (involves: 129P2/OlaHsd * 129S2/SvPas)	abnormal T cell differentiation	J:130559
Rr96^tm1Yzo/Rr96^tm1Yzo Tg(Cd4-cre)1Cwi/? (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	abnormal T cell differentiation	J:130559
	increased double-positive T cell number	J:130559
Rr96^tm1Yzo/Rr96^tm1Yzo Tg(Cd8a-cre,-GFP)1Yzo/? (involves: 129P2/OlaHsd)	increased double-positive T cell number	J:130559
Rr96^tm2Litt/Rr96⁺ Zbtb7b^tm1Itan/Zbtb7b^tm1Tani (involves: 129 * 129P2/OlaHsd * C57BL/6)	abnormal double-negative T cell morphology	J:141142
	decreased CD8-positive, alpha-beta T cell number	J:141142
Rr96^tm2Litt/Rr96⁺ Zbtb7b^tm1Tani/Zbtb7b^tm1Tani (involves: 129 * 129P2/OlaHsd * C57BL/6)	increased double-negative T cell number	J:141142
Rr96^tm2Litt/Rr96^tm2Litt (involves: 129P2/OlaHsd)	abnormal CD8-positive, alpha beta T cell morphology	J:80690
Rr96^tm2Litt/Rr96^tm2Litt Tfap4^tm1.1Litt/Tfap4^tm1.1Litt (involves: 129P2/OlaHsd * C57BL/6 * FVB/N)	abnormal T cell differentiation	J:176461
Rr97^tm3Welm/Rr97^tm3Welm (involves: 129 * C57BL/6)	abnormal CD4-positive T cell differentiation	J:126027
	abnormal CD8-positive, alpha-beta T cell differentiation	J:126027
	abnormal dendritic cell morphology	J:126027
	abnormal double-positive T cell morphology	J:126027
	abnormal gamma-delta intraepithelial T cell morphology	J:126027
	abnormal T cell differentiation	J:126027
Rr99^tm1Litt/Rr99^tm1Litt (either: (involves: 129P2/OlaHsd * AKR) or (involves: 129P2/OlaHsd * C57BL/6))	abnormal CD8-positive, alpha beta T cell morphology	J:50624
Rr100^tm2.1Welm/Rr100⁺ (involves: 129P2/OlaHsd * AKR.1 * C57BL/6)	abnormal T cell differentiation	J:113136
Rr100^tm2.1Welm/Rr100^tm2.1Welm (involves: 129P2/OlaHsd * C57BL/6)	abnormal T cell differentiation	J:113136
	abnormal T cell subpopulation ratio	J:113136
	decreased CD8-positive, alpha-beta T cell number	J:113136
	decreased double-positive T cell number	J:113136
	increased CD4-positive, alpha-beta T cell number	J:113136
Rr100^tm2.1Welm/Rr100^tm2.1Welm (involves: 129P2/OlaHsd)	abnormal T cell differentiation	J:158947
	decreased CD8-positive, alpha-beta T cell number	J:158947
	decreased double-positive T cell number	J:158947
	increased CD4-positive, alpha-beta T cell number	J:158947
Rr100^tm2.1Welm/Rr100^tm2.1Welm Tcra^tm1Mom/Tcra^tm1Mom (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	abnormal T cell morphology	J:113136
Rr104^tm1.2Mym/Rr104^tm1.2Mym (Not Specified)	abnormal erythropoiesis	J:175070
	anemia	J:175070
	decreased fetal derived definitive erythrocyte cell number	J:175070
	decreased hematocrit	J:175070
Rr104^tm1.2Mym/Rr104^tm1.2Mym Tg(Epo)458Mym/0 (involves: C57BL/6 DBA/2)	abnormal spleen morphology	J:231255
	anemia	J:231255
	decreased bone marrow cell number	J:231255
	decreased erythroblast number	J:231255
	decreased hematocrit	J:231255
Rr104^tm1.2Mym/Rr104^tm1.2Mym Tg(Epo)458Mym/Tg(Epo)458Mym (involves: C57BL/6 * DBA/2)	anemia	J:231255
Rr123^tm1.1Vbo/Rr123^tm1.1Vbo (involves: 129S4/SvJae * C57BL/6 * FVB/N)	abnormal regulatory T cell morphology	J:191815
	increased regulatory T cell number	J:191815
Rr148^tm1.1Fwa/Rr148^tm1.1Fwa (involves: 129S6/SvEvTac)	abnormal B cell differentiation	J:101400
	arrested B cell differentiation	J:101400
	decreased immature B cell number	J:101400
	small spleen	J:101400
	spleen hypoplasia	J:101400
Rr148^tm1.1Fwa/Rr148^tm1.1Fwa Rag2^tm1Fwa/Rag2^tm1Fwa (involves: 129S/SvEv * 129S6/SvEvTac)	abnormal B cell differentiation	J:101400
Rr148^tm1Anbo/Rr148^tm1Anbo (involves: 129/Sv * C57BL/6 * FVB/N)	abnormal immunoglobulin heavy chain V(D)J recombination	J:136307
	decreased immature B cell number	J:136307
	decreased mature B cell number	J:136307
	decreased pre-B cell number	J:136307
Rr148^tm1Fwa/Rr148^tm1Fwa (129S6/SvEvTac-Rr148^tm1Fwa)	abnormal immature B cell morphology	J:101400
	absent B cells	J:101400
	arrested B cell differentiation	J:101400
	small spleen	J:101400
	spleen hypoplasia	J:101400
Rr148^tm1Fwa/Rr148^tm1Fwa Rag2^tm1Fwa/Rag2^tm1Fwa (involves: 129S/SvEv * 129S6/SvEvTac)	abnormal B cell differentiation	J:101400
Rr148^tm2Anbo/Rr148^tm2Anbo (involves: 129/Sv * C57BL/6 * FVB/N)	abnormal immunoglobulin heavy chain V(D)J recombination	J:136307
	decreased immature B cell number	J:136307
	decreased mature B cell number	J:136307
	decreased pre-B cell number	J:136307
Rr155^tm1.1Erpi/Rr155^tm1.1Erpi (involves: 129P2/OlaHsd * C57BL/6 * FVB/N)	abnormal immunoglobulin level	J:160101
	decreased IgG1 level	J:160101
	decreased IgG2a level	J:160101
Rr156^tm6.1Cog/Rr156^tm6.1Cog (involves: 129P2/OlaHsd * C57BL/6)	decreased B cell number	J:165617
	decreased bone marrow cell number	J:165617
	decreased IgM level	J:165617
	hematopoietic system phenotype	J:165617
Rr156^tm6Cog/Rr156^tm6Cog (involves: 129P2/OlaHsd * C57BL/6)	decreased B cell number	J:165617
	decreased bone marrow cell number	J:165617
	decreased IgM level	J:165617
	hematopoietic system phenotype	J:165617
Rr158^tm1(Igh)Xu/Rr158^tm1(Igh)Xu (Not Specified)	decreased B cell number	J:124407
	decreased immature B cell number	J:124407
	increased pre-B cell number	J:124407
Rr158^tm1Cgn/Rr158^tm1Cgn (either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129S2/SvPas * C57BL/6))	abnormal B cell differentiation	J:12574, J:64287
	decreased mature B cell number	J:64287
	increased mature B cell number	J:64287
	spleen hypoplasia	J:64287
Rr158^tm2Cgn/Rr158^tm2Cgn (either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129S2/SvPas * C57BL/6))	abnormal B cell differentiation	J:12574
Rr158^tm2Xu/Rr158^tm2Xu (Not Specified)	decreased B cell number	J:124407
Rr159^tm1.1Fwa/Rr159⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell differentiation	J:113715
Rr159^tm1.1Fwa/Rr159^tm1.1Fwa (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell differentiation	J:113715
	decreased B cell number	J:113715
Rr159^tm1Fwa/Rr159⁺ (involves: 129P2/OlaHsd * C57BL/6)	increased B cell number	J:113715
Rr159^tm1Fwa/Rr159^tm1Fwa (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell differentiation	J:113715
	decreased B cell number	J:113715
Rr160^tm1Wtg/Rr160^tm1Wtg (involves: 129S6/SvEvTac * C57BL/6)	abnormal immunoglobulin level	J:134885
	abnormal mature B cell morphology	J:134885
	abnormal somatic hypermutation frequency	J:134885
	decreased follicular B cell number	J:134885
	increased transitional stage B cell number	J:134885
Rr161^tm2.2Wtg/Rr161^tm2.2Wtg (involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6)	abnormal B cell differentiation	J:167472
	abnormal immunoglobulin V(D)J recombination	J:167472
	decreased B cell number	J:167472
	decreased pro-B cell number	J:167472
	increased pre-B cell number	J:167472
Rr162^tm3.1Wtg/Rr162^tm3.1Wtg (involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6)	abnormal immunoglobulin V(D)J recombination	J:172855
Rr166^tm4.1Wtg/Rr166^tm4.1Wtg (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6)	abnormal B cell differentiation	J:193015
	abnormal B cell physiology	J:193015
	abnormal immunoglobulin level	J:193015
	abnormal immunoglobulin light chain V-J recombination	J:193015
	abnormal pre-B cell morphology	J:193015
Rr169^tm2Rao/Rr169⁺ (involves: 129S6/SvEvTac * C57BL/6J)	abnormal T-helper 1 cell differentiation	J:94039
Rr169^tm2Rao/Rr169^tm2Rao (involves: 129S6/SvEvTac * C57BL/6J)	abnormal T-helper 1 cell differentiation	J:94039
Rr170^tm1.1Iku/Rr170^tm1.1Iku (B6.Cg-Rr170^tm1.1Iku)	decreased T cell number	J:333539
	decreased T cell proliferation	J:333539
	hematopoietic system phenotype	J:333539
	increased T cell apoptosis	J:333539
Rr177^tm1Tow/Rr177^tm1Tow Tg(HBB)#Tow/0 (Not Specified)	abnormal hematopoietic system physiology	J:164803
Rr185^tm3Cog/Rr185^tm3Cog (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell morphology	J:71300
	abnormal class switch recombination	J:71300
	decreased IgA level	J:71300
	decreased IgE level	J:71300
	decreased IgG1 level	J:71300
	decreased IgG2a level	J:71300
	decreased IgG2b level	J:71300
	decreased IgG3 level	J:71300
	decreased IgG level	J:71300
	decreased IgM level	J:71300
	decreased immunoglobulin level	J:71300
Rr249^tm1.1Ebres/Rr249⁺ (involves: 129 * BALB/cJ * C57BL/6)	decreased common myeloid progenitor cell number	J:191756
	decreased erythroid progenitor cell number	J:191756
	decreased hematopoietic stem cell number	J:191756
Rr249^tm1.1Ebres/Rr249^tm1.1Ebres (involves: 129 * BALB/cJ * C57BL/6)	decreased common myeloid progenitor cell number	J:191756
	decreased erythroid progenitor cell number	J:191756
	decreased hematopoietic stem cell number	J:191756
Rr250^em1Ebres/Rr250^em1Ebres (C57BL/6N-Rr250^em1Ebres)	abnormal hematopoietic stem cell physiology	J:270526
	decreased erythrocyte cell number	J:270526
	decreased erythroid progenitor cell number	J:270526
	decreased hematocrit	J:270526
	decreased hematopoietic stem cell number	J:270526
	hematopoietic system phenotype	J:270526
	impaired hematopoiesis	J:270526
Rr253^em1Kmm/Rr253^em1Kmm (C57BL/6-Rr253^em1Kmm)	abnormal class switch recombination	J:316113
	abnormal effector T cell number	J:316113
	abnormal peritoneal macrophage morphology	J:316113
	abnormal spleen B cell follicle morphology	J:316113
	decreased B cell number	J:316113
	decreased mature NK cell number	J:316113
	decreased monocyte cell number	J:316113
	decreased plasmacytoid dendritic cell number	J:316113
	decreased spleen B cell follicle number	J:316113
	decreased spleen B cell follicle size	J:316113
	hematopoietic system phenotype	J:316113
	increased dendritic cell number	J:316113
	increased lymphocyte cell number	J:316113
	increased neutrophil cell number	J:316113
	increased NK cell number	J:316113
	increased T cell number	J:316113
	spleen hypoplasia	J:316113
Rr253^em3Kmm/Rr253^em3Kmm (C57BL/6J-Rr253^em3Kmm)	decreased dendritic cell number	J:334296
Rr253^em4Kmm/Rr253^em4Kmm (C57BL/6J-Rr253^em4Kmm)	hematopoietic system phenotype	J:334296
Rr253^em5Kmm/Rr253^em5Kmm (C57BL/6J-Rr253^em5Kmm)	decreased dendritic cell number	J:334296
Rr253^em5Kmm/Rr253^em5Kmm (C57BL/6J-Rr253^em5Kmm)	increased dendritic cell number	J:334296
Rr253^em6Kmm/Rr253^em6Kmm (C57BL/6J-Rr253^em6Kmm)	abnormal common myeloid progenitor cell morphology	J:334296
	abnormal T-helper 2 physiology	J:334296
	decreased dendritic cell number	J:334296
	decreased granulocyte monocyte progenitor cell number	J:334296
	decreased monocyte cell number	J:334296
	decreased plasmacytoid dendritic cell number	J:334296
	hematopoietic system phenotype	J:334296
	increased dendritic cell number	J:334296
Rr308^tm1.1Fwa/Rr308^tm1.1Fwa (involves: 129P2/OlaHsd)	abnormal T cell differentiation	J:82616, J:82395
Rr308^tm1.1Fwa/Rr308^tm1.1Fwa (involves: 129P2/OlaHsd)	abnormal T cell receptor alpha chain V-J recombination	J:82616
Rr308^tm1Fwa/Rr308^tm1Fwa (involves: 129P2/OlaHsd)	abnormal T cell differentiation	J:82616
Rr308^tm1Fwa/Rr308^tm1Fwa (involves: 129P2/OlaHsd)	abnormal T cell receptor alpha chain V-J recombination	J:82616
Rr308^tm2Fwa/Rr308^tm2Fwa (Not Specified)	abnormal T cell differentiation	J:82395
Rr320^tm1.1Fier/Rr320^tm1.1Fier (involves: 129 * 129X1/SvJ * C57BL/6)	hematopoietic system phenotype	J:126615
Rr320^tm1.1Mkg/Rr320⁺ (involves: 129)	anemia	J:60714
Rr320^tm1Ley/Rr320^tm1Ley (involves: 129X1/SvJ * C57BL/6)	decreased hematocrit	J:33053
	decreased mean corpuscular hemoglobin concentration	J:33053
	decreased mean corpuscular volume	J:33053
	reticulocytosis	J:33053
Rr320^tm2Mkg/Rr320⁺ (involves: 129S4/SvJaeSor)	anisopoikilocytosis	J:28981
Rr320^tm2Mkg/Rr320^tm2Mkg (involves: 129S4/SvJaeSor)	abnormal erythropoiesis	J:28981
	anemia	J:28981
	anisopoikilocytosis	J:28981
Rr320^tm3.1Mkg/Rr320^tm3.1Mkg (involves: 129S4/SvJaeSor)	hematopoietic system phenotype	J:51229
Rr338^em1Jeng/Rr338^em1Jeng (Not Specified)	abnormal T cell differentiation	J:232438
	abnormal T cell number	J:232438
	decreased CD4-positive, alpha-beta T cell number	J:232438
Rr347^em1Prdns/Rr347^em1Prdns (CBA/Ca-Rr347^em1Prdns)	absent Langerhans cell	J:281171
	decreased macrophage cell number	J:281171
	decreased microglial cell number	J:281171
	increased Ly6C low monocyte number	J:281171
Rr348^tm1.1Drhi/Rr348⁺ Rr349^tm1.1Wgw/Rr349⁺ (Not Specified)	decreased mean corpuscular hemoglobin	J:259286
	decreased mean corpuscular volume	J:259286
	reticulocytosis	J:259286
Rr349^tm1.1Wgw/Rr349⁺ (involves: 129P2/OlaHsd * CD-1)	decreased mean corpuscular hemoglobin	J:80121
Rr349^tm1.1Wgw/Rr349⁺ (involves: 129P2/OlaHsd * CD-1)	decreased mean corpuscular volume	J:80121
Rr349^tm1.1Wgw/Rr349^tm1.1Wgw (involves: 129P2/OlaHsd * CD-1)	abnormal erythropoiesis	J:80121
	abnormal hemoglobin	J:80121
	decreased mean corpuscular hemoglobin	J:80121
	decreased mean corpuscular volume	J:80121
Rr349^tm1Wgw/Rr349⁺ (involves: 129P2/OlaHsd)	abnormal hemoglobin	J:80121
	anisocytosis	J:80121
	decreased hemoglobin content	J:80121
	decreased mean corpuscular hemoglobin	J:80121
	decreased mean corpuscular volume	J:80121
	poikilocytosis	J:80121
Rr349^tm1Wgw/Rr349^tm1Wgw (involves: 129P2/OlaHsd)	abnormal erythrocyte morphology	J:80121
	abnormal hemoglobin	J:80121
	anemia	J:80121
Rr364^tm1.1Aak/Rr364^tm1.1Aak (129.129S2(Cg)-Rr364^tm1.1Aak)	abnormal class switch recombination	J:242276
	decreased IgG3 level	J:242276
	increased IgG2a level	J:242276
	increased IgG2b level	J:242276
Rr381^em1Kap/Rr381^em1Kap (involves: C57BL/6)	absent CD8-positive, alpha-beta T cells	J:333471
Rr381^em2Kap/Rr381^em2Kap (involves: C57BL/6)	hematopoietic system phenotype	J:333471
Rr381^em2Kap/Rr381^em2Kap Tg(TcrAND)53Hed/0 (involves: C57BL/6 * SJL)	hematopoietic system phenotype	J:333471
Rr381^em2Kap/Rr381^em2Kap Tg(TcraTcrb)1100Mjb/0 (involves: C57BL/6)	hematopoietic system phenotype	J:333471
Rr381^em3Kap/Rr381^em3Kap (involves: C57BL/6)	hematopoietic system phenotype	J:333471
Rr381^em4Kap/Rr381^em4Kap (involves: C57BL/6)	absent CD8-positive, alpha-beta T cells	J:333471
Rr381^em5Kap/Rr381^em5Kap (involves: C57BL/6)	absent CD8-positive, alpha-beta T cells	J:333471
Rr383^tm1Caob/Rr383^tm1Caob (B6.Cg-Rr383^tm1Caob)	decreased osteoclast cell number	J:131132
Rr394^em1Bhao/Rr394^em1Bhao (Not Specified)	abnormal T cell receptor alpha chain V-J recombination	J:333961
	decreased thymocyte number	J:333961
	hematopoietic system phenotype	J:333961
	increased DN3 thymocyte number	J:333961
Rr395^em1Bhao/Rr395^em1Bhao (Not Specified)	decreased double-positive T cell number	J:333961
	decreased thymocyte number	J:333961
	hematopoietic system phenotype	J:333961
	increased DN4 thymocyte number	J:333961
	increased thymocyte apoptosis	J:333961
Rr149356^tm1.1Pf/Rr149356^tm1.1Pf (either: 129P2/OlaHsd-Rr149356^tm1.1Pf or (involves: 129P2/OlaHsd * BALB/c))	abnormal T cell differentiation	J:34311
	abnormal thymus cortex morphology	J:34311
	abnormal thymus medulla morphology	J:34311
	abnormal thymus morphology	J:34311
	arrested T cell differentiation	J:34311
	decreased double-positive T cell number	J:34311
	decreased single-positive T cell number	J:34311
	decreased T cell number	J:34311
	decreased thymocyte number	J:34311
	increased double-negative T cell number	J:34311
	increased gamma-delta T cell number	J:34311
Rr149356^tm1Abnd/Rr149356^tm1Abnd (involves: 129S1/Sv * 129X1/SvJ)	abnormal T cell differentiation	J:137580
	abnormal thymus morphology	J:137580
	arrested T cell differentiation	J:137580
	decreased double-positive T cell number	J:137580
	decreased single-positive T cell number	J:137580
	decreased T cell number	J:137580
	increased double-negative T cell number	J:137580
	increased gamma-delta T cell number	J:137580
	thymus hypoplasia	J:137580
Rr149356^tm1Che/Rr149356^tm1Che (involves: 129S4/SvJae * C57BL/6)	abnormal double-negative T cell morphology	J:106246, J:107306
	abnormal double-positive T cell morphology	J:106246, J:107306
Rr149356^tm1Che/Rr149356^tm1Che Tcrd^tm1Mom/Tcrd^tm1Mom Trp53^tm1Tyj/Trp53^tm1Tyj (involves: 129P2/OlaHsd * 129S2/SvPas * 129S4/SvJae * C57BL/6)	abnormal double-negative T cell morphology	J:106246
Rr149356^tm1Che/Rr149356^tm1Che Trp53^tm1Tyj/Trp53^tm1Tyj (involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)	abnormal double-negative T cell morphology	J:106246
	abnormal double-positive T cell morphology	J:106246
Rr250409^tm1Lky/Rr250409^tm1Lky (involves: 129X1/SvJ * BALB/c * C57BL/6 * FVB)	decreased IgE level	J:125684
Rr275254^tm2.1Dhr/Rr275254^tm2.1Dhr (involves: 129S4/SvJae * C57BL/6)	abnormal gamma-delta T cell differentiation	J:75624
	abnormal T cell receptor gamma chain V-J recombination	J:75624
Rr275254^tm2Dhr/Rr275254^tm2Dhr (involves: 129S4/SvJae)	abnormal gamma-delta T cell differentiation	J:75624
Rr275254^tm2Dhr/Rr275254^tm2Dhr (involves: 129S4/SvJae)	abnormal T cell receptor gamma chain V-J recombination	J:75624
Rr282726^tm1Dhr/Rr282726^tm1Dhr (involves: 129S4/SvJae * C57BL/6)	abnormal gamma-delta T cell differentiation	J:75624
	abnormal T cell receptor gamma chain V-J recombination	J:75624
Rr282729^tm1.1Iku/Rr282729^tm1.1Iku (C57BL/6J-Rr316^tm1.1Iku)	abnormal T cell receptor gamma chain V-J recombination	J:288442
	decreased gamma-delta T cell number	J:288442
Rr299391^tm1.1Fwa/Rr299391⁺ (involves: 129P2/OlaHsd * FVB/N)	decreased T cell number	J:55401
	decreased thymocyte number	J:55401
Rr299391^tm1.1Fwa/Rr299391^tm1.1Fwa (involves: 129P2/OlaHsd * FVB/N)	decreased T cell number	J:55401
	decreased thymocyte number	J:55401
Rrad^{tm1.1(KOMP)Vlcg}/Rrad^{tm1.1(KOMP)Vlcg} (C57BL/6N-Rrad^{tm1.1(KOMP)Vlcg}/J)	increased mean corpuscular hemoglobin	J:211773
Rragc^em1Efe/Rragc⁺ (Not Specified)	abnormal B cell activation	J:320567
	abnormal B cell physiology	J:320567
	abnormal class switch recombination	J:320567
	decreased B cell proliferation	J:320567
	decreased germinal center B cell number	J:320567
	decreased IgG1 level	J:320567
	decreased IgM level	J:320567
	decreased plasma cell number	J:320567
	decreased spleen germinal center size	J:320567
	hematopoietic system phenotype	J:320567
Rragc^em1Efe/Rragc⁺ Tg(Vav-BCL2)69Jad/0 (Not Specified)	decreased germinal center B cell number	J:320567
Rragc^em1Efe/Rragc⁺ Tg(Vav-BCL2)69Jad/0 (Not Specified)	decreased spleen germinal center size	J:320567
Rras2^{em1(IMPC)Ccpcz}/Rras2^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Rras2^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
	increased NK cell number	J:211773
Rras2^{Gt(OST361011)Lex}/Rras2⁺ (involves: 129S5/SvEvBrd)	decreased B cell number	J:151653
	decreased follicular B cell number	J:151653
	decreased marginal zone B cell number	J:151653
	decreased memory T cell number	J:151653
	decreased spleen B cell follicle size	J:151653
	decreased spleen weight	J:151653
	decreased T cell number	J:151653
	spleen hypoplasia	J:151653
Rras2^{Gt(OST361011)Lex}/Rras2^{Gt(OST361011)Lex} (involves: 129S5/SvEvBrd)	abnormal B cell activation	J:151653
	abnormal B cell physiology	J:151653
	abnormal CD4-positive, alpha-beta T cell physiology	J:151653
	abnormal CD8-positive, alpha-beta T cell physiology	J:151653
	decreased B cell number	J:151653
	decreased B cell proliferation	J:151653
	decreased follicular B cell number	J:151653
	decreased marginal zone B cell number	J:151653
	decreased memory T cell number	J:151653
	decreased spleen B cell follicle size	J:151653
	decreased spleen weight	J:151653
	decreased T cell number	J:151653
	spleen hypoplasia	J:151653
Rras2^{Gt(OST361011)Lex}/Rras2^{Gt(OST361011)Lex} (B6.129S5-Rras2^{Gt(OST361011)Lex})	decreased B cell number	J:151653
	decreased memory T cell number	J:151653
	decreased T cell number	J:151653
Rras^{Gt(OST24882)Lex}/Rras^{Gt(OST24882)Lex} (B6;129S5-Rras^{Gt(OST24882)Lex}/Ieg)	decreased B cell number	J:82809
	increased CD4-positive, alpha-beta T cell number	J:82809
	increased CD8-positive, alpha-beta T cell number	J:82809
Rras^tm1Itl/Rras^tm1Itl (involves: 129S6/SvEvTac * C57BL/6)	abnormal dendritic cell morphology	J:181730
Rrbp1^em1(IMPC)J/Rrbp1^em1(IMPC)J (C57BL/6NJ-Rrbp1^em1(IMPC)J/Mmjax)	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
Rreb1^{tm1b(EUCOMM)Wtsi}/Rreb1⁺ (C57BL/6N-Rreb1^{tm1b(EUCOMM)Wtsi}/Wtsi)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	increased leukocyte cell number	J:211773
	increased red blood cell distribution width	J:211773
Rrm2b^{Gt(OST85254)Lex}/Rrm2b^{Gt(OST85254)Lex} (involves: 129S5/SvEvBrd * C57BL/6J)	decreased hematocrit	J:186071
	decreased hemoglobin content	J:186071
	spleen atrophy	J:186071
	thrombocytosis	J:186071
	thymus atrophy	J:186071
Rrm2b^tm1Ynak/Rrm2b^tm1Ynak (involves: 129 * C57BL/6J)	decreased spleen white pulp amount	J:84841
Rrm2b^tm1Ynak/Rrm2b^tm1Ynak (involves: 129 * C57BL/6J)	thymus cortex hypoplasia	J:84841
Rsad1^{tm1.1(KOMP)Vlcg}/Rsad1⁺ (C57BL/6N-Rsad1^{tm1.1(KOMP)Vlcg}/Ucd)	small thymus	J:211773
Rsad2^tm1Kchc/Rsad2^tm1Kchc (B6.129-Rsad2^tm1Kchc)	abnormal T-helper 2 cell differentiation	J:148305
Rsad2^tm1Kchc/Rsad2^tm1Kchc (B6.129-Rsad2^tm1Kchc)	decreased IgG1 level	J:148305
Rsph9^em1Jwji/Rsph9^em1Jwji (B6.Cg-Rsph9^em1Jwji)	increased microglial cell activation	J:294184
Rsph9^em1Jwji/Rsph9^em1Jwji (B6.Cg-Rsph9^em1Jwji)	microgliosis	J:294184
Rspo1^{tm2b(KOMP)Wtsi}/Rspo1^{tm2b(KOMP)Wtsi} (C57BL/6N-Rspo1^{tm2b(KOMP)Wtsi}/Ics)	increased lymphocyte cell number	J:211773
Rtbdn^{tm1a(EUCOMM)Wtsi}/Rtbdn^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Rtbdn^{tm1a(EUCOMM)Wtsi}/Wtsi)	thrombocytosis	J:211773
Rtcb^{tm1c(KOMP)Wtsi}/Rtcb^{tm1c(KOMP)Wtsi} Tg(Fcer2a-cre)5Mbu/0 (involves: C57BL/6 * CBA * SJL)	abnormal B cell number	J:216740
	abnormal B cell physiology	J:216740
	abnormal plasma cell morphology	J:216740
	decreased IgM level	J:216740
Rthyd1^NOD/MrkTac/? (involves: B10.Br/SgSnJ * NOD-H2^k)	abnormal T cell clonal deletion	J:94684
Rthyd2^B10.Br/SgSnJ/? (involves: B10.Br/SgSnJ * NOD-H2^k)	abnormal T cell clonal deletion	J:94684
Rthyd3^B10.Br/SgSnJ/? (involves: B10.Br/SgSnJ * NOD-H2^k)	abnormal T cell clonal deletion	J:94684
Rthyd5^NOD/MrkTac/? (involves: B10.Br/SgSnJ * NOD-H2^k)	abnormal T cell clonal deletion	J:94684
Rtn4^{em1(IMPC)Hmgu}/Rtn4^{em1(IMPC)Hmgu} (C57BL/6NCrl-Rtn4^{em1(IMPC)Hmgu}/Ieg)	increased mean platelet volume	J:211773
Rtn4rl2^em1(IMPC)Mbp/Rtn4rl2^em1(IMPC)Mbp (C57BL/6NCrl-Rtn4rl2^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased red blood cell distribution width	J:211773
Rtraf^{tm1b(EUCOMM)Hmgu}/Rtraf⁺ (C57BL/6N-Rtraf^{tm1b(EUCOMM)Hmgu}/H)	increased eosinophil cell number	J:211773
Rttn^em1(IMPC)Tcp/Rttn⁺ (C57BL/6NCrl-Rttn^em1(IMPC)Tcp/Tcp)	abnormal spleen morphology	J:211773
Rubcn^em1Dgre/Rubcn^em1Dgre (C57BL/6-Rubcn^em1Dgre)	abnormal macrophage physiology	J:261225
Rubcn^em1Dgre/Rubcn^em1Dgre (C57BL/6-Rubcn^em1Dgre)	hematopoietic system phenotype	J:261225
Rubcn^em1Dgre/Rubcn^em1Dgre (involves: C57BL/6 * C57BL/6N)	abnormal macrophage physiology	J:235399
	abnormal spleen morphology	J:235399
	increased CD8-positive, alpha-beta T cell number	J:235399
	increased IgG level	J:235399
	increased lymphocyte cell number	J:235399
	increased monocyte cell number	J:235399
	increased neutrophil cell number	J:235399
Rubcn^em1Dgre/Rubcn^em1Dgre Tg(CAG-EGFP/Map1lc3b)53Nmz/0 (involves: C57BL/6 * C57BL/6J * C57BL/6N * C57BL/6NCrlj * DBA/2)	abnormal macrophage morphology	J:261225
	abnormal macrophage physiology	J:261225
Rubcn^em1Dgre/Rubcn^em1Dgre Tg(CAG-EGFP/Map1lc3b)53Nmz/0 (involves: C57BL/6 * C57BL/6N * DBA/2)	abnormal macrophage physiology	J:235399
Rufy4^em1(IMPC)Mbp/Rufy4^em1(IMPC)Mbp (C57BL/6N-Rufy4^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Runx1^{tm1(cre/Esr1)Ims}/Runx1⁺ (either: (involves: C57BL/6 CBA) or (involves: C57BL/6 * CBA * ICR))	hematopoietic system phenotype	J:121435
Runx1^{tm1(RUNX1)Gcg}/Runx1^{tm1(RUNX1)Gcg} Tg(Mx1-cre)1Cgn/0 (involves: 129S1/Sv * C57BL/6 * CBA)	abnormal granulocyte differentiation	J:106800
	abnormal myelopoiesis	J:106801
	abnormal T cell differentiation	J:106800
	anemia	J:106800
	decreased CD4-positive, alpha-beta T cell number	J:106800
	decreased double-positive T cell number	J:106800
	increased CD8-positive, alpha-beta T cell number	J:106800
Runx1^{tm1(RUNX1/EVI1)Kmit}/Runx1⁺ (involves: C57BL/6 * CBA)	abnormal embryonic hematopoiesis	J:118892
	abnormal megakaryocyte morphology	J:118892
	abnormal myelopoiesis	J:118892
	decreased erythrocyte cell number	J:118892
Runx1^{tm1.1(RUNX1)Homy}/Runx1^{tm1.1(RUNX1)Homy} (B6.129P2-Runx1^{tm1.1(RUNX1*)Homy})	abnormal common myeloid progenitor cell morphology	J:164806
	abnormal megakaryocyte progenitor cell morphology	J:164806
	decreased erythroid progenitor cell number	J:164806
	decreased hematopoietic cell number	J:164806
	impaired hematopoiesis	J:164806
Runx1^tm1.1Glac/Runx1^tm1.1Glac (involves: 129P2/OlaHsd * C57BL/6 * ICR)	hematopoietic system phenotype	J:155698
Runx1^tm1.1Gss/Runx1^tm1.1Gss (involves: 129S4/SvJae * C57BL/6)	abnormal definitive hematopoiesis	J:157660
	decreased hematopoietic stem cell number	J:157660
Runx1^tm1Dez/Runx1⁺ (involves: 129S4/SvJae * C57BL/6)	impaired hematopoiesis	J:38705
Runx1^tm1Dow/Runx1^tm1Dow (involves: 129P2/OlaHsd * C57BL/6)	abnormal embryonic hematopoiesis	J:31130
Runx1^tm1Itan/Runx1^tm1Itan (involves: 129P2/OlaHsd)	hematopoietic system phenotype	J:132661
Runx1^tm1Medv/Runx1^tm1Medv (involves: 129P2/OlaHsd)	anemia	J:106769
Runx1^tm1Medv/Runx1^tm1Medv (involves: 129P2/OlaHsd)	impaired hematopoiesis	J:106769
Runx1^tm1Sata/Runx1^tm1Sata (involves: 129S4/SvJae * C57BL/6J)	abnormal definitive hematopoiesis	J:50937, J:63424
	abnormal erythropoiesis	J:63424
Runx1^tm1Soga/Runx1^tm1.1Soga Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	abnormal B cell differentiation	J:88511
	abnormal common myeloid progenitor cell morphology	J:88511
	abnormal definitive hematopoiesis	J:88511
	abnormal megakaryocyte differentiation	J:88511
	abnormal megakaryocyte morphology	J:88511
	abnormal megakaryocyte progenitor cell morphology	J:88511
	abnormal T cell differentiation	J:88511
	hematopoietic system phenotype	J:88511
	thrombocytopenia	J:88511
Runx1^tm1Soga/Runx1^tm1Soga Stag2^tm1.1Soga/Y Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6J * C57BL/6N * CBA/J)	abnormal bone marrow cell physiology	J:289000
	abnormal myeloid cell morphology	J:289000
	anemia	J:289000
	decreased erythroid progenitor cell number	J:289000
	decreased leukocyte cell number	J:289000
	increased hematopoietic stem cell number	J:289000
	increased mean corpuscular volume	J:289000
	increased red blood cell distribution width	J:289000
Runx1^tm1Spe/Runx1⁺ (either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6))	abnormal embryonic hematopoiesis	J:120100
	decreased CD4-positive, alpha-beta T cell number	J:120100
Runx1^tm1Spe/Runx1^tm1Spe (either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6))	abnormal erythropoiesis	J:35115
	impaired hematopoiesis	J:35115
	impaired myelopoiesis	J:35115
	increased nucleated erythrocyte cell number	J:35115
Runx1^tm1Spe/Runx1^tm1Yg (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6)	anemia	J:160791
Runx1^tm1Spe/Runx1^tm2Spe (either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6))	abnormal embryonic hematopoiesis	J:56184
Runx1^tm1Spe/Runx1^tm3Itan (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	hematopoietic system phenotype	J:160791
Runx1^tm1Tani/Runx1^tm1Tani Runx3^tm1Itan/Runx3^tm1Itan Tg(Cd4-cre)1Cwi/? (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	decreased CD8-positive, alpha-beta T cell number	J:125959
Runx1^tm1Tani/Runx1^tm1Tani Tg(Cd4-cre)1Cwi/? (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	abnormal CD4-positive T cell differentiation	J:125959
	abnormal CD8-positive, alpha-beta T cell differentiation	J:125959
	abnormal double-positive T cell morphology	J:125959
	decreased CD4-positive, alpha-beta T cell number	J:125959
Runx1^tm1Tani/Runx1^tm1Tani Tg(Lck-cre)1Cwi/? (involves: 129P2/OlaHsd)	arrested T cell differentiation	J:125959
	decreased double-positive T cell number	J:125959
	decreased thymocyte number	J:125959
	increased double-negative T cell number	J:125959
Runx1^tm1Toku/Runx1⁺ Runx3^tm1Itan/Runx3^tm1Itan Tg(Cd4-cre)1Cwi/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	decreased CD8-positive, alpha-beta T cell number	J:131081
Runx1^tm1Toku/Runx1^tm1Toku (involves: 129P2/OlaHsd * C57BL/6)	abnormal T cell subpopulation ratio	J:87697
	increased CD4-positive, alpha-beta T cell number	J:87697
	small thymus	J:87697
	thymus hypoplasia	J:87697
Runx1^tm1Toku/Runx1^tm1Toku Runx3^tm1Itan/Runx3⁺ Tg(Cd4-cre)1Cwi/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	decreased CD4-positive, alpha-beta T cell number	J:131081
	decreased CD8-positive, alpha-beta T cell number	J:131081
Runx1^tm1Toku/Runx1^tm1Toku Runx3^tm1Itan/Runx3^tm1Itan Tg(Cd4-cre)1Cwi/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	decreased CD4-positive, alpha-beta T cell number	J:131081
	decreased CD8-positive, alpha-beta T cell number	J:131081
Runx1^tm1Toku/Runx1^tm1Toku Tg(Cd4-cre)1Cwi/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	decreased CD8-positive, alpha-beta T cell number	J:131081
Runx1^tm1Yg/Runx1⁺ Tg(Runx1-GFP)#Itan/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	abnormal hematopoietic system morphology/development	J:160791
Runx1^tm1Yg/Runx1^tm1Yg (either: (involves: 129/Sv * 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * ICR) or (involves: 129S1/Sv * 129X1/SvJ * MF1))	abnormal definitive hematopoiesis	J:125830
	abnormal leukopoiesis	J:125830
	abnormal T cell differentiation	J:125830
	abnormal thymus corticomedullary boundary morphology	J:125830
	abnormal thymus lobule morphology	J:125830
	decreased single-positive T cell number	J:125830
	decreased thymocyte number	J:125830
	increased double-positive T cell number	J:125830
	increased thymocyte apoptosis	J:125830
	small thymus	J:125830
	thymus cyst	J:125830
	thymus hypoplasia	J:125830
Runx1^tm1Yg/Runx1^tm1Yg (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal bone marrow cell morphology/development	J:160791
Runx1^tm1Yg/Runx1^tm1Yg Tg(Lck-cre)1Jtak/? (either: (involves: 129/Sv * 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * ICR) or (involves: 129S1/Sv * 129X1/SvJ * MF1))	decreased T cell number	J:125830
Runx1^tm1Yg/Runx1^tm1Yg Tg(Runx1-GFP)#Itan/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	abnormal hematopoietic system morphology/development	J:160791
Runx1^{tm2(Runx1)Toku}/Runx1^{tm2(Runx1)Toku} (involves: 129P2/OlaHsd * C57BL/6)	abnormal T cell subpopulation ratio	J:87697
Runx1^{tm2.1(cre/Esr1)Ims}/Runx1^tm1Medv (involves: 129P2/OlaHsd C57BL/6)	abnormal hematopoietic system morphology/development	J:182232
	anemia	J:182232
	hematopoietic system phenotype	J:182232
Runx1^{tm2.1(cre/Esr1)Ims}/Runx1^{tm2.1(cre/Esr1)Ims} (involves: C57BL/6)	anemia	J:182232
Runx1^tm2.1Gss/Runx1^tm2.1Gss (involves: 129S4/SvJae * C57BL/6)	abnormal definitive hematopoiesis	J:214025
	abnormal erythrocyte morphology	J:214025
	abnormal erythroid progenitor cell morphology	J:214025
	abnormal erythropoiesis	J:214025
	abnormal leukocyte morphology	J:214025
	abnormal megakaryocyte differentiation	J:214025
	abnormal megakaryocyte morphology	J:214025
	abnormal spleen white pulp morphology	J:214025
	anemia	J:214025
	decreased CD8-positive, alpha-beta T cell number	J:214025
	decreased hematocrit	J:214025
	decreased immature B cell number	J:214025
	decreased mean corpuscular volume	J:214025
	decreased pre-pro B cell number	J:214025
	enlarged spleen	J:214025
	hematopoietic system phenotype	J:214025
	increased erythrocyte cell number	J:214025
	increased granulocyte number	J:214025
	increased hemoglobin content	J:214025
	increased macrophage cell number	J:214025
	increased mature B cell number	J:214025
	increased mean platelet volume	J:214025
	increased monocyte cell number	J:214025
	increased pro-B cell number	J:214025
	increased red blood cell distribution width	J:214025
	myeloid hyperplasia	J:214025
	thrombocytosis	J:214025
Runx1^tm2Buch/Runx1^tm2Buch Tg(Mx1-cre)1Cgn/? (involves: 129P2/OlaHsd * C57BL/6 * CBA)	abnormal common myeloid progenitor cell morphology	J:105709
	abnormal leukocyte morphology	J:105709
	abnormal megakaryocyte morphology	J:105709
	abnormal thymus lobule morphology	J:105709
	decreased CD4-positive, alpha-beta T cell number	J:105709
	decreased CD8-positive, alpha-beta T cell number	J:105709
	decreased double-positive T cell number	J:105709
	decreased lymphocyte cell number	J:105709
	decreased mature B cell number	J:105709
	decreased megakaryocyte cell number	J:105709
	decreased spleen white pulp amount	J:105709
	decreased T cell number	J:105709
	decreased thymus weight	J:105709
	impaired myelopoiesis	J:105709
	increased hematopoietic stem cell number	J:105709
	increased mast cell number	J:105709
	increased monocyte cell number	J:105709
	increased neutrophil cell number	J:105709
	increased number of Howell-Jolly bodies	J:105709
	increased spleen red pulp amount	J:105709
	increased spleen weight	J:105709
	thrombocytopenia	J:105709
Runx1^tm2Dow/Runx1⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal embryonic hematopoiesis	J:79160
Runx1^tm2Itan/Runx1^tm2Itan (involves: 129P2/OlaHsd)	hematopoietic system phenotype	J:132661
Runx1^{tm3(Runx3)Toku}/Runx1^{tm3(Runx3)Toku} (involves: 129P2/OlaHsd)	abnormal thymus medulla morphology	J:98965
	decreased leukocyte cell number	J:98965
	decreased lymphocyte cell number	J:98965
	decreased thymocyte number	J:98965
	small spleen	J:98965
	small thymus	J:98965
	thymus hypoplasia	J:98965
Runx1^tm3Dow/Runx1⁺ Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	abnormal hematopoietic system morphology/development	J:77129
	hematopoietic system phenotype	J:77129
Runx1^tm3Itan/Runx1^tm3Itan (involves: 129P2/OlaHsd * C57BL/6)	abnormal bone marrow cell morphology/development	J:160791
	decreased leukocyte cell number	J:160791
	increased hematopoietic stem cell number	J:160791
	thrombocytopenia	J:160791
Runx1^tm3Itan/Runx1^tm3Itan (involves: 129P2/OlaHsd)	decreased CD4-positive, alpha-beta T cell number	J:168918
Runx1^tm3Itan/Runx1^tm3Itan (involves: 129P2/OlaHsd)	decreased thymocyte number	J:168918
Runx1^tm3Itan/Runx1^tm3Itan Tg(Runx1-GFP)#Itan/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	abnormal hematopoietic system morphology/development	J:160791
Runx1^tm3Spe/Runx1^tm3Spe Spi1^tm2.1Dgt/Spi1^tm2.1Dgt Tg(Mx1-cre)1Cgn/0 (involves: 129S4/SvJae * C57BL/6 * CBA)	decreased B cell number	J:131217
	decreased thymus weight	J:131217
	increased granulocyte number	J:131217
	increased spleen weight	J:131217
Runx1^tm3Spe/Runx1^tm3Spe Tg(Cdh5-cre)1Spe/0 (involves: 129S1/SvImJ * 129S4/SvJae * C57BL/6)	abnormal hematopoietic stem cell morphology	J:145700
	anemia	J:145700
	decreased hematopoietic stem cell number	J:145700
Runx1^tm3Spe/Runx1^tm3Spe Tg(Mx1-cre)1Cgn/0 (involves: 129S4/SvJae * C57BL/6 * CBA)	abnormal myeloblast morphology/development	J:151639
	arrested T cell differentiation	J:131217
	decreased B cell number	J:151639
	decreased double-negative T cell number	J:131217
	decreased hematopoietic stem cell number	J:151639
	decreased thymus weight	J:131217
	increased double-negative T cell number	J:131217
	increased hematopoietic stem cell number	J:151639
	increased spleen weight	J:131217
	thrombocytopenia	J:131217
Runx1^tm3Spe/Runx1^tm3Spe Tg(VAV1-cre)1Graf/0 (involves: 129S4/SvJae)	abnormal common myeloid progenitor cell morphology	J:145700
	abnormal platelet morphology	J:145700
	decreased B cell number	J:145700
	decreased double-positive T cell number	J:145700
	decreased lymphocyte cell number	J:145700
	decreased thymocyte number	J:145700
	increased granulocyte number	J:145700
	increased hematopoietic stem cell number	J:145700
	increased monocyte cell number	J:145700
Runx1^tm3Spe/Runx1^tm3Spe U2af1^tm1.1Hev/U2af1⁺ Tg(Mx1-cre)1Cgn/0 (involves: 129S4/SvJae * 129S6/SvEvTac * BALB/c * C57BL/6 * CBA/J)	abnormal blood cell morphology	J:267082
	abnormal erythroid lineage cell morphology	J:267082
	abnormal myeloid cell morphology	J:267082
	increased myeloid cell number	J:267082
	thrombocytopenia	J:267082
Runx1^{tm4(Runx2)Toku}/Runx1^{tm4(Runx2)Toku} (involves: 129P2/OlaHsd)	decreased leukocyte cell number	J:98965
Runx1^tm4Spe/Runx1⁺ (involves: 129/Sv * C57BL/6)	abnormal embryonic hematopoiesis	J:120100
Runx1^tm4Spe/Runx1⁺ (involves: 129/Sv * C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:120100
Runx1^tm4Spe/Runx1^tm4Spe (involves: 129/Sv * C57BL/6)	abnormal embryonic hematopoiesis	J:120100
	decreased leukocyte cell number	J:120100
	decreased lymphocyte cell number	J:120100
	increased monocyte cell number	J:120100
	thrombocytopenia	J:120100
Runx1^tm5Spe/Runx1⁺ (involves: 129/Sv * C57BL/6)	abnormal embryonic hematopoiesis	J:120100
Runx1^tm5Spe/Runx1⁺ (involves: 129/Sv * C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:120100
Runx1^tm5Spe/Runx1^tm5Spe (involves: 129/Sv * C57BL/6)	abnormal embryonic hematopoiesis	J:120100
Runx1^tm6Spe/Runx1⁺ (involves: 129/Sv * C57BL/6)	abnormal embryonic hematopoiesis	J:120100
Runx1^tm6Spe/Runx1⁺ (involves: 129/Sv * C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:120100
Runx1^tm6Spe/Runx1^tm6Spe (involves: 129/Sv * C57BL/6)	abnormal embryonic hematopoiesis	J:120100
Runx1^tm7Spe/Runx1⁺ (involves: 129/Sv * C57BL/6)	abnormal embryonic hematopoiesis	J:120100
Runx1^tm7Spe/Runx1⁺ (involves: 129/Sv * C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:120100
Runx1^tm7Spe/Runx1^tm7Spe (involves: 129/Sv * C57BL/6)	abnormal embryonic hematopoiesis	J:120100
Runx1^tm8Spe/Runx1⁺ (involves: 129/Sv * C57BL/6)	abnormal embryonic hematopoiesis	J:120100
Runx1^tm8Spe/Runx1⁺ (involves: 129/Sv * C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:120100
Runx1^tm8Spe/Runx1^tm8Spe (involves: 129/Sv * C57BL/6)	abnormal embryonic hematopoiesis	J:120100
Runx2^tm1Kish/Runx2⁺ (involves: 129P2/OlaHsd * C57BL/6)	enlarged thymus	J:162258
Runx2^tm1Kish/Runx2^tm1Kish (involves: 129P2/OlaHsd * C57BL/6)	abnormal definitive hematopoiesis	J:53069
	abnormal osteoclast differentiation	J:59821, J:40783
	abnormal splenic cell ratio	J:53069
	anemia	J:53069
	decreased B cell number	J:53069
	decreased thymocyte number	J:40783
	enlarged spleen	J:53069
	extramedullary hematopoiesis	J:53069
	increased granulocyte number	J:53069
	increased nucleated erythrocyte cell number	J:53069
Runx2^tm1Mjo/Runx2^tm1Mjo (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	absent bone marrow cell	J:40784
	increased nucleated erythrocyte cell number	J:40784
Runx3^tm1Itan/Runx3^tm1Itan Tg(Cd4-cre)1Cwi/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	abnormal CD8-positive, alpha beta T cell morphology	J:125953
	abnormal CD8-positive, alpha-beta T cell differentiation	J:125953
	decreased CD8-positive, alpha-beta T cell number	J:131081
	increased IgA level	J:125953
Runx3^tm1Litt/Runx3^tm1Litt (involves: 129P2/OlaHsd)	abnormal CD8-positive, alpha-beta T cell differentiation	J:141144
Runx3^tm1Litt/Runx3^tm1Litt (involves: 129P2/OlaHsd)	abnormal double-positive T cell morphology	J:141144
Runx3^tm1Yg/Runx3^tm1Yg (either: (involves: 129S1/Sv * 129X1/SvJ * ICR) or (involves: 129S1/Sv * 129X1/SvJ * MF1))	abnormal dendritic cell differentiation	J:88424
	abnormal dendritic cell morphology	J:88424
	absent Langerhans cell	J:88424
	increased dendritic cell number	J:88424, J:100348
	increased IgE level	J:100348
Runx3^tm1Yg/Runx3^tm1Yg (involves: 129S1/Sv * 129X1/SvJ)	abnormal CD8-positive, alpha beta T cell morphology	J:109584
Runx3^tm2Yg/Runx3^tm2Yg (involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6 * ICR)	abnormal CD8-positive, alpha beta T cell morphology	J:109584
	abnormal dendritic cell differentiation	J:109584
Runx3^tm3.1Yg/Runx3^tm3.1Yg (Not Specified)	absent Langerhans cell	J:224898
Rusc1^em1(IMPC)J/Rusc1^em1(IMPC)J (C57BL/6NJ-Rusc1^em1(IMPC)J/J)	decreased mean corpuscular volume	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
Ruvbl1^tm1.1Oxbk/Ruvbl1^tm1.1Oxbk Tg(Mx1-cre)1Cgn/0 (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * CBA/J * SJL)	abnormal definitive hematopoiesis	J:220926
	abnormal hematopoietic stem cell physiology	J:220926
	absent hematopoietic stem cells	J:220926
	bone marrow failure	J:220926
	decreased bone marrow cell number	J:220926
	pancytopenia	J:220926
Ruvbl2^M1Btlr/Ruvbl2⁺ (involves: C57BL/6J)	abnormal class switch recombination	J:185495
	decreased CD4-positive, alpha-beta T cell number	J:185495
	decreased CD8-positive, alpha-beta T cell number	J:185495
	decreased double-positive T cell number	J:185495
	decreased IgG1 level	J:185495
	decreased IgG level	J:185495
	decreased IgM level	J:185495
	decreased T cell number	J:185495
	increased thymocyte number	J:185495
Rwdd1^{tm1b(KOMP)Wtsi}/Rwdd1^{tm1b(KOMP)Wtsi} (C57BL/6N-Rwdd1^{tm1b(KOMP)Wtsi}/Wtsi)	decreased CD8-positive, alpha-beta T cell number	J:211773
	decreased Ly6C-positive mature NK cell number	J:211773
	decreased regulatory T cell number	J:211773
	increased CD4-positive, alpha-beta T cell number	J:211773
	increased memory-marker gamma-delta T cell number	J:211773
	thrombocytopenia	J:211773
Rwdd2a^em1(IMPC)J/Rwdd2a^em1(IMPC)J (C57BL/6NJ-Rwdd2a^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Rxfp1^tm1Jgo/Rxfp1^tm1Jgo (involves: 129S5/SvEvBrd * C57BL/6)	hematopoietic system phenotype	J:87579
Rxfp2^{tm1a(EUCOMM)Wtsi}/Rxfp2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Rxfp2^{tm1a(EUCOMM)Wtsi}/Ieg)	decreased IgE level	J:165965
	increased monocyte cell number	J:165965
Rxfp2^{tm1b(EUCOMM)Wtsi}/Rxfp2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Rxfp2^{tm1b(EUCOMM)Wtsi}/Ieg)	increased erythrocyte cell number	J:211773
	increased hematocrit	J:211773
	increased hemoglobin content	J:211773
Rxfp4^{tm1.1(KOMP)Vlcg}/Rxfp4^{tm1.1(KOMP)Vlcg} (C57BL/6N-Rxfp4^{tm1.1(KOMP)Vlcg}/J)	decreased leukocyte cell number	J:211773
	thrombocytopenia	J:211773
Rxra^pke/Rxra^pke (C57BL/6J-Rxra^pke)	abnormal regulatory T cell physiology	J:103186
Rxra^pke/Rxra^pke (C57BL/6J-Rxra^pke)	abnormal T-helper 2 cell morphology	J:103186
Rxra^tm1Ipc/Rxra^tm4Ipc Rxrb^tm1Mma/Rxrb^tm1Pcn Tg(KRT14-cre/ERT2)1Ipc/0 (involves: 129S2/SvPas)	increased immunoglobulin level	J:102470
Rxra^tm1Krc/Rxra^tm1Krc Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	abnormal macrophage activation involved in immune response	J:168799
	abnormal peritoneal macrophage morphology	J:168799
	impaired macrophage phagocytosis	J:168799
	increased IgG level	J:168799
	increased IgM level	J:168799
Rxra^tm2Ipc/Rxra^tm4Ipc Tg(KRT14-cre)1Ipc/0 (involves: 129S2/SvPas * C57BL/6 * SJL)	abnormal Langerhans cell morphology	J:67149
Rxra^tm4Ipc/Rxra^tm4Ipc Rxrb^tm1Pcn/Rxrb^tm1Pcn Tg(KRT14-cre/ERT2)1Ipc/0 (involves: 129S2/SvPas)	enlarged spleen	J:102470
	increased leukocyte cell number	J:102470
Ryk^em1(IMPC)Mbp/Ryk⁺ (C57BL/6NCrl-Ryk^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
	increased monocyte cell number	J:211773
Ryr1^{tm1b(EUCOMM)Hmgu}/Ryr1⁺ (C57BL/6N-Ryr1^{tm1b(EUCOMM)Hmgu}/H)	increased spleen weight	J:211773
Ryr2^tm1.1Hnis/Ryr2^tm1.1Hnis (involves: C57BL/6)	abnormal spleen white pulp morphology	J:228787
	increased spleen weight	J:228787
	increased thymus weight	J:228787
	thymus cortex hyperplasia	J:228787
S1pr1^tm1.1Cys/S1pr1^tm1.1Cys (involves: 129P2/OlaHsd * C3H * C57BL/6)	abnormal B cell physiology	J:176118
	decreased B cell number	J:176118
S1pr1^tm1.1Thla/S1pr1^tm1.1Thla (B6.Cg-S1pr1^tm1.1Thla)	abnormal leukocyte migration	J:163389
	abnormal lymphocyte physiology	J:163389
	increased CD4-positive, alpha-beta T cell number	J:163389
	increased CD8-positive, alpha-beta T cell number	J:163389
S1pr1^tm1Cys/S1pr1^tm1Cys (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:176118
	decreased B cell number	J:176118
S1pr1^tm1Rlp/S1pr1^tm1Rlp (involves: 129S6/SvEvTac)	abnormal NK cell differentiation	J:154069
S1pr1^tm1Rlp/S1pr1^tm1Rlp (involves: 129S6/SvEvTac)	decreased NK cell number	J:154069
S1pr2^tm1Ajml/S1pr2^tm1Ajml (involves: 129S5/SvEvBrd * C57BL/6)	abnormal spleen marginal zone morphology	J:154439
	increased germinal center B cell number	J:154439
	increased spleen germinal center number	J:154439
	increased spleen germinal center size	J:154439
	increased T cell number	J:154439
S1pr2^tm1Rlp/S1pr2^tm1Rlp (involves: 129S6/SvEvTac * C57BL/6)	abnormal spleen germinal center morphology	J:174313
	decreased B cell apoptosis	J:174313
	increased B cell number	J:174313
	increased B cell proliferation	J:174313
	increased germinal center B cell number	J:174313
	increased T cell number	J:174313
S1pr3^tm1Rlp/S1pr3^tm1Rlp (involves: 129S6/SvEvTac * C57BL/6)	abnormal B cell physiology	J:91161
S1pr4^tm1Lipp/S1pr4^tm1Lipp (involves: 129X1/SvJ * C57BL/6J)	abnormal megakaryocyte morphology	J:179199
	abnormal thrombopoiesis	J:179199
	hematopoietic system phenotype	J:179199
S1pr4^tm2Lipp/S1pr4^tm2Lipp (involves: 129P2/OlaHsd * C57BL/6J)	hematopoietic system phenotype	J:179199
S1pr5^tm1Club/S1pr5^tm1Club (B6.129P2-S1pr5^tm1Club)	abnormal NK cell morphology	J:178789
	abnormal NK cell physiology	J:178789
	decreased NK cell number	J:178789
S1pr5^tm1Jch/S1pr5^tm1Jch (involves: 129P2/OlaHsd * C57BL/6)	abnormal NK cell differentiation	J:154069
S100a3^em1(IMPC)Mbp/S100a3^em1(IMPC)Mbp (C57BL/6NCrl-S100a3^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
S100a4^tm1.1Abres/S100a4^tm1.1Abres (B6.Cg-S100a4^tm1.1Abres)	abnormal eosinophil physiology	J:182865
	impaired macrophage chemotaxis	J:182865
S100a9^tm1Hogg/S100a9^tm1Hogg (involves: 129P2/OlaHsd * C57BL/6)	abnormal neutrophil morphology	J:82513
	abnormal neutrophil physiology	J:82513
S100a9^tm1Nck/S100a9^tm1Nck (involves: 129P2/OlaHsd * C57BL/6)	abnormal cellular extravasation	J:81642
Sac3d1^tm1Hnaka/Sac3d1⁺ (involves: 129P2/OlaHsd)	abnormal bone marrow cell morphology/development	J:144601
	abnormal common myeloid progenitor cell morphology	J:144601
	abnormal mast cell physiology	J:144601
	increased erythroid progenitor cell number	J:144601
Sac3d1^tm1Hnaka/Sac3d1^tm1Hnaka (involves: 129P2/OlaHsd)	abnormal B cell physiology	J:144601
	abnormal bone marrow cell morphology/development	J:144601
	abnormal common myeloid progenitor cell morphology	J:144601
	abnormal mast cell physiology	J:144601
	increased erythroid progenitor cell number	J:144601
	increased T cell proliferation	J:144601
	spleen hyperplasia	J:144601
	thymus hyperplasia	J:144601
Sacs^em1(IMPC)Tcp/Sacs⁺ (C57BL/6NCrl-Sacs^em1(IMPC)Tcp/Tcp)	increased mean corpuscular volume	J:211773
Sacs^em1(IMPC)Tcp/Sacs^em1(IMPC)Tcp (C57BL/6NCrl-Sacs^em1(IMPC)Tcp/Tcp)	abnormal spleen morphology	J:211773
	increased mean corpuscular volume	J:211773
Safb^tm1So/Safb^tm1So (involves: 129 * C57BL/6J)	abnormal erythropoiesis	J:97633
Sall3^{tm1.1(KOMP)Mbp}/Sall3⁺ (C57BL/6NCrl-Sall3^{tm1.1(KOMP)Mbp}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Samd1^tm1Pfi/Samd1^tm1Pfi (involves: C57BL/6J * C57BL/6N)	decreased erythrocyte cell number	J:333561
Samd3^{tm1.1(HBEGF)Wfkr}/Samd3⁺ (C57BL/6J-Samd3^{tm1.1(HBEGF)Wfkr})	abnormal NK cell differentiation	J:322359
	decreased memory T cell number	J:322359
	decreased NK cell number	J:322359
Samd3^{tm1.1(HBEGF)Wfkr}/Samd3^{tm1.1(HBEGF)Wfkr} (C57BL/6J-Samd3^{tm1.1(HBEGF)Wfkr})	decreased CD8-positive, alpha-beta memory T cell number	J:322359
Samd9l^tm1Homy/Samd9l⁺ (involves: 129P2/OlaHsd)	abnormal definitive hematopoiesis	J:202604
	abnormal erythroblast morphology	J:202604
	abnormal erythropoiesis	J:202604
	abnormal megakaryocyte morphology	J:202604
	abnormal myelopoiesis	J:202604
	abnormal neutrophil morphology	J:202604
	anemia	J:202604
	anisopoikilocytosis	J:202604
	decreased neutrophil cell number	J:202604
	enlarged spleen	J:202604
	giant platelets	J:202604
	increased bone marrow cell number	J:202604
	increased leukocyte cell number	J:202604
	increased number of Howell-Jolly bodies	J:202604
	polychromatophilia	J:202604
Samd9l^tm1Homy/Samd9l^tm1Homy (involves: 129P2/OlaHsd)	abnormal definitive hematopoiesis	J:202604
	abnormal erythroblast morphology	J:202604
	abnormal erythropoiesis	J:202604
	abnormal megakaryocyte morphology	J:202604
	abnormal myelopoiesis	J:202604
	abnormal neutrophil morphology	J:202604
	anemia	J:202604
	anisopoikilocytosis	J:202604
	decreased neutrophil cell number	J:202604
	enlarged spleen	J:202604
	giant platelets	J:202604
	increased bone marrow cell number	J:202604
	increased leukocyte cell number	J:202604
	increased number of Howell-Jolly bodies	J:202604
	polychromatophilia	J:202604
Samsn1^tm1Xyw/Samsn1^tm1Xyw (B6.129P2-Samsn1^tm1Xyw)	abnormal T-helper 1 physiology	J:158032
	abnormal T-helper 2 physiology	J:158032
	increased B cell proliferation	J:158032
	increased B-1a cell number	J:158032
	increased IgG3 level	J:158032
	increased IgM level	J:158032
	increased T cell proliferation	J:158032
Sap30^em1(IMPC)J/Sap30^em1(IMPC)J (C57BL/6NJ-Sap30^em1(IMPC)J/Mmjax)	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
Sap30bp^{Tg(Tyr)2375C-1Ove}/Sap30bp^{Tg(Tyr)2375C-1Ove} (FVB/N-Sap30bp^{Tg(Tyr)2375C-1Ove})	anemia	J:175597
Sap130^{tm1a(KOMP)Mbp}/Sap130⁺ (C57BL/6N-Sap130^{tm1a(KOMP)Mbp}/Wtsi)	decreased leukocyte cell number	J:211773
Sar1b^{tm1a(EUCOMM)Wtsi}/Sar1b⁺ (C57BL/6N-Sar1b^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased mean corpuscular hemoglobin	J:175295
Sarm1^tm1.1Diam/Sarm1^tm1.1Diam (involves: 129X1/SvJ * C57BL/6)	decreased microglial cell activation	J:200140
	hematopoietic system phenotype	J:200140
Sarnp^{tm1b(EUCOMM)Hmgu}/Sarnp⁺ (C57BL/6N-Sarnp^{tm1b(EUCOMM)Hmgu}/Ieg)	increased mean corpuscular hemoglobin	J:211773
Sart3^tm1.1Hbro/Sart3⁺ Tg(Tek-cre)1Ywa/0 (involves: C57BL/6 * SJL)	abnormal common myeloid progenitor cell morphology	J:173259
	abnormal definitive hematopoiesis	J:173259
	decreased erythroid progenitor cell number	J:173259
	decreased hematopoietic stem cell number	J:173259
Sash3^tm1Hlz/Sash3^tm1Hlz (B6.129P2-Sash3^tm1Hlz)	abnormal B cell morphology	J:102171
	abnormal B cell physiology	J:102171
	abnormal CD4-positive T cell differentiation	J:102171
	abnormal CD8-positive, alpha-beta T cell differentiation	J:102171
	abnormal marginal zone B cell physiology	J:102171
	abnormal T cell morphology	J:102171
	decreased double-positive T cell number	J:102171
	decreased IgG1 level	J:102171
	decreased IgG2a level	J:102171
	decreased IgG level	J:102171
	decreased IgM level	J:102171
	decreased marginal zone B cell number	J:102171
	decreased T cell proliferation	J:102171
Satb1^em1Zfa/Satb1^em1Zfa (involves: C57BL/6)	decreased common lymphocyte progenitor cell number	J:259392
Satb1^m1Anu/Satb1⁺ (C57L/6JAnu-Satb1^m1Anu)	abnormal CD4-positive, alpha beta T cell morphology	J:104190
Satb1^m1Anu/Satb1⁺ (C57L/6JAnu-Satb1^m1Anu)	abnormal CD8-positive, alpha beta T cell morphology	J:104190
Satb1^m1Anu/Satb1^m1Anu (C57L/6JAnu-Satb1^m1Anu)	abnormal CD4-positive, alpha beta T cell morphology	J:104190
Satb1^m1Anu/Satb1^m1Anu (C57L/6JAnu-Satb1^m1Anu)	abnormal CD8-positive, alpha beta T cell morphology	J:104190
Satb1^tm1Kos/Satb1^tm1Kos (involves: 129P2/OlaHsd * C57BL/6)	abnormal T cell differentiation	J:61085
	abnormal T cell proliferation	J:61085
	arrested T cell differentiation	J:61085
	decreased thymocyte number	J:61085
	small spleen	J:61085
	small thymus	J:61085
Satb1^tm2Kos/Satb1^tm2Kos Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: C57BL/6 * C57BL/10 * CBA/Ca)	absent regulatory T cells	J:252606
Satb2^em3(IMPC)Tcp/Satb2⁺ (C57BL/6NCrl-Satb2^em3(IMPC)Tcp/Tcp)	increased mean corpuscular volume	J:211773
Saxo1^{tm1b(EUCOMM)Hmgu}/Saxo1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Saxo1^{tm1b(EUCOMM)Hmgu}/Ics)	decreased lymphocyte cell number	J:211773
	increased eosinophil cell number	J:211773
Sbds^tm1Dats/Sbds^tm1Dats Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0 (involves: C57BL/6 * CD-1)	abnormal megakaryocyte morphology	J:158901
	abnormal myeloid leukocyte morphology	J:158901
	abnormal neutrophil morphology	J:158901
	decreased B cell number	J:158901
	decreased leukocyte cell number	J:158901
	decreased lymphocyte cell number	J:158901
	impaired hematopoiesis	J:158901
Sbf1^em1(IMPC)Mbp/Sbf1^em1(IMPC)Mbp (C57BL/6N-Sbf1^em1(IMPC)Mbp/MbpMmucd)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
	increased red blood cell distribution width	J:211773
Sbno1^{tm1b(EUCOMM)Hmgu}/Sbno1⁺ (C57BL/6N-Sbno1^{tm1b(EUCOMM)Hmgu}/H)	increased leukocyte cell number	J:211773
	increased red blood cell distribution width	J:211773
Sbno2^tm1.1Aki/Sbno2^tm1.1Aki (involves: 129 * C57BL/6)	abnormal osteoclast morphology	J:202853
	abnormal osteoclast physiology	J:202853
	hematopoietic system phenotype	J:202853
Sbw1^NZB/BlScr/Sbw1^NZB/BlScr (involves: NZB/BlScr * NZW/LacScr)	enlarged spleen	J:20991
Sbw2^NZB/BlScr/Sbw2^NZB/BlScr (involves: NZB * NZW)	enlarged spleen	J:20991
Sbw2^NZB/BlScr/Sbw2^NZW/LacScr (involves: NZB * NZW)	enlarged spleen	J:20991
Scand1^em1(IMPC)H/Scand1^em1(IMPC)H (C57BL/6NTac-Scand1^em1(IMPC)H/H)	decreased red blood cell distribution width	J:211773
	decreased spleen weight	J:211773
Scarb1^{tm1b(EUCOMM)Wtsi}/Scarb1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Scarb1^{tm1b(EUCOMM)Wtsi}/Bay)	enlarged spleen	J:211773
	increased spleen weight	J:211773
Scarb1^tm1Kri/Scarb1^tm1Kri (involves: 129S2/SvPas * C57BL/6)	abnormal erythrocyte morphology	J:75090
	anemia	J:75090
	macrocytosis	J:75090
	poikilocytosis	J:75090
Scarb2^em2(IMPC)Tcp/Scarb2^em2(IMPC)Tcp (C57BL/6NCrl-Scarb2^em2(IMPC)Tcp/Tcp)	decreased mean corpuscular volume	J:211773
	decreased monocyte cell number	J:211773
	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
	thrombocytosis	J:211773
Scarb2^tm1Psa/Scarb2^tm1Psa (involves: 129P2/OlaHsd * C57BL/6N)	microgliosis	J:216676
Scarf1^tm1Tkms/Scarf1^tm1Tkms (involves: C57BL/6)	abnormal B cell physiology	J:208237
	abnormal spleen morphology	J:208237
	enlarged spleen	J:208237
	impaired macrophage phagocytosis	J:208237
	increased B cell number	J:208237
	increased CD4-positive, alpha-beta T cell number	J:208237
	increased IgG level	J:208237
	increased lymphocyte cell number	J:208237
	increased spleen germinal center size	J:208237
	increased T follicular helper cell number	J:208237
Scel^{em1(IMPC)Ccpcz}/Scel^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Scel^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Scfd1^em1(IMPC)Tcp/Scfd1⁺ (C57BL/6N-Scfd1^em1(IMPC)Tcp/Tcp)	decreased mean corpuscular hemoglobin	J:211773
Scg5^em1(IMPC)Mbp/Scg5^em1(IMPC)Mbp (C57BL/6NCrl-Scg5^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased mean corpuscular volume	J:211773
	increased monocyte cell number	J:211773
Scg5^tm1Led/Scg5^tm1Led (either: 129S6/SvEvTac or (involves: 129S6/SvEvTac * FVB) or (involves: 129S6/SvEvTac * C57BL/6))	spleen atrophy	J:53349
Scgb1a1^tm1Abm/Scgb1a1⁺ (involves: 129S1/Sv * 129X1/SvJ)	increased IgA level	J:57504
Scgb1a1^tm1Abm/Scgb1a1^tm1Abm (involves: 129S1/Sv * 129X1/SvJ)	increased IgA level	J:57504
Scgn^em1Ezb/Scgn^em1Ezb (C57BL/6-Scgn^em1Ezb)	hematopoietic system phenotype	J:285572
Scimp^tm1Lex/Scimp^tm1Lex (B6;129S5-Scimp^tm1Lex/Mmucd)	anemia	J:171883
Scin^tm1Glog/Scin^tm1Glog Tg(Acp5-cre)4Rda/0 (either: (involves: 129 * C57BL/6) or (involves: 129 * C57BL/6 * CBA))	abnormal osteoclast differentiation	J:223220
	abnormal osteoclast morphology	J:223220
	abnormal osteoclast physiology	J:223220
Scmh1^tm1Yota/Scmh1^tm1Yota (involves: 129X1/SvJ * C57BL/6)	abnormal fetal liver hematopoietic progenitor cell morphology	J:194424
	abnormal hematopoietic stem cell morphology	J:194424
	decreased B cell number	J:194424
	decreased T cell number	J:194424
	increased hematopoietic stem cell number	J:194424
	myeloid hyperplasia	J:194424
Scml4^em1(IMPC)J/Scml4^em1(IMPC)J (C57BL/6NJ-Scml4^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Scn2a^tm1Mml/Scn2a^tm1Mml (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal hemoglobin	J:76457
Scn4a^{tm2b(KOMP)Wtsi}/Scn4a⁺ (C57BL/6N-Scn4a^{tm2b(KOMP)Wtsi}/H)	decreased mean platelet volume	J:211773
Scn8a^em1(IMPC)Bay/Scn8a⁺ (C57BL/6N-Scn8a^em1(IMPC)Bay/BayMmucd)	increased spleen weight	J:211773
Sco1^{tm1c(KOMP)Wtsi}/Sco1^{tm1c(KOMP)Wtsi} Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: C57BL/6 * C57BL/6N * DBA)	decreased leukocyte cell number	J:222036
	decreased spleen white pulp amount	J:222036
	hematopoietic system phenotype	J:222036
	increased spleen iron level	J:222036
	spleen atrophy	J:222036
Scpro1^DBA/2/? (involves: C57BL/6 * DBA/2)	abnormal definitive hematopoiesis	J:54115
Scpro2^DBA/2/? (involves: C57BL/6 * DBA/2)	abnormal definitive hematopoiesis	J:78926, J:54115
Scpro4^C57BL/6J/? (involves: C57BL/6J * DBA/2J)	abnormal definitive hematopoiesis	J:98123
Scpro5^C57BL/6J/? (involves: C57BL/6J * DBA/2J)	abnormal definitive hematopoiesis	J:98123
Scpro5^DBA/2J/Scpro5^DBA/2J (involves: C57BL/6J * DBA/2J)	abnormal definitive hematopoiesis	J:97354
Scpro6^C57BL/6J/Scpro6^C57BL/6J (D2.B6-Scpro6^C57BL/6J)	abnormal definitive hematopoiesis	J:118331
Scpro6^DBA/2J/? (involves: C57BL/6J * DBA/2J)	abnormal definitive hematopoiesis	J:98123
Scpro6^DBA/2J/Scpro6^DBA/2J (B6.D2-Scpro6^DBA/2J)	abnormal definitive hematopoiesis	J:118331
Scpro7^DBA/2J/? (involves: C57BL/6J * DBA/2J)	abnormal definitive hematopoiesis	J:98123
Scpro8^DBA/2J/? (involves: C57BL/6J * DBA/2J)	abnormal definitive hematopoiesis	J:98123
Scpro9^DBA/2J/? (involves: C57BL/6J * DBA/2J)	abnormal definitive hematopoiesis	J:98123
Scpro10^DBA/2J/? (involves: C57BL/6J * DBA/2J)	abnormal definitive hematopoiesis	J:98123
Scpro11^C57BL/6J/? (involves: C57BL/6J * DBA/2J)	abnormal definitive hematopoiesis	J:98123
Scr/Scr (involves: 101/H * C3H/HeH)	small thymus	J:3458
Sctr^tm1Bkcc/Sctr^tm1Bkcc (B6.129S7-Sctr^tm1Bkcc)	increased macrophage cell number	J:121376
Scube1^tm2.1Rbya/Scube1^tm2.1Rbya (Not Specified)	decreased platelet aggregation	J:223899
Scube1^tm2.1Rbya/Scube1^tm2.1Rbya (Not Specified)	hematopoietic system phenotype	J:223899
Scyl1^tm1.1Spel/Scyl1^tm1.1Spel (involves: 129S6/SvEvTac * C57BL/6J)	microgliosis	J:192445
Scyl1^tm1Spel/Scyl1^tm1Spel Tg(Nes-cre)1Kln/0 (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * SJL)	microgliosis	J:192445
Scyl2^tm1.1Spel/Scyl2^tm1.1Spel Tg(Nes-cre)1Kln/0 (involves: 129S6/SvEvTac * C57BL/6 * SJL)	microgliosis	J:225808
Sdc1^em1(IMPC)H/Sdc1^em1(IMPC)H (C57BL/6NTac-Sdc1^em1(IMPC)H/H)	increased mean platelet volume	J:211773
Sdc1^tm1Cma/Sdc1^tm1Cma (involves: 129S4/SvJae)	decreased IgG1 level	J:107378
Sdc2^{tm1b(KOMP)Wtsi}/Sdc2^{tm1b(KOMP)Wtsi} (C57BL/6N-Sdc2^{tm1b(KOMP)Wtsi}/Ieg)	decreased red blood cell distribution width	J:211773
Sdc4^{tm2b(KOMP)Wtsi}/Sdc4^{tm2b(KOMP)Wtsi} (C57BL/6N-Sdc4^{tm2b(KOMP)Wtsi}/H)	decreased lymphocyte cell number	J:211773
	decreased mean platelet volume	J:211773
	increased neutrophil cell number	J:211773
	increased red blood cell distribution width	J:211773
Sdhb^{Gt(AP0532)Wtsi}/Sdhb⁺ Sdhc^{Gt(BA0521)Wtsi}/Sdhc⁺ (B6;129P2-Sdhc^{Gt(BA0521)Wtsi} Sdhb^{Gt(AP0532)Wtsi})	abnormal hemoglobin content	J:242046
Sdhb^{Gt(AP0532)Wtsi}/Sdhb⁺ Sdhc^{Gt(BA0521)Wtsi}/Sdhc⁺ Sdhd^tm1Jlob/Sdhd⁺ (involves: 129P2/OlaHsd)	abnormal hemoglobin content	J:242046
Sdhb^{tm1b(EUCOMM)Hmgu}/Sdhb⁺ (C57BL/6N-Sdhb^{tm1b(EUCOMM)Hmgu}/Ieg)	decreased mean corpuscular hemoglobin concentration	J:211773
	decreased neutrophil cell number	J:211773
Sec23b^{Gt(AD0407)Wtsi}/Sec23b^{Gt(AD0407)Wtsi} (B6J.129P2-Sec23b^{Gt(AD0407)Wtsi})	hematopoietic system phenotype	J:186391
Sec23b^{Gt(AD0407)Wtsi}/Sec23b^{Gt(AD0407)Wtsi} (involves: 129P2/OlaHsd)	hematopoietic system phenotype	J:213188
Sec23b^{tm1d(EUCOMM)Wtsi}/Sec23b^{tm1d(EUCOMM)Wtsi} (involves: C57BL/6 * C57BL/6N * FVB/N * SJL)	hematopoietic system phenotype	J:213188
Sec24b^em1(IMPC)Tcp/Sec24b⁺ (C57BL/6NCrl-Sec24b^em1(IMPC)Tcp/Tcp)	enlarged spleen	J:211773
Sec63^{tm1b(EUCOMM)Hmgu}/Sec63⁺ (C57BL/6N-Sec63^{tm1b(EUCOMM)Hmgu}/Bay)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Secisbp2^{tm1a(EUCOMM)Wtsi}/Secisbp2⁺ (Not Specified)	increased NK cell number	J:165965
Secisbp2^{tm1c(EUCOMM)Wtsi}/Secisbp2^{tm1c(EUCOMM)Wtsi} (C57BL/6N-Secisbp2^{tm1a(EUCOMM)Wtsi}/H)	increased leukocyte cell number	J:211773
Secisbp2l^em1(IMPC)J/Secisbp2l^em1(IMPC)J (C57BL/6NJ-Secisbp2l^em1(IMPC)J/Mmjax)	decreased mean corpuscular hemoglobin	J:211773
Sectm1a^em1Gcfa/Sectm1a^em1Gcfa (C57BL/6-Sectm1a^em1Gcfa)	abnormal macrophage physiology	J:317204
Sele^tm1Alb/Sele^tm1Alb (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal spleen morphology	J:101979
Sele^tm1Alb/Sele^tm1Alb (involves: 129S7/SvEvBrd * C57BL/6)	increased neutrophil cell number	J:112286
Sele^tm1Dmil/Sele^tm1Dmil (involves: 129S4/SvJae * C57BL/6J)	abnormal leukocyte adhesion	J:113169
Sele^tm1Hyn/Sele^tm1Hyn Sell^tm1Hyn/Sell^tm1Hyn Selp^tm1Hyn/Selp^tm1Hyn (involves: 129S2/SvPas * C57BL/6)	impaired eosinophil recruitment	J:57973
	impaired leukocyte tethering or rolling	J:57973
	impaired neutrophil recruitment	J:57973
	increased eosinophil cell number	J:57973
	increased leukocyte cell number	J:57973
	increased monocyte cell number	J:57973
	increased neutrophil cell number	J:57973
Sele^tm1Hyn/Sele^tm1Hyn Selp^tm1Hyn/Selp^tm1Hyn (involves: 129S2/SvPas)	abnormal common myeloid progenitor cell morphology	J:31626
	abnormal definitive hematopoiesis	J:31626
	abnormal erythropoiesis	J:31626
	abnormal granulocyte differentiation	J:31626
	abnormal myelopoiesis	J:31626
	extramedullary hematopoiesis	J:31626
	impaired hematopoiesis	J:31626
	impaired leukocyte tethering or rolling	J:31626
	impaired neutrophil recruitment	J:31626
	increased eosinophil cell number	J:31626
	increased erythroid progenitor cell number	J:31626
	increased leukocyte cell number	J:31626
	increased lymphocyte cell number	J:31626
	increased monocyte cell number	J:31626
	increased neutrophil cell number	J:31626
	increased spleen red pulp amount	J:31626
	increased spleen weight	J:31626
	spleen hyperplasia	J:31626
Sele^tm1Hyn/Sele^tm1Hyn Selp^tm1Hyn/Selp^tm1Hyn (involves: 129S2/SvPas * C57BL/6)	impaired eosinophil recruitment	J:57973
	impaired leukocyte tethering or rolling	J:57973
	impaired neutrophil recruitment	J:57973
	increased eosinophil cell number	J:57973
	increased leukocyte cell number	J:57973
	increased monocyte cell number	J:57973
	increased neutrophil cell number	J:57973
Sele^tm1Roml/Sele^tm1Roml (involves: 129S1/Sv * C57BL/6)	abnormal T cell physiology	J:113536
Sele^tm1Roml/Sele^tm1Roml (involves: 129S1/Sv)	abnormal T cell physiology	J:113536
Sele^tm2Alb/Sele^tm2Alb Sell^tm2Alb/Sell^tm2Alb Selp^tm1Bay/Selp^tm1Bay (involves: 129S7/SvEvBrd * C57BL/6)	abnormal cellular extravasation	J:70682
	abnormal spleen B cell follicle morphology	J:70682
	abnormal spleen B cell follicle shape	J:106550
	abnormal spleen morphology	J:70682
	decreased spleen B cell follicle number	J:106550
	extramedullary hematopoiesis	J:70682
	impaired leukocyte tethering or rolling	J:70682
	increased eosinophil cell number	J:70682
	increased leukocyte cell number	J:70682
	increased monocyte cell number	J:70682
	increased neutrophil cell number	J:106550, J:70682
Sele^tm2Alb/Sele^tm2Alb Selp^tm1Bay/Selp^tm1Bay (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal leukocyte cell number	J:101979
	increased neutrophil cell number	J:101979
Sele^tm2Alb/Sele^tm2Alb Selp^tm1Bay/Selp^tm1Bay (involves: 129S7/SvEvBrd * C57BL/6)	abnormal neutrophil physiology	J:112286
	abnormal spleen B cell follicle morphology	J:70682
	decreased spleen B cell follicle number	J:70682
	extramedullary hematopoiesis	J:70682
	impaired leukocyte tethering or rolling	J:70682
	increased eosinophil cell number	J:70682
	increased leukocyte cell number	J:70682
	increased monocyte cell number	J:70682
	increased neutrophil cell number	J:70682, J:112286
Sele^tm2Hyn/Sele^tm2Hyn (involves: 129S2/SvPas * C57BL/6)	enhanced leukocyte tethering or rolling	J:57973
Sele^tm2Hyn/Sele^tm2Hyn (involves: 129S2/SvPas * C57BL/6)	impaired neutrophil recruitment	J:57973
Sele^tm2Hyn/Sele^tm2Hyn (B6.129S2-Sele^tm2Hyn)	decreased mast cell number	J:121083
Sele^tm2Hyn/Sele^tm2Hyn (B6.129S2-Sele^tm2Hyn)	increased mast cell number	J:121083
Selenbp1^{tm1b(KOMP)Wtsi}/Selenbp1^{tm1b(KOMP)Wtsi} (C57BL/6N-Selenbp1^{tm1b(KOMP)Wtsi}/Ucd)	decreased mean corpuscular hemoglobin concentration	J:211773
	increased mean corpuscular volume	J:211773
Selenbp1^tm1Hyama/Selenbp1^tm1Hyama (C57BL/6-Selenbp1^tm1Hyama)	decreased spleen weight	J:202420
	increased thymus weight	J:202420
Selenok^tm1.2Itl/Selenok^tm1.2Itl (involves: BALB/cJ * C57BL/6)	abnormal macrophage physiology	J:169169
	abnormal neutrophil physiology	J:169169
	abnormal T cell physiology	J:169169
	decreased T cell proliferation	J:169169
	impaired neutrophil chemotaxis	J:169169
Selenok^{tm1a(EUCOMM)Wtsi}/Selenok^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Selenok^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased mean platelet volume	J:211773
Selenow^em#Hwl/Selenow^em#Hwl (C57BL/6-Selenow^em#Hwl)	abnormal osteoclast differentiation	J:317012
Selenow^em#Hwl/Selenow^em#Hwl (C57BL/6-Selenow^em#Hwl)	decreased osteoclast cell number	J:317012
Sell^m1Btlr/Sell^m1Btlr (C57BL/6J-Sell^m1Btlr)	decreased single-positive T cell number	J:217794
Sell^m2Btlr/Sell^m2Btlr (C57BL/6J-Sell^m2Btlr)	decreased single-positive T cell number	J:231806
Sell^tm1.1Rpmc/Sell^tm1.1Rpmc (involves: 129S1/Sv * C57BL/6J * FVB/N)	abnormal granulocyte physiology	J:249558
	abnormal neutrophil physiology	J:249558
	hematopoietic system phenotype	J:249558
Sell^tm1Alb/Sell^tm1Alb (involves: 129S7/SvEvBrd * C57BL/6)	extramedullary hematopoiesis	J:70682
Sell^tm1Alb/Sell^tm1Alb (involves: 129S7/SvEvBrd * C57BL/6)	intermingled spleen red and white pulp	J:70682
Sell^{tm1b(EUCOMM)Hmgu}/Sell^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Sell^{tm1b(EUCOMM)Hmgu}/H)	increased spleen weight	J:211773
Sell^tm1Flv/Sell^tm1Flv (involves: 129S2/SvPas * C57BL/6)	decreased activated T cell number	J:89253
Sell^tm1Pest/Sell⁺ (involves: 129S4/SvJae * C57BL/6)	impaired leukocyte tethering or rolling	J:112550
Sell^tm1Pest/Sell^tm1Pest (involves: 129S4/SvJae)	abnormal leukocyte adhesion	J:111233
	impaired leukocyte tethering or rolling	J:111233
	increased T cell proliferation	J:111233
Sell^tm1Pest/Sell^tm1Pest (involves: 129S4/SvJae * C57BL/6)	abnormal leukocyte migration	J:112550
	abnormal splenic cell ratio	J:112550
	decreased T cell proliferation	J:112550
	enlarged spleen	J:112550
	impaired leukocyte tethering or rolling	J:112550
Sell^tm1Tft/Sell^tm1Tft (involves: 129P2/OlaHsd * C57BL/6)	abnormal cellular extravasation	J:25005
	abnormal leukocyte migration	J:25005
	enlarged spleen	J:25005
	impaired leukocyte tethering or rolling	J:25005
Sell^tm1Tft/Sell^tm1Tft (B6.129-Sell^tm1Tft)	abnormal cellular extravasation	J:66107
Sell^tm1Tft/Sell^tm1Tft (B6.129-Sell^tm1Tft)	abnormal leukocyte migration	J:66107
Sell^tm1Tft/Sell^tm1Tft (B6.129P2-Sell^tm1Tft)	abnormal cellular extravasation	J:48271
	abnormal regulatory T cell number	J:141931
	abnormal regulatory T cell physiology	J:141931
	impaired leukocyte tethering or rolling	J:48271
	increased monocyte cell number	J:48271, J:142184
	spleen hyperplasia	J:141931
Sell^tm2.1Tft/Sell^tm2.1Tft (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal neutrophil physiology	J:142184
	spleen hyperplasia	J:142184
Sell^tm2Hyn/Sell^tm2Hyn (involves: 129S2/SvPas * C57BL/6)	decreased monocyte cell number	J:57973
	impaired leukocyte tethering or rolling	J:57973
	impaired neutrophil recruitment	J:57973
Sell^tm2Hyn/Sell^tm2Hyn (involves: 129S2/SvPas * BALB/c)	impaired leukocyte tethering or rolling	J:114317
Sell^tm2Tft/Sell^tm2.1Tft (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal leukocyte migration	J:142184
	abnormal neutrophil physiology	J:142184
	abnormal regulatory T cell number	J:141931
	abnormal regulatory T cell physiology	J:141931
	impaired leukocyte tethering or rolling	J:142184
Sell^tm2Tft/Sell^tm2Tft (involves: 129S1/Sv * 129X1/SvJ)	spleen hyperplasia	J:142184
Sell^tm3Hyn/Sell^tm3Hyn Selp^tm1Hyn/Selp^tm1Hyn (involves: 129S2/SvPas * C57BL/6)	impaired eosinophil recruitment	J:57973
	impaired leukocyte tethering or rolling	J:57973
	impaired neutrophil recruitment	J:57973
	increased eosinophil cell number	J:57973
	increased leukocyte cell number	J:57973
	increased neutrophil cell number	J:57973
Sell^tm4Hyn/Sell^tm4Hyn Selp^tm1Hyn/Selp^tm1Hyn (involves: 129S2/SvPas * C57BL/6)	impaired leukocyte tethering or rolling	J:57973
	impaired neutrophil recruitment	J:57973
	increased eosinophil cell number	J:57973
Selp^tm1.1Rpmc/Selp^tm1.1Rpmc (B6.129S1-Selp^tm1.1Rpmc)	impaired leukocyte tethering or rolling	J:230041
Selp^tm1Bay/Selp^tm1Bay (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal leukocyte migration	J:24239
	abnormal spleen morphology	J:101979
	increased leukocyte cell number	J:101979
	increased neutrophil cell number	J:101979, J:24239
Selp^tm1Bay/Selp^tm1Bay (D1.129S7(B6J)-Selp^tm1Bay)	increased IgG level	J:57086
Selp^tm1Bay/Selp^tm1Bay (B6.129S7-Selp^tm1Bay/J)	abnormal T cell physiology	J:113536
Selp^tm1Bay/Selp^tm1Bay (either: B6.129S7-Selp^tm1Bay or (involves: 129S7/SvEvBrd * C57BL/6))	abnormal leukocyte tethering or rolling	J:31374
	increased leukocyte cell number	J:31374
Selp^tm1Bay/Selp^tm1Bay (involves: 129S7/SvEvBrd * C57BL/6)	increased neutrophil cell number	J:112286
Selp^tm1Bay/Selp^tm1Bay (B6.129S7-Selp^tm1Bay)	decreased mast cell number	J:121083
Selp^tm1Hyn/Selp^tm1Hyn (involves: 129S2/SvPas * C57BL/6J)	impaired leukocyte tethering or rolling	J:77329
	impaired neutrophil recruitment	J:77329
	increased neutrophil cell number	J:77329
Selp^tm1Hyn/Selp^tm1Hyn (involves: 129S2/SvPas)	impaired leukocyte tethering or rolling	J:29814
	impaired macrophage chemotaxis	J:29814
	increased neutrophil cell number	J:29814
Selp^tm1Hyn/Selp^tm1Hyn (involves: 129S2/SvPas * C57BL/6)	impaired eosinophil recruitment	J:57973
	impaired leukocyte tethering or rolling	J:57973
	impaired neutrophil recruitment	J:57973
	increased eosinophil cell number	J:57973
	increased neutrophil cell number	J:57973
Selp^tm2Hyn/Selp^tm2Hyn (involves: 129S2/SvPas * C57BL/6J)	impaired leukocyte tethering or rolling	J:51068
Selp^tm2Hyn/Selp^tm2Hyn (involves: 129S2/SvPas * C57BL/6J)	impaired neutrophil recruitment	J:51068
Selplg^tm1Fur/Selplg^tm1Fur (involves: 129/Sv * C57BL/6J * SJL)	impaired leukocyte tethering or rolling	J:75412
	impaired neutrophil chemotaxis	J:75412
	increased eosinophil cell number	J:75412
	increased neutrophil cell number	J:75412
Selplg^tm1Rpmc/Selplg^tm1Rpmc (involves: 129S1/Sv * C57BL/6J)	abnormal leukocyte adhesion	J:75829
	impaired leukocyte tethering or rolling	J:75829, J:138731
	increased eosinophil cell number	J:75829
	increased leukocyte cell number	J:75829
	increased lymphocyte cell number	J:75829
	increased neutrophil cell number	J:75829
Selplg^tm2Rpmc/Selplg^tm2Rpmc (B6.Cg-Selplg^tm2Rpmc)	impaired leukocyte tethering or rolling	J:138731
Sema3a^tm1.1Tyag/Sema3a^tm1.1Tyag (involves: C57BL/6 * CBA)	abnormal T cell physiology	J:161856
Sema3e^em1(IMPC)H/Sema3e^em1(IMPC)H (C57BL/6NTac-Sema3e^em1(IMPC)H/H)	decreased mean corpuscular volume	J:211773
Sema4a^tm1Kik/Sema4a^tm1Kik (either: B6.Cg-Sema4a^tm1Kik or C.Cg-Sema4a^tm1Kik)	abnormal CD4-positive, alpha-beta T cell physiology	J:97027
	abnormal T-helper 1 cell differentiation	J:97027
Sema4b^tm1Akum/Sema4b^tm1Akum (either: B6.Cg-Sema4b^tm1Akum or C.Cg-Sema4b^tm1Akum)	increased IgE level	J:169386
	increased IgG1 level	J:169386
Sema4d^{tm1b(EUCOMM)Wtsi}/Sema4d^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Sema4d^{tm1b(EUCOMM)Wtsi}/H)	enlarged spleen	J:211773
Sema4d^tm1Kik/Sema4d^tm1Kik (involves: 129P2/OlaHsd * C57BL/6)	abnormal B-1 B cell morphology	J:66033
	abnormal immunoglobulin level	J:66033
	decreased B cell proliferation	J:66033
	decreased B-1a cell number	J:66033
	decreased CD4-positive, alpha-beta T cell number	J:66033
	decreased spleen germinal center size	J:66033
	decreased T cell number	J:66033
	increased B cell number	J:66033
Sema5b^{tm1a(EUCOMM)Wtsi}/Sema5b^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Sema5b^{tm1a(EUCOMM)Wtsi}/Cnrm)	decreased T cell number	J:165965
Senp1^Gt(XG001)Byg/Senp1^Gt(XG001)Byg (involves: 129P2/OlaHsd)	abnormal erythropoiesis	J:141453
	anemia	J:141453
	decreased erythrocyte cell number	J:141453
	decreased erythroid progenitor cell number	J:141453
	hematopoietic system phenotype	J:141453
Senp1^tm1.1Wami/Senp1^tm1.1Wami (involves: 129 * C57BL/6)	abnormal erythropoiesis	J:163428
	abnormal granulocyte differentiation	J:163428
	abnormal hemoglobin content	J:163428
	abnormal megakaryocyte progenitor cell morphology	J:163428
	abnormal monocyte differentiation	J:163428
	anemia	J:163428
	decreased erythroid progenitor cell number	J:163428
Sepsecs^em1(IMPC)Tcp/Sepsecs⁺ (C57BL/6N-Sepsecs^em1(IMPC)Tcp/Tcp)	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular hemoglobin concentration	J:211773
Septin5^{tm1b(EUCOMM)Hmgu}/Septin5⁺ (C57BL/6N-Septin5^{tm1b(EUCOMM)Hmgu}/Rbrc)	small spleen	J:211773
	thrombocytopenia	J:211773
Septin5^tm1Wtr/Septin5^tm1Wtr (involves: 129S1/Sv * 129X1/SvJ)	abnormal platelet physiology	J:109519
	hematopoietic system phenotype	J:109519
	increased platelet aggregation	J:109519
Septin8^{tm1a(EUCOMM)Wtsi}/Septin8^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Septin8^{tm1a(EUCOMM)Wtsi}/Ics)	decreased mean corpuscular volume	J:165965
Septin9^tm2.1Emfu/Septin9^tm2.1Emfu Tg(Lck-cre)548Jxm/0 (involves: C57BL/6 * CBA)	abnormal T cell differentiation	J:205027
	decreased CD4-positive, alpha-beta memory T cell number	J:205027
	decreased CD4-positive, alpha-beta T cell number	J:205027
	decreased CD8-positive, alpha-beta memory T cell number	J:205027
	decreased CD8-positive, alpha-beta T cell number	J:205027
	decreased DN4 thymocyte number	J:205027
	decreased regulatory T cell number	J:205027
	decreased single-positive T cell number	J:205027
	decreased T cell number	J:205027
	decreased T cell proliferation	J:205027
	increased CD8-positive, alpha-beta memory T cell number	J:205027
	increased DN3 thymocyte number	J:205027
	increased double-negative T cell number	J:205027
Septin9^tm2.1Emfu/Septin9^tm2.1Emfu Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	decreased CD8-positive, alpha-beta T cell number	J:205027
Septin14^em1(IMPC)Tcp/Septin14^em1(IMPC)Tcp (C57BL/6NCrl-Septin14^em1(IMPC)Tcp/Tcp)	decreased hematocrit	J:211773
	decreased mean corpuscular volume	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
Serf1^{tm1a(EUCOMM)Hmgu}/Serf1^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Serf1^{tm1a(EUCOMM)Hmgu}/H)	decreased CD8-positive, alpha-beta T cell number	J:165965
	decreased T cell number	J:165965
Serpina3g^tm1.1Arp/Serpina3g^tm1.1Arp (involves: C57BL/6)	abnormal memory T cell morphology	J:189782
	decreased CD8-positive, alpha-beta memory T cell number	J:189782
	decreased T cell proliferation	J:189782
Serpina3g^tm1.1Arp/Serpina3g^tm1.1Arp Tg(TcrLCMV)#Sdz/0 (involves: C57BL/6 * DBA/2)	decreased T cell proliferation	J:189782
Serpina3i^em1(IMPC)J/Serpina3i^em1(IMPC)J (C57BL/6NJ-Serpina3i^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Serpina5^em1(IMPC)Mbp/Serpina5^em1(IMPC)Mbp (C57BL/6N-Serpina5^em1(IMPC)Mbp/MbpMmucd)	increased mean corpuscular volume	J:211773
Serpinb1a^tm1.1Cben/Serpinb1a^tm1.1Cben (129S6/SvEvTac-Serpinb1a^tm1.1Cben)	abnormal neutrophil physiology	J:125918
	decreased neutrophil cell number	J:125918
	impaired neutrophil chemotaxis	J:125918
Serpinb2^tm1Dgi/Serpinb2^tm1Dgi (involves: 129S2/SvPas * C57BL/6J * DBA/2J)	abnormal leukocyte cell number	J:52283
	decreased lymphocyte cell number	J:52283
	decreased monocyte cell number	J:52283
	decreased neutrophil cell number	J:52283
	thrombocytopenia	J:52283
Serpinb2^tm2Dgi/Serpinb2^tm2Dgi (involves: 129S2/SvPas * C57BL/6J * DBA/2J)	abnormal leukocyte cell number	J:52283
	decreased lymphocyte cell number	J:52283
	decreased monocyte cell number	J:52283
	decreased neutrophil cell number	J:52283
	thrombocytopenia	J:52283
Serpinb9^tm1.1Pib/Serpinb9^tm1.1Pib (involves: BALB/cJ * C57BL/6J)	decreased cytotoxic T cell apoptosis	J:252016
Serpinb9^tm1Arp/Serpinb9^tm1Arp (involves: C57BL/6)	abnormal CD8-positive, alpha-beta cytotoxic T cell morphology	J:113349
	abnormal cytotoxic T cell physiology	J:113349
	decreased cytotoxic T cell cytolysis	J:113349
Serpinb10^em1(IMPC)Mbp/Serpinb10^em1(IMPC)Mbp (C57BL/6NCrl-Serpinb10^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased spleen weight	J:211773
Serpinc1^tm1Dwr/Serpinc1^tm1Dwr (involves: 129S1/Sv * 129X1/SvJ)	enlarged spleen	J:115658
Serpind1^tm1Moto/Serpind1⁺ (B6.Cg-Serpind1^tm1Moto)	abnormal platelet aggregation	J:122173
Serpind1^tm1Moto/Serpind1⁺ (B6.Cg-Serpind1^tm1Moto)	hematopoietic system phenotype	J:122173
Serpine1^tm1Mlg/Serpine1^tm1Mlg (involves: 129S2/SvPas * C57BL/6)	hematopoietic system phenotype	J:39819
	increased granulocyte number	J:133227
Serpinf1^{tm1e.1(KOMP)Wtsi}/Serpinf1^{tm1e.1(KOMP)Wtsi} (C57BL/6N-Serpinf1^{tm1e.1(KOMP)Wtsi}/Bay)	abnormal spleen morphology	J:211773
	decreased mean corpuscular hemoglobin concentration	J:211773
Serpini2^pq/Serpini2^pq (involves: C57BL/6J)	abnormal B cell differentiation	J:115744
	abnormal pre-B cell morphology	J:115744
	abnormal pro-B cell morphology	J:115744
	decreased B cell number	J:115744
	decreased bone marrow cell number	J:115744
	decreased immature B cell number	J:115744
	decreased lymphocyte cell number	J:115744
	decreased pre-B cell number	J:115744
	decreased pro-B cell number	J:115744
	decreased T cell number	J:115744
	decreased thymocyte number	J:115744
	small spleen	J:115744
	small thymus	J:115744
	spleen hypoplasia	J:115744
	thymus hypoplasia	J:115744
Sertad2^{Gt(OST98734)Lex}/Sertad2^{Gt(OST98734)Lex} (B6.129S5-Sertad2^{Gt(OST98734)Lex})	abnormal macrophage physiology	J:194928
Sesn1^{tm1a(EUCOMM)Wtsi}/Sesn1^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6N)	abnormal class switch recombination	J:240602
	abnormal effector T cell number	J:240602
	decreased B cell number	J:240602
	enlarged spleen	J:240602
	increased immunoglobulin level	J:240602
	increased myeloid cell number	J:240602
	increased NK T cell number	J:240602
	increased single-positive T cell number	J:240602
	increased splenocyte number	J:240602
	increased T cell proliferation	J:240602
Sesn1^{tm1b(EUCOMM)Wtsi}/Sesn1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Sesn1^{tm1b(EUCOMM)Wtsi}/J)	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
Setd1a^{tm1a(EUCOMM)Wtsi}/Setd1a⁺ (C57BL/6N-Setd1a^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased leukocyte cell number	J:175295
Setd2^{tm1c(NCOM)Mfgc}/Setd2^{tm1c(NCOM)Mfgc} Tg(Lck-cre)#Zhu/0 (involves: C57BL/6 * SJL/J)	hematopoietic system phenotype	J:243973
	increased gamma-delta T cell number	J:243973
Setd3^{tm1.1(NCOM)Mfgc}/Setd3^{tm1.1(NCOM)Mfgc} (C57BL/6N-Setd3^{tm1.1(NCOM)Mfgc}/Tcp)	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
Setd5^tm1.1Mgn/Setd5^tm1.1Mgn (involves: 129S6/SvEvTac * CD-1)	hematopoietic system phenotype	J:237500
Setd5^{tm1a(EUCOMM)Wtsi}/Setd5⁺ (C57BL/6N-Setd5^{tm1a(EUCOMM)Wtsi}/Wtsi)	abnormal thymus morphology	J:239583
	increased monocyte cell number	J:211773
	increased regulatory T cell number	J:211773
	small thymus	J:239583
Setd6^{tm1.1(KOMP)Mbp}/Setd6^{tm1.1(KOMP)Mbp} (C57BL/6N-Setd6^{tm1.1(KOMP)Mbp}/J)	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
	increased erythrocyte cell number	J:211773
Setdb2^{tm1a(KOMP)Wtsi}/Setdb2^{tm1a(KOMP)Wtsi} (C57BL/6N-Setdb2^{tm1a(KOMP)Wtsi}/Ieg)	thrombocytopenia	J:165965
Setdb2^tm1Desr/Setdb2^tm1Desr (B6.Cg-Setdb2^tm1Desr)	increased neutrophil cell number	J:222611
Setx^{tm1b(EUCOMM)Wtsi}/Setx^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Setx^{tm1b(EUCOMM)Wtsi}/Ics)	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	increased eosinophil cell number	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
	increased NK cell number	J:211773
sevr/sevr (C3H/HeJ-sevr/GrsrJ)	thymus atrophy	J:109437
Sf3b1^tm1.1Mdf/Sf3b1⁺ Tet2^tm1.1Iaai/Tet2^tm1.1Iaai Tg(Mx1-cre)1Cgn/? (involves: 129S/SvEv * 129S4/SvJae * C57BL/6 * CBA/J)	abnormal erythroid progenitor cell morphology	J:234976
	abnormal erythropoiesis	J:234976
	abnormal megakaryocyte morphology	J:234976
	abnormal myelopoiesis	J:234976
	decreased B cell number	J:234976
	enlarged spleen	J:234976
	hypochromic macrocytic anemia	J:234976
	increased granulocyte number	J:234976
	increased hematopoietic stem cell number	J:234976
	increased mean corpuscular volume	J:234976
	macrocytosis	J:234976
Sf3b1^tm1.1Mdf/Sf3b1⁺ Tg(Mx1-cre)1Cgn/? (involves: 129S4/SvJae * C57BL/6 * CBA/J)	abnormal erythroid progenitor cell morphology	J:234976
	abnormal erythropoiesis	J:234976
	abnormal myelopoiesis	J:234976
	decreased erythrocyte cell number	J:234976
	decreased granulocyte monocyte progenitor cell number	J:234976
	hypochromic macrocytic anemia	J:234976
	impaired hematopoiesis	J:234976
	increased hematopoietic stem cell number	J:234976
	increased mean corpuscular volume	J:234976
	macrocytosis	J:234976
Sf3b1^tm1Hko/Sf3b1⁺ (Not Specified)	abnormal bone marrow cell morphology/development	J:324276
	decreased erythrocyte cell number	J:324276
	decreased hemoglobin content	J:324276
	extramedullary hematopoiesis	J:324276
	increased mean corpuscular volume	J:324276
	increased spleen red pulp amount	J:324276
	macrocytic anemia	J:324276
	thrombocytosis	J:324276
Sfn^tm1Mak/Sfn^tm1Mak (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell differentiation	J:168328
	abnormal spleen B cell follicle morphology	J:168328
	abnormal spleen morphology	J:168328
	absent spleen marginal zone	J:168328
	decreased B cell number	J:168328
	decreased B-1a cell number	J:168328
	decreased follicular B cell number	J:168328
	decreased IgG level	J:168328
	decreased IgM level	J:168328
	decreased marginal zone B cell number	J:168328
	increased B cell apoptosis	J:168328
	increased B cell proliferation	J:168328
Sfrp1^tm1Bsk/Sfrp1^tm1Bsk (involves: 129S5/SvEvBrd * C57BL/6)	decreased leukocyte cell number	J:89547
	decreased lymphocyte cell number	J:89547
	decreased neutrophil cell number	J:89547
Sfrp4^tm1.1Blan/Sfrp4^tm1.1Blan (Not Specified)	increased osteoclast cell number	J:234467
Sfrp4^tm1.1Lex/Sfrp4^tm1.1Lex (Not Specified)	increased osteoclast cell number	J:234467
Sftpa1^tm2Haw/Sftpa1^tm2Haw Sftpd^tm2Haw/Sftpd^tm2Haw (involves: C57BL/6J * CD-1)	abnormal alveolar macrophage morphology	J:86022
	increased monocyte cell number	J:86022
Sftpd^tm1Haw/Sftpd^tm1Haw (involves: C57BL/6J * CD-1)	abnormal alveolar macrophage morphology	J:98220, J:50147
Sftpd^tm1Haw/Sftpd^tm1Haw (involves: C57BL/6J * CD-1)	abnormal macrophage physiology	J:98220
Sftpd^tm1Jhf/Sftpd^tm1Jhf (involves: 129P2/OlaHsd * Black Swiss)	abnormal alveolar macrophage morphology	J:50436
	abnormal macrophage morphology	J:62282, J:50436
	abnormal macrophage physiology	J:62282
	abnormal neutrophil physiology	J:72681
	increased macrophage cell number	J:62282, J:50436
	increased neutrophil cell number	J:72681
Sfxn1^{tm1b(EUCOMM)Wtsi}/Sfxn1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Sfxn1^{tm1b(EUCOMM)Wtsi}/J)	thrombocytosis	J:211773
Sfxn4^{tm1b(KOMP)Wtsi}/Sfxn4^{tm1b(KOMP)Wtsi} (C57BL/6N-Sfxn4^{tm1b(KOMP)Wtsi}/J)	decreased leukocyte cell number	J:211773
Sgms1^{tm1a(EUCOMM)Wtsi}/Sgms1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Sgms1^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased mean corpuscular hemoglobin	J:211773
	increased mean platelet volume	J:211773
	thrombocytopenia	J:211773
Sgms2^tm1Jia/Sgms2^tm1Jia (involves: 129 * C57BL/6)	abnormal macrophage morphology	J:162226
	abnormal macrophage physiology	J:162192, J:162226
	hemolysis	J:162192
Sgpl1^{Gt(OST58278)Lex}/Sgpl1^{Gt(OST58278)Lex} (involves: 129S5/SvEvBrd * C57BL/6J)	abnormal definitive hematopoiesis	J:145159
	abnormal lymphopoiesis	J:145159
	abnormal osteoclast morphology	J:145159
	abnormal spleen periarteriolar lymphoid sheath morphology	J:145159
	decreased B cell number	J:145159
	decreased double-positive T cell number	J:145159
	decreased lymphocyte cell number	J:145159
	decreased neutrophil cell number	J:145159
	decreased pre-B cell number	J:145159
	decreased T cell number	J:145159
	increased CD4-positive, alpha-beta T cell number	J:145159
	increased CD8-positive, alpha-beta T cell number	J:145159
	increased granulocyte number	J:145159
	increased monocyte cell number	J:145159
	increased osteoclast cell number	J:145159
	spleen hypoplasia	J:145159
	thymus cortex hypoplasia	J:145159
	thymus hypoplasia	J:145159
	thymus medulla hyperplasia	J:145159
Sgpl1^{Gt(OST58278)Lex}/Sgpl1^{tm1(SGPL1)Lex} (involves: 129S5/SvEvBrd * C57BL/6J)	abnormal osteoclast morphology	J:145159
	decreased T cell number	J:145159
	thymus cortex hypoplasia	J:145159
	thymus medulla hyperplasia	J:145159
Sgpl1^{Gt(ROSA)78Sor}/Sgpl1^{Gt(ROSA)78Sor} (involves: 129S4/SvJaeSor)	anemia	J:117491
	decreased erythrocyte cell number	J:117491
	decreased hematocrit	J:117491
	decreased hemoglobin content	J:117491
	polychromatophilia	J:117491
	reticulocytosis	J:117491
Sgpl1^{Gt(ROSA)78Sor}/Sgpl1^{Gt(ROSA)78Sor} (involves: 129S4/SvJaeSor * C57BL/6)	abnormal leukocyte migration	J:187619
	abnormal T cell physiology	J:187619
	decreased lymphocyte cell number	J:187619
Sgpl1^{tm1(SGPL1)Lex}/Sgpl1^{tm1(SGPL1)Lex} (involves: 129S4/SvJae * 129S5/SvEvBrd * C57BL/6J)	abnormal thymus lobule morphology	J:145159
	decreased B cell number	J:145159
	decreased CD4-positive, alpha-beta T cell number	J:145159
	decreased CD8-positive, alpha-beta T cell number	J:145159
	decreased lymphocyte cell number	J:145159
	decreased T cell number	J:145159
	increased single-positive T cell number	J:145159
Sgpl1^tm1.2Npa/Sgpl1^tm1.2Npa (involves: BALB/cJ * C57BL/6)	spleen hypoplasia	J:199525
Sgsh^em3(IMPC)Tcp/Sgsh^em3(IMPC)Tcp (C57BL/6NCrl-Sgsh^em3(IMPC)Tcp/Tcp)	thrombocytosis	J:211773
Sgsh^mps3a/Sgsh^mps3a (involves: 129X1/SvJ * CD-1 * C57BL/6 * SJL)	enlarged spleen	J:72142
Sgsm1^{tm1b(EUCOMM)Wtsi}/Sgsm1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Sgsm1^{tm1b(EUCOMM)Wtsi}/Wtsi)	decreased CD4-positive, alpha-beta T cell number	J:211773
	increased CD8-positive, alpha-beta T cell number	J:211773
	increased red blood cell distribution width	J:211773
Sgta^{tm1b(KOMP)Mbp}/Sgta^{tm1b(KOMP)Mbp} (C57BL/6N-Sgta^{tm1b(KOMP)Mbp}/J)	decreased hematocrit	J:211773
Sh2b2^tm1Yeb/Sh2b2^tm1Yeb (involves: C57BL/6)	abnormal B cell differentiation	J:88527
	increased B-1 B cell number	J:88527
	increased IgG3 level	J:88527
Sh2b3^tm1Paw/Sh2b3^tm1Paw (either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))	abnormal granulocyte differentiation	J:77248
	abnormal leukocyte cell number	J:77248
	abnormal megakaryocyte morphology	J:77248
	abnormal monocyte differentiation	J:77248
	enlarged spleen	J:77248
	extramedullary hematopoiesis	J:77248
	increased B cell number	J:77248
	increased megakaryocyte cell number	J:77248
	spleen fibrosis	J:77248
	thrombocytosis	J:77248
Sh2b3^tm1Paw/Sh2b3^tm1Paw (B6.129-Sh2b3^tm1Paw)	anemia	J:107464
	increased bone marrow cell number	J:107464
	increased erythroid progenitor cell number	J:107464
	spleen hyperplasia	J:107464
Sh2b3^tm1Paw/Sh2b3^tm1Paw (involves: 129S1/Sv * 129X1/SvJ)	decreased B cell number	J:161643
	enlarged spleen	J:161643
	extramedullary hematopoiesis	J:161643
	increased granulocyte number	J:161643
	increased leukocyte cell number	J:161643
	increased lymphocyte cell number	J:161643
	increased monocyte cell number	J:161643
	increased neutrophil cell number	J:161643
	myeloid hyperplasia	J:161643
	thrombocytosis	J:161643
Sh2b3^tm1Rmp/Sh2b3^tm1Rmp (involves: 129S4/SvJae)	abnormal hematopoietic stem cell morphology	J:131265
Sh2d1a^tm1.1Knic/Y Gt(ROSA)26Sor^tm1(EYFP)Cos/Gt(ROSA)26Sor⁺ Ndor1^{Tg(UBC-cre/ERT2)1Ejb}/0 (involves: 129S/SvEv * 129X1/SvJ * C57BL/6)	abnormal NK T cell physiology	J:196692
Sh2d1a^tm1.1Knic/Sh2d1a^tm1.1Knic Gt(ROSA)26Sor^tm1(EYFP)Cos/Gt(ROSA)26Sor⁺ Ndor1^{Tg(UBC-cre/ERT2)1Ejb}/0 (involves: 129S/SvEv * 129X1/SvJ * C57BL/6)	abnormal NK T cell physiology	J:196692
Sh2d1a^tm1Cpt/Y (involves: 129S4/SvJae * C57BL/6)	abnormal germinal center B cell physiology	J:189126
	abnormal immunoglobulin level	J:189126
	abnormal NK T cell physiology	J:189126
	decreased NK T cell number	J:189126
	increased T cell proliferation	J:97756
Sh2d1a^tm1Cpt/Y (involves: 129S4/SvJae * BALB/c)	abnormal germinal center B cell morphology	J:189126
	decreased germinal center B cell number	J:189126
	decreased IgE level	J:97756
	decreased IgG level	J:189126
	decreased NK T cell number	J:189126
Sh2d1a^tm1Cpt/Y Tcra-J^tm1Tgi/Tcra-J^tm1Tgi (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * BALB/c)	decreased germinal center B cell number	J:189126
	decreased IgG level	J:189126
Sh2d1a^tm1Cpt/Sh2d1a⁺ (involves: 129S4/SvJae * C57BL/6)	increased T cell proliferation	J:97756
Sh2d1a^tm1Cpt/Sh2d1a^tm1Cpt (B6.129S4-Sh2d1a^tm1Cpt)	absent NK T cells	J:97690
	decreased IgG1 level	J:97388
	decreased IgM level	J:97388
	decreased NK T cell number	J:97690
	decreased transitional stage B cell number	J:97690
	increased B cell number	J:97388
	increased IgG2a level	J:97388
Sh2d1a^tm1Cpt/Sh2d1a^tm1Cpt (C.129S4-Sh2d1a^tm1Cpt)	decreased IgG level	J:97388
	decreased IgM level	J:97388
	decreased spleen germinal center number	J:97388
Sh2d1a^tm1Cpt/Sh2d1a^tm1Cpt (involves: 129S4/SvJae * C57BL/6)	abnormal germinal center B cell physiology	J:189126
	abnormal immunoglobulin level	J:189126
	abnormal NK T cell physiology	J:189126
	decreased NK T cell number	J:189126
	increased T cell proliferation	J:97756
Sh2d1a^tm1Cpt/Sh2d1a^tm1Cpt (involves: 129S4/SvJae * BALB/c)	abnormal germinal center B cell morphology	J:189126
	decreased germinal center B cell number	J:189126
	decreased IgE level	J:97756
	decreased IgG level	J:189126
	decreased NK T cell number	J:189126
Sh2d1a^tm1Cpt/Sh2d1a^tm1Cpt (involves: 129S4/SvJae)	impaired natural killer cell mediated cytotoxicity	J:166054
Sh2d1a^tm1Cpt/Sh2d1a^tm1Cpt Sh2d1b1/Sh2d1b2^tm1.1Cpt/Sh2d1b1/Sh2d1b2^tm1.1Cpt (involves: 129S4/SvJae * BALB/cJ)	impaired natural killer cell mediated cytotoxicity	J:166054
Sh2d1a^tm1Cpt/Sh2d1a^tm1Cpt Sh2d1b1/Sh2d1b2^tm1.1Cpt/Sh2d1b1/Sh2d1b2^tm1.1Cpt (involves: 129S4/SvJae * BALB/cJ)	impaired natural killer cell mediated cytotoxicity	J:166054
Sh2d1a^tm1Cpt/Sh2d1a^tm1Cpt Tcra-J^tm1Tgi/Tcra-J^tm1Tgi (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * BALB/c)	decreased germinal center B cell number	J:189126
	decreased IgG level	J:189126
Sh2d1a^tm1Lyin/Y (involves: 129S2/SvPas * C57BL/6)	decreased IgE level	J:97346
	decreased IgG level	J:97346
	decreased immunoglobulin level	J:97346
	increased CD8-positive, alpha-beta T cell number	J:97346
Sh2d1a^tm1Lyin/Sh2d1a^tm1Lyin (involves: 129S2/SvPas * C57BL/6)	decreased IgE level	J:97346
	decreased IgG level	J:97346
	decreased immunoglobulin level	J:97346
	increased CD8-positive, alpha-beta T cell number	J:97346
Sh2d1a^tm1Lyin/Sh2d1a^tm1Lyin (involves: 129S1/Sv * 129X1/SvJ)	impaired natural killer cell mediated cytotoxicity	J:110195
Sh2d1a^tm1Pls/Y (involves: 129S6/SvEvTac)	abnormal CD4-positive, alpha-beta T cell physiology	J:157915
	abnormal cytotoxic T cell physiology	J:187431
	abnormal long lived plasma cell morphology	J:157915
	abnormal NK T cell morphology	J:196692
	decreased CD4-positive, alpha-beta T cell number	J:157915
	decreased IgG level	J:157915
Sh2d1a^tm1Pls/Sh2d1a^tm1Pls (either: 129S6/SvEvTac or (involves: 129S6/SvEvTac * C57BL/6))	abnormal lymphocyte cell number	J:70032
	abnormal T-helper 1 cell morphology	J:70032
	abnormal T-helper 2 cell morphology	J:70032
	decreased IgE level	J:70032
	increased T cell proliferation	J:70032
Sh2d1a^tm1Pls/Sh2d1a^tm1Pls (B6.129S6-Sh2d1a^tm1Pls)	abnormal CD4-positive, alpha-beta T cell physiology	J:93886
	abnormal NK cell physiology	J:187430
	decreased IgE level	J:93886
Sh2d1a^tm1Pls/Sh2d1a^tm1Pls (involves: 129S6/SvEvTac)	abnormal CD4-positive, alpha-beta T cell physiology	J:157915
	abnormal cytotoxic T cell physiology	J:187431
	abnormal long lived plasma cell morphology	J:157915
	abnormal NK T cell morphology	J:196692
	decreased CD4-positive, alpha-beta T cell number	J:157915
	decreased IgG level	J:157915
Sh2d1a^tm1Pls/Sh2d1a^tm1Pls Sh2d1b1^tm3Vei/Sh2d1b1^tm3Vei (involves: 129S6/SvEvTac * C57BL/6)	abnormal NK cell physiology	J:187430
Sh2d1a^tm1Pls/Sh2d1a^tm1Pls Tg(TcraTcrb)425Cbn/? (involves: 129S6/SvEvTac * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:157915
Sh2d1a^tm1Pls/Sh2d1a^tm1Pls Tg(TcraTcrb)1100Mjb/0 (involves: 129S6/SvEvTac * C57BL/6)	abnormal cytotoxic T cell physiology	J:187431
	decreased cytotoxic T cell cytolysis	J:187431
Sh2d1a^tm1Vei/Sh2d1a^tm1Vei (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:93886
	abnormal memory T cell physiology	J:93886
	decreased IgE level	J:93886
Sh2d1a^tm1Vei/Sh2d1a^tm1Vei (B6.129-Sh2d1a^tm1Vei)	abnormal NK cell physiology	J:187430
Sh2d1a^tm1Vei/Sh2d1a^tm1Vei Sh2d1b1^tm3Vei/Sh2d1b1^tm3Vei (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal NK cell physiology	J:187430
Sh2d1a^tm2.1Cpt/Y Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ (involves: C57BL/6 * C57BL/6NTac)	abnormal germinal center B cell physiology	J:189126
	decreased IgG level	J:189126
	decreased IgM level	J:189126
Sh2d1a^tm2.1Cpt/Sh2d1a^tm2.1Cpt Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ (involves: C57BL/6 * C57BL/6NTac)	abnormal germinal center B cell physiology	J:189126
	decreased IgG level	J:189126
	decreased IgM level	J:189126
Sh2d1a^tm2.1Vei/Sh2d1a^tm2.1Vei (involves: C57BL/6)	decreased germinal center B cell number	J:131618
	decreased IgE level	J:131618
	decreased IgG1 level	J:131618
	decreased IgG2a level	J:131618
	decreased IgG2b level	J:131618
	decreased IgG3 level	J:131618
	decreased IgM level	J:131618
	decreased NK T cell number	J:131618
Sh2d1a^tm2Vei/Sh2d1a^tm2Vei Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	decreased germinal center B cell number	J:131618
	decreased IgE level	J:131618
	decreased IgG1 level	J:131618
	decreased IgG2a level	J:131618
	decreased IgG2b level	J:131618
	decreased IgG3 level	J:131618
	decreased IgM level	J:131618
	decreased NK T cell number	J:131618
Sh2d1a^tm2Vei/Sh2d1a^tm2Vei Tg(Lck-cre)1Cwi/0 (involves: C57BL/6)	decreased germinal center B cell number	J:131618
	decreased IgE level	J:131618
	decreased IgG1 level	J:131618
	decreased IgG2a level	J:131618
	decreased IgG2b level	J:131618
	decreased IgG3 level	J:131618
	decreased IgM level	J:131618
	decreased NK T cell number	J:131618
Sh2d1b1/Sh2d1b2^tm1.1Cpt/Sh2d1b1/Sh2d1b2^tm1.1Cpt (involves: BALB/cJ)	impaired natural killer cell mediated cytotoxicity	J:166054
Sh2d1b1/Sh2d1b2^tm1.1Cpt/Sh2d1b1/Sh2d1b2^tm1.1Cpt (involves: BALB/cJ)	impaired natural killer cell mediated cytotoxicity	J:166054
Sh2d1b1^tm1.1Cpt/Sh2d1b1^tm1.1Cpt (involves: BALB/cJ * C57BL/6)	impaired natural killer cell mediated cytotoxicity	J:166054
Sh2d1b1^tm1Vei/Sh2d1b1^tm1Vei (involves: 129S1/Sv * 129X1/SvJ)	increased natural killer cell mediated cytotoxicity	J:110195
Sh2d1b1^tm2Vei/Sh2d1b1^tm2Vei Sh2d1b2^tm1Vei/Sh2d1b2^tm1Vei (involves: 129S1/Sv * 129X1/SvJ)	impaired natural killer cell mediated cytotoxicity	J:145969
Sh2d1b1^tm3Vei/Sh2d1b1^tm3Vei (involves: C57BL/6)	abnormal NK cell physiology	J:187430
Sh2d1b2^tm1.1Cpt/Sh2d1b2^tm1.1Cpt (involves: BALB/cJ * C57BL/6)	impaired natural killer cell mediated cytotoxicity	J:166054
Sh2d1b2^tm1Vei/Sh2d1b2^tm1Vei (involves: 129S1/Sv * 129X1/SvJ)	impaired natural killer cell mediated cytotoxicity	J:145969
	increased natural killer cell mediated cytotoxicity	J:110195
Sh2d2a^tm1Jbs/Sh2d2a^tm1Jbs (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased T cell proliferation	J:64938
Sh2d3c^tm1Lex/Sh2d3c^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	abnormal B cell physiology	J:161448
	abnormal leukocyte migration	J:161448
	abnormal marginal zone B cell physiology	J:161448
	decreased IgG1 level	J:161448
	decreased IgG2b level	J:161448
	decreased IgG3 level	J:161448
	decreased IgM level	J:161448
	decreased marginal zone B cell number	J:161448
Sh3bp2^tm1.1Ics/Sh3bp2⁺ (involves: 129S2/SvPas * C57BL/6)	abnormal macrophage physiology	J:221901
Sh3bp2^tm1.1Ics/Sh3bp2^tm1.1Ics (involves: 129S2/SvPas * C57BL/6)	increased monocyte cell number	J:221901
Sh3bp2^tm1Bjro/Sh3bp2⁺ (involves: 129S4/SvJae * BALB/cJ * C57BL/6J)	abnormal osteoclast differentiation	J:117880
	abnormal osteoclast physiology	J:117880
	increased osteoclast cell number	J:117880
Sh3bp2^tm1Bjro/Sh3bp2^tm1Bjro (involves: 129S4/SvJae * BALB/cJ * C57BL/6J)	abnormal B cell number	J:117880
	abnormal macrophage physiology	J:117880
	abnormal osteoclast differentiation	J:117880
	abnormal osteoclast physiology	J:117880
	increased osteoclast cell number	J:117880
	increased spleen red pulp amount	J:117880
Sh3bp2^tm1Bjro/Sh3bp2^tm1Bjro Tnf^tm1Gkl/Tnf^tm1Gkl (involves: 129S/SvEv * 129S4/SvJae * BALB/cJ * C57BL/6J)	abnormal osteoclast differentiation	J:117880
Sh3bp2^tm1Geha/Sh3bp2^tm1Geha (Not Specified)	abnormal B cell number	J:110319
	abnormal B cell physiology	J:110319
	decreased B cell proliferation	J:110319
	increased pre-B cell number	J:110319
Sh3bp2^tm1Rtpl/Sh3bp2^tm1Rtpl (B6.129P2-Sh3bp2^tm1Rtpl)	abnormal B cell number	J:121380
	abnormal marginal zone B cell physiology	J:121380
	abnormal spleen marginal zone morphology	J:121380
	decreased B cell proliferation	J:121380
	decreased B-1 B cell number	J:121380
	decreased IgA level	J:121380
	decreased IgG1 level	J:121380
	decreased IgG3 level	J:121380
	decreased IgM level	J:121380
	decreased immunoglobulin level	J:121380
	decreased pro-B cell number	J:121380
	decreased transitional stage B cell number	J:121380
	increased B cell apoptosis	J:121380
	increased marginal zone B cell number	J:121380
Sh3bp2^tm1Rtpl/Sh3bp2^tm1Rtpl (involves: 129P2/OlaHsd * C57BL/6)	abnormal macrophage physiology	J:221901
	impaired macrophage phagocytosis	J:221901
Sh3kbp1^tm1Kuro/Sh3kbp1^tm1Kuro Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: BALB/c * C57BL/6 * NZB)	abnormal B cell physiology	J:176805
	abnormal lymphocyte cell number	J:176805
	decreased B cell number	J:176805
	decreased B-1a cell number	J:176805
	decreased follicular B cell number	J:176805
	decreased immature B cell number	J:176805
	decreased transitional stage T2 B cell number	J:176805
	decreased transitional stage T3 B cell number	J:176805
Sh3kbp1^tm1Kuro/Sh3kbp1^tm1Kuro Cd79a^tm1(cre)Reth/Cd79a⁺ Gt(ROSA)26Sor^{tm4(Ikbkb)Rsky}/? (involves: BALB/c * C57BL/6 * NZB)	decreased B-1a cell number	J:176805
Sh3pxd2a^{tm1b(EUCOMM)Wtsi}/Sh3pxd2a^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Sh3pxd2a^{tm1b(EUCOMM)Wtsi}/Wtsi)	abnormal thymus topology	J:239583
Sh3tc1^{tm1b(EUCOMM)Hmgu}/Sh3tc1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Sh3tc1^{tm1b(EUCOMM)Hmgu}/Orl)	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Shank2^{em2(IMPC)Rbrc}/Shank2^{em2(IMPC)Rbrc} (C57BL/6NJcl-Shank2^{em2(IMPC)Rbrc}/Rbrc)	abnormal neutrophil cell number	J:211773
	decreased erythrocyte cell number	J:211773
Sharpin^cpdm/Sharpin^cpdm (C57BL/KaLawRij-Sharpin^cpdm)	abnormal spleen morphology	J:53575
	abnormal spleen white pulp morphology	J:31745, J:53575
	absent spleen B cell follicles	J:53575
	absent spleen germinal center	J:53575
	absent spleen marginal zone	J:53575
	cutaneous mastocytosis	J:31745, J:14539
	decreased B cell number	J:53575
	decreased CD4-positive, alpha-beta T cell number	J:53575
	decreased IgA level	J:53575
	decreased IgE level	J:31745, J:53575
	decreased IgG level	J:53575
	decreased immunoglobulin level	J:53575
	decreased T cell number	J:53575
	enlarged spleen	J:14539, J:53575
	extramedullary hematopoiesis	J:31745, J:14539, J:53575
	increased bone marrow cell number	J:14539
	increased eosinophil cell number	J:31745, J:14539
	increased IgM level	J:53575
Sharpin^cpdm/Sharpin^cpdm (involves: C57BL/KaLawRij * FVB/NJ)	absent spleen B cell follicles	J:121810
	absent spleen germinal center	J:121810
Shc1^tm1Ravi/Shc1^tm1Ravi Tg(Lck-cre)1Cwi/? (involves: 129 * C57BL/6)	abnormal double-negative T cell morphology	J:78180
	decreased double-positive T cell number	J:78180
	decreased single-positive T cell number	J:78180
	thymus hypoplasia	J:78180
Shcbp1^{tm1d(EUCOMM)Wtsi}/Shcbp1^{tm1d(EUCOMM)Wtsi} (involves: C57BL/6N * FVB/N)	decreased B cell number	J:212898
	decreased CD4-positive, alpha-beta T cell number	J:212898
	decreased macrophage cell number	J:212898
	decreased T cell number	J:212898
Shisa6^em1(IMPC)Tcp/Shisa6^em1(IMPC)Tcp (C57BL/6N-Shisa6^em1(IMPC)Tcp/Tcp)	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Shisal1^{em1(IMPC)Ccpcz}/Shisal1^{em1(IMPC)Ccpcz} (C57BL/6N-Shisal1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Shld1^em1(IMPC)Mbp/Shld1^em1(IMPC)Mbp (C57BL/6NCrl-Shld1^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Shld1^{em1(IMPC)Wtsi}/Shld1^{em1(IMPC)Wtsi} (C57BL/6N-Shld1^{em1(IMPC)Wtsi}/Wtsi)	increased mean corpuscular hemoglobin	J:211773
	increased red blood cell distribution width	J:211773
Shld1^em1Nus/Shld1^em1Nus (involves: C57BL/6NCrl)	abnormal class switch recombination	J:307190
Shmt1^{tm1b(KOMP)Wtsi}/Shmt1^{tm1b(KOMP)Wtsi} (C57BL/6N-Shmt1^{tm1b(KOMP)Wtsi}/H)	increased mean platelet volume	J:211773
Shmt2^em1(IMPC)Bay/Shmt2⁺ (C57BL/6N-Shmt2^em1(IMPC)Bay/Bay)	increased spleen weight	J:211773
Shmt2^em1Jiha/Shmt2^em1Jiha (involves: C57BL/6JJcl)	anemia	J:259713
sho/sho (Not Specified)	small thymus	J:255
Shprh^em1(IMPC)Tcp/Shprh^em1(IMPC)Tcp (C57BL/6NCrl-Shprh^em1(IMPC)Tcp/Tcp)	decreased mean corpuscular hemoglobin concentration	J:211773
	enlarged thymus	J:211773
Sidt2^{em1(IMPC)Wtsi}/Sidt2^{em1(IMPC)Wtsi} (C57BL/6N-Sidt2^{em1(IMPC)Wtsi}/Wtsi)	thrombocytosis	J:211773
Sigirr^tm1Lix/Sigirr^tm1Lix (involves: 129S6/SvEvTac * BALB/c)	abnormal splenocyte proliferation	J:85151
Siglec1^{tm1(HBEGF)Mtka}/Siglec1^{tm1(HBEGF)Mtka} 1700016L21Rik^{Tg(Itgax-HBEGF/EGFP)57Lan}/? (involves: 129S1/Sv * 129X1/SvJ * FVB/N)	abnormal macrophage physiology	J:123958
	abnormal metallophilic macrophage morphology	J:123958
	abnormal spleen marginal zone macrophage morphology	J:123958
Siglec1^tm1Croc/Siglec1^tm1Croc (B6.129-Siglec1^tm1Croc)	abnormal B cell number	J:105546
	abnormal T cell subpopulation ratio	J:105546
	decreased follicular B cell number	J:105546
	decreased IgM level	J:105546
	impaired macrophage phagocytosis	J:189854
	increased CD8-positive, alpha-beta T cell number	J:105546
	increased marginal zone B cell number	J:105546
Siglec1^tm2.1Croc/Siglec1^tm2.1Croc (B6.129P2(C)-Siglec1^tm2.1Croc)	impaired macrophage phagocytosis	J:189854
Siglec15^tm1Yohi/Siglec15^tm1Yohi (B6.129S6-Siglec15^tm1Yohi)	abnormal osteoclast differentiation	J:193852
Siglece^tm1Arte/Siglece^tm1Arte (involves: C57BL/6)	abnormal macrophage physiology	J:195429
Siglece^tm1Arte/Siglece^tm1Arte (involves: C57BL/6)	abnormal neutrophil physiology	J:195429
Siglece^tm1Croc/Siglece^tm1Croc (B6.129P2-Siglece^tm1Croc)	abnormal macrophage physiology	J:195429
Siglece^tm1Croc/Siglece^tm1Croc (B6.129P2-Siglece^tm1Croc)	abnormal neutrophil physiology	J:195429
Siglecf^tm1.2Avrk/Siglecf^tm1.2Avrk (B6.129(FVB)-Siglecf^tm1.2Avrk)	abnormal eosinophil differentiation	J:204811
	abnormal eosinophil physiology	J:204811
	increased eosinophil cell number	J:204811
Siglecg^M1Btlr/Siglecg^M1Btlr (C57BL/6J-Siglecg^M1Btlr)	increased B-1 B cell number	J:265179
Siglecg^m2Btlr/Siglecg^m2Btlr (C57BL/6J-Siglecg^m2Btlr)	decreased CD8-positive, alpha-beta memory T cell number	J:265183
	increased B-1 B cell number	J:265183
	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:265183
Siglecg^M3Btlr/Siglecg^M3Btlr (C57BL/6J-Siglecg^M3Btlr)	decreased B-2 B cell number	J:265185
	decreased IgM level	J:265185
	increased B-1 B cell number	J:265185
	increased B-1a cell number	J:265185
Siglecg^M4Btlr/Siglecg^M4Btlr (C57BL/6J-Siglecg^M4Btlr)	increased B-1 B cell number	J:272021
Siglecg^M5Btlr/Siglecg^M5Btlr (C57BL/6J-Siglecg^M5Btlr)	increased B-1a cell number	J:272022
Siglecg^tm1Lnit/Siglecg^tm1Lnit (involves: BALB/c)	abnormal plasma cell differentiation	J:123353
	decreased IgG2a level	J:123353
	increased B-1 B cell number	J:123353
	increased B-1a cell number	J:123353
	increased B-1b cell number	J:123353
	increased IgM level	J:123353
Siglecg^tm1Yliu/Siglecg^tm1Yliu (C57BL/6-Siglecg^tm1Yliu)	increased B-1a cell number	J:130017
	increased IgM level	J:130017
	increased pre-B cell number	J:130017
Siglech^tm1.1Cfg/Siglech^tm1.1Cfg (involves: C57BL/6)	increased T cell proliferation	J:217719
Siglech^tm1.1Cln/Siglech⁺ Tg(CLEC4C-HBEGF)956Cln/0 (involves: C57BL/6)	decreased plasmacytoid dendritic cell number	J:166504
Siglech^tm1.1Ksat/Siglech^tm1.1Ksat (B6.Cg-Siglech^tm1.1Ksat)	abnormal regulatory T cell morphology	J:179283
	decreased plasmacytoid dendritic cell number	J:179283
	decreased T-helper 17 cell number	J:179283
	increased T-helper 17 cell number	J:179283
Sik3^{tm1a(EUCOMM)Hmgu}/Sik3^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Sik3^{tm1a(EUCOMM)Hmgu}/Wtsi)	decreased alpha-beta T cell number	J:211773
	decreased CD4-positive NK T cell number	J:211773
	decreased CD4-positive, alpha-beta T cell number	J:211773
	decreased CD5-positive gamma-delta T cell number	J:211773
	decreased early germinal center B cell number	J:211773
	decreased effector memory T-helper cell number	J:211773
	decreased erythrocyte cell number	J:211773
	decreased gamma-delta T cell number	J:211773
	decreased germinal center B cell number	J:211773
	decreased hematocrit	J:211773
	decreased KLRG1-positive NK cell number	J:211773
	decreased KLRG1-positive T-helper cell number	J:211773
	decreased Ly6C-positive mature NK cell number	J:211773
	decreased memory-marker CD4-negative NK T cell number	J:211773
	decreased memory-marker CD4-positive NK T cell number	J:211773
	decreased NK cell number	J:211773
	decreased NK T cell number	J:211773
	decreased regulatory T cell number	J:211773
	decreased T cell number	J:211773
	decreased T-helper cell number	J:211773
	increased CD4-negative NK T cell number	J:211773
	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	increased CD8-positive, alpha-beta T cell number	J:211773
	increased CD8-positive, naive alpha-beta T cell number	J:211773
	increased effector memory T-helper cell number	J:211773
	increased eosinophil cell number	J:211773
	increased follicular B cell number	J:211773
	increased granulocyte number	J:211773
	increased KLRG1+ CD8 alpha-beta T cell number	J:211773
	increased KLRG1-positive CD4-negative NK T cell number	J:211773
	increased KLRG1-positive CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	increased KLRG1-positive T-helper cell number	J:211773
	increased Ly6C-positive NK T cell number	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased mean platelet volume	J:211773
	increased memory-marker gamma-delta T cell number	J:211773
	increased memory-marker NK cell number	J:211773
	increased NK cell number	J:211773
	increased plasmacytoid dendritic cell number	J:211773
	increased red blood cell distribution width	J:211773
	thrombocytopenia	J:211773
Sim1^Rgsc646/Sim1⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	increased glycosylated hemoglobin level	J:133634
Sin3b^tm1.2Rdp/Sin3b^tm1.2Rdp (involves: 129 * C57BL/6 * FVB/N * SJL)	abnormal erythrocyte morphology	J:154855
	abnormal granulocyte differentiation	J:154855
	decreased erythrocyte cell number	J:154855
	decreased granulocyte number	J:154855
	decreased hemoglobin content	J:154855
	increased erythroid progenitor cell number	J:154855
	increased nucleated erythrocyte cell number	J:154855
	increased number of Howell-Jolly bodies	J:154855
Sinhcaf^tm1.2Hmd/Sinhcaf^tm1.2Hmd (involves: 129 * C57BL/6)	spleen hypoplasia	J:313620
Sipa1^tm1Nm/Sipa1⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased erythrocyte cell number	J:97239
	enlarged spleen	J:97239
	increased leukocyte cell number	J:97239
Sipa1^tm1Nm/Sipa1^tm1Nm (involves: 129P2/OlaHsd * C57BL/6)	abnormal bone marrow cell morphology/development	J:97239
	abnormal definitive hematopoiesis	J:97239
	anemia	J:97239
	enlarged spleen	J:97239
	extramedullary hematopoiesis	J:97239
	increased bone marrow cell number	J:97239
	increased granulocyte number	J:97239
	increased hematopoietic stem cell number	J:97239
	increased leukocyte cell number	J:97239
	pancytopenia	J:97239
	spleen hyperplasia	J:97239
Sirpa^{tm1b(EUCOMM)Hmgu}/Sirpa^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Sirpa^{tm1b(EUCOMM)Hmgu}/Bay)	enlarged spleen	J:211773
	increased spleen weight	J:211773
Sirpa^tm1Nog/Sirpa^tm1Nog (involves: 129P2/OlaHsd * C57BL/6)	abnormal macrophage physiology	J:79592
	decreased T cell number	J:79592
	increased megakaryocyte cell number	J:79592
	thrombocytopenia	J:79592
Sirt1^{tm1b(EUCOMM)Wtsi}/Sirt1⁺ (C57BL/6N-Sirt1^{tm1b(EUCOMM)Wtsi}/H)	increased basophil cell number	J:211773
Sirt1^tm1Mcby/Sirt1^tm1Mcby (involves: 129)	decreased CD8-positive, alpha-beta T cell number	J:81010
Sirt1^tm1Mcby/Sirt1^tm1Mcby (involves: 129S1/Sv * 129X1/SvJ * CD-1)	decreased CD8-positive, alpha-beta T cell number	J:81010
	increased immunoglobulin level	J:160869
Sirt1^tm2.1Mcby/Sirt1^tm2.1Mcby (involves: 129S1/Sv * 129X1/SvJ * CD-1)	enlarged spleen	J:180628
Sirt6^{tm1a(EUCOMM)Wtsi}/Sirt6⁺ (C57BL/6N-Sirt6^{tm1a(EUCOMM)Wtsi}/H)	increased mean corpuscular hemoglobin concentration	J:165965
Sirt6^tm1Fwa/Sirt6^tm1Fwa (involves: 129S6/SvEvTac * 129X1/SvJ)	abnormal B cell differentiation	J:112817
	abnormal lymphopoiesis	J:112817
	decreased bone marrow cell number	J:112817
	decreased double-positive T cell number	J:112817
	decreased leukocyte cell number	J:112817
	spleen hypoplasia	J:112817
Sirt7^tm1Evbo/Sirt7^tm1Evbo (involves: 129/Sv * C57BL/6)	increased granulocyte number	J:147652
Sirt7^tm1Fwa/Sirt7^tm1Fwa (involves: 129S1/Sv)	increased macrophage cell number	J:205529
Sit1^tm1Lsmn/Sit1^tm1Lsmn (B6.Cg-Sit1^tm1Lsmn)	abnormal lymphocyte cell number	J:100408
	abnormal T cell differentiation	J:100408
	abnormal T-helper 1 cell differentiation	J:100408
	decreased CD4-positive, alpha-beta T cell number	J:100408
	decreased CD8-positive, alpha-beta T cell number	J:100408
	increased double-positive T cell number	J:100408
	increased mature gamma-delta T cell number	J:100408
	increased T cell proliferation	J:100408
	thymus hyperplasia	J:100408
Sit1^tm1Lsmn/Sit1^tm1Lsmn Tg(TcraH-Y,TcrbH-Y)71Vbo/? (involves: C57BL/6 * C57BL/6J * DBA/2J)	abnormal CD8-positive, alpha beta T cell morphology	J:100408
	abnormal positive T cell selection	J:100408
	abnormal T cell differentiation	J:100408
Sit1^tm1Lsmn/Sit1^tm1Lsmn Tg(TcrLCMV)327Sdz/0 (involves: C57BL/6)	abnormal positive T cell selection	J:100408
	abnormal T cell selection	J:100408
	thymus hypoplasia	J:100408
Six1^em1(IMPC)Mbp/Six1⁺ (C57BL/6N-Six1^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	decreased leukocyte cell number	J:211773
	enlarged spleen	J:211773
	small spleen	J:211773
Six1^tm1Kwk/Six1^tm1Kwk (involves: 129P2/OlaHsd * C57BL/6)	athymia	J:104488
Six1^tm1Mair/Six1^tm1Mair (involves: 129S2/SvPas)	athymia	J:84417
Ska2^{tm1b(KOMP)Wtsi}/Ska2⁺ (C57BL/6N-Ska2^{tm1b(KOMP)Wtsi}/J)	thrombocytopenia	J:211773
Skap1^Gt713Lex/Skap1^Gt713Lex (B6.129S5-Skap1^Gt713Lex)	abnormal CD4-positive, alpha-beta T cell physiology	J:126545
	abnormal T cell physiology	J:126545
	decreased T cell proliferation	J:126545
Skap2^{Gt(VICTR20)21Lex}/Skap2^{Gt(VICTR20)21Lex} (B6.129S5-Skap2^{Gt(VICTR20)21Lex})	abnormal B cell activation	J:101373
	decreased B cell proliferation	J:101373
	decreased IgG2a level	J:101373
	decreased IgM level	J:101373
Skic3^em1(IMPC)Tcp/Skic3⁺ (C57BL/6NCrl-Skic3^em1(IMPC)Tcp/Tcp)	increased mean corpuscular hemoglobin concentration	J:211773
Skida1^{tm1(KOMP)Wtsi}/Skida1⁺ (C57BL/6N-Skida1^{tm1(KOMP)Wtsi}/Wtsi)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
Skida1^{tm1.1(KOMP)Wtsi}/Skida1⁺ (C57BL/6N-Skida1^{tm1.1(KOMP)Wtsi}/Ucd)	enlarged thymus	J:211773
Skida1^{tm1.1(KOMP)Wtsi}/Skida1^{tm1.1(KOMP)Wtsi} (C57BL/6N-Skida1^{tm1.1(KOMP)Wtsi}/Ucd)	enlarged thymus	J:211773
	small spleen	J:211773
Skil^tm1Spw/Skil^tm1Spw (either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))	decreased T cell proliferation	J:84554
	enlarged spleen	J:84554
Skil^tm2Spw/Skil^tm2Spw (either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))	decreased T cell proliferation	J:84554
Skint1^m1Tac/Skint1^m1Tac (FVB/NTac)	abnormal T cell differentiation	J:139711
Skint1^m1Tac/Skint1^m1Tac (FVB/NTac)	abnormal T cell morphology	J:139711
Skint2^em2Htaka/Skint2^em2Htaka (C57BL/6-Skint2^em2Htaka)	decreased dendritic epidermal T cell number	J:291989
skp/skp (CXB5/ByJ-skp/GrsrJ)	thymus atrophy	J:153578
Skp2^tm1Kin/Skp2^tm1Kin (involves: 129P2/OlaHsd)	abnormal immunoglobulin V(D)J recombination	J:168974
Sla2^{em1(IMPC)Ccpcz}/Sla2^{em1(IMPC)Ccpcz} (C57BL/6N-Sla2^{em1(IMPC)Ccpcz}/Ccpcz)	decreased NK cell number	J:211773
Sla^tm1Weis/Sla^tm1Weis (involves: 129 * C57BL/6)	abnormal double-positive T cell morphology	J:71804
Sla^tm1Weis/Sla^tm1Weis Sla2^tm1Amch/Sla2^tm1Amch (involves: 129)	abnormal dendritic cell differentiation	J:169170
	hematopoietic system phenotype	J:169170
Sla^tm1Weis/Sla^tm1Weis Tg(DO11.10)10Dlo/0 (involves: 129 * BALB/c * C3H * C57BL/6)	abnormal positive T cell selection	J:71804
	abnormal T cell differentiation	J:71804
Sla^tm1Weis/Sla^tm1Weis Zap70^tm1Weis/Zap70^tm1Weis (involves: 129 * 129X1/SvJ * C57BL/6)	abnormal T cell differentiation	J:71804
	decreased CD4-positive, alpha-beta T cell number	J:71804
Slamf1^tm1Cpt/Slamf1^tm1Cpt (B6.129S4-Slamf1^tm1Cpt)	abnormal macrophage physiology	J:90484
Slamf1^tm1Cpt/Slamf1^tm1Cpt (C.129S4-Slamf1^tm1Cpt)	abnormal macrophage physiology	J:90484
Slamf1^tm1Vei/Slamf1^tm1Vei (involves: 129 * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:133047, J:93886
Slamf6^tm1Dhow/Slamf6^tm1Dhow (involves: 129/Sv * C57BL/6)	abnormal neutrophil physiology	J:98995
	abnormal T-helper 2 physiology	J:98995
	impaired granulocyte bactericidal activity	J:98995
Slamf7^tm1Vei/Slamf7^tm1Vei (involves: 129S1/Sv * 129X1/SvJ)	impaired natural killer cell mediated cytotoxicity	J:145969
Slamf8^tm1Mill/Slamf8^tm1Mill (involves: BALB/c)	abnormal macrophage physiology	J:188963
Slamf9^em1Isha/Slamf9^em1Isha (involves: C57BL/6)	increased plasmacytoid dendritic cell number	J:279164
Slbp^{tm1.1(KOMP)Vlcg}/Slbp⁺ (C57BL/6N-Slbp^{tm1.1(KOMP)Vlcg}/J)	increased mean corpuscular hemoglobin	J:211773
Slc1a4^{tm1e(KOMP)Wtsi}/Slc1a4^{tm1e(KOMP)Wtsi} (C57BL/6N-Slc1a4^{tm1e(KOMP)Wtsi}/Wtsi)	increased red blood cell distribution width	J:211773
Slc1a5^tm1Tac/Slc1a5^tm1Tac (involves: 129S/SvEv * C57BL/6)	abnormal T cell physiology	J:254980
	abnormal T-helper 1 cell differentiation	J:254980
	abnormal T-helper 2 cell differentiation	J:254980
	abnormal T-helper 17 cell differentiation	J:254980
	decreased B cell number	J:254980
	decreased CD4-positive, alpha-beta memory T cell number	J:254980
	decreased T helper 1 cell number	J:254980
	decreased T-helper 17 cell number	J:254980
	increased CD4-positive, alpha-beta T cell number	J:254980
Slc2a2^{tm1b(KOMP)Wtsi}/Slc2a2⁺ (C57BL/6N-Slc2a2^{tm1b(KOMP)Wtsi}/Rbrc)	increased glycosylated hemoglobin level	J:211773
Slc2a5^{tm1b(EUCOMM)Wtsi}/Slc2a5^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Slc2a5^{tm1b(EUCOMM)Wtsi}/Ieg)	enlarged spleen	J:211773
Slc2a6^em1Kusu/Slc2a6^em1Kusu (involves: C57BL/6JCrlj)	abnormal macrophage physiology	J:270487
Slc2a10^G128E/Slc2a10^G128E (C3HeB/FeJ-Slc2a10^G128E)	abnormal spleen morphology	J:161835
Slc3a1^{tm1.1(KOMP)Vlcg}/Slc3a1^{tm1.1(KOMP)Vlcg} (C57BL/6N-Slc3a1^{tm1.1(KOMP)Vlcg}/Ucd)	abnormal spleen morphology	J:211773
	decreased mean corpuscular volume	J:211773
	enlarged spleen	J:211773
	increased eosinophil cell number	J:211773
	increased spleen weight	J:211773
Slc3a2^tm1.1Yait/Slc3a2^tm1.1Yait Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6NCrSlc)	abnormal macrophage antigen presentation	J:188365
	abnormal macrophage differentiation	J:188365
	abnormal macrophage morphology	J:188365
	abnormal macrophage physiology	J:188365
	impaired macrophage phagocytosis	J:188365
Slc4a1^l11Jus51/Slc4a1^l11Jus51 (involves: C57BL/6J)	abnormal definitive hematopoiesis	J:85113
	abnormal erythrocyte cell number	J:85113
	abnormal erythrocyte morphology	J:85113
	abnormal hemoglobin	J:85113
	anemia	J:85113
	decreased erythrocyte cell number	J:85113
	decreased hematocrit	J:85113
	decreased hemoglobin content	J:85113
	increased nucleated erythrocyte cell number	J:85113
	macrocytic anemia	J:85113
Slc4a1^tm1Ahc/Slc4a1^tm1Ahc (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal erythrocyte morphology	J:35637
	abnormal hemoglobin	J:35637
	abnormal mean corpuscular volume	J:35637
	decreased erythrocyte cell number	J:35637
	decreased hematocrit	J:35637
	decreased hemoglobin content	J:35637
	decreased mean corpuscular volume	J:35637
	enlarged spleen	J:35637
	microcytic anemia	J:35637
	microcytosis	J:35637
	spherocytosis	J:35637
Slc4a1^tm1Dmb/Slc4a1^tm1Dmb (involves: 129S6/SvEvTac)	abnormal bone marrow cell number	J:145243
	abnormal erythrocyte morphology	J:145243
	abnormal splenic cell ratio	J:145243
	increased erythrocyte osmotic fragility	J:145243
	poikilocytosis	J:145243
	reticulocytosis	J:145243
	stomatocytosis	J:145243
Slc4a1^tm1Llp/Slc4a1^tm1Llp (involves: 129S4/SvJae * C57BL/6J)	abnormal definitive hematopoiesis	J:35487
	abnormal erythrocyte morphology	J:35487
	abnormal mean corpuscular hemoglobin	J:35487
	abnormal proerythroblast morphology	J:85322
	absent erythroid progenitor cell	J:85321
	decreased erythrocyte cell number	J:35487
	decreased hematocrit	J:35487, J:148154
	decreased hemoglobin content	J:35487
	decreased mean corpuscular volume	J:35487
	enlarged spleen	J:35487
	hemolysis	J:148154
	hyperchromasia	J:35487
	increased nucleated erythrocyte cell number	J:35487
	microcytic anemia	J:35487
	microcytosis	J:35487
	poikilocytosis	J:35487
	polychromatophilia	J:35487
	reticulocytosis	J:35487, J:148154
	spherocytosis	J:35487
Slc4a1^tm1Llp/Slc4a1^tm1Llp (B6;129S4-Slc4a1^tm1Llp/J)	decreased hematocrit	J:120610
	hemolytic anemia	J:120610
	spherocytosis	J:120610
Slc4a1^tm1Llp/Slc4a1^wan (involves: 129S1/Sv * 129X1/SvJ * C3H/HeJ * C57BL/6J)	reticulocytosis	J:85321
Slc4a1^tm1Phsl/Slc4a1⁺ (involves: 129 * 129S6/SvEvTac * Black Swiss)	reticulocytosis	J:152245
Slc4a1^tm1Phsl/Slc4a1^tm1Phsl (involves: 129 * 129S6/SvEvTac * Black Swiss)	abnormal erythrocyte morphology	J:152245
	decreased hematocrit	J:152245
	decreased hemoglobin content	J:152245
	enlarged spleen	J:152245
	increased mean corpuscular volume	J:152245
	increased nucleated erythrocyte cell number	J:152245
	low mean erythrocyte cell number	J:152245
	reticulocytosis	J:152245
	thrombocytopenia	J:152245
Slc4a1^wan/Slc4a1^wan (C3H/HeJ-Slc4a1^wan/J)	abnormal erythroblast morphology	J:85322
	anemia	J:85321
	decreased erythrocyte cell number	J:85321
	decreased hematocrit	J:85321
	decreased hemoglobin content	J:85321
	decreased mean corpuscular volume	J:85321
	reticulocytopenia	J:85321
	spherocytosis	J:85321
Slc4a2^tm1Ges/Slc4a2^tm1Ges (involves: 129S6/SvEvTac)	abnormal osteoclast morphology	J:193823
Slc4a2^tm1Ges/Slc4a2^tm1Ges (involves: 129S6/SvEvTac)	abnormal osteoclast physiology	J:193823
Slc4a2^tm2Ges/Slc4a2^tm2Ges Ctsk^tm1(cre)Ska/Ctsk⁺ (involves: C57BL/6NCrlj * CBA/JNCrlj)	abnormal osteoclast morphology	J:193823
	abnormal osteoclast physiology	J:193823
Slc4a2^tm2Ges/Slc4a2^tm2Ges Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	abnormal osteoclast morphology	J:193823
	abnormal osteoclast physiology	J:193823
Slc4a4^tm1.1Slin/Slc4a4^tm1.1Slin (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	anemia	J:186877
	decreased hemoglobin content	J:186877
	enlarged spleen	J:186877
	increased spleen weight	J:186877
	reticulocytosis	J:186877
Slc4a4^tm1Ges/Slc4a4^tm1Ges (involves: 129S6/SvEvTac * Black Swiss)	abnormal megakaryocyte morphology	J:120867
	decreased hematocrit	J:120867
	decreased lymphocyte cell number	J:120867
	disorganized spleen B cell follicle	J:120867
	enlarged spleen	J:120867
	increased nucleated erythrocyte cell number	J:120867
	increased spleen red pulp amount	J:120867
	increased spleen white pulp amount	J:120867
Slc4a10^{tm1b(KOMP)Wtsi}/Slc4a10^{tm1b(KOMP)Wtsi} (C57BL/6N-Slc4a10^{tm1b(KOMP)Wtsi}/H)	increased hemoglobin content	J:211773
	small spleen	J:211773
Slc6a2^{tm1b(EUCOMM)Hmgu}/Slc6a2⁺ (C57BL/6N-Slc6a2^{tm1b(EUCOMM)Hmgu}/H)	decreased hemoglobin content	J:211773
Slc6a5^{tm1.1(KOMP)Vlcg}/Slc6a5⁺ (C57BL/6N-Slc6a5^{tm1.1(KOMP)Vlcg}/Ucd)	increased mean corpuscular hemoglobin concentration	J:211773
Slc6a6^em1(IMPC)Mbp/Slc6a6^em1(IMPC)Mbp (C57BL/6N-Slc6a6^em1(IMPC)Mbp/MbpMmucd)	decreased erythrocyte cell number	J:211773
	decreased hemoglobin content	J:211773
	increased monocyte cell number	J:211773
Slc6a8^tm1.2Lbar/Y (involves: 129 * 129S1/Sv * C57BL/6J * C57BL/6N)	microgliosis	J:238578
Slc6a14^{tm1b(KOMP)Wtsi}/Slc6a14^{tm1b(KOMP)Wtsi} (C57BL/6N-Slc6a14^{tm1b(KOMP)Wtsi}/Tcp)	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
Slc6a14^tm1Gana/Slc6a14^tm1Gana Tg(MMTV-PyVT)634Mul/0 (Not Specified)	abnormal immunoglobulin level	J:226105
Slc7a1^tm1Rbmn/Slc7a1^tm1Rbmn (either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: C57BL/6))	abnormal proerythroblast morphology	J:39649
	abnormal reticulocyte morphology	J:39649
	anemia	J:39649
	anisopoikilocytosis	J:39649
	decreased erythrocyte cell number	J:39649
	decreased hemoglobin content	J:39649
	decreased mean corpuscular hemoglobin	J:39649
	increased nucleated erythrocyte cell number	J:39649
Slc7a5^em1(IMPC)H/Slc7a5⁺ (C57BL/6NTac-Slc7a5^em1(IMPC)H/H)	increased basophil cell number	J:211773
Slc7a5^em1(IMPC)H/Slc7a5⁺ (C57BL/6NTac-Slc7a5^em1(IMPC)H/H)	increased mean corpuscular volume	J:211773
Slc7a7^em1Lbu/Slc7a7^em1Lbu (involves: 129/SvEv * C57BL/6)	abnormal spleen germinal center morphology	J:293773
	decreased lymphocyte cell number	J:293773
	decreased spleen weight	J:293773
	increased neutrophil cell number	J:293773
	increased spleen red pulp amount	J:293773
Slc7a7^{Gt(OST41878)Lex}/Slc7a7^{Gt(OST41878)Lex} (B6.129S-Slc7a7^{Gt(OST41878)Lex})	increased spleen weight	J:125847
Slc7a11^m1Mtka/Slc7a11^m1Mtka (C57BL/6-Slc7a11^m1Mtka)	abnormal macrophage physiology	J:159323
Slc7a11^sut/Slc7a11^sut (C3H/HeSnJ-Slc7a11^sut/J)	decreased platelet serotonin level	J:31616
Slc9a5^em1(IMPC)J/Slc9a5^em1(IMPC)J (C57BL/6NJ-Slc9a5^em1(IMPC)J/Mmjax)	decreased mean corpuscular hemoglobin concentration	J:211773
Slc9a6^tm1Dgen/Y (B6.129P2-Slc9a6^tm1Dgen/J)	microgliosis	J:262453
Slc9b1^em1(IMPC)Mbp/Slc9b1^em1(IMPC)Mbp (C57BL/6N-Slc9b1^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Slc11a1^em1(IMPC)Mbp/Slc11a1^em1(IMPC)Mbp (C57BL/6N-Slc11a1^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	decreased lymphocyte cell number	J:211773
	enlarged spleen	J:211773
	increased neutrophil cell number	J:211773
Slc11a2^mk/Slc11a2^mk (MK/ReJ)	anisocytosis	J:162917
	decreased cellular hemoglobin content	J:5167
	decreased hematocrit	J:5167
	decreased hemoglobin content	J:162917, J:5167
	decreased mean corpuscular hemoglobin	J:5167
	hemolysis	J:162917
	high mean erythrocyte cell number	J:5167
	hypochromic microcytic anemia	J:162917, J:5167
	increased erythrocyte clearance	J:162917
	increased spleen weight	J:5167
	microcytosis	J:5167
	reticulocytosis	J:162917, J:5167
Slc11a2^mk/Slc11a2^mk (involves: C57BL/6J * DBA/2J * WB/Re)	increased erythrocyte protoporphyrin level	J:5985
Slc11a2^mk/Slc11a2^mk (SEC.Cg-Slc11a2^mk)	anisocytosis	J:162917
	decreased cellular hemoglobin content	J:5167
	decreased erythrocyte osmotic fragility	J:5167
	decreased hematocrit	J:5167
	decreased hemoglobin content	J:162917, J:5167
	decreased mean corpuscular hemoglobin	J:5167
	hemolysis	J:162917
	high mean erythrocyte cell number	J:5167
	hypochromic microcytic anemia	J:162917, J:5167
	increased erythrocyte clearance	J:162917
	increased spleen weight	J:5167
	microcytosis	J:5167
	reticulocytosis	J:162917, J:5167
Slc11a2^tm1Nca/Slc11a2^tm1Nca (129S6.129S4-Slc11a2^tm1Nca)	abnormal erythrocyte morphology	J:98088
	anisocytosis	J:98088
	decreased erythrocyte cell number	J:98088
	decreased hematocrit	J:98088
	decreased hemoglobin content	J:98088
	decreased mean corpuscular hemoglobin concentration	J:98088
	decreased mean corpuscular volume	J:98088
	microcytic anemia	J:98088
	poikilocytosis	J:98088
Slc11a2^tm2Nca/Slc11a2^tm2Nca Tg(Vil1-cre)20Syr/? (involves: 129S6.129S4-Slc11a2^tm2Nca * C57BL/6 * DBA/2)	abnormal erythrocyte morphology	J:98088
	abnormal spleen morphology	J:98088
	anemia	J:98088
	decreased spleen iron level	J:98088
	enlarged spleen	J:98088
	extramedullary hematopoiesis	J:98088
	increased spleen red pulp amount	J:98088
Slc12a1^tm1Tkh/Slc12a1^tm1Tkh (involves: 129S6/SvEvTac)	increased hematocrit	J:62224
Slc12a2^em1Dlp/Slc12a2^em1Dlp (involves: C57BL/6J * DBA/2J)	increased lymphocyte cell number	J:285398
Slc12a4^Rbc10/Slc12a4⁺ (involves: BALB/c * C57BL/6J)	abnormal erythrocyte physiology	J:227339
Slc12a4^Rbc10/Slc12a4⁺ (involves: BALB/c * C57BL/6J)	microcytosis	J:227339
Slc12a4^Rbc10/Slc12a4^Rbc10 (involves: BALB/c * C57BL/6J)	abnormal erythrocyte physiology	J:227339
	hematopoietic system phenotype	J:227339
	hypochromic anemia	J:227339
	microcytosis	J:227339
Slc12a5^em1(IMPC)Mbp/Slc12a5⁺ (C57BL/6N-Slc12a5^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	small spleen	J:211773
Slc13a3^{tm1b(KOMP)Wtsi}/Slc13a3^{tm1b(KOMP)Wtsi} (C57BL/6N-Slc13a3^{tm1b(KOMP)Wtsi}/Ucd)	decreased lymphocyte cell number	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Slc13a5^{tm1b(EUCOMM)Hmgu}/Slc13a5^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Slc13a5^{tm1b(EUCOMM)Hmgu}/Ieg)	increased leukocyte cell number	J:211773
Slc14a1^tm1Ask/Slc14a1^tm1Ask (involves: C57BL/6J * CD-1)	decreased spleen weight	J:125840
Slc15a3^{tm1a(KOMP)Wtsi}/Slc15a3^{tm1a(KOMP)Wtsi} (C57BL/6N-Slc15a3^{tm1a(KOMP)Wtsi})	abnormal myeloid dendritic cell morphology	J:210445
Slc15a3^{tm1b(KOMP)Wtsi}/Slc15a3^{tm1b(KOMP)Wtsi} (C57BL/6N-Slc15a3^{tm1b(KOMP)Wtsi}/H)	decreased mean corpuscular volume	J:211773
	decreased red blood cell distribution width	J:211773
	increased monocyte cell number	J:211773
Slc17a1^em1(IMPC)J/Slc17a1^em1(IMPC)J (C57BL/6NJ-Slc17a1^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Slc19a1^tm1Gold/Slc19a1^tm1Gold (involves: 129/Sv * C57BL/6 * SJL)	abnormal erythropoiesis	J:68666
	abnormal hematopoietic system morphology/development	J:68666
	abnormal lymphopoiesis	J:68666
	decreased lymphocyte cell number	J:68666
	impaired hematopoiesis	J:68666
	small spleen	J:68666
	small thymus	J:68666
Slc19a2^tm1Ejn/Slc19a2^tm1Ejn (involves: 129S4/SvJae * 129S6/SvEvTac)	abnormal erythropoiesis	J:101675
	decreased erythrocyte cell number	J:101675
	thrombocytosis	J:101675
Slc19a2^tm1Gelb/Slc19a2^tm1Gelb (involves: 129X1/SvJ)	abnormal definitive hematopoiesis	J:79974
	abnormal erythropoiesis	J:79974
	abnormal myelopoiesis	J:79974
Slc20a1^tm1.1Lbek/Slc20a1^tm1.1Lbek Tg(Mx1-cre)1Cgn/0 (involves: 129S2/SvPas * C57BL/6 * C57BL/6J * CBA)	abnormal definitive hematopoiesis	J:194198
	decreased erythrocyte cell number	J:194198
	enlarged spleen	J:194198
	increased leukocyte cell number	J:194198
	intermingled spleen red and white pulp	J:194198
	spleen hyperplasia	J:194198
Slc20a1^tm1.2Cmg/Slc20a1^tm1.2Cmg (involves: 129S6/SvEvTac * C57BL/6 * CBA * DBA/2 * SJL)	anemia	J:156027
Slc20a1^tm1.2Lbek/Slc20a1^tm1.2Lbek (involves: 129S2/SvPas * BALB/c * C57BL/6 * C57BL/6J)	abnormal erythropoiesis	J:157997
	anemia	J:157997
	decreased common myeloid progenitor cell number	J:157997
	decreased erythroid progenitor cell number	J:157997
Slc20a1^tm1Lbek/Slc20a1^tm1.2Lbek (involves: 129S2/SvPas * BALB/c * C57BL/6 * C57BL/6J)	anemia	J:157997
	increased nucleated erythrocyte cell number	J:157997
Slc20a1^tm1Lbek/Slc20a1^tm1.2Lbek (involves: 129S2/SvPas * C57BL/6J)	abnormal erythropoiesis	J:194198
Slc20a1^tm1Lbek/Slc20a1^tm1Lbek (involves: 129S2/SvPas * C57BL/6J)	abnormal definitive hematopoiesis	J:194198
	abnormal erythrocyte morphology	J:157997
	abnormal erythropoiesis	J:194198
	abnormal spleen morphology	J:194198
	anemia	J:157997, J:194198
	decreased erythrocyte cell number	J:157997, J:194198
	decreased hematocrit	J:157997
	decreased hemoglobin content	J:157997, J:194198
	decreased mean corpuscular hemoglobin	J:157997
	echinocytosis	J:157997
	enlarged spleen	J:194198
	hematopoietic system phenotype	J:194198
	hemolytic anemia	J:157997
	increased spleen weight	J:157997
	reticulocytosis	J:157997
	schistocytosis	J:157997
	spherocytosis	J:157997
Slc20a2^{tm1a(EUCOMM)Wtsi}/Slc20a2^{tm1a(EUCOMM)Wtsi} (C57BL/6NTac-Slc20a2^{tm1a(EUCOMM)Wtsi}/Ieg)	microgliosis	J:223197
Slc22a6^tm1Dgen/Slc22a6^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6)	increased thymus weight	J:101679
Slc22a12^tm1Dgen/Slc22a12^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6)	hematopoietic system phenotype	J:101679
Slc22a29^em1(IMPC)Mbp/Slc22a29^em1(IMPC)Mbp (C57BL/6N-Slc22a29^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Slc23a4^{tm1a(KOMP)Wtsi}/Slc23a4^{tm1a(KOMP)Wtsi} (C57BL/6N-2010107G12Rik^{tm1a(KOMP)Wtsi}/Wtsi)	decreased leukocyte cell number	J:175295
Slc24a3^{em1(IMPC)Kmpc}/Slc24a3^{em1(IMPC)Kmpc} (C57BL/6NTac-Slc24a3^{em1(IMPC)Kmpc}/Kmpc)	increased mean platelet volume	J:211773
	thrombocytopenia	J:211773
Slc24a4^{tm1b(KOMP)Wtsi}/Slc24a4⁺ (C57BL/6N-Slc24a4^{tm1b(KOMP)Wtsi}/H)	decreased red blood cell distribution width	J:211773
	enlarged thymus	J:211773
Slc25a17^Gt(XB686)Byg/Slc25a17^Gt(XB686)Byg (involves: 129P2/OlaHsd * C57BL/6 * Swiss Webster)	abnormal Kupffer cell morphology	J:291257
Slc25a19^tm1Mjl/Slc25a19^tm1Mjl (either: (involves: 129S6/SvEvTac) or (involves: 129S6/SvEvTac * Black Swiss))	anemia	J:115337
Slc25a21^{tm1d(KOMP)Wtsi}/Slc25a21^{tm1d(KOMP)Wtsi} (B6Brd;B6Dnk;B6N-Tyr^c-Brd Slc25a21^{tm1a(KOMP)Wtsi}/Wtsi)	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
Slc25a28^tm1.2Dwrd/Slc25a28^tm1.2Dwrd (involves: 129S6/SvEvTac * C57BL/6NCrl)	hematopoietic system phenotype	J:300667
Slc25a37^tm1.1Kapl/Slc25a37^tm1.2Kapl Speer6-ps1^{Tg(Alb-cre)21Mgn}/? (involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6J * C57BL/6NCr * DBA)	enlarged spleen	J:173284
Slc25a37^tm1.1Kapl/Slc25a37^tm1.2Kapl Tg(Mx1-cre)1Cgn/? (involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6J * C57BL/6NCr * CBA)	abnormal B cell morphology	J:173284
	abnormal definitive hematopoiesis	J:173284
	abnormal erythropoiesis	J:173284
	abnormal lymphocyte morphology	J:173284
	abnormal spleen morphology	J:173284
	abnormal T cell morphology	J:173284
	anemia	J:173284
	decreased erythrocyte cell number	J:173284
	decreased hematocrit	J:173284
	decreased hemoglobin content	J:173284
	decreased mean corpuscular volume	J:173284
	enlarged spleen	J:173284
	increased erythroblast number	J:173284
	increased erythroid progenitor cell number	J:173284
Slc25a37^tm1.2Kapl/Slc25a37^tm1.2Kapl (involves: 129S1/Sv * 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6J * C57BL/6NCr)	decreased cellular hemoglobin content	J:173284
Slc25a42^em1(IMPC)J/Slc25a42⁺ (C57BL/6NJ-Slc25a42^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Slc25a46^atc/Slc25a46^atc (B6.Cg-Slc25a46^atc)	decreased spleen weight	J:242350
	decreased thymus weight	J:242350
	microgliosis	J:242350
	spleen hypoplasia	J:242350
	thymus hypoplasia	J:242350
Slc26a9^em1(IMPC)Mbp/Slc26a9⁺ (C57BL/6N-Slc26a9^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Slc28a3^em1(IMPC)H/Slc28a3^em1(IMPC)H (C57BL/6N-Slc28a3^em1(IMPC)H/H)	increased large unstained cell number	J:211773
	increased monocyte cell number	J:211773
Slc29a1^tm1Msg/Slc29a1^tm1Msg (involves: 129X1/SvJ)	abnormal erythrocyte physiology	J:244602
Slc29a1^{tm2b(NCOM)Mfgc}/Slc29a1^{tm2b(NCOM)Mfgc} (C57BL/6N-Slc29a1^{tm2b(NCOM)Mfgc}/Tcp)	decreased erythrocyte cell number	J:211773
	decreased mean corpuscular hemoglobin concentration	J:211773
	increased mean corpuscular volume	J:211773
Slc29a2^{Gt(OST207791)Lex}/Slc29a2^{Gt(OST207791)Lex} (involves: 129S5/SvEvBrd)	hematopoietic system phenotype	J:244602
Slc29a3^em1(IMPC)Mbp/Slc29a3^em1(IMPC)Mbp (C57BL/6NCrl-Slc29a3^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	increased spleen weight	J:211773
	small thymus	J:211773
Slc29a3^{em1(IMPC)Wtsi}/Slc29a3^{em1(IMPC)Wtsi} (C57BL/6N-Slc29a3^{em1(IMPC)Wtsi}/Wtsi)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular hemoglobin concentration	J:211773
	increased leukocyte cell number	J:211773
	increased mean platelet volume	J:211773
	increased red blood cell distribution width	J:211773
	thrombocytopenia	J:211773
Slc29a3^tm1Lex/Slc29a3^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	abnormal macrophage morphology	J:179286
	abnormal macrophage physiology	J:179286
	enlarged spleen	J:179286
	extramedullary hematopoiesis	J:179286
	increased macrophage apoptosis	J:179286
	increased macrophage cell number	J:179286
	myeloid hyperplasia	J:179286
Slc30a2^tm1Kgna/Slc30a2^tm1Kgna (involves: 129 * C57BL/6)	abnormal macrophage physiology	J:264481
Slc30a4^em1(IMPC)Tcp/Slc30a4^em1(IMPC)Tcp (C57BL/6NCrl-Slc30a4^em1(IMPC)Tcp/Tcp)	small thymus	J:211773
Slc30a8^{tm1a(KOMP)Wtsi}/Slc30a8^{tm1a(KOMP)Wtsi} (C57BL/6N-Slc30a8^{tm1a(KOMP)Wtsi}/Wtsi)	increased hemoglobin content	J:175295
	increased mean corpuscular hemoglobin	J:175295
Slc31a1^tm2Djt/Slc31a1^tm2Djt Tg(Vil1-cre)997Gum/0 (involves: 129 * C57BL/6 * FVB/N * SJL)	decreased spleen weight	J:129741
Slc33a1^tm1.1Lpu/Slc33a1⁺ (involves: 129S7/SvEvBrd * C57BL/6)	abnormal T cell activation	J:211266
	decreased B cell number	J:211266
	increased B cell number	J:211266
	increased neutrophil cell number	J:211266
	microgliosis	J:211266
Slc35c1^tm1Cknr/Slc35c1^tm1Cknr (involves: 129/Sv * 129P2/OlaHsd * C57BL/6)	abnormal leukocyte adhesion	J:121151
	impaired leukocyte tethering or rolling	J:121151
	increased eosinophil cell number	J:121151
	increased leukocyte cell number	J:121151
	increased lymphocyte cell number	J:121151
	increased monocyte cell number	J:121151
	increased neutrophil cell number	J:121151
Slc35d3^IAP/Slc35d3^IAP (involves: C3H/HeSn * C3H/HeSnJ * C57BL/6J)	decreased platelet serotonin level	J:137593
Slc37a2^em1(IMPC)Mbp/Slc37a2^em1(IMPC)Mbp (C57BL/6NCrl-Slc37a2^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Slc37a2^tm1Dgen/Slc37a2^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6J)	abnormal macrophage physiology	J:311521
Slc37a4^tm1Jyc/Slc37a4^tm1Jyc (involves: 129S4/SvJae * C57BL/6)	abnormal bone marrow cell morphology/development	J:86005
	abnormal myelopoiesis	J:86005
	abnormal neutrophil physiology	J:86005
	abnormal spleen morphology	J:86005
	absent spleen white pulp	J:86005
	decreased bone marrow cell number	J:86005
	decreased lymphocyte cell number	J:86005
	decreased neutrophil cell number	J:86005
	impaired neutrophil chemotaxis	J:86005
	small spleen	J:86005
Slc38a2^{tm1a(KOMP)Wtsi}/Slc38a2⁺ (C57BL/6N-Slc38a2^{tm1a(KOMP)Wtsi}/Wtsi)	increased leukocyte cell number	J:211773
	increased mean corpuscular hemoglobin	J:211773
Slc38a7^{em1(IMPC)Ccpcz}/Slc38a7^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Slc38a7^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Slc38a10^{tm1a(EUCOMM)Wtsi}/Slc38a10^{tm1a(EUCOMM)Wtsi} (B6JTyr;B6N-Slc38a10^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased erythrocyte cell number	J:175295
	decreased hemoglobin content	J:175295
Slc38a10^{tm2a(EUCOMM)Wtsi}/Slc38a10^{tm2a(EUCOMM)Wtsi} (C57BL/6N-Slc38a10^{tm2a(EUCOMM)Wtsi}/H)	decreased erythrocyte cell number	J:165965
	decreased hemoglobin content	J:165965
	increased mean corpuscular hemoglobin concentration	J:165965
	thrombocytopenia	J:165965
Slc39a3^tm1Gka/Slc39a3^tm1Gka (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal CD8-positive, alpha-beta cytotoxic T cell morphology	J:99161
	decreased double-positive T cell number	J:99161
	increased CD4-positive, alpha-beta T cell number	J:99161
Slc39a10^tm1.1Tfk/Slc39a10^tm1.1Tfk Tg(Foxn1-cre)8Ghr/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)	increased thymocyte apoptosis	J:254216
	thymus hypoplasia	J:254216
Slc40a1^ffe/Slc40a1⁺ (either: (involves: 129X1/SvJ * C57BL/6J) or (involves: C3H/HeJ * C57BL/6J))	abnormal erythrocyte morphology	J:118592
	abnormal macrophage physiology	J:118592
	anemia	J:118592
	anisocytosis	J:118592
	decreased mean corpuscular hemoglobin	J:118592
	leptocytosis	J:118592
Slc40a1^ffe/Slc40a1^ffe (involves: C3H/HeJ * C57BL/6J)	anemia	J:118592
Slc40a1^ffe/Slc40a1^ffe (involves: 129X1/SvJ * C57BL/6J)	anemia	J:118592
Slc40a1^Pcm/Slc40a1⁺ (involves: 101/H * C3H/HeH)	polycythemia	J:30568
Slc40a1^Pcm/Slc40a1⁺ (A.Cg-Slc40a1^Pcm)	abnormal spleen development	J:98335
	decreased spleen iron level	J:98335
	increased splenocyte apoptosis	J:98335
	polycythemia	J:89185
	small spleen	J:98335
Slc40a1^Pcm/Slc40a1^Pcm (A.Cg-Slc40a1^Pcm)	abnormal spleen development	J:98335
	decreased spleen iron level	J:98335
	hypochromic microcytic anemia	J:89185
	increased splenocyte apoptosis	J:98335
	small spleen	J:98335
Slc40a1^tm1.1Mmfe/Slc40a1⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased spleen iron level	J:215585
Slc40a1^tm1.1Mmfe/Slc40a1^tm1.1Mmfe (involves: 129P2/OlaHsd * C57BL/6)	decreased spleen iron level	J:215585
	increased erythrocyte cell number	J:215585
	increased hematocrit	J:215585
	increased hemoglobin content	J:215585
	increased mean corpuscular volume	J:215585
Slc40a1^tm1Nca/Slc40a1⁺ (involves: 129S4/SvJae * 129S6/SvEvTac)	decreased hemoglobin content	J:129846
	decreased mean corpuscular volume	J:129846
	hematopoietic system phenotype	J:129846
	increased spleen iron level	J:129846
Slc40a1^tm2Nca/Slc40a1^tm2Nca Tg(Vil1-cre/ERT2)23Syr/0 (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * DBA/2)	anemia	J:129846
	decreased hematocrit	J:129846
	decreased hemoglobin content	J:129846
	decreased spleen iron level	J:129846
Slc44a5^{tm1a(KOMP)Wtsi}/Slc44a5^{tm1a(KOMP)Wtsi} (C57BL/6N-Slc44a5^{tm1a(KOMP)Wtsi}/Wtsi)	increased mean corpuscular volume	J:175295
Slc46a2^tm1Moki/Slc46a2^tm1Moki (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	thymus hypoplasia	J:140121
Slc46a3^{tm1.1(KOMP)Vlcg}/Slc46a3^{tm1.1(KOMP)Vlcg} (C57BL/6N-Slc46a3^{tm1.1(KOMP)Vlcg}/J)	thrombocytosis	J:211773
Slc48a1^em1Ih/Slc48a1^em1Ih (involves: 129 * C57BL/6J)	abnormal macrophage morphology	J:282829
	abnormal macrophage physiology	J:282829
	abnormal spleen morphology	J:282829
	abnormal stress erythropoiesis	J:282829
	anemia	J:282829
	decreased hematocrit	J:282829
	decreased macrophage cell number	J:282829
	enlarged spleen	J:282829
	extramedullary hematopoiesis	J:282829
	impaired hematopoiesis	J:282829
	increased erythroblast number	J:282829
	increased spleen iron level	J:282829
Slc51b^em1(IMPC)Mbp/Slc51b^em1(IMPC)Mbp (C57BL/6NCrl-Slc51b^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased red blood cell distribution width	J:211773
Slco1a5^tm1Lex/Slco1a5^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	abnormal CD8-positive, alpha beta T cell morphology	J:103485
	increased B cell number	J:103485
Slco1b2^em1(IMPC)Mbp/Slco1b2^em1(IMPC)Mbp (C57BL/6NCrl-Slco1b2^em1(IMPC)Mbp/MbpMmucd)	increased red blood cell distribution width	J:211773
Sle1^NZM2410/Aeg/Sle1^NZM2410/Aeg Sle3^NZM2410/Aeg/Sle3^NZM2410/Aeg (B6;NZM-Sle1^NZM2410/Aeg Sle2^NZM2410/Aeg Sle3^NZM2410/Aeg/LmoJ)	abnormal marginal zone B cell physiology	J:138314
	increased marginal zone B cell number	J:138314
Sle1^NZW/Sle1^NZW Sles1^NZW/Sles1^NZW (involves: C57BL/6 * NZW)	abnormal T cell physiology	J:100678
Sle1^NZW/Sle1^NZW Tg(Tnfsf13b)1Fma/0 (involves: C57BL/6 * DBA/2J * NZW)	increased B cell number	J:134128
	increased IgG level	J:134128
	increased IgM level	J:134128
	increased marginal zone B cell number	J:134128
Sle3^NZM2410/Aeg/? (involves: C57BL/6J * NZM2410/Aeg)	increased IgG level	J:52863
Sle3^NZM2410/Aeg/? (involves: C57BL/6J * NZM2410/Aeg)	increased IgM level	J:52863
Sle11^BXSB/J/Sle11^BXSB/J (involves: BXSB/J * C57BL/10Ola)	increased IgG3 level	J:60445
Slfn1^{tm1.1(KOMP)Vlcg}/Slfn1^{tm1.1(KOMP)Vlcg} (C57BL/6NCrl-Slfn1^{tm1.1(KOMP)Vlcg}/MbpMmucd)	increased mean corpuscular volume	J:211773
Slfn2^m1Btlr/Slfn2^m1Btlr (C57BL/6J-Slfn2^m1Btlr)	abnormal leukocyte physiology	J:158985
	abnormal T cell activation	J:158985
	abnormal T cell proliferation	J:158985
	decreased CD4-positive, alpha-beta T cell number	J:158985
	decreased CD8-positive, alpha-beta T cell number	J:158985
	decreased monocyte cell number	J:158985
	decreased T cell proliferation	J:158985
	increased neutrophil cell number	J:158985
	increased T cell apoptosis	J:158985
Slfn2^m2Btlr/Slfn2^m2Btlr (C57BL/6J-Slfn2^m2Btlr)	decreased IgG level	J:234262
Slfn4^{tm1c(EUCOMM)Wtsi}/Slfn4^{tm1c(EUCOMM)Wtsi} Gli1^{tm3(cre/ERT2)Alj}/Gli1⁺ (involves: 129S6/SvEvTac * Black Swiss * C57BL/6 * Swiss Webster)	abnormal CD8-positive, alpha-beta cytotoxic T cell morphology	J:337060
Slfn14^em1(IMPC)Tcp/Slfn14^em1(IMPC)Tcp (C57BL/6NCrl-Slfn14^em1(IMPC)Tcp/Tcp)	decreased hematocrit	J:211773
	decreased mean corpuscular volume	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
	increased mean platelet volume	J:211773
	increased red blood cell distribution width	J:211773
Slfn14^em1Nvm/Slfn14⁺ (C57BL/6J-Slfn14^em1Nvm)	abnormal erythropoiesis	J:325381
	abnormal platelet morphology	J:325381
	abnormal proerythroblast morphology	J:325381
	decreased hemoglobin content	J:325381
	enlarged spleen	J:325381
	extramedullary hematopoiesis	J:325381
	hemolytic anemia	J:325381
	increased erythrocyte cell number	J:325381
	increased mean platelet volume	J:325381
	increased megakaryocyte-erythroid progenitor cell number	J:325381
	increased spleen weight	J:325381
	microcytosis	J:325381
Slit2^em1(IMPC)Mbp/Slit2⁺ (C57BL/6N-Slit2^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Slpd1^NZB/BlNJ/Slpd1^NZB/BlNJ (involves: DBA/2J * NZB/BlNJ)	increased B cell proliferation	J:124364
Slpi^tm1Nkw/Slpi^tm1Nkw (involves: 129P2/OlaHsd * C57BL/6)	abnormal macrophage physiology	J:82214
Slpi^tm1Nkw/Slpi^tm1Nkw (involves: 129P2/OlaHsd * C57BL/6)	increased B cell proliferation	J:82214
Slpi^tm1Smw/Slpi^tm1Smw (involves: 129S1/Sv * 129X1/SvJ)	abnormal platelet physiology	J:95293
Slu7^{tm1a(KOMP)Wtsi}/Slu7⁺ (C57BL/6N-Slu7^{tm1a(KOMP)Wtsi}/Wtsi)	decreased leukocyte cell number	J:211773
Slx4^{tm1a(EUCOMM)Wtsi}/Slx4^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Slx4^{tm1a(EUCOMM)Wtsi})	abnormal lymphopoiesis	J:168567
	decreased common myeloid progenitor cell number	J:168567
	decreased leukocyte cell number	J:168567
	increased erythrocyte cell number	J:168567
	thrombocytopenia	J:168567
Slx4^{tm1a(EUCOMM)Wtsi}/Slx4^{tm1a(EUCOMM)Wtsi} (B6JTyr;B6N-Slx4^{tm1a(EUCOMM)Wtsi}/Wtsi)	thrombocytopenia	J:165965
Smad2^tm1Cxd/Smad2⁺ Smad3^tm1Cxd/Smad3⁺ (involves: 129S6/SvEvTac * NIH Black Swiss)	increased erythrocyte cell number	J:70388
Smad3^tm1Cxd/Smad3^tm1Cxd (either: (involves: 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * NIH Black Swiss))	abnormal T cell activation	J:53510
	abnormal T cell physiology	J:53510
	abnormal thymus involution	J:53510
	extramedullary hematopoiesis	J:53510
	impaired neutrophil chemotaxis	J:53510
	increased leukocyte cell number	J:53510
	increased monocyte cell number	J:53510
	increased neutrophil cell number	J:53510
	small spleen	J:53510
	spleen hypoplasia	J:53510
	thymus hypoplasia	J:53510
Smad3^tm1Cxd/Smad3^tm1Cxd (involves: 129S6/SvEvTac)	abnormal leukocyte physiology	J:59673
Smad3^tm1Cxd/Smad3^tm1Cxd (involves: 129S6/SvEvTac)	decreased B cell apoptosis	J:140567
Smad3^tm1Cxd/Smad3^tm1Cxd (involves: 129S6/SvEvTac * C57BL/6)	abnormal CD4-positive T cell differentiation	J:136955
Smad3^tm1Xfw/Smad3^tm1Xfw (involves: 129/Sv * C57BL/6)	abnormal B cell proliferation	J:53948
Smad3^tm1Xfw/Smad3^tm1Xfw (involves: 129/Sv * C57BL/6)	abnormal T cell proliferation	J:53948
Smad4^tm2.1Cxd/Smad4^tm2.1Cxd Kdr^tm1(cre)Sato/Kdr⁺ (involves: 129S1/Sv * 129S6/SvEvTac)	abnormal embryonic hematopoiesis	J:112269
Smad4^tm2.1Cxd/Smad4^tm2.1Cxd Tg(Foxn1-cre)8Ghr/0 (B6.Cg-Smad4^tm2.1Cxd Tg(Foxn1-cre)8Ghr)	abnormal thymus physiology	J:138837
	small thymus	J:138837
Smad4^tm2.1Cxd/Smad4^tm2.1Cxd Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0 (involves: 129S6/SvEvTac * C57BL/6J * CD-1)	decreased osteoclast cell number	J:211171
Smad5^tm1.1Huy/Smad5^tm1.1Huy (involves: 129P2/OlaHsd)	abnormal definitive hematopoiesis	J:86157
Smad5^tm1Cxd/Smad5^tm1Cxd (either: (involves: 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * NIH Black Swiss))	abnormal embryonic hematopoiesis	J:53289
Smad7^{Gt(YHC053)Byg}/Smad7^{Gt(YHC053)Byg} (involves: 129P2/OlaHsd * C57BL/6J)	abnormal thymus morphology	J:212881
	thymus hypoplasia	J:212881
Smad7^tm1.1Ink/Smad7^tm1.1Ink Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	abnormal T-helper 1 cell differentiation	J:184670
	decreased activated T cell number	J:184670
	decreased T cell proliferation	J:184670
Smad7^tm1Gkh/Smad7^tm1Gkh Tg(Cd4-cre)1Cwi/0 (B6N.Cg-Tg(CD4-cre)1Cwi Smad7^tm1Gkh)	abnormal bone marrow cell physiology	J:213468
Smad7^tm1Rheu/Smad7^tm1Rheu (involves: 129S1/Sv * 129X1/SvJ * CD-1)	abnormal class switch recombination	J:120714
	decreased B cell proliferation	J:120714
	increased B cell apoptosis	J:120714
Smap1^tm1.1Sata/Smap1^tm1.1Sata (B6.Cg-Smap1^tm1.1Sata)	abnormal blood cell morphology/development	J:196385
	abnormal bone marrow cell morphology/development	J:196385
	abnormal erythrocyte morphology	J:196385
	abnormal megakaryocyte morphology	J:196385
	abnormal myelopoiesis	J:196385
	abnormal neutrophil morphology	J:196385
	abnormal platelet morphology	J:196385
	abnormal proerythroblast morphology	J:196385
	anemia	J:196385
	decreased hematocrit	J:196385
	decreased hemoglobin content	J:196385
	enlarged spleen	J:196385
	increased bone marrow cell number	J:196385
	increased erythrocyte cell number	J:196385
	increased erythroid progenitor cell number	J:196385
	increased mean corpuscular volume	J:196385
	increased neutrophil cell number	J:196385
	increased number of Howell-Jolly bodies	J:196385
	macrocytic anemia	J:196385
	polychromatophilia	J:196385
	reticulocytosis	J:196385
	thrombocytopenia	J:196385
Smarca4^enu1/Smarca4^tm1Mag (involves: 129S/Sv * C57BL/10 * CBA/Cbi)	abnormal blood cell morphology/development	J:103896
	abnormal erythrocyte morphology	J:103896
Smarca4^tm1.2Pcn/Smarca4^tm1.2Pcn Tg(Lck-cre)1Cwi/0 (Not Specified)	abnormal T cell morphology	J:144072
	decreased double-negative T cell number	J:144072
Smarca4^tm1.2Pcn/Smarca4^tm1.2Pcn Tg(Lck-cre)1Cwi/0 Tg(LCKprBCL2L1)12Sjk/0 (Not Specified)	abnormal T cell morphology	J:144072
	decreased double-positive T cell number	J:144072
	increased double-negative T cell number	J:144072
	increased thymocyte number	J:144072
Smarca4^tm1.2Pcn/Smarca4^tm1Mag Tg(Lck-cre)1Cwi/? (involves: 129S/Sv * C57BL/6 * DBA/2)	abnormal T cell differentiation	J:85191
	absent CD8-positive, alpha-beta T cells	J:85191
	arrested T cell differentiation	J:85191
	decreased CD4-positive, alpha-beta T cell number	J:85191
	decreased double-negative T cell number	J:85191
	decreased double-positive T cell number	J:85191
	thymus hypoplasia	J:85191
Smarca4^tm1.2Pcn/Smarca4^tm1Mag Tg(Lck-cre)1Cwi/? Tg(LCKprBCL2)36Sjk/? (involves: 129S/Sv * C57BL/6 * DBA/2)	arrested T cell differentiation	J:85191
Smarca4^tm1.2Pcn/Smarca4^tm1Tich Tg(Lck-cre)1Cwi/0 (involves: 129)	abnormal T cell morphology	J:144072
	decreased double-negative T cell number	J:144072
	decreased thymocyte number	J:144072
Smarca4^tm1.2Pcn/Smarca4^tm1Tich Tg(Lck-cre)1Cwi/0 Tg(LCKprBCL2L1)12Sjk/0 (involves: 129)	abnormal T cell morphology	J:144072
	decreased double-positive T cell number	J:144072
	increased double-negative T cell number	J:144072
	increased thymocyte number	J:144072
Smarca4^tm1Tich/Smarca4⁺ Tg(Lck-cre)1Cwi/0 (involves: 129)	decreased double-negative T cell number	J:144072
	decreased double-positive T cell number	J:144072
	decreased single-positive T cell number	J:144072
	decreased thymocyte number	J:144072
Smarcal1^tm1.1Cfbo/Smarcal1^tm1.1Cfbo (either: B6.129-Smarcal1^tm1.1Cfbo or (involves: 129 * C57BL/6))	decreased B cell number	J:183899
Smarcal1^{tm1a(EUCOMM)Wtsi}/Smarcal1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Smarcal1^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased hemoglobin content	J:175295
	increased mean corpuscular hemoglobin	J:175295
Smarcb1^tm1Sho/Smarcb1^tm2Sho Tg(Mx1-cre)1Cgn/? (involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6 * CBA)	abnormal bone marrow cell morphology/development	J:80224
	pancytopenia	J:80224
Smarcb1^tm1Sho/Smarcb1^tm3Sho Tg(Mx1-cre)1Cgn/? (involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6 * CBA)	abnormal blood cell morphology/development	J:80224
	abnormal spleen morphology	J:80224
	enlarged spleen	J:80224
	increased eosinophil cell number	J:80224
Smarcc1^tm2.1Rhs/Smarcc1^tm2.1Rhs Tg(Mx1-cre)1Cgn/0 (involves: BALB/c * C57BL/6 * CBA)	abnormal bone marrow cell morphology/development	J:184060
	abnormal common lymphocyte progenitor cell morphology	J:184060
	abnormal immature B cell morphology	J:184060
	abnormal immunoglobulin heavy chain V(D)J recombination	J:184060
	abnormal pre-B cell morphology	J:184060
	abnormal pro-B cell morphology	J:184060
	arrested B cell differentiation	J:184060
	decreased B cell number	J:184060
	decreased B cell proliferation	J:184060
	decreased early pro-B cell number	J:184060
	decreased follicular B cell number	J:184060
	decreased late pro-B cell number	J:184060
	decreased pro-B cell number	J:184060
	increased B cell apoptosis	J:184060
Smarcc2^em1(IMPC)J/Smarcc2⁺ (C57BL/6NJ-Smarcc2^em1(IMPC)J/Mmjax)	increased mean corpuscular volume	J:211773
Smarcd2^{tm1.1(KOMP)Vlcg}/Smarcd2⁺ (C57BL/6N-Smarcd2^{tm1.1(KOMP)Vlcg}/Ucd)	increased mean corpuscular volume	J:211773
Smarce1^em1(IMPC)J/Smarce1⁺ (C57BL/6NJ-Smarce1^em1(IMPC)J/Mmjax)	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
Smc3^{tm1a(EUCOMM)Wtsi}/Smc3⁺ (involves: C57BL/6N)	increased T cell number	J:200082
Smc3^{tm1a(EUCOMM)Wtsi}/Smc3⁺ (B6Dnk;B6Brd;B6N-Tyr^c-Brd Smc3^{tm1a(EUCOMM)Wtsi}/WtsiH)	decreased mean corpuscular hemoglobin	J:175295
Smc5^{tm1b(KOMP)Wtsi}/Smc5⁺ (C57BL/6N-Smc5^{tm1b(KOMP)Wtsi}/Ics)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased lymphocyte cell number	J:211773
	increased eosinophil cell number	J:211773
	increased neutrophil cell number	J:211773
	thrombocytopenia	J:211773
Smc6^tm1.1Arln/Smc6^tm1.1Arln (involves: 129P2/OlaHsd * C57BL/6 * FVB)	decreased IgG2b level	J:220422
	increased leukocyte cell number	J:220422
	macrocytosis	J:220422
	thrombocytosis	J:220422
Smcr8^em1Btlr/Smcr8^em1Btlr (C57BL/6J-Smcr8^em1Btlr)	enlarged spleen	J:268243
	increased CD4-positive, alpha-beta T cell number	J:268243
	increased CD8-positive, alpha-beta T cell number	J:268243
Smcr8^em2Btlr/Smcr8^em2Btlr (C57BL/6J-Smcr8^em2Btlr)	enlarged spleen	J:268243
	increased CD4-positive, alpha-beta T cell number	J:268243
	increased CD8-positive, alpha-beta T cell number	J:268243
Smg1^{Gt(AG0297)Wtsi}/Smg1⁺ (involves: 129P2/OlaHsd * C57BL/6)	enlarged spleen	J:193626
	hematopoietic system phenotype	J:193626
Smg6^em1(IMPC)Mbp/Smg6⁺ (C57BL/6NCrl-Smg6^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	decreased hematocrit	J:211773
	enlarged spleen	J:211773
Smg9^em1(IMPC)J/Smg9⁺ (C57BL/6NJ-Smg9^em1(IMPC)J/J)	decreased mean corpuscular hemoglobin concentration	J:211773
Smim3^tm1Anjm/Smim3⁺ Cd74^tm1Anjm/Cd74⁺ (involves: 129P2/OlaHsd * C57BL/6)	hematopoietic system phenotype	J:155870
Smim3^tm1Anjm/Smim3⁺ Cd74^tm1Anjm/Cd74⁺ Lmo2^tm2(cre)Thr/Lmo2⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal blood cell morphology	J:155870
	abnormal bone marrow cell number	J:155870
	abnormal common myeloid progenitor cell morphology	J:155870
	abnormal erythropoiesis	J:155870
	abnormal mast cell morphology	J:155870
	abnormal megakaryocyte morphology	J:155870
	abnormal megakaryocyte progenitor cell morphology	J:155870
	decreased bone marrow cell number	J:155870
	decreased erythrocyte cell number	J:155870
	decreased erythroid progenitor cell number	J:155870
	decreased granulocyte monocyte progenitor cell number	J:155870
	decreased granulocyte number	J:155870
	decreased hematopoietic stem cell number	J:155870
	decreased hemoglobin content	J:155870
	decreased megakaryocyte-erythroid progenitor cell number	J:155870
	decreased monocyte cell number	J:155870
	increased mean corpuscular volume	J:155870
	increased red blood cell distribution width	J:155870
	macrocytic anemia	J:155870
	macrocytosis	J:155870
	thrombocytopenia	J:155870
Smim3^tm1Anjm/Smim3⁺ Cd74^tm1Anjm/Cd74⁺ Lmo2^tm2(cre)Thr/Lmo2⁺ Trp53^tm1Brd/Trp53⁺ (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)	decreased erythrocyte cell number	J:155870
	decreased erythroid progenitor cell number	J:155870
	decreased granulocyte monocyte progenitor cell number	J:155870
	decreased hematopoietic stem cell number	J:155870
	decreased megakaryocyte-erythroid progenitor cell number	J:155870
	increased mean corpuscular volume	J:155870
	thrombocytopenia	J:155870
Smim3^tm1Anjm/Smim3⁺ Cd74^tm1Anjm/Cd74⁺ Lmo2^tm2(cre)Thr/Lmo2⁺ Trp53^tm1Brd/Trp53^tm1Brd (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)	hematopoietic system phenotype	J:155870
Smoc1^{tm1b(EUCOMM)Wtsi}/Smoc1⁺ (C57BL/6N-Smoc1^{tm1b(EUCOMM)Wtsi}/H)	decreased erythrocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	increased basophil cell number	J:211773
	increased large unstained cell number	J:211773
	increased neutrophil cell number	J:211773
	increased red blood cell distribution width	J:211773
Smoc1^{tm1b(EUCOMM)Wtsi}/Smoc1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Smoc1^{tm1b(EUCOMM)Wtsi}/H)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Smpd1^tm1Esc/Smpd1^tm1Esc (involves: 129S1/Sv * C57BL/6J)	abnormal granulocyte physiology	J:81982
Smpd1^tm1Esc/Smpd1^tm1Esc (involves: 129S1/Sv * C57BL/6J)	increased macrophage derived foam cell number	J:81982
Smpd1^tm1Wst/Smpd1^tm1Wst (involves: 129P2/OlaHsd * C57BL/6)	enlarged spleen	J:26748
	hepatosplenomegaly	J:26748
	increased macrophage derived foam cell number	J:26748
Smpdl3b^{tm1a(EUCOMM)Wtsi}/Smpdl3b^{tm1a(EUCOMM)Wtsi} (C57BL/6-Smpdl3b^{tm1a(EUCOMM)Wtsi})	abnormal macrophage morphology	J:224870
	increased neutrophil cell number	J:224870
Sms^{tm1a(EUCOMM)Wtsi}/Y (involves: C57BL/6 * C57BL/6N)	increased NK cell number	J:213427
Sms^{tm1a(EUCOMM)Wtsi}/Y (involves: C57BL/6 * C57BL/6N)	increased NK T cell number	J:213427
Smurf2^{Gt(RRA098)Byg}/Smurf2^{Gt(RRA098)Byg} (involves: 129P2/OlaHsd * C57BL/6)	enlarged spleen	J:189320
Snai2^tm1Look/Snai2^tm1Look (involves: 129X1/SvJ * C57BL/6)	abnormal hematopoietic system morphology/development	J:80652
Snai2^tm1Look/Snai2^tm1Look (involves: 129X1/SvJ * C57BL/6)	hematopoietic system phenotype	J:80652
Snai2^tm2Grid/Snai2⁺ Snai3^tm1.2Jhws/Snai3^tm1.2Jhws (involves: 129/Sv * 129S1/Sv * C57BL/6)	abnormal thymus cortex morphology	J:204710
	abnormal thymus medulla morphology	J:204710
	decreased B cell number	J:204710
	disorganized spleen B cell follicle	J:204710
Snai2^tm2Grid/Snai2^tm2Grid (involves: 129S1/Sv)	abnormal T cell differentiation	J:78323
	decreased hematocrit	J:78323
	decreased hemoglobin content	J:78323
	decreased leukocyte cell number	J:78323
	increased mean corpuscular volume	J:78323
	macrocytic anemia	J:78323
	small thymus	J:78323
	thrombocytopenia	J:78323
Snai2^tm2Grid/Snai2^tm2Grid Snai3^tm1.2Jhws/Snai3⁺ (involves: 129/Sv * 129S1/Sv * C57BL/6)	abnormal thymus cortex morphology	J:204710
	abnormal thymus medulla morphology	J:204710
	decreased B cell number	J:204710
	disorganized spleen B cell follicle	J:204710
	increased macrophage cell number	J:204710
	increased neutrophil cell number	J:204710
Snai2^tm2Grid/Snai2^tm2Grid Snai3^tm1.2Jhws/Snai3^tm1.2Jhws (involves: 129/Sv * 129S1/Sv * C57BL/6)	abnormal thymus cortex morphology	J:204710
	abnormal thymus involution	J:204710
	abnormal thymus medulla morphology	J:204710
	decreased B cell number	J:204710
	decreased double-positive T cell number	J:204710
	disorganized spleen B cell follicle	J:204710
	increased macrophage cell number	J:204710
	increased neutrophil cell number	J:204710
	increased single-positive T cell number	J:204710
	small spleen	J:204710
	small thymus	J:204710
	thymus fibrosis	J:204710
Snca^em1(IMPC)H/Snca^em1(IMPC)H (C57BL/6NTac-Snca^em1(IMPC)H/H)	increased mean platelet volume	J:211773
	increased spleen weight	J:211773
Snd1^em1(IMPC)Tcp/Snd1⁺ (C57BL/6NCrl-Snd1^em1(IMPC)Tcp/Tcp)	decreased lymphocyte cell number	J:211773
	decreased spleen weight	J:211773
	increased neutrophil cell number	J:211773
	small thymus	J:211773
Snord50a/Snord50b^tm1.1Soen/Snord50a/Snord50b^tm1.1Soen (B6.129P2-Snord50a/Snord50b^tm1.1Soen)	enlarged spleen	J:206419
Snord50a/Snord50b^tm1.1Soen/Snord50a/Snord50b^tm1.1Soen (B6.129P2-Snord50a/Snord50b^tm1.1Soen)	enlarged spleen	J:206419
Snrnp40^em1Btlr/Snrnp40^swp (C57BL/6J-Snrnp40^em1Btlr/Snrnp40^swp)	abnormal bone marrow cell morphology/development	J:282417
	abnormal CD4-positive, alpha-beta T cell physiology	J:282417
	abnormal CD8-positive, alpha-beta T cell physiology	J:282417
	abnormal thymus development	J:282417
	decreased B cell number	J:282417
	decreased CD4-positive, alpha-beta T cell number	J:282417
	decreased CD8-positive, alpha-beta T cell number	J:282417
	decreased common lymphocyte progenitor cell number	J:282417
	decreased DN1 thymic pro-T cell number	J:282417
	decreased DN4 thymocyte number	J:282417
	decreased erythrocyte cell number	J:282417
	decreased hematocrit	J:282417
	decreased hemoglobin content	J:282417
	decreased lymphocyte cell number	J:282417
	decreased monocyte cell number	J:282417
	decreased NK cell number	J:282417
	decreased T cell number	J:282417
	decreased T cell proliferation	J:282417
	impaired natural killer cell mediated cytotoxicity	J:282417
	increased central memory CD8 positive, alpha-beta T cell number	J:282417
	increased effector memory CD8-positive, alpha-beta T cell number	J:282417
	increased red blood cell distribution width	J:282417
	small thymus	J:282417
	thrombocytosis	J:282417
	thymus hypoplasia	J:282417
Snrnp200^{tm1b(KOMP)Mbp}/Snrnp200⁺ (C57BL/6N-Snrnp200^{tm1b(KOMP)Mbp}/H)	increased monocyte cell number	J:211773
Snx5^{tm1a(KOMP)Wtsi}/Snx5^{tm1a(KOMP)Wtsi} (B6JTyr;B6N-Snx5^{tm1a(KOMP)Wtsi}/Wtsi)	increased hematocrit	J:175295
Snx8^tm1Hbsh/Snx8^tm1Hbsh (Not Specified)	abnormal macrophage physiology	J:254306
Snx8^tm1Hbsh/Snx8^tm1Hbsh (Not Specified)	decreased macrophage cytokine production	J:254306
Snx8^{tm2a(EUCOMM)Hmgu}/Snx8^{tm2a(EUCOMM)Hmgu} (C57BL/6N-Snx8^{tm2a(EUCOMM)Hmgu}/Wtsi)	decreased mean corpuscular hemoglobin concentration	J:211773
	increased leukocyte cell number	J:211773
Snx10^em1Ael/Snx10^em1Ael (involves: 129 * C57BL/6J * C57BL/6JOlaHsd)	abnormal osteoclast morphology	J:289051
	abnormal osteoclast physiology	J:289051
	decreased osteoclast cell number	J:289051
Snx10^em2Ael/Snx10^em2Ael (involves: 129 * C57BL/6J * C57BL/6JOlaHsd)	abnormal osteoclast morphology	J:289051
	abnormal osteoclast physiology	J:289051
	decreased osteoclast cell number	J:289051
Snx10^{tm1a(EUCOMM)Raba}/Snx10^{tm1a(EUCOMM)Raba} (involves: 129S4/SvJae * C57BL/6 * C57BL/6J)	abnormal osteoclast physiology	J:224711
Snx13^{tm1b(EUCOMM)Hmgu}/Snx13⁺ (C57BL/6N-Snx13^{tm1b(EUCOMM)Hmgu}/Ieg)	decreased mean corpuscular volume	J:211773
	increased leukocyte cell number	J:211773
Snx14^em1(IMPC)H/Snx14⁺ (C57BL/6NTac-Snx14^em1(IMPC)H/H)	increased mean platelet volume	J:211773
Snx15^{tm1.1(KOMP)Vlcg}/Snx15^{tm1.1(KOMP)Vlcg} (C57BL/6N-Snx15^{tm1.1(KOMP)Vlcg}/J)	decreased leukocyte cell number	J:211773
Snx27^{tm1b(KOMP)Wtsi}/Snx27⁺ (C57BL/6N-Snx27^{tm1b(KOMP)Wtsi}/Ucd)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
Snx27^tm1Lslo/Snx27^tm1Lslo (involves: 129P2/OlaHsd)	small spleen	J:171001
Soat1^ald/Soat1^ald (AKR/O)	thymus hyperplasia	J:12157
Soat1^tm1Far/Soat1^tm1Far (involves: 129S4/SvJae * C57BL/6)	abnormal macrophage morphology	J:37049
Socs1^tm1.1Ayr/Socs1^tm1.1Ayr (involves: C57BL/6)	abnormal T cell physiology	J:226678
Socs1^tm1.1Ayr/Socs1^tm1.1Ayr (involves: C57BL/6)	decreased effector memory T-helper cell number	J:226678
Socs1^tm1Ayos/Socs1^tm1Ayos Foxp3^{tm4(YFP/icre)Ayr}/Foxp3⁺ (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)	increased regulatory T cell number	J:167922
Socs1^tm1Ayos/Socs1^tm1Ayos Tg(Lck-cre)1Jtak/0 (involves: 129S4/SvJae * C57BL/6)	abnormal CD4-positive T cell differentiation	J:132905
	abnormal CD4-positive, alpha-beta T cell physiology	J:132905
Socs1^tm1Ayos/Socs1^tm1Ayos Tg(Tek-cre)1Ywa/0 (involves: 129S4/SvJae * C57BL/6 * SJL)	decreased CD4-positive, alpha-beta T cell number	J:132905
	increased CD8-positive, alpha-beta T cell number	J:132905
Socs1^tm1Jni/Socs1^tm1Jni (Not Specified)	abnormal T cell differentiation	J:57475
	decreased B cell number	J:57475
	decreased thymocyte number	J:57475
Socs1^tm1Kish/Socs1^tm1Kish (involves: 129P2/OlaHsd * C57BL/6J)	abnormal spleen morphology	J:51685
	abnormal spleen white pulp morphology	J:51685
	absent thymus corticomedullary boundary	J:51685
	decreased lymphocyte cell number	J:51685
Socs1^tm1Kish/Socs1^tm1Kish (B6.129P2-Socs1^tm1Kish)	abnormal lymphocyte physiology	J:69472
	increased activated T cell number	J:69472
	increased NK T cell number	J:69472
	thymus atrophy	J:69472
Socs1^tm1Kish/Socs1^tm1Kish Stat1^tm1Rds/Stat1^tm1Rds (involves: 129/Sv * 129P2/OlaHsd * C57BL/6)	increased activated T cell number	J:69472
	thymus atrophy	J:69472
Socs1^tm1Kish/Socs1^tm1Kish Stat6^tm1Aki/Stat6^tm1Aki (involves: 129P2/OlaHsd * C57BL/6)	increased activated T cell number	J:69472
	thymus atrophy	J:69472
Socs1^tm1Wehi/Socs1^tm1Wehi (involves: 129S1/Sv * C57BL/6)	abnormal follicular B cell morphology	J:51281
	abnormal macrophage physiology	J:57474
	abnormal mature B cell morphology	J:51281
	abnormal spleen white pulp morphology	J:57474
	decreased B cell number	J:51281
	decreased bone marrow cell number	J:57474
	decreased eosinophil cell number	J:51281
	decreased hematocrit	J:51281
	decreased leukocyte cell number	J:57474
	decreased lymphocyte cell number	J:51281
	decreased pre-B cell number	J:51281
	hematopoietic system phenotype	J:57474
	increased spleen red pulp amount	J:51281
	small thymus	J:51281
	thrombocytopenia	J:51281
	thymus cortex atrophy	J:57474, J:51281
Socs1^tm1Wehi/Socs1^tm3Wehi Tg(Lck-cre)I57Jxm/0 (involves: 129P2/OlaHsd * C57BL/6 * ICR)	abnormal CD4-positive, alpha beta T cell morphology	J:83009
	abnormal CD8-positive, alpha beta T cell morphology	J:83009
	abnormal T cell activation	J:83009
	abnormal T cell differentiation	J:83009
	abnormal T cell subpopulation ratio	J:83009
	decreased B cell number	J:83009
	enlarged thymus medulla	J:83009
	increased CD4-positive, alpha-beta T cell number	J:83009
	increased CD8-positive, alpha-beta T cell number	J:83009
	thymus hyperplasia	J:83009
Socs1^tm2Wehi/Socs1^tm2Wehi (C57BL/6-Socs1^tm2Wehi)	absent spleen germinal center	J:72528
	extramedullary hematopoiesis	J:72528
	thymus atrophy	J:72528
Socs2^em1(IMPC)H/Socs2^em1(IMPC)H (C57BL/6NTac-Socs2^em1(IMPC)H/H)	increased spleen weight	J:211773
Socs2^tm1Wehi/Socs2^tm1Wehi (involves: C57BL/6 * C57BL/6J)	abnormal macrophage physiology	J:186227
Socs3^tm1Jni/Socs3^tm1Jni (involves: 129P2/OlaHsd)	abnormal embryonic erythropoiesis	J:57476
	hematopoietic system phenotype	J:57476
	increased erythrocyte cell number	J:57476
	increased nucleated erythrocyte cell number	J:57476
Socs3^tm1Robb/Socs3^tm1Robb (involves: C57BL/6)	abnormal blood cell morphology/development	J:145513
	abnormal bone marrow cell physiology	J:145513
	enlarged spleen	J:145513
	increased neutrophil cell number	J:145513
Socs3^tm1Wsa/Socs3^tm2Wsa Lyz2^tm1(cre)Ifo/? (involves: 129P2/OlaHsd * C57BL/6)	abnormal macrophage physiology	J:83645
Socs3^tm1Wsa/Socs3^tm2Wsa Tg(Vav1-cre)1Awr/0 (involves: C57BL/6)	abnormal definitive hematopoiesis	J:89785
	abnormal erythropoiesis	J:89785
	abnormal granulocyte differentiation	J:89785
	abnormal hematopoietic stem cell morphology	J:89785
	abnormal myelopoiesis	J:89785
	enlarged spleen	J:89785
	extramedullary hematopoiesis	J:89785
	increased neutrophil cell number	J:89785
Socs4^m1Nch/Socs4^m1Nch (C.C3Fe-Socs4^m1Nch)	abnormal T cell activation	J:241977
	decreased T cell number	J:241977
	increased T cell number	J:241977
Socs6^tm1Dlk/Socs6^tm1Dlk (involves: C57BL/6)	hematopoietic system phenotype	J:77039
Sod1^m1H/Sod1^m1H (involves: C3H/HeH * C57BL/6J)	microgliosis	J:219360
Sod1^tm1Cep/Sod1^tm1Cep (involves: 129S1/Sv * 129X1/SvJ)	abnormal common lymphocyte progenitor cell morphology	J:71134
	decreased common myeloid progenitor cell number	J:71134
	decreased erythrocyte cell number	J:71134
	decreased hemoglobin content	J:71134
Sod2^tm1Cje/Sod2^tm1Cje (involves: C57BL/6J * CD-1)	decreased hematocrit	J:29899
Sod2^tm1Leb/Sod2^tm1Leb (B6.129S7-Sod2^tm1Leb/J)	anemia	J:36148
	decreased bone marrow cell number	J:36148
	impaired myelopoiesis	J:36148
Son^{em1(IMPC)Wtsi}/Son^{em1(IMPC)Wtsi} (C57BL/6N-Son^{em1(IMPC)Wtsi}/Wtsi)	increased mean corpuscular hemoglobin	J:211773
Sorbs1^tm1Krc/Sorbs1^tm1Krc (B6.129-Sorbs1^tm1Krc)	decreased leukocyte cell number	J:121762
	decreased lymphocyte cell number	J:121762
	decreased monocyte cell number	J:121762
Sos1^tm1.1Les/Sos1^tm1.1Les Tg(Lck-cre)1Cwi/0 (involves: 129 * C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:174536
	decreased CD8-positive, alpha-beta T cell number	J:174536
	decreased DN4 thymocyte number	J:174536
	decreased double-negative T cell number	J:174536
	decreased double-positive T cell number	J:174536
	decreased gamma-delta T cell number	J:174536
	decreased T cell proliferation	J:174536
	decreased thymocyte number	J:174536
Sos1^tm1.2Rak/Sos1⁺ (involves: 129S/Sv * C57BL/6 * FVB/N * SJL)	abnormal common myeloid progenitor cell morphology	J:171873
	abnormal erythropoiesis	J:171873
	enlarged spleen	J:171873
	extramedullary hematopoiesis	J:171873
	increased leukocyte cell number	J:171873
	increased megakaryocyte cell number	J:171873
	increased neutrophil cell number	J:171873
	increased spleen red pulp amount	J:171873
Sostdc1^tm1Snd/Sostdc1^tm1Snd (involves: C57BL/6)	decreased osteoclast cell number	J:216098
Sox4^Igt4/Del(13)36H (involves: 101/H * C3H/HeH * C57BL/6)	thymus hypoplasia	J:141688
Sox4^tm1Cle/Sox4^tm1Cle (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell differentiation	J:32741
	absent pre-B cells	J:32741
	decreased pro-B cell number	J:32741
Sox4^tm2Cle/Sox4^tm2Cle (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell differentiation	J:32741
	absent pre-B cells	J:32741
	decreased pro-B cell number	J:32741
Sox11^tm1Weg/Sox11^tm1Weg (involves: 129S1/Sv * 129X1/SvJ)	absent spleen	J:92251
Sox11^tm2.2Weg/Sox11⁺ Sox4^tm1.1Vlf/Sox4⁺ (involves: 129 * C57BL/6 * FVB/N)	small spleen	J:175338
Sox11^tm2.2Weg/Sox11⁺ Sox12^tm2.1Weg/Sox12^tm2.1Weg Sox4^tm1.1Vlf/Sox4⁺ (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6)	small spleen	J:175338
Sox11^tm2.2Weg/Sox11^tm2.2Weg (involves: 129 * C57BL/6)	absent spleen	J:175338
Sox13^{tm1a(EUCOMM)Wtsi}/Sox13^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Sox13^{tm1a(EUCOMM)Wtsi}/Ics)	increased mean corpuscular hemoglobin concentration	J:165965
	increased mean corpuscular volume	J:165965
Sox13^tm1Jskg/Sox13⁺ (involves: C57BL/6)	decreased gamma-delta T cell number	J:117301
Sox13^tm1Jskg/Sox13^tm1Jskg (involves: C57BL/6)	decreased gamma-delta T cell number	J:117301
Sox13^tm1Jskg/Sox13^tm1Jskg (involves: C57BL/6)	increased T cell proliferation	J:117301
Sox14^{em1(IMPC)Ccpcz}/Sox14⁺ (C57BL/6N-Sox14^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Sox14^{em1(IMPC)Ccpcz}/Sox14^{em1(IMPC)Ccpcz} (C57BL/6N-Sox14^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Sox17^tm1Sjm/Sox17^tm1Sjm (BKa.129-Sox17^tm1Sjm)	abnormal embryonic hematopoiesis	J:123050
Sox17^tm1Sjm/Sox17^tm1Sjm (BKa.129-Sox17^tm1Sjm)	decreased hematopoietic stem cell number	J:123050
Sox17^tm1Sjm/Sox17^tm2Sjm Tg(Mx1-cre)1Cgn/0 (involves: 129/Sv * C3H * C57BL/6 * C57BL/Ka * CBA)	decreased bone marrow cell number	J:123050
	decreased hematopoietic stem cell number	J:123050
	decreased leukocyte cell number	J:123050
	spleen hypoplasia	J:123050
	thrombocytopenia	J:123050
	thymus hypoplasia	J:123050
Sox17^tm1Sjm/Sox17^tm2Sjm Tg(Tek-cre)12Flv/0 (involves: 129S1/Sv * 129X1/SvJ * C3H * C57BL/6 * C57BL/Ka)	abnormal embryonic hematopoiesis	J:123050
Sox18^{tm1.1(KOMP)Vlcg}/Sox18^{tm1.1(KOMP)Vlcg} (C57BL/6N-Sox18^{tm1.1(KOMP)Vlcg}/J)	increased mean corpuscular hemoglobin	J:211773
Sox21^em1(IMPC)Mbp/Sox21^em1(IMPC)Mbp (C57BL/6NCrl-Sox21^em1(IMPC)Mbp/MbpMmucd)	decreased lymphocyte cell number	J:211773
	increased mean corpuscular volume	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Sp1^tm1Phi/Sp1⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased erythroid progenitor cell number	J:123073
Sp1^tm1Phi/Sp1⁺ Sp3^tm1Sus/Sp3⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal erythropoiesis	J:123073
	anemia	J:123073
	decreased erythroid progenitor cell number	J:123073
Sp3^tm1Sus/Sp3⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal erythroid progenitor cell morphology	J:123073
Sp3^tm1Sus/Sp3^tm1Sus (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell differentiation	J:84837
	abnormal erythropoiesis	J:84837
	decreased CD4-positive, alpha-beta T cell number	J:84837
	small thymus	J:84837
Sp4^tm1Sus/Sp4^tm1Sus (involves: 129P2/OlaHsd * C57BL/6)	hematopoietic system phenotype	J:77894
	spleen hypoplasia	J:77894
	thymus hypoplasia	J:77894
Sp5^{tm1b(KOMP)Wtsi}/Sp5^{tm1b(KOMP)Wtsi} (C57BL/6N-Sp5^{tm1b(KOMP)Wtsi}/J)	decreased hematocrit	J:211773
Spag11a^em1(IMPC)Mbp/Spag11a^em1(IMPC)Mbp (C57BL/6NCrl-Spag11a^em1(IMPC)Mbp/Mmucd)	increased monocyte cell number	J:211773
Sparc^{tm1a(EUCOMM)Wtsi}/Sparc^{tm1a(EUCOMM)Wtsi} (B6JTyr;B6N-Sparc^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased mean corpuscular hemoglobin concentration	J:175295
Sparc^tm1Anjm/Sparc^tm1Anjm (involves: 129P2/OlaHsd * C57BL/6)	hematopoietic system phenotype	J:155870
Sparc^tm1Hwe/Sparc^tm1Hwe (involves: 129S/SvEv * C57BL/6J)	abnormal osteoclast morphology	J:61480
Sparc^tm1Hwe/Sparc^tm1Hwe (involves: 129S/SvEv * C57BL/6J)	decreased osteoclast cell number	J:61480
Spata2^{tm1.1(KOMP)Vlcg}/Spata2^{tm1.1(KOMP)Vlcg} (C57BL/6N-Spata2^{tm1.1(KOMP)Vlcg}/Ucd)	decreased lymphocyte cell number	J:211773
	increased eosinophil cell number	J:211773
Spata24^{tm1b(EUCOMM)Wtsi}/Spata24^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Spata24^{tm1b(EUCOMM)Wtsi}/BayMmucd)	decreased neutrophil cell number	J:211773
Spata31f3^{em1(IMPC)Ccpcz}/Spata31f3^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Spata31f3^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
	increased CD8-positive, alpha-beta T cell number	J:211773
	increased CD8-positive, naive alpha-beta T cell number	J:211773
Spdye4b^{tm3b(EUCOMM)Wtsi}/Spdye4b^{tm3b(EUCOMM)Wtsi} (C57BL/6N-Spdye4b^{tm3b(EUCOMM)Wtsi}/Bay)	abnormal spleen morphology	J:211773
Speg^{tm1b(KOMP)Wtsi}/Speg⁺ (C57BL/6N-Speg^{tm1b(KOMP)Wtsi}/Nju)	increased basophil cell number	J:211773
Spen^tm1Hon/Spen^tm1Hon (involves: 129P2/OlaHsd * C57BL/6J)	abnormal B cell differentiation	J:82332
Spg11^em1(IMPC)J/Spg11^em1(IMPC)J (C57BL/6NJ-Spg11^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Sphk1^em1(IMPC)Mbp/Sphk1^em1(IMPC)Mbp (C57BL/6N-Sphk1^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Sphk1^tm1.1Cgh/Sphk1^tm2Cgh Sphk2^tm1.1Cgh/Sphk2^tm1.1Cgh Tg(Mx1-cre)1Cgn/0 (involves: 129S4/SvJae * C57BL/6 * CBA)	abnormal NK cell differentiation	J:154069
	abnormal T cell differentiation	J:120783
	abnormal thymus cell ratio	J:120783
	decreased B cell number	J:120783
	decreased bone marrow cell number	J:120783
	decreased NK cell number	J:154069
	decreased T cell number	J:120783
	increased NK cell number	J:154069
Sphk1^tm1Npa/Sphk1^tm1Npa (BALB/c-Sphk1^tm1Npa)	increased B cell number	J:129314
Sphk2^tm1.1Stlp/Sphk2^tm1.1Stlp (involves: BALB/c)	abnormal CD4-positive, alpha-beta T cell physiology	J:153014
Sphk2^tm1Npa/Sphk2^tm1Npa (BALB/c-Sphk2^tm1Npa)	abnormal B cell physiology	J:129314
Sphk2^tm1Npa/Sphk2^tm1Npa (BALB/c-Sphk2^tm1Npa)	increased B cell number	J:129314
Spi1^tm1.1Dgt/Spi1^tm1.1Dgt (involves: 129S1/Sv * 129X1/SvJ)	abnormal definitive hematopoiesis	J:90331
	abnormal erythrocyte cell number	J:90331
	abnormal spleen morphology	J:90331
	decreased B cell number	J:90331
	enlarged spleen	J:90331
	spleen hyperplasia	J:90331
Spi1^tm1.1Nutt/Spi1^tm1.1Nutt (involves: C57BL/6 * BALB/cJ)	absent common myeloid progenitor cells	J:98188
Spi1^tm1.1Rpd/Spi1^tm1.1Rpd (involves: 129/Sv * Black Swiss * FVB/N)	abnormal common myeloid progenitor cell morphology	J:138501
Spi1^tm1.2Nutt/Spi1^tm1.2Nutt Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	abnormal bone marrow cell morphology/development	J:98188
	abnormal granulocyte differentiation	J:98188
	abnormal spleen morphology	J:98188
	absent common myeloid progenitor cells	J:98188
	absent erythrocytes	J:98188
	decreased B cell number	J:98188
	extramedullary hematopoiesis	J:98188
	increased granulocyte number	J:98188
Spi1^tm1.3Dgt/Spi1^tm1.3Dgt (involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6)	abnormal double-negative T cell morphology	J:106040
	abnormal T cell subpopulation ratio	J:106040
	arrested B cell differentiation	J:106040
	decreased B-1a cell number	J:106040
	decreased granulocyte number	J:106040
	decreased mature B cell number	J:106040
	decreased pre-B cell number	J:106040
	decreased pro-B cell number	J:106040
	decreased T cell number	J:106040
	decreased thymocyte number	J:106040
	increased B-1 B cell number	J:106040
	increased B-1b cell number	J:106040
	increased IgM level	J:106040
	increased lymphocyte cell number	J:106040
	increased T cell number	J:106040
	small thymus	J:106040
Spi1^tm1.3Dgt/Spi1^tm1.3Dgt (involves: 129 * BALB/c * C57BL/6)	abnormal definitive hematopoiesis	J:90331
	abnormal proerythroblast morphology	J:90331
	abnormal spleen morphology	J:90331
	decreased B cell number	J:90331
	enlarged spleen	J:90331
	increased neutrophil cell number	J:90331
	increased spleen weight	J:90331
	spleen hyperplasia	J:90331
Spi1^tm1.3Nutt/Spi1^tm1.3Nutt (C57BL/6-Sfpi1^tm1.3Nutt)	absent common myeloid progenitor cells	J:98188
Spi1^tm1Kast/Spi1⁺ (B6.129S2-Spi1^tm1Kast)	abnormal erythropoiesis	J:90543
	increased bone marrow cell number	J:196609
	increased hematopoietic stem cell number	J:196609
Spi1^tm1Kast/Spi1^tm1Kast (B6.129S2-Spi1^tm1Kast)	abnormal erythropoiesis	J:90543
	abnormal fetal derived definitive erythrocyte cell number	J:90543
	absent B cells	J:90543
	failure of myelopoiesis	J:90543
Spi1^tm1Ram/Spi1^tm1Ram (involves: 129S2/SvPas)	decreased macrophage cell number	J:101493
Spi1^tm1Ram/Spi1^tm1Ram (involves: 129S2/SvPas * C57BL/6)	abnormal B cell number	J:36473
	abnormal macrophage differentiation	J:36473
	abnormal microglial cell morphology	J:116087
	abnormal neutrophil differentiation	J:36473
	abnormal T cell differentiation	J:36473
	abnormal T cell number	J:36473
	absent mature B cells	J:36473
	decreased CD4-positive, alpha-beta T cell number	J:36473
	decreased CD8-positive, alpha-beta T cell number	J:36473
	decreased double-positive T cell number	J:36473
	decreased macrophage cell number	J:36473
	decreased neutrophil cell number	J:36473
	decreased spleen red pulp amount	J:36473
	decreased thymocyte number	J:36473
Spi1^tm1Rpd/Spi1^tm1Rpd (involves: 129/Sv * C57BL/6 * Black Swiss)	abnormal common myeloid progenitor cell morphology	J:123079
	abnormal myelopoiesis	J:123079
	arrested B cell differentiation	J:123079
	enlarged spleen	J:123079
	impaired myelopoiesis	J:123079
Spi1^tm1Rpd/Spi1^tm1Rpd (involves: 129)	abnormal common myeloid progenitor cell morphology	J:138501
Spi1^tm1Sing/Spi1⁺ Spib^tm1Mcs/Spib⁺ (involves: 129S/SvEv * 129X1/SvJ)	abnormal spleen germinal center morphology	J:88257
	decreased B cell proliferation	J:88257
	hematopoietic system phenotype	J:88257
Spi1^tm1Sing/Spi1⁺ Spib^tm1Mcs/Spib^tm1Mcs (involves: 129S/SvEv * 129X1/SvJ)	abnormal B cell differentiation	J:88257
	abnormal immature B cell morphology	J:88257
	absent spleen germinal center	J:88257
	decreased B cell number	J:88257
	decreased B cell proliferation	J:88257
	increased B cell apoptosis	J:88257
Spi1^tm1Sing/Spi1^tm1Sing (involves: 129S/SvEv)	abnormal B cell differentiation	J:20348
	abnormal common myeloid progenitor cell morphology	J:138501
	abnormal erythropoiesis	J:20348
	abnormal granulocyte morphology	J:20348
	abnormal leukopoiesis	J:20348
	abnormal monocyte morphology	J:20348
	abnormal T cell differentiation	J:20348
	anemia	J:20348
	decreased hematocrit	J:20348
Spi1^tm2.1Dgt/Spi1^tm2.1Dgt (B6.Cg-Spi1^tm2.1Dgt)	abnormal blood cell morphology/development	J:114150
	abnormal hematopoietic system physiology	J:114150
	decreased hematopoietic stem cell number	J:114150
Spi1^tm2.1Dgt/Spi1^tm2Dgt Tg(Mx1-cre)1Cgn/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	abnormal blood cell morphology/development	J:114150
Spi1^{tm2b(EUCOMM)Wtsi}/Spi1⁺ (C57BL/6N-Spi1^{tm2b(EUCOMM)Wtsi}/J)	decreased erythrocyte cell number	J:211773
	increased mean corpuscular volume	J:211773
Spi1^tm2Dgt/Spi1^tm2Dgt (B6.Cg-Spi1^tm2Dgt)	abnormal blood cell morphology/development	J:114150
Spi1^tm2Dgt/Spi1^tm2Dgt Tg(Mx1-cre)1Cgn/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	abnormal blood cell morphology/development	J:114150
Spi1^tm3Dgt/Spi1^tm3Dgt (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased B cell number	J:131217
	decreased double-negative T cell number	J:131217
	increased double-negative T cell number	J:131217
	increased granulocyte number	J:131217
Spi1^tm4.1Dgt/Spi1^tm4.1Dgt (B6.129(Cg)-Spi1^tm4.1Dgt)	abnormal hematopoietic stem cell physiology	J:196609
	hematopoietic system phenotype	J:196609
	increased bone marrow cell number	J:196609
	increased hematopoietic stem cell number	J:196609
	increased hematopoietic stem cell proliferation	J:196609
Spib^tm1Mcs/Spib^tm1Mcs (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal immature B cell morphology	J:88257
	decreased B cell proliferation	J:88257
Spib^tm1Mcs/Spib^tm1Mcs (involves: 129S1/Sv * 129X1/SvJ)	abnormal spleen B cell follicle morphology	J:45245
	abnormal spleen germinal center morphology	J:45245
	abnormal spleen white pulp morphology	J:45245
	decreased B cell proliferation	J:45245
	decreased IgG1 level	J:45245
	decreased IgG2a level	J:45245
	decreased IgG2b level	J:45245
	increased B cell apoptosis	J:45245
	increased IgM level	J:45245
Spic^tm1.1Kmm/Spic^tm1.1Kmm (involves: 129S6/SvEvTac * C57BL/6)	abnormal macrophage morphology	J:143900
	impaired macrophage phagocytosis	J:143900
	increased spleen iron level	J:143900
	increased spleen weight	J:143900
Spic^tm1Kmm/Spic^tm1Kmm (involves: 129S6/SvEvTac * C57BL/6)	abnormal macrophage morphology	J:143900
	impaired macrophage phagocytosis	J:143900
	increased spleen iron level	J:143900
	increased spleen weight	J:143900
Spice1^{tm1b(EUCOMM)Hmgu}/Spice1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Spice1^{tm1b(EUCOMM)Hmgu}/H)	increased red blood cell distribution width	J:211773
Spink1^tm1Kymm/Spink1^tm1Kymm (involves: C57BL/6NCrlj * CBA/JNCrlj)	small spleen	J:104647
Spink2^{tm1.1(KOMP)Vlcg}/Spink2^{tm1.1(KOMP)Vlcg} (C57BL/6N-Spink2^{tm1.1(KOMP)Vlcg}/Ucd)	decreased erythrocyte cell number	J:211773
	increased basophil cell number	J:211773
Spink5^m1Btlr/Spink5^m1Btlr (involves: C57BL/6J)	increased neutrophil cell number	J:183755
Spink6^{em1(IMPC)Ccpcz}/Spink6^{em1(IMPC)Ccpcz} (C57BL/6N-Spink6^{em1(IMPC)Ccpcz}/Ccpcz)	decreased Ly6C-positive immature NK cell number	J:211773
	decreased macrophage cell number	J:211773
	increased Ly6C-positive mature NK cell number	J:211773
	increased monocyte cell number	J:211773
Spink12^em1(IMPC)J/Spink12^em1(IMPC)J (C57BL/6NJ-Spink12^em1(IMPC)J/J)	increased mean corpuscular hemoglobin concentration	J:211773
Spink13^{em1(IMPC)Ccpcz}/Spink13^{em1(IMPC)Ccpcz} (C57BL/6N-Spink13^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Spink14^{tm1e(KOMP)Wtsi}/Spink14^{tm1e(KOMP)Wtsi} (C57BL/6N-Spink14^{tm1e(KOMP)Wtsi}/Wtsi)	decreased immature NK cell number	J:211773
	decreased macrophage cell number	J:211773
	decreased mature NK cell number	J:211773
	decreased NK cell number	J:211773
	increased memory-marker NK cell number	J:211773
Splq1^L6/Splq1^L6 (involves: L6 * M16i)	decreased spleen weight	J:87793
Splq1^L6/Splq1^M16i (involves: L6 * M16i)	decreased spleen weight	J:87793
Splq2^L6/Splq2^L6 (involves: L6 * M16i)	decreased spleen weight	J:87793
Splq2^L6/Splq2^M16i (involves: L6 * M16i)	decreased spleen weight	J:87793
Splq3^L6/Splq3^L6 (involves: L6 * M16i)	decreased spleen weight	J:87793
Splq4^L6/Splq4^L6 (involves: L6 * M16i)	decreased spleen weight	J:87793
Splq4^L6/Splq4^M16i (involves: L6 * M16i)	decreased spleen weight	J:87793
Splq5^L6/Splq5^L6 (involves: L6 * M16i)	decreased spleen weight	J:87793
Splq5^L6/Splq5^M16i (involves: L6 * M16i)	decreased spleen weight	J:87793
Splq6^L6/Splq6^L6 (involves: L6 * M16i)	decreased spleen weight	J:87793
Splq6^L6/Splq6^M16i (involves: L6 * M16i)	decreased spleen weight	J:87793
Splq7^L6/Splq7^L6 (involves: L6 * M16i)	decreased spleen weight	J:87793
Splq8^L6/Splq8^L6 (involves: L6 * M16i)	decreased spleen weight	J:87793
Splq8^L6/Splq8^M16i (involves: L6 * M16i)	decreased spleen weight	J:87793
Splq9^L6/Splq9^L6 (involves: L6 * M16i)	decreased spleen weight	J:87793
Splwt1^LG/J/? (involves: LG/J * SM/J)	increased spleen weight	J:94605
Spmip2^{tm1b(EUCOMM)Hmgu}/Spmip2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Spmip2^{tm1b(EUCOMM)Hmgu}/Bay)	abnormal spleen morphology	J:211773
Spn^tm1Bam/Spn^tm1Bam (involves: 129S4/SvJae * C57BL/6)	abnormal T cell physiology	J:29272
	hematopoietic system phenotype	J:29272
	increased T cell proliferation	J:29272, J:88252
Spns2^tm1.1Nmoc/Spns2^tm1.1Nmoc Tg(Tek-cre)1Ywa/0 (involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj * SJL)	abnormal B cell physiology	J:184558
	abnormal effector T cell morphology	J:184558
	abnormal T cell physiology	J:184558
	decreased CD4-positive, alpha-beta T cell number	J:184558
	decreased CD8-positive, alpha-beta T cell number	J:184558
	decreased mature B cell number	J:184558
	increased CD4-positive, alpha-beta T cell number	J:184558
	increased CD8-positive, alpha-beta T cell number	J:184558
Spns2^tm1.2Nmoc/Spns2^tm1.2Nmoc (involves: C57BL/6NCrlj * CBA/JNCrlj)	abnormal B cell physiology	J:184558
	abnormal T cell physiology	J:184558
	decreased B-1 B cell number	J:184558
	decreased CD4-positive, alpha-beta T cell number	J:184558
	decreased CD8-positive, alpha-beta T cell number	J:184558
	decreased follicular B cell number	J:184558
	decreased immature B cell number	J:184558
	decreased leukocyte cell number	J:184558
	decreased mature B cell number	J:184558
	decreased transitional stage T1 B cell number	J:184558
	increased CD4-positive, alpha-beta T cell number	J:184558
	increased CD8-positive, alpha-beta T cell number	J:184558
	increased single-positive T cell number	J:184558
Spns2^{tm1a(KOMP)Wtsi}/Spns2^{tm1a(KOMP)Wtsi} (B6JTyr;B6N-Spns2^{tm1a(KOMP)Wtsi}/Wtsi)	decreased leukocyte cell number	J:165965
Spns2^{tm1a(KOMP)Wtsi}/Spns2^{tm1a(KOMP)Wtsi} (involves: C57BL/6 * C57BL/6N)	decreased B cell number	J:188933, J:213427
	decreased B-1 B cell number	J:188933
	decreased CD4-positive, alpha-beta T cell number	J:188933, J:213427
	decreased CD8-positive, alpha-beta T cell number	J:188933, J:213427
	decreased follicular B cell number	J:188933
	decreased IgG1 level	J:188933
	decreased IgG level	J:188933
	decreased leukocyte cell number	J:188933, J:213427
	decreased mature B cell number	J:213427
	decreased T cell number	J:213427
	increased CD4-positive, alpha-beta T cell number	J:188933
	increased CD8-positive, alpha-beta T cell number	J:188933
	increased granulocyte number	J:213427
	increased monocyte cell number	J:213427
	increased NK cell number	J:213427
	increased NK T cell number	J:213427
Spns2^{tm1b(KOMP)Wtsi}/Spns2^{tm1b(KOMP)Wtsi} (involves: 129S7/SvEvBrd * C57BL/6 * C57BL/6N)	decreased B cell number	J:188933
	decreased CD4-positive, alpha-beta T cell number	J:188933
	decreased CD8-positive, alpha-beta T cell number	J:188933
	increased CD4-positive, alpha-beta T cell number	J:188933
	increased CD8-positive, alpha-beta T cell number	J:188933
Spns2^{tm1b(KOMP)Wtsi}/Spns2^{tm1b(KOMP)Wtsi} (B6Brd;B6Dnk;B6N-Tyr^c-Brd Spns2^{tm1b(KOMP)Wtsi}/WtsiH)	decreased leukocyte cell number	J:211773
	increased mean corpuscular hemoglobin	J:211773
Spns2^tm1Tni/Spns2^tm1Tni (B6.Cg-Spns2^tm1Tni)	abnormal leukocyte cell number	J:225108
	abnormal mature B cell number	J:225108
	abnormal thymus morphology	J:225108
	decreased leukocyte cell number	J:225108
	decreased lymphocyte cell number	J:225108
	decreased monocyte cell number	J:225108
	decreased single-positive T cell number	J:225108
	decreased thymocyte number	J:225108
Spns3^em1(IMPC)Tcp/Spns3^em1(IMPC)Tcp (C57BL/6NCrl-Spns3^em1(IMPC)Tcp/Tcp)	increased eosinophil cell number	J:211773
	increased red blood cell distribution width	J:211773
Spnw1^DBA/2/Spnw1^DBA/2 Spnw4^DU6i/Spnw4^DU6i (involves: DBA/2 * DU6i)	increased spleen weight	J:101006
Spo11^{tm2b(KOMP)Wtsi}/Spo11^{tm2b(KOMP)Wtsi} (C57BL/6N-Spo11^{tm2b(KOMP)Wtsi}/Bay)	abnormal spleen morphology	J:211773
	increased spleen weight	J:211773
Spop^{tm1b(KOMP)Wtsi}/Spop⁺ (C57BL/6N-Spop^{tm1b(KOMP)Wtsi}/Tcp)	small thymus	J:211773
Spp1^Ric-r/Spp1⁺ (C3H/Rv)	increased macrophage cell number	J:7240
Spp1^tm1.1Dhd/Spp1^tm1.1Dhd (involves: 129P2/OlaHsd * C57BL/6)	abnormal macrophage morphology	J:237104
	abnormal osteoclast physiology	J:237104
	decreased osteoclast cell number	J:237104
Spp1^tm1Blh/Spp1⁺ (involves: 129S6/SvEvTac * Black Swiss)	abnormal leukocyte migration	J:86531
Spp1^tm1Blh/Spp1^tm1Blh (B6.129S6(Cg)-Spp1^tm1Blh/J)	abnormal hematopoietic system physiology	J:133795
	decreased hematocrit	J:133795
	decreased hemoglobin content	J:133795
Spp1^tm1Blh/Spp1^tm1Blh (involves: 129S6/SvEvTac * Black Swiss)	abnormal leukocyte migration	J:86531
	abnormal leukocyte physiology	J:86531
	abnormal macrophage chemotaxis	J:140014
	abnormal macrophage physiology	J:127389
	decreased leukocyte cell number	J:86531
	decreased macrophage cell number	J:127389
	increased lymphocyte cell number	J:103050
Spp1^tm1Blh/Spp1^tm1Blh (B6.129S6-Spp1^tm1Blh)	abnormal microglial cell morphology	J:118432
Spp1^tm1Blh/Spp1^tm1Blh (involves: 129S6/SvEvTac * C57BL/6)	decreased dendritic cell number	J:119298
Spp1^tm1Blh/Spp1^tm1Blh (BKSW.129S6-Spp1^tm1Blh)	impaired macrophage chemotaxis	J:113585
Spp1^tm1Rit/Spp1^tm1Rit (involves: 129S7/SvEvBrd * C57BL/6)	abnormal osteoclast physiology	J:68872, J:56353
	decreased osteoclast cell number	J:115395
	increased osteoclast cell number	J:56353, J:56535
Spp1^tm1Rit/Spp1^tm1Rit (involves: 129S7/SvEvBrd)	abnormal blood cell morphology/development	J:117329
	increased bone marrow cell number	J:117329
	increased hematopoietic stem cell number	J:117329
Sppl2a^chompB/Sppl2a^chompB (involves: C57BL/6)	abnormal class switch recombination	J:194595
	decreased activation-induced B cell apoptosis	J:194595
	decreased B cell proliferation	J:194595
	decreased follicular B cell number	J:194595
	decreased IgG1 level	J:194595
	decreased IgG2b level	J:194595
	decreased IgG3 level	J:194595
	decreased IgM level	J:194595
	decreased marginal zone B cell number	J:194595
	decreased mature B cell number	J:194595
	decreased myeloid dendritic cell number	J:194595
	decreased plasmacytoid dendritic cell number	J:194595
	decreased transitional stage T2 B cell number	J:194595
Sppl2a^m1Anu/Sppl2a^m1Anu (involves: C57BL/6JAnu)	abnormal immunoglobulin level	J:194663
	abnormal mature B cell morphology	J:194663
	abnormal transitional stage B cell morphology	J:194663
	decreased IgG1 level	J:194663
	decreased IgM level	J:194663
	decreased marginal zone B cell number	J:194663
	decreased transitional stage T2 B cell number	J:194663
	decreased transitional stage T3 B cell number	J:194663
	hematopoietic system phenotype	J:194663
Sppl2a^m1Anu/Sppl2a^m1Anu Tg(Vav-BCL2)69Jad/? (involves: C57BL/6JAnu)	abnormal T cell number	J:194663
	decreased CD4-positive, alpha-beta T cell number	J:194663
	decreased double-negative T cell number	J:194663
	increased mature B cell number	J:194663
	increased plasmacytoid dendritic cell number	J:194663
Sppl2a^m1Btlr/Sppl2a^m1Btlr (C57BL/6J-Sppl2a^m1Btlr)	decreased IgG level	J:236687
Sppl2a^m2Btlr/Sppl2a^m2Btlr (C57BL/6J-Sppl2a^m2Btlr)	decreased IgG level	J:236688
Sppl2a^m2Btlr/Sppl2a^m2Btlr (C57BL/6J-Sppl2a^m2Btlr)	decreased IgM level	J:236688
Sppl2a^tm1Basc/Sppl2a^tm1Basc (involves: 129S1/Sv * 129X1/SvJ * C57BL/6NCrl)	abnormal B cell physiology	J:194664
	arrested B cell differentiation	J:194664
	decreased B cell number	J:194664
	decreased B-1 B cell number	J:194664
	decreased B-2 B cell number	J:194664
	decreased follicular B cell number	J:194664
	decreased IgA level	J:194664
	decreased IgG1 level	J:194664
	decreased IgG2a level	J:194664
	decreased IgG2b level	J:194664
	decreased IgG3 level	J:194664
	decreased IgM level	J:194664
	decreased marginal zone B cell number	J:194664
	decreased mature B cell number	J:194664
	decreased T cell number	J:194664
	decreased transitional stage T2 B cell number	J:194664
	small spleen	J:194664
Sppl2a^tm1Basc/Sppl2a^tm1Basc Sppl2b^{Gt(Ayu21-T160)Imeg}/Sppl2b^{Gt(Ayu21-T160)Imeg} (B6N.Cg-Sppl2a^tm1Basc Sppl2b^{Gt(Ayu21-T160)Imeg})	abnormal mature B cell morphology	J:213519
	decreased B cell number	J:213519
	decreased immunoglobulin level	J:213519
Sppl2a^tm1Dgen/Sppl2a^tm1Dgen (B6.129P2-Sppl2a^tm1Dgen)	decreased B cell number	J:194595
	decreased B-1 B cell number	J:194595
	decreased follicular B cell number	J:194595
	decreased IgA level	J:194595
	decreased IgG1 level	J:194595
	decreased IgG2b level	J:194595
	decreased IgG3 level	J:194595
	decreased IgM level	J:194595
	decreased myeloid dendritic cell number	J:194595
	decreased transitional stage T2 B cell number	J:194595
Sppl3^tm1Itl/Sppl3^em1Pomz Ncr1^{tm1.1(icre)Viv}/Ncr1⁺ (involves: 129S/SvEv * C57BL/6 * C57BL/6J)	abnormal NK cell differentiation	J:280182
	decreased mature NK cell number	J:280182
	decreased NK cell number	J:280182
	increased immature NK cell number	J:280182
Sppl3^tm1Itl/Sppl3^tm1Itl Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: 129S/SvEv * C57BL/6 * C57BL/10 * CBA/Ca)	abnormal NK cell differentiation	J:280182
	decreased mature NK cell number	J:280182
	decreased NK cell number	J:280182
	hematopoietic system phenotype	J:280182
	impaired natural killer cell mediated cytotoxicity	J:280182
	increased immature NK cell number	J:280182
Sppl3^tm1Itl/Sppl3^tm1Itl Ncr1^{tm1.1(icre)Viv}/Ncr1⁺ (involves: 129S/SvEv * C57BL/6)	abnormal NK cell differentiation	J:280182
	abnormal NK cell physiology	J:280182
	decreased mature NK cell number	J:280182
	decreased NK cell number	J:280182
	impaired natural killer cell mediated cytotoxicity	J:280182
	increased immature NK cell number	J:280182
Spr^em1(IMPC)H/Spr⁺ (C57BL/6N-Spr^em1(IMPC)H/H)	increased hematocrit	J:211773
	increased mean corpuscular volume	J:211773
	increased neutrophil cell number	J:211773
Spred1^{em1(IMPC)Ccpcz}/Spred1^{em1(IMPC)Ccpcz} (C57BL/6N-Spred1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	decreased lymphocyte cell number	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
	increased CD4-positive NK T cell number	J:211773
	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	increased effector memory CD8-positive, alpha-beta T cell number	J:211773
	increased effector memory T-helper cell number	J:211773
	increased memory-marker CD4-positive NK T cell number	J:211773
	increased neutrophil cell number	J:211773
	increased NK T cell number	J:211773
	increased spleen weight	J:211773
Spred1^tm1.1Ayos/Spred1^tm1.1Ayos (involves: 129 * C57BL/6 * SJL)	increased mast cell degranulation	J:186742
	increased mast cell number	J:186742
Spred1^tm1Hiin/Spred1^tm1Hiin (involves: C57BL/6)	abnormal eosinophil physiology	J:95263
Spred1^tm1Hiin/Spred1^tm1Hiin (involves: C57BL/6)	increased eosinophil cell number	J:95263
Spred2^em1(IMPC)Mbp/Spred2^em1(IMPC)Mbp (C57BL/6N-Spred2^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	decreased mean corpuscular volume	J:211773
	enlarged spleen	J:211773
	increased red blood cell distribution width	J:211773
Spred2^Gt(XB228)Byg/Spred2^Gt(XB228)Byg (involves: 129P2/OlaHsd * C57BL/6)	increased megakaryocyte cell number	J:100826
Spred2^tm1Taga/Spred2^tm1Taga (Not Specified)	abnormal definitive hematopoiesis	J:90463
Spred2^tm1Taga/Spred2^tm1Taga (Not Specified)	increased megakaryocyte cell number	J:90463
Sprol1^STS/A/? (involves: B10.O20/Dem * O20/A)	increased lymphocyte cell number	J:56029
Spryd3^{tm1b(EUCOMM)Hmgu}/Spryd3^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Spryd3^{tm1b(EUCOMM)Hmgu}/Ieg)	decreased mean corpuscular hemoglobin concentration	J:211773
Spryd4^{em1(IMPC)Ccpcz}/Spryd4^{em1(IMPC)Ccpcz} (C57BL/6N-Spryd4^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Spsb2^tm1Nch/Spsb2^tm1Nch (involves: C57BL/6)	thrombocytopenia	J:99226
Spta1^ihj/Spta1^ihj (involves: HRS/J * LAH)	abnormal spleen morphology	J:105409
	anisocytosis	J:105409
	enlarged spleen	J:105409
	hemolytic anemia	J:105409
	microcytosis	J:105409
	poikilocytosis	J:105409
	polychromatophilia	J:105409
	reticulocytosis	J:105409
	spherocytosis	J:105409
Spta1^sph-2Bc/Spta1^sph-2Bc (involves: SELH)	abnormal erythrocyte morphology	J:7048, J:7501
	abnormal spleen morphology	J:7048
	anisocytosis	J:7048
	decreased hematocrit	J:7048
	decreased hemoglobin content	J:7048
	enlarged spleen	J:7048
	erythroblastosis	J:7048
	extramedullary hematopoiesis	J:7048
	hemolytic anemia	J:7048
	increased bone marrow cell number	J:7048
	increased erythrocyte osmotic fragility	J:7048
	increased leukocyte cell number	J:7048
	poikilocytosis	J:7048
	reticulocytosis	J:7048
	schistocytosis	J:7048
	spherocytosis	J:7048
Spta1^sph-2Bc/Spta1^sph-2Bc ((WB.Cg-Spta1^sph-2Bc/Brk x B6.Cg-Spta1^sph-2Bc/Brk)F1)	abnormal erythrocyte morphology	J:62355
	abnormal red blood cell deformability	J:81125
	microcytosis	J:62355
Spta1^sph-2J/Spta1^sph-2J (C3HeB/FeJ-Spta1^sph-2J)	abnormal reticulocyte morphology	J:7501
Spta1^sph-3J/Spta1^sph-3J (NOD.Cg-H2^b Spta1^sph-3J)	abnormal erythrocyte morphology	J:157766
	anemia	J:157766
	anisocytosis	J:157766
	anisopoikilocytosis	J:157766
	decreased erythrocyte cell number	J:157766
	decreased hematocrit	J:157766
	decreased hemoglobin content	J:157766
	decreased mean corpuscular hemoglobin concentration	J:157766
	decreased spleen iron level	J:157766
	elliptocytosis	J:157766
	enlarged spleen	J:157766
	extramedullary hematopoiesis	J:157766
	hemolytic anemia	J:157766
	increased spleen weight	J:157766
	poikilocytosis	J:157766
	polychromatophilia	J:157766
	reticulocytosis	J:157766
	spherocytosis	J:157766
Spta1^sph-4J/Spta1^sph-4J (C57BL/6J-Spta1^sph-4J/Llp)	abnormal erythrocyte morphology	J:157766
	anemia	J:157766
	anisocytosis	J:157766
	anisopoikilocytosis	J:157766
	decreased erythrocyte cell number	J:157766
	decreased hematocrit	J:157766
	decreased hemoglobin content	J:157766
	decreased mean corpuscular hemoglobin concentration	J:157766
	enlarged spleen	J:157766
	extramedullary hematopoiesis	J:157766
	hemolytic anemia	J:157766
	increased mean corpuscular volume	J:157766
	increased spleen weight	J:157766
	poikilocytosis	J:157766
	polychromatophilia	J:157766
	reticulocytosis	J:157766
	spherocytosis	J:157766
Spta1^sph-Dem/Spta1^sph-Dem (CcS3/Dem-Spta1^sph-Dem)	abnormal erythrocyte morphology	J:62355
	anemia	J:66966
	elliptocytosis	J:62355, J:66966
	enlarged spleen	J:66966
	microcytosis	J:62355
Spta1^sph-ha/Spta1⁺ (either: (B6.D1-Spta1^sph-ha x WB.D1-Spta1^sph-ha)F1 or (WB.D1-Spta1^sph-ha x B6.D1-Spta1^sph-ha)F1)	increased erythrocyte protoporphyrin level	J:5985
Spta1^sph-ha/Spta1⁺ (involves: DBA/1J)	increased erythrocyte clearance	J:24829
Spta1^sph-ha/Spta1^sph-ha (involves: DBA/1J)	abnormal erythrocyte morphology	J:30699
	abnormal reticulocyte morphology	J:7501
	decreased hematocrit	J:24829
	decreased hemoglobin content	J:24829
	decreased mean corpuscular volume	J:24829
	enlarged spleen	J:30699, J:14946
	erythroblastosis	J:14946
	hemolytic anemia	J:30699
	hypochromic microcytic anemia	J:14946
	microcytic anemia	J:24729
	microcytosis	J:24729
Spta1^sph-ha/Spta1^sph-ha (either: (B6.D1-Spta1^sph-ha x WB.D1-Spta1^sph-ha)F1 or (WB.D1-Spta1^sph-ha x B6.D1-Spta1^sph-ha)F1)	abnormal bone marrow cell number	J:1967, J:6695
	abnormal erythrocyte physiology	J:30033
	abnormal erythropoiesis	J:6695
	abnormal spleen morphology	J:6695
	abnormal splenic cell ratio	J:1967
	decreased hematocrit	J:6695
	enlarged spleen	J:6695
	extramedullary hematopoiesis	J:12830
	hemolytic anemia	J:12830, J:1967, J:6695
	increased B cell number	J:1967
	increased B cell proliferation	J:1967
	increased bone marrow cell number	J:12830, J:6695
	increased CD4-positive, alpha-beta T cell number	J:1967
	increased CD8-positive, alpha-beta T cell number	J:1967
	increased erythrocyte protoporphyrin level	J:5985, J:6695
	increased erythroid progenitor cell number	J:6695
	increased IgA level	J:12830
	increased IgG level	J:12830
	increased leukocyte cell number	J:12830
	increased lymphocyte cell number	J:12830, J:1967
	increased monocyte cell number	J:12830
	increased neutrophil cell number	J:12830
	increased T cell number	J:1967
	increased T cell proliferation	J:1967
	macrocytosis	J:6695
	microcytosis	J:6695
	reticulocytosis	J:6695
	spherocytosis	J:6695
Spta1^sph-ha/Spta1^sph-ha ((WB.D1-Spta1^sph-ha/Brk x B6.D1-Spta1^sph-ha/Brk)F1)	abnormal erythrocyte morphology	J:62355
	abnormal erythrocyte physiology	J:162532
	abnormal red blood cell deformability	J:81125
	anisopoikilocytosis	J:162532
	decreased hematocrit	J:162532
	decreased hemoglobin content	J:162532
	enlarged spleen	J:162532
	extramedullary hematopoiesis	J:162532
	hemolysis	J:162532
	hemolytic anemia	J:162532
	increased erythrocyte clearance	J:162532
	increased erythrocyte osmotic fragility	J:162532
	increased mean corpuscular volume	J:162532
	increased nucleated erythrocyte cell number	J:162532
	low mean erythrocyte cell number	J:162532
	microcytosis	J:62355
	poikilocytosis	J:162532
	reticulocytosis	J:162532
	schistocytosis	J:162532
Spta1^sph/Spta1⁺ (either: (B6.C3-Spta1^sph x WB.C3-Spta1^sph)F1 or (WB.C3-Spta1^sph x B6.C3-Spta1^sph)F1)	increased erythrocyte protoporphyrin level	J:5985
Spta1^sph/Spta1^sph (involves: C3H)	abnormal reticulocyte morphology	J:7501
	decreased hematocrit	J:12276
	decreased hemoglobin content	J:12276
	hemolytic anemia	J:12276
	poikilocytosis	J:12276
	spherocytosis	J:12276
Spta1^sph/Spta1^sph (either: (B6.C3-Spta1^sph x WB.C3-Spta1^sph)F1 or (WB.C3-Spta1^sph x B6.C3-Spta1^sph)F1)	abnormal bone marrow cell number	J:6695
	abnormal erythrocyte physiology	J:30033
	abnormal erythropoiesis	J:6695
	abnormal spleen morphology	J:6695
	decreased hematocrit	J:6695
	enlarged spleen	J:6695
	hemolytic anemia	J:6695
	increased bone marrow cell number	J:6695
	increased erythrocyte protoporphyrin level	J:5985, J:111131
	increased erythroid progenitor cell number	J:6695
	macrocytosis	J:6695
	microcytosis	J:6695
	reticulocytosis	J:6695
	spherocytosis	J:6695
Spta1^sph/Spta1^sph ((WB.C3-Spta1^sph x B6.C3-Spta1^sph)F1)	abnormal erythrocyte morphology	J:62355
	abnormal erythrocyte osmotic lysis	J:162532
	abnormal erythrocyte physiology	J:162532
	anisopoikilocytosis	J:162532
	decreased cellular hemoglobin content	J:44313
	decreased erythrocyte cell number	J:44313
	decreased hematocrit	J:162532, J:44313
	decreased hemoglobin content	J:162532, J:44313
	enlarged spleen	J:162532, J:44313
	extramedullary hematopoiesis	J:162532
	hemolysis	J:162532
	hemolytic anemia	J:162532
	increased erythrocyte clearance	J:162532
	increased mean corpuscular volume	J:162532
	increased nucleated erythrocyte cell number	J:162532
	low mean erythrocyte cell number	J:162532
	microcytosis	J:62355
	poikilocytosis	J:162532
	reticulocytosis	J:162532
	schistocytosis	J:162532
Sptan1^em1(IMPC)Mbp/Sptan1⁺ (C57BL/6NCrl-Sptan1^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Sptb^em1(IMPC)J/Sptb⁺ (C57BL/6NJ-Sptb^em1(IMPC)J/Mmjax)	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
	increased erythrocyte cell number	J:211773
Sptb^ja/Sptb⁺ (129/Sv-Sptb^ja)	anemia	J:5985
Sptb^ja/Sptb⁺ (129/Sv-Sptb^ja)	increased erythrocyte protoporphyrin level	J:5985
Sptb^ja/Sptb⁺ (involves: 129/Sv * C57BL/6J * WB/Re)	increased erythrocyte protoporphyrin level	J:5985
Sptb^ja/Sptb⁺ ((WB.129-Sptb^ja/J x B6.129-Sptb^ja/J)F1)	increased erythrocyte clearance	J:44313
Sptb^ja/Sptb⁺ ((WB.129-Sptb^ja/J x B6.129-Sptb^ja/J)F1)	increased erythrocyte osmotic fragility	J:44313
Sptb^ja/Sptb^ja (129/Sv-Sptb^ja)	abnormal reticulocyte morphology	J:7501
	anisocytosis	J:305
	enlarged spleen	J:305
	hemolytic anemia	J:305
	poikilocytosis	J:305
	reticulocytosis	J:305
Sptb^ja/Sptb^ja (involves: 129/Sv * C57BL/6J * WB/Re)	increased erythrocyte protoporphyrin level	J:5985
Sptb^ja/Sptb^ja ((WB.129-Sptb^ja/J x B6.129-Sptb^ja/J)F1)	abnormal erythrocyte morphology	J:62355
	abnormal erythrocyte osmotic lysis	J:162532
	abnormal erythrocyte physiology	J:162532
	anisopoikilocytosis	J:162532
	decreased cellular hemoglobin content	J:44313
	decreased erythrocyte cell number	J:44313
	decreased hematocrit	J:162532, J:44313
	decreased hemoglobin content	J:162532, J:44313
	enlarged spleen	J:162532, J:44313
	extramedullary hematopoiesis	J:162532
	hemolysis	J:162532
	hemolytic anemia	J:162532
	increased erythrocyte clearance	J:162532
	increased nucleated erythrocyte cell number	J:162532
	increased spleen red pulp amount	J:44313
	low mean erythrocyte cell number	J:162532
	microcytosis	J:62355
	poikilocytosis	J:162532
	reticulocytosis	J:162532, J:44313
	schistocytosis	J:162532
Sptb^m1Jus/Sptb^m1Jus (involves: 129S6/SvEvTac * C57BL/6)	abnormal erythrocyte morphology	J:159750
	acanthocytosis	J:159750
	anemia	J:159750
	enlarged spleen	J:159750
	hemolysis	J:159750
	spherocytosis	J:159750
Sptbn2^{tm1b(EUCOMM)Hmgu}/Sptbn2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Sptbn2^{tm1b(EUCOMM)Hmgu}/H)	decreased hemoglobin content	J:211773
Sptlc2^tm1Yhir/Sptlc2^tm1Yhir Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ (involves: C57BL/6 * C57BL/6NTac)	abnormal spleen morphology	J:202954
	abnormal thymus morphology	J:202954
	decreased bone marrow cell number	J:202954
	decreased lymphocyte cell number	J:202954
	decreased spleen weight	J:202954
	decreased thymus weight	J:202954
	increased erythrocyte cell number	J:202954
	increased hematocrit	J:202954
	increased hemoglobin content	J:202954
	increased neutrophil cell number	J:202954
	reticulocytopenia	J:202954
Sptlc2^tm1Yhir/Sptlc2^tm1Yhir Tg(KRT5-cre)1Tak/0 (involves: C3H * C57BL/6)	abnormal dendritic epidermal T cell morphology	J:202388
	abnormal Langerhans cell morphology	J:202388
	increased dendritic cell number	J:202388
	increased gamma-delta T cell number	J:202388
	increased T-helper 17 cell number	J:202388
Spw1^SWR/J/Spw1^SWR/J Tg(CTSG-PML/RARA)135Ley/0 (involves: C3H/HeJ * C57BL/6J * SWR/J)	decreased spleen weight	J:139159
Spw2^SWR/J/? Tg(CTSG-PML/RARA)135Ley/0 (involves: C3H/HeJ * C57BL/6J * SWR/J)	decreased spleen weight	J:139159
Spw3^SWR/J/Spw3^SWR/J Tg(CTSG-PML/RARA)135Ley/0 (involves: C3H/HeJ * C57BL/6J * SWR/J)	increased spleen weight	J:139159
Spw4^SWR/J/Spw4^SWR/J Tg(CTSG-PML/RARA)135Ley/0 (involves: C3H/HeJ * C57BL/6J * SWR/J)	decreased spleen weight	J:139159
Spw5^SWR/J/Spw5^SWR/J Tg(CTSG-PML/RARA)135Ley/0 (involves: C3H/HeJ * C57BL/6J * SWR/J)	decreased spleen weight	J:139159
	increased spleen weight	J:139159
Spz1^em1(IMPC)Mbp/Spz1^em1(IMPC)Mbp (C57BL/6N-Spz1^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased neutrophil cell number	J:211773
	increased red blood cell distribution width	J:211773
Sqstm1^tm1.1Sral/Sqstm1⁺ (involves: 129/Sv * 129P2/OlaHsd * C57BL/6)	abnormal osteoclast differentiation	J:173755
	increased osteoclast cell number	J:173755
Sqstm1^tm1.1Sral/Sqstm1^tm1.1Sral (involves: 129/Sv * 129P2/OlaHsd * C57BL/6)	abnormal osteoclast differentiation	J:173755
	abnormal osteoclast morphology	J:173755
	increased osteoclast cell number	J:173755
Sqstm1^{tm1a(KOMP)Wtsi}/Sqstm1^{tm1a(KOMP)Wtsi} (B6JTyr;B6N-Sqstm1^{tm1a(KOMP)Wtsi}/Wtsi)	decreased mean corpuscular hemoglobin	J:175295
Sqstm1^tm1Jjw/Sqstm1^tm1Jjw (involves: 129 * C57BL/6)	abnormal osteoclast differentiation	J:141179
Sqstm1^tm1Jjw/Sqstm1^tm1Jjw (involves: 129 * C57BL/6)	abnormal osteoclast physiology	J:141179
Sqstm1^tm1Jmos/Sqstm1^tm1Jmos (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal osteoclast differentiation	J:90010
	decreased osteoclast cell number	J:90010
Sqstm1^tm1Keta/Sqstm1^tm1Keta (involves: 129 * C57BL/6N)	abnormal osteoclast differentiation	J:264183
Sqstm1^tm1Keta/Sqstm1^tm1Keta (involves: 129 * C57BL/6N)	abnormal osteoclast physiology	J:264183
Src^tm1Sor/Src^tm1Sor (either: 129S7/SvEvBrd-Src^tm1Sor or (involves: 129S7/SvEvBrd * C57BL/6J))	hematopoietic system phenotype	J:67040
Srcap^{em1(IMPC)Wtsi}/Srcap⁺ (C57BL/6N-Srcap^{em1(IMPC)Wtsi}/Wtsi)	thrombocytopenia	J:211773
Srd5a2^em1(IMPC)Mbp/Srd5a2^em1(IMPC)Mbp (C57BL/6N-Srd5a2^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	small spleen	J:211773
Srf^tm1Rmn/Srf^tm1Rmn H2az2^{Tg(Wnt1-cre)11Rth}/H2az2⁺ (involves: 129S6/SvEvTac * C57BL/6J * CBA/J)	athymia	J:144862
Srf^tm2Nor/Srf^tm2Nor Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd)	abnormal mature B cell morphology	J:124767
	absent marginal zone B cells	J:124767
	decreased B cell number	J:124767
	decreased B-1 B cell number	J:124767
Srf^tm2Nor/Srf^tm2Nor Tg(Cd4-cre)1Cwi/? (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	decreased CD4-positive, alpha-beta T cell number	J:124767
	decreased CD8-positive, alpha-beta T cell number	J:124767
	decreased T cell number	J:124767
	decreased thymocyte number	J:124767
Srgn^tm1Mabr/Srgn^tm1Mabr (involves: 129X1/SvJ)	abnormal mast cell morphology	J:93338
Srgn^tm1Mabr/Srgn^tm1Mabr (involves: 129X1/SvJ)	decreased mast cell number	J:93338
Srpk3^{tm1b(KOMP)Wtsi}/Y (C57BL/6N-Srpk3^{tm1b(KOMP)Wtsi}/Ucd)	increased monocyte cell number	J:211773
Srprb^{tm2b(EUCOMM)Hmgu}/Srprb⁺ (C57BL/6N-Srprb^{tm2b(EUCOMM)Hmgu}/Bay)	decreased mean corpuscular volume	J:211773
Srpx^tm1Hzi/Srpx^tm1Hzi (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal lymphocyte morphology	J:119999
	enlarged spleen	J:119999
Srr^Rgsc34/Srr⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	abnormal neutrophil physiology	J:133634
Srrt^tm1.1Thsn/Srrt^tm1.2Thsn Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	abnormal thymus physiology	J:152729
	decreased bone marrow cell number	J:152729
	increased splenocyte apoptosis	J:152729
Srsf2^tm1.1Oaw/Srsf2⁺ Tg(Mx1-cre)1Cgn/? (B6.Cg-Tg(Mx1-cre)1Cgn Srsf2^tm1.1Oaw)	abnormal erythroid progenitor cell morphology	J:221404
	abnormal erythropoiesis	J:221404
	abnormal hematopoietic stem cell physiology	J:221404
	abnormal hematopoietic system physiology	J:221404
	abnormal myelopoiesis	J:221404
	abnormal neutrophil morphology	J:221404
	decreased B cell number	J:221404
	failure of myelopoiesis	J:221404
	impaired hematopoiesis	J:221404
	increased hematopoietic stem cell number	J:221404
	macrocytic anemia	J:221404
Srsf2^tm1Xdfu/Srsf2⁺ Tg(Lck-cre)I57Jxm/? (involves: 129S4/SvJae * 129X1/SvJ * ICR)	decreased thymocyte number	J:88668
	decreased thymus weight	J:88668
Srsf2^tm1Xdfu/Srsf2^tm1Xdfu Tg(Lck-cre)I57Jxm/? (involves: 129S4/SvJae * 129X1/SvJ * ICR)	abnormal spleen white pulp morphology	J:88668
	abnormal T cell differentiation	J:88668
	absent thymus corticomedullary boundary	J:88668
	decreased double-positive T cell number	J:88668
	decreased T cell number	J:88668
	decreased thymocyte number	J:88668
	increased double-negative T cell number	J:88668
	small thymus	J:88668
Srsf2^tm1Xdfu/Srsf2^tm1Xdfu Tg(Mx1-cre)1Cgn/? (involves: 129S4/SvJae * C57BL/6J * CBA/J)	abnormal hematopoietic system physiology	J:221404
	bone marrow failure	J:221404
	impaired hematopoiesis	J:221404
Srsf3^tm1Pjln/Srsf3^tm1Pjln Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: 129P2/OlaHsd * BALB/c)	decreased B cell number	J:113645
	decreased pre-B cell number	J:113645
	decreased pro-B cell number	J:113645
Srsf3^tm1Pjln/Srsf3^tm1Pjln Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: BALB/c * C57BL/6 * DBA)	abnormal thymus development	J:205756
Srsf5^em1Nju/Srsf5^em1Nju (C57BL/6JGpt-Srsf5^em1Nju)	small spleen	J:311867
Srsf9^em1(IMPC)J/Srsf9⁺ (C57BL/6NJ-Srsf9^em1(IMPC)J/Mmjax)	thrombocytopenia	J:211773
Ss18l1^em1Zqi/Ss18l1⁺ (involves: C57BL/6)	increased microglial cell activation	J:278840
Ss18l1^em1Zqi/Ss18l1^em1Zqi (involves: C57BL/6)	increased microglial cell activation	J:278840
Ss18l1^em2Zqi/Ss18l1^em2Zqi (involves: C57BL/6)	increased microglial cell activation	J:278840
Ssb^tm1Rjma/Ssb^tm2.1Rjma Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: 129S/SvEv * BALB/c)	arrested B cell differentiation	J:207687
	decreased B cell number	J:207687
	decreased IgG level	J:207687
	decreased IgM level	J:207687
	decreased spleen weight	J:207687
	small spleen	J:207687
Ssbp2^tm1Lana/Ssbp2^tm1Lana (involves: 129S/SvEv * C57BL/6)	anemia	J:162035
	decreased lymphocyte cell number	J:162035
	increased pre-B cell number	J:162035
	pancytopenia	J:162035
Ssbp2^tm1Lana/Ssbp2^tm1Lana Trp53^tm1Tyj/Trp53^tm1Tyj (involves: 129S/SvEv * 129S2/SvPas * BALB/c * C57BL/6)	thymus hypoplasia	J:162035
Ssc5d^{em1(IMPC)Wtsi}/Ssc5d^{em1(IMPC)Wtsi} (C57BL/6N-Ssc5d^{em1(IMPC)Wtsi}/Wtsi)	increased mean platelet volume	J:211773
Ssh2^em1(IMPC)J/Ssh2^em1(IMPC)J (C57BL/6NJ-Ssh2^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Sspn^{tm1b(EUCOMM)Hmgu}/Sspn^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Sspn^{tm1b(EUCOMM)Hmgu}/Ieg)	increased hematocrit	J:211773
	increased leukocyte cell number	J:211773
Ssr1^em1(IMPC)Mbp/Ssr1⁺ (C57BL/6N-Ssr1^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Ssr2^{tm1b(EUCOMM)Wtsi}/Ssr2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Ssr2^{tm1b(EUCOMM)Wtsi}/Wtsi)	abnormal thymus morphology	J:239583
Sstr2^em1(IMPC)Mbp/Sstr2^em1(IMPC)Mbp (C57BL/6N-Sstr2^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	small spleen	J:211773
Sstr4^tm1Szo/Sstr4^tm1Szo (B6.129P2-Sstr4^tm1Szo)	abnormal granulocyte morphology	J:152015
Sstr4^tm1Szo/Sstr4^tm1Szo (B6.129P2-Sstr4^tm1Szo)	abnormal neutrophil physiology	J:152015
St3gal2^tm1Jxm/St3gal2^tm1Jxm (involves: C57BL/6)	hematopoietic system phenotype	J:80119
St3gal2^tm1Jxm/St3gal2^tm1Jxm (Not Specified)	decreased T cell proliferation	J:217719
	increased spleen germinal center size	J:217719
	increased T cell number	J:217719
St3gal3^tm1Jxm/St3gal3^tm1Jxm (involves: C57BL/6)	hematopoietic system phenotype	J:80119
St3gal4^tm1.1Jxm/St3gal4^tm1.1Jxm (B6.129-St3gal4^tm1.1Jxm)	abnormal leukocyte tethering or rolling	J:117085
	abnormal platelet physiology	J:136946
	thrombocytopenia	J:136946
St3gal4^tm1.1Jxm/St3gal4^tm1.1Jxm (involves: 129S1/Sv * 129X1/SvJ)	abnormal leukocyte migration	J:189086
	decreased lymphocyte cell number	J:189086
	hematopoietic system phenotype	J:189086
	increased mean platelet volume	J:189086
	thrombocytopenia	J:189086
St3gal4^tm1.1Jxm/St3gal4^tm1.1Jxm St3gal6^tm1.1Jxm/St3gal6^tm1.1Jxm (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal leukocyte migration	J:189086
	decreased lymphocyte cell number	J:189086
	hematopoietic system phenotype	J:189086
	impaired leukocyte tethering or rolling	J:189086
	impaired neutrophil recruitment	J:189086
	increased leukocyte cell number	J:189086
	increased mean platelet volume	J:189086
	increased neutrophil cell number	J:189086
	thrombocytopenia	J:189086
St3gal6^tm1.1Jxm/St3gal6^tm1.1Jxm (B6.Cg-St3gal6^tm1.1Jxm)	impaired leukocyte tethering or rolling	J:189086
St3gal6^tm1.1Jxm/St3gal6^tm1.1Jxm (B6.Cg-St3gal6^tm1.1Jxm)	impaired neutrophil recruitment	J:189086
St6gal1^tm1Jlau/St6gal1^tm1Jlau (129S4/SvJae-St6gal1^tm1Jlau)	abnormal neutrophil physiology	J:140702
St6gal1^tm1Jlau/St6gal1^tm1Jlau (B6.129S4-St6gal1^tm1Jlau)	abnormal myelopoiesis	J:140547
	abnormal neutrophil physiology	J:140547
	increased neutrophil cell number	J:140547
St6gal1^tm1Jxm/St6gal1^tm1Jxm (involves: 129S1/Sv * 129X1/SvJ)	decreased marginal zone B cell number	J:132991
	decreased transitional stage B cell number	J:132991
	increased neutrophil cell number	J:140547
St6galnac2^tm1.1Cfg/St6galnac2^tm1.1Cfg (involves: 129S1/Sv * 129X1/SvJ)	abnormal erythropoiesis	J:217719
	decreased IgA level	J:217719
	increased B cell proliferation	J:217719
	increased pre-B cell number	J:217719
	increased spleen germinal center size	J:217719
St7^em1(IMPC)J/St7^em1(IMPC)J (C57BL/6NJ-St7^em1(IMPC)J/Mmjax)	decreased mean corpuscular volume	J:211773
St8sia1^tm1Kfk/St8sia1^tm1Kfk (Not Specified)	decreased CD8-positive, alpha-beta T cell number	J:73818
St8sia1^tm1Kfk/St8sia1^tm1Kfk (Not Specified)	increased T cell proliferation	J:73818
St8sia6^em1(IMPC)Mbp/St8sia6^em1(IMPC)Mbp (C57BL/6N-St8sia6^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
St14^tm1Bug/St14^tm1Bug (involves: 129P2/OlaHsd * Black Swiss)	decreased double-positive T cell number	J:87125
	increased thymocyte apoptosis	J:87125
St14^tm2Bug/St14^tm3Bug Tg(MMTV-cre)4Mam/0 (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J * FVB/NJ * N:Black Swiss)	decreased CD4-positive, alpha-beta T cell number	J:213072
	decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:213072
	decreased CD8-positive, alpha-beta T cell number	J:213072
	decreased regulatory T cell number	J:213072
	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:213072
	increased effector memory CD4-positive, alpha-beta T cell number	J:213072
	increased effector memory CD8-positive, alpha-beta T cell number	J:213072
Stag1^em1(IMPC)Mbp/Stag1⁺ (C57BL/6N-Stag1^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	small spleen	J:211773
Stag1^{Gt(P099A04)Wrst}/Stag1^{Gt(P099A04)Wrst} (involves: 129S2/SvPas)	abnormal definitive hematopoiesis	J:184719
Stag2^tm1.1Soga/Y Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6J * C57BL/6N * CBA/J)	abnormal hematopoietic precursor cell morphology	J:289000
	abnormal hematopoietic stem cell physiology	J:289000
	abnormal hematopoietic system morphology/development	J:289000
	decreased B cell number	J:289000
	decreased common lymphocyte progenitor cell number	J:289000
	decreased erythroid progenitor cell number	J:289000
	decreased leukocyte cell number	J:289000
	decreased megakaryocyte-erythroid progenitor cell number	J:289000
	enlarged spleen	J:289000
	extramedullary hematopoiesis	J:289000
	increased common myeloid progenitor cell number	J:289000
	increased granulocyte monocyte progenitor cell number	J:289000
	increased granulocyte number	J:289000
	increased hematopoietic stem cell number	J:289000
	increased monocyte cell number	J:289000
	increased red blood cell distribution width	J:289000
Stam^tm2Sug/Stam^tm2Sug Stam2^tm1Sug/Stam2^tm1Sug Tg(Lck-cre)I57Jxm/0 (involves: 129S4/SvJae * C57BL/6 * ICR)	decreased T cell number	J:80617
	decreased T cell proliferation	J:80617
Stard7^{tm1a(EUCOMM)Wtsi}/Stard7⁺ (involves: C57BL/6N)	hematopoietic system phenotype	J:242746
Stard7^{tm1a(EUCOMM)Wtsi}/Stard7⁺ (involves: C57BL/6N)	increased CD11b-high dendritic cell number	J:242746
Stard10^{tm1b(KOMP)Wtsi}/Stard10^{tm1b(KOMP)Wtsi} (C57BL/6N-Stard10^{tm1b(KOMP)Wtsi}/H)	increased mean platelet volume	J:211773
Stard13^{tm1a(KOMP)Wtsi}/Stard13^{tm1a(KOMP)Wtsi} (B6JTyr;B6N-Stard13^{tm1a(KOMP)Wtsi}/Wtsi)	decreased hematocrit	J:175295
Stard13^{tm1a(KOMP)Wtsi}/Stard13^{tm1a(KOMP)Wtsi} (involves: C57BL/6 * C57BL/6N)	decreased hematocrit	J:213427
	decreased hemoglobin content	J:213427
Stat1^fae/Stat1^fae (C57BL/6JSfdAnu-Stat1^fae/Anu)	abnormal T cell activation	J:105311
	abnormal T-helper 2 physiology	J:105311
	increased IgG level	J:105311
Stat1^m1Btlr/Stat1^m1Btlr (C57BL/6J-Stat1^m1Btlr)	abnormal macrophage physiology	J:105543
Stat1^m2Btlr/Stat1^m2Btlr (C57BL/6J-Stat1^m2Btlr)	decreased NK cell degranulation	J:134096
Stat1^m2Btlr/Stat1^m2Btlr (C57BL/6J-Stat1^m2Btlr)	impaired natural killer cell mediated cytotoxicity	J:134096
Stat1^m3Btlr/Stat1^m3Btlr (C57BL/6J-Stat1^m3Btlr)	impaired natural killer cell mediated cytotoxicity	J:254835
Stat1^m4Btlr/Stat1^m4Btlr (C57BL/6J-Stat1^m4Btlr)	abnormal CD8-positive, naive alpha-beta T cell number	J:264800
	decreased B cell number	J:264800
	decreased B-1 B cell number	J:264800
	decreased CD8-positive, alpha-beta T cell number	J:264800
	decreased NK cell number	J:264800
	decreased single-positive T cell number	J:264800
	increased CD4-positive, alpha-beta T cell number	J:264800
	increased effector memory CD8-positive, alpha-beta T cell number	J:264800
	increased NK T cell number	J:264800
Stat1^m5Btlr/Stat1^m5Btlr (C57BL/6J-Stat1^m5Btlr)	abnormal CD4-positive T cell differentiation	J:274938
	abnormal CD8-positive, alpha-beta T cell differentiation	J:274938
	abnormal T cell differentiation	J:274938
	decreased CD8-positive, naive alpha-beta T cell number	J:274938
	decreased cytotoxic T cell cytolysis	J:274938
	increased CD4-positive, alpha-beta T cell number	J:274938
	increased effector memory CD4-positive, alpha-beta T cell number	J:274938
	increased effector memory CD8-positive, alpha-beta T cell number	J:274938
	increased T cell number	J:274938
Stat1^tm1Dlv/Stat1^tm1Dlv (either: (involves: 129S/SvEv * C57BL/6) or (involves: 129S/SvEv * C57BL/6 * CD-1))	abnormal leukocyte physiology	J:31325
Stat1^tm1Dlv/Stat1^tm1Dlv (involves: 129S/SvEv)	abnormal MHC II cell surface expression on macrophages	J:130622
Stat1^tm1Dlv/Stat1^tm1Dlv (B6.129S-Stat1^tm1Dlv)	abnormal NK cell physiology	J:79552
Stat1^tm1Dlv/Stat1^tm1Dlv (B6.129S-Stat1^tm1Dlv)	impaired natural killer cell mediated cytotoxicity	J:79552
Stat1^tm1Rds/Stat1^tm1Rds (involves: 129)	abnormal common myeloid progenitor cell morphology	J:109408
Stat1^tm1Rds/Stat1^tm1Rds (129S6/SvEv-Stat1^tm1Rds/Tac)	abnormal macrophage physiology	J:136368
	abnormal osteoclast differentiation	J:131353
	increased NK T cell number	J:122801
Stat1^tm1Rds/Stat1^tm1Rds (B6.129-Stat1^tm1Rds)	increased osteoclast cell number	J:84894
Stat1^tm1Rds/Stat1^tm1Rds Stat3^tm2Aki/Stat3^tm2Aki Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129/Sv * 129P2/OlaHsd * C57BL/6)	increased CD4-positive, alpha-beta T cell number	J:83280
Stat1^tm1Tdec/Stat1^tm1Tdec (involves: 129P2/OlaHsd * BALB/c)	abnormal macrophage physiology	J:130622
	abnormal MHC II cell surface expression on macrophages	J:130622
Stat1^tm1Uvin/Stat1^tm1Uvin (involves: 129 * C57BL/6)	increased macrophage nitric oxide production	J:174863
Stat1^{tm2b(EUCOMM)Wtsi}/Stat1^{tm2b(EUCOMM)Wtsi} (C57BL/6N-Stat1^{tm2b(EUCOMM)Wtsi}/Orl)	decreased lymphocyte cell number	J:211773
	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
	increased large unstained cell number	J:211773
	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Stat2^m1Btlr/Stat2^m1Btlr (C57BL/6J-Stat2^m1Btlr)	decreased CD8-positive, alpha-beta T cell number	J:265265
	decreased central memory CD8 positive, alpha-beta T cell number	J:265265
	decreased single-positive T cell number	J:265265
Stat2^p117/Stat2^p117 (C57BL/6J-Stat2^P117)	decreased dendritic cell number	J:164049
Stat2^p117/Stat2^p117 (C57BL/6J-Stat2^P117)	decreased plasmacytoid dendritic cell number	J:164049
Stat2^tm1Shnd/Stat2^tm1Shnd (involves: 129S1/Sv * 129X1/SvJ)	abnormal T cell differentiation	J:66564
Stat3^tm1Dlv/Stat3^tm1Dlv Tg(Cd4-cre)1Cwi/? (involves: 129 * C57BL/6 * DBA/2)	abnormal CD4-positive T cell differentiation	J:124293
Stat3^tm1Dlv/Stat3^tm1Dlv Tg(Csf1r-icre)1Jwp/0 (involves: 129P2/OlaHsd * C57BL/6 * FVB)	increased granulocyte number	J:156593
	increased macrophage cell number	J:156593
	increased T cell number	J:156593
Stat3^tm1Dlv/Stat3^tm1Dlv Tg(MMTV-cre)4Mam/0 (involves: 129P2/OlaHsd * C57BL/6J * FVB)	decreased T-helper 17 cell number	J:120176
Stat3^tm1Dnl/Stat3^tm1Dlv (involves: C57BL/6)	decreased thymocyte number	J:87599
Stat3^tm1Dnl/Stat3^tm1Dlv (involves: C57BL/6)	increased thymocyte apoptosis	J:87599
Stat3^tm1Flv/Stat3^tm1Flv Tg(Tek-cre)12Flv/0 (involves: 129 * C3H * C57BL/6)	abnormal T-helper 1 physiology	J:81973
	increased leukocyte cell number	J:81973
Stat3^tm1Vpo/Stat3^tm1Vpo Tg(Mx1-cre)1Cgn/0 (involves: 129P2/OlaHsd * BALB/cAn * C57BL/6 * CBA)	abnormal macrophage physiology	J:89194
Stat3^tm1Vpo/Stat3^tm2Vpo Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA * BALB/cAn)	abnormal macrophage physiology	J:89194
Stat3^tm1Xyfu/Stat3^tm1.1Xyfu Tg(Ttr-cre)10-3Xyfu/? (involves: 129S1/Sv * C57BL/6)	increased monocyte cell number	J:128719
	increased neutrophil cell number	J:128719
Stat3^tm2Aki/Stat3^tm2Aki Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6)	increased CD4-positive, alpha-beta T cell number	J:83280
	increased dendritic cell number	J:83280
	increased macrophage cell number	J:83280
Stat3^tm2Aki/Stat3^tm2Aki Tg(Lck-cre)1Jtak/0 (involves: 129P2/OlaHsd)	decreased T cell proliferation	J:50443
	increased T cell apoptosis	J:50443
Stat3^tm3Vpo/Stat3^tm3Vpo (involves: C57BL/6 * CBA * BALB/cAn)	abnormal macrophage physiology	J:89194
Stat4^tm1Gru/Stat4^tm1Gru (involves: 129S2/SvPas * BALB/c)	abnormal lymphocyte physiology	J:34059
	abnormal NK cell physiology	J:34059
	abnormal T cell proliferation	J:34059
	abnormal T-helper 1 physiology	J:34059
	abnormal T-helper 2 physiology	J:34059
Stat4^tm1Gru/Stat4^tm1Gru (C.129S2-Stat4^tm1Gru)	abnormal CD4-positive T cell differentiation	J:143729
Stat4^tm1Gru/Stat4^tm1Gru Tg(Ins2-NP)25-3Olds/0 (involves: 129S2/SvPas * BALB/c * C57BL/6)	abnormal cytotoxic T cell physiology	J:107047
Stat4^tm1Jni/Stat4^tm1Jni (involves: 129P2/OlaHsd * C57BL/6)	abnormal NK cell physiology	J:79552
Stat5a^tm1.1Wjl/Stat5a^tm1.1Wjl Stat5b^tm2.1Wjl/Stat5b^tm2.1Wjl (involves: 129S6/SvEvTac * C57BL/6J * FVB/N)	abnormal leukocyte morphology	J:187325
	abnormal regulatory T cell physiology	J:187325
	abnormal T cell subpopulation ratio	J:187325
	decreased CD8-positive, alpha-beta T cell number	J:187325
	decreased erythrocyte cell number	J:187325
	decreased hematocrit	J:187325
	decreased hemoglobin content	J:187325
	decreased NK cell number	J:187325
	decreased T cell proliferation	J:187325
	increased T cell apoptosis	J:187325
Stat5a^tm1Jni/Stat5a^tm1Jni Stat5b^tm2Jni/Stat5b^tm2Jni (either: (involves: 129P2/OlaHsd) or (involves: 129X1/SvJ))	abnormal myelopoiesis	J:77412
	decreased leukocyte cell number	J:77412
	decreased T cell number	J:77412
	increased neutrophil cell number	J:77412
Stat5a^tm1Jni/Stat5a^tm1Jni Stat5b^tm2Jni/Stat5b^tm2Jni (involves: 129 * C57BL/6)	abnormal mast cell differentiation	J:84889
	abnormal mast cell physiology	J:84889
	absent mast cells	J:84889
	decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:122463
Stat5a^tm1Mam/Stat5a^tm1Mam (C.129S6-Stat5a^tm1Mam)	abnormal mast cell differentiation	J:101855
	abnormal mast cell morphology	J:101855
	decreased mast cell number	J:101855
Stat5a^tm1Mam/Stat5a^tm1Mam (involves: 129S6/SvEvTac * C57BL/6)	decreased NK cell number	J:112035
	decreased splenocyte number	J:112035
	impaired natural killer cell mediated cytotoxicity	J:112035
Stat5a^tm2Mam/Stat5a^tm2Mam Stat5b^tm1Mam/Stat5b⁺ (involves: 129S6/SvEvTac)	abnormal lymphopoiesis	J:258967
Stat5a^tm2Mam/Stat5a^tm2Mam Stat5b^tm1Mam/Stat5b^tm1Mam Tg(Lck-cre)I57Jxm/0 (involves: 129 * 129S6/SvEvTac * C57BL/6 * ICR)	abnormal T cell subpopulation ratio	J:122463
	decreased CD8-positive, alpha-beta T cell number	J:122463
	enlarged spleen	J:122463
Stat5a^tm2Mam/Stat5a^tm2Mam Stat5b^tm1Mam/Stat5b^tm1Mam Tg(Mx1-cre)1Cgn/0 (involves: 129S6/SvEvTac * C57BL/6 * CBA)	abnormal leukopoiesis	J:155489
	abnormal neutrophil differentiation	J:155489
	abnormal neutrophil physiology	J:155489
	anemia	J:155489
	decreased erythrocyte cell number	J:155489
	decreased hematocrit	J:155489
	decreased hemoglobin content	J:155489
	decreased leukocyte cell number	J:155489
	decreased lymphocyte cell number	J:155489
	decreased monocyte cell number	J:155489
	decreased neutrophil cell number	J:155489
Stat5a^tm2Mam/Stat5a^tm2Mam Stat5b^tm1Mam/Stat5b^tm1Mam Tg(Tek-cre)1Ywa/0 (involves: 129S6/SvEvTac * C57BL/6 * SJL)	abnormal proerythroblast morphology	J:138904
	anisocytosis	J:138904
	decreased erythrocyte cell number	J:138904
	decreased erythroid progenitor cell number	J:138904
	decreased hematocrit	J:138904
	decreased mean corpuscular hemoglobin	J:138904
	hypochromic microcytic anemia	J:138904
	increased red blood cell distribution width	J:138904
	microcytosis	J:138904
	poikilocytosis	J:138904
	reticulocytosis	J:138904
Stat5b^tm1Hwd/Stat5b^tm1Hwd (involves: C57BL/6)	abnormal double-negative T cell morphology	J:112035
	abnormal lymphocyte cell number	J:112035
	abnormal lymphocyte morphology	J:112035
	decreased CD8-positive, alpha-beta T cell number	J:112035
	decreased NK cell number	J:112035
	decreased splenocyte number	J:112035
	decreased T cell proliferation	J:112035
	decreased thymocyte number	J:112035
	impaired natural killer cell mediated cytotoxicity	J:112035
Stat5b^tm1Mam/Stat5b^tm1Mam Tg(Lck-cre)I57Jxm/0 (involves: 129 * 129S6/SvEvTac * C57BL/6 * ICR)	abnormal T cell subpopulation ratio	J:122463
	decreased CD8-positive, alpha-beta T cell number	J:122463
	enlarged spleen	J:122463
Stat5b^tm1Mam/Stat5b^tm1Mam Tg(Mx1-cre)1Cgn/0 (involves: 129S6/SvEvTac * C57BL/6 * CBA)	abnormal leukopoiesis	J:155489
	abnormal neutrophil differentiation	J:155489
	abnormal neutrophil physiology	J:155489
	anemia	J:155489
	decreased erythrocyte cell number	J:155489
	decreased hematocrit	J:155489
	decreased hemoglobin content	J:155489
	decreased leukocyte cell number	J:155489
	decreased lymphocyte cell number	J:155489
	decreased monocyte cell number	J:155489
	decreased neutrophil cell number	J:155489
Stat5b^tm1Mam/Stat5b^tm1Mam Tg(Tek-cre)1Ywa/0 (involves: 129S6/SvEvTac * C57BL/6 * SJL)	abnormal proerythroblast morphology	J:138904
	anisocytosis	J:138904
	decreased erythrocyte cell number	J:138904
	decreased erythroid progenitor cell number	J:138904
	decreased hematocrit	J:138904
	decreased mean corpuscular hemoglobin	J:138904
	hypochromic microcytic anemia	J:138904
	increased red blood cell distribution width	J:138904
	microcytosis	J:138904
	poikilocytosis	J:138904
	reticulocytosis	J:138904
Stat6^tm1Aki/Stat6^tm1Aki (involves: 129P2/OlaHsd)	abnormal T-helper 2 physiology	J:32561
	decreased B cell proliferation	J:32561
	decreased IgE level	J:32561
	decreased IgG1 level	J:32561
	decreased T cell proliferation	J:32561
	decreased T-helper 2 cell number	J:172134
	increased IgA level	J:32561
	increased IgG level	J:32561
Stat6^tm1Aki/Stat6^tm1Aki Tg(KRT14-CASP1)1Miz/0 (involves: 129P2/OlaHsd * C57BL/6)	decreased IgE level	J:78602
	decreased IgG1 level	J:78602
Stat6^tm1Gru/Stat6^tm1Gru (C.129S2-Stat6^tm1Gru/J)	abnormal CD4-positive T cell differentiation	J:204829
	abnormal CD8-positive, alpha beta T cell morphology	J:125259
	decreased IgA level	J:107370
	decreased IgG3 level	J:107370
	decreased IgM level	J:107370
Stat6^tm1Gru/Stat6^tm1Gru (129S2/SvPas-Stat6^tm1Gru)	abnormal T-helper 2 cell differentiation	J:31932
	decreased IgE level	J:31932
	decreased T cell proliferation	J:31932
Stat6^tm1Gru/Stat6^tm1Gru (involves: 129S2/SvPas * BALB/c)	abnormal granulocyte physiology	J:85386
	abnormal macrophage physiology	J:85386
	impaired eosinophil chemotaxis	J:85386
	impaired neutrophil chemotaxis	J:85386
Stat6^tm1Gru/Stat6^tm1Gru (C.129S2-Stat6^tm1Gru)	abnormal cytotoxic T cell physiology	J:65894
	abnormal immunoglobulin level	J:66222
	abnormal leukocyte migration	J:74497
	abnormal leukocyte physiology	J:74497
	decreased IgE level	J:74497, J:66222
	decreased IgG1 level	J:66222
	impaired eosinophil recruitment	J:66222
	increased IgG2a level	J:66222
Stat6^tm1Jni/Stat6^tm1Jni (involves: 129S/SvEv)	abnormal B cell physiology	J:32607
	abnormal B cell proliferation	J:32607
	abnormal class switch recombination	J:32607
	abnormal T-helper 1 cell differentiation	J:32607
	abnormal T-helper 2 cell differentiation	J:32607
	increased B cell apoptosis	J:146533
Stat6^tm1Jni/Stat6^tm1Jni (involves: 129S/SvEv * C57BL/6)	abnormal mast cell morphology	J:110429
	abnormal T-helper 1 cell differentiation	J:51096
	decreased IgE level	J:51096
	decreased IgG1 level	J:51096
	increased IgE level	J:110429
	increased IgG1 level	J:110429
	increased IgG2a level	J:51096
Stau2^em1(IMPC)Mbp/Stau2^em1(IMPC)Mbp (C57BL/6N-Stau2^em1(IMPC)Mbp/MbpMmucd)	increased hematocrit	J:211773
	increased hemoglobin content	J:211773
	increased monocyte cell number	J:211773
Steap3^fred/Steap3^fred (C57BL/6-Steap3^fred)	abnormal erythrocyte physiology	J:145194
	anisopoikilocytosis	J:145194
	decreased hemoglobin content	J:145194
	enlarged spleen	J:145194
	hematopoietic system phenotype	J:145194
	hypochromic microcytic anemia	J:145194
	leptocytosis	J:145194
	polychromatophilia	J:145194
	reticulocytosis	J:145194
Steap3^tm1.1Atel/Steap3^tm1.1Atel (involves: C57BL/6)	abnormal erythropoiesis	J:154356
	abnormal reticulocyte morphology	J:154356
	abnormal spleen morphology	J:154356
	abnormal spleen red pulp morphology	J:154356
	anisopoikilocytosis	J:154356
	decreased mean corpuscular hemoglobin	J:154356
	decreased mean corpuscular volume	J:154356
	decreased splenocyte apoptosis	J:154356
	extramedullary hematopoiesis	J:154356
	increased erythrocyte cell number	J:154356
	increased erythroid progenitor cell number	J:154356
	increased spleen weight	J:154356
	increased spleen white pulp amount	J:154356
	microcytic anemia	J:154356
	thrombocytosis	J:154356
Steap3^tm1.1Mdf/Steap3^tm1.1Mdf (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6J * CBA/J)	abnormal erythrocyte morphology	J:103440
	abnormal reticulocyte morphology	J:103440
	anisopoikilocytosis	J:103440
	decreased hematocrit	J:103440
	decreased hemoglobin content	J:103440
	decreased mean corpuscular hemoglobin	J:103440
	decreased mean corpuscular hemoglobin concentration	J:103440
	decreased mean corpuscular volume	J:103440
	increased erythrocyte cell number	J:103440
	reticulocytosis	J:103440
	thrombocytosis	J:103440
Steap4^tm1Dgen/Steap4^tm1Dgen (involves: 129P2/OlaHsd)	increased macrophage cell number	J:187736
Stim1^em1(IMPC)Mbp/Stim1⁺ (C57BL/6N-Stim1^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Stim1^{Gt(RRS558)Byg}/Stim1^{Gt(RRS558)Byg} (involves: 129P2/OlaHsd * C57BL/6)	abnormal platelet activation	J:137364
	decreased platelet aggregation	J:137364
	hematopoietic system phenotype	J:137364
Stim1^Sax/Stim1⁺ (involves: C3HeB/FeJ * C57BL/6)	abnormal platelet activation	J:127381
	abnormal thrombopoiesis	J:127381
	enlarged spleen	J:127381
	increased megakaryocyte cell number	J:127381
	increased spleen red pulp amount	J:127381
	thrombocytopenia	J:127381
Stim1^tm1.1Kuro/Stim1^tm1.1Kuro (C57BL/6-Stim1^tm1.1Kuro)	decreased mast cell degranulation	J:130477
Stim1^tm1.1Pg/Stim1⁺ (involves: C57BL/6)	decreased Ly6C low monocyte number	J:285187
	decreased NK cell number	J:285187
	enlarged spleen	J:285187
	increased Ly6C high monocyte number	J:285187
	thrombocytopenia	J:285187
Stim1^tm1Kuro/Stim1^tm1Kuro Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: BALB/c * C57BL/6)	abnormal B cell physiology	J:172608
	decreased B cell proliferation	J:172608
Stim1^tm1Kuro/Stim1^tm1Kuro Stim2^tm1.1Kuro/Stim2^tm1.1Kuro Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: BALB/c * C57BL/6)	abnormal B cell physiology	J:172608
	decreased B cell proliferation	J:172608
	increased CD4-positive, alpha-beta T cell number	J:172608
	increased CD8-positive, alpha-beta T cell number	J:172608
	increased regulatory T cell number	J:172608
Stim1^tm1Rao/Stim1^tm1Rao Stim2^tm1Rao/Stim2^tm1Rao Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2 * SJL)	abnormal B cell differentiation	J:133262
	abnormal CD4-positive, alpha-beta T cell physiology	J:133262
	abnormal granulocyte morphology	J:133262
	abnormal T cell differentiation	J:133262
	decreased regulatory T cell number	J:133262
	decreased T cell proliferation	J:133262
	enlarged spleen	J:133262
	increased germinal center B cell number	J:133262
	increased IgG1 level	J:133262
	increased lymphocyte cell number	J:133262
	increased spleen germinal center number	J:133262
Stim1^tm1Rao/Stim1^tm1Rao Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2 * SJL)	abnormal CD4-positive, alpha-beta T cell physiology	J:133262
	increased lymphocyte cell number	J:133262
Stim2^tm1.1Kuro/Stim2^tm1.1Kuro Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: BALB/c * C57BL/6)	abnormal B cell physiology	J:172608
Stim2^tm1Rao/Stim2^tm1Rao Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2 * SJL)	abnormal CD4-positive, alpha-beta T cell physiology	J:133262
	abnormal T-helper 1 physiology	J:133262
	abnormal T-helper 2 physiology	J:133262
Sting1^em1Jmin/Sting1⁺ (involves: C57BL/6N)	abnormal spleen morphology	J:251372
	decreased single-positive T cell number	J:251372
	enlarged spleen	J:251372
	increased IgM level	J:251372
	increased myeloid cell number	J:251372
Sting1^gt/Sting1^gt (C57BL/6-Sting1^gt)	abnormal macrophage physiology	J:201167
Sting1^gt/Sting1^gt (involves: C57BL/6)	hematopoietic system phenotype	J:265023
Stk3^tm1.1Yy/Stk3^tm1Yy Stk4^tm1.1Yy/Stk4^tm1.1Yy Tg(CAG-cre/Esr1)5Amc/0 (involves: C57BL/6 CBA)	enlarged spleen	J:156541
Stk3^tm1Dlim/Stk3^tm1Dlim Stk4^tm1Dlim/Stk4^tm1Dlim (Not Specified)	abnormal embryonic hematopoiesis	J:155001
Stk4^{Gt(AJ0315)Wtsi}/Stk4^{Gt(AJ0315)Wtsi} (B6.129P2-Stk4^{Gt(AJ0315)Wtsi})	abnormal memory T cell number	J:142674
	abnormal T cell differentiation	J:142674
	decreased CD4-positive, alpha-beta T cell number	J:142674
	decreased CD8-positive, alpha-beta T cell number	J:142674
	decreased spleen white pulp amount	J:142674
	increased T cell apoptosis	J:142674
	increased T cell proliferation	J:142674
Stk4^m1Btlr/Stk4^m1Btlr (C57BL/6J-Stk4^m1Btlr)	decreased B cell number	J:265233
	decreased CD4-positive, alpha-beta T cell number	J:265233
	decreased CD8-positive, alpha-beta T cell number	J:265233
	decreased IgD level	J:265233
	decreased single-positive T cell number	J:265233
	decreased T cell number	J:265233
	increased IgE level	J:265233
	increased IgM level	J:265233
	increased macrophage cell number	J:265233
	increased neutrophil cell number	J:265233
	increased NK cell number	J:265233
Stk4^m2Btlr/Stk4^m2Btlr (C57BL/6J-Stk4^m2Btlr)	decreased B-1 B cell number	J:265237
	decreased B-2 B cell number	J:265237
	decreased CD4-positive, alpha-beta T cell number	J:265237
	decreased CD8-positive, alpha-beta T cell number	J:265237
	decreased CD8-positive, naive alpha-beta T cell number	J:265237
	decreased IgD level	J:265237
	decreased single-positive T cell number	J:265237
	decreased T cell number	J:265237
	increased B-1b cell number	J:265237
	increased central memory CD4-positive, alpha-beta T cell number	J:265237
	increased central memory CD8 positive, alpha-beta T cell number	J:265237
	increased dendritic cell number	J:265237
	increased effector memory CD4-positive, alpha-beta T cell number	J:265237
	increased effector memory CD8-positive, alpha-beta T cell number	J:265237
	increased IgE level	J:265237
	increased macrophage cell number	J:265237
	increased neutrophil cell number	J:265237
	increased NK cell number	J:265237
Stk4^m3Btlr/Stk4^m3Btlr (C57BL/6J-Stk4^m3Btlr)	decreased CD4-positive, alpha-beta T cell number	J:265245
	decreased CD8-positive, alpha-beta T cell number	J:265245
	decreased single-positive T cell number	J:265245
	decreased T cell number	J:265245
Stk4^m4Btlr/Stk4^m4Btlr (C57BL/6J-Stk4^m4Btlr)	decreased CD11b-high dendritic cell number	J:272536
	decreased IgD level	J:272536
	decreased IgG level	J:272536
	increased B-1b cell number	J:272536
	increased dendritic cell number	J:272536
Stk4^m5Btlr/Stk4^m5Btlr (C57BL/6J-Stk4^m5Btlr)	abnormal CD4-positive T cell differentiation	J:272743
	abnormal T cell differentiation	J:272743
	decreased CD4-positive, alpha-beta T cell number	J:272743
	increased central memory CD4-positive, alpha-beta T cell number	J:272743
Stk4^tm1.1Kina/Stk4^tm1.1Kina (involves: C57BL/6)	abnormal B cell physiology	J:148791
	abnormal leukocyte adhesion	J:148791
	abnormal leukocyte migration	J:148791
	abnormal marginal zone B cell morphology	J:148791
	abnormal spleen B cell follicle morphology	J:148791
	abnormal T cell physiology	J:148791
	decreased B cell number	J:148791
	decreased lymphocyte cell number	J:148791
	decreased marginal zone B cell number	J:148791
	decreased myeloid dendritic cell number	J:148791
	decreased spleen B cell follicle size	J:148791
	decreased T cell number	J:148791
	increased single-positive T cell number	J:148791
	increased T cell proliferation	J:148791
	thymus hyperplasia	J:148791
Stk4^tm1.1Wtao/Stk4^tm1.2Wtao Tg(Lck-cre)#Zhu/0 (involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * SJL/J)	decreased CD4-positive, alpha-beta T cell number	J:152323
	decreased CD8-positive, alpha-beta T cell number	J:152323
	decreased T cell number	J:152323
	increased single-positive T cell number	J:152323
	increased thymocyte number	J:152323
Stk4^tm1.2Wtao/Stk4^tm1.2Wtao (involves: 129S4/SvJaeSor * 129S6/SvEvTac)	abnormal CD4-positive, alpha-beta T cell physiology	J:152323
	abnormal CD8-positive, alpha-beta T cell physiology	J:152323
	abnormal T cell physiology	J:152323
	decreased B cell number	J:152323
	decreased CD4-positive, alpha-beta T cell number	J:152323
	decreased CD8-positive, alpha-beta T cell number	J:152323
	decreased lymphocyte cell number	J:152323
	increased single-positive T cell number	J:152323
	increased thymocyte number	J:152323
Stk4^tm1Dlim/Stk4^tm1Dlim (Not Specified)	abnormal T cell physiology	J:155001
Stk4^tm1Dlim/Stk4^tm1Dlim (Not Specified)	decreased T cell number	J:155001
Stk10^tm1Hkar/Stk10^tm1Hkar (involves: 129S1/Sv)	abnormal T cell physiology	J:60738
Stk11^tm1.1Mlfr/Stk11⁺ (involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6J)	enlarged spleen	J:104347
Stk11^tm1.1Sjm/Stk11^tm1.1Sjm Ndor1^{Tg(UBC-cre/ERT2)1Ejb}/0 (involves: 129S/SvEv * C57BL/6 * SJL)	abnormal bone marrow cell physiology	J:165090
Stk11^tm1.1Sjm/Stk11^tm1.1Sjm Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA * SJL)	abnormal bone marrow cell morphology/development	J:165090
	abnormal bone marrow cell physiology	J:165090
	decreased bone marrow cell number	J:165090
	decreased erythrocyte cell number	J:165090
	decreased hematopoietic stem cell number	J:165090
	decreased leukocyte cell number	J:165090
	increased hematopoietic stem cell number	J:165090
	pancytopenia	J:165090
	thrombocytopenia	J:165090
	thymus hypoplasia	J:165090
Stk16^{tm1.1(KOMP)Vlcg}/Stk16^{tm1.1(KOMP)Vlcg} (C57BL/6N-Stk16^{tm1.1(KOMP)Vlcg}/J)	increased hemoglobin content	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
Stk17b^tm1Hed/Stk17b^tm1Hed (involves: 129X1/SvJ * C57BL/6)	increased T cell proliferation	J:94685
Stk17b^tm1Hed/Stk17b^tm1Hed (B6.129X1-Stk17b^tm1Hed)	decreased double-positive T cell number	J:94685
	increased CD4-positive, alpha-beta T cell number	J:94685
	increased memory T cell number	J:94685
	increased T cell proliferation	J:94685
Stk24^{Gt(AM0826)Wtsi}/Stk24^{Gt(AM0826)Wtsi} (B6.129P2-Stk24^{Gt(AM0826)Wtsi})	abnormal neutrophil morphology	J:256076
	abnormal neutrophil physiology	J:256076
	hematopoietic system phenotype	J:256076
Stk26^{tm1b(EUCOMM)Hmgu}/Y (C57BL/6N-Stk26^{tm1b(EUCOMM)Hmgu}/Ccpcz)	decreased mean platelet volume	J:211773
	increased NK T cell number	J:211773
Stk26^{tm1b(EUCOMM)Hmgu}/Stk26^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Stk26^{tm1b(EUCOMM)Hmgu}/Ccpcz)	decreased mean platelet volume	J:211773
	decreased monocyte cell number	J:211773
Stk33^em1(IMPC)J/Stk33^em1(IMPC)J (C57BL/6NJ-Stk33^em1(IMPC)J/Mmjax)	thrombocytopenia	J:211773
Stk35^em1(IMPC)J/Stk35^em1(IMPC)J (C57BL/6N-Stk35^em1(IMPC)J/J)	decreased mean corpuscular hemoglobin	J:211773
Stk36^tm1Fjs/Stk36^tm1Fjs (involves: 129S1/Sv * C57BL/6)	spleen atrophy	J:116391
Stk36^tm1Fjs/Stk36^tm1Fjs (involves: 129S1/Sv * C57BL/6)	thymus atrophy	J:116391
Stk38^{tm1b(KOMP)Wtsi}/Stk38⁺ (C57BL/6N-Stk38^{tm1b(KOMP)Wtsi}/J)	increased leukocyte cell number	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
Stk38^tm1Hem/Stk38^tm1Hem (involves: 129P2/Ola * C57BL/6)	abnormal T cell physiology	J:185408
Stk38^tm1Hem/Stk38^tm1Hem (involves: 129P2/Ola * C57BL/6)	decreased thymocyte apoptosis	J:185408
Stk39^tm1Pawe/Stk39^tm1Pawe (involves: 129S6/SvEvTac * C57BL/6J)	increased hematocrit	J:287773
Stk39^tm1Pawe/Stk39^tm1Pawe Pvalb^tm1(cre)Arbr/Pvalb⁺ (B6.129-Stk39^tm1Pawe Pvalb^tm1(cre)Arbr)	decreased hematocrit	J:287773
Stmn3^em1(IMPC)J/Stmn3^em1(IMPC)J (C57BL/6NJ-Stmn3^em1(IMPC)J/Mmjax)	decreased mean corpuscular hemoglobin	J:211773
Stom^tm1Wcm/Stom^tm1Wcm (involves: 129S1/Sv * 129X1/SvJ)	hematopoietic system phenotype	J:54046
Stoml1^em1(IMPC)Tcp/Stoml1^em1(IMPC)Tcp (C57BL/6N-Stoml1^em1(IMPC)Tcp/Tcp)	enlarged spleen	J:211773
Stox2^{tm2b(EUCOMM)Hmgu}/Stox2⁺ (C57BL/6N-Stox2^{tm2b(EUCOMM)Hmgu}/J)	decreased mean corpuscular hemoglobin	J:211773
Stra6l^{tm1b(KOMP)Wtsi}/Stra6l^{tm1b(KOMP)Wtsi} (C57BL/6N-Stra6l^{tm1b(KOMP)Wtsi}/Ucd)	decreased lymphocyte cell number	J:211773
	increased basophil cell number	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
	increased mean platelet volume	J:211773
	increased neutrophil cell number	J:211773
	increased red blood cell distribution width	J:211773
Stradb^{tm1b(KOMP)Wtsi}/Stradb^{tm1b(KOMP)Wtsi} (C57BL/6N-Stradb^{tm1b(KOMP)Wtsi}/Ics)	decreased mean corpuscular volume	J:211773
Strbp^{em1(IMPC)Hmgu}/Strbp^{em1(IMPC)Hmgu} (C57BL/6N-Strbp^{em1(IMPC)Hmgu}/Ieg)	increased mean corpuscular volume	J:211773
	increased mean platelet volume	J:211773
Strn4^{tm1b(EUCOMM)Hmgu}/Strn4⁺ (C57BL/6NCrl-Strn4^{tm1b(EUCOMM)Hmgu}/Ccpcz)	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular hemoglobin concentration	J:211773
Stt3b^em1(IMPC)J/Stt3b⁺ (C57BL/6NJ-Stt3b^em1(IMPC)J/Mmjax)	decreased mean corpuscular hemoglobin	J:211773
Stub1^tm1Cpat/Stub1^tm1Cpat (involves: 129S/SvEv * C57BL/6)	increased thymocyte apoptosis	J:86213
	thymus atrophy	J:86213
	thymus hypoplasia	J:86213
Stx2^{tm1b(EUCOMM)Wtsi}/Stx2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Stx2^{tm1b(EUCOMM)Wtsi}/J)	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular hemoglobin concentration	J:211773
	decreased mean corpuscular volume	J:211773
	increased erythrocyte cell number	J:211773
Stx2^tm1Dcru/Stx2^tm1Dcru (involves: 129X1/SvJ)	hematopoietic system phenotype	J:189176
Stx2^tm1Dcru/Stx2^tm1Dcru Stx4a^tm2Jpes/Stx4a^tm2Jpes Tg(Pf4-icre)Q3Rsko/0 (involves: 129X1/SvJ * C57BL/6)	hematopoietic system phenotype	J:189176
Stx3^{Gt(EUCE320f12)1.1Hmgu}/Stx3^{Gt(EUCE320f12)1.1Hmgu} Tg(Cma1-cre)ARoer/0 (B6.Cg-Stx3^{Gt(EUCE320f12)1.1Hmgu} Tg(Cma1-cre)ARoer)	abnormal mast cell degranulation	J:275367
	decreased mast cell degranulation	J:275367
Stx3^{Gt(EUCE320f12)1.2Hmgu}/Stx3⁺ (B6.129P2(Cg)-Stx3^{Gt(EUCE320f12)1.2Hmgu})	abnormal mast cell degranulation	J:275367
Stx4a^tm2Jpes/Stx4a^tm2Jpes Tg(Pf4-icre)Q3Rsko/0 (involves: C57BL/6)	hematopoietic system phenotype	J:189176
Stx5a^{tm1b(EUCOMM)Hmgu}/Stx5a⁺ (C57BL/6N-Stx5a^{tm1b(EUCOMM)Hmgu}/Ieg)	increased red blood cell distribution width	J:211773
Stx7^{em1(IMPC)Rbrc}/Stx7^{em1(IMPC)Rbrc} (C57BL/6NJcl-Stx7^{em1(IMPC)Rbrc}/Rbrc)	abnormal thymus morphology	J:211773
	decreased large unstained cell number	J:211773
	small thymus	J:211773
Stx8^{tm2a(EUCOMM)Wtsi}/Stx8^{tm2a(EUCOMM)Wtsi} (involves: C57BL/6N)	abnormal platelet dense granule physiology	J:218388
	abnormal platelet physiology	J:218388
	decreased platelet aggregation	J:218388
	hematopoietic system phenotype	J:218388
Stx11^em1(IMPC)Mbp/Stx11^em1(IMPC)Mbp (C57BL/6N-Stx11^em1(IMPC)Mbp/MbpMmucd)	increased lymphocyte cell number	J:211773
Stx11^tm1.2Ics/Stx11^tm1.2Ics (involves: C57BL/6NTac)	abnormal cytotoxic T cell physiology	J:193137
	decreased cytotoxic T cell cytolysis	J:193137
	decreased erythrocyte cell number	J:193137
	decreased leukocyte cell number	J:193137
	decreased neutrophil cell number	J:193137
	decreased NK cell degranulation	J:193137
	pancytopenia	J:193137
	thrombocytopenia	J:193137
Stx11^tm1Bupa/Stx11^tm1Bupa (B6.129-Stx11^tm1Bupa)	abnormal lymphocyte physiology	J:191103
	abnormal neutrophil physiology	J:191103
	impaired natural killer cell mediated cytotoxicity	J:191103
Stxbp1^{tm1b(EUCOMM)Hmgu}/Stxbp1⁺ (C57BL/6N-Stxbp1^{tm1b(EUCOMM)Hmgu}/J)	decreased hematocrit	J:211773
	increased mean corpuscular volume	J:211773
Stxbp2^tm1Bdic/Stxbp2⁺ (involves: 129S * C57BL/6)	decreased mast cell degranulation	J:188931
sty/sty (Not Specified)	small thymus	J:3675
Sucnr1^tm1Dgen/Sucnr1^tm1Dgen (B6.129P2-Sucnr1^tm1Dgen)	abnormal T cell activation	J:143337
Sucnr1^tm1Dgen/Sucnr1^tm1Dgen (B6.129P2-Sucnr1^tm1Dgen)	decreased T cell proliferation	J:143337
Suco^{Gt(KST050)Byg}/Suco^{Gt(KST050)Byg} (involves: 129P2/OlaHsd * C57BL/6 * CD-1)	abnormal osteoclast physiology	J:159823
	decreased osteoclast cell number	J:159823
Sugct^tm1.2Kald/Sugct^tm1.2Kald (B6.Cg-Sugct^tm1.2Kald)	increased macrophage cell number	J:293423
Sugp1^em1(IMPC)Mbp/Sugp1⁺ (C57BL/6NCrl-Sugp1^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Sult1a1^{em1(IMPC)Ccpcz}/Sult1a1^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Sult1a1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Sult1e1^tm1Song/Sult1e1^tm1Song (B6.129S6-Sult1e1^tm1Song)	abnormal platelet physiology	J:96050
Sumf1^{Gt(RST760)Byg}/Sumf1^{Gt(RST760)Byg} (involves: 129P2/OlaHsd * C57BL/6)	abnormal macrophage morphology	J:120146
	abnormal microglial cell morphology	J:120146
	increased macrophage cell number	J:120146
Sun1^{tm1b(EUCOMM)Wtsi}/Sun1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Sun1^{tm1b(EUCOMM)Wtsi}/Orl)	decreased lymphocyte cell number	J:211773
	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Sun2^{tm1b(EUCOMM)Hmgu}/Sun2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Sun2^{tm1b(EUCOMM)Hmgu}/Bay)	increased large unstained cell number	J:211773
Sun5^em1(IMPC)Mbp/Sun5^em1(IMPC)Mbp (C57BL/6N-Sun5^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	thrombocytopenia	J:211773
Supt4a^{tm1b(EUCOMM)Hmgu}/Supt4a⁺ (C57BL/6N-Supt4a^{tm1b(EUCOMM)Hmgu}/Tcp)	decreased mean corpuscular hemoglobin concentration	J:211773
Supv3l1^tm2.1Jkl/Supv3l1^tm2.2Jkl Tg(CAG-cre/Esr1)5Amc/0 (involves: 129P2/OlaHsd 129S4/SvJaeSor * C57BL/6 * FVB/N)	abnormal T cell differentiation	J:144991
	decreased CD4-positive, alpha-beta T cell number	J:144991
	decreased CD8-positive, alpha-beta T cell number	J:144991
	decreased double-negative T cell number	J:144991
	decreased double-positive T cell number	J:144991
	increased macrophage derived foam cell number	J:144991
	thymus atrophy	J:144991
	thymus hypoplasia	J:144991
Supv3l1^tm2Jkl/Supv3l1^tm2Jkl Tg(CAG-cre/Esr1)5Amc/0 (involves: 129P2/OlaHsd C57BL/6)	abnormal T cell differentiation	J:144991
	decreased CD4-positive, alpha-beta T cell number	J:144991
	decreased CD8-positive, alpha-beta T cell number	J:144991
	decreased double-negative T cell number	J:144991
	decreased double-positive T cell number	J:144991
	increased macrophage derived foam cell number	J:144991
	thymus atrophy	J:144991
	thymus hypoplasia	J:144991
Supv3l1^tm2Jkl/Supv3l1^tm2Jkl Tg(Mx1-cre)1Cgn/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	increased macrophage derived foam cell number	J:144991
	increased plasma cell number	J:144991
Susd1^em1(IMPC)H/Susd1^em1(IMPC)H (C57BL/6NTac-Susd1^em1(IMPC)H/H)	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
	increased red blood cell distribution width	J:211773
Susd4^tm1Lex/Susd4^tm1Lex (B6.129S5-Susd4^tm1Lex)	abnormal microglial cell morphology	J:306852
Susd4^tm1Lex/Susd4^tm1Lex (B6.129S5-Susd4^tm1Lex)	increased microglial cell activation	J:306852
Susd6^{tm1b(KOMP)Wtsi}/Susd6^{tm1b(KOMP)Wtsi} (C57BL/6N-Susd6^{tm1b(KOMP)Wtsi}/Bay)	decreased monocyte cell number	J:211773
	decreased neutrophil cell number	J:211773
	enlarged spleen	J:211773
	increased lymphocyte cell number	J:211773
	thrombocytopenia	J:211773
Suv39h1^tm1Jnw/Suv39h1^tm1Jnw (involves: 129)	abnormal T-helper 2 physiology	J:186702
Suz12^Plt8/Suz12⁺ (involves: 129 * C57BL/6)	increased leukocyte cell number	J:136262
	increased lymphocyte cell number	J:136262
	thrombocytosis	J:136262
Svep1^{tm1b(EUCOMM)Hmgu}/Svep1⁺ (C57BL/6N-Svep1^{tm1b(EUCOMM)Hmgu}/J)	increased erythrocyte cell number	J:211773
	increased hematocrit	J:211773
	increased hemoglobin content	J:211773
Svil^{Gt(RRF043)Byg}/Svil^{Gt(RRF043)Byg} (B6.129P2-Svil^{Gt(RRF043)Byg})	abnormal platelet morphology	J:198612
	abnormal platelet physiology	J:198612
	increased platelet aggregation	J:198612
Svop^em1(IMPC)H/Svop^em1(IMPC)H (C57BL/6N-Svop^em1(IMPC)H/H)	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
Swap70^tm1Jess/Swap70^tm1Jess (involves: 129T2/SvEms * 129X1/SvJ)	abnormal class switch recombination	J:71160
	decreased IgE level	J:71160
Swq6^C57BL/6J/Swq6^CAST/EiJ (involves: C57BL/6J * CAST/EiJ)	increased spleen weight	J:117545
Swq6^CAST/EiJ/Swq6^CAST/EiJ (involves: C57BL/6J * CAST/EiJ)	increased spleen weight	J:117545
Swqnd1^NMRI8/Fbn/? (involves: DBA/2OlaHsd * NMRI8/Fbn)	decreased spleen weight	J:122125
Swqnd2^NMRI8/Fbn/? (involves: DBA/2OlaHsd * NMRI8/Fbn)	decreased spleen weight	J:122125
Swrl1^SWR/Swrl1^SWR (involves: NZB * SWR)	increased IgG3 level	J:96263
Swt1^em1(IMPC)J/Swt1^em1(IMPC)J (C57BL/6NJ-Swt1^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Syk^m1Btlr/Syk^m1Btlr (involves: C57BL/6J)	decreased B cell number	J:199281
Syk^m1Btlr/Syk^m1Btlr (involves: C57BL/6J)	increased neutrophil cell number	J:199281
Syk^M2Btlr/Syk⁺ (C57BL/6J-Syk^M2Btlr)	abnormal NK cell differentiation	J:231803
Syk^M2Btlr/Syk^M2Btlr (C57BL/6J-Syk^M2Btlr)	abnormal NK cell differentiation	J:231803
Syk^{tm1.1(cre)Fkfr}/Syk^{tm1.1(cre)Fkfr} Gt(ROSA)26Sor^tm1(EYFP)Cos/Gt(ROSA)26Sor^tm1(EYFP)Cos (involves: 129S1/Sv * 129X1/SvJ)	decreased leukocyte cell number	J:159112
	increased leukocyte cell number	J:159112
Syk^tm1.1Nns/Syk^tm1.1Nns Tg(Pf4-icre)Q3Rsko/0 (involves: C57BL/6)	abnormal platelet physiology	J:181715
Syk^tm1.1Tara/Syk^tm1.1Tara (involves: 129P2/OlaHsd * C57BL/6)	arrested B cell differentiation	J:115080
	increased B cell proliferation	J:114816
Syk^tm1.2Tara/Syk^tm1.2Tara Tg(Cr2-cre)3Cgn/0 (involves: 129P2/OlaHsd)	abnormal B cell morphology	J:208904
Syk^tm1Kuro/Syk^tm1Kuro Zap70^tm1Dlo/Zap70^tm1Dlo Cd79a^tm1(cre)Reth/? (involves: 129P2/OlaHsd * BALB/c * C57BL/6)	abnormal pro-B cell differentiation	J:134528
Syk^tm1Paw/Syk^tm1Paw (involves: 129S1/Sv * 129X1/SvJ)	abnormal B cell differentiation	J:29797
	absent pre-B cells	J:29797
	decreased late pro-B cell number	J:29797
Syk^tm1Tyb/Syk^tm1.2Tara Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	abnormal neutrophil physiology	J:155479
	impaired granulocyte bactericidal activity	J:155479
Syk^tm1Tyb/Syk^tm1.2Tara Tg(S100A8-cre,-EGFP)1Ilw/0 (involves: 129P2/OlaHsd * 129S2/SvPas * C3H * C57BL/6)	impaired granulocyte bactericidal activity	J:155479
Syk^tm1Tyb/Syk^tm1Tyb (involves: 129S2/SvPas * C57BL/6 * DBA/2)	abnormal T cell number	J:29796
	arrested B cell differentiation	J:29796
Syk^tm1Tyb/Syk^tm1Tyb (involves: 129S2/SvPas * C57BL/6)	abnormal osteoclast differentiation	J:89583
Syk^tm1Tyb/Syk^tm1Tyb (involves: 129S2/SvPas)	abnormal neutrophil physiology	J:155479
	impaired granulocyte bactericidal activity	J:155479
	impaired neutrophil phagocytosis	J:155479
Syk^{tm2.1(ZAP70)Fkfr}/Syk^{tm2.1(ZAP70)Fkfr} (B6.129-Syk^{tm2.1(ZAP70)Fkfr})	abnormal B cell physiology	J:188422
	abnormal neutrophil physiology	J:188422
	arrested B cell differentiation	J:188422
	decreased B cell number	J:188422
	decreased bone marrow cell number	J:188422
	decreased DN1 thymic pro-T cell number	J:188422
	decreased IgG1 level	J:188422
	decreased IgG2a level	J:188422
	decreased IgG2b level	J:188422
	decreased marginal zone B cell number	J:188422
	decreased mature B cell number	J:188422
	decreased transitional stage B cell number	J:188422
	decreased transitional stage T1 B cell number	J:188422
	decreased transitional stage T2 B cell number	J:188422
	increased B cell apoptosis	J:188422
	increased CD4-positive, alpha-beta memory T cell number	J:188422
	increased CD4-positive, alpha-beta T cell number	J:188422
	increased CD8-positive, alpha-beta memory T cell number	J:188422
	increased CD8-positive, alpha-beta T cell number	J:188422
	increased DN3 thymocyte number	J:188422
	increased IgM level	J:188422
Sympk^{Tg(Tyr)2381AOve}/Sympk^{Tg(Tyr)2381AOve} (FVB/N-Sympk^{Tg(Tyr)2381AOve})	anemia	J:175597
Syn3^{tm1.1(KOMP)Vlcg}/Syn3^{tm1.1(KOMP)Vlcg} (C57BL/6N-Syn3^{tm1.1(KOMP)Vlcg}/J)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
Syncrip^{tm1b(EUCOMM)Hmgu}/Syncrip⁺ (C57BL/6N-Syncrip^{tm1b(EUCOMM)Hmgu}/Ieg)	decreased mean platelet volume	J:211773
Syne2^em1(IMPC)J/Syne2^em1(IMPC)J (C57BL/6N-Syne2^em1(IMPC)J/J)	decreased mean corpuscular volume	J:211773
Syngr1^{em1(IMPC)Ccpcz}/Syngr1^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Syngr1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Syngr3^em1Pave/Syngr3⁺ Tg(Prnp-MAPTP301S)PS19Vle/0 (involves: C3H C57BL/6)	microgliosis	J:303506
Synj1^{tm1b(EUCOMM)Wtsi}/Synj1⁺ (C57BL/6N-Synj1^{tm1b(EUCOMM)Wtsi}/H)	decreased monocyte cell number	J:211773
	decreased neutrophil cell number	J:211773
	decreased red blood cell distribution width	J:211773
	increased lymphocyte cell number	J:211773
Synpo2^{tm1b(EUCOMM)Wtsi}/Synpo2⁺ (C57BL/6N-Synpo2^{tm1b(EUCOMM)Wtsi}/Ics)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Syt9^em1(IMPC)Tcp/Syt9^em1(IMPC)Tcp (C57BL/6N-Syt9^em1(IMPC)Tcp/Tcp)	increased red blood cell distribution width	J:211773
Syt17^{tm1b(KOMP)Wtsi}/Syt17^{tm1b(KOMP)Wtsi} (C57BL/6N-Syt17^{tm1b(KOMP)Wtsi}/Ucd)	increased mean corpuscular volume	J:211773
Sytl1^{tm1a(KOMP)Wtsi}/Sytl1^{tm1a(KOMP)Wtsi} (B6JTyr;B6N-Sytl1^{tm1a(KOMP)Wtsi}/Wtsi)	decreased hemoglobin content	J:175295
	increased hematocrit	J:175295
Sytl1^{tm1a(KOMP)Wtsi}/Sytl1^{tm1a(KOMP)Wtsi} (involves: C57BL/6 * C57BL/6N)	decreased CD4-positive, alpha-beta T cell number	J:213427
	decreased IgG2b level	J:213427
	decreased mature B cell number	J:213427
	decreased T cell number	J:213427
	increased mean platelet volume	J:213427
	increased regulatory T cell number	J:213427
t^AE5/t^AE5 (Not Specified)	abnormal spleen morphology	J:83862
	abnormal thymus cortex morphology	J:83862
	abnormal thymus morphology	J:83862
	decreased spleen white pulp amount	J:83862
	increased mast cell number	J:83862
	increased megakaryocyte cell number	J:83862
	thymus cortex hypoplasia	J:83862
Taar8b^em1(IMPC)Mbp/Taar8b^em1(IMPC)Mbp (C57BL/6N-Taar8b^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Tab2^tm2.1Aki/Tab2^tm2.1Aki Tab3^tm1Aki/Tab3^tm1Aki Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:195289
	decreased B cell proliferation	J:195289
	decreased B-1a cell number	J:195289
	decreased IgD level	J:195289
	decreased IgE level	J:195289
	decreased IgG level	J:195289
	decreased immunoglobulin level	J:195289
	decreased mature B cell number	J:195289
	decreased plasma cell number	J:195289
	increased B cell apoptosis	J:195289
Tac4^tm1Albe/Tac4^tm1Albe (B6.129P2-Tac4^tm1Albe)	increased pro-B cell number	J:166471
Tacc3^tm1Jni/Tacc3^tm1Jni (involves: 129P2/OlaHsd * C57BL/6)	abnormal definitive hematopoiesis	J:74762
	decreased hematopoietic stem cell number	J:74762
	decreased thymocyte number	J:74762
	small thymus	J:74762
Tacr1^tm1Nge/Tacr1^tm1Nge (involves: 129S4/SvJae * C57BL)	abnormal mast cell physiology	J:84660
Taf7^tm1.1Dss/Taf7^tm1.2Dss Tg(Cd8a*-cre)B8Asin/0 (involves: C57BL/6)	abnormal T cell differentiation	J:185745
	decreased CD4-positive, alpha-beta T cell number	J:185745
	decreased CD8-positive, alpha-beta T cell number	J:185745
	decreased double-positive T cell number	J:185745
	decreased single-positive T cell number	J:185745
	decreased T cell number	J:185745
	decreased T cell proliferation	J:185745
	decreased thymocyte number	J:185745
Taf7^tm1.1Dss/Taf7^tm1.2Dss Tg(Lck-cre)1Cwi/0 (involves: C57BL/6)	abnormal T cell differentiation	J:185745
	abnormal thymus physiology	J:185745
	decreased CD4-positive, alpha-beta T cell number	J:185745
	decreased CD8-positive, alpha-beta T cell number	J:185745
	decreased double-positive T cell number	J:185745
	decreased thymocyte number	J:185745
	increased double-negative T cell number	J:185745
	small thymus	J:185745
Taf15^em1(IMPC)Mbp/Taf15^em1(IMPC)Mbp (C57BL/6NCrl-Taf15^em1(IMPC)Mbp/MbpMmucd)	increased lymphocyte cell number	J:211773
Tafa4^em1(IMPC)Mbp/Tafa4^em1(IMPC)Mbp (C57BL/6N-Tafa4^em1(IMPC)Mbp/MbpMmucd)	increased hematocrit	J:211773
Tagap1^em1(IMPC)Tcp/Tagap1⁺ (C57BL/6N-Tagap1^em1(IMPC)Tcp/Tcp)	enlarged spleen	J:211773
Tagln2^em1(IMPC)Tcp/Tagln2^em1(IMPC)Tcp (C57BL/6N-Tagln2^em1(IMPC)Tcp/Tcp)	decreased lymphocyte cell number	J:211773
	enlarged spleen	J:211773
	increased mean platelet volume	J:211773
	increased neutrophil cell number	J:211773
	increased red blood cell distribution width	J:211773
Tagln2^tm1Cdj/Tagln2^tm1Cdj (involves: 129S4/SvJae * C57BL/6)	abnormal cytotoxic T cell physiology	J:256656
	abnormal T cell physiology	J:256656
Tagln2^tm1Cdj/Tagln2^tm1Cdj Tg(TcraTcrb)425Cbn/0 (involves: 129S4/SvJae * C57BL/6)	abnormal T cell activation	J:256656
Tagln2^tm1Cdj/Tagln2^tm1Cdj Tg(TcraTcrb)1100Mjb/0 (involves: 129S4/SvJae * C57BL/6)	abnormal T cell activation	J:256656
Tal1^Hpt/Tal1⁺ (HPT/Le)	abnormal erythropoiesis	J:1780
	anemia	J:1780
	decreased leukocyte cell number	J:1780
Tal1^tm1.1Bgo/Tal1^tm1.1Bgo (Not Specified)	abnormal bone marrow cell morphology/development	J:203178
	hematopoietic system phenotype	J:203178
	increased hematopoietic stem cell number	J:203178
Tal1^tm1Por/Tal1^tm1Por (involves: 129P2/OlaHsd)	abnormal embryonic erythropoiesis	J:139179
	abnormal erythroid progenitor cell morphology	J:139179
	abnormal erythropoiesis	J:139179
	anisocytosis	J:139179
	decreased hematocrit	J:139179
	decreased hemoglobin content	J:139179
	decreased mean corpuscular hemoglobin concentration	J:139179
	decreased mean corpuscular volume	J:139179
	extramedullary hematopoiesis	J:139179
	increased red blood cell distribution width	J:139179
	increased spleen weight	J:139179
	microcytic anemia	J:139179
Tal1^tm1Sho/Tal1^tm1Sho (involves: 129S4/SvJae)	abnormal embryonic hematopoiesis	J:23061
	absent common myeloid progenitor cells	J:23061
	anemia	J:23061
Tal1^tm1Wehi/Tal1^tm1Wehi (involves: 129S1/Sv * C57BL/6)	abnormal embryonic hematopoiesis	J:27458
Tal1^tm2Sho/Tal1^tm2Sho Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	anemia	J:83215
	thrombocytopenia	J:83215
Tal1^tm2Wehi/Tal1^tm2Wehi (involves: 129S1/Sv * C57BL/6)	abnormal embryonic hematopoiesis	J:58825
Tal1^tm2Wehi/Tal1^tm2Wehi (involves: 129S1/Sv * C57BL/6)	anemia	J:58825
Tal1^tm3Wehi/Tal1^tm2Wehi Tg(Mx1-cre)1Cgn/0 (involves: 129S1/Sv * C57BL/6 * CBA)	abnormal erythropoiesis	J:81826
	abnormal megakaryocyte morphology	J:81826
	abnormal megakaryocyte progenitor cell morphology	J:81826
	abnormal proerythroblast morphology	J:81826
	abnormal splenic cell ratio	J:81826
	anemia	J:81826
	decreased bone marrow cell number	J:81826
	impaired hematopoiesis	J:81826
	thrombocytopenia	J:81826
Tal2^tm1Thr/Tal2^tm1Thr (involves: 129 * C57BL/6)	hematopoietic system phenotype	J:65762
Tank^tm1Aki/Tank^tm1Aki (involves: 129/Sv * C57BL/6)	abnormal macrophage physiology	J:151757
	increased B cell proliferation	J:151757
	increased IgA level	J:151757
	increased IgG1 level	J:151757
	increased IgG2a level	J:151757
	increased IgG2b level	J:151757
	increased IgM level	J:151757
	increased mature B cell number	J:151757
	increased plasma cell number	J:151757
	spleen hyperplasia	J:151757
Tap1^m1Btlr/Tap1^m1Btlr (C57BL/6J-Tap1^m1Btlr)	decreased CD8-positive, alpha-beta memory T cell number	J:254888
Tap1^m1Btlr/Tap1^m1Btlr (C57BL/6J-Tap1^m1Btlr)	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:254888
Tap1^m2Btlr/Tap1^m2Btlr (C57BL/6J-Tap1^m2Btlr)	decreased CD8-positive, alpha-beta T cell number	J:236697
Tap1^m2Btlr/Tap1^m2Btlr (C57BL/6J-Tap1^m2Btlr)	impaired hematopoiesis	J:236697
Tap1^rose/Tap1^rose (C57BL/6JAnu-Tap1^rose/AnuApb)	decreased CD8-positive, alpha-beta T cell number	J:166104
Tap1^tm1Arp/Tap1^tm1Arp (involves: 129S2/SvPas * C57BL/6)	abnormal lymphocyte physiology	J:122479
	absent CD8-positive, alpha-beta T cells	J:3524
	decreased double-negative T cell number	J:3524
Tap1^tm1Arp/Tap1^tm1Arp (involves: 129S2/SvPas)	decreased CD8-positive, alpha-beta T cell number	J:64177, J:64349
Tap1^tm1Arp/Tap1^tm1Arp (involves: 129S2/SvPas)	decreased cytotoxic T cell cytolysis	J:64349
Tap1^tm1Arp/Tap1^tm1Arp (B6.129S2-Tap1^tm1Arp/J)	decreased CD8-positive, alpha-beta T cell number	J:123934
Tap1^tm1Arp/Tap1^tm1Arp (B6.129S2-Tap1^tm1Arp/J)	increased T-helper 1 cell number	J:123934
Tap2^jas/Tap2^jas (C57BL/6JSfdAnu-Tap2^jas/AnuApb)	absent CD8-positive, alpha-beta T cells	J:104190
Tap2^jas/Tap2^jas (C57BL/6JSfdAnu-Tap2^jas/AnuApb)	decreased CD8-positive, alpha-beta T cell number	J:166104
Tap2^m1Btlr/Tap2^m1Btlr (C57BL/6J-Tap2^m1Btlr)	abnormal cytotoxic T cell physiology	J:159355
	abnormal NK cell physiology	J:159355
	absent CD8-positive, alpha-beta T cells	J:159355
Tap2^m2Btlr/Tap2^m2Btlr (C57BL/6J-Tap2^m2Btlr)	decreased CD8-positive, alpha-beta T cell number	J:217145
Tap2^m2Btlr/Tap2^m2Btlr (C57BL/6J-Tap2^m2Btlr)	increased CD4-positive, alpha-beta T cell number	J:217145
Tap2^m3Btlr/Tap2^m3Btlr (C57BL/6J-Tap2^m3Btlr)	decreased CD8-positive, alpha-beta T cell number	J:254929
	decreased CD8-positive, naive alpha-beta T cell number	J:254929
	decreased effector memory CD4-positive, alpha-beta T cell number	J:254929
	decreased NK T cell number	J:254929
	increased CD4-positive, alpha-beta T cell number	J:254929
	increased central memory CD8 positive, alpha-beta T cell number	J:254929
Tap2^M4Btlr/Tap2^M4Btlr (C57BL/6J-Tap2^M4Btlr)	increased CD4-positive, alpha-beta T cell number	J:272847
Tapbp^tm1Gjh/Tapbp^tm1Gjh (involves: 129S2/SvPas)	abnormal NK cell physiology	J:64349
	decreased cytotoxic T cell cytolysis	J:64349
	decreased T cell number	J:64349
Tapbp^tm1Luc/Tapbp^tm1Luc (involves: 129S6/SvEvTac * C57BL/6)	abnormal lymphocyte physiology	J:122479
Tapbp^tm1Luc/Tapbp^tm1Luc (involves: 129S6/SvEvTac)	abnormal cytotoxic T cell physiology	J:64177
Tapbp^tm1Luc/Tapbp^tm1Luc (involves: 129S6/SvEvTac)	decreased CD8-positive, alpha-beta T cell number	J:64177
Tapbp^tm1Luc/Tapbp^tm1Luc Tg(TcraTcrb)1100Mjb/? (involves: 129S6/SvEvTac * C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:64177
	abnormal CD8-positive, alpha beta T cell morphology	J:64177
	abnormal negative T cell selection	J:64177
	abnormal positive T cell selection	J:64177
Tapt1^{TgTn(sb-cHS4,Tyr)2508GOve}/Tapt1^{TgTn(sb-cHS4,Tyr)2508GOve} (FVB/N-Tapt1^{TgTn(sb-cHS4,Tyr)2508GOve})	anemia	J:175597
Tardbp^tm1.1Neas/Tardbp^tm1.1Neas (B6(C3)-Tardbp^tm1.1Neas)	microgliosis	J:283769
Tardbp^{tm1b(EUCOMM)Wtsi}/Tardbp⁺ (C57BL/6N-Tardbp^{tm1b(EUCOMM)Wtsi}/H)	decreased mean platelet volume	J:211773
Tardbp^tm2.1Neas/Tardbp^tm2.1Neas (B6(C3)-Tardbp^tm2.1Neas)	microgliosis	J:283769
Tarm1^tm1Yiw/Tarm1^tm1Yiw (involves: C57BL/6 * C57BL/6NSlc)	abnormal dendritic cell differentiation	J:301164
	abnormal lymphocyte physiology	J:301164
	decreased B cell number	J:301164
	decreased CD4-positive, alpha-beta T cell number	J:301164
	decreased dendritic cell number	J:301164
	decreased IgG2a level	J:301164
	decreased IgG2b level	J:301164
	decreased IgG3 level	J:301164
	decreased T cell proliferation	J:301164
Tars3^em1(IMPC)J/Tars3^em1(IMPC)J (C57BL/6NJ-Tars3^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Tas2r131^em1(IMPC)Bay/Tas2r131^em1(IMPC)Bay (C57BL/6N-Tas2r131^em1(IMPC)Bay/Bay)	abnormal spleen morphology	J:211773
Tas2r139^em1(IMPC)Mbp/Tas2r139^em1(IMPC)Mbp (C57BL/6NCrl-Tas2r139^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	small spleen	J:211773
Tasp1^tm1Jjdh/Tasp1^tm1Jjdh Tg(Mx1-cre)1Cgn/? (involves: 129X1/SvJ * C57BL/6 * CBA)	decreased double-positive T cell number	J:112159
	decreased thymocyte number	J:112159
	decreased thymus weight	J:112159
Tax1bp1^tm1Ktj/Tax1bp1^tm1Ktj (B6.129P2-Tax1bp1^tm1Ktj)	abnormal leukocyte physiology	J:131849
	abnormal macrophage chemotaxis	J:131849
	abnormal neutrophil physiology	J:131849
	abnormal T cell physiology	J:131849
tb/tb (Not Specified)	abnormal thymus involution	J:12166
Tb2r1^DBA/2J/? (involves: C57BL/6J * DBA/2J)	abnormal definitive hematopoiesis	J:87437
Tb2r1^DBA/2J/Tb2r1^DBA/2J (B6.D2-(D4Mit37-tel))	abnormal definitive hematopoiesis	J:140749
Tbata^tm1Faf/Tbata^tm1Faf (involves: 129P2/OlaHsd * C57BL/6)	abnormal thymus epithelium morphology	J:166065
	enlarged thymus	J:166065
	increased double-negative T cell number	J:166065
	increased thymocyte number	J:166065
	thymus hyperplasia	J:166065
Tbc1d4^tm1.1Arte/Tbc1d4^tm1.1Arte (involves: C57BL/6)	decreased spleen weight	J:169477
Tbc1d4^{tm1b(EUCOMM)Hmgu}/Tbc1d4^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Tbc1d4^{tm1b(EUCOMM)Hmgu}/J)	decreased leukocyte cell number	J:211773
	increased hematocrit	J:211773
	increased mean corpuscular volume	J:211773
Tbc1d8b^em1(IMPC)Bay/Y (C57BL/6N-Tbc1d8b^em1(IMPC)Bay/BayMmucd)	decreased spleen weight	J:211773
Tbc1d9b^em1(IMPC)J/Tbc1d9b^em1(IMPC)J (C57BL/6NJ-Tbc1d9b^em1(IMPC)J/Mmjax)	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
Tbc1d10c^tm1.1Psou/Tbc1d10c^tm1.2Psou Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: 129S2/SvPas * BALB/c * C57BL/6J)	abnormal B cell physiology	J:211913
	increased IgG level	J:211913
	increased IgM level	J:211913
Tbc1d10c^tm1.2Psou/Tbc1d10c^tm1.2Psou (involves: 129S2/SvPas * C57BL/6J)	abnormal B cell physiology	J:211913
	abnormal T cell activation	J:211913
	increased IgG level	J:211913
	increased T cell proliferation	J:211913
Tbc1d20^em1(IMPC)Mbp/Tbc1d20⁺ (C57BL/6N-Tbc1d20^em1(IMPC)Mbp/MbpMmucd)	increased red blood cell distribution width	J:211773
Tbc1d22a^{tm1b(KOMP)Wtsi}/Tbc1d22a^{tm1b(KOMP)Wtsi} (C57BL/6N-Tbc1d22a^{tm1b(KOMP)Wtsi}/Wtsi)	increased mean platelet volume	J:211773
	increased red blood cell distribution width	J:211773
	thrombocytopenia	J:211773
Tbc1d32^b2b2284Clo/Tbc1d32^b2b2284Clo (C57BL/6J-Tbc1d32^b2b2284Clo)	spleen hypoplasia	J:175213
Tbk1^M1Btlr/Tbk1⁺ (involves: C57BL/6J)	abnormal macrophage physiology	J:188770
Tbk1^tm1.1Lex/Tbk1⁺ (involves: 129S4/SvJae * 129S5/SvEvBrd)	decreased basophil cell number	J:166476
Tbk1^tm1.1Lex/Tbk1⁺ (involves: 129S4/SvJae * 129S5/SvEvBrd)	decreased eosinophil cell number	J:166476
Tbk1^tm1.1Lex/Tbk1^tm1.1Lex (involves: 129S4/SvJae * 129S5/SvEvBrd)	decreased NK T cell number	J:166476
	increased IgA level	J:166476
	increased monocyte cell number	J:166476
	increased NK T cell number	J:166476
	increased spleen weight	J:166476
Tbk1^tm1Aki/Tbk1^tm1Aki Tnf^tm1Sek/Tnf^tm1Sek (involves: 129P2/OlaHsd * C57BL/6 * CBA)	abnormal cytotoxic T cell physiology	J:132662
	decreased cytotoxic T cell cytolysis	J:132662
	decreased IgG1 level	J:132662
	decreased IgG2a level	J:132662
	decreased IgG level	J:132662
Tbk1^tm1Arte/Tbk1^tm1Arte Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129/SvEv * 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:188560
	abnormal class switch recombination	J:188560
	increased IgA level	J:188560
	increased IgM level	J:188560
	increased mature B cell number	J:188560
Tbk1^tm1Arte/Tbk1^tm1Arte Map3k14^tm1Rds/Map3k14^tm1Rds Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129/SvEv * 129P2/OlaHsd * C57BL/6)	abnormal B cell differentiation	J:188560
	abnormal immunoglobulin level	J:188560
Tbkbp1^tm1Aki/Tbkbp1^tm1Aki (Not Specified)	hematopoietic system phenotype	J:204786
Tbkbp1^{tm1b(EUCOMM)Wtsi}/Tbkbp1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Tbkbp1^{tm1b(EUCOMM)Wtsi}/H)	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
Tbp^tm1.1Ees/Tbp^tm1.1Ees (B6.129X1(Cg)-Tbp^tm1.1Ees)	hemophagocytosis	J:77714
Tbrg1^{tm1a(KOMP)Wtsi}/Tbrg1^{tm1a(KOMP)Wtsi} (C57BL/6N-Tbrg1^{tm1a(KOMP)Wtsi})	enlarged spleen	J:225146
	hematopoietic system phenotype	J:225146
	increased marginal zone B cell number	J:225146
	increased spleen white pulp amount	J:225146
Tbx1^m1H/Tbx1^m1H (involves: C3H/HeH * C57BL/6J)	small thymus	J:169366
Tbx1^m1Jlk/Tbx1^m1Jlk (129/Sv-Tbx1^m1Jlk)	athymia	J:146769
Tbx1^m1Jlk/Tbx1^tm1Bld (involves: 129)	athymia	J:146769
Tbx1^tm1.1Dsr/Tbx1^tm1.1Dsr (either: 129/Sv or (involves: 129/Sv * C57BL/6))	athymia	J:93588
Tbx1^tm1Bem/Tbx1^tm1Bem (FVB.Cg-Tbx1^tm1Bem)	athymia	J:91664
Tbx1^tm1Bem/Tbx1^tm1Bem (FVB.Cg-Tbx1^tm1Bem)	thymus hypoplasia	J:91664
Tbx1^tm1Bld/Tbx1^tm1Bld (involves: 129S7/SvEvBrd)	athymia	J:146769
Tbx1^tm1Bld/Tbx1^tm2.1Bem Tfap2a^tm1(cre)Moon/Tfap2a⁺ (either: (involves: 129/Sv * C57BL/6 * SJL) or (involves: 129/Sv * C57BL/6J * CBA * SJL))	athymia	J:154590
	thymus hypoplasia	J:154590
Tbx1^tm1Bld/Tbx1^tm5Bld (involves: 129S7/SvEvBrd * C57BL/6)	athymia	J:112457
Tbx1^tm1Dsr/Tbx1^tm1Dsr (either: 129/Sv or (involves: 129/Sv * C57BL/6))	athymia	J:93588
Tbx1^tm1Pa/Tbx1^tm1Pa (either: (involves: 129) or (involves: 129 * C57BL/6) or (involves: 129 * C57BL/6 * Swiss Webster))	abnormal thymus development	J:70730
	athymia	J:70730
Tbx1^tm2.1Bem/Tbx1^tm2.2Bem Foxg1^tm1(cre)Skm/Foxg1⁺ (involves: 129 * C57BL/6J * SJL * Swiss Webster)	athymia	J:105980
Tbx3^em1(IMPC)Mbp/Tbx3⁺ (C57BL/6NCrl-Tbx3^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Tbx20^em1(IMPC)Mbp/Tbx20⁺ (C57BL/6N-Tbx20^em1(IMPC)Mbp/MbpMmucd)	increased neutrophil cell number	J:211773
Tbx21^duane/Tbx21^duane (C57BL/6-Tbx21^duane)	abnormal NK cell differentiation	J:154069
	absent NK T cells	J:154069
	decreased NK cell number	J:154069
	increased NK cell number	J:154069
Tbx21^m1Btlr/Tbx21^m1Btlr (C57BL/6J-Tbx21^m1Btlr)	increased CD8-positive, alpha-beta T cell number	J:267478
	increased effector memory CD8-positive, alpha-beta T cell number	J:267478
	increased IgM level	J:267478
Tbx21^tm1Glm/Tbx21⁺ (involves: 129S6/SvEvTac * C57BL/6)	abnormal NK cell physiology	J:73833
Tbx21^tm1Glm/Tbx21⁺ (involves: 129S6/SvEvTac * C57BL/6)	decreased T helper 1 cell number	J:73833
Tbx21^tm1Glm/Tbx21^tm1Glm (involves: 129S6/SvEvTac * C57BL/6)	abnormal CD8-positive, alpha-beta cytotoxic T cell morphology	J:73833
	abnormal immunoglobulin level	J:73833
	abnormal NK cell physiology	J:73833
	abnormal T-helper 1 cell differentiation	J:73833
	decreased T helper 1 cell number	J:73833
	impaired natural killer cell mediated cytotoxicity	J:73833
	increased natural killer cell mediated cytotoxicity	J:73833
	increased T-helper 2 cell number	J:73833
Tbx21^tm1Glm/Tbx21^tm1Glm (C.129S6-Tbx21^tm1Glm/J)	abnormal CD4-positive, alpha-beta T cell physiology	J:111932
Tbx21^tm1Glm/Tbx21^tm1Glm (B6.129S6-Tbx21^tm1Glm)	abnormal CD4-positive T cell differentiation	J:143729
Tbx21^tm1Glm/Tbx21^tm1Glm (involves: 129S6/SvEvTac)	abnormal leukocyte migration	J:163822
	decreased CD4-positive, alpha-beta T cell number	J:163822
	decreased memory T cell number	J:163822
Tbx21^tm1Srnr/Tbx21⁺ (involves: C57BL/6)	absent NK T cells	J:112679
Tbx21^tm1Srnr/Tbx21⁺ (involves: C57BL/6)	decreased NK cell number	J:112679
Tbx21^tm1Srnr/Tbx21^tm1Srnr (involves: C57BL/6)	abnormal T-helper 1 cell morphology	J:112679
Tbx21^tm1Srnr/Tbx21^tm1Srnr (involves: C57BL/6)	decreased NK T cell number	J:112679
Tbx21^tm2Srnr/Tbx21⁺ Tg(Cd4-cre)1Cwi/0 (involves: 129 * C57BL/6 * DBA/2)	decreased CD8-positive, alpha-beta T cell number	J:174315
Tbx21^tm2Srnr/Tbx21^tm2Srnr Tg(Cd4-cre)1Cwi/0 (involves: 129 * C57BL/6 * DBA/2)	decreased CD8-positive, alpha-beta T cell number	J:174315
Tbx22^{tm1.1(KOMP)Vlcg}/Tbx22^{tm1.1(KOMP)Vlcg} (C57BL/6N-Tbx22^{tm1.1(KOMP)Vlcg}/J)	increased mean corpuscular hemoglobin	J:211773
Tbxa2r^tm1Cof/Tbxa2r^tm1Cof (either: (involves: 129P2/OlaHsd * C57BL/6 * DBA/2) or (involves: 129P2/OlaHsd * 129S/SvEv))	abnormal platelet aggregation	J:52125
Tbxa2r^tm1Cof/Tbxa2r^tm1Cof (C.129P2(B6)-Tbxa2r^tm1Cof)	abnormal platelet physiology	J:79049
Tbxa2r^tm1Sna/Tbxa2r^tm1Sna (either: (involves: 129/Ola * BALB/c) or (involves: 129/Ola * C57BL/6))	enlarged spleen	J:84085
Tbxas1^tm1Swl/Tbxas1⁺ (involves: 129P2/OlaHsd * BALB/c * C57BL/6J)	decreased platelet aggregation	J:90922
Tbxas1^tm1Swl/Tbxas1^tm1Swl (involves: 129P2/OlaHsd * BALB/c * C57BL/6J)	decreased platelet aggregation	J:90922
Tcaf2^{em1(IMPC)Ccpcz}/Tcaf2^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Tcaf2^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
	increased erythrocyte cell number	J:211773
	increased hematocrit	J:211773
	increased hemoglobin content	J:211773
Tcaim^{tm1b(EUCOMM)Wtsi}/Tcaim^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Tcaim^{tm1b(EUCOMM)Wtsi}/H)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Tcdel1^C57BL/6/Tcdel1^NOD/ShiLtDoi (involves: C57BL/6 * NOD/ShLtDoi * SJL)	decreased double-negative T cell number	J:97046
	increased double-positive T cell number	J:97046
Tcdel1^NOD/ShiLtDoi/Tcdel1^NOD/ShiLtDoi (involves: C57BL/6 * NOD/ShLtDoi * SJL)	decreased double-negative T cell number	J:97046
	increased double-positive T cell number	J:97046
Tcdel2^C57BL/6/Tcdel2^NOD/ShiLtDoi (involves: C57BL/6 * NOD/ShLtDoi * SJL)	decreased double-negative T cell number	J:97046
	increased double-positive T cell number	J:97046
Tcdel2^NOD/ShiLtDoi/Tcdel2^NOD/ShiLtDoi (involves: C57BL/6 * NOD/ShLtDoi * SJL)	decreased double-negative T cell number	J:97046
	increased double-positive T cell number	J:97046
Tcea1^tm1Skmz/Tcea1^tm1Skmz (involves: 129P2/OlaHsd * C57BL/6JJcl)	abnormal erythropoiesis	J:107421
	abnormal hematopoietic stem cell morphology	J:107421
	anemia	J:107421
Tcea2^em1(IMPC)J/Tcea2^em1(IMPC)J (C57BL/6NJ-Tcea2^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Tceal9^{tm1a(KOMP)Wtsi}/Y (C57BL/6N-Tceal9^{tm1a(KOMP)Wtsi}/Wtsi)	increased mean platelet volume	J:211773
	increased red blood cell distribution width	J:211773
Tcf3^tm1(PBX1)Mlc/Tcf3⁺ Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:226241
	abnormal pro-B cell differentiation	J:226241
	abnormal pro-B cell morphology	J:226241
	anemia	J:226241
	arrested B cell differentiation	J:226241
	decreased B cell number	J:226241
	decreased immature B cell number	J:226241
	enlarged spleen	J:226241
	increased leukocyte cell number	J:226241
	thrombocytopenia	J:226241
Tcf3^tm1(PBX1)Mlc/Tcf3⁺ Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: BALB/c * C57BL/6)	anemia	J:226241
	arrested B cell differentiation	J:226241
	decreased B cell number	J:226241
	decreased immature B cell number	J:226241
	enlarged spleen	J:226241
	increased leukocyte cell number	J:226241
	thrombocytopenia	J:226241
Tcf3^tm1(PBX1)Mlc/Tcf3⁺ Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * C57BL/6J * CBA/J)	anemia	J:226241
	arrested B cell differentiation	J:226241
	decreased B cell number	J:226241
	decreased immature B cell number	J:226241
	enlarged spleen	J:226241
	increased leukocyte cell number	J:226241
	thrombocytopenia	J:226241
Tcf3^{tm1(TCF3/HLF)Homy}/Tcf3⁺ (involves: 129P2/OlaHsd * C57BL/6)	hematopoietic system phenotype	J:160392
Tcf3^{tm1(TCF3/HLF)Homy}/Tcf3⁺ Tg(Mx1-cre)1Cgn/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	abnormal B cell differentiation	J:160392
	hematopoietic system phenotype	J:160392
	increased B cell number	J:160392
Tcf3^tm1.1Mbu/Tcf3⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell differentiation	J:137719
Tcf3^tm1Cmu/Tcf3⁺ (either: 129P2/OlaHsd-Tcf3^tm1Cmu or (involves: 129P2/OlaHsd * FVB/N))	decreased B cell number	J:67011
Tcf3^tm1Cmu/Tcf3^tm1Cmu (either: 129P2/OlaHsd-Tcf3^tm1Cmu or (involves: 129P2/OlaHsd * FVB/N))	abnormal blood cell morphology/development	J:67011
	abnormal immunoglobulin heavy chain V(D)J recombination	J:67011
	abnormal immunoglobulin V(D)J recombination	J:67011
	abnormal T cell subpopulation ratio	J:67011
	decreased B cell number	J:67011
	decreased lymphocyte cell number	J:67011
Tcf3^tm1Mbu/Tcf3^tm1.2Mbu Tg(Aicda-cre)9Mbu/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA * SJL)	abnormal germinal center B cell morphology	J:137719
	decreased B cell number	J:137719
	decreased germinal center B cell number	J:137719
Tcf3^tm1Mbu/Tcf3^tm1.2Mbu Tg(Fcer2a-cre)5Mbu/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA * SJL)	abnormal germinal center B cell morphology	J:137719
	decreased B cell number	J:137719
	decreased germinal center B cell number	J:137719
	increased marginal zone B cell number	J:137719
Tcf3^tm1Mbu/Tcf3^tm1Mbu Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: 129P2/OlaHsd * C57BL/10 * CBA/Ca)	decreased pro-B cell number	J:137719
Tcf3^tm1Wein/Tcf3⁺ (either: (involves: 129/Sv * 129S4/SvJaeSor) or (involves: 129S4/SvJaeSor * C57BL/6J))	decreased B cell number	J:22134
Tcf3^tm1Wein/Tcf3⁺ (involves: 129S4/SvJaeSor)	abnormal B cell number	J:91042
Tcf3^tm1Wein/Tcf3⁺ (involves: 129S4/SvJaeSor)	decreased pre-B cell number	J:91042
Tcf3^tm1Wein/Tcf3^tm1Wein (either: (involves: 129 * 129S4/SvJaeSor) or (involves: 129S4/SvJaeSor * C57BL/6J))	abnormal B cell number	J:22134
	abnormal lymphocyte cell number	J:22134
	spleen atrophy	J:22134
Tcf3^tm1Wein/Tcf3^tm1Wein (involves: 129S4/SvJaeSor * C57BL/6)	enlarged thymus	J:44278
Tcf3^tm1Wein/Tcf3^tm3Zhu (involves: 129/Sv * 129S4/SvJaeSor * C57BL/6)	decreased pro-B cell number	J:47671
Tcf3^tm1Xhsu/Tcf3^tm1Xhsu (B6.129X1-Tcf3^tm1Xhsu)	increased B cell number	J:132669
Tcf3^tm1Xhsu/Tcf3^tm1Xhsu Tg(Lck-Stat5b)1Mafa/0 (involves: 129X1/SvJ C57BL/6 * FVB/N)	increased B cell proliferation	J:132669
Tcf3^tm1Zhu/Tcf3^tm1Zhu (involves: 129)	abnormal hematopoietic stem cell morphology	J:47671
Tcf3^tm1Zhu/Tcf3^tm1Zhu (involves: 129)	decreased B cell number	J:47671
Tcf3^tm1Zhu/Tcf3^tm1Zhu (involves: 129 * C57BL/6J)	decreased double-positive T cell number	J:136143
	increased double-negative T cell number	J:136143
	increased single-positive T cell number	J:136143
	thymus hypoplasia	J:136143
Tcf3^tm1Zhu/Tcf3^tm2Zhu (involves: 129 * C57BL/6)	decreased B cell number	J:47671
Tcf3^tm2Cmu/Tcf3^tm2Cmu (involves: 129P2/OlaHsd)	abnormal lymphopoiesis	J:118827
	absent pre-B cells	J:118827
	absent pro-B cells	J:118827
	decreased dendritic cell number	J:118827
	decreased NK cell number	J:118827
Tcf3^tm2Wein/Tcf3^tm2Wein (Not Specified)	abnormal hematopoietic system morphology/development	J:47671
Tcf3^tm2Zhu/Tcf3^tm2Zhu (involves: 129 * C57BL/6)	abnormal hematopoietic stem cell morphology	J:47671
	decreased pre-B cell number	J:47671
	decreased pro-B cell number	J:47671
Tcf3^tm3.1Cmu/Tcf3^tm3.1Cmu (involves: 129S/SvEv * FVB/N)	abnormal B cell differentiation	J:153423
	abnormal immunoglobulin light chain V-J recombination	J:153423
	decreased pre-B cell number	J:153423
Tcf3^tm3Zhu/Tcf3^tm3Zhu (involves: 129/Sv * C57BL/6)	decreased B cell number	J:47671
Tcf3^tm4.1Cmu/Tcf3^tm4.1Cmu (involves: 129S/SvEv * FVB/N)	abnormal immunoglobulin light chain V-J recombination	J:153423
	absent B cells	J:153423
	arrested B cell differentiation	J:153423
	decreased pro-B cell number	J:153423
Tcf3^{tm6(Esr1)Zhu}/Tcf3^{tm6(Esr1)Zhu} (involves: 129/Sv * C57BL/6)	abnormal immunoglobulin heavy chain V(D)J recombination	J:154788
	arrested B cell differentiation	J:154788
Tcf4^tm1.1Hmb/Tcf4⁺ (involves: 129P2/OlaHsd * C57BL/6J)	increased double-negative T cell number	J:136143
Tcf4^tm1.1Hmb/Tcf4^tm1.1Hmb (involves: 129P2/OlaHsd * C57BL/6J)	abnormal T cell differentiation	J:136143
	abnormal T cell physiology	J:136143
	increased double-negative T cell number	J:136143
Tcf4^tm1Hmb/Tcf4^tm1Zhu Tg(Kit-cre)143Hmb/? (involves: 129P2/OlaHsd * C57BL/6 * CBA)	abnormal B cell differentiation	J:65236
	decreased double-positive T cell number	J:65236
	decreased thymocyte number	J:65236
	spleen hypoplasia	J:65236
Tcf4^tm1Zhu/Tcf4⁺ Tcf3^tm1Wein/Tcf3⁺ (involves: 129P2/OlaHsd)	decreased pro-B cell number	J:43324
Tcf4^tm1Zhu/Tcf4^tm1Zhu (involves: 129P2/OlaHsd * C57BL/6)	decreased pro-B cell number	J:43324
Tcf7^{tm1a(EUCOMM)Wtsi}/Tcf7^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Tcf7^{tm1a(EUCOMM)Wtsi}/Ics)	decreased CD4-positive, alpha-beta T cell number	J:165965
	decreased T cell number	J:165965
	increased B cell number	J:165965
Tcf7^tm1Cle/Tcf7^tm1Cle (involves: 129P2/OlaHsd)	abnormal memory T cell physiology	J:189838
	abnormal T cell differentiation	J:23255
	decreased CD8-positive, alpha-beta T cell number	J:189838
	decreased double-positive T cell number	J:23255
	decreased single-positive T cell number	J:23255
	decreased T cell number	J:23255
	increased osteoclast cell number	J:98430
	thymus cortex hypoplasia	J:23255
	thymus hypoplasia	J:23255
Tcf7^tm2Cle/Tcf7^tm2Cle (involves: 129P2/OlaHsd)	decreased double-positive T cell number	J:23255
	decreased single-positive T cell number	J:23255
	thymus hypoplasia	J:23255
Tcf7l2^{tm1a(EUCOMM)Wtsi}/Tcf7l2⁺ (C57BL/6N-Tcf7l2^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased mean platelet volume	J:211773
	increased red blood cell distribution width	J:211773
Tcf12^m1Btlr/Tcf12^m1Btlr (C57BL/6J-Tcf12^M1Btlr)	increased CD8-positive, alpha-beta T cell number	J:267564
Tcf12^M2Btlr/Tcf12^M2Btlr (C57BL/6J-Tcf12^M2Btlr)	decreased CD4-positive, alpha-beta T cell number	J:267666
	increased CD8-positive, alpha-beta T cell number	J:267666
	increased effector memory CD4-positive, alpha-beta T cell number	J:267666
Tcf12^M3Btlr/Tcf12^M3Btlr (C57BL/6J-Tcf12^M3Btlr)	decreased B cell number	J:271971
	decreased CD4-positive, alpha-beta T cell number	J:271971
	increased CD8-positive, alpha-beta T cell number	J:271971
Tcf12^m4Btlr/Tcf12^m4Btlr (C57BL/6J-Tcf12^m4Btlr)	abnormal B cell morphology	J:271972
	abnormal T cell morphology	J:271972
	decreased CD4-positive, alpha-beta T cell number	J:271972
	increased CD8-positive, alpha-beta T cell number	J:271972
Tcf12^tm1Zhu/Tcf12⁺ Tcf3^tm1Wein/Tcf3⁺ (involves: 129S4/SvJaeSor)	decreased pro-B cell number	J:43324
Tcf12^tm1Zhu/Tcf12⁺ Tcf3^tm4Zhu/Tcf3^tm4Zhu Tg(Lck-cre)#Zhu/0 (involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6 * SJL)	abnormal T cell differentiation	J:75746
	increased double-negative T cell number	J:75746
	increased single-positive T cell number	J:75746
Tcf12^tm1Zhu/Tcf12⁺ Tcf4^tm1Zhu/Tcf4⁺ (involves: 129P2/OlaHsd * 129S7/SvEvBrd)	decreased pro-B cell number	J:43324
Tcf12^tm1Zhu/Tcf12^tm1Zhu (involves: 129/Sv * C57BL/6)	decreased pro-B cell number	J:43324
Tcf12^tm1Zhu/Tcf12^tm1Zhu (involves: 129S7/SvEvBrd)	arrested T cell differentiation	J:120411
Tcf12^tm1Zhu/Tcf12^tm1Zhu (involves: 129S7/SvEvBrd)	decreased thymocyte number	J:120411
Tcf12^tm1Zhu/Tcf12^tm1Zhu (involves: 129S7/SvEvBrd * C57BL/6J)	decreased double-positive T cell number	J:136143
	increased CD8-positive, alpha-beta T cell number	J:136143
	increased double-negative T cell number	J:136143
	thymus hypoplasia	J:136143
Tcf12^tm1Zhu/Tcf12^tm2Zhu (involves: 129S7/SvEvBrd)	arrested T cell differentiation	J:120411
Tcf12^tm2Zhu/Tcf12⁺ (Not Specified)	hematopoietic system phenotype	J:120411
Tcf12^tm2Zhu/Tcf12^tm2Zhu (Not Specified)	abnormal B cell differentiation	J:120411
	abnormal T cell differentiation	J:120411
	absent T cells	J:120411
	arrested T cell differentiation	J:120411
	decreased double-positive T cell number	J:120411
	decreased immature B cell number	J:120411
	decreased pre-B cell number	J:120411
	decreased pro-B cell number	J:120411
	decreased thymocyte number	J:120411
	increased double-negative T cell number	J:120411
	thymus hypoplasia	J:120411
Tcf12^tm2Zhu/Tcf12^tm2Zhu Tg(TcrAND)53Hed/0 (involves: C57BL/6 * SJL)	abnormal CD4-positive, alpha beta T cell morphology	J:120411
	abnormal T cell subpopulation ratio	J:120411
	arrested T cell differentiation	J:120411
	increased T cell number	J:120411
Tcf12^tm3Zhu/Tcf12^tm3Zhu Tcf3^tm4Zhu/Tcf3^tm4Zhu Tg(Cd4-cre)1Cwi/0 (involves: 129S4/SvJae * C57BL/6 * DBA/2)	abnormal CD8-positive, alpha beta T cell morphology	J:129171
	abnormal T cell differentiation	J:129171
	decreased CD4-positive, alpha-beta T cell number	J:129171
	increased CD8-positive, alpha-beta T cell number	J:129171
Tcf12^tm3Zhu/Tcf12^tm3Zhu Tcf3^tm4Zhu/Tcf3^tm4Zhu Tg(Lck-cre)#Zhu/0 (involves: 129S4/SvJae * C57BL/6 * SJL/J)	decreased double-positive T cell number	J:129570
	decreased T cell number	J:129570
	increased double-negative T cell number	J:129570
	increased T cell proliferation	J:129570
	thymus hypoplasia	J:129570
Tcf12^tm3Zhu/Tcf12^tm3Zhu Tg(Lck-cre)#Zhu/0 (involves: C57BL/6 * SJL/J)	decreased thymocyte number	J:129570
	increased CD8-positive, alpha-beta T cell number	J:129570
Tcf21^em1(IMPC)Mbp/Tcf21⁺ (C57BL/6NCrl-Tcf21^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	small spleen	J:211773
Tcf21^tm1Eno/Tcf21^tm1Eno (involves: 129 * Black Swiss)	abnormal spleen development	J:64068
Tcf21^tm1Eno/Tcf21^tm1Eno (involves: 129 * Black Swiss)	absent spleen	J:64068
Tcf21^tm2Eno/Tcf21^tm2Eno (involves: 129 * Black Swiss)	abnormal spleen development	J:64068
Tcf21^tm2Eno/Tcf21^tm2Eno (involves: 129 * Black Swiss)	absent spleen	J:64068
Tcf25^em1(IMPC)Mbp/Tcf25^em1(IMPC)Mbp (C57BL/6NCrl-Tcf25^em1(IMPC)Mbp/Mmucd)	thrombocytopenia	J:211773
Tcim^tm1Icle/Tcim^tm1Icle (B6.129-Tcim^tm1Icle)	abnormal erythrocyte morphology	J:217318
	abnormal hemopoiesis	J:217318
	abnormal mononuclear cell morphology	J:217318
	decreased mean corpuscular hemoglobin	J:217318
	decreased mean corpuscular volume	J:217318
	increased common myeloid progenitor cell number	J:217318
	increased eosinophil cell number	J:217318
	increased erythrocyte cell number	J:217318
	increased erythroid progenitor cell number	J:217318
	increased granulocyte monocyte progenitor cell number	J:217318
	increased hematopoietic stem cell number	J:217318
	increased leukocyte cell number	J:217318
	increased lymphocyte cell number	J:217318
	increased monocyte cell number	J:217318
	increased neutrophil cell number	J:217318
	increased red blood cell distribution width	J:217318
	myeloid hyperplasia	J:217318
Tcirg1^M1Jeau/Tcirg1⁺ (either: (involves: C3H/HeJ * C57BL/6) or (involves: C3H/HeJ * C57BL/6 * FVB/N))	abnormal osteoclast morphology	J:196503
	abnormal osteoclast physiology	J:196503
	increased osteoclast cell number	J:196503
Tcirg1^oc/Tcirg1^oc (B6C3Fe a/a-Tcirg1^oc/J)	abnormal osteoclast morphology	J:7870
	extramedullary hematopoiesis	J:7870
	increased megakaryocyte cell number	J:7870
Tcirg1^tm1.2Ywd/Tcirg1^tm1.2Ywd (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N * SJL)	abnormal macrophage physiology	J:150327
Tcirg1^tm1Utku/Tcirg1^tm1Utku (involves: 129X1/SvJ * C57BL/6)	abnormal spleen B cell corona morphology	J:92730
	abnormal spleen morphology	J:92730
	abnormal spleen periarteriolar lymphoid sheath morphology	J:92730
	abnormal spleen red pulp morphology	J:92730
	abnormal spleen white pulp morphology	J:92730
	decreased B cell number	J:92730
	decreased lymphocyte cell number	J:92730
	decreased spleen B cell follicle size	J:92730
	decreased T cell number	J:92730
	increased granulocyte number	J:92730
	increased IgG1 level	J:92730
	increased IgG2a level	J:92730
	increased IgM level	J:92730
	increased immunoglobulin level	J:92730
	increased spleen germinal center number	J:92730
	thymus atrophy	J:92730
Tcirg1^tm1Ypl/Tcirg1^tm1Ypl (involves: 129S4/SvJae * C57BL/6J)	abnormal osteoclast physiology	J:58795
Tcpm1^BALB/c/Tcpm1^BALB/c (involves: BALB/c * C57BL/10)	abnormal effector T cell morphology	J:36255
Tcpm1^BALB/c/Tcpm1^C57BL/10Sn (involves: BALB/c * C57BL/10)	abnormal effector T cell morphology	J:36255
Tcra-J^tm1Jpdv/Tcra-J^tm1Jpdv (involves: 129P2/OlaHsd)	abnormal T cell differentiation	J:77518
Tcra-J^tm1Kgwa/Tcra-J^tm1Kgwa Tg(Tcrb2B4)1Mmd/0 (involves: 129P2/OlaHsd * C3H/HeJ * C57BL/6J)	abnormal T cell differentiation	J:50143
	increased double-positive T cell number	J:50143
Tcra-J^tm1Slek/Tcra-J^tm1Slek (involves: 129P2/OlaHsd)	abnormal T cell differentiation	J:101398
	decreased double-positive T cell number	J:101398
	decreased single-positive T cell number	J:101398
	increased double-negative T cell number	J:101398
	increased thymocyte number	J:101398
Tcra-J^tm1Tgi/Tcra-J^tm1Tgi (B6.129-Tcra-J^tm1Tgi)	decreased activated T cell number	J:99107
	decreased B cell number	J:99107
	decreased IgE level	J:121037
	decreased IgG level	J:99107
Tcra-J^tm1Tgi/Tcra-J^tm1Tgi (involves: 129S1/Sv * 129X1/SvJ * BALB/c)	abnormal eosinophil cell number	J:84720
	decreased IgE level	J:84720
Tcra-J^tm1Tgi/Tcra-J^tm1Tgi (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased NK T cell number	J:89695
Tcra-J^tm2.3Krg/Tcra-J^tm2.3Krg (involves: 129S/SvEv * C57BL/6)	abnormal T cell receptor alpha chain V-J recombination	J:147326
Tcra-J^tm3.1Krg/Tcra-J^tm3.1Krg (involves: 129S6/SvEvTac)	abnormal T cell differentiation	J:128344
Tcra-J^tm4.1Krg/Tcra-J^tm4.1Krg (involves: 129S6/SvEvTac)	abnormal T cell receptor alpha chain V-J recombination	J:147326
Tcra-J^tm5Krg/Tcra-J^tm5Krg (involves: 129S6/SvEvTac)	abnormal T cell receptor alpha chain V-J recombination	J:147326
Tcra^Ln1Ogu/Tcra⁺ (involves: 129/Sv * C57BL/6)	abnormal NK T cell morphology	J:152041
	abnormal T cell subpopulation ratio	J:152041
	decreased IgG2a level	J:152041
	decreased splenocyte number	J:152041
	decreased thymocyte number	J:152041
	increased IgG1 level	J:152041
	increased NK T cell number	J:152041
Tcra^Ln1Ogu/Tcra⁺ Tcrb^Ln1Ogu/Tcrb⁺ (involves: 129/Sv * C57BL/6)	abnormal T cell morphology	J:152069
Tcra^Ln2Ogu/Tcra⁺ Tcrb^Ln2Ogu/Tcrb⁺ (involves: 129/Sv * C57BL/6)	abnormal T cell morphology	J:152069
Tcra^Ln3Jae/Tcra⁺ (B6.Cg-Tcra^Ln3Jae)	abnormal double-negative T cell morphology	J:143006
	decreased CD4-positive, alpha-beta T cell number	J:143006
	decreased double-positive T cell number	J:143006
	increased CD8-positive, alpha-beta T cell number	J:143006
	thymus hypoplasia	J:143006
Tcra^Ln3Jae/Tcra⁺ Tcrb^Ln3Jae/Tcrb⁺ (B6.Cg-Tcrb^Ln3Jae Tcra^Ln3Jae)	abnormal double-negative T cell morphology	J:143006
	abnormal T cell differentiation	J:143006
	absent gamma-delta T cells	J:143006
	decreased CD4-positive, alpha-beta T cell number	J:143006
	decreased double-positive T cell number	J:143006
	increased CD8-positive, alpha-beta T cell number	J:143006
	thymus hypoplasia	J:143006
Tcra^tm1Cgn/Tcra^tm1Cgn Tg(Mx1-cre)1Cgn/0 (involves: 129S7/SvEvBrd * C57BL/6 * CBA)	abnormal CD4-positive, alpha beta T cell morphology	J:79298
	abnormal CD8-positive, alpha beta T cell morphology	J:79298
	abnormal memory T cell morphology	J:79298
	abnormal T cell morphology	J:79298
Tcra^tm1Cgn/Tcra^tm1Mass Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	abnormal T cell physiology	J:201417
	increased T cell number	J:201417
Tcra^tm1Mass/Tcra⁺ Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	abnormal NK T cell morphology	J:201417
	decreased NK cell number	J:201417
	increased NK T cell number	J:201417
Tcra^tm1Mass/Tcra⁺ Tg(Nes-cre)Wme/0 (involves: C57BL/6 * CBA)	abnormal positive T cell selection	J:201417
	decreased NK T cell number	J:201417
	decreased thymocyte number	J:201417
	increased double-negative T cell number	J:201417
Tcra^tm1Mass/Tcra^tm1Mass (involves: C57BL/6)	arrested T cell differentiation	J:201417
Tcra^tm1Mjo/Tcra⁺ (NOD.129P2-Tcra^tm1Mjo)	abnormal T cell physiology	J:108590
Tcra^tm1Mjo/Tcra^tm1Mjo (involves: 129P2/OlaHsd * BALB/c)	abnormal splenic cell ratio	J:1292
	abnormal T cell morphology	J:1292
	abnormal thymus cortex morphology	J:1292
	absent thymus medulla	J:1292
	enlarged thymus cortex	J:1292
	increased activated T cell number	J:111129
	increased B cell number	J:111129
	increased IgE level	J:111129
	increased IgG1 level	J:111129
	increased immunoglobulin level	J:111129
Tcra^tm1Mjo/Tcra^tm1Mjo (NOD.129P2-Tcra^tm1Mjo)	increased activated T cell number	J:52940
Tcra^tm1Mjo/Tcra^tm1Mjo (involves: 129P2/OlaHsd)	decreased T cell proliferation	J:110898
	enlarged spleen	J:110898
	increased activated T cell number	J:110898
	increased gamma-delta T cell number	J:110898
	increased T cell number	J:110898
	spleen hyperplasia	J:110898
Tcra^tm1Mom/Tcra/Tcrd^{tm1.1(Tcra)Rsky} H2^b/H2^b Tg(Tcrb)93Vbo/? (involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)	abnormal double-negative T cell morphology	J:131357
	abnormal double-positive T cell morphology	J:81564
	abnormal negative T cell selection	J:81564
	abnormal T cell differentiation	J:81564
	decreased double-positive T cell number	J:131357
	decreased thymocyte number	J:131357
Tcra^tm1Mom/Tcra/Tcrd^{tm1.1(Tcra)Rsky} H2^d/H2^d Ptcra^tm1Vbo/Ptcra^tm1Vbo Tg(Tcrb)93Vbo/? (involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)	abnormal T cell differentiation	J:131357
	decreased thymocyte number	J:131357
Tcra^tm1Mom/Tcra^tm1Mom (involves: 129S2/SvPas)	absent T cells	J:88620
Tcra^tm1Mom/Tcra^tm1Mom (B6.129S2-Tcra^tm1Mom)	increased mature gamma-delta T cell number	J:135597
Tcra^tm1Mom/Tcra^tm1Mom (involves: 129S2/SvPas * C57BL/6)	arrested T cell differentiation	J:3206
	decreased CD4-positive, alpha-beta T cell number	J:3206
	decreased CD8-positive, alpha-beta T cell number	J:3206
	decreased IgG level	J:119344
	increased gamma-delta intraepithelial T cell number	J:15221
Tcra^tm1Mom/Tcra^tm1Mom Tcra-J^tm1Kgwa/Tcra-J^tm1Kgwa (involves: 129P2/OlaHsd * 129S2/SvPas * C3H/HeJ * C57BL/6J)	increased double-negative T cell number	J:50143
Tcra^tm1Mom/Tcra^tm1Mom Tcrb^tm1Mom/Tcrb^tm1Mom (involves: 129 * BALB/c * C57BL/6)	arrested T cell differentiation	J:3206
	decreased double-positive T cell number	J:3206
	thymus hypoplasia	J:3206
Tcra^tm1Mom/Tcra^tm1Mom Tcrg^tm1.1Hish/Tcrg^tm1.1Hish (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	absent gamma-delta T cells	J:135597
	impaired macrophage chemotaxis	J:135597
	impaired neutrophil recruitment	J:135597
Tcra^tm1Mom/Tcra^tm1Mom Tg(CD19-Tnfsf7)#Rvl/0 (involves: 129P2/OlaHsd * C57BL/6)	absent T cells	J:88620
Tcra^tm1Mom/Tcra^tm1Mom Tg(Lck-Akt1E40K)E-3Pnt/0 (involves: 129S2/SvPas C3H/He * C57BL/6)	arrested T cell differentiation	J:135903
Tcra^tm1Mom/Tcra^tm1Mom Tg(TcraAV19AJ33)1Shima/? (involves: 129S2/SvPas * C57BL/6)	abnormal NK T cell morphology	J:140924
	abnormal NK T cell physiology	J:140924
Tcrb^Ln3Jae/Tcrb⁺ (B6.Cg-Tcrb^Ln3Jae)	abnormal double-negative T cell morphology	J:143006
Tcrb^Ln3Jae/Tcrb⁺ (B6.Cg-Tcrb^Ln3Jae)	absent gamma-delta T cells	J:143006
Tcrb^tm1(Tcrb)Chb/Tcrb^tm1(Tcrb)Chb (Not Specified)	abnormal double-negative T cell morphology	J:147947
	abnormal T cell morphology	J:147947
	decreased CD8-positive, alpha-beta T cell number	J:147947
	increased single-positive T cell number	J:147947
Tcrb^tm1(Tcrb)Chb/Tcrb^tm1Slek (Not Specified)	abnormal double-negative T cell morphology	J:147947
	abnormal T cell morphology	J:147947
	abnormal T cell receptor beta chain V(D)J recombination	J:147947
	decreased CD8-positive, alpha-beta T cell number	J:147947
	increased single-positive T cell number	J:147947
Tcrb^tm1(Tcrb)Fwa/Tcrb^tm1(Tcrb)Fwa (involves: 129)	abnormal T cell receptor beta chain V(D)J recombination	J:131995
Tcrb^tm1Mom/Tcrb⁺ Tg(SOD1G93A)1Gur/0 (B6.Cg-Tcrb^tm1Mom Tg(SOD1G93A)1Gur/J)	abnormal microglial cell physiology	J:143173
Tcrb^tm1Mom/Tcrb^tm1Mom (involves: 129P2/OlaHsd * BALB/c)	arrested T cell differentiation	J:3206
	decreased CD4-positive, alpha-beta T cell number	J:3206
	decreased CD8-positive, alpha-beta T cell number	J:3206
	decreased double-positive T cell number	J:3206
	thymus hypoplasia	J:3206
Tcrb^tm1Mom/Tcrb^tm1Mom Tcrd^tm1Mom/Tcrd^tm1Mom (involves: 129P2/OlaHsd * C57BL/6)	decreased IgG level	J:119344
Tcrb^tm1Mom/Tcrb^tm1Mom Tcrd^tm1Mom/Tcrd^tm1Mom (B6.129P2-Tcrb^tm1Mom Tcrd^tm1Mom/J)	abnormal transitional stage B cell morphology	J:187766
	decreased IgE level	J:125656
	decreased IgG1 level	J:125656
	decreased IgG level	J:125656, J:187766
	decreased plasma cell number	J:187766
	decreased T cell number	J:187766
	increased B cell number	J:187766
	increased follicular B cell number	J:187766
	increased IgM level	J:187766
	increased immature B cell number	J:187766
	increased marginal zone B cell number	J:187766
	increased mature B cell number	J:187766
	increased transitional stage T2 B cell number	J:187766
	increased transitional stage T3 B cell number	J:187766
Tcrb^tm1Mom/Tcrb^tm1Mom Tcrd^tm1Mom/Tcrd^tm1Mom (involves: 129 * BALB/c * C57BL/6)	absent CD4-positive, alpha-beta T cells	J:3206
	absent CD8-positive, alpha-beta T cells	J:3206
	arrested T cell differentiation	J:3206
	decreased double-positive T cell number	J:3206
	thymus hypoplasia	J:3206
Tcrb^tm1Mom/Tcrb^tm1Mom Tcrd^tm1Mom/Tcrd^tm1Mom (involves: 129P2/OlaHsd)	decreased IgA level	J:97824
	decreased lymphocyte cell number	J:97824
	increased T cell number	J:97824
Tcrb^tm1Mom/Tcrb^tm1Mom Tcrd^tm1Mom/Tcrd^tm1Mom Igh-J^{tm2(3H9-VDJ)Mwg}/Igh-J⁺ (B6.129P2-Tcrb^tm1Mom Igh-J^{tm2(3H9-VDJ)Mwg} Tcrd^tm1Mom)	increased marginal zone B cell number	J:142389
	spleen hypoplasia	J:142389
Tcrb^tm1Mom/Tcrb^tm1Mom Tcrd^tm1Mom/Tcrd^tm1Mom Traf3ip2^tm1.1Lix/Traf3ip2^tm1.1Lix (B6.129-Tcrb^tm1Mom Traf3ip2^tm1.1Lix Tcrd^tm1Mom)	abnormal transitional stage B cell morphology	J:187766
	decreased IgG level	J:187766
	decreased T cell number	J:187766
	increased IgM level	J:187766
	increased immature B cell number	J:187766
	increased marginal zone B cell number	J:187766
Tcrb^tm1Mom/Tcrb^tm1Mom Tg(H2-K-Cd86)7All/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	abnormal B cell differentiation	J:112475
	abnormal B cell morphology	J:112475
	decreased B cell number	J:112475
	hematopoietic system phenotype	J:112475
Tcrb^tm1Mom/Tcrb^tm1Mom Tg(H2-K-Cd86)27All/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	hematopoietic system phenotype	J:112475
Tcrb^tm1Mom/Tcrb^tm1Mom Tg(KRT5-rtTA)1Glk/0 Tg(tetO/CMV-Tslp)#Sfz/0 (involves: 129P2/OlaHsd * C3H * C57BL/6 * FVB/N)	decreased IgE level	J:100506
Tcrb^tm1Slek/Tcrb^tm5Slek (Not Specified)	abnormal T cell receptor beta chain V(D)J recombination	J:143738
Tcrb^tm1Slek/Tcrb^tm6Slek (Not Specified)	abnormal T cell receptor beta chain V(D)J recombination	J:143738
Tcrb^tm2(Tcrb)Fwa/Tcrb^tm3Slek (involves: 129)	abnormal T cell receptor beta chain V(D)J recombination	J:132446
Tcrb^tm2Slek/Tcrb^tm2Slek (Not Specified)	arrested T cell differentiation	J:119552
Tcrb^tm2Slek/Tcrb^tm2Slek (Not Specified)	decreased T cell number	J:119552
Tcrb^tm2Slek/Tcrb^tm2Slek Trbv13-2^tm1(CD2)Zhu/Trbv13-2^tm1(CD2)Zhu (involves: 129 * C57BL/6)	abnormal T cell differentiation	J:121608
Tcrb^tm3Slek/Tcrb^tm3Slek (Not Specified)	arrested T cell differentiation	J:119552
Tcrb^tm3Slek/Tcrb^tm3Slek (Not Specified)	decreased T cell number	J:119552
Tcrb^tm5Slek/Tcrb^tm5Slek (Not Specified)	abnormal T cell receptor beta chain V(D)J recombination	J:143738
Tcrb^tm6Slek/Tcrb^tm6Slek (Not Specified)	abnormal T cell receptor beta chain V(D)J recombination	J:143738
Tcrb^tm7Slek/Tcrb^tm7Slek (Not Specified)	abnormal T cell receptor beta chain V(D)J recombination	J:143738
Tcrd-V1^tm1Kjk/Tcrd-V1^tm1Kjk (involves: 129P2/OlaHsd * C57BL/6)	abnormal gamma-delta T cell differentiation	J:64863
	abnormal mature gamma-delta T cell morphology	J:64863
	abnormal T cell receptor delta chain V(D)J recombination	J:64863
	decreased gamma-delta intraepithelial T cell number	J:64863
Tcrd-V1^tm1Kjk/Tcrd-V1^tm1Kjk (B6.129P2-Tcrd-V1^tm1Kjk)	abnormal T cell receptor delta chain V(D)J recombination	J:128525
Tcrd-V1^tm1Kjk/Tcrd-V1^tm1Kjk (B6.129P2-Tcrd-V1^tm1Kjk)	decreased gamma-delta intraepithelial T cell number	J:128525
Tcrd^tm1Mom/Tcrd^tm1Mom (either: (involves: 129P2/OlaHsd * BALB/cJ) or (involves: 129P2/OlaHsd * C57BL/6))	abnormal gamma-delta T cell differentiation	J:3865
	absent gamma-delta T cells	J:3865
Tcrd^tm1Mom/Tcrd^tm1Mom Tcrg^tm2.1Dhr/Tcrg^tm2.1Dhr (involves: 129 * C57BL/6)	abnormal T cell receptor gamma chain V-J recombination	J:75624
Tcrg^tm1.1Dhr/Tcrg^tm1.1Dhr (involves: 129)	abnormal T cell receptor gamma chain V-J recombination	J:133974
Tcrg^tm1.1Hish/Tcrg^tm1.1Hish (involves: 129P2/OlaHsd * C57BL/6)	absent gamma-delta T cells	J:135597
Tcrg^tm1Dhr/Tcrg^tm1Dhr (involves: 129)	abnormal T cell receptor gamma chain V-J recombination	J:133974
Tcrg^tm1Scar/Tcrg^tm1Scar (B6.Cg-Tcrg^tm1Scar)	enlarged spleen	J:105477
	enlarged thymus	J:105477
	impaired granulocyte bactericidal activity	J:105477
	increased macrophage cell number	J:105477
	increased T cell number	J:105477
	spleen hyperplasia	J:105477
	thymus hyperplasia	J:105477
Tcrg^tm2.1Dhr/Tcrg^tm2.1Dhr (involves: 129S4/SvJae * C57BL/6)	abnormal gamma-delta T cell differentiation	J:75624
	abnormal T cell receptor gamma chain V-J recombination	J:75624
Tdp1^em1(IMPC)Tcp/Tdp1^em1(IMPC)Tcp (C57BL/6NCrl-Tdp1^em1(IMPC)Tcp/Tcp)	decreased mean corpuscular volume	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
	increased red blood cell distribution width	J:211773
Tdp2^tm1.1Huy/Tdp2^tm1.1Huy (involves: 129P2/OlaHsd * CD-1)	abnormal erythroblast morphology	J:195301
	abnormal immature B cell morphology	J:195301
	abnormal lymphopoiesis	J:195301
	decreased double-positive T cell number	J:195301
	spleen atrophy	J:195301
	thymus atrophy	J:195301
Tdrd3^{Gt(RRK474)Byg}/Tdrd3^{Gt(RRK474)Byg} (involves: 129P2/OlaHsd)	abnormal B cell differentiation	J:210647
	abnormal B cell physiology	J:210647
Tec^tm1Welm/Tec^tm1Welm (involves: 129P2/OlaHsd * C57BL/6)	decreased platelet aggregation	J:86448
Teddm1a^em1(IMPC)Tcp/Teddm1a^em1(IMPC)Tcp (C57BL/6N-Teddm1a^em1(IMPC)Tcp/Tcp)	decreased leukocyte cell number	J:211773
Tek^tm1Ber/Tek^tm1Ber (involves: 129S1/Sv * 129X1/SvJ * CD-1)	abnormal definitive hematopoiesis	J:99096
Tek^tm1Dmt/Tek^tm1Dmt (involves: 129S1/Sv * 129X1/SvJ * CD-1)	abnormal definitive hematopoiesis	J:99096
Tekt1^{em1(IMPC)Ccpcz}/Tekt1^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Tekt1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Tenm1^em1(IMPC)Tcp/Y (C57BL/6NCrl-Tenm1^em1(IMPC)Tcp/Tcp)	decreased mean corpuscular hemoglobin	J:211773
Tenm1^em1(IMPC)Tcp/Y (C57BL/6NCrl-Tenm1^em1(IMPC)Tcp/Tcp)	decreased mean corpuscular volume	J:211773
Tenm1^em1(IMPC)Tcp/Tenm1^em1(IMPC)Tcp (C57BL/6NCrl-Tenm1^em1(IMPC)Tcp/Tcp)	decreased hematocrit	J:211773
	decreased mean corpuscular volume	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
Tenm4^em1(IMPC)Tcp/Tenm4^em1(IMPC)Tcp (C57BL/6NCrl-Tenm4^em1(IMPC)Tcp/Tcp)	decreased spleen weight	J:211773
Tent5a^{em1(IMPC)Ccpcz}/Tent5a^{em1(IMPC)Ccpcz} (C57BL/6N-Tent5a^{em1(IMPC)Ccpcz}/Ccpcz)	decreased Ly6C-positive mature NK cell number	J:211773
	decreased lymphocyte cell number	J:211773
	increased granulocyte number	J:211773
	increased leukocyte cell number	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
	thrombocytosis	J:211773
Tent5c^em1Adki/Tent5c^em1Adki (involves: C57BL/6J * CBA)	decreased B cell proliferation	J:252302
	decreased hemoglobin content	J:252302
	decreased mean corpuscular hemoglobin concentration	J:252302
	decreased mean corpuscular volume	J:252302
	hypochromic microcytic anemia	J:252302
	increased erythrocyte cell number	J:252302
Tent5c^em1Hncs/Tent5c^em1Hncs (involves: C57BL/6J * DBA)	decreased hematocrit	J:277640
	decreased hemoglobin content	J:277640
	decreased mean corpuscular hemoglobin	J:277640
	decreased mean corpuscular hemoglobin concentration	J:277640
	decreased mean corpuscular volume	J:277640
	increased erythrocyte cell number	J:277640
	thrombocytosis	J:277640
Tent5c^{tm1b(KOMP)Wtsi}/Tent5c⁺ (C57BL/6N-Tent5c^{tm1b(KOMP)Wtsi}/Wtsi)	decreased mean corpuscular hemoglobin	J:211773
Terb1^{tm1b(KOMP)Mbp}/Terb1⁺ (C57BL/6N-Terb1^{tm1b(KOMP)Mbp}/Ucd)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Terc^tm1Rdp/Terc^tm1Rdp (involves: 129/Sv * C57BL/6J * SJL)	decreased B cell proliferation	J:60223
	decreased spleen B cell follicle number	J:60223
	decreased spleen germinal center number	J:60223
	decreased T cell proliferation	J:60223
	increased B cell apoptosis	J:60223
Terf2ip^em1(IMPC)Mbp/Terf2ip^em1(IMPC)Mbp (C57BL/6N-Terf2ip^em1(IMPC)Mbp/MbpMmucd)	decreased red blood cell distribution width	J:211773
Tert^tm2.1Rdp/Tert^tm2.1Rdp (involves: C57BL/6)	decreased spleen weight	J:167227
Tert^tm2.1Rdp/Tert^tm2.1Rdp (involves: C57BL/6)	spleen atrophy	J:167227
Tesc^tm1Itl/Tesc^tm1Itl (B6.Cg-Tesc^tm1Itl)	hematopoietic system phenotype	J:182299
Tespa1^tm1Smoc/Tespa1^tm1Smoc (B6.129-Tespa1^tmSmoc)	abnormal T cell differentiation	J:186446
	abnormal thymus morphology	J:186446
	decreased CD4-positive, alpha-beta T cell number	J:186446
	decreased CD8-positive, alpha-beta T cell number	J:186446
	decreased regulatory T cell number	J:186446
	decreased T cell number	J:186446
	decreased T cell proliferation	J:186446
	increased memory T cell number	J:186446
	increased T cell proliferation	J:186446
	small thymus medulla	J:186446
Tespa1^tm1Smoc/Tespa1^tm1Smoc Tg(TcraH-Y,TcrbH-Y)71Vbo/0 (involves: 129 * C57BL/6 * DBA/2J)	decreased CD8-positive, alpha-beta T cell number	J:186446
Tespa1^tm1Smoc/Tespa1^tm1Smoc Tg(TcraTcrb)425Cbn/0 (B6.Cg-Tespa1^tm1Smoc Tg(TcraTcrb)425Cbn)	abnormal T cell differentiation	J:186446
	decreased CD4-positive, alpha-beta T cell number	J:186446
	decreased CD8-positive, alpha-beta T cell number	J:186446
Tespa1^tm1Smoc/Tespa1^tm1Smoc Tg(TcraTcrb)1100Mjb/0 (B6.Cg-Tespa1^tm1Smoc Tg(TcraTcrb)1100Mjb)	abnormal T cell differentiation	J:186446
	decreased CD4-positive, alpha-beta T cell number	J:186446
	decreased CD8-positive, alpha-beta T cell number	J:186446
Tet1^tm1.1Jae/Tet1^tm1.1Jae (involves: 129S4/SvJae * C57BL/6)	decreased neutrophil cell number	J:175858
Tet1^tm1.2Jae/Tet1^tm1.2Jae Tet2^tm1.1Iaai/Tet2⁺ Tet3^tm1.1Yzhg/Tet3^tm1.1Yzhg Tg(Rorc-cre)1Litt/0 (involves: 129 * 129S/SvEv * 129S4/SvJae * C57BL/6 * FVB)	decreased effector memory T-helper cell number	J:333574
Tet1^tm1.2Jae/Tet1^tm1.2Jae Tet2^tm1.1Iaai/Tet2^tm1.1Iaai Tet3^tm1.1Yzhg/Tet3^tm1.1Yzhg Tg(Rorc-cre)1Litt/0 (involves: 129 * 129S/SvEv * 129S4/SvJae * C57BL/6 * FVB)	enlarged spleen	J:333574
Tet2^{Gt(AN0709)Wtsi}/Tet2⁺ (B6.129P2-Tet2^{Gt(AN0709)Wtsi})	abnormal monocyte differentiation	J:174052
	abnormal spleen morphology	J:174052
	anemia	J:174052
	decreased erythrocyte cell number	J:174052
	enlarged spleen	J:174052
	increased B cell number	J:174052
	increased erythroid progenitor cell number	J:174052
	increased leukocyte cell number	J:174052
	increased monocyte cell number	J:174052
	thrombocytopenia	J:174052
Tet2^{Gt(AN0709)Wtsi}/Tet2^{Gt(AN0709)Wtsi} (B6.129P2-Tet2^{Gt(AN0709)Wtsi})	abnormal common myeloid progenitor cell morphology	J:174052
	abnormal monocyte differentiation	J:174052
	abnormal spleen morphology	J:174052
	anemia	J:174052
	decreased erythrocyte cell number	J:174052
	decreased pre-B cell number	J:174052
	decreased pro-B cell number	J:174052
	enlarged spleen	J:174052
	extramedullary hematopoiesis	J:174052
	increased B cell number	J:174052
	increased DN1 thymic pro-T cell number	J:174052
	increased double-negative T cell number	J:174052
	increased erythroid progenitor cell number	J:174052
	increased hematopoietic stem cell number	J:174052
	increased leukocyte cell number	J:174052
	increased monocyte cell number	J:174052
	thrombocytopenia	J:174052
Tet2^tm1.1Iaai/Tet2⁺ Tg(VAV1-cre)1Graf/0 (involves: 129S/SvEv * C57BL/6)	abnormal hematopoietic stem cell physiology	J:174053
	extramedullary hematopoiesis	J:174053
	increased hematopoietic cell number	J:174053
	increased leukocyte cell number	J:174053
	increased monocyte cell number	J:174053
Tet2^tm1.1Iaai/Tet2^tm1.1Iaai Tg(Mx1-cre)1Cgn/0 (involves: 129S/SvEv * C57BL/6 * CBA)	abnormal erythropoiesis	J:234976
	abnormal hematopoietic stem cell physiology	J:174053
	abnormal myelopoiesis	J:234976
	decreased B cell number	J:234976
	enlarged spleen	J:234976
	increased granulocyte number	J:234976
	increased hematopoietic stem cell number	J:234976
Tet2^tm1.1Iaai/Tet2^tm1.1Iaai Tg(VAV1-cre)1Graf/0 (involves: 129S/SvEv * C57BL/6)	abnormal common myeloid progenitor cell morphology	J:174053
	abnormal hematopoietic stem cell physiology	J:174053
	abnormal myeloid leukocyte morphology	J:174053
	enlarged spleen	J:174053
	extramedullary hematopoiesis	J:174053
	increased hematopoietic cell number	J:174053
	increased leukocyte cell number	J:174053
	increased monocyte cell number	J:174053
	increased spleen weight	J:174053
	myeloid hyperplasia	J:174053
Tet2^tm1.1Mjxu/Tet2⁺ (involves: 129 * C57BL/6)	enlarged spleen	J:178415
	increased leukocyte cell number	J:178415
	increased monocyte cell number	J:178415
	myeloid hyperplasia	J:178415
Tet2^tm1.1Mjxu/Tet2^tm1.1Mjxu (involves: 129 * C57BL/6)	abnormal common myeloid progenitor cell morphology	J:178415
	abnormal hematopoietic stem cell physiology	J:178415
	anemia	J:178415
	enlarged spleen	J:178415
	increased bone marrow cell number	J:178415
	increased erythrocyte cell number	J:178415
	increased hematopoietic stem cell number	J:178415
	increased hemoglobin content	J:178415
	increased leukocyte cell number	J:178415
	increased monocyte cell number	J:178415
	increased neutrophil cell number	J:178415
	myeloid hyperplasia	J:178415
Tet2^tm1.2Rao/Tet2^tm1.2Rao (involves: C57BL/6NTac)	abnormal definitive hematopoiesis	J:175222
	abnormal myelopoiesis	J:175222
	increased bone marrow cell number	J:175222
	increased hematopoietic stem cell number	J:175222
	increased splenocyte number	J:175222
Tet2^tm1Ics/Tet2^tm1Ics Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	abnormal common myeloid progenitor cell morphology	J:174052
	abnormal proerythroblast morphology	J:174052
	abnormal spleen morphology	J:174052
	decreased erythrocyte cell number	J:174052
	decreased pre-B cell number	J:174052
	decreased pro-B cell number	J:174052
	enlarged spleen	J:174052
	extramedullary hematopoiesis	J:174052
	increased B cell number	J:174052
	increased DN1 thymic pro-T cell number	J:174052
	increased double-negative T cell number	J:174052
	increased erythroblast number	J:174052
	increased hematopoietic stem cell number	J:174052
	increased leukocyte cell number	J:174052
	increased monocyte cell number	J:174052
	increased spleen red pulp amount	J:174052
	thrombocytopenia	J:174052
Tex2^{tm1.1(KOMP)Vlcg}/Tex2⁺ (C57BL/6N-Tex2^{tm1.1(KOMP)Vlcg}/J)	decreased leukocyte cell number	J:211773
	decreased mean corpuscular hemoglobin concentration	J:211773
	increased mean corpuscular volume	J:211773
Tex2^{tm1.1(KOMP)Vlcg}/Tex2^{tm1.1(KOMP)Vlcg} (C57BL/6N-Tex2^{tm1.1(KOMP)Vlcg}/J)	decreased mean corpuscular volume	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
Tex21^em1(IMPC)J/Tex21^em1(IMPC)J (C57BL/6NJ-Tex21^em1(IMPC)J/Mmjax)	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
Tex29^{tm1.1(KOMP)Vlcg}/Tex29^{tm1.1(KOMP)Vlcg} (C57BL/6N-Tex29^{tm1.1(KOMP)Vlcg}/J)	decreased leukocyte cell number	J:211773
Tex261^{tm1b(EUCOMM)Wtsi}/Tex261^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Tex261^{tm1b(EUCOMM)Wtsi}/Wtsi)	decreased hemoglobin content	J:211773
	increased leukocyte cell number	J:211773
	increased red blood cell distribution width	J:211773
Tfap4^{tm1.1(KOMP)Vlcg}/Tfap4^{tm1.1(KOMP)Vlcg} (C57BL/6N-Tfap4^{tm1.1(KOMP)Vlcg}/Ucd)	decreased thymus weight	J:211773
	increased mean corpuscular volume	J:211773
	increased red blood cell distribution width	J:211773
Tfap4^tm1.1Litt/Tfap4^tm1.1Litt (involves: 129P2/OlaHsd * C57BL/6 * FVB/N)	abnormal T cell differentiation	J:176461
Tfeb^{tm1a(EUCOMM)Wtsi}/Tfeb⁺ (C57BL/6N-Tfeb^{tm1a(EUCOMM)Wtsi}/Bay)	decreased hemoglobin content	J:211773
Tfr2^{em1(IMPC)Rbrc}/Tfr2^{em1(IMPC)Rbrc} (C57BL/6N-Tfr2^{em1(IMPC)Rbrc}/Rbrc)	abnormal erythrocyte cell number	J:211773
	abnormal hemoglobin content	J:211773
	abnormal mean corpuscular hemoglobin	J:211773
	abnormal mean corpuscular hemoglobin concentration	J:211773
	abnormal mean corpuscular volume	J:211773
	decreased erythrocyte cell number	J:211773
	increased hemoglobin content	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
	increased mean corpuscular volume	J:211773
Tfr2^tm1.1Anro/Tfr2^tm1.1Anro (129.Cg-Tfr2^tm1.1Anro)	increased cellular hemoglobin content	J:160785
	increased hemoglobin content	J:160785
	increased spleen iron level	J:160785
	macrocytic anemia	J:160785
Tfr2^tm1.1Nsub/Tfr2^tm1.1Nsub (involves: 129T2/SvEms * C57BL/6)	decreased spleen iron level	J:114330
Tfr2^tm1.1Nsub/Tfr2^tm1.1Nsub (involves: 129T2/SvEms)	increased spleen iron level	J:160785
Tfr2^tm1Slu/Tfr2^tm1Slu (involves: 129X1/SvJ * C57BL/6J)	decreased spleen iron level	J:78360
Tfr2^tm1Slu/Tfr2^tm1Slu (involves: 129X1/SvJ * C57BL/6J)	hematopoietic system phenotype	J:78360
Tfrc^em1(IMPC)H/Tfrc⁺ (C57BL/6N-Tfrc^em1(IMPC)H/H)	decreased hemoglobin content	J:211773
	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular hemoglobin concentration	J:211773
	decreased mean corpuscular volume	J:211773
	increased erythrocyte cell number	J:211773
	increased large unstained cell number	J:211773
	increased red blood cell distribution width	J:211773
Tfrc^Mvd001/Tfrc⁺ (C3HeB/FeJ-Tfrc^Mvd001)	decreased mean corpuscular hemoglobin	J:186868
	decreased mean corpuscular volume	J:186868
	increased erythrocyte cell number	J:186868
Tfrc^Rbc6/Tfrc⁺ (involves: C57BL/6)	abnormal hematopoietic system morphology/development	J:330452
	decreased hematocrit	J:330452
	decreased hemoglobin content	J:330452
	decreased mean corpuscular hemoglobin	J:330452
	decreased mean corpuscular volume	J:330452
	increased erythrocyte cell number	J:330452
	increased red blood cell distribution width	J:330452
	microcytic anemia	J:330452
Tfrc^tm1Nca/Tfrc⁺ (either: (involves: 129S4/SvJae * 129S6/SvEvTac) or (involves: 129S4/SvJae * C57BL/6))	abnormal erythropoiesis	J:54107
	decreased mean corpuscular hemoglobin	J:54107
	decreased mean corpuscular volume	J:54107
	decreased spleen iron level	J:54107
	hematopoietic system phenotype	J:54107
	increased erythrocyte cell number	J:54107
	microcytosis	J:54107
Tfrc^tm1Nca/Tfrc^tm1Nca (either: (involves: 129S4/SvJae * 129S6/SvEvTac) or (involves: 129S4/SvJae * C57BL/6))	abnormal embryonic erythrocyte morphology	J:54107
	abnormal embryonic erythropoiesis	J:54107
	anemia	J:54107
	decreased erythroid progenitor cell number	J:54107
Tfrc^tm2Nca/Tfrc^tm2Nca (involves: 129S4/SvJae * FVB/N)	hypochromic microcytic anemia	J:133221
Tg(Acp5-Adam8)#Rood/0 (involves: BALB/c * C57BL/6)	abnormal osteoclast differentiation	J:172936
	abnormal osteoclast morphology	J:172936
	increased osteoclast cell number	J:172936
Tg(Acp5-Selenow)#Djeo/0 (involves: FVB/N)	abnormal osteoclast differentiation	J:317012
Tg(Acp5-Selenow)#Djeo/0 (involves: FVB/N)	increased osteoclast cell number	J:317012
Tg(ACTA1-Il15)10941Lsq/0 (involves: C3H * C57BL/6)	hematopoietic system phenotype	J:145611
Tg(ACTA1-Il15)11650Lsq/0 (involves: C3H C57BL/6)	hematopoietic system phenotype	J:145611
Tg(ACTB-Eif4e)#Ppp/0 Tg(IghMyc)22Bri/0 (involves: C57BL * SJL)	decreased B cell apoptosis	J:89878
Tg(ACTB-Mgat3)2Nta/0 (involves: C57BL/6 * DBA/2)	abnormal definitive hematopoiesis	J:80227
	decreased erythrocyte cell number	J:80227
	decreased erythroid progenitor cell number	J:80227
	decreased hemoglobin content	J:80227
	decreased leukocyte cell number	J:80227
	decreased lymphocyte cell number	J:80227
	decreased neutrophil cell number	J:80227
	decreased spleen B cell follicle number	J:80227
	pancytopenia	J:80227
	spleen atrophy	J:80227
	thrombocytopenia	J:80227
Tg(ACTB-TNFRSF6B)754Jwu/? (B6.Cg-Tg(Actb-TNFRSF6B)754Jwu)	abnormal CD4-positive, alpha beta T cell morphology	J:148162
	anemia	J:148162
	decreased leukocyte cell number	J:148162
	enlarged spleen	J:148162
	increased B-1a cell number	J:148162
	increased IgE level	J:148162
	increased IgG1 level	J:148162
	increased IgG2b level	J:148162
	thrombocytopenia	J:148162
Tg(Actb-Tnfsf4)1Nish/0 (B6.D2-Tg(Actb-Tnfsf4)1Nish)	increased T cell proliferation	J:80214
Tg(Alb1-cre)7Gsc/0 Tfr2^tm1.1Anro/Tfr2^tm1.1Anro (involves: 129/Sv * C57BL/6 * FVB/N)	hematopoietic system phenotype	J:160785
Tg(Alb1-GP33/H2-K^b)1Hpi/0 (B6.Cg-Tg(Alb1-GP33/H2-K^b)1Hpi)	abnormal cytotoxic T cell physiology	J:162605
Tg(Alb1-GP33/H2-K^b)1Hpi/0 (B6.Cg-Tg(Alb1-GP33/H2-K^b)1Hpi)	decreased cytotoxic T cell cytolysis	J:162605
Tg(Alb1-GP33/H2-K^b)1Hpi/0 Tg(TcrLCMV)318Sdz/0 (involves: C57BL/6 * DBA/2)	decreased CD8-positive, alpha-beta T cell number	J:162605
Tg(Alb1-Myc)#Sst/0 Tg(MtTGFA)Lmb/0 (involves: C57BL/6 * CBA * CD-1)	decreased NK cell number	J:176432
	increased NK T cell number	J:176432
Tg(Alb-PDGFC)#Jcam/0 (involves: C57BL/6)	enlarged spleen	J:211984
Tg(Amy1TAg)501Knw/0 (involves: C57BL/6)	abnormal CD8-positive, alpha-beta T cell physiology	J:84288
Tg(ANX6)2Agh/0 (FVB/N-Tg(ANX6)2Agh)	thymus cortex hypoplasia	J:92579
Tg(aP2-SREBF1c)9884Reh/0 (involves: C57BL/6J * SJL)	enlarged spleen	J:50770
Tg(APCS-Tnfsf11)#aKhs/0 (C57BL/6J-Tg(APCS-Tnfsf11)#aKhs)	abnormal osteoclast morphology	J:264357
	enlarged thymus medulla	J:264357
	increased osteoclast cell number	J:264357
Tg(APOA1)1Rub/Tg(APOA1)1Rub (C57BL/6-Tg(APOA1)1Rub/J)	abnormal hematopoietic system physiology	J:190966
	abnormal spleen weight	J:190966
	decreased hematopoietic stem cell number	J:190966
	increased hematopoietic stem cell number	J:190966
Tg(APOC1)1Lmh/Tg(APOC1)1Lmh (C57BL/6-Tg(APOC1)1Lmh)	enlarged spleen	J:65036
Tg(APOC1)1Lmh/Tg(APOC1)1Lmh (involves: C57BL/6)	increased IgE level	J:135501
Tg(APOC1)1Lmh/Tg(APOC1)1Lmh (involves: C57BL/6)	increased mast cell degranulation	J:135501
Tg(APOE-FGF23R176Q)#Ack/0 (involves: C57BL/6J CBA)	decreased osteoclast cell number	J:93981
Tg(APP695)3Dbo/0 Tg(PSEN1dE9)S9Dbo/0 (Not Specified)	abnormal microglial cell morphology	J:139070
Tg(APPSWE)2576Kha/0 (involves: C57BL/6 * SJL)	microgliosis	J:159623
Tg(APPswe,PSEN1dE9)85Dbo/0 (D2.Cg-Tg(APPswe,PSEN1dE9)85Dbo)	microgliosis	J:227541
Tg(APPSwFlLon,PSEN1M146LL286V)6799Vas/? (involves: C57BL/6 * SJL)	increased microglial cell activation	J:208030
Tg(B2M)55Hpl/? Tg(CD8aCD8b)57Scr/? Tg(HLA-B)22Hpl/? (involves: C57BL/6 * C57BL/LiA * CBA)	abnormal cytotoxic T cell physiology	J:127813
Tg(B19-RNAi:Il3)241Ckn/? (involves: BALB/cJ * C57BL/6J * FVB/N)	abnormal B cell differentiation	J:107618
	enlarged spleen	J:107618
	increased pre-B cell number	J:107618
Tg(BCL2)22Wehi/0 (involves: C57BL/6JWehi * SJL/JWehi)	abnormal B cell differentiation	J:93111
	abnormal B cell physiology	J:93111
	increased B cell number	J:93111
Tg(BCL2)22Wehi/0 (involves: C57BL/6J * C57BL/6JWehi)	increased B cell number	J:88565
Tg(BCL2)22Wehi/0 Tg(IghMyc)22Bri/0 (involves: C57BL/6 * C57BL/6JWehi * SJL/J * SJL/JWehi)	abnormal B cell morphology	J:69571
	abnormal pre-B cell morphology	J:69571
	enlarged spleen	J:69571
	enlarged thymus	J:69571
	increased B cell number	J:69571
	increased leukocyte cell number	J:69571
	increased pre-B cell number	J:69571
Tg(BCL2)25Wehi/0 (involves: C57BL/6JWehi * SJL/JWehi)	abnormal B cell differentiation	J:131912
	abnormal plasma cell differentiation	J:131912
	abnormal T cell physiology	J:93111
	increased T cell number	J:93111
Tg(BCL2)36Wehi/0 (involves: C57BL/6JWehi * SJL/JWehi)	abnormal B cell physiology	J:93111
	abnormal T cell physiology	J:93111
	increased B cell number	J:93111
	increased immunoglobulin level	J:93111
	increased T cell number	J:93111
Tg(BCL2)36Wehi/? (B6.Cg-Tg(BCL2)36Wehi/J)	abnormal B cell proliferation	J:90963
Tg(BCL2)36Wehi/? (B6.Cg-Tg(BCL2)36Wehi/J)	decreased B cell apoptosis	J:90963
Tg(BCL2/IGH)1Tjd/? (involves: C3H/He * C57BL/6)	abnormal B cell physiology	J:81147
	abnormal mononuclear cell differentiation	J:81147
	enlarged spleen	J:81147
	increased B cell number	J:81147
	increased spleen white pulp amount	J:81147
	spleen hyperplasia	J:81147
Tg(BCL2/IGH)#Jcre/0 Tg(H2-K/Igh-Traf2)#Ywc/0 (involves: BALB/c C57BL/6 * CBA/J * FVB/N * SJL/J * SWR/J)	abnormal spleen marginal zone morphology	J:94116
	decreased B cell apoptosis	J:94116
	enlarged spleen	J:94116
	increased B cell number	J:94116
	increased B-1a cell number	J:94116
	increased B-1b cell number	J:94116
	increased marginal zone B cell number	J:94116
	increased spleen weight	J:94116
Tg(BCL2/IGH)M23Tjd/? (involves: C3H/He * C57BL/6)	abnormal B cell physiology	J:81147
	abnormal mononuclear cell differentiation	J:81147
	enlarged spleen	J:81147
	increased B cell number	J:81147
	increased spleen white pulp amount	J:81147
	spleen hyperplasia	J:81147
Tg(C9orf72)500Lpwr/0 (FVB/NJ-Tg(C9orf72)500Lpwr)	microgliosis	J:239579
Tg(CAG-Btc)2Ewo/0 (FVB/N-Tg(CAG-Btc)2Ewo)	increased spleen weight	J:103364
Tg(CAG-Btc)4Ewo/0 (FVB/N-Tg(CAG-Btc)4Ewo)	increased spleen weight	J:103364
Tg(CAG-C1qtnf6)#Yiw/0 (involves: C57BL/6JJcl)	decreased IgG level	J:227217
Tg(CAG-cre/Esr1)5Amc/0 Tgfbr2^tm1.2Hlm/Tgfbr2^tm1.2Hlm (involves: 129S6/SvEvTac C57BL/6 * CBA)	microgliosis	J:221181
Tg(CAG-DPP4)4Yuzh/0 (C57BL/6-Tg(CAG-DPP4)4Yuzh)	abnormal spleen morphology	J:286175
Tg(CAG-DPP4)52Ctkt/0 (involves: C3H/HeJ * C57BL/6J)	abnormal mononuclear cell morphology	J:227925
Tg(CAG-DPP4)52Ctkt/0 (involves: C3H/HeJ * C57BL/6J)	increased microglial cell activation	J:227925
Tg(CAG-dsRed2/RNAi:Tardbp)6Zxu/0 (involves: C57BL/6 * C57BL/6J * FVB/NJ * SJL)	microgliosis	J:207750
Tg(CAG-Has2)99Nita/0 Tg(MMTV-cre)4Mam/0 Tg(MMTVneu)202Mul/0 (FVB.Cg-Tg(CAG-Has2)99Nita Tg(MMTV-cre)4Mam Tg(MMTVneu)202Mul)	impaired macrophage chemotaxis	J:164205
	increased macrophage cell number	J:164205
Tg(CAG-Ncoa6)71Hwl/0 (involves: FVB)	spleen atrophy	J:80609
Tg(CAG-Ncoa6)71Hwl/0 (involves: FVB)	thymus atrophy	J:80609
Tg(CAG-Ncoa6)87Hwl/0 (involves: FVB)	spleen atrophy	J:80609
Tg(CAG-Ncoa6)87Hwl/0 (involves: FVB)	thymus atrophy	J:80609
Tg(CAG-Ncoa6)104Hwl/0 (involves: FVB)	spleen atrophy	J:80609
Tg(CAG-Ncoa6)104Hwl/0 (involves: FVB)	thymus atrophy	J:80609
Tg(CAG-PLA2G3)#aMurm/0 (Not Specified)	increased mast cell degranulation	J:197334
Tg(CAG-Ptafr)1Tksh/0 (B6;D2-Tg(CAG-Ptafr)1Tksh/TkshRbrc)	increased mast cell number	J:38639
Tg(CAG-RPS19R62W)#Dmb/0 Tg(Prnp-GFP/cre)1Blw/0 (involves: 129S6/SvEvTac FVB/N)	abnormal erythropoiesis	J:165876
	anemia	J:165876
	decreased erythrocyte cell number	J:165876
	decreased erythroid progenitor cell number	J:165876
	decreased hematocrit	J:165876
	decreased hemoglobin content	J:165876
	reticulocytopenia	J:165876
Tg(CAG-SAC/EGFP)35Rang/0 (involves: C3H * C57BL/6)	hematopoietic system phenotype	J:125633
Tg(CAG-SPTLC1C133W)8EAmcc/0 (involves: C3H C57BL/6)	microgliosis	J:155748
Tg(Camk2a-tTA)1Mmay/0 Tg(tetO-APPSwInd)Dbo/0 (involves: C3H/HeJ * C57BL/6J)	microgliosis	J:236737
Tg(Camk2a-tTA)1Mmay/0 Tg(tetO-LRRK2)C77Cai/0 Tg(tetO-SNCA*A53T)E2Cai/0 (involves: C57BL/6)	microgliosis	J:156512
Tg(Camk2a-tTA)1Mmay/0 Tg(tetO-LRRK2)C7874Cai/0 Tg(tetO-SNCA*A53T)E2Cai/0 (involves: C57BL/6)	microgliosis	J:156512
Tg(Camk2a-tTA)1Mmay/0 Tg(tetO-LRRK2G2019S)E3Cai/0 Tg(tetO-SNCAA53T)E2Cai/0 (involves: C57BL/6)	microgliosis	J:156512
Tg(Camk2a-tTA)1Mmay/0 Tg(tetO-Mtor)#Atai/0 (involves: C57BL/6 DBA/2 * ICR)	microgliosis	J:211789
Tg(Camk2a-tTA)1Mmay/0 Tg(tetO-SNCA*A53T)E2Cai/0 (involves: C57BL/6)	microgliosis	J:156512
Tg(Camk2a-tTA)1Mmay/0 Tg(tetO-TARDBP)12Vle/0 (involves: C3H/HeJ * C57BL/6J)	microgliosis	J:170756
Tg(CD2-Ccdc86)1Hfuj/? (B6.FVB-Tg(CD2-Ccdc86)1Hfuj)	abnormal T cell morphology	J:151722
Tg(CD2-Ccdc86)1Hfuj/? (B6.FVB-Tg(CD2-Ccdc86)1Hfuj)	increased T cell apoptosis	J:151722
Tg(CD2-Ceacam1*4L)1Rsb/0 (involves: C57BL/6)	abnormal T cell physiology	J:116136
	decreased T cell number	J:116136
	decreased T cell proliferation	J:116136
Tg(CD2-Ceacam14L)1Rsb/0 Tg(TcraTcrb)425Cbn/0 (involves: BALB/c C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:116136
Tg(CD2-Foxj1)#Stlp/0 (C57BL/6-Tg(CD2-Foxj1)#Stlp)	abnormal T cell physiology	J:122222
	decreased CD4-positive, alpha-beta T cell number	J:122222
	decreased CD8-positive, alpha-beta T cell number	J:122222
	increased single-positive T cell number	J:122222
Tg(CD2-Ifngr2)1Pbro/? (B6.Cg-Tg(CD2-Ifngr2)1Pbro)	abnormal T-helper 1 cell differentiation	J:134448
Tg(CD2-Ifngr2)1Pbro/? (B6.Cg-Tg(CD2-Ifngr2)1Pbro)	abnormal T-helper 1 physiology	J:134448
Tg(CD2-Ifngr2)2Pbro/? (B6.Cg-Tg(CD2-Ifngr2)2Pbro)	abnormal T-helper 1 cell differentiation	J:134448
Tg(CD2-Ifngr2)2Pbro/? (B6.Cg-Tg(CD2-Ifngr2)2Pbro)	abnormal T-helper 1 physiology	J:134448
Tg(CD2-Ifngr2)2Pbro/? (NOD.Cg-Tg(CD2-Ifngr2)2Pbro)	abnormal splenic cell ratio	J:81981
Tg(CD2-Ifngr2)2Pbro/? (NOD.Cg-Tg(CD2-Ifngr2)2Pbro)	abnormal T-helper 1 physiology	J:81981
Tg(CD2-LAT2)1Wz/0 (Not Specified)	abnormal CD8-positive, alpha-beta T cell physiology	J:116157
Tg(CD2-Lmo2)#Thr/0 (involves: C57BL/6 * CBA)	enlarged spleen	J:102058
Tg(CD2-Lmo2)#Thr/0 (involves: C57BL/6 * CBA)	enlarged thymus	J:102058
Tg(CD2-Lrch1)#Liux/0 (involves: C57BL/6)	abnormal cellular extravasation	J:238772
Tg(CD2-Mir181d)38Oers/0 (involves: C57BL/6)	decreased CD8-positive, alpha-beta T cell number	J:212571
	decreased double-positive T cell number	J:212571
	decreased T cell number	J:212571
	thymus atrophy	J:212571
Tg(CD2-Mir181d)38Oers/0 Tg(TcraTcrb)425Cbn/0 (involves: C3H * C57BL/6)	decreased T cell number	J:212571
Tg(CD2-Myb/en)2Kmw/? (involves: C57BL/10 * CBA)	abnormal single-positive T cell number	J:126456
	decreased T cell number	J:126456
	decreased T cell proliferation	J:126456
	increased double-negative T cell number	J:126456
Tg(CD2-Myb/en)2Kmw/Tg(CD2-Myb/en)2Kmw (involves: C57BL/10 * CBA)	decreased double-positive T cell number	J:126456
	decreased T cell number	J:126456
	decreased T cell proliferation	J:126456
	increased double-negative T cell number	J:126456
	small spleen	J:126456
	small thymus	J:126456
Tg(CD2-Nfat5)1Snh/0 (involves: BALB/c * C57BL/6)	abnormal cytotoxic T cell physiology	J:80066
	abnormal T cell differentiation	J:80066
	abnormal T cell physiology	J:80066
	decreased CD4-positive, alpha-beta T cell number	J:80066
	decreased CD8-positive, alpha-beta T cell number	J:80066
	decreased splenocyte proliferation	J:80066
	decreased T cell number	J:80066
	decreased T cell proliferation	J:80066
	spleen hypoplasia	J:80066
	thymus hypoplasia	J:80066
Tg(CD2-Ppp2ca)#Gct/0 (involves: C57BL/6J)	abnormal T cell subpopulation ratio	J:184067
	enlarged spleen	J:184067
	increased germinal center B cell number	J:184067
	increased neutrophil cell number	J:184067
Tg(CD2-Rorc)#Staka/0 (involves: C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:236222
	abnormal T-helper 17 cell physiology	J:236222
	decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:230700
	decreased CD8-positive, alpha-beta T cell number	J:236222
	decreased IgG2c level	J:236222
	decreased IgG3 level	J:236222
	decreased IgG level	J:236222
	increased effector memory CD4-positive, alpha-beta T cell number	J:230700
Tg(CD2-S1PR1)1Ejg/? (involves: C57BL/6 * DBA/2)	abnormal lymphocyte chemotaxis	J:96558
	decreased activated T cell number	J:96558
	decreased T cell proliferation	J:96558
	impaired leukocyte migration	J:96558
	increased activated T cell number	J:96558
	increased IgE level	J:96558
	increased T cell number	J:96558
Tg(CD2-Sh2d1a)#Vei/0 (involves: 129S1/Sv * 129X1/SvJ)	increased natural killer cell mediated cytotoxicity	J:110195
Tg(CD2-Sh2d1b1)#Vei/0 (B6.Cg-Tg(CD2-Sh2d1b1)#Vei)	impaired natural killer cell mediated cytotoxicity	J:110195
Tg(CD2-Sh2d1b2)#Vei/0 (B6.Cg-Tg(CD2-Sh2d1b2)#Vei)	impaired natural killer cell mediated cytotoxicity	J:110195
Tg(Cd2-Smad7)#Chbe/0 (involves: C57BL/6)	abnormal T-helper 1 cell differentiation	J:184670
Tg(CD2-TcraF5,CD2-TcrbF5)1Kio/0 (involves: C57BL/10)	abnormal positive T cell selection	J:113713
Tg(CD2-TcraF5,CD2-TcrbF5)1Kio/0 (involves: C57BL/10)	increased CD8-positive, alpha-beta T cell number	J:113713
Tg(CD2-TcraF5,CD2-TcrbF5)1Kio/0 (involves: C57BL/10 * CBA/Ca)	decreased CD8-positive, alpha-beta T cell number	J:113713
Tg(CD2-TcraF5,CD2-TcrbF5)1Kio/0 (involves: BALB/c * C57BL/10)	decreased CD8-positive, alpha-beta T cell number	J:113713
Tg(CD2-TcraF5,CD2-TcrbF5)1Kio/? (involves: 129S1/Sv * 129X1/SvJ * C57BL/10 * FVB/N)	abnormal positive T cell selection	J:126026
	decreased CD4-positive, alpha-beta T cell number	J:126026
	increased CD8-positive, alpha-beta T cell number	J:126026
Tg(CD2-TcraF5,CD2-TcrbF5)1Kio/0 Tg(Cd4-BCL2G101AD102AD103A)AWnt/0 (involves: C57BL/6 C57BL/10)	abnormal T cell clonal deletion	J:217939
	decreased thymocyte apoptosis	J:217939
	increased T cell number	J:217939
Tg(CD2-TcraF5,CD2-TcrbF5)1Kio/0 Tg(LCKprBCL2)36Sjk/0 (involves: C57BL/6 * C57BL/10)	abnormal T cell clonal deletion	J:217939
	decreased thymocyte apoptosis	J:217939
Tg(CD2-Tgfbr2)1Grs/0 (C57BL/6-Tg(CD2-Tgfbr2)1Grs/Nci)	enlarged spleen	J:97523
Tg(CD2-Tgfbr2)1Grs/0 (C57BL/6-Tg(CD2-Tgfbr2)1Grs/Nci)	increased T cell proliferation	J:97523
Tg(CD2-Tgfbr2)1Grs/? (C57BL/6-Tg(CD2-Tgfbr2)1Grs/Nci)	abnormal CD8-positive, alpha beta T cell morphology	J:93665
Tg(CD2-Tgfbr2)1Grs/? (C57BL/6-Tg(CD2-Tgfbr2)1Grs/Nci)	increased T cell proliferation	J:93665
Tg(CD2-Zbtb7b)C8Rbo/? (involves: C57BL/6)	absent CD8-positive, alpha-beta T cells	J:97610
Tg(CD2-Zbtb7b)C8Rbo/? (involves: C57BL/6)	increased CD4-positive, alpha-beta T cell number	J:97610
Tg(CD2-Zbtb7b)C8Rbo/? Tg(TcraH-Y,TcrbH-Y)71Vbo/? (involves: C57BL/6 * DBA/2J)	abnormal T cell differentiation	J:97610
Tg(CD2-Zbtb7b)C8Rbo/? Tg(TcrLCMV)327Sdz/? (involves: C57BL/6 * DBA/2J)	abnormal T cell differentiation	J:97610
Tg(CD2-Zbtb7b)C8Rbo/? Themis^tm1Lov/Themis^tm1Lov (involves: 129)	abnormal T cell differentiation	J:151075
Tg(Cd3d-Il5)NJ.1638Nal/? (involves: C57BL/6J * CBA/J)	abnormal eosinophil differentiation	J:123440
	abnormal spleen morphology	J:123440
	abnormal T cell number	J:123440
	erythroblastosis	J:123440
	increased eosinophil cell number	J:123440
	increased leukocyte cell number	J:123440
	increased mature B cell number	J:123440
	increased monocyte cell number	J:123440
	increased neutrophil cell number	J:123440
	increased spleen weight	J:123440
Tg(CD3E)26Cpt/Tg(CD3E)26Cpt (involves: C57BL/6J * CBA/J)	abnormal thymus corticomedullary boundary morphology	J:81711
	absent NK cells	J:81711
	arrested T cell differentiation	J:81711
	decreased double-positive T cell number	J:54756
	decreased T cell number	J:54756
	decreased thymocyte number	J:81711
	decreased uterine NK cell number	J:134589
	thymus hypoplasia	J:54756
Tg(Cd4-BCL2G101AD102A*D103A)AWnt/0 (involves: C57BL/6)	abnormal CD4-positive, alpha-beta T cell number	J:217939
	abnormal splenic cell ratio	J:217939
	abnormal T cell clonal deletion	J:217939
	abnormal T cell proliferation	J:217939
	abnormal T cell subpopulation ratio	J:217939
	decreased double-positive T cell number	J:217939
	decreased thymocyte apoptosis	J:217939
	enlarged spleen	J:217939
	increased activated T cell number	J:217939
	increased B cell number	J:217939
	increased central memory CD8 positive, alpha-beta T cell number	J:217939
	increased myeloid cell number	J:217939
	increased regulatory T cell number	J:217939
	increased single-positive T cell number	J:217939
	increased T cell number	J:217939
Tg(Cd4-BCL2G101AD102AD103A)AWnt/0 (involves: C57BL/6 CBA/J)	abnormal T cell clonal deletion	J:217939
	decreased thymocyte apoptosis	J:217939
Tg(Cd4-BCL2G101AD102AD103A)AWnt/0 Tg(Nr4a1-EGFP/cre)820Khog/0 (involves: C57BL/6 C57BL/6J)	abnormal T cell clonal deletion	J:217939
	decreased thymocyte apoptosis	J:217939
Tg(Cd4-BCL2G101AD102AD103A)AWnt/0 Tg(TcraH-Y,TcrbH-Y)71Vbo/0 (involves: C57BL/6 C57BL/6J * DBA/2J)	abnormal T cell clonal deletion	J:217939
	decreased thymocyte apoptosis	J:217939
Tg(CD4-CIITA)357Ccum/? (involves: C57BL/6 * C57BL/6J * SJL)	increased osteoclast cell number	J:233241
Tg(Cd4-cre)1Cwi/0 Trmt6^em1Hbgl/Trmt6^em1Hbgl (involves: C57BL/6 * DBA/2J)	decreased CD4-positive, alpha-beta T cell number	J:336736
	decreased T cell proliferation	J:336736
Tg(Cd4-cre)1Cwi/0 Trmt61a^em1Hbgl/Trmt61a^em1Hbgl (involves: C57BL/6 * DBA/2J)	abnormal CD4-positive T cell differentiation	J:336736
	abnormal T cell activation	J:336736
	decreased CD4-positive, alpha-beta T cell number	J:336736
	decreased CD8-positive, alpha-beta T cell number	J:336736
	decreased T cell proliferation	J:336736
	increased CD4-positive, alpha-beta T cell number	J:336736
	increased CD8-positive, alpha-beta T cell number	J:336736
Tg(Cd4-Dtx1)1Mzl/? (involves: C57BL/6)	abnormal T cell activation	J:151605
	abnormal thymocyte activation	J:151605
	decreased T cell proliferation	J:151605
Tg(CD4-HIV)F21380Pjo/0 (involves: C3H * C57BL/6)	spleen atrophy	J:78756
Tg(CD4-HIV)F21380Pjo/0 (involves: C3H * C57BL/6)	thymus atrophy	J:78756
Tg(CD4-HIV)F21388Pjo/0 (involves: C3H * C57BL/6)	spleen atrophy	J:78756
Tg(CD4-HIV)F21388Pjo/0 (involves: C3H * C57BL/6)	thymus atrophy	J:78756
Tg(CD4-HIV)F21407Pjo/0 (involves: C3H * C57BL/6)	spleen atrophy	J:78756
Tg(CD4-HIV)F21407Pjo/0 (involves: C3H * C57BL/6)	thymus atrophy	J:78756
Tg(CD4-HIV)F26605Pjo/0 (involves: C3H * C57BL/6)	spleen atrophy	J:78756
Tg(CD4-HIV)F26605Pjo/0 (involves: C3H * C57BL/6)	thymus atrophy	J:78756
Tg(CD4-HIV)F26622Pjo/0 (involves: C3H * C57BL/6)	spleen atrophy	J:78756
Tg(CD4-HIV)F26622Pjo/0 (involves: C3H * C57BL/6)	thymus atrophy	J:78756
Tg(CD4-HIV)F26990Pjo/0 (involves: C3H * C57BL/6)	spleen atrophy	J:78756
Tg(CD4-HIV)F26990Pjo/0 (involves: C3H * C57BL/6)	thymus atrophy	J:78756
Tg(CD4-HIV)F27011Pjo/0 (involves: C3H * C57BL/6)	spleen atrophy	J:78756
Tg(CD4-HIV)F27011Pjo/0 (involves: C3H * C57BL/6)	thymus atrophy	J:78756
Tg(CD4-HIV)F27367Pjo/0 (involves: C3H * C57BL/6)	spleen atrophy	J:78756
Tg(CD4-HIV)F27367Pjo/0 (involves: C3H * C57BL/6)	thymus atrophy	J:78756
Tg(Cd4-Il17rb)#Cdon/? (involves: C57BL/6)	abnormal T cell differentiation	J:158594
	hematopoietic system phenotype	J:158594
	increased eosinophil cell number	J:158594
Tg(Cd4-NPM/ALK)N1Ingh/0 (either: (involves: BALB/c * Swiss Webster) or (involves: C57BL/6 * Swiss Webster))	increased immunoglobulin level	J:82127
Tg(Cd4-NPM/ALK)N1Ingh/0 (involves: C57BL/6 * Swiss Webster)	abnormal T cell differentiation	J:235890
	abnormal T cell morphology	J:235890
	increased DN3 thymocyte number	J:235890
Tg(Cd4-NPM/ALK)N1Ingh/0 Tg(TcraTcrb)1100Mjb/0 (involves: C57BL/6 * Swiss Webster)	abnormal double-negative T cell morphology	J:235890
	abnormal thymus morphology	J:235890
Tg(Cd4-TGFBR2)16Flv/? (involves: C3H * C57BL/6 * C57BL/10 * C57BR/cd)	abnormal T cell activation	J:97554
	abnormal T cell proliferation	J:97554
	abnormal thymus involution	J:97554
	decreased B cell number	J:97554
	increased IgA level	J:97554
	increased IgG1 level	J:97554
	increased IgG2a level	J:97554
	increased immunoglobulin level	J:97554
	increased memory T cell number	J:97554
	spleen hyperplasia	J:97554
Tg(Cd4-TGFBR2)16Flv/? (involves: C3H * C57BL/6)	abnormal CD8-positive, alpha-beta regulatory T cell morphology	J:134473
Tg(Cd4-TGFBR2)16Flv/? (involves: C3H * C57BL/6)	abnormal T cell proliferation	J:134473
Tg(Cd4-Zbtb16)1797Aben/? (C57BL/6-Tg(Cd4-Zbtb16)1797Aben)	decreased CD4-positive, alpha-beta T cell number	J:139690
	increased CD4-positive, alpha-beta memory T cell number	J:139690
	increased T-helper 2 cell number	J:139690
Tg(Cd8aCd8b)3Erob/0 (involves: C57BL/6 * DBA/2)	abnormal CD8-positive, alpha-beta T cell differentiation	J:93004
	abnormal double-positive T cell morphology	J:93004
	decreased CD4-positive, alpha-beta T cell number	J:93004
	decreased double-negative T cell number	J:93004
	increased CD8-positive, alpha-beta T cell number	J:93004
Tg(Cd8aCd8b)3Erob/0 Tg(TcraH-Y,TcrbH-Y)71Vbo/0 (involves: C57BL/6 * DBA/2)	abnormal CD4-positive, alpha beta T cell morphology	J:93004
	abnormal CD8-positive, alpha-beta T cell differentiation	J:93004
	increased CD8-positive, alpha-beta T cell number	J:93004
Tg(CD8aCD8b)57Scr/? (B6;SJL-Tg(CD8aCD8b)57Scr/J)	abnormal cytotoxic T cell physiology	J:92994
Tg(CD8aCD8b)57Scr/? (B6;SJL-Tg(CD8aCD8b)57Scr/J)	abnormal effector T cell morphology	J:92994
Tg(Cd8b1)46Erob/0 (involves: 129S4/SvJae * C57BL/6 * CBA)	abnormal T cell subpopulation ratio	J:110916
	decreased T cell number	J:110916
	decreased thymocyte number	J:110916
Tg(CD19)1Tft/0 (involves: C57BL/6 * C57BL/6J * SJL)	decreased B cell number	J:27236
Tg(CD19)1Tft/0 (involves: C57BL/6 * C57BL/6J * SJL)	increased B cell proliferation	J:27236
Tg(CD19)1Tft/Tg(CD19)1Tft (involves: C57BL/6 * C57BL/6J * SJL)	decreased B cell number	J:27236
	decreased IgG1 level	J:27236
	decreased IgG3 level	J:27236
	decreased immature B cell number	J:27236
	increased B cell proliferation	J:27236
	increased IgG2a level	J:27236
	increased IgG2b level	J:27236
	increased IgM level	J:27236
Tg(CD19-Tnfsf7)#Rvl/0 (involves: C57BL/6)	abnormal metallophilic macrophage morphology	J:88620
	abnormal spleen marginal zone macrophage morphology	J:88620
	abnormal spleen marginal zone morphology	J:88620
	decreased B cell number	J:88620
	decreased mature B cell number	J:88620
	decreased transitional stage B cell number	J:88620
Tg(CD46)2Gsv/0 (involves: C57BL/6 * FVB/N)	decreased cytotoxic T cell cytolysis	J:109895
Tg(Cd68-BCL2)535Medz/0 (involves: 129 * C57BL/6)	enlarged spleen	J:82809
Tg(Cd74-Nlrc4*)1Kyas/0 (involves: C57BL/6N)	abnormal spleen morphology	J:219652
	enlarged spleen	J:219652
	increased neutrophil cell number	J:219652
	increased splenocyte number	J:219652
	increased T cell number	J:219652
Tg(Cd79b-TCL1A)BKTeit/0 (involves: C3H * C57BL/6)	abnormal spleen morphology	J:79703
	abnormal thymus morphology	J:79703
	decreased B cell apoptosis	J:79703
	decreased T cell apoptosis	J:79703
	enlarged spleen	J:79703
	increased B cell proliferation	J:79703
	increased lymphocyte cell number	J:79703
	increased T cell proliferation	J:79703
Tg(CD207-Dta)312Dhka/? (FVB-Tg(CD207-Dta)312Dhka)	absent Langerhans cell	J:113309
Tg(CLEC4C-HBEGF)956Cln/0 (C57BL/6-Tg(CLEC4C-HBEGF)956Cln)	abnormal cytotoxic T cell physiology	J:166504
	abnormal NK cell physiology	J:166504
	abnormal NK T cell physiology	J:166504
	decreased CD8-positive, alpha-beta T cell number	J:166504
	decreased plasmacytoid dendritic cell number	J:166504
	decreased splenocyte number	J:166504
	impaired natural killer cell mediated cytotoxicity	J:166504
	small spleen	J:166504
Tg(Cma1-cre)ARoer/0 Tg(Kit*D814V)1Roer/0 (involves: C57BL/6)	increased mast cell number	J:169611
Tg(Cma1-cre)ARoer/0 Tg(Kit*D814V)3Roer/0 (involves: C57BL/6)	increased mast cell number	J:169611
Tg(CMV-cre)1Cgn/0 Tg(KitD814V)1Roer/0 (involves: BALB/cJ C57BL/6)	abnormal erythrocyte physiology	J:169611
	abnormal erythropoiesis	J:169611
	increased mast cell number	J:169611
	increased nucleated erythrocyte cell number	J:169611
Tg(CMV-cre)1Cgn/0 Tg(KitD814V)3Roer/0 (involves: BALB/cJ C57BL/6)	abnormal erythrocyte physiology	J:169611
	abnormal erythropoiesis	J:169611
	increased mast cell number	J:169611
	increased nucleated erythrocyte cell number	J:169611
Tg(CMV-cre)1Cgn/0 Trp53^tm4Att/Trp53⁺ (involves: 129S4/SvJae * BALB/cJ * C57BL/6J)	small thymus	J:217080
Tg(CMV-IghvaD11)CCat/0 Tg(CMV-IgkvaD11)BCat/0 (involves: C57BL/6 * SJL)	abnormal splenic cell ratio	J:79946
	increased splenocyte apoptosis	J:79946
Tg(CMV-IghvaD11)DCat/0 Tg(CMV-IgkvaD11)ACat/0 (involves: C57BL/6 * SJL)	abnormal splenic cell ratio	J:79946
	increased splenocyte apoptosis	J:79946
Tg(CMV-SALL4_iB)#Chai/? (Not Specified)	abnormal erythrocyte morphology	J:115037
	abnormal leukocyte morphology	J:115037
	abnormal megakaryocyte morphology	J:115037
	abnormal myelopoiesis	J:115037
	abnormal neutrophil morphology	J:115037
	anemia	J:115037
	decreased leukocyte cell number	J:115037
	decreased neutrophil cell number	J:115037
	giant platelets	J:115037
	increased bone marrow cell number	J:115037
	increased erythroid progenitor cell number	J:115037
	increased nucleated erythrocyte cell number	J:115037
	myeloid hyperplasia	J:115037
Tg(CMV-SART3)#Hbro/0 (Not Specified)	abnormal common myeloid progenitor cell morphology	J:173259
	abnormal definitive hematopoiesis	J:173259
	decreased erythroid progenitor cell number	J:173259
	increased erythroid progenitor cell number	J:173259
Tg(Cnp-EGFR)10Nrat/0 (involves: C57BL/6 * SJL)	increased mast cell number	J:95933
Tg(Cnp-Gpr17)1Qrlu/0 (Not Specified)	microgliosis	J:154602
Tg(Col1a1-cre)1Kry/0 Vdr^tm2Ska/Vdr^tm2Ska (involves: C57BL/6J * C57BL/6NCrlj * CBA/JNCrlj * FVB/N)	abnormal osteoclast differentiation	J:196471
	decreased osteoclast cell number	J:196471
Tg(Col1a1-Dkk1)1Hmk/? (B6.FVB-Tg(Col1a1-Dkk1)1Hmk)	abnormal definitive hematopoiesis	J:238121
	abnormal hematopoietic stem cell physiology	J:238121
	abnormal osteoclast physiology	J:158620
	increased common lymphocyte progenitor cell number	J:238121
	increased osteoclast cell number	J:158620
Tg(Col1a1-FGF2,-Sapphire)203Mmh/Tg(Col1a1-FGF2,-Sapphire)203Mmh (involves: FVB/N)	increased osteoclast cell number	J:159949
Tg(Col1a1-Runx2)#Pmt/0 (involves: BALB/c * C57BL/6)	increased osteoclast cell number	J:167992
Tg(Col1a1-TK*)#Rowe/0 (involves: CD-1)	decreased bone marrow cell number	J:112520
	decreased osteoclast cell number	J:112520, J:217781
	increased spleen weight	J:112520
Tg(Col1a1-tTA)139Niss/0 Tg(tetO-HTR4D100A)7Niss/0 (FVB/N-Tg(Col1a1-tTA)139Niss Tg(tetO-HTR4D100A)7Niss)	increased osteoclast cell number	J:131617
Tg(Col2a1-Fgfr3/GH)BDor/0 (FVB/N-Tg(Col2a1-Fgfr3/GH)BDor)	abnormal osteoclast differentiation	J:50292
Tg(Col10a1-Tg*L2263P)1Rpbh/0 (Not Specified)	decreased osteoclast cell number	J:154052
Tg(Col10a1-TgL2263P)1Rpbh/Tg(Col10a1-TgL2263P)1Rpbh (Not Specified)	decreased osteoclast cell number	J:154052
Tg(Cr2-cre)3Cgn/? Xrcc4^tm1Fwa/Xrcc4^tm2Fwa (involves: 129P2/OlaHsd * 129S6/SvEvTac)	abnormal class switch recombination	J:150339
Tg(Crh)227.1Pbl/0 (involves: C57BL/6 * SJL)	decreased spleen weight	J:92996
Tg(Crh)227.1Pbl/0 (involves: C57BL/6 * SJL)	decreased thymus weight	J:92996
Tg(CSTG-NPM1/RARA)#Sjch/0 (involves: C57BL/6)	enlarged spleen	J:55196
Tg(CSTG-NPM1/RARA)#Sjch/0 (involves: C57BL/6)	increased spleen red pulp amount	J:55196
Tg(CTSG-NUMA1/RARA)#Skr/0 (involves: C57BL/6)	abnormal definitive hematopoiesis	J:88103
	abnormal spleen morphology	J:88103
	abnormal spleen red pulp morphology	J:88103
	decreased common myeloid progenitor cell number	J:88103
	decreased erythroid progenitor cell number	J:88103
	enlarged spleen	J:88103
	increased bone marrow cell number	J:88103
	increased granulocyte number	J:88103
	increased leukocyte cell number	J:88103
	increased neutrophil cell number	J:88103
	increased spleen germinal center size	J:88103
	increased spleen white pulp amount	J:88103
	thrombocytopenia	J:88103
Tg(CTSG-PML/RARA)135Ley/? (Not Specified)	abnormal leukocyte cell number	J:77881
	abnormal myeloblast morphology/development	J:77881
	abnormal spleen red pulp morphology	J:77881
	anemia	J:77881
	enlarged spleen	J:77881
	spleen hyperplasia	J:77881
	thrombocytopenia	J:77881
Tg(CTSG-PML/RARA)135Ley/? (involves: C3H * C57BL/6)	abnormal myeloblast morphology/development	J:59080
	abnormal spleen red pulp morphology	J:59080
	anemia	J:59080
	enlarged spleen	J:59080
	increased leukocyte cell number	J:59080
	thrombocytopenia	J:59080
Tg(CTSG-PML/RARA)135Ley/0 Tg(CTSG-RARA/PML)#Ley/0 (involves: C3H * C57BL/6)	abnormal spleen red pulp morphology	J:59080
	anemia	J:59080
	enlarged spleen	J:59080
	increased leukocyte cell number	J:59080
	thrombocytopenia	J:59080
Tg(CTSG-PML/RARA)135Ley/0 Wbcc1^SWR/J/? (involves: C3H/HeJ * C57BL/6J * SWR/J)	decreased leukocyte cell number	J:139159
Tg(CTSG-PML/RARA)135Ley/0 Wbcc2^SWR/J/? (involves: C3H/HeJ * C57BL/6J * SWR/J)	increased leukocyte cell number	J:139159
Tg(CTSG-PML/RARA)135Ley/0 Wbcc3^SWR/J/? (involves: C3H/HeJ * C57BL/6J * SWR/J)	increased leukocyte cell number	J:139159
Tg(CTSG-PML/RARA)6179Ppp/0 (Not Specified)	abnormal definitive hematopoiesis	J:40373
	abnormal myelopoiesis	J:40373
	decreased erythroid progenitor cell number	J:40373
	increased granulocyte number	J:40373
	increased leukocyte cell number	J:40373
Tg(CTSG-PML/RARA)#Ppp/0 (Not Specified)	abnormal definitive hematopoiesis	J:40373
	abnormal myelopoiesis	J:78201, J:40373
	decreased erythroid progenitor cell number	J:40373
	increased granulocyte number	J:40373
	increased leukocyte cell number	J:40373
Tg(CTSG-RARA/PML)#Ley/0 (involves: C3H * C57BL/6)	hematopoietic system phenotype	J:59080
Tg(CTSG-RARA/ZBTB16)#Ppp/0 (Not Specified)	abnormal myelopoiesis	J:65878
	enlarged spleen	J:65878
	myeloid hyperplasia	J:65878
	thrombocytopenia	J:65878
Tg(CTSG-RARA/ZBTB16)#Ppp/0 Tg(CTSG-ZBTB16/RARA)#Ppp/0 (Not Specified)	abnormal bone marrow cell physiology	J:65878
	abnormal definitive hematopoiesis	J:65878
	abnormal myelopoiesis	J:65878
	anemia	J:65878
	increased leukocyte cell number	J:65878
	thrombocytopenia	J:65878
Tg(CTSG-RARA/ZBTB16)#Sjch/0 Tg(CTSG-ZBTB16/RARA)#Sjch/0 (Not Specified)	impaired hematopoiesis	J:194312
Tg(CTSG-ZBTB16/RARA)#Ppp/0 (Not Specified)	abnormal myelopoiesis	J:78201
Tg(CTSG-ZBTB16/RARA)#Ppp/0 (Not Specified)	increased leukocyte cell number	J:65878, J:78201
Tg(CTSG-ZBTB16/RARA)#Sjch/0 (involves: C57BL/6)	abnormal bone marrow cell physiology	J:55196
	abnormal myelopoiesis	J:55196
	abnormal spleen morphology	J:55196
	abnormal spleen red pulp morphology	J:55196
	enlarged spleen	J:55196
	increased leukocyte cell number	J:55196
	myeloid hyperplasia	J:55196
Tg(CYP1A1-PPARD)#Jfoe/0 (involves: C57BL/6J * CBA)	increased T cell proliferation	J:158907
Tg(DMD-APP)7Neve/0 (involves: C57BL/6 SJL)	abnormal microglial cell morphology	J:100978
Tg(DMD-APP)18Neve/0 (involves: C57BL/6 SJL)	abnormal microglial cell morphology	J:100978
Tg(DO11.10)10Dlo/? (involves: BALB/c * C3H * C57BL/6)	abnormal thymus physiology	J:70572
	decreased CD4-positive, alpha-beta T cell number	J:70572
	decreased double-positive T cell number	J:70572
Tg(DO11.10)10Dlo/? Tox^tm1.1Kay/Tox^tm1.1Kay (involves: 129S/Sv * BALB/c * C3H * C57BL/6)	arrested T cell differentiation	J:131287
	decreased T cell number	J:131287
Tg(ED-L2-IL1RN/IL1B)#Tcw/? (B6.Cg-Tg(ED-L2-IL1RN/IL1B)#Tcw)	enlarged spleen	J:180282
Tg(EEF1A1-SHC1)1Ravi/? Tg(Lck-cre)1Cwi/? (involves: 129 C57BL/6)	abnormal double-negative T cell morphology	J:78180
	decreased double-positive T cell number	J:78180
	decreased single-positive T cell number	J:78180
	thymus hypoplasia	J:78180
Tg(EIF1AX-Il31ra)1Jagr/0 (involves: C3H * C57BL/6)	abnormal leukopoiesis	J:91124
	cutaneous mastocytosis	J:91124
	decreased T cell number	J:91124
	increased activated T cell number	J:91124
	increased B cell number	J:91124
	increased memory T cell number	J:91124
Tg(Ela-KRASG12D)9Eps/0 (involves: C57BL/6 FVB)	increased regulatory T cell number	J:231759
Tg(Ela-KRASG12D)9Eps/0 Tg(Mt1-TGFBR2)AM3Epb/0 (involves: C57BL/6 * FVB)	increased regulatory T cell number	J:231759
Tg(Ela-KRASG12D)9Eps/0 Tgfbr1^tm1Bopa/Tgfbr1⁺ (involves: 129S1/SvImJ C57BL/6 * FVB)	increased CD8-positive, alpha-beta T cell number	J:231759
Tg(Emu-Pim1)64aBrn/0 (involves: C57BL/6LiA * CBA)	enlarged spleen	J:79624
Tg(Emu-Pim1)64aBrn/0 (involves: C57BL/6LiA * CBA)	enlarged thymus	J:79624
Tg(Emu-TXLNA)1Amjr/0 (B6.Cg-Tg(Emu-TXLNA)1Amjr)	abnormal B cell physiology	J:117018
	enlarged spleen	J:117018
	increased B cell number	J:117018
	increased B-1 B cell number	J:117018
	increased B-2 B cell number	J:117018
	increased germinal center B cell number	J:117018
	increased IgA level	J:117018
	increased IgG2a level	J:117018
	increased IgM level	J:117018
	increased immunoglobulin level	J:117018
	increased marginal zone B cell number	J:117018
	increased plasma cell number	J:117018
Tg(Emu-Zfp521)1Homy/0 (Not Specified)	abnormal B cell differentiation	J:160392
	hematopoietic system phenotype	J:160392
	increased B cell number	J:160392
Tg(EmuSR-HDAC9)1468Kpet/0 (involves: C57BL/6 * CBA)	abnormal lymphocyte physiology	J:237420
	abnormal spleen marginal zone morphology	J:237420
	enlarged spleen	J:237420
	increased B cell number	J:237420
	increased B cell proliferation	J:237420
Tg(EmuSR-tTa)83Bop/0 Tg(IghMyc)22Bri/0 Tg(tetO-RNAi:Trp53)ASlowe/0 (involves: C57BL * C57BL/6 * FVB/N * SJL)	enlarged spleen	J:123006
Tg(EmuSR-tTa)83Bop/Tg(EmuSR-tTa)83Bop Tg(tetO-NPM1/ALK,-luc)2Gde/0 (involves: FVB/N)	enlarged spleen	J:160236
Tg(EmuSR-tTa)83Bop/Tg(EmuSR-tTa)83Bop Tg(tetO-TPM3/ALK,-luc)2Gde/0 (involves: FVB/N)	enlarged spleen	J:160236
Tg(Eno2-Hgf)1Tnak/0 Tg(SOD1G93A)^dl1Gur/0 (involves: C57BL/6 C57BL/6J * SJL/J)	microgliosis	J:128738
Tg(Eno2-Hmox1)2Main/Tg(Eno2-Hmox1)2Main (involves: C57BL/6J)	enlarged spleen	J:120240
Tg(EPO33)72Ptc/0 (involves: C57BL/6J * SJL/J)	enlarged spleen	J:92650
Tg(EPO33)72Ptc/0 (involves: C57BL/6J * SJL/J)	increased hematocrit	J:92650
Tg(Fabp2-Arg1)1Wla/Tg(Fabp2-Arg1)1Wla (involves: FVB)	abnormal B cell differentiation	J:80204
	decreased B cell number	J:80204
	decreased IgM level	J:80204
	decreased pre-B cell number	J:80204
	decreased spleen B cell follicle number	J:80204
	decreased spleen weight	J:80556
	decreased transitional stage B cell number	J:80204
	small spleen	J:80204
Tg(Fabp4-Angptl2)5Yo/0 (involves: C57BL/6)	abnormal macrophage chemotaxis	J:152387
Tg(Fabp4-Phb*Y114F)#Smis/0 (Not Specified)	abnormal spleen morphology	J:227976
	enlarged spleen	J:227976
	increased lymphocyte cell number	J:227976
Tg(FCGR2A)11Mkz/0 (involves: C57BL/6 * SJL)	abnormal platelet morphology	J:93244
Tg(FCGR2A)11Mkz/0 Tg(PF4)#Zcy/0 (involves: C57BL/6 * SJL)	thrombocytopenia	J:72220
Tg(FCGR2A)11Mkz/Tg(FCGR2A)11Mkz (involves: C57BL/6 * SJL)	abnormal macrophage physiology	J:136516
Tg(FCGR2A)11Mkz/Tg(FCGR2A)11Mkz (involves: C57BL/6 * SJL)	increased IgG2a level	J:136516
Tg(Fli1)1Ber/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1)	increased thymocyte number	J:33052
Tg(FOXJ1-ACE2)1Rba/0 (involves: C3H * C57BL/6)	decreased lymphocyte cell number	J:288386
Tg(Foxp3-HBEGF/EGFP)23.2Spar/0 (involves: C57BL/6NCrl)	decreased regulatory T cell number	J:125295
	enlarged spleen	J:125295
	increased spleen red pulp amount	J:125295
	increased spleen white pulp amount	J:125295
Tg(Gata1-Dyrk3)FND-IDowo/0 (involves: C57BL/6 * DBA/2)	abnormal erythropoiesis	J:144586
Tg(Gata1-Dyrk3)FND-IDowo/0 (involves: C57BL/6 * DBA/2)	decreased erythroid progenitor cell number	J:144586
Tg(Gata1-Zfpm1)1Sho/0 Zfpm1^tm1Sho/Zfpm1^tm1Sho (involves: 129S1/Sv * C57BL/6N * CD-1)	hematopoietic system phenotype	J:99745
Tg(Gfap-gp120)2Lms/0 (involves: C57BL/6 * SJL)	abnormal microglial cell morphology	J:146427
Tg(Gfap-gp120)2Lms/0 (involves: C57BL/6 * SJL)	microgliosis	J:146427
Tg(Gfap-gp120)10Lms/0 (involves: C57BL/6 * SJL)	microgliosis	J:146427
Tg(Gfap-rtTA,tetO-MAOB,-lacZ)1Jkan/0 (involves: C57BL/6)	abnormal microglial cell activation	J:132679
Tg(Gfap-rtTA,tetO-MAOB,-lacZ)1Jkan/0 (involves: C57BL/6)	abnormal microglial cell morphology	J:132679
Tg(Gfap-TK)7.1Mvs/0 (involves: C57BL/10 * CBA * CFLP)	anemia	J:104241
	decreased erythrocyte cell number	J:104241
	increased neutrophil cell number	J:104241
	increased nucleated erythrocyte cell number	J:104241
Tg(GNB1L,TBX1,GP1BB,SEPT5)23Bem/0 (either: FVB-Tg(GNB1L,TBX1,GP1BB,SEPT5)23Bem or (involves: C57BL/6 * FVB))	abnormal thymus development	J:67796
	abnormal thymus lobule morphology	J:67796
	decreased thymocyte number	J:67796
	thymus hypoplasia	J:67796
Tg(H2-Aa)26Dim/? Tg(H2-Ab1)62Dim/? (B6.Cg-Tg(H2-Aa)26Dim Tg(H2-Ab1)62Dim)	increased immunoglobulin level	J:110897
Tg(H2-D-Il15)3304Clgr/? (FVB/N-Tg(H2-D-Il15)3304Clgr)	abnormal lymphocyte physiology	J:67478
	abnormal T cell morphology	J:67478
	abnormal T cell subpopulation ratio	J:67478
	enlarged spleen	J:67478
	increased bone marrow cell number	J:67478
	increased lymphocyte cell number	J:67478
	increased memory T cell number	J:67478
	increased NK cell number	J:67478
	increased spleen white pulp amount	J:67478
Tg(H2-Ea)16Dim/? (involves: C57BL/6 * SJL)	increased immunoglobulin level	J:111128
Tg(H2-Ea-G6pc2)69Tkay/? (NOD-Tg(H2-Ea-G6pc2)69Tkay)	abnormal CD4-positive, alpha-beta T cell physiology	J:117352
	abnormal CD8-positive, alpha beta T cell morphology	J:117352
	decreased T cell proliferation	J:117352
Tg(H2-Ea-HA)HACIIAjca/0 Tg(Tcra/Tcrb)1Vbo/0 (C.Cg-Tg(H2-Ea-HA)HACIIAjca Tg(Tcra/Tcrb)1Vbo)	abnormal CD4-positive, alpha beta T cell morphology	J:209872
	increased IgG level	J:209872
Tg(H2-Ea-HA)HACIIAjca/0 Tg(TcraS106-1,TcrbS106-1)TS1SWAjca/0 (C.Cg-Tg(H2-Ea-HA)HACIIAjca Tg(TcraS106-1,TcrbS106-1)TS1SWAjca)	abnormal CD4-positive, alpha beta T cell morphology	J:209872
	abnormal CD4-positive, alpha-beta T cell physiology	J:209872
	increased IgG level	J:209872
Tg(H2-Ea-Il7)10Rhdr/0 (involves: C57BL/6)	abnormal B cell morphology	J:81133
Tg(H2-Ea-Il7)10Rhdr/0 (involves: C57BL/6)	abnormal double-negative T cell morphology	J:81133
Tg(H2-Ea-Il7)10Rhdr/0 (involves: C57BL/6 * DBA/2)	increased pre-B cell number	J:171924
Tg(H2-Ea-Il7)10Rhdr/0 (involves: C57BL/6 * DBA/2)	increased pro-B cell number	J:171924
Tg(H2-Ea-Ins2)1Wehi/0 (NOD/ShiLtJWehi-Tg(H2-Ea-Ins2)1Wehi)	abnormal T cell proliferation	J:100232
Tg(H2-Ea-Ins2)1Wehi/Tg(H2-Ea-Ins2)1Wehi (NOD/ShiLtJWehi-Tg(H2-Ea-Ins2)1Wehi)	abnormal CD8-positive, alpha beta T cell morphology	J:117352
	decreased T cell proliferation	J:117352
	hematopoietic system phenotype	J:117352
Tg(H2-Ea-LACK)1Ngkh/0 (C.Cg-Tg(H2-Ea-LACK)1Ngkh)	abnormal T-helper 1 physiology	J:181384
	abnormal T-helper 2 physiology	J:181384
	decreased T-helper 2 cell number	J:181384
	increased T-helper 1 cell number	J:181384
Tg(H2-Ea-Tnfsf9)16Lpc/0 (involves: C57BL/6)	abnormal B cell physiology	J:132372
	decreased B cell number	J:132372
	decreased IgG level	J:132372
	decreased spleen B cell follicle number	J:132372
	enlarged spleen	J:132372
	increased granulocyte number	J:132372
	increased lymphocyte cell number	J:132372
	increased macrophage cell number	J:132372
	increased memory T cell number	J:145439
	increased NK cell number	J:132372
	spleen hyperplasia	J:132372
Tg(H2-K-BCL2)1Josd/0 (involves: C57BL/6 * C57BL/Ka * C3H)	abnormal hematopoietic system morphology/development	J:80894
	enlarged spleen	J:80894
	enlarged thymus	J:80894
	increased hematopoietic stem cell number	J:80894
	increased leukocyte cell number	J:80894
Tg(H2-K-Cd86)7All/0 (involves: C57BL/6J * CBA)	abnormal B cell differentiation	J:112475
	decreased B cell number	J:112475
	increased CD4-positive, alpha-beta T cell number	J:112475
	increased CD8-positive, alpha-beta T cell number	J:112475
Tg(H2-K-Cd86)7All/0 (B6.Cg-Tg(H2-K-Cd86)7All)	decreased B cell number	J:112266
	decreased CD4-positive, alpha-beta T cell number	J:112266
	increased CD8-positive, alpha-beta T cell number	J:112266
	increased T cell number	J:112266
Tg(H2-K-Cd86)7All/0 (involves: BALB/c * C57BL/6 * CBA)	increased splenocyte number	J:112266
Tg(H2-K-Cd86)7All/0 (involves: BALB/c * C57BL/6 * CBA)	spleen hyperplasia	J:112266
Tg(H2-K-Cd86)27All/0 (involves: C57BL/6J * CBA)	abnormal B cell differentiation	J:112475
Tg(H2-K-Cd86)27All/0 (involves: C57BL/6J * CBA)	decreased B cell number	J:112475
Tg(H2-K-Cd86)31All/0 (involves: C57BL/6J * CBA)	increased CD4-positive, alpha-beta T cell number	J:112475
Tg(H2-K-Cd86)31All/0 (involves: C57BL/6J * CBA)	increased CD8-positive, alpha-beta T cell number	J:112475
Tg(H2-K-DUSP5)21Wjl/0 (involves: C57BL/6J * CBA)	abnormal T cell number	J:138077
	decreased single-positive T cell number	J:138077
	decreased T cell proliferation	J:138077
	increased CD4-positive, alpha-beta T cell number	J:138077
	increased CD8-positive, alpha-beta T cell number	J:138077
	increased double-positive T cell number	J:138077
	increased plasma cell number	J:138077
	increased single-positive T cell number	J:138077
Tg(H2-K-Fosl1)1Wag/0 (involves: C57BL/6 * CBA)	anemia	J:64494
	enlarged spleen	J:64494
	extramedullary hematopoiesis	J:64494
Tg(H2-K-Fosl2,-EGFP)13Wag/0 (either: 129.Cg-Tg(H2-K-Fosl2,-EGFP)13Wag or B6.Cg-Tg(H2-K-Fosl2,-EGFP)13Wag)	thymus fibrosis	J:139032
Tg(H2-K-HLA-G,B2M)1Alm/0 (CBA/Ca-Tg(H2-K-HLA-G,B2M)1Alm/CmwJ)	abnormal cytotoxic T cell physiology	J:140016
	increased T cell proliferation	J:140016
Tg(H2-K-Hmga1)#Lmsr/0 (involves: C57BL/6 * SJL)	increased leukocyte cell number	J:90252
Tg(H2-K-IL6)2Srj/0 (B6.Cg-Tg(H2-K-IL6)2Srj)	abnormal definitive hematopoiesis	J:185153
	abnormal granulocyte morphology	J:185153
	abnormal spleen germinal center morphology	J:185153
	abnormal spleen red pulp morphology	J:185153
	enlarged spleen	J:185153
	extramedullary hematopoiesis	J:185153
	increased IgG level	J:185153
	increased megakaryocyte cell number	J:185153
	increased plasma cell number	J:185153
Tg(H2-K-MC159/EGFP)13Fkmc/0 (involves: C57BL/6)	abnormal lymphopoiesis	J:138050
	decreased B cell apoptosis	J:138050
	decreased T cell apoptosis	J:138050
	enlarged spleen	J:138050
	increased B cell proliferation	J:138050
	increased follicular B cell number	J:138050
Tg(H2-K-MC159/EGFP)13Fkmc/Tg(H2-K-MC159/EGFP)13Fkmc (involves: C57BL/6)	increased double-negative T cell number	J:138050
	increased IgG2b level	J:138050
	increased T cell number	J:138050
Tg(H2-K-TcrbP14)128Mak/? (involves: C57BL/6 * C57L * DBA/2)	abnormal CD8-positive, alpha-beta T cell differentiation	J:111265
	abnormal T cell clonal deletion	J:111265
	abnormal T cell differentiation	J:111265
	increased CD8-positive, alpha-beta T cell number	J:111265
Tg(H2-K^b-IL21)5Wjl/0 (involves: 129)	abnormal B cell differentiation	J:93740
	abnormal class switch recombination	J:93740
	decreased follicular B cell number	J:93740
	decreased marginal zone B cell number	J:93740
	decreased mature B cell number	J:93740
	decreased transitional stage T2 B cell number	J:93740
	increased B cell apoptosis	J:93740
	increased IgG1 level	J:93740
	increased IgM level	J:93740
	increased immature B cell number	J:93740
	increased transitional stage T1 B cell number	J:93740
Tg(H2-K^b-Jak2V617F)2Shmd/0 (involves: C57BL/6 DBA/2)	abnormal definitive hematopoiesis	J:130189
	abnormal megakaryocyte morphology	J:130189
	abnormal spleen morphology	J:130189
	anemia	J:130189
	decreased erythroblast number	J:130189
	decreased erythrocyte cell number	J:130189
	decreased erythroid progenitor cell number	J:130189
	decreased hematocrit	J:130189
	decreased hemoglobin content	J:130189
	enhanced megakaryocyte emperipolesis	J:130189
	enlarged spleen	J:130189
	giant platelets	J:130189
	increased leukocyte cell number	J:130189
	increased megakaryocyte cell number	J:130189
	increased neutrophil cell number	J:130189
	increased number of Howell-Jolly bodies	J:130189
	increased spleen red pulp amount	J:130189
	increased spleen weight	J:130189
	myeloid hyperplasia	J:130189
	polychromatophilia	J:130189
	spleen fibrosis	J:130189
	thrombocytosis	J:130189
Tg(H2-K^b-Tcra,-Tcrb)1640Kurs/0 (SJL.FVB-Tg(H2-K^b-Tcra,-Tcrb)1640Kurs)	increased T-helper 1 cell number	J:149511
	increased T-helper 17 cell number	J:149511
Tg(H2-L-IL6)1Kish/Tg(H2-L-IL6)1Kish (C57BL/6-Tg(H2-L-IL6)1Kish)	abnormal bone marrow cell morphology/development	J:128016
	abnormal definitive hematopoiesis	J:128016
	abnormal myelopoiesis	J:128016
	anemia	J:128016
	decreased erythrocyte cell number	J:128016
	decreased hemoglobin content	J:128016
	enlarged spleen	J:128016, J:138762
	increased IgG1 level	J:128016
	increased megakaryocyte cell number	J:128016
	increased monocyte cell number	J:128016
	increased neutrophil cell number	J:128016
	increased plasma cell number	J:128016, J:138762
	thrombocytosis	J:128016
Tg(H2-L-IL6)40Csk/0 (involves: C57BL/6)	enlarged spleen	J:207264
Tg(H2-L-IL6)40Csk/0 (involves: C57BL/6)	increased spleen weight	J:207264
Tg(H2-L-IL6)46Kish/Tg(H2-L-IL6)46Kish (C57BL/6-Tg(H2-L-IL6)46Kish)	increased immunoglobulin level	J:40405
	increased plasma cell number	J:40405
Tg(H2-L-IL6)46Kish/Tg(H2-L-IL6)46Kish (involves: BALB/c * C57BL/6)	increased IgA level	J:40405
	increased immunoglobulin level	J:40405
Tg(H2-L-IL6)46Kish/Tg(H2-L-IL6)46Kish (C.B6-Tg(H2-L-IL6)46Kish)	abnormal spleen trabecular artery morphology	J:177820
	abnormal spleen trabecular vein morphology	J:177820
	enlarged spleen	J:177820
	increased IgG1 level	J:74377
	increased IgG2b level	J:74377
	increased IgG level	J:74377
Tg(H2KePCC)2403Stoe/? Tg(TcraTcrbAD10)1Hed/? (involves: C57BL/6 * SJL)	decreased CD4-positive, alpha-beta T cell number	J:92997
Tg(H2KmPCC)2939Stoe/0 Tg(Tcra2B4)1Mmd/0 Tg(Tcrb2B4)1Mmd/0 (involves: C3H/HeJ * C57BL/6 * SJL)	abnormal T cell differentiation	J:50143
	decreased T cell proliferation	J:50143
	decreased thymocyte number	J:50143
Tg(H2KmPCC)2939Stoe/? Tg(TcrAND)53Hed/? (involves: C57BL/6 * SJL)	decreased CD4-positive, alpha-beta T cell number	J:92997
Tg(H2KmPCC)2939Stoe/? Tg(TcraTcrbAD10)1Hed/? (involves: C57BL/6 * SJL)	decreased CD4-positive, alpha-beta T cell number	J:92997
Tg(HBB-Gata1)G4Phi/Y (involves: 129P2/OlaHsd * FVB)	abnormal erythropoiesis	J:63773
Tg(HBB-Gata1)G4Phi/Y (involves: 129P2/OlaHsd * FVB)	anemia	J:63773
Tg(HBB-Gata1)G4Phi/Y (involves: FVB)	abnormal erythropoiesis	J:98277
Tg(HBB-Gata1)G4Phi/Y (involves: FVB)	anemia	J:98277
Tg(HBB-lacZ)ALey/0 (involves: C57BL/6NTac)	hematopoietic system phenotype	J:203044
Tg(HBB-Myc)#Cos/0 (involves: C57BL/6J * CBA/J)	anemia	J:276641
Tg(HBB-Myc)#Cos/0 (involves: C57BL/6J * CBA/J)	decreased hematocrit	J:276641
Tg(HBVX,-Myc)#Skp/Tg(HBVX,-Myc)#Skp (Not Specified)	abnormal definitive hematopoiesis	J:81098
Tg(HBVX,-Myc)#Skp/Tg(HBVX,-Myc)#Skp (Not Specified)	increased macrophage cell number	J:81098
Tg(HCRT-tTA)1Ahky/0 Tg(tetO-DTA)1Gfi/0 (B6.Cg-Tg(HCRT-tTA)1Ahky Tg(tetO-DTA)1Gfi)	increased microglial cell activation	J:211045
Tg(HLA-A2/H2-K)1Scr/? (involves: C57BL/6)	abnormal cytotoxic T cell physiology	J:127813
Tg(HLA-DRA0101,HLA-DRB10101)1Dmz/Tg(HLA-DRA0101,HLA-DRB10101)1Dmz (involves: C57BL/6 * C57BL/10Sn * SJL/J)	abnormal T cell physiology	J:108635
Tg(Igh3H9)41Mwg/? (involves: C57BL/6 * SJL)	abnormal B cell differentiation	J:119625
Tg(Igh3H9)41Mwg/? (involves: C57BL/6 * SJL)	decreased IgD level	J:119625
Tg(Igh*-Mir125b-1)5Toki/0 (Not Specified)	decreased hemoglobin content	J:178816
Tg(Igh*-Mir125b-1)5Toki/0 (Not Specified)	enlarged spleen	J:178816
Tg(Igh*-Mir125b-1)116Toki/0 (Not Specified)	decreased B cell apoptosis	J:178816
	decreased hemoglobin content	J:178816
	enlarged spleen	J:178816
	increased B cell number	J:178816
	increased bone marrow cell number	J:178816
Tg(Igh-3/Igh-6VD93)1241Ust/? (C57BL/6-Tg(Igh-3/Igh-6VD93)1241Ust)	abnormal B cell morphology	J:135209
	decreased pre-B cell number	J:135209
Tg(Igh-3VD93)343Ust/? (involves: C57BL/6 * SJL)	abnormal B cell morphology	J:135209
Tg(Igh-3VD93)343Ust/? (involves: C57BL/6 * SJL)	decreased pre-B cell number	J:135209
Tg(Igh-6-Cd80)1Gjf/0 (involves: FVB)	abnormal CD4-positive, alpha-beta T cell physiology	J:44271
	abnormal T cell activation	J:44271
	decreased B cell number	J:44271
	decreased immunoglobulin level	J:112474
Tg(Igh-6-Cd80)1Gjf/0 (B6.Cg-Tg(Igh-6-Cd80)1Gjf)	abnormal T cell number	J:112266
Tg(Igh-6-Cd80)1Gjf/0 (B6.Cg-Tg(Igh-6-Cd80)1Gjf)	hematopoietic system phenotype	J:112266
Tg(Igh-6-Cd80)1Gjf/0 (involves: BALB/c * C57BL/6 * CBA)	hematopoietic system phenotype	J:112266
Tg(Igh-6-Cd80)1Gjf/0 (NOD.FVB-Tg(Igh-6-Cd80)1Gjf/JbsJ)	abnormal B cell activation	J:131077
	abnormal bone marrow cell number	J:131077
	abnormal CD8-positive, alpha-beta T cell physiology	J:131077
	decreased B cell number	J:131077
	decreased B-2 B cell number	J:131077
	decreased follicular B cell number	J:131077
	decreased IgG1 level	J:131077
	decreased IgG2b level	J:131077
	decreased IgG3 level	J:131077
	decreased IgM level	J:131077
	decreased immature B cell number	J:131077
	decreased immunoglobulin level	J:131077
	decreased mature B cell number	J:131077
Tg(Igh-6-Cd86)1Akab/0 (involves: FVB)	abnormal CD4-positive, alpha-beta T cell physiology	J:44271
Tg(Igh-6-Cd86)1Akab/0 (involves: FVB)	decreased B cell number	J:44271
Tg(Igh-6/Igh-V125)2Jwt/0 Tg(Igk-C/Igk-V125)1Jwt/0 (NOD.B6-Tg(Igh-6/Igh-V125)2Jwt Tg(Igk-C/Igk-V125)1Jwt)	abnormal B cell number	J:91865
Tg(Igh-Abl1)40Sco/0 (involves: C57BL/6JWehi * SJL/JWehi)	enlarged spleen	J:78204
Tg(Igh-HMGA2)#Cro/0 (FVB/N-Tg(Igh-HMGA2)#Cro)	abnormal splenic cell ratio	J:233225
	decreased B cell number	J:233225
	decreased IgG1 level	J:233225
	decreased IgG2a level	J:233225
	decreased IgG2b level	J:233225
	decreased IgG3 level	J:233225
	decreased T cell number	J:233225
	enlarged spleen	J:233225
	increased T cell number	J:233225
Tg(Igh-HOX11)11Idd/0 (CD-1)	abnormal immunoglobulin V(D)J recombination	J:52782
	increased leukocyte cell number	J:52782
	myeloid hyperplasia	J:52782
	spleen hyperplasia	J:52782
Tg(Igh-Lmp2a)ERlon/0 (involves: C57BL/6 * SJL)	abnormal B cell proliferation	J:129571
Tg(Igh-Lmp2a)ERlon/0 (involves: C57BL/6 * SJL)	decreased B cell number	J:129571
Tg(Igh-Maf)68Staka/0 (C57BL/6-Tg(Igh-Maf)68Staka)	abnormal spleen morphology	J:168074
	enlarged spleen	J:168074
	increased IgG level	J:168074
	increased IgM level	J:168074
	increased immunoglobulin level	J:168074
	increased plasma cell number	J:168074
Tg(Igh-Maf)524Staka/0 (involves: C57BL/6 * C57BL/6J * DBA/2)	abnormal spleen morphology	J:168074
	enlarged spleen	J:168074
	increased IgG level	J:168074
	increased IgM level	J:168074
	increased immunoglobulin level	J:168074
	increased plasma cell number	J:168074
Tg(Igh-Mir29a,-Mir29b-1,-hrGFP)#Cro/0 (FVB/N-Tg(Igh-Mir29a,-Mir29b-1,-hrGFP)#Cro)	abnormal B cell physiology	J:162077
	abnormal lymphopoiesis	J:162077
	abnormal spleen morphology	J:162077
	decreased IgG1 level	J:162077
	decreased IgG2a level	J:162077
	decreased IgG2b level	J:162077
	enlarged spleen	J:162077
	increased B cell proliferation	J:162077
	increased B-1a cell number	J:162077
	spleen hyperplasia	J:162077
Tg(Igh-Mir29a,-Mir29b-1,-hrGFP)#Cro/0 Tg(Igh-V186.2-TCL1A)3Cro/0 (involves: C3H * C57BL/6 * FVB/N)	increased B-1a cell number	J:162077
	spleen hyperplasia	J:162077
Tg(Igh-Mir155)8Cro/0 (involves: FVB/N)	abnormal lymphopoiesis	J:109591
	abnormal spleen B cell follicle morphology	J:109591
	decreased leukocyte cell number	J:109591
	decreased spleen white pulp amount	J:109591
	enlarged spleen	J:109591
	extramedullary hematopoiesis	J:109591
	increased B cell number	J:109591
	increased B cell proliferation	J:109591
	increased pre-B cell number	J:109591
	increased spleen white pulp amount	J:109591
	intermingled spleen red and white pulp	J:109591
Tg(Igh-Mir155)10Cro/0 (involves: FVB/N)	enlarged spleen	J:109591
Tg(Igh-Mir210)#aKgcs/Tg(Igh-Mir210)#aKgcs (B6.Cg-Tg(Igh-Mir210)#aKgcs)	abnormal class switch recombination	J:205868
	abnormal spleen marginal zone morphology	J:205868
	decreased IgA level	J:205868
	decreased IgG1 level	J:205868
	decreased IgG2a level	J:205868
	decreased IgG2b level	J:205868
	decreased IgG3 level	J:205868
	decreased marginal zone B cell number	J:205868
	decreased mature B cell number	J:205868
	decreased pre-B cell number	J:205868
	decreased pro-B cell number	J:205868
	increased B-1a cell number	J:205868
Tg(Igh-Pim1)1Brn/0 (involves: C57BL/6LiA * CBA)	enlarged spleen	J:79624
Tg(Igh-Pim1)1Brn/0 (involves: C57BL/6LiA * CBA)	enlarged thymus	J:79624
Tg(Igh-ROR1)1Kip/0 (C57BL/6-Tg(Igh-ROR1)1Kip)	enlarged spleen	J:206368
	increased lymphocyte cell number	J:206368
	increased mature B cell number	J:206368
Tg(Igh-ROR1)1Kip/0 Tg(Igh-V186.2-TCL1A)3Cro/0 (B6.Cg-Tg(Igh-ROR1)1Kip Tg(Igh-V186.2-TCL1A)3Cro)	enlarged spleen	J:206368
	increased lymphocyte cell number	J:206368
	increased mature B cell number	J:206368
Tg(Igh-TCL1A)1Ypek/0 (FVB/N-Tg(Igh-TCL1A)1Ypek)	abnormal lymphocyte physiology	J:160184
	decreased IgG1 level	J:160184
	decreased IgG2a level	J:160184
	decreased IgG2b level	J:160184
	decreased IgG3 level	J:160184
	decreased IgM level	J:160184
	enlarged spleen	J:160184
Tg(Igh-V186.2-TCL1A)3Cro/0 (involves: C3H * C57BL/6)	abnormal B cell morphology	J:76574
	increased marginal zone B cell number	J:76574
	spleen hyperplasia	J:76574
Tg(Igh-V-CD40lg)#Tsub/0 (involves: C57BL/6)	enlarged spleen	J:89855
	increased IgG level	J:89855
	increased IgM level	J:89855
	increased splenocyte number	J:89855
	increased splenocyte proliferation	J:89855
Tg(IGH@)SALed/0 (involves: C57BL/6 CD-1)	abnormal mature B cell morphology	J:131938
Tg(IGH@yH1)2BJkbv/0 (involves: 129P2/OlaHsd)	abnormal B cell morphology	J:23827
	abnormal immunoglobulin heavy chain V(D)J recombination	J:23827
	abnormal immunoglobulin level	J:23827
Tg(IGH@yH1)2BJkbv/0 Tg(IGK@yK1)9.2CJkbv/0 (involves: 129P2/OlaHsd)	abnormal B cell morphology	J:23827
	abnormal immunoglobulin level	J:23827
Tg(IghelMD4)4Ccg/0 (involves: C3H/HeJ * C57BL/6)	decreased pre-B cell number	J:115059
Tg(IghelMD4)4Ccg/0 (involves: C3H/HeJ * C57BL/6)	decreased pro-B cell number	J:115059
Tg(IghelMD4)4Ccg/0 (involves: C57BL/6)	abnormal B cell activation	J:73608
	decreased pre-B cell number	J:115059
	decreased pro-B cell number	J:115059
Tg(IghelMD4)4Ccg/0 (C57BL/6-Tg(IghelMD4)4Ccg)	abnormal B cell morphology	J:78308, J:109923, J:132538
	abnormal B-2 B cell morphology	J:132538
	abnormal germinal center B cell morphology	J:109923
	abnormal immature B cell morphology	J:109923
	abnormal mature B cell morphology	J:89156, J:109923
	abnormal plasma cell morphology	J:109923
	abnormal pro-B cell morphology	J:109923
	increased IgG2b level	J:132538
	increased IgM level	J:78308, J:132538
	increased immature B cell number	J:78308, J:132538
Tg(IghelMD4)4Ccg/0 Tg(KLK4mHEL)6Ccg/0 (NOD.B6-Tg(IghelMD4)4Ccg Tg(KLK4mHEL)6Ccg/Dvs)	decreased B cell number	J:89156
Tg(IghelMD4)4Ccg/0 Tg(KLK4mHEL)6Ccg/0 (C57BL/6-Tg(IghelMD4)4Ccg Tg(KLK4mHEL)6Ccg)	decreased B cell number	J:89156
Tg(IghelMD4)4Ccg/? Tg(KLK4mHEL)6Ccg/? (involves: C57BL/6)	arrested B cell differentiation	J:78307
	decreased mature B cell number	J:78307
	increased immature B cell number	J:78307
Tg(IghelMD4)4Ccg/0 Tg(ML5sHEL)5Ccg/0 (NOD.B6-Tg(IghelMD4)4Ccg Tg(ML5sHEL)5Ccg/Dvs)	abnormal B cell clonal deletion	J:89156
	abnormal B cell morphology	J:89156
	decreased IgM level	J:89156
Tg(IghelMD4)4Ccg/0 Tg(ML5sHEL)5Ccg/0 (C57BL/6-Tg(IghelMD4)4Ccg Tg(ML5sHEL)5Ccg)	abnormal germinal center B cell morphology	J:109923
	abnormal immature B cell morphology	J:109923
	abnormal mature B cell morphology	J:109923
	abnormal plasma cell morphology	J:109923
	abnormal pro-B cell morphology	J:109923
	abnormal spleen B cell follicle morphology	J:109923
	decreased B cell number	J:89156
	decreased IgM level	J:89156, J:78308
Tg(IghelMD4)4Ccg/0 Tg(ML5sHEL)5Ccg/0 (involves: C57BL/6)	abnormal B cell physiology	J:76134
	abnormal spleen primary B follicle morphology	J:76134
	decreased B cell number	J:76134
	decreased marginal zone B cell number	J:132538
Tg(IghelMD4)4Ccg/Tg(IghelMD4)4Ccg (NOD.B6-Tg(IghelMD4)4Ccg/DvsJ)	abnormal mature B cell morphology	J:80859, J:89156
	abnormal T cell proliferation	J:80859
	decreased CD8-positive, alpha-beta T cell number	J:80859
Tg(IghelMD4)4Ccg/Tg(IghelMD4)4Ccg (involves: C57BL/6)	decreased pre-B cell number	J:171924
Tg(IghelMD4)4Ccg/Tg(IghelMD4)4Ccg (involves: C57BL/6)	decreased pro-B cell number	J:171924
Tg(Ighm-Ctla4Ig/Cd80)1Jbs/0 (involves: FVB/N)	abnormal B cell physiology	J:113109
Tg(IghMyc)22Bri/? (involves: C57BL * C57BL/6 * SJL)	enlarged spleen	J:121564
Tg(IghMyc)22Bri/? (involves: C57BL * C57BL/6 * SJL)	increased lymphocyte cell number	J:121564
Tg(IghMyc)22Bri/0 (involves: C57BL/6 * SJL)	abnormal lymphopoiesis	J:78177
	enlarged spleen	J:78177
	enlarged thymus	J:78177
	increased leukocyte cell number	J:186117
	increased pre-B cell number	J:223213
Tg(IghMyc)22Bri/0 (B6.Cg-Tg(IghMyc)22Bri/J)	spleen hyperplasia	J:164200
Tg(IghMyc)22Bri/0 (involves: C57BL/6N * SJL)	increased B cell apoptosis	J:214383
Tg(IghMyc)22Bri/0 Tg(Igk-V21-Bax)1967Bvn/0 (involves: C57BL/6 * FVB/N)	enlarged spleen	J:89049
	increased transitional stage B cell number	J:89049
Tg(IghMyc)22Bri/0 Xiap^tm1Hs/Xiap^tm1Hs (B6.Cg-Xiap^tm1Hs Tg(IghMyc)22Bri)	decreased B cell proliferation	J:138979
	decreased leukocyte cell number	J:138979
	increased B cell apoptosis	J:138979
Tg(Igk-Eik-H2-Ea^d)1Flv/0 Tg(Tcra1H3.1,Tcrb1H3.1)1Vire/0 (involves: C57BL/6 * SJL)	decreased double-positive T cell number	J:124574
	thymus hypoplasia	J:124574
Tg(Igk-Lta/Ltb)4Cys/0 (involves: C57BL/6J * DBA/2J)	abnormal B cell morphology	J:73100
Tg(Igk-Lta/Ltb)10Cys/0 (involves: C57BL/6J * DBA/2J)	abnormal B cell morphology	J:73100
Tg(Igk-V21-Bax)1967Bvn/0 (involves: FVB/N)	abnormal plasma cell morphology	J:89049
	increased IgA level	J:89049
	increased IgE level	J:89049
	increased IgG1 level	J:89049
	increased IgG2a level	J:89049
	increased IgG level	J:89049, J:90901
	increased IgM level	J:89049
	increased immunoglobulin level	J:89049
	increased transitional stage B cell number	J:89049
Tg(IGK@yK1)9.2CJkbv/0 (involves: 129P2/OlaHsd)	abnormal B cell morphology	J:23827
	abnormal immunoglobulin level	J:23827
	abnormal immunoglobulin light chain V-J recombination	J:23827
Tg(Igkv3-5-MYC)24Plbe/0 (C57BL/6J-Tg(Igkv3-5-MYC)DLoxP4Plbe/PlbeMmmh)	abnormal hemoglobin	J:131912
	abnormal immunoglobulin level	J:131912
	abnormal plasma cell differentiation	J:131912
	anemia	J:131912
	increased IgG1 level	J:131912
	increased IgG3 level	J:131912
	increased plasma cell number	J:131912
Tg(Igl-2MOPC315)1275Ust/? (C57BL/6-Tg(Igl-2MOPC315)1275Ust)	abnormal B cell morphology	J:134666
	decreased IgM level	J:134666
	decreased immature B cell number	J:134666
Tg(ILK3mHEL)3Ccg/0 Tg(TcrHEL3A9)1Mmd/0 (involves: C57BL/6JSfd * C57BL/10Sg * C57BR/cd)	abnormal CD4-positive, alpha beta T cell morphology	J:78309
	abnormal CD4-positive, alpha-beta T cell physiology	J:78309
	abnormal T cell activation	J:78309
	abnormal T cell proliferation	J:78309
	decreased CD4-positive, alpha-beta T cell number	J:78309
Tg(Ins2-GP)34-20Olds/0 (involves: BALB/c * C57BL/6)	abnormal lymphocyte physiology	J:81287
Tg(Ins2-GP)34-20Olds/0 (involves: BALB/c * C57BL/6)	abnormal T cell physiology	J:81287
Tg(Ins2-GP)#Psoh/0 Tg(TcrLCMV)327Sdz/0 (involves: C57BL/6 * DBA/2)	abnormal B cell selection	J:81285
Tg(Ins2-HA)165Bri/0 (B10.Cg- H2^d Tg(Ins2-HA)165Bri/ShrmJ)	abnormal CD4-positive, alpha-beta T cell physiology	J:86430
Tg(Ins2-HA)165Bri/0 (B10.Cg- H2^d Tg(Ins2-HA)165Bri/ShrmJ)	decreased T cell proliferation	J:86430
Tg(Ins2-OVA)59Wehi/? (involves: BALB/c * C57BL/6)	abnormal T cell activation	J:99560
Tg(Ins2-TFRC/OVA)296Wehi/0 (involves: C57BL/6)	abnormal CD8-positive, alpha beta T cell morphology	J:98589
Tg(Ins2-TFRC/OVA)296Wehi/0 (involves: C57BL/6)	abnormal leukocyte migration	J:98589
Tg(Ins2-TFRC/OVA)296Wehi/0 1700016L21Rik^{Tg(Itgax-HBEGF/EGFP)57Lan}/0 (involves: C57BL/6 * FVB)	decreased T cell proliferation	J:122114
Tg(Ins2-TFRC/OVA)296Wehi/0 Tg(TcraTcrb)425Cbn/0 (involves: 129P2/OlaHsd * C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:135154
	increased double-positive T cell number	J:135154
Tg(Ins2-Tnf)17Flv/0 (involves: C57BL/6)	decreased CD8-positive, alpha-beta T cell number	J:93555
Tg(Ins2-Tnf)17Flv/0 (involves: C57BL/6)	increased CD4-positive, alpha-beta T cell number	J:93555
Tg(ITGAL-Hhex)2Hro/0 (C3HeB/FeJ-Tg(ITGAL-Hhex)2Hro)	abnormal common myeloid progenitor cell morphology	J:80777
	abnormal definitive hematopoiesis	J:80777
	abnormal double-negative T cell morphology	J:80777
	abnormal thymus corticomedullary boundary morphology	J:80777
	decreased double-positive T cell number	J:80777
	decreased leukocyte cell number	J:80777
	decreased lymphocyte cell number	J:80777
	decreased T cell number	J:80777
	increased CD8-positive, alpha-beta T cell number	J:80777
	increased erythroid progenitor cell number	J:80777
	thymus hypoplasia	J:80777
Tg(ITGAL-Ptprc)FWcr/Tg(ITGAL-Ptprc)FWcr (involves: BALB/c * C57BL/6)	abnormal T cell differentiation	J:158876
Tg(Itgam-FCAR)83Rcmo/0 (involves: C57BL/6 * NOD)	increased IgA level	J:120534
Tg(ITGAM-HBEGF/EGFP)34Lan/0 (involves: FVB/N)	abnormal macrophage morphology	J:95141
	decreased macrophage cell number	J:95141
	increased neutrophil cell number	J:95141
Tg(ITGAM-HBEGF/EGFP)34Lan/0 (NOD.FVB-Tg(ITGAM-HBEGF/EGFP)34Lan/Jdk)	decreased macrophage cell number	J:137009
Tg(Itgax-EGFP,-cre,-HBEGF,-luc)2Gjh/0 (C57BL/6-Tg(Itgax-EGFP,-cre,-HBEGF,-luc)2Gjh)	increased monocyte cell number	J:194800
	increased neutrophil cell number	J:194800
Tg(Itgax-HBEGF/OVA/EGFP)1Garbi/0 (C57BL/6-Tg(Itgax-HBEGF/OVA/EGFP)1Garbi)	decreased dendritic cell number	J:194800
	increased neutrophil cell number	J:194800
Tg(Itgax-TGFBR2)1Flv/0 (C.Cg-Tg(Itgax-TGFBR2)1Flv)	abnormal NK cell differentiation	J:98953
Tg(Itgax-TGFBR2)1Flv/0 (C.Cg-Tg(Itgax-TGFBR2)1Flv)	increased NK cell number	J:98953
Tg(IVL-KLK5)#Hov/0 (involves: C57BL/6 * CBA)	enlarged spleen	J:210758
	increased activated T cell number	J:210758
	increased IgE level	J:210758
Tg(JAK2V617F)FF1Rsko/0 Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: C57BL/6 C57BL/10 * CBA/Ca)	abnormal common myeloid progenitor cell morphology	J:134364
	abnormal erythropoiesis	J:134364
	abnormal megakaryocyte progenitor cell morphology	J:134364
	abnormal myelopoiesis	J:134364
	abnormal spleen morphology	J:134364
	decreased B cell number	J:134364
	decreased hemoglobin content	J:134364
	decreased T cell number	J:134364
	enlarged spleen	J:134364
	extramedullary hematopoiesis	J:134364
	increased bone marrow cell number	J:134364
	increased erythroid progenitor cell number	J:134364
	increased megakaryocyte cell number	J:134364
	increased neutrophil cell number	J:134364
	spleen fibrosis	J:134364
	thrombocytosis	J:134364
Tg(JAK2V617F)FF1Rsko/0 Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 CBA)	abnormal erythropoiesis	J:134364
	abnormal megakaryocyte progenitor cell morphology	J:134364
	abnormal myelopoiesis	J:134364
	abnormal spleen morphology	J:134364
	decreased B cell number	J:134364
	decreased mean corpuscular volume	J:134364
	decreased T cell number	J:134364
	enlarged spleen	J:134364
	extramedullary hematopoiesis	J:134364
	increased bone marrow cell number	J:134364
	increased erythrocyte cell number	J:134364
	increased erythroid progenitor cell number	J:134364
	increased hemoglobin content	J:134364
	increased megakaryocyte cell number	J:134364
	increased neutrophil cell number	J:134364
	spleen fibrosis	J:134364
	thrombocytosis	J:134364
Tg(JAK2*V617F)FF1Rsko/0 Tg(Pf4-icre)Q3Rsko/0 (involves: C57BL/6)	abnormal megakaryocyte progenitor cell morphology	J:206659
Tg(JAK2V617F)FF1Rsko/0 Tg(Tek-cre)1Arnd/0 (involves: C57BL/6 CBA * DBA/2)	abnormal common myeloid progenitor cell morphology	J:206659
	abnormal erythropoiesis	J:206659
	abnormal megakaryocyte progenitor cell morphology	J:206659
	decreased platelet aggregation	J:206659
	decreased T cell number	J:206659
	enlarged spleen	J:206659
	increased megakaryocyte cell number	J:206659
	increased neutrophil cell number	J:206659
	increased red blood cell distribution width	J:206659
	thrombocytosis	J:206659
Tg(K18-ACE2)2Prlmn/0 (B6.Cg-Tg(K18-ACE2)2Prlmn/J)	increased IgG level	J:302313
	increased IgM level	J:302313
	increased leukocyte cell number	J:294084
	increased lymphocyte cell number	J:302313
	increased macrophage cell number	J:294084, J:302313
	increased neutrophil cell number	J:294084, J:300960, J:302313
	increased T cell number	J:300960
	microgliosis	J:294084
Tg(KitD814V)1Roer/0 Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 CBA)	abnormal bone marrow cell physiology	J:169611
	abnormal mast cell morphology	J:169611
	enlarged spleen	J:169611
	increased mast cell number	J:169611
Tg(KitD814V)2Roer/0 Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 CBA)	abnormal bone marrow cell physiology	J:169611
	abnormal mast cell morphology	J:169611
	increased mast cell number	J:169611
Tg(KitD814V)3Roer/0 Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 CBA)	abnormal bone marrow cell physiology	J:169611
	abnormal mast cell morphology	J:169611
	enlarged spleen	J:169611
	increased mast cell number	J:169611
Tg(KLK4mHEL)6Ccg/0 Tg(TcrHEL3A9)1Mmd/0 (involves: C57BL/6 * C57BL/10 * C57BR/cd)	decreased CD4-positive, alpha-beta T cell number	J:78309
	decreased double-positive T cell number	J:78309
Tg(KRT5-IKBKB)2Armz/0 (involves: C57BL/6 * DBA/2)	abnormal melanophage morphology	J:160072
Tg(KRT5-rtTA)1Glk/0 Tg(tetO-Tfrc/EGFP/Ova)#Sfz/0 Tg(tetO/CMV-Tslp)#Sfz/0 (involves: C3H * C57BL/6 * FVB/N)	increased T cell proliferation	J:199558
Tg(KRT5-rtTA)1Glk/0 Tg(tetO/CMV-Tslp)#Sfz/0 (involves: C3H * C57BL/6 * FVB/N)	decreased IgG2a level	J:100506
	enlarged spleen	J:100506
	increased CD4-positive, alpha-beta T cell number	J:100506
	increased IgE level	J:100506
	increased IgG1 level	J:100506
Tg(KRT5-rtTA)1Glk/0 Tg(tetO/CMV-Tslp)#Sfz/0 (C.Cg-Tg(KRT5-rtTA)1Glk Tg(tetO/CMV-Tslp)#Sfz)	abnormal B cell activation	J:182756
	decreased hematocrit	J:182756
	increased B cell proliferation	J:182756
	increased susceptibility to autoimmune hemolytic anemia	J:182756
Tg(KRT5-rtTA)#Glk/0 Tg(tetO-cre)1Jaw/0 Wls^tm1.1Lan/Wls^tm1.1Lan (involves: 129S6/SvEvTac * C57BL/6 * FVB/N)	cutaneous mastocytosis	J:204142
Tg(KRT5-TGFB1)F2020Xjw/0 (involves: C57BL/6 * DBA/2 * ICR)	abnormal Langerhans cell morphology	J:90118
	cutaneous mastocytosis	J:90118
	decreased Langerhans cell number	J:90118
Tg(KRT5-tTA)1216Glk/0 Tg(tetO-Il13)1Tazh/0 (B6.Cg-Tg(KRT5-tTA)1216Glk Tg(tetO-Il13)1Tazh)	cutaneous mastocytosis	J:150232
	increased IgE level	J:150232
	increased IgG1 level	J:150232
Tg(KRT14-CASP1)1Miz/0 (involves: C57BL/6)	abnormal T cell physiology	J:78602
	decreased T cell number	J:78602
	increased IgE level	J:78602
	increased IgG1 level	J:78602
	increased neutrophil cell number	J:78602
Tg(KRT14-FLT4/IGHG1)#Ali/0 (either: (involves: FVB/N) or (involves: BALB/c * DBA))	abnormal mononuclear phagocyte morphology	J:201429
Tg(Krt14-Ifnk)#Cya/0 (C57BL/6N-Tg(Krt14-Ifnk)#Cya)	enlarged spleen	J:322130
Tg(KRT14-Il4)#Lsch/0 (involves: BALB/cBy * C57BL/6)	decreased IgG2a level	J:126285
	increased IgE level	J:126285
	increased IgG1 level	J:126285
	increased mast cell degranulation	J:126285
Tg(KRT14-Il18)#Knak/0 (C57BL/6-Tg(KRT14-Il18)#Knak)	abnormal T cell physiology	J:78602
	decreased T cell number	J:78602
	increased IgE level	J:78602
	increased IgG1 level	J:78602
	increased neutrophil cell number	J:78602
Tg(KRT14-Tslp)1Pcn/0 (involves: C57BL/6 * SJL)	abnormal lymphocyte physiology	J:102470
	enlarged spleen	J:102470
	increased immunoglobulin level	J:102470
Tg(KRT14-Vegfa)3Dtm/0 (FVB/N-Tg(KRT14-Vegfa)3Dtm)	abnormal leukocyte adhesion	J:104245
	enhanced leukocyte tethering or rolling	J:104245
	increased macrophage cell number	J:111924
	increased mast cell number	J:104245
Tg(KRT14-VP16/NR1I2)13Sdub/? (involves: C57BL/6)	abnormal CD4-positive, alpha-beta T cell number	J:258435
	abnormal CD8-positive, alpha beta T cell morphology	J:258435
	abnormal dendritic cell migration	J:258435
	increased dendritic cell number	J:258435
	increased effector memory T-helper cell number	J:258435
	increased gamma-delta T cell number	J:258435
	increased IgE level	J:258435
	increased IgG1 level	J:258435
	increased leukocyte cell number	J:258435
Tg(KRT18-DPP4)3Pbmj/0 (involves: C57BL/6J * SJL/J)	abnormal mononuclear cell morphology	J:286231
Tg(KRT18-DPP4)3Pbmj/0 (involves: C57BL/6J * SJL/J)	increased lymphocyte cell number	J:286231
Tg(LANA,vFLIP,vCYC)801Dtmr/? (involves: C57BL/6)	abnormal B cell activation	J:196403
	abnormal B cell differentiation	J:196403
	abnormal germinal center B cell physiology	J:196403
	abnormal marginal zone B cell morphology	J:196403
	abnormal marginal zone B cell physiology	J:196403
	abnormal spleen morphology	J:196403
	enlarged spleen	J:196403
	extramedullary hematopoiesis	J:196403
	increased B cell proliferation	J:196403
	increased germinal center B cell number	J:196403
	increased IgG1 level	J:196403
	increased IgG3 level	J:196403
	increased marginal zone B cell number	J:196403
	increased mature B cell number	J:196403
	increased megakaryocyte cell number	J:196403
	increased plasma cell number	J:196403
Tg(Lck-Akt1)M-1Pnt/0 (involves: C3H/He C57BL/6)	decreased thymocyte number	J:73487
	enlarged spleen	J:73487
	increased double-negative T cell number	J:135903
	increased single-positive T cell number	J:135903
Tg(Lck-Akt1E40K)E-3Pnt/0 (involves: C3H/He C57BL/6)	decreased thymocyte number	J:73487
Tg(Lck-Akt1E40K)E-3Pnt/0 (involves: C3H/He C57BL/6)	enlarged spleen	J:73487
Tg(Lck-Akt1*E40K)E-3Pnt/0 (Not Specified)	abnormal T cell differentiation	J:144975
Tg(Lck-Bcl2l1)1Cant/? (B6.Cg-Tg(Lck-Bcl2l1)1Cant)	increased memory T cell number	J:77507
Tg(Lck-Bcl2l1)1Cant/? (B6.Cg-Tg(Lck-Bcl2l1)1Cant)	increased T cell proliferation	J:77507
Tg(Lck-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	decreased thymocyte number	J:226234
Tg(Lck-cre)548Jxm/? Tgfb1^tm2.1Doe/Tgfb1^tm2.1Doe (involves: 129S6/SvEvTac * Black Swiss * C57BL/6 * CBA)	abnormal T cell activation	J:150024
	abnormal T cell subpopulation ratio	J:150024
	decreased spleen weight	J:150024
	decreased thymus weight	J:150024
	spleen hypoplasia	J:150024
	thymus hypoplasia	J:150024
Tg(Lck-cre)548Jxm/? Upf2^tm1Btp/Upf2^tm1Btp (involves: 129P2/OlaHsd * C57BL/6 * CBA)	abnormal T cell receptor beta chain V(D)J recombination	J:134765
	decreased CD4-positive, alpha-beta T cell number	J:134765
	decreased CD8-positive, alpha-beta T cell number	J:134765
	decreased double-positive T cell number	J:134765
	thymus hypoplasia	J:134765
Tg(Lck-cre)I57Jxm/? Traf2^tm1Rbr/Traf2^tm1Rbr (involves: C57BL/6 * ICR)	absent follicular B cells	J:132877
	absent marginal zone B cells	J:132877
	decreased mature B cell number	J:132877
Tg(Lck-cre)I57Jxm/? Traf3^tm1Rbr/Traf3^tm1Rbr (involves: C57BL/6 * ICR * SJL)	abnormal T cell physiology	J:132877
	decreased CD4-positive, alpha-beta T cell number	J:132877
	decreased CD8-positive, alpha-beta T cell number	J:132877
Tg(Lck-CrmA)1Hed/0 (involves: BALB/c * C57BL/6J)	decreased T cell apoptosis	J:100451
Tg(Lck-CrmA)1Hed/? (involves: BALB/c * C57BL/6J)	decreased thymocyte apoptosis	J:100451
Tg(Lck-Cxadr)1Jdgr/0 (FVB-Tg(Lck-Cxadr)1Jdgr)	abnormal T cell physiology	J:109884
	decreased T cell apoptosis	J:109884
	decreased T cell proliferation	J:109884
Tg(Lck-FADD)1Hed/0 (involves: BALB/c * C57BL/6)	abnormal T cell proliferation	J:100451
	arrested T cell differentiation	J:100451
	decreased T cell number	J:100451
	decreased thymocyte number	J:100451
Tg(Lck-FADD)1Hed/? (involves: BALB/c * C57BL/6)	abnormal T cell physiology	J:100451
Tg(Lck-FADD)1Hed/? (involves: BALB/c * C57BL/6)	decreased thymocyte apoptosis	J:100451
Tg(Lck-FADD)1Hed/Tg(Lck-FADD)1Hed (involves: BALB/c * C57BL/6)	abnormal T cell differentiation	J:100451
	decreased T cell number	J:100451
	decreased thymocyte number	J:100451
Tg(Lck-Hhex)1Hro/0 (C3HeB/FeJ-Tg(Lck-Hhex)1Hro)	abnormal double-negative T cell morphology	J:80777
	decreased double-positive T cell number	J:80777
	decreased leukocyte cell number	J:80777
	decreased lymphocyte cell number	J:80777
	decreased T cell number	J:80777
	increased CD8-positive, alpha-beta T cell number	J:80777
	thymus hyperplasia	J:80777
Tg(Lck-Il31)1Jagr/0 (involves: C3H * C57BL/6)	abnormal leukopoiesis	J:91124
	cutaneous mastocytosis	J:91124
	decreased T cell number	J:91124
	increased activated T cell number	J:91124
	increased B cell number	J:91124
	increased memory T cell number	J:91124
Tg(Lck-LMO1)11Sjk/0 Tg(STIL-TAL1)A5(3)Alpa/0 (involves: C3H * C3H/HeRos * C57BL/6 * C57BL/10Ros)	decreased bone marrow cell number	J:40868
	decreased erythrocyte cell number	J:40868
	enlarged spleen	J:40868
	enlarged thymus	J:40868
	increased leukocyte cell number	J:40868
	thrombocytopenia	J:40868
Tg(LCK-NFKBIA)5Dwb/0 (involves: C57BL/6 * DBA/2)	abnormal CD8-positive, alpha-beta T cell differentiation	J:93003
	decreased CD4-positive, alpha-beta T cell number	J:93003
	decreased CD8-positive, alpha-beta T cell number	J:93003
	decreased T cell proliferation	J:93003
	increased T cell apoptosis	J:93003
Tg(LCK-NFKBIA)5Dwb/? (involves: BALB/c * C57BL/6 * DBA/2)	abnormal T-helper 1 physiology	J:145531
Tg(Lck-Notch3)#Issc/0 (involves: C57BL/6 * DBA/2)	abnormal T cell differentiation	J:63300
	enlarged spleen	J:63300
	increased double-negative T cell number	J:63300
	increased thymocyte number	J:63300
	thymus hyperplasia	J:63300
Tg(Lck-Socs3)1Kubo/0 (Not Specified)	abnormal CD4-positive T cell differentiation	J:132905
	decreased T cell number	J:128797
	decreased T cell proliferation	J:128797
	decreased thymocyte number	J:128797
Tg(Lck-Sox13)#Jskg/0 (involves: C57BL/6)	decreased double-positive T cell number	J:117301
	decreased T cell proliferation	J:117301
	decreased thymocyte number	J:117301
	increased thymocyte apoptosis	J:117301
Tg(Lck-Stat5b*)1Mafa/0 (Not Specified)	decreased mature B cell number	J:132669
Tg(Lck-Stat5b*)1Mafa/0 (Not Specified)	increased B cell proliferation	J:132669
Tg(Lck-Stk17b)26.1Wals/? (B6.Cg-Tg(Lck-Stk17b)26.1Wals)	decreased CD4-positive, alpha-beta T cell number	J:149973
	decreased CD8-positive, alpha-beta T cell number	J:149973
	decreased single-positive T cell number	J:149973
	decreased thymocyte number	J:149973
	enlarged spleen	J:149973
	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:149973
	increased double-positive T cell number	J:149973
	increased spleen weight	J:149973
	increased T cell proliferation	J:149973
	spleen hyperplasia	J:149973
Tg(Lck-Stk17b)26.1Wals/? Tg(TcraH-Y,TcrbH-Y)71Vbo/? (involves: C57BL/6 * C57BL/10)	abnormal T cell differentiation	J:149973
	decreased CD8-positive, alpha-beta T cell number	J:149973
	decreased thymocyte number	J:149973
	increased CD8-positive, alpha-beta T cell number	J:149973
Tg(Lck-Tal1)4709Led/0 (FVB/N-Tg(Lck-Tal1)4709Led)	abnormal thymus morphology	J:36076
Tg(Lck-Tal1)4709Led/0 (FVB/N-Tg(Lck-Tal1)4709Led)	enlarged spleen	J:36076
Tg(Lck-Tax)53Hall/0 (involves: C57BL/6)	enlarged spleen	J:129531
Tg(Lck-Tax)53Hall/0 (involves: C57BL/6)	hepatosplenomegaly	J:129531
Tg(Lck-Tnfsf4)1Nish/0 (B6.Cg-Tg(Lck-Tnfsf4)1Nish)	abnormal CD4-positive, alpha-beta T cell physiology	J:194882
	abnormal T cell subpopulation ratio	J:194882
	increased CD4-positive, alpha-beta T cell number	J:194882
	increased regulatory T cell number	J:194882
	increased T cell proliferation	J:80214
Tg(Lck-Tnfsf4)1Nish/0 (C.Cg-Tg(Lck-Tnfsf4)1Nish)	abnormal CD4-positive, alpha-beta T cell physiology	J:194882
	increased CD4-positive, alpha-beta T cell number	J:194882
	increased regulatory T cell number	J:194882
Tg(Lck-TNFSF13)3919Mhah/0 (B6.Cg-Tg(Lck-TNFSF13)3919Mhah)	abnormal spleen morphology	J:94628
	decreased B cell apoptosis	J:94628
	increased B cell number	J:94628
	increased B-1 B cell number	J:94628
	increased CD4-positive, alpha-beta T cell number	J:94628
	increased CD8-positive, alpha-beta T cell number	J:94628
	increased IgA level	J:94628
	intermingled spleen red and white pulp	J:94628
	spleen hyperplasia	J:94628
Tg(Lck-Tnfsf14)24Yxf/? (C57BL/6-Tg(Lck-Tnfsf14)24Yxf)	abnormal T cell physiology	J:120962, J:129951
	extramedullary hematopoiesis	J:129951
	increased IgA level	J:128976
	increased IgG level	J:128976
	increased spleen weight	J:129951
	increased T cell proliferation	J:129951
	spleen hyperplasia	J:129951
Tg(Lck-Tnfsf15,-EGFP)#Targ/0 (involves: C57BL/6)	increased CD4-positive, alpha-beta memory T cell number	J:169462
Tg(Lck-Tnfsf15,-EGFP)#Targ/0 (involves: C57BL/6)	increased CD8-positive, alpha-beta memory T cell number	J:169462
Tg(Lck-Tslp)1Chea/0 (B6.Cg-Tg(Lck-Tslp)1Chea)	enlarged spleen	J:72982
	increased immunoglobulin level	J:72982
	increased spleen weight	J:72982
Tg(Lck-VIPR2)1Ejg/0 (C57BL/6-Tg(Lck-VIPR2)1Ejg)	increased eosinophil cell number	J:127974
	increased IgE level	J:127974
	increased IgG1 level	J:127974
Tg(Lck/Emu-Rftn1)1Ayos/? (involves: C57BL/6)	increased IgG1 level	J:150299
	increased IgG2a level	J:150299
	increased IgG3 level	J:150299
	increased IgM level	J:150299
	increased T cell proliferation	J:150299
Tg(LckIl4)1315Dbl/0 (involves: C57BL/6J * DBA/2J)	abnormal osteoclast physiology	J:107359
	abnormal T cell activation	J:92453
	abnormal T cell differentiation	J:92453
	abnormal T cell number	J:92453
	abnormal thymocyte activation	J:92453
	abnormal thymus cell ratio	J:92453
	abnormal thymus morphology	J:92453
	absent CD8-positive, alpha-beta T cells	J:92453
	decreased CD4-positive, alpha-beta T cell number	J:92453
	decreased double-positive T cell number	J:92453
	increased CD4-positive, alpha-beta T cell number	J:92453
	increased CD8-positive, alpha-beta T cell number	J:92453
	increased double-negative T cell number	J:92453
	increased IgG2a level	J:92453
	thymus cortex hypoplasia	J:92453
	thymus hypoplasia	J:92453
Tg(LckNotch1)9Erob/? (involves: C57BL/6 * CBA/J)	abnormal CD8-positive, alpha-beta T cell differentiation	J:93005
	abnormal thymus cell ratio	J:93005
	decreased CD4-positive, alpha-beta T cell number	J:93005
	increased CD8-positive, alpha-beta T cell number	J:93005
Tg(LCKprBCL2)36Sjk/? (involves: C3H * C57BL/6)	abnormal T cell number	J:28635
	abnormal T cell subpopulation ratio	J:11548
	abnormal thymus cell ratio	J:11548
	decreased T cell apoptosis	J:11548
	increased CD8-positive, alpha-beta T cell number	J:11548
	increased T cell number	J:11548
Tg(LCKprBCL2)36Sjk/0 (B6.Cg-Tg(LCKprBCL2)36Sjk)	abnormal CD4-positive, alpha-beta T cell number	J:217939
	abnormal T cell subpopulation ratio	J:217939
	increased regulatory T cell number	J:217939
Tg(LCKprBCL2)36Sjk/0 (involves: C57BL/6 * CBA/J)	abnormal T cell clonal deletion	J:217939
Tg(LCKprBCL2)36Sjk/0 (involves: C57BL/6 * CBA/J)	decreased thymocyte apoptosis	J:217939
Tg(LCKprBCL2)36Sjk/0 Tg(Nr4a1-EGFP/cre)820Khog/0 (involves: C57BL/6 * C57BL/6J)	abnormal T cell clonal deletion	J:217939
	decreased thymocyte apoptosis	J:217939
Tg(LCKprBCL2)36Sjk/0 Tg(TcraH-Y,TcrbH-Y)71Vbo/0 (involves: C57BL/6 * C57BL/6J * DBA/2J)	abnormal T cell clonal deletion	J:217939
	decreased thymocyte apoptosis	J:217939
Tg(LCR-HBA2,LCR-HBB)1Cos/0 (involves: C57BL/6J CBA/J)	abnormal erythrocyte morphology	J:94193
	abnormal erythrocyte physiology	J:94193
	anemia	J:94193
	decreased hematocrit	J:94193
	enlarged spleen	J:94193
	increased mean corpuscular hemoglobin concentration	J:94193
Tg(Ly6a-BCR/ABL1)IS1AIsg/0 (involves: C57BL/6J * CBA)	abnormal spleen morphology	J:144382
	increased leukocyte cell number	J:144382
	increased neutrophil cell number	J:144382
	increased spleen red pulp amount	J:144382
	increased spleen weight	J:144382
Tg(Ly6a-BCR/ABL1)IS1BIsg/0 (involves: C57BL/6J * CBA)	abnormal spleen morphology	J:144382
	increased leukocyte cell number	J:144382
	increased neutrophil cell number	J:144382
	increased spleen red pulp amount	J:144382
	increased spleen weight	J:144382
Tg(Ly6a-GCSAM)102AIsg/0 (involves: C57BL/6J * CBA)	abnormal spleen morphology	J:221238
	decreased B-1 B cell number	J:221238
	enlarged spleen	J:221238
	increased B cell proliferation	J:221238
	increased B-1 B cell number	J:221238
	increased IgG level	J:221238
	increased spleen white pulp amount	J:221238
Tg(Ly6a-SET/NUP214)2969Gcg/0 (involves: FVB/NJ)	abnormal B cell differentiation	J:142938
	abnormal common myeloid progenitor cell morphology	J:142938
	abnormal definitive hematopoiesis	J:142938
	decreased leukocyte cell number	J:142938
	decreased lymphocyte cell number	J:142938
	decreased pre-B cell number	J:142938
	decreased pro-B cell number	J:142938
	increased B cell apoptosis	J:142938
Tg(Ly6a-TK,-BCR/ABL1)IS9AIsg/0 (involves: C57BL/6J * CBA)	increased leukocyte cell number	J:144382
Tg(Ly6a-TK,-BCR/ABL1)IS9AIsg/0 (involves: C57BL/6J * CBA)	increased neutrophil cell number	J:144382
Tg(Ly6e-MALT1)#Isg/0 (involves: C57BL/6 * CBA)	increased hematopoietic stem cell number	J:185590
	increased mature B cell number	J:185590
	increased pre-B cell number	J:185590
	increased pro-B cell number	J:185590
Tg(MCL1)8Caig/0 (involves: C57BL/6 * SJL)	abnormal common myeloid progenitor cell morphology	J:50604, J:69755
	abnormal immature B cell morphology	J:50604
	abnormal leukocyte physiology	J:50604
	abnormal macrophage apoptosis	J:95913
	abnormal mast cell differentiation	J:50604
	abnormal monocyte differentiation	J:50604
	decreased B cell apoptosis	J:50604
	decreased splenocyte apoptosis	J:50604
	decreased T cell apoptosis	J:50604
	extramedullary hematopoiesis	J:50604
	increased erythroid progenitor cell number	J:50604
	increased spleen white pulp amount	J:50604
	increased thymocyte number	J:50604
	spleen hyperplasia	J:50604
Tg(Mcpt8-cre)1Voeh/0 (involves: C57BL/6)	decreased basophil cell number	J:164432
Tg(Mcpt8-cre)1Voeh/0 (involves: C57BL/6)	hematopoietic system phenotype	J:164432
Tg(ML5sHEL)5Ccg/0 Tg(TcrHEL3A9)1Mmd/0 (involves: C57BL/6 * C57BL/10 * C57BR/cd)	abnormal CD4-positive, alpha beta T cell morphology	J:78309
	abnormal CD4-positive, alpha-beta T cell physiology	J:78309
	abnormal T cell activation	J:78309
	abnormal T cell proliferation	J:78309
	decreased CD4-positive, alpha-beta T cell number	J:78309
	decreased double-positive T cell number	J:78309
Tg(ML5sHEL)5Ccg/0 Tg(TcrHEL3A9)1Mmd/0 Tg(TLK2mHEL)2Ccg/0 (involves: C57BL/6JSfd * C57BL/10 * C57BR/cd)	abnormal CD4-positive, alpha beta T cell morphology	J:78309
	abnormal CD4-positive, alpha-beta T cell physiology	J:78309
	abnormal T cell activation	J:78309
	abnormal T cell proliferation	J:78309
	decreased CD4-positive, alpha-beta T cell number	J:78309
	decreased double-positive T cell number	J:78309
Tg(MMTV-Erbb2)9Pjo/0 (involves: BALB/c * C3H * C57BL/6)	enlarged spleen	J:72129
Tg(MMTV-Erbb2)9Pjo/0 (involves: BALB/c * C3H * C57BL/6)	increased spleen red pulp amount	J:72129
Tg(MMTV-Erbb2)10Pjo/0 (involves: BALB/c * C3H * C57BL/6)	enlarged spleen	J:72129
Tg(MMTV-Erbb2)10Pjo/0 (involves: BALB/c * C3H * C57BL/6)	increased spleen red pulp amount	J:72129
Tg(MMTV-Erbb2)12Pjo/0 (involves: BALB/c * C3H * C57BL/6)	enlarged spleen	J:72129
Tg(MMTV-Erbb2)12Pjo/0 (involves: BALB/c * C3H * C57BL/6)	increased spleen red pulp amount	J:72129
Tg(MMTV-Erbb2)17Pjo/0 (involves: BALB/c * C3H * C57BL/6)	enlarged spleen	J:72129
Tg(MMTV-Erbb2)17Pjo/0 (involves: BALB/c * C3H * C57BL/6)	increased spleen red pulp amount	J:72129
Tg(MMTV-PyVT)#Mul/0 (B6.FVB-Tg(MMTV-PyVT)#Mul)	abnormal splenic cell ratio	J:147923
	abnormal T cell physiology	J:147923
	decreased B cell proliferation	J:147923
	decreased splenocyte proliferation	J:147923
	decreased T cell proliferation	J:147923
	enlarged spleen	J:147923
	increased myeloid cell number	J:147923
	increased regulatory T cell number	J:147923
	increased splenocyte number	J:147923
Tg(MMTV-Scgb1a1)#Abm/0 (involves: C57BL/6 * SJL)	increased IgA level	J:57504
Tg(Mpz-RAF1/ESR1)A668Ayld/0 (involves: C57BL/6J * CBA/J)	increased macrophage cell number	J:182703
	increased mast cell number	J:182703
	increased neutrophil cell number	J:182703
	increased T cell number	J:182703
Tg(Msr1-MMP9)#Apar/0 (B6.Cg-Tg(Msr1-MMP9)#Apar)	abnormal macrophage physiology	J:136830
Tg(Mt1-IL6)28Gci/0 (involves: C57BL/6 * DBA/2)	abnormal spleen morphology	J:18424
	enlarged spleen	J:177825, J:18424
	extramedullary hematopoiesis	J:177825
	increased granulocyte number	J:177825
	increased IgG1 level	J:18424
	increased IgG level	J:177825, J:18424
	increased leukocyte cell number	J:18424
	increased mean platelet volume	J:18424
	increased megakaryocyte cell number	J:177825, J:18424
	increased neutrophil cell number	J:18424
	increased plasma cell number	J:177825, J:18424
	increased plasmacytoid dendritic cell number	J:177825
Tg(MUC1)79.24Gend/0 (involves: C57BL/6)	increased IgG level	J:154046
Tg(MUC1)79.24Gend/0 (involves: C57BL/6)	increased IgM level	J:154046
Tg(Mx1-cre)1Cgn/0 Tg(Tal1-tTA)19Dgt/0 Tg(tetO-BCR/ABL1)2Dgt/0 TgTn(pb-sb-GrOnc)#aGsva/0 (involves: C57BL/6 * CBA/J * DBA/2 * FVB/N)	increased granulocyte number	J:227558
	increased leukocyte cell number	J:227558
Tg(Mx1-cre)1Cgn/0 Thoc5^tm1Tate/Thoc5^tm1Tate (involves: C57BL/6 * CBA)	abnormal bone marrow cell physiology	J:169944
	abnormal lymphopoiesis	J:169944
	anemia	J:169944
	decreased bone marrow cell number	J:169944
	decreased common myeloid progenitor cell number	J:169944
	decreased erythrocyte cell number	J:169944
	decreased hematocrit	J:169944
	decreased hematopoietic stem cell number	J:169944
	decreased hemoglobin content	J:169944
	decreased leukocyte cell number	J:169944
	decreased spleen weight	J:169944
	thrombocytopenia	J:169944
Tg(Mx1-cre)1Cgn/0 Tnfrsf13c^tm2.1Mass/Tnfrsf13c^tm2.1Mass (involves: C57BL/6 * CBA)	abnormal bone marrow cell morphology/development	J:170519
	abnormal bone marrow cell physiology	J:170519
	increased immature B cell number	J:170519
	increased pre-B cell number	J:170519
	increased pro-B cell number	J:170519
Tg(Mx1-cre)1Cgn/0 Traf2^tm1Rbr/Traf2^tm1Rbr (involves: C57BL/6 * CBA)	abnormal spleen marginal zone morphology	J:93890
	abnormal spleen morphology	J:93890
	enlarged spleen	J:93890
	increased B cell number	J:93890
	increased marginal zone B cell number	J:93890
Tg(Mx1-cre)1Cgn/0 U2af1^tm1.1Hev/U2af1⁺ (involves: 129S6/SvEvTac * BALB/c * C57BL/6 * C57BL/6J * CBA/J)	abnormal bone marrow cell morphology/development	J:267082
	decreased erythrocyte cell number	J:267082
	decreased hematocrit	J:267082
	decreased hematopoietic stem cell number	J:267082
	decreased hemoglobin content	J:267082
	decreased leukocyte cell number	J:267082
	increased mean corpuscular volume	J:267082
	macrocytic anemia	J:267082
Tg(Mx1-cre)1Cgn/0 U2af1^tm1Mohi/U2af1^tm1Mohi (involves: C57BL/6J * CBA/J)	abnormal bone marrow cell morphology/development	J:308564
	abnormal hematopoietic stem cell physiology	J:308564
	anemia	J:308564
	bone marrow failure	J:308564
	decreased bone marrow cell number	J:308564
	decreased common myeloid progenitor cell number	J:308564
	decreased erythrocyte cell number	J:308564
	decreased erythroid progenitor cell number	J:308564
	decreased hematopoietic stem cell number	J:308564
	decreased hemoglobin content	J:308564
	decreased leukocyte cell number	J:308564
	decreased megakaryocyte progenitor cell number	J:308564
	decreased neutrophil cell number	J:308564
	pancytopenia	J:308564
	thrombocytopenia	J:308564
Tg(Mx1-cre)1Cgn/0 Zmiz1^{tm1c(EUCOMM)Hmgu}/Zmiz1^{tm1c(EUCOMM)Hmgu} (involves: C57BL/6 * C57BL/6J * C57BL/6N * CBA/J)	decreased B cell number	J:234445
	decreased NK cell number	J:234445
	decreased T cell number	J:234445
	thymus hypoplasia	J:234445
Tg(Mx1-cre)1Cgn/0 Znrf1^tm1Lchs/Znrf1^tm1Lchs (involves: C57BL/6)	abnormal hematopoietic system physiology	J:250572
Tg(Myh6-IGF1)34Pia/0 (FVB/N-Tg(Myh6-IGF1)34Pia)	increased spleen weight	J:35215
Tg(Myl1-SOD1G93A)#Amu/0 (FVB/NJ-Tg(Myl1-SOD1G93A)#Amu)	increased microglial cell activation	J:143747
Tg(Nlrp1b)1Die/0 (involves: 129S1/SvImJ * C57BL/6 * SJL)	abnormal macrophage physiology	J:99748
Tg(Nr4a1-EGFP/cre)820Khog/0 (C57BL/6-Tg(Nr4a1-EGFP/cre)820Khog)	hematopoietic system phenotype	J:172415
Tg(PF4-tTA/VP16)42Kra/0 Tg(tetO-Aurkb,lacZ)41Kra/0 (FVB/NJ-Tg(tetO-Aurkb,lacZ)41Kra Tg(PF4-tTA/VP16)42Kra)	abnormal platelet physiology	J:104239
	abnormal thrombopoiesis	J:104239
Tg(PF4MER)6Kra/? (FVB/N-Tg(PF4MER)6Kra)	abnormal megakaryocyte differentiation	J:35507
	abnormal megakaryocyte morphology	J:35507
	enlarged spleen	J:35507
	increased megakaryocyte cell number	J:35507
Tg(Pgk1-HA)1.1Vbo/? Tg(Tcra/Tcrb)1Vbo/? (involves: 129 * BALB/c * C57BL/6J * DBA/2J)	decreased CD4-positive, alpha-beta T cell number	J:125750
	increased double-positive T cell number	J:125750
	increased regulatory T cell number	J:125750
Tg(Pgk1-HA)1.1Vbo/? Tg(Tcra/Tcrb)1Vbo/? (C.Cg-Tg(Pgk1-HA)1.1Vbo Tg(Tcra/Tcrb)1Vbo)	abnormal regulatory T cell physiology	J:112603
	increased regulatory T cell number	J:112603
Tg(PGK1-KITLG220)441Daw/Tg(PGK1-KITLG220)441Daw (C3H/HeJ-Tg(PGK1-KITLG*220)441Daw)	abnormal thymus morphology	J:32600
Tg(Pkd1)6Mtru/0 (involves: C57BL/6J * CBA/J)	decreased hematocrit	J:157952
Tg(Pkd1)18Mtru/0 (involves: C57BL/6J * CBA/J)	decreased hematocrit	J:157952
Tg(Pkd1)26Mtru/0 (involves: C57BL/6J * CBA/J)	decreased hematocrit	J:157952
Tg(Pkd1)39Mtru/0 (involves: C57BL/6J CBA/J)	decreased hematocrit	J:198147
Tg(Pklr-HRASG12V)21Ak/0 (involves: C57BL/6 DBA/2)	abnormal thymus morphology	J:44803
Tg(Pklr-HRASG12V)21Ak/0 (involves: C57BL/6 DBA/2)	enlarged thymus	J:44803
Tg(Pklr-Myc)73Ak/0 (B6.Cg-Tg(Pklr-Myc)73Ak)	decreased NK T cell number	J:184496
Tg(Plp1-LMNB1)1108Qsp/0 (involves: FVB/N)	microgliosis	J:226169
Tg(Plp1-SNCA)1Haa/0 (involves: C57BL/6 * DBA/2)	microgliosis	J:96778
Tg(PML-RARA)556Kog/? (involves: FVB/N)	abnormal neutrophil differentiation	J:39327
	anemia	J:39327
	thrombocytopenia	J:39327
Tg(PML-RARA)556Kog/0 (FVB/N-Tg(PML-RARA)556Kog)	anemia	J:262172
	enlarged spleen	J:262172
	increased leukocyte cell number	J:262172
	thrombocytosis	J:262172
Tg(PMP22)C61Clh/0 (B6.Cg-Tg(PMP22)C61Clh)	increased macrophage cell number	J:158350
Tg(Prdx6)153Pgn/0 (C57BL/6-Tg(Prdx6)153Pgn/Pgn)	abnormal macrophage physiology	J:86528
Tg(Prnp-APP)1Hmor/0 (B6.Cg-Tg(Prnp-APP)1Hmor)	microgliosis	J:159623
Tg(Prnp-FUS)WT3Cshw/0 (involves: C57BL/6 * Crl:CD-1(ICR))	microgliosis	J:189360
Tg(Prnp-FUS)WT3Cshw/Tg(Prnp-FUS)WT3Cshw (involves: C57BL/6 * Crl:CD-1(ICR))	microgliosis	J:189360
Tg(Prnp-ITM2B)7Jckr/0 (C57BL/6-Tg(Prnp-ITM2B)7Jckr)	microgliosis	J:159279
Tg(Prnp-MAPTR406W)21807Dwst/? (FVB/N-Tg(Prnp-MAPTR406W)21807Dwst)	microgliosis	J:95971
Tg(Prnp-PFN1C71G)22Zxu/0 Tg(Thy1-PFN1C71G)67Zxu/Tg(Thy1-PFN1*C71G)67Zxu (involves: FVB/N)	microgliosis	J:235427
Tg(Prnp-TARDBP)96Dwc/0 Tg(Prnp-TARDBPQ331K)31Dwc/0 (involves: C3H C57BL/6)	microgliosis	J:239141
Tg(Prnp-TARDBPQ331K)31Dwc/? (involves: C3H C57BL/6)	microgliosis	J:239141
Tg(Psp-Rbbp4)1Yoha/0 (involves: C57BL/6)	abnormal T cell activation	J:141378
Tg(Psp-Rbbp4)1Yoha/0 (involves: C57BL/6)	increased marginal zone B cell number	J:141378
Tg(PTH-CCND1)PC2Anar/0 (FVB/N-Tg(PTH-CCND1)PC2Anar)	increased osteoclast cell number	J:69423
Tg(rv-CYCLIN)29Dlh/0 (involves: C57BL/6 * SJL)	spleen hyperplasia	J:62478
Tg(Scgb1a1-Il13)2Eli/? (involves: C57BL/6 * CBA)	abnormal leukocyte physiology	J:53612
Tg(Scgb1a1-rtTA)1Jaw/0 Tg(tetO-Aimp1)29872Mcla/0 (involves: 129 * C57BL/6)	increased macrophage cell number	J:173904
Tg(Scgb1a1-rtTA,-tTS,tetO-CHI3L1)1Eli/0 (Not Specified)	abnormal macrophage morphology	J:148490
	decreased T cell apoptosis	J:148490
	increased T-helper 2 cell number	J:148490
Tg(Scgb1a1-rtTA,tetO-Ifng)14Eli/0 (involves: C57BL/6 * CBA)	increased lymphocyte cell number	J:100854
	increased macrophage cell number	J:100854
	increased neutrophil cell number	J:100854
Tg(Scgb1a1-rtTA,tetO-Il13)1Eli/0 (involves: C57BL/6 * CBA)	abnormal T-helper 2 physiology	J:148490
Tg(Scgb1a1-rtTA,tetO-Il13)1Eli/0 (involves: C57BL/6 * CBA)	increased T-helper 2 cell number	J:148490
Tg(SERPINA1-IGHG1/Il1rl1)423Zbz/? (involves: C3H * C57BL/6)	abnormal eosinophil physiology	J:63507
Tg(SERPINA1-IGHG1/Il1rl1)423Zbz/? (involves: C3H * C57BL/6)	increased eosinophil cell number	J:63507
Tg(SERPINC1-SV40)A1Pbr/0 (involves: C57BL/6 * DBA/2)	anisocytosis	J:101541
X/Tg(SERPINC1-SV40)BPbr (involves: C57BL/6 * DBA/2)	increased macrophage cell number	J:84204
Tg(SFTPC-Il18)AThos/0 (B6N.Cg-Tg(SFTPC-Il18)AThos)	abnormal spleen morphology	J:147547
Tg(SFTPC-Il18)AThos/0 (B6N.Cg-Tg(SFTPC-Il18)AThos)	enlarged spleen	J:147547
Tg(SFTPC-rtTA,tetO-Tnf)320-1Gwho/0 (involves: C57BL/6 * SJL)	abnormal B cell morphology	J:97297
	abnormal CD4-positive, alpha beta T cell morphology	J:97297
	abnormal dendritic cell morphology	J:97297
	abnormal T cell morphology	J:97297
	increased CD8-positive, alpha-beta T cell number	J:97297
	increased lymphocyte cell number	J:97297
	increased neutrophil cell number	J:97297
Tg(SFTPC-Tnf)2Pva/0 (involves: C57BL/6 * DBA/2)	abnormal platelet cell number	J:28120
Tg(SOD1G93A)1Gur/0 (B6.Cg-Tg(SOD1G93A)1Gur/J)	abnormal spleen morphology	J:138237
	abnormal T cell physiology	J:138237
	decreased spleen weight	J:138237
	decreased splenocyte number	J:138237
Tg(SOD1G93A)1Gur/0 (B6SJL-Tg(SOD1G93A)1Gur/J)	abnormal lymphocyte morphology	J:129215
	abnormal microglial cell morphology	J:165019, J:143173
	abnormal spleen morphology	J:138237
	abnormal splenic cell ratio	J:138237
	abnormal splenocyte morphology	J:138237
	decreased eosinophil cell number	J:129215
	decreased leukocyte cell number	J:129215
	decreased lymphocyte cell number	J:129215
	decreased monocyte cell number	J:129215
	decreased spleen weight	J:138237
	increased basophil cell number	J:129215
	microgliosis	J:146652, J:165019, J:110437, J:143173
	small spleen	J:138237
Tg(SOD1G93A)^dl1Gur/0 (involves: C57BL/6 C57BL/6J * SJL/J)	microgliosis	J:128738
Tg(SOD1H46R)LAra/0 (involves: C57BL/6 DBA/2)	microgliosis	J:221350
Tg(SOD1H46RC111S)PAra/0 (involves: C57BL/6 * DBA/2)	microgliosis	J:221350
Tg(SOD1H46RC111S)PAra/Tg(SOD1H46RC111S)PAra (involves: C57BL/6 * DBA/2)	microgliosis	J:221350
Tg(SOD1H46RC111S)QAra/0 (involves: C57BL/6 * DBA/2)	microgliosis	J:221350
Tg(SOD1L126Z)45Dbo/0 (involves: C3H/HeJ C57BL/6J)	microgliosis	J:219482
Tg(Stat3*)9199Alau/0 (involves: C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:210877
	abnormal T-helper 17 cell differentiation	J:210877
	decreased IgG1 level	J:210877
	decreased IgG3 level	J:210877
	increased IgE level	J:210877
	increased neutrophil cell number	J:210877
Tg(SV40-Ahr)1Poe/0 (involves: C57BL/6 * CBA)	absent B-1a cells	J:82428
	decreased B-1 B cell number	J:82428
	decreased thymus weight	J:77977
	increased B-2 B cell number	J:82428
	increased mature B cell number	J:82428
	increased pre-B cell number	J:82428
	increased pro-B cell number	J:82428
Tg(SV40-Igh-64C8)H3Hon/0 Tg(SV40-Igk4C8)L1Hon/0 (involves: C57BL/6)	abnormal B cell clonal deletion	J:139864
	abnormal B cell number	J:139864
	decreased hematocrit	J:139864
	hemolytic anemia	J:139864
	increased erythrocyte clearance	J:139864
Tg(SV)427Bri/0 (C57BL/6J-Tg(SV)427Bri)	enlarged thymus	J:79096
Tg(Tagln-rtTA)E1Jwst/0 Tg(tetO-BMPR2*T504)1Jwst/0 (involves: FVB/N)	increased hematocrit	J:98898
Tg(TARDBP)#Jpj/0 (involves: C3H * C57BL/6)	microgliosis	J:195184
Tg(TARDBPA315T)#Jpj/0 (involves: C3H C57BL/6)	microgliosis	J:195184
Tg(TARDBPG348C)#Jpj/0 (involves: C3H C57BL/6)	microgliosis	J:195184
Tg(TCF3/HLF)1Mlc/0 (involves: FVB/N)	abnormal CD4-positive, alpha beta T cell morphology	J:55022
	abnormal thymus involution	J:55022
	arrested T cell differentiation	J:55022
	decreased CD4-positive, alpha-beta T cell number	J:55022
	decreased CD8-positive, alpha-beta T cell number	J:55022
	decreased double-positive T cell number	J:55022
	decreased T cell number	J:55022
	decreased thymocyte number	J:55022
	thymus hypoplasia	J:55022
Tg(Tcra2B4)1Mmd/? (involves: C3H/HeJ * C57BL/6)	abnormal thymus cell ratio	J:92992
	decreased CD4-positive, alpha-beta T cell number	J:92992
	decreased double-positive T cell number	J:92992
	decreased thymocyte number	J:92992
	increased double-negative T cell number	J:92992
Tg(Tcra2C,Tcrb2C)1Dlo/? (involves: C57BL/6 * SJL)	abnormal CD8-positive, alpha beta T cell morphology	J:125259
Tg(Tcra2C,Tcrb2C)1Dlo/? (involves: C57L * DBA/2 * SJL)	abnormal memory T cell physiology	J:95380
	decreased lymphocyte cell number	J:95380
	decreased thymocyte number	J:95380
	increased CD4-positive, alpha-beta T cell number	J:95380
Tg(Tcra2D2,Tcrb2D2)1Kuch/0 (involves: C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:83278
Tg(Tcra2D2,Tcrb2D2)1Kuch/0 (involves: 129P2/OlaHsd * C57BL/6)	abnormal T-helper 1 cell number	J:189919
	decreased T cell proliferation	J:189919
	decreased T-helper 2 cell number	J:189919
	decreased T-helper 17 cell number	J:189919
	increased T cell apoptosis	J:189919
	increased T cell proliferation	J:189919
Tg(Tcra5CC7,Tcrb5CC7)IWep/0 (involves: C57BL/6)	abnormal T cell activation	J:73608
Tg(Tcra51-11.5,Tcrb51-11.5)AR206Ayr/0 (involves: C57BL/6 * DBA/2)	abnormal positive T cell selection	J:125548
Tg(Tcra,Tcrb)3Ayr/0 (involves: C57BL/6 * DBA/2)	abnormal positive T cell selection	J:125548
Tg(Tcra,Tcrb)3Ayr/0 (involves: C57BL/6 * DBA/2)	decreased T cell proliferation	J:80775
Tg(Tcra,Tcrb)24Efro/0 (D1.Cg-Tg(Tcra,Tcrb)24Efro)	abnormal T cell differentiation	J:104243
	decreased T cell proliferation	J:104243
	increased memory T cell number	J:104243
	increased T cell proliferation	J:104243
Tg(Tcra,Tcrb)HRCAll/0 (B6.Cg-Tg(Tcra,Tcrb)HRCAll)	abnormal T cell subpopulation ratio	J:131347
	decreased CD4-positive, alpha-beta T cell number	J:131347
	decreased cytotoxic T cell cytolysis	J:131347
	increased CD8-positive, alpha-beta T cell number	J:131347
Tg(Tcra,Tcrb)HRVAll/0 (B6.Cg-Tg(Tcra,Tcrb)HRVAll)	abnormal T cell subpopulation ratio	J:131347
	decreased CD4-positive, alpha-beta T cell number	J:131347
	increased CD8-positive, alpha-beta T cell number	J:131347
Tg(TcraAI4)1Dvs/0 (NOD-Tg(TcraAI4)1Dvs)	abnormal CD4-positive, alpha beta T cell morphology	J:93553
Tg(TcraAI4)1Dvs/0 Tg(TcrbAI4)1Dvs/0 (NOD-Tg(TcraAI4)1Dvs Tg(TcrbAI4)1Dvs)	abnormal CD4-positive, alpha beta T cell morphology	J:93553
	abnormal CD8-positive, alpha beta T cell morphology	J:94192
	abnormal cytotoxic T cell physiology	J:94192
Tg(TcraAV19AJ33)1Shima/? (involves: 129S4/SvJae * C57BL/6)	abnormal NK T cell morphology	J:112657
Tg(TcraAV19AJ33)1Shima/? (involves: 129S4/SvJae * C57BL/6)	abnormal NK T cell physiology	J:112657
Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0 (NOD.Cg-Tg(TcraBDC2.5,TcrbBDC2.5)1Doi)	increased activated T cell number	J:52940
Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0 (involves: C57BL/6 * NOD * SJL)	decreased dendritic cell number	J:137009
Tg(TcraCl1,TcrbCl1)1Shrm/0 (B10.Cg-Thy1^a H2^d Tg(TcraCl1,TcrbCl1)1Shrm)	abnormal T cell subpopulation ratio	J:97745
Tg(TcraCl4,TcrbCl4)1Shrm/? (B10.Cg-H2^d Tg(TcraCl4,TcrbCl4)1Shrm)	abnormal CD8-positive, alpha-beta T cell differentiation	J:99756
	abnormal T cell subpopulation ratio	J:99756
Tg(TcraDN32D3)#Alhn/0 (involves: NOD)	decreased NK cell number	J:201417
	decreased thymocyte number	J:201417
	increased double-negative T cell number	J:201417
Tg(TcraH-Y,TcrbH-Y)71Vbo/? (involves: C57BL/6J * C57L/J * DBA/2J)	abnormal double-negative T cell morphology	J:79738
	abnormal T cell differentiation	J:79738, J:90776
	decreased thymocyte number	J:79738
	thymus hypoplasia	J:79738
Tg(TcraH-Y,TcrbH-Y)71Vbo/? (involves: C57BL/6 * DBA/2J)	abnormal cytotoxic T cell physiology	J:66565
Tg(TcraH-Y,TcrbH-Y)71Vbo/? (involves: C57BL/6 * DBA/2J)	abnormal T cell differentiation	J:97610
Tg(TcraH-Y,TcrbH-Y)71Vbo/? Themis^tm1Gasc/Themis^tm1Gasc (involves: 129S6/SvEvTac * C57BL/6 * DBA/2)	abnormal negative T cell selection	J:151074
	abnormal positive T cell selection	J:151074
Tg(TcraH-Y,TcrbH-Y)71Vbo/? Themis^tm1Lov/Themis^tm1Lov (involves: 129 * C57BL/6 * DBA/2)	abnormal negative T cell selection	J:151075
	abnormal positive T cell selection	J:151075
	decreased single-positive T cell number	J:151075
	increased double-positive T cell number	J:151075
Tg(TcraH-Y,TcrbH-Y)71Vbo/0 Tnfrsf25^tm1Mjo/Tnfrsf25^tm1Mjo (involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)	abnormal negative T cell selection	J:84536
	abnormal thymus morphology	J:84536
	increased thymocyte number	J:84536
Tg(TcrAND)53Hed/? (involves: A/WySnSg * C57BL/6 * C57BL/10SnSg * SJL)	abnormal positive T cell selection	J:85777
	abnormal T cell differentiation	J:85777
	abnormal T cell proliferation	J:85777
	abnormal T cell subpopulation ratio	J:85777
	abnormal thymocyte activation	J:85777
	decreased CD8-positive, alpha-beta T cell number	J:85777
	decreased double-positive T cell number	J:85777
	increased CD4-positive, alpha-beta T cell number	J:85777
Tg(TcrAND)53Hed/? (involves: C57BL/6 * SJL)	increased CD4-positive, alpha-beta T cell number	J:124701
Tg(TcrAND)53Hed/? Themis^tm1Gasc/Themis^tm1Gasc (involves: 129S6/SvEvTac * C57BL/6 * SJL)	abnormal positive T cell selection	J:151074
	decreased CD4-positive, alpha-beta T cell number	J:151074
	decreased CD8-positive, alpha-beta T cell number	J:151074
	increased double-positive T cell number	J:151074
Tg(TcrAND)53Hed/? Themis^tm1Lov/Themis^tm1Lov (involves: 129 * C57BL/6 * SJL)	abnormal positive T cell selection	J:151075
	decreased single-positive T cell number	J:151075
	increased double-positive T cell number	J:151075
Tg(TcrAND)53Hed/? Zbtb7b^tm1.1Rbo/Zbtb7b^tm1.1Rbo (involves: C57BL/6 * SJL)	abnormal T cell differentiation	J:141145
Tg(TcraR28,TcrbR28)KRNDim/0 (involves: C57BL/6 * NOD * SJL)	abnormal lymphocyte cell number	J:36815
	abnormal macrophage chemotaxis	J:36815
	abnormal T cell activation	J:36815
	abnormal T cell clonal deletion	J:36815
	abnormal T cell proliferation	J:36815
	decreased CD4-positive, alpha-beta T cell number	J:36815
	decreased CD8-positive, alpha-beta T cell number	J:36815
	enlarged spleen	J:36815
	impaired neutrophil recruitment	J:36815
	increased B cell number	J:36815
	increased IgG1 level	J:36815
Tg(TcraTcrb)8Rest/? (C57BL/6-Tg(TcraTcrb)8Rest)	abnormal CD8-positive, alpha-beta cytotoxic T cell morphology	J:85058
Tg(TcraTcrb)8Rest/? (C57BL/6-Tg(TcraTcrb)8Rest)	abnormal cytotoxic T cell physiology	J:85058
Tg(TcraTcrb)425Cbn/0 (involves: BALB/c * C57BL/6)	abnormal positive T cell selection	J:125548
Tg(TcraTcrb)425Cbn/? (involves: BALB/c * C57BL/6)	abnormal positive T cell selection	J:87876
Tg(TcraTcrb)425Cbn/? (involves: BALB/c * C57BL/6)	increased CD4-positive, alpha-beta T cell number	J:87876
Tg(TcraTcrb)425Cbn/0 Trim30a^tm1Yjk/Trim30a^tm1Yjk (involves: 129P2/OlaHsd * BALB/c * C57BL/6)	increased T cell proliferation	J:215171
Tg(TcraTcrb)425Cbn/0 Trip10^tm1.1Geha/Trip10^tm1.1Geha (B6.Cg-Trip10^tm1.1Geha Tg(TcraTcrb)425Cbn)	abnormal effector T cell morphology	J:164363
	decreased CD4-positive, alpha-beta T cell number	J:164363
Tg(TcraTcrb)1100Mjb/? (involves: C57BL/6)	abnormal CD8-positive, alpha beta T cell morphology	J:92867
	abnormal cytotoxic T cell physiology	J:92867, J:133645
	abnormal positive T cell selection	J:92867, J:133645
	abnormal T cell clonal deletion	J:92867
	abnormal T cell subpopulation ratio	J:92867, J:133645
	decreased CD4-positive, alpha-beta T cell number	J:133645
	increased CD8-positive, alpha-beta T cell number	J:92867, J:133645
	increased T cell proliferation	J:92867
Tg(TcraTcrb)1100Mjb/? Themis^tm1Gasc/Themis^tm1Gasc (involves: 129S6/SvEvTac * C57BL/6)	abnormal positive T cell selection	J:151074
	decreased CD8-positive, alpha-beta T cell number	J:151074
	increased double-positive T cell number	J:151074
Tg(Tcrb)93Vbo/0 (involves: C57BL/LiA * CBA/BrA)	abnormal T cell morphology	J:93247
Tg(Tcrb)93Vbo/0 (involves: C57BL/LiA * CBA/BrA)	abnormal T cell receptor beta chain V(D)J recombination	J:93247
Tg(Tcrb)93Vbo/0 (involves: C57BL/6 * C57BL/LiA * CBA/BrA)	abnormal CD8-positive, alpha-beta T cell differentiation	J:66565
	abnormal cytotoxic T cell physiology	J:66565
	abnormal T cell clonal deletion	J:66565
Tg(Tcrb-TCF3/PBX1)19Gusa/0 (involves: C3H * C57BL/6 * C57BL/6J)	decreased thymocyte number	J:95693
Tg(Tcrb-TCF3/PBX1)23Gusa/0 (involves: C3H * C57BL/6 * C57BL/6J)	decreased thymocyte number	J:95693
Tg(TcrbAI4)1Dvs/0 (NOD-Tg(TcrbAI4)1Dvs)	abnormal CD4-positive, alpha beta T cell morphology	J:93553
Tg(TcrHEL3A9)1Mmd/0 (involves: C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:73608
	abnormal T cell activation	J:73608
	increased T cell proliferation	J:73608
Tg(TcrHEL3A9)1Mmd/0 (involves: C57BL/6 * C57BL/10 * C57BR/cd)	abnormal CD4-positive, alpha beta T cell morphology	J:78309
	abnormal double-positive T cell morphology	J:78309
	abnormal T cell activation	J:78309
	abnormal T cell proliferation	J:78309
	abnormal thymus cell ratio	J:78309
	decreased CD4-positive, alpha-beta T cell number	J:78309
Tg(TcrHEL3A9)1Mmd/0 Tg(TLK2mHEL)2Ccg/0 (involves: C57BL/6 * C57BL/10 * C57BR/cd)	abnormal CD4-positive, alpha beta T cell morphology	J:78309
	abnormal CD4-positive, alpha-beta T cell physiology	J:78309
	abnormal T cell activation	J:78309
	abnormal T cell proliferation	J:78309
	decreased CD4-positive, alpha-beta T cell number	J:78309
	decreased double-positive T cell number	J:78309
Tg(TcrLCMV)1Aox/? (C57BL/6-Tg(TcrLCMV)1Aox)	abnormal cytotoxic T cell physiology	J:92228
	decreased CD8-positive, alpha-beta T cell number	J:92228
	decreased double-positive T cell number	J:92228
	increased CD4-positive, alpha-beta T cell number	J:92228
	increased double-negative T cell number	J:92228
	increased IgG level	J:92228
Tg(TcrLCMV)2Aox/? (C57BL/6-Tg(TcrLCMV)2Aox)	abnormal cytotoxic T cell physiology	J:92228
	decreased CD8-positive, alpha-beta T cell number	J:92228
	decreased double-positive T cell number	J:92228
	increased CD4-positive, alpha-beta T cell number	J:92228
	increased double-negative T cell number	J:92228
Tg(TcrLCMV)327Sdz/0 (involves: C57BL/6 * DBA/2)	decreased CD8-positive, alpha-beta T cell number	J:77696
	decreased cytotoxic T cell cytolysis	J:77696
	decreased double-positive T cell number	J:77696
	decreased T cell proliferation	J:77696
	thymus hypoplasia	J:77696
Tg(TcrLCMV)327Sdz/? (involves: C57BL/6 * DBA/2J)	abnormal T cell differentiation	J:97610
Tg(TcrLCMV)327Sdz/? (involves: C57BL/6 * DBA/2J)	decreased CD4-positive, alpha-beta T cell number	J:97610
Tg(Tek-cre)1Ywa/0 Thbd^tm2Rdr/Thbd^tm2Wlr (involves: 129S2/SvPas * C57BL/6 * SJL)	increased megakaryocyte cell number	J:71269
	increased spleen weight	J:71269
	thrombocytopenia	J:71269
Tg(Tek-Jam3)1Maal/? (B6.Cg-Tg(Tek-Jam3)1Maal)	abnormal cellular extravasation	J:99020
	abnormal leukocyte adhesion	J:99020
	abnormal leukocyte physiology	J:99020
	impaired neutrophil chemotaxis	J:99020
Tg(Tek-Procr)1Cte/0 (B6.FVB-Tg(Tek-Procr)1Cte)	abnormal platelet physiology	J:119637
Tg(Tek-tTA)1Dmt/0 Tg(tetO-Tek)1Dmt/0 (involves: CD-1)	abnormal spleen red pulp morphology	J:137745
	abnormal spleen white pulp morphology	J:137745
	enlarged spleen	J:137745
	increased eosinophil cell number	J:137745
	increased T cell number	J:137745
Tg(tetO-BCR/ABL1)2Dgt/0 Tg(MMTVtTA)1Mam/0 (involves: C57BL/6 * FVB/N * SJL)	anemia	J:72377
	enlarged spleen	J:72377
	increased leukocyte cell number	J:72377
	thrombocytopenia	J:72377
Tg(tetO-BCR/ABL1)2Dgt/0 Tg(Tal1-tTA)19Dgt/0 (involves: C57BL/6 * DBA/2 * FVB/N)	abnormal common myeloid progenitor cell morphology	J:96511
	abnormal definitive hematopoiesis	J:96511
	abnormal lymphopoiesis	J:96511
	abnormal myeloblast morphology/development	J:96511
	abnormal spleen red pulp morphology	J:96511
	abnormal splenic cell ratio	J:96511
	enlarged spleen	J:96511
	increased bone marrow cell number	J:96511
	increased hematopoietic stem cell number	J:96511
	increased leukocyte cell number	J:96511
	increased megakaryocyte cell number	J:96511
	increased neutrophil cell number	J:96511
Tg(tetO-BCR/ABL1)27Dgt/0 Tg(MMTVtTA)1Mam/0 (involves: C57BL/6 * FVB/N * SJL)	anemia	J:72377
	enlarged spleen	J:72377
	increased leukocyte cell number	J:72377
	thrombocytopenia	J:72377
Tg(TG-SV40)#Cled/0 (involves: C57BL/6J * DBA/2J)	spleen hypoplasia	J:209788
Tg(TG-SV40)#Cled/0 (involves: C57BL/6J * DBA/2J)	thymus hypoplasia	J:209788
Tg(Th-SNCA)5Eric/Tg(Th-SNCA)5Eric (involves: C57BL/6)	abnormal microglial cell physiology	J:140907
Tg(Thy1-APP)3Somm/0 (involves: C57BL/6J * DBA/2)	microgliosis	J:134832
Tg(Thy1-AppR609DK612E)2Vln/0 (involves: C57BL * CBA/J)	abnormal microglial cell morphology	J:32213
Tg(Thy1-AppR609DK612E)4Vln/0 (involves: FVB)	abnormal microglial cell morphology	J:32213
Tg(Thy1-AppR609DK612E)6Vln/0 (involves: FVB)	abnormal microglial cell morphology	J:32213
Tg(Thy1-APPDutch)#Jckr/0 (involves: C57BL/6J)	microgliosis	J:92796
Tg(Thy1-APPSw)10Jiri/0 (involves: C3H * C57BL/6)	microgliosis	J:128647
Tg(Thy1-APPSw)10Jiri/0 Tg(Thy1-PSEN1M146V)#Jiri/0 (B6.Cg-Tg(Thy1-APPSw)10Jiri Tg(Thy1-PSEN1M146V)#Jiri)	microgliosis	J:156577
Tg(Thy1-APPSw,Thy1-PSEN1*L166P)21Jckr/0 Trem2^em1Gela/Trem2⁺ (involves: C57BL/6J)	abnormal hematopoietic system physiology	J:264653
	decreased myeloid cell number	J:264653
Tg(Thy1-APPSw,Thy1-PSEN1L166P)21Jckr/0 Trem2^{tm1(KOMP)Vlcg}/Trem2⁺ (involves: C57BL/6J C57BL/6NTac)	abnormal hematopoietic system physiology	J:264653
	decreased myeloid cell number	J:264653
Tg(Thy1-APPSwDutIowa)BWevn/0 (involves: C57BL/6)	abnormal microglial cell physiology	J:124911
Tg(Thy1-APPSweLon)41Ema/0 (involves: C57BL/6 * DBA/2)	microgliosis	J:162842
Tg(Thy1-Fcer2a)2431Putt/? (involves: BALB/c * C57BL/6)	decreased IgE level	J:20421
	decreased IgG1 level	J:20421
	increased eosinophil cell number	J:20421
Tg(Thy1-FUS)1Dit/0 (B6.Cg-Tg(Thy1-FUS)1Dit)	microgliosis	J:287782
Tg(Thy1-FUS)1Dit/0 Tg(Thy1-TARDBP)4Singh/0 (involves: C57BL/6J DBA/2J * SJL/J)	microgliosis	J:287782
Tg(Thy1-FUS)19Vlb/0 (B6.Cg-Tg(Thy1-FUS)19Vlb)	microgliosis	J:203550
Tg(Thy1-MAPT)1Avil/Tg(Thy1-MAPT)1Avil (involves: C57BL/6 * CBA)	microgliosis	J:201700
Tg(Thy1-PSEN1M146V,-APPSwe)10Arte/Tg(Thy1-PSEN1M146V,-APPSwe)10Arte (involves: C57BL/6 * CBA)	microgliosis	J:155410
Tg(Thy1-Snca)1S13Putt/? (involves: C57BL/6)	microgliosis	J:177661
Tg(Thy1-SNCA)61Ema/0 (involves: C57BL/6 * DBA/2)	abnormal microglial cell activation	J:238066
Tg(Thy1-SNCA)61Ema/0 (involves: C57BL/6 * DBA/2)	abnormal microglial cell morphology	J:238066
Tg(Thy1-Sncg)HvP36Putt/? (C57BL/6-Tg(Thy1-Sncg)HvP36Putt)	microgliosis	J:185793
Tg(Thy1-TARDBP)4Singh/0 (involves: C57BL/6J * SJL/J)	microgliosis	J:157550
Tg(Thy1-TARDBP)4Singh/Tg(Thy1-TARDBP)4Singh (involves: C57BL/6J * SJL/J)	microgliosis	J:157550
Tg(Thy1-TARDBP)6Singh/Tg(Thy1-TARDBP)6Singh (involves: C57BL/6 * C57BL/6J * SJL)	microgliosis	J:157550
Tg(Thy1-UBQLN2P497S)3Mont/? (involves: C3H C57BL/6 * C57BL/6J)	increased microglial cell activation	J:239510
Tg(Thy1-UBQLN2P506T)6Mont/? (involves: C3H C57BL/6 * C57BL/6J)	decreased microglial cell activation	J:239510
Tg(Thy1/THY1)T6Gsv/0 (involves: C57BL/10 * CBA)	abnormal mononuclear cell morphology	J:294621
	increased macrophage derived foam cell number	J:294621
	increased neutrophil cell number	J:294621
Tg(Thy1/THY1)T12Gsv/0 (involves: C57BL/10 * CBA)	increased IgG level	J:133943
Tg(Thy1/THY1)T12Gsv/0 (involves: C57BL/10 * CBA)	increased IgM level	J:133943
Tg(Tk1-DPP4)27Ysj/0 (involves: C57BL/6 * FVB/N)	abnormal macrophage activation involved in immune response	J:290259
Tg(Tlr7)1Boll/0 (involves: C57BL/6)	abnormal dendritic cell morphology	J:127600
	abnormal spleen morphology	J:127600
	anemia	J:127600
	decreased spleen white pulp amount	J:127600
	enlarged spleen	J:127600
	extramedullary hematopoiesis	J:127600
	thrombocytopenia	J:127600
X/Tg(Tlr7)6Boll (involves: C57BL/6)	abnormal B cell activation	J:127600
	abnormal B cell morphology	J:127600
	abnormal dendritic cell morphology	J:127600
	abnormal T cell activation	J:127600
	decreased marginal zone B cell number	J:127600
	enlarged spleen	J:127600
	increased mature B cell number	J:127600
	increased splenocyte proliferation	J:127600
Tg(TNF)197Gkl/0 (involves: C57BL/6 * CBA)	abnormal osteoclast differentiation	J:97992
Tg(TNF)197Gkl/0 (involves: C57BL/6 * CBA)	increased osteoclast cell number	J:97992
Tg(Tnf)6074Gkl/0 (involves: C57BL/6 * CBA)	abnormal microglial cell morphology	J:106592
Tg(TNFSF11)5519Edou/0 (involves: C57BL/6J * CBA/J)	increased osteoclast cell number	J:233240
Tg(Tnfsf13b)1Fma/0 (involves: C57BL/6 * DBA/2J)	abnormal B cell morphology	J:58798
	abnormal B cell physiology	J:58798
	abnormal spleen follicular dendritic cell network	J:58798
	abnormal spleen morphology	J:58798
	abnormal spleen periarteriolar lymphoid sheath morphology	J:58798
	abnormal T cell number	J:58798
	abnormal T cell physiology	J:58798
	abnormal T cell subpopulation ratio	J:58798
	enlarged spleen	J:58798
	hematopoietic system phenotype	J:58798
	increased B cell number	J:58798
	increased IgG level	J:58798
	increased IgM level	J:58798
	increased immunoglobulin level	J:58798
	increased lymphocyte cell number	J:58798
	increased marginal zone B cell number	J:58798
	increased mature B cell number	J:58798
	increased plasma cell number	J:58798
	increased spleen B cell follicle size	J:58798
	increased spleen germinal center size	J:58798
	increased T cell number	J:58798
Tg(Tnfsf13b)1Fma/0 (B6.Cg-Tg(Tnfsf13b)1Fma)	abnormal B cell differentiation	J:73711
	abnormal B-1 B cell morphology	J:114782
	abnormal spleen germinal center morphology	J:114782
	abnormal spleen marginal zone morphology	J:114782
	increased B cell number	J:114782
	increased B-1a cell number	J:114782
	increased B-1b cell number	J:114782
	increased IgA level	J:114782
	increased plasma cell number	J:114782
Tg(Tnfsf13b)1Fma/0 (involves: C57BL/6J * DBA/2J)	abnormal B cell differentiation	J:115788
Tg(Tnfsf13b)1Fma/0 (involves: C57BL/6J * DBA/2J)	abnormal B-1 B cell morphology	J:115788
Tg(Tnfsf13b)1Fma/? (B6.Cg-Tg(Tnfsf13b)1Fma)	abnormal B cell activation	J:113556
	abnormal marginal zone B cell physiology	J:113556
	abnormal spleen marginal zone morphology	J:113556
	increased B cell number	J:113556
	increased marginal zone B cell number	J:113556
	increased transitional stage B cell number	J:113556
Tg(Tnfsf13b)1Fma/? Tnfrsf13b^tm1Rjb/Tnfrsf13b^tm1Rjb (B6.Cg-Tnfrsf13b^tm1Rjb Tg(Tnfsf13b)1Fma)	abnormal class switch recombination	J:113556
Tg(Tnfsf13b)1Fma/? Tnfrsf13c^tm1Mass/Tnfrsf13c^tm1Mass (B6.Cg-Tnfrsf13c^tm1Mass Tg(Tnfsf13b)1Fma)	abnormal class switch recombination	J:113556
Tg(Tnfsf13b)1Fma/0 Tnfsf14^tm1Kpf/Tnfsf14^tm1Kpf (involves: 129P2/OlaHsd * C57BL/6 * DBA/2J)	abnormal spleen germinal center morphology	J:114782
	abnormal spleen marginal zone morphology	J:114782
	increased B cell number	J:114782
	increased IgA level	J:114782
	increased plasma cell number	J:114782
Tg(Tnfsf13b)1Fma/Tg(Tnfsf13b)1Fma (involves: C57BL/6 * DBA/2)	abnormal immunoglobulin level	J:178227
	increased B cell number	J:178227
	increased IgA level	J:178227
	increased IgM level	J:178227
	increased immunoglobulin level	J:178227
	increased marginal zone B cell number	J:178227
	increased transitional stage T2 B cell number	J:178227
Tg(Tox)1Kay/? Tox^tm1.1Kay/Tox^tm1.1Kay (involves: 129S6/SvEvTac * C57BL/6)	abnormal T cell number	J:131287
Tg(Trp53)1Srn/0 (involves: C57BL/6 * CBA)	increased thymocyte apoptosis	J:80311
Tg(Trp53)1Srn/0 Trp53^tm1Tyj/Trp53^tm1Tyj (involves: 129S2/SvPas * C57BL/6 * CBA)	decreased thymocyte apoptosis	J:80311
Tg(Trp53)bSrn/0 (involves: C57BL/6 * CBA)	increased thymocyte apoptosis	J:80311
Tg(Trp53A135V)L3Ber/0 (involves: C57BL/6 * CD-1)	decreased spleen weight	J:73757
Tg(Ttr-IGF1)1Sykr/0 (FVB/N-Tg(Ttr-IGF1)1Sykr)	increased spleen weight	J:157350
Tg(UBC-scFv)2Nemz/0 (involves: C57BL/6 * DBA/2)	abnormal B cell differentiation	J:96759
	abnormal B cell morphology	J:96759
	abnormal B cell receptor editing	J:96759
	abnormal B-1 B cell morphology	J:96759
	abnormal immunoglobulin level	J:96759
	abnormal mature B cell morphology	J:96759
	decreased mature B cell number	J:96759
	decreased splenocyte number	J:96759
	spleen hypoplasia	J:96759
Tg(Vav1-Asxl1Y588X)#Fcy/0 (C57BL/6-Tg(Vav1-Asxl1Y588X)#Fcy)	abnormal definitive hematopoiesis	J:257690
	abnormal hematopoietic stem cell physiology	J:257690
	abnormal myeloid cell morphology	J:257690
	abnormal neutrophil morphology	J:257690
	abnormal spleen morphology	J:257690
	decreased erythrocyte cell number	J:257690
	decreased hemoglobin content	J:257690
	decreased leukocyte cell number	J:257690
	decreased lymphocyte cell number	J:257690
	decreased megakaryocyte-erythroid progenitor cell number	J:257690
	enlarged spleen	J:257690
	hepatosplenomegaly	J:257690
	increased granulocyte monocyte progenitor cell number	J:257690
	increased hematopoietic stem cell number	J:257690
	increased leukocyte cell number	J:257690
	increased megakaryocyte cell number	J:257690
	increased monocyte cell number	J:257690
	increased myeloid cell number	J:257690
	increased neutrophil cell number	J:257690
	increased number of Howell-Jolly bodies	J:257690
	thrombocytosis	J:257690
Tg(Vav1-ERG)#Jpim/0 (involves: C57BL/6)	abnormal thymus morphology	J:174808
	enlarged spleen	J:174808
	enlarged thymus	J:174808
Tg(Vav1-JAK2V617F)AZjz/0 (involves: C57BL/6 DBA/2)	abnormal blood cell morphology/development	J:135993
	abnormal definitive hematopoiesis	J:135993
	abnormal megakaryocyte progenitor cell morphology	J:135993
	enlarged spleen	J:135993
	giant platelets	J:135993
	increased erythrocyte cell number	J:135993
	increased granulocyte number	J:135993
	increased hematocrit	J:135993
	increased hemoglobin content	J:135993
	increased leukocyte cell number	J:135993
	increased megakaryocyte cell number	J:135993
	increased spleen weight	J:135993
	microcytosis	J:135993
	spleen fibrosis	J:135993
	thrombocytosis	J:135993
Tg(Vav1-Lin28b)C3Apla/0 (involves: C57BL/6)	abnormal T cell differentiation	J:189197
	abnormal thymus cell ratio	J:189197
	abnormal thymus cortex morphology	J:189197
	abnormal thymus corticomedullary boundary morphology	J:189197
	anemia	J:189197
	decreased CD4-positive, alpha-beta T cell number	J:189197
	decreased CD8-positive, alpha-beta T cell number	J:189197
	decreased double-positive T cell number	J:189197
	decreased leukocyte cell number	J:189197
	decreased lymphocyte cell number	J:189197
	decreased thymocyte number	J:189197
	enlarged spleen	J:189197
	enlarged thymus medulla	J:189197
	increased CD8-positive, alpha-beta T cell number	J:189197
	increased effector memory CD4-positive, alpha-beta T cell number	J:189197
	increased effector memory CD8-positive, alpha-beta T cell number	J:189197
	increased eosinophil cell number	J:189197
	increased IgG level	J:189197
	increased neutrophil cell number	J:189197
	increased T cell proliferation	J:189197
Tg(Vav1-NUP98/HOXD13)C1Apla/0 (FVB/N-Tg(Vav1-NUP98/HOXD13)C1Apla)	abnormal bone marrow cell morphology/development	J:107446
	abnormal definitive hematopoiesis	J:107446
	abnormal erythroid progenitor cell morphology	J:107446
	abnormal megakaryocyte morphology	J:107446
	abnormal neutrophil morphology	J:107446
	anemia	J:107446
	anisocytosis	J:107446
	decreased leukocyte cell number	J:107446
	giant platelets	J:107446
	increased bone marrow cell number	J:107446
	increased erythroblast number	J:107446
	increased mean corpuscular volume	J:107446
	increased nucleated erythrocyte cell number	J:107446
	poikilocytosis	J:107446
	polychromatophilia	J:107446
Tg(Vav1-NUP98/HOXD13)G2Apla/0 (C57BL/6-Tg(Vav1-NUP98/HOXD13)G2Apla)	abnormal definitive hematopoiesis	J:107446
	abnormal neutrophil morphology	J:107446
	anisocytosis	J:107446
	decreased leukocyte cell number	J:107446
	decreased lymphocyte cell number	J:107446
	decreased neutrophil cell number	J:107446
	increased nucleated erythrocyte cell number	J:107446
	poikilocytosis	J:107446
	polychromatophilia	J:107446
Tg(Vav1-STAT5BN642H)726Biat/0 (C57BL/6NCrl-Tg(Vav1-STAT5BN642H)726Biat)	abnormal bone marrow cell morphology/development	J:257519
	abnormal effector T cell number	J:257519
	abnormal spleen morphology	J:257519
	enlarged spleen	J:257519
	increased CD4-positive, alpha-beta T cell number	J:257519
	increased CD8-positive, alpha-beta T cell number	J:257519
	increased common lymphocyte progenitor cell number	J:257519
	increased common myeloid progenitor cell number	J:257519
	increased hematopoietic stem cell number	J:257519
	increased leukocyte cell number	J:257519
	increased T cell proliferation	J:257519
Tg(Vav-BCL2)69Jad/0 (involves: C57BL/6J)	abnormal class switch recombination	J:88565
	abnormal lymphocyte cell number	J:88565
	abnormal somatic hypermutation frequency	J:88565
	abnormal spleen germinal center morphology	J:88565
	enlarged spleen	J:88565
	increased B cell number	J:88565
	increased CD4-positive, alpha-beta T cell number	J:88565
	increased CD8-positive, alpha-beta T cell number	J:88565
	increased spleen germinal center number	J:88565
	increased spleen germinal center size	J:88565
	increased T cell number	J:88565
Tg(Vil1-cre)997Gum/? Tlr5^tm1.1Gewr/Tlr5^tm1.1Gewr (involves: C57BL/6J * C57BL/6NTac * SJL/J)	enlarged spleen	J:229155
Tg(Vil1-cre)997Gum/0 Tnfrsf11a^tm1.1Irw/Tnfrsf11a^tm1.1Irw (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac * SJL)	decreased IgA level	J:226603
	decreased plasma cell number	J:226603
Tg(VIM-Tag)3Pau/0 (involves: C57BL/6 * SJL/J)	enlarged thymus	J:91542
	increased double-negative T cell number	J:91542
	thymus hyperplasia	J:91542
Tg^cog/Tg^cog (involves: AKR/J * C57BL/6By)	anemia	J:8567
Tg^cog/Tg^cog (involves: AKR/J * C57BL/6By)	decreased hematocrit	J:8567
Tg^m3Btlr/Tg^m3Btlr (C57BL/6J-Tg^m3Btlr)	decreased B cell number	J:265197
Tg^m3Btlr/Tg^m3Btlr (C57BL/6J-Tg^m3Btlr)	decreased IgE level	J:265197
Tg^m4Btlr/Tg^m4Btlr (C57BL/6J-Tg^m4Btlr)	decreased B cell number	J:272522
	decreased B-2 B cell number	J:272522
	increased alpha-beta T cell number	J:272522
	increased B-1a cell number	J:272522
	increased CD4-positive, alpha-beta T cell number	J:272522
	increased CD8-positive, alpha-beta T cell number	J:272522
	increased central memory CD4-positive, alpha-beta T cell number	J:272522
	increased IgE level	J:272522
	increased macrophage cell number	J:272522
Tg^M5Btlr/Tg^M5Btlr (C57BL/6J-Tg^M5Btlr)	increased central memory CD4-positive, alpha-beta T cell number	J:272523
Tg^m6Btlr/Tg^m6Btlr (C57BL/6J-Tg^m6Btlr)	increased alpha-beta T cell number	J:272525
tga/tga (C57BL/6J-tga)	thymus hypoplasia	J:94456
Tgfb1^{tm1(Tgfb3)Kul}/Tgfb1^{tm1(Tgfb3)Kul} (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal T cell morphology	J:204892
	increased monocyte cell number	J:204892
	increased regulatory T cell number	J:204892
Tgfb1^tm1Doe/Tgfb1^tm1Doe (involves: 129S2/SvPas * CF-1)	increased leukocyte cell number	J:2892
Tgfb1^tm1Doe/Tgfb1^tm1Doe (involves: 129S2/SvPas * CF-1)	small spleen	J:2892
Tgfb1^tm1Doe/Tgfb1^tm1Doe (C.129S2-Tgfb1^tm1Doe)	decreased CD4-positive, alpha-beta T cell number	J:69346
	increased CD4-positive, alpha-beta T cell number	J:69346
	increased T-helper 1 cell number	J:69346
Tgfb1^tm1Jmu/Tgfb1^tm1Jmu (involves: 129S6/SvEvTac * C57BL/6)	absent Langerhans cell	J:120085
Tgfb1^tm1Jmu/Tgfb1^tm1Jmu (involves: 129S6/SvEvTac * C57BL/6 * Swiss Webster)	absent Langerhans cell	J:120085
Tgfb1^tm1N/Tgfb1^tm1N (involves: 129S/SvEv)	absent Langerhans cell	J:120085
Tgfb1^tm1N/Tgfb1^tm1N (involves: 129S/SvEv * C57BL/6J * NIH/Ola)	abnormal embryonic erythropoiesis	J:26913
	abnormal embryonic hematopoiesis	J:26913
Tgfb1^tm1Rif/Tgfb1^tm1Rif (either: (involves: 129) or (involves: 129S/SvEv * C57BL/6))	absent Langerhans cell	J:142353
Tgfb1^tm2Flv/B9d2/Tgfb1^tm1Flv Tg(CD207-cre)1Dhka/? (involves: 129S6/SvEvTac * C57BL/6J * SJL/J)	decreased Langerhans cell number	J:126147
Tgfb1^tm3.1Flv/Tgfb1^tm3.1Flv Tg(Cd4-cre)1Cwi/0 (involves: 129 * C57BL/6 * DBA/2 * NOD)	increased regulatory T cell number	J:196160
	increased T-helper 1 cell number	J:196160
Tgfb1^tm3.1Flv/Tgfb1^tm3.1Flv Tg(Cd4-cre)1Cwi/0 Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0 (involves: 129 * C57BL/6 * DBA/2 * NOD * SJL)	increased regulatory T cell number	J:196160
	increased T-helper 1 cell number	J:196160
Tgfb2^tm1Doe/Tgfb2^tm1Doe (involves: 129P2/OlaHsd * Black Swiss)	abnormal macrophage physiology	J:73681
Tgfbi^tm1Zhao/Tgfbi^tm1Zhao (involves: 129 * C57BL/6J)	enlarged spleen	J:143036
Tgfbi^tm1Zhao/Tgfbi^tm1Zhao (involves: 129 * C57BL/6J)	increased B cell number	J:143036
Tgfbr1^tm1.1Karl/Tgfbr1^tm1.1Karl Tg(Mx1-cre)1Cgn/0 (involves: 129 * C57BL/6 * CBA)	hematopoietic system phenotype	J:86262
	increased hematopoietic stem cell proliferation	J:86262
Tgfbr2^tm1.1Karl/Tgfbr2^tm1.1Karl (involves: 129/Sv * C57BL/6)	abnormal erythropoiesis	J:77844
Tgfbr2^tm1.2Hlm/Tgfbr2^tm1.2Hlm Tg(Cd4-cre)1Cwi/0 (involves: 129S6/SvEvTac * C57BL/6 * DBA/2)	abnormal T cell activation	J:148747
Tgfbr2^tm1.2Hlm/Tgfbr2^tm1.2Hlm Tg(Cd4-cre)1Cwi/0 Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0 (involves: 129 * C57BL/6 * DBA/2 * NOD * SJL)	abnormal spleen morphology	J:196160
	decreased regulatory T cell number	J:196160
	increased regulatory T cell number	J:196160
Tgfbr2^tm1.2Hlm/Tgfbr2^tm1.2Hlm Tg(CD207-cre)1Dhka/? (involves: 129S6/SvEvTac * C57BL/6J * SJL/J)	decreased Langerhans cell number	J:126147
Tgfbr2^tm1.2Hlm/Tgfbr2^tm1.2Hlm Tg(Foxp3-EGFP/cre)1cJbs/0 Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0 (involves: 129S6/SvEvTac * C57BL/6 * NOD * SJL)	increased regulatory T cell number	J:196160
Tgfbr2^tm1Karl/Tgfbr2^tm1Karl H2az2^{Tg(Wnt1-cre)11Rth}/H2az2⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	small thymus	J:96359
Tgfbr2^tm1Karl/Tgfbr2^tm1Karl Tg(Mx1-cre)1Cgn/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	small thymus	J:77844
Tgfbr2^tm1Mmt/Tgfbr2^tm1Mmt (involves: 129S2/SvPas * C57BL/6J)	abnormal embryonic hematopoiesis	J:73414
Tgfbr3^tm1Stv/Tgfbr3^tm1Stv (involves: 129/Sv * C57BL/6)	abnormal definitive hematopoiesis	J:83727
	abnormal spleen morphology	J:83727
	decreased spleen white pulp amount	J:83727
Tgm2^tm1.1Rmgr/Tgm2^tm1.1Rmgr (involves: 129S1/SvImJ * C57BL/6)	abnormal T cell physiology	J:95130
Tgm2^tm1Gml/Tgm2^tm1Gml (involves: 129X1/SvJ * C57BL/6)	decreased erythrocyte cell number	J:75566
Tgm2^tm1Gml/Tgm2^tm1Gml (involves: 129X1/SvJ * C57BL/6)	decreased hematocrit	J:75566
Tgm2^tm1Gml/Tgm2^tm1Gml (involves: C57BL/6)	increased macrophage cell number	J:131975
Tgm2^tm1Gml/Tgm2^tm1Gml (involves: C57BL/6 * DBA/1LacJ)	abnormal thymus morphology	J:132254
Tgm2^tm1Gml/Tgm2^tm1Gml (involves: C57BL/6 * DBA/1LacJ)	impaired macrophage phagocytosis	J:132254
TgTn(pb-CAG-Gm614)#Cya/0 (involves: C57BL/6)	decreased B cell apoptosis	J:307345
TgTn(pb-CAG-Gm40600)#Rew/0 (C57BL/6-TgTn(pb-CAG-Gm40600)#Rew)	abnormal plasmablast number	J:311878
	decreased B cell number	J:311878
	decreased IgA level	J:311878
	decreased IgE level	J:311878
	decreased IgG1 level	J:311878
	decreased IgG2b level	J:311878
	decreased IgG2c level	J:311878
	decreased IgG3 level	J:311878
	decreased IgG level	J:311878
	decreased IgM level	J:311878
	decreased plasma cell number	J:311878
	increased B cell number	J:311878
	increased IgA level	J:311878
	increased IgE level	J:311878
	increased IgG1 level	J:311878
	increased IgG2b level	J:311878
	increased IgG2c level	J:311878
	increased IgG3 level	J:311878
	increased IgG level	J:311878
	increased IgM level	J:311878
	increased plasma cell number	J:311878
Thap11^em1Poche/Thap11^em1Poche (C57BL/6J-Thap11^em1Poche)	decreased erythrocyte cell number	J:317822
	decreased hematocrit	J:317822
	decreased hemoglobin content	J:317822
	thrombocytopenia	J:317822
Thbd^tm1Wlr/Thbd^tm1Wlr (B6.129S2-Thbd^tm1Wlr)	abnormal spleen morphology	J:111502
Thbd^tm1Wlr/Thbd^tm2Rdr (involves: 129S2/SvPas * C57BL/6)	abnormal spleen morphology	J:111502, J:47676
Thbd^tm2.1Emc/Thbd^tm2.1Emc (involves: 129/Sv * BALB/c * C57BL/6)	abnormal leukocyte adhesion	J:118000
	abnormal leukocyte physiology	J:118000
Thbd^tm2Emc/Thbd^tm2Emc (either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))	abnormal leukocyte physiology	J:118000
Thbs1^tm1Hyn/Thbs1^tm1Hyn (either: (involves: 129S2/SvPas * 129/Sv) or (involves: 129S2/SvPas * C57BL/6))	increased eosinophil cell number	J:46182
	increased leukocyte cell number	J:46182
	increased lymphocyte cell number	J:46182
	increased monocyte cell number	J:46182
	increased neutrophil cell number	J:46182
Thbs1^tm1Hyn/Thbs1^tm1Hyn (involves: 129S2/SvPas * C57BL/6)	decreased regulatory T cell number	J:153126
Thbs1^tm1Hyn/Thbs1^tm1Hyn (involves: 129S2/SvPas * C57BL/6)	increased CD4-positive, alpha-beta T cell number	J:153126
Thbs1^tm1Hyn/Thbs1^tm1Hyn Thbs2^tm1Bst/Thbs2^tm1Bst (involves: 129T2/SvEms * 129X1/SvJ)	impaired macrophage chemotaxis	J:78876
Thbs2^em1(IMPC)Mbp/Thbs2^em1(IMPC)Mbp (C57BL/6NCrl-Thbs2^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Thbs2^tm1Bst/Thbs2^tm1Bst (either: (involves: 129S4/SvJae * 129X1/SvJ) or (involves: 129X1/SvJ))	thrombocytosis	J:45509
Thbs4^tm1Dgen/Thbs4^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6)	hematopoietic system phenotype	J:101679
Themis^5AT161/Themis^5AT161 (involves: C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:151076
	decreased CD8-positive, alpha-beta T cell number	J:151076
	decreased regulatory T cell number	J:151076
	decreased single-positive T cell number	J:151076
Themis^m1Btlr/Themis^m1Btlr (C57BL/6J-Themis^m1Btlr)	abnormal lymphocyte morphology	J:211400
	decreased B-1a cell number	J:211400
	decreased CD4-positive, alpha-beta T cell number	J:211400
	decreased CD8-positive, alpha-beta T cell number	J:211400
Themis^m2Btlr/Themis^m2Btlr (C57BL/6J-Themis^m2Btlr)	decreased CD4-positive, alpha-beta T cell number	J:236691
	decreased T cell number	J:236691
	impaired hematopoiesis	J:236691
	increased CD8-positive, alpha-beta T cell number	J:236691
	increased effector memory CD4-positive, alpha-beta T cell number	J:236691
Themis^m3Btlr/Themis^m3Btlr (C57BL/6J-Themis^m3Btlr)	abnormal CD8-positive, alpha-beta cytotoxic T cell morphology	J:254834
	decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:254834
	decreased CD8-positive, alpha-beta memory T cell number	J:254834
	decreased CD8-positive, naive alpha-beta T cell number	J:254834
	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:254834
	increased CD8-positive, alpha-beta memory T cell number	J:254834
	increased central memory CD4-positive, alpha-beta T cell number	J:254834
	increased central memory CD8 positive, alpha-beta T cell number	J:254834
	increased effector memory CD4-positive, alpha-beta T cell number	J:254834
Themis^M4Btlr/Themis^M4Btlr (C57BL/6J-Themis^M4Btlr)	decreased CD4-positive, alpha-beta T cell number	J:272849
Themis^m5Btlr/Themis^m5Btlr (C57BL/6J-Themis^m5Btlr)	abnormal CD4-positive T cell differentiation	J:274716
	abnormal CD8-positive, alpha-beta T cell differentiation	J:274716
	abnormal T cell differentiation	J:274716
	decreased alpha-beta T cell number	J:274716
	decreased CD4-positive, alpha-beta T cell number	J:274716
	decreased CD8-positive, alpha-beta T cell number	J:274716
	decreased CD8-positive, naive alpha-beta T cell number	J:274716
	increased CD8-positive, alpha-beta memory T cell number	J:274716
	increased central memory CD4-positive, alpha-beta T cell number	J:274716
	increased central memory CD8 positive, alpha-beta T cell number	J:274716
	increased effector memory CD4-positive, alpha-beta T cell number	J:274716
	increased effector memory CD8-positive, alpha-beta T cell number	J:274716
	increased NK T cell number	J:274716
Themis^Spotr/Themis⁺ (C57BL/6-Themis^Spotr)	decreased CD4-positive, alpha-beta T cell number	J:152601
Themis^Spotr/Themis⁺ (C57BL/6-Themis^Spotr)	decreased CD8-positive, alpha-beta T cell number	J:152601
Themis^Spotr/Themis^Spotr (C57BL/6-Themis^Spotr)	abnormal T cell differentiation	J:152601
	decreased CD4-positive, alpha-beta T cell number	J:152601
	decreased CD8-positive, alpha-beta T cell number	J:152601
	small thymus medulla	J:152601
Themis^tm1.1Hko/Themis⁺ (Not Specified)	decreased CD4-positive, alpha-beta T cell number	J:152601
Themis^tm1.1Hko/Themis⁺ (Not Specified)	decreased CD8-positive, alpha-beta T cell number	J:152601
Themis^tm1.1Hko/Themis^tm1.1Hko (Not Specified)	decreased CD4-positive, alpha-beta T cell number	J:152601
	decreased CD8-positive, alpha-beta T cell number	J:152601
	decreased single-positive T cell number	J:152601
Themis^tm1Gasc/Themis^tm1Gasc (B6.129S-Themis^tm1Gasc)	abnormal memory T cell morphology	J:151074
	abnormal positive T cell selection	J:151074
	abnormal regulatory T cell morphology	J:151074
	abnormal thymus medulla morphology	J:151074
	decreased CD4-positive, alpha-beta T cell number	J:151074
	decreased CD8-positive, alpha-beta T cell number	J:151074
	decreased T cell proliferation	J:151074
	decreased thymocyte number	J:151074
	increased double-positive T cell number	J:151074
Themis^tm1Hasu/Themis⁺ (involves: C57BL/6 * CBA)	decreased CD4-positive, alpha-beta T cell number	J:153235
Themis^tm1Hasu/Themis⁺ (involves: C57BL/6 * CBA)	decreased CD8-positive, alpha-beta T cell number	J:153235
Themis^tm1Hasu/Themis^tm1Hasu (involves: C57BL/6 * CBA)	abnormal T cell differentiation	J:153235
	decreased CD4-positive, alpha-beta T cell number	J:153235
	decreased CD8-positive, alpha-beta T cell number	J:153235
	decreased splenocyte number	J:153235
	decreased thymocyte number	J:153235
	increased memory T cell number	J:153235
	increased T cell proliferation	J:153235
Themis^tm1Lov/Themis^tm1Lov (involves: 129)	abnormal negative T cell selection	J:151075
	abnormal T cell differentiation	J:151075
	decreased CD4-positive, alpha-beta T cell number	J:151075
	decreased CD8-positive, alpha-beta T cell number	J:151075
	decreased regulatory T cell number	J:151075
	decreased single-positive T cell number	J:151075
	increased memory T cell number	J:151075
Thoc1^{em1(IMPC)Ccpcz}/Thoc1⁺ (C57BL/6NCrl-Thoc1^{em1(IMPC)Ccpcz}/Ccpcz)	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
	increased mean platelet volume	J:211773
Thoc7^em1(IMPC)J/Thoc7⁺ (C57BL/6NJ-Thoc7^em1(IMPC)J/Mmjax)	increased mean corpuscular hemoglobin concentration	J:211773
Thop1^em1(IMPC)Mbp/Thop1^em1(IMPC)Mbp (C57BL/6NCrl-Thop1^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	decreased leukocyte cell number	J:211773
	enlarged spleen	J:211773
Thop1^{Gt(CSG163)Byg}/Thop1^{Gt(CSG163)Byg} (B6.129P2-Thop1^{Gt(CSG163)Byg})	decreased lymphocyte cell number	J:290567
	increased granulocyte number	J:290567
	increased monocyte cell number	J:290567
	thrombocytopenia	J:290567
Thpo^{tm1.1(KOMP)Vlcg}/Thpo^{tm1.1(KOMP)Vlcg} (C57BL/6N-Thpo^{tm1.1(KOMP)Vlcg}/Ucd)	increased mean platelet volume	J:211773
	thrombocytopenia	J:211773
Thpo^tm1Mwm/Thpo⁺ (involves: 129S2/SvPas * C57BL/6)	thrombocytopenia	J:83262
Thpo^tm1Mwm/Thpo^tm1Mwm (involves: 129S2/SvPas * C57BL/6)	decreased megakaryocyte cell number	J:83262
	increased mean platelet volume	J:83262
	thrombocytopenia	J:83262
Thra^em1Ffla/Thra⁺ (C57BL/6-Thra^em1Ffla)	decreased hemoglobin content	J:268664
Thra^em2Ffla/Thra⁺ (C57BL/6-Thra^em2Ffla)	decreased hemoglobin content	J:268664
Thra^{tm1b(EUCOMM)Wtsi}/Thra⁺ (C57BL/6N-Thra^{tm1b(EUCOMM)Wtsi}/Ics)	increased hematocrit	J:211773
Thra^tm1Ffla/Thra⁺ Tg(Sycp1-cre)4Min/? (involves: 129/Sv * C57BL/6 * DBA/2)	decreased spleen weight	J:125353
Thra^tm1Syc/Thra⁺ (involves: 129S6/SvEvTac * C57BL/6J * NIH Black Swiss)	abnormal osteoclast physiology	J:217018
	decreased osteoclast cell number	J:217018
Thra^tm2Jas/Thra^tm2Jas (involves: 129)	abnormal osteoclast physiology	J:120899
Thra^tm2Jas/Thra^tm2Jas (involves: 129)	decreased osteoclast cell number	J:120899
Thra^tm2Ven/Thra^tm2Ven (involves: 129P2/OlaHsd * BALB/c)	abnormal osteoclast physiology	J:72959
Thrb^tm1Olc/Thrb^tm1Olc (involves: 129)	abnormal osteoclast physiology	J:120899
Thrb^tm1Olc/Thrb^tm1Olc (involves: 129)	increased osteoclast cell number	J:120899
Thrb^{tm2a(EUCOMM)Wtsi}/Thrb^{tm2a(EUCOMM)Wtsi} (C57BL/6N-Thrb^{tm2a(EUCOMM)Wtsi}/H)	decreased hemoglobin content	J:165965
Thsd1^{tm1.1(KOMP)Vlcg}/Thsd1^{tm1.1(KOMP)Vlcg} (C57BL/6N-Thsd1^{tm1.1(KOMP)Vlcg}/J)	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
Thyct1^C57BL/6J/Thyct1^C57BL/6J Thyct2^C57BL/6J/Thyct2^C57BL/6J (involves: C57BL/6J * DBA/2J)	thymus hyperplasia	J:85261
Thyct1^DBA/2J/Thyct1^DBA/2J Thyct2^DBA/2J/Thyct2^DBA/2J (involves: C57BL/6J * DBA/2J)	thymus hypoplasia	J:85261
Thypr1^DBA/2J/? (involves: C57BL/6J * DBA/2J)	increased T cell proliferation	J:76931
Thypr2^DBA/2J/? (involves: C57BL/6J * DBA/2J)	increased T cell proliferation	J:76931
Tia1^tm1Andp/Tia1^tm1Andp (C.129S2-Tia1^tm1Andp)	abnormal macrophage physiology	J:88770
Tia1^tm1Andp/Tia1^tm1Andp (C.129S2-Tia1^tm1Andp)	hematopoietic system phenotype	J:88770
Tia1^tm1Andp/Tia1^tm1Andp Zfp36^tm1Pjb/Zfp36^tm1Pjb (B6.Cg-Tia1^tm1Andp Zfp36^tm1Pjb)	abnormal macrophage physiology	J:88443
	increased neutrophil cell number	J:88443
Tial1^{tm1b(EUCOMM)Wtsi}/Tial1⁺ (C57BL/6N-Tial1^{tm1b(EUCOMM)Wtsi}/Wtsi)	thrombocytosis	J:211773
Ticam1^Lps2/Ticam1^Lps2 (involves: C57BL/6)	abnormal macrophage physiology	J:84896
	decreased macrophage apoptosis	J:84896, J:92674
	decreased macrophage cytokine production	J:84896
	decreased macrophage nitric oxide production	J:84896
Ticam1^Lps2/Ticam1^Lps2 (C57BL/6J-Ticam1^Lps2/J)	decreased CD8-positive, alpha-beta T cell number	J:288471
	decreased Ly6C low monocyte number	J:288471
	increased Ly6C high monocyte number	J:288471
	increased macrophage cell number	J:288471
	increased neutrophil cell number	J:288471
	increased plasmacytoid dendritic cell number	J:288471
Ticam1^Lps2/Ticam1^Lps2 Myd88^tm1Aki/Myd88^tm1Aki (involves: 129P2/OlaHsd * C57BL/6)	abnormal macrophage physiology	J:84896
Ticam1^M2Btlr/Ticam1⁺ (C57BL/6J-Ticam1^M2Btlr)	abnormal macrophage physiology	J:234240
Ticam1^M2Btlr/Ticam1⁺ (C57BL/6J-Ticam1^M2Btlr)	decreased macrophage cytokine production	J:234240
Ticam1^M2Btlr/Ticam1^M2Btlr (C57BL/6J-Ticam1^M2Btlr)	abnormal macrophage physiology	J:234240
Ticam1^M2Btlr/Ticam1^M2Btlr (C57BL/6J-Ticam1^M2Btlr)	decreased macrophage cytokine production	J:234240
Ticam1^tm1Aki/Ticam1^tm1Aki (involves: 129P2/OlaHsd)	abnormal B cell activation	J:174941
	abnormal B cell physiology	J:84679
	abnormal macrophage physiology	J:174941, J:84679
	abnormal microglial cell physiology	J:185198
	abnormal NK cell physiology	J:174941
	abnormal NK T cell physiology	J:174941
	decreased splenocyte proliferation	J:84679
	impaired macrophage phagocytosis	J:185198
Ticam1^tm1Aki/Ticam1^tm1Aki (involves: 129P2/OlaHsd * C57BL/6)	decreased CD8-positive, alpha-beta T cell number	J:130954
	decreased IgG2a level	J:130954
	decreased IgG level	J:130954
Ticam1^tm1Aki/Ticam1^tm1Aki (B6.129P2-Ticam1^tm1Aki)	decreased macrophage cytokine production	J:144301
Ticam1^tm1Aki/Ticam1^tm1Aki (B6.129P2-Ticam1^tm1Aki)	impaired neutrophil recruitment	J:144301
Ticam1^tm1Tsse/Ticam1^tm1Tsse (B6.129-Ticam1^tm1Tsse)	impaired natural killer cell mediated cytotoxicity	J:118750
Tifab^em1(IMPC)J/Tifab^em1(IMPC)J (C57BL/6NJ-Tifab^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Tifab^tm1.1Dsta/Tifab⁺ (involves: 129 * C57BL/6 * C57BL/6J)	abnormal hematopoietic stem cell morphology	J:229024
	decreased hematopoietic cell number	J:229024
	decreased hematopoietic stem cell proliferation	J:229024
	enlarged spleen	J:229024
Tifab^tm1.1Dsta/Tifab^tm1.1Dsta (involves: 129 * C57BL/6 * C57BL/6J)	abnormal hematopoietic stem cell morphology	J:229024
	abnormal neutrophil morphology	J:229024
	decreased hematopoietic cell number	J:229024
	decreased hematopoietic stem cell proliferation	J:229024
	decreased leukocyte cell number	J:229024
	decreased lymphocyte cell number	J:229024
	decreased monocyte cell number	J:229024
	decreased neutrophil cell number	J:229024
	enlarged spleen	J:229024
Tigit^tm1Sdl/Tigit^tm1Sdl (involves: C57BL/6)	increased T cell proliferation	J:168902
Timd2^{tm1(GAL4)Pdre}/Timd2^{tm1(GAL4)Pdre} (C.129S4-Timd2^{tm1(GAL4)Pdre})	increased eosinophil cell number	J:125054
	increased lymphocyte cell number	J:125054
Timd4^tm1Kuch/Timd4^tm1Kuch (C57BL/6-Timd4^tm1Kuch)	abnormal B cell physiology	J:160747
	abnormal macrophage physiology	J:160747
	increased IgA level	J:160747
	increased IgG2a level	J:160747
	increased IgG2b level	J:160747
	increased splenocyte proliferation	J:160747
Timd4^tm1Osa/Timd4^tm1Osa (involves: C57BL/6)	impaired macrophage phagocytosis	J:187181
Timd4^tm1Wouy/Timd4^tm1Wouy (involves: 129)	abnormal macrophage physiology	J:160304
	impaired macrophage phagocytosis	J:160304
	increased IgG2a level	J:160304
	increased leukocyte cell number	J:160304
	increased lymphocyte cell number	J:160304
Timd6^{tm1b(KOMP)Wtsi}/Timd6⁺ (C57BL/6N-Timd6^{tm1b(KOMP)Wtsi}/H)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
	increased spleen weight	J:211773
Timm8a1^em1(IMPC)Tcp/Timm8a1^em1(IMPC)Tcp (C57BL/6NCrl-Timm8a1^em1(IMPC)Tcp/Tcp)	increased red blood cell distribution width	J:211773
Timm13^em1(IMPC)Tcp/Timm13⁺ (C57BL/6NCrl-Timm13^em1(IMPC)Tcp/Tcp)	abnormal spleen morphology	J:211773
	enlarged thymus	J:211773
Timmdc1^{Gt(OST407011)Lex}/Timmdc1⁺ (B6;129S5-Timmdc1^{Gt(OST407011)Lex}/Mmucd)	increased CD4-positive, alpha-beta T cell number	J:171883
Timp1^tm1Pds/Timp1^tm1Pds (involves: 129S4/SvJae)	decreased bone marrow cell number	J:100411
Timp1^tm1Pds/Timp1^tm1Pds (involves: 129S4/SvJae)	hematopoietic system phenotype	J:100411
Timp1^tm1Pds/Timp1^tm1Pds (involves: 129S4/SvJae * C57BL/6)	increased neutrophil cell number	J:112941
Timp2^{em1(IMPC)Hmgu}/Timp2^{em1(IMPC)Hmgu} (C57BL/6N-Timp2^{em1(IMPC)Hmgu}/Ieg)	decreased mean corpuscular volume	J:211773
	increased B cell number	J:211773
	increased B-2 B cell number	J:211773
	increased follicular B cell number	J:211773
Timp2^tm1Pds/Timp2^tm1Pds (involves: 129S4/SvJae * C57BL/6)	increased neutrophil cell number	J:112941
Timp3^{tm1.1(KOMP)Vlcg}/Timp3^{tm1.1(KOMP)Vlcg} (C57BL/6N-Timp3^{tm1.1(KOMP)Vlcg}/J)	increased mean corpuscular volume	J:211773
Timp3^tm1Rkho/Timp3^tm1Rkho Tnf^tm1Gkl/Tnf^tm1Gkl (involves: 129 * 129S/SvEv * C57BL/6)	increased neutrophil cell number	J:112033
Timp4^em1(IMPC)Mbp/Timp4^em1(IMPC)Mbp (C57BL/6N-Timp4^em1(IMPC)Mbp/MbpMmucd)	small spleen	J:211773
Tincr^{em1(IMPC)Ccpcz}/Tincr^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Tincr^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Tinf2^tm2.2Tdl/Tinf2⁺ (involves: BALB/cJ * C57BL/6)	myeloid hyperplasia	J:207367
Tinf2^tm2.2Tdl/Tinf2⁺ (involves: BALB/cJ * C57BL/6)	pancytopenia	J:207367
Tiparp^{Gt(ROSA)79Sor}/Tiparp^{Gt(ROSA)79Sor} (involves: 129S4/SvJaeSor)	anemia	J:117491
	decreased erythrocyte cell number	J:117491
	decreased hematocrit	J:117491
	decreased hemoglobin content	J:117491
	polychromatophilia	J:117491
	reticulocytosis	J:117491
Tiparp^{Gt(ROSA)79Sor}/Tiparp^{Gt(ROSA)79Sor} (involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6J)	abnormal thymus involution	J:250417
Tiparp^{tm1b(EUCOMM)Wtsi}/Tiparp^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Tiparp^{tm1b(EUCOMM)Wtsi}/Tcp)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Tirap^tm1Aki/Tirap^tm1Aki (involves: 129P2/OlaHsd * C57BL/6)	decreased IgG3 level	J:137066
Tirap^tm1Medz/Tirap^tm1Medz (involves: 129S1/Sv * C57BL/6)	abnormal macrophage physiology	J:96773
Tirap^tm1Medz/Tirap^tm1Medz (involves: 129S1/Sv * C57BL/6)	decreased B cell proliferation	J:96773
Tirap^tm1Medz/Tirap^tm1Medz (involves: 129S1/Sv)	abnormal macrophage physiology	J:96018
Tk1^tm1Vnd/Tk1^tm1Vnd (involves: 129P2/OlaHsd * C57BL/6)	small spleen	J:101669
Tk1^tm1Vnd/Tk1^tm1Vnd (involves: 129P2/OlaHsd * C57BL/6)	spleen hypoplasia	J:101669
Tkfc^{em1(IMPC)Ccpcz}/Tkfc^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Tkfc^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Tlcd5^{tm1.1(KOMP)Vlcg}/Tlcd5^{tm1.1(KOMP)Vlcg} (C57BL/6N-Tlcd5^{tm1.1(KOMP)Vlcg}/J)	increased mean corpuscular hemoglobin concentration	J:211773
Tle3^em1(IMPC)Mbp/Tle3^em1(IMPC)Mbp (C57BL/6N-Tle3^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	small spleen	J:211773
Tle4^em1(IMPC)Mbp/Tle4^em1(IMPC)Mbp (C57BL/6NCrl-Tle4^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Tle4^tm1.2Dasw/Tle4^tm1.2Dasw (B6.129S6(Cg)-Tle4^tm1.2Dasw)	abnormal hematopoietic stem cell physiology	J:219243
	abnormal lymphopoiesis	J:219243
	abnormal thymus morphology	J:219243
	decreased B cell number	J:219243
	decreased bone marrow cell number	J:219243
	decreased common myeloid progenitor cell number	J:219243
	decreased DN2 thymocyte number	J:219243
	decreased double-positive T cell number	J:219243
	decreased follicular B cell number	J:219243
	decreased hematopoietic stem cell number	J:219243
	decreased leukocyte cell number	J:219243
	decreased lymphocyte cell number	J:219243
	decreased pre-pro B cell number	J:219243
	decreased spleen B cell follicle number	J:219243
	increased NK T cell number	J:219243
	increased thymocyte apoptosis	J:219243
	spleen hypoplasia	J:219243
	thymus atrophy	J:219243
	thymus hypoplasia	J:219243
Tlf2^NOD/Smrf/? (involves: NOD/Smrf * NON/Lt)	increased CD8-positive, alpha-beta T cell number	J:49676
Tlf^NOD/Smrf/? (involves: NOD/Smrf * NON/Lt)	increased CD4-positive, alpha-beta T cell number	J:49676
Tlk1^{tm1b(EUCOMM)Hmgu}/Tlk1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Tlk1^{tm1b(EUCOMM)Hmgu}/J)	decreased mean corpuscular hemoglobin	J:211773
	thrombocytopenia	J:211773
Tlk2^tm1Strc/Tlk2^tm1Strc (Not Specified)	anemia	J:268910
Tll1^b2b2476Clo/Tll1^b2b2476Clo (C57BL/6J-Tll1^b2b2476Clo)	thymus hypoplasia	J:175213
Tln1^tm1.1Bpet/Tln1^tm4.1Crit Tg(Pf4-icre)Q3Rsko/0 (involves: 129P2/OlaHsd * C57BL/6)	abnormal platelet physiology	J:177971
Tln1^tm4.1Crit/Tln1^tm4.1Crit Tg(Mx1-cre)1Cgn/? (involves: 129P2/OlaHsd * C57BL/6 * CBA)	abnormal platelet activation	J:129708
	abnormal platelet morphology	J:129708
	abnormal platelet shape	J:129708
Tln1^tm4.1Crit/Tln1^tm4.1Crit Tg(Pf4-icre)Q3Rsko/? (involves: 129P2/OlaHsd)	abnormal megakaryocyte morphology	J:131289
	abnormal platelet activation	J:129707
	decreased hematocrit	J:129707
	decreased hemoglobin content	J:129707
	low mean erythrocyte cell number	J:129707
	thrombocytopenia	J:129707
Tlr1^tm1Flv/Tlr1^tm1Flv (involves: 129S1/Sv)	abnormal macrophage physiology	J:95726
Tlr1^tm1Flv/Tlr1^tm1Flv (involves: 129S1/Sv)	decreased immunoglobulin level	J:95726
Tlr2^lngd/Tlr2^lngd (C57BL/6J-Tlr2^lngd)	abnormal macrophage physiology	J:94077
Tlr2^tm1Aki/Tlr2^tm1Aki (involves: 129P2/OlaHsd * C57BL/6)	abnormal macrophage physiology	J:76115, J:95726
	decreased immunoglobulin level	J:95726
	decreased microglial cell activation	J:122551
Tlr2^tm1Aki/Tlr2^tm1Aki (B6.129P2-Tlr2^tm1Aki)	increased T cell number	J:118954
Tlr2^tm1Aki/Tlr2^tm1Aki (involves: 129P2/OlaHsd)	abnormal leukocyte migration	J:171379
	abnormal macrophage physiology	J:103464, J:130138, J:70578
	abnormal osteoclast physiology	J:130138
	increased B cell apoptosis	J:135830
Tlr2^tm1Aki/Tlr2^tm1Aki Tlr4^tm1Aki/Tlr4^tm1Aki (involves: 129P2/OlaHsd * C57BL/6)	abnormal macrophage physiology	J:117688
	decreased IgG3 level	J:117688
Tlr2^tm1Kir/Tlr2^tm1Kir (either: (involves: 129/Sv * C57BL/6) or (involves: 129/Sv * C57BL/6 * C57BL/6J))	abnormal macrophage physiology	J:85323
	decreased macrophage cytokine production	J:85323
	decreased macrophage nitric oxide production	J:85323
Tlr2^tm1Kir/Tlr2^tm1Kir (Not Specified)	abnormal macrophage physiology	J:96018
Tlr2^tm1Kir/Tlr2^tm1Kir (B6.129-Tlr2^tm1Kir)	abnormal cellular extravasation	J:171028
Tlr2^tm1Kir/Tlr2^tm1Kir (B6.129-Tlr2^tm1Kir)	decreased splenocyte proliferation	J:121930
Tlr2^tm1Kir/Tlr2^tm1Kir Tlr4^Lps-d/Tlr4^Lps-d (C3.Cg-Tlr2^tm1Kir Tlr4^Lps-d)	abnormal macrophage physiology	J:121930
Tlr3^M1Btlr/Tlr3⁺ (C57BL/6J-Tlr3^M1Btlr)	decreased macrophage cytokine production	J:224670
Tlr3^M1Btlr/Tlr3^M1Btlr (C57BL/6J-Tlr3^M1Btlr)	decreased macrophage cytokine production	J:224670
Tlr3^tm1Flv/Tlr3^tm1Flv (involves: 129S1/Sv * C57BL/6)	abnormal B cell physiology	J:72167
Tlr3^tm1Flv/Tlr3^tm1Flv (involves: 129S1/Sv * C57BL/6)	abnormal macrophage physiology	J:72167
Tlr3^tm1Flv/Tlr3^tm1Flv (involves: C57BL/6)	abnormal macrophage physiology	J:86617
Tlr3^tm1Flv/Tlr3^tm1Flv (Not Specified)	abnormal NK cell physiology	J:88906
Tlr3^tm1Flv/Tlr3^tm1Flv (Not Specified)	abnormal NK T cell physiology	J:88906
Tlr4^lps-4Btlr/Tlr4⁺ (C57BL/6J-Tlr4^lps-4Btlr)	decreased macrophage cytokine production	J:224664
Tlr4^lps-4Btlr/Tlr4^lps-4Btlr (C57BL/6J-Tlr4^lps-4Btlr)	decreased macrophage apoptosis	J:224664
Tlr4^lps-4Btlr/Tlr4^lps-4Btlr (C57BL/6J-Tlr4^lps-4Btlr)	decreased macrophage cytokine production	J:224664
Tlr4^lps-5Btlr/Tlr4^lps-5Btlr (C57BL/6J-Tlr4^lps-5Btlr)	decreased B cell number	J:224666
	decreased macrophage cytokine production	J:224666
	decreased memory B cell number	J:224666
Tlr4^Lps-6Btlr/Tlr4⁺ (C57BL/6J-Tlr4^Lps-6Btlr)	decreased macrophage cytokine production	J:224667
Tlr4^Lps-6Btlr/Tlr4^Lps-6Btlr (C57BL/6J-Tlr4^Lps-6Btlr)	decreased macrophage cytokine production	J:224667
Tlr4^lps-7Btlr/Tlr4⁺ (C57BL/6J-Tlr4^Lps-7Btlr)	decreased macrophage cytokine production	J:234239
Tlr4^lps-7Btlr/Tlr4^lps-7Btlr (C57BL/6J-Tlr4^Lps-7Btlr)	decreased macrophage cytokine production	J:234239
Tlr4^Lps-8Btlr/Tlr4⁺ (C57BL/6J-Tlr4^Lps-8Btlr)	decreased macrophage cytokine production	J:234241
Tlr4^Lps-8Btlr/Tlr4^Lps-8Btlr (C57BL/6J-Tlr4^Lps-8Btlr)	decreased macrophage cytokine production	J:234241
Tlr4^lps-Btlr/Tlr4^lps-Btlr (C57BL/6J-Tlr4^lps-Btlr)	abnormal macrophage physiology	J:128416
Tlr4^Lps-d/Tlr4^Lps-d (involves: C3H/HeJ)	abnormal osteoclast differentiation	J:131353
Tlr4^Lps-d/Tlr4^Lps-d (involves: C3H/HeJ)	abnormal T-helper 2 physiology	J:96356
Tlr4^Lps-d/Tlr4^Lps-d (C3H/HeJ-Tlr4^Lps-d)	abnormal macrophage chemotaxis	J:122597
	abnormal microglial cell physiology	J:99051
	abnormal phagocyte morphology	J:125179
	abnormal spleen weight	J:37271
	hematopoietic system phenotype	J:135830
Tlr4^Lps-d/Tlr4^Lps-d Tg(IghelMD4)4Ccg/0 Tg(KLK4mHEL)6Ccg/0 (involves: 129P2/OlaHsd * C3H/HeJ * C57BL/6)	decreased B cell number	J:115059
	increased B-1 B cell number	J:115059
Tlr4^lps-del/Tlr4^lps-del (C57BL/10ScCr)	abnormal macrophage physiology	J:88996
Tlr4^lps-del/Tlr4^lps-del (C57BL/10ScN)	increased spleen weight	J:37271
Tlr4^lps-n/Tlr4^lps-n (C3H/HeN)	increased spleen weight	J:37271
Tlr4^tm1Aki/Tlr4^tm1Aki (involves: 129P2/OlaHsd * C57BL/6J)	decreased hemoglobin content	J:98224
Tlr4^tm1Aki/Tlr4^tm1Aki (involves: 129P2/OlaHsd * C57BL/6J)	impaired neutrophil chemotaxis	J:98224
Tlr4^tm1Aki/Tlr4^tm1Aki (involves: 129P2/OlaHsd * C57BL/6)	abnormal macrophage physiology	J:76115
Tlr4^tm1Aki/Tlr4^tm1Aki (involves: 129P2/OlaHsd * C57BL/6)	decreased B cell proliferation	J:76115
Tlr5^tm1Aki/Tlr5^tm1Aki (involves: 129P2/OlaHsd * C57BL/6)	abnormal macrophage physiology	J:112671
Tlr5^tm1Aki/Tlr5^tm1Aki (involves: 129P2/OlaHsd)	enlarged spleen	J:229155
Tlr5^tm1Flv/Tlr5^tm1Flv (involves: 129S1/Sv * C57BL/6)	decreased neutrophil cell number	J:111778
Tlr5^tm1Flv/Tlr5^tm1Flv (involves: 129S1/Sv)	abnormal leukocyte migration	J:171379
Tlr6^int/Tlr6^int (C57BL/6-Tlr6^int)	abnormal macrophage physiology	J:110094
Tlr6^m2Btlr/Tlr6^m2Btlr (C57BL/6J-Tlr6^m2Btlr)	abnormal macrophage physiology	J:144166
Tlr6^m3Btlr/Tlr6^m3Btlr (C57BL/6J-Tlr6^m3Btlr)	abnormal macrophage physiology	J:144167
Tlr6^m4Btlr/Tlr6^m4Btlr (C57BL/6J-Tlr6^m4Btlr)	abnormal macrophage physiology	J:144168
Tlr6^tm1Aki/Tlr6^tm1Aki (involves: 129P2/OlaHsd * C57BL/6)	abnormal macrophage physiology	J:70578
Tlr7^em2Anu/Y (C57BL/6NCrl-Tlr7^em2Anu)	abnormal B cell physiology	J:324448
	abnormal macrophage physiology	J:324448
	decreased B cell apoptosis	J:324448
	decreased B cell proliferation	J:324448
	enlarged spleen	J:324448
	increased CD4-positive, alpha-beta T cell number	J:324448
	increased effector memory CD4-positive, alpha-beta T cell number	J:324448
	increased T follicular helper cell number	J:324448
Tlr7^em2Anu/Tlr7⁺ (C57BL/6NCrl-Tlr7^em2Anu)	abnormal mature B cell morphology	J:324448
	decreased marginal zone B cell number	J:324448
	enlarged spleen	J:324448
	increased B cell number	J:324448
	increased CD4-positive, alpha-beta T cell number	J:324448
	increased germinal center B cell number	J:324448
	increased plasma cell number	J:324448
	increased spleen germinal center number	J:324448
	increased T follicular helper cell number	J:324448
	spleen hyperplasia	J:324448
	thrombocytopenia	J:324448
Tlr7^em2Anu/Tlr7^em2Anu (C57BL/6NCrl-Tlr7^em2Anu)	abnormal mature B cell morphology	J:324448
	decreased leukocyte cell number	J:324448
	decreased marginal zone B cell number	J:324448
	enlarged spleen	J:324448
	increased B cell number	J:324448
	increased CD4-positive, alpha-beta T cell number	J:324448
	increased effector memory CD4-positive, alpha-beta T cell number	J:324448
	increased germinal center B cell number	J:324448
	increased plasma cell number	J:324448
	increased spleen germinal center number	J:324448
	increased T follicular helper cell number	J:324448
	spleen hyperplasia	J:324448
Tlr7^rsq1/Y (C57BL/6J-Tlr7^rsq1)	abnormal macrophage physiology	J:128404
Tlr7^rsq1/Tlr7^rsq1 (C57BL/6J-Tlr7^rsq1)	abnormal macrophage physiology	J:128404
Tlr7^rsq2/Y (C57BL/6J-Tlr7^rsq2)	abnormal macrophage physiology	J:140020
Tlr7^tm1Aki/Tlr7^tm1Aki (involves: 129P2/OlaHsd * C57BL/6)	hematopoietic system phenotype	J:137066
Tlr7^tm1Aki/Tlr7^tm1Aki Unc93b1^tm1.1Kmiy/Unc93b1^tm1.1Kmiy (involves: 129P2/OlaHsd * C57BL/6)	hematopoietic system phenotype	J:174308
Tlr7^tm1Flv/Y (B6.129S1-Tlr7^tm1Flv)	decreased splenocyte proliferation	J:127600
Tlr7^tm1Flv/Y (B6.129S1-Tlr7^tm1Flv)	increased marginal zone B cell number	J:127600
Tlr7^tm1Flv/Y X/Yaa (B6.Cg-Tlr7^tm1Flv Yaa)	hematopoietic system phenotype	J:127600
Tlr7^tm1Flv/Tlr7^tm1Flv (B6.129S1-Tlr7^tm1Flv)	decreased IgG1 level	J:165267
	decreased IgG2a level	J:165267
	decreased IgG level	J:165267
	decreased IgM level	J:165267
Tlr8/Tlr7^tm1Vlcg/Tlr8/Tlr7^tm1Vlcg (B6.Cg-Tlr8/Tlr7^tm1Vlcg)	decreased follicular B cell number	J:165267
	increased marginal zone B cell number	J:165267
Tlr8/Tlr7^tm1Vlcg/Tlr7⁺ Tlr8/Tlr7^tm1Vlcg/Tlr8^tm1Vlcg (B6.Cg-Tlr8/Tlr7^tm1Vlcg Tlr8^tm1Vlcg)	abnormal spleen marginal zone morphology	J:165267
	decreased IgG level	J:165267
	decreased IgM level	J:165267
	decreased marginal zone B cell number	J:165267
	increased IgG level	J:165267
	increased IgM level	J:165267
	increased marginal zone B cell number	J:165267
Tlr8/Tlr7^tm1Vlcg/Tlr8/Tlr7^tm1Vlcg (B6.Cg-Tlr8/Tlr7^tm1Vlcg Tlr8^tm1Vlcg)	decreased follicular B cell number	J:165267
	increased marginal zone B cell number	J:165267
Tlr8^tm1Vlcg/Tlr8^tm1Vlcg (B6.129S1-Tlr8^tm1Vlcg)	abnormal spleen marginal zone morphology	J:165267
	decreased B-1a cell number	J:165267
	decreased B-1b cell number	J:165267
	decreased dendritic cell number	J:165267
	decreased IgG1 level	J:165267
	decreased marginal zone B cell number	J:165267
	enlarged spleen	J:165267
	increased B-2 B cell number	J:165267
	increased IgG2a level	J:165267
	increased IgG level	J:165267
	increased IgM level	J:165267
	increased spleen weight	J:165267
Tlr9^M1Btlr/Tlr9^M1Btlr (involves: C57BL/6)	abnormal macrophage physiology	J:88906
	abnormal NK cell physiology	J:88906
	abnormal NK T cell physiology	J:88906
Tlr9^M2Btlr/Tlr9⁺ (C57BL/6J-Tlr9^M2Btlr)	abnormal macrophage physiology	J:128405
Tlr9^M2Btlr/Tlr9^M2Btlr (C57BL/6J-Tlr9^M2Btlr)	abnormal macrophage physiology	J:128405
Tlr9^m3Btlr/Tlr9^m3Btlr (C57BL/6J-Tlr9^m3Btlr)	abnormal macrophage physiology	J:128406
Tlr9^m3Btlr/Tlr9^m3Btlr (C57BL/6J-Tlr9^m3Btlr)	decreased B cell proliferation	J:128406
Tlr9^m4Btlr/Tlr9⁺ (C57BL/6J-Tlr9^m4Btlr)	abnormal macrophage physiology	J:132489
Tlr9^m4Btlr/Tlr9⁺ (C57BL/6J-Tlr9^m4Btlr)	decreased B cell proliferation	J:132489
Tlr9^M5Btlr/? (C57BL/6J-Tlr9^M5Btlr)	abnormal macrophage physiology	J:147856
Tlr9^tm1Aki/Tlr9^tm1Aki (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:66049
	abnormal macrophage physiology	J:117688, J:66049
	abnormal T-helper 1 physiology	J:66049
Tlr9^tm1Aki/Tlr9^tm1Aki (B6.129P2-Tlr9^tm1Aki)	impaired natural killer cell mediated cytotoxicity	J:125611
Tlr9^tm1Aki/Tlr9^tm1Aki (involves: 129P2/OlaHsd)	abnormal leukocyte migration	J:171379
Tlr9^tm1Aki/Tlr9^tm1Aki Tg(IghelMD4)4Ccg/0 Tg(KLK4mHEL)6Ccg/0 (involves: 129P2/OlaHsd * C57BL/6)	decreased mature B cell number	J:115059
	increased B-1 B cell number	J:115059
Tlr9^tm1Aki/Tlr9^tm1Aki Unc93b1^tm1.1Kmiy/Unc93b1^tm1.1Kmiy (involves: 129P2/OlaHsd * C57BL/6)	thrombocytopenia	J:174308
Tlr12^tm1Gho/Tlr12^tm1Gho (Not Specified)	abnormal macrophage physiology	J:89754
tlss/tlss (Not Specified)	enlarged spleen	J:169366
tlss/tlss (Not Specified)	enlarged thymus	J:169366
Tlx1^{tm1.1(cre/ERT2)Rygo}/Tlx1^{tm1.1(cre/ERT2)Rygo} (involves: C57BL/6 * C57BL/6JJcl * C57BL/6NSlc)	absent spleen	J:217489
Tlx1^tm1Sjk/Tlx1^tm1Sjk (involves: 129S2/SvPas)	abnormal spleen development	J:17695
	abnormal spleen mesenchyme morphology	J:17695
	absent spleen	J:17695
	increased leukocyte cell number	J:17695
	increased lymphocyte cell number	J:17695
	increased neutrophil cell number	J:17695
	increased number of Howell-Jolly bodies	J:17695
Tlx1^tm1Thr/Tlx1^tm1Thr (involves: 129P2/OlaHsd * MF1)	abnormal spleen development	J:28700
	absent spleen	J:28700
	increased splenocyte apoptosis	J:28700
Tm2d1^em1(IMPC)Bay/Tm2d1⁺ (C57BL/6N-Tm2d1^em1(IMPC)Bay/Bay)	decreased mean corpuscular hemoglobin concentration	J:211773
Tm2d1^em1(IMPC)Bay/Tm2d1⁺ (C57BL/6N-Tm2d1^em1(IMPC)Bay/Bay)	increased hematocrit	J:211773
Tm4sf20^em1(IMPC)Bay/Tm4sf20^em1(IMPC)Bay (C57BL/6N-Tm4sf20^em1(IMPC)Bay/BayMmucd)	decreased spleen weight	J:211773
Tm7sf2^{tm1b(KOMP)Wtsi}/Tm7sf2^{tm1b(KOMP)Wtsi} (C57BL/6N-Tm7sf2^{tm1b(KOMP)Wtsi}/Orl)	decreased lymphocyte cell number	J:211773
	increased eosinophil cell number	J:211773
Tm9sf2^em1(IMPC)Tcp/Tm9sf2⁺ (C57BL/6N-Tm9sf2^em1(IMPC)Tcp/Tcp)	decreased mean corpuscular hemoglobin concentration	J:211773
Tmc6^tm1.1Les/Tmc6^tm1.1Les (B6.129S6(Cg)-Tmc6^tm1.1Les)	decreased CD4-positive, alpha-beta T cell number	J:300461
Tmc6^tm1.1Les/Tmc6^tm1.1Les (B6.129S6(Cg)-Tmc6^tm1.1Les)	decreased CD8-positive, alpha-beta T cell number	J:300461
Tmc7^em1(IMPC)Mbp/Tmc7^em1(IMPC)Mbp (C57BL/6NCrl-Tmc7^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Tmc8^tm1.1Les/Tmc8^tm1.1Les (B6.129S6(Cg)-Tmc8^tm1.1Les)	decreased CD4-positive, alpha-beta T cell number	J:300461
Tmc8^tm1.1Les/Tmc8^tm1.1Les (B6.129S6(Cg)-Tmc8^tm1.1Les)	decreased CD8-positive, alpha-beta T cell number	J:300461
Tmcc2^em1(IMPC)Mbp/Tmcc2⁺ (C57BL/6N-Tmcc2^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Tmcc2^em1Tar/Tmcc2^em1Tar (involves: C57BL/6JTar * CBA/WTar)	abnormal erythrocyte morphology	J:325992
	abnormal erythroid progenitor cell morphology	J:325992
	abnormal erythropoiesis	J:325992
	anemia	J:325992
	decreased erythrocyte cell number	J:325992
	decreased hematocrit	J:325992
	decreased hemoglobin content	J:325992
	decreased mean corpuscular hemoglobin concentration	J:325992
	extramedullary hematopoiesis	J:325992
	increased erythrocyte cell number	J:325992
	increased erythroid progenitor cell number	J:325992
	increased hematocrit	J:325992
	increased hemoglobin content	J:325992
	increased mean corpuscular volume	J:325992
	increased nucleated erythrocyte cell number	J:325992
	macrocytic anemia	J:325992
Tmco1^em1(IMPC)J/Tmco1⁺ (C57BL/6NJ-Tmco1^em1(IMPC)J/J)	increased leukocyte cell number	J:211773
Tmem8b^em1(IMPC)Tcp/Tmem8b⁺ (C57BL/6N-Tmem8b^em1(IMPC)Tcp/Tcp)	increased basophil cell number	J:211773
Tmem9b^em1(IMPC)J/Tmem9b^em1(IMPC)J (C57BL/6NJ-Tmem9b^em1(IMPC)J/J)	decreased mean corpuscular volume	J:211773
Tmem11^em1(IMPC)Tcp/Tmem11^em1(IMPC)Tcp (C57BL/6N-Tmem11^em1(IMPC)Tcp/Tcp)	increased red blood cell distribution width	J:211773
Tmem14c^{Gt(E295C12)Wrst}/Tmem14c^{Gt(E295C12)Wrst} (B6;129P2-Tmem14c^{Gt(E295C12)Wrst}/Llp)	abnormal erythropoiesis	J:212530
	abnormal hemoglobin	J:212530
	anemia	J:212530
	decreased cellular hemoglobin content	J:212530
Tmem35a^{tm1.1(KOMP)Vlcg}/Y (B6(FVB)-Tmem35a^{tm1.1(KOMP)Vlcg})	spleen hyperplasia	J:244268
Tmem45a^em1(IMPC)Mbp/Tmem45a^em1(IMPC)Mbp (C57BL/6N-Tmem45a^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	small spleen	J:211773
Tmem60^{em1(IMPC)Ccpcz}/Tmem60^{em1(IMPC)Ccpcz} (C57BL/6N-Tmem60^{em1(IMPC)Ccpcz}/Ccpcz)	decreased effector memory T-helper cell number	J:211773
Tmem64^{Gt(SYA242)Byg}/Tmem64^{Gt(SYA242)Byg} (involves: 129P2/OlaHsd * C57BL/6)	abnormal osteoclast differentiation	J:198051
	decreased osteoclast cell number	J:198051
Tmem72^{tm1b(KOMP)Wtsi}/Tmem72^{tm1b(KOMP)Wtsi} (C57BL/6N-Tmem72^{tm1b(KOMP)Wtsi}/Kmpc)	increased erythrocyte cell number	J:211773
	increased hematocrit	J:211773
	increased hemoglobin content	J:211773
Tmem74^em1(IMPC)Tcp/Tmem74^em1(IMPC)Tcp (C57BL/6NCrl-Tmem74^em1(IMPC)Tcp/Tcp)	enlarged spleen	J:211773
	small thymus	J:211773
Tmem79^ma/Tmem79^ma (B6.CBACaGr-Tmem79^ma/J)	increased IgE level	J:202453
Tmem79^{tm1.1(KOMP)Wtsi}/Tmem79^{tm1.1(KOMP)Wtsi} (C57BL/6N-Tmem79^{tm1.1(KOMP)Wtsi}/J)	increased mean corpuscular hemoglobin	J:211773
Tmem88b^em1(IMPC)Mbp/Tmem88b^em1(IMPC)Mbp (C57BL/6N-Tmem88b^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
Tmem94^{tm1a(EUCOMM)Wtsi}/Tmem94⁺ (C57BL/6N-Tmem94^{tm1a(EUCOMM)Wtsi}/Ics)	increased mean corpuscular hemoglobin concentration	J:165965
Tmem97^{tm1.1(KOMP)Vlcg}/Tmem97^{tm1.1(KOMP)Vlcg} (C57BL/6N-Tmem97^{tm1.1(KOMP)Vlcg}/Ucd)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	increased red blood cell distribution width	J:211773
Tmem100^{tm1e.1(KOMP)Wtsi}/Tmem100⁺ (C57BL/6N-Tmem100^{tm1e.1(KOMP)Wtsi}/Tcp)	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
Tmem102^tm1.1Jyen/Tmem102^tm1.1Jyen (B6.Cg-Tmem102^tm1.1Jyen)	abnormal leukocyte adhesion	J:200103
	impaired leukocyte migration	J:200103
Tmem109^tm1Yamt/Tmem109^tm1Yamt (B6.Cg-Tmem109^tm1Yamt)	decreased thymocyte apoptosis	J:157864
Tmem116^{tm1b(EUCOMM)Hmgu}/Tmem116^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Tmem116^{tm1b(EUCOMM)Hmgu}/Ieg)	enlarged spleen	J:211773
Tmem121b^em1(IMPC)Tcp/Tmem121b^em1(IMPC)Tcp (C57BL/6NCrl-Tmem121b^em1(IMPC)Tcp/Tcp)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Tmem126a^{tm1a(EUCOMM)Wtsi}/Tmem126a^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Tmem126a^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased alpha-beta T cell number	J:211773
	decreased CD4-positive, alpha-beta T cell number	J:211773
	decreased T-helper cell number	J:211773
Tmem127^{tm1(KOMP)Wtsi}/Tmem127^{tm1(KOMP)Wtsi} (C57BL/6N-Tmem127^{tm1(KOMP)Wtsi}/Wtsi)	decreased B cell number	J:211773
	decreased B-2 B cell number	J:211773
	decreased CD4-positive, alpha-beta T cell number	J:211773
	decreased effector memory CD8-positive, alpha-beta T cell number	J:211773
	decreased KLRG1-positive NK cell number	J:211773
	decreased KLRG1-positive T-helper cell number	J:211773
	decreased Ly6C high monocyte number	J:211773
	decreased memory-marker NK cell number	J:211773
	decreased monocyte cell number	J:211773
	decreased neutrophil cell number	J:211773
	decreased NK cell number	J:211773
	decreased plasmacytoid dendritic cell number	J:211773
	increased alpha-beta T cell number	J:211773
	increased CD4-positive, alpha-beta T cell number	J:211773
	increased CD8-positive, alpha-beta T cell number	J:211773
	increased CD8-positive, naive alpha-beta T cell number	J:211773
	increased KLRG1-positive NK cell number	J:211773
	increased Ly6C low monocyte number	J:211773
	increased memory-marker NK cell number	J:211773
	increased T cell number	J:211773
	thrombocytopenia	J:211773
Tmem129^{tm1.1(KOMP)Vlcg}/Tmem129^{tm1.1(KOMP)Vlcg} (C57BL/6N-Tmem129^{tm1.1(KOMP)Vlcg}/J)	decreased mean corpuscular hemoglobin concentration	J:211773
Tmem138^{tm1b(EUCOMM)Wtsi}/Tmem138^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Tmem138^{tm1b(EUCOMM)Wtsi}/BayMmucd)	increased spleen weight	J:211773
Tmem150b^{em1(IMPC)Ccpcz}/Tmem150b^{em1(IMPC)Ccpcz} (C57BL/6N-Tmem150b^{em1(IMPC)Ccpcz}/Ccpcz)	decreased eosinophil cell number	J:211773
	decreased memory-marker CD4-positive NK T cell number	J:211773
Tmem163^em1Lwbch/Tmem163^em1Lwbch (C57BL/6J-Tmem163^em1Lwbch)	abnormal platelet physiology	J:323340
	decreased platelet aggregation	J:323340
	decreased platelet dense granule number	J:323340
	hematopoietic system phenotype	J:323340
Tmem165^{tm1e(EUCOMM)Wtsi}/Tmem165^{tm1e(EUCOMM)Wtsi} (B6JTyr;B6N-Tmem165^{tm1e(EUCOMM)Wtsi}/Wtsi)	increased mean corpuscular volume	J:175295
Tmem178^tm1Lex/Tmem178^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	abnormal osteoclast differentiation	J:228311
	abnormal osteoclast physiology	J:228311
	increased osteoclast cell number	J:228311
Tmem203^em1(IMPC)H/Tmem203^em1(IMPC)H (C57BL/6N-Tmem203^em1(IMPC)H/H)	increased mean corpuscular volume	J:211773
Tmem209^em1(IMPC)Tcp/Tmem209⁺ (C57BL/6NCrl-Tmem209^em1(IMPC)Tcp/Tcp)	enlarged spleen	J:211773
Tmem212^em1(IMPC)J/Tmem212^em1(IMPC)J (C57BL/6NJ-Tmem212^em1(IMPC)J/Mmjax)	increased erythrocyte cell number	J:211773
	thrombocytosis	J:211773
Tmem219^{tm1(KOMP)Vlcg}/Tmem219^{tm1(KOMP)Vlcg} (B6J.B6N-Tmem219^{tm1(KOMP)Vlcg})	increased eosinophil cell number	J:236976
	increased IgE level	J:236976
Tmem225^em1(IMPC)Mbp/Tmem225^em1(IMPC)Mbp (C57BL/6N-Tmem225^em1(IMPC)Mbp/MbpMmucd)	small spleen	J:211773
Tmem234^tm1Lex/Tmem234^tm1Lex (B6;129S5-Tmem234^tm1Lex/Mmucd)	increased IgG2a level	J:171883
Tmem248^{tm1.1(KOMP)Vlcg}/Tmem248^{tm1.1(KOMP)Vlcg} (C57BL/6N-Tmem248^{tm1.1(KOMP)Vlcg}/Ucd)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased thymus weight	J:211773
	increased monocyte cell number	J:211773
	small spleen	J:211773
	small thymus	J:211773
Tmem256^{tm1.1(KOMP)Vlcg}/Tmem256^{tm1.1(KOMP)Vlcg} (C57BL/6N-Tmem256^{tm1.1(KOMP)Vlcg}/Ucd)	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	decreased mean corpuscular hemoglobin	J:211773
	increased monocyte cell number	J:211773
Tmem263^em1Gww/Tmem263^em1Gww (C57BL/6J-Tmem263^em1Gww)	decreased spleen weight	J:345905
Tmigd3^{Tg(H2-K-CALR)del52Shmd}/0 (involves: C57BL/6 DBA/2)	abnormal megakaryocyte differentiation	J:241724
	abnormal megakaryocyte morphology	J:241724
	increased common myeloid progenitor cell number	J:241724
	increased megakaryocyte cell number	J:241724
	increased megakaryocyte-erythroid progenitor cell number	J:241724
	thrombocytosis	J:241724
Tmod1^tm1Sung/Tmod1^tm1Sung (involves: 129S1/Sv * 129X1/SvJ)	abnormal embryonic erythrocyte morphology	J:89956
	abnormal erythrocyte morphology	J:89956
	anemia	J:89956
Tmod2^{tm1b(KOMP)Wtsi}/Tmod2^{tm1b(KOMP)Wtsi} (C57BL/6N-Tmod2^{tm1b(KOMP)Wtsi}/J)	decreased erythrocyte cell number	J:211773
	decreased hemoglobin content	J:211773
Tmod3^{Gt(RRF004)Byg}/Tmod3^{Gt(RRF004)Byg} (involves: 129P2/OlaHsd * C57BL/6J)	abnormal erythroblast morphology	J:208725
	abnormal erythropoiesis	J:208725
	anemia	J:208725
	decreased erythrocyte cell number	J:208725
	decreased erythroid progenitor cell number	J:208725
	increased nucleated erythrocyte cell number	J:208725
Tmpo^tm1.1Foi/Tmpo^tm1.1Foi (involves: 129S1/Sv * C57BL/6)	increased erythroid progenitor cell number	J:145628
Tmpo^tm1.1Foi/Tmpo^tm1.1Foi (involves: 129S1/Sv * C57BL/6)	increased hematocrit	J:145628
Tmprss6^hem8/Tmprss6^hem8 (C57BL/6J-Tmprss6^hem8)	decreased mean corpuscular hemoglobin	J:237155
	decreased mean corpuscular volume	J:237155
	hematopoietic system phenotype	J:237155
Tmprss6^hem8/Tmprss6^tm1Dgen (involves: C57BL/6 * C57BL/6J)	decreased mean corpuscular hemoglobin	J:237155
	decreased mean corpuscular volume	J:237155
	reticulocytosis	J:237155
Tmprss6^msk/Tmprss6^msk (C57BL/6J-Tmprss6^msk)	decreased hemoglobin content	J:134446
	decreased mean corpuscular volume	J:134446
	decreased spleen iron level	J:134446
	microcytic anemia	J:134446
Tmprss6^{tm1b(EUCOMM)Wtsi}/Tmprss6^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Tmprss6^{tm1b(EUCOMM)Wtsi}/Ics)	decreased CD8-positive, alpha-beta T cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular hemoglobin concentration	J:211773
	decreased mean corpuscular volume	J:211773
	decreased NK cell number	J:211773
	increased CD11b-high dendritic cell number	J:211773
	increased effector memory CD8-positive, alpha-beta T cell number	J:211773
	increased Ly6C-positive mature NK cell number	J:211773
Tmprss6^tm1Dgen/Tmprss6⁺ (B6.129P2-Tmprss6^tm1Dgen/Crl)	decreased mean corpuscular hemoglobin concentration	J:160248
	decreased mean corpuscular volume	J:160248
	decreased spleen iron level	J:160248
Tmprss6^tm1Dgen/Tmprss6⁺ (involves: 129P2/OlaHsd * 129S4/SvJae * 129S6/SvEvTac * C57BL/6)	decreased mean corpuscular hemoglobin concentration	J:160248
	decreased mean corpuscular volume	J:160248
Tmprss6^tm1Dgen/Tmprss6^tm1Dgen (B6.129P2-Tmprss6^tm1Dgen/Crl)	abnormal erythrocyte morphology	J:160248
	decreased erythrocyte cell number	J:160248
	decreased hematocrit	J:160248
	decreased hemoglobin content	J:160248
	decreased mean corpuscular hemoglobin	J:237155
	decreased mean corpuscular hemoglobin concentration	J:160248
	decreased mean corpuscular volume	J:237155, J:160248
	decreased spleen iron level	J:160248
	extramedullary hematopoiesis	J:160248
	increased red blood cell distribution width	J:160248
	increased spleen weight	J:160248
	microcytic anemia	J:160248
	reticulocytosis	J:237155
Tmprss6^tm1Dgen/Tmprss6^tm1Dgen (involves: 129P2/OlaHsd * 129S4/SvJae * 129S6/SvEvTac * C57BL/6)	decreased erythrocyte cell number	J:160248
	decreased hematocrit	J:160248
	decreased hemoglobin content	J:160248
	decreased mean corpuscular hemoglobin concentration	J:160248
	decreased mean corpuscular volume	J:160248
	increased red blood cell distribution width	J:160248
	microcytic anemia	J:160248
Tmprss6^tm1Otin/Tmprss6^tm1Otin (involves: 129P2/OlaHsd * C57BL/6J)	abnormal erythrocyte morphology	J:138734
	anemia	J:138734
	anisopoikilocytosis	J:138734
Tmprss6^tm1Otin/Tmprss6^tm1Otin (involves: 129P2/OlaHsd * C57BL/6)	decreased hemoglobin content	J:185154
	microcytosis	J:185154
Tmprss15^{tm1a(KOMP)Wtsi}/Tmprss15^{tm1a(KOMP)Wtsi} (C57BL/6N-Tmprss15^{tm1a(KOMP)Wtsi}/Wtsi)	increased leukocyte cell number	J:175295
	increased mean corpuscular hemoglobin	J:175295
Tmsb4x^em1(IMPC)Mbp/Tmsb4x^em1(IMPC)Mbp (C57BL/6NCrl-Tmsb4x^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Tmub1^tm1Lex/Tmub1^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	increased monocyte cell number	J:171883
Tmub2^{tm1b(KOMP)Wtsi}/Tmub2^{tm1b(KOMP)Wtsi} (C57BL/6N-Tmub2^{tm1b(KOMP)Wtsi}/Tcp)	decreased lymphocyte cell number	J:211773
	increased eosinophil cell number	J:211773
Tnf^M2Btlr/Tnf⁺ (C57BL/6J-Tnf^M2Btlr)	decreased macrophage cytokine production	J:213047
Tnf^tm1.2Sned/Tnf^tm1.2Sned (involves: 129/Sv * C57BL/6)	increased leukocyte cell number	J:97783
Tnf^tm1Gkl/Tnf^tm1Gkl (involves: 129S/SvEv * C57BL/6)	abnormal lymphocyte physiology	J:114740
	abnormal macrophage physiology	J:114740
	abnormal spleen follicular dendritic cell network	J:42579
	abnormal spleen primary B follicle morphology	J:47673
	absent spleen germinal center	J:47673, J:114740
Tnf^tm1Gkl/Tnf^tm1Gkl (either: B6.129-Tnf^tm1Gkl or (involves: 129 * C57BL/6))	increased leukocyte cell number	J:97783
	increased lymphocyte cell number	J:97783
	increased neutrophil cell number	J:97783
Tnf^tm1Gkl/Tnf^tm1Gkl (involves: 129S/SvEv * C57BL/6J)	abnormal metallophilic macrophage morphology	J:124642
	abnormal spleen follicular dendritic cell network	J:124642
	abnormal spleen marginal sinus morphology	J:124642
	abnormal spleen primary B follicle morphology	J:124642
	absent spleen germinal center	J:124642
Tnf^tm1Jods/Tnf^tm1Jods (involves: C57BL/6)	abnormal metallophilic macrophage morphology	J:98591
	abnormal spleen marginal sinus morphology	J:43602
	abnormal spleen primary B follicle morphology	J:43602, J:98591
	abnormal spleen white pulp morphology	J:43602, J:98591
	absent spleen germinal center	J:98591
	increased leukocyte cell number	J:43602
Tnf^tm1Jods/Tnf^tm1Jods (C57BL/6-Lta^tm1Jods)	abnormal spleen B cell follicle morphology	J:78229
Tnf^tm1Ljo/Tnf^tm1Ljo (involves: 129S1/Sv)	absent spleen germinal center	J:80616, J:41992
	decreased IgG level	J:41992
	decreased spleen B cell follicle number	J:95684
	decreased spleen white pulp amount	J:80616
Tnf^tm1Ljo/Tnf^tm1Ljo (either: B6.129-Tnf^tm1Ljo or (involves: 129 * C57BL/6))	increased leukocyte cell number	J:97783
	increased lymphocyte cell number	J:97783
	increased neutrophil cell number	J:97783
Tnf^tm1Ljo/Tnf^tm1Ljo (involves: 129S1/Sv * C57BL/6)	abnormal neutrophil physiology	J:127028
	decreased immunoglobulin level	J:127028
	increased neutrophil cell number	J:127028
Tnf^tm1Sek/Tnf^tm1Sek (B6.Cg-Tnf^tm1Sek)	abnormal macrophage physiology	J:44841
Tnf^tm1Sek/Tnf^tm1Sek (B6.Cg-Tnf^tm1Sek)	absent spleen germinal center	J:44841
Tnf^tm2Gkl/Tnf⁺ (involves: 129S/SvEv * C57BL/6)	abnormal alpha-beta intraepithelial T cell morphology	J:136667
	abnormal CD4-positive, alpha-beta T cell physiology	J:136667
	abnormal CD8-positive, alpha beta T cell morphology	J:136667
	abnormal T cell physiology	J:136667
	abnormal T cell subpopulation ratio	J:136667
	abnormal T-helper 17 cell physiology	J:204922
	increased dendritic cell number	J:204922
Tnf^tm2Gkl/Tnf⁺ (involves: 129S/SvEv * C57BL/6J)	abnormal cytotoxic T cell physiology	J:108572
	abnormal myelopoiesis	J:108572
	enlarged spleen	J:108572
	increased CD8-positive, alpha-beta T cell number	J:108572
Tnf^tm2Gkl/Tnf⁺ (B6.129S-Tnf^tm2Gkl/Jarn)	abnormal CD4-positive, alpha-beta T cell physiology	J:145626
	abnormal CD8-positive, alpha beta T cell morphology	J:131978
	increased CD4-positive, alpha-beta memory T cell number	J:145626
	increased CD4-positive, alpha-beta T cell number	J:145626
Tnf^tm2Gkl/Tnf^tm2Gkl (involves: 129S/SvEv * C57BL/6)	thymus hypoplasia	J:54056
Tnf^tm2Jods/Tnf^tm2Jods (involves: C57BL/6)	decreased immunoglobulin level	J:127028
Tnf^tm2Jods/Tnf^tm2Jods (C57BL/6-Tnf^tm2Jods)	abnormal metallophilic macrophage morphology	J:98591
	abnormal spleen follicular dendritic cell network	J:98591
	abnormal spleen primary B follicle morphology	J:98591
	abnormal spleen white pulp morphology	J:98591
	decreased spleen germinal center number	J:98591
	decreased spleen germinal center size	J:98591
Tnf^tm3Gkl/Tnf^tm3Gkl (involves: 129S/SvEv * C57BL/6)	abnormal lymphocyte physiology	J:114740
	abnormal spleen primary B follicle morphology	J:114740
	absent spleen germinal center	J:114740
	decreased IgG1 level	J:114740
Tnf^tm3Gkl/Tnf^tm3Gkl Zfp36^tm1Pjb/Zfp36^tm1Pjb (involves: 129S/SvEv * C57BL/6)	myeloid hyperplasia	J:114740
Tnfaip3^m1Apb/Tnfaip3^m1Apb (C57BL/6-Tnfaip3^m1Apb)	increased effector memory T-helper cell number	J:324062
	increased macrophage cell number	J:324062
	increased microglial cell activation	J:324062
Tnfaip3^tm1.1Gho/Tnfaip3^tm1.1Gho (involves: C57BL/6J)	enlarged spleen	J:217021
	increased myeloid cell number	J:217021
	increased myeloid cell number in bone marrow	J:217021
Tnfaip3^tm1Ama/Tnfaip3^tm1Ama (Not Specified)	increased granulocyte number	J:92931
	increased lymphocyte cell number	J:92931
	increased macrophage cell number	J:92931
Tnfaip3^tm1Homy/Tnfaip3^tm1Homy Tg(Mx1-cre)1Cgn/? (involves: 129S6/SvEvTac * C57BL/6J * CBA/J)	abnormal B cell number	J:212681
	abnormal blood cell morphology/development	J:212681
	abnormal myelopoiesis	J:212681
	abnormal spleen morphology	J:212681
	anemia	J:212681
	hematopoietic system phenotype	J:212681
Tnfaip3^tm2Ama/Tnfaip3^tm2Ama Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell activation	J:163917
	abnormal B cell morphology	J:163917
	abnormal B-1a B cell morphology	J:163917
	decreased B cell apoptosis	J:163917
	decreased B cell number	J:163917
	increased B cell number	J:163917
	increased B cell proliferation	J:163917
	increased germinal center B cell number	J:163917
	increased IgG level	J:163917
	increased IgM level	J:163917
	increased immature B cell number	J:163917
	increased immunoglobulin level	J:163917
	increased plasma cell number	J:163917
	increased T cell number	J:163917
Tnfaip3^tm3.1Ama/Tnfaip3^tm3.1Ama (C57BL/6J-Tnfaip3^tm3.1Ama)	enlarged spleen	J:203160
	increased B cell number	J:203160
	increased CD4-positive, alpha-beta T cell number	J:203160
	increased CD8-positive, alpha-beta T cell number	J:203160
	myeloid hyperplasia	J:203160
Tnfaip3^tm4.1Ama/Tnfaip3^tm4.1Ama (C57BL/6J-Tnfaip3^tm4.1Ama)	enlarged spleen	J:203160
	increased B cell number	J:203160
	increased CD4-positive, alpha-beta T cell number	J:203160
	increased CD8-positive, alpha-beta T cell number	J:203160
	myeloid hyperplasia	J:203160
Tnfaip8^{Gt(IST13629C1)Tigm}/Tnfaip8^{Gt(IST13629C1)Tigm} (involves: C57BL/6N)	increased neutrophil cell number	J:223320
	small spleen	J:223320
Tnfaip8^{Gt(IST13629C1)Tigm}/Tnfaip8^{Gt(IST13629C1)Tigm} Tnfaip8l1^em1Huwa/Tnfaip8l1^em1Huwa (involves: C57BL/6 * C57BL/6N)	decreased spleen weight	J:342074
	increased leukocyte cell number	J:342074
	increased T-helper 17 cell number	J:342074
Tnfaip8l1^em1(IMPC)Mbp/Tnfaip8l1^em1(IMPC)Mbp (C57BL/6N-Tnfaip8l1^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	small spleen	J:211773
Tnfaip8l1^em1Huwa/Tnfaip8l1^em1Huwa (C57BL/6-Tnfaip8l1^em1Huwa)	hematopoietic system phenotype	J:342074
Tnfaip8l2^tm1Yhcn/Tnfaip8l2^tm1Yhcn (129S6/SvEvTac-Tnfaip8l2^tm1Yhcn)	abnormal B cell activation	J:139785
	abnormal B cell physiology	J:139785
	abnormal CD4-positive, alpha-beta T cell physiology	J:139785
	abnormal cytotoxic T cell physiology	J:139785
	abnormal leukocyte morphology	J:139785
	abnormal macrophage activation involved in immune response	J:139785
	abnormal myeloid dendritic cell morphology	J:139785
	abnormal spleen morphology	J:139785
	abnormal T cell apoptosis	J:139785
	decreased IgG2a level	J:139785
	decreased IgG2b level	J:139785
	enlarged spleen	J:139785
	increased B cell number	J:139785
	increased spleen white pulp amount	J:139785
	increased T cell number	J:139785
	spleen hyperplasia	J:139785
Tnfrsf1a^{em1(IMPC)Ccpcz}/Tnfrsf1a^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Tnfrsf1a^{em1(IMPC)Ccpcz}/Ccpcz)	increased effector memory CD8-positive, alpha-beta T cell number	J:211773
	increased neutrophil cell number	J:211773
	increased NK cell number	J:211773
Tnfrsf1a^tm1Blt/Tnfrsf1a^tm1Blt (involves: 129P2/OlaHsd * C57BL/6)	decreased IgG1 level	J:115225
Tnfrsf1a^tm1Blt/Tnfrsf1a^tm1Blt Tnfrsf1b^tm1Mwm/Tnfrsf1b^tm1Mwm (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	absent spleen germinal center	J:119206
	decreased IgG1 level	J:115225
Tnfrsf1a^tm1Imx/Tnfrsf1a^tm1Imx (C57BL/6-Tnfrsf1a^tm1Imx)	decreased microglial cell number	J:112713
Tnfrsf1a^tm1Imx/Tnfrsf1a^tm1Imx (C57BL/6-Tnfrsf1a^tm1Imx/J)	abnormal macrophage physiology	J:160543
Tnfrsf1a^tm1Imx/Tnfrsf1a^tm1Imx Tg(Thy1-APP)3Somm/0 (involves: C57BL/6 * C57BL/6J * DBA/2)	microgliosis	J:134832
Tnfrsf1a^tm1Imx/Tnfrsf1a^tm1Imx Tnfrsf1b^tm1Imx/Tnfrsf1b^tm1Imx (involves: 129S7/SvEvBrd * C57BL/6)	decreased microglial cell activation	J:33864
Tnfrsf1a^tm1Mak/Tnfrsf1a^tm1Mak (involves: 129S2/SvPas)	abnormal spleen germinal center morphology	J:139030
Tnfrsf1a^tm1Mak/Tnfrsf1a^tm1Mak (involves: 129S2/SvPas)	decreased IgG level	J:139030
Tnfrsf1a^tm1Mak/Tnfrsf1a^tm1Mak Tnip1^{Gt(E059E05)Wrst}/Tnip1^{Gt(E059E05)Wrst} (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	anemia	J:180054
	decreased hemoglobin content	J:180054
	increased neutrophil cell number	J:180054
	spleen hyperplasia	J:180054
Tnfrsf1a^tm1Rsie/Tnfrsf1a^tm1Rsie (B6.Cg-Tnfrsf1a^tm1Rsie)	abnormal macrophage physiology	J:160543
Tnfrsf1a^tm2.1Rsie/Tnfrsf1a⁺ (B6.Cg-Tnfrsf1a^tm2.1Rsie)	abnormal macrophage physiology	J:160543
Tnfrsf1a^tm2.1Rsie/Tnfrsf1a^tm2.1Rsie (B6.Cg-Tnfrsf1a^tm2.1Rsie)	abnormal macrophage physiology	J:160543
Tnfrsf1a^{tm2b(EUCOMM)Wtsi}/Tnfrsf1a^{tm2b(EUCOMM)Wtsi} (C57BL/6N-Tnfrsf1a^{tm2b(EUCOMM)Wtsi}/H)	decreased monocyte cell number	J:211773
	decreased neutrophil cell number	J:211773
	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
	increased large unstained cell number	J:211773
	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
Tnfrsf1b^{tm1a(EUCOMM)Wtsi}/Tnfrsf1b^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Tnfrsf1b^{tm1a(EUCOMM)Wtsi}/Ics)	decreased T cell number	J:165965
Tnfrsf1b^tm1Imx/Tnfrsf1b^tm1Imx (involves: 129S7/SvEvBrd * C57BL/6)	microgliosis	J:112713
Tnfrsf1b^tm1Mwm/Tnfrsf1b^tm1Mwm (B6.129S2-Tnfrsf1b^tm1Mwm/J)	decreased T cell proliferation	J:107039
Tnfrsf4^tm1Mfb/Tnfrsf4^tm1Mfb (involves: 129P2/OlaHsd * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:59204
Tnfrsf4^tm1Nik/Tnfrsf4^tm1Nik (involves: 129S4/SvJae * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:64552
	abnormal T-helper 2 physiology	J:68588
	decreased T cell proliferation	J:58979, J:64552
Tnfrsf8^tm1Mak/Tnfrsf8^tm1Mak (involves: 129P2/OlaHsd * C57BL/6)	enlarged thymus	J:62854
	increased thymocyte number	J:62854
Tnfrsf9^em1Ygch/Tnfrsf9^em1Ygch (NOD/ShiLtDvs-Tnfrsf9^em1Ygch)	abnormal T cell physiology	J:208927
Tnfrsf9^em2Ygch/Tnfrsf9^em2Ygch (NOD/ShiLtDvs-Tnfrsf9^em2Ygch)	abnormal T cell physiology	J:208927
Tnfrsf9^m1Btlr/Tnfrsf9^m1Btlr (C57BL/6J-Tnfrsf9^m1Btlr)	decreased CD8-positive, alpha-beta T cell number	J:265260
	decreased CD8-positive, naive alpha-beta T cell number	J:265260
	decreased single-positive T cell number	J:265260
	increased B cell number	J:265260
	increased effector memory CD4-positive, alpha-beta T cell number	J:265260
	increased effector memory CD8-positive, alpha-beta T cell number	J:265260
Tnfrsf9^tm1Byk/Tnfrsf9^tm1Byk (B6.Cg-Tnfrsf9^tm1Byk)	abnormal common myeloid progenitor cell morphology	J:83996
	abnormal cytotoxic T cell physiology	J:83996
	decreased IgG2a level	J:83996
	decreased IgG3 level	J:83996
	increased T cell proliferation	J:83996
Tnfrsf9^tm1Byk/Tnfrsf9^tm1Byk (C.Cg-Tnfrsf9^tm1Byk)	abnormal common myeloid progenitor cell morphology	J:83996
	abnormal cytotoxic T cell physiology	J:83722
	abnormal immunoglobulin level	J:83996
	decreased IgG2a level	J:83996
	decreased IgG3 level	J:83996
	increased IgA level	J:83722
	increased IgG2a level	J:83722
	increased IgG2b level	J:83722
	increased splenocyte proliferation	J:83722
	increased T cell proliferation	J:83996
Tnfrsf9^tm1Lpc/Tnfrsf9^tm1Lpc (B6.129-Tnfrsf9^tm1Lpc)	abnormal memory T cell physiology	J:145439
Tnfrsf10b^tm1Wnt/Tnfrsf10b^tm1Wnt (involves: 129S6/SvEvTac * C57BL/6)	increased NK cell number	J:94681
Tnfrsf10b^tm1Wsed/Tnfrsf10b^tm1Wsed (involves: 129P2/OlaHsd)	enlarged thymus	J:96816
Tnfrsf11a^del8/Tnfrsf11a^del8 (involves: 129)	abnormal hematopoietic system morphology/development	J:111512
	anemia	J:111512
	decreased osteoclast cell number	J:111512
	enlarged spleen	J:111512
	extramedullary hematopoiesis	J:111512
Tnfrsf11a^tm1.1Sral/Tnfrsf11a⁺ (B6.129P2(Cg)-Tnfrsf11a^tm1.1Sral)	abnormal osteoclast differentiation	J:312215
	abnormal osteoclast physiology	J:312215
	increased osteoclast cell number	J:312215
Tnfrsf11a^tm1.1Sral/Tnfrsf11a^tm1.1Sral (B6.129P2(Cg)-Tnfrsf11a^tm1.1Sral)	abnormal osteoclast differentiation	J:312215
	decreased osteoclast cell number	J:312215
Tnfrsf11a^tm1.2Pngr/Tnfrsf11a^tm1.2Pngr (B6.Cg-Tnfrsf11a^tm1.2Pngr)	decreased osteoclast cell number	J:155398
Tnfrsf11a^tm1Imx/Tnfrsf11a^tm1Imx (involves: 129 * C57BL/6)	abnormal common myeloid progenitor cell morphology	J:57899
	abnormal osteoclast differentiation	J:57899
	decreased B cell number	J:57899
	decreased bone marrow cell number	J:57899
	decreased mature B cell number	J:57899
	decreased osteoclast cell number	J:57899
	decreased spleen germinal center size	J:57899
	extramedullary hematopoiesis	J:57899
	increased granulocyte number	J:57899
	increased neutrophil cell number	J:57899
	spleen hyperplasia	J:57899
Tnfrsf11a^tm1Imx/Tnfrsf11a^tm1Imx (involves: 129)	abnormal negative T cell selection	J:125864
Tnfrsf11a^tm1Imx/Tnfrsf11a^tm1Imx (involves: 129)	abnormal thymus epithelium morphology	J:125864
Tnfrsf11a^tm1Kost/Tnfrsf11a^tm1Kost (involves: 129/Sv * Black Swiss)	abnormal osteoclast morphology	J:166279
Tnfrsf11b^em1(IMPC)Mbp/Tnfrsf11b^em1(IMPC)Mbp (C57BL/6N-Tnfrsf11b^em1(IMPC)Mbp/MbpMmucd)	small spleen	J:211773
Tnfrsf11b^tm1Eac/Tnfrsf11b^tm1Eac (involves: 129S4/SvJaeSor)	abnormal immunoglobulin level	J:67105
	abnormal pro-B cell differentiation	J:67105
	increased B cell number	J:67105
	increased immature B cell number	J:67105
	increased pro-B cell number	J:67105
Tnfrsf11b^tm1Khs/Tnfrsf11b^tm1Khs (involves: 129P2/OlaHsd * C57BL/6)	abnormal osteoclast differentiation	J:111153, J:48325
	abnormal osteoclast physiology	J:111153
	increased osteoclast cell number	J:80503
Tnfrsf11b^tm1Wss/Tnfrsf11b^tm1Wss (either: (involves: 129X1/SvJ * C57BL/6) or (involves: 129X1/SvJ * Black Swiss))	abnormal osteoclast morphology	J:47602
Tnfrsf13b^tm1Cmac/Tnfrsf13b^tm1Cmac (Not Specified)	enlarged spleen	J:91914
Tnfrsf13b^tm1Cmac/Tnfrsf13b^tm1Cmac (Not Specified)	increased B cell number	J:91914
Tnfrsf13b^tm1Rjb/Tnfrsf13b^tm1Rjb (involves: 129X1/SvJ * C57BL/6)	abnormal B cell activation	J:69474
	decreased IgA level	J:69474
	decreased IgM level	J:69474
	increased B cell number	J:69474
	increased B cell proliferation	J:69474
	increased spleen weight	J:69474
Tnfrsf13b^tm1Rjb/Tnfrsf13b^tm1Rjb (involves: 129X1/SvJ)	abnormal class switch recombination	J:95288
	decreased IgA level	J:95288
	decreased IgE level	J:95288
	decreased IgG1 level	J:95288
Tnfrsf13b^tm1Vmd/Tnfrsf13b^tm1Vmd (involves: C57BL/6)	abnormal immunoglobulin level	J:70172
	abnormal spleen morphology	J:70172
	abnormal spleen periarteriolar lymphoid sheath morphology	J:70172, J:82331
	abnormal spleen primary B follicle morphology	J:70172
	enlarged spleen	J:70172, J:82331
	increased B cell number	J:70172, J:82331
	increased B cell proliferation	J:70172
	increased follicular B cell number	J:70172
	increased IgG1 level	J:70172
	increased marginal zone B cell number	J:70172
	increased mature B cell number	J:70172
	increased spleen germinal center size	J:70172
	increased spleen white pulp amount	J:70172
	increased transitional stage B cell number	J:70172
Tnfrsf13c^Bcmd1/Tnfrsf13c^Bcmd1 (A/WySnJ)	abnormal lymphocyte physiology	J:92334
	decreased B cell proliferation	J:122315
	decreased IgG level	J:122315
	decreased T cell proliferation	J:92334
Tnfrsf13c^m1Btlr/Tnfrsf13c^m1Btlr (C57BL/6J-Tnfrsf13c^m1Btlr)	decreased B cell number	J:265247
Tnfrsf13c^M2Btlr/Tnfrsf13c^M2Btlr (C57BL/6J-Tnfrsf13c^M2Btlr)	decreased B cell number	J:265247
Tnfrsf13c^tm1Mass/Tnfrsf13c^tm1Mass (C57BL/6-Tnfrsf13c^tm1Mass)	abnormal B cell physiology	J:113556
	absent marginal zone B cells	J:92732
	arrested B cell differentiation	J:92732
	decreased B-2 B cell number	J:92732
	decreased IgG1 level	J:92732
	decreased IgG2a level	J:92732
	decreased IgG2b level	J:92732
	decreased IgG3 level	J:92732
	decreased IgG level	J:92732
	decreased IgM level	J:92732
	decreased mature B cell number	J:92732
Tnfrsf13c^tm1Mass/Tnfrsf13c^tm1Mass (involves: C57BL/6)	decreased lymphocyte cell number	J:139293
Tnfrsf13c^tm1Mass/Tnfrsf13c^tm1Mass (involves: C57BL/6)	decreased mature B cell number	J:139293
Tnfrsf13c^tm1Mass/Tnfrsf13c^tm1Mass Traf2^tm1Rbr/Traf2^tm1Rbr (involves: C57BL/6)	decreased germinal center B cell number	J:172843
	decreased spleen germinal center size	J:172843
Tnfrsf13c^tm1Msc/Tnfrsf13c^tm1Msc (involves: 129P2/OlaHsd * C57BL/6)	absent marginal zone B cells	J:92676
	absent transitional stage B cells	J:92676
	decreased B cell number	J:92676
	decreased B-2 B cell number	J:92676
	decreased IgD level	J:92676
	decreased IgG1 level	J:92676
	decreased IgG level	J:92676
	decreased IgM level	J:92676
Tnfrsf14^tm1Kpf/Tnfrsf14^tm1Kpf (B6.129P2-Tnfrsf14^tm1Kpf)	abnormal T cell physiology	J:99456
Tnfrsf14^tm1Kpf/Tnfrsf14^tm1Kpf (B6.129P2-Tnfrsf14^tm1Kpf)	increased T cell proliferation	J:99456
Tnfrsf17^tm1Kplm/Tnfrsf17^tm1Kplm (involves: 129P2/OlaHsd * C57BL/6)	decreased plasma cell number	J:124543
Tnfrsf18^tm1Ppp/Tnfrsf18^tm1Ppp (involves: 129/Sv * C57BL/6)	abnormal T cell activation	J:77393
	increased T cell apoptosis	J:77393
	increased T cell proliferation	J:77393
Tnfrsf21^tm1Ddy/Tnfrsf21^tm1Ddy (involves: 129S1/Sv * 129X1/SvJ)	abnormal T-helper 1 physiology	J:70594
	abnormal T-helper 2 physiology	J:70594
	increased B cell proliferation	J:109341
	increased IgG1 level	J:109341
	increased IgG2a level	J:109341
	increased IgG2b level	J:109341
	increased IgG3 level	J:109341
	increased IgM level	J:109341
	increased spleen germinal center size	J:109341
	increased T cell proliferation	J:70594
Tnfrsf21^tm1Vmd/Tnfrsf21^tm1Vmd (involves: C57BL/6)	abnormal T-helper 2 physiology	J:72761
	increased CD4-positive, alpha-beta T cell number	J:72761
	increased CD8-positive, alpha-beta T cell number	J:72761
	increased IgE level	J:72761
	increased IgG1 level	J:72761
	increased IgG2a level	J:72761
	increased IgM level	J:72761
	increased T cell number	J:72761
	increased T cell proliferation	J:72761
Tnfrsf25^tm1Mjo/Tnfrsf25^tm1Mjo (involves: 129P2/OlaHsd)	abnormal negative T cell selection	J:84536
	decreased T cell apoptosis	J:84536
	enlarged thymus	J:84536
	increased thymocyte number	J:84536
Tnfsf4^tm1Shr/Tnfsf4^tm1Shr (involves: 129S4/SvJae)	decreased T cell proliferation	J:59203
Tnfsf4^tm1Sug/Tnfsf4^tm1Sug (B6.129S4-Tnfsf4^tm1Sug)	decreased T cell proliferation	J:80214
Tnfsf9^tm1Thw/Tnfsf9^tm1Thw (involves: 129 * C57BL/6)	abnormal cytotoxic T cell physiology	J:76373
Tnfsf10^tm1Mjs/Tnfsf10^tm1Mjs (C.129-Tnfsf10^tm1Mjs)	abnormal negative T cell selection	J:82145
	hematopoietic system phenotype	J:84838
	impaired natural killer cell mediated cytotoxicity	J:73948
	thymus hyperplasia	J:84838, J:82145
Tnfsf10^tm1Mjs/Tnfsf10^tm1Mjs (B6.129-Tnfsf10^tm1Mjs)	abnormal negative T cell selection	J:82145
	hematopoietic system phenotype	J:84838
	increased IgG1 level	J:82145
	increased IgG2a level	J:82145
	thymus hyperplasia	J:82145
Tnfsf11^tles/Tnfsf11^tles (involves: 129S6/SvEvTac * C57BL/6J)	decreased osteoclast cell number	J:179743
	enlarged spleen	J:179743
	thymus hypoplasia	J:179743
Tnfsf11^tles/Tnfsf11^tm1Pngr (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J)	decreased osteoclast cell number	J:179743
Tnfsf11^tm1.1Caob/Tnfsf11^tm1.1Caob Tg(Dmp1-cre)1Jqfe/0 (involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6 * FVB)	abnormal osteoclast cell number	J:177558
	decreased osteoclast cell number	J:177558
Tnfsf11^tm1.1Caob/Tnfsf11^tm1.1Caob Tg(Prrx1-cre)1Cjt/0 (involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6)	decreased osteoclast cell number	J:177558
Tnfsf11^tm1.1Htaka/Tnfsf11^tm1.2Htaka Tg(Dmp1-cre)1Jqfe/0 (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * FVB/N)	decreased osteoclast cell number	J:177557
Tnfsf11^tm1.2Htaka/Tnfsf11⁺ (B6.Cg-Tnfsf11^tm1.2Htaka)	decreased osteoclast cell number	J:177557
Tnfsf11^tm1.2Htaka/Tnfsf11^tm1.2Htaka (B6.Cg-Tnfsf11^tm1.2Htaka)	decreased osteoclast cell number	J:177557
	increased spleen weight	J:177557
Tnfsf11^tm1Pngr/Tnfsf11^tm1Pngr (involves: 129P2/OlaHsd * C57BL/6)	abnormal pro-B cell differentiation	J:52369
	arrested T cell differentiation	J:52369
	decreased immature B cell number	J:52369
	decreased mature B cell number	J:52369
	decreased osteoclast cell number	J:52369
	decreased thymus weight	J:52369
	extramedullary hematopoiesis	J:52369
	hematopoietic system phenotype	J:52369
	increased spleen weight	J:52369
	macrocytic anemia	J:52369
	thymus hypoplasia	J:52369
Tnfsf11^tm1Pngr/Tnfsf11^tm1Pngr (involves: 129P2/OlaHsd)	abnormal thymus epithelium morphology	J:173115
Tnfsf11^tm1Ywc/Tnfsf11^tm1Ywc (involves: 129P2/OlaHsd)	abnormal spleen B cell follicle morphology	J:65888
	abnormal spleen marginal zone morphology	J:65888
	abnormal spleen morphology	J:65888
	abnormal splenic cell ratio	J:233265
	abnormal thymus cell ratio	J:233265
	decreased bone marrow cell number	J:233265
	decreased Langerhans cell number	J:137471
	decreased osteoclast cell number	J:65888, J:64737
	decreased spleen white pulp amount	J:233265
	extramedullary hematopoiesis	J:233265
	increased spleen red pulp amount	J:233265
	small thymus medulla	J:233265
Tnfsf12^tm1Ash/Tnfsf12^tm1Ash (B6.129-Tnfsf12^tm1Ash)	abnormal leukocyte morphology	J:104801
	enlarged spleen	J:104801
	increased double-positive T cell number	J:104801
	increased memory T cell number	J:104801
	increased NK cell number	J:104801
	increased T-helper 1 cell number	J:104801
Tnfsf13^tm1Geha/Tnfsf13^tm1Geha (involves: 129S4/SvJae)	abnormal class switch recombination	J:88910
	decreased IgA level	J:88910
	decreased IgM level	J:88910
	increased IgG level	J:88910
	increased memory T cell number	J:88910
	increased spleen germinal center number	J:88910
	increased spleen germinal center size	J:88910
Tnfsf13^tm1Pod/Tnfsf13⁺ (B6.Cg-Tnfsf13^tm1Pod)	decreased IgA level	J:141374
Tnfsf13^tm1Pod/Tnfsf13^tm1Pod (B6.Cg-Tnfsf13^tm1Pod)	decreased IgA level	J:141374
	decreased IgG2a level	J:141374
	increased IgG1 level	J:141374
	increased T cell proliferation	J:141374
Tnfsf13b^m1Anu/Tnfsf13b^m1Anu (C57BL/6JAnu-Tnfsf13b^m1Anu/AnuApb)	abnormal B cell differentiation	J:104190
	decreased mature B cell number	J:104190
	increased immature B cell number	J:104190
Tnfsf13b^M1Btlr/Tnfsf13b⁺ (C57BL/6J-Tnfsf13b^M1Btlr)	decreased B cell number	J:220069
	decreased IgG level	J:220069
	decreased IgM level	J:220069
	increased single-positive T cell number	J:220069
	increased T cell number	J:220069
Tnfsf13b^M1Btlr/Tnfsf13b^M1Btlr (C57BL/6J-Tnfsf13b^M1Btlr)	decreased B cell number	J:220069
	decreased IgG level	J:220069
	decreased IgM level	J:220069
	increased single-positive T cell number	J:220069
	increased T cell number	J:220069
Tnfsf13b^m2Btlr/Tnfsf13b^m2Btlr (C57BL/6J-Tnfsf13b^m2Btlr)	decreased B cell number	J:220070
Tnfsf13b^m2Btlr/Tnfsf13b^m2Btlr (C57BL/6J-Tnfsf13b^m2Btlr)	decreased IgG level	J:220070
Tnfsf13b^m3Btlr/Tnfsf13b^m3Btlr (C57BL/6J-Tnfsf13b^m3Btlr)	abnormal lymphocyte morphology	J:272850
Tnfsf13b^m3Btlr/Tnfsf13b^m3Btlr (C57BL/6J-Tnfsf13b^m3Btlr)	decreased B cell number	J:272850
Tnfsf13b^tm1Cleg/Tnfsf13b^tm1Cleg (involves: 129S5/SvEvBrd)	abnormal B cell differentiation	J:71301
	abnormal B cell physiology	J:71301
	abnormal leukocyte morphology	J:71301
	decreased follicular B cell number	J:71301
	decreased IgG level	J:71301
	decreased IgM level	J:71301
	decreased mature B cell number	J:71301
	decreased memory T cell number	J:71301
	increased T cell number	J:71301
	spleen hypoplasia	J:71301
Tnfsf13b^tm1Msc/Tnfsf13b⁺ (involves: 129S2/SvPas * C57BL/6)	decreased immunoglobulin level	J:71681
Tnfsf13b^tm1Msc/Tnfsf13b^tm1Msc (involves: 129S2/SvPas * C57BL/6)	abnormal B cell differentiation	J:71681
	arrested B cell differentiation	J:71681
	decreased B cell number	J:71681
	decreased follicular B cell number	J:71681
	decreased immunoglobulin level	J:71681
	decreased marginal zone B cell number	J:71681
	decreased spleen weight	J:71681
Tnfsf13b^tm1Msc/Tnfsf13b^tm1Msc (involves: 129S2/SvPas)	decreased B cell number	J:138560
	decreased follicular B cell number	J:138560
	decreased T cell proliferation	J:92334
	decreased transitional stage B cell number	J:138560
Tnfsf13b^tm1Msc/Tnfsf13b^tm1Msc Traf2^tm1Rbr/Traf2^tm1Rbr (involves: 129S2/SvPas * C57BL/6)	absent follicular B cells	J:132877
	absent marginal zone B cells	J:132877
	decreased mature B cell number	J:132877
Tnfsf14^tm1Ddy/Tnfsf14^tm1Ddy (involves: 129S1/Sv * 129X1/SvJ)	abnormal cytotoxic T cell physiology	J:84366
	abnormal T cell activation	J:84366
	decreased T cell proliferation	J:84366
Tnfsf14^tm1Kpf/Tnfsf14^tm1Kpf (involves: 129P2/OlaHsd * C57BL/6)	abnormal T cell subpopulation ratio	J:77250
	decreased cytotoxic T cell cytolysis	J:77250
	decreased splenocyte proliferation	J:77250
	decreased T cell proliferation	J:77250
Tnfsf14^tm1Kpf/Tnfsf14^tm1Kpf (involves: 129P2/OlaHsd)	abnormal gamma-delta T cell morphology	J:169863
Tnfsf14^tm1Kpf/Tnfsf14^tm1Kpf (B6.129P2-Tnfsf14^tm1Kpf)	abnormal osteoclast differentiation	J:294030
Tnfsf14^tm1Lpc/Tnfsf14^tm1Lpc (involves: 129X1/SvJ * C57BL/6)	abnormal cytotoxic T cell physiology	J:76414
	decreased cytotoxic T cell cytolysis	J:76414
Tnfsf15^tm1Cdon/Tnfsf15^tm1Cdon (B6.129-Tnfsf15^tm1Cdon)	abnormal dendritic cell differentiation	J:136280
Tnfsf15^tm1Hluo/Tnfsf15^tm1Hluo (D1LacJ.129(B6)-Tnfsf15^tm1Hluo)	decreased B cell number	J:207029
	decreased germinal center B cell number	J:207029
	decreased IgG2a level	J:207029
	decreased IgG2b level	J:207029
	decreased IgG level	J:207029
	decreased plasma cell number	J:207029
	decreased T cell number	J:207029
	decreased T follicular helper cell number	J:207029
Tnfsf15^tm1Lex/Tnfsf15^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	increased NK cell number	J:82809
Tnfsf18^{tm1.1(KOMP)Vlcg}/Tnfsf18^{tm1.1(KOMP)Vlcg} (C57BL/6N-Tnfsf18^{tm1.1(KOMP)Vlcg}/J)	increased hematocrit	J:211773
Tnip1^{Gt(E059E05)Wrst}/Tnip1^{Gt(E059E05)Wrst} (involves: 129P2/OlaHsd * C57BL/6)	anemia	J:180054
	decreased hemoglobin content	J:180054
	enlarged spleen	J:180054
	increased IgA level	J:180054
	increased IgG1 level	J:180054
	increased IgG2b level	J:180054
	increased IgM level	J:180054
	increased neutrophil cell number	J:180054
	spleen hyperplasia	J:180054
Tnip1^m1Btlr/Tnip1^m1Btlr (C57BL/6J-Tnip1^m1Btlr)	decreased B cell number	J:265175
	decreased B-2 B cell number	J:265175
	increased B-1a cell number	J:265175
	increased B-1b cell number	J:265175
	increased dendritic cell number	J:265175
	increased IgA level	J:265175
	increased IgE level	J:265175
	increased macrophage cell number	J:265175
Tnip1^tm1.1Ama/Tnip1^tm1.1Ama (involves: C57BL/6J)	anemia	J:145539
Tnip1^tm1.1Ama/Tnip1^tm1.1Ama (involves: C57BL/6J)	decreased hematocrit	J:145539
Tnip1^tm1.1Pcoh/Tnip1^tm1.1Pcoh (involves: 129P2/OlaHsd * C57BL/6)	abnormal effector T cell morphology	J:176826
	abnormal plasma cell morphology	J:176826
	abnormal spleen germinal center morphology	J:176826
	enlarged spleen	J:176826
	increased B cell number	J:176826
	increased B cell proliferation	J:176826
	increased germinal center B cell number	J:176826
	increased granulocyte number	J:176826
	increased IgA level	J:176826
	increased IgE level	J:176826
	increased IgG1 level	J:176826
	increased IgG2a level	J:176826
	increased IgG2b level	J:176826
	increased IgG3 level	J:176826
	increased IgG level	J:176826
	increased IgM level	J:176826
	increased immunoglobulin level	J:176826
	increased monocyte cell number	J:176826
	increased plasma cell number	J:176826
	increased spleen red pulp amount	J:176826
	increased spleen weight	J:176826
	increased spleen white pulp amount	J:176826
	increased T follicular helper cell number	J:176826
Tnip1^tm1.2Ama/Tnip1^tm1.2Ama Tg(Itgax-cre)1-1Reiz/0 (involves: C57BL/6 * C57BL/6J * CBA)	abnormal hematopoietic stem cell physiology	J:205446
	abnormal leukocyte morphology	J:205446
	enlarged spleen	J:205446
	increased memory T cell number	J:205446
	increased plasmacytoid dendritic cell number	J:205446
Tnip1^{tm1b(EUCOMM)Hmgu}/Tnip1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Tnip1^{tm1b(EUCOMM)Hmgu}/H)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	decreased lymphocyte cell number	J:211773
	increased basophil cell number	J:211773
	increased large unstained cell number	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
	increased mean platelet volume	J:211773
	increased monocyte cell number	J:211773
	increased red blood cell distribution width	J:211773
	increased spleen weight	J:211773
	thrombocytopenia	J:211773
Tnip2^tm1.1Sley/Tnip2^tm1.1Sley (involves: 129S4/SvJae * 129S8/SvEv * C57BL/6)	abnormal macrophage physiology	J:112395
Tnks^{em1(IMPC)Hmgu}/Tnks^{em1(IMPC)Hmgu} (C57BL/6N-Tnks^{em1(IMPC)Hmgu}/Ieg)	decreased erythrocyte cell number	J:211773
	increased mean corpuscular volume	J:211773
	increased mean platelet volume	J:211773
	increased red blood cell distribution width	J:211773
	thrombocytopenia	J:211773
Tnn^em1(IMPC)Mbp/Tnn^em1(IMPC)Mbp (C57BL/6NCrl-Tnn^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Tnr^{em1(IMPC)Rbrc}/Tnr^{em1(IMPC)Rbrc} (C57BL/6NJcl-Tnr^{em1(IMPC)Rbrc}/Rbrc)	increased spleen weight	J:211773
Tnrc6a^Gt(XE786)Byg/Tnrc6a^Gt(XE786)Byg (involves: 129P2/OlaHsd * C57BL/6)	decreased erythrocyte cell number	J:182447
	decreased hematopoietic cell number	J:182447
	impaired hematopoiesis	J:182447
Tns2^nph/Tns2^nph (involves: ICR)	decreased hematocrit	J:24698
Tns3^Gt(XK294)Byg/Tns3^Gt(XK294)Byg (involves: 129P2/OlaHsd * C57BL/6)	small spleen	J:96666
Tnxb^{tm1b(EUCOMM)Hmgu}/Tnxb^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Tnxb^{tm1b(EUCOMM)Hmgu}/H)	enlarged spleen	J:211773
Tob2^tm1Tya/Tob2^tm1Tya (involves: 129S4/SvJae * C57BL/6)	abnormal osteoclast differentiation	J:134287
	abnormal osteoclast physiology	J:134287
	increased osteoclast cell number	J:134287
Tom1l2^Gt(XG909)Byg/Tom1l2⁺ (involves: 129P2/OlaHsd * C57BL/6J)	enlarged spleen	J:133892
Tom1l2^Gt(XG909)Byg/Tom1l2^Gt(XG909)Byg (involves: 129P2/OlaHsd * C57BL/6J)	abnormal spleen B cell follicle morphology	J:133892
	abnormal spleen morphology	J:133892
	abnormal spleen periarteriolar lymphoid sheath morphology	J:133892
	abnormal splenic cell ratio	J:133892
	enlarged spleen	J:133892
	increased B cell number	J:133892
	increased CD4-positive, alpha-beta T cell number	J:133892
	increased CD8-positive, alpha-beta T cell number	J:133892
	increased leukocyte cell number	J:133892
	increased spleen white pulp amount	J:133892
	increased T cell number	J:133892
	thrombocytopenia	J:133892
Tomm5^{Gt(OST44663)Lex}/Tomm5^{Gt(OST44663)Lex} (involves: 129S5/SvEvBrd * C57BL/6)	increased bone marrow cell number	J:186382
	increased eosinophil cell number	J:186382
	thymus atrophy	J:186382
Tomm20^em1(IMPC)J/Tomm20⁺ (C57BL/6NJ-Tomm20^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Tomm22^em1(IMPC)J/Tomm22⁺ (C57BL/6NJ-Tomm22^em1(IMPC)J/J)	decreased mean corpuscular hemoglobin	J:211773
Tomm40^em1(IMPC)J/Tomm40⁺ (C57BL/6NJ-Tomm40^em1(IMPC)J/J)	decreased mean corpuscular hemoglobin	J:211773
Tomm40^em1(IMPC)J/Tomm40⁺ (C57BL/6NJ-Tomm40^em1(IMPC)J/J)	decreased mean corpuscular hemoglobin concentration	J:211773
Top2a^em2(IMPC)Tcp/Top2a⁺ (C57BL/6NCrl-Top2a^em2(IMPC)Tcp/Tcp)	increased mean corpuscular volume	J:211773
	small spleen	J:211773
	small thymus	J:211773
Top2b^em1(IMPC)Mbp/Top2b⁺ (C57BL/6NCrl-Top2b^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	small spleen	J:211773
Top3b^tm1Jcw/Top3b^tm1Jcw (involves: 129S6/SvEvTac * C57BL/6)	enlarged spleen	J:69405
Tox2^em1(IMPC)H/Tox2^em1(IMPC)H (C57BL/6NTac-Tox2^em1(IMPC)H/H)	decreased mean platelet volume	J:211773
Tox^tm1.1Kay/Tox^tm1.1Kay (involves: 129S6/SvEvTac)	abnormal CD4-positive T cell differentiation	J:131287
	abnormal CD4-positive, CD25-positive, alpha-beta regulatory T cell morphology	J:131287
	abnormal CD8-positive, alpha beta T cell morphology	J:131287
	decreased CD4-positive, alpha-beta T cell number	J:131287
	decreased cytotoxic T cell cytolysis	J:131287
	decreased NK T cell number	J:131287
Tox^tm1.1Kay/Tox^tm1.1Kay (involves: 129S6/SvEvTac * C57BL/6)	abnormal positive T cell selection	J:164687
	abnormal spleen morphology	J:164687
	decreased NK cell number	J:164687
Tox^{tm1b(KOMP)Wtsi}/Tox^{tm1b(KOMP)Wtsi} (C57BL/6N-Tox^{tm1b(KOMP)Wtsi}/Tcp)	increased spleen weight	J:211773
Tox^tm1Kay/Tox^tm1Kay Tg(Lck-cre)1Cwi/0 (involves: 129S6/SvEvTac * C57BL/6)	abnormal CD4-positive T cell differentiation	J:164687
Tpcn1^{tm1.1(KOMP)Vlcg}/Tpcn1^{tm1.1(KOMP)Vlcg} (C57BL/6N-Tpcn1^{tm1.1(KOMP)Vlcg}/J)	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
Tpcn1^tm1.1Dren/Tpcn1^tm1.1Dren Tpcn2^tm1.1Dren/Tpcn2^tm1.1Dren (Not Specified)	abnormal macrophage physiology	J:189070
Tpcn2^{tm1b(EUCOMM)Hmgu}/Tpcn2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Tpcn2^{tm1b(EUCOMM)Hmgu}/H)	increased eosinophil cell number	J:211773
Tph2^em1(IMPC)Mbp/Tph2⁺ (C57BL/6N-Tph2^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Tph2^em1(IMPC)Mbp/Tph2^em1(IMPC)Mbp (C57BL/6N-Tph2^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased eosinophil cell number	J:211773
Tpi1^a-m6Neu/Tpi1^a-m6Neu (involves: 101/El * C3H/El)	decreased hematocrit	J:163223
	decreased hemoglobin content	J:163223
	decreased mean corpuscular hemoglobin concentration	J:163223
	hemolytic anemia	J:163223
	increased mean corpuscular volume	J:163223
	increased spleen weight	J:163223
Tpi1^rbc19/Tpi1^rbc19 (SJL-Tpi1^rbc19)	abnormal erythrocyte physiology	J:263104
	abnormal erythropoiesis	J:263104
	abnormal spleen red pulp morphology	J:263104
	decreased erythrocyte cell number	J:263104
	decreased hematocrit	J:263104
	enlarged spleen	J:263104
	hemolytic anemia	J:263104
	increased mean corpuscular hemoglobin	J:263104
	macrocytic anemia	J:263104
	macrocytosis	J:263104
	polychromatophilia	J:263104
	reticulocytosis	J:263104
Tpmt^tm1Rlng/Tpmt⁺ (involves: 129P2/OlaHsd * C57BL/6 * NMRI)	thrombocytosis	J:121737
Tpmt^tm1Rlng/Tpmt^tm1Rlng (involves: 129P2/OlaHsd * C57BL/6 * NMRI)	abnormal blood cell morphology/development	J:121737
	thrombocytosis	J:121737
Tpo^em1(IMPC)H/Tpo⁺ (C57BL/6NTac-Tpo^em1(IMPC)H/H)	increased mean platelet volume	J:211773
Tpo^em1(IMPC)H/Tpo^em1(IMPC)H (C57BL/6NTac-Tpo^em1(IMPC)H/H)	decreased spleen weight	J:211773
Tpo^R479C/Tpo^R479C (involves: ICR)	decreased erythrocyte cell number	J:112930
	decreased hematocrit	J:112930
	small spleen	J:112930
Tpp2^{Gt(OST432061)Lex}/Tpp2^{Gt(OST432061)Lex} (B6.129S5-Tpp2^{Gt(OST432061)Lex})	hematopoietic system phenotype	J:157195
Tpp2^tm1.1Gnie/Tpp2^tm1.1Gnie (involves: 129S6/SvEvTac * C57BL/6)	abnormal cytotoxic T cell physiology	J:133572
	abnormal spleen morphology	J:133572
	abnormal splenic cell ratio	J:133572
	decreased CD8-positive, alpha-beta T cell number	J:133572
	decreased double-positive T cell number	J:133572
	decreased T cell number	J:133572
	enlarged spleen	J:133572
	extramedullary hematopoiesis	J:133572
	increased double-negative T cell number	J:133572
	increased single-positive T cell number	J:133572
	increased spleen red pulp amount	J:133572
	increased T cell apoptosis	J:133572
	increased T cell number	J:133572
	thymus atrophy	J:133572
Tpp2^tm1.1Gnie/Tpp2^tm1.1Gnie (involves: 129S6/SvEvTac)	abnormal CD4-positive T cell differentiation	J:221205
	abnormal CD8-positive, alpha-beta T cell differentiation	J:221205
	abnormal lymphocyte physiology	J:221205
	decreased leukocyte cell number	J:221205
	enlarged spleen	J:221205
	increased B cell number	J:221205
	increased memory T cell number	J:221205
Tppp3^{em1(IMPC)Ccpcz}/Tppp3⁺ (C57BL/6NCrl-Tppp3^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
	increased CD4-positive NK T cell number	J:211773
	increased memory-marker CD4-positive NK T cell number	J:211773
Tppp^{tm1.1(KOMP)Vlcg}/Tppp^{tm1.1(KOMP)Vlcg} (C57BL/6N-Tppp^{tm1.1(KOMP)Vlcg}/J)	increased erythrocyte cell number	J:211773
	increased hematocrit	J:211773
	increased hemoglobin content	J:211773
Tpsab1^m1/Tpsab1^m1 (involves: C57BL/6J)	abnormal mast cell differentiation	J:142880
Tpsab1^m1/Tpsab1^m1 Tpsb2^tm1(cre)Adch/Tpsb2^tm1(cre)Adch (B6.Cg-Tpsb2^tm1(cre)Adch Tpsab1^m1)	abnormal mast cell differentiation	J:142880
Tpsb2^tm1.1Mfg/Tpsb2^tm1.1Mfg (B6.129-Tpsb2^tm1.1Mfg)	abnormal mast cell differentiation	J:142880
	impaired eosinophil recruitment	J:133373
	impaired neutrophil chemotaxis	J:142880
Tpx2^{Gt(D028B03)Wrst}/Tpx2⁺ (involves: 129S2/SvPas * C57BL/6J)	abnormal splenocyte morphology	J:184948
Tra2a^{tm2b(EUCOMM)Hmgu}/Tra2a⁺ (C57BL/6N-Tra2a^{tm2b(EUCOMM)Hmgu}/Bay)	increased basophil cell number	J:211773
Trabd2b^{em2(IMPC)Ccpcz}/Trabd2b^{em2(IMPC)Ccpcz} (C57BL/6N-Trabd2b^{em2(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Tradd^tm1.1Mak/Tradd^tm1.1Mak (either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * FVB/N))	abnormal spleen follicular dendritic cell network	J:138824
	absent spleen germinal center	J:138824
Tradd^tm1.1Mpa/Tradd^tm1.1Mpa (involves: BALB/cJ * C57BL/6)	abnormal spleen germinal center morphology	J:139030
Tradd^tm1.1Mpa/Tradd^tm1.1Mpa (involves: BALB/cJ * C57BL/6)	decreased IgG level	J:139030
Traf1^tm1Tsi/Traf1^tm1Tsi (involves: 129S4/SvJae * C57BL/6)	increased lymphocyte cell number	J:72327
Traf1^tm1Tsi/Traf1^tm1Tsi (involves: 129S4/SvJae * C57BL/6)	increased T cell proliferation	J:72327
Traf2^{tm1a(EUCOMM)Wtsi}/Traf2⁺ (C57BL/6N-Traf2^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased alpha-beta T cell number	J:211773
	decreased CD8-positive, alpha-beta T cell number	J:211773
Traf2^tm1Mak/Traf2^tm1Mak (either: (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * BALB/c * C57BL/6J))	absent spleen germinal center	J:44360
	decreased double-positive T cell number	J:44360
	decreased immature B cell number	J:44360
	decreased lymphocyte cell number	J:44360
	decreased thymocyte number	J:44360
	increased granulocyte number	J:44360
	increased thymocyte apoptosis	J:44360
	spleen atrophy	J:44360
	thymus atrophy	J:44360
Traf3^m1Btlr/Traf3^m1Btlr (C57BL/6J-Traf3^m1Btlr)	decreased mature B cell number	J:212064
Traf3^m2Btlr/Traf3^m2Btlr (C57BL/6J-Traf3^m2Btlr)	decreased IgG level	J:217797
Traf3^tm1Bal/Traf3^tm1Bal (involves: 129S4/SvJae * C57BL/6J)	abnormal B cell differentiation	J:37065
	abnormal T cell physiology	J:37065
	decreased double-positive T cell number	J:37065
	decreased leukocyte cell number	J:37065
	decreased thymocyte number	J:37065
	spleen hypoplasia	J:37065
Traf3^tm1Bshp/Traf3^tm1Bshp Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * SJL)	abnormal leukocyte morphology	J:124329
	abnormal spleen germinal center morphology	J:124329
	decreased B cell apoptosis	J:124329
	decreased T cell number	J:124329
	enlarged spleen	J:124329
	increased B cell number	J:124329
	increased follicular B cell number	J:124329
	increased IgA level	J:124329
	increased IgG2a level	J:124329
	increased IgG2b level	J:124329
	increased IgG3 level	J:124329
	increased IgG level	J:124329
	increased IgM level	J:124329
	increased marginal zone B cell number	J:124329
	increased spleen white pulp amount	J:124329
	increased transitional stage B cell number	J:124329
Traf3ip2^adjm/Traf3ip2^adjm (KOR-Traf3ip2^adjm)	increased IgE level	J:162859
Traf3ip2^adjm/Traf3ip2^adjm (A.KOR-Traf3ip2^adjm)	increased IgE level	J:162859
Traf3ip2^adjm/Traf3ip2^adjm (B6.KOR-Traf3ip2^adjm)	increased IgE level	J:162859
Traf3ip2^adjm/Traf3ip2^adjm (C.KOR-Traf3ip2^adjm)	increased IgE level	J:162859
Traf3ip2^adjm/Traf3ip2^adjm (AK.KOR-Traf3ip2^adjm)	increased IgE level	J:162859
Traf3ip2^tm1.1Lix/Traf3ip2^tm1.1Lix (involves: 129/Sv * BALB/c)	abnormal spleen B cell corona morphology	J:93923
	enlarged spleen	J:93923
	increased B cell number	J:93923
	increased dendritic cell number	J:93923
	increased IgE level	J:93923
	increased IgG level	J:93923
	increased immunoglobulin level	J:93923
Traf3ip2^tm1.1Lix/Traf3ip2^tm1.1Lix (C.129-Traf3ip2^tm1.1Lix)	increased follicular B cell number	J:138560
	increased marginal zone B cell number	J:138560
	increased transitional stage B cell number	J:138560
Traf3ip2^tm1.1Lix/Traf3ip2^tm1.1Lix (B6.129-Traf3ip2^tm1.1Lix)	abnormal transitional stage B cell morphology	J:187766
	enlarged spleen	J:187766
	increased B cell number	J:187766
	increased IgG1 level	J:187766
	increased IgG2c level	J:187766
	increased IgG level	J:187766
	increased immature B cell number	J:187766
	increased marginal zone B cell number	J:187766
	increased spleen weight	J:187766
	spleen hyperplasia	J:187766
Traf3ip2^tm1.1Lix/Traf3ip2^tm1.1Lix Tnfsf13b^tm1Msc/Tnfsf13b^tm1Msc (involves: 129 * 129S2/SvPas * BALB/c)	decreased B cell number	J:138560
	decreased follicular B cell number	J:138560
	decreased mature B cell number	J:138560
	decreased transitional stage B cell number	J:138560
	enlarged spleen	J:93923
Traf3ip2^tm1Lix/Traf3ip2^tm1.1Lix Tg(CD19-cre/ERT2)1Cgn/0 (involves: 129/Sv * BALB/c)	enlarged spleen	J:93923
	increased B cell number	J:93923
	increased dendritic cell number	J:93923
	increased immunoglobulin level	J:93923
Traf3ip2^tm1Sbn/Traf3ip2^tm1Sbn (either: B6.129-Traf3ip2^tm1Sbn or (involves: 129) or (involves: 129 * BALB/c))	impaired eosinophil recruitment	J:144320
	impaired macrophage chemotaxis	J:144320
	impaired neutrophil recruitment	J:144320
Traf3ip3^{tm1a(KOMP)Wtsi}/Traf3ip3^{tm1a(KOMP)Wtsi} (C57BL/6N-Traf3ip3^{tm1a(KOMP)Wtsi}/Wtsi)	decreased leukocyte cell number	J:175295
Traf3ip3^{tm1b(KOMP)Wtsi}/Traf3ip3^{tm1b(KOMP)Wtsi} (involves: BALB/cJ * C57BL/6N)	abnormal T cell differentiation	J:226431
	decreased CD4-positive, alpha-beta memory T cell number	J:226431
	decreased CD8-positive, alpha-beta memory T cell number	J:226431
	decreased regulatory T cell number	J:226431
	decreased T cell number	J:226431
	decreased thymocyte number	J:226431
	increased double-positive T cell number	J:226431
	increased gamma-delta T cell number	J:226431
Traf5^tm1Hna/Traf5^tm1Hna (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal B cell proliferation	J:57114
	abnormal T cell proliferation	J:57114
	decreased IgG1 level	J:57114
	decreased IgM level	J:57114
Traf6^tm1Jino/Traf6^tm1Jino (involves: 129P2/OlaHsd * C57BL/6)	abnormal osteoclast differentiation	J:77453
	decreased immature B cell number	J:77453
Traf6^tm1Mak/Traf6^tm1Mak (involves: 129P3/J)	abnormal macrophage physiology	J:54467
	abnormal osteoclast morphology	J:54467
	abnormal osteoclast physiology	J:54467
	decreased B cell proliferation	J:54467
	enlarged spleen	J:54467
	hypochromic anemia	J:54467
Traf6^tm1Ywc/Traf6^tm1Ywc (Not Specified)	abnormal dendritic cell differentiation	J:85808
	abnormal spleen morphology	J:85808
	absent spleen white pulp	J:85808
	decreased dendritic cell number	J:85808
	enlarged spleen	J:85808
	thymus atrophy	J:85808
Traf6^tm2Ywc/Traf6^tm2Ywc Tg(Cd4-cre)1Cwi/? (involves: C57BL/6 * DBA/2)	increased activated T cell number	J:130882
	increased memory T cell number	J:130882
Traj18^em1Hwata/Traj18^em1Hwata (C57BL/6-Traj18^em1Hwata)	absent NK T cells	J:256533
Traj18^em1Hwata/Traj18^em1Hwata (C.B6-Traj18^em1Hwata)	absent NK T cells	J:256533
Traj18^tm1.1Kro/Traj18^tm1.1Kro (involves: C57BL/6NTac)	absent NK T cells	J:232957
Traj33^em#Dig/Traj33^em#Dig (involves: C57BL/6)	decreased T cell number	J:276912
Trank1^em1(IMPC)J/Trank1^em1(IMPC)J (C57BL/6NJ-Trank1^em1(IMPC)J/Mmjax)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
Trap1^em1(IMPC)Mbp/Trap1^em1(IMPC)Mbp (C57BL/6N-Trap1^em1(IMPC)Mbp/MbpMmucd)	decreased monocyte cell number	J:211773
	thrombocytopenia	J:211773
Trap1^{Gt(E150H04)Wrst}/Trap1^{Gt(E150H04)Wrst} (involves: 129P2/OlaHsd * C57BL/6)	spleen hyperplasia	J:226880
Trappc1^em1(IMPC)Mbp/Trappc1⁺ (C57BL/6NCrl-Trappc1^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Trappc2l^em1(IMPC)Mbp/Trappc2l^em1(IMPC)Mbp (C57BL/6N-Trappc2l^em1(IMPC)Mbp/Ucd)	abnormal spleen morphology	J:211773
	decreased erythrocyte cell number	J:211773
	enlarged spleen	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
	increased mean platelet volume	J:211773
Trappc9^{tm1a(EUCOMM)Wtsi}/Trappc9^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Trappc9^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased CD11b-low dendritic cell number	J:211773
	decreased gamma-delta T cell number	J:211773
	decreased KLRG1-positive NK cell number	J:211773
	decreased mean corpuscular hemoglobin	J:211773
	increased CD11b-high dendritic cell number	J:211773
	increased Ly6C high monocyte number	J:211773
	increased Ly6C low monocyte number	J:211773
	increased mean platelet volume	J:211773
	increased monocyte cell number	J:211773
	increased red blood cell distribution width	J:211773
Trappc10^b2b2416Clo/Trappc10^b2b2416Clo (Trappc10^b2b2416Clo)	thymus hypoplasia	J:175213
Trappc10^{tm1b(KOMP)Wtsi}/Trappc10^{tm1b(KOMP)Wtsi} (C57BL/6N-Trappc10^{tm1b(KOMP)Wtsi}/Wtsi)	decreased mean corpuscular hemoglobin	J:211773
	increased mean platelet volume	J:211773
Trat1^tm1Lsmn/Trat1^tm1Lsmn (B6.129X1-Trat1^tm1Lsmn)	decreased bone marrow cell number	J:108406
	spleen hypoplasia	J:108406
	thymus hypoplasia	J:108406
Trbv13-2^tm1(CD2)Zhu/Trbv13-2^tm1(CD2)Zhu (involves: 129 * C57BL/6)	abnormal T cell differentiation	J:121608
Trbv13-2^tm1(CD2)Zhu/Trbv13-2^tm1(CD2)Zhu (involves: 129 * C57BL/6 * SJL)	abnormal T cell differentiation	J:121608
Trbv14^tm1Che/Trbv14^tm1Che (involves: 129S4/SvJae)	decreased T cell number	J:92288
Trbv14^tm2Che/Trbv14^tm2Che (involves: 129S4/SvJae)	decreased T cell number	J:92288
Trdmt1^{Gt(OST19279)Lex}/Trdmt1^{Gt(OST19279)Lex} (involves: 129S5/SvEvBrd * C57BL/6J)	decreased NK cell number	J:103485
Trdmt1^{tm1b(EUCOMM)Hmgu}/Trdmt1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Trdmt1^{tm1b(EUCOMM)Hmgu}/H)	decreased mean platelet volume	J:211773
Treh^em1(IMPC)H/Treh^em1(IMPC)H (C57BL/6N-Treh^em1(IMPC)H/H)	increased eosinophil cell number	J:211773
Trem1^tm1.1Ahoru/Trem1^tm1.1Ahoru (C57BL/6-Trem1^tm1.1Ahoru)	decreased monocyte cell number	J:191035
	decreased neutrophil cell number	J:191035
Trem2^em2Bwef/Trem2⁺ (involves: C57BL/6J * DBA/2J * FVB/N)	decreased macrophage cell number	J:242126
Trem2^em2Bwef/Trem2^em2Bwef (involves: C57BL/6J * DBA/2J * FVB/N)	decreased macrophage cell number	J:242126
	decreased macrophage proliferation	J:242126
	decreased microglial cell activation	J:242126
	impaired macrophage phagocytosis	J:242126
	increased macrophage apoptosis	J:242126
Trem2^{tm1(KOMP)Vlcg}/Trem2^{tm1(KOMP)Vlcg} (C57BL/6N-Trem2^{tm1(KOMP)Vlcg})	abnormal microglial cell physiology	J:239381
	decreased microglial cell activation	J:239381
Treml1^tm1Mcvic/Treml1^tm1Mcvic (C57BL/6-Treml1^tm1Mcvic)	decreased platelet aggregation	J:150578
Treml1^tm1Mcvic/Treml1^tm1Mcvic (C57BL/6-Treml1^tm1Mcvic)	thrombocytopenia	J:150578
Trex1^em3Gpt/Trex1^em3Gpt (C57BL/6JGpt-Trex1^em3Gpt)	enlarged spleen	J:330879
Trex1^em3Gpt/Trex1^em3Gpt (C57BL/6JGpt-Trex1^em3Gpt)	increased spleen weight	J:330879
Trex1^tm1.1Fwpe/Trex1⁺ (involves: 129S1/SvImJ * 129S4/SvJae * 129S6/SvEvTac)	increased CD4-positive, alpha-beta T cell number	J:220965
Trex1^tm1.1Fwpe/Trex1^tm1.1Fwpe (involves: 129S1/SvImJ * 129S4/SvJae * 129S6/SvEvTac)	abnormal T cell activation	J:220965
	enlarged spleen	J:220965
	increased B cell number	J:220965
	increased CD4-positive, alpha-beta T cell number	J:220965
	increased IgG level	J:220965
	increased plasma cell number	J:220965
	increased regulatory T cell number	J:220965
	increased spleen weight	J:220965
	increased splenocyte number	J:220965
Trex1^tm1Tld/Trex1^tm1Tld (involves: 129P2/OlaHsd)	abnormal spleen marginal zone morphology	J:92264
	enlarged spleen	J:92264
	increased spleen B cell follicle size	J:92264
	thymus cortex hypoplasia	J:92264
Trex1^tm1Tld/Trex1^tm1Tld (involves: 129P2/OlaHsd * C57BL/6)	increased IgG level	J:181257
Trf^em1(IMPC)J/Trf⁺ (C57BL/6NJ-Trf^em1(IMPC)J/Mmjax)	increased mean corpuscular hemoglobin	J:211773
Trf^{em1(IMPC)Rbrc}/Trf⁺ (C57BL/6NJcl-Trf^{em1(IMPC)Rbrc}/Rbrc)	abnormal mean corpuscular hemoglobin	J:211773
Trf^hpx/Trf⁺ (BALB/cJ-Trf^hpx)	hematopoietic system phenotype	J:64456
Trf^hpx/Trf^hpx (BALB/cJ-Trf^hpx)	abnormal reticulocyte morphology	J:8936
	anisocytosis	J:8936
	decreased erythrocyte cell number	J:8936
	decreased hematocrit	J:8936
	decreased hemoglobin content	J:8936
	decreased mean corpuscular hemoglobin concentration	J:64456, J:8936
	decreased mean corpuscular volume	J:8936
	hypochromic anemia	J:64456, J:8936
	poikilocytosis	J:8936
	spherocytosis	J:8936
Trgc1^tm1.2Dhr/Trgc1^tm1.2Dhr (either: 129S4/SvJae or (involves: 129S4/SvJae * C57BL/6))	decreased gamma-delta T cell number	J:91304
Tria4^STS/A/? (involves: BALB/c * STS/A)	abnormal leukocyte physiology	J:56029
Tria5^STS/A/? (involves: BALB/cHeA * STS/A)	abnormal leukocyte physiology	J:56029
Trib1^tm1Aki/Trib1^tm1Aki (involves: 129P2/OlaHsd)	abnormal common myeloid progenitor cell morphology	J:196449
	abnormal spleen red pulp morphology	J:196449
	decreased eosinophil cell number	J:196449
	decreased macrophage cell number	J:196449
	decreased spleen iron level	J:196449
	increased neutrophil cell number	J:196449
Trib2^{Tg(Thy1-Trh/APP)2.1Ingm}/Trib2⁺ Tg(Thy1-APP)2.2Ingm/0 (involves: C57BL/6 * DBA/1)	microgliosis	J:176575
Trib2^{Tg(Thy1-Trh/APP)2.1Ingm}/Trib2^{Tg(Thy1-Trh/APP)2.1Ingm} (involves: C57BL/6 * DBA/1)	microgliosis	J:176575
Trib2^tm1Lex/Trib2^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	decreased B cell number	J:82809
	increased CD8-positive, alpha-beta T cell number	J:82809
Trib2^tm1Myam/Trib2^tm1Myam (involves: 129X1/SvJ * C57BL/6)	hematopoietic system phenotype	J:196449
Trib3^tm1Myam/Trib3^tm1Myam (involves: 129X1/SvJ * C57BL/6)	hematopoietic system phenotype	J:196449
Trib3^tm1Tord/Trib3^tm1Tord (involves: C57BL/6)	abnormal mast cell physiology	J:192615
Trib3^tm1Tord/Trib3^tm1Tord (involves: C57BL/6)	decreased mast cell degranulation	J:192615
Trim8^{em1(IMPC)Wtsi}/Trim8^{em1(IMPC)Wtsi} (C57BL/6N-Trim8^{em1(IMPC)Wtsi}/Wtsi)	increased mean corpuscular hemoglobin	J:211773
Trim8^tm1Hbsh/Trim8^tm1Hbsh (involves: 129S6/SvEvTac)	increased macrophage cytokine production	J:251270
Trim9^{em1(IMPC)Ccpcz}/Trim9^{em1(IMPC)Ccpcz} (C57BL/6N-Trim9^{em1(IMPC)Ccpcz}/Ccpcz)	decreased effector memory T-helper cell number	J:211773
	decreased spleen weight	J:211773
Trim13^em1(IMPC)Tcp/Trim13^em1(IMPC)Tcp (C57BL/6N-Trim13^em1(IMPC)Tcp/Tcp)	enlarged thymus	J:211773
Trim16^em1(IMPC)Tcp/Trim16^em1(IMPC)Tcp (C57BL/6NCrl-Trim16^em1(IMPC)Tcp/Tcp)	increased red blood cell distribution width	J:211773
Trim21^tm1Hm/Trim21^tm1Hm (involves: C57BL/6)	abnormal bone marrow cell morphology/development	J:149298
Trim21^tm1Mwah/Trim21^tm1Mwah (C57BL/6-Trim21^tm1Mwah)	abnormal T cell activation	J:151775
Trim21^tm1Mwah/Trim21^tm1Mwah (C57BL/6-Trim21^tm1Mwah)	enlarged spleen	J:151775
Trim27^{Gt(345D11)Cmhd}/Trim27^{Gt(345D11)Cmhd} (B6.129-Trim27^{Gt(345D11)Cmhd})	abnormal T-helper 1 physiology	J:180433
	abnormal T-helper 2 physiology	J:180433
Trim30a^tm1Yjk/Trim30a^tm1Yjk (B6.129P2-Trim30a^tm1Yjk)	abnormal CD4-positive, alpha-beta T cell physiology	J:215171
	abnormal T cell subpopulation ratio	J:215171
	increased CD4-positive, alpha-beta T cell number	J:215171
	increased T cell proliferation	J:215171
Trim31^em1Cya/Trim31^em1Cya (involves: C57BL/6)	increased Ly6C high monocyte number	J:243237
Trim31^em1Cya/Trim31^em1Cya (involves: C57BL/6)	increased neutrophil cell number	J:243237
Trim35^em1Smoc/Trim35^em1Smoc (C57BL/6J-Trim35^em1Smoc)	decreased macrophage cytokine production	J:303214
Trim37^{Gt(RRO307)Byg}/Trim37^{Gt(RRO307)Byg} (B6J.129P2-Trim37^{Gt(RRO307)Byg})	enlarged spleen	J:232482
Trim39^{tm1b(EUCOMM)Hmgu}/Trim39^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Trim39^{tm1b(EUCOMM)Hmgu}/H)	increased large unstained cell number	J:211773
	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
Trim40^em1Caox/Trim40^em1Caox (involves: C57BL/6J)	abnormal macrophage physiology	J:255265
Trim46^em1(IMPC)J/Trim46^em1(IMPC)J (C57BL/6NJ-Trim46^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Trim50^{tm1b(KOMP)Wtsi}/Trim50^{tm1b(KOMP)Wtsi} (C57BL/6N-Trim50^{tm1b(KOMP)Wtsi}/BayMmucd)	decreased spleen weight	J:211773
Trim56^{tm1a(EUCOMM)Wtsi}/Trim56^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Trim56^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased regulatory T cell number	J:211773
Trim58^em1(IMPC)Mbp/Trim58^em1(IMPC)Mbp (C57BL/6N-Trim58^em1(IMPC)Mbp/MbpMmucd)	increased mean corpuscular volume	J:211773
Trim66^{tm1a(EUCOMM)Wtsi}/Trim66^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Trim66^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased mean corpuscular hemoglobin	J:175295
Trio^em1(IMPC)H/Trio⁺ (C57BL/6NTac-Trio^em1(IMPC)H/H)	increased neutrophil cell number	J:211773
Trip6^{tm1b(EUCOMM)Hmgu}/Trip6⁺ (C57BL/6N-Trip6^{tm1b(EUCOMM)Hmgu}/Bay)	enlarged spleen	J:211773
Trip10^tm1.1Geha/Trip10^tm1.1Geha (B6.129S1-Trip10^tm1.1Geha)	abnormal spleen germinal center morphology	J:164363
	abnormal T cell physiology	J:164363
	decreased IgE level	J:164363
	decreased IgG level	J:164363
	decreased spleen germinal center number	J:164363
	decreased spleen germinal center size	J:164363
Trip13^{tm1.1(KOMP)Vlcg}/Trip13^{tm1.1(KOMP)Vlcg} (C57BL/6N-Trip13^{tm1.1(KOMP)Vlcg}/Ucd)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	increased leukocyte cell number	J:211773
	increased mean corpuscular hemoglobin	J:211773
Trmq1^C57BL/6J/Trmq1^DBA/2J (involves: C57BL/6J * DBA/2J)	abnormal CD4-positive, alpha beta T cell morphology	J:77603
Trmq1^DBA/2J/Trmq1^DBA/2J (involves: C57BL/6J * DBA/2J)	abnormal CD4-positive, alpha beta T cell morphology	J:77603
Trmq2^C57BL/6J/Trmq2^C57BL/6J (involves: C57BL/6J * DBA/2J)	abnormal CD4-positive, alpha beta T cell morphology	J:77603
Trmq2^C57BL/6J/Trmq2^DBA/2J (involves: C57BL/6J * DBA/2J)	abnormal CD4-positive, alpha beta T cell morphology	J:77603
Trmq3^DBA/1J/Trmq3^FVB/N (involves: DBA/1J * FVB/N)	abnormal CD4-positive, alpha beta T cell morphology	J:116665
Trmq3^FVB/N/? (involves: DBA/1J * FVB/N)	abnormal CD4-positive, alpha beta T cell morphology	J:94347
Trmq3^FVB/N/? (involves: DBA/1J * FVB/N)	abnormal T cell proliferation	J:94347
Trmq3^FVB/N/Trmq3^FVB/N (involves: DBA/1J * FVB/N)	abnormal CD4-positive, alpha beta T cell morphology	J:116665
Trmq4^RIIIS/J/Trmq4^RIIIS/J Trmq5^RIIIS/J/Trmq5^RIIIS/J (involves: B10.RIII * RIIIS/J)	abnormal CD4-positive, alpha beta T cell morphology	J:95848
Trmt1^{tm1b(EUCOMM)Hmgu}/Trmt1⁺ (C57BL/6N-Trmt1^{tm1b(EUCOMM)Hmgu}/Ics)	increased mean corpuscular volume	J:211773
Trmt2a^{tm2b(EUCOMM)Wtsi}/Trmt2a^{tm2b(EUCOMM)Wtsi} (C57BL/6N-Trmt2a^{tm2b(EUCOMM)Wtsi}/Wtsi)	decreased leukocyte cell number	J:211773
Trnt1^{tm1a(EUCOMM)Hmgu}/Trnt1⁺ (Not Specified)	decreased mean corpuscular hemoglobin concentration	J:165965
Trp53^tm1.1Awbr/Trp53^tm1.1Awbr (involves: C57BL/6)	decreased thymocyte apoptosis	J:173271
Trp53^tm1.1Awbr/Trp53^tm1.1Awbr (involves: C57BL/6)	increased pro-B cell number	J:169434
Trp53^tm1.1Manf/Trp53^tm1.1Manf (Not Specified)	abnormal definitive hematopoiesis	J:201153
	abnormal spleen morphology	J:201153
	abnormal spleen white pulp morphology	J:201153
	abnormal thymus morphology	J:201153
	anemia	J:201153
	decreased bone marrow cell number	J:201153
	decreased hematopoietic stem cell proliferation	J:201153
	decreased neutrophil cell number	J:201153
	extramedullary hematopoiesis	J:201153
	small spleen	J:201153
	small thymus	J:201153
	thrombocytopenia	J:201153
Trp53^tm1.1Manf/Trp53^tm1.1Manf (involves: C57BL/6J)	abnormal definitive hematopoiesis	J:201153
	abnormal spleen morphology	J:201153
	abnormal spleen white pulp morphology	J:201153
	abnormal thymus morphology	J:201153
	anemia	J:201153
	decreased bone marrow cell number	J:201153
	decreased hematopoietic stem cell proliferation	J:201153
	decreased neutrophil cell number	J:201153
	extramedullary hematopoiesis	J:201153
	small spleen	J:201153
	small thymus	J:201153
	thrombocytopenia	J:201153
Trp53^tm1.1Thst/Trp53⁺ (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)	spleen hyperplasia	J:198482
Trp53^tm1.1Thst/Trp53^tm1.1Thst (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)	decreased thymocyte apoptosis	J:198482
	spleen hyperplasia	J:198482
Trp53^tm1.1Tldo/Trp53^tm1.1Tldo (involves: 129S2/SvPas * BALB/c * C57BL/6)	decreased bone marrow cell number	J:199308
	increased thymocyte apoptosis	J:199308
	pancytopenia	J:199308
Trp53^tm1.1Wgu/Trp53^tm1.1Wgu (involves: 129S6/SvEvTac * C57BL/6)	decreased thymocyte apoptosis	J:186159
Trp53^tm1.2Awbr/Trp53⁺ (involves: C57BL/6)	abnormal lymphocyte morphology	J:173271
Trp53^tm1.2Awbr/Trp53⁺ (involves: C57BL/6)	extramedullary hematopoiesis	J:173271
Trp53^tm1.2Awbr/Trp53^tm1.2Awbr (involves: C57BL/6)	abnormal common myeloid progenitor cell morphology	J:173271
	abnormal lymphocyte morphology	J:173271
	decreased thymocyte apoptosis	J:173271
	enlarged spleen	J:173271
	extramedullary hematopoiesis	J:173271
	increased splenocyte proliferation	J:173271
Trp53^{tm1b(EUCOMM)Hmgu}/Trp53^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Trp53^{tm1b(EUCOMM)Hmgu}/H)	increased large unstained cell number	J:211773
Trp53^tm1Brd/Trp53^tm1Brd (involves: 129S7/SvEvBrd)	abnormal thymus physiology	J:175018
Trp53^tm1Brd/Trp53^tm1Brd (involves: 129S7/SvEvBrd)	decreased thymocyte apoptosis	J:186159
Trp53^tm1Brd/Trp53^tm1Brd Trp73^tm2Mak/Trp73^tm2Mak (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J)	decreased thymocyte apoptosis	J:157905
Trp53^tm1Brd/Trp53^tm8Xu (involves: 129S7/SvEvBrd)	anemia	J:170216
	decreased bone marrow cell number	J:170216
	decreased hematopoietic stem cell number	J:170216
	decreased leukocyte cell number	J:170216
Trp53^tm1Glo/Trp53^tm1Glo (involves: 129S7/SvEvBrd * C57BL/6J)	decreased thymocyte apoptosis	J:172038
Trp53^tm1Holl/Trp53^tm7.1Xu (involves: 129P2/OlaHsd)	decreased thymocyte apoptosis	J:160414
Trp53^tm1Ldo/Trp53⁺ (involves: 129S7/SvEvBrd * C57BL/6)	decreased spleen weight	J:73757
Trp53^tm1Ldo/Trp53⁺ (involves: 129S7/SvEvBrd * C57BL/6)	spleen hypoplasia	J:73757
Trp53^tm1Sia/Trp53^tm1Sia (involves: C57BL/6NCrlj * CBA/JNCrlj)	increased leukocyte cell number	J:233347
	increased spleen weight	J:233347
	increased thymus weight	J:233347
	thrombocytopenia	J:233347
Trp53^tm1Thst/Trp53⁺ (involves: 129S1/Sv * 129X1/SvJ)	spleen hyperplasia	J:198482
Trp53^tm1Thst/Trp53^tm1.1Thst (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)	spleen hyperplasia	J:198482
Trp53^tm1Thst/Trp53^tm1Thst (involves: 129S1/Sv * 129X1/SvJ)	decreased thymocyte apoptosis	J:198482
Trp53^tm1Tyj/Trp53⁺ (involves: 129S2/SvPas)	abnormal hematopoietic system physiology	J:158953
Trp53^tm1Tyj/Trp53⁺ (involves: 129S2/SvPas)	decreased thymocyte apoptosis	J:158953
Trp53^tm1Tyj/Trp53⁺ (involves: 129S2/SvPas * C57BL/6 * CBA)	decreased thymocyte apoptosis	J:80311
Trp53^tm1Tyj/Trp53^tm1.1Umol (involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6 * C57BL/6NTac)	increased hematopoietic stem cell number	J:228632
Trp53^tm1Tyj/Trp53^tm1Tyj (involves: 129S2/SvPas)	decreased splenocyte apoptosis	J:195018
	decreased T cell apoptosis	J:109354
	decreased thymocyte apoptosis	J:158953, J:195018, J:126920
Trp53^tm1Tyj/Trp53^tm1Tyj (involves: 129S2/SvPas * C57BL/6 * CBA)	decreased thymocyte apoptosis	J:80311
Trp53^tm1Tyj/Trp53^tm1Tyj Xrcc4^tm1Fwa/Xrcc4^tm1Fwa (involves: 129P2/OlaHsd * 129S2/SvPas)	abnormal lymphopoiesis	J:61973
Trp53^tm1Tyj/Trp53^tm2.1Umol (involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6 * C57BL/6NTac)	increased hematopoietic stem cell number	J:228632
Trp53^tm1Xu/Trp53^tm1Xu (involves: 129S4/SvJae)	abnormal thymocyte apoptosis	J:86185
Trp53^tm1Yjc/Trp53^tm1Yjc (B6.129S1-Trp53^tm1Yjc)	abnormal spleen marginal zone morphology	J:195018
	abnormal spleen white pulp morphology	J:195018
	decreased splenocyte apoptosis	J:195018
	enlarged spleen	J:195018
Trp53^tm2.1Snj/Trp53^tm2.1Snj (involves: 129S4/SvJae * C57BL/6)	abnormal thymus physiology	J:175018
Trp53^tm2.1Wgu/Trp53^tm2.1Wgu (involves: 129S6/SvEvTac * C57BL/6)	decreased thymocyte apoptosis	J:186159
Trp53^tm2Wahl/Trp53^tm2Wahl (involves: 129S4/SvJae * C57BL/6)	abnormal definitive hematopoiesis	J:174375
	abnormal hematopoietic stem cell physiology	J:174375
	abnormal megakaryocyte progenitor cell morphology	J:174375
	decreased bone marrow cell number	J:174375
	decreased common myeloid progenitor cell number	J:174375
	decreased erythrocyte cell number	J:174375
	decreased erythroid progenitor cell number	J:174375
	decreased hematocrit	J:174375
	decreased leukocyte cell number	J:174375
	decreased spleen red pulp amount	J:174375
	thrombocytopenia	J:174375
Trp53^tm2Xu/Trp53^tm2Xu (involves: 129S6/SvEvTac)	decreased T cell apoptosis	J:109354
Trp53^tm2Xu/Trp53^tm2Xu (involves: 129S6/SvEvTac)	decreased T cell proliferation	J:109354
Trp53^tm3.1Glo/Trp53⁺ (B6.129S7-Trp53^tm3.1Glo)	extramedullary hematopoiesis	J:317504
	hepatosplenomegaly	J:317504
	increased leukocyte cell number	J:317504
	macrocytic anemia	J:317504
Trp53^tm3.1Holl/Trp53^tm3.1Holl (Not Specified)	increased thymocyte apoptosis	J:191183
Trp53^tm7.1Xu/Trp53⁺ (Not Specified)	abnormal thymus physiology	J:160414
Trp53^tm7.1Xu/Trp53^tm7.1Xu (Not Specified)	abnormal thymus physiology	J:160414
Trp53^tm7.1Xu/Trp53^tm7.1Xu (Not Specified)	decreased thymocyte apoptosis	J:160414
Trp53bp1^{Gt(OST94324)Lex}/Trp53bp1^{Gt(OST94324)Lex} (involves: 129S5/SvEvBrd)	abnormal T cell differentiation	J:83164
	decreased mature B cell number	J:83164
	decreased T cell number	J:83164
	small thymus	J:83164
	thymus hypoplasia	J:83164
Trp53bp1^m2Btlr/Trp53bp1^m2Btlr (C57BL/6J-Trp53bp1^m2Btlr)	decreased B cell number	J:254841
	decreased CD8-positive, naive alpha-beta T cell number	J:254841
	decreased IgD level	J:254841
	decreased IgG level	J:254841
	increased central memory CD4-positive, alpha-beta T cell number	J:254841
Trp53bp1^m3Btlr/Trp53bp1^m3Btlr (C57BL/6J-Trp53bp1^m3Btlr)	decreased IgD level	J:254848
Trp53bp1^m4Btlr/Trp53bp1^m4Btlr (C57BL/6J-Trp53bp1^m4Btlr)	decreased IgD level	J:254852
Trp53bp1^m5Btlr/Trp53bp1^m5Btlr (C57BL/6J-Trp53bp1^m5Btlr)	decreased IgD level	J:272848
Trp53bp1^tm1Jc/Trp53bp1^tm1Jc (involves: 129 * C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:82512
	increased double-negative T cell number	J:82512
	thymus hypoplasia	J:82512
Trp53bp1^tm1Jc/Trp53bp1^tm1Jc (involves: 129)	abnormal class switch recombination	J:194603, J:231089, J:307190
Trp53bp2^{tm1b(EUCOMM)Hmgu}/Trp53bp2⁺ (C57BL/6N-Trp53bp2^{tm1b(EUCOMM)Hmgu}/H)	increased hemoglobin content	J:211773
Trp53bp2^tm1Cdlo/Trp53bp2⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal T cell physiology	J:146764
Trp53bp2^tm1Xlu/Trp53bp2^tm1Xlu (C.129S6-Trp53bp2^tm1Xlu)	small thymus	J:240594
Trp73^em1(IMPC)H/Trp73⁺ (C57BL/6NTac-Trp73^em1(IMPC)H/H)	decreased spleen weight	J:211773
	increased eosinophil cell number	J:211773
	thrombocytosis	J:211773
Trp73^tm2Mak/Trp73^tm2Mak (either: B6.129P2-Trp73^tm2Mak or (involves: 129P2/OlaHsd * C57BL/6J))	increased thymocyte apoptosis	J:157905
Trpc1^em1(IMPC)H/Trpc1^em1(IMPC)H (C57BL/6N-Trpc1^em1(IMPC)H/H)	increased spleen weight	J:211773
Trpc2^tm1Dlc/Trpc2^tm1Dlc (involves: 129S1/Sv)	abnormal erythroblast morphology	J:189490
	abnormal erythrocyte physiology	J:189490
	decreased mean corpuscular hemoglobin concentration	J:189490
	increased hematocrit	J:189490
	increased mean corpuscular volume	J:189490
Trpc2^tm1Dlc/Trpc2^tm1Dlc Trpc3^tm1.1Bmil/Trpc3^tm1.1Bmil (involves: 129S1/Sv * FVB/N)	abnormal erythroblast morphology	J:189490
	abnormal erythrocyte physiology	J:189490
	decreased mean corpuscular hemoglobin concentration	J:189490
	increased hematocrit	J:189490
	increased mean corpuscular volume	J:189490
Trpc3^tm1.1Bmil/Trpc3^tm1.1Bmil (involves: FVB/N)	hematopoietic system phenotype	J:189490
Trpm2^tm1Lhj/Trpm2^tm1Lhj (Not Specified)	abnormal macrophage morphology	J:202791
Trpm2^tm1Lhj/Trpm2^tm1Lhj (Not Specified)	abnormal macrophage physiology	J:202791
Trpm2^tm1Yamo/Trpm2^tm1Yamo (involves: 129S4/SvJae * C57BL/6J)	abnormal leukocyte physiology	J:137676
	abnormal macrophage physiology	J:137676
	impaired neutrophil recruitment	J:137676
Trpm4^tm1.1Knt/Trpm4^tm1.1Knt (Not Specified)	decreased dendritic cell number	J:140991
Trpm4^tm1.1Knt/Trpm4^tm1.1Knt Trpm5^tm1Csz/Trpm5^tm1Csz (involves: 129S1/Sv * 129X1/SvJ)	decreased dendritic cell number	J:140991
Trpm6^{tm1b(KOMP)Wtsi}/Trpm6⁺ (C57BL/6N-Trpm6^{tm1b(KOMP)Wtsi}/Orl)	decreased mean corpuscular volume	J:211773
Trpm7^tm1Agry/Trpm7⁺ (involves: 129)	decreased erythrocyte magnesium level	J:205665
Trpm7^{tm1b(KOMP)Wtsi}/Trpm7⁺ (C57BL/6N-Trpm7^{tm1b(KOMP)Wtsi}/H)	thrombocytosis	J:211773
Trpm7^tm1Clph/Trpm7^tm1.1Clph Tg(Lck-cre)548Jxm/0 (involves: 129S4/SvJae * C57BL/6 * CBA)	abnormal T cell differentiation	J:140630
	abnormal T cell physiology	J:140630
	abnormal thymus cell ratio	J:140630
	abnormal thymus corticomedullary boundary morphology	J:140630
	abnormal thymus medulla morphology	J:140630
	abnormal thymus morphology	J:140630
	decreased T cell number	J:140630
	decreased thymocyte number	J:140630
Trpv2^tm1Mijc/Trpv2^tm1Mijc (involves: 129S6/SvEvTac * C57BL/6)	impaired macrophage chemotaxis	J:158505
	impaired macrophage phagocytosis	J:158505
Trpv5^tm1Bind/Trpv5^tm1Bind (involves: 129 * C57BL/6)	increased osteoclast cell number	J:86949
Trrap^{tm1a(EUCOMM)Wtsi}/Trrap⁺ (B6JTyr;B6N-Trrap^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased mean corpuscular volume	J:175295
Trub1^{tm1b(EUCOMM)Hmgu}/Trub1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Trub1^{tm1b(EUCOMM)Hmgu}/Bay)	thrombocytosis	J:211773
Try10^em1(IMPC)J/Try10^em1(IMPC)J (C57BL/6NJ-Try10^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Ts(16C-tel)1Cje/0 (involves: C57BL/6J * Rb(11.16)2H * Rb(16.17)32Lub)	abnormal spleen B cell follicle morphology	J:174270
	abnormal spleen B cell follicle shape	J:241597
	abnormal spleen red pulp morphology	J:174270
	increased spleen B cell follicle size	J:241597
Ts(17¹⁶)65Dn/0 (involves: C3H/HeJ * C57BL/6J * DBA/2J)	abnormal spleen B cell follicle morphology	J:174270
	abnormal spleen B cell follicle shape	J:174270
	abnormal spleen red pulp morphology	J:174270
	increased spleen B cell follicle size	J:174270
Tsc2^tm2.2Djk/Tsc2^tm2.2Djk (involves: 129S4/SvJae * C57BL/6)	abnormal embryonic hematopoiesis	J:149326
Tsc22d1^tm1Clgr/Tsc22d1^tm1Clgr (B6.129P2-Tsc22d1^tm1Clgr)	abnormal bone marrow cell physiology	J:148897
Tsc22d3^tm1.2Efmd/Y (Not Specified)	abnormal T cell subpopulation ratio	J:201728
Tsc22d3^tm1.2Hum/Y (involves: 129S1/SvImJ)	abnormal thymus cell ratio	J:223992
	decreased DN3 thymocyte number	J:223992
	decreased thymus weight	J:223992
	increased DN4 thymocyte number	J:223992
	increased erythroblast number	J:223992
Tshr^hyt/Tshr^hyt (CBy.RF-Tshr^hyt/J)	decreased B cell number	J:111014
Tshr^hyt/Tshr^hyt (CBy.RF-Tshr^hyt/J)	increased pro-B cell number	J:111014
Tshr^hyt/Tshr^hyt (involves: BALB/cByJ * RF/J)	anemia	J:6479
Tsil^{Tg(Myc)12ALvn}/Tsil^{Tg(Myc)12ALvn} (involves: C57BL/6 * SJL/J)	increased double-positive T cell number	J:33857
tsl/tsl (B6NTacTcu.CByJNarl-tsl)	abnormal hemopoiesis	J:275934
tsl/tsl (CByJNarl(B6NTacTcu)-tsl)	abnormal hemopoiesis	J:275934
Tslp^{tm1(KOMP)Vlcg}/Tslp^{tm1(KOMP)Vlcg} (involves: C57BL/6 * C57BL/6NTac)	abnormal immunoglobulin level	J:187770
	abnormal T-helper 2 cell differentiation	J:187770
Tslp^tm1.1Pcn/Tslp^tm1.1Pcn Tg(KRT14-cre)1Ipc/0 (involves: 129 * C57BL/6 * SJL)	decreased eosinophil cell number	J:146511
	decreased IgE level	J:146511
	decreased lymphocyte cell number	J:146511
Tslp^tm1Sfz/Tslp^tm1Sfz (involves: 129)	abnormal T-helper 2 physiology	J:197193
Tsn^{Gt(OST63223)Lex}/Tsn^{Gt(OST63223)Lex} (involves: 129S5/SvEvBrd * C57BL/6J)	hematopoietic system phenotype	J:85466
Tsn^tm1Jmat/Tsn^tm1Jmat (involves: 129/Sv * C57BL/6)	abnormal definitive hematopoiesis	J:222381
Tspan2^tm1Hbw/Tspan2^tm1Hbw (C57BL/6-Tspan2^tm1Hbw)	microgliosis	J:201143
Tspan3^{Gt(NPX312)Byg}/Tspan3^{Gt(NPX312)Byg} (involves: 129P2/OlaHsd * C57BL/6)	decreased hematopoietic stem cell number	J:231800
Tspan9^em1Tshu/Tspan9^em1Tshu (C57BL/6-Tspan9^em1Tshu)	abnormal macrophage morphology	J:307067
	abnormal neutrophil morphology	J:307067
	decreased neutrophil cell number	J:307067
Tspan18^{tm1.1(KOMP)Vlcg}/Tspan18^{tm1.1(KOMP)Vlcg} (C57BL/6N-Tspan18^{tm1.1(KOMP)Vlcg}/J)	increased mean corpuscular hemoglobin	J:211773
Tspan32^em1(IMPC)Mbp/Tspan32^em1(IMPC)Mbp (C57BL/6N-Tspan32^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	decreased mean corpuscular volume	J:211773
	enlarged spleen	J:211773
Tspan32^{Gt(pMS-1)1Jmt}/Tspan32^{Gt(pMS-1)1Jmt} (involves: 129S1/Sv)	increased T cell proliferation	J:78033
Tspan33^tm1Stsa/Tspan33^tm1Stsa (involves: 129S1/Sv * 129X1/SvJ)	abnormal erythrocyte morphology	J:143158
	abnormal spleen morphology	J:143158
	abnormal splenic cell ratio	J:143158
	anemia	J:143158
	decreased erythrocyte cell number	J:143158
	decreased hematocrit	J:143158
	enlarged spleen	J:143158
	extramedullary hematopoiesis	J:143158
	increased monocyte cell number	J:143158
	leptocytosis	J:143158
	macrocytosis	J:143158
	reticulocytosis	J:143158
	thrombocytopenia	J:143158
Tspo2^em1Muti/Tspo2⁺ (C57BL/6-Tspo2^em1Muti)	abnormal erythroblast morphology	J:292525
	decreased erythrocyte cell number	J:292525
	hematopoietic system phenotype	J:292525
Tspo2^em1Muti/Tspo2^em1Muti (C57BL/6-Tspo2^em1Muti)	abnormal erythroblast morphology	J:292525
	decreased erythrocyte cell number	J:292525
	decreased hematocrit	J:292525
	decreased hemoglobin content	J:292525
	hematopoietic system phenotype	J:292525
	increased erythrocyte sodium:potassium-exchanging ATPase activity	J:292525
	reticulocytosis	J:292525
Tspo^tm1.1Guwu/Tspo^tm1.1Guwu (involves: C57BL/6)	hematopoietic system phenotype	J:219189
Tspo^tm1.1Guwu/Tspo^tm1.1Guwu (involves: C57BL/6)	increased NK cell number	J:219189
Tssk5^{tm1.1(KOMP)Vlcg}/Tssk5^{tm1.1(KOMP)Vlcg} (C57BL/6N-Tssk5^{tm1.1(KOMP)Vlcg}/J)	decreased leukocyte cell number	J:211773
Tst^{tm1(KOMP)Vlcg}/Tst^{tm1(KOMP)Vlcg} (C57BL/6N-Tst^{tm1(KOMP)Vlcg}/Ucd)	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
Tst^{tm1.1(KOMP)Vlcg}/Tst^{tm1.1(KOMP)Vlcg} (C57BL/6N-Tst^{tm1.1(KOMP)Vlcg}/Ucd)	increased mean corpuscular volume	J:211773
Tstd1^em1(IMPC)J/Tstd1^em1(IMPC)J (C57BL/6NJ-Tstd1^em1(IMPC)J/Mmjax)	increased erythrocyte cell number	J:211773
	increased hematocrit	J:211773
	increased leukocyte cell number	J:211773
Ttc7^fsn-Jic/Ttc7^fsn-Jic (B6.INT-Ttc7^fsn-Jic)	anemia	J:115742
Ttc7^fsn-Jic/Ttc7^fsn-Jic (B6.INT-Ttc7^fsn-Jic)	increased fetal derived definitive erythrocyte cell number	J:115742
Ttc7^fsn-Jic/Ttc7^fsn-Jic (CBy.INT-Ttc7^fsn-Jic)	anemia	J:115742
Ttc7^fsn-Jic/Ttc7^fsn-Jic (C3.INT-Ttc7^fsn-Jic)	abnormal erythrocyte morphology	J:115742
	acanthocytosis	J:115742
	anemia	J:115742
	dacryocytosis	J:115742
	decreased hematocrit	J:115742
	decreased spleen white pulp amount	J:115742
	decreased thymus weight	J:115742
	extramedullary hematopoiesis	J:115742
	increased nucleated erythrocyte cell number	J:115742
	increased spleen red pulp amount	J:115742
	increased spleen weight	J:115742
	low mean erythrocyte cell number	J:115742
	thrombocytosis	J:115742
Ttc7^fsn/Ttc7^fsn (CByJ.A-Ttc7^fsn)	abnormal erythropoiesis	J:92699
	anemia	J:30519, J:92699
	decreased hematocrit	J:92699
	decreased hemoglobin content	J:92699
	decreased mean corpuscular volume	J:92699
	enlarged spleen	J:29200, J:30519
	extramedullary hematopoiesis	J:92699
	low mean erythrocyte cell number	J:92699
	small thymus	J:29200
	thymus cortex hypoplasia	J:29200
Ttc7^fsn/Ttc7^fsn (involves: A/J)	anemia	J:2777
Ttc7^fsn/Ttc7^fsn (involves: A/J * BALB/cByJ)	increased dendritic epidermal T cell number	J:14506
Ttc7^fsn/Ttc7^fsn (involves: A/J * BALB/cByJ)	increased Langerhans cell number	J:14506
Ttc7^hea/Ttc7^hea (CFO)	abnormal definitive hematopoiesis	J:7515
	abnormal erythrocyte cell number	J:7515
	abnormal erythrocyte morphology	J:7515
	anemia	J:7515
	anisocytosis	J:7515
	decreased hematocrit	J:7515
	decreased hemoglobin content	J:7515
	decreased megakaryocyte cell number	J:7515
	enlarged spleen	J:7515
	erythroblastosis	J:7515
	increased leukocyte cell number	J:7515
	low mean erythrocyte cell number	J:7515
	poikilocytosis	J:7515
	polychromatophilia	J:7515
	reticulocytosis	J:7515
Ttc7^hea/Ttc7^hea (WBB6F1)	abnormal erythrocyte cell number	J:92699
	abnormal erythrocyte morphology	J:92699
	abnormal erythropoiesis	J:92699
	anemia	J:92699
	anisocytosis	J:92699
	decreased hematocrit	J:92699
	decreased hemoglobin content	J:92699
	erythroblastosis	J:92699
	extramedullary hematopoiesis	J:92699
	low mean erythrocyte cell number	J:92699
	poikilocytosis	J:92699
	polychromatophilia	J:92699
Ttc9^tm1Vcl/Ttc9⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	thymus hyperplasia	J:241703
Ttc9^tm1Vcl/Ttc9^tm1Vcl (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	increased spleen weight	J:241703
	increased thymus weight	J:241703
	thymus hyperplasia	J:241703
Ttc28^{tm1b(EUCOMM)Hmgu}/Ttc28^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Ttc28^{tm1b(EUCOMM)Hmgu}/Tcp)	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
	increased red blood cell distribution width	J:211773
Ttc39a^{tm1b(KOMP)Mbp}/Ttc39a^{tm1b(KOMP)Mbp} (C57BL/6N-Ttc39a^{tm1b(KOMP)Mbp}/Orl)	decreased mean corpuscular hemoglobin concentration	J:211773
Ttc39aos1^tm1Kaf/Ttc39aos1^tm1Kaf (C57BL/6-Ttc39aos1^tm1Kaf)	hematopoietic system phenotype	J:234649
Ttc39b^{tm1e(EUCOMM)Wtsi}/Ttc39b^{tm1e(EUCOMM)Wtsi} (Not Specified)	thrombocytosis	J:165965
Tti2^{tm1b(KOMP)Wtsi}/Tti2⁺ (C57BL/6N-Tti2^{tm1b(KOMP)Wtsi}/Ics)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Ttyh3^em1(IMPC)Tcp/Ttyh3^em1(IMPC)Tcp (C57BL/6NCrl-Ttyh3^em1(IMPC)Tcp/Tcp)	decreased mean corpuscular volume	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
Tuba4a^m1Frla/Tuba4a^m1Frla (BALB/c-Tuba4a^m1Frla)	abnormal megakaryocyte differentiation	J:286522
	abnormal platelet morphology	J:286522
	abnormal platelet shape	J:286522
	increased mean platelet volume	J:286522
	thrombocytopenia	J:286522
Tubal3^em1(IMPC)J/Tubal3^em1(IMPC)J (C57BL/6NJ-Tubal3^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
	decreased mean corpuscular hemoglobin	J:211773
Tubb1^tm1Shiv/Tubb1^tm1Shiv (involves: 129/Sv * BALB/c)	abnormal platelet shape	J:94498
Tubb1^tm1Shiv/Tubb1^tm1Shiv (involves: 129/Sv * BALB/c)	thrombocytopenia	J:94498
Tubb1^tm1Shiv/Tubb1^tm1Shiv (Not Specified)	abnormal platelet physiology	J:95293
Tubb1^tm1Shiv/Tubb1^tm1Shiv (Not Specified)	abnormal platelet shape	J:95293
Tulp3^tm1Jng/Tulp3^tm1Jng (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	anemia	J:70060
Tulp4^{tm1a(KOMP)Wtsi}/Tulp4⁺ (involves: C57BL/6N * C57BL/6NRj)	hematopoietic system phenotype	J:344151
Tulp4^{tm1a(KOMP)Wtsi}/Tulp4^{tm1a(KOMP)Wtsi} (involves: C57BL/6N * C57BL/6NRj)	abnormal thymus topology	J:344151
Tusc2^tm1Avi/Tusc2⁺ (involves: 129S1/Sv * C57BL/6J)	decreased erythrocyte cell number	J:119985
Tusc2^tm1Avi/Tusc2^tm1Avi (involves: 129S1/Sv * C57BL/6J)	abnormal NK cell differentiation	J:119985
	decreased erythrocyte cell number	J:119985
	decreased NK cell number	J:119985
	increased leukocyte cell number	J:119985
Tusc2^tm1Avi/Tusc2^tm1Avi (involves: 129S1/Sv)	decreased T cell proliferation	J:309768
	decreased thymocyte number	J:309768
	increased macrophage cell number	J:309768
	increased monocyte cell number	J:309768
	increased myeloid cell number	J:309768
Tut4^{tm1a(KOMP)Wtsi}/Tut4^{tm1a(KOMP)Wtsi} (C57BL/6N-Tut4^{tm1a(KOMP)Wtsi}/Wtsi)	decreased mean platelet volume	J:211773
Twist2^tm1(cre)Dor/Twist2^tm1(cre)Dor (involves: 129/Sv * 129X1/SvJ)	abnormal spleen morphology	J:81485
	abnormal spleen white pulp morphology	J:81485
	abnormal thymus cortex morphology	J:81485
	abnormal thymus medulla morphology	J:81485
	abnormal thymus morphology	J:81485
	thymus atrophy	J:81485
Twsg1^tm1Nosa/Twsg1^tm1Nosa (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell differentiation	J:82738
	abnormal bone marrow cell morphology/development	J:82738
	abnormal spleen development	J:82738
	abnormal thymus development	J:82738
	decreased double-positive T cell number	J:82738
	decreased erythrocyte cell number	J:82738
	decreased immature B cell number	J:82738
	decreased lymphocyte cell number	J:82738
	decreased pre-B cell number	J:82738
	decreased pro-B cell number	J:82738
	decreased spleen white pulp amount	J:82738
	decreased splenocyte number	J:82738
	decreased thymocyte number	J:82738
	increased granulocyte number	J:82738
	increased monocyte cell number	J:82738
	increased single-positive T cell number	J:82738
	increased thymocyte apoptosis	J:82738
	thrombocytopenia	J:82738
	thymus atrophy	J:82738
Txlna^{tm1b(EUCOMM)Hmgu}/Txlna⁺ (C57BL/6N-Txlna^{tm1b(EUCOMM)Hmgu}/H)	decreased hemoglobin content	J:211773
	increased large unstained cell number	J:211773
Txlna^{tm1b(EUCOMM)Hmgu}/Txlna^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Txlna^{tm1b(EUCOMM)Hmgu}/H)	increased large unstained cell number	J:211773
	increased lymphocyte cell number	J:211773
Txndc11^em1(IMPC)J/Txndc11^em1(IMPC)J (C57BL/6NJ-Txndc11^em1(IMPC)J/Mmjax)	decreased mean corpuscular hemoglobin	J:211773
Txnip^tm1Yu/Txnip^tm1Yu (involves: 129)	abnormal NK cell morphology	J:96677
	abnormal NK cell physiology	J:96677
	decreased CD8-positive, alpha-beta T cell number	J:96677
	decreased NK cell number	J:96677
	decreased NK T cell number	J:96677
	increased lymphocyte cell number	J:96677
	increased regulatory T cell number	J:96677
	increased T cell proliferation	J:96677
Txnl1^em1(IMPC)Tcp/Txnl1^em1(IMPC)Tcp (C57BL/6NCrl-Txnl1^em1(IMPC)Tcp/Tcp)	decreased hematocrit	J:211773
	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
	increased erythrocyte cell number	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
	increased monocyte cell number	J:211773
Txnrd2^tm1.1Marc/Txnrd2^tm1.1Marc (involves: 129P2/OlaHsd * C57BL/6)	abnormal definitive hematopoiesis	J:94136
	anemia	J:94136
Tyk2^E775K/Tyk2^E775K (B10.D1-H2^q/SgJ)	abnormal T-helper 1 physiology	J:69051
	decreased IgG1 level	J:69051
	decreased IgG2a level	J:69051
	decreased IgG level	J:69051
Tyk2^tm1Biat/Tyk2^tm1Biat (involves: 129P2/OlaHsd * C57BL/6)	decreased macrophage nitric oxide production	J:65408
Tyk2^tm1Shmd/Tyk2^tm1Shmd (involves: 129P2/OlaHsd)	abnormal common myeloid progenitor cell morphology	J:109408
	abnormal splenocyte physiology	J:65409
	abnormal T cell differentiation	J:65409
	abnormal T cell physiology	J:65409
Tyk2^{tm2b(EUCOMM)Hmgu}/Tyk2^{tm2b(EUCOMM)Hmgu} (C57BL/6N-Tyk2^{tm2b(EUCOMM)Hmgu}/Ieg)	decreased plasmacytoid dendritic cell number	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
	thrombocytopenia	J:211773
Tyro3^{em1(IMPC)Ccpcz}/Tyro3^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Tyro3^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
	increased eosinophil cell number	J:211773
Tyrobp^tm1.1Viv/Tyrobp^tm1.1Viv (involves: 129P2/OlaHsd * C57BL/6)	decreased uterine NK cell number	J:100668
Tyrobp^tm1.1Viv/Tyrobp^tm1.1Viv (involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)	impaired natural killer cell mediated cytotoxicity	J:64764
	increased dendritic cell number	J:64764
Tyrobp^tm1.1Viv/Tyrobp^tm1.1Viv (B6.129P2-Tyrobp^tm1.1Viv)	abnormal microglial cell morphology	J:95232
	abnormal myelopoiesis	J:95232
	abnormal osteoclast physiology	J:129304, J:95232
Tyrobp^tm1Lll/Tyrobp^tm1Lll (involves: 129P2/OlaHsd * C57BL/6)	abnormal osteoclast differentiation	J:89583
	decreased T cell proliferation	J:64763
	impaired natural killer cell mediated cytotoxicity	J:64763
	increased dendritic cell number	J:64763
	increased natural killer cell mediated cytotoxicity	J:64763
Tyrobp^tm1Lll/Tyrobp^tm1Lll (B6.129P2-Tyrobp^tm1Lll)	abnormal NK T cell physiology	J:147867
Tyrobp^tm1Ttk/Tyrobp^tm1Ttk (involves: 129P2/OlaHsd * C57BL/6)	abnormal osteoclast morphology	J:81823
	abnormal osteoclast physiology	J:81823
Tyrobp^tm1Ttk/Tyrobp^tm1Ttk (B6.129P2-Tyrobp^tm1Ttk)	increased B cell proliferation	J:177613
	increased germinal center B cell number	J:177613
	increased IgG2a level	J:177613
	increased IgG3 level	J:177613
	increased spleen germinal center number	J:177613
	increased spleen germinal center size	J:177613
Tyw1^{tm1b(KOMP)Wtsi}/Tyw1^{tm1b(KOMP)Wtsi} (C57BL/6N-Tyw1^{tm1b(KOMP)Wtsi}/J)	decreased hematocrit	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
U2af2^em1(IMPC)J/U2af2⁺ (C57BL/6NJ-U2af2^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
U2surp^em1(IMPC)J/U2surp⁺ (C57BL/6NJ-U2surp^em1(IMPC)J/Mmjax)	increased erythrocyte cell number	J:211773
	increased hematocrit	J:211773
Uaca^tm1Kiy/Uaca^tm1Kiy (B6.129P2-Uaca^tm1Kiy)	abnormal Kupffer cell morphology	J:157049
Uaca^tm1Kiy/Uaca^tm1Kiy (B6.129P2-Uaca^tm1Kiy)	decreased dendritic cell number	J:157049
Ubac1^em1(IMPC)J/Ubac1^em1(IMPC)J (C57BL/6NJ-Ubac1^em1(IMPC)J/Mmjax)	decreased mean corpuscular volume	J:211773
	increased erythrocyte cell number	J:211773
	increased hemoglobin content	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
Ubash3b^tm1Jni/Ubash3b^tm1Jni Ubash3a^tm1Jni/Ubash3a^tm1Jni (Not Specified)	increased mature B cell number	J:89761
	increased splenocyte number	J:89761
	increased T cell proliferation	J:89761
Ubc^tm1Rrk/Ubc^tm1Rrk (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal embryonic hematopoiesis	J:122574
Ubd^{tm1b(EUCOMM)Wtsi}/Ubd^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Ubd^{tm1b(EUCOMM)Wtsi}/Ccpcz)	abnormal thymus morphology	J:211773
	decreased memory-marker CD4-positive NK T cell number	J:211773
	increased CD4-positive, CD25-positive NK T cell number	J:211773
	small thymus	J:211773
Ubd^tm1Smwe/Ubd^tm1Smwe (B6.129S6-Ubd^tm1Smwe)	abnormal lymphocyte physiology	J:110321
Ube2b^{tm1b(EUCOMM)Wtsi}/Ube2b⁺ (C57BL/6N-Ube2b^{tm1b(EUCOMM)Wtsi}/Ics)	decreased basophil cell number	J:211773
	decreased neutrophil cell number	J:211773
	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
Ube2d1^{tm3e(EUCOMM)Wtsi}/Ube2d1^{tm3e(EUCOMM)Wtsi} (C57BL/6N-Ube2d1^{tm3e(EUCOMM)Wtsi}/Wtsi)	increased mean corpuscular hemoglobin	J:211773
	increased mean platelet volume	J:211773
Ube2e2^{tm1b(KOMP)Wtsi}/Ube2e2^{tm1b(KOMP)Wtsi} (C57BL/6N-Ube2e2^{tm1b(KOMP)Wtsi}/Ucd)	increased mean corpuscular volume	J:211773
Ube2i^em1(IMPC)J/Ube2i⁺ (C57BL/6NJ-Ube2i^em1(IMPC)J/Mmjax)	decreased erythrocyte cell number	J:211773
	increased leukocyte cell number	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
Ube2i^tm1.1Adej/Ube2i⁺ (involves: 129S1/Sv * BALB/c * C57BL/6)	abnormal blood cell morphology/development	J:104945
Ube2j2^{em1(IMPC)Rbrc}/Ube2j2^{em1(IMPC)Rbrc} (C57BL/6NJcl-Ube2j2^{em1(IMPC)Rbrc}/Rbrc)	abnormal mean corpuscular volume	J:211773
	abnormal platelet cell number	J:211773
	decreased erythrocyte cell number	J:211773
	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	increased eosinophil cell number	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
Ube2n^{em1(IMPC)Ccpcz}/Ube2n⁺ (C57BL/6N-Ube2n^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Ube2n^{Gt(OST374154)Lex}/Ube2n⁺ (involves: 129S5/SvEvBrd * C57BL/6)	abnormal leukocyte physiology	J:120846
	abnormal macrophage physiology	J:120846
	decreased B cell proliferation	J:120846
	decreased T cell proliferation	J:120846
Ube2n^tm1Aki/Ube2n^tm1Aki Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal macrophage physiology	J:112287
Ube2w^{tm1d(EUCOMM)Wtsi}/Ube2w^{tm1d(EUCOMM)Wtsi} (involves: 129 * C57BL/6N)	increased neutrophil cell number	J:230053
Ube3a^{em1(IMPC)Hmgu}/Ube3a⁺ (C57BL/6N-Ube3a^{em1(IMPC)Hmgu}/Ieg)	increased hematocrit	J:211773
Ube3c^{tm1b(EUCOMM)Hmgu}/Ube3c^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Ube3c^{tm1b(EUCOMM)Hmgu}/Rbrc)	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
Ube3c^{tm1b(EUCOMM)Hmgu}/Ube3c^{tm1b(EUCOMM)Hmgu} (C57BL/6NCrl-Ube3c^{tm1b(EUCOMM)Hmgu}/Rbrc)	decreased CD4-negative NK T cell number	J:211773
	decreased CD5-positive Ly6C-positive T cell number	J:211773
	decreased Ly6C-positive immature NK cell number	J:211773
	decreased Ly6C-positive NK T cell number	J:211773
	increased effector memory CD8-positive, alpha-beta T cell number	J:211773
Ubl4b^{em1(IMPC)Ccpcz}/Ubl4b^{em1(IMPC)Ccpcz} (C57BL/6N-Ubl4b^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Ubl7^em1(IMPC)Tcp/Ubl7^em1(IMPC)Tcp (C57BL/6N-Ubl7^em1(IMPC)Tcp/Tcp)	increased hematocrit	J:211773
	increased hemoglobin content	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
Ubn2^em1(IMPC)Tcp/Ubn2⁺ (C57BL/6N-Ubn2^em1(IMPC)Tcp/Tcp)	decreased mean corpuscular hemoglobin	J:211773
Ubn2^em1(IMPC)Tcp/Ubn2⁺ (C57BL/6N-Ubn2^em1(IMPC)Tcp/Tcp)	decreased mean corpuscular hemoglobin concentration	J:211773
Ubox5^{tm1b(EUCOMM)Hmgu}/Ubox5^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Ubox5^{tm1b(EUCOMM)Hmgu}/Tcp)	increased neutrophil cell number	J:211773
Ubqln4^em1(IMPC)Mbp/Ubqln4^em1(IMPC)Mbp (C57BL/6NCrl-Ubqln4^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	small spleen	J:211773
Ubr7^em1(IMPC)Tcp/Ubr7^em1(IMPC)Tcp (C57BL/6NCrl-Ubr7^em1(IMPC)Tcp/Tcp)	decreased mean corpuscular hemoglobin	J:211773
Ubtf^em1(IMPC)Mbp/Ubtf⁺ (C57BL/6NCrl-Ubtf^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	decreased leukocyte cell number	J:211773
	enlarged spleen	J:211773
Ubxn1^em1(IMPC)J/Ubxn1^em1(IMPC)J (C57BL/6N-Ubxn1^em1(IMPC)J/J)	increased mean corpuscular volume	J:211773
Uchl1^gad/Uchl1^gad (involves: CBA/Nga * RFM/Nga)	hematopoietic system phenotype	J:30954
Uck2^em1(IMPC)J/Uck2^em1(IMPC)J (C57BL/6NJ-Uck2^em1(IMPC)J/Mmjax)	decreased mean corpuscular hemoglobin concentration	J:211773
	increased mean corpuscular volume	J:211773
Uckl1^em1(IMPC)J/Uckl1^em1(IMPC)J (C57BL/6NJ-Uckl1^em1(IMPC)J/Mmjax)	decreased mean corpuscular hemoglobin	J:211773
	increased erythrocyte cell number	J:211773
Ucp1^{tm1b(EUCOMM)Hmgu}/Ucp1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Ucp1^{tm1b(EUCOMM)Hmgu}/Ieg)	increased erythrocyte cell number	J:211773
	increased hematocrit	J:211773
Ucp2^tm1Rcq/Ucp2^tm1Rcq (involves: 129X1/SvJ * C57BL/6J)	abnormal macrophage physiology	J:66262
Ucp2^tm1Rcq/Ucp2^tm1Rcq (involves: 129X1/SvJ * C57BL/6)	hematopoietic system phenotype	J:120450
Uevld^{tm1a(EUCOMM)Wtsi}/Uevld^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Uevld^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased leukocyte cell number	J:211773
Ufl1^{tm1a(EUCOMM)Wtsi}/Ufl1^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6N)	anemia	J:238253
	decreased erythroid progenitor cell number	J:238253
	increased nucleated erythrocyte cell number	J:238253
Ufl1^{tm1c(EUCOMM)Wtsi}/Ufl1^{tm1c(EUCOMM)Wtsi} Gt(ROSA)26Sor^{tm1(cre/ERT2)Tyj}/Gt(ROSA)26Sor⁺ (involves: 129S4/SvJae * C3H * C57BL/6 * C57BL/6N)	abnormal bone marrow cell physiology	J:238253
	anemia	J:238253
	decreased erythrocyte cell number	J:238253
	decreased erythroid progenitor cell number	J:238253
	decreased granulocyte number	J:238253
	decreased hematocrit	J:238253
	decreased hemoglobin content	J:238253
	decreased leukocyte cell number	J:238253
	decreased lymphocyte cell number	J:238253
	decreased monocyte cell number	J:238253
	pancytopenia	J:238253
	thrombocytopenia	J:238253
Ugcg^em1(IMPC)H/Ugcg⁺ (C57BL/6NTac-Ugcg^em1(IMPC)H/H)	decreased lymphocyte cell number	J:211773
Ugcg^em1(IMPC)H/Ugcg⁺ (C57BL/6NTac-Ugcg^em1(IMPC)H/H)	increased neutrophil cell number	J:211773
Uhrf1^{tm1a(EUCOMM)Wtsi}/Uhrf1⁺ (Not Specified)	increased NK cell number	J:165965
Uhrf2^{tm1b(EUCOMM)Wtsi}/Uhrf2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Uhrf2^{tm1b(EUCOMM)Wtsi}/Tcp)	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
Ulk1^tm1.1Thsn/Ulk1^tm1.1Thsn (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)	abnormal erythrocyte morphology	J:139213
	abnormal erythropoiesis	J:139213
	abnormal reticulocyte morphology	J:139213
	increased mean corpuscular hemoglobin concentration	J:139213
	increased mean corpuscular volume	J:139213
	increased red blood cell distribution width	J:139213
	increased spleen weight	J:139213
	reticulocytosis	J:139213
Ulk3^em2(IMPC)Tcp/Ulk3^em2(IMPC)Tcp (C57BL/6NCrl-Ulk3^em2(IMPC)Tcp/Tcp)	abnormal spleen morphology	J:211773
	decreased neutrophil cell number	J:211773
Umodl1^{tm1a(KOMP)Wtsi}/Umodl1^{tm1a(KOMP)Wtsi} (C57BL/6N-Umodl1^{tm1a(KOMP)Wtsi}/Wtsi)	increased mean corpuscular hemoglobin	J:211773
Unc13d^Jinx/Unc13d^Jinx (C57BL/6J-Unc13d^Jinx/Mmucd)	abnormal macrophage physiology	J:105543
	abnormal NK cell physiology	J:119974
	anemia	J:119974
	decreased cytotoxic T cell cytolysis	J:119974
	enlarged spleen	J:119974
	hemophagocytosis	J:119974
	increased CD8-positive, alpha-beta T cell number	J:119974
	increased monocyte cell number	J:119974
	increased neutrophil cell number	J:119974
	thrombocytopenia	J:119974
Unc13d^{tm1(KOMP)Vlcg}/Unc13d^{tm1(KOMP)Vlcg} (involves: C57BL/6NTac)	abnormal platelet dense granule physiology	J:231217
	decreased platelet aggregation	J:231217
	hematopoietic system phenotype	J:231217
Unc93b1^3d/Unc93b1^3d (C57BL/6J-Unc93b1^3d)	abnormal macrophage physiology	J:105484
Unc93b1^3d/Unc93b1^3d (C57BL/6-Unc93b1^3d)	abnormal dendritic cell morphology	J:159599
Unc93b1^{tm1(KOMP)Vlcg}/Unc93b1^{tm1(KOMP)Vlcg} (involves: C57BL/6NTac)	abnormal dendritic cell morphology	J:211069
Unc93b1^tm1.1Kmiy/Unc93b1^tm1.1Kmiy (involves: 129P2/OlaHsd * C57BL/6)	abnormal erythrocyte physiology	J:174308
	abnormal T-helper 1 cell differentiation	J:174308
	abnormal T-helper 17 cell differentiation	J:174308
	anemia	J:174308
	decreased B cell proliferation	J:174308
	decreased marginal zone B cell number	J:174308
	enlarged spleen	J:174308
	increased B cell number	J:174308
	increased B cell proliferation	J:174308
	increased CD4-positive, alpha-beta memory T cell number	J:174308
	increased erythroblast number	J:174308
	increased IgG2a level	J:174308
	increased IgG2b level	J:174308
	increased memory T cell number	J:174308
	increased spleen weight	J:174308
	increased T-helper 1 cell number	J:174308
	increased T-helper 17 cell number	J:174308
	thrombocytopenia	J:174308
Ung^tm1Tld/Ung^tm1Tld (Not Specified)	abnormal class switch recombination	J:79590
	decreased IgG3 level	J:79590
	enlarged spleen	J:85353
	enlarged thymus	J:85353
	increased IgM level	J:79590
	spleen hyperplasia	J:85353
Ung^tm1Tld/Ung^tm1Tld (involves: 129P2/OlaHsd)	abnormal class switch recombination	J:306598
Ung^tm1Tld/Ung^tm1Tld (involves: 129P2/OlaHsd)	abnormal somatic hypermutation frequency	J:155454
Unk^{tm1a(KOMP)Wtsi}/Unk^{tm1a(KOMP)Wtsi} (C57BL/6N-Unk^{tm1a(KOMP)Wtsi}/Wtsi)	decreased mean corpuscular hemoglobin	J:211773
	increased erythrocyte cell number	J:211773
Upf2^tm1Btp/Upf2^tm1Btp Tg(Mx1-cre)1Cgn/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	abnormal B cell number	J:134765
	abnormal bone marrow cell morphology/development	J:134765
	abnormal common lymphocyte progenitor cell morphology	J:134765
	anemia	J:134765
	decreased granulocyte number	J:134765
	decreased hematocrit	J:134765
	decreased hematopoietic stem cell number	J:134765
	decreased hemoglobin content	J:134765
	decreased T cell proliferation	J:134765
	low mean erythrocyte cell number	J:134765
Upf3b^em1(IMPC)Tcp/Y (C57BL/6NCrl-Upf3b^em1(IMPC)Tcp/Tcp)	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	small thymus	J:211773
Upf3b^em1(IMPC)Tcp/Upf3b^em1(IMPC)Tcp (C57BL/6NCrl-Upf3b^em1(IMPC)Tcp/Tcp)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
	small thymus	J:211773
Uqcrb^{tm1b(EUCOMM)Wtsi}/Uqcrb⁺ (C57BL/6N-Uqcrb^{tm1b(EUCOMM)Wtsi}/Ieg)	increased leukocyte cell number	J:211773
Uqcrq^{tm1b(EUCOMM)Hmgu}/Uqcrq⁺ (C57BL/6N-Uqcrq^{tm1b(EUCOMM)Hmgu}/H)	decreased mean platelet volume	J:211773
Urah^plt2/Urah^plt2 (C57BL/6-Urah^plt2)	abnormal megakaryocyte progenitor cell morphology	J:164423
	abnormal NK cell morphology	J:267227
	decreased CD8-positive, alpha-beta T cell number	J:267227
	increased megakaryocyte cell number	J:164423
	increased T cell proliferation	J:267227
	thrombocytosis	J:164423
Uros^tm1Cged/Uros^tm1Cged (involves: 129S2/SvPas)	anisocytosis	J:105776
	enlarged spleen	J:105776
	hemolytic anemia	J:105776
	hypochromic microcytic anemia	J:105776
	increased bone marrow cell number	J:105776
	increased spleen red pulp amount	J:105776
	poikilocytosis	J:105776
Uros^tm2Rjde/Uros^tm3Rjde (involves: 129S6/SvEvTac * C57BL/6)	abnormal erythropoiesis	J:132542
	enlarged spleen	J:132542
	hematopoietic system phenotype	J:132542
	hemolysis	J:132542
	hemolytic anemia	J:132542
	increased spleen iron level	J:132542
	reticulocytosis	J:132542
Uros^tm3Rjde/Uros^tm3Rjde (involves: 129S6/SvEvTac * C57BL/6)	hematopoietic system phenotype	J:132542
Ush1c^{tm1a(KOMP)Wtsi}/Ush1c^{tm1a(KOMP)Wtsi} (C57BL/6N-Ush1c^{tm1a(KOMP)Wtsi}/Wtsi)	increased red blood cell distribution width	J:211773
Usp1^tm1.1Ada/Usp1^tm1.1Ada (C57BL/6-Usp1^tm1.1Ada)	decreased bone marrow cell number	J:146616
Usp1^{tm1b(KOMP)Wtsi}/Usp1^{tm1b(KOMP)Wtsi} (C57BL/6N-Usp1^{tm1b(KOMP)Wtsi}/Wtsi)	decreased erythrocyte cell number	J:211773
	increased mean corpuscular hemoglobin	J:211773
Usp2^{tm1b(EUCOMM)Wtsi}/Usp2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Usp2^{tm1b(EUCOMM)Wtsi}/H)	decreased mean corpuscular volume	J:211773
Usp4^tm1Xilu/Usp4^tm1Xilu (B6.129-Usp4^tm1Xilu)	increased splenocyte apoptosis	J:173192
Usp4^tm1Xilu/Usp4^tm1Xilu (B6.129-Usp4^tm1Xilu)	increased thymocyte apoptosis	J:173192
Usp5^{tm1a(EUCOMM)Hmgu}/Usp5⁺ (C57BL/6N-Usp5^{tm1a(EUCOMM)Hmgu}/Wtsi)	decreased leukocyte cell number	J:211773
Usp11^{tm1(KOMP)Wtsi}/Usp11^{tm1(KOMP)Wtsi} (C57BL/6N-Usp11^{tm1(KOMP)Wtsi}/Wtsi)	increased mean corpuscular hemoglobin	J:211773
Usp12^{tm1a(EUCOMM)Hmgu}/Usp12^{tm1a(EUCOMM)Hmgu} (Not Specified)	decreased CD8-positive, alpha-beta T cell number	J:165965
	decreased IgA level	J:165965
	decreased mean corpuscular hemoglobin concentration	J:165965
Usp15^L749R/Usp15^L749R (involves: 129S1/SvImJ * C57BL/6J)	abnormal T-helper 1 physiology	J:259382
Usp15^{tm1b(EUCOMM)Wtsi}/Usp15^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Usp15^{tm1b(EUCOMM)Wtsi}/Wtsi)	increased leukocyte cell number	J:211773
	increased mean platelet volume	J:211773
Usp16^{tm1b(EUCOMM)Hmgu}/Usp16⁺ (C57BL/6N-Usp16^{tm1b(EUCOMM)Hmgu}/Nju)	decreased mean platelet volume	J:211773
	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
Usp17lc^tm1Khb/Usp17lc⁺ (either: 129-Usp17lc^tm1Khb or (involves: 129S/SvEv * C57BL/6J))	decreased regulatory T cell number	J:191761
	increased B cell number	J:191761
	increased CD4-positive, alpha-beta T cell number	J:191761
	increased CD8-positive, alpha-beta T cell number	J:191761
	increased thymus weight	J:191761
Usp18^ity9/Usp18^ity9 (involves: 129S1/SvImJ * C57BL/6)	abnormal lymphocyte morphology	J:163843
	anemia	J:163843
	decreased leukocyte cell number	J:163843
	thrombocytopenia	J:163843
Usp19^{tm1b(EUCOMM)Hmgu}/Usp19⁺ (C57BL/6N-Usp19^{tm1b(EUCOMM)Hmgu}/Wtsi)	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
Usp21^tm1.1Jhy/Usp21^tm1.1Jhy (B6.129S7(Cg)-Usp21^tm1.1Jhy)	enlarged spleen	J:208320
	hematopoietic system phenotype	J:208320
	increased macrophage cell number	J:208320
	increased neutrophil cell number	J:208320
	increased spleen weight	J:208320
	increased splenocyte number	J:208320
Usp21^{tm1a(EUCOMM)Wtsi}/Usp21^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Usp21^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased mean corpuscular hemoglobin	J:211773
	increased leukocyte cell number	J:211773
Usp22^{tm1a(KOMP)Wtsi}/Usp22⁺ (C57BL/6N-Usp22^{tm1a(KOMP)Wtsi}/Wtsi)	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
	increased red blood cell distribution width	J:211773
Usp22^{tm1b(KOMP)Wtsi}/Usp22⁺ (C57BL/6N-Usp22^{tm1b(KOMP)Wtsi}/Wtsi)	increased monocyte cell number	J:211773
Usp24^{tm1a(KOMP)Wtsi}/Usp24^{tm1a(KOMP)Wtsi} (C57BL/6N-Usp24^{tm1a(KOMP)Wtsi}/Wtsi)	decreased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
Usp25^{Gt(RRS805)Byg}/Usp25^{Gt(RRS805)Byg} (involves: 129P2/OlaHsd)	increased neutrophil cell number	J:188557
Usp28^{Gt(EUCE0037g10)Hmgu}/Usp28^{Gt(EUCE0037g10)Hmgu} (involves: 129P2/OlaHsd * C57BL/6J)	decreased spleen weight	J:215354
	decreased splenocyte number	J:215354
Usp30^{tm2b(EUCOMM)Hmgu}/Usp30^{tm2b(EUCOMM)Hmgu} (C57BL/6N-Usp30^{tm2b(EUCOMM)Hmgu}/Wtsi)	thrombocytopenia	J:211773
Usp32^{em1(IMPC)Mhzh}/Usp32⁺ (C57BL/6N-Usp32^{em1(IMPC)Mhzh}/Mhzh)	decreased mean corpuscular hemoglobin concentration	J:211773
	decreased neutrophil cell number	J:211773
	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
	increased mean corpuscular volume	J:211773
	increased mean platelet volume	J:211773
	increased red blood cell distribution width	J:211773
	thrombocytosis	J:211773
Usp33^{tm1a(EUCOMM)Wtsi}/Usp33^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Usp33^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased mean corpuscular hemoglobin	J:175295
	thrombocytosis	J:175295
Usp37^{em1(IMPC)Wtsi}/Usp37⁺ (C57BL/6N-Usp37^{em1(IMPC)Wtsi}/Wtsi)	increased mean corpuscular hemoglobin	J:211773
Usp38^{tm1b(EUCOMM)Hmgu}/Usp38^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Usp38^{tm1b(EUCOMM)Hmgu}/H)	increased mean corpuscular volume	J:211773
	thrombocytopenia	J:211773
Usp42^{tm2a(EUCOMM)Wtsi}/Usp42^{tm2a(EUCOMM)Wtsi} (B6JTyr;B6N-Usp42^{tm2a(EUCOMM)Wtsi}/Wtsi)	thrombocytopenia	J:175295
Usp42^{tm2a(EUCOMM)Wtsi}/Usp42^{tm2a(EUCOMM)Wtsi} (involves: C57BL/6 * C57BL/6N)	increased CD4-positive, alpha-beta T cell number	J:213427
	increased T cell number	J:213427
Usp45^em1(IMPC)H/Usp45^em1(IMPC)H (C57BL/6NTac-Usp45^em1(IMPC)H/H)	decreased neutrophil cell number	J:211773
	decreased spleen weight	J:211773
Usp49^em1Gpt/Usp49^em1Gpt (involves: C57BL/6NGpt)	hematopoietic system phenotype	J:285681
Usp54^{tm1b(KOMP)Wtsi}/Usp54^{tm1b(KOMP)Wtsi} (C57BL/6N-Usp54^{tm1b(KOMP)Wtsi}/H)	decreased hemoglobin content	J:211773
	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
	increased red blood cell distribution width	J:211773
Utp4^em1(IMPC)J/Utp4⁺ (C57BL/6NJ-Utp4^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Uxs1^tm1Lex/Uxs1⁺ (B6;129S5-Uxs1^tm1Lex/Mmucd)	increased IgG1 level	J:171883
Vamp2^tm1Sud/Vamp2⁺ (involves: 129P2/OlaHsd * C57BL/6J)	hematopoietic system phenotype	J:121010
Vamp2^tm1Sud/Vamp2⁺ Vamp3^tm1Jpes/Vamp3^tm1Jpes (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6J)	hematopoietic system phenotype	J:121010
Vamp3^tm1Jpes/Vamp3^tm1Jpes (involves: 129P2/OlaHsd * C57BL/6J)	abnormal platelet physiology	J:121010
Vamp4^{em1(IMPC)Ccpcz}/Vamp4^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Vamp4^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Vamp8^{Gt(OST20346)Lex}/Vamp8^{Gt(OST20346)Lex} (involves: 129S5/SvEvBrd * C57BL/6)	abnormal mast cell physiology	J:131926
Vamp8^tm1Hong/Vamp8^tm1Hong (involves: 129P2/OlaHsd * C57BL/6)	decreased mast cell degranulation	J:133439
Vamp8^tm1Hong/Vamp8^tm1Hong (involves: 129P2/OlaHsd * C57BL/6J)	abnormal platelet activation	J:121010
	abnormal platelet physiology	J:121010
	hematopoietic system phenotype	J:121010
Vangl1^{tm1e(KOMP)Wtsi}/Vangl1⁺ (C57BL/6N-Vangl1^{tm1e(KOMP)Wtsi}/Wtsi)	increased mean corpuscular hemoglobin	J:175295
Vasp^tm1Mzim/Vasp^tm1Mzim (involves: 129P2/OlaHsd * C57BL/6)	abnormal platelet activation	J:56356
	hematopoietic system phenotype	J:56356
	increased megakaryocyte cell number	J:56356
Vasp^tm1Ref/Vasp^tm1Ref (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal platelet physiology	J:51905
	hematopoietic system phenotype	J:51905
	increased platelet aggregation	J:51905
Vav1^m1Anu/Vav1^m1Anu (C57BL/6JAnu-Vav1^m1Anu)	increased T cell number	J:104190
Vav1^m1Btlr/Vav1^m1Btlr (C57BL/6J-Vav1^m1Btlr)	decreased B-1 B cell number	J:265128
	decreased CD4-positive, alpha-beta T cell number	J:265128
	decreased CD8-positive, alpha-beta T cell number	J:265128
	decreased CD8-positive, naive alpha-beta T cell number	J:265128
	decreased IgD level	J:265128
	decreased IgG level	J:265128
	decreased single-positive T cell number	J:265128
	decreased T cell number	J:265128
	increased central memory CD4-positive, alpha-beta T cell number	J:265128
	increased central memory CD8 positive, alpha-beta T cell number	J:265128
	increased effector memory CD4-positive, alpha-beta T cell number	J:265128
	increased IgM level	J:265128
Vav1^m2Btlr/Vav1^m2Btlr (C57BL/6J-Vav1^m2Btlr)	decreased B-1 B cell number	J:265130
Vav1^M3Btlr/Vav1^M3Btlr (C57BL/6J-Vav1^M3Btlr)	decreased IgG level	J:272527
Vav1^M4Btlr/Vav1^M4Btlr (C57BL/6J-Vav1^M4Btlr)	abnormal CD4-positive T cell differentiation	J:272528
	abnormal CD8-positive, alpha-beta T cell differentiation	J:272528
	abnormal T cell differentiation	J:272528
	decreased B-1 B cell number	J:272528
	decreased CD4-positive, alpha-beta T cell number	J:272528
	decreased CD8-positive, naive alpha-beta T cell number	J:272528
	increased central memory CD4-positive, alpha-beta T cell number	J:272528
	increased central memory CD8 positive, alpha-beta T cell number	J:272528
	increased effector memory CD4-positive, alpha-beta T cell number	J:272528
	increased effector memory CD8-positive, alpha-beta T cell number	J:272528
Vav1^M5Btlr/Vav1^M5Btlr (C57BL/6J-Vav1^M5Btlr)	decreased CD8-positive, alpha-beta T cell number	J:272529
Vav1^tm1Tyb/Vav1^tm1Tyb (involves: 129S2/SvPas * 129S8/SvEv)	abnormal T cell physiology	J:113270
	decreased CD4-positive, alpha-beta T cell number	J:113270
	decreased double-negative T cell number	J:113270
	decreased T cell proliferation	J:113270
Vav1^tm1Tyb/Vav1^tm1Tyb (involves: 129S4/SvJae * 129S8/SvEv * C57BL/10 * C57BR/cd)	abnormal CD4-positive, alpha beta T cell morphology	J:113270
	abnormal negative T cell selection	J:113270
Vav1^tm1Tyb/Vav1^tm1Tyb (involves: 129S2/SvPas)	abnormal double-negative T cell morphology	J:79323
	abnormal T cell physiology	J:86654, J:79323
	decreased double-positive T cell number	J:79323
	decreased mature B cell number	J:86654
	decreased single-positive T cell number	J:79323
	decreased T cell proliferation	J:86654
	decreased thymocyte number	J:86654
	thymus hypoplasia	J:79323
Vav1^tm1Tyb/Vav1^tm1Tyb (C.129S2-Vav1^tm1Tyb)	abnormal negative T cell selection	J:79323
Vav1^tm1Tyb/Vav1^tm1Tyb (involves: 129S2/SvPas * C57BL/10 * C57BR/cd)	abnormal CD4-positive, alpha beta T cell morphology	J:79323
	abnormal T cell physiology	J:128985
	decreased T cell proliferation	J:128985
Vav1^tm1Tyb/Vav1^tm1Tyb (either: (involves: 129S4/SvJae * 129S8/SvEv) or (involves: 129S4/SvJae * 129S8/SvEv * C57BL/10 * C57BR/cd))	abnormal CD8-positive, alpha-beta T cell physiology	J:190087
	abnormal lymphocyte cell number	J:190087
	abnormal T cell number	J:190087
	decreased double-positive T cell number	J:190087
	increased DN2 thymocyte number	J:190087
	increased DN3 thymocyte number	J:190087
	increased double-negative T cell number	J:190087
Vav1^tm1Tyb/Vav1^tm1Tyb Vav2^tm1Kdf/Vav2^tm1Kdf (involves: 129S1/Sv * 129S2/SvPas)	decreased B cell proliferation	J:86654
	decreased double-negative T cell number	J:86654
	decreased double-positive T cell number	J:86654
	decreased mature B cell number	J:86654
	decreased single-positive T cell number	J:86654
	decreased T cell number	J:86654
	decreased T cell proliferation	J:86654
	decreased thymocyte number	J:86654
Vav1^tm1Tyb/Vav1^tm1Tyb Vav2^tm1Kdf/Vav2^tm1Kdf Vav3^tm1Swat/Vav3^tm1Swat (involves: 129S1/Sv * 129S2/SvPas * 129S6/SvEvTac * C57BL/6)	abnormal B cell physiology	J:86654
	abnormal T cell physiology	J:86654
	arrested B cell differentiation	J:86654
	arrested T cell differentiation	J:86654
	decreased B cell proliferation	J:86654
	decreased double-positive T cell number	J:86654
	decreased follicular B cell number	J:86654
	decreased IgG1 level	J:86654
	decreased IgG2b level	J:86654
	decreased IgG3 level	J:86654
	decreased IgM level	J:86654
	decreased immunoglobulin level	J:86654
	decreased marginal zone B cell number	J:86654
	decreased mature B cell number	J:86654
	decreased single-positive T cell number	J:86654
	decreased T cell number	J:86654
	decreased T cell proliferation	J:86654
	decreased thymocyte number	J:86654
	decreased transitional stage T2 B cell number	J:86654
	increased immature B cell number	J:86654
	increased transitional stage T1 B cell number	J:86654
Vav1^tm1Tyb/Vav1^tm1Tyb Vav2^tm1Kdf/Vav2^tm1Kdf Vav3^tm1Swat/Vav3^tm1Swat (involves: 129S1/Sv * 129S2/SvPas * 129S6/SvEvTac)	abnormal macrophage physiology	J:145345
	abnormal neutrophil physiology	J:145345
	abnormal NK cell physiology	J:187430
Vav1^tm1Tyb/Vav1^tm1Tyb Vav2^tm1Tnr/Vav2^tm1Tnr (involves: 129P2/OlaHsd * 129S2/SvPas)	abnormal B cell physiology	J:69807
	decreased B cell number	J:69807
	decreased B cell proliferation	J:69807
	decreased CD4-positive, alpha-beta T cell number	J:69807
	decreased CD8-positive, alpha-beta T cell number	J:69807
	decreased follicular B cell number	J:69807
	decreased immature B cell number	J:69807
	decreased mature B cell number	J:69807
Vav1^tm1Tyb/Vav1^tm1Tyb Vav3^tm1Swat/Vav3^tm1Swat (involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6)	decreased B cell proliferation	J:86654
	decreased double-negative T cell number	J:86654
	decreased double-positive T cell number	J:86654
	decreased mature B cell number	J:86654
	decreased single-positive T cell number	J:86654
	decreased T cell number	J:86654
	decreased T cell proliferation	J:86654
Vav1^tm2Bbd/Vav1^tm2Bbd (involves: 129S1/Sv * 129X1/SvJ * CD-1)	abnormal T cell activation	J:47596
	abnormal T cell differentiation	J:47596
	decreased B-1 B cell number	J:47596
	decreased CD4-positive, alpha-beta T cell number	J:47596
	decreased CD8-positive, alpha-beta T cell number	J:47596
	decreased T cell proliferation	J:47596
	thymus hypoplasia	J:47596
Vav1^tm2Bbd/Vav1^tm2Bbd (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal B cell number	J:55647
	abnormal splenic cell ratio	J:69806
	abnormal T cell differentiation	J:47596
	abnormal T cell number	J:47596
	decreased B cell proliferation	J:55647, J:69806
	decreased B-1 B cell number	J:55647
	decreased CD4-positive, alpha-beta T cell number	J:47596
	decreased CD8-positive, alpha-beta T cell number	J:47596
	decreased IgG1 level	J:55647
	decreased IgG2a level	J:55647
	decreased IgG3 level	J:69806
	decreased IgG level	J:55647
	increased double-negative T cell number	J:47596
	increased transitional stage B cell number	J:69806
Vav1^tm2Bbd/Vav1^tm2Bbd (B6.129-Vav1^tm2Bbd)	abnormal CD4-positive T cell differentiation	J:141390
	abnormal positive T cell selection	J:141390
	abnormal T cell physiology	J:141390
	decreased double-positive T cell number	J:141390
	decreased NK T cell number	J:71161
	decreased T cell number	J:141390
	impaired natural killer cell mediated cytotoxicity	J:71161
Vav1^tm2Bbd/Vav1^tm2Bbd Vav2^tm1Kdf/Vav2^tm1Kdf (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal B cell activation	J:69806
	abnormal B cell differentiation	J:69806
	abnormal splenic cell ratio	J:69806
	abnormal T cell differentiation	J:69806
	decreased B cell number	J:69806
	decreased B cell proliferation	J:69806
	decreased B-1 B cell number	J:69806
	decreased CD8-positive, alpha-beta T cell number	J:69806
	decreased IgG1 level	J:69806
	decreased IgG2b level	J:69806
	decreased IgG3 level	J:69806
	decreased IgM level	J:69806
	decreased immunoglobulin level	J:69806
	decreased mature B cell number	J:69806
	decreased T cell number	J:69806
	thymus hypoplasia	J:69806
Vav1^tm2Tyb/Vav1^tm2Tyb (involves: 129S4/SvJae * 129S8/SvEv)	abnormal T cell physiology	J:113270
	decreased CD4-positive, alpha-beta T cell number	J:113270
	decreased double-negative T cell number	J:113270
	decreased T cell proliferation	J:113270
Vav1^tm2Tyb/Vav1^tm2Tyb (involves: 129S4/SvJae * 129S8/SvEv * C57BL/10 * C57BR/cd)	abnormal CD4-positive, alpha beta T cell morphology	J:113270
	abnormal negative T cell selection	J:113270
Vav1^tm4Tyb/Vav1^tm4Tyb (either: 129S8.129S4-Vav1^tm4Tyb or (involves: 129S4/SvJae * 129S8/SvEv * C57BL/10 * C57BR/cd))	abnormal CD4-positive, alpha-beta T cell physiology	J:190087
	abnormal CD8-positive, alpha-beta T cell physiology	J:190087
	abnormal lymphocyte cell number	J:190087
	abnormal T cell number	J:190087
	abnormal T cell physiology	J:190087
	increased DN2 thymocyte number	J:190087
	increased DN3 thymocyte number	J:190087
Vav2^tm1Kdf/Vav2^tm1Kdf (involves: 129S1/Sv * C57BL/6)	decreased B cell proliferation	J:69806
	decreased IgG3 level	J:69806
	decreased mature B cell number	J:69806
Vav2^tm1Tnr/Vav2^tm1Tnr (involves: 129P2/OlaHsd)	abnormal class switch recombination	J:69807
	decreased B cell number	J:69807
	decreased B cell proliferation	J:69807
	decreased IgG1 level	J:69807
	decreased IgG2b level	J:69807
	decreased IgG3 level	J:69807
	decreased IgM level	J:69807
	decreased spleen germinal center number	J:69807
Vcam1^tm1Dmil/Vcam1^tm1Dmil (either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6))	increased monocyte cell number	J:69597
Vcam1^tm1Dmil/Vcam1^tm1Dmil (C.129S4-Vcam1^tm1Dmil)	increased B cell number	J:69597
	increased leukocyte cell number	J:69597
	increased monocyte cell number	J:69597
	increased T cell number	J:69597
Vcam1^tm2Flv/Vcam1^tm2Flv Tg(Mx1-cre)1Cgn/0 (involves: 129S1/Sv * C57BL/6 * CBA)	abnormal blood cell morphology/development	J:123142
	decreased bone marrow cell number	J:123142
Vcam1^tm2Flv/Vcam1^tm3Flv Tg(Tek-cre)12Flv/0 (involves: 129S1/Sv * C3H * C57BL/6)	abnormal B cell physiology	J:68147
	abnormal blood cell morphology/development	J:107447, J:123142
	abnormal bone marrow cell morphology/development	J:107447, J:123142
	abnormal CD4-positive, alpha-beta T cell physiology	J:68147
	abnormal CD8-positive, alpha-beta T cell physiology	J:68147
	abnormal lymphocyte physiology	J:68147
	abnormal splenic cell ratio	J:107447
	decreased B cell number	J:68147
	decreased bone marrow cell number	J:107447, J:68147
	decreased CD4-positive, alpha-beta T cell number	J:68147
	decreased CD8-positive, alpha-beta T cell number	J:68147
	decreased immature B cell number	J:68147
	increased immature B cell number	J:68147
	increased leukocyte cell number	J:107447, J:68147
	spleen hyperplasia	J:107447
Vcam1^tm2Roml/Vcam1^tm2Roml Tg(Mx1-cre)1Cgn/? (involves: 129S1/Sv * C57BL/6 * CBA)	decreased B cell number	J:68148
	decreased mature B cell number	J:68148
	decreased transitional stage B cell number	J:68148
	increased B cell number	J:68148
	increased immature B cell number	J:68148
	increased mature B cell number	J:68148
	increased transitional stage B cell number	J:68148
Vcan^em2(IMPC)Mbp/Vcan⁺ (C57BL/6NCrl-Vcan^em2(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Vcp^tm1Itl/Vcp⁺ (B6.129S-Vcp^tm1Itl)	abnormal osteoclast differentiation	J:166230
Vcp^tm1Itl/Vcp⁺ (B6.129S-Vcp^tm1Itl)	increased osteoclast cell number	J:166230
Vdac2^tm1.1Ehyc/Vdac2^tm1.1Ehyc Bax^tm2Sjk/Bax^tm2Sjk Tg(Lck-cre)1Cwi/? (involves: 129X1/SvJ * C57BL/6 * DBA/2)	decreased thymocyte number	J:220951
	small thymus	J:220951
Vdac2^tm1.1Ehyc/Vdac2^tm1.1Ehyc Tg(Lck-cre)1Cwi/? (involves: 129X1/SvJ * C57BL/6 * DBA/2)	abnormal thymocyte apoptosis	J:220951
	decreased thymocyte number	J:220951
	small thymus	J:220951
Vdr^tm1Gcm/Vdr^tm1Gcm Tg(Col2a1-cre)1Bhr/? (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)	decreased osteoclast cell number	J:117377
Vdr^tm1Mbd/Vdr^tm1Mbd (involves: 129S4/SvJae * C57BL/6)	increased thymus weight	J:107077
Vdr^tm1Mbd/Vdr^tm1Mbd (involves: 129S4/SvJae * C57BL/6)	thymus hyperplasia	J:107077
Vdr^tm1Rge/Vdr^tm1Rge (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal macrophage physiology	J:134827
Vdr^tm1Ska/Vdr^tm1Ska (involves: C57BL/6NCrlj * CBA/JNCrlj)	abnormal macrophage chemotaxis	J:112519
Vdr^tm1Ska/Vdr^tm1Ska (involves: C57BL/6NCrlj * CBA/JNCrlj)	decreased splenocyte proliferation	J:112519
Vdr^tm1Ska/Vdr^tm1Ska (NOD.Cg-Vdr^tm1Ska/CmatJ)	abnormal dendritic cell differentiation	J:127787
	abnormal T cell number	J:127787
	decreased regulatory T cell number	J:127787
Vegfa^tm1Pec/Vegfa^tm1Pec (involves: 129S1/Sv * 129X1/SvJ)	abnormal thymus morphology	J:81698
	athymia	J:81698
	decreased lymphocyte cell number	J:81698
	ectopic thymus	J:81698
	thymus hypoplasia	J:81698
Vegfa^tm2.1Nagy/Vegfa^tm2.1Nagy (involves: 129S1/Sv * 129X1/SvJ * CD-1)	pancytopenia	J:75937
Vegfa^tm2Gne/Vegfa⁺ Tg(Nphs1-cre)1Seq/0 (involves: 129)	anemia	J:82440
Vegfa^tm2Gne/Vegfa^tm2Gne Tg(Mx1-cre)1Cgn/0 (involves: 129/Sv * C57BL/6 * CBA)	extramedullary hematopoiesis	J:52793
Vegfb^{tm1b(EUCOMM)Hmgu}/Vegfb^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Vegfb^{tm1b(EUCOMM)Hmgu}/J)	increased erythrocyte cell number	J:211773
	increased hemoglobin content	J:211773
Vegfd^{em1(IMPC)Ccpcz}/Vegfd^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Vegfd^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Vezt^{tm1b(EUCOMM)Hmgu}/Vezt⁺ (C57BL/6N-Vezt^{tm1b(EUCOMM)Hmgu}/J)	increased mean corpuscular volume	J:211773
Vgf^em1(IMPC)H/Vgf^em1(IMPC)H (C57BL/6NTac-Vgf^em1(IMPC)H/H)	decreased spleen weight	J:211773
Vhl^tm1Jae/Vhl^tm1Jae Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S4/SvJae * BALB/c * C57BL/6 * DBA)	polycythemia	J:67505
Vhl^tm1Jae/Vhl^tm1Jae Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S4/SvJae * C57BL/6 * DBA)	increased hematocrit	J:144666
	reticulocytosis	J:144666
Vhl^tm1Jae/Vhl^tm1Jae Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0 (involves: 129S4/SvJae * CD-1)	abnormal blood cell morphology/development	J:186085
	decreased bone marrow cell number	J:186085
	decreased lymphocyte cell number	J:186085
	enlarged spleen	J:186085
	extramedullary hematopoiesis	J:186085
	increased erythrocyte cell number	J:186085
	increased erythroid progenitor cell number	J:186085
	increased hematocrit	J:186085
	increased hematopoietic stem cell number	J:186085
	polycythemia	J:186085
Vhl^tm1Mcs/Vhl^tm1Mcs (involves: 129S4/SvJae * C57BL/6 * FVB/N)	abnormal common myeloid progenitor cell morphology	J:130780
	abnormal erythropoiesis	J:130780
	abnormal spleen morphology	J:130780
	decreased spleen white pulp amount	J:130780
	hematopoietic system phenotype	J:130780
	increased erythrocyte cell number	J:130780
	increased erythroid progenitor cell number	J:130780
	increased hematocrit	J:130780
	increased hemoglobin content	J:130780
	increased leukocyte cell number	J:130780
	increased megakaryocyte cell number	J:130780
	increased spleen red pulp amount	J:130780
	increased spleen weight	J:130780
	polycythemia	J:130780
Vil1^{em1(IMPC)Wtsi}/Vil1^{em1(IMPC)Wtsi} (C57BL/6N-Vil1^{em1(IMPC)Wtsi}/Wtsi)	increased red blood cell distribution width	J:211773
Vim^tm1Cba/Vim^tm1Cba (involves: 129S2/SvPas * C57BL/6)	abnormal cellular extravasation	J:129405
	abnormal leukocyte adhesion	J:129405
	abnormal leukocyte migration	J:129405
	abnormal leukocyte tethering or rolling	J:129405
Vipr2^tm1Ajh/Vipr2^tm1Ajh (B6.129P2-Vipr2^tm1Ajh)	decreased IgE level	J:72933
Vkorc1^tm1.1Kry/Vkorc1^tm1.1Kry Tg(BGLAP-cre)1Clem/0 (involves: FVB/NJ)	hematopoietic system phenotype	J:264734
Vkorc1l1^em1(IMPC)J/Vkorc1l1^em1(IMPC)J (C57BL/6NJ-Vkorc1l1^em1(IMPC)J/Mmjax)	decreased erythrocyte cell number	J:211773
	decreased leukocyte cell number	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
Vkorc1l1^tm1.2Kry/Vkorc1l1^tm1.2Kry (involves: FVB/N)	hematopoietic system phenotype	J:264734
Vldlr^em1(IMPC)Mbp/Vldlr^em1(IMPC)Mbp (C57BL/6N-Vldlr^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
Vnn3^{em1(IMPC)Ccpcz}/Vnn3^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Vnn3^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Vpreb1a^tm1Ilm/Vpreb1a^tm1Ilm (involves: 129P2/OlaHsd * C57BL/6)	abnormal pre-B cell morphology	J:53512
	arrested B cell differentiation	J:53512
Vpreb1a^tm1Ilm/Vpreb1a^tm1Ilm (B6.129P2-Vpreb1a^tm1Ilm)	decreased pre-B cell number	J:104211
Vpreb1a^tm1Ilm/Vpreb1a^tm1Ilm (B6.129P2-Vpreb1a^tm1Ilm)	increased pre-B cell number	J:104211
Vpreb1a^tm1Ilm/Vpreb1a^tm1Ilm Vpreb1b^tm1Ilm/Vpreb1b⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased mature B cell number	J:104211
	decreased pre-B cell number	J:104211
	increased pre-B cell number	J:104211
Vpreb1a^tm1Ilm/Vpreb1a^tm1Ilm Vpreb1b^tm1Ilm/Vpreb1b^tm1Ilm (B6.129P2-Vpreb1a^tm1Ilm Vpreb1b^tm1Ilm)	abnormal B cell differentiation	J:67609
	abnormal immature B cell morphology	J:67609
	abnormal splenic cell ratio	J:67609
	decreased B-1a cell number	J:67609
	decreased bone marrow cell number	J:67609
	decreased IgG level	J:67609
	decreased mature B cell number	J:67609
	decreased pre-B cell number	J:67609
	increased pre-B cell number	J:67609
Vps4a^{tm1b(EUCOMM)Hmgu}/Vps4a⁺ (C57BL/6N-Vps4a^{tm1b(EUCOMM)Hmgu}/Bay)	enlarged spleen	J:211773
	increased spleen weight	J:211773
Vps13a^tm1Asan/Vps13a^tm1Asan (involves: 129S/SvEv * C57BL/6J)	acanthocytosis	J:96243
	anisopoikilocytosis	J:96243
	increased erythrocyte osmotic fragility	J:96243
Vps13a^{tm1b(EUCOMM)Wtsi}/Vps13a^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Vps13a^{tm1b(EUCOMM)Wtsi}/Wtsi)	decreased plasmacytoid dendritic cell number	J:211773
	decreased T-helper cell number	J:211773
Vps13b^em1(IMPC)Tcp/Vps13b^em1(IMPC)Tcp (C57BL/6N-Vps13b^em1(IMPC)Tcp/Tcp)	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	increased mean corpuscular volume	J:211773
	small spleen	J:211773
Vps13c^{tm1b(EUCOMM)Hmgu}/Vps13c^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Vps13c^{tm1b(EUCOMM)Hmgu}/Ieg)	decreased hematocrit	J:211773
	increased red blood cell distribution width	J:211773
Vps13c^{tm1b(EUCOMM)Hmgu}/Vps13c^{tm1b(EUCOMM)Hmgu} (C57BL/6NTac-Vps13c^{tm1b(EUCOMM)Hmgu}/Ieg)	increased red blood cell distribution width	J:211773
Vps33a^bf/Vps33a^bf (C57BL/6J-Vps33a^bf)	abnormal platelet physiology	J:88018
Vps33a^bf/Vps33a^bf (C57BL/6J-Vps33a^bf)	decreased platelet aggregation	J:88018
Vps33a^em2(IMPC)Tcp/Vps33a⁺ (C57BL/6NCrl-Vps33a^em2(IMPC)Tcp/Tcp)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
	increased red blood cell distribution width	J:211773
	increased spleen weight	J:211773
Vps33b^tm1.1Arte/Vps33b^tm1.1Arte Gt(ROSA)26Sor^{tm1(cre/ERT2)Tyj}/Gt(ROSA)26Sor⁺ (involves: C57BL/6 * C57BL/6J)	abnormal megakaryocyte morphology	J:222766
	decreased dendritic cell number	J:222766
	decreased lymphocyte cell number	J:222766
	decreased mean platelet volume	J:222766
	decreased platelet aggregation	J:222766
	decreased platelet alpha-granule number	J:222766
	enlarged spleen	J:222766
	extramedullary hematopoiesis	J:222766
	increased macrophage cell number	J:222766
	increased megakaryocyte cell number	J:222766
	increased monocyte cell number	J:222766
	increased neutrophil cell number	J:222766
	thrombocytosis	J:222766
Vps35^tm1.1Mjff/Vps35^tm1.1Mjff (B6.Cg-Vps35^tm1.1Mjff)	microgliosis	J:303283
Vps54^wr/Vps54^wr (involves: C57BL/6J * C57BL/Fa)	increased microglial cell activation	J:181019
Vrk3^em1(IMPC)Mbp/Vrk3^em1(IMPC)Mbp (C57BL/6NCrl-Vrk3^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Vsig4^{tm1b(EUCOMM)Hmgu}/Y (C57BL/6N-Vsig4^{tm1b(EUCOMM)Hmgu}/J)	decreased mean corpuscular hemoglobin	J:211773
Vsig4^tm1Gne/Vsig4^tm1Gne (C57BL/6-Vsig4^tm1Gne)	abnormal macrophage physiology	J:281762
	increased T-helper 1 cell number	J:281762
	increased T-helper 17 cell number	J:281762
Vsig10^{em1(IMPC)Wtsi}/Vsig10^{em1(IMPC)Wtsi} (C57BL/6N-Vsig10^{em1(IMPC)Wtsi}/Wtsi)	increased leukocyte cell number	J:211773
Vsir^tm1Lex/Vsir^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	abnormal T cell activation	J:222944
	increased IgA level	J:222944
	increased IgM level	J:222944
Vtcn1^tm1Lpc/Vtcn1^tm1Lpc (B6.129S-Vtcn1^tm1Lpc)	abnormal myelopoiesis	J:145712
Vtcn1^tm1Lpc/Vtcn1^tm1Lpc (B6.129S-Vtcn1^tm1Lpc)	increased neutrophil cell number	J:145712
Vtcn1^tm1Xxz/Vtcn1^tm1Xxz (involves: 129S4/SvJae * BALB/c * C57BL/6)	increased CD4-positive, alpha-beta T cell number	J:177612
	increased T-helper 1 cell number	J:177612
	increased T-helper 17 cell number	J:177612
Vtn^tm1Dgi/Vtn^tm1Dgi (B6.129S2-Vtn^tm1Dgi)	abnormal platelet aggregation	J:134443
Vwf^tm1.1Diac/Vwf^tm1.1Diac (Not Specified)	abnormal platelet activation	J:181672
Vwf^tm1.1Geno/Vwf⁺ (involves: C57BL/6)	abnormal platelet aggregation	J:250145
	abnormal platelet physiology	J:250145
	decreased platelet aggregation	J:250145
	increased hemoglobin content	J:250145
	increased mean platelet volume	J:250145
	thrombocytopenia	J:250145
Vwf^tm1.1Geno/Vwf^tm1.1Geno (involves: C57BL/6)	abnormal platelet aggregation	J:250145
	abnormal platelet physiology	J:250145
	decreased platelet aggregation	J:250145
	increased hemoglobin content	J:250145
	increased mean platelet volume	J:250145
	thrombocytopenia	J:250145
Vwf^tm1.1Vhf/Vwf⁺ (involves: C57BL/6J * C57BL/6N)	abnormal platelet physiology	J:295694
Vwf^tm1.1Vhf/Vwf^tm1.1Vhf (involves: C57BL/6J * C57BL/6N)	abnormal platelet physiology	J:295694
Vwf^tm1Wgr/Vwf^tm1Wgr (involves: 129S2/SvPas * C57BL/6J)	abnormal platelet physiology	J:49083
Wac^{tm2b(EUCOMM)Wtsi}/Wac⁺ (C57BL/6N-Wac^{tm2b(EUCOMM)Wtsi}/Wtsi)	decreased eosinophil cell number	J:211773
	increased Ly6C low monocyte number	J:211773
	increased mean platelet volume	J:211773
	increased monocyte cell number	J:211773
Wars1^{tm1b(EUCOMM)Hmgu}/Wars1⁺ (C57BL/6N-Wars^{tm1b(EUCOMM)Hmgu}/Ieg)	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
	increased erythrocyte cell number	J:211773
	increased red blood cell distribution width	J:211773
Was^tm1Itl/Y (Not Specified)	abnormal dendritic cell morphology	J:153247
	abnormal lymphocyte morphology	J:153247
	decreased NK cell number	J:153247
	decreased T cell number	J:153247
	decreased T cell proliferation	J:153247
	increased B cell number	J:153247
	increased follicular B cell number	J:153247
	increased leukocyte cell number	J:153247
	increased splenocyte number	J:153247
	spleen hyperplasia	J:153247
	thrombocytopenia	J:153247
Was^tm1Itl/Was^tm1Itl (Not Specified)	abnormal dendritic cell morphology	J:153247
	abnormal lymphocyte morphology	J:153247
	decreased NK cell number	J:153247
	decreased T cell number	J:153247
	decreased T cell proliferation	J:153247
	increased B cell number	J:153247
	increased follicular B cell number	J:153247
	increased leukocyte cell number	J:153247
	increased splenocyte number	J:153247
	spleen hyperplasia	J:153247
	thrombocytopenia	J:153247
Was^tm1Kas/Was^tm1Kas (involves: 129/Sv * C57BL/6)	decreased B cell number	J:87875
	decreased double-positive T cell number	J:87875
	decreased lymphocyte cell number	J:87875
	decreased T cell number	J:87875
	thrombocytopenia	J:87875
	thymus hypoplasia	J:87875
Was^tm1Sbs/Y (involves: 129S6/SvEvTac)	abnormal dendritic cell morphology	J:153247
	abnormal lymphocyte morphology	J:153247
	decreased NK cell number	J:153247
	decreased T cell number	J:153247
	decreased T cell proliferation	J:153247
	increased B cell number	J:153247
	increased follicular B cell number	J:153247
	increased leukocyte cell number	J:153247
	increased monocyte cell number	J:153247
	increased splenocyte number	J:153247
	spleen hyperplasia	J:153247
	thrombocytopenia	J:153247
Was^tm1Sbs/Y (involves: 129S6/SvEvTac * C57BL/6)	abnormal B cell physiology	J:182528
	decreased marginal zone B cell number	J:182528
	decreased mature B cell number	J:182528
	increased germinal center B cell number	J:182528
	increased IgA level	J:182528
	increased IgE level	J:182528
	increased IgM level	J:182528
	increased plasma cell number	J:182528
	thrombocytopenia	J:182528
Was^tm1Sbs/Was^tm1Sbs (either: (involves: 129S6/SvEvTac) or (involves: 129S6/SvEvTac * C57BL/6))	decreased B cell number	J:48836
	decreased lymphocyte cell number	J:48836
	decreased T cell number	J:48836
	decreased T cell proliferation	J:48836
	increased neutrophil cell number	J:48836
	thrombocytopenia	J:48836
Was^tm1Sbs/Was^tm1Sbs (involves: C57BL/6 * CBA)	abnormal B cell physiology	J:95909
Was^tm1Sbs/Was^tm1Sbs (involves: 129S/SvEv)	abnormal bone marrow cell morphology/development	J:84888
	abnormal mast cell morphology	J:86835
	abnormal mast cell physiology	J:86835
	abnormal osteoclast differentiation	J:90542
	abnormal osteoclast physiology	J:90542
Was^tm1Sbs/Was^tm1Sbs (involves: BALB/c)	decreased T cell proliferation	J:84131
Was^tm1Sbs/Was^tm1Sbs (involves: 129S6/SvEvTac)	abnormal dendritic cell morphology	J:153247
	abnormal double-negative T cell morphology	J:125309
	abnormal double-positive T cell morphology	J:125309
	abnormal lymphocyte morphology	J:153247
	abnormal thymocyte activation	J:125309
	decreased NK cell number	J:153247
	decreased T cell number	J:153247
	decreased T cell proliferation	J:153247
	increased B cell number	J:153247
	increased follicular B cell number	J:153247
	increased leukocyte cell number	J:153247
	increased monocyte cell number	J:153247
	increased splenocyte number	J:153247
	spleen hyperplasia	J:153247
	thrombocytopenia	J:153247
Was^tm1Sbs/Was^tm1Sbs (129S6/SvEvTac-Was^tm1Sbs/J)	increased IgA level	J:180407
Was^tm1Sbs/Was^tm1Sbs (129S6/SvEvTac-Was^tm1Sbs/J)	increased IgM level	J:180407
Was^tm1Sbs/Was^tm1Sbs (involves: 129S6/SvEvTac * C57BL/6)	abnormal B cell physiology	J:182528
	abnormal megakaryocyte morphology	J:195436
	decreased marginal zone B cell number	J:182528
	decreased mature B cell number	J:182528
	increased germinal center B cell number	J:182528
	increased IgA level	J:182528
	increased IgE level	J:182528
	increased IgM level	J:182528
	increased plasma cell number	J:182528
	thrombocytopenia	J:182528
Was^tm1Sbs/Was^tm1Sbs Wasl^tm2Sbs/Wasl^tm2Sbs Tg(Lck-cre)1Cwi/? (involves: 129S6/SvEvTac * C57BL/6)	abnormal double-negative T cell morphology	J:125309
	abnormal double-positive T cell morphology	J:125309
	abnormal thymocyte activation	J:125309
	decreased regulatory T cell number	J:125309
	decreased single-positive T cell number	J:125309
	decreased T cell number	J:125309
	decreased thymocyte number	J:125309
	increased single-positive T cell number	J:125309
Was^tm2Itl/Y (Not Specified)	abnormal dendritic cell morphology	J:153247
	abnormal lymphocyte morphology	J:153247
	decreased NK cell number	J:153247
	decreased T cell number	J:153247
	decreased T cell proliferation	J:153247
	increased B cell number	J:153247
	increased follicular B cell number	J:153247
	increased leukocyte cell number	J:153247
	increased splenocyte number	J:153247
	thrombocytopenia	J:153247
Was^tm2Itl/Was^tm2Itl (Not Specified)	abnormal dendritic cell morphology	J:153247
	abnormal lymphocyte morphology	J:153247
	decreased NK cell number	J:153247
	decreased T cell number	J:153247
	decreased T cell proliferation	J:153247
	increased B cell number	J:153247
	increased follicular B cell number	J:153247
	increased leukocyte cell number	J:153247
	increased splenocyte number	J:153247
	thrombocytopenia	J:153247
Wasf3^tm1Tta/Wasf3^tm1Tta (Not Specified)	hematopoietic system phenotype	J:149119
Washc5^{tm1a(EUCOMM)Hmgu}/Washc5⁺ (C57BL/6N-Washc5^{tm1a(EUCOMM)Hmgu}/Ieg)	increased mean corpuscular hemoglobin concentration	J:165965
Wbcq1^C57BLKS/J/Wbcq1^C57BLKS/J (involves: C57BLKS/J * SM/J)	increased leukocyte cell number	J:102636
Wbcq1^C57BLKS/J/Wbcq1^SM/J (involves: C57BLKS/J * SM/J)	increased leukocyte cell number	J:102636
Wbcq2^C57BLKS/J/Wbcq2^SM/J (involves: C57BLKS/J * SM/J)	increased leukocyte cell number	J:102636
Wbcq2^C57BLKS/J/Wbcq2^SM/J Wbcq3^C57BLKS/J/Wbcq3^C57BLKS/J (involves: C57BLKS/J * SM/J)	increased leukocyte cell number	J:102636
Wbcq2^SM/J/Wbcq2^SM/J (involves: C57BLKS/J * SM/J)	increased leukocyte cell number	J:102636
Wbcq2^SM/J/Wbcq2^SM/J Wbcq3^C57BLKS/J/Wbcq3^C57BLKS/J (involves: C57BLKS/J * SM/J)	increased leukocyte cell number	J:102636
Wbcq3^C57BLKS/J/Wbcq3^SM/J (involves: C57BLKS/J * SM/J)	increased leukocyte cell number	J:102636
Wbcq3^SM/J/Wbcq3^SM/J (involves: C57BLKS/J * SM/J)	increased leukocyte cell number	J:102636
Wbcq4^NZW/LacJ/Wbcq4^NZW/LacJ (involves: NZW/LacJ * SM/J)	increased leukocyte cell number	J:102636
Wbcq4^NZW/LacJ/Wbcq4^SM/J (involves: NZW/LacJ * SM/J)	increased leukocyte cell number	J:102636
Wbcq5^NZW/LacJ/Wbcq5^NZW/LacJ (involves: NZW/LacJ * SM/J)	increased leukocyte cell number	J:102636
Wbcq6^NZW/LacJ/Wbcq6^NZW/LacJ (involves: NZW/LacJ * SM/J)	increased leukocyte cell number	J:102636
Wbcq6^SM/J/Wbcq6^SM/J (involves: NZW/LacJ * SM/J)	increased leukocyte cell number	J:102636
Wbp1l^{tm2a(EUCOMM)Hmgu}/Wbp1l^{tm2a(EUCOMM)Hmgu} (involves: C57BL/6N)	abnormal embryonic hematopoiesis	J:284781
	abnormal pre-B cell morphology	J:284781
	decreased B cell number	J:284781
	decreased B-1 B cell number	J:284781
	decreased pre-B cell number	J:284781
	decreased pro-B cell number	J:284781
	increased dendritic cell number	J:284781
	increased hematopoietic stem cell number	J:284781
	increased marginal zone B cell number	J:284781
Wbp1l^{tm2c(EUCOMM)Hmgu}/Wbp1l^{tm2c(EUCOMM)Hmgu} Gt(ROSA)26Sor^{tm1(cre/ERT2)Tyj}/Gt(ROSA)26Sor⁺ (involves: 129S4/SvJae * C57BL/6N * SJL)	abnormal bone marrow cell physiology	J:284781
Wbp2^{tm2a(EUCOMM)Wtsi}/Wbp2^{tm2a(EUCOMM)Wtsi} (C57BL/6N-Wbp2^{tm2a(EUCOMM)Wtsi}/Cnrm)	increased leukocyte cell number	J:165965
Wbp11^em1Gcha/Wbp11⁺ (involves: C57BL/6J * FVB/N)	ectopic thymus	J:300837
Wdfy3^em1(IMPC)Mbp/Wdfy3⁺ (C57BL/6N-Wdfy3^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Wdfy4^em1(IMPC)J/Wdfy4^em1(IMPC)J (C57BL/6NJ-Wdfy4^em1(IMPC)J/J)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
Wdfy4^em1Jkln/Wdfy4^em1Jkln (C57BL/6J-Wdfy4^em1Jkln)	decreased dendritic cell number	J:326216
Wdr1^Gt(XN462)Byg/Wdr1^rede (involves: 129P2/OlaHsd * C57BL/6)	thrombocytopenia	J:134092
Wdr1^rede/Wdr1^rede (C57BL/6-Wdr1^rede)	abnormal erythropoiesis	J:134092
	abnormal megakaryocyte morphology	J:134092
	abnormal myelopoiesis	J:134092
	abnormal osteoclast physiology	J:134092
	abnormal platelet alpha-granule morphology	J:134092
	abnormal platelet dense granule morphology	J:134092
	abnormal platelet morphology	J:134092
	abnormal platelet shape	J:134092
	abnormal thrombopoiesis	J:134092
	anemia	J:134092
	impaired neutrophil chemotaxis	J:134092
	increased mean platelet volume	J:134092
	increased megakaryocyte cell number	J:134092
	increased neutrophil cell number	J:134092
	increased osteoclast cell number	J:134092
	thrombocytopenia	J:134092
Wdr11^em1(IMPC)Mbp/Wdr11^em1(IMPC)Mbp (C57BL/6NCrl-Wdr11^em1(IMPC)Mbp/Mmucd)	increased red blood cell distribution width	J:211773
Wdr24^{tm1b(KOMP)Mbp}/Wdr24⁺ (C57BL/6N-Wdr24^{tm1b(KOMP)Mbp}/J)	decreased hematocrit	J:211773
Wdr27^{em1(IMPC)Ccpcz}/Wdr27^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Wdr27^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Wdr33^em1(IMPC)Tcp/Wdr33⁺ (C57BL/6NCrl-Wdr33^em1(IMPC)Tcp/Tcp)	decreased mean corpuscular hemoglobin concentration	J:211773
Wdr37^{tm1a(KOMP)Wtsi}/Wdr37^{tm1a(KOMP)Wtsi} (C57BL/6N-Wdr37^{tm1a(KOMP)Wtsi}/Wtsi)	decreased leukocyte cell number	J:211773
Wdr41^em1(IMPC)J/Wdr41^em1(IMPC)J (C57BL/6NJ-Wdr41^em1(IMPC)J/Mmjax)	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
Wdr41^m1Btlr/Wdr41^m1Btlr (C57BL/6J-Wdr41^m1Btlr)	increased CD4-positive, alpha-beta T cell number	J:268243
Wdr41^m1Btlr/Wdr41^m1Btlr (C57BL/6J-Wdr41^m1Btlr)	increased CD8-positive, alpha-beta T cell number	J:268243
Wdr41^m2Btlr/Wdr41^m2Btlr (C57BL/6J-Wdr41^m2Btlr)	increased CD4-positive, alpha-beta T cell number	J:268243
Wdr41^m2Btlr/Wdr41^m2Btlr (C57BL/6J-Wdr41^m2Btlr)	increased CD8-positive, alpha-beta T cell number	J:268243
Wdr45^em1Wrst/Y (involves: C57BL/6N * FVB)	anisocytosis	J:307284
	increased erythrocyte cell number	J:307284
	increased hemoglobin content	J:307284
	increased leukocyte cell number	J:307284
Wdr45^em1Wrst/Wdr45^em1Wrst (involves: C57BL/6N * FVB)	anisocytosis	J:307284
Wdr45^em1Wrst/Wdr45^em1Wrst (involves: C57BL/6N * FVB)	hematopoietic system phenotype	J:307284
Wdr47^{tm1a(EUCOMM)Wtsi}/Wdr47^{tm1a(EUCOMM)Wtsi} (B6JTyr;B6N-Wdr47^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased hemoglobin content	J:165965
Wdr53^em1(IMPC)J/Wdr53^em1(IMPC)J (C57BL/6NJ-Wdr53^em1(IMPC)J/Mmjax)	increased erythrocyte cell number	J:211773
	increased hematocrit	J:211773
Wdr59^{tm1b(EUCOMM)Wtsi}/Wdr59⁺ (C57BL/6N-Wdr59^{tm1b(EUCOMM)Wtsi}/Wtsi)	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
	decreased leukocyte cell number	J:211773
Wee1^{tm1b(EUCOMM)Wtsi}/Wee1⁺ (C57BL/6N-Wee1^{tm1b(EUCOMM)Wtsi}/Tcp)	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular hemoglobin concentration	J:211773
Wfdc2^em1Fcw/Wfdc2^em1Fcw (involves: C57)	hematopoietic system phenotype	J:293623
Whrn^wi/Whrn^wi (involves: C57BL/6J * STOCK a Tyrp1^b Myo5a^d Oca2^p Ednrb^s)	decreased leukocyte cell number	J:5538
	decreased thymus weight	J:5037
Wipf1^tm1Geha/Wipf1^tm1Geha (involves: 129S6/SvEvTac)	abnormal T cell physiology	J:74719
	decreased T cell proliferation	J:74719
	decreased thymocyte number	J:74719
	increased B cell proliferation	J:74719
	increased IgE level	J:74719
	increased IgM level	J:74719
	thymus hypoplasia	J:74719
Wipf1^tm1Geha/Wipf1^tm1Geha (involves: 129S6/SvEvTac * C57BL/6)	abnormal alpha-beta T cell morphology	J:116168
	abnormal bone marrow cell morphology/development	J:116168
	abnormal erythropoiesis	J:116168
	abnormal hemopoiesis	J:116168
	abnormal lymphopoiesis	J:116168
	abnormal spleen morphology	J:116168
	abnormal thymus morphology	J:116168
	decreased B cell number	J:116168
	decreased follicular B cell number	J:116168
	decreased lymphocyte cell number	J:116168
	decreased marginal zone B cell number	J:116168
	decreased spleen white pulp amount	J:116168
	decreased thymus weight	J:116168
	enlarged spleen	J:116168
	increased granulocyte number	J:116168
	increased IgA level	J:116168
	increased monocyte cell number	J:116168
	increased spleen red pulp amount	J:116168
Wipi1^em1(IMPC)Mbp/Wipi1^em1(IMPC)Mbp (C57BL/6NCrl-Wipi1^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Wls^tm1.1Arte/Wls^tm1.1Arte Krt14^tm1(cre)Wbm/Krt14⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal T cell differentiation	J:202499
	abnormal T cell physiology	J:202499
	abnormal T cell subpopulation ratio	J:202499
	cutaneous mastocytosis	J:202499
	decreased double-positive T cell number	J:202499
	decreased gamma-delta T cell number	J:202499
	decreased T cell number	J:202499
	decreased thymus weight	J:202499
	increased double-negative T cell number	J:202499
	increased macrophage cell number	J:202499
	increased neutrophil cell number	J:202499
	increased T cell proliferation	J:202499
	small thymus medulla	J:202499
	thymus atrophy	J:202499
	thymus hypoplasia	J:202499
Wnk1^tm2.1Juha/Wnk1⁺ Tg(Pgk1-cre)1Lni/0 (involves: 129S2/SvPas * BALB/c * C57BL/6 * SJL)	decreased hematocrit	J:200742
Wnt1^tm1Brd/Wnt1^tm1Brd (involves: 129S7/SvEvBrd * C57BL/6J)	decreased thymocyte number	J:75999
Wnt1^tm1Brd/Wnt1^tm1Brd Wnt4^tm1Amc/Wnt4^tm1Amc (involves: 129S1/Sv * 129S7/SvEvBrd * C57BL/6J)	decreased thymocyte number	J:75999
Wnt2b^{tm1b(EUCOMM)Wtsi}/Wnt2b^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Wnt2b^{tm1b(EUCOMM)Wtsi}/Tcp)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	small spleen	J:211773
Wnt4^tm1Amc/Wnt4^tm1Amc (involves: 129S1/Sv)	decreased thymocyte number	J:75999
Wnt5a^b2b3077.1Clo/Wnt5a^b2b3077.1Clo (C57BL/6J-Wnt5a^b2b3077.1Clo)	thymus hypoplasia	J:175213
Wnt6^{tm1b(NCOM)Mfgc}/Wnt6⁺ (C57BL/6N-Wnt6^{tm1b(NCOM)Mfgc}/Tcp)	decreased mean corpuscular hemoglobin concentration	J:211773
Wrn^b2b3121.1Clo/Wrn^b2b3121.1Clo (C57BL/6J-Wrn^b2b3121.1Clo)	thymus hypoplasia	J:175213
Wrn^tm1Lgu/Wrn^tm1Lgu (B6J.Cg-Wrn^tm1Lgu)	increased osteoclast cell number	J:213181
Wrnip1^{tm1a(EUCOMM)Wtsi}/Wrnip1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Wrnip1^{tm1a(EUCOMM)Wtsi}/Cnrm)	decreased T cell number	J:165965
Wrnip1^{tm1b(EUCOMM)Wtsi}/Wrnip1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Wrnip1^{tm1b(EUCOMM)Wtsi}/Ieg)	increased mean corpuscular volume	J:211773
Wt1^tm1Jae/Wt1^tm1Jae (involves: 129S4/SvJae * C57BL/6 * MF1)	abnormal spleen development	J:56651
	absent spleen	J:56651
	increased splenocyte apoptosis	J:56651
Wwox^em1Mald/Wwox^em1Mald (FVB/N-Wwox^em1Mald)	microgliosis	J:339564
Wwox^tm1.1Mald/Wwox^tm1.1Mald (involves: C57BL/6 * FVB/N)	abnormal thymus cortex morphology	J:155406
	anemia	J:155406
	decreased leukocyte cell number	J:155406
	decreased spleen weight	J:155406
	decreased thymus weight	J:155406
	small spleen	J:155406
	spleen atrophy	J:155406
Wwox^tm1Ria/Wwox⁺ (involves: 129X1/SvJ * C57BL/6)	enlarged spleen	J:120064
Wwox^tm1Ria/Wwox^tm1Ria (involves: 129X1/SvJ * C57BL/6J)	abnormal osteoclast physiology	J:138140
Xbp1^{tm1a(EUCOMM)Wtsi}/Xbp1⁺ (C57BL/6N-Xbp1^{tm1a(EUCOMM)Wtsi}/Ics)	decreased IgG1 level	J:165965
	decreased T cell number	J:165965
Xbp1^{tm1b(EUCOMM)Wtsi}/Xbp1⁺ (C57BL/6N-Xbp1^{tm1b(EUCOMM)Wtsi}/Ics)	decreased large unstained cell number	J:211773
	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	decreased red blood cell distribution width	J:211773
	increased mean corpuscular hemoglobin	J:211773
	increased mean corpuscular volume	J:211773
Xbp1^tm1Glm/Xbp1^tm1Glm (involves: 129S2/SvPas)	anemia	J:59916
Xbp1^tm1Glm/Xbp1^tm1Glm (involves: 129S2/SvPas)	impaired hematopoiesis	J:59916
Xcl1^tm1.1Dnax/Xcl1^tm1.1Dnax (either: (involves: 129/Sv * BALB/c) or (involves: 129/Sv * C57BL/6))	decreased dendritic cell number	J:176844
	decreased regulatory T cell number	J:176844
	increased dendritic cell number	J:176844
Xcl1^tm1Rakr/Xcl1^tm1Rakr (B6.129-Xcl1^tm1Rakr)	decreased cytotoxic T cell cytolysis	J:155297
Xcl1^tm1Rakr/Xcl1^tm1Rakr Tg(TcraTcrb)1100Mjb/0 (involves: 129/Sv * C57BL/6)	abnormal CD8-positive, alpha-beta T cell physiology	J:155297
	decreased cytotoxic T cell cytolysis	J:155297
	decreased T cell number	J:155297
Xcr1^{tm2(HBEGF/Venus)Ksho}/Xcr1⁺ (involves: C57BL/6 * C57BL/6J)	abnormal CD8-positive, alpha-beta T cell physiology	J:204851
	decreased dendritic cell number	J:204851
Xk^tm1Ariv/Y (B6.Cg-Xk^tm1Ariv)	abnormal erythrocyte ion content	J:212528
	increased erythrocyte magnesium level	J:212528
	increased mean corpuscular hemoglobin concentration	J:212528
Xpa^tm1Hvs/Xpa^tm1Hvs (involves: 129P2/OlaHsd * C57BL/6)	anemia	J:28710
Xpa^tm1Hvs/Xpa^tm1Hvs (involves: 129P2/OlaHsd * C57BL/6)	impaired hematopoiesis	J:28710
Xpa^tm1Tnka/Xpa^tm1Tnka (involves: C57BL/6 * CBA)	abnormal lymphocyte physiology	J:55739
	abnormal NK cell physiology	J:55739
	increased NK cell number	J:55739
Xpna/Xpna (involves: 101/H * BALB/c * C3H/HeH)	anemia	J:169366
Xpnpep1^{tm1a(KOMP)Wtsi}/Xpnpep1^{tm1a(KOMP)Wtsi} (C57BL/6N-Xpnpep1^{tm1a(KOMP)Wtsi}/Wtsi)	abnormal thymus morphology	J:239583
	increased gamma-delta T cell number	J:211773
	increased NK cell number	J:211773
Xpo5^em1(IMPC)Mbp/Xpo5⁺ (C57BL/6NCrl-Xpo5^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Xpo7^em1.1Gmkf/Xpo7^em1.1Gmkf (involves: C57BL/6 * FVB/N)	abnormal hematopoietic system physiology	J:331429
	abnormal stress erythropoiesis	J:331429
	anemia	J:331429
	decreased erythrocyte cell number	J:331429
	decreased hematocrit	J:331429
	hematopoietic system phenotype	J:331429
	increased erythroid progenitor cell number	J:331429
	increased red blood cell distribution width	J:331429
	reticulocytosis	J:331429
Xpo7^{tm1c(KOMP)Wtsi}/Xpo7^{tm1c(KOMP)Wtsi} Gt(ROSA)26Sor^{tm1(cre/ERT2)Tyj}/Gt(ROSA)26Sor⁺ (involves: 129S4/SvJae * C57BL/6N)	decreased hematocrit	J:331429
Xpo7^{tm1d(KOMP)Wtsi}/Xpo7^{tm1d(KOMP)Wtsi} (involves: C57BL/6N * FVB/N)	abnormal erythroid lineage cell morphology	J:331429
	abnormal stress erythropoiesis	J:331429
	anemia	J:331429
	hematopoietic system phenotype	J:331429
	increased red blood cell distribution width	J:331429
	reticulocytosis	J:331429
Xrcc3^{tm1b(KOMP)Mbp}/Xrcc3⁺ (C57BL/6N-Xrcc3^{tm1b(KOMP)Mbp}/J)	decreased mean corpuscular volume	J:211773
Xrcc4^tm1Fwa/Xrcc4^tm1Fwa (involves: 129P2/OlaHsd * C57BL/6)	thymus hypoplasia	J:65218
Xrcc5^m1Btlr/Xrcc5^m1Btlr (C57BL/6J-Xrcc5^m1Btlr)	abnormal B cell differentiation	J:274736
	abnormal CD8-positive, alpha-beta T cell differentiation	J:274736
	abnormal T cell differentiation	J:274736
	decreased B-2 B cell number	J:274736
	decreased CD4-positive, alpha-beta T cell number	J:274736
	decreased CD8-positive, alpha-beta T cell number	J:274736
	decreased CD8-positive, naive alpha-beta T cell number	J:274736
	decreased T cell number	J:274736
	increased B-1a cell number	J:274736
	increased B-1b cell number	J:274736
	increased CD4-positive, alpha-beta T cell number	J:274736
	increased dendritic cell number	J:274736
	increased effector memory CD4-positive, alpha-beta T cell number	J:274736
	increased effector memory CD8-positive, alpha-beta T cell number	J:274736
	increased neutrophil cell number	J:274736
Xrcc5^tm1Dbr/Xrcc5^tm1Dbr (involves: 129S1/Sv * C57BL/6)	abnormal B cell differentiation	J:34834
	absent T cells	J:34834
	arrested B cell differentiation	J:34834
	arrested T cell differentiation	J:34834
	increased double-negative T cell number	J:34834
	thymus hypoplasia	J:34834
Xrcc5^tm1Dbr/Xrcc5^tm1Dbr Lig4^tm1Fwa/Lig4^tm1Fwa (involves: 129S6/SvEvTac * C57BL/6)	abnormal lymphocyte morphology	J:80467
Xrcc5^tm1Nus/Xrcc5^tm1Nus (involves: 129S1/Sv * 129X1/SvJ)	abnormal bone marrow cell morphology/development	J:108657
	abnormal class switch recombination	J:120658
	spleen hypoplasia	J:108657
	thymus hypoplasia	J:108657
Xrcc6^avon/Xrcc6^avon (involves: C57BL/6JAnu)	decreased B cell number	J:104190
Xrcc6^avon/Xrcc6^avon (involves: C57BL/6JAnu)	decreased T cell number	J:104190
Xrcc6^tm1Fwa/Xrcc6^tm1Fwa (involves: 129S6/SvEvTac * C57BL/6J)	abnormal B cell differentiation	J:44361
	abnormal B cell morphology	J:44361
	abnormal T cell differentiation	J:44361
	abnormal T cell morphology	J:44361
	absent immature B cells	J:44361
	absent mature B cells	J:44361
	absent pre-B cells	J:44361
	arrested B cell differentiation	J:44361
	decreased IgM level	J:44361
	decreased single-positive T cell number	J:44361
	decreased thymocyte number	J:44361
	increased double-positive T cell number	J:44361
Xrcc6^tm1Gcl/Xrcc6^tm1Gcl (involves: 129S1/Sv * C57BL/6)	abnormal B cell differentiation	J:108657
	abnormal bone marrow cell morphology/development	J:108657
	absent mature B cells	J:108657
	decreased spleen white pulp amount	J:108657
	small spleen	J:108657
	small thymus	J:108657
	spleen hypoplasia	J:108657
	thymus hypoplasia	J:108657
Xylt1^npo/Xylt1^npo (involves: C57BL/6J * FVB/NJ)	abnormal osteoclast differentiation	J:205339
X/Yaa ((NZB x BXSB)F1)	decreased erythrocyte cell number	J:6235
X/Yaa ((NZB x BXSB)F1)	increased spleen weight	J:6235
X/Yaa (BXSB/MpJ)	abnormal B cell differentiation	J:108760
	abnormal spleen B cell follicle morphology	J:179430
	abnormal T cell subpopulation ratio	J:179430
	decreased erythrocyte cell number	J:6235
	increased IgG1 level	J:179430, J:93740
	increased IgG2a level	J:179430
	increased IgG2b level	J:179430
	increased IgG3 level	J:93740
	increased monocyte cell number	J:7308
	increased plasma cell number	J:108760
	increased spleen weight	J:6235
	increased splenocyte number	J:179430
X/Yaa (BXSB/MpJScr)	decreased CD4-positive, alpha-beta T cell number	J:10973
	increased IgG level	J:10973
	increased monocyte cell number	J:10973
X/Yaa ((NZB x B6.SB/Le-Yaa)F1)	increased monocyte cell number	J:129409
X/Yaa (B6.SB-Yaa/J)	decreased marginal zone B cell number	J:127600
X/Yaa (B6.SB-Yaa/J)	increased splenocyte proliferation	J:127600
Ybx1^tm1Tuch/Ybx1^tm1Tuch (involves: 129S/SvEv * C57BL/6)	abnormal definitive hematopoiesis	J:117725
Ydjc^{tm1(KOMP)Wtsi}/Ydjc^{tm1(KOMP)Wtsi} (C57BL/6N-Ydjc^{tm1(KOMP)Wtsi}/Wtsi)	increased effector memory T-helper cell number	J:211773
	increased germinal center B cell number	J:211773
Ydjc^{tm1.1(KOMP)Vlcg}/Ydjc^{tm1.1(KOMP)Vlcg} (C57BL/6N-Ydjc^{tm1.1(KOMP)Vlcg}/J)	increased erythrocyte cell number	J:211773
	increased hematocrit	J:211773
	increased hemoglobin content	J:211773
Yeats4^em1Zfa/Yeats4^em1Zfa Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: C57BL/6 * C57BL/10 * CBA/Ca)	abnormal lymphocyte physiology	J:282740
	abnormal lymphopoiesis	J:282740
	decreased lymphocyte cell number	J:282740
Yipf5^{tm1b(EUCOMM)Hmgu}/Yipf5⁺ (C57BL/6N-Yipf5^{tm1b(EUCOMM)Hmgu}/Ics)	decreased erythrocyte cell number	J:211773
Yipf6^em1(IMPC)Mbp/Yipf6^em1(IMPC)Mbp (C57BL/6N-Yipf6^em1(IMPC)Mbp/MbpMmucd)	increased monocyte cell number	J:211773
Ykt6^em1(IMPC)J/Ykt6⁺ (C57BL/6NJ-Ykt6^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Yod1^tm1bNarl/Yod1^tm1bNarl (C57BL/6N-Yod1^tm1bNarl/Narl)	decreased lymphocyte cell number	J:211773
Yod1^tm1bNarl/Yod1^tm1bNarl (C57BL/6N-Yod1^tm1bNarl/Narl)	increased neutrophil cell number	J:211773
Ypel3^{tm1.1(KOMP)Vlcg}/Ypel3^{tm1.1(KOMP)Vlcg} (C57BL/6N-Ypel3^{tm1.1(KOMP)Vlcg}/Ucd)	increased mean corpuscular volume	J:211773
Ythdf3^em1(IMPC)Mbp/Ythdf3^em1(IMPC)Mbp (C57BL/6N-Ythdf3^em1(IMPC)Mbp/MbpMmucd)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Ythdf3^em1Caox/Ythdf3^em1Caox (involves: C57BL/6J)	abnormal macrophage physiology	J:276397
Ywhab^{tm1b(EUCOMM)Hmgu}/Ywhab^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Ywhab^{tm1b(EUCOMM)Hmgu}/Ieg)	thrombocytopenia	J:211773
Ywhaz^{tm1b(EUCOMM)Hmgu}/Ywhaz⁺ (C57BL/6N-Ywhaz^{tm1b(EUCOMM)Hmgu}/Tcp)	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
Zap70^m1Btlr/Zap70^m1Btlr (involves: C57BL/6J)	abnormal class switch recombination	J:185495
	absent CD4-positive, alpha-beta T cells	J:167119
	absent CD8-positive, alpha-beta T cells	J:167119
	decreased IgG level	J:185495
	decreased T cell number	J:185495
Zap70^m1Saka/Zap70^m1Saka (involves: BALB/c)	abnormal positive T cell selection	J:154166, J:86607
	abnormal splenic cell ratio	J:154166
	abnormal T cell clonal deletion	J:154166
	abnormal T cell differentiation	J:86607
	abnormal T cell selection	J:86607
	abnormal thymocyte activation	J:154166
	abnormal thymus cell ratio	J:154166
	decreased CD4-positive, alpha-beta T cell number	J:154166, J:86607
	decreased CD8-positive, alpha-beta T cell number	J:154166, J:86607
	decreased regulatory T cell number	J:154166
	decreased T cell proliferation	J:154166, J:86607
	increased activated T cell number	J:154166
	increased B cell number	J:86607
	increased immunoglobulin level	J:86607
	increased memory T cell number	J:154166
Zap70^m1Saka/Zap70^m1Saka Tg(DO11.10)10Dlo/0 (involves: BALB/c * C3H * C57BL/6)	decreased T cell number	J:86607
	decreased T cell proliferation	J:86607
Zap70^m1Saka/Zap70^m1Saka Tg(TcraH-Y,TcrbH-Y)71Vbo/0 (involves: BALB/c * C57BL/6J * DBA/2J)	abnormal positive T cell selection	J:86607
Zap70^m1Saka/Zap70^tm2.1Weis (involves: 129S4/SvJae * BALB/c)	abnormal T cell clonal deletion	J:154166
Zap70^m2Btlr/Zap70^m2Btlr (involves: C57BL/6J)	decreased T cell number	J:174837
Zap70^m3Btlr/Zap70^m3Btlr (C57BL/6J-Zap70^m3Btlr)	decreased IgG level	J:225043
Zap70^m4Btlr/Zap70^m4Btlr (C57BL/6J-Zap70^m4Btlr)	decreased CD4-positive, alpha-beta T cell number	J:236698
	decreased CD8-positive, alpha-beta T cell number	J:236698
	decreased T cell number	J:236698
	impaired hematopoiesis	J:236698
Zap70^m5Btlr/Zap70^m5Btlr (C57BL/6J-Zap70^m5Btlr)	decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:254830
	decreased CD8-positive, alpha-beta T cell number	J:254830
	decreased CD8-positive, naive alpha-beta T cell number	J:254830
	decreased IgG level	J:254830
	increased B cell number	J:254830
	increased central memory CD4-positive, alpha-beta T cell number	J:254830
	increased central memory CD8 positive, alpha-beta T cell number	J:254830
	increased effector memory CD4-positive, alpha-beta T cell number	J:254830
Zap70^m6Btlr/Zap70^m6Btlr (C57BL/6J-Zap70^m6Btlr)	decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:254831
	decreased CD8-positive, alpha-beta T cell number	J:254831
	decreased CD8-positive, naive alpha-beta T cell number	J:254831
	decreased IgG level	J:254831
	increased B cell number	J:254831
	increased central memory CD4-positive, alpha-beta T cell number	J:254831
	increased central memory CD8 positive, alpha-beta T cell number	J:254831
	increased effector memory CD4-positive, alpha-beta T cell number	J:254831
Zap70^m6Hefl/Zap70^m6Hefl (C3HeB/FeJ-Zap70^m6Hefl)	abnormal T cell differentiation	J:137446
	decreased CD4-positive, alpha-beta T cell number	J:137446
	decreased CD8-positive, alpha-beta T cell number	J:137446
	decreased T cell number	J:137446
	increased IgE level	J:137446
	increased IgG1 level	J:137446
Zap70^m6Hefl/Zap70^tm1Weis (involves: 129X1/SvJ * C3HeB/FeJ * C57BL/10 * DBA/2)	decreased T cell number	J:137446
	increased IgE level	J:137446
Zap70^m7Btlr/Zap70^m7Btlr (C57BL/6J-Zap70^m7Btlr)	decreased IgG level	J:254832
	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:254832
	increased central memory CD8 positive, alpha-beta T cell number	J:254832
Zap70^m8Btlr/Zap70^m8Btlr (C57BL/6J-Zap70^m8Btlr)	decreased CD8-positive, naive alpha-beta T cell number	J:272864
Zap70^m8Btlr/Zap70^m8Btlr (C57BL/6J-Zap70^m8Btlr)	increased central memory CD8 positive, alpha-beta T cell number	J:272864
Zap70^mrtle/Zap70^mrtle (C57BL/6JSfdAnu-Zap70^mrtle/Apb)	abnormal positive T cell selection	J:104190
	abnormal T cell subpopulation ratio	J:104190
	absent T cells	J:104190
	arrested T cell differentiation	J:104190
	decreased T cell number	J:104190
Zap70^mrtle/Zap70^mrtle (involves: C57BL/6JSfdAnu)	abnormal double-positive T cell morphology	J:211510
	abnormal regulatory T cell number	J:211510
	decreased CD4-positive, alpha-beta T cell number	J:211510
	decreased CD8-positive, alpha-beta T cell number	J:211510
	increased double-positive T cell number	J:211510
Zap70^mrtle/Zap70^rps (involves: C57BL/6 * C57BL/6JSfdAnu)	abnormal CD4-positive, alpha beta T cell morphology	J:211510
	abnormal double-positive T cell morphology	J:211510
	abnormal regulatory T cell number	J:211510
	decreased CD4-positive, alpha-beta T cell number	J:211510
	decreased CD8-positive, alpha-beta T cell number	J:211510
	increased double-positive T cell number	J:211510
Zap70^mur/Zap70^mur (C57BL/6Apb-Zap70^mur/ApbH)	abnormal T cell activation	J:104190
	abnormal T cell physiology	J:104190
	decreased T cell number	J:104190
	increased IgG2b level	J:104190
Zap70^st/Zap70^st (involves: C57BL/6)	abnormal T cell physiology	J:41170
	arrested T cell differentiation	J:41170
	decreased T cell number	J:41170
	thymus hypoplasia	J:41170
Zap70^st/Zap70^tm1Dlo (involves: C57BL/6)	arrested T cell differentiation	J:41170
Zap70^tm1.1Mmal/Zap70^tm1.1Mmal Tg(TcrLCMV)327Sdz/0 (involves: 129P2/OlaHsd * BALB/cJ * C57BL/6 * DBA/2)	abnormal T cell proliferation	J:71099
Zap70^tm1Dlo/Zap70^tm1Dlo (involves: 129P2/OlaHsd)	increased double-positive T cell number	J:97610
Zap70^tm1Weis/Zap70^tm1Weis (involves: 129X1/SvJ * C57BL/6J)	abnormal splenic cell ratio	J:74974
	abnormal T cell differentiation	J:74974
	arrested T cell differentiation	J:74974
Zap70^tm2.1Mmal/Zap70^tm2.1Mmal Tg(TcraH-Y,TcrbH-Y)71Vbo/0 (involves: 129P2/OlaHsd * BALB/cJ * C57BL/6J * DBA/2J)	abnormal T cell morphology	J:71099
	abnormal thymus cell ratio	J:71099
Zap70^tm2.1Mmal/Zap70^tm2.1Mmal Tg(TcrLCMV)327Sdz/0 (involves: 129P2/OlaHsd * BALB/cJ * C57BL/6 * DBA/2)	abnormal T cell morphology	J:71099
Zap70^tm2.1Weis/Zap70^tm2.1Weis (B6.129S4-Zap70^tm2.1Weis)	abnormal CD8-positive, alpha-beta T cell differentiation	J:154166
	abnormal thymus cell ratio	J:154166
	decreased CD4-positive, alpha-beta T cell number	J:154166
	decreased CD8-positive, alpha-beta T cell number	J:154166
Zap70^tm2.1Weis/Zap70^tm2.1Weis (C.129S4-Zap70^tm2.1Weis)	abnormal positive T cell selection	J:154166
	abnormal regulatory T cell physiology	J:154166
	abnormal splenic cell ratio	J:154166
	abnormal T cell clonal deletion	J:154166
	abnormal thymocyte activation	J:154166
	abnormal thymus cell ratio	J:154166
	decreased CD4-positive, alpha-beta T cell number	J:154166
	decreased CD8-positive, alpha-beta T cell number	J:154166
	decreased regulatory T cell number	J:154166
	decreased T cell proliferation	J:154166
	increased activated T cell number	J:154166
	increased memory T cell number	J:154166
Zap70^tm2.1Weis/Zap70^tm2.1Weis Tg(DO11.10)10Dlo/? (involves: 129S4/SvJae * BALB/c * C3H * C57BL/6)	abnormal positive T cell selection	J:154166
Zap70^tm2.1Weis/Zap70^tm2.1Weis Tg(TcraH-Y,TcrbH-Y)71Vbo/? (involves: 129S4/SvJae * C57BL/6J * DBA/2J)	abnormal positive T cell selection	J:154166
	abnormal T cell clonal deletion	J:154166
Zbed4^{tm1.1(KOMP)Mbp}/Zbed4⁺ (C57BL/6N-Zbed4^{tm1.1(KOMP)Mbp}/Ucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Zbtb1^m1Btlr/Zbtb1^m1Btlr (involves: C3H/HeN * C57BL/6J)	abnormal B cell differentiation	J:178820
	abnormal T cell differentiation	J:178820
	abnormal thymus morphology	J:178820
	decreased B cell number	J:178820
	decreased CD4-positive, alpha-beta T cell number	J:178820
	decreased CD8-positive, alpha-beta T cell number	J:178820
	decreased DN2 thymocyte number	J:178820
	decreased DN3 thymocyte number	J:178820
	decreased DN4 thymocyte number	J:178820
	decreased double-positive T cell number	J:178820
	decreased follicular B cell number	J:178820
	decreased NK cell number	J:178820
	decreased T cell number	J:178820
	decreased transitional stage B cell number	J:178820
	hematopoietic system phenotype	J:178820
	increased B cell number	J:178820
	thymus hypoplasia	J:178820
Zbtb1^m2Btlr/Zbtb1^m2Btlr (C57BL/6J-Zbtb1^m2Btlr)	abnormal CD8-positive, alpha-beta T cell differentiation	J:272845
Zbtb1^m2Btlr/Zbtb1^m2Btlr (C57BL/6J-Zbtb1^m2Btlr)	increased central memory CD8 positive, alpha-beta T cell number	J:272845
Zbtb7a^tm1Ppp/Zbtb7a^tm1Ppp (B6.129S1-Zbtb7a^tm1Ppp)	abnormal lymphopoiesis	J:121576
	decreased B cell number	J:121576
	decreased pro-B cell number	J:121576
	hematopoietic system phenotype	J:121576
Zbtb7a^tm1Ppp/Zbtb7a^tm2Ppp Tg(Mx1-cre)1Cgn/0 (involves: 129S1/Sv * C57BL/6 * CBA)	abnormal B cell differentiation	J:121576
	abnormal double-positive T cell morphology	J:121576
	decreased B cell number	J:121576
	decreased leukocyte cell number	J:121576
	increased hematopoietic stem cell number	J:121576
Zbtb7b^hd/Zbtb7b^hd (involves: 129/Sv * BALB/c * C3H * C57BL/6)	abnormal CD4-positive T cell differentiation	J:48734
	absent CD4-positive, alpha-beta T cells	J:48734
	increased CD8-positive, alpha-beta T cell number	J:48734
Zbtb7b^hpls/Zbtb7b^hpls (involves: C57BL/6JAnu)	decreased CD4-positive, alpha-beta T cell number	J:104190
Zbtb7b^tm1.1Rbo/Zbtb7b^tm1.1Rbo (Not Specified)	abnormal CD8-positive, alpha-beta T cell number	J:141145
	abnormal T cell differentiation	J:141145
	decreased CD4-positive, alpha-beta T cell number	J:141145
Zbtb7b^tm1.1Skok/Zbtb7b^tm1.1Skok (involves: 129/Sv * C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:169841
Zbtb7b^tm1Itan/Zbtb7b^tm1Tani (involves: 129 * C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:141142
	abnormal CD4-positive, alpha-beta T cell physiology	J:141142
	decreased CD4-positive, alpha-beta T cell number	J:141142
	increased CD8-positive, alpha-beta T cell number	J:141142
	increased double-negative T cell number	J:141142
Zbtb7b^tm1Itan/Zbtb7b^tm2Itan (involves: 129 * C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:141142
	increased CD8-positive, alpha-beta T cell number	J:141142
	increased double-negative T cell number	J:141142
Zbtb7b^tm1Litt/Zbtb7b^tm1.2Litt (involves: C57BL/6)	abnormal double-positive T cell morphology	J:141144
	decreased CD4-positive, alpha-beta T cell number	J:141144
	increased CD8-positive, alpha-beta T cell number	J:141144
Zbtb7b^tm1Tani/Zbtb7b^tm1Tani (involves: 129 * C57BL/6)	increased double-negative T cell number	J:141142
Zbtb7b^tm2Litt/Zbtb7b^tm1.2Litt (involves: 129P2/OlaHsd)	decreased CD4-positive, alpha-beta T cell number	J:141144
Zbtb7b^tm2Litt/Zbtb7b^tm1.2Litt Tg(Lck-cre)1Cwi/? (involves: 129P2/OlaHsd * C57BL/6)	abnormal T cell differentiation	J:141144
	decreased CD4-positive, alpha-beta T cell number	J:141144
Zbtb7b^tm2Litt/Zbtb7b^tm2Litt (involves: 129P2/OlaHsd * C57BL/6 * FVB/N)	absent CD4-positive, alpha-beta T cells	J:141519
Zbtb7b^tm2Tani/Zbtb7b⁺ (Not Specified)	decreased CD8-positive, alpha-beta T cell number	J:131081
Zbtb7b^tm4.1Itan/Zbtb7b^tm4.1Itan (Not Specified)	decreased CD4-positive, alpha-beta T cell number	J:193321
Zbtb7b^tm4.1Itan/Zbtb7b^tm4.1Itan (Not Specified)	increased CD8-positive, alpha-beta T cell number	J:193321
Zbtb7b^tm6.1Itan/Zbtb7b^tm6.1Itan Tg(Cd4-cre)1Cwi/? (involves: C57BL/6 * DBA/2)	decreased CD8-positive, alpha-beta T cell number	J:195348
Zbtb7b^tm7Itan/Zbtb7b^tm7Itan (Not Specified)	decreased CD4-positive, alpha-beta T cell number	J:195348
Zbtb16^em1(IMPC)Mbp/Zbtb16^em1(IMPC)Mbp (C57BL/6NCrl-Zbtb16^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	small spleen	J:211773
Zbtb16^lu/Zbtb16^lu (B6.C3-Zbtb16^lu/J)	decreased NK T cell number	J:139690
Zbtb16^tm1Geno/Zbtb16^tm1Geno (Not Specified)	abnormal bone marrow cell physiology	J:199097
Zbtb16^tm1Ppp/Zbtb16^tm1Ppp (involves: 129S1/Sv)	hematopoietic system phenotype	J:65878
Zbtb16^tm2Geno/Zbtb16^tm2Geno (Not Specified)	abnormal bone marrow cell physiology	J:199097
Zbtb17^tm1Cksn/Zbtb17^tm1Cksn Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (B6.Cg-Zbtb17^tm1Cksn Commd10^{Tg(Vav1-icre)A2Kio})	arrested T cell differentiation	J:170508
	decreased DN1 thymic pro-T cell number	J:170508
	decreased DN2 thymocyte number	J:170508
	decreased DN3 thymocyte number	J:170508
	decreased double-negative T cell number	J:170508
	decreased gamma-delta T cell number	J:170508
	decreased T cell number	J:170508
	decreased thymocyte number	J:170508
	increased T cell apoptosis	J:170508
	thymus hypoplasia	J:170508
Zbtb24^{tm1b(EUCOMM)Hmgu}/Zbtb24⁺ (C57BL/6N-Zbtb24^{tm1b(EUCOMM)Hmgu}/Ieg)	decreased red blood cell distribution width	J:211773
Zbtb32^tm1Iho/Zbtb32^tm1Iho (involves: BALB/c)	increased T cell proliferation	J:94944
Zbtb32^tm1Iho/Zbtb32^tm1Iho (involves: C57BL/6)	increased T cell proliferation	J:94944
Zbtb32^tm2Ppp/Zbtb32^tm2Ppp (involves: 129S1/Sv)	abnormal definitive hematopoiesis	J:95119
Zbtb32^tm2Ppp/Zbtb32^tm2Ppp (involves: 129S1/Sv)	increased T cell proliferation	J:95119
Zbtb43^{tm1b(KOMP)Mbp}/Zbtb43^{tm1b(KOMP)Mbp} (C57BL/6N-Zbtb43^{tm1b(KOMP)Mbp}/J)	increased mean corpuscular volume	J:211773
Zbtb46^{tm1(HBEGF)Mnz}/Zbtb46⁺ (C57BL/6-Zbtb46^{tm1(HBEGF)Mnz})	abnormal memory T cell physiology	J:189122
	abnormal T-helper 1 physiology	J:189122
	decreased dendritic cell number	J:189122
	increased monocyte cell number	J:189122
	increased neutrophil cell number	J:189122
Zbtb46^tm2.1Mnz/Zbtb46^tm2.1Mnz (involves: C57BL/6)	abnormal dendritic cell morphology	J:191314
	decreased dendritic cell number	J:191314
	increased dendritic cell number	J:191314
Zc2hc1c^{em1(IMPC)Ccpcz}/Zc2hc1c^{em1(IMPC)Ccpcz} (C57BL/6N-Zc2hc1c^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Zc3h7a^em1(IMPC)J/Zc3h7a^em1(IMPC)J (C57BL/6NJ-Zc3h7a^em1(IMPC)J/Mmjax)	decreased mean corpuscular hemoglobin	J:211773
Zc3h7b^em1(IMPC)J/Zc3h7b^em1(IMPC)J (C57BL/6NJ-Zc3h7b^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Zc3h8^{em1(IMPC)Ccpcz}/Zc3h8⁺ (C57BL/6N-Zc3h8^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	decreased CD8-positive, naive alpha-beta T cell number	J:211773
	enlarged spleen	J:211773
Zc3h11a^em1(IMPC)Mbp/Zc3h11a⁺ (C57BL/6NCrl-Zc3h11a^em1(IMPC)Mbp/Mmucd)	abnormal thymus morphology	J:211773
	decreased erythrocyte cell number	J:211773
	decreased hematocrit	J:211773
	decreased hemoglobin content	J:211773
Zc3h12a^tm1Aki/Zc3h12a^tm1Aki (involves: 129X1/SvJ * C57BL/6)	abnormal class switch recombination	J:147868
	abnormal proerythroblast morphology	J:147868
	anemia	J:147868
	decreased hematocrit	J:147868
	decreased hemoglobin content	J:147868
	enlarged spleen	J:147868
	increased IgA level	J:147868
	increased IgG1 level	J:147868
	increased IgG2a level	J:147868
	increased IgG2b level	J:147868
	increased IgG3 level	J:147868
	increased IgM level	J:147868
	increased immunoglobulin level	J:147868
	increased leukocyte cell number	J:147868
	increased memory T cell number	J:147868
	increased plasma cell number	J:147868
	thrombocytosis	J:147868
Zc3h12a^{tm1b(EUCOMM)Hmgu}/Zc3h12a⁺ (C57BL/6N-Zc3h12a^{tm1b(EUCOMM)Hmgu}/Ieg)	increased mean corpuscular volume	J:211773
Zc3h12a^{tm1c(EUCOMM)Hmgu}/Zc3h12a^{tm1c(EUCOMM)Hmgu} Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: C57BL/6 * C57BL/6N * DBA)	enlarged spleen	J:304105
	increased IgG level	J:304105
	increased IgM level	J:304105
Zc3h12a^tm1Fum/Zc3h12a^tm1Fum (C57BL/6-Zc3h12a^tm1Fum)	enlarged spleen	J:176866
Zc3h12b^em1(IMPC)Tcp/Zc3h12b^em1(IMPC)Tcp (C57BL/6NCrl-Zc3h12b^em1(IMPC)Tcp/Tcp)	increased mean corpuscular hemoglobin concentration	J:211773
Zc3h12c^em1(IMPC)Tcp/Zc3h12c^em1(IMPC)Tcp (C57BL/6NCrl-Zc3h12c^em1(IMPC)Tcp/Tcp)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Zc3h12c^{tm2c(EUCOMM)Hmgu}/Zc3h12c^{tm2c(EUCOMM)Hmgu} Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6N)	increased B cell number	J:277714
	increased CD4-positive, alpha-beta T cell number	J:277714
	increased effector memory CD8-positive, alpha-beta T cell number	J:277714
	increased immature B cell number	J:277714
	increased marginal zone B cell number	J:277714
Zc3h12c^{tm2d(EUCOMM)Hmgu}/Zc3h12c^{tm2d(EUCOMM)Hmgu} (involves: 129S4/SvJaeSor * C57BL/6N)	decreased CD8-positive, alpha-beta T cell number	J:277714
	decreased germinal center B cell number	J:277714
	decreased macrophage cell number	J:277714
	extramedullary hematopoiesis	J:277714
	increased B cell number	J:277714
	increased CD4-positive, alpha-beta T cell number	J:277714
	increased effector memory CD4-positive, alpha-beta T cell number	J:277714
	increased IgA level	J:277714
	increased IgG level	J:277714
	increased IgM level	J:277714
	increased immature B cell number	J:277714
	increased marginal zone B cell number	J:277714
	increased myeloid cell number	J:277714
	increased splenocyte number	J:277714
	increased T cell number	J:277714
Zc3h12d^{tm1b(EUCOMM)Hmgu}/Zc3h12d^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Zc3h12d^{tm1b(EUCOMM)Hmgu}/Orl)	decreased lymphocyte cell number	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Zc3h12d^tm1Tom/Zc3h12d^tm1Tom (B6.Cg-Zc3h12d^tm1Tom)	increased T cell proliferation	J:209383
Zc3h12d^tm1Tom/Zc3h12d^tm1Tom (B6.Cg-Zc3h12d^tm1Tom)	increased T-helper 17 cell number	J:209383
Zc3h13^em1(IMPC)J/Zc3h13⁺ (C57BL/6NJ-Zc3h13^em1(IMPC)J/Mmjax)	decreased hemoglobin content	J:211773
Zc3hav1l^{tm1b(EUCOMM)Wtsi}/Zc3hav1l^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Zc3hav1l^{tm1b(EUCOMM)Wtsi}/Tcp)	increased eosinophil cell number	J:211773
Zcchc2^em1(IMPC)J/Zcchc2^em1(IMPC)J (C57BL/6NJ-Zcchc2^em1(IMPC)J/Mmjax)	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
Zcchc17^{em1(IMPC)Hmgu}/Zcchc17^{em1(IMPC)Hmgu} (C57BL/6NCrl-Zcchc17^{em1(IMPC)Hmgu}/Ieg)	increased mean platelet volume	J:211773
	increased spleen weight	J:211773
Zdbf2^em1(IMPC)J/Zdbf2^em1(IMPC)J (C57BL/6NJ-Zdbf2^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Zdhhc2^em1Eko/Zdhhc2^em1Eko (C57BL/6-Zdhhc2^em1Eko)	abnormal T cell activation	J:303593
	decreased dendritic epidermal T cell number	J:303593
	decreased leukocyte cell number	J:303593
	decreased plasmacytoid dendritic cell number	J:303593
	increased alpha-beta T cell number	J:303593
	increased gamma-delta T cell number	J:303593
Zdhhc5^{tm1e.1(EUCOMM)Hmgu}/Zdhhc5^{tm1e.1(EUCOMM)Hmgu} (C57BL/6NCrl-Zdhhc5^{tm1e.1(EUCOMM)Hmgu}/Ieg)	increased mean platelet volume	J:211773
Zdhhc9^tm1Lex/Y (involves: 129S5/SvEvBrd * C57BL/6)	abnormal bone marrow cell physiology	J:231488
	abnormal leukocyte physiology	J:231488
	hematopoietic system phenotype	J:231488
Zdhhc13^skc4/Zdhhc13^skc4 (involves: 129S6/SvEvTac * C3H * C57BL/6)	abnormal Kupffer cell morphology	J:161519
	decreased leukocyte cell number	J:161519
	enlarged spleen	J:161519
	increased neutrophil cell number	J:161519
Zdhhc23^{tm1.1(KOMP)Vlcg}/Zdhhc23^{tm1.1(KOMP)Vlcg} (C57BL/6N-Zdhhc23^{tm1.1(KOMP)Vlcg}/Ucd)	thrombocytosis	J:211773
Zeb1^m1Btlr/Zeb1^m1Btlr (involves: C57BL/6J)	abnormal B cell differentiation	J:185495
	abnormal class switch recombination	J:185495
	abnormal memory B cell physiology	J:185495
	absent marginal zone B cells	J:185495
	decreased B cell proliferation	J:185495
	decreased B-1 B cell number	J:185495
	decreased B-1a cell number	J:185495
	decreased B-1b cell number	J:185495
	decreased double-positive T cell number	J:185495
	decreased germinal center B cell number	J:185495
	decreased IgG1 level	J:185495
	decreased IgG level	J:185495
	decreased IgM level	J:185495
	decreased NK cell number	J:185495
	increased single-positive T cell number	J:185495
	increased thymocyte number	J:185495
Zeb1^tm1Yhi/Zeb1^tm1Yhi (B6.129P2-Zeb1^tm1Yhi)	abnormal T cell differentiation	J:39865
	abnormal T cell subpopulation ratio	J:39865
	abnormal thymus development	J:39865
	decreased CD8-positive, alpha-beta T cell number	J:39865
	decreased double-positive T cell number	J:39865
	decreased lymphocyte cell number	J:39865
	decreased splenocyte number	J:39865
	decreased T cell number	J:39865
	decreased thymocyte number	J:39865
	small thymus	J:39865
	thymus hypoplasia	J:39865
Zeb1^tm2Yhi/Zeb1^tm2Yhi (B6.129-Zeb1^tm2Yhi)	decreased thymocyte number	J:45575
Zeb1^tm2Yhi/Zeb1^tm2Yhi (B6.129-Zeb1^tm2Yhi)	thymus hypoplasia	J:45575
Zeb1^Tw/Zeb1⁺ (B6.Cg-Zeb1^Tw)	decreased leukocyte cell number	J:177274
	decreased lymphocyte cell number	J:177274
	decreased neutrophil cell number	J:177274
	small spleen	J:177274
	small thymus	J:177274
Zfand2b^tm1Otin/Zfand2b⁺ (involves: 129S7/SvEvBrd * C57BL/6)	hematopoietic system phenotype	J:233169
	increased granulocyte number	J:233169
Zfand2b^tm1Otin/Zfand2b^tm1Otin (involves: 129S7/SvEvBrd * C57BL/6)	abnormal bone marrow hematopoietic cell morphology	J:233169
	abnormal definitive hematopoiesis	J:233169
	abnormal hematopoietic stem cell morphology	J:233169
	abnormal hematopoietic stem cell physiology	J:233169
	abnormal myeloid cell morphology	J:233169
	abnormal myeloid leukocyte morphology	J:233169
	decreased bone marrow cell number	J:233169
	decreased lymphocyte cell number	J:233169
	decreased myeloid cell number in bone marrow	J:233169
	enlarged spleen	J:233169
	extramedullary hematopoiesis	J:233169
	increased bone marrow cell number	J:233169
	increased common myeloid progenitor cell number	J:233169
	increased granulocyte monocyte progenitor cell number	J:233169
	increased granulocyte number	J:233169
	increased hematocrit	J:233169
	increased hematopoietic stem cell number	J:233169
	increased leukocyte cell number	J:233169
	increased lymphocyte cell number	J:233169
	increased megakaryocyte-erythroid progenitor cell number	J:233169
	increased myeloid cell number	J:233169
	increased nucleated erythrocyte cell number	J:233169
	increased spleen weight	J:233169
	thrombocytosis	J:233169
Zfand3^em1(IMPC)J/Zfand3^em1(IMPC)J (C57BL/6NJ-Zfand3^em1(IMPC)J/Mmjax)	decreased erythrocyte cell number	J:211773
	decreased leukocyte cell number	J:211773
	increased mean corpuscular volume	J:211773
	thrombocytopenia	J:211773
Zfand6^em1(IMPC)Mbp/Zfand6^em1(IMPC)Mbp (C57BL/6N-Zfand6^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased mean corpuscular volume	J:211773
Zfat^{em1(IMPC)Ccpcz}/Zfat⁺ (C57BL/6NCrl-Zfat^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Zfat^tm1Sawa/Zfat^tm1Sawa (B6.Cg-Zfat^tm1Sawa)	abnormal embryonic hematopoiesis	J:163605
Zfat^tm2.1Sawa/Zfat^tm2.1Sawa Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * C57BL/6JJcl * C57BL/6NCrSlc * DBA/2)	abnormal CD4-positive, alpha-beta T cell physiology	J:187164
	abnormal CD8-positive, alpha-beta T cell differentiation	J:187164
	decreased CD4-positive, alpha-beta T cell number	J:187164
	decreased CD8-positive, alpha-beta T cell number	J:187164
	decreased T cell proliferation	J:187164
	increased T cell apoptosis	J:187164
Zfp7^em1(IMPC)J/Zfp7^em1(IMPC)J (C57BL/6NJ-Zfp7^em1(IMPC)J/Mmjax)	decreased mean corpuscular hemoglobin	J:211773
Zfp13^{tm1a(EUCOMM)Hmgu}/Zfp13^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Zfp13^{tm1a(EUCOMM)Hmgu}/Ics)	decreased hemoglobin content	J:165965
Zfp14^tm1Xch/Zfp14⁺ (involves: C57BL/6)	spleen hyperplasia	J:331393
Zfp14^tm1Xch/Zfp14⁺ (involves: C57BL/6)	thymus hyperplasia	J:331393
Zfp14^tm1Xch/Zfp14^tm1Xch (involves: C57BL/6)	spleen hyperplasia	J:331393
Zfp14^tm1Xch/Zfp14^tm1Xch (involves: C57BL/6)	thymus hyperplasia	J:331393
Zfp35^tm1Naka/Zfp35^tm1Naka (either: B6.Cg-Zfp35^tm1Naka or C.Cg-Zfp35^tm1Naka)	abnormal T-helper 2 cell differentiation	J:153828
	increased eosinophil cell number	J:153828
Zfp36^{tm1(KOMP)Vlcg}/Zfp36⁺ (C57BL/6N-Zfp36^{tm1(KOMP)Vlcg}/Nju)	decreased mean corpuscular volume	J:211773
	increased leukocyte cell number	J:211773
Zfp36^tm1Pjb/Zfp36^tm1Pjb (Not Specified)	abnormal thymus cortex morphology	J:33986
	abnormal thymus medulla morphology	J:33986
	enlarged spleen	J:33986
	extramedullary hematopoiesis	J:33986
	increased leukocyte cell number	J:33986
	spleen hyperplasia	J:33986
	thymus hypoplasia	J:33986
Zfp36^tm1Pjb/Zfp36^tm1Pjb (B6.Cg-Zfp36^tm1Pjb)	abnormal macrophage physiology	J:88443
	decreased lymphocyte cell number	J:214114
	increased granulocyte number	J:214114
	increased monocyte cell number	J:214114
	increased neutrophil cell number	J:214114
	thrombocytosis	J:214114
Zfp36^tm4.1Pjb/Zfp36^tm4.1Pjb Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N)	enlarged spleen	J:188677
	increased spleen weight	J:188677
Zfp36l1^tm1.1Tnr/Zfp36l1^tm1.1Tnr Zfp36l2^tm1.1Tnr/Zfp36l2^tm1.1Tnr Tg(CD2-icre)4Kio/0 (involves: C57BL/6 * C57BL/10 * CBA/Ca * SJL)	abnormal thymus development	J:162388
	enlarged spleen	J:162388
	thymus atrophy	J:162388
Zfp36l1^tm1Seb/Zfp36l1^tm1Seb (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	abnormal embryonic erythropoiesis	J:113396
	anemia	J:113396
Zfp36l2^tm2Pjb/Zfp36l2^tm2Pjb (involves: 129S7/SvEvBrd * C57BL/6)	abnormal bone marrow cell physiology	J:152911
	abnormal definitive hematopoiesis	J:152911
	abnormal embryonic hematopoiesis	J:152911
	anemia	J:152911
	decreased bone marrow cell number	J:152911
	decreased erythrocyte cell number	J:152911
	decreased hematocrit	J:152911
	decreased hemoglobin content	J:152911
	decreased leukocyte cell number	J:152911
	decreased neutrophil cell number	J:152911
	decreased splenocyte number	J:152911
	extramedullary hematopoiesis	J:152911
	increased nucleated erythrocyte cell number	J:152911
	pancytopenia	J:152911
	thrombocytopenia	J:152911
Zfp106^{tm1a(KOMP)Wtsi}/Zfp106⁺ (B6JTyr;B6N-Zfp106^{tm1a(KOMP)Wtsi}/Wtsi)	decreased mean corpuscular hemoglobin	J:165965
Zfp106^{tm1a(KOMP)Wtsi}/Zfp106^{tm1a(KOMP)Wtsi} (involves: C57BL/6Brd * C57BL/6Dnk * C57BL/6N)	microgliosis	J:229162
Zfp119a^{tm1b(EUCOMM)Hmgu}/Zfp119a^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Zfp119a^{tm1b(EUCOMM)Hmgu}/Ieg)	increased leukocyte cell number	J:211773
Zfp131^tm1.1Mytk/Zfp131^tm1.1Mytk Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * C57BL/6N * DBA/2)	abnormal T cell subpopulation ratio	J:271921
	abnormal thymocyte activation	J:271921
	decreased CD4-positive, alpha-beta T cell number	J:271921
	decreased CD8-positive, alpha-beta T cell number	J:271921
	decreased T cell number	J:271921
	decreased T cell proliferation	J:271921
Zfp131^tm1.1Mytk/Zfp131^tm1.2Mytk Tg(Lck-cre)1Jtak/0 (involves: C57BL/6N * FVB/N)	abnormal double-negative T cell morphology	J:271921
	abnormal T cell differentiation	J:271921
	arrested T cell differentiation	J:271921
	decreased CD4-positive, alpha-beta T cell number	J:271921
	decreased CD8-positive, alpha-beta T cell number	J:271921
	decreased DN2 thymocyte number	J:271921
	decreased DN3 thymocyte number	J:271921
	decreased DN4 thymocyte number	J:271921
	decreased double-negative T cell number	J:271921
	decreased double-positive T cell number	J:271921
	decreased T cell proliferation	J:271921
	decreased thymocyte number	J:271921
Zfp142^{tm1b(EUCOMM)Wtsi}/Zfp142^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Zfp142^{tm1b(EUCOMM)Wtsi}/Bay)	abnormal spleen morphology	J:211773
Zfp160^{tm1b(EUCOMM)Wtsi}/Zfp160^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Zfp160^{tm1b(EUCOMM)Wtsi}/BayMmucd)	decreased spleen weight	J:211773
Zfp174^em1(IMPC)J/Zfp174^em1(IMPC)J (C57BL/6NJ-Zfp174^em1(IMPC)J/J)	increased mean corpuscular hemoglobin concentration	J:211773
Zfp207^{tm1b(EUCOMM)Hmgu}/Zfp207⁺ (C57BL/6N-Zfp207^{tm1b(EUCOMM)Hmgu}/H)	decreased lymphocyte cell number	J:211773
	decreased mean corpuscular volume	J:211773
	increased neutrophil cell number	J:211773
Zfp219^{tm1b(EUCOMM)Hmgu}/Zfp219⁺ (C57BL/6N-Zfp219^{tm1b(EUCOMM)Hmgu}/Wtsi)	thrombocytosis	J:211773
Zfp236^em1(IMPC)Mbp/Zfp236⁺ (C57BL/6NCrl-Zfp236^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Zfp260^{tm1b(NCOM)Mfgc}/Zfp260⁺ (C57BL/6N-Zfp260^{tm1b(NCOM)Mfgc}/Tcp)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Zfp275^{tm1.1(NCOM)Mfgc}/Y (C57BL/6N-Zfp275^{tm1.1(NCOM)Mfgc}/Tcp)	decreased mean corpuscular hemoglobin concentration	J:211773
Zfp280d^{em1(IMPC)Hmgu}/Zfp280d^{em1(IMPC)Hmgu} (C57BL/6N-Zfp280d^{em1(IMPC)Hmgu}/Ieg)	decreased mean corpuscular hemoglobin concentration	J:211773
Zfp281^em1(IMPC)Mbp/Zfp281⁺ (C57BL/6N-Zfp281^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	small spleen	J:211773
Zfp292^em1Zfa/Zfp292^em1Zfa (involves: C57BL/6)	decreased common lymphocyte progenitor cell number	J:259392
Zfp318^m1Anu/Zfp318⁺ (C57BL/6JAnu-Zfp318^m1Anu)	decreased IgD level	J:207375
Zfp318^m1Anu/Zfp318⁺ (C57BL/6JAnu-Zfp318^m1Anu)	increased IgM level	J:207375
Zfp318^m1Anu/Zfp318^m1Anu (C57BL/6JAnu-Zfp318^m1Anu)	abnormal B cell number	J:104190
	abnormal follicular B cell physiology	J:207375
	abnormal marginal zone B cell physiology	J:207375
	decreased IgD level	J:207375, J:104190
	hematopoietic system phenotype	J:207375
	increased IgM level	J:207375, J:104190
	increased mature B cell number	J:207375
Zfp318^M1Btlr/Zfp318⁺ (C57BL/6J-Zfp318^M1Btlr)	decreased IgD level	J:218965
Zfp318^M1Btlr/Zfp318^M1Btlr (C57BL/6J-Zfp318^M1Btlr)	decreased IgD level	J:218965
Zfp318^tm1.1Jhws/Zfp318^tm1.1Jhws Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (B6.Cg-Zfp318^tm1.1Jhws Tg^Vav1-creA2Kio)	decreased IgD level	J:215815
	decreased transitional stage T2 B cell number	J:215815
	increased IgM level	J:215815
Zfp318^tm1Hhag/Zfp318^tm1Hhag (involves: 129 * C57BL/6)	decreased IgD level	J:207375
	hematopoietic system phenotype	J:207375
	increased IgM level	J:207375
Zfp335^blt/Zfp335^blt (involves: C57BL/6)	abnormal CD4-positive T cell differentiation	J:214793
	abnormal CD8-positive, alpha-beta T cell differentiation	J:214793
	abnormal T cell differentiation	J:214793
	decreased B cell number	J:214793
	decreased CD4-positive, alpha-beta memory T cell number	J:214793
	decreased CD4-positive, alpha-beta T cell number	J:214793
	decreased CD8-positive, alpha-beta memory T cell number	J:214793
	decreased CD8-positive, alpha-beta T cell number	J:214793
	decreased NK T cell number	J:214793
	decreased regulatory T cell number	J:214793
	decreased single-positive T cell number	J:214793
Zfp354a^em1(IMPC)Mbp/Zfp354a^em1(IMPC)Mbp (C57BL/6NCrl-Zfp354a^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Zfp366^b2b2834Clo/Zfp366^b2b2834Clo (C57BL/6J-Zfp366^b2b2834Clo)	thymus hypoplasia	J:175213
Zfp385a^tm1Ber/Zfp385a^tm1Ber (involves: 129S1/Sv * 129X1/SvJ * CD-1)	abnormal megakaryocyte morphology	J:93829
	abnormal platelet morphology	J:93829
	decreased platelet alpha-granule number	J:93829
Zfp445^{tm1b(EUCOMM)Hmgu}/Zfp445^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Zfp445^{tm1b(EUCOMM)Hmgu}/Ieg)	increased red blood cell distribution width	J:211773
Zfp462^em1(IMPC)Tcp/Zfp462⁺ (C57BL/6N-Zfp462^em1(IMPC)Tcp/Tcp)	thrombocytopenia	J:211773
Zfp467^{tm1.1(KOMP)Vlcg}/Zfp467^{tm1.1(KOMP)Vlcg} (B6(Cg)-Zfp467^{tm1.1(KOMP)Vlcg})	abnormal osteoclast physiology	J:302865
	increased osteoclast cell number	J:302865
Zfp469^em1(IMPC)Mbp/Zfp469^em1(IMPC)Mbp (C57BL/6N-Zfp469^em1(IMPC)Mbp/MbpMmucd)	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
Zfp474^{em1(IMPC)Ccpcz}/Zfp474^{em1(IMPC)Ccpcz} (C57BL/6N-Zfp474^{em1(IMPC)Ccpcz}/Ccpcz)	decreased lymphocyte cell number	J:211773
	increased eosinophil cell number	J:211773
	increased neutrophil cell number	J:211773
	increased red blood cell distribution width	J:211773
Zfp488^em1(IMPC)Bay/Zfp488^em1(IMPC)Bay (C57BL/6N-Zfp488^em1(IMPC)Bay/Bay)	abnormal spleen morphology	J:211773
Zfp503^em1(IMPC)Mbp/Zfp503⁺ (C57BL/6N-Zfp503^em1(IMPC)Mbp/Ucd)	increased basophil cell number	J:211773
Zfp513^em1(IMPC)J/Zfp513^em1(IMPC)J (C57BL/6NJ-Zfp513^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Zfp521^tm1Nohk/Zfp521^tm1Nohk (B6J.Cg-Zfp521^tm1Nohk)	decreased spleen weight	J:214267
Zfp521^tm1Nohk/Zfp521^tm1Nohk (B6J.Cg-Zfp521^tm1Nohk)	decreased thymus weight	J:214267
Zfp532^em1(IMPC)J/Zfp532⁺ (C57BL/6NJ-Zfp532^em1(IMPC)J/J)	decreased mean corpuscular volume	J:211773
	increased erythrocyte cell number	J:211773
	thrombocytosis	J:211773
Zfp536^{tm1.1(KOMP)Wtsi}/Zfp536⁺ (C57BL/6N-Zfp536^{tm1.1(KOMP)Wtsi}/Ucd)	increased hemoglobin content	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
Zfp593^em1(IMPC)J/Zfp593^em1(IMPC)J (C57BL/6NJ-Zfp593^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Zfp595^{tm1b(KOMP)Wtsi}/Zfp595^{tm1b(KOMP)Wtsi} (C57BL/6N-Zfp595^{tm1b(KOMP)Wtsi}/Bay)	decreased eosinophil cell number	J:211773
	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
Zfp612^em1(IMPC)J/Zfp612^em1(IMPC)J (C57BL/6NJ-Zfp612^em1(IMPC)J/J)	decreased mean corpuscular volume	J:211773
Zfp616^{tm1b(KOMP)Wtsi}/Zfp616^{tm1b(KOMP)Wtsi} (C57BL/6N-Zfp616^{tm1b(KOMP)Wtsi}/Wtsi)	increased KLRG1-positive T-helper cell number	J:211773
Zfp629^em1(IMPC)Tcp/Zfp629^em1(IMPC)Tcp (C57BL/6N-Zfp629^em1(IMPC)Tcp/Tcp)	small spleen	J:211773
Zfp637^{em1(IMPC)Wtsi}/Zfp637^{em1(IMPC)Wtsi} (C57BL/6N-Zfp637^{em1(IMPC)Wtsi}/Wtsi)	increased mean platelet volume	J:211773
Zfp638^em1(IMPC)J/Zfp638⁺ (C57BL/6NJ-Zfp638^em1(IMPC)J/Mmjax)	increased erythrocyte cell number	J:211773
	increased leukocyte cell number	J:211773
Zfp639^tm1.2Jaty/Zfp639^tm1.2Jaty (involves: 129 * BALB/cJ * C57BL/6 * SJL)	increased common myeloid progenitor cell number	J:305874
Zfp641^em1(IMPC)J/Zfp641^em1(IMPC)J (C57BL/6NJ-Zfp641^em1(IMPC)J/J)	decreased mean corpuscular volume	J:211773
	increased hemoglobin content	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
Zfp644^{em1(IMPC)Ccpcz}/Zfp644^{em1(IMPC)Ccpcz} (C57BL/6N-Zfp644^{em1(IMPC)Ccpcz}/Ccpcz)	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
Zfp683^{Gt(OST314703)Lex}/Zfp683^{Gt(OST314703)Lex} (B6.129S5-Zfp683^{Gt(OST314703)Lex})	abnormal NK T cell morphology	J:187727
	decreased NK T cell number	J:187727
Zfp689^{tm1.1(KOMP)Vlcg}/Zfp689^{tm1.1(KOMP)Vlcg} (C57BL/6N-Zfp689^{tm1.1(KOMP)Vlcg}/J)	decreased hematocrit	J:211773
	increased hemoglobin content	J:211773
	thrombocytosis	J:211773
Zfp729b^em1(IMPC)J/Zfp729b^em1(IMPC)J (C57BL/6NJ-Zfp729b^em1(IMPC)J/Mmjax)	decreased mean corpuscular hemoglobin	J:211773
Zfp760^{tm1a(EUCOMM)Hmgu}/Zfp760⁺ (C57BL/6N-Zfp760^{tm1a(EUCOMM)Hmgu}/Ieg)	decreased IgE level	J:165965
	increased erythrocyte cell number	J:165965
	increased hematocrit	J:165965
	thrombocytopenia	J:165965
Zfp787^em1(IMPC)J/Zfp787^em1(IMPC)J (C57BL/6NJ-Zfp787^em1(IMPC)J/Mmjax)	thrombocytopenia	J:211773
Zfp804a^em1(IMPC)Tcp/Zfp804a^em1(IMPC)Tcp (C57BL/6N-Zfp804a^em1(IMPC)Tcp/Tcp)	increased mean corpuscular volume	J:211773
	thrombocytopenia	J:211773
Zfp871^{tm1a(EUCOMM)Wtsi}/Zfp871⁺ (C57BL/6N-Zfp871^{tm1a(EUCOMM)Wtsi}/BayMmucd)	spleen hyperplasia	J:317166
	thymus hyperplasia	J:317166
Zfp950^{Gt(ROSA)76Sor}/Zfp950^{Gt(ROSA)76Sor} (involves: 129S4/SvJaeSor)	anemia	J:117491
	decreased erythrocyte cell number	J:117491
	decreased hematocrit	J:117491
	decreased hemoglobin content	J:117491
	polychromatophilia	J:117491
	reticulocytosis	J:117491
Zfpm1^tm1.1Esv/Zfpm1^tm1.1Esv (involves: 129S6/SvEvTac * C57BL/6)	abnormal bone marrow cell number	J:156475
	abnormal common myeloid progenitor cell morphology	J:156475
	abnormal erythropoiesis	J:156475
	abnormal megakaryocyte differentiation	J:156475
	abnormal megakaryocyte progenitor cell morphology	J:156475
	abnormal spleen morphology	J:156475
	decreased megakaryocyte cell number	J:156475
	extramedullary hematopoiesis	J:156475
	increased erythrocyte cell number	J:156475
	increased erythroid progenitor cell number	J:156475
	increased granulocyte number	J:156475
	increased hemoglobin concentration distribution width	J:156475
	increased mean platelet volume	J:156475
	increased neutrophil cell number	J:156475
	increased spleen red pulp amount	J:156475
	increased spleen weight	J:156475
	thrombocytopenia	J:156475
Zfpm1^tm1.1Geab/Zfpm1⁺ (Not Specified)	increased hemoglobin concentration distribution width	J:156393
Zfpm1^tm1.1Geab/Zfpm1⁺ (Not Specified)	thrombocytopenia	J:156393
Zfpm1^tm1.1Geab/Zfpm1^tm1.1Geab (Not Specified)	abnormal erythropoiesis	J:156393
	abnormal megakaryocyte morphology	J:156393
	abnormal megakaryocyte progenitor cell morphology	J:156393
	abnormal platelet morphology	J:156393
	anemia	J:156393
	decreased erythroid progenitor cell number	J:156393
	decreased platelet alpha-granule number	J:156393
	decreased spleen white pulp amount	J:156393
	enlarged spleen	J:156393
	extramedullary hematopoiesis	J:156393
	hematopoietic system phenotype	J:156393
	increased hemoglobin concentration distribution width	J:156393
	increased mean platelet volume	J:156393
	increased monocyte cell number	J:156393
	increased neutrophil cell number	J:156393
	increased red blood cell distribution width	J:156393
	increased spleen weight	J:156393
	reticulocytosis	J:156393
	spleen hypoplasia	J:156393
	thrombocytopenia	J:156393, J:162629
Zfpm1^tm1Sho/Zfpm1^tm1Sho (either: (involves: 129S1/Sv) or (involves: 129S1/Sv * C57BL/6))	abnormal embryonic erythropoiesis	J:47281
	abnormal erythropoiesis	J:47281
	abnormal megakaryocyte differentiation	J:47281
	anemia	J:47281
	impaired hematopoiesis	J:47281
Zfpm1^tm1Sho/Zfpm1^tm1Sho (involves: 129S1/Sv)	abnormal erythropoiesis	J:77724
Zfpm1^tm1Sho/Zfpm1^tm1Sho (involves: 129S1/Sv)	abnormal megakaryocyte progenitor cell morphology	J:77724
Zfpm1^tm2Sho/Zfpm1^tm2Sho (either: (involves: 129S1/Sv) or (involves: 129S1/Sv * C57BL/6))	abnormal embryonic erythropoiesis	J:47281
	abnormal erythropoiesis	J:47281
	abnormal megakaryocyte differentiation	J:47281
	anemia	J:47281
	impaired hematopoiesis	J:47281
Zftraf1^em1(IMPC)H/Zftraf1^em1(IMPC)H (C57BL/6NTac-Zftraf1^em1(IMPC)H/H)	decreased eosinophil cell number	J:211773
	decreased red blood cell distribution width	J:211773
Zfx^tm1.1Reiz/Y Gt(ROSA)26Sor^{tm1(cre/ERT2)Thl}/Gt(ROSA)26Sor⁺ (involves: 129/Sv * 129S6/SvEvTac)	abnormal common lymphocyte progenitor cell morphology	J:149654
	abnormal hematopoietic system physiology	J:149654
	decreased hematopoietic stem cell number	J:149654
Zfx^tm1.1Reiz/Y Tg(Mx1-cre)1Cgn/0 (involves: 129S6/SvEvTac * C57BL/6 * CBA)	abnormal common lymphocyte progenitor cell morphology	J:149654
	abnormal hematopoietic system physiology	J:149654
	decreased hematopoietic stem cell number	J:149654
	decreased lymphocyte cell number	J:149654
	impaired hematopoiesis	J:149654
Zfx^tm1.1Reiz/Y Tg(Tek-cre)12Flv/0 (involves: 129S6/SvEvTac * C3H * C57BL/6)	abnormal common lymphocyte progenitor cell morphology	J:149654
	abnormal hematopoietic system physiology	J:149654
	decreased hematopoietic stem cell number	J:149654
	decreased mature B cell number	J:149654
	decreased T cell number	J:149654
Zfx^tm1.2Reiz/Y (involves: 129S6/SvEvTac * C57BL/6 * DBA/2)	decreased hematopoietic stem cell number	J:149654
Zfx^tm1.2Reiz/Zfx^tm1.2Reiz (involves: 129S6/SvEvTac * C57BL/6 * DBA/2)	decreased hematopoietic stem cell number	J:149654
Zfyve16^{tm2a(KOMP)Wtsi}/Zfyve16^{tm2a(KOMP)Wtsi} (C57BL/6N-Zfyve16^{tm2a(KOMP)Wtsi})	decreased B cell number	J:302014
	decreased B cell proliferation	J:302014
	increased common lymphocyte progenitor cell number	J:302014
	increased T cell number	J:302014
Zfyve26^em1(IMPC)J/Zfyve26^em1(IMPC)J (C57BL/6NJ-Zfyve26^em1(IMPC)J/J)	decreased mean corpuscular hemoglobin	J:211773
Zic2^iso/Zic2^iso (involves: C3H/HeH * C57BL/6)	abnormal spleen morphology	J:268103
	abnormal spleen size	J:268103
	absent spleen	J:268103
Zic3^tm1Bca/Y (involves: 129S7/SvEvBrd * C57BL/6)	spleen hypoplasia	J:75951
Zic3^tm1Bca/Zic3⁺ (involves: 129S7/SvEvBrd * C57BL/6)	spleen hypoplasia	J:75951
Zic3^tm1Bca/Zic3^tm1Bca (involves: 129S7/SvEvBrd * C57BL/6)	spleen hypoplasia	J:75951
Zkscan7^em1(IMPC)Mbp/Zkscan7^em1(IMPC)Mbp (C57BL/6N-Zkscan7^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Zkscan17^{tm1b(EUCOMM)Wtsi}/Zkscan17⁺ (C57BL/6N-Zkscan17^{tm1b(EUCOMM)Wtsi}/Wtsi)	thrombocytopenia	J:211773
Zmiz1^tm1Zsu/Zmiz1^tm1Zsu (involves: 129S6/SvEvTac * C57BL/6J)	hematopoietic system phenotype	J:128915
Zmpste24^tm1Otin/Zmpste24^tm1Otin (involves: 129P2/Ola * C57BL/6)	abnormal thymus corticomedullary boundary morphology	J:76209
	thymus hypoplasia	J:76209
Zmym2^em1(IMPC)J/Zmym2⁺ (C57BL/6NJ-Zmym2^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Zmynd8^{tm1a(EUCOMM)Wtsi}/Zmynd8⁺ (B6JTyr;B6N-Zmynd8^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased mean corpuscular hemoglobin	J:175295
Znhit2^em1(IMPC)J/Znhit2⁺ (C57BL/6NJ-Znhit2^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Zranb1^{tm1a(EUCOMM)Hmgu}/Zranb1^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Zranb1^{tm1a(EUCOMM)Hmgu}/Ics)	thrombocytosis	J:211773
Zranb1^{tm1c(EUCOMM)Hmgu}/Zranb1^{tm1c(EUCOMM)Hmgu} Tg(Itgax-cre)1-1Reiz/0 (involves: 129S4/SvJaeSor * C57BL/6N * CBA)	decreased T helper 1 cell number	J:235701
	decreased T-helper 17 cell number	J:235701
Zranb1^{tm1d(EUCOMM)Hmgu}/Zranb1^{tm1d(EUCOMM)Hmgu} (involves: 129S4/SvJaeSor * BALB/cJ * C57BL/6N)	decreased CD4-positive, alpha-beta T cell number	J:235701
	decreased T helper 1 cell number	J:235701
	decreased T-helper 17 cell number	J:235701
Zrsr2^em1(IMPC)Mbp/Y (C57BL/6N-Zrsr2^em1(IMPC)Mbp/MbpMmucd)	decreased lymphocyte cell number	J:211773
Zrsr2^em1(IMPC)Mbp/Y (C57BL/6N-Zrsr2^em1(IMPC)Mbp/MbpMmucd)	increased neutrophil cell number	J:211773
Zscan10^{Gt(285B6)1.1Cmhd}/Zscan10^{Gt(285B6)1.1Cmhd} (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)	abnormal IgG level	J:221010
	abnormal T cell subpopulation ratio	J:221010
	decreased spleen weight	J:221010
	decreased T cell number	J:221010
	increased B cell number	J:221010
	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:221010
	increased IgG1 level	J:221010
	increased IgG2b level	J:221010
	increased mature NK cell number	J:221010
	increased mean platelet volume	J:221010
	thrombocytopenia	J:221010
Zswim1^{tm1b(KOMP)Mbp}/Zswim1^{tm1b(KOMP)Mbp} (C57BL/6N-Zswim1^{tm1b(KOMP)Mbp}/Nju)	decreased hematocrit	J:211773
	decreased lymphocyte cell number	J:211773
	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
	decreased monocyte cell number	J:211773
	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
	increased erythrocyte cell number	J:211773
	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
	increased mean corpuscular hemoglobin concentration	J:211773
	increased mean platelet volume	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
	increased red blood cell distribution width	J:211773
Zswim6^em1(IMPC)J/Zswim6⁺ (C57BL/6NJ-Zswim6^em1(IMPC)J/Mmjax)	increased mean corpuscular hemoglobin	J:211773
Zwilch^{tm1.1(KOMP)Vlcg}/Zwilch⁺ (C57BL/6N-Zwilch^{tm1.1(KOMP)Vlcg}/J)	increased mean corpuscular hemoglobin	J:211773
Zzef1^{tm2.1(KOMP)Vlcg}/Zzef1^{tm2.1(KOMP)Vlcg} (B6N(Cg)-Zzef1^{tm2.1(KOMP)Vlcg}/J)	increased mean corpuscular hemoglobin	J:211773

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 04/09/2024 MGI 6.23